# RGD-PIPELINE: ftp-file-extracts
# MODULE: annotations-version-1.2.0 (Jul 27, 2026)
# GENERATED-ON: 2026/08/15
# PURPOSE: annotations about active Human objects extracted from RGD database
# ONTOLOGY: ChEBI: ChEBI Ontology
# CONTACT: rgd.data@mcw.edu
# FORMAT: tab delimited text
# NOTES: multiple values in a single column are separated by '|'
#
# MIGRATION NOTE (July 2026): these files were previously located in the
#   'annotated_rgd_objects_by_ontology/with_terms' directory and named using the organism
#   genus (f.e. 'rattus_terms_go'). They are now located in the 'annotations/with_terms' directory,
#   named with the RGD species short name (f.e. 'rat_terms_go.txt.gz'), and gzip-compressed.
#
#COLUMN INFORMATION:
#
#1   RGD_ID	          unique RGD_ID of the annotated object
#2   OBJECT_SYMBOL      official symbol of the annotated object
#3   OBJECT_NAME        official name of the annotated object
#4   OBJECT_TYPE        annotated object data type: one of ['gene','qtl','strain']
#5   TERM_ACC_ID        ontology term accession id
#6   TERM_NAME          ontology term name
#7   QUALIFIER          optional qualifier
#8   EVIDENCE           evidence
#9   WITH               with info
#10  ASPECT             aspect
#11  REFERENCES         db references (Reference RGDID|PUBMED ID)
#12  CREATED_DATE       created date
#13  ASSIGNED_BY        assigned by
#14  MESH_OMIM_ID       MESH:xxx or OMIM:xxx id corresponding to RDO:xxx id found in TERM_ACC_ID column (RGD/CTD Disease Ontology annotations only)
#15  CURATION_NOTES     curation notes provided by RGD curators
#16  ORIGINAL_REFERENCE original reference
RGD_ID	OBJECT_SYMBOL	OBJECT_NAME	OBJECT_TYPE	TERM_ACC_ID	TERM_NAME	QUALIFIER	EVIDENCE	WITH	ASPECT	REFERENCES	CREATED_DATE	ASSIGNED_BY	MESH_OMIM_ID	CURATION_NOTES	ORIGINAL_REFERENCE
10002683	LINC01416	long independently transcribed non-coding RNA 1416	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of LINC01416 mRNA	PMID:41430723
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:408345430	E	RGD:6480464	20241105	CTD	MESH:C084079	triptonide affects the expression of TTC41 mRNA	PMID:33045310
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20150428	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of TTC41P mRNA	PMID:24763279
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:408345430	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TTC41 mRNA	PMID:39241906
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TTC41P gene	PMID:27153756
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:408345430	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTC41 mRNA	PMID:40504410
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTC41P mRNA	PMID:34032870
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:408345430	E	RGD:6480464	20241105	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTC41 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTC41 mRNA	PMID:34876320|PMID:40504410
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:408345430	E	RGD:6480464	20241105	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTC41 mRNA	PMID:34876320
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:408345430	E	RGD:6480464	20241105	CTD	MESH:C009495	titanium dioxide results in decreased expression of TTC41 mRNA	PMID:35295148
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1302940	E	RGD:6480464	20211102	CTD	MESH:C006780	bisphenol A results in decreased expression of TTC41 mRNA; bisphenol A results in decreased expression of TTC41P mRNA	PMID:25181051|PMID:34947998
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:408345430	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in decreased expression of TTC41 mRNA	PMID:32156529
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1302940	E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in increased expression of TTC41 mRNA	PMID:32528016
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:408345430	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TTC41 mRNA	PMID:38685157
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TTC41P mRNA	PMID:38568856
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:408345430	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTC41 mRNA	PMID:40504410
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:408345430	E	RGD:6480464	20241105	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTC41 mRNA	PMID:34876320
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:408345430	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TTC41 mRNA	PMID:38701926
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:63618	pravastatin	decreases expression	ISO	RGD:408345430	E	RGD:6480464	20241105	CTD	MESH:D017035	Pravastatin results in decreased expression of TTC41 mRNA	PMID:27225895
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:408345430	E	RGD:6480464	20241105	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of TTC41 mRNA	PMID:31388691
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:408345430	E	RGD:6480464	20241105	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with Pioglitazone] results in decreased expression of TTC41 mRNA	PMID:27935865
10002693	TTC41P	tetratricopeptide repeat domain 41, pseudogene	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:408345430	E	RGD:6480464	20241105	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTC41 mRNA	PMID:34876320
10002854	MCPH1-AS1	MCPH1 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of MCPH1-AS1 mRNA	PMID:29301061|PMID:38568856
10002854	MCPH1-AS1	MCPH1 antisense RNA 1	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of MCPH1-AS1 mRNA	PMID:31745603
10002854	MCPH1-AS1	MCPH1 antisense RNA 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MCPH1-AS1 mRNA	PMID:38568856
10002854	MCPH1-AS1	MCPH1 antisense RNA 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of MCPH1-AS1 mRNA	PMID:31629900
10002866	LINC01607	long independently transcribed non-coding RNA 1607	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of LINC01607 mRNA	PMID:39245080
10002876	LINC01608	long independently transcribed non-coding RNA 1608	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01608 intron	PMID:30157460
10002876	LINC01608	long independently transcribed non-coding RNA 1608	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of LINC01608 mRNA	PMID:28988120
10002894	UBR5-DT	UBR5 divergent transcript	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of UBR5-DT mRNA	PMID:32763439
10002903	LINC01606	long independently transcribed non-coding RNA 1606	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC01606 intron	PMID:30157460
10002903	LINC01606	long independently transcribed non-coding RNA 1606	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01606 intron	PMID:30157460
10002903	LINC01606	long independently transcribed non-coding RNA 1606	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of LINC01606 mRNA	PMID:28988120
10002925	LINC01605	long independently transcribed non-coding RNA 1605	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in decreased expression of LINC01605 mRNA	PMID:28986285
10002925	LINC01605	long independently transcribed non-coding RNA 1605	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC01605 mRNA	PMID:30851411
10002925	LINC01605	long independently transcribed non-coding RNA 1605	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01605 mRNA	PMID:29301061
10002925	LINC01605	long independently transcribed non-coding RNA 1605	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01605 mRNA	PMID:38568856|PMID:39719251
10002925	LINC01605	long independently transcribed non-coding RNA 1605	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of LINC01605 mRNA	PMID:31715268
10002925	LINC01605	long independently transcribed non-coding RNA 1605	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC01605 intron	PMID:30157460
10002925	LINC01605	long independently transcribed non-coding RNA 1605	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of LINC01605 mRNA	PMID:31629900
10002925	LINC01605	long independently transcribed non-coding RNA 1605	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC01605 intron	PMID:30157460
10002925	LINC01605	long independently transcribed non-coding RNA 1605	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC01605 mRNA	PMID:30851411
10002925	LINC01605	long independently transcribed non-coding RNA 1605	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC01605 mRNA	PMID:38568856
10002948	MINCR	MYC-induced long non-coding RNA	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MINCR mRNA	PMID:38218311
10002948	MINCR	MYC-induced long non-coding RNA	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of MINCR mRNA	PMID:24768652
10002948	MINCR	MYC-induced long non-coding RNA	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MINCR mRNA	PMID:38568856
10002948	MINCR	MYC-induced long non-coding RNA	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MINCR mRNA	PMID:38832940
10002959	CA3-AS1	CA3 antisense RNA 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CA3-AS1 mRNA	PMID:30851411
10002959	CA3-AS1	CA3 antisense RNA 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CA3-AS1 mRNA	PMID:30851411
10002976	PKIA-AS1	PKIA antisense RNA 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of PKIA-AS1 mRNA	PMID:41028656
10002976	PKIA-AS1	PKIA antisense RNA 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of PKIA-AS1 mRNA	PMID:41028656
10002976	PKIA-AS1	PKIA antisense RNA 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:D001564	[AHR gene mutant form affects the susceptibility to Benzo(a)pyrene] which results in increased expression of PKIA-AS1	PMID:38036013
10002976	PKIA-AS1	PKIA antisense RNA 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of PKIA-AS1 mRNA	PMID:41028656
10002985	LINC01609	long independently transcribed non-coding RNA 1609	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC01609 polyA tail	PMID:30157460
10002985	LINC01609	long independently transcribed non-coding RNA 1609	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01609 mRNA	PMID:41028656
10002985	LINC01609	long independently transcribed non-coding RNA 1609	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01609 mRNA	PMID:41028656
10002985	LINC01609	long independently transcribed non-coding RNA 1609	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01609 polyA tail	PMID:30157460
10002985	LINC01609	long independently transcribed non-coding RNA 1609	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01609 mRNA	PMID:41028656
10002996	PARTICL	promoter of MAT2A antisense radiation-induced circulating long non-coding RNA	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1613016	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of PARTICL mRNA	PMID:40945087
10002996	PARTICL	promoter of MAT2A antisense radiation-induced circulating long non-coding RNA	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1613016	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PARTICL mRNA	PMID:39241906
10002996	PARTICL	promoter of MAT2A antisense radiation-induced circulating long non-coding RNA	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PARTICL mRNA	PMID:27392435
10002996	PARTICL	promoter of MAT2A antisense radiation-induced circulating long non-coding RNA	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1613016	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of PARTICL mRNA	PMID:38685157
10002996	PARTICL	promoter of MAT2A antisense radiation-induced circulating long non-coding RNA	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PARTICL mRNA	PMID:38832940
10002996	PARTICL	promoter of MAT2A antisense radiation-induced circulating long non-coding RNA	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1613016	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PARTICL mRNA	PMID:28973697
10003000	LINC01602	long independently transcribed non-coding RNA 1602	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01602 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01602 mRNA	PMID:35811015
10003000	LINC01602	long independently transcribed non-coding RNA 1602	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150505	CTD	MESH:D000082	Acetaminophen results in decreased expression of LINC01602 mRNA	PMID:22230336
10003000	LINC01602	long independently transcribed non-coding RNA 1602	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC01602 mRNA	PMID:35811015
10003000	LINC01602	long independently transcribed non-coding RNA 1602	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01602 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01602 mRNA	PMID:35811015
10003008	RDH10-AS1	RDH10 antisense RNA 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RDH10-AS1 mRNA	PMID:37199045
10040878	CROCC2	ciliary rootlet coiled-coil, rootletin family member 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1621187	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CROCC2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CROCC2 mRNA	PMID:34911549
10040878	CROCC2	ciliary rootlet coiled-coil, rootletin family member 2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1621187	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of CROCC2 mRNA	PMID:32186404
10040878	CROCC2	ciliary rootlet coiled-coil, rootletin family member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CROCC2 intron	PMID:30157460
10040878	CROCC2	ciliary rootlet coiled-coil, rootletin family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CROCC2 mRNA	PMID:38036013
10040878	CROCC2	ciliary rootlet coiled-coil, rootletin family member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1621187	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of CROCC2 mRNA	PMID:40203079
10040878	CROCC2	ciliary rootlet coiled-coil, rootletin family member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621187	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CROCC2 mRNA	PMID:30951980
10040878	CROCC2	ciliary rootlet coiled-coil, rootletin family member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1621187	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in decreased expression of CROCC2 mRNA]	PMID:40203079
10040878	CROCC2	ciliary rootlet coiled-coil, rootletin family member 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1621187	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CROCC2 mRNA	PMID:30951980
10040878	CROCC2	ciliary rootlet coiled-coil, rootletin family member 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1621187	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CROCC2 mRNA	PMID:27106021
10043079	AK6P1	adenylate kinase 6 pseudogene 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of AK6P1 mRNA	PMID:40706910
10043458	GTF2IP20	general transcription factor IIi pseudogene 20	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of GTF2IP20 mRNA	PMID:38218311
10043458	GTF2IP20	general transcription factor IIi pseudogene 20	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GTF2IP20 mRNA	PMID:35811015
10043458	GTF2IP20	general transcription factor IIi pseudogene 20	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of GTF2IP20 mRNA	PMID:38568856
10043458	GTF2IP20	general transcription factor IIi pseudogene 20	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of GTF2IP20 mRNA	PMID:33212167
10043458	GTF2IP20	general transcription factor IIi pseudogene 20	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GTF2IP20 mRNA	PMID:26472689
10043458	GTF2IP20	general transcription factor IIi pseudogene 20	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GTF2IP20 mRNA	PMID:35811015
10043509	TUBB8B	tubulin beta 8B	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of TUBB8B protein	PMID:31195006
10043521	LRP1-AS	LRP1 antisense RNA	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LRP1-AS mRNA	PMID:35811015
10043521	LRP1-AS	LRP1 antisense RNA	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRP1-AS mRNA	PMID:35811015
10043521	LRP1-AS	LRP1 antisense RNA	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRP1-AS mRNA	PMID:35811015
10043559	GTF2IP4	general transcription factor IIi pseudogene 4	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of GTF2IP4 mRNA	PMID:38218311
10043559	GTF2IP4	general transcription factor IIi pseudogene 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GTF2IP4 mRNA	PMID:29803840
10043559	GTF2IP4	general transcription factor IIi pseudogene 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GTF2IP4 mRNA	PMID:38568856
10043559	GTF2IP4	general transcription factor IIi pseudogene 4	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of GTF2IP4 mRNA	PMID:31533062
10043559	GTF2IP4	general transcription factor IIi pseudogene 4	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	fipronil results in increased expression of GTF2IP4 mRNA	PMID:28991164
10043559	GTF2IP4	general transcription factor IIi pseudogene 4	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in increased expression of GTF2IP4 mRNA	PMID:28991164
10043559	GTF2IP4	general transcription factor IIi pseudogene 4	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in increased expression of GTF2IP4 mRNA	PMID:28991164
10045714	BCLAF1P2	BCL2 associated transcription factor 1 pseudogene 2	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C008261	lead acetate results in decreased expression of BCLAF1P2 mRNA	PMID:37939567
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of UQCRHL mRNA	PMID:33647349
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UQCRHL mRNA	PMID:35301059
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of UQCRHL mRNA	PMID:27392435
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in decreased expression of UQCRHL mRNA	PMID:32368861
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D012402	PSME4 protein promotes the reaction [Rotenone results in decreased expression of UQCRHL protein]	PMID:32368861
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UQCRHL mRNA	PMID:30851411
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of UQCRHL mRNA	PMID:32763439
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of UQCRHL mRNA	PMID:37690743
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UQCRHL mRNA	PMID:37042841
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UQCRHL mRNA	PMID:35301059
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of UQCRHL mRNA	PMID:31533062
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of UQCRHL mRNA	PMID:26352163
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of UQCRHL mRNA	PMID:29067470
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UQCRHL mRNA	PMID:30851411
10045718	UQCRHL	ubiquinol-cytochrome c reductase hinge protein like	gene	CHEBI:94688	5-methyl-4-oxido-2-pyrazin-4-iumcarboxylic acid	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C027696	acipimox results in increased expression of UQCRHL mRNA	PMID:25352640
10045737	TP53TG3F	TP53 target 3 family member F	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of TP53TG3F mRNA	PMID:38825487
10045909	KLF18	KLF transcription factor 18	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of KLF18 mRNA	PMID:41028656
10045909	KLF18	KLF transcription factor 18	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of KLF18 mRNA	PMID:41028656
10045909	KLF18	KLF transcription factor 18	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of KLF18 mRNA	PMID:41028656
10045909	KLF18	KLF transcription factor 18	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1310095	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP353 mRNA	PMID:25181051
10045919	SNHG25	small nucleolar RNA host gene 25	gene	CHEBI:16170	mercury(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008628	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNHG25 mRNA	PMID:32949613
10045919	SNHG25	small nucleolar RNA host gene 25	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNHG25 mRNA	PMID:32949613
10045919	SNHG25	small nucleolar RNA host gene 25	gene	CHEBI:25195	mercury atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008628	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNHG25 mRNA	PMID:32949613
10045919	SNHG25	small nucleolar RNA host gene 25	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SNHG25 mRNA	PMID:34089799
10045919	SNHG25	small nucleolar RNA host gene 25	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C027561	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNHG25 mRNA	PMID:32949613
10045919	SNHG25	small nucleolar RNA host gene 25	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C012125	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNHG25 mRNA	PMID:32949613
10045919	SNHG25	small nucleolar RNA host gene 25	gene	CHEBI:37187	lead nitrate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017461	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in increased expression of SNHG25 mRNA	PMID:32949613
10053574	GSG1L2	GSG1 like 2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:2293965	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of GSG1L2 mRNA	PMID:27131904
10053574	GSG1L2	GSG1 like 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of GSG1L2 mRNA	PMID:40706910
10053574	GSG1L2	GSG1 like 2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:2293965	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of GSG1L2 mRNA	PMID:27131904
10053891	FRG1JP	FSHD region gene 1 family member J, pseudogene	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FRG1JP mRNA	PMID:31533062
10053891	FRG1JP	FSHD region gene 1 family member J, pseudogene	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	fipronil results in decreased expression of FRG1JP mRNA	PMID:28991164
10053891	FRG1JP	FSHD region gene 1 family member J, pseudogene	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of FRG1JP mRNA	PMID:28991164
10053891	FRG1JP	FSHD region gene 1 family member J, pseudogene	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of FRG1JP mRNA	PMID:28991164
10053911	FRG1HP	FSHD region gene 1 family member H, pseudogene	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of FRG1HP mRNA	PMID:31614463
10053911	FRG1HP	FSHD region gene 1 family member H, pseudogene	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FRG1HP mRNA	PMID:30851411
10053911	FRG1HP	FSHD region gene 1 family member H, pseudogene	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FRG1HP mRNA	PMID:31533062
10053911	FRG1HP	FSHD region gene 1 family member H, pseudogene	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of FRG1HP mRNA	PMID:40419075
10053911	FRG1HP	FSHD region gene 1 family member H, pseudogene	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of FRG1HP mRNA	PMID:28991164
10053911	FRG1HP	FSHD region gene 1 family member H, pseudogene	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of FRG1HP mRNA	PMID:28991164
10053911	FRG1HP	FSHD region gene 1 family member H, pseudogene	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FRG1HP mRNA	PMID:30851411
10053938	FRG1CP	FSHD region gene 1 family member C, pseudogene	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FRG1CP mRNA	PMID:21867686
10053938	FRG1CP	FSHD region gene 1 family member C, pseudogene	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FRG1CP mRNA	PMID:33212167
10053938	FRG1CP	FSHD region gene 1 family member C, pseudogene	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of FRG1CP mRNA	PMID:32763439
10053938	FRG1CP	FSHD region gene 1 family member C, pseudogene	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of FRG1CP mRNA	PMID:39719251
10053938	FRG1CP	FSHD region gene 1 family member C, pseudogene	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FRG1CP mRNA	PMID:38568856
10054344	DANT2	DXZ4 associated non-coding transcript 2, distal	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of DANT2 mRNA	PMID:29301061
10054362	LCAL1	lung cancer associated lncRNA 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of LCAL1 mRNA	PMID:38568856
10054362	LCAL1	lung cancer associated lncRNA 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of LCAL1 mRNA	PMID:29955902
10054362	LCAL1	lung cancer associated lncRNA 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LCAL1 mRNA	PMID:38568856
10054362	LCAL1	lung cancer associated lncRNA 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LCAL1 mRNA	PMID:38568856
10054362	LCAL1	lung cancer associated lncRNA 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of LCAL1 mRNA	PMID:24449571
10054362	LCAL1	lung cancer associated lncRNA 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LCAL1 mRNA	PMID:38832940
10059032	LINC01456	long independently transcribed non-coding RNA 1456	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01456 intron	PMID:30157460
10059032	LINC01456	long independently transcribed non-coding RNA 1456	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01456 polyA tail	PMID:30157460
10059032	LINC01456	long independently transcribed non-coding RNA 1456	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC01456 polyA tail	PMID:30157460
10059032	LINC01456	long independently transcribed non-coding RNA 1456	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC01456 polyA tail	PMID:30157460
10059043	KCNK15-AS1	KCNK15 and WISP2 antisense RNA 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KCNK15-AS1 intron	PMID:30157460
10059043	KCNK15-AS1	KCNK15 and WISP2 antisense RNA 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of KCNK15-AS1 intron	PMID:30157460
10059043	KCNK15-AS1	KCNK15 and WISP2 antisense RNA 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of KCNK15-AS1 intron	PMID:30157460
10059045	PCSK6-AS1	PCSK6 antisense RNA 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PCSK6-AS1 mRNA	PMID:30851411
10059045	PCSK6-AS1	PCSK6 antisense RNA 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PCSK6-AS1 mRNA	PMID:30851411
10059050	FAM30C	family with sequence similarity 30 member C	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FAM30C intron	PMID:30157460
10059080	LINC01173	long independently transcribed non-coding RNA 1173	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01173 intron	PMID:30157460
10059083	GRPEL2-AS1	GRPEL2 antisense RNA 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GRPEL2-AS1 mRNA	PMID:30851411
10059083	GRPEL2-AS1	GRPEL2 antisense RNA 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of GRPEL2-AS1 mRNA	PMID:28988120
10059083	GRPEL2-AS1	GRPEL2 antisense RNA 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GRPEL2-AS1 mRNA	PMID:30851411
10059095	TBC1D3E	TBC1 domain family member 3E	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TBC1D3E mRNA	PMID:37042841
10059095	TBC1D3E	TBC1 domain family member 3E	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of TBC1D3E promoter	PMID:30157460
10059095	TBC1D3E	TBC1 domain family member 3E	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TBC1D3E promoter	PMID:30157460
10059095	TBC1D3E	TBC1 domain family member 3E	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TBC1D3E mRNA	PMID:39836092
10059095	TBC1D3E	TBC1 domain family member 3E	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TBC1D3E mRNA	PMID:39836092
10059095	TBC1D3E	TBC1 domain family member 3E	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TBC1D3E promoter	PMID:30157460
10059095	TBC1D3E	TBC1 domain family member 3E	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of TBC1D3E mRNA	PMID:34979203
10059095	TBC1D3E	TBC1 domain family member 3E	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TBC1D3E promoter	PMID:30157460
10059095	TBC1D3E	TBC1 domain family member 3E	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TBC1D3E mRNA	PMID:37042841
10059095	TBC1D3E	TBC1 domain family member 3E	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TBC1D3E mRNA	PMID:39836092
10059095	TBC1D3E	TBC1 domain family member 3E	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of TBC1D3E mRNA	PMID:31629900
10059095	TBC1D3E	TBC1 domain family member 3E	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TBC1D3E promoter	PMID:30157460
10059154	LINC01037	long independently transcribed non-coding RNA 1037	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01037 intron	PMID:30157460
10059226	ARF4-AS1	ARF4 antisense RNA 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ARF4-AS1 mRNA	PMID:33212167
10059226	ARF4-AS1	ARF4 antisense RNA 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARF4-AS1 mRNA	PMID:38568856
10059240	DIRC3-AS1	DIRC3 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DIRC3-AS1 mRNA	PMID:38568856
10059434	FARSA-AS1	FARSA antisense RNA 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FARSA-AS1 mRNA	PMID:36602393
10059434	FARSA-AS1	FARSA antisense RNA 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FARSA-AS1 mRNA	PMID:36602393
10059440	LINC00604	long independently transcribed non-coding RNA 604	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC00604 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC00604 mRNA	PMID:35811015
10059440	LINC00604	long independently transcribed non-coding RNA 604	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC00604 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC00604 mRNA	PMID:35811015
10059442	LINC01035	long independently transcribed non-coding RNA 1035	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01035 mRNA	PMID:35811015
10059442	LINC01035	long independently transcribed non-coding RNA 1035	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01035 mRNA	PMID:35811015
10059556	LINC01381	long independently transcribed non-coding RNA 1381	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of LINC01381 mRNA	PMID:28988120
10065	ACLY	ATP citrate lyase	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of ACLY protein	PMID:39638853
10065	ACLY	ATP citrate lyase	gene	CHEBI:10607	n-propyl gallate	affects expression	ISO	RGD:2018	E	RGD:6480464	20141111	CTD	MESH:D011435	Propyl Gallate affects the expression of ACLY mRNA	PMID:18539377
10065	ACLY	ATP citrate lyase	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ACLY mRNA	PMID:35967413
10065	ACLY	ATP citrate lyase	gene	CHEBI:132824	spathulenol	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C013258	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA	PMID:38000518
10065	ACLY	ATP citrate lyase	gene	CHEBI:134716	brexpiprazole	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C000591922	brexpiprazole results in decreased expression of ACLY mRNA; brexpiprazole results in decreased expression of ACLY protein	PMID:37347510
10065	ACLY	ATP citrate lyase	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of ACLY mRNA	PMID:31016361
10065	ACLY	ATP citrate lyase	gene	CHEBI:135338	guggulsterone	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20191210	CTD	MESH:C023617	pregna-4,17-diene-3,16-dione inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA]	PMID:31421115
10065	ACLY	ATP citrate lyase	gene	CHEBI:139523	Rosavin	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C529148	rosavin results in increased expression of ACLY mRNA	PMID:20706672
10065	ACLY	ATP citrate lyase	gene	CHEBI:15351	acetyl-CoA	affects abundance	ISO	RGD:10064	E	RGD:6480464	20240604	CTD	MESH:D000105	ACLY protein affects the abundance of Acetyl Coenzyme A	PMID:36933457
10065	ACLY	ATP citrate lyase	gene	CHEBI:15351	acetyl-CoA	increases abundance	ISO	RGD:10064	E	RGD:6480464	20170613	CTD	MESH:D000105	ACLY protein results in increased abundance of Acetyl Coenzyme A	PMID:28077572
10065	ACLY	ATP citrate lyase	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACLY gene	PMID:20938992
10065	ACLY	ATP citrate lyase	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of ACLY mRNA	PMID:32845096
10065	ACLY	ATP citrate lyase	gene	CHEBI:15379	dioxygen	increases phosphorylation	EXP		E	RGD:6480464	20190910	CTD	MESH:D010100	Oxygen deficiency results in increased phosphorylation of ACLY protein	PMID:26087400
10065	ACLY	ATP citrate lyase	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACLY mRNA	PMID:30529165
10065	ACLY	ATP citrate lyase	gene	CHEBI:15396	(R)-camphor	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D002164	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA	PMID:38000518
10065	ACLY	ATP citrate lyase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ACLY mRNA	PMID:36331819
10065	ACLY	ATP citrate lyase	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:10064	E	RGD:6480464	20191210	CTD	MESH:D019308	Palmitic Acid results in increased expression of ACLY mRNA	PMID:31421115
10065	ACLY	ATP citrate lyase	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20191210	CTD	MESH:D019308	acanthoic acid inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA]; GW 3965 inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA]	PMID:31421115
10065	ACLY	ATP citrate lyase	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20140513	CTD	MESH:D001280	[lard co-treated with Cholesterol co-treated with Sucrose co-treated with Atrazine] results in increased expression of ACLY mRNA	PMID:24440342
10065	ACLY	ATP citrate lyase	gene	CHEBI:16112	chlorogenic acid	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D002726	Chlorogenic Acid results in increased expression of ACLY mRNA	PMID:20706672
10065	ACLY	ATP citrate lyase	gene	CHEBI:16113	cholesterol	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20140513	CTD	MESH:D002784	[lard co-treated with Cholesterol co-treated with Sucrose co-treated with Atrazine] results in increased expression of ACLY mRNA; [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Ethinyl Estradiol] results in increased expression of ACLY mRNA	PMID:24440342
10065	ACLY	ATP citrate lyase	gene	CHEBI:16196	oleic acid	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D019301	Oleic Acid results in decreased expression of ACLY mRNA	PMID:31340670
10065	ACLY	ATP citrate lyase	gene	CHEBI:16196	oleic acid	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:D019301	[[Vehicle Emissions results in increased abundance of Particulate Matter] which co-treated with Oleic Acid] results in decreased expression of ACLY mRNA; [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACLY mRNA	PMID:30611723|PMID:31340670
10065	ACLY	ATP citrate lyase	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:10064	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ACLY mRNA	PMID:30319688
10065	ACLY	ATP citrate lyase	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:10064	E	RGD:6480464	20160510	CTD	MESH:D000431	Ethanol results in increased expression of ACLY mRNA	PMID:12036955|PMID:19167417
10065	ACLY	ATP citrate lyase	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:2018	E	RGD:6480464	20120918	CTD	MESH:D000431	Ethanol results in increased expression of ACLY mRNA	PMID:16946407|PMID:19371623
10065	ACLY	ATP citrate lyase	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of ACLY mRNA	PMID:17347304
10065	ACLY	ATP citrate lyase	gene	CHEBI:16243	quercetin	decreases activity	ISO	RGD:10064	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased activity of ACLY protein	PMID:17032037
10065	ACLY	ATP citrate lyase	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of ACLY mRNA	PMID:20596804
10065	ACLY	ATP citrate lyase	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:10064	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of ACLY mRNA	PMID:17032037
10065	ACLY	ATP citrate lyase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:10064	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ACLY mRNA	PMID:39241906
10065	ACLY	ATP citrate lyase	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C040048	[Metformin co-treated with caffeic acid] results in decreased expression of ACLY protein	PMID:28576465
10065	ACLY	ATP citrate lyase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:10064	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of ACLY mRNA	PMID:19484750|PMID:39298647
10065	ACLY	ATP citrate lyase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:2018	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ACLY mRNA	PMID:32145629
10065	ACLY	ATP citrate lyase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ACLY mRNA	PMID:31614463
10065	ACLY	ATP citrate lyase	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:2018	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ACLY protein	PMID:21673325
10065	ACLY	ATP citrate lyase	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACLY gene	PMID:20938992
10065	ACLY	ATP citrate lyase	gene	CHEBI:16716	benzene	affects expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene affects the expression of ACLY mRNA	PMID:15878777
10065	ACLY	ATP citrate lyase	gene	CHEBI:16742	orotic acid	increases expression	ISO	RGD:2018	E	RGD:6480464	20240806	CTD	MESH:D009963	Orotic Acid results in increased expression of ACLY mRNA	PMID:17203948
10065	ACLY	ATP citrate lyase	gene	CHEBI:168262	Ganoderic acid A	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C515005	ganoderic acid A results in decreased expression of ACLY mRNA	PMID:29852127
10065	ACLY	ATP citrate lyase	gene	CHEBI:168262	Ganoderic acid A	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20210504	CTD	MESH:C515005	[Dietary Fats co-treated with ganoderic acid A] affects the expression of ACLY mRNA	PMID:29852127
10065	ACLY	ATP citrate lyase	gene	CHEBI:16827	corticosterone	multiple interactions	ISO	RGD:2018	E	RGD:6480464	20120501	CTD	MESH:D003345	[Corticosterone co-treated with oleoyl-estrone] affects the expression of ACLY mRNA	PMID:19545626
10065	ACLY	ATP citrate lyase	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ACLY mRNA	PMID:23649840
10065	ACLY	ATP citrate lyase	gene	CHEBI:16899	D-mannitol	increases expression	ISO	RGD:10064	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in increased expression of ACLY mRNA	PMID:25270620
10065	ACLY	ATP citrate lyase	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of ACLY mRNA	PMID:17572062
10065	ACLY	ATP citrate lyase	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D005947	Glucose deficiency results in increased expression of ACLY mRNA; Glucose deficiency results in increased expression of ACLY protein	PMID:26811028
10065	ACLY	ATP citrate lyase	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:2018	E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in increased expression of ACLY mRNA	PMID:24349266
10065	ACLY	ATP citrate lyase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ACLY mRNA	PMID:22205965
10065	ACLY	ATP citrate lyase	gene	CHEBI:173086	ferrostatin-1	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C573944	ferrostatin-1 inhibits the reaction [darolutamide results in decreased expression of ACLY mRNA]	PMID:39309439
10065	ACLY	ATP citrate lyase	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:10064	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of ACLY mRNA	PMID:16579987
10065	ACLY	ATP citrate lyase	gene	CHEBI:17351	linoleic acid	decreases expression	ISO	RGD:2018	E	RGD:6480464	20170303	CTD	MESH:D019787	Linoleic Acid results in decreased expression of ACLY mRNA	PMID:14563831
10065	ACLY	ATP citrate lyase	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C040048	[Metformin co-treated with caffeic acid] results in decreased expression of ACLY protein	PMID:28576465
10065	ACLY	ATP citrate lyase	gene	CHEBI:175090	Oleacein	decreases activity	EXP		E	RGD:6480464	20210706	CTD	MESH:C578055	oleacein results in decreased activity of ACLY protein	PMID:31150784
10065	ACLY	ATP citrate lyase	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased expression of ACLY mRNA	PMID:26717081
10065	ACLY	ATP citrate lyase	gene	CHEBI:17578	toluene	increases methylation	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased methylation of ACLY gene	PMID:26717081
10065	ACLY	ATP citrate lyase	gene	CHEBI:17580	linalool	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C018584	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA	PMID:38000518
10065	ACLY	ATP citrate lyase	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D005947	Glucose deficiency results in increased expression of ACLY mRNA; Glucose deficiency results in increased expression of ACLY protein	PMID:26811028
10065	ACLY	ATP citrate lyase	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:2018	E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in increased expression of ACLY mRNA	PMID:24349266
10065	ACLY	ATP citrate lyase	gene	CHEBI:17650	cortisol	increases expression	EXP		E	RGD:6480464	20190702	CTD	MESH:D006854	Hydrocortisone results in increased expression of ACLY mRNA	PMID:30776459
10065	ACLY	ATP citrate lyase	gene	CHEBI:177046	Prothioconazole-desthio	increases expression	ISO	RGD:10064	E	RGD:6480464	20260804	CTD	MESH:C000656708	prothioconazole-desthio results in increased expression of ACLY mRNA	PMID:37248020
10065	ACLY	ATP citrate lyase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:10064	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ACLY mRNA	PMID:19850644|PMID:35550907
10065	ACLY	ATP citrate lyase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20120412	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA; [diisononyl phthalate co-treated with Diethylhexyl Phthalate] results in decreased methylation of ACLY gene; [diisononyl phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of ACLY mRNA; [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACLY mRNA; PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACLY mRNA]	PMID:19850644|PMID:28433925|PMID:33391822|PMID:35739755
10065	ACLY	ATP citrate lyase	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ACLY protein	PMID:37730182
10065	ACLY	ATP citrate lyase	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ACLY mRNA	PMID:28818685
10065	ACLY	ATP citrate lyase	gene	CHEBI:17992	sucrose	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20140513	CTD	MESH:D013395	[lard co-treated with Cholesterol co-treated with Sucrose co-treated with Atrazine] results in increased expression of ACLY mRNA; [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Ethinyl Estradiol] results in increased expression of ACLY mRNA	PMID:24440342
10065	ACLY	ATP citrate lyase	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of ACLY exon; aflatoxin B2 results in decreased methylation of ACLY intron	PMID:30157460
10065	ACLY	ATP citrate lyase	gene	CHEBI:18208	benzylpenicillin	increases expression	ISO	RGD:10064	E	RGD:6480464	20161213	CTD	MESH:D010400	Penicillin G results in increased expression of ACLY mRNA	PMID:27503388
10065	ACLY	ATP citrate lyase	gene	CHEBI:18208	benzylpenicillin	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20161213	CTD	MESH:D010400	[Penicillin G co-treated with Erythromycin] results in increased expression of ACLY mRNA	PMID:27503388
10065	ACLY	ATP citrate lyase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ACLY mRNA	PMID:36331819
10065	ACLY	ATP citrate lyase	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:10064	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of ACLY mRNA	PMID:33914522
10065	ACLY	ATP citrate lyase	gene	CHEBI:192461	toosendanin	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C036454	toosendanin results in decreased expression of ACLY mRNA	PMID:38570025
10065	ACLY	ATP citrate lyase	gene	CHEBI:195250	corn oil	affects expression	ISO	RGD:2018	E	RGD:6480464	20230704	CTD	MESH:D003314	Corn Oil affects the expression of ACLY mRNA	PMID:16360708
10065	ACLY	ATP citrate lyase	gene	CHEBI:233299	(-)-acanthoic acid	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20250408	CTD	MESH:C099958	acanthoic acid inhibits the reaction [Dietary Fats results in increased expression of ACLY mRNA]; acanthoic acid inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA]	PMID:31421115
10065	ACLY	ATP citrate lyase	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ACLY protein	PMID:23301498
10065	ACLY	ATP citrate lyase	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ACLY mRNA	PMID:23649840
10065	ACLY	ATP citrate lyase	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:10064	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ACLY mRNA	PMID:19770486
10065	ACLY	ATP citrate lyase	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:2018	E	RGD:6480464	20140311	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ACLY mRNA	PMID:23385219
10065	ACLY	ATP citrate lyase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ACLY intron	PMID:30157460
10065	ACLY	ATP citrate lyase	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ACLY exon	PMID:30157460
10065	ACLY	ATP citrate lyase	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:2018	E	RGD:6480464	20150414	CTD	MESH:D016604	[sulforaphane co-treated with Aflatoxin B1] affects the expression of ACLY mRNA	PMID:25450479
10065	ACLY	ATP citrate lyase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ACLY mRNA	PMID:23649840
10065	ACLY	ATP citrate lyase	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:10064	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of ACLY mRNA	PMID:18579281
10065	ACLY	ATP citrate lyase	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:10064	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of ACLY mRNA	PMID:16183385
10065	ACLY	ATP citrate lyase	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:2018	E	RGD:6480464	20150714	CTD	MESH:D010126	Ozone results in decreased expression of ACLY mRNA	PMID:25838073
10065	ACLY	ATP citrate lyase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of ACLY mRNA	PMID:32845096
10065	ACLY	ATP citrate lyase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ACLY mRNA	PMID:34911549
10065	ACLY	ATP citrate lyase	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D000638	Amiodarone results in increased expression of ACLY mRNA	PMID:32535746
10065	ACLY	ATP citrate lyase	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:2018	E	RGD:6480464	20230801	CTD	MESH:D000638	Amiodarone results in increased expression of ACLY mRNA	PMID:32084307
10065	ACLY	ATP citrate lyase	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ACLY protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ACLY protein	PMID:38598786
10065	ACLY	ATP citrate lyase	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:2018	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of ACLY mRNA	PMID:15671213
10065	ACLY	ATP citrate lyase	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:10064	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of ACLY mRNA	PMID:31919559
10065	ACLY	ATP citrate lyase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACLY mRNA	PMID:17522070
10065	ACLY	ATP citrate lyase	gene	CHEBI:27432	alpha-linolenic acid	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D017962	alpha-Linolenic Acid results in decreased expression of ACLY mRNA	PMID:14563831
10065	ACLY	ATP citrate lyase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACLY gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ACLY mRNA]	PMID:20938992|PMID:22206623
10065	ACLY	ATP citrate lyase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACLY mRNA	PMID:40512198
10065	ACLY	ATP citrate lyase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACLY mRNA	PMID:32045263
10065	ACLY	ATP citrate lyase	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ACLY protein	PMID:35688186
10065	ACLY	ATP citrate lyase	gene	CHEBI:27732	caffeine	increases expression	ISO	RGD:2018	E	RGD:6480464	20190702	CTD	MESH:D002110	Caffeine results in increased expression of ACLY mRNA	PMID:30776459
10065	ACLY	ATP citrate lyase	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:10064	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of ACLY protein	PMID:37208198
10065	ACLY	ATP citrate lyase	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:2018	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ACLY mRNA	PMID:31881176
10065	ACLY	ATP citrate lyase	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in increased expression of ACLY mRNA	PMID:20706672
10065	ACLY	ATP citrate lyase	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:2018	E	RGD:6480464	20160822	CTD	MESH:C059514	[Dietary Fats co-treated with resveratrol] affects the expression of ACLY mRNA; resveratrol inhibits the reaction [Dietary Fats results in increased expression of ACLY protein]	PMID:26055348
10065	ACLY	ATP citrate lyase	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in decreased expression of ACLY protein	PMID:37834424
10065	ACLY	ATP citrate lyase	gene	CHEBI:27902	tetracycline	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in decreased expression of ACLY mRNA	PMID:17522070
10065	ACLY	ATP citrate lyase	gene	CHEBI:27961	1,8-cineole	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D000077591	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA	PMID:38000518
10065	ACLY	ATP citrate lyase	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of ACLY protein	PMID:20884965
10065	ACLY	ATP citrate lyase	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of ACLY mRNA	PMID:20706672
10065	ACLY	ATP citrate lyase	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	ESR2 promotes the reaction [Genistein results in decreased expression of ACLY protein]	PMID:20884965
10065	ACLY	ATP citrate lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:10064	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACLY mRNA	PMID:21570461|PMID:26377647
10065	ACLY	ATP citrate lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:10064	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACLY mRNA	PMID:18295293|PMID:26290441|PMID:28213091
10065	ACLY	ATP citrate lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:2018	E	RGD:6480464	20130122	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACLY mRNA	PMID:16054898|PMID:20959002|PMID:21215274|PMID:21724226
10065	ACLY	ATP citrate lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:10064	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACLY mRNA	PMID:21846477
10065	ACLY	ATP citrate lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:2018	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACLY mRNA	PMID:34747641
10065	ACLY	ATP citrate lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20120918	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACLY mRNA; Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in increased expression of ACLY mRNA]	PMID:21846477|PMID:28433925
10065	ACLY	ATP citrate lyase	gene	CHEBI:28200	2-chloroethanol	increases expression	ISO	RGD:10064	E	RGD:6480464	20160822	CTD	MESH:D005023	Ethylene Chlorohydrin results in increased expression of ACLY mRNA	PMID:26962056
10065	ACLY	ATP citrate lyase	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:2018	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of ACLY mRNA	PMID:28374803
10065	ACLY	ATP citrate lyase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of ACLY mRNA; Rotenone results in increased expression of ACLY protein	PMID:33512557|PMID:39603559
10065	ACLY	ATP citrate lyase	gene	CHEBI:28201	rotenone	increases oxidation	ISO	RGD:2018	E	RGD:6480464	20190910	CTD	MESH:D012402	Rotenone results in increased oxidation of ACLY protein	PMID:30951809
10065	ACLY	ATP citrate lyase	gene	CHEBI:28509	chloroethene	increases expression	ISO	RGD:10064	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride metabolite results in increased expression of ACLY mRNA; Vinyl Chloride results in increased expression of ACLY mRNA	PMID:18579281|PMID:26962056
10065	ACLY	ATP citrate lyase	gene	CHEBI:28527	rutin	decreases activity	ISO	RGD:10064	E	RGD:6480464	20120412	CTD	MESH:D012431	Rutin results in decreased activity of ACLY protein	PMID:17032037
10065	ACLY	ATP citrate lyase	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:10064	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in decreased expression of ACLY mRNA	PMID:17205981
10065	ACLY	ATP citrate lyase	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:2018	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of ACLY mRNA	PMID:26033743
10065	ACLY	ATP citrate lyase	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ACLY mRNA	PMID:29803840
10065	ACLY	ATP citrate lyase	gene	CHEBI:28757	fructose	increases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D005632	Fructose results in increased expression of ACLY mRNA	PMID:1396700
10065	ACLY	ATP citrate lyase	gene	CHEBI:28794	coumarin	affects expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin affects the expression of ACLY mRNA	PMID:16963487
10065	ACLY	ATP citrate lyase	gene	CHEBI:28984	aluminium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in increased expression of and results in increased activity of ACLY protein	PMID:17762189
10065	ACLY	ATP citrate lyase	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of ACLY mRNA	PMID:34032870
10065	ACLY	ATP citrate lyase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ACLY mRNA	PMID:38568856|PMID:39719251
10065	ACLY	ATP citrate lyase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:10064	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ACLY mRNA	PMID:19822182
10065	ACLY	ATP citrate lyase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACLY mRNA	PMID:40512198
10065	ACLY	ATP citrate lyase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20220208	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACLY mRNA	PMID:32045263
10065	ACLY	ATP citrate lyase	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of ACLY mRNA	PMID:29453283
10065	ACLY	ATP citrate lyase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ACLY exon	PMID:30157460
10065	ACLY	ATP citrate lyase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:10064	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACLY mRNA	PMID:22228805
10065	ACLY	ATP citrate lyase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ACLY 5' UTR	PMID:27901495
10065	ACLY	ATP citrate lyase	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ACLY mRNA]	PMID:22228805
10065	ACLY	ATP citrate lyase	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:10064	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of ACLY mRNA	PMID:33053406
10065	ACLY	ATP citrate lyase	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:10064	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in decreased expression of ACLY mRNA	PMID:17205981
10065	ACLY	ATP citrate lyase	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:2018	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of ACLY mRNA	PMID:26033743
10065	ACLY	ATP citrate lyase	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:2018	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of ACLY mRNA	PMID:15671213
10065	ACLY	ATP citrate lyase	gene	CHEBI:30563	silicon dioxide	affects secretion	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog affects the secretion of ACLY protein	PMID:25895662
10065	ACLY	ATP citrate lyase	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:10064	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ACLY mRNA	PMID:23221170
10065	ACLY	ATP citrate lyase	gene	CHEBI:30563	silicon dioxide	increases activity	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D012822	Silicon Dioxide results in increased activity of ACLY protein	PMID:1647683
10065	ACLY	ATP citrate lyase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ACLY mRNA	PMID:34454013
10065	ACLY	ATP citrate lyase	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:10064	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ACLY mRNA	PMID:39716349
10065	ACLY	ATP citrate lyase	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of ACLY mRNA	PMID:16483693
10065	ACLY	ATP citrate lyase	gene	CHEBI:31739	josamycin	affects response to substance	EXP		E	RGD:6480464	20200609	CTD	MESH:D015570	ACLY protein affects the susceptibility to Josamycin	PMID:31915244
10065	ACLY	ATP citrate lyase	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:2018	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of ACLY mRNA	PMID:32479839
10065	ACLY	ATP citrate lyase	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:2018	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ACLY mRNA	PMID:30047161
10065	ACLY	ATP citrate lyase	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:2018	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of ACLY mRNA	PMID:24136188
10065	ACLY	ATP citrate lyase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:10064	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACLY mRNA	PMID:35295148
10065	ACLY	ATP citrate lyase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:10064	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ACLY gene	PMID:35295148
10065	ACLY	ATP citrate lyase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:10064	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ACLY mRNA	PMID:23557971
10065	ACLY	ATP citrate lyase	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:2018	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of ACLY mRNA	PMID:34492290
10065	ACLY	ATP citrate lyase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:10064	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ACLY mRNA	PMID:18445702|PMID:23811191
10065	ACLY	ATP citrate lyase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ACLY mRNA	PMID:19162173
10065	ACLY	ATP citrate lyase	gene	CHEBI:32888	gamma-hexachlorocyclohexane	affects activity	ISO	RGD:2018	E	RGD:6480464	20130122	CTD	MESH:D001556	Hexachlorocyclohexane affects the activity of ACLY protein	PMID:7535533
10065	ACLY	ATP citrate lyase	gene	CHEBI:32888	gamma-hexachlorocyclohexane	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D001556	Hexachlorocyclohexane results in decreased expression of ACLY mRNA	PMID:17785943
10065	ACLY	ATP citrate lyase	gene	CHEBI:33007	chromium(6+)	increases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of ACLY protein	PMID:32525551
10065	ACLY	ATP citrate lyase	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:10064	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of ACLY mRNA	PMID:33914522
10065	ACLY	ATP citrate lyase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ACLY mRNA	PMID:30903817
10065	ACLY	ATP citrate lyase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:2018	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ACLY mRNA	PMID:32145629
10065	ACLY	ATP citrate lyase	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:10064	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ACLY promoter	PMID:27334623
10065	ACLY	ATP citrate lyase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of ACLY protein	PMID:37567409
10065	ACLY	ATP citrate lyase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2018	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ACLY mRNA; bisphenol A results in decreased expression of ACLY protein	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
10065	ACLY	ATP citrate lyase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:10064	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in increased expression of ACLY mRNA; bisphenol A results in increased expression of ACLY protein; bisphenol A results in increased expression of ACLY protein modified form	PMID:21932408|PMID:37105096
10065	ACLY	ATP citrate lyase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2018	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ACLY mRNA	PMID:25181051|PMID:27178563
10065	ACLY	ATP citrate lyase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA; [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACLY mRNA	PMID:28433925|PMID:35739755
10065	ACLY	ATP citrate lyase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:2018	E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of ACLY mRNA	PMID:27914987
10065	ACLY	ATP citrate lyase	gene	CHEBI:33629	aluminium(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in increased expression of and results in increased activity of ACLY protein	PMID:17762189
10065	ACLY	ATP citrate lyase	gene	CHEBI:3392	carbendazim	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20260707	CTD	MESH:C006698	[carbendazim co-treated with prochloraz] results in decreased expression of ACLY mRNA	PMID:38123780
10065	ACLY	ATP citrate lyase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20180116	CTD	MESH:C014024	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACLY mRNA	PMID:28433925
10065	ACLY	ATP citrate lyase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:10064	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ACLY mRNA	PMID:39298647|PMID:40203079
10065	ACLY	ATP citrate lyase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ACLY mRNA; bisphenol S results in increased expression of ACLY protein	PMID:31121516|PMID:34186270
10065	ACLY	ATP citrate lyase	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ACLY exon	PMID:30157460
10065	ACLY	ATP citrate lyase	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ACLY protein	PMID:34186270
10065	ACLY	ATP citrate lyase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:10064	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ACLY mRNA	PMID:38685157
10065	ACLY	ATP citrate lyase	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ACLY protein	PMID:34186270
10065	ACLY	ATP citrate lyase	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20240402	CTD	MESH:C027561	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA	PMID:35739755
10065	ACLY	ATP citrate lyase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:10064	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ACLY mRNA	PMID:37019170
10065	ACLY	ATP citrate lyase	gene	CHEBI:34679	Di-n-octyl phthalate	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20240402	CTD	MESH:C010715	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA	PMID:35739755
10065	ACLY	ATP citrate lyase	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:2018	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of ACLY mRNA	PMID:22546817
10065	ACLY	ATP citrate lyase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:2018	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ACLY mRNA	PMID:17379624
10065	ACLY	ATP citrate lyase	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20240402	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA	PMID:35739755
10065	ACLY	ATP citrate lyase	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:2018	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of ACLY mRNA	PMID:22546817
10065	ACLY	ATP citrate lyase	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20240402	CTD	MESH:C007379	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA	PMID:35739755
10065	ACLY	ATP citrate lyase	gene	CHEBI:34709	Diisodecyl phthalate	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20240402	CTD	MESH:C042080	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA	PMID:35739755
10065	ACLY	ATP citrate lyase	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to ACLY protein	PMID:32991956
10065	ACLY	ATP citrate lyase	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ACLY protein	PMID:38598786
10065	ACLY	ATP citrate lyase	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:2018	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of ACLY mRNA	PMID:22546817
10065	ACLY	ATP citrate lyase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ACLY mRNA	PMID:37042841
10065	ACLY	ATP citrate lyase	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:2018	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of ACLY mRNA	PMID:30589522
10065	ACLY	ATP citrate lyase	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:10064	E	RGD:6480464	20260113	CTD	MESH:C005445	triphenyl phosphate results in increased expression of ACLY mRNA	PMID:40048564
10065	ACLY	ATP citrate lyase	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of ACLY mRNA	PMID:17522070
10065	ACLY	ATP citrate lyase	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:2018	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ACLY mRNA	PMID:30723492
10065	ACLY	ATP citrate lyase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:2018	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ACLY mRNA	PMID:25993096
10065	ACLY	ATP citrate lyase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:10064	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ACLY mRNA	PMID:37482320
10065	ACLY	ATP citrate lyase	gene	CHEBI:35459	diisononyl phthalate	increases expression	ISO	RGD:10064	E	RGD:6480464	20250204	CTD	MESH:C012125	diisononyl phthalate results in increased expression of ACLY mRNA	PMID:33391822
10065	ACLY	ATP citrate lyase	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20240402	CTD	MESH:C012125	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA; [diisononyl phthalate co-treated with Diethylhexyl Phthalate] results in decreased methylation of ACLY gene; [diisononyl phthalate co-treated with Diethylhexyl Phthalate] results in increased expression of ACLY mRNA	PMID:33391822|PMID:35739755
10065	ACLY	ATP citrate lyase	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ACLY mRNA	PMID:19162173
10065	ACLY	ATP citrate lyase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20140311	CTD	MESH:C023036	Dietary Fats, Unsaturated promotes the reaction [perfluorooctanoic acid results in increased expression of ACLY mRNA]	PMID:23626681
10065	ACLY	ATP citrate lyase	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:2018	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of ACLY mRNA	PMID:26194646
10065	ACLY	ATP citrate lyase	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ACLY mRNA	PMID:19162173
10065	ACLY	ATP citrate lyase	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:2018	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ACLY mRNA	PMID:30047161
10065	ACLY	ATP citrate lyase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ACLY mRNA	PMID:19320972|PMID:19376846
10065	ACLY	ATP citrate lyase	gene	CHEBI:3639	chlorothalonil	decreases expression	ISO	RGD:10064	E	RGD:6480464	20210810	CTD	MESH:C005806	tetrachloroisophthalonitrile results in decreased expression of ACLY mRNA	PMID:33246813
10065	ACLY	ATP citrate lyase	gene	CHEBI:3639	chlorothalonil	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20210810	CTD	MESH:C005806	[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of ACLY mRNA	PMID:33246813
10065	ACLY	ATP citrate lyase	gene	CHEBI:36773	camphor	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D002164	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA	PMID:38000518
10065	ACLY	ATP citrate lyase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate results in decreased expression of ACLY mRNA; Clofibrate results in decreased expression of ACLY protein	PMID:16470657|PMID:17522070|PMID:8240402
10065	ACLY	ATP citrate lyase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:10064	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ACLY mRNA	PMID:40194260
10065	ACLY	ATP citrate lyase	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ACLY mRNA	PMID:28302478
10065	ACLY	ATP citrate lyase	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ACLY mRNA	PMID:31533062
10065	ACLY	ATP citrate lyase	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ACLY mRNA	PMID:19167446
10065	ACLY	ATP citrate lyase	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACLY mRNA	PMID:19167446
10065	ACLY	ATP citrate lyase	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of ACLY mRNA	PMID:26352163
10065	ACLY	ATP citrate lyase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ACLY mRNA	PMID:40419075
10065	ACLY	ATP citrate lyase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:10064	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ACLY mRNA	PMID:21705711
10065	ACLY	ATP citrate lyase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ACLY mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ACLY mRNA	PMID:36331819
10065	ACLY	ATP citrate lyase	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:2018	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of ACLY mRNA	PMID:25993096
10065	ACLY	ATP citrate lyase	gene	CHEBI:3962	curcumin	affects expression	ISO	RGD:10064	E	RGD:6480464	20161025	CTD	MESH:D003474	Curcumin affects the expression of ACLY mRNA	PMID:27208389
10065	ACLY	ATP citrate lyase	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:2018	E	RGD:6480464	20161025	CTD	MESH:D003474	Curcumin results in decreased expression of ACLY mRNA	PMID:27208389
10065	ACLY	ATP citrate lyase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ACLY mRNA	PMID:25979313
10065	ACLY	ATP citrate lyase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:10064	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ACLY mRNA	PMID:17292431
10065	ACLY	ATP citrate lyase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased expression of ACLY mRNA; Valproic Acid results in increased expression of ACLY protein	PMID:30003287
10065	ACLY	ATP citrate lyase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:10064	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of ACLY mRNA	PMID:24489787
10065	ACLY	ATP citrate lyase	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	NR1H3 protein affects the reaction [Valproic Acid results in increased expression of ACLY mRNA]	PMID:30003287
10065	ACLY	ATP citrate lyase	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:2018	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of ACLY mRNA	PMID:41580965
10065	ACLY	ATP citrate lyase	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:2018	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ACLY mRNA	PMID:30047161
10065	ACLY	ATP citrate lyase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of ACLY mRNA	PMID:20106945
10065	ACLY	ATP citrate lyase	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:10064	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ACLY mRNA	PMID:20937368
10065	ACLY	ATP citrate lyase	gene	CHEBI:41791	calyculin A	increases expression	ISO	RGD:10064	E	RGD:6480464	20150127	CTD	MESH:C059041	calyculin A results in increased expression of ACLY mRNA	PMID:25270620
10065	ACLY	ATP citrate lyase	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in decreased expression of ACLY mRNA	PMID:17522070
10065	ACLY	ATP citrate lyase	gene	CHEBI:42355	erythromycin A	increases expression	ISO	RGD:10064	E	RGD:6480464	20161213	CTD	MESH:D004917	Erythromycin results in increased expression of ACLY mRNA	PMID:27503388
10065	ACLY	ATP citrate lyase	gene	CHEBI:42355	erythromycin A	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20161213	CTD	MESH:D004917	[Penicillin G co-treated with Erythromycin] results in increased expression of ACLY mRNA	PMID:27503388
10065	ACLY	ATP citrate lyase	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D005947	Glucose deficiency results in increased expression of ACLY mRNA; Glucose deficiency results in increased expression of ACLY protein	PMID:26811028
10065	ACLY	ATP citrate lyase	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:2018	E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in increased expression of ACLY mRNA	PMID:24349266
10065	ACLY	ATP citrate lyase	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:2018	E	RGD:6480464	20160412	CTD	MESH:D008727	Methotrexate results in decreased expression of ACLY mRNA	PMID:24136188
10065	ACLY	ATP citrate lyase	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:2018	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of ACLY mRNA	PMID:24136188
10065	ACLY	ATP citrate lyase	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ACLY mRNA	PMID:38832940
10065	ACLY	ATP citrate lyase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:10064	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACLY mRNA	PMID:17562736
10065	ACLY	ATP citrate lyase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120501	CTD	MESH:D000082	Acetaminophen results in decreased expression of ACLY mRNA	PMID:15084756|PMID:17522070
10065	ACLY	ATP citrate lyase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:10064	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in increased expression of ACLY mRNA	PMID:29246445
10065	ACLY	ATP citrate lyase	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20150414	CTD	MESH:D000082	[CTH gene mutant form results in increased susceptibility to Acetaminophen] which results in increased expression of ACLY protein; PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of ACLY mRNA]	PMID:25499718|PMID:29246445
10065	ACLY	ATP citrate lyase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACLY mRNA	PMID:40512198
10065	ACLY	ATP citrate lyase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACLY mRNA	PMID:32045263
10065	ACLY	ATP citrate lyase	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:2018	E	RGD:6480464	20150414	CTD	MESH:C016766	[sulforaphane co-treated with Aflatoxin B1] affects the expression of ACLY mRNA	PMID:25450479
10065	ACLY	ATP citrate lyase	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:2018	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ACLY mRNA	PMID:29391264
10065	ACLY	ATP citrate lyase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of ACLY mRNA	PMID:20706672
10065	ACLY	ATP citrate lyase	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:10064	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ACLY mRNA	PMID:35436446
10065	ACLY	ATP citrate lyase	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:2018	E	RGD:6480464	20180515	CTD	MESH:C109476	epoxiconazole results in increased expression of ACLY mRNA	PMID:29038839
10065	ACLY	ATP citrate lyase	gene	CHEBI:4846	erythromycin estolate	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D004918	Erythromycin Estolate results in decreased expression of ACLY mRNA	PMID:17522070
10065	ACLY	ATP citrate lyase	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120613	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of ACLY mRNA	PMID:15953391|PMID:17108234
10065	ACLY	ATP citrate lyase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20140513	CTD	MESH:D004997	[lard co-treated with Cholesterol co-treated with Sucrose co-treated with Ethinyl Estradiol] results in increased expression of ACLY mRNA	PMID:24440342
10065	ACLY	ATP citrate lyase	gene	CHEBI:49662	indometacin	affects expression	ISO	RGD:10064	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin affects the expression of ACLY mRNA	PMID:17546600
10065	ACLY	ATP citrate lyase	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D007213	Indomethacin results in increased expression of ACLY mRNA	PMID:32535746
10065	ACLY	ATP citrate lyase	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:10064	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ACLY mRNA	PMID:39716349
10065	ACLY	ATP citrate lyase	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:10064	E	RGD:6480464	20140715	CTD	MESH:D011345	Fenofibrate results in increased expression of ACLY mRNA	PMID:23063693
10065	ACLY	ATP citrate lyase	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20140715	CTD	MESH:D011345	PPARA gene mutant form inhibits the reaction [Fenofibrate results in increased expression of ACLY mRNA]	PMID:23063693
10065	ACLY	ATP citrate lyase	gene	CHEBI:50027	sabinene	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C035127	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA	PMID:38000518
10065	ACLY	ATP citrate lyase	gene	CHEBI:50045	(+)-beta-thujone	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C005790	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA	PMID:38000518
10065	ACLY	ATP citrate lyase	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D008770	Methylnitrosourea results in increased expression of ACLY mRNA	PMID:16525678
10065	ACLY	ATP citrate lyase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:10064	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ACLY mRNA; Nanotubes, Carbon results in decreased expression of ACLY mRNA	PMID:25554681|PMID:25620056
10065	ACLY	ATP citrate lyase	gene	CHEBI:50692	mifepristone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of ACLY mRNA	PMID:17584828
10065	ACLY	ATP citrate lyase	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of ACLY mRNA	PMID:19162173
10065	ACLY	ATP citrate lyase	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D005485	Flutamide results in increased expression of ACLY mRNA	PMID:21525395
10065	ACLY	ATP citrate lyase	gene	CHEBI:5759	Honokiol	decreases expression	ISO	RGD:2018	E	RGD:6480464	20170228	CTD	MESH:C005499	honokiol results in decreased expression of ACLY mRNA	PMID:19371623
10065	ACLY	ATP citrate lyase	gene	CHEBI:6030	isoniazide	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in decreased expression of ACLY protein	PMID:40015660
10065	ACLY	ATP citrate lyase	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of ACLY mRNA	PMID:20436886
10065	ACLY	ATP citrate lyase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ACLY protein	PMID:32959892
10065	ACLY	ATP citrate lyase	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:2018	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of ACLY mRNA	PMID:24136188
10065	ACLY	ATP citrate lyase	gene	CHEBI:63637	vemurafenib	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C551177	[BRAF protein affects the susceptibility to Vemurafenib] which affects the expression of ACLY mRNA; trametinib affects the reaction [[BRAF protein affects the susceptibility to Vemurafenib] which affects the expression of ACLY mRNA]	PMID:29950559
10065	ACLY	ATP citrate lyase	gene	CHEBI:6382	Lasiocarpine	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in decreased expression of ACLY mRNA	PMID:40054833
10065	ACLY	ATP citrate lyase	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:10064	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ACLY mRNA	PMID:23650126
10065	ACLY	ATP citrate lyase	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20200331	CTD	MESH:D012970	[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ACLY mRNA	PMID:19001666
10065	ACLY	ATP citrate lyase	gene	CHEBI:6469	linalyl acetate	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C074463	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA	PMID:38000518
10065	ACLY	ATP citrate lyase	gene	CHEBI:65585	carnosic acid	increases expression	ISO	RGD:10064	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in increased expression of ACLY protein	PMID:35926579
10065	ACLY	ATP citrate lyase	gene	CHEBI:6801	metformin	affects expression	ISO	RGD:2018	E	RGD:6480464	20200114	CTD	MESH:D008687	Metformin affects the expression of ACLY mRNA	PMID:31324951
10065	ACLY	ATP citrate lyase	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D008687	[Metformin co-treated with caffeic acid] results in decreased expression of ACLY protein	PMID:28576465
10065	ACLY	ATP citrate lyase	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ACLY exon	PMID:30157460
10065	ACLY	ATP citrate lyase	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:10064	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of ACLY mRNA	PMID:27462272
10065	ACLY	ATP citrate lyase	gene	CHEBI:72544	flavonoids	increases expression	ISO	RGD:2018	E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in increased expression of ACLY mRNA	PMID:18035473
10065	ACLY	ATP citrate lyase	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ACLY protein	PMID:34186270
10065	ACLY	ATP citrate lyase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:10064	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ACLY mRNA	PMID:22206623
10065	ACLY	ATP citrate lyase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ACLY mRNA]	PMID:22206623
10065	ACLY	ATP citrate lyase	gene	CHEBI:7459	naloxone	decreases expression	ISO	RGD:2018	E	RGD:6480464	20120412	CTD	MESH:D009270	Naloxone results in decreased expression of ACLY mRNA	PMID:17522070
10065	ACLY	ATP citrate lyase	gene	CHEBI:747353	darolutamide	decreases expression	EXP		E	RGD:6480464	20260224	CTD	MESH:C000607739	darolutamide results in decreased expression of ACLY mRNA	PMID:39309439
10065	ACLY	ATP citrate lyase	gene	CHEBI:747353	darolutamide	multiple interactions	EXP		E	RGD:6480464	20260224	CTD	MESH:C000607739	ferrostatin-1 inhibits the reaction [darolutamide results in decreased expression of ACLY mRNA]	PMID:39309439
10065	ACLY	ATP citrate lyase	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ACLY protein	PMID:37664457
10065	ACLY	ATP citrate lyase	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:2018	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ACLY mRNA	PMID:24136188
10065	ACLY	ATP citrate lyase	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:2018	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of ACLY mRNA	PMID:27225895
10065	ACLY	ATP citrate lyase	gene	CHEBI:75170	zaragozic acid A	increases expression	ISO	RGD:10064	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of ACLY mRNA	PMID:27225895
10065	ACLY	ATP citrate lyase	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol co-treated with Sucrose co-treated with Atrazine] results in increased expression of ACLY mRNA; [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Ethinyl Estradiol] results in increased expression of ACLY mRNA	PMID:24440342
10065	ACLY	ATP citrate lyase	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of ACLY mRNA	PMID:28960945
10065	ACLY	ATP citrate lyase	gene	CHEBI:756996	imeglimin	decreases expression	ISO	RGD:10064	E	RGD:6480464	20260714	CTD	MESH:C575881	imeglimin results in decreased expression of ACLY mRNA	PMID:40713970
10065	ACLY	ATP citrate lyase	gene	CHEBI:75701	sarin	decreases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of ACLY mRNA	PMID:19522546
10065	ACLY	ATP citrate lyase	gene	CHEBI:757488	omega-3 fatty acids	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20260714	CTD	MESH:D015525	Fatty Acids, Omega-3 results in decreased expression of and results in decreased phosphorylation of ACLY protein; NR1H2 gene mutant form promotes the reaction [Fatty Acids, Omega-3 results in decreased expression of and results in decreased phosphorylation of ACLY protein]; NR1H3 gene mutant form promotes the reaction [Fatty Acids, Omega-3 results in decreased expression of and results in decreased phosphorylation of ACLY protein]	PMID:23333450
10065	ACLY	ATP citrate lyase	gene	CHEBI:7599	Nivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in decreased expression of ACLY protein	PMID:39638853
10065	ACLY	ATP citrate lyase	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C560077	trametinib affects the reaction [[BRAF protein affects the susceptibility to Vemurafenib] which affects the expression of ACLY mRNA]	PMID:29950559
10065	ACLY	ATP citrate lyase	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of ACLY protein	PMID:39638853
10065	ACLY	ATP citrate lyase	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of ACLY protein	PMID:39638853
10065	ACLY	ATP citrate lyase	gene	CHEBI:7797	Osajin	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:C485800	osajin results in increased expression of ACLY mRNA	PMID:20706672
10065	ACLY	ATP citrate lyase	gene	CHEBI:78334	(R)-linalyl acetate	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C074463	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA	PMID:38000518
10065	ACLY	ATP citrate lyase	gene	CHEBI:79995	GW 3965	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20191210	CTD	MESH:C473027	GW 3965 inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA]	PMID:31421115
10065	ACLY	ATP citrate lyase	gene	CHEBI:79997	GW 4064	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:C412815	[GW 4064 co-treated with Oleic Acid] results in decreased expression of ACLY mRNA	PMID:30611723
10065	ACLY	ATP citrate lyase	gene	CHEBI:8064	phenformin	decreases expression	ISO	RGD:2018	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of ACLY mRNA	PMID:31324951
10065	ACLY	ATP citrate lyase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:10064	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ACLY mRNA	PMID:23091169
10065	ACLY	ATP citrate lyase	gene	CHEBI:80774	tauroursodeoxycholic acid	decreases expression	ISO	RGD:2018	E	RGD:6480464	20141111	CTD	MESH:C031655	ursodoxicoltaurine results in decreased expression of ACLY mRNA	PMID:15885361
10065	ACLY	ATP citrate lyase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:2018	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ACLY mRNA	PMID:21724226|PMID:32109520
10065	ACLY	ATP citrate lyase	gene	CHEBI:81508	2,3,4,7,8-Pentachlorodibenzofuran	decreases expression	ISO	RGD:2018	E	RGD:6480464	20141111	CTD	MESH:C038890	2,3,4,7,8-pentachlorodibenzofuran results in decreased expression of ACLY mRNA	PMID:21724226
10065	ACLY	ATP citrate lyase	gene	CHEBI:81543	Tributyltin oxide	decreases phosphorylation	ISO	RGD:10064	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased phosphorylation of ACLY protein	PMID:22174045
10065	ACLY	ATP citrate lyase	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACLY mRNA	PMID:19167446
10065	ACLY	ATP citrate lyase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:2018	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ACLY mRNA	PMID:20056577
10065	ACLY	ATP citrate lyase	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:2018	E	RGD:6480464	20180515	CTD	MESH:C093628	cyproconazole results in increased expression of ACLY mRNA	PMID:29038839
10065	ACLY	ATP citrate lyase	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:2018	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of ACLY protein	PMID:28903499
10065	ACLY	ATP citrate lyase	gene	CHEBI:81927	enilconazole	increases expression	ISO	RGD:10064	E	RGD:6480464	20260804	CTD	MESH:C017435	enilconazole results in increased expression of ACLY mRNA	PMID:38232526
10065	ACLY	ATP citrate lyase	gene	CHEBI:82033	propamocarb	decreases expression	ISO	RGD:10064	E	RGD:6480464	20190219	CTD	MESH:C033205	propamocarb results in decreased expression of ACLY mRNA	PMID:29137890
10065	ACLY	ATP citrate lyase	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of ACLY mRNA	PMID:33512557
10065	ACLY	ATP citrate lyase	gene	CHEBI:8329	Pomiferin	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:C474837	pomiferin results in increased expression of ACLY mRNA	PMID:20706672
10065	ACLY	ATP citrate lyase	gene	CHEBI:8434	prochloraz	decreases expression	ISO	RGD:10064	E	RGD:6480464	20260707	CTD	MESH:C045362	prochloraz results in decreased expression of ACLY mRNA	PMID:38123780
10065	ACLY	ATP citrate lyase	gene	CHEBI:8434	prochloraz	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20260707	CTD	MESH:C045362	[carbendazim co-treated with prochloraz] results in decreased expression of ACLY mRNA	PMID:38123780
10065	ACLY	ATP citrate lyase	gene	CHEBI:8450	procymidone	decreases expression	ISO	RGD:10064	E	RGD:6480464	20210810	CTD	MESH:C035988	procymidone results in decreased expression of ACLY mRNA	PMID:33246813
10065	ACLY	ATP citrate lyase	gene	CHEBI:8450	procymidone	increases expression	ISO	RGD:10064	E	RGD:6480464	20230606	CTD	MESH:C035988	procymidone results in increased expression of ACLY mRNA	PMID:36764477
10065	ACLY	ATP citrate lyase	gene	CHEBI:8450	procymidone	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20210810	CTD	MESH:C035988	[procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of ACLY mRNA	PMID:33246813
10065	ACLY	ATP citrate lyase	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:2018	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of ACLY mRNA	PMID:30047161
10065	ACLY	ATP citrate lyase	gene	CHEBI:8493	Propiverine	affects binding	ISO	RGD:2018	E	RGD:6480464	20180410	CTD	MESH:C015586	propiverine binds to ACLY protein	PMID:29273565
10065	ACLY	ATP citrate lyase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:2018	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ACLY mRNA	PMID:30047161
10065	ACLY	ATP citrate lyase	gene	CHEBI:8633	puerarin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C033607	puerarin results in increased expression of ACLY mRNA	PMID:20706672
10065	ACLY	ATP citrate lyase	gene	CHEBI:88046	cylindrospermopsin	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C089595	cylindrospermopsin results in decreased expression of ACLY mRNA	PMID:38735451
10065	ACLY	ATP citrate lyase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ACLY protein	PMID:37664457
10065	ACLY	ATP citrate lyase	gene	CHEBI:9144	silibinin	decreases phosphorylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C440975	Silybin results in decreased phosphorylation of ACLY protein	PMID:25294820
10065	ACLY	ATP citrate lyase	gene	CHEBI:93310	N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide	multiple interactions	ISO	RGD:10064	E	RGD:6480464	20181016	CTD	MESH:C492919	N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Particulate Matter results in increased expression of ACLY protein]	PMID:29635361
10065	ACLY	ATP citrate lyase	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D013467	Sulindac results in increased expression of ACLY mRNA	PMID:32535746
10065	ACLY	ATP citrate lyase	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:2018	E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in decreased expression of ACLY mRNA	PMID:26141394
10065	ACLY	ATP citrate lyase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ACLY mRNA	PMID:38568856
10065	ACLY	ATP citrate lyase	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:10064	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of ACLY protein	PMID:24648495
10065	ACLY	ATP citrate lyase	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:2018	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of ACLY protein	PMID:35544339
10065	ACLY	ATP citrate lyase	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ACLY protein	PMID:38598786
10065	ACLY	ATP citrate lyase	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:10064	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of ACLY mRNA	PMID:32835833
10065	ACLY	ATP citrate lyase	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of ACLY mRNA	PMID:25572481
10067	ACO1	aconitase 1	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:10066	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of ACO1 protein	PMID:36252740
10067	ACO1	aconitase 1	gene	CHEBI:1224	2-nitrofluorene	increases expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:C019499	2-nitrofluorene results in increased expression of ACO1 mRNA	PMID:15890375
10067	ACO1	aconitase 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:10066	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ACO1 mRNA	PMID:33045310
10067	ACO1	aconitase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACO1 mRNA]	PMID:31150632
10067	ACO1	aconitase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ACO1 mRNA	PMID:33167477
10067	ACO1	aconitase 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of ACO1 mRNA	PMID:23724009
10067	ACO1	aconitase 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ACO1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ACO1 mRNA	PMID:32699268
10067	ACO1	aconitase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20181016	CTD	MESH:D010100	[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein; Oxygen inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein]	PMID:16135072
10067	ACO1	aconitase 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ACO1 mRNA	PMID:20044591
10067	ACO1	aconitase 1	gene	CHEBI:16240	hydrogen peroxide	increases activity	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased activity of ACO1 protein	PMID:15664434
10067	ACO1	aconitase 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of ACO1 mRNA	PMID:17103110
10067	ACO1	aconitase 1	gene	CHEBI:16412	lipopolysaccharide	increases activity	ISO	RGD:10066	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased activity of ACO1 protein	PMID:11054110
10067	ACO1	aconitase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:10066	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ACO1 mRNA	PMID:39241906
10067	ACO1	aconitase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of ACO1 protein	PMID:11054110
10067	ACO1	aconitase 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of ACO1 mRNA	PMID:16684588
10067	ACO1	aconitase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of ACO1 mRNA	PMID:21185374
10067	ACO1	aconitase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:10066	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ACO1 mRNA	PMID:39298647
10067	ACO1	aconitase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ACO1 mRNA	PMID:26496021
10067	ACO1	aconitase 1	gene	CHEBI:16480	nitric oxide	decreases expression	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide results in decreased expression of ACO1 mRNA	PMID:16886906
10067	ACO1	aconitase 1	gene	CHEBI:16480	nitric oxide	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:D009569	STAT5A protein affects the reaction [Nitric Oxide results in decreased expression of ACO1 mRNA]; STAT5B protein affects the reaction [Nitric Oxide results in decreased expression of ACO1 mRNA]	PMID:16886906
10067	ACO1	aconitase 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:2019	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ACO1 mRNA	PMID:33387578
10067	ACO1	aconitase 1	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D005947	Glucose results in increased expression of ACO1 protein	PMID:38483099
10067	ACO1	aconitase 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:2019	E	RGD:6480464	20240806	CTD	MESH:D005947	Glucose results in increased expression of ACO1 protein	PMID:38483099
10067	ACO1	aconitase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20181016	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein; Oxygen inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein]	PMID:16135072
10067	ACO1	aconitase 1	gene	CHEBI:174045	Fluorocitric acid	decreases activity	ISO	RGD:2019	E	RGD:6480464	20210706	CTD	MESH:C007744	fluorocitrate results in decreased activity of ACO1 protein	PMID:17469137
10067	ACO1	aconitase 1	gene	CHEBI:17580	linalool	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C018584	linalool results in increased expression of ACO1 mRNA	PMID:24752549
10067	ACO1	aconitase 1	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D005947	Glucose results in increased expression of ACO1 protein	PMID:38483099
10067	ACO1	aconitase 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:2019	E	RGD:6480464	20240806	CTD	MESH:D005947	Glucose results in increased expression of ACO1 protein	PMID:38483099
10067	ACO1	aconitase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20181016	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein; Oxygen inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein]	PMID:16135072
10067	ACO1	aconitase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACO1 mRNA	PMID:36331819
10067	ACO1	aconitase 1	gene	CHEBI:18248	iron atom	affects metabolic processing	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:D007501	ACO1 protein affects the metabolism of Iron	PMID:17194590
10067	ACO1	aconitase 1	gene	CHEBI:18248	iron atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D007501	Iron inhibits the reaction [nickel chloride results in increased activity of ACO1 protein]; Iron inhibits the reaction [Nickel results in increased activity of ACO1 protein]	PMID:16039939|PMID:16877034
10067	ACO1	aconitase 1	gene	CHEBI:18248	iron atom	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20120814	CTD	MESH:D007501	[Deferoxamine results in decreased abundance of Iron] which results in increased activity of ACO1 protein	PMID:15893546
10067	ACO1	aconitase 1	gene	CHEBI:18291	manganese atom	decreases activity	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased activity of ACO1 protein	PMID:17469137
10067	ACO1	aconitase 1	gene	CHEBI:18291	manganese atom	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased activity of ACO1 protein	PMID:16386771
10067	ACO1	aconitase 1	gene	CHEBI:18291	manganese atom	increases activity	ISO	RGD:2019	E	RGD:6480464	20120501	CTD	MESH:D008345	Manganese results in increased activity of ACO1 protein	PMID:16545456|PMID:16568477
10067	ACO1	aconitase 1	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased stability of [ACO1 protein binds to SLC11A2 mRNA]	PMID:16729984
10067	ACO1	aconitase 1	gene	CHEBI:18421	superoxide	decreases activity	ISO	RGD:10066	E	RGD:6480464	20190219	CTD	MESH:D013481	Superoxides results in decreased activity of ACO1 protein	PMID:28542246
10067	ACO1	aconitase 1	gene	CHEBI:18421	superoxide	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20190219	CTD	MESH:D013481	[SOD1 protein results in decreased abundance of Superoxides] which results in increased expression of ACO1 protein	PMID:28542246
10067	ACO1	aconitase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	affects expression	ISO	RGD:2019	E	RGD:6480464	20170516	CTD	MESH:D000517	alpha-Chlorohydrin affects the expression of ACO1 protein	PMID:26597043
10067	ACO1	aconitase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:2019	E	RGD:6480464	20170516	CTD	MESH:D000517	alpha-Chlorohydrin analog results in decreased expression of ACO1 protein	PMID:26597043
10067	ACO1	aconitase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:2019	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ACO1 mRNA	PMID:28522335
10067	ACO1	aconitase 1	gene	CHEBI:188851	Muraglitazar	increases expression	ISO	RGD:2019	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of ACO1 mRNA	PMID:21515302
10067	ACO1	aconitase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACO1 mRNA	PMID:35301059
10067	ACO1	aconitase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACO1 mRNA	PMID:37236586
10067	ACO1	aconitase 1	gene	CHEBI:231505	gallium nitrate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C027235	gallium nitrate results in increased expression of ACO1 mRNA	PMID:18586083
10067	ACO1	aconitase 1	gene	CHEBI:235319	Pervanadate	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20251014	CTD	MESH:C076715	pervanadate inhibits the reaction [EGF protein results in decreased activity of ACO1 protein]; pervanadate inhibits the reaction [TRH protein results in decreased activity of ACO1 protein]; pervanadate promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein]	PMID:10889193
10067	ACO1	aconitase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ACO1 mRNA	PMID:15890375
10067	ACO1	aconitase 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ACO1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ACO1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of ACO1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of ACO1 mRNA	PMID:32699268|PMID:35430440
10067	ACO1	aconitase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ACO1 mRNA	PMID:34911549
10067	ACO1	aconitase 1	gene	CHEBI:2663	amiodarone	affects expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of ACO1 mRNA	PMID:19483382
10067	ACO1	aconitase 1	gene	CHEBI:27363	zinc atom	decreases activity	ISO	RGD:10066	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased activity of ACO1 protein	PMID:18073202
10067	ACO1	aconitase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:10066	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACO1 mRNA	PMID:31919559
10067	ACO1	aconitase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:2019	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACO1 mRNA	PMID:31150632
10067	ACO1	aconitase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACO1 mRNA]	PMID:31150632
10067	ACO1	aconitase 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:10066	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ACO1 mRNA	PMID:25629700
10067	ACO1	aconitase 1	gene	CHEBI:27504	mitomycin C	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	ACO1 protein affects the susceptibility to Mitomycin	PMID:16217747
10067	ACO1	aconitase 1	gene	CHEBI:27563	arsenic atom	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased activity of ACO1 protein	PMID:16386771
10067	ACO1	aconitase 1	gene	CHEBI:27638	cobalt atom	increases activity	EXP		E	RGD:6480464	20120717	CTD	MESH:D003035	Cobalt results in increased activity of ACO1 protein	PMID:16386771|PMID:16877034
10067	ACO1	aconitase 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ACO1 protein	PMID:38460933
10067	ACO1	aconitase 1	gene	CHEBI:27698	vanadium atom	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D014639	Vanadium results in increased activity of ACO1 protein	PMID:16386771
10067	ACO1	aconitase 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ACO1 mRNA	PMID:25583101
10067	ACO1	aconitase 1	gene	CHEBI:28112	nickel atom	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in increased activity of ACO1 protein	PMID:16386771|PMID:16877034
10067	ACO1	aconitase 1	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D009532	ferric sulfate inhibits the reaction [Nickel results in increased activity of ACO1 protein]; Iron inhibits the reaction [Nickel results in increased activity of ACO1 protein]	PMID:16877034
10067	ACO1	aconitase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:10066	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACO1 mRNA	PMID:21570461
10067	ACO1	aconitase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases activity	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased activity of ACO1 protein	PMID:9443932
10067	ACO1	aconitase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACO1 mRNA; Tetrachlorodibenzodioxin results in decreased expression of ACO1 protein	PMID:18163543|PMID:28213091
10067	ACO1	aconitase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACO1 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ACO1 gene]	PMID:17942748|PMID:28213091
10067	ACO1	aconitase 1	gene	CHEBI:28201	rotenone	decreases activity	EXP		E	RGD:6480464	20130416	CTD	MESH:D012402	Rotenone results in decreased activity of ACO1 protein	PMID:21570952
10067	ACO1	aconitase 1	gene	CHEBI:28201	rotenone	increases activity	EXP		E	RGD:6480464	20130416	CTD	MESH:D012402	Rotenone results in increased activity of ACO1 protein	PMID:21570952
10067	ACO1	aconitase 1	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:2019	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of ACO1 mRNA	PMID:22465980
10067	ACO1	aconitase 1	gene	CHEBI:28694	copper atom	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	Copper results in increased activity of ACO1 protein	PMID:16386771
10067	ACO1	aconitase 1	gene	CHEBI:28748	doxorubicin	affects activity	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin affects the activity of ACO1 protein	PMID:11731422
10067	ACO1	aconitase 1	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	ACO1 protein affects the susceptibility to Doxorubicin	PMID:16217747
10067	ACO1	aconitase 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ACO1 mRNA	PMID:29803840
10067	ACO1	aconitase 1	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Aspartame] affects the expression of ACO1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACO1 mRNA	PMID:23783067
10067	ACO1	aconitase 1	gene	CHEBI:28794	coumarin	affects expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin affects the expression of ACO1 mRNA	PMID:16963487
10067	ACO1	aconitase 1	gene	CHEBI:28869	menadione	affects activity	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the activity of ACO1 protein	PMID:10037708
10067	ACO1	aconitase 1	gene	CHEBI:28984	aluminium atom	decreases activity	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in decreased activity of ACO1 protein	PMID:10806405
10067	ACO1	aconitase 1	gene	CHEBI:29287	gold atom	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which results in increased expression of ACO1 mRNA	PMID:28433809
10067	ACO1	aconitase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:2019	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of ACO1 protein	PMID:29459688
10067	ACO1	aconitase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:10066	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ACO1 exon; Benzo(a)pyrene results in decreased methylation of ACO1 intron	PMID:27901495
10067	ACO1	aconitase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:10066	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACO1 mRNA	PMID:22228805
10067	ACO1	aconitase 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20140812	CTD	MESH:D001564	[Soot co-treated with Benzo(a)pyrene] results in increased expression of ACO1 protein	PMID:24464499
10067	ACO1	aconitase 1	gene	CHEBI:30050	gold(0)	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which results in increased expression of ACO1 mRNA	PMID:28433809
10067	ACO1	aconitase 1	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:2019	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of ACO1 mRNA	PMID:22465980
10067	ACO1	aconitase 1	gene	CHEBI:30052	copper(0)	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	Copper results in increased activity of ACO1 protein	PMID:16386771
10067	ACO1	aconitase 1	gene	CHEBI:30185	zinc(0)	decreases activity	ISO	RGD:10066	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased activity of ACO1 protein	PMID:18073202
10067	ACO1	aconitase 1	gene	CHEBI:3023	benzbromarone	affects expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of ACO1 mRNA	PMID:19483382
10067	ACO1	aconitase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ACO1 protein	PMID:19364129
10067	ACO1	aconitase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ACO1 mRNA	PMID:20458559
10067	ACO1	aconitase 1	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of ACO1 mRNA	PMID:16483693
10067	ACO1	aconitase 1	gene	CHEBI:31604	ferric ammonium citrate	decreases activity	ISO	RGD:10066	E	RGD:6480464	20130122	CTD	MESH:C013531	ferric ammonium citrate results in decreased activity of ACO1 protein	PMID:18073202
10067	ACO1	aconitase 1	gene	CHEBI:31604	ferric ammonium citrate	increases activity	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:C013531	ferric ammonium citrate results in increased activity of ACO1 protein	PMID:11054110
10067	ACO1	aconitase 1	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ACO1 gene	PMID:31601247
10067	ACO1	aconitase 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:2019	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ACO1 mRNA	PMID:30047161
10067	ACO1	aconitase 1	gene	CHEBI:32195	Tesaglitazar	increases expression	ISO	RGD:2019	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of ACO1 mRNA	PMID:21515302
10067	ACO1	aconitase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:10066	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of ACO1 mRNA	PMID:29264374
10067	ACO1	aconitase 1	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of ACO1 mRNA	PMID:19483382
10067	ACO1	aconitase 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:2019	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ACO1 mRNA	PMID:34492290
10067	ACO1	aconitase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ACO1 mRNA	PMID:18648102
10067	ACO1	aconitase 1	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of ACO1 mRNA	PMID:19483382
10067	ACO1	aconitase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:2019	E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of ACO1 mRNA	PMID:15890375|PMID:16940010|PMID:19162173|PMID:22484513
10067	ACO1	aconitase 1	gene	CHEBI:32687	piperonyl butoxide	increases expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of ACO1 mRNA	PMID:15890375
10067	ACO1	aconitase 1	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	increases expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ACO1 mRNA	PMID:15890375
10067	ACO1	aconitase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of ACO1 protein	PMID:34186270
10067	ACO1	aconitase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ACO1 gene	PMID:31601247
10067	ACO1	aconitase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2019	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ACO1 mRNA	PMID:25181051
10067	ACO1	aconitase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of ACO1 mRNA	PMID:26496021
10067	ACO1	aconitase 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of ACO1 protein	PMID:31675489
10067	ACO1	aconitase 1	gene	CHEBI:33629	aluminium(0)	decreases activity	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in decreased activity of ACO1 protein	PMID:10806405
10067	ACO1	aconitase 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:10066	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ACO1 mRNA	PMID:26682919
10067	ACO1	aconitase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:10066	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of ACO1 mRNA	PMID:39298647
10067	ACO1	aconitase 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ACO1 protein	PMID:34186270
10067	ACO1	aconitase 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ACO1 protein	PMID:34186270
10067	ACO1	aconitase 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:10066	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ACO1 mRNA	PMID:37019170
10067	ACO1	aconitase 1	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of ACO1 mRNA	PMID:17602206
10067	ACO1	aconitase 1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of ACO1 gene	PMID:22964155
10067	ACO1	aconitase 1	gene	CHEBI:34887	nickel dichloride	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C022838	nickel chloride results in decreased activity of ACO1 protein	PMID:17018869
10067	ACO1	aconitase 1	gene	CHEBI:34887	nickel dichloride	increases activity	EXP		E	RGD:6480464	20120814	CTD	MESH:C022838	nickel chloride results in increased activity of ACO1 protein	PMID:16039939|PMID:16649251
10067	ACO1	aconitase 1	gene	CHEBI:34887	nickel dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	[nickel chloride results in increased activity of ACO1 protein] inhibits the reaction [ferrous sulfate results in increased expression of FTL protein]; [nickel chloride results in increased activity of ACO1 protein] which results in increased expression of and results in increased stability of TFRC mRNA; Iron inhibits the reaction [nickel chloride results in increased activity of ACO1 protein]	PMID:16039939
10067	ACO1	aconitase 1	gene	CHEBI:34905	paraquat	decreases activity	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in decreased activity of ACO1 protein	PMID:11520895|PMID:17324120
10067	ACO1	aconitase 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:10066	E	RGD:6480464	20190219	CTD	MESH:D010269	Paraquat results in decreased expression of ACO1 protein	PMID:28542246
10067	ACO1	aconitase 1	gene	CHEBI:34905	paraquat	increases activity	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in increased activity of ACO1 protein	PMID:15664434
10067	ACO1	aconitase 1	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:2019	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of ACO1 mRNA	PMID:30589522
10067	ACO1	aconitase 1	gene	CHEBI:35154	manganese(0)	decreases activity	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased activity of ACO1 protein	PMID:17469137
10067	ACO1	aconitase 1	gene	CHEBI:35154	manganese(0)	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased activity of ACO1 protein	PMID:16386771
10067	ACO1	aconitase 1	gene	CHEBI:35154	manganese(0)	increases activity	ISO	RGD:2019	E	RGD:6480464	20120501	CTD	MESH:D008345	Manganese results in increased activity of ACO1 protein	PMID:16545456|PMID:16568477
10067	ACO1	aconitase 1	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased stability of [ACO1 protein binds to SLC11A2 mRNA]	PMID:16729984
10067	ACO1	aconitase 1	gene	CHEBI:35170	vanadium(0)	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D014639	Vanadium results in increased activity of ACO1 protein	PMID:16386771
10067	ACO1	aconitase 1	gene	CHEBI:35456	cadmium dichloride	affects localization	ISO	RGD:2019	E	RGD:6480464	20141223	CTD	MESH:D019256	Cadmium Chloride affects the localization of ACO1 protein	PMID:25106854
10067	ACO1	aconitase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ACO1 mRNA	PMID:38568856
10067	ACO1	aconitase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ACO1 mRNA	PMID:26472689
10067	ACO1	aconitase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACO1 mRNA; Cadmium Chloride results in decreased activity of and affects the folding of ACO1 protein	PMID:25106854|PMID:35301059
10067	ACO1	aconitase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACO1 mRNA	PMID:37236586
10067	ACO1	aconitase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20141223	CTD	MESH:D019256	Butylated Hydroxyanisole inhibits the reaction [Cadmium Chloride affects the localization of ACO1 protein]; Cadmium Chloride promotes the reaction [ACO1 protein binds to ACO1 protein]; Cadmium Chloride results in decreased expression of and results in decreased activity of ACO1 protein; KN 93 inhibits the reaction [Cadmium Chloride affects the localization of ACO1 protein]	PMID:25106854
10067	ACO1	aconitase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ACO1 mRNA	PMID:19162173|PMID:28511854
10067	ACO1	aconitase 1	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:2019	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ACO1 gene	PMID:22079235
10067	ACO1	aconitase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:2019	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ACO1 mRNA	PMID:24386269
10067	ACO1	aconitase 1	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of ACO1 mRNA	PMID:15890375
10067	ACO1	aconitase 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ACO1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ACO1 mRNA	PMID:32699268
10067	ACO1	aconitase 1	gene	CHEBI:37187	lead nitrate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate results in decreased expression of ACO1 protein	PMID:22502979
10067	ACO1	aconitase 1	gene	CHEBI:37187	lead nitrate	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C017461	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in decreased expression of ACO1 protein]	PMID:22502979
10067	ACO1	aconitase 1	gene	CHEBI:3750	clofibrate	affects expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of ACO1 mRNA	PMID:19483382
10067	ACO1	aconitase 1	gene	CHEBI:3750	clofibrate	increases activity	ISO	RGD:2019	E	RGD:6480464	20120613	CTD	MESH:D002994	Clofibrate results in increased activity of ACO1 protein	PMID:11969379
10067	ACO1	aconitase 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases activity	ISO	RGD:10066	E	RGD:6480464	20181016	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein	PMID:10889193
10067	ACO1	aconitase 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases activity	ISO	RGD:2019	E	RGD:6480464	20181016	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein	PMID:10889193
10067	ACO1	aconitase 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20181016	CTD	MESH:D013755	Tetradecanoylphorbol Acetate inhibits the reaction [TRH protein results in increased activity of ACO1 protein]	PMID:10889193
10067	ACO1	aconitase 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20181016	CTD	MESH:D013755	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein]; Okadaic Acid promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein]; pervanadate promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein]	PMID:10889193
10067	ACO1	aconitase 1	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20181016	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [TRH protein results in increased activity of ACO1 protein]	PMID:10889193
10067	ACO1	aconitase 1	gene	CHEBI:37825	p-toluidine	increases expression	ISO	RGD:2019	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of ACO1 mRNA	PMID:27638505
10067	ACO1	aconitase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACO1 mRNA	PMID:36331819
10067	ACO1	aconitase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ACO1 mRNA	PMID:25979313
10067	ACO1	aconitase 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:2019	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ACO1 mRNA	PMID:30047161
10067	ACO1	aconitase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of ACO1 mRNA	PMID:20106945
10067	ACO1	aconitase 1	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of ACO1 mRNA	PMID:25047013
10067	ACO1	aconitase 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ACO1 mRNA	PMID:15890375
10067	ACO1	aconitase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:10066	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ACO1 mRNA	PMID:28973697
10067	ACO1	aconitase 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D005947	Glucose results in increased expression of ACO1 protein	PMID:38483099
10067	ACO1	aconitase 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:2019	E	RGD:6480464	20240806	CTD	MESH:D005947	Glucose results in increased expression of ACO1 protein	PMID:38483099
10067	ACO1	aconitase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20181016	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein; Oxygen inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein]	PMID:16135072
10067	ACO1	aconitase 1	gene	CHEBI:4356	desferrioxamine B	increases activity	EXP		E	RGD:6480464	20190611	CTD	MESH:D003676	Deferoxamine results in increased activity of ACO1 protein	PMID:10397746
10067	ACO1	aconitase 1	gene	CHEBI:4356	desferrioxamine B	increases activity	ISO	RGD:10066	E	RGD:6480464	20130122	CTD	MESH:D003676	Deferoxamine results in increased activity of ACO1 protein	PMID:11054110|PMID:18073202
10067	ACO1	aconitase 1	gene	CHEBI:4356	desferrioxamine B	increases activity	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D003676	Deferoxamine results in increased activity of ACO1 protein	PMID:16568477
10067	ACO1	aconitase 1	gene	CHEBI:4356	desferrioxamine B	increases expression	ISO	RGD:2019	E	RGD:6480464	20141223	CTD	MESH:D003676	Deferoxamine results in increased expression of ACO1 protein	PMID:25106854
10067	ACO1	aconitase 1	gene	CHEBI:4356	desferrioxamine B	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20120814	CTD	MESH:D003676	[Deferoxamine results in decreased abundance of Iron] which results in increased activity of ACO1 protein	PMID:15893546
10067	ACO1	aconitase 1	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:2019	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of ACO1 mRNA	PMID:24136188
10067	ACO1	aconitase 1	gene	CHEBI:44658	okadaic acid	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20181016	CTD	MESH:D019319	Okadaic Acid inhibits the reaction [EGF protein results in decreased activity of ACO1 protein]; Okadaic Acid inhibits the reaction [TRH protein results in decreased activity of ACO1 protein]; Okadaic Acid promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein]	PMID:10889193
10067	ACO1	aconitase 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ACO1 mRNA	PMID:28542535
10067	ACO1	aconitase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACO1 mRNA	PMID:17562736
10067	ACO1	aconitase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ACO1 mRNA	PMID:29067470
10067	ACO1	aconitase 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ACO1 protein	PMID:38460933
10067	ACO1	aconitase 1	gene	CHEBI:47217	arsane	increases activity	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased activity of ACO1 protein	PMID:16386771
10067	ACO1	aconitase 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:2019	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ACO1 mRNA	PMID:29391264
10067	ACO1	aconitase 1	gene	CHEBI:4811	epoxiconazole	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20180515	CTD	MESH:C109476	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ACO1 mRNA	PMID:29038839
10067	ACO1	aconitase 1	gene	CHEBI:4886	L-ethionine	affects expression	ISO	RGD:2019	E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of ACO1 mRNA	PMID:19483382
10067	ACO1	aconitase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACO1 mRNA	PMID:17942748
10067	ACO1	aconitase 1	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:10066	E	RGD:6480464	20150127	CTD	MESH:D005047	Etoposide results in increased expression of ACO1 mRNA	PMID:25270620
10067	ACO1	aconitase 1	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:10066	E	RGD:6480464	20181016	CTD	MESH:C029892	cupric chloride results in decreased expression of ACO1 protein	PMID:29617964
10067	ACO1	aconitase 1	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:2019	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of ACO1 mRNA	PMID:36868495
10067	ACO1	aconitase 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ACO1 protein	PMID:19364129
10067	ACO1	aconitase 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ACO1 mRNA	PMID:20458559
10067	ACO1	aconitase 1	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:2019	E	RGD:6480464	20121113	CTD	MESH:D011345	Fenofibrate results in increased expression of ACO1 mRNA	PMID:17264098
10067	ACO1	aconitase 1	gene	CHEBI:50385	hemin	decreases activity	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D006427	Hemin results in decreased activity of ACO1 protein	PMID:16568477
10067	ACO1	aconitase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:10066	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ACO1 mRNA; Nanotubes, Carbon results in decreased expression of ACO1 mRNA	PMID:25620056
10067	ACO1	aconitase 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:2019	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ACO1 mRNA	PMID:30047161
10067	ACO1	aconitase 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:2019	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ACO1 mRNA	PMID:24793618
10067	ACO1	aconitase 1	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in decreased expression of ACO1 mRNA	PMID:16780908
10067	ACO1	aconitase 1	gene	CHEBI:53438	iron(3+) sulfate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C024823	ferric sulfate inhibits the reaction [Nickel results in increased activity of ACO1 protein]	PMID:16877034
10067	ACO1	aconitase 1	gene	CHEBI:6030	isoniazide	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in decreased expression of ACO1 mRNA	PMID:40015660
10067	ACO1	aconitase 1	gene	CHEBI:6030	isoniazide	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of ACO1 protein	PMID:40015660
10067	ACO1	aconitase 1	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of ACO1 mRNA	PMID:20436886
10067	ACO1	aconitase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ACO1 protein	PMID:32959892
10067	ACO1	aconitase 1	gene	CHEBI:63041	manganese(II) chloride	increases activity	ISO	RGD:2019	E	RGD:6480464	20120814	CTD	MESH:C025340	manganese chloride results in increased activity of ACO1 protein	PMID:15893546|PMID:16545456|PMID:16568477
10067	ACO1	aconitase 1	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:2019	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of ACO1 mRNA	PMID:24136188
10067	ACO1	aconitase 1	gene	CHEBI:6382	Lasiocarpine	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in decreased expression of ACO1 mRNA	PMID:40054833
10067	ACO1	aconitase 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:10066	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of ACO1 mRNA	PMID:19812364
10067	ACO1	aconitase 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:2019	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of ACO1 mRNA	PMID:24136188
10067	ACO1	aconitase 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of ACO1 mRNA	PMID:15336504
10067	ACO1	aconitase 1	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACO1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of ACO1 mRNA	PMID:23783067
10067	ACO1	aconitase 1	gene	CHEBI:6773	Mesaconitine	increases expression	ISO	RGD:2019	E	RGD:6480464	20231031	CTD	MESH:C019470	mesaconitine results in increased expression of ACO1 protein	PMID:37182599
10067	ACO1	aconitase 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D008694	Methamphetamine results in increased expression of ACO1 protein	PMID:19826936
10067	ACO1	aconitase 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:2019	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ACO1 mRNA	PMID:30467583
10067	ACO1	aconitase 1	gene	CHEBI:6820	methapyrilene	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of ACO1 mRNA	PMID:28935588
10067	ACO1	aconitase 1	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D008701	Methapyrilene results in increased expression of ACO1 mRNA	PMID:15890375
10067	ACO1	aconitase 1	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:10066	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of ACO1 mRNA	PMID:27462272
10067	ACO1	aconitase 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ACO1 mRNA	PMID:31758290
10067	ACO1	aconitase 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ACO1 protein	PMID:34186270
10067	ACO1	aconitase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:10066	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ACO1 mRNA	PMID:22206623
10067	ACO1	aconitase 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:2019	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ACO1 mRNA	PMID:24136188
10067	ACO1	aconitase 1	gene	CHEBI:75832	iron(2+) sulfate (anhydrous)	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C020748	[nickel chloride results in increased activity of ACO1 protein] inhibits the reaction [ferrous sulfate results in increased expression of FTL protein]	PMID:16039939
10067	ACO1	aconitase 1	gene	CHEBI:76359	butylated hydroxyanisole	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20141223	CTD	MESH:D002083	Butylated Hydroxyanisole inhibits the reaction [Cadmium Chloride affects the localization of ACO1 protein]	PMID:25106854
10067	ACO1	aconitase 1	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	ISO	RGD:2019	E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of ACO1 mRNA	PMID:19483382
10067	ACO1	aconitase 1	gene	CHEBI:7772	omeprazole	affects expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of ACO1 mRNA	PMID:19483382
10067	ACO1	aconitase 1	gene	CHEBI:78741	oxidopamine	affects response to substance	ISO	RGD:10066	E	RGD:6480464	20181016	CTD	MESH:D016627	ACO1 protein affects the susceptibility to Oxidopamine	PMID:19913091
10067	ACO1	aconitase 1	gene	CHEBI:78741	oxidopamine	increases expression	ISO	RGD:10066	E	RGD:6480464	20181016	CTD	MESH:D016627	Oxidopamine results in increased expression of ACO1 mRNA	PMID:19913091
10067	ACO1	aconitase 1	gene	CHEBI:78741	oxidopamine	multiple interactions	ISO	RGD:10066	E	RGD:6480464	20181016	CTD	MESH:D016627	[ACO1 protein affects the susceptibility to Oxidopamine] which results in decreased expression of HEPH mRNA; Oxidopamine promotes the reaction [ACO1 protein results in decreased expression of SLC40A1 mRNA]	PMID:19913091
10067	ACO1	aconitase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ACO1 gene]	PMID:28238834
10067	ACO1	aconitase 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ACO1 mRNA	PMID:19159669
10067	ACO1	aconitase 1	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:10066	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of ACO1 mRNA	PMID:22538082
10067	ACO1	aconitase 1	gene	CHEBI:81758	cyproconazole	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20180515	CTD	MESH:C093628	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ACO1 mRNA	PMID:29038839
10067	ACO1	aconitase 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ACO1 protein	PMID:31675489
10067	ACO1	aconitase 1	gene	CHEBI:82664	iron(0)	affects metabolic processing	ISO	RGD:10066	E	RGD:6480464	20140902	CTD	MESH:D007501	ACO1 protein affects the metabolism of Iron	PMID:17194590
10067	ACO1	aconitase 1	gene	CHEBI:82664	iron(0)	multiple interactions	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron inhibits the reaction [nickel chloride results in increased activity of ACO1 protein]; Iron inhibits the reaction [Nickel results in increased activity of ACO1 protein]	PMID:16039939|PMID:16877034
10067	ACO1	aconitase 1	gene	CHEBI:82664	iron(0)	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20140902	CTD	MESH:D007501	[Deferoxamine results in decreased abundance of Iron] which results in increased activity of ACO1 protein	PMID:15893546
10067	ACO1	aconitase 1	gene	CHEBI:84050	trabectedin	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C099150	Trabectedin results in increased expression of ACO1 mRNA; Trabectedin results in increased expression of ACO1 protein	PMID:36396105
10067	ACO1	aconitase 1	gene	CHEBI:8434	prochloraz	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20180515	CTD	MESH:C045362	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACO1 mRNA	PMID:29038839
10067	ACO1	aconitase 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:2019	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of ACO1 mRNA	PMID:30047161
10067	ACO1	aconitase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of ACO1 mRNA	PMID:19483382
10067	ACO1	aconitase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:2019	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ACO1 mRNA	PMID:30047161
10067	ACO1	aconitase 1	gene	CHEBI:91460	KN-93	multiple interactions	ISO	RGD:2019	E	RGD:6480464	20160503	CTD	MESH:C072105	KN 93 inhibits the reaction [Cadmium Chloride affects the localization of ACO1 protein]	PMID:25106854
10067	ACO1	aconitase 1	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:2019	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ACO1 mRNA	PMID:19281266
10067	ACO1	aconitase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ACO1 mRNA	PMID:21346803
10067	ACO1	aconitase 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ACO1 mRNA	PMID:38568856
10067	ACO1	aconitase 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:2019	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of ACO1 protein	PMID:35544339
10067	ACO1	aconitase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:2019	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ACO1 mRNA	PMID:21346803
10067	ACO1	aconitase 1	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:2019	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of ACO1 mRNA	PMID:21515302
10067	ACO1	aconitase 1	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:2019	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of ACO1 gene	PMID:31079544
10069	ACP1	acid phosphatase 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ACP1 mRNA	PMID:25812627
10069	ACP1	acid phosphatase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of ACP1 mRNA	PMID:21934132|PMID:33167477
10069	ACP1	acid phosphatase 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ACP1 mRNA	PMID:26079696
10069	ACP1	acid phosphatase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:10068	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ACP1 mRNA	PMID:39241906
10069	ACP1	acid phosphatase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:10068	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ACP1 mRNA	PMID:39298647
10069	ACP1	acid phosphatase 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:10068	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of ACP1 mRNA	PMID:19448997
10069	ACP1	acid phosphatase 1	gene	CHEBI:17440	4-nitrophenyl phosphate	increases hydrolysis	EXP		E	RGD:6480464	20161115	CTD	MESH:C008644	ACP1 protein results in increased hydrolysis of nitrophenylphosphate	PMID:24287560
10069	ACP1	acid phosphatase 1	gene	CHEBI:17440	4-nitrophenyl phosphate	multiple interactions	EXP		E	RGD:6480464	20161115	CTD	MESH:C008644	Benzoic Acid analog inhibits the reaction [ACP1 protein results in increased hydrolysis of nitrophenylphosphate]; Thiazolidines analog inhibits the reaction [ACP1 protein results in increased hydrolysis of nitrophenylphosphate]	PMID:24287560
10069	ACP1	acid phosphatase 1	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:10068	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of ACP1 mRNA	PMID:17997037
10069	ACP1	acid phosphatase 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ACP1 protein	PMID:37730182
10069	ACP1	acid phosphatase 1	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:10068	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of ACP1 mRNA	PMID:17997037
10069	ACP1	acid phosphatase 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:2020	E	RGD:6480464	20130618	CTD	MESH:D002104	Cadmium results in increased expression of ACP1 mRNA	PMID:17327700
10069	ACP1	acid phosphatase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ACP1 mRNA	PMID:27153756
10069	ACP1	acid phosphatase 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ACP1 mRNA	PMID:35430440
10069	ACP1	acid phosphatase 1	gene	CHEBI:2654	aminoglutethimide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in decreased expression of ACP1 protein	PMID:26102013
10069	ACP1	acid phosphatase 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ACP1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ACP1 protein	PMID:38598786
10069	ACP1	acid phosphatase 1	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D014747	ACP1 protein affects the susceptibility to Vinblastine	PMID:16217747
10069	ACP1	acid phosphatase 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:10068	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ACP1 mRNA	PMID:25629700
10069	ACP1	acid phosphatase 1	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ACP1 mRNA	PMID:19244175
10069	ACP1	acid phosphatase 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ACP1 protein	PMID:38460933
10069	ACP1	acid phosphatase 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:10068	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ACP1 protein	PMID:25505154
10069	ACP1	acid phosphatase 1	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of ACP1 mRNA	PMID:28903495
10069	ACP1	acid phosphatase 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ACP1 mRNA	PMID:24768652|PMID:25583101
10069	ACP1	acid phosphatase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:2020	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACP1 mRNA	PMID:32109520
10069	ACP1	acid phosphatase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:2020	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACP1 mRNA	PMID:34747641
10069	ACP1	acid phosphatase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:10068	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACP1 mRNA	PMID:17942748
10069	ACP1	acid phosphatase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ACP1 protein	PMID:33212167
10069	ACP1	acid phosphatase 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ACP1 mRNA	PMID:30851411
10069	ACP1	acid phosphatase 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:10068	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ACP1 protein	PMID:28918527
10069	ACP1	acid phosphatase 1	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	ACP1 protein affects the susceptibility to Doxorubicin	PMID:16217747
10069	ACP1	acid phosphatase 1	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ACP1 mRNA	PMID:25523186
10069	ACP1	acid phosphatase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of ACP1 protein	PMID:38228842
10069	ACP1	acid phosphatase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ACP1 promoter	PMID:27901495
10069	ACP1	acid phosphatase 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:10068	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to ACP1 promoter]	PMID:19654925
10069	ACP1	acid phosphatase 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ACP1 mRNA]; arsenite promotes the reaction [G3BP1 protein binds to ACP1 protein]	PMID:32406909
10069	ACP1	acid phosphatase 1	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ACP1 mRNA	PMID:25523186
10069	ACP1	acid phosphatase 1	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of ACP1 mRNA	PMID:25075043
10069	ACP1	acid phosphatase 1	gene	CHEBI:30746	benzoic acid	decreases activity	EXP		E	RGD:6480464	20161213	CTD	MESH:D019817	Benzoic Acid analog results in decreased activity of ACP1 protein	PMID:24287560
10069	ACP1	acid phosphatase 1	gene	CHEBI:30746	benzoic acid	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D019817	Benzoic Acid analog inhibits the reaction [ACP1 protein results in increased hydrolysis of nitrophenylphosphate]	PMID:24287560
10069	ACP1	acid phosphatase 1	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:2020	E	RGD:6480464	20130618	CTD	MESH:D000643	Ammonium Chloride affects the expression of ACP1 mRNA	PMID:16483693
10069	ACP1	acid phosphatase 1	gene	CHEBI:31746	kainic acid	decreases expression	ISO	RGD:10068	E	RGD:6480464	20120412	CTD	MESH:D007608	Kainic Acid results in decreased expression of ACP1 mRNA	PMID:17997037
10069	ACP1	acid phosphatase 1	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:2020	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ACP1 mRNA	PMID:25729387
10069	ACP1	acid phosphatase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:2020	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ACP1 mRNA	PMID:25729387
10069	ACP1	acid phosphatase 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:10068	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ACP1 promoter alternative form	PMID:35295148
10069	ACP1	acid phosphatase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:10068	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ACP1 mRNA	PMID:18648102
10069	ACP1	acid phosphatase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of ACP1 protein	PMID:31675489
10069	ACP1	acid phosphatase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ACP1 protein	PMID:34186270|PMID:37567409
10069	ACP1	acid phosphatase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:10068	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ACP1 mRNA	PMID:33221593
10069	ACP1	acid phosphatase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2020	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ACP1 mRNA	PMID:25181051|PMID:32145629|PMID:34947998
10069	ACP1	acid phosphatase 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ACP1 gene	PMID:31601247
10069	ACP1	acid phosphatase 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of ACP1 protein	PMID:31675489
10069	ACP1	acid phosphatase 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of ACP1 mRNA	PMID:19244175
10069	ACP1	acid phosphatase 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:10068	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ACP1 mRNA	PMID:17361019|PMID:21266533
10069	ACP1	acid phosphatase 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to ACP1 protein	PMID:32991956
10069	ACP1	acid phosphatase 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:10068	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ACP1 mRNA	PMID:34813904
10069	ACP1	acid phosphatase 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ACP1 protein	PMID:38598786
10069	ACP1	acid phosphatase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:2020	E	RGD:6480464	20130618	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ACP1 mRNA	PMID:17327700
10069	ACP1	acid phosphatase 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ACP1 protein	PMID:22609092
10069	ACP1	acid phosphatase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ACP1 mRNA	PMID:25812627
10069	ACP1	acid phosphatase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:10068	E	RGD:6480464	20240206	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ACP1 protein	PMID:37422089
10069	ACP1	acid phosphatase 1	gene	CHEBI:35622	thiazolidines	decreases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:D053778	Thiazolidines analog results in decreased activity of ACP1 protein	PMID:24287560
10069	ACP1	acid phosphatase 1	gene	CHEBI:35622	thiazolidines	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D053778	Thiazolidines analog inhibits the reaction [ACP1 protein results in increased hydrolysis of nitrophenylphosphate]	PMID:24287560
10069	ACP1	acid phosphatase 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ACP1 mRNA	PMID:24449571
10069	ACP1	acid phosphatase 1	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ACP1 mRNA	PMID:19244175
10069	ACP1	acid phosphatase 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:10068	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ACP1 mRNA	PMID:17585979
10069	ACP1	acid phosphatase 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:10068	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ACP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACP1 mRNA]	PMID:17585979
10069	ACP1	acid phosphatase 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ACP1 mRNA	PMID:28302478
10069	ACP1	acid phosphatase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ACP1 mRNA	PMID:31533062
10069	ACP1	acid phosphatase 1	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of ACP1 mRNA	PMID:26352163|PMID:28476498
10069	ACP1	acid phosphatase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ACP1 mRNA	PMID:25812627
10069	ACP1	acid phosphatase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ACP1 mRNA	PMID:25979313
10069	ACP1	acid phosphatase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:10068	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ACP1 mRNA	PMID:17963808
10069	ACP1	acid phosphatase 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ACP1 gene	PMID:29154799
10069	ACP1	acid phosphatase 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:10068	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ACP1 mRNA	PMID:17555576
10069	ACP1	acid phosphatase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:10068	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ACP1 mRNA	PMID:28973697
10069	ACP1	acid phosphatase 1	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ACP1 protein	PMID:20543569
10069	ACP1	acid phosphatase 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:10068	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ACP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACP1 mRNA]	PMID:17585979
10069	ACP1	acid phosphatase 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ACP1 protein	PMID:38460933
10069	ACP1	acid phosphatase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:10068	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ACP1 mRNA	PMID:17555576
10069	ACP1	acid phosphatase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:10068	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACP1 mRNA	PMID:17942748
10069	ACP1	acid phosphatase 1	gene	CHEBI:50035	alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of ACP1 mRNA	PMID:25075043
10069	ACP1	acid phosphatase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:10068	E	RGD:6480464	20200714	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ACP1 mRNA	PMID:31978390
10069	ACP1	acid phosphatase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:10068	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ACP1 mRNA; Nanotubes, Carbon results in increased expression of ACP1 mRNA	PMID:25554681
10069	ACP1	acid phosphatase 1	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:2020	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of ACP1 mRNA	PMID:23962444
10069	ACP1	acid phosphatase 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:2020	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ACP1 mRNA	PMID:24136188
10069	ACP1	acid phosphatase 1	gene	CHEBI:6030	isoniazide	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of ACP1 protein	PMID:40015660
10069	ACP1	acid phosphatase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ACP1 protein	PMID:32959892
10069	ACP1	acid phosphatase 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:2020	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of ACP1 mRNA	PMID:25729387
10069	ACP1	acid phosphatase 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:2020	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ACP1 mRNA	PMID:25729387
10069	ACP1	acid phosphatase 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:10068	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of ACP1 mRNA	PMID:19812364
10069	ACP1	acid phosphatase 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:10068	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ACP1 mRNA	PMID:23650126
10069	ACP1	acid phosphatase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:10068	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ACP1 mRNA	PMID:22206623
10069	ACP1	acid phosphatase 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ACP1 protein	PMID:37664457
10069	ACP1	acid phosphatase 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:2020	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ACP1 mRNA	PMID:24136188
10069	ACP1	acid phosphatase 1	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of ACP1 protein	PMID:39638853
10069	ACP1	acid phosphatase 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ACP1 mRNA	PMID:30851411
10069	ACP1	acid phosphatase 1	gene	CHEBI:78870	sodium nitrite	increases activity	EXP		E	RGD:6480464	20151215	CTD	MESH:D012977	Sodium Nitrite results in increased activity of ACP1 protein	PMID:26231821
10069	ACP1	acid phosphatase 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:2020	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ACP1 mRNA	PMID:32109520
10069	ACP1	acid phosphatase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ACP1 protein	PMID:31675489
10069	ACP1	acid phosphatase 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ACP1 protein	PMID:31675489
10069	ACP1	acid phosphatase 1	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ACP1 mRNA	PMID:26079696
10069	ACP1	acid phosphatase 1	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of ACP1 protein	PMID:38348393
10069	ACP1	acid phosphatase 1	gene	CHEBI:90633	perfluorododecanoic acid	increases expression	ISO	RGD:2020	E	RGD:6480464	20170303	CTD	MESH:C522391	perfluorododecanoic acid results in increased expression of ACP1 protein	PMID:19854247
10069	ACP1	acid phosphatase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ACP1 protein	PMID:37664457
10069	ACP1	acid phosphatase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:2020	E	RGD:6480464	20130618	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ACP1 mRNA	PMID:21346803
10069	ACP1	acid phosphatase 1	gene	CHEBI:9422	tebufenpyrad	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of ACP1 mRNA	PMID:33512557
10069	ACP1	acid phosphatase 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ACP1 protein	PMID:38598786
10069	ACP1	acid phosphatase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:2020	E	RGD:6480464	20130618	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ACP1 mRNA	PMID:21346803
10069	ACP1	acid phosphatase 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:2020	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of ACP1 mRNA	PMID:23034163
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ACP2 protein]	PMID:38195004
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:10070	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ACP2 mRNA	PMID:20188158
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ACP2 mRNA	PMID:33167477
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:10070	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACP2 mRNA	PMID:36331819
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:16170	mercury(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of ACP2 mRNA	PMID:17547211
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:10070	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ACP2 mRNA	PMID:30319688
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:10070	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ACP2 mRNA	PMID:39298647
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:16482	naphthalene	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C031721	naphthalene affects the expression of ACP2 protein	PMID:28803881
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:16482	naphthalene	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C031721	[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein	PMID:28803881
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACP2 mRNA	PMID:37042841
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:10070	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of ACP2 mRNA	PMID:23892564
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:10070	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ACP2 mRNA	PMID:34319233
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:2021	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ACP2 mRNA	PMID:33387578
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ACP2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ACP2 protein	PMID:38195004
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ACP2 mRNA	PMID:27153756
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:25195	mercury atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of ACP2 mRNA	PMID:17547211
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:10070	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ACP2 mRNA]	PMID:22206623
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:10070	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACP2 mRNA	PMID:40504410
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000966	Antimony Potassium Tartrate results in decreased expression of ACP2 mRNA	PMID:17547211
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:28073	chromium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002857	Chromium results in decreased expression of ACP2 mRNA	PMID:17547211
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:10070	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACP2 mRNA	PMID:21570461
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:10070	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACP2 mRNA	PMID:19770486
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:2021	E	RGD:6480464	20130122	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACP2 mRNA	PMID:16054898|PMID:18178546|PMID:18796159|PMID:20959002|PMID:22342509|PMID:32109520
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of ACP2 protein	PMID:39603559
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:2021	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ACP2 mRNA	PMID:28959563
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ACP2 mRNA	PMID:29803840
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:28851	phenanthrene	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C031181	phenanthrene affects the expression of ACP2 protein	PMID:28803881
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:28851	phenanthrene	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C031181	[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein	PMID:28803881
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:10070	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACP2 mRNA	PMID:40504410
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:10070	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACP2 mRNA	PMID:22228805
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:30304	antimony(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000965	Antimony results in decreased expression of ACP2 mRNA	PMID:17547211
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ACP2 mRNA	PMID:35984750
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:2021	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of ACP2 mRNA	PMID:16483693
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:2021	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ACP2 mRNA	PMID:30047161
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:10070	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ACP2 promoter alternative form	PMID:35295148
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:2021	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ACP2 mRNA	PMID:34492290
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:10070	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ACP2 mRNA	PMID:18648102
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:10070	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ACP2 mRNA	PMID:18301758
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ACP2 mRNA	PMID:30903817
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:2021	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ACP2 mRNA	PMID:25181051
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2021	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ACP2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ACP2 protein	PMID:34186270|PMID:37567409
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ACP2 mRNA	PMID:25979313
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:2021	E	RGD:6480464	20130122	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ACP2 mRNA	PMID:20959002
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of ACP2 protein	PMID:34186270
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ACP2 protein	PMID:34186270
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:10070	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ACP2 mRNA	PMID:37019170
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ACP2 mRNA	PMID:37042841
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:35298	anthracene	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C034020	anthracene affects the expression of ACP2 protein	PMID:28803881
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:35298	anthracene	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C034020	[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein	PMID:28803881
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ACP2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ACP2 protein	PMID:38195004
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:2021	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ACP2 mRNA	PMID:24386269
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of ACP2 mRNA	PMID:17547211
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ACP2 mRNA	PMID:24449571
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:3764	clotrimazole	increases expression	ISO	RGD:2021	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of ACP2 mRNA	PMID:30047161
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:2021	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of ACP2 mRNA	PMID:27638505
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:38922	dibenzofurans	increases expression	ISO	RGD:10070	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in increased expression of ACP2 mRNA	PMID:34254344
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:39106	pyrene	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C030984	pyrene affects the expression of ACP2 protein	PMID:28803881
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:39106	pyrene	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C030984	[naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein	PMID:28803881
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:10070	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACP2 mRNA	PMID:36331819
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:2021	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ACP2 mRNA	PMID:30047161
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ACP2 mRNA	PMID:20106945|PMID:25562108
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:10070	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACP2 mRNA	PMID:17562736
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:2021	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ACP2 mRNA	PMID:33387578
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:10070	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACP2 mRNA	PMID:40504410
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:10070	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ACP2 mRNA	PMID:35436446
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:10070	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of ACP2 mRNA	PMID:22334560
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:10070	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ACP2 mRNA; Nanotubes, Carbon results in increased expression of ACP2 mRNA	PMID:25554681
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:2021	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of ACP2 mRNA	PMID:34044035
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:2021	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ACP2 mRNA	PMID:24793618
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ACP2 mRNA	PMID:17547211
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ACP2 protein	PMID:32959892
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:2021	E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of ACP2 mRNA	PMID:18178546
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:2021	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of ACP2 mRNA	PMID:24136188
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:641	N-methyl-4-phenylpyridinium	affects expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium affects the expression of ACP2 mRNA	PMID:12710931
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of ACP2 mRNA	PMID:17547211
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of ACP2 mRNA	PMID:22101062
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ACP2 mRNA	PMID:31758290
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ACP2 protein	PMID:34186270
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:10070	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ACP2 mRNA	PMID:22206623
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:10070	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ACP2 mRNA]	PMID:22206623
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ACP2 protein	PMID:37664457
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:2021	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ACP2 mRNA	PMID:24136188
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:10070	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ACP2 mRNA	PMID:23091169
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:10070	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of ACP2 mRNA	PMID:22334560
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:10070	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in increased expression of ACP2 mRNA	PMID:21278054|PMID:22334560
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:2021	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ACP2 mRNA	PMID:30047161
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ACP2 protein	PMID:37664457
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:2021	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ACP2 mRNA	PMID:19281266
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in increased expression of ACP2 mRNA	PMID:11906190
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ACP2 mRNA	PMID:38568856
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ACP2 mRNA	PMID:29301935
10071	ACP2	acid phosphatase 2, lysosomal	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:2021	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ACP2 mRNA	PMID:21346803
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ACP5 mRNA	PMID:38218311
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of ACP5 mRNA	PMID:21551480
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ACP5 mRNA	PMID:26272509
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA	PMID:27188386
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:132624	columbianadin	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20260602	CTD	MESH:C064386	columbianadin inhibits the reaction [Dexamethasone results in increased expression of ACP5 protein]	PMID:40791102
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:133663	thymol sulfate(1-)	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20181016	CTD	MESH:D013943	Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]	PMID:30048646
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:136004	linsidomine	increases oxidation	ISO	RGD:2022	E	RGD:6480464	20180220	CTD	MESH:C002385	linsidomine results in increased oxidation of ACP5 protein	PMID:28086193
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:10072	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ACP5 mRNA	PMID:26251327
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:10072	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of ACP5 promoter	PMID:26251327
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:10072	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of ACP5 mRNA	PMID:16604517
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACP5 mRNA	PMID:36189433
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ACP5 mRNA	PMID:33729688
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:15940	nicotinic acid	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20250204	CTD	MESH:D009525	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Niacin inhibits the reaction [ferric ammonium citrate results in increased expression of ACP5 protein]]; Niacin inhibits the reaction [ferric ammonium citrate results in increased expression of ACP5 protein]	PMID:38081572
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:16171	NMN zwitterion	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20190219	CTD	MESH:D009537	Nicotinamide Mononucleotide inhibits the reaction [Aluminum Chloride results in increased expression of ACP5 protein]	PMID:30292833
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:10072	E	RGD:6480464	20140408	CTD	MESH:D000431	Ethanol results in increased expression of ACP5 mRNA	PMID:22892342
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20140408	CTD	MESH:D000431	Vitamin D inhibits the reaction [Ethanol results in increased expression of ACP5 mRNA]	PMID:22892342
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:10072	E	RGD:6480464	20251007	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ACP5 mRNA	PMID:31966594
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20251007	CTD	MESH:D006861	protosappanin A inhibits the reaction [Hydrogen Peroxide results in increased expression of ACP5 mRNA]	PMID:31966594
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:10072	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ACP5 mRNA; Lipopolysaccharides results in increased expression of ACP5 protein	PMID:22067001|PMID:30048646|PMID:39111524
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:2022	E	RGD:6480464	20241203	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ACP5 protein	PMID:39111524
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20161228	CTD	MESH:D008070	CSF1R affects the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA]; ganoderic acid A inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]	PMID:22067001|PMID:30048646|PMID:39111524
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20241203	CTD	MESH:D008070	ganoderic acid A inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]	PMID:39111524
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:10072	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ACP5 mRNA	PMID:39298647
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of ACP5 protein	PMID:15917159
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ACP5 mRNA	PMID:30165855
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACP5 mRNA	PMID:37042841
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:168262	Ganoderic acid A	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20241203	CTD	MESH:C515005	ganoderic acid A inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]	PMID:39111524
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:168262	Ganoderic acid A	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20241203	CTD	MESH:C515005	ganoderic acid A inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]	PMID:39111524
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:17158	methylglyoxal	increases expression	ISO	RGD:10072	E	RGD:6480464	20190910	CTD	MESH:D011765	Pyruvaldehyde results in increased expression of ACP5 mRNA	PMID:31103701
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:17158	methylglyoxal	increases expression	ISO	RGD:2022	E	RGD:6480464	20190910	CTD	MESH:D011765	Pyruvaldehyde results in increased expression of ACP5 mRNA; Pyruvaldehyde results in increased expression of ACP5 protein	PMID:31103701
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:17158	methylglyoxal	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20190219	CTD	MESH:D011765	[TNFSF11 protein co-treated with Pyruvaldehyde] affects the activity of ACP5 protein; [TNFSF11 protein co-treated with Pyruvaldehyde] results in decreased activity of ACP5 protein; bergenin inhibits the reaction [[TNFSF11 protein co-treated with Pyruvaldehyde] results in decreased activity of ACP5 protein]; MAPK8 protein affects the reaction [Pyruvaldehyde results in increased expression of ACP5 mRNA]	PMID:30217477|PMID:31103701|PMID:31369791
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of ACP5 mRNA	PMID:38160208
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:10072	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ACP5 mRNA	PMID:39922521
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACP5 mRNA	PMID:36189433
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of ACP5 mRNA	PMID:15917159
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:10072	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ACP5 mRNA	PMID:39922521
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:10072	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ACP5 mRNA	PMID:34319233
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002117	Calcitriol results in decreased expression of ACP5 protein	PMID:21985997
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:2022	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ACP5 mRNA	PMID:22061828
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:10072	E	RGD:6480464	20190312	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of ACP5 mRNA	PMID:30529163
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:18088	formononetin	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20221206	CTD	MESH:C007768	formononetin inhibits the reaction [Streptozocin results in increased activity of ACP5 protein]; formononetin inhibits the reaction [Streptozocin results in increased expression of ACP5 mRNA]	PMID:35315182
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:201431	Cyclosporin H	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20231219	CTD	MESH:C050025	cyclosporin H inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]	PMID:15207740
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:10072	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in decreased expression of ACP5 protein	PMID:34674107
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:2022	E	RGD:6480464	20140211	CTD	MESH:D002104	Cadmium results in increased expression of ACP5 protein alternative form	PMID:23954550
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20200609	CTD	MESH:D002104	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein]; 2-aminoethoxydiphenyl borate affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein]; [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with TNFSF11 protein] results in increased expression of ACP5 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACP5 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACP5 protein; [Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 mRNA; [Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein; [NFE2L2 protein affects the susceptibility to Cadmium] which affects the expression of ACP5 protein; KN 93 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein]; LGR4 protein inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with TNFSF11 protein] results in increased expression of ACP5 protein]; linarin inhibits the reaction [Cadmium results in decreased expression of ACP5 protein]; STO 609 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein]; W 7 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein]	PMID:31793751|PMID:32522522|PMID:34674107|PMID:35772369|PMID:37325564|PMID:38896780
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACP5 protein	PMID:35772369
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ACP5 mRNA	PMID:19549813
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ACP5 mRNA	PMID:27153756
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ACP5 mRNA	PMID:21641981
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:2567	alendronic acid	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20170207	CTD	MESH:D019386	Alendronate inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein]; Alendronate inhibits the reaction [Dexamethasone results in increased expression of ACP5 protein]; Alendronate inhibits the reaction [Modafinil results in increased expression of ACP5 mRNA]	PMID:27387537|PMID:29649498|PMID:40791102
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ACP5 mRNA	PMID:34911549
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27214	uranium atom	increases expression	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium results in increased expression of ACP5 protein	PMID:16436523
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27214	uranium atom	increases secretion	ISO	RGD:2022	E	RGD:6480464	20180828	CTD	MESH:D014501	Uranium results in increased secretion of ACP5 protein	PMID:29477364
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27214	uranium atom	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20180828	CTD	MESH:D014501	GHRL protein inhibits the reaction [Uranium results in increased secretion of ACP5 protein]	PMID:29477364
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27300	vitamin D	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20170303	CTD	MESH:D014807	Vitamin D inhibits the reaction [Ethanol results in increased expression of ACP5 mRNA]	PMID:22892342
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27363	zinc atom	decreases activity	ISO	RGD:2022	E	RGD:6480464	20130212	CTD	MESH:D015032	Zinc deficiency results in decreased activity of ACP5 protein	PMID:21893222
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:2022	E	RGD:6480464	20130212	CTD	MESH:D015032	Zinc deficiency results in decreased expression of ACP5 mRNA	PMID:21893222
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:10072	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACP5 mRNA	PMID:31919559
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27607	thymol	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20181016	CTD	MESH:D013943	Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]	PMID:30048646
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ACP5 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of ACP5 protein	PMID:38460933
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:2022	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ACP5 mRNA	PMID:31881176
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased activity of ACP5 protein]	PMID:16267019
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ACP5 mRNA	PMID:27594783
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ACP5 mRNA	PMID:27392435
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:27998	tungsten	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20210209	CTD	MESH:D014414	Tungsten promotes the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]	PMID:33146397
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28073	chromium atom	decreases activity	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:D002857	Chromium results in decreased activity of ACP5 protein	PMID:16866188
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of ACP5 mRNA	PMID:12075121
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20130122	CTD	MESH:D019833	[Zinc Sulfate co-treated with Genistein co-treated with CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of ACP5 mRNA	PMID:17295206
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:2022	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACP5 mRNA	PMID:34747641
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:2022	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACP5 mRNA	PMID:32109520
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:10072	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACP5 mRNA	PMID:17035482|PMID:21041162
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:2022	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACP5 mRNA	PMID:33387578
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACP5 mRNA; Tetrachlorodibenzodioxin results in increased expression of and results in increased secretion of ACP5 protein	PMID:17942748|PMID:29673856
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28177	theophylline	increases expression	ISO	RGD:2022	E	RGD:6480464	20160607	CTD	MESH:D013806	Theophylline results in increased expression of ACP5 mRNA; Theophylline results in increased expression of ACP5 protein	PMID:26851681
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28179	benzamide	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20181113	CTD	MESH:C037689	benzamide analog inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of ACP5 mRNA]	PMID:29935282
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:2022	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of ACP5 mRNA	PMID:28374803
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20130416	CTD	MESH:D012402	Rotenone inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]	PMID:19900598
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ACP5 mRNA	PMID:33212167
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ACP5 mRNA	PMID:30851411
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28618	1,4-dichlorobenzene	increases expression	ISO	RGD:10072	E	RGD:6480464	20171114	CTD	MESH:C018511	4-dichlorobenzene results in increased expression of ACP5 mRNA	PMID:26975756
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:10072	E	RGD:6480464	20180410	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ACP5 protein	PMID:29127033
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:10072	E	RGD:6480464	20180410	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ACP5 mRNA	PMID:29127033|PMID:32156525
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20180410	CTD	MESH:D012969	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Sodium Fluoride results in increased expression of ACP5 mRNA]; [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Sodium Fluoride] affects the expression of ACP5 protein; Sodium Fluoride promotes the reaction [TNFSF11 protein results in increased expression of ACP5 protein]	PMID:29127033|PMID:32156525
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ACP5 mRNA	PMID:29803840
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28819	naringin	decreases expression	ISO	RGD:10072	E	RGD:6480464	20150512	CTD	MESH:C005274	naringin results in decreased expression of ACP5 mRNA	PMID:24376342
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:28819	naringin	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20150512	CTD	MESH:C005274	naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of ACP5 mRNA]; naringin inhibits the reaction [Polymethyl Methacrylate analog results in increased expression of and results in increased activity of ACP5 protein]	PMID:21835177|PMID:24376342
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:2942	azadirachtin A	decreases expression	ISO	RGD:10072	E	RGD:6480464	20201215	CTD	MESH:C010329	azadirachtin results in decreased expression of ACP5 mRNA	PMID:31225646
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:2942	azadirachtin A	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20201215	CTD	MESH:C010329	azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of ACP5 mRNA]	PMID:31225646
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20190409	CTD	MESH:C017947	[NFE2L2 protein affects the susceptibility to sodium arsenite] which affects the expression of ACP5 protein	PMID:30742845
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ACP5 5' UTR; Benzo(a)pyrene affects the methylation of ACP5 promoter	PMID:27901495
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:2022	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACP5 mRNA	PMID:21839799
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:29865	benzo[a]pyrene	increases activity	ISO	RGD:10072	E	RGD:6480464	20221004	CTD	MESH:D001564	Benzo(a)pyrene results in increased activity of ACP5 protein	PMID:35777681
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACP5 mRNA	PMID:20064835|PMID:22316170
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:3001	beclomethasone	decreases activity	EXP		E	RGD:6480464	20131210	CTD	MESH:D001507	Beclomethasone results in decreased activity of ACP5 protein	PMID:8429434
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:30185	zinc(0)	decreases activity	ISO	RGD:2022	E	RGD:6480464	20130212	CTD	MESH:D015032	Zinc deficiency results in decreased activity of ACP5 protein	PMID:21893222
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:2022	E	RGD:6480464	20130212	CTD	MESH:D015032	Zinc deficiency results in decreased expression of ACP5 mRNA	PMID:21893222
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:30187	aluminium oxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000537	Aluminum Oxide results in decreased expression of ACP5 mRNA	PMID:15585240
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ACP5 mRNA	PMID:23806026|PMID:25895662
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:10072	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ACP5 mRNA	PMID:29341224|PMID:38811393
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ACP5 mRNA	PMID:35984750
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:30812	iron dichloride	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:C029451	ferrous chloride inhibits the reaction [Dithionite results in decreased activity of ACP5 protein]	PMID:6886379
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:31604	ferric ammonium citrate	increases expression	ISO	RGD:10072	E	RGD:6480464	20250204	CTD	MESH:C013531	ferric ammonium citrate results in increased expression of ACP5 protein	PMID:38081572
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:31604	ferric ammonium citrate	increases expression	ISO	RGD:2022	E	RGD:6480464	20230404	CTD	MESH:C013531	ferric ammonium citrate results in increased expression of ACP5 protein	PMID:36087815
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:31604	ferric ammonium citrate	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20250204	CTD	MESH:C013531	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Niacin inhibits the reaction [ferric ammonium citrate results in increased expression of ACP5 protein]]; Niacin inhibits the reaction [ferric ammonium citrate results in increased expression of ACP5 protein]	PMID:38081572
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:31604	ferric ammonium citrate	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20230404	CTD	MESH:C013531	Silybin inhibits the reaction [ferric ammonium citrate results in increased expression of ACP5 protein]	PMID:36087815
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:31801	Maxacalcitol	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C051883	maxacalcitol results in decreased expression of ACP5; maxacalcitol results in decreased expression of ACP5 protein	PMID:11576942|PMID:8840326
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:31859	modafinil	increases expression	ISO	RGD:2022	E	RGD:6480464	20180828	CTD	MESH:C048833	modafinil results in increased expression of ACP5 mRNA; modafinil results in increased expression of ACP5 protein	PMID:29649498
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:31859	modafinil	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20180828	CTD	MESH:C048833	Alendronate inhibits the reaction [modafinil results in increased expression of ACP5 mRNA]	PMID:29649498
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:2022	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of ACP5 mRNA	PMID:25729387
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of ACP5 mRNA	PMID:25729387
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:2022	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ACP5 mRNA	PMID:30047161
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:10072	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACP5 mRNA	PMID:23557971|PMID:35295148
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:2022	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ACP5 mRNA	PMID:23411599
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ACP5 mRNA	PMID:28943392
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:2022	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ACP5 mRNA	PMID:25380136
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2022	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of ACP5 mRNA	PMID:32145629
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:10072	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ACP5 mRNA	PMID:32156529|PMID:33221593|PMID:34585602|PMID:38701888
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2022	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ACP5 mRNA	PMID:25181051
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:2022	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ACP5 gene	PMID:28505145
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:34039	1,2,4-trimethylbenzene	decreases expression	ISO	RGD:2022	E	RGD:6480464	20120918	CTD	MESH:C010313	pseudocumene results in decreased expression of ACP5 protein	PMID:17337753
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:10072	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ACP5 mRNA	PMID:39298647
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:10072	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ACP5 promoter	PMID:33297965
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:10072	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ACP5 mRNA	PMID:32715474
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:10072	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of ACP5 mRNA	PMID:25270620
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ACP5 mRNA	PMID:19638242
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ACP5 mRNA	PMID:28943392
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:2022	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of ACP5 mRNA	PMID:35163327
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:35176	zinc sulfate	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20130122	CTD	MESH:D019287	[Cryptoxanthins co-treated with Zinc Sulfate] results in decreased expression of ACP5 mRNA; [CSF1 protein co-treated with TNFSF11 protein co-treated with Cryptoxanthins co-treated with Zinc Sulfate] results in decreased expression of ACP5 mRNA; [Zinc Sulfate co-treated with Genistein co-treated with CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of ACP5 mRNA	PMID:17295206|PMID:18636177
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:2022	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ACP5 mRNA	PMID:25380136
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ACP5 mRNA	PMID:38382870
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:2022	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ACP5 mRNA	PMID:25993096
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20120717	CTD	MESH:D019256	[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with TNFSF11 protein] results in increased expression of ACP5 protein; [Cadmium Chloride co-treated with TNFSF11] results in increased activity of ACP5 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACP5 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACP5 protein; LGR4 protein inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with TNFSF11 protein] results in increased expression of ACP5 protein]	PMID:21723911|PMID:31793751|PMID:35772369|PMID:37325564
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACP5 protein	PMID:35772369
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:35559	furan	increases expression	ISO	RGD:2022	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ACP5 mRNA	PMID:25539665
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:2022	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of ACP5 mRNA	PMID:25380136
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:3647	chlorpromazine	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20120412	CTD	MESH:D002746	Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]	PMID:21869564
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:3720	cisapride	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20190910	CTD	MESH:D020117	Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]	PMID:31150804
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:10072	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ACP5 mRNA	PMID:17585979
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:38397	perfluorononanoic acid	affects expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C101816	perfluoro-n-nonanoic acid affects the expression of ACP5 protein	PMID:38537583
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:2022	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of ACP5 mRNA	PMID:23125180
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:2022	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of ACP5 mRNA	PMID:22561333
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:10072	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ACP5 mRNA	PMID:17292431
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ACP5 mRNA	PMID:29154799
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ACP5 mRNA	PMID:23179753|PMID:26272509
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA	PMID:27188386
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:2022	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ACP5 mRNA	PMID:30047161|PMID:41580965
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:4027	cyclophosphamide	increases secretion	ISO	RGD:2022	E	RGD:6480464	20260303	CTD	MESH:D003520	Cyclophosphamide results in increased secretion of ACP5 protein	PMID:16751992
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:4027	cyclophosphamide	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20260303	CTD	MESH:D003520	icariin inhibits the reaction [Cyclophosphamide results in increased secretion of ACP5 protein]	PMID:16751992
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of ACP5 mRNA	PMID:27989131
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]	PMID:15207740
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:41879	dexamethasone	increases activity	ISO	RGD:2022	E	RGD:6480464	20170207	CTD	MESH:D003907	Dexamethasone results in increased activity of ACP5 protein	PMID:27387537|PMID:28363435
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:10072	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in increased expression of ACP5 mRNA	PMID:21041162
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:2022	E	RGD:6480464	20260602	CTD	MESH:D003907	Dexamethasone results in increased expression of ACP5 protein	PMID:40791102
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	[Thalidomide co-treated with Dexamethasone] results in decreased expression of ACP5 protein	PMID:16079895
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20170207	CTD	MESH:D003907	Alendronate inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein]; Alendronate inhibits the reaction [Dexamethasone results in increased expression of ACP5 protein]; caffeic acid phenethyl ester inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein]; columbianadin inhibits the reaction [Dexamethasone results in increased expression of ACP5 protein]; ginsenoside Rg3 inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein]	PMID:27387537|PMID:28363435|PMID:40791102
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:10072	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ACP5 mRNA	PMID:21041162
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:42160	dithionite(2-)	decreases activity	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:D004227	Dithionite results in decreased activity of ACP5 protein	PMID:6886379
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:42160	dithionite(2-)	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:D004227	ferrous chloride inhibits the reaction [Dithionite results in decreased activity of ACP5 protein]	PMID:6886379
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:10072	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ACP5 mRNA	PMID:28973697
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:42588	4-hydroxyphenyl retinamide	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide inhibits the reaction [TNF protein results in increased expression of ACP5 protein]	PMID:16230421
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:10072	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ACP5 mRNA	PMID:39922521
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:4356	desferrioxamine B	decreases activity	ISO	RGD:10072	E	RGD:6480464	20191008	CTD	MESH:D003676	Deferoxamine results in decreased activity of ACP5 protein	PMID:31238089
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:4356	desferrioxamine B	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20191008	CTD	MESH:D003676	Deferoxamine inhibits the reaction [TF protein results in increased activity of ACP5 protein]; TF protein inhibits the reaction [Deferoxamine results in decreased activity of ACP5 protein]	PMID:31238089
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:10072	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACP5 mRNA	PMID:17562736
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:4629	diosgenin	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20130702	CTD	MESH:D004144	Diosgenin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]	PMID:16331273
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:4630	diosmetin	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20230404	CTD	MESH:C039602	diosmetin inhibits the reaction [RANK Ligand affects the expression of ACP5 mRNA]	PMID:36563736
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ACP5 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of ACP5 protein	PMID:38460933
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:4775	ellagic acid	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20210309	CTD	MESH:D004610	Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]	PMID:32971123
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:10072	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of ACP5 mRNA	PMID:30529165
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:479072	2-aminopurine	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20190702	CTD	MESH:D015075	2-Aminopurine inhibits the reaction [[TNF protein co-treated with TNFSF11 protein] results in increased expression of ACP5 protein]	PMID:25739386
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:48107	nitric acid	increases expression	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:D017942	Nitric Acid results in increased expression of ACP5 protein	PMID:16436523
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:10072	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ACP5 mRNA	PMID:17555576
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:10072	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ACP5 mRNA	PMID:17942748
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACP5 mRNA	PMID:17942748
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:2022	E	RGD:6480464	20150825	CTD	MESH:D007213	Indomethacin results in decreased expression of ACP5 mRNA	PMID:25972201
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ACP5 mRNA	PMID:17145863
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:10072	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ACP5 mRNA; Nanotubes, Carbon results in decreased expression of ACP5 mRNA	PMID:25620056
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:10072	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ACP5 mRNA; Nanotubes, Carbon results in increased expression of ACP5 mRNA	PMID:25554681
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:2022	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ACP5 mRNA	PMID:30047161
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ACP5 mRNA	PMID:35964746
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:5118	fluoxetine	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20120613	CTD	MESH:D005473	Fluoxetine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]	PMID:15312242
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:53205	poly(methyl methacrylate) macromolecule	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20150512	CTD	MESH:D019904	naringin inhibits the reaction [Polymethyl Methacrylate analog results in increased expression of and results in increased activity of ACP5 protein]; Polymethyl Methacrylate analog results in increased expression of and results in increased activity of ACP5 protein	PMID:24376342
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:53227	poly(ethylene)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020959	Polyethylene results in decreased expression of ACP5 mRNA	PMID:15585240
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:53444	potassium dichromate	decreases activity	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:D011192	Potassium Dichromate results in decreased activity of ACP5 protein	PMID:16866188
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:5557	guanethidine	affects expression	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:D006145	Guanethidine affects the expression of ACP5 protein	PMID:14527964
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:5557	guanethidine	increases expression	ISO	RGD:2022	E	RGD:6480464	20120412	CTD	MESH:D006145	Guanethidine results in increased expression of ACP5 mRNA	PMID:14527964
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:5625	Harpagoside	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20250902	CTD	MESH:C033249	harpagoside inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; harpagoside inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]	PMID:26308264|PMID:28106392|PMID:35948905
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:10072	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ACP5 mRNA	PMID:38701926
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:59016	neohesperidin	decreases expression	ISO	RGD:10072	E	RGD:6480464	20250902	CTD	MESH:C546526	neohesperidin results in decreased expression of ACP5 mRNA	PMID:27664516
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ACP5 protein	PMID:32959892
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:61057	tacrolimus hydrate	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20120412	CTD	MESH:D016559	Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]	PMID:15207740
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of ACP5 mRNA	PMID:27188386
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:2022	E	RGD:6480464	20120717	CTD	MESH:C025340	manganese chloride results in increased expression of ACP5 mRNA	PMID:22281203|PMID:28801915
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:63041	manganese(II) chloride	increases methylation	ISO	RGD:2022	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased methylation of ACP5 gene	PMID:28801915
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACP5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACP5 mRNA	PMID:21641980|PMID:26378955
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:2022	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of ACP5 mRNA	PMID:25729387
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of ACP5 mRNA	PMID:25729387
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:2022	E	RGD:6480464	20130611	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ACP5 mRNA	PMID:16026605
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:6682	mangiferin	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20120412	CTD	MESH:C013592	mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]	PMID:20683903
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:6698	(-)-matairesinol	decreases activity	ISO	RGD:10072	E	RGD:6480464	20230404	CTD	MESH:C068935	matairesinol results in decreased activity of ACP5 protein	PMID:24444335
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:67991	(20S)-ginsenoside Rg3	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20170207	CTD	MESH:C097367	ginsenoside Rg3 inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein]	PMID:27387537
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:69202	protosappanin A	affects expression	ISO	RGD:10072	E	RGD:6480464	20251007	CTD	MESH:C090723	protosappanin A affects the expression of ACP5 protein	PMID:31966594
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:69202	protosappanin A	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20251007	CTD	MESH:C090723	protosappanin A inhibits the reaction [Hydrogen Peroxide results in increased expression of ACP5 mRNA]	PMID:31966594
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:2022	E	RGD:6480464	20231031	CTD	MESH:C057862	cyanoginosin LR results in increased expression of ACP5 protein	PMID:37467923
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:69499	Bergenin	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20191210	CTD	MESH:C006741	bergenin inhibits the reaction [[TNFSF11 protein co-treated with Pyruvaldehyde] results in decreased activity of ACP5 protein]	PMID:31369791
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:7005	morusin	decreases expression	ISO	RGD:10072	E	RGD:6480464	20240702	CTD	MESH:C057451	morusin results in decreased expression of ACP5 mRNA	PMID:38522564
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:748790	exenatide	increases expression	ISO	RGD:2022	E	RGD:6480464	20260714	CTD	MESH:D000077270	Exenatide results in increased expression of ACP5 protein	PMID:19586609
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:749217	halofuginone	increases activity	ISO	RGD:2022	E	RGD:6480464	20260721	CTD	MESH:C010176	halofuginone results in increased activity of ACP5 protein	PMID:17180598
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:749217	halofuginone	increases expression	ISO	RGD:2022	E	RGD:6480464	20260721	CTD	MESH:C010176	halofuginone results in increased expression of ACP5 mRNA	PMID:17180598
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:7553	niclosamide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]	PMID:26792726
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:7553	niclosamide	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of ACP5 mRNA]	PMID:28824321
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:755912	aluminum chloride	increases activity	ISO	RGD:2022	E	RGD:6480464	20260714	CTD	MESH:D000077410	Aluminum Chloride results in increased activity of ACP5 protein	PMID:27720690
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:755912	aluminum chloride	increases expression	ISO	RGD:2022	E	RGD:6480464	20260714	CTD	MESH:D000077410	Aluminum Chloride results in increased expression of ACP5 protein	PMID:30292833
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:755912	aluminum chloride	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20260714	CTD	MESH:D000077410	Nicotinamide Mononucleotide inhibits the reaction [Aluminum Chloride results in increased expression of ACP5 protein]	PMID:30292833
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:2022	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of ACP5 mRNA	PMID:33484710
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ACP5 mRNA	PMID:30851411
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:78420	icariin	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20260303	CTD	MESH:C056599	icariin inhibits the reaction [Cyclophosphamide results in increased secretion of ACP5 protein]	PMID:16751992
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA	PMID:27188386
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:79068	crocin-1	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20190312	CTD	MESH:C029036	crocin promotes the reaction [pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein]]	PMID:30580027
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:79516	Nonylphenol	decreases expression	ISO	RGD:2022	E	RGD:6480464	20240903	CTD	MESH:C025256	nonylphenol results in decreased expression of ACP5 protein	PMID:34219512
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:8062	phenethyl caffeate	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20170613	CTD	MESH:C055494	caffeic acid phenethyl ester inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein]	PMID:28363435
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:80852	Morroniside	decreases expression	ISO	RGD:10072	E	RGD:6480464	20221004	CTD	MESH:C488401	morroniside results in decreased expression of ACP5 mRNA	PMID:34638983
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:10072	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ACP5 mRNA	PMID:38648751
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:10072	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of ACP5 mRNA	PMID:39847705
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:2022	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of ACP5 mRNA	PMID:30047161
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:2022	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ACP5 mRNA	PMID:30047161
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:90369	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20250204	CTD	MESH:C550547	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Niacin inhibits the reaction [ferric ammonium citrate results in increased expression of ACP5 protein]]	PMID:38081572
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:9053	sclareol	decreases expression	ISO	RGD:10072	E	RGD:6480464	20210706	CTD	MESH:C070760	sclareol results in decreased expression of ACP5 mRNA; sclareol results in decreased expression of ACP5 protein	PMID:33423118
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:9053	sclareol	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20210706	CTD	MESH:C070760	sclareol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; sclareol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]	PMID:33423118
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20190312	CTD	MESH:C432165	crocin promotes the reaction [pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein]]; pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein]	PMID:30580027
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA	PMID:27188386
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:91108	SB 431542	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20180410	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Sodium Fluoride results in increased expression of ACP5 mRNA]; [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Sodium Fluoride] affects the expression of ACP5 protein	PMID:29127033
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:9144	silibinin	multiple interactions	ISO	RGD:2022	E	RGD:6480464	20230404	CTD	MESH:C440975	Silybin inhibits the reaction [ferric ammonium citrate results in increased expression of ACP5 protein]	PMID:36087815
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:91460	KN-93	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20200915	CTD	MESH:C072105	KN 93 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein]	PMID:32522522
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:2022	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ACP5 mRNA	PMID:19281266
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:9271	stevioside	decreases secretion	ISO	RGD:2022	E	RGD:6480464	20180703	CTD	MESH:C012043	stevioside results in decreased secretion of ACP5 protein	PMID:21089163
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:9288	streptozocin	increases activity	ISO	RGD:10072	E	RGD:6480464	20221206	CTD	MESH:D013311	Streptozocin results in increased activity of ACP5 protein	PMID:35315182
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:10072	E	RGD:6480464	20221206	CTD	MESH:D013311	Streptozocin results in increased expression of ACP5 mRNA	PMID:35315182
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20221206	CTD	MESH:D013311	formononetin inhibits the reaction [Streptozocin results in increased activity of ACP5 protein]; formononetin inhibits the reaction [Streptozocin results in increased expression of ACP5 mRNA]	PMID:35315182
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:9434	telmisartan	decreases activity	ISO	RGD:2022	E	RGD:329956421|PMID:33364953	20230720	RGD	MESH:C084178	telmisartan decreases enzyme activity of Trap, Acp5 in serum of rats with periodontal disease	
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:95129	4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide	multiple interactions	ISO	RGD:10072	E	RGD:6480464	20190910	CTD	MESH:D020117	Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]	PMID:31150804
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:9513	thalidomide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013792	[Thalidomide co-treated with Dexamethasone] results in decreased expression of ACP5 protein	PMID:16079895
10073	ACP5	acid phosphatase 5, tartrate resistant	gene	CHEBI:9944	venlafaxine hydrochloride	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069470	Venlafaxine Hydrochloride results in decreased expression of ACP5 mRNA	PMID:16341940
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of ATP7A mRNA	PMID:26272509
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATP7A mRNA	PMID:27188386
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:10215	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ATP7A mRNA	PMID:20188158|PMID:26251327
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:15355	acetylcholine	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D000109	ATP7A mutant form inhibits the reaction [AGT protein results in increased susceptibility to Acetylcholine]; tempol inhibits the reaction [ATP7A mutant form inhibits the reaction [AGT protein results in increased susceptibility to Acetylcholine]]	PMID:18768397
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of ATP7A mRNA	PMID:16012519|PMID:21934132
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:15379	dioxygen	affects localization	ISO	RGD:10215	E	RGD:6480464	20120814	CTD	MESH:D010100	Oxygen deficiency affects the localization of ATP7A protein	PMID:19351718
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ATP7A mRNA	PMID:24614111
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:10215	E	RGD:6480464	20120814	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ATP7A mRNA; Oxygen deficiency results in increased expression of ATP7A protein	PMID:19351718|PMID:24614111
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20120814	CTD	MESH:D010100	tetrathiomolybdate inhibits the reaction [Oxygen deficiency affects the localization of ATP7A protein]	PMID:19351718
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:15422	ATP	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D000255	[Copper co-treated with Adenosine Triphosphate] results in increased phosphorylation of ATP7A protein	PMID:20964302
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ATP7A mRNA	PMID:26079696
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of ATP7A protein	PMID:28073184
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ATP7A mRNA	PMID:22378314
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D006861	ATP7A protein promotes the reaction [Paraquat results in increased chemical synthesis of Hydrogen Peroxide]; Hydrogen Peroxide promotes the reaction [CLU protein binds to ATP7A protein]	PMID:21242307|PMID:29058724
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ATP7A mRNA	PMID:21632981
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:10215	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATP7A mRNA	PMID:22369063|PMID:39241906
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATP7A mRNA	PMID:37042841
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ATP7A protein	PMID:37730182
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:180664	4-hydroxy-TEMPO	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20211109	CTD	MESH:C001803	tempol inhibits the reaction [ATP7A mutant form inhibits the reaction [AGT protein results in increased susceptibility to Acetylcholine]]; tempol inhibits the reaction [ATP7A mutant form promotes the reaction [AGT protein results in increased abundance of Superoxides]]	PMID:18768397
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ATP7A intron	PMID:30157460
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:18248	iron atom	affects metabolic processing	ISO	RGD:10215	E	RGD:6480464	20150512	CTD	MESH:D007501	ATP7A protein mutant form affects the metabolism of Iron	PMID:25247420
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:18248	iron atom	affects transport	ISO	RGD:2179	E	RGD:6480464	20150609	CTD	MESH:D007501	ATP7A mutant form affects the transport of Iron	PMID:24174620
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:18248	iron atom	decreases oxidation	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:D007501	ATP7A gene mutant form results in decreased oxidation of Iron	PMID:23776592
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:D007501	Iron deficiency results in increased expression of ATP7A mRNA	PMID:23776592|PMID:24089420
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:2179	E	RGD:6480464	20151013	CTD	MESH:D007501	Iron deficiency results in increased expression of ATP7A; Iron deficiency results in increased expression of ATP7A mRNA; Iron deficiency results in increased expression of ATP7A protein	PMID:16629162|PMID:21852364|PMID:23174565|PMID:23814049|PMID:24089420|PMID:24174620
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:18248	iron atom	increases response to substance	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:D007501	ATP7A gene mutant form results in increased susceptibility to Iron deficiency	PMID:23776592
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:18248	iron atom	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:D007501	[ATP7A gene mutant form co-treated with Iron deficiency] results in increased uptake of Copper; [ATP7A gene mutant form co-treated with Iron deficiency] results in increased uptake of Iron; ATP7A gene mutant form promotes the reaction [Iron deficiency results in increased expression of MT1 mRNA]; Iron deficiency inhibits the reaction [ATP7A gene mutant form results in decreased oxidation of Iron]	PMID:23776592
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:18248	iron atom	multiple interactions	ISO	RGD:2179	E	RGD:6480464	20150609	CTD	MESH:D007501	[Iron deficiency results in increased expression of ATP7A] which results in increased abundance of Copper	PMID:24174620
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:18291	manganese atom	affects localization	ISO	RGD:2179	E	RGD:6480464	20140715	CTD	MESH:D008345	Manganese affects the localization of ATP7A protein	PMID:24614235
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:18291	manganese atom	decreases expression	ISO	RGD:2179	E	RGD:6480464	20140715	CTD	MESH:D008345	Manganese results in decreased expression of ATP7A mRNA; Manganese results in decreased expression of ATP7A protein	PMID:24614235
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:18320	1,4-dithiothreitol	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D004229	Dithiothreitol inhibits the reaction [Ethylmaleimide results in increased glutathionylation of ATP7A protein]	PMID:20566629
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:18421	superoxide	increases abundance	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D013481	ATP7A mutant form results in increased abundance of Superoxides	PMID:18768397
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:18421	superoxide	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D013481	[ATP7A protein results in increased activity of SOD3 protein] which results in decreased chemical synthesis of Superoxides; ATP7A gene mutant form promotes the reaction [Streptozocin results in increased chemical synthesis of Superoxides]; ATP7A mutant form promotes the reaction [AGT protein results in increased abundance of Superoxides]; ATP7A protein inhibits the reaction [Streptozocin results in increased chemical synthesis of Superoxides]; tempol inhibits the reaction [ATP7A mutant form promotes the reaction [AGT protein results in increased abundance of Superoxides]]	PMID:18768397|PMID:23884884
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of ATP7A mRNA	PMID:24376830
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:2179	E	RGD:6480464	20210406	CTD	MESH:D002104	Cadmium results in increased expression of ATP7A mRNA; Cadmium results in increased expression of ATP7A protein	PMID:32879253
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP7A mRNA	PMID:29950665
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D019327	Copper Sulfate results in increased expression of ATP7A protein	PMID:24815816
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ATP7A mRNA	PMID:23649840
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATP7A gene	PMID:27153756
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:25179	melanins	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D008543	[TYR protein co-treated with ATP7A protein] results in increased abundance of Melanins	PMID:11092760
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ATP7A mRNA	PMID:23649840
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:10215	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ATP7A mRNA	PMID:27339419
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP7A mRNA	PMID:22206623
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27617	monensin A	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:D008985	Monensin inhibits the reaction [ATP7A protein affects the localization of Doxorubicin]	PMID:17510416
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27641	cycloheximide	decreases expression	ISO	RGD:2179	E	RGD:6480464	20151013	CTD	MESH:D003513	Cycloheximide results in decreased expression of ATP7A protein	PMID:23174565
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:2179	E	RGD:6480464	20151013	CTD	MESH:D003513	cupric chloride inhibits the reaction [Cycloheximide results in decreased expression of ATP7A protein]	PMID:23174565
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:2179	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ATP7A mRNA	PMID:31881176
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ATP7A mRNA	PMID:23557933
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20250708	CTD	MESH:D007854	[[cupric chloride results in increased abundance of Copper] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of ATP7A protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of ATP7A protein	PMID:40010429
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27899	cisplatin	affects localization	EXP		E	RGD:6480464	20150512	CTD	MESH:D002945	Cisplatin affects the localization of ATP7A protein	PMID:24150977
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20140311	CTD	MESH:D002945	ATP7A protein affects the susceptibility to Cisplatin	PMID:17609664
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002945	Cisplatin results in decreased expression of ATP7A mRNA	PMID:38462020
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:10215	E	RGD:6480464	20240806	CTD	MESH:D002945	Cisplatin results in decreased expression of ATP7A	PMID:38462020
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20151013	CTD	MESH:D002945	ATP7A protein results in decreased susceptibility to Cisplatin	PMID:17510416|PMID:25801007
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27899	cisplatin	decreases response to substance	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D002945	ATP7A protein results in decreased susceptibility to Cisplatin	PMID:16170571
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of ATP7A mRNA	PMID:21151649
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27899	cisplatin	increases response to substance	EXP		E	RGD:6480464	20151013	CTD	MESH:D002945	ATP7A mutant form results in increased susceptibility to Cisplatin	PMID:22304828
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D002945	[ATOX1 protein binds to Cisplatin] promotes the reaction [ATP7A protein binds to and results in increased metabolism of Cisplatin]; [MIR495 mRNA results in decreased expression of ATP7A protein] which results in increased susceptibility to Cisplatin; ATP7A protein inhibits the reaction [MIR495 mRNA results in increased uptake of and results in increased susceptibility to Cisplatin]; ATP7A protein promotes the reaction [ANXA4 protein results in decreased susceptibility to Cisplatin]	PMID:23751120|PMID:24038379|PMID:24150977
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:10215	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of ATP7A mRNA	PMID:30912803
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:10215	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATP7A mRNA	PMID:21570461
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:10215	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATP7A mRNA	PMID:19770486|PMID:33956508
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:2179	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATP7A mRNA	PMID:32109520
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP7A mRNA	PMID:17942748
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ATP7A mRNA	PMID:28001369
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ATP7A mRNA	PMID:33212167
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ATP7A mRNA	PMID:30851411
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28445	vincristine	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	ATP7A protein results in decreased susceptibility to Vincristine	PMID:17510416
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	ATP7A protein binds to Copper; Copper binds to ATP7A protein	PMID:16873374|PMID:22577880
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	affects export	ISO	RGD:10215	E	RGD:6480464	20121113	CTD	MESH:D003300	ATP7A protein affects the export of Copper	PMID:21409224
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	affects localization	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	Copper affects the localization of ATP7A protein	PMID:20964302|PMID:23423674
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	affects localization	ISO	RGD:10215	E	RGD:6480464	20120814	CTD	MESH:D003300	ATP7A gene mutant form affects the localization of Copper; Copper affects the localization of ATP7A protein	PMID:17483305|PMID:20671235|PMID:22089129|PMID:25337692
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	affects localization	ISO	RGD:2179	E	RGD:6480464	20140715	CTD	MESH:D003300	Copper affects the localization of ATP7A protein	PMID:20671235|PMID:24614235
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	affects metabolic processing	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	ATP7A protein affects the metabolism of Copper	PMID:16890543
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	affects transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	ATP7A protein affects the transport of Copper	PMID:17109627
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	decreases abundance	EXP		E	RGD:6480464	20120814	CTD	MESH:D003300	ATP7A gene mutant form results in decreased abundance of Copper; ATP7A protein mutant form results in decreased abundance of Copper; ATP7A protein results in decreased abundance of Copper	PMID:11350187|PMID:14985339|PMID:15923132|PMID:24522273
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	decreases abundance	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:D003300	ATP7A gene mutant form results in decreased abundance of Copper; ATP7A protein mutant form results in decreased abundance of Copper; ATP7A protein results in decreased abundance of Copper	PMID:21336677|PMID:23776592|PMID:25247420
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	decreases export	ISO	RGD:2179	E	RGD:6480464	20140610	CTD	MESH:D003300	ATP7A mutant form results in decreased export of Copper	PMID:24316150
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	increases abundance	EXP		E	RGD:6480464	20120814	CTD	MESH:D003300	ATP7A gene mutant form results in increased abundance of Copper	PMID:15923132
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	increases abundance	ISO	RGD:10215	E	RGD:6480464	20120814	CTD	MESH:D003300	ATP7A gene mutant form results in increased abundance of Copper	PMID:15467011
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	increases export	EXP		E	RGD:6480464	20120918	CTD	MESH:D003300	ATP7A protein results in increased export of Copper	PMID:16397091|PMID:17975309|PMID:18779306
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:2179	E	RGD:6480464	20120412	CTD	MESH:D003300	Copper results in increased expression of ATP7A mRNA	PMID:15591161
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	increases secretion	ISO	RGD:2179	E	RGD:6480464	20120412	CTD	MESH:D003300	ATP7A protein results in increased secretion of Copper	PMID:16741141
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	increases transport	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	ATP7A protein results in increased transport of Copper	PMID:21667063
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	increases transport	ISO	RGD:2179	E	RGD:6480464	20140715	CTD	MESH:D003300	ATP7A protein results in increased transport of Copper	PMID:24614235
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	[ATP7A protein affects the oxidation of SCO1 protein] which affects the abundance of Copper; [COMMD1 protein results in increased activity of ATP7A protein mutant form] which results in increased transport of Copper; [Copper binds to ATP7A protein] which results in decreased oxidation of Copper; [Copper co-treated with Adenosine Triphosphate] results in increased phosphorylation of ATP7A protein; [NSC 689534 binds to Copper] which results in increased expression of ATP7A mRNA; [Tetradecanoylphorbol Acetate results in increased expression of ATP7A protein] which results in increased export of Copper; AP1S1 gene mutant form inhibits the reaction [Copper affects the localization of ATP7A protein]; ARF1 mutant form inhibits the reaction [ATP7A gene mutant form results in decreased export of and results in increased abundance of Copper]; ATP7A gene mutant form affects the reaction [STX5 mutant form results in decreased uptake of Copper]; ATP7A gene mutant form results in decreased export of and results in increased abundance of Copper; ATP7A protein results in decreased susceptibility to [cupric chloride results in increased abundance of Copper]; ATP7A protein results in decreased uptake of [cupric chloride results in increased abundance of Copper]; Copper binds to and affects the folding of ATP7A protein; Copper results in increased phosphorylation of and affects the localization of ATP7A protein; Copper results in increased phosphorylation of and results in increased activity of ATP7A protein; Estrogens promotes the reaction [ATP7A protein affects the transport of Copper]	PMID:10841766|PMID:17009961|PMID:17109627|PMID:19205902|PMID:19576997|PMID:20964302|PMID:20971185|PMID:21034850|PMID:21188142|PMID:21646353|PMID:21667063|PMID:23345593|PMID:23423674|PMID:32278528
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20120814	CTD	MESH:D003300	[[cupric chloride results in increased abundance of Copper] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of ATP7A protein; [ATP7A gene mutant form co-treated with Iron deficiency] results in increased uptake of Copper; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ACTR2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ADRA1B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of AFMID mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of APCS mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of APRT mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ARL10 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of BNIP3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of BZW2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CCND1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CCNG1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CCT2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CCT5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CD9 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CDK1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CHRNB1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CKS1B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CLCA2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CLDN3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CLDN6 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CST6 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CYP2B9 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of DDX49 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of DHCR24 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of DUSP18 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of DUSP6 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of EEF1B2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of EIF1AX mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of EIF6 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of FABP5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of FXYD5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of GART mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of GDF15 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of GLUL mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of GTF2H4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HILPDA mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HMGA1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HMGCS1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HSPA9 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ID2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of IDH3B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of IDI1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of IFITM3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of IL33 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ISYNA1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ITSN1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KIF5B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT13 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT19 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT7 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of L1CAM mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of LY6A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of LY6C2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MAL mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MAST2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MGST3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MIA2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MYBBP1A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NOLC1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NOP14 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NT5DC2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PA2G4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PAK2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PAQR7 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PBK mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PEA15A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PES1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PEX3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PGLYRP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PHF24 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PIP5K1B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PLAA mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PRKAG1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PRKG2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PSMB3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of RNF126 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of RRAD mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SCGB3A2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SFN mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SLC38A1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SMC2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SPAST mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SPRR1A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of TK1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of TMCO1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of TPRKB mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of TUBA4A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of VAC14 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of VEGFC mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of WDR75 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of WFDC2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of YBX3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ZDHHC13 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ZFP518B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ABCC5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ABI1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ACTA2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADD3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADGRE5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADGRL2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of AIF1L mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ALDH1A1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ALKBH5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ANKRD44 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ANXA6 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of APLP2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of APP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of AQP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ARID1B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ARL4C mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ARRDC3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ARXES1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATL2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATP11A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATP1B1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATP6V0D1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of B2M mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of BMP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of BST1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CALD1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CARTPT mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CBX5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CCDC80 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CCN4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDC42 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDC50A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDH11 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDH13 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDH2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDON mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CKAP4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CLEC4A1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CLIC4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CLU mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of COL4A1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of COLGALT1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CPD mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CPE mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CPT1A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CRTAP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CSRP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CST3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CTSA mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CTSL mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CXADR mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CYB5R4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DAG1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DDAH1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DHRS3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DKK3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DUSP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DUSP16 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of EGR1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ENAH mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ENPP5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of EXTL3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FADS3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FAM98A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FARP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FHL1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FNDC3B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FOLR1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FSCN1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FSTL1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FYN mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GABARAPL1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GAS1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GNAI2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GRB10 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GRCC10 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GSTM1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GSTM2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GSTM7 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of H6PD mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of HEXA mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of HEY1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of HS6ST2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of HSPG2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of IFI27L1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of IL12B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of IL1R1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of INA mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ITGB5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of JAK1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LAMC1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LAMP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LARGE1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LOX mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LOXL1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LPP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MACF1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MAP1LC3B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MAP4K3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MBD1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MFGE8 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MFSD1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MKRN2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MORF4L1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MSTO1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MT1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MYL12A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MYL12B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NEDD4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NFAT5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NREP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NRP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NRXN2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of OAT mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of OSBPL9 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PALLD mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PARM1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PCOLCE mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PDIA4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PFKP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PFN2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PICALM mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PKD2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PLSCR2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of POSTN mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PRNP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RASL11A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RASL11B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RBPMS mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RETREG1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RMND5A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SDC2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SELENOP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SENP6 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SEPTIN4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SERINC3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SERPINH1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SHC1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SLC25A13 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SLC25A36 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPARC mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPART mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPG21 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SSH1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ST3GAL2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of STX12 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TAGLN3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TCEAL8 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TGFBR2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of THBS1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of THBS2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TIMP2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TIMP3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TMEM176B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TMEM18 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TMEM33 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TMT1A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TNC mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TNS1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TNS2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TPM4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TPP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TRP53INP2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TSC22D1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TSHZ1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TSPAN3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TSPAN5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TTC3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TXLNG mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of UBE2D2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of UBE2J1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of VCL mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of VIM mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of VWA5A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of WWTR1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of XPC mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of YBX1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ZBED3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ZFP91 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ZMYND8 mRNA; ATP7A protein binds to and results in increased transport of Copper; ATP7A protein mutant form inhibits the reaction [Copper affects the localization of ATP7A protein]; ATP7A protein mutant form results in decreased export of and results in increased abundance of Copper; ATP7A protein promotes the reaction [Copper binds to CP protein]; Copper binds to and affects the localization of ATP7A protein; Omeprazole inhibits the reaction [Copper affects the localization of ATP7A protein]	PMID:15467011|PMID:19351718|PMID:22089129|PMID:23776592|PMID:25337692|PMID:40010429
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:2179	E	RGD:6480464	20120412	CTD	MESH:D003300	[Iron deficiency results in increased expression of ATP7A] which results in increased abundance of Copper; PRL protein promotes the reaction [ATP7A protein results in increased secretion of Copper]	PMID:16741141|PMID:24174620
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28748	doxorubicin	affects localization	EXP		E	RGD:6480464	20120814	CTD	MESH:D004317	ATP7A protein affects the localization of Doxorubicin	PMID:17510416
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28748	doxorubicin	decreases response to substance	EXP		E	RGD:6480464	20120814	CTD	MESH:D004317	ATP7A protein results in decreased susceptibility to Doxorubicin	PMID:17510416
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28748	doxorubicin	increases export	EXP		E	RGD:6480464	20120814	CTD	MESH:D004317	ATP7A protein results in increased export of Doxorubicin	PMID:17510416
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:10215	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of ATP7A mRNA	PMID:39631538
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:D004317	Brefeldin A inhibits the reaction [ATP7A protein affects the localization of Doxorubicin]; Monensin inhibits the reaction [ATP7A protein affects the localization of Doxorubicin]	PMID:17510416
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:10215	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATP7A mRNA	PMID:37682722
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ATP7A mRNA	PMID:38568856
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATP7A promoter	PMID:27901495
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:10215	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATP7A mRNA	PMID:20504355|PMID:22228805
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATP7A exon	PMID:27901495
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	ATP7A protein binds to Copper; Copper binds to ATP7A protein	PMID:16873374|PMID:22577880
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	affects export	ISO	RGD:10215	E	RGD:6480464	20121113	CTD	MESH:D003300	ATP7A protein affects the export of Copper	PMID:21409224
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	affects localization	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	Copper affects the localization of ATP7A protein	PMID:20964302|PMID:23423674
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	affects localization	ISO	RGD:10215	E	RGD:6480464	20120814	CTD	MESH:D003300	ATP7A gene mutant form affects the localization of Copper; Copper affects the localization of ATP7A protein	PMID:17483305|PMID:20671235|PMID:22089129|PMID:25337692
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	affects localization	ISO	RGD:2179	E	RGD:6480464	20140715	CTD	MESH:D003300	Copper affects the localization of ATP7A protein	PMID:20671235|PMID:24614235
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	affects metabolic processing	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	ATP7A protein affects the metabolism of Copper	PMID:16890543
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	affects transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	ATP7A protein affects the transport of Copper	PMID:17109627
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	decreases abundance	EXP		E	RGD:6480464	20120814	CTD	MESH:D003300	ATP7A gene mutant form results in decreased abundance of Copper; ATP7A protein mutant form results in decreased abundance of Copper; ATP7A protein results in decreased abundance of Copper	PMID:11350187|PMID:14985339|PMID:15923132|PMID:24522273
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	decreases abundance	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:D003300	ATP7A gene mutant form results in decreased abundance of Copper; ATP7A protein mutant form results in decreased abundance of Copper; ATP7A protein results in decreased abundance of Copper	PMID:21336677|PMID:23776592|PMID:25247420
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	decreases export	ISO	RGD:2179	E	RGD:6480464	20140610	CTD	MESH:D003300	ATP7A mutant form results in decreased export of Copper	PMID:24316150
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	increases abundance	EXP		E	RGD:6480464	20120814	CTD	MESH:D003300	ATP7A gene mutant form results in increased abundance of Copper	PMID:15923132
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	increases abundance	ISO	RGD:10215	E	RGD:6480464	20120814	CTD	MESH:D003300	ATP7A gene mutant form results in increased abundance of Copper	PMID:15467011
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	increases export	EXP		E	RGD:6480464	20120918	CTD	MESH:D003300	ATP7A protein results in increased export of Copper	PMID:16397091|PMID:17975309|PMID:18779306
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:2179	E	RGD:6480464	20120412	CTD	MESH:D003300	Copper results in increased expression of ATP7A mRNA	PMID:15591161
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	increases secretion	ISO	RGD:2179	E	RGD:6480464	20120412	CTD	MESH:D003300	ATP7A protein results in increased secretion of Copper	PMID:16741141
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	increases transport	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	ATP7A protein results in increased transport of Copper	PMID:21667063
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	increases transport	ISO	RGD:2179	E	RGD:6480464	20140715	CTD	MESH:D003300	ATP7A protein results in increased transport of Copper	PMID:24614235
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	[ATP7A protein affects the oxidation of SCO1 protein] which affects the abundance of Copper; [COMMD1 protein results in increased activity of ATP7A protein mutant form] which results in increased transport of Copper; [Copper binds to ATP7A protein] which results in decreased oxidation of Copper; [Copper co-treated with Adenosine Triphosphate] results in increased phosphorylation of ATP7A protein; [NSC 689534 binds to Copper] which results in increased expression of ATP7A mRNA; [Tetradecanoylphorbol Acetate results in increased expression of ATP7A protein] which results in increased export of Copper; AP1S1 gene mutant form inhibits the reaction [Copper affects the localization of ATP7A protein]; ARF1 mutant form inhibits the reaction [ATP7A gene mutant form results in decreased export of and results in increased abundance of Copper]; ATP7A gene mutant form affects the reaction [STX5 mutant form results in decreased uptake of Copper]; ATP7A gene mutant form results in decreased export of and results in increased abundance of Copper; ATP7A protein results in decreased susceptibility to [cupric chloride results in increased abundance of Copper]; ATP7A protein results in decreased uptake of [cupric chloride results in increased abundance of Copper]; Copper binds to and affects the folding of ATP7A protein; Copper results in increased phosphorylation of and affects the localization of ATP7A protein; Copper results in increased phosphorylation of and results in increased activity of ATP7A protein; Estrogens promotes the reaction [ATP7A protein affects the transport of Copper]	PMID:10841766|PMID:17009961|PMID:17109627|PMID:19205902|PMID:19576997|PMID:20964302|PMID:20971185|PMID:21034850|PMID:21188142|PMID:21646353|PMID:21667063|PMID:23345593|PMID:23423674|PMID:32278528
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20120814	CTD	MESH:D003300	[[cupric chloride results in increased abundance of Copper] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of ATP7A protein; [ATP7A gene mutant form co-treated with Iron deficiency] results in increased uptake of Copper; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ACTR2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ADRA1B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of AFMID mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of APCS mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of APRT mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ARL10 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of BNIP3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of BZW2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CCND1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CCNG1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CCT2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CCT5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CD9 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CDK1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CHRNB1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CKS1B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CLCA2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CLDN3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CLDN6 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CST6 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CYP2B9 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of DDX49 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of DHCR24 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of DUSP18 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of DUSP6 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of EEF1B2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of EIF1AX mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of EIF6 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of FABP5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of FXYD5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of GART mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of GDF15 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of GLUL mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of GTF2H4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HILPDA mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HMGA1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HMGCS1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of HSPA9 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ID2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of IDH3B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of IDI1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of IFITM3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of IL33 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ISYNA1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ITSN1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KIF5B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT13 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT19 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of KRT7 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of L1CAM mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of LY6A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of LY6C2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MAL mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MAST2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MGST3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MIA2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MYBBP1A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NOLC1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NOP14 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NT5DC2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PA2G4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PAK2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PAQR7 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PBK mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PEA15A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PES1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PEX3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PGLYRP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PHF24 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PIP5K1B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PLAA mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PRKAG1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PRKG2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PSMB3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of RNF126 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of RRAD mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SCGB3A2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SFN mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SLC38A1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SMC2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SPAST mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SPRR1A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of TK1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of TMCO1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of TPRKB mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of TUBA4A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of VAC14 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of VEGFC mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of WDR75 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of WFDC2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of YBX3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ZDHHC13 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of ZFP518B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ABCC5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ABI1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ACTA2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADD3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADGRE5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADGRL2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of AIF1L mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ALDH1A1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ALKBH5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ANKRD44 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ANXA6 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of APLP2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of APP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of AQP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ARID1B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ARL4C mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ARRDC3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ARXES1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATL2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATP11A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATP1B1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATP6V0D1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of B2M mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of BMP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of BST1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CALD1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CARTPT mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CBX5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CCDC80 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CCN4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDC42 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDC50A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDH11 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDH13 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDH2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CDON mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CKAP4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CLEC4A1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CLIC4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CLU mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of COL4A1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of COLGALT1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CPD mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CPE mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CPT1A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CRTAP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CSRP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CST3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CTSA mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CTSL mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CXADR mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of CYB5R4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DAG1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DDAH1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DHRS3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DKK3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DUSP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DUSP16 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of EGR1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ENAH mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ENPP5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of EXTL3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FADS3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FAM98A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FARP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FHL1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FNDC3B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FOLR1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FSCN1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FSTL1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FYN mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GABARAPL1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GAS1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GNAI2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GRB10 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GRCC10 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GSTM1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GSTM2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GSTM7 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of H6PD mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of HEXA mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of HEY1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of HS6ST2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of HSPG2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of IFI27L1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of IL12B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of IL1R1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of INA mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ITGB5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of JAK1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LAMC1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LAMP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LARGE1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LOX mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LOXL1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of LPP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MACF1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MAP1LC3B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MAP4K3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MBD1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MFGE8 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MFSD1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MKRN2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MORF4L1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MSTO1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MT1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MYL12A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MYL12B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NEDD4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NFAT5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NREP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NRP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of NRXN2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of OAT mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of OSBPL9 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PALLD mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PARM1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PCOLCE mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PDIA4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PFKP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PFN2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PICALM mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PKD2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PLSCR2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of POSTN mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PRNP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RASL11A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RASL11B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RBPMS mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RETREG1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of RMND5A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SDC2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SELENOP mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SENP6 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SEPTIN4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SERINC3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SERPINH1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SHC1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SLC25A13 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SLC25A36 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPARC mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPART mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPG21 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SSH1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ST3GAL2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of STX12 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TAGLN3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TCEAL8 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TGFBR2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of THBS1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of THBS2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TIMP2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TIMP3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TMEM176B mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TMEM18 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TMEM33 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TMT1A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TNC mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TNS1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TNS2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TPM4 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TPP1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TRP53INP2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TSC22D1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TSHZ1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TSPAN3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TSPAN5 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TTC3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of TXLNG mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of UBE2D2 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of UBE2J1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of VCL mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of VIM mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of VWA5A mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of WWTR1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of XPC mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of YBX1 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ZBED3 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ZFP91 mRNA; [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ZMYND8 mRNA; ATP7A protein binds to and results in increased transport of Copper; ATP7A protein mutant form inhibits the reaction [Copper affects the localization of ATP7A protein]; ATP7A protein mutant form results in decreased export of and results in increased abundance of Copper; ATP7A protein promotes the reaction [Copper binds to CP protein]; Copper binds to and affects the localization of ATP7A protein; Omeprazole inhibits the reaction [Copper affects the localization of ATP7A protein]	PMID:15467011|PMID:19351718|PMID:22089129|PMID:23776592|PMID:25337692|PMID:40010429
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:2179	E	RGD:6480464	20120412	CTD	MESH:D003300	[Iron deficiency results in increased expression of ATP7A] which results in increased abundance of Copper; PRL protein promotes the reaction [ATP7A protein results in increased secretion of Copper]	PMID:16741141|PMID:24174620
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30341	silver monochloride	affects localization	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:C037548	silver chloride affects the localization of ATP7A protein	PMID:16317117
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30512	silver atom	affects binding	EXP		E	RGD:6480464	20120717	CTD	MESH:D012834	Silver binds to ATP7A protein	PMID:10841766|PMID:21646353
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30512	silver atom	affects localization	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D012834	Silver affects the localization of ATP7A protein	PMID:16317117
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:10215	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ATP7A mRNA	PMID:27131904
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ATP7A mRNA	PMID:25895662
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:10215	E	RGD:6480464	20241105	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ATP7A mRNA	PMID:38403151
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:10215	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ATP7A mRNA	PMID:35676786
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:30703	tetrathiomolybdate(2-)	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20120814	CTD	MESH:C020809	tetrathiomolybdate inhibits the reaction [Oxygen deficiency affects the localization of ATP7A protein]	PMID:19351718
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:2179	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of ATP7A mRNA	PMID:16483693
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:31355	carboplatin	affects localization	EXP		E	RGD:6480464	20150512	CTD	MESH:D016190	Carboplatin affects the localization of ATP7A protein	PMID:24150977
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:31355	carboplatin	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D016190	[MIR495 mRNA results in decreased expression of ATP7A protein] which results in increased susceptibility to Carboplatin; ATP7A protein promotes the reaction [ANXA4 protein results in decreased susceptibility to Carboplatin]	PMID:24038379|PMID:24150977
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:2179	E	RGD:6480464	20140610	CTD	MESH:C008261	lead acetate results in decreased expression of ATP7A mRNA; lead acetate results in decreased expression of ATP7A protein	PMID:24316150
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:2179	E	RGD:6480464	20151013	CTD	MESH:C008261	lead acetate results in increased expression of ATP7A mRNA	PMID:25579025
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20250708	CTD	MESH:C008261	[[cupric chloride results in increased abundance of Copper] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of ATP7A protein; [lead acetate results in increased abundance of Lead] which results in decreased expression of ATP7A protein	PMID:40010429
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:2179	E	RGD:6480464	20120814	CTD	MESH:C008261	ATP7A protein modified form inhibits the reaction [lead acetate binds to HSPA5 protein]	PMID:10702365
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:31856	mithramycin	decreases expression	ISO	RGD:2179	E	RGD:6480464	20150512	CTD	MESH:D008926	Plicamycin results in decreased expression of ATP7A mRNA	PMID:23814049
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:31856	mithramycin	multiple interactions	ISO	RGD:2179	E	RGD:6480464	20150512	CTD	MESH:D008926	Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of ATP7A mRNA]	PMID:23814049
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:31941	oxaliplatin	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	ATP7A protein affects the susceptibility to oxaliplatin	PMID:16773204|PMID:17609664
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:31941	oxaliplatin	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	ATP7A protein results in decreased susceptibility to oxaliplatin	PMID:25801007
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of ATP7A mRNA	PMID:16773204
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[MIR495 mRNA results in decreased expression of ATP7A protein] which results in increased susceptibility to oxaliplatin	PMID:24038379
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:10215	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ATP7A mRNA	PMID:29264374
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP7A mRNA	PMID:29950665
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:2179	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ATP7A mRNA	PMID:23411599
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ATP7A mRNA	PMID:20813756
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ATP7A mRNA	PMID:19710929
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of ATP7A mRNA	PMID:30690063
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:2179	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ATP7A mRNA	PMID:25181051
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:10215	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased expression of ATP7A mRNA; bisphenol A results in decreased expression of ATP7A protein	PMID:27690074
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ATP7A mRNA	PMID:29275510
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2179	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ATP7A mRNA	PMID:30816183|PMID:34947998|PMID:41034487
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:33364	platinum	increases uptake	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D010984	ATP7A protein results in increased uptake of Platinum	PMID:16170571
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:33400	platinum(0)	increases uptake	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D010984	ATP7A protein results in increased uptake of Platinum	PMID:16170571
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:10215	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of ATP7A mRNA	PMID:26682919
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:10215	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ATP7A exon	PMID:33297965
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:10215	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ATP7A mRNA	PMID:40203079
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of ATP7A intron	PMID:30157460
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP7A mRNA	PMID:29950665
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ATP7A mRNA	PMID:21266533
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D010269	Paraquat results in increased expression of ATP7A mRNA	PMID:34097952
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:34905	paraquat	increases response to substance	EXP		E	RGD:6480464	20190219	CTD	MESH:D010269	ATP7A protein results in increased susceptibility to Paraquat	PMID:29058724
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D010269	ATP7A protein promotes the reaction [Paraquat results in increased chemical synthesis of Hydrogen Peroxide]	PMID:29058724
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:35154	manganese(0)	affects localization	ISO	RGD:2179	E	RGD:6480464	20140715	CTD	MESH:D008345	Manganese affects the localization of ATP7A protein	PMID:24614235
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:35154	manganese(0)	decreases expression	ISO	RGD:2179	E	RGD:6480464	20140715	CTD	MESH:D008345	Manganese results in decreased expression of ATP7A mRNA; Manganese results in decreased expression of ATP7A protein	PMID:24614235
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ATP7A mRNA	PMID:38568856
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:10215	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ATP7A mRNA	PMID:24982889
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C018021	cobaltous chloride results in increased expression of ATP7A mRNA	PMID:24614111
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:2179	E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in increased expression of ATP7A mRNA	PMID:23814049
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:2179	E	RGD:6480464	20150512	CTD	MESH:C018021	Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of ATP7A mRNA]	PMID:23814049
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of ATP7A protein	PMID:19205902
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:D013755	[Tetradecanoylphorbol Acetate results in increased expression of ATP7A protein] which results in increased export of Copper; ATP7A protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of FLT1 mRNA]	PMID:19205902
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:10215	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ATP7A mRNA	PMID:40194260
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:2179	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ATP7A mRNA	PMID:23125180
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:39501	2,2,2-tetramine	increases expression	ISO	RGD:2179	E	RGD:6480464	20150512	CTD	MESH:D014266	Trientine results in increased expression of ATP7A mRNA; Trientine results in increased expression of ATP7A protein	PMID:24927960
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:2179	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of ATP7A mRNA	PMID:29427782
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:10215	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATP7A mRNA	PMID:20546886
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of ATP7A mRNA	PMID:19101580|PMID:29154799
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ATP7A gene	PMID:29154799
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATP7A mRNA	PMID:25562108
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:10215	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATP7A mRNA	PMID:19770486
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:42106	L-1,4-dithiothreitol	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D004229	Dithiothreitol inhibits the reaction [Ethylmaleimide results in increased glutathionylation of ATP7A protein]	PMID:20566629
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:4356	desferrioxamine B	increases expression	ISO	RGD:2179	E	RGD:6480464	20151013	CTD	MESH:D003676	Deferoxamine results in increased expression of ATP7A mRNA	PMID:23174565
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:4356	desferrioxamine B	multiple interactions	ISO	RGD:2179	E	RGD:6480464	20151013	CTD	MESH:D003676	cupric chloride promotes the reaction [Deferoxamine results in increased expression of ATP7A mRNA]; Deferoxamine promotes the reaction [cupric chloride results in increased expression of ATP7A protein]	PMID:23174565
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:44485	N-ethylmaleimide	increases glutathionylation	EXP		E	RGD:6480464	20151013	CTD	MESH:D005033	Ethylmaleimide results in increased glutathionylation of ATP7A protein	PMID:20566629
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:44485	N-ethylmaleimide	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D005033	Dithiothreitol inhibits the reaction [Ethylmaleimide results in increased glutathionylation of ATP7A protein]	PMID:20566629
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:45863	paclitaxel	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	ATP7A protein results in decreased susceptibility to Paclitaxel	PMID:17510416
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of ATP7A mRNA	PMID:20737486
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in increased expression of ATP7A mRNA	PMID:28542535
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ATP7A mRNA	PMID:17562736
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide analog results in increased expression of ATP7A mRNA; cupric oxide analog results in increased expression of ATP7A protein	PMID:24815816
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of ATP7A mRNA	PMID:40706910
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:48080	brefeldin A	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:D020126	Brefeldin A inhibits the reaction [ATP7A protein affects the localization of Doxorubicin]	PMID:17510416
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:48958	1,1'-azobis(N,N-dimethylformamide)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003958	Diamide promotes the reaction [CLU protein binds to ATP7A protein]	PMID:21242307
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:10215	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of ATP7A mRNA; Ethinyl Estradiol results in decreased expression of ATP7A protein	PMID:27690074
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ATP7A mRNA	PMID:17942748
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP7A mRNA	PMID:17942748
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:4911	etoposide	decreases response to substance	EXP		E	RGD:6480464	20120814	CTD	MESH:D005047	ATP7A protein results in decreased susceptibility to Etoposide	PMID:17510416
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:49553	copper(II) chloride	affects localization	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:C029892	cupric chloride affects the localization of ATP7A protein	PMID:16317117|PMID:25337692
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:49553	copper(II) chloride	decreases glutathionylation	EXP		E	RGD:6480464	20151013	CTD	MESH:C029892	cupric chloride results in decreased glutathionylation of ATP7A protein	PMID:20566629
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:49553	copper(II) chloride	increases expression	ISO	RGD:2179	E	RGD:6480464	20151013	CTD	MESH:C029892	cupric chloride results in increased expression of ATP7A protein	PMID:23174565
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:49553	copper(II) chloride	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:C029892	ATP7A protein results in increased transport of cupric chloride	PMID:17009961
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:49553	copper(II) chloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C029892	ATP7A protein results in decreased susceptibility to [cupric chloride results in increased abundance of Copper]; ATP7A protein results in decreased uptake of [cupric chloride results in increased abundance of Copper]; cupric chloride inhibits the reaction [bathocuproine sulfonate inhibits the reaction [ATP7A protein results in increased activity of TYR protein]]; cupric chloride promotes the reaction [CLU protein binds to ATP7A protein]	PMID:11092760|PMID:21242307|PMID:32278528
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:49553	copper(II) chloride	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:C029892	[[cupric chloride results in increased abundance of Copper] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of ATP7A protein; Omeprazole inhibits the reaction [cupric chloride affects the localization of ATP7A protein]	PMID:25337692|PMID:40010429
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:49553	copper(II) chloride	multiple interactions	ISO	RGD:2179	E	RGD:6480464	20151013	CTD	MESH:C029892	cupric chloride inhibits the reaction [Cycloheximide results in decreased expression of ATP7A protein]; cupric chloride promotes the reaction [Deferoxamine results in increased expression of ATP7A mRNA]; Deferoxamine promotes the reaction [cupric chloride results in increased expression of ATP7A protein]	PMID:23174565
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:10215	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ATP7A mRNA	PMID:35676786
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:2179	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of ATP7A mRNA	PMID:22504374
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:50729	mitoxantrone	decreases response to substance	EXP		E	RGD:6480464	20120814	CTD	MESH:D008942	ATP7A protein results in decreased susceptibility to Mitoxantrone	PMID:17510416
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:2179	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of ATP7A mRNA	PMID:20080153
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:63041	manganese(II) chloride	affects localization	ISO	RGD:2179	E	RGD:6480464	20140715	CTD	MESH:C025340	manganese chloride affects the localization of ATP7A protein	PMID:24614235
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:2179	E	RGD:6480464	20140715	CTD	MESH:C025340	manganese chloride results in decreased expression of ATP7A mRNA; manganese chloride results in decreased expression of ATP7A protein	PMID:24614235
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ATP7A mRNA	PMID:26378955
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:63934	bathocuproine disulfonic acid	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:C028559	[Penicillamine co-treated with bathocuproine sulfonate] promotes the reaction [CLU protein binds to ATP7A protein]; bathocuproine sulfonate inhibits the reaction [ATP7A protein results in increased activity of TYR protein]; cupric chloride inhibits the reaction [bathocuproine sulfonate inhibits the reaction [ATP7A protein results in increased activity of TYR protein]]	PMID:11092760|PMID:21242307
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of ATP7A intron	PMID:30157460
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP7A mRNA	PMID:22206623
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:2179	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of ATP7A mRNA	PMID:27840820
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ATP7A mRNA	PMID:22714537
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:2179	E	RGD:6480464	20151013	CTD	MESH:C007350	nitrofen results in decreased expression of ATP7A mRNA; nitrofen results in decreased expression of ATP7A protein	PMID:25319798
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:D009853	Omeprazole inhibits the reaction [ATP7A protein results in increased activity of TYR protein]	PMID:25337692
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:D009853	Omeprazole inhibits the reaction [Copper affects the localization of ATP7A protein]; Omeprazole inhibits the reaction [cupric chloride affects the localization of ATP7A protein]	PMID:25337692
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:7772	omeprazole	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:D009853	Omeprazole inhibits the reaction [ATP7A protein results in increased activity of TYR protein]	PMID:25337692
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:7772	omeprazole	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:D009853	Omeprazole inhibits the reaction [Copper affects the localization of ATP7A protein]; Omeprazole inhibits the reaction [cupric chloride affects the localization of ATP7A protein]	PMID:25337692
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ATP7A mRNA	PMID:30851411
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATP7A mRNA	PMID:27188386
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:78782	pyrrolidine dithiocarbamate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C020972	pyrrolidine dithiocarbamic acid results in decreased expression of ATP7A	PMID:25070243
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:7959	D-penicillamine	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D010396	[Penicillamine co-treated with bathocuproine sulfonate] promotes the reaction [CLU protein binds to ATP7A protein]	PMID:21242307
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:80630	irinotecan	decreases response to substance	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	ATP7A protein results in decreased susceptibility to Irinotecan	PMID:17510416
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:80630	irinotecan	increases export	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	ATP7A protein results in increased export of Irinotecan	PMID:17510416
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:2179	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ATP7A mRNA	PMID:23914054
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:82664	iron(0)	affects metabolic processing	ISO	RGD:10215	E	RGD:6480464	20150512	CTD	MESH:D007501	ATP7A protein mutant form affects the metabolism of Iron	PMID:25247420
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:82664	iron(0)	affects transport	ISO	RGD:2179	E	RGD:6480464	20150609	CTD	MESH:D007501	ATP7A mutant form affects the transport of Iron	PMID:24174620
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:82664	iron(0)	decreases oxidation	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:D007501	ATP7A gene mutant form results in decreased oxidation of Iron	PMID:23776592
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:D007501	Iron deficiency results in increased expression of ATP7A mRNA	PMID:23776592|PMID:24089420
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:2179	E	RGD:6480464	20151013	CTD	MESH:D007501	Iron deficiency results in increased expression of ATP7A; Iron deficiency results in increased expression of ATP7A mRNA; Iron deficiency results in increased expression of ATP7A protein	PMID:16629162|PMID:21852364|PMID:23174565|PMID:23814049|PMID:24089420|PMID:24174620
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:82664	iron(0)	increases response to substance	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:D007501	ATP7A gene mutant form results in increased susceptibility to Iron deficiency	PMID:23776592
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:82664	iron(0)	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20150609	CTD	MESH:D007501	[ATP7A gene mutant form co-treated with Iron deficiency] results in increased uptake of Copper; [ATP7A gene mutant form co-treated with Iron deficiency] results in increased uptake of Iron; ATP7A gene mutant form promotes the reaction [Iron deficiency results in increased expression of MT1 mRNA]; Iron deficiency inhibits the reaction [ATP7A gene mutant form results in decreased oxidation of Iron]	PMID:23776592
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:82664	iron(0)	multiple interactions	ISO	RGD:2179	E	RGD:6480464	20150609	CTD	MESH:D007501	[Iron deficiency results in increased expression of ATP7A] which results in increased abundance of Copper	PMID:24174620
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:10215	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ATP7A mRNA	PMID:21795629
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:2179	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of ATP7A mRNA	PMID:22504374
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:85609	satraplatin	decreases response to substance	ISO	RGD:10215	E	RGD:6480464	20170303	CTD	MESH:C081294	ATP7A protein results in decreased susceptibility to satraplatin metabolite	PMID:16170571
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATP7A mRNA	PMID:27188386
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:91222	neocuproine	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20160315	CTD	MESH:C002701	neocuproine inhibits the reaction [ATP7A protein mutant form promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CXCL1 protein]]; neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein]]; neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL7 protein]]; neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IFNG protein]]; neocuproine promotes the reaction [ATP7A protein mutant form inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of VEGFA protein]]	PMID:23604539
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:9141	silver(0)	affects binding	EXP		E	RGD:6480464	20120717	CTD	MESH:D012834	Silver binds to ATP7A protein	PMID:10841766|PMID:21646353
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:9141	silver(0)	affects localization	ISO	RGD:10215	E	RGD:6480464	20120412	CTD	MESH:D012834	Silver affects the localization of ATP7A protein	PMID:16317117
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:10215	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ATP7A mRNA	PMID:27131904
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:9288	streptozocin	decreases expression	ISO	RGD:10215	E	RGD:6480464	20150512	CTD	MESH:D013311	Streptozocin results in decreased expression of ATP7A protein	PMID:23884884
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:10215	E	RGD:6480464	20150512	CTD	MESH:D013311	ATP7A gene mutant form promotes the reaction [Streptozocin results in increased chemical synthesis of Superoxides]; ATP7A protein inhibits the reaction [Streptozocin results in increased chemical synthesis of Superoxides]; INS protein inhibits the reaction [Streptozocin results in decreased expression of ATP7A protein]	PMID:23884884
10216	ATP7A	ATPase copper transporting alpha	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:10215	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ATP7A mRNA	PMID:28973697
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CEACAM1 mRNA	PMID:38218311
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in increased expression of CEACAM1 mRNA	PMID:24172598
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CEACAM1 mRNA	PMID:27188386
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:67396	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CEACAM1 mRNA]	PMID:31150632
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:138858	Azaspiracid	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C406592	azaspiracid results in increased expression of CEACAM1 mRNA	PMID:21853993|PMID:28939011
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:10240	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CEACAM1 mRNA	PMID:26251327
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:144400	dinophysistoxin 1	increases expression	EXP		E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in increased expression of CEACAM1 mRNA	PMID:21853993|PMID:28939011
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of CEACAM1 mRNA	PMID:23830798|PMID:33167477
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CEACAM1 mRNA	PMID:36331819
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CEACAM1 mRNA	PMID:26079696
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of CEACAM1 mRNA	PMID:39506029
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CEACAM1 mRNA	PMID:20044591
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:10240	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CEACAM1 mRNA	PMID:39241906
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D004958	Estradiol affects the expression of CEACAM1 mRNA	PMID:15598610|PMID:39298647
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:67396	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of CEACAM1 mRNA	PMID:32145629
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of CEACAM1 mRNA	PMID:19619570
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D004958	Estradiol results in increased expression of CEACAM1 mRNA	PMID:15289156
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CEACAM1 mRNA	PMID:19619570
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CEACAM1 mRNA	PMID:38568856
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:67396	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CEACAM1 mRNA	PMID:33387578
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CEACAM1 mRNA	PMID:37042841
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:16767	3,4-dichloroaniline	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in increased expression of CEACAM1 mRNA	PMID:24172598
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of CEACAM1 mRNA	PMID:28937961
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CEACAM1 mRNA	PMID:23649840
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D011374	Progesterone results in increased expression of CEACAM1 mRNA	PMID:18692832
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17234	glucose	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D005947	Glucose results in decreased expression of CEACAM1 mRNA	PMID:19924377
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17234	glucose	decreases secretion	EXP		E	RGD:6480464	20120814	CTD	MESH:D005947	Glucose results in decreased secretion of CEACAM1 protein	PMID:19924377
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:D005947	cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of CEACAM1 mRNA]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased secretion of CEACAM1 protein]	PMID:19924377
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CEACAM1 mRNA	PMID:37992649
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of CEACAM1 mRNA	PMID:33359661
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D013739	Testosterone results in decreased expression of CEACAM1 mRNA	PMID:20600201|PMID:21669218
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17634	D-glucose	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D005947	Glucose results in decreased expression of CEACAM1 mRNA	PMID:19924377
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17634	D-glucose	decreases secretion	EXP		E	RGD:6480464	20120814	CTD	MESH:D005947	Glucose results in decreased secretion of CEACAM1 protein	PMID:19924377
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:D005947	cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of CEACAM1 mRNA]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased secretion of CEACAM1 protein]	PMID:19924377
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CEACAM1 mRNA	PMID:37992649
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:10240	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CEACAM1 mRNA	PMID:17997037
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CEACAM1 mRNA	PMID:36774801
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of CEACAM1 mRNA	PMID:26485663
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CEACAM1 mRNA	PMID:36331819
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of CEACAM1 mRNA	PMID:17103032
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:10240	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of CEACAM1 mRNA	PMID:33914522
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:67396	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CEACAM1 protein	PMID:34915118
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:10240	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CEACAM1 mRNA	PMID:17997037
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CEACAM1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CEACAM1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEACAM1 mRNA	PMID:28111341|PMID:37236586
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CEACAM1 mRNA	PMID:23649840
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:24631	hydrazines	decreases expression	ISO	RGD:10240	E	RGD:6480464	20170117	CTD	MESH:D006834	Hydrazines results in decreased expression of CEACAM1 mRNA	PMID:21647536
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CEACAM1 protein	PMID:20106945
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CEACAM1 mRNA	PMID:19770486
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CEACAM1 mRNA	PMID:21641981|PMID:22100608
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CEACAM1 mRNA	PMID:23649840
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of CEACAM1 mRNA	PMID:25102026
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases secretion	EXP		E	RGD:6480464	20210608	CTD	MESH:D009151	Mustard Gas results in increased secretion of CEACAM1 protein	PMID:33491125
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	Ozone results in increased expression of CEACAM1 mRNA	PMID:31476115
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D010126	Ozone results in increased expression of CEACAM1 mRNA	PMID:19555225
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:67396	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of CEACAM1 mRNA	PMID:16330353
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:67396	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of CEACAM1 mRNA	PMID:11717422
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:10240	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of CEACAM1 mRNA	PMID:31919559
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:67396	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CEACAM1 mRNA	PMID:17522070|PMID:31150632
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20181016	CTD	MESH:D002251	[PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of CEACAM1 mRNA	PMID:29987408
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:67396	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CEACAM1 mRNA]	PMID:31150632
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D005492	[Folic Acid deficiency co-treated with Methotrexate] results in increased expression of CEACAM1 mRNA	PMID:24657277
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CEACAM1 mRNA	PMID:40504410
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002166	Camptothecin results in increased expression of CEACAM1 mRNA	PMID:17374387|PMID:38460933
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of CEACAM1 mRNA	PMID:38460933
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of CEACAM1 mRNA	PMID:38460933
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CEACAM1 protein	PMID:35688186
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C059514	resveratrol results in increased expression of CEACAM1 mRNA	PMID:15280659|PMID:25888808
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of CEACAM1 mRNA	PMID:23300844
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CEACAM1 mRNA	PMID:27392435
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CEACAM1 mRNA; [Cisplatin co-treated with Paclitaxel] results in increased expression of CEACAM1 mRNA	PMID:20705681|PMID:27392435
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:10240	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CEACAM1 mRNA	PMID:30912803
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D014640	Vancomycin results in increased expression of CEACAM1 mRNA	PMID:18930951
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:10240	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of CEACAM1 mRNA	PMID:32186404
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D019833	Genistein results in increased expression of CEACAM1 mRNA	PMID:15289156
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:67396	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of CEACAM1 mRNA	PMID:12075121
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CEACAM1 mRNA	PMID:19619570
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CEACAM1 mRNA	PMID:19770486
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:67396	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CEACAM1 mRNA	PMID:20959002|PMID:23238561|PMID:33387578
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CEACAM1 mRNA	PMID:23152189
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CEACAM1 mRNA	PMID:23238561
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:67396	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CEACAM1 mRNA	PMID:16054898|PMID:18796159|PMID:32109520|PMID:34747641
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CEACAM1 mRNA	PMID:19619570
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28177	theophylline	decreases expression	ISO	RGD:67396	E	RGD:6480464	20120412	CTD	MESH:D013806	Theophylline results in decreased expression of CEACAM1 mRNA	PMID:17522070
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CEACAM1 mRNA	PMID:33212167
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of CEACAM1 mRNA	PMID:23649840
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28593	quinidine	increases expression	ISO	RGD:67396	E	RGD:6480464	20120412	CTD	MESH:D011802	Quinidine results in increased expression of CEACAM1 mRNA	PMID:17522070
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:67396	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CEACAM1 mRNA	PMID:28959563
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CEACAM1 mRNA	PMID:37992649
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:28940	calciol	increases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D002762	Cholecalciferol results in increased expression of CEACAM1 mRNA	PMID:17170073
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CEACAM1 mRNA	PMID:38568856
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CEACAM1 mRNA	PMID:40504410
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CEACAM1 mRNA	PMID:19770486
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CEACAM1 mRNA	PMID:21632981|PMID:26238291|PMID:32234424
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:10240	E	RGD:6480464	20230606	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CEACAM1 protein	PMID:35920545
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CEACAM1 3' UTR; Benzo(a)pyrene results in increased methylation of CEACAM1 5' UTR; Benzo(a)pyrene results in increased methylation of CEACAM1 promoter	PMID:27901495
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20230606	CTD	MESH:D001564	Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of CEACAM1 protein]	PMID:35920545
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:67396	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of CEACAM1 mRNA	PMID:11717422
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CEACAM1 mRNA	PMID:25895662
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CEACAM1 mRNA	PMID:22300531
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CEACAM1 mRNA	PMID:26238291
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:67396	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CEACAM1 mRNA	PMID:16483693
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:67396	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of CEACAM1 mRNA	PMID:24136188
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:31746	kainic acid	increases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D007608	Kainic Acid results in increased expression of CEACAM1 mRNA	PMID:17997037
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:67396	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of CEACAM1 mRNA	PMID:22641619
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:C008261	lead acetate results in increased expression of CEACAM1 mRNA	PMID:22609695
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:31767	lead diacetate	increases methylation	ISO	RGD:67396	E	RGD:6480464	20180828	CTD	MESH:C008261	lead acetate results in increased methylation of CEACAM1 gene	PMID:29571894
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:67396	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of CEACAM1 mRNA	PMID:25729387
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:67396	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of CEACAM1 mRNA	PMID:24136188
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:10240	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CEACAM1 mRNA	PMID:23557971
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:67396	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CEACAM1 mRNA	PMID:34492290
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CEACAM1 mRNA	PMID:18648102
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:10240	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of CEACAM1 mRNA	PMID:16221962|PMID:17426115|PMID:20059764|PMID:23811191
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CEACAM1 mRNA]	PMID:20059764
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:10240	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CEACAM1 mRNA	PMID:28472532
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:10240	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of CEACAM1 mRNA	PMID:33914522
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:67396	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CEACAM1 mRNA	PMID:25181051|PMID:32145629
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased expression of CEACAM1 mRNA	PMID:22576693
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:10240	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CEACAM1 mRNA	PMID:33221593
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:67396	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of CEACAM1 mRNA	PMID:12075121|PMID:41034487
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:10240	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CEACAM1 mRNA	PMID:39298647
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:10240	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CEACAM1 mRNA	PMID:30951980
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:67396	E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of CEACAM1 mRNA	PMID:17602206
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:10240	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of CEACAM1 mRNA	PMID:34813904
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:10240	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of CEACAM1 mRNA	PMID:34813904
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:67396	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CEACAM1 mRNA	PMID:18164116
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CEACAM1 mRNA	PMID:37042841
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:67396	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of CEACAM1 mRNA	PMID:30589522
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CEACAM1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CEACAM1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEACAM1 mRNA	PMID:28111341|PMID:37236586
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CEACAM1 mRNA	PMID:24449571
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D002994	Clofibrate results in decreased expression of CEACAM1 mRNA	PMID:17585979
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of CEACAM1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CEACAM1 mRNA]	PMID:17585979
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:67396	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of CEACAM1 mRNA	PMID:27638505
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:38221	fumonisin B1	decreases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:C056933	fumonisin B1 results in decreased expression of CEACAM1 mRNA	PMID:16221962
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:10240	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CEACAM1 mRNA	PMID:40194260
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CEACAM1 mRNA	PMID:28302478
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CEACAM1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CEACAM1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CEACAM1 mRNA	PMID:36331819
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D002737	Chloroprene results in increased expression of CEACAM1 mRNA	PMID:23125180
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D014635	Valproic Acid affects the expression of CEACAM1 mRNA	PMID:17292431
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CEACAM1 gene	PMID:29154799
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in increased expression of CEACAM1 mRNA	PMID:23527032
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CEACAM1 mRNA	PMID:20106945|PMID:25562108
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D016572	Cyclosporine results in decreased expression of CEACAM1 mRNA	PMID:19770486
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:40953	doramapimod	decreases expression	ISO	RGD:67396	E	RGD:6480464	20170228	CTD	MESH:C452139	doramapimod results in decreased expression of CEACAM1 mRNA	PMID:24303162
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:67396	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of CEACAM1 mRNA	PMID:17522070
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CEACAM1 mRNA	PMID:15289156
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:41977	daunorubicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003630	Daunorubicin results in increased expression of CEACAM1 mRNA	PMID:17374387
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:10240	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CEACAM1 mRNA	PMID:28973697
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in decreased expression of CEACAM1 mRNA	PMID:19924377
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases secretion	EXP		E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in decreased secretion of CEACAM1 protein	PMID:19924377
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20140304	CTD	MESH:D005947	cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of CEACAM1 mRNA]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased secretion of CEACAM1 protein]	PMID:19924377
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CEACAM1 mRNA	PMID:37992649
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:43572	kojic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of CEACAM1 mRNA	PMID:16595896
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of CEACAM1 mRNA	PMID:23649840
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:44185	methotrexate	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	[Folic Acid deficiency co-treated with Methotrexate] results in increased expression of CEACAM1 mRNA	PMID:24657277
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:67396	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of CEACAM1 mRNA	PMID:24136188
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	[Cisplatin co-treated with Paclitaxel] results in increased expression of CEACAM1 mRNA	PMID:20705681
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CEACAM1 mRNA	PMID:24935251
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CEACAM1 mRNA	PMID:21420995|PMID:29067470
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:67396	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in decreased expression of CEACAM1 mRNA	PMID:17522070
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of CEACAM1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CEACAM1 mRNA]	PMID:17585979
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:4631	diosmin	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20230606	CTD	MESH:D004145	Diosmin inhibits the reaction [Benzo(a)pyrene results in increased expression of CEACAM1 protein]	PMID:35920545
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:10240	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CEACAM1 mRNA	PMID:29279043
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CEACAM1 mRNA	PMID:25351596
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:46742	Nutlin-3	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of CEACAM1 mRNA	PMID:38460933
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of CEACAM1 mRNA	PMID:38460933
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:10240	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CEACAM1 mRNA	PMID:40504410
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of CEACAM1 mRNA	PMID:40706910
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:4846	erythromycin estolate	decreases expression	ISO	RGD:67396	E	RGD:6480464	20120412	CTD	MESH:D004918	Erythromycin Estolate results in decreased expression of CEACAM1 mRNA	PMID:17522070
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:67396	E	RGD:6480464	20120515	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CEACAM1 mRNA	PMID:12075121|PMID:12655037|PMID:15834898
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of CEACAM1 mRNA	PMID:17374387
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of CEACAM1 mRNA	PMID:32234424
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of CEACAM1 mRNA	PMID:23300844
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:5130	flurbiprofen	increases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D005480	Flurbiprofen results in increased expression of CEACAM1 mRNA	PMID:16949054
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:67396	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of CEACAM1 mRNA	PMID:24793618
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:5855	ibuprofen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007052	Ibuprofen affects the expression of CEACAM1 mRNA	PMID:17070997
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:10240	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CEACAM1 mRNA	PMID:38701926
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of CEACAM1 mRNA	PMID:20436886
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:67396	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of CEACAM1 mRNA	PMID:25729387
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:67396	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of CEACAM1 mRNA	PMID:25729387
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CEACAM1 mRNA	PMID:28988120
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:67396	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of CEACAM1 mRNA	PMID:24136188
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:67396	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CEACAM1 mRNA	PMID:30467583
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:10240	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CEACAM1 mRNA	PMID:22206623
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:67396	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of CEACAM1 mRNA	PMID:24136188
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of CEACAM1 mRNA	PMID:28960945
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:67396	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of CEACAM1 mRNA	PMID:33484710
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:67396	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CEACAM1 mRNA	PMID:18164116
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:D010634	Phenobarbital results in decreased expression of CEACAM1 mRNA	PMID:23091169
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:10240	E	RGD:6480464	20150127	CTD	MESH:D010634	Phenobarbital results in increased expression of CEACAM1 mRNA	PMID:19270015|PMID:25270620
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:67396	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of CEACAM1 mRNA	PMID:32109520
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of CEACAM1 mRNA	PMID:26705709
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:10240	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of CEACAM1 mRNA	PMID:31558096
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of CEACAM1 mRNA	PMID:32234424
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:67396	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CEACAM1 mRNA	PMID:23914054
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:10240	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of CEACAM1 mRNA	PMID:21795629
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:10240	E	RGD:6480464	20131220	CTD	MESH:C045950	propiconazole results in decreased expression of CEACAM1 mRNA	PMID:21278054
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:8887	rofecoxib	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C116926	rofecoxib affects the expression of CEACAM1 mRNA	PMID:17070997
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CEACAM1 mRNA	PMID:38568856
10241	CEACAM1	CEA cell adhesion molecule 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:10240	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CEACAM1 mRNA	PMID:28973697
10249	BSG	basigin (Ok blood group)	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of BSG mRNA	PMID:38218311
10249	BSG	basigin (Ok blood group)	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:2220	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of BSG mRNA	PMID:21551480
10249	BSG	basigin (Ok blood group)	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:2220	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BSG mRNA]	PMID:31150632
10249	BSG	basigin (Ok blood group)	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of BSG mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of BSG mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of BSG mRNA	PMID:32699268|PMID:32845096
10249	BSG	basigin (Ok blood group)	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of BSG mRNA	PMID:22378314
10249	BSG	basigin (Ok blood group)	gene	CHEBI:15930	atrazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001280	[Atrazine co-treated with Arsenates] results in increased expression of BSG mRNA	PMID:18585445
10249	BSG	basigin (Ok blood group)	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:10248	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of BSG mRNA	PMID:30319688
10249	BSG	basigin (Ok blood group)	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:2220	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in decreased expression of BSG mRNA	PMID:17920746
10249	BSG	basigin (Ok blood group)	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of BSG mRNA	PMID:30517762
10249	BSG	basigin (Ok blood group)	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of BSG mRNA	PMID:21632981
10249	BSG	basigin (Ok blood group)	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of BSG mRNA	PMID:35877022
10249	BSG	basigin (Ok blood group)	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of BSG mRNA	PMID:19167446
10249	BSG	basigin (Ok blood group)	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:10248	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of BSG mRNA	PMID:15289156
10249	BSG	basigin (Ok blood group)	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20120412	CTD	MESH:D014241	PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of BSG mRNA]	PMID:15363585
10249	BSG	basigin (Ok blood group)	gene	CHEBI:16695	uridine 5'-monophosphate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D014542	Uridine Monophosphate results in decreased expression of BSG protein	PMID:36574092
10249	BSG	basigin (Ok blood group)	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20160510	CTD	MESH:D001554	Benzene results in increased expression of BSG mRNA	PMID:24993241
10249	BSG	basigin (Ok blood group)	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:2220	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of BSG mRNA	PMID:26496021
10249	BSG	basigin (Ok blood group)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:10248	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of BSG mRNA	PMID:19850644|PMID:33754040
10249	BSG	basigin (Ok blood group)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of BSG mRNA]	PMID:19850644
10249	BSG	basigin (Ok blood group)	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of BSG protein	PMID:37730182
10249	BSG	basigin (Ok blood group)	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:2220	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of BSG mRNA	PMID:33387578
10249	BSG	basigin (Ok blood group)	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of BSG mRNA	PMID:28818685
10249	BSG	basigin (Ok blood group)	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BSG mRNA	PMID:36331819
10249	BSG	basigin (Ok blood group)	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:2220	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of BSG protein	PMID:34915118
10249	BSG	basigin (Ok blood group)	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	ISO	RGD:2220	E	RGD:6480464	20220906	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of BSG mRNA	PMID:35103375
10249	BSG	basigin (Ok blood group)	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:2220	E	RGD:6480464	20220906	CTD	MESH:D008769	corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BSG mRNA]	PMID:35103375
10249	BSG	basigin (Ok blood group)	gene	CHEBI:229272	N6-(2-Hydroxyethyl)adenosine	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C528186	N6-(2-hydroxyethyl)adenosine results in decreased expression of BSG protein	PMID:36574092
10249	BSG	basigin (Ok blood group)	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BSG mRNA	PMID:37236586
10249	BSG	basigin (Ok blood group)	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of BSG protein	PMID:23301498
10249	BSG	basigin (Ok blood group)	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:10248	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of BSG mRNA	PMID:19770486
10249	BSG	basigin (Ok blood group)	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:10248	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of BSG mRNA	PMID:18955075
10249	BSG	basigin (Ok blood group)	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:10248	E	RGD:6480464	20250401	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of BSG protein	PMID:39910959
10249	BSG	basigin (Ok blood group)	gene	CHEBI:2564	aldrin	decreases expression	ISO	RGD:10248	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in decreased expression of BSG mRNA	PMID:18579281
10249	BSG	basigin (Ok blood group)	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of BSG mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of BSG mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of BSG mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of BSG mRNA	PMID:32699268|PMID:32845096
10249	BSG	basigin (Ok blood group)	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of BSG mRNA	PMID:19774075
10249	BSG	basigin (Ok blood group)	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of BSG protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of BSG protein	PMID:38598786
10249	BSG	basigin (Ok blood group)	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20220111	CTD	MESH:D015032	[Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of BSG protein]	PMID:34508822
10249	BSG	basigin (Ok blood group)	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:2220	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of BSG mRNA	PMID:31150632
10249	BSG	basigin (Ok blood group)	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of BSG mRNA	PMID:30517762
10249	BSG	basigin (Ok blood group)	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:2220	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BSG mRNA]	PMID:31150632
10249	BSG	basigin (Ok blood group)	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of BSG mRNA]	PMID:22206623
10249	BSG	basigin (Ok blood group)	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BSG mRNA	PMID:40504410
10249	BSG	basigin (Ok blood group)	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of BSG protein	PMID:35688186
10249	BSG	basigin (Ok blood group)	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:10248	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of BSG protein	PMID:36173347
10249	BSG	basigin (Ok blood group)	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in decreased expression of BSG protein	PMID:17007354
10249	BSG	basigin (Ok blood group)	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130212	CTD	MESH:C059514	2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in decreased expression of BSG protein]; resveratrol inhibits the reaction [BSG protein results in increased expression of and results in increased secretion of IL18 protein]; resveratrol inhibits the reaction [BSG protein results in increased expression of IL18 mRNA]; resveratrol inhibits the reaction [IL18 protein results in increased expression of BSG mRNA]; resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]; resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG]	PMID:17007354|PMID:17055343|PMID:18647594|PMID:19561311
10249	BSG	basigin (Ok blood group)	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20220111	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of BSG protein; [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of BSG protein]	PMID:34508822
10249	BSG	basigin (Ok blood group)	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	BSG protein results in decreased susceptibility to Cisplatin	PMID:21165561
10249	BSG	basigin (Ok blood group)	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[[BSG binds to PPIA] which results in decreased susceptibility to Cisplatin] which results in increased expression of MMP9; [BSG binds to PPIA] which results in decreased susceptibility to Cisplatin	PMID:21956400
10249	BSG	basigin (Ok blood group)	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:10248	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of BSG mRNA	PMID:15289156
10249	BSG	basigin (Ok blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:10248	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BSG mRNA	PMID:21570461|PMID:24680724|PMID:26377647
10249	BSG	basigin (Ok blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:2220	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BSG mRNA	PMID:34747641
10249	BSG	basigin (Ok blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:10248	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BSG mRNA	PMID:33956508
10249	BSG	basigin (Ok blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:2220	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BSG mRNA	PMID:33387578
10249	BSG	basigin (Ok blood group)	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of BSG mRNA	PMID:33212167
10249	BSG	basigin (Ok blood group)	gene	CHEBI:28284	N(6),N(6)-dimethyladenosine	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C021013	N(6),N(6)-dimethyladenosine results in decreased expression of BSG protein	PMID:36574092
10249	BSG	basigin (Ok blood group)	gene	CHEBI:28509	chloroethene	decreases expression	ISO	RGD:10248	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in decreased expression of BSG mRNA	PMID:18579281
10249	BSG	basigin (Ok blood group)	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:2220	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of BSG mRNA	PMID:28959563
10249	BSG	basigin (Ok blood group)	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of BSG mRNA	PMID:29803840
10249	BSG	basigin (Ok blood group)	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of BSG protein	PMID:35688186
10249	BSG	basigin (Ok blood group)	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of BSG mRNA	PMID:29432896
10249	BSG	basigin (Ok blood group)	gene	CHEBI:29014	cordycepin	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C058120	cordycepin results in decreased expression of BSG protein	PMID:36574092
10249	BSG	basigin (Ok blood group)	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of BSG mRNA	PMID:24570342|PMID:39719251
10249	BSG	basigin (Ok blood group)	gene	CHEBI:29678	sodium arsenite	increases methylation	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased methylation of BSG gene	PMID:24570342
10249	BSG	basigin (Ok blood group)	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BSG mRNA	PMID:40504410
10249	BSG	basigin (Ok blood group)	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of BSG mRNA	PMID:22378314
10249	BSG	basigin (Ok blood group)	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BSG 3' UTR	PMID:27901495
10249	BSG	basigin (Ok blood group)	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of BSG mRNA	PMID:20106945|PMID:21632981
10249	BSG	basigin (Ok blood group)	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of BSG promoter	PMID:27901495
10249	BSG	basigin (Ok blood group)	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:10248	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of BSG exon; Benzo(a)pyrene results in decreased methylation of BSG intron	PMID:27901495
10249	BSG	basigin (Ok blood group)	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20220111	CTD	MESH:D015032	[Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of BSG protein]	PMID:34508822
10249	BSG	basigin (Ok blood group)	gene	CHEBI:3048	benzatropine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in decreased expression of BSG protein	PMID:34122009
10249	BSG	basigin (Ok blood group)	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:10248	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of BSG mRNA	PMID:27131904
10249	BSG	basigin (Ok blood group)	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of BSG mRNA	PMID:25895662
10249	BSG	basigin (Ok blood group)	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of BSG mRNA; Arsenic Trioxide results in decreased expression of BSG protein	PMID:23232515
10249	BSG	basigin (Ok blood group)	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:2220	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of BSG mRNA	PMID:16483693
10249	BSG	basigin (Ok blood group)	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of BSG gene	PMID:31601247
10249	BSG	basigin (Ok blood group)	gene	CHEBI:31767	lead diacetate	affects expression	ISO	RGD:10248	E	RGD:6480464	20190312	CTD	MESH:C008261	lead acetate affects the expression of BSG mRNA	PMID:30615929
10249	BSG	basigin (Ok blood group)	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20190312	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of BSG protein; [Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of BSG protein]; lead acetate results in decreased expression of and affects the localization of BSG protein	PMID:30615929|PMID:34508822
10249	BSG	basigin (Ok blood group)	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:10248	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BSG gene	PMID:35295148
10249	BSG	basigin (Ok blood group)	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:10248	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of BSG promoter	PMID:35295148
10249	BSG	basigin (Ok blood group)	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:10248	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of BSG mRNA	PMID:18301758|PMID:20813756|PMID:23811191
10249	BSG	basigin (Ok blood group)	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of BSG mRNA	PMID:20813756
10249	BSG	basigin (Ok blood group)	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of BSG mRNA	PMID:30903817
10249	BSG	basigin (Ok blood group)	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:10248	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of BSG mRNA	PMID:35598803
10249	BSG	basigin (Ok blood group)	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of BSG protein	PMID:34186270
10249	BSG	basigin (Ok blood group)	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2220	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of BSG mRNA; bisphenol A results in increased expression of BSG protein	PMID:25181051|PMID:32145629
10249	BSG	basigin (Ok blood group)	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of BSG gene	PMID:31601247
10249	BSG	basigin (Ok blood group)	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:2220	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BSG mRNA; [bisphenol A co-treated with Testosterone] results in increased expression of BSG mRNA	PMID:26496021|PMID:36041667
10249	BSG	basigin (Ok blood group)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:10248	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of BSG mRNA	PMID:39298647
10249	BSG	basigin (Ok blood group)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of BSG protein	PMID:34186270
10249	BSG	basigin (Ok blood group)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:2220	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BSG mRNA	PMID:36041667
10249	BSG	basigin (Ok blood group)	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of BSG protein	PMID:34186270
10249	BSG	basigin (Ok blood group)	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:2220	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BSG mRNA	PMID:36041667
10249	BSG	basigin (Ok blood group)	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of BSG protein	PMID:34186270
10249	BSG	basigin (Ok blood group)	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:10248	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of BSG mRNA	PMID:37019170
10249	BSG	basigin (Ok blood group)	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:2220	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of BSG mRNA	PMID:21266533
10249	BSG	basigin (Ok blood group)	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of BSG protein	PMID:38598786
10249	BSG	basigin (Ok blood group)	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:10248	E	RGD:6480464	20190219	CTD	MESH:D010269	Paraquat results in increased expression of BSG protein	PMID:29287252
10249	BSG	basigin (Ok blood group)	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BSG mRNA	PMID:37042841
10249	BSG	basigin (Ok blood group)	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:10248	E	RGD:6480464	20190312	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of BSG mRNA	PMID:30615929
10249	BSG	basigin (Ok blood group)	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20190312	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BSG mRNA; Cadmium Chloride affects the expression of and affects the localization of BSG protein	PMID:30615929|PMID:37236586
10249	BSG	basigin (Ok blood group)	gene	CHEBI:35559	furan	increases expression	ISO	RGD:2220	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of BSG mRNA	PMID:26194646
10249	BSG	basigin (Ok blood group)	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:2220	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of BSG gene	PMID:22079235
10249	BSG	basigin (Ok blood group)	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of BSG mRNA	PMID:19376846
10249	BSG	basigin (Ok blood group)	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of BSG mRNA	PMID:25339124
10249	BSG	basigin (Ok blood group)	gene	CHEBI:35842	antirheumatic drug	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	[Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of BSG mRNA; [Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of BSG protein	PMID:23146660
10249	BSG	basigin (Ok blood group)	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:10248	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of BSG mRNA	PMID:18353800
10249	BSG	basigin (Ok blood group)	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of BSG mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of BSG mRNA	PMID:32699268
10249	BSG	basigin (Ok blood group)	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:10248	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of BSG mRNA	PMID:17585979
10249	BSG	basigin (Ok blood group)	gene	CHEBI:3750	clofibrate	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D002994	Clofibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA]; Clofibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]	PMID:16860414
10249	BSG	basigin (Ok blood group)	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA; Tetradecanoylphorbol Acetate results in increased expression of BSG protein	PMID:16860414|PMID:17055343|PMID:18647594
10249	BSG	basigin (Ok blood group)	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]]; Clofibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA]; Clofibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]; Pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA]; Pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]; Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]; Resveratrol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG]; SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA]; SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]	PMID:16860414|PMID:17055343|PMID:18647594
10249	BSG	basigin (Ok blood group)	gene	CHEBI:3884	corilagin	multiple interactions	ISO	RGD:2220	E	RGD:6480464	20220906	CTD	MESH:C049096	corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BSG mRNA]	PMID:35103375
10249	BSG	basigin (Ok blood group)	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BSG mRNA	PMID:19167446
10249	BSG	basigin (Ok blood group)	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of BSG mRNA	PMID:26352163
10249	BSG	basigin (Ok blood group)	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BSG mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of BSG mRNA	PMID:36331819
10249	BSG	basigin (Ok blood group)	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:10248	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of BSG mRNA	PMID:31558096
10249	BSG	basigin (Ok blood group)	gene	CHEBI:3962	curcumin	decreases response to substance	ISO	RGD:10248	E	RGD:6480464	20120412	CTD	MESH:D003474	BSG protein results in decreased susceptibility to Curcumin	PMID:18379992
10249	BSG	basigin (Ok blood group)	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BSG mRNA	PMID:25979313
10249	BSG	basigin (Ok blood group)	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of BSG mRNA	PMID:23179753
10249	BSG	basigin (Ok blood group)	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of BSG gene	PMID:29154799
10249	BSG	basigin (Ok blood group)	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:2220	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of BSG mRNA	PMID:41580965
10249	BSG	basigin (Ok blood group)	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:10248	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of BSG mRNA	PMID:15331540
10249	BSG	basigin (Ok blood group)	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:10248	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of BSG mRNA	PMID:15289156
10249	BSG	basigin (Ok blood group)	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of BSG mRNA	PMID:33512557
10249	BSG	basigin (Ok blood group)	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in decreased expression of BSG mRNA	PMID:25339124
10249	BSG	basigin (Ok blood group)	gene	CHEBI:44185	methotrexate	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	[Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of BSG mRNA; [Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of BSG protein	PMID:23146660
10249	BSG	basigin (Ok blood group)	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of BSG mRNA	PMID:28542535
10249	BSG	basigin (Ok blood group)	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BSG mRNA	PMID:40504410
10249	BSG	basigin (Ok blood group)	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of BSG protein	PMID:25470785
10249	BSG	basigin (Ok blood group)	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:10248	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of BSG mRNA	PMID:17942748
10249	BSG	basigin (Ok blood group)	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:2220	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of BSG mRNA	PMID:17108234
10249	BSG	basigin (Ok blood group)	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of BSG mRNA; Arsenic Trioxide results in decreased expression of BSG protein	PMID:23232515
10249	BSG	basigin (Ok blood group)	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of BSG mRNA	PMID:20436886
10249	BSG	basigin (Ok blood group)	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of BSG protein	PMID:32959892
10249	BSG	basigin (Ok blood group)	gene	CHEBI:62984	zinc acetate	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20220111	CTD	MESH:D019345	[Zinc Acetate results in increased abundance of Zinc] inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of BSG protein]	PMID:34508822
10249	BSG	basigin (Ok blood group)	gene	CHEBI:65347	carfilzomib	decreases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C524865	carfilzomib results in decreased expression of BSG mRNA	PMID:27769052
10249	BSG	basigin (Ok blood group)	gene	CHEBI:65347	carfilzomib	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:C524865	carfilzomib promotes the reaction [[Dronabinol co-treated with Cannabidiol] results in decreased expression of BSG mRNA]	PMID:27769052
10249	BSG	basigin (Ok blood group)	gene	CHEBI:68641	(-)-cotinine	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:D003367	[Tobacco Smoke Pollution results in increased abundance of Cotinine] which affects the methylation of BSG gene	PMID:34009014
10249	BSG	basigin (Ok blood group)	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:10248	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of BSG mRNA	PMID:17383702
10249	BSG	basigin (Ok blood group)	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D002185	Cannabidiol results in decreased expression of BSG mRNA	PMID:27769052
10249	BSG	basigin (Ok blood group)	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D002185	[Dronabinol co-treated with Cannabidiol] results in decreased expression of BSG mRNA; Cannabidiol promotes the reaction [Dronabinol results in decreased expression of BSG mRNA]; carfilzomib promotes the reaction [[Dronabinol co-treated with Cannabidiol] results in decreased expression of BSG mRNA]; Dronabinol promotes the reaction [Cannabidiol results in decreased expression of BSG mRNA]	PMID:27769052
10249	BSG	basigin (Ok blood group)	gene	CHEBI:72544	flavonoids	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in increased expression of BSG mRNA	PMID:15465739
10249	BSG	basigin (Ok blood group)	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of BSG mRNA	PMID:31758290
10249	BSG	basigin (Ok blood group)	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of BSG protein	PMID:34186270
10249	BSG	basigin (Ok blood group)	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:10248	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of BSG mRNA	PMID:22206623
10249	BSG	basigin (Ok blood group)	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:10248	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of BSG mRNA]	PMID:22206623
10249	BSG	basigin (Ok blood group)	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of BSG protein	PMID:37664457
10249	BSG	basigin (Ok blood group)	gene	CHEBI:77986	dibenziodolium	multiple interactions	EXP		E	RGD:6480464	20140415	CTD	MESH:C007517	diphenyleneiodonium inhibits the reaction [IL18 protein results in increased expression of BSG mRNA]	PMID:19561311
10249	BSG	basigin (Ok blood group)	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BSG mRNA	PMID:19167446
10249	BSG	basigin (Ok blood group)	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:10248	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of BSG mRNA	PMID:38648751
10249	BSG	basigin (Ok blood group)	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of BSG mRNA	PMID:33512557
10249	BSG	basigin (Ok blood group)	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:2220	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of BSG protein	PMID:28903499
10249	BSG	basigin (Ok blood group)	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:10248	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of BSG mRNA	PMID:31558096
10249	BSG	basigin (Ok blood group)	gene	CHEBI:8228	pioglitazone	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C060836	pioglitazone results in decreased expression of BSG protein	PMID:17007354
10249	BSG	basigin (Ok blood group)	gene	CHEBI:8228	pioglitazone	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C060836	2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]]; pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA]; pioglitazone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]	PMID:16860414|PMID:17055343
10249	BSG	basigin (Ok blood group)	gene	CHEBI:90705	SB 203580	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C093642	SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG mRNA]; SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BSG protein]	PMID:18647594
10249	BSG	basigin (Ok blood group)	gene	CHEBI:91108	SB 431542	increases expression	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of BSG protein	PMID:25670856
10249	BSG	basigin (Ok blood group)	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of BSG protein	PMID:37664457
10249	BSG	basigin (Ok blood group)	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:10248	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of BSG mRNA	PMID:27131904
10249	BSG	basigin (Ok blood group)	gene	CHEBI:9190	solasodine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C012037	solasodine results in decreased expression of BSG mRNA	PMID:28283413
10249	BSG	basigin (Ok blood group)	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of BSG protein	PMID:38598786
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:101278	diltiazem	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20161025	CTD	MESH:D004110	Diltiazem inhibits the reaction [Iron-Dextran Complex affects the expression of CACNA1C protein]	PMID:27095094
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:114786	sodium disulfite	decreases expression	ISO	RGD:2245	E	RGD:6480464	20220906	CTD	MESH:C005200	sodium metabisulfite results in decreased expression of CACNA1C mRNA; sodium metabisulfite results in decreased expression of CACNA1C protein	PMID:25463229|PMID:26015265
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CACNA1C mRNA	PMID:33045310
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:135937	enzacamene	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20170307	CTD	MESH:C038939	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] affects the expression of CACNA1C mRNA; [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CACNA1C mRNA	PMID:25607892
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:136004	linsidomine	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C002385	[linsidomine co-treated with Peroxynitrous Acid] results in increased nitrosation of CACNA1C protein	PMID:17551092
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:2245	E	RGD:6480464	20130416	CTD	MESH:D014212	Tretinoin results in increased expression of CACNA1C mRNA	PMID:23056435
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CACNA1C mRNA	PMID:33729688
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of CACNA1C mRNA	PMID:26079696
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:2245	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of CACNA1C gene	PMID:35440735
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1550302	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CACNA1C mRNA	PMID:30319688
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20220607	CTD	MESH:D000431	Ethanol results in decreased expression of CACNA1C mRNA; Ethanol results in decreased expression of CACNA1C protein	PMID:34864093
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550302	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CACNA1C mRNA	PMID:30319688
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:2245	E	RGD:6480464	20250204	CTD	MESH:D000431	Ethanol results in increased expression of CACNA1C mRNA; Ethanol results in increased expression of CACNA1C protein	PMID:27905406
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20220607	CTD	MESH:D000431	ferrostatin-1 inhibits the reaction [Ethanol results in decreased expression of CACNA1C mRNA]	PMID:34864093
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20250204	CTD	MESH:D000431	Ethanol deficiency affects the reaction [Ethanol results in increased expression of CACNA1C mRNA]	PMID:27905406
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:16598	DDE	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20160705	CTD	MESH:D003633	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA	PMID:25607892
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:16602	trichloroethene	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CACNA1C mRNA	PMID:25847060
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:2245	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CACNA1C mRNA	PMID:33387578
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of CACNA1C gene	PMID:30521419
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of CACNA1C mRNA	PMID:34673133
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:2245	E	RGD:6480464	20191112	CTD	MESH:D005557	Formaldehyde results in decreased expression of CACNA1C protein	PMID:30974163
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:2245	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of CACNA1C mRNA	PMID:20726854
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of CACNA1C gene	PMID:33872906
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:173086	ferrostatin-1	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20220607	CTD	MESH:C573944	ferrostatin-1 inhibits the reaction [Ethanol results in decreased expression of CACNA1C mRNA]	PMID:34864093
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1550302	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CACNA1C protein	PMID:11756415
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:177406	Bardoxolone methyl	decreases activity	EXP		E	RGD:6480464	20210907	CTD	MESH:C445068	bardoxolone methyl results in decreased activity of CACNA1C protein	PMID:28790194
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:2245	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CACNA1C mRNA	PMID:20920545
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of CACNA1C gene	PMID:33872906
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20160705	CTD	MESH:D004051	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA	PMID:25607892
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CACNA1C exon; aflatoxin B2 results in increased methylation of CACNA1C intron	PMID:30157460
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:18248	iron atom	multiple interactions	EXP		E	RGD:6480464	20210504	CTD	MESH:D007501	[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein]	PMID:33285147
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:18422	sulfur dioxide	decreases expression	ISO	RGD:2245	E	RGD:6480464	20240604	CTD	MESH:D013458	Sulfur Dioxide results in decreased expression of CACNA1C mRNA; Sulfur Dioxide results in decreased expression of CACNA1C protein	PMID:26112951
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1550302	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CACNA1C protein	PMID:11756415
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:22977	cadmium atom	affects expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D002104	Cadmium affects the expression of CACNA1C mRNA	PMID:36321828
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in increased expression of CACNA1C mRNA	PMID:29993192
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CACNA1C mRNA	PMID:35301059
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CACNA1C mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CACNA1C mRNA	PMID:37325564|PMID:40850461
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:22984	calcium atom	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	CACNA1C protein results in increased transport of Calcium	PMID:15299022
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:22984	calcium atom	increases transport	ISO	RGD:2245	E	RGD:6480464	20120412	CTD	MESH:D002118	CACNA1C protein results in increased transport of Calcium	PMID:14634047
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:22984	calcium atom	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D002118	[CACNA1C protein co-treated with CACNB3 protein] results in increased transport of Calcium; [CACNA2D4 protein binds to CACNA1C protein binds to CACNB3 protein] which results in increased transport of Calcium; CACNA2D4 protein promotes the reaction [[CACNA1C protein co-treated with CACNB3 protein] results in increased transport of Calcium]	PMID:12181424
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:22984	calcium atom	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20120412	CTD	MESH:D002118	Allethrins inhibits the reaction [CACNA1C protein results in increased transport of Calcium]	PMID:14634047
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:2245	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of CACNA1C protein	PMID:33236894
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CACNA1C mRNA	PMID:32234424
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CACNA1C gene	PMID:27153756
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CACNA1C exon; Aflatoxin B1 results in increased methylation of CACNA1C intron	PMID:30157460
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:25351	mevalonic acid	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20230502	CTD	MESH:D008798	Mevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of CACNA1C mRNA]; Mevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of CACNA1C protein]; Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1C mRNA]; Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1C protein]	PMID:19791473
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:25942	peroxynitrous acid	increases metabolic processing	EXP		E	RGD:6480464	20121218	CTD	MESH:D030421	Peroxynitrous Acid results in increased metabolism of CACNA1C protein alternative form	PMID:20128810
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:25942	peroxynitrous acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D030421	[linsidomine co-treated with Peroxynitrous Acid] results in increased nitrosation of CACNA1C protein; [Peroxynitrous Acid results in increased metabolism of CACNA1C protein alternative form] which results in decreased phosphorylation of CREB1 protein; Peroxynitrous Acid inhibits the reaction [[Potassium Chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein]	PMID:17551092|PMID:20128810
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:2663	amiodarone	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in decreased expression of CACNA1C mRNA	PMID:15520326
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:2245	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CACNA1C mRNA; Amphetamine results in increased expression of CACNA1C protein	PMID:15329393
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:2245	E	RGD:6480464	20120515	CTD	MESH:D015032	Zinc results in increased expression of CACNA1C mRNA	PMID:15159208|PMID:17074742
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:2245	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CACNA1C mRNA	PMID:31150632
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CACNA1C gene	PMID:25304211
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:2245	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CACNA1C mRNA	PMID:31881176
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in decreased expression of CACNA1C mRNA	PMID:22610192
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CACNA1C mRNA	PMID:28903495
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of CACNA1C mRNA	PMID:21151649
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CACNA1C mRNA	PMID:19465110
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:2245	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CACNA1C mRNA	PMID:32109520
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CACNA1C promoter]	PMID:19654925
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:2245	E	RGD:6480464	20200609	CTD	MESH:D012402	Rotenone results in increased expression of CACNA1C mRNA	PMID:31585160
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20200609	CTD	MESH:D012402	[3-bromo-2-oxopropionic acid co-treated with Rotenone] results in increased expression of CACNA1C mRNA	PMID:31585160
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:28748	doxorubicin	affects methylation	ISO	RGD:2245	E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of CACNA1C gene	PMID:28962528
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CACNA1C mRNA	PMID:29803840
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:2904	atenolol	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D001262	CACNA1C gene polymorphism results in increased susceptibility to Atenolol	PMID:20031608
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29320	calcium(0)	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	CACNA1C protein results in increased transport of Calcium	PMID:15299022
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29320	calcium(0)	increases transport	ISO	RGD:2245	E	RGD:6480464	20120412	CTD	MESH:D002118	CACNA1C protein results in increased transport of Calcium	PMID:14634047
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29320	calcium(0)	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D002118	[CACNA1C protein co-treated with CACNB3 protein] results in increased transport of Calcium; [CACNA2D4 protein binds to CACNA1C protein binds to CACNB3 protein] which results in increased transport of Calcium; CACNA2D4 protein promotes the reaction [[CACNA1C protein co-treated with CACNB3 protein] results in increased transport of Calcium]	PMID:12181424
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29320	calcium(0)	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20120412	CTD	MESH:D002118	Allethrins inhibits the reaction [CACNA1C protein results in increased transport of Calcium]	PMID:14634047
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of CACNA1C gene	PMID:28589171
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CACNA1C mRNA	PMID:21776218
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CACNA1C mRNA	PMID:38568856
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1550302	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of CACNA1C mRNA	PMID:17127020
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CACNA1C 3' UTR; Benzo(a)pyrene affects the methylation of CACNA1C exon; Benzo(a)pyrene affects the methylation of CACNA1C intron	PMID:27901495|PMID:30157460
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1550302	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CACNA1C exon; Benzo(a)pyrene affects the methylation of CACNA1C intron	PMID:27901495
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CACNA1C mRNA	PMID:22316170
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CACNA1C promoter	PMID:27901495
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1550302	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CACNA1C intron	PMID:27901495
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to CACNA1C promoter]	PMID:19654925
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:2245	E	RGD:6480464	20120515	CTD	MESH:D015032	Zinc results in increased expression of CACNA1C mRNA	PMID:15159208|PMID:17074742
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CACNA1C mRNA	PMID:27131904
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CACNA1C mRNA	PMID:24831965
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CACNA1C gene	PMID:31601247
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CACNA1C gene	PMID:31601247
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550302	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CACNA1C gene	PMID:35295148
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550302	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CACNA1C gene	PMID:35295148
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:32588	potassium chloride	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D011189	[Potassium Chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein; Nifedipine inhibits the reaction [[Potassium Chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein]; Peroxynitrous Acid inhibits the reaction [[Potassium Chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein]	PMID:20128810
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:32595	barium(0)	increases transport	ISO	RGD:2245	E	RGD:6480464	20120412	CTD	MESH:D001464	CACNA1C protein results in increased transport of Barium	PMID:17569661
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33192	sodium cyanide	increases phosphorylation	ISO	RGD:1550302	E	RGD:6480464	20191112	CTD	MESH:D012966	Sodium Cyanide results in increased phosphorylation of CACNA1C protein	PMID:31173149
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33192	sodium cyanide	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20191112	CTD	MESH:D012966	[Sodium Cyanide results in increased activity of PRKCE protein] which results in increased phosphorylation of CACNA1C protein; Methylene Blue inhibits the reaction [Sodium Cyanide results in increased phosphorylation of CACNA1C protein]	PMID:31173149
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:2245	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of CACNA1C mRNA	PMID:30816183
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C006780	bisphenol A results in decreased expression of CACNA1C mRNA	PMID:36385337
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CACNA1C mRNA	PMID:32156529
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2245	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CACNA1C mRNA	PMID:25181051
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CACNA1C gene	PMID:31601247
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of CACNA1C mRNA	PMID:17989879
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550302	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of CACNA1C mRNA	PMID:30951980|PMID:32370801|PMID:34585602
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1550302	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CACNA1C promoter	PMID:27312807
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CACNA1C gene	PMID:31601247
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20181113	CTD	MESH:C006780	[bisphenol A co-treated with Streptozocin] results in decreased expression of CACNA1C mRNA	PMID:29935216
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] affects the expression of CACNA1C mRNA; [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CACNA1C mRNA	PMID:25607892
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of CACNA1C mRNA	PMID:35321852
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550302	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CACNA1C gene	PMID:31683443
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550302	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CACNA1C mRNA	PMID:30951980
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of CACNA1C intron	PMID:30157460
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CACNA1C exon	PMID:30157460
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20120412	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1C protein; Allethrins inhibits the reaction [CACNA1C protein results in increased transport of Calcium]	PMID:14634047|PMID:34896426
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550302	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CACNA1C mRNA	PMID:30951980
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:2245	E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CACNA1C mRNA	PMID:18668222
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20160705	CTD	MESH:D003993	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA	PMID:25607892
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1550302	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CACNA1C mRNA	PMID:24535843
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:2245	E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of CACNA1C mRNA	PMID:18198484
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of CACNA1C mRNA	PMID:36117858
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CACNA1C mRNA	PMID:37042841
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:35176	zinc sulfate	increases expression	ISO	RGD:2245	E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in increased expression of CACNA1C mRNA	PMID:17074742
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:2245	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CACNA1C mRNA	PMID:36928142
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CACNA1C mRNA	PMID:38568856
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CACNA1C mRNA	PMID:35301059
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CACNA1C mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CACNA1C mRNA	PMID:37325564|PMID:40850461
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:35497	androgen antagonist	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20170228	CTD	MESH:D000726	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] affects the expression of CACNA1C mRNA	PMID:25607892
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:35559	furan	increases expression	ISO	RGD:2245	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CACNA1C mRNA	PMID:27387713
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:38940	sunitinib	decreases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C473478	sunitinib results in decreased activity of CACNA1C protein	PMID:23707608
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CACNA1C mRNA	PMID:31533062
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20190910	CTD	MESH:C473478	Sunitinib results in decreased expression of CACNA1C protein	PMID:31025080
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:38940	sunitinib	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20190910	CTD	MESH:C473478	PIK3CA protein inhibits the reaction [Sunitinib results in decreased expression of CACNA1C protein]	PMID:31025080
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:2245	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of CACNA1C protein	PMID:34896426
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of CACNA1C mRNA	PMID:23125180
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:2245	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of CACNA1C mRNA	PMID:29427782
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:2245	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of CACNA1C mRNA	PMID:29427782
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CACNA1C gene	PMID:29154799
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of CACNA1C gene	PMID:29501571
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1C protein	PMID:34896426
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1C protein	PMID:34896426
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of CACNA1C mRNA	PMID:24449571
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of CACNA1C mRNA	PMID:21678067
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:2245	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CACNA1C mRNA	PMID:33387578
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20160705	CTD	MESH:D000082	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] affects the expression of CACNA1C mRNA	PMID:25607892
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CACNA1C gene	PMID:25304211
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:2245	E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in decreased expression of CACNA1C mRNA	PMID:31464424
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550302	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CACNA1C mRNA	PMID:35436446
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:4811	epoxiconazole	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20160705	CTD	MESH:C109476	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA	PMID:25607892
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:48843	disodium selenite	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20130514	CTD	MESH:D018038	[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of CACNA1C mRNA	PMID:23274088
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of CACNA1C mRNA	PMID:20498617
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CACNA1C mRNA	PMID:24831965
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:2245	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of CACNA1C mRNA	PMID:30307764
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1C protein	PMID:34896426
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of CACNA1C mRNA	PMID:36117858
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:2245	E	RGD:6480464	20150512	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of CACNA1C mRNA; Trinitrobenzenesulfonic Acid results in increased expression of CACNA1C protein	PMID:23537331
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of CACNA1C mRNA	PMID:36907384
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:64310	crizotinib	decreases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C551994	crizotinib results in decreased activity of CACNA1C protein	PMID:23707608
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:2245	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of CACNA1C mRNA; Isoproterenol results in increased expression of CACNA1C protein	PMID:17526999|PMID:39855041
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20250506	CTD	MESH:D007545	coomassie Brilliant Blue inhibits the reaction [Isoproterenol results in increased expression of CACNA1C protein]	PMID:39855041
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:64356	pregabalin	affects localization	ISO	RGD:2245	E	RGD:6480464	20170110	CTD	MESH:D000069583	Pregabalin affects the localization of CACNA1C protein	PMID:22949532
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:6482	linuron	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20160705	CTD	MESH:D008044	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA	PMID:25607892
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:65457	astragaloside IV	multiple interactions	EXP		E	RGD:6480464	20210504	CTD	MESH:C052064	astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein]	PMID:33285147
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:6651	malathion	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in increased expression of CACNA1C mRNA	PMID:37047231
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:6809	methamphetamine	decreases methylation	ISO	RGD:1550302	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased methylation of CACNA1C promoter	PMID:26307267
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1550302	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of CACNA1C mRNA; Methamphetamine results in increased expression of CACNA1C protein	PMID:26307267
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:2245	E	RGD:6480464	20230307	CTD	MESH:D008694	Methamphetamine results in increased expression of CACNA1C mRNA	PMID:35863504
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of CACNA1C intron	PMID:30157460
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CACNA1C exon	PMID:30157460
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:2245	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CACNA1C gene	PMID:35440735
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:68554	deferiprone	multiple interactions	EXP		E	RGD:6480464	20210504	CTD	MESH:C044919	Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein]	PMID:33285147
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:68584	ezogabine	affects activity	EXP		E	RGD:6480464	20180116	CTD	MESH:C101866	ezogabine affects the activity of CACNA1C protein	PMID:28641963
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:6872	methylene blue	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20191112	CTD	MESH:D008751	Methylene Blue inhibits the reaction [Sodium Cyanide results in increased phosphorylation of CACNA1C protein]	PMID:31173149
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CACNA1C mRNA	PMID:22206623
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:7494	nefazodone	affects activity	EXP		E	RGD:6480464	20170516	CTD	MESH:C051752	nefazodone affects the activity of CACNA1C protein	PMID:26821276
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:7565	nifedipine	affects response to substance	ISO	RGD:1550302	E	RGD:6480464	20120412	CTD	MESH:D009543	CACNA1C protein affects the susceptibility to Nifedipine	PMID:18441296
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:7565	nifedipine	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D009543	Nifedipine inhibits the reaction [[Potassium Chloride co-treated with CACNA1C protein alternative form] results in increased phosphorylation of CREB1 protein]	PMID:20128810
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:7575	nimodipine	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20161025	CTD	MESH:D009553	Nimodipine inhibits the reaction [Iron-Dextran Complex affects the expression of CACNA1C protein]	PMID:27095094
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:77733	2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile	decreases expression	ISO	RGD:2245	E	RGD:6480464	20140805	CTD	MESH:D014700	Verapamil results in decreased expression of CACNA1C mRNA; Verapamil results in decreased expression of CACNA1C protein	PMID:19791473
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:77733	2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile	increases response to substance	EXP		E	RGD:6480464	20140805	CTD	MESH:D014700	CACNA1C gene polymorphism results in increased susceptibility to Verapamil	PMID:20031608
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:77733	2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20161025	CTD	MESH:D014700	Verapamil inhibits the reaction [Iron-Dextran Complex affects the expression of CACNA1C protein]	PMID:27095094
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:77733	2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20140805	CTD	MESH:D014700	Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1C mRNA]; Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1C protein]	PMID:19791473
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:78291	iron dextran	affects expression	ISO	RGD:1550302	E	RGD:6480464	20161025	CTD	MESH:D007505	Iron-Dextran Complex affects the expression of CACNA1C protein	PMID:27095094
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:78291	iron dextran	multiple interactions	EXP		E	RGD:6480464	20210504	CTD	MESH:D007505	[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein]	PMID:33285147
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:78291	iron dextran	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20161025	CTD	MESH:D007505	Diltiazem inhibits the reaction [Iron-Dextran Complex affects the expression of CACNA1C protein]; Nimodipine inhibits the reaction [Iron-Dextran Complex affects the expression of CACNA1C protein]; Verapamil inhibits the reaction [Iron-Dextran Complex affects the expression of CACNA1C protein]	PMID:27095094
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CACNA1C gene]	PMID:28238834
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:2245	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CACNA1C mRNA	PMID:32109520
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550302	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CACNA1C mRNA	PMID:38648751
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:8207	(+)-pilocarpine	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in decreased expression of CACNA1C protein	PMID:17265461
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:8207	(+)-pilocarpine	increases expression	ISO	RGD:1550302	E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in increased expression of CACNA1C protein	PMID:17265461
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CACNA1C mRNA	PMID:27935865
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:82527	Ptaquiloside	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20141111	CTD	MESH:C043680	[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of CACNA1C mRNA	PMID:23274088
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:82664	iron(0)	multiple interactions	EXP		E	RGD:6480464	20210504	CTD	MESH:D007501	[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein; astragaloside A inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein]; Deferiprone inhibits the reaction [[Iron-Dextran Complex results in increased abundance of Iron] which results in increased expression of CACNA1C protein]	PMID:33285147
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550302	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of CACNA1C mRNA	PMID:21795629
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:8434	prochloraz	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20160705	CTD	MESH:C045362	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA	PMID:25607892
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:8450	procymidone	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20160705	CTD	MESH:C035988	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA	PMID:25607892
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:88542	Butylparaben	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20200407	CTD	MESH:C038091	[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] affects the expression of CACNA1C mRNA; [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CACNA1C mRNA	PMID:25607892
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CACNA1C mRNA	PMID:27131904
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:9150	simvastatin	decreases expression	ISO	RGD:2245	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in decreased expression of CACNA1C mRNA; Simvastatin results in decreased expression of CACNA1C protein	PMID:19791473
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:9150	simvastatin	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20120501	CTD	MESH:D019821	Mevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of CACNA1C mRNA]; Mevalonic Acid inhibits the reaction [Simvastatin results in decreased expression of CACNA1C protein]	PMID:19791473
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1550302	E	RGD:6480464	20181113	CTD	MESH:D013311	Streptozocin results in increased expression of CACNA1C mRNA	PMID:29935216
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20181113	CTD	MESH:D013311	[bisphenol A co-treated with Streptozocin] results in decreased expression of CACNA1C mRNA; [octylphenol co-treated with Streptozocin] results in decreased expression of CACNA1C mRNA	PMID:29935216
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1550302	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of CACNA1C mRNA	PMID:26006729|PMID:26217789
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:9948	verapamil	decreases expression	ISO	RGD:2245	E	RGD:6480464	20120501	CTD	MESH:D014700	Verapamil results in decreased expression of CACNA1C mRNA; Verapamil results in decreased expression of CACNA1C protein	PMID:19791473
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:9948	verapamil	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D014700	CACNA1C gene polymorphism results in increased susceptibility to Verapamil	PMID:20031608
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:9948	verapamil	multiple interactions	ISO	RGD:1550302	E	RGD:6480464	20161025	CTD	MESH:D014700	Verapamil inhibits the reaction [Iron-Dextran Complex affects the expression of CACNA1C protein]	PMID:27095094
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:9948	verapamil	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20120501	CTD	MESH:D014700	Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1C mRNA]; Mevalonic Acid inhibits the reaction [Verapamil results in decreased expression of CACNA1C protein]	PMID:19791473
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:2245	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CACNA1C mRNA	PMID:23034163
10268	CACNA1C	calcium voltage-gated channel subunit alpha1 C	gene	CHEBI:9986	vinclozolin	multiple interactions	ISO	RGD:2245	E	RGD:6480464	20160705	CTD	MESH:C025643	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in increased expression of CACNA1C mRNA	PMID:25607892
10291	CASR	calcium sensing receptor	gene	CHEBI:10022	deoxynivalenol	multiple interactions	ISO	RGD:1553551	E	RGD:6480464	20150609	CTD	MESH:C007262	CASR affects the reaction [deoxynivalenol results in increased secretion of CCK protein]	PMID:25787141
10291	CASR	calcium sensing receptor	gene	CHEBI:133151	methyl beta-cyclodextrin	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C108732	methyl-beta-cyclodextrin inhibits the reaction [CASR protein results in increased uptake of Calcium]	PMID:21562303
10291	CASR	calcium sensing receptor	gene	CHEBI:145121	SKF-96365 hydrochloride	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C063159	1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [CASR protein results in increased uptake of Calcium]	PMID:21562303
10291	CASR	calcium sensing receptor	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1553551	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of CASR mRNA	PMID:36189433
10291	CASR	calcium sensing receptor	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:2277	E	RGD:6480464	20210406	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CASR mRNA; Oxygen deficiency results in increased expression of CASR protein	PMID:32956540
10291	CASR	calcium sensing receptor	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20210406	CTD	MESH:D010100	Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of CASR mRNA]; Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of CASR protein]	PMID:32956540
10291	CASR	calcium sensing receptor	gene	CHEBI:15746	spermine	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D013096	2-aminoethoxydiphenyl borate inhibits the reaction [Spermine binds to and results in increased activity of CASR protein]; [Spermine binds to and results in increased activity of CASR protein] which results in increased uptake of Calcium; Lanthanum inhibits the reaction [Spermine binds to and results in increased activity of CASR protein]; Spermine binds to and results in increased activity of CASR protein	PMID:17041782
10291	CASR	calcium sensing receptor	gene	CHEBI:15746	spermine	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20120412	CTD	MESH:D013096	NPS R-467 promotes the reaction [Spermine binds to and results in increased activity of CASR protein]; Phenylephrine inhibits the reaction [Spermine binds to and results in increased activity of CASR protein]; Spermine binds to and results in increased activity of CASR protein; Thapsigargin inhibits the reaction [Spermine binds to and results in increased activity of CASR protein]	PMID:11071898
10291	CASR	calcium sensing receptor	gene	CHEBI:16261	chitosan	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20260113	CTD	MESH:D048271	Chitosan inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of CASR protein]	PMID:40738241
10291	CASR	calcium sensing receptor	gene	CHEBI:16595	1D-myo-inositol 1,4,5-trisphosphate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015544	[CASR protein mutant form results in increased susceptibility to Calcium] which results in increased abundance of Inositol 1,4,5-Trisphosphate	PMID:7874174
10291	CASR	calcium sensing receptor	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1553551	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of CASR mRNA	PMID:20403060
10291	CASR	calcium sensing receptor	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1553551	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone deficiency results in increased expression of CASR mRNA	PMID:21045173
10291	CASR	calcium sensing receptor	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1553551	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone inhibits the reaction [Testosterone deficiency results in increased expression of CASR mRNA]	PMID:21045173
10291	CASR	calcium sensing receptor	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:2277	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CASR mRNA	PMID:27523638
10291	CASR	calcium sensing receptor	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:2277	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CASR mRNA	PMID:26577399
10291	CASR	calcium sensing receptor	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:2277	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CASR mRNA; Calcitriol results in increased expression of CASR protein	PMID:15788476
10291	CASR	calcium sensing receptor	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:2277	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CASR protein	PMID:16850027
10291	CASR	calcium sensing receptor	gene	CHEBI:17833	gentamycin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	CASR protein promotes the reaction [Gentamicins results in increased phosphorylation of and results in increased activity of MAPK1 protein]; CASR protein promotes the reaction [Gentamicins results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Gentamicins binds to and results in increased activity of CASR protein	PMID:17537980
10291	CASR	calcium sensing receptor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20200915	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CASR protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASR protein; CASR protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]; CASR protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP9 protein]; CASR protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of AKT1 protein]	PMID:27872163|PMID:32599263
10291	CASR	calcium sensing receptor	gene	CHEBI:22984	calcium atom	affects expression	ISO	RGD:2277	E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium affects the expression of CASR mRNA; Calcium affects the expression of CASR protein	PMID:15788476
10291	CASR	calcium sensing receptor	gene	CHEBI:22984	calcium atom	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	CASR protein mutant form results in decreased susceptibility to Calcium	PMID:9011580
10291	CASR	calcium sensing receptor	gene	CHEBI:22984	calcium atom	increases activity	EXP		E	RGD:6480464	20120613	CTD	MESH:D002118	Calcium results in increased activity of CASR protein	PMID:17041782
10291	CASR	calcium sensing receptor	gene	CHEBI:22984	calcium atom	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium results in increased phosphorylation of CASR protein	PMID:17376781
10291	CASR	calcium sensing receptor	gene	CHEBI:22984	calcium atom	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	CASR gene mutant form results in increased susceptibility to Calcium; CASR protein mutant form results in increased susceptibility to Calcium	PMID:11089548|PMID:11701698|PMID:7874174
10291	CASR	calcium sensing receptor	gene	CHEBI:22984	calcium atom	increases uptake	EXP		E	RGD:6480464	20120613	CTD	MESH:D002118	CASR protein results in increased uptake of Calcium	PMID:21562303
10291	CASR	calcium sensing receptor	gene	CHEBI:22984	calcium atom	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D002118	1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [CASR protein results in increased uptake of Calcium]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [CASR protein results in increased uptake of Calcium]; 2-aminoethoxydiphenyl borate inhibits the reaction [Calcium binds to and results in increased activity of CASR protein]; 2-aminoethoxydiphenyl borate inhibits the reaction [CASR protein results in increased uptake of Calcium]; [2-quinoxaline-carboxamide-N-adamantan-1-yl binds to and results in decreased activity of CASR protein] inhibits the reaction [Nickel results in increased abundance of Calcium]; [Calcium binds to and results in increased activity of CASR protein] which results in increased uptake of Calcium; [CASR protein mutant form results in increased susceptibility to Calcium] which results in increased abundance of Inositol 1,4,5-Trisphosphate; [Spermine binds to and results in increased activity of CASR protein] which results in increased uptake of Calcium; bisindolylmaleimide I inhibits the reaction [NPS R-467 promotes the reaction [Calcium results in increased phosphorylation of CASR protein]]; Calcium Chloride promotes the reaction [Calcium results in increased phosphorylation of CASR protein]; CASR mutant form inhibits the reaction [Calcium results in increased expression of KRT1 mRNA]; CASR mutant form inhibits the reaction [Calcium results in increased expression of KRT1 protein]; CASR mutant form inhibits the reaction [Calcium results in increased expression of LORICRIN mRNA]; CASR mutant form inhibits the reaction [Calcium results in increased expression of LORICRIN protein]; CASR mutant form inhibits the reaction [Calcium results in increased expression of WNT5A protein]; CASR protein affects the reaction [Nickel results in increased abundance of Calcium]; CASR protein promotes the reaction [TRPC6 protein results in increased uptake of Calcium]; chelerythrine inhibits the reaction [CASR protein results in increased uptake of Calcium]; Flufenamic Acid promotes the reaction [CASR protein results in increased uptake of Calcium]; Lanthanum inhibits the reaction [Calcium binds to and results in increased activity of CASR protein]; Lanthanum inhibits the reaction [CASR protein results in increased uptake of Calcium]; methyl-beta-cyclodextrin inhibits the reaction [CASR protein results in increased uptake of Calcium]; N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine affects the reaction [CASR gene mutant form results in increased susceptibility to Calcium]; N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine promotes the reaction [CASR protein results in increased susceptibility to Calcium]; NPS R-467 promotes the reaction [Calcium results in increased phosphorylation of CASR protein]; Pertussis Toxin inhibits the reaction [CASR protein results in increased uptake of Calcium]	PMID:11089548|PMID:17041782|PMID:17376781|PMID:19781536|PMID:21562303|PMID:24658506|PMID:7874174
10291	CASR	calcium sensing receptor	gene	CHEBI:22984	calcium atom	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20130312	CTD	MESH:D002118	[Aluminum binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Calcium binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Calcium binds to and results in increased activity of CASR protein] which results in increased abundance of Inositol Phosphates; [Gadolinium binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Magnesium binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Neomycin binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; Calcium binds to and results in increased activity of CASR protein; Gadolinium inhibits the reaction [Calcium binds to and results in increased activity of CASR protein]	PMID:10231437|PMID:11071898
10291	CASR	calcium sensing receptor	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CASR gene	PMID:27153756
10291	CASR	calcium sensing receptor	gene	CHEBI:25107	magnesium atom	increases expression	ISO	RGD:2277	E	RGD:6480464	20120412	CTD	MESH:D008274	Magnesium results in increased expression of CASR mRNA; Magnesium results in increased expression of CASR protein	PMID:11563847
10291	CASR	calcium sensing receptor	gene	CHEBI:25107	magnesium atom	increases response to substance	ISO	RGD:1553551	E	RGD:6480464	20120412	CTD	MESH:D008274	CASR protein results in increased susceptibility to Magnesium	PMID:15068510
10291	CASR	calcium sensing receptor	gene	CHEBI:25107	magnesium atom	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20130312	CTD	MESH:D008274	[Magnesium binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Magnesium binds to and results in increased activity of CASR protein] which results in increased abundance of Inositol Phosphates; Magnesium binds to and results in increased activity of CASR protein	PMID:10231437
10291	CASR	calcium sensing receptor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20120412	CTD	MESH:D010126	[Ozone co-treated with Chlorine] results in decreased expression of CASR mRNA	PMID:18636392
10291	CASR	calcium sensing receptor	gene	CHEBI:2637	amikacin	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D000583	Amikacin results in increased activity of CASR protein	PMID:19884751
10291	CASR	calcium sensing receptor	gene	CHEBI:2666	amitriptyline	decreases expression	ISO	RGD:2277	E	RGD:6480464	20130416	CTD	MESH:D000639	Amitriptyline results in decreased expression of CASR mRNA	PMID:22341215
10291	CASR	calcium sensing receptor	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1553551	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CASR mRNA	PMID:28960355
10291	CASR	calcium sensing receptor	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CASR mRNA	PMID:23557933
10291	CASR	calcium sensing receptor	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1553551	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of CASR mRNA	PMID:18930951
10291	CASR	calcium sensing receptor	gene	CHEBI:28112	nickel atom	increases activity	EXP		E	RGD:6480464	20120501	CTD	MESH:D009532	Nickel results in increased activity of CASR protein	PMID:19781536
10291	CASR	calcium sensing receptor	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D009532	[2-quinoxaline-carboxamide-N-adamantan-1-yl binds to and results in decreased activity of CASR protein] inhibits the reaction [Nickel results in increased abundance of Calcium]; [2-quinoxaline-carboxamide-N-adamantan-1-yl binds to and results in decreased activity of CASR protein] inhibits the reaction [Nickel results in increased expression of ACTA2 mRNA]; [2-quinoxaline-carboxamide-N-adamantan-1-yl binds to and results in decreased activity of CASR protein] inhibits the reaction [Nickel results in increased expression of COL1A1 mRNA]; [2-quinoxaline-carboxamide-N-adamantan-1-yl binds to and results in decreased activity of CASR protein] inhibits the reaction [Nickel results in increased expression of ICAM1 mRNA]; [2-quinoxaline-carboxamide-N-adamantan-1-yl binds to and results in decreased activity of CASR protein] inhibits the reaction [Nickel results in increased expression of IL1B mRNA]; [2-quinoxaline-carboxamide-N-adamantan-1-yl binds to and results in decreased activity of CASR protein] inhibits the reaction [Nickel results in increased expression of TNF mRNA]; [2-quinoxaline-carboxamide-N-adamantan-1-yl binds to and results in decreased activity of CASR protein] which results in decreased susceptibility to Nickel; CASR protein affects the reaction [Nickel results in increased abundance of Calcium]	PMID:19781536
10291	CASR	calcium sensing receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:2277	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CASR mRNA	PMID:32109520
10291	CASR	calcium sensing receptor	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of CASR mRNA	PMID:29955902
10291	CASR	calcium sensing receptor	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:2277	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of CASR protein	PMID:35544339
10291	CASR	calcium sensing receptor	gene	CHEBI:28659	phosphorus atom	affects abundance	EXP		E	RGD:6480464	20120412	CTD	MESH:D010758	CASR protein affects the abundance of Phosphorus	PMID:11589681
10291	CASR	calcium sensing receptor	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1553551	E	RGD:6480464	20121009	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CASR mRNA	PMID:21340527|PMID:27862939
10291	CASR	calcium sensing receptor	gene	CHEBI:28984	aluminium atom	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20130312	CTD	MESH:D000535	[Aluminum binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Aluminum binds to and results in increased activity of CASR protein] which results in increased abundance of Inositol Phosphates; Aluminum binds to and results in increased activity of CASR protein	PMID:10231437
10291	CASR	calcium sensing receptor	gene	CHEBI:29310	dichlorine	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20120412	CTD	MESH:D002713	[Ozone co-treated with Chlorine] results in decreased expression of CASR mRNA	PMID:18636392
10291	CASR	calcium sensing receptor	gene	CHEBI:29320	calcium(0)	affects expression	ISO	RGD:2277	E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium affects the expression of CASR mRNA; Calcium affects the expression of CASR protein	PMID:15788476
10291	CASR	calcium sensing receptor	gene	CHEBI:29320	calcium(0)	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	CASR protein mutant form results in decreased susceptibility to Calcium	PMID:9011580
10291	CASR	calcium sensing receptor	gene	CHEBI:29320	calcium(0)	increases activity	EXP		E	RGD:6480464	20120613	CTD	MESH:D002118	Calcium results in increased activity of CASR protein	PMID:17041782
10291	CASR	calcium sensing receptor	gene	CHEBI:29320	calcium(0)	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium results in increased phosphorylation of CASR protein	PMID:17376781
10291	CASR	calcium sensing receptor	gene	CHEBI:29320	calcium(0)	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	CASR gene mutant form results in increased susceptibility to Calcium; CASR protein mutant form results in increased susceptibility to Calcium	PMID:11089548|PMID:11701698|PMID:7874174
10291	CASR	calcium sensing receptor	gene	CHEBI:29320	calcium(0)	increases uptake	EXP		E	RGD:6480464	20120613	CTD	MESH:D002118	CASR protein results in increased uptake of Calcium	PMID:21562303
10291	CASR	calcium sensing receptor	gene	CHEBI:29320	calcium(0)	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D002118	1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [CASR protein results in increased uptake of Calcium]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [CASR protein results in increased uptake of Calcium]; 2-aminoethoxydiphenyl borate inhibits the reaction [Calcium binds to and results in increased activity of CASR protein]; 2-aminoethoxydiphenyl borate inhibits the reaction [CASR protein results in increased uptake of Calcium]; [2-quinoxaline-carboxamide-N-adamantan-1-yl binds to and results in decreased activity of CASR protein] inhibits the reaction [Nickel results in increased abundance of Calcium]; [Calcium binds to and results in increased activity of CASR protein] which results in increased uptake of Calcium; [CASR protein mutant form results in increased susceptibility to Calcium] which results in increased abundance of Inositol 1,4,5-Trisphosphate; [Spermine binds to and results in increased activity of CASR protein] which results in increased uptake of Calcium; bisindolylmaleimide I inhibits the reaction [NPS R-467 promotes the reaction [Calcium results in increased phosphorylation of CASR protein]]; Calcium Chloride promotes the reaction [Calcium results in increased phosphorylation of CASR protein]; CASR mutant form inhibits the reaction [Calcium results in increased expression of KRT1 mRNA]; CASR mutant form inhibits the reaction [Calcium results in increased expression of KRT1 protein]; CASR mutant form inhibits the reaction [Calcium results in increased expression of LORICRIN mRNA]; CASR mutant form inhibits the reaction [Calcium results in increased expression of LORICRIN protein]; CASR mutant form inhibits the reaction [Calcium results in increased expression of WNT5A protein]; CASR protein affects the reaction [Nickel results in increased abundance of Calcium]; CASR protein promotes the reaction [TRPC6 protein results in increased uptake of Calcium]; chelerythrine inhibits the reaction [CASR protein results in increased uptake of Calcium]; Flufenamic Acid promotes the reaction [CASR protein results in increased uptake of Calcium]; Lanthanum inhibits the reaction [Calcium binds to and results in increased activity of CASR protein]; Lanthanum inhibits the reaction [CASR protein results in increased uptake of Calcium]; methyl-beta-cyclodextrin inhibits the reaction [CASR protein results in increased uptake of Calcium]; N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine affects the reaction [CASR gene mutant form results in increased susceptibility to Calcium]; N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine promotes the reaction [CASR protein results in increased susceptibility to Calcium]; NPS R-467 promotes the reaction [Calcium results in increased phosphorylation of CASR protein]; Pertussis Toxin inhibits the reaction [CASR protein results in increased uptake of Calcium]	PMID:11089548|PMID:17041782|PMID:17376781|PMID:19781536|PMID:21562303|PMID:24658506|PMID:7874174
10291	CASR	calcium sensing receptor	gene	CHEBI:29320	calcium(0)	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20130312	CTD	MESH:D002118	[Aluminum binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Calcium binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Calcium binds to and results in increased activity of CASR protein] which results in increased abundance of Inositol Phosphates; [Gadolinium binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Magnesium binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Neomycin binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; Calcium binds to and results in increased activity of CASR protein; Gadolinium inhibits the reaction [Calcium binds to and results in increased activity of CASR protein]	PMID:10231437|PMID:11071898
10291	CASR	calcium sensing receptor	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:2277	E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of CASR mRNA; sodium arsenite results in decreased expression of CASR protein	PMID:35314868|PMID:38266420
10291	CASR	calcium sensing receptor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1553551	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of CASR mRNA	PMID:37682722
10291	CASR	calcium sensing receptor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CASR 5' UTR; Benzo(a)pyrene affects the methylation of CASR promoter	PMID:27901495
10291	CASR	calcium sensing receptor	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:2277	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CASR mRNA	PMID:21839799
10291	CASR	calcium sensing receptor	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CASR 3' UTR	PMID:27901495
10291	CASR	calcium sensing receptor	gene	CHEBI:30207	phosphorus(.)	affects abundance	EXP		E	RGD:6480464	20120412	CTD	MESH:D010758	CASR protein affects the abundance of Phosphorus	PMID:11589681
10291	CASR	calcium sensing receptor	gene	CHEBI:30440	thallium atom	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20250311	CTD	MESH:D013793	[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of CASR mRNA	PMID:39361050
10291	CASR	calcium sensing receptor	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:2277	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CASR mRNA	PMID:16483693
10291	CASR	calcium sensing receptor	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CASR gene	PMID:31601247
10291	CASR	calcium sensing receptor	gene	CHEBI:3312	calcium dichloride	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D002122	Calcium Chloride results in increased activity of CASR protein	PMID:16316325
10291	CASR	calcium sensing receptor	gene	CHEBI:3312	calcium dichloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002122	Calcium Chloride promotes the reaction [Calcium results in increased phosphorylation of CASR protein]	PMID:17376781
10291	CASR	calcium sensing receptor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2277	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CASR mRNA	PMID:30816183|PMID:32528016|PMID:34947998
10291	CASR	calcium sensing receptor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2277	E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of CASR mRNA	PMID:36779543
10291	CASR	calcium sensing receptor	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CASR gene	PMID:31601247
10291	CASR	calcium sensing receptor	gene	CHEBI:33324	strontium atom	affects activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D013324	Strontium affects the activity of CASR protein	PMID:15068510
10291	CASR	calcium sensing receptor	gene	CHEBI:33324	strontium atom	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D013324	CASR protein results in increased susceptibility to Strontium	PMID:15068510
10291	CASR	calcium sensing receptor	gene	CHEBI:33336	lanthanum atom	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D007811	Lanthanum inhibits the reaction [Calcium binds to and results in increased activity of CASR protein]; Lanthanum inhibits the reaction [CASR protein results in increased uptake of Calcium]; Lanthanum inhibits the reaction [Spermine binds to and results in increased activity of CASR protein]	PMID:17041782|PMID:21562303
10291	CASR	calcium sensing receptor	gene	CHEBI:33375	gadolinium atom	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20130312	CTD	MESH:D005682	[Gadolinium binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Gadolinium binds to and results in increased activity of CASR protein] which results in increased abundance of Inositol Phosphates; Gadolinium binds to and results in increased activity of CASR protein; Gadolinium inhibits the reaction [Calcium binds to and results in increased activity of CASR protein]	PMID:10231437|PMID:11071898
10291	CASR	calcium sensing receptor	gene	CHEBI:33629	aluminium(0)	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20130312	CTD	MESH:D000535	[Aluminum binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Aluminum binds to and results in increased activity of CASR protein] which results in increased abundance of Inositol Phosphates; Aluminum binds to and results in increased activity of CASR protein	PMID:10231437
10291	CASR	calcium sensing receptor	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1553551	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of CASR mRNA	PMID:26682919
10291	CASR	calcium sensing receptor	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:2277	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CASR mRNA	PMID:15620428
10291	CASR	calcium sensing receptor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20200915	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CASR protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CASR protein; CASR protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]; CASR protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP9 protein]; CASR protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of AKT1 protein]	PMID:27872163|PMID:32599263
10291	CASR	calcium sensing receptor	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20210406	CTD	MESH:D002738	Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of CASR mRNA]; Chloroquine inhibits the reaction [Oxygen deficiency results in increased expression of CASR protein]	PMID:32956540
10291	CASR	calcium sensing receptor	gene	CHEBI:41072	3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C070515	bisindolylmaleimide I inhibits the reaction [NPS R-467 promotes the reaction [Calcium results in increased phosphorylation of CASR protein]]	PMID:17376781
10291	CASR	calcium sensing receptor	gene	CHEBI:41791	calyculin A	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C059041	calyculin A promotes the reaction [phorbolol myristate acetate results in increased phosphorylation of CASR protein]	PMID:17376781
10291	CASR	calcium sensing receptor	gene	CHEBI:42638	flufenamic acid	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D005439	Flufenamic Acid promotes the reaction [CASR protein results in increased uptake of Calcium]	PMID:21562303
10291	CASR	calcium sensing receptor	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of CASR mRNA	PMID:24449571
10291	CASR	calcium sensing receptor	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of CASR mRNA	PMID:24714768
10291	CASR	calcium sensing receptor	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:2277	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of CASR gene	PMID:37958445
10291	CASR	calcium sensing receptor	gene	CHEBI:6030	isoniazide	affects expression	ISO	RGD:2277	E	RGD:6480464	20120501	CTD	MESH:D007538	Isoniazid affects the expression of CASR mRNA	PMID:20623750
10291	CASR	calcium sensing receptor	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:2277	E	RGD:6480464	20201006	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CASR mRNA	PMID:32387197
10291	CASR	calcium sensing receptor	gene	CHEBI:7507	neomycin	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:D009355	CASR protein promotes the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; CASR protein promotes the reaction [Neomycin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Neomycin binds to and results in increased activity of CASR protein	PMID:17537980
10291	CASR	calcium sensing receptor	gene	CHEBI:7507	neomycin	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20140805	CTD	MESH:D009355	[Neomycin binds to and results in increased activity of CASR protein] which results in increased abundance of Calcium; [Neomycin binds to and results in increased activity of CASR protein] which results in increased abundance of Inositol Phosphates; Neomycin binds to and results in increased activity of CASR protein	PMID:10231437
10291	CASR	calcium sensing receptor	gene	CHEBI:755912	aluminum chloride	increases activity	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077410	Aluminum Chloride results in increased activity of CASR protein	PMID:16316325
10291	CASR	calcium sensing receptor	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:2277	E	RGD:6480464	20190219	CTD	MESH:C007350	nitrofen results in increased expression of CASR mRNA; nitrofen results in increased expression of CASR protein	PMID:28983729
10291	CASR	calcium sensing receptor	gene	CHEBI:78373	chelerythrine	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:C016299	chelerythrine inhibits the reaction [CASR protein results in increased uptake of Calcium]	PMID:21562303
10291	CASR	calcium sensing receptor	gene	CHEBI:79516	Nonylphenol	decreases expression	ISO	RGD:2277	E	RGD:6480464	20141111	CTD	MESH:C025256	nonylphenol results in decreased expression of CASR mRNA	PMID:15620428
10291	CASR	calcium sensing receptor	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CASR gene]	PMID:28238834
10291	CASR	calcium sensing receptor	gene	CHEBI:8093	phenylephrine	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine inhibits the reaction [Spermine binds to and results in increased activity of CASR protein]	PMID:11071898
10291	CASR	calcium sensing receptor	gene	CHEBI:81836	thallium sulfate	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20250311	CTD	MESH:C013707	[thallium sulfate results in increased abundance of Thallium] which results in decreased expression of CASR mRNA	PMID:39361050
10291	CASR	calcium sensing receptor	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:2277	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CASR mRNA	PMID:24780913|PMID:25825206
10291	CASR	calcium sensing receptor	gene	CHEBI:90690	U-73122	multiple interactions	EXP		E	RGD:6480464	20160105	CTD	MESH:C060229	1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [CASR protein results in increased uptake of Calcium]	PMID:21562303
10291	CASR	calcium sensing receptor	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20260113	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in decreased expression of CASR protein; Chitosan inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of CASR protein]	PMID:40738241
10291	CASR	calcium sensing receptor	gene	CHEBI:9516	thapsigargin	multiple interactions	ISO	RGD:2277	E	RGD:6480464	20120412	CTD	MESH:D019284	Thapsigargin inhibits the reaction [Spermine binds to and results in increased activity of CASR protein]	PMID:11071898
10291	CASR	calcium sensing receptor	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:2277	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of CASR mRNA	PMID:21515302
10305	CD2	CD2 molecule	gene	CHEBI:125472	N-(6-acetamidohexyl)acetamide	decreases expression	ISO	RGD:10304	E	RGD:6480464	20170228	CTD	MESH:C014026	hexamethylene bisacetamide results in decreased expression of CD2 mRNA	PMID:26941288
10305	CD2	CD2 molecule	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:10304	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD2 mRNA	PMID:30529165
10305	CD2	CD2 molecule	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:10304	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CD2 mRNA	PMID:39298647
10305	CD2	CD2 molecule	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CD2 mRNA	PMID:37042841
10305	CD2	CD2 molecule	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CD2 mRNA	PMID:23649840
10305	CD2	CD2 molecule	gene	CHEBI:17627	ferroheme b	increases expression	ISO	RGD:10304	E	RGD:6480464	20120814	CTD	MESH:D006418	Heme metabolite results in increased expression of CD2 mRNA	PMID:19191707
10305	CD2	CD2 molecule	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:2297	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CD2 mRNA	PMID:22061828
10305	CD2	CD2 molecule	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CD2 gene	PMID:27153756
10305	CD2	CD2 molecule	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:10304	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CD2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CD2 mRNA	PMID:34911549
10305	CD2	CD2 molecule	gene	CHEBI:26355	heme b	increases expression	ISO	RGD:10304	E	RGD:6480464	20140805	CTD	MESH:D006418	Heme metabolite results in increased expression of CD2 mRNA	PMID:19191707
10305	CD2	CD2 molecule	gene	CHEBI:2682	amphotericin B	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in increased expression of CD2 mRNA	PMID:28534445
10305	CD2	CD2 molecule	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:D001151	Arsenic results in increased methylation of CD2 gene	PMID:27838757
10305	CD2	CD2 molecule	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CD2 mRNA	PMID:32525701
10305	CD2	CD2 molecule	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:2297	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CD2 mRNA	PMID:31881176
10305	CD2	CD2 molecule	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:10304	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of CD2 mRNA	PMID:40618947
10305	CD2	CD2 molecule	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:10304	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of CD2 mRNA	PMID:32186404
10305	CD2	CD2 molecule	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CD2 mRNA	PMID:25583101
10305	CD2	CD2 molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:2297	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CD2 mRNA	PMID:34747641
10305	CD2	CD2 molecule	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:10304	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD2 mRNA	PMID:34876320
10305	CD2	CD2 molecule	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:10304	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD2 mRNA	PMID:34876320
10305	CD2	CD2 molecule	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:10304	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CD2 mRNA	PMID:21569818
10305	CD2	CD2 molecule	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CD2 promoter	PMID:27901495
10305	CD2	CD2 molecule	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:10304	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CD2 mRNA	PMID:29341224
10305	CD2	CD2 molecule	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:2297	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CD2 mRNA	PMID:16483693
10305	CD2	CD2 molecule	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:10304	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of CD2 mRNA	PMID:36087614
10305	CD2	CD2 molecule	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:10304	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CD2 mRNA	PMID:23557971
10305	CD2	CD2 molecule	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:10304	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CD2 mRNA	PMID:18648102
10305	CD2	CD2 molecule	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:10304	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CD2 mRNA	PMID:20813756
10305	CD2	CD2 molecule	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2297	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CD2 mRNA	PMID:25181051
10305	CD2	CD2 molecule	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:10304	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of CD2 promoter	PMID:27312807
10305	CD2	CD2 molecule	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:10304	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CD2 mRNA	PMID:32156529|PMID:38701888
10305	CD2	CD2 molecule	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2297	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of CD2 mRNA	PMID:41034487
10305	CD2	CD2 molecule	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CD2 protein	PMID:21623697
10305	CD2	CD2 molecule	gene	CHEBI:33418	graphite	affects expression	ISO	RGD:2297	E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of CD2 mRNA	PMID:29933104
10305	CD2	CD2 molecule	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:10304	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of CD2 promoter	PMID:33297965
10305	CD2	CD2 molecule	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:10304	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CD2 mRNA	PMID:38685157
10305	CD2	CD2 molecule	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CD2 mRNA	PMID:37042841
10305	CD2	CD2 molecule	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:2297	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of CD2 mRNA	PMID:35163327
10305	CD2	CD2 molecule	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:2297	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CD2 mRNA	PMID:35163327
10305	CD2	CD2 molecule	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:2297	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CD2 mRNA	PMID:35163327
10305	CD2	CD2 molecule	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CD2 mRNA	PMID:24449571
10305	CD2	CD2 molecule	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:10304	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of CD2 mRNA	PMID:17585979
10305	CD2	CD2 molecule	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:10304	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of CD2 mRNA	PMID:29038090
10305	CD2	CD2 molecule	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:10304	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of CD2 mRNA	PMID:23125180
10305	CD2	CD2 molecule	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:10304	E	RGD:6480464	20120515	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of CD2 mRNA	PMID:21041162
10305	CD2	CD2 molecule	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:10304	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of CD2 mRNA	PMID:21041162
10305	CD2	CD2 molecule	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of CD2 mRNA	PMID:17400583
10305	CD2	CD2 molecule	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:10304	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CD2 mRNA	PMID:26941288
10305	CD2	CD2 molecule	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of CD2 mRNA	PMID:26690555
10305	CD2	CD2 molecule	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	[Dietary Carbohydrates co-treated with Acetaminophen] results in decreased expression of CD2 mRNA	PMID:17093179
10305	CD2	CD2 molecule	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:D001151	Arsenic results in increased methylation of CD2 gene	PMID:27838757
10305	CD2	CD2 molecule	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CD2 mRNA	PMID:32525701
10305	CD2	CD2 molecule	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:2297	E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in increased expression of CD2 mRNA	PMID:16122865
10305	CD2	CD2 molecule	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:10304	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD2 mRNA	PMID:34876320
10305	CD2	CD2 molecule	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of CD2 mRNA	PMID:18175754
10305	CD2	CD2 molecule	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:10304	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CD2 mRNA; Nanotubes, Carbon results in decreased expression of CD2 mRNA	PMID:25554681
10305	CD2	CD2 molecule	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:10304	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CD2 mRNA	PMID:35964746
10305	CD2	CD2 molecule	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:10304	E	RGD:6480464	20120412	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CD2 mRNA	PMID:16141432
10305	CD2	CD2 molecule	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:10304	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CD2 mRNA	PMID:38701926
10305	CD2	CD2 molecule	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of CD2 mRNA	PMID:20436886
10305	CD2	CD2 molecule	gene	CHEBI:61057	tacrolimus hydrate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016559	Tacrolimus inhibits the reaction [CD2 protein results in increased expression of IL2 protein]	PMID:1705513
10305	CD2	CD2 molecule	gene	CHEBI:72544	flavonoids	increases expression	ISO	RGD:2297	E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in increased expression of CD2 mRNA	PMID:18035473
10305	CD2	CD2 molecule	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CD2 mRNA	PMID:31758290
10305	CD2	CD2 molecule	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:10304	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CD2 mRNA	PMID:22206623
10305	CD2	CD2 molecule	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CD2 mRNA	PMID:32525701
10305	CD2	CD2 molecule	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:10304	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CD2 mRNA	PMID:34876320
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:10355	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CHRNA4 mRNA	PMID:33045310
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:133305	sulfoxaflor	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20250902	CTD	MESH:C560328	sulfoxaflor inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; sulfoxaflor inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; sulfoxaflor results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein]; sulfoxaflor results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein mutant form binds to CHRNB2 protein mutant form binds to CHRNB2 protein mutant form]; sulfoxaflor results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:39800138
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:133354	bentonite	multiple interactions	EXP		E	RGD:6480464	20161004	CTD	MESH:D001546	Bentonite inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]	PMID:22750351
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:133997	flupyradifurone	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20250902	CTD	MESH:C000606086	flupyradifurone inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; flupyradifurone inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; flupyradifurone results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein]; flupyradifurone results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein mutant form binds to CHRNB2 protein mutant form binds to CHRNB2 protein mutant form]; flupyradifurone results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:39800138
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of CHRNA4 mRNA	PMID:34925699
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]	PMID:20132834
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:140621	cisatracurium	multiple interactions	EXP		E	RGD:6480464	20180508	CTD	MESH:C101584	cisatracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:16931985
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:145170	13-desmethylspirolide C	multiple interactions	EXP		E	RGD:6480464	20191105	CTD	MESH:C517170	13-desmethylspirolide C binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:26063663
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:15354	choline	affects activity	ISO	RGD:2346	E	RGD:6480464	20171010	CTD	MESH:D002794	Choline affects the activity of CHRNA4 protein	PMID:19047205
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:15354	choline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D002794	Choline affects the activity of [CHRNA4 protein binds to CHRNB2 protein]; Choline inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]	PMID:14645658
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20230704	CTD	MESH:D002794	Choline inhibits the reaction [Sodium Fluoride results in decreased expression of CHRNA4 mRNA]	PMID:36286330
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:15355	acetylcholine	affects binding	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D000109	Acetylcholine analog binds to [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:19252481
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:15355	acetylcholine	increases response to substance	ISO	RGD:10355	E	RGD:6480464	20120412	CTD	MESH:D000109	CHRNA4 protein mutant form results in increased susceptibility to Acetylcholine	PMID:16339034
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:15355	acetylcholine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000109	1-Butanol affects the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; 2,4,2',4'-tetrachlorobiphenyl inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; 3,5-dibromo-2-(2,4-dibromophenoxy)phenol inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; 4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; 4-octylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; [3,5-dibromo-2-(2,4-dibromophenoxy)phenol co-treated with 2,4,2',4'-tetrachlorobiphenyl] inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; [Estradiol co-treated with Acetylcholine] results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; [Ethinyl Estradiol co-treated with Acetylcholine] results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; [Progesterone co-treated with Acetylcholine] results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB4 protein]; Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]; Acetylcholine results in increased activity of [CHRNB4 protein binds to CHRNA4 protein]; Aluminum Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; antimony trioxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Atracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Atropine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Bentonite inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; bisphenol A inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; cisatracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; clothianidin promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; decabromobiphenyl ether inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; desformylflustrabromine promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Dichlorvos inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Diethylstilbestrol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Ethinyl Estradiol promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Fire Trol 934 inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Flame Retardants inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Flame Retardants inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Galantamine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; imidacloprid inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Magnesium Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Mivacurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Pancuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Physostigmine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Rivastigmine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Rocuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Scopolamine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tacrine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; tetrabromobisphenol A inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; tetrabromobisphenol A inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Toluene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; triphenyl phosphate inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]; Tubocurarine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Ethinyl Estradiol promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]]; Vecuronium Bromide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:11517245|PMID:11711029|PMID:12604691|PMID:14645658|PMID:15733544|PMID:15885267|PMID:16931985|PMID:20132834|PMID:20861069|PMID:21538459|PMID:21905680|PMID:22547355|PMID:22750351|PMID:34628512|PMID:39914504|PMID:9454827
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:15355	acetylcholine	multiple interactions	ISO	RGD:2346	E	RGD:2303194|PMID:15016836	20210901	RGD	MESH:D000109	acetylcholine affects binding to Chrna4 protein; acetylcholine competes with [Epibatidine binds to Chrna4 protein]	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:15355	acetylcholine	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20130611	CTD	MESH:D000109	[CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein mutant form binds to CHRNB2 protein mutant form] which results in increased susceptibility to Acetylcholine; [CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein mutant form binds to CHRNB2 protein mutant form binds to CHRNB2 protein mutant form] which results in decreased susceptibility to Acetylcholine; [CHRNA4 protein binds to CHRNB2 protein mutant form] which results in increased susceptibility to Acetylcholine; [CHRNA4 protein co-treated with CHRNB2 protein mutant form] inhibits the reaction [Calcium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein co-treated with CHRNB2 protein] affects the reaction [Barium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein co-treated with CHRNB2 protein] affects the reaction [Calcium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein co-treated with CHRNB2 protein] affects the susceptibility to Acetylcholine; [CHRNA4 protein mutant form co-treated with CHRNB2 protein] inhibits the reaction [Barium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein mutant form co-treated with CHRNB2 protein] inhibits the reaction [Calcium results in increased susceptibility to Acetylcholine]; [Ethinyl Estradiol co-treated with Acetylcholine] results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA4 protein binds to CHRNB2 protein]; [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA4 protein binds to CHRNB4 protein]; [pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine; Acetylcholine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein]; Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein binds to CHRNB2 protein]; Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; clothianidin inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; Dihydro-beta-Erythroidine inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; Excitatory Amino Acid Antagonists inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; FG 9041 inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; flupyradifurone inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; flupyradifurone inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; imidacloprid inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; imidacloprid inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; Mecamylamine inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; sulfoxaflor inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; sulfoxaflor inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Toluene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Urethane promotes the reaction [Acetylcholine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:11517245|PMID:11812690|PMID:12130716|PMID:12754307|PMID:15885267|PMID:18385335|PMID:39800138
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:10355	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of CHRNA4 mRNA; Tretinoin results in decreased expression of CHRNA4 protein	PMID:17203487
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin promotes the reaction [epibatidine binds to CHRNA4 protein]	PMID:17203487
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:10355	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CHRNA4 mRNA	PMID:24205000
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:10355	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CHRNA4 mRNA	PMID:30319688
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:16469	17beta-estradiol	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol binds to CHRNA4 protein	PMID:11517245
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:10355	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CHRNA4 mRNA	PMID:39298647
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Acetylcholine] results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:11517245
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:16684	atropine	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D001285	Atropine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:16684	atropine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001285	Atropine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:16684	atropine	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20130416	CTD	MESH:D001285	Atropine promotes the reaction [Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 mRNA]]; Atropine promotes the reaction [Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 protein]]	PMID:21791372
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:10355	E	RGD:6480464	20220308	CTD	MESH:D001554	Benzene results in decreased expression of CHRNA4 mRNA	PMID:34624356
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:16794	scopolamine	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D012601	Scopolamine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:16794	scopolamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012601	Scopolamine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Acetylcholine] results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:11517245
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CHRNA4 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHRNA4 mRNA]	PMID:37992649
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17300	tetrachloroethene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013750	Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:15885267
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17300	tetrachloroethene	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D013750	Tetrachloroethylene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:15885267
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17578	toluene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014050	Toluene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:15885267
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17578	toluene	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D014050	Toluene inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:15885267
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CHRNA4 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHRNA4 mRNA]	PMID:37992649
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17688	(S)-nicotine	affects binding	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:9336329
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17688	(S)-nicotine	affects binding	ISO	RGD:2346	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine analog binds to [CHRNA4 protein binds to CHRNB2 protein]; Nicotine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:15615518|PMID:19252481
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17688	(S)-nicotine	affects response to substance	ISO	RGD:10355	E	RGD:6480464	20161213	CTD	MESH:D009538	CHRNA4 gene polymorphism affects the susceptibility to Nicotine; CHRNA4 protein affects the susceptibility to Nicotine; CHRNA4 protein mutant form affects the susceptibility to Nicotine	PMID:10734154|PMID:10942032|PMID:19404753
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:10355	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of CHRNA4 mRNA	PMID:17135361
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:2346	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of CHRNA4 mRNA	PMID:20060465
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CHRNA4 protein	PMID:19139119|PMID:20106947
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:10355	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CHRNA4 mRNA; Nicotine results in increased expression of CHRNA4 protein	PMID:14500745|PMID:19594327|PMID:29293602|PMID:7756618
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:2346	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CHRNA4 mRNA; Nicotine results in increased expression of CHRNA4 protein	PMID:24368670|PMID:28555334|PMID:29486207|PMID:31846720|PMID:34153408
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17688	(S)-nicotine	increases response to substance	ISO	RGD:10355	E	RGD:6480464	20161213	CTD	MESH:D009538	CHRNA4 protein mutant form results in increased susceptibility to Nicotine	PMID:16339034
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	[CHRNA4 protein binds to CHRNB2 protein] which results in increased susceptibility to Nicotine; [Lobeline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] inhibits the reaction [Nicotine results in increased phosphorylation of MAPK1 protein]; [Lobeline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] inhibits the reaction [Nicotine results in increased phosphorylation of MAPK3 protein]; [Lobeline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] inhibits the reaction [Nicotine results in increased phosphorylation of STAT3 protein]; Nicotine inhibits the reaction [cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Nicotine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Nicotine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Nicotine results in increased activity of [CHRNB4 protein binds to CHRNA4 protein]; Rosiglitazone inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]	PMID:14645658|PMID:18448488|PMID:19139119|PMID:20943775|PMID:34628512|PMID:9336329|PMID:9454827
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20161213	CTD	MESH:D009538	[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide co-treated with Nicotine] inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of CHRNA4 protein]; cytisine inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]; Hexamethonium inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]; Nicotine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CHRNA4 protein]; Tubocurarine inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]	PMID:15551346|PMID:19481067|PMID:19594327|PMID:7756618
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20161213	CTD	MESH:D009538	1-(5-azido-6-chloropyridin-3-ylmethyl)-2-nitroiminoimidazolidine inhibits the reaction [Nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein]]; [Dihydro-beta-Erythroidine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in decreased susceptibility to Nicotine; [Nicotine co-treated with Benzo(a)pyrene] results in decreased expression of [CHRNA4 protein binds to CHRNB2 protein]; Bungarotoxins inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]; Cocaine inhibits the reaction [Nicotine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Dihydro-beta-Erythroidine analog inhibits the reaction [Nicotine results in increased expression of CHRNA4 mRNA]; imidacloprid analog inhibits the reaction [Nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein]]; N-(5-azido-6-chloropyridin-3-ylmethyl)-N'-methyl-N''-nitroguanidine inhibits the reaction [Nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein]]; Nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein]; Nicotine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Nicotine results in increased expression of [CHRNA4 protein binds to CHRNB2 protein]	PMID:10336510|PMID:10377228|PMID:10945867|PMID:11124396|PMID:11150171|PMID:16915382|PMID:28555334|PMID:30247698|PMID:34153408
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20210608	CTD	MESH:D004051	Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of CHRNA4 mRNA]	PMID:33484791
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:2346	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CHRNA4 mRNA	PMID:26577399
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:10355	E	RGD:6480464	20160510	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CHRNA4 protein	PMID:19594327
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20160510	CTD	MESH:D015632	Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CHRNA4 protein]	PMID:19594327
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:17967	urethane	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D014520	Urethane promotes the reaction [Acetylcholine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:11812690
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18243	dopamine	affects binding	ISO	RGD:2346	E	RGD:8549526|PMID:22550286	20210820	RGD	MESH:D004298	dopamine binds to Chrna4 protein in rat brain striatal sections	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	affects binding	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:9336329
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	affects binding	ISO	RGD:2346	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine analog binds to [CHRNA4 protein binds to CHRNB2 protein]; Nicotine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:15615518|PMID:19252481
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	affects response to substance	ISO	RGD:10355	E	RGD:6480464	20161213	CTD	MESH:D009538	CHRNA4 gene polymorphism affects the susceptibility to Nicotine; CHRNA4 protein affects the susceptibility to Nicotine; CHRNA4 protein mutant form affects the susceptibility to Nicotine	PMID:10734154|PMID:10942032|PMID:19404753
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:10355	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of CHRNA4 mRNA	PMID:17135361
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:2346	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of CHRNA4 mRNA	PMID:20060465
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CHRNA4 protein	PMID:19139119|PMID:20106947
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:10355	E	RGD:598154614|PMID:33242460	20250430	RGD	MESH:D009538	nicotine increases expression of Chrna4 protein in prefrontal cortex, striatum and hippocampus	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:10355	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CHRNA4 mRNA; Nicotine results in increased expression of CHRNA4 protein	PMID:14500745|PMID:19594327|PMID:29293602|PMID:7756618
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:2346	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CHRNA4 mRNA; Nicotine results in increased expression of CHRNA4 protein	PMID:24368670|PMID:28555334|PMID:29486207|PMID:31846720|PMID:34153408
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	increases response to substance	ISO	RGD:10355	E	RGD:6480464	20161213	CTD	MESH:D009538	CHRNA4 protein mutant form results in increased susceptibility to Nicotine	PMID:16339034
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	[CHRNA4 protein binds to CHRNB2 protein] which results in increased susceptibility to Nicotine; [Lobeline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] inhibits the reaction [Nicotine results in increased phosphorylation of MAPK1 protein]; [Lobeline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] inhibits the reaction [Nicotine results in increased phosphorylation of MAPK3 protein]; [Lobeline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] inhibits the reaction [Nicotine results in increased phosphorylation of STAT3 protein]; Nicotine inhibits the reaction [cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Nicotine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Nicotine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Nicotine results in increased activity of [CHRNB4 protein binds to CHRNA4 protein]; Rosiglitazone inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]	PMID:14645658|PMID:18448488|PMID:19139119|PMID:20943775|PMID:34628512|PMID:9336329|PMID:9454827
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20161213	CTD	MESH:D009538	[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide co-treated with Nicotine] inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of CHRNA4 protein]; cytisine inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]; Hexamethonium inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]; Nicotine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CHRNA4 protein]; Tubocurarine inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]	PMID:15551346|PMID:19481067|PMID:19594327|PMID:7756618
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:2346	E	RGD:2303194|PMID:15016836	20210901	RGD	MESH:D009538	nicotine affects binding to Chrna4 protein; nicotine competes with [Epibatidine binds to Chrna4 protein]	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:2346	E	RGD:2303195|PMID:16129735	20210902	RGD	MESH:D009538	nicotine affects binding to Chrna4 protein; nicotine inhibits the reaction [epibatidine affects binding to Chrna4 protein] in rat retina	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20161213	CTD	MESH:D009538	1-(5-azido-6-chloropyridin-3-ylmethyl)-2-nitroiminoimidazolidine inhibits the reaction [Nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein]]; [Dihydro-beta-Erythroidine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in decreased susceptibility to Nicotine; [Nicotine co-treated with Benzo(a)pyrene] results in decreased expression of [CHRNA4 protein binds to CHRNB2 protein]; Bungarotoxins inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]; Cocaine inhibits the reaction [Nicotine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Dihydro-beta-Erythroidine analog inhibits the reaction [Nicotine results in increased expression of CHRNA4 mRNA]; imidacloprid analog inhibits the reaction [Nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein]]; N-(5-azido-6-chloropyridin-3-ylmethyl)-N'-methyl-N''-nitroguanidine inhibits the reaction [Nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein]]; Nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein]; Nicotine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Nicotine results in increased expression of [CHRNA4 protein binds to CHRNB2 protein]	PMID:10336510|PMID:10377228|PMID:10945867|PMID:11124396|PMID:11150171|PMID:16915382|PMID:28555334|PMID:30247698|PMID:34153408
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:188610	Desformylflustrabromine	multiple interactions	EXP		E	RGD:6480464	20220104	CTD	MESH:C524215	desformylflustrabromine promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:21905680
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CHRNA4 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CHRNA4 mRNA	PMID:37325564|PMID:40850461
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:22984	calcium atom	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D002118	[CHRNA4 protein co-treated with CHRNB2 protein mutant form] inhibits the reaction [Calcium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein co-treated with CHRNB2 protein] affects the reaction [Calcium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein mutant form co-treated with CHRNB2 protein] inhibits the reaction [Calcium results in increased susceptibility to Acetylcholine]	PMID:12754307
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:234389	3,5-dibromo-2-(2,4-dibromophenoxy)phenol	multiple interactions	EXP		E	RGD:6480464	20250610	CTD	MESH:C085794	3,5-dibromo-2-(2,4-dibromophenoxy)phenol inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; [3,5-dibromo-2-(2,4-dibromophenoxy)phenol co-treated with 2,4,2',4'-tetrachlorobiphenyl] inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:20861069
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:2555	aldicarb	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D000448	Aldicarb results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]	PMID:14644616
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:10355	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of CHRNA4 mRNA	PMID:18579281
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D010126	[Ozone co-treated with Chlorine] results in increased expression of CHRNA4 mRNA	PMID:18636392
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:26421	pyridines	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D011725	Pyridines binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:21962147
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of CHRNA4 mRNA	PMID:12734012
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CHRNA4 gene	PMID:25304211
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHRNA4 mRNA	PMID:40504410
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CHRNA4 mRNA	PMID:19244175
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20260707	CTD	MESH:C010974	Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHRNA4 mRNA]	PMID:37992649
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:10355	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of CHRNA4 mRNA	PMID:28960355
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:27827	paraoxon	decreases expression	ISO	RGD:2346	E	RGD:6480464	20130416	CTD	MESH:D010261	Paraoxon results in decreased expression of CHRNA4 mRNA; Paraoxon results in decreased expression of CHRNA4 protein	PMID:21791372
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:27827	paraoxon	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20130416	CTD	MESH:D010261	Atropine promotes the reaction [Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 mRNA]]; Atropine promotes the reaction [Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 protein]]; Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 mRNA]; Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 protein]	PMID:21791372
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of CHRNA4 mRNA	PMID:12569576
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CHRNA4 mRNA	PMID:23557933
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:27953	physostigmine	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D010830	Physostigmine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:27953	physostigmine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010830	Physostigmine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; Physostigmine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Physostigmine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Physostigmine results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:14645658|PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine inhibits the reaction [Nicotine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:10336510
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:10355	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of CHRNA4 mRNA	PMID:18930951
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:10355	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of CHRNA4 mRNA	PMID:32186404
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20130611	CTD	MESH:D019833	[Genistein co-treated with Methoxychlor] results in decreased expression of CHRNA4 mRNA	PMID:21782745
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in decreased expression of CHRNA4 mRNA	PMID:18812211
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:10355	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHRNA4 mRNA	PMID:24680724|PMID:26377647
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:10355	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHRNA4 mRNA	PMID:26290441
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CHRNA4 promoter]	PMID:19654925
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of CHRNA4 mRNA	PMID:33512557
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CHRNA4 mRNA	PMID:33212167
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28509	chloroethene	increases expression	ISO	RGD:10355	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in increased expression of CHRNA4 mRNA	PMID:18579281
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:2346	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CHRNA4 mRNA	PMID:28959563
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:10355	E	RGD:6480464	20230704	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CHRNA4 mRNA	PMID:36286330
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:2346	E	RGD:6480464	20120918	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CHRNA4 protein	PMID:19900517
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20230704	CTD	MESH:D012969	Choline inhibits the reaction [Sodium Fluoride results in decreased expression of CHRNA4 mRNA]	PMID:36286330
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CHRNA4 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHRNA4 mRNA]	PMID:37992649
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D020001	1-Butanol affects the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; 1-Butanol binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Dihydro-beta-Erythroidine inhibits the reaction [1-Butanol binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Mecamylamine inhibits the reaction [1-Butanol binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:12604691
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:2914	atracurium	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D001279	Atracurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:16931985
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:29310	dichlorine	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D002713	[Ozone co-treated with Chlorine] results in increased expression of CHRNA4 mRNA	PMID:18636392
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:29320	calcium(0)	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D002118	[CHRNA4 protein co-treated with CHRNB2 protein mutant form] inhibits the reaction [Calcium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein co-treated with CHRNB2 protein] affects the reaction [Calcium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein mutant form co-treated with CHRNB2 protein] inhibits the reaction [Calcium results in increased susceptibility to Acetylcholine]	PMID:12754307
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CHRNA4 mRNA	PMID:38568856
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHRNA4 mRNA	PMID:40504410
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D014415	Tunicamycin results in increased expression of CHRNA4 mRNA	PMID:33545341
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHRNA4 3' UTR	PMID:27901495
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CHRNA4 promoter	PMID:27901495
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CHRNA4 exon	PMID:27901495
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20201006	CTD	MESH:D001564	[corannulene co-treated with Benzo(a)pyrene] results in increased expression of CHRNA4 mRNA	PMID:32417428
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20190219	CTD	MESH:D001564	[Nicotine co-treated with Benzo(a)pyrene] results in decreased expression of [CHRNA4 protein binds to CHRNB2 protein]	PMID:30247698
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:10355	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in increased expression of CHRNA4 mRNA	PMID:33053406
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:2346	E	RGD:6480464	20210706	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CHRNA4 mRNA	PMID:32721576
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CHRNA4 mRNA	PMID:16483693
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of CHRNA4 mRNA	PMID:37690743
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CHRNA4 gene	PMID:31601247
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:31695	indigo carmine	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20141111	CTD	MESH:D007203	[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in decreased expression of CHRNA4 protein	PMID:23429044
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:31823	mercury dichloride	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120814	CTD	MESH:D008627	[Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA4 protein binds to CHRNB2 protein]; [Mercuric Chloride co-treated with Acetylcholine] affects the activity of [CHRNA4 protein binds to CHRNB4 protein]	PMID:12130716
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:10355	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CHRNA4 gene	PMID:35295148
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:32595	barium(0)	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D001464	[CHRNA4 protein co-treated with CHRNB2 protein] affects the reaction [Barium results in increased susceptibility to Acetylcholine]; [CHRNA4 protein mutant form co-treated with CHRNB2 protein] inhibits the reaction [Barium results in increased susceptibility to Acetylcholine]	PMID:12754307
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:33130	aluminium hydroxide	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D000536	Aluminum Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]	PMID:22750351
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:10355	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CHRNA4 mRNA	PMID:32156529
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2346	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CHRNA4 mRNA; bisphenol A results in decreased expression of CHRNA4 protein	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:37495067
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:10355	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of CHRNA4 promoter	PMID:27312807
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:10355	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in increased expression of CHRNA4 mRNA	PMID:21932408
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:11711029
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A promotes the reaction [CHRNA4 protein binds to METTL3 protein]; bisphenol A results in decreased expression of and results in increased methylation of CHRNA4 mRNA; METTL3 protein promotes the reaction [bisphenol A results in decreased expression of CHRNA4 protein]	PMID:37495067
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C020806	tetrabromobisphenol A inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; tetrabromobisphenol A inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]	PMID:22547355|PMID:22750351
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:3385	carbachol	affects binding	ISO	RGD:2346	E	RGD:6480464	20161213	CTD	MESH:D002217	Carbachol binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:15615518
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:3385	carbachol	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D002217	Carbachol inhibits the reaction [decamethonium binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Carbachol inhibits the reaction [Dihydro-beta-Erythroidine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Carbachol inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Carbachol inhibits the reaction [methyllycaconitine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Carbachol results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:14645658
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:3385	carbachol	multiple interactions	ISO	RGD:2346	E	RGD:2303194|PMID:15016836	20210901	RGD	MESH:D002217	carbachol affects binding to Chrna4 protein; carbachol competes with [Epibatidine binds to Chrna4 protein]	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:3387	carbamazepine	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D002220	Carbamazepine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:12110613
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:3390	carbaryl	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D012721	Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; Carbaryl results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]	PMID:14644616
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:10355	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of CHRNA4 mRNA	PMID:26682919
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34204	2,2',4,4'-tetrachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C035976	2,4,2',4'-tetrachlorobiphenyl inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; [3,5-dibromo-2-(2,4-dibromophenoxy)phenol co-treated with 2,4,2',4'-tetrachlorobiphenyl] inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:20861069
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:10355	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of CHRNA4 mRNA	PMID:30951980|PMID:33297965
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34432	4-octylphenol	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:C080417	4-octylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:11711029
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34440	4-nonylphenol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C041594	4-nonylphenol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:11711029
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34533	Amaranth	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20141111	CTD	MESH:D000548	[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in decreased expression of CHRNA4 protein	PMID:23429044
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34556	bendiocarb	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:C007725	bendiocarb results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]	PMID:14644616
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:10355	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of CHRNA4 mRNA	PMID:30951980|PMID:38685157
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:10355	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CHRNA4 mRNA	PMID:37019170
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon affects the expression of CHRNA4 mRNA	PMID:18812211
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34690	dichlorvos	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004006	Dichlorvos inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D004026	Dieldrin affects the expression of CHRNA4 mRNA	PMID:18812211
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34705	dihydro-beta-erythroidine	affects binding	ISO	RGD:2346	E	RGD:6480464	20140708	CTD	MESH:D004079	[CHRNA4 protein binds to CHRNB4 protein] which binds to Dihydro-beta-Erythroidine	PMID:9687574
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34705	dihydro-beta-erythroidine	multiple interactions	EXP		E	RGD:6480464	20140708	CTD	MESH:D004079	Carbachol inhibits the reaction [Dihydro-beta-Erythroidine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Dihydro-beta-Erythroidine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; Dihydro-beta-Erythroidine inhibits the reaction [1-Butanol binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Dihydro-beta-Erythroidine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Dihydro-beta-Erythroidine results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:12604691|PMID:14645658
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34705	dihydro-beta-erythroidine	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20140708	CTD	MESH:D004079	Dihydro-beta-Erythroidine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; Dihydro-beta-Erythroidine inhibits the reaction [3-(2-(pyrrolidinyl)methoxy)pyridine analog results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:16569710|PMID:20100906
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34705	dihydro-beta-erythroidine	multiple interactions	ISO	RGD:2346	E	RGD:2303194|PMID:15016836	20210901	RGD	MESH:D004079	dihydro-beta-erythroidine affects binding to Chrna4 protein; dihydro-beta-erythroidine competes with [Epibatidine binds to Chrna4 protein]	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34705	dihydro-beta-erythroidine	multiple interactions	ISO	RGD:2346	E	RGD:2303195|PMID:16129735	20210902	RGD	MESH:D004079	dihydro-beta-erythroidine affects binding to Chrna4 protein; dihydro-beta-erythroidine inhibits the reaction [epibatidine affects binding to Chrna4 protein] in rat retina	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34705	dihydro-beta-erythroidine	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20140708	CTD	MESH:D004079	[Dihydro-beta-Erythroidine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in decreased susceptibility to Nicotine; Dihydro-beta-Erythroidine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]; Dihydro-beta-Erythroidine analog inhibits the reaction [Nicotine results in increased expression of CHRNA4 mRNA]; Dihydro-beta-Erythroidine inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; Dihydro-beta-Erythroidine results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:10945867|PMID:11600638|PMID:16915382|PMID:18385335|PMID:19047205|PMID:28555334
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:10355	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CHRNA4 mRNA	PMID:24535843
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:34938	propoxur	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D001074	Propoxur results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]	PMID:14644616
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:35033	triphenyl phosphate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C005445	triphenyl phosphate inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]	PMID:22750351
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CHRNA4 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CHRNA4 mRNA	PMID:37325564|PMID:40850461
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:10355	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of CHRNA4 mRNA	PMID:28962523
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CHRNA4 mRNA	PMID:19244175
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:38314	pyrazines	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D011719	Pyrazines binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:21962147
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:10355	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CHRNA4 mRNA	PMID:40194260
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:38604	pyrimidifen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of CHRNA4 mRNA	PMID:33512557
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:10355	E	RGD:6480464	20201103	CTD	MESH:C464485	acetamiprid results in decreased expression of CHRNA4 mRNA	PMID:30103633
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:39178	clothianidin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C480342	clothianidin promotes the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:21538459
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:39178	clothianidin	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20250902	CTD	MESH:C480342	clothianidin inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; clothianidin results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein]; clothianidin results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein mutant form binds to CHRNB2 protein mutant form binds to CHRNB2 protein mutant form]; clothianidin results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:39800138
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:10355	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CHRNA4 mRNA	PMID:17292431
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CHRNA4 gene	PMID:29154799
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4055	cytisine	affects binding	EXP		E	RGD:6480464	20130702	CTD	MESH:C004712	cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:9336329
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4055	cytisine	affects expression	ISO	RGD:10355	E	RGD:6480464	20130702	CTD	MESH:C004712	cytisine affects the expression of CHRNA4 protein	PMID:7756618
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4055	cytisine	multiple interactions	EXP		E	RGD:6480464	20130702	CTD	MESH:C004712	cytisine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; cytisine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; cytisine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; cytisine results in increased activity of [CHRNB4 protein binds to CHRNA4 protein]; Nicotine inhibits the reaction [cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]]; pozanicline inhibits the reaction [cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]]	PMID:14645658|PMID:20331614|PMID:9336329|PMID:9454827
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4055	cytisine	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20130702	CTD	MESH:C004712	cytisine inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]	PMID:7756618
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4055	cytisine	multiple interactions	ISO	RGD:2346	E	RGD:2303194|PMID:15016836	20210901	RGD	MESH:C004712	cytisine affects binding to Chrna4 protein; cytisine competes with [Epibatidine binds to Chrna4 protein]	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4055	cytisine	multiple interactions	ISO	RGD:2346	E	RGD:2303195|PMID:16129735	20210902	RGD	MESH:C004712	cytisine affects binding to Chrna4 protein; cytisine inhibits the reaction [epibatidine affects binding to Chrna4 protein] in rat retina	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of CHRNA4 mRNA	PMID:33512557
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:11711029
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:41922	diethylstilbestrol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:11711029
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:41934	decamethonium	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:C033019	Carbachol inhibits the reaction [decamethonium binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]]; decamethonium binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; decamethonium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; decamethonium results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:14645658
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CHRNA4 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHRNA4 mRNA]	PMID:37992649
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4290	1,1-dimethyl-4-phenylpiperazinium iodide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D004246	Dimethylphenylpiperazinium Iodide inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Dimethylphenylpiperazinium Iodide results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Dimethylphenylpiperazinium Iodide results in increased activity of [CHRNB4 protein binds to CHRNA4 protein]	PMID:14645658|PMID:9454827
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4290	1,1-dimethyl-4-phenylpiperazinium iodide	multiple interactions	ISO	RGD:2346	E	RGD:2303194|PMID:15016836	20210901	RGD	MESH:D004246	1,1-dimethyl-4-phenylpiperazinium iodide affects binding to Chrna4 protein; 1,1-dimethyl-4-phenylpiperazinium iodide competes with [Epibatidine binds to Chrna4 protein]	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:42944	galanthamine	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D005702	Galantamine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:42944	galanthamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005702	Galantamine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of CHRNA4 mRNA	PMID:33512557
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:43931	methyllycaconitine	affects activity	ISO	RGD:2346	E	RGD:6480464	20171010	CTD	MESH:C054634	methyllycaconitine affects the activity of CHRNA4 protein	PMID:19047205
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:43931	methyllycaconitine	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C054634	Carbachol inhibits the reaction [methyllycaconitine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]]; methyllycaconitine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; methyllycaconitine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; methyllycaconitine results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:14645658
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:43931	methyllycaconitine	multiple interactions	ISO	RGD:2346	E	RGD:2303194|PMID:15016836	20210901	RGD	MESH:C054634	methyllycaconitine affects binding to Chrna4 protein; methyllycaconitine competes with [Epibatidine binds to Chrna4 protein]	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:45652	succinylcholine	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013390	Succinylcholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]	PMID:14645658
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:45980	tacrine	increases expression	ISO	RGD:10355	E	RGD:6480464	20120515	CTD	MESH:D013619	Tacrine results in increased expression of CHRNA4 protein	PMID:8930989
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:45980	tacrine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013619	Tacrine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:45980	tacrine	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20120515	CTD	MESH:D013619	Mecamylamine inhibits the reaction [Tacrine results in increased expression of CHRNA4 protein]	PMID:8930989
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:10355	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CHRNA4 mRNA	PMID:17562736
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of CHRNA4 mRNA]	PMID:15016801
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CHRNA4 gene	PMID:25304211
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHRNA4 mRNA	PMID:40504410
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4738	EPTC	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20141111	CTD	MESH:C036251	EPTC results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; EPTC results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]	PMID:14644616
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4803	epibatidine	affects binding	EXP		E	RGD:6480464	20141111	CTD	MESH:C082748	[CHRNB4 protein binds to CHRNA4 protein] which binds to epibatidine; epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:14645658|PMID:9454827
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4803	epibatidine	affects binding	ISO	RGD:10355	E	RGD:6480464	20141111	CTD	MESH:C082748	epibatidine binds to CHRNA4 protein	PMID:17203487
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4803	epibatidine	affects binding	ISO	RGD:2346	E	RGD:2303194|PMID:15016836	20210901	RGD	MESH:C082748	Epibatidine binds to Chrna4 protein	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4803	epibatidine	affects binding	ISO	RGD:2346	E	RGD:2303195|PMID:16129735	20210902	RGD	MESH:C082748	epibatidine binds to Chrnb4 protein in the rat retina	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4803	epibatidine	affects binding	ISO	RGD:2346	E	RGD:6480464	20141111	CTD	MESH:C082748	epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:11124396|PMID:15615518|PMID:21942635
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4803	epibatidine	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C082748	Acetylcholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Acetylthiocholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Alcuronium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Carbachol inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Choline inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; cytisine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; decamethonium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Dihydro-beta-Erythroidine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Dimethylphenylpiperazinium Iodide inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; epibatidine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; epibatidine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Hexamethonium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Lobeline inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; methyllycaconitine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Nicotine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Pancuronium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Physostigmine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; subecholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Succinylcholine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Vecuronium Bromide inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]	PMID:14645658|PMID:22060139
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4803	epibatidine	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20141111	CTD	MESH:C082748	Tretinoin promotes the reaction [epibatidine binds to CHRNA4 protein]	PMID:17203487
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4803	epibatidine	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20141111	CTD	MESH:C082748	2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; epibatidine binds to [CHRNA4 protein co-treated with CHRNB2 protein]; epibatidine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; sazetidine-A analog inhibits the reaction [epibatidine binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:10728888|PMID:21905669|PMID:21942635
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:10355	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CHRNA4 mRNA	PMID:35436446
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:48723	(-)-lobeline	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008120	[Lobeline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] inhibits the reaction [Nicotine results in increased phosphorylation of MAPK1 protein]; [Lobeline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] inhibits the reaction [Nicotine results in increased phosphorylation of MAPK3 protein]; [Lobeline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]] inhibits the reaction [Nicotine results in increased phosphorylation of STAT3 protein]; Lobeline inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Lobeline results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:14645658|PMID:18448488
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	[Ethinyl Estradiol co-treated with Acetylcholine] results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; Ethinyl Estradiol promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Ethinyl Estradiol promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]]	PMID:11517245|PMID:11711029
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D004997	[Ethinyl Estradiol co-treated with Acetylcholine] results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:11517245
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:5009	fenoxycarb	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:C052034	fenoxycarb results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; fenoxycarb results in decreased activity of [CHRNA4 protein binds to CHRNB4 protein]	PMID:14644616
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:10355	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CHRNA4 mRNA; Nanotubes, Carbon results in decreased expression of CHRNA4 mRNA	PMID:25620056
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:10355	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of CHRNA4 mRNA	PMID:26377693
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:10355	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CHRNA4 mRNA	PMID:23608068
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:55313	alcuronium	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D000443	Alcuronium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Alcuronium results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:14645658
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:5693	hexachlorophene	decreases expression	ISO	RGD:10355	E	RGD:6480464	20180515	CTD	MESH:D006582	Hexachlorophene results in decreased expression of CHRNA4 mRNA	PMID:25943520
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:5700	Hexamethonium	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D018738	Hexamethonium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Hexamethonium results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:14645658
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:5700	Hexamethonium	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20141111	CTD	MESH:D018738	Hexamethonium inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]	PMID:7756618
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:5870	imidacloprid	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C082359	imidacloprid inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; imidacloprid results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; imidacloprid results in increased activity of [CHRNA4 protein binds to CHRNB4 protein]	PMID:21538459|PMID:34628512
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20180116	CTD	MESH:C082359	imidacloprid affects the activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein]; imidacloprid affects the activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein binds to CHRNB2 protein]; imidacloprid affects the activity of [CHRNA4 protein binds to CHRNB2 protein]; imidacloprid analog inhibits the reaction [Nicotine analog binds to [CHRNA4 protein co-treated with CHRNB2 protein]]; imidacloprid binds to [CHRNA4 protein co-treated with CHRNB2 protein]; imidacloprid inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; imidacloprid inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein binds to CHRNB2 protein binds to CHRNB2 protein]]; imidacloprid results in increased activity of [CHRNA4 protein binds to CHRNA4 protein binds to CHRNB2 protein mutant form binds to CHRNB2 protein mutant form binds to CHRNB2 protein mutant form]	PMID:10377228|PMID:10728888|PMID:39800138
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:61000	erythrosin B	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20250506	CTD	MESH:D004923	[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in decreased expression of CHRNA4 protein	PMID:23429044
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:6637	magnesium dihydroxide	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D008276	Magnesium Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]	PMID:22750351
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:6706	Mecamylamine	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D008464	Mecamylamine binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]; Mecamylamine inhibits the reaction [1-Butanol binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Mecamylamine inhibits the reaction [desnitroimidacloprid results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Mecamylamine results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:12604691|PMID:14645658|PMID:34628512
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:6706	Mecamylamine	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20141111	CTD	MESH:D008464	Mecamylamine inhibits the reaction [Tacrine results in increased expression of CHRNA4 protein]	PMID:8930989
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:6706	Mecamylamine	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20141111	CTD	MESH:D008464	Atropine promotes the reaction [Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 mRNA]]; Atropine promotes the reaction [Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 protein]]; Mecamylamine inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 mRNA]; Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 protein]	PMID:18385335|PMID:21791372
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:68318	galanthamine Trifluoroacetic acid	affects binding	EXP		E	RGD:6480464	20141111	CTD	MESH:D005702	Galantamine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:68318	galanthamine Trifluoroacetic acid	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D005702	Galantamine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:6842	methoxychlor	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20130611	CTD	MESH:D008731	[Genistein co-treated with Methoxychlor] results in decreased expression of CHRNA4 mRNA	PMID:21782745
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:68508	diethyl maleate	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C014476	diethyl maleate results in increased expression of CHRNA4 mRNA	PMID:33545341
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:6958	Mivacurium	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C049430	mivacurium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:16931985
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:73458	NS-398	increases expression	ISO	RGD:10355	E	RGD:6480464	20130604	CTD	MESH:C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of CHRNA4 protein	PMID:15551346
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:73458	NS-398	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20130604	CTD	MESH:C080955	[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide co-treated with Nicotine] inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of CHRNA4 protein]	PMID:15551346
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:74	(S)-anabasine	affects binding	ISO	RGD:2346	E	RGD:6480464	20120412	CTD	MESH:D000691	Anabasine analog binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:15615518
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:748528	pozanicline	affects binding	EXP		E	RGD:6480464	20260714	CTD	MESH:C108326	pozanicline binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:9336329
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:748528	pozanicline	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C108326	pozanicline inhibits the reaction [cytisine binds to [CHRNA4 protein binds to CHRNB2 protein]]	PMID:9336329
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:748528	pozanicline	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20260714	CTD	MESH:C108326	[pozanicline binds to CHRNB2 protein] results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]; pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNA5 protein binds to CHRNB2 protein]; pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:19481067
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:748528	pozanicline	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20260714	CTD	MESH:C108326	[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine; Dihydro-beta-Erythroidine inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; Excitatory Amino Acid Antagonists inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; FG 9041 inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]; Mecamylamine inhibits the reaction [[pozanicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] which results in increased secretion of Acetylcholine]	PMID:18385335
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:748698	ispronicline	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C490152	ispronicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:20167427
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:753160	lard	increases expression	ISO	RGD:2346	E	RGD:6480464	20260714	CTD	MESH:C029310	lard results in increased expression of CHRNA4 mRNA	PMID:26115784
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:2346	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of CHRNA4 mRNA	PMID:26720608
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:78734	tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate	affects binding	EXP		E	RGD:6480464	20140805	CTD	MESH:D001285	Atropine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:78734	tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:D001285	Atropine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:78734	tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20140805	CTD	MESH:D001285	Atropine promotes the reaction [Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 mRNA]]; Atropine promotes the reaction [Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 protein]]	PMID:21791372
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:7907	pancuronium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D010197	Pancuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Pancuronium inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Pancuronium results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:14645658|PMID:16931985
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:10355	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of CHRNA4 mRNA	PMID:23091169
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:80713	Citreoviridin	affects expression	ISO	RGD:10355	E	RGD:6480464	20181016	CTD	MESH:C014416	citreoviridin affects the expression of CHRNA4 mRNA	PMID:30071239
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:10355	E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of CHRNA4 mRNA	PMID:26254212
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:81794	thifluzamide	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of CHRNA4 mRNA	PMID:33512557
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:82289	Antimony trioxide	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C037554	antimony trioxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]	PMID:22750351
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:82411	Brilliant Blue	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20170303	CTD	MESH:C006796	[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in decreased expression of CHRNA4 protein	PMID:23429044
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:82436	decabromodiphenyl ether	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]]	PMID:22750351
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:82538	Sunset Yellow FCF	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20141111	CTD	MESH:C005842	[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in decreased expression of CHRNA4 protein	PMID:23429044
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of CHRNA4 mRNA	PMID:33512557
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:84500	varenicline	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D000068580	Varenicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:20207347|PMID:20331614|PMID:20373480|PMID:20388087
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:84500	varenicline	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20170303	CTD	MESH:D000068580	Varenicline binds to and results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:20100906
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:84500	varenicline	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20170303	CTD	MESH:D000068580	Varenicline binds to and results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:16766716
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:84500	varenicline	multiple interactions	ISO	RGD:2346	E	RGD:8549526|PMID:22550286	20210820	RGD	MESH:D000068580	varenicline binds to Chrna4 protein; varenicline inhibits [alpha-conotoxin MII binds to Chrna4 protein] in rat brain striatal sections	
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:2346	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CHRNA4 mRNA	PMID:24780913
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:8874	rivastigmine	affects binding	EXP		E	RGD:6480464	20170303	CTD	MESH:C072506	Rivastigmine binds to [CHRNA4 protein binds to CHRNB2 protein]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:8874	rivastigmine	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C072506	Rivastigmine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:15733544
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:8884	rocuronium	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:C061870	rocuronium inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]	PMID:16931985
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in decreased expression of CHRNA4 mRNA; Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of CHRNA4 mRNA]	PMID:33484791
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:10355	E	RGD:6480464	20160119	CTD	MESH:D013605	T-2 Toxin results in decreased expression of CHRNA4 mRNA	PMID:26314264
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:9405	tartrazine	multiple interactions	ISO	RGD:2346	E	RGD:6480464	20140311	CTD	MESH:D013645	[ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with Indigo Carmine co-treated with Erythrosine co-treated with azo rubin S] results in decreased expression of CHRNA4 protein	PMID:23429044
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:10355	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of CHRNA4 mRNA	PMID:32835833
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:9774	tubocurarine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014403	Tubocurarine inhibits the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Tubocurarine inhibits the reaction [Ethinyl Estradiol promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]]]; Tubocurarine results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:11711029|PMID:14645658|PMID:16931985
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:9774	tubocurarine	multiple interactions	ISO	RGD:10355	E	RGD:6480464	20120515	CTD	MESH:D014403	Tubocurarine inhibits the reaction [Nicotine results in increased expression of CHRNA4 protein]	PMID:7756618
10356	CHRNA4	cholinergic receptor nicotinic alpha 4 subunit	gene	CHEBI:9940	vecuronium bromide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D014673	Vecuronium Bromide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]]; Vecuronium Bromide inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]]; Vecuronium Bromide results in decreased activity of [CHRNA4 protein binds to CHRNB2 protein]	PMID:14645658|PMID:16931985
10398866	RNA5SP439	RNA, 5S ribosomal pseudogene 439	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of RNA5SP439 mRNA	PMID:25879800
10398868	EFCAB14P1	EF-hand calcium binding domain 14 pseudogene 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EFCAB14P1 mRNA	PMID:26472689
10398876	RNU4-36P	RNA, U4 small nuclear 36, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNU4-36P mRNA	PMID:38568856
10398880	RNU6-1060P	RNA, U6 small nuclear 1060, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNU6-1060P mRNA	PMID:38568856
10398880	RNU6-1060P	RNA, U6 small nuclear 1060, pseudogene	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RNU6-1060P mRNA	PMID:38568856
10398884	HLA-DQB1-AS1	HLA-DQB1 antisense RNA 1	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of HLA-DQB1-AS1 mRNA	PMID:39245080
10398884	HLA-DQB1-AS1	HLA-DQB1 antisense RNA 1	gene	CHEBI:44915	propofol	increases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:D015742	Propofol results in increased expression of HLA-DQB1-AS1 mRNA	PMID:35238236
10398903	RNY3P8	RNY3 pseudogene 8	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RNY3P8 mRNA	PMID:31173147
10398918	RNU6-945P	RNA, U6 small nuclear 945, pseudogene	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of RNU6-945P mRNA	PMID:32763439
10398929	RNA5SP498	RNA, 5S ribosomal pseudogene 498	gene	CHEBI:24527	herbicide	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D006540	Herbicides results in increased expression of RNA5SP498 mRNA	PMID:28711546
10398957	RNU6-388P	RNA, U6 small nuclear 388, pseudogene	gene	CHEBI:24527	herbicide	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D006540	Herbicides results in increased expression of RNU6-388P mRNA	PMID:28711546
10398991	RN7SL97P	RNA, 7SL, cytoplasmic 97, pseudogene	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of RN7SL97P mRNA	PMID:33359661
10398993	RNU6-173P	RNA, U6 small nuclear 173, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RNU6-173P mRNA	PMID:35811015
10398993	RNU6-173P	RNA, U6 small nuclear 173, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of RNU6-173P mRNA	PMID:35811015
10398993	RNU6-173P	RNA, U6 small nuclear 173, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RNU6-173P mRNA	PMID:35811015
10398997	RNU6-925P	RNA, U6 small nuclear 925, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RNU6-925P mRNA	PMID:35811015
10398997	RNU6-925P	RNA, U6 small nuclear 925, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RNU6-925P mRNA	PMID:35811015
10399005	RN7SL181P	RNA, 7SL, cytoplasmic 181, pseudogene	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RN7SL181P mRNA	PMID:33670352
10399007	HMGN2P47	high mobility group nucleosomal binding domain 2 pseudogene 47	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HMGN2P47 mRNA	PMID:32234424
10399022	RN7SKP276	RN7SK pseudogene 276	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RN7SKP276 mRNA	PMID:35811015
10399022	RN7SKP276	RN7SK pseudogene 276	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SKP276 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RN7SKP276 mRNA	PMID:35811015
10399022	RN7SKP276	RN7SK pseudogene 276	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SKP276 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RN7SKP276 mRNA	PMID:35811015
10399056	RNU6-384P	RNA, U6 small nuclear 384, pseudogene	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D000431	Ethanol results in increased expression of RNU6-384P	PMID:37149095
10399057	RNU6-510P	RNA, U6 small nuclear 510, pseudogene	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of RNU6-510P mRNA	PMID:29301935
10399073	RN7SL849P	RNA, 7SL, cytoplasmic 849, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RN7SL849P mRNA	PMID:38568856
10399090	RN7SL189P	RNA, 7SL, cytoplasmic 189, pseudogene	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of RN7SL189P mRNA	PMID:33359661
10399113	RN7SL165P	RNA, 7SL, cytoplasmic 165, pseudogene	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SL165P mRNA	PMID:33359661
10399113	RN7SL165P	RNA, 7SL, cytoplasmic 165, pseudogene	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RN7SL165P mRNA	PMID:33212167
10399126	RNU6-1004P	RNA, U6 small nuclear 1004, pseudogene	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of RNU6-1004P mRNA	PMID:28711546
10399181	RNU6ATAC18P	RNA, U6atac small nuclear 18, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RNU6ATAC18P mRNA	PMID:35811015
10399181	RNU6ATAC18P	RNA, U6atac small nuclear 18, pseudogene	gene	CHEBI:24527	herbicide	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D006540	Herbicides results in increased expression of RNU6ATAC18P mRNA	PMID:28711546
10399181	RNU6ATAC18P	RNA, U6atac small nuclear 18, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RNU6ATAC18P mRNA	PMID:35811015
10399193	SLC25A36P1	SLC25A36 pseudogene 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC25A36P1 mRNA	PMID:33212167
10399210	EIF1P5	eukaryotic translation initiation factor 1 pseudogene 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EIF1P5 mRNA	PMID:38568856
10399223	RNU6ATAC16P	RNA, U6atac small nuclear 16, pseudogene	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNU6ATAC16P mRNA	PMID:35811015
10399223	RNU6ATAC16P	RNA, U6atac small nuclear 16, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNU6ATAC16P mRNA	PMID:35811015
10399223	RNU6ATAC16P	RNA, U6atac small nuclear 16, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNU6ATAC16P mRNA	PMID:35811015
10399286	SDCBP2P1	syndecan binding protein 2 pseudogene 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of SDCBP2P1 mRNA	PMID:41028656
10399286	SDCBP2P1	syndecan binding protein 2 pseudogene 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SDCBP2P1 mRNA	PMID:41028656
10399286	SDCBP2P1	syndecan binding protein 2 pseudogene 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SDCBP2P1 mRNA	PMID:41028656
10399286	SDCBP2P1	syndecan binding protein 2 pseudogene 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SDCBP2P1 mRNA	PMID:26472689
10399292	RNU6-722P	RNA, U6 small nuclear 722, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNU6-722P mRNA	PMID:38568856
10399296	GTF2IP14	general transcription factor IIi pseudogene 14	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of GTF2IP14 mRNA	PMID:33212167
10399296	GTF2IP14	general transcription factor IIi pseudogene 14	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GTF2IP14 mRNA	PMID:26472689
10399322	RNU6-1266P	RNA, U6 small nuclear 1266, pseudogene	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNU6-1266P mRNA	PMID:33212167
10399329	UBE2FP3	UBE2F pseudogene 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of UBE2FP3 mRNA	PMID:33212167
10399333	RN7SL292P	RNA, 7SL, cytoplasmic 292, pseudogene	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of RN7SL292P mRNA	PMID:33359661
10399369	RNU7-141P	RNA, U7 small nuclear 141 pseudogene	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of RNU7-141P mRNA	PMID:28711546
10399388	RNU4-15P	RNA, U4 small nuclear 15, pseudogene	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D000431	Ethanol results in increased expression of RNU4-15P	PMID:37149095
10399432	RNU6-494P	RNA, U6 small nuclear 494, pseudogene	gene	CHEBI:32914	cetylpyridinium	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D002594	Cetylpyridinium results in increased expression of RNU6-494P	PMID:37149095
10399480	RN7SL14P	RNA, 7SL, cytoplasmic 14, pseudogene	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SL14P mRNA	PMID:33359661
10399502	RNU7-90P	RNA, U7 small nuclear 90 pseudogene	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1612344	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of RNU7 promoter	PMID:27312807
10399511	RN7SL868P	RNA, 7SL, cytoplasmic 868, pseudogene	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SL868P mRNA	PMID:33359661
10399549	RN7SL178P	RNA, 7SL, cytoplasmic 178, pseudogene	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of RN7SL178P mRNA	PMID:33359661
10399559	HSPE1P27	heat shock protein family E (Hsp10) member 1 pseudogene 27	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of HSPE1P27 mRNA	PMID:38568856
10399561	RNY4P37	RNY4 pseudogene 37	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNY4P37 mRNA	PMID:33212167
10399564	RNU2-51P	RNA, U2 small nuclear 51, pseudogene	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RNU2-51P mRNA	PMID:38568856
10399566	RNU6-514P	RNA, U6 small nuclear 514, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNU6-514P mRNA	PMID:38568856
10399581	MDC1-AS1	MDC1 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of MDC1-AS1 mRNA	PMID:34032870
10399596	IGKV1OR9-2	immunoglobulin kappa variable 1/OR9-2 (pseudogene)	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IGKV1OR9-2 mRNA	PMID:35811015
10399596	IGKV1OR9-2	immunoglobulin kappa variable 1/OR9-2 (pseudogene)	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IGKV1OR9-2 mRNA	PMID:35811015
10399597	DUX4L50	double homeobox 4 like 50 (pseudogene)	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of DUX4L50 mRNA	PMID:37690743
10399642	RN7SL63P	RNA, 7SL, cytoplasmic 63, pseudogene	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SL63P mRNA	PMID:33359661
10399664	RN7SKP203	RN7SK pseudogene 203	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RN7SKP203 mRNA	PMID:35811015
10399664	RN7SKP203	RN7SK pseudogene 203	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RN7SKP203 mRNA	PMID:35811015
10399688	RN7SL672P	RNA, 7SL, cytoplasmic 672, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RN7SL672P mRNA	PMID:38568856
10399700	BACH1-AS1	BACH1 antisense RNA 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of BACH1-AS1 mRNA	PMID:41028656
10399700	BACH1-AS1	BACH1 antisense RNA 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of BACH1-AS1 mRNA	PMID:41028656
10399700	BACH1-AS1	BACH1 antisense RNA 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of BACH1-AS1 mRNA	PMID:41028656
10399713	RAP2CP1	RAP2C pseudogene 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RAP2CP1 mRNA	PMID:35811015
10399713	RAP2CP1	RAP2C pseudogene 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of RAP2CP1 mRNA]	PMID:35811015
10399713	RAP2CP1	RAP2C pseudogene 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of RAP2CP1 mRNA]	PMID:35811015
10399717	RNU6-454P	RNA, U6 small nuclear 454, pseudogene	gene	CHEBI:3020	benzalkonium chloride	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D001548	Benzalkonium Compounds results in decreased expression of RNU6-454P	PMID:37149095
10399735	CARS1P2	cysteinyl-tRNA synthetase 1 pseudogene 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CARS1P2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CARS1P2 mRNA	PMID:35811015
10399735	CARS1P2	cysteinyl-tRNA synthetase 1 pseudogene 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of CARS1P2 mRNA	PMID:35811015
10399735	CARS1P2	cysteinyl-tRNA synthetase 1 pseudogene 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CARS1P2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CARS1P2 mRNA	PMID:35811015
10399759	MTCO1P4	MT-CO1 pseudogene 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MTCO1P4 mRNA	PMID:35811015
10399759	MTCO1P4	MT-CO1 pseudogene 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MTCO1P4 mRNA	PMID:35811015
10399759	MTCO1P4	MT-CO1 pseudogene 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MTCO1P4 mRNA	PMID:38568856
10399759	MTCO1P4	MT-CO1 pseudogene 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MTCO1P4 mRNA	PMID:35811015
10399781	RNU6-367P	RNA, U6 small nuclear 367, pseudogene	gene	CHEBI:32914	cetylpyridinium	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D002594	Cetylpyridinium results in decreased expression of RNU6-367P	PMID:37149095
10399782	RNU6-3P	RNA, U6 small nuclear 3, pseudogene	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of RNU6-3P mRNA	PMID:31745603
10399785	SOD1P1	superoxide dismutase 1 pseudogene 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SOD1P1 mRNA	PMID:38568856
10399795	RNU6-667P	RNA, U6 small nuclear 667, pseudogene	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of RNU6-667P mRNA	PMID:28711546
10399798	RNU1-138P	RNA, U1 small nuclear 138, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNU1-138P mRNA	PMID:38568856
10399798	RNU1-138P	RNA, U1 small nuclear 138, pseudogene	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RNU1-138P mRNA	PMID:38568856
10399846	MCCC1-AS1	MCCC1 antisense RNA 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MCCC1-AS1 mRNA	PMID:32763439
10399876	RN7SL822P	RNA, 7SL, cytoplasmic 822, pseudogene	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:6484513	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of RN7S1 mRNA	PMID:37995155
10399876	RN7SL822P	RNA, 7SL, cytoplasmic 822, pseudogene	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:6484513	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of RN7S1 mRNA	PMID:39984025
10399881	RNU6-334P	RNA, U6 small nuclear 334, pseudogene	gene	CHEBI:32914	cetylpyridinium	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D002594	Cetylpyridinium results in increased expression of RNU6-334P	PMID:37149095
10399889	RNU6-1278P	RNA, U6 small nuclear 1278, pseudogene	gene	CHEBI:32914	cetylpyridinium	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D002594	Cetylpyridinium results in increased expression of RNU6-1278P	PMID:37149095
10399891	RNU2-62P	RNA, U2 small nuclear 62, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNU2-62P mRNA	PMID:38568856
10399891	RNU2-62P	RNA, U2 small nuclear 62, pseudogene	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RNU2-62P mRNA	PMID:38568856
10399899	RNU4-79P	RNA, U4 small nuclear 79, pseudogene	gene	CHEBI:31264	benzethonium chloride	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D001558	Benzethonium results in increased expression of RNU4-79P	PMID:37149095
10399899	RNU4-79P	RNA, U4 small nuclear 79, pseudogene	gene	CHEBI:94725	dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D001558	Benzethonium results in increased expression of RNU4-79P	PMID:37149095
10399906	GPAA1P2	glycosylphosphatidylinositol anchor attachment 1 pseudogene 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of GPAA1P2 mRNA	PMID:38832940
10399941	RNU6-1024P	RNA, U6 small nuclear 1024, pseudogene	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of RNU6-1024P mRNA	PMID:28711546
10399948	VTA1P1	vesicle trafficking 1 pseudogene 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of VTA1P1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of VTA1P1 mRNA	PMID:35811015
10399948	VTA1P1	vesicle trafficking 1 pseudogene 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of VTA1P1 mRNA	PMID:35811015
10399948	VTA1P1	vesicle trafficking 1 pseudogene 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of VTA1P1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of VTA1P1 mRNA	PMID:35811015
10399971	RNU2-28P	RNA, U2 small nuclear 28, pseudogene	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RNU2-28P mRNA	PMID:38568856
10399993	RN7SL336P	RNA, 7SL, cytoplasmic 336, pseudogene	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RN7SL336P mRNA	PMID:33212167
10400000	RNU6-1014P	RNA, U6 small nuclear 1014, pseudogene	gene	CHEBI:31264	benzethonium chloride	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D001558	Benzethonium results in increased expression of RNU6-1014P	PMID:37149095
10400000	RNU6-1014P	RNA, U6 small nuclear 1014, pseudogene	gene	CHEBI:32146	sodium hypochlorite	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D012973	Sodium Hypochlorite results in increased expression of RNU6-1014P	PMID:37149095
10400000	RNU6-1014P	RNA, U6 small nuclear 1014, pseudogene	gene	CHEBI:94725	dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D001558	Benzethonium results in increased expression of RNU6-1014P	PMID:37149095
10400019	RNU6-177P	RNA, U6 small nuclear 177, pseudogene	gene	CHEBI:24527	herbicide	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D006540	Herbicides results in decreased expression of RNU6-177P mRNA	PMID:28711546
10400033	RNU7-136P	RNA, U7 small nuclear 136 pseudogene	gene	CHEBI:32914	cetylpyridinium	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D002594	Cetylpyridinium results in decreased expression of RNU7-136P	PMID:37149095
10400046	RNU6-643P	RNA, U6 small nuclear 643, pseudogene	gene	CHEBI:3020	benzalkonium chloride	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D001548	Benzalkonium Compounds results in decreased expression of RNU6-643P	PMID:37149095
10400048	RNU6-893P	RNA, U6 small nuclear 893, pseudogene	gene	CHEBI:24527	herbicide	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D006540	Herbicides results in decreased expression of RNU6-893P mRNA	PMID:28711546
10400064	RN7SL197P	RNA, 7SL, cytoplasmic 197, pseudogene	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of RN7SL197P mRNA	PMID:33359661
10400065	RN7SL605P	RNA, 7SL, cytoplasmic 605, pseudogene	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of RN7SL605P mRNA	PMID:41028656
10400065	RN7SL605P	RNA, 7SL, cytoplasmic 605, pseudogene	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of RN7SL605P mRNA	PMID:41028656
10400065	RN7SL605P	RNA, 7SL, cytoplasmic 605, pseudogene	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of RN7SL605P mRNA	PMID:41028656
10400067	RNU6ATAC35P	RNA, U6atac small nuclear 35, pseudogene	gene	CHEBI:44915	propofol	decreases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:D015742	Propofol results in decreased expression of RNU6ATAC35P mRNA	PMID:35238236
10400094	RNU6-1258P	RNA, U6 small nuclear 1258, pseudogene	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of RNU6-1258P mRNA	PMID:28711546
10400103	RN7SL333P	RNA, 7SL, cytoplasmic 333, pseudogene	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of RN7SL333P mRNA	PMID:32763439
10400103	RN7SL333P	RNA, 7SL, cytoplasmic 333, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of RN7SL333P mRNA	PMID:34032870
10400124	RN7SL316P	RNA, 7SL, cytoplasmic 316, pseudogene	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SL316P mRNA	PMID:33359661
10400148	RNU6-659P	RNA, U6 small nuclear 659, pseudogene	gene	CHEBI:193591	Didecyldimethylammonium	increases expression	EXP		E	RGD:6480464	20221018	CTD	MESH:C027118	didecyldimethylammonium results in increased expression of RNU6-659P mRNA	PMID:32763356
10400148	RNU6-659P	RNA, U6 small nuclear 659, pseudogene	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RNU6-659P mRNA	PMID:38568856
10400156	RNU6-1085P	RNA, U6 small nuclear 1085, pseudogene	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNU6-1085P mRNA	PMID:33212167
10400181	RNU7-172P	RNA, U7 small nuclear 172 pseudogene	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of RNU7-172P mRNA	PMID:28711546
10400203	RNU6-4P	RNA, U6 small nuclear 4, pseudogene	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C006780	bisphenol A results in increased expression of RNU6-4P mRNA	PMID:33476716
10400209	RN7SKP228	RN7SK pseudogene 228	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SKP228 mRNA	PMID:33359661
10400220	RNU6-1161P	RNA, U6 small nuclear 1161, pseudogene	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of RNU6-1161P mRNA	PMID:34032870
10400254	RNU4-60P	RNA, U4 small nuclear 60, pseudogene	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of RNU4-60P mRNA	PMID:28711546
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1315919	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of THEM7 mRNA	PMID:36331819
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315919	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of THEM7 mRNA	PMID:27339419
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315919	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of THEM7 mRNA	PMID:36331819
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1315919	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in increased expression of THEM7 mRNA	PMID:29279043
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1315919	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of THEM7 mRNA	PMID:31919559
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1315919	E	RGD:6480464	20181016	CTD	MESH:D002251	[PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of THEM7 mRNA	PMID:29987408
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1315919	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of THEM7 mRNA	PMID:32186404
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315919	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of THEM7 mRNA	PMID:26377647
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315919	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of THEM7 mRNA	PMID:26290441
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1315919	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of THEM7 promoter	PMID:27312807
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315919	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of THEM7 mRNA	PMID:39298647
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1315919	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of THEM7 intron	PMID:28392331
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1315919	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of THEM7 mRNA	PMID:39529242
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315919	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of THEM7 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of THEM7 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of THEM7 mRNA	PMID:36331819
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1315919	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of THEM7 mRNA	PMID:28973697
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1315919	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of THEM7 mRNA	PMID:35436446
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1315919	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of THEM7 mRNA	PMID:31388691
10400384	THEM7P	thioesterase superfamily member 7, pseudogene	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1315919	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of THEM7 mRNA	PMID:28973697
10400401	RNU6-415P	RNA, U6 small nuclear 415, pseudogene	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of RNU6-415P mRNA	PMID:31745603
10400447	SNRPGP19	small nuclear ribonucleoprotein polypeptide G pseudogene 19	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SNRPGP19 mRNA	PMID:33212167
10400475	RNU7-134P	RNA, U7 small nuclear 134 pseudogene	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of RNU7-134P mRNA	PMID:28711546
10400476	RN7SKP60	RN7SK pseudogene 60	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1624517	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MIRT2 mRNA	PMID:36331819
10400476	RN7SKP60	RN7SK pseudogene 60	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1624517	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MIRT2 mRNA	PMID:36331819
10400476	RN7SKP60	RN7SK pseudogene 60	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1624517	E	RGD:6480464	20190423	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MIRT2 mRNA	PMID:26290441
10400476	RN7SKP60	RN7SK pseudogene 60	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1624517	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MIRT2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MIRT2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MIRT2 mRNA	PMID:36331819
10400476	RN7SKP60	RN7SK pseudogene 60	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1624517	E	RGD:6480464	20190423	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MIRT2 mRNA	PMID:27935865
10400476	RN7SKP60	RN7SK pseudogene 60	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1624517	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of MIRT2 mRNA	PMID:39847705
10400493	LINC00449	long intergenic non-protein coding RNA 449	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC00449 mRNA	PMID:34032870
10400498	RNU6-306P	RNA, U6 small nuclear 306, pseudogene	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of RNU6-306P mRNA	PMID:28711546
10400517	RN7SKP31	RN7SK pseudogene 31	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SKP31 mRNA	PMID:33359661
10400538	RN7SL396P	RNA, 7SL, cytoplasmic 396, pseudogene	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RN7SL396P mRNA	PMID:32234424
10400655	TRIM80P	tripartite motif containing 80, pseudogene	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1615479	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TRIM80 mRNA	PMID:33045310
10400655	TRIM80P	tripartite motif containing 80, pseudogene	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1615479	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TRIM80 mRNA	PMID:36331819
10400655	TRIM80P	tripartite motif containing 80, pseudogene	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1615479	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of TRIM80 mRNA	PMID:34813904
10400655	TRIM80P	tripartite motif containing 80, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TRIM80P mRNA	PMID:34032870
10400655	TRIM80P	tripartite motif containing 80, pseudogene	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1615479	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRIM80 exon; Benzo(a)pyrene results in decreased methylation of TRIM80 intron	PMID:27901495
10400655	TRIM80P	tripartite motif containing 80, pseudogene	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1615479	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of TRIM80 promoter	PMID:27312807
10400655	TRIM80P	tripartite motif containing 80, pseudogene	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1615479	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TRIM80 gene	PMID:31683443
10400655	TRIM80P	tripartite motif containing 80, pseudogene	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1615479	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TRIM80 mRNA	PMID:36331819
10400658	PHB1P6	PHB1 pseudogene 6	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of PHB1P6 mRNA	PMID:36318118
10400672	BMS1P22	BMS1 pseudogene 22	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of BMS1P22 mRNA	PMID:28988120
10400701	H3P4	H3 histone pseudogene 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of H3P4 mRNA	PMID:33212167
10400712	RNU4-39P	RNA, U4 small nuclear 39, pseudogene	gene	CHEBI:32146	sodium hypochlorite	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D012973	Sodium Hypochlorite results in decreased expression of RNU4-39P	PMID:37149095
10400752	RN7SKP65	RN7SK pseudogene 65	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RN7SKP65 mRNA	PMID:38568856
10400757	RPPH1-3P	ribonuclease P RNA component H1, 3 pseudogene	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1612751	E	RGD:6480464	20210323	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RPRL2 mRNA	PMID:24205000
10400757	RPPH1-3P	ribonuclease P RNA component H1, 3 pseudogene	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1612751	E	RGD:6480464	20210323	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RPRL2 mRNA	PMID:19850644
10400757	RPPH1-3P	ribonuclease P RNA component H1, 3 pseudogene	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1612751	E	RGD:6480464	20210323	CTD	MESH:D004051	PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of RPRL2 mRNA]	PMID:19850644
10400757	RPPH1-3P	ribonuclease P RNA component H1, 3 pseudogene	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1612751	E	RGD:6480464	20210323	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RPRL2 mRNA; Nanotubes, Carbon results in decreased expression of RPRL2 mRNA	PMID:25554681|PMID:25620056
10400765	RNU2-10P	RNA, U2 small nuclear 10, pseudogene	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RNU2-10P mRNA	PMID:38568856
10400768	RN7SL138P	RNA, 7SL, cytoplasmic 138, pseudogene	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RN7SL138P mRNA	PMID:35811015
10400768	RN7SL138P	RNA, 7SL, cytoplasmic 138, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SL138P mRNA	PMID:35811015
10400768	RN7SL138P	RNA, 7SL, cytoplasmic 138, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SL138P mRNA	PMID:35811015
10400775	RN7SL689P	RNA, 7SL, cytoplasmic 689, pseudogene	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RN7SL689P mRNA	PMID:33212167
10400779	SUMO2P18	SUMO2 pseudogene 18	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SUMO2P18 mRNA	PMID:33212167
10400781	NOP56P3	NOP56 ribonucleoprotein pseudogene 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NOP56P3 mRNA	PMID:33212167
10400783	RNU6-376P	RNA, U6 small nuclear 376, pseudogene	gene	CHEBI:17824	propan-2-ol	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D019840	2-Propanol results in increased expression of RNU6-376P	PMID:37149095
10400827	RN7SKP106	RN7SK pseudogene 106	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RN7SKP106 mRNA	PMID:38218311
10400842	RN7SL128P	RNA, 7SL, cytoplasmic 128, pseudogene	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RN7SL128P mRNA	PMID:32234424
10400940	LINC01615	long independently transcribed non-coding RNA 1615	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC01615 intron	PMID:30157460
10400940	LINC01615	long independently transcribed non-coding RNA 1615	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01615 intron	PMID:30157460
10400964	CCDC188	coiled-coil domain containing 188	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CCDC188 mRNA	PMID:33212167
10400964	CCDC188	coiled-coil domain containing 188	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1621006	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of CCDC188 mRNA	PMID:37682722
10400964	CCDC188	coiled-coil domain containing 188	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1563782	E	RGD:6480464	20151215	CTD	MESH:C006780	bisphenol A results in decreased expression of CCDC188 mRNA	PMID:25181051
10400964	CCDC188	coiled-coil domain containing 188	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1621006	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CCDC188 mRNA	PMID:40194260
10400964	CCDC188	coiled-coil domain containing 188	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of CCDC188 mRNA	PMID:36318118
10401000	DACOR1	DNMT1-associated colon cancer repressed lncRNA 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of DACOR1 mRNA	PMID:29301061
10401054	LINC01616	long independently transcribed non-coding RNA 1616	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01616 mRNA	PMID:41028656
10401054	LINC01616	long independently transcribed non-coding RNA 1616	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01616 mRNA	PMID:41028656
10401054	LINC01616	long independently transcribed non-coding RNA 1616	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01616 mRNA	PMID:41028656
10401179	TREHP1	trehalase pseudogene 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TREHP1 mRNA	PMID:38568856
10401682	PTGES3P2	prostaglandin E synthase 3 pseudogene 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PTGES3P2 mRNA	PMID:29301935
10401694	SNORA92	small nucleolar RNA, H/ACA box 92	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SNORA92 polyA tail	PMID:30157460
10401741	MIR34AHG	MIR34A host gene	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MIR34AHG mRNA	PMID:35811015
10401741	MIR34AHG	MIR34A host gene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MIR34AHG mRNA]	PMID:35811015
10401741	MIR34AHG	MIR34A host gene	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of MIR34AHG mRNA	PMID:39613055
10401741	MIR34AHG	MIR34A host gene	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of MIR34AHG mRNA	PMID:36695872
10401741	MIR34AHG	MIR34A host gene	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of MIR34AHG mRNA	PMID:39613055
10401741	MIR34AHG	MIR34A host gene	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MIR34AHG mRNA	PMID:36139627
10401741	MIR34AHG	MIR34A host gene	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MIR34AHG mRNA	PMID:32763439
10401741	MIR34AHG	MIR34A host gene	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MIR34AHG intron	PMID:30157460
10401741	MIR34AHG	MIR34A host gene	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MIR34AHG mRNA	PMID:32234424
10401741	MIR34AHG	MIR34A host gene	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of MIR34AHG mRNA	PMID:39613055
10401741	MIR34AHG	MIR34A host gene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MIR34AHG mRNA]	PMID:35811015
10401741	MIR34AHG	MIR34A host gene	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MIR34AHG mRNA	PMID:36139627
10401741	MIR34AHG	MIR34A host gene	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MIR34AHG mRNA	PMID:38568856
10401963	LINC00680	long independently transcribed non-coding RNA 680	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LINC00680 mRNA	PMID:36139627
10401963	LINC00680	long independently transcribed non-coding RNA 680	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC00680 mRNA	PMID:33212167
10401963	LINC00680	long independently transcribed non-coding RNA 680	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC00680 mRNA	PMID:38568856
10401963	LINC00680	long independently transcribed non-coding RNA 680	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LINC00680 mRNA	PMID:38568856
10401963	LINC00680	long independently transcribed non-coding RNA 680	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of LINC00680 mRNA	PMID:28988120
10401963	LINC00680	long independently transcribed non-coding RNA 680	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LINC00680 mRNA	PMID:36139627
10402027	KRT8P50	keratin 8 pseudogene 50	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KRT8P50 mRNA	PMID:38832940
10402212	MIR3681HG	MIR3681 host gene	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MIR3681HG intron	PMID:30157460
10402234	RPSAP69	ribosomal protein SA pseudogene 69	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of RPSAP69 mRNA	PMID:41028656
10402234	RPSAP69	ribosomal protein SA pseudogene 69	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of RPSAP69 mRNA	PMID:41028656
10402234	RPSAP69	ribosomal protein SA pseudogene 69	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of RPSAP69 mRNA	PMID:41028656
10402235	OLFM5P	olfactomedin family member 5, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of OLFM5P mRNA	PMID:35811015
10402235	OLFM5P	olfactomedin family member 5, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of OLFM5P mRNA	PMID:35811015
10402243	MIR3945HG	MIR3945 host gene	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MIR3945HG mRNA	PMID:35811015
10402243	MIR3945HG	MIR3945 host gene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MIR3945HG mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MIR3945HG mRNA	PMID:35811015
10402243	MIR3945HG	MIR3945 host gene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MIR3945HG mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MIR3945HG mRNA	PMID:35811015
10402251	MIR193BHG	MIR193b-365a host gene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MIR193BHG mRNA	PMID:35811015
10402251	MIR193BHG	MIR193b-365a host gene	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MIR193BHG mRNA	PMID:33212167
10402251	MIR193BHG	MIR193b-365a host gene	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MIR193BHG mRNA	PMID:38832940
10402251	MIR193BHG	MIR193b-365a host gene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of MIR193BHG mRNA	PMID:35811015
10402251	MIR193BHG	MIR193b-365a host gene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MIR193BHG mRNA	PMID:35811015
10402285	CCDC74BP1	coiled-coil domain containing 74B pseudogene 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCDC74BP1 mRNA	PMID:34032870
10402300	VDAC2P4	VDAC2 pseudogene 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of VDAC2P4 mRNA	PMID:38568856
10402323	MUC20P1	mucin 20, cell surface associated pseudogene 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MUC20P1 mRNA	PMID:33212167
10402345	MIR4290HG	MIR4290 host gene	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MIR4290HG	PMID:38036013
10402345	MIR4290HG	MIR4290 host gene	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of MIR4290HG gene	PMID:31601247
10402345	MIR4290HG	MIR4290 host gene	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of MIR4290HG gene	PMID:31601247
10402643	LYRM4-AS1	LYRM4 antisense RNA 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LYRM4-AS1 intron	PMID:30157460
10402643	LYRM4-AS1	LYRM4 antisense RNA 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LYRM4-AS1 intron	PMID:30157460
10402643	LYRM4-AS1	LYRM4 antisense RNA 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LYRM4-AS1 intron	PMID:30157460
10402643	LYRM4-AS1	LYRM4 antisense RNA 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LYRM4-AS1 intron	PMID:30157460
10402673	PACRG-AS3	PACRG antisense RNA 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PACRG-AS3 mRNA	PMID:35301059
10402673	PACRG-AS3	PACRG antisense RNA 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PACRG-AS3 mRNA	PMID:35301059
10402683	LINC01623	long independently transcribed non-coding RNA 1623	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LINC01623 gene	PMID:31601247
10402689	LINC01622	long independently transcribed non-coding RNA 1622	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC01622 intron	PMID:30157460
10402689	LINC01622	long independently transcribed non-coding RNA 1622	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01622 promoter	PMID:27901495
10402689	LINC01622	long independently transcribed non-coding RNA 1622	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC01622 intron	PMID:30157460
10402689	LINC01622	long independently transcribed non-coding RNA 1622	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC01622 intron	PMID:30157460
10402702	MIR548XHG	MIR548X host gene	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MIR548XHG intron	PMID:30157460
10402712	MIR5689HG	MIR5689 host gene	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of MIR5689HG mRNA	PMID:34032870
10402712	MIR5689HG	MIR5689 host gene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MIR5689HG mRNA	PMID:38568856
10402712	MIR5689HG	MIR5689 host gene	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MIR5689HG mRNA	PMID:38568856
10402712	MIR5689HG	MIR5689 host gene	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MIR5689HG mRNA	PMID:38832940
10402712	MIR5689HG	MIR5689 host gene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of MIR5689HG mRNA	PMID:35811015
10402713	LINC01624	long independently transcribed non-coding RNA 1624	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LINC01624 mRNA	PMID:35811015
10402713	LINC01624	long independently transcribed non-coding RNA 1624	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01624 mRNA	PMID:35811015
10402713	LINC01624	long independently transcribed non-coding RNA 1624	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01624 mRNA	PMID:41028656
10402713	LINC01624	long independently transcribed non-coding RNA 1624	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01624 mRNA	PMID:41028656
10402713	LINC01624	long independently transcribed non-coding RNA 1624	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01624 mRNA	PMID:41028656
10402713	LINC01624	long independently transcribed non-coding RNA 1624	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01624 mRNA	PMID:35811015
10402719	UST-AS1	UST antisense RNA 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of UST-AS1 mRNA	PMID:31533062
10402981	SLC68A2P	solute carrier family 68 member 2, pseudogene	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621477	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SLC68A2 mRNA	PMID:33045310
10402981	SLC68A2P	solute carrier family 68 member 2, pseudogene	gene	CHEBI:16836	4-nitrophenol	increases expression	ISO	RGD:1621477	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in increased expression of SLC68A2 mRNA	PMID:34673133
10402981	SLC68A2P	solute carrier family 68 member 2, pseudogene	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1621477	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of SLC68A2 mRNA	PMID:39922521
10402981	SLC68A2P	solute carrier family 68 member 2, pseudogene	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1621477	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SLC68A2 mRNA	PMID:33848595
10402981	SLC68A2P	solute carrier family 68 member 2, pseudogene	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1621477	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of SLC68A2 mRNA]	PMID:33848595
10402981	SLC68A2P	solute carrier family 68 member 2, pseudogene	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1621477	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of SLC68A2 mRNA	PMID:39922521
10402981	SLC68A2P	solute carrier family 68 member 2, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1621477	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC68A2 mRNA	PMID:37682722
10402981	SLC68A2P	solute carrier family 68 member 2, pseudogene	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1582763	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of MFSD13B mRNA	PMID:41034487
10402981	SLC68A2P	solute carrier family 68 member 2, pseudogene	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1621477	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of SLC68A2 mRNA	PMID:39922521
10402981	SLC68A2P	solute carrier family 68 member 2, pseudogene	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1621477	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of SLC68A2 mRNA	PMID:38701926
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CCDC18-AS1 mRNA	PMID:27392435
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CCDC18-AS1 mRNA	PMID:27392435
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CCDC18-AS1 mRNA	PMID:30851411
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCDC18-AS1 mRNA	PMID:34032870
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CCDC18-AS1 mRNA	PMID:31533062
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CCDC18-AS1 mRNA	PMID:26272509
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC18-AS1 mRNA	PMID:27188386
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	fipronil results in decreased expression of CCDC18-AS1 mRNA	PMID:28991164
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of CCDC18-AS1 mRNA	PMID:28991164
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CCDC18-AS1 mRNA	PMID:24810058
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of CCDC18-AS1 mRNA	PMID:28991164
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of CCDC18-AS1 mRNA	PMID:28960945
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CCDC18-AS1 mRNA	PMID:30851411
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC18-AS1 mRNA	PMID:27188386
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of CCDC18-AS1 mRNA	PMID:39904859
10411941	CCDC18-AS1	CCDC18 antisense RNA 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCDC18-AS1 mRNA	PMID:27188386
10411961	LINC01629	long independently transcribed non-coding RNA 1629	gene	CHEBI:26523	reactive oxygen species	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017382	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of EPB41L1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of THY1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MEF2A mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MYPN mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of OTOG mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of STAB1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of TRIM8 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of ZNF672 mRNA; [Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA	PMID:33656867
10411961	LINC01629	long independently transcribed non-coding RNA 1629	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LINC01629 mRNA	PMID:32234424
10411961	LINC01629	long independently transcribed non-coding RNA 1629	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of EPB41L1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in decreased expression of THY1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MEF2A mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of MYPN mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of OTOG mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of STAB1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of TRIM8 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA] which results in increased expression of ZNF672 mRNA; [Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01629 mRNA	PMID:33656867
10411987	DHRSX-IT1	DHRSX intronic transcript 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DHRSX-IT1 mRNA	PMID:33212167
10411996	GAS1RR	GAS1 adjacent regulatory RNA	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of GAS1RR mRNA	PMID:27188386
10411996	GAS1RR	GAS1 adjacent regulatory RNA	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GAS1RR intron	PMID:30157460
10411996	GAS1RR	GAS1 adjacent regulatory RNA	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GAS1RR mRNA	PMID:38568856
10411996	GAS1RR	GAS1 adjacent regulatory RNA	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of GAS1RR mRNA	PMID:26705709
10411996	GAS1RR	GAS1 adjacent regulatory RNA	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of GAS1RR mRNA	PMID:38832940
10411996	GAS1RR	GAS1 adjacent regulatory RNA	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of GAS1RR mRNA	PMID:26705709
10412374	RPL23AP92	ribosomal protein L23a pseudogene 92	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RPL23AP92 mRNA	PMID:33670352
10412396	EIF1P7	eukaryotic translation initiation factor 1 pseudogene 7	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of EIF1P7 mRNA	PMID:31745603
10412407	RN7SL832P	RNA, 7SL, cytoplasmic 832, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RN7SL832P mRNA	PMID:38568856
10412407	RN7SL832P	RNA, 7SL, cytoplasmic 832, pseudogene	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RN7SL832P mRNA	PMID:38568856
10412410	RNU6-529P	RNA, U6 small nuclear 529, pseudogene	gene	CHEBI:131762	dodecyldimethylamine N-oxide	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:C014518	dodecyldimethylamine oxide results in increased expression of RNU6-529P mRNA	PMID:40571133
10412410	RNU6-529P	RNA, U6 small nuclear 529, pseudogene	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNU6-529P mRNA	PMID:33212167
10412420	RN7SL477P	RNA, 7SL, cytoplasmic 477, pseudogene	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of RN7SL477P mRNA	PMID:33359661
10412444	RN7SL499P	RNA, 7SL, cytoplasmic 499, pseudogene	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of RN7SL499P mRNA	PMID:33359661
10412445	RN7SL845P	RNA, 7SL, cytoplasmic 845, pseudogene	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SL845P mRNA	PMID:33359661
10412448	RN7SL569P	RNA, 7SL, cytoplasmic 569, pseudogene	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SL569P mRNA	PMID:33359661
10412448	RN7SL569P	RNA, 7SL, cytoplasmic 569, pseudogene	gene	CHEBI:34575	bisphenol F	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C008745	bisphenol F results in decreased expression of RN7SL569P mRNA	PMID:33476716
10412460	RRM1-AS1	RRM1 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of RRM1-AS1 mRNA	PMID:34032870
10412464	RN7SL549P	RNA, 7SL, cytoplasmic 549, pseudogene	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SL549P mRNA	PMID:33359661
10412484	RNU2-63P	RNA, U2 small nuclear 63, pseudogene	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in increased expression of RNU2-63P mRNA	PMID:41028656
10412484	RNU2-63P	RNA, U2 small nuclear 63, pseudogene	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in decreased expression of RNU2-63P mRNA	PMID:37386098
10412484	RNU2-63P	RNA, U2 small nuclear 63, pseudogene	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of RNU2-63P mRNA	PMID:41028656
10412484	RNU2-63P	RNA, U2 small nuclear 63, pseudogene	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of RNU2-63P mRNA	PMID:41028656
10412484	RNU2-63P	RNA, U2 small nuclear 63, pseudogene	gene	CHEBI:3020	benzalkonium chloride	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D001548	Benzalkonium Compounds results in decreased expression of RNU2-63P	PMID:37149095
10412487	RN7SL568P	RNA, 7SL, cytoplasmic 568, pseudogene	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SL568P mRNA	PMID:33359661
10412487	RN7SL568P	RNA, 7SL, cytoplasmic 568, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RN7SL568P mRNA	PMID:38568856
10412498	MTATP8P2	MT-ATP8 pseudogene 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MTATP8P2 mRNA	PMID:36326898
10412514	RN7SL470P	RNA, 7SL, cytoplasmic 470, pseudogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RN7SL470P mRNA	PMID:35811015
10412514	RN7SL470P	RNA, 7SL, cytoplasmic 470, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SL470P mRNA	PMID:35811015
10412514	RN7SL470P	RNA, 7SL, cytoplasmic 470, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SL470P mRNA	PMID:35811015
10412526	CST12P	cystatin 12, pseudogene	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1550919	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of CST12 mRNA; Tretinoin results in increased expression of CST9 mRNA	PMID:36189433
10412526	CST12P	cystatin 12, pseudogene	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550919	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CST12 mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CST9 mRNA	PMID:36189433
10412526	CST12P	cystatin 12, pseudogene	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550919	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CST12 mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CST9 mRNA	PMID:36189433
10412526	CST12P	cystatin 12, pseudogene	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550919	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CST12 mRNA; Diethylhexyl Phthalate results in decreased expression of CST9 mRNA	PMID:34319233
10412526	CST12P	cystatin 12, pseudogene	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550919	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CST12 mRNA; Diethylhexyl Phthalate results in increased expression of CST9 mRNA	PMID:33754040
10412526	CST12P	cystatin 12, pseudogene	gene	CHEBI:28436	delphinidin	decreases expression	ISO	RGD:1550919	E	RGD:6480464	20240604	CTD	MESH:C017185	delphinidin results in decreased expression of CST12 mRNA	PMID:38291899
10412526	CST12P	cystatin 12, pseudogene	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1550919	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of CST12 protein	PMID:28918527
10412526	CST12P	cystatin 12, pseudogene	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1550919	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of CST12 mRNA	PMID:39631538
10412526	CST12P	cystatin 12, pseudogene	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550919	E	RGD:6480464	20260811	CTD	MESH:C009495	titanium dioxide results in decreased expression of CST9 mRNA	PMID:23557971
10412526	CST12P	cystatin 12, pseudogene	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550919	E	RGD:6480464	20260811	CTD	MESH:C006253	pirinixic acid results in increased expression of CST9 mRNA	PMID:20813756
10412526	CST12P	cystatin 12, pseudogene	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1550919	E	RGD:6480464	20220705	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CST12 mRNA	PMID:35230478
10412526	CST12P	cystatin 12, pseudogene	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550919	E	RGD:6480464	20151124	CTD	MESH:D000082	Acetaminophen affects the expression of CST12 mRNA	PMID:17562736
10412546	RNA5SP221	RNA, 5S ribosomal pseudogene 221	gene	CHEBI:756028	mivebresib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in increased expression of RNA5SP221 mRNA	PMID:35486664
10412583	RN7SKP66	RN7SK pseudogene 66	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SKP66 mRNA	PMID:33359661
10412585	BOLA3P4	bolA family member 3 pseudogene 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of BOLA3P4 mRNA	PMID:38568856
10412585	BOLA3P4	bolA family member 3 pseudogene 4	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of BOLA3P4 mRNA	PMID:38568856
10412597	EIF1P6	eukaryotic translation initiation factor 1 pseudogene 6	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of EIF1P6 mRNA	PMID:33212167
10412597	EIF1P6	eukaryotic translation initiation factor 1 pseudogene 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EIF1P6 mRNA	PMID:38568856
10412609	RNU6-612P	RNA, U6 small nuclear 612, pseudogene	gene	CHEBI:30769	citric acid	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D019343	Citric Acid results in increased expression of RNU6-612P	PMID:37149095
10412609	RNU6-612P	RNA, U6 small nuclear 612, pseudogene	gene	CHEBI:32914	cetylpyridinium	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D002594	Cetylpyridinium results in increased expression of RNU6-612P	PMID:37149095
10412624	RN7SKP271	RN7SK pseudogene 271	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RN7SKP271 mRNA	PMID:33212167
10412631	RN7SL455P	RNA, 7SL, cytoplasmic 455, pseudogene	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RN7SL455P mRNA	PMID:38568856
10412632	RNU7-113P	RNA, U7 small nuclear 113 pseudogene	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of RNU7-113P mRNA	PMID:28711546
10413043	MTATP6P1	MT-ATP6 pseudogene 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MTATP6P1 mRNA	PMID:33212167
10413043	MTATP6P1	MT-ATP6 pseudogene 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MTATP6P1 mRNA	PMID:38568856
10413043	MTATP6P1	MT-ATP6 pseudogene 1	gene	CHEBI:3000	beauvericin	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C004456	beauvericin results in decreased expression of MTATP6P1 mRNA	PMID:29203277
10413043	MTATP6P1	MT-ATP6 pseudogene 1	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of MTATP6P1 mRNA	PMID:31745603
10413043	MTATP6P1	MT-ATP6 pseudogene 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of MTATP6P1 mRNA	PMID:38479592
10413043	MTATP6P1	MT-ATP6 pseudogene 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MTATP6P1 mRNA	PMID:33670352
10413043	MTATP6P1	MT-ATP6 pseudogene 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MTATP6P1 mRNA	PMID:38568856
10413043	MTATP6P1	MT-ATP6 pseudogene 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MTATP6P1 mRNA	PMID:38568856
10413047	RNY1P16	RNY1 pseudogene 16	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of RNY1P16 mRNA	PMID:31745603
10413087	RNVU1-32	RNA, variant U1 small nuclear 32	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RNVU1-32 mRNA	PMID:35811015
10413087	RNVU1-32	RNA, variant U1 small nuclear 32	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNVU1-32 mRNA	PMID:35811015
10413087	RNVU1-32	RNA, variant U1 small nuclear 32	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNVU1-32 mRNA	PMID:35811015
10413109	RNU4-40P	RNA, U4 small nuclear 40, pseudogene	gene	CHEBI:24527	herbicide	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D006540	Herbicides results in increased expression of RNU4-40P mRNA	PMID:28711546
10413123	RNU6-403P	RNA, U6 small nuclear 403, pseudogene	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNU6-403P mRNA	PMID:35811015
10413123	RNU6-403P	RNA, U6 small nuclear 403, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of RNU6-403P mRNA]	PMID:35811015
10413123	RNU6-403P	RNA, U6 small nuclear 403, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNU6-403P mRNA	PMID:38568856
10413123	RNU6-403P	RNA, U6 small nuclear 403, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of RNU6-403P mRNA]	PMID:35811015
10413139	RNU6-611P	RNA, U6 small nuclear 611, pseudogene	gene	CHEBI:24527	herbicide	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D006540	Herbicides results in decreased expression of RNU6-611P mRNA	PMID:28711546
10413139	RNU6-611P	RNA, U6 small nuclear 611, pseudogene	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of RNU6-611P mRNA	PMID:28711546
10413161	RNU6-179P	RNA, U6 small nuclear 179, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNU6-179P mRNA	PMID:38568856
10413163	RNU6-1045P	RNA, U6 small nuclear 1045, pseudogene	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C008745	bisphenol F results in increased expression of RNU6-1045P mRNA	PMID:33476716
10413179	RN7SL559P	RNA, 7SL, cytoplasmic 559, pseudogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RN7SL559P mRNA	PMID:35811015
10413179	RN7SL559P	RNA, 7SL, cytoplasmic 559, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SL559P mRNA	PMID:35811015
10413179	RN7SL559P	RNA, 7SL, cytoplasmic 559, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SL559P mRNA	PMID:35811015
10413184	RN7SL200P	RNA, 7SL, cytoplasmic 200, pseudogene	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RN7SL200P mRNA	PMID:38568856
10413229	RN7SL403P	RNA, 7SL, cytoplasmic 403, pseudogene	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SL403P mRNA	PMID:33359661
10413242	RNU6-490P	RNA, U6 small nuclear 490, pseudogene	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of RNU6-490P	PMID:37149095
10413242	RNU6-490P	RNA, U6 small nuclear 490, pseudogene	gene	CHEBI:31264	benzethonium chloride	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D001558	Benzethonium results in decreased expression of RNU6-490P	PMID:37149095
10413242	RNU6-490P	RNA, U6 small nuclear 490, pseudogene	gene	CHEBI:32146	sodium hypochlorite	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D012973	Sodium Hypochlorite results in decreased expression of RNU6-490P	PMID:37149095
10413242	RNU6-490P	RNA, U6 small nuclear 490, pseudogene	gene	CHEBI:32914	cetylpyridinium	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D002594	Cetylpyridinium results in decreased expression of RNU6-490P	PMID:37149095
10413242	RNU6-490P	RNA, U6 small nuclear 490, pseudogene	gene	CHEBI:94725	dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D001558	Benzethonium results in decreased expression of RNU6-490P	PMID:37149095
10413245	RNU6-890P	RNA, U6 small nuclear 890, pseudogene	gene	CHEBI:756028	mivebresib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in increased expression of RNU6-890P mRNA	PMID:35486664
10413253	RN7SKP26	RN7SK pseudogene 26	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RN7SKP26 mRNA	PMID:35811015
10413253	RN7SKP26	RN7SK pseudogene 26	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of RN7SKP26 mRNA]	PMID:35811015
10413253	RN7SKP26	RN7SK pseudogene 26	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of RN7SKP26 mRNA]	PMID:35811015
10413259	RN7SL399P	RNA, 7SL, cytoplasmic 399, pseudogene	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of RN7SL399P mRNA	PMID:34032870
10413275	RNU6-431P	RNA, U6 small nuclear 431, pseudogene	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of RNU6-431P mRNA	PMID:31745603
10413281	RN7SL751P	RNA, 7SL, cytoplasmic 751, pseudogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RN7SL751P mRNA	PMID:35811015
10413281	RN7SL751P	RNA, 7SL, cytoplasmic 751, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SL751P mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RN7SL751P mRNA	PMID:35811015
10413281	RN7SL751P	RNA, 7SL, cytoplasmic 751, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SL751P mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RN7SL751P mRNA	PMID:35811015
10413290	RNU6-807P	RNA, U6 small nuclear 807, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RNU6-807P mRNA	PMID:35811015
10413290	RNU6-807P	RNA, U6 small nuclear 807, pseudogene	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D004958	Estradiol results in increased expression of RNU6-807P mRNA	PMID:28711546
10413290	RNU6-807P	RNA, U6 small nuclear 807, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RNU6-807P mRNA	PMID:35811015
10413294	RNU6-118P	RNA, U6 small nuclear 118, pseudogene	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of RNU6-118P mRNA	PMID:34032870
10413335	RN7SKP96	RN7SK pseudogene 96	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of RN7SKP96 mRNA	PMID:41028656
10413335	RN7SKP96	RN7SK pseudogene 96	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of RN7SKP96 mRNA	PMID:41028656
10413335	RN7SKP96	RN7SK pseudogene 96	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of RN7SKP96 mRNA	PMID:41028656
10413340	RNU6-583P	RNA, U6 small nuclear 583, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of RNU6-583P mRNA	PMID:34032870
10413351	RN7SL32P	RNA, 7SL, cytoplasmic 32, pseudogene	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RN7SL32P mRNA	PMID:35811015
10413351	RN7SL32P	RNA, 7SL, cytoplasmic 32, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SL32P mRNA	PMID:35811015
10413351	RN7SL32P	RNA, 7SL, cytoplasmic 32, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SL32P mRNA	PMID:35811015
10413384	RNU6-1160P	RNA, U6 small nuclear 1160, pseudogene	gene	CHEBI:17824	propan-2-ol	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D019840	2-Propanol results in increased expression of RNU6-1160P	PMID:37149095
10413400	RNU6-1316P	RNA, U6 small nuclear 1316, pseudogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RNU6-1316P mRNA	PMID:35811015
10413400	RNU6-1316P	RNA, U6 small nuclear 1316, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNU6-1316P mRNA	PMID:35811015
10413400	RNU6-1316P	RNA, U6 small nuclear 1316, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNU6-1316P mRNA	PMID:35811015
10413403	RNU6-853P	RNA, U6 small nuclear 853, pseudogene	gene	CHEBI:24527	herbicide	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D006540	Herbicides results in increased expression of RNU6-853P mRNA	PMID:28711546
10413408	RN7SL535P	RNA, 7SL, cytoplasmic 535, pseudogene	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of RN7SL535P mRNA	PMID:38568856
10413410	KLF17P2	KLF17 pseudogene 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of KLF17P2 mRNA	PMID:38832940
10413419	RN7SKP151	RN7SK pseudogene 151	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of RN7SKP151 mRNA	PMID:41028656
10413419	RN7SKP151	RN7SK pseudogene 151	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of RN7SKP151 mRNA	PMID:41028656
10413419	RN7SKP151	RN7SK pseudogene 151	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of RN7SKP151 mRNA	PMID:41028656
10413428	RN7SKP97	RN7SK pseudogene 97	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of RN7SKP97 mRNA	PMID:32234424
10413430	RNU6-548P	RNA, U6 small nuclear 548, pseudogene	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D000431	Ethanol results in increased expression of RNU6-548P	PMID:37149095
10413445	MTATP8P1	MT-ATP8 pseudogene 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MTATP8P1 mRNA	PMID:38218311
10413475	RNU6-638P	RNA, U6 small nuclear 638, pseudogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RNU6-638P mRNA	PMID:35811015
10413475	RNU6-638P	RNA, U6 small nuclear 638, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNU6-638P mRNA	PMID:35811015
10413475	RNU6-638P	RNA, U6 small nuclear 638, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNU6-638P mRNA	PMID:35811015
10413486	RN7SL466P	RNA, 7SL, cytoplasmic 466, pseudogene	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RN7SL466P mRNA	PMID:33359661
10413548	RN7SL364P	RNA, 7SL, cytoplasmic 364, pseudogene	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RN7SL364P mRNA	PMID:38568856
10413568	RNU6-1062P	RNA, U6 small nuclear 1062, pseudogene	gene	CHEBI:32914	cetylpyridinium	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D002594	Cetylpyridinium results in increased expression of RNU6-1062P	PMID:37149095
10413572	RNU6-37P	RNA, U6 small nuclear 37, pseudogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RNU6-37P mRNA	PMID:35811015
10413572	RNU6-37P	RNA, U6 small nuclear 37, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNU6-37P mRNA	PMID:35811015
10413572	RNU6-37P	RNA, U6 small nuclear 37, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNU6-37P mRNA	PMID:35811015
10413596	RNU6-767P	RNA, U6 small nuclear 767, pseudogene	gene	CHEBI:31264	benzethonium chloride	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D001558	Benzethonium results in decreased expression of RNU6-767P	PMID:37149095
10413596	RNU6-767P	RNA, U6 small nuclear 767, pseudogene	gene	CHEBI:94725	dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D001558	Benzethonium results in decreased expression of RNU6-767P	PMID:37149095
10413600	RN7SKP269	RN7SK pseudogene 269	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RN7SKP269 mRNA	PMID:38218311
10413615	RNU6-301P	RNA, U6 small nuclear 301, pseudogene	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D000431	Ethanol results in decreased expression of RNU6-301P	PMID:37149095
10413615	RNU6-301P	RNA, U6 small nuclear 301, pseudogene	gene	CHEBI:193591	Didecyldimethylammonium	decreases expression	EXP		E	RGD:6480464	20221018	CTD	MESH:C027118	didecyldimethylammonium results in decreased expression of RNU6-301P mRNA	PMID:32763356
10413643	RNU6-998P	RNA, U6 small nuclear 998, pseudogene	gene	CHEBI:24527	herbicide	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D006540	Herbicides results in decreased expression of RNU6-998P mRNA	PMID:28711546
10413643	RNU6-998P	RNA, U6 small nuclear 998, pseudogene	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of RNU6-998P mRNA	PMID:28711546
10413681	CYP4F26P	cytochrome P450 family 4 subfamily F member 26, pseudogene	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of CYP4F26P mRNA	PMID:41028656
10413681	CYP4F26P	cytochrome P450 family 4 subfamily F member 26, pseudogene	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CYP4F26P mRNA	PMID:33212167
10413681	CYP4F26P	cytochrome P450 family 4 subfamily F member 26, pseudogene	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CYP4F26P mRNA	PMID:41028656
10413681	CYP4F26P	cytochrome P450 family 4 subfamily F member 26, pseudogene	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CYP4F26P mRNA	PMID:41028656
10413681	CYP4F26P	cytochrome P450 family 4 subfamily F member 26, pseudogene	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CYP4F26P mRNA	PMID:38832940
10413681	CYP4F26P	cytochrome P450 family 4 subfamily F member 26, pseudogene	gene	CHEBI:44915	propofol	decreases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:D015742	Propofol results in decreased expression of CYP4F26P mRNA	PMID:35238236
10413683	RN7SL788P	RNA, 7SL, cytoplasmic 788, pseudogene	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RN7SL788P mRNA	PMID:38568856
10413686	RN7SKP56	RN7SK pseudogene 56	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of RN7SKP56 mRNA	PMID:28711546
10413688	MTND6P4	MT-ND6 pseudogene 4	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MTND6P4 mRNA	PMID:29301935
10413719	NDUFB4P12	NADH:ubiquinone oxidoreductase subunit B4 pseudogene 12	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NDUFB4P12 mRNA	PMID:29432896
10413733	GK-IT1	GK intronic transcript 1	gene	CHEBI:29191	hydroxyl	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-IT1 mRNA] which results in increased expression of GK mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-IT1 mRNA	PMID:33656867
10413733	GK-IT1	GK intronic transcript 1	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-IT1 mRNA] which results in increased expression of GK mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GK-IT1 mRNA	PMID:33656867
10413740	RNU6-90P	RNA, U6 small nuclear 90, pseudogene	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of RNU6-90P	PMID:37149095
10413753	RNU4-38P	RNA, U4 small nuclear 38, pseudogene	gene	CHEBI:24527	herbicide	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D006540	Herbicides results in increased expression of RNU4-38P mRNA	PMID:28711546
10413753	RNU4-38P	RNA, U4 small nuclear 38, pseudogene	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of RNU4-38P mRNA	PMID:28711546
10413755	RNU6-97P	RNA, U6 small nuclear 97, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNU6-97P mRNA	PMID:38568856
10413773	RNU6-125P	RNA, U6 small nuclear 125, pseudogene	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of RNU6-125P	PMID:37149095
10413788	RNU6-789P	RNA, U6 small nuclear 789, pseudogene	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of RNU6-789P	PMID:37149095
10413805	RN7SKP80	RN7SK pseudogene 80	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RN7SKP80 mRNA	PMID:33212167
10413805	RN7SKP80	RN7SK pseudogene 80	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RN7SKP80 mRNA	PMID:38568856
10413835	RN7SL326P	RNA, 7SL, cytoplasmic 326, pseudogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RN7SL326P mRNA	PMID:35811015
10413835	RN7SL326P	RNA, 7SL, cytoplasmic 326, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of RN7SL326P mRNA]	PMID:35811015
10413835	RN7SL326P	RNA, 7SL, cytoplasmic 326, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of RN7SL326P mRNA]	PMID:35811015
10413839	RN7SL280P	RNA, 7SL, cytoplasmic 280, pseudogene	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of RN7SL280P mRNA	PMID:29301935
10413840	RN7SL124P	RNA, 7SL, cytoplasmic 124, pseudogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RN7SL124P mRNA	PMID:35811015
10413840	RN7SL124P	RNA, 7SL, cytoplasmic 124, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SL124P mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RN7SL124P mRNA	PMID:35811015
10413840	RN7SL124P	RNA, 7SL, cytoplasmic 124, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RN7SL124P mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RN7SL124P mRNA	PMID:35811015
10449059	SMPD5	sphingomyelin phosphodiesterase 5 (pseudogene)	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1642410	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SMPD5 mRNA	PMID:39241906
10449059	SMPD5	sphingomyelin phosphodiesterase 5 (pseudogene)	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:2323312	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SMPD5 mRNA	PMID:33387578
10449059	SMPD5	sphingomyelin phosphodiesterase 5 (pseudogene)	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20151222	CTD	MESH:C005556	propionaldehyde results in decreased expression of SMPD5 mRNA	PMID:26079696
10449059	SMPD5	sphingomyelin phosphodiesterase 5 (pseudogene)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1642410	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SMPD5 mRNA	PMID:34319233
10449059	SMPD5	sphingomyelin phosphodiesterase 5 (pseudogene)	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2323312	E	RGD:6480464	20160112	CTD	MESH:C006780	bisphenol A results in decreased expression of SMPD5 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
10449059	SMPD5	sphingomyelin phosphodiesterase 5 (pseudogene)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1642410	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of SMPD5 promoter	PMID:33297965
10449059	SMPD5	sphingomyelin phosphodiesterase 5 (pseudogene)	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1642410	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SMPD5 mRNA	PMID:38685157
10449059	SMPD5	sphingomyelin phosphodiesterase 5 (pseudogene)	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1642410	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of SMPD5 gene	PMID:38995845
10449059	SMPD5	sphingomyelin phosphodiesterase 5 (pseudogene)	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SMPD5 mRNA	PMID:38568856
10449059	SMPD5	sphingomyelin phosphodiesterase 5 (pseudogene)	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:2323312	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SMPD5 mRNA	PMID:33453195
10449059	SMPD5	sphingomyelin phosphodiesterase 5 (pseudogene)	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1642410	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of SMPD5 mRNA	PMID:28962523
10449059	SMPD5	sphingomyelin phosphodiesterase 5 (pseudogene)	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1642410	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of SMPD5 mRNA	PMID:36851058
10449059	SMPD5	sphingomyelin phosphodiesterase 5 (pseudogene)	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:2323312	E	RGD:6480464	20160112	CTD	MESH:D011441	Propylthiouracil results in increased expression of SMPD5 mRNA	PMID:24780913
10449094	RNA5SP334	RNA, 5S ribosomal pseudogene 334	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RNA5SP334 mRNA	PMID:38568856
10449213	CCDC192	coiled-coil domain containing 192	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1623912	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CCDC192 mRNA	PMID:39241906
10449213	CCDC192	coiled-coil domain containing 192	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1623912	E	RGD:6480464	20200804	CTD	MESH:D004317	Doxorubicin results in increased expression of CCDC192 mRNA	PMID:28608983
10449213	CCDC192	coiled-coil domain containing 192	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CCDC192 mRNA	PMID:33670352
10449213	CCDC192	coiled-coil domain containing 192	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CCDC192 mRNA	PMID:28628672
10449213	CCDC192	coiled-coil domain containing 192	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CCDC192 mRNA	PMID:28628672
10449213	CCDC192	coiled-coil domain containing 192	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CCDC192 mRNA	PMID:28628672
10449213	CCDC192	coiled-coil domain containing 192	gene	CHEBI:52136	glufosinate	decreases expression	ISO	RGD:1623912	E	RGD:6480464	20230905	CTD	MESH:C003121	phosphinothricin results in decreased expression of CCDC192 mRNA	PMID:34597628
10449213	CCDC192	coiled-coil domain containing 192	gene	CHEBI:6651	malathion	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in increased expression of CCDC192 mRNA	PMID:37047231
10449326	TEX13C	TEX13 family member C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of TEX13C protein	PMID:31675489
10449326	TEX13C	TEX13 family member C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1563975	E	RGD:6480464	20230627	CTD	MESH:C006780	bisphenol A results in decreased expression of TEX13C mRNA	PMID:25181051
10449326	TEX13C	TEX13 family member C	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of TEX13C protein	PMID:31675489
10449326	TEX13C	TEX13 family member C	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of TEX13C mRNA	PMID:31675489
10449326	TEX13C	TEX13 family member C	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TEX13C protein	PMID:31675489
10449361	TEX13D	TEX13 family member D	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:2299041	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of TEX13D mRNA	PMID:36189433
10449361	TEX13D	TEX13 family member D	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:2299041	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TEX13D mRNA	PMID:36189433
10449361	TEX13D	TEX13 family member D	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:2299041	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TEX13D mRNA	PMID:36189433
10449361	TEX13D	TEX13 family member D	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:2299041	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TEX13D mRNA	PMID:35436446
10449362	CCDC92B	coiled-coil domain containing 92B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1616364	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CCDC92B mRNA	PMID:33045310
10449362	CCDC92B	coiled-coil domain containing 92B	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1616364	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CCDC92B mRNA	PMID:36189433
10449362	CCDC92B	coiled-coil domain containing 92B	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1616364	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CCDC92B mRNA	PMID:36189433
10449362	CCDC92B	coiled-coil domain containing 92B	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CCDC92B intron	PMID:30157460
10449362	CCDC92B	coiled-coil domain containing 92B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1616364	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC92B mRNA	PMID:34876320
10449362	CCDC92B	coiled-coil domain containing 92B	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1616364	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC92B mRNA	PMID:34876320
10449362	CCDC92B	coiled-coil domain containing 92B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1616364	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CCDC92B mRNA	PMID:35295148
10449362	CCDC92B	coiled-coil domain containing 92B	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1616364	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of CCDC92B mRNA	PMID:28392331
10449362	CCDC92B	coiled-coil domain containing 92B	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1562276	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of CCDC92B mRNA	PMID:32680482
10449362	CCDC92B	coiled-coil domain containing 92B	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1616364	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC92B mRNA	PMID:34876320
10449362	CCDC92B	coiled-coil domain containing 92B	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1616364	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CCDC92B mRNA	PMID:34876320
10450273	NDUFB4P11	NADH:ubiquinone oxidoreductase subunit B4 pseudogene 11	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NDUFB4P11 mRNA	PMID:35811015
10450273	NDUFB4P11	NADH:ubiquinone oxidoreductase subunit B4 pseudogene 11	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NDUFB4P11 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of NDUFB4P11 mRNA	PMID:35811015
10450273	NDUFB4P11	NADH:ubiquinone oxidoreductase subunit B4 pseudogene 11	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NDUFB4P11 mRNA	PMID:33212167
10450273	NDUFB4P11	NADH:ubiquinone oxidoreductase subunit B4 pseudogene 11	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NDUFB4P11 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of NDUFB4P11 mRNA	PMID:35811015
10450277	LAPTM4BP2	lysosomal protein transmembrane 4 beta pseudogene 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of LAPTM4BP2 mRNA	PMID:34032870
10450332	RHOXF1P3	Rhox homeobox family member 1 pseudogene 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RHOXF1P3 mRNA	PMID:38568856
10450345	MTND4P34	MT-ND4 pseudogene 34	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of MTND4P34 mRNA	PMID:41028656
10450345	MTND4P34	MT-ND4 pseudogene 34	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MTND4P34 mRNA	PMID:41028656
10450345	MTND4P34	MT-ND4 pseudogene 34	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MTND4P34 mRNA	PMID:41028656
10450361	NDUFA5P11	NADH:ubiquinone oxidoreductase subunit A5 pseudogene 11	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NDUFA5P11 mRNA	PMID:35811015
10450361	NDUFA5P11	NADH:ubiquinone oxidoreductase subunit A5 pseudogene 11	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NDUFA5P11 mRNA	PMID:35811015
10450374	RNFT1P3	ring finger protein, transmembrane 1 pseudogene 3	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of RNFT1P3 mRNA	PMID:31745603
10450375	MIR3142HG	MIR3142 host gene	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MIR3142HG mRNA	PMID:35811015
10450375	MIR3142HG	MIR3142 host gene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MIR3142HG mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MIR3142HG mRNA	PMID:35811015
10450375	MIR3142HG	MIR3142 host gene	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of MIR3142HG mRNA	PMID:39613055
10450375	MIR3142HG	MIR3142 host gene	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of MIR3142HG mRNA	PMID:39613055
10450375	MIR3142HG	MIR3142 host gene	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MIR3142HG mRNA	PMID:33212167
10450375	MIR3142HG	MIR3142 host gene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of MIR3142HG mRNA	PMID:34032870
10450375	MIR3142HG	MIR3142 host gene	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of MIR3142HG mRNA	PMID:39613055
10450375	MIR3142HG	MIR3142 host gene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MIR3142HG mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MIR3142HG mRNA	PMID:35811015
10450375	MIR3142HG	MIR3142 host gene	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of MIR3142HG mRNA	PMID:35486664
10450389	ODF2-AS1	ODF2 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of ODF2-AS1 mRNA	PMID:34032870
10450394	SLC47A1P1	SLC47A1 pseudogene 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of SLC47A1P1 mRNA	PMID:41028656
10450394	SLC47A1P1	SLC47A1 pseudogene 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SLC47A1P1 mRNA	PMID:41028656
10450394	SLC47A1P1	SLC47A1 pseudogene 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SLC47A1P1 mRNA	PMID:41028656
10450396	MTCO1P12	MT-CO1 pseudogene 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MTCO1P12 mRNA	PMID:30096437
10450396	MTCO1P12	MT-CO1 pseudogene 12	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MTCO1P12 mRNA	PMID:33212167
10450396	MTCO1P12	MT-CO1 pseudogene 12	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MTCO1P12 mRNA	PMID:38568856
10450396	MTCO1P12	MT-CO1 pseudogene 12	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MTCO1P12 mRNA	PMID:33670352
10450396	MTCO1P12	MT-CO1 pseudogene 12	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MTCO1P12 mRNA	PMID:38568856
10450399	NDUFB4P8	NADH:ubiquinone oxidoreductase subunit B4 pseudogene 8	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NDUFB4P8 mRNA	PMID:33212167
10450405	MTCO1P42	MT-CO1 pseudogene 42	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of MTCO1P42 mRNA	PMID:41028656
10450405	MTCO1P42	MT-CO1 pseudogene 42	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MTCO1P42 mRNA	PMID:41028656
10450405	MTCO1P42	MT-CO1 pseudogene 42	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MTCO1P42 mRNA	PMID:41028656
10450416	MTCO2P12	MT-CO2 pseudogene 12	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MTCO2P12 mRNA	PMID:33212167
10450416	MTCO2P12	MT-CO2 pseudogene 12	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MTCO2P12 mRNA	PMID:37939567|PMID:38568856
10450416	MTCO2P12	MT-CO2 pseudogene 12	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of MTCO2P12 mRNA	PMID:31745603
10450416	MTCO2P12	MT-CO2 pseudogene 12	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MTCO2P12 mRNA	PMID:38568856
10450416	MTCO2P12	MT-CO2 pseudogene 12	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MTCO2P12 mRNA	PMID:38568856
10450420	MTCYBP5	MT-CYB pseudogene 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of MTCYBP5 mRNA	PMID:41028656
10450420	MTCYBP5	MT-CYB pseudogene 5	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MTCYBP5 mRNA	PMID:41028656
10450420	MTCYBP5	MT-CYB pseudogene 5	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MTCYBP5 mRNA	PMID:41028656
10450633	RNU6-322P	RNA, U6 small nuclear 322, pseudogene	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNU6-322P mRNA	PMID:33212167
10450643	RN7SL736P	RNA, 7SL, cytoplasmic 736, pseudogene	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of RN7SL736P mRNA	PMID:40706910
10450704	RNU1-70P	RNA, U1 small nuclear 70, pseudogene	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RNU1-70P mRNA	PMID:32234424
10450704	RNU1-70P	RNA, U1 small nuclear 70, pseudogene	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of RNU1-70P mRNA	PMID:32234424
10450710	LINC01077	long independently transcribed non-coding RNA 1077	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01077 mRNA	PMID:35811015
10450710	LINC01077	long independently transcribed non-coding RNA 1077	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01077 mRNA	PMID:35811015
10450713	IQCA1-AS1	IQCA1 antisense RNA 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of IQCA1-AS1 mRNA	PMID:33212167
10755360	SEPTIN14P23	septin 14 pseudogene 23	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SEPTIN14P23 mRNA	PMID:26472689
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of AOX3 mRNA]	PMID:19467301
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AOX3 mRNA	PMID:30529165
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AOX3 mRNA	PMID:36331819
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1622280	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of AOX3 mRNA	PMID:39298647
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D004958	Estradiol results in increased expression of AOX3 mRNA	PMID:19484750
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:16482	naphthalene	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C031721	naphthalene results in decreased expression of AOX3 mRNA	PMID:18757308
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D014241	Trichloroethylene results in decreased expression of AOX3 mRNA	PMID:25549359
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D013739	Testosterone results in increased expression of AOX3 mRNA	PMID:21669218
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D004051	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of AOX3 mRNA	PMID:28433925
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AOX3 mRNA	PMID:36331819
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of AOX3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of AOX3 mRNA	PMID:27106289|PMID:34911549
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:2663	amiodarone	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D000638	Amiodarone results in decreased expression of AOX3 mRNA	PMID:24535564
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AOX3 mRNA	PMID:27339419|PMID:31919559
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D012643	Selenium deficiency results in increased expression of AOX3 mRNA; Selenium results in increased expression of AOX3 mRNA	PMID:16170372
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C024565	ethylene dichloride results in decreased expression of AOX3 mRNA	PMID:28189721|PMID:28960355
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20200211	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of AOX3 mRNA]	PMID:31298478
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AOX3 mRNA	PMID:26377647|PMID:28213091
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AOX3 mRNA; Tetrachlorodibenzodioxin results in increased expression of AOX3 protein	PMID:15664268|PMID:19770486|PMID:19933214
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of AOX3 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to AOX3 gene]; tungstate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AOX3 protein]	PMID:15664268|PMID:28213091|PMID:28433925
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of AOX3 mRNA	PMID:37682722
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AOX3 mRNA	PMID:22228805
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AOX3 mRNA	PMID:19770486|PMID:21569818
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of AOX3 mRNA]	PMID:22228805
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D012834	Silver results in increased expression of AOX3 mRNA	PMID:27131904
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C009495	titanium dioxide results in decreased expression of AOX3 mRNA	PMID:27760801
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1622280	E	RGD:6480464	20200211	CTD	MESH:C009495	titanium dioxide results in increased expression of AOX3 mRNA	PMID:31298478
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20200211	CTD	MESH:C009495	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of AOX3 mRNA]	PMID:31298478
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C006253	pirinixic acid results in decreased expression of AOX3 mRNA	PMID:18445702|PMID:20813756|PMID:23811191
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in decreased expression of AOX3 mRNA	PMID:20813756
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1622280	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of AOX3 mRNA	PMID:30951980
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C006780	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of AOX3 mRNA	PMID:28433925
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C014024	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of AOX3 mRNA	PMID:28433925
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1622280	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of AOX3 mRNA	PMID:30951980|PMID:39298647
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1622280	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of AOX3 mRNA	PMID:30951980
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of AOX3 mRNA	PMID:34813904
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of AOX3 mRNA	PMID:24535843
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in decreased expression of AOX3 protein	PMID:39748354
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of AOX3 mRNA	PMID:28903501|PMID:42178049
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of AOX3 mRNA	PMID:28962523
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D012643	Selenium deficiency results in increased expression of AOX3 mRNA; Selenium results in increased expression of AOX3 mRNA	PMID:16170372
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:38922	dibenzofurans	increases expression	ISO	RGD:1622280	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in increased expression of AOX3 mRNA	PMID:34254344
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AOX3 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AOX3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of AOX3 mRNA	PMID:36331819
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D014635	Valproic Acid results in decreased expression of AOX3 mRNA	PMID:24535564
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D016572	Cyclosporine results in decreased expression of AOX3 mRNA	PMID:19770486
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D000082	Acetaminophen affects the expression of AOX3 mRNA	PMID:17562736
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in decreased expression of AOX3 mRNA	PMID:29246445
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of AOX3 mRNA]	PMID:29246445
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:46502	tungstate	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C045951	tungstate results in decreased expression of AOX3 protein	PMID:15664268
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:46502	tungstate	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C045951	tungstate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of AOX3 protein]	PMID:15664268
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:47032	1,4-dioxane	increases expression	ISO	RGD:1622280	E	RGD:6480464	20211109	CTD	MESH:C025223	1,4-dioxane results in increased expression of AOX3 mRNA	PMID:33693819
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in decreased expression of AOX3 mRNA	PMID:31099283
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C109476	epoxiconazole results in decreased expression of AOX3 mRNA	PMID:22334560
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of AOX3 mRNA; Nanotubes, Carbon results in decreased expression of AOX3 mRNA	PMID:25554681|PMID:25620056
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:6076	itraconazole	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in decreased expression of AOX3 mRNA	PMID:31099283
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:65408	andrographolide	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C030419	[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of AOX3 mRNA	PMID:19737545
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1622280	E	RGD:6480464	20231031	CTD	MESH:C057862	cyanoginosin LR results in increased expression of AOX3 mRNA	PMID:37342990
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D019324	[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of AOX3 mRNA	PMID:19737545
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D010634	Phenobarbital affects the expression of AOX3 mRNA	PMID:23091169
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D010695	Phlorhizin results in decreased expression of AOX3 mRNA	PMID:22538082
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1622280	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of AOX3 mRNA	PMID:38648751
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C093628	cyproconazole results in decreased expression of AOX3 mRNA	PMID:22334560
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:81760	difenoconazole	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20230905	CTD	MESH:C115058	difenoconazole results in decreased expression of AOX3 mRNA	PMID:34425431
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:C045950	propiconazole results in decreased expression of AOX3 mRNA	PMID:21278054|PMID:22334560
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1622280	E	RGD:6480464	20180424	CTD	MESH:D012834	Silver results in increased expression of AOX3 mRNA	PMID:27131904
10755376	AOX3P	aldehyde oxidase 3, pseudogene	gene	CHEBI:94366	2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one	decreases expression	ISO	RGD:1622280	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in decreased expression of AOX3 mRNA	PMID:31099283
10755390	CYP4F60P	cytochrome P450 family 4 subfamily F member 60, pseudogene	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CYP4F60P mRNA	PMID:33212167
10755394	SEPTIN14P20	septin 14 pseudogene 20	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SEPTIN14P20 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of SEPTIN14P20 mRNA	PMID:39836092
10755394	SEPTIN14P20	septin 14 pseudogene 20	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SEPTIN14P20 mRNA	PMID:39836092
10755394	SEPTIN14P20	septin 14 pseudogene 20	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SEPTIN14P20 mRNA	PMID:27392435
10755394	SEPTIN14P20	septin 14 pseudogene 20	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D019344	Lactic Acid results in increased expression of SEPTIN14P20 mRNA	PMID:30851411
10755394	SEPTIN14P20	septin 14 pseudogene 20	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SEPTIN14P20 mRNA	PMID:39836092
10755394	SEPTIN14P20	septin 14 pseudogene 20	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SEPTIN14P20 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of SEPTIN14P20 mRNA	PMID:39836092
10755394	SEPTIN14P20	septin 14 pseudogene 20	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SEPTIN14P20 mRNA	PMID:39836092
10755394	SEPTIN14P20	septin 14 pseudogene 20	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C082360	fipronil results in increased expression of SEPTIN14P20 mRNA	PMID:28991164
10755394	SEPTIN14P20	septin 14 pseudogene 20	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of SEPTIN14P20 mRNA	PMID:31629900
10755394	SEPTIN14P20	septin 14 pseudogene 20	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SEPTIN14P20 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of SEPTIN14P20 mRNA	PMID:39836092
10755394	SEPTIN14P20	septin 14 pseudogene 20	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D019344	Lactic Acid results in increased expression of SEPTIN14P20 mRNA	PMID:30851411
10755591	UPK3BP1	uroplakin 3B pseudogene 1	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of UPK3BP1 mRNA	PMID:37690743
10755593	PDZPH1P	PDZ and pleckstrin homology domains 1, pseudogene	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1560925	E	RGD:6480464	20220510	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PDZPH1 mRNA]	PMID:31150632
10755593	PDZPH1P	PDZ and pleckstrin homology domains 1, pseudogene	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1621522	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PDZPH1 mRNA	PMID:30319688
10755593	PDZPH1P	PDZ and pleckstrin homology domains 1, pseudogene	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1560925	E	RGD:6480464	20220510	CTD	MESH:D014241	Trichloroethylene results in increased expression of PDZPH1 mRNA	PMID:33387578
10755593	PDZPH1P	PDZ and pleckstrin homology domains 1, pseudogene	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1560925	E	RGD:6480464	20220510	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PDZPH1 mRNA	PMID:31150632
10755593	PDZPH1P	PDZ and pleckstrin homology domains 1, pseudogene	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1560925	E	RGD:6480464	20220510	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PDZPH1 mRNA]	PMID:31150632
10755593	PDZPH1P	PDZ and pleckstrin homology domains 1, pseudogene	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1621522	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PDZPH1 mRNA	PMID:32186404
10755593	PDZPH1P	PDZ and pleckstrin homology domains 1, pseudogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1560925	E	RGD:6480464	20220510	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PDZPH1 mRNA	PMID:20059583
10755593	PDZPH1P	PDZ and pleckstrin homology domains 1, pseudogene	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1560925	E	RGD:6480464	20220510	CTD	MESH:C030110	Oxaliplatin results in increased expression of PDZPH1 mRNA	PMID:25729387
10755593	PDZPH1P	PDZ and pleckstrin homology domains 1, pseudogene	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1560925	E	RGD:6480464	20220510	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in increased expression of PDZPH1 mRNA	PMID:25729387
10755593	PDZPH1P	PDZ and pleckstrin homology domains 1, pseudogene	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1560925	E	RGD:6480464	20220510	CTD	MESH:C006780	bisphenol A results in decreased expression of PDZPH1 mRNA	PMID:25181051
10755593	PDZPH1P	PDZ and pleckstrin homology domains 1, pseudogene	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1621522	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PDZPH1 exon; butylbenzyl phthalate results in increased methylation of PDZPH1 intron	PMID:28392331
10755593	PDZPH1P	PDZ and pleckstrin homology domains 1, pseudogene	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1560925	E	RGD:6480464	20220510	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in increased expression of PDZPH1 mRNA	PMID:25729387
10755593	PDZPH1P	PDZ and pleckstrin homology domains 1, pseudogene	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1560925	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PDZPH1 gene	PMID:35440735
10755662	SMURF2P1	SMAD specific E3 ubiquitin protein ligase 2 pseudogene 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SMURF2P1 mRNA	PMID:33212167
10755670	CDK2AP2P2	cyclin dependent kinase 2 associated protein 2 pseudogene 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CDK2AP2P2 mRNA	PMID:35811015
10755670	CDK2AP2P2	cyclin dependent kinase 2 associated protein 2 pseudogene 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CDK2AP2P2 mRNA	PMID:35811015
10768917	GTF2IP7	general transcription factor IIi pseudogene 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GTF2IP7 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of GTF2IP7 mRNA	PMID:35811015
10768917	GTF2IP7	general transcription factor IIi pseudogene 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of GTF2IP7 mRNA	PMID:35811015
10768917	GTF2IP7	general transcription factor IIi pseudogene 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GTF2IP7 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of GTF2IP7 mRNA	PMID:35811015
10769049	GTF2IP12	general transcription factor IIi pseudogene 12	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of GTF2IP12 mRNA	PMID:32763439
10769213	GTF2IP13	general transcription factor IIi pseudogene 13	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of GTF2IP13 mRNA	PMID:33212167
10769213	GTF2IP13	general transcription factor IIi pseudogene 13	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GTF2IP13 mRNA	PMID:38568856
10769319	CLEC12A-AS1	CLEC12A antisense RNA 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CLEC12A-AS1 mRNA	PMID:32763439
11038749	LINC01460	long independently transcribed non-coding RNA 1460	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC01460 mRNA	PMID:33212167
11038760	NOC2LP1	NOC2 like nucleolar associated transcriptional repressor pseudogene 1	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of NOC2LP1 mRNA	PMID:37690743
11038760	NOC2LP1	NOC2 like nucleolar associated transcriptional repressor pseudogene 1	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of NOC2LP1 mRNA	PMID:36318118
11039061	LINC00863	long independently transcribed non-coding RNA 863	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of LINC00863 mRNA	PMID:31614463
11039061	LINC00863	long independently transcribed non-coding RNA 863	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of LINC00863 mRNA	PMID:38568856
11039061	LINC00863	long independently transcribed non-coding RNA 863	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC00863 mRNA	PMID:33212167
11039061	LINC00863	long independently transcribed non-coding RNA 863	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LINC00863 gene	PMID:29154799
11039061	LINC00863	long independently transcribed non-coding RNA 863	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in increased expression of LINC00863 mRNA	PMID:28991164
11039061	LINC00863	long independently transcribed non-coding RNA 863	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in increased expression of LINC00863 mRNA	PMID:28991164
11039065	LINC00543	long independently transcribed non-coding RNA 543	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC00543 promoter	PMID:30157460
11039065	LINC00543	long independently transcribed non-coding RNA 543	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC00543 mRNA	PMID:29301061
11039065	LINC00543	long independently transcribed non-coding RNA 543	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC00543 mRNA	PMID:32234424
11039065	LINC00543	long independently transcribed non-coding RNA 543	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC00543 mRNA	PMID:38832940
11039094	LINC01451	long independently transcribed non-coding RNA 1451	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC01451 mRNA	PMID:30851411
11039094	LINC01451	long independently transcribed non-coding RNA 1451	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC01451 mRNA	PMID:30851411
11039105	LINC01376	long independently transcribed non-coding RNA 1376	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC01376 mRNA	PMID:30851411
11039105	LINC01376	long independently transcribed non-coding RNA 1376	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01376 mRNA	PMID:29301061|PMID:34032870
11039105	LINC01376	long independently transcribed non-coding RNA 1376	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01376 mRNA	PMID:38568856
11039105	LINC01376	long independently transcribed non-coding RNA 1376	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01376 mRNA	PMID:38832940
11039105	LINC01376	long independently transcribed non-coding RNA 1376	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC01376 mRNA	PMID:30851411
11039126	CASC22	cancer susceptibility 22	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of CASC22 mRNA	PMID:29301061
11039174	SEMA3F-AS1	SEMA3F antisense RNA 1	gene	CHEBI:28077	rifampicin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in decreased expression of SEMA3F-AS1 mRNA	PMID:24552687
11039187	BFSP2-AS1	BFSP2 antisense RNA 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of BFSP2-AS1 promoter	PMID:30157460
11039187	BFSP2-AS1	BFSP2 antisense RNA 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of BFSP2-AS1 mRNA	PMID:24449571
11039187	BFSP2-AS1	BFSP2 antisense RNA 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20160308	CTD	MESH:D008727	Methotrexate results in increased expression of BFSP2-AS1 mRNA	PMID:24449571
11039274	GCC2-AS1	GCC2 antisense RNA 1	gene	CHEBI:29191	hydroxyl	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mRNA] which results in increased expression of GCC2 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mRNA	PMID:33656867
11039274	GCC2-AS1	GCC2 antisense RNA 1	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mRNA] which results in increased expression of GCC2 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of GCC2-AS1 mRNA	PMID:33656867
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550275	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CYP2C23 mRNA	PMID:33045310
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of CYP2C23 mRNA]	PMID:19467301
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CYP2C23 mRNA	PMID:36331819
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:15843	arachidonic acid	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D016718	CYP2C23 mRNA promotes the reaction [[Arachidonic Acid co-treated with VEGFA protein] results in increased phosphorylation of MAPK1 protein]; CYP2C23 mRNA promotes the reaction [[Arachidonic Acid co-treated with VEGFA protein] results in increased phosphorylation of MAPK3 protein]; CYP2C23 mRNA promotes the reaction [Arachidonic Acid results in increased phosphorylation of MAPK1 protein]; CYP2C23 mRNA promotes the reaction [Arachidonic Acid results in increased phosphorylation of MAPK3 protein]	PMID:19464254
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CYP2C23 mRNA	PMID:39298647
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP2C23 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP2C23 mRNA	PMID:37992649
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:17241	1H-pyrazole	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:C031280	pyrazole results in decreased expression of CYP2C23 mRNA	PMID:17945193
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1550275	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of CYP2C23 mRNA	PMID:28973375
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP2C23 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP2C23 mRNA	PMID:37992649
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1550275	E	RGD:6480464	20180828	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CYP2C23 mRNA	PMID:29627306
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP2C23 mRNA	PMID:29950665
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CYP2C23 mRNA	PMID:19770486
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CYP2C23 mRNA	PMID:27339419|PMID:31919559
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP2C23 mRNA]	PMID:37992649
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20200211	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CYP2C23 mRNA]	PMID:31298478
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:27999	tolbutamide	increases metabolic processing	ISO	RGD:1550275	E	RGD:6480464	20190409	CTD	MESH:D014044	CYP2C23 protein results in increased metabolism of Tolbutamide	PMID:30503582
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:27999	tolbutamide	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20190409	CTD	MESH:D014044	[CYP2C23 protein results in increased metabolism of Tolbutamide] which results in increased chemical synthesis of 4'-hydroxytolbutamide	PMID:30503582
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D014640	Vancomycin results in increased expression of CYP2C23 mRNA	PMID:18930951
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CYP2C23 mRNA	PMID:26377647
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CYP2C23 mRNA	PMID:28213091
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP2C23 gene]	PMID:28213091
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D004317	Doxorubicin results in increased expression of CYP2C23 mRNA	PMID:26873546
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D004317	[Doxorubicin co-treated with Dexrazoxane] results in decreased expression of CYP2C23 mRNA	PMID:26873546
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP2C23 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP2C23 mRNA	PMID:37992649
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP2C23 mRNA]	PMID:37992649
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CYP2C23 mRNA	PMID:23221170
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20251007	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CYP2C23 mRNA	PMID:38758479
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20200211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CYP2C23 mRNA	PMID:31298478
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP2C23 mRNA; Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CYP2C23 mRNA]	PMID:29950665|PMID:31298478
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:C006253	pirinixic acid results in decreased expression of CYP2C23 mRNA; pirinixic acid results in decreased expression of CYP2C23 protein	PMID:17405874|PMID:20813756|PMID:23811191
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:C006253	pirinixic acid results in increased expression of CYP2C23 mRNA	PMID:17426115
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in decreased expression of CYP2C23 mRNA; PPARA protein affects the reaction [pirinixic acid results in decreased expression of CYP2C23 mRNA]	PMID:17405874|PMID:20813756
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CYP2C23 mRNA	PMID:33221593
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550275	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CYP2C23 mRNA	PMID:32156529
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CYP2C23 mRNA	PMID:39298647|PMID:40203079
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP2C23 mRNA	PMID:29950665
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:35459	diisononyl phthalate	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20250204	CTD	MESH:C012125	diisononyl phthalate results in decreased expression of CYP2C23 mRNA	PMID:33391822
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of CYP2C23 mRNA	PMID:27413110
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CYP2C23 mRNA	PMID:36331819
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of CYP2C23 mRNA	PMID:29038090
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D013629	Tamoxifen results in decreased expression of CYP2C23 mRNA	PMID:25123088
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP2C23 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP2C23 mRNA	PMID:37992649
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D000082	Acetaminophen affects the expression of CYP2C23 mRNA	PMID:17562736
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in decreased expression of CYP2C23 mRNA	PMID:29246445
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of CYP2C23 mRNA]	PMID:29246445
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in decreased expression of CYP2C23 mRNA	PMID:26934552
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20251007	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CYP2C23 mRNA	PMID:38758479
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:50223	(+)-dexrazoxane	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D064730	[Doxorubicin co-treated with Dexrazoxane] results in decreased expression of CYP2C23 mRNA	PMID:26873546
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CYP2C23 mRNA	PMID:25620056
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:63618	pravastatin	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of CYP2C23 mRNA	PMID:27225895
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:63799	4-hydroxytolbutamide	multiple interactions	ISO	RGD:1550275	E	RGD:6480464	20190409	CTD	MESH:C031014	[CYP2C23 protein results in increased metabolism of Tolbutamide] which results in increased chemical synthesis of 4'-hydroxytolbutamide	PMID:30503582
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CYP2C23 mRNA	PMID:22206623
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1550275	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of CYP2C23 mRNA	PMID:27225895
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550275	E	RGD:6480464	20171212	CTD	MESH:D010634	Phenobarbital affects the expression of CYP2C23 mRNA	PMID:23091169
11041837	CYP2C23P	cytochrome P450 family 2 subfamily C member 23, pseudogene	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550275	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CYP2C23 mRNA	PMID:38648751
11052114	LY6L	lymphocyte antigen 6 family member L	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1597652	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY6L mRNA	PMID:32741896
11052114	LY6L	lymphocyte antigen 6 family member L	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1597652	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY6L mRNA	PMID:32741896
11052114	LY6L	lymphocyte antigen 6 family member L	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1597652	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of LY6L mRNA	PMID:27523638
11052114	LY6L	lymphocyte antigen 6 family member L	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1597652	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of LY6L mRNA	PMID:32680482
11052114	LY6L	lymphocyte antigen 6 family member L	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1597652	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LY6L mRNA	PMID:32741896
11081057	ATXN2-AS	ATXN2 antisense RNA	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATXN2-AS mRNA	PMID:32234424
11084732	LINC01630	long independently transcribed non-coding RNA 1630	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01630 mRNA	PMID:38568856
11084732	LINC01630	long independently transcribed non-coding RNA 1630	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC01630 mRNA	PMID:32234424
11084732	LINC01630	long independently transcribed non-coding RNA 1630	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LINC01630 gene	PMID:31601247
11084732	LINC01630	long independently transcribed non-coding RNA 1630	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LINC01630 gene	PMID:31601247
11084732	LINC01630	long independently transcribed non-coding RNA 1630	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01630 mRNA	PMID:38832940
11084743	LINC01931	long independently transcribed non-coding RNA 1931	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01931 mRNA	PMID:34032870
11084743	LINC01931	long independently transcribed non-coding RNA 1931	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01931 mRNA	PMID:29301061
11084743	LINC01931	long independently transcribed non-coding RNA 1931	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC01931 mRNA	PMID:35811015
11084824	LIPC-AS1	LIPC antisense RNA 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LIPC-AS1 intron	PMID:30157460
11084824	LIPC-AS1	LIPC antisense RNA 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LIPC-AS1 intron	PMID:30157460
11120594	OSTM1-AS1	OSTM1 antisense RNA 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of OSTM1-AS1 intron	PMID:30157460
11231739	GASAL1	growth arrest associated lncRNA 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of GASAL1 mRNA	PMID:38218311
11231739	GASAL1	growth arrest associated lncRNA 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of GASAL1 mRNA	PMID:33212167
11231739	GASAL1	growth arrest associated lncRNA 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of GASAL1 mRNA	PMID:34032870
11324	TAGLN	transgelin	gene	CHEBI:10033	warfarin	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20141111	CTD	MESH:D014859	[Warfarin co-treated with Vitamin K 1] results in decreased expression of TAGLN mRNA	PMID:23990204
11324	TAGLN	transgelin	gene	CHEBI:10033	warfarin	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20170725	CTD	MESH:D014859	[Warfarin co-treated with Vitamin K co-treated with Quercetin] results in increased expression of TAGLN mRNA	PMID:23117658
11324	TAGLN	transgelin	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TAGLN mRNA	PMID:38218311
11324	TAGLN	transgelin	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:3723	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of TAGLN mRNA	PMID:21551480
11324	TAGLN	transgelin	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:3723	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of TAGLN mRNA	PMID:21551480
11324	TAGLN	transgelin	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of TAGLN mRNA	PMID:26272509
11324	TAGLN	transgelin	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAGLN mRNA	PMID:27188386
11324	TAGLN	transgelin	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:11323	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TAGLN mRNA	PMID:33045310
11324	TAGLN	transgelin	gene	CHEBI:135357	zimeldine	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015031	Zimeldine results in decreased expression of TAGLN mRNA	PMID:15342952|PMID:17175557
11324	TAGLN	transgelin	gene	CHEBI:136608	Theaflavin 3,3'-digallate	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate inhibits the reaction [PDGFBB protein results in decreased expression of TAGLN protein]	PMID:35903325
11324	TAGLN	transgelin	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TAGLN mRNA	PMID:20938992
11324	TAGLN	transgelin	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin affects the expression of TAGLN mRNA	PMID:15498508
11324	TAGLN	transgelin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of TAGLN mRNA	PMID:17069765
11324	TAGLN	transgelin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:3723	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of TAGLN mRNA; Tretinoin results in increased expression of TAGLN protein	PMID:17151820
11324	TAGLN	transgelin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of TAGLN protein	PMID:39571964
11324	TAGLN	transgelin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of TAGLN mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of TAGLN mRNA	PMID:30951980
11324	TAGLN	transgelin	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TAGLN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TAGLN mRNA	PMID:32699268
11324	TAGLN	transgelin	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20140408	CTD	MESH:D010100	Oxygen deficiency inhibits the reaction [darinaparsin results in increased expression of TAGLN mRNA]	PMID:22535156
11324	TAGLN	transgelin	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TAGLN mRNA	PMID:26079696
11324	TAGLN	transgelin	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:11323	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of TAGLN mRNA	PMID:40945087
11324	TAGLN	transgelin	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D000431	Ethanol results in decreased expression of TAGLN mRNA	PMID:31059573
11324	TAGLN	transgelin	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TAGLN mRNA	PMID:29432896
11324	TAGLN	transgelin	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of TAGLN mRNA	PMID:32949572|PMID:39709020
11324	TAGLN	transgelin	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TAGLN mRNA	PMID:21632981
11324	TAGLN	transgelin	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:3723	E	RGD:6480464	20170725	CTD	MESH:D011794	Quercetin results in increased expression of TAGLN mRNA	PMID:23117658
11324	TAGLN	transgelin	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20170725	CTD	MESH:D011794	[Warfarin co-treated with Vitamin K co-treated with Quercetin] results in increased expression of TAGLN mRNA	PMID:23117658
11324	TAGLN	transgelin	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of TAGLN mRNA	PMID:30510588
11324	TAGLN	transgelin	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of TAGLN mRNA	PMID:22574217
11324	TAGLN	transgelin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:11323	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TAGLN mRNA; Estradiol results in decreased expression of TAGLN protein	PMID:26903627|PMID:39298647
11324	TAGLN	transgelin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:3723	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of TAGLN mRNA	PMID:32145629
11324	TAGLN	transgelin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of TAGLN mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of TAGLN mRNA	PMID:20823114|PMID:30165855
11324	TAGLN	transgelin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of TAGLN mRNA	PMID:26496021
11324	TAGLN	transgelin	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:3723	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TAGLN mRNA	PMID:33387578
11324	TAGLN	transgelin	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TAGLN mRNA	PMID:20938992
11324	TAGLN	transgelin	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of TAGLN mRNA	PMID:27664576
11324	TAGLN	transgelin	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of TAGLN mRNA	PMID:18037150
11324	TAGLN	transgelin	gene	CHEBI:17234	glucose	increases secretion	EXP		E	RGD:6480464	20160822	CTD	MESH:D005947	Glucose deficiency results in increased secretion of TAGLN protein	PMID:24802182
11324	TAGLN	transgelin	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:3723	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of TAGLN mRNA	PMID:22967744
11324	TAGLN	transgelin	gene	CHEBI:17634	D-glucose	increases secretion	EXP		E	RGD:6480464	20160822	CTD	MESH:D005947	Glucose deficiency results in increased secretion of TAGLN protein	PMID:24802182
11324	TAGLN	transgelin	gene	CHEBI:177387	brequinar	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C046943	brequinar results in decreased expression of TAGLN mRNA	PMID:39900124
11324	TAGLN	transgelin	gene	CHEBI:177387	brequinar	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C046943	brequinar results in increased expression of TAGLN mRNA	PMID:39900124
11324	TAGLN	transgelin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TAGLN mRNA	PMID:31163220
11324	TAGLN	transgelin	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:3723	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TAGLN mRNA	PMID:26577399
11324	TAGLN	transgelin	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:3723	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TAGLN mRNA	PMID:33387578
11324	TAGLN	transgelin	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TAGLN mRNA	PMID:28818685
11324	TAGLN	transgelin	gene	CHEBI:18067	phylloquinone	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20140408	CTD	MESH:D010837	[Warfarin co-treated with Vitamin K 1] results in decreased expression of TAGLN mRNA	PMID:23990204
11324	TAGLN	transgelin	gene	CHEBI:18088	formononetin	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C007768	formononetin results in decreased expression of TAGLN mRNA	PMID:37793997
11324	TAGLN	transgelin	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAGLN mRNA	PMID:39836092
11324	TAGLN	transgelin	gene	CHEBI:188851	Muraglitazar	decreases expression	ISO	RGD:3723	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of TAGLN mRNA	PMID:21515302
11324	TAGLN	transgelin	gene	CHEBI:193591	Didecyldimethylammonium	decreases expression	EXP		E	RGD:6480464	20221018	CTD	MESH:C027118	didecyldimethylammonium results in decreased expression of TAGLN mRNA	PMID:32763356
11324	TAGLN	transgelin	gene	CHEBI:207229	dihydroartemisinin	affects binding	EXP		E	RGD:6480464	20170303	CTD	MESH:C039060	artenimol analog binds to TAGLN protein	PMID:26340163
11324	TAGLN	transgelin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TAGLN mRNA	PMID:37325564
11324	TAGLN	transgelin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TAGLN mRNA	PMID:39012411
11324	TAGLN	transgelin	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TAGLN mRNA	PMID:19549813
11324	TAGLN	transgelin	gene	CHEBI:23808	dimethylarsinous acid	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C472511	dimethylarsinous acid results in increased expression of TAGLN mRNA	PMID:23876855
11324	TAGLN	transgelin	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TAGLN mRNA	PMID:27153756
11324	TAGLN	transgelin	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D009151	Mustard Gas results in decreased expression of TAGLN mRNA	PMID:33491125
11324	TAGLN	transgelin	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20120918	CTD	MESH:D015127	[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of TAGLN protein	PMID:22248470
11324	TAGLN	transgelin	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TAGLN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TAGLN mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TAGLN mRNA	PMID:32699268
11324	TAGLN	transgelin	gene	CHEBI:2663	amiodarone	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D000638	Amiodarone results in decreased expression of TAGLN mRNA	PMID:17175557|PMID:17567588
11324	TAGLN	transgelin	gene	CHEBI:2666	amitriptyline	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D000639	Amitriptyline results in decreased expression of TAGLN mRNA	PMID:15342952|PMID:17175557|PMID:17567588
11324	TAGLN	transgelin	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of TAGLN protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of TAGLN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of TAGLN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of TAGLN protein	PMID:38598786
11324	TAGLN	transgelin	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:3723	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of TAGLN mRNA	PMID:30779732
11324	TAGLN	transgelin	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:11323	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TAGLN mRNA	PMID:31919559
11324	TAGLN	transgelin	gene	CHEBI:27470	folic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid affects the expression of TAGLN mRNA	PMID:17320366
11324	TAGLN	transgelin	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TAGLN mRNA	PMID:27293554
11324	TAGLN	transgelin	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:11323	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TAGLN mRNA	PMID:25629700
11324	TAGLN	transgelin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TAGLN mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TAGLN mRNA	PMID:20938992|PMID:22206623
11324	TAGLN	transgelin	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of TAGLN mRNA	PMID:18414638
11324	TAGLN	transgelin	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAGLN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAGLN mRNA	PMID:39836092
11324	TAGLN	transgelin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAGLN mRNA	PMID:40504410
11324	TAGLN	transgelin	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of TAGLN mRNA	PMID:33512557
11324	TAGLN	transgelin	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of TAGLN mRNA	PMID:26272509
11324	TAGLN	transgelin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAGLN mRNA	PMID:27188386
11324	TAGLN	transgelin	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of TAGLN protein	PMID:35688186
11324	TAGLN	transgelin	gene	CHEBI:27810	resorcinol	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in decreased expression of TAGLN mRNA	PMID:22623647
11324	TAGLN	transgelin	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:3723	E	RGD:6480464	20120918	CTD	MESH:C059514	resveratrol results in decreased expression of TAGLN mRNA	PMID:20797428
11324	TAGLN	transgelin	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of TAGLN mRNA	PMID:23300844
11324	TAGLN	transgelin	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TAGLN mRNA	PMID:27392435
11324	TAGLN	transgelin	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:3723	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of TAGLN protein	PMID:22023808
11324	TAGLN	transgelin	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of TAGLN mRNA	PMID:27392435
11324	TAGLN	transgelin	gene	CHEBI:27902	tetracycline	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013752	Tetracycline results in decreased expression of TAGLN mRNA	PMID:17175557
11324	TAGLN	transgelin	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:11323	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of TAGLN mRNA	PMID:18930951
11324	TAGLN	transgelin	gene	CHEBI:28088	genistein	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein affects the expression of TAGLN mRNA	PMID:26865667
11324	TAGLN	transgelin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:3723	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TAGLN mRNA	PMID:22298810|PMID:34747641
11324	TAGLN	transgelin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:3723	E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TAGLN mRNA	PMID:19692669|PMID:21724226|PMID:32109520
11324	TAGLN	transgelin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:11323	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TAGLN mRNA	PMID:26290441
11324	TAGLN	transgelin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:3723	E	RGD:6480464	20130122	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TAGLN mRNA	PMID:20959002|PMID:33387578
11324	TAGLN	transgelin	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of TAGLN mRNA	PMID:33512557
11324	TAGLN	transgelin	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TAGLN mRNA	PMID:34089799
11324	TAGLN	transgelin	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TAGLN mRNA	PMID:23179753|PMID:26272509|PMID:28001369
11324	TAGLN	transgelin	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAGLN mRNA	PMID:27188386
11324	TAGLN	transgelin	gene	CHEBI:28384	vitamin K	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20170725	CTD	MESH:D014812	[Warfarin co-treated with Vitamin K co-treated with Quercetin] results in increased expression of TAGLN mRNA	PMID:23117658
11324	TAGLN	transgelin	gene	CHEBI:28593	quinidine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011802	Quinidine results in decreased expression of TAGLN mRNA	PMID:17567588
11324	TAGLN	transgelin	gene	CHEBI:28680	cytarabine	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of TAGLN mRNA	PMID:21198554
11324	TAGLN	transgelin	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TAGLN mRNA	PMID:20971185
11324	TAGLN	transgelin	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of TAGLN protein	PMID:29385562
11324	TAGLN	transgelin	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:11323	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin affects the expression of TAGLN mRNA	PMID:15033991
11324	TAGLN	transgelin	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TAGLN mRNA	PMID:29803840
11324	TAGLN	transgelin	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of TAGLN mRNA	PMID:15870702
11324	TAGLN	transgelin	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TAGLN mRNA	PMID:29432896
11324	TAGLN	transgelin	gene	CHEBI:28971	ampicillin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000667	Ampicillin results in increased expression of TAGLN mRNA	PMID:21632981
11324	TAGLN	transgelin	gene	CHEBI:29073	L-ascorbic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D001205	Ascorbic Acid results in increased expression of TAGLN mRNA	PMID:18607632
11324	TAGLN	transgelin	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D001205	[Ascorbic Acid co-treated with TGFB1 protein] results in increased expression of TAGLN mRNA	PMID:18607632
11324	TAGLN	transgelin	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of TAGLN mRNA	PMID:36057382
11324	TAGLN	transgelin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TAGLN mRNA	PMID:22714537|PMID:34032870
11324	TAGLN	transgelin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:11323	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TAGLN protein	PMID:26135927
11324	TAGLN	transgelin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:3723	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of TAGLN protein	PMID:29459688
11324	TAGLN	transgelin	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of TAGLN mRNA	PMID:12634122|PMID:38568856
11324	TAGLN	transgelin	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAGLN mRNA; [sodium arsenite co-treated with Tretinoin] results in increased expression of TAGLN protein; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAGLN mRNA	PMID:39571964|PMID:39836092
11324	TAGLN	transgelin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAGLN mRNA	PMID:40504410
11324	TAGLN	transgelin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TAGLN mRNA	PMID:20106945|PMID:21632981
11324	TAGLN	transgelin	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TAGLN 5' UTR; Benzo(a)pyrene results in decreased methylation of TAGLN promoter	PMID:27901495
11324	TAGLN	transgelin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:11323	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAGLN mRNA	PMID:22228805
11324	TAGLN	transgelin	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:11323	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of TAGLN protein	PMID:37955338
11324	TAGLN	transgelin	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of TAGLN mRNA	PMID:36057382
11324	TAGLN	transgelin	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TAGLN mRNA	PMID:20971185
11324	TAGLN	transgelin	gene	CHEBI:30145	lithium atom	increases expression	ISO	RGD:11323	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in increased expression of TAGLN protein	PMID:40770094
11324	TAGLN	transgelin	gene	CHEBI:30146	lithium hydride	increases expression	ISO	RGD:11323	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in increased expression of TAGLN protein	PMID:40770094
11324	TAGLN	transgelin	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:11323	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TAGLN mRNA	PMID:27131904
11324	TAGLN	transgelin	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of TAGLN mRNA	PMID:28959546
11324	TAGLN	transgelin	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TAGLN mRNA	PMID:25895662
11324	TAGLN	transgelin	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:11323	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TAGLN mRNA	PMID:23221170
11324	TAGLN	transgelin	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TAGLN protein	PMID:39059093
11324	TAGLN	transgelin	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:3723	E	RGD:6480464	20251007	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TAGLN protein	PMID:39059093
11324	TAGLN	transgelin	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to TAGLN protein]; Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein]]	PMID:26598702|PMID:39059093
11324	TAGLN	transgelin	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20251007	CTD	MESH:C006632	Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein]	PMID:39059093
11324	TAGLN	transgelin	gene	CHEBI:30703	tetrathiomolybdate(2-)	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C020809	tetrathiomolybdate results in increased expression of TAGLN mRNA	PMID:37290678
11324	TAGLN	transgelin	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:3723	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of TAGLN mRNA	PMID:16483693
11324	TAGLN	transgelin	gene	CHEBI:3139	bleomycin A2	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:D001761	Bleomycin results in decreased expression of TAGLN mRNA	PMID:40645554
11324	TAGLN	transgelin	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:3723	E	RGD:6480464	20151215	CTD	MESH:D001761	Bleomycin results in increased expression of TAGLN protein	PMID:25933445
11324	TAGLN	transgelin	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of TAGLN mRNA	PMID:38568856
11324	TAGLN	transgelin	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:3723	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of TAGLN mRNA	PMID:22641619
11324	TAGLN	transgelin	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:3723	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of TAGLN mRNA	PMID:25729387
11324	TAGLN	transgelin	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of TAGLN mRNA	PMID:25729387
11324	TAGLN	transgelin	gene	CHEBI:32181	tamibarotene	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of TAGLN mRNA	PMID:15498508
11324	TAGLN	transgelin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:11323	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of TAGLN mRNA	PMID:23557971
11324	TAGLN	transgelin	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:3723	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TAGLN mRNA	PMID:34492290
11324	TAGLN	transgelin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:11323	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of TAGLN mRNA	PMID:18648102
11324	TAGLN	transgelin	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:11323	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TAGLN mRNA	PMID:23811191
11324	TAGLN	transgelin	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of TAGLN mRNA	PMID:38479592
11324	TAGLN	transgelin	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:3723	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TAGLN mRNA	PMID:25181051
11324	TAGLN	transgelin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TAGLN mRNA; bisphenol A results in decreased expression of TAGLN protein	PMID:29275510|PMID:29718440|PMID:31675489
11324	TAGLN	transgelin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:11323	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of TAGLN mRNA	PMID:37105096
11324	TAGLN	transgelin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of TAGLN protein	PMID:34186270|PMID:37567409
11324	TAGLN	transgelin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:11323	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TAGLN mRNA	PMID:30951980
11324	TAGLN	transgelin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:3723	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of TAGLN mRNA	PMID:12075121|PMID:32145629
11324	TAGLN	transgelin	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:3723	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TAGLN gene	PMID:28505145
11324	TAGLN	transgelin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of TAGLN mRNA; [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of TAGLN protein	PMID:30951980|PMID:35999755
11324	TAGLN	transgelin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of TAGLN mRNA	PMID:26496021
11324	TAGLN	transgelin	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of TAGLN protein	PMID:31675489
11324	TAGLN	transgelin	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of TAGLN mRNA	PMID:19244175
11324	TAGLN	transgelin	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TAGLN mRNA	PMID:25979313
11324	TAGLN	transgelin	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of TAGLN mRNA	PMID:19041380
11324	TAGLN	transgelin	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	TAGLN mRNA affects the susceptibility to Carmustine	PMID:16365179
11324	TAGLN	transgelin	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:3723	E	RGD:6480464	20120501	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TAGLN mRNA	PMID:19692669
11324	TAGLN	transgelin	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:3723	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TAGLN mRNA	PMID:23196670
11324	TAGLN	transgelin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:11323	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S affects the expression of TAGLN mRNA	PMID:30951980
11324	TAGLN	transgelin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:11323	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of TAGLN promoter	PMID:33297965
11324	TAGLN	transgelin	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:11323	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of TAGLN mRNA	PMID:26377693
11324	TAGLN	transgelin	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:11323	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TAGLN mRNA	PMID:38685157
11324	TAGLN	transgelin	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of TAGLN protein	PMID:34186270
11324	TAGLN	transgelin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:11323	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TAGLN mRNA	PMID:30951980
11324	TAGLN	transgelin	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of TAGLN mRNA	PMID:30951980
11324	TAGLN	transgelin	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TAGLN protein	PMID:34186270
11324	TAGLN	transgelin	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:3723	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of TAGLN mRNA	PMID:21241498
11324	TAGLN	transgelin	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20230207	CTD	MESH:D016264	[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of TAGLN protein	PMID:35999755
11324	TAGLN	transgelin	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:3723	E	RGD:6480464	20150127	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TAGLN mRNA; Dibutyl Phthalate results in decreased expression of TAGLN protein	PMID:24893172|PMID:35926758
11324	TAGLN	transgelin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:11323	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TAGLN mRNA	PMID:21266533
11324	TAGLN	transgelin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:3723	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TAGLN mRNA	PMID:21266533
11324	TAGLN	transgelin	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of TAGLN protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of TAGLN protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of TAGLN protein	PMID:38598786
11324	TAGLN	transgelin	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20120412	CTD	MESH:D015056	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TAGLN mRNA	PMID:16054899
11324	TAGLN	transgelin	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TAGLN mRNA	PMID:18164116
11324	TAGLN	transgelin	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of TAGLN mRNA	PMID:29024780
11324	TAGLN	transgelin	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TAGLN mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TAGLN mRNA	PMID:35163327
11324	TAGLN	transgelin	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAGLN mRNA	PMID:39836092
11324	TAGLN	transgelin	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of TAGLN mRNA	PMID:17175557
11324	TAGLN	transgelin	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:3723	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of TAGLN mRNA	PMID:30723492
11324	TAGLN	transgelin	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TAGLN mRNA	PMID:38568856
11324	TAGLN	transgelin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TAGLN mRNA	PMID:37325564
11324	TAGLN	transgelin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TAGLN mRNA	PMID:39012411
11324	TAGLN	transgelin	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TAGLN mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TAGLN mRNA	PMID:35163327
11324	TAGLN	transgelin	gene	CHEBI:35553	perhexiline	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D010480	Perhexiline results in decreased expression of TAGLN mRNA	PMID:15342952|PMID:17175557
11324	TAGLN	transgelin	gene	CHEBI:35559	furan	increases expression	ISO	RGD:3723	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TAGLN mRNA	PMID:27387713
11324	TAGLN	transgelin	gene	CHEBI:3647	chlorpromazine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D002746	Chlorpromazine results in decreased expression of TAGLN mRNA	PMID:17175557
11324	TAGLN	transgelin	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TAGLN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TAGLN mRNA	PMID:32699268
11324	TAGLN	transgelin	gene	CHEBI:3723	citalopram	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015283	Citalopram results in decreased expression of TAGLN mRNA	PMID:17567588
11324	TAGLN	transgelin	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in decreased expression of TAGLN mRNA	PMID:15380616
11324	TAGLN	transgelin	gene	CHEBI:3764	clotrimazole	increases expression	ISO	RGD:3723	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of TAGLN mRNA	PMID:30047161
11324	TAGLN	transgelin	gene	CHEBI:3766	clozapine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003024	Clozapine results in decreased expression of TAGLN mRNA	PMID:15342952|PMID:17175557
11324	TAGLN	transgelin	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:11323	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TAGLN mRNA	PMID:40194260
11324	TAGLN	transgelin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:11323	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TAGLN mRNA	PMID:40194260
11324	TAGLN	transgelin	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of TAGLN mRNA	PMID:33512557
11324	TAGLN	transgelin	gene	CHEBI:38757	isoflavones	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20170303	CTD	MESH:D007529	[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of TAGLN protein; [ENNG co-treated with Isoflavones] results in increased expression of TAGLN protein	PMID:22248470
11324	TAGLN	transgelin	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TAGLN mRNA	PMID:31533062
11324	TAGLN	transgelin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TAGLN mRNA	PMID:40419075
11324	TAGLN	transgelin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:11323	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TAGLN protein	PMID:26178269
11324	TAGLN	transgelin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:3723	E	RGD:6480464	20121009	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TAGLN mRNA	PMID:22237054
11324	TAGLN	transgelin	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:11323	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of TAGLN mRNA	PMID:29038090
11324	TAGLN	transgelin	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:3723	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of TAGLN mRNA	PMID:22561333|PMID:25993096
11324	TAGLN	transgelin	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TAGLN mRNA	PMID:25979313
11324	TAGLN	transgelin	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of TAGLN mRNA	PMID:17175557|PMID:24935251|PMID:28001369|PMID:29154799
11324	TAGLN	transgelin	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:3723	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of TAGLN mRNA	PMID:29427782
11324	TAGLN	transgelin	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TAGLN mRNA	PMID:23179753|PMID:27188386
11324	TAGLN	transgelin	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TAGLN gene	PMID:29154799
11324	TAGLN	transgelin	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:3723	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TAGLN mRNA	PMID:30047161|PMID:41580965
11324	TAGLN	transgelin	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine affects the expression of TAGLN mRNA	PMID:20106945
11324	TAGLN	transgelin	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of TAGLN mRNA	PMID:22147139
11324	TAGLN	transgelin	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TAGLN mRNA	PMID:21632981|PMID:25562108
11324	TAGLN	transgelin	gene	CHEBI:40909	azoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of TAGLN mRNA	PMID:33512557
11324	TAGLN	transgelin	gene	CHEBI:41072	3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C070515	bisindolylmaleimide I results in decreased expression of TAGLN mRNA	PMID:15380616
11324	TAGLN	transgelin	gene	CHEBI:41774	tamoxifen	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013629	Tamoxifen results in decreased expression of TAGLN mRNA	PMID:15342952|PMID:17175557|PMID:17567588
11324	TAGLN	transgelin	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:3723	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in decreased expression of TAGLN mRNA	PMID:14618091
11324	TAGLN	transgelin	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20120412	CTD	MESH:D003907	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TAGLN mRNA	PMID:16054899
11324	TAGLN	transgelin	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:3723	E	RGD:6480464	20230606	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of TAGLN mRNA	PMID:37077353
11324	TAGLN	transgelin	gene	CHEBI:42355	erythromycin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004917	Erythromycin results in decreased expression of TAGLN mRNA	PMID:17567588
11324	TAGLN	transgelin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:11323	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TAGLN mRNA	PMID:28973697
11324	TAGLN	transgelin	gene	CHEBI:42758	aldehydo-D-glucose	increases secretion	EXP		E	RGD:6480464	20160822	CTD	MESH:D005947	Glucose deficiency results in increased secretion of TAGLN protein	PMID:24802182
11324	TAGLN	transgelin	gene	CHEBI:42839	3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	increases expression	ISO	RGD:3723	E	RGD:6480464	20120412	CTD	MESH:D011692	Puromycin Aminonucleoside results in increased expression of TAGLN mRNA; Puromycin Aminonucleoside results in increased expression of TAGLN protein	PMID:19617259
11324	TAGLN	transgelin	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of TAGLN mRNA	PMID:33512557
11324	TAGLN	transgelin	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in decreased expression of TAGLN mRNA	PMID:17320366
11324	TAGLN	transgelin	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:11323	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in decreased expression of TAGLN mRNA	PMID:17320366
11324	TAGLN	transgelin	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of TAGLN mRNA	PMID:26272509
11324	TAGLN	transgelin	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAGLN mRNA	PMID:27188386
11324	TAGLN	transgelin	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of TAGLN mRNA	PMID:24935251|PMID:26272509
11324	TAGLN	transgelin	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:11323	E	RGD:6480464	20150127	CTD	MESH:C012589	trichostatin A results in increased expression of TAGLN mRNA	PMID:23463510
11324	TAGLN	transgelin	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAGLN mRNA	PMID:27188386
11324	TAGLN	transgelin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:11323	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TAGLN mRNA	PMID:17562736
11324	TAGLN	transgelin	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D000082	Acetaminophen results in decreased expression of TAGLN mRNA	PMID:17175557|PMID:26690555
11324	TAGLN	transgelin	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:11323	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in increased expression of TAGLN mRNA	PMID:29246445
11324	TAGLN	transgelin	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of TAGLN mRNA]	PMID:29246445
11324	TAGLN	transgelin	gene	CHEBI:4629	diosgenin	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D004144	Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein]]	PMID:39059093
11324	TAGLN	transgelin	gene	CHEBI:4629	diosgenin	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20251007	CTD	MESH:D004144	Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein]	PMID:39059093
11324	TAGLN	transgelin	gene	CHEBI:46342	undecane	increases expression	ISO	RGD:3723	E	RGD:6480464	20120918	CTD	MESH:C022884	undecane results in increased expression of TAGLN protein	PMID:17337753
11324	TAGLN	transgelin	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120515	CTD	MESH:D005472	TAGLN protein affects the susceptibility to Fluorouracil	PMID:15352031|PMID:16217747
11324	TAGLN	transgelin	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of TAGLN protein	PMID:15352031
11324	TAGLN	transgelin	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TAGLN mRNA	PMID:29432896
11324	TAGLN	transgelin	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TAGLN mRNA	PMID:29523930
11324	TAGLN	transgelin	gene	CHEBI:46790	2-methoxyethanol	decreases expression	ISO	RGD:3723	E	RGD:6480464	20240806	CTD	MESH:C005219	methyl cellosolve results in decreased expression of TAGLN protein	PMID:15928459
11324	TAGLN	transgelin	gene	CHEBI:4710	doxepin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004316	Doxepin results in decreased expression of TAGLN mRNA	PMID:17567588
11324	TAGLN	transgelin	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of TAGLN mRNA	PMID:18414638
11324	TAGLN	transgelin	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAGLN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAGLN mRNA	PMID:39836092
11324	TAGLN	transgelin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAGLN mRNA	PMID:40504410
11324	TAGLN	transgelin	gene	CHEBI:47499	imipramine	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D007099	Imipramine results in decreased expression of TAGLN mRNA	PMID:15342952|PMID:17567588
11324	TAGLN	transgelin	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D007654	Ketoconazole results in decreased expression of TAGLN mRNA	PMID:17175557
11324	TAGLN	transgelin	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:3723	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of TAGLN mRNA	PMID:37077353
11324	TAGLN	transgelin	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of TAGLN mRNA	PMID:31675489
11324	TAGLN	transgelin	gene	CHEBI:47780	clomipramine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D002997	Clomipramine results in decreased expression of TAGLN mRNA	PMID:17175557
11324	TAGLN	transgelin	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:3723	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TAGLN mRNA	PMID:29391264
11324	TAGLN	transgelin	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TAGLN mRNA	PMID:26865667
11324	TAGLN	transgelin	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:11323	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TAGLN mRNA	PMID:17555576
11324	TAGLN	transgelin	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:3723	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TAGLN mRNA	PMID:12075121
11324	TAGLN	transgelin	gene	CHEBI:4917	eugenol	increases expression	ISO	RGD:3723	E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in increased expression of TAGLN protein	PMID:39793947
11324	TAGLN	transgelin	gene	CHEBI:49703	latrunculin B	decreases expression	ISO	RGD:3723	E	RGD:6480464	20191112	CTD	MESH:C037068	latrunculin B results in decreased expression of TAGLN mRNA	PMID:11035001
11324	TAGLN	transgelin	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TAGLN protein	PMID:39059093
11324	TAGLN	transgelin	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:3723	E	RGD:6480464	20251007	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TAGLN protein	PMID:39059093
11324	TAGLN	transgelin	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to TAGLN protein]; Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein]; NR3C1 promotes the reaction [Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein]]	PMID:26598702|PMID:39059093
11324	TAGLN	transgelin	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20251007	CTD	MESH:C032793	Diosgenin inhibits the reaction [Arsenic Trioxide results in increased expression of TAGLN protein]	PMID:39059093
11324	TAGLN	transgelin	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of TAGLN mRNA	PMID:20823114
11324	TAGLN	transgelin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of TAGLN mRNA	PMID:23300844
11324	TAGLN	transgelin	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:3723	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of TAGLN mRNA	PMID:30307764
11324	TAGLN	transgelin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:11323	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TAGLN mRNA	PMID:25620056
11324	TAGLN	transgelin	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:3723	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of TAGLN mRNA	PMID:34044035
11324	TAGLN	transgelin	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:3723	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TAGLN mRNA	PMID:30047161
11324	TAGLN	transgelin	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:11323	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of TAGLN mRNA	PMID:40234311
11324	TAGLN	transgelin	gene	CHEBI:50729	mitoxantrone	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	TAGLN protein affects the susceptibility to Mitoxantrone	PMID:16217747
11324	TAGLN	transgelin	gene	CHEBI:5118	fluoxetine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D005473	Fluoxetine results in decreased expression of TAGLN mRNA	PMID:15342952|PMID:17175557|PMID:17567588
11324	TAGLN	transgelin	gene	CHEBI:529996	cytochalasin D	increases expression	ISO	RGD:3723	E	RGD:6480464	20191112	CTD	MESH:D015638	Cytochalasin D results in increased expression of TAGLN mRNA	PMID:11035001
11324	TAGLN	transgelin	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of TAGLN mRNA	PMID:22714537
11324	TAGLN	transgelin	gene	CHEBI:53050	trimellitic anhydride	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of TAGLN mRNA	PMID:40645554
11324	TAGLN	transgelin	gene	CHEBI:5352	Gingerenone A	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C000604237	gingerenone A results in increased expression of TAGLN mRNA	PMID:35326237
11324	TAGLN	transgelin	gene	CHEBI:5613	haloperidol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006220	Haloperidol results in decreased expression of TAGLN mRNA	PMID:17175557
11324	TAGLN	transgelin	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of TAGLN mRNA	PMID:17237267
11324	TAGLN	transgelin	gene	CHEBI:6067	isotretinoin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	[LAQ824 co-treated with Isotretinoin] results in increased expression of TAGLN mRNA	PMID:17237267
11324	TAGLN	transgelin	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAGLN mRNA	PMID:39836092
11324	TAGLN	transgelin	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:3723	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of TAGLN mRNA	PMID:25729387
11324	TAGLN	transgelin	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of TAGLN mRNA	PMID:25729387
11324	TAGLN	transgelin	gene	CHEBI:6382	Lasiocarpine	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in decreased expression of TAGLN mRNA	PMID:40054833
11324	TAGLN	transgelin	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:11323	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of TAGLN mRNA	PMID:19812364
11324	TAGLN	transgelin	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of TAGLN mRNA	PMID:28988120
11324	TAGLN	transgelin	gene	CHEBI:6538	loratadine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D017336	Loratadine results in decreased expression of TAGLN mRNA	PMID:15342952|PMID:17567588
11324	TAGLN	transgelin	gene	CHEBI:66104	jaspamide	increases expression	ISO	RGD:11323	E	RGD:6480464	20130611	CTD	MESH:C057531	jasplakinolide results in increased expression of TAGLN protein	PMID:15184395
11324	TAGLN	transgelin	gene	CHEBI:66104	jaspamide	increases expression	ISO	RGD:3723	E	RGD:6480464	20191112	CTD	MESH:C057531	jasplakinolide results in increased expression of TAGLN mRNA	PMID:11035001
11324	TAGLN	transgelin	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of TAGLN mRNA	PMID:20823114
11324	TAGLN	transgelin	gene	CHEBI:6773	Mesaconitine	increases expression	ISO	RGD:3723	E	RGD:6480464	20231031	CTD	MESH:C019470	mesaconitine results in increased expression of TAGLN protein	PMID:37182599
11324	TAGLN	transgelin	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:3723	E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of TAGLN mRNA	PMID:28935588
11324	TAGLN	transgelin	gene	CHEBI:68508	diethyl maleate	decreases expression	ISO	RGD:3723	E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in decreased expression of TAGLN mRNA	PMID:21161181
11324	TAGLN	transgelin	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:11323	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased expression of TAGLN mRNA	PMID:31052254
11324	TAGLN	transgelin	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TAGLN mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TAGLN mRNA]	PMID:27935865|PMID:29891994
11324	TAGLN	transgelin	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	TAGLN mRNA affects the susceptibility to temozolomide	PMID:16365179
11324	TAGLN	transgelin	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TAGLN protein	PMID:34186270
11324	TAGLN	transgelin	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:11323	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TAGLN mRNA	PMID:22206623
11324	TAGLN	transgelin	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TAGLN mRNA	PMID:22206623
11324	TAGLN	transgelin	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TAGLN protein	PMID:37664457
11324	TAGLN	transgelin	gene	CHEBI:749217	halofuginone	increases expression	ISO	RGD:3723	E	RGD:6480464	20260721	CTD	MESH:C010176	halofuginone results in increased expression of TAGLN mRNA	PMID:17180598
11324	TAGLN	transgelin	gene	CHEBI:75393	Y-27632	decreases expression	ISO	RGD:3723	E	RGD:6480464	20191112	CTD	MESH:C108830	Y 27632 results in decreased expression of TAGLN mRNA	PMID:11035001
11324	TAGLN	transgelin	gene	CHEBI:75984	flecainide	decreases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D005424	Flecainide results in decreased expression of TAGLN mRNA	PMID:17175557
11324	TAGLN	transgelin	gene	CHEBI:76290	PhIP	decreases expression	ISO	RGD:3723	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of TAGLN mRNA	PMID:15059925
11324	TAGLN	transgelin	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:3723	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of TAGLN mRNA	PMID:15215175
11324	TAGLN	transgelin	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of TAGLN mRNA	PMID:17175557|PMID:32858204
11324	TAGLN	transgelin	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of TAGLN mRNA	PMID:18164116
11324	TAGLN	transgelin	gene	CHEBI:77397	1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015283	Citalopram results in decreased expression of TAGLN mRNA	PMID:17567588
11324	TAGLN	transgelin	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAGLN mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAGLN mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAGLN mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAGLN mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAGLN mRNA	PMID:27188386
11324	TAGLN	transgelin	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TAGLN gene]	PMID:28238834
11324	TAGLN	transgelin	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D010634	Phenobarbital results in decreased expression of TAGLN mRNA	PMID:17175557
11324	TAGLN	transgelin	gene	CHEBI:80774	tauroursodeoxycholic acid	decreases expression	ISO	RGD:3723	E	RGD:6480464	20141111	CTD	MESH:C031655	ursodoxicoltaurine results in decreased expression of TAGLN mRNA	PMID:15885361
11324	TAGLN	transgelin	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:3723	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of TAGLN mRNA	PMID:32109520
11324	TAGLN	transgelin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:11323	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TAGLN mRNA	PMID:38648751
11324	TAGLN	transgelin	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TAGLN protein	PMID:31675489
11324	TAGLN	transgelin	gene	CHEBI:81981	chlorotoluron	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C007033	chlortoluron results in decreased expression of TAGLN mRNA	PMID:39207506
11324	TAGLN	transgelin	gene	CHEBI:8228	pioglitazone	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C060836	Pioglitazone results in decreased expression of TAGLN mRNA	PMID:30031879
11324	TAGLN	transgelin	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:11323	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of TAGLN mRNA	PMID:27935865
11324	TAGLN	transgelin	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of TAGLN protein	PMID:31675489
11324	TAGLN	transgelin	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of TAGLN mRNA	PMID:33512557
11324	TAGLN	transgelin	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:11323	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of TAGLN mRNA	PMID:27029645
11324	TAGLN	transgelin	gene	CHEBI:85014	2,5-hexanedione	decreases expression	ISO	RGD:3723	E	RGD:6480464	20240806	CTD	MESH:C011269	2,5-hexanedione results in decreased expression of TAGLN protein	PMID:15928459
11324	TAGLN	transgelin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:3723	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TAGLN mRNA	PMID:30047161
11324	TAGLN	transgelin	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TAGLN protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAGLN mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAGLN mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAGLN mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAGLN mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAGLN mRNA	PMID:27188386|PMID:37664457
11324	TAGLN	transgelin	gene	CHEBI:9123	sertraline	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020280	Sertraline results in decreased expression of TAGLN mRNA	PMID:15342952
11324	TAGLN	transgelin	gene	CHEBI:9130	sevoflurane	multiple interactions	ISO	RGD:3723	E	RGD:6480464	20250311	CTD	MESH:C009250	Sevoflurane inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in decreased expression of TAGLN mRNA]; Sevoflurane inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in decreased expression of TAGLN protein]; TRAF6 protein inhibits the reaction [Sevoflurane inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in decreased expression of TAGLN mRNA]]; TRAF6 protein inhibits the reaction [Sevoflurane inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in decreased expression of TAGLN protein]]	PMID:39127353
11324	TAGLN	transgelin	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:11323	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TAGLN mRNA	PMID:27131904
11324	TAGLN	transgelin	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of TAGLN mRNA	PMID:28959546
11324	TAGLN	transgelin	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:3723	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TAGLN mRNA	PMID:19281266
11324	TAGLN	transgelin	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of TAGLN mRNA	PMID:33512557
11324	TAGLN	transgelin	gene	CHEBI:94402	1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C084597	chlorcyclizine results in decreased expression of TAGLN mRNA	PMID:15342952
11324	TAGLN	transgelin	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TAGLN mRNA	PMID:38568856
11324	TAGLN	transgelin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of TAGLN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of TAGLN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of TAGLN protein	PMID:38598786
11324	TAGLN	transgelin	gene	CHEBI:9566	thioridazine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013881	Thioridazine results in decreased expression of TAGLN mRNA	PMID:15342952|PMID:17175557
11324	TAGLN	transgelin	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C032910	triadimefon results in decreased expression of TAGLN mRNA	PMID:26705709
11324	TAGLN	transgelin	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:3723	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in decreased expression of TAGLN mRNA	PMID:21515302
11324	TAGLN	transgelin	gene	CHEBI:9907	ursodeoxycholic acid	decreases expression	ISO	RGD:3723	E	RGD:6480464	20120613	CTD	MESH:D014580	Ursodeoxycholic Acid results in decreased expression of TAGLN mRNA	PMID:15885361
11324	TAGLN	transgelin	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:3723	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of TAGLN mRNA	PMID:19015723
11324	TAGLN	transgelin	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:3723	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of TAGLN mRNA	PMID:22570695
11352781	FGF7P3	fibroblast growth factor 7 pseudogene 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of FGF7P3 mRNA	PMID:31614463
11352781	FGF7P3	fibroblast growth factor 7 pseudogene 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160726	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of FGF7P3 mRNA	PMID:20382639
11352781	FGF7P3	fibroblast growth factor 7 pseudogene 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FGF7P3 mRNA	PMID:31533062
11352781	FGF7P3	fibroblast growth factor 7 pseudogene 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160726	CTD	MESH:C012589	trichostatin A results in decreased expression of FGF7P3 mRNA	PMID:24935251
11352781	FGF7P3	fibroblast growth factor 7 pseudogene 3	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of FGF7P3 mRNA	PMID:29522793
11352787	MISP3	MISP family member 3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MISP3 mRNA	PMID:38218311
11352787	MISP3	MISP family member 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1321061	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MISP3 mRNA	PMID:33045310
11352787	MISP3	MISP family member 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1321061	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of MISP3 mRNA	PMID:36189433
11352787	MISP3	MISP family member 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1321061	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MISP3 mRNA	PMID:36189433
11352787	MISP3	MISP family member 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1321061	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of MISP3 mRNA	PMID:40945087
11352787	MISP3	MISP family member 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of MISP3 mRNA	PMID:31614463
11352787	MISP3	MISP family member 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of MISP3 mRNA	PMID:30165855
11352787	MISP3	MISP family member 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1310262	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MISP3 mRNA	PMID:33387578
11352787	MISP3	MISP family member 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MISP3 mRNA	PMID:37042841
11352787	MISP3	MISP family member 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1321061	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MISP3 mRNA	PMID:37992649
11352787	MISP3	MISP family member 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1321061	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of MISP3 mRNA	PMID:36189433
11352787	MISP3	MISP family member 3	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1321061	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MISP3 mRNA	PMID:36706583
11352787	MISP3	MISP family member 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1321061	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MISP3 mRNA	PMID:37992649
11352787	MISP3	MISP family member 3	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1310262	E	RGD:6480464	20161115	CTD	MESH:C016517	indole-3-carbinol affects the expression of MISP3 mRNA	PMID:21396975
11352787	MISP3	MISP family member 3	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1310262	E	RGD:6480464	20161025	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of MISP3 mRNA	PMID:19480007
11352787	MISP3	MISP family member 3	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1321061	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of MISP3 mRNA	PMID:38723480
11352787	MISP3	MISP family member 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1321061	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in increased expression of MISP3 mRNA]	PMID:38723480
11352787	MISP3	MISP family member 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MISP3 mRNA	PMID:27392435
11352787	MISP3	MISP family member 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MISP3 mRNA	PMID:32763439
11352787	MISP3	MISP family member 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1321061	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of MISP3 mRNA	PMID:39631538
11352787	MISP3	MISP family member 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1321061	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MISP3 mRNA	PMID:37992649
11352787	MISP3	MISP family member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1310262	E	RGD:6480464	20161115	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MISP3 mRNA	PMID:21839799
11352787	MISP3	MISP family member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MISP3 promoter	PMID:27901495
11352787	MISP3	MISP family member 3	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1310262	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of MISP3 mRNA	PMID:38458666
11352787	MISP3	MISP family member 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1310262	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MISP3 mRNA	PMID:34947998
11352787	MISP3	MISP family member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1321061	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MISP3 mRNA	PMID:40203079
11352787	MISP3	MISP family member 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1321061	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MISP3 mRNA	PMID:37019170
11352787	MISP3	MISP family member 3	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1310262	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of MISP3 mRNA	PMID:32680482
11352787	MISP3	MISP family member 3	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1310262	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of MISP3 mRNA	PMID:38458666
11352787	MISP3	MISP family member 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1321061	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MISP3 mRNA	PMID:37992649
11352787	MISP3	MISP family member 3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MISP3 mRNA	PMID:38832940
11352787	MISP3	MISP family member 3	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1321061	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of MISP3 mRNA	PMID:38723480
11352787	MISP3	MISP family member 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1321061	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in increased expression of MISP3 mRNA]	PMID:38723480
11352787	MISP3	MISP family member 3	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of MISP3 mRNA	PMID:28988120
11352787	MISP3	MISP family member 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1310262	E	RGD:6480464	20161115	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MISP3 mRNA	PMID:24780913
11352787	MISP3	MISP family member 3	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1321061	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MISP3 mRNA	PMID:36706583
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of NMRAL2P mRNA	PMID:38218311
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NMRAL2P mRNA	PMID:35811015
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of NMRAL2P mRNA; S-(1,2-dichlorovinyl)cysteine promotes the reaction [Lipopolysaccharides results in increased expression of NMRAL2P mRNA]	PMID:35811015
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of NMRAL2P mRNA	PMID:29221148|PMID:31256213
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:193591	Didecyldimethylammonium	increases expression	EXP		E	RGD:6480464	20221018	CTD	MESH:C027118	didecyldimethylammonium results in increased expression of NMRAL2P mRNA	PMID:32763356
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NMRAL2P mRNA	PMID:21867686
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of NMRAL2P mRNA	PMID:27392435
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of NMRAL2P mRNA	PMID:27392435
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:2948	azathioprine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of NMRAL2P mRNA	PMID:22623647
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of NMRAL2P mRNA	PMID:34032870
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NMRAL2P mRNA	PMID:38568856
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to NMRAL2P mRNA]	PMID:32406909
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of NMRAL2P mRNA	PMID:38568856
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NMRAL2P mRNA	PMID:30903817
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of NMRAL2P mRNA	PMID:29275510
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NMRAL2P mRNA	PMID:28628672
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of NMRAL2P mRNA	PMID:38568856
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NMRAL2P mRNA	PMID:28628672
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NMRAL2P mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NMRAL2P mRNA	PMID:28628672
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D010269	Paraquat results in increased expression of NMRAL2P mRNA	PMID:35182771
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D016572	Cyclosporine results in increased expression of NMRAL2P mRNA	PMID:33631201
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NMRAL2P mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NMRAL2P mRNA	PMID:28628672
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of NMRAL2P mRNA	PMID:35811015|PMID:36576512
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of NMRAL2P mRNA; S-(1,2-dichlorovinyl)cysteine promotes the reaction [Lipopolysaccharides results in increased expression of NMRAL2P mRNA]	PMID:35811015
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of NMRAL2P mRNA	PMID:32234424
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of NMRAL2P mRNA	PMID:38568856
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NMRAL2P mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NMRAL2P mRNA	PMID:28628672
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:64648	enniatin	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C100264	enniatins results in increased expression of NMRAL2P mRNA	PMID:36016515
11353885	NMRAL2P	NmrA like redox sensor 2, pseudogene	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of NMRAL2P mRNA	PMID:38568856
11520750	RPL10P15	ribosomal protein L10 pseudogene 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL10P15 mRNA	PMID:33670352
11520755	DHFRP3	dihydrofolate reductase pseudogene 3	gene	CHEBI:6651	malathion	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in decreased expression of DHFRP3 mRNA	PMID:37047231
11520759	MTDHP1	metadherin pseudogene 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MTDHP1 mRNA	PMID:33212167
11520768	RPL10P13	ribosomal protein L10 pseudogene 13	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RPL10P13 mRNA	PMID:38568856
11520768	RPL10P13	ribosomal protein L10 pseudogene 13	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C100187	chloropicrin results in increased expression of RPL10P13 mRNA	PMID:26352163
11520768	RPL10P13	ribosomal protein L10 pseudogene 13	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RPL10P13 mRNA	PMID:31758290
11520772	RPL10P12	ribosomal protein L10 pseudogene 12	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RPL10P12 mRNA	PMID:23557933
11520773	RPL10P6	ribosomal protein L10 pseudogene 6	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C100187	chloropicrin results in increased expression of RPL10P6 mRNA	PMID:26352163
11520777	RPL10P8	ribosomal protein L10 pseudogene 8	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D013739	Testosterone results in decreased expression of RPL10P8 mRNA	PMID:21592394
11520777	RPL10P8	ribosomal protein L10 pseudogene 8	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of RPL10P8 mRNA	PMID:21592394
11520777	RPL10P8	ribosomal protein L10 pseudogene 8	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D002117	Calcitriol results in decreased expression of RPL10P8 mRNA	PMID:21592394
11520777	RPL10P8	ribosomal protein L10 pseudogene 8	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of RPL10P8 mRNA	PMID:21592394
11520777	RPL10P8	ribosomal protein L10 pseudogene 8	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of RPL10P8 mRNA	PMID:29453283
11520777	RPL10P8	ribosomal protein L10 pseudogene 8	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RPL10P8 mRNA	PMID:31758290
11520778	MTDHP4	metadherin pseudogene 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MTDHP4 mRNA	PMID:33212167
11531437	XIAPP3	X-linked inhibitor of apoptosis pseudogene 3	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of XIAPP3 mRNA	PMID:36318118
11531438	XIAPP2	X-linked inhibitor of apoptosis pseudogene 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of XIAPP2 mRNA	PMID:41028656
11531438	XIAPP2	X-linked inhibitor of apoptosis pseudogene 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of XIAPP2 mRNA	PMID:41028656
11531438	XIAPP2	X-linked inhibitor of apoptosis pseudogene 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of XIAPP2 mRNA	PMID:41028656
11531439	FKBP1BP1	FKBP prolyl isomerase 1B pseudogene 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FKBP1BP1 mRNA	PMID:35811015
11531439	FKBP1BP1	FKBP prolyl isomerase 1B pseudogene 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FKBP1BP1 mRNA	PMID:35811015
11531439	FKBP1BP1	FKBP prolyl isomerase 1B pseudogene 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FKBP1BP1 mRNA	PMID:35811015
11537410	NPIPB12	nuclear pore complex interacting protein family member B12	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NPIPB12 mRNA	PMID:33212167
11537411	NPIPB2	nuclear pore complex interacting protein family member B2	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of NPIPB2 mRNA	PMID:29432896
11537411	NPIPB2	nuclear pore complex interacting protein family member B2	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of NPIPB2 mRNA	PMID:29432896
11537411	NPIPB2	nuclear pore complex interacting protein family member B2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NPIPB2 mRNA	PMID:38568856
11537411	NPIPB2	nuclear pore complex interacting protein family member B2	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of NPIPB2 mRNA	PMID:29453283
11537411	NPIPB2	nuclear pore complex interacting protein family member B2	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of NPIPB2 mRNA	PMID:35984750
11537411	NPIPB2	nuclear pore complex interacting protein family member B2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NPIPB2 mRNA	PMID:38568856
11537411	NPIPB2	nuclear pore complex interacting protein family member B2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of NPIPB2 mRNA	PMID:36326898
11537411	NPIPB2	nuclear pore complex interacting protein family member B2	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C100187	chloropicrin results in increased expression of NPIPB2 mRNA	PMID:28476498
11537411	NPIPB2	nuclear pore complex interacting protein family member B2	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in increased expression of NPIPB2 mRNA	PMID:29453283
11537412	NPIPB10P	nuclear pore complex interacting protein family, member B10, pseudogene	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of NPIPB10P mRNA	PMID:37690743
11537413	NPIPB13	nuclear pore complex interacting protein family, member B13	gene	CHEBI:30778	gallic acid	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of NPIPB13 mRNA	PMID:34408198
11537413	NPIPB13	nuclear pore complex interacting protein family, member B13	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NPIPB13 mRNA	PMID:37042841
11537413	NPIPB13	nuclear pore complex interacting protein family, member B13	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of NPIPB13 mRNA	PMID:29523930
11552590	PEG13	paternally expressed 13	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PEG13 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of PEG13 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PEG13 mRNA	PMID:32699268|PMID:32845096
11552590	PEG13	paternally expressed 13	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1615533	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PEG13 mRNA	PMID:39241906
11552590	PEG13	paternally expressed 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1615533	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of PEG13 gene	PMID:38833407
11552590	PEG13	paternally expressed 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1615533	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PEG13 mRNA	PMID:39150890
11552590	PEG13	paternally expressed 13	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PEG13 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of PEG13 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PEG13 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of PEG13 mRNA	PMID:32699268|PMID:32845096
11552590	PEG13	paternally expressed 13	gene	CHEBI:27889	lead(0)	decreases methylation	ISO	RGD:1615533	E	RGD:6480464	20250311	CTD	MESH:D007854	Lead results in decreased methylation of PEG13 gene	PMID:38833407
11552590	PEG13	paternally expressed 13	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1615533	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PEG13 mRNA	PMID:27131904
11552590	PEG13	paternally expressed 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1615533	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PEG13 mRNA	PMID:34585602
11552590	PEG13	paternally expressed 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1615533	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PEG13 exon	PMID:33297965
11552590	PEG13	paternally expressed 13	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1615533	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PEG13 mRNA	PMID:39150890
11552590	PEG13	paternally expressed 13	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1615533	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PEG13 mRNA	PMID:39150890
11552590	PEG13	paternally expressed 13	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1615533	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PEG13 mRNA	PMID:39150890
11552590	PEG13	paternally expressed 13	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1615533	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PEG13 mRNA	PMID:39150890
11552590	PEG13	paternally expressed 13	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PEG13 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PEG13 mRNA	PMID:32699268
11552590	PEG13	paternally expressed 13	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1615533	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PEG13 mRNA	PMID:29279043
11552590	PEG13	paternally expressed 13	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1615533	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of PEG13 mRNA	PMID:29279043
11552590	PEG13	paternally expressed 13	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615533	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PEG13 mRNA; Nanotubes, Carbon results in decreased expression of PEG13 mRNA	PMID:25554681
11552590	PEG13	paternally expressed 13	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1615533	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PEG13 mRNA	PMID:35964746
11552590	PEG13	paternally expressed 13	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1615533	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PEG13 mRNA	PMID:39150890
11552590	PEG13	paternally expressed 13	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1615533	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PEG13 mRNA	PMID:39847705
11552590	PEG13	paternally expressed 13	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1615533	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PEG13 mRNA	PMID:27131904
11553952	ERVK3-1	endogenous retrovirus group K3 member 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ERVK3-1 mRNA	PMID:38218311
11553952	ERVK3-1	endogenous retrovirus group K3 member 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ERVK3-1 mRNA	PMID:37042841
11553952	ERVK3-1	endogenous retrovirus group K3 member 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ERVK3-1 mRNA	PMID:27153756
11553952	ERVK3-1	endogenous retrovirus group K3 member 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ERVK3-1 mRNA	PMID:33212167
11553952	ERVK3-1	endogenous retrovirus group K3 member 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ERVK3-1 mRNA	PMID:29803840
11553952	ERVK3-1	endogenous retrovirus group K3 member 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ERVK3-1 mRNA	PMID:29275510
11554226	FBXW7-AS1	FBXW7 antisense RNA 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D010126	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA] which results in increased expression of FBXW7 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of DEAR mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA	PMID:33656867|PMID:41430723
11554226	FBXW7-AS1	FBXW7 antisense RNA 1	gene	CHEBI:29191	hydroxyl	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA] which results in increased expression of FBXW7 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA	PMID:33656867
11554226	FBXW7-AS1	FBXW7 antisense RNA 1	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA] which results in increased expression of FBXW7 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA] which results in increased expression of FBXW7 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of FBXW7-AS1 mRNA	PMID:33656867
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1311793	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PRAG1 mRNA]	PMID:31150632
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1332292	E	RGD:6480464	20161213	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PRAG1 mRNA	PMID:20188158
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1332292	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PRAG1 mRNA	PMID:30319688
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D011794	Quercetin results in increased expression of PRAG1 mRNA	PMID:21632981
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of PRAG1 mRNA	PMID:29581250
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332292	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PRAG1 mRNA	PMID:39241906
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PRAG1 mRNA	PMID:35811015
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of PRAG1 mRNA	PMID:30510588
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20161101	CTD	MESH:D004958	Estradiol affects the expression of PRAG1 mRNA	PMID:22574217
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20161101	CTD	MESH:D004958	Estradiol results in increased expression of PRAG1 mRNA	PMID:24758408|PMID:31614463
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20161101	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of PRAG1 mRNA; EGF protein promotes the reaction [Estradiol results in increased expression of PRAG1 mRNA]	PMID:20660070|PMID:24758408
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1311793	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PRAG1 mRNA	PMID:33387578
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PRAG1 mRNA	PMID:37042841
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D005557	Formaldehyde results in decreased expression of PRAG1 mRNA	PMID:20655997
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of PRAG1 mRNA	PMID:20660070
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C005556	propionaldehyde results in increased expression of PRAG1 mRNA	PMID:26079696
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1332292	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PRAG1 mRNA	PMID:37992649
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1332292	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PRAG1 mRNA	PMID:37992649
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PRAG1 protein	PMID:37730182
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRAG1 mRNA	PMID:36139627
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1332292	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PRAG1 mRNA	PMID:36331819
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1332292	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of PRAG1 mRNA	PMID:27462272
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20161101	CTD	MESH:D019327	Copper Sulfate results in increased expression of PRAG1 mRNA	PMID:19549813
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1311793	E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PRAG1 mRNA	PMID:25378103
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1311793	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PRAG1 mRNA	PMID:31150632
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1332292	E	RGD:6480464	20161213	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PRAG1 mRNA	PMID:17484886
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1311793	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PRAG1 mRNA]	PMID:31150632
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D001151	Arsenic affects the methylation of PRAG1 gene	PMID:25304211
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1332292	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRAG1 mRNA	PMID:40504410
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20161101	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PRAG1 mRNA	PMID:26272509
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161101	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRAG1 mRNA	PMID:27188386
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PRAG1 protein	PMID:35688186
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1332292	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of PRAG1 mRNA	PMID:28960355
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1311793	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PRAG1 mRNA	PMID:31881176
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of PRAG1 mRNA	PMID:27594783
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1332292	E	RGD:6480464	20161213	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRAG1 mRNA	PMID:26377647
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases phosphorylation	ISO	RGD:1311793	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased phosphorylation of PRAG1 protein	PMID:23298284
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20161101	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRAG1 mRNA	PMID:20106945|PMID:21632981|PMID:26238291
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1311793	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRAG1 mRNA	PMID:33387578
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1332292	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of PRAG1 mRNA	PMID:32937126
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1311793	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PRAG1 mRNA	PMID:28959563
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PRAG1 mRNA	PMID:29803840
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PRAG1 mRNA	PMID:30031762
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1332292	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PRAG1 mRNA	PMID:37992649
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of PRAG1 protein	PMID:35688186
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PRAG1 mRNA	PMID:29432896
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:2948	azathioprine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of PRAG1 mRNA	PMID:22623647
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of PRAG1 mRNA	PMID:39719251
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of PRAG1 mRNA	PMID:34032870|PMID:38568856
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1332292	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRAG1 mRNA	PMID:40504410
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20161101	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PRAG1 mRNA	PMID:21632981|PMID:22316170|PMID:26238291
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20161101	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of PRAG1 gene	PMID:25435355
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of PRAG1 mRNA	PMID:28959546
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1332292	E	RGD:6480464	20161213	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PRAG1 mRNA	PMID:23221170
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1311793	E	RGD:6480464	20170516	CTD	MESH:C004312	glycidol results in increased expression of PRAG1 mRNA	PMID:24915197
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1332292	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PRAG1 gene	PMID:35295148
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1332292	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PRAG1 gene	PMID:35295148
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1311793	E	RGD:6480464	20170516	CTD	MESH:D013853	Thioacetamide results in increased expression of PRAG1 mRNA	PMID:23411599|PMID:34492290
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1311793	E	RGD:6480464	20170516	CTD	MESH:C006780	bisphenol A results in decreased expression of PRAG1 mRNA	PMID:25181051
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1311793	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of PRAG1 mRNA	PMID:30816183|PMID:34947998|PMID:41034487
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332292	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of PRAG1 mRNA	PMID:32156529
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1332292	E	RGD:6480464	20161213	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of PRAG1 mRNA	PMID:26377693
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1332292	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PRAG1 mRNA	PMID:37019170
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PRAG1 mRNA	PMID:37042841
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1311793	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PRAG1 mRNA	PMID:35163327
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1311793	E	RGD:6480464	20170516	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PRAG1 promoter	PMID:22457795
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PRAG1 mRNA	PMID:38174414
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1311793	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PRAG1 mRNA	PMID:35163327
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1311793	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of PRAG1 mRNA	PMID:27387713
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PRAG1 mRNA	PMID:28302478
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PRAG1 mRNA	PMID:31533062
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1332292	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PRAG1 mRNA	PMID:36331819
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1332292	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of PRAG1 mRNA	PMID:29038090
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20161101	CTD	MESH:D014635	Valproic Acid affects the expression of PRAG1 mRNA	PMID:25979313
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1311793	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of PRAG1 mRNA	PMID:29427782
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161101	CTD	MESH:D014635	Valproic Acid results in increased expression of PRAG1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PRAG1 gene	PMID:29154799
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161101	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRAG1 mRNA	PMID:27188386
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1332292	E	RGD:6480464	20161213	CTD	MESH:D014635	Valproic Acid inhibits the reaction [Dexamethasone results in increased expression of PRAG1 mRNA]	PMID:23946490
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of PRAG1 mRNA	PMID:27989131
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20161101	CTD	MESH:D016572	Cyclosporine results in increased expression of PRAG1 mRNA	PMID:20106945|PMID:25562108
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:41607	crotonaldehyde	decreases expression	EXP		E	RGD:6480464	20161101	CTD	MESH:C012796	2-butenal results in decreased expression of PRAG1 mRNA	PMID:20471460
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1332292	E	RGD:6480464	20161213	CTD	MESH:D003907	Dexamethasone results in increased expression of PRAG1 mRNA	PMID:23946490
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1332292	E	RGD:6480464	20161213	CTD	MESH:D003907	Valproic Acid inhibits the reaction [Dexamethasone results in increased expression of PRAG1 mRNA]	PMID:23946490
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1332292	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PRAG1 mRNA	PMID:28973697
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1332292	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PRAG1 mRNA	PMID:37992649
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PRAG1 mRNA	PMID:38832940
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20161101	CTD	MESH:C012589	trichostatin A results in increased expression of PRAG1 mRNA	PMID:24935251|PMID:26272509
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161101	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRAG1 mRNA	PMID:27188386
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of PRAG1 mRNA	PMID:29067470
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of PRAG1 mRNA	PMID:33725128
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PRAG1 mRNA	PMID:35811015
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PRAG1 mRNA	PMID:29523930
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:46680	serpentine asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased expression of PRAG1 mRNA	PMID:29523930
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D001151	Arsenic affects the methylation of PRAG1 gene	PMID:25304211
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1332292	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PRAG1 mRNA	PMID:40504410
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1311793	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PRAG1 mRNA	PMID:29391264
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1332292	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of PRAG1 mRNA	PMID:35436446
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1332292	E	RGD:6480464	20161213	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PRAG1 mRNA	PMID:19042947
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1332292	E	RGD:6480464	20161213	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of PRAG1 mRNA	PMID:23608068
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of PRAG1 mRNA	PMID:28988120
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1311793	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PRAG1 gene	PMID:35440735
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1332292	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PRAG1 mRNA	PMID:22206623
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PRAG1 mRNA	PMID:22714537
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRAG1 mRNA	PMID:36139627
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRAG1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRAG1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRAG1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRAG1 mRNA	PMID:27188386
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1311793	E	RGD:6480464	20170516	CTD	MESH:D011441	Propylthiouracil affects the expression of PRAG1 mRNA	PMID:24780913
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1311793	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of PRAG1 mRNA	PMID:25825206
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of PRAG1 mRNA	PMID:26272509
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRAG1 mRNA	PMID:27188386
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:8922	Rutecarpine	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C028632	rutecarpine results in decreased expression of PRAG1 mRNA	PMID:34955744
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRAG1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRAG1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRAG1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRAG1 mRNA	PMID:27188386
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of PRAG1 mRNA	PMID:28959546
11554295	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PRAG1 mRNA	PMID:29301935
11556256	NCOA4P2	nuclear receptor coactivator 4 pseudogene 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NCOA4P2 mRNA	PMID:33212167
11556265	WDR45P1	WD repeat domain 45 pseudogene 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of WDR45P1 mRNA	PMID:41028656
11556265	WDR45P1	WD repeat domain 45 pseudogene 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of WDR45P1 mRNA	PMID:41028656
11556265	WDR45P1	WD repeat domain 45 pseudogene 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of WDR45P1 mRNA	PMID:41028656
11556267	MAPK8IP1P2	mitogen-activated protein kinase 8 interacting protein 1 pseudogene 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MAPK8IP1P2 gene	PMID:29154799
11560509	MTATP6P19	MT-ATP6 pseudogene 19	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of MTATP6P19 mRNA	PMID:41028656
11560509	MTATP6P19	MT-ATP6 pseudogene 19	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MTATP6P19 mRNA	PMID:41028656
11560509	MTATP6P19	MT-ATP6 pseudogene 19	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MTATP6P19 mRNA	PMID:41028656
11560514	PRXL2AP2	peroxiredoxin like 2A pseudogene 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PRXL2AP2 mRNA	PMID:33212167
11561989	LINC01777	long independently transcribed non-coding RNA 1777	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01777 promoter	PMID:27901495
11561989	LINC01777	long independently transcribed non-coding RNA 1777	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LINC01777 gene	PMID:29154799
11562003	LINC01634	long independently transcribed non-coding RNA 1634	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LINC01634 promoter	PMID:27901495
11562062	LINC01724	long independently transcribed non-coding RNA 1724	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01724 mRNA	PMID:38568856
11562073	LINC01716	long independently transcribed non-coding RNA 1716	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC01716 intron	PMID:30157460
11562073	LINC01716	long independently transcribed non-coding RNA 1716	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC01716 intron	PMID:30157460
11562073	LINC01716	long independently transcribed non-coding RNA 1716	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC01716 intron	PMID:30157460
11562087	LINC01684	long independently transcribed non-coding RNA 1684	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01684 mRNA	PMID:38568856
11562143	LINC01698	long independently transcribed non-coding RNA 1698	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of LINC01698 mRNA	PMID:29955902
11562156	LINC01798	long independently transcribed non-coding RNA 1798	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of LINC01798 mRNA	PMID:30510588
11562156	LINC01798	long independently transcribed non-coding RNA 1798	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC01798 intron	PMID:30157460
11562156	LINC01798	long independently transcribed non-coding RNA 1798	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01798 mRNA	PMID:41028656
11562156	LINC01798	long independently transcribed non-coding RNA 1798	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01798 mRNA	PMID:41028656
11562156	LINC01798	long independently transcribed non-coding RNA 1798	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01798 intron	PMID:30157460
11562156	LINC01798	long independently transcribed non-coding RNA 1798	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01798 mRNA	PMID:41028656
11562170	LINC01733	long independently transcribed non-coding RNA 1733	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01733 mRNA	PMID:38568856
11562201	LINC01811	long independently transcribed non-coding RNA 1811	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01811 mRNA	PMID:41028656
11562201	LINC01811	long independently transcribed non-coding RNA 1811	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01811 mRNA	PMID:41028656
11562201	LINC01811	long independently transcribed non-coding RNA 1811	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01811 mRNA	PMID:41028656
11562268	LINC01659	long independently transcribed non-coding RNA 1659	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of LINC01659 mRNA	PMID:30510588
11562326	ACBD3-AS1	ACBD3 antisense RNA 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D010126	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA] which results in increased expression of ACBD3 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA	PMID:33656867
11562326	ACBD3-AS1	ACBD3 antisense RNA 1	gene	CHEBI:29191	hydroxyl	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA] which results in increased expression of ACBD3 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA	PMID:33656867
11562326	ACBD3-AS1	ACBD3 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ACBD3-AS1 mRNA	PMID:34032870
11562326	ACBD3-AS1	ACBD3 antisense RNA 1	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA] which results in increased expression of ACBD3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA] which results in increased expression of ACBD3 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of ACBD3-AS1 mRNA	PMID:33656867
11562349	LINC01736	long independently transcribed non-coding RNA 1736	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LINC01736 mRNA	PMID:35811015
11562349	LINC01736	long independently transcribed non-coding RNA 1736	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01736 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LINC01736 mRNA	PMID:35811015
11562349	LINC01736	long independently transcribed non-coding RNA 1736	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of LINC01736 mRNA	PMID:35811015
11562349	LINC01736	long independently transcribed non-coding RNA 1736	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01736 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LINC01736 mRNA	PMID:35811015
11562365	LINC01720	long independently transcribed non-coding RNA 1720	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01720 intron	PMID:30157460
11562365	LINC01720	long independently transcribed non-coding RNA 1720	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01720 mRNA	PMID:29301061
11562365	LINC01720	long independently transcribed non-coding RNA 1720	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of LINC01720 mRNA	PMID:31758290
11562436	LINC01719	long independently transcribed non-coding RNA 1719	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01719 mRNA	PMID:35811015
11562436	LINC01719	long independently transcribed non-coding RNA 1719	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LINC01719 mRNA	PMID:29803840
11562436	LINC01719	long independently transcribed non-coding RNA 1719	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of LINC01719 mRNA	PMID:34973136
11562436	LINC01719	long independently transcribed non-coding RNA 1719	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01719 mRNA	PMID:35811015
11562447	LINC01754	long independently transcribed non-coding RNA 1754	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01754 promoter	PMID:30157460
11562447	LINC01754	long independently transcribed non-coding RNA 1754	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC01754 promoter	PMID:30157460
11562447	LINC01754	long independently transcribed non-coding RNA 1754	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC01754 promoter	PMID:30157460
11562468	LINC01770	long independently transcribed non-coding RNA 1770	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC01770 mRNA	PMID:30851411
11562468	LINC01770	long independently transcribed non-coding RNA 1770	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC01770 mRNA	PMID:30851411
11562517	LINC01753	long independently transcribed non-coding RNA 1753	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01753 intron	PMID:30157460
11562542	LINC01785	long independently transcribed non-coding RNA 1785	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01785 mRNA	PMID:41028656
11562542	LINC01785	long independently transcribed non-coding RNA 1785	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01785 mRNA	PMID:41028656
11562542	LINC01785	long independently transcribed non-coding RNA 1785	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01785 mRNA	PMID:41028656
11562565	LINC01721	long independently transcribed non-coding RNA 1721	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01721 mRNA	PMID:41028656
11562565	LINC01721	long independently transcribed non-coding RNA 1721	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01721 mRNA	PMID:41028656
11562565	LINC01721	long independently transcribed non-coding RNA 1721	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01721 mRNA	PMID:41028656
11562575	LINC01783	long independently transcribed non-coding RNA 1783	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:D001564	[AHR gene mutant form affects the susceptibility to Benzo(a)pyrene] which results in decreased expression of LINC01783	PMID:38036013
11562575	LINC01783	long independently transcribed non-coding RNA 1783	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01783 mRNA	PMID:38568856
11562575	LINC01783	long independently transcribed non-coding RNA 1783	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LINC01783 gene	PMID:29154799
11562607	LINC01788	long independently transcribed non-coding RNA 1788	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of LINC01788 mRNA	PMID:39245080
11562623	LINC01790	long independently transcribed non-coding RNA 1790	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC01790 intron	PMID:30157460
11562623	LINC01790	long independently transcribed non-coding RNA 1790	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC01790 intron	PMID:30157460
11562633	LINC01787	long independently transcribed non-coding RNA 1787	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01787 mRNA	PMID:29301061
11562633	LINC01787	long independently transcribed non-coding RNA 1787	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC01787 mRNA	PMID:32234424
11562633	LINC01787	long independently transcribed non-coding RNA 1787	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01787 mRNA	PMID:38832940
11562633	LINC01787	long independently transcribed non-coding RNA 1787	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of LINC01787 mRNA	PMID:32234424
11562647	LINC01647	long independently transcribed non-coding RNA 1647	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01647 mRNA	PMID:38568856
11562647	LINC01647	long independently transcribed non-coding RNA 1647	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01647 mRNA	PMID:38568856
11562647	LINC01647	long independently transcribed non-coding RNA 1647	gene	CHEBI:756028	mivebresib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in increased expression of LINC01647 mRNA	PMID:35486664
11562647	LINC01647	long independently transcribed non-coding RNA 1647	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC01647 mRNA	PMID:38568856
11562680	LINC01744	long independently transcribed non-coding RNA 1744	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01744 mRNA	PMID:38568856
11562725	LINC01743	long independently transcribed non-coding RNA 1743	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01743 intron	PMID:30157460
11562725	LINC01743	long independently transcribed non-coding RNA 1743	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01743 mRNA	PMID:29301061
11562725	LINC01743	long independently transcribed non-coding RNA 1743	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of LINC01743 gene	PMID:31601247
11562725	LINC01743	long independently transcribed non-coding RNA 1743	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of LINC01743 gene	PMID:31601247
11562733	LINC01635	long independently transcribed non-coding RNA 1635	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01635 mRNA	PMID:35811015
11562733	LINC01635	long independently transcribed non-coding RNA 1635	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01635 mRNA	PMID:35811015
11562733	LINC01635	long independently transcribed non-coding RNA 1635	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of LINC01635 mRNA	PMID:31629900
11562758	LINC01748	long independently transcribed non-coding RNA 1748	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01748 mRNA	PMID:41028656
11562758	LINC01748	long independently transcribed non-coding RNA 1748	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01748 mRNA	PMID:41028656
11562758	LINC01748	long independently transcribed non-coding RNA 1748	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01748 mRNA	PMID:38568856
11562758	LINC01748	long independently transcribed non-coding RNA 1748	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01748 mRNA	PMID:41028656
11562832	LINC01639	long independently transcribed non-coding RNA 1639	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC01639 intron	PMID:30157460
11562902	PSG8-AS1	PSG8 antisense RNA 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of PSG8-AS1 mRNA	PMID:41028656
11562902	PSG8-AS1	PSG8 antisense RNA 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of PSG8-AS1 mRNA	PMID:41028656
11562902	PSG8-AS1	PSG8 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of PSG8-AS1 mRNA	PMID:29301061
11562902	PSG8-AS1	PSG8 antisense RNA 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of PSG8-AS1 mRNA	PMID:41028656
11562902	PSG8-AS1	PSG8 antisense RNA 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PSG8-AS1 mRNA	PMID:38832940
11562967	LINC01730	long independently transcribed non-coding RNA 1730	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of LINC01730 mRNA	PMID:38568856
11562967	LINC01730	long independently transcribed non-coding RNA 1730	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC01730 mRNA	PMID:33212167
11562977	LINC01766	long independently transcribed non-coding RNA 1766	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of LINC01766 mRNA	PMID:39245080
11563019	LINC01808	long independently transcribed non-coding RNA 1808	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01808 mRNA	PMID:38568856
11563044	LINC01781	long independently transcribed non-coding RNA 1781	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LINC01781 mRNA	PMID:33212167
11563044	LINC01781	long independently transcribed non-coding RNA 1781	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01781 mRNA	PMID:29301061
11563044	LINC01781	long independently transcribed non-coding RNA 1781	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01781 intron	PMID:30157460
11563044	LINC01781	long independently transcribed non-coding RNA 1781	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC01781 intron	PMID:30157460
11563044	LINC01781	long independently transcribed non-coding RNA 1781	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC01781 intron	PMID:30157460
11563058	LINC01655	long intergenic non-protein coding RNA 1655	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01655 mRNA	PMID:38568856
11563292	LINC01755	long independently transcribed non-coding RNA 1755	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01755 mRNA	PMID:41028656
11563292	LINC01755	long independently transcribed non-coding RNA 1755	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01755 mRNA	PMID:41028656
11563292	LINC01755	long independently transcribed non-coding RNA 1755	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01755 mRNA	PMID:41028656
11563327	LINC01768	long independently transcribed non-coding RNA 1768	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01768 mRNA	PMID:35811015
11563327	LINC01768	long independently transcribed non-coding RNA 1768	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC01768 mRNA	PMID:35811015
11563327	LINC01768	long independently transcribed non-coding RNA 1768	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01768 mRNA	PMID:35811015
11563340	LINC01740	long independently transcribed non-coding RNA 1740	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01740 mRNA	PMID:35811015
11563340	LINC01740	long independently transcribed non-coding RNA 1740	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of LINC01740 mRNA	PMID:39245080
11563340	LINC01740	long independently transcribed non-coding RNA 1740	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC01740 mRNA	PMID:35811015
11563340	LINC01740	long independently transcribed non-coding RNA 1740	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01740 mRNA	PMID:35811015
11563348	UCA1-AS1	UCA1 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of UCA1-AS1 mRNA	PMID:34032870
11563371	LINC01776	long independently transcribed non-coding RNA 1776	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of LINC01776 gene	PMID:31601247
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1557285	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TMEM269 mRNA	PMID:33045310
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TMEM269 mRNA	PMID:36139627
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1563015	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TMEM269 mRNA	PMID:33387578
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1563015	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TMEM269 mRNA	PMID:31881176
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TMEM269 mRNA	PMID:27392435
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of TMEM269 mRNA	PMID:27392435
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TMEM269 mRNA	PMID:33212167
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1563015	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TMEM269 mRNA	PMID:28959563
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TMEM269 mRNA	PMID:32763439
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1563015	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TMEM269 gene	PMID:28505145
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1563015	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TMEM269 mRNA	PMID:36041667
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1557285	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of TMEM269 mRNA	PMID:40203079
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1563015	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TMEM269 mRNA	PMID:36041667
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1563015	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TMEM269 mRNA	PMID:36041667
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1557285	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TMEM269 mRNA	PMID:37019170
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1563015	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TMEM269 mRNA	PMID:33453195
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1557285	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TMEM269 mRNA	PMID:40194260
11563379	TMEM269	transmembrane protein 269	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TMEM269 mRNA	PMID:36139627
11563408	LINC01792	long independently transcribed non-coding RNA 1792	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01792 mRNA	PMID:38568856
11563408	LINC01792	long independently transcribed non-coding RNA 1792	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of LINC01792 mRNA	PMID:40434365
11563479	NTRAS	non-coding transcript regulating alternative splicing	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NTRAS mRNA	PMID:33212167
11563487	LINC01772	long independently transcribed non-coding RNA 1772	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC01772 promoter	PMID:30157460
11563487	LINC01772	long independently transcribed non-coding RNA 1772	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC01772 promoter	PMID:30157460
11563487	LINC01772	long independently transcribed non-coding RNA 1772	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01772 promoter	PMID:30157460
11563487	LINC01772	long independently transcribed non-coding RNA 1772	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC01772 promoter	PMID:30157460
11563487	LINC01772	long independently transcribed non-coding RNA 1772	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01772 mRNA	PMID:38832940
11563487	LINC01772	long independently transcribed non-coding RNA 1772	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC01772 promoter	PMID:30157460
11563554	LINC01801	long independently transcribed non-coding RNA 1801	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LINC01801 mRNA	PMID:36139627
11563554	LINC01801	long independently transcribed non-coding RNA 1801	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LINC01801 mRNA	PMID:31533062
11563554	LINC01801	long independently transcribed non-coding RNA 1801	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01801 mRNA	PMID:38832940
11563554	LINC01801	long independently transcribed non-coding RNA 1801	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LINC01801 mRNA	PMID:36139627
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of IGFL2-AS1 mRNA	PMID:38218311
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of IGFL2-AS1 mRNA	PMID:38568856
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IGFL2-AS1 mRNA	PMID:32234424
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:28842	octadecanoic acid	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C031183	stearic acid results in increased expression of IGFL2-AS1 mRNA	PMID:32347412
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of IGFL2-AS1 mRNA	PMID:38568856
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of IGFL2-AS1 mRNA	PMID:29301061
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IGFL2-AS1 mRNA	PMID:32234424
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of IGFL2-AS1 mRNA	PMID:38568856
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in decreased expression of IGFL2-AS1 mRNA	PMID:38568856
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A results in decreased expression of IGFL2-AS1 mRNA	PMID:38568856
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C543008	bisphenol S results in decreased expression of IGFL2-AS1 mRNA	PMID:38568856
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:34575	bisphenol F	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008745	bisphenol F results in decreased expression of IGFL2-AS1 mRNA	PMID:38568856
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of IGFL2-AS1 mRNA	PMID:37738295
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of IGFL2-AS1 mRNA	PMID:38832940
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of IGFL2-AS1 mRNA	PMID:38568856
11563568	IGFL2-AS1	IGFL2 antisense RNA 1	gene	CHEBI:80799	Bufotalin	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of IGFL2-AS1 mRNA	PMID:39904859
11563610	LINC01722	long independently transcribed non-coding RNA 1722	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01722 mRNA	PMID:41028656
11563610	LINC01722	long independently transcribed non-coding RNA 1722	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01722 mRNA	PMID:41028656
11563610	LINC01722	long independently transcribed non-coding RNA 1722	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01722 mRNA	PMID:41028656
11563636	LINC01632	long independently transcribed non-coding RNA 1632	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01632 mRNA	PMID:35811015
11563636	LINC01632	long independently transcribed non-coding RNA 1632	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01632 mRNA	PMID:38568856
11563636	LINC01632	long independently transcribed non-coding RNA 1632	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC01632 mRNA	PMID:35811015
11563636	LINC01632	long independently transcribed non-coding RNA 1632	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01632 mRNA	PMID:35811015
11563658	LINC01702	long independently transcribed non-coding RNA 1702	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01702 mRNA	PMID:29301061
11563658	LINC01702	long independently transcribed non-coding RNA 1702	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01702 mRNA	PMID:38832940
11563687	LINC01638	long independently transcribed non-coding RNA 1638	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of LINC01638 mRNA	PMID:36695872
11563687	LINC01638	long independently transcribed non-coding RNA 1638	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC01638 mRNA	PMID:38832940
11563748	LINC01762	long independently transcribed non-coding RNA 1762	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC01762 intron	PMID:30157460
11563748	LINC01762	long independently transcribed non-coding RNA 1762	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC01762 intron	PMID:30157460
11563765	LNCTAM34A	long non coding transcriptional activator of miR34a	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LNCTAM34A mRNA	PMID:38832940
11563773	LINC01707	long independently transcribed non-coding RNA 1707	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC01707 intron	PMID:30157460
11563773	LINC01707	long independently transcribed non-coding RNA 1707	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC01707 intron	PMID:30157460
11563773	LINC01707	long independently transcribed non-coding RNA 1707	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC01707 intron	PMID:30157460
11563796	LINC01711	long independently transcribed non-coding RNA 1711	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of LINC01711 mRNA	PMID:29955902
11563796	LINC01711	long independently transcribed non-coding RNA 1711	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01711 mRNA	PMID:38568856
11563796	LINC01711	long independently transcribed non-coding RNA 1711	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of LINC01711 mRNA	PMID:31715268
11563796	LINC01711	long independently transcribed non-coding RNA 1711	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LINC01711 gene	PMID:29154799
11563796	LINC01711	long independently transcribed non-coding RNA 1711	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC01711 mRNA	PMID:38832940
11563800	LINC01692	long independently transcribed non-coding RNA 1692	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of LINC01692 gene	PMID:31601247
11563826	LINC01807	long independently transcribed non-coding RNA 1807	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC01807 intron	PMID:30157460
11563826	LINC01807	long independently transcribed non-coding RNA 1807	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01807 mRNA	PMID:38832940
11563866	LINC01633	long independently transcribed non-coding RNA 1633	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01633 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01633 mRNA	PMID:35811015
11563866	LINC01633	long independently transcribed non-coding RNA 1633	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01633 mRNA	PMID:38568856
11563866	LINC01633	long independently transcribed non-coding RNA 1633	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC01633 mRNA	PMID:35811015
11563866	LINC01633	long independently transcribed non-coding RNA 1633	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01633 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01633 mRNA	PMID:35811015
11563873	LINC01752	long independently transcribed non-coding RNA 1752	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC01752 promoter	PMID:30157460
11563879	LINC01683	long independently transcribed non-coding RNA 1683	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC01683 promoter	PMID:30157460
11563879	LINC01683	long independently transcribed non-coding RNA 1683	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01683 promoter	PMID:30157460
11563892	LINC01789	long independently transcribed non-coding RNA 1789	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01789 mRNA	PMID:29301061
11563915	LINC01705	long independently transcribed non-coding RNA 1705	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01705 mRNA	PMID:35811015
11563915	LINC01705	long independently transcribed non-coding RNA 1705	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01705 mRNA	PMID:38568856
11563915	LINC01705	long independently transcribed non-coding RNA 1705	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01705 mRNA	PMID:38568856
11563915	LINC01705	long independently transcribed non-coding RNA 1705	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC01705 mRNA	PMID:35811015
11563915	LINC01705	long independently transcribed non-coding RNA 1705	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01705 mRNA	PMID:35811015
11563915	LINC01705	long independently transcribed non-coding RNA 1705	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC01705 mRNA	PMID:38568856
11563924	LINC01686	long independently transcribed non-coding RNA 1686	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LINC01686 mRNA	PMID:35811015
11563924	LINC01686	long independently transcribed non-coding RNA 1686	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of LINC01686 mRNA]	PMID:35811015
11563924	LINC01686	long independently transcribed non-coding RNA 1686	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of LINC01686 mRNA	PMID:27905399
11563924	LINC01686	long independently transcribed non-coding RNA 1686	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of LINC01686 mRNA]	PMID:35811015
11563928	LINC01697	long independently transcribed non-coding RNA 1697	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01697 mRNA	PMID:38568856
11563928	LINC01697	long independently transcribed non-coding RNA 1697	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC01697 mRNA	PMID:32234424
11563928	LINC01697	long independently transcribed non-coding RNA 1697	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC01697 intron	PMID:30157460
11563928	LINC01697	long independently transcribed non-coding RNA 1697	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01697 mRNA	PMID:38832940
11563928	LINC01697	long independently transcribed non-coding RNA 1697	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC01697 intron	PMID:30157460
11563967	LINC01750	long independently transcribed non-coding RNA 1750	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC01750 mRNA	PMID:32234424
11563967	LINC01750	long independently transcribed non-coding RNA 1750	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01750 mRNA	PMID:38832940
11563967	LINC01750	long independently transcribed non-coding RNA 1750	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of LINC01750 mRNA	PMID:28991164
11563967	LINC01750	long independently transcribed non-coding RNA 1750	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of LINC01750 mRNA	PMID:28991164
11564006	LINC01687	long independently transcribed non-coding RNA 1687	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01687 mRNA	PMID:38568856
11564006	LINC01687	long independently transcribed non-coding RNA 1687	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01687 mRNA	PMID:38832940
11564028	LINC01786	long independently transcribed non-coding RNA 1786	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D010126	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA] which results in increased expression of SCNN1D mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA	PMID:33656867
11564028	LINC01786	long independently transcribed non-coding RNA 1786	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC01786 mRNA	PMID:33212167
11564028	LINC01786	long independently transcribed non-coding RNA 1786	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of LINC01786 mRNA	PMID:32763439
11564028	LINC01786	long independently transcribed non-coding RNA 1786	gene	CHEBI:29191	hydroxyl	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA] which results in increased expression of SCNN1D mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA	PMID:33656867
11564028	LINC01786	long independently transcribed non-coding RNA 1786	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA] which results in increased expression of SCNN1D mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA] which results in increased expression of SCNN1D mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01786 mRNA	PMID:33656867
11564052	LINC01710	long independently transcribed non-coding RNA 1710	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01710 mRNA	PMID:38568856
11564061	LINC01703	long independently transcribed non-coding RNA 1703	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC01703 promoter	PMID:30157460
11564061	LINC01703	long independently transcribed non-coding RNA 1703	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01703 mRNA	PMID:38832940
11564061	LINC01703	long independently transcribed non-coding RNA 1703	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC01703 promoter	PMID:30157460
11564061	LINC01703	long independently transcribed non-coding RNA 1703	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of LINC01703 mRNA	PMID:39904859
11564090	LINC01778	long independently transcribed non-coding RNA 1778	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01778 mRNA	PMID:35811015
11564090	LINC01778	long independently transcribed non-coding RNA 1778	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC01778 mRNA	PMID:33212167
11564090	LINC01778	long independently transcribed non-coding RNA 1778	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC01778 mRNA	PMID:38832940
11564090	LINC01778	long independently transcribed non-coding RNA 1778	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01778 mRNA	PMID:35811015
11564204	LINC01806	long independently transcribed non-coding RNA 1806	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC01806 mRNA	PMID:30851411
11564204	LINC01806	long independently transcribed non-coding RNA 1806	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01806 mRNA	PMID:38568856
11564204	LINC01806	long independently transcribed non-coding RNA 1806	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC01806 promoter	PMID:30157460
11564204	LINC01806	long independently transcribed non-coding RNA 1806	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01806 mRNA	PMID:38832940
11564204	LINC01806	long independently transcribed non-coding RNA 1806	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC01806 promoter	PMID:30157460
11564204	LINC01806	long independently transcribed non-coding RNA 1806	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC01806 mRNA	PMID:30851411
11564219	LINC01679	long independently transcribed non-coding RNA 1679	gene	CHEBI:26523	reactive oxygen species	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017382	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of CELF3 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PGPEP1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PSMB11 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of ZNF37A mRNA; [Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA	PMID:33656867
11564219	LINC01679	long independently transcribed non-coding RNA 1679	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of CELF3 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PGPEP1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of PSMB11 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA] which results in increased expression of ZNF37A mRNA; [Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of LINC01679 mRNA	PMID:33656867
11564243	LINC01727	long independently transcribed non-coding RNA 1727	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01727 mRNA	PMID:29301061
11564243	LINC01727	long independently transcribed non-coding RNA 1727	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:2314650	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NKX2-2OS gene	PMID:35295148
11564243	LINC01727	long independently transcribed non-coding RNA 1727	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:2314650	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NKX2-2OS promoter	PMID:35295148
11564292	LINC01796	long independently transcribed non-coding RNA 1796	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01796 mRNA	PMID:38568856
11564309	LINC01701	long independently transcribed non-coding RNA 1701	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01701 mRNA	PMID:35811015
11564309	LINC01701	long independently transcribed non-coding RNA 1701	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01701 mRNA	PMID:35811015
11565208	LINC01816	long independently transcribed non-coding RNA 1816	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01816 mRNA	PMID:38568856
11565208	LINC01816	long independently transcribed non-coding RNA 1816	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of LINC01816 mRNA	PMID:31533062
11565225	LINC01822	long independently transcribed non-coding RNA 1822	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01822 mRNA	PMID:38568856
11565225	LINC01822	long independently transcribed non-coding RNA 1822	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LINC01822 mRNA	PMID:32234424
11565225	LINC01822	long independently transcribed non-coding RNA 1822	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC01822 mRNA	PMID:38832940
11565233	LINC01831	long independently transcribed non-coding RNA 1831	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01831 mRNA	PMID:29301061
11565233	LINC01831	long independently transcribed non-coding RNA 1831	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC01831 mRNA	PMID:32234424
11565239	LINC01821	long independently transcribed non-coding RNA 1821	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC01821 intron	PMID:30157460
11565239	LINC01821	long independently transcribed non-coding RNA 1821	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01821 mRNA	PMID:41028656
11565239	LINC01821	long independently transcribed non-coding RNA 1821	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01821 mRNA	PMID:41028656
11565239	LINC01821	long independently transcribed non-coding RNA 1821	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01821 mRNA	PMID:41028656
11565253	LINC01819	long independently transcribed non-coding RNA 1819	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of LINC01819 mRNA	PMID:30510588
11565253	LINC01819	long independently transcribed non-coding RNA 1819	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01819 mRNA	PMID:41028656
11565253	LINC01819	long independently transcribed non-coding RNA 1819	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01819 mRNA	PMID:41028656
11565253	LINC01819	long independently transcribed non-coding RNA 1819	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01819 mRNA	PMID:41028656
11565253	LINC01819	long independently transcribed non-coding RNA 1819	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of LINC01819 mRNA	PMID:35486664
11565267	LINC01818	long independently transcribed non-coding RNA 1818	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01818 mRNA	PMID:38832940
11565278	LINC01820	long independently transcribed non-coding RNA 1820	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC01820 mRNA	PMID:30851411
11565278	LINC01820	long independently transcribed non-coding RNA 1820	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC01820 mRNA	PMID:30851411
11565291	LINC01148	long independently transcribed non-coding RNA 1148	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LINC01148 gene	PMID:31601247
11565291	LINC01148	long independently transcribed non-coding RNA 1148	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LINC01148 gene	PMID:31601247
11565303	LINC01823	long independently transcribed non-coding RNA 1823	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01823 mRNA	PMID:38568856
11565324	LINC01814	long intergenic non-protein coding RNA 1814	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01814 mRNA	PMID:41028656
11565324	LINC01814	long intergenic non-protein coding RNA 1814	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01814 mRNA	PMID:41028656
11565324	LINC01814	long intergenic non-protein coding RNA 1814	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01814 mRNA	PMID:41028656
11565324	LINC01814	long intergenic non-protein coding RNA 1814	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C543008	bisphenol S results in decreased expression of LINC01814 mRNA	PMID:33476716
11565338	LINC01345	long independently transcribed non-coding RNA 1345	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of LINC01345 mRNA	PMID:38218311
11565421	LINC01829	long independently transcribed non-coding RNA 1829	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01829 mRNA	PMID:38568856
11565963	LINC01836	long independently transcribed non-coding RNA 1836	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of LINC01836 mRNA	PMID:38218311
11565970	LINC01842	long independently transcribed non-coding RNA 1842	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC01842 intron	PMID:30157460
11565970	LINC01842	long independently transcribed non-coding RNA 1842	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC01842 intron	PMID:30157460
11565970	LINC01842	long independently transcribed non-coding RNA 1842	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC01842 intron	PMID:30157460
11565983	PGR-AS1	PGR antisense RNA 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of PGR-AS1 mRNA	PMID:31614463
11565995	LINC01841	long independently transcribed non-coding RNA 1841	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC01841 intron	PMID:30157460
11565995	LINC01841	long independently transcribed non-coding RNA 1841	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01841 intron	PMID:30157460
11565995	LINC01841	long independently transcribed non-coding RNA 1841	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC01841 intron	PMID:30157460
11565995	LINC01841	long independently transcribed non-coding RNA 1841	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC01841 intron	PMID:30157460
11568708	LINC01942	long independently transcribed non-coding RNA 1942	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of LINC01942 mRNA	PMID:38218311
11568708	LINC01942	long independently transcribed non-coding RNA 1942	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01942 mRNA	PMID:38568856
11568708	LINC01942	long independently transcribed non-coding RNA 1942	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01942 mRNA	PMID:38832940
11568725	TBC1D3D	TBC1 domain family member 3D	gene	CHEBI:132446	perfluorobutanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C539348	perfluorobutanesulfonic acid results in decreased expression of TBC1D3D mRNA	PMID:40334771
11568725	TBC1D3D	TBC1 domain family member 3D	gene	CHEBI:132446	perfluorobutanesulfonic acid	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C539348	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of TBC1D3D mRNA	PMID:40334771
11568725	TBC1D3D	TBC1 domain family member 3D	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of TBC1D3D mRNA	PMID:40865780
11568725	TBC1D3D	TBC1 domain family member 3D	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C010974	Glyphosate results in increased expression of TBC1D3D mRNA	PMID:40865780
11568725	TBC1D3D	TBC1 domain family member 3D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of TBC1D3D mRNA	PMID:29704546
11568725	TBC1D3D	TBC1 domain family member 3D	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C006780	bisphenol A results in increased expression of TBC1D3D mRNA	PMID:37244401
11568725	TBC1D3D	TBC1 domain family member 3D	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TBC1D3D mRNA	PMID:37042841
11568725	TBC1D3D	TBC1 domain family member 3D	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of TBC1D3D mRNA	PMID:40334771
11568725	TBC1D3D	TBC1 domain family member 3D	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C023036	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of TBC1D3D mRNA	PMID:40334771
11568725	TBC1D3D	TBC1 domain family member 3D	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TBC1D3D mRNA	PMID:40334771
11568725	TBC1D3D	TBC1 domain family member 3D	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of TBC1D3D mRNA	PMID:40334771
11568805	LINC01888	long independently transcribed non-coding RNA 1888	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01888 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01888 mRNA	PMID:35811015
11568805	LINC01888	long independently transcribed non-coding RNA 1888	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC01888 mRNA	PMID:35811015
11568805	LINC01888	long independently transcribed non-coding RNA 1888	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01888 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01888 mRNA	PMID:35811015
11568822	LINC01950	long independently transcribed non-coding RNA 1950	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01950 mRNA	PMID:38568856
11568832	LINC01901	long independently transcribed non-coding RNA 1901	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC01901 mRNA	PMID:38832940
11568845	LINC01937	long independently transcribed non-coding RNA 1937	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01937 mRNA	PMID:38568856
11568888	LINC01883	long independently transcribed non-coding RNA 1883	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01883 polyA tail	PMID:30157460
11568902	LINC01914	long independently transcribed non-coding RNA 1914	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC01914 mRNA	PMID:38832940
11568944	LINC01238	long intergenic non-protein coding RNA 1238	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of LINC01238 mRNA	PMID:38218311
11568944	LINC01238	long intergenic non-protein coding RNA 1238	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of LINC01238 mRNA	PMID:30510588
11568944	LINC01238	long intergenic non-protein coding RNA 1238	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC01238 intron	PMID:30157460
11568944	LINC01238	long intergenic non-protein coding RNA 1238	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01238 intron	PMID:30157460
11568944	LINC01238	long intergenic non-protein coding RNA 1238	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LINC01238 mRNA	PMID:33212167
11568944	LINC01238	long intergenic non-protein coding RNA 1238	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC01238 intron	PMID:30157460
11568944	LINC01238	long intergenic non-protein coding RNA 1238	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01238 mRNA	PMID:38832940
11568944	LINC01238	long intergenic non-protein coding RNA 1238	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of LINC01238 mRNA	PMID:31629900
11568944	LINC01238	long intergenic non-protein coding RNA 1238	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC01238 intron	PMID:30157460
11569033	LINC01852	long independently transcribed non-coding RNA 1852	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01852 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LINC01852 mRNA	PMID:35811015
11569033	LINC01852	long independently transcribed non-coding RNA 1852	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LINC01852 mRNA	PMID:36139627
11569033	LINC01852	long independently transcribed non-coding RNA 1852	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01852 mRNA	PMID:38832940
11569033	LINC01852	long independently transcribed non-coding RNA 1852	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01852 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LINC01852 mRNA	PMID:35811015
11569033	LINC01852	long independently transcribed non-coding RNA 1852	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LINC01852 mRNA	PMID:36139627
11569073	LINC01915	long independently transcribed non-coding RNA 1915	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01915 polyA tail	PMID:30157460
11569073	LINC01915	long independently transcribed non-coding RNA 1915	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01915 mRNA	PMID:38568856
11569081	LINC01910	long independently transcribed non-coding RNA 1910	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01910 promoter	PMID:30157460
11569081	LINC01910	long independently transcribed non-coding RNA 1910	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC01910 mRNA	PMID:38832940
11569124	LINC01886	long independently transcribed non-coding RNA 1886	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01886 mRNA	PMID:38568856
11569139	LINC01943	long independently transcribed non-coding RNA 1943	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01943 mRNA	PMID:38568856
11569139	LINC01943	long independently transcribed non-coding RNA 1943	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of LINC01943 mRNA	PMID:31629900
11569153	LINC01896	long independently transcribed non-coding RNA 1896	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LINC01896 mRNA	PMID:28001369
11569153	LINC01896	long independently transcribed non-coding RNA 1896	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of LINC01896 mRNA	PMID:28001369
11569188	LINC01954	long independently transcribed non-coding RNA 1954	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of LINC01954 mRNA	PMID:31614463
11569188	LINC01954	long independently transcribed non-coding RNA 1954	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of LINC01954 mRNA	PMID:32234424
11569188	LINC01954	long independently transcribed non-coding RNA 1954	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC01954 mRNA	PMID:32234424
11569188	LINC01954	long independently transcribed non-coding RNA 1954	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of LINC01954 mRNA	PMID:32234424
11569188	LINC01954	long independently transcribed non-coding RNA 1954	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of LINC01954 mRNA	PMID:32234424
11569268	LINC01857	long independently transcribed non-coding RNA 1857	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01857 mRNA	PMID:35811015
11569268	LINC01857	long independently transcribed non-coding RNA 1857	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01857 mRNA	PMID:35811015
11569283	LINC01881	long independently transcribed non-coding RNA 1881	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of LINC01881 mRNA	PMID:39245080
11569283	LINC01881	long independently transcribed non-coding RNA 1881	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:D001151	Arsenic results in increased methylation of LINC01881 gene	PMID:27838757
11569283	LINC01881	long independently transcribed non-coding RNA 1881	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01881 mRNA	PMID:34032870
11569283	LINC01881	long independently transcribed non-coding RNA 1881	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LINC01881 mRNA	PMID:32588087
11569283	LINC01881	long independently transcribed non-coding RNA 1881	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LINC01881 mRNA	PMID:31533062
11569283	LINC01881	long independently transcribed non-coding RNA 1881	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:D001151	Arsenic results in increased methylation of LINC01881 gene	PMID:27838757
11569316	LINC01929	long independently transcribed non-coding RNA 1929	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01929 mRNA	PMID:29301061
11569316	LINC01929	long independently transcribed non-coding RNA 1929	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of LINC01929 mRNA	PMID:31715268
11569324	LINC01885	long independently transcribed non-coding RNA 1885	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01885 mRNA	PMID:38832940
11569357	LINC01878	long independently transcribed non-coding RNA 1878	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01878 intron	PMID:30157460
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of LINC01963 mRNA	PMID:38218311
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LINC01963 mRNA	PMID:36139627
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20161214	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of LINC01963 mRNA	PMID:26272509
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161214	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LINC01963 mRNA	PMID:27188386
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of LINC01963 mRNA	PMID:29955902
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20161214	CTD	MESH:C004925	methylmercuric chloride results in increased expression of LINC01963 mRNA	PMID:23179753|PMID:27188386
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC01963 mRNA	PMID:33212167
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LINC01963 mRNA	PMID:29803840
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01963 mRNA	PMID:39719251
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of LINC01963 gene	PMID:31601247
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of LINC01963 mRNA	PMID:31745603
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of LINC01963 gene	PMID:31601247
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LINC01963 mRNA	PMID:38568856
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of LINC01963 mRNA	PMID:31533062
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161214	CTD	MESH:D014635	Valproic Acid results in increased expression of LINC01963 mRNA	PMID:23179753|PMID:26272509|PMID:27188386|PMID:28001369
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161214	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LINC01963 mRNA	PMID:27188386
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01963 mRNA	PMID:38832940
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	fipronil results in decreased expression of LINC01963 mRNA	PMID:28991164
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of LINC01963 mRNA	PMID:28991164
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of LINC01963 mRNA	PMID:28991164
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LINC01963 mRNA	PMID:36139627
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LINC01963 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LINC01963 mRNA	PMID:27188386
11569372	LINC01963	long independently transcribed non-coding RNA 1963	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LINC01963 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LINC01963 mRNA	PMID:27188386
11569429	TBC1D8-AS1	TBC1D8 antisense RNA 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TBC1D8-AS1 mRNA	PMID:33670352
11569469	LINC01924	long independently transcribed non-coding RNA 1924	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in increased expression of LINC01924 mRNA	PMID:27905399
11569469	LINC01924	long independently transcribed non-coding RNA 1924	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01924 intron	PMID:30157460
11569521	LINC01933	long independently transcribed non-coding RNA 1933	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC01933 intron	PMID:30157460
11569521	LINC01933	long independently transcribed non-coding RNA 1933	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01933 mRNA	PMID:34032870
11569521	LINC01933	long independently transcribed non-coding RNA 1933	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161214	CTD	MESH:D014635	Valproic Acid results in increased expression of LINC01933 mRNA	PMID:26272509
11569521	LINC01933	long independently transcribed non-coding RNA 1933	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC01933 mRNA	PMID:38568856
11569657	PSD2-AS1	PSD2 antisense RNA 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of PSD2-AS1 mRNA	PMID:31629900
11569679	LINC01947	long independently transcribed non-coding RNA 1947	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01947 intron	PMID:30157460
11569679	LINC01947	long independently transcribed non-coding RNA 1947	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01947 mRNA	PMID:38568856
11569735	LINC01920	long independently transcribed non-coding RNA 1920	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC01920 mRNA	PMID:30851411
11569735	LINC01920	long independently transcribed non-coding RNA 1920	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01920 mRNA	PMID:38568856
11569735	LINC01920	long independently transcribed non-coding RNA 1920	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC01920 mRNA	PMID:30851411
11569749	DCST1-AS1	DCST1 antisense RNA 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DCST1-AS1 mRNA	PMID:38218311
11569749	DCST1-AS1	DCST1 antisense RNA 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of DCST1-AS1 mRNA	PMID:27392435
11569749	DCST1-AS1	DCST1 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of DCST1-AS1 mRNA	PMID:34032870
11569749	DCST1-AS1	DCST1 antisense RNA 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of DCST1-AS1 mRNA	PMID:38832940
11569781	LINC01909	long independently transcribed non-coding RNA 1909	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of LINC01909 mRNA	PMID:29955902
11569781	LINC01909	long independently transcribed non-coding RNA 1909	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC01909 mRNA	PMID:33212167
11569799	LINC01908	long independently transcribed non-coding RNA 1908	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01908 mRNA	PMID:41028656
11569799	LINC01908	long independently transcribed non-coding RNA 1908	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01908 mRNA	PMID:41028656
11569799	LINC01908	long independently transcribed non-coding RNA 1908	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01908 mRNA	PMID:41028656
11569823	SLC25A48-AS1	SLC25A48 antisense RNA 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SLC25A48-AS1 mRNA	PMID:30851411
11569823	SLC25A48-AS1	SLC25A48 antisense RNA 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC25A48-AS1 promoter	PMID:27901495
11569823	SLC25A48-AS1	SLC25A48 antisense RNA 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SLC25A48-AS1 mRNA	PMID:30851411
11569857	LINC01934	long independently transcribed non-coding RNA 1934	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC01934 mRNA	PMID:33212167
11569869	LINC01907	long independently transcribed non-coding RNA 1907	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LINC01907 mRNA	PMID:35811015
11569869	LINC01907	long independently transcribed non-coding RNA 1907	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01907 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LINC01907 mRNA	PMID:35811015
11569869	LINC01907	long independently transcribed non-coding RNA 1907	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of LINC01907 gene	PMID:31601247
11569869	LINC01907	long independently transcribed non-coding RNA 1907	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01907 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LINC01907 mRNA	PMID:35811015
11569869	LINC01907	long independently transcribed non-coding RNA 1907	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of LINC01907 mRNA	PMID:31629900
11569879	LINC01843	long independently transcribed non-coding RNA 1843	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of LINC01843 mRNA	PMID:39904859
11569879	LINC01843	long independently transcribed non-coding RNA 1843	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of LINC01843 mRNA	PMID:38568856
11569885	LINC01873	long independently transcribed non-coding RNA 1873	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of LINC01873 mRNA	PMID:35967413
11569885	LINC01873	long independently transcribed non-coding RNA 1873	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01873 mRNA	PMID:38568856
11569893	LINC01844	long intergenic non-protein coding RNA 1844	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LINC01844 mRNA	PMID:36139627
11569893	LINC01844	long intergenic non-protein coding RNA 1844	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LINC01844 mRNA	PMID:29803840
11569893	LINC01844	long intergenic non-protein coding RNA 1844	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LINC01844 mRNA	PMID:36139627
11569917	LINC01927	long independently transcribed non-coding RNA 1927	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC01927 promoter	PMID:30157460
11569917	LINC01927	long independently transcribed non-coding RNA 1927	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC01927 promoter	PMID:30157460
11569929	LINC01932	long independently transcribed non-coding RNA 1932	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01932 mRNA	PMID:34032870
11569973	LINC01948	long independently transcribed non-coding RNA 1948	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of LINC01948 mRNA	PMID:38218311
11569973	LINC01948	long independently transcribed non-coding RNA 1948	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of LINC01948 mRNA	PMID:35486664
11569973	LINC01948	long independently transcribed non-coding RNA 1948	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC01948 mRNA	PMID:38568856
11570043	MYOSLID	myocardin-induced smooth muscle lncRNA, inducer of differentiation	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MYOSLID mRNA	PMID:38568856
11570043	MYOSLID	myocardin-induced smooth muscle lncRNA, inducer of differentiation	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MYOSLID mRNA	PMID:32234424
11570043	MYOSLID	myocardin-induced smooth muscle lncRNA, inducer of differentiation	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MYOSLID mRNA	PMID:38568856
11570043	MYOSLID	myocardin-induced smooth muscle lncRNA, inducer of differentiation	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of MYOSLID mRNA	PMID:38568856
11570064	PLAC9P1	placenta associated 9 pseudogene 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PLAC9P1 promoter	PMID:27901495
11570072	LINC01903	long independently transcribed non-coding RNA 1903	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01903 mRNA	PMID:41028656
11570072	LINC01903	long independently transcribed non-coding RNA 1903	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01903 mRNA	PMID:41028656
11570072	LINC01903	long independently transcribed non-coding RNA 1903	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01903 mRNA	PMID:41028656
11570079	LINC01928	long independently transcribed non-coding RNA 1928	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01928 polyA tail	PMID:30157460
11570121	LINC01880	long independently transcribed non-coding RNA 1880	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC01880 intron	PMID:30157460
11570139	LINC01922	long independently transcribed non-coding RNA 1922	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in increased expression of LINC01922 mRNA	PMID:27905399
11570145	LINC01902	long independently transcribed non-coding RNA 1902	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01902 mRNA	PMID:41028656
11570145	LINC01902	long independently transcribed non-coding RNA 1902	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01902 mRNA	PMID:41028656
11570145	LINC01902	long independently transcribed non-coding RNA 1902	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01902 mRNA	PMID:41028656
11570185	LINC01845	long independently transcribed non-coding RNA 1845	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LINC01845 promoter	PMID:27901495
11570256	PRAL	p53 regulation associated lncRNA	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PRAL mRNA	PMID:35811015
11570256	PRAL	p53 regulation associated lncRNA	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PRAL mRNA]	PMID:35811015
11570256	PRAL	p53 regulation associated lncRNA	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of PRAL mRNA]	PMID:35811015
11570257	LINC01894	long independently transcribed non-coding RNA 1894	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01894 intron	PMID:30157460
11570257	LINC01894	long independently transcribed non-coding RNA 1894	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01894 mRNA	PMID:38832940
11570294	LINC01965	long independently transcribed non-coding RNA 1965	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01965 mRNA	PMID:41028656
11570294	LINC01965	long independently transcribed non-coding RNA 1965	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01965 mRNA	PMID:41028656
11570294	LINC01965	long independently transcribed non-coding RNA 1965	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01965 mRNA	PMID:41028656
11570311	LINC01854	long independently transcribed non-coding RNA 1854	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of LINC01854 mRNA	PMID:38218311
11570311	LINC01854	long independently transcribed non-coding RNA 1854	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in increased expression of LINC01854 mRNA	PMID:27905399
11570311	LINC01854	long independently transcribed non-coding RNA 1854	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01854 mRNA	PMID:38568856
11570311	LINC01854	long independently transcribed non-coding RNA 1854	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of LINC01854 mRNA	PMID:31629900
11570327	LINC01962	long independently transcribed non-coding RNA 1962	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of LINC01962 mRNA	PMID:31614463
11570327	LINC01962	long independently transcribed non-coding RNA 1962	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC01962 mRNA	PMID:30851411
11570327	LINC01962	long independently transcribed non-coding RNA 1962	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01962 mRNA	PMID:38568856
11570327	LINC01962	long independently transcribed non-coding RNA 1962	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of LINC01962 mRNA	PMID:36326898
11570327	LINC01962	long independently transcribed non-coding RNA 1962	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC01962 mRNA	PMID:30851411
11570333	SEMA6A-AS2	SEMA6A antisense RNA 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SEMA6A-AS2 mRNA	PMID:38568856
11570367	LINC01876	long independently transcribed non-coding RNA 1876	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC01876 intron	PMID:30157460
11570367	LINC01876	long independently transcribed non-coding RNA 1876	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01876 mRNA	PMID:38832940
11570567	LINC02016	long independently transcribed non-coding RNA 2016	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02016 mRNA	PMID:38568856
11570567	LINC02016	long independently transcribed non-coding RNA 2016	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC02016 mRNA	PMID:38568856
11570579	LINC01978	long independently transcribed non-coding RNA 1978	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of LINC01978 mRNA	PMID:38218311
11570579	LINC01978	long independently transcribed non-coding RNA 1978	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LINC01978 mRNA	PMID:40419235
11570579	LINC01978	long independently transcribed non-coding RNA 1978	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC01978 mRNA	PMID:38832940
11570585	LINC02037	long independently transcribed non-coding RNA 2037	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC02037 polyA tail	PMID:30157460
11570585	LINC02037	long independently transcribed non-coding RNA 2037	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02037 mRNA	PMID:38832940
11570585	LINC02037	long independently transcribed non-coding RNA 2037	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC02037 polyA tail	PMID:30157460
11570595	SNHG30	small nucleolar RNA host gene 30	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SNHG30 mRNA	PMID:33212167
11570595	SNHG30	small nucleolar RNA host gene 30	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNHG30 mRNA	PMID:38568856
11570595	SNHG30	small nucleolar RNA host gene 30	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SNHG30 mRNA	PMID:38568856
11570601	LINC01967	long independently transcribed non-coding RNA 1967	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01967 mRNA	PMID:41028656
11570601	LINC01967	long independently transcribed non-coding RNA 1967	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01967 mRNA	PMID:41028656
11570601	LINC01967	long independently transcribed non-coding RNA 1967	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01967 mRNA	PMID:41028656
11570620	LINC01970	long independently transcribed non-coding RNA 1970	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01970 mRNA	PMID:35811015
11570620	LINC01970	long independently transcribed non-coding RNA 1970	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of LINC01970 mRNA	PMID:27905399
11570620	LINC01970	long independently transcribed non-coding RNA 1970	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC01970 mRNA	PMID:35811015
11570635	LINC02009	long independently transcribed non-coding RNA 2009	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02009 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02009 mRNA	PMID:35811015
11570635	LINC02009	long independently transcribed non-coding RNA 2009	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of LINC02009 mRNA	PMID:38568856
11570635	LINC02009	long independently transcribed non-coding RNA 2009	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02009 intron	PMID:30157460
11570635	LINC02009	long independently transcribed non-coding RNA 2009	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC02009 mRNA	PMID:38832940
11570635	LINC02009	long independently transcribed non-coding RNA 2009	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC02009 mRNA	PMID:35811015
11570635	LINC02009	long independently transcribed non-coding RNA 2009	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02009 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02009 mRNA	PMID:35811015
11570702	LINC02025	long independently transcribed non-coding RNA 2025	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC02025 mRNA	PMID:30851411
11570702	LINC02025	long independently transcribed non-coding RNA 2025	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC02025 mRNA	PMID:30851411
11570728	LINC02043	long independently transcribed non-coding RNA 2043	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC02043 mRNA	PMID:33212167
11570745	LINC02006	long independently transcribed non-coding RNA 2006	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02006 mRNA	PMID:38568856
11570745	LINC02006	long independently transcribed non-coding RNA 2006	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02006 intron	PMID:30157460
11570745	LINC02006	long independently transcribed non-coding RNA 2006	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC02006 mRNA	PMID:38568856
11570764	LINC02032	long independently transcribed non-coding RNA 2032	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02032 mRNA	PMID:41028656
11570764	LINC02032	long independently transcribed non-coding RNA 2032	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02032 mRNA	PMID:41028656
11570764	LINC02032	long independently transcribed non-coding RNA 2032	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02032 mRNA	PMID:41028656
11570779	LINC02042	long independently transcribed non-coding RNA 2042	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02042 polyA tail	PMID:30157460
11570801	LINC02028	long independently transcribed non-coding RNA 2028	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC02028 mRNA	PMID:38568856
11570823	LINC01996	long independently transcribed non-coding RNA 1996	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D010126	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01996 mRNA] which results in increased expression of SMTNL2 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01996 mRNA	PMID:33656867
11570823	LINC01996	long independently transcribed non-coding RNA 1996	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01996 mRNA] which results in increased expression of SMTNL2 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC01996 mRNA	PMID:33656867
11570830	LINC01993	long independently transcribed non-coding RNA 1993	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC01993 mRNA	PMID:38568856
11570852	LINC01980	long independently transcribed non-coding RNA 1980	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01980 mRNA	PMID:38568856
11570897	LINC02031	long independently transcribed non-coding RNA 2031	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of LINC02031 mRNA	PMID:39245080
11570897	LINC02031	long independently transcribed non-coding RNA 2031	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of LINC02031 mRNA	PMID:34032870
11570971	LINC02000	long independently transcribed non-coding RNA 2000	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC02000 mRNA	PMID:38568856
11571013	ARHGAP27P1	Rho GTPase activating protein 27 pseudogene 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ARHGAP27P1 mRNA	PMID:31614463
11571013	ARHGAP27P1	Rho GTPase activating protein 27 pseudogene 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ARHGAP27P1 mRNA]	PMID:32406909
11571013	ARHGAP27P1	Rho GTPase activating protein 27 pseudogene 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ARHGAP27P1 gene	PMID:29154799
11571013	ARHGAP27P1	Rho GTPase activating protein 27 pseudogene 1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ARHGAP27P1 mRNA	PMID:28988120
11571021	TILAM	TGF-beta induced lncRNA activating myofibroblasts	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of TILAM mRNA	PMID:30510588
11571029	LINC01979	long independently transcribed non-coding RNA 1979	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of LINC01979 mRNA	PMID:32763439
11571051	LINC02008	long independently transcribed non-coding RNA 2008	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02008 intron	PMID:30157460
11571051	LINC02008	long independently transcribed non-coding RNA 2008	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02008 mRNA	PMID:38568856
11571051	LINC02008	long independently transcribed non-coding RNA 2008	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02008 intron	PMID:30157460
11571051	LINC02008	long independently transcribed non-coding RNA 2008	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02008 intron	PMID:30157460
11571066	LINC02019	long independently transcribed non-coding RNA 2019	gene	CHEBI:29191	hydroxyl	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC02019 mRNA] which results in increased expression of DOCK3 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC02019 mRNA	PMID:33656867
11571066	LINC02019	long independently transcribed non-coding RNA 2019	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC02019 mRNA] which results in increased expression of DOCK3 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of LINC02019 mRNA	PMID:33656867
11571073	BPTFP1	bromodomain PHD finger transcription factor pseudogene 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of BPTFP1 mRNA	PMID:38832940
11571102	LINC02018	long independently transcribed non-coding RNA 2018	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02018 intron	PMID:30157460
11571102	LINC02018	long independently transcribed non-coding RNA 2018	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC02018 mRNA	PMID:32234424
11571102	LINC02018	long independently transcribed non-coding RNA 2018	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC02018 mRNA	PMID:38568856
11571199	LINC01975	long independently transcribed non-coding RNA 1975	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC01975 intron	PMID:30157460
11571199	LINC01975	long independently transcribed non-coding RNA 1975	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01975 intron	PMID:30157460
11571223	LINC02012	long independently transcribed non-coding RNA 2012	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of LINC02012 mRNA	PMID:38568856
11571223	LINC02012	long independently transcribed non-coding RNA 2012	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC02012 mRNA	PMID:30851411
11571223	LINC02012	long independently transcribed non-coding RNA 2012	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC02012 mRNA	PMID:30851411
11571229	LINC02015	long independently transcribed non-coding RNA 2015	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LINC02015 mRNA	PMID:35811015
11571229	LINC02015	long independently transcribed non-coding RNA 2015	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of LINC02015 mRNA]	PMID:35811015
11571229	LINC02015	long independently transcribed non-coding RNA 2015	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02015 mRNA	PMID:34032870|PMID:38568856
11571229	LINC02015	long independently transcribed non-coding RNA 2015	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LINC02015 mRNA	PMID:32234424
11571229	LINC02015	long independently transcribed non-coding RNA 2015	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of LINC02015 mRNA	PMID:38568856
11571229	LINC02015	long independently transcribed non-coding RNA 2015	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of LINC02015 mRNA]	PMID:35811015
11571229	LINC02015	long independently transcribed non-coding RNA 2015	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of LINC02015 mRNA	PMID:38568856
11571229	LINC02015	long independently transcribed non-coding RNA 2015	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of LINC02015 mRNA	PMID:38568856
11571254	LINC02005	long independently transcribed non-coding RNA 2005	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02005 mRNA	PMID:35811015
11571254	LINC02005	long independently transcribed non-coding RNA 2005	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02005 mRNA	PMID:35811015
11571273	ARHGAP27P1-BPTFP1-KPNA2P3	ARHGAP27P1-BPTFP1-KPNA2P3 readthrough, transcribed pseudogene	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ARHGAP27P1-BPTFP1-KPNA2P3 mRNA	PMID:33212167
11571273	ARHGAP27P1-BPTFP1-KPNA2P3	ARHGAP27P1-BPTFP1-KPNA2P3 readthrough, transcribed pseudogene	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	fipronil results in decreased expression of ARHGAP27P1-BPTFP1-KPNA2P3 mRNA	PMID:28991164
11571273	ARHGAP27P1-BPTFP1-KPNA2P3	ARHGAP27P1-BPTFP1-KPNA2P3 readthrough, transcribed pseudogene	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of ARHGAP27P1-BPTFP1-KPNA2P3 mRNA	PMID:28991164
11571273	ARHGAP27P1-BPTFP1-KPNA2P3	ARHGAP27P1-BPTFP1-KPNA2P3 readthrough, transcribed pseudogene	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of ARHGAP27P1-BPTFP1-KPNA2P3 mRNA	PMID:28991164
11571298	LINC02034	long independently transcribed non-coding RNA 2034	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02034 mRNA	PMID:38568856
11571360	LINC02026	long independently transcribed non-coding RNA 2026	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC02026 intron	PMID:30157460
11571360	LINC02026	long independently transcribed non-coding RNA 2026	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02026 intron	PMID:30157460
11571360	LINC02026	long independently transcribed non-coding RNA 2026	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02026 intron	PMID:30157460
11571360	LINC02026	long independently transcribed non-coding RNA 2026	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LINC02026 gene	PMID:31601247
11571397	LINC01992	long independently transcribed non-coding RNA 1992	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC01992 intron	PMID:30157460
11571397	LINC01992	long independently transcribed non-coding RNA 1992	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01992 mRNA	PMID:41028656
11571397	LINC01992	long independently transcribed non-coding RNA 1992	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01992 mRNA	PMID:41028656
11571397	LINC01992	long independently transcribed non-coding RNA 1992	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01992 mRNA	PMID:41028656
11571424	LINC02022	long independently transcribed non-coding RNA 2022	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC02022 intron	PMID:30157460
11571424	LINC02022	long independently transcribed non-coding RNA 2022	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02022 intron	PMID:30157460
11571441	LINC02044	long independently transcribed non-coding RNA 2044	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02044 intron	PMID:30157460
11571441	LINC02044	long independently transcribed non-coding RNA 2044	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02044 intron	PMID:30157460
11571451	LINC02021	long independently transcribed non-coding RNA 2021	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02021 mRNA	PMID:35811015
11571451	LINC02021	long independently transcribed non-coding RNA 2021	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02021 mRNA	PMID:38832940
11571451	LINC02021	long independently transcribed non-coding RNA 2021	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02021 mRNA	PMID:35811015
11571482	LINC02004	long independently transcribed non-coding RNA 2004	gene	CHEBI:28358	rac-lactic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of LINC02004 mRNA	PMID:30851411
11571482	LINC02004	long independently transcribed non-coding RNA 2004	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of LINC02004 mRNA	PMID:30851411
11571495	LINC01971	long independently transcribed non-coding RNA 1971	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC01971 mRNA	PMID:33212167
11571521	LINC01991	long independently transcribed non-coding RNA 1991	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01991 mRNA	PMID:35811015
11571521	LINC01991	long independently transcribed non-coding RNA 1991	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC01991 mRNA	PMID:35811015
11571532	CDYLP1	CDYL pseudogene 1	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of CDYLP1 mRNA	PMID:37690743
11571532	CDYLP1	CDYL pseudogene 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C006780	bisphenol A results in decreased expression of CDYLP1 mRNA	PMID:33476716
11571532	CDYLP1	CDYL pseudogene 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CDYLP1 mRNA	PMID:33476716
11571532	CDYLP1	CDYL pseudogene 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C543008	bisphenol S results in decreased expression of CDYLP1 mRNA	PMID:33476716
11571532	CDYLP1	CDYL pseudogene 1	gene	CHEBI:34575	bisphenol F	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C008745	bisphenol F results in decreased expression of CDYLP1 mRNA	PMID:33476716
11571558	LINC02036	long intergenic non-protein coding RNA 2036	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02036 mRNA	PMID:29301061
11571569	LINC01968	long independently transcribed non-coding RNA 1968	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC01968 intron	PMID:30157460
11571569	LINC01968	long independently transcribed non-coding RNA 1968	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC01968 mRNA	PMID:41028656
11571569	LINC01968	long independently transcribed non-coding RNA 1968	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01968 mRNA	PMID:41028656
11571569	LINC01968	long independently transcribed non-coding RNA 1968	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC01968 mRNA	PMID:41028656
11571592	LINC02027	long independently transcribed non-coding RNA 2027	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02027 mRNA	PMID:41028656
11571592	LINC02027	long independently transcribed non-coding RNA 2027	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02027 mRNA	PMID:41028656
11571592	LINC02027	long independently transcribed non-coding RNA 2027	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC02027 mRNA	PMID:32234424
11571592	LINC02027	long independently transcribed non-coding RNA 2027	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02027 mRNA	PMID:41028656
11571592	LINC02027	long independently transcribed non-coding RNA 2027	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of LINC02027 mRNA	PMID:32234424
11571592	LINC02027	long independently transcribed non-coding RNA 2027	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of LINC02027 mRNA	PMID:32234424
11571598	LINC02035	long independently transcribed non-coding RNA 2035	gene	CHEBI:15756	hexadecanoic acid	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of LINC02035 mRNA	PMID:39506029
11571598	LINC02035	long independently transcribed non-coding RNA 2035	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of LINC02035 mRNA	PMID:31614463
11571598	LINC02035	long independently transcribed non-coding RNA 2035	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC02035 mRNA	PMID:33212167
11571598	LINC02035	long independently transcribed non-coding RNA 2035	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC02035 mRNA	PMID:30851411
11571598	LINC02035	long independently transcribed non-coding RNA 2035	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LINC02035 mRNA	PMID:29803840
11571598	LINC02035	long independently transcribed non-coding RNA 2035	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02035 mRNA	PMID:34032870
11571598	LINC02035	long independently transcribed non-coding RNA 2035	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LINC02035 promoter	PMID:27901495
11571598	LINC02035	long independently transcribed non-coding RNA 2035	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of LINC02035 gene	PMID:31601247
11571598	LINC02035	long independently transcribed non-coding RNA 2035	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02035 mRNA	PMID:38832940
11571598	LINC02035	long independently transcribed non-coding RNA 2035	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of LINC02035 mRNA	PMID:28991164
11571598	LINC02035	long independently transcribed non-coding RNA 2035	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of LINC02035 mRNA	PMID:28991164
11571598	LINC02035	long independently transcribed non-coding RNA 2035	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of LINC02035 mRNA	PMID:31758290
11571598	LINC02035	long independently transcribed non-coding RNA 2035	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC02035 mRNA	PMID:30851411
11571602	LINC01977	long independently transcribed non-coding RNA 1977	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC01977 mRNA	PMID:38568856
11575055	LINC02091	long independently transcribed non-coding RNA 2091	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02091 intron	PMID:30157460
11575055	LINC02091	long independently transcribed non-coding RNA 2091	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC02091 intron	PMID:30157460
11575055	LINC02091	long independently transcribed non-coding RNA 2091	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC02091 intron	PMID:30157460
11575069	NDST1-AS1	NDST1 antisense RNA 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NDST1-AS1 intron	PMID:30157460
11575069	NDST1-AS1	NDST1 antisense RNA 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of NDST1-AS1 mRNA	PMID:30851411
11575069	NDST1-AS1	NDST1 antisense RNA 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of NDST1-AS1 mRNA	PMID:30851411
11575085	LINC02068	long independently transcribed non-coding RNA 2068	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in increased expression of LINC02068 mRNA	PMID:30616060
11575085	LINC02068	long independently transcribed non-coding RNA 2068	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC02068 mRNA	PMID:38568856
11575094	LINC02054	long independently transcribed non-coding RNA 2054	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02054 mRNA	PMID:41028656
11575094	LINC02054	long independently transcribed non-coding RNA 2054	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02054 mRNA	PMID:41028656
11575094	LINC02054	long independently transcribed non-coding RNA 2054	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02054 mRNA	PMID:41028656
11575121	LINC02114	long independently transcribed non-coding RNA 2114	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of LINC02114 mRNA	PMID:27905399
11575127	LINC02064	long independently transcribed non-coding RNA 2064	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of LINC02064 mRNA	PMID:31016361
11575139	LINC02119	long independently transcribed non-coding RNA 2119	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of LINC02119 mRNA	PMID:28988120
11575139	LINC02119	long independently transcribed non-coding RNA 2119	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of LINC02119 mRNA	PMID:35486664
11575145	LINC02120	long independently transcribed non-coding RNA 2120	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of LINC02120 mRNA	PMID:37047231
11575181	ROCR	regulator of chondrogenesis RNA	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of ROCR mRNA	PMID:29301061
11575189	LINC02107	long independently transcribed non-coding RNA 2107	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02107 intron	PMID:30157460
11575212	LINC02067	long independently transcribed non-coding RNA 2067	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02067 mRNA	PMID:41028656
11575212	LINC02067	long independently transcribed non-coding RNA 2067	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02067 mRNA	PMID:41028656
11575212	LINC02067	long independently transcribed non-coding RNA 2067	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02067 mRNA	PMID:41028656
11575259	LINC02055	long independently transcribed non-coding RNA 2055	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02055 mRNA	PMID:38568856
11575259	LINC02055	long independently transcribed non-coding RNA 2055	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02055 mRNA	PMID:38832940
11575312	CHD1-DT	CHD1 divergent transcript	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CHD1-DT mRNA	PMID:33212167
11575345	SCAT1	S-phase cancer associated transcript 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SCAT1 mRNA	PMID:33212167
11575345	SCAT1	S-phase cancer associated transcript 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SCAT1 intron	PMID:30157460
11575345	SCAT1	S-phase cancer associated transcript 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SCAT1 mRNA	PMID:36326898
11575345	SCAT1	S-phase cancer associated transcript 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of SCAT1 mRNA	PMID:40706910
11575345	SCAT1	S-phase cancer associated transcript 1	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of SCAT1 mRNA	PMID:35486664
11575371	SEMA5A-AS1	SEMA5A antisense RNA 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SEMA5A-AS1 mRNA	PMID:34973136
11575379	LINC02052	long independently transcribed non-coding RNA 2052	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02052 intron	PMID:30157460
11575397	LINC02065	long independently transcribed non-coding RNA 2065	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC02065 mRNA	PMID:33212167
11575429	LINC02099	long independently transcribed non-coding RNA 2099	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02099 intron	PMID:30157460
11575429	LINC02099	long independently transcribed non-coding RNA 2099	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02099 intron	PMID:30157460
11575447	LINC02089	long independently transcribed non-coding RNA 2089	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02089 mRNA	PMID:38568856
11575447	LINC02089	long independently transcribed non-coding RNA 2089	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC02089 mRNA	PMID:38568856
11575577	LINC02104	long independently transcribed non-coding RNA 2104	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of LINC02104 mRNA	PMID:39245080
11575577	LINC02104	long independently transcribed non-coding RNA 2104	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02104 mRNA	PMID:29301061
11575614	LINC00513	long independently transcribed non-coding RNA 513	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of LINC00513 mRNA	PMID:31614463
11575614	LINC00513	long independently transcribed non-coding RNA 513	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC00513 mRNA	PMID:33212167
11575614	LINC00513	long independently transcribed non-coding RNA 513	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC00513 mRNA	PMID:38568856
11575614	LINC00513	long independently transcribed non-coding RNA 513	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC00513 mRNA	PMID:38568856
11575614	LINC00513	long independently transcribed non-coding RNA 513	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of LINC00513 mRNA	PMID:27989131
11575614	LINC00513	long independently transcribed non-coding RNA 513	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC00513 mRNA	PMID:38832940
11575637	LINC02077	long independently transcribed non-coding RNA 2077	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02077 mRNA	PMID:38568856
11575674	LINC02108	long independently transcribed non-coding RNA 2108	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02108 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02108 mRNA	PMID:35811015
11575674	LINC02108	long independently transcribed non-coding RNA 2108	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC02108 mRNA	PMID:35811015
11575674	LINC02108	long independently transcribed non-coding RNA 2108	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02108 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02108 mRNA	PMID:35811015
11575674	LINC02108	long independently transcribed non-coding RNA 2108	gene	CHEBI:53473	beryllium sulfate	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:C020711	beryllium sulfate results in decreased expression of LINC02108 mRNA	PMID:35679967
11575684	LINC02102	long independently transcribed non-coding RNA 2102	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LINC02102 mRNA	PMID:36139627
11575684	LINC02102	long independently transcribed non-coding RNA 2102	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02102 intron	PMID:30157460
11575684	LINC02102	long independently transcribed non-coding RNA 2102	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02102 intron	PMID:30157460
11575684	LINC02102	long independently transcribed non-coding RNA 2102	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LINC02102 mRNA	PMID:36139627
11575753	LINC02053	long independently transcribed non-coding RNA 2053	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02053 mRNA	PMID:41028656
11575753	LINC02053	long independently transcribed non-coding RNA 2053	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02053 mRNA	PMID:41028656
11575753	LINC02053	long independently transcribed non-coding RNA 2053	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02053 mRNA	PMID:41028656
11575759	LINC02090	long independently transcribed non-coding RNA 2090	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LINC02090 mRNA	PMID:35811015
11575759	LINC02090	long independently transcribed non-coding RNA 2090	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02090 mRNA	PMID:35811015
11575759	LINC02090	long independently transcribed non-coding RNA 2090	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02090 mRNA	PMID:35811015
11575759	LINC02090	long independently transcribed non-coding RNA 2090	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of LINC02090 mRNA	PMID:40706910
11575776	LINC02112	long independently transcribed non-coding RNA 2112	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in increased expression of LINC02112 mRNA	PMID:27905399
11575776	LINC02112	long independently transcribed non-coding RNA 2112	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of LINC02112 gene	PMID:31601247
11575776	LINC02112	long independently transcribed non-coding RNA 2112	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LINC02112 gene	PMID:31601247
11575776	LINC02112	long independently transcribed non-coding RNA 2112	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of LINC02112 gene	PMID:31601247
11575817	LINC02057	long independently transcribed non-coding RNA 2057	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02057 mRNA	PMID:34032870
11575817	LINC02057	long independently transcribed non-coding RNA 2057	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LINC02057 mRNA	PMID:32234424
11575817	LINC02057	long independently transcribed non-coding RNA 2057	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC02057 mRNA	PMID:38832940
11575836	LINC02092	long independently transcribed non-coding RNA 2092	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02092 intron; Aflatoxin B1 results in decreased methylation of LINC02092 promoter	PMID:30157460
11575836	LINC02092	long independently transcribed non-coding RNA 2092	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02092 promoter	PMID:30157460
11575836	LINC02092	long independently transcribed non-coding RNA 2092	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC02092 mRNA	PMID:38568856
11575836	LINC02092	long independently transcribed non-coding RNA 2092	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02092 promoter	PMID:30157460
11575886	LINC02098	long independently transcribed non-coding RNA 2098	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02098 intron	PMID:30157460
11575914	LINC02086	long independently transcribed non-coding RNA 2086	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02086 mRNA	PMID:29301061
11576014	LINC02103	long independently transcribed non-coding RNA 2103	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02103 mRNA	PMID:29301061
11576014	LINC02103	long independently transcribed non-coding RNA 2103	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC02103 intron	PMID:30157460
11576014	LINC02103	long independently transcribed non-coding RNA 2103	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC02103 intron	PMID:30157460
11576020	SMIM15-AS1	SMIM15 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SMIM15-AS1 mRNA	PMID:34032870
11576044	LINC02105	long independently transcribed non-coding RNA 2105	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02105 mRNA	PMID:38568856
11576077	LINC02084	long independently transcribed non-coding RNA 2084	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02084 mRNA	PMID:38568856
11576103	RDUR	RIG-I dependent antiviral response regulator RNA	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RDUR mRNA	PMID:30851411
11576103	RDUR	RIG-I dependent antiviral response regulator RNA	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RDUR promoter	PMID:27901495
11576103	RDUR	RIG-I dependent antiviral response regulator RNA	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RDUR gene	PMID:31601247
11576103	RDUR	RIG-I dependent antiviral response regulator RNA	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of RDUR mRNA	PMID:40419075
11576103	RDUR	RIG-I dependent antiviral response regulator RNA	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RDUR mRNA	PMID:30851411
11576113	LINC02074	long independently transcribed non-coding RNA 2074	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02074 mRNA	PMID:38568856
11576152	LIX1L-AS1	LIX1L antisense RNA 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of LIX1L-AS1 mRNA	PMID:34032870
11576213	LINC02078	long independently transcribed non-coding RNA 2078	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C005556	propionaldehyde results in increased expression of LINC02078 mRNA	PMID:26079696
11576973	LINC00355	long independently transcribed non-coding RNA 355	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC00355 mRNA	PMID:35811015
11576973	LINC00355	long independently transcribed non-coding RNA 355	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20170117	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of LINC00355 mRNA	PMID:27188386
11576973	LINC00355	long independently transcribed non-coding RNA 355	gene	CHEBI:44915	propofol	increases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:D015742	Propofol results in increased expression of LINC00355 mRNA	PMID:35238236
11576973	LINC00355	long independently transcribed non-coding RNA 355	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC00355 mRNA	PMID:35811015
11576974	CCDC13-AS2	CCDC13 antisense RNA 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CCDC13-AS2 mRNA	PMID:30851411
11576974	CCDC13-AS2	CCDC13 antisense RNA 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of CCDC13-AS2 mRNA	PMID:29301061
11576974	CCDC13-AS2	CCDC13 antisense RNA 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CCDC13-AS2 mRNA	PMID:32234424
11576974	CCDC13-AS2	CCDC13 antisense RNA 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CCDC13-AS2 mRNA	PMID:32234424
11576974	CCDC13-AS2	CCDC13 antisense RNA 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CCDC13-AS2 mRNA	PMID:30851411
11576974	CCDC13-AS2	CCDC13 antisense RNA 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of CCDC13-AS2 mRNA	PMID:32234424
11576974	CCDC13-AS2	CCDC13 antisense RNA 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CCDC13-AS2 mRNA	PMID:38568856
11576980	LINC02150	long independently transcribed non-coding RNA 2150	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of LINC02150 mRNA	PMID:31629900
11577000	ELF3-AS1	ELF3 antisense RNA 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ELF3-AS1 mRNA	PMID:35811015
11577000	ELF3-AS1	ELF3 antisense RNA 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ELF3-AS1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of ELF3-AS1 mRNA	PMID:35811015
11577000	ELF3-AS1	ELF3 antisense RNA 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ELF3-AS1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of ELF3-AS1 mRNA	PMID:35811015
11577018	LINC02137	long independently transcribed non-coding RNA 2137	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02137 mRNA	PMID:38568856
11577075	LINC02147	long independently transcribed non-coding RNA 2147	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC02147 intron	PMID:30157460
11577083	LINC01181	long independently transcribed non-coding RNA 1181	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LINC01181 mRNA	PMID:35811015
11577083	LINC01181	long independently transcribed non-coding RNA 1181	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of LINC01181 mRNA]	PMID:35811015
11577083	LINC01181	long independently transcribed non-coding RNA 1181	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC01181 mRNA	PMID:30851411
11577083	LINC01181	long independently transcribed non-coding RNA 1181	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of LINC01181 mRNA]	PMID:35811015
11577083	LINC01181	long independently transcribed non-coding RNA 1181	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC01181 mRNA	PMID:30851411
11577083	LINC01181	long independently transcribed non-coding RNA 1181	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC01181 mRNA	PMID:38568856
11577084	CERNA1	competing endogenous lncRNA 1 for miR-4707-5p and miR-4767	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CERNA1 mRNA	PMID:35811015
11577084	CERNA1	competing endogenous lncRNA 1 for miR-4707-5p and miR-4767	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CERNA1 mRNA	PMID:35811015
11577084	CERNA1	competing endogenous lncRNA 1 for miR-4707-5p and miR-4767	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CERNA1 mRNA	PMID:35811015
11577092	LINC02125	long independently transcribed non-coding RNA 2125	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LINC02125 mRNA	PMID:34973136
11577092	LINC02125	long independently transcribed non-coding RNA 2125	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02125 mRNA	PMID:38832940
11577109	LINC02161	long independently transcribed non-coding RNA 2161	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of LINC02161 mRNA	PMID:39245080
11577128	LINC02132	long independently transcribed non-coding RNA 2132	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LINC02132 mRNA	PMID:35811015
11577128	LINC02132	long independently transcribed non-coding RNA 2132	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02132 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02132 mRNA	PMID:35811015
11577128	LINC02132	long independently transcribed non-coding RNA 2132	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02132 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02132 mRNA	PMID:35811015
11577135	MAGI1-IT1	MAGI1 intronic transcript 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of MAGI1-IT1 mRNA	PMID:41028656
11577135	MAGI1-IT1	MAGI1 intronic transcript 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MAGI1-IT1 mRNA	PMID:41028656
11577135	MAGI1-IT1	MAGI1 intronic transcript 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MAGI1-IT1 mRNA	PMID:41028656
11577136	LINC02139	long independently transcribed non-coding RNA 2139	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LINC02139 mRNA	PMID:35811015
11577136	LINC02139	long independently transcribed non-coding RNA 2139	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02139 mRNA	PMID:35811015
11577136	LINC02139	long independently transcribed non-coding RNA 2139	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of LINC02139 mRNA	PMID:29955902
11577136	LINC02139	long independently transcribed non-coding RNA 2139	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02139 mRNA	PMID:35811015
11577150	LINC02133	long independently transcribed non-coding RNA 2133	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02133 intron	PMID:30157460
11577150	LINC02133	long independently transcribed non-coding RNA 2133	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02133 intron	PMID:30157460
11577150	LINC02133	long independently transcribed non-coding RNA 2133	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC02133 intron	PMID:30157460
11577150	LINC02133	long independently transcribed non-coding RNA 2133	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC02133 intron	PMID:30157460
11577164	LINC02162	long independently transcribed non-coding RNA 2162	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02162 intron	PMID:30157460
11577219	LINC00328	long independently transcribed non-coding RNA 328	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of LINC00328 mRNA	PMID:31256213
11577219	LINC00328	long independently transcribed non-coding RNA 328	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC00328 mRNA	PMID:30851411
11577219	LINC00328	long independently transcribed non-coding RNA 328	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC00328 mRNA	PMID:30851411
11577225	LINC02141	long independently transcribed non-coding RNA 2141	gene	CHEBI:29678	sodium arsenite	decreases methylation	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased methylation of LINC02141 intron	PMID:32844245
11577225	LINC02141	long independently transcribed non-coding RNA 2141	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02141 mRNA	PMID:32844245
11577225	LINC02141	long independently transcribed non-coding RNA 2141	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC02141 mRNA	PMID:32234424
11577225	LINC02141	long independently transcribed non-coding RNA 2141	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02141 mRNA	PMID:38832940
11577310	LINC02159	long independently transcribed non-coding RNA 2159	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02159 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02159 mRNA	PMID:35811015
11577310	LINC02159	long independently transcribed non-coding RNA 2159	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC02159 mRNA	PMID:30851411
11577310	LINC02159	long independently transcribed non-coding RNA 2159	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02159 mRNA	PMID:34032870
11577310	LINC02159	long independently transcribed non-coding RNA 2159	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LINC02159 promoter	PMID:27901495
11577310	LINC02159	long independently transcribed non-coding RNA 2159	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC02159 mRNA	PMID:35811015
11577310	LINC02159	long independently transcribed non-coding RNA 2159	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02159 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02159 mRNA	PMID:35811015
11577310	LINC02159	long independently transcribed non-coding RNA 2159	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC02159 mRNA	PMID:30851411
11577318	LINC02153	long independently transcribed non-coding RNA 2153	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LINC02153 gene	PMID:31601247
11577340	FAM236D	family with sequence similarity 236 member D	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1564177	E	RGD:6480464	20220405	CTD	MESH:D003471	Cuprizone results in increased expression of FAM236D mRNA	PMID:27523638
11577340	FAM236D	family with sequence similarity 236 member D	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1564177	E	RGD:6480464	20220405	CTD	MESH:D020106	Acrylamide results in decreased expression of FAM236D mRNA	PMID:28959563
11577340	FAM236D	family with sequence similarity 236 member D	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1564177	E	RGD:6480464	20220405	CTD	MESH:C039281	furan results in decreased expression of FAM236D mRNA	PMID:26194646
11577362	LINC02140	long independently transcribed non-coding RNA 2140	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of LINC02140 mRNA	PMID:28001369
11667205	ARLNC1	androgen receptor regulated long noncoding RNA 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C543008	bisphenol S results in increased expression of ARLNC1 mRNA	PMID:33476716
11667216	LINC02177	long independently transcribed non-coding RNA 2177	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC02177 intron	PMID:30157460
11667216	LINC02177	long independently transcribed non-coding RNA 2177	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02177 intron	PMID:30157460
11667216	LINC02177	long independently transcribed non-coding RNA 2177	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02177 intron	PMID:30157460
11667216	LINC02177	long independently transcribed non-coding RNA 2177	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02177 mRNA	PMID:38832940
11667216	LINC02177	long independently transcribed non-coding RNA 2177	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02177 intron	PMID:30157460
11667228	TAB3-AS1	TAB3 antisense RNA 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D010126	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA] which results in increased expression of TAB3 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA	PMID:33656867
11667228	TAB3-AS1	TAB3 antisense RNA 1	gene	CHEBI:29191	hydroxyl	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA] which results in increased expression of TAB3 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA	PMID:33656867
11667228	TAB3-AS1	TAB3 antisense RNA 1	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA] which results in increased expression of TAB3 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA] which results in increased expression of TAB3 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of TAB3-AS1 mRNA	PMID:33656867
11667229	LINC02167	long independently transcribed non-coding RNA 2167	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02167 intron	PMID:30157460
11667229	LINC02167	long independently transcribed non-coding RNA 2167	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02167 intron	PMID:30157460
11667229	LINC02167	long independently transcribed non-coding RNA 2167	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02167 intron	PMID:30157460
11667263	LINC02198	long independently transcribed non-coding RNA 2198	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LINC02198 mRNA	PMID:35811015
11667263	LINC02198	long independently transcribed non-coding RNA 2198	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02198 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02198 mRNA	PMID:35811015
11667263	LINC02198	long independently transcribed non-coding RNA 2198	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02198 polyA tail	PMID:30157460
11667263	LINC02198	long independently transcribed non-coding RNA 2198	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC02198 mRNA	PMID:35811015
11667263	LINC02198	long independently transcribed non-coding RNA 2198	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02198 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02198 mRNA	PMID:35811015
11667294	LINC02171	long independently transcribed non-coding RNA 2171	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC02171 intron	PMID:30157460
11667315	FOXP1-IT1	FOXP1 intronic transcript 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of FOXP1-IT1 mRNA	PMID:30851411
11667315	FOXP1-IT1	FOXP1 intronic transcript 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20170124	CTD	MESH:D014635	Valproic Acid affects the expression of FOXP1-IT1 mRNA	PMID:25979313
11667315	FOXP1-IT1	FOXP1 intronic transcript 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of FOXP1-IT1 mRNA	PMID:30851411
11667322	LINC02182	long independently transcribed non-coding RNA 2182	gene	CHEBI:24527	herbicide	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:D006540	[Herbicides results in increased abundance of Picloram] which affects the methylation of LINC02182 gene	PMID:34516295
11667322	LINC02182	long independently transcribed non-coding RNA 2182	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of LINC02182 mRNA	PMID:29955902
11667322	LINC02182	long independently transcribed non-coding RNA 2182	gene	CHEBI:34922	picloram	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:D010846	[Herbicides results in increased abundance of Picloram] which affects the methylation of LINC02182 gene	PMID:34516295
11667337	LINC01597	long independently transcribed non-coding RNA 1597	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC01597 intron	PMID:30157460
11667337	LINC01597	long independently transcribed non-coding RNA 1597	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC01597 mRNA	PMID:29301061
11667337	LINC01597	long independently transcribed non-coding RNA 1597	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC01597 intron	PMID:30157460
11667338	LINC02181	long independently transcribed non-coding RNA 2181	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02181 mRNA	PMID:38568856
11667353	LINC02164	long independently transcribed non-coding RNA 2164	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02164 mRNA	PMID:38568856
11667353	LINC02164	long independently transcribed non-coding RNA 2164	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC02164 mRNA	PMID:38568856
11667422	LINC02175	long independently transcribed non-coding RNA 2175	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02175 mRNA	PMID:38832940
11667446	LINC02166	long independently transcribed non-coding RNA 2166	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of LINC02166 mRNA	PMID:38568856
11667446	LINC02166	long independently transcribed non-coding RNA 2166	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC02166 mRNA	PMID:32234424
11667446	LINC02166	long independently transcribed non-coding RNA 2166	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of LINC02166 mRNA	PMID:32234424
11667446	LINC02166	long independently transcribed non-coding RNA 2166	gene	CHEBI:6382	Lasiocarpine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005136	lasiocarpine results in decreased expression of LINC02166 mRNA	PMID:32234424
11667468	LINC02192	long independently transcribed non-coding RNA 2192	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of LINC02192 intron	PMID:30157460
11667482	LINC02200	long independently transcribed non-coding RNA 2200	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of LINC02200 mRNA	PMID:30510588
11667542	LINC01165	long independently transcribed non-coding RNA 1165	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20170124	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of LINC01165 mRNA	PMID:24763279
11667543	COL25A1-DT	COL25A1 divergent transcript	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20170124	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of COL25A1-DT mRNA	PMID:24763279
11667544	LINC02188	long independently transcribed non-coding RNA 2188	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02188 intron	PMID:30157460
11667544	LINC02188	long independently transcribed non-coding RNA 2188	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02188 mRNA	PMID:38568856
11667544	LINC02188	long independently transcribed non-coding RNA 2188	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02188 intron	PMID:30157460
11667544	LINC02188	long independently transcribed non-coding RNA 2188	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C008745	bisphenol F results in increased expression of LINC02188 mRNA	PMID:33476716
11667544	LINC02188	long independently transcribed non-coding RNA 2188	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02188 intron	PMID:30157460
11667557	LINC02202	long independently transcribed non-coding RNA 2202	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LINC02202 mRNA	PMID:35811015
11667557	LINC02202	long independently transcribed non-coding RNA 2202	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02202 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02202 mRNA	PMID:35811015
11667557	LINC02202	long independently transcribed non-coding RNA 2202	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC02202 intron	PMID:30157460
11667557	LINC02202	long independently transcribed non-coding RNA 2202	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02202 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02202 mRNA	PMID:35811015
11667557	LINC02202	long independently transcribed non-coding RNA 2202	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC02202 intron	PMID:30157460
11667589	CXXC4-AS1	CXXC4 antisense RNA 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CXXC4-AS1 intron	PMID:30157460
11667658	FAM215B	family with sequence similarity 215 member B	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20170124	CTD	MESH:D019327	Copper Sulfate results in increased expression of FAM215B mRNA	PMID:19549813
11667659	TNK2-AS1	TNK2 antisense RNA 1	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20170124	CTD	MESH:C005556	propionaldehyde results in decreased expression of TNK2-AS1 mRNA	PMID:26079696
11667659	TNK2-AS1	TNK2 antisense RNA 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TNK2-AS1 mRNA	PMID:30851411
11667659	TNK2-AS1	TNK2 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TNK2-AS1 mRNA	PMID:34032870
11667659	TNK2-AS1	TNK2 antisense RNA 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TNK2-AS1 mRNA	PMID:30851411
11667660	LINC02185	long independently transcribed non-coding RNA 2185	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LINC02185 mRNA	PMID:35811015
11667660	LINC02185	long independently transcribed non-coding RNA 2185	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02185 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LINC02185 mRNA	PMID:35811015
11667660	LINC02185	long independently transcribed non-coding RNA 2185	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02185 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LINC02185 mRNA	PMID:35811015
11667700	LINC02169	long independently transcribed non-coding RNA 2169	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02169 mRNA	PMID:38568856
11667700	LINC02169	long independently transcribed non-coding RNA 2169	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02169 intron	PMID:30157460
11667708	LINC02193	long intergenic non-protein coding RNA 2193	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of LINC02193 mRNA	PMID:34032870
12436917	SMASR	SMAD3 associated long non-coding RNA	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SMASR mRNA	PMID:36139627
12436917	SMASR	SMAD3 associated long non-coding RNA	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SMASR intron	PMID:30157460
12436917	SMASR	SMAD3 associated long non-coding RNA	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SMASR intron	PMID:30157460
12436917	SMASR	SMAD3 associated long non-coding RNA	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SMASR mRNA	PMID:36139627
12437028	LINC02203	long independently transcribed non-coding RNA 2203	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LINC02203 gene	PMID:29154799
126775191	USP38-DT	USP38 divergent transcript	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of USP38-DT mRNA	PMID:38832940
126848816	SLCO5A1-AS1	SLCO5A1 antisense RNA 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SLCO5A1-AS1 mRNA	PMID:38832940
126848816	SLCO5A1-AS1	SLCO5A1 antisense RNA 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of SLCO5A1-AS1 mRNA	PMID:40706910
126848817	FAM151B-DT	FAM151B divergent transcript	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FAM151B-DT mRNA	PMID:38832940
126848818	ANKHD1-DT	ANKHD1 divergent transcript	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ANKHD1-DT mRNA	PMID:38832940
126848826	TNPO1-DT	TNPO1 divergent transcript	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TNPO1-DT mRNA	PMID:35811015
126848826	TNPO1-DT	TNPO1 divergent transcript	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of TNPO1-DT mRNA	PMID:35811015
126848826	TNPO1-DT	TNPO1 divergent transcript	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TNPO1-DT mRNA	PMID:35811015
127338330	BTBD3-AS1	BTBD3 antisense RNA 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of BTBD3-AS1 mRNA	PMID:34973136
12738276	SNORA1B	small nucleolar RNA, H/ACA box 1B	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of SNORA1B mRNA	PMID:39245080
12738279	SNORA74D	small nucleolar RNA, H/ACA box 74D	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:4821083	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of MIR1949 mRNA	PMID:28960355
12738279	SNORA74D	small nucleolar RNA, H/ACA box 74D	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:4821083	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MIR1949 mRNA	PMID:35676786
12738279	SNORA74D	small nucleolar RNA, H/ACA box 74D	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:4821083	E	RGD:6480464	20180410	CTD	MESH:C009495	titanium dioxide results in increased expression of MIR1949 mRNA	PMID:29247641
12738279	SNORA74D	small nucleolar RNA, H/ACA box 74D	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:4821083	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MIR1949 mRNA	PMID:35676786
12738279	SNORA74D	small nucleolar RNA, H/ACA box 74D	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:4821083	E	RGD:6480464	20180828	CTD	MESH:D016559	Tacrolimus results in increased expression of MIR1949 mRNA	PMID:29362864
12738282	SNORA9B	small nucleolar RNA, H/ACA box 9B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C006780	bisphenol A results in increased expression of SNORA9B mRNA	PMID:33476716
12738286	SNORA31B	small nucleolar RNA, H/ACA box 31B	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SNORA31B mRNA	PMID:29803840
12738289	SNORA10B	small nucleolar RNA, H/ACA box 10B	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of SNORA10B mRNA	PMID:39245080
12738289	SNORA10B	small nucleolar RNA, H/ACA box 10B	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SNORA10B mRNA	PMID:29803840
12738301	SNORD28B	small nucleolar RNA, C/D box 28B	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of SNORD28B mRNA	PMID:39245080
12738310	SNORD3F	small nucleolar RNA, C/D box 3F	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SNORD3F mRNA	PMID:33212167
12738315	SNORD19C	small nucleolar RNA, C/D box 19C	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of SNORD19C mRNA	PMID:35877022
12738315	SNORD19C	small nucleolar RNA, C/D box 19C	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNORD19C mRNA	PMID:34032870
12738316	SNORA35B	small nucleolar RNA, H/ACA box 35B	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of SNORA35B mRNA	PMID:41028656
12738316	SNORA35B	small nucleolar RNA, H/ACA box 35B	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SNORA35B mRNA	PMID:41028656
12738316	SNORA35B	small nucleolar RNA, H/ACA box 35B	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SNORA35B mRNA	PMID:29803840
12738316	SNORA35B	small nucleolar RNA, H/ACA box 35B	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SNORA35B mRNA	PMID:41028656
12738319	BUB1B-PAK6	BUB1B-PAK6 readthrough	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of BUB1B-PAK6 mRNA	PMID:30165855
12738319	BUB1B-PAK6	BUB1B-PAK6 readthrough	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of BUB1B-PAK6 mRNA	PMID:34032870
12738319	BUB1B-PAK6	BUB1B-PAK6 readthrough	gene	CHEBI:78576	aflatoxin M1	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in increased expression of BUB1B-PAK6 mRNA	PMID:30928695
12738357	SNORA63C	small nucleolar RNA, H/ACA box 63C	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of SNORA63C mRNA	PMID:39245080
12743382	SNORD167	small nucleolar RNA, C/D box 167	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SNORD167 polyA tail	PMID:30157460
12743382	SNORD167	small nucleolar RNA, C/D box 167	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SNORD167 polyA tail	PMID:30157460
12743421	SNORD159	small nucleolar RNA, C/D box 159	gene	CHEBI:72676	versicolorin A	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C029826	versicolorin A results in increased expression of SNORD159 mRNA	PMID:32106047
12743423	LINC02212	long independently transcribed non-coding RNA 2212	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02212 intron	PMID:30157460
12743481	LINC02210-CRHR1	LINC02210-CRHR1 readthrough	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02210-CRHR1 intron	PMID:30157460
12743481	LINC02210-CRHR1	LINC02210-CRHR1 readthrough	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of LINC02210-CRHR1 mRNA	PMID:29955902
12743481	LINC02210-CRHR1	LINC02210-CRHR1 readthrough	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of LINC02210-CRHR1 mRNA	PMID:32763439
12743481	LINC02210-CRHR1	LINC02210-CRHR1 readthrough	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02210-CRHR1 intron	PMID:30157460
12743481	LINC02210-CRHR1	LINC02210-CRHR1 readthrough	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02210-CRHR1 intron	PMID:30157460
12743481	LINC02210-CRHR1	LINC02210-CRHR1 readthrough	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02210-CRHR1 intron	PMID:30157460
12743538	SNORA119	small nucleolar RNA, H/ACA box 119	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of SNORA119 polyA tail	PMID:30157460
12789454	LINC02228	long independently transcribed non-coding RNA 2228	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02228 mRNA	PMID:29301061
12789483	LINC02223	long independently transcribed non-coding RNA 2223	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02223 mRNA	PMID:29301061
12789483	LINC02223	long independently transcribed non-coding RNA 2223	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC02223 mRNA	PMID:38568856
12789483	LINC02223	long independently transcribed non-coding RNA 2223	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02223 mRNA	PMID:38832940
12789504	MHENCR	melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MHENCR mRNA	PMID:32763439
12789504	MHENCR	melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MHENCR mRNA	PMID:38568856
12789504	MHENCR	melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MHENCR mRNA	PMID:38568856
12789504	MHENCR	melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MHENCR mRNA	PMID:38832940
12789504	MHENCR	melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of MHENCR mRNA	PMID:28988120
12789504	MHENCR	melanoma highly expressed competing endogenous lncRNA for miR-425 and miR-489	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MHENCR mRNA	PMID:38568856
12789513	LINC02240	long independently transcribed non-coding RNA 2240	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02240 mRNA	PMID:38568856
12789513	LINC02240	long independently transcribed non-coding RNA 2240	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC02240 mRNA	PMID:38568856
12789523	CDH18-AS1	CDH18 antisense RNA 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CDH18-AS1 intron	PMID:30157460
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1623575	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of IQANK1 mRNA	PMID:37995155
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IQANK1 mRNA	PMID:36139627
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20200609	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of IQANK1 intron	PMID:30157460
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D002945	Cisplatin results in increased expression of IQANK1 mRNA	PMID:27392435
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of IQANK1 mRNA	PMID:27392435
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of IQANK1 mRNA	PMID:32763439
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of IQANK1 mRNA	PMID:38568856
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1623575	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of IQANK1 mRNA	PMID:39232337
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of IQANK1 mRNA	PMID:37690743
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of IQANK1 gene	PMID:31601247
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1563870	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of IQANK1 mRNA	PMID:41034487
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of IQANK1 gene	PMID:31601247
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1623575	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in increased expression of IQANK1 mRNA	PMID:35093514
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1623575	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of IQANK1 mRNA	PMID:39529242
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IQANK1 mRNA	PMID:38832940
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C082360	fipronil results in decreased expression of IQANK1 mRNA	PMID:28991164
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of IQANK1 mRNA	PMID:28991164
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:52136	glufosinate	decreases expression	ISO	RGD:1623575	E	RGD:6480464	20230905	CTD	MESH:C003121	phosphinothricin results in decreased expression of IQANK1 mRNA	PMID:34597628
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1623575	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of IQANK1 mRNA	PMID:38701926
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1623575	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of IQANK1 protein	PMID:36851058
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1563870	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of IQANK1 gene	PMID:35440735
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of IQANK1 mRNA	PMID:28991164
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IQANK1 mRNA	PMID:36139627
12789538	IQANK1	IQ motif and ankyrin repeat containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1563870	E	RGD:6480464	20170613	CTD	MESH:D011441	Propylthiouracil results in increased expression of IQANK1 mRNA	PMID:24780913
12789580	TMEM225B	transmembrane protein 225B	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20170221	CTD	MESH:D009532	Nickel results in decreased expression of TMEM225B mRNA	PMID:24768652|PMID:25583101
12789580	TMEM225B	transmembrane protein 225B	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of TMEM225B intron	PMID:30157460
12789580	TMEM225B	transmembrane protein 225B	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170221	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM225B mRNA	PMID:26272509
12789580	TMEM225B	transmembrane protein 225B	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20170221	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM225B mRNA	PMID:27188386
12789580	TMEM225B	transmembrane protein 225B	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TMEM225B mRNA	PMID:38832940
12789580	TMEM225B	transmembrane protein 225B	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of TMEM225B intron	PMID:30157460
12789580	TMEM225B	transmembrane protein 225B	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20170221	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM225B mRNA	PMID:27188386
12789580	TMEM225B	transmembrane protein 225B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20170221	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM225B mRNA	PMID:27188386
12789631	LINC02227	long independently transcribed non-coding RNA 2227	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02227 intron	PMID:30157460
12789631	LINC02227	long independently transcribed non-coding RNA 2227	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02227 intron	PMID:30157460
12789631	LINC02227	long independently transcribed non-coding RNA 2227	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of LINC02227 intron	PMID:30157460
12789631	LINC02227	long independently transcribed non-coding RNA 2227	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of LINC02227 intron	PMID:30157460
12789647	LINC02226	long independently transcribed non-coding RNA 2226	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02226 intron	PMID:30157460
12789647	LINC02226	long independently transcribed non-coding RNA 2226	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of LINC02226 gene	PMID:31601247
12789685	LINC02232	long independently transcribed non-coding RNA 2232	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of LINC02232 mRNA	PMID:27905399
12790724	PPP1R12A-AS1	PPP1R12A antisense RNA 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PPP1R12A-AS1 mRNA	PMID:38832940
12790724	PPP1R12A-AS1	PPP1R12A antisense RNA 1	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of PPP1R12A-AS1 mRNA	PMID:39904859
12790725	MTND5P42	MT-ND5 pseudogene 42	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MTND5P42 mRNA	PMID:33212167
12790726	LINC02241	long independently transcribed non-coding RNA 2241	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02241 intron	PMID:30157460
12790726	LINC02241	long independently transcribed non-coding RNA 2241	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02241 intron	PMID:30157460
12790726	LINC02241	long independently transcribed non-coding RNA 2241	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02241 intron	PMID:30157460
12790726	LINC02241	long independently transcribed non-coding RNA 2241	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02241 mRNA	PMID:38832940
12790726	LINC02241	long independently transcribed non-coding RNA 2241	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02241 intron	PMID:30157460
12790785	CD44-AS1	CD44 antisense RNA 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CD44-AS1 mRNA	PMID:35811015
12790785	CD44-AS1	CD44 antisense RNA 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CD44-AS1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CD44-AS1 mRNA	PMID:35811015
12790785	CD44-AS1	CD44 antisense RNA 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of CD44-AS1 mRNA	PMID:41028656
12790785	CD44-AS1	CD44 antisense RNA 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CD44-AS1 mRNA	PMID:41028656
12790785	CD44-AS1	CD44 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CD44-AS1 mRNA	PMID:34032870
12790785	CD44-AS1	CD44 antisense RNA 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CD44-AS1 mRNA	PMID:41028656
12790785	CD44-AS1	CD44 antisense RNA 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CD44-AS1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CD44-AS1 mRNA	PMID:35811015
12790802	SLC9A3-AS1	SLC9A3 antisense RNA 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC9A3-AS1 mRNA	PMID:38568856
12790802	SLC9A3-AS1	SLC9A3 antisense RNA 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC9A3-AS1 mRNA	PMID:33212167
12790802	SLC9A3-AS1	SLC9A3 antisense RNA 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SLC9A3-AS1 mRNA	PMID:32763439
12790802	SLC9A3-AS1	SLC9A3 antisense RNA 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of SLC9A3-AS1 mRNA	PMID:36804509
12790818	LINC02234	long intergenic non-protein coding RNA 2234	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LINC02234 mRNA	PMID:35811015
12790818	LINC02234	long intergenic non-protein coding RNA 2234	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02234 mRNA	PMID:34032870
12790818	LINC02234	long intergenic non-protein coding RNA 2234	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LINC02234 mRNA	PMID:35811015
12790819	KRT7-AS	KRT7 antisense RNA 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KRT7-AS mRNA	PMID:36602393
12790819	KRT7-AS	KRT7 antisense RNA 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D010126	[[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA] which results in decreased expression of KRT7 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA	PMID:33656867
12790819	KRT7-AS	KRT7 antisense RNA 1	gene	CHEBI:29191	hydroxyl	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA] which results in decreased expression of KRT7 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA	PMID:33656867
12790819	KRT7-AS	KRT7 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of KRT7-AS mRNA	PMID:38568856
12790819	KRT7-AS	KRT7 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of KRT7-AS mRNA	PMID:34032870
12790819	KRT7-AS	KRT7 antisense RNA 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KRT7-AS mRNA	PMID:36602393
12790819	KRT7-AS	KRT7 antisense RNA 1	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA] which results in decreased expression of KRT7 mRNA; [[Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA] which results in decreased expression of KRT7 mRNA; [Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in decreased expression of KRT7-AS mRNA	PMID:33656867
12790819	KRT7-AS	KRT7 antisense RNA 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of KRT7-AS mRNA	PMID:38568856
12790821	HDAC2-AS2	HDAC2 and HS3ST5 antisense RNA 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of HDAC2-AS2 mRNA	PMID:34032870
12790843	LINC02237	long independently transcribed non-coding RNA 2237	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC02237 polyA tail	PMID:30157460
12790843	LINC02237	long independently transcribed non-coding RNA 2237	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC02237 polyA tail	PMID:30157460
12790844	TDRKH-AS1	TDRKH antisense RNA 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TDRKH-AS1 mRNA	PMID:32763439
12790844	TDRKH-AS1	TDRKH antisense RNA 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TDRKH-AS1 polyA tail	PMID:30157460
12790844	TDRKH-AS1	TDRKH antisense RNA 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of TDRKH-AS1 mRNA	PMID:36326898
12790844	TDRKH-AS1	TDRKH antisense RNA 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TDRKH-AS1 polyA tail	PMID:30157460
12790844	TDRKH-AS1	TDRKH antisense RNA 1	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of TDRKH-AS1 mRNA	PMID:39904859
12790849	LINC02243	long independently transcribed non-coding RNA 2243	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LINC02243 mRNA	PMID:34973136
12790860	MIR4422HG	MIR4422 host gene	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of MIR4422HG mRNA	PMID:41028656
12790860	MIR4422HG	MIR4422 host gene	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MIR4422HG mRNA	PMID:41028656
12790860	MIR4422HG	MIR4422 host gene	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of MIR4422HG mRNA	PMID:41028656
12790867	LINC02154	long independently transcribed non-coding RNA 2154	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LINC02154 mRNA	PMID:35811015
12790867	LINC02154	long independently transcribed non-coding RNA 2154	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02154 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02154 mRNA	PMID:35811015
12790867	LINC02154	long independently transcribed non-coding RNA 2154	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02154 mRNA	PMID:38568856
12790867	LINC02154	long independently transcribed non-coding RNA 2154	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC02154 mRNA	PMID:38832940
12790867	LINC02154	long independently transcribed non-coding RNA 2154	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC02154 mRNA	PMID:35811015
12790867	LINC02154	long independently transcribed non-coding RNA 2154	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02154 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02154 mRNA	PMID:35811015
12790869	MEF2C-AS2	MEF2C antisense RNA 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of MEF2C-AS2 intron	PMID:30157460
12790877	PNMA6E	PNMA family member 6E	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PNMA6E exon	PMID:30157460
12790878	POC1B-AS1	POC1B antisense RNA 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of POC1B-AS1 polyA tail	PMID:30157460
12790878	POC1B-AS1	POC1B antisense RNA 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of POC1B-AS1 mRNA	PMID:33212167
12790880	ZFHX2-AS1	ZFHX2 antisense RNA 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1607096	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ZFHX2OS mRNA	PMID:34319233
12790880	ZFHX2-AS1	ZFHX2 antisense RNA 1	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1607096	E	RGD:6480464	20170411	CTD	MESH:C006253	pirinixic acid affects the expression of ZFHX2OS mRNA	PMID:19136022
12790880	ZFHX2-AS1	ZFHX2 antisense RNA 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1607096	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in increased expression of ZFHX2OS mRNA	PMID:29161229
12790880	ZFHX2-AS1	ZFHX2 antisense RNA 1	gene	CHEBI:34696	dieldrin	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D004026	Dieldrin results in decreased expression of ZFHX2-AS1 mRNA	PMID:38723972
12790880	ZFHX2-AS1	ZFHX2 antisense RNA 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1607096	E	RGD:6480464	20170411	CTD	MESH:D010634	Phenobarbital affects the expression of ZFHX2OS mRNA	PMID:19136022
12790903	LINC02236	long independently transcribed non-coding RNA 2236	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02236 intron	PMID:30157460
12790904	LINC02245	long independently transcribed non-coding RNA 2245	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02245 intron	PMID:30157460
12790904	LINC02245	long independently transcribed non-coding RNA 2245	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of LINC02245 mRNA	PMID:34973136
12790904	LINC02245	long independently transcribed non-coding RNA 2245	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC02245 intron	PMID:30157460
12790904	LINC02245	long independently transcribed non-coding RNA 2245	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC02245 mRNA	PMID:38832940
12790904	LINC02245	long independently transcribed non-coding RNA 2245	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC02245 intron	PMID:30157460
12790913	LNCSRLR	lncRNA sorafenib resistance in renal cell carcinoma associated	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LNCSRLR mRNA	PMID:33212167
12790913	LNCSRLR	lncRNA sorafenib resistance in renal cell carcinoma associated	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LNCSRLR mRNA	PMID:38832940
12790918	LINC02235	long independently transcribed non-coding RNA 2235	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02235 mRNA	PMID:41028656
12790918	LINC02235	long independently transcribed non-coding RNA 2235	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02235 mRNA	PMID:41028656
12790918	LINC02235	long independently transcribed non-coding RNA 2235	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02235 mRNA	PMID:41028656
12791080	LINC02256	long independently transcribed non-coding RNA 2256	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02256 mRNA	PMID:38832940
12791088	LINC02254	long intergenic non-protein coding RNA 2254	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02254 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02254 mRNA	PMID:35811015
12791088	LINC02254	long intergenic non-protein coding RNA 2254	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC02254 mRNA	PMID:35811015
12791088	LINC02254	long intergenic non-protein coding RNA 2254	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02254 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02254 mRNA	PMID:35811015
12791100	TMBIM7P	transmembrane BAX inhibitor motif containing 7, pseudogene	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315350	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TMBIM7 mRNA	PMID:34319233
12791100	TMBIM7P	transmembrane BAX inhibitor motif containing 7, pseudogene	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306626	E	RGD:6480464	20170613	CTD	MESH:C016517	indole-3-carbinol affects the expression of TMBIM7 mRNA	PMID:21396975
12791100	TMBIM7P	transmembrane BAX inhibitor motif containing 7, pseudogene	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TMBIM7P intron	PMID:30157460
12791100	TMBIM7P	transmembrane BAX inhibitor motif containing 7, pseudogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TMBIM7P mRNA	PMID:34032870
12791100	TMBIM7P	transmembrane BAX inhibitor motif containing 7, pseudogene	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315350	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TMBIM7 mRNA	PMID:29264374
12791100	TMBIM7P	transmembrane BAX inhibitor motif containing 7, pseudogene	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306626	E	RGD:6480464	20170321	CTD	MESH:C006780	bisphenol A results in decreased expression of TMBIM7 mRNA	PMID:25181051
12791100	TMBIM7P	transmembrane BAX inhibitor motif containing 7, pseudogene	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306626	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TMBIM7 mRNA	PMID:34947998
12791100	TMBIM7P	transmembrane BAX inhibitor motif containing 7, pseudogene	gene	CHEBI:63041	manganese(II) chloride	decreases methylation	ISO	RGD:1306626	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased methylation of TMBIM7 gene	PMID:28801915
12791100	TMBIM7P	transmembrane BAX inhibitor motif containing 7, pseudogene	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases methylation	ISO	RGD:1306626	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased methylation of TMBIM7 gene	PMID:28801915
12791100	TMBIM7P	transmembrane BAX inhibitor motif containing 7, pseudogene	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1306626	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TMBIM7 mRNA	PMID:28801915
12791100	TMBIM7P	transmembrane BAX inhibitor motif containing 7, pseudogene	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306626	E	RGD:6480464	20170613	CTD	MESH:D011441	Propylthiouracil results in increased expression of TMBIM7 mRNA	PMID:24780913
12791176	LINC02250	long independently transcribed non-coding RNA 2250	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02250 mRNA	PMID:38568856
12791197	SNHG26	small nucleolar RNA host gene 26	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SNHG26 mRNA	PMID:38568856
12791197	SNHG26	small nucleolar RNA host gene 26	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SNHG26 mRNA	PMID:33212167
12791197	SNHG26	small nucleolar RNA host gene 26	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNHG26 mRNA	PMID:38568856
12791197	SNHG26	small nucleolar RNA host gene 26	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SNHG26 mRNA	PMID:38568856
12791198	LINC02251	long independently transcribed non-coding RNA 2251	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02251 mRNA	PMID:41028656
12791198	LINC02251	long independently transcribed non-coding RNA 2251	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02251 mRNA	PMID:41028656
12791198	LINC02251	long independently transcribed non-coding RNA 2251	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02251 mRNA	PMID:41028656
12791213	ZNF710-AS1	ZNF710 antisense RNA 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZNF710-AS1 mRNA	PMID:33212167
12791213	ZNF710-AS1	ZNF710 antisense RNA 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ZNF710-AS1 mRNA	PMID:32763439
12791213	ZNF710-AS1	ZNF710 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF710-AS1 mRNA	PMID:34032870
12791213	ZNF710-AS1	ZNF710 antisense RNA 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ZNF710-AS1 mRNA	PMID:38832940
12791214	LINC02249	long independently transcribed non-coding RNA 2249	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LINC02249 promoter	PMID:27901495
12791214	LINC02249	long independently transcribed non-coding RNA 2249	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LINC02249 gene	PMID:29154799
12791214	LINC02249	long independently transcribed non-coding RNA 2249	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of LINC02249 mRNA	PMID:24810058
12791222	ASMER1	adipocyte associated metabolic related lncRNA 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ASMER1 intron	PMID:30157460
12791222	ASMER1	adipocyte associated metabolic related lncRNA 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ASMER1 intron	PMID:30157460
12791222	ASMER1	adipocyte associated metabolic related lncRNA 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ASMER1 intron	PMID:30157460
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PDXDC2P intron	PMID:30157460
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PDXDC2P mRNA	PMID:28628672
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PDXDC2P mRNA	PMID:28628672
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PDXDC2P mRNA	PMID:28628672
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PDXDC2P mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PDXDC2P mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PDXDC2P mRNA	PMID:28628672
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of PDXDC2P mRNA	PMID:29024780
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PDXDC2P mRNA	PMID:40419075
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PDXDC2P gene	PMID:29154799
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PDXDC2P mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PDXDC2P mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PDXDC2P mRNA	PMID:28628672
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PDXDC2P mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PDXDC2P mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PDXDC2P mRNA	PMID:28628672
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	fipronil results in decreased expression of PDXDC2P mRNA	PMID:28991164
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of PDXDC2P mRNA	PMID:28991164
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:7071	N,N-diethyl-m-toluamide	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	DEET results in decreased expression of PDXDC2P mRNA	PMID:28991164
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of PDXDC2P mRNA	PMID:28991164
12791239	PDXDC2P	pyridoxal dependent decarboxylase domain containing 2, pseudogene	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PDXDC2P mRNA	PMID:29301935
12791240	ITFG2-AS1	ITFG2 antisense RNA 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ITFG2-AS1 mRNA	PMID:35811015
12791240	ITFG2-AS1	ITFG2 antisense RNA 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ITFG2-AS1 gene	PMID:31601247
12791240	ITFG2-AS1	ITFG2 antisense RNA 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ITFG2-AS1 mRNA	PMID:35811015
12791241	INO80-AS1	INO80 antisense RNA 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of INO80-AS1 mRNA	PMID:35811015
12791241	INO80-AS1	INO80 antisense RNA 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of INO80-AS1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of INO80-AS1 mRNA	PMID:35811015
12791241	INO80-AS1	INO80 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of INO80-AS1 mRNA	PMID:38568856
12791241	INO80-AS1	INO80 antisense RNA 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of INO80-AS1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of INO80-AS1 mRNA	PMID:35811015
12791241	INO80-AS1	INO80 antisense RNA 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of INO80-AS1 mRNA	PMID:38568856
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1307378	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SCART1 mRNA	PMID:32741896
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1307378	E	RGD:6480464	20210406	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of CD163L1 mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SCART1 mRNA	PMID:26496021|PMID:32741896
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SCART1 mRNA	PMID:32234424
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SCART1 promoter	PMID:27901495
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SCART1 mRNA	PMID:32234424
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of SCART1 gene	PMID:31601247
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1307378	E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in decreased expression of CD163L1 mRNA	PMID:25181051
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1316544	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of SCART1 mRNA	PMID:32156529
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of SCART1 gene	PMID:31601247
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1307378	E	RGD:6480464	20260811	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of CD163L1 mRNA	PMID:26496021
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1316544	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of SCART1 exon	PMID:33297965
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of SCART1 gene	PMID:31601247
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of SCART1 mRNA	PMID:37047231
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SCART1 mRNA	PMID:37042841
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1307378	E	RGD:6480464	20260811	CTD	MESH:C039281	furan results in decreased expression of CD163L1 mRNA	PMID:25539665
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1307378	E	RGD:6480464	20260811	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of CD163L1 mRNA	PMID:30047161
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SCART1 gene	PMID:29154799
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1307378	E	RGD:6480464	20260811	CTD	MESH:D000640	Amitrole results in decreased expression of CD163L1 mRNA	PMID:30047161
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of SCART1 mRNA	PMID:40706910
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of SCART1 mRNA	PMID:32234424
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	fipronil results in decreased expression of SCART1 mRNA	PMID:28991164
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of SCART1 mRNA	PMID:28991164
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1307378	E	RGD:6480464	20260811	CTD	MESH:D008713	Methimazole results in decreased expression of CD163L1 mRNA	PMID:30047161
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	DEET results in decreased expression of SCART1 mRNA	PMID:28991164
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of SCART1 mRNA	PMID:28991164
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1307378	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SCART1 mRNA	PMID:32741896
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of SCART1 mRNA	PMID:32234424
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1307378	E	RGD:6480464	20260811	CTD	MESH:C045950	propiconazole results in decreased expression of CD163L1 mRNA	PMID:30047161
12792009	SCART1	scavenger receptor family member expressed on T cells 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1307378	E	RGD:6480464	20260811	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CD163L1 mRNA	PMID:30047161
12792063	MMP2-AS1	MMP2 antisense RNA 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MMP2-AS1 mRNA	PMID:35811015
12792063	MMP2-AS1	MMP2 antisense RNA 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP2-AS1 mRNA]	PMID:35811015
12792063	MMP2-AS1	MMP2 antisense RNA 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of MMP2-AS1 mRNA]	PMID:35811015
12792116	MIR200CHG	MIR200C and MIR141 host gene	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of MIR200CHG mRNA	PMID:34032870
12792123	MTCO3P12	MT-CO3 pseudogene 12	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MTCO3P12 mRNA	PMID:32234424
12792123	MTCO3P12	MT-CO3 pseudogene 12	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MTCO3P12 mRNA	PMID:33212167
12792123	MTCO3P12	MT-CO3 pseudogene 12	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MTCO3P12 mRNA	PMID:38568856
12792123	MTCO3P12	MT-CO3 pseudogene 12	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MTCO3P12 mRNA	PMID:32234424
12792123	MTCO3P12	MT-CO3 pseudogene 12	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of MTCO3P12 mRNA	PMID:31745603
12792123	MTCO3P12	MT-CO3 pseudogene 12	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of MTCO3P12 mRNA	PMID:32234424
12792123	MTCO3P12	MT-CO3 pseudogene 12	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MTCO3P12 mRNA	PMID:38568856
12792187	SPINT1-AS1	SPINT1 antisense RNA 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SPINT1-AS1 mRNA	PMID:38568856
12792187	SPINT1-AS1	SPINT1 antisense RNA 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SPINT1-AS1 mRNA	PMID:38568856
12798437	RNA18SN4	RNA, 18S ribosomal N4	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D014284	Triiodothyronine results in increased expression of RNA18SN4 mRNA	PMID:23397585
12798437	RNA18SN4	RNA, 18S ribosomal N4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RNA18SN4 mRNA	PMID:23557933
12798437	RNA18SN4	RNA, 18S ribosomal N4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C006780	bisphenol A results in decreased expression of RNA18SN4 mRNA	PMID:25047013
12798437	RNA18SN4	RNA, 18S ribosomal N4	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C100187	chloropicrin results in increased expression of RNA18SN4 mRNA	PMID:26352163
12798437	RNA18SN4	RNA, 18S ribosomal N4	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D003907	Dexamethasone results in decreased expression of RNA18SN4 mRNA	PMID:25047013
12798447	RNA5-8SN4	RNA, 5.8S ribosomal N4	gene	CHEBI:17234	glucose	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in decreased expression of RNA5-8SN4 mRNA	PMID:39613055
12798447	RNA5-8SN4	RNA, 5.8S ribosomal N4	gene	CHEBI:17634	D-glucose	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in decreased expression of RNA5-8SN4 mRNA	PMID:39613055
12798447	RNA5-8SN4	RNA, 5.8S ribosomal N4	gene	CHEBI:28077	rifampicin	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D012293	Rifampin results in decreased expression of RNA5-8SN4 mRNA	PMID:24552687
12798447	RNA5-8SN4	RNA, 5.8S ribosomal N4	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in decreased expression of RNA5-8SN4 mRNA	PMID:39613055
12798448	LINP1	lncRNA in non-homologous end joining pathway 1	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of LINP1 mRNA	PMID:34032870
12798448	LINP1	lncRNA in non-homologous end joining pathway 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINP1 polyA tail	PMID:30157460
12798448	LINP1	lncRNA in non-homologous end joining pathway 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LINP1 mRNA	PMID:38568856
12798448	LINP1	lncRNA in non-homologous end joining pathway 1	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINP1 polyA tail	PMID:30157460
12798449	MIR3936HG	MIR3936 host gene	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of MIR3936HG mRNA	PMID:38568856
12798449	MIR3936HG	MIR3936 host gene	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MIR3936HG mRNA	PMID:32763439
12798449	MIR3936HG	MIR3936 host gene	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of MIR3936HG mRNA	PMID:34032870
12798449	MIR3936HG	MIR3936 host gene	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MIR3936HG mRNA	PMID:31533062
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SNHG14 mRNA	PMID:27188386
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:2290320	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SNHG14 mRNA	PMID:33045310
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:2290320	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SNHG14 mRNA	PMID:30529165
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:2290320	E	RGD:6480464	20231205	CTD	MESH:D019308	[Oleic Acid co-treated with Palmitic Acid] results in increased expression of SNHG14 mRNA; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of DDIT3 protein]]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HSPA5 protein]]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 protein]]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of BACE1 protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of DDIT3 protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HSPA5 protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of MIR497 mRNA]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of BACE1 protein]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of DDIT3 protein]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HSPA5 protein]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 protein]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]	PMID:37009739
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:2290320	E	RGD:6480464	20231205	CTD	MESH:D019301	[Oleic Acid co-treated with Palmitic Acid] results in increased expression of SNHG14 mRNA; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of DDIT3 protein]]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HSPA5 protein]]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 protein]]; BACE1 protein affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of BACE1 protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of DDIT3 protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HSPA5 protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 protein]]; MIR497 affects the reaction [SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of MIR497 mRNA]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of BACE1 protein]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of DDIT3 protein]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of HSPA5 protein]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL1B protein]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of IL6 protein]; SNHG14 affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of TNF protein]	PMID:37009739
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D000431	Ethanol results in decreased expression of SNHG14 mRNA	PMID:28986285
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SNHG14 mRNA	PMID:34529319
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:D008070	SNHG14 mRNA promotes the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; SNHG14 mRNA promotes the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; SNHG14 mRNA promotes the reaction [Lipopolysaccharides results in increased expression of TNF protein]	PMID:34529319
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:2290320	E	RGD:6480464	20260804	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SNHG14 mRNA	PMID:25510870
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SNHG14 mRNA	PMID:38568856
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of SNHG14 mRNA	PMID:39245080
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:2290320	E	RGD:6480464	20260804	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SNHG14 mRNA	PMID:25510870
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:2290320	E	RGD:6480464	20260804	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SNHG14 mRNA	PMID:25510870
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:2290320	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SNHG14 mRNA	PMID:25629700
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20260804	CTD	MESH:D001151	Arsenic affects the methylation of SNHG14 gene	PMID:25304211
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20170328	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SNHG14 mRNA	PMID:26272509
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA	PMID:27188386
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D002945	Cisplatin results in increased expression of SNHG14 mRNA	PMID:27392435
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SNHG14 mRNA	PMID:27392435
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D009532	Nickel results in decreased expression of SNHG14 mRNA	PMID:25583101
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D012402	Rotenone results in decreased expression of SNHG14 mRNA	PMID:29955902
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SNHG14 mRNA	PMID:28001369
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SNHG14 mRNA	PMID:30851411
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:28618	1,4-dichlorobenzene	increases expression	ISO	RGD:2290320	E	RGD:6480464	20171114	CTD	MESH:C018511	4-dichlorobenzene results in increased expression of SNHG14 mRNA	PMID:26975756
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:2290320	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of SNHG14 mRNA	PMID:39631538
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNHG14 mRNA	PMID:29301061|PMID:34032870
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SNHG14 mRNA	PMID:17879257|PMID:38568856
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20260804	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SNHG14 promoter	PMID:27901495
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to SNHG14 mRNA]	PMID:32406909
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SNHG14 gene	PMID:31601247
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:2290320	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SNHG14 mRNA	PMID:29264374
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:2290320	E	RGD:6480464	20170328	CTD	MESH:C006253	pirinixic acid results in increased expression of SNHG14 mRNA	PMID:23811191
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2290320	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of SNHG14 mRNA	PMID:35598803
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20260804	CTD	MESH:C006780	bisphenol A results in increased methylation of SNHG14 gene	PMID:31601247
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SNHG14 gene	PMID:31601247
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:2290320	E	RGD:6480464	20260804	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SNHG14 mRNA	PMID:25510870
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:2290320	E	RGD:6480464	20260804	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SNHG14 mRNA	PMID:25510870
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:2290320	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SNHG14 mRNA	PMID:38685157
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:2290320	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with LIF protein] results in increased expression of SNHG14 mRNA	PMID:30951980
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of SNHG14 mRNA	PMID:29024780
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D014635	Valproic Acid affects the expression of SNHG14 mRNA	PMID:25979313
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170328	CTD	MESH:D014635	Valproic Acid results in decreased expression of SNHG14 mRNA	PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20260804	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SNHG14 gene	PMID:29154799
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA	PMID:27188386
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D016572	Cyclosporine results in decreased expression of SNHG14 mRNA	PMID:27989131
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20170328	CTD	MESH:C012589	trichostatin A results in decreased expression of SNHG14 mRNA	PMID:24935251|PMID:26272509
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA	PMID:27188386
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20260804	CTD	MESH:D001151	Arsenic affects the methylation of SNHG14 gene	PMID:25304211
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20170328	CTD	MESH:C042720	mercuric bromide results in decreased expression of SNHG14 mRNA	PMID:26272509
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA	PMID:27188386
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D000069286	Bortezomib results in increased expression of SNHG14 mRNA	PMID:20977926
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:2290320	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SNHG14 mRNA	PMID:22206623
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SNHG14 mRNA	PMID:30851411
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SNHG14 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA	PMID:27188386
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:2290320	E	RGD:6480464	20170328	CTD	MESH:D010634	Phenobarbital affects the expression of SNHG14 mRNA	PMID:23091169
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:80799	Bufotalin	affects expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin affects the expression of SNHG14 mRNA	PMID:39904859
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA	PMID:27188386
12798467	SNHG14	small nucleolar RNA host gene 14	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SNHG14 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNHG14 mRNA	PMID:27188386
12798468	RNA45SN4	RNA, 45S pre-ribosomal N4	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D005557	Formaldehyde results in decreased expression of RNA45SN4 mRNA	PMID:27664576
12798468	RNA45SN4	RNA, 45S pre-ribosomal N4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D014635	Valproic Acid results in increased expression of RNA45SN4 mRNA	PMID:28001369
12798485	ATP2C2-AS1	ATP2C2 antisense RNA 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of ATP2C2-AS1 mRNA	PMID:41028656
12798485	ATP2C2-AS1	ATP2C2 antisense RNA 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ATP2C2-AS1 mRNA	PMID:33212167
12798485	ATP2C2-AS1	ATP2C2 antisense RNA 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ATP2C2-AS1 mRNA	PMID:41028656
12798485	ATP2C2-AS1	ATP2C2 antisense RNA 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ATP2C2-AS1 mRNA	PMID:41028656
12798485	ATP2C2-AS1	ATP2C2 antisense RNA 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ATP2C2-AS1 mRNA	PMID:38479592
12798494	TMEM132D-AS1	TMEM132D antisense RNA 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TMEM132D-AS1 intron	PMID:30157460
12798807	LINC02273	long independently transcribed non-coding RNA 2273	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of LINC02273 mRNA	PMID:35967413
12798807	LINC02273	long independently transcribed non-coding RNA 2273	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02273 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02273 mRNA	PMID:35811015
12798807	LINC02273	long independently transcribed non-coding RNA 2273	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02273 mRNA	PMID:29301061|PMID:38568856
12798807	LINC02273	long independently transcribed non-coding RNA 2273	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC02273 mRNA	PMID:38832940
12798807	LINC02273	long independently transcribed non-coding RNA 2273	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC02273 mRNA	PMID:35811015
12798807	LINC02273	long independently transcribed non-coding RNA 2273	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02273 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02273 mRNA	PMID:35811015
12798807	LINC02273	long independently transcribed non-coding RNA 2273	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC02273 mRNA	PMID:38568856
12798818	LINC02269	long independently transcribed non-coding RNA 2269	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC02269 mRNA	PMID:32234424
12798818	LINC02269	long independently transcribed non-coding RNA 2269	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02269 mRNA	PMID:38832940
12798818	LINC02269	long independently transcribed non-coding RNA 2269	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of LINC02269 mRNA	PMID:32234424
12798818	LINC02269	long independently transcribed non-coding RNA 2269	gene	CHEBI:6382	Lasiocarpine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005136	lasiocarpine results in decreased expression of LINC02269 mRNA	PMID:32234424
12798818	LINC02269	long independently transcribed non-coding RNA 2269	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of LINC02269 mRNA	PMID:32234424
12798874	LINC02421	long independently transcribed non-coding RNA 2421	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC02421 mRNA	PMID:38568856
12798886	LINC02352	long independently transcribed non-coding RNA 2352	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of LINC02352 mRNA	PMID:27905399
12798886	LINC02352	long independently transcribed non-coding RNA 2352	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02352 mRNA	PMID:38832940
12798903	LINC02336	long independently transcribed non-coding RNA 2336	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC02336 mRNA	PMID:38568856
12798933	LINC02361	long independently transcribed non-coding RNA 2361	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of LINC02361 mRNA	PMID:38568856
12798933	LINC02361	long independently transcribed non-coding RNA 2361	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02361 mRNA	PMID:29301061
12798968	LINC02351	long independently transcribed non-coding RNA 2351	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC02351 intron	PMID:30157460
12798968	LINC02351	long independently transcribed non-coding RNA 2351	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02351 intron	PMID:30157460
12798968	LINC02351	long independently transcribed non-coding RNA 2351	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02351 mRNA	PMID:41028656
12798968	LINC02351	long independently transcribed non-coding RNA 2351	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02351 mRNA	PMID:41028656
12798968	LINC02351	long independently transcribed non-coding RNA 2351	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02351 intron	PMID:30157460
12798968	LINC02351	long independently transcribed non-coding RNA 2351	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02351 mRNA	PMID:41028656
12798968	LINC02351	long independently transcribed non-coding RNA 2351	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02351 intron	PMID:30157460
12798968	LINC02351	long independently transcribed non-coding RNA 2351	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02351 intron	PMID:30157460
12799083	LINC02288	long independently transcribed non-coding RNA 2288	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02288 intron	PMID:30157460
12799083	LINC02288	long independently transcribed non-coding RNA 2288	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC02288 intron	PMID:30157460
12799083	LINC02288	long independently transcribed non-coding RNA 2288	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC02288 intron	PMID:30157460
12799152	LINC02347	long independently transcribed non-coding RNA 2347	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02347 mRNA	PMID:41028656
12799152	LINC02347	long independently transcribed non-coding RNA 2347	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02347 mRNA	PMID:41028656
12799152	LINC02347	long independently transcribed non-coding RNA 2347	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LINC02347 promoter	PMID:27901495
12799152	LINC02347	long independently transcribed non-coding RNA 2347	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02347 mRNA	PMID:41028656
12799205	LINC02381	long independently transcribed non-coding RNA 2381	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of LINC02381 mRNA	PMID:30510588
12799205	LINC02381	long independently transcribed non-coding RNA 2381	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of LINC02381 mRNA	PMID:33359661
12799205	LINC02381	long independently transcribed non-coding RNA 2381	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC02381 mRNA	PMID:33212167
12799205	LINC02381	long independently transcribed non-coding RNA 2381	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC02381 mRNA	PMID:30851411
12799205	LINC02381	long independently transcribed non-coding RNA 2381	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02381 mRNA	PMID:38568856
12799205	LINC02381	long independently transcribed non-coding RNA 2381	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LINC02381 promoter	PMID:27901495
12799205	LINC02381	long independently transcribed non-coding RNA 2381	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of LINC02381 mRNA	PMID:29154799
12799205	LINC02381	long independently transcribed non-coding RNA 2381	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of LINC02381 mRNA	PMID:32234424
12799205	LINC02381	long independently transcribed non-coding RNA 2381	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC02381 mRNA	PMID:30851411
12799211	EDDM13	epididymal protein 13	gene	CHEBI:174733	Licochalcone B	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of EDDM13 mRNA	PMID:33647349
12799211	EDDM13	epididymal protein 13	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EDDM13 intron	PMID:30157460
12799211	EDDM13	epididymal protein 13	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1613833	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of EDDM13 promoter	PMID:28392331
12799211	EDDM13	epididymal protein 13	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EDDM13 mRNA	PMID:37042841
12799211	EDDM13	epididymal protein 13	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1613833	E	RGD:6480464	20230404	CTD	MESH:D017313	Fenretinide results in increased expression of EDDM13 mRNA	PMID:28973697
12799261	LINC02392	long independently transcribed non-coding RNA 2392	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LINC02392 mRNA	PMID:35811015
12799261	LINC02392	long independently transcribed non-coding RNA 2392	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02392 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02392 mRNA	PMID:35811015
12799261	LINC02392	long independently transcribed non-coding RNA 2392	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02392 mRNA	PMID:38568856
12799261	LINC02392	long independently transcribed non-coding RNA 2392	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02392 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02392 mRNA	PMID:35811015
12799384	LINC02387	long independently transcribed non-coding RNA 2387	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC02387 intron	PMID:30157460
12799384	LINC02387	long independently transcribed non-coding RNA 2387	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02387 intron	PMID:30157460
12799384	LINC02387	long independently transcribed non-coding RNA 2387	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC02387 intron	PMID:30157460
12799384	LINC02387	long independently transcribed non-coding RNA 2387	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC02387 intron	PMID:30157460
12799391	LINC02308	long independently transcribed non-coding RNA 2308	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of LINC02308 mRNA	PMID:29955902
12799399	LINC02328	long independently transcribed non-coding RNA 2328	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02328 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02328 mRNA	PMID:35811015
12799399	LINC02328	long independently transcribed non-coding RNA 2328	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02328 mRNA	PMID:38568856
12799399	LINC02328	long independently transcribed non-coding RNA 2328	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC02328 mRNA	PMID:38832940
12799399	LINC02328	long independently transcribed non-coding RNA 2328	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02328 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02328 mRNA	PMID:35811015
12799416	LINC02263	long independently transcribed non-coding RNA 2263	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02263 mRNA	PMID:41028656
12799416	LINC02263	long independently transcribed non-coding RNA 2263	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02263 mRNA	PMID:41028656
12799416	LINC02263	long independently transcribed non-coding RNA 2263	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02263 mRNA	PMID:34032870
12799416	LINC02263	long independently transcribed non-coding RNA 2263	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02263 mRNA	PMID:41028656
12799416	LINC02263	long independently transcribed non-coding RNA 2263	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02263 mRNA	PMID:38832940
12799439	ADGRD1-AS1	ADGRD1 antisense RNA 1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ADGRD1-AS1 mRNA	PMID:30510588
12799460	LINC02359	long independently transcribed non-coding RNA 2359	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02359 mRNA	PMID:41028656
12799460	LINC02359	long independently transcribed non-coding RNA 2359	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02359 mRNA	PMID:41028656
12799460	LINC02359	long independently transcribed non-coding RNA 2359	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02359 mRNA	PMID:41028656
12799480	LINC02284	long independently transcribed non-coding RNA 2284	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02284 mRNA	PMID:41028656
12799480	LINC02284	long independently transcribed non-coding RNA 2284	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02284 mRNA	PMID:41028656
12799480	LINC02284	long independently transcribed non-coding RNA 2284	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02284 mRNA	PMID:41028656
12799525	LINC02291	long independently transcribed non-coding RNA 2291	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of LINC02291 mRNA	PMID:39245080
12799525	LINC02291	long independently transcribed non-coding RNA 2291	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LINC02291 gene	PMID:31601247
12799525	LINC02291	long independently transcribed non-coding RNA 2291	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LINC02291 gene	PMID:31601247
12799547	LINC02334	long independently transcribed non-coding RNA 2334	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02334 mRNA	PMID:38568856
12799564	LINC02293	long independently transcribed non-coding RNA 2293	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of LINC02293 mRNA	PMID:29955902
12799564	LINC02293	long independently transcribed non-coding RNA 2293	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02293 mRNA	PMID:38832940
12799579	LINC02413	long independently transcribed non-coding RNA 2413	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of LINC02413 mRNA	PMID:38218311
12799579	LINC02413	long independently transcribed non-coding RNA 2413	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02413 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02413 mRNA	PMID:35811015
12799579	LINC02413	long independently transcribed non-coding RNA 2413	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC02413 mRNA	PMID:35811015
12799579	LINC02413	long independently transcribed non-coding RNA 2413	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02413 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02413 mRNA	PMID:35811015
12799579	LINC02413	long independently transcribed non-coding RNA 2413	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of LINC02413 mRNA	PMID:35486664
12799590	LINC02383	long independently transcribed non-coding RNA 2383	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02383 mRNA	PMID:38568856
12799605	FAM237A	family with sequence similarity 237 member A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FAM237A 5' UTR; Benzo(a)pyrene results in increased methylation of FAM237A promoter	PMID:27901495
12799617	LINC02404	long independently transcribed non-coding RNA 2404	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02404 mRNA	PMID:38832940
12799636	TEX48	testis expressed 48	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1623136	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of TEX48 mRNA	PMID:35295148
12799653	LINC02259	long independently transcribed non-coding RNA 2259	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC02259 intron	PMID:30157460
12799681	LNCOG	lncRNA osteogenesis associated	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LNCOG mRNA	PMID:35811015
12799681	LNCOG	lncRNA osteogenesis associated	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LNCOG intron	PMID:30157460
12799681	LNCOG	lncRNA osteogenesis associated	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of LNCOG mRNA	PMID:29301061|PMID:38568856
12799681	LNCOG	lncRNA osteogenesis associated	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LNCOG mRNA	PMID:32234424
12799681	LNCOG	lncRNA osteogenesis associated	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LNCOG intron	PMID:30157460
12799681	LNCOG	lncRNA osteogenesis associated	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LNCOG mRNA	PMID:38568856
12799681	LNCOG	lncRNA osteogenesis associated	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LNCOG mRNA	PMID:38832940
12799681	LNCOG	lncRNA osteogenesis associated	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LNCOG mRNA	PMID:35811015
12799681	LNCOG	lncRNA osteogenesis associated	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LNCOG mRNA	PMID:35811015
12799681	LNCOG	lncRNA osteogenesis associated	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LNCOG intron	PMID:30157460
12799681	LNCOG	lncRNA osteogenesis associated	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of LNCOG mRNA	PMID:32234424
12799681	LNCOG	lncRNA osteogenesis associated	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LNCOG mRNA	PMID:38568856
12799708	LINC02310	long independently transcribed non-coding RNA 2310	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02310 mRNA	PMID:38568856
12799708	LINC02310	long independently transcribed non-coding RNA 2310	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC02310 mRNA	PMID:38568856
12799739	LINC02385	long independently transcribed non-coding RNA 2385	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02385 mRNA	PMID:38568856
12799789	LINC02324	long independently transcribed non-coding RNA 2324	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02324 mRNA	PMID:38568856
12799806	LINC02405	long independently transcribed non-coding RNA 2405	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of LINC02405 mRNA	PMID:38218311
12799806	LINC02405	long independently transcribed non-coding RNA 2405	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02405 mRNA	PMID:38832940
12799822	LINC02280	long independently transcribed non-coding RNA 2280	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC02280 mRNA	PMID:30851411
12799822	LINC02280	long independently transcribed non-coding RNA 2280	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LINC02280 mRNA	PMID:30851411
12799954	LINC02389	long independently transcribed non-coding RNA 2389	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02389 intron	PMID:30157460
12799954	LINC02389	long independently transcribed non-coding RNA 2389	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of LINC02389 mRNA	PMID:31715268
12800002	LINC02327	long independently transcribed non-coding RNA 2327	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02327 mRNA	PMID:38568856
12800002	LINC02327	long independently transcribed non-coding RNA 2327	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC02327 mRNA	PMID:38568856
12800096	SEC23A-AS1	SEC23A antisense RNA 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SEC23A-AS1 mRNA	PMID:34032870
12800103	LINC02323	long independently transcribed non-coding RNA 2323	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02323 mRNA	PMID:38568856
12800103	LINC02323	long independently transcribed non-coding RNA 2323	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LINC02323 mRNA	PMID:38568856
12800103	LINC02323	long independently transcribed non-coding RNA 2323	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC02323 mRNA	PMID:38832940
12800149	LINC02363	long independently transcribed non-coding RNA 2363	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02363 mRNA	PMID:35811015
12800149	LINC02363	long independently transcribed non-coding RNA 2363	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02363 intron	PMID:30157460
12800149	LINC02363	long independently transcribed non-coding RNA 2363	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02363 mRNA	PMID:41028656
12800149	LINC02363	long independently transcribed non-coding RNA 2363	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC02363 mRNA	PMID:33212167
12800149	LINC02363	long independently transcribed non-coding RNA 2363	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02363 mRNA	PMID:41028656
12800149	LINC02363	long independently transcribed non-coding RNA 2363	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02363 mRNA	PMID:41028656
12800149	LINC02363	long independently transcribed non-coding RNA 2363	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02363 mRNA	PMID:38832940
12800149	LINC02363	long independently transcribed non-coding RNA 2363	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02363 mRNA	PMID:35811015
12800149	LINC02363	long independently transcribed non-coding RNA 2363	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of LINC02363 mRNA	PMID:28991164
12800149	LINC02363	long independently transcribed non-coding RNA 2363	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of LINC02363 mRNA	PMID:28991164
12800157	LINC02274	long independently transcribed non-coding RNA 2274	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LINC02274 mRNA	PMID:33212167
12800157	LINC02274	long independently transcribed non-coding RNA 2274	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC02274 mRNA	PMID:38832940
12800174	LINC02357	long independently transcribed non-coding RNA 2357	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02357 mRNA	PMID:35811015
12800174	LINC02357	long independently transcribed non-coding RNA 2357	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02357 mRNA	PMID:35811015
12800233	LINC02325	long independently transcribed non-coding RNA 2325	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of LINC02325 mRNA	PMID:29955902
12800233	LINC02325	long independently transcribed non-coding RNA 2325	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02325 intron	PMID:30157460
12800309	LINC02315	long independently transcribed non-coding RNA 2315	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to LINC02315 mRNA]	PMID:32406909
12800348	LINC02416	long independently transcribed non-coding RNA 2416	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LINC02416 mRNA	PMID:35811015
12800348	LINC02416	long independently transcribed non-coding RNA 2416	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02416 mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of LINC02416 mRNA]	PMID:35811015
12800348	LINC02416	long independently transcribed non-coding RNA 2416	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02416 mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of LINC02416 mRNA]	PMID:35811015
12800367	LINC02382	long independently transcribed non-coding RNA 2382	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02382 mRNA	PMID:38832940
12800373	LINC02314	long independently transcribed non-coding RNA 2314	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02314 polyA tail	PMID:30157460
12800385	LINC02402	long independently transcribed non-coding RNA 2402	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02402 intron	PMID:30157460
12800385	LINC02402	long independently transcribed non-coding RNA 2402	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02402 intron	PMID:30157460
12800385	LINC02402	long independently transcribed non-coding RNA 2402	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02402 intron	PMID:30157460
12800428	LINC02303	long independently transcribed non-coding RNA 2303	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02303 mRNA	PMID:38832940
12800480	LINC02418	long independently transcribed non-coding RNA 2418	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02418 promoter	PMID:27901495
12800480	LINC02418	long independently transcribed non-coding RNA 2418	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC02418 mRNA	PMID:38568856
12800541	LINC02362	long independently transcribed non-coding RNA 2362	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02362 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02362 mRNA	PMID:35811015
12800541	LINC02362	long independently transcribed non-coding RNA 2362	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC02362 mRNA	PMID:33212167
12800541	LINC02362	long independently transcribed non-coding RNA 2362	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02362 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02362 mRNA	PMID:35811015
12800558	LINC02378	long independently transcribed non-coding RNA 2378	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02378 intron	PMID:30157460
12800567	LINC02376	long independently transcribed non-coding RNA 2376	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02376 intron; Aflatoxin B1 results in increased methylation of LINC02376 promoter	PMID:30157460
12800567	LINC02376	long independently transcribed non-coding RNA 2376	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02376 mRNA	PMID:38568856
12800589	TMEM202-AS1	TMEM202 antisense RNA 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TMEM202-AS1 mRNA	PMID:38832940
12800690	LINC02424	long independently transcribed non-coding RNA 2424	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02424 intron	PMID:30157460
12800696	LINC02340	long intergenic non-protein coding RNA 2340	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02340 mRNA	PMID:35811015
12800696	LINC02340	long intergenic non-protein coding RNA 2340	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC02340 mRNA	PMID:33212167
12800696	LINC02340	long intergenic non-protein coding RNA 2340	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of LINC02340 mRNA	PMID:32763439
12800696	LINC02340	long intergenic non-protein coding RNA 2340	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02340 mRNA	PMID:38568856
12800696	LINC02340	long intergenic non-protein coding RNA 2340	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02340 mRNA	PMID:35811015
12800696	LINC02340	long intergenic non-protein coding RNA 2340	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC02340 mRNA	PMID:38568856
12800750	LINC02337	long independently transcribed non-coding RNA 2337	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC02337 intron	PMID:30157460
12800750	LINC02337	long independently transcribed non-coding RNA 2337	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02337 intron	PMID:30157460
12800750	LINC02337	long independently transcribed non-coding RNA 2337	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of LINC02337 mRNA	PMID:40706910
12800765	LINC02372	long independently transcribed non-coding RNA 2372	gene	CHEBI:34911	permethrin	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in decreased expression of LINC02372 mRNA	PMID:37047231
12800765	LINC02372	long independently transcribed non-coding RNA 2372	gene	CHEBI:6651	malathion	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in decreased expression of LINC02372 mRNA	PMID:37047231
12800773	LINC02296	long independently transcribed non-coding RNA 2296	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02296 mRNA	PMID:38568856
12800773	LINC02296	long independently transcribed non-coding RNA 2296	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC02296 mRNA	PMID:38568856
12800808	LINC02267	long independently transcribed non-coding RNA 2267	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02267 intron	PMID:30157460
12800808	LINC02267	long independently transcribed non-coding RNA 2267	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02267 intron	PMID:30157460
12800847	LINC02348	long independently transcribed non-coding RNA 2348	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LINC02348 mRNA	PMID:32588087
12800847	LINC02348	long independently transcribed non-coding RNA 2348	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of LINC02348 mRNA	PMID:32588087|PMID:36864359
12800847	LINC02348	long independently transcribed non-coding RNA 2348	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02348 mRNA	PMID:38832940
12800847	LINC02348	long independently transcribed non-coding RNA 2348	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of LINC02348 mRNA	PMID:35486664
12800907	LINC02371	long independently transcribed non-coding RNA 2371	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02371 mRNA	PMID:41028656
12800907	LINC02371	long independently transcribed non-coding RNA 2371	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02371 mRNA	PMID:41028656
12800907	LINC02371	long independently transcribed non-coding RNA 2371	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02371 mRNA	PMID:41028656
12800916	FAM237B	family with sequence similarity 237 member B	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1616943	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of FAM237B mRNA	PMID:39529242
12800933	LINC02388	long independently transcribed non-coding RNA 2388	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC02388 intron	PMID:30157460
12800933	LINC02388	long independently transcribed non-coding RNA 2388	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02388 intron	PMID:30157460
12800933	LINC02388	long independently transcribed non-coding RNA 2388	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02388 mRNA	PMID:41028656
12800933	LINC02388	long independently transcribed non-coding RNA 2388	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02388 mRNA	PMID:41028656
12800933	LINC02388	long independently transcribed non-coding RNA 2388	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02388 mRNA	PMID:41028656
12800959	VASH1-AS1	VASH1 antisense RNA 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of VASH1-AS1 mRNA	PMID:31614463
12800959	VASH1-AS1	VASH1 antisense RNA 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of VASH1-AS1 mRNA	PMID:32763439
12800959	VASH1-AS1	VASH1 antisense RNA 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of VASH1-AS1 mRNA	PMID:38832940
12800976	LINC02369	long independently transcribed non-coding RNA 2369	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02369 mRNA	PMID:29301061
12801010	LINC02268	long independently transcribed non-coding RNA 2268	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02268 mRNA	PMID:38832940
12801022	HSFX3	heat shock transcription factor family, X-linked member 3	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of HSFX3 mRNA	PMID:35984750
12801022	HSFX3	heat shock transcription factor family, X-linked member 3	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of HSFX3 mRNA	PMID:31734321
12801061	LINC02290	long independently transcribed non-coding RNA 2290	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02290 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02290 mRNA	PMID:35811015
12801061	LINC02290	long independently transcribed non-coding RNA 2290	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02290 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02290 mRNA	PMID:35811015
12801163	LINC02346	long independently transcribed non-coding RNA 2346	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02346 intron; Aflatoxin B1 results in increased methylation of LINC02346 promoter	PMID:30157460
12801163	LINC02346	long independently transcribed non-coding RNA 2346	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02346 mRNA	PMID:41028656
12801163	LINC02346	long independently transcribed non-coding RNA 2346	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02346 mRNA	PMID:41028656
12801163	LINC02346	long independently transcribed non-coding RNA 2346	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02346 mRNA	PMID:41028656
12801163	LINC02346	long independently transcribed non-coding RNA 2346	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of LINC02346 gene	PMID:31601247
12801163	LINC02346	long independently transcribed non-coding RNA 2346	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LINC02346 gene	PMID:31601247
12801163	LINC02346	long independently transcribed non-coding RNA 2346	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of LINC02346 gene	PMID:31601247
12801163	LINC02346	long independently transcribed non-coding RNA 2346	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of LINC02346 gene	PMID:31601247
12801185	LINC02292	long independently transcribed non-coding RNA 2292	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02292 intron	PMID:30157460
12801193	LINC02289	long independently transcribed non-coding RNA 2289	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of LINC02289 mRNA	PMID:38568856
12801201	LINC02316	long independently transcribed non-coding RNA 2316	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02316 mRNA	PMID:41028656
12801201	LINC02316	long independently transcribed non-coding RNA 2316	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02316 mRNA	PMID:41028656
12801201	LINC02316	long independently transcribed non-coding RNA 2316	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02316 mRNA	PMID:41028656
12801236	LINC02331	long independently transcribed non-coding RNA 2331	gene	CHEBI:15756	hexadecanoic acid	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of LINC02331 mRNA	PMID:39506029
12801236	LINC02331	long independently transcribed non-coding RNA 2331	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02331 mRNA	PMID:38568856
12801295	LINC02330	long independently transcribed non-coding RNA 2330	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02330 mRNA	PMID:38568856
12801304	LINC02384	long independently transcribed non-coding RNA 2384	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LINC02384 mRNA	PMID:35811015
12801304	LINC02384	long independently transcribed non-coding RNA 2384	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02384 mRNA	PMID:35811015
12801304	LINC02384	long independently transcribed non-coding RNA 2384	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02384 mRNA	PMID:35811015
12801304	LINC02384	long independently transcribed non-coding RNA 2384	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of LINC02384 mRNA	PMID:32234424
12801327	LINC02302	long intergenic non-protein coding RNA 2302	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02302 mRNA	PMID:29301061
12801342	LINC02356	long independently transcribed non-coding RNA 2356	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC02356 mRNA	PMID:33212167
12801349	LINC02427	long independently transcribed non-coding RNA 2427	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02427 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02427 mRNA	PMID:35811015
12801349	LINC02427	long independently transcribed non-coding RNA 2427	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02427 mRNA	PMID:38568856
12801349	LINC02427	long independently transcribed non-coding RNA 2427	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02427 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02427 mRNA	PMID:35811015
12801358	LINC02365	long independently transcribed non-coding RNA 2365	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC02365 intron	PMID:30157460
12801358	LINC02365	long independently transcribed non-coding RNA 2365	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02365 intron	PMID:30157460
12801358	LINC02365	long independently transcribed non-coding RNA 2365	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC02365 mRNA	PMID:33212167
12801358	LINC02365	long independently transcribed non-coding RNA 2365	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02365 intron	PMID:30157460
12801358	LINC02365	long independently transcribed non-coding RNA 2365	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of LINC02365 mRNA	PMID:28988120
12801358	LINC02365	long independently transcribed non-coding RNA 2365	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02365 intron	PMID:30157460
12801500	LINC02473	long independently transcribed non-coding RNA 2473	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C006780	bisphenol A results in decreased expression of LINC02473 mRNA	PMID:33476716
12801500	LINC02473	long independently transcribed non-coding RNA 2473	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of LINC02473 mRNA	PMID:33476716
12801507	LUARIS	lncRNA upregulator of antiviral response interferon signaling	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LUARIS mRNA	PMID:32234424
12801507	LUARIS	lncRNA upregulator of antiviral response interferon signaling	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LUARIS promoter	PMID:30157460
12801507	LUARIS	lncRNA upregulator of antiviral response interferon signaling	gene	CHEBI:29678	sodium arsenite	decreases methylation	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased methylation of LUARIS promoter	PMID:32844245
12801507	LUARIS	lncRNA upregulator of antiviral response interferon signaling	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of LUARIS mRNA	PMID:29301061|PMID:32844245
12801507	LUARIS	lncRNA upregulator of antiviral response interferon signaling	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LUARIS promoter	PMID:30157460
12801507	LUARIS	lncRNA upregulator of antiviral response interferon signaling	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LUARIS mRNA	PMID:38832940
12801507	LUARIS	lncRNA upregulator of antiviral response interferon signaling	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of LUARIS mRNA	PMID:31629900
12801524	LINC02458	long independently transcribed non-coding RNA 2458	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02458 mRNA	PMID:38568856
12801554	LINC02475	long independently transcribed non-coding RNA 2475	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02475 mRNA	PMID:38832940
12801578	LINC02429	long independently transcribed non-coding RNA 2429	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02429 mRNA	PMID:41028656
12801578	LINC02429	long independently transcribed non-coding RNA 2429	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02429 mRNA	PMID:41028656
12801578	LINC02429	long independently transcribed non-coding RNA 2429	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02429 mRNA	PMID:41028656
12801606	LINC02452	long independently transcribed non-coding RNA 2452	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02452 mRNA	PMID:41028656
12801606	LINC02452	long independently transcribed non-coding RNA 2452	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02452 mRNA	PMID:41028656
12801606	LINC02452	long independently transcribed non-coding RNA 2452	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02452 mRNA	PMID:41028656
12801639	FAM240A	family with sequence similarity 240 member A	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1621309	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of FAM240A mRNA	PMID:35436446
12801674	LINC02471	long independently transcribed non-coding RNA 2471	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02471 mRNA	PMID:41028656
12801674	LINC02471	long independently transcribed non-coding RNA 2471	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02471 mRNA	PMID:41028656
12801674	LINC02471	long independently transcribed non-coding RNA 2471	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02471 mRNA	PMID:41028656
12801705	LINC02436	long independently transcribed non-coding RNA 2436	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LINC02436 mRNA	PMID:35301059
12801705	LINC02436	long independently transcribed non-coding RNA 2436	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC02436 mRNA	PMID:38568856
12801705	LINC02436	long independently transcribed non-coding RNA 2436	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LINC02436 mRNA	PMID:35301059
12801833	LINC02450	long independently transcribed non-coding RNA 2450	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02450 intron	PMID:30157460
12801852	LINC02464	long independently transcribed non-coding RNA 2464	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02464 mRNA	PMID:38568856
12801919	LINC02432	long independently transcribed non-coding RNA 2432	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LINC02432 mRNA	PMID:35811015
12801919	LINC02432	long independently transcribed non-coding RNA 2432	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of LINC02432 mRNA]	PMID:35811015
12801919	LINC02432	long independently transcribed non-coding RNA 2432	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of LINC02432 mRNA	PMID:31745603
12801919	LINC02432	long independently transcribed non-coding RNA 2432	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC02432 mRNA	PMID:38832940
12801919	LINC02432	long independently transcribed non-coding RNA 2432	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of LINC02432 mRNA]	PMID:35811015
12802052	LINC02431	long independently transcribed non-coding RNA 2431	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LINC02431 mRNA	PMID:21867686
12802052	LINC02431	long independently transcribed non-coding RNA 2431	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC02431 mRNA	PMID:38568856
12802095	LINC02447	long independently transcribed non-coding RNA 2447	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LINC02447 promoter	PMID:27901495
12802138	LINC02434	long independently transcribed non-coding RNA 2434	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02434 mRNA	PMID:38568856
12802138	LINC02434	long independently transcribed non-coding RNA 2434	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of LINC02434 mRNA	PMID:31745603
12802138	LINC02434	long independently transcribed non-coding RNA 2434	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC02434 mRNA	PMID:38568856
12802138	LINC02434	long independently transcribed non-coding RNA 2434	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02434 mRNA	PMID:38832940
12802190	LINC02449	long independently transcribed non-coding RNA 2449	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LINC02449 mRNA	PMID:36139627
12802190	LINC02449	long independently transcribed non-coding RNA 2449	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of LINC02449 mRNA	PMID:32763439
12802190	LINC02449	long independently transcribed non-coding RNA 2449	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LINC02449 mRNA	PMID:36139627
12802232	LINC02453	long independently transcribed non-coding RNA 2453	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02453 mRNA	PMID:35811015
12802232	LINC02453	long independently transcribed non-coding RNA 2453	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02453 mRNA	PMID:29301061
12802232	LINC02453	long independently transcribed non-coding RNA 2453	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02453 mRNA	PMID:35811015
12802250	LINC02454	long independently transcribed non-coding RNA 2454	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of LINC02454 mRNA	PMID:38218311
12802250	LINC02454	long independently transcribed non-coding RNA 2454	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02454 mRNA	PMID:34032870
12802250	LINC02454	long independently transcribed non-coding RNA 2454	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC02454 mRNA	PMID:38832940
12802271	LINC02443	long independently transcribed non-coding RNA 2443	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC02443 polyA tail	PMID:30157460
12802271	LINC02443	long independently transcribed non-coding RNA 2443	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02443 polyA tail	PMID:30157460
12802271	LINC02443	long independently transcribed non-coding RNA 2443	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02443 polyA tail	PMID:30157460
12879508	TEX50	testis expressed 50	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TEX50 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TEX50 mRNA	PMID:35811015
12879508	TEX50	testis expressed 50	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TEX50 mRNA	PMID:35301059
12879508	TEX50	testis expressed 50	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1617476	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TEX50 mRNA	PMID:32715474
12879508	TEX50	testis expressed 50	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:7711400	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TEX50 mRNA	PMID:33453195
12879508	TEX50	testis expressed 50	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TEX50 mRNA	PMID:35301059
12879508	TEX50	testis expressed 50	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of TEX50 mRNA	PMID:35811015
12879508	TEX50	testis expressed 50	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TEX50 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TEX50 mRNA	PMID:35811015
12879508	TEX50	testis expressed 50	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1617476	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of TEX50 mRNA	PMID:29279043
12879508	TEX50	testis expressed 50	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:7711400	E	RGD:6480464	20260303	CTD	MESH:D005485	Flutamide results in decreased expression of TEX50 mRNA	PMID:40381864
12879528	GABPB1-IT1	GABPB1 intronic transcript	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GABPB1-IT1 mRNA	PMID:38568856
12879528	GABPB1-IT1	GABPB1 intronic transcript	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GABPB1-IT1 mRNA	PMID:31533062
12879528	GABPB1-IT1	GABPB1 intronic transcript	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of GABPB1-IT1 mRNA	PMID:38832940
12879532	AFF1-AS1	AFF1 antisense RNA 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of AFF1-AS1 mRNA	PMID:31533062
12879532	AFF1-AS1	AFF1 antisense RNA 1	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of AFF1-AS1 mRNA	PMID:28991164
12879532	AFF1-AS1	AFF1 antisense RNA 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of AFF1-AS1 mRNA	PMID:28991164
12879598	LINC02478	long independently transcribed non-coding RNA 2478	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02478 mRNA	PMID:35811015
12879598	LINC02478	long independently transcribed non-coding RNA 2478	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02478 intron	PMID:30157460
12879598	LINC02478	long independently transcribed non-coding RNA 2478	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02478 mRNA	PMID:35811015
12879605	SOD2-OT1	SOD2 overlapping transcript 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SOD2-OT1 mRNA	PMID:35811015
12879605	SOD2-OT1	SOD2 overlapping transcript 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of SOD2-OT1 mRNA]	PMID:35811015
12879605	SOD2-OT1	SOD2 overlapping transcript 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SOD2-OT1 polyA tail	PMID:30157460
12879605	SOD2-OT1	SOD2 overlapping transcript 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SOD2-OT1 mRNA	PMID:30851411
12879605	SOD2-OT1	SOD2 overlapping transcript 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of SOD2-OT1 mRNA	PMID:28595984
12879605	SOD2-OT1	SOD2 overlapping transcript 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SOD2-OT1 polyA tail	PMID:30157460
12879605	SOD2-OT1	SOD2 overlapping transcript 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SOD2-OT1 mRNA	PMID:32588087
12879605	SOD2-OT1	SOD2 overlapping transcript 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SOD2-OT1 mRNA	PMID:31533062
12879605	SOD2-OT1	SOD2 overlapping transcript 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SOD2-OT1 mRNA	PMID:36864359
12879605	SOD2-OT1	SOD2 overlapping transcript 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SOD2-OT1 mRNA	PMID:38832940
12879605	SOD2-OT1	SOD2 overlapping transcript 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of SOD2-OT1 mRNA]	PMID:35811015
12879605	SOD2-OT1	SOD2 overlapping transcript 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SOD2-OT1 mRNA	PMID:30851411
12879657	TEX51	testis expressed 51	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:9640312	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TEX51 mRNA	PMID:37567420
12879657	TEX51	testis expressed 51	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:9640312	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TEX51 mRNA	PMID:37567420
12879657	TEX51	testis expressed 51	gene	CHEBI:24527	herbicide	multiple interactions	ISO	RGD:9640312	E	RGD:6480464	20231031	CTD	MESH:D006540	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TEX51 mRNA	PMID:37567420
12879657	TEX51	testis expressed 51	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:9640312	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TEX51 mRNA	PMID:37567420
12879657	TEX51	testis expressed 51	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:9640312	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of TEX51 mRNA	PMID:40203079
12879657	TEX51	testis expressed 51	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:9640312	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TEX51 mRNA	PMID:37019170
12879657	TEX51	testis expressed 51	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:9640312	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TEX51 mRNA	PMID:37567420
12879657	TEX51	testis expressed 51	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:9640312	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of TEX51 mRNA	PMID:37567420
12879734	IQCM	IQ motif containing M	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of IQCM mRNA	PMID:29301061
12879734	IQCM	IQ motif containing M	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of IQCM mRNA	PMID:38568856
12880068	LINC02481	long independently transcribed non-coding RNA 2481	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D010126	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC02481 mRNA] which results in increased expression of S100P mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC02481 mRNA	PMID:33656867
12880068	LINC02481	long independently transcribed non-coding RNA 2481	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC02481 mRNA] which results in increased expression of S100P mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC02481 mRNA	PMID:33656867
12880068	LINC02481	long independently transcribed non-coding RNA 2481	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of LINC02481 mRNA	PMID:35486664
12880068	LINC02481	long independently transcribed non-coding RNA 2481	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC02481 mRNA	PMID:38568856
12880129	LINC02482	long independently transcribed non-coding RNA 2482	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of LINC02482 mRNA	PMID:35967413
12880129	LINC02482	long independently transcribed non-coding RNA 2482	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02482 mRNA	PMID:34032870
12880129	LINC02482	long independently transcribed non-coding RNA 2482	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02482 mRNA	PMID:38832940
12880129	LINC02482	long independently transcribed non-coding RNA 2482	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of LINC02482 mRNA	PMID:24810058
12880129	LINC02482	long independently transcribed non-coding RNA 2482	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of LINC02482 mRNA	PMID:38568856
12880256	PNMA6F	PNMA family member 6F	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PNMA6F polyA tail	PMID:30157460
12880256	PNMA6F	PNMA family member 6F	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of PNMA6F polyA tail	PMID:30157460
12880277	LINC02484	long independently transcribed non-coding RNA 2484	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of LINC02484 mRNA	PMID:31745603
12880325	LINC02485	long independently transcribed non-coding RNA 2485	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02485 mRNA	PMID:38568856
12880355	MIR4453HG	MIR4453 host gene	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MIR4453HG gene	PMID:28458013
12880355	MIR4453HG	MIR4453 host gene	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MIR4453HG mRNA	PMID:33212167
12880355	MIR4453HG	MIR4453 host gene	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MIR4453HG mRNA	PMID:32763439
12880355	MIR4453HG	MIR4453 host gene	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MIR4453HG mRNA	PMID:38568856
12880355	MIR4453HG	MIR4453 host gene	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of MIR4453HG mRNA	PMID:31715268
12880355	MIR4453HG	MIR4453 host gene	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MIR4453HG mRNA	PMID:38568856
12880355	MIR4453HG	MIR4453 host gene	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MIR4453HG mRNA	PMID:31533062
12880355	MIR4453HG	MIR4453 host gene	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	fipronil results in decreased expression of MIR4453HG mRNA	PMID:28991164
12880355	MIR4453HG	MIR4453 host gene	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of MIR4453HG mRNA	PMID:28991164
12880355	MIR4453HG	MIR4453 host gene	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of MIR4453HG mRNA	PMID:28991164
12902695	LINC02497	long independently transcribed non-coding RNA 2497	gene	CHEBI:34911	permethrin	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in decreased expression of LINC02497 mRNA	PMID:37047231
12902760	LINC02493	long independently transcribed non-coding RNA 2493	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of LINC02493 mRNA	PMID:31016361
12902801	STK32A-AS1	STK32A antisense RNA 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in increased expression of STK32A-AS1 mRNA	PMID:41028656
12902801	STK32A-AS1	STK32A antisense RNA 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of STK32A-AS1 mRNA	PMID:41028656
12902801	STK32A-AS1	STK32A antisense RNA 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of STK32A-AS1 mRNA	PMID:41028656
12902826	JAKMIP1-DT	JAKMIP1 divergent transcript	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of JAKMIP1-DT mRNA	PMID:37690743
12902826	JAKMIP1-DT	JAKMIP1 divergent transcript	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of JAKMIP1-DT gene; [bisphenol F co-treated with Fulvestrant] results in decreased methylation of JAKMIP1-DT gene	PMID:31601247
12902826	JAKMIP1-DT	JAKMIP1 divergent transcript	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of JAKMIP1-DT gene	PMID:31601247
12902826	JAKMIP1-DT	JAKMIP1 divergent transcript	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of JAKMIP1-DT gene	PMID:31601247
12902826	JAKMIP1-DT	JAKMIP1 divergent transcript	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of JAKMIP1-DT gene	PMID:31601247
12902911	LINC02487	long independently transcribed non-coding RNA 2487	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LINC02487 mRNA	PMID:35811015
12902911	LINC02487	long independently transcribed non-coding RNA 2487	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02487 mRNA	PMID:35811015
12902911	LINC02487	long independently transcribed non-coding RNA 2487	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02487 intron	PMID:30157460
12902911	LINC02487	long independently transcribed non-coding RNA 2487	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC02487 mRNA	PMID:38832940
12902911	LINC02487	long independently transcribed non-coding RNA 2487	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02487 mRNA	PMID:35811015
12902911	LINC02487	long independently transcribed non-coding RNA 2487	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of LINC02487 mRNA	PMID:28988120
12902992	LINC02499	long independently transcribed non-coding RNA 2499	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC02499 mRNA	PMID:32234424
12902992	LINC02499	long independently transcribed non-coding RNA 2499	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LINC02499 mRNA	PMID:32588087
12902992	LINC02499	long independently transcribed non-coding RNA 2499	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of LINC02499 mRNA	PMID:32588087|PMID:36864359
12902992	LINC02499	long independently transcribed non-coding RNA 2499	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02499 mRNA	PMID:38832940
12902992	LINC02499	long independently transcribed non-coding RNA 2499	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of LINC02499 mRNA	PMID:32234424
12902992	LINC02499	long independently transcribed non-coding RNA 2499	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	fipronil results in decreased expression of LINC02499 mRNA	PMID:28991164
12902992	LINC02499	long independently transcribed non-coding RNA 2499	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of LINC02499 mRNA	PMID:28991164
12902992	LINC02499	long independently transcribed non-coding RNA 2499	gene	CHEBI:7071	N,N-diethyl-m-toluamide	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	DEET results in decreased expression of LINC02499 mRNA	PMID:28991164
12902992	LINC02499	long independently transcribed non-coding RNA 2499	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of LINC02499 mRNA	PMID:28991164
12902992	LINC02499	long independently transcribed non-coding RNA 2499	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of LINC02499 mRNA	PMID:32234424
12903027	TNFRSF14-AS1	TNFRSF14 antisense RNA 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of TNFRSF14-AS1 mRNA	PMID:35967413
12903027	TNFRSF14-AS1	TNFRSF14 antisense RNA 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TNFRSF14-AS1 gene	PMID:29154799
12903027	TNFRSF14-AS1	TNFRSF14 antisense RNA 1	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	fipronil results in increased expression of TNFRSF14-AS1 mRNA	PMID:28991164
12903074	CERNA2	competing endogenous lncRNA 2 for microRNA let-7b	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CERNA2 mRNA	PMID:33212167
12903074	CERNA2	competing endogenous lncRNA 2 for microRNA let-7b	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of CERNA2 mRNA	PMID:34032870
12903074	CERNA2	competing endogenous lncRNA 2 for microRNA let-7b	gene	CHEBI:32914	cetylpyridinium	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D002594	Cetylpyridinium results in decreased expression of CERNA2	PMID:37149095
12903117	SNHG27	small nucleolar RNA host gene 27	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of SNHG27 mRNA	PMID:39245080
12903117	SNHG27	small nucleolar RNA host gene 27	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of SNHG27 mRNA	PMID:32234424
12903136	SPRY4-AS1	SPRY4 antisense RNA 1	gene	CHEBI:132606	mono(2-ethyl-5-oxohexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C080276	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of SPRY4-AS1 mRNA	PMID:37160244
12903136	SPRY4-AS1	SPRY4 antisense RNA 1	gene	CHEBI:132607	mono(2-ethyl-5-hydroxyhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C479069	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of SPRY4-AS1 mRNA	PMID:37160244
12903136	SPRY4-AS1	SPRY4 antisense RNA 1	gene	CHEBI:132611	mono(5-carboxy-2-ethylpentyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C051450	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of SPRY4-AS1 mRNA	PMID:37160244
12903136	SPRY4-AS1	SPRY4 antisense RNA 1	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C103325	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of SPRY4-AS1 mRNA	PMID:37160244
12903136	SPRY4-AS1	SPRY4 antisense RNA 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C016599	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of SPRY4-AS1 mRNA	PMID:37160244
12903136	SPRY4-AS1	SPRY4 antisense RNA 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of SPRY4-AS1 mRNA	PMID:29955902
12903136	SPRY4-AS1	SPRY4 antisense RNA 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SPRY4-AS1 mRNA	PMID:38568856
12903136	SPRY4-AS1	SPRY4 antisense RNA 1	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C581825	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of SPRY4-AS1 mRNA	PMID:37160244
12903136	SPRY4-AS1	SPRY4 antisense RNA 1	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C028577	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of SPRY4-AS1 mRNA	PMID:37160244
12903227	LINC02492	long independently transcribed non-coding RNA 2492	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC02492 intron	PMID:30157460
12903227	LINC02492	long independently transcribed non-coding RNA 2492	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC02492 intron	PMID:30157460
12904079	LINC02518	long independently transcribed non-coding RNA 2518	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02518 mRNA	PMID:39719251
12904079	LINC02518	long independently transcribed non-coding RNA 2518	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC02518 mRNA	PMID:38568856
12904079	LINC02518	long independently transcribed non-coding RNA 2518	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02518 mRNA	PMID:38832940
12904116	MYMX	myomixer, myoblast fusion factor	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1620251	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MYMX mRNA	PMID:33045310
12904116	MYMX	myomixer, myoblast fusion factor	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1620251	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of MYMX mRNA	PMID:39984025
12904116	MYMX	myomixer, myoblast fusion factor	gene	CHEBI:28618	1,4-dichlorobenzene	increases expression	ISO	RGD:1620251	E	RGD:6480464	20171114	CTD	MESH:C018511	4-dichlorobenzene results in increased expression of MYMX mRNA	PMID:26975756
12904116	MYMX	myomixer, myoblast fusion factor	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1620251	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MYMX mRNA	PMID:32715474
12904201	SMILR	smooth muscle induced lncRNA, enhancer of proliferation	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of SMILR mRNA	PMID:34032870
12904201	SMILR	smooth muscle induced lncRNA, enhancer of proliferation	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SMILR intron	PMID:30157460
12904211	RNA5-8SN3	RNA, 5.8S ribosomal N3	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RNA5-8SN3 mRNA	PMID:29803840
12904259	LINC02519	long independently transcribed non-coding RNA 2519	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02519 mRNA	PMID:29301061
12904326	LINC02505	long independently transcribed non-coding RNA 2505	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02505 intron	PMID:30157460
12904335	LINC01833	long independently transcribed non-coding RNA 1833	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC01833 mRNA	PMID:38832940
12904347	RNA5-8SN2	RNA, 5.8S ribosomal N2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNA5-8SN2 mRNA	PMID:33212167
12904347	RNA5-8SN2	RNA, 5.8S ribosomal N2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RNA5-8SN2 mRNA	PMID:29803840
12904348	LINC02520	long independently transcribed non-coding RNA 2520	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02520 intron	PMID:30157460
12904348	LINC02520	long independently transcribed non-coding RNA 2520	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02520 intron	PMID:30157460
12904358	LINC02503	long independently transcribed non-coding RNA 2503	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02503 mRNA	PMID:41028656
12904358	LINC02503	long independently transcribed non-coding RNA 2503	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02503 mRNA	PMID:41028656
12904358	LINC02503	long independently transcribed non-coding RNA 2503	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02503 mRNA	PMID:41028656
12904410	LINC02511	long independently transcribed non-coding RNA 2511	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02511 intron	PMID:30157460
12904410	LINC02511	long independently transcribed non-coding RNA 2511	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LINC02511 intron	PMID:30157460
12904410	LINC02511	long independently transcribed non-coding RNA 2511	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02511 mRNA	PMID:38832940
12904410	LINC02511	long independently transcribed non-coding RNA 2511	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LINC02511 intron	PMID:30157460
12904446	DM1-AS	DM1 locus antisense RNA	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of DM1-AS mRNA	PMID:36695872
12904446	DM1-AS	DM1 locus antisense RNA	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of DM1-AS mRNA	PMID:34032870
12904446	DM1-AS	DM1 locus antisense RNA	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DM1-AS mRNA	PMID:32234424
12904446	DM1-AS	DM1 locus antisense RNA	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of DM1-AS mRNA	PMID:32234424
12904495	LINC02516	long independently transcribed non-coding RNA 2516	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02516 intron	PMID:30157460
12904495	LINC02516	long independently transcribed non-coding RNA 2516	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02516 intron	PMID:30157460
12904495	LINC02516	long independently transcribed non-coding RNA 2516	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02516 intron	PMID:30157460
12904515	HTD2	hydroxyacyl-thioester dehydratase type 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:13208237	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of HTD2 mRNA	PMID:37682722
12904515	HTD2	hydroxyacyl-thioester dehydratase type 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of HTD2 mRNA	PMID:38832940
12904515	HTD2	hydroxyacyl-thioester dehydratase type 2	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of HTD2 mRNA	PMID:38825487
12904518	LINC02506	long independently transcribed non-coding RNA 2506	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of LINC02506 intron	PMID:30157460
12904518	LINC02506	long independently transcribed non-coding RNA 2506	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02506 intron	PMID:30157460
12904550	LINC00237	long independently transcribed non-coding RNA 237	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LINC00237 intron	PMID:30157460
12904550	LINC00237	long independently transcribed non-coding RNA 237	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC00237 intron	PMID:30157460
12904550	LINC00237	long independently transcribed non-coding RNA 237	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC00237 mRNA	PMID:35811015
12904608	RNA28SN5	RNA, 28S ribosomal N5	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of RNA28SN5 mRNA	PMID:29453283
12904608	RNA28SN5	RNA, 28S ribosomal N5	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C100187	chloropicrin results in decreased expression of RNA28SN5 mRNA	PMID:28476498
12904608	RNA28SN5	RNA, 28S ribosomal N5	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RNA28SN5 mRNA	PMID:31758290
12904781	LINC02525	long independently transcribed non-coding RNA 2525	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC02525 intron	PMID:30157460
12904781	LINC02525	long independently transcribed non-coding RNA 2525	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of LINC02525 mRNA	PMID:29955902
12904781	LINC02525	long independently transcribed non-coding RNA 2525	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of LINC02525 mRNA	PMID:28302478
12904781	LINC02525	long independently transcribed non-coding RNA 2525	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of LINC02525 mRNA	PMID:24810058
12904805	MIR548A1HG	MIR548A1 host gene	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MIR548A1HG mRNA	PMID:33212167
12904869	LINC02523	long independently transcribed non-coding RNA 2523	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LINC02523 intron	PMID:30157460
12904869	LINC02523	long independently transcribed non-coding RNA 2523	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02523 mRNA	PMID:38832940
12905004	LINC02529	long independently transcribed non-coding RNA 2529	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LINC02529 intron	PMID:30157460
12905004	LINC02529	long independently transcribed non-coding RNA 2529	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LINC02529 intron	PMID:30157460
12905012	LINC02527	long independently transcribed non-coding RNA 2527	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC02527 mRNA	PMID:30851411
12905012	LINC02527	long independently transcribed non-coding RNA 2527	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC02527 mRNA	PMID:30851411
12907514	C3orf85	chromosome 3 open reading frame 85	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of C3ORF85 mRNA	PMID:39506029
12907514	C3orf85	chromosome 3 open reading frame 85	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of C3ORF85 mRNA	PMID:29301061
12907514	C3orf85	chromosome 3 open reading frame 85	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of C3ORF85 mRNA	PMID:32234424
12907514	C3orf85	chromosome 3 open reading frame 85	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of C3ORF85 mRNA	PMID:38832940
12907514	C3orf85	chromosome 3 open reading frame 85	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	fipronil results in decreased expression of C3ORF85 mRNA	PMID:28991164
12907523	RNA5-8SP10	RNA, 5.8S ribosomal pseudogene 10	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:5687331	E	RGD:6480464	20211228	CTD	MESH:D001280	Atrazine affects the methylation of RN5-8S gene	PMID:28931070
12907523	RNA5-8SP10	RNA, 5.8S ribosomal pseudogene 10	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:5687331	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of RN5-8S mRNA	PMID:41580963
12907523	RNA5-8SP10	RNA, 5.8S ribosomal pseudogene 10	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:5687331	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of RN5-8S gene	PMID:31011160
12907523	RNA5-8SP10	RNA, 5.8S ribosomal pseudogene 10	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:5687331	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of RN5-8S mRNA	PMID:26302742
12907523	RNA5-8SP10	RNA, 5.8S ribosomal pseudogene 10	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:5687331	E	RGD:6480464	20211228	CTD	MESH:C082360	fipronil results in increased expression of RN5-8S mRNA	PMID:34044035
12907523	RNA5-8SP10	RNA, 5.8S ribosomal pseudogene 10	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:5687331	E	RGD:6480464	20211228	CTD	MESH:C025643	vinclozolin results in decreased methylation of RN5-8S gene	PMID:30207508
12907524	EXOC1L	exocyst complex component 1 like	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EXOC1L mRNA	PMID:35811015
12907524	EXOC1L	exocyst complex component 1 like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EXOC1L promoter	PMID:27901495
12907524	EXOC1L	exocyst complex component 1 like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1613787	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of EXOC1L promoter	PMID:33297965
12907524	EXOC1L	exocyst complex component 1 like	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of EXOC1L mRNA	PMID:35811015
12907524	EXOC1L	exocyst complex component 1 like	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EXOC1L mRNA	PMID:35811015
12907532	LINC02532	long independently transcribed non-coding RNA 2532	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02532 mRNA	PMID:29301061
12907532	LINC02532	long independently transcribed non-coding RNA 2532	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC02532; Benzo(a)pyrene results in decreased expression of LINC02532 mRNA	PMID:32234424|PMID:38036013
12907532	LINC02532	long independently transcribed non-coding RNA 2532	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of LINC02532 gene	PMID:31601247
12907532	LINC02532	long independently transcribed non-coding RNA 2532	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of LINC02532 gene	PMID:31601247
12907532	LINC02532	long independently transcribed non-coding RNA 2532	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02532 mRNA	PMID:38832940
12907532	LINC02532	long independently transcribed non-coding RNA 2532	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of LINC02532 mRNA	PMID:28991164
12907532	LINC02532	long independently transcribed non-coding RNA 2532	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of LINC02532 mRNA	PMID:28991164
12910157	LINC02552	long independently transcribed non-coding RNA 2552	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02552 mRNA	PMID:38568856
12910157	LINC02552	long independently transcribed non-coding RNA 2552	gene	CHEBI:34911	permethrin	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in decreased expression of LINC02552 mRNA	PMID:37047231
12910157	LINC02552	long independently transcribed non-coding RNA 2552	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02552 mRNA	PMID:38832940
12910167	LINC02537	long independently transcribed non-coding RNA 2537	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02537 mRNA	PMID:38568856
12910167	LINC02537	long independently transcribed non-coding RNA 2537	gene	CHEBI:6651	malathion	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in decreased expression of LINC02537 mRNA	PMID:37047231
12910210	LINC02542	long independently transcribed non-coding RNA 2542	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of LINC02542 mRNA	PMID:38218311
12910210	LINC02542	long independently transcribed non-coding RNA 2542	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LINC02542 intron	PMID:30157460
12910253	LINC02548	long independently transcribed non-coding RNA 2548	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02548 mRNA	PMID:38568856
12910338	LINC02551	long independently transcribed non-coding RNA 2551	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02551 mRNA	PMID:38568856
12910338	LINC02551	long independently transcribed non-coding RNA 2551	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC02551 mRNA	PMID:38568856
12910352	PINCR	p53-induced noncoding RNA	gene	CHEBI:26523	reactive oxygen species	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017382	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in decreased expression of MPP6 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of COL7A1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of IL1RL1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of ZNF503 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of ZNF662 mRNA; [Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA	PMID:33656867
12910352	PINCR	p53-induced noncoding RNA	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of PINCR mRNA	PMID:29301061|PMID:38568856
12910352	PINCR	p53-induced noncoding RNA	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PINCR mRNA	PMID:32234424
12910352	PINCR	p53-induced noncoding RNA	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PINCR mRNA	PMID:33670352
12910352	PINCR	p53-induced noncoding RNA	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in decreased expression of MPP6 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of COL7A1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of IL1RL1 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of ZNF503 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA] which results in increased expression of ZNF662 mRNA; [Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of PINCR mRNA	PMID:33656867
12910352	PINCR	p53-induced noncoding RNA	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of PINCR mRNA	PMID:32234424
12910366	LINC02535	long independently transcribed non-coding RNA 2535	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC02535 mRNA	PMID:33212167
12910366	LINC02535	long independently transcribed non-coding RNA 2535	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02535 mRNA	PMID:38568856
12910366	LINC02535	long independently transcribed non-coding RNA 2535	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LINC02535 mRNA	PMID:32234424
12910366	LINC02535	long independently transcribed non-coding RNA 2535	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LINC02535 mRNA	PMID:38832940
12910366	LINC02535	long independently transcribed non-coding RNA 2535	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of LINC02535 mRNA	PMID:32234424
12910366	LINC02535	long independently transcribed non-coding RNA 2535	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of LINC02535 mRNA	PMID:35486664
12910388	LINC02547	long independently transcribed non-coding RNA 2547	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02547 mRNA	PMID:35811015
12910388	LINC02547	long independently transcribed non-coding RNA 2547	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LINC02547 mRNA	PMID:33212167
12910388	LINC02547	long independently transcribed non-coding RNA 2547	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC02547 mRNA	PMID:35811015
12910388	LINC02547	long independently transcribed non-coding RNA 2547	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02547 mRNA	PMID:35811015
12910402	LINC02541	long independently transcribed non-coding RNA 2541	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LINC02541 mRNA	PMID:35811015
12910402	LINC02541	long independently transcribed non-coding RNA 2541	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02541 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02541 mRNA	PMID:35811015
12910402	LINC02541	long independently transcribed non-coding RNA 2541	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC02541 mRNA	PMID:30851411
12910402	LINC02541	long independently transcribed non-coding RNA 2541	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC02541 mRNA	PMID:34032870
12910402	LINC02541	long independently transcribed non-coding RNA 2541	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LINC02541 mRNA	PMID:32234424
12910402	LINC02541	long independently transcribed non-coding RNA 2541	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC02541 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC02541 mRNA	PMID:35811015
12910402	LINC02541	long independently transcribed non-coding RNA 2541	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LINC02541 mRNA	PMID:30851411
12910402	LINC02541	long independently transcribed non-coding RNA 2541	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of LINC02541 mRNA	PMID:32234424
12910410	LINC02533	long independently transcribed non-coding RNA 2533	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D002104	Cadmium results in increased expression of LINC02533 mRNA	PMID:33559965
12910410	LINC02533	long independently transcribed non-coding RNA 2533	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LINC02533 polyA tail	PMID:30157460
12910410	LINC02533	long independently transcribed non-coding RNA 2533	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC02533 mRNA	PMID:38568856
12910433	LINC02540	long independently transcribed non-coding RNA 2540	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02540 mRNA	PMID:41028656
12910433	LINC02540	long independently transcribed non-coding RNA 2540	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02540 mRNA	PMID:41028656
12910433	LINC02540	long independently transcribed non-coding RNA 2540	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02540 mRNA	PMID:41028656
12910446	LINC02550	long independently transcribed non-coding RNA 2550	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LINC02550 mRNA	PMID:32234424
12910582	LINC02556	long independently transcribed non-coding RNA 2556	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LINC02556 mRNA	PMID:41028656
12910582	LINC02556	long independently transcribed non-coding RNA 2556	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02556 mRNA	PMID:41028656
12910582	LINC02556	long independently transcribed non-coding RNA 2556	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LINC02556 mRNA	PMID:41028656
12910636	CLMAT3	colorectal liver metastasis associated transcript 3	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CLMAT3 mRNA	PMID:30510588
12910663	LINC02558	long independently transcribed non-coding RNA 2558	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LINC02558 intron	PMID:30157460
12910914	LINC01690	long independently transcribed non-coding RNA 1690	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC01690 mRNA	PMID:29301061
12910920	CTXND2	cortexin domain containing 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1613626	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CTXND2 mRNA	PMID:38701926
12914182	GNG14	G protein subunit gamma 14	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1592634	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of GNG14 mRNA	PMID:32145629
12914182	GNG14	G protein subunit gamma 14	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1592634	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GNG14 mRNA	PMID:33387578
12914182	GNG14	G protein subunit gamma 14	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of GNG14 mRNA	PMID:33212167
12914182	GNG14	G protein subunit gamma 14	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1592634	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of GNG14 mRNA	PMID:32145629
12914182	GNG14	G protein subunit gamma 14	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1592634	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in increased expression of GNG14 mRNA	PMID:29427782
12914182	GNG14	G protein subunit gamma 14	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of GNG14 mRNA	PMID:31629900
12914182	GNG14	G protein subunit gamma 14	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1592634	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GNG14 mRNA	PMID:25825206
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:13792741	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EEF1AKMT4 mRNA	PMID:39241906
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:7732114	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of EEF1AKMT4 mRNA	PMID:32145629
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of EEF1AKMT4 mRNA	PMID:38568856
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:7732114	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of EEF1AKMT4 mRNA	PMID:41580963
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:13792741	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EEF1AKMT4 mRNA	PMID:22206623
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:7732114	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EEF1AKMT4 mRNA	PMID:33387578
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of EEF1AKMT4 mRNA	PMID:34032870
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of EEF1AKMT4 mRNA	PMID:38568856
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:7732114	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EEF1AKMT4 mRNA	PMID:34492290
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:7732114	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of EEF1AKMT4 mRNA	PMID:32145629
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:7732114	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of EEF1AKMT4 mRNA	PMID:32680482
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of EEF1AKMT4 mRNA	PMID:38832940
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:7732114	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EEF1AKMT4 mRNA	PMID:33387578
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:13792741	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of EEF1AKMT4 mRNA	PMID:40234311
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EEF1AKMT4 protein	PMID:32959892
12914190	EEF1AKMT4	EEF1A lysine methyltransferase 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:13792741	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EEF1AKMT4 mRNA	PMID:22206623
12914191	NPY4R2	neuropeptide Y receptor Y4-2	gene	CHEBI:174733	Licochalcone B	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of NPY4R2 mRNA	PMID:33647349
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of COL9A1 mRNA	PMID:26272509
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COL9A1 mRNA	PMID:27188386
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of COL9A1 mRNA	PMID:21934132
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of COL9A1 mRNA	PMID:35811015
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of COL9A1 mRNA	PMID:30510588
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1309425	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of COL9A1 mRNA	PMID:33387578
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1319762	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in decreased expression of COL9A1 mRNA	PMID:19693291
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1319762	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in increased expression of COL9A1 mRNA	PMID:19693291
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1309425	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of COL9A1 mRNA	PMID:26577399|PMID:27523638
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1319762	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of COL9A1 mRNA	PMID:27462272
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of COL9A1 intron	PMID:30157460
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1319762	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of COL9A1 mRNA	PMID:25629700
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of COL9A1 mRNA	PMID:26272509
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COL9A1 mRNA	PMID:27188386
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1319762	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of COL9A1 mRNA	PMID:28960355
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1319762	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COL9A1 mRNA	PMID:21570461
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1309425	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COL9A1 mRNA	PMID:32109520
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of COL9A1 mRNA	PMID:32763439
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:28680	cytarabine	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of COL9A1 mRNA	PMID:21198554
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COL9A1 mRNA	PMID:30031762
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1309425	E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of COL9A1 mRNA	PMID:35314868
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1319762	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of COL9A1 mRNA	PMID:36209798
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of COL9A1 5' UTR	PMID:27901495
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1309425	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of COL9A1 mRNA	PMID:11578147
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1309425	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of COL9A1 mRNA	PMID:23411599
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1309425	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of COL9A1 mRNA	PMID:25181051|PMID:34947998
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1309425	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of COL9A1 mRNA	PMID:30816183|PMID:32528016
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1319762	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of COL9A1 mRNA	PMID:30951980
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of COL9A1 mRNA	PMID:25979313
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:3423	carmustine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of COL9A1 mRNA	PMID:15980968
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1319762	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of COL9A1 gene	PMID:31683443
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1319762	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of COL9A1 mRNA	PMID:30951980
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1319762	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of COL9A1 exon	PMID:33297965
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1319762	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of COL9A1 mRNA	PMID:30951980
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1319762	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of COL9A1 mRNA	PMID:37019170
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:34631	chlorpyrifos	decreases methylation	ISO	RGD:1309425	E	RGD:6480464	20210907	CTD	MESH:D004390	Chlorpyrifos results in decreased methylation of COL9A1 gene	PMID:32905263
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1319762	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of COL9A1 mRNA	PMID:32715474
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:34631	chlorpyrifos	increases methylation	ISO	RGD:1309425	E	RGD:6480464	20210907	CTD	MESH:D004390	Chlorpyrifos results in increased methylation of COL9A1 gene	PMID:32905263
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1309425	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of COL9A1 mRNA	PMID:35163327
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1309425	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of COL9A1 mRNA	PMID:35163327
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1309425	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of COL9A1 mRNA	PMID:24386269
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of COL9A1 mRNA	PMID:31533062
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COL9A1 mRNA	PMID:25979313
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of COL9A1 mRNA	PMID:23179753|PMID:26272509
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COL9A1 mRNA	PMID:27188386
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:41879	dexamethasone	affects expression	ISO	RGD:1319762	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone affects the expression of COL9A1 mRNA	PMID:21277400
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of COL9A1 mRNA	PMID:26690555
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of COL9A1 mRNA	PMID:35811015
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COL9A1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COL9A1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COL9A1 mRNA	PMID:27188386
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COL9A1 gene]	PMID:28238834
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1309425	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of COL9A1 mRNA	PMID:19162173
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1309425	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of COL9A1 mRNA	PMID:32109520
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:81980	triticonazole	increases expression	ISO	RGD:1309425	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in increased expression of COL9A1 mRNA	PMID:36084822
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of COL9A1 mRNA	PMID:32234424
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:82527	Ptaquiloside	decreases expression	ISO	RGD:1319762	E	RGD:6480464	20141111	CTD	MESH:C043680	ptaquiloside results in decreased expression of COL9A1 mRNA	PMID:23274088
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COL9A1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COL9A1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COL9A1 mRNA	PMID:27188386
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1319762	E	RGD:6480464	20141111	CTD	MESH:D013605	T-2 Toxin results in decreased expression of COL9A1 mRNA	PMID:22800716
1298223	COL9A1	collagen type IX alpha 1 chain	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1309425	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of COL9A1 gene	PMID:31682807
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TNFRSF1B mRNA	PMID:38218311
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:731571	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TNFRSF1B mRNA	PMID:20188158
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:731571	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TNFRSF1B mRNA	PMID:20188158
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TNFRSF1B mRNA	PMID:36331819
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16057	prenyl diphosphate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C043060	3,3-dimethylallyl pyrophosphate results in increased expression of TNFRSF1B protein	PMID:12932289
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D000431	Ethanol results in increased expression of TNFRSF1B protein modified form	PMID:26733986
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D000431	Ethanol inhibits the reaction [FOXO3 protein results in increased expression of TNFRSF1B mRNA]	PMID:26470730
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16240	hydrogen peroxide	decreases response to substance	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	TNFRSF1B protein results in decreased susceptibility to Hydrogen Peroxide	PMID:22110694
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of TNFRSF1B mRNA	PMID:15309432
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:731571	E	RGD:6480464	20240109	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TNFRSF1B protein	PMID:37177863
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFRSF1B protein	PMID:10072544
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:731571	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFRSF1B mRNA; Lipopolysaccharides results in increased expression of TNFRSF1B protein	PMID:10975854|PMID:19133137|PMID:22169119|PMID:25890327|PMID:26582142
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of TNFRSF1B mRNA; NFKBIA protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF1B protein]	PMID:10072544|PMID:31059760
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20161228	CTD	MESH:D008070	(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF1B mRNA]; [IL10 protein co-treated with Dexamethasone] inhibits the reaction [Lipopolysaccharides results in decreased expression of TNFRSF1B protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in decreased expression of TNFRSF1B protein]; IL10 protein inhibits the reaction [Lipopolysaccharides results in decreased expression of TNFRSF1B protein]; procyanidin B3 inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF1B mRNA]; terameprocol inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF1B protein]; TLR4 protein affects the reaction [IL10 protein inhibits the reaction [Lipopolysaccharides results in decreased expression of TNFRSF1B protein]]; TLR4 protein affects the reaction [Lipopolysaccharides results in decreased expression of TNFRSF1B protein]; TLR4 protein affects the reaction [TNFRSF1A protein affects the reaction [Lipopolysaccharides results in decreased expression of TNFRSF1B protein]]; TNFRSF1A protein affects the reaction [IL10 protein inhibits the reaction [Lipopolysaccharides results in decreased expression of TNFRSF1B protein]]; TNFRSF1A protein affects the reaction [Lipopolysaccharides results in decreased expression of TNFRSF1B protein]; TNFRSF1A protein affects the reaction [TLR4 protein affects the reaction [Lipopolysaccharides results in decreased expression of TNFRSF1B protein]]	PMID:19133137|PMID:22169119|PMID:25890327|PMID:37177863
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:731571	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TNFRSF1B mRNA	PMID:39298647
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of TNFRSF1B mRNA	PMID:20660070
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:621238	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNFRSF1B mRNA	PMID:32741896
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16598	DDE	affects expression	ISO	RGD:621238	E	RGD:6480464	20140909	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene affects the expression of TNFRSF1B mRNA	PMID:24576310
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:621238	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TNFRSF1B mRNA	PMID:33387578
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20240903	CTD	MESH:D014241	[Trichloroethylene co-treated with GNLY protein] results in increased expression of TNFRSF1B protein	PMID:38485042
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:16796	melatonin	increases response to substance	ISO	RGD:731571	E	RGD:6480464	20121218	CTD	MESH:D008550	TNFRSF1B protein results in increased susceptibility to Melatonin	PMID:21342247
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:168396	mycophenolic acid	increases expression	ISO	RGD:731571	E	RGD:6480464	20120501	CTD	MESH:D009173	Mycophenolic Acid results in increased expression of TNFRSF1B mRNA	PMID:19818335
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of TNFRSF1B mRNA	PMID:20660070
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:17183	sanguinarine	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C005705	[sanguinarine co-treated with arsenic trioxide] results in increased expression of TNFRSF1B mRNA	PMID:24345465
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:17245	carbon monoxide	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002248	Carbon Monoxide results in increased expression of TNFRSF1B protein modified form	PMID:18629312
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:17315	D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine analog inhibits the reaction [TNF results in increased expression of TNFRSF1B mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of TNFRSF1B mRNA]	PMID:18173918
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:621238	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNFRSF1B mRNA	PMID:32741896
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:17558	quercitrin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in decreased expression of TNFRSF1B mRNA	PMID:25193878
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone results in increased expression of TNFRSF1B protein	PMID:34200499
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:731571	E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone results in increased expression of TNFRSF1B mRNA	PMID:22414385
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:17594	hydroquinone	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C031927	alpha-naphthoflavone inhibits the reaction [hydroquinone results in increased expression of TNFRSF1B protein]	PMID:34200499
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:731571	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of TNFRSF1B mRNA	PMID:23892564
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TNFRSF1B mRNA	PMID:35818422
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250708	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Asian ginseng] results in increased expression of TNFRSF1B mRNA	PMID:35818422
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:177802	Cuprizon	affects expression	ISO	RGD:621238	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of TNFRSF1B mRNA	PMID:27523638
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:621238	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of TNFRSF1B mRNA	PMID:26577399
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:177824	terameprocol	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20210907	CTD	MESH:C076852	terameprocol inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF1B protein]	PMID:19133137
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TNFRSF1B mRNA	PMID:36331819
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:18422	sulfur dioxide	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:D013458	[Air Pollutants results in increased abundance of Sulfur Dioxide] which results in decreased expression of TNFRSF1B mRNA	PMID:32248990
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:200715	Brevianamide A	increases expression	ISO	RGD:731571	E	RGD:6480464	20231219	CTD	MESH:C006794	brevianamide A results in increased expression of TNFRSF1B mRNA	PMID:19818335
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:20993	aldehydo-D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine analog inhibits the reaction [TNF results in increased expression of TNFRSF1B mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of TNFRSF1B mRNA]	PMID:18173918
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:211551	TMC-120A	decreases expression	ISO	RGD:731571	E	RGD:6480464	20231219	CTD	MESH:C402696	TMC 120A results in decreased expression of TNFRSF1B mRNA	PMID:19818335
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:22718	benzoates	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in decreased expression of TNFRSF1B mRNA	PMID:29472718
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D002104	Cadmium results in increased expression of TNFRSF1B mRNA	PMID:33559965
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TNFRSF1B mRNA	PMID:37236586|PMID:37776818
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:621238	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TNFRSF1B mRNA	PMID:22129741
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of TNFRSF1B intron	PMID:30157460
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:25187	p-menthan-3-ol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of TNFRSF1B mRNA	PMID:26760959
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TNFRSF1B mRNA	PMID:23649840
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D009151	TNF protein affects the reaction [Mustard Gas affects the expression of TNFRSF1B mRNA]	PMID:16173061
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:25812	ozone	affects expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone affects the expression of TNFRSF1B mRNA	PMID:11159038
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	Ozone results in increased expression of TNFRSF1B mRNA	PMID:31476115
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of TNFRSF1B protein	PMID:15516495|PMID:16002559
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	[Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF1B mRNA	PMID:31476115
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TNFRSF1B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TNFRSF1B mRNA; [TNFRSF1B co-treated with CPE] promotes the reaction [[Air Pollutants results in increased abundance of Ozone] which results in increased expression of IL23A mRNA]; IL6 gene mutant form inhibits the reaction [Ozone results in increased expression of TNFRSF1B protein]; TNFRSF1A protein affects the reaction [Ozone affects the expression of TNFRSF1B mRNA]; TNFRSF1B affects the reaction [[CPE affects the susceptibility to Ozone] which affects the expression of IL5 mRNA]; TNFRSF1B affects the reaction [CPE affects the susceptibility to Ozone]; TNFRSF1B affects the reaction [Ozone results in increased expression of CCL20 protein]; TNFRSF1B promotes the reaction [[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CCL20 mRNA]; TNFRSF1B promotes the reaction [[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CSF3 protein]; TNFRSF1B promotes the reaction [[Air Pollutants results in increased abundance of Ozone] which results in increased expression of IL17A mRNA]; TNFRSF1B protein affects the reaction [Ozone affects the expression of TNFRSF1A mRNA]	PMID:11159038|PMID:15516495|PMID:23434795|PMID:24823369|PMID:34911549
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:2607	Aloe emodin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C518327	aloe emodin results in increased expression of TNFRSF1B protein	PMID:19928967
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of TNFRSF1B mRNA	PMID:15672453
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of TNFRSF1B mRNA	PMID:17484886
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27385	tetrachloromethane	decreases response to substance	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D002251	TNFRSF1B gene mutant form results in decreased susceptibility to Carbon Tetrachloride	PMID:15760680
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:621238	E	RGD:6480464	20140513	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TNFRSF1B protein	PMID:24389507
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:731571	E	RGD:6480464	20181016	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TNFRSF1B protein	PMID:29987408
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20181016	CTD	MESH:D002251	PANX1 protein affects the reaction [Carbon Tetrachloride results in increased expression of TNFRSF1B protein]	PMID:29987408
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D001151	Arsenic affects the expression of TNFRSF1B protein	PMID:24675094
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TNFRSF1B gene	PMID:25304211
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:621238	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of TNFRSF1B gene	PMID:31011160
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27881	resveratrol	increases response to substance	ISO	RGD:731571	E	RGD:6480464	20121218	CTD	MESH:C059514	TNFRSF1B protein results in increased susceptibility to resveratrol	PMID:21342247
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D007854	Lead results in increased expression of TNFRSF1B protein	PMID:22142875
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of TNFRSF1B mRNA	PMID:23300844
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of TNFRSF1B mRNA; Cisplatin results in increased expression of TNFRSF1B protein	PMID:15701814|PMID:24975837|PMID:26546572
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D002945	SB 203580 inhibits the reaction [Cisplatin results in increased expression of TNFRSF1B protein]	PMID:15701814
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of TNFRSF1B mRNA	PMID:15681117
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of TNFRSF1B mRNA	PMID:23195993
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TNFRSF1B mRNA	PMID:24768652|PMID:25583101
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TNFRSF1B mRNA	PMID:22298810
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TNFRSF1B mRNA	PMID:20702594
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:621238	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TNFRSF1B mRNA	PMID:34747641
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases response to substance	ISO	RGD:731571	E	RGD:6480464	20140715	CTD	MESH:D013749	TNFRSF1B gene mutant form results in decreased susceptibility to Tetrachlorodibenzodioxin	PMID:24718703
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:621238	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFRSF1B mRNA	PMID:19520675
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:731571	E	RGD:6480464	20120814	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFRSF1B mRNA	PMID:12167310|PMID:15310856|PMID:16891777|PMID:19933214
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D013749	AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of TNFRSF1B mRNA]	PMID:16891777
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28148	sodium stibogluconate	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D000967	Antimony Sodium Gluconate results in decreased expression of TNFRSF1B protein	PMID:7844400
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TNFRSF1B mRNA	PMID:33212167
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28393	beta-D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine analog inhibits the reaction [TNF results in increased expression of TNFRSF1B mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of TNFRSF1B mRNA]	PMID:18173918
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28748	doxorubicin	affects response to substance	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D004317	TNFRSF1B protein affects the susceptibility to Doxorubicin	PMID:16618758
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TNFRSF1B mRNA	PMID:29803840
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:621238	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of TNFRSF1B protein	PMID:17651020
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D004317	TNFRSF1B protein affects the reaction [Doxorubicin affects the expression of PLCD1 mRNA]; TNFRSF1B protein affects the reaction [Doxorubicin affects the expression of PLCD1 protein]; TNFRSF1B protein affects the reaction [Doxorubicin results in decreased expression of FAS protein]	PMID:16505099|PMID:16618758
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:621238	E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TNFRSF1B mRNA	PMID:22129741
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of TNFRSF1B gene	PMID:28589171
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of TNFRSF1B mRNA	PMID:29301061
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:731571	E	RGD:6480464	20200114	CTD	MESH:C017947	sodium arsenite results in decreased expression of TNFRSF1B mRNA	PMID:31532247
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFRSF1B mRNA	PMID:12634122
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TNFRSF1B promoter	PMID:27901495
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:731571	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TNFRSF1B mRNA	PMID:21569818
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TNFRSF1B mRNA	PMID:20713471
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TNFRSF1B exon	PMID:27901495
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of TNFRSF1B mRNA	PMID:18191166
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TNFRSF1B mRNA	PMID:20382639
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TNFRSF1B mRNA	PMID:15761015
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:621238	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TNFRSF1B mRNA	PMID:19730151
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:731571	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TNFRSF1B mRNA	PMID:12243866
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TNFRSF1B mRNA	PMID:24345465
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of TNFRSF1B mRNA	PMID:24345465
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:31186	alfacalcidol	decreases expression	EXP		E	RGD:6480464	20140204	CTD	MESH:C008088	alfacalcidol results in decreased expression of TNFRSF1B protein modified form	PMID:15044820
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:621238	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of TNFRSF1B mRNA	PMID:16483693
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:31236	aripiprazole	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:C094645	[Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF1B mRNA	PMID:31476115
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:621238	E	RGD:6480464	20120412	CTD	MESH:D001761	Bleomycin results in increased expression of TNFRSF1B protein	PMID:15371238
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:3139	bleomycin A2	increases response to substance	ISO	RGD:731571	E	RGD:6480464	20120501	CTD	MESH:D001761	TNFRSF1B results in increased susceptibility to Bleomycin	PMID:12003776
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of TNFRSF1B mRNA	PMID:37690743
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:731571	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of TNFRSF1B mRNA	PMID:21829687
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C008261	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFRSF1B mRNA	PMID:12634122
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:731571	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TNFRSF1B gene	PMID:35295148
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:731571	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TNFRSF1B mRNA	PMID:23557971
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:621238	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TNFRSF1B mRNA	PMID:34492290
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TNFRSF1B mRNA	PMID:18445702
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TNFRSF1B mRNA	PMID:19710929
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of TNFRSF1B mRNA	PMID:28329830
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:33101	nitrogen dioxide	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D009585	Nitrogen Dioxide results in increased expression of TNFRSF1B protein modified form	PMID:18629312
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:731571	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A affects the expression of TNFRSF1B mRNA	PMID:35341816
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:621238	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TNFRSF1B mRNA	PMID:30816183|PMID:32528016
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C006780	bisphenol A results in increased expression of TNFRSF1B mRNA	PMID:33312107
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:621238	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TNFRSF1B mRNA	PMID:25181051
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	ISO	RGD:621238	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of TNFRSF1B mRNA	PMID:22937105
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:621238	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in increased expression of TNFRSF1B mRNA; o,p'-DDT results in increased expression of TNFRSF1B mRNA	PMID:22937105
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:731571	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of TNFRSF1B mRNA	PMID:26682919
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:731571	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TNFRSF1B mRNA	PMID:39298647
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C543008	bisphenol S results in increased expression of TNFRSF1B mRNA	PMID:33312107
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:34444	4-tert-butylphenol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006862	butylphen results in increased expression of TNFRSF1B protein	PMID:15816839
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C008745	bisphenol F results in increased expression of TNFRSF1B mRNA	PMID:33312107
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:731571	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of TNFRSF1B enhancer	PMID:28392331
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:731571	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TNFRSF1B mRNA	PMID:28392331
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:731571	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TNFRSF1B intron	PMID:28392331
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D016264	Dextran Sulfate results in increased expression of TNFRSF1B mRNA	PMID:20824662
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:621238	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TNFRSF1B mRNA	PMID:22129741
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D010269	Paraquat results in increased expression of TNFRSF1B protein	PMID:36108500
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TNFRSF1B mRNA	PMID:37042841
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:35455	1-naphthyl isothiocyanate	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D015058	[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of TNFRSF1B mRNA	PMID:27344345
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:731571	E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TNFRSF1B mRNA	PMID:15501611
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFRSF1B mRNA	PMID:12634122
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TNFRSF1B mRNA	PMID:37236586|PMID:37776818
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:35546	perfluorodecanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C036567	perfluorodecanoic acid results in decreased expression of TNFRSF1B protein	PMID:32916415
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:731571	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TNFRSF1B mRNA	PMID:28903501
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TNFRSF1B mRNA	PMID:24449571
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20200331	CTD	MESH:D002738	Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of TNFRSF1B protein]	PMID:22341560
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:731571	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of TNFRSF1B mRNA	PMID:18353800
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:36482	hopane	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C025206	hopane results in increased expression of TNFRSF1B	PMID:20123637
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:37187	lead nitrate	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate affects the reaction [TNFRSF1B affects the expression of MT1 mRNA]; lead nitrate affects the reaction [TNFRSF1B affects the expression of MT2 mRNA]	PMID:11891201
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of TNFRSF1B protein	PMID:10072544
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TNFRSF1B mRNA]; [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TNFRSF1B mRNA; NFKBIA protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TNFRSF1B protein]	PMID:10072544|PMID:15477007
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:37659	oleanolic acid	increases expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D009828	Oleanolic Acid results in increased expression of TNFRSF1B mRNA	PMID:18706400
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:731571	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TNFRSF1B mRNA	PMID:40194260
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TNFRSF1B mRNA	PMID:32588087
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TNFRSF1B mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TNFRSF1B mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of TNFRSF1B mRNA	PMID:36331819
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [TNF protein results in increased expression of TNFRSF1B mRNA]; Curcumin inhibits the reaction [TNF protein results in increased expression of TNFRSF1B protein]	PMID:17666914
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TNFRSF1B mRNA	PMID:25979313
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of TNFRSF1B mRNA	PMID:28001369|PMID:29154799
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20240109	CTD	MESH:D003907	[IL10 protein co-treated with Dexamethasone] inhibits the reaction [Lipopolysaccharides results in decreased expression of TNFRSF1B protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in decreased expression of TNFRSF1B protein]	PMID:37177863
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:731571	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TNFRSF1B mRNA	PMID:28973697
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:43602	obeticholic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in increased expression of TNFRSF1B mRNA	PMID:27939613
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TNFRSF1B mRNA	PMID:38832940
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TNFRSF1B mRNA	PMID:17562736
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of TNFRSF1B mRNA	PMID:26690555
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of TNFRSF1B mRNA	PMID:12540782
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of TNFRSF1B mRNA	PMID:31059760
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D000082	O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of TNFRSF1B mRNA]	PMID:12540782
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TNFRSF1B protein affects the susceptibility to Fluorouracil	PMID:16477629
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of TNFRSF1B mRNA	PMID:24714768
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:46661	asbestos	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001194	Asbestos results in decreased expression of TNFRSF1B mRNA	PMID:22398240
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:46661	asbestos	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001194	Asbestos results in increased expression of TNFRSF1B mRNA	PMID:22398240
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:46680	serpentine asbestos	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20201006	CTD	MESH:D017632	[TNFRSF1A gene mutant form co-treated with TNFRSF1B gene mutant form] inhibits the reaction [Asbestos, Serpentine results in increased expression of PDGFA mRNA]; [TNFRSF1A gene mutant form co-treated with TNFRSF1B gene mutant form] inhibits the reaction [Asbestos, Serpentine results in increased expression of TGFA mRNA]; [TNFRSF1A gene mutant form co-treated with TNFRSF1B gene mutant form] results in decreased susceptibility to Asbestos, Serpentine	PMID:9846974
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of TNFRSF1B protein	PMID:24675094
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TNFRSF1B gene	PMID:25304211
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:47426	furosemide	affects expression	ISO	RGD:621238	E	RGD:6480464	20120412	CTD	MESH:D005665	Furosemide affects the expression of TNFRSF1B mRNA	PMID:17497460
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:621238	E	RGD:6480464	20160412	CTD	MESH:D007654	Ketoconazole results in increased expression of TNFRSF1B mRNA	PMID:25808816
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:731571	E	RGD:6480464	20160412	CTD	MESH:D007654	Ketoconazole results in increased expression of TNFRSF1B mRNA	PMID:25808816
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine analog inhibits the reaction [TNF results in increased expression of TNFRSF1B mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of TNFRSF1B mRNA]	PMID:18173918
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:731571	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of TNFRSF1B mRNA	PMID:35436446
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:48242	dichromium trioxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C023600	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of TNFRSF1B mRNA	PMID:12634122
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:621238	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TNFRSF1B mRNA	PMID:17557909
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:49668	gefitinib	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C419708	gefitinib results in decreased expression of TNFRSF1B mRNA	PMID:16685379
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TNFRSF1B mRNA	PMID:15761015
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:621238	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TNFRSF1B mRNA	PMID:19730151
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:731571	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TNFRSF1B mRNA	PMID:12243866
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TNFRSF1B mRNA	PMID:24345465
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of TNFRSF1B mRNA	PMID:24345465
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of TNFRSF1B mRNA	PMID:23300844
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of TNFRSF1B protein	PMID:19117987
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:50385	hemin	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D006427	Hemin results in increased expression of TNFRSF1B protein	PMID:39486598
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:731571	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of TNFRSF1B mRNA	PMID:23845593
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:731571	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TNFRSF1B mRNA; Nanotubes, Carbon results in increased expression of TNFRSF1B mRNA	PMID:25554681
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:52071	dextran	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20160119	CTD	MESH:D003911	[Dextrans co-treated with ferrite analog] results in decreased expression of TNFRSF1B mRNA	PMID:26576301
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of TNFRSF1B mRNA	PMID:16780908
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:5643	Heliotrine	increases expression	ISO	RGD:621238	E	RGD:6480464	20211109	CTD	MESH:C010178	heliotrine results in increased expression of TNFRSF1B mRNA	PMID:34185104
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:731571	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TNFRSF1B mRNA	PMID:38701926
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:63613	nevirapine	increases expression	ISO	RGD:731571	E	RGD:6480464	20240903	CTD	MESH:D019829	Nevirapine results in increased expression of TNFRSF1B mRNA	PMID:38636494
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNFRSF1B mRNA	PMID:21641980
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:63637	vemurafenib	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:C551177	[(+)-JQ1 compound co-treated with vemurafenib] results in increased expression of TNFRSF1B protein	PMID:27169980
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:63791	lenalidomide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C467567	lenalidomide results in decreased expression of TNFRSF1B mRNA	PMID:15618473
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of TNFRSF1B mRNA	PMID:19812364
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:63934	bathocuproine disulfonic acid	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:C028559	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TNFRSF1B mRNA]	PMID:15477007
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:63954	ionomycin	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:D015759	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TNFRSF1B mRNA]; [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TNFRSF1B mRNA	PMID:15477007
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TNFRSF1B mRNA	PMID:24810058
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:64243	monosodium L-glutamate	increases secretion	ISO	RGD:731571	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased secretion of TNFRSF1B protein	PMID:27918843
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20200317	CTD	MESH:D012970	Plant Extracts inhibits the reaction [Sodium Glutamate results in increased secretion of TNFRSF1B protein]	PMID:27918843
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:6954	Mitotane	increases expression	ISO	RGD:621238	E	RGD:6480464	20191114	CTD	MESH:D008939	Mitotane analog results in increased expression of TNFRSF1B mRNA; Mitotane results in increased expression of TNFRSF1B mRNA	PMID:23485034
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:69832	osthole	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C046627	osthol results in increased expression of TNFRSF1B protein	PMID:29319219
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TNFRSF1B mRNA	PMID:31758290
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:72583	WR-1065	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20130305	CTD	MESH:C020174	[TNFRSF1A protein co-treated with TNFRSF1B protein] affects the reaction [N-(2-mercaptoethyl)-1,3-diaminopropane results in increased activity of SOD2]	PMID:21945096
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:731571	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TNFRSF1B mRNA	PMID:22206623
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:753435	ginseng, asian	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C000713447	[Diethylhexyl Phthalate co-treated with Asian ginseng] results in increased expression of TNFRSF1B mRNA	PMID:35818422
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:75630	procyanidin B3	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20170124	CTD	MESH:C479581	procyanidin B3 inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF1B mRNA]	PMID:22169119
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:76995	alpha-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C011512	alpha-naphthoflavone inhibits the reaction [hydroquinone results in increased expression of TNFRSF1B protein]	PMID:34200499
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:621238	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNFRSF1B mRNA	PMID:32741896
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:7726	octreotide	increases expression	ISO	RGD:621238	E	RGD:6480464	20141111	CTD	MESH:D015282	Octreotide results in increased expression of TNFRSF1B mRNA; Octreotide results in increased expression of TNFRSF1B protein	PMID:21692635
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:78741	oxidopamine	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D016627	TNFRSF1B protein results in decreased susceptibility to Oxidopamine	PMID:22110694
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	EXP		E	RGD:6480464	20140708	CTD	MESH:C020972	[bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TNFRSF1B mRNA]	PMID:15477007
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:80706	Aflatoxin G1	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20230801	CTD	MESH:C027955	TNFRSF1B protein inhibits the reaction [aflatoxin G1 results in increased expression of CXCL2 mRNA]; TNFRSF1B protein inhibits the reaction [aflatoxin G1 results in increased expression of CYP2E1 mRNA]; TNFRSF1B protein inhibits the reaction [aflatoxin G1 results in increased expression of CYP2E1 protein]; TNFRSF1B protein inhibits the reaction [aflatoxin G1 results in increased expression of H2AX protein]; TNFRSF1B protein inhibits the reaction [aflatoxin G1 results in increased expression of IL6 mRNA]; TNFRSF1B protein inhibits the reaction [aflatoxin G1 results in increased expression of TNF mRNA]; TNFRSF1B protein inhibits the reaction [aflatoxin G1 results in increased expression of TNF protein]	PMID:36997055
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:731571	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of TNFRSF1B mRNA	PMID:20702594
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of TNFRSF1B mRNA	PMID:38995820
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:8228	pioglitazone	increases secretion	ISO	RGD:731571	E	RGD:6480464	20200317	CTD	MESH:C060836	Pioglitazone results in increased secretion of TNFRSF1B protein	PMID:27918843
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:82577	Fusarenone X	increases expression	ISO	RGD:731571	E	RGD:6480464	20150310	CTD	MESH:C002469	fusarenon-X results in increased expression of TNFRSF1B mRNA	PMID:24983900
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:83493	perfluoroundecanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C101814	perfluoroundecanoic acid results in decreased expression of TNFRSF1B protein	PMID:32916415
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:621238	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of TNFRSF1B mRNA	PMID:24780913
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:731571	E	RGD:6480464	20170303	CTD	MESH:C093642	SB 203580 inhibits the reaction [Cisplatin results in increased expression of TNFRSF1B protein]	PMID:15701814
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:621238	E	RGD:6480464	20211109	CTD	MESH:C009237	senecionine results in increased expression of TNFRSF1B mRNA	PMID:34185104
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:9150	simvastatin	decreases expression	ISO	RGD:731571	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in decreased expression of TNFRSF1B mRNA	PMID:18310456
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:731571	E	RGD:6480464	20120412	CTD	MESH:D013311	Streptozocin results in increased expression of TNFRSF1B mRNA	PMID:20446767
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:9288	streptozocin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013311	TNF protein inhibits the reaction [Streptozocin results in increased expression of TNFRSF1B mRNA]	PMID:20446767
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:9513	thalidomide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013792	Thalidomide results in decreased expression of TNFRSF1B mRNA	PMID:15618473
1298224	TNFRSF1B	TNF receptor superfamily member 1B	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:621238	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of TNFRSF1B mRNA	PMID:18629315
1298347	CASP7	caspase 7	gene	CHEBI:10022	deoxynivalenol	increases activity	EXP		E	RGD:6480464	20170516	CTD	MESH:C007262	deoxynivalenol results in increased activity of CASP7 protein	PMID:27757495
1298347	CASP7	caspase 7	gene	CHEBI:10112	zileuton	increases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C063449	zileuton results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:10112	zileuton	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C063449	Palmitic Acid promotes the reaction [zileuton results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CASP7 mRNA	PMID:38218311
1298347	CASP7	caspase 7	gene	CHEBI:109895	beta-carboline	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C010262	norharman results in increased expression of CASP7 mRNA	PMID:35985368
1298347	CASP7	caspase 7	gene	CHEBI:113532	thymoquinone	increases cleavage	EXP		E	RGD:6480464	20201006	CTD	MESH:C003466	thymoquinone results in increased cleavage of CASP7 protein	PMID:29981725|PMID:34627931|PMID:39829401
1298347	CASP7	caspase 7	gene	CHEBI:113532	thymoquinone	increases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:C003466	thymoquinone results in increased expression of CASP7 protein modified form	PMID:31433961
1298347	CASP7	caspase 7	gene	CHEBI:113532	thymoquinone	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:C003466	Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of CASP7 protein modified form]	PMID:31433961|PMID:34627931
1298347	CASP7	caspase 7	gene	CHEBI:131793	SKF 38393	multiple interactions	EXP		E	RGD:6480464	20160503	CTD	MESH:D015647	2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased activity of and results in increased cleavage of CASP7 protein; Acetylcysteine inhibits the reaction [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased activity of and results in increased cleavage of CASP7 protein]	PMID:17136323
1298347	CASP7	caspase 7	gene	CHEBI:132098	methoxyacetic acid	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	[1-aminomethylphosphonic acid co-treated with methoxyacetic acid] results in increased cleavage of and results in increased activity of CASP7 protein	PMID:26006246
1298347	CASP7	caspase 7	gene	CHEBI:135649	alpidem	increases activity	EXP		E	RGD:6480464	20170307	CTD	MESH:C052036	alpidem results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:135649	alpidem	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C052036	Palmitic Acid promotes the reaction [alpidem results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:136185	VX nerve agent	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C009680	VX-agent results in increased expression of CASP7 mRNA	PMID:38555327
1298347	CASP7	caspase 7	gene	CHEBI:141063	rubimaillin	increases activity	EXP		E	RGD:6480464	20180703	CTD	MESH:C046245	rubimaillin results in increased activity of CASP7 protein	PMID:19716835
1298347	CASP7	caspase 7	gene	CHEBI:141063	rubimaillin	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:C046245	BCL2L1 protein inhibits the reaction [rubimaillin results in increased activity of CASP7 protein]; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [rubimaillin results in increased activity of CASP7 protein]	PMID:19716835
1298347	CASP7	caspase 7	gene	CHEBI:145994	remdesivir	decreases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:C000606551	remdesivir results in decreased expression of CASP7 protein	PMID:35417658
1298347	CASP7	caspase 7	gene	CHEBI:149681	methcathinone	increases expression	EXP		E	RGD:6480464	20200602	CTD	MESH:C047806	monomethylpropion results in increased expression of CASP7 mRNA	PMID:22303338
1298347	CASP7	caspase 7	gene	CHEBI:149838	Cryptotanshinone	increases activity	EXP		E	RGD:6480464	20200602	CTD	MESH:C037886	cryptotanshinone results in increased activity of CASP7 protein	PMID:26564229
1298347	CASP7	caspase 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CASP7 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CASP7 gene	PMID:20938992
1298347	CASP7	caspase 7	gene	CHEBI:15365	acetylsalicylic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased cleavage of and results in increased activity of CASP7 protein	PMID:15481331
1298347	CASP7	caspase 7	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in increased expression of CASP7 mRNA	PMID:15894607|PMID:16166294|PMID:33167477|PMID:34742744
1298347	CASP7	caspase 7	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	[Tretinoin co-treated with Zoledronic Acid] results in increased activity of CASP7 protein; CRABP2 protein promotes the reaction [Tretinoin results in increased cleavage of and results in increased activity of CASP7 protein]; Cycloheximide inhibits the reaction [Tretinoin results in increased expression of CASP7 mRNA]; Tretinoin results in increased cleavage of and results in increased activity of CASP7 protein	PMID:16166294|PMID:20349282
1298347	CASP7	caspase 7	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin promotes the reaction [arsenic trioxide results in increased cleavage of CASP7 protein]	PMID:15688020
1298347	CASP7	caspase 7	gene	CHEBI:15368	acrolein	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D000171	Acrolein results in increased activity of CASP7 protein	PMID:19596284
1298347	CASP7	caspase 7	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CASP7 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CASP7 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CASP7 mRNA	PMID:32699268|PMID:32845096
1298347	CASP7	caspase 7	gene	CHEBI:15600	(+)-catechin	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D002392	Catechin results in increased expression of CASP7 mRNA	PMID:23706674
1298347	CASP7	caspase 7	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D002392	Catechin inhibits the reaction [catechol results in increased activity of CASP7 protein]	PMID:20347921
1298347	CASP7	caspase 7	gene	CHEBI:15738	staurosporine	increases activity	EXP		E	RGD:6480464	20150825	CTD	MESH:D019311	Staurosporine results in increased activity of CASP7 protein	PMID:16402917|PMID:18832097|PMID:19352495|PMID:21864672|PMID:24912781|PMID:25586182
1298347	CASP7	caspase 7	gene	CHEBI:15738	staurosporine	increases activity	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D019311	Staurosporine results in increased activity of CASP7 protein	PMID:19406941
1298347	CASP7	caspase 7	gene	CHEBI:15738	staurosporine	increases cleavage	EXP		E	RGD:6480464	20170613	CTD	MESH:D019311	Staurosporine results in increased cleavage of CASP7 protein	PMID:26124276
1298347	CASP7	caspase 7	gene	CHEBI:15738	staurosporine	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D019311	Staurosporine results in increased expression of CASP7 protein modified form	PMID:27539959
1298347	CASP7	caspase 7	gene	CHEBI:15738	staurosporine	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:D019311	DOCK1 protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein]; ELMO1 protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein]; EOMES protein inhibits the reaction [Staurosporine results in increased expression of CASP7 protein modified form]	PMID:25586182|PMID:27539959
1298347	CASP7	caspase 7	gene	CHEBI:15738	staurosporine	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D019311	EGF protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein]; IGF1 protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein]	PMID:19406941
1298347	CASP7	caspase 7	gene	CHEBI:15746	spermine	decreases activity	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D013096	Spermine results in decreased activity of CASP7 protein	PMID:11281655
1298347	CASP7	caspase 7	gene	CHEBI:15756	hexadecanoic acid	increases activity	ISO	RGD:620944	E	RGD:6480464	20121113	CTD	MESH:D019308	Palmitic Acid results in increased activity of CASP7 protein	PMID:17194744|PMID:22413010
1298347	CASP7	caspase 7	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D019308	Palmitic Acid promotes the reaction [alpidem results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Clomipramine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Clozapine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Cyclosporine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Dipyridamole results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Estrone results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [fipexide results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Flecainide results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Fluoxetine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Fluvoxamine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Imipramine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Loratadine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Mitoxantrone results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [nefazodone results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Nimodipine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Nortriptyline results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Phentolamine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Pyrimethamine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Riluzole results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Risperidone results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Spironolactone results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [Ticlopidine results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [troglitazone results in increased activity of CASP7 protein]; Palmitic Acid promotes the reaction [zileuton results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D019308	[T0901317 co-treated with Alitretinoin] promotes the reaction [Palmitic Acid results in increased activity of CASP7 protein]; T0901317 promotes the reaction [Palmitic Acid results in increased activity of CASP7 protein]	PMID:17194744
1298347	CASP7	caspase 7	gene	CHEBI:15864	luteolin	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D047311	Luteolin results in increased activity of CASP7 protein	PMID:21074525
1298347	CASP7	caspase 7	gene	CHEBI:16130	DDT	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D003634	DDT results in increased activity of CASP7 protein	PMID:15603917
1298347	CASP7	caspase 7	gene	CHEBI:16130	DDT	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003634	SB 203580 inhibits the reaction [DDT results in increased activity of CASP7 protein]	PMID:15603917
1298347	CASP7	caspase 7	gene	CHEBI:16236	ethanol	increases activity	ISO	RGD:1553182	E	RGD:6480464	20260602	CTD	MESH:D000431	Ethanol results in increased activity of CASP7 protein	PMID:37562971
1298347	CASP7	caspase 7	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20260602	CTD	MESH:D000431	cinnabarinic acid inhibits the reaction [Ethanol results in increased activity of CASP7 protein]	PMID:37562971
1298347	CASP7	caspase 7	gene	CHEBI:16240	hydrogen peroxide	increases activity	EXP		E	RGD:6480464	20120918	CTD	MESH:D006861	Hydrogen Peroxide results in increased activity of CASP7 protein	PMID:19706323
1298347	CASP7	caspase 7	gene	CHEBI:16240	hydrogen peroxide	increases activity	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased activity of CASP7 protein	PMID:16249675
1298347	CASP7	caspase 7	gene	CHEBI:16240	hydrogen peroxide	increases cleavage	EXP		E	RGD:6480464	20211109	CTD	MESH:D006861	Hydrogen Peroxide results in increased cleavage of CASP7 protein	PMID:34077701
1298347	CASP7	caspase 7	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D006861	Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP7 protein]; formononetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP7 protein]; HGF protein inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP7 protein]; Hydrogen Peroxide results in decreased expression of and results in increased cleavage of CASP7 protein	PMID:31313457|PMID:34077701
1298347	CASP7	caspase 7	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D006861	Isoflurane inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP7 protein]	PMID:16249675
1298347	CASP7	caspase 7	gene	CHEBI:16243	quercetin	increases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:D011794	Quercetin results in increased activity of CASP7 protein	PMID:21138867|PMID:24726691
1298347	CASP7	caspase 7	gene	CHEBI:16243	quercetin	increases cleavage	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in increased cleavage of CASP7 protein	PMID:14688022|PMID:18787224
1298347	CASP7	caspase 7	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in increased expression of CASP7 protein; Quercetin results in increased expression of CASP7 protein modified form	PMID:14767529|PMID:19017364|PMID:30152185
1298347	CASP7	caspase 7	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased cleavage of CASP7 protein]; HSPA5 protein inhibits the reaction [Quercetin results in increased expression of CASP7 protein modified form]; MCL1 protein inhibits the reaction [Quercetin results in increased activity of CASP7 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP7 protein]; U 0126 inhibits the reaction [Quercetin results in increased cleavage of CASP7 protein]	PMID:14688022|PMID:19017364|PMID:21138867|PMID:27050144
1298347	CASP7	caspase 7	gene	CHEBI:16261	chitosan	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20241001	CTD	MESH:D048271	Chitosan promotes the reaction [Curcumin inhibits the reaction [fenpropathrin results in increased expression of CASP7 mRNA]]	PMID:38369055
1298347	CASP7	caspase 7	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases activity	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone analog results in increased activity of CASP7	PMID:17303658
1298347	CASP7	caspase 7	gene	CHEBI:16336	hyaluronic acid	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D006820	[Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of CASP7 protein]; [Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CASP7 mRNA]	PMID:17879260
1298347	CASP7	caspase 7	gene	CHEBI:16374	menaquinone	increases cleavage	EXP		E	RGD:6480464	20180828	CTD	MESH:D024482	Vitamin K 2 results in increased cleavage of CASP7 protein	PMID:29432837
1298347	CASP7	caspase 7	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CASP7 protein	PMID:21844306
1298347	CASP7	caspase 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20161228	CTD	MESH:D008070	[Galactosamine co-treated with Lipopolysaccharides] results in increased activity of CASP7 protein; Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased activity of CASP7 protein]	PMID:21146893
1298347	CASP7	caspase 7	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of CASP7 mRNA	PMID:14699072
1298347	CASP7	caspase 7	gene	CHEBI:16469	17beta-estradiol	decreases activity	EXP		E	RGD:6480464	20230801	CTD	MESH:D004958	Estradiol results in decreased activity of CASP7 protein	PMID:26470790
1298347	CASP7	caspase 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D004958	Estradiol results in decreased expression of CASP7 mRNA	PMID:23373633
1298347	CASP7	caspase 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553182	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CASP7 mRNA	PMID:39298647
1298347	CASP7	caspase 7	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of CASP7 mRNA	PMID:31614463
1298347	CASP7	caspase 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of CASP7 mRNA; [Estradiol co-treated with EGF protein] results in increased expression of CASP7 mRNA; Estradiol promotes the reaction [ESR2 protein affects the expression of CASP7 mRNA]	PMID:20404318|PMID:24758408
1298347	CASP7	caspase 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20160315	CTD	MESH:D004958	[resveratrol co-treated with Estradiol] results in increased activity of CASP7 protein	PMID:24894866
1298347	CASP7	caspase 7	gene	CHEBI:16480	nitric oxide	decreases cleavage	EXP		E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide results in decreased cleavage of CASP7 protein	PMID:10222263
1298347	CASP7	caspase 7	gene	CHEBI:16509	1,4-benzoquinone	decreases activity	EXP		E	RGD:6480464	20161213	CTD	MESH:C004532	quinone results in decreased activity of CASP7 protein	PMID:22960397
1298347	CASP7	caspase 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CASP7 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CASP7 gene	PMID:20938992
1298347	CASP7	caspase 7	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1553182	E	RGD:6480464	20230404	CTD	MESH:D001554	Benzene results in increased expression of CASP7 mRNA	PMID:36306860
1298347	CASP7	caspase 7	gene	CHEBI:16716	benzene	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20230404	CTD	MESH:D001554	shikonin inhibits the reaction [Benzene results in increased expression of CASP7 mRNA]	PMID:36306860
1298347	CASP7	caspase 7	gene	CHEBI:16856	glutathione	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D005978	Glutathione inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased cleavage of CASP7 protein]; Glutathione inhibits the reaction [NR4A1 protein affects the cleavage of CASP7 protein]	PMID:24515801
1298347	CASP7	caspase 7	gene	CHEBI:17158	methylglyoxal	increases cleavage	EXP		E	RGD:6480464	20220308	CTD	MESH:D011765	Pyruvaldehyde results in increased cleavage of CASP7 protein	PMID:33930484
1298347	CASP7	caspase 7	gene	CHEBI:17158	methylglyoxal	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:D011765	pimagedine inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP7 protein]; pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP7 protein]	PMID:33930484
1298347	CASP7	caspase 7	gene	CHEBI:17230	homocysteine	increases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:D006710	Homocysteine results in increased activity of CASP7 protein	PMID:21237187
1298347	CASP7	caspase 7	gene	CHEBI:17230	homocysteine	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D006710	mecobalamin inhibits the reaction [Homocysteine results in increased activity of CASP7 protein]	PMID:21237187
1298347	CASP7	caspase 7	gene	CHEBI:17241	1H-pyrazole	decreases expression	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in decreased expression of CASP7 mRNA	PMID:17945193
1298347	CASP7	caspase 7	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases activity	EXP		E	RGD:6480464	20130514	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased activity of CASP7 protein	PMID:23360888
1298347	CASP7	caspase 7	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:620944	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of CASP7 protein	PMID:36889213
1298347	CASP7	caspase 7	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20240402	CTD	MESH:C016599	PTGS2 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP7 protein]	PMID:36889213
1298347	CASP7	caspase 7	gene	CHEBI:17245	carbon monoxide	increases activity	ISO	RGD:620944	E	RGD:6480464	20150714	CTD	MESH:D002248	Carbon Monoxide results in increased activity of CASP7 protein	PMID:25562542
1298347	CASP7	caspase 7	gene	CHEBI:17263	estrone	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D004970	Estrone results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:17263	estrone	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D004970	Palmitic Acid promotes the reaction [Estrone results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:17356	2-acetamidofluorene	increases activity	ISO	RGD:620944	E	RGD:6480464	20140408	CTD	MESH:D015073	2-Acetylaminofluorene results in increased activity of CASP7 protein	PMID:23665045
1298347	CASP7	caspase 7	gene	CHEBI:17356	2-acetamidofluorene	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20140408	CTD	MESH:D015073	Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP7 protein]	PMID:23665045
1298347	CASP7	caspase 7	gene	CHEBI:174748	C.I. Natural Red 20	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20230404	CTD	MESH:C016101	shikonin inhibits the reaction [Benzene results in increased expression of CASP7 mRNA]	PMID:36306860
1298347	CASP7	caspase 7	gene	CHEBI:175387	Isoangustone A	increases cleavage	EXP		E	RGD:6480464	20210706	CTD	MESH:C551631	isoangustone A results in increased cleavage of CASP7 protein	PMID:20229524
1298347	CASP7	caspase 7	gene	CHEBI:17594	hydroquinone	decreases activity	EXP		E	RGD:6480464	20130416	CTD	MESH:C031927	hydroquinone results in decreased activity of CASP7 protein	PMID:22960397
1298347	CASP7	caspase 7	gene	CHEBI:17594	hydroquinone	increases cleavage	EXP		E	RGD:6480464	20120501	CTD	MESH:C031927	hydroquinone results in increased cleavage of CASP7 protein	PMID:19064679
1298347	CASP7	caspase 7	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C031927	hydroquinone results in increased expression of CASP7 protein modified form	PMID:28886972
1298347	CASP7	caspase 7	gene	CHEBI:17594	hydroquinone	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:C031927	Lithium Chloride inhibits the reaction [hydroquinone results in increased expression of CASP7 protein modified form]; WRN protein inhibits the reaction [hydroquinone results in increased cleavage of CASP7 protein]	PMID:19064679|PMID:28886972
1298347	CASP7	caspase 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases activity	EXP		E	RGD:6480464	20120918	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased activity of CASP7 protein	PMID:21864672
1298347	CASP7	caspase 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CASP7 mRNA	PMID:31709857
1298347	CASP7	caspase 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1553182	E	RGD:6480464	20241105	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CASP7 mRNA	PMID:33162236|PMID:37975621
1298347	CASP7	caspase 7	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:D002117	Calcitriol results in increased expression of CASP7 protein	PMID:31628941
1298347	CASP7	caspase 7	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20200331	CTD	MESH:D002117	[Calcitriol co-treated with Curcumin] promotes the reaction [Paclitaxel results in increased expression of CASP7 protein]; Calcitriol inhibits the reaction [Curcumin inhibits the reaction [Paclitaxel results in increased expression of CASP7 protein]]; Calcitriol inhibits the reaction [Paclitaxel results in increased expression of CASP7 protein]; Curcumin inhibits the reaction [Calcitriol inhibits the reaction [Paclitaxel results in increased expression of CASP7 protein]]	PMID:31628941
1298347	CASP7	caspase 7	gene	CHEBI:17846	(S)-naringenin	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C005273	naringenin results in increased expression of CASP7 protein modified form	PMID:27838343
1298347	CASP7	caspase 7	gene	CHEBI:180664	4-hydroxy-TEMPO	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C001803	tempol inhibits the reaction [[sulindac sulfide co-treated with TNF protein] results in increased activity of CASP7 protein]; tempol results in increased cleavage of and results in increased activity of CASP7 protein	PMID:20371263|PMID:26177467
1298347	CASP7	caspase 7	gene	CHEBI:18088	formononetin	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C007768	formononetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP7 protein]	PMID:34077701
1298347	CASP7	caspase 7	gene	CHEBI:18135	catechol	increases activity	EXP		E	RGD:6480464	20120717	CTD	MESH:C034221	catechol results in increased activity of CASP7 protein	PMID:20347921
1298347	CASP7	caspase 7	gene	CHEBI:18135	catechol	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C034221	Catechin inhibits the reaction [catechol results in increased activity of CASP7 protein]; Memantine inhibits the reaction [catechol results in increased activity of CASP7 protein]	PMID:20347921
1298347	CASP7	caspase 7	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D024502	alpha-Tocopherol inhibits the reaction [S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP7 protein]; alpha-Tocopherol promotes the reaction [Amiodarone results in increased activity of CASP7 protein]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP7 protein]]	PMID:23042730|PMID:29129777
1298347	CASP7	caspase 7	gene	CHEBI:18243	dopamine	increases activity	EXP		E	RGD:6480464	20121113	CTD	MESH:D004298	Dopamine results in increased activity of CASP7 protein	PMID:19410601
1298347	CASP7	caspase 7	gene	CHEBI:18243	dopamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004298	Acetylcysteine inhibits the reaction [Dopamine results in increased activity of and results in increased cleavage of CASP7 protein]; Dopamine results in increased activity of and results in increased cleavage of CASP7 protein	PMID:17136323
1298347	CASP7	caspase 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CASP7 mRNA	PMID:36331819
1298347	CASP7	caspase 7	gene	CHEBI:18291	manganese atom	increases activity	ISO	RGD:620944	E	RGD:6480464	20121113	CTD	MESH:D008345	Manganese results in increased activity of CASP7 protein	PMID:22427945
1298347	CASP7	caspase 7	gene	CHEBI:18357	(R)-noradrenaline	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D009638	Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of and results in increased cleavage of CASP7 protein]; Norepinephrine results in increased activity of and results in increased cleavage of CASP7 protein	PMID:17136323
1298347	CASP7	caspase 7	gene	CHEBI:18388	apigenin	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D047310	Apigenin results in increased activity of CASP7 protein	PMID:19647729
1298347	CASP7	caspase 7	gene	CHEBI:18388	apigenin	increases cleavage	EXP		E	RGD:6480464	20120412	CTD	MESH:D047310	Apigenin results in increased cleavage of CASP7 protein	PMID:15486995
1298347	CASP7	caspase 7	gene	CHEBI:18406	AICA ribonucleotide	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:C031143	AICA ribonucleotide inhibits the reaction [sunitinib results in increased cleavage of CASP7 protein]	PMID:21906609
1298347	CASP7	caspase 7	gene	CHEBI:185842	Lupiwighteone	increases cleavage	EXP		E	RGD:6480464	20220104	CTD	MESH:C000602100	lupiwighteone results in increased cleavage of CASP7 protein	PMID:31604113
1298347	CASP7	caspase 7	gene	CHEBI:187088	Muconic dialdehyde	increases cleavage	EXP		E	RGD:6480464	20220308	CTD	MESH:C034476	muconaldehyde results in increased cleavage of CASP7 protein	PMID:34624356
1298347	CASP7	caspase 7	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of CASP7 mRNA	PMID:27732882
1298347	CASP7	caspase 7	gene	CHEBI:18721	3-chloropropane-1,2-diol	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of and results in increased cleavage of CASP7 protein	PMID:27732882
1298347	CASP7	caspase 7	gene	CHEBI:188106	Myrtucommulone A	decreases expression	ISO	RGD:1553182	E	RGD:6480464	20220104	CTD	MESH:C455139	myrtucommulone A results in decreased expression of CASP7 mRNA	PMID:26032814
1298347	CASP7	caspase 7	gene	CHEBI:210866	Antrocin	increases cleavage	EXP		E	RGD:6480464	20231219	CTD	MESH:C558369	antrocin analog results in increased cleavage of CASP7 protein	PMID:36565974
1298347	CASP7	caspase 7	gene	CHEBI:22689	bafilomycin A1	decreases activity	EXP		E	RGD:6480464	20150825	CTD	MESH:C040929	bafilomycin A1 results in decreased activity of CASP7 protein	PMID:25981168
1298347	CASP7	caspase 7	gene	CHEBI:22689	bafilomycin A1	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C040929	bafilomycin A1 results in increased activity of CASP7 protein	PMID:20371669
1298347	CASP7	caspase 7	gene	CHEBI:22689	bafilomycin A1	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20260113	CTD	MESH:C040929	bafilomycin A1 promotes the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased cleavage of CASP7 protein]	PMID:40049439
1298347	CASP7	caspase 7	gene	CHEBI:22977	cadmium atom	increases activity	EXP		E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased activity of CASP7 protein	PMID:20600546|PMID:31078004
1298347	CASP7	caspase 7	gene	CHEBI:22977	cadmium atom	increases activity	ISO	RGD:620944	E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased activity of CASP7 protein	PMID:16478757|PMID:18463101
1298347	CASP7	caspase 7	gene	CHEBI:22977	cadmium atom	increases cleavage	ISO	RGD:620944	E	RGD:6480464	20170207	CTD	MESH:D002104	Cadmium results in increased cleavage of CASP7 protein	PMID:27658547
1298347	CASP7	caspase 7	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240109	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP7 protein	PMID:37300854
1298347	CASP7	caspase 7	gene	CHEBI:229924	pifithrin-alpha hydrobromide	multiple interactions	EXP		E	RGD:6480464	20240409	CTD	MESH:C121565	pifithrin promotes the reaction [Etoposide results in increased activity of CASP7 protein]	PMID:26259609
1298347	CASP7	caspase 7	gene	CHEBI:229924	pifithrin-alpha hydrobromide	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20240409	CTD	MESH:C121565	pifithrin inhibits the reaction [cordycepin results in increased cleavage of CASP7 protein]	PMID:24704558
1298347	CASP7	caspase 7	gene	CHEBI:229996	2'-Hydroxy-2,3,5'-trimethoxychalcone	increases cleavage	EXP		E	RGD:6480464	20240507	CTD	MESH:C576975	2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of CASP7 protein	PMID:30408460
1298347	CASP7	caspase 7	gene	CHEBI:229996	2'-Hydroxy-2,3,5'-trimethoxychalcone	multiple interactions	EXP		E	RGD:6480464	20240507	CTD	MESH:C576975	Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of CASP7 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of CASP7 protein]	PMID:30408460
1298347	CASP7	caspase 7	gene	CHEBI:230507	ARV-825	increases activity	EXP		E	RGD:6480464	20240507	CTD	MESH:C000606252	ARV-825 results in increased activity of CASP7 protein	PMID:26051217
1298347	CASP7	caspase 7	gene	CHEBI:23086	chalcones	increases cleavage	EXP		E	RGD:6480464	20190312	CTD	MESH:D047188	Chalcones analog results in increased cleavage of CASP7 protein	PMID:30576621
1298347	CASP7	caspase 7	gene	CHEBI:23086	chalcones	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:D047188	BCL2 protein inhibits the reaction [Chalcones analog results in increased cleavage of CASP7 protein]	PMID:30576621
1298347	CASP7	caspase 7	gene	CHEBI:232299	3',4'-dimethoxyflavone	increases cleavage	EXP		E	RGD:6480464	20241119	CTD	MESH:C509288	3',4'-dimethoxyflavone analog results in increased cleavage of CASP7 protein	PMID:29630880
1298347	CASP7	caspase 7	gene	CHEBI:232424	MitoTEMPO	multiple interactions	EXP		E	RGD:6480464	20250708	CTD	MESH:C555916	MitoTEMPO inhibits the reaction [linderalactone results in increased cleavage of CASP7 protein]	PMID:33066004
1298347	CASP7	caspase 7	gene	CHEBI:232608	2,5-dimethylcelecoxib	increases activity	EXP		E	RGD:6480464	20241203	CTD	MESH:C506698	2,5-dimethylcelecoxib results in increased activity of CASP7 protein	PMID:18485224
1298347	CASP7	caspase 7	gene	CHEBI:232809	NMS-873	increases activity	EXP		E	RGD:6480464	20250107	CTD	MESH:C000623013	NMS-873 results in increased activity of CASP7 protein	PMID:27434122
1298347	CASP7	caspase 7	gene	CHEBI:234003	RV 538	increases expression	EXP		E	RGD:6480464	20250610	CTD	MESH:C033110	RV 538 results in increased expression of CASP7 protein modified form	PMID:25195822
1298347	CASP7	caspase 7	gene	CHEBI:23414	copper(II) sulfate	increases activity	EXP		E	RGD:6480464	20151013	CTD	MESH:D019327	Copper Sulfate results in increased activity of CASP7 protein	PMID:21765606
1298347	CASP7	caspase 7	gene	CHEBI:23414	copper(II) sulfate	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D019327	(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1,3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid inhibits the reaction [Copper Sulfate results in increased activity of CASP7 protein]	PMID:21765606
1298347	CASP7	caspase 7	gene	CHEBI:2423	acetylleucyl-leucyl-norleucinal	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:C063261	acetylleucyl-leucyl-norleucinal promotes the reaction [Immunologic Factors results in increased expression of CASP7 protein modified form]	PMID:29974605
1298347	CASP7	caspase 7	gene	CHEBI:24436	guanidines	increases cleavage	EXP		E	RGD:6480464	20170303	CTD	MESH:D006146	Guanidines analog results in increased cleavage of CASP7 protein	PMID:23147571
1298347	CASP7	caspase 7	gene	CHEBI:24527	herbicide	increases activity	EXP		E	RGD:6480464	20170228	CTD	MESH:D006540	Herbicides results in increased activity of CASP7 protein	PMID:19105591|PMID:22337346|PMID:24719846
1298347	CASP7	caspase 7	gene	CHEBI:24527	herbicide	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:D006540	[Glyphosate co-treated with Herbicides] results in increased activity of CASP7 protein; insecticidal crystal protein, Bacillus Thuringiensis inhibits the reaction [Herbicides results in increased activity of CASP7 protein]	PMID:19539684|PMID:22337346
1298347	CASP7	caspase 7	gene	CHEBI:24814	indole-3-methanol	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C016517	indole-3-carbinol results in decreased expression of CASP7 protein	PMID:29992829
1298347	CASP7	caspase 7	gene	CHEBI:24814	indole-3-methanol	increases activity	ISO	RGD:620944	E	RGD:6480464	20250204	CTD	MESH:C016517	indole-3-carbinol results in increased activity of CASP7 protein	PMID:17297389
1298347	CASP7	caspase 7	gene	CHEBI:24814	indole-3-methanol	increases cleavage	EXP		E	RGD:6480464	20241001	CTD	MESH:C016517	indole-3-carbinol results in increased cleavage of CASP7 protein	PMID:33118390
1298347	CASP7	caspase 7	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:C016517	indole-3-carbinol results in decreased expression of and results in increased cleavage of CASP7 protein	PMID:34085558
1298347	CASP7	caspase 7	gene	CHEBI:25187	p-menthan-3-ol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of CASP7 mRNA	PMID:26760959
1298347	CASP7	caspase 7	gene	CHEBI:25351	mevalonic acid	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008798	Mevalonic Acid inhibits the reaction [Simvastatin results in increased activity of CASP7 protein]; Mevalonic Acid inhibits the reaction [Simvastatin results in increased cleavage of CASP7 protein]	PMID:20045437|PMID:20427495
1298347	CASP7	caspase 7	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased activity of CASP7 protein	PMID:12482751
1298347	CASP7	caspase 7	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases cleavage	EXP		E	RGD:6480464	20120918	CTD	MESH:D009151	Mustard Gas results in increased cleavage of CASP7 protein	PMID:20435105
1298347	CASP7	caspase 7	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of CASP7 mRNA	PMID:15674843
1298347	CASP7	caspase 7	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D009151	acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Mustard Gas results in increased cleavage of CASP7 protein]; BRCA2 protein inhibits the reaction [Mustard Gas results in increased cleavage of CASP7 protein]; CALM1 protein promotes the reaction [Mustard Gas results in increased cleavage of and results in increased activity of CASP7 protein]; FADD protein affects the reaction [Mustard Gas results in increased cleavage of CASP7 protein]; Mustard Gas promotes the reaction [CASP3 protein results in increased cleavage of CASP7 protein]; Mustard Gas results in increased cleavage of and results in increased activity of CASP7 protein	PMID:12482751|PMID:16935404|PMID:20435105
1298347	CASP7	caspase 7	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CASP7 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CASP7 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CASP7 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of CASP7 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of CASP7 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1298347	CASP7	caspase 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CASP7 mRNA	PMID:34911549
1298347	CASP7	caspase 7	gene	CHEBI:26523	reactive oxygen species	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D017382	[XCT790 results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP7 protein; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[XCT790 results in increased abundance of Reactive Oxygen Species] which results in increased activity of CASP7 protein]	PMID:19464277
1298347	CASP7	caspase 7	gene	CHEBI:2663	amiodarone	increases activity	EXP		E	RGD:6480464	20130514	CTD	MESH:D000638	Amiodarone results in increased activity of CASP7 protein	PMID:23042730|PMID:23135547
1298347	CASP7	caspase 7	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1553182	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of CASP7 mRNA	PMID:24489787
1298347	CASP7	caspase 7	gene	CHEBI:2663	amiodarone	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D000638	alpha-Tocopherol promotes the reaction [Amiodarone results in increased activity of CASP7 protein]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP7 protein]]; TNF protein promotes the reaction [Amiodarone results in increased activity of CASP7 protein]	PMID:23042730
1298347	CASP7	caspase 7	gene	CHEBI:2668	amlodipine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D017311	[Amlodipine co-treated with Topotecan] results in increased activity of CASP7 protein	PMID:16516327
1298347	CASP7	caspase 7	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:620944	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of CASP7 mRNA	PMID:30779732
1298347	CASP7	caspase 7	gene	CHEBI:27086	tributylstannane	increases activity	ISO	RGD:620944	E	RGD:6480464	20120613	CTD	MESH:C011559	tributyltin results in increased activity of CASP7 protein	PMID:21683754
1298347	CASP7	caspase 7	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20260113	CTD	MESH:D015032	ZBP1 protein inhibits the reaction [Zinc inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased cleavage of CASP7 protein]]; Zinc inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased cleavage of CASP7 protein]	PMID:40348119
1298347	CASP7	caspase 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1553182	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CASP7 mRNA	PMID:31919559
1298347	CASP7	caspase 7	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [Doxorubicin results in decreased expression of CASP7 mRNA]	PMID:30581319
1298347	CASP7	caspase 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CASP7 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CASP7 gene	PMID:20938992
1298347	CASP7	caspase 7	gene	CHEBI:27504	mitomycin C	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	Mitomycin results in increased cleavage of and results in increased activity of CASP7 protein	PMID:12181741
1298347	CASP7	caspase 7	gene	CHEBI:27617	monensin A	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D008985	Monensin results in increased activity of CASP7 protein	PMID:20799912
1298347	CASP7	caspase 7	gene	CHEBI:27617	monensin A	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008985	Lithium inhibits the reaction [Monensin results in increased activity of CASP7 protein]	PMID:20799912
1298347	CASP7	caspase 7	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [Tretinoin results in increased expression of CASP7 mRNA]; Cycloheximide promotes the reaction [FAS protein results in increased activity of CASP7 protein]	PMID:12760867|PMID:16166294
1298347	CASP7	caspase 7	gene	CHEBI:27656	camptothecin	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D002166	Camptothecin results in decreased expression of CASP7 mRNA	PMID:30581319
1298347	CASP7	caspase 7	gene	CHEBI:27656	camptothecin	increases activity	EXP		E	RGD:6480464	20150414	CTD	MESH:D002166	Camptothecin results in increased activity of CASP7 protein	PMID:22302033|PMID:24726431
1298347	CASP7	caspase 7	gene	CHEBI:27656	camptothecin	multiple interactions	EXP		E	RGD:6480464	20140909	CTD	MESH:D002166	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Camptothecin results in increased activity of CASP7 protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [Camptothecin results in increased activity of CASP7 protein]; palbociclib inhibits the reaction [Camptothecin results in increased activity of CASP7 protein]	PMID:22302033|PMID:24726431
1298347	CASP7	caspase 7	gene	CHEBI:27666	actinomycin D	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in decreased expression of CASP7 mRNA	PMID:16001973
1298347	CASP7	caspase 7	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of CASP7 protein; [Dactinomycin co-treated with TNFSF10 protein] results in increased activity of CASP7 protein; [TNF co-treated with Dactinomycin] results in increased activity of CASP7 protein; [TNF protein co-treated with Dactinomycin] results in increased activity of CASP7 protein; Dactinomycin promotes the reaction [TNF results in increased activity of CASP7 protein]	PMID:16492401|PMID:17707539|PMID:21496118|PMID:38460933
1298347	CASP7	caspase 7	gene	CHEBI:27744	glyphosate	increases activity	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased activity of CASP7 protein	PMID:19105591
1298347	CASP7	caspase 7	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of CASP7 mRNA	PMID:31874349
1298347	CASP7	caspase 7	gene	CHEBI:27744	glyphosate	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	[Glyphosate co-treated with Herbicides] results in increased activity of CASP7 protein	PMID:19539684
1298347	CASP7	caspase 7	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20240206	CTD	MESH:C010974	[Surface-Active Agents co-treated with Glyphosate] results in increased activity of CASP7 protein	PMID:23099315
1298347	CASP7	caspase 7	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:620944	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CASP7 mRNA	PMID:31881176
1298347	CASP7	caspase 7	gene	CHEBI:27869	chloroacetic acid	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20130514	CTD	MESH:C006972	chloroacetic acid results in increased cleavage of and results in increased activity of CASP7 protein; SB 203580 inhibits the reaction [chloroacetic acid results in increased activity of CASP7 protein]	PMID:23103613
1298347	CASP7	caspase 7	gene	CHEBI:27881	resveratrol	decreases activity	ISO	RGD:1553182	E	RGD:6480464	20141111	CTD	MESH:C059514	resveratrol results in decreased activity of CASP7 protein	PMID:23227865
1298347	CASP7	caspase 7	gene	CHEBI:27881	resveratrol	increases activity	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased activity of CASP7 protein	PMID:19738051|PMID:21205742|PMID:21304978|PMID:24726691|PMID:26055805
1298347	CASP7	caspase 7	gene	CHEBI:27881	resveratrol	increases activity	ISO	RGD:620944	E	RGD:6480464	20160315	CTD	MESH:C059514	resveratrol results in increased activity of CASP7 protein	PMID:24894866
1298347	CASP7	caspase 7	gene	CHEBI:27881	resveratrol	increases cleavage	EXP		E	RGD:6480464	20130416	CTD	MESH:C059514	resveratrol results in increased cleavage of CASP7 protein	PMID:23152798
1298347	CASP7	caspase 7	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C059514	resveratrol results in increased expression of CASP7	PMID:23495037
1298347	CASP7	caspase 7	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	[clofarabine co-treated with resveratrol] promotes the reaction [BCL2L1 mutant form results in increased activity of CASP7 protein]; [clofarabine co-treated with resveratrol] results in increased activity of CASP7 protein; [resveratrol co-treated with clofarabine] promotes the reaction [MCL1 mutant form results in increased activity of CASP7 protein]; [resveratrol co-treated with clofarabine] results in increased activity of CASP7 protein; [resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP7 protein; ATF3 protein promotes the reaction [resveratrol results in increased activity of CASP7 protein]; BCL2L1 protein affects the reaction [[clofarabine co-treated with resveratrol] results in increased activity of CASP7 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[resveratrol co-treated with clofarabine] promotes the reaction [MCL1 mutant form results in increased activity of CASP7 protein]]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[resveratrol co-treated with clofarabine] results in increased activity of CASP7 protein]; resveratrol inhibits the reaction [benzo(e)pyrene results in increased activity of CASP7 protein]; resveratrol promotes the reaction [TNFSF10 protein results in increased cleavage of CASP7 protein]	PMID:14749477|PMID:17823925|PMID:19959636|PMID:21205742|PMID:24924397|PMID:25408576
1298347	CASP7	caspase 7	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20160315	CTD	MESH:C059514	[resveratrol co-treated with Estradiol] results in increased activity of CASP7 protein; resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased activity of CASP7 protein]; SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Tobacco Smoke Pollution results in increased activity of CASP7 protein]]	PMID:18424637|PMID:24894866
1298347	CASP7	caspase 7	gene	CHEBI:27899	cisplatin	increases activity	EXP		E	RGD:6480464	20120918	CTD	MESH:D002945	Cisplatin results in increased activity of CASP7 protein	PMID:20654585|PMID:21420390|PMID:21801448
1298347	CASP7	caspase 7	gene	CHEBI:27899	cisplatin	increases cleavage	ISO	RGD:1553182	E	RGD:6480464	20230404	CTD	MESH:D002945	Cisplatin results in increased cleavage of CASP7 protein	PMID:36372261
1298347	CASP7	caspase 7	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D002945	Cisplatin results in increased expression of CASP7 mRNA	PMID:18483502|PMID:27594783
1298347	CASP7	caspase 7	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with CDKN1A protein] results in increased cleavage of CASP7 protein; [Cisplatin co-treated with CDKN1A protein] results in increased expression of CASP7 mRNA; [Cisplatin co-treated with fisetin] promotes the reaction [CASP9 protein results in increased cleavage of CASP7 protein]; Cisplatin promotes the reaction [Metformin results in increased activity of CASP7 protein]	PMID:18483502|PMID:21216935|PMID:21388661
1298347	CASP7	caspase 7	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with Vinorelbine] results in decreased expression of CASP7 mRNA; PAK2 protein modified form promotes the reaction [Cisplatin results in increased activity of CASP7 protein]; Sodium Acetate inhibits the reaction [Cisplatin results in increased cleavage of CASP7 protein]	PMID:21499899|PMID:21544650|PMID:36372261
1298347	CASP7	caspase 7	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20141223	CTD	MESH:D002945	Cisplatin results in increased cleavage of and results in increased activity of CASP7 protein; CTNNA1 gene affects the reaction [Cisplatin results in increased cleavage of and results in increased activity of CASP7 protein]	PMID:24973089
1298347	CASP7	caspase 7	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein inhibits the reaction [benzo(e)pyrene results in increased activity of CASP7 protein]	PMID:19959636
1298347	CASP7	caspase 7	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:D009532	Nickel results in increased cleavage of and results in increased activity of CASP7 protein	PMID:24068677
1298347	CASP7	caspase 7	gene	CHEBI:28115	methylcobalamin	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:C019476	mecobalamin inhibits the reaction [Homocysteine results in increased activity of CASP7 protein]	PMID:21237187
1298347	CASP7	caspase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553182	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CASP7 mRNA	PMID:21570461
1298347	CASP7	caspase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases activity	ISO	RGD:1553182	E	RGD:6480464	20230502	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased activity of CASP7 protein	PMID:36782369
1298347	CASP7	caspase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CASP7 mRNA	PMID:12167310
1298347	CASP7	caspase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CASP7 mRNA	PMID:19520675
1298347	CASP7	caspase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin inhibits the reaction [Etoposide results in increased activity of CASP7 protein]	PMID:20299546
1298347	CASP7	caspase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CASP7 mRNA	PMID:17942748
1298347	CASP7	caspase 7	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of CASP7 protein	PMID:39603559
1298347	CASP7	caspase 7	gene	CHEBI:28201	rotenone	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased activity of CASP7 protein	PMID:16402917|PMID:37473966
1298347	CASP7	caspase 7	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of CASP7 mRNA	PMID:32368861
1298347	CASP7	caspase 7	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	MT1B protein inhibits the reaction [Rotenone results in increased activity of CASP7 protein]; MT2A protein inhibits the reaction [Rotenone results in increased activity of CASP7 protein]	PMID:16402917
1298347	CASP7	caspase 7	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1553182	E	RGD:6480464	20140610	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CASP7 mRNA; methylmercuric chloride results in increased expression of CASP7 protein modified form	PMID:23202902|PMID:31330229
1298347	CASP7	caspase 7	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20191210	CTD	MESH:C004925	Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; DDIT3 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; HSP90B1 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; HSPA5 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; XBP1 protein promotes the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]	PMID:31330229
1298347	CASP7	caspase 7	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of CASP7 mRNA	PMID:39709020
1298347	CASP7	caspase 7	gene	CHEBI:28527	rutin	increases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:D012431	Rutin results in increased activity of CASP7 protein	PMID:24726691
1298347	CASP7	caspase 7	gene	CHEBI:28527	rutin	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20161213	CTD	MESH:D012431	Rutin inhibits the reaction [Oxidopamine results in increased expression of CASP7 mRNA]	PMID:25129099
1298347	CASP7	caspase 7	gene	CHEBI:28584	gossypol	increases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:D006072	Gossypol results in increased activity of CASP7 protein	PMID:19825521
1298347	CASP7	caspase 7	gene	CHEBI:28584	gossypol	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D006072	[zoledronic acid co-treated with Gossypol] results in increased activity of CASP7 protein	PMID:19825521
1298347	CASP7	caspase 7	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CASP7 mRNA	PMID:32763439
1298347	CASP7	caspase 7	gene	CHEBI:28685	molybdenum atom	increases activity	EXP		E	RGD:6480464	20151110	CTD	MESH:D008982	Molybdenum analog results in increased activity of CASP7 protein	PMID:26391003
1298347	CASP7	caspase 7	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CASP7 mRNA; [NSC 689534 binds to Copper] which results in increased activity of CASP7 protein	PMID:20971185|PMID:30911355
1298347	CASP7	caspase 7	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20121009	CTD	MESH:D003300	[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP7 protein; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP7 protein]	PMID:22085843
1298347	CASP7	caspase 7	gene	CHEBI:28709	eriocitrin	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C114706	eriocitrin results in increased expression of CASP7 protein	PMID:34724282
1298347	CASP7	caspase 7	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D019328	Buthionine Sulfoximine promotes the reaction [O(2)-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate affects the cleavage of CASP7 protein]	PMID:20962031
1298347	CASP7	caspase 7	gene	CHEBI:28748	doxorubicin	affects activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin affects the activity of CASP7 protein	PMID:15870702
1298347	CASP7	caspase 7	gene	CHEBI:28748	doxorubicin	increases activity	EXP		E	RGD:6480464	20150414	CTD	MESH:D004317	Doxorubicin results in increased activity of CASP7 protein	PMID:11502879|PMID:19106633|PMID:22302033|PMID:22687995|PMID:23300809
1298347	CASP7	caspase 7	gene	CHEBI:28748	doxorubicin	increases activity	ISO	RGD:1553182	E	RGD:6480464	20161025	CTD	MESH:D004317	Doxorubicin results in increased activity of CASP7 protein	PMID:27155237|PMID:27255381
1298347	CASP7	caspase 7	gene	CHEBI:28748	doxorubicin	increases activity	ISO	RGD:620944	E	RGD:6480464	20161025	CTD	MESH:D004317	Doxorubicin results in increased activity of CASP7 protein	PMID:27255381
1298347	CASP7	caspase 7	gene	CHEBI:28748	doxorubicin	increases cleavage	EXP		E	RGD:6480464	20160119	CTD	MESH:D004317	Doxorubicin results in increased cleavage of CASP7 protein	PMID:17653088|PMID:26208482
1298347	CASP7	caspase 7	gene	CHEBI:28748	doxorubicin	increases cleavage	ISO	RGD:1553182	E	RGD:6480464	20250506	CTD	MESH:D004317	Doxorubicin results in increased cleavage of CASP7 protein	PMID:38943348
1298347	CASP7	caspase 7	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of CASP7 mRNA	PMID:16001973|PMID:16705698
1298347	CASP7	caspase 7	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20130212	CTD	MESH:D004317	[Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased activity of CASP7 protein; [gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]] which affects the cleavage of CASP7 protein; Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]] which affects the cleavage of CASP7 protein]; Cotinine inhibits the reaction [Doxorubicin results in increased activity of CASP7 protein]; Doxorubicin inhibits the reaction [Thapsigargin results in increased activity of and results in increased cleavage of CASP7 protein]; Doxorubicin results in increased activity of and results in increased cleavage of CASP7 protein; Doxorubicin results in increased cleavage of and results in increased activity of CASP7 protein; Folic Acid inhibits the reaction [Doxorubicin results in decreased expression of CASP7 mRNA]; GPX1 protein inhibits the reaction [Doxorubicin results in increased activity of CASP7 protein]; palbociclib inhibits the reaction [Doxorubicin results in increased activity of CASP7 protein]; PI103 promotes the reaction [Doxorubicin results in increased activity of CASP7 protein]; TNFSF10 protein promotes the reaction [Doxorubicin results in increased activity of CASP7 protein]	PMID:11502879|PMID:16024631|PMID:16168113|PMID:16298333|PMID:19106633|PMID:22302033|PMID:22687995|PMID:23300809|PMID:25824409|PMID:30581319
1298347	CASP7	caspase 7	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D004317	[Verapamil results in decreased expression of ABCB1] promotes the reaction [Doxorubicin results in increased activity of CASP7 protein]; Doxorubicin promotes the reaction [AZD 6244 results in increased cleavage of CASP7 protein]; PARP1 gene mutant form promotes the reaction [Doxorubicin results in increased activity of CASP7 protein]	PMID:15861398|PMID:17876044
1298347	CASP7	caspase 7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20190507	CTD	MESH:D005632	[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein; dapagliflozin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]; dapagliflozin promotes the reaction [Metformin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]]; Metformin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]; Metformin promotes the reaction [dapagliflozin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]]	PMID:30551545
1298347	CASP7	caspase 7	gene	CHEBI:28790	serotonin	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:D012701	Serotonin inhibits the reaction [7-ketocholesterol results in increased activity of CASP7 protein]	PMID:24650663
1298347	CASP7	caspase 7	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of CASP7 protein	PMID:35688186
1298347	CASP7	caspase 7	gene	CHEBI:28802	flavonols	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D044948	Flavonols results in increased activity of and results in increased cleavage of CASP7 protein	PMID:28235426
1298347	CASP7	caspase 7	gene	CHEBI:28812	(aminomethyl)phosphonic acid	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:C036423	[1-aminomethylphosphonic acid co-treated with methoxyacetic acid] results in increased cleavage of and results in increased activity of CASP7 protein	PMID:26006246
1298347	CASP7	caspase 7	gene	CHEBI:28842	octadecanoic acid	increases activity	ISO	RGD:620944	E	RGD:6480464	20121113	CTD	MESH:C031183	stearic acid results in increased activity of CASP7 protein	PMID:22413010
1298347	CASP7	caspase 7	gene	CHEBI:28854	2,4-D	increases cleavage	ISO	RGD:620944	E	RGD:6480464	20250603	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in increased cleavage of CASP7 protein	PMID:39921193
1298347	CASP7	caspase 7	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20250603	CTD	MESH:D015084	Acetylcysteine inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased cleavage of CASP7 protein]; dorsomorphin inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased cleavage of CASP7 protein]; PRKAA1 protein affects the reaction [2,4-Dichlorophenoxyacetic Acid results in increased activity of CASP7 protein]	PMID:39921193
1298347	CASP7	caspase 7	gene	CHEBI:28863	flavanones	increases cleavage	EXP		E	RGD:6480464	20170303	CTD	MESH:D044950	Flavanones results in increased cleavage of CASP7 protein	PMID:21616090
1298347	CASP7	caspase 7	gene	CHEBI:28863	flavanones	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D044950	2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one promotes the reaction [Flavanones results in increased cleavage of CASP7 protein]; CDKN1A gene mutant form promotes the reaction [Flavanones results in increased cleavage of CASP7 protein]; PI103 promotes the reaction [Flavanones results in increased cleavage of CASP7 protein]; TP53 gene mutant form promotes the reaction [Flavanones results in increased cleavage of CASP7 protein]; U 0126 promotes the reaction [Flavanones results in increased cleavage of CASP7 protein]	PMID:21616090
1298347	CASP7	caspase 7	gene	CHEBI:28939	N-acetyl-L-cysteine	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:D000111	Acetylcysteine results in decreased expression of CASP7 protein modified form	PMID:31433961
1298347	CASP7	caspase 7	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D000111	Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]] which affects the cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine results in increased activity of and results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [2-hydroxy-3',5,5'-trimethoxychalcone results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [[cholix toxin, Vibrio cholerae co-treated with TNF protein] results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [arsenite results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [Dopamine results in increased activity of and results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [ellipticine results in increased cleavage of and results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [fucoxanthin results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [geldanamycin results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [isoalantolactone results in increased expression of CASP7 protein modified form]; Acetylcysteine inhibits the reaction [Isoproterenol results in increased activity of and results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [Norepinephrine results in increased activity of and results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [thymoquinone results in increased expression of CASP7 protein modified form]; Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of CASP7 protein]; Acetylcysteine promotes the reaction [dihydromyricetin results in increased cleavage of CASP7 protein]	PMID:17136323|PMID:19771260|PMID:20594983|PMID:21843585|PMID:22260869|PMID:24998639|PMID:25824409|PMID:27106530|PMID:27539140|PMID:28087840|PMID:28161410|PMID:29800641|PMID:30408460|PMID:30917517|PMID:31313457|PMID:31433961|PMID:34627931|PMID:37146930
1298347	CASP7	caspase 7	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120918	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of CASP7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased expression of CASP7 protein modified form]; Acetylcysteine inhibits the reaction [Methylmercury Compounds results in increased expression of CASP7 mRNA]; Acetylcysteine inhibits the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased cleavage of CASP7 protein]	PMID:21549813|PMID:22909951|PMID:24157283|PMID:31330229|PMID:36252918|PMID:40049439
1298347	CASP7	caspase 7	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20120918	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased cleavage of CASP7 protein]	PMID:21145380|PMID:22085843|PMID:23405080|PMID:38379848|PMID:39921193|PMID:40368022
1298347	CASP7	caspase 7	gene	CHEBI:28955	2-methoxy-17beta-estradiol	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C022830	2-Methoxyestradiol results in increased expression of CASP7 protein modified form	PMID:23967052
1298347	CASP7	caspase 7	gene	CHEBI:28955	2-methoxy-17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C022830	Arsenic Trioxide promotes the reaction [2-Methoxyestradiol results in increased expression of CASP7 protein modified form]	PMID:23967052
1298347	CASP7	caspase 7	gene	CHEBI:29014	cordycepin	increases cleavage	ISO	RGD:620944	E	RGD:6480464	20140812	CTD	MESH:C058120	cordycepin results in increased cleavage of CASP7 protein	PMID:24704558
1298347	CASP7	caspase 7	gene	CHEBI:29014	cordycepin	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20140812	CTD	MESH:C058120	acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [cordycepin results in increased cleavage of CASP7 protein]; ADORA2A mutant form inhibits the reaction [cordycepin results in increased cleavage of CASP7 protein]; pifithrin inhibits the reaction [cordycepin results in increased cleavage of CASP7 protein]; TP53 mutant form inhibits the reaction [cordycepin results in increased cleavage of CASP7 protein]; ZM 241385 inhibits the reaction [cordycepin results in increased cleavage of CASP7 protein]	PMID:24704558
1298347	CASP7	caspase 7	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D001205	[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of CASP7 protein; [Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CASP7 mRNA; [Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of CASP7 protein]; [Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CASP7 mRNA]; Ascorbic Acid promotes the reaction [chromium hexavalent ion results in increased cleavage of CASP7 protein]	PMID:17301063|PMID:17879260
1298347	CASP7	caspase 7	gene	CHEBI:29287	gold atom	increases cleavage	EXP		E	RGD:6480464	20170516	CTD	MESH:D006046	Gold analog results in increased cleavage of CASP7 protein	PMID:26551149
1298347	CASP7	caspase 7	gene	CHEBI:29310	dichlorine	increases activity	EXP		E	RGD:6480464	20260407	CTD	MESH:D002713	Chlorine results in increased activity of CASP7 protein	PMID:41442163
1298347	CASP7	caspase 7	gene	CHEBI:29639	N-(3-oxododecanoyl)homoserine lactone	increases activity	ISO	RGD:1553182	E	RGD:6480464	20170303	CTD	MESH:C109860	N-(3-oxododecanoyl)homoserine lactone results in increased activity of CASP7 protein	PMID:25627690
1298347	CASP7	caspase 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CASP7 mRNA	PMID:12760830
1298347	CASP7	caspase 7	gene	CHEBI:29678	sodium arsenite	increases activity	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased activity of CASP7 protein	PMID:17202112|PMID:25923732
1298347	CASP7	caspase 7	gene	CHEBI:29678	sodium arsenite	increases activity	ISO	RGD:1553182	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased activity of CASP7 protein	PMID:16447264
1298347	CASP7	caspase 7	gene	CHEBI:29678	sodium arsenite	increases cleavage	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased cleavage of CASP7 protein	PMID:21642427
1298347	CASP7	caspase 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CASP7 mRNA	PMID:38100851
1298347	CASP7	caspase 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:620944	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of CASP7 mRNA	PMID:37449383
1298347	CASP7	caspase 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	EIF4E protein modified form inhibits the reaction [sodium arsenite results in increased activity of CASP7 protein]	PMID:25923732
1298347	CASP7	caspase 7	gene	CHEBI:29699	tunicamycin	increases activity	EXP		E	RGD:6480464	20120613	CTD	MESH:D014415	Tunicamycin results in increased activity of CASP7 protein	PMID:19139269
1298347	CASP7	caspase 7	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1553182	E	RGD:6480464	20191210	CTD	MESH:D014415	Tunicamycin results in increased expression of CASP7 protein modified form	PMID:31330229
1298347	CASP7	caspase 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CASP7 promoter	PMID:27901495
1298347	CASP7	caspase 7	gene	CHEBI:29865	benzo[a]pyrene	increases activity	ISO	RGD:1553182	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased activity of CASP7 protein	PMID:19874837
1298347	CASP7	caspase 7	gene	CHEBI:29865	benzo[a]pyrene	increases activity	ISO	RGD:620944	E	RGD:6480464	20191112	CTD	MESH:D001564	Benzo(a)pyrene results in increased activity of CASP7 protein	PMID:31368503
1298347	CASP7	caspase 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CASP7 mRNA; Benzo(a)pyrene results in increased expression of CASP7 protein	PMID:22581694|PMID:24239969
1298347	CASP7	caspase 7	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D001564	CYP1B1 mutant form inhibits the reaction [Benzo(a)pyrene results in increased expression of CASP7 mRNA]	PMID:24239969
1298347	CASP7	caspase 7	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120918	CTD	MESH:D001564	Chlordan promotes the reaction [Benzo(a)pyrene results in increased activity of CASP7 protein]; GJA1 mutant form promotes the reaction [Benzo(a)pyrene results in increased activity of CASP7 protein]	PMID:19874837
1298347	CASP7	caspase 7	gene	CHEBI:29866	arsenite(3-)	increases activity	EXP		E	RGD:6480464	20121218	CTD	MESH:C015001	arsenite results in increased activity of CASP7 protein	PMID:22260869
1298347	CASP7	caspase 7	gene	CHEBI:29866	arsenite(3-)	increases activity	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased activity of CASP7 protein	PMID:18316066
1298347	CASP7	caspase 7	gene	CHEBI:29866	arsenite(3-)	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C015001	arsenite results in increased expression of CASP7 protein	PMID:26677073
1298347	CASP7	caspase 7	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:C015001	[arsenite results in decreased activity of PARP1 protein] which results in decreased cleavage of and results in decreased activity of CASP7 protein; Acetylcysteine inhibits the reaction [arsenite results in increased activity of CASP7 protein]; arsenite results in decreased cleavage of and results in decreased activity of CASP7 protein; TP53 mutant form inhibits the reaction [arsenite results in increased activity of CASP7 protein]	PMID:22260869|PMID:22387748
1298347	CASP7	caspase 7	gene	CHEBI:3000	beauvericin	increases activity	ISO	RGD:620944	E	RGD:6480464	20150414	CTD	MESH:C004456	beauvericin results in increased activity of CASP7 protein	PMID:25178661
1298347	CASP7	caspase 7	gene	CHEBI:30050	gold(0)	increases cleavage	EXP		E	RGD:6480464	20170516	CTD	MESH:D006046	Gold analog results in increased cleavage of CASP7 protein	PMID:26551149
1298347	CASP7	caspase 7	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CASP7 mRNA; [NSC 689534 binds to Copper] which results in increased activity of CASP7 protein	PMID:20971185|PMID:30911355
1298347	CASP7	caspase 7	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20121009	CTD	MESH:D003300	[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP7 protein; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP7 protein]	PMID:22085843
1298347	CASP7	caspase 7	gene	CHEBI:30145	lithium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium inhibits the reaction [Monensin results in increased activity of CASP7 protein]	PMID:20799912
1298347	CASP7	caspase 7	gene	CHEBI:30146	lithium hydride	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium inhibits the reaction [Monensin results in increased activity of CASP7 protein]	PMID:20799912
1298347	CASP7	caspase 7	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20260113	CTD	MESH:D015032	ZBP1 protein inhibits the reaction [Zinc inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased cleavage of CASP7 protein]]; Zinc inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased cleavage of CASP7 protein]	PMID:40348119
1298347	CASP7	caspase 7	gene	CHEBI:30304	antimony(0)	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20260303	CTD	MESH:D000965	4-phenylbutyric acid inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased cleavage of CASP7 protein]; [antimony trichloride results in increased abundance of Antimony] which results in increased cleavage of CASP7 protein; Acetylcysteine inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased cleavage of CASP7 protein]; pyrazolanthrone inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased cleavage of CASP7 protein]	PMID:40368022
1298347	CASP7	caspase 7	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1553182	E	RGD:6480464	20241203	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CASP7 protein	PMID:39362619
1298347	CASP7	caspase 7	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1553182	E	RGD:6480464	20241203	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CASP7 mRNA	PMID:39362619
1298347	CASP7	caspase 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases cleavage	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of CASP7 protein	PMID:21983885
1298347	CASP7	caspase 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	BAX protein affects the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of CASP7 protein]; TP53 protein affects the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased cleavage of CASP7 protein]	PMID:21983885
1298347	CASP7	caspase 7	gene	CHEBI:30621	diarsenic trioxide	increases activity	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased activity of CASP7 protein	PMID:12181429|PMID:12883267|PMID:15493360|PMID:16360329|PMID:19771260|PMID:22199276
1298347	CASP7	caspase 7	gene	CHEBI:30621	diarsenic trioxide	increases activity	ISO	RGD:1553182	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased activity of CASP7 protein	PMID:24157283
1298347	CASP7	caspase 7	gene	CHEBI:30621	diarsenic trioxide	increases activity	ISO	RGD:620944	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased activity of CASP7 protein	PMID:20937774|PMID:21145380
1298347	CASP7	caspase 7	gene	CHEBI:30621	diarsenic trioxide	increases cleavage	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased cleavage of CASP7 protein	PMID:12480548|PMID:19695276|PMID:20408844
1298347	CASP7	caspase 7	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Arsenic Trioxide co-treated with apatinib] results in increased cleavage of CASP7 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Arsenic Trioxide promotes the reaction [2-Methoxyestradiol results in increased expression of CASP7 protein modified form]	PMID:19771260|PMID:23967052|PMID:39223679
1298347	CASP7	caspase 7	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20191114	CTD	MESH:C006632	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP7 protein; DDIT3 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; HSPA5 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP7 protein]	PMID:15688020|PMID:24157283
1298347	CASP7	caspase 7	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20191114	CTD	MESH:C006632	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]	PMID:20937774|PMID:21145380
1298347	CASP7	caspase 7	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of CASP7 mRNA	PMID:34408198
1298347	CASP7	caspase 7	gene	CHEBI:30778	gallic acid	increases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:D005707	Gallic Acid results in increased activity of CASP7 protein	PMID:24726691
1298347	CASP7	caspase 7	gene	CHEBI:3087	betulinic acid	increases activity	EXP		E	RGD:6480464	20230207	CTD	MESH:C002070	Betulinic Acid results in increased activity of CASP7 protein	PMID:22260869
1298347	CASP7	caspase 7	gene	CHEBI:3087	betulinic acid	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C002070	VDAC1 protein inhibits the reaction [Betulinic Acid results in increased expression of CASP7 protein modified form]	PMID:30136359
1298347	CASP7	caspase 7	gene	CHEBI:3090	bicalutamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C053541	bicalutamide promotes the reaction [Niclosamide results in increased expression of CASP7 protein modified form]	PMID:28500234
1298347	CASP7	caspase 7	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CASP7 mRNA	PMID:16483693
1298347	CASP7	caspase 7	gene	CHEBI:31206	ammonium chloride	increases expression	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride results in increased expression of CASP7 protein	PMID:16483693
1298347	CASP7	caspase 7	gene	CHEBI:31355	carboplatin	increases activity	EXP		E	RGD:6480464	20150414	CTD	MESH:D016190	Carboplatin results in increased activity of CASP7 protein	PMID:22302033
1298347	CASP7	caspase 7	gene	CHEBI:31355	carboplatin	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D016190	palbociclib inhibits the reaction [Carboplatin results in increased activity of CASP7 protein]	PMID:22302033
1298347	CASP7	caspase 7	gene	CHEBI:31401	cilostazol	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:C045645	cilostazol inhibits the reaction [Nitroprusside results in increased activity of CASP7 protein]	PMID:18311796
1298347	CASP7	caspase 7	gene	CHEBI:31530	edaravone	increases activity	EXP		E	RGD:6480464	20150609	CTD	MESH:C005435	Edaravone analog results in increased activity of CASP7 protein	PMID:25684395
1298347	CASP7	caspase 7	gene	CHEBI:31622	flunitrazepam	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D005445	CYP3A4 protein affects the reaction [Flunitrazepam results in increased activity of CASP7 protein]	PMID:19005028
1298347	CASP7	caspase 7	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1553182	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of CASP7 mRNA	PMID:23202902
1298347	CASP7	caspase 7	gene	CHEBI:31823	mercury dichloride	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20130416	CTD	MESH:D008627	[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of CASP7 protein; Acetylcysteine inhibits the reaction [[Mercuric Chloride co-treated with prolinedithiocarbamate] results in increased degradation of CASP7 protein]	PMID:22909951
1298347	CASP7	caspase 7	gene	CHEBI:31912	nimetazepam	multiple interactions	EXP		E	RGD:6480464	20140415	CTD	MESH:C002714	CYP3A4 protein affects the reaction [nimetazepam results in increased activity of CASP7 protein]	PMID:19005028
1298347	CASP7	caspase 7	gene	CHEBI:32063	propylparaben	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C006068	propylparaben results in increased expression of CASP7 mRNA	PMID:24481588
1298347	CASP7	caspase 7	gene	CHEBI:32076	zinc pyrithione	increases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C010423	pyrithione zinc results in increased activity of CASP7 protein	PMID:20151177
1298347	CASP7	caspase 7	gene	CHEBI:32138	sodium acetate trihydrate	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20230404	CTD	MESH:D019346	Sodium Acetate inhibits the reaction [Cisplatin results in increased cleavage of CASP7 protein]	PMID:36372261
1298347	CASP7	caspase 7	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:620944	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CASP7 mRNA	PMID:30047161
1298347	CASP7	caspase 7	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:620944	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of CASP7 mRNA	PMID:24136188
1298347	CASP7	caspase 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1553182	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CASP7 gene	PMID:35295148
1298347	CASP7	caspase 7	gene	CHEBI:32234	titanium dioxide	increases activity	EXP		E	RGD:6480464	20161115	CTD	MESH:C009495	titanium dioxide results in increased activity of CASP7 protein	PMID:19783790
1298347	CASP7	caspase 7	gene	CHEBI:32234	titanium dioxide	increases cleavage	EXP		E	RGD:6480464	20190409	CTD	MESH:C009495	titanium dioxide results in increased cleavage of CASP7 protein	PMID:30126039
1298347	CASP7	caspase 7	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:620944	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CASP7 mRNA	PMID:25380136
1298347	CASP7	caspase 7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CASP7 mRNA	PMID:19162173
1298347	CASP7	caspase 7	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1553182	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of CASP7 mRNA	PMID:19191707
1298347	CASP7	caspase 7	gene	CHEBI:32849	TEMPO	increases activity	ISO	RGD:1553182	E	RGD:6480464	20150609	CTD	MESH:C003959	TEMPO results in increased activity of CASP7 protein	PMID:25882087
1298347	CASP7	caspase 7	gene	CHEBI:32849	TEMPO	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20150609	CTD	MESH:C003959	pyrazolanthrone inhibits the reaction [TEMPO results in increased activity of CASP7 protein]	PMID:25882087
1298347	CASP7	caspase 7	gene	CHEBI:32888	gamma-hexachlorocyclohexane	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20121009	CTD	MESH:D001556	[Hexachlorocyclohexane co-treated with Dieldrin] results in increased activity of CASP7 protein	PMID:20036686
1298347	CASP7	caspase 7	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1553182	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CASP7 mRNA	PMID:28472532
1298347	CASP7	caspase 7	gene	CHEBI:33007	chromium(6+)	increases activity	EXP		E	RGD:6480464	20130723	CTD	MESH:C074702	chromium hexavalent ion results in increased activity of CASP7 protein	PMID:15831465
1298347	CASP7	caspase 7	gene	CHEBI:33007	chromium(6+)	increases cleavage	EXP		E	RGD:6480464	20130611	CTD	MESH:C074702	chromium hexavalent ion results in increased cleavage of CASP7 protein	PMID:17301063
1298347	CASP7	caspase 7	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:C074702	Ascorbic Acid promotes the reaction [chromium hexavalent ion results in increased cleavage of CASP7 protein]; MLH1 protein affects the reaction [chromium hexavalent ion results in increased activity of CASP7 protein]	PMID:15831465|PMID:17301063
1298347	CASP7	caspase 7	gene	CHEBI:3305	Calcimycin	increases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:D000001	Calcimycin results in increased activity of CASP7 protein	PMID:19139269
1298347	CASP7	caspase 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in decreased expression of CASP7 protein	PMID:21277958
1298347	CASP7	caspase 7	gene	CHEBI:33216	bisphenol A	increases activity	EXP		E	RGD:6480464	20241203	CTD	MESH:C006780	bisphenol A results in increased activity of CASP7 protein	PMID:39059691
1298347	CASP7	caspase 7	gene	CHEBI:33216	bisphenol A	increases cleavage	ISO	RGD:1553182	E	RGD:6480464	20210504	CTD	MESH:C006780	bisphenol A results in increased cleavage of CASP7 protein	PMID:33771661
1298347	CASP7	caspase 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of CASP7 mRNA; bisphenol A results in increased expression of CASP7 protein	PMID:34186270|PMID:38736411
1298347	CASP7	caspase 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1553182	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of CASP7 mRNA; bisphenol A results in increased expression of CASP7 protein	PMID:31201698|PMID:31453682|PMID:32488702
1298347	CASP7	caspase 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:620944	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CASP7 mRNA	PMID:25181051
1298347	CASP7	caspase 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C006780	bisphenol A results in decreased expression of and results in increased cleavage of CASP7 protein	PMID:38372072
1298347	CASP7	caspase 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20230404	CTD	MESH:C006780	Drugs, Chinese Herbal inhibits the reaction [bisphenol A results in increased expression of CASP7 protein]	PMID:32488702
1298347	CASP7	caspase 7	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:C020806	tetrabromobisphenol A results in increased activity of CASP7 protein	PMID:22485137
1298347	CASP7	caspase 7	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases cleavage	ISO	RGD:1553182	E	RGD:6480464	20250708	CTD	MESH:C020806	tetrabromobisphenol A results in increased cleavage of CASP7 protein	PMID:39586487
1298347	CASP7	caspase 7	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20250708	CTD	MESH:C020806	DDIT3 protein promotes the reaction [tetrabromobisphenol A results in increased cleavage of CASP7 protein]; dorsomorphin inhibits the reaction [tetrabromobisphenol A results in increased cleavage of CASP7 protein]; MAPK11 protein promotes the reaction [tetrabromobisphenol A results in increased cleavage of CASP7 protein]; MAPK12 protein promotes the reaction [tetrabromobisphenol A results in increased cleavage of CASP7 protein]; MAPK13 protein promotes the reaction [tetrabromobisphenol A results in increased cleavage of CASP7 protein]; MAPK14 protein promotes the reaction [tetrabromobisphenol A results in increased cleavage of CASP7 protein]; PRKAA1 protein promotes the reaction [tetrabromobisphenol A results in increased cleavage of CASP7 protein]; PRKAA2 protein promotes the reaction [tetrabromobisphenol A results in increased cleavage of CASP7 protein]; SB 203580 inhibits the reaction [tetrabromobisphenol A results in increased cleavage of CASP7 protein]	PMID:39586487
1298347	CASP7	caspase 7	gene	CHEBI:3374	capsaicin	increases activity	EXP		E	RGD:6480464	20120918	CTD	MESH:D002211	Capsaicin results in increased activity of CASP7 protein	PMID:19139269|PMID:19699254|PMID:19855437
1298347	CASP7	caspase 7	gene	CHEBI:3374	capsaicin	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D002211	[Capsaicin co-treated with TNFSF10 protein] results in increased cleavage of CASP7 protein	PMID:19939880
1298347	CASP7	caspase 7	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	ISO	RGD:620944	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of CASP7 mRNA	PMID:22937105
1298347	CASP7	caspase 7	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:620944	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of CASP7 mRNA	PMID:22937105
1298347	CASP7	caspase 7	gene	CHEBI:34205	2,2',4,5-tetrachlorobiphenyl	affects activity	ISO	RGD:1553182	E	RGD:6480464	20170303	CTD	MESH:C042128	2,4,4',5-tetrachlorobiphenyl affects the activity of CASP7 protein	PMID:19362103
1298347	CASP7	caspase 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553182	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CASP7 mRNA	PMID:39298647
1298347	CASP7	caspase 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CASP7 protein	PMID:34186270
1298347	CASP7	caspase 7	gene	CHEBI:34385	4-aminopyridine	increases activity	ISO	RGD:620944	E	RGD:6480464	20140610	CTD	MESH:D015761	4-Aminopyridine results in increased activity of CASP7 protein	PMID:24378259
1298347	CASP7	caspase 7	gene	CHEBI:34440	4-nonylphenol	decreases expression	ISO	RGD:620944	E	RGD:6480464	20161025	CTD	MESH:C041594	4-nonylphenol results in decreased expression of CASP7 mRNA	PMID:27109770
1298347	CASP7	caspase 7	gene	CHEBI:34567	benzo[e]pyrene	increases activity	EXP		E	RGD:6480464	20140415	CTD	MESH:C026487	benzo(e)pyrene results in increased activity of CASP7 protein	PMID:18586875|PMID:19959636
1298347	CASP7	caspase 7	gene	CHEBI:34567	benzo[e]pyrene	increases activity	ISO	RGD:620944	E	RGD:6480464	20140415	CTD	MESH:C026487	benzo(e)pyrene results in increased activity of CASP7 protein	PMID:19899995
1298347	CASP7	caspase 7	gene	CHEBI:34567	benzo[e]pyrene	multiple interactions	EXP		E	RGD:6480464	20140415	CTD	MESH:C026487	Genistein inhibits the reaction [benzo(e)pyrene results in increased activity of CASP7 protein]; Memantine inhibits the reaction [benzo(e)pyrene results in increased activity of CASP7 protein]; resveratrol inhibits the reaction [benzo(e)pyrene results in increased activity of CASP7 protein]	PMID:19959636
1298347	CASP7	caspase 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1553182	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CASP7 mRNA	PMID:31453682
1298347	CASP7	caspase 7	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CASP7 mRNA	PMID:28628672
1298347	CASP7	caspase 7	gene	CHEBI:34631	chlorpyrifos	increases activity	ISO	RGD:1553182	E	RGD:6480464	20151215	CTD	MESH:D004390	Chlorpyrifos results in increased activity of CASP7 protein	PMID:26210949
1298347	CASP7	caspase 7	gene	CHEBI:34631	chlorpyrifos	increases cleavage	ISO	RGD:1553182	E	RGD:6480464	20230404	CTD	MESH:D004390	Chlorpyrifos results in increased cleavage of CASP7 protein	PMID:36252918
1298347	CASP7	caspase 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1553182	E	RGD:6480464	20190312	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CASP7 mRNA	PMID:27737797
1298347	CASP7	caspase 7	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20230404	CTD	MESH:D004390	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Chlorpyrifos results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [Chlorpyrifos results in increased cleavage of CASP7 protein]; DDIT3 protein affects the reaction [Chlorpyrifos results in increased cleavage of CASP7 protein]	PMID:36252918
1298347	CASP7	caspase 7	gene	CHEBI:34679	Di-n-octyl phthalate	decreases expression	ISO	RGD:1553182	E	RGD:6480464	20180515	CTD	MESH:C010715	di-n-octyl phthalate results in decreased expression of CASP7 protein	PMID:29128616
1298347	CASP7	caspase 7	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:620944	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of CASP7 mRNA	PMID:22546817
1298347	CASP7	caspase 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CASP7 mRNA	PMID:21266533
1298347	CASP7	caspase 7	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1553182	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CASP7 mRNA	PMID:17361019
1298347	CASP7	caspase 7	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:620944	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CASP7 mRNA	PMID:22546817
1298347	CASP7	caspase 7	gene	CHEBI:34696	dieldrin	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20121009	CTD	MESH:D004026	[Hexachlorocyclohexane co-treated with Dieldrin] results in increased activity of CASP7 protein	PMID:20036686
1298347	CASP7	caspase 7	gene	CHEBI:34741	equol	increases cleavage	EXP		E	RGD:6480464	20141111	CTD	MESH:D060754	Equol results in increased cleavage of CASP7 protein	PMID:18973749
1298347	CASP7	caspase 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CASP7 mRNA	PMID:28628672
1298347	CASP7	caspase 7	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1553182	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of CASP7 mRNA	PMID:34813904
1298347	CASP7	caspase 7	gene	CHEBI:34873	N-nitrosodiethylamine	increases activity	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased activity of CASP7 protein	PMID:21167249
1298347	CASP7	caspase 7	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D004052	CLOCK protein promotes the reaction [Diethylnitrosamine results in increased activity of CASP7 protein]	PMID:21167249
1298347	CASP7	caspase 7	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:620944	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CASP7 mRNA	PMID:22546817
1298347	CASP7	caspase 7	gene	CHEBI:34887	nickel dichloride	increases activity	ISO	RGD:620944	E	RGD:6480464	20120613	CTD	MESH:C022838	nickel chloride results in increased activity of CASP7 protein	PMID:21843586
1298347	CASP7	caspase 7	gene	CHEBI:34887	nickel dichloride	increases cleavage	EXP		E	RGD:6480464	20151110	CTD	MESH:C022838	nickel chloride results in increased cleavage of CASP7 protein	PMID:21828359|PMID:22172632|PMID:28552779
1298347	CASP7	caspase 7	gene	CHEBI:34887	nickel dichloride	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:C022838	cobaltous chloride promotes the reaction [nickel chloride results in increased cleavage of CASP7 protein]; nickel chloride promotes the reaction [cobaltous chloride results in increased cleavage of CASP7 protein]	PMID:22172632
1298347	CASP7	caspase 7	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20120613	CTD	MESH:C022838	pyrazolanthrone inhibits the reaction [nickel chloride results in increased activity of CASP7 protein]	PMID:21843586
1298347	CASP7	caspase 7	gene	CHEBI:34905	paraquat	increases activity	EXP		E	RGD:6480464	20150310	CTD	MESH:D010269	Paraquat results in increased activity of CASP7 protein	PMID:24866057
1298347	CASP7	caspase 7	gene	CHEBI:34905	paraquat	increases activity	ISO	RGD:620944	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in increased activity of CASP7 protein	PMID:17324951|PMID:22678742
1298347	CASP7	caspase 7	gene	CHEBI:34905	paraquat	increases cleavage	ISO	RGD:620944	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased cleavage of CASP7 protein	PMID:38379848
1298347	CASP7	caspase 7	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of CASP7 mRNA	PMID:18836921
1298347	CASP7	caspase 7	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D010269	CAT protein inhibits the reaction [Paraquat results in increased activity of CASP7 protein]	PMID:24866057
1298347	CASP7	caspase 7	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20130416	CTD	MESH:D010269	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Paraquat results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [Paraquat results in increased cleavage of CASP7 protein]; NFE2L2 mutant form inhibits the reaction [Paraquat results in increased activity of CASP7 protein]	PMID:22678742|PMID:38379848
1298347	CASP7	caspase 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CASP7 mRNA	PMID:37042841
1298347	CASP7	caspase 7	gene	CHEBI:35154	manganese(0)	increases activity	ISO	RGD:620944	E	RGD:6480464	20121113	CTD	MESH:D008345	Manganese results in increased activity of CASP7 protein	PMID:22427945
1298347	CASP7	caspase 7	gene	CHEBI:35299	dibenz[a,h]anthracene	increases activity	ISO	RGD:620944	E	RGD:6480464	20191112	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased activity of CASP7 protein	PMID:31368503
1298347	CASP7	caspase 7	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:620944	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of CASP7 mRNA	PMID:25380136
1298347	CASP7	caspase 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CASP7 mRNA	PMID:12160620|PMID:19426795|PMID:38568856
1298347	CASP7	caspase 7	gene	CHEBI:35456	cadmium dichloride	increases activity	EXP		E	RGD:6480464	20150414	CTD	MESH:D019256	Cadmium Chloride results in increased activity of CASP7 protein	PMID:17943274
1298347	CASP7	caspase 7	gene	CHEBI:35456	cadmium dichloride	increases activity	ISO	RGD:1553182	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased activity of CASP7 protein	PMID:26026611
1298347	CASP7	caspase 7	gene	CHEBI:35456	cadmium dichloride	increases activity	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased activity of CASP7 protein	PMID:16478757
1298347	CASP7	caspase 7	gene	CHEBI:35456	cadmium dichloride	increases cleavage	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased cleavage of CASP7 protein	PMID:26046303
1298347	CASP7	caspase 7	gene	CHEBI:35456	cadmium dichloride	increases cleavage	ISO	RGD:1553182	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased cleavage of CASP7 protein	PMID:26046303
1298347	CASP7	caspase 7	gene	CHEBI:35456	cadmium dichloride	increases cleavage	ISO	RGD:620944	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased cleavage of CASP7 protein	PMID:23405080|PMID:26046303
1298347	CASP7	caspase 7	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1553182	E	RGD:6480464	20150414	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CASP7 mRNA	PMID:25409916
1298347	CASP7	caspase 7	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:620944	E	RGD:6480464	20191210	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CASP7 protein modified form	PMID:31348969
1298347	CASP7	caspase 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240109	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP7 protein; Sirolimus inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP7 protein]	PMID:26046303|PMID:37300854
1298347	CASP7	caspase 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20150414	CTD	MESH:D019256	[Cadmium Chloride co-treated with Potassium Dichromate] results in increased expression of CASP7 mRNA; ACHE mutant form inhibits the reaction [Cadmium Chloride results in increased activity of CASP7 protein]; APP mutant form inhibits the reaction [Cadmium Chloride results in increased activity of CASP7 protein]; CHRM1 mutant form promotes the reaction [Cadmium Chloride results in increased activity of CASP7 protein]; GSK3B mutant form inhibits the reaction [Cadmium Chloride results in increased activity of CASP7 protein]; Sirolimus inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP7 protein]	PMID:25409916|PMID:26026611|PMID:26046303
1298347	CASP7	caspase 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20150825	CTD	MESH:D019256	Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP7 protein]; DDIT3 protein promotes the reaction [Cadmium Chloride results in increased expression of CASP7 protein modified form]; pyrazolanthrone inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP7 protein]; Sirolimus inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP7 protein]	PMID:23405080|PMID:26046303|PMID:31348969
1298347	CASP7	caspase 7	gene	CHEBI:35696	cobalt dichloride	increases cleavage	EXP		E	RGD:6480464	20151110	CTD	MESH:C018021	cobaltous chloride results in increased cleavage of CASP7 protein	PMID:22172632
1298347	CASP7	caspase 7	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CASP7 mRNA	PMID:19376846
1298347	CASP7	caspase 7	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:C018021	cobaltous chloride promotes the reaction [nickel chloride results in increased cleavage of CASP7 protein]; nickel chloride promotes the reaction [cobaltous chloride results in increased cleavage of CASP7 protein]	PMID:22172632
1298347	CASP7	caspase 7	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	ISO	RGD:620944	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of CASP7 mRNA	PMID:25380136
1298347	CASP7	caspase 7	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CASP7 mRNA	PMID:24449571
1298347	CASP7	caspase 7	gene	CHEBI:3638	chloroquine	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D002738	Chloroquine promotes the reaction [usnic acid results in increased activity of CASP7 protein]	PMID:25078063
1298347	CASP7	caspase 7	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20260113	CTD	MESH:D002738	Chloroquine promotes the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased cleavage of CASP7 protein]	PMID:40049439
1298347	CASP7	caspase 7	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CASP7 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CASP7 mRNA	PMID:32699268
1298347	CASP7	caspase 7	gene	CHEBI:3699	cimetidine	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D002927	Cimetidine results in increased activity of CASP7 protein	PMID:17273750
1298347	CASP7	caspase 7	gene	CHEBI:37187	lead nitrate	decreases expression	ISO	RGD:1553182	E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate results in decreased expression of CASP7 mRNA	PMID:11891201
1298347	CASP7	caspase 7	gene	CHEBI:37187	lead nitrate	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate affects the reaction [CASP7 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CASP7 affects the expression of MT2 mRNA]	PMID:11891201
1298347	CASP7	caspase 7	gene	CHEBI:37397	chondroitin sulfate	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D002809	[Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of CASP7 protein]; [Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CASP7 mRNA]	PMID:17879260
1298347	CASP7	caspase 7	gene	CHEBI:3766	clozapine	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D003024	Clozapine results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:3766	clozapine	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D003024	Palmitic Acid promotes the reaction [Clozapine results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:38119	brassinin	increases activity	EXP		E	RGD:6480464	20140909	CTD	MESH:C089020	brassinin analog results in increased activity of CASP7 protein	PMID:24747292
1298347	CASP7	caspase 7	gene	CHEBI:38221	fumonisin B1	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:C056933	[fumonisin B1 results in decreased chemical synthesis of Ceramides] which results in decreased expression of CASP7 protein modified form	PMID:25195822
1298347	CASP7	caspase 7	gene	CHEBI:38319	usnic acid	decreases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in decreased expression of CASP7 mRNA	PMID:32508146
1298347	CASP7	caspase 7	gene	CHEBI:38319	usnic acid	increases activity	EXP		E	RGD:6480464	20150714	CTD	MESH:C073339	usnic acid results in increased activity of CASP7 protein	PMID:25078063|PMID:25870318|PMID:38724177
1298347	CASP7	caspase 7	gene	CHEBI:38319	usnic acid	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:C073339	3-methyladenine promotes the reaction [usnic acid results in increased activity of CASP7 protein]; 4-phenylbutyric acid inhibits the reaction [usnic acid results in increased activity of CASP7 protein]; Chloroquine promotes the reaction [usnic acid results in increased activity of CASP7 protein]; pyrazolanthrone promotes the reaction [usnic acid results in increased activity of CASP7 protein]	PMID:25078063|PMID:25870318
1298347	CASP7	caspase 7	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1553182	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CASP7 mRNA	PMID:40194260
1298347	CASP7	caspase 7	gene	CHEBI:38518	benzophenanthridine	increases activity	EXP		E	RGD:6480464	20170117	CTD	MESH:D053119	Benzophenanthridines analog results in increased activity of CASP7 protein	PMID:23117580
1298347	CASP7	caspase 7	gene	CHEBI:38635	3-methyladenine	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C025946	3-methyladenine results in increased activity of CASP7 protein	PMID:20371669
1298347	CASP7	caspase 7	gene	CHEBI:38635	3-methyladenine	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:C025946	3-methyladenine promotes the reaction [usnic acid results in increased activity of CASP7 protein]	PMID:25078063
1298347	CASP7	caspase 7	gene	CHEBI:38635	3-methyladenine	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20260113	CTD	MESH:C025946	3-methyladenine inhibits the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased cleavage of CASP7 protein]	PMID:40049439
1298347	CASP7	caspase 7	gene	CHEBI:38940	sunitinib	increases cleavage	EXP		E	RGD:6480464	20170303	CTD	MESH:C473478	sunitinib results in increased cleavage of CASP7 protein	PMID:21906609
1298347	CASP7	caspase 7	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CASP7 mRNA	PMID:31533062
1298347	CASP7	caspase 7	gene	CHEBI:38940	sunitinib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C473478	AICA ribonucleotide inhibits the reaction [sunitinib results in increased cleavage of CASP7 protein]; Metformin inhibits the reaction [sunitinib results in increased cleavage of CASP7 protein]	PMID:21906609
1298347	CASP7	caspase 7	gene	CHEBI:3908	coumestrol	increases expression	ISO	RGD:620944	E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of CASP7 protein	PMID:19165469
1298347	CASP7	caspase 7	gene	CHEBI:39106	pyrene	increases activity	ISO	RGD:620944	E	RGD:6480464	20191112	CTD	MESH:C030984	pyrene results in increased activity of CASP7 protein	PMID:31368503
1298347	CASP7	caspase 7	gene	CHEBI:39353	fenpropathrin	increases expression	ISO	RGD:620944	E	RGD:6480464	20241001	CTD	MESH:C044267	fenpropathrin results in increased expression of CASP7 mRNA	PMID:38369055
1298347	CASP7	caspase 7	gene	CHEBI:39353	fenpropathrin	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20241001	CTD	MESH:C044267	Chitosan promotes the reaction [Curcumin inhibits the reaction [fenpropathrin results in increased expression of CASP7 mRNA]]; Curcumin inhibits the reaction [fenpropathrin results in increased expression of CASP7 mRNA]	PMID:38369055
1298347	CASP7	caspase 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CASP7 mRNA	PMID:36331819
1298347	CASP7	caspase 7	gene	CHEBI:3944	cucurbitacin E	increases cleavage	EXP		E	RGD:6480464	20161025	CTD	MESH:C102326	cucurbitacin E results in increased cleavage of CASP7 protein	PMID:27106530
1298347	CASP7	caspase 7	gene	CHEBI:3944	cucurbitacin E	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C102326	acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [cucurbitacin E results in increased cleavage of CASP7 protein]; Acetylcysteine inhibits the reaction [cucurbitacin E results in increased cleavage of CASP7 protein]	PMID:27106530
1298347	CASP7	caspase 7	gene	CHEBI:3947	cucurbitacin I	increases cleavage	EXP		E	RGD:6480464	20141223	CTD	MESH:C038106	cucurbitacin I results in increased cleavage of CASP7 protein	PMID:24858077
1298347	CASP7	caspase 7	gene	CHEBI:39483	sodium dichromate	increases activity	ISO	RGD:1553182	E	RGD:6480464	20120918	CTD	MESH:C016104	sodium bichromate results in increased activity of CASP7 protein	PMID:20298709
1298347	CASP7	caspase 7	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1553182	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of CASP7 mRNA	PMID:31558096
1298347	CASP7	caspase 7	gene	CHEBI:39483	sodium dichromate	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120918	CTD	MESH:C016104	CAT protein inhibits the reaction [sodium bichromate results in increased activity of CASP7 protein]; TRP53 mutant form inhibits the reaction [sodium bichromate results in increased activity of CASP7 protein]	PMID:20298709
1298347	CASP7	caspase 7	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of CASP7 mRNA	PMID:16101141
1298347	CASP7	caspase 7	gene	CHEBI:3962	curcumin	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:D003474	Curcumin results in increased expression of CASP7 protein	PMID:31628941
1298347	CASP7	caspase 7	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	[Calcitriol co-treated with Curcumin] promotes the reaction [Paclitaxel results in increased expression of CASP7 protein]; [Curcumin co-treated with Sirolimus] results in increased activity of CASP7 protein; Calcitriol inhibits the reaction [Curcumin inhibits the reaction [Paclitaxel results in increased expression of CASP7 protein]]; Curcumin inhibits the reaction [Calcitriol inhibits the reaction [Paclitaxel results in increased expression of CASP7 protein]]; Curcumin inhibits the reaction [Paclitaxel results in increased expression of CASP7 protein]; Curcumin results in increased cleavage of and results in increased activity of CASP7 protein	PMID:16023083|PMID:19373661|PMID:31628941
1298347	CASP7	caspase 7	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20241001	CTD	MESH:D003474	Chitosan promotes the reaction [Curcumin inhibits the reaction [fenpropathrin results in increased expression of CASP7 mRNA]]; Curcumin inhibits the reaction [fenpropathrin results in increased expression of CASP7 mRNA]	PMID:38369055
1298347	CASP7	caspase 7	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CASP7 mRNA	PMID:25979313
1298347	CASP7	caspase 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CASP7 mRNA	PMID:23179753|PMID:24935251|PMID:27188386
1298347	CASP7	caspase 7	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D014635	Valproic Acid inhibits the reaction [Oxidopamine results in increased cleavage of CASP7 protein]	PMID:32167238
1298347	CASP7	caspase 7	gene	CHEBI:4031	cyclosporin A	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D016572	Cyclosporine results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CASP7 mRNA	PMID:20106945
1298347	CASP7	caspase 7	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D016572	Palmitic Acid promotes the reaction [Cyclosporine results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20260113	CTD	MESH:D016572	Cyclosporine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased cleavage of CASP7 protein]	PMID:40348119
1298347	CASP7	caspase 7	gene	CHEBI:4042	cypermethrin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C017160	cypermethrin results in increased expression of CASP7 mRNA	PMID:27704156
1298347	CASP7	caspase 7	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20120918	CTD	MESH:C017160	cypermethrin results in increased cleavage of and results in increased activity of CASP7 protein	PMID:22048644
1298347	CASP7	caspase 7	gene	CHEBI:40618	aminoguanidine	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C004479	pimagedine inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP7 protein]	PMID:33930484
1298347	CASP7	caspase 7	gene	CHEBI:41423	celecoxib	affects activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C105934	Celecoxib analog affects the activity of CASP7 protein	PMID:18485224
1298347	CASP7	caspase 7	gene	CHEBI:41423	celecoxib	increases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C105934	Celecoxib results in increased activity of CASP7; Celecoxib results in increased activity of CASP7 protein	PMID:18202791|PMID:18485224
1298347	CASP7	caspase 7	gene	CHEBI:41423	celecoxib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C105934	Celecoxib results in increased cleavage of and results in increased activity of CASP7 protein; TNFSF10 protein promotes the reaction [Celecoxib results in increased cleavage of and results in increased activity of CASP7 protein]	PMID:15572759
1298347	CASP7	caspase 7	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	EXP		E	RGD:6480464	20140909	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [Sertraline results in increased activity of CASP7 protein]; 4-phenylbutyric acid inhibits the reaction [usnic acid results in increased activity of CASP7 protein]	PMID:24865413|PMID:25870318
1298347	CASP7	caspase 7	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20210504	CTD	MESH:C075773	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of CASP7 protein]]; 4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of CASP7 protein]	PMID:33771661
1298347	CASP7	caspase 7	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20220208	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of CASP7 protein]; 4-phenylbutyric acid inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased cleavage of CASP7 protein]	PMID:33922211|PMID:40368022
1298347	CASP7	caspase 7	gene	CHEBI:41607	crotonaldehyde	increases activity	ISO	RGD:620944	E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in increased activity of CASP7 protein	PMID:23535401
1298347	CASP7	caspase 7	gene	CHEBI:41688	crystal violet	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:D005840	Gentian Violet results in increased cleavage of and results in increased activity of CASP7 protein	PMID:26177467
1298347	CASP7	caspase 7	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CASP7 mRNA	PMID:14699072
1298347	CASP7	caspase 7	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in decreased expression of CASP7 mRNA; Tamoxifen promotes the reaction [methylselenic acid results in increased cleavage of CASP7 protein]	PMID:18790785|PMID:19059307
1298347	CASP7	caspase 7	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CASP7 mRNA	PMID:28628672
1298347	CASP7	caspase 7	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone inhibits the reaction [TGFB1 protein results in increased activity of CASP7 protein]	PMID:15388240
1298347	CASP7	caspase 7	gene	CHEBI:42068	idarubicin	increases expression	ISO	RGD:1553182	E	RGD:6480464	20240806	CTD	MESH:D015255	Idarubicin results in increased expression of CASP7 mRNA	PMID:34787021
1298347	CASP7	caspase 7	gene	CHEBI:42567	fisetin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C017875	[Cisplatin co-treated with fisetin] promotes the reaction [CASP9 protein results in increased cleavage of CASP7 protein]; fisetin promotes the reaction [CASP9 protein results in increased cleavage of CASP7 protein]	PMID:21216935
1298347	CASP7	caspase 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases activity	EXP		E	RGD:6480464	20120515	CTD	MESH:D017313	Fenretinide results in increased activity of CASP7 protein	PMID:16675469|PMID:20022965
1298347	CASP7	caspase 7	gene	CHEBI:42725	3-methyl-3H-imidazo[4,5-f]quinolin-2-amine	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C029216	2-amino-3-methylimidazo(4,5-f)quinoline results in increased expression of CASP7 mRNA	PMID:35985368
1298347	CASP7	caspase 7	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C107676	deguelin metabolite results in increased expression of CASP7 protein modified form; deguelin results in increased expression of CASP7 protein modified form	PMID:19139008
1298347	CASP7	caspase 7	gene	CHEBI:44185	methotrexate	increases cleavage	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased cleavage of CASP7 protein	PMID:18483502|PMID:24967384
1298347	CASP7	caspase 7	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of CASP7 mRNA	PMID:21678067
1298347	CASP7	caspase 7	gene	CHEBI:44185	methotrexate	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	[Methotrexate co-treated with CDKN1A protein] results in increased cleavage of CASP7 protein; [Methotrexate co-treated with CDKN1A protein] results in increased expression of CASP7 mRNA; ESRRA protein inhibits the reaction [Methotrexate results in increased cleavage of CASP7 protein]	PMID:18483502|PMID:24967384
1298347	CASP7	caspase 7	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1553182	E	RGD:6480464	20161025	CTD	MESH:D006918	Hydroxyurea results in increased expression of CASP7 mRNA	PMID:27208086
1298347	CASP7	caspase 7	gene	CHEBI:44442	6-(cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C475622	4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine promotes the reaction [1-(3-((2-(dimethylamino)ethyl)carbamoyl)phenyl)-3-(4-(bis(2-chloroethyl)amino)phenyl)urea results in increased cleavage of CASP7 protein]	PMID:26208482
1298347	CASP7	caspase 7	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CASP7 mRNA	PMID:38832940
1298347	CASP7	caspase 7	gene	CHEBI:44658	okadaic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019319	Okadaic Acid results in increased cleavage of and results in increased activity of CASP7 protein	PMID:19084044
1298347	CASP7	caspase 7	gene	CHEBI:4466	dexmedetomidine	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D020927	Dexmedetomidine results in increased activity of CASP7 protein	PMID:18724006
1298347	CASP7	caspase 7	gene	CHEBI:45716	vorinostat	increases cleavage	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased cleavage of CASP7 protein	PMID:15897598
1298347	CASP7	caspase 7	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[decitabine co-treated with vorinostat] affects the expression of CASP7 mRNA	PMID:17330099
1298347	CASP7	caspase 7	gene	CHEBI:45863	paclitaxel	increases activity	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased activity of CASP7 protein	PMID:22302033
1298347	CASP7	caspase 7	gene	CHEBI:45863	paclitaxel	increases cleavage	EXP		E	RGD:6480464	20170207	CTD	MESH:D017239	Paclitaxel results in increased cleavage of CASP7 protein	PMID:27664577
1298347	CASP7	caspase 7	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of CASP7 mRNA; Paclitaxel results in increased expression of CASP7 protein	PMID:18058816|PMID:31433962|PMID:31628941
1298347	CASP7	caspase 7	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	[Calcitriol co-treated with Curcumin] promotes the reaction [Paclitaxel results in increased expression of CASP7 protein]; [Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased activity of CASP7 protein; [Resveratrol co-treated with Paclitaxel] results in increased cleavage of and results in increased activity of CASP7 protein; [Sirolimus co-treated with Paclitaxel] results in increased cleavage of CASP7 protein; Calcitriol inhibits the reaction [Curcumin inhibits the reaction [Paclitaxel results in increased expression of CASP7 protein]]; Calcitriol inhibits the reaction [Paclitaxel results in increased expression of CASP7 protein]; Curcumin inhibits the reaction [Calcitriol inhibits the reaction [Paclitaxel results in increased expression of CASP7 protein]]; Curcumin inhibits the reaction [Paclitaxel results in increased expression of CASP7 protein]; palbociclib inhibits the reaction [Paclitaxel results in increased activity of CASP7 protein]	PMID:14749477|PMID:15753396|PMID:16168113|PMID:22302033|PMID:31628941
1298347	CASP7	caspase 7	gene	CHEBI:46024	trichostatin A	decreases expression	ISO	RGD:620944	E	RGD:6480464	20140211	CTD	MESH:C012589	trichostatin A results in decreased expression of CASP7 mRNA	PMID:23558232
1298347	CASP7	caspase 7	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CASP7 mRNA	PMID:24935251
1298347	CASP7	caspase 7	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C012589	[Bortezomib co-treated with trichostatin A] results in increased cleavage of and results in increased activity of CASP7 protein	PMID:16904634
1298347	CASP7	caspase 7	gene	CHEBI:4609	Dimethyl phthalate	increases expression	ISO	RGD:620944	E	RGD:6480464	20230905	CTD	MESH:C024629	dimethyl phthalate results in increased expression of CASP7 mRNA	PMID:35598668
1298347	CASP7	caspase 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CASP7 mRNA	PMID:17562736
1298347	CASP7	caspase 7	gene	CHEBI:46195	paracetamol	decreases activity	EXP		E	RGD:6480464	20140909	CTD	MESH:D000082	Acetaminophen results in decreased activity of CASP7 protein	PMID:24912781
1298347	CASP7	caspase 7	gene	CHEBI:4631	diosmin	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20141111	CTD	MESH:D004145	Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased activity of CASP7 protein]	PMID:23665045
1298347	CASP7	caspase 7	gene	CHEBI:46345	5-fluorouracil	increases cleavage	EXP		E	RGD:6480464	20160119	CTD	MESH:D005472	Fluorouracil results in increased cleavage of CASP7 protein	PMID:26544897
1298347	CASP7	caspase 7	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D005472	Fluorouracil results in increased expression of CASP7 mRNA	PMID:34151400
1298347	CASP7	caspase 7	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	[Doxorubicin co-treated with Paclitaxel co-treated with Fluorouracil] results in increased activity of CASP7 protein	PMID:16168113
1298347	CASP7	caspase 7	gene	CHEBI:4653	dipyridamole	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D004176	Dipyridamole results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:4653	dipyridamole	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D004176	Palmitic Acid promotes the reaction [Dipyridamole results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:46557	zoledronic acid	increases activity	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased activity of CASP7 protein	PMID:19825521
1298347	CASP7	caspase 7	gene	CHEBI:46557	zoledronic acid	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	[Tretinoin co-treated with zoledronic acid] results in increased activity of CASP7 protein; [zoledronic acid co-treated with Gossypol] results in increased activity of CASP7 protein	PMID:19825521|PMID:20349282
1298347	CASP7	caspase 7	gene	CHEBI:4659	disulfiram	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D004221	Disulfiram results in increased activity of CASP7 protein	PMID:17026967
1298347	CASP7	caspase 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases activity	EXP		E	RGD:6480464	20180515	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP7 protein	PMID:29129777
1298347	CASP7	caspase 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C039961	alpha-Tocopherol inhibits the reaction [S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP7 protein]	PMID:29129777
1298347	CASP7	caspase 7	gene	CHEBI:46666	crocidolite asbestos	increases activity	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased activity of CASP7 protein	PMID:19783790
1298347	CASP7	caspase 7	gene	CHEBI:46742	Nutlin-3	increases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C482205	nutlin 3 results in increased activity of CASP7 protein	PMID:22260869
1298347	CASP7	caspase 7	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of CASP7 protein; TP53 mutant form inhibits the reaction [nutlin 3 results in increased activity of CASP7 protein]	PMID:22260869|PMID:38460933
1298347	CASP7	caspase 7	gene	CHEBI:46932	dihydrocapsaicin	increases activity	EXP		E	RGD:6480464	20120613	CTD	MESH:C012906	dihydrocapsaicin results in increased activity of CASP7 protein	PMID:19139269
1298347	CASP7	caspase 7	gene	CHEBI:47499	imipramine	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D007099	Imipramine results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:47499	imipramine	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D007099	Palmitic Acid promotes the reaction [Imipramine results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:620944	E	RGD:6480464	20160412	CTD	MESH:D007654	Ketoconazole results in increased expression of CASP7 mRNA	PMID:25808816
1298347	CASP7	caspase 7	gene	CHEBI:47575	ABT-737	increases activity	EXP		E	RGD:6480464	20210504	CTD	MESH:C501332	ABT-737 results in increased activity of CASP7 protein	PMID:20038611
1298347	CASP7	caspase 7	gene	CHEBI:4776	ellipticine	multiple interactions	EXP		E	RGD:6480464	20140415	CTD	MESH:C034192	Acetylcysteine inhibits the reaction [ellipticine results in increased cleavage of and results in increased activity of CASP7 protein]; Butylated Hydroxyanisole inhibits the reaction [ellipticine results in increased cleavage of and results in increased activity of CASP7 protein]; ellipticine results in increased cleavage of and results in increased activity of CASP7 protein; pyrazolanthrone inhibits the reaction [ellipticine results in increased cleavage of and results in increased activity of CASP7 protein]; U 0126 inhibits the reaction [ellipticine results in increased cleavage of and results in increased activity of CASP7 protein]	PMID:21843585
1298347	CASP7	caspase 7	gene	CHEBI:47780	clomipramine	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D002997	Clomipramine results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:47780	clomipramine	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D002997	Palmitic Acid promotes the reaction [Clomipramine results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:47807	sulforaphane	increases activity	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:C016766	sulforaphane results in increased activity of CASP7 protein	PMID:17942926
1298347	CASP7	caspase 7	gene	CHEBI:4791	endosulfan	increases activity	EXP		E	RGD:6480464	20120918	CTD	MESH:D004726	Endosulfan results in increased activity of CASP7 protein	PMID:20361990
1298347	CASP7	caspase 7	gene	CHEBI:4791	endosulfan	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D004726	benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Endosulfan results in increased activity of CASP7 protein]	PMID:20361990
1298347	CASP7	caspase 7	gene	CHEBI:480999	vinorelbine	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:C030852	[Cisplatin co-treated with vinorelbine] results in decreased expression of CASP7 mRNA	PMID:21544650
1298347	CASP7	caspase 7	gene	CHEBI:4811	epoxiconazole	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20180515	CTD	MESH:C109476	[cyproconazole co-treated with epoxiconazole] results in increased expression of CASP7 mRNA	PMID:29038839
1298347	CASP7	caspase 7	gene	CHEBI:48607	lithium chloride	multiple interactions	EXP		E	RGD:6480464	20181113	CTD	MESH:D018021	Lithium Chloride inhibits the reaction [hydroquinone results in increased expression of CASP7 protein modified form]	PMID:28886972
1298347	CASP7	caspase 7	gene	CHEBI:48843	disodium selenite	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite affects the expression of CASP7 mRNA	PMID:16705456
1298347	CASP7	caspase 7	gene	CHEBI:48843	disodium selenite	increases cleavage	EXP		E	RGD:6480464	20170613	CTD	MESH:D018038	Sodium Selenite results in increased cleavage of CASP7 protein	PMID:28161410
1298347	CASP7	caspase 7	gene	CHEBI:48843	disodium selenite	multiple interactions	EXP		E	RGD:6480464	20170613	CTD	MESH:D018038	Sodium Selenite inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]	PMID:28161410
1298347	CASP7	caspase 7	gene	CHEBI:490095	esculetin	increases cleavage	EXP		E	RGD:6480464	20200609	CTD	MESH:C007628	esculetin results in increased cleavage of CASP7 protein	PMID:31313495
1298347	CASP7	caspase 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CASP7 mRNA	PMID:17557909
1298347	CASP7	caspase 7	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CASP7 mRNA	PMID:17942748
1298347	CASP7	caspase 7	gene	CHEBI:4909	etodolac	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D017308	Etodolac results in increased activity of CASP7 protein	PMID:16046235
1298347	CASP7	caspase 7	gene	CHEBI:4911	etoposide	increases activity	EXP		E	RGD:6480464	20160210	CTD	MESH:D005047	Etoposide results in increased activity of CASP7 protein	PMID:18056177|PMID:20299546|PMID:21801448|PMID:22302033|PMID:26259609
1298347	CASP7	caspase 7	gene	CHEBI:4911	etoposide	increases activity	ISO	RGD:1553182	E	RGD:6480464	20121009	CTD	MESH:D005047	Etoposide results in increased activity of CASP7 protein	PMID:22275372
1298347	CASP7	caspase 7	gene	CHEBI:4911	etoposide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	[STAT1 protein results in increased activity of CASP7 protein] which results in increased susceptibility to Etoposide; benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [Etoposide results in increased activity of CASP7 protein]; palbociclib inhibits the reaction [Etoposide results in increased activity of CASP7 protein]; pifithrin promotes the reaction [Etoposide results in increased activity of CASP7 protein]; Tetrachlorodibenzodioxin inhibits the reaction [Etoposide results in increased activity of CASP7 protein]; TP73 mutant form inhibits the reaction [Etoposide results in increased activity of CASP7 protein]	PMID:18056177|PMID:18649362|PMID:20299546|PMID:21801448|PMID:22302033|PMID:26259609
1298347	CASP7	caspase 7	gene	CHEBI:4911	etoposide	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20121009	CTD	MESH:D005047	2-tert-butylhydroquinone inhibits the reaction [Etoposide results in increased activity of CASP7 protein]	PMID:22275372
1298347	CASP7	caspase 7	gene	CHEBI:4917	eugenol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D005054	Eugenol results in increased expression of CASP7 mRNA	PMID:30518369
1298347	CASP7	caspase 7	gene	CHEBI:49553	copper(II) chloride	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:C029892	[prolinedithiocarbamate analog co-treated with cupric chloride] results in increased activity of CASP7 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[prolinedithiocarbamate analog co-treated with cupric chloride] results in increased activity of CASP7 protein]	PMID:21035945
1298347	CASP7	caspase 7	gene	CHEBI:49553	copper(II) chloride	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20120717	CTD	MESH:C029892	[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP7 protein; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP7 protein]; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP7 protein]	PMID:20920558
1298347	CASP7	caspase 7	gene	CHEBI:49603	lapatinib	increases activity	EXP		E	RGD:6480464	20240206	CTD	MESH:C490728	Lapatinib results in increased activity of CASP7 protein	PMID:37788138
1298347	CASP7	caspase 7	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CASP7 mRNA	PMID:28628672
1298347	CASP7	caspase 7	gene	CHEBI:49900	arsenous acid	increases activity	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased activity of CASP7 protein	PMID:12181429|PMID:12883267|PMID:15493360|PMID:16360329|PMID:19771260|PMID:22199276
1298347	CASP7	caspase 7	gene	CHEBI:49900	arsenous acid	increases activity	ISO	RGD:1553182	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased activity of CASP7 protein	PMID:24157283
1298347	CASP7	caspase 7	gene	CHEBI:49900	arsenous acid	increases activity	ISO	RGD:620944	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased activity of CASP7 protein	PMID:20937774|PMID:21145380
1298347	CASP7	caspase 7	gene	CHEBI:49900	arsenous acid	increases cleavage	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased cleavage of CASP7 protein	PMID:12480548|PMID:19695276|PMID:20408844
1298347	CASP7	caspase 7	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Arsenic Trioxide co-treated with apatinib] results in increased cleavage of CASP7 protein; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Arsenic Trioxide promotes the reaction [2-Methoxyestradiol results in increased expression of CASP7 protein modified form]	PMID:19771260|PMID:23967052|PMID:39223679
1298347	CASP7	caspase 7	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20191114	CTD	MESH:C032793	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Arsenic Trioxide results in increased cleavage of and results in increased activity of CASP7 protein; DDIT3 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; HSPA5 mutant form inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; pyrazolanthrone inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; Tretinoin promotes the reaction [Arsenic Trioxide results in increased cleavage of CASP7 protein]	PMID:15688020|PMID:24157283
1298347	CASP7	caspase 7	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20191114	CTD	MESH:C032793	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Arsenic Trioxide results in increased activity of CASP7 protein]	PMID:20937774|PMID:21145380
1298347	CASP7	caspase 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine affects the methylation of CASP7 gene] which affects the expression of CASP7 protein; [Decitabine co-treated with Vorinostat] affects the expression of CASP7 mRNA	PMID:17330099|PMID:18649362
1298347	CASP7	caspase 7	gene	CHEBI:50225	razoxane	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D011929	Razoxane results in increased activity of CASP7 protein	PMID:10487526
1298347	CASP7	caspase 7	gene	CHEBI:50292	cadmium sulfate	increases activity	ISO	RGD:1553182	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate results in increased activity of CASP7 protein	PMID:14687664
1298347	CASP7	caspase 7	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120814	CTD	MESH:C037123	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cadmium sulfate results in increased activity of CASP7 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [cadmium sulfate results in increased activity of CASP7 protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [cadmium sulfate results in increased activity of CASP7 protein]	PMID:14687664
1298347	CASP7	caspase 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1553182	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CASP7 mRNA	PMID:25620056
1298347	CASP7	caspase 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1553182	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CASP7 mRNA; Nanotubes, Carbon results in increased expression of CASP7 mRNA	PMID:25554681
1298347	CASP7	caspase 7	gene	CHEBI:5063	fipronil	increases activity	EXP		E	RGD:6480464	20130514	CTD	MESH:C082360	fipronil results in increased activity of CASP7 protein	PMID:17084830
1298347	CASP7	caspase 7	gene	CHEBI:50648	9-cis-retinoic acid	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20191114	CTD	MESH:C103303	[T0901317 co-treated with Alitretinoin] promotes the reaction [Palmitic Acid results in increased activity of CASP7 protein]	PMID:17194744
1298347	CASP7	caspase 7	gene	CHEBI:50659	dronedarone	increases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C118667	dronedarone results in increased activity of CASP7 protein	PMID:23135547
1298347	CASP7	caspase 7	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:620944	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CASP7 mRNA	PMID:30047161
1298347	CASP7	caspase 7	gene	CHEBI:50694	minocycline	decreases expression	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D008911	Minocycline results in decreased expression of CASP7 mRNA	PMID:14998631
1298347	CASP7	caspase 7	gene	CHEBI:50694	minocycline	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D008911	Minocycline results in decreased expression of and results in decreased activity of CASP7 protein	PMID:14998631
1298347	CASP7	caspase 7	gene	CHEBI:50729	mitoxantrone	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D008942	Mitoxantrone results in increased activity of CASP7 protein	PMID:12948851|PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:50729	mitoxantrone	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D008942	Palmitic Acid promotes the reaction [Mitoxantrone results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:50833	cadmium sulfide	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C034939	cadmium sulfide results in decreased expression of CASP7 mRNA	PMID:27866839
1298347	CASP7	caspase 7	gene	CHEBI:50924	sorafenib	increases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C471405	sorafenib results in increased activity of CASP7 protein	PMID:19770576|PMID:20054642
1298347	CASP7	caspase 7	gene	CHEBI:50924	sorafenib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C471405	[sorafenib co-treated with TNFSF10 protein] results in increased cleavage of and results in increased activity of CASP7 protein; sorafenib results in increased cleavage of and results in increased activity of CASP7 protein	PMID:16109713|PMID:17909059
1298347	CASP7	caspase 7	gene	CHEBI:5118	fluoxetine	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D005473	Fluoxetine results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:5118	fluoxetine	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D005473	Palmitic Acid promotes the reaction [Fluoxetine results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:620944	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CASP7 mRNA	PMID:24136188
1298347	CASP7	caspase 7	gene	CHEBI:5138	fluvoxamine	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D016666	Fluvoxamine results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:5138	fluvoxamine	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D016666	Palmitic Acid promotes the reaction [Fluvoxamine results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:5186	fucoxanthin	increases cleavage	EXP		E	RGD:6480464	20120918	CTD	MESH:C025164	fucoxanthin results in increased cleavage of CASP7 protein	PMID:20594983
1298347	CASP7	caspase 7	gene	CHEBI:5186	fucoxanthin	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:C025164	Acetylcysteine inhibits the reaction [fucoxanthin results in increased cleavage of CASP7 protein]	PMID:20594983
1298347	CASP7	caspase 7	gene	CHEBI:52172	nilotinib	increases activity	EXP		E	RGD:6480464	20170228	CTD	MESH:C498826	nilotinib results in increased activity of CASP7 protein	PMID:23707608
1298347	CASP7	caspase 7	gene	CHEBI:52172	nilotinib	increases cleavage	EXP		E	RGD:6480464	20170228	CTD	MESH:C498826	nilotinib results in increased cleavage of CASP7 protein	PMID:23883479
1298347	CASP7	caspase 7	gene	CHEBI:52289	wortmannin	multiple interactions	EXP		E	RGD:6480464	20150127	CTD	MESH:C009687	wortmannin promotes the reaction [ochratoxin A results in increased activity of CASP7 protein]	PMID:25002221
1298347	CASP7	caspase 7	gene	CHEBI:52492	mancozeb	increases activity	EXP		E	RGD:6480464	20140708	CTD	MESH:C013099	mancozeb results in increased activity of CASP7 protein	PMID:22824503
1298347	CASP7	caspase 7	gene	CHEBI:52497	maneb	increases activity	EXP		E	RGD:6480464	20130514	CTD	MESH:D008344	Maneb results in increased activity of CASP7 protein	PMID:22824503
1298347	CASP7	caspase 7	gene	CHEBI:52717	bortezomib	increases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased activity of CASP7 protein	PMID:18342500|PMID:18534018|PMID:20022965|PMID:20524303|PMID:23300809
1298347	CASP7	caspase 7	gene	CHEBI:52717	bortezomib	increases cleavage	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased cleavage of CASP7 protein	PMID:16617327|PMID:31540997
1298347	CASP7	caspase 7	gene	CHEBI:52717	bortezomib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	[Bortezomib co-treated with trichostatin A] results in increased cleavage of and results in increased activity of CASP7 protein; Bortezomib promotes the reaction [ZFAND2A protein affects the cleavage of CASP7 protein]; Bortezomib results in increased cleavage of and results in increased activity of CASP7 protein; SCIO-469 promotes the reaction [Bortezomib results in increased cleavage of CASP7 protein]; ZFAND2A protein affects the reaction [Bortezomib results in increased cleavage of CASP7 protein]	PMID:16024631|PMID:16617327|PMID:16904634|PMID:31540997
1298347	CASP7	caspase 7	gene	CHEBI:5292	geldanamycin	increases activity	EXP		E	RGD:6480464	20141223	CTD	MESH:C001277	geldanamycin results in increased activity of CASP7 protein	PMID:24998639
1298347	CASP7	caspase 7	gene	CHEBI:5292	geldanamycin	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:C001277	Acetylcysteine inhibits the reaction [geldanamycin results in increased activity of CASP7 protein]	PMID:24998639
1298347	CASP7	caspase 7	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CASP7 protein	PMID:23718831
1298347	CASP7	caspase 7	gene	CHEBI:53444	potassium dichromate	increases cleavage	EXP		E	RGD:6480464	20231031	CTD	MESH:D011192	Potassium Dichromate results in increased cleavage of CASP7 protein	PMID:37146930
1298347	CASP7	caspase 7	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1553182	E	RGD:6480464	20150414	CTD	MESH:D011192	Potassium Dichromate results in increased expression of CASP7 mRNA	PMID:25409916
1298347	CASP7	caspase 7	gene	CHEBI:53444	potassium dichromate	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D011192	Acetylcysteine inhibits the reaction [Potassium Dichromate results in increased cleavage of CASP7 protein]	PMID:37146930
1298347	CASP7	caspase 7	gene	CHEBI:53444	potassium dichromate	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20150414	CTD	MESH:D011192	[Cadmium Chloride co-treated with Potassium Dichromate] results in increased expression of CASP7 mRNA	PMID:25409916
1298347	CASP7	caspase 7	gene	CHEBI:5525	gossypin	increases cleavage	EXP		E	RGD:6480464	20240109	CTD	MESH:C022944	gossypin results in increased cleavage of CASP7 protein	PMID:30536456
1298347	CASP7	caspase 7	gene	CHEBI:5623	harman	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C005010	harman results in increased expression of CASP7 mRNA	PMID:35985368
1298347	CASP7	caspase 7	gene	CHEBI:567361	cladribine	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D017338	Cladribine results in increased activity of CASP7 protein	PMID:12948851
1298347	CASP7	caspase 7	gene	CHEBI:567361	cladribine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D017338	Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased activity of CASP7 protein]	PMID:12948851
1298347	CASP7	caspase 7	gene	CHEBI:5981	isoalantolactone	increases cleavage	EXP		E	RGD:6480464	20181113	CTD	MESH:C032787	isoalantolactone results in increased cleavage of CASP7 protein	PMID:29800641
1298347	CASP7	caspase 7	gene	CHEBI:5981	isoalantolactone	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C032787	isoalantolactone results in increased expression of CASP7 protein modified form	PMID:29800641
1298347	CASP7	caspase 7	gene	CHEBI:5981	isoalantolactone	multiple interactions	EXP		E	RGD:6480464	20181113	CTD	MESH:C032787	Acetylcysteine inhibits the reaction [isoalantolactone results in increased expression of CASP7 protein modified form]; benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [isoalantolactone results in increased expression of CASP7 protein modified form]; TNFRSF10B protein promotes the reaction [isoalantolactone results in increased expression of CASP7 protein modified form]	PMID:29800641
1298347	CASP7	caspase 7	gene	CHEBI:6015	isoflurane	increases expression	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D007530	Isoflurane results in increased expression of CASP7 mRNA	PMID:16978161
1298347	CASP7	caspase 7	gene	CHEBI:6015	isoflurane	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D007530	Isoflurane inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP7 protein]	PMID:16249675
1298347	CASP7	caspase 7	gene	CHEBI:60312	2-amino-2-deoxy-D-galactopyranose	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D005688	[Galactosamine co-treated with Lipopolysaccharides] results in increased activity of CASP7 protein; Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased activity of CASP7 protein]	PMID:21146893
1298347	CASP7	caspase 7	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CASP7 protein	PMID:32959892
1298347	CASP7	caspase 7	gene	CHEBI:61076	belinostat	increases cleavage	EXP		E	RGD:6480464	20230801	CTD	MESH:C487081	belinostat results in increased cleavage of CASP7 protein	PMID:25537862
1298347	CASP7	caspase 7	gene	CHEBI:63508	oleandrigenin	increases activity	EXP		E	RGD:6480464	20250603	CTD	MESH:C008701	oleandrigenin results in increased activity of CASP7 protein	PMID:32645647
1298347	CASP7	caspase 7	gene	CHEBI:63580	ribavirin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012254	Ribavirin promotes the reaction [FAS protein results in increased activity of CASP7 protein]	PMID:12760867
1298347	CASP7	caspase 7	gene	CHEBI:63619	propafenone	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D011405	Propafenone results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	[Amlodipine co-treated with Topotecan] results in increased activity of CASP7 protein	PMID:16516327
1298347	CASP7	caspase 7	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases activity	ISO	RGD:620944	E	RGD:2311460|PMID:18316105	20211222	RGD	MESH:D020122	tert-butylhydroperoxide decreases activity of Casp7 protein in hepatocyte cytosol	
1298347	CASP7	caspase 7	gene	CHEBI:64090	tert-butyl hydroperoxide	increases cleavage	EXP		E	RGD:6480464	20161213	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased cleavage of CASP7 protein	PMID:27050144
1298347	CASP7	caspase 7	gene	CHEBI:64090	tert-butyl hydroperoxide	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020122	Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP7 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP7 protein]	PMID:27050144
1298347	CASP7	caspase 7	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases activity	EXP		E	RGD:6480464	20150714	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased activity of CASP7 protein	PMID:24989254
1298347	CASP7	caspase 7	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CASP7 protein	PMID:38685306
1298347	CASP7	caspase 7	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D015655	MIR29A inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of CASP7 protein]	PMID:38685306
1298347	CASP7	caspase 7	gene	CHEBI:64294	7-ketocholesterol	increases activity	EXP		E	RGD:6480464	20160607	CTD	MESH:C003001	7-ketocholesterol results in increased activity of CASP7 protein	PMID:24650663
1298347	CASP7	caspase 7	gene	CHEBI:64294	7-ketocholesterol	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:C003001	Serotonin inhibits the reaction [7-ketocholesterol results in increased activity of CASP7 protein]	PMID:24650663
1298347	CASP7	caspase 7	gene	CHEBI:64310	crizotinib	increases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C551994	crizotinib results in increased activity of CASP7 protein	PMID:23707608
1298347	CASP7	caspase 7	gene	CHEBI:64312	memantine	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D008559	Memantine inhibits the reaction [benzo(e)pyrene results in increased activity of CASP7 protein]; Memantine inhibits the reaction [catechol results in increased activity of CASP7 protein]	PMID:19959636|PMID:20347921
1298347	CASP7	caspase 7	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:620944	E	RGD:6480464	20140812	CTD	MESH:D007545	Isoproterenol results in decreased expression of CASP7 mRNA	PMID:24286936
1298347	CASP7	caspase 7	gene	CHEBI:64317	isoprenaline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D007545	Acetylcysteine inhibits the reaction [Isoproterenol results in increased activity of and results in increased cleavage of CASP7 protein]; Isoproterenol results in increased activity of and results in increased cleavage of CASP7 protein	PMID:17136323
1298347	CASP7	caspase 7	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20211109	CTD	MESH:D007545	[Isoproterenol co-treated with POSTN protein] results in decreased expression of CASP7 mRNA	PMID:30303030
1298347	CASP7	caspase 7	gene	CHEBI:6504	lithium carbonate	increases expression	ISO	RGD:1553182	E	RGD:6480464	20220809	CTD	MESH:D016651	Lithium Carbonate results in increased expression of CASP7 protein	PMID:34984798
1298347	CASP7	caspase 7	gene	CHEBI:65329	LY294002	increases activity	ISO	RGD:620944	E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased activity of CASP7 protein	PMID:16487511
1298347	CASP7	caspase 7	gene	CHEBI:65329	LY294002	increases cleavage	EXP		E	RGD:6480464	20161213	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased cleavage of CASP7 protein	PMID:14688022
1298347	CASP7	caspase 7	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120814	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cadmium sulfate results in increased activity of CASP7 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Chlorpyrifos results in increased cleavage of CASP7 protein]	PMID:14687664|PMID:36252918
1298347	CASP7	caspase 7	gene	CHEBI:6538	loratadine	increases activity	EXP		E	RGD:6480464	20191114	CTD	MESH:D017336	Loratadine results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:6538	loratadine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:D017336	Palmitic Acid promotes the reaction [Loratadine results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:66172	sappanchalcone	increases cleavage	EXP		E	RGD:6480464	20200915	CTD	MESH:C044363	sappanchalcone results in increased cleavage of CASP7 protein	PMID:32590072
1298347	CASP7	caspase 7	gene	CHEBI:66331	xanthohumol	increases activity	EXP		E	RGD:6480464	20190219	CTD	MESH:C104536	xanthohumol results in increased activity of CASP7 protein	PMID:30240731
1298347	CASP7	caspase 7	gene	CHEBI:66331	xanthohumol	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:C104536	xanthohumol results in increased cleavage of and results in increased activity of CASP7 protein	PMID:15995977
1298347	CASP7	caspase 7	gene	CHEBI:6704	mebendazole	increases activity	EXP		E	RGD:6480464	20240206	CTD	MESH:D008463	Mebendazole results in increased activity of CASP7 protein	PMID:37473966
1298347	CASP7	caspase 7	gene	CHEBI:67271	MK-2206	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C548887	[MK 2206 co-treated with platycodin D] results in increased activity of CASP7 protein	PMID:27897231
1298347	CASP7	caspase 7	gene	CHEBI:67521	(-)-gambogic acid	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:C052659	[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]] which affects the cleavage of CASP7 protein; Acetylcysteine affects the reaction [[gambogic acid affects the reaction [ABCB1 protein affects the susceptibility to Doxorubicin]] which affects the cleavage of CASP7 protein]	PMID:25824409
1298347	CASP7	caspase 7	gene	CHEBI:67547	alpha-mangostin	increases activity	EXP		E	RGD:6480464	20140812	CTD	MESH:C021053	mangostin results in increased activity of CASP7 protein	PMID:24480042
1298347	CASP7	caspase 7	gene	CHEBI:67547	alpha-mangostin	multiple interactions	EXP		E	RGD:6480464	20140812	CTD	MESH:C021053	ESR1 protein affects the reaction [mangostin results in increased activity of CASP7 protein]	PMID:24480042
1298347	CASP7	caspase 7	gene	CHEBI:6801	metformin	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D008687	Metformin results in increased activity of CASP7 protein	PMID:21388661
1298347	CASP7	caspase 7	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008687	Cisplatin promotes the reaction [Metformin results in increased activity of CASP7 protein]; Metformin inhibits the reaction [sunitinib results in increased cleavage of CASP7 protein]	PMID:21388661|PMID:21906609
1298347	CASP7	caspase 7	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20190507	CTD	MESH:D008687	dapagliflozin promotes the reaction [Metformin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]]; Metformin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]; Metformin promotes the reaction [dapagliflozin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]]	PMID:30551545
1298347	CASP7	caspase 7	gene	CHEBI:681569	clofarabine	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C068329	[Clofarabine co-treated with Resveratrol] promotes the reaction [BCL2L1 mutant form results in increased activity of CASP7 protein]; [Clofarabine co-treated with Resveratrol] results in increased activity of CASP7 protein; [Resveratrol co-treated with Clofarabine] promotes the reaction [MCL1 mutant form results in increased activity of CASP7 protein]; [Resveratrol co-treated with Clofarabine] results in increased activity of CASP7 protein; BCL2L1 protein affects the reaction [[Clofarabine co-treated with Resveratrol] results in increased activity of CASP7 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[Resveratrol co-treated with Clofarabine] promotes the reaction [MCL1 mutant form results in increased activity of CASP7 protein]]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [[Resveratrol co-treated with Clofarabine] results in increased activity of CASP7 protein]	PMID:24924397|PMID:25408576
1298347	CASP7	caspase 7	gene	CHEBI:6842	methoxychlor	increases activity	ISO	RGD:1553182	E	RGD:6480464	20130611	CTD	MESH:D008731	Methoxychlor results in increased activity of CASP7 protein	PMID:20568958|PMID:22306526
1298347	CASP7	caspase 7	gene	CHEBI:6842	methoxychlor	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20121009	CTD	MESH:D008731	ESR1 gene mutant form promotes the reaction [Methoxychlor results in increased activity of CASP7 protein]	PMID:22306526
1298347	CASP7	caspase 7	gene	CHEBI:68641	(-)-cotinine	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D003367	Cotinine inhibits the reaction [Doxorubicin results in increased activity of CASP7 protein]	PMID:22687995
1298347	CASP7	caspase 7	gene	CHEBI:69074	linderalactone	increases cleavage	EXP		E	RGD:6480464	20250708	CTD	MESH:C477965	linderalactone results in increased cleavage of CASP7 protein	PMID:33066004
1298347	CASP7	caspase 7	gene	CHEBI:69074	linderalactone	multiple interactions	EXP		E	RGD:6480464	20250708	CTD	MESH:C477965	MitoTEMPO inhibits the reaction [linderalactone results in increased cleavage of CASP7 protein]	PMID:33066004
1298347	CASP7	caspase 7	gene	CHEBI:6925	microcystin-LR	increases cleavage	EXP		E	RGD:6480464	20230502	CTD	MESH:C057862	cyanoginosin LR results in increased cleavage of CASP7 protein	PMID:36435412
1298347	CASP7	caspase 7	gene	CHEBI:69355	casticin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C054133	casticin results in increased expression of CASP7 protein	PMID:27862857
1298347	CASP7	caspase 7	gene	CHEBI:69478	cannabidiol	increases cleavage	EXP		E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in increased cleavage of CASP7 protein	PMID:33244087
1298347	CASP7	caspase 7	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in increased expression of CASP7 mRNA; Cannabidiol results in increased expression of CASP7 protein	PMID:34575494
1298347	CASP7	caspase 7	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cannabidiol co-treated with moringin] results in decreased expression of CASP7 mRNA	PMID:30096889
1298347	CASP7	caspase 7	gene	CHEBI:6954	Mitotane	increases activity	EXP		E	RGD:6480464	20191114	CTD	MESH:D008939	Mitotane results in increased activity of CASP7 protein	PMID:23254310
1298347	CASP7	caspase 7	gene	CHEBI:6954	Mitotane	increases expression	ISO	RGD:620944	E	RGD:6480464	20191114	CTD	MESH:D008939	Mitotane results in increased expression of CASP7 mRNA	PMID:23485034
1298347	CASP7	caspase 7	gene	CHEBI:70436	platycodin D	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C108953	[MK 2206 co-treated with platycodin D] results in increased activity of CASP7 protein	PMID:27897231
1298347	CASP7	caspase 7	gene	CHEBI:71019	omacetaxine mepesuccinate	increases cleavage	EXP		E	RGD:6480464	20200714	CTD	MESH:C001652	Homoharringtonine results in increased cleavage of CASP7 protein	PMID:31726078
1298347	CASP7	caspase 7	gene	CHEBI:72564	temozolomide	increases activity	EXP		E	RGD:6480464	20160510	CTD	MESH:C047246	temozolomide results in increased activity of CASP7 protein	PMID:26911376
1298347	CASP7	caspase 7	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CASP7 mRNA	PMID:31758290
1298347	CASP7	caspase 7	gene	CHEBI:72754	bisphenol AF	increases activity	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased activity of CASP7 protein	PMID:39059691
1298347	CASP7	caspase 7	gene	CHEBI:73295	WIN 55212-2	decreases cleavage	EXP		E	RGD:6480464	20190910	CTD	MESH:C070417	(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in decreased cleavage of CASP7 protein	PMID:30776504
1298347	CASP7	caspase 7	gene	CHEBI:73458	NS-398	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20130604	CTD	MESH:C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [cadmium sulfate results in increased activity of CASP7 protein]	PMID:14687664
1298347	CASP7	caspase 7	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1553182	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of CASP7 mRNA	PMID:22206623
1298347	CASP7	caspase 7	gene	CHEBI:74023	dioscin	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C019357	dioscin results in increased expression of CASP7 mRNA	PMID:29990575
1298347	CASP7	caspase 7	gene	CHEBI:74856	antimony trichloride	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20260303	CTD	MESH:C054672	4-phenylbutyric acid inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased cleavage of CASP7 protein]; [antimony trichloride results in increased abundance of Antimony] which results in increased cleavage of CASP7 protein; Acetylcysteine inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased cleavage of CASP7 protein]; pyrazolanthrone inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased cleavage of CASP7 protein]	PMID:40368022
1298347	CASP7	caspase 7	gene	CHEBI:7494	nefazodone	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:C051752	nefazodone results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:7494	nefazodone	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:C051752	Palmitic Acid promotes the reaction [nefazodone results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:749587	bendamustine hydrochloride	increases activity	EXP		E	RGD:6480464	20260721	CTD	MESH:D000069461	Bendamustine Hydrochloride results in increased activity of CASP7 protein	PMID:12948851
1298347	CASP7	caspase 7	gene	CHEBI:749587	bendamustine hydrochloride	multiple interactions	EXP		E	RGD:6480464	20260721	CTD	MESH:D000069461	Cladribine promotes the reaction [Bendamustine Hydrochloride results in increased activity of CASP7 protein]	PMID:12948851
1298347	CASP7	caspase 7	gene	CHEBI:7496	nelfinavir	increases activity	EXP		E	RGD:6480464	20140708	CTD	MESH:D019888	Nelfinavir results in increased activity of CASP7 protein	PMID:20105315
1298347	CASP7	caspase 7	gene	CHEBI:75092	morin	increases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:C008548	morin results in increased activity of CASP7 protein	PMID:24726691
1298347	CASP7	caspase 7	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases activity	EXP		E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of CASP7 protein	PMID:19139269
1298347	CASP7	caspase 7	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CASP7 protein modified form	PMID:25977998
1298347	CASP7	caspase 7	gene	CHEBI:75292	phenanthridone	multiple interactions	EXP		E	RGD:6480464	20200211	CTD	MESH:C040601	[eprenetapopt co-treated with phenanthridone] results in increased cleavage of CASP7 protein	PMID:29416738
1298347	CASP7	caspase 7	gene	CHEBI:75408	sulindac sulfide	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C025462	[sulindac sulfide co-treated with TNF protein] results in increased activity of CASP7 protein; tempol inhibits the reaction [[sulindac sulfide co-treated with TNF protein] results in increased activity of CASP7 protein]	PMID:20371263
1298347	CASP7	caspase 7	gene	CHEBI:754906	afuresertib	increases activity	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased activity of CASP7 protein	PMID:28960945
1298347	CASP7	caspase 7	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	[eprenetapopt co-treated with phenanthridone] results in increased cleavage of CASP7 protein	PMID:29416738
1298347	CASP7	caspase 7	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in increased expression of CASP7 protein modified form	PMID:26116531|PMID:28500234
1298347	CASP7	caspase 7	gene	CHEBI:7553	niclosamide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	bicalutamide promotes the reaction [Niclosamide results in increased expression of CASP7 protein modified form]	PMID:28500234
1298347	CASP7	caspase 7	gene	CHEBI:755540	docetaxel	increases activity	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	Docetaxel results in increased activity of CASP7 protein	PMID:27334972
1298347	CASP7	caspase 7	gene	CHEBI:755540	docetaxel	increases cleavage	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	Docetaxel results in increased cleavage of CASP7 protein	PMID:20404319
1298347	CASP7	caspase 7	gene	CHEBI:755540	docetaxel	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	DLL4 inhibits the reaction [Docetaxel results in increased activity of CASP7 protein]	PMID:27334972
1298347	CASP7	caspase 7	gene	CHEBI:756028	mivebresib	increases cleavage	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in increased cleavage of CASP7 protein	PMID:30647404
1298347	CASP7	caspase 7	gene	CHEBI:7575	nimodipine	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D009553	Nimodipine results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:7575	nimodipine	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D009553	Palmitic Acid promotes the reaction [Nimodipine results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:7581	nitrazepam	multiple interactions	EXP		E	RGD:6480464	20140415	CTD	MESH:D009567	CYP3A4 protein affects the reaction [Nitrazepam results in increased activity of CASP7 protein]	PMID:19005028
1298347	CASP7	caspase 7	gene	CHEBI:75832	iron(2+) sulfate (anhydrous)	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:C020748	[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of CASP7 protein; [Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CASP7 mRNA; [Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased activity of CASP7 protein]; [Hyaluronic Acid co-treated with Chondroitin Sulfates] inhibits the reaction [[Ascorbic Acid co-treated with ferrous sulfate] results in increased expression of CASP7 mRNA]	PMID:17879260
1298347	CASP7	caspase 7	gene	CHEBI:7596	nitroprusside	increases activity	EXP		E	RGD:6480464	20121009	CTD	MESH:D009599	Nitroprusside results in increased activity of CASP7 protein	PMID:22178905
1298347	CASP7	caspase 7	gene	CHEBI:7596	nitroprusside	increases activity	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D009599	Nitroprusside results in increased activity of CASP7 protein	PMID:18311796
1298347	CASP7	caspase 7	gene	CHEBI:7596	nitroprusside	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009599	Nitroprusside results in increased expression of CASP7 mRNA	PMID:15708893
1298347	CASP7	caspase 7	gene	CHEBI:7596	nitroprusside	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D009599	Ursodeoxycholic Acid inhibits the reaction [Nitroprusside results in increased activity of CASP7 protein]	PMID:22178905
1298347	CASP7	caspase 7	gene	CHEBI:7596	nitroprusside	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D009599	cilostazol inhibits the reaction [Nitroprusside results in increased activity of CASP7 protein]	PMID:18311796
1298347	CASP7	caspase 7	gene	CHEBI:75984	flecainide	increases activity	EXP		E	RGD:6480464	20131112	CTD	MESH:D005424	Flecainide results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:75984	flecainide	multiple interactions	EXP		E	RGD:6480464	20131112	CTD	MESH:D005424	Palmitic Acid promotes the reaction [Flecainide results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C560077	[GNAQ gene mutant form results in increased susceptibility to [trametinib co-treated with omipalisib]] which results in increased cleavage of CASP7 protein	PMID:22733540
1298347	CASP7	caspase 7	gene	CHEBI:76359	butylated hydroxyanisole	multiple interactions	EXP		E	RGD:6480464	20140107	CTD	MESH:D002083	Butylated Hydroxyanisole inhibits the reaction [ellipticine results in increased cleavage of and results in increased activity of CASP7 protein]	PMID:21843585
1298347	CASP7	caspase 7	gene	CHEBI:7640	nortriptyline	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D009661	Nortriptyline results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:7640	nortriptyline	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D009661	Palmitic Acid promotes the reaction [Nortriptyline results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:77012	methylseleninic acid	increases cleavage	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased cleavage of CASP7 protein	PMID:16204082|PMID:18790785|PMID:28161410
1298347	CASP7	caspase 7	gene	CHEBI:77012	methylseleninic acid	multiple interactions	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	Acetylcysteine inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; HSPA5 protein inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; methylselenic acid inhibits the reaction [CASP7 protein binds to HSPA5 protein]; Sodium Selenite inhibits the reaction [methylselenic acid results in increased cleavage of CASP7 protein]; Tamoxifen promotes the reaction [methylselenic acid results in increased cleavage of CASP7 protein]	PMID:16204082|PMID:18790785|PMID:28161410
1298347	CASP7	caspase 7	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in decreased expression of CASP7 mRNA	PMID:17316727
1298347	CASP7	caspase 7	gene	CHEBI:7719	ochratoxin A	increases activity	EXP		E	RGD:6480464	20150127	CTD	MESH:C025589	ochratoxin A results in increased activity of CASP7 protein	PMID:25002221
1298347	CASP7	caspase 7	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:620944	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of CASP7 mRNA	PMID:19562491
1298347	CASP7	caspase 7	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20150127	CTD	MESH:C025589	U 0126 inhibits the reaction [ochratoxin A results in increased activity of CASP7 protein]; wortmannin promotes the reaction [ochratoxin A results in increased activity of CASP7 protein]	PMID:25002221
1298347	CASP7	caspase 7	gene	CHEBI:77733	2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20140805	CTD	MESH:D014700	[Verapamil results in decreased expression of ABCB1] promotes the reaction [Doxorubicin results in increased activity of CASP7 protein]	PMID:15861398
1298347	CASP7	caspase 7	gene	CHEBI:78373	chelerythrine	increases cleavage	EXP		E	RGD:6480464	20170613	CTD	MESH:C016299	chelerythrine results in increased cleavage of CASP7 protein	PMID:26124276
1298347	CASP7	caspase 7	gene	CHEBI:78505	venom	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D014757	Viper Venoms results in increased expression of CASP7 mRNA; Viper Venoms results in increased expression of CASP7 protein	PMID:27613483
1298347	CASP7	caspase 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20250708	CTD	MESH:C516138	dorsomorphin inhibits the reaction [O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in increased cleavage of CASP7 protein]; dorsomorphin inhibits the reaction [tetrabromobisphenol A results in increased cleavage of CASP7 protein]	PMID:39586487|PMID:40049439
1298347	CASP7	caspase 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20220208	CTD	MESH:C516138	dorsomorphin inhibits the reaction [2,4-Dichlorophenoxyacetic Acid results in increased cleavage of CASP7 protein]; dorsomorphin inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of CASP7 protein]	PMID:33922211|PMID:39921193
1298347	CASP7	caspase 7	gene	CHEBI:78741	oxidopamine	increases cleavage	EXP		E	RGD:6480464	20210406	CTD	MESH:D016627	Oxidopamine results in increased cleavage of CASP7 protein	PMID:32167238
1298347	CASP7	caspase 7	gene	CHEBI:78741	oxidopamine	increases expression	ISO	RGD:620944	E	RGD:6480464	20161213	CTD	MESH:D016627	Oxidopamine results in increased expression of CASP7 mRNA	PMID:25129099
1298347	CASP7	caspase 7	gene	CHEBI:78741	oxidopamine	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D016627	Valproic Acid inhibits the reaction [Oxidopamine results in increased cleavage of CASP7 protein]	PMID:32167238
1298347	CASP7	caspase 7	gene	CHEBI:78741	oxidopamine	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20161213	CTD	MESH:D016627	Levodopa inhibits the reaction [Oxidopamine results in increased expression of CASP7 mRNA]; Rutin inhibits the reaction [Oxidopamine results in increased expression of CASP7 mRNA]	PMID:25129099
1298347	CASP7	caspase 7	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20140708	CTD	MESH:C020972	[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP7 protein; [cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP7 protein; Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in increased cleavage of CASP7 protein]; MAPK8 protein promotes the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased activity of CASP7 protein]; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP7 protein]	PMID:20920558|PMID:22085843
1298347	CASP7	caspase 7	gene	CHEBI:78886	2-tert-butylhydroquinone	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20140708	CTD	MESH:C018855	2-tert-butylhydroquinone inhibits the reaction [Etoposide results in increased activity of CASP7 protein]	PMID:22275372
1298347	CASP7	caspase 7	gene	CHEBI:79089	ceric oxide	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C030583	ceric oxide analog affects the expression of CASP7 mRNA	PMID:22960666
1298347	CASP7	caspase 7	gene	CHEBI:7983	pentobarbital	increases expression	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D010424	Pentobarbital results in increased expression of CASP7 mRNA	PMID:16978161
1298347	CASP7	caspase 7	gene	CHEBI:80025	Salinomycin	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C010327	salinomycin results in increased expression of CASP7 mRNA	PMID:35914560
1298347	CASP7	caspase 7	gene	CHEBI:80774	tauroursodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C031655	ursodoxicoltaurine inhibits the reaction [SERPINA1 protein mutant form results in increased activity of CASP7 protein]; ursodoxicoltaurine inhibits the reaction [Thapsigargin results in increased activity of CASP7 protein]	PMID:12198651|PMID:17559149
1298347	CASP7	caspase 7	gene	CHEBI:80799	Bufotalin	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:C004600	bufotalin promotes the reaction [TNFSF10 protein results in increased cleavage of CASP7 protein]	PMID:21887462
1298347	CASP7	caspase 7	gene	CHEBI:8081	phentolamine	increases activity	EXP		E	RGD:6480464	20130903	CTD	MESH:D010646	Phentolamine results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:8081	phentolamine	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:D010646	Palmitic Acid promotes the reaction [Phentolamine results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:81068	Shikonin	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20230404	CTD	MESH:C016101	shikonin inhibits the reaction [Benzene results in increased expression of CASP7 mRNA]	PMID:36306860
1298347	CASP7	caspase 7	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	affects activity	ISO	RGD:1553182	E	RGD:6480464	20141111	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl affects the activity of CASP7 protein	PMID:19362103
1298347	CASP7	caspase 7	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1553182	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of CASP7 mRNA	PMID:22434021
1298347	CASP7	caspase 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CASP7 mRNA	PMID:27589474
1298347	CASP7	caspase 7	gene	CHEBI:81758	cyproconazole	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20180515	CTD	MESH:C093628	[cyproconazole co-treated with epoxiconazole] results in increased expression of CASP7 mRNA	PMID:29038839
1298347	CASP7	caspase 7	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1553182	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of CASP7 mRNA	PMID:31558096
1298347	CASP7	caspase 7	gene	CHEBI:82436	decabromodiphenyl ether	increases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased activity of CASP7 protein	PMID:22485137
1298347	CASP7	caspase 7	gene	CHEBI:8499	propranolol	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D011433	Propranolol results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:620944	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CASP7 mRNA	PMID:30047161
1298347	CASP7	caspase 7	gene	CHEBI:85078	dapagliflozin	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20210608	CTD	MESH:C529054	dapagliflozin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]; dapagliflozin promotes the reaction [Metformin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]]; Metformin promotes the reaction [dapagliflozin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]]	PMID:30551545
1298347	CASP7	caspase 7	gene	CHEBI:85993	palbociclib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib inhibits the reaction [Camptothecin results in increased activity of CASP7 protein]; palbociclib inhibits the reaction [Carboplatin results in increased activity of CASP7 protein]; palbociclib inhibits the reaction [Doxorubicin results in increased activity of CASP7 protein]; palbociclib inhibits the reaction [Etoposide results in increased activity of CASP7 protein]; palbociclib inhibits the reaction [Paclitaxel results in increased activity of CASP7 protein]	PMID:22302033
1298347	CASP7	caspase 7	gene	CHEBI:85993	palbociclib	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20170303	CTD	MESH:C500026	[CDKN2A gene mutant form results in increased susceptibility to palbociclib] which affects the activity of CASP7 protein	PMID:24098593
1298347	CASP7	caspase 7	gene	CHEBI:8630	pterostilbene	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C107773	pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP7 protein]	PMID:33930484
1298347	CASP7	caspase 7	gene	CHEBI:8673	pyrimethamine	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D011739	Pyrimethamine results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:8673	pyrimethamine	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D011739	Palmitic Acid promotes the reaction [Pyrimethamine results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of CASP7 mRNA	PMID:14699072
1298347	CASP7	caspase 7	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of CASP7 mRNA	PMID:19059307
1298347	CASP7	caspase 7	gene	CHEBI:88046	cylindrospermopsin	decreases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in decreased expression of CASP7 mRNA	PMID:23726867
1298347	CASP7	caspase 7	gene	CHEBI:88173	brilliant green	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:C006798	brilliant green results in increased cleavage of and results in increased activity of CASP7 protein	PMID:26177467
1298347	CASP7	caspase 7	gene	CHEBI:8863	Riluzole	increases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:D019782	Riluzole results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:8863	Riluzole	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D019782	Palmitic Acid promotes the reaction [Riluzole results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:8871	risperidone	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D018967	Risperidone results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:8871	risperidone	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D018967	Palmitic Acid promotes the reaction [Risperidone results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:90227	selumetinib	increases cleavage	ISO	RGD:1553182	E	RGD:6480464	20170228	CTD	MESH:C517975	AZD 6244 results in increased cleavage of CASP7 protein	PMID:17876044
1298347	CASP7	caspase 7	gene	CHEBI:90227	selumetinib	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20170228	CTD	MESH:C517975	Doxorubicin promotes the reaction [AZD 6244 results in increased cleavage of CASP7 protein]	PMID:17876044
1298347	CASP7	caspase 7	gene	CHEBI:90369	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C550547	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Camptothecin results in increased activity of CASP7 protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [Camptothecin results in increased activity of CASP7 protein]	PMID:24726431
1298347	CASP7	caspase 7	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [ellipticine results in increased cleavage of and results in increased activity of CASP7 protein]; pyrazolanthrone promotes the reaction [dihydromyricetin results in increased cleavage of CASP7 protein]; pyrazolanthrone promotes the reaction [usnic acid results in increased activity of CASP7 protein]	PMID:21843585|PMID:25078063|PMID:27539140
1298347	CASP7	caspase 7	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [arsenic trioxide results in increased activity of CASP7 protein]; pyrazolanthrone inhibits the reaction [TEMPO results in increased activity of CASP7 protein]	PMID:24157283|PMID:25882087
1298347	CASP7	caspase 7	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased cleavage of CASP7 protein]; pyrazolanthrone inhibits the reaction [[antimony trichloride results in increased abundance of Antimony] which results in increased cleavage of CASP7 protein]; pyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in increased cleavage of CASP7 protein]; pyrazolanthrone inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP7 protein]; pyrazolanthrone inhibits the reaction [nickel chloride results in increased activity of CASP7 protein]	PMID:20920558|PMID:21843586|PMID:23405080|PMID:33922211|PMID:40368022
1298347	CASP7	caspase 7	gene	CHEBI:90705	SB 203580	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C093642	SB 203580 inhibits the reaction [DDT results in increased activity of CASP7 protein]	PMID:15603917
1298347	CASP7	caspase 7	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20170303	CTD	MESH:C093642	SB 203580 inhibits the reaction [chloroacetic acid results in increased activity of CASP7 protein]; SB 203580 inhibits the reaction [tetrabromobisphenol A results in increased cleavage of CASP7 protein]	PMID:23103613|PMID:39586487
1298347	CASP7	caspase 7	gene	CHEBI:9123	sertraline	increases activity	EXP		E	RGD:6480464	20140909	CTD	MESH:D020280	Sertraline results in increased activity of CASP7 protein	PMID:24865413
1298347	CASP7	caspase 7	gene	CHEBI:9123	sertraline	multiple interactions	EXP		E	RGD:6480464	20140909	CTD	MESH:D020280	4-phenylbutyric acid inhibits the reaction [Sertraline results in increased activity of CASP7 protein]	PMID:24865413
1298347	CASP7	caspase 7	gene	CHEBI:9126	Sesamol	increases activity	EXP		E	RGD:6480464	20161025	CTD	MESH:C025583	sesamol results in increased activity of CASP7 protein	PMID:27270451
1298347	CASP7	caspase 7	gene	CHEBI:9130	sevoflurane	increases activity	EXP		E	RGD:6480464	20161213	CTD	MESH:C009250	sevoflurane results in increased activity of CASP7 protein	PMID:16678324
1298347	CASP7	caspase 7	gene	CHEBI:91450	sapanisertib	increases cleavage	EXP		E	RGD:6480464	20240702	CTD	MESH:C572449	sapanisertib results in increased cleavage of CASP7 protein	PMID:26536665
1298347	CASP7	caspase 7	gene	CHEBI:9150	simvastatin	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D019821	Simvastatin results in increased activity of CASP7 protein	PMID:20427495
1298347	CASP7	caspase 7	gene	CHEBI:9150	simvastatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019821	Mevalonic Acid inhibits the reaction [Simvastatin results in increased activity of CASP7 protein]; Mevalonic Acid inhibits the reaction [Simvastatin results in increased cleavage of CASP7 protein]; Simvastatin results in increased cleavage of and results in increased activity of CASP7 protein	PMID:19253821|PMID:20045437|PMID:20427495
1298347	CASP7	caspase 7	gene	CHEBI:9168	sirolimus	decreases activity	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in decreased activity of CASP7 protein	PMID:20031680
1298347	CASP7	caspase 7	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	[Curcumin co-treated with Sirolimus] results in increased activity of CASP7 protein; [Sirolimus co-treated with Paclitaxel] results in increased cleavage of CASP7 protein; Sirolimus inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP7 protein]	PMID:15753396|PMID:19373661|PMID:26046303
1298347	CASP7	caspase 7	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20251104	CTD	MESH:D020123	Sirolimus inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP7 protein]	PMID:26046303
1298347	CASP7	caspase 7	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20251104	CTD	MESH:D020123	Sirolimus inhibits the reaction [Cadmium Chloride results in increased cleavage of CASP7 protein]	PMID:26046303
1298347	CASP7	caspase 7	gene	CHEBI:9190	solasodine	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:C012037	solasodine results in increased cleavage of and results in decreased expression of CASP7 protein	PMID:37121296
1298347	CASP7	caspase 7	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:620944	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of CASP7 mRNA	PMID:19281266
1298347	CASP7	caspase 7	gene	CHEBI:9241	spironolactone	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D013148	Spironolactone results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:9241	spironolactone	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D013148	Palmitic Acid promotes the reaction [Spironolactone results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:D013311	Streptozocin results in increased expression of CASP7 protein	PMID:15976052
1298347	CASP7	caspase 7	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:620944	E	RGD:6480464	20190507	CTD	MESH:D013311	[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein; dapagliflozin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]; dapagliflozin promotes the reaction [Metformin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]]; Metformin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]; Metformin promotes the reaction [dapagliflozin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of CASP7 protein]]	PMID:30551545
1298347	CASP7	caspase 7	gene	CHEBI:9381	T-2 toxin	increases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:D013605	T-2 Toxin results in increased activity of CASP7 protein	PMID:19524637
1298347	CASP7	caspase 7	gene	CHEBI:9449	terbutaline	multiple interactions	EXP		E	RGD:6480464	20130305	CTD	MESH:D013726	[Terbutaline results in increased activity of ADRB2 protein] inhibits the reaction [Shiga Toxin 2 results in increased activity of CASP7 protein]; Terbutaline inhibits the reaction [Shiga Toxin 2 results in increased activity of CASP7 protein]	PMID:12826277
1298347	CASP7	caspase 7	gene	CHEBI:94598	1-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-2-(4-chlorophenoxy)ethanone	increases activity	EXP		E	RGD:6480464	20170307	CTD	MESH:C038628	fipexide results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:94598	1-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-2-(4-chlorophenoxy)ethanone	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C038628	Palmitic Acid promotes the reaction [fipexide results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:95082	molibresib	increases activity	EXP		E	RGD:6480464	20240702	CTD	MESH:C554645	molibresib results in increased activity of CASP7 protein	PMID:26911376
1298347	CASP7	caspase 7	gene	CHEBI:95093	omipalisib	multiple interactions	EXP		E	RGD:6480464	20220614	CTD	MESH:C561454	[GNAQ gene mutant form results in increased susceptibility to [trametinib co-treated with omipalisib]] which results in increased cleavage of CASP7 protein	PMID:22733540
1298347	CASP7	caspase 7	gene	CHEBI:9516	thapsigargin	increases activity	EXP		E	RGD:6480464	20120918	CTD	MESH:D019284	Thapsigargin results in increased activity of CASP7 protein	PMID:12198651|PMID:17559149|PMID:19139269|PMID:20022965
1298347	CASP7	caspase 7	gene	CHEBI:9516	thapsigargin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019284	Doxorubicin inhibits the reaction [Thapsigargin results in increased activity of and results in increased cleavage of CASP7 protein]; Thapsigargin results in increased activity of and results in increased cleavage of CASP7 protein; ursodoxicoltaurine inhibits the reaction [Thapsigargin results in increased activity of CASP7 protein]	PMID:12198651|PMID:16298333
1298347	CASP7	caspase 7	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:620944	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CASP7 mRNA	PMID:21346803
1298347	CASP7	caspase 7	gene	CHEBI:9588	ticlopidine	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:D013988	Ticlopidine results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:9588	ticlopidine	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D013988	Palmitic Acid promotes the reaction [Ticlopidine results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:9631	Tomentosin	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:C454646	tomentosin results in decreased expression of CASP7 protein	PMID:30917517|PMID:32787465
1298347	CASP7	caspase 7	gene	CHEBI:9631	Tomentosin	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C454646	tomentosin results in increased expression of CASP7 mRNA	PMID:35988885
1298347	CASP7	caspase 7	gene	CHEBI:9631	Tomentosin	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:C454646	Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of CASP7 protein]	PMID:30917517
1298347	CASP7	caspase 7	gene	CHEBI:9642	N-tosyl-L-phenylalanyl chloromethyl ketone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014108	Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of and results in increased activity of CASP7 protein; TP53 protein promotes the reaction [Tosylphenylalanyl Chloromethyl Ketone results in increased activity of CASP7 protein]	PMID:12821135
1298347	CASP7	caspase 7	gene	CHEBI:9747	Triptolide	increases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:C001899	triptolide results in increased activity of CASP7 protein	PMID:21640813
1298347	CASP7	caspase 7	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:620944	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of CASP7 protein	PMID:32519852
1298347	CASP7	caspase 7	gene	CHEBI:9753	troglitazone	increases activity	EXP		E	RGD:6480464	20130312	CTD	MESH:C057693	troglitazone results in increased activity of CASP7 protein	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:9753	troglitazone	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:C057693	Palmitic Acid promotes the reaction [troglitazone results in increased activity of CASP7 protein]	PMID:22700542
1298347	CASP7	caspase 7	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:620944	E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of CASP7 mRNA	PMID:24136188
1298347	CASP7	caspase 7	gene	CHEBI:9907	ursodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014580	Ursodeoxycholic Acid analog inhibits the reaction [TNF protein results in increased activity of CASP7 protein]; Ursodeoxycholic Acid inhibits the reaction [Nitroprusside results in increased activity of CASP7 protein]	PMID:21146893|PMID:22178905
1298347	CASP7	caspase 7	gene	CHEBI:9907	ursodeoxycholic acid	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D014580	Ursodeoxycholic Acid analog inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in increased activity of CASP7 protein]	PMID:21146893
1298347	CASP7	caspase 7	gene	CHEBI:9908	ursolic acid	increases activity	ISO	RGD:1553182	E	RGD:6480464	20240206	CTD	MESH:C005466	Ursolic Acid results in increased activity of CASP7 protein	PMID:19329757
1298347	CASP7	caspase 7	gene	CHEBI:9948	verapamil	multiple interactions	ISO	RGD:1553182	E	RGD:6480464	20120412	CTD	MESH:D014700	[Verapamil results in decreased expression of ABCB1] promotes the reaction [Doxorubicin results in increased activity of CASP7 protein]	PMID:15861398
1298347	CASP7	caspase 7	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:620944	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CASP7 mRNA	PMID:23034163
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:10022	deoxynivalenol	decreases activity	ISO	RGD:1552190	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in decreased activity of ZEB1 protein	PMID:11893416
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:10022	deoxynivalenol	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20141111	CTD	MESH:C007262	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [deoxynivalenol results in decreased expression of ZEB1 protein]	PMID:11893416
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:10033	warfarin	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D014859	Warfarin results in decreased expression of ZEB1 protein	PMID:26206560
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:113532	thymoquinone	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C003466	thymoquinone results in decreased expression of ZEB1 protein	PMID:35774120
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:113532	thymoquinone	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:C003466	thymoquinone promotes the reaction [cordycepin results in decreased expression of ZEB1 protein]	PMID:35774120
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:3831	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of ZEB1 mRNA	PMID:25152437
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:3831	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of ZEB1 mRNA	PMID:21551480
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of ZEB1 mRNA	PMID:26272509
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA	PMID:27188386
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1552190	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ZEB1 mRNA	PMID:33045310
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:132824	spathulenol	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C013258	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ZEB1 mRNA	PMID:38000518
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:136608	Theaflavin 3,3'-digallate	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C585473	theaflavin-3,3'-digallate results in decreased expression of ZEB1 protein	PMID:40962244
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:137392	chlormequat chloride	increases expression	ISO	RGD:3831	E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of ZEB1 protein	PMID:34958886
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ZEB1 mRNA	PMID:26251327
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ZEB1 protein; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZEB1 gene	PMID:20548288|PMID:20938992
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of ZEB1 mRNA	PMID:21934132|PMID:30093655
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20190507	CTD	MESH:D014212	Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of ZEB1 mRNA]; Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of ZEB1 mRNA]	PMID:30093655
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ZEB1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of ZEB1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ZEB1 mRNA	PMID:32699268|PMID:32845096
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ZEB1 mRNA	PMID:25351418
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D010100	DICER1 protein inhibits the reaction [Oxygen deficiency results in increased expression of ZEB1 mRNA]	PMID:25351418
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:15396	(R)-camphor	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D002164	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ZEB1 mRNA	PMID:38000518
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZEB1 mRNA	PMID:36331819
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of ZEB1 mRNA	PMID:39506029
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of ZEB1 mRNA	PMID:40945087
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:16113	cholesterol	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D002784	Cholesterol inhibits the reaction [arachidonyl dopamine results in decreased expression of ZEB1 mRNA]	PMID:33393692
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552190	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ZEB1 mRNA	PMID:30319688
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552190	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ZEB1 mRNA	PMID:30319688
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZEB1 mRNA	PMID:39241906
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ZEB1 mRNA	PMID:30510588
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of ZEB1 mRNA	PMID:15289156
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of ZEB1 mRNA	PMID:12154049|PMID:31614463|PMID:36581016
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ZEB1 mRNA	PMID:30165855
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZEB1 mRNA	PMID:25510870
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ZEB1 protein; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZEB1 gene	PMID:20548288|PMID:20938992
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZEB1 mRNA	PMID:37042841
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ZEB1 mRNA	PMID:20655997|PMID:23649840
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of ZEB1 mRNA	PMID:20864642
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:17356	2-acetamidofluorene	decreases expression	ISO	RGD:3831	E	RGD:6480464	20120814	CTD	MESH:D015073	2-Acetylaminofluorene results in decreased expression of ZEB1 protein	PMID:19167416
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:17580	linalool	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C018584	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ZEB1 mRNA	PMID:38000518
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of ZEB1 mRNA	PMID:16949557
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of ZEB1 protein	PMID:37730182
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:3831	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ZEB1 mRNA	PMID:22061828|PMID:33387578
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:181932	3-Nitrobenzanthrone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C117220	3-nitrobenzanthrone results in increased expression of ZEB1 mRNA	PMID:34036453
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of ZEB1 mRNA	PMID:16949557
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002104	Cadmium results in increased expression of ZEB1 protein	PMID:34488496
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:22977	cadmium atom	increases methylation	EXP		E	RGD:6480464	20240806	CTD	MESH:D002104	Cadmium results in increased methylation of ZEB1 mRNA	PMID:34488496
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZEB1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZEB1 mRNA; Resveratrol inhibits the reaction [Cadmium results in increased expression of ZEB1 protein]; Resveratrol inhibits the reaction [Cadmium results in increased methylation of ZEB1 mRNA]	PMID:29741670|PMID:34488496|PMID:36671501
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZEB1 mRNA	PMID:25510870
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZEB1 mRNA	PMID:25510870
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ZEB1 mRNA	PMID:19549813
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552190	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ZEB1 mRNA	PMID:19770486
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ZEB1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of ZEB1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ZEB1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of ZEB1 mRNA	PMID:32699268|PMID:32845096
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ZEB1 mRNA	PMID:34911549
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27363	zinc atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of ZEB1 mRNA	PMID:16979875
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ZEB1 mRNA	PMID:16979875
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ZEB1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ZEB1 protein; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZEB1 gene	PMID:20548288|PMID:20938992|PMID:22206623
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZEB1 gene	PMID:25304211
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1552190	E	RGD:6480464	20210907	CTD	MESH:D001151	Arsenic results in increased expression of ZEB1 mRNA	PMID:33124703
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D001151	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 protein]; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 protein	PMID:32645460|PMID:39818140
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ZEB1 mRNA	PMID:19244175
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27617	monensin A	increases response to substance	EXP		E	RGD:6480464	20190507	CTD	MESH:D008985	ZEB1 protein results in increased susceptibility to Monensin	PMID:30718715
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA	PMID:27188386
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ZEB1 protein	PMID:35688186
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol results in decreased expression of ZEB1 mRNA; resveratrol results in decreased expression of ZEB1 protein	PMID:21304978|PMID:22692956|PMID:26934322
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in increased expression of ZEB1 mRNA	PMID:12154049
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C059514	3-deazaneplanocin inhibits the reaction [Resveratrol results in decreased expression of ZEB1 mRNA]; EZH2 mRNA promotes the reaction [Resveratrol results in decreased expression of ZEB1 mRNA]; Resveratrol inhibits the reaction [Cadmium results in increased expression of ZEB1 protein]; Resveratrol inhibits the reaction [Cadmium results in increased methylation of ZEB1 mRNA]	PMID:26934322|PMID:34488496
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:3831	E	RGD:6480464	20250311	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in increased expression of ZEB1 mRNA	PMID:39276841
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27961	1,8-cineole	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D000077591	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ZEB1 mRNA	PMID:38000518
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ZEB1 mRNA	PMID:30912803
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of ZEB1 mRNA	PMID:15289156
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:3831	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of ZEB1 gene	PMID:28505145
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28112	nickel atom	increases methylation	EXP		E	RGD:6480464	20250805	CTD	MESH:D009532	Nickel results in increased methylation of ZEB1 gene	PMID:39326548
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552190	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZEB1 mRNA	PMID:21570461
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20170110	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZEB1 mRNA	PMID:27562557|PMID:37172768
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552190	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZEB1 mRNA	PMID:15034205|PMID:21354282|PMID:24058054
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:3831	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZEB1 mRNA	PMID:15644576|PMID:34747641
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZEB1 mRNA; AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of ZEB1 mRNA]	PMID:15034205|PMID:17942748
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ZEB1 mRNA	PMID:28001369
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZEB1 mRNA	PMID:33212167
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28262	dimethyl sulfoxide	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:D004121	[Dimethyl Sulfoxide co-treated with TGFB1 protein] results in increased expression of ZEB1 mRNA	PMID:35366062
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20121218	CTD	MESH:D004317	ZEB1 protein affects the susceptibility to Doxorubicin	PMID:19839049
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZEB1 mRNA	PMID:29803840
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D004317	[Doxorubicin co-treated with cordycepin] results in decreased expression of ZEB1 protein	PMID:35186504
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28794	coumarin	decreases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:C030123	coumarin analog results in decreased expression of ZEB1 mRNA	PMID:32578917
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:28869	menadione	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of ZEB1 protein	PMID:31238027
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29014	cordycepin	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C058120	cordycepin results in decreased expression of ZEB1 mRNA	PMID:35774120
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29014	cordycepin	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20231205	CTD	MESH:C058120	cordycepin results in decreased expression of ZEB1 protein	PMID:35774120
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29014	cordycepin	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:C058120	[Doxorubicin co-treated with cordycepin] results in decreased expression of ZEB1 protein; cordycepin results in decreased expression of and results in decreased localization of ZEB1 protein; thymoquinone promotes the reaction [cordycepin results in decreased expression of ZEB1 protein]	PMID:35186504|PMID:35774120
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ZEB1 gene	PMID:28589171
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZEB1 mRNA	PMID:22714537
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ZEB1 mRNA; sodium arsenite results in increased expression of ZEB1 protein	PMID:12760830|PMID:21292642|PMID:29216394|PMID:30167605|PMID:35750204|PMID:36989763|PMID:38568856
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:C017947	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 protein]; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 protein; LRP6 mRNA alternative form promotes the reaction [sodium arsenite results in increased expression of ZEB1 protein]; MIR455 mRNA inhibits the reaction [sodium arsenite results in increased expression of ZEB1 protein]	PMID:29216394|PMID:32645460|PMID:39818140
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:3831	E	RGD:6480464	20251007	CTD	MESH:C017947	[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 mRNA]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein]	PMID:39722890
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZEB1 exon	PMID:27901495
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZEB1 mRNA	PMID:30659931
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZEB1 mRNA	PMID:27221058
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552190	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZEB1 mRNA	PMID:15034205
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of ZEB1 mRNA]	PMID:15034205
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ZEB1 mRNA]	PMID:32406909
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:30185	zinc(0)	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of ZEB1 mRNA	PMID:16979875
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ZEB1 mRNA	PMID:16979875
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in increased expression of ZEB1 mRNA	PMID:26014281|PMID:26551752
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ZEB1 protein	PMID:29113749
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1552190	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ZEB1 mRNA; Silicon Dioxide results in increased expression of ZEB1 protein	PMID:29113749|PMID:35271943
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:3831	E	RGD:6480464	20240806	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ZEB1 mRNA; Silicon Dioxide results in increased expression of ZEB1 protein	PMID:34779285|PMID:38491797
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:30563	silicon dioxide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D012822	[Silicon Dioxide results in increased secretion of TGFB1 protein] which results in increased expression of ZEB1 protein; MIR200C mRNA inhibits the reaction [Silicon Dioxide results in increased expression of ZEB1 protein]	PMID:29113749
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20191008	CTD	MESH:D012822	MIR200C mRNA inhibits the reaction [Silicon Dioxide results in increased expression of ZEB1 protein]	PMID:29113749
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:3831	E	RGD:6480464	20250506	CTD	MESH:D012822	MIR204 inhibits the reaction [Silicon Dioxide results in increased expression of ZEB1 protein]; TGFBR1 protein inhibits the reaction [MIR204 inhibits the reaction [Silicon Dioxide results in increased expression of ZEB1 protein]]; TGFBR1 protein promotes the reaction [Silicon Dioxide results in increased expression of ZEB1 protein]	PMID:38491797
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZEB1 mRNA	PMID:19150397
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ZEB1 mRNA	PMID:30093655
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:30621	diarsenic trioxide	increases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	ZEB1 protein results in increased susceptibility to Arsenic Trioxide	PMID:20707922
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of ZEB1 mRNA]; Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of ZEB1 mRNA]	PMID:30093655
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:3831	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of ZEB1 mRNA	PMID:16483693
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:3831	E	RGD:6480464	20250311	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in increased expression of ZEB1 mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 mRNA]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein]	PMID:39276841|PMID:39722890
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:3831	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of ZEB1 mRNA	PMID:16507785
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ZEB1 mRNA	PMID:17762391
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:32090	Rebamipide	multiple interactions	ISO	RGD:3831	E	RGD:6480464	20141111	CTD	MESH:C052785	rebamipide inhibits the reaction [Indomethacin results in increased expression of ZEB1 mRNA]	PMID:16184411
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ZEB1 mRNA	PMID:23557971
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552190	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZEB1 gene; titanium dioxide results in decreased methylation of ZEB1 promoter	PMID:35295148
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:32234	titanium dioxide	increases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZEB1 promoter	PMID:34973136
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552190	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZEB1 promoter	PMID:35295148
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:33007	chromium(6+)	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of ZEB1 mRNA	PMID:23518002
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZEB1 mRNA	PMID:33221593
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:3831	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZEB1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:3831	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of ZEB1 gene	PMID:28505145
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of ZEB1 mRNA	PMID:19244175
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of ZEB1 mRNA	PMID:19041380
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZEB1 mRNA	PMID:25510870
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZEB1 mRNA	PMID:25510870
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C005290	oxybenzone results in increased expression of ZEB1 mRNA	PMID:36581016
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1552190	E	RGD:6480464	20190910	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ZEB1 protein	PMID:31212022
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases stability	EXP		E	RGD:6480464	20190910	CTD	MESH:C027561	butylbenzyl phthalate results in increased stability of ZEB1 protein	PMID:31212022
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C027561	ATM protein affects the reaction [butylbenzyl phthalate results in increased expression of ZEB1 protein]; butylbenzyl phthalate results in increased expression of and affects the localization of ZEB1 protein; butylbenzyl phthalate results in increased expression of and results in increased stability of ZEB1 mRNA; MIR655 mRNA inhibits the reaction [butylbenzyl phthalate results in increased expression of ZEB1 protein]; ZEB1 protein affects the reaction [butylbenzyl phthalate results in increased expression of MMP2 protein]	PMID:31212022
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20190910	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of and results in increased stability of ZEB1 mRNA; MIR655 mRNA inhibits the reaction [butylbenzyl phthalate results in increased expression of ZEB1 mRNA]; ZEB1 protein affects the reaction [butylbenzyl phthalate results in increased expression of MMP2 protein]	PMID:31212022
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552190	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ZEB1 mRNA	PMID:20350560
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZEB1 mRNA; Cadmium Chloride results in increased expression of ZEB1 protein	PMID:30998937|PMID:34905088
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZEB1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZEB1 mRNA	PMID:29741670|PMID:36671501
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:3831	E	RGD:6480464	20251007	CTD	MESH:D019256	[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 mRNA]; CAT inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 mRNA]; GCLC inhibits the reaction [[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in increased expression of ZEB1 protein]	PMID:39722890
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:35546	perfluorodecanoic acid	increases expression	ISO	RGD:1552190	E	RGD:6480464	20200915	CTD	MESH:C036567	perfluorodecanoic acid results in increased expression of ZEB1 mRNA	PMID:32534105
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:35546	perfluorodecanoic acid	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20200915	CTD	MESH:C036567	PPARA protein affects the reaction [perfluorodecanoic acid results in increased expression of ZEB1 mRNA]	PMID:32534105
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1552190	E	RGD:6480464	20200915	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ZEB1 mRNA	PMID:32534105
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of ZEB1 mRNA	PMID:19376846
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ZEB1 mRNA	PMID:24449571
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ZEB1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ZEB1 mRNA	PMID:32699268
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:36773	camphor	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D002164	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ZEB1 mRNA	PMID:38000518
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ZEB1 mRNA	PMID:19244175
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of ZEB1 mRNA	PMID:16979875
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20120412	CTD	MESH:D013755	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [deoxynivalenol results in decreased expression of ZEB1 protein]	PMID:11893416
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552190	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ZEB1 mRNA	PMID:32534105
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:38397	perfluorononanoic acid	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20220111	CTD	MESH:C101816	PPARA protein affects the reaction [perfluoro-n-nonanoic acid results in increased expression of ZEB1 mRNA]	PMID:32534105
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ZEB1 mRNA	PMID:28302478
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ZEB1 mRNA	PMID:27153767
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZEB1 mRNA	PMID:36331819
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZEB1 mRNA	PMID:25979313
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZEB1 mRNA; Valproic Acid results in decreased expression of ZEB1 protein	PMID:19628293|PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:28001369
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA	PMID:27188386
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZEB1 mRNA	PMID:20106945|PMID:25562108
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of ZEB1 mRNA	PMID:25047013
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of ZEB1 mRNA	PMID:15289156
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:3831	E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of ZEB1 mRNA	PMID:36653537
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1552190	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of ZEB1 mRNA	PMID:18502557
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:44616	afimoxifene	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C016601	afimoxifene results in increased expression of ZEB1 mRNA	PMID:12154049
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D017239	[NOTCH1 protein results in decreased susceptibility to Paclitaxel] which results in increased expression of ZEB1 protein	PMID:34048126
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20231003	CTD	MESH:D017239	[glabridin co-treated with Paclitaxel] results in decreased expression of ZEB1 protein	PMID:37419298
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of ZEB1 mRNA	PMID:24935251|PMID:26272509
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA	PMID:27188386
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of ZEB1 mRNA	PMID:21420995
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ZEB1 mRNA	PMID:29279043
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of ZEB1 protein	PMID:30609805
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZEB1 gene	PMID:25304211
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1552190	E	RGD:6480464	20210907	CTD	MESH:D001151	Arsenic results in increased expression of ZEB1 mRNA	PMID:33124703
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D001151	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 protein]; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 protein	PMID:32645460|PMID:39818140
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:47381	diclofenac	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004008	Diclofenac results in decreased expression of ZEB1 protein	PMID:19628293
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:4778	embelin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C010945	embelin results in decreased expression of ZEB1 protein	PMID:24694877
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of ZEB1 mRNA	PMID:26833863
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZEB1 mRNA	PMID:17942748
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of ZEB1 mRNA	PMID:16984733
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:3831	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of ZEB1 mRNA	PMID:16184411
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:3831	E	RGD:6480464	20120412	CTD	MESH:D007213	rebamipide inhibits the reaction [Indomethacin results in increased expression of ZEB1 mRNA]	PMID:16184411
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ZEB1 mRNA	PMID:30093655
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:49900	arsenous acid	increases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	ZEB1 protein results in increased susceptibility to Arsenic Trioxide	PMID:20707922
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of ZEB1 mRNA]; Tretinoin promotes the reaction [Arsenic Trioxide results in decreased expression of ZEB1 mRNA]	PMID:30093655
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:50027	sabinene	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C035127	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ZEB1 mRNA	PMID:38000518
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:50045	(+)-beta-thujone	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C005790	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ZEB1 mRNA	PMID:38000518
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D008770	Methylnitrosourea results in increased expression of ZEB1 mRNA	PMID:27221058
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C014347	Decitabine results in decreased expression of ZEB1 protein	PMID:29320940
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ZEB1 mRNA	PMID:25554681
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:50924	sorafenib	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20170303	CTD	MESH:C471405	sorafenib results in decreased expression of ZEB1 mRNA	PMID:21360571
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of ZEB1 mRNA	PMID:22714537
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of ZEB1 mRNA	PMID:18651567
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:5369	glabridin	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20231003	CTD	MESH:C107601	[glabridin co-treated with Paclitaxel] results in decreased expression of ZEB1 protein	PMID:37419298
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA	PMID:27188386
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	ZEB1 protein affects the susceptibility to Topotecan	PMID:16217747
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:63954	ionomycin	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20120412	CTD	MESH:D015759	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] promotes the reaction [deoxynivalenol results in decreased expression of ZEB1 protein]	PMID:11893416
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:63959	celastrol	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C050414	celastrol results in decreased expression of ZEB1 mRNA	PMID:39181414
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ZEB1 mRNA	PMID:28988120
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of ZEB1 mRNA	PMID:36907384
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:6469	linalyl acetate	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C074463	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ZEB1 mRNA	PMID:38000518
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:65329	LY294002	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of ZEB1 mRNA; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of ZEB1 protein	PMID:39818140
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZEB1 protein]	PMID:39818140
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:67271	MK-2206	increases expression	ISO	RGD:1552190	E	RGD:6480464	20190702	CTD	MESH:C548887	MK 2206 results in increased expression of ZEB1 mRNA	PMID:30723155
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:67271	MK-2206	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20190702	CTD	MESH:C548887	[U 0126 co-treated with MK 2206] results in increased expression of ZEB1 mRNA	PMID:30723155
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:3831	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ZEB1 gene	PMID:35440735
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:6980	monocrotaline	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D016686	Monocrotaline results in increased expression of ZEB1 protein	PMID:36942326
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:6980	monocrotaline	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D016686	Propylthiouracil inhibits the reaction [Monocrotaline results in increased expression of ZEB1 protein]	PMID:36942326
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:71314	cycloastragenol	multiple interactions	ISO	RGD:3831	E	RGD:267358468|PMID:32068187	20230418	RGD	MESH:C061014	cycloastragenol inhibits the reaction [acute myocardial infarction decreases expression of Zeb1 protein in myocardium]	
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552190	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ZEB1 mRNA	PMID:22206623
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ZEB1 mRNA	PMID:22714537
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ZEB1 protein	PMID:31285264
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:75701	sarin	decreases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of ZEB1 mRNA	PMID:19522546
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:78334	(R)-linalyl acetate	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C074463	[beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in increased expression of ZEB1 mRNA	PMID:38000518
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA	PMID:27188386
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of ZEB1 mRNA	PMID:23091169
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:3831	E	RGD:6480464	20140311	CTD	MESH:D010634	Phenobarbital results in decreased expression of ZEB1 protein	PMID:24157574
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of ZEB1 mRNA	PMID:39904859
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:3831	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of ZEB1 mRNA	PMID:17553608
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:83784	galaxolide	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C033119	galaxolide results in increased expression of ZEB1 mRNA	PMID:34687775
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:83784	galaxolide	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C033119	acetyl methyl tetramethyl tetralin promotes the reaction [galaxolide results in increased expression of ZEB1 mRNA]; galaxolide promotes the reaction [acetyl methyl tetramethyl tetralin results in increased expression of ZEB1 mRNA]	PMID:34687775
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552190	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ZEB1 mRNA	PMID:21795629
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1552190	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of ZEB1 mRNA	PMID:21278054
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil inhibits the reaction [Monocrotaline results in increased expression of ZEB1 protein]	PMID:36942326
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of ZEB1 mRNA	PMID:26272509
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA	PMID:27188386
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:85993	palbociclib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib inhibits the reaction [[CDK6 protein binds to CCND3 protein] which results in increased phosphorylation of ZEB1 protein]	PMID:22094256
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of ZEB1 mRNA	PMID:16497877
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:88249	PD 0325901	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C506614	[mirdametinib co-treated with (+)-JQ1 compound] results in decreased expression of ZEB1 mRNA	PMID:25119042
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZEB1 mRNA	PMID:27188386
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in increased expression of ZEB1 mRNA	PMID:26014281|PMID:26551752
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ZEB1 mRNA	PMID:17440010
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:9513	thalidomide	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013792	Thalidomide results in decreased expression of ZEB1 protein	PMID:34520751
1299953	ZEB1	zinc finger E-box binding homeobox 1	gene	CHEBI:9513	thalidomide	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D013792	FGD5-AS1 inhibits the reaction [Thalidomide results in decreased expression of ZEB1 protein]	PMID:34520751
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of ABCA5 mRNA	PMID:26272509
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCA5 mRNA	PMID:27188386
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:136004	linsidomine	increases oxidation	ISO	RGD:628661	E	RGD:6480464	20180220	CTD	MESH:C002385	linsidomine results in increased oxidation of ABCA5 protein	PMID:28086193
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1551371	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ABCA5 mRNA	PMID:20938992
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of ABCA5 mRNA	PMID:21934132
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABCA5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABCA5 mRNA	PMID:32699268
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1551371	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ABCA5 mRNA	PMID:30319688
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ABCA5 mRNA	PMID:21632981
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of ABCA5 mRNA	PMID:29581250
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551371	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ABCA5 mRNA	PMID:39298647
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1551371	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of ABCA5 mRNA	PMID:29980752
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:628661	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ABCA5 mRNA	PMID:33387578
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1551371	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ABCA5 mRNA	PMID:20938992
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1551371	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of ABCA5 mRNA	PMID:28973375
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1551371	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of ABCA5 mRNA	PMID:33848595
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1551371	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ABCA5 mRNA	PMID:34319233
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:628661	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ABCA5 mRNA	PMID:33387578
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:18291	manganese atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of ABCA5 mRNA	PMID:17175027
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ABCA5 mRNA	PMID:39836092
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ABCA5 mRNA	PMID:16283523
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:24556	1,3,5-trinitro-1,3,5-triazinane	increases expression	ISO	RGD:628661	E	RGD:6480464	20160315	CTD	MESH:C009160	cyclonite results in increased expression of ABCA5 mRNA	PMID:25559034
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ABCA5 mRNA	PMID:22100608|PMID:27153756
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1551371	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ABCA5 mRNA	PMID:19770486
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABCA5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABCA5 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ABCA5 mRNA	PMID:32699268
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1551371	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ABCA5 mRNA	PMID:31919559
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:628661	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ABCA5 mRNA	PMID:31150632
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551371	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ABCA5 mRNA	PMID:25629700
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551371	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ABCA5 mRNA	PMID:20938992
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ABCA5 gene	PMID:25304211
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ABCA5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABCA5 mRNA	PMID:39836092|PMID:40512198
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:628661	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ABCA5 mRNA	PMID:31881176
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of ABCA5 promoter	PMID:22847954
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1551371	E	RGD:6480464	20120412	CTD	MESH:D003042	HDAC5 affects the reaction [Cocaine affects the expression of ABCA5 mRNA]	PMID:17988634
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1551371	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of ABCA5 mRNA	PMID:32186404
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABCA5 mRNA	PMID:22574217
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:628661	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABCA5 mRNA	PMID:32109520
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABCA5 mRNA	PMID:20106945|PMID:21632981
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ABCA5 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:28445	vincristine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	[Vincristine results in decreased susceptibility to Vincristine] which affects the expression of ABCA5 mRNA	PMID:19944135
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ABCA5 mRNA	PMID:20971185
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1551371	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ABCA5 protein	PMID:28918527
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D004317	Doxorubicin affects the expression of ABCA5 mRNA	PMID:25529476
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ABCA5 mRNA	PMID:29803840
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1551371	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of ABCA5 mRNA	PMID:39631538
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of ABCA5 mRNA]	PMID:31004932
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABCA5 mRNA	PMID:28595984|PMID:31004932|PMID:34032870
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ABCA5 mRNA	PMID:38568856
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ABCA5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABCA5 mRNA; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of ABCA5 mRNA]	PMID:31004932|PMID:39836092|PMID:40512198
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1551371	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ABCA5 intron	PMID:27901495
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABCA5 mRNA	PMID:21632981|PMID:30453624
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ABCA5 promoter	PMID:27901495
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:29866	arsenite(3-)	decreases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased methylation of ABCA5 promoter	PMID:23974009
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ABCA5 mRNA	PMID:20971185
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of ABCA5 mRNA	PMID:34408198
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:628661	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of ABCA5 mRNA	PMID:16483693
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1551371	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ABCA5 mRNA	PMID:23557971
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551371	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ABCA5 gene; titanium dioxide results in increased methylation of ABCA5 promoter	PMID:35295148
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:628661	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ABCA5 mRNA	PMID:23411599|PMID:34492290
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCA5 mRNA	PMID:33670352
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:628661	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCA5 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551371	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ABCA5 mRNA	PMID:26063408
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551371	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ABCA5 mRNA	PMID:40203079
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:628661	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ABCA5 mRNA	PMID:20360939
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:628661	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ABCA5 mRNA	PMID:32680482
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1551371	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of ABCA5 mRNA	PMID:36117858
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:35154	manganese(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of ABCA5 mRNA	PMID:17175027
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ABCA5 mRNA	PMID:39836092
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:35559	furan	increases expression	ISO	RGD:628661	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ABCA5 mRNA	PMID:25539665
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABCA5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABCA5 mRNA	PMID:32699268
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:3763	clorgyline	increases expression	EXP		E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of ABCA5 mRNA	PMID:19691856
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1551371	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ABCA5 mRNA	PMID:40194260
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of ABCA5 promoter	PMID:22847954
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of ABCA5 promoter	PMID:22847954
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ABCA5 mRNA	PMID:25979313
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:628661	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of ABCA5 mRNA	PMID:29427782
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ABCA5 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1551371	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in increased expression of ABCA5 mRNA	PMID:19136453
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCA5 mRNA	PMID:27188386
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of ABCA5 mRNA	PMID:25562108
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of ABCA5 mRNA	PMID:20106945
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in increased expression of ABCA5 mRNA	PMID:21632981
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1551371	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ABCA5 mRNA	PMID:28973697
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of ABCA5 mRNA	PMID:20737486
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of ABCA5 mRNA	PMID:24935251|PMID:26272509
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ABCA5 mRNA	PMID:24935251
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCA5 mRNA	PMID:27188386
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:628661	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ABCA5 mRNA	PMID:33387578
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ABCA5 gene	PMID:25304211
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ABCA5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABCA5 mRNA	PMID:39836092|PMID:40512198
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:628661	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ABCA5 mRNA	PMID:29097150
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1551371	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ABCA5 mRNA; Nanotubes, Carbon results in decreased expression of ABCA5 mRNA	PMID:25554681
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:628661	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of ABCA5 mRNA	PMID:21983209
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1551371	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of ABCA5 mRNA	PMID:36117858
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ABCA5 mRNA	PMID:22714537
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of ABCA5 mRNA	PMID:17175027
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ABCA5 mRNA	PMID:39836092
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:755540	docetaxel	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	[Docetaxel results in decreased susceptibility to Docetaxel] which results in increased expression of ABCA5 mRNA	PMID:19944135
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:756028	mivebresib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in increased expression of ABCA5 mRNA	PMID:35486664
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCA5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCA5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCA5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCA5 mRNA	PMID:27188386
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:8062	phenethyl caffeate	multiple interactions	ISO	RGD:628661	E	RGD:6480464	20130903	CTD	MESH:C055494	[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of ABCA5 mRNA	PMID:20360939
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:628661	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ABCA5 mRNA	PMID:32109520
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:81543	Tributyltin oxide	increases phosphorylation	ISO	RGD:1551371	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased phosphorylation of ABCA5 protein	PMID:22174045
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1551371	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ABCA5 mRNA	PMID:30294300
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1551371	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ABCA5 mRNA	PMID:21795629
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of ABCA5 mRNA	PMID:26272509
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCA5 mRNA	PMID:27188386
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCA5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCA5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCA5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABCA5 mRNA	PMID:27188386
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1551371	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ABCA5 mRNA	PMID:35537566
1300038	ABCA5	ATP binding cassette subfamily A member 5	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:628661	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of ABCA5 gene	PMID:31682807
1312050	SGCB	sarcoglycan beta	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312051	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SGCB mRNA	PMID:20938992
1312050	SGCB	sarcoglycan beta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of SGCB mRNA	PMID:17045167
1312050	SGCB	sarcoglycan beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312051	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SGCB mRNA	PMID:39241906
1312050	SGCB	sarcoglycan beta	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1594202	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of SGCB mRNA	PMID:20068009|PMID:32145629
1312050	SGCB	sarcoglycan beta	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312051	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of SGCB mRNA	PMID:33711761
1312050	SGCB	sarcoglycan beta	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312051	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SGCB mRNA	PMID:20938992
1312050	SGCB	sarcoglycan beta	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312051	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SGCB mRNA	PMID:36331819
1312050	SGCB	sarcoglycan beta	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1594202	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SGCB mRNA	PMID:23630614|PMID:25378103|PMID:33354967
1312050	SGCB	sarcoglycan beta	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SGCB mRNA	PMID:23649840
1312050	SGCB	sarcoglycan beta	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312051	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SGCB mRNA	PMID:20938992
1312050	SGCB	sarcoglycan beta	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SGCB mRNA	PMID:26272509
1312050	SGCB	sarcoglycan beta	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGCB mRNA	PMID:27188386
1312050	SGCB	sarcoglycan beta	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1594202	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SGCB mRNA	PMID:31881176
1312050	SGCB	sarcoglycan beta	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312051	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in decreased expression of SGCB mRNA	PMID:22610192
1312050	SGCB	sarcoglycan beta	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of SGCB mRNA	PMID:19921347
1312050	SGCB	sarcoglycan beta	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of SGCB mRNA	PMID:12629581
1312050	SGCB	sarcoglycan beta	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of SGCB mRNA	PMID:18000554
1312050	SGCB	sarcoglycan beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1594202	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SGCB mRNA	PMID:33387578
1312050	SGCB	sarcoglycan beta	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of SGCB mRNA	PMID:33512557
1312050	SGCB	sarcoglycan beta	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SGCB mRNA	PMID:28001369
1312050	SGCB	sarcoglycan beta	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SGCB mRNA	PMID:23179753|PMID:26272509
1312050	SGCB	sarcoglycan beta	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1594202	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SGCB mRNA	PMID:28959563
1312050	SGCB	sarcoglycan beta	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SGCB mRNA	PMID:21632981|PMID:26238291
1312050	SGCB	sarcoglycan beta	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312051	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SGCB mRNA	PMID:22228805
1312050	SGCB	sarcoglycan beta	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SGCB promoter	PMID:27901495
1312050	SGCB	sarcoglycan beta	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1594202	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SGCB mRNA	PMID:23411599|PMID:34492290
1312050	SGCB	sarcoglycan beta	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312051	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SGCB mRNA	PMID:18301758|PMID:23811191
1312050	SGCB	sarcoglycan beta	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SGCB mRNA	PMID:19710929
1312050	SGCB	sarcoglycan beta	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1594202	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SGCB mRNA	PMID:25181051
1312050	SGCB	sarcoglycan beta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of SGCB mRNA	PMID:29275510
1312050	SGCB	sarcoglycan beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1594202	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SGCB mRNA	PMID:32145629|PMID:34947998
1312050	SGCB	sarcoglycan beta	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312051	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SGCB mRNA	PMID:26682919
1312050	SGCB	sarcoglycan beta	gene	CHEBI:34260	anthracen-2-amine	increases expression	ISO	RGD:1594202	E	RGD:6480464	20130312	CTD	MESH:C006593	2-anthramine results in increased expression of SGCB mRNA	PMID:23038007
1312050	SGCB	sarcoglycan beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312051	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SGCB mRNA	PMID:39298647
1312050	SGCB	sarcoglycan beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SGCB mRNA	PMID:37042841
1312050	SGCB	sarcoglycan beta	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1594202	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of SGCB mRNA	PMID:25380136
1312050	SGCB	sarcoglycan beta	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1594202	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of SGCB mRNA	PMID:25539665|PMID:27387713
1312050	SGCB	sarcoglycan beta	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1594202	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of SGCB mRNA	PMID:25380136
1312050	SGCB	sarcoglycan beta	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SGCB mRNA	PMID:24449571
1312050	SGCB	sarcoglycan beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SGCB mRNA	PMID:40419075
1312050	SGCB	sarcoglycan beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312051	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SGCB mRNA	PMID:36331819
1312050	SGCB	sarcoglycan beta	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1594202	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of SGCB mRNA	PMID:23125180
1312050	SGCB	sarcoglycan beta	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1594202	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of SGCB mRNA	PMID:25993096
1312050	SGCB	sarcoglycan beta	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SGCB mRNA	PMID:25979313
1312050	SGCB	sarcoglycan beta	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of SGCB mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1312050	SGCB	sarcoglycan beta	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312051	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of SGCB mRNA	PMID:21427059
1312050	SGCB	sarcoglycan beta	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGCB mRNA	PMID:27188386
1312050	SGCB	sarcoglycan beta	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1594202	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SGCB mRNA	PMID:30047161
1312050	SGCB	sarcoglycan beta	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312051	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SGCB mRNA	PMID:28973697
1312050	SGCB	sarcoglycan beta	gene	CHEBI:45863	paclitaxel	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	SGCB protein affects the susceptibility to Paclitaxel	PMID:16217747
1312050	SGCB	sarcoglycan beta	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SGCB mRNA	PMID:24935251|PMID:26272509
1312050	SGCB	sarcoglycan beta	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGCB mRNA	PMID:27188386
1312050	SGCB	sarcoglycan beta	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SGCB mRNA	PMID:22230336
1312050	SGCB	sarcoglycan beta	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1594202	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SGCB mRNA	PMID:33387578
1312050	SGCB	sarcoglycan beta	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of SGCB mRNA	PMID:23228038
1312050	SGCB	sarcoglycan beta	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312051	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SGCB mRNA	PMID:25554681
1312050	SGCB	sarcoglycan beta	gene	CHEBI:5643	Heliotrine	increases expression	ISO	RGD:1594202	E	RGD:6480464	20200915	CTD	MESH:C010178	heliotrine results in increased expression of SGCB mRNA	PMID:32419051
1312050	SGCB	sarcoglycan beta	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1312051	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of SGCB mRNA	PMID:36907384
1312050	SGCB	sarcoglycan beta	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1594202	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of SGCB mRNA	PMID:30467583
1312050	SGCB	sarcoglycan beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGCB mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGCB mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGCB mRNA	PMID:27188386
1312050	SGCB	sarcoglycan beta	gene	CHEBI:81794	thifluzamide	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of SGCB mRNA	PMID:33512557
1312050	SGCB	sarcoglycan beta	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1594202	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SGCB mRNA	PMID:23640034
1312050	SGCB	sarcoglycan beta	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312051	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SGCB mRNA	PMID:21795629
1312050	SGCB	sarcoglycan beta	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1594202	E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of SGCB mRNA	PMID:32419051
1312050	SGCB	sarcoglycan beta	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGCB mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGCB mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGCB mRNA	PMID:27188386
1312050	SGCB	sarcoglycan beta	gene	CHEBI:9422	tebufenpyrad	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of SGCB mRNA	PMID:33512557
1312050	SGCB	sarcoglycan beta	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312051	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of SGCB protein	PMID:24648495
1312050	SGCB	sarcoglycan beta	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312051	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SGCB mRNA	PMID:35537566
1312050	SGCB	sarcoglycan beta	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1594202	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of SGCB mRNA	PMID:19015723
1312050	SGCB	sarcoglycan beta	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1594202	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of SGCB mRNA	PMID:20566332
1312050	SGCB	sarcoglycan beta	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1594202	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of SGCB mRNA	PMID:23555832
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of USH1G mRNA	PMID:26079696
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of USH1G mRNA	PMID:22378314
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of USH1G mRNA	PMID:30165855
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1304551	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of USH1G mRNA	PMID:23829299
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1549969	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of USH1G mRNA	PMID:36706583
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304551	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of USH1G mRNA	PMID:27523638
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of USH1G mRNA	PMID:36139627
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304551	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of USH1G mRNA	PMID:39012411
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304551	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of USH1G mRNA	PMID:21396975
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of USH1G mRNA	PMID:38460933
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of USH1G mRNA	PMID:23557933
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304551	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of USH1G mRNA	PMID:22298810
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of USH1G mRNA	PMID:29301061|PMID:39719251
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1549969	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of USH1G mRNA	PMID:37682722
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of USH1G mRNA	PMID:32234424
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1549969	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of USH1G mRNA	PMID:23735875
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of USH1G gene	PMID:25435355
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of USH1G mRNA	PMID:35984750
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1549969	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of USH1G gene	PMID:35295148
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1549969	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of USH1G promoter	PMID:35295148
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304551	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of USH1G mRNA	PMID:30816183|PMID:32528016
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1304551	E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of USH1G mRNA	PMID:23829299
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1549969	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of USH1G intron	PMID:28392331
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1549969	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of USH1G gene	PMID:38995845
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304551	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of USH1G mRNA	PMID:39012411
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of USH1G gene	PMID:29154799
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of USH1G mRNA	PMID:38460933
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of USH1G mRNA	PMID:24810058
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of USH1G mRNA	PMID:36139627
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1304551	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of USH1G mRNA	PMID:32109520
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of USH1G mRNA	PMID:26079696
1312053	USH1G	USH1 protein network component sans	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1549969	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of USH1G mRNA	PMID:36706583
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312055	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ARHGEF4 mRNA	PMID:33045310
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of ARHGEF4 mRNA	PMID:21934132
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312055	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ARHGEF4 mRNA	PMID:36189433
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ARHGEF4 mRNA	PMID:17175027
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ARHGEF4 mRNA	PMID:26079696
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312055	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARHGEF4 mRNA	PMID:39241906
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ARHGEF4 mRNA	PMID:30165855
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1586179	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ARHGEF4 mRNA	PMID:23829299
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1586179	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ARHGEF4 mRNA	PMID:33387578
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ARHGEF4 mRNA	PMID:26079696
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312055	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ARHGEF4 mRNA	PMID:36189433
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ARHGEF4 mRNA	PMID:33359661
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312055	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of ARHGEF4 mRNA	PMID:33848595
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ARHGEF4 mRNA	PMID:31163220
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ARHGEF4 intron	PMID:30157460
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:18291	manganese atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of ARHGEF4 mRNA	PMID:17175027
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1312055	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of ARHGEF4 mRNA	PMID:27462272
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1312055	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of ARHGEF4 mRNA	PMID:39984025
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ARHGEF4 mRNA	PMID:32234424
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ARHGEF4 gene	PMID:27153756
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312055	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of ARHGEF4 mRNA	PMID:25629700
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ARHGEF4 mRNA	PMID:40512198
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ARHGEF4 mRNA	PMID:26272509
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA	PMID:27188386
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1586179	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of ARHGEF4 gene	PMID:35440735
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ARHGEF4 mRNA	PMID:28903495
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of ARHGEF4 gene	PMID:31636367
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312055	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGEF4 mRNA	PMID:21570461
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ARHGEF4 mRNA	PMID:28001369
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARHGEF4 mRNA	PMID:33212167
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ARHGEF4 mRNA	PMID:32763439
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312055	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of ARHGEF4 mRNA	PMID:36227756
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARHGEF4 mRNA	PMID:38568856
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGEF4 mRNA	PMID:29301061|PMID:34032870
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ARHGEF4 mRNA	PMID:40512198
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARHGEF4 intron	PMID:30157460
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ARHGEF4 5' UTR; Benzo(a)pyrene results in increased methylation of ARHGEF4 promoter	PMID:27901495
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ARHGEF4 mRNA	PMID:25895662
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ARHGEF4 gene	PMID:31601247
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312055	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ARHGEF4 mRNA	PMID:29264374
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1586179	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ARHGEF4 mRNA	PMID:19167457
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1586179	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARHGEF4 mRNA	PMID:25181051
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGEF4 mRNA	PMID:25047013
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1586179	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGEF4 mRNA	PMID:30816183
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ARHGEF4 gene	PMID:31601247
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	affects expression	ISO	RGD:1586179	E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl affects the expression of ARHGEF4 mRNA	PMID:23829299
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312055	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ARHGEF4 gene	PMID:31683443
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312055	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ARHGEF4 exon	PMID:33297965
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ARHGEF4 intron	PMID:30157460
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312055	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ARHGEF4 mRNA	PMID:28392331
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312055	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ARHGEF4 mRNA	PMID:17361019|PMID:21266533
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1586179	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARHGEF4 mRNA	PMID:21266533
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARHGEF4 mRNA	PMID:37042841
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1586179	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARHGEF4 mRNA	PMID:35163327
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:35154	manganese(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of ARHGEF4 mRNA	PMID:17175027
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARHGEF4 mRNA	PMID:38174414
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1586179	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARHGEF4 mRNA	PMID:35163327
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ARHGEF4 mRNA	PMID:24449571
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ARHGEF4 mRNA	PMID:31533062
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARHGEF4 mRNA	PMID:25979313
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312055	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ARHGEF4 mRNA	PMID:17963808
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARHGEF4 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ARHGEF4 gene	PMID:29154799
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA	PMID:27188386
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312055	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ARHGEF4 mRNA	PMID:28973697
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ARHGEF4 mRNA	PMID:38832940
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of ARHGEF4 mRNA	PMID:26272509|PMID:27188386
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA	PMID:27188386
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of ARHGEF4 mRNA	PMID:24935251|PMID:26272509
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA	PMID:27188386
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGEF4 mRNA	PMID:26690555
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ARHGEF4 mRNA	PMID:29067470
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of ARHGEF4 mRNA	PMID:24714768
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of ARHGEF4 promoter	PMID:29626692
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of ARHGEF4 promoter	PMID:29626692
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:46680	serpentine asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of ARHGEF4 promoter	PMID:29626692
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ARHGEF4 mRNA	PMID:40512198
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312055	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ARHGEF4 mRNA	PMID:25554681
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of ARHGEF4 mRNA	PMID:27188386
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in increased expression of ARHGEF4 mRNA	PMID:17175027
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:63041	manganese(II) chloride	increases methylation	ISO	RGD:1586179	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased methylation of ARHGEF4 gene	PMID:28801915
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1586179	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ARHGEF4 mRNA	PMID:28801915
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases methylation	ISO	RGD:1586179	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased methylation of ARHGEF4 gene	PMID:28801915
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ARHGEF4 mRNA	PMID:22079614
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ARHGEF4 intron	PMID:30157460
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ARHGEF4 mRNA	PMID:31758290
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1586179	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of ARHGEF4 mRNA	PMID:27840820
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA	PMID:27188386
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARHGEF4 gene]	PMID:28238834
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1586179	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ARHGEF4 mRNA	PMID:32109520
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ARHGEF4 mRNA	PMID:26079696
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF4 mRNA	PMID:27188386
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1586179	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ARHGEF4 mRNA	PMID:19281266
1312054	ARHGEF4	Rho guanine nucleotide exchange factor 4	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of ARHGEF4 mRNA	PMID:27188386
1312056	IFI35	interferon induced protein 35	gene	CHEBI:10110	zidovudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with IFNA1 protein] results in increased expression of IFI35 mRNA	PMID:20370541
1312056	IFI35	interferon induced protein 35	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304553	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IFI35 mRNA]	PMID:31150632
1312056	IFI35	interferon induced protein 35	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of IFI35 protein	PMID:36641056
1312056	IFI35	interferon induced protein 35	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in increased expression of IFI35 mRNA	PMID:15498508|PMID:33167477
1312056	IFI35	interferon induced protein 35	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1304553	E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI35 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of IFI35 mRNA	PMID:33729688
1312056	IFI35	interferon induced protein 35	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IFI35 protein	PMID:30501627
1312056	IFI35	interferon induced protein 35	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312057	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IFI35 mRNA	PMID:22687549|PMID:26582142|PMID:39241906
1312056	IFI35	interferon induced protein 35	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20161228	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFI35 mRNA]; genipin inhibits the reaction [Lipopolysaccharides results in increased expression of IFI35 mRNA]	PMID:22687549|PMID:39241906
1312056	IFI35	interferon induced protein 35	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of IFI35 mRNA	PMID:30510588
1312056	IFI35	interferon induced protein 35	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of IFI35 mRNA	PMID:39298647
1312056	IFI35	interferon induced protein 35	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of IFI35 mRNA	PMID:21185374
1312056	IFI35	interferon induced protein 35	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of IFI35 mRNA	PMID:30165855
1312056	IFI35	interferon induced protein 35	gene	CHEBI:16548	chlordecone	affects response to substance	EXP		E	RGD:6480464	20150609	CTD	MESH:D007631	IFI35 gene SNP affects the susceptibility to Chlordecone	PMID:25622337
1312056	IFI35	interferon induced protein 35	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of IFI35 mRNA	PMID:28973375
1312056	IFI35	interferon induced protein 35	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of IFI35 mRNA	PMID:21592394
1312056	IFI35	interferon induced protein 35	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of IFI35 mRNA	PMID:21592394
1312056	IFI35	interferon induced protein 35	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312057	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of IFI35 mRNA	PMID:23892564
1312056	IFI35	interferon induced protein 35	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of IFI35 mRNA	PMID:36139627
1312056	IFI35	interferon induced protein 35	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of IFI35 mRNA	PMID:21592394
1312056	IFI35	interferon induced protein 35	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of IFI35 mRNA	PMID:21592394
1312056	IFI35	interferon induced protein 35	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of IFI35 mRNA	PMID:28818685
1312056	IFI35	interferon induced protein 35	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1312057	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of IFI35 mRNA	PMID:39984025
1312056	IFI35	interferon induced protein 35	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of IFI35 mRNA	PMID:23649840
1312056	IFI35	interferon induced protein 35	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1312057	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of IFI35 gene	PMID:27776689
1312056	IFI35	interferon induced protein 35	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304553	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IFI35 mRNA	PMID:31150632
1312056	IFI35	interferon induced protein 35	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304553	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IFI35 mRNA]	PMID:31150632
1312056	IFI35	interferon induced protein 35	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312057	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid deficiency results in increased expression of IFI35 mRNA	PMID:32304770
1312056	IFI35	interferon induced protein 35	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of IFI35 mRNA]	PMID:22206623
1312056	IFI35	interferon induced protein 35	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IFI35 mRNA	PMID:40504410
1312056	IFI35	interferon induced protein 35	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of IFI35 mRNA	PMID:19244175
1312056	IFI35	interferon induced protein 35	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of IFI35 mRNA	PMID:38460933
1312056	IFI35	interferon induced protein 35	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of IFI35 mRNA	PMID:38460933
1312056	IFI35	interferon induced protein 35	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of IFI35 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of IFI35 mRNA	PMID:23557933
1312056	IFI35	interferon induced protein 35	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of IFI35 mRNA; Cisplatin results in increased expression of IFI35 protein	PMID:27392435|PMID:40654249
1312056	IFI35	interferon induced protein 35	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312057	E	RGD:6480464	20260602	CTD	MESH:D002945	Cisplatin results in increased expression of IFI35 protein	PMID:40654249
1312056	IFI35	interferon induced protein 35	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of IFI35 mRNA; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]	PMID:27392435|PMID:40654249
1312056	IFI35	interferon induced protein 35	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260602	CTD	MESH:D002945	erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]; ML385 inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; ML385 inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]]; ML385 inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]]	PMID:40654249
1312056	IFI35	interferon induced protein 35	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of IFI35 mRNA	PMID:18930951
1312056	IFI35	interferon induced protein 35	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of IFI35 mRNA	PMID:23195993
1312056	IFI35	interferon induced protein 35	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IFI35 mRNA	PMID:25583101
1312056	IFI35	interferon induced protein 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312057	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IFI35 mRNA	PMID:21570461
1312056	IFI35	interferon induced protein 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304553	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IFI35 mRNA	PMID:21215274|PMID:32109520
1312056	IFI35	interferon induced protein 35	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1304553	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of IFI35 mRNA	PMID:19013527
1312056	IFI35	interferon induced protein 35	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of IFI35 mRNA	PMID:33212167
1312056	IFI35	interferon induced protein 35	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IFI35 mRNA	PMID:29803840
1312056	IFI35	interferon induced protein 35	gene	CHEBI:28824	stigmasterol	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20181113	CTD	MESH:D013265	Stigmasterol results in decreased expression of IFI35 mRNA	PMID:30245210
1312056	IFI35	interferon induced protein 35	gene	CHEBI:28854	2,4-D	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of IFI35 mRNA	PMID:40294809
1312056	IFI35	interferon induced protein 35	gene	CHEBI:28984	aluminium atom	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20231031	CTD	MESH:D000535	Aluminum results in decreased expression of IFI35 mRNA	PMID:37544489
1312056	IFI35	interferon induced protein 35	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D001379	Azathioprine results in decreased expression of IFI35 mRNA	PMID:19192274
1312056	IFI35	interferon induced protein 35	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of IFI35 mRNA	PMID:38568856
1312056	IFI35	interferon induced protein 35	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IFI35 mRNA	PMID:40504410
1312056	IFI35	interferon induced protein 35	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312057	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IFI35 mRNA	PMID:23735875
1312056	IFI35	interferon induced protein 35	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of IFI35 mRNA	PMID:27131904
1312056	IFI35	interferon induced protein 35	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of IFI35 mRNA	PMID:20542052
1312056	IFI35	interferon induced protein 35	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of IFI35 mRNA	PMID:15498508
1312056	IFI35	interferon induced protein 35	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304553	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of IFI35 mRNA	PMID:23411599|PMID:34492290
1312056	IFI35	interferon induced protein 35	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312057	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of IFI35 mRNA	PMID:28472532
1312056	IFI35	interferon induced protein 35	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304553	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of IFI35 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312056	IFI35	interferon induced protein 35	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of IFI35 mRNA	PMID:29275510
1312056	IFI35	interferon induced protein 35	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304553	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of IFI35 mRNA	PMID:25181051
1312056	IFI35	interferon induced protein 35	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of IFI35 mRNA	PMID:19244175
1312056	IFI35	interferon induced protein 35	gene	CHEBI:33629	aluminium(0)	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20231031	CTD	MESH:D000535	Aluminum results in decreased expression of IFI35 mRNA	PMID:37544489
1312056	IFI35	interferon induced protein 35	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312057	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of IFI35 mRNA	PMID:30951980|PMID:39298647
1312056	IFI35	interferon induced protein 35	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312057	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of IFI35 mRNA	PMID:30951980
1312056	IFI35	interferon induced protein 35	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312057	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of IFI35 promoter	PMID:28392331
1312056	IFI35	interferon induced protein 35	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304553	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of IFI35 mRNA	PMID:21266533
1312056	IFI35	interferon induced protein 35	gene	CHEBI:34696	dieldrin	decreases expression	ISO	RGD:1304553	E	RGD:6480464	20210907	CTD	MESH:D004026	Dieldrin results in decreased expression of IFI35 mRNA	PMID:34051100
1312056	IFI35	interferon induced protein 35	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFI35 mRNA]	PMID:39241906
1312056	IFI35	interferon induced protein 35	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IFI35 mRNA	PMID:37042841
1312056	IFI35	interferon induced protein 35	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of IFI35 mRNA	PMID:37738295
1312056	IFI35	interferon induced protein 35	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of IFI35 mRNA	PMID:19244175
1312056	IFI35	interferon induced protein 35	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of IFI35 mRNA	PMID:29154799
1312056	IFI35	interferon induced protein 35	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304553	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of IFI35 mRNA	PMID:41580965
1312056	IFI35	interferon induced protein 35	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of IFI35 mRNA	PMID:25562108
1312056	IFI35	interferon induced protein 35	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in increased expression of IFI35 mRNA	PMID:20106945|PMID:22147139|PMID:27989131
1312056	IFI35	interferon induced protein 35	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312057	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of IFI35 mRNA	PMID:20937368
1312056	IFI35	interferon induced protein 35	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in decreased expression of IFI35 mRNA	PMID:19192274
1312056	IFI35	interferon induced protein 35	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IFI35 mRNA	PMID:38832940
1312056	IFI35	interferon induced protein 35	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312057	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IFI35 mRNA	PMID:17562736
1312056	IFI35	interferon induced protein 35	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of IFI35 mRNA	PMID:16101138
1312056	IFI35	interferon induced protein 35	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of IFI35 mRNA	PMID:38460933
1312056	IFI35	interferon induced protein 35	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IFI35 mRNA	PMID:40504410
1312056	IFI35	interferon induced protein 35	gene	CHEBI:47381	diclofenac	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D004008	Diclofenac results in decreased expression of IFI35 mRNA	PMID:19192274
1312056	IFI35	interferon induced protein 35	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312057	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IFI35 mRNA; Nanotubes, Carbon results in increased expression of IFI35 mRNA	PMID:25554681
1312056	IFI35	interferon induced protein 35	gene	CHEBI:5298	Genipin	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20141111	CTD	MESH:C007834	genipin inhibits the reaction [Lipopolysaccharides results in increased expression of IFI35 mRNA]	PMID:22687549
1312056	IFI35	interferon induced protein 35	gene	CHEBI:5516	sodium aurothiomalate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D006052	Gold Sodium Thiomalate results in decreased expression of IFI35 mRNA	PMID:19192274
1312056	IFI35	interferon induced protein 35	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of IFI35 mRNA	PMID:20436886
1312056	IFI35	interferon induced protein 35	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of IFI35 protein	PMID:32959892
1312056	IFI35	interferon induced protein 35	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI35 mRNA	PMID:21641980
1312056	IFI35	interferon induced protein 35	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of IFI35 mRNA	PMID:15336504
1312056	IFI35	interferon induced protein 35	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1304553	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of IFI35 mRNA	PMID:28801915
1312056	IFI35	interferon induced protein 35	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304553	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of IFI35 mRNA	PMID:30467583
1312056	IFI35	interferon induced protein 35	gene	CHEBI:6888	6alpha-methylprednisolone	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008775	Methylprednisolone results in decreased expression of IFI35 mRNA	PMID:19192274
1312056	IFI35	interferon induced protein 35	gene	CHEBI:71200	tofacitinib	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C479163	tofacitinib results in decreased expression of IFI35 mRNA	PMID:25487280
1312056	IFI35	interferon induced protein 35	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of IFI35 mRNA	PMID:31758290
1312056	IFI35	interferon induced protein 35	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312057	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IFI35 mRNA	PMID:22206623
1312056	IFI35	interferon induced protein 35	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of IFI35 mRNA]	PMID:22206623
1312056	IFI35	interferon induced protein 35	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1304553	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of IFI35 mRNA	PMID:24136188
1312056	IFI35	interferon induced protein 35	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of IFI35 mRNA	PMID:36139627
1312056	IFI35	interferon induced protein 35	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1304553	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of IFI35 mRNA	PMID:22124623
1312056	IFI35	interferon induced protein 35	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312057	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of IFI35 mRNA	PMID:30294300
1312056	IFI35	interferon induced protein 35	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFI35 mRNA]	PMID:39241906
1312056	IFI35	interferon induced protein 35	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of IFI35 mRNA	PMID:31734321
1312056	IFI35	interferon induced protein 35	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312057	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of IFI35 mRNA	PMID:27131904
1312056	IFI35	interferon induced protein 35	gene	CHEBI:94287	erastin	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:C477224	erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]]	PMID:40654249
1312056	IFI35	interferon induced protein 35	gene	CHEBI:94287	erastin	multiple interactions	ISO	RGD:1312057	E	RGD:6480464	20260602	CTD	MESH:C477224	erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of GPX4 protein]]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of NFE2L2 protein]]	PMID:40654249
1312056	IFI35	interferon induced protein 35	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of IFI35 mRNA	PMID:29301935
1312056	IFI35	interferon induced protein 35	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312057	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of IFI35 mRNA	PMID:35537566
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312060	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of COG3 mRNA	PMID:30319688
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312060	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of COG3 mRNA	PMID:39298647
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [COG3 protein binds to ESR1 protein]	PMID:27156127
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COG3 mRNA	PMID:37042841
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of COG3 mRNA	PMID:20655997
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312060	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of COG3 mRNA	PMID:23892564
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of COG3 gene	PMID:27153756
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304555	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of COG3 mRNA	PMID:31150632
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312060	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of COG3 mRNA	PMID:27339419|PMID:31919559
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312060	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of COG3 mRNA	PMID:25629700
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312060	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COG3 mRNA	PMID:22206623
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of COG3 mRNA	PMID:23557933
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312060	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COG3 mRNA	PMID:21570461
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312060	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of COG3 mRNA	PMID:25975270
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of COG3 protein	PMID:39603559
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of COG3 mRNA	PMID:30851411
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304555	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of COG3 mRNA	PMID:28959563
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COG3 mRNA	PMID:29803840
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of COG3 protein	PMID:30528433|PMID:38228842
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312060	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of COG3 mRNA	PMID:36209798
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of COG3 mRNA	PMID:22378314
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312060	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COG3 exon; Benzo(a)pyrene results in increased methylation of COG3 intron	PMID:27901495
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to COG3 mRNA]	PMID:32406909
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312060	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of COG3 mRNA	PMID:23221170
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of COG3 mRNA	PMID:26238291
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of COG3 gene	PMID:31601247
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304555	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of COG3 mRNA	PMID:24136188
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312060	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of COG3 gene	PMID:35295148
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of COG3 mRNA	PMID:19710929
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of COG3 protein	PMID:31675489
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312060	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of COG3 mRNA	PMID:33221593
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of COG3 protein	PMID:37567409
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304555	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of COG3 mRNA	PMID:30816183
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of COG3 gene	PMID:31601247
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312060	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of COG3 mRNA	PMID:39298647
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312060	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of COG3 mRNA	PMID:37019170
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312060	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of COG3 mRNA	PMID:34813904
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COG3 mRNA	PMID:38174414
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of COG3 mRNA	PMID:28302478
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of COG3 mRNA	PMID:31533062
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1304555	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of COG3 mRNA	PMID:23125180
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312060	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of COG3 mRNA	PMID:17292431
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of COG3 mRNA	PMID:20106945|PMID:27989131
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312060	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of COG3 mRNA	PMID:18502557
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312060	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of COG3 mRNA	PMID:17562736
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of COG3 mRNA	PMID:21420995
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304555	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COG3 mRNA	PMID:33387578
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304555	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of COG3 mRNA	PMID:29391264
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312060	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of COG3 mRNA	PMID:35964746
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of COG3 protein	PMID:32959892
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312060	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COG3 mRNA	PMID:22206623
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1312060	E	RGD:6480464	20220607	CTD	MESH:C038405	nivalenol results in increased expression of COG3 mRNA	PMID:35016910
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of COG3 mRNA	PMID:30851411
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COG3 gene]	PMID:28238834
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of COG3 protein	PMID:31675489
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304555	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of COG3 mRNA	PMID:21346803
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of COG3 mRNA	PMID:38568856
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of COG3 mRNA	PMID:22378314
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1312060	E	RGD:6480464	20140715	CTD	MESH:D013849	Thimerosal results in increased expression of COG3 mRNA	PMID:24675092
1312059	COG3	component of oligomeric golgi complex 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304555	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of COG3 mRNA	PMID:21346803
1312061	ACTG1	actin gamma 1	gene	CHEBI:10093	yohimbine	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D015016	Yohimbine results in increased expression of ACTG1 mRNA	PMID:21983523
1312061	ACTG1	actin gamma 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ACTG1 mRNA	PMID:38218311
1312061	ACTG1	actin gamma 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ACTG1 mRNA	PMID:38218311
1312061	ACTG1	actin gamma 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ACTG1 mRNA	PMID:35967413
1312061	ACTG1	actin gamma 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ACTG1 mRNA	PMID:33045310
1312061	ACTG1	actin gamma 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304556	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTG1 mRNA]	PMID:31150632
1312061	ACTG1	actin gamma 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1549970	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ACTG1 mRNA	PMID:20188158
1312061	ACTG1	actin gamma 1	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1549970	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin affects the expression of ACTG1 protein	PMID:15789344
1312061	ACTG1	actin gamma 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ACTG1 mRNA	PMID:23724009
1312061	ACTG1	actin gamma 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of ACTG1 protein	PMID:39571964
1312061	ACTG1	actin gamma 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ACTG1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ACTG1 mRNA	PMID:32699268
1312061	ACTG1	actin gamma 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D010100	ACTG1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]	PMID:21124846
1312061	ACTG1	actin gamma 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1549970	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ACTG1 mRNA	PMID:30319688
1312061	ACTG1	actin gamma 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D000431	Ethanol results in increased expression of ACTG1 protein	PMID:23702218
1312061	ACTG1	actin gamma 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of ACTG1 mRNA	PMID:30319688
1312061	ACTG1	actin gamma 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of ACTG1 mRNA	PMID:11179685
1312061	ACTG1	actin gamma 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ACTG1 mRNA	PMID:39298647
1312061	ACTG1	actin gamma 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of ACTG1 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Estradiol results in decreased expression of ACTG1 mRNA]	PMID:11179685
1312061	ACTG1	actin gamma 1	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ACTG1 mRNA	PMID:38568856
1312061	ACTG1	actin gamma 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACTG1 mRNA	PMID:37042841
1312061	ACTG1	actin gamma 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of ACTG1 mRNA	PMID:18045764
1312061	ACTG1	actin gamma 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ACTG1 mRNA	PMID:21179406
1312061	ACTG1	actin gamma 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D005947	ACTG1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]	PMID:21124846
1312061	ACTG1	actin gamma 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACTG1 mRNA	PMID:37992649
1312061	ACTG1	actin gamma 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20240903	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased expression of ACTG1 mRNA	PMID:38730545
1312061	ACTG1	actin gamma 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D005947	ACTG1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]	PMID:21124846
1312061	ACTG1	actin gamma 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACTG1 mRNA	PMID:37992649
1312061	ACTG1	actin gamma 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of ACTG1 mRNA	PMID:23892564
1312061	ACTG1	actin gamma 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1549970	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ACTG1 mRNA	PMID:19850644
1312061	ACTG1	actin gamma 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20120412	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased expression of ACTG1 mRNA; PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACTG1 mRNA]	PMID:19850644|PMID:38730545
1312061	ACTG1	actin gamma 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304556	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ACTG1 mRNA	PMID:22061828
1312061	ACTG1	actin gamma 1	gene	CHEBI:18243	dopamine	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D004298	Dopamine results in increased expression of ACTG1 mRNA	PMID:21983523
1312061	ACTG1	actin gamma 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of ACTG1 mRNA	PMID:27462272
1312061	ACTG1	actin gamma 1	gene	CHEBI:207229	dihydroartemisinin	affects binding	EXP		E	RGD:6480464	20170303	CTD	MESH:C039060	artenimol analog binds to ACTG1 protein	PMID:26340163
1312061	ACTG1	actin gamma 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ACTG1 mRNA	PMID:19549813
1312061	ACTG1	actin gamma 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ACTG1 protein	PMID:23301498
1312061	ACTG1	actin gamma 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304556	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ACTG1 mRNA	PMID:33354967
1312061	ACTG1	actin gamma 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ACTG1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ACTG1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of ACTG1 mRNA	PMID:32699268
1312061	ACTG1	actin gamma 1	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1304556	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of ACTG1 mRNA	PMID:30779732
1312061	ACTG1	actin gamma 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304556	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ACTG1 mRNA	PMID:31150632
1312061	ACTG1	actin gamma 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1549970	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ACTG1 mRNA	PMID:17084009
1312061	ACTG1	actin gamma 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304556	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTG1 mRNA]	PMID:31150632
1312061	ACTG1	actin gamma 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ACTG1 mRNA]	PMID:22206623
1312061	ACTG1	actin gamma 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ACTG1 mRNA	PMID:19244175
1312061	ACTG1	actin gamma 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1549970	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of ACTG1 mRNA	PMID:28189721|PMID:28960355
1312061	ACTG1	actin gamma 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ACTG1 mRNA	PMID:27392435
1312061	ACTG1	actin gamma 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ACTG1 mRNA	PMID:27392435
1312061	ACTG1	actin gamma 1	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in decreased expression of ACTG1 mRNA	PMID:22228119
1312061	ACTG1	actin gamma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304556	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACTG1 mRNA	PMID:34747641
1312061	ACTG1	actin gamma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACTG1 mRNA; Tetrachlorodibenzodioxin results in decreased expression of ACTG1 protein	PMID:16054898|PMID:16548065|PMID:33387578
1312061	ACTG1	actin gamma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACTG1 protein	PMID:19201780
1312061	ACTG1	actin gamma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [Estradiol results in decreased expression of ACTG1 mRNA]	PMID:11179685
1312061	ACTG1	actin gamma 1	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1304556	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone affects the expression of ACTG1 mRNA	PMID:28374803
1312061	ACTG1	actin gamma 1	gene	CHEBI:28201	rotenone	increases oxidation	ISO	RGD:1304556	E	RGD:6480464	20190910	CTD	MESH:D012402	Rotenone results in increased oxidation of ACTG1 protein	PMID:30951809
1312061	ACTG1	actin gamma 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ACTG1 mRNA	PMID:30851411
1312061	ACTG1	actin gamma 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ACTG1 mRNA	PMID:32763439
1312061	ACTG1	actin gamma 1	gene	CHEBI:28694	copper atom	affects binding	EXP		E	RGD:6480464	20120814	CTD	MESH:D003300	ACTG1 protein binds to Copper	PMID:15359738
1312061	ACTG1	actin gamma 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ACTG1 mRNA	PMID:30911355
1312061	ACTG1	actin gamma 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ACTG1 protein	PMID:27548804
1312061	ACTG1	actin gamma 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ACTG1 mRNA	PMID:39631538
1312061	ACTG1	actin gamma 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ACTG1 mRNA	PMID:29803840
1312061	ACTG1	actin gamma 1	gene	CHEBI:28748	doxorubicin	increases oxidation	ISO	RGD:1304556	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin results in increased oxidation of ACTG1 protein	PMID:28818578
1312061	ACTG1	actin gamma 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACTG1 mRNA	PMID:37992649
1312061	ACTG1	actin gamma 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of ACTG1 mRNA	PMID:35314868
1312061	ACTG1	actin gamma 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ACTG1 mRNA	PMID:38568856
1312061	ACTG1	actin gamma 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in increased expression of ACTG1 protein; [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of ACTG1 mRNA; sodium arsenite promotes the reaction [ACTG1 protein binds to CAPRIN1 protein]	PMID:32076005|PMID:33939924|PMID:39571964
1312061	ACTG1	actin gamma 1	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of ACTG1 mRNA	PMID:22378314
1312061	ACTG1	actin gamma 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACTG1 mRNA	PMID:20064835
1312061	ACTG1	actin gamma 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ACTG1 3' UTR	PMID:27901495
1312061	ACTG1	actin gamma 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C015001	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of ACTG1 mRNA	PMID:32076005
1312061	ACTG1	actin gamma 1	gene	CHEBI:30052	copper(0)	affects binding	EXP		E	RGD:6480464	20120814	CTD	MESH:D003300	ACTG1 protein binds to Copper	PMID:15359738
1312061	ACTG1	actin gamma 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ACTG1 mRNA	PMID:30911355
1312061	ACTG1	actin gamma 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ACTG1 mRNA	PMID:20458559
1312061	ACTG1	actin gamma 1	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1549970	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of ACTG1 mRNA	PMID:36087614
1312061	ACTG1	actin gamma 1	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304556	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of ACTG1 mRNA	PMID:24136188
1312061	ACTG1	actin gamma 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304556	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ACTG1 mRNA	PMID:30047161
1312061	ACTG1	actin gamma 1	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of ACTG1 mRNA	PMID:24136188
1312061	ACTG1	actin gamma 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACTG1 mRNA	PMID:23557971
1312061	ACTG1	actin gamma 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1549970	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ACTG1 promoter alternative form	PMID:35295148
1312061	ACTG1	actin gamma 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304556	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ACTG1 mRNA	PMID:34492290
1312061	ACTG1	actin gamma 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1549970	E	RGD:6480464	20120515	CTD	MESH:C006253	pirinixic acid results in increased expression of ACTG1 mRNA	PMID:16221962|PMID:18445702
1312061	ACTG1	actin gamma 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ACTG1 mRNA	PMID:38479592
1312061	ACTG1	actin gamma 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ACTG1 mRNA	PMID:30903817
1312061	ACTG1	actin gamma 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304556	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ACTG1 mRNA	PMID:30903817
1312061	ACTG1	actin gamma 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of ACTG1 protein	PMID:31675489
1312061	ACTG1	actin gamma 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ACTG1 mRNA	PMID:33221593
1312061	ACTG1	actin gamma 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of ACTG1 protein	PMID:37567409
1312061	ACTG1	actin gamma 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304556	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ACTG1 mRNA	PMID:25181051
1312061	ACTG1	actin gamma 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1549970	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in increased expression of ACTG1 mRNA	PMID:35479511
1312061	ACTG1	actin gamma 1	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of ACTG1 mRNA	PMID:12082028
1312061	ACTG1	actin gamma 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ACTG1 mRNA	PMID:39298647
1312061	ACTG1	actin gamma 1	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ACTG1 mRNA	PMID:26377693
1312061	ACTG1	actin gamma 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1549970	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ACTG1 mRNA	PMID:38685157
1312061	ACTG1	actin gamma 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ACTG1 mRNA	PMID:21266533
1312061	ACTG1	actin gamma 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1549970	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ACTG1 mRNA	PMID:17361019|PMID:21266533
1312061	ACTG1	actin gamma 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1549970	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ACTG1 mRNA	PMID:34813904
1312061	ACTG1	actin gamma 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ACTG1 mRNA	PMID:19638242
1312061	ACTG1	actin gamma 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in decreased expression of ACTG1 protein	PMID:39748354
1312061	ACTG1	actin gamma 1	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of ACTG1 mRNA	PMID:30589522
1312061	ACTG1	actin gamma 1	gene	CHEBI:35176	zinc sulfate	affects expression	EXP		E	RGD:6480464	20150127	CTD	MESH:D019287	Zinc Sulfate affects the expression of ACTG1 protein	PMID:25162517
1312061	ACTG1	actin gamma 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304556	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ACTG1 mRNA	PMID:30723492
1312061	ACTG1	actin gamma 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ACTG1 mRNA	PMID:38568856
1312061	ACTG1	actin gamma 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ACTG1 mRNA	PMID:19162173|PMID:30047161
1312061	ACTG1	actin gamma 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1549970	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of ACTG1 mRNA	PMID:28962523
1312061	ACTG1	actin gamma 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ACTG1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ACTG1 mRNA	PMID:32699268
1312061	ACTG1	actin gamma 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ACTG1 mRNA	PMID:19244175
1312061	ACTG1	actin gamma 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ACTG1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACTG1 mRNA]	PMID:17585979
1312061	ACTG1	actin gamma 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of ACTG1 protein	PMID:17152098
1312061	ACTG1	actin gamma 1	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1549970	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 results in increased expression of ACTG1 mRNA	PMID:16221962
1312061	ACTG1	actin gamma 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1549970	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ACTG1 mRNA	PMID:40194260
1312061	ACTG1	actin gamma 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ACTG1 mRNA	PMID:28302478
1312061	ACTG1	actin gamma 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ACTG1 mRNA	PMID:40419075
1312061	ACTG1	actin gamma 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1549970	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ACTG1 mRNA	PMID:17292431
1312061	ACTG1	actin gamma 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304556	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ACTG1 mRNA	PMID:30047161
1312061	ACTG1	actin gamma 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ACTG1 mRNA	PMID:25562108
1312061	ACTG1	actin gamma 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1549970	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ACTG1 mRNA	PMID:20937368
1312061	ACTG1	actin gamma 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D005947	ACTG1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]	PMID:21124846
1312061	ACTG1	actin gamma 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACTG1 mRNA	PMID:37992649
1312061	ACTG1	actin gamma 1	gene	CHEBI:42839	3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D011692	Puromycin Aminonucleoside results in decreased expression of ACTG1 protein	PMID:19264907
1312061	ACTG1	actin gamma 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1549970	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of ACTG1 mRNA	PMID:18502557
1312061	ACTG1	actin gamma 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1549970	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACTG1 mRNA	PMID:17562736
1312061	ACTG1	actin gamma 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of ACTG1 protein	PMID:22230336
1312061	ACTG1	actin gamma 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20120613	CTD	MESH:D000082	Acetaminophen results in increased expression of ACTG1 mRNA	PMID:11264010|PMID:18544908
1312061	ACTG1	actin gamma 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ACTG1 mRNA; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ACTG1 mRNA]; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACTG1 mRNA]	PMID:17585979|PMID:18700144
1312061	ACTG1	actin gamma 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in decreased expression of ACTG1 mRNA	PMID:31464424
1312061	ACTG1	actin gamma 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ACTG1 mRNA	PMID:12082028
1312061	ACTG1	actin gamma 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ACTG1 mRNA	PMID:14976129
1312061	ACTG1	actin gamma 1	gene	CHEBI:4917	eugenol	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in decreased expression of ACTG1 protein	PMID:39793947
1312061	ACTG1	actin gamma 1	gene	CHEBI:4948	Evodiamine	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine results in increased expression of ACTG1 mRNA	PMID:32057900
1312061	ACTG1	actin gamma 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ACTG1 mRNA	PMID:20458559
1312061	ACTG1	actin gamma 1	gene	CHEBI:5002	fenoldopam	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D018818	Fenoldopam results in increased expression of ACTG1 mRNA	PMID:21983523
1312061	ACTG1	actin gamma 1	gene	CHEBI:50182	3,3'-diindolylmethane	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C016392	3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of ACTG1 mRNA]	PMID:11179685
1312061	ACTG1	actin gamma 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1549970	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ACTG1 mRNA	PMID:25620056
1312061	ACTG1	actin gamma 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1549970	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ACTG1 mRNA; Nanotubes, Carbon results in increased expression of ACTG1 mRNA	PMID:25554681
1312061	ACTG1	actin gamma 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304556	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ACTG1 mRNA	PMID:30047161
1312061	ACTG1	actin gamma 1	gene	CHEBI:50859	bexarotene	increases expression	ISO	RGD:1304556	E	RGD:6480464	20170303	CTD	MESH:C095105	bexarotene results in increased expression of ACTG1 mRNA	PMID:16648578
1312061	ACTG1	actin gamma 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ACTG1 mRNA	PMID:35964746
1312061	ACTG1	actin gamma 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304556	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ACTG1 mRNA	PMID:24136188
1312061	ACTG1	actin gamma 1	gene	CHEBI:517248	bufalin	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C022777	bufalin results in increased expression of ACTG1 protein	PMID:23091618
1312061	ACTG1	actin gamma 1	gene	CHEBI:52492	mancozeb	increases expression	ISO	RGD:1549970	E	RGD:6480464	20140708	CTD	MESH:C013099	mancozeb results in increased expression of ACTG1 protein	PMID:21375462
1312061	ACTG1	actin gamma 1	gene	CHEBI:529996	cytochalasin D	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D015638	Cytochalasin D inhibits the reaction [UPF1 protein binds to ACTG1 protein]; Cytochalasin D inhibits the reaction [UPF2 protein binds to ACTG1 protein]; Cytochalasin D inhibits the reaction [UPF3B protein binds to ACTG1 protein]	PMID:28743738
1312061	ACTG1	actin gamma 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1549970	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ACTG1 mRNA	PMID:19042947
1312061	ACTG1	actin gamma 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ACTG1 protein	PMID:18563748
1312061	ACTG1	actin gamma 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ACTG1 protein	PMID:32959892
1312061	ACTG1	actin gamma 1	gene	CHEBI:63598	levofloxacin	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of ACTG1 mRNA	PMID:24136188
1312061	ACTG1	actin gamma 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ACTG1 mRNA	PMID:28988120
1312061	ACTG1	actin gamma 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1549970	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ACTG1 protein	PMID:26558463
1312061	ACTG1	actin gamma 1	gene	CHEBI:66104	jaspamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C057531	jasplakinolide inhibits the reaction [UPF1 protein binds to ACTG1 protein]; jasplakinolide inhibits the reaction [UPF2 protein binds to ACTG1 protein]; jasplakinolide inhibits the reaction [UPF3B protein binds to ACTG1 protein]	PMID:28743738
1312061	ACTG1	actin gamma 1	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D008694	Methamphetamine results in decreased expression of ACTG1 protein	PMID:19826936
1312061	ACTG1	actin gamma 1	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1304556	E	RGD:6480464	20230307	CTD	MESH:C057862	cyanoginosin LR results in increased expression of ACTG1 protein	PMID:22430071
1312061	ACTG1	actin gamma 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1549970	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ACTG1 mRNA	PMID:22206623
1312061	ACTG1	actin gamma 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ACTG1 mRNA]	PMID:22206623
1312061	ACTG1	actin gamma 1	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of ACTG1 mRNA	PMID:15215175
1312061	ACTG1	actin gamma 1	gene	CHEBI:76326	N-nitrosomorpholine	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:C002741	N-nitrosomorpholine results in decreased expression of ACTG1 protein	PMID:19716841
1312061	ACTG1	actin gamma 1	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of ACTG1 protein	PMID:19716841
1312061	ACTG1	actin gamma 1	gene	CHEBI:76987	metacetamol	increases expression	ISO	RGD:1549970	E	RGD:6480464	20140204	CTD	MESH:C026137	3-hydroxyacetanilide results in increased expression of ACTG1 mRNA	PMID:18544908
1312061	ACTG1	actin gamma 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ACTG1 mRNA	PMID:30851411
1312061	ACTG1	actin gamma 1	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of ACTG1 protein	PMID:19550292
1312061	ACTG1	actin gamma 1	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1549970	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 promotes the reaction [NR1H4 protein binds to ACTG1 gene]	PMID:20091679
1312061	ACTG1	actin gamma 1	gene	CHEBI:80025	Salinomycin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of ACTG1 mRNA	PMID:19682730
1312061	ACTG1	actin gamma 1	gene	CHEBI:8064	phenformin	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of ACTG1 mRNA	PMID:31324951
1312061	ACTG1	actin gamma 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D010634	Phenobarbital results in decreased expression of ACTG1 mRNA	PMID:19162173
1312061	ACTG1	actin gamma 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1304556	E	RGD:6480464	20140304	CTD	MESH:D010634	Phenobarbital results in increased expression of ACTG1 mRNA	PMID:12082028
1312061	ACTG1	actin gamma 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1549970	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ACTG1 mRNA	PMID:31388691
1312061	ACTG1	actin gamma 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1549970	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ACTG1 mRNA	PMID:38648751
1312061	ACTG1	actin gamma 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1549970	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ACTG1 mRNA	PMID:30294300
1312061	ACTG1	actin gamma 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304556	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ACTG1 mRNA	PMID:24780913|PMID:30047161|PMID:36843608
1312061	ACTG1	actin gamma 1	gene	CHEBI:90633	perfluorododecanoic acid	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20170303	CTD	MESH:C522391	perfluorododecanoic acid results in decreased expression of ACTG1 protein	PMID:26168851
1312061	ACTG1	actin gamma 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ACTG1 mRNA	PMID:38568856
1312061	ACTG1	actin gamma 1	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of ACTG1 mRNA	PMID:22378314
1312061	ACTG1	actin gamma 1	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of ACTG1 mRNA	PMID:19140230
1312061	ACTG1	actin gamma 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1304556	E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of ACTG1 mRNA	PMID:24136188
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of PGLYRP3 mRNA	PMID:26079696
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D002104	[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of PGLYRP3 mRNA	PMID:21481475
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D012643	[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of PGLYRP3 mRNA	PMID:21481475
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of PGLYRP3 mRNA	PMID:19921347
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PGLYRP3 mRNA	PMID:23152189
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PGLYRP3 mRNA	PMID:30851411
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of PGLYRP3 mRNA	PMID:34032870
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PGLYRP3 promoter	PMID:27901495
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:3020	benzalkonium chloride	increases expression	ISO	RGD:1312064	E	RGD:6480464	20190219	CTD	MESH:D001548	Benzalkonium Compounds results in increased expression of PGLYRP3 mRNA	PMID:30171875
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312064	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PGLYRP3 mRNA	PMID:29264374
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1312064	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of PGLYRP3 mRNA	PMID:19191707
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1593164	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PGLYRP3 mRNA	PMID:25181051
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1593164	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of PGLYRP3 mRNA	PMID:41034487
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D012643	[Cadmium analog co-treated with Selenium analog co-treated with zinc sulfide analog] results in increased expression of PGLYRP3 mRNA	PMID:21481475
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312064	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of PGLYRP3 mRNA	PMID:39529242
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of PGLYRP3 mRNA	PMID:26690555
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1593164	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PGLYRP3 gene	PMID:35440735
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PGLYRP3 mRNA	PMID:30851411
1312063	PGLYRP3	peptidoglycan recognition protein 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PGLYRP3 gene]	PMID:28238834
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:10033	warfarin	decreases expression	ISO	RGD:1312066	E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin results in decreased expression of DSTN mRNA	PMID:20493250
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1312066	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of DSTN protein	PMID:36252740
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312066	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of DSTN mRNA	PMID:37995155
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312066	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DSTN mRNA	PMID:39752319
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1588366	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of DSTN mRNA	PMID:30071829
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312066	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of DSTN mRNA	PMID:16604517
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:16136	hydrogen sulfide	affects expression	ISO	RGD:1312066	E	RGD:6480464	20181113	CTD	MESH:D006862	Hydrogen Sulfide affects the expression of DSTN protein	PMID:29932956
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1588366	E	RGD:6480464	20140722	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of DSTN protein	PMID:23178681
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1588366	E	RGD:6480464	20140722	CTD	MESH:D006861	Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of DSTN protein]	PMID:23178681
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of DSTN mRNA	PMID:21632981
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:16336	hyaluronic acid	decreases expression	ISO	RGD:1588366	E	RGD:6480464	20140722	CTD	MESH:D006820	Hyaluronic Acid analog results in decreased expression of DSTN protein	PMID:23178681
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:16336	hyaluronic acid	multiple interactions	ISO	RGD:1588366	E	RGD:6480464	20140722	CTD	MESH:D006820	Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of DSTN protein]	PMID:23178681
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1588366	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DSTN mRNA	PMID:33387578
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312066	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DSTN mRNA	PMID:39752319
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in decreased expression of DSTN protein	PMID:34122009
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DSTN protein	PMID:37730182
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312066	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DSTN mRNA	PMID:36331819
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of DSTN mRNA	PMID:12634122
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:22977	cadmium atom	affects localization	ISO	RGD:1312066	E	RGD:6480464	20150310	CTD	MESH:D002104	Cadmium affects the localization of DSTN protein	PMID:24077948
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of DSTN mRNA	PMID:24376830
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312066	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in increased expression of DSTN mRNA	PMID:24067728
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:22977	cadmium atom	increases oxidation	ISO	RGD:1312066	E	RGD:6480464	20150310	CTD	MESH:D002104	Cadmium results in increased oxidation of DSTN protein	PMID:24077948
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DSTN mRNA	PMID:19549813
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DSTN protein	PMID:23301498
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of DSTN mRNA	PMID:23649840
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DSTN mRNA	PMID:23649840
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of DSTN protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DSTN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DSTN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of DSTN protein	PMID:38598786
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312066	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DSTN mRNA	PMID:31919559
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312066	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DSTN mRNA	PMID:22206623
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DSTN protein	PMID:38460933
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:27881	resveratrol	affects expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol affects the expression of DSTN protein	PMID:22234583
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1588366	E	RGD:6480464	20140722	CTD	MESH:D019833	Genistein results in increased expression of DSTN mRNA	PMID:17341692
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312066	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DSTN mRNA	PMID:21570461
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DSTN mRNA	PMID:20106945|PMID:21632981
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1588366	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DSTN mRNA	PMID:34747641
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312066	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of DSTN mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DSTN mRNA	PMID:16214954|PMID:17942748
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DSTN mRNA	PMID:28001369
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DSTN mRNA	PMID:33212167
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1588366	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of DSTN mRNA	PMID:28959563
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of DSTN mRNA	PMID:29803840
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DSTN mRNA; sodium arsenite results in decreased expression of DSTN protein	PMID:22714537|PMID:39571964
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	[sodium arsenite co-treated with lead acetate] results in decreased expression of DSTN protein	PMID:38072110
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312066	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DSTN mRNA	PMID:22228805
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DSTN promoter	PMID:27901495
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to DSTN mRNA]	PMID:32406909
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in decreased expression of DSTN protein	PMID:38072110
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1588366	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of DSTN mRNA	PMID:30047161
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312066	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DSTN gene	PMID:35295148
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312066	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of DSTN promoter	PMID:35295148
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312066	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of DSTN mRNA; bisphenol A results in decreased expression of DSTN protein	PMID:24909818|PMID:26063408|PMID:33221593|PMID:37105096
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of DSTN protein	PMID:37567409
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1588366	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DSTN mRNA	PMID:25181051
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1588366	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DSTN gene	PMID:28505145
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1312066	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of DSTN mRNA	PMID:24096037
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1588366	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of DSTN mRNA	PMID:24096037
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of DSTN protein	PMID:34186270
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312066	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DSTN mRNA	PMID:39298647
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312066	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DSTN mRNA	PMID:38685157
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312066	E	RGD:6480464	20220607	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DSTN protein	PMID:34864091
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1588366	E	RGD:6480464	20140722	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DSTN mRNA	PMID:21266533
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of DSTN protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of DSTN protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DSTN protein	PMID:38598786
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DSTN mRNA	PMID:37042841
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:35176	zinc sulfate	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of DSTN mRNA	PMID:12756304
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of DSTN mRNA	PMID:24449571
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312066	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DSTN mRNA	PMID:40194260
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:38757	isoflavones	multiple interactions	ISO	RGD:1588366	E	RGD:6480464	20170303	CTD	MESH:D007529	[ENNG co-treated with Isoflavones] results in increased expression of DSTN protein	PMID:22248470
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DSTN mRNA	PMID:31533062
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of DSTN mRNA	PMID:26352163
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DSTN mRNA	PMID:40419075
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312066	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DSTN mRNA	PMID:36331819
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of DSTN mRNA	PMID:28001369
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of DSTN mRNA	PMID:23179753|PMID:26272509
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSTN mRNA	PMID:27188386
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1588366	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of DSTN mRNA	PMID:30047161
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:40303	lovastatin	decreases expression	ISO	RGD:1312066	E	RGD:6480464	20120814	CTD	MESH:D008148	Lovastatin results in decreased expression of DSTN mRNA	PMID:20493250
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DSTN mRNA	PMID:25562108
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312066	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DSTN mRNA	PMID:28973697
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:43572	kojic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of DSTN mRNA	PMID:16595896
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019319	Okadaic Acid results in decreased expression of DSTN protein	PMID:19397276
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of DSTN mRNA	PMID:29523930
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DSTN protein	PMID:38460933
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312066	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of DSTN mRNA	PMID:35436446
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312066	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DSTN mRNA	PMID:17942748|PMID:24096037
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1588366	E	RGD:6480464	20140722	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DSTN mRNA	PMID:24096037
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312066	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DSTN mRNA	PMID:17942748
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1588366	E	RGD:6480464	20210706	CTD	MESH:C017690	fenvalerate results in decreased expression of DSTN protein	PMID:33656234
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312066	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DSTN mRNA; Nanotubes, Carbon results in increased expression of DSTN mRNA	PMID:25620056
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1588366	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of DSTN mRNA	PMID:34044035
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1588366	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of DSTN mRNA	PMID:30047161
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312066	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DSTN mRNA	PMID:35964746
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1588366	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DSTN mRNA	PMID:24136188
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of DSTN mRNA	PMID:22714537
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:6015	isoflurane	increases methylation	ISO	RGD:1312066	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in increased methylation of DSTN mRNA	PMID:35249202
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DSTN protein	PMID:32959892
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312066	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DSTN mRNA	PMID:23650126
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1588366	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of DSTN mRNA	PMID:24136188
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312066	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DSTN protein	PMID:26558463
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312066	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of DSTN protein	PMID:36851058
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of DSTN protein	PMID:34122009
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312066	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DSTN mRNA	PMID:39752319
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DSTN protein	PMID:34186270
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312066	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DSTN mRNA	PMID:22206623
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312066	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DSTN mRNA	PMID:22206623
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1588366	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of DSTN mRNA	PMID:24136188
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of DSTN protein	PMID:31285264
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSTN mRNA	PMID:27188386
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DSTN gene]	PMID:28238834
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312066	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DSTN mRNA	PMID:38648751
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DSTN protein	PMID:38348393
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312066	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of DSTN mRNA	PMID:39847705
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1588366	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of DSTN mRNA	PMID:30047161
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1588366	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of DSTN mRNA	PMID:30047161
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of DSTN mRNA	PMID:12756304
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312066	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DSTN mRNA	PMID:39752319
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSTN mRNA	PMID:27188386
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1588366	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of DSTN mRNA	PMID:19281266
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:9381	T-2 toxin	affects expression	ISO	RGD:1588366	E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin affects the expression of DSTN protein	PMID:26141394
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of DSTN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DSTN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of DSTN protein	PMID:38598786
1312065	DSTN	destrin, actin depolymerizing factor	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1588366	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of DSTN mRNA	PMID:19015723
1312067	WNT6	Wnt family member 6	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of WNT6 mRNA	PMID:38218311
1312067	WNT6	Wnt family member 6	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of WNT6 mRNA	PMID:33045310
1312067	WNT6	Wnt family member 6	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312068	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of WNT6 mRNA	PMID:37995155
1312067	WNT6	Wnt family member 6	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of WNT6 mRNA	PMID:34925699
1312067	WNT6	Wnt family member 6	gene	CHEBI:144400	dinophysistoxin 1	decreases expression	EXP		E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in decreased expression of WNT6 mRNA	PMID:28939011
1312067	WNT6	Wnt family member 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of WNT6 mRNA	PMID:16604517
1312067	WNT6	Wnt family member 6	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of WNT6 mRNA	PMID:20044591
1312067	WNT6	Wnt family member 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of WNT6 mRNA	PMID:35811015
1312067	WNT6	Wnt family member 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of WNT6 mRNA]	PMID:35811015
1312067	WNT6	Wnt family member 6	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of WNT6 mRNA	PMID:30510588
1312067	WNT6	Wnt family member 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312068	E	RGD:6480464	20130416	CTD	MESH:D004958	Estradiol results in increased expression of WNT6 mRNA	PMID:23144751
1312067	WNT6	Wnt family member 6	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in increased expression of WNT6 mRNA	PMID:28937961
1312067	WNT6	Wnt family member 6	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of WNT6 mRNA	PMID:26079696
1312067	WNT6	Wnt family member 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of WNT6 mRNA	PMID:34319233
1312067	WNT6	Wnt family member 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of WNT6 mRNA	PMID:31163220
1312067	WNT6	Wnt family member 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312068	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of WNT6 mRNA	PMID:33754040
1312067	WNT6	Wnt family member 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1304559	E	RGD:6480464	20191112	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA	PMID:31199487
1312067	WNT6	Wnt family member 6	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased expression of WNT6 mRNA	PMID:22562489
1312067	WNT6	Wnt family member 6	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20241203	CTD	MESH:D001397	[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT6 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT6 mRNA]	PMID:31715269
1312067	WNT6	Wnt family member 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20121218	CTD	MESH:D005492	[Folic Acid co-treated with sodium arsenite] results in increased methylation of WNT6 mRNA	PMID:22959928
1312067	WNT6	Wnt family member 6	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of WNT6 mRNA	PMID:26272509
1312067	WNT6	Wnt family member 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1312067	WNT6	Wnt family member 6	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of WNT6 mRNA	PMID:32186404
1312067	WNT6	Wnt family member 6	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1304559	E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in decreased expression of WNT6 mRNA	PMID:19130878
1312067	WNT6	Wnt family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312068	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WNT6 mRNA	PMID:21570461
1312067	WNT6	Wnt family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304559	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WNT6 mRNA	PMID:32109520
1312067	WNT6	Wnt family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WNT6 mRNA	PMID:20106945|PMID:21296121|PMID:21632981
1312067	WNT6	Wnt family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WNT6 mRNA	PMID:17942748
1312067	WNT6	Wnt family member 6	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of WNT6 mRNA	PMID:26272509
1312067	WNT6	Wnt family member 6	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1312067	WNT6	Wnt family member 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of WNT6 mRNA	PMID:37682722
1312067	WNT6	Wnt family member 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of WNT6 mRNA	PMID:38568856
1312067	WNT6	Wnt family member 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20161228	CTD	MESH:C017947	[Folic Acid co-treated with sodium arsenite] results in increased methylation of WNT6 mRNA	PMID:22959928
1312067	WNT6	Wnt family member 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WNT6 mRNA	PMID:21632981
1312067	WNT6	Wnt family member 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WNT6 3' UTR; Benzo(a)pyrene results in increased methylation of WNT6 promoter	PMID:27901495
1312067	WNT6	Wnt family member 6	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of WNT6 mRNA	PMID:25895662
1312067	WNT6	Wnt family member 6	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312068	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of WNT6 mRNA	PMID:29341224
1312067	WNT6	Wnt family member 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of WNT6 mRNA	PMID:29264374
1312067	WNT6	Wnt family member 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312068	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of WNT6 promoter	PMID:35295148
1312067	WNT6	Wnt family member 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304559	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of WNT6 mRNA	PMID:34492290
1312067	WNT6	Wnt family member 6	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of WNT6 mRNA	PMID:17950772
1312067	WNT6	Wnt family member 6	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20120412	CTD	MESH:C006253	NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of WNT6 mRNA]	PMID:17950772
1312067	WNT6	Wnt family member 6	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1312068	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of WNT6 mRNA	PMID:19191707
1312067	WNT6	Wnt family member 6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304559	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of WNT6 mRNA	PMID:25181051
1312067	WNT6	Wnt family member 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304559	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of WNT6 mRNA	PMID:30816183|PMID:31129395|PMID:34947998|PMID:38750585
1312067	WNT6	Wnt family member 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312068	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of WNT6 mRNA	PMID:32156529
1312067	WNT6	Wnt family member 6	gene	CHEBI:3390	carbaryl	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D012721	Carbaryl results in decreased expression of WNT6 mRNA	PMID:27829164
1312067	WNT6	Wnt family member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312068	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of WNT6 mRNA	PMID:30951980|PMID:40203079
1312067	WNT6	Wnt family member 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312068	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of WNT6 mRNA	PMID:30951980
1312067	WNT6	Wnt family member 6	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1304559	E	RGD:6480464	20191112	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA	PMID:31199487
1312067	WNT6	Wnt family member 6	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20200519	CTD	MESH:D016264	[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT6 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT6 mRNA]	PMID:31715269
1312067	WNT6	Wnt family member 6	gene	CHEBI:34682	diazinon	increases expression	ISO	RGD:1304559	E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon results in increased expression of WNT6 mRNA	PMID:19130878
1312067	WNT6	Wnt family member 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of WNT6 mRNA	PMID:17361019|PMID:21266533
1312067	WNT6	Wnt family member 6	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1304559	E	RGD:6480464	20191112	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA	PMID:31199487
1312067	WNT6	Wnt family member 6	gene	CHEBI:34696	dieldrin	increases expression	ISO	RGD:1304559	E	RGD:6480464	20120412	CTD	MESH:D004026	Dieldrin results in increased expression of WNT6 mRNA	PMID:19130878
1312067	WNT6	Wnt family member 6	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1304559	E	RGD:6480464	20191112	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA	PMID:31199487
1312067	WNT6	Wnt family member 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312068	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of WNT6 mRNA	PMID:20478370
1312067	WNT6	Wnt family member 6	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1304559	E	RGD:6480464	20191112	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA	PMID:31199487
1312067	WNT6	Wnt family member 6	gene	CHEBI:36791	escitalopram	decreases expression	ISO	RGD:1304559	E	RGD:6480464	20250204	CTD	MESH:D000089983	Escitalopram results in decreased expression of WNT6 mRNA	PMID:28467792
1312067	WNT6	Wnt family member 6	gene	CHEBI:3723	citalopram	decreases expression	ISO	RGD:1304559	E	RGD:6480464	20250204	CTD	MESH:D015283	Citalopram results in decreased expression of WNT6 mRNA	PMID:28467792
1312067	WNT6	Wnt family member 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1304559	E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of WNT6 mRNA	PMID:35594946
1312067	WNT6	Wnt family member 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of WNT6 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1312067	WNT6	Wnt family member 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1304559	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in increased expression of WNT6 mRNA	PMID:29427782
1312067	WNT6	Wnt family member 6	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1312067	WNT6	Wnt family member 6	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304559	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of WNT6 mRNA	PMID:30047161
1312067	WNT6	Wnt family member 6	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of WNT6 mRNA	PMID:24935251
1312067	WNT6	Wnt family member 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of WNT6 mRNA	PMID:22230336|PMID:29067470
1312067	WNT6	Wnt family member 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304559	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of WNT6 mRNA	PMID:33387578
1312067	WNT6	Wnt family member 6	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of WNT6 mRNA]	PMID:35811015
1312067	WNT6	Wnt family member 6	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of WNT6 mRNA	PMID:31838189
1312067	WNT6	Wnt family member 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WNT6 mRNA	PMID:17942748
1312067	WNT6	Wnt family member 6	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of WNT6 mRNA	PMID:32234424
1312067	WNT6	Wnt family member 6	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1312067	WNT6	Wnt family member 6	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304559	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of WNT6 mRNA	PMID:30307764
1312067	WNT6	Wnt family member 6	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304559	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of WNT6 mRNA	PMID:30047161
1312067	WNT6	Wnt family member 6	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1304559	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of WNT6 mRNA	PMID:28801915
1312067	WNT6	Wnt family member 6	gene	CHEBI:63959	celastrol	multiple interactions	ISO	RGD:1312068	E	RGD:6480464	20210608	CTD	MESH:C050414	celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of WNT6 mRNA]	PMID:31715269
1312067	WNT6	Wnt family member 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1304559	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of WNT6 mRNA	PMID:28801915
1312067	WNT6	Wnt family member 6	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312068	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of WNT6 mRNA	PMID:22206623
1312067	WNT6	Wnt family member 6	gene	CHEBI:755665	etc-159	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000620782	ETC-159 results in decreased expression of WNT6 mRNA	PMID:39647516
1312067	WNT6	Wnt family member 6	gene	CHEBI:755665	etc-159	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20260714	CTD	MESH:C000620782	ETC-159 results in decreased expression of WNT6 mRNA	PMID:39647516
1312067	WNT6	Wnt family member 6	gene	CHEBI:77397	1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile	decreases expression	ISO	RGD:1304559	E	RGD:6480464	20250204	CTD	MESH:D015283	Citalopram results in decreased expression of WNT6 mRNA	PMID:28467792
1312067	WNT6	Wnt family member 6	gene	CHEBI:78030	LGK974	decreases expression	ISO	RGD:1312068	E	RGD:6480464	20250902	CTD	MESH:C586458	LGK974 results in decreased expression of WNT6 mRNA	PMID:39647516
1312067	WNT6	Wnt family member 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1312067	WNT6	Wnt family member 6	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1304559	E	RGD:6480464	20191112	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WNT6 mRNA	PMID:31199487
1312067	WNT6	Wnt family member 6	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to WNT6 gene]	PMID:28238834
1312067	WNT6	Wnt family member 6	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304559	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of WNT6 mRNA	PMID:32109520
1312067	WNT6	Wnt family member 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304559	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of WNT6 mRNA	PMID:24780913|PMID:30047161
1312067	WNT6	Wnt family member 6	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1312067	WNT6	Wnt family member 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT6 mRNA	PMID:27188386
1312067	WNT6	Wnt family member 6	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of WNT6 mRNA	PMID:38568856
1312067	WNT6	Wnt family member 6	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304559	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of WNT6 mRNA	PMID:20566332
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CHCHD6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CHCHD6 mRNA	PMID:32699268
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CHCHD6 mRNA	PMID:36331819
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1549972	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CHCHD6 mRNA	PMID:30319688
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1549972	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CHCHD6 mRNA	PMID:30319688
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CHCHD6 mRNA	PMID:21179406
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1549972	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CHCHD6 mRNA	PMID:39241906
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304561	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of CHCHD6 mRNA	PMID:32145629
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHCHD6 mRNA	PMID:37992649
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of CHCHD6 mRNA	PMID:36314267
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHCHD6 mRNA	PMID:37992649
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CHCHD6 mRNA	PMID:28818685
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CHCHD6 intron	PMID:30157460
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CHCHD6 mRNA	PMID:36331819
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:19452	2-amino-4,6-dinitrotoluene	affects expression	ISO	RGD:1304561	E	RGD:6480464	20140304	CTD	MESH:C035208	2-amino-4,6-dinitrotoluene affects the expression of CHCHD6 mRNA	PMID:21346803
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304561	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of CHCHD6 mRNA	PMID:21396975
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1304561	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHCHD6 mRNA	PMID:22129741
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CHCHD6 mRNA	PMID:19770486
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CHCHD6 intron	PMID:30157460
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of CHCHD6 mRNA	PMID:25102026
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of CHCHD6 mRNA	PMID:32553695
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CHCHD6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CHCHD6 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of CHCHD6 mRNA	PMID:32699268
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304561	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CHCHD6 mRNA	PMID:31150632
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHCHD6 mRNA	PMID:22206623
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CHCHD6 mRNA	PMID:28960355
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CHCHD6 mRNA	PMID:28903495
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in decreased expression of CHCHD6 mRNA	PMID:24280081|PMID:27392435|PMID:27594783
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1304561	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of CHCHD6 mRNA	PMID:22023808
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in decreased expression of CHCHD6 mRNA	PMID:24280081|PMID:25270620
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of CHCHD6 mRNA	PMID:27392435
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:27924	phenylhydrazine	increases expression	ISO	RGD:1304561	E	RGD:6480464	20120412	CTD	MESH:C030299	phenylhydrazine results in increased expression of CHCHD6 mRNA	PMID:17698508
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1549972	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHCHD6 mRNA	PMID:21570461
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304561	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHCHD6 mRNA	PMID:34747641
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CHCHD6 mRNA	PMID:17942748
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CHCHD6 mRNA	PMID:33212167
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHCHD6 mRNA	PMID:37992649
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CHCHD6 mRNA	PMID:38568856
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1549972	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of CHCHD6 gene	PMID:39894169
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHCHD6 intron; Benzo(a)pyrene affects the methylation of CHCHD6 promoter	PMID:27901495|PMID:30157460
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CHCHD6 mRNA	PMID:20064835|PMID:26238291
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CHCHD6 mRNA	PMID:19770486|PMID:21715664
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CHCHD6 3' UTR	PMID:27901495
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1549972	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CHCHD6 mRNA	PMID:22228805
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CHCHD6 mRNA]	PMID:22228805
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CHCHD6 gene	PMID:31601247
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304561	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of CHCHD6 mRNA	PMID:24136188
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CHCHD6 mRNA	PMID:23557971
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1304561	E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of CHCHD6 mRNA	PMID:19162173|PMID:22484513
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1549972	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CHCHD6 mRNA	PMID:18301758|PMID:20813756|PMID:23811191
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:32687	piperonyl butoxide	increases expression	ISO	RGD:1304561	E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of CHCHD6 mRNA	PMID:22484513
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1549972	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CHCHD6 mRNA	PMID:28472532
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304561	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CHCHD6 mRNA	PMID:32145629|PMID:34947998
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CHCHD6 gene	PMID:31601247
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304561	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CHCHD6 mRNA	PMID:25181051
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304561	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CHCHD6 gene	PMID:28505145
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CHCHD6 gene	PMID:31601247
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1549972	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CHCHD6 mRNA	PMID:39298647
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CHCHD6 intron	PMID:30157460
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CHCHD6 mRNA	PMID:32715474
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1304561	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHCHD6 mRNA	PMID:17602206
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CHCHD6 mRNA	PMID:21266533
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of CHCHD6 mRNA	PMID:34813904
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304561	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHCHD6 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CHCHD6 mRNA	PMID:17602206|PMID:22129741
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304561	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of CHCHD6 mRNA	PMID:32680482
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1304561	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CHCHD6 mRNA	PMID:19162173
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1304561	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CHCHD6 mRNA	PMID:19162173
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CHCHD6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CHCHD6 mRNA	PMID:32699268
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of CHCHD6 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CHCHD6 mRNA]	PMID:17585979
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1549972	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CHCHD6 mRNA	PMID:40194260
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CHCHD6 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CHCHD6 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CHCHD6 mRNA	PMID:36331819
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CHCHD6 mRNA	PMID:25979313
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1549972	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CHCHD6 mRNA	PMID:17963808
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CHCHD6 gene	PMID:29154799
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CHCHD6 mRNA	PMID:20106945
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CHCHD6 mRNA	PMID:37992649
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1304561	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CHCHD6 mRNA	PMID:24136188
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CHCHD6 mRNA	PMID:38832940
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1304561	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of CHCHD6 mRNA	PMID:21346803
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1549972	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CHCHD6 mRNA	PMID:17562736
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of CHCHD6 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CHCHD6 mRNA]	PMID:17585979
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1549972	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CHCHD6 mRNA	PMID:17942748
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CHCHD6 mRNA	PMID:17942748
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CHCHD6 mRNA	PMID:25554681
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1549972	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CHCHD6 mRNA; Nanotubes, Carbon results in increased expression of CHCHD6 mRNA	PMID:25620056
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1304561	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CHCHD6 mRNA	PMID:24136188
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1304561	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of CHCHD6 mRNA	PMID:23962444
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	ISO	RGD:1304561	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of CHCHD6 mRNA	PMID:19162173
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304561	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CHCHD6 mRNA	PMID:24136188
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1304561	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CHCHD6 mRNA	PMID:24136188
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1304561	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CHCHD6 mRNA	PMID:28801915
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CHCHD6 intron	PMID:30157460
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304561	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CHCHD6 gene	PMID:35440735
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CHCHD6 mRNA	PMID:31758290
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1549972	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHCHD6 mRNA	PMID:22206623
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1304561	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CHCHD6 mRNA	PMID:24136188
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of CHCHD6 mRNA	PMID:32858204
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1304561	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of CHCHD6 mRNA	PMID:21346803
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CHCHD6 gene]	PMID:28238834
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:8050	phenacetin	increases expression	ISO	RGD:1304561	E	RGD:6480464	20120412	CTD	MESH:D010615	Phenacetin results in increased expression of CHCHD6 mRNA	PMID:17698508
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1304561	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of CHCHD6 mRNA	PMID:19162173
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:8093	phenylephrine	increases expression	ISO	RGD:1304561	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in increased expression of CHCHD6 mRNA	PMID:18158353
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:8228	pioglitazone	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C060836	Pioglitazone results in decreased expression of CHCHD6 mRNA	PMID:30031879
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304561	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CHCHD6 mRNA	PMID:21346803
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1549972	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of CHCHD6 protein	PMID:24648495
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304561	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CHCHD6 mRNA	PMID:21346803
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1304561	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of CHCHD6 protein	PMID:32519852
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1549972	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of CHCHD6 mRNA	PMID:28973697
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304561	E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of CHCHD6 mRNA	PMID:22615374
1312070	CHCHD6	coiled-coil-helix-coiled-coil-helix domain containing 6	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1304561	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of CHCHD6 gene	PMID:31682807
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D014212	Tretinoin results in decreased expression of SYNE3 mRNA	PMID:23724009
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of SYNE3 mRNA	PMID:26516004
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SYNE3 mRNA	PMID:35811015
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SYNE3 mRNA	PMID:31614463
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of SYNE3 mRNA	PMID:20404318
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SYNE3 mRNA	PMID:37042841
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of SYNE3 mRNA	PMID:27664576
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SYNE3 mRNA	PMID:36695872
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SYNE3 mRNA	PMID:36139627
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SYNE3 mRNA	PMID:28818685
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of SYNE3 3' UTR	PMID:30157460
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312073	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SYNE3 mRNA	PMID:37236586
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1304563	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SYNE3 mRNA	PMID:33354967
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20170110	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SYNE3 gene	PMID:27153756
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SYNE3 gene	PMID:25304211
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA	PMID:27188386
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312073	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of SYNE3 mRNA	PMID:35897073
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312073	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of SYNE3 protein	PMID:25505154
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1304563	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of SYNE3 gene	PMID:28505145
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304563	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SYNE3 mRNA	PMID:33387578
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SYNE3 mRNA	PMID:29803840
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D024483	Vitamin K 3 affects the expression of SYNE3 mRNA	PMID:20044591
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:C028473	SYNE3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine	PMID:21177773
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SYNE3 promoter	PMID:27901495
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SYNE3 mRNA	PMID:22316170|PMID:26238291
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312073	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SYNE3 mRNA	PMID:27195522
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312073	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SYNE3 mRNA	PMID:27131904
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SYNE3 mRNA	PMID:25351596
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SYNE3 mRNA	PMID:26238291
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1304563	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of SYNE3 mRNA	PMID:24395379
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304563	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SYNE3 mRNA	PMID:25181051
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A analog results in increased expression of SYNE3 mRNA; bisphenol A results in increased expression of SYNE3 mRNA	PMID:29275510|PMID:32387340|PMID:36232920
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312073	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of SYNE3 mRNA	PMID:32156529
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304563	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of SYNE3 gene	PMID:28505145
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312073	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of SYNE3 mRNA	PMID:33297965|PMID:39298647|PMID:40203079
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SYNE3 mRNA	PMID:37042841
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SYNE3 mRNA	PMID:38568856
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312073	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SYNE3 mRNA	PMID:37236586
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1304563	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of SYNE3 mRNA	PMID:25539665
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312073	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SYNE3 mRNA	PMID:40194260
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SYNE3 mRNA	PMID:31533062
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D014635	Valproic Acid results in increased expression of SYNE3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SYNE3 gene	PMID:29154799
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA	PMID:27188386
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SYNE3 mRNA	PMID:25562108|PMID:27989131
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D003907	Dexamethasone results in increased expression of SYNE3 mRNA	PMID:25047013
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312073	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SYNE3 mRNA	PMID:28973697
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D000082	Acetaminophen results in decreased expression of SYNE3 mRNA	PMID:21420995
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304563	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SYNE3 mRNA	PMID:33387578
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SYNE3 mRNA	PMID:35811015
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SYNE3 gene	PMID:25304211
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312073	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SYNE3 mRNA	PMID:25554681
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of SYNE3 mRNA	PMID:28991164
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304563	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SYNE3 mRNA	PMID:30047161
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of SYNE3 mRNA	PMID:28991164
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SYNE3 mRNA	PMID:31758290
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of SYNE3 mRNA	PMID:29522793
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SYNE3 mRNA	PMID:36139627
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA	PMID:27188386
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of SYNE3 mRNA	PMID:26705709
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304563	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SYNE3 mRNA	PMID:24780913
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:C496932	panobinostat results in increased expression of SYNE3 mRNA	PMID:26272509
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA	PMID:27188386
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNE3 mRNA	PMID:27188386
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312073	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SYNE3 mRNA	PMID:27131904
1312072	SYNE3	spectrin repeat containing nuclear envelope family member 3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SYNE3 mRNA	PMID:29301935
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312075	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of RUFY2 mRNA	PMID:33045310
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RUFY2 gene	PMID:20938992
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of RUFY2 mRNA	PMID:23724009
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUFY2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUFY2 mRNA	PMID:32699268
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RUFY2 mRNA	PMID:26079696
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312075	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RUFY2 mRNA	PMID:30319688
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RUFY2 mRNA	PMID:25510870
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RUFY2 gene	PMID:20938992
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of RUFY2 mRNA	PMID:20655997|PMID:23649840
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RUFY2 mRNA	PMID:28818685
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RUFY2 mRNA	PMID:39836092
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RUFY2 mRNA	PMID:35301059
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RUFY2 mRNA	PMID:25510870
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RUFY2 mRNA	PMID:25510870
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RUFY2 mRNA	PMID:23649840
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RUFY2 intron	PMID:30157460
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of RUFY2 mRNA	PMID:23649840
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUFY2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUFY2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RUFY2 mRNA	PMID:32699268
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RUFY2 gene	PMID:20938992
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RUFY2 gene	PMID:25304211
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RUFY2 mRNA	PMID:40504410
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of RUFY2 mRNA	PMID:26272509
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RUFY2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUFY2 mRNA	PMID:27188386
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312075	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RUFY2 mRNA	PMID:28960355
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312075	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RUFY2 mRNA	PMID:21570461
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RUFY2 mRNA	PMID:17942748
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1592188	E	RGD:6480464	20170516	CTD	MESH:D012402	Rotenone results in decreased expression of RUFY2 mRNA	PMID:27900601
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RUFY2 mRNA	PMID:28001369
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RUFY2 mRNA	PMID:23179753|PMID:27188386
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RUFY2 mRNA	PMID:33212167
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RUFY2 mRNA	PMID:30851411
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1592188	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of RUFY2 mRNA	PMID:28959563
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RUFY2 mRNA	PMID:29803840
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RUFY2 mRNA	PMID:38568856
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RUFY2 mRNA	PMID:40504410
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RUFY2 mRNA	PMID:27858113
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of RUFY2 gene	PMID:31601247
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312075	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RUFY2 mRNA	PMID:33221593
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1592188	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RUFY2 mRNA	PMID:25181051|PMID:30816183
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1592188	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of RUFY2 mRNA	PMID:41034487
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of RUFY2 mRNA	PMID:19244175
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RUFY2 mRNA	PMID:25510870
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RUFY2 mRNA	PMID:25510870
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RUFY2 mRNA	PMID:27858113
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312075	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RUFY2 mRNA	PMID:38685157
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312075	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of RUFY2 intron	PMID:28392331
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RUFY2 mRNA	PMID:37042841
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RUFY2 mRNA	PMID:39836092
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RUFY2 mRNA	PMID:26472689
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RUFY2 mRNA	PMID:35301059
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RUFY2 mRNA	PMID:24449571
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUFY2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUFY2 mRNA	PMID:32699268
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RUFY2 mRNA	PMID:40419075
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RUFY2 mRNA	PMID:23179753|PMID:24383497|PMID:28001369
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUFY2 mRNA	PMID:27188386
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of RUFY2 mRNA	PMID:24449571
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of RUFY2 mRNA	PMID:24935251
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RUFY2 mRNA	PMID:24935251
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of RUFY2 mRNA	PMID:21420995
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RUFY2 gene	PMID:25304211
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RUFY2 mRNA	PMID:40504410
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RUFY2 mRNA	PMID:17942748
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312075	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RUFY2 mRNA; Nanotubes, Carbon results in decreased expression of RUFY2 mRNA	PMID:25554681
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RUFY2 mRNA	PMID:27858113
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1312075	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of RUFY2 mRNA	PMID:27858113
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of RUFY2 mRNA	PMID:26705709
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RUFY2 mRNA	PMID:39836092
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of RUFY2 mRNA	PMID:28988120
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1592188	E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of RUFY2 mRNA	PMID:39938710
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1312075	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of RUFY2 mRNA	PMID:27858113
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RUFY2 mRNA	PMID:30851411
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RUFY2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUFY2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUFY2 mRNA	PMID:27188386
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RUFY2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUFY2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUFY2 mRNA	PMID:27188386
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1592188	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RUFY2 mRNA	PMID:19281266
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of RUFY2 mRNA	PMID:27188386
1312074	RUFY2	RUN and FYVE domain containing 2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1592188	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RUFY2 mRNA	PMID:19015723
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SENP6 mRNA	PMID:33045310
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SENP6 gene	PMID:20938992
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SENP6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SENP6 mRNA	PMID:32699268
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SENP6 mRNA	PMID:26079696
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SENP6 mRNA	PMID:22378314
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1312077	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of SENP6 mRNA	PMID:20362636
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:16170	mercury(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of SENP6 mRNA	PMID:16823088
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312077	E	RGD:6480464	20200331	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SENP6 mRNA; Lipopolysaccharides results in increased expression of SENP6 protein	PMID:26807181
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20200331	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Chloroquine] results in increased expression of SENP6 protein; [MIR669N mRNA results in decreased expression of SENP6 protein] promotes the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]; [MIR669N mRNA results in decreased expression of SENP6 protein] promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; [MIR669N mRNA results in decreased expression of SENP6 protein] promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; MIR669N mRNA inhibits the reaction [Lipopolysaccharides results in increased expression of SENP6 protein]; SENP6 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]; SENP6 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; SENP6 protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]	PMID:26807181
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312077	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SENP6 mRNA	PMID:39298647
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:16602	trichloroethene	decreases methylation	ISO	RGD:1304565	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of SENP6 gene	PMID:27618143
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SENP6 gene	PMID:20938992
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SENP6 mRNA	PMID:37042841
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of SENP6 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SENP6 mRNA]	PMID:20230807
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SENP6 protein	PMID:37730182
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1312077	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SENP6 mRNA	PMID:20230807
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of SENP6 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of SENP6 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SENP6 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SENP6 mRNA]	PMID:20230807
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of SENP6 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SENP6 mRNA]	PMID:20230807
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SENP6 mRNA	PMID:37236586
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SENP6 mRNA	PMID:19549813
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SENP6 protein	PMID:23301498
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:25195	mercury atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of SENP6 mRNA	PMID:16823088
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SENP6 mRNA	PMID:23649840
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SENP6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SENP6 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of SENP6 mRNA	PMID:32699268
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SENP6 mRNA	PMID:25629700
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SENP6 gene	PMID:20938992
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of SENP6 mRNA	PMID:38723480
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:D001151	SENP6 protein affects the reaction [Arsenic results in decreased expression of FTO protein]; SENP6 protein affects the reaction [Arsenic results in increased expression of GCLM protein]; SENP6 protein affects the reaction [Arsenic results in increased expression of HMOX1 protein]	PMID:38723480
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SENP6 mRNA	PMID:26272509
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP6 mRNA	PMID:27188386
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SENP6 protein	PMID:35688186
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of SENP6 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SENP6 mRNA]	PMID:20230807
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SENP6 mRNA	PMID:23557933
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SENP6 mRNA	PMID:30912803
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312077	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SENP6 mRNA	PMID:21570461
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304565	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SENP6 mRNA	PMID:34747641
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SENP6 mRNA	PMID:17942748
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of SENP6 mRNA	PMID:33512557
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SENP6 mRNA	PMID:28001369
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SENP6 mRNA	PMID:33212167
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SENP6 mRNA	PMID:15467011
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SENP6 protein	PMID:35688186
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SENP6 mRNA	PMID:20064835
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SENP6 mRNA	PMID:15467011
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SENP6 gene	PMID:31601247
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1304565	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of SENP6 mRNA	PMID:22641619
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304565	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SENP6 mRNA	PMID:25729387
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304565	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of SENP6 mRNA	PMID:30047161
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312077	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SENP6 gene	PMID:35295148
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304565	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SENP6 mRNA	PMID:34492290
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of SENP6 mRNA	PMID:22576693
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304565	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SENP6 mRNA	PMID:34947998
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SENP6 mRNA	PMID:33221593
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304565	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SENP6 mRNA	PMID:25181051|PMID:30816183
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of SENP6 gene	PMID:22576693
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SENP6 gene	PMID:31601247
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312077	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SENP6 intron	PMID:28392331
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304565	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SENP6 mRNA	PMID:33453195
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SENP6 mRNA	PMID:26472689
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SENP6 mRNA	PMID:37236586
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1304565	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SENP6 mRNA	PMID:30047161
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20200331	CTD	MESH:D002738	[Lipopolysaccharides co-treated with Chloroquine] results in increased expression of SENP6 protein	PMID:26807181
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SENP6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SENP6 mRNA	PMID:32699268
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:3763	clorgyline	increases expression	EXP		E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of SENP6 mRNA	PMID:19691856
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SENP6 mRNA	PMID:31533062
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SENP6 mRNA	PMID:27153767
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SENP6 mRNA	PMID:25979313
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312077	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SENP6 mRNA	PMID:17963808
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SENP6 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of SENP6 mRNA	PMID:21427059
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SENP6 gene	PMID:29154799
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP6 mRNA	PMID:27188386
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304565	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SENP6 mRNA	PMID:30047161
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SENP6 mRNA	PMID:25562108
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SENP6 mRNA	PMID:20106945
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of SENP6 mRNA	PMID:33512557
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:44485	N-ethylmaleimide	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:D005033	Ethylmaleimide inhibits the reaction [SUMO2 protein binds to SENP6 protein]	PMID:26060329
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SENP6 mRNA	PMID:22083351
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of SENP6 mRNA	PMID:28542535
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of SENP6 mRNA	PMID:24935251
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SENP6 mRNA	PMID:21420995
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304565	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SENP6 mRNA	PMID:33387578
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SENP6 mRNA	PMID:29279043
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of SENP6 mRNA	PMID:38723480
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:D001151	SENP6 protein affects the reaction [Arsenic results in decreased expression of FTO protein]; SENP6 protein affects the reaction [Arsenic results in increased expression of GCLM protein]; SENP6 protein affects the reaction [Arsenic results in increased expression of HMOX1 protein]	PMID:38723480
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312077	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SENP6 mRNA	PMID:17942748
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304565	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SENP6 mRNA	PMID:30047161
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1304565	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SENP6 mRNA	PMID:25729387
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304565	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SENP6 mRNA	PMID:25729387
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SENP6 mRNA	PMID:23650126
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312077	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SENP6 mRNA	PMID:22206623
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of SENP6 protein	PMID:31285264
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP6 mRNA	PMID:27188386
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of SENP6 mRNA	PMID:18927307
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1312077	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of SENP6 mRNA	PMID:31558096
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of SENP6 mRNA	PMID:26079696
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304565	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SENP6 mRNA	PMID:30047161
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:85990	panobinostat	affects expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat affects the expression of SENP6 mRNA	PMID:26733615
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	(+)-JQ1 compound promotes the reaction [panobinostat affects the expression of SENP6 mRNA]; panobinostat promotes the reaction [(+)-JQ1 compound affects the expression of SENP6 mRNA]	PMID:26733615
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP6 mRNA	PMID:27188386
1312076	SENP6	SUMO specific peptidase 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304565	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SENP6 mRNA	PMID:21346803
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:10106	zearalenone	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D015025	Zearalenone results in decreased expression of IGSF9 mRNA	PMID:36828454
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGSF9 mRNA	PMID:20938992
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IGSF9 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of IGSF9 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of IGSF9 mRNA	PMID:32699268|PMID:32845096
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IGSF9 mRNA	PMID:36331819
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of IGSF9 mRNA	PMID:26079696
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of IGSF9 mRNA	PMID:20044591
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D004958	Estradiol results in decreased expression of IGSF9 mRNA	PMID:36828454
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304566	E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of IGSF9 mRNA	PMID:32145629|PMID:35192832
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in decreased expression of IGSF9 mRNA	PMID:20404318
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGSF9 mRNA	PMID:25510870
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGSF9 mRNA	PMID:20938992
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of IGSF9 mRNA	PMID:21179406
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGSF9 mRNA	PMID:37992649
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of IGSF9 mRNA	PMID:21592394
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312079	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of IGSF9 mRNA	PMID:33848595
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of IGSF9 mRNA	PMID:21592394
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGSF9 mRNA	PMID:37992649
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of IGSF9 mRNA	PMID:34319233
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of IGSF9 mRNA	PMID:21592394
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of IGSF9 mRNA	PMID:26485663
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of IGSF9 mRNA	PMID:21592394
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304566	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of IGSF9 mRNA	PMID:33387578
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of IGSF9 intron	PMID:30157460
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IGSF9 mRNA	PMID:28111341
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGSF9 mRNA	PMID:25510870
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGSF9 mRNA	PMID:25510870
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of IGSF9 exon; Aflatoxin B1 results in decreased methylation of IGSF9 gene	PMID:27153756|PMID:30157460
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IGSF9 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of IGSF9 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of IGSF9 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of IGSF9 mRNA	PMID:32699268|PMID:32845096
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1312079	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of IGSF9 mRNA	PMID:31939706
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304566	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IGSF9 mRNA	PMID:31150632
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IGSF9 mRNA	PMID:20938992
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of IGSF9 mRNA	PMID:40512198
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304566	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of IGSF9 mRNA	PMID:31881176
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of IGSF9 mRNA	PMID:23557933
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of IGSF9 mRNA	PMID:28903495
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312079	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IGSF9 mRNA	PMID:21570461
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304566	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IGSF9 mRNA	PMID:33387578
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of IGSF9 mRNA	PMID:32763439
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IGSF9 mRNA	PMID:30031762
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGSF9 mRNA	PMID:37992649
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of IGSF9 mRNA	PMID:29301061
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of IGSF9 mRNA	PMID:40512198
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of IGSF9 mRNA	PMID:22378314
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IGSF9 3' UTR; Benzo(a)pyrene affects the methylation of IGSF9 5' UTR; Benzo(a)pyrene affects the methylation of IGSF9 intron	PMID:27901495|PMID:30157460
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IGSF9 mRNA	PMID:32234424
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of IGSF9 promoter	PMID:27901495
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312079	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IGSF9 mRNA	PMID:22228805|PMID:23735875
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of IGSF9 mRNA]	PMID:22228805
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of IGSF9 mRNA	PMID:18929588
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in decreased expression of IGSF9 mRNA]	PMID:18929588
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of IGSF9 mRNA	PMID:35984750
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312079	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IGSF9 promoter	PMID:35295148
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312079	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of IGSF9 mRNA	PMID:20813756
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of IGSF9 gene	PMID:23968726
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304566	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of IGSF9 mRNA	PMID:25181051
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of IGSF9 mRNA	PMID:36828454
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304566	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of IGSF9 mRNA	PMID:32145629|PMID:35192832
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312079	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of IGSF9 promoter	PMID:27312807
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312079	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in increased expression of IGSF9 mRNA	PMID:29165653|PMID:32156529
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGSF9 mRNA	PMID:25510870
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGSF9 mRNA	PMID:25510870
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of IGSF9 mRNA	PMID:40203079
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of IGSF9 exon; benzo(e)pyrene results in decreased methylation of IGSF9 promoter	PMID:30157460
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1304566	E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein	PMID:34896426
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of IGSF9 gene	PMID:22964155
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312079	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of IGSF9 mRNA	PMID:21266533
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of IGSF9 gene	PMID:23968726
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304566	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of IGSF9 mRNA	PMID:35163327
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IGSF9 mRNA	PMID:28111341
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304566	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of IGSF9 mRNA	PMID:35163327
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IGSF9 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of IGSF9 mRNA	PMID:32699268
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of IGSF9 mRNA	PMID:31533062
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1304566	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of IGSF9 protein	PMID:34896426
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of IGSF9 mRNA	PMID:39529242
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of IGSF9 mRNA	PMID:36331819
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IGSF9 mRNA	PMID:25979313
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of IGSF9 mRNA	PMID:23179753|PMID:28001369
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of IGSF9 gene	PMID:29154799
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20180220	CTD	MESH:D014635	KDM1A protein affects the reaction [Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]]; Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]	PMID:27645313
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1304566	E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein	PMID:34896426
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1304566	E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein	PMID:34896426
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20180220	CTD	MESH:D003907	Dexamethasone results in decreased expression of IGSF9 mRNA	PMID:27645313
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20180220	CTD	MESH:D003907	[HDAC1 protein co-treated with HDAC2 protein] affects the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]; apicidin inhibits the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]; HDAC1 protein affects the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]; KDM1A protein affects the reaction [Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]]; Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]	PMID:27645313
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312079	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGSF9 mRNA	PMID:37992649
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304566	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of IGSF9 mRNA	PMID:33387578
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of IGSF9 mRNA	PMID:40512198
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of IGSF9 mRNA	PMID:32234424
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1304566	E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein	PMID:34896426
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of IGSF9 mRNA; Nanotubes, Carbon results in decreased expression of IGSF9 mRNA	PMID:25554681
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304566	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in increased expression of IGSF9 mRNA	PMID:41580965
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1304566	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of IGSF9 mRNA	PMID:20080153
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:64648	enniatin	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C100264	enniatins results in increased expression of IGSF9 mRNA	PMID:36016515
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of IGSF9 exon; Methapyrilene results in decreased methylation of IGSF9 promoter	PMID:30157460
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312079	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IGSF9 mRNA	PMID:22206623
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1312079	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of IGSF9 mRNA	PMID:27858113
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	ISO	RGD:1304566	E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of IGSF9 promoter	PMID:27415467
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IGSF9 gene]	PMID:28238834
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of IGSF9 mRNA	PMID:32234424
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312079	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of IGSF9 mRNA	PMID:39847705
1312078	IGSF9	immunoglobulin superfamily member 9	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304566	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of IGSF9 mRNA	PMID:24780913
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of P3H2 mRNA	PMID:26272509
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P3H2 mRNA	PMID:27188386
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of P3H2 mRNA	PMID:21934132
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of P3H2 mRNA	PMID:24236059
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in increased expression of P3H2 mRNA	PMID:23378141
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	[Ethanol co-treated with Folic Acid] results in increased expression of P3H2 mRNA	PMID:23378141
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of P3H2 mRNA	PMID:39241906
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of P3H2 mRNA	PMID:35811015
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of P3H2 mRNA]	PMID:35811015
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P3H2 mRNA]	PMID:39241906
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of P3H2 mRNA	PMID:20660070
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304568	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of P3H2 mRNA	PMID:26496021
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of P3H2 mRNA	PMID:21540246
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of P3H2 mRNA	PMID:20660070
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H2 mRNA	PMID:37992649
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1312082	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of P3H2 mRNA	PMID:28973375
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304568	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of P3H2 mRNA	PMID:26496021
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H2 mRNA	PMID:37992649
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of P3H2 mRNA	PMID:36139627
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:17967	urethane	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane affects the expression of P3H2 mRNA	PMID:28818685
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of P3H2 mRNA	PMID:37325564
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of P3H2 mRNA	PMID:27153756
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of P3H2 gene	PMID:27153756
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312082	E	RGD:6480464	20160705	CTD	MESH:D005492	Folic Acid results in increased expression of P3H2 mRNA	PMID:25006883
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D005492	[Ethanol co-treated with Folic Acid] results in increased expression of P3H2 mRNA	PMID:23378141
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of P3H2 mRNA	PMID:36861143
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of P3H2 mRNA	PMID:26272509
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P3H2 mRNA	PMID:27188386
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304568	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of P3H2 mRNA	PMID:31881176
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of P3H2 mRNA	PMID:19921347
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	P3H2 protein affects the susceptibility to Cisplatin	PMID:16217747
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of P3H2 mRNA	PMID:27392435
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of P3H2 mRNA	PMID:23625948
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312082	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of P3H2 mRNA	PMID:18930951
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304568	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of P3H2 mRNA	PMID:32109520
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312082	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of P3H2 mRNA	PMID:21354282
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312082	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of P3H2 mRNA	PMID:19933214
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304568	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of P3H2 mRNA	PMID:28959563
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H2 mRNA	PMID:37992649
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of P3H2 mRNA	PMID:22714537|PMID:38568856
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of P3H2 5' UTR	PMID:27901495
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of P3H2 mRNA	PMID:21871943
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312082	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of P3H2 exon; Benzo(a)pyrene results in decreased methylation of P3H2 intron	PMID:27901495
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of P3H2 mRNA	PMID:20064835
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312082	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of P3H2 mRNA	PMID:22228805
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of P3H2 promoter	PMID:27901495
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of P3H2 mRNA	PMID:19150397
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312082	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of P3H2 mRNA	PMID:39716349
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312082	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of P3H2 gene	PMID:35295148
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312082	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of P3H2 mRNA	PMID:35295148
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of P3H2 mRNA	PMID:29275510
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of P3H2 gene	PMID:31601247
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304568	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of P3H2 gene	PMID:28505145
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304568	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of P3H2 mRNA; [bisphenol A co-treated with Testosterone] results in increased expression of P3H2 mRNA	PMID:26496021
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312082	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of P3H2 mRNA	PMID:26682919
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of P3H2 mRNA	PMID:36804509
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of P3H2 mRNA	PMID:23146750
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of P3H2 protein	PMID:31945527
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312082	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of P3H2 mRNA	PMID:30951980
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of P3H2 mRNA	PMID:21527772
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P3H2 mRNA]	PMID:39241906
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of P3H2 mRNA	PMID:38568856
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of P3H2 mRNA	PMID:37325564
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of P3H2 mRNA	PMID:24449571
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of P3H2 mRNA	PMID:31533062
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of P3H2 mRNA	PMID:40419075
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312082	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of P3H2 mRNA	PMID:17292431
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of P3H2 mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of P3H2 mRNA	PMID:20106945
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of P3H2 mRNA	PMID:25047013
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H2 mRNA	PMID:37992649
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of P3H2 mRNA	PMID:29067470
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of P3H2 mRNA	PMID:24714768
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of P3H2 mRNA	PMID:35811015
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of P3H2 mRNA]	PMID:35811015
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of P3H2 mRNA	PMID:36861143
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of P3H2 mRNA	PMID:18936297
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of P3H2 mRNA	PMID:38568856
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312082	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of P3H2 mRNA	PMID:39716349
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312082	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of P3H2 mRNA	PMID:19042947
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of P3H2 protein	PMID:32959892
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312082	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of P3H2 mRNA	PMID:20003209
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of P3H2 mRNA	PMID:31758290
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of P3H2 mRNA	PMID:29522793
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of P3H2 mRNA	PMID:36139627
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of P3H2 mRNA	PMID:32858204
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1304568	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of P3H2 mRNA	PMID:23665939
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P3H2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P3H2 mRNA	PMID:27188386
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of P3H2 mRNA	PMID:23146750
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312082	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P3H2 mRNA]	PMID:39241906
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P3H2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of P3H2 mRNA	PMID:27188386
1312081	P3H2	prolyl 3-hydroxylase 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of P3H2 mRNA	PMID:38568856
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1304569	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of FEM1B mRNA	PMID:21551480
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of FEM1B mRNA	PMID:22574217
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312084	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of FEM1B mRNA	PMID:39298647
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FEM1B mRNA	PMID:37042841
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of FEM1B mRNA	PMID:20655997
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304569	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FEM1B mRNA	PMID:33387578
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FEM1B mRNA	PMID:28818685
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of FEM1B mRNA	PMID:24376830
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304569	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FEM1B mRNA	PMID:39012411
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FEM1B gene	PMID:27153756
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312084	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FEM1B mRNA	PMID:19770486
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312084	E	RGD:6480464	20120412	CTD	MESH:D010126	pyrazolanthrone promotes the reaction [Ozone results in increased expression of FEM1B mRNA]	PMID:17460151
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1304569	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of FEM1B gene	PMID:35440735
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of FEM1B mRNA	PMID:23557933
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of FEM1B mRNA	PMID:28903495
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312084	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FEM1B mRNA	PMID:21570461|PMID:24680724
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304569	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FEM1B mRNA	PMID:33387578
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304569	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FEM1B mRNA	PMID:32109520
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312084	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FEM1B mRNA	PMID:19465110
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FEM1B mRNA	PMID:28001369
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of FEM1B mRNA	PMID:29803840
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:29014	cordycepin	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C058120	cordycepin affects the expression of FEM1B mRNA	PMID:28099944
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1312084	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased methylation of FEM1B gene	PMID:39894169
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FEM1B promoter	PMID:27901495
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FEM1B 3' UTR	PMID:27901495
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312084	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of FEM1B mRNA	PMID:19073995
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304569	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of FEM1B mRNA	PMID:30047161
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312084	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FEM1B gene; titanium dioxide results in decreased methylation of FEM1B promoter	PMID:35295148
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312084	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide analog results in increased expression of FEM1B mRNA; titanium dioxide results in increased expression of FEM1B mRNA	PMID:23557971|PMID:25111187
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304569	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of FEM1B mRNA	PMID:23411599|PMID:34492290
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312084	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of FEM1B mRNA	PMID:17426115
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312084	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of FEM1B mRNA	PMID:16985257
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304569	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of FEM1B mRNA	PMID:26982218
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304569	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FEM1B mRNA	PMID:25181051|PMID:29097150
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312084	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of FEM1B mRNA	PMID:39298647
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1304569	E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FEM1B protein	PMID:34896426
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1304569	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of FEM1B mRNA	PMID:22546817
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1304569	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of FEM1B mRNA	PMID:22546817
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of FEM1B mRNA	PMID:17312168
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FEM1B mRNA	PMID:37042841
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1312084	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride affects the expression of FEM1B mRNA	PMID:18974090
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FEM1B mRNA; Cadmium Chloride results in decreased expression of FEM1B protein	PMID:38185225|PMID:38568856
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304569	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FEM1B mRNA	PMID:33453195
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304569	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FEM1B mRNA	PMID:39012411
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of FEM1B mRNA	PMID:19376846
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304569	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of FEM1B mRNA	PMID:24386269
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312084	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of FEM1B mRNA	PMID:40194260
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FEM1B mRNA	PMID:31533062
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:39098	pyrethrins	increases expression	ISO	RGD:1304569	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in increased expression of FEM1B protein	PMID:34896426
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FEM1B gene	PMID:29154799
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FEM1B mRNA	PMID:20106945|PMID:25562108
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1304569	E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FEM1B protein	PMID:34896426
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1304569	E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FEM1B protein	PMID:34896426
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312084	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FEM1B mRNA	PMID:28973697
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312084	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FEM1B mRNA	PMID:17562736
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304569	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FEM1B mRNA	PMID:33387578
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of FEM1B mRNA	PMID:20977926
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304569	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FEM1B mRNA	PMID:29097150
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1304569	E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FEM1B protein	PMID:34896426
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:50292	cadmium sulfate	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C037123	cadmium sulfate results in decreased expression of FEM1B mRNA	PMID:21783983
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304569	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of FEM1B mRNA	PMID:30047161
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1304569	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of FEM1B mRNA	PMID:20080153
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1312084	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of FEM1B mRNA	PMID:19812364
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of FEM1B mRNA	PMID:19159669
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of FEM1B mRNA	PMID:19095052
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304569	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of FEM1B mRNA	PMID:30047161
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1312084	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone promotes the reaction [Ozone results in increased expression of FEM1B mRNA]	PMID:17460151
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304569	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FEM1B mRNA	PMID:21346803
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of FEM1B mRNA	PMID:38568856
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of FEM1B mRNA	PMID:29301935
1312083	FEM1B	fem-1 homolog B	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304569	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of FEM1B mRNA	PMID:21346803
1312086	EBPL	EBP like	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of EBPL mRNA	PMID:27188386
1312086	EBPL	EBP like	gene	CHEBI:132098	methoxyacetic acid	decreases expression	ISO	RGD:1304571	E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of EBPL mRNA	PMID:20864626
1312086	EBPL	EBP like	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EBPL gene	PMID:20938992
1312086	EBPL	EBP like	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of EBPL mRNA	PMID:33167477
1312086	EBPL	EBP like	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of EBPL mRNA	PMID:36331819
1312086	EBPL	EBP like	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of EBPL mRNA	PMID:39298647
1312086	EBPL	EBP like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of EBPL mRNA	PMID:30165855
1312086	EBPL	EBP like	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304571	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of EBPL mRNA	PMID:33387578
1312086	EBPL	EBP like	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EBPL gene	PMID:20938992
1312086	EBPL	EBP like	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of EBPL mRNA	PMID:23649840
1312086	EBPL	EBP like	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of EBPL mRNA	PMID:23892564
1312086	EBPL	EBP like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312087	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EBPL mRNA	PMID:33754040
1312086	EBPL	EBP like	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EBPL mRNA	PMID:28818685
1312086	EBPL	EBP like	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EBPL mRNA	PMID:36331819
1312086	EBPL	EBP like	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of EBPL mRNA	PMID:23649840
1312086	EBPL	EBP like	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of EBPL mRNA	PMID:27339419|PMID:31919559
1312086	EBPL	EBP like	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EBPL gene	PMID:20938992
1312086	EBPL	EBP like	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EBPL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EBPL mRNA	PMID:39836092|PMID:40512198
1312086	EBPL	EBP like	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:1304571	E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of EBPL mRNA	PMID:20864626
1312086	EBPL	EBP like	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of EBPL mRNA	PMID:27594783
1312086	EBPL	EBP like	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312087	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of EBPL mRNA	PMID:30912803
1312086	EBPL	EBP like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312087	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EBPL mRNA	PMID:21570461|PMID:26377647
1312086	EBPL	EBP like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304571	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EBPL mRNA	PMID:32109520
1312086	EBPL	EBP like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EBPL mRNA	PMID:17949056
1312086	EBPL	EBP like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EBPL mRNA	PMID:17942748
1312086	EBPL	EBP like	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1304571	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of EBPL mRNA	PMID:20864626
1312086	EBPL	EBP like	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EBPL mRNA	PMID:33212167
1312086	EBPL	EBP like	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of EBPL mRNA	PMID:38568856
1312086	EBPL	EBP like	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EBPL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EBPL mRNA	PMID:39836092|PMID:40512198
1312086	EBPL	EBP like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EBPL mRNA	PMID:20064835
1312086	EBPL	EBP like	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EBPL promoter	PMID:27901495
1312086	EBPL	EBP like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312087	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EBPL mRNA	PMID:22228805
1312086	EBPL	EBP like	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of EBPL mRNA]	PMID:22228805
1312086	EBPL	EBP like	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of EBPL mRNA	PMID:39716349
1312086	EBPL	EBP like	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of EBPL mRNA	PMID:34408198
1312086	EBPL	EBP like	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1304571	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of EBPL mRNA	PMID:22641619
1312086	EBPL	EBP like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312087	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EBPL gene	PMID:35295148
1312086	EBPL	EBP like	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312087	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of EBPL mRNA	PMID:18301758
1312086	EBPL	EBP like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304571	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EBPL mRNA	PMID:25181051|PMID:34947998
1312086	EBPL	EBP like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of EBPL mRNA	PMID:39298647
1312086	EBPL	EBP like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312087	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of EBPL mRNA	PMID:40203079
1312086	EBPL	EBP like	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304571	E	RGD:6480464	20150512	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of EBPL mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of EBPL promoter	PMID:25374375
1312086	EBPL	EBP like	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in decreased expression of EBPL protein	PMID:39748354
1312086	EBPL	EBP like	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EBPL mRNA	PMID:37042841
1312086	EBPL	EBP like	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304571	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of EBPL mRNA	PMID:35163327
1312086	EBPL	EBP like	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304571	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of EBPL mRNA	PMID:35163327
1312086	EBPL	EBP like	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312087	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of EBPL mRNA	PMID:40194260
1312086	EBPL	EBP like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EBPL mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of EBPL mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of EBPL mRNA	PMID:36331819
1312086	EBPL	EBP like	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of EBPL mRNA	PMID:23179753
1312086	EBPL	EBP like	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of EBPL mRNA	PMID:19770486
1312086	EBPL	EBP like	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1304571	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of EBPL mRNA	PMID:24136188
1312086	EBPL	EBP like	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312087	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EBPL mRNA	PMID:17562736
1312086	EBPL	EBP like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of EBPL mRNA	PMID:29067470
1312086	EBPL	EBP like	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EBPL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EBPL mRNA	PMID:39836092|PMID:40512198
1312086	EBPL	EBP like	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of EBPL mRNA	PMID:18175754
1312086	EBPL	EBP like	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304571	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EBPL mRNA	PMID:17557909
1312086	EBPL	EBP like	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312087	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EBPL mRNA	PMID:17942748
1312086	EBPL	EBP like	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of EBPL mRNA	PMID:39716349
1312086	EBPL	EBP like	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of EBPL mRNA; Nanotubes, Carbon results in decreased expression of EBPL mRNA	PMID:25554681
1312086	EBPL	EBP like	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304571	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of EBPL mRNA	PMID:24793618
1312086	EBPL	EBP like	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1304571	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of EBPL mRNA	PMID:21983209
1312086	EBPL	EBP like	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1304571	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of EBPL mRNA	PMID:20080153
1312086	EBPL	EBP like	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1304571	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of EBPL mRNA	PMID:24136188
1312086	EBPL	EBP like	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312087	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of EBPL mRNA	PMID:23650126
1312086	EBPL	EBP like	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of EBPL mRNA	PMID:31758290
1312086	EBPL	EBP like	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312087	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EBPL mRNA	PMID:22206623
1312086	EBPL	EBP like	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1304571	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of EBPL mRNA	PMID:24136188
1312086	EBPL	EBP like	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EBPL gene]	PMID:28238834
1312086	EBPL	EBP like	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1304571	E	RGD:6480464	20150512	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of EBPL mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of EBPL promoter	PMID:25374375
1312086	EBPL	EBP like	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1304571	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of EBPL mRNA	PMID:20345932
1312086	EBPL	EBP like	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312087	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of EBPL mRNA	PMID:39847705
1312086	EBPL	EBP like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304571	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EBPL mRNA	PMID:25825206
1312086	EBPL	EBP like	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1304571	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of EBPL mRNA	PMID:20864626
1312086	EBPL	EBP like	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of EBPL mRNA	PMID:38568856
1312086	EBPL	EBP like	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304571	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of EBPL mRNA	PMID:22570695
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MAST2 mRNA	PMID:38218311
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312090	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of MAST2 mRNA	PMID:33045310
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304573	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAST2 mRNA]	PMID:31150632
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MAST2 mRNA	PMID:33167477
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312090	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MAST2 mRNA	PMID:30319688
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of MAST2 protein	PMID:35688186
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312090	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MAST2 mRNA	PMID:39241906
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312090	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MAST2 mRNA	PMID:39298647
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of MAST2 mRNA	PMID:33848595
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of MAST2 mRNA]	PMID:33848595
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312090	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MAST2 mRNA	PMID:23892564
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1312090	E	RGD:6480464	20210608	CTD	MESH:D009538	Nicotine results in increased expression of MAST2 mRNA	PMID:33640489
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MAST2 protein	PMID:37730182
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304573	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of MAST2 mRNA	PMID:22061828
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAST2 mRNA	PMID:36331819
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAST2 mRNA	PMID:39836092
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1312090	E	RGD:6480464	20210608	CTD	MESH:D009538	Nicotine results in increased expression of MAST2 mRNA	PMID:33640489
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAST2 mRNA	PMID:28111341
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MAST2 mRNA	PMID:19549813
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of MAST2 mRNA	PMID:34911549
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304573	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAST2 mRNA	PMID:31150632
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312090	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAST2 mRNA	PMID:31919559
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304573	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAST2 mRNA]	PMID:31150632
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAST2 mRNA	PMID:22206623
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAST2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAST2 mRNA	PMID:39836092
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAST2 mRNA	PMID:40504410
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MAST2 protein	PMID:35688186
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MAST2 mRNA	PMID:30912803
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of MAST2 mRNA	PMID:26865667
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312090	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAST2 mRNA	PMID:21570461
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MAST2 mRNA	PMID:33212167
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MAST2 mRNA	PMID:15467011
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of MAST2 protein	PMID:35688186
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAST2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAST2 mRNA	PMID:39836092
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAST2 mRNA	PMID:40504410
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MAST2 intron	PMID:30157460
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312090	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAST2 mRNA	PMID:22228805
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MAST2 mRNA	PMID:15467011
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1304573	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of MAST2 mRNA	PMID:24915197
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of MAST2 gene	PMID:31601247
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312090	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of MAST2 mRNA	PMID:21829687
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312090	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MAST2 gene	PMID:35295148
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312090	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MAST2 mRNA	PMID:23811191
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1304573	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of MAST2 mRNA	PMID:19167457
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304573	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MAST2 mRNA	PMID:25181051
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304573	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MAST2 mRNA	PMID:30816183|PMID:33296240
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of MAST2 mRNA	PMID:38074096
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of MAST2 gene	PMID:31601247
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304573	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of MAST2 protein	PMID:24552547
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of MAST2 gene	PMID:31601247
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MAST2 mRNA	PMID:38685157
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312090	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MAST2 mRNA	PMID:21266533
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MAST2 mRNA	PMID:34813904
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of MAST2 mRNA	PMID:34813904
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAST2 mRNA	PMID:39836092
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAST2 mRNA	PMID:28111341
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MAST2 mRNA	PMID:24449571
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of MAST2 mRNA	PMID:28302478
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAST2 mRNA	PMID:36331819
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312090	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MAST2 mRNA	PMID:17292431
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304573	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of MAST2 mRNA	PMID:29427782
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MAST2 mRNA	PMID:38832940
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312090	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAST2 mRNA	PMID:17562736
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of MAST2 mRNA	PMID:29067470
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAST2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAST2 mRNA	PMID:39836092
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAST2 mRNA	PMID:40504410
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of MAST2 mRNA	PMID:40706910
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1304573	E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MAST2 mRNA	PMID:26865667
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304573	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of MAST2 mRNA	PMID:30307764
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312090	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of MAST2 mRNA	PMID:25554681
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MAST2 mRNA	PMID:35964746
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAST2 mRNA	PMID:39836092
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312090	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of MAST2 mRNA	PMID:26307267
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MAST2 mRNA	PMID:22206623
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312090	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAST2 mRNA	PMID:22206623
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:7599	Nivalenol	decreases expression	ISO	RGD:1312090	E	RGD:6480464	20220607	CTD	MESH:C038405	nivalenol results in decreased expression of MAST2 mRNA	PMID:35016910
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MAST2 gene]	PMID:28238834
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312090	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MAST2 mRNA	PMID:23091169
1312089	MAST2	microtubule associated serine/threonine kinase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304573	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MAST2 mRNA	PMID:21346803
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312093	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of MAP3K3 mRNA	PMID:20188158
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MAP3K3 mRNA	PMID:33167477
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of MAP3K3 protein	PMID:23645742
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:16336	hyaluronic acid	multiple interactions	ISO	RGD:1312093	E	RGD:6480464	20130416	CTD	MESH:D006820	MAP3K3 protein promotes the reaction [TGFB2 protein results in increased abundance of Hyaluronic Acid]	PMID:20633555
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D004958	Estradiol results in increased expression of MAP3K3 mRNA	PMID:23094148
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1312093	E	RGD:6480464	20120412	CTD	MESH:D014241	PPARA protein inhibits the reaction [Trichloroethylene results in decreased expression of MAP3K3 mRNA]	PMID:15363585
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MAP3K3 mRNA	PMID:37042841
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of MAP3K3 gene	PMID:33872906
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of MAP3K3 gene	PMID:33872906
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MAP3K3 protein	PMID:37730182
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304575	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MAP3K3 mRNA	PMID:22061828
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MAP3K3 mRNA	PMID:28818685
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP3K3 mRNA	PMID:39836092
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:23643	depsipeptide	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D047630	Depsipeptides results in increased expression of MAP3K3 mRNA	PMID:17064661
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:23643	depsipeptide	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D047630	[decitabine co-treated with Depsipeptides] results in increased expression of MAP3K3 mRNA	PMID:17064661
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of MAP3K3 mRNA	PMID:26760959
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312093	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAP3K3 mRNA	PMID:34911549
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1304575	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of MAP3K3 mRNA	PMID:30779732
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MAP3K3 protein	PMID:35688186
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of MAP3K3 mRNA	PMID:31295307
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312093	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAP3K3 mRNA	PMID:21570461
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MAP3K3 mRNA	PMID:30851411
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MAP3K3 mRNA	PMID:30911355
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MAP3K3 mRNA]	PMID:32406909
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MAP3K3 mRNA	PMID:30911355
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of MAP3K3 mRNA	PMID:27188386
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304575	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAP3K3 mRNA	PMID:25729387
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:32095	retinyl acetate	increases expression	ISO	RGD:1312093	E	RGD:6480464	20120412	CTD	MESH:C009166	retinol acetate results in increased expression of MAP3K3 mRNA	PMID:16772331
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312093	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MAP3K3 gene	PMID:35295148
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MAP3K3 mRNA	PMID:19710929
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1304575	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of MAP3K3 mRNA	PMID:19167457
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304575	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MAP3K3 mRNA	PMID:25181051
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304575	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MAP3K3 mRNA	PMID:30816183
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304575	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MAP3K3 gene	PMID:28505145
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312093	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MAP3K3 mRNA	PMID:21266533
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312093	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MAP3K3 mRNA	PMID:34813904
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312093	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of MAP3K3 mRNA	PMID:34813904
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MAP3K3 mRNA	PMID:37042841
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP3K3 mRNA	PMID:39836092
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304575	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MAP3K3 mRNA	PMID:33453195
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:4357	deguelin	affects expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C107676	deguelin affects the expression of MAP3K3 protein	PMID:25322282
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:4488	diallyl disulfide	affects expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C028009	diallyl disulfide affects the expression of MAP3K3 protein	PMID:21695758
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:4489	Diallyl sulfide	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C038491	allyl sulfide affects the expression of MAP3K3 protein	PMID:21695758
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MAP3K3 mRNA	PMID:27188386
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of MAP3K3 mRNA	PMID:22083351
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312093	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAP3K3 mRNA	PMID:17562736
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MAP3K3 mRNA	PMID:22230336
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with Depsipeptides] results in increased expression of MAP3K3 mRNA	PMID:17064661
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:517248	bufalin	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C022777	bufalin results in decreased expression of MAP3K3 protein	PMID:23949904
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1312093	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of MAP3K3 mRNA	PMID:20829426
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP3K3 mRNA	PMID:39836092
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304575	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAP3K3 mRNA	PMID:25729387
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312093	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of MAP3K3 protein	PMID:36851058
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1304575	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of MAP3K3 mRNA	PMID:28954212
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:6842	methoxychlor	affects expression	ISO	RGD:1312093	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor affects the expression of MAP3K3 mRNA	PMID:20829426
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of MAP3K3 mRNA	PMID:31801206
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312093	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of MAP3K3 mRNA	PMID:22206623
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MAP3K3 mRNA	PMID:37199045
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MAP3K3 mRNA	PMID:30851411
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:78492	diallyl trisulfide	affects expression	EXP		E	RGD:6480464	20140610	CTD	MESH:C042577	diallyl trisulfide affects the expression of MAP3K3 protein	PMID:21695758
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1312093	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of MAP3K3 mRNA	PMID:31388691
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1304575	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MAP3K3 mRNA	PMID:23640034
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1304575	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MAP3K3 mRNA	PMID:23914054
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MAP3K3 mRNA	PMID:27188386
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304575	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MAP3K3 mRNA	PMID:21346803
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304575	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MAP3K3 mRNA	PMID:23034163
1312092	MAP3K3	mitogen-activated protein kinase kinase kinase 3	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1304575	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of MAP3K3 gene	PMID:31682807
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312096	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ZFP13 mRNA	PMID:20938992
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZNF205 mRNA	PMID:26079696
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ZNF205 mRNA	PMID:38568856
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312096	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ZFP13 mRNA	PMID:20938992
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:16899	D-mannitol	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in decreased expression of ZFP13 mRNA	PMID:25270620
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of ZNF205 mRNA	PMID:19774075
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312096	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ZFP13 mRNA	PMID:20938992
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ZNF205 protein	PMID:35688186
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of ZFP13 mRNA	PMID:35489704
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ZFP13 mRNA	PMID:28960355
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304577	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP13 mRNA	PMID:32109520
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZNF205 mRNA	PMID:33212167
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF205 mRNA	PMID:29803840
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZFP13 mRNA	PMID:39631538
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of ZNF205 mRNA	PMID:34408198
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312096	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP13 gene	PMID:35295148
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312096	E	RGD:6480464	20131008	CTD	MESH:C009495	titanium dioxide results in increased expression of ZFP13 mRNA	PMID:23131501
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312096	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZFP13 gene	PMID:35295148
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1304577	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ZFP13 mRNA	PMID:19167457
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304577	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZNF205 mRNA	PMID:25181051
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP13 mRNA	PMID:33221593
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304577	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP13 mRNA	PMID:34947998
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312096	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP13 mRNA	PMID:32156529
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304577	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZFP13 gene	PMID:28505145
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312096	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ZFP13 gene	PMID:31683443
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ZFP13 mRNA	PMID:39298647
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312096	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZFP13 mRNA	PMID:24982889
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1304577	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of ZFP13 promoter	PMID:22457795
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312096	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ZFP13 mRNA	PMID:39529242
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZNF205 gene	PMID:29154799
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1312096	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of ZFP13 mRNA	PMID:22078008
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF205 protein	PMID:31285264
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1304577	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in increased expression of ZFP13 mRNA	PMID:26720608
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312096	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ZFP13 mRNA	PMID:31388691
1312095	ZNF205	zinc finger protein 205	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312096	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ZFP13 mRNA	PMID:40826991
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:10106	zearalenone	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D015025	Zearalenone results in decreased expression of HSD17B14 mRNA	PMID:19371625
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of HSD17B14 mRNA	PMID:31016361
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:15846	NAD(+)	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D009243	NAD binds to and results in increased activity of HSD17B14 protein	PMID:25526675
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of HSD17B14 protein	PMID:18951874
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of HSD17B14 mRNA	PMID:21185374
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1588673	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of HSD17B14 mRNA	PMID:33387578
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HSD17B14 mRNA	PMID:36139627
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of HSD17B14 intron	PMID:30157460
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1312098	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of HSD17B14 mRNA	PMID:39984025
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of HSD17B14 mRNA	PMID:27153756
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:C010974	Glyphosate results in increased expression of HSD17B14 mRNA	PMID:40294809
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of HSD17B14 mRNA	PMID:23300844
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of HSD17B14 mRNA	PMID:27392435
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312098	E	RGD:6480464	20140114	CTD	MESH:D014640	Vancomycin results in increased expression of HSD17B14 mRNA	PMID:18930951
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D019833	Genistein results in decreased expression of HSD17B14 mRNA	PMID:19371625
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312098	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HSD17B14 mRNA	PMID:21570461
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of HSD17B14 protein	PMID:18951874
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of HSD17B14 mRNA	PMID:29955902
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HSD17B14 mRNA	PMID:33212167
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1588673	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of HSD17B14 mRNA	PMID:26033743
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:28854	2,4-D	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in increased expression of HSD17B14 mRNA	PMID:40294809
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HSD17B14 mRNA	PMID:38568856
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HSD17B14 5' UTR; Benzo(a)pyrene affects the methylation of HSD17B14 intron	PMID:27901495|PMID:30157460
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312098	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HSD17B14 mRNA	PMID:23735875
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312098	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HSD17B14 exon; Benzo(a)pyrene results in increased methylation of HSD17B14 intron	PMID:27901495
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1588673	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of HSD17B14 mRNA	PMID:26033743
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312098	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of HSD17B14 mRNA	PMID:27131904
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of HSD17B14 mRNA	PMID:25895662
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1588673	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of HSD17B14 mRNA	PMID:34492290
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:C006780	bisphenol A results in decreased expression of HSD17B14 mRNA	PMID:19371625
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of HSD17B14 mRNA; bisphenol A results in increased expression of HSD17B14 protein	PMID:27685785|PMID:29275510
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312098	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of HSD17B14 mRNA	PMID:40203079
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312098	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in decreased expression of HSD17B14 mRNA]	PMID:40203079
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of HSD17B14 intron	PMID:30157460
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312098	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of HSD17B14 mRNA	PMID:37019170
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1588673	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of HSD17B14 mRNA	PMID:35163327
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1588673	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of HSD17B14 mRNA	PMID:30723492
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of HSD17B14 mRNA	PMID:38568856
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1588673	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of HSD17B14 mRNA	PMID:35163327
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of HSD17B14 mRNA	PMID:24449571
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of HSD17B14 mRNA	PMID:31533062
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312098	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of HSD17B14 protein	PMID:26178269
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of HSD17B14 mRNA	PMID:24935251|PMID:28001369
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:40279	allopurinol	decreases expression	ISO	RGD:1588673	E	RGD:6480464	20241203	CTD	MESH:D000493	Allopurinol results in decreased expression of HSD17B14 mRNA	PMID:37876353
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312098	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of HSD17B14 mRNA	PMID:28973697
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:44215	NAD zwitterion	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D009243	NAD binds to and results in increased activity of HSD17B14 protein	PMID:25526675
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of HSD17B14 mRNA	PMID:24935251
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312098	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of HSD17B14 mRNA	PMID:35436446
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of HSD17B14 mRNA	PMID:23300844
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1588673	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of HSD17B14 mRNA	PMID:30307764
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C082360	fipronil results in increased expression of HSD17B14 mRNA	PMID:27091632
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C082360	[fipronil co-treated with DEET] results in increased expression of HSD17B14 mRNA	PMID:27091632
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312098	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of HSD17B14 mRNA	PMID:35964746
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:5118	fluoxetine	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D005473	Fluoxetine results in increased expression of HSD17B14 mRNA	PMID:37386098
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1312098	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of HSD17B14 mRNA	PMID:26377693
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of HSD17B14 mRNA	PMID:24810058
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSD17B14 mRNA	PMID:22079614
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of HSD17B14 intron	PMID:30157460
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D003671	[fipronil co-treated with DEET] results in increased expression of HSD17B14 mRNA	PMID:27091632
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of HSD17B14 mRNA	PMID:31758290
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312098	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HSD17B14 mRNA	PMID:22206623
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of HSD17B14 mRNA	PMID:36318118
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HSD17B14 mRNA	PMID:36139627
1312097	HSD17B14	hydroxysteroid 17-beta dehydrogenase 14	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312098	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of HSD17B14 mRNA	PMID:27131904
1312101	HEBP1	heme binding protein 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of HEBP1 mRNA	PMID:27188386
1312101	HEBP1	heme binding protein 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304581	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HEBP1 mRNA]	PMID:31150632
1312101	HEBP1	heme binding protein 1	gene	CHEBI:144400	dinophysistoxin 1	decreases expression	EXP		E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in decreased expression of HEBP1 mRNA	PMID:28939011
1312101	HEBP1	heme binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of HEBP1 mRNA	PMID:33167477
1312101	HEBP1	heme binding protein 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of HEBP1 mRNA	PMID:22378314
1312101	HEBP1	heme binding protein 1	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1304581	E	RGD:6480464	20140114	CTD	MESH:D000431	Ethanol results in decreased expression of HEBP1 protein	PMID:23702218
1312101	HEBP1	heme binding protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312102	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HEBP1 mRNA	PMID:39241906
1312101	HEBP1	heme binding protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of HEBP1 mRNA	PMID:19619570|PMID:21185374
1312101	HEBP1	heme binding protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of HEBP1 mRNA	PMID:19619570
1312101	HEBP1	heme binding protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of HEBP1 gene	PMID:33872906
1312101	HEBP1	heme binding protein 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312102	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of HEBP1 mRNA	PMID:33848595
1312101	HEBP1	heme binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of HEBP1 gene	PMID:33872906
1312101	HEBP1	heme binding protein 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304581	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of HEBP1 mRNA	PMID:33387578
1312101	HEBP1	heme binding protein 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of HEBP1 mRNA	PMID:19549813
1312101	HEBP1	heme binding protein 1	gene	CHEBI:234430	gardiquimod	decreases expression	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in decreased expression of HEBP1 mRNA	PMID:28003376
1312101	HEBP1	heme binding protein 1	gene	CHEBI:234430	gardiquimod	multiple interactions	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of HEBP1 mRNA]	PMID:28003376
1312101	HEBP1	heme binding protein 1	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1304581	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of HEBP1 protein	PMID:33236894
1312101	HEBP1	heme binding protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HEBP1 gene	PMID:27153756
1312101	HEBP1	heme binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of HEBP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of HEBP1 mRNA	PMID:34911549
1312101	HEBP1	heme binding protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304581	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of HEBP1 mRNA	PMID:31150632
1312101	HEBP1	heme binding protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of HEBP1 mRNA	PMID:27339419|PMID:31919559
1312101	HEBP1	heme binding protein 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304581	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HEBP1 mRNA]	PMID:31150632
1312101	HEBP1	heme binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of HEBP1 mRNA	PMID:40504410
1312101	HEBP1	heme binding protein 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of HEBP1 protein	PMID:38460933
1312101	HEBP1	heme binding protein 1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1304581	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA	PMID:33854195
1312101	HEBP1	heme binding protein 1	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304581	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of HEBP1 mRNA	PMID:31881176
1312101	HEBP1	heme binding protein 1	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of HEBP1 mRNA	PMID:19921347
1312101	HEBP1	heme binding protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of HEBP1 mRNA	PMID:40618947
1312101	HEBP1	heme binding protein 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of HEBP1 mRNA	PMID:27594783
1312101	HEBP1	heme binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HEBP1 mRNA	PMID:19619570
1312101	HEBP1	heme binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HEBP1 mRNA	PMID:19770486|PMID:28213091
1312101	HEBP1	heme binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304581	E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HEBP1 mRNA	PMID:26232522|PMID:34747641
1312101	HEBP1	heme binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312102	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HEBP1 mRNA	PMID:19933214
1312101	HEBP1	heme binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of HEBP1 mRNA	PMID:19619570
1312101	HEBP1	heme binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to HEBP1 gene]	PMID:28213091
1312101	HEBP1	heme binding protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304581	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of HEBP1 mRNA	PMID:28959563
1312101	HEBP1	heme binding protein 1	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1304581	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of HEBP1 mRNA	PMID:30556269
1312101	HEBP1	heme binding protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312102	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of HEBP1 mRNA	PMID:39631538
1312101	HEBP1	heme binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HEBP1 mRNA; sodium arsenite results in increased expression of HEBP1 protein	PMID:38568856|PMID:39571964
1312101	HEBP1	heme binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of HEBP1 mRNA	PMID:40504410
1312101	HEBP1	heme binding protein 1	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of HEBP1 mRNA	PMID:22378314
1312101	HEBP1	heme binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HEBP1 mRNA	PMID:20106945|PMID:21632981
1312101	HEBP1	heme binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312102	E	RGD:6480464	20240604	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HEBP1 mRNA	PMID:38641015
1312101	HEBP1	heme binding protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to HEBP1 mRNA]	PMID:32406909
1312101	HEBP1	heme binding protein 1	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1304581	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of HEBP1 mRNA	PMID:30556269
1312101	HEBP1	heme binding protein 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304581	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HEBP1 mRNA	PMID:25729387
1312101	HEBP1	heme binding protein 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312102	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of HEBP1 mRNA	PMID:23557971
1312101	HEBP1	heme binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of HEBP1 mRNA	PMID:27760801
1312101	HEBP1	heme binding protein 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304581	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of HEBP1 mRNA	PMID:34492290
1312101	HEBP1	heme binding protein 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1304581	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of HEBP1 promoter	PMID:27415467
1312101	HEBP1	heme binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of HEBP1 protein	PMID:31675489
1312101	HEBP1	heme binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304581	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of HEBP1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312101	HEBP1	heme binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of HEBP1 protein	PMID:37567409
1312101	HEBP1	heme binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304581	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of HEBP1 mRNA	PMID:25181051|PMID:32145629
1312101	HEBP1	heme binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312102	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of HEBP1 mRNA	PMID:32156529
1312101	HEBP1	heme binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312102	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of HEBP1 mRNA	PMID:40203079
1312101	HEBP1	heme binding protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20250311	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of HEBP1 mRNA	PMID:32308655
1312101	HEBP1	heme binding protein 1	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1312102	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of HEBP1 mRNA	PMID:31558096
1312101	HEBP1	heme binding protein 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1304581	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HEBP1 protein	PMID:34058248
1312101	HEBP1	heme binding protein 1	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1304581	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA	PMID:33854195
1312101	HEBP1	heme binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HEBP1 mRNA	PMID:37042841
1312101	HEBP1	heme binding protein 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304581	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of HEBP1 mRNA	PMID:35163327
1312101	HEBP1	heme binding protein 1	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1304581	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of HEBP1 mRNA	PMID:18500788
1312101	HEBP1	heme binding protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304581	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of HEBP1 mRNA	PMID:35163327
1312101	HEBP1	heme binding protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of HEBP1 mRNA	PMID:19376846
1312101	HEBP1	heme binding protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of HEBP1 mRNA	PMID:17585979
1312101	HEBP1	heme binding protein 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of HEBP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HEBP1 mRNA]	PMID:17585979
1312101	HEBP1	heme binding protein 1	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of HEBP1 mRNA]	PMID:28003376
1312101	HEBP1	heme binding protein 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312102	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of HEBP1 mRNA	PMID:40194260
1312101	HEBP1	heme binding protein 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HEBP1 mRNA	PMID:19167446
1312101	HEBP1	heme binding protein 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312102	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of HEBP1 mRNA	PMID:39529242
1312101	HEBP1	heme binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of HEBP1 mRNA	PMID:40419075
1312101	HEBP1	heme binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HEBP1 mRNA	PMID:25979313
1312101	HEBP1	heme binding protein 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of HEBP1 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386
1312101	HEBP1	heme binding protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312102	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of HEBP1 mRNA	PMID:21427059
1312101	HEBP1	heme binding protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of HEBP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HEBP1 mRNA	PMID:17183730|PMID:27188386
1312101	HEBP1	heme binding protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of HEBP1 mRNA	PMID:19770486
1312101	HEBP1	heme binding protein 1	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1304581	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA	PMID:33854195
1312101	HEBP1	heme binding protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of HEBP1 mRNA	PMID:28973697
1312101	HEBP1	heme binding protein 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of HEBP1 mRNA	PMID:38832940
1312101	HEBP1	heme binding protein 1	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1304581	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA	PMID:33854195
1312101	HEBP1	heme binding protein 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of HEBP1 mRNA	PMID:24935251
1312101	HEBP1	heme binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312102	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HEBP1 mRNA	PMID:17562736
1312101	HEBP1	heme binding protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312102	E	RGD:6480464	20130416	CTD	MESH:D000082	Acetaminophen results in decreased expression of HEBP1 protein	PMID:22939915
1312101	HEBP1	heme binding protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of HEBP1 mRNA	PMID:25704631
1312101	HEBP1	heme binding protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304581	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HEBP1 mRNA	PMID:33387578
1312101	HEBP1	heme binding protein 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of HEBP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HEBP1 mRNA]	PMID:17585979
1312101	HEBP1	heme binding protein 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of HEBP1 protein	PMID:38460933
1312101	HEBP1	heme binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312102	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of HEBP1 mRNA	PMID:40504410
1312101	HEBP1	heme binding protein 1	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1304581	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of HEBP1 mRNA	PMID:37077353
1312101	HEBP1	heme binding protein 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312102	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of HEBP1 mRNA	PMID:35436446
1312101	HEBP1	heme binding protein 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312102	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of HEBP1 mRNA	PMID:25554681
1312101	HEBP1	heme binding protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312102	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of HEBP1 mRNA	PMID:25554681
1312101	HEBP1	heme binding protein 1	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1312102	E	RGD:6480464	20141223	CTD	MESH:C000499	ferric oxide analog results in increased expression of HEBP1 mRNA	PMID:25086211
1312101	HEBP1	heme binding protein 1	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of HEBP1 mRNA	PMID:17183730
1312101	HEBP1	heme binding protein 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312102	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of HEBP1 mRNA	PMID:38701926
1312101	HEBP1	heme binding protein 1	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1304581	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA	PMID:33854195
1312101	HEBP1	heme binding protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HEBP1 protein	PMID:32959892
1312101	HEBP1	heme binding protein 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304581	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HEBP1 mRNA	PMID:25729387
1312101	HEBP1	heme binding protein 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1312102	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of HEBP1 mRNA	PMID:19812364
1312101	HEBP1	heme binding protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of HEBP1 mRNA	PMID:24810058
1312101	HEBP1	heme binding protein 1	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312102	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of HEBP1 protein	PMID:36851058
1312101	HEBP1	heme binding protein 1	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1312102	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of HEBP1 mRNA	PMID:22078008
1312101	HEBP1	heme binding protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of HEBP1 protein	PMID:34186270
1312101	HEBP1	heme binding protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HEBP1 mRNA	PMID:27188386
1312101	HEBP1	heme binding protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HEBP1 gene]	PMID:28238834
1312101	HEBP1	heme binding protein 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312102	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of HEBP1 mRNA	PMID:19270015
1312101	HEBP1	heme binding protein 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HEBP1 mRNA	PMID:19167446
1312101	HEBP1	heme binding protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312102	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of HEBP1 mRNA	PMID:38648751
1312101	HEBP1	heme binding protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HEBP1 protein	PMID:31675489
1312101	HEBP1	heme binding protein 1	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1312102	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of HEBP1 mRNA	PMID:31558096
1312101	HEBP1	heme binding protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304581	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of HEBP1 mRNA	PMID:24780913
1312101	HEBP1	heme binding protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HEBP1 mRNA	PMID:27188386
1312101	HEBP1	heme binding protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304581	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of HEBP1 mRNA	PMID:21346803
1312101	HEBP1	heme binding protein 1	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of HEBP1 mRNA	PMID:27188386
1312103	MTM1	myotubularin 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MTM1 mRNA	PMID:25510870
1312103	MTM1	myotubularin 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304582	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MTM1 mRNA	PMID:33387578
1312103	MTM1	myotubularin 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MTM1 mRNA	PMID:37042841
1312103	MTM1	myotubularin 1	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in decreased expression of MTM1 mRNA	PMID:17178593
1312103	MTM1	myotubularin 1	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in decreased expression of MTM1 mRNA	PMID:17178593
1312103	MTM1	myotubularin 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MTM1 protein	PMID:37730182
1312103	MTM1	myotubularin 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304582	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MTM1 mRNA	PMID:33387578
1312103	MTM1	myotubularin 1	gene	CHEBI:18291	manganese atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of MTM1 mRNA	PMID:17175027
1312103	MTM1	myotubularin 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of MTM1 mRNA	PMID:28860664
1312103	MTM1	myotubularin 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTM1 mRNA	PMID:37236586
1312103	MTM1	myotubularin 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MTM1 mRNA	PMID:25510870
1312103	MTM1	myotubularin 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MTM1 mRNA	PMID:25510870
1312103	MTM1	myotubularin 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MTM1 gene	PMID:27153756
1312103	MTM1	myotubularin 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312104	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MTM1 mRNA	PMID:31919559
1312103	MTM1	myotubularin 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MTM1 protein	PMID:35688186
1312103	MTM1	myotubularin 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MTM1 mRNA	PMID:23557933
1312103	MTM1	myotubularin 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312104	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of MTM1 mRNA	PMID:30912803
1312103	MTM1	myotubularin 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312104	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of MTM1 mRNA	PMID:32186404
1312103	MTM1	myotubularin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304582	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MTM1 mRNA	PMID:32109520|PMID:33387578
1312103	MTM1	myotubularin 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MTM1 mRNA	PMID:28001369
1312103	MTM1	myotubularin 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MTM1 mRNA	PMID:30851411
1312103	MTM1	myotubularin 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of MTM1 mRNA	PMID:39719251
1312103	MTM1	myotubularin 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MTM1 5' UTR; Benzo(a)pyrene affects the methylation of MTM1 exon; Benzo(a)pyrene affects the methylation of MTM1 promoter	PMID:27901495
1312103	MTM1	myotubularin 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MTM1 mRNA	PMID:19770486
1312103	MTM1	myotubularin 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MTM1 mRNA]	PMID:32406909
1312103	MTM1	myotubularin 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of MTM1 mRNA	PMID:18445702
1312103	MTM1	myotubularin 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312104	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MTM1 mRNA	PMID:17950772|PMID:18301758|PMID:20813756|PMID:23811191
1312103	MTM1	myotubularin 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of MTM1 mRNA]	PMID:17950772
1312103	MTM1	myotubularin 1	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of MTM1 mRNA	PMID:30690063
1312103	MTM1	myotubularin 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1304582	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of MTM1 mRNA	PMID:19167457
1312103	MTM1	myotubularin 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304582	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MTM1 mRNA	PMID:25181051
1312103	MTM1	myotubularin 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304582	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MTM1 gene	PMID:28505145
1312103	MTM1	myotubularin 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of MTM1 mRNA	PMID:19244175
1312103	MTM1	myotubularin 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MTM1 mRNA	PMID:25510870
1312103	MTM1	myotubularin 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MTM1 mRNA	PMID:25510870
1312103	MTM1	myotubularin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312104	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MTM1 mRNA	PMID:39298647|PMID:40203079
1312103	MTM1	myotubularin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in increased expression of MTM1 mRNA]	PMID:40203079
1312103	MTM1	myotubularin 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MTM1 mRNA	PMID:17361019|PMID:21266533
1312103	MTM1	myotubularin 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MTM1 mRNA	PMID:37042841
1312103	MTM1	myotubularin 1	gene	CHEBI:35154	manganese(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of MTM1 mRNA	PMID:17175027
1312103	MTM1	myotubularin 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MTM1 mRNA	PMID:38568856
1312103	MTM1	myotubularin 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312104	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MTM1 mRNA	PMID:37236586
1312103	MTM1	myotubularin 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MTM1 mRNA	PMID:28302478
1312103	MTM1	myotubularin 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MTM1 mRNA	PMID:31533062
1312103	MTM1	myotubularin 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312104	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of MTM1 mRNA	PMID:39529242
1312103	MTM1	myotubularin 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MTM1 gene	PMID:29154799
1312103	MTM1	myotubularin 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of MTM1 mRNA	PMID:20106945
1312103	MTM1	myotubularin 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312104	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MTM1 mRNA	PMID:28973697
1312103	MTM1	myotubularin 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in decreased expression of MTM1 mRNA	PMID:17178593
1312103	MTM1	myotubularin 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of MTM1 mRNA	PMID:17400583
1312103	MTM1	myotubularin 1	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTM1 mRNA	PMID:27188386
1312103	MTM1	myotubularin 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of MTM1 mRNA	PMID:26272509
1312103	MTM1	myotubularin 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of MTM1 mRNA	PMID:31675489
1312103	MTM1	myotubularin 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304582	E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in increased expression of MTM1 mRNA	PMID:31464424
1312103	MTM1	myotubularin 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MTM1 mRNA	PMID:22079256
1312103	MTM1	myotubularin 1	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of MTM1 mRNA	PMID:17175027
1312103	MTM1	myotubularin 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312104	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MTM1 mRNA	PMID:22206623
1312103	MTM1	myotubularin 1	gene	CHEBI:749016	gossypol acetic acid	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in increased expression of MTM1 protein	PMID:29938581
1312103	MTM1	myotubularin 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MTM1 mRNA	PMID:22079256|PMID:22714537
1312103	MTM1	myotubularin 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MTM1 mRNA	PMID:22079256
1312103	MTM1	myotubularin 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MTM1 mRNA	PMID:37199045
1312103	MTM1	myotubularin 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MTM1 mRNA	PMID:30851411
1312103	MTM1	myotubularin 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTM1 mRNA	PMID:27188386
1312103	MTM1	myotubularin 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312104	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MTM1 mRNA	PMID:23091169
1312103	MTM1	myotubularin 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312104	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of MTM1 mRNA	PMID:19270015
1312103	MTM1	myotubularin 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MTM1 protein	PMID:31675489
1312103	MTM1	myotubularin 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MTM1 protein	PMID:31675489
1312103	MTM1	myotubularin 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312104	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of MTM1 mRNA	PMID:21795629
1312103	MTM1	myotubularin 1	gene	CHEBI:85014	2,5-hexanedione	increases expression	ISO	RGD:1304582	E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione results in increased expression of MTM1 mRNA	PMID:22952946
1312103	MTM1	myotubularin 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MTM1 mRNA	PMID:27188386
1312103	MTM1	myotubularin 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304582	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MTM1 mRNA	PMID:21346803
1312103	MTM1	myotubularin 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304582	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MTM1 mRNA	PMID:23034163
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of AGO4 mRNA	PMID:26272509
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA	PMID:27188386
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304583	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AGO4 mRNA]	PMID:31150632
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of AGO4 mRNA	PMID:23724009
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of AGO4 mRNA	PMID:24763279
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C018475	butyraldehyde results in decreased expression of AGO4 mRNA	PMID:26079696
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of AGO4 mRNA	PMID:39241906
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of AGO4 mRNA	PMID:31614463
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304583	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of AGO4 mRNA	PMID:32145629
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of AGO4 mRNA	PMID:22217510
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AGO4 mRNA	PMID:25510870
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304583	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of AGO4 mRNA	PMID:26577399
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AGO4 mRNA	PMID:37325564
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AGO4 mRNA	PMID:25510870
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AGO4 mRNA	PMID:25510870
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of AGO4 mRNA	PMID:23649840
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of AGO4 intron	PMID:30157460
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312106	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of AGO4 mRNA	PMID:19770486
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of AGO4 mRNA	PMID:23649840
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of AGO4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of AGO4 mRNA	PMID:35430440|PMID:41430723
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304583	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AGO4 mRNA	PMID:31150632
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304583	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AGO4 mRNA]	PMID:31150632
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of AGO4 mRNA	PMID:21867686
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AGO4 mRNA	PMID:39836092
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AGO4 mRNA	PMID:40504410
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of AGO4 mRNA	PMID:26272509
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA	PMID:27188386
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of AGO4 mRNA	PMID:23557933
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of AGO4 mRNA	PMID:27392435
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of AGO4 mRNA	PMID:27392435
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:27928	parathion	decreases methylation	EXP		E	RGD:6480464	20130514	CTD	MESH:D010278	Parathion results in decreased methylation of AGO4 promoter	PMID:22847954
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312106	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AGO4 mRNA	PMID:21570461
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of AGO4 mRNA	PMID:28001369
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of AGO4 mRNA	PMID:33212167
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304583	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of AGO4 mRNA	PMID:28959563
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of AGO4 mRNA	PMID:29803840
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AGO4 mRNA	PMID:39836092
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AGO4 mRNA	PMID:40504410
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AGO4 mRNA	PMID:22228805
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312106	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AGO4 mRNA	PMID:22228805
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AGO4 promoter	PMID:27901495
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of AGO4 mRNA]	PMID:22228805
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of AGO4 mRNA	PMID:26014281
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304583	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of AGO4 mRNA	PMID:30047161
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312106	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AGO4 gene	PMID:35295148
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304583	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of AGO4 mRNA	PMID:34492290
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312106	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of AGO4 mRNA	PMID:20813756
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312106	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of AGO4 mRNA	PMID:28472532
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304583	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of AGO4 mRNA	PMID:30816183|PMID:32145629|PMID:32528016
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304583	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of AGO4 mRNA	PMID:34947998|PMID:41034487
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of AGO4 mRNA	PMID:24752500
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AGO4 mRNA	PMID:25510870
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of AGO4 mRNA	PMID:25510870
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of AGO4 mRNA	PMID:39298647
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1312106	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of AGO4 mRNA	PMID:36464114
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AGO4 mRNA	PMID:37042841
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AGO4 mRNA	PMID:37325564
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:38689	fonofos	decreases methylation	EXP		E	RGD:6480464	20130514	CTD	MESH:D004397	Fonofos results in decreased methylation of AGO4 promoter	PMID:22847954
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:38960	terbufos	decreases methylation	EXP		E	RGD:6480464	20130514	CTD	MESH:C012568	terbufos results in decreased methylation of AGO4 promoter	PMID:22847954
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AGO4 mRNA	PMID:25979313
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of AGO4 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA	PMID:27188386
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312106	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of AGO4 mRNA	PMID:18502557
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of AGO4 mRNA	PMID:22230336
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AGO4 mRNA	PMID:39836092
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312106	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AGO4 mRNA	PMID:40504410
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D004008	Diclofenac affects the expression of AGO4 mRNA	PMID:24752500
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304583	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of AGO4 mRNA	PMID:29391264
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of AGO4 mRNA; Nanotubes, Carbon results in decreased expression of AGO4 mRNA	PMID:25554681|PMID:25620056
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304583	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of AGO4 mRNA	PMID:30047161
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20160210	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of AGO4 mRNA	PMID:26377693
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of AGO4 mRNA	PMID:19042947
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312106	E	RGD:6480464	20151013	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of AGO4 mRNA	PMID:23608068
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1312106	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of AGO4 mRNA	PMID:36464114
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312106	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of AGO4 mRNA	PMID:22206623
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA	PMID:27188386
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AGO4 gene]	PMID:28238834
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312106	E	RGD:6480464	20151013	CTD	MESH:D010634	Phenobarbital affects the expression of AGO4 mRNA	PMID:23091169
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C046012	pentanal results in decreased expression of AGO4 mRNA	PMID:26079696
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304583	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of AGO4 mRNA	PMID:30047161
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304583	E	RGD:6480464	20151013	CTD	MESH:D011441	Propylthiouracil results in increased expression of AGO4 mRNA	PMID:24780913
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AGO4 mRNA	PMID:27188386
1312105	AGO4	argonaute RISC component 4	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of AGO4 mRNA	PMID:26014281
1312107	FBXO28	F-box protein 28	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of FBXO28 mRNA	PMID:31863870
1312107	FBXO28	F-box protein 28	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of FBXO28 mRNA	PMID:24763279
1312107	FBXO28	F-box protein 28	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of FBXO28 mRNA	PMID:22378314
1312107	FBXO28	F-box protein 28	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1549977	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of FBXO28 mRNA	PMID:30319688
1312107	FBXO28	F-box protein 28	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of FBXO28 mRNA	PMID:21632981
1312107	FBXO28	F-box protein 28	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in decreased expression of FBXO28 mRNA	PMID:16631469
1312107	FBXO28	F-box protein 28	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1549977	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FBXO28 mRNA	PMID:34319233
1312107	FBXO28	F-box protein 28	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FBXO28 protein	PMID:37730182
1312107	FBXO28	F-box protein 28	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304584	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of FBXO28 mRNA	PMID:33387578
1312107	FBXO28	F-box protein 28	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1549977	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXO28 mRNA	PMID:37236586
1312107	FBXO28	F-box protein 28	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FBXO28 mRNA	PMID:18593933
1312107	FBXO28	F-box protein 28	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO28 mRNA	PMID:39836092
1312107	FBXO28	F-box protein 28	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of FBXO28 mRNA	PMID:19244175
1312107	FBXO28	F-box protein 28	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of FBXO28 mRNA	PMID:19244175
1312107	FBXO28	F-box protein 28	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1549977	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXO28 mRNA	PMID:21570461
1312107	FBXO28	F-box protein 28	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1549977	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBXO28 mRNA	PMID:24680724
1312107	FBXO28	F-box protein 28	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FBXO28 mRNA	PMID:28001369
1312107	FBXO28	F-box protein 28	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBXO28 mRNA	PMID:30851411
1312107	FBXO28	F-box protein 28	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of FBXO28 mRNA	PMID:32763439
1312107	FBXO28	F-box protein 28	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXO28 mRNA	PMID:38568856
1312107	FBXO28	F-box protein 28	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO28 mRNA	PMID:39836092
1312107	FBXO28	F-box protein 28	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBXO28 promoter	PMID:27901495
1312107	FBXO28	F-box protein 28	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FBXO28 mRNA	PMID:18593933
1312107	FBXO28	F-box protein 28	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of FBXO28 gene	PMID:31601247
1312107	FBXO28	F-box protein 28	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXO28 gene	PMID:31601247
1312107	FBXO28	F-box protein 28	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304584	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of FBXO28 mRNA	PMID:23411599|PMID:34492290
1312107	FBXO28	F-box protein 28	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304584	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXO28 mRNA	PMID:25181051
1312107	FBXO28	F-box protein 28	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304584	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of FBXO28 mRNA	PMID:30816183|PMID:32528016
1312107	FBXO28	F-box protein 28	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of FBXO28 gene	PMID:31601247
1312107	FBXO28	F-box protein 28	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXO28 gene	PMID:31601247
1312107	FBXO28	F-box protein 28	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of FBXO28 mRNA	PMID:19244175
1312107	FBXO28	F-box protein 28	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FBXO28 mRNA	PMID:38174414|PMID:38568856
1312107	FBXO28	F-box protein 28	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1549977	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXO28 mRNA	PMID:37236586
1312107	FBXO28	F-box protein 28	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1304584	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of FBXO28 gene	PMID:22079235
1312107	FBXO28	F-box protein 28	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of FBXO28 mRNA	PMID:19244175
1312107	FBXO28	F-box protein 28	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of FBXO28 mRNA	PMID:19244175
1312107	FBXO28	F-box protein 28	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of FBXO28 mRNA	PMID:28302478
1312107	FBXO28	F-box protein 28	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FBXO28 mRNA	PMID:25979313
1312107	FBXO28	F-box protein 28	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXO28 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1312107	FBXO28	F-box protein 28	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1549977	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXO28 mRNA	PMID:21427059
1312107	FBXO28	F-box protein 28	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of FBXO28 mRNA	PMID:24935251
1312107	FBXO28	F-box protein 28	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of FBXO28 mRNA	PMID:21420995
1312107	FBXO28	F-box protein 28	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO28 mRNA	PMID:39836092
1312107	FBXO28	F-box protein 28	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of FBXO28 mRNA	PMID:23228038
1312107	FBXO28	F-box protein 28	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304584	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of FBXO28 mRNA	PMID:30307764
1312107	FBXO28	F-box protein 28	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1304584	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of FBXO28 mRNA	PMID:19564919
1312107	FBXO28	F-box protein 28	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1549977	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FBXO28 mRNA	PMID:22206623
1312107	FBXO28	F-box protein 28	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBXO28 mRNA	PMID:30851411
1312107	FBXO28	F-box protein 28	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of FBXO28 mRNA	PMID:24921660
1312107	FBXO28	F-box protein 28	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304584	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FBXO28 mRNA	PMID:21346803
1312107	FBXO28	F-box protein 28	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304584	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of FBXO28 mRNA	PMID:23034163
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of ABCA12 mRNA	PMID:31016361
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ABCA12 mRNA	PMID:23724009
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1620735	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ABCA12 mRNA	PMID:36189433
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ABCA12 mRNA	PMID:26079696
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ABCA12 mRNA	PMID:22378314
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ABCA12 mRNA	PMID:21632981
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ABCA12 mRNA	PMID:35811015
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ABCA12 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of ABCA12 mRNA	PMID:35811015
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of ABCA12 mRNA	PMID:19619570|PMID:21185374
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ABCA12 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of ABCA12 mRNA	PMID:19619570|PMID:30165855
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ABCA12 mRNA	PMID:38568856
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:16602	trichloroethene	affects response to substance	EXP		E	RGD:6480464	20140114	CTD	MESH:D014241	ABCA12 affects the susceptibility to Trichloroethylene	PMID:23994554
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ABCA12 mRNA	PMID:23649840
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1620735	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ABCA12 mRNA	PMID:22401849
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1620735	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ABCA12 mRNA	PMID:36189433
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of ABCA12 mRNA	PMID:21592394
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of ABCA12 mRNA	PMID:21592394
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of ABCA12 mRNA	PMID:21592394
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of ABCA12 mRNA	PMID:21592394
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304586	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ABCA12 mRNA	PMID:33387578
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ABCA12 mRNA	PMID:23649840
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ABCA12 protein	PMID:20106945
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ABCA12 gene	PMID:27153756
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ABCA12 mRNA	PMID:22100608|PMID:32234424
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ABCA12 mRNA	PMID:23649840
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:2682	amphotericin B	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of ABCA12 mRNA	PMID:28534445
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABCA12 mRNA	PMID:32525701
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of ABCA12 mRNA	PMID:38460933
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ABCA12 mRNA	PMID:38460933
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ABCA12 mRNA	PMID:27392435
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ABCA12 mRNA	PMID:27392435
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ABCA12 mRNA	PMID:19619570|PMID:20106945
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABCA12 mRNA	PMID:23152189
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ABCA12 mRNA	PMID:19619570
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ABCA12 mRNA	PMID:33212167
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABCA12 mRNA	PMID:30851411
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of ABCA12 mRNA	PMID:23649840
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:28445	vincristine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	[Vincristine results in decreased susceptibility to Vincristine] which results in increased expression of ABCA12 mRNA	PMID:19944135
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:29678	sodium arsenite	decreases methylation	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ABCA12 intron	PMID:32844245
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ABCA12 mRNA	PMID:29301061|PMID:32844245|PMID:39719251
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ABCA12 3' UTR	PMID:27901495
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABCA12 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:32234424
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:29866	arsenite(3-)	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased expression of ABCA12 mRNA	PMID:23974009
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:3020	benzalkonium chloride	increases expression	EXP		E	RGD:6480464	20170103	CTD	MESH:D001548	Benzalkonium Compounds results in increased expression of ABCA12 mRNA	PMID:25377654
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ABCA12 gene	PMID:31601247
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCA12 mRNA	PMID:22576693
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304586	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCA12 mRNA	PMID:25181051
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ABCA12 gene	PMID:31601247
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of ABCA12 gene	PMID:22576693
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ABCA12 gene	PMID:31601247
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1620735	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ABCA12 mRNA	PMID:26377693
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1620735	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ABCA12 intron	PMID:28392331
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ABCA12 mRNA	PMID:38568856
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ABCA12 mRNA	PMID:38174414
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:36015	1,1,1-trichloroethane	increases expression	ISO	RGD:1620735	E	RGD:6480464	20150127	CTD	MESH:C024566	1,1,1-trichloroethane results in increased expression of ABCA12 mRNA	PMID:25270620
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ABCA12 mRNA	PMID:32588087
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620735	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ABCA12 mRNA	PMID:40194260
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ABCA12 gene	PMID:29154799
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ABCA12 mRNA	PMID:20106945
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of ABCA12 mRNA	PMID:23649840
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ABCA12 mRNA	PMID:29067470
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304586	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ABCA12 mRNA	PMID:33387578
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of ABCA12 mRNA	PMID:24714768
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ABCA12 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of ABCA12 mRNA	PMID:35811015
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:46742	Nutlin-3	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of ABCA12 mRNA	PMID:38460933
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ABCA12 mRNA	PMID:38460933
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABCA12 mRNA	PMID:32525701
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:51052	lucanthone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in increased expression of ABCA12 mRNA	PMID:21148553
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1620735	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ABCA12 mRNA	PMID:23608068
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1620735	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ABCA12 mRNA	PMID:22206623
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of ABCA12 mRNA	PMID:36318118
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:755540	docetaxel	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	[Docetaxel results in decreased susceptibility to Docetaxel] which affects the expression of ABCA12 mRNA	PMID:19944135
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABCA12 mRNA	PMID:30851411
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ABCA12 gene]	PMID:28238834
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABCA12 mRNA	PMID:32525701
1312110	ABCA12	ATP binding cassette subfamily A member 12	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of ABCA12 mRNA	PMID:25377654
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1304587	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of C10H1ORF35 mRNA	PMID:22967744
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of C1ORF35 protein	PMID:37730182
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of C1ORF35 mRNA	PMID:19549813
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of C1ORF35 protein	PMID:23301498
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of C1ORF35 mRNA	PMID:35430440
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of C1ORF35 gene	PMID:25304211
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304587	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of C10H1ORF35 mRNA	PMID:22298810
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of C1ORF35 protein	PMID:33212167
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304587	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of C10H1ORF35 mRNA	PMID:28959563
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304587	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of C10H1ORF35 mRNA	PMID:30556269
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:28748	doxorubicin	increases oxidation	ISO	RGD:1304587	E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin results in increased oxidation of C10H1ORF35 protein	PMID:28818578
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of C1ORF35 mRNA	PMID:39719251
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C1ORF35 promoter	PMID:27901495
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304587	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of C10H1ORF35 mRNA	PMID:30556269
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in decreased expression of C1ORF35 mRNA	PMID:34973136
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304587	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of C1ORF35 mRNA	PMID:25181051
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:46345	5-fluorouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil affects the expression of C1ORF35 mRNA	PMID:16584549
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of C1ORF35 gene	PMID:25304211
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304587	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of C10H1ORF35 mRNA	PMID:29391264
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1304587	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of C10H1ORF35 mRNA	PMID:17557909
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of C1ORF35 protein	PMID:32959892
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of C1ORF35 mRNA	PMID:37199045
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of C1ORF35 protein	PMID:31285264
1312112	C1orf35	chromosome 1 open reading frame 35	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304587	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of C10H1ORF35 mRNA	PMID:23034163
1312114	LPIN2	lipin 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of LPIN2 mRNA	PMID:33045310
1312114	LPIN2	lipin 2	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of LPIN2 mRNA	PMID:39506029
1312114	LPIN2	lipin 2	gene	CHEBI:16196	oleic acid	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:D019301	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in decreased expression of LPIN2 mRNA; [GW 4064 co-treated with Oleic Acid] results in decreased expression of LPIN2 mRNA	PMID:30611723
1312114	LPIN2	lipin 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312115	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of LPIN2 mRNA	PMID:30319688
1312114	LPIN2	lipin 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LPIN2 mRNA	PMID:39241906
1312114	LPIN2	lipin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of LPIN2 mRNA	PMID:19484750|PMID:39298647
1312114	LPIN2	lipin 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312115	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of LPIN2 mRNA	PMID:25549359
1312114	LPIN2	lipin 2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1312115	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of LPIN2 mRNA	PMID:28973375
1312114	LPIN2	lipin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LPIN2 mRNA	PMID:19850644
1312114	LPIN2	lipin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20180116	CTD	MESH:D004051	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of LPIN2 mRNA	PMID:28433925
1312114	LPIN2	lipin 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of LPIN2 protein	PMID:37730182
1312114	LPIN2	lipin 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LPIN2 intron	PMID:30157460
1312114	LPIN2	lipin 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LPIN2 mRNA	PMID:36331819
1312114	LPIN2	lipin 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LPIN2 mRNA	PMID:39836092
1312114	LPIN2	lipin 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LPIN2 mRNA	PMID:37236586
1312114	LPIN2	lipin 2	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304588	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of LPIN2 mRNA	PMID:21396975
1312114	LPIN2	lipin 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LPIN2 gene	PMID:27153756
1312114	LPIN2	lipin 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of LPIN2 mRNA	PMID:23649840
1312114	LPIN2	lipin 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312115	E	RGD:6480464	20120501	CTD	MESH:D010126	Ozone results in increased expression of LPIN2 mRNA	PMID:17095637|PMID:19555225
1312114	LPIN2	lipin 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of LPIN2 mRNA	PMID:34911549
1312114	LPIN2	lipin 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of LPIN2 mRNA	PMID:17484886|PMID:31919559
1312114	LPIN2	lipin 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LPIN2 mRNA	PMID:25629700
1312114	LPIN2	lipin 2	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of LPIN2 mRNA	PMID:19654921
1312114	LPIN2	lipin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LPIN2 mRNA	PMID:39836092
1312114	LPIN2	lipin 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of LPIN2 protein	PMID:35688186
1312114	LPIN2	lipin 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LPIN2 mRNA	PMID:28189721|PMID:28960355
1312114	LPIN2	lipin 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1304588	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of LPIN2 mRNA	PMID:25905778
1312114	LPIN2	lipin 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of LPIN2 mRNA	PMID:27594783
1312114	LPIN2	lipin 2	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1312115	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of LPIN2 mRNA	PMID:34813904
1312114	LPIN2	lipin 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of LPIN2 mRNA	PMID:30912803
1312114	LPIN2	lipin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312115	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LPIN2 mRNA	PMID:21570461
1312114	LPIN2	lipin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304588	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LPIN2 mRNA	PMID:21215274|PMID:33387578
1312114	LPIN2	lipin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312115	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LPIN2 mRNA	PMID:15328365|PMID:15800033|PMID:16611356|PMID:19770486|PMID:21889950|PMID:23864506|PMID:23994337|PMID:25975270|PMID:26290441|PMID:28213091|PMID:28238261
1312114	LPIN2	lipin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20150825	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of LPIN2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LPIN2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to LPIN2 gene]	PMID:25975270|PMID:28213091|PMID:28433925
1312114	LPIN2	lipin 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1304588	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of LPIN2 mRNA	PMID:28374803
1312114	LPIN2	lipin 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LPIN2 mRNA	PMID:30851411
1312114	LPIN2	lipin 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of LPIN2 mRNA	PMID:27862939
1312114	LPIN2	lipin 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LPIN2 mRNA	PMID:29803840
1312114	LPIN2	lipin 2	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of LPIN2 protein	PMID:35688186
1312114	LPIN2	lipin 2	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of LPIN2 mRNA	PMID:34032870
1312114	LPIN2	lipin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of LPIN2 mRNA	PMID:37956786
1312114	LPIN2	lipin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of LPIN2 mRNA	PMID:39515575
1312114	LPIN2	lipin 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LPIN2 mRNA	PMID:38568856
1312114	LPIN2	lipin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LPIN2 mRNA	PMID:39836092
1312114	LPIN2	lipin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LPIN2 mRNA	PMID:32234424
1312114	LPIN2	lipin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312115	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LPIN2 mRNA	PMID:19770486|PMID:21569818|PMID:21964900
1312114	LPIN2	lipin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LPIN2 promoter	PMID:27901495
1312114	LPIN2	lipin 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to LPIN2 mRNA]	PMID:32406909
1312114	LPIN2	lipin 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of LPIN2 mRNA	PMID:23806026
1312114	LPIN2	lipin 2	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of LPIN2 gene	PMID:31601247
1312114	LPIN2	lipin 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of LPIN2 mRNA	PMID:23557971
1312114	LPIN2	lipin 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304588	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of LPIN2 mRNA	PMID:34492290
1312114	LPIN2	lipin 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312115	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of LPIN2 mRNA	PMID:17426115|PMID:18301758|PMID:18445702|PMID:19850644|PMID:20813756|PMID:23811191
1312114	LPIN2	lipin 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LPIN2 mRNA; PPARA protein promotes the reaction [pirinixic acid results in decreased expression of LPIN2 mRNA]	PMID:19710929|PMID:19850644
1312114	LPIN2	lipin 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of LPIN2 mRNA	PMID:30903817
1312114	LPIN2	lipin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304588	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LPIN2 mRNA	PMID:25181051
1312114	LPIN2	lipin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304588	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of LPIN2 mRNA	PMID:30816183|PMID:32528016
1312114	LPIN2	lipin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312115	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of LPIN2 mRNA	PMID:34585602
1312114	LPIN2	lipin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20180116	CTD	MESH:C006780	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of LPIN2 mRNA	PMID:28433925
1312114	LPIN2	lipin 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of LPIN2 mRNA	PMID:25979313
1312114	LPIN2	lipin 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20180116	CTD	MESH:C014024	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of LPIN2 mRNA	PMID:28433925
1312114	LPIN2	lipin 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1312115	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LPIN2 mRNA	PMID:23994337
1312114	LPIN2	lipin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LPIN2 mRNA	PMID:39298647
1312114	LPIN2	lipin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312115	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of LPIN2 mRNA	PMID:40203079
1312114	LPIN2	lipin 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of LPIN2 mRNA	PMID:28392331
1312114	LPIN2	lipin 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312115	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LPIN2 intron	PMID:28392331
1312114	LPIN2	lipin 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of LPIN2 mRNA	PMID:32715474
1312114	LPIN2	lipin 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of LPIN2 gene	PMID:22964155
1312114	LPIN2	lipin 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LPIN2 mRNA	PMID:21266533
1312114	LPIN2	lipin 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312115	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of LPIN2 mRNA	PMID:34813904
1312114	LPIN2	lipin 2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in decreased expression of LPIN2 mRNA	PMID:17215068
1312114	LPIN2	lipin 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304588	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in increased expression of LPIN2 mRNA	PMID:12242611
1312114	LPIN2	lipin 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in increased expression of LPIN2 mRNA	PMID:17215068
1312114	LPIN2	lipin 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LPIN2 mRNA	PMID:37042841
1312114	LPIN2	lipin 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1304588	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of LPIN2 mRNA	PMID:30589522
1312114	LPIN2	lipin 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LPIN2 mRNA	PMID:39836092
1312114	LPIN2	lipin 2	gene	CHEBI:35176	zinc sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of LPIN2 mRNA	PMID:16330358
1312114	LPIN2	lipin 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304588	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of LPIN2 mRNA	PMID:30723492
1312114	LPIN2	lipin 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304588	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LPIN2 mRNA	PMID:33453195
1312114	LPIN2	lipin 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LPIN2 mRNA	PMID:37236586
1312114	LPIN2	lipin 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312115	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of LPIN2 mRNA	PMID:28903501
1312114	LPIN2	lipin 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312115	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of LPIN2 mRNA	PMID:28962523
1312114	LPIN2	lipin 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312115	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of LPIN2 mRNA	PMID:18353800
1312114	LPIN2	lipin 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312115	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of LPIN2 mRNA	PMID:23811191
1312114	LPIN2	lipin 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of LPIN2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LPIN2 mRNA]	PMID:17585979
1312114	LPIN2	lipin 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LPIN2 mRNA	PMID:31533062
1312114	LPIN2	lipin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LPIN2 mRNA	PMID:36331819
1312114	LPIN2	lipin 2	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1312115	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of LPIN2 mRNA	PMID:29038090
1312114	LPIN2	lipin 2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312115	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of LPIN2 mRNA	PMID:23125180
1312114	LPIN2	lipin 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304588	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of LPIN2 mRNA	PMID:38685447|PMID:41580965
1312114	LPIN2	lipin 2	gene	CHEBI:40303	lovastatin	decreases response to substance	EXP		E	RGD:6480464	20120501	CTD	MESH:D008148	LPIN2 SNP results in decreased susceptibility to Lovastatin	PMID:21483694
1312114	LPIN2	lipin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of LPIN2 mRNA	PMID:20106945
1312114	LPIN2	lipin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of LPIN2 mRNA	PMID:19770486
1312114	LPIN2	lipin 2	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of LPIN2 promoter	PMID:27989131
1312114	LPIN2	lipin 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of LPIN2 mRNA	PMID:25562108
1312114	LPIN2	lipin 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312115	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of LPIN2 mRNA	PMID:28973697
1312114	LPIN2	lipin 2	gene	CHEBI:43602	obeticholic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of LPIN2 mRNA	PMID:27939613
1312114	LPIN2	lipin 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LPIN2 mRNA	PMID:38832940
1312114	LPIN2	lipin 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LPIN2 mRNA	PMID:17562736
1312114	LPIN2	lipin 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of LPIN2 mRNA	PMID:21420995
1312114	LPIN2	lipin 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of LPIN2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LPIN2 mRNA]	PMID:17585979
1312114	LPIN2	lipin 2	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of LPIN2 mRNA	PMID:19654921
1312114	LPIN2	lipin 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LPIN2 mRNA	PMID:39836092
1312114	LPIN2	lipin 2	gene	CHEBI:47318	6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:C475093	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in decreased expression of LPIN2 mRNA	PMID:30611723
1312114	LPIN2	lipin 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of LPIN2 mRNA	PMID:30529165
1312114	LPIN2	lipin 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304588	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of LPIN2 mRNA	PMID:29391264
1312114	LPIN2	lipin 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of LPIN2 mRNA	PMID:35436446
1312114	LPIN2	lipin 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LPIN2 mRNA; Nanotubes, Carbon results in decreased expression of LPIN2 mRNA	PMID:25554681|PMID:25620056
1312114	LPIN2	lipin 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304588	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of LPIN2 mRNA	PMID:41580965
1312114	LPIN2	lipin 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LPIN2 mRNA	PMID:39836092
1312114	LPIN2	lipin 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of LPIN2 mRNA	PMID:15336504
1312114	LPIN2	lipin 2	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1304588	E	RGD:6480464	20200114	CTD	MESH:D008687	Metformin results in decreased expression of LPIN2 mRNA	PMID:31324951
1312114	LPIN2	lipin 2	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304588	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of LPIN2 mRNA	PMID:30467583
1312114	LPIN2	lipin 2	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of LPIN2 mRNA	PMID:17383702
1312114	LPIN2	lipin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LPIN2 mRNA	PMID:22206623
1312114	LPIN2	lipin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1304588	E	RGD:6480464	20180220	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LPIN2 mRNA	PMID:27840820
1312114	LPIN2	lipin 2	gene	CHEBI:7438	N-methylformamide	increases expression	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide analog results in increased expression of LPIN2 mRNA; methylformamide results in increased expression of LPIN2 mRNA	PMID:17040096
1312114	LPIN2	lipin 2	gene	CHEBI:749301	potassium perchlorate	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of LPIN2 mRNA	PMID:29673971
1312114	LPIN2	lipin 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1312115	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of LPIN2 mRNA	PMID:23994337
1312114	LPIN2	lipin 2	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1304588	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of LPIN2 mRNA	PMID:23665939
1312114	LPIN2	lipin 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LPIN2 mRNA	PMID:30851411
1312114	LPIN2	lipin 2	gene	CHEBI:79997	GW 4064	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C412815	GW 4064 results in decreased expression of LPIN2 mRNA	PMID:30611723
1312114	LPIN2	lipin 2	gene	CHEBI:79997	GW 4064	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:C412815	[GW 4064 co-treated with Oleic Acid] results in decreased expression of LPIN2 mRNA	PMID:30611723
1312114	LPIN2	lipin 2	gene	CHEBI:80025	Salinomycin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of LPIN2 mRNA	PMID:19682730
1312114	LPIN2	lipin 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of LPIN2 mRNA	PMID:19270015|PMID:19850644|PMID:23091169
1312114	LPIN2	lipin 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312115	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein promotes the reaction [Phenobarbital results in decreased expression of LPIN2 mRNA]	PMID:19850644
1312114	LPIN2	lipin 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1304588	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of LPIN2 mRNA	PMID:27291303
1312114	LPIN2	lipin 2	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of LPIN2 mRNA	PMID:26377693
1312114	LPIN2	lipin 2	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1304588	E	RGD:6480464	20160822	CTD	MESH:D013311	Streptozocin results in increased expression of LPIN2 mRNA	PMID:25905778
1312114	LPIN2	lipin 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304588	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LPIN2 mRNA	PMID:21346803
1312114	LPIN2	lipin 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312115	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of LPIN2 mRNA	PMID:28973697
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of SNAPC2 mRNA	PMID:22378314
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNAPC2 mRNA	PMID:37042841
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312117	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SNAPC2 mRNA	PMID:33754040
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304589	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SNAPC2 mRNA	PMID:33387578
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SNAPC2 mRNA	PMID:28818685
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNAPC2 mRNA	PMID:36331819
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC2 mRNA	PMID:39836092
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of SNAPC2 mRNA	PMID:23369406
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNAPC2 mRNA	PMID:22206623
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNAPC2 mRNA	PMID:39836092
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1304589	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of SNAPC2 mRNA	PMID:20187946
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312117	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNAPC2 mRNA	PMID:21570461
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SNAPC2 mRNA	PMID:16467188
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304589	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNAPC2 mRNA	PMID:33387578
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of SNAPC2 mRNA	PMID:17942748
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SNAPC2 mRNA	PMID:29803840
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SNAPC2 mRNA	PMID:38568856|PMID:39719251
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNAPC2 mRNA	PMID:39836092
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SNAPC2 promoter	PMID:27901495
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of SNAPC2 gene	PMID:31601247
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312117	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNAPC2 gene	PMID:35295148
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SNAPC2 mRNA	PMID:18648102
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312117	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SNAPC2 promoter	PMID:27334623
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304589	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SNAPC2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312117	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SNAPC2 gene	PMID:31683443
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312117	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SNAPC2 mRNA	PMID:39298647
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312117	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SNAPC2 mRNA	PMID:37019170
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SNAPC2 gene	PMID:22964155
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312117	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SNAPC2 mRNA	PMID:17361019|PMID:21266533
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC2 mRNA	PMID:39836092
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1304589	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of SNAPC2 mRNA	PMID:18500788
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1304589	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of SNAPC2 promoter	PMID:22457795
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNAPC2 mRNA	PMID:36331819
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SNAPC2 gene	PMID:29154799
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SNAPC2 mRNA	PMID:17555576
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNAPC2 mRNA	PMID:17562736
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of SNAPC2 mRNA	PMID:29067470
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304589	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SNAPC2 mRNA	PMID:33387578
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNAPC2 mRNA	PMID:39836092
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SNAPC2 mRNA	PMID:17555576
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1312117	E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of SNAPC2 mRNA	PMID:16467188|PMID:17942748
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of SNAPC2 mRNA	PMID:17942748
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SNAPC2 mRNA	PMID:35964746
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC2 mRNA	PMID:39836092
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SNAPC2 mRNA	PMID:31758290
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312117	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SNAPC2 mRNA	PMID:22206623
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312117	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNAPC2 mRNA	PMID:22206623
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1304589	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SNAPC2 mRNA	PMID:23640034
1312116	SNAPC2	small nuclear RNA activating complex polypeptide 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304589	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SNAPC2 mRNA	PMID:23034163
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312120	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ART1 mRNA	PMID:33045310
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:17323	trans-pinosylvin	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C049032	pinosylvin results in increased expression of ART1 mRNA	PMID:23333577
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304591	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in increased expression of ART1 mRNA]	PMID:20032058
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304591	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ART1 mRNA	PMID:26577399|PMID:27523638
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:2038	5-azacytidine	increases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of ART1 mRNA	PMID:20823114
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ART1 mRNA	PMID:35301059
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1304591	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of ART1 mRNA	PMID:17074742
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312120	E	RGD:6480464	20240206	CTD	MESH:D002945	ART1 protein inhibits the reaction [Cisplatin results in increased cleavage of PARP1 protein]	PMID:24676941
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304591	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ART1 mRNA	PMID:22298810
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ART1 mRNA	PMID:33212167
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304591	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ART1 mRNA	PMID:28959563
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of ART1 mRNA	PMID:29301061
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ART1 promoter	PMID:27901495
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312120	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ART1 mRNA	PMID:22228805
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ART1 5' UTR	PMID:27901495
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1304591	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of ART1 mRNA	PMID:17074742
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ART1 gene	PMID:31601247
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312120	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ART1 mRNA	PMID:23557971
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312120	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ART1 mRNA	PMID:18648102
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1312120	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ART1 gene	PMID:23968726
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ART1 gene	PMID:31601247
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304591	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ART1 mRNA	PMID:25181051
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ART1 gene	PMID:31601247
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312120	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ART1 exon	PMID:33297965
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312120	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ART1 mRNA	PMID:21266533
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312120	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ART1 gene	PMID:23968726
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1304591	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of ART1 mRNA	PMID:35163327
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304591	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ART1 mRNA	PMID:35163327
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:35176	zinc sulfate	decreases expression	ISO	RGD:1304591	E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of ART1 mRNA	PMID:17074742
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ART1 mRNA	PMID:35301059
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304591	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ART1 mRNA	PMID:35163327
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:36011	pinosylvin	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C049032	pinosylvin results in increased expression of ART1 mRNA	PMID:23333577
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1312120	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of ART1 mRNA	PMID:17555576
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1304591	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of ART1 mRNA	PMID:20032058
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312120	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of ART1 mRNA	PMID:22733784
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1304591	E	RGD:6480464	20120412	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in increased expression of ART1 mRNA]	PMID:20032058
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304591	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ART1 mRNA	PMID:30307764
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1312120	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ART1 mRNA	PMID:27935865
1312119	ART1	ADP-ribosyltransferase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304591	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ART1 mRNA	PMID:24780913
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312124	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COG1 mRNA	PMID:33045310
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of COG1 gene	PMID:20938992
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312124	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of COG1 mRNA	PMID:39241906
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of COG1 gene	PMID:20938992
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COG1 mRNA	PMID:37042841
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312124	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of COG1 protein	PMID:20463053
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312124	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of COG1 mRNA	PMID:23892564
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of COG1 protein	PMID:37730182
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304594	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of COG1 mRNA	PMID:33387578
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of COG1 mRNA	PMID:28818685
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COG1 protein]	PMID:32272095
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COG1 mRNA	PMID:19549813
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of COG1 mRNA	PMID:23649840
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of COG1 mRNA	PMID:22100608
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of COG1 gene	PMID:20938992
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of COG1 gene	PMID:25304211
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COG1 mRNA	PMID:40504410
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312124	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of COG1 mRNA	PMID:30912803
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of COG1 mRNA	PMID:33212167
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:28748	doxorubicin	affects methylation	ISO	RGD:1304594	E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of COG1 gene	PMID:28962528
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COG1 mRNA	PMID:29803840
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312124	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of COG1 mRNA	PMID:39631538
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of COG1 protein	PMID:35688186
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of COG1 mRNA	PMID:38568856
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COG1 mRNA	PMID:40504410
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COG1 promoter	PMID:27901495
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312124	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of COG1 gene	PMID:35295148
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of COG1 protein	PMID:31675489
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304594	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of COG1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304594	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of COG1 mRNA	PMID:25181051
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304594	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of COG1 gene	PMID:28505145
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304594	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of COG1 mRNA	PMID:36041667
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of COG1 protein	PMID:31675489
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of COG1 gene	PMID:31601247
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304594	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of COG1 mRNA	PMID:36041667
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304594	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of COG1 mRNA	PMID:36041667
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312124	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of COG1 mRNA	PMID:37019170
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1312124	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of COG1 protein	PMID:32272095
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COG1 protein]	PMID:32272095
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304594	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COG1 mRNA	PMID:33453195
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312124	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of COG1 mRNA	PMID:17585979
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of COG1 mRNA	PMID:31533062
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COG1 mRNA	PMID:25979313
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of COG1 mRNA; Valproic Acid results in decreased expression of COG1 protein	PMID:29501571
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of COG1 gene	PMID:29154799|PMID:29501571
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of COG1 mRNA	PMID:20106945
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304594	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COG1 mRNA	PMID:33387578
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of COG1 mRNA	PMID:29523930
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312124	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of COG1 mRNA	PMID:19446018
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of COG1 gene	PMID:25304211
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COG1 mRNA	PMID:40504410
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of COG1 mRNA	PMID:31675489
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312124	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of COG1 mRNA	PMID:35964746
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of COG1 protein	PMID:32959892
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of COG1 mRNA	PMID:31758290
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of COG1 protein	PMID:31675489
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312124	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of COG1 mRNA	PMID:40826991
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of COG1 mRNA	PMID:22378314
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304594	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of COG1 mRNA	PMID:21346803
1312123	COG1	component of oligomeric golgi complex 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304594	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of COG1 mRNA	PMID:23034163
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TMEM268 mRNA	PMID:26272509
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM268 mRNA	PMID:27188386
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TMEM268 mRNA	PMID:26079696
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TMEM268 mRNA	PMID:22378314
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TMEM268 mRNA	PMID:21632981
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of TMEM268 mRNA	PMID:29581250
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312126	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TMEM268 mRNA	PMID:39241906
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of TMEM268 mRNA	PMID:20106945|PMID:31614463
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312126	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TMEM268 mRNA	PMID:39298647
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304595	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMEM268 mRNA	PMID:33387578
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312126	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TMEM268 mRNA	PMID:36331819
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TMEM268 mRNA	PMID:19549813
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312126	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TMEM268 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TMEM268 mRNA	PMID:34911549
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304595	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TMEM268 mRNA	PMID:31150632
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1304595	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA	PMID:33854195
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of TMEM268 mRNA	PMID:27594783
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM268 mRNA	PMID:20106945|PMID:21632981
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304595	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM268 mRNA	PMID:32109520
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TMEM268 mRNA	PMID:28001369
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of TMEM268 mRNA	PMID:26272509
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM268 mRNA	PMID:27188386
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304595	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TMEM268 mRNA	PMID:28959563
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TMEM268 mRNA	PMID:29803840
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of TMEM268 mRNA	PMID:29453283
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMEM268 promoter	PMID:27901495
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of TMEM268 mRNA	PMID:31745603
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304595	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TMEM268 mRNA	PMID:25181051
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM268 mRNA	PMID:29275510
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304595	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM268 mRNA	PMID:34947998
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304595	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TMEM268 gene	PMID:28505145
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TMEM268 mRNA	PMID:25979313
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1304595	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA	PMID:33854195
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of TMEM268 gene	PMID:22964155
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304595	E	RGD:6480464	20161025	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TMEM268 mRNA	PMID:21266533
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312126	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TMEM268 mRNA	PMID:34813904
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1304595	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of TMEM268 mRNA	PMID:30589522
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of TMEM268 mRNA	PMID:29024780
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TMEM268 mRNA	PMID:26472689
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TMEM268 mRNA	PMID:32588087
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of TMEM268 mRNA	PMID:28302478
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TMEM268 mRNA	PMID:31533062
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312126	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TMEM268 mRNA	PMID:36331819
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM268 mRNA	PMID:25979313
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM268 mRNA	PMID:22083351|PMID:28001369
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304595	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of TMEM268 mRNA	PMID:38685447|PMID:41580965
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TMEM268 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1304595	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA	PMID:33854195
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312126	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TMEM268 mRNA	PMID:28973697
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:C111237	vorinostat results in decreased expression of TMEM268 mRNA	PMID:22083351|PMID:27188386
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1304595	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA	PMID:33854195
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TMEM268 mRNA	PMID:28542535
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of TMEM268 mRNA	PMID:26690555
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM268 mRNA	PMID:29067470
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304595	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM268 mRNA	PMID:33387578
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304595	E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of TMEM268 mRNA	PMID:38685447|PMID:41580965
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1304595	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA	PMID:33854195
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM268 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM268 mRNA	PMID:27188386
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of TMEM268 mRNA	PMID:35688559
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM268 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMEM268 mRNA	PMID:27188386
1312125	TMEM268	transmembrane protein 268	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304595	E	RGD:6480464	20161025	CTD	MESH:C025643	vinclozolin results in increased expression of TMEM268 mRNA	PMID:20566332
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NDUFA7 mRNA	PMID:38218311
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of NDUFA7 mRNA	PMID:38218311
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1304597	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of NDUFA7 mRNA	PMID:21551480
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of NDUFA7 mRNA]	PMID:19467301
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312129	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NDUFA7 mRNA	PMID:39241906
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFA7 mRNA	PMID:31059760
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of NDUFA7 mRNA	PMID:39298647
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NDUFA7 mRNA	PMID:25510870
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20161025	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of NDUFA7 mRNA	PMID:27167697
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17578	toluene	affects expression	ISO	RGD:1304597	E	RGD:6480464	20130507	CTD	MESH:D014050	Toluene affects the expression of NDUFA7 mRNA	PMID:21827849
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1304597	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of NDUFA7 mRNA	PMID:22967744
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NDUFA7 mRNA	PMID:28412506|PMID:36774801
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NDUFA7 mRNA	PMID:35550907
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312129	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NDUFA7 mRNA	PMID:33754040
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304597	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NDUFA7 mRNA	PMID:33387578
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NDUFA7 mRNA	PMID:36331819
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NDUFA7 mRNA	PMID:25510870
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NDUFA7 mRNA	PMID:25510870
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NDUFA7 mRNA	PMID:23649840
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of NDUFA7 mRNA	PMID:35430440
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D014747	NDUFA7 protein affects the susceptibility to Vinblastine	PMID:16217747
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304597	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NDUFA7 mRNA	PMID:33387578
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NDUFA7 mRNA	PMID:40504410
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of NDUFA7 mRNA	PMID:19244175
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312129	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of NDUFA7 mRNA	PMID:22610192
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312129	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of NDUFA7 mRNA	PMID:30912803
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312129	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NDUFA7 mRNA	PMID:21570461
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304597	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFA7 mRNA	PMID:34747641
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304597	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NDUFA7 mRNA	PMID:33387578
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312129	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NDUFA7 mRNA	PMID:19770486|PMID:20399798
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1304597	E	RGD:6480464	20130507	CTD	MESH:D003300	Copper results in decreased expression of NDUFA7 mRNA	PMID:22465980
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of NDUFA7 mRNA	PMID:36989763
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of NDUFA7 mRNA	PMID:38685555
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NDUFA7 mRNA	PMID:40504410
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NDUFA7 mRNA	PMID:22378314
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NDUFA7 protein	PMID:32717239
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1304597	E	RGD:6480464	20130507	CTD	MESH:D003300	Copper results in decreased expression of NDUFA7 mRNA	PMID:22465980
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1304597	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of NDUFA7 mRNA	PMID:16483693
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of NDUFA7 mRNA	PMID:21829687
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1304597	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of NDUFA7 mRNA	PMID:24136188
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304597	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of NDUFA7 mRNA	PMID:34492290
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NDUFA7 mRNA	PMID:30903817
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFA7 mRNA	PMID:25047013
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304597	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFA7 mRNA	PMID:25181051|PMID:32145629
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFA7 mRNA	PMID:35598803
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFA7 protein	PMID:37567409
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304597	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFA7 mRNA	PMID:30816183|PMID:32528016
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312129	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFA7 mRNA	PMID:33221593|PMID:38074096
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304597	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NDUFA7 gene	PMID:28505145
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of NDUFA7 mRNA	PMID:19244175
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of NDUFA7 mRNA	PMID:19244175
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NDUFA7 mRNA	PMID:25510870
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NDUFA7 mRNA	PMID:25510870
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312129	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NDUFA7 mRNA	PMID:39298647|PMID:40203079
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312129	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NDUFA7 mRNA	PMID:37019170
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NDUFA7 mRNA	PMID:17361019
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312129	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of NDUFA7 mRNA	PMID:34813904
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312129	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of NDUFA7 mRNA	PMID:17942915
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of NDUFA7 mRNA]	PMID:17942915
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of NDUFA7 protein	PMID:26879310
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NDUFA7 mRNA	PMID:19320972
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of NDUFA7 mRNA	PMID:19244175
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20130416	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NDUFA7 mRNA	PMID:20936131
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20130416	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NDUFA7 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NDUFA7 mRNA; PPARA protein inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of NDUFA7 mRNA]	PMID:20936131|PMID:36331819
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304597	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of NDUFA7 mRNA	PMID:41580965
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NDUFA7 mRNA	PMID:25562108
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1304597	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of NDUFA7 mRNA	PMID:24136188
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of NDUFA7 mRNA	PMID:25704631
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304597	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NDUFA7 mRNA	PMID:33387578
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFA7 mRNA	PMID:31059760
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NDUFA7 mRNA	PMID:40504410
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:47381	diclofenac	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20240702	CTD	MESH:D004008	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of NDUFA7 mRNA	PMID:37844793
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312129	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of NDUFA7 mRNA	PMID:35436446
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20240702	CTD	MESH:D004997	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of NDUFA7 mRNA	PMID:37844793
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of NDUFA7 mRNA	PMID:19194470
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20120814	CTD	MESH:D005485	Flutamide results in decreased expression of NDUFA7 mRNA	PMID:19442681
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:5855	ibuprofen	multiple interactions	ISO	RGD:1312129	E	RGD:6480464	20240702	CTD	MESH:D007052	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of NDUFA7 mRNA	PMID:37844793
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:1304597	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of NDUFA7 mRNA	PMID:24136188
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312129	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of NDUFA7 mRNA	PMID:23650126
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of NDUFA7 mRNA	PMID:15336504
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312129	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NDUFA7 mRNA	PMID:22206623
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of NDUFA7 mRNA	PMID:22576131
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in increased expression of NDUFA7 mRNA	PMID:17316727
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1312129	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in increased expression of NDUFA7 mRNA	PMID:22538082
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:90943	osimertinib	increases expression	ISO	RGD:1304597	E	RGD:6480464	20250506	CTD	MESH:C000603933	osimertinib results in increased expression of NDUFA7 protein	PMID:38734218
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304597	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of NDUFA7 mRNA	PMID:19281266
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of NDUFA7 mRNA	PMID:22378314
1312128	NDUFA7	NADH:ubiquinone oxidoreductase subunit A7	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1304597	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of NDUFA7 protein	PMID:32519852
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312132	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of POLRMT mRNA	PMID:33045310
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of POLRMT mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of POLRMT mRNA	PMID:32699268
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of POLRMT mRNA	PMID:36331819
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of POLRMT mRNA	PMID:22378314
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312132	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POLRMT mRNA	PMID:39241906
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of POLRMT mRNA	PMID:23019147
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312132	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of POLRMT mRNA	PMID:39298647
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of POLRMT mRNA	PMID:37042841
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:17558	quercitrin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in decreased expression of POLRMT mRNA	PMID:25193878
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:17626	citraconic acid	increases expression	ISO	RGD:1312132	E	RGD:6480464	20180220	CTD	MESH:C073341	citraconic acid results in increased expression of POLRMT mRNA	PMID:27277809
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:17626	citraconic acid	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20180220	CTD	MESH:C073341	NFE2L2 protein affects the reaction [citraconic acid results in increased expression of POLRMT mRNA]	PMID:27277809
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312132	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of POLRMT mRNA	PMID:23892564
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of POLRMT protein	PMID:23301498
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312132	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of POLRMT mRNA	PMID:19770486
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of POLRMT mRNA	PMID:23649840
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of POLRMT mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of POLRMT mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of POLRMT mRNA	PMID:32699268
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304599	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of POLRMT mRNA	PMID:30779732
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POLRMT mRNA	PMID:22206623
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POLRMT mRNA	PMID:40504410
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of POLRMT mRNA	PMID:30912803
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of POLRMT mRNA	PMID:23019147
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312132	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLRMT mRNA	PMID:21570461
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304599	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POLRMT mRNA	PMID:21215274
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POLRMT mRNA	PMID:19465110
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304599	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POLRMT mRNA	PMID:33387578
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLRMT mRNA	PMID:17942748
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of POLRMT mRNA	PMID:32763439
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1304599	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of POLRMT protein	PMID:18845810
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1304599	E	RGD:6480464	20120412	CTD	MESH:D004317	HMOX1 protein inhibits the reaction [Doxorubicin results in decreased expression of POLRMT protein]	PMID:18845810
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of POLRMT mRNA	PMID:34032870
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POLRMT mRNA	PMID:40504410
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of POLRMT 3' UTR	PMID:27901495
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of POLRMT mRNA	PMID:19073995
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304599	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of POLRMT mRNA	PMID:30047161
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312132	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of POLRMT gene	PMID:35295148
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304599	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of POLRMT mRNA	PMID:34492290
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of POLRMT gene	PMID:23968726
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304599	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of POLRMT mRNA	PMID:41034487
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of POLRMT mRNA	PMID:34813904
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of POLRMT mRNA	PMID:34813904
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of POLRMT gene	PMID:23968726
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304599	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of POLRMT mRNA	PMID:33453195
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of POLRMT mRNA	PMID:25812627
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of POLRMT mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of POLRMT mRNA	PMID:32699268
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312132	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of POLRMT mRNA	PMID:17585979
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of POLRMT mRNA	PMID:25812627
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of POLRMT mRNA	PMID:25812627
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of POLRMT mRNA	PMID:36331819
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of POLRMT gene	PMID:29154799
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304599	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of POLRMT mRNA	PMID:30047161
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of POLRMT mRNA	PMID:21420995|PMID:31059760
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in decreased expression of POLRMT mRNA	PMID:17585979
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POLRMT mRNA	PMID:40504410
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLRMT mRNA	PMID:17942748
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of POLRMT mRNA	PMID:38568856
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304599	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of POLRMT mRNA	PMID:30047161
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312132	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of POLRMT mRNA	PMID:22206623
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POLRMT mRNA	PMID:22206623
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:749635	bms-986094	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C553340	BMS-986094 results in decreased expression of POLRMT protein	PMID:27466212
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:76004	dimethyl fumarate	increases expression	ISO	RGD:1312132	E	RGD:6480464	20180220	CTD	MESH:C056020	Dimethyl Fumarate results in increased expression of POLRMT mRNA	PMID:27277809
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:76004	dimethyl fumarate	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20180220	CTD	MESH:C056020	NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of POLRMT mRNA]	PMID:27277809
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304599	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of POLRMT mRNA	PMID:30047161
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of POLRMT mRNA	PMID:38568856
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of POLRMT mRNA	PMID:27188386
1312131	POLRMT	RNA polymerase mitochondrial	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1312132	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of POLRMT mRNA	PMID:18930950
1312133	PAPPA2	pappalysin 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1620878	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of PAPPA2 mRNA	PMID:37995155
1312133	PAPPA2	pappalysin 2	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of PAPPA2 mRNA	PMID:31016361
1312133	PAPPA2	pappalysin 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of PAPPA2 mRNA	PMID:21934132
1312133	PAPPA2	pappalysin 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1620878	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of PAPPA2 mRNA	PMID:36189433
1312133	PAPPA2	pappalysin 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1620878	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PAPPA2 mRNA	PMID:36189433
1312133	PAPPA2	pappalysin 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1620878	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PAPPA2 mRNA	PMID:30319688
1312133	PAPPA2	pappalysin 2	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of PAPPA2 mRNA	PMID:26339600
1312133	PAPPA2	pappalysin 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1620878	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PAPPA2 mRNA	PMID:37567420
1312133	PAPPA2	pappalysin 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1620878	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PAPPA2 mRNA	PMID:36189433
1312133	PAPPA2	pappalysin 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1620878	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of PAPPA2 mRNA	PMID:20403060
1312133	PAPPA2	pappalysin 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1620878	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PAPPA2 mRNA	PMID:37567420
1312133	PAPPA2	pappalysin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PAPPA2 mRNA	PMID:31163220
1312133	PAPPA2	pappalysin 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1620878	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PAPPA2 mRNA	PMID:37236586
1312133	PAPPA2	pappalysin 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PAPPA2 mRNA	PMID:40288432
1312133	PAPPA2	pappalysin 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PAPPA2 gene	PMID:27153756
1312133	PAPPA2	pappalysin 2	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	PAPPA2 protein affects the susceptibility to Cisplatin	PMID:16217747
1312133	PAPPA2	pappalysin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1591785	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PAPPA2 mRNA	PMID:32109520|PMID:33387578
1312133	PAPPA2	pappalysin 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PAPPA2 mRNA	PMID:33212167
1312133	PAPPA2	pappalysin 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of PAPPA2 mRNA	PMID:20971185
1312133	PAPPA2	pappalysin 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PAPPA2 mRNA	PMID:29803840
1312133	PAPPA2	pappalysin 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1620878	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PAPPA2 mRNA	PMID:37567420
1312133	PAPPA2	pappalysin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of PAPPA2 mRNA	PMID:34032870
1312133	PAPPA2	pappalysin 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PAPPA2 mRNA	PMID:38568856
1312133	PAPPA2	pappalysin 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PAPPA2 promoter	PMID:27901495
1312133	PAPPA2	pappalysin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PAPPA2 5' UTR	PMID:27901495
1312133	PAPPA2	pappalysin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PAPPA2 3' UTR	PMID:27901495
1312133	PAPPA2	pappalysin 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of PAPPA2 mRNA	PMID:20971185
1312133	PAPPA2	pappalysin 2	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1591785	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in increased expression of PAPPA2 mRNA	PMID:38458666
1312133	PAPPA2	pappalysin 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1620878	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PAPPA2 mRNA	PMID:35676786
1312133	PAPPA2	pappalysin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1591785	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PAPPA2 mRNA	PMID:30816183|PMID:32528016
1312133	PAPPA2	pappalysin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1591785	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of PAPPA2 mRNA	PMID:29097150|PMID:34947998
1312133	PAPPA2	pappalysin 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1591785	E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PAPPA2 mRNA	PMID:32119087
1312133	PAPPA2	pappalysin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1620878	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PAPPA2 mRNA	PMID:30951980
1312133	PAPPA2	pappalysin 2	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1620878	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of PAPPA2 mRNA	PMID:26377693
1312133	PAPPA2	pappalysin 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1620878	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PAPPA2 mRNA	PMID:30951980
1312133	PAPPA2	pappalysin 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1620878	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of PAPPA2 intron	PMID:28392331
1312133	PAPPA2	pappalysin 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1620878	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PAPPA2 mRNA	PMID:37019170
1312133	PAPPA2	pappalysin 2	gene	CHEBI:34840	methyl methacrylate	increases expression	ISO	RGD:1620878	E	RGD:6480464	20120412	CTD	MESH:D020366	Methylmethacrylate results in increased expression of PAPPA2 mRNA	PMID:16916219
1312133	PAPPA2	pappalysin 2	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1591785	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in increased expression of PAPPA2 mRNA	PMID:38458666
1312133	PAPPA2	pappalysin 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1620878	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PAPPA2 mRNA	PMID:37236586
1312133	PAPPA2	pappalysin 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PAPPA2 mRNA	PMID:36326898
1312133	PAPPA2	pappalysin 2	gene	CHEBI:38561	fluvastatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C065180	[zoledronic acid co-treated with fluvastatin] results in increased expression of PAPPA2 mRNA	PMID:16996129
1312133	PAPPA2	pappalysin 2	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of PAPPA2 mRNA	PMID:40434365
1312133	PAPPA2	pappalysin 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PAPPA2 mRNA	PMID:31533062
1312133	PAPPA2	pappalysin 2	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1620878	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of PAPPA2 mRNA	PMID:29038090
1312133	PAPPA2	pappalysin 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PAPPA2 mRNA	PMID:25979313
1312133	PAPPA2	pappalysin 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PAPPA2 gene	PMID:29154799
1312133	PAPPA2	pappalysin 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PAPPA2 mRNA	PMID:24383497
1312133	PAPPA2	pappalysin 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1620878	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PAPPA2 mRNA	PMID:37567420
1312133	PAPPA2	pappalysin 2	gene	CHEBI:4488	diallyl disulfide	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C028009	diallyl disulfide inhibits the reaction [tobacco tar analog results in increased expression of PAPPA2 mRNA]	PMID:36758788
1312133	PAPPA2	pappalysin 2	gene	CHEBI:4489	Diallyl sulfide	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C038491	allyl sulfide inhibits the reaction [tobacco tar analog results in increased expression of PAPPA2 mRNA]	PMID:36758788
1312133	PAPPA2	pappalysin 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1620878	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PAPPA2 mRNA	PMID:17562736
1312133	PAPPA2	pappalysin 2	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of PAPPA2 mRNA	PMID:24714768
1312133	PAPPA2	pappalysin 2	gene	CHEBI:46557	zoledronic acid	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	[zoledronic acid co-treated with fluvastatin] results in increased expression of PAPPA2 mRNA	PMID:16996129
1312133	PAPPA2	pappalysin 2	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of PAPPA2 mRNA	PMID:24383545
1312133	PAPPA2	pappalysin 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1620878	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PAPPA2 mRNA	PMID:35676786
1312133	PAPPA2	pappalysin 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1620878	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PAPPA2 mRNA	PMID:25554681
1312133	PAPPA2	pappalysin 2	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1620878	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PAPPA2 mRNA	PMID:37567420
1312133	PAPPA2	pappalysin 2	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1591785	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of PAPPA2 mRNA	PMID:33484710
1312133	PAPPA2	pappalysin 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PAPPA2 gene]	PMID:28238834
1312133	PAPPA2	pappalysin 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1591785	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PAPPA2 mRNA	PMID:32109520
1312133	PAPPA2	pappalysin 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1620878	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PAPPA2 mRNA	PMID:38648751
1312133	PAPPA2	pappalysin 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of PAPPA2 mRNA	PMID:26705709
1312133	PAPPA2	pappalysin 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PAPPA2 mRNA	PMID:38568856
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:10110	zidovudine	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D015215	Zidovudine results in increased expression of NRF1 mRNA	PMID:17926646
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:132098	methoxyacetic acid	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of NRF1 mRNA	PMID:20864626
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312138	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of NRF1 mRNA	PMID:33045310
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NRF1 mRNA]	PMID:31150632
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:134301	salvianolic acid B	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20240604	CTD	MESH:C076944	salvianolic acid B inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 mRNA]; salvianolic acid B inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 protein]	PMID:33994527
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NRF1 mRNA	PMID:20188158
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:142921	3-phenylprop-2-enal	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in decreased expression of NRF1 mRNA	PMID:28219650
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:15365	acetylsalicylic acid	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20231031	CTD	MESH:D001241	Aspirin inhibits the reaction [Cisplatin results in decreased expression of NRF1 protein]	PMID:37179038
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20141223	CTD	MESH:D014212	Tretinoin inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of NRF1 mRNA]]	PMID:23331247
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:15368	acrolein	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20220510	CTD	MESH:D000171	Acrolein results in decreased expression of NRF1 mRNA	PMID:35150775
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20240604	CTD	MESH:D010100	[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein]	PMID:36806343
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20171010	CTD	MESH:D010100	[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NRF1 protein; genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NRF1 protein]	PMID:28477916
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:15756	hexadecanoic acid	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of NRF1 mRNA	PMID:39506029
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20201215	CTD	MESH:D019308	[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NRF1 mRNA; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NRF1 mRNA]	PMID:26847930
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D001280	Atrazine results in decreased expression of NRF1 mRNA	PMID:27114639
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1304603	E	RGD:6480464	20160705	CTD	MESH:D001280	Atrazine results in increased expression of NRF1 mRNA	PMID:27114639
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20250204	CTD	MESH:C015329	Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NRF1 mRNA]	PMID:33908429
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20201215	CTD	MESH:D019301	[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NRF1 mRNA; FOXO1 protein affects the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of NRF1 mRNA]	PMID:26847930
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of NRF1 mRNA	PMID:20044591
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:16240	hydrogen peroxide	affects response to substance	EXP		E	RGD:6480464	20170516	CTD	MESH:D006861	NRF1 protein affects the susceptibility to Hydrogen Peroxide	PMID:21051700
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of NRF1 mRNA	PMID:23859249
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D006861	resveratrol inhibits the reaction [Hydrogen Peroxide results in decreased expression of NRF1 mRNA]	PMID:23859249
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20160210	CTD	MESH:D011794	Quercetin inhibits the reaction [aluminum lactate results in decreased expression of NRF1 mRNA]; Quercetin inhibits the reaction [aluminum lactate results in decreased expression of NRF1 protein]; Quercetin inhibits the reaction [Atorvastatin affects the expression of NRF1 mRNA]	PMID:21775390|PMID:26493151
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of NRF1 mRNA	PMID:39241906
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in increased expression of NRF1 mRNA	PMID:20302909|PMID:22105178|PMID:33352482
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	ESR1 protein alternative form inhibits the reaction [Estradiol results in increased expression of NRF1 mRNA]; fulvestrant inhibits the reaction [Estradiol results in increased expression of NRF1 mRNA]; Vehicle Emissions inhibits the reaction [Estradiol results in increased expression of NRF1 mRNA]	PMID:20302909|PMID:22105178
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Norepinephrine] results in decreased expression of NRF1 mRNA	PMID:16954335
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NRF1 mRNA	PMID:37042841
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20180313	CTD	MESH:D008550	Melatonin inhibits the reaction [Carbon Tetrachloride results in decreased expression of NRF1 protein]	PMID:26882442
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of NRF1 mRNA	PMID:20655997|PMID:23649840
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17158	methylglyoxal	increases expression	ISO	RGD:1304603	E	RGD:6480464	20141223	CTD	MESH:D011765	Pyruvaldehyde results in increased expression of NRF1 mRNA	PMID:23331247
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17158	methylglyoxal	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20141223	CTD	MESH:D011765	monascin inhibits the reaction [Pyruvaldehyde results in increased expression of NRF1 mRNA]; Silymarin inhibits the reaction [Pyruvaldehyde results in increased expression of NRF1 mRNA]; Tretinoin inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of NRF1 mRNA]]	PMID:23331247
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20240604	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein]	PMID:36806343
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1312138	E	RGD:6480464	20200915	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate affects the expression of NRF1 mRNA	PMID:32522588
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17245	carbon monoxide	increases expression	ISO	RGD:1304603	E	RGD:6480464	20120412	CTD	MESH:D002248	Carbon Monoxide results in increased expression of NRF1 protein	PMID:17179207
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17245	carbon monoxide	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D002248	Carbon Monoxide results in increased expression of NRF1 mRNA	PMID:17179207
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17245	carbon monoxide	increases localization	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D002248	Carbon Monoxide results in increased localization of NRF1 protein	PMID:18845810
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17245	carbon monoxide	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20120412	CTD	MESH:D002248	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Carbon Monoxide results in increased expression of NRF1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to PPARGC1A protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide results in increased expression of NRF1 protein]; Carbon Monoxide promotes the reaction [NRF1 protein binds to PPARGC1A protein]; Carbon Monoxide promotes the reaction [NRF1 protein binds to TFAM promoter]; CAT protein inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to TFAM promoter]]	PMID:17179207
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17245	carbon monoxide	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D002248	AKT1 protein affects the reaction [Carbon Monoxide results in increased localization of NRF1 protein]; Carbon Monoxide promotes the reaction [NFE2L2 protein binds to NRF1 promoter]	PMID:18845810
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20240604	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein]	PMID:36806343
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NRF1 mRNA; Diethylhexyl Phthalate results in decreased expression of NRF1 protein	PMID:34822940
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312138	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NRF1 mRNA	PMID:33908429
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20250204	CTD	MESH:D004051	Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NRF1 mRNA]	PMID:33908429
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17793	calycosin	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20230404	CTD	MESH:C121707	7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of and affects the localization of NRF1 protein]; 7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NRF1 mRNA]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of ATP5F1A mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of ATP5F1A protein]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NDUFB8 mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NDUFB8 protein]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of SDHB mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of SDHB protein]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of UQCRC2 mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of UQCRC2 protein]]; SR18292 inhibits the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NRF1 mRNA]]	PMID:36436616
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of NRF1 protein	PMID:37730182
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1304603	E	RGD:6480464	20181113	CTD	MESH:D002117	Calcitriol results in increased expression of NRF1 protein	PMID:30194976
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20260804	CTD	MESH:D005839	Gentamicins results in decreased expression of NRF1 protein	PMID:42173392
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17833	gentamycin	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20260804	CTD	MESH:D005839	Formoterol Fumarate inhibits the reaction [Gentamicins results in decreased expression of NRF1 protein]	PMID:42173392
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20130416	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NRF1 protein	PMID:21856379
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NRF1 mRNA	PMID:28818685
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:18315	pyrroloquinoline quinone	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D045542	PQQ Cofactor results in increased expression of NRF1 mRNA	PMID:28578007
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:18357	(R)-noradrenaline	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20120412	CTD	MESH:D009638	[Estradiol co-treated with Norepinephrine] results in decreased expression of NRF1 mRNA	PMID:16954335
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:18406	AICA ribonucleotide	increases expression	ISO	RGD:1304603	E	RGD:6480464	20130122	CTD	MESH:C031143	AICA ribonucleotide results in increased expression of NRF1 mRNA	PMID:20438809
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:18406	AICA ribonucleotide	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20130122	CTD	MESH:C031143	dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased expression of NRF1 mRNA]	PMID:20438809
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:18422	sulfur dioxide	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20160822	CTD	MESH:D013458	Sulfur Dioxide results in decreased expression of NRF1 mRNA; Sulfur Dioxide results in decreased expression of NRF1 protein	PMID:26980303
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:18422	sulfur dioxide	increases expression	ISO	RGD:1304603	E	RGD:6480464	20121009	CTD	MESH:D013458	Sulfur Dioxide results in increased expression of NRF1 protein	PMID:22677886
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:191854	arachidonyl-2'-chloroethylamide	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20220614	CTD	MESH:C119325	arachidonyl-2-chloroethylamide results in decreased expression of NRF1 mRNA	PMID:26847930
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:191854	arachidonyl-2'-chloroethylamide	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20220614	CTD	MESH:C119325	FOXO1 protein affects the reaction [arachidonyl-2-chloroethylamide results in decreased expression of NRF1 mRNA]	PMID:26847930
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1304603	E	RGD:6480464	20150512	CTD	MESH:D002104	Cadmium results in increased expression of NRF1 mRNA	PMID:25388156
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:232424	MitoTEMPO	multiple interactions	EXP		E	RGD:6480464	20241203	CTD	MESH:C555916	MitoTEMPO inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]	PMID:29729358
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:232553	imisopasem manganese	increases expression	ISO	RGD:1304603	E	RGD:6480464	20241203	CTD	MESH:C121876	imisopasem manganese results in increased expression of NRF1 protein	PMID:28483572
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:232553	imisopasem manganese	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20241203	CTD	MESH:C121876	Alloxan affects the reaction [imisopasem manganese results in increased expression of NRF1 protein]	PMID:28483572
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NRF1 mRNA	PMID:19549813
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20240903	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NRF1 mRNA; Copper Sulfate results in decreased expression of NRF1 protein	PMID:38124272
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NRF1 protein	PMID:23301498
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NRF1 mRNA	PMID:19770486
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NRF1 gene; Aflatoxin B1 results in increased methylation of NRF1 intron	PMID:27153756|PMID:30157460
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312138	E	RGD:6480464	20200519	CTD	MESH:D010126	Ozone results in increased expression of NRF1 mRNA	PMID:27240593
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:26523	reactive oxygen species	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D017382	NRF1 mutant form promotes the reaction [Benzo(a)pyrene results in increased abundance of Reactive Oxygen Species]	PMID:21401886
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:26709	sodium hydrogensulfite	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20160822	CTD	MESH:C009279	sodium bisulfite results in decreased expression of NRF1 mRNA; sodium bisulfite results in decreased expression of NRF1 protein	PMID:26980303
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:26709	sodium hydrogensulfite	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20160822	CTD	MESH:C009279	Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of NRF1 mRNA]	PMID:26980303
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of NRF1 mRNA	PMID:15672453
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of NRF1 mRNA	PMID:18593933
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20180313	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NRF1 protein	PMID:26882442
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304603	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NRF1 mRNA	PMID:31150632
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20180313	CTD	MESH:D002251	Melatonin inhibits the reaction [Carbon Tetrachloride results in decreased expression of NRF1 protein]; schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NRF1 mRNA]	PMID:26882442|PMID:31150632
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in decreased expression of NRF1 mRNA	PMID:25270620
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NRF1 gene	PMID:25304211
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27563	arsenic atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased expression of NRF1 mRNA	PMID:21514422
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NRF1 mRNA	PMID:39836092
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27568	selenium atom	increases expression	ISO	RGD:1304603	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of NRF1 mRNA	PMID:17936198
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20120412	CTD	MESH:D012643	NRF1 protein promotes the reaction [Selenium results in increased expression of TFAM mRNA]	PMID:17936198
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of NRF1 mRNA	PMID:20864626
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20120717	CTD	MESH:C059514	resveratrol results in decreased expression of NRF1 mRNA	PMID:21270273
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C059514	resveratrol results in increased expression of NRF1 mRNA	PMID:22105178|PMID:24041027
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1304603	E	RGD:6480464	20130212	CTD	MESH:C059514	Resveratrol results in increased expression of NRF1 mRNA; Resveratrol results in increased expression of NRF1 protein	PMID:20429690|PMID:20438809|PMID:32619457
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312138	E	RGD:6480464	20121218	CTD	MESH:C059514	Resveratrol results in increased expression of NRF1 mRNA; Resveratrol results in increased expression of NRF1 protein	PMID:20561979|PMID:24041027|PMID:34216621
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:C059514	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]; [Plant Extracts co-treated with Resveratrol] results in increased expression of NRF1 mRNA; Fulvestrant inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]; HMOX1 mutant form inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]; Resveratrol inhibits the reaction [Hydrogen Peroxide results in decreased expression of NRF1 mRNA]; Resveratrol promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NRF1 mRNA]; tin protoporphyrin IX inhibits the reaction [Resveratrol promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NRF1 mRNA]]; tin protoporphyrin IX inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]	PMID:22105178|PMID:23557933|PMID:23859249|PMID:24041027
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20130122	CTD	MESH:C059514	dorsomorphin inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]; Resveratrol affects the reaction [Benzo(a)pyrene affects the expression of NRF1 mRNA]; Resveratrol affects the reaction [Benzo(a)pyrene affects the expression of NRF1 protein]; Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of NRF1 mRNA]	PMID:20438809|PMID:21632075|PMID:32619457
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20141111	CTD	MESH:C059514	[Dietary Fats co-treated with Resveratrol] results in increased expression of NRF1 mRNA; [lipopolysaccharide, E coli O55-B5 co-treated with Resveratrol] results in increased expression of NRF1 mRNA; SIRT1 protein affects the reaction [Resveratrol results in increased expression of NRF1 mRNA]; STK11 protein affects the reaction [Resveratrol results in increased expression of NRF1 mRNA]; tin protoporphyrin IX inhibits the reaction [[lipopolysaccharide, E coli O55-B5 co-treated with Resveratrol] results in increased expression of NRF1 mRNA]; tin protoporphyrin IX inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]	PMID:24041027|PMID:29197120|PMID:34216621
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in decreased expression of NRF1 mRNA; Cisplatin results in decreased expression of NRF1 protein	PMID:25270620|PMID:37179038
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20231031	CTD	MESH:D002945	Aspirin inhibits the reaction [Cisplatin results in decreased expression of NRF1 protein]	PMID:37179038
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20230801	CTD	MESH:D009532	[nickel chloride results in increased abundance of Nickel] which results in decreased expression of NRF1 mRNA	PMID:36794572
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312138	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NRF1 mRNA	PMID:21570461|PMID:24058054
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NRF1 mRNA	PMID:21296121
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312138	E	RGD:6480464	20171010	CTD	MESH:D012402	Rotenone results in increased expression of NRF1 mRNA	PMID:21536665
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20171010	CTD	MESH:D012402	PPARGC1A protein affects the reaction [Rotenone results in increased expression of NRF1 mRNA]	PMID:21536665
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NRF1 mRNA	PMID:20864626
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28498	acadesine	increases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:C011651	acadesine results in increased expression of NRF1 protein	PMID:28556920
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28498	acadesine	multiple interactions	EXP		E	RGD:6480464	20200310	CTD	MESH:C011651	acadesine inhibits the reaction [Isoniazid results in decreased expression of NRF1 protein]	PMID:28556920
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28694	copper atom	decreases response to substance	ISO	RGD:1312138	E	RGD:6480464	20150512	CTD	MESH:D003300	NRF1 gene results in decreased susceptibility to Copper	PMID:24462598
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304603	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper deficiency results in increased expression of NRF1 protein	PMID:11694003
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20150512	CTD	MESH:D003300	NRF1 gene promotes the reaction [Copper results in increased expression of MT1 mRNA]	PMID:24462598
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D004317	Doxorubicin results in decreased expression of NRF1 protein	PMID:28456571|PMID:29729358
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D004317	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]; Erythropoietin inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]; MitoTEMPO inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]; SIRT1 protein affects the reaction [Doxorubicin results in decreased expression of NRF1 protein]; SIRT1 protein affects the reaction [Erythropoietin inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]]	PMID:28456571|PMID:29729358
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20161213	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of NRF1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of NRF1 mRNA]; Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of NRF1 mRNA]; Acetylcysteine inhibits the reaction [sodium bisulfite results in decreased expression of NRF1 mRNA]	PMID:21775390|PMID:26980303|PMID:35403558|PMID:36493885
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of NRF1 mRNA	PMID:29319823
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of NRF1 protein	PMID:38228842
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20170207	CTD	MESH:C017947	sodium arsenite results in decreased expression of NRF1 mRNA; sodium arsenite results in decreased expression of NRF1 protein	PMID:26767369|PMID:27425645|PMID:37730054
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of NRF1 mRNA	PMID:29301061|PMID:34032870
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NRF1 mRNA	PMID:39836092
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20170207	CTD	MESH:C017947	sodium arsenite results in decreased expression of and affects the localization of NRF1 protein	PMID:27425645
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NRF1 mRNA	PMID:22378314
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1304603	E	RGD:6480464	20200915	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of NRF1 mRNA; Benzo(a)pyrene affects the expression of NRF1 protein	PMID:32619457
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NRF1 5' UTR	PMID:27901495
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NRF1 mRNA; Benzo(a)pyrene results in decreased expression of NRF1 protein	PMID:21401886|PMID:22865514
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312138	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NRF1 3' UTR; Benzo(a)pyrene results in decreased methylation of NRF1 exon	PMID:27901495
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NRF1 mRNA	PMID:22228805
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	NRF1 mutant form inhibits the reaction [Benzo(a)pyrene results in decreased expression of TFAM protein]; NRF1 mutant form promotes the reaction [Benzo(a)pyrene results in increased abundance of Reactive Oxygen Species]	PMID:21401886
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20200915	CTD	MESH:D001564	Resveratrol affects the reaction [Benzo(a)pyrene affects the expression of NRF1 mRNA]; Resveratrol affects the reaction [Benzo(a)pyrene affects the expression of NRF1 protein]	PMID:32619457
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to NRF1 promoter]; Benzo(a)pyrene promotes the reaction [NRF1 protein binds to GSTA1 gene]	PMID:11961136|PMID:19654925
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:30052	copper(0)	decreases response to substance	ISO	RGD:1312138	E	RGD:6480464	20150512	CTD	MESH:D003300	NRF1 gene results in decreased susceptibility to Copper	PMID:24462598
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304603	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper deficiency results in increased expression of NRF1 protein	PMID:11694003
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20150512	CTD	MESH:D003300	NRF1 gene promotes the reaction [Copper results in increased expression of MT1 mRNA]	PMID:24462598
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of NRF1 mRNA	PMID:18593933
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NRF1 mRNA	PMID:19150397
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:30621	diarsenic trioxide	affects methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide affects the methylation of NRF1 promoter	PMID:26046465
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1304603	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of NRF1 mRNA	PMID:16483693
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:31633	formoterol fumarate	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20260804	CTD	MESH:D000068759	Formoterol Fumarate inhibits the reaction [Gentamicins results in decreased expression of NRF1 protein]	PMID:42173392
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C070081	fulvestrant inhibits the reaction [afimoxifene results in increased expression of NRF1 mRNA]; fulvestrant inhibits the reaction [Estradiol results in increased expression of NRF1 mRNA]; fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of NRF1 mRNA]; fulvestrant inhibits the reaction [resveratrol results in increased expression of NRF1 mRNA]	PMID:22105178
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NRF1 mRNA	PMID:25729387
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312138	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NRF1 gene	PMID:35295148
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of NRF1 mRNA	PMID:18648102
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:32588	potassium chloride	increases expression	ISO	RGD:1304603	E	RGD:6480464	20130122	CTD	MESH:D011189	Potassium Chloride results in increased expression of NRF1 mRNA; Potassium Chloride results in increased expression of NRF1 protein	PMID:20438809
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of NRF1 mRNA	PMID:23777605
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of NRF1 mRNA	PMID:24105817
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304603	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NRF1 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:33375	gadolinium atom	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20260203	CTD	MESH:D005682	[gadolinium chloride results in increased abundance of Gadolinium] which results in decreased expression of NRF1 protein; [gadolinium oxide results in increased abundance of Gadolinium] which results in decreased expression of NRF1 protein	PMID:40796065
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:34283	oxybenzone	increases expression	ISO	RGD:1304603	E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of NRF1 mRNA	PMID:30316929
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of NRF1 mRNA	PMID:26520405
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20170516	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of NRF1 mRNA	PMID:27923775
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:34679	Di-n-octyl phthalate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010715	di-n-octyl phthalate results in decreased expression of NRF1 mRNA; di-n-octyl phthalate results in decreased expression of NRF1 protein	PMID:34822940
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20170725	CTD	MESH:D004137	Dinitrochlorobenzene results in decreased expression of NRF1 mRNA	PMID:28219650
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of NRF1 mRNA	PMID:34813904
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20180515	CTD	MESH:D015056	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of NRF1 mRNA; [Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of NRF1 mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of NRF1 mRNA	PMID:29288687|PMID:32417366
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of NRF1 mRNA	PMID:34813904
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:34887	nickel dichloride	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20240702	CTD	MESH:C022838	nickel chloride results in decreased expression of NRF1 mRNA; nickel chloride results in decreased expression of NRF1 protein	PMID:38552765
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20230801	CTD	MESH:C022838	[nickel chloride results in increased abundance of Nickel] which results in decreased expression of NRF1 mRNA	PMID:36794572
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20230404	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NRF1 mRNA	PMID:36493885
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20230404	CTD	MESH:D019256	Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of NRF1 mRNA]	PMID:36493885
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1304603	E	RGD:6480464	20120717	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of NRF1 mRNA	PMID:19616056
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of NRF1 mRNA	PMID:30047161
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of NRF1 mRNA	PMID:24449571
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:36904	elemental selenium	increases expression	ISO	RGD:1304603	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of NRF1 mRNA	PMID:17936198
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20120412	CTD	MESH:D012643	NRF1 protein promotes the reaction [Selenium results in increased expression of TFAM mRNA]	PMID:17936198
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:37288	gadolinium trichloride	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20260203	CTD	MESH:C038958	[gadolinium chloride results in increased abundance of Gadolinium] which results in decreased expression of NRF1 protein	PMID:40796065
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of NRF1 mRNA	PMID:27638505
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:38630	indoxacarb	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20260707	CTD	MESH:C401104	indoxacarb results in decreased expression of NRF1 mRNA	PMID:41306723
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:38728	monocrotophos	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20230502	CTD	MESH:D008999	Monocrotophos results in decreased expression of NRF1 mRNA	PMID:35403558
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:38728	monocrotophos	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20230502	CTD	MESH:D008999	Acetylcysteine inhibits the reaction [Monocrotophos results in decreased expression of NRF1 mRNA]	PMID:35403558
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of NRF1 mRNA	PMID:36331819
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NRF1 mRNA	PMID:25979313
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of NRF1 mRNA	PMID:28001369
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of NRF1 mRNA	PMID:21427059
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of NRF1 mRNA	PMID:30047161
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of NRF1 promoter	PMID:27989131
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:4045	cyprodinil	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C108338	cyprodinil results in increased expression of NRF1 mRNA	PMID:33352482
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20180515	CTD	MESH:D003907	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of NRF1 mRNA; [Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of NRF1 mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of NRF1 mRNA	PMID:29288687|PMID:32417366
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:42017	2,4-dinitrophenol	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D019297	2,4-Dinitrophenol results in increased expression of NRF1 mRNA	PMID:11784294
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:42478	ethidium	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004996	Ethidium results in increased expression of NRF1 mRNA	PMID:22712077
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312138	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of NRF1 mRNA	PMID:28973697
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20240604	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of NRF1 protein]	PMID:36806343
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:42839	3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	affects expression	ISO	RGD:1304603	E	RGD:6480464	20120412	CTD	MESH:D011692	Puromycin Aminonucleoside affects the expression of NRF1 mRNA	PMID:16609681
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:44032	indinavir	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D019469	Indinavir results in increased expression of NRF1 mRNA	PMID:17926646
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:44616	afimoxifene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C016601	afimoxifene results in increased expression of NRF1 mRNA	PMID:22105178
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C016601	Fulvestrant inhibits the reaction [afimoxifene results in increased expression of NRF1 mRNA]; Vehicle Emissions inhibits the reaction [afimoxifene results in increased expression of NRF1 mRNA]	PMID:22105178
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NRF1 mRNA	PMID:38832940
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of NRF1 mRNA	PMID:29067470
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312138	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of NRF1 protein	PMID:28827156|PMID:33271250
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NRF1 gene	PMID:25304211
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:47217	arsane	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased expression of NRF1 mRNA	PMID:21514422
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NRF1 mRNA	PMID:39836092
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C016766	sulforaphane results in increased expression of NRF1 protein	PMID:27993529
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:4784	enalapril	increases expression	ISO	RGD:1304603	E	RGD:6480464	20120501	CTD	MESH:D004656	Enalapril results in increased expression of NRF1 mRNA	PMID:18765277
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:49900	arsenous acid	affects methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide affects the methylation of NRF1 promoter	PMID:26046465
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304603	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of NRF1 mRNA	PMID:30307764
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:50385	hemin	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20181113	CTD	MESH:D006427	Hemin inhibits the reaction [manganese chloride affects the expression of NRF1 protein]	PMID:30040983
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of NRF1 mRNA	PMID:30047161
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:50686	atorvastatin calcium	affects expression	ISO	RGD:1304603	E	RGD:6480464	20170303	CTD	MESH:D000069059	Atorvastatin affects the expression of NRF1 mRNA	PMID:21775390
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1304603	E	RGD:6480464	20170303	CTD	MESH:D000069059	Atorvastatin results in increased expression of NRF1 mRNA	PMID:21775390
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:50686	atorvastatin calcium	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20170303	CTD	MESH:D000069059	Acetylcysteine inhibits the reaction [Atorvastatin results in increased expression of NRF1 mRNA]; Quercetin inhibits the reaction [Atorvastatin affects the expression of NRF1 mRNA]	PMID:21775390
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NRF1 mRNA	PMID:35964746
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:5298	Genipin	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20171010	CTD	MESH:C007834	genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of NRF1 protein]	PMID:28477916
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NRF1 mRNA	PMID:19042947
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:5352	Gingerenone A	increases expression	ISO	RGD:1312138	E	RGD:6480464	20240305	CTD	MESH:C000604237	gingerenone A results in increased expression of NRF1 mRNA	PMID:28556482
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:6030	isoniazide	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D007538	Isoniazid results in decreased expression of NRF1 protein	PMID:28556920
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:6030	isoniazide	multiple interactions	EXP		E	RGD:6480464	20200310	CTD	MESH:D007538	acadesine inhibits the reaction [Isoniazid results in decreased expression of NRF1 protein]	PMID:28556920
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:63041	manganese(II) chloride	affects expression	ISO	RGD:1304603	E	RGD:6480464	20181113	CTD	MESH:C025340	manganese chloride affects the expression of NRF1 protein	PMID:30040983
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20181113	CTD	MESH:C025340	Hemin inhibits the reaction [manganese chloride affects the expression of NRF1 protein]	PMID:30040983
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:63581	stavudine	increases expression	ISO	RGD:1312138	E	RGD:6480464	20120412	CTD	MESH:D018119	Stavudine results in increased expression of NRF1 mRNA	PMID:17926646
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of NRF1 mRNA	PMID:25729387
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NRF1 mRNA	PMID:25729387
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:63933	Aroclor 1254	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of NRF1 mRNA	PMID:16934159
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:63949	2,3-bis(4-hydroxyphenyl)propionitrile	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C486182	2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of NRF1 mRNA	PMID:22105178
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 mRNA; 1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 protein	PMID:26141122
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20240604	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 mRNA; 1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 protein	PMID:33994527
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:D015655	PPARGC1A protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 mRNA]; PPARGC1A protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 protein]	PMID:26141122
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20240604	CTD	MESH:D015655	salvianolic acid B inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 mRNA]; salvianolic acid B inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of NRF1 protein]	PMID:33994527
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:64108	8-bromo-3',5'-cyclic GMP	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016276	8-bromocyclic GMP results in increased expression of NRF1 mRNA	PMID:24041027
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:64108	8-bromo-3',5'-cyclic GMP	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C016276	tin protoporphyrin IX inhibits the reaction [8-bromocyclic GMP results in increased expression of NRF1 mRNA]	PMID:24041027
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:6451	Licarin A	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20180515	CTD	MESH:C432503	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of NRF1 mRNA	PMID:29288687
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:64648	enniatin	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20170228	CTD	MESH:C100264	enniatins results in decreased expression of NRF1 mRNA	PMID:27163883
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltiprotoporphyrin results in increased expression of NRF1 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tricarbonylchloro(glycinato)ruthenium(II) results in increased expression of NRF1 mRNA]	PMID:24041027
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide promotes the reaction [NRF1 protein binds to PPARGC1A protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carbon Monoxide results in increased expression of NRF1 protein]	PMID:17179207
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:6541	losartan	increases expression	ISO	RGD:1304603	E	RGD:6480464	20120501	CTD	MESH:D019808	Losartan results in increased expression of NRF1 mRNA	PMID:18765277
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:6751	mepanipyrim	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C104083	mepanipyrim results in increased expression of NRF1 mRNA	PMID:33352482
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:6801	metformin	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D008687	Metformin results in increased expression of NRF1 mRNA	PMID:16380484
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1312138	E	RGD:6480464	20160412	CTD	MESH:D008687	Metformin results in increased expression of NRF1 mRNA	PMID:24428821
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312138	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of NRF1 mRNA	PMID:26307267
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]	PMID:29729358
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:75633	procyanidin B1	increases expression	ISO	RGD:1312138	E	RGD:6480464	20260804	CTD	MESH:C479579	procyanidin B1 results in increased expression of NRF1 mRNA	PMID:42097479
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:756647	ripretinib	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20260714	CTD	MESH:C000707850	ripretinib results in decreased expression of NRF1 mRNA; ripretinib results in decreased expression of NRF1 protein	PMID:36933644
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:76451	alloxan	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20171010	CTD	MESH:D000496	Alloxan affects the reaction [imisopasem manganese results in increased expression of NRF1 protein]	PMID:28483572
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20161228	CTD	MESH:C516138	dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased expression of NRF1 mRNA]; dorsomorphin inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]	PMID:20438809
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:81579	Erythropoietin	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D004921	Erythropoietin results in increased expression of NRF1 protein	PMID:28456571
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:81579	Erythropoietin	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D004921	Erythropoietin inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]; SIRT1 protein affects the reaction [Erythropoietin inhibits the reaction [Doxorubicin results in decreased expression of NRF1 protein]]	PMID:28456571
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20230404	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NRF1 mRNA; 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NRF1 protein	PMID:36269211
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20230404	CTD	MESH:C511295	MIR128-1 promotes the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NRF1 mRNA]; MIR128-1 promotes the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NRF1 protein]; ZLN005 inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NRF1 mRNA]; ZLN005 inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NRF1 protein]	PMID:36269211
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:81763	fludioxonil	increases expression	EXP		E	RGD:6480464	20141104	CTD	MESH:C108339	fludioxonil results in increased expression of NRF1 mRNA	PMID:23436777
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:82008	Flumetralin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C000617134	flumetralin results in increased expression of NRF1 mRNA	PMID:33352482
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:82035	propham	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C100175	propham results in increased expression of NRF1 mRNA	PMID:33352482
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:82621	monascin	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20170303	CTD	MESH:C517880	monascin inhibits the reaction [Pyruvaldehyde results in increased expression of NRF1 mRNA]; Tretinoin inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of NRF1 mRNA]]	PMID:23331247
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NRF1 mRNA	PMID:30047161
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:85994	lenvatinib	affects expression	ISO	RGD:1304603	E	RGD:6480464	20220111	CTD	MESH:C531958	lenvatinib affects the expression of NRF1 mRNA	PMID:34019861
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:8674	pyrimethanil	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C108337	pyrimethanil results in increased expression of NRF1 mRNA	PMID:33352482
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:8772	raloxifene	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of NRF1 mRNA	PMID:22105178
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	fulvestrant inhibits the reaction [Raloxifene Hydrochloride results in increased expression of NRF1 mRNA]; Vehicle Emissions inhibits the reaction [Raloxifene Hydrochloride results in increased expression of NRF1 mRNA]	PMID:22105178
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of NRF1 mRNA	PMID:20864626
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:90724	AM-251	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20201215	CTD	MESH:C103505	AM 251 inhibits the reaction [Dietary Fats results in decreased expression of NRF1 mRNA]	PMID:26847930
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:91091	CHIR 99021	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20190611	CTD	MESH:C473711	Chir 99021 results in decreased expression of NRF1 mRNA	PMID:29883716
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:91215	1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one	multiple interactions	EXP		E	RGD:6480464	20170221	CTD	MESH:C095284	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Resveratrol results in increased expression of NRF1 mRNA]; 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [S-nitro-N-acetylpenicillamine results in increased expression of NRF1 mRNA]	PMID:24041027
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:91215	1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20170221	CTD	MESH:C095284	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Carbon Monoxide results in increased expression of NRF1 protein]	PMID:17179207
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of NRF1 mRNA	PMID:19281266
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:9381	T-2 toxin	affects expression	ISO	RGD:1304603	E	RGD:6480464	20181113	CTD	MESH:D013605	T-2 Toxin affects the expression of NRF1 mRNA	PMID:29870751
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D013605	T-2 Toxin results in decreased expression of NRF1 mRNA; T-2 Toxin results in decreased expression of NRF1 protein	PMID:35842139
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20170516	CTD	MESH:D013605	T-2 Toxin results in decreased expression of NRF1 protein	PMID:27363784
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:9381	T-2 toxin	multiple interactions	EXP		E	RGD:6480464	20200114	CTD	MESH:D013605	NFE2L2 protein affects the reaction [T-2 Toxin results in decreased expression of NRF1 mRNA]; NFE2L2 protein affects the reaction [T-2 Toxin results in decreased expression of NRF1 protein]; T-2 Toxin promotes the reaction [NRF1 protein binds to CYP1A1 promoter]	PMID:31470059|PMID:35842139
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:9381	T-2 toxin	multiple interactions	ISO	RGD:1312138	E	RGD:6480464	20170516	CTD	MESH:D013605	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [T-2 Toxin results in decreased expression of NRF1 protein]	PMID:27363784
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of NRF1 mRNA	PMID:22378314
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:9516	thapsigargin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	NRF1 protein inhibits the reaction [Thapsigargin results in decreased phosphorylation of AKT1 protein]	PMID:22378314
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1304603	E	RGD:6480464	20230404	CTD	MESH:C001899	triptolide results in decreased expression of NRF1 mRNA	PMID:36436616
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1312138	E	RGD:6480464	20180828	CTD	MESH:C001899	triptolide results in decreased expression of NRF1 mRNA	PMID:29723566
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:9747	Triptolide	multiple interactions	ISO	RGD:1304603	E	RGD:6480464	20230404	CTD	MESH:C001899	7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of and affects the localization of NRF1 protein]; 7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NRF1 mRNA]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of ATP5F1A mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of ATP5F1A protein]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NDUFB8 mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NDUFB8 protein]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of SDHB mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of SDHB protein]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of UQCRC2 mRNA]]; NRF1 protein affects the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of UQCRC2 protein]]; SR18292 inhibits the reaction [7,3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of NRF1 mRNA]]; triptolide results in decreased expression of and affects the localization of NRF1 protein	PMID:36436616
1312137	NRF1	nuclear respiratory factor 1	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1304603	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of NRF1 mRNA	PMID:14563825
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:10101	zalcitabine	multiple interactions	ISO	RGD:1304604	E	RGD:6480464	20180918	CTD	MESH:D016047	[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of SENP5 mRNA	PMID:18606552
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1304604	E	RGD:6480464	20180918	CTD	MESH:D004237	Diuron results in increased expression of SENP5 mRNA	PMID:21551480
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312140	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SENP5 mRNA	PMID:26251327
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SENP5 mRNA	PMID:33167477
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312140	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SENP5 mRNA	PMID:39241906
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of SENP5 mRNA	PMID:20106945
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312140	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SENP5 mRNA	PMID:39298647
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304604	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SENP5 mRNA	PMID:33387578
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312140	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SENP5 mRNA	PMID:33754040
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of SENP5 intron	PMID:30157460
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SENP5 mRNA	PMID:19549813
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SENP5 gene; Aflatoxin B1 results in increased methylation of SENP5 intron	PMID:27153756|PMID:30157460
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SENP5 mRNA	PMID:23649840
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SENP5 mRNA	PMID:18593933
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of SENP5 protein	PMID:35688186
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312140	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SENP5 mRNA	PMID:28960355
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SENP5 mRNA	PMID:23557933
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312140	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SENP5 mRNA	PMID:21570461
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304604	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SENP5 mRNA	PMID:33387578
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312140	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SENP5 mRNA	PMID:31961203
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SENP5 mRNA	PMID:28001369
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SENP5 mRNA	PMID:29803840
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SENP5 mRNA	PMID:38568856
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SENP5 intron; Benzo(a)pyrene affects the methylation of SENP5 promoter	PMID:27901495|PMID:30157460
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SENP5 mRNA	PMID:18593933
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SENP5 mRNA	PMID:26238291
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304604	E	RGD:6480464	20180918	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SENP5 mRNA	PMID:25729387
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304604	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SENP5 mRNA	PMID:34492290
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312140	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SENP5 mRNA	PMID:23811191
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304604	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SENP5 mRNA	PMID:30816183|PMID:32528016
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312140	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SENP5 mRNA	PMID:33221593
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:3374	capsaicin	decreases expression	ISO	RGD:1304604	E	RGD:6480464	20180918	CTD	MESH:D002211	Capsaicin results in decreased expression of SENP5 mRNA	PMID:20349343
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312140	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SENP5 mRNA	PMID:39298647
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SENP5 intron	PMID:30157460
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304604	E	RGD:6480464	20180918	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SENP5 mRNA	PMID:21266533
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SENP5 mRNA	PMID:37042841
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SENP5 mRNA	PMID:31533062
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of SENP5 mRNA	PMID:29154799
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SENP5 mRNA	PMID:20106945
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312140	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of SENP5 mRNA	PMID:18502557
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of SENP5 mRNA	PMID:28542535
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312140	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SENP5 mRNA	PMID:17562736
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312140	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SENP5 mRNA	PMID:29279043
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:48981	quinolin-8-ol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of SENP5 mRNA	PMID:21632981
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:50692	mifepristone	decreases expression	ISO	RGD:1304604	E	RGD:6480464	20180918	CTD	MESH:D015735	Mifepristone results in decreased expression of SENP5 mRNA	PMID:25972201
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304604	E	RGD:6480464	20180918	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SENP5 mRNA	PMID:25729387
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SENP5 intron	PMID:30157460
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SENP5 mRNA	PMID:19159669
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SENP5 mRNA	PMID:38568856
1312139	SENP5	SUMO specific peptidase 5	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304604	E	RGD:6480464	20180918	CTD	MESH:C025643	vinclozolin affects the expression of SENP5 mRNA	PMID:19015723
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of AGR2 mRNA	PMID:38218311
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of AGR2 mRNA	PMID:25812627
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of AGR2 protein	PMID:36641056
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of AGR2 mRNA	PMID:20044591
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of AGR2 mRNA	PMID:21632981
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone affects the expression of AGR2 mRNA	PMID:17094431
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of AGR2 mRNA	PMID:29581250
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of AGR2 mRNA	PMID:23019147
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of AGR2 mRNA; Estradiol results in increased expression of AGR2 protein	PMID:16474171|PMID:19167446|PMID:20531310|PMID:21185374
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1304606	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of AGR2 mRNA	PMID:32145629
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of AGR2 mRNA; Estradiol promotes the reaction [[ESR1 protein binds to AGR2 promoter] which results in increased expression of AGR2 mRNA]; Estradiol promotes the reaction [ESR1 protein binds to AGR2 promoter]	PMID:20531310|PMID:30165855
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304606	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of AGR2 mRNA	PMID:26496021
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312143	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of AGR2 mRNA	PMID:33711761
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304606	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of AGR2 mRNA	PMID:33387578
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17245	carbon monoxide	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20200310	CTD	MESH:D002248	[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of AGR2 mRNA	PMID:29621558
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17347	testosterone	affects expression	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone affects the expression of AGR2 mRNA	PMID:17003280
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of AGR2 mRNA	PMID:21592394
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of AGR2 mRNA	PMID:21592394
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304606	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of AGR2 mRNA	PMID:26496021
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of AGR2 mRNA	PMID:36139627
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of AGR2 mRNA	PMID:21592394
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of AGR2 mRNA	PMID:21592394
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:18422	sulfur dioxide	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20200310	CTD	MESH:D013458	[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of AGR2 mRNA	PMID:29621558
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304606	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AGR2 mRNA	PMID:39012411
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of AGR2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of AGR2 mRNA	PMID:34911549
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312143	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of AGR2 mRNA	PMID:20857495
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27470	folic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid results in increased expression of AGR2 mRNA	PMID:17868486
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AGR2 mRNA	PMID:22206623
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of AGR2 mRNA	PMID:32525701
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312143	E	RGD:6480464	20240604	CTD	MESH:C010974	Glyphosate results in decreased expression of AGR2 mRNA	PMID:33713393
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of AGR2 mRNA	PMID:19167446
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of AGR2 mRNA	PMID:27392435
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28088	genistein	affects expression	ISO	RGD:1312143	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein affects the expression of AGR2 mRNA	PMID:32186404
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of AGR2 mRNA	PMID:16474171
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AGR2 mRNA; Tetrachlorodibenzodioxin results in increased expression of AGR2 protein	PMID:18061397|PMID:20106945|PMID:20299546|PMID:21632981|PMID:26238291
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of AGR2 protein]; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to AGR2 promoter]	PMID:20299546
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AGR2 mRNA	PMID:17942748
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of AGR2 mRNA	PMID:39709020
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28689	dehydroepiandrosterone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003687	Dehydroepiandrosterone affects the expression of AGR2 mRNA	PMID:17094431
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28842	octadecanoic acid	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C031183	stearic acid results in increased expression of AGR2 mRNA	PMID:32347412
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of AGR2 mRNA	PMID:20044591
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of AGR2 mRNA	PMID:39719251
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312143	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of AGR2 mRNA	PMID:17077188|PMID:17350061
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite co-treated with Diethylstilbestrol] results in increased expression of AGR2 mRNA	PMID:19665456
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AGR2 mRNA; Benzo(a)pyrene results in increased expression of AGR2 protein	PMID:18061397|PMID:20106945|PMID:20299546|PMID:21632981|PMID:21871943|PMID:22316170|PMID:26238291|PMID:32234424
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of AGR2 mRNA	PMID:18991936
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312143	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of AGR2 mRNA	PMID:20857495
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of AGR2 mRNA	PMID:25895662
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	AGR2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of AGR2 mRNA	PMID:22521957
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:3090	bicalutamide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of AGR2 mRNA	PMID:15638997
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:31348	capecitabine	increases response to substance	EXP		E	RGD:6480464	20170228	CTD	MESH:C110904	AGR2 protein results in increased susceptibility to Capecitabine	PMID:16734730
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:31521	doxifluridine	increases response to substance	EXP		E	RGD:6480464	20130806	CTD	MESH:C025034	AGR2 protein results in increased susceptibility to doxifluridine	PMID:16734730
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:31638	fulvestrant	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	AGR2 protein affects the susceptibility to fulvestrant	PMID:20525379
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312143	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of AGR2 mRNA	PMID:23557971
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of AGR2 mRNA	PMID:17426115
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304606	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of AGR2 mRNA	PMID:25181051
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of AGR2 mRNA	PMID:16474171
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312143	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of AGR2 mRNA	PMID:32156529
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304606	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of AGR2 mRNA; [bisphenol A co-treated with Testosterone] results in decreased expression of AGR2 mRNA	PMID:26496021
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1304606	E	RGD:6480464	20170613	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of AGR2 mRNA	PMID:28300664
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to AGR2 promoter]	PMID:20348232
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015056	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AGR2 mRNA	PMID:16997883
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1312143	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in decreased expression of AGR2 protein	PMID:39748354
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of AGR2 mRNA	PMID:29024780
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AGR2 mRNA	PMID:38174414
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304606	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AGR2 mRNA	PMID:39012411
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304606	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of AGR2 mRNA	PMID:27387713
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of AGR2 mRNA	PMID:19376846
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of AGR2 mRNA	PMID:25812627
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of AGR2 mRNA	PMID:28302478
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of AGR2 mRNA	PMID:19167446
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of AGR2 mRNA	PMID:19167446
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312143	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of AGR2 mRNA	PMID:23125180
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of AGR2 mRNA	PMID:17198877
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of AGR2 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:41774	tamoxifen	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	AGR2 protein affects the susceptibility to Tamoxifen	PMID:20525379
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:41774	tamoxifen	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	AGR2 protein results in decreased susceptibility to Tamoxifen	PMID:20531310
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:41774	tamoxifen	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of AGR2 mRNA; Tamoxifen results in increased expression of AGR2 protein	PMID:20531310
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen promotes the reaction [[ESR1 protein binds to AGR2 promoter] which results in increased expression of AGR2 mRNA]; Tamoxifen promotes the reaction [ESR1 protein binds to AGR2 promoter]	PMID:20531310
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AGR2 mRNA	PMID:16997883
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:41922	diethylstilbestrol	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:D004054	[sodium arsenite co-treated with Diethylstilbestrol] results in increased expression of AGR2 mRNA	PMID:19665456
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of AGR2 mRNA; Okadaic Acid results in increased expression of AGR2 protein	PMID:38832940
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of AGR2 mRNA]	PMID:15016801
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of AGR2 mRNA	PMID:24714768
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1312143	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of AGR2 mRNA	PMID:16251409
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of AGR2 mRNA	PMID:32525701
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of AGR2 mRNA	PMID:18175754
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304606	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AGR2 mRNA	PMID:17557909
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AGR2 mRNA	PMID:17942748
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AGR2 mRNA	PMID:17942748
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of AGR2 mRNA	PMID:32234424
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	AGR2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of AGR2 mRNA	PMID:22521957
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312143	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of AGR2 mRNA	PMID:25554681
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312143	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of AGR2 mRNA	PMID:25554681
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304606	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in decreased expression of AGR2 mRNA	PMID:22504374
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1312143	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of AGR2 mRNA	PMID:17982090
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of AGR2 mRNA	PMID:20436886
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AGR2 protein	PMID:32959892
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:64153	tanespimycin	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:C112765	tanespimycin analog results in increased expression of AGR2 protein; tanespimycin results in increased expression of AGR2 protein	PMID:31370342
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:64153	tanespimycin	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:C112765	[tanespimycin co-treated with VER 155008] results in increased expression of AGR2 protein	PMID:31370342
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:64211	8-Br-cAMP	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015124	[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AGR2 mRNA	PMID:16997883
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312143	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AGR2 mRNA	PMID:22206623
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1304606	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of AGR2 mRNA	PMID:33484710
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of AGR2 mRNA	PMID:36139627
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of AGR2 mRNA	PMID:19167446
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:81980	triticonazole	decreases expression	ISO	RGD:1304606	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of AGR2 mRNA	PMID:36084822
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of AGR2 mRNA	PMID:32525701
1312142	AGR2	anterior gradient 2, protein disulphide isomerase family member	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304606	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in decreased expression of AGR2 mRNA	PMID:22504374
1312146	ACTR6	actin related protein 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ACTR6 mRNA	PMID:26251327
1312146	ACTR6	actin related protein 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ACTR6 mRNA	PMID:33167477
1312146	ACTR6	actin related protein 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312147	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ACTR6 mRNA	PMID:30319688
1312146	ACTR6	actin related protein 6	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ACTR6 mRNA	PMID:20044591
1312146	ACTR6	actin related protein 6	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ACTR6 mRNA	PMID:21632981
1312146	ACTR6	actin related protein 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ACTR6 mRNA	PMID:39298647
1312146	ACTR6	actin related protein 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304609	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of ACTR6 mRNA	PMID:26496021
1312146	ACTR6	actin related protein 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACTR6 mRNA	PMID:37042841
1312146	ACTR6	actin related protein 6	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ACTR6 mRNA	PMID:21179406
1312146	ACTR6	actin related protein 6	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ACTR6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ACTR6 mRNA	PMID:39836092
1312146	ACTR6	actin related protein 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACTR6 mRNA	PMID:35301059
1312146	ACTR6	actin related protein 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ACTR6 gene	PMID:27153756
1312146	ACTR6	actin related protein 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312147	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACTR6 mRNA	PMID:22206623
1312146	ACTR6	actin related protein 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ACTR6 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of ACTR6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACTR6 mRNA	PMID:39836092|PMID:40512198
1312146	ACTR6	actin related protein 6	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ACTR6 mRNA	PMID:28189721|PMID:28960355
1312146	ACTR6	actin related protein 6	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ACTR6 mRNA	PMID:23557933
1312146	ACTR6	actin related protein 6	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312147	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of ACTR6 mRNA	PMID:30912803
1312146	ACTR6	actin related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312147	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ACTR6 mRNA	PMID:25975270
1312146	ACTR6	actin related protein 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ACTR6 mRNA	PMID:30851411
1312146	ACTR6	actin related protein 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of ACTR6 mRNA	PMID:39719251
1312146	ACTR6	actin related protein 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ACTR6 mRNA	PMID:38568856
1312146	ACTR6	actin related protein 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ACTR6 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of ACTR6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACTR6 mRNA	PMID:39836092|PMID:40512198
1312146	ACTR6	actin related protein 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312147	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACTR6 mRNA	PMID:19770486
1312146	ACTR6	actin related protein 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ACTR6 mRNA]	PMID:32406909
1312146	ACTR6	actin related protein 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312147	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ACTR6 gene	PMID:35295148
1312146	ACTR6	actin related protein 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304609	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ACTR6 mRNA	PMID:23411599|PMID:34492290
1312146	ACTR6	actin related protein 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312147	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ACTR6 mRNA	PMID:18301758
1312146	ACTR6	actin related protein 6	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ACTR6 gene	PMID:31601247
1312146	ACTR6	actin related protein 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312147	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ACTR6 mRNA	PMID:32156529|PMID:33221593|PMID:38074096
1312146	ACTR6	actin related protein 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304609	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of ACTR6 mRNA	PMID:26496021
1312146	ACTR6	actin related protein 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ACTR6 mRNA	PMID:39298647
1312146	ACTR6	actin related protein 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of ACTR6 gene	PMID:31601247
1312146	ACTR6	actin related protein 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312147	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ACTR6 mRNA	PMID:38685157
1312146	ACTR6	actin related protein 6	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ACTR6 mRNA	PMID:28628672
1312146	ACTR6	actin related protein 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ACTR6 mRNA	PMID:37019170
1312146	ACTR6	actin related protein 6	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ACTR6 mRNA	PMID:28628672
1312146	ACTR6	actin related protein 6	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ACTR6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ACTR6 mRNA	PMID:39836092
1312146	ACTR6	actin related protein 6	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ACTR6 mRNA	PMID:26472689
1312146	ACTR6	actin related protein 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACTR6 mRNA	PMID:35301059
1312146	ACTR6	actin related protein 6	gene	CHEBI:35559	furan	decreases methylation	ISO	RGD:1304609	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in decreased methylation of ACTR6 gene	PMID:22079235
1312146	ACTR6	actin related protein 6	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of ACTR6 mRNA	PMID:19376846
1312146	ACTR6	actin related protein 6	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ACTR6 mRNA	PMID:28302478
1312146	ACTR6	actin related protein 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ACTR6 mRNA	PMID:27153767
1312146	ACTR6	actin related protein 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312147	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ACTR6 mRNA	PMID:17292431
1312146	ACTR6	actin related protein 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in increased expression of ACTR6 mRNA	PMID:22083351|PMID:29154799
1312146	ACTR6	actin related protein 6	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ACTR6 mRNA	PMID:28628672
1312146	ACTR6	actin related protein 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312147	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACTR6 mRNA	PMID:17562736
1312146	ACTR6	actin related protein 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ACTR6 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of ACTR6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACTR6 mRNA	PMID:39836092|PMID:40512198
1312146	ACTR6	actin related protein 6	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ACTR6 mRNA	PMID:28628672
1312146	ACTR6	actin related protein 6	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of ACTR6 mRNA	PMID:40234311
1312146	ACTR6	actin related protein 6	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ACTR6 protein	PMID:32959892
1312146	ACTR6	actin related protein 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ACTR6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ACTR6 mRNA	PMID:39836092
1312146	ACTR6	actin related protein 6	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ACTR6 mRNA	PMID:31758290
1312146	ACTR6	actin related protein 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ACTR6 mRNA	PMID:22206623
1312146	ACTR6	actin related protein 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312147	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACTR6 mRNA	PMID:22206623
1312146	ACTR6	actin related protein 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ACTR6 mRNA	PMID:30851411
1312146	ACTR6	actin related protein 6	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ACTR6 mRNA	PMID:30928695
1312146	ACTR6	actin related protein 6	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312147	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ACTR6 mRNA	PMID:19270015
1312146	ACTR6	actin related protein 6	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312147	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ACTR6 mRNA	PMID:39847705
1312146	ACTR6	actin related protein 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304609	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ACTR6 mRNA	PMID:21346803
1312146	ACTR6	actin related protein 6	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1312147	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of ACTR6 mRNA	PMID:26217789
1312146	ACTR6	actin related protein 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304609	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ACTR6 mRNA	PMID:21346803
1312146	ACTR6	actin related protein 6	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304609	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of ACTR6 mRNA	PMID:23555832
1312148	ATG14	autophagy related 14	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of ATG14 mRNA	PMID:31863870
1312148	ATG14	autophagy related 14	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312149	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ATG14 mRNA	PMID:33045310
1312148	ATG14	autophagy related 14	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATG14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATG14 mRNA	PMID:32699268
1312148	ATG14	autophagy related 14	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ATG14 mRNA	PMID:26079696
1312148	ATG14	autophagy related 14	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1304610	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of ATG14 mRNA	PMID:36841081
1312148	ATG14	autophagy related 14	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312149	E	RGD:6480464	20201103	CTD	MESH:D001280	Atrazine results in increased expression of ATG14 mRNA	PMID:30360616
1312148	ATG14	autophagy related 14	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1312149	E	RGD:6480464	20201103	CTD	MESH:D001280	Lycopene inhibits the reaction [Atrazine results in increased expression of ATG14 mRNA]	PMID:30360616
1312148	ATG14	autophagy related 14	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1312149	E	RGD:6480464	20201103	CTD	MESH:C015329	Lycopene inhibits the reaction [Atrazine results in increased expression of ATG14 mRNA]	PMID:30360616
1312148	ATG14	autophagy related 14	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312149	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ATG14 mRNA	PMID:30319688
1312148	ATG14	autophagy related 14	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312149	E	RGD:6480464	20140513	CTD	MESH:D000431	Ethanol results in increased expression of ATG14 mRNA	PMID:24095927
1312148	ATG14	autophagy related 14	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312149	E	RGD:6480464	20140513	CTD	MESH:D000431	FOXO3 gene mutant form inhibits the reaction [Ethanol results in increased expression of ATG14 mRNA]	PMID:24095927
1312148	ATG14	autophagy related 14	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of ATG14 protein	PMID:35688186
1312148	ATG14	autophagy related 14	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312149	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ATG14 mRNA	PMID:39241906
1312148	ATG14	autophagy related 14	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312149	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ATG14 mRNA	PMID:39298647
1312148	ATG14	autophagy related 14	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312149	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ATG14 mRNA	PMID:34319233
1312148	ATG14	autophagy related 14	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304610	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATG14 mRNA	PMID:33387578
1312148	ATG14	autophagy related 14	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ATG14 mRNA	PMID:28818685
1312148	ATG14	autophagy related 14	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ATG14 mRNA	PMID:19549813
1312148	ATG14	autophagy related 14	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATG14 gene	PMID:27153756
1312148	ATG14	autophagy related 14	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ATG14 mRNA	PMID:23649840
1312148	ATG14	autophagy related 14	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATG14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATG14 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of ATG14 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ATG14 mRNA	PMID:32699268|PMID:35430440
1312148	ATG14	autophagy related 14	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312149	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of ATG14 mRNA	PMID:31919559
1312148	ATG14	autophagy related 14	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312149	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ATG14 mRNA	PMID:22206623
1312148	ATG14	autophagy related 14	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATG14 mRNA	PMID:39836092
1312148	ATG14	autophagy related 14	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ATG14 mRNA	PMID:19244175
1312148	ATG14	autophagy related 14	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312149	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of ATG14 mRNA	PMID:31352102
1312148	ATG14	autophagy related 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304610	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATG14 mRNA	PMID:33387578
1312148	ATG14	autophagy related 14	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATG14 mRNA	PMID:29803840
1312148	ATG14	autophagy related 14	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA]	PMID:34439521
1312148	ATG14	autophagy related 14	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ATG14 mRNA	PMID:38568856
1312148	ATG14	autophagy related 14	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATG14 mRNA	PMID:39836092
1312148	ATG14	autophagy related 14	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATG14 intron	PMID:30157460
1312148	ATG14	autophagy related 14	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304610	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ATG14 mRNA	PMID:30047161
1312148	ATG14	autophagy related 14	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of ATG14 mRNA	PMID:23146750
1312148	ATG14	autophagy related 14	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ATG14 mRNA	PMID:34439521
1312148	ATG14	autophagy related 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304610	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ATG14 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1312148	ATG14	autophagy related 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312149	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ATG14 mRNA	PMID:33221593
1312148	ATG14	autophagy related 14	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304610	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ATG14 gene	PMID:28505145
1312148	ATG14	autophagy related 14	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA]; astaxanthine inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA]	PMID:34439521
1312148	ATG14	autophagy related 14	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of ATG14 mRNA	PMID:23146750
1312148	ATG14	autophagy related 14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312149	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ATG14 mRNA	PMID:39298647
1312148	ATG14	autophagy related 14	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312149	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ATG14 intron	PMID:28392331
1312148	ATG14	autophagy related 14	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATG14 mRNA	PMID:37042841
1312148	ATG14	autophagy related 14	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ATG14 mRNA	PMID:38568856
1312148	ATG14	autophagy related 14	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ATG14 mRNA	PMID:23146750
1312148	ATG14	autophagy related 14	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312149	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ATG14 mRNA	PMID:28903501
1312148	ATG14	autophagy related 14	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ATG14 mRNA	PMID:19320972|PMID:19376846
1312148	ATG14	autophagy related 14	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304610	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ATG14 mRNA	PMID:24386269
1312148	ATG14	autophagy related 14	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATG14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATG14 mRNA	PMID:32699268
1312148	ATG14	autophagy related 14	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ATG14 mRNA	PMID:19244175
1312148	ATG14	autophagy related 14	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of ATG14 mRNA	PMID:40434365
1312148	ATG14	autophagy related 14	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ATG14 mRNA	PMID:31533062
1312148	ATG14	autophagy related 14	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of ATG14 mRNA	PMID:19167446
1312148	ATG14	autophagy related 14	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATG14 mRNA	PMID:23179753
1312148	ATG14	autophagy related 14	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304610	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ATG14 mRNA	PMID:30047161
1312148	ATG14	autophagy related 14	gene	CHEBI:40968	astaxanthin	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C005948	astaxanthine inhibits the reaction [bisphenol A results in increased expression of ATG14 mRNA]	PMID:34439521
1312148	ATG14	autophagy related 14	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D003907	Dexamethasone results in increased expression of ATG14 protein	PMID:33359579
1312148	ATG14	autophagy related 14	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1304610	E	RGD:6480464	20210406	CTD	MESH:D003907	Dexamethasone results in increased expression of ATG14 protein	PMID:33359579
1312148	ATG14	autophagy related 14	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D003907	5-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid inhibits the reaction [Dexamethasone results in increased expression of ATG14 protein]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of ATG14 protein]	PMID:33359579
1312148	ATG14	autophagy related 14	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1304610	E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ATG14 mRNA	PMID:36653537
1312148	ATG14	autophagy related 14	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312149	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of ATG14 mRNA	PMID:17562736
1312148	ATG14	autophagy related 14	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATG14 mRNA	PMID:39836092
1312148	ATG14	autophagy related 14	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312149	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ATG14 mRNA; Nanotubes, Carbon results in decreased expression of ATG14 mRNA	PMID:25554681
1312148	ATG14	autophagy related 14	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304610	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ATG14 mRNA	PMID:30047161
1312148	ATG14	autophagy related 14	gene	CHEBI:50692	mifepristone	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D015735	Mifepristone inhibits the reaction [Dexamethasone results in increased expression of ATG14 protein]	PMID:33359579
1312148	ATG14	autophagy related 14	gene	CHEBI:50833	cadmium sulfide	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C034939	cadmium sulfide results in increased expression of ATG14 mRNA	PMID:27866839
1312148	ATG14	autophagy related 14	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304610	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of ATG14 mRNA	PMID:24793618
1312148	ATG14	autophagy related 14	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1304610	E	RGD:6480464	20200915	CTD	MESH:D008694	Methamphetamine results in increased expression of ATG14 mRNA	PMID:32676729
1312148	ATG14	autophagy related 14	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312149	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ATG14 mRNA	PMID:22206623
1312148	ATG14	autophagy related 14	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312149	E	RGD:6480464	20120522	CTD	MESH:D010634	Phenobarbital results in increased expression of ATG14 mRNA	PMID:19270015
1312148	ATG14	autophagy related 14	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312149	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ATG14 mRNA	PMID:31388691
1312148	ATG14	autophagy related 14	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ATG14 mRNA	PMID:23146750
1312148	ATG14	autophagy related 14	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ATG14 mRNA	PMID:26079696
1312148	ATG14	autophagy related 14	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312149	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of ATG14 mRNA	PMID:39847705
1312148	ATG14	autophagy related 14	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304610	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ATG14 mRNA	PMID:30047161
1312148	ATG14	autophagy related 14	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304610	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ATG14 mRNA	PMID:19281266
1312148	ATG14	autophagy related 14	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1312149	E	RGD:6480464	20150825	CTD	MESH:D013605	T-2 Toxin results in increased expression of ATG14 mRNA	PMID:26138683
1312148	ATG14	autophagy related 14	gene	CHEBI:9763	trovafloxacin	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C080163	trovafloxacin results in increased expression of ATG14 mRNA	PMID:33609687
1312148	ATG14	autophagy related 14	gene	CHEBI:9763	trovafloxacin	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:C080163	TNF protein inhibits the reaction [trovafloxacin results in increased expression of ATG14 mRNA]	PMID:33609687
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1549986	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ZKSCAN17 mRNA	PMID:33045310
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1304611	E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in increased expression of ZFP496 mRNA	PMID:35192832
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZKSCAN17 mRNA	PMID:25510870
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304611	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ZNF496 mRNA	PMID:22061828
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZKSCAN17 mRNA	PMID:36331819
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of ZKSCAN17 mRNA	PMID:28111341
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZKSCAN17 mRNA	PMID:25510870
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZKSCAN17 mRNA	PMID:25510870
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1304611	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ZFP496 mRNA	PMID:33354967
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304611	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZFP496 mRNA	PMID:30779732
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZKSCAN17 mRNA	PMID:22206623
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1549986	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ZKSCAN17 mRNA	PMID:28960355
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ZNF496 mRNA	PMID:27392435
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1549986	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZKSCAN17 mRNA	PMID:21570461|PMID:24058054
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304611	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP496 mRNA	PMID:21215274
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304611	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP496 mRNA	PMID:33387578
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1549986	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZKSCAN17 mRNA	PMID:19465110
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ZNF496 mRNA	PMID:32763439
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ZNF496 promoter	PMID:27901495
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of ZNF496 promoter	PMID:23974009
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of ZNF496 gene	PMID:31601247
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ZNF496 gene	PMID:31601247
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304611	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ZFP496 mRNA	PMID:30047161
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1549986	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZKSCAN17 gene; titanium dioxide results in decreased methylation of ZKSCAN17 promoter	PMID:35295148
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1549986	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ZKSCAN17 mRNA	PMID:18301758
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of ZNF496 mRNA	PMID:20170705
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304611	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF496 mRNA	PMID:25181051
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1549986	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ZKSCAN17 promoter	PMID:27334623
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304611	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP496 mRNA	PMID:32145629
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304611	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP496 mRNA	PMID:34947998
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ZNF496 gene	PMID:31601247
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ZNF496 gene	PMID:31601247
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZKSCAN17 mRNA	PMID:25510870
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZKSCAN17 mRNA	PMID:25510870
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1549986	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ZKSCAN17 mRNA	PMID:39298647
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1549986	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZKSCAN17 mRNA	PMID:37019170
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of ZKSCAN17 mRNA	PMID:28111341
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304611	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ZFP496 mRNA	PMID:24386269
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1549986	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of ZKSCAN17 mRNA	PMID:23811191
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of ZNF496 mRNA	PMID:19167446
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZKSCAN17 mRNA	PMID:36331819
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF496 mRNA	PMID:23179753
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304611	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ZFP496 mRNA	PMID:30047161
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF496 mRNA	PMID:25562108
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1549986	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZKSCAN17 mRNA	PMID:17562736
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZNF496 mRNA	PMID:22230336
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1549986	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ZKSCAN17 mRNA	PMID:35436446
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:4998	fenarimol	increases expression	ISO	RGD:1304611	E	RGD:6480464	20171114	CTD	MESH:C033789	fenarimol results in increased expression of ZFP496 mRNA	PMID:28970091
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of ZNF496 mRNA]	PMID:21095227
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304611	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ZFP496 mRNA	PMID:30047161
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1549986	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZKSCAN17 mRNA	PMID:22206623
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF496 protein	PMID:31285264
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	affects expression	ISO	RGD:1549986	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl affects the expression of ZKSCAN17 mRNA	PMID:31388691
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1304611	E	RGD:6480464	20171114	CTD	MESH:C045950	propiconazole results in increased expression of ZFP496 mRNA	PMID:28970091
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304611	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZFP496 mRNA	PMID:30047161
1312150	ZNF496	zinc finger protein 496	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1549986	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ZNF496 mRNA	PMID:28973697
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RASGRP3 mRNA	PMID:33167477
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RASGRP3 mRNA	PMID:30529165
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of RASGRP3 mRNA	PMID:24763279
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RASGRP3 mRNA	PMID:26079696
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:16243	quercetin	affects expression	ISO	RGD:1304612	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin affects the expression of RASGRP3 mRNA	PMID:18178720
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of RASGRP3 mRNA	PMID:22185406
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]	PMID:22185406
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RASGRP3 mRNA	PMID:22185406|PMID:39241906
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RASGRP3 mRNA	PMID:35811015
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20161228	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]; Dexamethasone promotes the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]; Quercetin inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]; tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]	PMID:22185406|PMID:39241906
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of RASGRP3 mRNA	PMID:31614463
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASGRP3 mRNA	PMID:37992649
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASGRP3 mRNA	PMID:37992649
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304612	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RASGRP3 mRNA	PMID:27523638
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RASGRP3 protein	PMID:37730182
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304612	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RASGRP3 mRNA	PMID:33387578
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1304612	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of RASGRP3 mRNA	PMID:28522335
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RASGRP3 mRNA	PMID:29950665
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RASGRP3 mRNA	PMID:27153756
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1304612	E	RGD:6480464	20200114	CTD	MESH:D010126	Ozone results in decreased expression of RASGRP3 mRNA	PMID:31397875
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RASGRP3 mRNA	PMID:41430723
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RASGRP3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RASGRP3 mRNA	PMID:34911549
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RASGRP3 gene	PMID:25304211
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304612	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RASGRP3 mRNA	PMID:31881176
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of RASGRP3 mRNA	PMID:27392435
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RASGRP3 mRNA	PMID:27392435
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312153	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASGRP3 mRNA	PMID:21570461
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304612	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RASGRP3 mRNA	PMID:34747641
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RASGRP3 mRNA	PMID:19933214
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RASGRP3 mRNA	PMID:33212167
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304612	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of RASGRP3 mRNA	PMID:28959563
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of RASGRP3 mRNA	PMID:30911355
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RASGRP3 mRNA	PMID:29803840
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of RASGRP3 mRNA	PMID:39631538
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASGRP3 mRNA	PMID:37992649
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of RASGRP3 mRNA	PMID:25879800
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASGRP3 mRNA	PMID:34876320
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASGRP3 mRNA	PMID:34876320
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312153	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RASGRP3 mRNA	PMID:22228805|PMID:22610609|PMID:32417428
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RASGRP3 5' UTR; Benzo(a)pyrene results in increased methylation of RASGRP3 promoter	PMID:27901495
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASGRP3 mRNA	PMID:27858113
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of RASGRP3 mRNA	PMID:30911355
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312153	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of RASGRP3 mRNA	PMID:27131904
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RASGRP3 mRNA	PMID:25895662
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RASGRP3 gene	PMID:31601247
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304612	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RASGRP3 mRNA	PMID:25729387
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312153	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of RASGRP3 mRNA	PMID:23557971
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RASGRP3 mRNA	PMID:29950665
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RASGRP3 mRNA	PMID:18648102
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RASGRP3 mRNA	PMID:19710929
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1312153	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of RASGRP3 mRNA	PMID:19191707
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:33007	chromium(6+)	affects expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RASGRP3 mRNA	PMID:30690063
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RASGRP3 mRNA	PMID:29275510
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304612	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RASGRP3 mRNA	PMID:25181051|PMID:34947998
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312153	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of RASGRP3 mRNA	PMID:30951980
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304612	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RASGRP3 gene	PMID:28505145
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RASGRP3 gene	PMID:31601247
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:33276	delta-tocotrienol	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20161213	CTD	MESH:C082097	tocotrienol, delta results in decreased expression of RASGRP3 mRNA	PMID:22185406
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:33276	delta-tocotrienol	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20161213	CTD	MESH:C082097	tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]	PMID:22185406
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312153	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of RASGRP3 mRNA	PMID:30951980|PMID:39298647|PMID:40203079
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312153	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of RASGRP3 mRNA	PMID:26377693
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASGRP3 mRNA	PMID:27858113
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312153	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RASGRP3 mRNA	PMID:30951980
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312153	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RASGRP3 intron	PMID:28392331
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of RASGRP3 mRNA	PMID:29950665
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304612	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RASGRP3 mRNA	PMID:21266533
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]	PMID:39241906
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RASGRP3 mRNA	PMID:37042841
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312153	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of RASGRP3 mRNA	PMID:26377693
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RASGRP3 mRNA	PMID:38382870
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RASGRP3 mRNA	PMID:19320972
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1304612	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RASGRP3 mRNA	PMID:24386269
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RASGRP3 mRNA	PMID:24449571
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:35842	antirheumatic drug	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	[Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of RASGRP3 mRNA	PMID:16817978
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312153	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RASGRP3 mRNA	PMID:40194260
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of RASGRP3 mRNA	PMID:29038090
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of RASGRP3 mRNA	PMID:23125180
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RASGRP3 mRNA	PMID:25979313
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of RASGRP3 mRNA	PMID:29154799
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RASGRP3 gene	PMID:29154799
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20161213	CTD	MESH:D003907	Dexamethasone results in decreased expression of RASGRP3 mRNA	PMID:22185406
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20161213	CTD	MESH:D003907	Dexamethasone promotes the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]	PMID:22185406
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312153	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RASGRP3 mRNA	PMID:28973697
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASGRP3 mRNA	PMID:37992649
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:44185	methotrexate	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	[Antirheumatic Agents co-treated with Methotrexate] results in decreased expression of RASGRP3 mRNA	PMID:16817978
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RASGRP3 mRNA	PMID:38832940
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1304612	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of RASGRP3 mRNA	PMID:33387578
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RASGRP3 mRNA	PMID:35811015
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RASGRP3 gene	PMID:25304211
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of RASGRP3 mRNA	PMID:31838189
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304612	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RASGRP3 mRNA	PMID:29391264
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RASGRP3 mRNA	PMID:22079256
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASGRP3 mRNA	PMID:34876320
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RASGRP3 mRNA; Nanotubes, Carbon results in decreased expression of RASGRP3 mRNA	PMID:25554681
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RASGRP3 mRNA	PMID:35964746
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASGRP3 mRNA	PMID:27858113
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RASGRP3 mRNA	PMID:27858113
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASGRP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RASGRP3 mRNA	PMID:21641980|PMID:26378955
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1304612	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of RASGRP3 mRNA	PMID:25729387
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304612	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RASGRP3 mRNA	PMID:25729387
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of RASGRP3 mRNA	PMID:15336504
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in increased expression of RASGRP3 mRNA	PMID:25290377
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312153	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RASGRP3 mRNA	PMID:22206623
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RASGRP3 mRNA	PMID:22079256
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RASGRP3 mRNA	PMID:22714537
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RASGRP3 mRNA	PMID:22079256
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RASGRP3 gene]	PMID:28238834
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:81980	triticonazole	decreases expression	ISO	RGD:1304612	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of RASGRP3 mRNA	PMID:36084822
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of RASGRP3 mRNA	PMID:26079696
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312153	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RASGRP3 mRNA	PMID:39847705
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RASGRP3 mRNA	PMID:34876320
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304612	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RASGRP3 mRNA	PMID:25825206
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312153	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]	PMID:39241906
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of RASGRP3 mRNA	PMID:24921660
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312153	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of RASGRP3 mRNA	PMID:27131904
1312152	RASGRP3	RAS guanyl releasing protein 3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312153	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of RASGRP3 mRNA	PMID:28973697
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CLYBL mRNA	PMID:25812627
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CLYBL gene	PMID:20938992
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CLYBL mRNA	PMID:33167477
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of CLYBL protein	PMID:39571964
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312157	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CLYBL mRNA	PMID:20880076
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CLYBL mRNA	PMID:36331819
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304615	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CLYBL gene	PMID:28931070
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CLYBL mRNA	PMID:22378314
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CLYBL mRNA	PMID:21632981
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312157	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CLYBL mRNA	PMID:39241906
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with resveratrol] results in increased expression of CLYBL mRNA	PMID:26667767
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CLYBL mRNA	PMID:30165855
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of CLYBL mRNA	PMID:33711761
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CLYBL gene	PMID:20938992
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304615	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of CLYBL mRNA	PMID:26496021
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CLYBL mRNA	PMID:31163220
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312157	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CLYBL mRNA	PMID:19850644
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of CLYBL mRNA]	PMID:19850644
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304615	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CLYBL mRNA	PMID:26577399
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CLYBL mRNA	PMID:28818685
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CLYBL mRNA	PMID:36331819
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304615	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CLYBL mRNA	PMID:28522335
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312157	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of CLYBL mRNA	PMID:27462272
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CLYBL mRNA	PMID:19549813
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304615	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of CLYBL mRNA	PMID:21396975
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CLYBL protein	PMID:20106945
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CLYBL mRNA	PMID:21641981|PMID:27153756
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1304615	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CLYBL mRNA	PMID:33354967
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CLYBL mRNA	PMID:19770486
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CLYBL intron	PMID:30157460
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CLYBL mRNA	PMID:23649840
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304615	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CLYBL mRNA	PMID:31150632
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CLYBL mRNA	PMID:31919559
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CLYBL mRNA	PMID:25629700
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CLYBL gene	PMID:20938992
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CLYBL mRNA	PMID:26272509
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CLYBL mRNA	PMID:27188386
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1304615	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CLYBL mRNA	PMID:26302742
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304615	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of CLYBL mRNA	PMID:31881176
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[Lipopolysaccharides co-treated with resveratrol] results in increased expression of CLYBL mRNA	PMID:26667767
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in decreased expression of CLYBL mRNA	PMID:24280081|PMID:27594783
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in decreased expression of CLYBL mRNA	PMID:24280081
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1304615	E	RGD:6480464	20160412	CTD	MESH:D003042	Cocaine results in increased expression of CLYBL protein	PMID:25100957
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CLYBL mRNA	PMID:25583101
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304615	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLYBL mRNA	PMID:22298810
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304615	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLYBL mRNA	PMID:21215274
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLYBL mRNA	PMID:19770486
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CLYBL mRNA	PMID:21802500
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CLYBL mRNA	PMID:33212167
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CLYBL mRNA	PMID:32763439
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CLYBL protein	PMID:28918527
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CLYBL mRNA	PMID:37682722
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1312157	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of CLYBL gene	PMID:39894169
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312157	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of CLYBL mRNA	PMID:20883709
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	[sodium arsenite co-treated with lead acetate] results in increased expression of CLYBL protein; [sodium arsenite co-treated with Tretinoin] results in decreased expression of CLYBL protein	PMID:38072110|PMID:39571964
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLYBL mRNA	PMID:21632981|PMID:26238291|PMID:32234424
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLYBL mRNA	PMID:19770486
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CLYBL 3' UTR	PMID:27901495
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CLYBL mRNA	PMID:21802500
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CLYBL mRNA	PMID:25895662
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CLYBL mRNA	PMID:26238291
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in increased expression of CLYBL protein	PMID:38072110
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CLYBL mRNA	PMID:23557971
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304615	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of CLYBL mRNA	PMID:23411599|PMID:34492290
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312157	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CLYBL mRNA	PMID:17426115|PMID:18301758|PMID:23811191
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	EXP		E	RGD:6480464	20250708	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of CLYBL gene	PMID:38723642
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304615	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CLYBL mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CLYBL gene	PMID:31601247
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304615	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CLYBL gene	PMID:28505145
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304615	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of CLYBL mRNA	PMID:26496021
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of CLYBL mRNA	PMID:26682919
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312157	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CLYBL mRNA	PMID:39298647|PMID:40203079
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1304615	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CLYBL mRNA	PMID:17602206
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304615	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CLYBL mRNA	PMID:21266533
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CLYBL mRNA	PMID:21266533
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304615	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLYBL mRNA; [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CLYBL mRNA	PMID:17602206|PMID:18164116
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1304615	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of CLYBL mRNA	PMID:32680482
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CLYBL mRNA	PMID:37042841
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304615	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CLYBL mRNA	PMID:25993096
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304615	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CLYBL mRNA	PMID:33453195
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312157	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CLYBL mRNA	PMID:20883709
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CLYBL mRNA	PMID:25812627
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CLYBL protein	PMID:26879310
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312157	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CLYBL mRNA	PMID:18353800
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CLYBL mRNA	PMID:25812627
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312157	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CLYBL mRNA	PMID:40194260
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CLYBL mRNA	PMID:25812627
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312157	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CLYBL mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CLYBL mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CLYBL mRNA	PMID:36331819
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CLYBL mRNA	PMID:25979313
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312157	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CLYBL mRNA	PMID:17292431
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of CLYBL mRNA	PMID:19101580|PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CLYBL gene	PMID:29154799
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of CLYBL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLYBL mRNA	PMID:17183730|PMID:27188386
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304615	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of CLYBL mRNA	PMID:41580965
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CLYBL mRNA	PMID:20106945
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of CLYBL mRNA	PMID:19770486
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:41977	daunorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D003630	CLYBL affects the susceptibility to Daunorubicin	PMID:17545624
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CLYBL mRNA	PMID:28973697
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CLYBL mRNA	PMID:38832940
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CLYBL mRNA	PMID:24935251
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312157	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CLYBL mRNA	PMID:17562736
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of CLYBL mRNA	PMID:25704631
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304615	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CLYBL mRNA	PMID:33387578
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1312157	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of CLYBL mRNA	PMID:30529165
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304615	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CLYBL mRNA	PMID:29391264
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CLYBL mRNA	PMID:32234424
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of CLYBL mRNA	PMID:17183730
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304615	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CLYBL gene	PMID:35440735
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CLYBL mRNA	PMID:31758290
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CLYBL mRNA	PMID:22206623
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:76604	MeIQx	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in decreased expression of CLYBL mRNA	PMID:20816883
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1304615	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLYBL mRNA	PMID:18164116
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CLYBL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLYBL mRNA	PMID:27188386
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1312157	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of CLYBL mRNA	PMID:22538082
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CLYBL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CLYBL mRNA	PMID:27188386
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304615	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CLYBL mRNA	PMID:21346803
1312156	CLYBL	citramalyl-CoA lyase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304615	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CLYBL mRNA	PMID:21346803
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of NOP2 protein	PMID:39638853
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304616	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOP2 mRNA]	PMID:31150632
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:D014212	Tretinoin results in decreased expression of NOL1 mRNA	PMID:16604517
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOP2 mRNA	PMID:32699268
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NOP2 mRNA	PMID:26516004
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1304616	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NOP2 mRNA	PMID:33729688
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP2 mRNA	PMID:30529165
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of NOP2 protein	PMID:31494107
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312159	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NOP2 mRNA	PMID:39241906
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP2 mRNA]	PMID:39241906
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of NOP2 mRNA	PMID:23019147|PMID:31614463
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NOP2 mRNA	PMID:37042841
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304616	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of NOP2 mRNA	PMID:26577399
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NOP2 protein	PMID:37730182
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP2 mRNA	PMID:39836092
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304616	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of NOP2 protein	PMID:34915118
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:22718	benzoates	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in decreased expression of NOP2 mRNA	PMID:29472718
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NOP2 mRNA	PMID:37236586
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NOP2 gene	PMID:27153756
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOP2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of NOP2 mRNA	PMID:32699268
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304616	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of NOP2 mRNA	PMID:30779732
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304616	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NOP2 mRNA	PMID:31150632
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312159	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NOP2 mRNA	PMID:27339419|PMID:31919559
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304616	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOP2 mRNA]	PMID:31150632
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NOP2 mRNA	PMID:22206623
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP2 mRNA	PMID:39836092
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP2 mRNA	PMID:40504410
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of NOP2 protein	PMID:35688186
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NOP2 mRNA	PMID:23557933
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of NOP2 mRNA	PMID:19921347
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of NOP2 mRNA	PMID:27594783
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of NOP2 mRNA	PMID:23019147
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of NOP2 mRNA	PMID:24768652|PMID:25583101
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NOL1 mRNA	PMID:21570461
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NOP2 mRNA	PMID:22903824
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304616	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of NOP2 mRNA	PMID:28374803
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of NOP2 mRNA	PMID:28001369
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of NOP2 mRNA	PMID:32763439
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NOP2 mRNA	PMID:29803840
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of NOP2 protein	PMID:35688186
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP2 mRNA	PMID:39836092
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP2 mRNA	PMID:40504410
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NOP2 mRNA	PMID:26238291
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of NOP2 mRNA	PMID:25075043
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304616	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of NOP2 mRNA	PMID:24136188
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NOP2 gene	PMID:35295148
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NOP2 promoter	PMID:35295148
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304616	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of NOP2 mRNA	PMID:34492290
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of NOL1 mRNA	PMID:18648102
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312159	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NOP2 mRNA	PMID:23811191
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NOP2 mRNA	PMID:30903817
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304616	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NOP2 mRNA	PMID:25181051
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of NOP2 protein	PMID:37567409
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312159	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of NOP2 mRNA	PMID:37894381
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of NOP2 gene	PMID:31601247
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304616	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NOP2 mRNA	PMID:36041667
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312159	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NOP2 mRNA	PMID:39298647
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304616	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NOP2 mRNA	PMID:36041667
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312159	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of NOP2 mRNA	PMID:38685157
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOP2 mRNA	PMID:28628672
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304616	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NOP2 mRNA	PMID:36041667
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312159	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NOP2 mRNA	PMID:37019170
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1304616	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of NOP2 mRNA	PMID:22546817
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of NOP2 gene	PMID:22964155
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1304616	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of NOP2 mRNA	PMID:22546817
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to NOP2 protein	PMID:32991956
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOP2 mRNA	PMID:28628672
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304616	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of NOP2 mRNA	PMID:32680482
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP2 mRNA]	PMID:39241906
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP2 mRNA	PMID:39836092
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NOP2 mRNA	PMID:38174414
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NOP2 mRNA	PMID:12160620|PMID:38568856
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NOP2 mRNA	PMID:37236586
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312159	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of NOP2 mRNA	PMID:28903501
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOP2 mRNA	PMID:32699268
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NOP2 mRNA	PMID:32588087
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of NOP2 mRNA	PMID:31533062
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NOP2 mRNA	PMID:25979313
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312159	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NOP2 mRNA	PMID:17292431
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:D014635	Valproic Acid results in decreased expression of NOL1 mRNA	PMID:19136453|PMID:20546886
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of NOP2 mRNA	PMID:23179753
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of NOP2 mRNA	PMID:25562108
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOP2 mRNA	PMID:28628672
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:D008727	Methotrexate affects the expression of NOL1 mRNA	PMID:18502557
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312159	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NOP2 mRNA	PMID:25270620
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:D000082	Acetaminophen affects the expression of NOL1 mRNA	PMID:17562736
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304616	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NOP2 mRNA	PMID:33387578
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP2 mRNA	PMID:39836092
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP2 mRNA	PMID:40504410
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312159	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of NOP2 mRNA	PMID:35436446
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NOL1 mRNA	PMID:17942748
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of NOP2 mRNA	PMID:28628672
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:50035	alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of NOP2 mRNA	PMID:25075043
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312159	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NOP2 mRNA; Nanotubes, Carbon results in increased expression of NOP2 mRNA	PMID:25554681
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NOP2 mRNA	PMID:35964746
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304616	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NOP2 mRNA	PMID:24136188
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1312159	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of NOP2 mRNA	PMID:26377693
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312159	E	RGD:6480464	20241001	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NOL1 mRNA	PMID:19042947
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NOP2 protein	PMID:32959892
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NOP2 mRNA	PMID:39836092
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of NOP2 mRNA	PMID:31758290
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of NOP2 protein	PMID:34186270
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NOP2 mRNA	PMID:22206623
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NOP2 protein	PMID:37664457
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of NOP2 protein	PMID:31285264
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312159	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of NOP2 mRNA	PMID:30294300
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of NOP2 protein	PMID:38348393
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312159	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP2 mRNA]	PMID:39241906
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NOP2 protein	PMID:37664457
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of NOP2 mRNA	PMID:34581912
1312158	NOP2	NOP2 nucleolar protein	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312159	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of NOP2 mRNA	PMID:32835833
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of KDELR2 mRNA	PMID:35967413
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KDELR2 mRNA	PMID:39752319
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1304618	E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in increased expression of KDELR2 protein	PMID:40631627
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of KDELR2 mRNA	PMID:22378314
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1312162	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of KDELR2 mRNA	PMID:25056781
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of KDELR2 mRNA	PMID:29581250
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312162	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of KDELR2 mRNA	PMID:39241906
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312162	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of KDELR2 mRNA	PMID:39298647
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KDELR2 mRNA	PMID:19448997
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KDELR2 mRNA	PMID:37042841
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of KDELR2 mRNA	PMID:23649840
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of KDELR2 mRNA	PMID:21179406
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1304618	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of KDELR2 protein	PMID:40631627
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KDELR2 mRNA	PMID:39752319
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1304618	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of KDELR2 protein	PMID:40631627
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KDELR2 mRNA	PMID:31163220
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312162	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KDELR2 mRNA	PMID:33754040
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1312162	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of KDELR2 gene	PMID:32864567
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304618	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KDELR2 mRNA	PMID:33387578
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304618	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of KDELR2 mRNA	PMID:22061828
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:188855	Octicizer	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C018535	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of KDELR2 protein	PMID:42015365
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312162	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of KDELR2 mRNA	PMID:27462272
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of KDELR2 mRNA	PMID:19549813
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1312162	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of KDELR2 mRNA	PMID:25056781
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of KDELR2 mRNA	PMID:23649840
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:2663	amiodarone	affects expression	ISO	RGD:1304618	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of KDELR2 mRNA	PMID:19483382
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312162	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KDELR2 mRNA	PMID:27339419|PMID:31919559
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312162	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KDELR2 mRNA	PMID:25629700
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of KDELR2 mRNA	PMID:26272509
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA	PMID:27188386
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of KDELR2 mRNA	PMID:26865667
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of KDELR2 mRNA	PMID:24768652|PMID:25583101
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312162	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KDELR2 mRNA	PMID:21570461
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KDELR2 mRNA	PMID:17942748
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KDELR2 mRNA	PMID:17942748
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1304618	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of KDELR2 mRNA	PMID:19013527
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of KDELR2 mRNA	PMID:28001369
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:28428	beta-hexachlorocyclohexane	increases expression	ISO	RGD:1312162	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in increased expression of KDELR2 mRNA	PMID:25270620
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KDELR2 mRNA	PMID:38568856|PMID:39719251
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of KDELR2 mRNA	PMID:22378314
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KDELR2 mRNA	PMID:26238291
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KDELR2 promoter	PMID:27901495
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:3023	benzbromarone	affects expression	ISO	RGD:1304618	E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of KDELR2 mRNA	PMID:19483382
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304618	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of KDELR2 mRNA	PMID:24136188
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312162	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KDELR2 promoter	PMID:35295148
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1304618	E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of KDELR2 mRNA	PMID:19483382
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1304618	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of KDELR2 mRNA	PMID:19483382
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of KDELR2 mRNA	PMID:18445702
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of KDELR2 mRNA	PMID:30903817
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304618	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of KDELR2 mRNA	PMID:30816183|PMID:34947998
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of KDELR2 mRNA	PMID:25979313
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312162	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KDELR2 mRNA	PMID:37019170
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312162	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of KDELR2 mRNA	PMID:34813904
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:35033	triphenyl phosphate	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C005445	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of KDELR2 protein	PMID:42015365
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C031324	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of KDELR2 protein	PMID:42015365
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C013320	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of KDELR2 protein	PMID:42015365
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:3750	clofibrate	affects expression	ISO	RGD:1304618	E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of KDELR2 mRNA	PMID:19483382
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of KDELR2 mRNA	PMID:33512557
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304618	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of KDELR2 mRNA	PMID:29427782
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of KDELR2 mRNA	PMID:19101580|PMID:23179753|PMID:23527032|PMID:26272509
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA	PMID:27188386
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304618	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of KDELR2 mRNA	PMID:38685447|PMID:41580965
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of KDELR2 mRNA	PMID:25562108
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of KDELR2 mRNA	PMID:20106945|PMID:27989131
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of KDELR2 mRNA	PMID:17555576
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1304618	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of KDELR2 protein	PMID:40631627
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of KDELR2 mRNA	PMID:24935251|PMID:26272509
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA	PMID:27188386
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KDELR2 mRNA	PMID:17562736
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of KDELR2 mRNA	PMID:18687144
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1304618	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of KDELR2 mRNA	PMID:29391264
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4886	L-ethionine	affects expression	ISO	RGD:1304618	E	RGD:6480464	20130618	CTD	MESH:D005001	Ethionine affects the expression of KDELR2 mRNA	PMID:19483382
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1304618	E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of KDELR2 mRNA	PMID:26865667
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312162	E	RGD:6480464	20120613	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of KDELR2 mRNA	PMID:17555576|PMID:17942748
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KDELR2 mRNA	PMID:17942748
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1312162	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate results in increased expression of KDELR2 mRNA	PMID:16221973
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312162	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of KDELR2 mRNA; Nanotubes, Carbon results in increased expression of KDELR2 mRNA	PMID:25554681|PMID:25620056
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304618	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of KDELR2 mRNA	PMID:41580965
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:50692	mifepristone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of KDELR2 mRNA	PMID:17584828
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of KDELR2 mRNA	PMID:35964746
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304618	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KDELR2 mRNA	PMID:24136188
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of KDELR2 protein	PMID:32959892
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KDELR2 mRNA	PMID:39752319
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of KDELR2 mRNA	PMID:31758290
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312162	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KDELR2 mRNA	PMID:22206623
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:755208	eprenetapopt	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of KDELR2 mRNA	PMID:19946333
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of KDELR2 mRNA]	PMID:19946333
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1312162	E	RGD:6480464	20220607	CTD	MESH:C038405	nivalenol results in increased expression of KDELR2 mRNA	PMID:35016910
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of KDELR2 mRNA	PMID:18548127
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	ISO	RGD:1304618	E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of KDELR2 mRNA	PMID:19483382
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:7772	omeprazole	affects expression	ISO	RGD:1304618	E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of KDELR2 mRNA	PMID:19483382
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA	PMID:27188386
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:80025	Salinomycin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of KDELR2 mRNA	PMID:19682730
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1312162	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of KDELR2 mRNA	PMID:31388691
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312162	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of KDELR2 mRNA	PMID:30294300
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of KDELR2 mRNA	PMID:19095052
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of KDELR2 mRNA	PMID:38995820
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of KDELR2 mRNA	PMID:33512557
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of KDELR2 mRNA	PMID:21858171
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of KDELR2 mRNA	PMID:33512557
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312162	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of KDELR2 mRNA	PMID:21278054
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1304618	E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of KDELR2 mRNA	PMID:19483382
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312162	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KDELR2 mRNA	PMID:39752319
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KDELR2 mRNA	PMID:27188386
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of KDELR2 mRNA	PMID:31863870
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of KDELR2 mRNA	PMID:22378314
1312161	KDELR2	KDEL endoplasmic reticulum protein retention receptor 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304618	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of KDELR2 mRNA	PMID:23034163
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312164	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of AGO1 mRNA	PMID:33045310
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312164	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AGO1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AGO1 gene	PMID:20938992
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of AGO1 mRNA	PMID:16140955|PMID:33167477
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312164	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AGO1 mRNA	PMID:30529165
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of AGO1 mRNA	PMID:24763279
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of AGO1 mRNA	PMID:39241906
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of AGO1 mRNA	PMID:22574217
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312164	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of AGO1 mRNA	PMID:39298647
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304619	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of AGO1 mRNA	PMID:26496021
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312164	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AGO1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AGO1 gene	PMID:20938992
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of AGO1 mRNA	PMID:37042841
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D001554	Benzene results in increased expression of AGO1 mRNA	PMID:19162166
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304619	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of AGO1 mRNA	PMID:22061828
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of AGO1 mRNA	PMID:28818685
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312164	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AGO1 mRNA	PMID:36331819
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1304619	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of AGO1 protein	PMID:33236894
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of AGO1 gene	PMID:27153756
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of AGO1 exon	PMID:30157460
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304619	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of AGO1 mRNA	PMID:30779732
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304619	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AGO1 mRNA	PMID:31150632
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AGO1 mRNA	PMID:31919559
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312164	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AGO1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AGO1 gene	PMID:20938992
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of AGO1 mRNA	PMID:28903495
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of AGO1 mRNA	PMID:27594783
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of AGO1 mRNA	PMID:27392435
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of AGO1 mRNA	PMID:30912803
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of AGO1 mRNA	PMID:28001369
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of AGO1 mRNA	PMID:32763439
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of AGO1 mRNA	PMID:20044591
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of AGO1 mRNA	PMID:38568856
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of AGO1 mRNA	PMID:16014739
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite promotes the reaction [H3-3A protein binds to AGO1 protein]	PMID:37734572
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312164	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of AGO1 protein	PMID:37955338
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312164	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of AGO1 mRNA	PMID:23557971
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312164	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of AGO1 mRNA	PMID:18648102
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304619	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of AGO1 mRNA	PMID:32145629
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304619	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of AGO1 mRNA	PMID:30816183|PMID:32528016
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304619	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of AGO1 mRNA; [bisphenol A co-treated with Estradiol] results in decreased expression of AGO1 mRNA	PMID:26496021|PMID:36041667
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of AGO1 mRNA	PMID:25979313
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of AGO1 mRNA	PMID:39298647
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304619	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of AGO1 mRNA	PMID:36041667
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304619	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of AGO1 mRNA	PMID:36041667
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312164	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of AGO1 mRNA	PMID:37019170
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AGO1 mRNA	PMID:38382870
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312164	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of AGO1 mRNA	PMID:22698814
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of AGO1 mRNA	PMID:19320972
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of AGO1 mRNA	PMID:28302478
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312164	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AGO1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of AGO1 mRNA	PMID:36331819
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of AGO1 mRNA	PMID:26272509
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304619	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of AGO1 mRNA	PMID:38685447|PMID:41580965
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of AGO1 mRNA	PMID:20106945
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of AGO1 mRNA	PMID:27188386
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304619	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AGO1 mRNA	PMID:29097150
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of AGO1 mRNA; Nanotubes, Carbon results in decreased expression of AGO1 mRNA	PMID:25554681
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304619	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of AGO1 mRNA	PMID:41580965
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AGO1 protein	PMID:32959892
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of AGO1 mRNA	PMID:22206623
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of AGO1 protein	PMID:37664457
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AGO1 gene]	PMID:28238834
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of AGO1 protein	PMID:37664457
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:94402	1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine	decreases expression	ISO	RGD:1304619	E	RGD:6480464	20171010	CTD	MESH:C084597	chlorcyclizine results in decreased expression of AGO1 mRNA	PMID:21058326
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of AGO1 mRNA	PMID:38568856
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of AGO1 mRNA	PMID:27188386
1312163	AGO1	argonaute RISC component 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312164	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of AGO1 mRNA	PMID:28973697
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of MAP3K6 mRNA	PMID:27188386
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304625	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP3K6 mRNA]	PMID:31150632
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1312171	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in increased expression of MAP3K6 mRNA	PMID:33227293
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP3K6 mRNA	PMID:20938992
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MAP3K6 mRNA	PMID:33167477
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1304625	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of MAP3K6 mRNA	PMID:20488242
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15368	acrolein	increases expression	ISO	RGD:1304625	E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein results in increased expression of MAP3K6 mRNA	PMID:38090360
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1304625	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MAP3K6 mRNA	PMID:33729688
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MAP3K6 mRNA	PMID:30529165
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MAP3K6 mRNA	PMID:22378314
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16136	hydrogen sulfide	increases expression	ISO	RGD:1312171	E	RGD:6480464	20200519	CTD	MESH:D006862	Hydrogen Sulfide results in increased expression of MAP3K6 mRNA	PMID:31843631
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312171	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MAP3K6 mRNA	PMID:30319688
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of MAP3K6 mRNA	PMID:29581250
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of MAP3K6 mRNA	PMID:30510588
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MAP3K6 mRNA	PMID:39298647
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312171	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of MAP3K6 mRNA	PMID:19484750
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312171	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of MAP3K6 mRNA	PMID:18978301
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP3K6 mRNA	PMID:20938992
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MAP3K6 gene	PMID:30521419
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAP3K6 mRNA	PMID:37992649
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAP3K6 mRNA	PMID:37992649
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304625	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MAP3K6 mRNA	PMID:33387578
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MAP3K6 mRNA	PMID:28818685
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1312171	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of MAP3K6 mRNA	PMID:39984025
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased expression of MAP3K6 mRNA	PMID:22562489
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAP3K6 mRNA	PMID:37236586
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:230826	AB-Fubinaca	increases expression	ISO	RGD:1304625	E	RGD:6480464	20240507	CTD	MESH:C000615602	AB-FUBINACA results in increased expression of MAP3K6 mRNA	PMID:26517302
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MAP3K6 gene	PMID:28458013
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120501	CTD	MESH:D010126	Ozone results in increased expression of MAP3K6 mRNA	PMID:17095637|PMID:19555225
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAP3K6 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MAP3K6 mRNA; pyrazolanthrone inhibits the reaction [Ozone results in increased expression of MAP3K6 mRNA]	PMID:17460151|PMID:27106289|PMID:34911549
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in decreased expression of MAP3K6 mRNA	PMID:31939706
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304625	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAP3K6 mRNA	PMID:31150632
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312171	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAP3K6 mRNA	PMID:27339419|PMID:31919559
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304625	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP3K6 mRNA]	PMID:31150632
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20180313	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of MAP3K6 mRNA	PMID:26778414
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP3K6 mRNA	PMID:20938992
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of MAP3K6 mRNA	PMID:19654921
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP3K6 mRNA	PMID:40512198
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP3K6 mRNA	PMID:40504410
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304625	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MAP3K6 mRNA	PMID:31881176
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of MAP3K6 mRNA	PMID:23300844
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312171	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of MAP3K6 mRNA	PMID:40618947
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MAP3K6 mRNA	PMID:27392435
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form] results in decreased expression of MAP3K6 mRNA	PMID:23625948
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312171	E	RGD:6480464	20160412	CTD	MESH:D019833	Genistein results in increased expression of MAP3K6 mRNA	PMID:24967385
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312171	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAP3K6 mRNA	PMID:21570461
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAP3K6 mRNA	PMID:26238291
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAP3K6 mRNA	PMID:17035482
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MAP3K6 mRNA	PMID:25975270
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MAP3K6 mRNA	PMID:32763439
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304625	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of MAP3K6 mRNA	PMID:28959563
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MAP3K6 mRNA	PMID:30911355
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120918	CTD	MESH:D004317	Doxorubicin results in increased expression of MAP3K6 mRNA	PMID:21040762|PMID:39631538
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20120918	CTD	MESH:D004317	[[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of MAP3K6 mRNA	PMID:21040762
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAP3K6 mRNA	PMID:37992649
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:28940	calciol	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in decreased expression of MAP3K6 mRNA	PMID:16508948
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of MAP3K6 mRNA	PMID:34032870
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP3K6 mRNA	PMID:40512198
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP3K6 mRNA	PMID:40504410
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MAP3K6 promoter	PMID:27901495
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAP3K6 protein	PMID:32717239
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1304625	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAP3K6 mRNA	PMID:21839799
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAP3K6 mRNA	PMID:26238291|PMID:32234424
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120717	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAP3K6 mRNA	PMID:20504355|PMID:21569818
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MAP3K6 mRNA	PMID:30911355
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MAP3K6 mRNA	PMID:26238291
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312171	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MAP3K6 mRNA	PMID:35676786
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:30778	gallic acid	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of MAP3K6 mRNA	PMID:34408198
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1304625	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of MAP3K6 mRNA	PMID:32479839
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of MAP3K6 mRNA	PMID:19464567|PMID:23557971
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312171	E	RGD:6480464	20130611	CTD	MESH:C009495	titanium dioxide results in increased expression of MAP3K6 mRNA	PMID:27760801
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312171	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MAP3K6 gene	PMID:35295148
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304625	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MAP3K6 mRNA	PMID:23411599|PMID:34492290
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MAP3K6 mRNA	PMID:18445702
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312171	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MAP3K6 mRNA	PMID:28472532
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1304625	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of MAP3K6 mRNA	PMID:19167457
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304625	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MAP3K6 mRNA	PMID:32145629|PMID:34947998
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304625	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MAP3K6 mRNA	PMID:25181051
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312171	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MAP3K6 mRNA	PMID:32156529
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP3K6 mRNA	PMID:28628672
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312171	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MAP3K6 gene	PMID:31683443
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312171	E	RGD:6480464	20240206	CTD	MESH:C543008	bisphenol S results in increased expression of MAP3K6 mRNA	PMID:37611474
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312171	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of MAP3K6 exon; bisphenol S results in increased methylation of MAP3K6 promoter	PMID:33297965
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312171	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MAP3K6 mRNA	PMID:26377693
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MAP3K6 mRNA	PMID:38685157
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K6 mRNA	PMID:28628672
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1304625	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of MAP3K6 mRNA	PMID:22546817
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304625	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MAP3K6 mRNA	PMID:21266533
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1304625	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of MAP3K6 mRNA	PMID:22546817
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP3K6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K6 mRNA	PMID:28628672
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20180313	CTD	MESH:D004052	[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in increased expression of MAP3K6 mRNA	PMID:26778414
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in increased expression of MAP3K6 mRNA	PMID:12595580|PMID:21463325
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MAP3K6 mRNA	PMID:37042841
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312171	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MAP3K6 mRNA	PMID:26377693
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304625	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MAP3K6 mRNA	PMID:30723492
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MAP3K6 mRNA	PMID:38174414
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304625	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MAP3K6 mRNA	PMID:33453195
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MAP3K6 mRNA	PMID:38382870
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAP3K6 mRNA	PMID:37236586
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304625	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of MAP3K6 mRNA	PMID:25539665|PMID:26194646
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312171	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of MAP3K6 mRNA	PMID:28903501
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MAP3K6 mRNA	PMID:24449571
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312171	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of MAP3K6 mRNA	PMID:18353800
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1312171	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of MAP3K6 mRNA	PMID:29038090
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312171	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of MAP3K6 mRNA	PMID:23125180
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of MAP3K6 mRNA	PMID:21427059
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MAP3K6 gene	PMID:29154799
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312171	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of MAP3K6 mRNA	PMID:22733784
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP3K6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K6 mRNA	PMID:28628672
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAP3K6 mRNA	PMID:37992649
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of MAP3K6 mRNA	PMID:18502557
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of MAP3K6 mRNA	PMID:24449571
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of MAP3K6 mRNA	PMID:24935251
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAP3K6 mRNA	PMID:17562736
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304625	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of MAP3K6 mRNA	PMID:32479839|PMID:33387578
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of MAP3K6 mRNA	PMID:19420014
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of MAP3K6 mRNA	PMID:17331233
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of MAP3K6 promoter	PMID:29626692
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of MAP3K6 promoter	PMID:29626692
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:46680	serpentine asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of MAP3K6 promoter	PMID:29626692
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of MAP3K6 mRNA	PMID:19654921
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP3K6 mRNA	PMID:40512198
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP3K6 mRNA	PMID:40504410
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of MAP3K6 mRNA	PMID:30529165
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of MAP3K6 mRNA	PMID:30529165
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of MAP3K6 mRNA	PMID:17441966
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MAP3K6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MAP3K6 mRNA	PMID:28628672
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312171	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MAP3K6 mRNA	PMID:35676786
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of MAP3K6 mRNA	PMID:23300844
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304625	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of MAP3K6 mRNA	PMID:30307764
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312171	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of MAP3K6 mRNA; Nanotubes, Carbon analog affects the expression of MAP3K6 mRNA	PMID:25554681
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312171	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MAP3K6 mRNA; Nanotubes, Carbon results in increased expression of MAP3K6 mRNA	PMID:25620056
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:50845	doxycycline	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20120412	CTD	MESH:D004318	Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MAP3K6 mRNA]	PMID:18089841
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304625	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of MAP3K6 mRNA	PMID:24793618
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:52492	mancozeb	increases expression	ISO	RGD:1312171	E	RGD:6480464	20230905	CTD	MESH:C013099	mancozeb results in increased expression of MAP3K6 mRNA	PMID:36007320
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312171	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of MAP3K6 mRNA	PMID:19042947
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	decreases expression	ISO	RGD:1304625	E	RGD:6480464	20150512	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in decreased expression of MAP3K6 mRNA	PMID:23537331
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MAP3K6 mRNA	PMID:15336504
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of MAP3K6 mRNA	PMID:25234470
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312171	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of MAP3K6 mRNA	PMID:36851058
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in decreased expression of MAP3K6 mRNA	PMID:16982809
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312171	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of MAP3K6 mRNA	PMID:18089841|PMID:20003209
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20120515	CTD	MESH:D007545	Doxycycline inhibits the reaction [Isoproterenol results in increased expression of MAP3K6 mRNA]	PMID:18089841
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1304625	E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of MAP3K6 mRNA	PMID:28935588
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312171	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of MAP3K6 mRNA	PMID:31052254
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MAP3K6 mRNA	PMID:37199045
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1304625	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in increased expression of MAP3K6 mRNA	PMID:20097248
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MAP3K6 mRNA	PMID:19159669
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1304625	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MAP3K6 mRNA	PMID:27291303
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312171	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MAP3K6 mRNA	PMID:39847705
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304625	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MAP3K6 mRNA	PMID:24780913
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1312171	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [Ozone results in increased expression of MAP3K6 mRNA]	PMID:17460151
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304625	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MAP3K6 mRNA	PMID:21346803
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MAP3K6 mRNA	PMID:38568856
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MAP3K6 mRNA	PMID:29301935
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MAP3K6 mRNA	PMID:27188386
1312170	MAP3K6	mitogen-activated protein kinase kinase kinase 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304625	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MAP3K6 mRNA	PMID:21346803
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C018475	butyraldehyde results in decreased expression of CCSER2 mRNA	PMID:26079696
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1304626	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of CCSER2 mRNA	PMID:36841081
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20150127	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of CCSER2 protein	PMID:18951874
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551286	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CCSER2 mRNA	PMID:39241906
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1551286	E	RGD:6480464	20140715	CTD	MESH:D004958	Estradiol results in decreased expression of CCSER2 mRNA	PMID:19484750
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CCSER2 mRNA	PMID:38568856
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304626	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CCSER2 mRNA	PMID:33387578
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CCSER2 mRNA	PMID:37042841
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1551286	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CCSER2 mRNA	PMID:34319233
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304626	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CCSER2 mRNA	PMID:33387578
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CCSER2 mRNA	PMID:28818685
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCSER2 mRNA	PMID:35301059
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1551286	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CCSER2 mRNA	PMID:19770486
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CCSER2 mRNA	PMID:23649840
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CCSER2 mRNA	PMID:18593933
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CCSER2 mRNA	PMID:22206623
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:27563	arsenic atom	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D001151	Arsenic results in increased expression of CCSER2 mRNA alternative form	PMID:42191081
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:27563	arsenic atom	increases response to substance	EXP		E	RGD:6480464	20260804	CTD	MESH:D001151	CCSER2 mRNA alternative form results in increased susceptibility to Arsenic	PMID:42191081
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D001151	[CCSER2 mRNA alternative form results in increased susceptibility to Arsenic] which results in increased expression of PIK3CA mRNA	PMID:42191081
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCSER2 mRNA	PMID:40504410
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CCSER2 mRNA	PMID:19244175
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CCSER2 protein	PMID:35688186
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of CCSER2 mRNA	PMID:28903495
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1551286	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of CCSER2 mRNA	PMID:18930951
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304626	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCSER2 mRNA	PMID:34747641
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551286	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCSER2 mRNA	PMID:21570461
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304626	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCSER2 mRNA	PMID:32109520|PMID:33387578
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1551286	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCSER2 mRNA	PMID:15034205|PMID:21354282
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CCSER2 mRNA]	PMID:15034205
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20150127	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of CCSER2 protein	PMID:18951874
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CCSER2 mRNA	PMID:33212167
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of CCSER2 mRNA	PMID:39709020
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CCSER2 mRNA	PMID:29803840
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CCSER2 mRNA	PMID:38568856
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCSER2 mRNA	PMID:40504410
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551286	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCSER2 mRNA	PMID:15034205|PMID:21715664
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCSER2 5' UTR; Benzo(a)pyrene results in increased methylation of CCSER2 promoter	PMID:27901495
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of CCSER2 mRNA]	PMID:15034205
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CCSER2 mRNA]	PMID:32406909
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CCSER2 mRNA	PMID:18593933
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1304626	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of CCSER2 mRNA	PMID:32479839
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304626	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of CCSER2 mRNA	PMID:30816183
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304626	E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in decreased expression of CCSER2 mRNA	PMID:25181051
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304626	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of CCSER2 mRNA	PMID:29097150|PMID:41034487
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1304626	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of CCSER2 gene	PMID:33148267
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CCSER2 mRNA	PMID:37042841
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1304626	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of CCSER2 mRNA	PMID:30589522
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCSER2 mRNA	PMID:35301059
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CCSER2 mRNA	PMID:19376846
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CCSER2 mRNA	PMID:24449571
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CCSER2 mRNA	PMID:19244175
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CCSER2 mRNA	PMID:31533062
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1304626	E	RGD:6480464	20140715	CTD	MESH:D002737	Chloroprene results in increased expression of CCSER2 mRNA	PMID:23125180
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304626	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of CCSER2 mRNA	PMID:29427782
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of CCSER2 mRNA	PMID:28001369|PMID:29154799
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CCSER2 gene	PMID:29154799
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D016572	Cyclosporine results in increased expression of CCSER2 mRNA	PMID:20106945|PMID:25562108
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1551286	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CCSER2 mRNA	PMID:28973697
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of CCSER2 mRNA	PMID:21420995|PMID:29067470
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304626	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CCSER2 mRNA	PMID:33387578
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:47217	arsane	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D001151	Arsenic results in increased expression of CCSER2 mRNA alternative form	PMID:42191081
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:47217	arsane	increases response to substance	EXP		E	RGD:6480464	20260804	CTD	MESH:D001151	CCSER2 mRNA alternative form results in increased susceptibility to Arsenic	PMID:42191081
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:D001151	[CCSER2 mRNA alternative form results in increased susceptibility to Arsenic] which results in increased expression of PIK3CA mRNA	PMID:42191081
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCSER2 mRNA	PMID:40504410
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCSER2 mRNA	PMID:22079256
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304626	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CCSER2 mRNA	PMID:29097150
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of CCSER2 mRNA	PMID:23228038
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1304626	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of CCSER2 mRNA	PMID:30307764
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1551286	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CCSER2 mRNA; Nanotubes, Carbon results in decreased expression of CCSER2 mRNA	PMID:25554681
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CCSER2 mRNA	PMID:28988120
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1304626	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of CCSER2 gene	PMID:33148267
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CCSER2 mRNA	PMID:31758290
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1551286	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of CCSER2 mRNA	PMID:22206623
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551286	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CCSER2 mRNA	PMID:22206623
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CCSER2 mRNA	PMID:22079256
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CCSER2 mRNA	PMID:22079256
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1551286	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CCSER2 mRNA	PMID:23091169
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304626	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CCSER2 mRNA	PMID:32109520
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1551286	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of CCSER2 mRNA	PMID:21795629
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CCSER2 mRNA	PMID:38568856
1312172	CCSER2	coiled-coil serine rich protein 2	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of CCSER2 mRNA	PMID:29301935
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:10138	[6]-Shogaol	increases expression	ISO	RGD:1549990	E	RGD:6480464	20141111	CTD	MESH:C040115	[shogaol results in increased expression of BDNF protein] which results in increased expression of CHAT protein; shogaol results in increased expression of CHAT protein	PMID:22381256
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:10138	[6]-Shogaol	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20141111	CTD	MESH:C040115	[shogaol co-treated with Hydrogen Peroxide] results in increased expression of CHAT protein; shogaol inhibits the reaction [Hydrogen Peroxide results in decreased expression of CHAT protein]; staurosporine aglycone inhibits the reaction [[shogaol co-treated with Hydrogen Peroxide] results in increased expression of CHAT protein]	PMID:22381256
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:116314	oleamide	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C029407	oleylamide results in increased activity of CHAT protein	PMID:12843655
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D014212	Tretinoin results in decreased expression of CHAT protein	PMID:36805303
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D014212	Tretinoin results in increased expression of CHAT mRNA	PMID:38070836
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of CHAT mRNA; Tretinoin results in increased expression of CHAT protein	PMID:17203487|PMID:19135036
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:D014212	anatoxin a promotes the reaction [Tretinoin results in increased expression of CHAT mRNA]	PMID:38070836
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D014212	[Bucladesine co-treated with Tretinoin] results in increased activity of CHAT protein; [Tretinoin co-treated with Bucladesine] results in increased activity of CHAT protein	PMID:16724269|PMID:29665406
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of CHAT mRNA	PMID:26079696
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:15891	taurine	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20151013	CTD	MESH:D013654	Taurine inhibits the reaction [Manganese results in decreased activity of CHAT protein]	PMID:24885898
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20141014	CTD	MESH:D008628	Mercury results in decreased expression of CHAT mRNA	PMID:7781173
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20121113	CTD	MESH:D000431	Ethanol results in decreased expression of CHAT mRNA; Ethanol results in decreased expression of CHAT protein	PMID:17045751|PMID:19100286
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20230502	CTD	MESH:D000431	Ethanol results in decreased expression of CHAT mRNA	PMID:35863473
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D000431	Cyanamide affects the reaction [Ethanol results in decreased expression of CHAT mRNA]; Cyanamide affects the reaction [Ethanol results in decreased expression of CHAT protein]	PMID:17045751
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of CHAT mRNA; Ethanol promotes the reaction [Dietary Fats results in decreased expression of CHAT mRNA]	PMID:30319688|PMID:35863473
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20121009	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of CHAT protein	PMID:22381256
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20121009	CTD	MESH:D006861	[shogaol co-treated with Hydrogen Peroxide] results in increased expression of CHAT protein; shogaol inhibits the reaction [Hydrogen Peroxide results in decreased expression of CHAT protein]; staurosporine aglycone inhibits the reaction [[shogaol co-treated with Hydrogen Peroxide] results in increased expression of CHAT protein]	PMID:22381256
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20170110	CTD	MESH:D011794	Quercetin inhibits the reaction [Cadmium Chloride results in decreased expression of CHAT mRNA]; Quercetin inhibits the reaction [Cadmium Chloride results in decreased expression of CHAT protein]	PMID:27389774
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CHAT mRNA	PMID:30510588
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid inhibits the reaction [aluminum chloride results in decreased expression of CHAT protein]	PMID:18482095
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16494	lipoic acid	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D008063	[Thioctic Acid co-treated with Pilocarpine] results in increased activity of CHAT protein	PMID:19669875
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16675	quinolinic acid	decreases activity	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D017378	Quinolinic Acid results in decreased activity of CHAT protein	PMID:2976130
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16675	quinolinic acid	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D017378	Dizocilpine Maleate inhibits the reaction [Quinolinic Acid results in decreased activity of CHAT protein]	PMID:2976130
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16698	cyanamide	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D003484	Cyanamide affects the reaction [Ethanol results in decreased expression of CHAT mRNA]; Cyanamide affects the reaction [Ethanol results in decreased expression of CHAT protein]	PMID:17045751
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20250114	CTD	MESH:D001554	Benzene results in decreased expression of CHAT mRNA	PMID:37084897
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16794	scopolamine	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D012601	Scopolamine results in decreased activity of CHAT protein	PMID:20694781
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16794	scopolamine	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20151110	CTD	MESH:D012601	Scopolamine results in decreased activity of CHAT protein	PMID:26408985|PMID:29133030
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16794	scopolamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012601	kangshuai yizhi inhibits the reaction [Scopolamine results in decreased activity of CHAT protein]	PMID:20694781
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:16794	scopolamine	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20151110	CTD	MESH:D012601	protopanaxadiol inhibits the reaction [Scopolamine results in decreased activity of CHAT protein]; Serotonin analog inhibits the reaction [Scopolamine results in decreased activity of CHAT protein]	PMID:26408985|PMID:29133030
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone inhibits the reaction [VPS54 gene mutant form results in decreased activity of CHAT protein]; Progesterone inhibits the reaction [VPS54 gene mutant form results in decreased expression of CHAT protein]; Progesterone inhibits the reaction [VPS54 mutant form results in decreased expression of CHAT protein]	PMID:17052708|PMID:19693665
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1304627	E	RGD:6480464	20120918	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of CHAT mRNA	PMID:21145954
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20130312	CTD	MESH:C040048	caffeic acid inhibits the reaction [aluminum chloride results in decreased expression of CHAT protein]	PMID:18482095
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:176788	dizocilpine maleate	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20210803	CTD	MESH:D016291	Dizocilpine Maleate inhibits the reaction [Quinolinic Acid results in decreased activity of CHAT protein]	PMID:2976130
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:17688	(S)-nicotine	decreases activity	ISO	RGD:1304627	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased activity of CHAT protein	PMID:21633116
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:17688	(S)-nicotine	increases activity	ISO	RGD:1304627	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased activity of CHAT protein	PMID:21633116|PMID:30247698
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [Vanadium results in decreased expression of CHAT protein]; Nicotine promotes the reaction [Bucladesine results in increased expression of CHAT protein]	PMID:20361958|PMID:22119111
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20150609	CTD	MESH:D024502	[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein; Tobacco Smoke Pollution inhibits the reaction [[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein]	PMID:25891525
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:18291	manganese atom	decreases activity	ISO	RGD:1304627	E	RGD:6480464	20151013	CTD	MESH:D008345	Manganese results in decreased activity of CHAT protein	PMID:24885898
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20151013	CTD	MESH:D008345	Taurine inhibits the reaction [Manganese results in decreased activity of CHAT protein]	PMID:24885898
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20190910	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased activity of CHAT protein	PMID:30738988
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:18723	nicotine	decreases activity	ISO	RGD:1304627	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased activity of CHAT protein	PMID:21633116
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:18723	nicotine	increases activity	ISO	RGD:1304627	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased activity of CHAT protein	PMID:21633116|PMID:30247698
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [Vanadium results in decreased expression of CHAT protein]; Nicotine promotes the reaction [Bucladesine results in increased expression of CHAT protein]	PMID:20361958|PMID:22119111
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:201674	icaritin	increases expression	ISO	RGD:1549990	E	RGD:6480464	20231219	CTD	MESH:C499403	icaritin results in increased expression of CHAT protein	PMID:19135036
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D001374	Azacitidine results in increased expression of CHAT mRNA; Azacitidine results in increased expression of CHAT protein	PMID:19151599
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of CHAT mRNA	PMID:24376830
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20200714	CTD	MESH:D002104	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of CHAT mRNA	PMID:31904401
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:24527	herbicide	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20200804	CTD	MESH:D006540	Herbicides results in decreased expression of CHAT protein	PMID:31991143
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:24848	inositol	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20170303	CTD	MESH:D007294	Inositol inhibits the reaction [Streptozocin affects the localization of CHAT protein]	PMID:2431858
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304627	E	RGD:6480464	20151215	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CHAT mRNA	PMID:26260870
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20141014	CTD	MESH:D008628	Mercury results in decreased expression of CHAT mRNA	PMID:7781173
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:2663	amiodarone	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20150714	CTD	MESH:D000638	Amiodarone results in decreased expression of CHAT protein	PMID:25659768
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:2666	amitriptyline	increases expression	ISO	RGD:1304627	E	RGD:6480464	20120613	CTD	MESH:D000639	Amitriptyline results in increased expression of CHAT mRNA	PMID:21820738
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:2706	Anatoxin a	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:C509783	anatoxin a promotes the reaction [Tretinoin results in increased expression of CHAT mRNA]	PMID:38070836
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:27086	tributylstannane	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:C011559	tributyltin results in decreased activity of CHAT protein	PMID:9015740
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of CHAT mRNA; Arsenic results in decreased expression of CHAT protein	PMID:37624150
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of CHAT protein	PMID:37624150
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:27698	vanadium atom	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of CHAT protein	PMID:22119111
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:27698	vanadium atom	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20121009	CTD	MESH:D014639	Nicotine inhibits the reaction [Vanadium results in decreased expression of CHAT protein]	PMID:22119111
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1304627	E	RGD:6480464	20150310	CTD	MESH:C059514	resveratrol results in increased expression of CHAT protein	PMID:23075401
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CHAT mRNA	PMID:23557933
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:27928	parathion	affects expression	ISO	RGD:1304627	E	RGD:6480464	20120515	CTD	MESH:D010278	Parathion affects the expression of CHAT protein	PMID:18941570|PMID:19590683
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20170516	CTD	MESH:D010278	Parathion results in decreased expression of CHAT protein	PMID:20015457
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:27928	parathion	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20120515	CTD	MESH:D010278	Dietary Fats affects the reaction [Parathion affects the expression of CHAT protein]	PMID:19590683
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:27953	physostigmine	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20120814	CTD	MESH:D010830	Physostigmine results in decreased expression of CHAT protein	PMID:22640809
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:27953	physostigmine	increases expression	ISO	RGD:1304627	E	RGD:6480464	20120814	CTD	MESH:D010830	Physostigmine results in increased expression of CHAT protein	PMID:22640809
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1549990	E	RGD:6480464	20230404	CTD	MESH:D003042	Cocaine results in increased expression of CHAT protein	PMID:35597300
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28061	alpha-D-galactose	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20140805	CTD	MESH:D005690	Galactose results in decreased activity of CHAT protein	PMID:23612000
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28061	alpha-D-galactose	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20140805	CTD	MESH:D005690	catalpol inhibits the reaction [Galactose results in decreased activity of CHAT protein]	PMID:23612000
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHAT mRNA	PMID:32109520
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28197	daidzein	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C004742	daidzein results in increased activity of CHAT protein	PMID:16428827
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20231003	CTD	MESH:D012402	Rotenone results in decreased expression of CHAT protein	PMID:35919817
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28260	galactose	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20140311	CTD	MESH:D005690	Galactose results in decreased activity of CHAT protein	PMID:23612000
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28260	galactose	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20140311	CTD	MESH:D005690	catalpol inhibits the reaction [Galactose results in decreased activity of CHAT protein]	PMID:23612000
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28527	rutin	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20230801	CTD	MESH:D012431	Rutin inhibits the reaction [Acrylamide results in decreased expression of CHAT protein]	PMID:36657526
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28619	acrylamide	decreases activity	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D020106	Acrylamide results in decreased activity of CHAT protein	PMID:11779407
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CHAT mRNA; Acrylamide results in decreased expression of CHAT protein	PMID:28959563|PMID:36657526
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of CHAT mRNA	PMID:30807115
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28619	acrylamide	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D020106	NTF3 protein inhibits the reaction [Acrylamide results in decreased activity of CHAT protein]; Rutin inhibits the reaction [Acrylamide results in decreased expression of CHAT protein]	PMID:11779407|PMID:36657526
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28680	cytarabine	increases activity	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D003561	Cytarabine results in increased activity of CHAT protein	PMID:2900045
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28748	doxorubicin	affects methylation	ISO	RGD:1304627	E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of CHAT gene	PMID:28962528
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of CHAT mRNA	PMID:39631538
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28790	serotonin	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20151110	CTD	MESH:D012701	Serotonin analog inhibits the reaction [Scopolamine results in decreased activity of CHAT protein]	PMID:26408985
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28939	N-acetyl-L-cysteine	increases expression	ISO	RGD:1304627	E	RGD:6480464	20150609	CTD	MESH:D000111	Acetylcysteine results in increased expression of CHAT protein	PMID:25891525
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20150609	CTD	MESH:D000111	[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein; Tobacco Smoke Pollution inhibits the reaction [[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein]	PMID:25891525
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28984	aluminium atom	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in decreased activity of CHAT protein	PMID:16724269
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28984	aluminium atom	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in decreased expression of CHAT protein	PMID:16928369
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:28984	aluminium atom	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D000535	APP protein promotes the reaction [Aluminum results in decreased activity of CHAT protein]; meloxicam inhibits the reaction [Aluminum results in decreased expression of CHAT protein]	PMID:16724269|PMID:16928369
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20150609	CTD	MESH:D001205	[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein; Tobacco Smoke Pollution inhibits the reaction [[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein]	PMID:25891525
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CHAT protein	PMID:21839772|PMID:24517892|PMID:30051311
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:29678	sodium arsenite	increases activity	ISO	RGD:1549990	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased activity of CHAT protein	PMID:3437937
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CHAT mRNA	PMID:38568856
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20161228	CTD	MESH:C017947	Curcumin inhibits the reaction [sodium arsenite results in decreased expression of CHAT protein]	PMID:21839772
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHAT promoter	PMID:27901495
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20170516	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CHAT protein	PMID:28049045
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases activity	ISO	RGD:1304627	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene results in increased activity of CHAT protein	PMID:30247698
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CHAT exon	PMID:27901495
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CHAT promoter	PMID:23974009
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:30314	(R)-lipoic acid	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D008063	[Thioctic Acid co-treated with Pilocarpine] results in increased activity of CHAT protein	PMID:19669875
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:3093	bifenthrin	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20181113	CTD	MESH:C099952	bifenthrin results in decreased expression of CHAT mRNA	PMID:29775722
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CHAT mRNA	PMID:16483693
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CHAT gene	PMID:31601247
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CHAT gene	PMID:31601247
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of CHAT mRNA	PMID:23411599
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of CHAT protein	PMID:31675489
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CHAT mRNA	PMID:25181051
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of CHAT mRNA	PMID:32365465|PMID:34655688
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304627	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CHAT gene	PMID:28505145
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CHAT gene	PMID:31601247
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20220705	CTD	MESH:C006780	bisphenol A results in decreased expression of and results in decreased activity of CHAT protein; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of CHAT protein]	PMID:34655688
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CHAT protein	PMID:31675489
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20230704	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CHAT protein	PMID:35950316
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:33629	aluminium(0)	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in decreased activity of CHAT protein	PMID:16724269
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:33629	aluminium(0)	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in decreased expression of CHAT protein	PMID:16928369
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:33629	aluminium(0)	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D000535	APP protein promotes the reaction [Aluminum results in decreased activity of CHAT protein]; meloxicam inhibits the reaction [Aluminum results in decreased expression of CHAT protein]	PMID:16724269|PMID:16928369
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of CHAT gene	PMID:31601247
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:34631	chlorpyrifos	affects activity	ISO	RGD:1549990	E	RGD:6480464	20210112	CTD	MESH:D004390	Chlorpyrifos affects the activity of CHAT protein	PMID:33007016
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20120613	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CHAT mRNA	PMID:17452286|PMID:18812211
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:34631	chlorpyrifos	increases activity	ISO	RGD:1549990	E	RGD:6480464	20210112	CTD	MESH:D004390	Chlorpyrifos results in increased activity of CHAT protein	PMID:33007016
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20151215	CTD	MESH:D004390	CHAT protein affects the reaction [Chlorpyrifos results in increased expression of ACHE mRNA]	PMID:26210949
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:34682	diazinon	decreases activity	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon results in decreased activity of CHAT protein	PMID:16675431
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:34682	diazinon	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon results in decreased expression of CHAT mRNA	PMID:17452286|PMID:18812211|PMID:29108742
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:34690	dichlorvos	increases activity	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D004006	Dichlorvos results in increased activity of CHAT protein	PMID:17722737
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of CHAT mRNA	PMID:19542621
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:34905	paraquat	decreases activity	ISO	RGD:1304627	E	RGD:6480464	20150310	CTD	MESH:D010269	Paraquat results in decreased activity of CHAT protein	PMID:24521700
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20171114	CTD	MESH:D010269	Paraquat results in decreased expression of CHAT mRNA	PMID:28916328
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin co-treated with DEET] results in increased activity of CHAT protein	PMID:11248143
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:35154	manganese(0)	decreases activity	ISO	RGD:1304627	E	RGD:6480464	20151013	CTD	MESH:D008345	Manganese results in decreased activity of CHAT protein	PMID:24885898
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20151013	CTD	MESH:D008345	Taurine inhibits the reaction [Manganese results in decreased activity of CHAT protein]	PMID:24885898
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20190910	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased activity of CHAT protein	PMID:30738988
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:35170	vanadium(0)	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of CHAT protein	PMID:22119111
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:35170	vanadium(0)	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20121009	CTD	MESH:D014639	Nicotine inhibits the reaction [Vanadium results in decreased expression of CHAT protein]	PMID:22119111
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20141223	CTD	MESH:D019256	Cadmium Chloride results in decreased activity of CHAT protein	PMID:25201352
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20170110	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CHAT mRNA; Cadmium Chloride results in decreased expression of CHAT protein	PMID:27389774
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20170110	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CHAT protein	PMID:27377441
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20170110	CTD	MESH:D019256	Quercetin inhibits the reaction [Cadmium Chloride results in decreased expression of CHAT mRNA]; Quercetin inhibits the reaction [Cadmium Chloride results in decreased expression of CHAT protein]	PMID:27389774
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20170110	CTD	MESH:D019256	[[Cadmium Chloride results in decreased activity of CHRM1 protein] which affects the expression of ACHE mRNA alternative form] which results in decreased expression of CHAT protein; [Cadmium Chloride results in decreased activity of CHRM1 protein] which results in decreased expression of CHAT protein; [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of CHAT mRNA; ACHE mRNA promotes the reaction [Cadmium Chloride results in decreased expression of CHAT protein]; CHRM1 mRNA inhibits the reaction [Cadmium Chloride results in decreased expression of CHAT protein]	PMID:27377441|PMID:31904401
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20200714	CTD	MESH:D013755	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of CHAT mRNA	PMID:31904401
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:39178	clothianidin	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20230905	CTD	MESH:C480342	clothianidin results in decreased expression of CHAT mRNA	PMID:35264496
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases activity	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased activity of CHAT protein	PMID:12773772
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20121009	CTD	MESH:D003474	Curcumin inhibits the reaction [sodium arsenite results in decreased expression of CHAT protein]	PMID:21839772
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CHAT mRNA	PMID:30047161
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:4034	cyfluthrin	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20160210	CTD	MESH:C052570	cyfluthrin results in decreased expression of CHAT protein	PMID:26604153
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20190312	CTD	MESH:C017160	cypermethrin results in decreased expression of CHAT mRNA; cypermethrin results in decreased expression of CHAT protein	PMID:26115703
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20180703	CTD	MESH:D003907	Dexamethasone results in decreased expression of CHAT protein	PMID:29524569
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:43931	methyllycaconitine	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C054634	methyllycaconitine inhibits the reaction [SLURP1 protein results in increased expression of CHAT]	PMID:24365495
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:44485	N-ethylmaleimide	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20121218	CTD	MESH:D005033	Ethylmaleimide results in decreased activity of CHAT protein	PMID:3437937
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:45980	tacrine	increases expression	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D013619	Tacrine results in increased expression of CHAT protein	PMID:15990178
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of CHAT mRNA; Arsenic results in decreased expression of CHAT protein	PMID:37624150
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of CHAT protein	PMID:37624150
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of CHAT mRNA	PMID:31675489
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:48765	dimethylarsinic acid	increases activity	ISO	RGD:1549990	E	RGD:6480464	20121218	CTD	MESH:D002101	Cacodylic Acid results in increased activity of CHAT protein	PMID:21440049
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:50095	bucladesine	increases expression	ISO	RGD:1304627	E	RGD:6480464	20121218	CTD	MESH:D003994	Bucladesine results in increased expression of CHAT protein	PMID:20361958
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20121218	CTD	MESH:D003994	Nicotine promotes the reaction [Bucladesine results in increased expression of CHAT protein]	PMID:20361958
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D003994	[Bucladesine co-treated with Tretinoin] results in increased activity of CHAT protein; [Tretinoin co-treated with Bucladesine] results in increased activity of CHAT protein	PMID:16724269|PMID:29665406
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:50648	9-cis-retinoic acid	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C103303	Alitretinoin results in decreased expression of CHAT protein	PMID:36805303
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CHAT mRNA	PMID:30047161
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1304627	E	RGD:6480464	20250114	CTD	MESH:C082359	imidacloprid results in increased expression of CHAT mRNA	PMID:39002876
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:6015	isoflurane	decreases activity	ISO	RGD:1304627	E	RGD:6480464	20211207	CTD	MESH:D007530	Isoflurane results in decreased activity of CHAT protein	PMID:28084090
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:6015	isoflurane	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20211207	CTD	MESH:D007530	rhodioloside inhibits the reaction [Isoflurane results in decreased activity of CHAT protein]	PMID:28084090
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20190910	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased activity of CHAT protein	PMID:30738988
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:6741	meloxicam	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20140107	CTD	MESH:C065757	meloxicam inhibits the reaction [Aluminum results in decreased expression of CHAT protein]	PMID:16928369
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:67988	ginsenoside Rd	increases expression	ISO	RGD:1549990	E	RGD:6480464	20140408	CTD	MESH:C049863	ginsenoside Rd results in increased expression of CHAT mRNA; ginsenoside Rd results in increased expression of CHAT protein	PMID:24599032
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:67988	ginsenoside Rd	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20140408	CTD	MESH:C049863	staurosporine aglycone inhibits the reaction [ginsenoside Rd results in increased expression of CHAT mRNA]; staurosporine aglycone inhibits the reaction [ginsenoside Rd results in increased expression of CHAT protein]	PMID:24599032
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:6809	methamphetamine	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D008694	Methamphetamine results in decreased activity of CHAT protein	PMID:10089005
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:69797	catalpol	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20141111	CTD	MESH:C078040	catalpol inhibits the reaction [Galactose results in decreased activity of CHAT protein]	PMID:23612000
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20130409	CTD	MESH:D003671	[Pyridostigmine Bromide co-treated with Permethrin co-treated with DEET] results in increased activity of CHAT protein	PMID:11248143
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:755912	aluminum chloride	decreases activity	ISO	RGD:1304627	E	RGD:6480464	20260714	CTD	MESH:D000077410	Aluminum Chloride results in decreased activity of CHAT protein	PMID:2303807
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:755912	aluminum chloride	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20260714	CTD	MESH:D000077410	Aluminum Chloride results in decreased expression of CHAT protein	PMID:18482095
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:755912	aluminum chloride	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20260714	CTD	MESH:D000077410	caffeic acid inhibits the reaction [Aluminum Chloride results in decreased expression of CHAT protein]	PMID:18482095
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:75701	sarin	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of CHAT protein	PMID:22640809
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:7596	nitroprusside	decreases activity	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D009599	Nitroprusside results in decreased activity of CHAT protein	PMID:16724269
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:7596	nitroprusside	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20120412	CTD	MESH:D009599	APP protein promotes the reaction [Nitroprusside results in decreased activity of CHAT protein]	PMID:16724269
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:76237	(20R)-protopanaxadiol	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20180410	CTD	MESH:C062916	protopanaxadiol inhibits the reaction [Scopolamine results in decreased activity of CHAT protein]	PMID:29133030
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CHAT mRNA	PMID:20816883
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:77148	ginsenoside Re	increases expression	ISO	RGD:1549990	E	RGD:6480464	20140408	CTD	MESH:C049864	ginsenoside Re results in increased expression of CHAT mRNA; ginsenoside Re results in increased expression of CHAT protein	PMID:24599032
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:77148	ginsenoside Re	multiple interactions	ISO	RGD:1549990	E	RGD:6480464	20140408	CTD	MESH:C049864	staurosporine aglycone inhibits the reaction [ginsenoside Re results in increased expression of CHAT mRNA]; staurosporine aglycone inhibits the reaction [ginsenoside Re results in increased expression of CHAT protein]	PMID:24599032
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:77149	notoginsenoside R1	increases expression	ISO	RGD:1549990	E	RGD:6480464	20151110	CTD	MESH:C072936	notoginsenoside R1 results in increased expression of CHAT	PMID:25714973
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CHAT gene]	PMID:28238834
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CHAT mRNA	PMID:32109520
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CHAT protein	PMID:31675489
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:8207	(+)-pilocarpine	decreases activity	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in decreased activity of CHAT protein	PMID:19669875|PMID:19932735
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:8207	(+)-pilocarpine	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in decreased expression of CHAT protein	PMID:19941057
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:8207	(+)-pilocarpine	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D010862	[Thioctic Acid co-treated with Pilocarpine] results in increased activity of CHAT protein	PMID:19669875
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CHAT protein	PMID:31675489
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1549990	E	RGD:6480464	20230704	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CHAT protein	PMID:35950316
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20141111	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin co-treated with DEET] results in increased activity of CHAT protein	PMID:11248143
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:8874	rivastigmine	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20210406	CTD	MESH:C072506	Rivastigmine inhibits the reaction [Streptozocin results in decreased expression of CHAT protein]	PMID:32805344
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:9009	Salidroside	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20211207	CTD	MESH:C009172	rhodioloside inhibits the reaction [Isoflurane results in decreased activity of CHAT protein]	PMID:28084090
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:9150	simvastatin	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin inhibits the reaction [ITGAL affects the susceptibility to and affects the activity of CHAT protein]; Simvastatin inhibits the reaction [ITGAL affects the susceptibility to and affects the expression of CHAT mRNA]	PMID:16828882
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:9288	streptozocin	affects localization	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D013311	Streptozocin affects the localization of CHAT protein	PMID:2431858
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:9288	streptozocin	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20210406	CTD	MESH:D013311	Streptozocin results in decreased expression of CHAT protein	PMID:32805344
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1304627	E	RGD:6480464	20120412	CTD	MESH:D013311	Inositol inhibits the reaction [Streptozocin affects the localization of CHAT protein]; Phycocyanin inhibits the reaction [Streptozocin results in decreased expression of CHAT protein]; Rivastigmine inhibits the reaction [Streptozocin results in decreased expression of CHAT protein]	PMID:2431858|PMID:32805344
1312173	CHAT	choline O-acetyltransferase	gene	CHEBI:9449	terbutaline	decreases expression	ISO	RGD:1304627	E	RGD:6480464	20180703	CTD	MESH:D013726	Terbutaline results in decreased expression of CHAT protein	PMID:29524569
1312174	EXOG	exo/endonuclease G	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of EXOG mRNA	PMID:38218311
1312174	EXOG	exo/endonuclease G	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312175	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EXOG mRNA	PMID:33045310
1312174	EXOG	exo/endonuclease G	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312175	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of EXOG mRNA	PMID:20188158
1312174	EXOG	exo/endonuclease G	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of EXOG mRNA	PMID:33167477
1312174	EXOG	exo/endonuclease G	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312175	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of EXOG mRNA	PMID:39298647
1312174	EXOG	exo/endonuclease G	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of EXOG mRNA	PMID:38568856
1312174	EXOG	exo/endonuclease G	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312175	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EXOG mRNA	PMID:34319233
1312174	EXOG	exo/endonuclease G	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304628	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EXOG mRNA	PMID:33387578
1312174	EXOG	exo/endonuclease G	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304628	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of EXOG mRNA	PMID:21396975
1312174	EXOG	exo/endonuclease G	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312175	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EXOG mRNA	PMID:19770486
1312174	EXOG	exo/endonuclease G	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of EXOG mRNA	PMID:23649840
1312174	EXOG	exo/endonuclease G	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312175	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EXOG mRNA	PMID:40504410
1312174	EXOG	exo/endonuclease G	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of EXOG mRNA	PMID:23557933
1312174	EXOG	exo/endonuclease G	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of EXOG mRNA	PMID:27594783
1312174	EXOG	exo/endonuclease G	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of EXOG mRNA	PMID:25583101
1312174	EXOG	exo/endonuclease G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312175	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EXOG mRNA	PMID:21570461
1312174	EXOG	exo/endonuclease G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312175	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EXOG mRNA	PMID:19465110
1312174	EXOG	exo/endonuclease G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312175	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EXOG mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of EXOG mRNA	PMID:17942748|PMID:25975270
1312174	EXOG	exo/endonuclease G	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312175	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of EXOG mRNA	PMID:32937126
1312174	EXOG	exo/endonuclease G	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1304628	E	RGD:6480464	20231205	CTD	MESH:D012402	[EXOG protein co-treated with Rotenone] results in decreased expression of PPARGC1A mRNA; [EXOG protein co-treated with Rotenone] results in decreased expression of PPARGC1A protein; [EXOG protein co-treated with Rotenone] results in decreased expression of SSBP1 protein; EXOG protein inhibits the reaction [Rotenone results in decreased expression of HSF1 protein]; EXOG protein inhibits the reaction [Rotenone results in decreased expression of TFAM mRNA]; EXOG protein inhibits the reaction [Rotenone results in decreased expression of TFAM protein]; EXOG protein inhibits the reaction [Rotenone results in decreased expression of TH protein]; Rotenone affects the expression of and affects the localization of EXOG protein; ZLN005 affects the reaction [Rotenone affects the expression of EXOG protein]	PMID:33515431
1312174	EXOG	exo/endonuclease G	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of EXOG mRNA	PMID:23649840
1312174	EXOG	exo/endonuclease G	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of EXOG mRNA	PMID:21198554
1312174	EXOG	exo/endonuclease G	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EXOG mRNA	PMID:29803840
1312174	EXOG	exo/endonuclease G	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312175	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EXOG mRNA	PMID:40504410
1312174	EXOG	exo/endonuclease G	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EXOG promoter	PMID:27901495
1312174	EXOG	exo/endonuclease G	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EXOG 3' UTR	PMID:27901495
1312174	EXOG	exo/endonuclease G	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312175	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EXOG intron	PMID:27901495
1312174	EXOG	exo/endonuclease G	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D012834	Silver analog results in increased expression of EXOG mRNA; Silver results in increased expression of EXOG mRNA	PMID:24974767
1312174	EXOG	exo/endonuclease G	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312175	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of EXOG mRNA	PMID:27131904
1312174	EXOG	exo/endonuclease G	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of EXOG mRNA	PMID:25351596
1312174	EXOG	exo/endonuclease G	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of EXOG mRNA	PMID:15761015
1312174	EXOG	exo/endonuclease G	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304628	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EXOG mRNA	PMID:34492290
1312174	EXOG	exo/endonuclease G	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304628	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EXOG mRNA	PMID:25181051
1312174	EXOG	exo/endonuclease G	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304628	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of EXOG mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312174	EXOG	exo/endonuclease G	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304628	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of EXOG gene	PMID:28505145
1312174	EXOG	exo/endonuclease G	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304628	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EXOG mRNA	PMID:36041667
1312174	EXOG	exo/endonuclease G	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304628	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EXOG mRNA	PMID:36041667
1312174	EXOG	exo/endonuclease G	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of EXOG intron	PMID:30157460
1312174	EXOG	exo/endonuclease G	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304628	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EXOG mRNA	PMID:36041667
1312174	EXOG	exo/endonuclease G	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312175	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of EXOG mRNA	PMID:37019170
1312174	EXOG	exo/endonuclease G	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312175	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EXOG mRNA	PMID:21266533
1312174	EXOG	exo/endonuclease G	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312175	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of EXOG mRNA	PMID:21266533
1312174	EXOG	exo/endonuclease G	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EXOG mRNA	PMID:37042841
1312174	EXOG	exo/endonuclease G	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304628	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EXOG mRNA	PMID:33453195
1312174	EXOG	exo/endonuclease G	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EXOG mRNA	PMID:19320972
1312174	EXOG	exo/endonuclease G	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of EXOG mRNA	PMID:24449571
1312174	EXOG	exo/endonuclease G	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of EXOG mRNA	PMID:31533062
1312174	EXOG	exo/endonuclease G	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EXOG mRNA	PMID:25979313
1312174	EXOG	exo/endonuclease G	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EXOG mRNA	PMID:23179753
1312174	EXOG	exo/endonuclease G	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312175	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of EXOG mRNA	PMID:28973697
1312174	EXOG	exo/endonuclease G	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of EXOG mRNA	PMID:23649840
1312174	EXOG	exo/endonuclease G	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in decreased expression of EXOG mRNA	PMID:28542535
1312174	EXOG	exo/endonuclease G	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304628	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EXOG mRNA	PMID:33387578
1312174	EXOG	exo/endonuclease G	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312175	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EXOG mRNA	PMID:40504410
1312174	EXOG	exo/endonuclease G	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of EXOG mRNA	PMID:18175754
1312174	EXOG	exo/endonuclease G	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312175	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EXOG mRNA	PMID:17942748
1312174	EXOG	exo/endonuclease G	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312175	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EXOG mRNA	PMID:17942748
1312174	EXOG	exo/endonuclease G	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of EXOG mRNA	PMID:15761015
1312174	EXOG	exo/endonuclease G	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of EXOG intron	PMID:30157460
1312174	EXOG	exo/endonuclease G	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304628	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of EXOG gene	PMID:35440735
1312174	EXOG	exo/endonuclease G	gene	CHEBI:6887	methylphenidate	decreases expression	ISO	RGD:1312175	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in decreased expression of EXOG mRNA	PMID:22470460
1312174	EXOG	exo/endonuclease G	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of EXOG mRNA	PMID:36318118
1312174	EXOG	exo/endonuclease G	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EXOG gene]	PMID:28238834
1312174	EXOG	exo/endonuclease G	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1304628	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of EXOG mRNA	PMID:32109520
1312174	EXOG	exo/endonuclease G	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D012834	Silver analog results in increased expression of EXOG mRNA; Silver results in increased expression of EXOG mRNA	PMID:24974767
1312174	EXOG	exo/endonuclease G	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312175	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of EXOG mRNA	PMID:27131904
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ACER2 mRNA	PMID:38218311
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1304629	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of ACER2 mRNA	PMID:21551480
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1622080	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ACER2 mRNA	PMID:33045310
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ACER2 mRNA	PMID:20188158
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACER2 mRNA	PMID:20938992
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ACER2 mRNA	PMID:33167477
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ACER2 mRNA	PMID:26516004
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304629	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of ACER2 gene	PMID:28931070
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1304629	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of ACER2 mRNA	PMID:32145629
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ACER2 mRNA	PMID:39298647
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1622080	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ACER2 mRNA	PMID:33711761
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACER2 mRNA	PMID:20938992
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACER2 mRNA	PMID:37992649
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1304629	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of ACER2 mRNA	PMID:22967744
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACER2 mRNA	PMID:37992649
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ACER2 mRNA	PMID:28818685
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACER2 mRNA	PMID:36331819
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:2208	purine-6-thiol	increases expression	ISO	RGD:1304629	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of ACER2 mRNA	PMID:23358152
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304629	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ACER2 mRNA	PMID:21396975
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ACER2 mRNA	PMID:32234424
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304629	E	RGD:6480464	20140311	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ACER2 mRNA	PMID:23385219
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:2564	aldrin	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in decreased expression of ACER2 mRNA	PMID:18579281
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of ACER2 mRNA	PMID:19555225
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1304629	E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of ACER2 mRNA	PMID:35737395
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ACER2 mRNA	PMID:34911549
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1304629	E	RGD:6480464	20180703	CTD	MESH:D000638	Amiodarone results in increased expression of ACER2 mRNA	PMID:25580480
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304629	E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ACER2 mRNA	PMID:30723492|PMID:31150632|PMID:33387578
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACER2 mRNA	PMID:20938992
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACER2 mRNA	PMID:40504410
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of ACER2 mRNA	PMID:38460933
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ACER2 mRNA	PMID:38460933
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1304629	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ACER2 mRNA	PMID:25905778
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1304629	E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of ACER2 mRNA	PMID:25905778
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ACER2 mRNA	PMID:27392435
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1622080	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of ACER2 mRNA	PMID:40618947
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ACER2 mRNA	PMID:27392435
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:27903	(2,4,5-trichlorophenoxy)acetic acid	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20130514	CTD	MESH:D015085	2,4,5-Trichlorophenoxyacetic Acid results in decreased expression of ACER2 mRNA	PMID:18579281
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304629	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACER2 mRNA	PMID:34747641
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622080	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACER2 mRNA	PMID:21570461|PMID:26377647
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304629	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACER2 mRNA	PMID:32109520|PMID:33387578
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1622080	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACER2 mRNA	PMID:26290441
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304629	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of ACER2 mRNA	PMID:28374803
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ACER2 mRNA	PMID:30851411
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:28509	chloroethene	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in decreased expression of ACER2 mRNA	PMID:18579281
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1622080	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in increased expression of ACER2 mRNA	PMID:35032568
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ACER2 mRNA	PMID:30031762
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1622080	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of ACER2 mRNA	PMID:39631538
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACER2 mRNA	PMID:37992649
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of ACER2 mRNA	PMID:39719251
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACER2 mRNA	PMID:40504410
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ACER2 promoter	PMID:27901495
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACER2 mRNA	PMID:32234424
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1622080	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACER2 mRNA	PMID:27195522|PMID:32417428
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304629	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of ACER2 mRNA	PMID:24136188
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1304629	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of ACER2 mRNA	PMID:22641619
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1304629	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of ACER2 mRNA	PMID:32479839
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304629	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of ACER2 mRNA	PMID:25729387
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1304629	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACER2 mRNA	PMID:30012374
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACER2 mRNA	PMID:23557971
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622080	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ACER2 gene	PMID:35295148
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304629	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ACER2 mRNA	PMID:34492290
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1622080	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ACER2 mRNA	PMID:18301758|PMID:23811191
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1304629	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ACER2 mRNA	PMID:19167457
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A affects the expression of ACER2 mRNA	PMID:22574217
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ACER2 gene	PMID:31601247
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304629	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ACER2 mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:34947998
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1622080	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ACER2 mRNA	PMID:26063408|PMID:33221593
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ACER2 mRNA	PMID:26682919
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:3423	carmustine	increases expression	ISO	RGD:1304629	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in increased expression of ACER2 mRNA	PMID:16005536
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ACER2 mRNA	PMID:39298647
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1622080	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ACER2 mRNA	PMID:37019170
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ACER2 mRNA	PMID:37042841
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1304629	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of ACER2 mRNA	PMID:30589522
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304629	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ACER2 mRNA	PMID:25993096
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1304629	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ACER2 mRNA	PMID:35163327
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304629	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of ACER2 mRNA	PMID:26194646
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1304629	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ACER2 mRNA	PMID:30047161
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1622080	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ACER2 mRNA	PMID:28903501
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ACER2 mRNA	PMID:31533062
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACER2 mRNA	PMID:36331819
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1304629	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ACER2 mRNA	PMID:23125180
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20190219	CTD	MESH:C017160	cypermethrin results in decreased expression of ACER2 mRNA	PMID:29020013
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ACER2 mRNA	PMID:28973697
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACER2 mRNA	PMID:37992649
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of ACER2 mRNA	PMID:24657277
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1304629	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in increased expression of ACER2 mRNA	PMID:16005536
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ACER2 mRNA	PMID:38832940
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622080	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACER2 mRNA	PMID:17562736
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ACER2 mRNA	PMID:22230336|PMID:29067470
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304629	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of ACER2 mRNA	PMID:32479839|PMID:33387578
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ACER2 mRNA	PMID:29279043
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1622080	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of ACER2 mRNA	PMID:29279043
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:46742	Nutlin-3	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of ACER2 mRNA	PMID:38460933
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ACER2 mRNA	PMID:38460933
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1622080	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACER2 mRNA	PMID:40504410
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of ACER2 mRNA	PMID:30529165
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ACER2 mRNA	PMID:35436446
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ACER2 mRNA	PMID:25554681
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1622080	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ACER2 mRNA	PMID:25620056
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1304629	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of ACER2 mRNA	PMID:23962444
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:50667	mercaptopurine	increases expression	ISO	RGD:1304629	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of ACER2 mRNA	PMID:23358152
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304629	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ACER2 mRNA	PMID:30047161
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304629	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of ACER2 mRNA	PMID:25729387
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1622080	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of ACER2 mRNA	PMID:20003209
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1622080	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ACER2 mRNA	PMID:22206623
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ACER2 mRNA	PMID:30851411
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1304629	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ACER2 mRNA	PMID:27291303
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of ACER2 mRNA	PMID:30458266
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of ACER2 mRNA	PMID:32234424
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1304629	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ACER2 mRNA	PMID:23640034
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304629	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ACER2 mRNA	PMID:24780913
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304629	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of ACER2 mRNA	PMID:25825206|PMID:30047161
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D020123	Sirolimus inhibits the reaction [TP73 protein results in decreased expression of ACER2 mRNA]	PMID:21245298
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1304629	E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of ACER2 mRNA	PMID:25905778
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	ISO	RGD:1304629	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of ACER2 mRNA	PMID:23358152
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:9555	tioguanine	increases expression	ISO	RGD:1304629	E	RGD:6480464	20130305	CTD	MESH:D013866	Thioguanine results in increased expression of ACER2 mRNA	PMID:16005536
1312176	ACER2	alkaline ceramidase 2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304629	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ACER2 mRNA	PMID:19015723
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1551976	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ZFP169 mRNA	PMID:33045310
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304631	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ZFP169 mRNA	PMID:26496021
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304631	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP169 mRNA	PMID:33387578
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1304631	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ZFP169 mRNA	PMID:33354967
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304631	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZFP169 mRNA	PMID:30779732
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304631	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ZFP169 mRNA	PMID:31150632
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF169 gene	PMID:25304211
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304631	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP169 mRNA	PMID:33387578
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ZNF169 mRNA	PMID:32763439
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304631	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ZFP169 mRNA	PMID:28959563
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZNF169 5' UTR	PMID:27901495
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1551976	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ZFP169 mRNA	PMID:35295148
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551976	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP169 promoter	PMID:35295148
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304631	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF169 mRNA	PMID:25181051
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1551976	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP169 mRNA	PMID:33221593|PMID:38074096
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZNF169 gene	PMID:31601247
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304631	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of ZFP169 mRNA	PMID:26496021
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551976	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ZFP169 mRNA	PMID:39298647
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:34575	bisphenol F	affects expression	ISO	RGD:1551976	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F affects the expression of ZFP169 mRNA	PMID:38685157
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZNF169 mRNA	PMID:38382870|PMID:38568856
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1304631	E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of ZFP169 mRNA	PMID:27281708
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ZNF169 mRNA	PMID:38832940
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF169 gene	PMID:25304211
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551976	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFP169 mRNA	PMID:22206623
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF169 protein	PMID:31285264
1312178	ZNF169	zinc finger protein 169	gene	CHEBI:85014	2,5-hexanedione	decreases expression	ISO	RGD:1304631	E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione results in decreased expression of ZFP169 protein	PMID:19033394
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312181	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SOCS6 mRNA	PMID:33045310
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SOCS6 gene	PMID:20938992
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SOCS6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SOCS6 mRNA	PMID:32699268
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1312181	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of SOCS6 mRNA	PMID:20362636
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SOCS6 mRNA	PMID:21632981
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of SOCS6 mRNA	PMID:20106945
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SOCS6 gene	PMID:20938992
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of SOCS6 mRNA	PMID:20655997
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312181	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SOCS6 mRNA	PMID:23892564
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SOCS6 protein	PMID:37730182
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304632	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SOCS6 mRNA	PMID:33387578
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SOCS6 mRNA	PMID:28818685
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SOCS6 mRNA	PMID:35301059
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SOCS6 mRNA	PMID:37236586
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SOCS6 mRNA	PMID:19549813
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SOCS6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SOCS6 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of SOCS6 mRNA	PMID:32699268
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of SOCS6 mRNA	PMID:19774075
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SOCS6 gene	PMID:20938992
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:27641	cycloheximide	increases expression	ISO	RGD:1312181	E	RGD:6480464	20130611	CTD	MESH:D003513	Cycloheximide results in increased expression of SOCS6 mRNA	PMID:23237828
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SOCS6 protein	PMID:35688186
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SOCS6 mRNA	PMID:27392435
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304632	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SOCS6 mRNA	PMID:22298810
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312181	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SOCS6 mRNA	PMID:21570461
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304632	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SOCS6 mRNA	PMID:33387578
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SOCS6 mRNA	PMID:19770486
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SOCS6 mRNA	PMID:17942748
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SOCS6 mRNA	PMID:33212167
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of SOCS6 mRNA	PMID:29803840
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SOCS6 mRNA	PMID:38568856
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SOCS6 promoter	PMID:27901495
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312181	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SOCS6 mRNA	PMID:22228805
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SOCS6 mRNA]	PMID:22228805
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SOCS6 mRNA	PMID:27131904
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of SOCS6 mRNA	PMID:20382639
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SOCS6 mRNA	PMID:20018196
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312181	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SOCS6 gene	PMID:35295148
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304632	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SOCS6 mRNA	PMID:34492290
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SOCS6 mRNA	PMID:30903817
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304632	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SOCS6 mRNA	PMID:34947998
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304632	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SOCS6 mRNA	PMID:30816183
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304632	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SOCS6 gene	PMID:28505145
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of SOCS6 mRNA	PMID:24752500
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SOCS6 mRNA	PMID:34813904
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SOCS6 mRNA	PMID:37042841
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SOCS6 mRNA	PMID:35301059
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SOCS6 mRNA	PMID:37236586
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SOCS6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SOCS6 mRNA	PMID:32699268
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SOCS6 mRNA	PMID:25979313
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312181	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SOCS6 mRNA	PMID:17963808
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SOCS6 mRNA	PMID:23179753|PMID:24935251|PMID:27188386
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SOCS6 gene	PMID:29154799
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SOCS6 mRNA	PMID:19770486
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SOCS6 mRNA	PMID:20106945|PMID:25562108
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SOCS6 mRNA	PMID:38832940
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SOCS6 mRNA	PMID:26272509
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOCS6 mRNA	PMID:27188386
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312181	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SOCS6 mRNA	PMID:17562736
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of SOCS6 mRNA	PMID:22230336
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of SOCS6 mRNA	PMID:24752500
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SOCS6 mRNA	PMID:35436446
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312181	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SOCS6 mRNA	PMID:17942748
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SOCS6 mRNA	PMID:17942748
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1312181	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of SOCS6 mRNA	PMID:21318169
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1312181	E	RGD:6480464	20120613	CTD	MESH:D011345	PPARA protein affects the reaction [Fenofibrate results in increased expression of SOCS6 mRNA]	PMID:21318169
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SOCS6 mRNA	PMID:28988120
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of SOCS6 mRNA	PMID:15336504
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SOCS6 mRNA	PMID:22206623
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1304632	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of SOCS6 mRNA	PMID:27840820
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SOCS6 mRNA	PMID:37199045
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOCS6 mRNA	PMID:27188386
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SOCS6 mRNA	PMID:19159669
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312181	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SOCS6 mRNA	PMID:23091169
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312181	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SOCS6 mRNA	PMID:31388691
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOCS6 mRNA	PMID:27188386
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312181	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SOCS6 mRNA	PMID:27131904
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304632	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SOCS6 mRNA	PMID:19281266
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304632	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SOCS6 mRNA	PMID:21346803
1312180	SOCS6	suppressor of cytokine signaling 6	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SOCS6 mRNA	PMID:29301935
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TRAF3 mRNA	PMID:38218311
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TRAF3 mRNA	PMID:33045310
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:136185	VX nerve agent	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C009680	VX-agent results in increased expression of TRAF3 mRNA	PMID:38555327
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TRAF3 mRNA	PMID:33167477
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TRAF3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TRAF3 mRNA	PMID:32699268
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304633	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of TRAF3 gene	PMID:35440735
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of TRAF3 mRNA	PMID:40945087
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312183	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TRAF3 mRNA	PMID:30319688
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312183	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TRAF3 mRNA	PMID:30319688
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312183	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TRAF3 mRNA	PMID:39241906
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20200331	CTD	MESH:D008070	Lipopolysaccharides promotes the reaction [APPL1 protein binds to TRAF3 protein]	PMID:25780039
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of TRAF3 mRNA	PMID:23019147|PMID:24758408|PMID:31614463
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein promotes the reaction [Estradiol results in increased expression of TRAF3 mRNA]	PMID:24758408
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of TRAF3 mRNA	PMID:19448997
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRAF3 mRNA	PMID:37042841
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of TRAF3 mRNA	PMID:19162166
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312183	E	RGD:6480464	20150414	CTD	MESH:D005947	Glucose results in increased expression of TRAF3 protein	PMID:25516495
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20150414	CTD	MESH:D005947	tempol inhibits the reaction [Glucose results in increased expression of TRAF3 protein]; TRAF3 affects the reaction [Glucose results in increased cleavage of CASP3 protein]	PMID:25516495
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312183	E	RGD:6480464	20150414	CTD	MESH:D005947	Glucose results in increased expression of TRAF3 protein	PMID:25516495
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20150414	CTD	MESH:D005947	tempol inhibits the reaction [Glucose results in increased expression of TRAF3 protein]; TRAF3 affects the reaction [Glucose results in increased cleavage of CASP3 protein]	PMID:25516495
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20250708	CTD	MESH:D004051	[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TRAF3 mRNA	PMID:39947446
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304633	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of TRAF3 mRNA	PMID:26577399
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:17948	(+)-taxifolin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C003377	taxifolin results in increased expression of TRAF3 mRNA	PMID:17541156
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1304633	E	RGD:6480464	20120412	CTD	MESH:D014520	Urethane results in increased expression of TRAF3 mRNA	PMID:16978161
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:180664	4-hydroxy-TEMPO	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20211109	CTD	MESH:C001803	tempol inhibits the reaction [Glucose results in increased expression of TRAF3 protein]	PMID:25516495
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TRAF3 mRNA	PMID:36331819
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TRAF3 mRNA	PMID:19549813
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TRAF3 mRNA	PMID:23649840
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRAF3 mRNA	PMID:19770486
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:25187	p-menthan-3-ol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of TRAF3 mRNA	PMID:26760959
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TRAF3 mRNA	PMID:23649840
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120515	CTD	MESH:D009151	Mustard Gas results in increased expression of TRAF3 mRNA	PMID:15674843|PMID:18955075
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TRAF3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TRAF3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TRAF3 mRNA	PMID:32699268
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304633	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TRAF3 mRNA	PMID:30779732
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304633	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TRAF3 mRNA	PMID:31150632
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TRAF3 mRNA	PMID:22206623
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRAF3 gene	PMID:25304211
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TRAF3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAF3 mRNA	PMID:39836092|PMID:40512198
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAF3 mRNA	PMID:40504410
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312183	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of TRAF3 mRNA	PMID:35897073
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312183	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of TRAF3 mRNA	PMID:28189721|PMID:28960355
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TRAF3 mRNA	PMID:23557933
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312183	E	RGD:6480464	20160210	CTD	MESH:D002945	Cisplatin results in increased expression of TRAF3 mRNA	PMID:26546572
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20160210	CTD	MESH:D002945	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Cisplatin results in increased expression of TRAF3 mRNA]	PMID:26546572
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TRAF3 mRNA	PMID:30912803
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of TRAF3 mRNA	PMID:24768652
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304633	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRAF3 mRNA	PMID:22298810
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312183	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRAF3 mRNA	PMID:21570461
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304633	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRAF3 mRNA	PMID:19520675
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRAF3 mRNA	PMID:12167310|PMID:19770486
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRAF3 mRNA	PMID:17942748
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304633	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TRAF3 mRNA	PMID:28959563
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of TRAF3 mRNA	PMID:30911355
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20121009	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TRAF3 mRNA	PMID:21340527
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRAF3 mRNA	PMID:39631538
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of TRAF3 gene	PMID:28589171
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRAF3 mRNA	PMID:12760830
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TRAF3 mRNA	PMID:34032870
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TRAF3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAF3 mRNA	PMID:39836092|PMID:40512198
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAF3 mRNA	PMID:40504410
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:29852	methylarsonic acid	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:C020300	monomethylarsonic acid results in decreased expression of TRAF3 mRNA	PMID:15345372
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TRAF3 intron	PMID:30157460
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TRAF3 mRNA	PMID:19770486
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRAF3 5' UTR	PMID:27901495
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TRAF3 mRNA	PMID:22228805
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRAF3 promoter	PMID:27901495
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of TRAF3 mRNA]	PMID:22228805
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of TRAF3 mRNA	PMID:30911355
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TRAF3 mRNA	PMID:25895662
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TRAF3 mRNA	PMID:19150397
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TRAF3 mRNA	PMID:17530438
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312183	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TRAF3 mRNA	PMID:23557971
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304633	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TRAF3 mRNA	PMID:23411599|PMID:34492290
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of TRAF3 mRNA	PMID:19191707
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of TRAF3 mRNA	PMID:33312107|PMID:36232920
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304633	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TRAF3 mRNA	PMID:25181051
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304633	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TRAF3 gene	PMID:28505145
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:3374	capsaicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002211	Capsaicin results in increased expression of TRAF3 mRNA	PMID:19502594
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1304633	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of TRAF3 mRNA	PMID:22937105
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C543008	bisphenol S results in increased expression of TRAF3 mRNA	PMID:33312107
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312183	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TRAF3 mRNA	PMID:39298647
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C008745	bisphenol F results in increased expression of TRAF3 mRNA	PMID:33312107
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312183	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TRAF3 intron	PMID:28392331
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20250708	CTD	MESH:C027561	[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TRAF3 mRNA	PMID:39947446
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20250708	CTD	MESH:D003993	[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TRAF3 mRNA	PMID:39947446
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20250708	CTD	MESH:C007379	[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TRAF3 mRNA	PMID:39947446
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in decreased expression of TRAF3 mRNA	PMID:18836921
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304633	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of TRAF3 mRNA	PMID:32680482
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1304633	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of TRAF3 gene	PMID:33148267
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRAF3 mRNA	PMID:38382870
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20250708	CTD	MESH:C012125	[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TRAF3 mRNA	PMID:39947446
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304633	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased expression of TRAF3 mRNA	PMID:20562052|PMID:22079235
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TRAF3 mRNA	PMID:24449571
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TRAF3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TRAF3 mRNA	PMID:32699268
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:38319	usnic acid	increases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in increased expression of TRAF3 mRNA	PMID:32508146
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TRAF3 mRNA	PMID:36331819
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:3962	curcumin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in increased expression of TRAF3 mRNA	PMID:16101141
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304633	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of TRAF3 mRNA	PMID:29427782
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TRAF3 gene	PMID:29154799
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304633	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of TRAF3 mRNA	PMID:38685447|PMID:41580965
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of TRAF3 mRNA	PMID:15766595
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312183	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TRAF3 mRNA	PMID:28973697
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312183	E	RGD:6480464	20150414	CTD	MESH:D005947	Glucose results in increased expression of TRAF3 protein	PMID:25516495
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20150414	CTD	MESH:D005947	tempol inhibits the reaction [Glucose results in increased expression of TRAF3 protein]; TRAF3 affects the reaction [Glucose results in increased cleavage of CASP3 protein]	PMID:25516495
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of TRAF3 mRNA	PMID:17400583
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TRAF3 mRNA	PMID:38832940
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of TRAF3 mRNA	PMID:29309887
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRAF3 mRNA	PMID:21420995
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TRAF3 mRNA	PMID:22230336|PMID:29067470
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of TRAF3 mRNA	PMID:19036117|PMID:24714768
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRAF3 gene	PMID:25304211
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TRAF3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAF3 mRNA	PMID:39836092|PMID:40512198
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRAF3 mRNA	PMID:40504410
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of TRAF3 mRNA	PMID:15345372
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TRAF3 mRNA	PMID:17942748
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRAF3 mRNA	PMID:17942748
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TRAF3 mRNA	PMID:17530438
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304633	E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of TRAF3 mRNA	PMID:38685447|PMID:41580965
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:5801	hydroxychloroquine	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D006886	Hydroxychloroquine results in increased expression of TRAF3 mRNA	PMID:25321315
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:5801	hydroxychloroquine	increases expression	ISO	RGD:1312183	E	RGD:6480464	20200519	CTD	MESH:D006886	Hydroxychloroquine results in increased expression of TRAF3 mRNA	PMID:25321315
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:6015	isoflurane	decreases expression	ISO	RGD:1304633	E	RGD:6480464	20120412	CTD	MESH:D007530	Isoflurane results in decreased expression of TRAF3 mRNA	PMID:16978161
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of TRAF3 mRNA	PMID:29309887
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304633	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TRAF3 gene	PMID:35440735
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:69478	cannabidiol	affects methylation	ISO	RGD:1304633	E	RGD:6480464	20190219	CTD	MESH:D002185	Cannabidiol affects the methylation of TRAF3 gene	PMID:30521419
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1304633	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of TRAF3 gene	PMID:33148267
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TRAF3 mRNA	PMID:22206623
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:76612	ibrutinib	decreases response to substance	EXP		E	RGD:6480464	20170110	CTD	MESH:C551803	TRAF3 protein mutant form results in decreased susceptibility to ibrutinib	PMID:26254443
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1312183	E	RGD:6480464	20250708	CTD	MESH:C025605	[diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in decreased expression of TRAF3 mRNA	PMID:39947446
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:7983	pentobarbital	decreases expression	ISO	RGD:1304633	E	RGD:6480464	20120412	CTD	MESH:D010424	Pentobarbital results in decreased expression of TRAF3 mRNA	PMID:16978161
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of TRAF3 mRNA	PMID:31388691
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1304633	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TRAF3 mRNA	PMID:27291303
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:82288	o-anisidine	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C003898	2-anisidine results in decreased expression of TRAF3 mRNA	PMID:28089782
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1304633	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of TRAF3 mRNA	PMID:23640034
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:82577	Fusarenone X	decreases expression	ISO	RGD:1312183	E	RGD:6480464	20150310	CTD	MESH:C002469	fusarenon-X results in decreased expression of TRAF3 mRNA	PMID:24983900
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312183	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of TRAF3 mRNA	PMID:21278054
1312182	TRAF3	TNF receptor associated factor 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304633	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TRAF3 mRNA	PMID:21346803
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DPH2 mRNA	PMID:38218311
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of DPH2 mRNA	PMID:23724009|PMID:33167477
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DPH2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DPH2 mRNA	PMID:32699268
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DPH2 mRNA	PMID:30529165
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of DPH2 mRNA	PMID:22378314
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DPH2 mRNA	PMID:20044591
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1623210	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DPH2 mRNA	PMID:39241906
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of DPH2 mRNA	PMID:23019147|PMID:31614463
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DPH2 mRNA	PMID:37042841
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1623210	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of DPH2 mRNA	PMID:23892564
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of DPH2 protein	PMID:37730182
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304634	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DPH2 mRNA	PMID:33387578
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DPH2 mRNA	PMID:28818685
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DPH2 mRNA	PMID:36331819
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH2 mRNA	PMID:39836092
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304634	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of DPH2 protein	PMID:34915118
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DPH2 mRNA	PMID:35301059
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DPH2 mRNA	PMID:19549813
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DPH2 protein	PMID:23301498
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of DPH2 mRNA	PMID:23649840
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DPH2 mRNA	PMID:23649840
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DPH2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DPH2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DPH2 mRNA	PMID:32699268
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of DPH2 mRNA]	PMID:22206623
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH2 mRNA	PMID:39836092
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DPH2 mRNA	PMID:40504410
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of DPH2 mRNA	PMID:27594783
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1623210	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of DPH2 mRNA	PMID:30912803
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of DPH2 mRNA	PMID:25583101
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623210	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DPH2 mRNA	PMID:21570461
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of DPH2 mRNA	PMID:32763439
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DPH2 mRNA	PMID:38568856
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH2 mRNA	PMID:39836092
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DPH2 mRNA	PMID:40504410
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1623210	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DPH2 mRNA	PMID:19770486
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1623210	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DPH2 mRNA	PMID:22228805
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DPH2 protein]	PMID:26598702
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1623210	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of DPH2 mRNA	PMID:29264374
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623210	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DPH2 gene	PMID:35295148
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304634	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DPH2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1623210	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DPH2 mRNA	PMID:33221593
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623210	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of DPH2 mRNA	PMID:40203079
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of DPH2 gene	PMID:31601247
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1623210	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DPH2 mRNA	PMID:37019170
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of DPH2 gene	PMID:22964155
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1623210	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DPH2 mRNA	PMID:21266533
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH2 mRNA	PMID:39836092
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DPH2 mRNA	PMID:38568856
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DPH2 mRNA	PMID:35301059
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304634	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of DPH2 mRNA	PMID:24386269
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DPH2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DPH2 mRNA	PMID:32699268
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DPH2 mRNA	PMID:32588087
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of DPH2 mRNA	PMID:28302478
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DPH2 mRNA	PMID:36331819
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1623210	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of DPH2 mRNA	PMID:21427059
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DPH2 mRNA	PMID:23179753
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623210	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DPH2 mRNA	PMID:17562736
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304634	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DPH2 mRNA	PMID:33387578
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH2 mRNA	PMID:39836092
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DPH2 mRNA	PMID:40504410
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304634	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of DPH2 mRNA	PMID:29391264
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to DPH2 protein]	PMID:26598702
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1623210	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DPH2 mRNA; Nanotubes, Carbon results in increased expression of DPH2 mRNA	PMID:25554681
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH2 mRNA	PMID:39836092
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of DPH2 mRNA	PMID:31758290
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1623210	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DPH2 mRNA	PMID:22206623
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1623210	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of DPH2 mRNA]	PMID:22206623
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of DPH2 mRNA	PMID:18927307
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of DPH2 mRNA	PMID:24921660
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304634	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of DPH2 mRNA	PMID:19281266
1312184	DPH2	diphthamide biosynthesis 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DPH2 mRNA	PMID:38568856
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1304635	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ATP6V1G3 mRNA	PMID:30071829
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP6V1G3 mRNA	PMID:25510870
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312187	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of ATP6V1G3 mRNA	PMID:33711761
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304635	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ATP6V1G3 mRNA	PMID:22061828
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1304635	E	RGD:6480464	20130514	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of ATP6V1G3 mRNA	PMID:20409345
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V1G3 mRNA	PMID:29950665
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP6V1G3 mRNA	PMID:25510870
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP6V1G3 mRNA	PMID:25510870
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATP6V1G3 gene	PMID:27153756
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ATP6V1G3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ATP6V1G3 mRNA	PMID:27106289|PMID:34911549
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304635	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ATP6V1G3 mRNA	PMID:30779732
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304635	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ATP6V1G3 mRNA	PMID:26033743
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1304635	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of ATP6V1G3 mRNA	PMID:26033743
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATP6V1G3 mRNA	PMID:22316170
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304635	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ATP6V1G3 mRNA	PMID:26033743
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1304635	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of ATP6V1G3 mRNA	PMID:26033743
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312187	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of ATP6V1G3 mRNA	PMID:35295148
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V1G3 mRNA	PMID:29950665
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304635	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ATP6V1G3 mRNA	PMID:25181051
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ATP6V1G3 gene	PMID:31601247
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP6V1G3 mRNA	PMID:25510870
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ATP6V1G3 mRNA	PMID:25510870
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312187	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V1G3 mRNA	PMID:29950665
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1304635	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of ATP6V1G3 mRNA	PMID:36868495
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304635	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ATP6V1G3 mRNA	PMID:30307764
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304635	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of ATP6V1G3 mRNA	PMID:22504374
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312187	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of ATP6V1G3 mRNA	PMID:23650126
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312187	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of ATP6V1G3 protein	PMID:36851058
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATP6V1G3 gene]	PMID:28238834
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312187	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ATP6V1G3 mRNA	PMID:38648751
1312186	ATP6V1G3	ATPase H+ transporting V1 subunit G3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304635	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of ATP6V1G3 mRNA	PMID:22504374|PMID:25825206
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1304636	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of SEMA4A mRNA	PMID:21551480
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312189	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SEMA4A mRNA	PMID:33045310
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D014212	Tretinoin results in increased expression of SEMA4A mRNA	PMID:38091671
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1304636	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of SEMA4A mRNA	PMID:33729688
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312189	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of SEMA4A mRNA	PMID:30319688
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of SEMA4A mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of SEMA4A mRNA	PMID:22217510|PMID:30165855
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SEMA4A mRNA	PMID:37042841
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of SEMA4A mRNA	PMID:33647349
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SEMA4A mRNA	PMID:33387578
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304636	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SEMA4A mRNA	PMID:22061828
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SEMA4A mRNA	PMID:28818685
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:188851	Muraglitazar	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of SEMA4A mRNA	PMID:21515302
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:192408	bromoacetate	increases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:C016274	bromoacetate results in increased expression of SEMA4A mRNA	PMID:19753638
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SEMA4A exon	PMID:30157460
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SEMA4A mRNA	PMID:26035830
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SEMA4A mRNA	PMID:22171008
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SEMA4A mRNA	PMID:31150632
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SEMA4A mRNA	PMID:31919559
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SEMA4A mRNA	PMID:22206623
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SEMA4A mRNA	PMID:32525701
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SEMA4A mRNA	PMID:31881176
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1304636	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of SEMA4A mRNA	PMID:15691709
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304636	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEMA4A mRNA	PMID:34747641
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312189	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEMA4A mRNA	PMID:21570461
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEMA4A mRNA	PMID:17942748
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SEMA4A mRNA	PMID:33212167
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304636	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SEMA4A mRNA	PMID:28959563
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SEMA4A mRNA	PMID:30556269
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SEMA4A mRNA	PMID:37682722|PMID:39515575
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SEMA4A mRNA	PMID:38568856|PMID:39719251
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20210406	CTD	MESH:C017947	SEMA3A protein inhibits the reaction [sodium arsenite results in increased expression of SEMA4A protein]; SEMA4A protein promotes the reaction [sodium arsenite results in decreased expression of SEMA3A protein]; SEMA4A protein promotes the reaction [sodium arsenite results in increased expression of IL1B protein]; SEMA4A protein promotes the reaction [sodium arsenite results in increased expression of IL6 protein]; SEMA4A protein promotes the reaction [sodium arsenite results in increased expression of NLRP3 protein]; SEMA4A protein promotes the reaction [sodium arsenite results in increased expression of RELA protein]; SEMA4A protein promotes the reaction [sodium arsenite results in increased phosphorylation of AKT2 protein]; sodium arsenite results in increased expression of and results in increased secretion of SEMA4A protein	PMID:33290778
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SEMA4A 5' UTR	PMID:27901495
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SEMA4A mRNA	PMID:22228805
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SEMA4A promoter	PMID:27901495
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312189	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in increased expression of SEMA4A mRNA	PMID:33053406
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SEMA4A mRNA	PMID:30556269
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SEMA4A mRNA	PMID:22171008
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SEMA4A mRNA	PMID:19073995
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SEMA4A mRNA	PMID:25895662
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1304636	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SEMA4A mRNA	PMID:22431001
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304636	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SEMA4A mRNA	PMID:24136188
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:32195	Tesaglitazar	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of SEMA4A mRNA	PMID:21515302
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1304636	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of SEMA4A mRNA	PMID:30012374
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312189	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SEMA4A mRNA	PMID:23557971
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304636	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SEMA4A mRNA	PMID:34492290
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1304636	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SEMA4A mRNA	PMID:30723492
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SEMA4A mRNA	PMID:18445702|PMID:20059764
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of SEMA4A mRNA]	PMID:20059764
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304636	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SEMA4A mRNA	PMID:25181051
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312189	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SEMA4A mRNA	PMID:32156529|PMID:33221593|PMID:34585602|PMID:38701888
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SEMA4A mRNA	PMID:39298647|PMID:40203079
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312189	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SEMA4A promoter	PMID:28392331
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SEMA4A mRNA	PMID:21266533
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of SEMA4A mRNA	PMID:34813904
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SEMA4A mRNA	PMID:34813904
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SEMA4A mRNA	PMID:32680482
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in decreased expression of SEMA4A mRNA	PMID:16797015
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SEMA4A mRNA	PMID:37042841
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304636	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SEMA4A mRNA	PMID:25993096
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SEMA4A mRNA	PMID:24386269
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SEMA4A mRNA	PMID:24449571
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SEMA4A mRNA	PMID:40194260
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SEMA4A mRNA	PMID:31533062
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SEMA4A mRNA	PMID:17292431
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SEMA4A gene	PMID:29154799
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of SEMA4A mRNA	PMID:17183730
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of SEMA4A mRNA	PMID:17400583
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304636	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SEMA4A mRNA	PMID:33387578
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SEMA4A mRNA	PMID:32525701
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SEMA4A mRNA	PMID:29391264
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEMA4A mRNA	PMID:17942748
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312189	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SEMA4A mRNA	PMID:25554681
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of SEMA4A mRNA	PMID:17183730
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312189	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SEMA4A mRNA	PMID:38701926
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SEMA4A mRNA	PMID:21641980
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of SEMA4A mRNA	PMID:19812364
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SEMA4A mRNA	PMID:22206623
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312189	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SEMA4A mRNA	PMID:22206623
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of SEMA4A mRNA	PMID:36318118
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of SEMA4A mRNA	PMID:39847705
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SEMA4A mRNA	PMID:32525701
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312189	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of SEMA4A mRNA	PMID:21278054
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of SEMA4A mRNA	PMID:19281266
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in decreased expression of SEMA4A mRNA	PMID:21515302
1312188	SEMA4A	semaphorin 4A	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304636	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SEMA4A mRNA	PMID:23034163
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312191	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LTO1 mRNA	PMID:33045310
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ORAOV1 mRNA	PMID:33167477
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of LTO1 mRNA	PMID:22378314
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312191	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of LTO1 mRNA	PMID:33711761
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LTO1 mRNA	PMID:37042841
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of LTO1 mRNA	PMID:23649840
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of LTO1 mRNA	PMID:21179406
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304637	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LTO1 mRNA	PMID:33387578
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LTO1 mRNA	PMID:39836092
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LTO1 protein	PMID:23301498
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of LTO1 mRNA	PMID:23649840
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LTO1 mRNA	PMID:19770486
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of LTO1 mRNA	PMID:23649840
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LTO1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LTO1 mRNA	PMID:39836092
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312191	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LTO1 mRNA	PMID:40504410
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312191	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ORAOV1 mRNA	PMID:28960355
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LTO1 mRNA	PMID:21570461
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LTO1 mRNA	PMID:17942748
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LTO1 mRNA	PMID:33212167
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of LTO1 mRNA	PMID:23649840
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LTO1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LTO1 mRNA	PMID:39836092
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312191	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LTO1 mRNA	PMID:40504410
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LTO1 mRNA	PMID:22228805
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ORAOV1 promoter	PMID:27901495
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of LTO1 mRNA	PMID:26014281
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304637	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of LTO1 mRNA	PMID:23411599|PMID:34492290
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:C006253	pirinixic acid results in increased expression of LTO1 mRNA	PMID:18301758
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LTO1 mRNA	PMID:19710929
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of LTO1 mRNA	PMID:29275510
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LTO1 gene	PMID:31601247
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304637	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LTO1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312191	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of LTO1 mRNA	PMID:39298647
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304637	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ORAOV1 mRNA	PMID:32680482
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LTO1 mRNA	PMID:39836092
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LTO1 mRNA	PMID:38568856
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LTO1 mRNA	PMID:24449571
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of LTO1 mRNA	PMID:20106945|PMID:25562108
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of LTO1 mRNA	PMID:24935251
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D000082	Acetaminophen affects the expression of LTO1 mRNA	PMID:17562736
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304637	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LTO1 mRNA	PMID:33387578
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LTO1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LTO1 mRNA	PMID:39836092
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312191	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LTO1 mRNA	PMID:40504410
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304637	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of LTO1 mRNA	PMID:29391264
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LTO1 mRNA	PMID:17942748
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LTO1 mRNA	PMID:17942748
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:5130	flurbiprofen	decreases expression	ISO	RGD:1312191	E	RGD:6480464	20181113	CTD	MESH:D005480	Flurbiprofen results in decreased expression of LTO1 mRNA	PMID:16949054
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LTO1 mRNA	PMID:39836092
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1304637	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of LTO1 mRNA	PMID:30467583
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312191	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ORAOV1 mRNA	PMID:22206623
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of LTO1 mRNA	PMID:37199045
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of LTO1 mRNA	PMID:26014281
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304637	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LTO1 mRNA	PMID:21346803
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304637	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LTO1 mRNA	PMID:21346803
1312190	LTO1	LTO1 maturation factor of ABCE1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312191	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of ORAOV1 mRNA	PMID:32835833
1312192	COQ4	coenzyme Q4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1551979	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COQ4 mRNA	PMID:33045310
1312192	COQ4	coenzyme Q4	gene	CHEBI:137392	chlormequat chloride	increases expression	ISO	RGD:1304638	E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of COQ4 protein	PMID:34958886
1312192	COQ4	coenzyme Q4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of COQ4 mRNA	PMID:36331819
1312192	COQ4	coenzyme Q4	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of COQ4 mRNA	PMID:22378314
1312192	COQ4	coenzyme Q4	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of COQ4 mRNA	PMID:18951874|PMID:21308897
1312192	COQ4	coenzyme Q4	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of COQ4 protein	PMID:18951874
1312192	COQ4	coenzyme Q4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COQ4 mRNA	PMID:37042841
1312192	COQ4	coenzyme Q4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304638	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of COQ4 mRNA	PMID:33387578
1312192	COQ4	coenzyme Q4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COQ4 mRNA	PMID:36331819
1312192	COQ4	coenzyme Q4	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of COQ4 mRNA	PMID:39836092
1312192	COQ4	coenzyme Q4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COQ4 mRNA	PMID:19549813
1312192	COQ4	coenzyme Q4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of COQ4 mRNA	PMID:35430440
1312192	COQ4	coenzyme Q4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COQ4 mRNA	PMID:22206623
1312192	COQ4	coenzyme Q4	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of COQ4 gene	PMID:25304211
1312192	COQ4	coenzyme Q4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304638	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COQ4 mRNA	PMID:22298810
1312192	COQ4	coenzyme Q4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551979	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COQ4 mRNA	PMID:20702594|PMID:21570461
1312192	COQ4	coenzyme Q4	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of COQ4 protein	PMID:18951874
1312192	COQ4	coenzyme Q4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of COQ4 mRNA	PMID:32763439
1312192	COQ4	coenzyme Q4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COQ4 mRNA	PMID:29803840
1312192	COQ4	coenzyme Q4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1551979	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of COQ4 mRNA	PMID:26873546
1312192	COQ4	coenzyme Q4	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20160607	CTD	MESH:D004317	[Doxorubicin co-treated with Dexrazoxane] results in increased expression of COQ4 mRNA	PMID:26873546
1312192	COQ4	coenzyme Q4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of COQ4 mRNA	PMID:38568856
1312192	COQ4	coenzyme Q4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1551979	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of COQ4 mRNA	PMID:20883709
1312192	COQ4	coenzyme Q4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551979	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of COQ4 mRNA	PMID:22228805
1312192	COQ4	coenzyme Q4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to COQ4 promoter]	PMID:19654925
1312192	COQ4	coenzyme Q4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1551979	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of COQ4 mRNA	PMID:17426115|PMID:18301758|PMID:20813756|PMID:23811191
1312192	COQ4	coenzyme Q4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of COQ4 mRNA	PMID:33670352
1312192	COQ4	coenzyme Q4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304638	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of COQ4 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1312192	COQ4	coenzyme Q4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551979	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of COQ4 mRNA	PMID:33297965
1312192	COQ4	coenzyme Q4	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1551979	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of COQ4 mRNA	PMID:28392331
1312192	COQ4	coenzyme Q4	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of COQ4 mRNA	PMID:39836092
1312192	COQ4	coenzyme Q4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1551979	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of COQ4 mRNA	PMID:20883709
1312192	COQ4	coenzyme Q4	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304638	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of COQ4 mRNA	PMID:25539665
1312192	COQ4	coenzyme Q4	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of COQ4 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of COQ4 mRNA]	PMID:17585979
1312192	COQ4	coenzyme Q4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of COQ4 mRNA	PMID:40419075
1312192	COQ4	coenzyme Q4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COQ4 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of COQ4 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of COQ4 mRNA	PMID:36331819
1312192	COQ4	coenzyme Q4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of COQ4 mRNA	PMID:17183730
1312192	COQ4	coenzyme Q4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of COQ4 mRNA	PMID:25704631
1312192	COQ4	coenzyme Q4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304638	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COQ4 mRNA	PMID:33387578
1312192	COQ4	coenzyme Q4	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of COQ4 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of COQ4 mRNA]	PMID:17585979
1312192	COQ4	coenzyme Q4	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of COQ4 mRNA	PMID:20977926
1312192	COQ4	coenzyme Q4	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of COQ4 gene	PMID:25304211
1312192	COQ4	coenzyme Q4	gene	CHEBI:50223	(+)-dexrazoxane	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20170303	CTD	MESH:D064730	[Doxorubicin co-treated with Dexrazoxane] results in increased expression of COQ4 mRNA	PMID:26873546
1312192	COQ4	coenzyme Q4	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1304638	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of COQ4 mRNA	PMID:23962444
1312192	COQ4	coenzyme Q4	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of COQ4 mRNA	PMID:17183730
1312192	COQ4	coenzyme Q4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of COQ4 mRNA	PMID:39836092
1312192	COQ4	coenzyme Q4	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of COQ4 mRNA	PMID:28988120|PMID:29427785
1312192	COQ4	coenzyme Q4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551979	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COQ4 mRNA	PMID:22206623
1312192	COQ4	coenzyme Q4	gene	CHEBI:75458	carbonyl cyanide p-trifluoromethoxyphenylhydrazone	increases expression	EXP		E	RGD:6480464	20131008	CTD	MESH:D002259	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in increased expression of COQ4 mRNA	PMID:21308897
1312192	COQ4	coenzyme Q4	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of COQ4 mRNA	PMID:19159669
1312192	COQ4	coenzyme Q4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1551979	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of COQ4 mRNA	PMID:20702594
1312192	COQ4	coenzyme Q4	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of COQ4 mRNA	PMID:38568856
1312194	LIG4	DNA ligase 4	gene	CHEBI:133326	barium sulfate	increases expression	ISO	RGD:1304639	E	RGD:6480464	20191008	CTD	MESH:D001466	Barium Sulfate results in increased expression of LIG4 mRNA	PMID:29463257
1312194	LIG4	DNA ligase 4	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of LIG4 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of LIG4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of LIG4 mRNA	PMID:32699268|PMID:32845096
1312194	LIG4	DNA ligase 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1304639	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LIG4 mRNA	PMID:33729688
1312194	LIG4	DNA ligase 4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LIG4 mRNA	PMID:36331819
1312194	LIG4	DNA ligase 4	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of LIG4 mRNA	PMID:21751221
1312194	LIG4	DNA ligase 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304639	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of LIG4 mRNA	PMID:26496021
1312194	LIG4	DNA ligase 4	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312195	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of LIG4 mRNA	PMID:33711761
1312194	LIG4	DNA ligase 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304639	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LIG4 mRNA	PMID:33387578
1312194	LIG4	DNA ligase 4	gene	CHEBI:16796	melatonin	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:D008550	Melatonin promotes the reaction [bisphenol A results in increased expression of LIG4 mRNA]	PMID:36633214
1312194	LIG4	DNA ligase 4	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20241105	CTD	MESH:D008550	Melatonin promotes the reaction [bisphenol A results in increased expression of LIG4 mRNA]	PMID:36633214
1312194	LIG4	DNA ligase 4	gene	CHEBI:17356	2-acetamidofluorene	decreases expression	ISO	RGD:1304639	E	RGD:6480464	20120814	CTD	MESH:D015073	2-Acetylaminofluorene results in decreased expression of LIG4 mRNA	PMID:19167416
1312194	LIG4	DNA ligase 4	gene	CHEBI:17521	(-)-quinic acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:D011801	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of LIG4 mRNA	PMID:21751221
1312194	LIG4	DNA ligase 4	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of LIG4 mRNA	PMID:16949557
1312194	LIG4	DNA ligase 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1304639	E	RGD:6480464	20231031	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of LIG4 mRNA	PMID:37258237
1312194	LIG4	DNA ligase 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312195	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LIG4 mRNA	PMID:34319233
1312194	LIG4	DNA ligase 4	gene	CHEBI:1784	biphenyl-4-amine	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C006757	4-biphenylamine results in increased expression of LIG4 mRNA	PMID:32905825
1312194	LIG4	DNA ligase 4	gene	CHEBI:1784	biphenyl-4-amine	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C006757	TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of LIG4 mRNA]	PMID:32905825
1312194	LIG4	DNA ligase 4	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of LIG4 mRNA	PMID:28818685
1312194	LIG4	DNA ligase 4	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of LIG4 mRNA	PMID:16949557
1312194	LIG4	DNA ligase 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LIG4 gene	PMID:27153756
1312194	LIG4	DNA ligase 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304639	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LIG4 mRNA	PMID:33354967
1312194	LIG4	DNA ligase 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of LIG4 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of LIG4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of LIG4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of LIG4 mRNA	PMID:32699268|PMID:32845096
1312194	LIG4	DNA ligase 4	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of LIG4 mRNA; Arsenic results in decreased expression of LIG4 protein	PMID:21332098
1312194	LIG4	DNA ligase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG4 mRNA]; Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG4 protein]	PMID:21332098
1312194	LIG4	DNA ligase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LIG4 mRNA	PMID:40504410
1312194	LIG4	DNA ligase 4	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of LIG4 mRNA	PMID:26272509
1312194	LIG4	DNA ligase 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIG4 mRNA	PMID:27188386
1312194	LIG4	DNA ligase 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of LIG4 mRNA	PMID:23557933
1312194	LIG4	DNA ligase 4	gene	CHEBI:27889	lead(0)	affects response to substance	EXP		E	RGD:6480464	20140610	CTD	MESH:D007854	LIG4 gene polymorphism affects the susceptibility to Lead	PMID:22466227
1312194	LIG4	DNA ligase 4	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of LIG4 promoter	PMID:22847954
1312194	LIG4	DNA ligase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of LIG4 mRNA	PMID:25975270
1312194	LIG4	DNA ligase 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LIG4 mRNA	PMID:28001369
1312194	LIG4	DNA ligase 4	gene	CHEBI:28553	selenocystine	decreases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C009226	selenocystine results in decreased expression of LIG4 protein	PMID:39461470
1312194	LIG4	DNA ligase 4	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304639	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of LIG4 mRNA	PMID:30556269
1312194	LIG4	DNA ligase 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LIG4 mRNA	PMID:29803840
1312194	LIG4	DNA ligase 4	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	LIG4 protein affects the reaction [Doxorubicin results in increased activity of CASP3 protein]; LIG4 protein affects the reaction [Doxorubicin results in increased activity of CASP8 protein]; LIG4 protein affects the reaction [Doxorubicin results in increased activity of CASP9 protein]	PMID:18508926
1312194	LIG4	DNA ligase 4	gene	CHEBI:29287	gold atom	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which affects the expression of LIG4 mRNA	PMID:28433809
1312194	LIG4	DNA ligase 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LIG4 mRNA	PMID:40504410
1312194	LIG4	DNA ligase 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LIG4 5' UTR	PMID:27901495
1312194	LIG4	DNA ligase 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312195	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LIG4 mRNA	PMID:22228805
1312194	LIG4	DNA ligase 4	gene	CHEBI:30050	gold(0)	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which affects the expression of LIG4 mRNA	PMID:28433809
1312194	LIG4	DNA ligase 4	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304639	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of LIG4 mRNA	PMID:30556269
1312194	LIG4	DNA ligase 4	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of LIG4 mRNA	PMID:34408198
1312194	LIG4	DNA ligase 4	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1304639	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of LIG4 mRNA	PMID:22641619
1312194	LIG4	DNA ligase 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312195	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LIG4 gene	PMID:35295148
1312194	LIG4	DNA ligase 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312195	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LIG4 promoter alternative form	PMID:35295148
1312194	LIG4	DNA ligase 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304639	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of LIG4 mRNA	PMID:23411599|PMID:34492290|PMID:37258237
1312194	LIG4	DNA ligase 4	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of LIG4 mRNA	PMID:38479592
1312194	LIG4	DNA ligase 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of LIG4 mRNA	PMID:36633214
1312194	LIG4	DNA ligase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304639	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LIG4 mRNA	PMID:35192832
1312194	LIG4	DNA ligase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312195	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of LIG4 mRNA	PMID:36633214
1312194	LIG4	DNA ligase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:C006780	Melatonin promotes the reaction [bisphenol A results in increased expression of LIG4 mRNA]	PMID:36633214
1312194	LIG4	DNA ligase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304639	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of LIG4 mRNA	PMID:26496021
1312194	LIG4	DNA ligase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20241105	CTD	MESH:C006780	Melatonin promotes the reaction [bisphenol A results in increased expression of LIG4 mRNA]	PMID:36633214
1312194	LIG4	DNA ligase 4	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of LIG4 mRNA	PMID:19041380
1312194	LIG4	DNA ligase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312195	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of LIG4 mRNA	PMID:39298647
1312194	LIG4	DNA ligase 4	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312195	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of LIG4 mRNA	PMID:26377693
1312194	LIG4	DNA ligase 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312195	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of LIG4 mRNA	PMID:38685157
1312194	LIG4	DNA ligase 4	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C022838	nickel chloride results in decreased expression of LIG4 mRNA	PMID:28472268
1312194	LIG4	DNA ligase 4	gene	CHEBI:35019	tributyl phosphate	increases expression	ISO	RGD:1312195	E	RGD:6480464	20260303	CTD	MESH:C009524	tributyl phosphate results in increased expression of LIG4 mRNA	PMID:40389058
1312194	LIG4	DNA ligase 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LIG4 mRNA	PMID:37042841
1312194	LIG4	DNA ligase 4	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	increases expression	ISO	RGD:1312195	E	RGD:6480464	20260303	CTD	MESH:C031324	tris(chloroethyl)phosphate results in increased expression of LIG4 mRNA	PMID:40389058
1312194	LIG4	DNA ligase 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LIG4 mRNA	PMID:40054833
1312194	LIG4	DNA ligase 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LIG4 mRNA	PMID:24449571
1312194	LIG4	DNA ligase 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of LIG4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of LIG4 mRNA	PMID:32699268
1312194	LIG4	DNA ligase 4	gene	CHEBI:3763	clorgyline	increases expression	EXP		E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of LIG4 mRNA	PMID:19691856
1312194	LIG4	DNA ligase 4	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of LIG4 promoter	PMID:22847954
1312194	LIG4	DNA ligase 4	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of LIG4 promoter	PMID:22847954
1312194	LIG4	DNA ligase 4	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of LIG4 mRNA	PMID:19167446
1312194	LIG4	DNA ligase 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of LIG4 mRNA	PMID:27153767
1312194	LIG4	DNA ligase 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LIG4 mRNA	PMID:36331819
1312194	LIG4	DNA ligase 4	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG4 mRNA]; Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG4 protein]	PMID:21332098
1312194	LIG4	DNA ligase 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LIG4 mRNA	PMID:25979313
1312194	LIG4	DNA ligase 4	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304639	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of LIG4 mRNA	PMID:29427782
1312194	LIG4	DNA ligase 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of LIG4 mRNA	PMID:19101580|PMID:23179753|PMID:24935251
1312194	LIG4	DNA ligase 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of LIG4 mRNA	PMID:25562108
1312194	LIG4	DNA ligase 4	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of LIG4 mRNA	PMID:24935251
1312194	LIG4	DNA ligase 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312195	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen affects the expression of LIG4 mRNA	PMID:29540258
1312194	LIG4	DNA ligase 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304639	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LIG4 mRNA	PMID:33387578
1312194	LIG4	DNA ligase 4	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of LIG4 mRNA	PMID:18687144
1312194	LIG4	DNA ligase 4	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of LIG4 mRNA; Arsenic results in decreased expression of LIG4 protein	PMID:21332098
1312194	LIG4	DNA ligase 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG4 mRNA]; Curcumin inhibits the reaction [Arsenic results in decreased expression of LIG4 protein]	PMID:21332098
1312194	LIG4	DNA ligase 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312195	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LIG4 mRNA	PMID:40504410
1312194	LIG4	DNA ligase 4	gene	CHEBI:48607	lithium chloride	increases expression	ISO	RGD:1304639	E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in increased expression of LIG4 mRNA; Lithium Chloride results in increased expression of LIG4 protein	PMID:19285016
1312194	LIG4	DNA ligase 4	gene	CHEBI:5000	fenfluramine	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D005277	Fenfluramine results in increased expression of LIG4 mRNA	PMID:22140631
1312194	LIG4	DNA ligase 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312195	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of LIG4 mRNA	PMID:25620056
1312194	LIG4	DNA ligase 4	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of LIG4 mRNA	PMID:20977926
1312194	LIG4	DNA ligase 4	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LIG4 mRNA	PMID:26378955
1312194	LIG4	DNA ligase 4	gene	CHEBI:6382	Lasiocarpine	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in decreased expression of LIG4 mRNA	PMID:40054833
1312194	LIG4	DNA ligase 4	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312195	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of LIG4 mRNA	PMID:19812364
1312194	LIG4	DNA ligase 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312195	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LIG4 mRNA	PMID:22206623
1312194	LIG4	DNA ligase 4	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1304639	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased expression of LIG4 mRNA	PMID:37162024
1312194	LIG4	DNA ligase 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIG4 mRNA	PMID:27188386
1312194	LIG4	DNA ligase 4	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of LIG4 mRNA	PMID:30928695
1312194	LIG4	DNA ligase 4	gene	CHEBI:79089	ceric oxide	affects expression	ISO	RGD:1304639	E	RGD:6480464	20191008	CTD	MESH:C030583	ceric oxide affects the expression of LIG4 mRNA	PMID:29463257
1312194	LIG4	DNA ligase 4	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312195	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of LIG4 mRNA	PMID:21278054
1312194	LIG4	DNA ligase 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304639	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of LIG4 mRNA	PMID:24780913
1312194	LIG4	DNA ligase 4	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of LIG4 mRNA	PMID:23726867
1312194	LIG4	DNA ligase 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LIG4 mRNA	PMID:27188386
1312194	LIG4	DNA ligase 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304639	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LIG4 mRNA	PMID:21346803
1312194	LIG4	DNA ligase 4	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of LIG4 mRNA	PMID:29301935
1312194	LIG4	DNA ligase 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304639	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LIG4 mRNA	PMID:21346803
1312194	LIG4	DNA ligase 4	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304639	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of LIG4 mRNA	PMID:23034163
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1557044	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CPSF6 mRNA	PMID:33045310
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CPSF6 mRNA	PMID:26251327
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1557044	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of CPSF6 protein	PMID:31494107
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304640	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CPSF6 mRNA	PMID:33387578
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CPSF6 mRNA	PMID:37042841
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CPSF6 mRNA	PMID:23649840
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CPSF6 protein	PMID:37730182
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304640	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CPSF6 mRNA	PMID:22061828
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CPSF6 mRNA	PMID:28818685
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304640	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CPSF6 protein	PMID:34915118
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CPSF6 mRNA	PMID:23649840
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CPSF6 gene	PMID:27153756
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CPSF6 mRNA	PMID:23649840
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CPSF6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CPSF6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CPSF6 protein	PMID:38598786
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304640	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CPSF6 mRNA	PMID:31150632
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CPSF6 mRNA	PMID:25629700
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1557044	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF6 mRNA	PMID:40504410
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CPSF6 mRNA	PMID:26272509
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF6 mRNA	PMID:27188386
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CPSF6 protein	PMID:35688186
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1304640	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of CPSF6 mRNA	PMID:25905778
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557044	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CPSF6 mRNA	PMID:21570461
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304640	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CPSF6 mRNA	PMID:32109520|PMID:33387578
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304640	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CPSF6 mRNA	PMID:34747641
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1557044	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CPSF6 mRNA	PMID:19465110|PMID:19770486
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CPSF6 mRNA	PMID:33212167
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of CPSF6 mRNA	PMID:23649840
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304640	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of CPSF6 mRNA	PMID:30556269
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CPSF6 mRNA	PMID:20971185
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of CPSF6 mRNA	PMID:29803840
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CPSF6 mRNA	PMID:38568856
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:29678	sodium arsenite	increases activity	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in increased activity of CPSF6 protein	PMID:30528433
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1557044	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF6 mRNA	PMID:40504410
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1557044	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CPSF6 mRNA	PMID:22228805
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CPSF6 promoter	PMID:27901495
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304640	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of CPSF6 mRNA	PMID:30556269
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CPSF6 mRNA	PMID:20971185
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304640	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CPSF6 mRNA	PMID:25729387
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557044	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CPSF6 gene	PMID:35295148
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304640	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CPSF6 mRNA	PMID:34492290
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of CPSF6 mRNA	PMID:20170705
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CPSF6 mRNA; bisphenol A results in decreased expression of CPSF6 protein	PMID:29275510|PMID:31675489
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CPSF6 mRNA	PMID:33221593
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of CPSF6 mRNA	PMID:36232920
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304640	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CPSF6 mRNA	PMID:25181051|PMID:33296240|PMID:38750585
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304640	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CPSF6 gene	PMID:28505145
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CPSF6 protein	PMID:31675489
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of CPSF6 mRNA	PMID:24752500
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1557044	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CPSF6 mRNA	PMID:39298647
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of CPSF6 mRNA	PMID:28392331
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CPSF6 protein	PMID:38598786
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1557044	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of CPSF6 mRNA	PMID:34813904
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CPSF6 mRNA	PMID:37042841
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1304640	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of CPSF6 mRNA	PMID:30589522
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CPSF6 mRNA	PMID:19376846
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CPSF6 mRNA	PMID:24449571
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CPSF6 mRNA	PMID:25979313
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304640	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of CPSF6 mRNA	PMID:29427782
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CPSF6 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CPSF6 gene	PMID:29154799
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF6 mRNA	PMID:27188386
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304640	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of CPSF6 mRNA	PMID:38685447
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CPSF6 mRNA	PMID:25562108
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of CPSF6 mRNA	PMID:19770486
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of CPSF6 mRNA	PMID:23649840
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557044	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CPSF6 mRNA	PMID:17562736
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304640	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CPSF6 mRNA	PMID:33387578
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of CPSF6 mRNA	PMID:21420995
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1557044	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF6 mRNA	PMID:40504410
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of CPSF6 mRNA	PMID:24752500
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of CPSF6 mRNA	PMID:16984733
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CPSF6 protein	PMID:32959892
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304640	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CPSF6 mRNA	PMID:25729387
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of CPSF6 mRNA	PMID:28988120
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304640	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CPSF6 gene	PMID:35440735
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of CPSF6 mRNA	PMID:27462272
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CPSF6 mRNA	PMID:22206623
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF6 mRNA	PMID:27188386
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1304640	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of CPSF6 mRNA	PMID:20345932
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304640	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CPSF6 mRNA	PMID:32109520
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CPSF6 protein	PMID:31675489
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1304640	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of CPSF6 protein	PMID:28903499
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CPSF6 protein	PMID:31675489
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of CPSF6 mRNA	PMID:21858171
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1557044	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of CPSF6 mRNA	PMID:21795629
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1557044	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of CPSF6 mRNA	PMID:21795629
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1557044	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of CPSF6 mRNA	PMID:21278054
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPSF6 mRNA	PMID:27188386
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304640	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CPSF6 mRNA	PMID:21346803
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CPSF6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CPSF6 protein	PMID:38598786
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304640	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CPSF6 mRNA	PMID:21346803
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304640	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of CPSF6 mRNA	PMID:22570695
1312196	CPSF6	cleavage and polyadenylation specific factor 6	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304640	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of CPSF6 mRNA	PMID:23034163
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of STIM2 mRNA	PMID:38218311
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312199	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of STIM2 mRNA]	PMID:19467301
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312199	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of STIM2 mRNA	PMID:20188158
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of STIM2 mRNA	PMID:22378314
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of STIM2 mRNA	PMID:18951874
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:16243	quercetin	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin affects the expression of STIM2 mRNA	PMID:21632981
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312199	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of STIM2 mRNA	PMID:39241906
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of STIM2 mRNA	PMID:39298647
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of STIM2 mRNA	PMID:34319233
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304641	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of STIM2 mRNA	PMID:26577399
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of STIM2 protein	PMID:37730182
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304641	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of STIM2 mRNA	PMID:33387578
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of STIM2 mRNA	PMID:28818685
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312199	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STIM2 mRNA	PMID:37236586
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of STIM2 gene	PMID:27153756
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of STIM2 gene	PMID:25304211
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of STIM2 protein	PMID:35688186
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of STIM2 mRNA	PMID:28903495
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304641	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STIM2 mRNA	PMID:22298810
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304641	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of STIM2 mRNA	PMID:21215274|PMID:33387578|PMID:34747641
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of STIM2 mRNA	PMID:20106945|PMID:21632981
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312199	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of STIM2 mRNA	PMID:28922406
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of STIM2 mRNA	PMID:28001369
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of STIM2 mRNA	PMID:33212167
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of STIM2 mRNA	PMID:30851411
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of STIM2 mRNA	PMID:29803840
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of STIM2 protein	PMID:35688186
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STIM2 mRNA	PMID:21632981
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312199	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of STIM2 gene	PMID:35295148
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of STIM2 mRNA	PMID:23811191
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of STIM2 mRNA	PMID:33670352
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304641	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STIM2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304641	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of STIM2 mRNA	PMID:34947998
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of STIM2 mRNA	PMID:28628672
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of STIM2 mRNA	PMID:39298647
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312199	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of STIM2 exon	PMID:33297965
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304641	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of STIM2 mRNA	PMID:21266533
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of STIM2 mRNA	PMID:28628672
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:34967	rimonabant	affects expression	ISO	RGD:1312199	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant affects the expression of STIM2 mRNA	PMID:19030233
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1312199	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of STIM2 mRNA]	PMID:19030233
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304641	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of STIM2 mRNA	PMID:33453195
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312199	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STIM2 mRNA	PMID:37236586
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of STIM2 mRNA	PMID:24449571
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of STIM2 mRNA	PMID:23811191
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of STIM2 mRNA	PMID:40194260
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STIM2 mRNA	PMID:25979313
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of STIM2 mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of STIM2 mRNA	PMID:28628672
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of STIM2 mRNA	PMID:38832940
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312199	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of STIM2 mRNA	PMID:17562736
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of STIM2 mRNA	PMID:21420995
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304641	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of STIM2 mRNA	PMID:33387578
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of STIM2 gene	PMID:25304211
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1312199	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of STIM2 mRNA	PMID:35436446
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of STIM2 mRNA	PMID:28628672
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of STIM2 mRNA	PMID:20977926
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of STIM2 protein	PMID:32959892
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of STIM2 mRNA	PMID:22206623
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of STIM2 mRNA	PMID:30851411
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312199	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of STIM2 mRNA	PMID:19270015
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of STIM2 mRNA	PMID:26079696
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312199	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of STIM2 mRNA	PMID:21278054
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312199	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of STIM2 protein	PMID:24648495
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of STIM2 mRNA	PMID:27188386
1312198	STIM2	stromal interaction molecule 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304641	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of STIM2 mRNA	PMID:22570695
1312200	FOXD2	forkhead box D2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312201	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FOXD2 mRNA	PMID:33045310
1312200	FOXD2	forkhead box D2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXD2 gene	PMID:20938992
1312200	FOXD2	forkhead box D2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of FOXD2 mRNA	PMID:30951980
1312200	FOXD2	forkhead box D2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of FOXD2 mRNA	PMID:20044591
1312200	FOXD2	forkhead box D2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of FOXD2 mRNA	PMID:31614463
1312200	FOXD2	forkhead box D2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304642	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FOXD2 mRNA	PMID:33387578
1312200	FOXD2	forkhead box D2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXD2 gene	PMID:20938992
1312200	FOXD2	forkhead box D2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20250902	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FOXD2 mRNA; [imeglimin co-treated with Glucose] results in increased expression of FOXD2 mRNA	PMID:34588186|PMID:37992649
1312200	FOXD2	forkhead box D2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20250902	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FOXD2 mRNA; [imeglimin co-treated with Glucose] results in increased expression of FOXD2 mRNA	PMID:34588186|PMID:37992649
1312200	FOXD2	forkhead box D2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304642	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FOXD2 mRNA	PMID:33387578
1312200	FOXD2	forkhead box D2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FOXD2 mRNA	PMID:19549813
1312200	FOXD2	forkhead box D2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1304642	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD2 mRNA	PMID:22129741
1312200	FOXD2	forkhead box D2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXD2 gene	PMID:20938992
1312200	FOXD2	forkhead box D2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXD2 mRNA	PMID:23557933
1312200	FOXD2	forkhead box D2	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of FOXD2 mRNA	PMID:23300844
1312200	FOXD2	forkhead box D2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of FOXD2 mRNA	PMID:27392435
1312200	FOXD2	forkhead box D2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312201	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FOXD2 mRNA	PMID:24058054
1312200	FOXD2	forkhead box D2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FOXD2 mRNA	PMID:37992649
1312200	FOXD2	forkhead box D2	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of FOXD2 mRNA	PMID:20044591
1312200	FOXD2	forkhead box D2	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1304642	E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD2 mRNA	PMID:22129741
1312200	FOXD2	forkhead box D2	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of FOXD2 mRNA	PMID:29453283
1312200	FOXD2	forkhead box D2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FOXD2 mRNA	PMID:32234424
1312200	FOXD2	forkhead box D2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FOXD2 3' UTR; Benzo(a)pyrene results in increased methylation of FOXD2 exon	PMID:27901495
1312200	FOXD2	forkhead box D2	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of FOXD2 promoter	PMID:23974009
1312200	FOXD2	forkhead box D2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of FOXD2 mRNA	PMID:25895662
1312200	FOXD2	forkhead box D2	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1312201	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of FOXD2 gene	PMID:35295148
1312200	FOXD2	forkhead box D2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312201	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FOXD2 enhancer	PMID:35295148
1312200	FOXD2	forkhead box D2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312201	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of FOXD2 promoter	PMID:27334623
1312200	FOXD2	forkhead box D2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312201	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of FOXD2 mRNA	PMID:30951980
1312200	FOXD2	forkhead box D2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of FOXD2 gene	PMID:31601247
1312200	FOXD2	forkhead box D2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312201	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FOXD2 mRNA	PMID:30951980
1312200	FOXD2	forkhead box D2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of FOXD2 mRNA	PMID:30951980
1312200	FOXD2	forkhead box D2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312201	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of FOXD2 mRNA	PMID:30951980
1312200	FOXD2	forkhead box D2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312201	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of FOXD2 mRNA	PMID:32715474|PMID:37019170
1312200	FOXD2	forkhead box D2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304642	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FOXD2 mRNA	PMID:22129741
1312200	FOXD2	forkhead box D2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FOXD2 mRNA	PMID:37042841
1312200	FOXD2	forkhead box D2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of FOXD2 mRNA	PMID:24449571
1312200	FOXD2	forkhead box D2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312201	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of FOXD2 mRNA	PMID:17292431
1312200	FOXD2	forkhead box D2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in increased expression of FOXD2 mRNA	PMID:23527032
1312200	FOXD2	forkhead box D2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FOXD2 gene	PMID:29154799
1312200	FOXD2	forkhead box D2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20250902	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FOXD2 mRNA; [imeglimin co-treated with Glucose] results in increased expression of FOXD2 mRNA	PMID:34588186|PMID:37992649
1312200	FOXD2	forkhead box D2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304642	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FOXD2 mRNA	PMID:33387578
1312200	FOXD2	forkhead box D2	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of FOXD2 promoter	PMID:29626692
1312200	FOXD2	forkhead box D2	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of FOXD2 promoter	PMID:29626692
1312200	FOXD2	forkhead box D2	gene	CHEBI:46680	serpentine asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of FOXD2 promoter	PMID:29626692
1312200	FOXD2	forkhead box D2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of FOXD2 mRNA	PMID:23300844
1312200	FOXD2	forkhead box D2	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of FOXD2 mRNA	PMID:28988120
1312200	FOXD2	forkhead box D2	gene	CHEBI:756996	imeglimin	multiple interactions	ISO	RGD:1312201	E	RGD:6480464	20260714	CTD	MESH:C575881	[imeglimin co-treated with Glucose] results in increased expression of FOXD2 mRNA	PMID:34588186
1312200	FOXD2	forkhead box D2	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312201	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of FOXD2 mRNA	PMID:40826991
1312200	FOXD2	forkhead box D2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of FOXD2 mRNA	PMID:38568856
1312200	FOXD2	forkhead box D2	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in decreased expression of FOXD2 mRNA	PMID:29453283
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SLC52A3 mRNA	PMID:26272509
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA	PMID:27188386
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312204	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of SLC52A3 mRNA	PMID:36189433
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312204	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC52A3 mRNA	PMID:36189433
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1304644	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of SLC52A3 mRNA	PMID:36841081
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D001280	Atrazine results in increased expression of SLC52A3 mRNA	PMID:22378314
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:16238	FAD	multiple interactions	ISO	RGD:1304644	E	RGD:6480464	20120412	CTD	MESH:D005182	Flavin-Adenine Dinucleotide inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]	PMID:19122205
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312204	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SLC52A3 mRNA	PMID:39241906
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304644	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of SLC52A3 mRNA	PMID:26496021
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC52A3 mRNA	PMID:38568856
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304644	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC52A3 mRNA	PMID:33387578
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:17015	riboflavin	increases transport	ISO	RGD:1304644	E	RGD:6480464	20120412	CTD	MESH:D012256	SLC52A3 protein results in increased transport of Riboflavin	PMID:19122205
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:17015	riboflavin	multiple interactions	ISO	RGD:1304644	E	RGD:6480464	20120412	CTD	MESH:D012256	Acids promotes the reaction [SLC52A3 protein results in increased transport of Riboflavin]; Amiloride inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]; Flavin Mononucleotide inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]; Flavin-Adenine Dinucleotide inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]; lumiflavin inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]	PMID:19122205
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SLC52A3 mRNA	PMID:26079696
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312204	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC52A3 mRNA	PMID:37992649
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312204	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SLC52A3 mRNA	PMID:36189433
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312204	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SLC52A3 mRNA	PMID:36189433
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SLC52A3 mRNA	PMID:33359661
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312204	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SLC52A3 mRNA	PMID:33848595
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:17621	FMN	multiple interactions	ISO	RGD:1304644	E	RGD:6480464	20120412	CTD	MESH:D005486	Flavin Mononucleotide inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]	PMID:19122205
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312204	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC52A3 mRNA	PMID:37992649
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312204	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SLC52A3 mRNA	PMID:34319233
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304644	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SLC52A3 mRNA	PMID:33387578
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:2639	amiloride	multiple interactions	ISO	RGD:1304644	E	RGD:6480464	20120412	CTD	MESH:D000584	Amiloride inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]	PMID:19122205
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC52A3 mRNA	PMID:40512198
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304644	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLC52A3 mRNA	PMID:31881176
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC52A3 mRNA	PMID:23557933
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC52A3 mRNA	PMID:30851411
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304644	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SLC52A3 mRNA	PMID:28959563
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312204	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC52A3 mRNA	PMID:37992649
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:29021	hexane	decreases methylation	ISO	RGD:1304644	E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of SLC52A3 promoter	PMID:23740543
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:29678	sodium arsenite	decreases methylation	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased methylation of SLC52A3 intron	PMID:32844245
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC52A3 mRNA	PMID:29301061|PMID:32844245
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of SLC52A3 promoter; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC52A3 mRNA	PMID:18448484|PMID:40512198
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SLC52A3 exon; Benzo(a)pyrene results in decreased methylation of SLC52A3 promoter	PMID:27901495
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC52A3 mRNA	PMID:32234424
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312204	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SLC52A3 mRNA	PMID:27131904
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SLC52A3 mRNA	PMID:25895662
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312204	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SLC52A3 mRNA	PMID:23557971
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304644	E	RGD:6480464	20160210	CTD	MESH:C006780	bisphenol A affects the expression of SLC52A3 mRNA	PMID:25181051
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304644	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC52A3 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312204	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC52A3 mRNA	PMID:30245210
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of SLC52A3 mRNA	PMID:31715268
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312204	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of SLC52A3 mRNA	PMID:32156529
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304644	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of SLC52A3 mRNA	PMID:26496021
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312204	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SLC52A3 mRNA	PMID:26682919
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of SLC52A3 gene	PMID:31601247
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312204	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SLC52A3 mRNA	PMID:37019170
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1304644	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SLC52A3 gene	PMID:22079235
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SLC52A3 mRNA	PMID:24449571
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312204	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLC52A3 mRNA	PMID:40194260
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLC52A3 mRNA	PMID:25979313
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC52A3 mRNA	PMID:23179753|PMID:23527032|PMID:26272509
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA	PMID:27188386
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312204	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SLC52A3 mRNA	PMID:28973697
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312204	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC52A3 mRNA	PMID:37992649
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:43661	lumiflavin	multiple interactions	ISO	RGD:1304644	E	RGD:6480464	20120412	CTD	MESH:C001922	lumiflavin inhibits the reaction [SLC52A3 protein results in increased transport of Riboflavin]	PMID:19122205
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304644	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC52A3 mRNA	PMID:33387578
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC52A3 mRNA	PMID:40512198
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304644	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SLC52A3 mRNA	PMID:30307764
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312204	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SLC52A3 mRNA	PMID:25554681
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312204	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC52A3 mRNA	PMID:22206623
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC52A3 mRNA	PMID:30851411
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA	PMID:27188386
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of SLC52A3 mRNA	PMID:26272509
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA	PMID:27188386
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC52A3 mRNA	PMID:27188386
1312203	SLC52A3	solute carrier family 52 member 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312204	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SLC52A3 mRNA	PMID:27131904
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of DIS3 mRNA	PMID:26272509
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIS3 mRNA	PMID:27188386
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312207	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DIS3 mRNA	PMID:30529165
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312207	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DIS3 mRNA	PMID:39241906
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304646	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DIS3 mRNA	PMID:33387578
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DIS3 mRNA	PMID:37042841
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312207	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of DIS3 mRNA	PMID:23892564
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in decreased expression of DIS3 protein	PMID:34122009
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DIS3 protein	PMID:37730182
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of DIS3 mRNA	PMID:24067728
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of DIS3 mRNA	PMID:24376830
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DIS3 protein	PMID:23301498
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DIS3 gene	PMID:27153756
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304646	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DIS3 mRNA	PMID:31150632
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312207	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DIS3 mRNA	PMID:27339419|PMID:31919559
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312207	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DIS3 mRNA	PMID:22206623
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312207	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of DIS3 mRNA	PMID:28960355
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DIS3 mRNA	PMID:23557933
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312207	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of DIS3 mRNA	PMID:40618947
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312207	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DIS3 mRNA	PMID:21570461
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of DIS3 protein	PMID:39603559
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DIS3 mRNA	PMID:28001369
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of DIS3 mRNA	PMID:22378314
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312207	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of DIS3 protein	PMID:37955338
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DIS3 mRNA	PMID:25351596
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of DIS3 mRNA	PMID:23557971|PMID:29264374
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312207	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DIS3 promoter	PMID:35295148
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304646	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DIS3 mRNA	PMID:23411599|PMID:34492290
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312207	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of DIS3 mRNA	PMID:23811191
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of DIS3 protein	PMID:31675489|PMID:37567409
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DIS3 mRNA	PMID:33221593
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of DIS3 mRNA	PMID:40203079
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312207	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DIS3 mRNA	PMID:39298647
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DIS3 mRNA	PMID:37019170
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DIS3 mRNA	PMID:37042841
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312207	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of DIS3 mRNA	PMID:28903501
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DIS3 mRNA	PMID:28302478
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of DIS3 mRNA	PMID:39529242
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of DIS3 mRNA	PMID:31558096
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312207	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DIS3 mRNA	PMID:17292431
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DIS3 gene	PMID:29154799
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of DIS3 mRNA	PMID:28542535
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312207	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DIS3 mRNA	PMID:17562736
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304646	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DIS3 mRNA	PMID:33387578
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312207	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of DIS3 mRNA	PMID:35436446
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312207	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DIS3 mRNA; Nanotubes, Carbon results in increased expression of DIS3 mRNA	PMID:25554681|PMID:25620056
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:50729	mitoxantrone	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	DIS3 protein affects the susceptibility to Mitoxantrone	PMID:16217747
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312207	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DIS3 mRNA	PMID:19042947
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DIS3 protein	PMID:32959892
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1304646	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of DIS3 mRNA	PMID:19564919
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of DIS3 protein	PMID:34122009
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312207	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DIS3 mRNA	PMID:22206623
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312207	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DIS3 mRNA	PMID:22206623
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DIS3 protein	PMID:37664457
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIS3 mRNA	PMID:27188386
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312207	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of DIS3 mRNA	PMID:30294300
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DIS3 protein	PMID:31675489
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of DIS3 protein	PMID:31675489
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DIS3 protein	PMID:38348393
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DIS3 protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DIS3 mRNA	PMID:27188386|PMID:37664457
1312206	DIS3	DIS3 exosome endoribonuclease and 3'-5' exoribonuclease	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304646	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of DIS3 mRNA	PMID:23555832
1312208	SNX6	sorting nexin 6	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312209	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of SNX6 mRNA	PMID:37995155
1312208	SNX6	sorting nexin 6	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of SNX6 mRNA	PMID:22378314
1312208	SNX6	sorting nexin 6	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312209	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SNX6 mRNA	PMID:23892564
1312208	SNX6	sorting nexin 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312209	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SNX6 mRNA	PMID:33754040
1312208	SNX6	sorting nexin 6	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304647	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SNX6 protein	PMID:22061828
1312208	SNX6	sorting nexin 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312209	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNX6 mRNA	PMID:36331819
1312208	SNX6	sorting nexin 6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SNX6 mRNA	PMID:19549813
1312208	SNX6	sorting nexin 6	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SNX6 protein	PMID:23301498
1312208	SNX6	sorting nexin 6	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1312209	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of SNX6 mRNA	PMID:19376150
1312208	SNX6	sorting nexin 6	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SNX6 mRNA	PMID:35430440
1312208	SNX6	sorting nexin 6	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SNX6 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SNX6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SNX6 protein	PMID:38598786
1312208	SNX6	sorting nexin 6	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of SNX6 mRNA	PMID:15672453
1312208	SNX6	sorting nexin 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312209	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SNX6 mRNA	PMID:31919559
1312208	SNX6	sorting nexin 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312209	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX6 mRNA	PMID:22206623
1312208	SNX6	sorting nexin 6	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312209	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SNX6 mRNA	PMID:28960355
1312208	SNX6	sorting nexin 6	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1304647	E	RGD:6480464	20190702	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of SNX6 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SNX6 protein	PMID:30738087
1312208	SNX6	sorting nexin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304647	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX6 mRNA	PMID:34747641
1312208	SNX6	sorting nexin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312209	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX6 mRNA	PMID:21570461
1312208	SNX6	sorting nexin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312209	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNX6 mRNA	PMID:15034205
1312208	SNX6	sorting nexin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312209	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of SNX6 mRNA]	PMID:15034205
1312208	SNX6	sorting nexin 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SNX6 mRNA	PMID:33212167
1312208	SNX6	sorting nexin 6	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of SNX6 mRNA	PMID:25523186
1312208	SNX6	sorting nexin 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNX6 protein	PMID:38228842
1312208	SNX6	sorting nexin 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1304647	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNX6 protein	PMID:29459688
1312208	SNX6	sorting nexin 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SNX6 mRNA	PMID:38568856
1312208	SNX6	sorting nexin 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNX6 mRNA alternative form	PMID:40419235
1312208	SNX6	sorting nexin 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312209	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNX6 mRNA	PMID:15034205
1312208	SNX6	sorting nexin 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SNX6 promoter	PMID:27901495
1312208	SNX6	sorting nexin 6	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312209	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of SNX6 mRNA]	PMID:15034205
1312208	SNX6	sorting nexin 6	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of SNX6 mRNA	PMID:25523186
1312208	SNX6	sorting nexin 6	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1304647	E	RGD:6480464	20190702	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of SNX6 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of SNX6 protein	PMID:30738087
1312208	SNX6	sorting nexin 6	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312209	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of SNX6 mRNA	PMID:17656681
1312208	SNX6	sorting nexin 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312209	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SNX6 gene	PMID:35295148
1312208	SNX6	sorting nexin 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304647	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SNX6 mRNA	PMID:23411599|PMID:34492290
1312208	SNX6	sorting nexin 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312209	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SNX6 mRNA	PMID:18648102
1312208	SNX6	sorting nexin 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of SNX6 protein	PMID:31675489
1312208	SNX6	sorting nexin 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SNX6 protein	PMID:37567409
1312208	SNX6	sorting nexin 6	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of SNX6 mRNA	PMID:19244175
1312208	SNX6	sorting nexin 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SNX6 protein	PMID:34186270
1312208	SNX6	sorting nexin 6	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312209	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of SNX6 mRNA	PMID:28392331
1312208	SNX6	sorting nexin 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312209	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SNX6 mRNA	PMID:17361019
1312208	SNX6	sorting nexin 6	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SNX6 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SNX6 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SNX6 protein	PMID:38598786
1312208	SNX6	sorting nexin 6	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312209	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SNX6 mRNA	PMID:34813904
1312208	SNX6	sorting nexin 6	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SNX6 mRNA	PMID:24449571
1312208	SNX6	sorting nexin 6	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of SNX6 protein	PMID:34122009
1312208	SNX6	sorting nexin 6	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SNX6 mRNA	PMID:28302478
1312208	SNX6	sorting nexin 6	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SNX6 mRNA	PMID:31533062
1312208	SNX6	sorting nexin 6	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX6 mRNA	PMID:19167446
1312208	SNX6	sorting nexin 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312209	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNX6 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SNX6 mRNA	PMID:36331819
1312208	SNX6	sorting nexin 6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SNX6 mRNA	PMID:23179753|PMID:27188386
1312208	SNX6	sorting nexin 6	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of SNX6 mRNA	PMID:21163907|PMID:27989131
1312208	SNX6	sorting nexin 6	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312209	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SNX6 mRNA	PMID:28973697
1312208	SNX6	sorting nexin 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312209	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNX6 mRNA	PMID:17562736
1312208	SNX6	sorting nexin 6	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	SNX6 protein affects the susceptibility to Fluorouracil	PMID:16217747
1312208	SNX6	sorting nexin 6	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SNX6 protein	PMID:32959892
1312208	SNX6	sorting nexin 6	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312209	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SNX6 mRNA	PMID:23650126
1312208	SNX6	sorting nexin 6	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SNX6 protein	PMID:34186270
1312208	SNX6	sorting nexin 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312209	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SNX6 mRNA	PMID:22206623
1312208	SNX6	sorting nexin 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312209	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX6 mRNA	PMID:22206623
1312208	SNX6	sorting nexin 6	gene	CHEBI:80025	Salinomycin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of SNX6 mRNA	PMID:19682730
1312208	SNX6	sorting nexin 6	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX6 mRNA	PMID:19167446
1312208	SNX6	sorting nexin 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304647	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SNX6 mRNA	PMID:21346803
1312208	SNX6	sorting nexin 6	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SNX6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SNX6 protein	PMID:38598786
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of PSKH1 mRNA	PMID:31016361
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551980	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PSKH1 mRNA	PMID:39241906
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304648	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PSKH1 mRNA	PMID:33387578
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PSKH1 mRNA	PMID:37042841
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304648	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PSKH1 mRNA	PMID:33387578
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1551980	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PSKH1 mRNA	PMID:36331819
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PSKH1 mRNA	PMID:19549813
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304648	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PSKH1 mRNA	PMID:31150632
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551980	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSKH1 mRNA	PMID:21570461
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304648	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PSKH1 mRNA	PMID:33387578
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PSKH1 mRNA	PMID:29803840
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PSKH1 mRNA	PMID:38568856
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of PSKH1 mRNA	PMID:39719251
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PSKH1 promoter	PMID:27901495
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PSKH1 mRNA	PMID:22316170|PMID:26238291
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PSKH1 5' UTR	PMID:27901495
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of PSKH1 mRNA	PMID:35984750
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551980	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PSKH1 gene	PMID:35295148
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304648	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PSKH1 mRNA	PMID:34492290
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1551980	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PSKH1 mRNA	PMID:20813756
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304648	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PSKH1 mRNA	PMID:34947998
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304648	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PSKH1 mRNA	PMID:25181051
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551980	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PSKH1 mRNA	PMID:39298647
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PSKH1 mRNA	PMID:28628672
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1551980	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PSKH1 mRNA	PMID:34813904
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PSKH1 mRNA	PMID:28628672
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1551980	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of PSKH1 mRNA	PMID:34813904
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1551980	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PSKH1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PSKH1 mRNA	PMID:36331819
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PSKH1 gene	PMID:29154799
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PSKH1 mRNA	PMID:25562108
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1551980	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of PSKH1 mRNA	PMID:25123088
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PSKH1 mRNA	PMID:28628672
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PSKH1 mRNA	PMID:38832940
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of PSKH1 mRNA	PMID:22077320
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PSKH1 mRNA	PMID:28628672
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of PSKH1 mRNA	PMID:28988120
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PSKH1 mRNA	PMID:37199045
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PSKH1 mRNA	PMID:29301935
1312210	PSKH1	protein serine kinase H1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304648	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PSKH1 mRNA	PMID:23034163
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of CDC14A mRNA	PMID:35967413
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CDC14A mRNA	PMID:26272509
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA	PMID:27188386
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of CDC14A mRNA	PMID:23727915
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of CDC14A mRNA	PMID:30510588
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [CDC14A protein binds to ESR1 protein]	PMID:27156127
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304649	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of CDC14A mRNA	PMID:26496021
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CDC14A mRNA	PMID:37042841
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312212	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDC14A mRNA	PMID:37992649
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312212	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of CDC14A mRNA	PMID:33848595
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312212	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of CDC14A mRNA]	PMID:33848595
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312212	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDC14A mRNA	PMID:37992649
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304649	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CDC14A mRNA	PMID:26577399
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CDC14A protein	PMID:37730182
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CDC14A mRNA	PMID:28818685
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304649	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDC14A mRNA	PMID:39012411
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CDC14A mRNA	PMID:35430440
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312212	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CDC14A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CDC14A mRNA	PMID:27106289|PMID:34911549
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1304649	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of CDC14A mRNA	PMID:31129395
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CDC14A mRNA	PMID:26272509
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA	PMID:27188386
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304649	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CDC14A mRNA	PMID:31881176
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of CDC14A mRNA	PMID:27392435
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1312212	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in increased expression of CDC14A mRNA	PMID:18922574
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304649	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC14A mRNA	PMID:22298810|PMID:32109520
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304649	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC14A mRNA	PMID:33387578
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304649	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDC14A mRNA	PMID:34747641
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CDC14A mRNA	PMID:30911355
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDC14A mRNA	PMID:29803840
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312212	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDC14A mRNA	PMID:37992649
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of CDC14A gene	PMID:28589171
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDC14A mRNA	PMID:34032870
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312212	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDC14A mRNA	PMID:37682722
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CDC14A mRNA	PMID:38568856
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CDC14A mRNA	PMID:22316170
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312212	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CDC14A mRNA	PMID:19770486
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to CDC14A mRNA]	PMID:32406909
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CDC14A mRNA	PMID:30911355
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CDC14A gene	PMID:31601247
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304649	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CDC14A mRNA	PMID:25729387
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:32130	silver(1+) nitrate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in increased expression of CDC14A mRNA	PMID:22831968
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312212	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CDC14A mRNA	PMID:23557971
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312212	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDC14A gene	PMID:35295148
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312212	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CDC14A mRNA	PMID:35295148
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312212	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CDC14A gene	PMID:35295148
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312212	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CDC14A mRNA	PMID:28472532
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304649	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CDC14A mRNA	PMID:25181051
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304649	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CDC14A mRNA	PMID:30816183|PMID:32528016
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CDC14A gene	PMID:31601247
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304649	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of CDC14A mRNA; [bisphenol A co-treated with tributyltin] results in decreased expression of CDC14A mRNA	PMID:26496021|PMID:31129395
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:3374	capsaicin	increases expression	ISO	RGD:1304649	E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin results in increased expression of CDC14A mRNA	PMID:20349343
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312212	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CDC14A gene	PMID:31683443
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312212	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of CDC14A intron	PMID:28392331
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304649	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CDC14A mRNA	PMID:21266533
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312212	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CDC14A mRNA	PMID:21266533
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDC14A mRNA	PMID:37042841
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304649	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDC14A mRNA	PMID:39012411
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1304649	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CDC14A mRNA	PMID:24386269
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CDC14A mRNA	PMID:31533062
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CDC14A mRNA	PMID:25979313
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CDC14A mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA	PMID:27188386
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312212	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDC14A mRNA	PMID:37992649
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:4356	desferrioxamine B	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003676	Deferoxamine results in increased expression of CDC14A mRNA alternative form	PMID:16760464
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CDC14A mRNA	PMID:38832940
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CDC14A mRNA	PMID:24935251|PMID:26272509
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA	PMID:27188386
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304649	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDC14A mRNA	PMID:33387578
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of CDC14A mRNA	PMID:24714768
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304649	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CDC14A mRNA	PMID:29391264
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CDC14A mRNA	PMID:32234424
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:50594	carbon nanotube	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CDC14A mRNA	PMID:15585362
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312212	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CDC14A mRNA; Nanotubes, Carbon results in decreased expression of CDC14A mRNA	PMID:25554681
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304649	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of CDC14A mRNA	PMID:24793618
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312212	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CDC14A mRNA	PMID:38701926
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1304649	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of CDC14A mRNA	PMID:25729387
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304649	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CDC14A mRNA	PMID:25729387
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CDC14A mRNA	PMID:28988120
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1304649	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CDC14A mRNA	PMID:27567155
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312212	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of CDC14A mRNA	PMID:22206623
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA	PMID:27188386
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CDC14A gene]	PMID:28238834
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:79995	GW 3965	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C473027	GW 3965 results in increased expression of CDC14A mRNA	PMID:31437187
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312212	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of CDC14A mRNA	PMID:30953684
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC14A mRNA	PMID:27188386
1312211	CDC14A	cell division cycle 14A	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304649	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CDC14A mRNA	PMID:19015723
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PPP1R13B mRNA	PMID:38218311
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PPP1R13B mRNA	PMID:21934132|PMID:23724009
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1304651	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of PPP1R13B mRNA	PMID:20488242
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPP1R13B mRNA	PMID:36331819
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PPP1R13B mRNA	PMID:22378314
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of PPP1R13B mRNA	PMID:30510588
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312215	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PPP1R13B mRNA	PMID:39298647
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PPP1R13B mRNA	PMID:21179406
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of PPP1R13B mRNA	PMID:33647349
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312215	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PPP1R13B mRNA	PMID:23892564
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PPP1R13B protein	PMID:37730182
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304651	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of PPP1R13B mRNA	PMID:22061828
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304651	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PPP1R13B mRNA	PMID:33387578
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PPP1R13B mRNA	PMID:28818685
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312215	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PPP1R13B mRNA	PMID:19770486
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PPP1R13B mRNA	PMID:23649840
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PPP1R13B mRNA	PMID:35430440
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PPP1R13B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PPP1R13B mRNA	PMID:34911549
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PPP1R13B mRNA	PMID:22206623
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPP1R13B gene	PMID:25304211
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PPP1R13B mRNA	PMID:40512198
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PPP1R13B protein	PMID:35688186
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PPP1R13B mRNA	PMID:27392435
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PPP1R13B mRNA	PMID:27392435
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312215	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPP1R13B mRNA	PMID:21570461|PMID:24680724
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304651	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPP1R13B mRNA	PMID:33387578
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PPP1R13B mRNA	PMID:29803840
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPP1R13B mRNA	PMID:39900124
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312215	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPP1R13B protein	PMID:29044176
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PPP1R13B mRNA	PMID:38568856
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PPP1R13B mRNA	PMID:40512198
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D014415	Tunicamycin results in decreased expression of PPP1R13B mRNA	PMID:39900124
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PPP1R13B promoter	PMID:27901495
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312215	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PPP1R13B intron	PMID:27901495
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PPP1R13B mRNA]	PMID:32406909
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PPP1R13B mRNA	PMID:21461292
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PPP1R13B mRNA	PMID:19710929
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304651	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of PPP1R13B mRNA	PMID:33296240
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PPP1R13B gene	PMID:31601247
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304651	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PPP1R13B mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312215	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PPP1R13B mRNA	PMID:26063408
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of PPP1R13B mRNA	PMID:36804509
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312215	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PPP1R13B mRNA	PMID:30951980|PMID:33297965
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312215	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of PPP1R13B promoter	PMID:33297965
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312215	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PPP1R13B mRNA	PMID:30951980
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1312215	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of PPP1R13B mRNA	PMID:31558096
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1304651	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of PPP1R13B mRNA	PMID:22546817
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:34687	dibutyl phthalate	affects expression	ISO	RGD:1304651	E	RGD:6480464	20190910	CTD	MESH:D003993	Dibutyl Phthalate affects the expression of PPP1R13B mRNA	PMID:30934153
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1304651	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of PPP1R13B mRNA	PMID:22546817
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1304651	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of PPP1R13B mRNA	PMID:22546817
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPP1R13B mRNA	PMID:37042841
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride affects the expression of PPP1R13B mRNA	PMID:23828170
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PPP1R13B mRNA	PMID:28302478
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PPP1R13B mRNA	PMID:31533062
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PPP1R13B mRNA	PMID:40419075
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPP1R13B mRNA	PMID:36331819
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312215	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PPP1R13B mRNA	PMID:17963808
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PPP1R13B gene	PMID:29154799
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:4042	cypermethrin	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C017160	cypermethrin results in increased expression of PPP1R13B protein	PMID:36063984
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312215	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PPP1R13B mRNA	PMID:17555576
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PPP1R13B mRNA	PMID:38832940
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312215	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PPP1R13B mRNA	PMID:17562736
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of PPP1R13B mRNA	PMID:26690555
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPP1R13B gene	PMID:25304211
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PPP1R13B mRNA	PMID:40512198
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312215	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PPP1R13B mRNA	PMID:17555576
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PPP1R13B mRNA	PMID:21461292
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312215	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PPP1R13B mRNA; Nanotubes, Carbon results in decreased expression of PPP1R13B mRNA	PMID:25554681
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PPP1R13B mRNA	PMID:35964746
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PPP1R13B mRNA	PMID:31758290
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312215	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PPP1R13B mRNA	PMID:22206623
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312215	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PPP1R13B mRNA	PMID:22206623
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304651	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PPP1R13B mRNA	PMID:32109520
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of PPP1R13B mRNA	PMID:16202921
1312214	PPP1R13B	protein phosphatase 1 regulatory subunit 13B	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PPP1R13B mRNA	PMID:38568856
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MAD1L1 mRNA	PMID:38218311
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312219	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of MAD1L1 mRNA	PMID:33045310
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1596881	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MAD1L1 mRNA]	PMID:31150632
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MAD1L1 mRNA	PMID:16140955
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MAD1L1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MAD1L1 mRNA	PMID:32699268
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1596881	E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in decreased expression of MAD1L1 protein	PMID:40631627
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MAD1L1 mRNA	PMID:21632981
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D011794	Quercetin results in increased expression of MAD1L1 protein	PMID:14750173
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312219	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MAD1L1 mRNA	PMID:39241906
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:164200	triclosan	increases methylation	EXP		E	RGD:6480464	20220607	CTD	MESH:D014260	Triclosan results in increased methylation of MAD1L1 gene	PMID:34523531
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of MAD1L1 mRNA	PMID:16474171
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of MAD1L1 mRNA	PMID:20404318
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MAD1L1 mRNA	PMID:37042841
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MAD1L1 gene	PMID:30521419
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1312219	E	RGD:6480464	20221101	CTD	MESH:D008550	Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of MAD1L1 mRNA]; Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of MAD1L1 protein]	PMID:35643323
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of MAD1L1 mRNA	PMID:23649840
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1596881	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of MAD1L1 protein	PMID:40631627
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1596881	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of MAD1L1 protein	PMID:40631627
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1596881	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MAD1L1 mRNA	PMID:26577399
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MAD1L1 protein	PMID:37730182
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MAD1L1 mRNA	PMID:36139627
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of MAD1L1 intron	PMID:30157460
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:2038	5-azacytidine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001374	Azacitidine results in decreased expression of MAD1L1 mRNA	PMID:19194470
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MAD1L1 mRNA	PMID:19549813
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MAD1L1 mRNA	PMID:23649840
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MAD1L1 protein	PMID:20106945
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of MAD1L1 intron	PMID:30157460
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MAD1L1 mRNA	PMID:22100608|PMID:27153756|PMID:32234424
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MAD1L1 mRNA	PMID:23649840
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MAD1L1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MAD1L1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of MAD1L1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of MAD1L1 mRNA	PMID:32699268|PMID:35430440
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1596881	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MAD1L1 mRNA	PMID:31150632
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1596881	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MAD1L1 mRNA]	PMID:31150632
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MAD1L1 gene	PMID:25304211
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312219	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAD1L1 mRNA	PMID:40504410
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C024565	ethylene dichloride results in increased expression of MAD1L1 mRNA alternative form	PMID:37028497
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of MAD1L1 mRNA	PMID:21532991|PMID:27392435
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312219	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of MAD1L1 mRNA	PMID:40618947
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312219	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MAD1L1 mRNA	PMID:30912803
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of MAD1L1 mRNA	PMID:16474171
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312219	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAD1L1 mRNA	PMID:21570461
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1596881	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAD1L1 mRNA	PMID:33387578
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312219	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAD1L1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MAD1L1 mRNA	PMID:17942748|PMID:25975270
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1596881	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of MAD1L1 mRNA	PMID:28959563
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MAD1L1 mRNA	PMID:29803840
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of MAD1L1 mRNA	PMID:34032870
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312219	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAD1L1 mRNA	PMID:40504410
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MAD1L1 intron	PMID:30157460
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAD1L1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291|PMID:32234424
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312219	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAD1L1 mRNA	PMID:22228805
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312219	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MAD1L1 exon; Benzo(a)pyrene results in increased methylation of MAD1L1 intron	PMID:27901495
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312219	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of MAD1L1 protein	PMID:37955338
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAD1L1 mRNA	PMID:19150397|PMID:20382639|PMID:26238291
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312219	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MAD1L1 mRNA	PMID:39716349
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of MAD1L1 gene	PMID:31601247
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1596881	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAD1L1 mRNA	PMID:25729387
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1596881	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MAD1L1 mRNA	PMID:30047161
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1596881	E	RGD:6480464	20180515	CTD	MESH:D013853	Thioacetamide results in decreased expression of MAD1L1 mRNA	PMID:26011634|PMID:34492290
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312219	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of MAD1L1 mRNA	PMID:23811191
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MAD1L1 mRNA	PMID:19710929
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of MAD1L1 mRNA	PMID:38479592
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312219	E	RGD:6480464	20221101	CTD	MESH:C074702	[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of MAD1L1 mRNA; [sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of MAD1L1 protein; Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of MAD1L1 mRNA]; Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of MAD1L1 protein]	PMID:35643323
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of MAD1L1 gene	PMID:31601247
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of MAD1L1 protein	PMID:31675489
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1596881	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MAD1L1 mRNA	PMID:25181051|PMID:34947998
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of MAD1L1 mRNA	PMID:16474171
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1596881	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of MAD1L1 mRNA	PMID:32145629
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of MAD1L1 gene	PMID:31601247
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MAD1L1 protein	PMID:31675489
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:34093	1-Hydroxypyrene	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C033146	[Metals, Heavy co-treated with 1-hydroxypyrene] results in increased methylation of MAD1L1 gene	PMID:39164771
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1312219	E	RGD:6480464	20120412	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of MAD1L1 mRNA	PMID:20005886
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:3423	carmustine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of MAD1L1 mRNA	PMID:15980968
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312219	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of MAD1L1 mRNA	PMID:20713471
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of MAD1L1 protein	PMID:31945527
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312219	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of MAD1L1 mRNA	PMID:39298647
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MAD1L1 gene	PMID:31601247
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of MAD1L1 intron	PMID:30157460
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1312219	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of MAD1L1 intron	PMID:28392331
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312219	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MAD1L1 mRNA	PMID:37019170
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1596881	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MAD1L1 mRNA	PMID:21266533
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1596881	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] affects the methylation of MAD1L1 gene	PMID:33148267
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MAD1L1 mRNA	PMID:36326898
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312219	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of MAD1L1 mRNA	PMID:28903501
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MAD1L1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MAD1L1 mRNA	PMID:32699268
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of MAD1L1 mRNA	PMID:19031421
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in decreased expression of MAD1L1 protein	PMID:17152098
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MAD1L1 gene	PMID:29154799
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1596881	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MAD1L1 mRNA	PMID:30047161
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of MAD1L1 promoter	PMID:27989131
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312219	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MAD1L1 mRNA	PMID:28973697
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1596881	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of MAD1L1 protein	PMID:40631627
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MAD1L1 mRNA	PMID:38832940
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of MAD1L1 gene	PMID:29523930
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:46666	crocidolite asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased methylation of MAD1L1 gene	PMID:29523930
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MAD1L1 gene	PMID:25304211
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312219	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAD1L1 mRNA	PMID:40504410
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of MAD1L1 mRNA	PMID:31675489
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1596881	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MAD1L1 mRNA	PMID:29391264
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312219	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAD1L1 mRNA	PMID:17942748
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of MAD1L1 mRNA	PMID:32234424
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1596881	E	RGD:6480464	20180515	CTD	MESH:C005223	methyleugenol results in decreased expression of MAD1L1 mRNA	PMID:26011634
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312219	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MAD1L1 mRNA	PMID:39716349
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312219	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MAD1L1 mRNA	PMID:25554681
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1596881	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MAD1L1 mRNA	PMID:30047161
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MAD1L1 protein	PMID:32959892
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1596881	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAD1L1 mRNA	PMID:25729387
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of MAD1L1 intron	PMID:30157460
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1596881	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MAD1L1 gene	PMID:35440735
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1596881	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] affects the methylation of MAD1L1 gene	PMID:33148267
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312219	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MAD1L1 mRNA	PMID:22206623
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MAD1L1 protein	PMID:31285264
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MAD1L1 mRNA	PMID:36139627
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:78671	sodium chromate	multiple interactions	ISO	RGD:1312219	E	RGD:6480464	20221101	CTD	MESH:C028982	[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of MAD1L1 mRNA; [sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of MAD1L1 protein; Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of MAD1L1 mRNA]; Melatonin inhibits the reaction [[sodium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of MAD1L1 protein]	PMID:35643323
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312219	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MAD1L1 mRNA	PMID:23091169
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1596881	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of MAD1L1 mRNA	PMID:30047161
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MAD1L1 protein	PMID:31675489
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MAD1L1 protein	PMID:31675489
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312219	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MAD1L1 mRNA	PMID:39847705
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:8461	promethazine	decreases expression	ISO	RGD:1596881	E	RGD:6480464	20180515	CTD	MESH:D011398	Promethazine results in decreased expression of MAD1L1 mRNA	PMID:26011634
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1596881	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of MAD1L1 mRNA	PMID:30047161
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312219	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of MAD1L1 mRNA	PMID:40826991
1312218	MAD1L1	mitotic arrest deficient 1 like 1	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1596881	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of MAD1L1 mRNA	PMID:30047161
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623014	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TMPRSS7 mRNA	PMID:33045310
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of TMPRSS7 mRNA	PMID:34925699
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1623014	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TMPRSS7 mRNA	PMID:20188158
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1623014	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMPRSS7 mRNA	PMID:36331819
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TMPRSS7 mRNA	PMID:26079696
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304655	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of TMPRSS7 gene	PMID:35440735
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304655	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMPRSS7 mRNA	PMID:33387578
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TMPRSS7 mRNA	PMID:26079696
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1623014	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TMPRSS7 mRNA	PMID:34319233
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304655	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TMPRSS7 mRNA	PMID:33387578
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1623014	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMPRSS7 mRNA	PMID:36331819
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:2208	purine-6-thiol	increases expression	ISO	RGD:1304655	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of TMPRSS7 mRNA	PMID:23358152
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1623014	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of TMPRSS7 mRNA	PMID:27776689
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1304655	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TMPRSS7 mRNA	PMID:22129741
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TMPRSS7 mRNA	PMID:27392435
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TMPRSS7 mRNA	PMID:27392435
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1623014	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of TMPRSS7 mRNA	PMID:32186404
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623014	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMPRSS7 mRNA	PMID:21570461
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304655	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMPRSS7 mRNA	PMID:32109520|PMID:33387578
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMPRSS7 mRNA	PMID:34032870
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of TMPRSS7 mRNA	PMID:29301061
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMPRSS7 5' UTR; Benzo(a)pyrene results in increased methylation of TMPRSS7 promoter	PMID:27901495
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1623014	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TMPRSS7 mRNA	PMID:29264374
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304655	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TMPRSS7 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304655	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of TMPRSS7 mRNA	PMID:22129741
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304655	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TMPRSS7 mRNA	PMID:27387713
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1623014	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TMPRSS7 mRNA	PMID:40194260
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623014	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMPRSS7 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMPRSS7 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TMPRSS7 mRNA	PMID:36331819
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623014	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TMPRSS7 mRNA	PMID:17562736
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:50667	mercaptopurine	increases expression	ISO	RGD:1304655	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of TMPRSS7 mRNA	PMID:23358152
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:6456	lidocaine	decreases expression	ISO	RGD:1304655	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in decreased expression of TMPRSS7 mRNA	PMID:35283115
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1304655	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of TMPRSS7 mRNA	PMID:27840820
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1304655	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of TMPRSS7 mRNA	PMID:32109520
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of TMPRSS7 mRNA	PMID:26079696
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304655	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TMPRSS7 mRNA	PMID:24780913
1312220	TMPRSS7	transmembrane serine protease 7	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	ISO	RGD:1304655	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of TMPRSS7 mRNA	PMID:23358152
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551983	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZDHHC6 mRNA	PMID:39241906
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZDHHC6 mRNA	PMID:37042841
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ZDHHC6 mRNA	PMID:21179406
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1551983	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of ZDHHC6 mRNA	PMID:23892564
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304657	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZDHHC6 mRNA	PMID:33387578
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:19452	2-amino-4,6-dinitrotoluene	affects expression	ISO	RGD:1304657	E	RGD:6480464	20140304	CTD	MESH:C035208	2-amino-4,6-dinitrotoluene affects the expression of ZDHHC6 mRNA	PMID:21346803
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304657	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZDHHC6 mRNA	PMID:39012411
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ZDHHC6 mRNA	PMID:35430440
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZDHHC6 mRNA	PMID:25629700
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1551983	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZDHHC6 mRNA	PMID:22206623
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551983	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZDHHC6 mRNA	PMID:21570461
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZDHHC6 mRNA	PMID:33212167
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZDHHC6 mRNA	PMID:29803840
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ZDHHC6 gene	PMID:28589171
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZDHHC6 mRNA	PMID:20883709
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ZDHHC6 mRNA	PMID:20458559
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551983	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZDHHC6 gene	PMID:35295148
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304657	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZDHHC6 mRNA	PMID:34492290
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1551983	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ZDHHC6 mRNA	PMID:18648102
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304657	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZDHHC6 mRNA	PMID:25181051
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1551983	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZDHHC6 mRNA	PMID:33221593
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304657	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZDHHC6 gene	PMID:28505145
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551983	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ZDHHC6 mRNA	PMID:39298647
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZDHHC6 mRNA	PMID:37019170
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ZDHHC6 mRNA	PMID:21266533
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZDHHC6 mRNA	PMID:20883709
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304657	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZDHHC6 mRNA	PMID:39012411
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ZDHHC6 mRNA	PMID:17585979
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ZDHHC6 mRNA	PMID:19167446
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZDHHC6 mRNA	PMID:25979313
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ZDHHC6 mRNA	PMID:23179753|PMID:29154799
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZDHHC6 mRNA	PMID:25562108
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of ZDHHC6 mRNA	PMID:33512557
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ZDHHC6 mRNA	PMID:22230336
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1551983	E	RGD:6480464	20120412	CTD	MESH:D000082	MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ZDHHC6 mRNA]	PMID:18700144
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ZDHHC6 mRNA	PMID:20458559
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:50292	cadmium sulfate	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20120717	CTD	MESH:C037123	cadmium sulfate results in decreased expression of ZDHHC6 mRNA	PMID:19274763
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1551983	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ZDHHC6 mRNA	PMID:25554681
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1551983	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ZDHHC6 mRNA	PMID:35964746
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ZDHHC6 mRNA	PMID:28988120
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ZDHHC6 mRNA	PMID:15003993
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1551983	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZDHHC6 mRNA	PMID:22206623
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1551983	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of ZDHHC6 mRNA	PMID:30953684
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304657	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ZDHHC6 mRNA	PMID:19281266
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ZDHHC6 mRNA	PMID:38568856
1312223	ZDHHC6	zDHHC palmitoyltransferase 6	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304657	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ZDHHC6 mRNA	PMID:23034163
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TENM4 mRNA	PMID:27188386
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TENM4 mRNA	PMID:33045310
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1304658	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TENM4 mRNA	PMID:30071829
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of TENM4; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TENM4 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TENM4 gene	PMID:20938992
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304658	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of TENM4 gene	PMID:28931070|PMID:35440735
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312225	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TENM4 mRNA	PMID:30319688
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312225	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TENM4 mRNA	PMID:30319688
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of TENM4 mRNA	PMID:19619570
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of TENM4 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TENM4 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of TENM4 mRNA	PMID:19619570|PMID:20660070|PMID:30165855
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of TENM4; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TENM4 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TENM4 gene	PMID:20938992
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of TENM4 mRNA	PMID:34673133
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of TENM4 mRNA	PMID:20660070
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA	PMID:37992649
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of TENM4 mRNA	PMID:31256213
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA	PMID:37992649
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	ISO	RGD:1312225	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of TENM4 exon; Diethylhexyl Phthalate results in decreased methylation of TENM4 gene; Diethylhexyl Phthalate results in decreased methylation of TENM4 intron	PMID:32864567
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312225	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TENM4 mRNA	PMID:33754040
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304658	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TENM4 mRNA	PMID:33387578
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of TENM4 intron	PMID:30157460
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:254496	7,12-dimethyltetraphene	affects expression	ISO	RGD:1312225	E	RGD:6480464	20120501	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene affects the expression of TENM4 mRNA	PMID:21785161
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304658	E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TENM4 mRNA	PMID:30723492
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of TENM4; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TENM4 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TENM4 gene	PMID:20938992
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TENM4 mRNA	PMID:40512198
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:1304658	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of TENM4 gene	PMID:31011160
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA]	PMID:37992649
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20120412	CTD	MESH:D003042	[Cocaine co-treated with FOS protein mutant form] results in increased expression of TENM4 mRNA	PMID:18355967
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312225	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TENM4 mRNA	PMID:21570461
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TENM4 mRNA	PMID:19619570
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TENM4 mRNA	PMID:19619570
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20210209	CTD	MESH:D013749	[Tetrachlorodibenzodioxin affects the methylation of TENM4 intron] which results in decreased expression of TENM4 mRNA	PMID:33017471
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TENM4 mRNA	PMID:28001369
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TENM4 mRNA	PMID:33212167
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of TENM4 mRNA	PMID:30807115
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304658	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TENM4 mRNA	PMID:26033743
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TENM4 mRNA	PMID:20971185
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TENM4 mRNA	PMID:29803840
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA	PMID:37992649
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA]	PMID:37992649
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of TENM4 gene	PMID:28589171
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TENM4 mRNA	PMID:34032870
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TENM4 mRNA	PMID:40512198
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1312225	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of TENM4 mRNA	PMID:22342234
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TENM4 5' UTR; Benzo(a)pyrene affects the methylation of TENM4 intron	PMID:27901495|PMID:30157460
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TENM4 mRNA	PMID:20713471|PMID:22228805|PMID:22610609
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312225	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TENM4 exon; Benzo(a)pyrene results in decreased methylation of TENM4 intron	PMID:27901495
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304658	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TENM4 mRNA	PMID:26033743
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TENM4 mRNA	PMID:20971185
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TENM4 mRNA	PMID:27131904
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TENM4 mRNA	PMID:25351596
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TENM4 mRNA	PMID:35984750
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of TENM4 gene	PMID:31601247
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of TENM4 gene	PMID:31601247
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of TENM4 mRNA	PMID:23557971
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312225	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TENM4 gene; titanium dioxide results in decreased methylation of TENM4 promoter	PMID:35295148
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312225	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TENM4 promoter	PMID:35295148
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1304658	E	RGD:6480464	20130618	CTD	MESH:C069837	fullerene C60 results in decreased expression of TENM4 mRNA	PMID:19167457
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of TENM4 gene	PMID:31601247
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304658	E	RGD:6480464	20150414	CTD	MESH:C006780	bisphenol A results in decreased expression of TENM4 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of TENM4 mRNA	PMID:27685785|PMID:29275510
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304658	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of TENM4 mRNA	PMID:29097150|PMID:41034487
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312225	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TENM4 mRNA	PMID:30951980|PMID:38701888
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304658	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TENM4 gene	PMID:28505145
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of TENM4 gene	PMID:31601247
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304658	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TENM4 mRNA	PMID:36041667
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1312225	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of TENM4 mRNA	PMID:20713471
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TENM4 mRNA	PMID:40203079
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TENM4 gene	PMID:31601247
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312225	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TENM4 mRNA	PMID:30951980
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312225	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of TENM4 exon	PMID:33297965
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304658	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TENM4 mRNA	PMID:36041667
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TENM4 intron	PMID:30157460
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TENM4 mRNA	PMID:38685157
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312225	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TENM4 mRNA	PMID:30951980
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304658	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TENM4 mRNA	PMID:36041667
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TENM4 mRNA	PMID:21266533
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1312225	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of TENM4 gene	PMID:38995845
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1304658	E	RGD:6480464	20150714	CTD	MESH:C039281	furan results in decreased expression of TENM4 mRNA	PMID:25539665
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312225	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TENM4 mRNA	PMID:40194260
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TENM4 mRNA	PMID:31533062
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of TENM4 mRNA	PMID:39529242
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TENM4 mRNA	PMID:25979313
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1304658	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of TENM4 mRNA	PMID:29427782
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TENM4 mRNA	PMID:23179753|PMID:25192806|PMID:26272509|PMID:27188386
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENM4 mRNA	PMID:27188386
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TENM4 mRNA	PMID:28973697
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TENM4 mRNA	PMID:37992649
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of TENM4 mRNA	PMID:24935251|PMID:26272509
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENM4 mRNA	PMID:27188386
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304658	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TENM4 mRNA	PMID:33387578
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of TENM4 mRNA	PMID:24714768
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of TENM4 5' UTR	PMID:29523930
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TENM4 mRNA	PMID:40512198
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304658	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TENM4 mRNA	PMID:29391264
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312225	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TENM4 mRNA	PMID:35436446
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304658	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TENM4 mRNA	PMID:29097150
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TENM4 mRNA; Nanotubes, Carbon results in decreased expression of TENM4 mRNA	PMID:25554681
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1304658	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of TENM4 mRNA	PMID:34044035
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1312225	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of TENM4 mRNA	PMID:26377693
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of TENM4 mRNA	PMID:15336504
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1304658	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TENM4 mRNA	PMID:28801915|PMID:37269647
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TENM4 intron	PMID:30157460
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304658	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TENM4 gene	PMID:35440735
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TENM4 mRNA	PMID:31758290
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1304658	E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of TENM4 mRNA	PMID:39938710
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312225	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TENM4 mRNA	PMID:22206623
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1312225	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of TENM4 mRNA	PMID:25566086
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1312225	E	RGD:6480464	20160315	CTD	MESH:C072553	MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of TENM4 mRNA]	PMID:25566086
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENM4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENM4 mRNA	PMID:27188386
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304658	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of TENM4 mRNA	PMID:32109520
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of TENM4 mRNA	PMID:26705709
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304658	E	RGD:6480464	20150414	CTD	MESH:D011441	Propylthiouracil results in increased expression of TENM4 mRNA	PMID:24780913
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENM4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENM4 mRNA	PMID:27188386
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312225	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TENM4 mRNA	PMID:27131904
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TENM4 mRNA	PMID:38568856
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1304658	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of TENM4 gene	PMID:31079544
1312224	TENM4	teneurin transmembrane protein 4	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304658	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of TENM4 mRNA	PMID:23555832
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20250506	CTD	MESH:D015025	Zearalenone results in increased expression of ARHGEF2 protein	PMID:39306225
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ARHGEF2 mRNA	PMID:38218311
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312227	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ARHGEF2 mRNA	PMID:33045310
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGEF2 mRNA	PMID:20938992
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of ARHGEF2 mRNA	PMID:16054129|PMID:33167477
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312227	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ARHGEF2 mRNA	PMID:30319688
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ARHGEF2 protein	PMID:22226621
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	ARHGEF2 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein]; ARHGEF2 mutant form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; ARHGEF2 mutant form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein]; ARHGEF2 mutant form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]; ARHGEF2 mutant form inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]; Lipopolysaccharides promotes the reaction [TLR4 protein binds to ARHGEF2 protein]; TLR4 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of ARHGEF2 protein]	PMID:22226621
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312227	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ARHGEF2 mRNA	PMID:39298647
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ARHGEF2 mRNA	PMID:20823114
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304659	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGEF2 mRNA	PMID:32741896
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304659	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ARHGEF2 mRNA	PMID:33387578
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGEF2 mRNA	PMID:20938992
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17151	xylitol	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D014993	Xylitol results in increased expression of ARHGEF2 mRNA	PMID:32275922
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGEF2 mRNA	PMID:37992649
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304659	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGEF2 mRNA	PMID:32741896
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of ARHGEF2 mRNA	PMID:31256213
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGEF2 mRNA	PMID:37992649
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312227	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of ARHGEF2 mRNA	PMID:23892564
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	ISO	RGD:1312227	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of ARHGEF2 gene	PMID:34319233
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA	PMID:39150890
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ARHGEF2 protein	PMID:37730182
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304659	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ARHGEF2 mRNA	PMID:33387578
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ARHGEF2 mRNA	PMID:28818685
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARHGEF2 mRNA	PMID:36331819
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of ARHGEF2 mRNA	PMID:17103032
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:187088	Muconic dialdehyde	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C034476	muconaldehyde results in decreased expression of ARHGEF2 mRNA	PMID:40300100
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:2038	5-azacytidine	decreases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in decreased expression of ARHGEF2 mRNA	PMID:20823114
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ARHGEF2 mRNA	PMID:35430440
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGEF2 mRNA	PMID:20938992
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ARHGEF2 gene	PMID:25304211
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ARHGEF2 protein	PMID:35688186
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304659	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ARHGEF2 mRNA	PMID:31881176
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312227	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ARHGEF2 protein	PMID:25505154
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of ARHGEF2 gene	PMID:31636367
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of ARHGEF2 mRNA	PMID:23300844
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ARHGEF2 mRNA	PMID:27392435
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1304659	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ARHGEF2 mRNA	PMID:22023808
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ARHGEF2 mRNA]; Cisplatin promotes the reaction [jinfukang results in decreased expression of ARHGEF2 mRNA]; jinfukang promotes the reaction [Cisplatin results in decreased expression of ARHGEF2 mRNA]	PMID:21858171|PMID:27392435
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312227	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ARHGEF2 mRNA	PMID:30912803
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ARHGEF2 mRNA	PMID:23195993
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304659	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGEF2 mRNA	PMID:34747641
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312227	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGEF2 mRNA	PMID:21570461
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304659	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGEF2 mRNA	PMID:21215274
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304659	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARHGEF2 mRNA	PMID:33387578
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1304659	E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of ARHGEF2 mRNA]	PMID:21215274
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ARHGEF2 protein	PMID:39603559
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ARHGEF2 mRNA	PMID:33212167
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ARHGEF2 mRNA	PMID:20971185
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGEF2 mRNA	PMID:37992649
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of ARHGEF2 protein	PMID:35688186
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of ARHGEF2 mRNA	PMID:34032870
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARHGEF2 mRNA	PMID:28595984
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGEF2 mRNA	PMID:29301061|PMID:38568856|PMID:39719251
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of ARHGEF2 mRNA; Tunicamycin results in increased expression of ARHGEF2 protein	PMID:22378314|PMID:29453283|PMID:33545341
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARHGEF2 protein	PMID:32717239
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312227	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARHGEF2 mRNA	PMID:19770486
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARHGEF2 mRNA	PMID:32234424
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ARHGEF2 mRNA	PMID:20971185
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ARHGEF2 mRNA	PMID:25895662
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312227	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARHGEF2 gene; titanium dioxide results in decreased methylation of ARHGEF2 promoter	PMID:35295148
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312227	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ARHGEF2 gene	PMID:35295148
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304659	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ARHGEF2 mRNA	PMID:34492290
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312227	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ARHGEF2 mRNA	PMID:23811191
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312227	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ARHGEF2 mRNA	PMID:28472532
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of ARHGEF2 mRNA	PMID:28329830
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ARHGEF2 mRNA	PMID:30903817
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGEF2 mRNA	PMID:20678512
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304659	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGEF2 mRNA	PMID:30816183
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGEF2 mRNA; bisphenol A results in increased expression of ARHGEF2 protein	PMID:29275510|PMID:34186270
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304659	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGEF2 mRNA	PMID:34947998
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of ARHGEF2 mRNA	PMID:24752500
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312227	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ARHGEF2 exon	PMID:33297965
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGEF2 mRNA	PMID:28628672
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ARHGEF2 protein	PMID:34186270
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA	PMID:39150890
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA	PMID:39150890
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA	PMID:39150890
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGEF2 mRNA	PMID:28628672
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304659	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ARHGEF2 mRNA	PMID:18164116
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARHGEF2 mRNA	PMID:37042841
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304659	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ARHGEF2 mRNA	PMID:35163327
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARHGEF2 mRNA	PMID:25851441|PMID:38568856
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA	PMID:39150890
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ARHGEF2 protein	PMID:26879310
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304659	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ARHGEF2 mRNA	PMID:35163327
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ARHGEF2 mRNA	PMID:19376846
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304659	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ARHGEF2 mRNA	PMID:24386269
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ARHGEF2 mRNA	PMID:32588087
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ARHGEF2 mRNA	PMID:28302478
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ARHGEF2 mRNA	PMID:31533062
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of ARHGEF2 mRNA	PMID:31626844
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of ARHGEF2 mRNA	PMID:26352163
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ARHGEF2 mRNA	PMID:40419075
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARHGEF2 mRNA	PMID:36331819
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARHGEF2 mRNA	PMID:25979313
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARHGEF2 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF2 mRNA	PMID:27188386
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304659	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of ARHGEF2 mRNA	PMID:38685447|PMID:41580965
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ARHGEF2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312227	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of ARHGEF2 mRNA	PMID:19770486
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312227	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of ARHGEF2 mRNA	PMID:22733784
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGEF2 mRNA	PMID:28628672
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGEF2 mRNA	PMID:37992649
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of ARHGEF2 mRNA	PMID:33512557
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ARHGEF2 mRNA	PMID:38832940
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304659	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGEF2 mRNA	PMID:33387578
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ARHGEF2 mRNA	PMID:29067470
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of ARHGEF2 mRNA	PMID:33725128
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ARHGEF2 gene	PMID:25304211
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of ARHGEF2 mRNA	PMID:24752500
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ARHGEF2 mRNA	PMID:28628672
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ARHGEF2 mRNA	PMID:20823114
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ARHGEF2 mRNA	PMID:23300844
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312227	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARHGEF2 mRNA; Nanotubes, Carbon results in decreased expression of ARHGEF2 mRNA	PMID:25554681
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304659	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of ARHGEF2 mRNA	PMID:41580965
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312227	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of ARHGEF2 mRNA	PMID:40234311
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304659	E	RGD:6480464	20260303	CTD	MESH:D005485	Flutamide results in decreased expression of ARHGEF2 mRNA	PMID:40381864
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ARHGEF2 protein	PMID:32959892
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312227	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ARHGEF2 mRNA	PMID:22776087
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ARHGEF2 mRNA	PMID:22079614
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:64227	ciglitazone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C039671	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ARHGEF2 mRNA	PMID:16197558
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:6704	mebendazole	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D008463	Mebendazole results in decreased expression of ARHGEF2 protein	PMID:30075109
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of ARHGEF2 mRNA	PMID:20823114
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312227	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ARHGEF2 mRNA	PMID:26307267
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304659	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ARHGEF2 mRNA	PMID:30467583
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1312227	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in increased expression of ARHGEF2 mRNA	PMID:17654400
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ARHGEF2 protein	PMID:34186270
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ARHGEF2 mRNA	PMID:37199045
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1304659	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGEF2 mRNA	PMID:32741896
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:77012	methylseleninic acid	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of ARHGEF2 mRNA	PMID:18548127
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1304659	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ARHGEF2 mRNA	PMID:18164116
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:77095	flubendazole	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C018945	flubendazole results in decreased expression of ARHGEF2 protein	PMID:30075109
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:77131	sinapic acid	increases expression	ISO	RGD:1312227	E	RGD:6480464	20230404	CTD	MESH:C073734	sinapinic acid analog results in increased expression of ARHGEF2 mRNA	PMID:36279966
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF2 mRNA	PMID:27188386
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1312227	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGEF2 mRNA	PMID:39150890
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARHGEF2 gene]	PMID:28238834
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312227	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ARHGEF2 mRNA	PMID:31388691
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ARHGEF2 protein	PMID:31675489
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of ARHGEF2 mRNA	PMID:33512557
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ARHGEF2 protein	PMID:31675489
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of ARHGEF2 mRNA	PMID:21858171
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ARHGEF2 mRNA]	PMID:21858171
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of ARHGEF2 mRNA	PMID:33512557
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304659	E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARHGEF2 mRNA	PMID:33150595
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases methylation	ISO	RGD:1304659	E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in increased methylation of ARHGEF2 promoter	PMID:33150595
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGEF2 mRNA	PMID:27188386
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:9150	simvastatin	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of ARHGEF2 mRNA	PMID:14630613
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ARHGEF2 mRNA	PMID:38568856
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of ARHGEF2 mRNA	PMID:22378314
1312226	ARHGEF2	Rho/Rac guanine nucleotide exchange factor 2	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of ARHGEF2 mRNA	PMID:19140230
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1312229	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide analog results in increased expression of CCL27A mRNA; graphene oxide results in increased expression of CCL27A mRNA	PMID:33227293
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:15379	dioxygen	increases secretion	ISO	RGD:1312229	E	RGD:6480464	20260707	CTD	MESH:D010100	Oxygen deficiency results in increased secretion of CCL27A protein	PMID:41319837
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20260707	CTD	MESH:D010100	[Vehicle Emissions results in increased abundance of Air Pollutants] promotes the reaction [Oxygen deficiency results in increased secretion of CCL27A protein]	PMID:41319837
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:15551	prostaglandin E2	multiple interactions	EXP		E	RGD:6480464	20160510	CTD	MESH:D015232	Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 mRNA]]; Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]; Dinoprostone deficiency inhibits the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 mRNA]]; Dinoprostone deficiency inhibits the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]	PMID:16784723
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CCL27A mRNA	PMID:39241906
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D004958	Estradiol results in decreased expression of CCL27 mRNA; Estradiol results in decreased expression of CCL27A mRNA	PMID:19693291|PMID:39298647
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:16548	chlordecone	affects expression	ISO	RGD:1312229	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone affects the expression of CCL27A mRNA	PMID:29980752
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CCL27 mRNA	PMID:33387578
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D013739	Testosterone results in decreased expression of CCL27 mRNA	PMID:19693291
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CCL27 mRNA	PMID:26577399
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:18224	isoeugenol	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C036643	isoeugenol results in increased expression of CCL27 mRNA	PMID:17936526
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCL27A mRNA	PMID:37236586
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CCL27 mRNA	PMID:19770486
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D015032	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL27 mRNA	PMID:23503329
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:27638	cobalt atom	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D003035	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL27 mRNA	PMID:23503329
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CCL27A mRNA	PMID:35897073
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CCL27A mRNA	PMID:28960355
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of CCL27 mRNA	PMID:31881176
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:27928	parathion	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in decreased methylation of CCL27 promoter	PMID:22847954
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D009532	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL27 mRNA	PMID:23503329
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCL27 mRNA	PMID:21570461
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CCL27 mRNA	PMID:21215274
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of CCL27 mRNA	PMID:29955902
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CCL27 mRNA	PMID:28959563
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CCL27 promoter	PMID:27901495
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CCL27 mRNA	PMID:17879257
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCL27 mRNA	PMID:22228805
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CCL27 promoter	PMID:23974009
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D015032	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL27 mRNA	PMID:23503329
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CCL27A mRNA	PMID:29095437
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20191114	CTD	MESH:C006632	Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CCL27A mRNA]	PMID:29095437
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CCL27 mRNA	PMID:30047161
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CCL27A mRNA	PMID:29264374
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CCL27 mRNA	PMID:34492290
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CCL27 mRNA	PMID:18648102
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304660	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CCL27 mRNA	PMID:25181051
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CCL27 mRNA	PMID:30816183
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:33418	graphite	increases expression	ISO	RGD:1304660	E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite results in increased expression of CCL27 mRNA	PMID:29933104
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:3437	carteolol	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D002354	Carteolol results in increased expression of CCL27 mRNA	PMID:37120125
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CCL27A mRNA	PMID:39298647
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CCL27A mRNA	PMID:38685157
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312229	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CCL27A mRNA	PMID:37019170
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1312229	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in increased expression of CCL27A mRNA	PMID:35093514
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D015056	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL27 mRNA	PMID:23503329
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCL27A mRNA	PMID:37236586
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:38689	fonofos	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in decreased methylation of CCL27 promoter	PMID:22847954
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:38960	terbufos	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in decreased methylation of CCL27 promoter	PMID:22847954
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:39233	emamectin benzoate	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C108024	emamectin benzoate results in increased expression of CCL27 mRNA	PMID:36269090
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of CCL27 mRNA	PMID:25993096
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CCL27 gene	PMID:29154799
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CCL27 mRNA	PMID:30047161
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D016572	Cyclosporine results in decreased expression of CCL27 mRNA	PMID:19770486
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D003907	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL27 mRNA	PMID:23503329
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:D000082	Acetaminophen affects the expression of CCL27 mRNA	PMID:17562736
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CCL27 mRNA	PMID:33387578
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312229	E	RGD:6480464	20131220	CTD	MESH:D000082	Acetaminophen results in increased expression of CCL27A mRNA	PMID:17585979
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312229	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CCL27A mRNA	PMID:29279043
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:46790	2-methoxyethanol	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20130312	CTD	MESH:C005219	methyl cellosolve results in decreased expression of CCL27 mRNA	PMID:21061450
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:47519	ketoconazole	multiple interactions	EXP		E	RGD:6480464	20160510	CTD	MESH:D007654	Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 mRNA]]; Dinoprostone deficiency inhibits the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]; Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 mRNA]; Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 protein]; PTGER2 protein promotes the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]; PTGER3 protein promotes the reaction [Ketoconazole inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]	PMID:16784723
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304660	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CCL27 mRNA	PMID:29391264
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CCL27A mRNA	PMID:29095437
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20191114	CTD	MESH:C032793	Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CCL27A mRNA]	PMID:29095437
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:50545	trans-isoeugenol	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C036643	isoeugenol results in increased expression of CCL27 mRNA	PMID:17936526
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CCL27A mRNA; Nanotubes, Carbon results in decreased expression of CCL27A mRNA	PMID:25554681|PMID:25620056
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CCL27 mRNA	PMID:30047161
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of CCL27A mRNA	PMID:26377693
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:53001	nickel sulfate	increases secretion	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased secretion of CCL27 protein	PMID:15679580
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20150811	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of CCL27 mRNA	PMID:19042947
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:53444	potassium dichromate	increases secretion	EXP		E	RGD:6480464	20120717	CTD	MESH:D011192	Potassium Dichromate results in increased secretion of CCL27 protein	PMID:15679580
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312229	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CCL27A mRNA	PMID:38701926
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1312229	E	RGD:6480464	20190219	CTD	MESH:D008687	Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CCL27A mRNA]	PMID:29095437
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312229	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CCL27A mRNA	PMID:22206623
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CCL27 gene]	PMID:28238834
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:8093	phenylephrine	increases expression	ISO	RGD:1304660	E	RGD:6480464	20130312	CTD	MESH:D010656	Phenylephrine results in increased expression of CCL27 mRNA	PMID:18158353
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312229	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of CCL27A mRNA	PMID:39847705
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:8434	prochloraz	increases expression	ISO	RGD:1312229	E	RGD:6480464	20260707	CTD	MESH:C045362	prochloraz results in increased expression of CCL27A mRNA	PMID:39210919
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CCL27 mRNA	PMID:30047161
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:8984	sodium dodecyl sulfate	increases secretion	EXP		E	RGD:6480464	20120717	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased secretion of CCL27 protein	PMID:15679580
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304660	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CCL27 mRNA	PMID:19281266
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304660	E	RGD:6480464	20130312	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CCL27 mRNA	PMID:21346803
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:9448	terbinafine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C041359	Dinoprostone deficiency inhibits the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 mRNA]]; Dinoprostone deficiency inhibits the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]; PTGER2 protein promotes the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]; PTGER3 protein promotes the reaction [terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 protein]]; terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 mRNA]; terbinafine inhibits the reaction [TNF protein results in increased expression of CCL27 protein]	PMID:16784723
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304660	E	RGD:6480464	20130312	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CCL27 mRNA	PMID:21346803
1312228	CCL27	C-C motif chemokine ligand 27	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304660	E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of CCL27 mRNA	PMID:22615374
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304661	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of SERPINB13 gene	PMID:28931070
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SERPINB13 mRNA	PMID:35811015
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of SERPINB13 mRNA	PMID:30165855
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SERPINB13 mRNA	PMID:38568856
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of SERPINB13 mRNA	PMID:16002434
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SERPINB13 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of SERPINB13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SERPINB13 protein	PMID:38598786
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SERPINB13 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SERPINB13 mRNA	PMID:32525701|PMID:40512198
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SERPINB13 mRNA	PMID:25583101
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312231	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SERPINB13 mRNA	PMID:21570461
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SERPINB13 mRNA	PMID:23152189
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SERPINB13 mRNA	PMID:30851411
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312231	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SERPINB13 mRNA	PMID:27862939
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SERPINB13 mRNA	PMID:38568856
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SERPINB13 mRNA	PMID:39719251
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SERPINB13 mRNA	PMID:40512198
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SERPINB13 5' UTR	PMID:27901495
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SERPINB13 promoter	PMID:27901495
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312231	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to SERPINB13 promoter]	PMID:19654925
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:3020	benzalkonium chloride	multiple interactions	ISO	RGD:1312231	E	RGD:6480464	20190219	CTD	MESH:D001548	[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SERPINB13 mRNA	PMID:30171875
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SERPINB13 mRNA	PMID:25351596
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304661	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SERPINB13 mRNA	PMID:25181051|PMID:41034487
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of SERPINB13 gene	PMID:31601247
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to SERPINB13 protein	PMID:32991956
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SERPINB13 protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of SERPINB13 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SERPINB13 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of SERPINB13 protein	PMID:38598786
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SERPINB13 mRNA	PMID:38174414
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1304661	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of SERPINB13 promoter	PMID:22457795
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of SERPINB13 mRNA	PMID:19376846
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SERPINB13 mRNA	PMID:35811015
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SERPINB13 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SERPINB13 mRNA	PMID:32525701|PMID:40512198
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312231	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SERPINB13 mRNA	PMID:35436446
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of SERPINB13 mRNA	PMID:38568856
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SERPINB13 mRNA	PMID:30851411
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SERPINB13 gene]	PMID:28238834
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:81922	flusilazole	increases expression	ISO	RGD:1304661	E	RGD:6480464	20210810	CTD	MESH:C061365	flusilazole results in increased expression of SERPINB13 mRNA	PMID:33032228
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:81980	triticonazole	increases expression	ISO	RGD:1304661	E	RGD:6480464	20210810	CTD	MESH:C412303	triticonazole results in increased expression of SERPINB13 mRNA	PMID:33032228
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SERPINB13 mRNA	PMID:32525701
1312230	SERPINB13	serpin family B member 13	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SERPINB13 protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of SERPINB13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SERPINB13 protein	PMID:38598786
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:10093	yohimbine	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20180116	CTD	MESH:D015016	[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA	PMID:28843594
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PLA2G12A mRNA	PMID:26272509|PMID:27188386
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA	PMID:27188386
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312233	E	RGD:6480464	20240903	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PLA2G12A mRNA	PMID:38458531
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of PLA2G12A mRNA	PMID:21934132
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLA2G12A mRNA	PMID:30529165
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PLA2G12A mRNA	PMID:36331819
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304662	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of PLA2G12A gene	PMID:35440735
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:15950	(S)-coclaurine	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20180116	CTD	MESH:C004690	[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA	PMID:28843594
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312233	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in increased expression of PLA2G12A mRNA	PMID:19167417
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of PLA2G12A mRNA	PMID:39709020
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1304662	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of PLA2G12A mRNA	PMID:32145629
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of PLA2G12A mRNA	PMID:19167446
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312233	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of PLA2G12A mRNA	PMID:33711761
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PLA2G12A mRNA	PMID:38568856
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of PLA2G12A mRNA	PMID:19448997
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PLA2G12A mRNA	PMID:37042841
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of PLA2G12A mRNA	PMID:38685446
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of PLA2G12A gene	PMID:33872906
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1312233	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of PLA2G12A mRNA	PMID:17997037
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of PLA2G12A gene	PMID:33872906
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLA2G12A mRNA	PMID:36331819
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:18417	(RS)-coclaurine	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20180116	CTD	MESH:C004690	[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA	PMID:28843594
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:18418	(RS)-norcoclaurine	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20180116	CTD	MESH:C012348	[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA	PMID:28843594
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1312233	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of PLA2G12A mRNA	PMID:17997037
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:196319	(+/-)-Aegeline	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20231003	CTD	MESH:C560978	[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA	PMID:28843594
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G12A mRNA	PMID:29950665
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PLA2G12A mRNA	PMID:19549813
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1304662	E	RGD:6480464	20130806	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PLA2G12A mRNA	PMID:22129741
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304662	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PLA2G12A mRNA	PMID:23385219|PMID:23630614|PMID:25378103
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1304662	E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of PLA2G12A mRNA	PMID:35737395
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PLA2G12A mRNA	PMID:34911549
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1304662	E	RGD:6480464	20260407	CTD	MESH:D000638	Amiodarone results in increased expression of PLA2G12A mRNA	PMID:40216313
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312233	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PLA2G12A mRNA	PMID:27339419|PMID:31919559
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312233	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PLA2G12A mRNA	PMID:25629700
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLA2G12A mRNA	PMID:40504410
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PLA2G12A mRNA	PMID:19244175
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of PLA2G12A mRNA	PMID:19244175
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20180116	CTD	MESH:D002110	[Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of PLA2G12A mRNA	PMID:28843594
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PLA2G12A mRNA	PMID:28903495
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312233	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of PLA2G12A mRNA	PMID:40618947
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304662	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLA2G12A mRNA	PMID:22298810|PMID:34747641
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312233	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLA2G12A mRNA	PMID:20702594|PMID:21570461|PMID:24680724|PMID:26377647
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304662	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLA2G12A mRNA	PMID:21215274|PMID:23238561|PMID:32387183
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312233	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLA2G12A mRNA	PMID:18796159|PMID:20005886|PMID:21851831|PMID:22230337|PMID:23238561|PMID:25975270|PMID:26290441
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1304662	E	RGD:6480464	20130806	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G12A mRNA]	PMID:21215274
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:D013749	2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G12A mRNA]; [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of PLA2G12A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PLA2G12A mRNA; Tetrachlorodibenzodioxin promotes the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PLA2G12A mRNA]	PMID:16214954|PMID:21851831|PMID:25975270
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304662	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of PLA2G12A mRNA	PMID:28374803
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PLA2G12A mRNA	PMID:23179753
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:28428	beta-hexachlorocyclohexane	increases expression	ISO	RGD:1312233	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in increased expression of PLA2G12A mRNA	PMID:25270620
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312233	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of PLA2G12A mRNA	PMID:39631538
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:28794	coumarin	increases expression	ISO	RGD:1304662	E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of PLA2G12A mRNA	PMID:18480146
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLA2G12A mRNA	PMID:40504410
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312233	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLA2G12A mRNA	PMID:19770486
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLA2G12A gene	PMID:31601247
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1304662	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of PLA2G12A mRNA	PMID:24136188
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312233	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLA2G12A promoter	PMID:35295148
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G12A mRNA	PMID:29950665
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304662	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PLA2G12A mRNA	PMID:23411599
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PLA2G12A mRNA	PMID:18648102
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1304662	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PLA2G12A mRNA	PMID:25380136
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312233	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PLA2G12A mRNA	PMID:18445702|PMID:23811191
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:32687	piperonyl butoxide	increases expression	ISO	RGD:1304662	E	RGD:6480464	20130806	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of PLA2G12A mRNA	PMID:22484513
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312233	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PLA2G12A mRNA	PMID:28472532
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304662	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of PLA2G12A mRNA	PMID:32145629
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304662	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PLA2G12A mRNA	PMID:25181051
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304662	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PLA2G12A gene	PMID:28505145
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLA2G12A gene	PMID:31601247
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of PLA2G12A mRNA	PMID:19244175
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of PLA2G12A mRNA	PMID:19244175
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of PLA2G12A mRNA	PMID:24752500
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1312233	E	RGD:6480464	20120918	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PLA2G12A mRNA	PMID:20005886|PMID:21851831
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20120918	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl affects the reaction [NR1I2 protein affects the expression of PLA2G12A mRNA]; 2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PLA2G12A mRNA]; Tetrachlorodibenzodioxin promotes the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of PLA2G12A mRNA]	PMID:21851831|PMID:32352317
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of PLA2G12A mRNA	PMID:20702594
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312233	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of PLA2G12A mRNA	PMID:40203079
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20241001	CTD	MESH:C008745	[Dietary Fats co-treated with bisphenol F] results in decreased expression of PLA2G12A mRNA	PMID:36632902
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312233	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PLA2G12A mRNA	PMID:37019170
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of PLA2G12A mRNA	PMID:29950665
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312233	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PLA2G12A mRNA	PMID:17361019|PMID:21266533
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:1312233	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of PLA2G12A mRNA	PMID:25270620
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304662	E	RGD:6480464	20130806	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PLA2G12A mRNA	PMID:22129741
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PLA2G12A mRNA	PMID:37042841
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304662	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of PLA2G12A mRNA	PMID:25380136
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304662	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PLA2G12A mRNA	PMID:25993096
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304662	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of PLA2G12A mRNA	PMID:26194646
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1304662	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of PLA2G12A mRNA	PMID:30047161
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312233	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of PLA2G12A mRNA	PMID:28903501
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PLA2G12A mRNA	PMID:19376846
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1304662	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of PLA2G12A mRNA	PMID:25380136
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PLA2G12A mRNA	PMID:24449571
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PLA2G12A mRNA	PMID:19244175
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of PLA2G12A mRNA	PMID:19244175
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PLA2G12A mRNA	PMID:31533062
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLA2G12A mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PLA2G12A mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PLA2G12A mRNA	PMID:36331819
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1304662	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of PLA2G12A mRNA	PMID:25993096
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLA2G12A mRNA	PMID:25979313
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of PLA2G12A mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA	PMID:27188386
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of PLA2G12A mRNA	PMID:20106945
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of PLA2G12A mRNA	PMID:24449571
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1304662	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of PLA2G12A mRNA	PMID:24136188
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PLA2G12A mRNA	PMID:24935251
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PLA2G12A mRNA	PMID:17562736
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of PLA2G12A mRNA	PMID:21420995
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304662	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of PLA2G12A mRNA	PMID:17202762
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLA2G12A mRNA	PMID:40504410
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of PLA2G12A mRNA	PMID:24752500
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312233	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of PLA2G12A mRNA	PMID:22334560
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312233	E	RGD:6480464	20200714	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of PLA2G12A mRNA	PMID:31978390
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312233	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PLA2G12A mRNA; Nanotubes, Carbon results in increased expression of PLA2G12A mRNA	PMID:25620056
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PLA2G12A mRNA	PMID:35964746
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304662	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PLA2G12A mRNA	PMID:24136188
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of PLA2G12A mRNA	PMID:17982090
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1312233	E	RGD:6480464	20150127	CTD	MESH:D016559	Tacrolimus results in increased expression of PLA2G12A mRNA	PMID:25270620
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:63598	levofloxacin	increases expression	ISO	RGD:1304662	E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in increased expression of PLA2G12A mRNA	PMID:24136188
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:63613	nevirapine	increases expression	ISO	RGD:1312233	E	RGD:6480464	20240903	CTD	MESH:D019829	Nevirapine results in increased expression of PLA2G12A mRNA	PMID:38636494
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1304662	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of PLA2G12A mRNA	PMID:24136188
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312233	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of PLA2G12A mRNA	PMID:25270620
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1304662	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of PLA2G12A mRNA	PMID:24136188
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312233	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of PLA2G12A mRNA	PMID:36851058
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:6801	metformin	affects expression	ISO	RGD:1304662	E	RGD:6480464	20200114	CTD	MESH:D008687	Metformin affects the expression of PLA2G12A mRNA	PMID:31324951
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1304662	E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of PLA2G12A mRNA	PMID:28935588
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312233	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of PLA2G12A mRNA	PMID:31052254
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:72754	bisphenol AF	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20250114	CTD	MESH:C583074	[Dietary Fats co-treated with bisphenol AF] results in decreased expression of PLA2G12A mRNA	PMID:36632902
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312233	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PLA2G12A mRNA	PMID:22206623
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1304662	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PLA2G12A mRNA	PMID:24136188
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:756996	imeglimin	increases expression	ISO	RGD:1312233	E	RGD:6480464	20260714	CTD	MESH:C575881	imeglimin results in increased expression of PLA2G12A mRNA	PMID:40713970
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1304662	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of PLA2G12A mRNA	PMID:33484710
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA	PMID:27188386
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:8064	phenformin	increases expression	ISO	RGD:1304662	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in increased expression of PLA2G12A mRNA	PMID:31324951
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312233	E	RGD:6480464	20150127	CTD	MESH:D010634	Phenobarbital results in increased expression of PLA2G12A mRNA	PMID:19270015|PMID:19482888|PMID:23091169|PMID:25270620
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312233	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PLA2G12A mRNA]	PMID:19482888
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1312233	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of PLA2G12A mRNA	PMID:22334560
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:81760	difenoconazole	increases expression	ISO	RGD:1312233	E	RGD:6480464	20230905	CTD	MESH:C115058	difenoconazole results in increased expression of PLA2G12A mRNA	PMID:34425431
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312233	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in increased expression of PLA2G12A mRNA	PMID:22334560
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304662	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of PLA2G12A mRNA	PMID:30047161
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G12A mRNA	PMID:27188386
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PLA2G12A mRNA	PMID:38568856
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304662	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PLA2G12A mRNA	PMID:21346803
1312232	PLA2G12A	phospholipase A2 group XIIA	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1304662	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of PLA2G12A gene	PMID:31079544
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1594556	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of TNFAIP2 mRNA	PMID:25152437
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TNFAIP2 mRNA	PMID:27188386
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312235	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TNFAIP2 mRNA	PMID:37995155
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:144804	nickel subsulfide	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide results in decreased expression of TNFAIP2 mRNA	PMID:12760830
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D014212	Tretinoin results in increased expression of TNFAIP2 mRNA	PMID:15498508|PMID:16129123|PMID:17218384|PMID:33167477
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312235	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNFAIP2 mRNA	PMID:30529165
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D019308	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of TNFAIP2 mRNA	PMID:30547786
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of TNFAIP2 mRNA	PMID:22378314
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:16196	oleic acid	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D019301	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of TNFAIP2 mRNA	PMID:30547786
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1594556	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in decreased expression of TNFAIP2 mRNA	PMID:16098508
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312235	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TNFAIP2 mRNA	PMID:39241906
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFAIP2 mRNA	PMID:35811015
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312235	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFAIP2 mRNA	PMID:25890327|PMID:26582142
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of TNFAIP2 mRNA; [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TNFAIP2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TNFAIP2 mRNA	PMID:35811015|PMID:35877022
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312235	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TNFAIP2 mRNA	PMID:39298647
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1594556	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNFAIP2 mRNA	PMID:32741896
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TNFAIP2 mRNA	PMID:37042841
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of TNFAIP2 mRNA	PMID:17938736
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of TNFAIP2 mRNA	PMID:17251523
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1594556	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNFAIP2 mRNA	PMID:32741896
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of TNFAIP2 mRNA	PMID:31256213
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:17660	N(6)-dimethylallyladenine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C001478	N(6)-(delta(2)-isopentenyl)adenine results in increased expression of TNFAIP2 mRNA	PMID:16129123
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of TNFAIP2 mRNA	PMID:16129123
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:18185	gamma-tocopherol	increases expression	ISO	RGD:1312235	E	RGD:6480464	20180116	CTD	MESH:D024505	Tocopherols results in increased expression of TNFAIP2 mRNA	PMID:17056531
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:188851	Muraglitazar	decreases expression	ISO	RGD:1594556	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of TNFAIP2 mRNA	PMID:21515302
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312235	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of TNFAIP2 mRNA	PMID:24067728
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312235	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TNFAIP2 mRNA	PMID:37325564
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TNFAIP2 3' UTR	PMID:30157460
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:25187	p-menthan-3-ol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of TNFAIP2 mRNA	PMID:26760959
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of TNFAIP2 mRNA	PMID:15674844
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of TNFAIP2 mRNA	PMID:35430440
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312235	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TNFAIP2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TNFAIP2 mRNA	PMID:34911549
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:27013	tocopherol	increases expression	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:D024505	Tocopherols results in increased expression of TNFAIP2 mRNA	PMID:17056531
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312235	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TNFAIP2 mRNA	PMID:31919559
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TNFAIP2 mRNA	PMID:40512198
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TNFAIP2 mRNA	PMID:19244175
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of TNFAIP2 mRNA	PMID:26272509
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFAIP2 mRNA	PMID:27188386
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1594556	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TNFAIP2 mRNA	PMID:33854195
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312235	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of TNFAIP2 mRNA	PMID:28960355
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of TNFAIP2 mRNA	PMID:27594783
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TNFAIP2 mRNA	PMID:25583101
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TNFAIP2 mRNA	PMID:22298810
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312235	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TNFAIP2 mRNA	PMID:18343893|PMID:21570461|PMID:26377647
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1594556	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TNFAIP2 mRNA	PMID:22298810
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFAIP2 mRNA	PMID:19692669
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312235	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFAIP2 mRNA	PMID:15328365|PMID:15800033|PMID:16611356|PMID:18796159|PMID:19770486|PMID:19933214|PMID:21851831|PMID:21889950|PMID:21995607|PMID:23994337|PMID:26290441
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1594556	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFAIP2 mRNA	PMID:33387578
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of TNFAIP2 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TNFAIP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TNFAIP2 mRNA; AHR affects the reaction [Tetrachlorodibenzodioxin results in increased expression of TNFAIP2 mRNA]	PMID:16214954|PMID:17942748|PMID:21995607|PMID:25975270
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1594556	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of TNFAIP2 mRNA	PMID:28374803
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TNFAIP2 mRNA	PMID:28001369
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TNFAIP2 mRNA	PMID:33212167
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TNFAIP2 mRNA	PMID:29803840
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of TNFAIP2 mRNA	PMID:19277126
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:28940	calciol	increases expression	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in increased expression of TNFAIP2 mRNA	PMID:17170073
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D001379	Azathioprine results in decreased expression of TNFAIP2 mRNA	PMID:19192274
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TNFAIP2 mRNA	PMID:12727804|PMID:12760830|PMID:38568856
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of TNFAIP2 mRNA	PMID:39719251
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312235	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of TNFAIP2 mRNA	PMID:16014739
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TNFAIP2 mRNA	PMID:40512198
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TNFAIP2 intron; Benzo(a)pyrene affects the methylation of TNFAIP2 promoter	PMID:27901495|PMID:30157460
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1594556	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TNFAIP2 mRNA	PMID:21839799
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TNFAIP2 mRNA; Benzo(a)pyrene results in increased expression of TNFAIP2 protein	PMID:22316170|PMID:32234424|PMID:32717239
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312235	E	RGD:6480464	20130723	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TNFAIP2 mRNA	PMID:14625279|PMID:19770486|PMID:21995607|PMID:22228805
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TNFAIP2 5' UTR	PMID:27901495
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312235	E	RGD:6480464	20121113	CTD	MESH:D001564	[Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of TNFAIP2 mRNA]; AHR affects the reaction [Benzo(a)pyrene results in increased expression of TNFAIP2 mRNA]; Benzo(a)pyrene promotes the reaction [AHR protein binds to TNFAIP2 promoter]	PMID:14625279|PMID:21995607
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312235	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TNFAIP2 mRNA	PMID:27131904
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TNFAIP2 mRNA; Silicon Dioxide results in increased expression of TNFAIP2 mRNA	PMID:23806026|PMID:25351596
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TNFAIP2 mRNA	PMID:19150397
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:30769	citric acid	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D019343	Citric Acid results in decreased expression of TNFAIP2 mRNA	PMID:37149095
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1594556	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of TNFAIP2 mRNA	PMID:24136188
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1594556	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of TNFAIP2 mRNA	PMID:32479839
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1594556	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TNFAIP2 mRNA	PMID:30047161
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of TNFAIP2 mRNA	PMID:15498508
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:32195	Tesaglitazar	decreases expression	ISO	RGD:1594556	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of TNFAIP2 mRNA	PMID:21515302
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312235	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TNFAIP2 gene; titanium dioxide results in decreased methylation of TNFAIP2 promoter	PMID:35295148
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1594556	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of TNFAIP2 mRNA	PMID:30012374
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1594556	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of TNFAIP2 mRNA	PMID:34492290
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of TNFAIP2 mRNA	PMID:18445702
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TNFAIP2 mRNA	PMID:19710929
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of TNFAIP2 mRNA	PMID:12419474
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C006780	bisphenol A analog results in decreased expression of TNFAIP2 mRNA; bisphenol A results in decreased expression of TNFAIP2 protein	PMID:32387340|PMID:33376534
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312235	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of TNFAIP2 mRNA	PMID:32156529
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1594556	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TNFAIP2 mRNA	PMID:25181051|PMID:32145629
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TNFAIP2 mRNA	PMID:19692669
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1312235	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TNFAIP2 mRNA	PMID:23994337
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312235	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of TNFAIP2 mRNA	PMID:39298647
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312235	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TNFAIP2 gene	PMID:31683443
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312235	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TNFAIP2 mRNA	PMID:40203079
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312235	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of TNFAIP2 mRNA	PMID:33297965
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312235	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of TNFAIP2 mRNA	PMID:28392331
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1594556	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TNFAIP2 mRNA	PMID:33854195
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:34682	diazinon	decreases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of TNFAIP2 gene	PMID:22964155
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1594556	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TNFAIP2 mRNA	PMID:21266533
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of TNFAIP2 mRNA	PMID:17312168
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TNFAIP2 mRNA	PMID:37042841
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1594556	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TNFAIP2 mRNA	PMID:35163327
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TNFAIP2 mRNA	PMID:12760830|PMID:38568856
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TNFAIP2 mRNA	PMID:38174414
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312235	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TNFAIP2 mRNA	PMID:37325564
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1594556	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of TNFAIP2 mRNA	PMID:35163327
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1594556	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TNFAIP2 mRNA	PMID:35163327
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1594556	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of TNFAIP2 mRNA	PMID:26194646
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1312235	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of TNFAIP2 mRNA	PMID:28903501
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1594556	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TNFAIP2 mRNA	PMID:30047161
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TNFAIP2 mRNA	PMID:24449571
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TNFAIP2 mRNA	PMID:19244175
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312235	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of TNFAIP2 mRNA	PMID:23811191
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TNFAIP2 mRNA	PMID:32588087
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of TNFAIP2 mRNA	PMID:40434365
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TNFAIP2 mRNA	PMID:40419075
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of TNFAIP2 mRNA	PMID:29154799
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312235	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in increased expression of TNFAIP2 mRNA	PMID:20546886
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1594556	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TNFAIP2 mRNA	PMID:30047161
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of TNFAIP2 mRNA	PMID:20106945
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1594556	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TNFAIP2 mRNA	PMID:33854195
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312235	E	RGD:6480464	20120613	CTD	MESH:D013629	Tamoxifen affects the expression of TNFAIP2 mRNA	PMID:17555576|PMID:20937368
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1312235	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of TNFAIP2 mRNA	PMID:25123088
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312235	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TNFAIP2 mRNA	PMID:28973697
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in decreased expression of TNFAIP2 mRNA	PMID:19192274
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TNFAIP2 mRNA	PMID:38832940
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1594556	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TNFAIP2 mRNA	PMID:33854195
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TNFAIP2 mRNA	PMID:17562736
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1594556	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of TNFAIP2 mRNA	PMID:32479839
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of TNFAIP2 mRNA	PMID:24714768
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TNFAIP2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TNFAIP2 mRNA	PMID:35811015
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of TNFAIP2 mRNA	PMID:24160326|PMID:25757056
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of TNFAIP2 mRNA	PMID:25351596
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:46680	serpentine asbestos	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine affects the expression of TNFAIP2 mRNA	PMID:24160326
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TNFAIP2 mRNA	PMID:40512198
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of TNFAIP2 mRNA	PMID:31675489
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of TNFAIP2 mRNA	PMID:26833863
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1594556	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TNFAIP2 mRNA	PMID:29391264
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TNFAIP2 mRNA	PMID:22079256
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312235	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TNFAIP2 mRNA	PMID:35436446
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TNFAIP2 mRNA	PMID:17555576
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TNFAIP2 mRNA	PMID:17942748
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of TNFAIP2 mRNA	PMID:38568856
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:50594	carbon nanotube	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TNFAIP2 mRNA	PMID:15585362
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312235	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TNFAIP2 mRNA; Nanotubes, Carbon results in increased expression of TNFAIP2 mRNA	PMID:25554681|PMID:25620056
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1594556	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TNFAIP2 mRNA	PMID:30047161
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312235	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of TNFAIP2 mRNA	PMID:40234311
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of TNFAIP2 mRNA	PMID:22714537
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:53444	potassium dichromate	multiple interactions	ISO	RGD:1312235	E	RGD:6480464	20130723	CTD	MESH:D011192	[Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of TNFAIP2 mRNA]	PMID:14625279
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:5516	sodium aurothiomalate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D006052	Gold Sodium Thiomalate results in decreased expression of TNFAIP2 mRNA	PMID:19192274
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312235	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TNFAIP2 mRNA	PMID:38701926
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1594556	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TNFAIP2 mRNA	PMID:33854195
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TNFAIP2 protein	PMID:32959892
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1594556	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of TNFAIP2 mRNA	PMID:28801915
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312235	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNFAIP2 mRNA	PMID:21641980
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of TNFAIP2 mRNA	PMID:28988120
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TNFAIP2 mRNA	PMID:24810058
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312235	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of TNFAIP2 protein	PMID:36851058
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:6888	6alpha-methylprednisolone	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008775	Methylprednisolone results in decreased expression of TNFAIP2 mRNA	PMID:19192274
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312235	E	RGD:6480464	20141111	CTD	MESH:D002185	Cannabidiol results in increased expression of TNFAIP2 mRNA	PMID:21542829
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TNFAIP2 mRNA	PMID:31758290
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312235	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TNFAIP2 mRNA	PMID:22206623
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TNFAIP2 mRNA	PMID:22079256
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TNFAIP2 mRNA	PMID:22079256
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312235	E	RGD:6480464	20130903	CTD	MESH:C027373	[Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of TNFAIP2 mRNA]	PMID:14625279
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TNFAIP2 mRNA	PMID:37199045
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1594556	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of TNFAIP2 mRNA	PMID:32741896
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1312235	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of TNFAIP2 mRNA	PMID:23994337
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1594556	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of TNFAIP2 mRNA	PMID:23665939
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:7823	oxazepam	increases expression	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:D010076	Oxazepam results in increased expression of TNFAIP2 mRNA; Oxazepam results in increased expression of TNFAIP2 protein	PMID:12727805
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFAIP2 mRNA	PMID:27188386
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TNFAIP2 gene]	PMID:28238834
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:8064	phenformin	increases expression	ISO	RGD:1594556	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in increased expression of TNFAIP2 mRNA	PMID:31324951
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of TNFAIP2 mRNA	PMID:19159669
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312235	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TNFAIP2 mRNA	PMID:23091169
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of TNFAIP2 mRNA	PMID:19270015
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312235	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TNFAIP2 mRNA	PMID:19270015
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1312235	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of TNFAIP2 mRNA	PMID:18343893
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312235	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TNFAIP2 mRNA	PMID:38648751
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1594556	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TNFAIP2 mRNA	PMID:27291303
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1312235	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of TNFAIP2 mRNA	PMID:38995820
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of TNFAIP2 protein	PMID:31675489
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:8378	prednisolone	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D011239	Prednisolone results in decreased expression of TNFAIP2 mRNA	PMID:19192274
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of TNFAIP2 mRNA	PMID:12727804
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1594556	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of TNFAIP2 mRNA	PMID:25825206
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNFAIP2 mRNA	PMID:27188386
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312235	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TNFAIP2 mRNA	PMID:27131904
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TNFAIP2 mRNA	PMID:38568856
1312234	TNFAIP2	TNF alpha induced protein 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1594556	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in decreased expression of TNFAIP2 mRNA	PMID:21515302
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D015025	Zearalenone results in increased expression of SLC39A6 mRNA	PMID:28965971
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304664	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC39A6 mRNA]	PMID:31150632
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312237	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SLC39A6 mRNA	PMID:30319688
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312237	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SLC39A6 mRNA; Lipopolysaccharides results in decreased expression of SLC39A6 protein	PMID:16892068|PMID:17126599
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312237	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SLC39A6 mRNA	PMID:39241906
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20161228	CTD	MESH:D008070	SLC39A6 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Zinc]; TICAM1 protein affects the reaction [Lipopolysaccharides results in decreased expression of SLC39A6 protein]	PMID:16892068
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of SLC39A6 mRNA	PMID:16514628
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304664	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC39A6 mRNA	PMID:33387578
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SLC39A6 mRNA	PMID:16949557
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304664	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SLC39A6 mRNA	PMID:27523638
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SLC39A6 protein	PMID:37730182
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:D002117	Calcitriol results in decreased expression of SLC39A6 mRNA	PMID:20089671
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC39A6 mRNA	PMID:39836092
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SLC39A6 mRNA	PMID:16949557
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304664	E	RGD:6480464	20260303	CTD	MESH:D002104	[zinc chloride co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] results in decreased expression of SLC39A6 mRNA	PMID:30714133
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:231505	gallium nitrate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C027235	gallium nitrate results in decreased expression of SLC39A6 mRNA	PMID:18586083
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC39A6 mRNA	PMID:29950665
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SLC39A6 mRNA	PMID:19549813
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SLC39A6 protein	PMID:23301498
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of SLC39A6 mRNA	PMID:19376150
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SLC39A6 protein	PMID:20106945
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLC39A6 mRNA	PMID:27153756
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SLC39A6 gene	PMID:27153756
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	affects expression	ISO	RGD:1304664	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of SLC39A6 mRNA	PMID:15867272
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	affects uptake	EXP		E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A6 protein affects the uptake of Zinc	PMID:18272141
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of SLC39A6 mRNA	PMID:17085522
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312237	E	RGD:6480464	20141223	CTD	MESH:D015032	Zinc deficiency results in increased expression of SLC39A6 protein	PMID:25088245
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A6 protein results in increased transport of Zinc	PMID:18326752
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	increases uptake	EXP		E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A6 protein results in increased uptake of Zinc	PMID:12839489
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130212	CTD	MESH:D015032	Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form results in decreased susceptibility to trichostatin A]]	PMID:19887557
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A6 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Zinc]	PMID:16892068
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304664	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SLC39A6 mRNA	PMID:31150632
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312237	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SLC39A6 mRNA	PMID:27339419|PMID:31919559
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304664	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC39A6 mRNA]	PMID:31150632
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC39A6 mRNA	PMID:39836092
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312237	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SLC39A6 mRNA	PMID:28960355
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304664	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLC39A6 mRNA	PMID:31881176
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of SLC39A6 mRNA	PMID:18930951
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312237	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC39A6 mRNA	PMID:21570461
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304664	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC39A6 mRNA	PMID:34747641
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC39A6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC39A6 mRNA	PMID:17942748|PMID:25975270
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SLC39A6 mRNA	PMID:39709020
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SLC39A6 mRNA	PMID:32763439
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLC39A6 mRNA	PMID:29803840
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312237	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of SLC39A6 mRNA	PMID:39631538
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC39A6 mRNA	PMID:39836092
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC39A6 mRNA	PMID:32234424
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312237	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC39A6 mRNA	PMID:22228805|PMID:23735875
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of SLC39A6 promoter	PMID:23974009
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	affects expression	ISO	RGD:1304664	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of SLC39A6 mRNA	PMID:15867272
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	affects uptake	EXP		E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A6 protein affects the uptake of Zinc	PMID:18272141
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of SLC39A6 mRNA	PMID:17085522
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312237	E	RGD:6480464	20141223	CTD	MESH:D015032	Zinc deficiency results in increased expression of SLC39A6 protein	PMID:25088245
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A6 protein results in increased transport of Zinc	PMID:18326752
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	increases uptake	EXP		E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A6 protein results in increased uptake of Zinc	PMID:12839489
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130212	CTD	MESH:D015032	Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form results in decreased susceptibility to trichostatin A]]	PMID:19887557
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A6 protein inhibits the reaction [Lipopolysaccharides results in decreased abundance of Zinc]	PMID:16892068
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SLC39A6 mRNA	PMID:26238291
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:31638	fulvestrant	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of SLC39A6 mRNA	PMID:16514628
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304664	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SLC39A6 mRNA	PMID:30047161
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312237	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SLC39A6 gene	PMID:35295148
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC39A6 mRNA	PMID:29950665
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304664	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SLC39A6 mRNA	PMID:34492290
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1304664	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SLC39A6 mRNA	PMID:25380136
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC39A6 mRNA	PMID:19710929
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of SLC39A6 mRNA	PMID:38479592
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304664	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SLC39A6 mRNA	PMID:25181051
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304664	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC39A6 mRNA	PMID:30816183|PMID:34947998
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SLC39A6 mRNA	PMID:26363213
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312237	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SLC39A6 mRNA	PMID:26682919
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312237	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SLC39A6 mRNA	PMID:38685157
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SLC39A6 mRNA	PMID:29950665
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SLC39A6 mRNA	PMID:21266533
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of SLC39A6 mRNA	PMID:36117858
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC39A6 mRNA	PMID:37042841
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC39A6 mRNA	PMID:39836092
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304664	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of SLC39A6 mRNA	PMID:25380136
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1304664	E	RGD:6480464	20180703	CTD	MESH:D019256	Cadmium Chloride affects the expression of SLC39A6 mRNA	PMID:29548726
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304664	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SLC39A6 mRNA	PMID:33453195
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304664	E	RGD:6480464	20260303	CTD	MESH:D019256	[zinc chloride co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] results in decreased expression of SLC39A6 mRNA	PMID:30714133
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1304664	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SLC39A6 mRNA	PMID:30047161
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1304664	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of SLC39A6 mRNA	PMID:25380136
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SLC39A6 mRNA	PMID:28302478
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1312237	E	RGD:6480464	20120515	CTD	MESH:C031763	1,3-butadiene results in increased expression of SLC39A6 mRNA	PMID:21147608
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLC39A6 mRNA	PMID:25979313
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of SLC39A6 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC39A6 mRNA	PMID:29154799
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A6 mRNA	PMID:27188386
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304664	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SLC39A6 mRNA	PMID:30047161
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1304664	E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in increased expression of SLC39A6 mRNA	PMID:27281708
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SLC39A6 mRNA	PMID:20106945
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:44616	afimoxifene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of SLC39A6 mRNA	PMID:16514628
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SLC39A6 mRNA	PMID:38832940
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:45716	vorinostat	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	SLC39A6 mutant form results in decreased susceptibility to vorinostat	PMID:19887557
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SLC39A6 mRNA	PMID:24935251|PMID:26272509
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:46024	trichostatin A	decreases response to substance	EXP		E	RGD:6480464	20130212	CTD	MESH:C012589	SLC39A6 mutant form results in decreased susceptibility to trichostatin A	PMID:19887557
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:C012589	trichostatin A results in increased expression of SLC39A6 mRNA; trichostatin A results in increased expression of SLC39A6 protein	PMID:19887557
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20130212	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A6 mRNA; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form results in decreased susceptibility to trichostatin A]; SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]; SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]; SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]; SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form results in decreased susceptibility to trichostatin A]]	PMID:19887557|PMID:27188386
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLC39A6 mRNA	PMID:17562736
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC39A6 mRNA	PMID:29067470
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC39A6 mRNA	PMID:19420014
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of SLC39A6 mRNA	PMID:21148743
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC39A6 mRNA	PMID:39836092
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC39A6 mRNA	PMID:17942748
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of SLC39A6 mRNA	PMID:23228038
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:49976	zinc dichloride	multiple interactions	ISO	RGD:1304664	E	RGD:6480464	20260303	CTD	MESH:C016837	[zinc chloride co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] results in decreased expression of SLC39A6 mRNA	PMID:30714133
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304664	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SLC39A6 mRNA	PMID:30047161
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304664	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of SLC39A6 mRNA	PMID:24793618
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312237	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of SLC39A6 mRNA	PMID:36117858
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of SLC39A6 mRNA	PMID:26705709
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312237	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SLC39A6 mRNA	PMID:19042947
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SLC39A6 mRNA	PMID:39836092
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312237	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC39A6 mRNA	PMID:23650126
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1304664	E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of SLC39A6 mRNA	PMID:28935588
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312237	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of SLC39A6 mRNA	PMID:31052254
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of SLC39A6 mRNA	PMID:30559759
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A6 mRNA	PMID:27188386
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC39A6 gene]	PMID:28238834
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312237	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SLC39A6 mRNA	PMID:21278054
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304664	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SLC39A6 mRNA	PMID:24780913|PMID:30047161
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of SLC39A6 mRNA	PMID:26272509
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of SLC39A6 mRNA	PMID:16514628
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form results in decreased susceptibility to trichostatin A]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2L1 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased cleavage of CASP3 protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in increased expression of BAX protein]]]; Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form results in decreased susceptibility to trichostatin A]]	PMID:19887557
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC39A6 mRNA	PMID:27188386
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304664	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SLC39A6 mRNA	PMID:19281266
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304664	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SLC39A6 mRNA	PMID:21346803
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SLC39A6 mRNA	PMID:38568856
1312236	SLC39A6	solute carrier family 39 member 6	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304664	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of SLC39A6 mRNA	PMID:22570695
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PCDHB4 mRNA	PMID:27188386
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PCDHB4 mRNA	PMID:22378314
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1312239	E	RGD:6480464	20201201	CTD	MESH:D008628	Mercury results in decreased expression of PCDHB4 mRNA	PMID:22008530
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDHB4 mRNA	PMID:20823114
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:16602	trichloroethene	decreases methylation	ISO	RGD:1304665	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of PCDHB4 gene	PMID:27618143
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312239	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PCDHB4 mRNA	PMID:34319233
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:2038	5-azacytidine	decreases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in decreased expression of PCDHB4 mRNA	PMID:20823114
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDHB4 gene	PMID:27153756
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1312239	E	RGD:6480464	20201201	CTD	MESH:D008628	Mercury results in decreased expression of PCDHB4 mRNA	PMID:22008530
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312239	E	RGD:6480464	20201201	CTD	MESH:D005492	Folic Acid results in decreased expression of PCDHB4 mRNA	PMID:25629700
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PCDHB4 mRNA	PMID:25583101
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304665	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDHB4 mRNA	PMID:33387578
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PCDHB4 mRNA	PMID:28001369
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304665	E	RGD:6480464	20160906	CTD	MESH:D003300	Copper deficiency results in increased expression of PCDHB4 mRNA	PMID:26033743
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDHB4 promoter	PMID:27901495
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PCDHB4 exon	PMID:27901495
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304665	E	RGD:6480464	20160906	CTD	MESH:D003300	Copper deficiency results in increased expression of PCDHB4 mRNA	PMID:26033743
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304665	E	RGD:6480464	20160906	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDHB4 mRNA	PMID:25181051|PMID:34947998
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312239	E	RGD:6480464	20201201	CTD	MESH:C008745	bisphenol F results in decreased expression of PCDHB4 mRNA	PMID:30951980
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PCDHB4 mRNA	PMID:25979313
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCDHB4 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB4 mRNA	PMID:27188386
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PCDHB4 mRNA	PMID:20106945
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PCDHB4 mRNA	PMID:27188386
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of PCDHB4 mRNA	PMID:18175754
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDHB4 mRNA	PMID:20823114
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312239	E	RGD:6480464	20201201	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PCDHB4 mRNA	PMID:23608068
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:63618	pravastatin	increases expression	ISO	RGD:1304665	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of PCDHB4 mRNA	PMID:27225895
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:63618	pravastatin	increases expression	ISO	RGD:1312239	E	RGD:6480464	20201201	CTD	MESH:D017035	Pravastatin results in increased expression of PCDHB4 mRNA	PMID:27225895
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PCDHB4 mRNA	PMID:24810058
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PCDHB4 mRNA	PMID:20147733
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDHB4 mRNA	PMID:20823114
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312239	E	RGD:6480464	20201201	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PCDHB4 mRNA	PMID:22206623
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB4 mRNA	PMID:27188386
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDHB4 gene]	PMID:28238834
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1312239	E	RGD:6480464	20240430	CTD	MESH:C028577	monobutyl phthalate results in increased expression of PCDHB4 mRNA	PMID:35278568
1312238	PCDHB4	protocadherin beta 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB4 mRNA	PMID:27188386
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of PAIP2 mRNA	PMID:21934132
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312241	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PAIP2 mRNA	PMID:30529165
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312241	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PAIP2 mRNA	PMID:30319688
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PAIP2 mRNA	PMID:29432896
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312241	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PAIP2 mRNA	PMID:39241906
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of PAIP2 mRNA	PMID:31614463
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312241	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PAIP2 mRNA	PMID:39298647
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005947	Glucose promotes the reaction [PAIP2 protein binds to SLC2A5 3' UTR]	PMID:12820898
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005947	Glucose promotes the reaction [PAIP2 protein binds to SLC2A5 3' UTR]	PMID:12820898
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312241	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PAIP2 mRNA	PMID:37236586
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PAIP2 mRNA	PMID:23649840
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PAIP2 mRNA	PMID:23649840
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PAIP2 mRNA	PMID:35430440
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PAIP2 gene	PMID:25304211
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312241	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PAIP2 mRNA	PMID:28189721|PMID:28960355
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312241	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PAIP2 mRNA	PMID:21570461
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1359176	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PAIP2 mRNA	PMID:34747641
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312241	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PAIP2 mRNA	PMID:17942748
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PAIP2 mRNA	PMID:33212167
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312241	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of PAIP2 mRNA]; MT2 affects the reaction [Copper results in increased expression of PAIP2 mRNA]	PMID:16629173
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:28757	fructose	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005632	Fructose promotes the reaction [PAIP2 protein binds to SLC2A5 3' UTR]	PMID:12820898
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PAIP2 mRNA	PMID:38568856
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312241	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PAIP2 mRNA	PMID:15034205|PMID:22228805
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PAIP2 promoter	PMID:27901495
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312241	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of PAIP2 mRNA]	PMID:15034205
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312241	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of PAIP2 mRNA]; MT2 affects the reaction [Copper results in increased expression of PAIP2 mRNA]	PMID:16629173
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1359176	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PAIP2 mRNA	PMID:30047161
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312241	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PAIP2 gene	PMID:35295148
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312241	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PAIP2 mRNA	PMID:23811191
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of PAIP2 protein	PMID:37567409
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of PAIP2 protein	PMID:34186270
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1359176	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PAIP2 mRNA	PMID:25181051|PMID:30816183
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PAIP2 mRNA	PMID:28628672
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PAIP2 protein	PMID:34186270
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312241	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PAIP2 mRNA	PMID:21266533
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PAIP2 mRNA	PMID:28628672
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312241	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of PAIP2 mRNA	PMID:34813904
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PAIP2 mRNA	PMID:37042841
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312241	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PAIP2 mRNA	PMID:37236586
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312241	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of PAIP2 mRNA	PMID:23811191
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PAIP2 mRNA	PMID:28302478
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of PAIP2 mRNA	PMID:23179753
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1359176	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PAIP2 mRNA	PMID:30047161
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PAIP2 mRNA	PMID:28628672
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose promotes the reaction [PAIP2 protein binds to SLC2A5 3' UTR]	PMID:12820898
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312241	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PAIP2 mRNA	PMID:17562736
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PAIP2 gene	PMID:25304211
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of PAIP2 mRNA	PMID:22077320
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312241	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PAIP2 mRNA	PMID:17942748
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1359176	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PAIP2 mRNA	PMID:17108234
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312241	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PAIP2 mRNA	PMID:17942748
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PAIP2 mRNA	PMID:28628672
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312241	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PAIP2 mRNA; Nanotubes, Carbon results in decreased expression of PAIP2 mRNA	PMID:25554681
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1359176	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PAIP2 mRNA	PMID:30047161
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PAIP2 protein	PMID:23718831
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312241	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PAIP2 mRNA	PMID:23650126
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PAIP2 protein	PMID:34186270
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312241	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PAIP2 mRNA	PMID:22206623
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312241	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of PAIP2 mRNA	PMID:31388691
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1359176	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PAIP2 mRNA	PMID:30047161
1312240	PAIP2	poly(A) binding protein interacting protein 2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1359176	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PAIP2 mRNA	PMID:19281266
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KCNA10 gene	PMID:27153756
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:26216	potassium atom	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D011188	KCNA10 protein results in increased transport of Potassium	PMID:10836990
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:26216	potassium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011188	4-Aminopyridine inhibits the reaction [KCNA10 protein results in increased transport of Potassium]; 4-O-methyl-12-O-tetradecanoylphorbol 13-acetate inhibits the reaction [KCNA10 protein results in increased transport of Potassium]; Barium inhibits the reaction [KCNA10 protein results in increased transport of Potassium]; Pimozide inhibits the reaction [KCNA10 protein results in increased transport of Potassium]; Verapamil inhibits the reaction [KCNA10 protein results in increased transport of Potassium]	PMID:10836990
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KCNA10 gene	PMID:25304211
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of KCNA10 mRNA	PMID:23557933
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of KCNA10 gene	PMID:28589171
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KCNA10 promoter	PMID:27901495
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:32595	barium(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001464	Barium inhibits the reaction [KCNA10 protein results in increased transport of Potassium]	PMID:10836990
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304667	E	RGD:6480464	20150623	CTD	MESH:C006780	bisphenol A results in decreased expression of KCNA10 mRNA	PMID:25181051
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304667	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of KCNA10 mRNA	PMID:41034487
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1621289	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KCNA10 promoter	PMID:27312807
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:34385	4-aminopyridine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015761	4-Aminopyridine inhibits the reaction [KCNA10 protein results in increased transport of Potassium]	PMID:10836990
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1621289	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of KCNA10 intron	PMID:28392331
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1621289	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of KCNA10 mRNA	PMID:32715474
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KCNA10 mRNA	PMID:38832940
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KCNA10 gene	PMID:25304211
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:77733	2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:D014700	Verapamil inhibits the reaction [KCNA10 protein results in increased transport of Potassium]	PMID:10836990
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KCNA10 gene]	PMID:28238834
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:8212	pimozide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010868	Pimozide inhibits the reaction [KCNA10 protein results in increased transport of Potassium]	PMID:10836990
1312242	KCNA10	potassium voltage-gated channel subfamily A member 10	gene	CHEBI:9948	verapamil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014700	Verapamil inhibits the reaction [KCNA10 protein results in increased transport of Potassium]	PMID:10836990
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312245	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of BLMH mRNA	PMID:33045310
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304668	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BLMH mRNA]	PMID:31150632
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of BLMH protein]	PMID:38195004
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of BLMH mRNA	PMID:14976132
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of BLMH mRNA	PMID:15498508|PMID:33167477
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of BLMH mRNA	PMID:16054129
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312245	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of BLMH mRNA	PMID:39298647
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of BLMH mRNA	PMID:38568856
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304668	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of BLMH mRNA	PMID:33387578
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of BLMH protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of BLMH protein	PMID:38195004
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1304668	E	RGD:6480464	20150623	CTD	MESH:D015032	Zinc deficiency results in increased expression of BLMH mRNA	PMID:16140947
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1304668	E	RGD:6480464	20150623	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of BLMH mRNA]	PMID:16140947
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304668	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BLMH mRNA	PMID:31150632
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304668	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BLMH mRNA]	PMID:31150632
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of BLMH mRNA	PMID:32525701
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of BLMH protein	PMID:38460933
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1304668	E	RGD:6480464	20150623	CTD	MESH:D002945	Cisplatin results in decreased expression of BLMH mRNA	PMID:18172885
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of BLMH mRNA	PMID:27392435
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312245	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BLMH mRNA	PMID:21570461
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BLMH mRNA	PMID:23152189
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of BLMH protein	PMID:39603559
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of BLMH mRNA	PMID:32763439
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of BLMH mRNA	PMID:29803840
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of BLMH mRNA	PMID:38568856|PMID:39719251
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312245	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of BLMH mRNA	PMID:36209798
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BLMH promoter	PMID:27901495
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1304668	E	RGD:6480464	20150623	CTD	MESH:D015032	Zinc deficiency results in increased expression of BLMH mRNA	PMID:16140947
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1304668	E	RGD:6480464	20150623	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of BLMH mRNA]	PMID:16140947
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BLMH mRNA	PMID:20382639
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1304668	E	RGD:6480464	20150623	CTD	MESH:D000643	Ammonium Chloride affects the expression of BLMH mRNA	PMID:16483693
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:31355	carboplatin	decreases expression	ISO	RGD:1304668	E	RGD:6480464	20150623	CTD	MESH:D016190	Carboplatin results in decreased expression of BLMH mRNA	PMID:18172885
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:3139	bleomycin A2	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D001761	BLMH gene polymorphism affects the susceptibility to Bleomycin	PMID:12082022
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of BLMH mRNA	PMID:15498508
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312245	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of BLMH mRNA	PMID:18301758
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of BLMH mRNA	PMID:19710929
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of BLMH mRNA; bisphenol A results in decreased expression of BLMH protein	PMID:29275510|PMID:34186270
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304668	E	RGD:6480464	20150623	CTD	MESH:C006780	bisphenol A results in decreased expression of BLMH mRNA	PMID:25181051|PMID:34947998
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of BLMH gene	PMID:31601247
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312245	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of BLMH mRNA	PMID:39298647
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1312245	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of BLMH mRNA	PMID:26377693
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312245	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of BLMH mRNA	PMID:38685157
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312245	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of BLMH mRNA	PMID:37019170
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BLMH mRNA	PMID:37042841
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of BLMH mRNA	PMID:26472689|PMID:38174414
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of BLMH protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of BLMH protein	PMID:38195004
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of BLMH protein	PMID:26879310
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of BLMH mRNA	PMID:40434365
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of BLMH mRNA	PMID:31533062
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1304668	E	RGD:6480464	20150623	CTD	MESH:C016104	sodium bichromate results in increased expression of BLMH mRNA	PMID:12325037
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BLMH mRNA	PMID:25979313
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312245	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of BLMH mRNA	PMID:17292431
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of BLMH mRNA	PMID:29154799
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312245	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of BLMH mRNA	PMID:28973697
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312245	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of BLMH mRNA	PMID:17562736
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of BLMH protein	PMID:38460933
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of BLMH mRNA	PMID:32525701
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312245	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of BLMH mRNA	PMID:25554681
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1304668	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of BLMH mRNA	PMID:24136188
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304668	E	RGD:6480464	20150623	CTD	MESH:D005485	Flutamide results in decreased expression of BLMH mRNA	PMID:24793618
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304668	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of BLMH mRNA	PMID:24136188
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of BLMH protein	PMID:32959892
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312245	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of BLMH mRNA	PMID:23650126
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304668	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of BLMH gene	PMID:35440735
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of BLMH protein	PMID:34186270
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of BLMH protein	PMID:37664457
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of BLMH protein	PMID:39638853
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of BLMH protein	PMID:39638853
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BLMH gene]	PMID:28238834
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in decreased expression of BLMH mRNA	PMID:19084549
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1304668	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of BLMH protein	PMID:28903499
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of BLMH mRNA	PMID:33512557
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of BLMH protein	PMID:38348393
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of BLMH mRNA	PMID:32525701
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1304668	E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in increased expression of BLMH mRNA	PMID:26923065
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of BLMH protein	PMID:37664457
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304668	E	RGD:6480464	20150623	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of BLMH mRNA	PMID:21346803
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1304668	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of BLMH mRNA	PMID:24136188
1312244	BLMH	bleomycin hydrolase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304668	E	RGD:6480464	20150623	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of BLMH mRNA	PMID:21346803
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CCNDBP1 mRNA	PMID:38218311
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1304669	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of CCNDBP1 mRNA	PMID:21551480
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312247	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CCNDBP1 mRNA	PMID:26251327
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of CCNDBP1 mRNA	PMID:23724009|PMID:33167477
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CCNDBP1 mRNA	PMID:26079696
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312247	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CCNDBP1 mRNA	PMID:30319688
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312247	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CCNDBP1 mRNA	PMID:39241906
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of CCNDBP1 mRNA	PMID:23019147|PMID:31614463
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of CCNDBP1 mRNA	PMID:33359661
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CCNDBP1 mRNA	PMID:28818685
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CCNDBP1 mRNA	PMID:19549813
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CCNDBP1 mRNA	PMID:27153756
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CCNDBP1 gene	PMID:27153756
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CCNDBP1 mRNA	PMID:23649840
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:27385	tetrachloromethane	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002251	CCNDBP1 protein results in decreased susceptibility to Carbon Tetrachloride	PMID:16501603
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312247	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCNDBP1 mRNA	PMID:22206623
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCNDBP1 mRNA	PMID:40512198
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of CCNDBP1 mRNA	PMID:23300844
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312247	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCNDBP1 mRNA	PMID:21570461
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304669	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCNDBP1 mRNA	PMID:32109520
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CCNDBP1 mRNA	PMID:33212167
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of CCNDBP1 mRNA	PMID:39709020
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Thiosemicarbazones binds to Copper] which results in increased expression of CCNDBP1 protein	PMID:20931265
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312247	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of CCNDBP1 mRNA	PMID:27862939
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CCNDBP1 mRNA	PMID:38568856
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCNDBP1 mRNA	PMID:40512198
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312247	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCNDBP1 mRNA	PMID:22228805
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312247	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCNDBP1 exon; Benzo(a)pyrene results in increased methylation of CCNDBP1 intron	PMID:27901495
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CCNDBP1 mRNA]	PMID:32406909
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Thiosemicarbazones binds to Copper] which results in increased expression of CCNDBP1 protein	PMID:20931265
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312247	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CCNDBP1 gene	PMID:35295148
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312247	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CCNDBP1 mRNA	PMID:18648102
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304669	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CCNDBP1 mRNA	PMID:25181051
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1304669	E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CCNDBP1 mRNA	PMID:18668222
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	CCNDBP1 protein results in decreased susceptibility to Diethylnitrosamine	PMID:16501603
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CCNDBP1 mRNA	PMID:37042841
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:35861	dibenzo[a,l]pyrene	affects expression	ISO	RGD:1312247	E	RGD:6480464	20160210	CTD	MESH:C041517	dibenzo(a,l)pyrene affects the expression of CCNDBP1 mRNA	PMID:26496743
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312247	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of CCNDBP1 mRNA	PMID:17585979|PMID:23811191
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CCNDBP1 mRNA	PMID:28302478
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CCNDBP1 mRNA	PMID:40419075
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CCNDBP1 mRNA	PMID:25979313
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CCNDBP1 mRNA	PMID:29154799
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312247	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CCNDBP1 mRNA	PMID:17555576
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312247	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CCNDBP1 mRNA	PMID:17562736
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCNDBP1 mRNA	PMID:40512198
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312247	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CCNDBP1 mRNA	PMID:17555576
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of CCNDBP1 mRNA	PMID:23300844
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312247	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CCNDBP1 mRNA; Nanotubes, Carbon results in decreased expression of CCNDBP1 mRNA	PMID:25554681
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1312247	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of CCNDBP1 mRNA	PMID:26377693
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1304669	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of CCNDBP1 mRNA	PMID:20080153
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased expression of CCNDBP1 mRNA	PMID:27918106
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CCNDBP1 mRNA	PMID:31758290
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312247	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CCNDBP1 mRNA	PMID:22206623
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312247	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCNDBP1 mRNA	PMID:22206623
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of CCNDBP1 mRNA	PMID:26079696
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304669	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CCNDBP1 mRNA	PMID:21346803
1312246	CCNDBP1	cyclin D1 binding protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304669	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CCNDBP1 mRNA	PMID:23034163
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:132844	glycidyl methacrylate	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of SNAPC1 protein	PMID:36641056
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SNAPC1 mRNA	PMID:33167477
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SNAPC1 mRNA	PMID:24236059|PMID:26516004
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SNAPC1 mRNA	PMID:21179406
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of SNAPC1 mRNA	PMID:29581250
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SNAPC1 mRNA	PMID:31614463
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of SNAPC1 mRNA	PMID:21592394
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SNAPC1 mRNA	PMID:21592394
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312250	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SNAPC1 mRNA	PMID:34319233
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SNAPC1 mRNA	PMID:21592394
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SNAPC1 mRNA	PMID:21592394
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304671	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SNAPC1 mRNA	PMID:33387578
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:1304671	E	RGD:6480464	20120814	CTD	MESH:D007501	Iron deficiency results in increased expression of SNAPC1 mRNA	PMID:16629162
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312250	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNAPC1 mRNA	PMID:37236586
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SNAPC1 mRNA	PMID:19549813
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SNAPC1 protein	PMID:20106945
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312250	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SNAPC1 mRNA	PMID:25629700
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SNAPC1 mRNA	PMID:32525701
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SNAPC1 mRNA	PMID:27392435
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SNAPC1 mRNA	PMID:27392435
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312250	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNAPC1 mRNA	PMID:21570461
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SNAPC1 mRNA	PMID:28001369
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SNAPC1 mRNA	PMID:33212167
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:28358	rac-lactic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of SNAPC1 mRNA	PMID:30851411
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:28748	doxorubicin	affects methylation	ISO	RGD:1304671	E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of SNAPC1 gene	PMID:28962528
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SNAPC1 promoter	PMID:27901495
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312250	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNAPC1 mRNA	PMID:22228805
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SNAPC1 mRNA	PMID:26014281
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SNAPC1 mRNA	PMID:19150397|PMID:20018196
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304671	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SNAPC1 mRNA	PMID:30047161
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312250	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SNAPC1 mRNA	PMID:29264374
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312250	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNAPC1 gene; titanium dioxide results in decreased methylation of SNAPC1 promoter	PMID:35295148
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304671	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SNAPC1 mRNA	PMID:23411599
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312250	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SNAPC1 mRNA	PMID:19710929
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312250	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SNAPC1 mRNA	PMID:26063408
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304671	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNAPC1 mRNA	PMID:25181051
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:3423	carmustine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in increased expression of SNAPC1 mRNA	PMID:15980968
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of SNAPC1 mRNA	PMID:17312168
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SNAPC1 mRNA	PMID:38382870
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312250	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNAPC1 mRNA	PMID:37236586
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1304671	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SNAPC1 mRNA	PMID:30047161
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312250	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SNAPC1 mRNA	PMID:17292431
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SNAPC1 mRNA	PMID:28001369|PMID:29154799
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304671	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SNAPC1 mRNA	PMID:30047161
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SNAPC1 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1304671	E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of SNAPC1 mRNA	PMID:36653537
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:45863	paclitaxel	increases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	SNAPC1 protein results in increased susceptibility to Paclitaxel	PMID:16734730
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304671	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SNAPC1 mRNA	PMID:33387578
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005472	Fluorouracil results in decreased expression of SNAPC1 protein	PMID:15585135|PMID:16803524
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SNAPC1 mRNA	PMID:18687144
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SNAPC1 mRNA	PMID:32525701
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312250	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SNAPC1 mRNA	PMID:35436446
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of SNAPC1 mRNA	PMID:23228038
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312250	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SNAPC1 mRNA	PMID:25554681
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304671	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SNAPC1 mRNA	PMID:30047161
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	SNAPC1 protein affects the susceptibility to Topotecan	PMID:16217747
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SNAPC1 mRNA	PMID:28988120
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312250	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SNAPC1 mRNA	PMID:22206623
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of SNAPC1 mRNA	PMID:30851411
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of SNAPC1 mRNA	PMID:30928695
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SNAPC1 gene]	PMID:28238834
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SNAPC1 mRNA	PMID:19159669
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:1304671	E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of SNAPC1 mRNA	PMID:16629162
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SNAPC1 mRNA	PMID:32525701
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SNAPC1 mRNA	PMID:26014281
1312249	SNAPC1	small nuclear RNA activating complex polypeptide 1	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of SNAPC1 mRNA	PMID:17440010
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in decreased expression of OXCT1 mRNA	PMID:24172598
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of OXCT1 mRNA	PMID:20938992
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of OXCT1 mRNA	PMID:23724009|PMID:33167477
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of OXCT1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of OXCT1 mRNA	PMID:32699268
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of OXCT1 mRNA	PMID:26079696
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of OXCT1 mRNA	PMID:22378314
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:16136	hydrogen sulfide	increases expression	ISO	RGD:1312253	E	RGD:6480464	20181113	CTD	MESH:D006862	Hydrogen Sulfide results in increased expression of OXCT1 protein	PMID:29932956
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of OXCT1 mRNA	PMID:30319688
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of OXCT1 mRNA	PMID:39241906
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of OXCT1 mRNA]	PMID:39241906
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of OXCT1 mRNA	PMID:30510588
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1584008	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of OXCT1 mRNA	PMID:32145629
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:16602	trichloroethene	affects expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D014241	Trichloroethylene affects the expression of OXCT1 mRNA	PMID:21135412
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of OXCT1 mRNA	PMID:20938992
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of OXCT1 mRNA	PMID:23649840
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of OXCT1 mRNA	PMID:26079696
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of OXCT1 mRNA	PMID:37992649
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate affects the expression of OXCT1 mRNA	PMID:21195148
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:17303	morphine	decreases expression	ISO	RGD:1584008	E	RGD:6480464	20130416	CTD	MESH:D009020	Morphine results in decreased expression of OXCT1 protein	PMID:23056601
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D013739	Testosterone results in decreased expression of OXCT1 mRNA	PMID:20403060
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312253	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of OXCT1 mRNA	PMID:33848595
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of OXCT1 mRNA]	PMID:33848595
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of OXCT1 mRNA	PMID:37992649
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:17712	9H-xanthine	multiple interactions	ISO	RGD:1584008	E	RGD:6480464	20120717	CTD	MESH:D019820	[Xanthine co-treated with XDH protein] results in decreased expression of OXCT1 protein	PMID:19464573
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1584008	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of OXCT1 mRNA	PMID:22061828|PMID:33387578
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of OXCT1 mRNA	PMID:35301059
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1584008	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OXCT1 mRNA	PMID:39012411
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of OXCT1 mRNA	PMID:19770486
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of OXCT1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of OXCT1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of OXCT1 mRNA	PMID:32699268
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1584008	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of OXCT1 mRNA	PMID:17991464
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of OXCT1 protein	PMID:38598786
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1312253	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of OXCT1 mRNA	PMID:31939706
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312253	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of OXCT1 mRNA	PMID:27339419|PMID:31919559
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of OXCT1 mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of OXCT1 mRNA]	PMID:20938992|PMID:22206623
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of OXCT1 gene	PMID:25304211
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of OXCT1 mRNA	PMID:28960355
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1584008	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of OXCT1 mRNA	PMID:31881176
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of OXCT1 mRNA	PMID:19167446
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of OXCT1 mRNA	PMID:27392435
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1584008	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of OXCT1 mRNA	PMID:22023808
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of OXCT1 mRNA	PMID:27594783
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of OXCT1 mRNA	PMID:27392435
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of OXCT1 mRNA	PMID:23625948
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of OXCT1 promoter	PMID:22847954
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D014640	Vancomycin results in increased expression of OXCT1 mRNA	PMID:18930951
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of OXCT1 mRNA	PMID:26377647
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1584008	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of OXCT1 mRNA	PMID:32109520|PMID:34747641
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OXCT1 mRNA	PMID:21496263
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OXCT1 mRNA	PMID:19770486|PMID:21496263
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1584008	E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OXCT1 mRNA	PMID:26232522
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OXCT1 mRNA	PMID:17942748
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of OXCT1 mRNA	PMID:33512557
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of OXCT1 protein	PMID:39603559
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1584008	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of OXCT1 protein	PMID:35544339
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of OXCT1 mRNA	PMID:39709020
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D004317	Doxorubicin results in decreased expression of OXCT1 mRNA	PMID:26873546
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of OXCT1 mRNA	PMID:29803840
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of OXCT1 mRNA	PMID:37992649
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of OXCT1 mRNA	PMID:38568856
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of OXCT1 mRNA	PMID:37682722
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of OXCT1 mRNA	PMID:29301061|PMID:39719251
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312253	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of OXCT1 protein	PMID:29044176
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of OXCT1 mRNA	PMID:20064835
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of OXCT1 mRNA	PMID:19770486
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of OXCT1 promoter	PMID:27901495
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of OXCT1 mRNA	PMID:32234424
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of OXCT1 mRNA; arsenite results in decreased expression of OXCT1 protein	PMID:37955338
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of OXCT1 mRNA	PMID:25895662
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1584008	E	RGD:6480464	20120412	CTD	MESH:C032036	bromobenzene results in decreased expression of OXCT1 mRNA	PMID:15056800
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1584008	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of OXCT1 mRNA	PMID:25729387
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1584008	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of OXCT1 mRNA	PMID:34492290
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1584008	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of OXCT1 mRNA	PMID:30723492
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:C006253	pirinixic acid results in decreased expression of OXCT1 mRNA	PMID:17426115|PMID:18445702
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of OXCT1 mRNA	PMID:19710929
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312253	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of OXCT1 mRNA	PMID:28472532
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1584008	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of OXCT1 mRNA	PMID:25181051
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of OXCT1 mRNA; bisphenol A results in decreased expression of OXCT1 protein	PMID:29275510|PMID:34186270
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1584008	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of OXCT1 mRNA	PMID:34947998
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of OXCT1 gene	PMID:31601247
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1584008	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of OXCT1 mRNA	PMID:32145629
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of OXCT1 mRNA	PMID:28628672
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of OXCT1 mRNA	PMID:26682919
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of OXCT1 mRNA	PMID:33297965
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312253	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of OXCT1 promoter	PMID:33297965
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of OXCT1 protein	PMID:34186270
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of OXCT1 mRNA	PMID:26377693
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of OXCT1 protein	PMID:34186270
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of OXCT1 protein	PMID:34186270
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1584008	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of OXCT1 mRNA	PMID:21241498
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1312253	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of OXCT1 mRNA	PMID:31558096
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1584008	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of OXCT1 mRNA	PMID:20691718
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of OXCT1 mRNA	PMID:21266533
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1584008	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of OXCT1 mRNA	PMID:21266533
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of OXCT1 mRNA	PMID:28628672
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of OXCT1 mRNA]	PMID:39241906
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of OXCT1 mRNA	PMID:37042841
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1584008	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of OXCT1 mRNA	PMID:35163327
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of OXCT1 mRNA	PMID:35301059
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1584008	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OXCT1 mRNA	PMID:39012411
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1584008	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of OXCT1 mRNA	PMID:35163327
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of OXCT1 mRNA	PMID:19320972
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D002922	Ciguatoxins affects the expression of OXCT1 mRNA	PMID:18353800
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of OXCT1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of OXCT1 mRNA	PMID:32699268
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of OXCT1 promoter	PMID:22847954
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of OXCT1 promoter	PMID:22847954
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of OXCT1 mRNA	PMID:19167446
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OXCT1 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of OXCT1 mRNA	PMID:19167446
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of OXCT1 mRNA	PMID:40419075
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1312253	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of OXCT1 mRNA	PMID:31558096
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of OXCT1 mRNA	PMID:29154799
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of OXCT1 gene	PMID:29154799
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of OXCT1 mRNA	PMID:27989131
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D016572	Cyclosporine results in decreased expression of OXCT1 mRNA	PMID:19770486
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1584008	E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen results in increased activity of NOA1 protein] which results in decreased activity of OXCT1 protein	PMID:17283165
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of OXCT1 mRNA	PMID:28628672
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of OXCT1 mRNA	PMID:28973697
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of OXCT1 mRNA	PMID:37992649
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of OXCT1 mRNA	PMID:24449571
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:45979	thiabendazole	affects expression	ISO	RGD:1584008	E	RGD:6480464	20120412	CTD	MESH:D013827	Thiabendazole affects the expression of OXCT1 mRNA	PMID:18539377
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of OXCT1 mRNA	PMID:25704631
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1584008	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of OXCT1 mRNA	PMID:33387578
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	OXCT1 protein affects the susceptibility to Fluorouracil	PMID:16217747
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of OXCT1 mRNA]	PMID:15016801
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of OXCT1 gene	PMID:25304211
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1584008	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of OXCT1 mRNA	PMID:29391264
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:48517	7H-xanthine	multiple interactions	ISO	RGD:1584008	E	RGD:6480464	20121218	CTD	MESH:D019820	[Xanthine co-treated with XDH protein] results in decreased expression of OXCT1 protein	PMID:19464573
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of OXCT1 mRNA	PMID:17555576
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OXCT1 mRNA	PMID:17942748
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1584008	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of OXCT1 mRNA	PMID:36868495
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of OXCT1 mRNA	PMID:28628672
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of OXCT1 mRNA; Nanotubes, Carbon results in decreased expression of OXCT1 mRNA	PMID:25554681
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of OXCT1 mRNA	PMID:40234311
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:50729	mitoxantrone	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	OXCT1 protein affects the susceptibility to Mitoxantrone	PMID:16217747
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of OXCT1 mRNA	PMID:35964746
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:51397	1,3-dinitrobenzene	increases oxidation	ISO	RGD:1584008	E	RGD:6480464	20150512	CTD	MESH:C017906	3-dinitrobenzene results in increased oxidation of OXCT1 protein	PMID:25716674
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in decreased expression of OXCT1 mRNA	PMID:16780908
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of OXCT1 protein	PMID:32959892
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1584008	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of OXCT1 mRNA	PMID:25729387
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of OXCT1 mRNA	PMID:23650126
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1584008	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of OXCT1 mRNA	PMID:28801915
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1584008	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of OXCT1 gene	PMID:35440735
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of OXCT1 mRNA	PMID:31758290
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of OXCT1 protein	PMID:34186270
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312253	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of OXCT1 mRNA	PMID:22206623
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of OXCT1 mRNA]	PMID:22206623
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1584008	E	RGD:6480464	20211012	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of OXCT1 mRNA	PMID:33945839
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to OXCT1 gene]	PMID:28238834
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of OXCT1 mRNA	PMID:19167446
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1312253	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of OXCT1 mRNA	PMID:31558096
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of OXCT1 mRNA	PMID:33512557
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of OXCT1 mRNA	PMID:26079696
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312253	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of OXCT1 mRNA	PMID:21795629
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312253	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of OXCT1 mRNA]	PMID:39241906
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:88522	Monobutylphthalate	affects expression	ISO	RGD:1312253	E	RGD:6480464	20160726	CTD	MESH:C028577	monobutyl phthalate affects the expression of OXCT1 mRNA	PMID:21195148
1312252	OXCT1	3-oxoacid CoA-transferase 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of OXCT1 protein	PMID:38598786
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:10110	zidovudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with IFNA1 protein] results in decreased expression of DDR2 mRNA	PMID:20370541
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:619855	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of DDR2 mRNA	PMID:25152437
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312255	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of DDR2 mRNA	PMID:33045310
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of DDR2 mRNA	PMID:25812627
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:15343	acetaldehyde	increases expression	ISO	RGD:619855	E	RGD:150517731|PMID:23409069	20230412	RGD	MESH:D000079	Acetaldehyde increases expression of Ddr2 protein expression in hepatic stellate cells	
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of DDR2 mRNA; Tretinoin results in increased expression of DDR2 protein	PMID:21934132|PMID:30093655
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of DDR2 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of DDR2 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of DDR2 mRNA	PMID:30951980
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DDR2 mRNA	PMID:36331819
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of DDR2 mRNA	PMID:22378314
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312255	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of DDR2 mRNA	PMID:30319688
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:619855	E	RGD:150517731|PMID:23409069	20230412	RGD	MESH:D000431	Ethanol increases expression of Ddr2 protein expression in the liver	
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DDR2 mRNA	PMID:21179406
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of DDR2 mRNA	PMID:12419474
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DDR2 mRNA	PMID:25510870
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312255	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of DDR2 mRNA	PMID:33711761
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of DDR2 mRNA	PMID:38568856
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:619855	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DDR2 mRNA	PMID:33387578
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DDR2 mRNA	PMID:21179406
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DDR2 mRNA	PMID:37992649
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of DDR2 mRNA	PMID:33647349
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DDR2 mRNA	PMID:37992649
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:619855	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of DDR2 mRNA	PMID:26577399
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of DDR2 protein	PMID:37730182
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:619855	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DDR2 mRNA	PMID:33387578
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:181932	3-Nitrobenzanthrone	affects expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C117220	3-nitrobenzanthrone affects the expression of DDR2 mRNA	PMID:34036453
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DDR2 mRNA	PMID:37236586
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DDR2 mRNA	PMID:29950665
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DDR2 mRNA	PMID:25510870
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DDR2 mRNA	PMID:25510870
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of DDR2 mRNA	PMID:23649840
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DDR2 mRNA	PMID:23649840
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DDR2 mRNA	PMID:18593933
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of DDR2 mRNA	PMID:26272509
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDR2 mRNA	PMID:27188386
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of DDR2 mRNA	PMID:25667456
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of DDR2 mRNA	PMID:27392435
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of DDR2 mRNA	PMID:27392435
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:619855	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of DDR2 mRNA	PMID:17898221
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312255	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DDR2 mRNA	PMID:21570461
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312255	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DDR2 mRNA	PMID:33956508
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:619855	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DDR2 mRNA	PMID:32109520
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312255	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DDR2 mRNA	PMID:15034205
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:619855	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DDR2 mRNA	PMID:34747641
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of DDR2 mRNA	PMID:28001369
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of DDR2 mRNA	PMID:26272509
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDR2 mRNA	PMID:27188386
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:619855	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of DDR2 mRNA	PMID:28959563
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DDR2 mRNA	PMID:32763439
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of DDR2 mRNA	PMID:21198554
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:619855	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of DDR2 mRNA	PMID:30556269
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DDR2 mRNA	PMID:29803840
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312255	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of DDR2 mRNA	PMID:39631538
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DDR2 mRNA	PMID:37992649
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DDR2 mRNA	PMID:22714537|PMID:38568856
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312255	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of DDR2 mRNA	PMID:39095385
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DDR2 5' UTR; Benzo(a)pyrene affects the methylation of DDR2 exon	PMID:27901495
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DDR2 mRNA	PMID:32234424
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312255	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DDR2 mRNA	PMID:15034205
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:619855	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of DDR2 mRNA	PMID:30556269
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:30145	lithium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in decreased expression of DDR2 mRNA	PMID:21092101
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:30146	lithium hydride	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in decreased expression of DDR2 mRNA	PMID:21092101
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DDR2 mRNA	PMID:18593933
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1312255	E	RGD:6480464	20250603	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DDR2 mRNA	PMID:39826883
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DDR2 protein	PMID:30093655
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of DDR2 mRNA	PMID:35984750
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:619855	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of DDR2 mRNA	PMID:16483693
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:31236	aripiprazole	decreases expression	ISO	RGD:619855	E	RGD:6480464	20170228	CTD	MESH:C094645	Aripiprazole results in decreased expression of DDR2 mRNA	PMID:17868501
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:619855	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of DDR2 mRNA	PMID:22641619
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:619855	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of DDR2 mRNA	PMID:25729387
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312255	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of DDR2 mRNA	PMID:27760801|PMID:35295148
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C009495	titanium dioxide results in increased expression of DDR2 mRNA	PMID:19695317
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312255	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of DDR2 mRNA	PMID:29264374
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:C009495	[Vitallium analog binds to titanium dioxide] which results in increased expression of DDR2 mRNA	PMID:23825117
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DDR2 mRNA	PMID:29950665
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:619855	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of DDR2 mRNA	PMID:12832660
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of DDR2 mRNA	PMID:12419474
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:619855	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of DDR2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of DDR2 mRNA	PMID:29275510
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312255	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of DDR2 mRNA	PMID:30951980
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:619855	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DDR2 mRNA	PMID:25181051
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:619855	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DDR2 gene	PMID:28505145
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of DDR2 mRNA	PMID:30951980
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:619855	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DDR2 mRNA	PMID:36041667
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DDR2 mRNA	PMID:25510870
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DDR2 mRNA	PMID:25510870
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:619855	E	RGD:6480464	20180515	CTD	MESH:D008748	Methylcholanthrene results in increased expression of DDR2 mRNA	PMID:29094188
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:619855	E	RGD:6480464	20180515	CTD	MESH:D008748	alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DDR2 mRNA]	PMID:29094188
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312255	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of DDR2 mRNA	PMID:30951980
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of DDR2 mRNA	PMID:30951980
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:619855	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DDR2 mRNA	PMID:36041667
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312255	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of DDR2 mRNA	PMID:38685157
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312255	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of DDR2 mRNA	PMID:30951980
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of DDR2 mRNA	PMID:30951980
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:619855	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DDR2 mRNA	PMID:36041667
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312255	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DDR2 mRNA	PMID:34289071
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DDR2 mRNA	PMID:29950665
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DDR2 mRNA	PMID:37236586
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of DDR2 mRNA	PMID:25812627
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:619855	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of DDR2 mRNA	PMID:27387713
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DDR2 mRNA	PMID:19320972
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of DDR2 mRNA	PMID:24449571
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of DDR2 mRNA	PMID:40434365
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DDR2 mRNA	PMID:31533062
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of DDR2 mRNA	PMID:25812627|PMID:40419075
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DDR2 mRNA	PMID:36331819
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:619855	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of DDR2 mRNA	PMID:23125180
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DDR2 mRNA	PMID:25979313
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312255	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of DDR2 mRNA	PMID:24896083
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of DDR2 mRNA	PMID:20106945
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312255	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of DDR2 mRNA	PMID:17555576
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312255	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DDR2 mRNA	PMID:37992649
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DDR2 mRNA	PMID:38832940
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:619855	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DDR2 mRNA	PMID:33387578
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312255	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of DDR2 mRNA	PMID:29279043
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:619855	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of DDR2 mRNA	PMID:29391264
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312255	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DDR2 mRNA	PMID:17555576
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of DDR2 mRNA	PMID:32234424
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of DDR2 mRNA	PMID:26272509
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDR2 mRNA	PMID:27188386
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DDR2 protein	PMID:30093655
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of DDR2 mRNA	PMID:38825487
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of DDR2 mRNA	PMID:28673683
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312255	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DDR2 mRNA; Nanotubes, Carbon results in decreased expression of DDR2 mRNA	PMID:25554681
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:50692	mifepristone	decreases expression	ISO	RGD:619855	E	RGD:6480464	20150825	CTD	MESH:D015735	Mifepristone results in decreased expression of DDR2 mRNA	PMID:25972201
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of DDR2 mRNA	PMID:26705709
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of DDR2 mRNA	PMID:22714537
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312255	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of DDR2 mRNA	PMID:23608068
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:619855	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of DDR2 mRNA	PMID:25729387
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:619855	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of DDR2 mRNA	PMID:25729387
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312255	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of DDR2 mRNA	PMID:19812364
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of DDR2 mRNA	PMID:24810058
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312255	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of DDR2 mRNA	PMID:36851058
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:619855	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DDR2 gene	PMID:35440735
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of DDR2 mRNA	PMID:31758290
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DDR2 protein	PMID:34186270
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:619855	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DDR2 mRNA	PMID:27567155
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:76995	alpha-naphthoflavone	multiple interactions	ISO	RGD:619855	E	RGD:6480464	20180515	CTD	MESH:C011512	alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of DDR2 mRNA]	PMID:29094188
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDR2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDR2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDR2 mRNA	PMID:27188386
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:78543	ponatinib	decreases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C545373	ponatinib results in decreased activity of DDR2 protein	PMID:19878872
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DDR2 gene]	PMID:28238834
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:619855	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of DDR2 mRNA	PMID:32109520
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312255	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DDR2 mRNA	PMID:38648751
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of DDR2 mRNA	PMID:30458266
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of DDR2 mRNA	PMID:32234424
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1312255	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of DDR2 mRNA	PMID:27029645
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312255	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of DDR2 mRNA	PMID:21795629
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312255	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of DDR2 mRNA	PMID:21795629
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:619855	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of DDR2 mRNA	PMID:24780913
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDR2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDR2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DDR2 mRNA	PMID:27188386
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DDR2 mRNA	PMID:38568856
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312255	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of DDR2 protein	PMID:24648495
1312254	DDR2	discoidin domain receptor tyrosine kinase 2	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:619855	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of DDR2 gene	PMID:31079544
1312257	TOLLIP	toll interacting protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312258	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TOLLIP mRNA	PMID:33045310
1312257	TOLLIP	toll interacting protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312258	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TOLLIP mRNA	PMID:20188158
1312257	TOLLIP	toll interacting protein	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TOLLIP mRNA	PMID:26079696
1312257	TOLLIP	toll interacting protein	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312258	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TOLLIP mRNA	PMID:30319688
1312257	TOLLIP	toll interacting protein	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1312258	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in increased expression of TOLLIP protein	PMID:23353651
1312257	TOLLIP	toll interacting protein	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20161213	CTD	MESH:D011794	TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 affects the localization of RELA protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CD80 protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CD86 protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK1 protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of MAPK3 protein]]; TOLLIP protein affects the reaction [Quercetin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of NFKBIA protein]]	PMID:23353651
1312257	TOLLIP	toll interacting protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TOLLIP mRNA	PMID:39241906
1312257	TOLLIP	toll interacting protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TOLLIP mRNA	PMID:39298647
1312257	TOLLIP	toll interacting protein	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1304676	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of TOLLIP mRNA	PMID:23829299
1312257	TOLLIP	toll interacting protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TOLLIP mRNA	PMID:37042841
1312257	TOLLIP	toll interacting protein	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of TOLLIP mRNA	PMID:38160208
1312257	TOLLIP	toll interacting protein	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of TOLLIP mRNA	PMID:21669218
1312257	TOLLIP	toll interacting protein	gene	CHEBI:17627	ferroheme b	increases expression	ISO	RGD:1312258	E	RGD:6480464	20120814	CTD	MESH:D006418	Heme metabolite results in increased expression of TOLLIP mRNA	PMID:19191707
1312257	TOLLIP	toll interacting protein	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304676	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TOLLIP mRNA	PMID:33387578
1312257	TOLLIP	toll interacting protein	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TOLLIP mRNA	PMID:36331819
1312257	TOLLIP	toll interacting protein	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOLLIP mRNA	PMID:39836092
1312257	TOLLIP	toll interacting protein	gene	CHEBI:195250	corn oil	increases expression	ISO	RGD:1312258	E	RGD:6480464	20230704	CTD	MESH:D003314	Corn Oil results in increased expression of TOLLIP mRNA	PMID:33263755
1312257	TOLLIP	toll interacting protein	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312258	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of TOLLIP mRNA	PMID:27462272
1312257	TOLLIP	toll interacting protein	gene	CHEBI:211551	TMC-120A	increases expression	ISO	RGD:1312258	E	RGD:6480464	20231219	CTD	MESH:C402696	TMC 120A results in increased expression of TOLLIP mRNA	PMID:19818335
1312257	TOLLIP	toll interacting protein	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TOLLIP protein	PMID:23301498
1312257	TOLLIP	toll interacting protein	gene	CHEBI:24828	indoles	decreases expression	ISO	RGD:1304676	E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in decreased expression of TOLLIP mRNA	PMID:20521778
1312257	TOLLIP	toll interacting protein	gene	CHEBI:24828	indoles	increases expression	ISO	RGD:1304676	E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in increased expression of TOLLIP mRNA	PMID:20521778
1312257	TOLLIP	toll interacting protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TOLLIP promoter	PMID:30157460
1312257	TOLLIP	toll interacting protein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of TOLLIP mRNA	PMID:35430440
1312257	TOLLIP	toll interacting protein	gene	CHEBI:26355	heme b	increases expression	ISO	RGD:1312258	E	RGD:6480464	20140805	CTD	MESH:D006418	Heme metabolite results in increased expression of TOLLIP mRNA	PMID:19191707
1312257	TOLLIP	toll interacting protein	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of TOLLIP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of TOLLIP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of TOLLIP protein	PMID:38598786
1312257	TOLLIP	toll interacting protein	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TOLLIP gene	PMID:25304211
1312257	TOLLIP	toll interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOLLIP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOLLIP mRNA	PMID:39836092
1312257	TOLLIP	toll interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312258	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TOLLIP mRNA	PMID:21570461
1312257	TOLLIP	toll interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TOLLIP mRNA	PMID:25975270
1312257	TOLLIP	toll interacting protein	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304676	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of TOLLIP protein	PMID:35544339
1312257	TOLLIP	toll interacting protein	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TOLLIP mRNA	PMID:33212167
1312257	TOLLIP	toll interacting protein	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TOLLIP mRNA	PMID:32763439
1312257	TOLLIP	toll interacting protein	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1304676	E	RGD:6480464	20170110	CTD	MESH:D004317	[Doxorubicin co-treated with Fungal Polysaccharides] results in decreased expression of TOLLIP mRNA	PMID:27181935
1312257	TOLLIP	toll interacting protein	gene	CHEBI:28783	zinc protoporphyrin	decreases expression	ISO	RGD:1304676	E	RGD:6480464	20151013	CTD	MESH:C017803	zinc protoporphyrin results in decreased expression of TOLLIP protein	PMID:25780291
1312257	TOLLIP	toll interacting protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TOLLIP mRNA	PMID:21911445|PMID:31233874
1312257	TOLLIP	toll interacting protein	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TOLLIP mRNA	PMID:38568856
1312257	TOLLIP	toll interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOLLIP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOLLIP mRNA	PMID:39836092
1312257	TOLLIP	toll interacting protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TOLLIP 3' UTR; Benzo(a)pyrene affects the methylation of TOLLIP intron	PMID:27901495|PMID:30157460
1312257	TOLLIP	toll interacting protein	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D012834	Silver results in increased expression of TOLLIP mRNA	PMID:22342292
1312257	TOLLIP	toll interacting protein	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TOLLIP mRNA	PMID:19428942
1312257	TOLLIP	toll interacting protein	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TOLLIP gene	PMID:31601247
1312257	TOLLIP	toll interacting protein	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C009495	titanium dioxide results in decreased expression of TOLLIP mRNA	PMID:22342292
1312257	TOLLIP	toll interacting protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312258	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TOLLIP gene; titanium dioxide results in decreased methylation of TOLLIP promoter	PMID:35295148
1312257	TOLLIP	toll interacting protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304676	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TOLLIP mRNA	PMID:34492290
1312257	TOLLIP	toll interacting protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312258	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of TOLLIP mRNA	PMID:18648102
1312257	TOLLIP	toll interacting protein	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D009585	TOLLIP gene SNP results in increased susceptibility to [Air Pollutants results in increased abundance of Nitrogen Dioxide]	PMID:39009092
1312257	TOLLIP	toll interacting protein	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1304676	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of TOLLIP mRNA	PMID:19167457
1312257	TOLLIP	toll interacting protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304676	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TOLLIP mRNA	PMID:25181051
1312257	TOLLIP	toll interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of TOLLIP protein	PMID:31675489|PMID:34186270
1312257	TOLLIP	toll interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of TOLLIP mRNA	PMID:29275510
1312257	TOLLIP	toll interacting protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TOLLIP gene	PMID:31601247
1312257	TOLLIP	toll interacting protein	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304676	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TOLLIP mRNA	PMID:36041667
1312257	TOLLIP	toll interacting protein	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of TOLLIP protein	PMID:31675489
1312257	TOLLIP	toll interacting protein	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TOLLIP mRNA	PMID:25979313
1312257	TOLLIP	toll interacting protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1304676	E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of TOLLIP mRNA	PMID:23829299
1312257	TOLLIP	toll interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TOLLIP mRNA	PMID:39298647
1312257	TOLLIP	toll interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304676	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TOLLIP mRNA	PMID:36041667
1312257	TOLLIP	toll interacting protein	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of TOLLIP protein	PMID:34186270
1312257	TOLLIP	toll interacting protein	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304676	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TOLLIP mRNA	PMID:36041667
1312257	TOLLIP	toll interacting protein	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TOLLIP protein	PMID:34186270
1312257	TOLLIP	toll interacting protein	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20230404	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of TOLLIP protein	PMID:36543318
1312257	TOLLIP	toll interacting protein	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20230404	CTD	MESH:D016264	7-hydroxyl-1-methylindole-3-acetonitrile inhibits the reaction [Dextran Sulfate results in decreased expression of TOLLIP protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in decreased expression of TOLLIP protein]	PMID:36543318
1312257	TOLLIP	toll interacting protein	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of TOLLIP protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of TOLLIP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of TOLLIP protein	PMID:38598786
1312257	TOLLIP	toll interacting protein	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304676	E	RGD:6480464	20150310	CTD	MESH:D010269	Paraquat results in increased expression of TOLLIP protein	PMID:24521700
1312257	TOLLIP	toll interacting protein	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312258	E	RGD:6480464	20220111	CTD	MESH:D010269	Paraquat results in increased expression of TOLLIP mRNA; Paraquat results in increased expression of TOLLIP protein	PMID:33838153
1312257	TOLLIP	toll interacting protein	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20220111	CTD	MESH:D010269	rhyncophylline promotes the reaction [Paraquat results in increased expression of TOLLIP mRNA]; rhyncophylline promotes the reaction [Paraquat results in increased expression of TOLLIP protein]; TOLLIP protein promotes the reaction [rhyncophylline inhibits the reaction [Paraquat results in increased phosphorylation of IRAK1 protein]]	PMID:33838153
1312257	TOLLIP	toll interacting protein	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOLLIP mRNA	PMID:39836092
1312257	TOLLIP	toll interacting protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TOLLIP mRNA	PMID:33129824
1312257	TOLLIP	toll interacting protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304676	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TOLLIP mRNA	PMID:33453195
1312257	TOLLIP	toll interacting protein	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TOLLIP mRNA	PMID:31533062
1312257	TOLLIP	toll interacting protein	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312258	E	RGD:6480464	20260303	CTD	MESH:C473478	Sunitinib results in increased expression of TOLLIP protein	PMID:40449751
1312257	TOLLIP	toll interacting protein	gene	CHEBI:38940	sunitinib	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20260303	CTD	MESH:C473478	2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of TOLLIP protein]; N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of TOLLIP protein]]	PMID:40449751
1312257	TOLLIP	toll interacting protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TOLLIP mRNA	PMID:36331819
1312257	TOLLIP	toll interacting protein	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1304676	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of TOLLIP mRNA	PMID:23125180
1312257	TOLLIP	toll interacting protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312258	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TOLLIP mRNA	PMID:17562736
1312257	TOLLIP	toll interacting protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304676	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TOLLIP mRNA	PMID:33387578
1312257	TOLLIP	toll interacting protein	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of TOLLIP mRNA	PMID:20977926
1312257	TOLLIP	toll interacting protein	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of TOLLIP mRNA	PMID:21148743
1312257	TOLLIP	toll interacting protein	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TOLLIP gene	PMID:25304211
1312257	TOLLIP	toll interacting protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOLLIP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOLLIP mRNA	PMID:39836092
1312257	TOLLIP	toll interacting protein	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of TOLLIP mRNA	PMID:31675489
1312257	TOLLIP	toll interacting protein	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304676	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TOLLIP mRNA	PMID:29391264
1312257	TOLLIP	toll interacting protein	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TOLLIP mRNA	PMID:35436446
1312257	TOLLIP	toll interacting protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312258	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TOLLIP mRNA; Nanotubes, Carbon results in increased expression of TOLLIP mRNA	PMID:25554681|PMID:25620056
1312257	TOLLIP	toll interacting protein	gene	CHEBI:50834	cadmium selenide	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C058667	[cadmium selenide co-treated with zinc sulfide] results in increased expression of TOLLIP mRNA	PMID:22342292
1312257	TOLLIP	toll interacting protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TOLLIP mRNA	PMID:35964746
1312257	TOLLIP	toll interacting protein	gene	CHEBI:53509	erlotinib hydrochloride	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D000069347	[Erlotinib Hydrochloride results in decreased susceptibility to Erlotinib Hydrochloride] which results in increased expression of TOLLIP mRNA	PMID:27738319
1312257	TOLLIP	toll interacting protein	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TOLLIP protein	PMID:32959892
1312257	TOLLIP	toll interacting protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOLLIP mRNA	PMID:39836092
1312257	TOLLIP	toll interacting protein	gene	CHEBI:63948	trimethyltin	increases expression	ISO	RGD:1312258	E	RGD:6480464	20121113	CTD	MESH:C046488	trimethyltin results in increased expression of TOLLIP mRNA	PMID:21435392
1312257	TOLLIP	toll interacting protein	gene	CHEBI:6775	mesalamine	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20230404	CTD	MESH:D019804	Mesalamine inhibits the reaction [Dextran Sulfate results in decreased expression of TOLLIP protein]	PMID:36543318
1312257	TOLLIP	toll interacting protein	gene	CHEBI:68794	neoechinulin A	increases expression	ISO	RGD:1312258	E	RGD:6480464	20170228	CTD	MESH:C490266	neoechinulin A results in increased expression of TOLLIP mRNA	PMID:19818335
1312257	TOLLIP	toll interacting protein	gene	CHEBI:70069	Rhynchophylline	increases expression	ISO	RGD:1312258	E	RGD:6480464	20220111	CTD	MESH:C052714	rhyncophylline results in increased expression of TOLLIP mRNA; rhyncophylline results in increased expression of TOLLIP protein	PMID:33838153
1312257	TOLLIP	toll interacting protein	gene	CHEBI:70069	Rhynchophylline	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20220111	CTD	MESH:C052714	rhyncophylline promotes the reaction [Paraquat results in increased expression of TOLLIP mRNA]; rhyncophylline promotes the reaction [Paraquat results in increased expression of TOLLIP protein]; TOLLIP protein promotes the reaction [rhyncophylline inhibits the reaction [Paraquat results in increased phosphorylation of IRAK1 protein]]	PMID:33838153
1312257	TOLLIP	toll interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TOLLIP mRNA	PMID:22206623
1312257	TOLLIP	toll interacting protein	gene	CHEBI:79089	ceric oxide	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C030583	ceric oxide analog results in decreased expression of TOLLIP mRNA	PMID:24821434
1312257	TOLLIP	toll interacting protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312258	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TOLLIP mRNA	PMID:23091169
1312257	TOLLIP	toll interacting protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TOLLIP protein	PMID:31675489
1312257	TOLLIP	toll interacting protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1312258	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of TOLLIP mRNA	PMID:38995820
1312257	TOLLIP	toll interacting protein	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of TOLLIP protein	PMID:31675489
1312257	TOLLIP	toll interacting protein	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of TOLLIP mRNA	PMID:26079696
1312257	TOLLIP	toll interacting protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312258	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TOLLIP mRNA	PMID:39847705
1312257	TOLLIP	toll interacting protein	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D011070	TOLLIP affects the reaction [[[Vehicle Emissions results in increased abundance of Particulate Matter] which co-treated with Poly I-C] results in increased secretion of CXCL8 protein]	PMID:39009092
1312257	TOLLIP	toll interacting protein	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312258	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of TOLLIP mRNA	PMID:21278054
1312257	TOLLIP	toll interacting protein	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D012834	Silver results in increased expression of TOLLIP mRNA	PMID:22342292
1312257	TOLLIP	toll interacting protein	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TOLLIP mRNA	PMID:38568856
1312257	TOLLIP	toll interacting protein	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of TOLLIP mRNA	PMID:29301935
1312257	TOLLIP	toll interacting protein	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of TOLLIP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of TOLLIP protein	PMID:38598786
1312257	TOLLIP	toll interacting protein	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304676	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of TOLLIP mRNA	PMID:19015723
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312260	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PANK1 mRNA	PMID:33045310
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312260	E	RGD:6480464	20171010	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PANK1 mRNA	PMID:28558994
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304677	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PANK1 mRNA]	PMID:31150632
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PANK1 mRNA	PMID:39752319
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:134964	perflubutane	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C108042	perfluorobutane results in increased expression of PANK1 mRNA	PMID:23567314
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PANK1 mRNA	PMID:33167477
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:15379	dioxygen	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency affects the expression of PANK1 mRNA	PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PANK1 mRNA	PMID:30529165
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of PANK1 mRNA	PMID:36841081
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PANK1 mRNA	PMID:21632981
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312260	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of PANK1 mRNA	PMID:39298647
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of PANK1 mRNA	PMID:20106945
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of PANK1 mRNA	PMID:19484750
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304677	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PANK1 mRNA	PMID:32741896
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D005557	Formaldehyde results in decreased expression of PANK1 mRNA	PMID:20655997|PMID:23416264
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PANK1 mRNA	PMID:23649840
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PANK1 mRNA	PMID:21179406
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PANK1 mRNA	PMID:39752319
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1312260	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of PANK1 mRNA	PMID:17178593
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304677	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PANK1 mRNA	PMID:32741896
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PANK1 protein	PMID:37730182
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PANK1 mRNA	PMID:33387578
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PANK1 mRNA	PMID:28818685
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1312260	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of PANK1 mRNA	PMID:33914522
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1312260	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of PANK1 mRNA	PMID:17178593
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in decreased expression of PANK1 mRNA	PMID:34773240
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Selenium inhibits the reaction [Cadmium results in decreased expression of PANK1 mRNA]	PMID:34773240
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PANK1 mRNA	PMID:19549813
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PANK1 mRNA	PMID:23649840
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PANK1 mRNA	PMID:27153756
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PANK1 mRNA	PMID:19770486
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PANK1 gene	PMID:27153756
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PANK1 mRNA	PMID:23649840
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PANK1 mRNA	PMID:31150632
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PANK1 mRNA	PMID:27339419|PMID:31919559
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304677	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PANK1 mRNA]	PMID:31150632
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PANK1 mRNA	PMID:25629700
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in increased methylation of PANK1 gene	PMID:24525453
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PANK1 mRNA	PMID:32045263
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of PANK1 mRNA]	PMID:34773240
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of PANK1 mRNA	PMID:38460933
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of PANK1 mRNA	PMID:38460933
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of PANK1 mRNA	PMID:38460933
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PANK1 mRNA	PMID:31881176
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of PANK1 mRNA	PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of PANK1 mRNA	PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PANK1 mRNA	PMID:27392435
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PANK1 mRNA	PMID:27392435
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of PANK1 mRNA	PMID:18930951
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PANK1 mRNA	PMID:32186404
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PANK1 mRNA	PMID:24768652|PMID:25583101
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304677	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PANK1 mRNA	PMID:22298810
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312260	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PANK1 mRNA	PMID:21570461
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PANK1 mRNA	PMID:21215274|PMID:21724226|PMID:33387578
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PANK1 mRNA	PMID:17942748
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312260	E	RGD:6480464	20230905	CTD	MESH:D012402	Rotenone results in increased expression of PANK1 mRNA alternative form	PMID:35589691
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20230905	CTD	MESH:D012402	PANK1 mRNA alternative form affects the reaction [Rotenone results in decreased expression of TH protein]; PANK1 mRNA alternative form affects the reaction [Rotenone results in increased expression of SNCA mRNA]; PANK1 mRNA alternative form affects the reaction [Rotenone results in increased expression of SNCA protein]	PMID:35589691
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PANK1 mRNA	PMID:33212167
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1312260	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of PANK1 mRNA	PMID:17178593
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of PANK1 protein	PMID:35688186
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of PANK1 mRNA	PMID:22623647
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PANK1 mRNA	PMID:38568856|PMID:39719251
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20220208	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PANK1 mRNA	PMID:32045263
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of PANK1 mRNA	PMID:17127020
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PANK1 mRNA	PMID:32234424
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PANK1 promoter	PMID:27901495
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PANK1 mRNA]	PMID:22228805
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of PANK1 mRNA	PMID:26014281
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PANK1 mRNA	PMID:19073995
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:31175	adefovir pivoxil	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in decreased expression of PANK1 mRNA	PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PANK1 mRNA	PMID:24136188
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PANK1 mRNA	PMID:29264374
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312260	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PANK1 promoter	PMID:35295148
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PANK1 mRNA	PMID:34492290
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1304677	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PANK1 mRNA	PMID:16707586
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312260	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PANK1 mRNA	PMID:17426115|PMID:18301758|PMID:23811191
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PANK1 mRNA	PMID:19710929
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1312260	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of PANK1 mRNA	PMID:33914522
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of PANK1 mRNA	PMID:32156529|PMID:37894381
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304677	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PANK1 mRNA	PMID:25181051
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312260	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PANK1 mRNA	PMID:33221593
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PANK1 mRNA	PMID:39298647
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PANK1 mRNA	PMID:28392331
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PANK1 mRNA	PMID:37019170
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of PANK1 mRNA	PMID:35093514
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1304677	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of PANK1 mRNA	PMID:22110744
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of PANK1 mRNA	PMID:32680482
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PANK1 mRNA	PMID:37042841
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PANK1 mRNA	PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1304677	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PANK1 mRNA	PMID:28511854
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312260	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PANK1 mRNA	PMID:28558994
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PANK1 mRNA	PMID:24386269
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312260	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of PANK1 mRNA	PMID:28962523
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of PANK1 mRNA]	PMID:34773240
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of PANK1 mRNA	PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312260	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of PANK1 mRNA	PMID:23811191
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312260	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PANK1 mRNA	PMID:28558994
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:38397	perfluorononanoic acid	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20220111	CTD	MESH:C101816	PPARA protein affects the reaction [perfluoro-n-nonanoic acid results in increased expression of PANK1 mRNA]	PMID:28558994
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PANK1 mRNA	PMID:31533062
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312260	E	RGD:6480464	20171010	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PANK1 mRNA	PMID:28558994
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PANK1 mRNA	PMID:25979313
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PANK1 mRNA	PMID:17963808
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PANK1 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of PANK1 mRNA	PMID:21427059
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PANK1 gene	PMID:29154799
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of PANK1 mRNA	PMID:38685447|PMID:41580965
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PANK1 mRNA	PMID:20106945|PMID:25562108|PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PANK1 mRNA	PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312260	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PANK1 mRNA	PMID:28973697
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PANK1 mRNA	PMID:38832940
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PANK1 mRNA	PMID:17562736
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of PANK1 mRNA	PMID:29067470
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PANK1 mRNA	PMID:33387578
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of PANK1 mRNA	PMID:16557594
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of PANK1 mRNA	PMID:24714768|PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PANK1 mRNA	PMID:29523930
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of PANK1 mRNA	PMID:38460933
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in increased methylation of PANK1 gene	PMID:24525453
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PANK1 mRNA	PMID:32045263
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1312260	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of PANK1 mRNA	PMID:17178593
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PANK1 mRNA	PMID:17942748
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of PANK1 mRNA	PMID:32234424
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of PANK1 mRNA	PMID:16984733
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of PANK1 mRNA	PMID:25572481|PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1304677	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of PANK1 mRNA	PMID:16707586|PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of PANK1 mRNA	PMID:25620056
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1304677	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PANK1 mRNA	PMID:24136188
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of PANK1 mRNA	PMID:38685447|PMID:41580965
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of PANK1 mRNA	PMID:40234311
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of PANK1 mRNA	PMID:24136188
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:5855	ibuprofen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of PANK1 mRNA	PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:5855	ibuprofen	increases expression	ISO	RGD:1304677	E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of PANK1 mRNA	PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:5864	ifosfamide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of PANK1 mRNA	PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PANK1 protein	PMID:32959892
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of PANK1 mRNA	PMID:20080153
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PANK1 mRNA	PMID:21641980
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PANK1 mRNA	PMID:24810058
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of PANK1 mRNA	PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304677	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of PANK1 mRNA	PMID:30467583
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PANK1 mRNA	PMID:39752319
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PANK1 mRNA	PMID:22206623
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1304677	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of PANK1 mRNA	PMID:33484710
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1304677	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PANK1 mRNA	PMID:32741896
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312260	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of PANK1 mRNA	PMID:23091169
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312260	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PANK1 mRNA	PMID:38648751
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of PANK1 mRNA	PMID:21278054
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312260	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PANK1 mRNA	PMID:39752319
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of PANK1 mRNA	PMID:26014281
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304677	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PANK1 mRNA	PMID:21346803
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1312260	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of PANK1 mRNA	PMID:32835833
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1304677	E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in increased expression of PANK1 mRNA	PMID:25596134
1312259	PANK1	pantothenate kinase 1	gene	CHEBI:9986	vinclozolin	affects methylation	ISO	RGD:1304677	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin affects the methylation of PANK1 gene	PMID:31682807
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312262	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GDF1 mRNA	PMID:33045310
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312262	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in increased expression of GDF1 mRNA; [bisphenol F co-treated with Tretinoin] results in increased expression of GDF1 mRNA; [bisphenol S co-treated with Tretinoin] results in increased expression of GDF1 mRNA	PMID:30951980
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of GDF1 protein	PMID:33360347
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D006861	Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of GDF1 protein]	PMID:33360347
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304678	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GDF1 mRNA	PMID:33387578
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of GDF1 mRNA	PMID:22138414
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312262	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of GDF1 mRNA	PMID:22138414
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of GDF1 mRNA	PMID:18247414
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304678	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of GDF1 mRNA	PMID:22061828
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304678	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GDF1 mRNA	PMID:33387578
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of GDF1 mRNA	PMID:18247414
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304678	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GDF1 mRNA	PMID:39012411
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D009151	TNF protein affects the reaction [Mustard Gas affects the expression of GDF1 mRNA]	PMID:16173061
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [sodium arsenite results in decreased expression of GDF1 mRNA]; Folic Acid inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]	PMID:26537450|PMID:33360347
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:27878	2-naphthylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015081	2-Naphthylamine results in increased expression of GDF1 mRNA	PMID:18247414
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of GDF1 mRNA	PMID:12002526
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of GDF1 mRNA	PMID:28903495
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of GDF1 mRNA	PMID:27392435
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304678	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GDF1 mRNA	PMID:33387578
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GDF1 mRNA	PMID:29803840
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of GDF1 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]	PMID:33360347
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1304678	E	RGD:6480464	20210810	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]	PMID:33360347
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:C017947	sodium arsenite results in decreased expression of GDF1 mRNA; sodium arsenite results in decreased expression of GDF1 protein	PMID:26537450|PMID:33360347
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1304678	E	RGD:6480464	20210810	CTD	MESH:C017947	sodium arsenite results in decreased expression of GDF1 mRNA; sodium arsenite results in decreased expression of GDF1 protein	PMID:33360347
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:C017947	Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]; Folic Acid inhibits the reaction [sodium arsenite results in decreased expression of GDF1 mRNA]; Folic Acid inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]; SHC1 protein affects the reaction [sodium arsenite results in decreased expression of GDF1 protein]; SHC1 protein inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]; SIRT1 protein inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]; sodium arsenite inhibits the reaction [SP1 protein binds to GDF1 promoter]; SP1 protein affects the reaction [sodium arsenite results in decreased expression of GDF1 protein]	PMID:26537450|PMID:33360347
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1304678	E	RGD:6480464	20210810	CTD	MESH:C017947	Acetylcysteine inhibits the reaction [sodium arsenite results in decreased expression of GDF1 protein]	PMID:33360347
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GDF1 promoter	PMID:27901495
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GDF1 mRNA	PMID:18247414
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of GDF1 mRNA	PMID:29264374
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312262	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of GDF1 gene	PMID:35295148
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:33090	picene	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C056699	picene results in increased expression of GDF1 mRNA	PMID:32251684
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of GDF1 mRNA	PMID:26063408|PMID:30951980
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304678	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GDF1 mRNA	PMID:34947998
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312262	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in increased expression of GDF1 mRNA	PMID:30951980
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312262	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of GDF1 exon	PMID:33297965
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312262	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with LIF protein] results in decreased expression of GDF1 mRNA; [bisphenol S co-treated with Tretinoin] results in increased expression of GDF1 mRNA	PMID:30951980
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of GDF1 mRNA	PMID:30951980
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312262	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with LIF protein] results in decreased expression of GDF1 mRNA; [bisphenol F co-treated with Tretinoin] results in increased expression of GDF1 mRNA	PMID:30951980
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304678	E	RGD:6480464	20120522	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GDF1 mRNA	PMID:21266533
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GDF1 mRNA	PMID:21266533
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of GDF1 mRNA	PMID:37047231
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of GDF1 mRNA	PMID:26377693
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304678	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GDF1 mRNA	PMID:39012411
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312262	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GDF1 mRNA	PMID:40194260
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GDF1 mRNA	PMID:31533062
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GDF1 gene	PMID:29154799
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:4469	(S)-amphetamine	increases expression	ISO	RGD:1312262	E	RGD:6480464	20120412	CTD	MESH:D003913	Dextroamphetamine results in increased expression of GDF1 mRNA	PMID:12205029
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:4469	(S)-amphetamine	multiple interactions	ISO	RGD:1312262	E	RGD:6480464	20120412	CTD	MESH:D003913	SOD1 inhibits the reaction [Dextroamphetamine results in increased expression of GDF1 mRNA]	PMID:12205029
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304678	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GDF1 mRNA	PMID:33387578
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of GDF1 mRNA]	PMID:15016801
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304678	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GDF1 mRNA	PMID:29391264
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1304678	E	RGD:6480464	20120522	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of GDF1 mRNA	PMID:17557909
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GDF1 mRNA; Nanotubes, Carbon results in decreased expression of GDF1 mRNA	PMID:25554681
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of GDF1 mRNA	PMID:19042947
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312262	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of GDF1 mRNA	PMID:23608068
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:69478	cannabidiol	decreases methylation	ISO	RGD:1312262	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased methylation of GDF1 gene	PMID:33407853
1312261	GDF1	growth differentiation factor 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304678	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of GDF1 mRNA	PMID:19015723
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of CHORDC1 mRNA; deoxynivalenol results in increased expression of CHORDC1 protein	PMID:31863870|PMID:39638853
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of CHORDC1 protein	PMID:36252740
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1304679	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of CHORDC1 mRNA	PMID:21551480
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312264	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CHORDC1 mRNA	PMID:37995155
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CHORDC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CHORDC1 mRNA	PMID:32699268
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312264	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CHORDC1 mRNA	PMID:24205000
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:15422	ATP	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D000255	Adenosine Triphosphate promotes the reaction [CHORDC1 protein binds to PPP5C protein]; Adenosine Triphosphate promotes the reaction [CHORDC1 protein binds to SUGT1 protein]	PMID:23184943
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:15422	ATP	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20130514	CTD	MESH:D000255	Adenosine Triphosphate binds to and affects the folding of CHORDC1 protein; Adenosine Triphosphate promotes the reaction [CHORDC1 protein binds to CHORDC1 protein]; Adenosine Triphosphate promotes the reaction [CHORDC1 protein binds to HSP90AA1 protein]; Adenosine Triphosphate promotes the reaction [ITGB1BP2 protein binds to CHORDC1 protein]	PMID:23184943
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:15571	hydrazine	increases expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in increased expression of CHORDC1 mRNA	PMID:15282401
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of CHORDC1 mRNA	PMID:40865780
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312264	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CHORDC1 mRNA	PMID:30319688
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of CHORDC1 mRNA	PMID:30319688
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CHORDC1 mRNA	PMID:21632981
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312264	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CHORDC1 mRNA	PMID:39241906
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CHORDC1 mRNA]	PMID:39241906
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of CHORDC1 mRNA	PMID:20106945
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312264	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of CHORDC1 mRNA	PMID:33711761
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CHORDC1 mRNA	PMID:37042841
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:16761	ADP	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20130514	CTD	MESH:D000244	Adenosine Diphosphate binds to and affects the folding of CHORDC1 protein; Adenosine Diphosphate promotes the reaction [CHORDC1 protein binds to CHORDC1 protein]; Adenosine Diphosphate promotes the reaction [ITGB1BP2 protein binds to CHORDC1 protein]	PMID:23184943
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of CHORDC1 mRNA	PMID:18037150
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304679	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CHORDC1 mRNA	PMID:26577399
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304679	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CHORDC1 mRNA	PMID:33387578
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CHORDC1 mRNA	PMID:28818685
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CHORDC1 mRNA	PMID:39836092
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of CHORDC1 protein	PMID:28860664
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304679	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CHORDC1 mRNA	PMID:39012411
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CHORDC1 mRNA	PMID:19549813
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CHORDC1 protein	PMID:23301498
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of CHORDC1 mRNA	PMID:19376150
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CHORDC1 protein	PMID:20106945
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CHORDC1 mRNA	PMID:27153756
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CHORDC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CHORDC1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of CHORDC1 mRNA	PMID:32699268
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CHORDC1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of CHORDC1 protein	PMID:38598786
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CHORDC1 mRNA	PMID:18593933
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304679	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CHORDC1 mRNA	PMID:31150632
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312264	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CHORDC1 mRNA	PMID:27339419|PMID:31919559
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CHORDC1 mRNA	PMID:25629700
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of CHORDC1 promoter	PMID:21291286
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CHORDC1 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CHORDC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CHORDC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHORDC1 mRNA	PMID:32525701|PMID:39836092|PMID:40512198
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CHORDC1 mRNA	PMID:19244175
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of CHORDC1 protein	PMID:38460933
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CHORDC1 protein	PMID:35688186
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CHORDC1 mRNA	PMID:23557933
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of CHORDC1 mRNA	PMID:27594783
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312264	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHORDC1 mRNA	PMID:21570461
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304679	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHORDC1 mRNA	PMID:21215274
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304679	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CHORDC1 mRNA	PMID:32109520|PMID:33387578
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312264	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CHORDC1 mRNA	PMID:15034205
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CHORDC1 mRNA]	PMID:15034205
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1304679	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of CHORDC1 mRNA; Rotenone results in decreased expression of CHORDC1 protein	PMID:28374803|PMID:35544339
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CHORDC1 mRNA	PMID:33212167
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CHORDC1 mRNA	PMID:30851411
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA	PMID:27188386
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304679	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CHORDC1 mRNA	PMID:28959563
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CHORDC1 mRNA	PMID:32763439
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CHORDC1 mRNA	PMID:24690739
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of CHORDC1 mRNA	PMID:25523186
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CHORDC1 mRNA	PMID:38568856
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CHORDC1 mRNA; [sodium arsenite co-treated with lead acetate] results in increased expression of CHORDC1 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CHORDC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHORDC1 mRNA	PMID:38072110|PMID:39836092|PMID:40512198
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHORDC1 mRNA	PMID:34876320
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHORDC1 mRNA	PMID:34876320
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CHORDC1 protein	PMID:33278487
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312264	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CHORDC1 mRNA	PMID:15034205|PMID:19770486|PMID:21569818|PMID:22228805
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of CHORDC1 mRNA]	PMID:15034205
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CHORDC1 promoter	PMID:23974009
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CHORDC1 mRNA]	PMID:32406909
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of CHORDC1 mRNA	PMID:25523186
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CHORDC1 mRNA	PMID:24690739
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CHORDC1 mRNA	PMID:18593933
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of CHORDC1 mRNA	PMID:26014281|PMID:28959546
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CHORDC1 mRNA	PMID:25351596
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CHORDC1 protein]	PMID:26598702
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in increased expression of CHORDC1 protein	PMID:38072110
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1304679	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of CHORDC1 mRNA	PMID:16507785
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of CHORDC1 mRNA	PMID:31745603
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CHORDC1 mRNA	PMID:23557971|PMID:29264374
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312264	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CHORDC1 gene	PMID:35295148
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304679	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CHORDC1 mRNA	PMID:23411599|PMID:34492290
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CHORDC1 mRNA	PMID:18648102
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CHORDC1 mRNA	PMID:18445702
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312264	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CHORDC1 mRNA	PMID:18301758|PMID:23811191
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304679	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CHORDC1 mRNA	PMID:30903817
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CHORDC1 mRNA; bisphenol A results in decreased expression of CHORDC1 protein	PMID:29275510|PMID:37567409
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304679	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CHORDC1 mRNA	PMID:30816183
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304679	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CHORDC1 mRNA	PMID:25181051|PMID:32145629
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of CHORDC1 mRNA	PMID:19244175
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CHORDC1 mRNA	PMID:25979313
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312264	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CHORDC1 mRNA	PMID:39298647
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312264	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CHORDC1 mRNA	PMID:38685157
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CHORDC1 protein	PMID:34186270
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of CHORDC1 mRNA	PMID:28392331
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1312264	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of CHORDC1 protein	PMID:35362542
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of CHORDC1 protein]	PMID:35362542
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of CHORDC1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CHORDC1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of CHORDC1 protein	PMID:38598786
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CHORDC1 mRNA]	PMID:39241906
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CHORDC1 mRNA	PMID:37042841
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CHORDC1 mRNA	PMID:39836092
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of CHORDC1 mRNA	PMID:26377693
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304679	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CHORDC1 mRNA	PMID:33453195
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CHORDC1 mRNA	PMID:38568856
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304679	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CHORDC1 mRNA	PMID:19010381
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304679	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CHORDC1 mRNA	PMID:39012411
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CHORDC1 protein	PMID:26879310
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1304679	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CHORDC1 mRNA	PMID:19162173
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1304679	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CHORDC1 mRNA	PMID:19162173
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of CHORDC1 mRNA	PMID:19376846
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304679	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of CHORDC1 mRNA	PMID:24386269
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312264	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CHORDC1 mRNA	PMID:18353800
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CHORDC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CHORDC1 mRNA	PMID:32699268
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CHORDC1 mRNA	PMID:19244175
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of CHORDC1 protein	PMID:34122009
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CHORDC1 mRNA	PMID:28302478
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CHORDC1 mRNA	PMID:31533062
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1304679	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of CHORDC1 mRNA	PMID:25993096
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CHORDC1 mRNA	PMID:17292431|PMID:17963808
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CHORDC1 gene	PMID:29154799
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of CHORDC1 mRNA	PMID:29154799
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CHORDC1 mRNA	PMID:20106945|PMID:25562108
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CHORDC1 mRNA	PMID:20937368
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of CHORDC1 mRNA	PMID:18502557
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1304679	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CHORDC1 mRNA	PMID:24136188
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304679	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CHORDC1 mRNA	PMID:33387578
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of CHORDC1 mRNA	PMID:21420995
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of CHORDC1 mRNA	PMID:24690739
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of CHORDC1 mRNA	PMID:33725128
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of CHORDC1 protein	PMID:38460933
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of CHORDC1 promoter	PMID:21291286
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CHORDC1 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CHORDC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CHORDC1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHORDC1 mRNA	PMID:32525701|PMID:39836092|PMID:40512198
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of CHORDC1 mRNA	PMID:31838189
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:48607	lithium chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in increased expression of CHORDC1 mRNA	PMID:15711924
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHORDC1 mRNA	PMID:34876320
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of CHORDC1 protein]	PMID:35362542
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of CHORDC1 mRNA	PMID:17211630
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA	PMID:27188386
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CHORDC1 protein]	PMID:26598702
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1312264	E	RGD:6480464	20251104	CTD	MESH:C037123	cadmium sulfate results in increased expression of CHORDC1 mRNA	PMID:39152192
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CHORDC1 mRNA	PMID:25554681
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of CHORDC1 mRNA	PMID:40234311
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1304679	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of CHORDC1 mRNA	PMID:19162173
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CHORDC1 mRNA	PMID:35964746
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304679	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CHORDC1 mRNA	PMID:24136188
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of CHORDC1 mRNA	PMID:26377693
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of CHORDC1 mRNA	PMID:31629900
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:5613	haloperidol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in increased expression of CHORDC1 protein	PMID:34122009
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CHORDC1 protein	PMID:32959892
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1304679	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of CHORDC1 mRNA	PMID:20080153
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CHORDC1 mRNA	PMID:39836092
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1304679	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CHORDC1 mRNA	PMID:24136188
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:63959	celastrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C050414	celastrol results in increased expression of CHORDC1 mRNA	PMID:17010675
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of CHORDC1 mRNA	PMID:28988120
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of CHORDC1 mRNA	PMID:15336504
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:65954	gedunin	increases expression	EXP		E	RGD:6480464	20130305	CTD	MESH:C106014	gedunin results in increased expression of CHORDC1 mRNA	PMID:17010675
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1304679	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of CHORDC1 mRNA	PMID:19564919
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1304679	E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of CHORDC1 mRNA	PMID:19564919
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CHORDC1 mRNA	PMID:31758290
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CHORDC1 mRNA; bisphenol AF results in increased expression of CHORDC1 protein	PMID:25912373|PMID:34186270
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1304679	E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of CHORDC1 mRNA	PMID:39938710
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:73297	SCH 23390	multiple interactions	ISO	RGD:1304679	E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of CHORDC1 mRNA	PMID:19564919
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CHORDC1 protein	PMID:37664457
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1304679	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CHORDC1 mRNA	PMID:24136188
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CHORDC1 mRNA	PMID:22714537
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CHORDC1 mRNA	PMID:37199045
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of CHORDC1 protein	PMID:31285264
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CHORDC1 protein	PMID:39638853
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of CHORDC1 protein	PMID:39638853
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1304679	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of CHORDC1 mRNA	PMID:21346803
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CHORDC1 mRNA	PMID:30851411
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA	PMID:27188386
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:79369	elesclomol	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C512195	elesclomol results in increased expression of CHORDC1 mRNA	PMID:18723479
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1304679	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of CHORDC1 mRNA	PMID:19162173
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1312264	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of CHORDC1 mRNA	PMID:26377693
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CHORDC1 mRNA	PMID:32525701
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of CHORDC1 mRNA	PMID:34876320
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312264	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of CHORDC1 mRNA	PMID:21278054
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304679	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CHORDC1 mRNA	PMID:24780913
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312264	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CHORDC1 mRNA]	PMID:39241906
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CHORDC1 protein; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHORDC1 mRNA	PMID:27188386|PMID:37664457
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of CHORDC1 mRNA	PMID:26014281|PMID:28959546
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304679	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of CHORDC1 mRNA	PMID:19281266
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304679	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CHORDC1 mRNA	PMID:21346803
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CHORDC1 mRNA	PMID:38568856
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of CHORDC1 mRNA	PMID:29301935
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of CHORDC1 protein	PMID:38598786
1312263	CHORDC1	cysteine and histidine rich domain containing 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304679	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CHORDC1 mRNA	PMID:21346803
1312265	EPHA1	EPH receptor A1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of EPHA1 mRNA	PMID:38218311
1312265	EPHA1	EPH receptor A1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of EPHA1 mRNA	PMID:26272509
1312265	EPHA1	EPH receptor A1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA	PMID:27188386
1312265	EPHA1	EPH receptor A1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312266	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EPHA1 mRNA	PMID:33045310
1312265	EPHA1	EPH receptor A1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of EPHA1 mRNA	PMID:33167477
1312265	EPHA1	EPH receptor A1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EPHA1 mRNA	PMID:30529165
1312265	EPHA1	EPH receptor A1	gene	CHEBI:15930	atrazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001280	[Atrazine co-treated with Arsenates] results in increased expression of EPHA1 mRNA	PMID:18585445
1312265	EPHA1	EPH receptor A1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of EPHA1 mRNA	PMID:39298647
1312265	EPHA1	EPH receptor A1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of EPHA1 mRNA	PMID:12154049
1312265	EPHA1	EPH receptor A1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304680	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of EPHA1 mRNA	PMID:33387578
1312265	EPHA1	EPH receptor A1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312266	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of EPHA1 mRNA	PMID:39922521
1312265	EPHA1	EPH receptor A1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in decreased expression of EPHA1 mRNA	PMID:19693291
1312265	EPHA1	EPH receptor A1	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of EPHA1 mRNA	PMID:21592394
1312265	EPHA1	EPH receptor A1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312266	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in increased expression of EPHA1 mRNA	PMID:19693291
1312265	EPHA1	EPH receptor A1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of EPHA1 mRNA	PMID:21592394
1312265	EPHA1	EPH receptor A1	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1312266	E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of EPHA1 mRNA	PMID:17317680
1312265	EPHA1	EPH receptor A1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312266	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of EPHA1 mRNA	PMID:39922521
1312265	EPHA1	EPH receptor A1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of EPHA1 mRNA	PMID:21592394
1312265	EPHA1	EPH receptor A1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of EPHA1 mRNA	PMID:21592394
1312265	EPHA1	EPH receptor A1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304680	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of EPHA1 mRNA	PMID:33387578
1312265	EPHA1	EPH receptor A1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EPHA1 mRNA	PMID:28818685
1312265	EPHA1	EPH receptor A1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of EPHA1 exon	PMID:30157460
1312265	EPHA1	EPH receptor A1	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of EPHA1 mRNA	PMID:12634122
1312265	EPHA1	EPH receptor A1	gene	CHEBI:22727	benzopyran	multiple interactions	ISO	RGD:1304680	E	RGD:6480464	20170110	CTD	MESH:D001578	Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of and results in decreased activity of EPHA1 protein]; Benzopyrans results in increased expression of and results in increased activity of EPHA1 protein	PMID:25154877
1312265	EPHA1	EPH receptor A1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EPHA1 mRNA	PMID:37236586
1312265	EPHA1	EPH receptor A1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of EPHA1 mRNA	PMID:19549813
1312265	EPHA1	EPH receptor A1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304680	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of EPHA1 mRNA	PMID:21396975
1312265	EPHA1	EPH receptor A1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of EPHA1 mRNA	PMID:21641981|PMID:22100608|PMID:27153756
1312265	EPHA1	EPH receptor A1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EPHA1 exon	PMID:30157460
1312265	EPHA1	EPH receptor A1	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1304680	E	RGD:6480464	20150127	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of and results in decreased activity of EPHA1 protein; Benzopyrans inhibits the reaction [Aflatoxin B1 results in decreased expression of and results in decreased activity of EPHA1 protein]	PMID:25154877
1312265	EPHA1	EPH receptor A1	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1304680	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of EPHA1 mRNA	PMID:30779732
1312265	EPHA1	EPH receptor A1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EPHA1 gene	PMID:25304211
1312265	EPHA1	EPH receptor A1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EPHA1 mRNA	PMID:32525701
1312265	EPHA1	EPH receptor A1	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D000966	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA1 protein	PMID:32076005
1312265	EPHA1	EPH receptor A1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of EPHA1 protein	PMID:35688186
1312265	EPHA1	EPH receptor A1	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in increased expression of EPHA1 mRNA	PMID:12154049
1312265	EPHA1	EPH receptor A1	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1304680	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of EPHA1 mRNA	PMID:15691709
1312265	EPHA1	EPH receptor A1	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA	PMID:16963248
1312265	EPHA1	EPH receptor A1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPHA1 mRNA	PMID:19770486
1312265	EPHA1	EPH receptor A1	gene	CHEBI:28197	daidzein	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C004742	[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA	PMID:16963248
1312265	EPHA1	EPH receptor A1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EPHA1 mRNA	PMID:30851411
1312265	EPHA1	EPH receptor A1	gene	CHEBI:29287	gold atom	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in increased expression of EPHA1 mRNA	PMID:19695318
1312265	EPHA1	EPH receptor A1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of EPHA1 mRNA	PMID:29301061|PMID:38568856
1312265	EPHA1	EPH receptor A1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of EPHA1 mRNA	PMID:12760830
1312265	EPHA1	EPH receptor A1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C017947	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of EPHA1 protein	PMID:32076005
1312265	EPHA1	EPH receptor A1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312266	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of EPHA1 mRNA	PMID:17127020
1312265	EPHA1	EPH receptor A1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EPHA1 exon	PMID:30157460
1312265	EPHA1	EPH receptor A1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EPHA1 mRNA	PMID:32234424
1312265	EPHA1	EPH receptor A1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EPHA1 mRNA	PMID:19770486|PMID:22228805
1312265	EPHA1	EPH receptor A1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EPHA1 exon	PMID:27901495
1312265	EPHA1	EPH receptor A1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA	PMID:27858113
1312265	EPHA1	EPH receptor A1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C015001	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of EPHA1 protein	PMID:32076005
1312265	EPHA1	EPH receptor A1	gene	CHEBI:30050	gold(0)	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in increased expression of EPHA1 mRNA	PMID:19695318
1312265	EPHA1	EPH receptor A1	gene	CHEBI:30297	antimonite	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C061374	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA1 protein	PMID:32076005
1312265	EPHA1	EPH receptor A1	gene	CHEBI:31638	fulvestrant	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C070081	fulvestrant results in increased expression of EPHA1 mRNA	PMID:12154049
1312265	EPHA1	EPH receptor A1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of EPHA1 mRNA	PMID:29264374
1312265	EPHA1	EPH receptor A1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304680	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of EPHA1 mRNA	PMID:34492290
1312265	EPHA1	EPH receptor A1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of EPHA1 mRNA	PMID:18648102
1312265	EPHA1	EPH receptor A1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of EPHA1 mRNA	PMID:18445702|PMID:23811191
1312265	EPHA1	EPH receptor A1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of EPHA1 mRNA	PMID:19710929
1312265	EPHA1	EPH receptor A1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304680	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EPHA1 mRNA	PMID:25181051
1312265	EPHA1	EPH receptor A1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of EPHA1 gene	PMID:31601247
1312265	EPHA1	EPH receptor A1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312266	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of EPHA1 mRNA	PMID:32156529|PMID:34585602
1312265	EPHA1	EPH receptor A1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304680	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of EPHA1 gene	PMID:28505145
1312265	EPHA1	EPH receptor A1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of EPHA1 mRNA	PMID:25979313
1312265	EPHA1	EPH receptor A1	gene	CHEBI:34283	oxybenzone	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20250311	CTD	MESH:C005290	oxybenzone results in decreased expression of EPHA1 mRNA	PMID:39343157
1312265	EPHA1	EPH receptor A1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of EPHA1 mRNA	PMID:39298647
1312265	EPHA1	EPH receptor A1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312266	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of EPHA1 mRNA	PMID:30951980
1312265	EPHA1	EPH receptor A1	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA	PMID:27858113
1312265	EPHA1	EPH receptor A1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of EPHA1 exon	PMID:30157460
1312265	EPHA1	EPH receptor A1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312266	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of EPHA1 mRNA	PMID:30951980
1312265	EPHA1	EPH receptor A1	gene	CHEBI:34778	glycitein	multiple interactions	EXP		E	RGD:6480464	20141104	CTD	MESH:C086566	[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of EPHA1 mRNA	PMID:16963248
1312265	EPHA1	EPH receptor A1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EPHA1 mRNA	PMID:37042841
1312265	EPHA1	EPH receptor A1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304680	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of EPHA1 mRNA	PMID:35163327
1312265	EPHA1	EPH receptor A1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EPHA1 mRNA	PMID:37236586
1312265	EPHA1	EPH receptor A1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304680	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of EPHA1 mRNA	PMID:35163327
1312265	EPHA1	EPH receptor A1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of EPHA1 mRNA	PMID:28903501
1312265	EPHA1	EPH receptor A1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312266	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of EPHA1 mRNA	PMID:18353800
1312265	EPHA1	EPH receptor A1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of EPHA1 mRNA	PMID:23811191
1312265	EPHA1	EPH receptor A1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of EPHA1 mRNA	PMID:32588087
1312265	EPHA1	EPH receptor A1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of EPHA1 mRNA	PMID:31533062
1312265	EPHA1	EPH receptor A1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of EPHA1 mRNA	PMID:39529242
1312265	EPHA1	EPH receptor A1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of EPHA1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1312265	EPHA1	EPH receptor A1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA	PMID:27188386
1312265	EPHA1	EPH receptor A1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of EPHA1 mRNA	PMID:25562108
1312265	EPHA1	EPH receptor A1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312266	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of EPHA1 mRNA	PMID:28973697
1312265	EPHA1	EPH receptor A1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312266	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of EPHA1 mRNA	PMID:39922521
1312265	EPHA1	EPH receptor A1	gene	CHEBI:44616	afimoxifene	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C016601	afimoxifene results in increased expression of EPHA1 mRNA	PMID:12154049
1312265	EPHA1	EPH receptor A1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of EPHA1 mRNA	PMID:38832940
1312265	EPHA1	EPH receptor A1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of EPHA1 mRNA	PMID:24935251
1312265	EPHA1	EPH receptor A1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312266	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EPHA1 mRNA	PMID:17562736
1312265	EPHA1	EPH receptor A1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304680	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EPHA1 mRNA	PMID:33387578
1312265	EPHA1	EPH receptor A1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EPHA1 gene	PMID:25304211
1312265	EPHA1	EPH receptor A1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EPHA1 mRNA	PMID:32525701
1312265	EPHA1	EPH receptor A1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304680	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of EPHA1 mRNA	PMID:29391264
1312265	EPHA1	EPH receptor A1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased methylation of EPHA1 promoter	PMID:19277044
1312265	EPHA1	EPH receptor A1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of EPHA1 mRNA; Decitabine results in increased expression of EPHA1 protein	PMID:19277044
1312265	EPHA1	EPH receptor A1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of EPHA1 mRNA; Nanotubes, Carbon results in decreased expression of EPHA1 mRNA	PMID:25554681
1312265	EPHA1	EPH receptor A1	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1312266	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of EPHA1 mRNA	PMID:26377693
1312265	EPHA1	EPH receptor A1	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA	PMID:27858113
1312265	EPHA1	EPH receptor A1	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1312266	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of EPHA1 mRNA	PMID:27858113
1312265	EPHA1	EPH receptor A1	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of EPHA1 mRNA	PMID:20977926
1312265	EPHA1	EPH receptor A1	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of EPHA1 mRNA	PMID:26272509
1312265	EPHA1	EPH receptor A1	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA	PMID:27188386
1312265	EPHA1	EPH receptor A1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	affects expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium affects the expression of EPHA1 mRNA	PMID:12710931
1312265	EPHA1	EPH receptor A1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of EPHA1 exon	PMID:30157460
1312265	EPHA1	EPH receptor A1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EPHA1 mRNA	PMID:22206623
1312265	EPHA1	EPH receptor A1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EPHA1 mRNA	PMID:30851411
1312265	EPHA1	EPH receptor A1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA	PMID:27188386
1312265	EPHA1	EPH receptor A1	gene	CHEBI:78543	ponatinib	decreases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C545373	ponatinib results in decreased activity of EPHA1 protein	PMID:19878872
1312265	EPHA1	EPH receptor A1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EPHA1 gene]	PMID:28238834
1312265	EPHA1	EPH receptor A1	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EPHA1 mRNA	PMID:32525701
1312265	EPHA1	EPH receptor A1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312266	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of EPHA1 mRNA	PMID:21278054
1312265	EPHA1	EPH receptor A1	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA	PMID:27188386
1312265	EPHA1	EPH receptor A1	gene	CHEBI:8772	raloxifene	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of EPHA1 mRNA	PMID:12154049
1312265	EPHA1	EPH receptor A1	gene	CHEBI:88522	Monobutylphthalate	affects expression	ISO	RGD:1312266	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate affects the expression of EPHA1 mRNA	PMID:19162170
1312265	EPHA1	EPH receptor A1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA1 mRNA	PMID:27188386
1312265	EPHA1	EPH receptor A1	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of EPHA1 mRNA	PMID:29301935
1312265	EPHA1	EPH receptor A1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304680	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of EPHA1 mRNA	PMID:23034163
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312270	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SPTBN4 mRNA	PMID:33045310
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312270	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SPTBN4 mRNA	PMID:20188158
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312270	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SPTBN4 mRNA	PMID:30319688
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312270	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of SPTBN4 mRNA	PMID:30319688
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312270	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of SPTBN4 mRNA	PMID:39922521
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312270	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SPTBN4 mRNA	PMID:22401849
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312270	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of SPTBN4 mRNA	PMID:39922521
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SPTBN4 mRNA	PMID:36139627
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SPTBN4 intron	PMID:30157460
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312270	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of SPTBN4 mRNA	PMID:31626304
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304682	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SPTBN4 mRNA	PMID:31150632
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312270	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SPTBN4 mRNA	PMID:22206623
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SPTBN4 mRNA	PMID:28903495
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SPTBN4 mRNA	PMID:27392435
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304682	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPTBN4 mRNA	PMID:22298810
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312270	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPTBN4 mRNA	PMID:21570461
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SPTBN4 mRNA	PMID:33212167
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPTBN4 mRNA	PMID:34032870
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SPTBN4 mRNA	PMID:38568856
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SPTBN4 intron; Benzo(a)pyrene affects the methylation of SPTBN4 promoter	PMID:27901495|PMID:30157460
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SPTBN4 5' UTR	PMID:27901495
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SPTBN4 mRNA	PMID:25895662
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SPTBN4 mRNA	PMID:20458559
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of SPTBN4 mRNA	PMID:37690743
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPTBN4 gene	PMID:31601247
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312270	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SPTBN4 gene	PMID:35295148
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312270	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SPTBN4 gene	PMID:35295148
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312270	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SPTBN4 mRNA	PMID:18648102
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312270	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SPTBN4 mRNA	PMID:17950772
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312270	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of SPTBN4 mRNA]	PMID:17950772
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304682	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPTBN4 mRNA	PMID:25181051
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312270	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of SPTBN4 mRNA	PMID:32156529
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPTBN4 gene	PMID:31601247
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304682	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SPTBN4 mRNA	PMID:36041667
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of SPTBN4 gene	PMID:31601247
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312270	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of SPTBN4 exon	PMID:33297965
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304682	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SPTBN4 mRNA	PMID:36041667
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304682	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SPTBN4 mRNA	PMID:36041667
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312270	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SPTBN4 exon	PMID:28392331
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SPTBN4 gene	PMID:22964155
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304682	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of SPTBN4 mRNA	PMID:32680482
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304682	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SPTBN4 mRNA	PMID:35163327
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304682	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SPTBN4 mRNA	PMID:36928142
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304682	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SPTBN4 mRNA	PMID:35163327
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304682	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of SPTBN4 mRNA	PMID:27387713
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SPTBN4 mRNA	PMID:24449571
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312270	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SPTBN4 mRNA	PMID:40194260
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304682	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of SPTBN4 mRNA	PMID:29427782
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304682	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SPTBN4 mRNA	PMID:30047161
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312270	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of SPTBN4 mRNA	PMID:39922521
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SPTBN4 protein	PMID:38832940
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312270	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SPTBN4 mRNA	PMID:17562736
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312270	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SPTBN4 mRNA	PMID:19446018
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SPTBN4 mRNA	PMID:20458559
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304682	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SPTBN4 mRNA	PMID:30047161
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1304682	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of SPTBN4 mRNA	PMID:21983209
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1304682	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of SPTBN4 mRNA	PMID:20080153
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1312270	E	RGD:6480464	20150127	CTD	MESH:C014476	diethyl maleate results in increased expression of SPTBN4 mRNA	PMID:25270620
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312270	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SPTBN4 mRNA	PMID:22206623
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1304682	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of SPTBN4 mRNA	PMID:27840820
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312270	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SPTBN4 mRNA	PMID:22206623
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of SPTBN4 mRNA	PMID:36318118
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SPTBN4 mRNA	PMID:36139627
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SPTBN4 gene]	PMID:28238834
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304682	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SPTBN4 mRNA	PMID:30047161
1312269	SPTBN4	spectrin beta, non-erythrocytic 4	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312270	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of SPTBN4 mRNA	PMID:35537566
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312272	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GNAT1 mRNA	PMID:33045310
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of GNAT1 mRNA	PMID:34925699
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of GNAT1 mRNA	PMID:17218384
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:15368	acrolein	affects expression	ISO	RGD:1304683	E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein affects the expression of GNAT1 mRNA	PMID:38090360
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GNAT1 mRNA	PMID:36331819
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1304683	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of GNAT1 mRNA	PMID:36841081
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of GNAT1 mRNA	PMID:22378314
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304683	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of GNAT1 mRNA	PMID:32145629
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304683	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of GNAT1 mRNA	PMID:33387578
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of GNAT1 mRNA	PMID:21669218
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:177802	Cuprizon	affects expression	ISO	RGD:1304683	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of GNAT1 mRNA	PMID:27523638
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304683	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of GNAT1 mRNA	PMID:26577399
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304683	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of GNAT1 mRNA	PMID:22061828|PMID:33387578
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GNAT1 mRNA	PMID:36331819
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GNAT1 mRNA	PMID:35301059
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304683	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GNAT1 mRNA	PMID:39012411
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of GNAT1 mRNA	PMID:19770486
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of GNAT1 mRNA	PMID:19921347
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1304683	E	RGD:6480464	20180313	CTD	MESH:D003042	Cocaine results in increased expression of GNAT1 mRNA	PMID:27899881
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312272	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GNAT1 mRNA	PMID:26377647|PMID:28922406
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304683	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GNAT1 mRNA	PMID:33387578
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GNAT1 mRNA	PMID:18172886|PMID:26290441
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304683	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GNAT1 mRNA	PMID:21215274
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of GNAT1 mRNA	PMID:33212167
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GNAT1 mRNA	PMID:30851411
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1304683	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of GNAT1 protein	PMID:29459688
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of GNAT1 mRNA	PMID:33933676
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNAT1 mRNA	PMID:34876320
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNAT1 mRNA	PMID:34876320
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GNAT1 promoter	PMID:27901495
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GNAT1 mRNA	PMID:32234424
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312272	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of GNAT1 mRNA	PMID:23221170
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GNAT1 gene	PMID:31601247
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304683	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of GNAT1 mRNA	PMID:24136188
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1304683	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of GNAT1 mRNA	PMID:32479839
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304683	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of GNAT1 mRNA	PMID:30047161
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1304683	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of GNAT1 mRNA	PMID:30012374
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312272	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GNAT1 gene	PMID:35295148
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GNAT1 mRNA	PMID:19710929
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304683	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GNAT1 mRNA	PMID:25181051|PMID:32145629
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GNAT1 mRNA	PMID:33221593
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312272	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GNAT1 promoter	PMID:27312807
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GNAT1 gene	PMID:31601247
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in increased expression of GNAT1 mRNA	PMID:30616060
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312272	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of GNAT1 mRNA	PMID:39298647
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312272	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of GNAT1 mRNA	PMID:26377693
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of GNAT1 mRNA	PMID:38685157
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1304683	E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon affects the expression of GNAT1 mRNA	PMID:17452286
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312272	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of GNAT1 mRNA	PMID:26377693
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304683	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of GNAT1 mRNA	PMID:30723492
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GNAT1 mRNA	PMID:35301059
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304683	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GNAT1 mRNA	PMID:39012411
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of GNAT1 mRNA	PMID:40334771
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1304683	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of GNAT1 mRNA	PMID:28511854
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304683	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of GNAT1 mRNA	PMID:25539665
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1312272	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of GNAT1 mRNA	PMID:24183702
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312272	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of GNAT1 mRNA	PMID:28962523
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312272	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GNAT1 mRNA	PMID:40194260
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GNAT1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GNAT1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of GNAT1 mRNA	PMID:36331819
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1304683	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of GNAT1 mRNA	PMID:25993096
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GNAT1 gene	PMID:29154799
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304683	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of GNAT1 mRNA	PMID:30047161
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of GNAT1 mRNA	PMID:20937368
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of GNAT1 mRNA	PMID:25123088
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of GNAT1 mRNA	PMID:18502557
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GNAT1 mRNA	PMID:17562736
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304683	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GNAT1 mRNA	PMID:33387578
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304683	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of GNAT1 mRNA	PMID:32479839
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1312272	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of GNAT1 mRNA	PMID:26934552
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304683	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GNAT1 mRNA	PMID:29391264
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNAT1 mRNA	PMID:34876320
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312272	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of GNAT1 mRNA	PMID:25620056
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312272	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GNAT1 mRNA	PMID:25620056
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304683	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of GNAT1 mRNA	PMID:30047161
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:5643	Heliotrine	increases expression	ISO	RGD:1304683	E	RGD:6480464	20211109	CTD	MESH:C010178	heliotrine results in increased expression of GNAT1 mRNA	PMID:34185104
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312272	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of GNAT1 mRNA	PMID:36851058
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GNAT1 mRNA	PMID:22206623
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of GNAT1 mRNA	PMID:20816883
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:76604	MeIQx	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in decreased expression of GNAT1 mRNA	PMID:20816883
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GNAT1 mRNA	PMID:30851411
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GNAT1 gene]	PMID:28238834
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312272	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of GNAT1 mRNA	PMID:23091169
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of GNAT1 mRNA	PMID:19482888
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of GNAT1 mRNA]	PMID:19482888
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:8264	Platyphylline	increases expression	ISO	RGD:1304683	E	RGD:6480464	20211109	CTD	MESH:C008937	platyphylline results in increased expression of GNAT1 mRNA	PMID:34185104
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312272	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of GNAT1 mRNA	PMID:34876320
1312271	GNAT1	G protein subunit alpha transducin 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304683	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of GNAT1 mRNA	PMID:24780913|PMID:30047161
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of KDELC1 mRNA	PMID:38218311
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312274	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of KDELC1 mRNA	PMID:36331819
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of POGLUT2 mRNA	PMID:21632981
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312274	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POGLUT2 mRNA	PMID:39241906
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of POGLUT2 mRNA	PMID:28818685
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in increased expression of POGLUT2 mRNA	PMID:20368581
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of POGLUT2 mRNA	PMID:17103032
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304684	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of POGLUT2 protein	PMID:34915118
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of POGLUT2 mRNA	PMID:19549813
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of POGLUT2 gene	PMID:27153756
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312274	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of POGLUT2 mRNA	PMID:31919559
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POGLUT2 mRNA	PMID:21570461
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POGLUT2 mRNA	PMID:20106945|PMID:21632981
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of POGLUT2 mRNA	PMID:17942748
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of POGLUT2 mRNA	PMID:39709020
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of POGLUT2 mRNA	PMID:32763439
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of POGLUT2 mRNA	PMID:20971185
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of POGLUT2 mRNA	PMID:29803840
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of POGLUT2 mRNA	PMID:22714537|PMID:38568856
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POGLUT2 mRNA	PMID:22228805
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of POGLUT2 mRNA	PMID:20971185
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304684	E	RGD:6480464	20190611	CTD	MESH:D005897	Glafenine results in increased expression of POGLUT2 mRNA	PMID:24136188
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304684	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of POGLUT2 mRNA	PMID:34492290
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of POGLUT2 mRNA	PMID:29275510
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304684	E	RGD:6480464	20190611	CTD	MESH:C006780	bisphenol A results in increased expression of POGLUT2 mRNA	PMID:25181051
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POGLUT2 mRNA	PMID:28628672
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312274	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of POGLUT2 mRNA	PMID:38685157
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POGLUT2 mRNA	PMID:28628672
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312274	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of POGLUT2 mRNA	PMID:28392331
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of POGLUT2 gene	PMID:22964155
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of POGLUT2 mRNA	PMID:21266533
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POGLUT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POGLUT2 mRNA	PMID:28628672
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of POGLUT2 mRNA	PMID:38174414|PMID:38568856
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of POGLUT2 mRNA	PMID:28302478
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of POGLUT2 mRNA	PMID:40419075
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312274	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of KDELC1 mRNA	PMID:36331819
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of POGLUT2 mRNA	PMID:25979313
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D014635	Valproic Acid affects the expression of POGLUT2 mRNA	PMID:17292431
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of POGLUT2 mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of POGLUT2 mRNA	PMID:25562108
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:41423	celecoxib	affects expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:C105934	Celecoxib affects the expression of POGLUT2 mRNA	PMID:20562220
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D013629	Tamoxifen affects the expression of POGLUT2 mRNA	PMID:17555576
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POGLUT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POGLUT2 mRNA	PMID:28628672
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:43572	kojic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of POGLUT2 mRNA	PMID:16595896
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of POGLUT2 mRNA	PMID:38832940
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of POGLUT2 mRNA	PMID:22230336
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	Zoledronic Acid results in decreased expression of POGLUT2 mRNA	PMID:24714768
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of POGLUT2 mRNA	PMID:33581214
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of POGLUT2 mRNA	PMID:17555576
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1304684	E	RGD:6480464	20190611	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of POGLUT2 mRNA	PMID:17557909
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of POGLUT2 mRNA	PMID:17942748
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of POGLUT2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of POGLUT2 mRNA	PMID:28628672
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of POGLUT2 mRNA	PMID:25554681
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of POGLUT2 mRNA	PMID:22714537
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of POGLUT2 protein	PMID:32959892
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312274	E	RGD:6480464	20190611	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of POGLUT2 mRNA	PMID:23650126
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of POGLUT2 mRNA	PMID:15336504
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304684	E	RGD:6480464	20190611	CTD	MESH:D008701	Methapyrilene results in decreased expression of POGLUT2 mRNA	PMID:30467583
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312274	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KDELC1 mRNA	PMID:22206623
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KDELC1 gene]	PMID:28238834
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312274	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of POGLUT2 mRNA	PMID:31388691
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of POGLUT2 mRNA	PMID:20368581
1312273	POGLUT2	protein O-glucosyltransferase 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312274	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of KDELC1 mRNA	PMID:35537566
1312275	KLHL8	kelch like family member 8	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of KLHL8 mRNA	PMID:24763279
1312275	KLHL8	kelch like family member 8	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of KLHL8 mRNA	PMID:18951874
1312275	KLHL8	kelch like family member 8	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312276	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KLHL8 mRNA	PMID:39241906
1312275	KLHL8	kelch like family member 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KLHL8 mRNA	PMID:37042841
1312275	KLHL8	kelch like family member 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312276	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KLHL8 mRNA	PMID:34319233
1312275	KLHL8	kelch like family member 8	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304685	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KLHL8 mRNA	PMID:33387578
1312275	KLHL8	kelch like family member 8	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312276	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KLHL8 mRNA	PMID:19770486
1312275	KLHL8	kelch like family member 8	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304685	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of KLHL8 mRNA	PMID:30779732
1312275	KLHL8	kelch like family member 8	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312276	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of KLHL8 mRNA	PMID:17484886
1312275	KLHL8	kelch like family member 8	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLHL8 mRNA	PMID:39836092
1312275	KLHL8	kelch like family member 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312276	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of KLHL8 mRNA	PMID:40504410
1312275	KLHL8	kelch like family member 8	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304685	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of KLHL8 mRNA	PMID:31881176
1312275	KLHL8	kelch like family member 8	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of KLHL8 mRNA	PMID:23557933
1312275	KLHL8	kelch like family member 8	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of KLHL8 mRNA	PMID:23195993
1312275	KLHL8	kelch like family member 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312276	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KLHL8 mRNA	PMID:21570461
1312275	KLHL8	kelch like family member 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KLHL8 mRNA	PMID:17101203
1312275	KLHL8	kelch like family member 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLHL8 mRNA	PMID:39836092
1312275	KLHL8	kelch like family member 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312276	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of KLHL8 mRNA	PMID:40504410
1312275	KLHL8	kelch like family member 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KLHL8 promoter	PMID:27901495
1312275	KLHL8	kelch like family member 8	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KLHL8 5' UTR	PMID:27901495
1312275	KLHL8	kelch like family member 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312276	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KLHL8 mRNA	PMID:22228805
1312275	KLHL8	kelch like family member 8	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312276	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of KLHL8 mRNA]	PMID:22228805
1312275	KLHL8	kelch like family member 8	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KLHL8 mRNA	PMID:20018196
1312275	KLHL8	kelch like family member 8	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of KLHL8 mRNA	PMID:26238291
1312275	KLHL8	kelch like family member 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312276	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KLHL8 gene	PMID:35295148
1312275	KLHL8	kelch like family member 8	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304685	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of KLHL8 mRNA	PMID:23411599
1312275	KLHL8	kelch like family member 8	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312276	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of KLHL8 mRNA	PMID:18648102
1312275	KLHL8	kelch like family member 8	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of KLHL8 mRNA	PMID:19710929
1312275	KLHL8	kelch like family member 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304685	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KLHL8 mRNA	PMID:25181051
1312275	KLHL8	kelch like family member 8	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304685	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KLHL8 gene	PMID:28505145
1312275	KLHL8	kelch like family member 8	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312276	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of KLHL8 intron	PMID:28392331
1312275	KLHL8	kelch like family member 8	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1304685	E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KLHL8 mRNA	PMID:18668222
1312275	KLHL8	kelch like family member 8	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312276	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of KLHL8 mRNA	PMID:39529242
1312275	KLHL8	kelch like family member 8	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KLHL8 mRNA	PMID:25979313
1312275	KLHL8	kelch like family member 8	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of KLHL8 mRNA	PMID:19101580|PMID:29154799
1312275	KLHL8	kelch like family member 8	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304685	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of KLHL8 mRNA	PMID:41580965
1312275	KLHL8	kelch like family member 8	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312276	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of KLHL8 mRNA	PMID:28973697
1312275	KLHL8	kelch like family member 8	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of KLHL8 mRNA	PMID:24935251
1312275	KLHL8	kelch like family member 8	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304685	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KLHL8 mRNA	PMID:33387578
1312275	KLHL8	kelch like family member 8	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLHL8 mRNA	PMID:39836092
1312275	KLHL8	kelch like family member 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312276	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of KLHL8 mRNA	PMID:40504410
1312275	KLHL8	kelch like family member 8	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312276	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of KLHL8 mRNA; Nanotubes, Carbon results in decreased expression of KLHL8 mRNA	PMID:25554681
1312275	KLHL8	kelch like family member 8	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1304685	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of KLHL8 mRNA	PMID:20080153
1312275	KLHL8	kelch like family member 8	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312276	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of KLHL8 mRNA	PMID:22206623
1312275	KLHL8	kelch like family member 8	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304685	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of KLHL8 mRNA	PMID:21346803
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312281	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TUBGCP5 mRNA	PMID:26251327
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TUBGCP5 gene	PMID:20938992
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TUBGCP5 mRNA	PMID:33167477
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TUBGCP5 mRNA	PMID:38568856
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TUBGCP5 gene	PMID:20938992
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312281	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TUBGCP5 mRNA	PMID:34319233
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304689	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TUBGCP5 mRNA	PMID:33387578
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TUBGCP5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of TUBGCP5 mRNA	PMID:39836092
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TUBGCP5 mRNA	PMID:19549813
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312281	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TUBGCP5 mRNA	PMID:19770486
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TUBGCP5 mRNA	PMID:23649840
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TUBGCP5 gene	PMID:20938992
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TUBGCP5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TUBGCP5 mRNA	PMID:39836092
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TUBGCP5 mRNA	PMID:40504410
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TUBGCP5 mRNA	PMID:22574217
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312281	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TUBGCP5 mRNA	PMID:24680724
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312281	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TUBGCP5 mRNA	PMID:21354282
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1312281	E	RGD:6480464	20120613	CTD	MESH:D012402	Rotenone affects the expression of TUBGCP5 mRNA	PMID:21893155
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20120613	CTD	MESH:D012402	TRP53 affects the reaction [Rotenone affects the expression of TUBGCP5 mRNA]	PMID:21893155
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TUBGCP5 mRNA; aristolochic acid I results in decreased expression of TUBGCP5 protein	PMID:33212167
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of TUBGCP5 mRNA	PMID:23649840
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TUBGCP5 mRNA	PMID:32763439
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312281	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TUBGCP5 mRNA	PMID:27862939
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TUBGCP5 mRNA	PMID:38568856
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TUBGCP5 mRNA	PMID:34032870
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1304689	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of TUBGCP5 mRNA	PMID:21297353
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TUBGCP5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TUBGCP5 mRNA	PMID:39836092
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TUBGCP5 mRNA	PMID:40504410
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:3016	Benoxacor	decreases expression	ISO	RGD:1312281	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in decreased expression of TUBGCP5 mRNA	PMID:34850242
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312281	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TUBGCP5 promoter	PMID:35295148
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304689	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TUBGCP5 mRNA	PMID:30816183|PMID:34947998
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBGCP5 mRNA	PMID:28628672
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBGCP5 mRNA	PMID:28628672
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TUBGCP5 mRNA	PMID:37042841
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TUBGCP5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of TUBGCP5 mRNA	PMID:39836092
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TUBGCP5 mRNA	PMID:38174414|PMID:38568856
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TUBGCP5 mRNA	PMID:19376846
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TUBGCP5 mRNA	PMID:25562108
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBGCP5 mRNA	PMID:28628672
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of TUBGCP5 mRNA	PMID:23649840
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TUBGCP5 mRNA	PMID:21420995
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TUBGCP5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TUBGCP5 mRNA	PMID:39836092
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312281	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TUBGCP5 mRNA	PMID:40504410
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TUBGCP5 mRNA	PMID:22079256
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TUBGCP5 mRNA	PMID:28628672
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TUBGCP5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of TUBGCP5 mRNA	PMID:39836092
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312281	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TUBGCP5 mRNA	PMID:22206623
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TUBGCP5 mRNA	PMID:22079256
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TUBGCP5 mRNA	PMID:22079256
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312281	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of TUBGCP5 mRNA	PMID:39847705
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312281	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of TUBGCP5 mRNA	PMID:21795629
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TUBGCP5 mRNA	PMID:38568856
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TUBGCP5 mRNA	PMID:29301935
1312280	TUBGCP5	tubulin gamma complex component 5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304689	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TUBGCP5 mRNA	PMID:21346803
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:15379	dioxygen	affects methylation	ISO	RGD:1312284	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency affects the methylation of RABGAP1 promoter	PMID:24205000
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312284	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RABGAP1 mRNA	PMID:24205000
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312284	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RABGAP1 mRNA	PMID:36331819
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:15996	GTP	affects binding	ISO	RGD:1304691	E	RGD:6480464	20181016	CTD	MESH:D006160	[RAB3A protein binds to Guanosine Triphosphate] which binds to RABGAP1 protein	PMID:29289693
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:15996	GTP	multiple interactions	ISO	RGD:1304691	E	RGD:6480464	20181016	CTD	MESH:D006160	manganese chloride inhibits the reaction [[RAB3A protein binds to Guanosine Triphosphate] which binds to RABGAP1 protein]; SNCA protein promotes the reaction [manganese chloride inhibits the reaction [[RAB3A protein binds to Guanosine Triphosphate] which binds to RABGAP1 protein]]	PMID:29289693
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312284	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of RABGAP1 mRNA	PMID:30319688
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304691	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RABGAP1 gene	PMID:27618143
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of RABGAP1 mRNA	PMID:17938736
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RABGAP1 mRNA	PMID:21179406
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312284	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RABGAP1 mRNA	PMID:33754040
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304691	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RABGAP1 mRNA	PMID:27523638
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RABGAP1 protein	PMID:37730182
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RABGAP1 mRNA	PMID:23649840
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312284	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RABGAP1 mRNA	PMID:19770486
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RABGAP1 mRNA	PMID:23649840
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of RABGAP1 protein	PMID:38598786
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312284	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of RABGAP1 mRNA	PMID:25629700
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of RABGAP1 mRNA	PMID:19244175
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RABGAP1 mRNA	PMID:23557933
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of RABGAP1 mRNA	PMID:19921347
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304691	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RABGAP1 mRNA	PMID:21215274|PMID:33387578
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases phosphorylation	ISO	RGD:1304691	E	RGD:6480464	20140715	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased phosphorylation of RABGAP1 protein	PMID:23298284
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304691	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RABGAP1 mRNA	PMID:34747641
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312284	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of RABGAP1 mRNA	PMID:30807115
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of RABGAP1 protein	PMID:30528433
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of RABGAP1 mRNA	PMID:17879257|PMID:38568856
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RABGAP1 mRNA]	PMID:32406909
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of RABGAP1 mRNA	PMID:25895662
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RABGAP1 mRNA	PMID:19150397
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312284	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RABGAP1 gene; titanium dioxide results in decreased methylation of RABGAP1 promoter; titanium dioxide results in decreased methylation of RABGAP1 promoter alternative form	PMID:35295148
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312284	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RABGAP1 promoter	PMID:35295148
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312284	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RABGAP1 mRNA	PMID:18301758
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of RABGAP1 protein	PMID:31675489
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304691	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RABGAP1 mRNA	PMID:25181051
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of RABGAP1 mRNA	PMID:29275510
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304691	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of RABGAP1 mRNA	PMID:41034487
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of RABGAP1 protein	PMID:31675489
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of RABGAP1 mRNA	PMID:19244175
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312284	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of RABGAP1 promoter	PMID:33297965
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312284	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RABGAP1 mRNA	PMID:38685157
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of RABGAP1 protein	PMID:38598786
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RABGAP1 mRNA	PMID:37042841
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RABGAP1 mRNA	PMID:26472689|PMID:38174414
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1304691	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of RABGAP1 gene	PMID:22079235
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RABGAP1 mRNA	PMID:24449571
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of RABGAP1 mRNA	PMID:19244175
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RABGAP1 mRNA	PMID:31533062
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312284	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RABGAP1 mRNA	PMID:36331819
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312284	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RABGAP1 mRNA	PMID:17292431
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RABGAP1 mRNA	PMID:23179753
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RABGAP1 gene	PMID:29154799
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RABGAP1 mRNA	PMID:22230336
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RABGAP1 mRNA	PMID:22079256
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304691	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of RABGAP1 mRNA	PMID:30307764
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312284	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RABGAP1 mRNA; Nanotubes, Carbon results in decreased expression of RABGAP1 mRNA	PMID:25554681
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RABGAP1 protein	PMID:32959892
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1304691	E	RGD:6480464	20181016	CTD	MESH:C025340	manganese chloride inhibits the reaction [[RAB3A protein binds to Guanosine Triphosphate] which binds to RABGAP1 protein]; SNCA protein promotes the reaction [manganese chloride inhibits the reaction [[RAB3A protein binds to Guanosine Triphosphate] which binds to RABGAP1 protein]]	PMID:29289693
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of RABGAP1 mRNA	PMID:15336504
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RABGAP1 mRNA	PMID:22079614
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RABGAP1 mRNA	PMID:22079256
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RABGAP1 mRNA	PMID:22079256
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1312284	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of RABGAP1 mRNA	PMID:27858113
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RABGAP1 protein	PMID:31675489
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312284	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of RABGAP1 mRNA	PMID:21795629
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304691	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RABGAP1 mRNA	PMID:25825206
1312283	RABGAP1	RAB GTPase activating protein 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of RABGAP1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of RABGAP1 protein	PMID:38598786
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MMS22L mRNA	PMID:38218311
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MMS22L mRNA	PMID:33045310
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MMS22L mRNA	PMID:33167477
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MMS22L mRNA	PMID:26079696
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1620630	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MMS22L mRNA	PMID:39241906
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304693	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of MMS22L mRNA	PMID:32145629
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MMS22L mRNA	PMID:38568856
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MMS22L mRNA	PMID:37042841
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of MMS22L mRNA	PMID:26079696
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of MMS22L mRNA	PMID:38160208
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MMS22L mRNA	PMID:21592394
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of MMS22L mRNA	PMID:21592394
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304693	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MMS22L mRNA	PMID:26577399|PMID:27523638
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MMS22L mRNA	PMID:21592394
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of MMS22L mRNA	PMID:21592394
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of MMS22L intron	PMID:30157460
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MMS22L mRNA	PMID:22100608
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MMS22L intron	PMID:30157460
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20140408	CTD	MESH:D010126	Ozone results in decreased expression of MMS22L mRNA	PMID:24336422
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1620630	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MMS22L mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MMS22L mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of MMS22L mRNA	PMID:25658374|PMID:27106289|PMID:34911549
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1620630	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of MMS22L mRNA	PMID:25629700
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304693	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MMS22L mRNA	PMID:31881176
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1304693	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of MMS22L mRNA	PMID:22023808
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620630	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MMS22L mRNA	PMID:26377647
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304693	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MMS22L mRNA	PMID:32109520
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MMS22L mRNA	PMID:33212167
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304693	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of MMS22L mRNA	PMID:28959563
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:28794	coumarin	increases expression	ISO	RGD:1304693	E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of MMS22L mRNA	PMID:18480146
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:28876	melphalan	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of MMS22L mRNA	PMID:22363485
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MMS22L mRNA	PMID:38568856
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MMS22L intron	PMID:30157460
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MMS22L mRNA	PMID:20064835
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MMS22L mRNA	PMID:26238291|PMID:32234424
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MMS22L mRNA	PMID:26238291
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1304693	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of MMS22L mRNA	PMID:25729387
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304693	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MMS22L mRNA	PMID:25729387
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304693	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MMS22L mRNA	PMID:30047161
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620630	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MMS22L gene; titanium dioxide results in decreased methylation of MMS22L promoter	PMID:35295148
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1304693	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of MMS22L mRNA	PMID:34492290
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1620630	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MMS22L mRNA	PMID:20813756
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1620630	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of MMS22L mRNA	PMID:20813756
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304693	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MMS22L mRNA	PMID:25181051|PMID:32145629
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MMS22L mRNA	PMID:29275510|PMID:33670352
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of MMS22L mRNA	PMID:26063408
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304693	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of MMS22L mRNA	PMID:41034487
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304693	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MMS22L gene	PMID:28505145
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MMS22L mRNA	PMID:40203079
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of MMS22L mRNA	PMID:28392331
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MMS22L mRNA	PMID:21266533
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MMS22L mRNA	PMID:37042841
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304693	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MMS22L mRNA	PMID:30723492
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304693	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MMS22L mRNA	PMID:33453195
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304693	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of MMS22L mRNA	PMID:25539665|PMID:26194646
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1304693	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of MMS22L mRNA	PMID:30047161
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304693	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of MMS22L mRNA	PMID:24386269
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MMS22L mRNA	PMID:40194260
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MMS22L mRNA	PMID:31533062
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1620630	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MMS22L mRNA	PMID:39529242
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1304693	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of MMS22L mRNA	PMID:22110744
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304693	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MMS22L mRNA	PMID:30047161
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:41607	crotonaldehyde	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in decreased expression of MMS22L mRNA	PMID:20471460
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304693	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MMS22L mRNA	PMID:33387578
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304693	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MMS22L mRNA	PMID:30047161
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1620630	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MMS22L mRNA	PMID:19042947
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1620630	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MMS22L mRNA	PMID:38701926
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1304693	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MMS22L mRNA	PMID:25729387
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304693	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MMS22L mRNA	PMID:25729387
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1304693	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of MMS22L mRNA	PMID:35283115
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:754906	afuresertib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of MMS22L mRNA	PMID:28960945
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of MMS22L mRNA	PMID:30928695
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1620630	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MMS22L mRNA	PMID:23091169
1312286	MMS22L	MMS22 like, DNA repair protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304693	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MMS22L mRNA	PMID:24780913|PMID:30047161
1312287	KIAA0930	KIAA0930	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KIAA0930 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KIAA0930 mRNA	PMID:32699268
1312287	KIAA0930	KIAA0930	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of KIAA0930 protein	PMID:35688186
1312287	KIAA0930	KIAA0930	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KIAA0930 mRNA	PMID:37042841
1312287	KIAA0930	KIAA0930	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KIAA0930 protein	PMID:37730182
1312287	KIAA0930	KIAA0930	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of KIAA0930 intron	PMID:30157460
1312287	KIAA0930	KIAA0930	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KIAA0930 mRNA	PMID:39836092
1312287	KIAA0930	KIAA0930	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304694	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of KIAA0930 mRNA	PMID:28522335
1312287	KIAA0930	KIAA0930	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KIAA0930 intron	PMID:30157460
1312287	KIAA0930	KIAA0930	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KIAA0930 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KIAA0930 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of KIAA0930 mRNA	PMID:32699268
1312287	KIAA0930	KIAA0930	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KIAA0930 gene	PMID:25304211
1312287	KIAA0930	KIAA0930	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KIAA0930 mRNA	PMID:39836092
1312287	KIAA0930	KIAA0930	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of KIAA0930 mRNA	PMID:19684285
1312287	KIAA0930	KIAA0930	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of KIAA0930 protein	PMID:35688186
1312287	KIAA0930	KIAA0930	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of KIAA0930 mRNA	PMID:23300844
1312287	KIAA0930	KIAA0930	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of KIAA0930 mRNA	PMID:23195993
1312287	KIAA0930	KIAA0930	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KIAA0930 mRNA	PMID:19684285|PMID:20106945
1312287	KIAA0930	KIAA0930	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304694	E	RGD:6480464	20231205	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KIAA0930 mRNA	PMID:34747641
1312287	KIAA0930	KIAA0930	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of KIAA0930 mRNA; [Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of KIAA0930 mRNA	PMID:19684285|PMID:26159488
1312287	KIAA0930	KIAA0930	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304694	E	RGD:6480464	20231205	CTD	MESH:D012402	Rotenone results in increased expression of KIAA0930 mRNA	PMID:28374803
1312287	KIAA0930	KIAA0930	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KIAA0930 mRNA	PMID:29803840
1312287	KIAA0930	KIAA0930	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of KIAA0930 mRNA	PMID:34032870
1312287	KIAA0930	KIAA0930	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KIAA0930 mRNA	PMID:39836092
1312287	KIAA0930	KIAA0930	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KIAA0930 mRNA	PMID:20106945
1312287	KIAA0930	KIAA0930	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of KIAA0930 gene	PMID:31601247
1312287	KIAA0930	KIAA0930	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304694	E	RGD:6480464	20231205	CTD	MESH:D013853	Thioacetamide results in increased expression of KIAA0930 mRNA	PMID:23411599
1312287	KIAA0930	KIAA0930	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of KIAA0930 gene	PMID:31601247
1312287	KIAA0930	KIAA0930	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304694	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KIAA0930 mRNA	PMID:25181051
1312287	KIAA0930	KIAA0930	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of KIAA0930 gene	PMID:31601247
1312287	KIAA0930	KIAA0930	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of KIAA0930 mRNA	PMID:19244175
1312287	KIAA0930	KIAA0930	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of KIAA0930 intron	PMID:30157460
1312287	KIAA0930	KIAA0930	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KIAA0930 mRNA	PMID:39836092
1312287	KIAA0930	KIAA0930	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KIAA0930 mRNA	PMID:38568856
1312287	KIAA0930	KIAA0930	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KIAA0930 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KIAA0930 mRNA	PMID:32699268
1312287	KIAA0930	KIAA0930	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of KIAA0930 mRNA	PMID:31533062
1312287	KIAA0930	KIAA0930	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KIAA0930 mRNA	PMID:25979313
1312287	KIAA0930	KIAA0930	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of KIAA0930 mRNA	PMID:19101580|PMID:23179753|PMID:26272509|PMID:28001369
1312287	KIAA0930	KIAA0930	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIAA0930 mRNA	PMID:27188386
1312287	KIAA0930	KIAA0930	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of KIAA0930 mRNA	PMID:28542535
1312287	KIAA0930	KIAA0930	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of KIAA0930 mRNA	PMID:21420995
1312287	KIAA0930	KIAA0930	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of KIAA0930 mRNA	PMID:29067470
1312287	KIAA0930	KIAA0930	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304694	E	RGD:6480464	20231205	CTD	MESH:D000082	Acetaminophen results in increased expression of KIAA0930 mRNA	PMID:33387578
1312287	KIAA0930	KIAA0930	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of KIAA0930 mRNA	PMID:24714768
1312287	KIAA0930	KIAA0930	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KIAA0930 gene	PMID:25304211
1312287	KIAA0930	KIAA0930	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KIAA0930 mRNA	PMID:39836092
1312287	KIAA0930	KIAA0930	gene	CHEBI:4791	endosulfan	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D004726	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of KIAA0930 mRNA	PMID:26159488
1312287	KIAA0930	KIAA0930	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of KIAA0930 mRNA	PMID:23300844
1312287	KIAA0930	KIAA0930	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KIAA0930 mRNA	PMID:39836092
1312287	KIAA0930	KIAA0930	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of KIAA0930 mRNA	PMID:24810058
1312287	KIAA0930	KIAA0930	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of KIAA0930 intron	PMID:30157460
1312287	KIAA0930	KIAA0930	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIAA0930 mRNA	PMID:27188386
1312287	KIAA0930	KIAA0930	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304694	E	RGD:6480464	20231205	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of KIAA0930 mRNA	PMID:32109520
1312287	KIAA0930	KIAA0930	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1304694	E	RGD:6480464	20231205	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of KIAA0930 mRNA	PMID:27291303
1312287	KIAA0930	KIAA0930	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1304694	E	RGD:6480464	20231205	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of KIAA0930 mRNA	PMID:23914054
1312287	KIAA0930	KIAA0930	gene	CHEBI:85014	2,5-hexanedione	increases expression	ISO	RGD:1304694	E	RGD:6480464	20231205	CTD	MESH:C011269	2,5-hexanedione results in increased expression of KIAA0930 mRNA	PMID:22952946
1312287	KIAA0930	KIAA0930	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304694	E	RGD:6480464	20231205	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KIAA0930 mRNA	PMID:24780913
1312287	KIAA0930	KIAA0930	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIAA0930 mRNA	PMID:27188386
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1551989	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SLC39A13 mRNA	PMID:33045310
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1551989	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SLC39A13 mRNA	PMID:26251327
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1551989	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SLC39A13 mRNA	PMID:39241906
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1551989	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SLC39A13 mRNA	PMID:39298647
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLC39A13 mRNA	PMID:37042841
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1551989	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SLC39A13 mRNA	PMID:23892564
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:D002117	Calcitriol results in decreased expression of SLC39A13 mRNA	PMID:20089671
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304695	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SLC39A13 mRNA	PMID:33387578
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1551989	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLC39A13 mRNA	PMID:19770486
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:27363	zinc atom	affects localization	ISO	RGD:1551989	E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A13 protein affects the localization of Zinc	PMID:18985159
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1304695	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SLC39A13 mRNA	PMID:20859692
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1551989	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in increased expression of SLC39A13 mRNA	PMID:22228435
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:27363	zinc atom	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A13 protein results in increased transport of Zinc	PMID:18326752
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1551989	E	RGD:6480464	20130122	CTD	MESH:D015032	[[Zinc affects the localization of MTF1 protein] promotes the reaction [MTF1 protein binds to SLC39A13 promoter]] which results in increased expression of SLC39A13 mRNA; [Zinc affects the localization of MTF1 protein] promotes the reaction [MTF1 protein binds to SLC39A13 promoter]; [Zinc deficiency promotes the reaction [NFIC protein binds to SLC39A13 protein]] which results in decreased expression of SLC39A13 mRNA; Zinc deficiency promotes the reaction [NFIC protein binds to SLC39A13 protein]	PMID:22228435
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1551989	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SLC39A13 mRNA	PMID:28960355
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304695	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLC39A13 mRNA	PMID:31881176
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551989	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC39A13 mRNA	PMID:20702594|PMID:21570461
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304695	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC39A13 mRNA	PMID:34747641
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304695	E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC39A13 mRNA	PMID:26232522
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SLC39A13 mRNA	PMID:33212167
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SLC39A13 mRNA	PMID:32763439
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of SLC39A13 mRNA	PMID:29803840
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of SLC39A13 mRNA	PMID:20044591
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC39A13 mRNA	PMID:39719251
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1551989	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC39A13 mRNA	PMID:15034205
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SLC39A13 3' UTR	PMID:27901495
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1551989	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC39A13 mRNA	PMID:20713471
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:30185	zinc(0)	affects localization	ISO	RGD:1551989	E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A13 protein affects the localization of Zinc	PMID:18985159
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1304695	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SLC39A13 mRNA	PMID:20859692
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1551989	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in increased expression of SLC39A13 mRNA	PMID:22228435
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:30185	zinc(0)	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A13 protein results in increased transport of Zinc	PMID:18326752
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1551989	E	RGD:6480464	20130122	CTD	MESH:D015032	[[Zinc affects the localization of MTF1 protein] promotes the reaction [MTF1 protein binds to SLC39A13 promoter]] which results in increased expression of SLC39A13 mRNA; [Zinc affects the localization of MTF1 protein] promotes the reaction [MTF1 protein binds to SLC39A13 promoter]; [Zinc deficiency promotes the reaction [NFIC protein binds to SLC39A13 protein]] which results in decreased expression of SLC39A13 mRNA; Zinc deficiency promotes the reaction [NFIC protein binds to SLC39A13 protein]	PMID:22228435
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SLC39A13 mRNA	PMID:19128835
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1551989	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC39A13 promoter	PMID:35295148
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1551989	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SLC39A13 gene; titanium dioxide results in increased methylation of SLC39A13 promoter	PMID:35295148
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304695	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC39A13 mRNA	PMID:34492290
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304695	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC39A13 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304695	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SLC39A13 mRNA	PMID:25181051
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1551989	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SLC39A13 gene	PMID:31683443
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1551989	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SLC39A13 mRNA	PMID:37019170
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC39A13 mRNA	PMID:37042841
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304695	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SLC39A13 mRNA	PMID:35163327
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304695	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SLC39A13 mRNA	PMID:35163327
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SLC39A13 mRNA	PMID:19320972
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1304695	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SLC39A13 mRNA	PMID:24386269
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SLC39A13 mRNA	PMID:40419075
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1304695	E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in increased expression of SLC39A13 mRNA	PMID:27281708
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1551989	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLC39A13 mRNA	PMID:17562736
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304695	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC39A13 mRNA	PMID:33387578
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SLC39A13 mRNA	PMID:38568856
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SLC39A13 mRNA	PMID:19128835
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1551989	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SLC39A13 mRNA	PMID:22206623
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1551989	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of SLC39A13 mRNA	PMID:20702594
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1304695	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of SLC39A13 mRNA	PMID:32109520
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	ISO	RGD:1551989	E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of SLC39A13 mRNA	PMID:22228435
1312289	SLC39A13	solute carrier family 39 member 13	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304695	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SLC39A13 mRNA	PMID:21346803
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312291	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TXNDC15 mRNA	PMID:37995155
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TXNDC15 mRNA	PMID:26079696
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312291	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TXNDC15 mRNA	PMID:30319688
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TXNDC15 mRNA	PMID:21632981
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312291	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TXNDC15 mRNA	PMID:39298647
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TXNDC15 mRNA	PMID:37042841
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312291	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TXNDC15 mRNA	PMID:33754040
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312291	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TXNDC15 mRNA	PMID:36331819
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TXNDC15 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TXNDC15 mRNA	PMID:39836092
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TXNDC15 mRNA	PMID:19549813
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TXNDC15 gene	PMID:27153756
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304696	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TXNDC15 mRNA	PMID:31150632
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312291	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TXNDC15 mRNA	PMID:31919559
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312291	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TXNDC15 mRNA	PMID:22206623
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TXNDC15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC15 mRNA	PMID:39836092
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304696	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TXNDC15 mRNA	PMID:31881176
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1304696	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of TXNDC15 mRNA	PMID:20187946
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312291	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TXNDC15 mRNA	PMID:21570461
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304696	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TXNDC15 mRNA	PMID:33387578
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1304696	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of TXNDC15 mRNA	PMID:19013527
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of TXNDC15 mRNA	PMID:39719251
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TXNDC15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC15 mRNA	PMID:39836092
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1304696	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of TXNDC15 mRNA	PMID:24136188
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312291	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TXNDC15 gene	PMID:35295148
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	EXP		E	RGD:6480464	20250708	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of TXNDC15 gene	PMID:38723642
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304696	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of TXNDC15 mRNA	PMID:41034487
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304696	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TXNDC15 mRNA	PMID:25181051|PMID:34947998
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304696	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TXNDC15 gene	PMID:28505145
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TXNDC15 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TXNDC15 mRNA	PMID:39836092
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304696	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TXNDC15 mRNA	PMID:33453195
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TXNDC15 mRNA	PMID:31533062
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312291	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TXNDC15 mRNA	PMID:36331819
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TXNDC15 mRNA	PMID:25979313
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TXNDC15 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509|PMID:28001369|PMID:29154799
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TXNDC15 mRNA	PMID:27188386
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of TXNDC15 mRNA	PMID:20106945
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TXNDC15 mRNA	PMID:25562108|PMID:27989131
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312291	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TXNDC15 mRNA	PMID:17562736
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of TXNDC15 mRNA	PMID:29067470
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304696	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TXNDC15 mRNA	PMID:33387578
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TXNDC15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC15 mRNA	PMID:39836092
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of TXNDC15 mRNA	PMID:18175754
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312291	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TXNDC15 mRNA; Nanotubes, Carbon results in decreased expression of TXNDC15 mRNA	PMID:25620056
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TXNDC15 protein	PMID:32959892
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TXNDC15 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TXNDC15 mRNA	PMID:39836092
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312291	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of TXNDC15 mRNA	PMID:21641980
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312291	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TXNDC15 mRNA	PMID:22206623
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TXNDC15 mRNA	PMID:27188386
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312291	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TXNDC15 mRNA	PMID:39847705
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TXNDC15 mRNA	PMID:27188386
1312290	TXNDC15	thioredoxin domain containing 15	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312291	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TXNDC15 mRNA	PMID:35537566
1312292	ACTL7A	actin like 7A	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ACTL7A mRNA	PMID:20044591
1312292	ACTL7A	actin like 7A	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304697	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ACTL7A mRNA	PMID:33387578
1312292	ACTL7A	actin like 7A	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304697	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ACTL7A gene	PMID:27618143
1312292	ACTL7A	actin like 7A	gene	CHEBI:17578	toluene	decreases methylation	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased methylation of ACTL7A gene	PMID:26717081
1312292	ACTL7A	actin like 7A	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased expression of ACTL7A mRNA	PMID:26717081
1312292	ACTL7A	actin like 7A	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ACTL7A mRNA	PMID:21867686
1312292	ACTL7A	actin like 7A	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304697	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ACTL7A mRNA	PMID:31881176
1312292	ACTL7A	actin like 7A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312293	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACTL7A mRNA	PMID:21570461|PMID:24680724
1312292	ACTL7A	actin like 7A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304697	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACTL7A mRNA	PMID:33387578
1312292	ACTL7A	actin like 7A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312293	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACTL7A mRNA	PMID:17942748
1312292	ACTL7A	actin like 7A	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ACTL7A mRNA	PMID:33212167
1312292	ACTL7A	actin like 7A	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312293	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ACTL7A protein	PMID:28918527
1312292	ACTL7A	actin like 7A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ACTL7A mRNA	PMID:38568856
1312292	ACTL7A	actin like 7A	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1304697	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ACTL7A mRNA	PMID:19167457
1312292	ACTL7A	actin like 7A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304697	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ACTL7A mRNA	PMID:25181051
1312292	ACTL7A	actin like 7A	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ACTL7A gene	PMID:31601247
1312292	ACTL7A	actin like 7A	gene	CHEBI:34750	Ethylenethiourea	decreases expression	ISO	RGD:1304697	E	RGD:6480464	20190219	CTD	MESH:D005031	Ethylenethiourea results in decreased expression of ACTL7A mRNA	PMID:27905518
1312292	ACTL7A	actin like 7A	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ACTL7A gene	PMID:29154799
1312292	ACTL7A	actin like 7A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312293	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACTL7A mRNA	PMID:17942748
1312292	ACTL7A	actin like 7A	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312293	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ACTL7A mRNA	PMID:23608068
1312292	ACTL7A	actin like 7A	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ACTL7A gene]	PMID:28238834
1312292	ACTL7A	actin like 7A	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of ACTL7A mRNA	PMID:30458266
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1624076	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SRPRB mRNA	PMID:20188158
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SRPRB mRNA	PMID:33167477
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SRPRB mRNA	PMID:20044591
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1624076	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SRPRB mRNA	PMID:39241906
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SRPRB mRNA	PMID:31614463
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1624076	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SRPRB mRNA	PMID:39298647
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [SRPRB protein binds to ESR1 protein]	PMID:27156127
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SRPRB mRNA	PMID:37042841
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SRPRB mRNA	PMID:33359661
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SRPRB mRNA	PMID:33848595
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304698	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SRPRB mRNA	PMID:22061828
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SRPRB mRNA	PMID:36331819
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPRB mRNA	PMID:39836092
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SRPRB mRNA	PMID:19549813
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SRPRB protein	PMID:23301498
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:2663	amiodarone	affects expression	ISO	RGD:1304698	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of SRPRB mRNA	PMID:19483382
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304698	E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SRPRB mRNA	PMID:30723492
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1624076	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SRPRB mRNA	PMID:27339419|PMID:31919559
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPRB mRNA	PMID:39836092
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRPRB mRNA	PMID:40504410
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SRPRB protein	PMID:35688186
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1624076	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SRPRB mRNA	PMID:28960355
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1624076	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of SRPRB protein	PMID:25505154
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of SRPRB mRNA	PMID:32186404
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1624076	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SRPRB mRNA	PMID:21570461
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SRPRB mRNA	PMID:21354282
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SRPRB mRNA	PMID:17942748
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SRPRB mRNA	PMID:33212167
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of SRPRB mRNA	PMID:39631538
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1304698	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of SRPRB mRNA	PMID:19072884
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1304698	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of SRPRB protein	PMID:29459688
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPRB mRNA	PMID:39836092
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRPRB mRNA	PMID:40504410
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of SRPRB mRNA; Tunicamycin results in increased expression of SRPRB protein	PMID:22378314|PMID:29453283
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SRPRB mRNA	PMID:20127859
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:3023	benzbromarone	affects expression	ISO	RGD:1304698	E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of SRPRB mRNA	PMID:19483382
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1624076	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SRPRB mRNA	PMID:23221170
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SRPRB mRNA	PMID:19150397
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of SRPRB gene	PMID:31601247
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304698	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SRPRB mRNA	PMID:24136188
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1304698	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of SRPRB mRNA	PMID:24136188
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1624076	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of SRPRB mRNA	PMID:27760801
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1304698	E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of SRPRB mRNA	PMID:19483382
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1304698	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of SRPRB mRNA	PMID:19483382
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SRPRB mRNA	PMID:30903817
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304698	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SRPRB mRNA	PMID:34947998
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of SRPRB protein	PMID:34186270
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304698	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SRPRB mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SRPRB mRNA	PMID:25979313
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of SRPRB mRNA	PMID:33297965
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1624076	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SRPRB mRNA	PMID:39298647
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of SRPRB gene	PMID:31601247
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SRPRB protein	PMID:34186270
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1624076	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SRPRB mRNA	PMID:37019170
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1624076	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of SRPRB mRNA	PMID:34813904
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SRPRB mRNA	PMID:37042841
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPRB mRNA	PMID:39836092
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:35549	perfluorooctanoic acid	affects methylation	EXP		E	RGD:6480464	20220405	CTD	MESH:C023036	perfluorooctanoic acid affects the methylation of SRPRB gene	PMID:35266797
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1304698	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SRPRB gene	PMID:22079235
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:3750	clofibrate	affects expression	ISO	RGD:1304698	E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of SRPRB mRNA	PMID:19483382
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SRPRB mRNA	PMID:28302478
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SRPRB mRNA	PMID:19167446
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRPRB mRNA	PMID:19167446
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SRPRB mRNA	PMID:40419075
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SRPRB mRNA	PMID:36331819
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SRPRB gene	PMID:29154799
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SRPRB mRNA	PMID:23179753|PMID:29154799
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SRPRB mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1624076	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of SRPRB mRNA	PMID:19770486
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SRPRB mRNA	PMID:17555576
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of SRPRB mRNA	PMID:28542535
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SRPRB mRNA	PMID:17562736
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPRB mRNA	PMID:39836092
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRPRB mRNA	PMID:40504410
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1624076	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SRPRB mRNA	PMID:35436446
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:4886	L-ethionine	affects expression	ISO	RGD:1304698	E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of SRPRB mRNA	PMID:19483382
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SRPRB mRNA	PMID:17555576
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SRPRB mRNA	PMID:17942748
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SRPRB mRNA	PMID:17942748
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1624076	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SRPRB mRNA; Nanotubes, Carbon results in increased expression of SRPRB mRNA	PMID:25554681|PMID:25620056
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:50594	carbon nanotube	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	[Nanotubes, Carbon co-treated with calfactant] results in increased expression of SRPRB protein	PMID:23026733
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304698	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of SRPRB mRNA	PMID:24793618
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SRPRB protein	PMID:32959892
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPRB mRNA	PMID:39836092
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:63630	tolcapone	affects binding	ISO	RGD:1304698	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to SRPRB protein	PMID:19783845
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SRPRB mRNA	PMID:31758290
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SRPRB protein	PMID:34186270
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1624076	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SRPRB mRNA	PMID:22206623
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:749466	calfactant	multiple interactions	EXP		E	RGD:6480464	20260721	CTD	MESH:C117342	[Nanotubes, Carbon co-treated with calfactant] results in increased expression of SRPRB protein	PMID:23026733
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SRPRB mRNA	PMID:37199045
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	ISO	RGD:1304698	E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of SRPRB mRNA	PMID:19483382
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:7772	omeprazole	affects expression	ISO	RGD:1304698	E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of SRPRB mRNA	PMID:19483382
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SRPRB gene]	PMID:28238834
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SRPRB mRNA	PMID:19167446
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1624076	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SRPRB mRNA	PMID:30294300
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1624076	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SRPRB mRNA	PMID:21278054
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1304698	E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of SRPRB mRNA	PMID:19483382
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304698	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SRPRB mRNA	PMID:19281266
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SRPRB mRNA	PMID:38568856
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of SRPRB mRNA	PMID:22378314
1312294	SRPRB	SRP receptor subunit beta	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1304698	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of SRPRB protein	PMID:35544339
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C118739	entinostat results in increased expression of NAXE mRNA	PMID:27188386
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:133296	microcystin RR	decreases expression	EXP		E	RGD:6480464	20161004	CTD	MESH:C063855	microcystin RR results in decreased expression of NAXE protein	PMID:19111056
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312296	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NAXE mRNA	PMID:36331819
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NAXE mRNA	PMID:22378314
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of NAXE mRNA	PMID:39298647
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NAXE mRNA	PMID:37042841
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312296	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NAXE mRNA	PMID:33754040
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304699	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of NAXE mRNA	PMID:22061828
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D014520	Urethane results in decreased expression of NAXE mRNA	PMID:28818685
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of NAXE mRNA	PMID:23649840
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312296	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAXE mRNA	PMID:22206623
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of NAXE protein	PMID:37834424
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NAXE protein	PMID:38460933
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304699	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of NAXE mRNA	PMID:31881176
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312296	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NAXE mRNA	PMID:21570461
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312296	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to NAXE promoter]	PMID:19654925
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NAXE mRNA	PMID:33212167
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of NAXE mRNA	PMID:32763439
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of NAXE mRNA	PMID:29803840
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of APOA1BP protein; sodium arsenite results in decreased expression of NAXE mRNA	PMID:38228842|PMID:38568856
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of NAXE mRNA	PMID:34032870
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to NAXE mRNA]	PMID:32406909
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312296	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of APOA1BP gene	PMID:35295148
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304699	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of NAXE mRNA	PMID:34492290
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1304699	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of NAXE mRNA	PMID:19167457
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NAXE mRNA	PMID:33221593
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C006780	bisphenol A results in increased expression of NAXE mRNA	PMID:25047013
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304699	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NAXE mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312296	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of NAXE mRNA	PMID:40203079
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312296	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NAXE mRNA	PMID:37019170
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20170725	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NAXE mRNA	PMID:21266533
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312296	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of NAXE mRNA	PMID:34813904
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NAXE protein	PMID:24527689
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312296	E	RGD:6480464	20170725	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NAXE mRNA	PMID:24982889
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312296	E	RGD:6480464	20171114	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of NAXE protein	PMID:28126411|PMID:37422089
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NAXE mRNA	PMID:19320972
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of NAXE mRNA	PMID:24449571
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312296	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NAXE mRNA	PMID:40194260
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NAXE mRNA	PMID:40419075
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312296	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NAXE mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NAXE mRNA	PMID:36331819
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NAXE mRNA	PMID:25979313
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of NAXE mRNA	PMID:23179753|PMID:27188386
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312296	E	RGD:6480464	20170725	CTD	MESH:D014635	Valproic Acid results in increased expression of NAXE mRNA	PMID:21427059
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NAXE mRNA	PMID:20106945|PMID:25562108
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NAXE mRNA	PMID:22230336
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NAXE protein	PMID:38460933
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of NAXE protein	PMID:37834424
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NAXE protein	PMID:32959892
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20221206	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NAXE mRNA	PMID:22206623
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312296	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAXE mRNA	PMID:22206623
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of NAXE protein	PMID:37664457
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D010634	Phenobarbital results in decreased expression of NAXE protein	PMID:35881160
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20230502	CTD	MESH:D010634	Phenobarbital results in decreased expression of NAXE protein	PMID:35881160
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312296	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of NAXE mRNA	PMID:31388691
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of NAXE mRNA	PMID:40826991
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of NAXE protein	PMID:37664457
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1304699	E	RGD:6480464	20260804	CTD	MESH:D013605	T-2 Toxin results in increased expression of NAXE mRNA	PMID:42167635
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NAXE mRNA	PMID:38568856
1312295	NAXE	NAD(P)HX epimerase	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1312296	E	RGD:6480464	20170725	CTD	MESH:D013792	Thalidomide results in decreased expression of NAXE mRNA	PMID:26217789
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NDST2 mRNA	PMID:38218311
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304700	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NDST2 mRNA]	PMID:31150632
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:15365	acetylsalicylic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of NDST2 mRNA	PMID:11906190
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NDST2 mRNA	PMID:36331819
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1312298	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of NDST2 mRNA	PMID:15282401
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of NDST2 mRNA	PMID:26079696
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312298	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of NDST2 mRNA	PMID:30319688
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312298	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NDST2 mRNA	PMID:39241906
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NDST2 mRNA	PMID:37042841
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of NDST2 mRNA	PMID:21179406
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304700	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NDST2 mRNA	PMID:33387578
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NDST2 mRNA	PMID:36331819
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of NDST2 mRNA	PMID:39836092
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304700	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NDST2 mRNA	PMID:39012411
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NDST2 mRNA	PMID:19549813
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of NDST2 mRNA	PMID:35430440
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of NDST2 mRNA	PMID:34911549
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304700	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NDST2 mRNA	PMID:31150632
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304700	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NDST2 mRNA]	PMID:31150632
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NDST2 mRNA	PMID:39836092
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304700	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDST2 mRNA	PMID:33387578
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312298	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NDST2 mRNA	PMID:17942748
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NDST2 mRNA	PMID:17942748
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NDST2 mRNA	PMID:28001369
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NDST2 mRNA	PMID:30851411
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of NDST2 mRNA	PMID:32763439
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:28815	heparan sulfate	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20130416	CTD	MESH:D006497	Heparan Sulfate affects the susceptibility to [NDST1 protein co-treated with NDST2 protein]; Heparan Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK1 protein]; Heparan Sulfate inhibits the reaction [[NDST1 protein co-treated with NDST2 protein] affects the phosphorylation of MAPK3 protein]	PMID:19937756
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NDST2 mRNA	PMID:39836092
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312298	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NDST2 gene	PMID:35295148
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304700	E	RGD:6480464	20170214	CTD	MESH:D013853	Thioacetamide results in decreased expression of NDST2 mRNA	PMID:23411599
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312298	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of NDST2 mRNA	PMID:20813756
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304700	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NDST2 mRNA	PMID:34947998
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304700	E	RGD:6480464	20170214	CTD	MESH:C006780	bisphenol A results in increased expression of NDST2 mRNA	PMID:25181051|PMID:30816183
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304700	E	RGD:6480464	20170214	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NDST2 mRNA	PMID:21266533
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312298	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of NDST2 mRNA	PMID:34813904
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of NDST2 mRNA	PMID:39836092
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1304700	E	RGD:6480464	20170214	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of NDST2 promoter	PMID:22457795
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304700	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NDST2 mRNA	PMID:39012411
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NDST2 mRNA	PMID:19320972
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of NDST2 mRNA	PMID:24449571
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NDST2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NDST2 mRNA	PMID:36331819
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NDST2 mRNA	PMID:25979313
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312298	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NDST2 mRNA	PMID:17292431
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312298	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of NDST2 mRNA	PMID:21427059
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312298	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of NDST2 mRNA	PMID:21427059
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NDST2 gene	PMID:29154799
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D000082	Acetaminophen affects the expression of NDST2 mRNA	PMID:25458485
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312298	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of NDST2 mRNA	PMID:29279043
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NDST2 mRNA	PMID:39836092
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NDST2 mRNA	PMID:22079256
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312298	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NDST2 mRNA	PMID:17942748
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312298	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NDST2 mRNA	PMID:17942748
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of NDST2 mRNA	PMID:39836092
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1304700	E	RGD:6480464	20170214	CTD	MESH:D008694	Methamphetamine results in decreased expression of NDST2 mRNA	PMID:19564919
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:749301	potassium perchlorate	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of NDST2 mRNA	PMID:29673971
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of NDST2 mRNA	PMID:22079256
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NDST2 mRNA	PMID:22079256
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NDST2 mRNA	PMID:30851411
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304700	E	RGD:6480464	20170214	CTD	MESH:D012999	Soman results in decreased expression of NDST2 mRNA	PMID:19281266
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304700	E	RGD:6480464	20170214	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NDST2 mRNA	PMID:21346803
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in decreased expression of NDST2 mRNA	PMID:11906190
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312298	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of NDST2 mRNA	PMID:28973697
1312297	NDST2	N-deacetylase and N-sulfotransferase 2	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304700	E	RGD:6480464	20170214	CTD	MESH:C025643	vinclozolin results in increased expression of NDST2 mRNA	PMID:23034163
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D015025	Zearalenone results in increased expression of PRMT6 mRNA	PMID:32119988
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PRMT6 mRNA	PMID:33045310
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304701	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PRMT6 mRNA]	PMID:31150632
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of PRMT6 mRNA	PMID:31016361
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PRMT6 mRNA	PMID:33167477
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550002	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRMT6 mRNA	PMID:30529165
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PRMT6 mRNA	PMID:22378314
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:16118	berberine	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D001599	Berberine results in increased expression of PRMT6 mRNA	PMID:27311644
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550002	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PRMT6 mRNA	PMID:30319688
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PRMT6 mRNA	PMID:39241906
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of PRMT6 mRNA	PMID:31614463
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550002	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of PRMT6 mRNA	PMID:25210133
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PRMT6 mRNA	PMID:38568856
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PRMT6 mRNA	PMID:37042841
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:16680	S-adenosyl-L-homocysteine	decreases activity	EXP		E	RGD:6480464	20220111	CTD	MESH:D012435	S-Adenosylhomocysteine results in decreased activity of PRMT6 protein	PMID:33577917
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PRMT6 mRNA	PMID:20655997
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20241001	CTD	MESH:D005557	Formaldehyde results in decreased expression of PRMT6 mRNA; Formaldehyde results in decreased expression of PRMT6 protein	PMID:33233951
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PRMT6 mRNA	PMID:21179406
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1550002	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PRMT6 mRNA	PMID:23892564
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PRMT6 protein	PMID:37730182
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304701	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PRMT6 mRNA	PMID:33387578
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PRMT6 mRNA	PMID:28818685
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550002	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PRMT6 mRNA	PMID:37236586
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PRMT6 mRNA	PMID:19549813
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PRMT6 mRNA	PMID:23649840
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1550002	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PRMT6 mRNA	PMID:19770486
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PRMT6 gene	PMID:27153756
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PRMT6 mRNA	PMID:23649840
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304701	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PRMT6 mRNA	PMID:30779732
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304701	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PRMT6 mRNA	PMID:31150632
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304701	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PRMT6 mRNA]	PMID:31150632
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PRMT6 gene	PMID:25304211
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PRMT6 mRNA	PMID:32525701
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550002	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PRMT6 mRNA	PMID:28960355
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of PRMT6 mRNA	PMID:19371625
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of PRMT6 mRNA	PMID:19921347
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:27958	cocaine	affects response to substance	EXP		E	RGD:6480464	20180220	CTD	MESH:D003042	PRMT6 protein affects the susceptibility to Cocaine	PMID:27506785
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D003042	Cocaine results in decreased expression of PRMT6 mRNA	PMID:27506785
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1304701	E	RGD:11561325|PMID:27506785	20250326	RGD	MESH:D003042	cocaine decreases expression of Prmt6 mRNA and protein in nucleus accumbens	
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20180220	CTD	MESH:D003042	Cocaine results in decreased expression of PRMT6 mRNA; Cocaine results in decreased expression of PRMT6 protein	PMID:27506785
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:27958	cocaine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D003042	PRMT6 protein inhibits the reaction [Cocaine results in increased expression of SRCIN1 protein]	PMID:27506785
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PRMT6 mRNA	PMID:32186404
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550002	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRMT6 mRNA	PMID:21570461
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PRMT6 mRNA	PMID:28001369
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PRMT6 mRNA	PMID:33212167
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PRMT6 mRNA	PMID:32763439
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PRMT6 mRNA	PMID:38568856
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of PRMT6 mRNA	PMID:22378314
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRMT6 3' UTR	PMID:27901495
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PRMT6 exon	PMID:27901495
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PRMT6 mRNA	PMID:20382639
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of PRMT6 mRNA	PMID:35984750
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of PRMT6 mRNA	PMID:31745603
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PRMT6 mRNA	PMID:29264374
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304701	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PRMT6 mRNA	PMID:34492290
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PRMT6 mRNA	PMID:29275510
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304701	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PRMT6 mRNA	PMID:25181051|PMID:34973380
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of PRMT6 mRNA	PMID:26063408|PMID:33221593
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1550002	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of PRMT6 promoter	PMID:27312807
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304701	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of PRMT6 mRNA	PMID:30816183|PMID:34947998
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PRMT6 mRNA	PMID:21266533
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D010269	Paraquat results in decreased expression of PRMT6 mRNA	PMID:23613995
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PRMT6 mRNA	PMID:37042841
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PRMT6 mRNA	PMID:38174414
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550002	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PRMT6 mRNA	PMID:37236586
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304701	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PRMT6 mRNA	PMID:24386269
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PRMT6 mRNA	PMID:40194260
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PRMT6 mRNA	PMID:23179753
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PRMT6 mRNA	PMID:20106945|PMID:25562108
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1550002	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of PRMT6 mRNA	PMID:19770486
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PRMT6 mRNA	PMID:28542535
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550002	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PRMT6 mRNA	PMID:17562736
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304701	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRMT6 mRNA	PMID:33387578
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PRMT6 gene	PMID:25304211
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PRMT6 mRNA	PMID:32525701
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304701	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PRMT6 mRNA	PMID:29391264
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:50819	ferric oxide	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20141223	CTD	MESH:C000499	ferric oxide analog results in decreased expression of PRMT6 mRNA	PMID:25086211
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550002	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PRMT6 mRNA	PMID:19042947
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:63580	ribavirin	affects expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D012254	Ribavirin affects the expression of PRMT6 protein	PMID:34919946
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1550002	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of PRMT6 mRNA	PMID:39847705
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PRMT6 mRNA	PMID:32525701
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304701	E	RGD:6480464	20140916	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PRMT6 mRNA	PMID:21346803
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PRMT6 mRNA	PMID:29301935
1312299	PRMT6	protein arginine methyltransferase 6	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1550002	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of PRMT6 mRNA	PMID:35537566
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312304	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TNFRSF17 mRNA	PMID:33045310
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312304	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TNFRSF17 mRNA	PMID:39241906
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304703	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TNFRSF17 mRNA	PMID:33387578
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TNFRSF17 mRNA	PMID:37042841
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TNFRSF17 mRNA	PMID:23649840
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TNFRSF17 mRNA	PMID:23649840
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:25187	p-menthan-3-ol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of TNFRSF17 mRNA	PMID:26760959
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TNFRSF17 mRNA	PMID:23649840
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TNFRSF17 mRNA	PMID:22171008
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D001151	Arsenic affects the expression of TNFRSF17 protein	PMID:24675094
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:27924	phenylhydrazine	decreases expression	ISO	RGD:1304703	E	RGD:6480464	20120412	CTD	MESH:C030299	phenylhydrazine results in decreased expression of TNFRSF17 mRNA	PMID:17698508
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312304	E	RGD:6480464	20140513	CTD	MESH:D019833	Genistein results in increased expression of TNFRSF17 mRNA	PMID:22553218
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of TNFRSF17 mRNA	PMID:23195993
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312304	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TNFRSF17 mRNA	PMID:21570461|PMID:26377647
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of TNFRSF17 mRNA	PMID:23649840
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TNFRSF17 promoter	PMID:27901495
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TNFRSF17 mRNA	PMID:22171008
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TNFRSF17 mRNA	PMID:17530438
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C061133	tamibarotene results in increased expression of TNFRSF17 mRNA	PMID:17229644
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1304703	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of TNFRSF17 mRNA	PMID:30012374
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312304	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TNFRSF17 mRNA	PMID:23557971
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1304703	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of TNFRSF17 promoter	PMID:22457795
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304703	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TNFRSF17 mRNA	PMID:27387713
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of TNFRSF17 mRNA	PMID:23649840
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:44185	methotrexate	multiple interactions	EXP		E	RGD:6480464	20200331	CTD	MESH:D008727	[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of TNFRSF17 mRNA	PMID:28863153
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of TNFRSF17 protein	PMID:24675094
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TNFRSF17 mRNA	PMID:17530438
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:50161	motexafin gadolinium	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in decreased expression of TNFRSF17 mRNA	PMID:16357179
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TNFRSF17 mRNA	PMID:16357179
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312304	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TNFRSF17 mRNA	PMID:25554681
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:5801	hydroxychloroquine	multiple interactions	EXP		E	RGD:6480464	20200331	CTD	MESH:D006886	[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of TNFRSF17 mRNA	PMID:28863153
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312304	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TNFRSF17 mRNA	PMID:38701926
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:62984	zinc acetate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in decreased expression of TNFRSF17 mRNA	PMID:16357179
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:62984	zinc acetate	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TNFRSF17 mRNA	PMID:16357179
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:8050	phenacetin	decreases expression	ISO	RGD:1304703	E	RGD:6480464	20120412	CTD	MESH:D010615	Phenacetin results in decreased expression of TNFRSF17 mRNA	PMID:17698508
1312303	TNFRSF17	TNF receptor superfamily member 17	gene	CHEBI:9334	sulfasalazine	multiple interactions	EXP		E	RGD:6480464	20200331	CTD	MESH:D012460	[Hydroxychloroquine co-treated with Methotrexate co-treated with Sulfasalazine] results in decreased expression of TNFRSF17 mRNA	PMID:28863153
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RTRAF mRNA	PMID:33167477
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of RTRAF mRNA	PMID:24763279
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1304704	E	RGD:6480464	20180116	CTD	MESH:D000431	Ethanol results in increased expression of RTRAF protein	PMID:23702218
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312306	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RTRAF mRNA	PMID:39241906
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250401	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of RTRAF mRNA	PMID:30698749
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304704	E	RGD:6480464	20180116	CTD	MESH:D005839	Gentamicins results in increased expression of RTRAF protein	PMID:22061828
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RTRAF mRNA	PMID:19549813
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RTRAF protein	PMID:23301498
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RTRAF gene	PMID:27153756
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:2654	aminoglutethimide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in decreased expression of RTRAF protein	PMID:26102013
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1304704	E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in increased expression of RTRAF mRNA	PMID:31129395
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RTRAF mRNA	PMID:22206623
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of RTRAF protein	PMID:37834424
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTRAF mRNA	PMID:40504410
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RTRAF mRNA	PMID:23557933
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RTRAF mRNA	PMID:28903495
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RTRAF mRNA	PMID:27392435
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304704	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RTRAF mRNA	PMID:33387578
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RTRAF mRNA	PMID:29803840
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTRAF mRNA	PMID:40504410
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RTRAF promoter	PMID:27901495
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RTRAF mRNA]	PMID:32406909
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RTRAF gene	PMID:31601247
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:31739	josamycin	affects response to substance	EXP		E	RGD:6480464	20200609	CTD	MESH:D015570	RTRAF protein affects the susceptibility to Josamycin	PMID:31915244
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RTRAF mRNA; bisphenol A results in decreased expression of RTRAF protein	PMID:29275510|PMID:31675489
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312306	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RTRAF mRNA	PMID:33221593
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304704	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of RTRAF mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RTRAF gene	PMID:31601247
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of RTRAF protein	PMID:31675489
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312306	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RTRAF mRNA	PMID:39298647
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250401	CTD	MESH:C041594	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of RTRAF mRNA	PMID:30698749
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250401	CTD	MESH:C105260	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of RTRAF mRNA	PMID:30698749
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250401	CTD	MESH:C027561	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of RTRAF mRNA	PMID:30698749
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250401	CTD	MESH:D003993	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of RTRAF mRNA	PMID:30698749
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250401	CTD	MESH:C019566	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of RTRAF mRNA	PMID:30698749
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RTRAF mRNA	PMID:24449571
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of RTRAF mRNA	PMID:26352163
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RTRAF mRNA	PMID:20106945|PMID:25562108
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of RTRAF protein	PMID:37834424
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RTRAF mRNA	PMID:40504410
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of RTRAF mRNA	PMID:31675489
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312306	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RTRAF mRNA	PMID:35436446
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of RTRAF mRNA	PMID:18175754
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RTRAF mRNA	PMID:35964746
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304704	E	RGD:6480464	20180116	CTD	MESH:D005485	Flutamide results in increased expression of RTRAF mRNA	PMID:24136188
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RTRAF protein	PMID:32959892
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312306	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RTRAF mRNA	PMID:22206623
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RTRAF protein	PMID:31675489
1312305	RTRAF	RNA transcription, translation and transport factor	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1304704	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of RTRAF gene	PMID:31682807
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of VPS13A mRNA	PMID:38218311
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of VPS13A mRNA	PMID:35967413
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1553666	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of VPS13A mRNA	PMID:26251327
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1553666	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VPS13A gene	PMID:20938992
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1553666	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of VPS13A mRNA	PMID:30319688
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1311340	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of VPS13A mRNA	PMID:32145629
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1553666	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of VPS13A mRNA	PMID:39298647
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1553666	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VPS13A gene	PMID:20938992
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of VPS13A mRNA	PMID:37042841
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of VPS13A mRNA	PMID:23649840
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of VPS13A mRNA	PMID:21592394
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of VPS13A mRNA	PMID:21592394
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of VPS13A mRNA	PMID:21592394
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of VPS13A mRNA	PMID:21592394
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:18291	manganese atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of VPS13A mRNA	PMID:17175027
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VPS13A mRNA	PMID:35301059
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of VPS13A mRNA	PMID:19549813
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of VPS13A mRNA	PMID:23649840
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1553666	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of VPS13A mRNA	PMID:19770486
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of VPS13A mRNA	PMID:23649840
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1311340	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of VPS13A mRNA	PMID:41580963
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1553666	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of VPS13A mRNA	PMID:34911549
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1553666	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VPS13A gene	PMID:20938992
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1553666	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of VPS13A mRNA	PMID:28960355
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of VPS13A mRNA	PMID:23557933
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1553666	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of VPS13A mRNA	PMID:30912803
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1311340	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VPS13A mRNA	PMID:32109520
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1553666	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VPS13A mRNA	PMID:21570461
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1311340	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of VPS13A mRNA	PMID:33387578
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1553666	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VPS13A mRNA	PMID:28922406
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of VPS13A mRNA	PMID:28001369
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of VPS13A mRNA	PMID:33212167
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of VPS13A mRNA	PMID:23649840
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1311340	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of VPS13A mRNA	PMID:28959563
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of VPS13A mRNA	PMID:39719251
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of VPS13A mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of VPS13A mRNA alternative form	PMID:40419235
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to VPS13A mRNA]	PMID:32406909
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of VPS13A mRNA	PMID:19150397|PMID:26238291
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1553666	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of VPS13A gene; titanium dioxide results in increased methylation of VPS13A promoter	PMID:35295148
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1311340	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of VPS13A mRNA	PMID:34492290
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1553666	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of VPS13A mRNA	PMID:20813756
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1311340	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of VPS13A mRNA	PMID:32145629
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1311340	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of VPS13A mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1311340	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of VPS13A mRNA	PMID:33296240
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1553666	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of VPS13A mRNA	PMID:39298647
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of VPS13A mRNA	PMID:28628672
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1553666	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of VPS13A mRNA	PMID:37019170
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of VPS13A mRNA	PMID:28628672
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of VPS13A mRNA	PMID:37042841
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:35154	manganese(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of VPS13A mRNA	PMID:17175027
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1553666	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of VPS13A mRNA	PMID:26377693
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1553666	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride affects the expression of VPS13A mRNA	PMID:18974090
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1553666	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of VPS13A mRNA	PMID:24982889
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of VPS13A mRNA	PMID:38382870
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VPS13A mRNA	PMID:35301059
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1553666	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of VPS13A mRNA	PMID:18353800
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:3763	clorgyline	increases expression	EXP		E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of VPS13A mRNA	PMID:19691856
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of VPS13A mRNA	PMID:27153767
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of VPS13A mRNA	PMID:23179753|PMID:25979313
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1311340	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of VPS13A mRNA	PMID:29427782
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of VPS13A mRNA	PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VPS13A mRNA	PMID:27188386
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1311340	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of VPS13A mRNA	PMID:30047161
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of VPS13A mRNA	PMID:25562108
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of VPS13A mRNA	PMID:28628672
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of VPS13A mRNA	PMID:23649840
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of VPS13A mRNA	PMID:24935251
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1553666	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of VPS13A mRNA	PMID:17562736
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of VPS13A mRNA	PMID:21420995
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C088658	zoledronic acid results in increased expression of VPS13A protein	PMID:28871336
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of VPS13A mRNA	PMID:22079256
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1553666	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of VPS13A mRNA	PMID:35436446
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1311340	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of VPS13A mRNA	PMID:29097150
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of VPS13A mRNA	PMID:28628672
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1311340	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of VPS13A mRNA	PMID:30047161
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1311340	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of VPS13A mRNA	PMID:20080153
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of VPS13A mRNA	PMID:17175027
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1553666	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of VPS13A mRNA	PMID:22206623
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of VPS13A mRNA	PMID:22079256
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of VPS13A mRNA	PMID:22079256
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VPS13A mRNA	PMID:27188386
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to VPS13A gene]	PMID:28238834
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1311340	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of VPS13A mRNA	PMID:32109520
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1311340	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of VPS13A mRNA	PMID:30047161
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1553666	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of VPS13A mRNA	PMID:40826991
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VPS13A mRNA	PMID:27188386
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1553666	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of VPS13A mRNA	PMID:35537566
1312307	VPS13A	vacuolar protein sorting 13 homolog A	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1311340	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of VPS13A mRNA	PMID:23034163
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of LRFN1 mRNA	PMID:27188386
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312310	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LRFN1 gene	PMID:20938992
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312310	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of LRFN1 mRNA	PMID:30319688
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of LRFN1 mRNA	PMID:31614463
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312310	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LRFN1 gene	PMID:20938992
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of LRFN1 mRNA	PMID:26079696
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:174733	Licochalcone B	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of LRFN1 mRNA	PMID:33647349
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of LRFN1 mRNA	PMID:28818685
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1312310	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of LRFN1 mRNA	PMID:37748715
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LRFN1 mRNA	PMID:32234424
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of LRFN1 mRNA	PMID:35430440
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312310	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LRFN1 gene	PMID:20938992
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of LRFN1 mRNA	PMID:27392435
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304707	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRFN1 mRNA	PMID:33387578
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304707	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of LRFN1 mRNA	PMID:28959563
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:29021	hexane	increases methylation	ISO	RGD:1304707	E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in increased methylation of LRFN1 promoter	PMID:23740543
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LRFN1 mRNA	PMID:38568856
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312310	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRFN1 mRNA	PMID:27195522
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LRFN1 exon	PMID:27901495
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312310	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LRFN1 5' UTR; Benzo(a)pyrene results in decreased methylation of LRFN1 exon	PMID:27901495
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LRFN1 mRNA	PMID:32234424
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of LRFN1 mRNA	PMID:37690743
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LRFN1 gene	PMID:31601247
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312310	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRFN1 gene	PMID:35295148
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1304707	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of LRFN1 mRNA	PMID:19167457
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of LRFN1 mRNA	PMID:23146750
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304707	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LRFN1 mRNA	PMID:25181051
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304707	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of LRFN1 mRNA	PMID:30816183|PMID:34947998
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LRFN1 gene	PMID:31601247
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304707	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of LRFN1 mRNA	PMID:36041667
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LRFN1 mRNA	PMID:23146750
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304707	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of LRFN1 mRNA	PMID:36041667
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304707	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of LRFN1 mRNA	PMID:36041667
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312310	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LRFN1 intron	PMID:28392331
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1304707	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LRFN1 mRNA	PMID:20691718
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312310	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LRFN1 mRNA	PMID:37019170
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312310	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of LRFN1 mRNA	PMID:36117858
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LRFN1 mRNA	PMID:37042841
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312310	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LRFN1 mRNA	PMID:40194260
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of LRFN1 mRNA	PMID:31533062
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LRFN1 mRNA	PMID:25979313
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of LRFN1 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of LRFN1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRFN1 mRNA	PMID:17183730|PMID:27188386
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304707	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LRFN1 mRNA	PMID:33387578
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1312310	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of LRFN1 mRNA	PMID:29279043
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of LRFN1 mRNA	PMID:32234424
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304707	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of LRFN1 mRNA	PMID:30307764
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312310	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of LRFN1 mRNA	PMID:36117858
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of LRFN1 mRNA	PMID:17183730
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRFN1 mRNA	PMID:27188386
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of LRFN1 mRNA	PMID:23146750
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of LRFN1 mRNA	PMID:32234424
1312309	LRFN1	leucine rich repeat and fibronectin type III domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRFN1 mRNA	PMID:27188386
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:137832	Cacalol	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C497192	cacalol results in increased expression of DAPK2 mRNA	PMID:20665104
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:145121	SKF-96365 hydrochloride	multiple interactions	ISO	RGD:1304708	E	RGD:6480464	20201215	CTD	MESH:C063159	1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of DAPK2 protein]	PMID:32895711
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of DAPK2 mRNA; Tretinoin results in increased expression of DAPK2 protein	PMID:15498508|PMID:23830798|PMID:28978663|PMID:33167477
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D014212	DAPK2 protein affects the reaction [Tretinoin promotes the reaction [ATG5 protein binds to ATG12 protein]]; DAPK2 protein affects the reaction [Tretinoin promotes the reaction [bafilomycin A results in increased expression of MAP1LC3B protein modified form]]; TP73 protein affects the reaction [Tretinoin results in increased expression of DAPK2 mRNA]; TP73 protein affects the reaction [Tretinoin results in increased expression of DAPK2 protein]	PMID:28978663
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DAPK2 mRNA	PMID:30529165
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of DAPK2 mRNA	PMID:30510588
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of DAPK2 mRNA	PMID:19484750|PMID:39298647
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of DAPK2 mRNA	PMID:23373633|PMID:24758408|PMID:31614463
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein promotes the reaction [Estradiol results in increased expression of DAPK2 mRNA]	PMID:24758408
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312312	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of DAPK2 mRNA	PMID:33711761
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DAPK2 mRNA	PMID:37042841
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of DAPK2 mRNA	PMID:21592394
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of DAPK2 mRNA	PMID:21592394
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304708	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of DAPK2 mRNA	PMID:27523638
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of DAPK2 mRNA	PMID:21592394
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of DAPK2 mRNA	PMID:21592394
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of DAPK2 intron	PMID:30157460
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DAPK2 mRNA	PMID:19549813
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of DAPK2 mRNA	PMID:22100608|PMID:27153756
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DAPK2 intron	PMID:30157460
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of DAPK2 mRNA	PMID:26760959
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of DAPK2 mRNA	PMID:19774075
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312312	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of DAPK2 mRNA	PMID:25629700
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DAPK2 mRNA	PMID:22206623
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of DAPK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DAPK2 mRNA	PMID:40512198
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of DAPK2 mRNA	PMID:27392435
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of DAPK2 mRNA	PMID:40618947
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of DAPK2 mRNA	PMID:27392435
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304708	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DAPK2 mRNA	PMID:34747641
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304708	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DAPK2 mRNA	PMID:21215274
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304708	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DAPK2 mRNA	PMID:33387578
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312312	E	RGD:6480464	20150825	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DAPK2 mRNA	PMID:15310856|PMID:19770486|PMID:21889950|PMID:25975270
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1304708	E	RGD:6480464	20130806	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of DAPK2 mRNA]	PMID:21215274
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DAPK2 mRNA	PMID:25975270
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DAPK2 mRNA	PMID:33212167
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304708	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of DAPK2 mRNA	PMID:28959563
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DAPK2 mRNA	PMID:29803840
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DAPK2 mRNA	PMID:38568856|PMID:39719251
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312312	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of DAPK2 mRNA	PMID:39515575
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of DAPK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DAPK2 mRNA	PMID:40512198
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DAPK2 intron	PMID:30157460
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of DAPK2 mRNA]	PMID:22228805
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DAPK2 mRNA; Arsenic Trioxide results in increased expression of DAPK2 protein	PMID:28978663
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	DAPK2 protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; TP73 protein affects the reaction [Arsenic Trioxide results in increased expression of DAPK2 mRNA]; TP73 protein affects the reaction [Arsenic Trioxide results in increased expression of DAPK2 protein]	PMID:28978663
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of DAPK2 mRNA	PMID:38568856
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304708	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DAPK2 mRNA	PMID:25729387
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of DAPK2 mRNA	PMID:15498508
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312312	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DAPK2 gene; titanium dioxide results in decreased methylation of DAPK2 promoter	PMID:35295148
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of DAPK2 mRNA	PMID:17426115
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312312	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of DAPK2 mRNA	PMID:18301758
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304708	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DAPK2 mRNA	PMID:25181051|PMID:34947998
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304708	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DAPK2 mRNA	PMID:30816183|PMID:32528016
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312312	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of DAPK2 mRNA	PMID:32156529
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DAPK2 mRNA	PMID:25172293
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312312	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of DAPK2 mRNA	PMID:26682919
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20140715	CTD	MESH:D008748	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of DAPK2 mRNA	PMID:23519560
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DAPK2 mRNA	PMID:39298647
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of DAPK2 intron	PMID:30157460
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of DAPK2 mRNA	PMID:28392331
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312312	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DAPK2 intron	PMID:28392331
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312312	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DAPK2 mRNA	PMID:32715474
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312312	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of DAPK2 mRNA	PMID:24535843
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DAPK2 mRNA	PMID:37042841
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304708	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DAPK2 mRNA	PMID:35163327
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DAPK2 mRNA	PMID:38568856
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20121009	CTD	MESH:D019256	MT3 affects the reaction [Cadmium Chloride affects the expression of DAPK2 mRNA]	PMID:20371981
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of DAPK2 mRNA	PMID:27153767
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304708	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DAPK2 mRNA	PMID:35163327
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312312	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of DAPK2 mRNA	PMID:28962523
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312312	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of DAPK2 mRNA	PMID:18353800
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of DAPK2 mRNA	PMID:17585979
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20140715	CTD	MESH:D013755	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of DAPK2 mRNA	PMID:23519560
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:38319	usnic acid	increases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in increased expression of DAPK2 mRNA	PMID:32508146
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312312	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DAPK2 mRNA	PMID:40194260
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DAPK2 mRNA	PMID:31533062
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of DAPK2 mRNA	PMID:26272509
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312312	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of DAPK2 mRNA	PMID:21427059
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DAPK2 gene	PMID:29154799
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA	PMID:27188386
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304708	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of DAPK2 mRNA	PMID:41580965
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of DAPK2 mRNA	PMID:19770486
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312312	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DAPK2 mRNA	PMID:28973697
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA	PMID:27188386
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in increased expression of DAPK2 mRNA	PMID:16865256
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312312	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DAPK2 mRNA	PMID:17562736
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312312	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in increased expression of DAPK2 mRNA	PMID:17585979
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of DAPK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DAPK2 mRNA	PMID:40512198
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:47426	furosemide	affects expression	ISO	RGD:1304708	E	RGD:6480464	20130806	CTD	MESH:D005665	Furosemide affects the expression of DAPK2 mRNA	PMID:17497460
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of DAPK2 mRNA	PMID:38568856
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DAPK2 mRNA; Arsenic Trioxide results in increased expression of DAPK2 protein	PMID:28978663
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	DAPK2 protein affects the reaction [Arsenic Trioxide results in increased cleavage of CASP3 protein]; TP73 protein affects the reaction [Arsenic Trioxide results in increased expression of DAPK2 mRNA]; TP73 protein affects the reaction [Arsenic Trioxide results in increased expression of DAPK2 protein]	PMID:28978663
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of DAPK2 mRNA	PMID:19037991
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312312	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DAPK2 mRNA; Nanotubes, Carbon results in decreased expression of DAPK2 mRNA	PMID:25554681|PMID:25620056
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304708	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of DAPK2 mRNA	PMID:24136188
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:52717	bortezomib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	[BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in decreased expression of DAPK2 mRNA	PMID:25522274
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1304708	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of DAPK2 mRNA	PMID:25729387
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304708	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DAPK2 mRNA	PMID:25729387
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of DAPK2 intron	PMID:30157460
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304708	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DAPK2 gene	PMID:35440735
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312312	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DAPK2 mRNA	PMID:22206623
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1304708	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of DAPK2 mRNA	PMID:33484710
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1304708	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of DAPK2 mRNA	PMID:21346803
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA	PMID:27188386
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:8107	phenytoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010672	Phenytoin results in decreased expression of DAPK2 mRNA	PMID:14741686
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	affects expression	ISO	RGD:1304708	E	RGD:6480464	20190910	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl affects the expression of DAPK2 protein	PMID:31020377
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1304708	E	RGD:6480464	20190910	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of DAPK2 mRNA; 2,3',4,4',5-pentachlorobiphenyl results in increased expression of DAPK2 protein	PMID:31020377|PMID:32895711
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	multiple interactions	ISO	RGD:1304708	E	RGD:6480464	20190910	CTD	MESH:C070055	1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of DAPK2 protein]; 2,3',4,4',5-pentachlorobiphenyl promotes the reaction [TUBB3 protein binds to DAPK2 protein]; DAPK2 protein affects the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased phosphorylation of PIK3C3 protein]; DAPK2 protein affects the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased phosphorylation of PRKD1 protein]; TUBB3 protein promotes the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of DAPK2 protein]	PMID:31020377|PMID:32895711
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304708	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DAPK2 mRNA	PMID:24780913|PMID:25825206
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:87368	diethyl malate	affects expression	ISO	RGD:1312312	E	RGD:6480464	20170303	CTD	MESH:C058705	diethyl malate affects the expression of DAPK2 mRNA	PMID:24814887
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DAPK2 mRNA	PMID:27188386
1312311	DAPK2	death associated protein kinase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304708	E	RGD:6480464	20130806	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DAPK2 mRNA	PMID:21346803
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CA8 mRNA	PMID:33167477
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CA8 mRNA	PMID:35811015
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CA8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CA8 mRNA	PMID:35811015
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CA8 mRNA	PMID:30510588
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol affects the expression of CA8 mRNA	PMID:25321415
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of CA8 mRNA	PMID:30165855
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CA8 mRNA	PMID:38568856
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CA8 mRNA	PMID:22100608
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304709	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CA8 mRNA	PMID:33354967
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CA8 intron	PMID:30157460
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304709	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CA8 mRNA	PMID:31150632
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of CA8 mRNA	PMID:26272509
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA	PMID:27188386
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CA8 mRNA	PMID:28903495
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CA8 mRNA	PMID:38568856
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of CA8 mRNA	PMID:21714911
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CA8 3' UTR	PMID:27901495
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CA8 mRNA	PMID:22178795
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CA8 5' UTR; Benzo(a)pyrene results in increased methylation of CA8 promoter	PMID:27901495
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CA8 mRNA	PMID:23806026|PMID:25895662
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of CA8 mRNA	PMID:37690743
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304709	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CA8 mRNA	PMID:34492290
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of CA8 mRNA	PMID:27685785
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304709	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of CA8 mRNA	PMID:25181051
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304709	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CA8 mRNA	PMID:34947998
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to CA8 promoter]	PMID:20348232
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:34698	diethyl phthalate	decreases expression	ISO	RGD:1304709	E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of CA8 mRNA	PMID:32341500
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:34698	diethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C007379	[diethyl phthalate results in increased abundance of monoethyl phthalate] which results in decreased expression of CA8 mRNA	PMID:32341500
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CA8 mRNA	PMID:24449571
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CA8 mRNA	PMID:31533062
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CA8 mRNA	PMID:25979313
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CA8 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in decreased expression of CA8 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA	PMID:17183730|PMID:27188386
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CA8 mRNA	PMID:20106945
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312314	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CA8 mRNA	PMID:28973697
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CA8 mRNA	PMID:38832940
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CA8 mRNA	PMID:24935251
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of CA8 mRNA	PMID:26690555
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CA8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CA8 mRNA	PMID:35811015
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in decreased expression of CA8 mRNA	PMID:17183730
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CA8 mRNA	PMID:15336504
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of CA8 mRNA	PMID:20843944
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C581825	[diethyl phthalate results in increased abundance of monoethyl phthalate] which results in decreased expression of CA8 mRNA	PMID:32341500
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA	PMID:27188386
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1304709	E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CA8 mRNA	PMID:31826744
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of CA8 mRNA	PMID:26272509
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA	PMID:27188386
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CA8 mRNA	PMID:27188386
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CA8 mRNA	PMID:38568856
1312313	CA8	carbonic anhydrase 8 (inactive)	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312314	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CA8 mRNA	PMID:28973697
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ASXL2 gene	PMID:20938992
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of ASXL2 mRNA	PMID:24763279
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of ASXL2 protein	PMID:28073184
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ASXL2 mRNA	PMID:22378314
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ASXL2 gene	PMID:20938992
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ASXL2 mRNA	PMID:37042841
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ASXL2 mRNA	PMID:21179406
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:17627	ferroheme b	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20120814	CTD	MESH:D006418	Heme metabolite results in decreased expression of ASXL2 mRNA	PMID:19191707
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ASXL2 protein	PMID:37730182
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304710	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ASXL2 mRNA	PMID:33387578
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASXL2 mRNA	PMID:39836092
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASXL2 mRNA	PMID:35301059
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ASXL2 mRNA	PMID:28111341
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ASXL2 mRNA	PMID:19549813
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1614292	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ASXL2 mRNA	PMID:19770486
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ASXL2 gene	PMID:27153756
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ASXL2 mRNA	PMID:23649840
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ASXL2 mRNA	PMID:35430440
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:26355	heme b	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20140805	CTD	MESH:D006418	Heme metabolite results in decreased expression of ASXL2 mRNA	PMID:19191707
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ASXL2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ASXL2 gene	PMID:20938992|PMID:22206623
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASXL2 mRNA	PMID:39836092
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ASXL2 mRNA	PMID:19244175
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ASXL2 protein	PMID:35688186
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ASXL2 mRNA	PMID:27594783
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:27899	cisplatin	decreases phosphorylation	ISO	RGD:1614292	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased phosphorylation of ASXL2 protein	PMID:22006019
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ASXL2 mRNA	PMID:30912803
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614292	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASXL2 mRNA	PMID:21570461
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304710	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ASXL2 mRNA	PMID:32109520
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ASXL2 mRNA	PMID:33212167
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ASXL2 mRNA	PMID:30851411
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ASXL2 mRNA	PMID:38568856
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASXL2 mRNA	PMID:39836092
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ASXL2 mRNA	PMID:30453624
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614292	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASXL2 mRNA	PMID:22228805
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of ASXL2 mRNA	PMID:26014281
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ASXL2 mRNA	PMID:19150397|PMID:20018196
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ASXL2 mRNA	PMID:26238291
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ASXL2 mRNA	PMID:20458559
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614292	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ASXL2 gene	PMID:35295148
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1614292	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of ASXL2 mRNA	PMID:35598803
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:34093	1-Hydroxypyrene	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C033146	1-hydroxypyrene results in decreased expression of ASXL2 mRNA	PMID:21854004
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ASXL2 intron	PMID:30157460
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASXL2 mRNA	PMID:28628672
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ASXL2 mRNA	PMID:28392331
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASXL2 mRNA	PMID:28628672
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ASXL2 mRNA	PMID:37042841
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASXL2 mRNA	PMID:39836092
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASXL2 mRNA	PMID:35301059
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ASXL2 mRNA	PMID:28111341
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ASXL2 mRNA	PMID:19244175
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ASXL2 mRNA	PMID:40194260
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ASXL2 mRNA	PMID:28302478
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304710	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of ASXL2 mRNA	PMID:29427782
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ASXL2 mRNA	PMID:23179753|PMID:26272509
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL2 mRNA	PMID:27188386
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASXL2 mRNA	PMID:28628672
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ASXL2 mRNA	PMID:24935251
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614292	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ASXL2 mRNA	PMID:17562736
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASXL2 mRNA	PMID:39836092
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASXL2 mRNA	PMID:28628672
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ASXL2 mRNA	PMID:20458559
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ASXL2 mRNA; Nanotubes, Carbon results in decreased expression of ASXL2 mRNA	PMID:25554681
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASXL2 mRNA	PMID:39836092
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ASXL2 intron	PMID:30157460
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ASXL2 mRNA	PMID:22206623
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ASXL2 mRNA	PMID:22206623
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ASXL2 mRNA	PMID:30851411
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL2 mRNA	PMID:27188386
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ASXL2 gene]	PMID:28238834
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1614292	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ASXL2 mRNA	PMID:23091169
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1614292	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ASXL2 mRNA	PMID:31388691
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1614292	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of ASXL2 mRNA	PMID:38995820
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL2 mRNA	PMID:27188386
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of ASXL2 mRNA	PMID:26014281
1312315	ASXL2	ASXL transcriptional regulator 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1614292	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ASXL2 mRNA	PMID:28973697
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PPFIA3 mRNA	PMID:38218311
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623894	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PPFIA3 mRNA	PMID:33045310
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PPFIA3 mRNA	PMID:36189433
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:620054	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of PPFIA3 mRNA	PMID:36841081
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PPFIA3 mRNA	PMID:22378314
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1623894	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PPFIA3 mRNA	PMID:30319688
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1623894	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PPFIA3 mRNA	PMID:30319688
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of PPFIA3 mRNA	PMID:29581250
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1623894	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PPFIA3 mRNA	PMID:39241906
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PPFIA3 mRNA	PMID:30165855
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PPFIA3 mRNA	PMID:25510870
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PPFIA3 mRNA	PMID:36189433
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20210608	CTD	MESH:D004051	Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of PPFIA3 mRNA]	PMID:33484791
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PPFIA3 protein	PMID:37730182
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PPFIA3 mRNA	PMID:36139627
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:620054	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PPFIA3 mRNA	PMID:33387578
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PPFIA3 intron	PMID:30157460
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PPFIA3 mRNA	PMID:25510870
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PPFIA3 mRNA	PMID:25510870
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1623894	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of PPFIA3 gene	PMID:27776689
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPFIA3 mRNA	PMID:22206623
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPFIA3 gene	PMID:25304211
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PPFIA3 mRNA	PMID:26272509
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPFIA3 mRNA	PMID:27188386
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PPFIA3 protein	PMID:35688186
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of PPFIA3 protein	PMID:17075605
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1623894	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPFIA3 mRNA	PMID:15034205
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:620054	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPFIA3 mRNA	PMID:32109520|PMID:33387578
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PPFIA3 gene	PMID:28589171
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of PPFIA3 mRNA	PMID:39719251
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PPFIA3 5' UTR; Benzo(a)pyrene affects the methylation of PPFIA3 intron	PMID:27901495|PMID:30157460
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1623894	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PPFIA3 mRNA	PMID:15034205
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PPFIA3 3' UTR; Benzo(a)pyrene results in increased methylation of PPFIA3 promoter	PMID:27901495
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:620054	E	RGD:6480464	20120522	CTD	MESH:D000643	Ammonium Chloride affects the expression of PPFIA3 mRNA	PMID:16483693
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623894	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PPFIA3 gene	PMID:35295148
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1623894	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PPFIA3 gene	PMID:35295148
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:620054	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PPFIA3 mRNA	PMID:36041667
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PPFIA3 mRNA	PMID:25510870
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PPFIA3 mRNA	PMID:25510870
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1623894	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of PPFIA3 exon; bisphenol S affects the methylation of PPFIA3 gene	PMID:31683443|PMID:33297965
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623894	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of PPFIA3 mRNA	PMID:40203079
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:620054	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PPFIA3 mRNA	PMID:36041667
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:620054	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PPFIA3 mRNA	PMID:36041667
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of PPFIA3 gene	PMID:22964155
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of PPFIA3 mRNA; [Maneb co-treated with Paraquat] results in increased expression of PPFIA3 mRNA	PMID:36117858
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PPFIA3 mRNA	PMID:38568856
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1623894	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PPFIA3 mRNA	PMID:40194260
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PPFIA3 mRNA	PMID:28302478
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PPFIA3 mRNA	PMID:25979313
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PPFIA3 gene	PMID:29154799
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1623894	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of PPFIA3 mRNA	PMID:25123088
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PPFIA3 mRNA	PMID:38832940
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623894	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PPFIA3 mRNA	PMID:17562736
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:620054	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PPFIA3 mRNA	PMID:33387578
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1623894	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of PPFIA3 mRNA	PMID:29279043
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPFIA3 gene	PMID:25304211
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1623894	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PPFIA3 mRNA; Nanotubes, Carbon results in decreased expression of PPFIA3 mRNA	PMID:25554681
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1623894	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of PPFIA3 mRNA	PMID:26377693
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of PPFIA3 mRNA; [Maneb co-treated with Paraquat] results in increased expression of PPFIA3 mRNA	PMID:36117858
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PPFIA3 mRNA	PMID:21641980
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1623894	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of PPFIA3 protein	PMID:36851058
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1623894	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PPFIA3 mRNA	PMID:22206623
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PPFIA3 mRNA	PMID:22206623
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of PPFIA3 mRNA	PMID:36318118
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PPFIA3 mRNA	PMID:36139627
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPFIA3 mRNA	PMID:27188386
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PPFIA3 gene]	PMID:28238834
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1623894	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of PPFIA3 mRNA	PMID:31388691
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:620054	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PPFIA3 mRNA	PMID:21394737
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:620054	E	RGD:6480464	20241105	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PPFIA3 mRNA	PMID:37926403
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPFIA3 mRNA	PMID:27188386
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1623894	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of PPFIA3 mRNA; Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of PPFIA3 mRNA]	PMID:33484791
1312318	PPFIA3	PPFI scaffold protein A3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PPFIA3 mRNA	PMID:29301935
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312321	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ERAL1 mRNA	PMID:33045310
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312321	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ERAL1 mRNA	PMID:39241906
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ERAL1 mRNA	PMID:37042841
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312321	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ERAL1 mRNA	PMID:34319233
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304714	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ERAL1 mRNA	PMID:26577399
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ERAL1 protein	PMID:37730182
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304714	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ERAL1 mRNA	PMID:33387578
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304714	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ERAL1 protein	PMID:34915118
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ERAL1 mRNA	PMID:19549813
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304714	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ERAL1 mRNA	PMID:21396975
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312321	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ERAL1 mRNA	PMID:22206623
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ERAL1 gene	PMID:25304211
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304714	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ERAL1 mRNA	PMID:22298810
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312321	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ERAL1 mRNA	PMID:21570461
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304714	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ERAL1 mRNA	PMID:33387578
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312321	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with decitabine] results in increased expression of ERAL1 mRNA	PMID:15251184
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ERAL1 mRNA	PMID:33212167
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ERAL1 protein	PMID:35688186
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ERAL1 mRNA	PMID:38568856
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ERAL1 promoter	PMID:27901495
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ERAL1 mRNA]	PMID:32406909
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304714	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ERAL1 mRNA	PMID:30047161
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ERAL1 mRNA	PMID:19710929
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304714	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ERAL1 mRNA	PMID:25181051
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304714	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ERAL1 mRNA	PMID:34947998
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of ERAL1 protein	PMID:31945527
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312321	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ERAL1 mRNA	PMID:38685157
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERAL1 mRNA	PMID:28628672
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312321	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ERAL1 mRNA	PMID:21266533
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1304714	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of ERAL1 mRNA	PMID:22546817
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERAL1 mRNA	PMID:28628672
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1304714	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of ERAL1 mRNA	PMID:22546817
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312321	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ERAL1 mRNA	PMID:17585979
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304714	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ERAL1 mRNA	PMID:30047161
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERAL1 mRNA	PMID:28628672
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ERAL1 gene	PMID:25304211
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1304714	E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in decreased expression of ERAL1 mRNA	PMID:36653537
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312321	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ERAL1 mRNA	PMID:35436446
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERAL1 mRNA	PMID:28628672
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1312321	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of ERAL1 mRNA	PMID:15251184
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1312321	E	RGD:6480464	20191114	CTD	MESH:C014347	[Tetrachlorodibenzodioxin co-treated with Decitabine] results in increased expression of ERAL1 mRNA	PMID:15251184
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312321	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ERAL1 mRNA	PMID:22206623
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312321	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ERAL1 mRNA	PMID:22206623
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ERAL1 gene]	PMID:28238834
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1304714	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of ERAL1 mRNA	PMID:30047161
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312321	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ERAL1 mRNA	PMID:31388691
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312321	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of ERAL1 mRNA	PMID:30953684
1312320	ERAL1	Era like 12S mitochondrial rRNA chaperone 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304714	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ERAL1 mRNA	PMID:30047161
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312324	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CWF19L1 mRNA	PMID:20188158
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1304716	E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in increased expression of CWF19L1 protein	PMID:40631627
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CWF19L1 mRNA	PMID:22378314
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312324	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CWF19L1 mRNA	PMID:39298647
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1304716	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of CWF19L1 protein	PMID:40631627
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1304716	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of CWF19L1 protein	PMID:40631627
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304716	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CWF19L1 mRNA	PMID:33387578
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CWF19L1 mRNA	PMID:35301059
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CWF19L1 mRNA	PMID:19549813
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CWF19L1 protein	PMID:23301498
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CWF19L1 mRNA	PMID:23557933
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of CWF19L1 gene	PMID:31636367
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CWF19L1 mRNA	PMID:30851411
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CWF19L1 mRNA	PMID:29803840
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of CWF19L1 protein	PMID:38228842
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CWF19L1 mRNA]	PMID:32406909
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CWF19L1 mRNA	PMID:20458559
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304716	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CWF19L1 mRNA	PMID:34492290
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of CWF19L1 mRNA	PMID:38479592
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CWF19L1 mRNA	PMID:29275510
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304716	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CWF19L1 mRNA	PMID:25181051
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304716	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CWF19L1 mRNA	PMID:34947998
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304716	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CWF19L1 mRNA	PMID:36041667
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312324	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CWF19L1 mRNA	PMID:39298647
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312324	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CWF19L1 exon	PMID:33297965
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304716	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CWF19L1 mRNA	PMID:36041667
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CWF19L1 mRNA	PMID:28628672
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304716	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CWF19L1 mRNA	PMID:36041667
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1304716	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CWF19L1 mRNA	PMID:22546817
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CWF19L1 mRNA	PMID:28628672
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1304716	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CWF19L1 mRNA	PMID:22546817
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CWF19L1 mRNA	PMID:37042841
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CWF19L1 mRNA	PMID:35301059
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CWF19L1 mRNA	PMID:24449571
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CWF19L1 mRNA	PMID:28302478
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312324	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CWF19L1 mRNA	PMID:36331819
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304716	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of CWF19L1 mRNA	PMID:38685447|PMID:41580965
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1312324	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of CWF19L1 mRNA	PMID:25123088
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CWF19L1 mRNA	PMID:28628672
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1304716	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of CWF19L1 protein	PMID:40631627
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312324	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CWF19L1 mRNA	PMID:17562736
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of CWF19L1 mRNA	PMID:40706910
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CWF19L1 mRNA	PMID:28628672
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CWF19L1 mRNA	PMID:20458559
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312324	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CWF19L1 mRNA; Nanotubes, Carbon results in decreased expression of CWF19L1 mRNA	PMID:25620056
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304716	E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of CWF19L1 mRNA	PMID:38685447|PMID:41580965
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304716	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of CWF19L1 mRNA	PMID:24793618
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of CWF19L1 mRNA	PMID:20977926
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312324	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CWF19L1 mRNA	PMID:23608068
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CWF19L1 protein	PMID:32959892
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312324	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of CWF19L1 protein	PMID:36851058
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CWF19L1 mRNA	PMID:30851411
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:81980	triticonazole	decreases expression	ISO	RGD:1304716	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of CWF19L1 mRNA	PMID:36084822
1312323	CWF19L1	CWF19 like cell cycle control factor 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312324	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CWF19L1 mRNA	PMID:28973697
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C014638	beta-lapachone results in decreased expression of COA8 mRNA	PMID:38218311
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1620831	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of COA8 mRNA	PMID:39298647
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COA8 mRNA	PMID:37042841
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304719	E	RGD:6480464	20221206	CTD	MESH:D005839	Gentamicins results in increased expression of COA8 mRNA	PMID:33387578
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of COA8 mRNA	PMID:23369406
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COA8 mRNA	PMID:37236586
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of COA8 mRNA	PMID:19549813
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of COA8 polyA tail	PMID:30157460
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of COA8 mRNA	PMID:23649840
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of COA8 mRNA	PMID:22206623
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of COA8 mRNA	PMID:40504410
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of COA8 mRNA	PMID:28903495
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1620831	E	RGD:6480464	20200331	CTD	MESH:D014414	Tungsten results in increased expression of COA8 mRNA	PMID:30912803
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304719	E	RGD:6480464	20221206	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COA8 mRNA	PMID:33387578
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of COA8 mRNA	PMID:29803840
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of COA8 mRNA	PMID:29432896
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of COA8 mRNA	PMID:38568856
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of COA8 mRNA	PMID:40504410
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of COA8 polyA tail	PMID:30157460
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to COA8 mRNA]	PMID:32406909
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of COA8 gene	PMID:31601247
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1620831	E	RGD:6480464	20200331	CTD	MESH:C006780	bisphenol A results in decreased methylation of COA8 promoter	PMID:27312807
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304719	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of COA8 mRNA	PMID:25181051|PMID:30816183
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1620831	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of COA8 mRNA	PMID:37894381
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of COA8 gene	PMID:31601247
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304719	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of COA8 mRNA	PMID:36041667
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1620831	E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S affects the methylation of COA8 gene	PMID:31683443
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1620831	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of COA8 mRNA	PMID:39298647|PMID:40203079
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1620831	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of COA8 exon	PMID:33297965
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304719	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of COA8 mRNA	PMID:36041667
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1620831	E	RGD:6480464	20200331	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of COA8 mRNA	PMID:26377693
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304719	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of COA8 mRNA	PMID:36041667
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1620831	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of COA8 mRNA	PMID:37019170
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of COA8 gene	PMID:22964155
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1620831	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of COA8 mRNA	PMID:34813904
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COA8 mRNA	PMID:37236586
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of COA8 mRNA	PMID:31533062
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of COA8 mRNA	PMID:40419075
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of COA8 mRNA	PMID:20106945|PMID:25562108
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of COA8 mRNA	PMID:29523930
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of COA8 mRNA	PMID:40504410
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of COA8 mRNA	PMID:18175754
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620831	E	RGD:6480464	20200331	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of COA8 mRNA; Nanotubes, Carbon results in decreased expression of COA8 mRNA	PMID:25554681
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of COA8 mRNA	PMID:31758290
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1620831	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of COA8 mRNA	PMID:22206623
1312327	COA8	cytochrome c oxidase assembly factor 8	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1620831	E	RGD:6480464	20200331	CTD	MESH:C057693	Troglitazone results in decreased expression of COA8 mRNA	PMID:28973697
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1312329	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of IKZF4 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of IKZF4 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of IKZF4 mRNA	PMID:16931933
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312329	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of IKZF4 mRNA	PMID:37995155
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of IKZF4 mRNA	PMID:26079696
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of IKZF4 mRNA	PMID:22378314
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1312329	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in decreased expression of IKZF4 mRNA	PMID:15513904
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312329	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of IKZF4 mRNA	PMID:39298647
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:2319157	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of IKZF4 mRNA	PMID:33387578
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1312329	E	RGD:6480464	20250114	CTD	MESH:D001554	Benzene results in increased expression of IKZF4 mRNA	PMID:37084897
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312329	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of IKZF4 mRNA	PMID:39922521
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312329	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of IKZF4 mRNA	PMID:39922521
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of IKZF4 mRNA	PMID:31163220
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:2319157	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of IKZF4 mRNA	PMID:26577399
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of IKZF4 protein	PMID:37730182
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312329	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IKZF4 mRNA	PMID:36331819
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of IKZF4 protein	PMID:35688186
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312329	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of IKZF4 mRNA	PMID:28960355
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of IKZF4 mRNA	PMID:23557933
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312329	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of IKZF4 mRNA	PMID:40618947
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312329	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of IKZF4 mRNA	PMID:32937126
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312329	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of IKZF4 mRNA	PMID:37682722
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IKZF4 3' UTR; Benzo(a)pyrene results in increased methylation of IKZF4 exon	PMID:27901495
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312329	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IKZF4 mRNA	PMID:27858113
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:2319157	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of IKZF4 mRNA	PMID:32479839
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312329	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IKZF4 gene	PMID:35295148
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312329	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of IKZF4 promoter	PMID:27334623
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2319157	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of IKZF4 mRNA	PMID:30816183
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1312329	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of IKZF4 mRNA	PMID:26377693
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1312329	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IKZF4 mRNA	PMID:27858113
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312329	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of IKZF4 mRNA	PMID:37019170
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:2319157	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of IKZF4 mRNA	PMID:32680482
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IKZF4 mRNA	PMID:37042841
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:35299	dibenz[a,h]anthracene	affects expression	ISO	RGD:1312329	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene affects the expression of IKZF4 mRNA	PMID:26377693
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:2319157	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of IKZF4 mRNA	PMID:30723492
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:2319157	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of IKZF4 mRNA	PMID:24386269
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:37918	fluorescein 5-isothiocyanate	affects binding	EXP		E	RGD:6480464	20180116	CTD	MESH:D016650	Fluorescein-5-isothiocyanate binds to IKZF4 protein	PMID:27129696
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of IKZF4 mRNA	PMID:28302478
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312329	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IKZF4 mRNA	PMID:36331819
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IKZF4 mRNA	PMID:25979313
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of IKZF4 mRNA	PMID:23179753|PMID:28001369
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of IKZF4 gene	PMID:29154799
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:41607	crotonaldehyde	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in decreased expression of IKZF4 mRNA	PMID:20471460
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312329	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of IKZF4 mRNA	PMID:39922521
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:44032	indinavir	multiple interactions	ISO	RGD:1312329	E	RGD:6480464	20120412	CTD	MESH:D019469	[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of IKZF4 mRNA	PMID:16931933
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312329	E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate affects the expression of IKZF4 mRNA	PMID:18502557
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312329	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IKZF4 mRNA	PMID:17562736
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312329	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IKZF4 mRNA; Nanotubes, Carbon results in increased expression of IKZF4 mRNA	PMID:25554681
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1312329	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IKZF4 mRNA	PMID:27858113
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1312329	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of IKZF4 mRNA	PMID:27858113
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1312329	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of IKZF4 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of IKZF4 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of IKZF4 mRNA	PMID:16931933
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:63621	saquinavir	multiple interactions	ISO	RGD:1312329	E	RGD:6480464	20120412	CTD	MESH:D019258	[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of IKZF4 mRNA	PMID:16931933
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312329	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of IKZF4 mRNA	PMID:22206623
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1312329	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of IKZF4 mRNA	PMID:27858113
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312329	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of IKZF4 mRNA	PMID:23091169
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312329	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of IKZF4 mRNA	PMID:38648751
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of IKZF4 mRNA	PMID:26079696
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:2319157	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of IKZF4 mRNA	PMID:36843608
1312328	IKZF4	IKAROS family zinc finger 4	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of IKZF4 mRNA	PMID:29301935
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CADM4 mRNA	PMID:26272509
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA	PMID:27188386
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312332	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CADM4 mRNA	PMID:20188158
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of CADM4 mRNA	PMID:24763279
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312332	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CADM4 mRNA	PMID:30319688
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CADM4 mRNA	PMID:30165855
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA	PMID:37992649
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA	PMID:37992649
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CADM4 protein	PMID:37730182
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CADM4 mRNA	PMID:36331819
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CADM4 mRNA	PMID:39836092
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304722	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CADM4 mRNA	PMID:31150632
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312332	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of CADM4 mRNA	PMID:25629700
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CADM4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CADM4 mRNA	PMID:39836092
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA]	PMID:37992649
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312332	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CADM4 mRNA	PMID:28960355
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304722	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of CADM4 mRNA	PMID:31881176
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312332	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CADM4 mRNA	PMID:28922406
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304722	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CADM4 mRNA	PMID:26033743
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1304722	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CADM4 mRNA	PMID:26033743
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312332	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of CADM4 mRNA	PMID:39631538
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA	PMID:37992649
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA]	PMID:37992649
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CADM4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CADM4 mRNA	PMID:39836092
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CADM4 intron	PMID:30157460
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304722	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CADM4 mRNA	PMID:26033743
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1304722	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CADM4 mRNA	PMID:26033743
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312332	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CADM4 mRNA	PMID:27131904
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312332	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CADM4 promoter	PMID:35295148
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312332	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CADM4 mRNA	PMID:23557971
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304722	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CADM4 mRNA	PMID:34492290
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312332	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CADM4 mRNA	PMID:18648102
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304722	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CADM4 mRNA	PMID:25181051
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304722	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CADM4 mRNA	PMID:30816183|PMID:34947998|PMID:38750585
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312332	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CADM4 mRNA	PMID:32156529
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312332	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of CADM4 mRNA	PMID:26682919
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312332	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CADM4 gene	PMID:31683443
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312332	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CADM4 mRNA	PMID:39298647
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312332	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CADM4 intron	PMID:28392331
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312332	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CADM4 mRNA	PMID:37019170
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CADM4 mRNA	PMID:37042841
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304722	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CADM4 mRNA	PMID:35163327
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CADM4 mRNA	PMID:39836092
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304722	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CADM4 mRNA	PMID:35163327
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312332	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of CADM4 mRNA	PMID:28962523
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CADM4 mRNA	PMID:31533062
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CADM4 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CADM4 mRNA	PMID:36331819
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CADM4 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CADM4 gene	PMID:29154799
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CADM4 mRNA	PMID:23179753|PMID:27188386
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312332	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of CADM4 mRNA	PMID:21427059
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA	PMID:27188386
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312332	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CADM4 mRNA	PMID:37992649
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CADM4 mRNA	PMID:28542535
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CADM4 mRNA	PMID:24935251|PMID:26272509
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA	PMID:27188386
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CADM4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CADM4 mRNA	PMID:39836092
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312332	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CADM4 mRNA; Nanotubes, Carbon results in increased expression of CADM4 mRNA	PMID:25620056
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CADM4 protein	PMID:32959892
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CADM4 mRNA	PMID:39836092
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CADM4 mRNA	PMID:15336504
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1312332	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of CADM4 mRNA	PMID:20003209
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CADM4 mRNA	PMID:31758290
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CADM4 mRNA	PMID:22714537
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA	PMID:27188386
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312332	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CADM4 mRNA	PMID:23091169
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304722	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CADM4 mRNA	PMID:32109520
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312332	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CADM4 mRNA	PMID:30294300
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of CADM4 mRNA	PMID:26079696
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of CADM4 mRNA	PMID:26272509
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA	PMID:27188386
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CADM4 mRNA	PMID:27188386
1312331	CADM4	cell adhesion molecule 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312332	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CADM4 mRNA	PMID:27131904
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:132612	monobenzyl phthalate	decreases methylation	EXP		E	RGD:6480464	20260303	CTD	MESH:C103325	mono-benzyl phthalate results in decreased methylation of SOX21 gene	PMID:35032864
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312335	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SOX21 mRNA	PMID:20188158
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SOX21 mRNA	PMID:33359661
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304724	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of SOX21 mRNA	PMID:26496021
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SOX21 mRNA	PMID:31163220
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SOX21 mRNA	PMID:32525701
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SOX21 mRNA	PMID:26272509
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX21 mRNA	PMID:27188386
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:27889	lead(0)	increases methylation	ISO	RGD:1312335	E	RGD:6480464	20250311	CTD	MESH:D007854	Lead results in increased methylation of SOX21 gene	PMID:38833407
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of SOX21 mRNA	PMID:23300844
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SOX21 mRNA	PMID:27392435
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of SOX21 promoter	PMID:22847954
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312335	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SOX21 mRNA	PMID:24058054
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312335	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SOX21 mRNA	PMID:31961203
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:28680	cytarabine	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of SOX21 mRNA	PMID:21198554
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SOX21 exon	PMID:27901495
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SOX21 mRNA	PMID:22316170
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312335	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SOX21 mRNA	PMID:27195522
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SOX21 promoter	PMID:27901495
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312335	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SOX21 mRNA]	PMID:22228805
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:3020	benzalkonium chloride	multiple interactions	ISO	RGD:1312335	E	RGD:6480464	20190219	CTD	MESH:D001548	[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of SOX21 mRNA	PMID:30171875
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SOX21 mRNA	PMID:25895662
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of SOX21 mRNA	PMID:35984750
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312335	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SOX21 enhancer; titanium dioxide results in decreased methylation of SOX21 gene	PMID:35295148
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312335	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SOX21 gene	PMID:35295148
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312335	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SOX21 promoter	PMID:27334623
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C006780	bisphenol A results in decreased expression of SOX21 mRNA	PMID:33476716
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304724	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of SOX21 mRNA	PMID:26496021
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SOX21 mRNA	PMID:33476716
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:34107	1-nitropyrene	decreases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in decreased expression of SOX21 mRNA	PMID:19041380
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SOX21 mRNA	PMID:22941251
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of SOX21 promoter	PMID:22847954
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of SOX21 promoter	PMID:22847954
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312335	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SOX21 mRNA	PMID:17562736
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SOX21 mRNA	PMID:32525701
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SOX21 mRNA	PMID:23300844
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SOX21 mRNA	PMID:31758290
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312335	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SOX21 mRNA	PMID:22206623
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SOX21 mRNA	PMID:37199045
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX21 mRNA	PMID:27188386
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1304724	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SOX21 mRNA	PMID:23914054
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SOX21 mRNA	PMID:32525701
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304724	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SOX21 mRNA	PMID:36843608
1312334	SOX21	SRY-box transcription factor 21	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SOX21 mRNA	PMID:27188386
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1304725	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of DNAJB1 mRNA	PMID:21551480
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312337	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DNAJB1 mRNA	PMID:33045310
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20120918	CTD	MESH:D014212	Tretinoin results in decreased expression of DNAJB1 mRNA	PMID:20117194
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of DNAJB1 mRNA	PMID:33167477
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:15368	acrolein	increases expression	ISO	RGD:1304725	E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein results in increased expression of DNAJB1 mRNA	PMID:38090360
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJB1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJB1 mRNA	PMID:32699268
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312337	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DNAJB1 mRNA	PMID:30319688
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16240	hydrogen peroxide	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	DNAJB1 protein results in decreased susceptibility to Hydrogen Peroxide	PMID:11359866
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312337	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DNAJB1 mRNA	PMID:15919760|PMID:39241906
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of DNAJB1 mRNA	PMID:35877022
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DNAJB1 mRNA	PMID:20106945
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DNAJB1 mRNA	PMID:37042841
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16664	albendazole	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D015766	[Ivermectin co-treated with Albendazole] results in increased expression of DNAJB1 mRNA	PMID:16861626
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16716	benzene	decreases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in decreased expression of DNAJB1 mRNA	PMID:19162166
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:167162	L-ascorbic acid 2-phosphate	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C011669	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA	PMID:34480604
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D002635	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of DNAJB1 mRNA	PMID:17572062
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:16990	bilirubin IXalpha	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin affects the expression of DNAJB1 mRNA	PMID:20196124
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of DNAJB1 mRNA	PMID:18037150
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DNAJB1 mRNA	PMID:21179406
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of DNAJB1 mRNA	PMID:17945193
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of DNAJB1 mRNA	PMID:24356939
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of DNAJB1 mRNA	PMID:33647349
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1304725	E	RGD:6480464	20120918	CTD	MESH:D014050	Toluene results in decreased expression of DNAJB1 mRNA	PMID:22166486
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1304725	E	RGD:6480464	20120918	CTD	MESH:D014050	Toluene results in increased expression of DNAJB1 mRNA	PMID:22166486
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17580	linalool	increases expression	ISO	RGD:1304725	E	RGD:6480464	20130514	CTD	MESH:C018584	linalool results in increased expression of DNAJB1 mRNA	PMID:20536181
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C031927	hydroquinone results in increased expression of DNAJB1 mRNA	PMID:15452088
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17650	cortisol	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:D006854	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DNAJB1 mRNA	PMID:34480604
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006000	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:177406	Bardoxolone methyl	affects expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C445068	bardoxolone methyl affects the expression of DNAJB1 mRNA	PMID:34480604
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DNAJB1 mRNA	PMID:21318169
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1304725	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DNAJB1 mRNA	PMID:21318169
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312337	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DNAJB1 mRNA	PMID:33754040
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Haloperidol] results in decreased expression of DNAJB1 protein	PMID:34122009
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of DNAJB1 protein	PMID:37730182
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304725	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DNAJB1 mRNA	PMID:33387578
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DNAJB1 mRNA	PMID:28818685
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB1 mRNA	PMID:39836092
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304725	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of DNAJB1 protein	PMID:34915118
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of DNAJB1 mRNA; Cadmium results in increased expression of DNAJB1 protein	PMID:16020198|PMID:21120746|PMID:24284285|PMID:28860664|PMID:29993192|PMID:33559965
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1304725	E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in increased expression of DNAJB1 protein	PMID:16729991
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB1 mRNA	PMID:31738976|PMID:35301059
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304725	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB1 mRNA	PMID:39012411
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB1 mRNA	PMID:37236586
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:232796	cadmium acetate	increases expression	EXP		E	RGD:6480464	20250107	CTD	MESH:C028031	cadmium acetate results in increased expression of DNAJB1 mRNA	PMID:18155341
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DNAJB1 mRNA	PMID:19549813
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DNAJB1 gene	PMID:27153756
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DNAJB1 mRNA	PMID:23649840
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:25712	organoselenium compound	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:D016566	[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB1 mRNA	PMID:25167922
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJB1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJB1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of DNAJB1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DNAJB1 mRNA	PMID:32699268|PMID:35430440
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DNAJB1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DNAJB1 protein	PMID:38598786
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DNAJB1 mRNA	PMID:18593933
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304725	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DNAJB1 mRNA	PMID:18346771|PMID:31150632
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312337	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DNAJB1 mRNA	PMID:25270620|PMID:27339419|PMID:31919559
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006002	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB1 mRNA; [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of DNAJB1 mRNA	PMID:35809665|PMID:39836092
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D000966	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DNAJB1 mRNA	PMID:32076005
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DNAJB1 protein	PMID:38460933
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1304725	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA	PMID:33854195
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27810	resorcinol	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in decreased expression of DNAJB1 mRNA	PMID:22623647
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304725	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of DNAJB1 mRNA	PMID:31881176
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20200211	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DNAJB1 mRNA]	PMID:31298478
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of DNAJB1 mRNA	PMID:40618947
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of DNAJB1 mRNA	PMID:27392435
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of DNAJB1 mRNA	PMID:23195993
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312337	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DNAJB1 mRNA	PMID:21570461
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304725	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNAJB1 mRNA	PMID:21215274
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DNAJB1 mRNA	PMID:20106945|PMID:21632981
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304725	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DNAJB1 mRNA	PMID:33387578
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNAJB1 mRNA	PMID:17942748
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C004925	methylmercuric chloride results in increased expression of DNAJB1 mRNA	PMID:24356939|PMID:28001369
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of DNAJB1 mRNA	PMID:30851411
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA	PMID:27188386
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of DNAJB1 mRNA	PMID:23649840
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DNAJB1 mRNA	PMID:32763439
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of DNAJB1 mRNA; [Disulfiram binds to Copper] which results in decreased expression of DNAJB1 mRNA; [NSC 689534 binds to Copper] which results in increased expression of DNAJB1 mRNA; [Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB1 mRNA	PMID:20971185|PMID:24690739|PMID:25167922|PMID:35809665
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DNAJB1 mRNA	PMID:29803840
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of DNAJB1 mRNA	PMID:15033991
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D003840	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of DNAJB1 mRNA	PMID:20044591
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [elesclomol results in increased expression of DNAJB1 mRNA]	PMID:18723479
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:D001205	[[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA	PMID:34480604
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DNAJB1 mRNA; sodium arsenite results in increased expression of DNAJB1 protein	PMID:12679051|PMID:12760830|PMID:16729991|PMID:24516582|PMID:38568856
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1304725	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DNAJB1 protein	PMID:16729991
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312337	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DNAJB1 mRNA	PMID:16014739|PMID:25270620
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB1 mRNA; [sodium arsenite co-treated with lead acetate] results in increased expression of DNAJB1 protein; [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of DNAJB1 mRNA	PMID:32076005|PMID:38072110|PMID:39836092
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014415	Tunicamycin results in decreased expression of DNAJB1 mRNA	PMID:20196124
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of DNAJB1 mRNA; Benzo(a)pyrene results in increased expression of DNAJB1 mRNA	PMID:24356939
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNAJB1 mRNA	PMID:19770486|PMID:21569818|PMID:21715664
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of DNAJB1 mRNA	PMID:33053406
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29866	arsenite(3-)	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite results in increased expression of DNAJB1 mRNA	PMID:32406909
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C015001	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of DNAJB1 mRNA; arsenite promotes the reaction [G3BP1 protein binds to DNAJB1 mRNA]	PMID:32076005|PMID:32406909
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of DNAJB1 mRNA; [Disulfiram binds to Copper] which results in decreased expression of DNAJB1 mRNA; [NSC 689534 binds to Copper] which results in increased expression of DNAJB1 mRNA; [Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB1 mRNA	PMID:20971185|PMID:24690739|PMID:25167922|PMID:35809665
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DNAJB1 mRNA	PMID:18593933
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30297	antimonite	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C061374	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DNAJB1 mRNA	PMID:32076005
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of DNAJB1 mRNA	PMID:26014281|PMID:28959546
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DNAJB1 mRNA	PMID:25351596
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DNAJB1 mRNA	PMID:19073995
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DNAJB1 mRNA; Arsenic Trioxide results in increased expression of DNAJB1 protein	PMID:19417148|PMID:20458559|PMID:20724260|PMID:24356939
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	KNK 437 inhibits the reaction [Arsenic Trioxide results in increased expression of DNAJB1 protein]	PMID:20724260
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of DNAJB1 mRNA	PMID:35984750
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of DNAJB1 mRNA	PMID:21829687
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in increased expression of DNAJB1 protein	PMID:38072110
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32130	silver(1+) nitrate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in increased expression of DNAJB1 mRNA	PMID:22831968
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1304725	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of DNAJB1 mRNA	PMID:24136188
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1304725	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of DNAJB1 mRNA	PMID:30012374
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of DNAJB1 mRNA	PMID:23557971|PMID:27760801|PMID:29128614|PMID:29264374
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312337	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DNAJB1 gene	PMID:35295148
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312337	E	RGD:6480464	20130611	CTD	MESH:C009495	titanium dioxide results in increased expression of DNAJB1 mRNA	PMID:31298478
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312337	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of DNAJB1 gene	PMID:35295148
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20200211	CTD	MESH:C009495	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DNAJB1 mRNA]	PMID:31298478
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32497	thioacetamide	increases methylation	ISO	RGD:1304725	E	RGD:6480464	20170516	CTD	MESH:D013853	Thioacetamide results in increased methylation of DNAJB1 promoter	PMID:27914986
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of DNAJB1 mRNA	PMID:17426115
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1304725	E	RGD:6480464	20120717	CTD	MESH:C006253	pirinixic acid results in increased expression of DNAJB1 mRNA	PMID:19162173|PMID:21318169
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of DNAJB1 mRNA	PMID:18301758|PMID:21318169
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of DNAJB1 mRNA]	PMID:21318169
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312337	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of DNAJB1 mRNA	PMID:28472532
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304725	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DNAJB1 mRNA	PMID:25181051|PMID:30903817
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJB1 protein	PMID:31675489
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304725	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DNAJB1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312337	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DNAJB1 mRNA	PMID:33221593|PMID:39742910
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of DNAJB1 mRNA	PMID:24752500
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312337	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DNAJB1 mRNA	PMID:39298647
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of DNAJB1 mRNA	PMID:28628672
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of DNAJB1 mRNA	PMID:26377693
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1304725	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DNAJB1 mRNA	PMID:20691718
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312337	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DNAJB1 mRNA	PMID:37019170
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1304725	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA	PMID:33854195
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34682	diazinon	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D003976	Diazinon results in increased expression of DNAJB1 mRNA	PMID:24356939
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of DNAJB1 gene	PMID:22964155
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304725	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DNAJB1 mRNA	PMID:21266533
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34696	dieldrin	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D004026	Dieldrin results in increased expression of DNAJB1 mRNA	PMID:31068361
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DNAJB1 protein	PMID:38598786
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of DNAJB1 mRNA	PMID:28628672
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of DNAJB1 mRNA	PMID:18691550
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304725	E	RGD:6480464	20120412	CTD	MESH:D004052	[Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of DNAJB1 mRNA	PMID:18253720
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D004052	IKBKB protein inhibits the reaction [Diethylnitrosamine results in decreased expression of DNAJB1 mRNA]	PMID:18691550
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34905	paraquat	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D010269	DNAJB1 protein results in decreased susceptibility to Paraquat	PMID:11359866
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:34936	propanil	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D011411	Propanil results in increased expression of DNAJB1 mRNA	PMID:24356939
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DNAJB1 mRNA	PMID:37042841
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB1 mRNA	PMID:39836092
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of DNAJB1 mRNA	PMID:26377693
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304725	E	RGD:6480464	20121009	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of DNAJB1 mRNA	PMID:20551477
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35455	1-naphthyl isothiocyanate	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D015058	[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of DNAJB1 mRNA	PMID:27344345
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DNAJB1 mRNA	PMID:38382870
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNAJB1 mRNA	PMID:38568856
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304725	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNAJB1 mRNA; Cadmium Chloride results in increased expression of DNAJB1 protein	PMID:16729991|PMID:19010381|PMID:22110744
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB1 mRNA	PMID:31738976|PMID:35301059
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304725	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB1 mRNA	PMID:39012411
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB1 mRNA	PMID:37236586
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of DNAJB1 mRNA	PMID:25868421
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1304725	E	RGD:6480464	20120717	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of DNAJB1 mRNA	PMID:19162173|PMID:21318169
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of DNAJB1 mRNA	PMID:19320972|PMID:19376846|PMID:24356939
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304725	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of DNAJB1 mRNA	PMID:24386269
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D005999	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312337	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of DNAJB1 mRNA	PMID:18353800
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJB1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJB1 mRNA	PMID:32699268
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of DNAJB1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DNAJB1 mRNA]	PMID:17585979
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of DNAJB1 mRNA	PMID:40434365
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DNAJB1 mRNA	PMID:31533062
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of DNAJB1 mRNA	PMID:26352163
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312337	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of DNAJB1 mRNA	PMID:23125180
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016104	sodium bichromate results in decreased expression of DNAJB1 mRNA	PMID:12760830
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of DNAJB1 mRNA	PMID:29154799
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4027	cyclophosphamide	affects expression	ISO	RGD:1304725	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide affects the expression of DNAJB1 mRNA	PMID:18246545
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D003520	Cyclophosphamide metabolite results in increased expression of DNAJB1 mRNA	PMID:24356939
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DNAJB1 mRNA	PMID:20106945|PMID:25562108|PMID:32152650
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1304725	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA	PMID:33854195
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:41607	crotonaldehyde	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in increased expression of DNAJB1 mRNA	PMID:20471460
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312337	E	RGD:6480464	20120717	CTD	MESH:D013629	Tamoxifen affects the expression of DNAJB1 mRNA	PMID:17555576|PMID:20937368
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of DNAJB1 mRNA	PMID:28628672
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:42223	emodin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004642	Emodin results in increased expression of DNAJB1 mRNA	PMID:16045814
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4356	desferrioxamine B	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20250708	CTD	MESH:D003676	Deferoxamine results in decreased expression of DNAJB1 protein	PMID:39643152
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of DNAJB1 mRNA	PMID:33512557
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of DNAJB1 mRNA	PMID:18502557
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1304725	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of DNAJB1 mRNA	PMID:24136188
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DNAJB1 mRNA; Okadaic Acid results in increased expression of DNAJB1 protein	PMID:38832940
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1304725	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA	PMID:33854195
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in increased expression of DNAJB1 mRNA	PMID:19606018
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1304725	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DNAJB1 mRNA	PMID:18246545
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DNAJB1 mRNA	PMID:15606129|PMID:17562736
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAJB1 mRNA	PMID:21420995|PMID:22230336|PMID:29067470
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304725	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAJB1 mRNA	PMID:17202762|PMID:18246545|PMID:18346771|PMID:33387578
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120501	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAJB1 mRNA	PMID:11264010|PMID:12540782|PMID:18544908
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of DNAJB1 mRNA; O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of DNAJB1 mRNA]; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DNAJB1 mRNA]	PMID:12540782|PMID:17585979
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of DNAJB1 mRNA	PMID:24690739
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DNAJB1 mRNA	PMID:25351596
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DNAJB1 protein	PMID:38460933
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB1 mRNA; [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of DNAJB1 mRNA	PMID:35809665|PMID:39836092
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of DNAJB1 mRNA	PMID:22077320
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of DNAJB1 mRNA	PMID:24752500
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of DNAJB1 mRNA	PMID:31675489
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20190312	CTD	MESH:C016766	[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of DNAJB1 mRNA	PMID:30529165
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304725	E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in increased expression of DNAJB1 mRNA	PMID:31464424
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1312337	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of DNAJB1 mRNA	PMID:35436446
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1304725	E	RGD:6480464	20180515	CTD	MESH:C109476	epoxiconazole results in increased expression of DNAJB1 mRNA	PMID:29038839
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DNAJB1 mRNA	PMID:17555576
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DNAJB1 mRNA	PMID:17942748
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D004997	[Ethinyl Estradiol co-treated with Cholic Acids] affects the expression of DNAJB1 mRNA	PMID:27344345
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNAJB1 mRNA	PMID:17942748
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of DNAJB1 mRNA	PMID:17211630
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA	PMID:27188386
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1304725	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of DNAJB1 mRNA	PMID:18299717
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of DNAJB1 mRNA	PMID:28628672
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49668	gefitinib	increases secretion	EXP		E	RGD:6480464	20210406	CTD	MESH:C419708	Gefitinib metabolite results in increased secretion of DNAJB1 protein	PMID:33132241
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DNAJB1 mRNA; Arsenic Trioxide results in increased expression of DNAJB1 protein	PMID:19417148|PMID:20458559|PMID:20724260|PMID:24356939
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	KNK 437 inhibits the reaction [Arsenic Trioxide results in increased expression of DNAJB1 protein]	PMID:20724260
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1304725	E	RGD:6480464	20120412	CTD	MESH:D011345	[Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of DNAJB1 mRNA	PMID:18253720
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:50161	motexafin gadolinium	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of DNAJB1 mRNA	PMID:16357179
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium inhibits the reaction [Zinc Acetate results in decreased expression of DNAJB1 mRNA]	PMID:16357179
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:50292	cadmium sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate results in increased expression of DNAJB1 mRNA	PMID:12064557
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DNAJB1 mRNA	PMID:25620056
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312337	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DNAJB1 mRNA	PMID:25554681
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of DNAJB1 mRNA	PMID:40234311
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DNAJB1 mRNA	PMID:35964746
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304725	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DNAJB1 mRNA	PMID:24136188
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of DNAJB1 mRNA	PMID:26377693
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of DNAJB1 mRNA	PMID:15509775
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of DNAJB1 mRNA	PMID:31629900
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:5385	gliotoxin	increases expression	ISO	RGD:1304725	E	RGD:6480464	20120412	CTD	MESH:D005912	Gliotoxin results in increased expression of DNAJB1 mRNA	PMID:18346771
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:5613	haloperidol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in decreased expression of DNAJB1 protein	PMID:34122009
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1304725	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA	PMID:33854195
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DNAJB1 protein	PMID:32959892
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:6078	ivermectin	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D007559	[Ivermectin co-treated with Albendazole] results in increased expression of DNAJB1 mRNA	PMID:16861626
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of DNAJB1 mRNA	PMID:19606018
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:62878	XAV939	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C544261	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA	PMID:34480604
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:62984	zinc acetate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in decreased expression of DNAJB1 mRNA	PMID:16357179
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:62984	zinc acetate	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	motexafin gadolinium inhibits the reaction [Zinc Acetate results in decreased expression of DNAJB1 mRNA]	PMID:16357179
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB1 mRNA	PMID:39836092
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:63934	bathocuproine disulfonic acid	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:C028559	[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of DNAJB1 mRNA	PMID:15477007
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:63952	arsenic trichloride	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C050510	[Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of DNAJB1 mRNA	PMID:35809665
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:6402	leflunomide	affects expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide affects the expression of DNAJB1 mRNA	PMID:28988120
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1304725	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of DNAJB1 mRNA	PMID:24136188
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of DNAJB1 mRNA	PMID:15336504
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D015655	DNAJB1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SNCA mRNA]; DNAJB1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of SNCA protein]	PMID:16678164
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of DNAJB1 mRNA	PMID:37939859
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1304725	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of DNAJB1 mRNA	PMID:19564919
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1304725	E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of DNAJB1 mRNA; SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of DNAJB1 mRNA]	PMID:19564919
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:68508	diethyl maleate	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C014476	diethyl maleate results in increased expression of DNAJB1 mRNA	PMID:33545341|PMID:34480604
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D002185	Cannabidiol results in increased expression of DNAJB1 mRNA	PMID:26504004|PMID:31518892
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of DNAJB1 mRNA	PMID:31758290
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:73297	SCH 23390	multiple interactions	ISO	RGD:1304725	E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of DNAJB1 mRNA; SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of DNAJB1 mRNA]	PMID:19564919
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312337	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of DNAJB1 mRNA	PMID:22206623
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of DNAJB1 mRNA; [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DNAJB1 protein	PMID:34480604|PMID:37664457
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:C051752	nefazodone results in increased expression of DNAJB1 mRNA	PMID:32152650
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1304725	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of DNAJB1 mRNA	PMID:24136188
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:7494	nefazodone	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:C051752	[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of DNAJB1 mRNA	PMID:32152650
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1312337	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of DNAJB1 mRNA; benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of DNAJB1 protein	PMID:15525353|PMID:25566086
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:75261	arotinoid acid	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C038864	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DNAJB1 mRNA	PMID:34480604
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:75832	iron(2+) sulfate (anhydrous)	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:C020748	DNAJB1 protein results in decreased susceptibility to ferrous sulfate	PMID:11359866
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:76987	metacetamol	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20140204	CTD	MESH:C026137	3-hydroxyacetanilide results in decreased expression of DNAJB1 mRNA	PMID:18544908
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1304725	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of DNAJB1 mRNA	PMID:21346803
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of DNAJB1 mRNA	PMID:30851411
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA	PMID:27188386
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:78782	pyrrolidine dithiocarbamate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:C020972	pyrrolidine dithiocarbamic acid results in increased expression of DNAJB1 mRNA	PMID:15477007
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	EXP		E	RGD:6480464	20140708	CTD	MESH:C020972	[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of DNAJB1 mRNA	PMID:15477007
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:79369	elesclomol	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C512195	elesclomol results in increased expression of DNAJB1 mRNA	PMID:18723479
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:79369	elesclomol	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:C512195	Acetylcysteine inhibits the reaction [elesclomol results in increased expression of DNAJB1 mRNA]	PMID:18723479
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1304725	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of DNAJB1 mRNA	PMID:19162173
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of DNAJB1 mRNA	PMID:19270015
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312337	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of DNAJB1 mRNA	PMID:19482888|PMID:23091169
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312337	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of DNAJB1 mRNA]	PMID:19482888
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of DNAJB1 mRNA	PMID:22538082
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1312337	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in increased expression of DNAJB1 mRNA	PMID:22538082
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312337	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DNAJB1 mRNA	PMID:38648751
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNAJB1 protein	PMID:31675489
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of DNAJB1 protein	PMID:31675489
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of DNAJB1 mRNA	PMID:21858171
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312337	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of DNAJB1 mRNA	PMID:39847705
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312337	E	RGD:6480464	20120501	CTD	MESH:C045950	propiconazole results in increased expression of DNAJB1 mRNA	PMID:19363144|PMID:21278054
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8493	Propiverine	affects localization	ISO	RGD:1304725	E	RGD:6480464	20180410	CTD	MESH:C015586	propiverine affects the localization of DNAJB1 protein	PMID:29273565
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:8772	raloxifene	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of DNAJB1 mRNA	PMID:16497877
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:91091	CHIR 99021	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C473711	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of DNAJB1 mRNA; [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of DNAJB1 mRNA	PMID:34480604
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of DNAJB1 mRNA; [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DNAJB1 protein; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DNAJB1 mRNA	PMID:27188386|PMID:34480604|PMID:37664457
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of DNAJB1 mRNA	PMID:26014281|PMID:28959546
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304725	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of DNAJB1 mRNA	PMID:19281266
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304725	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DNAJB1 mRNA	PMID:21346803
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of DNAJB1 mRNA	PMID:33512557
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DNAJB1 mRNA	PMID:38568856
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9513	thalidomide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013792	Thalidomide analog results in increased expression of DNAJB1 mRNA	PMID:20525221
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013849	Thimerosal results in increased expression of DNAJB1 mRNA	PMID:16870260
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DNAJB1 protein	PMID:38598786
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312337	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of DNAJB1 mRNA	PMID:28973697
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304725	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of DNAJB1 mRNA	PMID:19015723
1312336	DNAJB1	DnaJ heat shock protein family (Hsp40) member B1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304725	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of DNAJB1 mRNA	PMID:23034163
1312341	SFN	stratifin	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SFN mRNA	PMID:38218311
1312341	SFN	stratifin	gene	CHEBI:110423	clodronic acid	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in increased expression of SFN mRNA	PMID:25596134
1312341	SFN	stratifin	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SFN mRNA	PMID:27188386
1312341	SFN	stratifin	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SFN mRNA	PMID:37995155
1312341	SFN	stratifin	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of SFN mRNA	PMID:34925699
1312341	SFN	stratifin	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SFN mRNA	PMID:20938992
1312341	SFN	stratifin	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of SFN mRNA	PMID:36189433
1312341	SFN	stratifin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of SFN mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of SFN mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of SFN mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SFN mRNA	PMID:30951980|PMID:36189433
1312341	SFN	stratifin	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SFN mRNA	PMID:25596134
1312341	SFN	stratifin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SFN mRNA	PMID:30529165
1312341	SFN	stratifin	gene	CHEBI:15864	luteolin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D047311	Luteolin results in increased expression of SFN mRNA; Luteolin results in increased expression of SFN protein	PMID:18331776
1312341	SFN	stratifin	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SFN mRNA	PMID:29432896
1312341	SFN	stratifin	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of SFN mRNA; Quercetin results in increased expression of SFN protein	PMID:14750173|PMID:18331776|PMID:21632981
1312341	SFN	stratifin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SFN mRNA	PMID:35811015
1312341	SFN	stratifin	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D004958	Estradiol results in decreased expression of SFN mRNA	PMID:23019147|PMID:23094148
1312341	SFN	stratifin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20250805	CTD	MESH:D004958	Estradiol results in decreased expression of SFN protein	PMID:26903627
1312341	SFN	stratifin	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of SFN mRNA	PMID:19167446
1312341	SFN	stratifin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of SFN mRNA; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of SFN protein	PMID:22534328
1312341	SFN	stratifin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of SFN mRNA	PMID:18556351
1312341	SFN	stratifin	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312342	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of SFN mRNA	PMID:18978301
1312341	SFN	stratifin	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304729	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SFN mRNA	PMID:33387578
1312341	SFN	stratifin	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SFN mRNA	PMID:20938992
1312341	SFN	stratifin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SFN mRNA	PMID:37042841
1312341	SFN	stratifin	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D001554	Benzene results in increased expression of SFN mRNA	PMID:33064461
1312341	SFN	stratifin	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of SFN mRNA	PMID:34673133
1312341	SFN	stratifin	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SFN mRNA	PMID:23649840
1312341	SFN	stratifin	gene	CHEBI:169105	Ethyl maltol	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C052408	ethyl maltol results in increased expression of SFN mRNA	PMID:37606557
1312341	SFN	stratifin	gene	CHEBI:169105	Ethyl maltol	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:C052408	APP protein inhibits the reaction [ethyl maltol results in increased expression of SFN mRNA]	PMID:37606557
1312341	SFN	stratifin	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of SFN mRNA	PMID:16966611
1312341	SFN	stratifin	gene	CHEBI:17026	progesterone	increases phosphorylation	ISO	RGD:1304729	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased phosphorylation of SFN protein	PMID:17303654
1312341	SFN	stratifin	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20130910	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of SFN mRNA	PMID:18556351
1312341	SFN	stratifin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SFN mRNA	PMID:36189433
1312341	SFN	stratifin	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1304729	E	RGD:6480464	20140715	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of SFN mRNA	PMID:19167416|PMID:22213190
1312341	SFN	stratifin	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of SFN mRNA	PMID:33647349
1312341	SFN	stratifin	gene	CHEBI:175901	gemcitabine	affects response to substance	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	SFN protein affects the susceptibility to Gemcitabine	PMID:26894857
1312341	SFN	stratifin	gene	CHEBI:175901	gemcitabine	decreases response to substance	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	SFN protein results in decreased susceptibility to Gemcitabine	PMID:25189999|PMID:26894857
1312341	SFN	stratifin	gene	CHEBI:175901	gemcitabine	increases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in increased methylation of SFN gene	PMID:25189999
1312341	SFN	stratifin	gene	CHEBI:175901	gemcitabine	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	[DNMT1 protein binds to SFN promoter] inhibits the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine]; [Gemcitabine results in decreased susceptibility to Gemcitabine] inhibits the reaction [DNMT1 protein binds to SFN promoter]; [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in decreased methylation of SFN gene; [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of SFN mRNA; [Gemcitabine results in decreased susceptibility to Gemcitabine] which results in increased expression of SFN protein; [UHRF1 protein promotes the reaction [DNMT1 protein binds to SFN promoter]] inhibits the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine]; SFN protein affects the reaction [YAP1 protein promotes the reaction [SFN protein results in decreased susceptibility to Gemcitabine]]; SFN protein inhibits the reaction [Gemcitabine results in increased activity of and results in increased cleavage of CASP8 protein]; SFN protein inhibits the reaction [Gemcitabine results in increased cleavage of PARP1 protein]; SFN protein promotes the reaction [Gemcitabine results in decreased susceptibility to Gemcitabine]; YAP1 protein promotes the reaction [SFN protein results in decreased susceptibility to Gemcitabine]	PMID:25189999|PMID:26894857
1312341	SFN	stratifin	gene	CHEBI:17594	hydroquinone	affects methylation	EXP		E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone affects the methylation of SFN promoter	PMID:23940045
1312341	SFN	stratifin	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone results in increased expression of SFN mRNA	PMID:23940045
1312341	SFN	stratifin	gene	CHEBI:17594	hydroquinone	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C031927	[hydroquinone affects the methylation of SFN promoter] which results in decreased abundance of 5-Methylcytosine; [hydroquinone affects the methylation of SFN promoter] which results in increased abundance of 5-hydroxymethylcytosine; TET1 protein affects the reaction [hydroquinone results in increased expression of SFN mRNA]	PMID:23940045
1312341	SFN	stratifin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SFN protein	PMID:31163220
1312341	SFN	stratifin	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SFN mRNA	PMID:36139627
1312341	SFN	stratifin	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of SFN mRNA	PMID:26485663
1312341	SFN	stratifin	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SFN mRNA	PMID:28818685
1312341	SFN	stratifin	gene	CHEBI:20689	6-O-methylguanine	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C008449	[O(6)-benzylguanine co-treated with O-(6)-methylguanine] results in decreased expression of SFN mRNA	PMID:29666243
1312341	SFN	stratifin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SFN mRNA	PMID:37325564
1312341	SFN	stratifin	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SFN mRNA	PMID:19549813
1312341	SFN	stratifin	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SFN mRNA	PMID:23649840
1312341	SFN	stratifin	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SFN protein	PMID:20106945
1312341	SFN	stratifin	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SFN mRNA	PMID:21527772|PMID:21632981|PMID:22100608|PMID:32234424
1312341	SFN	stratifin	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SFN mRNA	PMID:21527772|PMID:23649840
1312341	SFN	stratifin	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases alkylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased alkylation of SFN protein	PMID:18342354
1312341	SFN	stratifin	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of SFN mRNA	PMID:21527772
1312341	SFN	stratifin	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120515	CTD	MESH:D010126	Ozone results in increased expression of SFN mRNA	PMID:12763052|PMID:17095637|PMID:33026818
1312341	SFN	stratifin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SFN mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SFN mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of SFN mRNA	PMID:25658374|PMID:27106289|PMID:34911549
1312341	SFN	stratifin	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SFN protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of SFN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SFN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SFN protein	PMID:38598786
1312341	SFN	stratifin	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1312342	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of SFN mRNA	PMID:31939706
1312341	SFN	stratifin	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SFN mRNA	PMID:18593933
1312341	SFN	stratifin	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304729	E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SFN mRNA	PMID:30723492
1312341	SFN	stratifin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SFN mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SFN mRNA]	PMID:20938992|PMID:22206623
1312341	SFN	stratifin	gene	CHEBI:27551	5-methylcytosine	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:D044503	[hydroquinone affects the methylation of SFN promoter] which results in decreased abundance of 5-Methylcytosine	PMID:23940045
1312341	SFN	stratifin	gene	CHEBI:27563	arsenic atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased expression of SFN mRNA	PMID:19945496
1312341	SFN	stratifin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFN mRNA	PMID:40504410
1312341	SFN	stratifin	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of SFN mRNA	PMID:38460933
1312341	SFN	stratifin	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in increased expression of SFN mRNA	PMID:21527772
1312341	SFN	stratifin	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of SFN mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of SFN protein	PMID:38460933
1312341	SFN	stratifin	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SFN mRNA	PMID:26272509
1312341	SFN	stratifin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1312341	SFN	stratifin	gene	CHEBI:27871	chloroacetaldehyde	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in increased expression of SFN mRNA	PMID:25596134
1312341	SFN	stratifin	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002945	Cisplatin affects the expression of SFN mRNA	PMID:25450742
1312341	SFN	stratifin	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20180313	CTD	MESH:D002945	SFN protein affects the susceptibility to Cisplatin	PMID:26894857
1312341	SFN	stratifin	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of SFN protein	PMID:21924258
1312341	SFN	stratifin	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in increased expression of SFN mRNA	PMID:21532991|PMID:25596134|PMID:27392435
1312341	SFN	stratifin	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin promotes the reaction [jinfukang results in increased expression of SFN mRNA]; jinfukang promotes the reaction [Cisplatin results in increased expression of SFN mRNA]; SFN protein affects the susceptibility to [Fluorouracil co-treated with Cisplatin]	PMID:15999354|PMID:27392435
1312341	SFN	stratifin	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SFN mRNA	PMID:25583101
1312341	SFN	stratifin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SFN mRNA	PMID:21354282
1312341	SFN	stratifin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SFN mRNA	PMID:27913140
1312341	SFN	stratifin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SFN mRNA	PMID:19770486
1312341	SFN	stratifin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFN mRNA	PMID:17942748
1312341	SFN	stratifin	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SFN mRNA	PMID:28001369
1312341	SFN	stratifin	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SFN mRNA; aristolochic acid I results in increased expression of SFN protein	PMID:33212167
1312341	SFN	stratifin	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of SFN mRNA	PMID:26272509
1312341	SFN	stratifin	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1312341	SFN	stratifin	gene	CHEBI:28499	kaempferol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006552	kaempferol results in increased expression of SFN mRNA; kaempferol results in increased expression of SFN protein	PMID:18331776
1312341	SFN	stratifin	gene	CHEBI:28680	cytarabine	decreases response to substance	EXP		E	RGD:6480464	20160315	CTD	MESH:D003561	SFN protein results in decreased susceptibility to Cytarabine	PMID:25189999
1312341	SFN	stratifin	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304729	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of SFN mRNA	PMID:22465980
1312341	SFN	stratifin	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which affects the expression of SFN mRNA	PMID:30911355
1312341	SFN	stratifin	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SFN mRNA	PMID:15467011
1312341	SFN	stratifin	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312342	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SFN protein	PMID:27548804
1312341	SFN	stratifin	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20180313	CTD	MESH:D004317	SFN protein affects the susceptibility to Doxorubicin	PMID:26894857
1312341	SFN	stratifin	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004317	Doxorubicin results in decreased expression of SFN mRNA	PMID:24816189
1312341	SFN	stratifin	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004317	Doxorubicin results in increased expression of SFN protein	PMID:24816189
1312341	SFN	stratifin	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004317	TP53 protein mutant form affects the reaction [Doxorubicin results in decreased expression of SFN mRNA]; TP53 protein mutant form affects the reaction [Doxorubicin results in increased expression of SFN protein]	PMID:24816189
1312341	SFN	stratifin	gene	CHEBI:28830	chlorambucil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002699	Chlorambucil results in increased expression of SFN mRNA	PMID:18092340
1312341	SFN	stratifin	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SFN mRNA	PMID:29432896
1312341	SFN	stratifin	gene	CHEBI:2948	azathioprine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of SFN mRNA	PMID:22623647
1312341	SFN	stratifin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of SFN mRNA	PMID:12760830|PMID:38568856
1312341	SFN	stratifin	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of SFN mRNA	PMID:29301061|PMID:34032870|PMID:37939567|PMID:39719251
1312341	SFN	stratifin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFN mRNA	PMID:40504410
1312341	SFN	stratifin	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SFN promoter	PMID:27901495
1312341	SFN	stratifin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SFN mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:25690898|PMID:26238291|PMID:32234424|PMID:40280401
1312341	SFN	stratifin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SFN mRNA	PMID:19770486
1312341	SFN	stratifin	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of SFN gene	PMID:25435355
1312341	SFN	stratifin	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SFN mRNA	PMID:40280401
1312341	SFN	stratifin	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304729	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of SFN mRNA	PMID:22465980
1312341	SFN	stratifin	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which affects the expression of SFN mRNA	PMID:30911355
1312341	SFN	stratifin	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SFN mRNA	PMID:15467011
1312341	SFN	stratifin	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	ISO	RGD:1312342	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of SFN protein	PMID:24861204
1312341	SFN	stratifin	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SFN mRNA	PMID:18593933
1312341	SFN	stratifin	gene	CHEBI:3020	benzalkonium chloride	increases expression	ISO	RGD:1312342	E	RGD:6480464	20190219	CTD	MESH:D001548	Benzalkonium Compounds results in increased expression of SFN mRNA	PMID:30171875
1312341	SFN	stratifin	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312342	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SFN mRNA	PMID:27131904
1312341	SFN	stratifin	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	SFN protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1312341	SFN	stratifin	gene	CHEBI:30703	tetrathiomolybdate(2-)	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C020809	tetrathiomolybdate results in decreased expression of SFN mRNA	PMID:37290678
1312341	SFN	stratifin	gene	CHEBI:31175	adefovir pivoxil	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of SFN mRNA	PMID:25596134
1312341	SFN	stratifin	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of SFN mRNA	PMID:20680508
1312341	SFN	stratifin	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of SFN mRNA	PMID:37939567|PMID:38568856
1312341	SFN	stratifin	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304729	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SFN mRNA	PMID:30047161
1312341	SFN	stratifin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312342	E	RGD:6480464	20130611	CTD	MESH:C009495	titanium dioxide results in increased expression of SFN mRNA	PMID:27760801
1312341	SFN	stratifin	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312342	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SFN enhancer	PMID:35295148
1312341	SFN	stratifin	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304729	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SFN mRNA	PMID:34492290
1312341	SFN	stratifin	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SFN mRNA	PMID:17426115
1312341	SFN	stratifin	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SFN mRNA	PMID:30903817
1312341	SFN	stratifin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304729	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SFN mRNA	PMID:25181051
1312341	SFN	stratifin	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312342	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SFN promoter	PMID:27312807
1312341	SFN	stratifin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SFN protein	PMID:37567409
1312341	SFN	stratifin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312342	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of SFN mRNA	PMID:32156529
1312341	SFN	stratifin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of SFN mRNA	PMID:30951980
1312341	SFN	stratifin	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SFN mRNA	PMID:25979313
1312341	SFN	stratifin	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of SFN mRNA	PMID:38568856
1312341	SFN	stratifin	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20140715	CTD	MESH:C014024	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of SFN protein	PMID:23457121
1312341	SFN	stratifin	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20140715	CTD	MESH:C023035	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of SFN protein	PMID:23457121
1312341	SFN	stratifin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312342	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SFN mRNA	PMID:30951980
1312341	SFN	stratifin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in increased methylation of SFN promoter	PMID:30616060
1312341	SFN	stratifin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of SFN mRNA	PMID:30951980
1312341	SFN	stratifin	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SFN mRNA	PMID:40280401
1312341	SFN	stratifin	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of SFN mRNA	PMID:26377693
1312341	SFN	stratifin	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SFN mRNA	PMID:38685157
1312341	SFN	stratifin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312342	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SFN mRNA	PMID:30951980
1312341	SFN	stratifin	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of SFN mRNA	PMID:30951980
1312341	SFN	stratifin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304729	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SFN mRNA	PMID:21266533
1312341	SFN	stratifin	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SFN protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of SFN protein	PMID:38598786
1312341	SFN	stratifin	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20140715	CTD	MESH:D004052	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of SFN protein	PMID:23457121
1312341	SFN	stratifin	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304729	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of SFN mRNA	PMID:32680482
1312341	SFN	stratifin	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312342	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of SFN protein	PMID:39748354
1312341	SFN	stratifin	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SFN mRNA	PMID:37042841
1312341	SFN	stratifin	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304729	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SFN mRNA	PMID:35163327
1312341	SFN	stratifin	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304729	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of SFN mRNA	PMID:30723492
1312341	SFN	stratifin	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SFN mRNA	PMID:12160620|PMID:25596134|PMID:38568856
1312341	SFN	stratifin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304729	E	RGD:6480464	20191008	CTD	MESH:D019256	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of SFN mRNA	PMID:31077537
1312341	SFN	stratifin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SFN mRNA	PMID:37325564
1312341	SFN	stratifin	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20230207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SFN protein	PMID:36214631
1312341	SFN	stratifin	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312342	E	RGD:6480464	20240206	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SFN protein	PMID:37422089
1312341	SFN	stratifin	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304729	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SFN mRNA	PMID:35163327
1312341	SFN	stratifin	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of SFN mRNA	PMID:17547211
1312341	SFN	stratifin	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SFN mRNA	PMID:24449571
1312341	SFN	stratifin	gene	CHEBI:3696	cidofovir anhydrous	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in increased expression of SFN mRNA	PMID:25596134
1312341	SFN	stratifin	gene	CHEBI:38211	potassium bromate	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C019536	potassium bromate results in increased expression of SFN mRNA	PMID:30008028|PMID:30559759
1312341	SFN	stratifin	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SFN mRNA	PMID:32588087
1312341	SFN	stratifin	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SFN mRNA	PMID:19167446
1312341	SFN	stratifin	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFN mRNA	PMID:19167446
1312341	SFN	stratifin	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of SFN mRNA	PMID:26352163
1312341	SFN	stratifin	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312342	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of SFN mRNA	PMID:23125180
1312341	SFN	stratifin	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SFN mRNA	PMID:25979313
1312341	SFN	stratifin	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SFN mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799|PMID:30008028
1312341	SFN	stratifin	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1312341	SFN	stratifin	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304729	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SFN mRNA	PMID:30047161
1312341	SFN	stratifin	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of SFN mRNA	PMID:21527772
1312341	SFN	stratifin	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SFN mRNA	PMID:20106945|PMID:25562108|PMID:25596134|PMID:27989131|PMID:30008028
1312341	SFN	stratifin	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of SFN mRNA	PMID:17555576
1312341	SFN	stratifin	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SFN mRNA	PMID:15171707|PMID:16636312
1312341	SFN	stratifin	gene	CHEBI:43602	obeticholic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of SFN mRNA	PMID:27939613
1312341	SFN	stratifin	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of SFN mRNA	PMID:17379860|PMID:21678067
1312341	SFN	stratifin	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SFN mRNA	PMID:38832940
1312341	SFN	stratifin	gene	CHEBI:4488	diallyl disulfide	multiple interactions	ISO	RGD:1304729	E	RGD:6480464	20191008	CTD	MESH:C028009	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of SFN mRNA	PMID:31077537
1312341	SFN	stratifin	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1312341	SFN	stratifin	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of SFN mRNA	PMID:24935251|PMID:26272509
1312341	SFN	stratifin	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1312341	SFN	stratifin	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SFN mRNA	PMID:21420995|PMID:29067470
1312341	SFN	stratifin	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SFN mRNA	PMID:22230336
1312341	SFN	stratifin	gene	CHEBI:46345	5-fluorouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil affects the expression of SFN mRNA	PMID:16584549
1312341	SFN	stratifin	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005472	Fluorouracil results in increased expression of SFN mRNA	PMID:16557594|PMID:17982676
1312341	SFN	stratifin	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	SFN protein affects the susceptibility to [Fluorouracil co-treated with Cisplatin]; TP53 protein affects the reaction [Fluorouracil results in increased expression of SFN mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of SFN mRNA]	PMID:15016801|PMID:15999354|PMID:17982676
1312341	SFN	stratifin	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SFN mRNA	PMID:29432896
1312341	SFN	stratifin	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SFN mRNA	PMID:35811015
1312341	SFN	stratifin	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SFN protein	PMID:29553831
1312341	SFN	stratifin	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of SFN mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of SFN protein	PMID:38460933
1312341	SFN	stratifin	gene	CHEBI:47217	arsane	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased expression of SFN mRNA	PMID:19945496
1312341	SFN	stratifin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFN mRNA	PMID:40504410
1312341	SFN	stratifin	gene	CHEBI:47381	diclofenac	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D004008	Diclofenac results in increased expression of SFN mRNA	PMID:17379860
1312341	SFN	stratifin	gene	CHEBI:47807	sulforaphane	affects binding	EXP		E	RGD:6480464	20120717	CTD	MESH:C016766	SFN protein binds to sulforaphane	PMID:21838287
1312341	SFN	stratifin	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304729	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SFN mRNA	PMID:29391264
1312341	SFN	stratifin	gene	CHEBI:49	(+)-Tetrandrine	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C009438	tetrandrine results in increased expression of SFN protein	PMID:26822499
1312341	SFN	stratifin	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SFN mRNA	PMID:17555576|PMID:17942748
1312341	SFN	stratifin	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFN mRNA	PMID:17942748
1312341	SFN	stratifin	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of SFN mRNA	PMID:21527772
1312341	SFN	stratifin	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SFN mRNA	PMID:38568856
1312341	SFN	stratifin	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of SFN mRNA	PMID:26272509
1312341	SFN	stratifin	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1312341	SFN	stratifin	gene	CHEBI:49668	gefitinib	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C419708	gefitinib results in decreased expression of SFN mRNA	PMID:16685379
1312341	SFN	stratifin	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	SFN protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1312341	SFN	stratifin	gene	CHEBI:50035	alpha-phellandrene	increases expression	ISO	RGD:1312342	E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of SFN protein	PMID:24861204
1312341	SFN	stratifin	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D003994	[Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of SFN mRNA; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of SFN protein	PMID:22534328
1312341	SFN	stratifin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	ISO	RGD:1304729	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased methylation of SFN promoter	PMID:15979784
1312341	SFN	stratifin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of SFN protein	PMID:22534328|PMID:25189999
1312341	SFN	stratifin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1304729	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of SFN mRNA	PMID:15979784
1312341	SFN	stratifin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	[Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with Decitabine] results in increased expression of SFN mRNA	PMID:22534328
1312341	SFN	stratifin	gene	CHEBI:50594	carbon nanotube	affects expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of SFN protein	PMID:22001959
1312341	SFN	stratifin	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312342	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SFN mRNA; Nanotubes, Carbon results in increased expression of SFN mRNA	PMID:25554681
1312341	SFN	stratifin	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304729	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SFN mRNA	PMID:30047161
1312341	SFN	stratifin	gene	CHEBI:50729	mitoxantrone	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	SFN protein affects the susceptibility to Mitoxantrone	PMID:16217747
1312341	SFN	stratifin	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SFN mRNA	PMID:35964746
1312341	SFN	stratifin	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312342	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of SFN mRNA	PMID:26377693
1312341	SFN	stratifin	gene	CHEBI:51348	tetraphene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SFN mRNA	PMID:40280401
1312341	SFN	stratifin	gene	CHEBI:51687	chrysene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SFN mRNA	PMID:40280401
1312341	SFN	stratifin	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of SFN mRNA	PMID:20977926
1312341	SFN	stratifin	gene	CHEBI:52717	bortezomib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	[irinotecan co-treated with Bortezomib] results in decreased expression of SFN protein	PMID:16373703
1312341	SFN	stratifin	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1312342	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of SFN mRNA	PMID:16100012|PMID:16166746
1312341	SFN	stratifin	gene	CHEBI:5855	ibuprofen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of SFN mRNA	PMID:25596134
1312341	SFN	stratifin	gene	CHEBI:5864	ifosfamide	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in increased expression of SFN mRNA	PMID:25596134
1312341	SFN	stratifin	gene	CHEBI:6030	isoniazide	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D007538	Isoniazid results in decreased expression of SFN mRNA	PMID:30008028
1312341	SFN	stratifin	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SFN protein	PMID:32959892
1312341	SFN	stratifin	gene	CHEBI:6382	Lasiocarpine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005136	lasiocarpine results in increased expression of SFN mRNA	PMID:32234424
1312341	SFN	stratifin	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1304729	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SFN mRNA	PMID:28801915
1312341	SFN	stratifin	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312342	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SFN protein	PMID:26558463
1312341	SFN	stratifin	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of SFN mRNA	PMID:17547211
1312341	SFN	stratifin	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1304729	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of SFN mRNA	PMID:28954212
1312341	SFN	stratifin	gene	CHEBI:64317	isoprenaline	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D007545	Isoproterenol results in decreased expression of SFN mRNA	PMID:24286936
1312341	SFN	stratifin	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D017258	[Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine co-treated with decitabine] results in increased expression of SFN mRNA; [Estradiol co-treated with Medroxyprogesterone Acetate co-treated with Bucladesine] results in increased expression of SFN protein	PMID:22534328
1312341	SFN	stratifin	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1304729	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of SFN mRNA	PMID:25596134
1312341	SFN	stratifin	gene	CHEBI:68233	(Z)-3-butylidenephthalide	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C026105	butylidenephthalide results in increased expression of SFN protein	PMID:23770345
1312341	SFN	stratifin	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D002185	Cannabidiol results in increased expression of SFN mRNA	PMID:36519830
1312341	SFN	stratifin	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312342	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SFN mRNA	PMID:22206623
1312341	SFN	stratifin	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312342	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SFN mRNA]	PMID:22206623
1312341	SFN	stratifin	gene	CHEBI:748572	acyline	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C109238	acyline results in increased expression of SFN mRNA	PMID:17510436
1312341	SFN	stratifin	gene	CHEBI:748866	6-o-benzylguanine	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C064976	[O(6)-benzylguanine co-treated with O-(6)-methylguanine] results in decreased expression of SFN mRNA	PMID:29666243
1312341	SFN	stratifin	gene	CHEBI:75095	chrysin	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C043561	chrysin results in increased expression of SFN mRNA; chrysin results in increased expression of SFN protein	PMID:18331776
1312341	SFN	stratifin	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of SFN protein	PMID:31285264
1312341	SFN	stratifin	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SFN mRNA	PMID:36139627
1312341	SFN	stratifin	gene	CHEBI:76792	5-(hydroxymethyl)cytosine	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C011865	[hydroquinone affects the methylation of SFN promoter] which results in increased abundance of 5-hydroxymethylcytosine	PMID:23940045
1312341	SFN	stratifin	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of SFN mRNA; beta-Naphthoflavone results in increased expression of SFN protein	PMID:19737606|PMID:39638853
1312341	SFN	stratifin	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025589	ochratoxin A results in decreased expression of SFN mRNA	PMID:30008028|PMID:30559759
1312341	SFN	stratifin	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1304729	E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in increased expression of SFN mRNA	PMID:19237604
1312341	SFN	stratifin	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1312341	SFN	stratifin	gene	CHEBI:79997	GW 4064	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C412815	GW 4064 results in increased expression of SFN mRNA	PMID:31437187
1312341	SFN	stratifin	gene	CHEBI:80630	irinotecan	multiple interactions	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	[Irinotecan co-treated with Bortezomib] results in decreased expression of SFN protein	PMID:16373703
1312341	SFN	stratifin	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFN mRNA	PMID:19167446
1312341	SFN	stratifin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312342	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SFN mRNA	PMID:38648751
1312341	SFN	stratifin	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of SFN mRNA	PMID:32234424
1312341	SFN	stratifin	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312342	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SFN mRNA	PMID:39847705
1312341	SFN	stratifin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304729	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SFN mRNA	PMID:30047161
1312341	SFN	stratifin	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of SFN mRNA	PMID:26272509
1312341	SFN	stratifin	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1312341	SFN	stratifin	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SFN mRNA	PMID:18778698
1312341	SFN	stratifin	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	TP53 mutant form inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SFN mRNA]	PMID:18778698
1312341	SFN	stratifin	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFN mRNA	PMID:27188386
1312341	SFN	stratifin	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312342	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SFN mRNA	PMID:27131904
1312341	SFN	stratifin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SFN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SFN protein	PMID:38598786
1312341	SFN	stratifin	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312342	E	RGD:6480464	20170613	CTD	MESH:C001899	triptolide results in increased expression of SFN mRNA; triptolide results in increased expression of SFN protein	PMID:26990902|PMID:32835833
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of STYX mRNA	PMID:21934132
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of STYX mRNA	PMID:21632981
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1594806	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of STYX mRNA	PMID:33387578
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312346	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STYX mRNA	PMID:28111341
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of STYX mRNA	PMID:19549813
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1594806	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of STYX mRNA	PMID:33354967
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of STYX mRNA	PMID:23649840
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1594806	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of STYX mRNA	PMID:30779732
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1594806	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of STYX mRNA	PMID:33387578
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of STYX mRNA	PMID:21867686
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312346	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of STYX mRNA	PMID:25629700
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312346	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STYX mRNA	PMID:22206623
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of STYX mRNA	PMID:26272509
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STYX mRNA	PMID:27188386
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:27690	acetazolamide	increases expression	ISO	RGD:1312346	E	RGD:6480464	20120717	CTD	MESH:D000086	Acetazolamide results in increased expression of STYX mRNA	PMID:19274763
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312346	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of STYX mRNA	PMID:28960355
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of STYX protein	PMID:16803524
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312346	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STYX mRNA	PMID:21570461
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of STYX mRNA	PMID:20106945|PMID:21632981
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1594806	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of STYX mRNA	PMID:33387578
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312346	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STYX mRNA	PMID:17942748
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of STYX mRNA	PMID:28001369
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of STYX mRNA	PMID:26272509
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of STYX mRNA	PMID:33212167
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of STYX mRNA	PMID:30851411
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STYX mRNA	PMID:21632981
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312346	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STYX mRNA	PMID:22228805
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312346	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of STYX mRNA]	PMID:22228805
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of STYX mRNA	PMID:20458559
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312346	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STYX gene	PMID:35295148
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312346	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of STYX mRNA	PMID:18648102
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1594806	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of STYX mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STYX mRNA	PMID:28628672
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STYX mRNA	PMID:28628672
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of STYX mRNA	PMID:37042841
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312346	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STYX mRNA	PMID:28111341
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of STYX mRNA	PMID:27153767
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of STYX mRNA	PMID:17183730
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of STYX mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STYX mRNA	PMID:28628672
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312346	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of STYX mRNA	PMID:28973697
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312346	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of STYX mRNA	PMID:18502557
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of STYX mRNA	PMID:27188386
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of STYX mRNA	PMID:28542535
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of STYX mRNA	PMID:24935251|PMID:26272509
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STYX mRNA	PMID:27188386
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312346	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of STYX mRNA	PMID:17562736
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312346	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of STYX mRNA	PMID:29279043
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312346	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of STYX mRNA	PMID:35436446
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312346	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of STYX mRNA	PMID:17942748
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312346	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STYX mRNA	PMID:17942748
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STYX mRNA	PMID:28628672
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of STYX mRNA	PMID:20458559
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1594806	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of STYX mRNA	PMID:24793618
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of STYX mRNA	PMID:17183730
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:64213	cantharidin	increases expression	ISO	RGD:1312346	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in increased expression of STYX mRNA	PMID:36907384
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312346	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of STYX mRNA	PMID:22206623
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312346	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STYX mRNA	PMID:22206623
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	ISO	RGD:1594806	E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of STYX protein	PMID:19716841
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of STYX mRNA	PMID:30851411
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STYX mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STYX mRNA	PMID:27188386
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312346	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of STYX mRNA	PMID:23091169
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312346	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of STYX mRNA	PMID:21795629
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312346	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of STYX mRNA	PMID:21278054
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STYX mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STYX mRNA	PMID:27188386
1312345	STYX	serine/threonine/tyrosine interacting protein	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of STYX mRNA	PMID:27188386
1312347	EP400	E1A binding protein p400	gene	CHEBI:10022	deoxynivalenol	decreases phosphorylation	ISO	RGD:1557068	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in decreased phosphorylation of EP400 protein	PMID:23352502
1312347	EP400	E1A binding protein p400	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of EP400 mRNA	PMID:25596134
1312347	EP400	E1A binding protein p400	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1557068	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EP400 mRNA	PMID:33045310
1312347	EP400	E1A binding protein p400	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of EP400 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of EP400 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of EP400 mRNA	PMID:32699268|PMID:32845096
1312347	EP400	E1A binding protein p400	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of EP400 mRNA	PMID:25596134
1312347	EP400	E1A binding protein p400	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of EP400 mRNA	PMID:26079696
1312347	EP400	E1A binding protein p400	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304733	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of EP400 gene	PMID:35440735
1312347	EP400	E1A binding protein p400	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1557068	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of EP400 mRNA	PMID:30319688
1312347	EP400	E1A binding protein p400	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of EP400 protein	PMID:35688186
1312347	EP400	E1A binding protein p400	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of EP400 mRNA	PMID:31614463
1312347	EP400	E1A binding protein p400	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EP400 mRNA	PMID:25510870
1312347	EP400	E1A binding protein p400	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304733	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of EP400 gene	PMID:27618143
1312347	EP400	E1A binding protein p400	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of EP400 mRNA	PMID:23649840
1312347	EP400	E1A binding protein p400	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of EP400 protein	PMID:37730182
1312347	EP400	E1A binding protein p400	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304733	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EP400 mRNA	PMID:33387578
1312347	EP400	E1A binding protein p400	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EP400 mRNA	PMID:36331819
1312347	EP400	E1A binding protein p400	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EP400 mRNA	PMID:35301059
1312347	EP400	E1A binding protein p400	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EP400 mRNA	PMID:28111341
1312347	EP400	E1A binding protein p400	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EP400 mRNA	PMID:25510870
1312347	EP400	E1A binding protein p400	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EP400 mRNA	PMID:25510870
1312347	EP400	E1A binding protein p400	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of EP400 mRNA	PMID:19549813
1312347	EP400	E1A binding protein p400	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1557068	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EP400 mRNA	PMID:19770486
1312347	EP400	E1A binding protein p400	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EP400 intron	PMID:30157460
1312347	EP400	E1A binding protein p400	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of EP400 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of EP400 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of EP400 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of EP400 mRNA	PMID:32699268|PMID:32845096
1312347	EP400	E1A binding protein p400	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of EP400 protein	PMID:35688186
1312347	EP400	E1A binding protein p400	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1304733	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of EP400 gene	PMID:35440735
1312347	EP400	E1A binding protein p400	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of EP400 mRNA	PMID:25596134
1312347	EP400	E1A binding protein p400	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of EP400 mRNA	PMID:25596134
1312347	EP400	E1A binding protein p400	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1557068	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of EP400 mRNA	PMID:34813904
1312347	EP400	E1A binding protein p400	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of EP400 mRNA	PMID:30912803
1312347	EP400	E1A binding protein p400	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557068	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EP400 mRNA	PMID:21570461
1312347	EP400	E1A binding protein p400	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304733	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EP400 mRNA	PMID:33387578
1312347	EP400	E1A binding protein p400	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304733	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EP400 mRNA	PMID:34747641
1312347	EP400	E1A binding protein p400	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EP400 mRNA	PMID:17942748
1312347	EP400	E1A binding protein p400	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of EP400 mRNA	PMID:28001369
1312347	EP400	E1A binding protein p400	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EP400 mRNA	PMID:33212167
1312347	EP400	E1A binding protein p400	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of EP400 mRNA	PMID:30851411
1312347	EP400	E1A binding protein p400	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of EP400 protein	PMID:35688186
1312347	EP400	E1A binding protein p400	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of EP400 mRNA	PMID:29319823
1312347	EP400	E1A binding protein p400	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EP400 mRNA	PMID:38568856
1312347	EP400	E1A binding protein p400	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EP400 promoter	PMID:27901495
1312347	EP400	E1A binding protein p400	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EP400 mRNA	PMID:26238291
1312347	EP400	E1A binding protein p400	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1557068	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EP400 exon; Benzo(a)pyrene results in decreased methylation of EP400 intron	PMID:27901495
1312347	EP400	E1A binding protein p400	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EP400 mRNA	PMID:20504355
1312347	EP400	E1A binding protein p400	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to EP400 mRNA]	PMID:32406909
1312347	EP400	E1A binding protein p400	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557068	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EP400 promoter	PMID:35295148
1312347	EP400	E1A binding protein p400	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304733	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of EP400 mRNA	PMID:25181051
1312347	EP400	E1A binding protein p400	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of EP400 gene	PMID:31601247
1312347	EP400	E1A binding protein p400	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304733	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of EP400 mRNA	PMID:41034487
1312347	EP400	E1A binding protein p400	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EP400 mRNA	PMID:28628672
1312347	EP400	E1A binding protein p400	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EP400 mRNA	PMID:25510870
1312347	EP400	E1A binding protein p400	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EP400 mRNA	PMID:25510870
1312347	EP400	E1A binding protein p400	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of EP400 mRNA	PMID:39298647
1312347	EP400	E1A binding protein p400	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EP400 mRNA	PMID:28628672
1312347	EP400	E1A binding protein p400	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of EP400 intron	PMID:30157460
1312347	EP400	E1A binding protein p400	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EP400 mRNA	PMID:28628672
1312347	EP400	E1A binding protein p400	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1557068	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of EP400 promoter	PMID:28392331
1312347	EP400	E1A binding protein p400	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of EP400 mRNA	PMID:37019170
1312347	EP400	E1A binding protein p400	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of EP400 mRNA	PMID:34813904
1312347	EP400	E1A binding protein p400	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EP400 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EP400 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EP400 mRNA	PMID:28628672
1312347	EP400	E1A binding protein p400	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1557068	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of EP400 mRNA	PMID:34813904
1312347	EP400	E1A binding protein p400	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EP400 mRNA	PMID:37042841
1312347	EP400	E1A binding protein p400	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of EP400 mRNA	PMID:25596134
1312347	EP400	E1A binding protein p400	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EP400 mRNA	PMID:35301059
1312347	EP400	E1A binding protein p400	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EP400 mRNA	PMID:28111341
1312347	EP400	E1A binding protein p400	gene	CHEBI:35696	cobalt dichloride	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride affects the expression of EP400 mRNA alternative form	PMID:19320972
1312347	EP400	E1A binding protein p400	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of EP400 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of EP400 mRNA	PMID:32699268
1312347	EP400	E1A binding protein p400	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of EP400 mRNA	PMID:25596134
1312347	EP400	E1A binding protein p400	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of EP400 mRNA	PMID:28302478
1312347	EP400	E1A binding protein p400	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of EP400 mRNA	PMID:31533062
1312347	EP400	E1A binding protein p400	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EP400 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of EP400 mRNA	PMID:36331819
1312347	EP400	E1A binding protein p400	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of EP400 promoter	PMID:27989131
1312347	EP400	E1A binding protein p400	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of EP400 mRNA	PMID:17555576
1312347	EP400	E1A binding protein p400	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EP400 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EP400 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EP400 mRNA	PMID:28628672
1312347	EP400	E1A binding protein p400	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of EP400 mRNA	PMID:27188386
1312347	EP400	E1A binding protein p400	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EP400 mRNA	PMID:17562736
1312347	EP400	E1A binding protein p400	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of EP400 mRNA]	PMID:15016801
1312347	EP400	E1A binding protein p400	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of EP400 mRNA	PMID:25596134
1312347	EP400	E1A binding protein p400	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of EP400 mRNA	PMID:35436446
1312347	EP400	E1A binding protein p400	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EP400 mRNA	PMID:17942748
1312347	EP400	E1A binding protein p400	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EP400 mRNA	PMID:17942748
1312347	EP400	E1A binding protein p400	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of EP400 mRNA	PMID:23228038
1312347	EP400	E1A binding protein p400	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EP400 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EP400 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EP400 mRNA	PMID:28628672
1312347	EP400	E1A binding protein p400	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1304733	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of EP400 mRNA	PMID:25596134
1312347	EP400	E1A binding protein p400	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1557068	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of EP400 mRNA	PMID:40234311
1312347	EP400	E1A binding protein p400	gene	CHEBI:5864	ifosfamide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of EP400 mRNA	PMID:25596134
1312347	EP400	E1A binding protein p400	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1304733	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of EP400 mRNA	PMID:25729387
1312347	EP400	E1A binding protein p400	gene	CHEBI:6801	metformin	affects expression	ISO	RGD:1304733	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin affects the expression of EP400 mRNA	PMID:25596134
1312347	EP400	E1A binding protein p400	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1557068	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of EP400 mRNA	PMID:26307267
1312347	EP400	E1A binding protein p400	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of EP400 intron	PMID:30157460
1312347	EP400	E1A binding protein p400	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304733	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of EP400 gene	PMID:35440735
1312347	EP400	E1A binding protein p400	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of EP400 protein	PMID:31285264
1312347	EP400	E1A binding protein p400	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1304733	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of EP400 mRNA	PMID:21346803
1312347	EP400	E1A binding protein p400	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of EP400 mRNA	PMID:30851411
1312347	EP400	E1A binding protein p400	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of EP400 protein	PMID:38348393
1312347	EP400	E1A binding protein p400	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of EP400 mRNA	PMID:21278054
1312347	EP400	E1A binding protein p400	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of EP400 mRNA	PMID:38568856
1312347	EP400	E1A binding protein p400	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1557068	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of EP400 protein	PMID:24648495
1312347	EP400	E1A binding protein p400	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of EP400 mRNA	PMID:27188386
1312347	EP400	E1A binding protein p400	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304733	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EP400 mRNA	PMID:21346803
1312347	EP400	E1A binding protein p400	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1557068	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of EP400 mRNA	PMID:28973697
1312347	EP400	E1A binding protein p400	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304733	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of EP400 mRNA	PMID:23034163
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1304734	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of ELMO3 mRNA	PMID:21551480
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1304734	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of ELMO3 mRNA	PMID:36841081
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ELMO3 mRNA	PMID:29432896
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ELMO3 mRNA	PMID:25510870
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ELMO3 mRNA	PMID:37042841
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304734	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ELMO3 mRNA	PMID:26577399
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ELMO3 mRNA	PMID:37236586
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ELMO3 mRNA	PMID:25510870
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ELMO3 mRNA	PMID:25510870
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ELMO3 gene	PMID:27153756
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ELMO3 mRNA	PMID:35430440
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of ELMO3 mRNA	PMID:19774075
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ELMO3 mRNA	PMID:22206623
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ELMO3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELMO3 mRNA	PMID:40512198
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312349	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ELMO3 mRNA	PMID:21570461
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312349	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ELMO3 mRNA	PMID:19770486
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304734	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ELMO3 mRNA	PMID:32109520
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ELMO3 mRNA	PMID:33212167
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ELMO3 mRNA	PMID:29432896
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ELMO3 mRNA	PMID:38568856
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ELMO3 mRNA	PMID:39719251
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312349	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ELMO3 mRNA	PMID:16322246
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ELMO3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELMO3 mRNA	PMID:40512198
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ELMO3 promoter	PMID:27901495
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ELMO3 mRNA	PMID:20106945
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ELMO3 exon	PMID:27901495
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ELMO3 mRNA	PMID:26238291
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312349	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ELMO3 mRNA	PMID:22228805
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312349	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of ELMO3 protein	PMID:37955338
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ELMO3 mRNA	PMID:35984750
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1304734	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ELMO3 mRNA	PMID:25729387
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304734	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ELMO3 mRNA	PMID:25729387
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304734	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of ELMO3 mRNA	PMID:23411599|PMID:34492290
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312349	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ELMO3 mRNA	PMID:28472532
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304734	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ELMO3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312349	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ELMO3 mRNA	PMID:34585602
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304734	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ELMO3 gene	PMID:28505145
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ELMO3 mRNA	PMID:25510870
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ELMO3 mRNA	PMID:25510870
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ELMO3 mRNA	PMID:37042841
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ELMO3 mRNA	PMID:38568856
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ELMO3 mRNA	PMID:37236586
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1304734	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ELMO3 mRNA	PMID:24386269
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312349	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of ELMO3 mRNA	PMID:23811191
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312349	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ELMO3 mRNA	PMID:40194260
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ELMO3 mRNA	PMID:31533062
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ELMO3 mRNA	PMID:36331819
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1304734	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of ELMO3 mRNA	PMID:22110744
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312349	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ELMO3 mRNA	PMID:17292431|PMID:17963808
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ELMO3 mRNA	PMID:29154799
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ELMO3 gene	PMID:29154799
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ELMO3 mRNA	PMID:25562108
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312349	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ELMO3 mRNA	PMID:17555576
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of ELMO3 protein	PMID:15907983
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304734	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ELMO3 mRNA	PMID:33387578
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ELMO3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELMO3 mRNA	PMID:40512198
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312349	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ELMO3 mRNA	PMID:35436446
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312349	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ELMO3 mRNA	PMID:17555576
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304734	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ELMO3 mRNA	PMID:17557909
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of ELMO3 mRNA	PMID:38825487
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312349	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ELMO3 mRNA	PMID:25620056
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304734	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ELMO3 mRNA	PMID:25729387
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1312349	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of ELMO3 mRNA	PMID:22078008
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304734	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ELMO3 mRNA	PMID:30467583
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312349	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ELMO3 mRNA	PMID:22206623
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ELMO3 mRNA	PMID:38568856
1312348	ELMO3	engulfment and cell motility 3	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312349	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of ELMO3 mRNA	PMID:35537566
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312354	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ZFR2 mRNA	PMID:33045310
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of ZFR2 mRNA	PMID:21934132
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1304737	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of ZFR2 mRNA	PMID:36841081
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312354	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFR2 mRNA	PMID:39241906
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D004958	Estradiol results in increased expression of ZFR2 protein	PMID:33181973
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312354	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFR2 mRNA	PMID:37992649
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312354	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFR2 mRNA	PMID:37992649
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304737	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ZFR2 mRNA	PMID:33387578
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of ZFR2 intron	PMID:30157460
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312354	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ZFR2 mRNA	PMID:36331819
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of ZFR2 intron	PMID:30157460
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZFR2 gene	PMID:25304211
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ZFR2 mRNA	PMID:26272509
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFR2 mRNA	PMID:27188386
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312354	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ZFR2 mRNA	PMID:28960355
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304737	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFR2 mRNA	PMID:32109520
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304737	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFR2 mRNA	PMID:33387578
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of ZFR2 mRNA	PMID:29955902
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZFR2 mRNA	PMID:33212167
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of ZFR2 mRNA	PMID:26272509
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFR2 mRNA	PMID:27188386
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312354	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFR2 mRNA	PMID:37992649
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZFR2 3' UTR; Benzo(a)pyrene affects the methylation of ZFR2 intron; Benzo(a)pyrene affects the methylation of ZFR2 promoter	PMID:27901495|PMID:30157460
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ZFR2 gene	PMID:31601247
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304737	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ZFR2 mRNA	PMID:30047161
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312354	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFR2 gene; titanium dioxide results in decreased methylation of ZFR2 promoter alternative form	PMID:35295148
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304737	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZFR2 mRNA	PMID:34492290
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304737	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of ZFR2 mRNA	PMID:30816183
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312354	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFR2 mRNA	PMID:35598803
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZFR2 gene	PMID:31601247
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of ZFR2 protein	PMID:33181973
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ZFR2 gene	PMID:31601247
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ZFR2 mRNA	PMID:25979313
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312354	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ZFR2 gene	PMID:31683443
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312354	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ZFR2 mRNA	PMID:40203079
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of ZFR2 gene	PMID:31601247
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312354	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ZFR2 exon	PMID:33297965
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304737	E	RGD:6480464	20120522	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ZFR2 mRNA	PMID:21266533
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZFR2 mRNA	PMID:38568856
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304737	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ZFR2 mRNA	PMID:25539665
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312354	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ZFR2 mRNA	PMID:39529242
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312354	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ZFR2 mRNA	PMID:36331819
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZFR2 mRNA	PMID:28001369
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZFR2 gene	PMID:29154799
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304737	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ZFR2 mRNA	PMID:30047161
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312354	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFR2 mRNA	PMID:37992649
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZFR2 gene	PMID:25304211
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304737	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ZFR2 mRNA	PMID:29391264
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312354	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ZFR2 mRNA; Nanotubes, Carbon results in decreased expression of ZFR2 mRNA	PMID:25554681
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304737	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ZFR2 mRNA	PMID:30047161
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1304737	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ZFR2 mRNA	PMID:28801915
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFR2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFR2 mRNA	PMID:27188386
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304737	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZFR2 mRNA	PMID:30047161
1312353	ZFR2	zinc finger RNA binding protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFR2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFR2 mRNA	PMID:27188386
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of UBE4B mRNA	PMID:38218311
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of UBE4B mRNA	PMID:25812627
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of UBE4B mRNA	PMID:26251327
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312356	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE4B gene	PMID:20938992
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of UBE4B mRNA	PMID:26079696
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1312356	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of UBE4B mRNA	PMID:20362636
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312356	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of UBE4B mRNA	PMID:30319688
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304738	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of UBE4B mRNA	PMID:32145629
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312356	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE4B gene	PMID:20938992
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1312356	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of UBE4B mRNA	PMID:17945193
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of UBE4B protein	PMID:20463053
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304738	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of UBE4B mRNA	PMID:26577399
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of UBE4B protein	PMID:37730182
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of UBE4B intron	PMID:30157460
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304738	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBE4B mRNA	PMID:31150632
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312356	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of UBE4B mRNA	PMID:25629700
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312356	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of UBE4B mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE4B gene	PMID:20938992|PMID:22206623
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of UBE4B mRNA	PMID:19244175
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of UBE4B protein	PMID:35688186
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of UBE4B mRNA	PMID:27594783
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of UBE4B mRNA	PMID:34813904
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE4B mRNA	PMID:22574217
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304738	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE4B mRNA	PMID:22298810
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312356	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE4B mRNA	PMID:21570461
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304738	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBE4B mRNA	PMID:33387578
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304738	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBE4B mRNA	PMID:18796159|PMID:22342509|PMID:32109520
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of UBE4B mRNA	PMID:33212167
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304738	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of UBE4B mRNA	PMID:28959563
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of UBE4B mRNA	PMID:29803840
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of UBE4B protein	PMID:35688186
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of UBE4B intron	PMID:30157460
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of UBE4B mRNA	PMID:26238291
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of UBE4B promoter	PMID:27901495
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of UBE4B gene	PMID:25435355
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to UBE4B mRNA]	PMID:32406909
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of UBE4B mRNA	PMID:20458559
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304738	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of UBE4B mRNA	PMID:30047161
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312356	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBE4B gene; titanium dioxide results in decreased methylation of UBE4B promoter	PMID:35295148
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312356	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of UBE4B mRNA	PMID:21318169
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312356	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of UBE4B mRNA]	PMID:21318169
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1312356	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of UBE4B mRNA	PMID:19191707
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304738	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of UBE4B mRNA	PMID:25181051
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE4B protein	PMID:31675489
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304738	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE4B mRNA	PMID:32145629
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of UBE4B mRNA	PMID:29275510
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304738	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of UBE4B gene	PMID:28505145
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of UBE4B protein	PMID:31675489
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of UBE4B mRNA	PMID:19244175
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of UBE4B mRNA	PMID:25979313
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of UBE4B mRNA	PMID:33297965|PMID:39298647
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of UBE4B intron	PMID:30157460
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312356	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of UBE4B intron	PMID:28392331
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of UBE4B mRNA	PMID:37019170
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304738	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of UBE4B mRNA	PMID:21266533
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of UBE4B mRNA	PMID:34813904
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of UBE4B mRNA	PMID:34813904
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBE4B mRNA	PMID:37042841
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBE4B mRNA	PMID:38382870
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304738	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of UBE4B mRNA	PMID:24386269
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of UBE4B mRNA	PMID:19244175
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of UBE4B mRNA	PMID:25812627
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of UBE4B gene	PMID:29154799
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304738	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of UBE4B mRNA	PMID:30047161|PMID:38685447|PMID:41580965
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of UBE4B mRNA	PMID:25562108
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in decreased expression of UBE4B mRNA	PMID:25270620
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312356	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UBE4B mRNA	PMID:17562736
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of UBE4B mRNA	PMID:21420995
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304738	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of UBE4B mRNA	PMID:33387578
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of UBE4B mRNA	PMID:29279043
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304738	E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in decreased expression of UBE4B mRNA	PMID:31464424
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304738	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of UBE4B mRNA	PMID:29391264
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of UBE4B mRNA	PMID:35436446
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of UBE4B mRNA	PMID:20458559
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312356	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of UBE4B mRNA; Nanotubes, Carbon results in increased expression of UBE4B mRNA	PMID:25554681|PMID:25620056
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304738	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of UBE4B mRNA	PMID:30047161|PMID:38685447|PMID:41580965
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312356	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of UBE4B mRNA	PMID:35964746
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304738	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBE4B mRNA	PMID:24136188
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UBE4B protein	PMID:32959892
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1304738	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of UBE4B mRNA	PMID:24136188
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of UBE4B mRNA	PMID:28988120
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1304738	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of UBE4B mRNA	PMID:24136188
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of UBE4B intron	PMID:30157460
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304738	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of UBE4B gene	PMID:35440735
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of UBE4B mRNA	PMID:31758290
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312356	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of UBE4B mRNA	PMID:22206623
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312356	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of UBE4B mRNA	PMID:22206623
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1304738	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of UBE4B mRNA	PMID:24136188
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:77850	toxaphene	increases expression	ISO	RGD:1304738	E	RGD:6480464	20141014	CTD	MESH:D014112	Toxaphene results in increased expression of UBE4B mRNA	PMID:23153324
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of UBE4B protein	PMID:31675489
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304738	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of UBE4B mRNA	PMID:30047161
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:9123	sertraline	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D020280	Sertraline results in decreased expression of UBE4B mRNA	PMID:24865413
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304738	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of UBE4B mRNA	PMID:21346803
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304738	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of UBE4B mRNA	PMID:21346803
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312356	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of UBE4B mRNA	PMID:28973697
1312355	UBE4B	ubiquitination factor E4B	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304738	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of UBE4B mRNA	PMID:23034163
1312357	EXOSC3	exosome component 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of EXOSC3 mRNA	PMID:21934132
1312357	EXOSC3	exosome component 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of EXOSC3 protein	PMID:39571964
1312357	EXOSC3	exosome component 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of EXOSC3 mRNA	PMID:22378314
1312357	EXOSC3	exosome component 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of EXOSC3 mRNA	PMID:20044591
1312357	EXOSC3	exosome component 3	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of EXOSC3 protein	PMID:18951874
1312357	EXOSC3	exosome component 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312358	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EXOSC3 mRNA	PMID:39241906
1312357	EXOSC3	exosome component 3	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of EXOSC3 mRNA	PMID:21179406
1312357	EXOSC3	exosome component 3	gene	CHEBI:17347	testosterone	affects expression	ISO	RGD:1312358	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone affects the expression of EXOSC3 mRNA	PMID:20403060
1312357	EXOSC3	exosome component 3	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of EXOSC3 mRNA	PMID:31256213
1312357	EXOSC3	exosome component 3	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312358	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of EXOSC3 mRNA	PMID:23892564
1312357	EXOSC3	exosome component 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304739	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EXOSC3 mRNA	PMID:33387578
1312357	EXOSC3	exosome component 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EXOSC3 mRNA	PMID:28818685
1312357	EXOSC3	exosome component 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EXOSC3 protein	PMID:23301498
1312357	EXOSC3	exosome component 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of EXOSC3 mRNA	PMID:35430440
1312357	EXOSC3	exosome component 3	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1304739	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of EXOSC3 mRNA	PMID:31129395
1312357	EXOSC3	exosome component 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312358	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EXOSC3 mRNA	PMID:31919559
1312357	EXOSC3	exosome component 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312358	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of EXOSC3 mRNA	PMID:25629700
1312357	EXOSC3	exosome component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312358	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EXOSC3 mRNA	PMID:21570461
1312357	EXOSC3	exosome component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304739	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EXOSC3 mRNA	PMID:32109520
1312357	EXOSC3	exosome component 3	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of EXOSC3 protein	PMID:18951874
1312357	EXOSC3	exosome component 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of EXOSC3 mRNA	PMID:38568856
1312357	EXOSC3	exosome component 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in decreased expression of EXOSC3 protein	PMID:39571964
1312357	EXOSC3	exosome component 3	gene	CHEBI:29866	arsenite(3-)	affects expression	EXP		E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of EXOSC3 mRNA	PMID:22959463
1312357	EXOSC3	exosome component 3	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of EXOSC3 mRNA	PMID:25895662
1312357	EXOSC3	exosome component 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of EXOSC3 mRNA	PMID:19150397|PMID:20382639
1312357	EXOSC3	exosome component 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of EXOSC3 mRNA	PMID:29275510
1312357	EXOSC3	exosome component 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304739	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EXOSC3 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1312357	EXOSC3	exosome component 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304739	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of EXOSC3 mRNA	PMID:31129395
1312357	EXOSC3	exosome component 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EXOSC3 mRNA	PMID:28628672
1312357	EXOSC3	exosome component 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EXOSC3 mRNA	PMID:28628672
1312357	EXOSC3	exosome component 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EXOSC3 mRNA	PMID:37042841
1312357	EXOSC3	exosome component 3	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1304739	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of EXOSC3 promoter	PMID:22457795
1312357	EXOSC3	exosome component 3	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of EXOSC3 mRNA	PMID:28302478
1312357	EXOSC3	exosome component 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of EXOSC3 mRNA	PMID:31533062
1312357	EXOSC3	exosome component 3	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of EXOSC3 mRNA	PMID:19167446
1312357	EXOSC3	exosome component 3	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of EXOSC3 mRNA	PMID:26352163
1312357	EXOSC3	exosome component 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of EXOSC3 mRNA	PMID:27188386
1312357	EXOSC3	exosome component 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EXOSC3 mRNA	PMID:28628672
1312357	EXOSC3	exosome component 3	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of EXOSC3 mRNA	PMID:27188386
1312357	EXOSC3	exosome component 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304739	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EXOSC3 mRNA	PMID:33387578
1312357	EXOSC3	exosome component 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EXOSC3 mRNA	PMID:28628672
1312357	EXOSC3	exosome component 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312358	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of EXOSC3 mRNA	PMID:25554681
1312357	EXOSC3	exosome component 3	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312358	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of EXOSC3 mRNA	PMID:40234311
1312357	EXOSC3	exosome component 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312358	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EXOSC3 mRNA	PMID:35964746
1312357	EXOSC3	exosome component 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312358	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of EXOSC3 mRNA	PMID:19042947
1312357	EXOSC3	exosome component 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EXOSC3 protein	PMID:32959892
1312357	EXOSC3	exosome component 3	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1312358	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of EXOSC3 mRNA	PMID:28444820
1312357	EXOSC3	exosome component 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312358	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EXOSC3 mRNA	PMID:22206623
1312357	EXOSC3	exosome component 3	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of EXOSC3 protein	PMID:31285264
1312357	EXOSC3	exosome component 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EXOSC3 gene]	PMID:28238834
1312357	EXOSC3	exosome component 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312358	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of EXOSC3 mRNA	PMID:30294300
1312357	EXOSC3	exosome component 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of EXOSC3 mRNA	PMID:38568856
1312357	EXOSC3	exosome component 3	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304739	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of EXOSC3 mRNA	PMID:23034163
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PGBD2 mRNA	PMID:37042841
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of PGBD2 mRNA	PMID:33647349
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PGBD2 mRNA	PMID:28818685
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PGBD2 mRNA	PMID:19549813
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PGBD2 mRNA	PMID:23649840
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PGBD2 mRNA	PMID:23649840
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of PGBD2 mRNA	PMID:23195993
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of PGBD2 mRNA	PMID:29955902
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of PGBD2 mRNA	PMID:34032870
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PGBD2 mRNA	PMID:26238291
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of PGBD2 mRNA	PMID:35984750
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PGBD2 mRNA	PMID:37042841
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of PGBD2 mRNA	PMID:29024780
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PGBD2 mRNA	PMID:31533062
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PGBD2 mRNA	PMID:25562108
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of PGBD2 mRNA	PMID:36318118
1312360	PGBD2	piggyBac transposable element derived 2	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of PGBD2 mRNA	PMID:27188386
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of RAB37 mRNA	PMID:35967413
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RAB37 mRNA	PMID:26272509|PMID:27188386
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312362	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RAB37 mRNA	PMID:33045310
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:132446	perfluorobutanesulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C539348	perfluorobutanesulfonic acid results in increased expression of RAB37 mRNA	PMID:40334771
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RAB37 mRNA	PMID:33167477
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RAB37 mRNA	PMID:35811015
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of RAB37 mRNA	PMID:30510588
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of RAB37 mRNA	PMID:31614463
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:2319982	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RAB37 mRNA	PMID:32741896
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RAB37 mRNA	PMID:37042841
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RAB37 mRNA	PMID:33359661
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:2319982	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RAB37 mRNA	PMID:32741896
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RAB37 mRNA	PMID:21641981
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:2319982	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of RAB37 mRNA	PMID:31129395
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RAB37 gene	PMID:25304211
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of RAB37 mRNA	PMID:38460933
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of RAB37 mRNA	PMID:38460933
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of RAB37 mRNA	PMID:38460933
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312362	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of RAB37 mRNA	PMID:28960355
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RAB37 mRNA	PMID:27392435
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of RAB37 mRNA	PMID:27392435
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of RAB37 promoter	PMID:22847954
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312362	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of RAB37 mRNA	PMID:32186404
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312362	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RAB37 mRNA	PMID:21354282
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of RAB37 mRNA	PMID:29955902
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of RAB37 mRNA	PMID:21198554
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312362	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of RAB37 protein	PMID:27548804
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:28854	2,4-D	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of RAB37 mRNA	PMID:40294809
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312362	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of RAB37 mRNA	PMID:37682722
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	decreases methylation	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased methylation of RAB37 intron	PMID:32844245
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of RAB37 mRNA	PMID:29301061|PMID:32844245|PMID:34032870|PMID:38568856
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RAB37 exon; Benzo(a)pyrene affects the methylation of RAB37 promoter	PMID:27901495
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RAB37 3' UTR; Benzo(a)pyrene results in increased methylation of RAB37 5' UTR	PMID:27901495
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of RAB37 promoter	PMID:23974009
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RAB37 mRNA	PMID:25895662
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312362	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RAB37 mRNA	PMID:29341224
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312362	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RAB37 promoter	PMID:35295148
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312362	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of RAB37 mRNA	PMID:30951980
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:2319982	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of RAB37 mRNA	PMID:31129395
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312362	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RAB37 mRNA	PMID:39298647
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312362	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of RAB37 mRNA	PMID:30951980
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RAB37 intron	PMID:30157460
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312362	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RAB37 mRNA	PMID:30951980
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312362	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RAB37 mRNA	PMID:28392331
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312362	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RAB37 intron	PMID:28392331
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RAB37 mRNA	PMID:38382870
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of RAB37 promoter	PMID:22847954
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of RAB37 promoter	PMID:22847954
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312362	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of RAB37 mRNA	PMID:39529242
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RAB37 mRNA	PMID:25979313
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of RAB37 mRNA	PMID:28001369|PMID:29154799
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RAB37 gene	PMID:29154799
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of RAB37 mRNA	PMID:20106945
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RAB37 mRNA	PMID:38832940
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RAB37 mRNA	PMID:24935251
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of RAB37 mRNA	PMID:29067470
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RAB37 mRNA	PMID:35811015
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of RAB37 mRNA	PMID:38460933
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RAB37 gene	PMID:25304211
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:53050	trimellitic anhydride	decreases methylation	ISO	RGD:1312362	E	RGD:6480464	20140610	CTD	MESH:C015559	trimellitic anhydride results in decreased methylation of RAB37 promoter	PMID:24675093
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312362	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RAB37 mRNA	PMID:38701926
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RAB37 intron	PMID:30157460
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:2319982	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RAB37 mRNA	PMID:32741896
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RAB37 gene]	PMID:28238834
1312361	RAB37	RAB37, member RAS oncogene family	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of RAB37 mRNA	PMID:29301935
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of UST mRNA	PMID:36331819
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of UST mRNA	PMID:39506029
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304743	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of UST gene	PMID:28931070|PMID:35440735
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550016	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of UST mRNA	PMID:30319688
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of UST mRNA	PMID:35811015
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of UST mRNA	PMID:39298647
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of UST mRNA	PMID:30165855
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone promotes the reaction [Biomarkers metabolite binds to UST gene]	PMID:31084621
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of UST mRNA	PMID:23649840
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of UST mRNA	PMID:20864642
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UST mRNA	PMID:37992649
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UST mRNA	PMID:37992649
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304743	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of UST mRNA	PMID:26577399
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of UST mRNA	PMID:16002434
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of UST intron	PMID:30157460
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of UST mRNA	PMID:19549813
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of UST mRNA	PMID:23649840
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of UST intron	PMID:30157460
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of UST mRNA	PMID:22100608
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of UST mRNA	PMID:23649840
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of UST mRNA	PMID:32553695
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1550016	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of UST mRNA	PMID:18579281
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304743	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of UST mRNA	PMID:30779732
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of UST mRNA	PMID:25629700
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1304743	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of UST gene	PMID:35440735
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304743	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of UST mRNA	PMID:31881176
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of UST mRNA	PMID:19371625
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with panobinostat] affects the expression of UST mRNA	PMID:21791302
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UST mRNA	PMID:19933214
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304743	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UST mRNA	PMID:33387578
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of UST mRNA	PMID:33212167
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:28509	chloroethene	increases expression	ISO	RGD:1550016	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in increased expression of UST mRNA	PMID:18579281
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of UST mRNA	PMID:30807115
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of UST mRNA	PMID:29803840
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UST mRNA	PMID:37992649
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of UST mRNA	PMID:39515575
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UST mRNA	PMID:38568856
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of and affects the splicing of UST mRNA	PMID:25879800
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1550016	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of UST 3' UTR; Benzo(a)pyrene results in decreased methylation of UST exon; Benzo(a)pyrene results in decreased methylation of UST intron	PMID:27901495
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1550016	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of UST mRNA	PMID:27131904
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of UST mRNA	PMID:25895662
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of UST mRNA	PMID:29264374
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550016	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UST gene	PMID:35295148
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304743	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of UST mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550016	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in decreased expression of UST mRNA	PMID:39742910
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of UST gene	PMID:31601247
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of UST mRNA	PMID:29275510
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304743	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of UST gene	PMID:28505145
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of UST mRNA	PMID:25979313
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of UST gene	PMID:31601247
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550016	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of UST intron	PMID:28392331
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UST mRNA	PMID:37042841
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of UST mRNA	PMID:24449571
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of UST mRNA	PMID:31533062
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UST mRNA	PMID:19167446
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1550016	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of UST mRNA	PMID:39529242
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of UST mRNA	PMID:40419075
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of UST mRNA	PMID:36331819
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of UST mRNA	PMID:28001369
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of UST mRNA	PMID:23179753|PMID:27188386
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of UST gene	PMID:29154799
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of UST mRNA	PMID:20106945
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550016	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UST mRNA	PMID:37992649
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of UST mRNA	PMID:26690555|PMID:29067470
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304743	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of UST mRNA	PMID:33387578
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of UST mRNA	PMID:35811015
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of UST mRNA	PMID:35811015
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304743	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of UST mRNA	PMID:29391264
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of UST mRNA	PMID:31758290
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:78492	diallyl trisulfide	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in increased expression of UST mRNA	PMID:34995734
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of UST mRNA	PMID:30928695
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304743	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of UST mRNA	PMID:32109520
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UST mRNA	PMID:19167446
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304743	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of UST mRNA	PMID:24780913
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[Cisplatin co-treated with panobinostat] affects the expression of UST mRNA	PMID:21791302
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1550016	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of UST mRNA	PMID:27131904
1312363	UST	uronyl 2-sulfotransferase	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1304743	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of UST gene	PMID:31079544
1312365	STX11	syntaxin 11	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of STX11 mRNA	PMID:33167477
1312365	STX11	syntaxin 11	gene	CHEBI:15767	dichloromethane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008752	Methylene Chloride results in increased expression of STX11 mRNA	PMID:20359517
1312365	STX11	syntaxin 11	gene	CHEBI:16101	ethylbenzene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004912	ethylbenzene results in increased expression of STX11 mRNA	PMID:20359517
1312365	STX11	syntaxin 11	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of STX11 mRNA	PMID:35811015
1312365	STX11	syntaxin 11	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312366	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of STX11 mRNA	PMID:39241906
1312365	STX11	syntaxin 11	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STX11 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of STX11 mRNA	PMID:35811015
1312365	STX11	syntaxin 11	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312366	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of STX11 mRNA	PMID:39298647
1312365	STX11	syntaxin 11	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of STX11 mRNA	PMID:31614463
1312365	STX11	syntaxin 11	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304744	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STX11 mRNA	PMID:32741896
1312365	STX11	syntaxin 11	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of STX11 mRNA	PMID:20359517
1312365	STX11	syntaxin 11	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of STX11 mRNA	PMID:37042841
1312365	STX11	syntaxin 11	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in increased expression of STX11 mRNA	PMID:20359517
1312365	STX11	syntaxin 11	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312366	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of STX11 mRNA	PMID:37992649
1312365	STX11	syntaxin 11	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304744	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STX11 mRNA	PMID:32741896
1312365	STX11	syntaxin 11	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of STX11 mRNA	PMID:33647349
1312365	STX11	syntaxin 11	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014050	Toluene results in increased expression of STX11 mRNA	PMID:20359517
1312365	STX11	syntaxin 11	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312366	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of STX11 mRNA	PMID:37992649
1312365	STX11	syntaxin 11	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304744	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of STX11 mRNA	PMID:33387578
1312365	STX11	syntaxin 11	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of STX11 mRNA	PMID:28818685
1312365	STX11	syntaxin 11	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304744	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of STX11 mRNA	PMID:39012411
1312365	STX11	syntaxin 11	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of STX11 mRNA	PMID:22100608
1312365	STX11	syntaxin 11	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of STX11 mRNA	PMID:26760959
1312365	STX11	syntaxin 11	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of STX11 mRNA	PMID:23649840
1312365	STX11	syntaxin 11	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of STX11 mRNA	PMID:41430723
1312365	STX11	syntaxin 11	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of STX11 mRNA	PMID:19774075
1312365	STX11	syntaxin 11	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1304744	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of STX11 gene	PMID:35440735
1312365	STX11	syntaxin 11	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312366	E	RGD:6480464	20240604	CTD	MESH:C010974	Glyphosate results in decreased expression of STX11 mRNA	PMID:33713393
1312365	STX11	syntaxin 11	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312366	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of STX11 mRNA	PMID:28960355
1312365	STX11	syntaxin 11	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304744	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of STX11 mRNA	PMID:31881176
1312365	STX11	syntaxin 11	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of STX11 mRNA	PMID:27392435
1312365	STX11	syntaxin 11	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of STX11 mRNA	PMID:27594783
1312365	STX11	syntaxin 11	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of STX11 mRNA	PMID:27392435
1312365	STX11	syntaxin 11	gene	CHEBI:28063	o-xylene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C026114	2-xylene results in increased expression of STX11 mRNA	PMID:20359517
1312365	STX11	syntaxin 11	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of STX11 mRNA	PMID:24768652|PMID:25583101
1312365	STX11	syntaxin 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STX11 mRNA	PMID:22298810
1312365	STX11	syntaxin 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304744	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STX11 mRNA	PMID:22298810
1312365	STX11	syntaxin 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of STX11 mRNA	PMID:17101203
1312365	STX11	syntaxin 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304744	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of STX11 mRNA	PMID:33387578
1312365	STX11	syntaxin 11	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of STX11 mRNA	PMID:33212167
1312365	STX11	syntaxin 11	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312366	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of STX11 mRNA	PMID:37992649
1312365	STX11	syntaxin 11	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of STX11 mRNA	PMID:38568856
1312365	STX11	syntaxin 11	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STX11 5' UTR	PMID:27901495
1312365	STX11	syntaxin 11	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312366	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STX11 mRNA	PMID:21569818
1312365	STX11	syntaxin 11	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of STX11 3' UTR	PMID:27901495
1312365	STX11	syntaxin 11	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STX11 mRNA	PMID:32234424
1312365	STX11	syntaxin 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of STX11 promoter	PMID:27901495
1312365	STX11	syntaxin 11	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of STX11 mRNA	PMID:25895662
1312365	STX11	syntaxin 11	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304744	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of STX11 mRNA	PMID:34492290
1312365	STX11	syntaxin 11	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of STX11 mRNA	PMID:30690063
1312365	STX11	syntaxin 11	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304744	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of STX11 mRNA	PMID:25181051
1312365	STX11	syntaxin 11	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of STX11 mRNA	PMID:31715268
1312365	STX11	syntaxin 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312366	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of STX11 mRNA	PMID:32156529
1312365	STX11	syntaxin 11	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1312366	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of STX11 mRNA	PMID:25172293
1312365	STX11	syntaxin 11	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312366	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of STX11 mRNA	PMID:26682919
1312365	STX11	syntaxin 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of STX11 gene	PMID:31601247
1312365	STX11	syntaxin 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312366	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of STX11 mRNA	PMID:40203079
1312365	STX11	syntaxin 11	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304744	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of STX11 mRNA	PMID:21266533
1312365	STX11	syntaxin 11	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of STX11 mRNA	PMID:17374397
1312365	STX11	syntaxin 11	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of STX11 mRNA	PMID:37042841
1312365	STX11	syntaxin 11	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304744	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of STX11 mRNA	PMID:39012411
1312365	STX11	syntaxin 11	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of STX11 mRNA	PMID:24449571
1312365	STX11	syntaxin 11	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of STX11 mRNA	PMID:31533062
1312365	STX11	syntaxin 11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of STX11 mRNA	PMID:40419075
1312365	STX11	syntaxin 11	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312366	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of STX11 mRNA	PMID:29038090
1312365	STX11	syntaxin 11	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1304744	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of STX11 mRNA	PMID:23125180
1312365	STX11	syntaxin 11	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1312366	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of STX11 mRNA	PMID:23125180
1312365	STX11	syntaxin 11	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of STX11 gene	PMID:29154799
1312365	STX11	syntaxin 11	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of STX11 mRNA	PMID:17183730
1312365	STX11	syntaxin 11	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312366	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of STX11 mRNA	PMID:37992649
1312365	STX11	syntaxin 11	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of STX11 mRNA	PMID:38832940
1312365	STX11	syntaxin 11	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312366	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of STX11 mRNA	PMID:17562736
1312365	STX11	syntaxin 11	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of STX11 mRNA	PMID:29067470
1312365	STX11	syntaxin 11	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304744	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of STX11 mRNA	PMID:33387578
1312365	STX11	syntaxin 11	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STX11 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of STX11 mRNA	PMID:35811015
1312365	STX11	syntaxin 11	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304744	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of STX11 mRNA	PMID:29391264
1312365	STX11	syntaxin 11	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STX11 mRNA	PMID:22079256
1312365	STX11	syntaxin 11	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304744	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of STX11 mRNA	PMID:30307764
1312365	STX11	syntaxin 11	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312366	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of STX11 mRNA	PMID:25554681
1312365	STX11	syntaxin 11	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312366	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of STX11 mRNA	PMID:35964746
1312365	STX11	syntaxin 11	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	ISO	RGD:1304744	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of STX11 mRNA	PMID:21983209
1312365	STX11	syntaxin 11	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C029938	nickel sulfate results in increased expression of STX11 mRNA	PMID:16780908|PMID:17374397
1312365	STX11	syntaxin 11	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010081	Oxazolone results in increased expression of STX11 mRNA	PMID:17374397
1312365	STX11	syntaxin 11	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of STX11 mRNA	PMID:31629900
1312365	STX11	syntaxin 11	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of STX11 mRNA	PMID:17183730
1312365	STX11	syntaxin 11	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312366	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of STX11 mRNA	PMID:21641980
1312365	STX11	syntaxin 11	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1312366	E	RGD:6480464	20141111	CTD	MESH:D002185	Cannabidiol results in increased expression of STX11 mRNA	PMID:21542829
1312365	STX11	syntaxin 11	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of STX11 mRNA	PMID:31758290
1312365	STX11	syntaxin 11	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312366	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of STX11 mRNA	PMID:22206623
1312365	STX11	syntaxin 11	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of STX11 mRNA	PMID:22079256|PMID:22714537
1312365	STX11	syntaxin 11	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STX11 mRNA	PMID:22079256
1312365	STX11	syntaxin 11	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1304744	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of STX11 mRNA	PMID:32741896
1312365	STX11	syntaxin 11	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to STX11 gene]	PMID:28238834
1312365	STX11	syntaxin 11	gene	CHEBI:8093	phenylephrine	affects expression	ISO	RGD:1304744	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine affects the expression of STX11 mRNA	PMID:18158353
1312365	STX11	syntaxin 11	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of STX11 mRNA	PMID:38568856
1312365	STX11	syntaxin 11	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of STX11 mRNA	PMID:19140230
1312367	UBTFL1	upstream binding transcription factor like 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1622623	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of UBTFL1 mRNA	PMID:37315490
1312367	UBTFL1	upstream binding transcription factor like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of UBTFL1 exon	PMID:27901495
1312367	UBTFL1	upstream binding transcription factor like 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1622623	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of UBTFL1 mRNA	PMID:40194260
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:C007262	deoxynivalenol results in decreased expression of MBD2 protein	PMID:40749799
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:C007262	deoxynivalenol results in increased expression of MBD2 mRNA	PMID:40749799
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of MBD2 mRNA	PMID:27188386
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312369	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MBD2 gene	PMID:20938992
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of MBD2 mRNA	PMID:21934132
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MBD2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of MBD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MBD2 mRNA	PMID:32699268|PMID:32845096
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:15414	S-adenosyl-L-methionine	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D012436	S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in increased expression of MBD2 protein]	PMID:22558281
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of MBD2 mRNA	PMID:24763279
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1312369	E	RGD:6480464	20140211	CTD	MESH:D000431	Ethanol results in decreased expression of MBD2 mRNA; Ethanol results in decreased expression of MBD2 protein	PMID:23395981
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:16236	ethanol	increases degradation	ISO	RGD:1312369	E	RGD:6480464	20140211	CTD	MESH:D000431	Ethanol results in increased degradation of MBD2 protein	PMID:23395981
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312369	E	RGD:6480464	20140211	CTD	MESH:D000431	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Ethanol results in increased degradation of MBD2 protein]	PMID:23395981
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312369	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MBD2 mRNA	PMID:39241906
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:16469	17beta-estradiol	increases activity	EXP		E	RGD:6480464	20190312	CTD	MESH:D004958	Estradiol results in increased activity of MBD2 protein	PMID:30684530
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D004958	Estradiol results in increased expression of MBD2 mRNA	PMID:30684530
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [MBD2 protein binds to BRCA1 promoter]; Estradiol promotes the reaction [MBD2 protein binds to COMT promoter]; Resveratrol inhibits the reaction [[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [MBD2 protein binds to BRCA1 promoter]]; sulforaphane inhibits the reaction [Estradiol promotes the reaction [MBD2 protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Estradiol results in increased activity of MBD2 protein]; sulforaphane inhibits the reaction [Estradiol results in increased expression of MBD2 mRNA]	PMID:20631324|PMID:30684530
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1595452	E	RGD:6480464	20171010	CTD	MESH:D004958	[Testosterone co-treated with Estradiol] promotes the reaction [bisphenol A results in increased expression of MBD2 mRNA]; [Testosterone co-treated with Estradiol] promotes the reaction [estradiol-17 beta-benzoate results in increased expression of MBD2 mRNA]	PMID:22109888
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1595452	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of MBD2 gene	PMID:27618143
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312369	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MBD2 gene	PMID:20938992
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MBD2 mRNA	PMID:37042841
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D005557	Formaldehyde results in increased expression of MBD2 mRNA; Formaldehyde results in increased expression of MBD2 protein	PMID:21745553
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1595452	E	RGD:6480464	20171010	CTD	MESH:D013739	[Testosterone co-treated with Estradiol] promotes the reaction [bisphenol A results in increased expression of MBD2 mRNA]; [Testosterone co-treated with Estradiol] promotes the reaction [estradiol-17 beta-benzoate results in increased expression of MBD2 mRNA]	PMID:22109888
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C031927	hydroquinone results in decreased expression of MBD2 mRNA	PMID:22245671
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C031927	hydroquinone results in increased expression of MBD2 protein	PMID:30448557
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:17594	hydroquinone	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C031927	PARP1 protein affects the reaction [hydroquinone results in increased expression of MBD2 protein]	PMID:30448557
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312369	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MBD2 mRNA	PMID:33754040
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1595452	E	RGD:6480464	20150310	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MBD2 mRNA	PMID:25280772
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312369	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MBD2 mRNA	PMID:19770486
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MBD2 mRNA	PMID:23649840
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MBD2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of MBD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MBD2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of MBD2 mRNA	PMID:32699268|PMID:32845096
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312369	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MBD2 mRNA	PMID:31919559
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:27470	folic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid affects the expression of MBD2 mRNA	PMID:17311948
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312369	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MBD2 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MBD2 mRNA]	PMID:20938992|PMID:22206623
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MBD2 gene	PMID:25304211
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MBD2 mRNA	PMID:26272509
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD2 mRNA	PMID:27188386
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MBD2 protein	PMID:35688186
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol inhibits the reaction [[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [MBD2 protein binds to BRCA1 promoter]]; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [MBD2 protein binds to BRCA1 promoter]]	PMID:20631324|PMID:22197621
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:28088	genistein	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased activity of MBD2 protein	PMID:19221000
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:28088	genistein	increases activity	EXP		E	RGD:6480464	20190312	CTD	MESH:D019833	Genistein results in increased activity of MBD2 protein	PMID:30684530
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312369	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of MBD2 mRNA	PMID:32186404
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:D019833	Genistein promotes the reaction [MBD2 protein binds to COMT promoter]; sulforaphane inhibits the reaction [Genistein promotes the reaction [MBD2 protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Genistein results in increased activity of MBD2 protein]	PMID:30684530
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1595452	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MBD2 mRNA	PMID:34747641
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [MBD2 protein binds to BRCA1 promoter]; resveratrol inhibits the reaction [[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [MBD2 protein binds to BRCA1 promoter]]; resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [MBD2 protein binds to BRCA1 promoter]]; Tetrachlorodibenzodioxin inhibits the reaction [MBD2 protein binds to BRCA1 promoter]; Tetrachlorodibenzodioxin promotes the reaction [MBD2 protein binds to BRCA1 promoter]	PMID:20631324|PMID:22197621
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MBD2 mRNA	PMID:29803840
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of MBD2 protein	PMID:35688186
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1312369	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of MBD2 mRNA	PMID:20829426
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased expression of MBD2 mRNA	PMID:32844245
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MBD2 promoter	PMID:27901495
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MBD2 mRNA	PMID:25351596
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MBD2 mRNA	PMID:20382639
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MBD2 protein	PMID:22558281
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide results in increased expression of MBD2 protein]	PMID:22558281
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:3090	bicalutamide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of MBD2 mRNA	PMID:16631469
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1595452	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MBD2 mRNA	PMID:34492290
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312369	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MBD2 mRNA	PMID:33221593
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1595452	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MBD2 mRNA	PMID:30816183|PMID:32528016
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312369	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of MBD2 mRNA	PMID:30892605
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1595452	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MBD2 mRNA	PMID:22109888|PMID:25181051
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of MBD2 gene	PMID:31601247
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1595452	E	RGD:6480464	20171010	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MBD2 mRNA; [Testosterone co-treated with Estradiol] promotes the reaction [bisphenol A results in increased expression of MBD2 mRNA]	PMID:22109888|PMID:36041667
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1595452	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MBD2 mRNA	PMID:36041667
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MBD2 mRNA	PMID:28628672
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1595452	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MBD2 mRNA	PMID:36041667
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MBD2 mRNA	PMID:28628672
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312369	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of MBD2 mRNA	PMID:34813904
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of MBD2 mRNA	PMID:37047231
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MBD2 mRNA	PMID:37042841
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1595452	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MBD2 mRNA	PMID:33453195
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MBD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MBD2 mRNA	PMID:32699268
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:38221	fumonisin B1	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:C056933	fumonisin B1 results in increased expression of and results in increased activity of MBD2 protein	PMID:24280379
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid affects the expression of MBD2 mRNA	PMID:23179753
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of MBD2 mRNA	PMID:24383497|PMID:26272509|PMID:27188386
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312369	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of MBD2 mRNA	PMID:21427059
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD2 mRNA	PMID:27188386
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MBD2 mRNA	PMID:28628672
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1312369	E	RGD:6480464	20140513	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MBD2 mRNA	PMID:24316720
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of MBD2 mRNA	PMID:24935251
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C012589	[decitabine co-treated with trichostatin A] inhibits the reaction [MBD2 protein binds to CLDN3 promoter]	PMID:17986852
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312369	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MBD2 mRNA	PMID:17562736
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1595452	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MBD2 mRNA	PMID:33387578
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:46938	zebularine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C009131	pyrimidin-2-one beta-ribofuranoside results in decreased expression of MBD2 protein	PMID:19459041
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MBD2 gene	PMID:25304211
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:47807	sulforaphane	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane inhibits the reaction [Estradiol promotes the reaction [MBD2 protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Estradiol results in increased activity of MBD2 protein]; sulforaphane inhibits the reaction [Estradiol results in increased expression of MBD2 mRNA]; sulforaphane inhibits the reaction [Genistein promotes the reaction [MBD2 protein binds to COMT promoter]]; sulforaphane inhibits the reaction [Genistein results in increased activity of MBD2 protein]	PMID:30684530
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of MBD2 mRNA	PMID:26272509
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD2 mRNA	PMID:27188386
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MBD2 mRNA	PMID:28628672
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MBD2 protein	PMID:22558281
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	S-Adenosylmethionine inhibits the reaction [Arsenic Trioxide results in increased expression of MBD2 protein]	PMID:22558281
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases activity	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased activity of MBD2 protein	PMID:19221000
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with trichostatin A] inhibits the reaction [MBD2 protein binds to CLDN3 promoter]; Decitabine inhibits the reaction [MBD2 protein binds to BUB1B promoter]; Decitabine inhibits the reaction [MBD2 protein binds to CLDN3 promoter]	PMID:17464181|PMID:17986852
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1595452	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Dust results in increased expression of MBD2 mRNA]; Decitabine inhibits the reaction [Dust results in increased expression of MBD2 protein]	PMID:30815999
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312369	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MBD2 mRNA; Nanotubes, Carbon results in increased expression of MBD2 mRNA	PMID:25554681
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1595452	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MBD2 mRNA	PMID:24136188
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312369	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MBD2 mRNA	PMID:35964746
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1595452	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MBD2 mRNA	PMID:24136188
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312369	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of MBD2 mRNA	PMID:23650126
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:67040	S-adenosyl-L-methioninate	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:D012436	S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in increased expression of MBD2 protein]	PMID:22558281
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312369	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MBD2 mRNA	PMID:22206623
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312369	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MBD2 mRNA]	PMID:22206623
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:74926	patulin	increases expression	ISO	RGD:1312369	E	RGD:6480464	20250401	CTD	MESH:D010365	Patulin results in increased expression of MBD2 mRNA	PMID:38806716
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1312369	E	RGD:6480464	20140211	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Ethanol results in increased degradation of MBD2 protein]	PMID:23395981
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD2 mRNA	PMID:27188386
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312369	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MBD2 mRNA	PMID:23091169
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD2 mRNA	PMID:27188386
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:9352	sulindac	decreases expression	ISO	RGD:1595452	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of MBD2 mRNA	PMID:24136188
1312368	MBD2	methyl-CpG binding domain protein 2	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MBD2 mRNA	PMID:27188386
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ADCY9 mRNA	PMID:33045310
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:132446	perfluorobutanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C539348	perfluorobutanesulfonic acid results in decreased expression of ADCY9 mRNA	PMID:40334771
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:132446	perfluorobutanesulfonic acid	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C539348	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] affects the expression of ADCY9 mRNA	PMID:40334771
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304747	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADCY9 mRNA]	PMID:31150632
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ADCY9 mRNA	PMID:26079696
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312371	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ADCY9 mRNA	PMID:30319688
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312371	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ADCY9 mRNA	PMID:30319688
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1304747	E	RGD:6480464	20130312	CTD	MESH:D000431	Ethanol results in increased expression of ADCY9 mRNA	PMID:20655511
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312371	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ADCY9 mRNA	PMID:30319688
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ADCY9 mRNA	PMID:39241906
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ADCY9 mRNA	PMID:30510588
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ADCY9 mRNA	PMID:31614463
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1304747	E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in increased expression of ADCY9 mRNA	PMID:35192832
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312371	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ADCY9 mRNA	PMID:39298647
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304747	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of ADCY9 mRNA	PMID:26496021
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of ADCY9 gene	PMID:30521419
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1304747	E	RGD:6480464	20130312	CTD	MESH:D005557	Formaldehyde results in increased expression of ADCY9 mRNA	PMID:14756816
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304747	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ADCY9 mRNA	PMID:26577399
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ADCY9 protein	PMID:37730182
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:17833	gentamycin	affects expression	ISO	RGD:1304747	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins affects the expression of ADCY9 mRNA	PMID:33387578
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ADCY9 mRNA	PMID:36331819
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20251104	CTD	MESH:D002104	Cadmium results in decreased expression of ADCY9 mRNA	PMID:29656123
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20251104	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADCY9 mRNA; Selenium inhibits the reaction [Cadmium results in decreased expression of ADCY9 mRNA]	PMID:29656123|PMID:38382403
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:22984	calcium atom	multiple interactions	EXP		E	RGD:6480464	20201103	CTD	MESH:D002118	Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]; Tacrolimus inhibits the reaction [Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]]	PMID:30607468
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ADCY9 intron	PMID:30157460
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304747	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADCY9 mRNA	PMID:31150632
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADCY9 mRNA	PMID:31919559
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304747	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADCY9 mRNA]	PMID:31150632
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ADCY9 mRNA]	PMID:22206623
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADCY9 gene	PMID:25304211
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ADCY9 mRNA	PMID:39836092
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20251104	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of ADCY9 mRNA]	PMID:29656123
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ADCY9 protein	PMID:35688186
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in decreased expression of ADCY9 mRNA	PMID:22610192
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ADCY9 mRNA	PMID:28903495
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ADCY9 mRNA	PMID:27392435
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312371	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADCY9 mRNA	PMID:20702594
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304747	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADCY9 mRNA	PMID:21215274|PMID:33387578
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADCY9 mRNA	PMID:20106945|PMID:21632981
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADCY9 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ADCY9 mRNA	PMID:17942748|PMID:25975270
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304747	E	RGD:6480464	20130312	CTD	MESH:D012402	Rotenone results in increased expression of ADCY9 mRNA	PMID:19013527|PMID:28374803
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ADCY9 protein	PMID:35688186
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:29320	calcium(0)	multiple interactions	EXP		E	RGD:6480464	20201103	CTD	MESH:D002118	Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]; Tacrolimus inhibits the reaction [Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]]	PMID:30607468
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADCY9 mRNA	PMID:35202923
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312371	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of ADCY9 mRNA	PMID:36209798
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ADCY9 mRNA	PMID:39836092
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20240430	CTD	MESH:C017947	salvin inhibits the reaction [sodium arsenite results in decreased expression of ADCY9 mRNA]	PMID:35202923
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADCY9 3' UTR	PMID:27901495
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADCY9 mRNA	PMID:20064835
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADCY9 mRNA	PMID:30453624
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312371	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADCY9 mRNA	PMID:22228805
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312371	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADCY9 3' UTR; Benzo(a)pyrene results in increased methylation of ADCY9 exon	PMID:27901495
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ADCY9 mRNA	PMID:25895662
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ADCY9 mRNA	PMID:19150397|PMID:26238291
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ADCY9 mRNA	PMID:15761015
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:31429	colforsin daropate hydrochloride	increases activity	ISO	RGD:1312371	E	RGD:6480464	20201103	CTD	MESH:D005576	Colforsin results in increased activity of ADCY9 protein	PMID:30607468
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:31429	colforsin daropate hydrochloride	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20201103	CTD	MESH:D005576	[Colforsin co-treated with Miconazole] results in increased activity of ADCY9 protein	PMID:30607468
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304747	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ADCY9 mRNA	PMID:34492290
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ADCY9 mRNA	PMID:15375163
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304747	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of ADCY9 mRNA	PMID:32145629
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ADCY9 gene	PMID:31601247
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ADCY9 mRNA	PMID:29275510
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304747	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ADCY9 mRNA	PMID:25181051|PMID:29097150|PMID:41034487
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304747	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ADCY9 gene	PMID:28505145
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304747	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ADCY9 mRNA; [bisphenol A co-treated with Estradiol] results in increased expression of ADCY9 mRNA	PMID:26496021|PMID:36041667
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of ADCY9 mRNA	PMID:24752500
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ADCY9 mRNA	PMID:39298647
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ADCY9 gene	PMID:31601247
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312371	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ADCY9 mRNA	PMID:40203079
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304747	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ADCY9 mRNA	PMID:36041667
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304747	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ADCY9 mRNA	PMID:36041667
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ADCY9 mRNA	PMID:28392331
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312371	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ADCY9 intron	PMID:28392331
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1304747	E	RGD:6480464	20130312	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ADCY9 mRNA	PMID:17452286
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:34682	diazinon	decreases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of ADCY9 gene	PMID:22964155
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304747	E	RGD:6480464	20130312	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ADCY9 mRNA	PMID:21266533
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ADCY9 mRNA	PMID:34813904
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1304747	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ADCY9 mRNA	PMID:32680482
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADCY9 mRNA	PMID:37042841
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20251104	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADCY9 mRNA	PMID:38382403
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ADCY9 mRNA	PMID:40334771
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C023036	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] affects the expression of ADCY9 mRNA	PMID:40334771
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ADCY9 mRNA	PMID:24449571
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20251104	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of ADCY9 mRNA]	PMID:29656123
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:3764	clotrimazole	decreases activity	EXP		E	RGD:6480464	20201103	CTD	MESH:D003022	Clotrimazole results in decreased activity of ADCY9 protein	PMID:30607468
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:3764	clotrimazole	decreases activity	ISO	RGD:1312371	E	RGD:6480464	20201103	CTD	MESH:D003022	Clotrimazole results in decreased activity of ADCY9 protein	PMID:30607468
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312371	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADCY9 mRNA	PMID:40194260
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ADCY9 mRNA	PMID:28302478
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312371	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ADCY9 mRNA	PMID:39529242
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ADCY9 mRNA	PMID:40334771
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] affects the expression of ADCY9 mRNA	PMID:40334771
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ADCY9 mRNA	PMID:36331819
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of ADCY9 mRNA	PMID:15713895
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ADCY9 mRNA	PMID:25979313
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312371	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ADCY9 mRNA	PMID:17292431
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1304747	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of ADCY9 mRNA	PMID:29427782
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ADCY9 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY9 mRNA	PMID:27188386
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304747	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of ADCY9 mRNA	PMID:38685447
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304747	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ADCY9 mRNA	PMID:41580965
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ADCY9 mRNA	PMID:20106945|PMID:25562108
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of ADCY9 mRNA]	PMID:21233418
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:4469	(S)-amphetamine	increases expression	ISO	RGD:1312371	E	RGD:6480464	20120412	CTD	MESH:D003913	Dextroamphetamine results in increased expression of ADCY9 mRNA	PMID:12558987
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ADCY9 mRNA	PMID:24935251|PMID:26272509
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY9 mRNA	PMID:27188386
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312371	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ADCY9 mRNA	PMID:17562736
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADCY9 mRNA	PMID:21420995
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of ADCY9 mRNA	PMID:19219653
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADCY9 gene	PMID:25304211
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ADCY9 mRNA	PMID:39836092
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of ADCY9 mRNA	PMID:24752500
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in decreased expression of ADCY9 mRNA	PMID:26934552
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:4754	econazole	increases activity	ISO	RGD:1312371	E	RGD:6480464	20201103	CTD	MESH:D004464	Econazole results in increased activity of ADCY9 protein	PMID:30607468
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ADCY9 mRNA	PMID:35436446
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304747	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ADCY9 mRNA	PMID:29097150
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312371	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ADCY9 mRNA	PMID:17942748
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADCY9 mRNA	PMID:17942748
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ADCY9 mRNA	PMID:15761015
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ADCY9 mRNA; Nanotubes, Carbon results in decreased expression of ADCY9 mRNA	PMID:25554681|PMID:25620056
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:51081	nitrates	increases expression	ISO	RGD:1304747	E	RGD:6480464	20200915	CTD	MESH:D009566	Nitrates results in increased expression of ADCY9 mRNA	PMID:30022042
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304747	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ADCY9 mRNA	PMID:24136188
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of ADCY9 mRNA	PMID:19042947
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:61057	tacrolimus hydrate	multiple interactions	EXP		E	RGD:6480464	20201103	CTD	MESH:D016559	Tacrolimus inhibits the reaction [Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]]	PMID:30607468
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1304747	E	RGD:6480464	20130312	CTD	MESH:D007649	Ketamine results in increased expression of ADCY9 mRNA	PMID:20080153
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ADCY9 mRNA	PMID:28988120
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ADCY9 mRNA	PMID:15336504
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:64317	isoprenaline	multiple interactions	EXP		E	RGD:6480464	20201103	CTD	MESH:D007545	[Isoproterenol co-treated with Miconazole] results in increased activity of ADCY9 protein alternative form	PMID:30607468
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:65585	carnosic acid	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20240430	CTD	MESH:C018381	salvin inhibits the reaction [sodium arsenite results in decreased expression of ADCY9 mRNA]	PMID:35202923
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304747	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ADCY9 gene	PMID:35440735
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:6923	miconazole	increases activity	EXP		E	RGD:6480464	20201103	CTD	MESH:D008825	Miconazole results in increased activity of ADCY9 protein; Miconazole results in increased activity of ADCY9 protein alternative form	PMID:30607468
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:6923	miconazole	increases activity	ISO	RGD:1312371	E	RGD:6480464	20201103	CTD	MESH:D008825	Miconazole results in increased activity of ADCY9 protein	PMID:30607468
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:6923	miconazole	multiple interactions	EXP		E	RGD:6480464	20201103	CTD	MESH:D008825	[Isoproterenol co-treated with Miconazole] results in increased activity of ADCY9 protein alternative form; Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]; Tacrolimus inhibits the reaction [Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]]	PMID:30607468
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:6923	miconazole	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20201103	CTD	MESH:D008825	[Colforsin co-treated with Miconazole] results in increased activity of ADCY9 protein	PMID:30607468
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:69477	cannabigerol	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20210112	CTD	MESH:C037036	cannabigerol results in decreased expression of ADCY9 mRNA	PMID:33019509
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20210112	CTD	MESH:D002185	Cannabidiol results in decreased expression of ADCY9 mRNA	PMID:33019509
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312371	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ADCY9 mRNA	PMID:22206623
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312371	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ADCY9 mRNA]	PMID:22206623
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY9 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY9 mRNA	PMID:27188386
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1312371	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of ADCY9 mRNA	PMID:20702594
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304747	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ADCY9 mRNA	PMID:32109520
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of ADCY9 mRNA	PMID:21278054
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304747	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ADCY9 mRNA	PMID:24780913
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY9 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY9 mRNA	PMID:27188386
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304747	E	RGD:6480464	20130312	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ADCY9 mRNA	PMID:21346803
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:9464	testosterone enanthate	affects expression	ISO	RGD:1304747	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ADCY9 mRNA	PMID:25603467
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312371	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ADCY9 mRNA	PMID:28973697
1312370	ADCY9	adenylate cyclase 9	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1304747	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of ADCY9 gene	PMID:31079544
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:10136	gingerol	increases expression	ISO	RGD:1312374	E	RGD:6480464	20170303	CTD	MESH:C007845	gingerol results in increased expression of LRP6 mRNA	PMID:26498061
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of LRP6 mRNA	PMID:38218311
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of LRP6 mRNA	PMID:25152437
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of LRP6 mRNA	PMID:30071829
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of LRP6 mRNA	PMID:26251327
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of LRP6 mRNA	PMID:33167477
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312374	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of LRP6 mRNA	PMID:17064353
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D010100	Oxygen deficiency results in increased expression of LRP6 protein	PMID:34648812
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D010100	[Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased expression of LRP6 protein]	PMID:34648812
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of LRP6 mRNA	PMID:26079696
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of LRP6 mRNA	PMID:40945087
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:16236	ethanol	affects response to substance	ISO	RGD:1312374	E	RGD:6480464	20190910	CTD	MESH:D000431	LRP6 protein mutant form affects the susceptibility to Ethanol	PMID:30976847
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:16236	ethanol	decreases response to substance	EXP		E	RGD:6480464	20190910	CTD	MESH:D000431	LRP6 protein mutant form results in decreased susceptibility to Ethanol	PMID:30976847
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20190910	CTD	MESH:D000431	[LRP6 protein mutant form affects the susceptibility to Ethanol] which affects the expression of ALB protein; LRP6 protein affects the reaction [Ethanol results in increased activity of GPT protein]	PMID:30976847
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of LRP6 mRNA	PMID:12414654
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LRP6 mRNA	PMID:39241906
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of LRP6 mRNA	PMID:32145629
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LRP6 mRNA	PMID:39298647
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304749	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of LRP6 gene	PMID:27618143
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LRP6 mRNA	PMID:37042841
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:16827	corticosterone	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20260804	CTD	MESH:D003345	[Isoflurophate co-treated with Corticosterone] affects the methylation of LRP6	PMID:40606660
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of LRP6 mRNA	PMID:20655997
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312374	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LRP6 protein	PMID:35842051
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:17941	diisopropyl fluorophosphate	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20260804	CTD	MESH:D007531	[Isoflurophate co-treated with Corticosterone] affects the methylation of LRP6	PMID:40606660
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of LRP6 mRNA	PMID:28818685
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LRP6 mRNA	PMID:36331819
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRP6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LRP6 mRNA	PMID:39836092
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of LRP6 mRNA	PMID:17103032
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304749	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of LRP6 mRNA	PMID:28522335
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRP6 mRNA	PMID:35301059
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304749	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRP6 mRNA	PMID:39012411
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LRP6 gene	PMID:27153756
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LRP6 intron	PMID:30157460
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of LRP6 mRNA	PMID:30779732
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRP6 mRNA	PMID:39836092
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of LRP6 mRNA	PMID:26272509
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP6 mRNA	PMID:27188386
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of LRP6 protein	PMID:35688186
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of LRP6 mRNA	PMID:31295307
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of LRP6 mRNA	PMID:31881176
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:28061	alpha-D-galactose	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20231205	CTD	MESH:D005690	[Galactose co-treated with gentiopicroside analog] results in increased expression of LRP6 protein	PMID:36878094
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312374	E	RGD:6480464	20230404	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRP6 mRNA	PMID:36222588
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRP6 mRNA	PMID:20106945|PMID:21632981
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRP6 mRNA	PMID:21215274|PMID:33387578
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRP6 mRNA	PMID:33956508
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRP6 mRNA	PMID:12377990
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304749	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRP6 mRNA	PMID:32109520
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LRP6 mRNA	PMID:28001369
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LRP6 mRNA	PMID:33212167
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:28260	galactose	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20231205	CTD	MESH:D005690	[Galactose co-treated with gentiopicroside analog] results in increased expression of LRP6 protein	PMID:36878094
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:28869	menadione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 results in increased expression of LRP6 mRNA	PMID:12414654
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C017947	sodium arsenite results in increased expression of LRP6 mRNA; sodium arsenite results in increased expression of LRP6 mRNA alternative form	PMID:29216394|PMID:38568856
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312374	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of LRP6 mRNA	PMID:38906090
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:29678	sodium arsenite	increases phosphorylation	ISO	RGD:1312374	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased phosphorylation of LRP6 protein	PMID:38325618
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRP6 mRNA; LRP6 mRNA alternative form promotes the reaction [sodium arsenite results in decreased expression of CDH1 protein]; LRP6 mRNA alternative form promotes the reaction [sodium arsenite results in increased expression of VIM protein]; LRP6 mRNA alternative form promotes the reaction [sodium arsenite results in increased expression of ZEB1 protein]	PMID:29216394|PMID:39836092
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LRP6 intron	PMID:30157460
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRP6 mRNA	PMID:20106945|PMID:21632981|PMID:32234424
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312374	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LRP6 exon; Benzo(a)pyrene results in increased methylation of LRP6 intron	PMID:27901495
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LRP6 mRNA	PMID:19150397
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of LRP6 mRNA	PMID:27188386
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:32026	Poloxamer	multiple interactions	ISO	RGD:1304749	E	RGD:6480464	20210810	CTD	MESH:D020442	Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of LRP6 mRNA]]	PMID:32961231
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304749	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of LRP6 mRNA	PMID:30047161
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304749	E	RGD:6480464	20210810	CTD	MESH:D013853	Thioacetamide results in increased expression of LRP6 mRNA	PMID:32961231
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1304749	E	RGD:6480464	20210810	CTD	MESH:D013853	Niclosamide inhibits the reaction [Thioacetamide results in increased expression of LRP6 mRNA]; Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of LRP6 mRNA]]	PMID:32961231
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of LRP6 mRNA	PMID:30723492
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312374	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LRP6 mRNA	PMID:18301758
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LRP6 mRNA	PMID:19710929
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304749	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of LRP6 mRNA	PMID:25181051|PMID:32145629
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of LRP6 mRNA	PMID:25381574|PMID:25963729
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LRP6 mRNA	PMID:33221593
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of LRP6 mRNA	PMID:29275510
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304749	E	RGD:6480464	20160705	CTD	MESH:C006780	Curcumin inhibits the reaction [bisphenol A results in decreased expression of LRP6 mRNA]	PMID:25963729
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LRP6 mRNA	PMID:39298647
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312374	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of LRP6 mRNA	PMID:40203079
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1304749	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LRP6 mRNA	PMID:17602206
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312374	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LRP6 mRNA	PMID:21266533
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304749	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LRP6 mRNA	PMID:17602206
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRP6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LRP6 mRNA	PMID:39836092
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LRP6 mRNA	PMID:38568856
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LRP6 mRNA	PMID:36928142
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312374	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LRP6 mRNA	PMID:20478370
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRP6 mRNA	PMID:35301059
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304749	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRP6 mRNA	PMID:39012411
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of LRP6 mRNA	PMID:24449571
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LRP6 mRNA	PMID:40194260
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LRP6 mRNA	PMID:36331819
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1304749	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of LRP6 mRNA	PMID:23125180
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1304749	E	RGD:6480464	20160705	CTD	MESH:D003474	Curcumin results in increased expression of LRP6 mRNA	PMID:25963729
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1304749	E	RGD:6480464	20160705	CTD	MESH:D003474	Curcumin inhibits the reaction [bisphenol A results in decreased expression of LRP6 mRNA]	PMID:25963729
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRP6 mRNA	PMID:23179753|PMID:27188386
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRP6 mRNA	PMID:19136453
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LRP6 gene	PMID:29154799
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304749	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of LRP6 mRNA	PMID:30047161
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of LRP6 mRNA	PMID:20106945|PMID:25562108
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20250401	CTD	MESH:D003907	Dexamethasone results in decreased expression of LRP6 mRNA	PMID:38971901
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:43572	kojic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of LRP6 mRNA	PMID:16595896
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312374	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of LRP6 mRNA	PMID:18502557
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of LRP6 mRNA	PMID:27188386
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D017239	[Paclitaxel co-treated with FV-429 compound] inhibits the reaction [Oxygen deficiency results in increased expression of LRP6 protein]	PMID:34648812
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of LRP6 mRNA	PMID:22723015|PMID:26272509
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP6 mRNA	PMID:27188386
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRP6 mRNA	PMID:39836092
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:48607	lithium chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in increased expression of LRP6 mRNA	PMID:20069066
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:4887	ethosuximide	increases expression	ISO	RGD:1304749	E	RGD:6480464	20160210	CTD	MESH:D005013	Ethosuximide results in increased expression of LRP6 mRNA	PMID:26420483
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:4887	ethosuximide	multiple interactions	ISO	RGD:1304749	E	RGD:6480464	20160210	CTD	MESH:D005013	Ethosuximide inhibits the reaction [APP protein modified form results in decreased expression of LRP6 mRNA]	PMID:26420483
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304749	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LRP6 mRNA	PMID:29097150
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LRP6 mRNA; Nanotubes, Carbon results in decreased expression of LRP6 mRNA	PMID:25554681
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304749	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of LRP6 mRNA	PMID:30047161
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of LRP6 mRNA	PMID:24136188
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:51403	1,4-phenylenediamine	decreases phosphorylation	EXP		E	RGD:6480464	20170613	CTD	MESH:C029728	4-phenylenediamine results in decreased phosphorylation of LRP6 protein	PMID:26784575
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:5321	Gentiopicrin	multiple interactions	ISO	RGD:1312374	E	RGD:6480464	20231205	CTD	MESH:C012997	[Galactose co-treated with gentiopicroside analog] results in increased expression of LRP6 protein	PMID:36878094
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:53515	pluronic P-123	multiple interactions	ISO	RGD:1304749	E	RGD:6480464	20210810	CTD	MESH:D020442	Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of LRP6 mRNA]]	PMID:32961231
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRP6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LRP6 mRNA	PMID:39836092
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of LRP6 mRNA	PMID:24136188
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of LRP6 mRNA	PMID:12414654
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of LRP6 mRNA	PMID:30467583
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304749	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LRP6 gene	PMID:35440735
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312374	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of LRP6 mRNA	PMID:22206623
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of LRP6 mRNA	PMID:24136188
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide analog results in decreased expression of LRP6 protein; Niclosamide results in decreased expression of LRP6 protein	PMID:28284560
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:7553	niclosamide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of and results in decreased phosphorylation of LRP6 protein	PMID:24552774|PMID:24736023
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:7553	niclosamide	multiple interactions	ISO	RGD:1304749	E	RGD:6480464	20210810	CTD	MESH:D009534	Niclosamide inhibits the reaction [Thioacetamide results in increased expression of LRP6 mRNA]; Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of LRP6 mRNA]]	PMID:32961231
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP6 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP6 mRNA	PMID:27188386
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312374	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of LRP6 mRNA	PMID:23091169
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of LRP6 mRNA	PMID:32109520
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304749	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of LRP6 mRNA	PMID:30047161
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP6 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP6 mRNA	PMID:27188386
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:9150	simvastatin	decreases expression	ISO	RGD:1304749	E	RGD:6480464	20141223	CTD	MESH:D019821	Simvastatin results in decreased expression of LRP6 mRNA	PMID:25055962
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of LRP6 mRNA	PMID:27188386
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312374	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of LRP6 mRNA	PMID:28973697
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1304749	E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in increased expression of LRP6 mRNA	PMID:24136188
1312373	LRP6	LDL receptor related protein 6	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304749	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of LRP6 mRNA	PMID:19015723
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312376	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DQX1 mRNA	PMID:33045310
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312376	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DQX1 mRNA	PMID:39752319
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312376	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DQX1 mRNA	PMID:39241906
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DQX1 mRNA	PMID:35811015
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312376	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DQX1 mRNA	PMID:39298647
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of DQX1 mRNA	PMID:23649840
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312376	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DQX1 mRNA	PMID:39752319
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1591766	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of DQX1 mRNA	PMID:26577399|PMID:27523638
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1591766	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DQX1 mRNA	PMID:33387578
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DQX1 mRNA	PMID:28818685
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312376	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DQX1 mRNA	PMID:36331819
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312376	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DQX1 mRNA	PMID:37236586
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DQX1 mRNA	PMID:19549813
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of DQX1 mRNA	PMID:23649840
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1591766	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of DQX1 mRNA	PMID:21396975
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DQX1 mRNA	PMID:21641981|PMID:22100608
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DQX1 mRNA	PMID:23649840
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of DQX1 mRNA	PMID:38460933
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of DQX1 mRNA	PMID:38460933
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1591766	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DQX1 mRNA	PMID:31881176
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of DQX1 mRNA	PMID:27392435
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of DQX1 mRNA	PMID:27392435
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of DQX1 mRNA	PMID:24768652|PMID:25583101
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312376	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DQX1 mRNA	PMID:21570461
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1591766	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DQX1 mRNA	PMID:33387578
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312376	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of DQX1 mRNA	PMID:37682722
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DQX1 exon	PMID:27901495
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DQX1 mRNA	PMID:21632981|PMID:32234424
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1591766	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of DQX1 mRNA	PMID:30047161
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1591766	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DQX1 mRNA	PMID:23411599|PMID:34492290
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312376	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DQX1 mRNA	PMID:18648102
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DQX1 mRNA	PMID:19710929
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1591766	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DQX1 mRNA	PMID:25181051
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312376	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of DQX1 mRNA	PMID:32156529
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1591766	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of DQX1 mRNA	PMID:30816183|PMID:32145629|PMID:32528016
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DQX1 gene	PMID:31601247
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312376	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DQX1 mRNA	PMID:34585602
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1591766	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DQX1 gene	PMID:28505145
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312376	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DQX1 mRNA	PMID:39298647
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312376	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of DQX1 mRNA	PMID:38685157
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1591766	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of DQX1 mRNA	PMID:32680482
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312376	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DQX1 mRNA	PMID:37236586
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1591766	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of DQX1 mRNA	PMID:30047161
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312376	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DQX1 mRNA	PMID:40194260
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312376	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DQX1 mRNA	PMID:36331819
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1591766	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of DQX1 mRNA	PMID:30047161
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of DQX1 mRNA	PMID:25562108
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312376	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DQX1 mRNA	PMID:17562736
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1591766	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DQX1 mRNA	PMID:33387578
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DQX1 mRNA	PMID:35811015
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of DQX1 mRNA	PMID:38460933
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DQX1 mRNA	PMID:27188386
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1591766	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of DQX1 mRNA	PMID:30047161
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312376	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of DQX1 mRNA	PMID:23608068
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312376	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DQX1 mRNA	PMID:39752319
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312376	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DQX1 mRNA	PMID:22206623
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of DQX1 mRNA	PMID:36318118
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DQX1 mRNA	PMID:27188386
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312376	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DQX1 mRNA	PMID:38648751
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1591766	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DQX1 mRNA	PMID:24780913|PMID:30047161
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312376	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of DQX1 mRNA	PMID:39752319
1312375	DQX1	DEAQ-box RNA dependent ATPase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DQX1 mRNA	PMID:27188386
1312379	PCDH17	protocadherin 17	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PCDH17 mRNA	PMID:27188386
1312379	PCDH17	protocadherin 17	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1617378	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PCDH17 mRNA	PMID:33045310
1312379	PCDH17	protocadherin 17	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1304753	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PCDH17 mRNA	PMID:30071829
1312379	PCDH17	protocadherin 17	gene	CHEBI:15365	acetylsalicylic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of PCDH17 mRNA	PMID:11906190
1312379	PCDH17	protocadherin 17	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PCDH17 mRNA	PMID:21934132|PMID:23724009
1312379	PCDH17	protocadherin 17	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1617378	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PCDH17 mRNA	PMID:30319688
1312379	PCDH17	protocadherin 17	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1617378	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PCDH17 mRNA	PMID:30319688
1312379	PCDH17	protocadherin 17	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PCDH17 mRNA	PMID:35811015
1312379	PCDH17	protocadherin 17	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PCDH17 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PCDH17 mRNA	PMID:35811015
1312379	PCDH17	protocadherin 17	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304753	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PCDH17 mRNA	PMID:32741896
1312379	PCDH17	protocadherin 17	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304753	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PCDH17 mRNA	PMID:33387578
1312379	PCDH17	protocadherin 17	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of PCDH17 mRNA	PMID:33448797
1312379	PCDH17	protocadherin 17	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH17 mRNA; fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA]	PMID:33448797|PMID:37992649
1312379	PCDH17	protocadherin 17	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304753	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PCDH17 mRNA	PMID:32741896
1312379	PCDH17	protocadherin 17	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of PCDH17 mRNA	PMID:33448797
1312379	PCDH17	protocadherin 17	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH17 mRNA; fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA]	PMID:33448797|PMID:37992649
1312379	PCDH17	protocadherin 17	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304753	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PCDH17 mRNA	PMID:33387578
1312379	PCDH17	protocadherin 17	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of PCDH17 mRNA	PMID:27462272
1312379	PCDH17	protocadherin 17	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDH17 gene	PMID:27153756
1312379	PCDH17	protocadherin 17	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304753	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PCDH17 mRNA	PMID:23630614
1312379	PCDH17	protocadherin 17	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PCDH17 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PCDH17 mRNA	PMID:34911549
1312379	PCDH17	protocadherin 17	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of PCDH17 mRNA	PMID:19654921
1312379	PCDH17	protocadherin 17	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1617378	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of PCDH17 mRNA	PMID:32186404
1312379	PCDH17	protocadherin 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1617378	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PCDH17 mRNA	PMID:21570461
1312379	PCDH17	protocadherin 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304753	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDH17 mRNA	PMID:32109520
1312379	PCDH17	protocadherin 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304753	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PCDH17 mRNA	PMID:33387578
1312379	PCDH17	protocadherin 17	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of PCDH17 mRNA	PMID:29955902
1312379	PCDH17	protocadherin 17	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PCDH17 mRNA	PMID:28001369
1312379	PCDH17	protocadherin 17	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304753	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PCDH17 mRNA	PMID:28959563
1312379	PCDH17	protocadherin 17	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304753	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PCDH17 mRNA	PMID:26033743
1312379	PCDH17	protocadherin 17	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of PCDH17 mRNA	PMID:27862939
1312379	PCDH17	protocadherin 17	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PCDH17 mRNA	PMID:29803840
1312379	PCDH17	protocadherin 17	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH17 mRNA	PMID:37992649
1312379	PCDH17	protocadherin 17	gene	CHEBI:2896	astemizole	decreases expression	ISO	RGD:1304753	E	RGD:6480464	20120412	CTD	MESH:D016589	Astemizole results in decreased expression of PCDH17 mRNA	PMID:20221588
1312379	PCDH17	protocadherin 17	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PCDH17 gene	PMID:28589171
1312379	PCDH17	protocadherin 17	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PCDH17 mRNA	PMID:37682722
1312379	PCDH17	protocadherin 17	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDH17 promoter	PMID:27901495
1312379	PCDH17	protocadherin 17	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PCDH17 mRNA	PMID:21569818|PMID:22228805
1312379	PCDH17	protocadherin 17	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PCDH17 exon	PMID:27901495
1312379	PCDH17	protocadherin 17	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1617378	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PCDH17 mRNA	PMID:21964900|PMID:22610609|PMID:32417428
1312379	PCDH17	protocadherin 17	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PCDH17 5' UTR	PMID:27901495
1312379	PCDH17	protocadherin 17	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA	PMID:27858113
1312379	PCDH17	protocadherin 17	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of PCDH17 promoter	PMID:23974009
1312379	PCDH17	protocadherin 17	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304753	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PCDH17 mRNA	PMID:26033743
1312379	PCDH17	protocadherin 17	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCDH17 protein]	PMID:26598702
1312379	PCDH17	protocadherin 17	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of PCDH17 gene	PMID:31601247
1312379	PCDH17	protocadherin 17	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304753	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of PCDH17 mRNA	PMID:30047161
1312379	PCDH17	protocadherin 17	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1617378	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PCDH17 gene	PMID:35295148
1312379	PCDH17	protocadherin 17	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C009495	titanium dioxide results in increased expression of PCDH17 mRNA	PMID:19695317
1312379	PCDH17	protocadherin 17	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1617378	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of PCDH17 mRNA	PMID:23557971
1312379	PCDH17	protocadherin 17	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1617378	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PCDH17 promoter	PMID:35295148
1312379	PCDH17	protocadherin 17	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1617378	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PCDH17 mRNA	PMID:18301758|PMID:23811191
1312379	PCDH17	protocadherin 17	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1304753	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of PCDH17 mRNA	PMID:19167457
1312379	PCDH17	protocadherin 17	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304753	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PCDH17 mRNA	PMID:25181051
1312379	PCDH17	protocadherin 17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304753	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDH17 mRNA	PMID:30816183
1312379	PCDH17	protocadherin 17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDH17 mRNA	PMID:26063408
1312379	PCDH17	protocadherin 17	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1617378	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of PCDH17 mRNA	PMID:35479511|PMID:35598803
1312379	PCDH17	protocadherin 17	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1617378	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PCDH17 mRNA	PMID:26377693
1312379	PCDH17	protocadherin 17	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA	PMID:27858113
1312379	PCDH17	protocadherin 17	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1617378	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of PCDH17 mRNA	PMID:38685157
1312379	PCDH17	protocadherin 17	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1617378	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PCDH17 mRNA	PMID:24535843
1312379	PCDH17	protocadherin 17	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PCDH17 mRNA	PMID:24535843
1312379	PCDH17	protocadherin 17	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1617378	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of PCDH17 mRNA	PMID:26377693
1312379	PCDH17	protocadherin 17	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304753	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of PCDH17 mRNA	PMID:30723492
1312379	PCDH17	protocadherin 17	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304753	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PCDH17 mRNA	PMID:25993096
1312379	PCDH17	protocadherin 17	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PCDH17 mRNA	PMID:24449571
1312379	PCDH17	protocadherin 17	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PCDH17 mRNA	PMID:36331819
1312379	PCDH17	protocadherin 17	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1304753	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of PCDH17 mRNA	PMID:23125180
1312379	PCDH17	protocadherin 17	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PCDH17 mRNA	PMID:25979313
1312379	PCDH17	protocadherin 17	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304753	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PCDH17 mRNA	PMID:29427782
1312379	PCDH17	protocadherin 17	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCDH17 mRNA	PMID:24383497
1312379	PCDH17	protocadherin 17	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PCDH17 mRNA	PMID:19101580|PMID:23179753|PMID:28001369
1312379	PCDH17	protocadherin 17	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304753	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of PCDH17 mRNA	PMID:30047161
1312379	PCDH17	protocadherin 17	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of PCDH17 mRNA	PMID:33448797
1312379	PCDH17	protocadherin 17	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH17 mRNA; fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA]	PMID:33448797|PMID:37992649
1312379	PCDH17	protocadherin 17	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of PCDH17 mRNA	PMID:24935251
1312379	PCDH17	protocadherin 17	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PCDH17 mRNA	PMID:24935251
1312379	PCDH17	protocadherin 17	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1617378	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PCDH17 mRNA	PMID:17562736
1312379	PCDH17	protocadherin 17	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304753	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PCDH17 mRNA	PMID:33387578
1312379	PCDH17	protocadherin 17	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of PCDH17 mRNA	PMID:24714768
1312379	PCDH17	protocadherin 17	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of PCDH17 mRNA	PMID:35811015
1312379	PCDH17	protocadherin 17	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PCDH17 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PCDH17 mRNA	PMID:35811015
1312379	PCDH17	protocadherin 17	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of PCDH17 mRNA	PMID:19654921
1312379	PCDH17	protocadherin 17	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304753	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PCDH17 mRNA	PMID:29097150
1312379	PCDH17	protocadherin 17	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of PCDH17 mRNA	PMID:26272509
1312379	PCDH17	protocadherin 17	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA	PMID:27188386
1312379	PCDH17	protocadherin 17	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PCDH17 protein]	PMID:26598702
1312379	PCDH17	protocadherin 17	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of PCDH17 mRNA	PMID:25554681|PMID:25620056
1312379	PCDH17	protocadherin 17	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1617378	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PCDH17 mRNA	PMID:25554681
1312379	PCDH17	protocadherin 17	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304753	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of PCDH17 mRNA	PMID:30047161
1312379	PCDH17	protocadherin 17	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA	PMID:27858113
1312379	PCDH17	protocadherin 17	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PCDH17 mRNA	PMID:27858113
1312379	PCDH17	protocadherin 17	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in increased expression of PCDH17 mRNA]	PMID:33448797
1312379	PCDH17	protocadherin 17	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of PCDH17 mRNA	PMID:19042947
1312379	PCDH17	protocadherin 17	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of PCDH17 mRNA	PMID:31629900
1312379	PCDH17	protocadherin 17	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PCDH17 mRNA	PMID:24810058
1312379	PCDH17	protocadherin 17	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1304753	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PCDH17 mRNA	PMID:28801915
1312379	PCDH17	protocadherin 17	gene	CHEBI:6716	medroxyprogesterone acetate	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in decreased expression of PCDH17 mRNA	PMID:20843944
1312379	PCDH17	protocadherin 17	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of PCDH17 mRNA	PMID:27462272
1312379	PCDH17	protocadherin 17	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PCDH17 mRNA	PMID:31758290
1312379	PCDH17	protocadherin 17	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1617378	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PCDH17 mRNA	PMID:22206623
1312379	PCDH17	protocadherin 17	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PCDH17 mRNA	PMID:22714537
1312379	PCDH17	protocadherin 17	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1304753	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PCDH17 mRNA	PMID:32741896
1312379	PCDH17	protocadherin 17	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA	PMID:27188386
1312379	PCDH17	protocadherin 17	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1617378	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PCDH17 mRNA	PMID:24535843
1312379	PCDH17	protocadherin 17	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304753	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PCDH17 mRNA	PMID:32109520
1312379	PCDH17	protocadherin 17	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1617378	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PCDH17 mRNA	PMID:38648751
1312379	PCDH17	protocadherin 17	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1304753	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PCDH17 mRNA	PMID:21394737
1312379	PCDH17	protocadherin 17	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1304753	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of PCDH17 mRNA	PMID:23640034
1312379	PCDH17	protocadherin 17	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1304753	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of PCDH17 mRNA	PMID:30047161
1312379	PCDH17	protocadherin 17	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304753	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PCDH17 mRNA	PMID:24780913|PMID:30047161
1312379	PCDH17	protocadherin 17	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH17 mRNA	PMID:27188386
1312379	PCDH17	protocadherin 17	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in decreased expression of PCDH17 mRNA	PMID:11906190
1312379	PCDH17	protocadherin 17	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of PCDH17 mRNA	PMID:17440010
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of HCLS1 mRNA	PMID:15928584
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of HCLS1 mRNA	PMID:33167477
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of HCLS1 mRNA	PMID:26079696
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312381	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of HCLS1 mRNA	PMID:30319688
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of HCLS1 mRNA	PMID:21632981
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of HCLS1 mRNA	PMID:39298647
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304754	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HCLS1 mRNA	PMID:33387578
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of HCLS1 mRNA	PMID:21540246
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HCLS1 mRNA	PMID:37992649
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HCLS1 mRNA	PMID:37992649
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304754	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of HCLS1 mRNA	PMID:27523638
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Clozapine] results in decreased expression of HCLS1 protein	PMID:34122009
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304754	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of HCLS1 mRNA	PMID:22061828
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of HCLS1 gene	PMID:27153756
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of HCLS1 mRNA	PMID:25102026
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of HCLS1 mRNA	PMID:35430440
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of HCLS1 mRNA	PMID:34911549
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D014747	HCLS1 protein affects the susceptibility to Vinblastine	PMID:16217747
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of HCLS1 mRNA	PMID:25629700
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:27504	mitomycin C	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	HCLS1 protein affects the susceptibility to Mitomycin	PMID:16217747
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HCLS1 mRNA	PMID:40504410
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304754	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of HCLS1 mRNA	PMID:31881176
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of HCLS1 mRNA	PMID:23557933
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of HCLS1 mRNA	PMID:19921347
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of HCLS1 mRNA	PMID:25583101
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304754	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HCLS1 mRNA	PMID:34747641
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312381	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HCLS1 mRNA	PMID:21570461
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HCLS1 mRNA	PMID:33212167
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	HCLS1 protein affects the susceptibility to Doxorubicin	PMID:16217747
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HCLS1 mRNA	PMID:37992649
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of HCLS1 mRNA	PMID:34032870
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HCLS1 mRNA	PMID:22714537|PMID:38568856
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCLS1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HCLS1 mRNA	PMID:34876320|PMID:40504410
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCLS1 mRNA	PMID:34876320
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HCLS1 exon; Benzo(a)pyrene affects the methylation of HCLS1 promoter	PMID:27901495
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312381	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HCLS1 mRNA	PMID:22228805
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to HCLS1 promoter]	PMID:19654925
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HCLS1 mRNA	PMID:26705709
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1312381	E	RGD:6480464	20211207	CTD	MESH:D001761	Bleomycin results in increased expression of HCLS1 mRNA	PMID:30825431
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20211207	CTD	MESH:D001761	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of HCLS1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of HCLS1 mRNA]	PMID:30825431
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of HCLS1 mRNA	PMID:37690743
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312381	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of HCLS1 mRNA	PMID:23557971
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304754	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of HCLS1 mRNA	PMID:34492290
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312381	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of HCLS1 promoter	PMID:27334623
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304754	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HCLS1 mRNA	PMID:25181051
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304754	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HCLS1 gene	PMID:28505145
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of HCLS1 mRNA	PMID:39298647
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312381	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of HCLS1 mRNA	PMID:38685157
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312381	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of HCLS1 mRNA	PMID:28392331
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of HCLS1 protein	PMID:35362542
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of HCLS1 protein]	PMID:35362542
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HCLS1 mRNA	PMID:37042841
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1304754	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of HCLS1 mRNA	PMID:35163327
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of HCLS1 mRNA	PMID:25851441
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of HCLS1 mRNA	PMID:24449571
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:3766	clozapine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	[Cuprizone co-treated with Clozapine] results in decreased expression of HCLS1 protein	PMID:34122009
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of HCLS1 mRNA	PMID:23125180
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312381	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of HCLS1 mRNA	PMID:17292431
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HCLS1 mRNA	PMID:37992649
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:4469	(S)-amphetamine	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20120412	CTD	MESH:D003913	Dextroamphetamine results in decreased expression of HCLS1 mRNA	PMID:12558987
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312381	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HCLS1 mRNA	PMID:17562736
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of HCLS1 mRNA	PMID:26690555
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HCLS1 mRNA	PMID:40504410
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCLS1 mRNA	PMID:34876320
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of HCLS1 protein]	PMID:35362542
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HCLS1 mRNA	PMID:26705709
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312381	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of HCLS1 mRNA; Nanotubes, Carbon results in increased expression of HCLS1 mRNA	PMID:25554681
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312381	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of HCLS1 mRNA	PMID:40234311
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of HCLS1 mRNA	PMID:35964746
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304754	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of HCLS1 mRNA	PMID:24136188
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312381	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of HCLS1 mRNA	PMID:38701926
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of HCLS1 mRNA	PMID:20436886
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1304754	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of HCLS1 mRNA	PMID:35283115
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of HCLS1 mRNA]	PMID:30825431
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of HCLS1 mRNA	PMID:31758290
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:72754	bisphenol AF	decreases expression	ISO	RGD:1304754	E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in decreased expression of HCLS1 mRNA	PMID:39938710
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312381	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of HCLS1 mRNA	PMID:22206623
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:748998	lenabasum	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20260714	CTD	MESH:C471849	lenabasum inhibits the reaction [Bleomycin results in increased expression of HCLS1 mRNA]	PMID:30825431
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of HCLS1 mRNA	PMID:22714537
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312381	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of HCLS1 mRNA	PMID:34876320
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312381	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of HCLS1 mRNA	PMID:40826991
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of HCLS1 mRNA	PMID:31734321
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304754	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of HCLS1 mRNA	PMID:19281266
1312380	HCLS1	hematopoietic cell-specific Lyn substrate 1	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of HCLS1 mRNA	PMID:17440010
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PHLDA2 mRNA	PMID:38218311
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PHLDA2 mRNA	PMID:26272509
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312383	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PHLDA2 mRNA	PMID:33045310
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:142921	3-phenylprop-2-enal	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased expression of PHLDA2 mRNA	PMID:19524605
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:144400	dinophysistoxin 1	increases expression	EXP		E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in increased expression of PHLDA2 mRNA	PMID:28939011
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of PHLDA2 mRNA	PMID:23830798
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of PHLDA2 mRNA	PMID:16788091
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PHLDA2 mRNA	PMID:36189433
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PHLDA2 mRNA	PMID:36331819
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PHLDA2 mRNA	PMID:26079696
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PHLDA2 mRNA	PMID:20044591|PMID:23410634
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PHLDA2 mRNA	PMID:21632981
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	[Quercetin co-treated with Ascorbic Acid] results in increased expression of PHLDA2 mRNA	PMID:17639512
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of PHLDA2 mRNA	PMID:22574217
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of PHLDA2 mRNA	PMID:23019147|PMID:31614463
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of PHLDA2 mRNA	PMID:30165855
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304755	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PHLDA2 mRNA	PMID:33387578
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PHLDA2 mRNA	PMID:23649840
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of PHLDA2 mRNA	PMID:18037150
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PHLDA2 mRNA	PMID:36189433
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of PHLDA2 mRNA	PMID:33647349
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PHLDA2 mRNA	PMID:31163220
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PHLDA2 protein	PMID:37730182
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PHLDA2 mRNA	PMID:36139627
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PHLDA2 mRNA	PMID:28818685
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PHLDA2 mRNA	PMID:36331819
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:2208	purine-6-thiol	decreases expression	ISO	RGD:1304755	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of PHLDA2 mRNA	PMID:23358152
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PHLDA2 mRNA	PMID:35770551
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PHLDA2 mRNA	PMID:19549813
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PHLDA2 protein	PMID:20106945
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PHLDA2 mRNA	PMID:21641981|PMID:22100608|PMID:27153756|PMID:32234424
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of PHLDA2 mRNA	PMID:15674844
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of PHLDA2 mRNA	PMID:31626304
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PHLDA2 mRNA	PMID:34911549
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PHLDA2 mRNA	PMID:18593933
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312383	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PHLDA2 mRNA	PMID:31919559
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PHLDA2 mRNA	PMID:21867686
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PHLDA2 mRNA	PMID:26272509
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PHLDA2 mRNA	PMID:28960355
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304755	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PHLDA2 mRNA	PMID:31881176
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PHLDA2 mRNA	PMID:23557933
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:27899	cisplatin	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	PHLDA2 results in increased susceptibility to Cisplatin	PMID:22021909
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin affects the reaction [Piroxicam results in decreased expression of PHLDA2 mRNA]	PMID:21858171
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of PHLDA2 mRNA	PMID:15256057|PMID:23019147
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHLDA2 mRNA	PMID:26238291
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304755	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHLDA2 mRNA	PMID:33387578
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of PHLDA2 mRNA	PMID:29704546
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHLDA2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PHLDA2 mRNA	PMID:17942748|PMID:25975270
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PHLDA2 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PHLDA2 mRNA	PMID:33212167
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of PHLDA2 mRNA	PMID:26272509
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of PHLDA2 mRNA	PMID:24690739
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PHLDA2 mRNA	PMID:29803840
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D024483	Vitamin K 3 affects the expression of PHLDA2 mRNA	PMID:20044591|PMID:23410634
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001205	[Quercetin co-treated with Ascorbic Acid] results in increased expression of PHLDA2 mRNA	PMID:17639512
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:2948	azathioprine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of PHLDA2 mRNA	PMID:22623647
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of PHLDA2 mRNA	PMID:34032870
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of PHLDA2 mRNA	PMID:36209798|PMID:37682722
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PHLDA2 mRNA	PMID:21281968|PMID:38568856
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PHLDA2 mRNA	PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170|PMID:26238291|PMID:32234424
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PHLDA2 3' UTR; Benzo(a)pyrene results in increased methylation of PHLDA2 promoter	PMID:27901495
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of PHLDA2 mRNA	PMID:24690739
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PHLDA2 mRNA	PMID:18593933
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PHLDA2 mRNA	PMID:25895662
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PHLDA2 mRNA	PMID:19150397|PMID:26238291
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PHLDA2 mRNA	PMID:15761015
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of PHLDA2 mRNA	PMID:35984750
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of PHLDA2 mRNA	PMID:38568856
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304755	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PHLDA2 mRNA	PMID:30047161
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PHLDA2 mRNA	PMID:29264374
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312383	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PHLDA2 gene; titanium dioxide results in decreased methylation of PHLDA2 promoter	PMID:35295148
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304755	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PHLDA2 mRNA	PMID:23411599|PMID:34492290
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PHLDA2 mRNA	PMID:18648102
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312383	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PHLDA2 mRNA	PMID:28472532
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PHLDA2 mRNA	PMID:30903817
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304755	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PHLDA2 mRNA	PMID:25181051
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of PHLDA2 mRNA	PMID:26063408
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PHLDA2 mRNA	PMID:28628672
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PHLDA2 mRNA	PMID:25979313
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312383	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PHLDA2 mRNA	PMID:30951980
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312383	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PHLDA2 mRNA	PMID:30951980
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PHLDA2 mRNA	PMID:37019170
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of PHLDA2 gene	PMID:22964155
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PHLDA2 mRNA	PMID:28628672
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PHLDA2 mRNA	PMID:21527772
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PHLDA2 mRNA	PMID:24535843
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C022838	nickel chloride results in increased expression of PHLDA2 mRNA	PMID:17547211
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304755	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of PHLDA2 mRNA	PMID:32680482
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PHLDA2 mRNA	PMID:38174414|PMID:38568856
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PHLDA2 mRNA	PMID:35770551
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304755	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of PHLDA2 mRNA	PMID:25539665|PMID:26194646
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PHLDA2 mRNA	PMID:19320972
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PHLDA2 mRNA	PMID:19376846
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of PHLDA2 mRNA	PMID:17547211
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PHLDA2 mRNA	PMID:24449571
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDA2 mRNA	PMID:19167446
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PHLDA2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PHLDA2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PHLDA2 mRNA	PMID:36331819
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PHLDA2 mRNA	PMID:25979313
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of PHLDA2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PHLDA2 gene	PMID:29154799
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304755	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PHLDA2 mRNA	PMID:30047161
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of PHLDA2 mRNA	PMID:17403535
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PHLDA2 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PHLDA2 mRNA	PMID:28628672
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PHLDA2 mRNA	PMID:38832940
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PHLDA2 mRNA	PMID:26272509
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of PHLDA2 mRNA	PMID:24935251|PMID:26272509
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PHLDA2 mRNA	PMID:17562736
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of PHLDA2 mRNA	PMID:26690555
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of PHLDA2 mRNA	PMID:29067470
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304755	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PHLDA2 mRNA	PMID:33387578
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of PHLDA2 mRNA	PMID:24690739
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:47898	4'-epidoxorubicin	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D015251	PHLDA2 results in increased susceptibility to Epirubicin	PMID:22021909
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PHLDA2 mRNA	PMID:22079256
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHLDA2 mRNA	PMID:17942748
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of PHLDA2 mRNA	PMID:38568856
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of PHLDA2 mRNA	PMID:26272509
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of PHLDA2 mRNA	PMID:28628672
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:49668	gefitinib	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:C419708	PHLDA2 protein affects the susceptibility to gefitinib	PMID:15496427
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PHLDA2 mRNA	PMID:15761015
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of PHLDA2 mRNA	PMID:21856257
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:50594	carbon nanotube	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of PHLDA2 mRNA	PMID:29906516
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:50667	mercaptopurine	decreases expression	ISO	RGD:1304755	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of PHLDA2 mRNA	PMID:23358152
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304755	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PHLDA2 mRNA	PMID:30047161
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PHLDA2 protein	PMID:23718831
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of PHLDA2 mRNA	PMID:31629900
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312383	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of PHLDA2 mRNA	PMID:38701926
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of PHLDA2 mRNA	PMID:20436886
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of PHLDA2 mRNA	PMID:26272509
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1304755	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of PHLDA2 mRNA	PMID:25729387
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1304755	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of PHLDA2 mRNA	PMID:24136188
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:64090	tert-butyl hydroperoxide	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D020122	tert-Butylhydroperoxide affects the expression of PHLDA2 mRNA	PMID:23410634
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PHLDA2 mRNA	PMID:15336504
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in decreased expression of PHLDA2 mRNA	PMID:16982809
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PHLDA2 mRNA	PMID:31758290
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312383	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PHLDA2 mRNA	PMID:22206623
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PHLDA2 mRNA	PMID:22079256
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PHLDA2 mRNA	PMID:22079256
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PHLDA2 mRNA	PMID:37199045
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of PHLDA2 protein	PMID:31285264
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PHLDA2 mRNA	PMID:36139627
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1304755	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of PHLDA2 mRNA	PMID:23665939
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1312383	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of PHLDA2 mRNA	PMID:26655953
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:80630	irinotecan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in increased expression of PHLDA2 mRNA	PMID:20185912
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of PHLDA2 mRNA	PMID:19482888
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312383	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of PHLDA2 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PHLDA2 mRNA]	PMID:19482888|PMID:24535843
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDA2 mRNA	PMID:19167446
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of PHLDA2 mRNA	PMID:32234424
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of PHLDA2 mRNA	PMID:21858171
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin affects the reaction [Piroxicam results in decreased expression of PHLDA2 mRNA]	PMID:21858171
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of PHLDA2 mRNA	PMID:26079696
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304755	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PHLDA2 mRNA	PMID:24780913|PMID:25825206|PMID:30047161
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of PHLDA2 mRNA	PMID:26272509
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of PHLDA2 mRNA	PMID:24921660
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDA2 mRNA	PMID:27188386
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304755	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PHLDA2 mRNA	PMID:19281266
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304755	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PHLDA2 mRNA	PMID:21346803
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:94796	3,7-dihydropurine-6-thione	decreases expression	ISO	RGD:1304755	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in decreased expression of PHLDA2 mRNA	PMID:23358152
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PHLDA2 mRNA	PMID:38568856
1312382	PHLDA2	pleckstrin homology like domain family A member 2	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of PHLDA2 mRNA	PMID:19140230
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of FANK1 mRNA	PMID:26272509
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA	PMID:27188386
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of FANK1 mRNA	PMID:23724009
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of FANK1 mRNA	PMID:26079696
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312385	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FANK1 mRNA	PMID:30319688
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FANK1 mRNA	PMID:35811015
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of FANK1 mRNA	PMID:30510588
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304756	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of FANK1 mRNA	PMID:33387578
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312385	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FANK1 mRNA	PMID:34319233
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of FANK1 intron	PMID:30157460
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FANK1 gene; Aflatoxin B1 results in decreased methylation of FANK1 intron	PMID:27153756|PMID:30157460
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of FANK1 mRNA	PMID:27392435
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of FANK1 mRNA	PMID:27392435
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304756	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FANK1 mRNA	PMID:32109520
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312385	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FANK1 mRNA	PMID:17942748
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FANK1 mRNA	PMID:28001369
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of FANK1 mRNA	PMID:26272509
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA	PMID:27188386
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312385	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of FANK1 protein	PMID:28918527
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of FANK1 mRNA	PMID:34032870
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312385	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of FANK1 mRNA	PMID:37682722
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of FANK1 mRNA	PMID:25895662
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of FANK1 mRNA	PMID:23557971
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of FANK1 mRNA	PMID:20813756
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304756	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FANK1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:3392	carbendazim	increases expression	ISO	RGD:1304756	E	RGD:6480464	20121113	CTD	MESH:C006698	carbendazim results in increased expression of FANK1 mRNA	PMID:22952946
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312385	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FANK1 mRNA	PMID:30951980
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312385	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of FANK1 mRNA	PMID:30951980
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of FANK1 mRNA	PMID:37047231
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312385	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FANK1 mRNA	PMID:40194260
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of FANK1 mRNA	PMID:29154799
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FANK1 gene	PMID:29154799
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312385	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FANK1 mRNA	PMID:28973697
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FANK1 mRNA	PMID:38832940
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of FANK1 mRNA	PMID:24935251|PMID:26272509
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA	PMID:27188386
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FANK1 mRNA	PMID:35811015
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of FANK1 mRNA	PMID:40706910
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312385	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FANK1 mRNA	PMID:17942748
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312385	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FANK1 mRNA	PMID:17942748
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of FANK1 mRNA	PMID:32234424
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FANK1 mRNA; Nanotubes, Carbon results in decreased expression of FANK1 mRNA	PMID:25554681
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of FANK1 mRNA	PMID:23608068
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of FANK1 mRNA	PMID:38701926
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1304756	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of FANK1 mRNA	PMID:19564919
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:6887	methylphenidate	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in decreased expression of FANK1 mRNA	PMID:22470460
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312385	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FANK1 mRNA	PMID:22206623
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA	PMID:27188386
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FANK1 gene]	PMID:28238834
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:80491	pinostrobin	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C411294	pinostrobin results in increased expression of FANK1 mRNA	PMID:37777166
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of FANK1 mRNA	PMID:26079696
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304756	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of FANK1 mRNA	PMID:24780913
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of FANK1 mRNA	PMID:26272509
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA	PMID:27188386
1312384	FANK1	fibronectin type III and ankyrin repeat domains 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FANK1 mRNA	PMID:27188386
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ELAC1 mRNA	PMID:26251327
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ELAC1 mRNA	PMID:39241906
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ELAC1 mRNA	PMID:37042841
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304757	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ELAC1 mRNA	PMID:33387578
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ELAC1 mRNA	PMID:19549813
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ELAC1 gene	PMID:27153756
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ELAC1 mRNA	PMID:35430440
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1622152	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ELAC1 mRNA	PMID:34911549
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ELAC1 gene	PMID:25304211
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ELAC1 mRNA	PMID:23557933
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ELAC1 mRNA	PMID:28903495
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ELAC1 mRNA	PMID:27392435
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ELAC1 mRNA	PMID:27392435
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1622152	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ELAC1 promoter]	PMID:19654925
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ELAC1 mRNA	PMID:28001369
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ELAC1 mRNA	PMID:38568856
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ELAC1 3' UTR	PMID:27901495
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ELAC1 mRNA	PMID:25351596
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ELAC1 mRNA	PMID:35984750
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ELAC1 mRNA	PMID:29264374
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622152	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ELAC1 promoter	PMID:35295148
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304757	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ELAC1 mRNA	PMID:25181051
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ELAC1 mRNA	PMID:33221593
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304757	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ELAC1 gene	PMID:28505145
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ELAC1 mRNA	PMID:28628672
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ELAC1 mRNA	PMID:25979313
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ELAC1 mRNA	PMID:28628672
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ELAC1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ELAC1 mRNA	PMID:28628672
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1622152	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of ELAC1 protein	PMID:39748354
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ELAC1 mRNA	PMID:37042841
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ELAC1 mRNA	PMID:38174414
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in decreased expression of ELAC1 mRNA	PMID:24183702
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1304757	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ELAC1 gene	PMID:22079235
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:37918	fluorescein 5-isothiocyanate	affects binding	EXP		E	RGD:6480464	20180116	CTD	MESH:D016650	Fluorescein-5-isothiocyanate binds to ELAC1 protein	PMID:27129696
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1622152	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ELAC1 mRNA	PMID:40194260
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ELAC1 mRNA	PMID:28302478
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ELAC1 mRNA	PMID:25979313
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of ELAC1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:28001369
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ELAC1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ELAC1 mRNA	PMID:28628672
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ELAC1 mRNA	PMID:28973697
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ELAC1 mRNA	PMID:24935251
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ELAC1 mRNA	PMID:29279043
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ELAC1 gene	PMID:25304211
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1304757	E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in increased expression of ELAC1 mRNA	PMID:36653537
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ELAC1 mRNA	PMID:22079256
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ELAC1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ELAC1 mRNA	PMID:28628672
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1622152	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ELAC1 mRNA; Nanotubes, Carbon results in decreased expression of ELAC1 mRNA	PMID:25554681
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1622152	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ELAC1 mRNA	PMID:22206623
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ELAC1 mRNA	PMID:22079256
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ELAC1 mRNA	PMID:22079256
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304757	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of ELAC1 mRNA	PMID:25825206
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of ELAC1 mRNA	PMID:24921660
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ELAC1 mRNA	PMID:38568856
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ELAC1 mRNA	PMID:29301935
1312386	ELAC1	elaC ribonuclease Z 1	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of ELAC1 mRNA	PMID:27188386
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1304760	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of PI16 mRNA	PMID:25152437
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PI16 mRNA	PMID:20188158
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases methylation	ISO	RGD:1550019	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased methylation of PI16 promoter	PMID:26251327
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550019	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PI16 mRNA	PMID:26251327
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1304760	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PI16 mRNA	PMID:33729688
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:15940	nicotinic acid	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20161213	CTD	MESH:D009525	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of PI16 mRNA]	PMID:16940432
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550019	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PI16 mRNA	PMID:39241906
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PI16 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PI16 mRNA	PMID:35811015
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of PI16 mRNA	PMID:19484750
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of PI16 mRNA	PMID:26079696
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PI16 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PI16 mRNA	PMID:37567420|PMID:37992649
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PI16 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PI16 mRNA	PMID:37567420|PMID:37992649
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1304760	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PI16 promoter	PMID:23359474
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304760	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of PI16 mRNA	PMID:22061828|PMID:33387578
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:2208	purine-6-thiol	increases expression	ISO	RGD:1304760	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of PI16 mRNA	PMID:23358152
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1304760	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of PI16 mRNA	PMID:30779732
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304760	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PI16 mRNA	PMID:31881176
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20231003	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 5' UTR; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 exon; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 intron; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 promoter	PMID:33445541
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:28073	chromium atom	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20120412	CTD	MESH:D002857	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of PI16 mRNA]	PMID:16940432
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PI16 mRNA	PMID:32186404
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304760	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PI16 mRNA	PMID:34747641
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304760	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PI16 mRNA	PMID:28959563
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1304760	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of PI16 mRNA	PMID:30556269
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PI16 mRNA	PMID:29803840
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PI16 mRNA	PMID:39631538
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PI16 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PI16 mRNA	PMID:37567420|PMID:37992649
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of PI16 mRNA	PMID:39515575
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1550019	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of PI16 gene	PMID:39894169
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550019	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of PI16 mRNA	PMID:37682722
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PI16 mRNA	PMID:22610609
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550019	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PI16 mRNA	PMID:32417428
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1304760	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of PI16 mRNA	PMID:30556269
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PI16 mRNA	PMID:23806026
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PI16 gene	PMID:31601247
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20231003	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 5' UTR; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 exon; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 intron; [lead acetate results in increased abundance of Lead] which results in increased methylation of PI16 promoter	PMID:33445541
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of PI16 mRNA	PMID:23557971
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550019	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PI16 gene	PMID:35295148
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304760	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PI16 mRNA	PMID:34492290
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550019	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PI16 mRNA	PMID:20813756
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304760	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PI16 mRNA	PMID:25181051
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550019	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of PI16 mRNA	PMID:32156529
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PI16 gene	PMID:31601247
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304760	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PI16 promoter	PMID:23359474
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of PI16 mRNA; 2,5,2',5'-tetrachlorobiphenyl results in increased expression of PI16 mRNA	PMID:36804509
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550019	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PI16 mRNA	PMID:30951980
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550019	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PI16 exon; butylbenzyl phthalate results in increased methylation of PI16 intron	PMID:28392331
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1304760	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of PI16 promoter	PMID:23359474
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304760	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of PI16 mRNA	PMID:27387713
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550019	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PI16 mRNA	PMID:40194260
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1550019	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of PI16 mRNA	PMID:39529242
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of PI16 mRNA	PMID:29038090
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of PI16 mRNA	PMID:22733784
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PI16 mRNA	PMID:28973697
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PI16 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PI16 mRNA	PMID:37567420|PMID:37992649
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of PI16 mRNA	PMID:22230336
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of PI16 mRNA	PMID:35811015
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PI16 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PI16 mRNA	PMID:35811015
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PI16 mRNA; Nanotubes, Carbon results in decreased expression of PI16 mRNA	PMID:25554681|PMID:25620056
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550019	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PI16 mRNA	PMID:25620056
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:50667	mercaptopurine	increases expression	ISO	RGD:1304760	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of PI16 mRNA	PMID:23358152
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PI16 mRNA	PMID:36907384
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of PI16 mRNA	PMID:22078008
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1550019	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of PI16 mRNA	PMID:37567420
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PI16 gene]	PMID:28238834
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1550019	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PI16 mRNA	PMID:38648751
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304760	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PI16 mRNA	PMID:24780913
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304760	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PI16 mRNA	PMID:19281266
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	ISO	RGD:1304760	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of PI16 mRNA	PMID:23358152
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1550019	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of PI16 mRNA	PMID:28973697
1312389	PI16	peptidase inhibitor 16	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550019	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of PI16 mRNA	PMID:35537566
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MRPS6 mRNA	PMID:19074003
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312392	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MRPS6 gene	PMID:20938992
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MRPS6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MRPS6 mRNA	PMID:32699268
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRPS6 mRNA	PMID:22378314
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312392	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MRPS6 mRNA	PMID:30319688
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of MRPS6 mRNA	PMID:21632981
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312392	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPS6 mRNA	PMID:39241906
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of MRPS6 mRNA	PMID:31059760
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of MRPS6 mRNA	PMID:38568856
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312392	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MRPS6 gene	PMID:20938992
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of MRPS6 mRNA	PMID:18037150
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MRPS6 mRNA	PMID:21179406
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of MRPS6 mRNA	PMID:16002434
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D005839	Gentamicins results in decreased expression of MRPS6 mRNA	PMID:38447685
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MRPS6 mRNA	PMID:28818685
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312392	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPS6 mRNA	PMID:36331819
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MRPS6 mRNA	PMID:19549813
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MRPS6 protein	PMID:23301498
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MRPS6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MRPS6 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of MRPS6 mRNA	PMID:32699268
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:2322928	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of MRPS6 mRNA	PMID:30779732
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of MRPS6 mRNA	PMID:18593933
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312392	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MRPS6 mRNA	PMID:17484886
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312392	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MRPS6 mRNA	PMID:31919559
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312392	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS6 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MRPS6 gene	PMID:20938992|PMID:22206623
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312392	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS6 mRNA	PMID:40504410
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of MRPS6 mRNA	PMID:19167446
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of MRPS6 mRNA	PMID:27392435
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312392	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPS6 mRNA	PMID:21570461
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:2322928	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPS6 mRNA	PMID:34747641
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of MRPS6 mRNA	PMID:33512557
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MRPS6 mRNA	PMID:33212167
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of MRPS6 mRNA	PMID:32763439
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of MRPS6 mRNA	PMID:25523186
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:2322928	E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPS6 mRNA	PMID:35314868
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312392	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS6 mRNA	PMID:40504410
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MRPS6 mRNA	PMID:22378314
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MRPS6 promoter	PMID:27901495
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MRPS6 mRNA	PMID:20106945|PMID:21632981
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312392	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MRPS6 mRNA	PMID:19770486|PMID:22228805
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312392	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MRPS6 exon; Benzo(a)pyrene results in increased methylation of MRPS6 intron	PMID:27901495
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of MRPS6 promoter	PMID:23974009
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of MRPS6 mRNA	PMID:25523186
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of MRPS6 mRNA	PMID:18593933
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312392	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of MRPS6 mRNA	PMID:21829687
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:2322928	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of MRPS6 mRNA	PMID:25729387
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312392	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of MRPS6 mRNA	PMID:23557971
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312392	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MRPS6 gene	PMID:35295148
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1312392	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of MRPS6 mRNA	PMID:18648102
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312392	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of MRPS6 mRNA	PMID:17426115|PMID:18301758
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:32509	pirinixic acid	increases phosphorylation	ISO	RGD:1312392	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased phosphorylation of MRPS6 protein	PMID:18602970
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312392	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MRPS6 mRNA	PMID:28472532
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of MRPS6 mRNA	PMID:29275510
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2322928	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of MRPS6 mRNA	PMID:32145629
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of MRPS6 mRNA	PMID:19244175
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312392	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of MRPS6 mRNA	PMID:26682919
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:2322928	E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of MRPS6 mRNA	PMID:17316808
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312392	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPS6 mRNA	PMID:39298647
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MRPS6 mRNA	PMID:28628672
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312392	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of MRPS6 intron	PMID:28392331
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312392	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MRPS6 mRNA	PMID:21266533
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene results in decreased expression of MRPS6 mRNA	PMID:17374397
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MRPS6 mRNA	PMID:28628672
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of MRPS6 mRNA	PMID:17312168
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:2322928	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MRPS6 mRNA	PMID:32680482
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MRPS6 mRNA	PMID:37042841
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of MRPS6 mRNA	PMID:29024780
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MRPS6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MRPS6 mRNA	PMID:32699268
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MRPS6 mRNA	PMID:31533062
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of MRPS6 mRNA	PMID:19167446
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of MRPS6 mRNA	PMID:26352163
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312392	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPS6 mRNA	PMID:36331819
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRPS6 mRNA	PMID:25979313
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MRPS6 gene	PMID:29154799
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of MRPS6 mRNA	PMID:29154799
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MRPS6 mRNA	PMID:20106945
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312392	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MRPS6 mRNA	PMID:17555576
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MRPS6 mRNA	PMID:28628672
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312392	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of MRPS6 mRNA	PMID:28973697
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of MRPS6 mRNA	PMID:33512557
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MRPS6 mRNA	PMID:38832940
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of MRPS6 mRNA	PMID:21420995|PMID:31059760
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of MRPS6 mRNA	PMID:31059760
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312392	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS6 mRNA	PMID:40504410
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312392	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MRPS6 mRNA	PMID:17555576
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:2322928	E	RGD:6480464	20130806	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MRPS6 mRNA	PMID:17557909
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MRPS6 mRNA	PMID:28628672
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312392	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of MRPS6 mRNA	PMID:40234311
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312392	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of MRPS6 mRNA	PMID:26377693
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C029938	nickel sulfate results in decreased expression of MRPS6 mRNA	PMID:17374397
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010081	Oxazolone results in decreased expression of MRPS6 mRNA	PMID:17374397
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312392	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MRPS6 mRNA	PMID:21641980
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:2322928	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of MRPS6 mRNA	PMID:25729387
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:2322928	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of MRPS6 mRNA	PMID:25729387
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:6443	levonorgestrel	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MRPS6 mRNA	PMID:19074003
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of MRPS6 mRNA	PMID:37939859
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:2322928	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MRPS6 gene	PMID:35440735
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312392	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS6 mRNA	PMID:22206623
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MRPS6 gene]	PMID:28238834
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MRPS6 mRNA	PMID:19159669
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1312392	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of MRPS6 mRNA	PMID:31558096
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of MRPS6 mRNA	PMID:17440010
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of MRPS6 mRNA	PMID:22378314
1312391	MRPS6	mitochondrial ribosomal protein S6	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:2322928	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of MRPS6 gene	PMID:31682807
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:10033	warfarin	increases expression	ISO	RGD:1312395	E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin results in increased expression of CCT6A mRNA	PMID:20493250
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CCT6A mRNA	PMID:38218311
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304763	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCT6A mRNA]	PMID:31150632
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CCT6A mRNA	PMID:33167477
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CCT6A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CCT6A mRNA	PMID:32699268
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312395	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CCT6A mRNA	PMID:30319688
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CCT6A mRNA	PMID:20044591
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16325	lithocholic acid	decreases expression	EXP		E	RGD:6480464	20131210	CTD	MESH:D008095	Lithocholic Acid results in decreased expression of CCT6A protein	PMID:21224350
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312395	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CCT6A mRNA	PMID:39241906
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT6A mRNA]	PMID:39241906
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of CCT6A mRNA	PMID:15598610
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312395	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CCT6A mRNA	PMID:39298647
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304763	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of CCT6A mRNA	PMID:26496021
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CCT6A mRNA	PMID:38568856
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304763	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CCT6A mRNA	PMID:33387578
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of CCT6A mRNA	PMID:15363585
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D014241	PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of CCT6A protein]	PMID:15363585
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CCT6A mRNA	PMID:37042841
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of CCT6A protein	PMID:32044396
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1304763	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CCT6A mRNA	PMID:21318169
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CCT6A mRNA	PMID:21318169
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:177802	Cuprizon	affects expression	ISO	RGD:1304763	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of CCT6A mRNA	PMID:27523638
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	Cuprizone results in increased expression of CCT6A protein	PMID:34122009
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of CCT6A protein; [Cuprizone co-treated with Cannabidiol] results in decreased expression of CCT6A protein	PMID:34122009
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CCT6A protein	PMID:37730182
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304763	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CCT6A mRNA; Gentamicins results in increased expression of CCT6A protein	PMID:22061828|PMID:33387578
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CCT6A mRNA	PMID:36331819
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CCT6A mRNA	PMID:23649840
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1304763	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CCT6A mRNA	PMID:33354967
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:2504	aflatoxin B1	increases mutagenesis	ISO	RGD:1304763	E	RGD:6480464	20240109	CTD	MESH:D016604	Aflatoxin B1 results in increased mutagenesis of CCT6A gene	PMID:36908029
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CCT6A mRNA	PMID:23649840
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CCT6A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CCT6A mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of CCT6A mRNA	PMID:32699268
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:2654	aminoglutethimide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in decreased expression of CCT6A protein	PMID:26102013
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CCT6A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CCT6A protein	PMID:38598786
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CCT6A mRNA	PMID:18593933
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304763	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCT6A mRNA	PMID:31150632
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312395	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCT6A mRNA	PMID:31919559
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304763	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCT6A mRNA]	PMID:31150632
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CCT6A mRNA]	PMID:22206623
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CCT6A protein	PMID:35688186
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CCT6A mRNA	PMID:28903495
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in increased expression of CCT6A protein	PMID:37834424
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of CCT6A mRNA	PMID:27594783
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312395	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCT6A mRNA	PMID:21570461
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304763	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCT6A mRNA	PMID:34747641
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CCT6A mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCT6A mRNA	PMID:16214954|PMID:17942748
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of CCT6A mRNA	PMID:33512557
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CCT6A mRNA	PMID:32763439
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304763	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CCT6A mRNA	PMID:28959563
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCT6A mRNA; sodium arsenite results in decreased expression of CCT6A protein	PMID:30528433|PMID:38568856
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of CCT6A mRNA	PMID:29453283
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCT6A mRNA	PMID:22228805
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCT6A 3' UTR; Benzo(a)pyrene results in increased methylation of CCT6A promoter	PMID:27901495
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CCT6A mRNA	PMID:18593933
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of CCT6A protein	PMID:34122009
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:30563	silicon dioxide	affects secretion	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog affects the secretion of CCT6A protein	PMID:25895662
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CCT6A protein	PMID:19364129
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304763	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CCT6A mRNA	PMID:34492290
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1304763	E	RGD:6480464	20120717	CTD	MESH:C006253	pirinixic acid results in increased expression of CCT6A mRNA	PMID:19162173|PMID:21318169
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of CCT6A mRNA	PMID:15375163|PMID:18301758
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312395	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CCT6A mRNA	PMID:28472532
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:3312	calcium dichloride	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D002122	Calcium Chloride results in decreased expression of CCT6A protein	PMID:25824407
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1304763	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of CCT6A mRNA	PMID:19167457
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304763	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CCT6A mRNA	PMID:25181051
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CCT6A mRNA; bisphenol A results in decreased expression of CCT6A protein	PMID:29275510|PMID:34186270
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312395	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of CCT6A promoter	PMID:27312807
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304763	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CCT6A mRNA	PMID:30816183|PMID:41034487
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304763	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of CCT6A mRNA	PMID:26496021
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CCT6A protein	PMID:34186270
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312395	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CCT6A mRNA	PMID:39298647
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CCT6A protein	PMID:34186270
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CCT6A protein	PMID:34186270
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1312395	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of CCT6A mRNA	PMID:31558096
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CCT6A protein	PMID:38598786
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304763	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of CCT6A mRNA	PMID:32680482
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT6A mRNA]	PMID:39241906
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CCT6A mRNA	PMID:37042841
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CCT6A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CCT6A mRNA	PMID:32699268
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CCT6A mRNA	PMID:28302478
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CCT6A mRNA	PMID:36331819
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1312395	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of CCT6A mRNA	PMID:31558096
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1304763	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of CCT6A mRNA	PMID:25993096
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CCT6A mRNA	PMID:17292431
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1304763	E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in increased expression of CCT6A mRNA	PMID:21318169
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304763	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of CCT6A mRNA	PMID:38685447|PMID:41580965
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:40303	lovastatin	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120814	CTD	MESH:D008148	Lovastatin results in increased expression of CCT6A mRNA	PMID:20493250
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CCT6A mRNA	PMID:20106945
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of CCT6A mRNA	PMID:33512557
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1304763	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CCT6A mRNA	PMID:24136188
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CCT6A mRNA	PMID:38832940
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1304763	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of CCT6A mRNA	PMID:21346803
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CCT6A mRNA	PMID:17562736
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CCT6A mRNA	PMID:21420995
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of CCT6A protein	PMID:25470785
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of CCT6A protein	PMID:31195006
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of CCT6A mRNA	PMID:18175754
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CCT6A mRNA	PMID:17942748
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCT6A mRNA	PMID:17942748
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CCT6A protein	PMID:19364129
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312395	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CCT6A mRNA; Nanotubes, Carbon results in increased expression of CCT6A mRNA	PMID:25554681
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1304763	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CCT6A mRNA	PMID:24136188
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1304763	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of CCT6A mRNA	PMID:34044035
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304763	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of CCT6A mRNA	PMID:41580965
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312395	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of CCT6A mRNA	PMID:40234311
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CCT6A mRNA	PMID:35964746
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304763	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CCT6A mRNA	PMID:24136188
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CCT6A mRNA	PMID:19042947
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CCT6A protein	PMID:32959892
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1304763	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CCT6A mRNA	PMID:24136188
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:6723	megestrol acetate	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019290	Megestrol Acetate results in increased expression of CCT6A protein	PMID:16939895
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of CCT6A protein	PMID:34122009
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of CCT6A protein	PMID:34122009
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CCT6A protein	PMID:34186270
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312395	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CCT6A mRNA	PMID:22206623
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CCT6A mRNA]	PMID:22206623
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1304763	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CCT6A mRNA	PMID:24136188
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	ISO	RGD:1304763	E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of CCT6A protein	PMID:19716841
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CCT6A protein	PMID:39638853
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1304763	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of CCT6A mRNA	PMID:21346803
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of CCT6A mRNA	PMID:18927307
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312395	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CCT6A mRNA	PMID:30294300
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1312395	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of CCT6A mRNA	PMID:31558096
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312395	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of CCT6A mRNA	PMID:21278054
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312395	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT6A mRNA]	PMID:39241906
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304763	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CCT6A mRNA	PMID:21346803
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CCT6A protein	PMID:38598786
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304763	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CCT6A mRNA	PMID:21346803
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304763	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CCT6A mRNA	PMID:19015723
1312394	CCT6A	chaperonin containing TCP1 subunit 6A	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304763	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of CCT6A mRNA	PMID:20566332
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552002	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PPP2R1B mRNA	PMID:33045310
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552002	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PPP2R1B mRNA	PMID:26251327
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of PPP2R1B mRNA	PMID:15498508
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552002	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PPP2R1B mRNA	PMID:30319688
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PPP2R1B mRNA	PMID:21632981
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552002	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PPP2R1B mRNA; Estradiol results in increased expression of PPP2R1B protein	PMID:26903627|PMID:39298647
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:165219	PCB138	increases expression	ISO	RGD:1304764	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of PPP2R1B protein	PMID:21673325
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PPP2R1B mRNA	PMID:23649840
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PPP2R1B mRNA	PMID:33359661
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1552002	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PPP2R1B mRNA	PMID:23892564
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552002	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP2R1B mRNA	PMID:36331819
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of PPP2R1B mRNA	PMID:23369406
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D002104	Cadmium results in increased expression of PPP2R1B mRNA	PMID:31463135
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552002	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPP2R1B mRNA	PMID:37236586
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PPP2R1B mRNA	PMID:19549813
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PPP2R1B mRNA	PMID:22100608
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PPP2R1B gene	PMID:27153756
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PPP2R1B mRNA	PMID:19502547
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1304764	E	RGD:6480464	20260407	CTD	MESH:D000638	Amiodarone results in increased expression of PPP2R1B mRNA	PMID:40216313
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of PPP2R1B mRNA	PMID:31295307
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1552002	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PPP2R1B mRNA	PMID:28960355
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552002	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPP2R1B mRNA	PMID:21570461
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304764	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of PPP2R1B mRNA	PMID:28374803
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1552002	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of PPP2R1B mRNA	PMID:30807115
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of PPP2R1B mRNA	PMID:30911355
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPP2R1B protein]	PMID:18703135
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1304764	E	RGD:6480464	20120717	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPP2R1B protein]	PMID:18703135
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPP2R1B mRNA; sodium arsenite results in decreased expression of PPP2R1B protein	PMID:38228842|PMID:38568856
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of PPP2R1B mRNA	PMID:30911355
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PPP2R1B mRNA	PMID:25351596
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1304764	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of PPP2R1B mRNA	PMID:32479839
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304764	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of PPP2R1B mRNA	PMID:30047161
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:32181	tamibarotene	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of PPP2R1B mRNA	PMID:15498508
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304764	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PPP2R1B mRNA	PMID:23411599|PMID:34492290
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552002	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PPP2R1B mRNA	PMID:18301758
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1304764	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PPP2R1B mRNA	PMID:19167457
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of PPP2R1B protein	PMID:37567409
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304764	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PPP2R1B mRNA	PMID:25181051
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PPP2R1B gene	PMID:31601247
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of PPP2R1B mRNA	PMID:27685785
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304764	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PPP2R1B mRNA	PMID:34947998
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304764	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PPP2R1B gene	PMID:28505145
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of PPP2R1B protein	PMID:31675489
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of PPP2R1B mRNA	PMID:19244175
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of PPP2R1B mRNA	PMID:24752500
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552002	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PPP2R1B mRNA	PMID:39298647
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in increased expression of PPP2R1B mRNA	PMID:27685785
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to PPP2R1B protein	PMID:32991956
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPP2R1B mRNA	PMID:37042841
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1304764	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of PPP2R1B mRNA	PMID:30589522
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:35176	zinc sulfate	affects expression	EXP		E	RGD:6480464	20150127	CTD	MESH:D019287	Zinc Sulfate affects the expression of PPP2R1B protein	PMID:25162517
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PPP2R1B protein	PMID:18703135
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304764	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PPP2R1B mRNA; Cadmium Chloride results in decreased expression of PPP2R1B protein	PMID:18703135|PMID:33453195
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPP2R1B protein]	PMID:18703135
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304764	E	RGD:6480464	20120717	CTD	MESH:D019256	Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of PPP2R1B protein]	PMID:18703135
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552002	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPP2R1B mRNA	PMID:37236586
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PPP2R1B mRNA	PMID:28302478
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PPP2R1B mRNA	PMID:40419075
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552002	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP2R1B mRNA	PMID:36331819
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1304764	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of PPP2R1B mRNA	PMID:25993096
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PPP2R1B mRNA	PMID:25979313
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PPP2R1B mRNA	PMID:23179753|PMID:26272509
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of PPP2R1B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R1B mRNA	PMID:17183730|PMID:27188386
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304764	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of PPP2R1B mRNA	PMID:41580965
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304764	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of PPP2R1B mRNA	PMID:30047161
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of PPP2R1B mRNA	PMID:27989131
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:43602	obeticholic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in increased expression of PPP2R1B mRNA	PMID:27939613
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PPP2R1B mRNA	PMID:38832940
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:44975	1,10-phenanthroline	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C025205	1,10-phenanthroline results in decreased expression of PPP2R1B mRNA	PMID:19502547
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of PPP2R1B mRNA	PMID:26272509
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R1B mRNA	PMID:27188386
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of PPP2R1B mRNA	PMID:24752500
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of PPP2R1B mRNA	PMID:31675489
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552002	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of PPP2R1B mRNA	PMID:35436446
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552002	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PPP2R1B mRNA	PMID:25620056
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1304764	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PPP2R1B mRNA	PMID:24136188
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1304764	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of PPP2R1B mRNA	PMID:34044035
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304764	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of PPP2R1B mRNA	PMID:30047161
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304764	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of PPP2R1B mRNA	PMID:24793618
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1304764	E	RGD:6480464	20121009	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of PPP2R1B mRNA	PMID:22841810
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of PPP2R1B mRNA	PMID:16780908
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:53470	cobalt(2+) sulfate	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C026305	cobalt sulfate results in decreased expression of PPP2R1B mRNA	PMID:19502547
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of PPP2R1B mRNA	PMID:17183730
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PPP2R1B protein	PMID:32959892
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1304764	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of PPP2R1B mRNA	PMID:24136188
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:63924	riddelliine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PPP2R1B mRNA	PMID:33884520
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1304764	E	RGD:6480464	20121113	CTD	MESH:D008701	Methapyrilene results in increased expression of PPP2R1B mRNA	PMID:22484513
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:747853	Gedatolisib	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C549060	gedatolisib inhibits the reaction [PIK3CA protein modified form results in increased expression of PPP2R1B mRNA]	PMID:27542212
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:7553	niclosamide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide inhibits the reaction [PIK3CA protein modified form results in increased expression of PPP2R1B mRNA]	PMID:27542212
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of PPP2R1B mRNA	PMID:19287073
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R1B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R1B mRNA	PMID:27188386
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PPP2R1B gene]	PMID:28238834
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of PPP2R1B mRNA; 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PPP2R1B protein	PMID:19095052|PMID:31675489
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of PPP2R1B protein	PMID:31675489
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of PPP2R1B mRNA	PMID:21858171
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1304764	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of PPP2R1B mRNA	PMID:30047161
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:8493	Propiverine	affects binding	ISO	RGD:1304764	E	RGD:6480464	20180410	CTD	MESH:C015586	propiverine binds to PPP2R1B protein	PMID:29273565
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304764	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of PPP2R1B mRNA	PMID:30047161
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:8687	pyrvinium	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C024631	pyrvinium inhibits the reaction [PIK3CA protein modified form results in increased expression of PPP2R1B mRNA]	PMID:27542212
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R1B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP2R1B mRNA	PMID:27188386
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D020123	Sirolimus inhibits the reaction [PIK3CA protein modified form results in increased expression of PPP2R1B mRNA]	PMID:27542212
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PPP2R1B mRNA	PMID:38568856
1312396	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PPP2R1B mRNA	PMID:29301935
1312398	ANO6	anoctamin 6	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312399	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ANO6 mRNA	PMID:37995155
1312398	ANO6	anoctamin 6	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANO6 protein]	PMID:38195004
1312398	ANO6	anoctamin 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312399	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ANO6 mRNA	PMID:20188158
1312398	ANO6	anoctamin 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANO6 mRNA	PMID:20938992
1312398	ANO6	anoctamin 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of ANO6 mRNA	PMID:21934132
1312398	ANO6	anoctamin 6	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ANO6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ANO6 mRNA	PMID:32699268
1312398	ANO6	anoctamin 6	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ANO6 mRNA	PMID:26079696
1312398	ANO6	anoctamin 6	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304765	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of ANO6 gene	PMID:28931070
1312398	ANO6	anoctamin 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ANO6 mRNA	PMID:30165855
1312398	ANO6	anoctamin 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304765	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ANO6 mRNA	PMID:26496021
1312398	ANO6	anoctamin 6	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ANO6 mRNA	PMID:38568856
1312398	ANO6	anoctamin 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANO6 mRNA	PMID:20938992
1312398	ANO6	anoctamin 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANO6 mRNA	PMID:37992649
1312398	ANO6	anoctamin 6	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1304765	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of ANO6 mRNA	PMID:22967744
1312398	ANO6	anoctamin 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANO6 mRNA	PMID:37992649
1312398	ANO6	anoctamin 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312399	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ANO6 mRNA	PMID:33754040
1312398	ANO6	anoctamin 6	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ANO6 protein	PMID:37730182
1312398	ANO6	anoctamin 6	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304765	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ANO6 mRNA	PMID:33387578
1312398	ANO6	anoctamin 6	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D024502	alpha-Tocopherol inhibits the reaction [Ozone results in increased expression of ANO6 mRNA]	PMID:27886375
1312398	ANO6	anoctamin 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANO6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANO6 protein	PMID:38195004
1312398	ANO6	anoctamin 6	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANO6 mRNA	PMID:29950665
1312398	ANO6	anoctamin 6	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ANO6 mRNA	PMID:19549813
1312398	ANO6	anoctamin 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ANO6 gene; Aflatoxin B1 results in increased methylation of ANO6 intron	PMID:27153756|PMID:30157460
1312398	ANO6	anoctamin 6	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D010126	Ozone results in increased expression of ANO6 mRNA	PMID:27886375
1312398	ANO6	anoctamin 6	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ANO6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ANO6 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of ANO6 mRNA; alpha-Tocopherol inhibits the reaction [Ozone results in increased expression of ANO6 mRNA]	PMID:27886375|PMID:32699268
1312398	ANO6	anoctamin 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANO6 mRNA	PMID:20938992
1312398	ANO6	anoctamin 6	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ANO6 gene	PMID:25304211
1312398	ANO6	anoctamin 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANO6 mRNA	PMID:40504410
1312398	ANO6	anoctamin 6	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ANO6 mRNA	PMID:26272509
1312398	ANO6	anoctamin 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANO6 mRNA	PMID:27188386
1312398	ANO6	anoctamin 6	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304765	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ANO6 mRNA	PMID:31881176
1312398	ANO6	anoctamin 6	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ANO6 mRNA	PMID:27392435
1312398	ANO6	anoctamin 6	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ANO6 mRNA	PMID:27392435
1312398	ANO6	anoctamin 6	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1312399	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of ANO6 mRNA	PMID:18930951
1312398	ANO6	anoctamin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304765	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ANO6 mRNA	PMID:33387578
1312398	ANO6	anoctamin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304765	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ANO6 mRNA	PMID:34747641
1312398	ANO6	anoctamin 6	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of ANO6 protein	PMID:39603559
1312398	ANO6	anoctamin 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ANO6 mRNA	PMID:33212167
1312398	ANO6	anoctamin 6	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of ANO6 mRNA	PMID:24690739
1312398	ANO6	anoctamin 6	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ANO6 mRNA	PMID:29803840
1312398	ANO6	anoctamin 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANO6 mRNA	PMID:37992649
1312398	ANO6	anoctamin 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANO6 mRNA	PMID:40504410
1312398	ANO6	anoctamin 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312399	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ANO6 mRNA	PMID:19770486
1312398	ANO6	anoctamin 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312399	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ANO6 intron	PMID:27901495
1312398	ANO6	anoctamin 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ANO6 mRNA]	PMID:32406909
1312398	ANO6	anoctamin 6	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of ANO6 mRNA	PMID:24690739
1312398	ANO6	anoctamin 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ANO6 mRNA	PMID:19150397
1312398	ANO6	anoctamin 6	gene	CHEBI:30814	digallic acid	decreases activity	ISO	RGD:1312399	E	RGD:6480464	20150127	CTD	MESH:C067648	digallic acid results in decreased activity of ANO6 protein	PMID:24478309
1312398	ANO6	anoctamin 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312399	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ANO6 gene	PMID:35295148
1312398	ANO6	anoctamin 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312399	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ANO6 gene; titanium dioxide results in increased methylation of ANO6 promoter	PMID:35295148
1312398	ANO6	anoctamin 6	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANO6 mRNA	PMID:29950665
1312398	ANO6	anoctamin 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304765	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ANO6 mRNA	PMID:34492290
1312398	ANO6	anoctamin 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1304765	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ANO6 mRNA	PMID:25380136
1312398	ANO6	anoctamin 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312399	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ANO6 mRNA	PMID:18301758
1312398	ANO6	anoctamin 6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304765	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ANO6 mRNA	PMID:25181051
1312398	ANO6	anoctamin 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304765	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ANO6 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312398	ANO6	anoctamin 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ANO6 protein	PMID:34186270
1312398	ANO6	anoctamin 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304765	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ANO6 gene	PMID:28505145
1312398	ANO6	anoctamin 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304765	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of ANO6 mRNA	PMID:26496021
1312398	ANO6	anoctamin 6	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ANO6 mRNA	PMID:25979313
1312398	ANO6	anoctamin 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312399	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ANO6 mRNA	PMID:39298647
1312398	ANO6	anoctamin 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of ANO6 protein	PMID:34186270
1312398	ANO6	anoctamin 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312399	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ANO6 mRNA	PMID:40203079
1312398	ANO6	anoctamin 6	gene	CHEBI:34457	5-Nitro-2-(3-phenylpropylamino)benzoic acid	decreases activity	ISO	RGD:1312399	E	RGD:6480464	20150127	CTD	MESH:C058176	5-nitro-2-(3-phenylpropylamino)benzoic acid results in decreased activity of ANO6 protein	PMID:24478309
1312398	ANO6	anoctamin 6	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ANO6 protein	PMID:34186270
1312398	ANO6	anoctamin 6	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312399	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ANO6 intron	PMID:28392331
1312398	ANO6	anoctamin 6	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANO6 mRNA	PMID:29950665
1312398	ANO6	anoctamin 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312399	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ANO6 mRNA	PMID:21266533
1312398	ANO6	anoctamin 6	gene	CHEBI:34888	Niflumic acid	affects activity	ISO	RGD:1312399	E	RGD:6480464	20150127	CTD	MESH:D009544	Niflumic Acid affects the activity of ANO6 protein	PMID:24478309
1312398	ANO6	anoctamin 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ANO6 mRNA	PMID:37042841
1312398	ANO6	anoctamin 6	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304765	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ANO6 mRNA	PMID:25380136
1312398	ANO6	anoctamin 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANO6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ANO6 protein	PMID:38195004
1312398	ANO6	anoctamin 6	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ANO6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ANO6 mRNA	PMID:32699268
1312398	ANO6	anoctamin 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312399	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ANO6 mRNA	PMID:40194260
1312398	ANO6	anoctamin 6	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of ANO6 mRNA	PMID:19167446
1312398	ANO6	anoctamin 6	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANO6 mRNA	PMID:19167446
1312398	ANO6	anoctamin 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ANO6 mRNA	PMID:25979313
1312398	ANO6	anoctamin 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANO6 mRNA	PMID:37992649
1312398	ANO6	anoctamin 6	gene	CHEBI:4286	4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid	decreases activity	ISO	RGD:1312399	E	RGD:6480464	20150127	CTD	MESH:D017878	4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid results in decreased activity of ANO6 protein	PMID:24478309
1312398	ANO6	anoctamin 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304765	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ANO6 mRNA	PMID:33387578
1312398	ANO6	anoctamin 6	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of ANO6 mRNA	PMID:24690739
1312398	ANO6	anoctamin 6	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ANO6 gene	PMID:25304211
1312398	ANO6	anoctamin 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312399	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANO6 mRNA	PMID:40504410
1312398	ANO6	anoctamin 6	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases activity	ISO	RGD:1312399	E	RGD:6480464	20150127	CTD	MESH:C045651	epigallocatechin gallate results in decreased activity of ANO6 protein	PMID:24478309
1312398	ANO6	anoctamin 6	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304765	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ANO6 mRNA	PMID:24793618
1312398	ANO6	anoctamin 6	gene	CHEBI:51876	auramine O	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D001576	Benzophenoneidum results in increased expression of ANO6 protein	PMID:28722353
1312398	ANO6	anoctamin 6	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312399	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ANO6 mRNA	PMID:26307267
1312398	ANO6	anoctamin 6	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ANO6 protein	PMID:34186270
1312398	ANO6	anoctamin 6	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312399	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ANO6 mRNA	PMID:22206623
1312398	ANO6	anoctamin 6	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ANO6 mRNA	PMID:37199045
1312398	ANO6	anoctamin 6	gene	CHEBI:7719	ochratoxin A	increases methylation	ISO	RGD:1304765	E	RGD:6480464	20160210	CTD	MESH:C025589	ochratoxin A results in increased methylation of ANO6 gene	PMID:26431795
1312398	ANO6	anoctamin 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANO6 mRNA	PMID:27188386
1312398	ANO6	anoctamin 6	gene	CHEBI:81555	Enterolactone	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ANO6 mRNA	PMID:19167446
1312398	ANO6	anoctamin 6	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ANO6 mRNA	PMID:19167446
1312398	ANO6	anoctamin 6	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ANO6 mRNA	PMID:26079696
1312398	ANO6	anoctamin 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANO6 mRNA	PMID:27188386
1312398	ANO6	anoctamin 6	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304765	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ANO6 mRNA	PMID:19281266
1312398	ANO6	anoctamin 6	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ANO6 mRNA	PMID:38568856
1312398	ANO6	anoctamin 6	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1304765	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of ANO6 protein	PMID:32519852
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ARHGEF19 mRNA	PMID:33045310
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1550020	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ARHGEF19 mRNA	PMID:30319688
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550020	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ARHGEF19 mRNA	PMID:30319688
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ARHGEF19 mRNA	PMID:31614463
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550020	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ARHGEF19 mRNA	PMID:39298647
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARHGEF19 mRNA	PMID:37042841
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ARHGEF19 mRNA	PMID:26577399|PMID:27523638
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of ARHGEF19 mRNA	PMID:26485663
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ARHGEF19 mRNA	PMID:22061828
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ARHGEF19 mRNA	PMID:28818685
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARHGEF19 mRNA	PMID:36331819
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGEF19 mRNA	PMID:35301059
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGEF19 mRNA	PMID:37236586
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:23115	chlorohydrocarbon	multiple interactions	ISO	RGD:1304766	E	RGD:6480464	20210112	CTD	MESH:D006843	[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of ARHGEF19 mRNA	PMID:30744511
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARHGEF19 mRNA	PMID:22100608
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ARHGEF19 mRNA	PMID:31150632
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARHGEF19 mRNA	PMID:22206623
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550020	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of ARHGEF19 mRNA	PMID:28189721|PMID:28960355
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ARHGEF19 mRNA	PMID:27594783
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of ARHGEF19 protein	PMID:22006019
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ARHGEF19 mRNA	PMID:27392435
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304766	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGEF19 mRNA	PMID:22298810
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550020	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGEF19 mRNA	PMID:21570461
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGEF19 mRNA	PMID:21215274|PMID:21724226
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGEF19 mRNA	PMID:19770486|PMID:26290441
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ARHGEF19 promoter]	PMID:19654925
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1304766	E	RGD:6480464	20210112	CTD	MESH:C004925	[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in increased expression of ARHGEF19 mRNA	PMID:30744511
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ARHGEF19 mRNA	PMID:33212167
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304766	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ARHGEF19 mRNA	PMID:30556269
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARHGEF19 mRNA	PMID:39631538
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGEF19 mRNA	PMID:29301061|PMID:39719251
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550020	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGEF19 mRNA	PMID:37682722
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARHGEF19 5' UTR; Benzo(a)pyrene affects the methylation of ARHGEF19 promoter	PMID:27901495
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304766	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ARHGEF19 mRNA	PMID:30556269
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of ARHGEF19 mRNA	PMID:32479839
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550020	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ARHGEF19 gene	PMID:35295148
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ARHGEF19 mRNA	PMID:34492290
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ARHGEF19 mRNA	PMID:23811191
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARHGEF19 mRNA	PMID:19710929
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304766	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARHGEF19 mRNA	PMID:25181051
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGEF19 mRNA	PMID:25047013
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGEF19 mRNA	PMID:32145629|PMID:34947998
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304766	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGEF19 mRNA	PMID:30816183
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550020	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGEF19 mRNA	PMID:30951980|PMID:32156529
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1550020	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ARHGEF19 promoter	PMID:27312807
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of ARHGEF19 mRNA	PMID:25172293
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ARHGEF19 mRNA	PMID:25979313
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550020	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ARHGEF19 gene	PMID:31683443
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ARHGEF19 mRNA	PMID:39298647
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ARHGEF19 gene	PMID:31601247
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1550020	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ARHGEF19 exon	PMID:33297965
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550020	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ARHGEF19 mRNA	PMID:30951980
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550020	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ARHGEF19 mRNA	PMID:30951980
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550020	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ARHGEF19 intron	PMID:28392331
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ARHGEF19 mRNA	PMID:34813904
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ARHGEF19 mRNA	PMID:34813904
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ARHGEF19 mRNA	PMID:17942915
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARHGEF19 mRNA]	PMID:17942915
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ARHGEF19 mRNA	PMID:32680482
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35036	fentin chloride	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20231205	CTD	MESH:C012594	triphenyltin chloride results in decreased expression of ARHGEF19 mRNA	PMID:37156404
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304766	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARHGEF19 mRNA	PMID:35163327
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGEF19 mRNA	PMID:35301059
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGEF19 mRNA	PMID:37236586
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ARHGEF19 mRNA	PMID:25812627
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304766	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARHGEF19 mRNA	PMID:35163327
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ARHGEF19 mRNA	PMID:28903501
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ARHGEF19 mRNA	PMID:25812627
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ARHGEF19 mRNA	PMID:31533062
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ARHGEF19 mRNA	PMID:25812627
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ARHGEF19 mRNA	PMID:40419075
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARHGEF19 mRNA	PMID:36331819
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARHGEF19 mRNA	PMID:25979313
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ARHGEF19 mRNA	PMID:24383497
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of ARHGEF19 mRNA	PMID:21427059
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ARHGEF19 gene	PMID:29154799
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ARHGEF19 mRNA	PMID:19770486
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of ARHGEF19 mRNA	PMID:25123088
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550020	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ARHGEF19 mRNA	PMID:28973697
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of ARHGEF19 mRNA	PMID:24136188
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARHGEF19 mRNA	PMID:17562736
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1550020	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of ARHGEF19 mRNA	PMID:35436446
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of ARHGEF19 mRNA	PMID:23962444
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ARHGEF19 mRNA	PMID:24136188
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ARHGEF19 mRNA	PMID:38701926
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of ARHGEF19 mRNA	PMID:24136188
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of ARHGEF19 mRNA	PMID:24136188
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of ARHGEF19 mRNA	PMID:20843944
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20190910	CTD	MESH:C581157	XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ARHGEF19 mRNA]	PMID:29891994
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550020	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARHGEF19 mRNA	PMID:22206623
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ARHGEF19 mRNA	PMID:24136188
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:77131	sinapic acid	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20230404	CTD	MESH:C073734	sinapinic acid analog results in decreased expression of ARHGEF19 mRNA	PMID:36279966
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARHGEF19 gene]	PMID:28238834
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1550020	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of ARHGEF19 mRNA	PMID:19270015
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ARHGEF19 mRNA	PMID:21724226
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARHGEF19 mRNA	PMID:24780913
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304766	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ARHGEF19 mRNA	PMID:21346803
1312400	ARHGEF19	Rho guanine nucleotide exchange factor 19	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304766	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ARHGEF19 mRNA	PMID:23034163
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TRAF3IP2 mRNA	PMID:33167477
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TRAF3IP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TRAF3IP2 mRNA	PMID:32699268
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312404	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in increased expression of TRAF3IP2 mRNA	PMID:19167417
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TRAF3IP2 mRNA	PMID:31059760|PMID:35811015
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312404	E	RGD:6480464	20260602	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TRAF3IP2 protein	PMID:40852845
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRAF3IP2 mRNA	PMID:35811015
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312404	E	RGD:6480464	20260602	CTD	MESH:D008070	CDKN1A protein affects the reaction [Lipopolysaccharides results in increased expression of TRAF3IP2 protein]	PMID:40852845
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312404	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TRAF3IP2 mRNA	PMID:39298647
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1593240	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TRAF3IP2 mRNA	PMID:33387578
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1312404	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TRAF3IP2 mRNA	PMID:36706583
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1312404	E	RGD:6480464	20160607	CTD	MESH:D002117	Calcitriol inhibits the reaction [Bleomycin results in increased phosphorylation of ACT1 protein]	PMID:26520185
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312404	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAF3IP2 mRNA	PMID:37236586
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TRAF3IP2 mRNA	PMID:19549813
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1593240	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of TRAF3IP2 mRNA	PMID:21396975
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TRAF3IP2 gene	PMID:27153756
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TRAF3IP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TRAF3IP2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TRAF3IP2 mRNA	PMID:32699268
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1593240	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TRAF3IP2 mRNA	PMID:30779732
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRAF3IP2 mRNA	PMID:39836092
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1593240	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAF3IP2 mRNA	PMID:33854195
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of TRAF3IP2 mRNA	PMID:19921347
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of TRAF3IP2 mRNA	PMID:23300844
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TRAF3IP2 mRNA	PMID:27392435
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in decreased expression of TRAF3IP2 mRNA	PMID:21858171
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1593240	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRAF3IP2 mRNA	PMID:22298810
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1593240	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRAF3IP2 mRNA	PMID:33387578
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312404	E	RGD:6480464	20190219	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TRAF3IP2 mRNA; Sodium Fluoride results in increased expression of TRAF3IP2 protein	PMID:30225638
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:28775	hesperidin	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D006569	TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased cleavage of CASP3 protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of BAX protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of CCL7 mRNA]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of CXCL10 mRNA]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of IL1B mRNA]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of IL1B protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of RELA protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased expression of TLR4 protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]]; TRAF3IP2 protein inhibits the reaction [Hesperidin inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]]	PMID:39987982
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of TRAF3IP2 mRNA	PMID:20044591
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRAF3IP2 mRNA	PMID:38568856
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRAF3IP2 mRNA	PMID:39836092
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRAF3IP2 3' UTR	PMID:27901495
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRAF3IP2 promoter	PMID:27901495
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TRAF3IP2 mRNA	PMID:23806026
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TRAF3IP2 mRNA	PMID:15761015
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1312404	E	RGD:6480464	20160607	CTD	MESH:D001761	Calcitriol inhibits the reaction [Bleomycin results in increased phosphorylation of ACT1 protein]	PMID:26520185
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1593240	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of TRAF3IP2 mRNA	PMID:25729387
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1593240	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TRAF3IP2 mRNA	PMID:34492290
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312404	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of TRAF3IP2 mRNA	PMID:17426115
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1593240	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of TRAF3IP2 mRNA	PMID:19162173
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TRAF3IP2 mRNA	PMID:19710929
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1312404	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of TRAF3IP2 mRNA	PMID:19191707
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1593240	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TRAF3IP2 mRNA	PMID:35192832
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312404	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TRAF3IP2 mRNA	PMID:30951980
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1593240	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TRAF3IP2 mRNA	PMID:25181051
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312404	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TRAF3IP2 mRNA	PMID:30951980|PMID:39298647
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312404	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TRAF3IP2 mRNA	PMID:30951980
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312404	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TRAF3IP2 mRNA	PMID:37019170
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1593240	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAF3IP2 mRNA	PMID:33854195
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312404	E	RGD:6480464	20151013	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of ACT1 protein	PMID:23562983
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRAF3IP2 mRNA	PMID:37042841
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRAF3IP2 mRNA	PMID:38568856
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312404	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRAF3IP2 mRNA	PMID:37236586
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TRAF3IP2 mRNA	PMID:24449571
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TRAF3IP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TRAF3IP2 mRNA	PMID:32699268
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312404	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TRAF3IP2 mRNA	PMID:40194260
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TRAF3IP2 mRNA	PMID:31533062
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TRAF3IP2 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:29154799
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TRAF3IP2 gene	PMID:29154799
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRAF3IP2 mRNA	PMID:27188386
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TRAF3IP2 mRNA	PMID:25562108
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1593240	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAF3IP2 mRNA	PMID:33854195
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in decreased expression of TRAF3IP2 mRNA	PMID:19059307
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312404	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TRAF3IP2 mRNA	PMID:28973697
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1593240	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAF3IP2 mRNA	PMID:33854195
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRAF3IP2 mRNA	PMID:21420995
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1593240	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRAF3IP2 mRNA	PMID:33387578
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRAF3IP2 mRNA	PMID:35811015
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRAF3IP2 mRNA	PMID:39836092
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRAF3IP2 mRNA	PMID:22079256
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TRAF3IP2 mRNA	PMID:15761015
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of TRAF3IP2 mRNA	PMID:23300844
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312404	E	RGD:6480464	20151013	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of ACT1 protein	PMID:23562983
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1593240	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAF3IP2 mRNA	PMID:33854195
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1593240	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of TRAF3IP2 mRNA	PMID:25729387
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312404	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of TRAF3IP2 mRNA	PMID:19812364
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:64227	ciglitazone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C039671	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of TRAF3IP2 mRNA	PMID:16197558
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1312404	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of TRAF3IP2 mRNA	PMID:22078008
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TRAF3IP2 mRNA	PMID:22079256
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRAF3IP2 mRNA	PMID:22079256
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRAF3IP2 mRNA	PMID:27188386
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRAF3IP2 gene]	PMID:28238834
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in decreased expression of TRAF3IP2 mRNA	PMID:21858171
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of TRAF3IP2 mRNA	PMID:35688559
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1593240	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TRAF3IP2 mRNA	PMID:24780913
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1312404	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of TRAF3IP2 mRNA	PMID:36706583
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312404	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of TRAF3IP2 mRNA	PMID:40826991
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of TRAF3IP2 mRNA	PMID:19059307
1312403	TRAF3IP2	TRAF3 interacting protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRAF3IP2 mRNA	PMID:27188386
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CNOT3 mRNA	PMID:26272509
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT3 mRNA	PMID:27188386
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CNOT3 mRNA	PMID:33045310
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CNOT3 mRNA	PMID:37995155
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CNOT3 mRNA	PMID:32845096
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CNOT3 mRNA	PMID:22378314
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:16170	mercury(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of CNOT3 mRNA	PMID:19937285
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CNOT3 protein	PMID:37730182
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CNOT3 mRNA	PMID:28818685
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312408	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNOT3 mRNA	PMID:37236586
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:25195	mercury atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of CNOT3 mRNA	PMID:19937285
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CNOT3 mRNA	PMID:32845096
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CNOT3 mRNA	PMID:28903495
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CNOT3 mRNA	PMID:30912803
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312408	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CNOT3 mRNA	PMID:21570461
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CNOT3 mRNA	PMID:23179753|PMID:26272509
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNOT3 mRNA	PMID:27188386
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of CNOT3 mRNA	PMID:23649840
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of CNOT3 protein	PMID:38228842
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CNOT3 mRNA	PMID:20106945
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CNOT3 5' UTR	PMID:27901495
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CNOT3 mRNA	PMID:20018196
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of CNOT3 mRNA	PMID:17762391
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312408	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CNOT3 gene	PMID:35295148
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312408	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CNOT3 promoter	PMID:35295148
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1312408	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of CNOT3 mRNA	PMID:18648102
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304771	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CNOT3 mRNA	PMID:25181051
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312408	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of CNOT3 mRNA	PMID:26063408
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CNOT3 exon	PMID:30157460
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312408	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of CNOT3 mRNA	PMID:34813904
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CNOT3 mRNA	PMID:37042841
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CNOT3 mRNA	PMID:38568856
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312408	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNOT3 mRNA	PMID:37236586
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CNOT3 mRNA	PMID:24449571
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CNOT3 mRNA	PMID:28302478
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CNOT3 mRNA	PMID:24383497|PMID:24935251|PMID:26272509
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of CNOT3 mRNA	PMID:19136453|PMID:21427059
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312408	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of CNOT3 mRNA	PMID:21427059
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT3 mRNA	PMID:27188386
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	CNOT3 protein affects the susceptibility to Methotrexate	PMID:16217747
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of CNOT3 mRNA	PMID:24935251
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:5613	haloperidol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in decreased expression of CNOT3 protein	PMID:34122009
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CNOT3 protein	PMID:32959892
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CNOT3 exon	PMID:30157460
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312408	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CNOT3 mRNA	PMID:22206623
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1304771	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of CNOT3 mRNA	PMID:33484710
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT3 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNOT3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT3 mRNA	PMID:27188386
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CNOT3 gene]	PMID:28238834
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of CNOT3 mRNA	PMID:19270015
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CNOT3 mRNA	PMID:21278054
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of CNOT3 mRNA	PMID:40826991
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT3 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CNOT3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNOT3 mRNA	PMID:27188386
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of CNOT3 mRNA	PMID:17440010
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CNOT3 mRNA	PMID:38568856
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of CNOT3 mRNA	PMID:29301935
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312408	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CNOT3 mRNA	PMID:28973697
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304771	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of CNOT3 mRNA	PMID:23555832
1312407	CNOT3	CCR4-NOT transcription complex subunit 3	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304771	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of CNOT3 mRNA	PMID:23034163
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:100241	ciprofloxacin	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20180828	CTD	MESH:D002939	[Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of XIRP1 mRNA	PMID:29679711
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312414	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of XIRP1 mRNA	PMID:33045310
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312414	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of XIRP1 mRNA	PMID:37995155
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of XIRP1 mRNA	PMID:33167477
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1304776	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of XIRP1 mRNA	PMID:33729688
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:15746	spermine	increases expression	ISO	RGD:1312414	E	RGD:6480464	20120412	CTD	MESH:D013096	Spermine results in increased expression of XIRP1 mRNA	PMID:18673383
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1304776	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of XIRP1 mRNA	PMID:36841081
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312414	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of XIRP1 mRNA	PMID:30319688
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of XIRP1 mRNA	PMID:30517762
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of XIRP1 mRNA	PMID:35811015
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of XIRP1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of XIRP1 mRNA	PMID:35811015
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of XIRP1 mRNA	PMID:30510588
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of XIRP1 mRNA	PMID:37992649
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of XIRP1 mRNA	PMID:37992649
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304776	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of XIRP1 mRNA	PMID:27523638
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304776	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of XIRP1 mRNA	PMID:33387578
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:188851	Muraglitazar	decreases expression	ISO	RGD:1304776	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of XIRP1 mRNA	PMID:21515302
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of XIRP1 gene	PMID:27153756
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of XIRP1 mRNA	PMID:30517762
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of XIRP1 mRNA	PMID:23557933
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312414	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of XIRP1 mRNA	PMID:32186404
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312414	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of XIRP1 mRNA	PMID:21570461
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304776	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of XIRP1 mRNA	PMID:33387578
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:28216	methylmercury chloride	affects expression	ISO	RGD:1304776	E	RGD:6480464	20150324	CTD	MESH:C004925	methylmercuric chloride affects the expression of XIRP1 mRNA	PMID:20864626
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20180828	CTD	MESH:D019328	[Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of XIRP1 mRNA	PMID:29679711
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of XIRP1 mRNA	PMID:29803840
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312414	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of XIRP1 mRNA	PMID:39631538
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of XIRP1 mRNA	PMID:37992649
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:28838	lutein	increases expression	ISO	RGD:1312414	E	RGD:6480464	20140812	CTD	MESH:D014975	Lutein results in increased expression of XIRP1 mRNA	PMID:24865317
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of XIRP1 mRNA	PMID:38568856
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of XIRP1 5' UTR	PMID:27901495
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312414	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of XIRP1 mRNA	PMID:22228805
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of XIRP1 promoter	PMID:27901495
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1304776	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of XIRP1 mRNA	PMID:38458666
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312414	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of XIRP1 mRNA	PMID:29203145
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:32195	Tesaglitazar	decreases expression	ISO	RGD:1304776	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of XIRP1 mRNA	PMID:21515302
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312414	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of XIRP1 mRNA	PMID:35295148
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312414	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of XIRP1 enhancer	PMID:35295148
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304776	E	RGD:6480464	20150324	CTD	MESH:C006780	bisphenol A results in decreased expression of XIRP1 mRNA	PMID:25181051
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312414	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of XIRP1 promoter	PMID:27312807
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of XIRP1 protein	PMID:37567409
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312414	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of XIRP1 exon; bisphenol S affects the methylation of XIRP1 gene	PMID:31683443|PMID:33297965
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312414	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of XIRP1 mRNA	PMID:30951980
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312414	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of XIRP1 mRNA	PMID:30951980
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312414	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in increased expression of XIRP1 mRNA	PMID:12595580
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1304776	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of XIRP1 mRNA	PMID:38458666
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1304776	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of XIRP1 mRNA	PMID:35163327
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304776	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of XIRP1 mRNA	PMID:35163327
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1304776	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of XIRP1 mRNA	PMID:35163327
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304776	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of XIRP1 mRNA	PMID:35163327
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in increased expression of XIRP1 mRNA	PMID:22941251
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312414	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of XIRP1 mRNA	PMID:28962523
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312414	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of XIRP1 mRNA	PMID:40194260
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of XIRP1 gene	PMID:29154799
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of XIRP1 mRNA	PMID:37992649
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of XIRP1 mRNA	PMID:38832940
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of XIRP1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of XIRP1 mRNA	PMID:35811015
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:50686	atorvastatin calcium	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20180828	CTD	MESH:D000069059	[Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of XIRP1 mRNA	PMID:29679711
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304776	E	RGD:6480464	20260303	CTD	MESH:D005485	Flutamide results in decreased expression of XIRP1 mRNA	PMID:40381864
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:51397	1,3-dinitrobenzene	affects expression	ISO	RGD:1304776	E	RGD:6480464	20150324	CTD	MESH:C017906	3-dinitrobenzene affects the expression of XIRP1 mRNA	PMID:24140754
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of XIRP1 mRNA	PMID:31629900
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1304776	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of XIRP1 mRNA	PMID:37269647
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312414	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in increased expression of XIRP1 mRNA	PMID:36914120
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304776	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of XIRP1 gene	PMID:35440735
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of XIRP1 mRNA	PMID:29522793
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304776	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of XIRP1 mRNA	PMID:32109520
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312414	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of XIRP1 mRNA	PMID:38648751
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1312414	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of XIRP1 mRNA	PMID:27935865
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304776	E	RGD:6480464	20150324	CTD	MESH:D011441	Propylthiouracil results in decreased expression of XIRP1 mRNA	PMID:24780913
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304776	E	RGD:6480464	20150324	CTD	MESH:D012999	Soman results in increased expression of XIRP1 mRNA	PMID:19281266
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of XIRP1 mRNA	PMID:38568856
1312413	XIRP1	xin actin binding repeat containing 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1304776	E	RGD:6480464	20150324	CTD	MESH:C057693	troglitazone results in decreased expression of XIRP1 mRNA	PMID:21515302
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:10093	yohimbine	increases expression	ISO	RGD:1304777	E	RGD:6480464	20120918	CTD	MESH:D015016	Yohimbine results in increased expression of NRIP3 mRNA	PMID:21983523
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of NRIP3 mRNA	PMID:26272509
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of NRIP3 mRNA	PMID:27188386
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312416	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NRIP3 mRNA	PMID:33045310
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304777	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NRIP3 mRNA]	PMID:31150632
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:144400	dinophysistoxin 1	increases expression	EXP		E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in increased expression of NRIP3 mRNA	PMID:28939011
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRIP3 mRNA	PMID:30529165
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of NRIP3 mRNA	PMID:26079696
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of NRIP3 mRNA	PMID:22378314
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of NRIP3 mRNA	PMID:30319688
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of NRIP3 mRNA	PMID:22574217
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of NRIP3 mRNA	PMID:30165855
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312416	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of NRIP3 mRNA	PMID:18978301
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304777	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of NRIP3 mRNA	PMID:33387578
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of NRIP3 mRNA	PMID:19162166
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312416	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of NRIP3 mRNA	PMID:39922521
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312416	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of NRIP3 mRNA	PMID:33848595
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of NRIP3 mRNA]	PMID:33848595
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312416	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of NRIP3 mRNA	PMID:39922521
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NRIP3 mRNA	PMID:31163220
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304777	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of NRIP3 mRNA	PMID:26577399
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304777	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NRIP3 mRNA	PMID:33387578
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NRIP3 mRNA	PMID:28818685
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:18243	dopamine	increases expression	ISO	RGD:1304777	E	RGD:6480464	20120918	CTD	MESH:D004298	Dopamine results in increased expression of NRIP3 mRNA	PMID:21983523
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NRIP3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of NRIP3 mRNA	PMID:39836092
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of NRIP3 mRNA	PMID:19549813
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1304777	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of NRIP3 mRNA	PMID:33354967
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312416	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NRIP3 mRNA	PMID:19770486
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NRIP3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of NRIP3 mRNA	PMID:34911549
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304777	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NRIP3 mRNA	PMID:31150632
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304777	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NRIP3 mRNA]	PMID:31150632
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NRIP3 mRNA	PMID:21867686
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of NRIP3 mRNA	PMID:18414638
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NRIP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NRIP3 mRNA	PMID:39836092
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of NRIP3 mRNA	PMID:26272509
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304777	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of NRIP3 mRNA	PMID:31881176
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of NRIP3 mRNA	PMID:28903495
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of NRIP3 mRNA	PMID:27594783
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20120412	CTD	MESH:D003042	[Cocaine co-treated with FOS protein mutant form] results in increased expression of NRIP3 mRNA	PMID:18355967
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in increased expression of NRIP3 mRNA	PMID:20884965
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312416	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NRIP3 mRNA	PMID:21570461
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304777	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NRIP3 mRNA	PMID:33387578
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312416	E	RGD:6480464	20250708	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NRIP3 mRNA	PMID:39401686
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NRIP3 mRNA	PMID:17942748
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NRIP3 mRNA	PMID:28001369
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NRIP3 mRNA	PMID:33212167
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NRIP3 mRNA	PMID:30851411
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of NRIP3 mRNA	PMID:26272509
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304777	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of NRIP3 mRNA	PMID:28959563
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of NRIP3 mRNA	PMID:21198554
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304777	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of NRIP3 mRNA	PMID:26033743
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NRIP3 mRNA	PMID:38568856
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NRIP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NRIP3 mRNA	PMID:39836092
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NRIP3 promoter	PMID:27901495
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1304777	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NRIP3 mRNA	PMID:21839799
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312416	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NRIP3 mRNA	PMID:23735875
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NRIP3 5' UTR	PMID:27901495
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304777	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of NRIP3 mRNA	PMID:26033743
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312416	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of NRIP3 mRNA	PMID:27131904
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of NRIP3 mRNA; Silicon Dioxide results in increased expression of NRIP3 mRNA	PMID:25351596|PMID:25895662
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of NRIP3 mRNA	PMID:20458559
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1312416	E	RGD:6480464	20260407	CTD	MESH:D001761	Bleomycin results in increased expression of NRIP3 mRNA	PMID:40912499
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312416	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NRIP3 promoter	PMID:35295148
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304777	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of NRIP3 mRNA	PMID:34492290
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of NRIP3 mRNA	PMID:29275510
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304777	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of NRIP3 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312416	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of NRIP3 mRNA	PMID:32156529
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304777	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NRIP3 mRNA	PMID:25181051
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304777	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of NRIP3 mRNA	PMID:32680482
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NRIP3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of NRIP3 mRNA	PMID:39836092
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of NRIP3 mRNA	PMID:19320972|PMID:19376846
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NRIP3 mRNA	PMID:25979313
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of NRIP3 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of NRIP3 mRNA	PMID:19101580|PMID:23179753|PMID:27188386
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312416	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of NRIP3 mRNA	PMID:21427059
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304777	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of NRIP3 mRNA	PMID:38685447
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312416	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of NRIP3 mRNA	PMID:39922521
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of NRIP3 mRNA	PMID:24935251|PMID:26272509
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304777	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NRIP3 mRNA	PMID:33387578
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of NRIP3 mRNA	PMID:24714768
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of NRIP3 mRNA	PMID:18414638
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NRIP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NRIP3 mRNA	PMID:39836092
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1304777	E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in increased expression of NRIP3 mRNA	PMID:36653537
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304777	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of NRIP3 mRNA	PMID:29391264
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NRIP3 mRNA	PMID:17942748
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of NRIP3 mRNA	PMID:26272509
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of NRIP3 mRNA	PMID:20458559
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:5002	fenoldopam	increases expression	ISO	RGD:1304777	E	RGD:6480464	20120918	CTD	MESH:D018818	Fenoldopam results in increased expression of NRIP3 mRNA	PMID:21983523
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304777	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of NRIP3 mRNA	PMID:30307764
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312416	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NRIP3 mRNA; Nanotubes, Carbon results in increased expression of NRIP3 mRNA	PMID:25554681
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1304777	E	RGD:6480464	20200519	CTD	MESH:C082360	fipronil results in increased expression of NRIP3 mRNA	PMID:31881178
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1304777	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of NRIP3 mRNA	PMID:21983209
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:52717	bortezomib	increases expression	ISO	RGD:1304777	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of NRIP3 mRNA	PMID:20830808
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1304777	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of NRIP3 mRNA	PMID:20080153
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NRIP3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of NRIP3 mRNA	PMID:39836092
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	NRIP3 protein affects the susceptibility to Topotecan	PMID:16217747
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in increased expression of NRIP3 mRNA	PMID:16982809
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:70778	GW 7647	decreases expression	ISO	RGD:1304777	E	RGD:6480464	20200519	CTD	MESH:C453899	GW 7647 results in decreased expression of NRIP3 mRNA	PMID:31628012
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of NRIP3 mRNA	PMID:31758290
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312416	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NRIP3 mRNA	PMID:22206623
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1312416	E	RGD:6480464	20160315	CTD	MESH:C072553	[MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of NRIP3 mRNA	PMID:25566086
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of NRIP3 mRNA	PMID:22714537
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NRIP3 mRNA	PMID:37199045
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NRIP3 mRNA	PMID:30851411
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NRIP3 gene]	PMID:28238834
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304777	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of NRIP3 mRNA	PMID:32109520
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of NRIP3 mRNA	PMID:26079696
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304777	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NRIP3 mRNA	PMID:24780913
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304777	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of NRIP3 mRNA	PMID:36843608
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of NRIP3 mRNA	PMID:26272509
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1304777	E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of NRIP3 mRNA	PMID:29162477
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRIP3 mRNA	PMID:27188386
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312416	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of NRIP3 mRNA	PMID:27131904
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304777	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of NRIP3 mRNA	PMID:19281266
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in increased expression of NRIP3 mRNA	PMID:31863870
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of NRIP3 mRNA	PMID:38568856
1312415	NRIP3	nuclear receptor interacting protein 3	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304777	E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of NRIP3 mRNA	PMID:22615374
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in decreased expression of CERCAM mRNA	PMID:31863870
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1304778	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of CERCAM mRNA	PMID:25152437
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1621421	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CERCAM mRNA	PMID:36331819
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of CERCAM mRNA	PMID:30165855
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CERCAM mRNA	PMID:37042841
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1621421	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CERCAM mRNA	PMID:33754040
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304778	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CERCAM mRNA	PMID:33387578
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1621421	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of CERCAM mRNA	PMID:39984025
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of CERCAM mRNA	PMID:24376830
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1304778	E	RGD:6480464	20161025	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CERCAM mRNA	PMID:19480007
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of CERCAM mRNA	PMID:24768652
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621421	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CERCAM mRNA	PMID:21570461
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304778	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CERCAM mRNA	PMID:34747641
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1621421	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CERCAM mRNA	PMID:19465110
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CERCAM mRNA	PMID:33212167
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CERCAM mRNA	PMID:32763439
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304778	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CERCAM mRNA	PMID:28959563
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1304778	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of CERCAM mRNA	PMID:30556269
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CERCAM mRNA	PMID:29803840
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1621421	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CERCAM mRNA	PMID:37682722
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CERCAM promoter	PMID:27901495
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1304778	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of CERCAM mRNA	PMID:30556269
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1621421	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CERCAM promoter	PMID:35295148
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of CERCAM mRNA; bisphenol A results in decreased expression of CERCAM protein	PMID:31675489|PMID:36232920
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304778	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CERCAM mRNA	PMID:25181051
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of CERCAM protein	PMID:34186270
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CERCAM mRNA	PMID:25979313
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CERCAM protein	PMID:34186270
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CERCAM protein	PMID:34186270
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304778	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CERCAM mRNA	PMID:21266533
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1621421	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of CERCAM mRNA	PMID:36117858
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CERCAM mRNA	PMID:37042841
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304778	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CERCAM mRNA	PMID:35163327
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1304778	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CERCAM promoter	PMID:22457795
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304778	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CERCAM mRNA	PMID:33453195
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304778	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CERCAM mRNA	PMID:35163327
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304778	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CERCAM mRNA	PMID:27387713
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621421	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CERCAM mRNA	PMID:36331819
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1621421	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CERCAM mRNA	PMID:28973697
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304778	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CERCAM mRNA	PMID:33387578
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of CERCAM mRNA	PMID:31675489
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1621421	E	RGD:6480464	20150127	CTD	MESH:D005047	Etoposide results in increased expression of CERCAM mRNA	PMID:25270620
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1621421	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of CERCAM mRNA	PMID:36117858
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CERCAM gene]	PMID:28238834
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CERCAM protein	PMID:31675489
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CERCAM protein	PMID:31675489
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1621421	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of CERCAM mRNA	PMID:27029645
1312417	CERCAM	cerebral endothelial cell adhesion molecule	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304778	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CERCAM mRNA	PMID:24780913
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312421	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SPATS2 mRNA	PMID:20188158
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312421	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SPATS2 mRNA	PMID:30319688
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SPATS2 mRNA	PMID:37042841
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SPATS2 mRNA	PMID:23649840
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SPATS2 mRNA	PMID:21179406
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SPATS2 mRNA	PMID:28818685
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312421	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPATS2 mRNA	PMID:36331819
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SPATS2 mRNA	PMID:23649840
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SPATS2 mRNA	PMID:23649840
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SPATS2 mRNA	PMID:22171008
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312421	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SPATS2 mRNA	PMID:25629700
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SPATS2 mRNA	PMID:23557933
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in increased expression of SPATS2 mRNA	PMID:37386098
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304780	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPATS2 mRNA	PMID:34747641
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312421	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of SPATS2 mRNA	PMID:32937126
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SPATS2 mRNA	PMID:28001369
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SPATS2 mRNA	PMID:32763439
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPATS2 protein	PMID:30528433
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312421	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPATS2 protein	PMID:29044176
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SPATS2 mRNA	PMID:38568856
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite inhibits the reaction [SPATS2 protein binds to Ribonucleotides]	PMID:30528433
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SPATS2 promoter	PMID:27901495
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312421	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPATS2 mRNA	PMID:22228805
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312421	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to SPATS2 promoter]	PMID:19654925
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SPATS2 mRNA	PMID:22171008
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPATS2 gene; [bisphenol S co-treated with Fulvestrant] results in decreased methylation of SPATS2 gene	PMID:31601247
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312421	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SPATS2 gene; titanium dioxide results in decreased methylation of SPATS2 promoter	PMID:35295148
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304780	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SPATS2 mRNA	PMID:23411599
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of SPATS2 mRNA	PMID:17989879
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304780	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SPATS2 mRNA	PMID:34947998
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304780	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SPATS2 gene	PMID:28505145
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPATS2 gene	PMID:31601247
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312421	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SPATS2 mRNA	PMID:39298647
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of SPATS2 gene	PMID:31601247
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312421	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of SPATS2 mRNA	PMID:36117858
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SPATS2 mRNA	PMID:37042841
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SPATS2 mRNA	PMID:24449571
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SPATS2 mRNA	PMID:31533062
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312421	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPATS2 mRNA	PMID:36331819
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304780	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of SPATS2 mRNA	PMID:38685447|PMID:41580965
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1312421	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of SPATS2 mRNA	PMID:25123088
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312421	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SPATS2 mRNA	PMID:25554681
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304780	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of SPATS2 mRNA	PMID:41580965
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312421	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of SPATS2 mRNA	PMID:36117858
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SPATS2 protein	PMID:32959892
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312421	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SPATS2 mRNA	PMID:22206623
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SPATS2 mRNA	PMID:37199045
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312421	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SPATS2 mRNA	PMID:31388691
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1304780	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SPATS2 mRNA	PMID:23640034
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312421	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SPATS2 mRNA	PMID:39847705
1312420	SPATS2	spermatogenesis associated serine rich 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SPATS2 mRNA	PMID:38568856
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:15365	acetylsalicylic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of TRIT1 mRNA	PMID:11906190
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TRIT1 mRNA	PMID:33167477
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312423	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TRIT1 mRNA	PMID:36331819
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TRIT1 mRNA	PMID:22378314
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312423	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TRIT1 mRNA	PMID:39298647
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304781	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TRIT1 gene	PMID:27618143
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRIT1 mRNA	PMID:37042841
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TRIT1 mRNA	PMID:36314267
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312423	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TRIT1 mRNA	PMID:34319233
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of TRIT1 protein	PMID:37730182
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304781	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TRIT1 mRNA	PMID:33387578
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312423	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TRIT1 mRNA	PMID:37236586
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312423	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRIT1 mRNA	PMID:19770486
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1312423	E	RGD:6480464	20250401	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in decreased expression of TRIT1 protein	PMID:39910959
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of TRIT1 mRNA	PMID:35430440
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304781	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TRIT1 mRNA	PMID:31150632
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRIT1 gene	PMID:25304211
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TRIT1 mRNA	PMID:19244175
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TRIT1 protein	PMID:35688186
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TRIT1 mRNA	PMID:23557933
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312423	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRIT1 mRNA	PMID:21570461
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304781	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRIT1 mRNA	PMID:33387578
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312423	E	RGD:6480464	20120515	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TRIT1 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TRIT1 promoter]	PMID:19654925|PMID:25975270
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304781	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TRIT1 mRNA	PMID:30556269
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRIT1 mRNA	PMID:29803840
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRIT1 mRNA	PMID:38568856
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRIT1 promoter	PMID:27901495
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304781	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TRIT1 mRNA	PMID:30556269
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304781	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TRIT1 mRNA	PMID:23411599
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312423	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TRIT1 mRNA	PMID:18301758|PMID:23811191
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIT1 mRNA	PMID:20678512
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304781	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIT1 mRNA	PMID:25181051
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304781	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of TRIT1 mRNA	PMID:30816183|PMID:34947998
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of TRIT1 mRNA	PMID:19244175
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312423	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TRIT1 mRNA	PMID:38685157
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312423	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of TRIT1 mRNA	PMID:34813904
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304781	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TRIT1 mRNA	PMID:33453195
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312423	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TRIT1 mRNA	PMID:37236586
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of TRIT1 mRNA	PMID:19376846
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TRIT1 mRNA	PMID:19244175
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TRIT1 mRNA	PMID:28302478
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TRIT1 mRNA	PMID:31533062
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312423	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TRIT1 mRNA	PMID:36331819
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312423	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TRIT1 mRNA	PMID:17292431
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRIT1 mRNA	PMID:23179753
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of TRIT1 mRNA	PMID:29154799
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312423	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TRIT1 mRNA	PMID:28973697
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRIT1 mRNA	PMID:25704631
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312423	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TRIT1 mRNA	PMID:29279043
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRIT1 gene	PMID:25304211
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304781	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TRIT1 mRNA	PMID:24136188
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRIT1 gene]	PMID:28238834
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:80799	Bufotalin	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of TRIT1 mRNA	PMID:39904859
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304781	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TRIT1 mRNA	PMID:21346803
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in decreased expression of TRIT1 mRNA	PMID:11906190
1312422	TRIT1	tRNA isopentenyltransferase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304781	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TRIT1 mRNA	PMID:21346803
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1550090	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of RPRD1B mRNA	PMID:33045310
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1550090	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of RPRD1B mRNA	PMID:16604517
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPRD1B mRNA	PMID:25510870
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304782	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RPRD1B gene	PMID:27618143
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RPRD1B protein	PMID:37730182
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RPRD1B mRNA	PMID:36331819
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPRD1B mRNA	PMID:35301059
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPRD1B mRNA	PMID:25510870
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPRD1B mRNA	PMID:25510870
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RPRD1B mRNA	PMID:19549813
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RPRD1B mRNA	PMID:23649840
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RPRD1B mRNA	PMID:21867686
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RPRD1B protein	PMID:35688186
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1550090	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of RPRD1B protein	PMID:25505154
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550090	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPRD1B mRNA	PMID:21570461
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of RPRD1B protein	PMID:35688186
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of RPRD1B mRNA	PMID:29319823
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RPRD1B protein	PMID:20097212
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550090	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RPRD1B mRNA	PMID:22228805
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of RPRD1B gene	PMID:31601247
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of RPRD1B mRNA	PMID:31745603
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1550090	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of RPRD1B gene	PMID:35295148
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550090	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RPRD1B promoter	PMID:35295148
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550090	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of RPRD1B mRNA	PMID:29264374
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304782	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RPRD1B mRNA	PMID:25181051
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of RPRD1B protein	PMID:37567409
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304782	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of RPRD1B mRNA	PMID:30816183
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550090	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RPRD1B mRNA	PMID:26063408|PMID:33221593
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of RPRD1B mRNA	PMID:23146750
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPRD1B mRNA	PMID:25510870
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RPRD1B mRNA	PMID:25510870
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550090	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of RPRD1B gene	PMID:31683443
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550090	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RPRD1B mRNA	PMID:39298647
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550090	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RPRD1B mRNA	PMID:38685157
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RPRD1B mRNA	PMID:28628672
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1550090	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of RPRD1B mRNA	PMID:28392331
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1550090	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of RPRD1B mRNA	PMID:34813904
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RPRD1B mRNA	PMID:28628672
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1550090	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of RPRD1B mRNA	PMID:34813904
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RPRD1B protein	PMID:24527689
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPRD1B mRNA	PMID:35301059
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550090	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RPRD1B mRNA	PMID:36331819
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RPRD1B mRNA	PMID:25979313
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of RPRD1B mRNA; Valproic Acid results in decreased expression of RPRD1B protein	PMID:29501571
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of RPRD1B gene	PMID:29501571
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RPRD1B mRNA	PMID:28628672
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550090	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RPRD1B mRNA	PMID:17562736
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of RPRD1B mRNA	PMID:21420995
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	RPRD1B protein affects the susceptibility to Fluorouracil	PMID:15331170
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of RPRD1B mRNA	PMID:15331170
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RPRD1B mRNA	PMID:28628672
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RPRD1B protein	PMID:32959892
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550090	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RPRD1B mRNA	PMID:22206623
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1304782	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of RPRD1B mRNA	PMID:27840820
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RPRD1B protein	PMID:37664457
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:7602	nobiletin	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in increased expression of RPRD1B protein]	PMID:38348393
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:84070	sodium arsenate	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in increased expression of RPRD1B protein	PMID:38348393
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in increased expression of RPRD1B protein]	PMID:38348393
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:8772	raloxifene	affects response to substance	EXP		E	RGD:6480464	20230801	CTD	MESH:D020849	RPRD1B protein affects the susceptibility to Raloxifene Hydrochloride	PMID:24452636
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RPRD1B protein	PMID:37664457
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550090	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of RPRD1B mRNA	PMID:28973697
1312424	RPRD1B	regulation of nuclear pre-mRNA domain containing 1B	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304782	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of RPRD1B mRNA	PMID:23869203
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312427	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LMX1A mRNA	PMID:33045310
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LMX1A gene	PMID:20938992
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LMX1A gene	PMID:20938992
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304784	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of LMX1A mRNA	PMID:26577399
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LMX1A mRNA	PMID:35301059
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20260203	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LMX1A mRNA	PMID:40850461
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LMX1A gene	PMID:27153756
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LMX1A gene	PMID:20938992
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:27496	simazine	decreases expression	ISO	RGD:1312427	E	RGD:6480464	20220809	CTD	MESH:D012839	Simazine results in decreased expression of LMX1A mRNA; Simazine results in decreased expression of LMX1A protein	PMID:34936186
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:27496	simazine	increases expression	ISO	RGD:1312427	E	RGD:6480464	20210706	CTD	MESH:D012839	Simazine results in increased expression of LMX1A mRNA; Simazine results in increased expression of LMX1A protein	PMID:32822773
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:27496	simazine	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20210706	CTD	MESH:D012839	LMX1A protein promotes the reaction [Simazine results in increased expression of NR4A2 mRNA]; LMX1A protein promotes the reaction [Simazine results in increased expression of NR4A2 protein]; LMX1A protein promotes the reaction [Simazine results in increased expression of PITX3 mRNA]; LMX1A protein promotes the reaction [Simazine results in increased expression of PITX3 protein]; LMX1A protein promotes the reaction [Simazine results in increased expression of TH protein]; LMX1A protein promotes the reaction [Simazine results in increased expression of WNT1 mRNA]; LMX1A protein promotes the reaction [Simazine results in increased expression of WNT1 protein]	PMID:32822773
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of LMX1A mRNA	PMID:23557933
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1304784	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of LMX1A gene	PMID:28505145
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312427	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LMX1A mRNA	PMID:24058054
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LMX1A mRNA	PMID:28001369
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304784	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of LMX1A mRNA	PMID:28959563
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:C028473	LMX1A gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine	PMID:21177773
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LMX1A mRNA	PMID:29301061
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312427	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of LMX1A mRNA	PMID:36209798
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LMX1A intron; Benzo(a)pyrene affects the methylation of LMX1A promoter	PMID:27901495|PMID:30157460
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312427	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LMX1A mRNA	PMID:27195522
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LMX1A 3' UTR; Benzo(a)pyrene results in increased methylation of LMX1A 5' UTR	PMID:27901495
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of LMX1A promoter	PMID:23974009
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of LMX1A mRNA	PMID:20458559
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1304784	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of LMX1A mRNA	PMID:24395379
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of LMX1A gene	PMID:31601247
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312427	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LMX1A promoter	PMID:35295148
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312427	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of LMX1A mRNA	PMID:18648102
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312427	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of LMX1A promoter	PMID:27334623
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304784	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LMX1A mRNA	PMID:25181051
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304784	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of LMX1A mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312427	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of LMX1A mRNA	PMID:30951980
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304784	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LMX1A gene	PMID:28505145
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of LMX1A gene	PMID:31601247
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304784	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of LMX1A gene	PMID:28505145
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of LMX1A mRNA	PMID:31326446
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312427	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of LMX1A mRNA	PMID:40203079
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312427	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LMX1A mRNA	PMID:30951980
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in decreased expression of LMX1A mRNA]	PMID:40203079
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312427	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of LMX1A mRNA	PMID:30951980
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312427	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LMX1A intron	PMID:28392331
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:35004	Tetrachlorobisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C041181	tetrachlorodian results in decreased expression of LMX1A mRNA	PMID:31326446
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304784	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LMX1A mRNA	PMID:35163327
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304784	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of LMX1A mRNA	PMID:30723492
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LMX1A mRNA	PMID:35301059
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312427	E	RGD:6480464	20260203	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LMX1A mRNA	PMID:40850461
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304784	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LMX1A mRNA	PMID:35163327
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LMX1A mRNA	PMID:25979313
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of LMX1A mRNA	PMID:26272509
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMX1A mRNA	PMID:27188386
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of LMX1A promoter	PMID:29626692
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of LMX1A promoter	PMID:29626692
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:46680	serpentine asbestos	decreases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of LMX1A gene	PMID:29523930
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of LMX1A mRNA	PMID:20458559
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMX1A mRNA	PMID:27188386
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LMX1A gene]	PMID:28238834
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of LMX1A mRNA	PMID:31326446
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of LMX1A mRNA	PMID:26079696
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304784	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of LMX1A mRNA	PMID:25825206
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:8887	rofecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C116926	rofecoxib results in increased expression of LMX1A mRNA	PMID:17070997
1312426	LMX1A	LIM homeobox transcription factor 1 alpha	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMX1A mRNA	PMID:27188386
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312430	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RBPJL mRNA	PMID:33045310
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RBPJL mRNA	PMID:36189433
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1304786	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of RBPJL mRNA	PMID:36841081
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA	PMID:37567420
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RBPJL mRNA	PMID:36189433
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:172946	3-methylfuran	increases expression	ISO	RGD:1304786	E	RGD:6480464	20241001	CTD	MESH:C039851	3-methylfuran results in increased expression of RBPJL mRNA	PMID:38160780
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA	PMID:37567420
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312430	E	RGD:6480464	20210608	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RBPJL mRNA	PMID:33484791
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20210608	CTD	MESH:D004051	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in increased expression of RBPJL mRNA; [Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of RBPJL mRNA	PMID:31606821|PMID:33484791
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304786	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RBPJL mRNA	PMID:27523638
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304786	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of RBPJL mRNA	PMID:30779732
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312430	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of RBPJL mRNA	PMID:25629700
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304786	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RBPJL mRNA	PMID:31881176
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RBPJL mRNA	PMID:23557933
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312430	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RBPJL mRNA	PMID:24058054
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304786	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RBPJL mRNA	PMID:32109520|PMID:33387578
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RBPJL mRNA	PMID:33212167
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA	PMID:37567420
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20231031	CTD	MESH:D015084	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA	PMID:37567420
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RBPJL mRNA	PMID:38568856
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RBPJL 3' UTR	PMID:27901495
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of RBPJL gene	PMID:25435355
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304786	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RBPJL mRNA	PMID:30047161
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312430	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RBPJL promoter	PMID:35295148
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304786	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RBPJL mRNA	PMID:34492290
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312430	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of RBPJL promoter	PMID:27334623
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304786	E	RGD:6480464	20160719	CTD	MESH:C006780	bisphenol A results in increased expression of RBPJL mRNA	PMID:25181051|PMID:34947998
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312430	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of RBPJL exon	PMID:33297965
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1312430	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of RBPJL mRNA	PMID:26377693
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1312430	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of RBPJL mRNA	PMID:26377693
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1304786	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of RBPJL mRNA	PMID:32680482
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304786	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of RBPJL mRNA	PMID:30723492
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RBPJL mRNA	PMID:38568856
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304786	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RBPJL mRNA	PMID:33453195
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312430	E	RGD:6480464	20220308	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RBPJL mRNA	PMID:34666113
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304786	E	RGD:6480464	20160719	CTD	MESH:C039281	furan results in increased expression of RBPJL mRNA	PMID:25539665|PMID:38160780
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1304786	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of RBPJL mRNA	PMID:30047161
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312430	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RBPJL mRNA	PMID:17963808
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RBPJL gene	PMID:29154799
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304786	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RBPJL mRNA	PMID:30047161|PMID:38685447
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304786	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of RBPJL mRNA	PMID:41580965
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA	PMID:37567420
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312430	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of RBPJL mRNA	PMID:30529165
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304786	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RBPJL mRNA	PMID:29391264
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312430	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RBPJL mRNA	PMID:25554681
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304786	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RBPJL mRNA	PMID:30047161
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1312430	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of RBPJL mRNA	PMID:26377693
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1304786	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of RBPJL mRNA	PMID:28801915
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1304786	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RBPJL mRNA	PMID:28801915
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1312430	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of RBPJL mRNA	PMID:22078008
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:6842	methoxychlor	increases methylation	ISO	RGD:1304786	E	RGD:6480464	20160719	CTD	MESH:D008731	Methoxychlor results in increased methylation of RBPJL gene	PMID:23303685
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of RBPJL mRNA	PMID:37567420
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases methylation	ISO	RGD:1304786	E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in decreased methylation of RBPJL promoter	PMID:27415467
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RBPJL gene]	PMID:28238834
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1304786	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of RBPJL mRNA	PMID:32109520
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304786	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RBPJL mRNA	PMID:30047161
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1312430	E	RGD:6480464	20250401	CTD	MESH:D013311	Streptozocin results in increased expression of RBPJL mRNA	PMID:31606821
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312430	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in increased expression of RBPJL mRNA; [Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of RBPJL mRNA	PMID:31606821|PMID:33484791
1312429	RBPJL	recombination signal binding protein for immunoglobulin kappa J region like	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1304786	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of RBPJL mRNA	PMID:30047161
1312431	FBXO42	F-box protein 42	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FBXO42 gene	PMID:20938992
1312431	FBXO42	F-box protein 42	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550029	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of FBXO42 mRNA	PMID:30319688
1312431	FBXO42	F-box protein 42	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FBXO42 gene	PMID:20938992
1312431	FBXO42	F-box protein 42	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FBXO42 mRNA	PMID:37042841
1312431	FBXO42	F-box protein 42	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of FBXO42 mRNA	PMID:23649840
1312431	FBXO42	F-box protein 42	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of FBXO42 protein	PMID:37730182
1312431	FBXO42	F-box protein 42	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXO42 mRNA	PMID:39836092
1312431	FBXO42	F-box protein 42	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FBXO42 gene	PMID:20938992
1312431	FBXO42	F-box protein 42	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXO42 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO42 mRNA	PMID:39836092
1312431	FBXO42	F-box protein 42	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO42 mRNA	PMID:40504410
1312431	FBXO42	F-box protein 42	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1304787	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of FBXO42 gene	PMID:28505145
1312431	FBXO42	F-box protein 42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550029	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXO42 mRNA	PMID:21570461
1312431	FBXO42	F-box protein 42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to FBXO42 promoter]	PMID:19654925
1312431	FBXO42	F-box protein 42	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBXO42 mRNA	PMID:30851411
1312431	FBXO42	F-box protein 42	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FBXO42 mRNA	PMID:29803840
1312431	FBXO42	F-box protein 42	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of FBXO42 protein	PMID:35688186
1312431	FBXO42	F-box protein 42	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of FBXO42 gene	PMID:28589171
1312431	FBXO42	F-box protein 42	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXO42 mRNA	PMID:38568856
1312431	FBXO42	F-box protein 42	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXO42 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO42 mRNA	PMID:39836092
1312431	FBXO42	F-box protein 42	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO42 mRNA	PMID:40504410
1312431	FBXO42	F-box protein 42	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBXO42 promoter	PMID:27901495
1312431	FBXO42	F-box protein 42	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to FBXO42 mRNA]	PMID:32406909
1312431	FBXO42	F-box protein 42	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550029	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of FBXO42 mRNA	PMID:29264374
1312431	FBXO42	F-box protein 42	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550029	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXO42 gene	PMID:35295148
1312431	FBXO42	F-box protein 42	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550029	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FBXO42 promoter alternative form	PMID:35295148
1312431	FBXO42	F-box protein 42	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304787	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FBXO42 mRNA	PMID:34492290
1312431	FBXO42	F-box protein 42	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550029	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in decreased expression of FBXO42 mRNA	PMID:20813756|PMID:21318169
1312431	FBXO42	F-box protein 42	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of FBXO42 mRNA]	PMID:21318169
1312431	FBXO42	F-box protein 42	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of FBXO42 mRNA	PMID:30903817
1312431	FBXO42	F-box protein 42	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304787	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FBXO42 mRNA	PMID:25181051
1312431	FBXO42	F-box protein 42	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304787	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of FBXO42 mRNA	PMID:30816183|PMID:32528016
1312431	FBXO42	F-box protein 42	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304787	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of FBXO42 gene	PMID:28505145
1312431	FBXO42	F-box protein 42	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550029	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of FBXO42 gene	PMID:31683443
1312431	FBXO42	F-box protein 42	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550029	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FBXO42 mRNA	PMID:37019170
1312431	FBXO42	F-box protein 42	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FBXO42 mRNA	PMID:37042841
1312431	FBXO42	F-box protein 42	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXO42 mRNA	PMID:39836092
1312431	FBXO42	F-box protein 42	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXO42 mRNA	PMID:38568856
1312431	FBXO42	F-box protein 42	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304787	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXO42 mRNA	PMID:33453195
1312431	FBXO42	F-box protein 42	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FBXO42 mRNA	PMID:24449571
1312431	FBXO42	F-box protein 42	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FBXO42 mRNA	PMID:31533062
1312431	FBXO42	F-box protein 42	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FBXO42 mRNA	PMID:25979313
1312431	FBXO42	F-box protein 42	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304787	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of FBXO42 mRNA	PMID:29427782
1312431	FBXO42	F-box protein 42	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXO42 mRNA	PMID:29154799
1312431	FBXO42	F-box protein 42	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304787	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of FBXO42 mRNA	PMID:30047161
1312431	FBXO42	F-box protein 42	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FBXO42 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1312431	FBXO42	F-box protein 42	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of FBXO42 mRNA	PMID:25047013
1312431	FBXO42	F-box protein 42	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of FBXO42 mRNA	PMID:27188386
1312431	FBXO42	F-box protein 42	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550029	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FBXO42 mRNA	PMID:17562736
1312431	FBXO42	F-box protein 42	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXO42 mRNA	PMID:29067470
1312431	FBXO42	F-box protein 42	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304787	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXO42 mRNA	PMID:33387578
1312431	FBXO42	F-box protein 42	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXO42 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO42 mRNA	PMID:39836092
1312431	FBXO42	F-box protein 42	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550029	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO42 mRNA	PMID:40504410
1312431	FBXO42	F-box protein 42	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550029	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of FBXO42 mRNA; Nanotubes, Carbon results in increased expression of FBXO42 mRNA	PMID:25554681|PMID:25620056
1312431	FBXO42	F-box protein 42	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304787	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of FBXO42 mRNA	PMID:30047161
1312431	FBXO42	F-box protein 42	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXO42 mRNA	PMID:39836092
1312431	FBXO42	F-box protein 42	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304787	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FBXO42 gene	PMID:35440735
1312431	FBXO42	F-box protein 42	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550029	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FBXO42 mRNA	PMID:22206623
1312431	FBXO42	F-box protein 42	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBXO42 mRNA	PMID:30851411
1312431	FBXO42	F-box protein 42	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1304787	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of FBXO42 mRNA	PMID:30047161
1312431	FBXO42	F-box protein 42	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304787	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of FBXO42 mRNA	PMID:30047161
1312431	FBXO42	F-box protein 42	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304787	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FBXO42 mRNA	PMID:21346803
1312431	FBXO42	F-box protein 42	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in increased expression of FBXO42 mRNA	PMID:11906190
1312431	FBXO42	F-box protein 42	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304787	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of FBXO42 mRNA	PMID:21346803
1312431	FBXO42	F-box protein 42	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1304787	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of FBXO42 mRNA	PMID:30047161
1312431	FBXO42	F-box protein 42	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550029	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of FBXO42 mRNA	PMID:28973697
1312433	LACTB	lactamase beta	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of LACTB mRNA	PMID:26272509|PMID:27188386
1312433	LACTB	lactamase beta	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1312433	LACTB	lactamase beta	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of LACTB mRNA	PMID:31016361
1312433	LACTB	lactamase beta	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312434	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of LACTB mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LACTB gene	PMID:20938992
1312433	LACTB	lactamase beta	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of LACTB mRNA	PMID:33167477
1312433	LACTB	lactamase beta	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of LACTB mRNA	PMID:22378314
1312433	LACTB	lactamase beta	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LACTB mRNA	PMID:29432896
1312433	LACTB	lactamase beta	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of LACTB mRNA	PMID:21632981
1312433	LACTB	lactamase beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312434	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LACTB mRNA	PMID:39241906
1312433	LACTB	lactamase beta	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of LACTB mRNA	PMID:22574217
1312433	LACTB	lactamase beta	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of LACTB mRNA	PMID:19167446
1312433	LACTB	lactamase beta	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312434	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of LACTB mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LACTB gene	PMID:20938992
1312433	LACTB	lactamase beta	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LACTB mRNA	PMID:37042841
1312433	LACTB	lactamase beta	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of LACTB mRNA	PMID:26079696
1312433	LACTB	lactamase beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of LACTB mRNA	PMID:34319233
1312433	LACTB	lactamase beta	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304788	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LACTB mRNA	PMID:33387578
1312433	LACTB	lactamase beta	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304788	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LACTB mRNA	PMID:33354967
1312433	LACTB	lactamase beta	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of LACTB mRNA	PMID:23649840
1312433	LACTB	lactamase beta	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312434	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LACTB mRNA	PMID:34911549
1312433	LACTB	lactamase beta	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1304788	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of LACTB mRNA	PMID:30779732
1312433	LACTB	lactamase beta	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LACTB mRNA	PMID:27339419|PMID:31919559
1312433	LACTB	lactamase beta	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312434	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of LACTB mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LACTB gene	PMID:20938992
1312433	LACTB	lactamase beta	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of LACTB mRNA	PMID:26272509
1312433	LACTB	lactamase beta	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1312433	LACTB	lactamase beta	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of LACTB mRNA	PMID:23557933
1312433	LACTB	lactamase beta	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in increased expression of LACTB mRNA	PMID:37386098
1312433	LACTB	lactamase beta	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of LACTB mRNA	PMID:23300844
1312433	LACTB	lactamase beta	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of LACTB mRNA	PMID:24768652|PMID:25583101
1312433	LACTB	lactamase beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LACTB mRNA	PMID:21632981
1312433	LACTB	lactamase beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304788	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LACTB mRNA	PMID:34747641
1312433	LACTB	lactamase beta	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LACTB mRNA	PMID:23179753|PMID:27188386
1312433	LACTB	lactamase beta	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LACTB mRNA	PMID:33212167
1312433	LACTB	lactamase beta	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of LACTB protein	PMID:28918527
1312433	LACTB	lactamase beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of LACTB mRNA	PMID:26873546
1312433	LACTB	lactamase beta	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LACTB mRNA	PMID:38568856
1312433	LACTB	lactamase beta	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1304788	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of LACTB protein	PMID:29459688
1312433	LACTB	lactamase beta	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LACTB promoter	PMID:27901495
1312433	LACTB	lactamase beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LACTB mRNA	PMID:22228805
1312433	LACTB	lactamase beta	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1304788	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of LACTB mRNA	PMID:24136188
1312433	LACTB	lactamase beta	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312434	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of LACTB mRNA	PMID:23557971
1312433	LACTB	lactamase beta	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304788	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of LACTB mRNA	PMID:34492290
1312433	LACTB	lactamase beta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of LACTB mRNA	PMID:18648102
1312433	LACTB	lactamase beta	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of LACTB mRNA	PMID:18445702
1312433	LACTB	lactamase beta	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of LACTB mRNA	PMID:30690063
1312433	LACTB	lactamase beta	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1304788	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of LACTB mRNA	PMID:19167457
1312433	LACTB	lactamase beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304788	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LACTB mRNA	PMID:34947998
1312433	LACTB	lactamase beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312434	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LACTB mRNA	PMID:33221593
1312433	LACTB	lactamase beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304788	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of LACTB mRNA	PMID:30816183|PMID:32528016
1312433	LACTB	lactamase beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312434	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of LACTB mRNA	PMID:39298647
1312433	LACTB	lactamase beta	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312434	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of LACTB mRNA	PMID:38685157
1312433	LACTB	lactamase beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LACTB mRNA	PMID:37042841
1312433	LACTB	lactamase beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LACTB mRNA	PMID:38568856
1312433	LACTB	lactamase beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304788	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LACTB mRNA	PMID:33453195
1312433	LACTB	lactamase beta	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LACTB mRNA	PMID:24449571
1312433	LACTB	lactamase beta	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of LACTB mRNA	PMID:28302478
1312433	LACTB	lactamase beta	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of LACTB mRNA	PMID:19167446
1312433	LACTB	lactamase beta	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LACTB mRNA	PMID:25979313
1312433	LACTB	lactamase beta	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of LACTB mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1312433	LACTB	lactamase beta	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312434	E	RGD:6480464	20120918	CTD	MESH:D014635	Valproic Acid results in increased expression of LACTB mRNA	PMID:19136453|PMID:21427059
1312433	LACTB	lactamase beta	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1312433	LACTB	lactamase beta	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of LACTB mRNA	PMID:27989131
1312433	LACTB	lactamase beta	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of LACTB mRNA	PMID:27188386
1312433	LACTB	lactamase beta	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of LACTB mRNA	PMID:28542535
1312433	LACTB	lactamase beta	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of LACTB mRNA	PMID:24935251|PMID:26272509
1312433	LACTB	lactamase beta	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1312433	LACTB	lactamase beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312434	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LACTB mRNA	PMID:17562736
1312433	LACTB	lactamase beta	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of LACTB mRNA	PMID:25704631
1312433	LACTB	lactamase beta	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304788	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LACTB mRNA	PMID:33387578
1312433	LACTB	lactamase beta	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of LACTB mRNA	PMID:29523930
1312433	LACTB	lactamase beta	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304788	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of LACTB mRNA	PMID:29391264
1312433	LACTB	lactamase beta	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LACTB mRNA	PMID:22079256
1312433	LACTB	lactamase beta	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1312433	LACTB	lactamase beta	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of LACTB mRNA	PMID:23300844
1312433	LACTB	lactamase beta	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312434	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LACTB mRNA; Nanotubes, Carbon results in increased expression of LACTB mRNA	PMID:25554681
1312433	LACTB	lactamase beta	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LACTB protein	PMID:32959892
1312433	LACTB	lactamase beta	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of LACTB mRNA	PMID:26272509
1312433	LACTB	lactamase beta	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1312433	LACTB	lactamase beta	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1304788	E	RGD:6480464	20120412	CTD	MESH:D008694	Methamphetamine results in increased expression of LACTB mRNA	PMID:19149911
1312433	LACTB	lactamase beta	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of LACTB mRNA	PMID:27714895
1312433	LACTB	lactamase beta	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LACTB protein	PMID:34186270
1312433	LACTB	lactamase beta	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312434	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LACTB mRNA	PMID:22206623
1312433	LACTB	lactamase beta	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of LACTB mRNA	PMID:22079256|PMID:22714537
1312433	LACTB	lactamase beta	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LACTB mRNA	PMID:22079256
1312433	LACTB	lactamase beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1312433	LACTB	lactamase beta	gene	CHEBI:82341	Methylazoxymethanol acetate	increases expression	ISO	RGD:1304788	E	RGD:6480464	20171010	CTD	MESH:D008746	Methylazoxymethanol Acetate results in increased expression of LACTB mRNA	PMID:28349193
1312433	LACTB	lactamase beta	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of LACTB mRNA	PMID:26272509
1312433	LACTB	lactamase beta	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1312433	LACTB	lactamase beta	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LACTB mRNA	PMID:27188386
1312433	LACTB	lactamase beta	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LACTB mRNA	PMID:38568856
1312433	LACTB	lactamase beta	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304788	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LACTB mRNA	PMID:21346803
1312433	LACTB	lactamase beta	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304788	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of LACTB mRNA	PMID:22570695
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SERPINA9 mRNA	PMID:35811015
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SERPINA9 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SERPINA9 mRNA	PMID:35811015
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SERPINA9 mRNA	PMID:25549359
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304789	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SERPINA9 mRNA	PMID:33387578
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA	PMID:37992649
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA	PMID:37992649
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SERPINA9 mRNA	PMID:34319233
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304789	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SERPINA9 mRNA	PMID:33387578
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SERPINA9 mRNA	PMID:36331819
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SERPINA9 polyA tail	PMID:30157460
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:2663	amiodarone	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in decreased expression of SERPINA9 mRNA	PMID:24535564
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312436	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SERPINA9 mRNA	PMID:31919559
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1304789	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of SERPINA9 gene	PMID:31011160
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA]	PMID:37992649
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SERPINA9 mRNA	PMID:28189721|PMID:28960355
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of SERPINA9 mRNA	PMID:40618947
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312436	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of SERPINA9 mRNA	PMID:32186404
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SERPINA9 mRNA	PMID:30096437
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SERPINA9 mRNA	PMID:29803840
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of SERPINA9 mRNA	PMID:39631538
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA	PMID:37992649
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA]	PMID:37992649
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SERPINA9 promoter	PMID:27901495
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SERPINA9 mRNA	PMID:32417428
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SERPINA9 mRNA	PMID:23221170
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312436	E	RGD:6480464	20250401	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SERPINA9 mRNA	PMID:38811393
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1304789	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of SERPINA9 mRNA	PMID:16483693
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312436	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of SERPINA9 mRNA	PMID:23557971
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304789	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SERPINA9 mRNA	PMID:25181051
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312436	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SERPINA9 promoter	PMID:27312807
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of SERPINA9 mRNA	PMID:40203079
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312436	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SERPINA9 mRNA	PMID:39298647
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312436	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SERPINA9 mRNA	PMID:21266533
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1312436	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of SERPINA9 mRNA	PMID:24183702
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SERPINA9 mRNA	PMID:28903501
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of SERPINA9 mRNA	PMID:28962523
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312436	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SERPINA9 mRNA	PMID:40194260
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SERPINA9 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SERPINA9 mRNA	PMID:36331819
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312436	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of SERPINA9 mRNA	PMID:23125180
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in decreased expression of SERPINA9 mRNA	PMID:24535564
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SERPINA9 mRNA	PMID:37992649
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312436	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SERPINA9 mRNA	PMID:17562736
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304789	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SERPINA9 mRNA	PMID:33387578
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SERPINA9 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SERPINA9 mRNA	PMID:35811015
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in decreased expression of SERPINA9 mRNA	PMID:22334560
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312436	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SERPINA9 mRNA	PMID:35436446
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1312436	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate results in increased expression of SERPINA9 mRNA	PMID:16221973
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312436	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of SERPINA9 mRNA	PMID:25554681
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SERPINA9 mRNA; Nanotubes, Carbon results in decreased expression of SERPINA9 mRNA	PMID:25620056
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312436	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SERPINA9 mRNA	PMID:25554681
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20260113	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SERPINA9 mRNA	PMID:40930398
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SERPINA9 mRNA	PMID:22206623
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SERPINA9 mRNA	PMID:37199045
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SERPINA9 gene]	PMID:28238834
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of SERPINA9 mRNA	PMID:19270015|PMID:19482888|PMID:23091169
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312436	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SERPINA9 mRNA]	PMID:19482888
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in decreased expression of SERPINA9 mRNA	PMID:22334560
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20131210	CTD	MESH:C045950	propiconazole results in decreased expression of SERPINA9 mRNA	PMID:22334560|PMID:23970803
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon results in decreased expression of SERPINA9 mRNA	PMID:23970803
1312435	SERPINA9	serpin family A member 9	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312436	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SERPINA9 mRNA	PMID:28973697
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1312439	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in increased expression of BFAR protein	PMID:36252740
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of BFAR mRNA	PMID:38218311
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:136185	VX nerve agent	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C009680	VX-agent results in increased expression of BFAR mRNA	PMID:38555327
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D019308	[Palmitic Acid co-treated with Arsenic] affects the expression of BFAR mRNA	PMID:33736254
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312439	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of BFAR mRNA	PMID:30319688
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of BFAR mRNA	PMID:21632981
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312439	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of BFAR mRNA	PMID:18978301
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of BFAR mRNA	PMID:21179406
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BFAR mRNA	PMID:37325564
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:24828	indoles	decreases expression	ISO	RGD:1304791	E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in decreased expression of BFAR mRNA	PMID:20521778
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:24828	indoles	increases expression	ISO	RGD:1304791	E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in increased expression of BFAR mRNA	PMID:20521778
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312439	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BFAR mRNA	PMID:19770486
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of BFAR mRNA	PMID:26760959
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of BFAR mRNA	PMID:23033980
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of BFAR mRNA	PMID:35430440
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:27470	folic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid affects the expression of BFAR mRNA	PMID:16361273
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of BFAR mRNA	PMID:25629700
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D001151	[Palmitic Acid co-treated with Arsenic] affects the expression of BFAR mRNA	PMID:33736254
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of BFAR mRNA	PMID:28189721|PMID:28960355
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312439	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BFAR mRNA	PMID:21570461
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312439	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BFAR mRNA	PMID:19770486
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of BFAR mRNA	PMID:29803840
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:28748	doxorubicin	decreases response to substance	ISO	RGD:1312439	E	RGD:6480464	20120412	CTD	MESH:D004317	BFAR protein results in decreased susceptibility to Doxorubicin	PMID:18805781
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of BFAR mRNA	PMID:38568856|PMID:39719251
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BFAR mRNA	PMID:34876320
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BFAR mRNA	PMID:34876320
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of BFAR mRNA]	PMID:22228805
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:29866	arsenite(3-)	affects localization	ISO	RGD:1312439	E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite affects the localization of BFAR protein alternative form	PMID:34175335
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1304791	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of BFAR mRNA	PMID:19730151
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of BFAR mRNA	PMID:35676786
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of BFAR mRNA	PMID:20458559
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312439	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of BFAR mRNA	PMID:17426115|PMID:18301758|PMID:23811191
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304791	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of BFAR mRNA	PMID:25181051
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304791	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of BFAR mRNA	PMID:30816183|PMID:32528016
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of BFAR mRNA	PMID:39298647
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of BFAR mRNA	PMID:38685157
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1304791	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of BFAR mRNA	PMID:22546817
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304791	E	RGD:6480464	20161115	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of BFAR mRNA	PMID:21266533
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1304791	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of BFAR mRNA	PMID:22546817
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of BFAR mRNA	PMID:18836921
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BFAR mRNA	PMID:37042841
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:35456	cadmium dichloride	affects methylation	ISO	RGD:1304791	E	RGD:6480464	20161115	CTD	MESH:D019256	Cadmium Chloride affects the methylation of BFAR promoter	PMID:22457795
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of BFAR mRNA	PMID:38568856
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1304791	E	RGD:6480464	20161115	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of BFAR promoter	PMID:22457795
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BFAR mRNA	PMID:37325564
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304791	E	RGD:6480464	20161115	CTD	MESH:C018021	cobaltous chloride results in increased expression of BFAR mRNA	PMID:24386269
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:38319	usnic acid	increases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in increased expression of BFAR mRNA	PMID:32508146
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312439	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of BFAR mRNA	PMID:19770486
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:42223	emodin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004642	Emodin results in decreased expression of BFAR mRNA	PMID:16045814
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D001151	[Palmitic Acid co-treated with Arsenic] affects the expression of BFAR mRNA	PMID:33736254
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BFAR mRNA	PMID:34876320
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1304791	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of BFAR mRNA	PMID:19730151
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of BFAR mRNA	PMID:35676786
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of BFAR mRNA	PMID:20458559
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of BFAR mRNA; Nanotubes, Carbon results in decreased expression of BFAR mRNA	PMID:25554681
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of BFAR mRNA	PMID:40234311
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of BFAR mRNA	PMID:31758290
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of BFAR mRNA	PMID:22206623
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312439	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of BFAR mRNA	PMID:34876320
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:85014	2,5-hexanedione	increases expression	ISO	RGD:1304791	E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione results in increased expression of BFAR mRNA	PMID:22952946
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304791	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of BFAR mRNA	PMID:19281266
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312439	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of BFAR mRNA	PMID:17569031
1312438	BFAR	bifunctional apoptosis regulator	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304791	E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of BFAR mRNA	PMID:22615374
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GCFC2 mRNA	PMID:33167477
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of GCFC2 mRNA	PMID:21632981
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of GCFC2 mRNA	PMID:29581250
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312441	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GCFC2 mRNA	PMID:39241906
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of GCFC2 mRNA	PMID:38568856
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of GCFC2 protein	PMID:37730182
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304792	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GCFC2 mRNA	PMID:33387578
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of GCFC2 promoter	PMID:30157460
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:18291	manganese atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of GCFC2 mRNA	PMID:17175027
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCFC2 mRNA	PMID:39836092
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCFC2 mRNA	PMID:35301059
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GCFC2 protein	PMID:23301498
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304792	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GCFC2 mRNA	PMID:33354967
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GCFC2 mRNA	PMID:23649840
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20160210	CTD	MESH:D001151	Arsenic affects the methylation of GCFC2 gene	PMID:25304211
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCFC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCFC2 mRNA	PMID:39836092
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of GCFC2 protein	PMID:38460933
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of GCFC2 protein	PMID:35688186
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312441	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of GCFC2 mRNA	PMID:28960355
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304792	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of GCFC2 mRNA	PMID:31881176
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of GCFC2 mRNA	PMID:23557933
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312441	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GCFC2 mRNA	PMID:24058054
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304792	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GCFC2 mRNA	PMID:33387578
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GCFC2 mRNA	PMID:38568856
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCFC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCFC2 mRNA	PMID:39836092
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GCFC2 promoter	PMID:27901495
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of GCFC2 gene	PMID:31601247
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312441	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of GCFC2 mRNA	PMID:29264374
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304792	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of GCFC2 mRNA	PMID:23411599|PMID:34492290
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312441	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of GCFC2 promoter	PMID:27334623
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1312441	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of GCFC2 mRNA	PMID:37894381
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304792	E	RGD:6480464	20160210	CTD	MESH:C006780	bisphenol A results in increased expression of GCFC2 mRNA	PMID:25181051
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of GCFC2 mRNA	PMID:19244175
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of GCFC2 gene	PMID:31601247
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312441	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of GCFC2 mRNA	PMID:38685157
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of GCFC2 gene	PMID:22964155
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GCFC2 mRNA	PMID:37042841
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:35154	manganese(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of GCFC2 mRNA	PMID:17175027
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCFC2 mRNA	PMID:39836092
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304792	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GCFC2 mRNA	PMID:33453195
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCFC2 mRNA	PMID:35301059
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of GCFC2 mRNA	PMID:24449571
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GCFC2 mRNA	PMID:31533062
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GCFC2 mRNA	PMID:25562108
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of GCFC2 mRNA	PMID:27188386
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of GCFC2 protein	PMID:38460933
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20160210	CTD	MESH:D001151	Arsenic affects the methylation of GCFC2 gene	PMID:25304211
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCFC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCFC2 mRNA	PMID:39836092
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1304792	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of GCFC2 mRNA	PMID:23962444
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304792	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of GCFC2 mRNA	PMID:30047161
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312441	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of GCFC2 mRNA	PMID:23608068
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GCFC2 protein	PMID:32959892
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of GCFC2 mRNA	PMID:17175027
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCFC2 mRNA	PMID:39836092
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:64153	tanespimycin	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:C112765	tanespimycin analog results in increased expression of GCFC2 protein	PMID:31370342
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C025589	ochratoxin A results in decreased expression of GCFC2 mRNA	PMID:19287073
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304792	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GCFC2 mRNA	PMID:30047161
1312440	GCFC2	GC-rich sequence DNA-binding factor 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304792	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of GCFC2 mRNA	PMID:22570695|PMID:23034163
1312443	CENPB	centromere protein B	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1304794	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of CENPB mRNA	PMID:36841081
1312443	CENPB	centromere protein B	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312444	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CENPB mRNA	PMID:30319688
1312443	CENPB	centromere protein B	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312444	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CENPB mRNA	PMID:39241906
1312443	CENPB	centromere protein B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312444	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CENPB mRNA	PMID:39298647
1312443	CENPB	centromere protein B	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312444	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of CENPB mRNA	PMID:33711761
1312443	CENPB	centromere protein B	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CENPB mRNA	PMID:38568856
1312443	CENPB	centromere protein B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CENPB mRNA	PMID:37042841
1312443	CENPB	centromere protein B	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1304794	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of CENPB mRNA	PMID:22967744
1312443	CENPB	centromere protein B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CENPB mRNA	PMID:33754040|PMID:36174316
1312443	CENPB	centromere protein B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20250708	CTD	MESH:D004051	[[Polystyrenes results in increased abundance of Microplastics] which co-treated with Diethylhexyl Phthalate] results in decreased expression of CENPB mRNA	PMID:36174316
1312443	CENPB	centromere protein B	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CENPB protein	PMID:37730182
1312443	CENPB	centromere protein B	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304794	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of CENPB mRNA	PMID:22061828
1312443	CENPB	centromere protein B	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CENPB mRNA	PMID:28818685
1312443	CENPB	centromere protein B	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20250204	CTD	MESH:D016604	[CYP1A1 protein results in increased susceptibility to Aflatoxin B1] which results in increased expression of CENPB protein	PMID:38382706
1312443	CENPB	centromere protein B	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20201006	CTD	MESH:D015127	[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of CENPB mRNA	PMID:32553695
1312443	CENPB	centromere protein B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CENPB mRNA]	PMID:22206623
1312443	CENPB	centromere protein B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CENPB mRNA	PMID:40504410
1312443	CENPB	centromere protein B	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CENPB protein	PMID:35688186
1312443	CENPB	centromere protein B	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of CENPB mRNA	PMID:19921347
1312443	CENPB	centromere protein B	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CENPB mRNA	PMID:27594783
1312443	CENPB	centromere protein B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312444	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CENPB mRNA	PMID:21570461
1312443	CENPB	centromere protein B	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CENPB mRNA	PMID:32763439
1312443	CENPB	centromere protein B	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of CENPB mRNA	PMID:34032870
1312443	CENPB	centromere protein B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CENPB mRNA	PMID:38568856
1312443	CENPB	centromere protein B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CENPB mRNA	PMID:38568856|PMID:39719251
1312443	CENPB	centromere protein B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CENPB mRNA	PMID:40504410
1312443	CENPB	centromere protein B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312444	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of CENPB mRNA; Benzo(a)pyrene results in increased expression of CENPB mRNA	PMID:22228805|PMID:32553695
1312443	CENPB	centromere protein B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CENPB exon	PMID:27901495
1312443	CENPB	centromere protein B	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20230801	CTD	MESH:C015001	arsenite results in increased methylation of CENPB protein	PMID:23978223
1312443	CENPB	centromere protein B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CENPB mRNA	PMID:20382639
1312443	CENPB	centromere protein B	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of CENPB mRNA	PMID:35984750
1312443	CENPB	centromere protein B	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of CENPB mRNA	PMID:38479592
1312443	CENPB	centromere protein B	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312444	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of CENPB promoter	PMID:27334623
1312443	CENPB	centromere protein B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CENPB mRNA	PMID:29275510
1312443	CENPB	centromere protein B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304794	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CENPB mRNA	PMID:25181051
1312443	CENPB	centromere protein B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312444	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CENPB mRNA	PMID:32156529
1312443	CENPB	centromere protein B	gene	CHEBI:34107	1-nitropyrene	decreases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in decreased expression of CENPB mRNA	PMID:19041380
1312443	CENPB	centromere protein B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CENPB mRNA	PMID:39298647
1312443	CENPB	centromere protein B	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CENPB mRNA	PMID:17361019
1312443	CENPB	centromere protein B	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of CENPB mRNA	PMID:34813904
1312443	CENPB	centromere protein B	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of CENPB mRNA	PMID:34813904
1312443	CENPB	centromere protein B	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CENPB mRNA	PMID:19320972|PMID:19376846
1312443	CENPB	centromere protein B	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1304794	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CENPB mRNA	PMID:24386269
1312443	CENPB	centromere protein B	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of CENPB mRNA	PMID:17585979
1312443	CENPB	centromere protein B	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CENPB gene	PMID:29154799
1312443	CENPB	centromere protein B	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CENPB mRNA	PMID:28542535
1312443	CENPB	centromere protein B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CENPB mRNA	PMID:40504410
1312443	CENPB	centromere protein B	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CENPB mRNA	PMID:35964746
1312443	CENPB	centromere protein B	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of CENPB protein	PMID:23718831
1312443	CENPB	centromere protein B	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of CENPB mRNA	PMID:31629900
1312443	CENPB	centromere protein B	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CENPB mRNA	PMID:31758290
1312443	CENPB	centromere protein B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312444	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CENPB mRNA	PMID:22206623
1312443	CENPB	centromere protein B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312444	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CENPB mRNA]	PMID:22206623
1312443	CENPB	centromere protein B	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of CENPB protein	PMID:31285264
1312443	CENPB	centromere protein B	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312444	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CENPB mRNA	PMID:21278054
1312443	CENPB	centromere protein B	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304794	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of CENPB mRNA	PMID:19281266
1312443	CENPB	centromere protein B	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304794	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CENPB mRNA	PMID:21346803
1312443	CENPB	centromere protein B	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CENPB mRNA	PMID:38568856
1312443	CENPB	centromere protein B	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of CENPB mRNA	PMID:29301935
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1304795	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of APBB1IP mRNA	PMID:21551480|PMID:25152437
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312446	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of APBB1IP mRNA	PMID:20188158
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of APBB1IP mRNA	PMID:20938992
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of APBB1IP mRNA	PMID:33167477
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of APBB1IP mRNA	PMID:26079696
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312446	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of APBB1IP mRNA	PMID:30319688
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312446	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of APBB1IP mRNA	PMID:30319688
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of APBB1IP mRNA	PMID:35811015
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of APBB1IP mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of APBB1IP mRNA	PMID:35811015
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of APBB1IP mRNA	PMID:20938992
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of APBB1IP mRNA	PMID:27905399
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of APBB1IP mRNA	PMID:37992649
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of APBB1IP mRNA	PMID:37992649
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304795	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of APBB1IP mRNA	PMID:27523638
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304795	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of APBB1IP mRNA	PMID:22061828
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of APBB1IP mRNA	PMID:37748715
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of APBB1IP intron	PMID:30157460
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of APBB1IP mRNA	PMID:36331819
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1304795	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of APBB1IP mRNA	PMID:28522335
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of APBB1IP protein	PMID:20106945
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of APBB1IP intron	PMID:30157460
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of APBB1IP mRNA	PMID:41430723
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of APBB1IP mRNA	PMID:34911549
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of APBB1IP mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of APBB1IP mRNA	PMID:20938992|PMID:22206623
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of APBB1IP mRNA	PMID:40504410
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304795	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of APBB1IP mRNA	PMID:31881176
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of APBB1IP mRNA	PMID:30912803
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of APBB1IP mRNA	PMID:25583101
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of APBB1IP mRNA	PMID:20106945
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304795	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of APBB1IP mRNA	PMID:34747641
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of APBB1IP mRNA	PMID:37992649
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of APBB1IP mRNA	PMID:40504410
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of APBB1IP 5' UTR	PMID:27901495
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of APBB1IP mRNA	PMID:20064835|PMID:32234424
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of APBB1IP mRNA	PMID:22228805
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of APBB1IP mRNA	PMID:22316170
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of APBB1IP promoter	PMID:27901495
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of APBB1IP promoter	PMID:23974009
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1304795	E	RGD:6480464	20210706	CTD	MESH:D012822	Silicon Dioxide results in increased expression of APBB1IP mRNA	PMID:32721576
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of APBB1IP mRNA	PMID:20458559
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of APBB1IP mRNA	PMID:37690743
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of APBB1IP gene	PMID:31601247
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304795	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of APBB1IP mRNA	PMID:25729387
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312446	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of APBB1IP mRNA	PMID:23557971
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304795	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of APBB1IP mRNA	PMID:34492290
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of APBB1IP mRNA	PMID:18648102
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1304795	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of APBB1IP mRNA	PMID:25380136
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of APBB1IP mRNA	PMID:19710929
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of APBB1IP mRNA	PMID:38479592
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304795	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of APBB1IP mRNA	PMID:25181051
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304795	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of APBB1IP mRNA	PMID:24988533|PMID:30816183|PMID:32528016
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of APBB1IP gene	PMID:31601247
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312446	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of APBB1IP mRNA	PMID:32156529|PMID:38701888
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of APBB1IP gene	PMID:31601247
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of APBB1IP mRNA	PMID:39298647
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of APBB1IP protein	PMID:34186270
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312446	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of APBB1IP mRNA	PMID:30951980
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of APBB1IP protein	PMID:34186270
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of APBB1IP protein	PMID:34186270
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of APBB1IP mRNA	PMID:37042841
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304795	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of APBB1IP mRNA	PMID:25380136
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1304795	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of APBB1IP mRNA	PMID:25380136
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of APBB1IP mRNA	PMID:24449571
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:37415	alpha-amanitin	affects expression	ISO	RGD:1312446	E	RGD:6480464	20240903	CTD	MESH:D053959	Alpha-Amanitin affects the expression of APBB1IP mRNA	PMID:38531469
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of APBB1IP mRNA	PMID:36331819
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of APBB1IP mRNA	PMID:29038090
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312446	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of APBB1IP mRNA	PMID:17292431
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of APBB1IP mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APBB1IP mRNA	PMID:27188386
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of APBB1IP mRNA	PMID:20106945
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of APBB1IP mRNA	PMID:37992649
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1304795	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of APBB1IP mRNA	PMID:18754875
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312446	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of APBB1IP mRNA	PMID:17562736
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of APBB1IP mRNA	PMID:21420995|PMID:29067470
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of APBB1IP mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of APBB1IP mRNA	PMID:35811015
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of APBB1IP mRNA	PMID:40504410
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of APBB1IP mRNA	PMID:31838189
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of APBB1IP mRNA	PMID:32234424
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of APBB1IP mRNA	PMID:20458559
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312446	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of APBB1IP mRNA	PMID:40234311
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1312446	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of APBB1IP mRNA	PMID:17982090
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of APBB1IP mRNA	PMID:23608068
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312446	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of APBB1IP mRNA	PMID:38701926
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of APBB1IP protein	PMID:32959892
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1304795	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of APBB1IP mRNA	PMID:25729387
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304795	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of APBB1IP mRNA	PMID:25729387
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312446	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of APBB1IP mRNA	PMID:36851058
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of APBB1IP mRNA	PMID:22079614
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304795	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of APBB1IP gene	PMID:35440735
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of APBB1IP mRNA	PMID:31758290
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of APBB1IP protein	PMID:34186270
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312446	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of APBB1IP mRNA	PMID:22206623
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of APBB1IP mRNA	PMID:22714537
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of APBB1IP mRNA	PMID:37199045
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APBB1IP mRNA	PMID:27188386
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to APBB1IP gene]	PMID:28238834
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of APBB1IP mRNA	PMID:19159669
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304795	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of APBB1IP mRNA	PMID:24780913
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of APBB1IP mRNA	PMID:27188386
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304795	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of APBB1IP mRNA	PMID:19281266
1312445	APBB1IP	amyloid beta precursor protein binding family B member 1 interacting protein	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304795	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of APBB1IP mRNA	PMID:19015723
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312448	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of MRPL15 mRNA	PMID:33045310
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPL15 mRNA	PMID:23724009|PMID:33167477
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPL15 mRNA	PMID:16788091
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL15 mRNA	PMID:36331819
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1304796	E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in increased expression of MRPL15 protein	PMID:40631627
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRPL15 mRNA	PMID:22378314
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312448	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MRPL15 mRNA	PMID:30319688
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312448	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPL15 mRNA	PMID:39241906
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312448	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of MRPL15 mRNA	PMID:39298647
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MRPL15 mRNA	PMID:38568856
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MRPL15 mRNA	PMID:37042841
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1304796	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of MRPL15 protein	PMID:40631627
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MRPL15 mRNA	PMID:21669218
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1304796	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of MRPL15 protein	PMID:40631627
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MRPL15 mRNA	PMID:19850644
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of MRPL15 mRNA]	PMID:19850644
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL15 mRNA	PMID:36331819
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPL15 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of MRPL15 mRNA	PMID:39836092
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304796	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of MRPL15 protein	PMID:34915118
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPL15 mRNA	PMID:35301059
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MRPL15 mRNA	PMID:19549813
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPL15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL15 mRNA	PMID:39836092
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312448	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of MRPL15 mRNA	PMID:28960355
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312448	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of MRPL15 mRNA	PMID:22610192
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MRPL15 mRNA	PMID:23557933
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MRPL15 mRNA	PMID:28903495
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312448	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPL15 mRNA	PMID:21570461
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304796	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPL15 mRNA	PMID:33387578
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPL15 mRNA	PMID:19465110
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL15 mRNA	PMID:17942748
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MRPL15 mRNA	PMID:30851411
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPL15 mRNA	PMID:38568856|PMID:39719251
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPL15 mRNA	PMID:16014739
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPL15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL15 mRNA	PMID:39836092
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MRPL15 promoter	PMID:27901495
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of MRPL15 mRNA	PMID:19073995
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MRPL15 mRNA	PMID:20382639
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1304796	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of MRPL15 mRNA	PMID:24136188
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304796	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL15 mRNA	PMID:34947998
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL15 mRNA	PMID:26063408
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL15 protein	PMID:37567409
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304796	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL15 mRNA	PMID:25181051
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1304796	E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of MRPL15 mRNA	PMID:17316808
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of MRPL15 protein	PMID:31945527
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312448	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPL15 mRNA	PMID:39298647
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MRPL15 mRNA	PMID:21266533
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312448	E	RGD:6480464	20210209	CTD	MESH:D010269	Paraquat results in increased expression of MRPL15 mRNA	PMID:21463325
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20130514	CTD	MESH:D010269	[Paraquat co-treated with Maneb] results in decreased expression of MRPL15 mRNA	PMID:18386188
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPL15 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of MRPL15 mRNA	PMID:39836092
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MRPL15 mRNA	PMID:38174414|PMID:38568856
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1304796	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of MRPL15 promoter	PMID:22457795
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPL15 mRNA	PMID:35301059
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of MRPL15 mRNA	PMID:25908611
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MRPL15 mRNA	PMID:28302478
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MRPL15 mRNA	PMID:40419075
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL15 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL15 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MRPL15 mRNA	PMID:36331819
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of MRPL15 mRNA	PMID:19101580
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MRPL15 mRNA	PMID:23179753|PMID:26272509
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRPL15 mRNA	PMID:27188386
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312448	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MRPL15 mRNA	PMID:28973697
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1304796	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of MRPL15 protein	PMID:40631627
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of MRPL15 mRNA	PMID:28542535
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MRPL15 mRNA	PMID:17562736
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL15 mRNA	PMID:22230336|PMID:25704631|PMID:29067470
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MRPL15 mRNA	PMID:29279043
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPL15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL15 mRNA	PMID:39836092
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:47381	diclofenac	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20240702	CTD	MESH:D004008	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL15 mRNA	PMID:37844793
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MRPL15 mRNA	PMID:17942748
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:D004997	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL15 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL15 mRNA	PMID:17942748|PMID:37844793
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1304796	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of MRPL15 mRNA	PMID:36868495
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MRPL15 mRNA; Nanotubes, Carbon results in decreased expression of MRPL15 mRNA	PMID:25620056
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312448	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MRPL15 mRNA; Nanotubes, Carbon results in increased expression of MRPL15 mRNA	PMID:25554681
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20130514	CTD	MESH:D008344	[Paraquat co-treated with Maneb] results in decreased expression of MRPL15 mRNA	PMID:18386188
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:5855	ibuprofen	multiple interactions	ISO	RGD:1312448	E	RGD:6480464	20240702	CTD	MESH:D007052	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL15 mRNA	PMID:37844793
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MRPL15 protein	PMID:32959892
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPL15 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of MRPL15 mRNA	PMID:39836092
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MRPL15 protein	PMID:34186270
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312448	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MRPL15 mRNA	PMID:22206623
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:749016	gossypol acetic acid	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of MRPL15 protein	PMID:29938581
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MRPL15 mRNA	PMID:30851411
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRPL15 mRNA	PMID:27188386
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312448	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MRPL15 mRNA	PMID:23091169
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312448	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of MRPL15 mRNA	PMID:21278054
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRPL15 mRNA	PMID:27188386
1312447	MRPL15	mitochondrial ribosomal protein L15	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MRPL15 mRNA	PMID:38568856
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of B3GALNT1 mRNA	PMID:38218311
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1304797	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of B3GALNT1 mRNA	PMID:25152437
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of B3GALNT1 mRNA	PMID:26272509|PMID:27188386
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GALNT1 mRNA	PMID:27188386
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:132446	perfluorobutanesulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C539348	perfluorobutanesulfonic acid results in increased expression of B3GALNT1 mRNA	PMID:40885241
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312450	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of B3GALNT1 mRNA	PMID:37995155
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GALNT1 mRNA	PMID:20938992
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of B3GALNT1 mRNA	PMID:21934132
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B3GALNT1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B3GALNT1 mRNA	PMID:32699268
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of B3GALNT1 mRNA	PMID:35811015
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B3GALNT1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of B3GALNT1 mRNA	PMID:35811015
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of B3GALNT1 mRNA	PMID:39298647
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of B3GALNT1 mRNA	PMID:31614463
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312450	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of B3GALNT1 mRNA	PMID:19484750
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GALNT1 mRNA	PMID:20938992
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of B3GALNT1 mRNA	PMID:21179406
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA	PMID:37992649
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA	PMID:37992649
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of B3GALNT1 mRNA	PMID:31163220
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312450	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of B3GALNT1 mRNA	PMID:33754040|PMID:34319233
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304797	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of B3GALNT1 mRNA	PMID:33387578
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of B3GALNT1 mRNA	PMID:37748715
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of B3GALNT1 mRNA	PMID:39836092
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of B3GALNT1 mRNA	PMID:35301059
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of B3GALNT1 mRNA	PMID:37325564
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B3GALNT1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B3GALNT1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of B3GALNT1 mRNA	PMID:32699268
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1304797	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of B3GALNT1 mRNA	PMID:31129395
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304797	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of B3GALNT1 mRNA	PMID:31150632
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312450	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of B3GALNT1 mRNA	PMID:27339419|PMID:31919559
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of B3GALNT1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GALNT1 mRNA	PMID:20938992|PMID:22206623
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of B3GALNT1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of B3GALNT1 mRNA	PMID:39836092
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of B3GALNT1 mRNA	PMID:26272509
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B3GALNT1 mRNA	PMID:27188386
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA]	PMID:37992649
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304797	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of B3GALNT1 mRNA	PMID:31881176
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1304797	E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of B3GALNT1 mRNA	PMID:25905778
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of B3GALNT1 mRNA	PMID:28903495
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312450	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of B3GALNT1 mRNA	PMID:18930951
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304797	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of B3GALNT1 mRNA	PMID:22298810
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304797	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of B3GALNT1 mRNA	PMID:33387578
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of B3GALNT1 mRNA	PMID:28001369
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of B3GALNT1 mRNA	PMID:33212167
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of B3GALNT1 mRNA	PMID:29803840
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA	PMID:37992649
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA]	PMID:37992649
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of B3GALNT1 mRNA	PMID:37682722
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of B3GALNT1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of B3GALNT1 mRNA	PMID:39836092
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of B3GALNT1 mRNA	PMID:21964900|PMID:23735875
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of B3GALNT1 5' UTR	PMID:27901495
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of B3GALNT1 mRNA	PMID:32234424
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of B3GALNT1 promoter	PMID:27901495
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1304797	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of B3GALNT1 mRNA	PMID:32479839
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1304797	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of B3GALNT1 mRNA	PMID:25729387
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304797	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of B3GALNT1 mRNA	PMID:25729387
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312450	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of B3GALNT1 gene	PMID:35295148
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304797	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of B3GALNT1 mRNA	PMID:34492290
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1304797	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of B3GALNT1 mRNA	PMID:30723492
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of B3GALNT1 mRNA	PMID:20813756
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of B3GALNT1 mRNA	PMID:19710929
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304797	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of B3GALNT1 mRNA	PMID:30816183|PMID:32528016|PMID:33296240
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304797	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of B3GALNT1 mRNA	PMID:31129395
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of B3GALNT1 mRNA	PMID:39298647
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1304797	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of B3GALNT1 mRNA	PMID:19638242
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304797	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of B3GALNT1 mRNA	PMID:18164116
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of B3GALNT1 mRNA	PMID:39836092
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304797	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of B3GALNT1 mRNA	PMID:30723492
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of B3GALNT1 mRNA	PMID:35301059
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of B3GALNT1 mRNA	PMID:37325564
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304797	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of B3GALNT1 mRNA	PMID:27387713
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of B3GALNT1 mRNA	PMID:28962523
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B3GALNT1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B3GALNT1 mRNA	PMID:32699268
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of B3GALNT1 mRNA	PMID:19167446
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of B3GALNT1 mRNA	PMID:25979313
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of B3GALNT1 mRNA	PMID:23179753|PMID:25192806|PMID:27188386|PMID:28001369
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of B3GALNT1 gene	PMID:29154799
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of B3GALNT1 mRNA	PMID:27989131
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GALNT1 mRNA	PMID:37992649
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of B3GALNT1 mRNA	PMID:38832940
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of B3GALNT1 mRNA	PMID:27188386
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of B3GALNT1 mRNA	PMID:24935251|PMID:26272509
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GALNT1 mRNA	PMID:27188386
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304797	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of B3GALNT1 mRNA	PMID:33387578
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B3GALNT1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of B3GALNT1 mRNA	PMID:35811015
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of B3GALNT1 mRNA	PMID:29279043
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of B3GALNT1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of B3GALNT1 mRNA	PMID:39836092
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of B3GALNT1 mRNA	PMID:17145863
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1312450	E	RGD:6480464	20150127	CTD	MESH:C000499	ferric oxide analog results in increased expression of B3GALNT1 mRNA	PMID:24525745
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1304797	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of B3GALNT1 mRNA	PMID:21983209
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of B3GALNT1 mRNA	PMID:19042947
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of B3GALNT1 mRNA	PMID:27188386
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of B3GALNT1 mRNA	PMID:39836092
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1304797	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of B3GALNT1 mRNA	PMID:25729387
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304797	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of B3GALNT1 mRNA	PMID:25729387
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304797	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of B3GALNT1 mRNA	PMID:30467583
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312450	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of B3GALNT1 mRNA	PMID:22206623
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:7438	N-methylformamide	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide analog results in decreased expression of B3GALNT1 mRNA; methylformamide results in decreased expression of B3GALNT1 mRNA	PMID:17040096
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of B3GALNT1 mRNA	PMID:22714537
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1304797	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of B3GALNT1 mRNA	PMID:18164116
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GALNT1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B3GALNT1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GALNT1 mRNA	PMID:27188386
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of B3GALNT1 mRNA	PMID:30928695
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312450	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of B3GALNT1 mRNA	PMID:23091169
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of B3GALNT1 mRNA	PMID:19167446
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312450	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of B3GALNT1 mRNA	PMID:39847705
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304797	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of B3GALNT1 mRNA	PMID:24780913
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GALNT1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of B3GALNT1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GALNT1 mRNA	PMID:27188386
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1304797	E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of B3GALNT1 mRNA	PMID:25905778
1312449	B3GALNT1	beta-1,3-N-acetylgalactosaminyltransferase 1 (Globoside blood group)	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of B3GALNT1 mRNA	PMID:29301935
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ZNF184 mRNA	PMID:21632981
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552007	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFP184 mRNA	PMID:39241906
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP184 mRNA	PMID:25510870
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF184 mRNA	PMID:37042841
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of ZNF184 mRNA	PMID:20655997
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20210608	CTD	MESH:D004051	Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of ZFP184 mRNA]	PMID:33484791
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZNF184 mRNA	PMID:28818685
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP184 mRNA	PMID:25510870
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP184 mRNA	PMID:25510870
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZNF184 mRNA	PMID:19549813
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ZNF184 mRNA	PMID:23649840
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZNF184 mRNA	PMID:23649840
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552007	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ZFP184 mRNA	PMID:28960355
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of ZNF184 gene	PMID:31636367
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZNF184 mRNA	PMID:22574217
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552007	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP184 mRNA	PMID:21570461
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ZNF184 mRNA	PMID:30851411
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1552007	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of ZFP184 mRNA	PMID:30807115
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZNF184 promoter	PMID:27901495
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZNF184 mRNA	PMID:20382639
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552007	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ZFP184 mRNA	PMID:29264374
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP184 mRNA	PMID:25510870
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP184 mRNA	PMID:25510870
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552007	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ZFP184 mRNA	PMID:37019170
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552007	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ZFP184 mRNA	PMID:17361019
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF184 mRNA	PMID:37042841
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZNF184 mRNA	PMID:38568856
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZNF184 mRNA	PMID:25979313
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZNF184 gene	PMID:29154799
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ZNF184 mRNA	PMID:29154799
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF184 mRNA	PMID:20106945|PMID:25562108
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ZNF184 mRNA	PMID:22714537
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1552007	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ZFP184 mRNA	PMID:38701926
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ZNF184 mRNA	PMID:28988120
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552007	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ZFP184 mRNA	PMID:22206623
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF184 protein	PMID:31285264
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ZNF184 mRNA	PMID:30851411
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ZNF184 mRNA	PMID:30928695
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF184 gene]	PMID:28238834
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304798	E	RGD:6480464	20150602	CTD	MESH:D011441	Propylthiouracil results in increased expression of ZFP184 mRNA	PMID:24780913
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1552007	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of ZFP184 mRNA; Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of ZFP184 mRNA]	PMID:33484791
1312451	ZNF184	zinc finger protein 184	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304798	E	RGD:6480464	20150602	CTD	MESH:C025643	vinclozolin results in decreased expression of ZFP184 mRNA	PMID:22570695
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312454	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of DGUOK mRNA	PMID:33045310
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of DGUOK mRNA	PMID:21934132
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of DGUOK mRNA	PMID:36331819
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304799	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of DGUOK gene	PMID:28931070
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DGUOK mRNA	PMID:39241906
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:16794	scopolamine	increases expression	ISO	RGD:1304799	E	RGD:6480464	20120412	CTD	MESH:D012601	Scopolamine results in increased expression of DGUOK mRNA	PMID:17540011
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of DGUOK mRNA	PMID:33359661
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DGUOK mRNA	PMID:27153756
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304799	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DGUOK mRNA	PMID:31150632
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DGUOK mRNA	PMID:25629700
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DGUOK mRNA	PMID:22206623
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DGUOK mRNA	PMID:40504410
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312454	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of DGUOK mRNA	PMID:22610192
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of DGUOK mRNA	PMID:28903495
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in decreased expression of DGUOK mRNA	PMID:22228119
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of DGUOK mRNA	PMID:32186404
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312454	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DGUOK mRNA	PMID:21570461
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304799	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DGUOK mRNA	PMID:21215274
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DGUOK mRNA	PMID:17942748
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DGUOK mRNA	PMID:30851411
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of DGUOK mRNA	PMID:27862939
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of DGUOK mRNA	PMID:26873546
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DGUOK mRNA	PMID:38568856
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DGUOK mRNA	PMID:40504410
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DGUOK promoter	PMID:27901495
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312454	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of DGUOK protein	PMID:37955338
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to DGUOK mRNA]	PMID:32406909
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312454	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DGUOK gene	PMID:35295148
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304799	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of DGUOK mRNA	PMID:23411599
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DGUOK mRNA	PMID:18648102
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304799	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DGUOK mRNA	PMID:25181051
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304799	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of DGUOK mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304799	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DGUOK gene	PMID:28505145
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of DGUOK mRNA	PMID:38685157
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DGUOK mRNA	PMID:32715474
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304799	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DGUOK mRNA	PMID:21266533
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of DGUOK mRNA	PMID:17942915
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of DGUOK mRNA]	PMID:17942915
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DGUOK mRNA	PMID:37042841
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DGUOK mRNA	PMID:38568856
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1304799	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DGUOK mRNA	PMID:24386269
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of DGUOK mRNA	PMID:36331819
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DGUOK mRNA	PMID:25979313
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of DGUOK mRNA	PMID:23179753
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DGUOK mRNA	PMID:17562736
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of DGUOK mRNA	PMID:21420995|PMID:25704631
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DGUOK mRNA	PMID:40504410
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DGUOK mRNA	PMID:17555576
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DGUOK mRNA	PMID:17942748
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304799	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of DGUOK mRNA	PMID:30307764
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304799	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DGUOK gene	PMID:35440735
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DGUOK mRNA	PMID:22206623
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312454	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DGUOK mRNA	PMID:22206623
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:75701	sarin	decreases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of DGUOK mRNA	PMID:19522546
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:75701	sarin	increases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of DGUOK mRNA	PMID:19522546
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DGUOK mRNA	PMID:30851411
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312454	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of DGUOK mRNA	PMID:30294300
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1304799	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of DGUOK mRNA	PMID:23914054
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1312454	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of DGUOK protein	PMID:35357534
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312454	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of DGUOK mRNA	PMID:35537566
1312453	DGUOK	deoxyguanosine kinase	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304799	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of DGUOK mRNA	PMID:19015723
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312456	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of GGA2 mRNA	PMID:30319688
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312456	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of GGA2 mRNA	PMID:39298647
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of GGA2 mRNA	PMID:19162166
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGA2 mRNA	PMID:37992649
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312456	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of GGA2 mRNA	PMID:22401849
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of GGA2 promoter	PMID:33872906
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312456	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of GGA2 mRNA	PMID:33848595
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGA2 mRNA	PMID:37992649
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of GGA2 promoter	PMID:33872906
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304800	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of GGA2 mRNA	PMID:22061828|PMID:33387578
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304800	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of GGA2 protein	PMID:34915118
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GGA2 mRNA	PMID:37236586
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312456	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GGA2 mRNA	PMID:31919559
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312456	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GGA2 mRNA	PMID:25629700
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of GGA2 protein	PMID:35688186
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of GGA2 mRNA	PMID:23557933
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of GGA2 protein	PMID:39603559
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304800	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of GGA2 mRNA	PMID:28959563
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGA2 mRNA	PMID:37992649
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1312456	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of GGA2 mRNA	PMID:17127020
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GGA2 mRNA	PMID:26238291
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GGA2 protein	PMID:32717239
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1304800	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of GGA2 mRNA	PMID:24136188
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304800	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of GGA2 mRNA	PMID:25729387
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304800	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GGA2 mRNA	PMID:34492290
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of GGA2 mRNA	PMID:30903817
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of GGA2 mRNA	PMID:29275510
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304800	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GGA2 gene	PMID:28505145
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of GGA2 mRNA	PMID:25979313
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312456	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GGA2 mRNA	PMID:39298647
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312456	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of GGA2 mRNA	PMID:28392331
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312456	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GGA2 mRNA	PMID:37019170
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GGA2 mRNA	PMID:38568856
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304800	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GGA2 mRNA	PMID:33453195
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GGA2 mRNA	PMID:37236586
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312456	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GGA2 mRNA	PMID:40194260
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of GGA2 mRNA	PMID:19167446
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of GGA2 mRNA	PMID:40419075
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GGA2 mRNA	PMID:25979313
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of GGA2 mRNA	PMID:23179753|PMID:26272509
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GGA2 mRNA	PMID:27188386
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGA2 mRNA	PMID:37992649
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:44616	afimoxifene	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C016601	afimoxifene results in increased expression of GGA2 mRNA	PMID:16849584
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of GGA2 mRNA	PMID:24935251|PMID:26272509
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GGA2 mRNA	PMID:27188386
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312456	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GGA2 mRNA	PMID:17562736
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304800	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GGA2 mRNA	PMID:33387578
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304800	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GGA2 mRNA	PMID:29391264
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1304800	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of GGA2 mRNA	PMID:24136188
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of GGA2 mRNA	PMID:35964746
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of GGA2 protein	PMID:23718831
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:6015	isoflurane	decreases methylation	ISO	RGD:1312456	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in decreased methylation of GGA2 mRNA	PMID:35249202
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304800	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of GGA2 mRNA	PMID:25729387
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304800	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of GGA2 gene	PMID:35440735
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312456	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GGA2 mRNA	PMID:22206623
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GGA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GGA2 mRNA	PMID:27188386
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312456	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of GGA2 mRNA	PMID:30294300
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1312456	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of GGA2 mRNA	PMID:38995820
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of GGA2 mRNA	PMID:12756304
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GGA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GGA2 mRNA	PMID:27188386
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of GGA2 mRNA	PMID:38568856
1312455	GGA2	golgi associated, gamma adaptin ear containing, ARF binding protein 2	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of GGA2 mRNA	PMID:29301935
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1304801	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of S1PR4 mRNA	PMID:33729688
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of S1PR4 mRNA	PMID:30529165
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of S1PR4 mRNA	PMID:37042841
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1304801	E	RGD:6480464	20140610	CTD	MESH:D005947	Glucose results in decreased expression of S1PR4 mRNA	PMID:22406263
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of S1PR4 mRNA	PMID:37992649
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1304801	E	RGD:6480464	20140610	CTD	MESH:D005947	Glucose results in decreased expression of S1PR4 mRNA	PMID:22406263
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of S1PR4 mRNA	PMID:37992649
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of S1PR4 mRNA	PMID:36331819
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of S1PR4 mRNA	PMID:21641981|PMID:22100608
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of S1PR4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of S1PR4 mRNA	PMID:34911549
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312458	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of S1PR4 mRNA	PMID:25629700
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of S1PR4 mRNA	PMID:18414638
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:27698	vanadium atom	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of S1PR4 mRNA	PMID:19000753
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312458	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of S1PR4 mRNA	PMID:28960355
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304801	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of S1PR4 mRNA	PMID:31881176
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of S1PR4 mRNA	PMID:27392435
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304801	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of S1PR4 mRNA	PMID:34747641
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of S1PR4 mRNA	PMID:37992649
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S1PR4 mRNA	PMID:34876320
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S1PR4 mRNA	PMID:34876320
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of S1PR4 mRNA	PMID:21871943|PMID:22316170
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to S1PR4 promoter]	PMID:19654925
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304801	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of S1PR4 mRNA	PMID:34492290
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1304801	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of S1PR4 mRNA	PMID:19167457
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304801	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of S1PR4 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312458	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of S1PR4 mRNA	PMID:32156529
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312458	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of S1PR4 mRNA	PMID:37019170
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of S1PR4 mRNA	PMID:37042841
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1304801	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of S1PR4 mRNA	PMID:35163327
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:35170	vanadium(0)	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of S1PR4 mRNA	PMID:19000753
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1304801	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of S1PR4 promoter	PMID:22457795
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of S1PR4 mRNA	PMID:24449571
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312458	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of S1PR4 mRNA	PMID:40194260
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of S1PR4 mRNA	PMID:36331819
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of S1PR4 gene	PMID:29154799
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1304801	E	RGD:6480464	20140610	CTD	MESH:D005947	Glucose results in decreased expression of S1PR4 mRNA	PMID:22406263
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of S1PR4 mRNA	PMID:37992649
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of S1PR4 mRNA	PMID:26690555
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312458	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in increased expression of S1PR4 mRNA	PMID:17585979
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of S1PR4 mRNA	PMID:18414638
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S1PR4 mRNA	PMID:34876320
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of S1PR4 mRNA	PMID:35964746
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312458	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of S1PR4 mRNA	PMID:38701926
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of S1PR4 mRNA	PMID:28960945
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312458	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of S1PR4 mRNA	PMID:34876320
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1304801	E	RGD:6480464	20140610	CTD	MESH:D013311	Streptozocin results in increased expression of S1PR4 mRNA	PMID:22406263
1312457	S1PR4	sphingosine-1-phosphate receptor 4	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of S1PR4 mRNA	PMID:29301935
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of FRMD3 mRNA	PMID:23724009
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312460	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of FRMD3 mRNA	PMID:20880076
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1304802	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FRMD3 mRNA	PMID:33729688
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:16130	DDT	decreases expression	ISO	RGD:1304802	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of FRMD3 mRNA	PMID:30207508
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of FRMD3 mRNA	PMID:21632981
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of FRMD3 mRNA	PMID:30510588
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of FRMD3 mRNA	PMID:23019147
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of FRMD3 mRNA	PMID:20660070
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304802	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of FRMD3 mRNA	PMID:26496021
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of FRMD3 mRNA	PMID:38568856
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of FRMD3 mRNA	PMID:23649840
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of FRMD3 mRNA	PMID:20660070
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA	PMID:37567420
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of FRMD3 mRNA	PMID:36695872
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of FRMD3 mRNA	PMID:33359661
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA	PMID:37567420
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FRMD3 protein	PMID:37730182
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of FRMD3 intron	PMID:30157460
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FRMD3 mRNA	PMID:35301059
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20200714	CTD	MESH:D002104	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of FRMD3 mRNA	PMID:31904401
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:234430	gardiquimod	increases expression	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in increased expression of FRMD3 mRNA	PMID:28003376
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:234430	gardiquimod	multiple interactions	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FRMD3 mRNA]	PMID:28003376
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FRMD3 mRNA	PMID:27106289
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of FRMD3 mRNA	PMID:19774075
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312460	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FRMD3 mRNA	PMID:25629700
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of FRMD3 mRNA	PMID:26272509
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA	PMID:27188386
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312460	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of FRMD3 mRNA	PMID:28960355
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of FRMD3 mRNA	PMID:27392435
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of FRMD3 mRNA	PMID:27392435
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FRMD3 mRNA	PMID:28001369
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FRMD3 mRNA	PMID:33212167
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of FRMD3 mRNA	PMID:26272509
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA	PMID:27188386
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304802	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of FRMD3 mRNA	PMID:28959563
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of FRMD3 mRNA	PMID:32763439
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FRMD3 mRNA	PMID:29803840
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA	PMID:37567420
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1312460	E	RGD:6480464	20220809	CTD	MESH:C017947	sodium arsenite affects the expression of FRMD3 mRNA	PMID:26674514
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of and affects the splicing of FRMD3 mRNA	PMID:25879800
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FRMD3 mRNA	PMID:20106945|PMID:21632981
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of FRMD3 promoter	PMID:23974009
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of FRMD3 mRNA	PMID:25895662
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FRMD3 mRNA	PMID:20018196
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of FRMD3 gene	PMID:31601247
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of FRMD3 gene	PMID:31601247
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312460	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in decreased expression of FRMD3 mRNA	PMID:22613225
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312460	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FRMD3 gene	PMID:35295148
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312460	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FRMD3 gene	PMID:35295148
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FRMD3 mRNA	PMID:19710929
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312460	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of FRMD3 promoter	PMID:27334623
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of FRMD3 mRNA	PMID:31715268
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304802	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FRMD3 mRNA	PMID:25181051
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304802	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of FRMD3 mRNA	PMID:26496021
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of FRMD3 mRNA	PMID:36804509
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of FRMD3 gene	PMID:31601247
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FRMD3 mRNA	PMID:37042841
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FRMD3 mRNA	PMID:35301059
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20200714	CTD	MESH:D019256	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of FRMD3 mRNA	PMID:31904401
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20200714	CTD	MESH:D013755	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of FRMD3 mRNA	PMID:31904401
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of FRMD3 mRNA]	PMID:28003376
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FRMD3 mRNA	PMID:31533062
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of FRMD3 mRNA	PMID:19167446
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FRMD3 mRNA	PMID:25979313
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312460	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of FRMD3 mRNA	PMID:24896083
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of FRMD3 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRMD3 mRNA	PMID:27188386
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of FRMD3 mRNA	PMID:20106945|PMID:21632981
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA	PMID:37567420
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of FRMD3 mRNA	PMID:24935251
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of FRMD3 mRNA	PMID:26272509
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA	PMID:27188386
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of FRMD3 mRNA	PMID:22714537
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of FRMD3 mRNA	PMID:28988120
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of FRMD3 mRNA	PMID:31758290
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312460	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FRMD3 mRNA	PMID:22206623
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312460	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA	PMID:37567420
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in increased expression of FRMD3 mRNA	PMID:30559759
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRMD3 mRNA	PMID:27188386
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FRMD3 gene]	PMID:28238834
1312459	FRMD3	FERM domain containing 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FRMD3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRMD3 mRNA	PMID:27188386
1312462	TLL2	tolloid like 2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TLL2 mRNA	PMID:26272509
1312462	TLL2	tolloid like 2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TLL2 mRNA	PMID:27188386
1312462	TLL2	tolloid like 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312463	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TLL2 mRNA	PMID:33045310
1312462	TLL2	tolloid like 2	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of TLL2 mRNA	PMID:34925699
1312462	TLL2	tolloid like 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of TLL2 mRNA	PMID:23724009|PMID:33167477
1312462	TLL2	tolloid like 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312463	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TLL2 mRNA	PMID:39241906
1312462	TLL2	tolloid like 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of TLL2 mRNA	PMID:23019147
1312462	TLL2	tolloid like 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1559756	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TLL2 mRNA	PMID:33387578
1312462	TLL2	tolloid like 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of TLL2 mRNA	PMID:18070364
1312462	TLL2	tolloid like 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312463	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TLL2 mRNA	PMID:22401849
1312462	TLL2	tolloid like 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1559756	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TLL2 mRNA	PMID:33387578
1312462	TLL2	tolloid like 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TLL2 mRNA	PMID:28818685
1312462	TLL2	tolloid like 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TLL2 intron	PMID:30157460
1312462	TLL2	tolloid like 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TLL2 gene	PMID:27153756
1312462	TLL2	tolloid like 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of TLL2 mRNA	PMID:26272509
1312462	TLL2	tolloid like 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TLL2 mRNA	PMID:27188386
1312462	TLL2	tolloid like 2	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1559756	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of TLL2 gene	PMID:35440735
1312462	TLL2	tolloid like 2	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:1559756	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of TLL2 gene	PMID:31011160
1312462	TLL2	tolloid like 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of TLL2 mRNA	PMID:23019147
1312462	TLL2	tolloid like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TLL2 mRNA	PMID:21296121
1312462	TLL2	tolloid like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1559756	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TLL2 mRNA	PMID:32109520|PMID:33387578
1312462	TLL2	tolloid like 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TLL2 mRNA	PMID:28001369
1312462	TLL2	tolloid like 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1559756	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TLL2 mRNA	PMID:26033743
1312462	TLL2	tolloid like 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1559756	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of TLL2 mRNA	PMID:26033743
1312462	TLL2	tolloid like 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312463	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of TLL2 mRNA	PMID:36209798
1312462	TLL2	tolloid like 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TLL2 exon	PMID:30157460
1312462	TLL2	tolloid like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312463	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TLL2 mRNA	PMID:22228805
1312462	TLL2	tolloid like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312463	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TLL2 intron	PMID:27901495
1312462	TLL2	tolloid like 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TLL2 promoter	PMID:27901495
1312462	TLL2	tolloid like 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1559756	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TLL2 mRNA	PMID:26033743
1312462	TLL2	tolloid like 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1559756	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of TLL2 mRNA	PMID:26033743
1312462	TLL2	tolloid like 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TLL2 mRNA	PMID:26705709
1312462	TLL2	tolloid like 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312463	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TLL2 gene; titanium dioxide results in decreased methylation of TLL2 promoter	PMID:35295148
1312462	TLL2	tolloid like 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1559756	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TLL2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312462	TLL2	tolloid like 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1559756	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TLL2 gene	PMID:28505145
1312462	TLL2	tolloid like 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in increased expression of TLL2 mRNA	PMID:30616060
1312462	TLL2	tolloid like 2	gene	CHEBI:35176	zinc sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in increased expression of TLL2 mRNA	PMID:16330358
1312462	TLL2	tolloid like 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1559756	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TLL2 mRNA	PMID:33453195
1312462	TLL2	tolloid like 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312463	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TLL2 mRNA	PMID:40194260
1312462	TLL2	tolloid like 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TLL2 mRNA	PMID:40419075
1312462	TLL2	tolloid like 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1559756	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of TLL2 mRNA	PMID:29427782
1312462	TLL2	tolloid like 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of TLL2 mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1312462	TLL2	tolloid like 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312463	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of TLL2 mRNA	PMID:18502557
1312462	TLL2	tolloid like 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TLL2 mRNA	PMID:38832940
1312462	TLL2	tolloid like 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of TLL2 mRNA	PMID:26690555
1312462	TLL2	tolloid like 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1559756	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TLL2 mRNA	PMID:33387578
1312462	TLL2	tolloid like 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in increased expression of TLL2 mRNA	PMID:26615145
1312462	TLL2	tolloid like 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TLL2 mRNA	PMID:18936297
1312462	TLL2	tolloid like 2	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TLL2 mRNA	PMID:26705709
1312462	TLL2	tolloid like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1559756	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of TLL2 mRNA	PMID:27840820
1312462	TLL2	tolloid like 2	gene	CHEBI:756028	mivebresib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in increased expression of TLL2 mRNA	PMID:35486664
1312462	TLL2	tolloid like 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TLL2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TLL2 mRNA	PMID:27188386
1312462	TLL2	tolloid like 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of TLL2 mRNA	PMID:26705709
1312462	TLL2	tolloid like 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TLL2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TLL2 mRNA	PMID:27188386
1312462	TLL2	tolloid like 2	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1559756	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of TLL2 gene	PMID:31682807
1312464	KRT12	keratin 12	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1304805	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of KRT12 mRNA	PMID:21551480
1312464	KRT12	keratin 12	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KRT12 mRNA	PMID:35811015
1312464	KRT12	keratin 12	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of KRT12 mRNA]	PMID:35811015
1312464	KRT12	keratin 12	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1304805	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of KRT12 mRNA	PMID:20884683
1312464	KRT12	keratin 12	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1618846	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of KRT12 mRNA	PMID:22238285
1312464	KRT12	keratin 12	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KRT12 mRNA	PMID:19549813
1312464	KRT12	keratin 12	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KRT12 gene	PMID:27153756
1312464	KRT12	keratin 12	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT12 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of KRT12 protein	PMID:38598786
1312464	KRT12	keratin 12	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1618846	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of KRT12 mRNA	PMID:23625948
1312464	KRT12	keratin 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618846	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KRT12 mRNA	PMID:21570461
1312464	KRT12	keratin 12	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304805	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of KRT12 mRNA	PMID:28959563
1312464	KRT12	keratin 12	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304805	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of KRT12 mRNA	PMID:26033743
1312464	KRT12	keratin 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1618846	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT12 mRNA	PMID:34876320
1312464	KRT12	keratin 12	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1618846	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT12 mRNA	PMID:34876320
1312464	KRT12	keratin 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1618846	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KRT12 mRNA	PMID:23735875
1312464	KRT12	keratin 12	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KRT12 exon; Benzo(a)pyrene results in increased methylation of KRT12 promoter	PMID:27901495
1312464	KRT12	keratin 12	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304805	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of KRT12 mRNA	PMID:26033743
1312464	KRT12	keratin 12	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1618846	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of KRT12 mRNA	PMID:29264374
1312464	KRT12	keratin 12	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1618846	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of KRT12 mRNA	PMID:17426115
1312464	KRT12	keratin 12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304805	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT12 mRNA	PMID:25181051
1312464	KRT12	keratin 12	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1304805	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of KRT12 mRNA	PMID:22561333
1312464	KRT12	keratin 12	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1618846	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of KRT12 mRNA	PMID:22155349
1312464	KRT12	keratin 12	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KRT12 gene	PMID:29154799
1312464	KRT12	keratin 12	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of KRT12 mRNA	PMID:22230336
1312464	KRT12	keratin 12	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of KRT12 mRNA]	PMID:35811015
1312464	KRT12	keratin 12	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1618846	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of KRT12 mRNA	PMID:29279043
1312464	KRT12	keratin 12	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1618846	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT12 mRNA	PMID:34876320
1312464	KRT12	keratin 12	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KRT12 gene]	PMID:28238834
1312464	KRT12	keratin 12	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1618846	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of KRT12 mRNA	PMID:34876320
1312464	KRT12	keratin 12	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of KRT12 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of KRT12 protein	PMID:38598786
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552011	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PITPNC1 mRNA	PMID:37995155
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552011	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of PITPNC1 mRNA]	PMID:19467301
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552011	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PITPNC1 mRNA	PMID:20938992
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PITPNC1 mRNA	PMID:23724009
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:16243	quercetin	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin affects the expression of PITPNC1 mRNA	PMID:21632981
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PITPNC1 mRNA	PMID:39241906
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PITPNC1 mRNA	PMID:39298647
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of PITPNC1 mRNA	PMID:21795739
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PITPNC1 mRNA	PMID:20823114
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552011	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PITPNC1 mRNA	PMID:20938992
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PITPNC1 mRNA	PMID:23649840
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of PITPNC1 mRNA	PMID:27664576
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	ISO	RGD:1552011	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of PITPNC1 intron	PMID:32864567
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PITPNC1 mRNA	PMID:28818685
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1597047	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of PITPNC1 mRNA	PMID:28522335
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:2038	5-azacytidine	decreases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in decreased expression of PITPNC1 mRNA	PMID:20823114
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of PITPNC1 mRNA	PMID:21120746
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552011	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of PITPNC1 mRNA	PMID:37236586
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PITPNC1 mRNA	PMID:19549813
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PITPNC1 protein	PMID:20106945
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PITPNC1 intron	PMID:30157460
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552011	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PITPNC1 mRNA	PMID:19770486
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PITPNC1 exon; Aflatoxin B1 results in increased methylation of PITPNC1 gene	PMID:27153756|PMID:30157460
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PITPNC1 mRNA	PMID:23649840
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552011	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PITPNC1 mRNA	PMID:34911549
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1552011	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of PITPNC1 mRNA	PMID:25629700
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552011	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PITPNC1 mRNA	PMID:20938992
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PITPNC1 gene	PMID:25304211
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PITPNC1 protein	PMID:35688186
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PITPNC1 mRNA	PMID:28903495
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1552011	E	RGD:6480464	20231003	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in increased methylation of PITPNC1 intron	PMID:33445541
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PITPNC1 mRNA	PMID:27392435
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PITPNC1 mRNA	PMID:30912803
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in increased expression of PITPNC1 mRNA	PMID:20884965
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1552011	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of PITPNC1 mRNA	PMID:32186404
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of PITPNC1 mRNA	PMID:24768652
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552011	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PITPNC1 mRNA	PMID:19933214
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552011	E	RGD:6480464	20210209	CTD	MESH:D013749	[Tetrachlorodibenzodioxin affects the methylation of PITPNC1 intron] which results in decreased expression of PITPNC1 mRNA	PMID:33017471
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1597047	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of PITPNC1 mRNA	PMID:28374803
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PITPNC1 mRNA	PMID:28001369
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PITPNC1 mRNA	PMID:33212167
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	PITPNC1 protein affects the susceptibility to Doxorubicin	PMID:16217747
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PITPNC1 mRNA	PMID:29803840
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of PITPNC1 mRNA	PMID:29301061
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PITPNC1 intron	PMID:30157460
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PITPNC1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PITPNC1 mRNA	PMID:19770486|PMID:21569818|PMID:21715664|PMID:22228805
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1552011	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PITPNC1 intron	PMID:27901495
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PITPNC1 mRNA	PMID:26238291
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PITPNC1 mRNA	PMID:26705709
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1552011	E	RGD:6480464	20231003	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in increased methylation of PITPNC1 intron	PMID:33445541
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1552011	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of PITPNC1 mRNA	PMID:23557971
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of PITPNC1 mRNA	PMID:27760801|PMID:29264374
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552011	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PITPNC1 gene	PMID:35295148
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552011	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PITPNC1 gene; titanium dioxide results in increased methylation of PITPNC1 promoter alternative form	PMID:35295148
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of PITPNC1 mRNA	PMID:20813756|PMID:23811191
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:33083	fluoranthene	increases expression	ISO	RGD:1552011	E	RGD:6480464	20170725	CTD	MESH:C007738	fluoranthene results in increased expression of PITPNC1 mRNA	PMID:28329830
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1552011	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of PITPNC1 mRNA	PMID:28329830
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1597047	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PITPNC1 mRNA	PMID:25181051
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	PITPNC1 mRNA affects the susceptibility to Carmustine	PMID:16365179
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552011	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PITPNC1 gene	PMID:31683443
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of PITPNC1 mRNA	PMID:33297965|PMID:39298647
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1552011	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PITPNC1 exon	PMID:33297965
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PITPNC1 intron	PMID:30157460
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1552011	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of PITPNC1 intron	PMID:28392331
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:34631	chlorpyrifos	affects expression	ISO	RGD:1552011	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos affects the expression of PITPNC1 mRNA	PMID:37019170
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1552011	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of PITPNC1 mRNA	PMID:26377693
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PITPNC1 mRNA	PMID:26472689
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552011	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of PITPNC1 mRNA	PMID:37236586
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PITPNC1 mRNA	PMID:17681415
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PITPNC1 mRNA	PMID:40194260
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PITPNC1 mRNA	PMID:31533062
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of PITPNC1 mRNA	PMID:23125180
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PITPNC1 mRNA	PMID:25979313
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of PITPNC1 mRNA	PMID:28001369
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PITPNC1 gene	PMID:29154799
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of PITPNC1 mRNA	PMID:19770486
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PITPNC1 mRNA	PMID:25562108
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in decreased expression of PITPNC1 mRNA	PMID:19059307
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552011	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PITPNC1 mRNA	PMID:28973697
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PITPNC1 mRNA	PMID:38832940
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PITPNC1 mRNA	PMID:18769122
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PITPNC1 mRNA	PMID:24935251|PMID:26272509
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PITPNC1 mRNA	PMID:27188386
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PITPNC1 mRNA	PMID:22230336|PMID:29067470
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PITPNC1 gene	PMID:25304211
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PITPNC1 mRNA	PMID:35436446
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in decreased expression of PITPNC1 mRNA	PMID:17211630
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PITPNC1 mRNA	PMID:26705709
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PITPNC1 mRNA	PMID:20823114
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PITPNC1 mRNA; Nanotubes, Carbon results in decreased expression of PITPNC1 mRNA	PMID:25554681|PMID:25620056
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PITPNC1 mRNA	PMID:20147733
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of PITPNC1 mRNA	PMID:20003209
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PITPNC1 mRNA	PMID:20823114
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of PITPNC1 intron	PMID:30157460
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1597047	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PITPNC1 gene	PMID:35440735
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	PITPNC1 mRNA affects the susceptibility to temozolomide	PMID:16365179
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PITPNC1 mRNA	PMID:31758290
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552011	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PITPNC1 mRNA	PMID:22206623
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PITPNC1 mRNA	PMID:22714537
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PITPNC1 mRNA	PMID:37199045
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PITPNC1 mRNA	PMID:27188386
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552011	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of PITPNC1 mRNA	PMID:23091169
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1552011	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of PITPNC1 mRNA	PMID:31388691
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of PITPNC1 mRNA	PMID:19059307
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PITPNC1 mRNA	PMID:27188386
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1597047	E	RGD:6480464	20130416	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in decreased expression of PITPNC1 mRNA	PMID:20665664
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PITPNC1 mRNA	PMID:29301935
1312467	PITPNC1	phosphatidylinositol transfer protein cytoplasmic 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552011	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PITPNC1 mRNA	PMID:28973697
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ANKEF1 mRNA	PMID:26272509
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKEF1 mRNA	PMID:27188386
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ANKEF1 mRNA	PMID:21632981
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of ANKEF1 mRNA	PMID:21185374
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304809	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ANKEF1 mRNA	PMID:33387578
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ANKEF1 mRNA	PMID:37042841
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ANKEF1 mRNA	PMID:36139627
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ANKEF1 mRNA	PMID:28818685
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304809	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANKEF1 mRNA	PMID:39012411
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ANKEF1 mRNA	PMID:19549813
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ANKEF1 mRNA	PMID:23649840
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312471	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ANKEF1 mRNA	PMID:28960355
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304809	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ANKEF1 mRNA	PMID:31881176
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ANKEF1 mRNA	PMID:27594783
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ANKEF1 mRNA	PMID:28001369
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ANKEF1 mRNA	PMID:33212167
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ANKEF1 mRNA	PMID:29803840
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ANKEF1 mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20161115	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ANKEF1 gene	PMID:25435355
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ANKEF1 mRNA]	PMID:32406909
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ANKEF1 mRNA	PMID:25351596
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ANKEF1 mRNA	PMID:19710929
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304809	E	RGD:6480464	20150512	CTD	MESH:C006780	bisphenol A results in decreased expression of ANKEF1 mRNA	PMID:25181051
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312471	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of ANKEF1 mRNA	PMID:38701888
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312471	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ANKEF1 mRNA	PMID:40203079
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in increased expression of ANKEF1 mRNA	PMID:27685785
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312471	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ANKEF1 exon	PMID:33297965
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304809	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ANKEF1 mRNA	PMID:21266533
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ANKEF1 mRNA	PMID:37042841
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304809	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ANKEF1 mRNA	PMID:30723492
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ANKEF1 mRNA	PMID:38568856
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304809	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANKEF1 mRNA	PMID:39012411
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ANKEF1 mRNA	PMID:24935251|PMID:26272509|PMID:28001369
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKEF1 mRNA	PMID:27188386
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D016572	Cyclosporine results in decreased expression of ANKEF1 mRNA	PMID:25562108
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ANKEF1 mRNA	PMID:20106945
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312471	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ANKEF1 mRNA	PMID:28973697
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312471	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ANKEF1 mRNA	PMID:17562736
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of ANKEF1 mRNA	PMID:20977926
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ANKEF1 mRNA	PMID:25351596
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304809	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ANKEF1 mRNA	PMID:30307764
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312471	E	RGD:6480464	20150512	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ANKEF1 mRNA	PMID:23608068
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ANKEF1 protein	PMID:32959892
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312471	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ANKEF1 mRNA	PMID:22206623
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ANKEF1 mRNA	PMID:36139627
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKEF1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKEF1 mRNA	PMID:27188386
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1304809	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of ANKEF1 mRNA	PMID:32109520
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:82436	decabromodiphenyl ether	multiple interactions	ISO	RGD:1304809	E	RGD:6480464	20200714	CTD	MESH:C010902	[Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in decreased expression of ANKEF1 mRNA	PMID:32207525
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKEF1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKEF1 mRNA	PMID:27188386
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ANKEF1 mRNA	PMID:38568856
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ANKEF1 mRNA	PMID:29301935
1312470	ANKEF1	ankyrin repeat and EF-hand domain containing 1	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of ANKEF1 mRNA	PMID:27188386
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1304811	E	RGD:6480464	20150804	CTD	MESH:D004237	Diuron results in increased expression of TMC4 mRNA	PMID:21551480
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312474	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TMC4 mRNA	PMID:33045310
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312474	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of TMC4 mRNA	PMID:37995155
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMC4 mRNA	PMID:20938992
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMC4 mRNA	PMID:36331819
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TMC4 mRNA	PMID:26079696
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TMC4 mRNA	PMID:20044591
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TMC4 mRNA	PMID:35811015
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of TMC4 mRNA]	PMID:35811015
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312474	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TMC4 mRNA	PMID:39298647
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of TMC4 mRNA	PMID:30165855
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312474	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of TMC4 mRNA	PMID:33711761
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMC4 mRNA	PMID:20938992
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1312474	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of TMC4 mRNA	PMID:19693291
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TMC4 mRNA	PMID:26079696
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of TMC4 mRNA	PMID:21592394
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312474	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in increased expression of TMC4 mRNA	PMID:19693291
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of TMC4 mRNA	PMID:21592394
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of TMC4 mRNA	PMID:21592394|PMID:26485663
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of TMC4 mRNA	PMID:21592394
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1304811	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of TMC4 mRNA	PMID:28522335
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304811	E	RGD:6480464	20150804	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TMC4 mRNA	PMID:23630614
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of TMC4 mRNA	PMID:35430440
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TMC4 mRNA	PMID:34911549
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1304811	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of TMC4 mRNA	PMID:30779732
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1312474	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of TMC4 mRNA	PMID:31939706
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMC4 mRNA	PMID:20938992
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMC4 mRNA	PMID:40504410
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312474	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of TMC4 mRNA	PMID:28960355
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of TMC4 mRNA	PMID:19167446
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1304811	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of TMC4 gene	PMID:28505145
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TMC4 mRNA	PMID:24768652|PMID:25583101
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304811	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMC4 mRNA	PMID:32109520
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TMC4 mRNA	PMID:33212167
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TMC4 mRNA	PMID:32763439
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMC4 mRNA	PMID:34032870
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMC4 mRNA	PMID:40504410
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TMC4 exon; Benzo(a)pyrene results in decreased methylation of TMC4 promoter	PMID:27901495
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312474	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TMC4 mRNA	PMID:27131904
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TMC4 mRNA	PMID:25895662
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:32195	Tesaglitazar	decreases expression	ISO	RGD:1304811	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of TMC4 mRNA	PMID:21515302
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304811	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TMC4 mRNA	PMID:30816183|PMID:32528016
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312474	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TMC4 mRNA	PMID:32156529
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304811	E	RGD:6480464	20150804	CTD	MESH:C006780	bisphenol A results in increased expression of TMC4 mRNA	PMID:25181051
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304811	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of TMC4 gene	PMID:28505145
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312474	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TMC4 mRNA	PMID:30951980
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of TMC4 intron	PMID:30157460
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312474	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TMC4 mRNA	PMID:38685157
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:34698	diethyl phthalate	decreases expression	ISO	RGD:1304811	E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of TMC4 mRNA	PMID:32341500
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:34698	diethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C007379	[diethyl phthalate results in increased abundance of monoethyl phthalate] which results in decreased expression of TMC4 mRNA	PMID:32341500
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of TMC4 mRNA	PMID:36117858
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMC4 mRNA	PMID:37042841
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304811	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TMC4 mRNA	PMID:35163327
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304811	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TMC4 mRNA	PMID:35163327
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304811	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TMC4 mRNA	PMID:27387713
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of TMC4 mRNA	PMID:19167446
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in decreased expression of TMC4 mRNA	PMID:19167446
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TMC4 mRNA	PMID:36331819
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of TMC4 mRNA	PMID:28001369
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TMC4 gene	PMID:29154799
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312474	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TMC4 mRNA	PMID:28973697
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312474	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of TMC4 mRNA	PMID:18502557
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of TMC4 mRNA]	PMID:35811015
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TMC4 mRNA	PMID:40504410
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304811	E	RGD:6480464	20150804	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TMC4 mRNA	PMID:17557909
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of TMC4 mRNA	PMID:38825487
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:5118	fluoxetine	decreases expression	ISO	RGD:1304811	E	RGD:6480464	20150804	CTD	MESH:D005473	Fluoxetine results in decreased expression of TMC4 mRNA	PMID:17033635
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312474	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of TMC4 mRNA	PMID:26377693
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312474	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of TMC4 mRNA	PMID:36117858
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312474	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of TMC4 mRNA	PMID:23608068
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of TMC4 intron	PMID:30157460
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C581825	[diethyl phthalate results in increased abundance of monoethyl phthalate] which results in decreased expression of TMC4 mRNA	PMID:32341500
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312474	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of TMC4 mRNA	PMID:22206623
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1304811	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of TMC4 mRNA	PMID:32109520
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312474	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TMC4 mRNA	PMID:27131904
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1304811	E	RGD:6480464	20150804	CTD	MESH:C057693	troglitazone results in decreased expression of TMC4 mRNA	PMID:21515302
1312473	TMC4	transmembrane channel like 4	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304811	E	RGD:6480464	20150804	CTD	MESH:C025643	vinclozolin affects the expression of TMC4 mRNA	PMID:19015723
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312476	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FCHSD2 mRNA	PMID:33045310
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304812	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FCHSD2 mRNA]	PMID:31150632
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FCHSD2 mRNA	PMID:33167477
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of FCHSD2 mRNA	PMID:26079696
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of FCHSD2 protein	PMID:18951874
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of FCHSD2 mRNA	PMID:21632981
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FCHSD2 mRNA	PMID:39241906
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of FCHSD2 mRNA	PMID:39298647
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304812	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FCHSD2 mRNA	PMID:33387578
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FCHSD2 mRNA	PMID:37042841
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:16716	benzene	decreases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in decreased expression of FCHSD2 mRNA	PMID:19162166
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in decreased expression of FCHSD2 mRNA	PMID:27664576
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of FCHSD2 protein	PMID:37730182
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of FCHSD2 mRNA	PMID:16002434
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304812	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of FCHSD2 mRNA	PMID:22061828
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FCHSD2 mRNA	PMID:36331819
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FCHSD2 mRNA	PMID:35301059
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FCHSD2 mRNA	PMID:37236586
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of FCHSD2 mRNA	PMID:19549813
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	ISO	RGD:1304812	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of FCHSD2 mRNA	PMID:15651846
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304812	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of FCHSD2 mRNA	PMID:30779732
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304812	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FCHSD2 mRNA	PMID:31150632
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FCHSD2 mRNA	PMID:17484886|PMID:31919559
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304812	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FCHSD2 mRNA]	PMID:31150632
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FCHSD2 mRNA	PMID:25629700
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FCHSD2 mRNA	PMID:22206623
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FCHSD2 gene	PMID:25304211
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FCHSD2 mRNA	PMID:27188386
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of FCHSD2 protein	PMID:35688186
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of FCHSD2 mRNA	PMID:23557933
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of FCHSD2 mRNA	PMID:28903495
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of FCHSD2 mRNA	PMID:21603599
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of FCHSD2 mRNA	PMID:27392435
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of FCHSD2 mRNA	PMID:24768652
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FCHSD2 mRNA	PMID:22298810
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304812	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FCHSD2 mRNA	PMID:22298810
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312476	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FCHSD2 mRNA	PMID:21570461
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FCHSD2 mRNA	PMID:20106945|PMID:21632981
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304812	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FCHSD2 mRNA	PMID:21215274
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304812	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FCHSD2 mRNA	PMID:34747641
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312476	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FCHSD2 mRNA	PMID:21354282
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of FCHSD2 protein	PMID:18951874
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FCHSD2 mRNA	PMID:33212167
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of FCHSD2 mRNA	PMID:39709020
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FCHSD2 mRNA	PMID:30851411
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FCHSD2 mRNA	PMID:29803840
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of FCHSD2 mRNA	PMID:20371982
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FCHSD2 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FCHSD2 promoter	PMID:27901495
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312476	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FCHSD2 mRNA	PMID:22228805
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of FCHSD2 gene	PMID:31601247
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1304812	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of FCHSD2 mRNA	PMID:24136188
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304812	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of FCHSD2 mRNA	PMID:25729387
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312476	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FCHSD2 gene; titanium dioxide results in decreased methylation of FCHSD2 promoter	PMID:35295148
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304812	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FCHSD2 mRNA	PMID:34492290
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FCHSD2 mRNA	PMID:19710929
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304812	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of FCHSD2 mRNA	PMID:32145629
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FCHSD2 gene	PMID:31601247
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1304812	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of FCHSD2 gene	PMID:28505145
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304812	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FCHSD2 mRNA	PMID:25181051
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304812	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FCHSD2 gene	PMID:28505145
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of FCHSD2 gene	PMID:31601247
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312476	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of FCHSD2 mRNA	PMID:20713471
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of FCHSD2 mRNA	PMID:39298647
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312476	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of FCHSD2 mRNA	PMID:40203079
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312476	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of FCHSD2 mRNA	PMID:26377693
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of FCHSD2 gene	PMID:22964155
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312476	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of FCHSD2 mRNA	PMID:21266533
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1304812	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of FCHSD2 mRNA	PMID:35163327
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FCHSD2 mRNA	PMID:35301059
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FCHSD2 mRNA	PMID:37236586
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FCHSD2 mRNA	PMID:19320972
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FCHSD2 mRNA	PMID:36331819
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of FCHSD2 mRNA	PMID:23179753
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FCHSD2 mRNA	PMID:25562108
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1304812	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of FCHSD2 mRNA	PMID:24136188
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of FCHSD2 mRNA	PMID:24935251|PMID:26272509
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FCHSD2 mRNA	PMID:27188386
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of FCHSD2 mRNA	PMID:21420995|PMID:22230336
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of FCHSD2 mRNA	PMID:26690555
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304812	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FCHSD2 mRNA	PMID:33387578
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FCHSD2 mRNA	PMID:29279043
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FCHSD2 gene	PMID:25304211
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of FCHSD2 mRNA	PMID:40706910
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FCHSD2 mRNA	PMID:22079256
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FCHSD2 mRNA; Nanotubes, Carbon results in decreased expression of FCHSD2 mRNA	PMID:25554681
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FCHSD2 mRNA	PMID:35964746
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304812	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of FCHSD2 mRNA	PMID:24136188
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312476	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of FCHSD2 mRNA	PMID:23608068
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1304812	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of FCHSD2 mRNA	PMID:25729387
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304812	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of FCHSD2 mRNA	PMID:25729387
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of FCHSD2 mRNA	PMID:19812364
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304812	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of FCHSD2 mRNA	PMID:30467583
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:72676	versicolorin A	decreases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C029826	versicolorin A results in decreased expression of FCHSD2 mRNA	PMID:32106047
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312476	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FCHSD2 mRNA	PMID:22206623
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312476	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FCHSD2 mRNA	PMID:22206623
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of FCHSD2 mRNA	PMID:22079256
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FCHSD2 mRNA	PMID:22079256
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FCHSD2 mRNA	PMID:30851411
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FCHSD2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FCHSD2 mRNA	PMID:27188386
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FCHSD2 gene]	PMID:28238834
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312476	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of FCHSD2 mRNA	PMID:19270015
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304812	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of FCHSD2 mRNA	PMID:24780913
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FCHSD2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FCHSD2 mRNA	PMID:27188386
1312475	FCHSD2	FCH and double SH3 domains 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304812	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of FCHSD2 mRNA	PMID:22570695
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:132844	glycidyl methacrylate	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of RBMS2 protein	PMID:36641056
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of RBMS2 mRNA	PMID:15309432
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of RBMS2 mRNA	PMID:30165855
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304813	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RBMS2 mRNA	PMID:33387578
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of RBMS2 intron	PMID:30157460
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RBMS2 mRNA	PMID:35301059
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304813	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of RBMS2 mRNA	PMID:21396975
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RBMS2 mRNA	PMID:39836092
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of RBMS2 protein	PMID:35688186
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RBMS2 mRNA	PMID:27392435
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550035	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RBMS2 mRNA	PMID:30912803
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550035	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RBMS2 mRNA	PMID:21570461
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases phosphorylation	ISO	RGD:1304813	E	RGD:6480464	20140715	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased phosphorylation of RBMS2 protein	PMID:23298284
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RBMS2 mRNA	PMID:33212167
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RBMS2 mRNA	PMID:29803840
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RBMS2 mRNA	PMID:38568856
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RBMS2 mRNA	PMID:39836092
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1550035	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RBMS2 mRNA	PMID:18648102
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of RBMS2 mRNA	PMID:20170705
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304813	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RBMS2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of RBMS2 mRNA	PMID:25979313
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to RBMS2 promoter]	PMID:20348232
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1550035	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of RBMS2 intron	PMID:28392331
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550035	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RBMS2 mRNA	PMID:37019170
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550035	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RBMS2 mRNA	PMID:21266533
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of RBMS2 mRNA	PMID:29024780
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RBMS2 mRNA	PMID:21457566
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1304813	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of RBMS2 promoter	PMID:22457795
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RBMS2 mRNA	PMID:35301059
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RBMS2 mRNA	PMID:19320972
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RBMS2 mRNA	PMID:31533062
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RBMS2 mRNA	PMID:23179753|PMID:28001369
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RBMS2 mRNA	PMID:25562108
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550035	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of RBMS2 mRNA	PMID:28973697
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1550035	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of RBMS2 mRNA	PMID:18502557
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304813	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RBMS2 mRNA	PMID:33387578
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RBMS2 mRNA	PMID:39836092
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RBMS2 mRNA	PMID:31758290
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:78492	diallyl trisulfide	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in increased expression of RBMS2 mRNA	PMID:34995734
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:82341	Methylazoxymethanol acetate	decreases expression	ISO	RGD:1304813	E	RGD:6480464	20171010	CTD	MESH:D008746	Methylazoxymethanol Acetate results in decreased expression of RBMS2 mRNA	PMID:28349193
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550035	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RBMS2 mRNA	PMID:39847705
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304813	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RBMS2 mRNA	PMID:19281266
1312477	RBMS2	RNA binding motif single stranded interacting protein 2	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1304813	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of RBMS2 gene	PMID:31079544
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614141	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LOXHD1 mRNA	PMID:33045310
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304815	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of LOXHD1 gene	PMID:35440735
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:16130	DDT	increases methylation	ISO	RGD:1304815	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of LOXHD1 gene	PMID:30207508
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LOXHD1 mRNA	PMID:35811015
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1614141	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LOXHD1 mRNA	PMID:25510870
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304815	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of LOXHD1 gene	PMID:27618143
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of LOXHD1 gene	PMID:30521419
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1614141	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of LOXHD1 gene	PMID:34319233
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1614141	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LOXHD1 mRNA	PMID:25510870
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1614141	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LOXHD1 mRNA	PMID:25510870
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1614141	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LOXHD1 mRNA	PMID:25629700
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1614141	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LOXHD1 mRNA	PMID:28960355
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of LOXHD1 mRNA	PMID:41028656
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304815	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LOXHD1 mRNA	PMID:32109520
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304815	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of LOXHD1 mRNA	PMID:28959563
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LOXHD1 mRNA	PMID:41028656
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LOXHD1 promoter	PMID:27901495
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1614141	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LOXHD1 intron	PMID:27901495
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of LOXHD1 mRNA	PMID:41028656
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of LOXHD1 gene	PMID:31601247
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1614141	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of LOXHD1 mRNA	PMID:29264374
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304815	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LOXHD1 mRNA	PMID:25181051
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614141	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of LOXHD1 mRNA	PMID:32156529
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LOXHD1 gene	PMID:31601247
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of LOXHD1 gene	PMID:31601247
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1614141	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LOXHD1 mRNA	PMID:25510870
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1614141	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LOXHD1 mRNA	PMID:25510870
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1614141	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LOXHD1 intron	PMID:28392331
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1304815	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] affects the methylation of LOXHD1 gene	PMID:33148267
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of LOXHD1 mRNA	PMID:35811015
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of LOXHD1 mRNA	PMID:35811015
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1304815	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] affects the methylation of LOXHD1 gene	PMID:33148267
1312479	LOXHD1	lipoxygenase homology PLAT domains 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LOXHD1 gene]	PMID:28238834
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of FKBP15 mRNA	PMID:37995155
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of FKBP15 mRNA	PMID:26251327
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1621210	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of FKBP15 promoter	PMID:26251327
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of FKBP15 mRNA	PMID:33167477
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of FKBP15 protein	PMID:28073184
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FKBP15 mRNA	PMID:39241906
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FKBP15 mRNA	PMID:37042841
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of FKBP15 mRNA	PMID:23649840
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of FKBP15 mRNA	PMID:38685446
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304816	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of FKBP15 mRNA	PMID:26577399
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of FKBP15 protein	PMID:37730182
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of FKBP15 mRNA	PMID:39836092
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FKBP15 protein	PMID:23301498
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FKBP15 gene	PMID:27153756
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FKBP15 mRNA	PMID:39836092
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of FKBP15 protein	PMID:35688186
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of FKBP15 mRNA	PMID:30912803
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of FKBP15 mRNA	PMID:23195993
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304816	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FKBP15 mRNA	PMID:33387578
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FKBP15 mRNA	PMID:29803840
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of FKBP15 protein	PMID:35688186
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FKBP15 mRNA	PMID:38568856
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FKBP15 mRNA	PMID:39836092
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621210	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FKBP15 gene	PMID:35295148
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in decreased expression of FKBP15 mRNA	PMID:21318169
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1621210	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of FKBP15 mRNA]	PMID:21318169
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304816	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FKBP15 mRNA	PMID:25181051|PMID:30816183
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of FKBP15 mRNA	PMID:25047013
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FKBP15 gene	PMID:31601247
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP15 mRNA	PMID:28628672
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304816	E	RGD:6480464	20130618	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of FKBP15 mRNA	PMID:21266533
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP15 mRNA	PMID:28628672
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of FKBP15 mRNA	PMID:39836092
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FKBP15 mRNA	PMID:38174414|PMID:38568856
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of FKBP15 mRNA	PMID:24449571
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FKBP15 gene	PMID:29154799
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of FKBP15 mRNA	PMID:27989131
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP15 mRNA	PMID:28628672
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FKBP15 mRNA	PMID:39836092
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP15 mRNA	PMID:28628672
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1621210	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of FKBP15 mRNA	PMID:21318169
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1621210	E	RGD:6480464	20120613	CTD	MESH:D011345	[PPARA protein affects the susceptibility to Fenofibrate] which affects the expression of FKBP15 mRNA	PMID:21318169
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1621210	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FKBP15 mRNA	PMID:35964746
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FKBP15 protein	PMID:32959892
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1304816	E	RGD:6480464	20130618	CTD	MESH:D007649	Ketamine results in increased expression of FKBP15 mRNA	PMID:20080153
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of FKBP15 mRNA	PMID:39836092
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:6809	methamphetamine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008694	FKBP15 gene SNP affects the susceptibility to Methamphetamine	PMID:18316681
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FKBP15 mRNA	PMID:22206623
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1621210	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of FKBP15 mRNA	PMID:23091169
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1304816	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of FKBP15 mRNA	PMID:27291303
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1304816	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of FKBP15 protein	PMID:28903499
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1304816	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of FKBP15 mRNA	PMID:23640034
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of FKBP15 protein	PMID:38348393
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1621210	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of FKBP15 mRNA	PMID:21795629
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of FKBP15 mRNA	PMID:21278054
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1621210	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of FKBP15 mRNA	PMID:35537566
1312480	FKBP15	FKBP prolyl isomerase family member 15	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304816	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of FKBP15 mRNA	PMID:23555832
1312481	ATG7	autophagy related 7	gene	CHEBI:10429	beta-lapachone	affects response to substance	EXP		E	RGD:6480464	20130409	CTD	MESH:C014638	ATG7 protein affects the susceptibility to beta-lapachone	PMID:21035436
1312481	ATG7	autophagy related 7	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ATG7 protein	PMID:38218311
1312481	ATG7	autophagy related 7	gene	CHEBI:10429	beta-lapachone	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	3-methyladenine inhibits the reaction [beta-lapachone results in increased expression of ATG7 protein]	PMID:38218311
1312481	ATG7	autophagy related 7	gene	CHEBI:113532	thymoquinone	decreases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:C003466	thymoquinone results in decreased expression of ATG7 protein	PMID:31298468
1312481	ATG7	autophagy related 7	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1558502	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ATG7 mRNA	PMID:33045310
1312481	ATG7	autophagy related 7	gene	CHEBI:141517	tyloxapol	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20240402	CTD	MESH:C016811	tyloxapol results in decreased expression of ATG7 protein	PMID:36905866
1312481	ATG7	autophagy related 7	gene	CHEBI:141517	tyloxapol	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20240402	CTD	MESH:C016811	Escin inhibits the reaction [tyloxapol results in decreased expression of ATG7 protein]; Fenofibrate inhibits the reaction [tyloxapol results in decreased expression of ATG7 protein]	PMID:36905866
1312481	ATG7	autophagy related 7	gene	CHEBI:145372	gilteritinib	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20260505	CTD	MESH:C000609080	ATG7 protein affects the reaction [gilteritinib results in increased expression of GPT protein]	PMID:40578406
1312481	ATG7	autophagy related 7	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ATG7 mRNA	PMID:33167477
1312481	ATG7	autophagy related 7	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D014212	HSF1 protein affects the reaction [Tretinoin inhibits the reaction [sodium arsenite results in increased expression of ATG7 protein]]; Tretinoin inhibits the reaction [sodium arsenite results in increased expression of ATG7 protein]	PMID:30309986
1312481	ATG7	autophagy related 7	gene	CHEBI:15368	acrolein	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D000171	Acrolein results in increased expression of ATG7 protein	PMID:30205151
1312481	ATG7	autophagy related 7	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D000171	Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG7 protein]; ATG7 protein affects the reaction [Acrolein results in increased expression of CASP1 protein]; ATG7 protein affects the reaction [Acrolein results in increased expression of IL1B protein]; ATG7 protein affects the reaction [Acrolein results in increased expression of NLRP3 protein]; ATG7 protein affects the reaction [Acrolein results in increased lipidation of MAP1LC3B protein]	PMID:30205151|PMID:34238121
1312481	ATG7	autophagy related 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ATG7 mRNA	PMID:36331819
1312481	ATG7	autophagy related 7	gene	CHEBI:15603	L-leucine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200519	CTD	MESH:D007930	Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]]	PMID:31676321
1312481	ATG7	autophagy related 7	gene	CHEBI:15738	staurosporine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019311	ATG7 protein affects the susceptibility to Staurosporine	PMID:16497721
1312481	ATG7	autophagy related 7	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D019308	Palmitic Acid results in decreased expression of ATG7 protein	PMID:30208301
1312481	ATG7	autophagy related 7	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20190219	CTD	MESH:D019308	Palmitic Acid results in decreased expression of ATG7 protein	PMID:30208301
1312481	ATG7	autophagy related 7	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D019308	[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG7 protein; ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]]; ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG7 protein]; trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of ATG7 protein]	PMID:30208301|PMID:36905866
1312481	ATG7	autophagy related 7	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20190219	CTD	MESH:D019308	trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of ATG7 protein]	PMID:30208301
1312481	ATG7	autophagy related 7	gene	CHEBI:15866	2-deoxy-D-glucose	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003847	ATG7 protein inhibits the reaction [Deoxyglucose results in increased cleavage of CASP3 protein]; ATG7 protein inhibits the reaction [Deoxyglucose results in increased expression of DDIT3 protein]; ATG7 protein inhibits the reaction [Deoxyglucose results in increased expression of HSPA5 protein]; ATG7 protein promotes the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein]	PMID:20593179
1312481	ATG7	autophagy related 7	gene	CHEBI:15891	taurine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D013654	[Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]	PMID:29078374
1312481	ATG7	autophagy related 7	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1558502	E	RGD:6480464	20201103	CTD	MESH:D001280	Atrazine results in increased expression of ATG7 mRNA	PMID:30360616
1312481	ATG7	autophagy related 7	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20201103	CTD	MESH:D001280	Lycopene inhibits the reaction [Atrazine results in increased expression of ATG7 mRNA]	PMID:30360616
1312481	ATG7	autophagy related 7	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20201103	CTD	MESH:C015329	Lycopene inhibits the reaction [Atrazine results in increased expression of ATG7 mRNA]	PMID:30360616
1312481	ATG7	autophagy related 7	gene	CHEBI:16118	berberine	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20250401	CTD	MESH:D001599	Berberine inhibits the reaction [Glucose results in decreased expression of ATG7 protein]	PMID:39127087
1312481	ATG7	autophagy related 7	gene	CHEBI:16196	oleic acid	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D019301	[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG7 protein; Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG7 protein]	PMID:36905866
1312481	ATG7	autophagy related 7	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D000431	Ethanol results in increased expression of ATG7 mRNA	PMID:24095927
1312481	ATG7	autophagy related 7	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1558502	E	RGD:6480464	20160510	CTD	MESH:D000431	Ethanol results in increased expression of ATG7 mRNA; Ethanol results in increased expression of ATG7 protein	PMID:24095927|PMID:24492484
1312481	ATG7	autophagy related 7	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:D000431	ATG7 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]	PMID:34405320
1312481	ATG7	autophagy related 7	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20221206	CTD	MESH:D000431	Ethanol promotes the reaction [Mirtazapine results in increased expression of ATG7 mRNA]; HMGB1 protein affects the reaction [Ethanol promotes the reaction [Mirtazapine results in increased expression of ATG7 mRNA]]	PMID:35066094
1312481	ATG7	autophagy related 7	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20140513	CTD	MESH:D000431	ATG7 mutant form inhibits the reaction [Ethanol results in increased lipidation of MAP1LC3B protein]; Dactinomycin inhibits the reaction [Ethanol results in increased expression of ATG7 protein]; Ethanol promotes the reaction [Mirtazapine results in increased expression of ATG7 mRNA]; FOXO3 protein affects the reaction [Ethanol results in increased expression of ATG7 mRNA]	PMID:24095927|PMID:24492484|PMID:35066094
1312481	ATG7	autophagy related 7	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20140211	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ATG7 protein	PMID:23726866
1312481	ATG7	autophagy related 7	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in increased expression of ATG7 protein	PMID:25293876
1312481	ATG7	autophagy related 7	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20240109	CTD	MESH:D011794	Quercetin inhibits the reaction [Levetiracetam results in decreased expression of ATG7 protein]	PMID:37098359
1312481	ATG7	autophagy related 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20161228	CTD	MESH:D008070	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of ATG7 gene	PMID:21212295
1312481	ATG7	autophagy related 7	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D014260	Triclosan results in decreased expression of ATG7 mRNA	PMID:34681664
1312481	ATG7	autophagy related 7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1558502	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ATG7 mRNA	PMID:39298647
1312481	ATG7	autophagy related 7	gene	CHEBI:16509	1,4-benzoquinone	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:C004532	quinone results in increased expression of ATG7 protein	PMID:40854414
1312481	ATG7	autophagy related 7	gene	CHEBI:16598	DDE	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20201006	CTD	MESH:D003633	ATG7 protein affects the reaction [Dichlorodiphenyl Dichloroethylene results in increased activity of CASP3 protein]	PMID:32721735
1312481	ATG7	autophagy related 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATG7 mRNA	PMID:37042841
1312481	ATG7	autophagy related 7	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1558502	E	RGD:6480464	20260505	CTD	MESH:D001554	Benzene results in increased expression of ATG7 protein	PMID:40854414
1312481	ATG7	autophagy related 7	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D002635	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1312481	ATG7	autophagy related 7	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20221004	CTD	MESH:D008550	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]]; Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]; Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]; Melatonin inhibits the reaction [nickel chloride results in increased expression of ATG7 mRNA]; Melatonin inhibits the reaction [nickel chloride results in increased expression of ATG7 protein]; TXNRD3 gene mutant form inhibits the reaction [Melatonin inhibits the reaction [nickel chloride results in increased expression of ATG7 mRNA]]	PMID:35568058|PMID:36421005
1312481	ATG7	autophagy related 7	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1304817	E	RGD:6480464	20260303	CTD	MESH:D005557	Formaldehyde results in increased expression of ATG7 mRNA; Formaldehyde results in increased expression of ATG7 protein	PMID:40164397
1312481	ATG7	autophagy related 7	gene	CHEBI:16856	glutathione	multiple interactions	EXP		E	RGD:6480464	20180410	CTD	MESH:D005978	Glutathione inhibits the reaction [Apigenin results in increased expression of ATG7 protein]	PMID:29247770
1312481	ATG7	autophagy related 7	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1304817	E	RGD:6480464	20220705	CTD	MESH:D005947	Glucose results in decreased expression of ATG7 protein	PMID:35243728|PMID:39127087
1312481	ATG7	autophagy related 7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20220705	CTD	MESH:D005947	Berberine inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; Inositol inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of ATG7 protein]	PMID:35243728|PMID:39127087
1312481	ATG7	autophagy related 7	gene	CHEBI:173086	ferrostatin-1	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C573944	ferrostatin-1 results in decreased expression of ATG7 protein	PMID:38896176
1312481	ATG7	autophagy related 7	gene	CHEBI:173086	ferrostatin-1	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C573944	ferrostatin-1 inhibits the reaction [ochratoxin A results in increased expression of ATG7 protein]	PMID:38896176
1312481	ATG7	autophagy related 7	gene	CHEBI:173719	Curcumol	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20210706	CTD	MESH:C022801	curcumol inhibits the reaction [VEGFA protein results in increased expression of ATG7 protein]	PMID:33549628
1312481	ATG7	autophagy related 7	gene	CHEBI:17447	geraniol	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:C007836	geraniol inhibits the reaction [Rotenone results in decreased expression of ATG7 protein]	PMID:30141137
1312481	ATG7	autophagy related 7	gene	CHEBI:17548	alginic acid	increases expression	ISO	RGD:1558502	E	RGD:6480464	20220510	CTD	MESH:C008970	Alginic Acid results in increased expression of ATG7 protein	PMID:35066102
1312481	ATG7	autophagy related 7	gene	CHEBI:17558	quercitrin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in decreased expression of ATG7 mRNA	PMID:25193878
1312481	ATG7	autophagy related 7	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C031927	hydroquinone results in increased expression of ATG7 protein	PMID:35302183
1312481	ATG7	autophagy related 7	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1304817	E	RGD:6480464	20220705	CTD	MESH:D005947	Glucose results in decreased expression of ATG7 protein	PMID:35243728|PMID:39127087
1312481	ATG7	autophagy related 7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20220705	CTD	MESH:D005947	Berberine inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; Inositol inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of ATG7 protein]	PMID:35243728|PMID:39127087
1312481	ATG7	autophagy related 7	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006000	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1312481	ATG7	autophagy related 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1304817	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ATG7 protein	PMID:32710958
1312481	ATG7	autophagy related 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D004051	ATG7 protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of ACAA1A protein]	PMID:16332691
1312481	ATG7	autophagy related 7	gene	CHEBI:177680	onjisaponin B	decreases response to substance	ISO	RGD:1558502	E	RGD:6480464	20241203	CTD	MESH:C474233	ATG7 gene mutant form results in decreased susceptibility to onjisaponin B	PMID:24248062
1312481	ATG7	autophagy related 7	gene	CHEBI:17997	dinitrogen	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D009584	ATG7 protein inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]; ATG7 protein promotes the reaction [bafilomycin A inhibits the reaction [Nitrogen deficiency results in decreased expression of ULK1 protein]]	PMID:27629431
1312481	ATG7	autophagy related 7	gene	CHEBI:18123	N-methylnicotinate	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C009560	ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of PPARG protein]]; ATG7 protein affects the reaction [trigonelline inhibits the reaction [Palmitic Acid results in increased expression of SREBF1 protein]]; trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of ATG7 protein]	PMID:30208301
1312481	ATG7	autophagy related 7	gene	CHEBI:18123	N-methylnicotinate	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20190219	CTD	MESH:C009560	trigonelline inhibits the reaction [Palmitic Acid results in decreased expression of ATG7 protein]	PMID:30208301
1312481	ATG7	autophagy related 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATG7 mRNA	PMID:36331819
1312481	ATG7	autophagy related 7	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	ISO	RGD:1558502	E	RGD:6480464	20200331	CTD	MESH:D014284	Triiodothyronine results in increased expression of ATG7 mRNA	PMID:30209975
1312481	ATG7	autophagy related 7	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATG7 mRNA	PMID:39836092
1312481	ATG7	autophagy related 7	gene	CHEBI:18315	pyrroloquinoline quinone	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D045542	PQQ Cofactor inhibits the reaction [Doxorubicin results in increased expression of ATG7 protein]	PMID:31226464
1312481	ATG7	autophagy related 7	gene	CHEBI:18388	apigenin	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D047310	Apigenin results in increased expression of ATG7 protein	PMID:29247770
1312481	ATG7	autophagy related 7	gene	CHEBI:18388	apigenin	multiple interactions	EXP		E	RGD:6480464	20180410	CTD	MESH:D047310	Acetylcysteine inhibits the reaction [Apigenin results in increased expression of ATG7 protein]; Glutathione inhibits the reaction [Apigenin results in increased expression of ATG7 protein]	PMID:29247770
1312481	ATG7	autophagy related 7	gene	CHEBI:191949	(+)-isoborneol	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20260602	CTD	MESH:C022871	isoborneol inhibits the reaction [[Thioacetamide co-treated with Dietary Fats co-treated with Fructose] results in decreased expression of ATG7 protein]	PMID:39967315
1312481	ATG7	autophagy related 7	gene	CHEBI:229049	Alpinetin	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C436748	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[alpinetin co-treated with TNF protein] results in increased expression of ATG7 mRNA]; [alpinetin co-treated with TNF protein] results in increased expression of ATG7 mRNA; AHR protein affects the reaction [[alpinetin co-treated with TNF protein] results in increased expression of ATG7 mRNA]; TSC2 protein affects the reaction [[alpinetin co-treated with TNF protein] results in increased expression of ATG7 mRNA]	PMID:31676321
1312481	ATG7	autophagy related 7	gene	CHEBI:229049	Alpinetin	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20240206	CTD	MESH:C436748	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]]; alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]; Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]]	PMID:31676321
1312481	ATG7	autophagy related 7	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1304817	E	RGD:6480464	20251202	CTD	MESH:D002104	Cadmium results in increased expression of ATG7 protein	PMID:26582496
1312481	ATG7	autophagy related 7	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1558502	E	RGD:6480464	20240109	CTD	MESH:D002104	Cadmium results in increased expression of ATG7 protein	PMID:37148155
1312481	ATG7	autophagy related 7	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20200114	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA]; NUPR1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA]	PMID:31319114
1312481	ATG7	autophagy related 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA	PMID:37236586
1312481	ATG7	autophagy related 7	gene	CHEBI:231515	lanthanum trichloride	increases expression	ISO	RGD:1304817	E	RGD:6480464	20240702	CTD	MESH:C028521	lanthanum chloride results in increased expression of ATG7 protein	PMID:35090998
1312481	ATG7	autophagy related 7	gene	CHEBI:24848	inositol	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20220705	CTD	MESH:D007294	Inositol inhibits the reaction [Glucose results in decreased expression of ATG7 protein]	PMID:35243728
1312481	ATG7	autophagy related 7	gene	CHEBI:2500	Aescin	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D004928	Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of ATG7 protein]	PMID:36905866
1312481	ATG7	autophagy related 7	gene	CHEBI:2500	Aescin	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20240402	CTD	MESH:D004928	Escin inhibits the reaction [Dietary Fats results in decreased expression of ATG7 protein]; Escin inhibits the reaction [tyloxapol results in decreased expression of ATG7 protein]; NFE2L2 protein affects the reaction [Escin inhibits the reaction [Dietary Fats results in decreased expression of ATG7 protein]]	PMID:36905866
1312481	ATG7	autophagy related 7	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ATG7 mRNA	PMID:22100608
1312481	ATG7	autophagy related 7	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ATG7 intron	PMID:30157460
1312481	ATG7	autophagy related 7	gene	CHEBI:25676	oligopeptide	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D009842	Oligopeptides analog results in increased expression of ATG7 protein	PMID:24875536
1312481	ATG7	autophagy related 7	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D010126	Ozone results in increased expression of ATG7 mRNA	PMID:27206323
1312481	ATG7	autophagy related 7	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ATG7 mRNA	PMID:35430440
1312481	ATG7	autophagy related 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ATG7 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ATG7 mRNA	PMID:34911549
1312481	ATG7	autophagy related 7	gene	CHEBI:2663	amiodarone	affects response to substance	EXP		E	RGD:6480464	20131210	CTD	MESH:D000638	ATG7 protein affects the susceptibility to Amiodarone	PMID:23912912|PMID:32651653
1312481	ATG7	autophagy related 7	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20131210	CTD	MESH:D000638	Amiodarone results in increased expression of ATG7 protein	PMID:23912912
1312481	ATG7	autophagy related 7	gene	CHEBI:2663	amiodarone	multiple interactions	EXP		E	RGD:6480464	20131210	CTD	MESH:D000638	ATG7 protein affects the reaction [Amiodarone results in increased cleavage of CASP3 protein]	PMID:23912912
1312481	ATG7	autophagy related 7	gene	CHEBI:2687	amsacrine	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D000677	Amsacrine results in decreased expression of ATG7 protein	PMID:37451322
1312481	ATG7	autophagy related 7	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200609	CTD	MESH:D002251	[TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of ATG7 protein	PMID:31513885
1312481	ATG7	autophagy related 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATG7 mRNA	PMID:22206623
1312481	ATG7	autophagy related 7	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006002	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1312481	ATG7	autophagy related 7	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATG7 gene	PMID:25304211
1312481	ATG7	autophagy related 7	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATG7 mRNA; ATG7 protein affects the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HMOX1 protein]	PMID:32525701|PMID:39836092
1312481	ATG7	autophagy related 7	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D002166	Camptothecin results in increased expression of ATG7 protein	PMID:30266318
1312481	ATG7	autophagy related 7	gene	CHEBI:27656	camptothecin	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:D002166	Egtazic Acid inhibits the reaction [Camptothecin results in increased expression of ATG7 protein]; EIF2S1 protein affects the reaction [Camptothecin results in increased expression of ATG7 protein]; staurosporine aglycone inhibits the reaction [Camptothecin results in increased expression of ATG7 protein]	PMID:30266318
1312481	ATG7	autophagy related 7	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20140513	CTD	MESH:D003609	Dactinomycin inhibits the reaction [Ethanol results in increased expression of ATG7 protein]	PMID:24095927
1312481	ATG7	autophagy related 7	gene	CHEBI:27732	caffeine	increases response to substance	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D002110	ATG7 protein results in increased susceptibility to Caffeine; ATG7 results in increased susceptibility to Caffeine	PMID:21081844
1312481	ATG7	autophagy related 7	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20250311	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in increased expression of ATG7 mRNA	PMID:39276841
1312481	ATG7	autophagy related 7	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of ATG7 mRNA; Cisplatin results in decreased expression of ATG7 protein	PMID:19561079|PMID:28408137
1312481	ATG7	autophagy related 7	gene	CHEBI:27899	cisplatin	increases response to substance	ISO	RGD:1558502	E	RGD:6480464	20191008	CTD	MESH:D002945	ATG7 gene mutant form results in increased susceptibility to Cisplatin	PMID:29476062
1312481	ATG7	autophagy related 7	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20191008	CTD	MESH:D002945	ATG7 gene mutant form inhibits the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form]; ATG7 gene mutant form inhibits the reaction [trichostatin A inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]]; ATG7 gene mutant form inhibits the reaction [trichostatin A inhibits the reaction [Cisplatin results in increased expression of CASP3 protein modified form]]; ATG7 gene mutant form inhibits the reaction [trichostatin A promotes the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form]]; ATG7 gene mutant form promotes the reaction [Cisplatin results in increased activity of CASP protein]; ATG7 gene mutant form promotes the reaction [Cisplatin results in increased expression of CASP protein modified form]	PMID:29476062
1312481	ATG7	autophagy related 7	gene	CHEBI:28061	alpha-D-galactose	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D005690	Galactose results in decreased expression of ATG7 protein	PMID:28302704
1312481	ATG7	autophagy related 7	gene	CHEBI:28061	alpha-D-galactose	decreases expression	ISO	RGD:1304817	E	RGD:6480464	20181016	CTD	MESH:D005690	Galactose results in decreased expression of ATG7 protein	PMID:28302704
1312481	ATG7	autophagy related 7	gene	CHEBI:28061	alpha-D-galactose	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D005690	MIR34A mRNA promotes the reaction [Galactose results in decreased expression of ATG7 protein]	PMID:28302704
1312481	ATG7	autophagy related 7	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ATG7 mRNA	PMID:23195993
1312481	ATG7	autophagy related 7	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	[Nickel co-treated with austenitic steel analog] results in increased expression of ATG7 mRNA	PMID:23638002
1312481	ATG7	autophagy related 7	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20221004	CTD	MESH:D009532	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]; [nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA; [nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein; Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]; Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]	PMID:35568058
1312481	ATG7	autophagy related 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1558502	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATG7 mRNA	PMID:21570461
1312481	ATG7	autophagy related 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304817	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATG7 mRNA	PMID:32109520
1312481	ATG7	autophagy related 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases methylation	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased methylation of ATG7 gene	PMID:21212295
1312481	ATG7	autophagy related 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304817	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATG7 mRNA	PMID:33387578
1312481	ATG7	autophagy related 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATG7 mRNA; [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of ATG7 gene	PMID:17942748|PMID:21212295
1312481	ATG7	autophagy related 7	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20190702	CTD	MESH:D012402	Rotenone results in decreased expression of ATG7 protein	PMID:30141137
1312481	ATG7	autophagy related 7	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012402	Rotenone results in increased expression of ATG7 protein	PMID:25682864
1312481	ATG7	autophagy related 7	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:D012402	geraniol inhibits the reaction [Rotenone results in decreased expression of ATG7 protein]	PMID:30141137
1312481	ATG7	autophagy related 7	gene	CHEBI:28260	galactose	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D005690	Galactose results in decreased expression of ATG7 protein	PMID:28302704
1312481	ATG7	autophagy related 7	gene	CHEBI:28260	galactose	decreases expression	ISO	RGD:1304817	E	RGD:6480464	20181016	CTD	MESH:D005690	Galactose results in decreased expression of ATG7 protein	PMID:28302704
1312481	ATG7	autophagy related 7	gene	CHEBI:28260	galactose	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D005690	MIR34A mRNA promotes the reaction [Galactose results in decreased expression of ATG7 protein]	PMID:28302704
1312481	ATG7	autophagy related 7	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1304817	E	RGD:6480464	20141111	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ATG7 mRNA	PMID:24296261
1312481	ATG7	autophagy related 7	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1558502	E	RGD:6480464	20141111	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ATG7 mRNA; Sodium Fluoride results in increased expression of ATG7 protein	PMID:24296261
1312481	ATG7	autophagy related 7	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATG7 mRNA	PMID:29803840
1312481	ATG7	autophagy related 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1304817	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATG7 mRNA	PMID:39631538
1312481	ATG7	autophagy related 7	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004317	Doxorubicin results in increased expression of ATG7 protein	PMID:31226464
1312481	ATG7	autophagy related 7	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1558502	E	RGD:6480464	20250603	CTD	MESH:D004317	Doxorubicin results in increased expression of ATG7 mRNA	PMID:38324556
1312481	ATG7	autophagy related 7	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20140408	CTD	MESH:D004317	ATG7 mutant form inhibits the reaction [Doxorubicin results in increased degradation of SQSTM1 protein]; PQQ Cofactor inhibits the reaction [Doxorubicin results in increased expression of ATG7 protein]	PMID:22927544|PMID:31226464
1312481	ATG7	autophagy related 7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20260602	CTD	MESH:D005632	[Thioacetamide co-treated with Dietary Fats co-treated with Fructose] results in decreased expression of ATG7 protein; isoborneol inhibits the reaction [[Thioacetamide co-treated with Dietary Fats co-treated with Fructose] results in decreased expression of ATG7 protein]	PMID:39967315
1312481	ATG7	autophagy related 7	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D003840	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1312481	ATG7	autophagy related 7	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20180410	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA]; Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG7 protein]; Acetylcysteine inhibits the reaction [Apigenin results in increased expression of ATG7 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:29247770|PMID:29307831|PMID:30205151|PMID:31319114
1312481	ATG7	autophagy related 7	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20210907	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:33462182
1312481	ATG7	autophagy related 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ATG7 mRNA; sodium arsenite results in increased expression of ATG7 protein	PMID:30309986|PMID:39536963
1312481	ATG7	autophagy related 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1558502	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ATG7 mRNA	PMID:30097599|PMID:39490100
1312481	ATG7	autophagy related 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATG7 mRNA; HSF1 protein affects the reaction [sodium arsenite results in increased expression of ATG7 protein]; HSF1 protein affects the reaction [Tretinoin inhibits the reaction [sodium arsenite results in increased expression of ATG7 protein]]; sodium arsenite results in increased expression of and results in increased methylation of ATG7 mRNA; Tretinoin inhibits the reaction [sodium arsenite results in increased expression of ATG7 protein]	PMID:30309986|PMID:39490100|PMID:39836092
1312481	ATG7	autophagy related 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20161228	CTD	MESH:C017947	ATG7 mutant form inhibits the reaction [sodium arsenite results in decreased expression of SNCA]	PMID:25639566
1312481	ATG7	autophagy related 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20190409	CTD	MESH:C017947	[sodium arsenite co-treated with Dietary Fats] results in increased expression of ATG7 mRNA; ATG7 gene mutant form inhibits the reaction [sodium arsenite results in increased degradation of KEAP1 protein]; ATG7 gene mutant form inhibits the reaction [sodium arsenite results in increased degradation of SQSTM1 protein]; ATG7 gene mutant form inhibits the reaction [sodium arsenite results in increased expression of and results in increased lipidation of MAP1LC3B protein]	PMID:26483381|PMID:30097599
1312481	ATG7	autophagy related 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATG7 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:26238291
1312481	ATG7	autophagy related 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATG7 mRNA	PMID:19770486
1312481	ATG7	autophagy related 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1558502	E	RGD:6480464	20241203	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATG7 protein	PMID:39454710
1312481	ATG7	autophagy related 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1558502	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATG7 exon; Benzo(a)pyrene results in increased methylation of ATG7 intron	PMID:27901495
1312481	ATG7	autophagy related 7	gene	CHEBI:29866	arsenite(3-)	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite results in increased expression of ATG7 mRNA; arsenite results in increased expression of ATG7 protein	PMID:34929507
1312481	ATG7	autophagy related 7	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATG7 mRNA; Arsenic Trioxide results in increased expression of ATG7 protein	PMID:29307831|PMID:32284743
1312481	ATG7	autophagy related 7	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1558502	E	RGD:6480464	20210810	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATG7 mRNA	PMID:32781346|PMID:33462182
1312481	ATG7	autophagy related 7	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]; ATG7 protein promotes the reaction [Arsenic Trioxide results in increased degradation of BCR protein mutant form]; ATG7 protein promotes the reaction [Arsenic Trioxide results in increased degradation of FLT3 protein mutant form]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:22898604|PMID:29307831|PMID:32284743
1312481	ATG7	autophagy related 7	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20210907	CTD	MESH:C006632	3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:33462182
1312481	ATG7	autophagy related 7	gene	CHEBI:30740	ethylene glycol bis(2-aminoethyl)tetraacetic acid	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:D004533	Egtazic Acid inhibits the reaction [Camptothecin results in increased expression of ATG7 protein]	PMID:30266318
1312481	ATG7	autophagy related 7	gene	CHEBI:31243	atazanavir sulfate	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D000069446	Atazanavir Sulfate results in increased expression of ATG7 mRNA	PMID:32152650
1312481	ATG7	autophagy related 7	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D000069446	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1312481	ATG7	autophagy related 7	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20250311	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in increased expression of ATG7 mRNA	PMID:39276841
1312481	ATG7	autophagy related 7	gene	CHEBI:3218	2-(tert-butylimino)-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C083997	buprofezin results in increased expression of ATG7 mRNA	PMID:36287832
1312481	ATG7	autophagy related 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1558502	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATG7 gene	PMID:35295148
1312481	ATG7	autophagy related 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1558502	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ATG7 gene	PMID:35295148
1312481	ATG7	autophagy related 7	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304817	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ATG7 mRNA	PMID:34492290
1312481	ATG7	autophagy related 7	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20260602	CTD	MESH:D013853	[Thioacetamide co-treated with Dietary Fats co-treated with Fructose] results in decreased expression of ATG7 protein; isoborneol inhibits the reaction [[Thioacetamide co-treated with Dietary Fats co-treated with Fructose] results in decreased expression of ATG7 protein]	PMID:39967315
1312481	ATG7	autophagy related 7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1558502	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of ATG7 mRNA	PMID:21318169
1312481	ATG7	autophagy related 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of ATG7 mRNA]	PMID:21318169
1312481	ATG7	autophagy related 7	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of ATG7 mRNA	PMID:35550146
1312481	ATG7	autophagy related 7	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304817	E	RGD:6480464	20170516	CTD	MESH:C006780	bisphenol A affects the expression of ATG7 mRNA	PMID:27539358
1312481	ATG7	autophagy related 7	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1558502	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of ATG7 mRNA	PMID:37894381
1312481	ATG7	autophagy related 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304817	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ATG7 mRNA	PMID:34947998
1312481	ATG7	autophagy related 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of ATG7 mRNA	PMID:29741722
1312481	ATG7	autophagy related 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of ATG7 mRNA; bisphenol A results in increased expression of ATG7 protein	PMID:37257343
1312481	ATG7	autophagy related 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1558502	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ATG7 mRNA	PMID:26746108|PMID:34281243
1312481	ATG7	autophagy related 7	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304817	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ATG7 gene	PMID:28505145
1312481	ATG7	autophagy related 7	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1558502	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ATG7 promoter	PMID:27312807
1312481	ATG7	autophagy related 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	2-(7-(3,4-dimethoxyphenyl)imidazo(1,2-c)pyrimidin-5-ylamino)nicotinamide inhibits the reaction [bisphenol A results in increased expression of ATG7 protein]; bisphenol A promotes the reaction [NFE2L2 protein binds to ATG7 promoter]; NFE2L2 protein affects the reaction [bisphenol A results in increased expression of ATG7 mRNA]; NFE2L2 protein affects the reaction [bisphenol A results in increased expression of ATG7 protein]	PMID:37257343
1312481	ATG7	autophagy related 7	gene	CHEBI:34107	1-nitropyrene	affects response to substance	ISO	RGD:1558502	E	RGD:6480464	20180116	CTD	MESH:C032668	ATG7 protein affects the susceptibility to 1-nitropyrene	PMID:29078374
1312481	ATG7	autophagy related 7	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C032668	1-nitropyrene results in increased expression of ATG7 mRNA; 1-nitropyrene results in increased expression of ATG7 protein	PMID:29078374
1312481	ATG7	autophagy related 7	gene	CHEBI:34107	1-nitropyrene	increases expression	ISO	RGD:1558502	E	RGD:6480464	20180116	CTD	MESH:C032668	1-nitropyrene results in increased expression of ATG7 mRNA; 1-nitropyrene results in increased expression of ATG7 protein	PMID:29078374
1312481	ATG7	autophagy related 7	gene	CHEBI:34107	1-nitropyrene	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C032668	3-methyladenine inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]; [Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]; CEBPA protein inhibits the reaction [1-nitropyrene results in increased expression of ATG7 protein]; NDUFA1 protein inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]; NDUFA1 protein inhibits the reaction [1-nitropyrene results in increased expression of ATG7 protein]; NDUFA2 protein inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]; NDUFA2 protein inhibits the reaction [1-nitropyrene results in increased expression of ATG7 protein]	PMID:29078374
1312481	ATG7	autophagy related 7	gene	CHEBI:34107	1-nitropyrene	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20180116	CTD	MESH:C032668	ATG7 protein affects the reaction [1-nitropyrene results in increased expression of MAP1LC3B protein]; ATG7 protein affects the reaction [1-nitropyrene results in increased secretion of IL6 protein]	PMID:29078374
1312481	ATG7	autophagy related 7	gene	CHEBI:34211	2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20201006	CTD	MESH:C054919	ATG7 protein affects the reaction [2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene results in increased activity of CASP3 protein]	PMID:32721735
1312481	ATG7	autophagy related 7	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1558502	E	RGD:6480464	20240206	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of ATG7 mRNA	PMID:37080397
1312481	ATG7	autophagy related 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20180703	CTD	MESH:C543008	bisphenol S results in decreased expression of ATG7 mRNA	PMID:29741722
1312481	ATG7	autophagy related 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1558502	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ATG7 mRNA	PMID:39298647
1312481	ATG7	autophagy related 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1558502	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ATG7 exon	PMID:33297965
1312481	ATG7	autophagy related 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATG7 mRNA	PMID:28628672
1312481	ATG7	autophagy related 7	gene	CHEBI:34440	4-nonylphenol	increases expression	ISO	RGD:1304817	E	RGD:6480464	20170516	CTD	MESH:C041594	4-nonylphenol results in increased expression of ATG7 mRNA	PMID:28041982
1312481	ATG7	autophagy related 7	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ATG7 protein	PMID:34186270
1312481	ATG7	autophagy related 7	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ATG7 protein	PMID:34186270
1312481	ATG7	autophagy related 7	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1558502	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ATG7 intron	PMID:28392331
1312481	ATG7	autophagy related 7	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1558502	E	RGD:6480464	20200519	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ATG7 mRNA	PMID:31676321
1312481	ATG7	autophagy related 7	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200519	CTD	MESH:D016264	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]; alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]; Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]]	PMID:31676321
1312481	ATG7	autophagy related 7	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1558502	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ATG7 mRNA	PMID:34813904
1312481	ATG7	autophagy related 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATG7 mRNA	PMID:28628672
1312481	ATG7	autophagy related 7	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1558502	E	RGD:6480464	20230606	CTD	MESH:C022838	nickel chloride results in increased expression of ATG7 mRNA; nickel chloride results in increased expression of ATG7 protein	PMID:36421005
1312481	ATG7	autophagy related 7	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20221004	CTD	MESH:C022838	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]; [nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA; [nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein; Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]; Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]; Melatonin inhibits the reaction [nickel chloride results in increased expression of ATG7 mRNA]; Melatonin inhibits the reaction [nickel chloride results in increased expression of ATG7 protein]; TXNRD3 gene mutant form inhibits the reaction [Melatonin inhibits the reaction [nickel chloride results in increased expression of ATG7 mRNA]]; TXNRD3 gene mutant form promotes the reaction [nickel chloride results in increased expression of ATG7 mRNA]; TXNRD3 gene mutant form promotes the reaction [nickel chloride results in increased expression of ATG7 protein]	PMID:35568058|PMID:36421005
1312481	ATG7	autophagy related 7	gene	CHEBI:34905	paraquat	affects response to substance	ISO	RGD:1558502	E	RGD:6480464	20190219	CTD	MESH:D010269	ATG7 protein affects the susceptibility to Paraquat	PMID:28012437
1312481	ATG7	autophagy related 7	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:D010269	Paraquat results in decreased expression of ATG7 protein	PMID:32517337
1312481	ATG7	autophagy related 7	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D010269	Paraquat results in increased expression of ATG7 mRNA	PMID:27220436
1312481	ATG7	autophagy related 7	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1558502	E	RGD:6480464	20161115	CTD	MESH:D010269	Paraquat results in increased expression of ATG7 protein	PMID:27246695
1312481	ATG7	autophagy related 7	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D010269	3-methyladenine inhibits the reaction [vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG7 protein]]; vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG7 protein]	PMID:32517337
1312481	ATG7	autophagy related 7	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20161115	CTD	MESH:D010269	[ATG7 protein affects the susceptibility to Paraquat] which affects the expression of AKR1C3 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of ATM mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BACH1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BARD1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BLM mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BRCA1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BUB1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of BUB1B mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CCNA2 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CCNB1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CCNB2 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CCNE1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CCNE2 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CDC20 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CDC25C mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CDK1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CDK2 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CDKN1A mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of CHEK1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of FANCA mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of FANCB mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of FANCD2 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of KIF11 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of KIF14 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of KIF23 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of NBN mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of PLK1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of PLK4 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of PRC1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of SMC1A mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of STAT1 mRNA; [ATG7 protein affects the susceptibility to Paraquat] which affects the expression of TRP53 protein; ATG7 protein affects the reaction [Paraquat results in decreased expression of LMNB1 protein]; ATG7 protein affects the reaction [Paraquat results in increased expression of CDKN1A protein]; ATG7 protein affects the reaction [Paraquat results in increased expression of H2AX protein]; ATG7 protein affects the reaction [Paraquat results in increased expression of TRP53 mRNA]; Paraquat affects the reaction [ATG7 protein affects the expression of CDK1 mRNA]; Paraquat affects the reaction [ATG7 protein affects the expression of CDK1 protein]; Paraquat affects the reaction [ATG7 protein affects the expression of LMNB1 mRNA]; TLR4 protein affects the reaction [Paraquat results in increased expression of ATG7 protein]	PMID:27246695|PMID:28012437
1312481	ATG7	autophagy related 7	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of ATG7 gene	PMID:33148267
1312481	ATG7	autophagy related 7	gene	CHEBI:34956	ruthenium red	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20220607	CTD	MESH:D012430	Ruthenium Red inhibits the reaction [Cadmium Compounds results in increased expression of ATG7 protein]	PMID:34308505
1312481	ATG7	autophagy related 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATG7 mRNA	PMID:37042841
1312481	ATG7	autophagy related 7	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATG7 mRNA	PMID:39836092
1312481	ATG7	autophagy related 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304817	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ATG7 mRNA	PMID:33453195
1312481	ATG7	autophagy related 7	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATG7 protein	PMID:33127495
1312481	ATG7	autophagy related 7	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304817	E	RGD:6480464	20211012	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATG7 protein	PMID:33127495
1312481	ATG7	autophagy related 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20200114	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA]; NUPR1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA]	PMID:31319114
1312481	ATG7	autophagy related 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG7 mRNA	PMID:37236586
1312481	ATG7	autophagy related 7	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240305	CTD	MESH:C023036	[perfluorooctanoic acid co-treated with perfluorotetradecanoic acid] results in decreased expression of ATG7 mRNA	PMID:37806615
1312481	ATG7	autophagy related 7	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ATG7 mRNA	PMID:24449571
1312481	ATG7	autophagy related 7	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D005999	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1312481	ATG7	autophagy related 7	gene	CHEBI:36560	zinc oxide	increases expression	ISO	RGD:1304817	E	RGD:6480464	20220510	CTD	MESH:D015034	Zinc Oxide results in increased expression of ATG7 mRNA	PMID:32951350
1312481	ATG7	autophagy related 7	gene	CHEBI:37415	alpha-amanitin	increases expression	ISO	RGD:1304817	E	RGD:6480464	20231205	CTD	MESH:D053959	Alpha-Amanitin results in increased expression of ATG7 protein	PMID:37329965
1312481	ATG7	autophagy related 7	gene	CHEBI:37415	alpha-amanitin	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D053959	3-methyladenine inhibits the reaction [Alpha-Amanitin results in increased expression of ATG7 protein]	PMID:37329965
1312481	ATG7	autophagy related 7	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ATG7 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATG7 mRNA]	PMID:17585979
1312481	ATG7	autophagy related 7	gene	CHEBI:38635	3-methyladenine	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C025946	3-methyladenine results in decreased expression of ATG7 protein	PMID:32517337
1312481	ATG7	autophagy related 7	gene	CHEBI:38635	3-methyladenine	multiple interactions	EXP		E	RGD:6480464	20140408	CTD	MESH:C025946	3-methyladenine inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]; 3-methyladenine inhibits the reaction [Alpha-Amanitin results in increased expression of ATG7 protein]; 3-methyladenine inhibits the reaction [beta-lapachone results in increased expression of ATG7 protein]; 3-methyladenine inhibits the reaction [rottlerin results in increased expression of ATG7 protein]; 3-methyladenine inhibits the reaction [vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG7 protein]]; [Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in increased expression of ATG7 mRNA]	PMID:22902833|PMID:29078374|PMID:32517337|PMID:37329965|PMID:38218311
1312481	ATG7	autophagy related 7	gene	CHEBI:38635	3-methyladenine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20210907	CTD	MESH:C025946	3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:33462182
1312481	ATG7	autophagy related 7	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1558502	E	RGD:6480464	20260303	CTD	MESH:C473478	Sunitinib results in increased expression of ATG7 protein	PMID:40449751
1312481	ATG7	autophagy related 7	gene	CHEBI:38940	sunitinib	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20260303	CTD	MESH:C473478	2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of ATG7 protein]; N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of ATG7 protein]]	PMID:40449751
1312481	ATG7	autophagy related 7	gene	CHEBI:39381	buprofezin	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C083997	buprofezin results in increased expression of ATG7 mRNA	PMID:36287832
1312481	ATG7	autophagy related 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATG7 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ATG7 mRNA	PMID:36331819
1312481	ATG7	autophagy related 7	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304817	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ATG7 mRNA	PMID:41580965
1312481	ATG7	autophagy related 7	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20200714	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of ATG7 protein	PMID:32151603
1312481	ATG7	autophagy related 7	gene	CHEBI:4027	cyclophosphamide	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200714	CTD	MESH:D003520	Fungal Polysaccharides inhibits the reaction [Cyclophosphamide results in decreased expression of ATG7 protein]; Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of ATG7 protein]	PMID:32151603
1312481	ATG7	autophagy related 7	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D016572	Cyclosporine results in increased expression of ATG7 mRNA	PMID:32152650|PMID:34681664
1312481	ATG7	autophagy related 7	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1312481	ATG7	autophagy related 7	gene	CHEBI:4042	cypermethrin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C017160	cypermethrin results in increased expression of ATG7 mRNA	PMID:27704156
1312481	ATG7	autophagy related 7	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ATG7 mRNA	PMID:17555576
1312481	ATG7	autophagy related 7	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATG7 mRNA	PMID:28628672
1312481	ATG7	autophagy related 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ATG7 mRNA	PMID:28973697
1312481	ATG7	autophagy related 7	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1304817	E	RGD:6480464	20220705	CTD	MESH:D005947	Glucose results in decreased expression of ATG7 protein	PMID:35243728|PMID:39127087
1312481	ATG7	autophagy related 7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20220705	CTD	MESH:D005947	Berberine inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; Inositol inhibits the reaction [Glucose results in decreased expression of ATG7 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of ATG7 protein]	PMID:35243728|PMID:39127087
1312481	ATG7	autophagy related 7	gene	CHEBI:45716	vorinostat	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	ATG7 affects the susceptibility to vorinostat	PMID:21148553
1312481	ATG7	autophagy related 7	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ATG7 protein	PMID:20543569
1312481	ATG7	autophagy related 7	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	ATG7 protein promotes the reaction [vorinostat results in increased cleavage of MAP1LC3B protein]	PMID:17881280
1312481	ATG7	autophagy related 7	gene	CHEBI:46024	trichostatin A	decreases response to substance	ISO	RGD:1558502	E	RGD:6480464	20191008	CTD	MESH:C012589	ATG7 gene mutant form results in decreased susceptibility to trichostatin A	PMID:29476062
1312481	ATG7	autophagy related 7	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20191008	CTD	MESH:C012589	ATG7 gene mutant form inhibits the reaction [trichostatin A inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]]; ATG7 gene mutant form inhibits the reaction [trichostatin A inhibits the reaction [Cisplatin results in increased expression of CASP3 protein modified form]]; ATG7 gene mutant form inhibits the reaction [trichostatin A promotes the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form]]; ATG7 gene mutant form inhibits the reaction [trichostatin A results in increased expression of MAP1LC3B protein modified form]	PMID:29476062
1312481	ATG7	autophagy related 7	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ATG7 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATG7 mRNA]	PMID:17585979
1312481	ATG7	autophagy related 7	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1304817	E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of ATG7 mRNA	PMID:21061450
1312481	ATG7	autophagy related 7	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATG7 gene	PMID:25304211
1312481	ATG7	autophagy related 7	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATG7 mRNA; ATG7 protein affects the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HMOX1 protein]	PMID:32525701|PMID:39836092
1312481	ATG7	autophagy related 7	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of ATG7 mRNA	PMID:31675489
1312481	ATG7	autophagy related 7	gene	CHEBI:47898	4'-epidoxorubicin	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:D015251	[baicalein 5,6,7-trimethyl ether co-treated with Epirubicin] results in increased expression of ATG7 mRNA	PMID:38040128
1312481	ATG7	autophagy related 7	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1558502	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ATG7 mRNA	PMID:35436446
1312481	ATG7	autophagy related 7	gene	CHEBI:49	(+)-Tetrandrine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C009438	tetrandrine results in decreased expression of ATG7 protein	PMID:25266202
1312481	ATG7	autophagy related 7	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ATG7 mRNA	PMID:17555576
1312481	ATG7	autophagy related 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ATG7 mRNA	PMID:17942748
1312481	ATG7	autophagy related 7	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATG7 mRNA	PMID:17942748
1312481	ATG7	autophagy related 7	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1304817	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in increased expression of ATG7 mRNA	PMID:36868495
1312481	ATG7	autophagy related 7	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATG7 mRNA	PMID:28628672
1312481	ATG7	autophagy related 7	gene	CHEBI:49668	gefitinib	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C419708	gefitinib results in increased expression of ATG7 protein	PMID:21655094
1312481	ATG7	autophagy related 7	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATG7 mRNA; Arsenic Trioxide results in increased expression of ATG7 protein	PMID:29307831|PMID:32284743
1312481	ATG7	autophagy related 7	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1558502	E	RGD:6480464	20210810	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATG7 mRNA	PMID:32781346|PMID:33462182
1312481	ATG7	autophagy related 7	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]; ATG7 protein promotes the reaction [Arsenic Trioxide results in increased degradation of BCR protein mutant form]; ATG7 protein promotes the reaction [Arsenic Trioxide results in increased degradation of FLT3 protein mutant form]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:22898604|PMID:29307831|PMID:32284743
1312481	ATG7	autophagy related 7	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20210907	CTD	MESH:C032793	3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG7 mRNA]	PMID:33462182
1312481	ATG7	autophagy related 7	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1558502	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of ATG7 mRNA	PMID:21318169
1312481	ATG7	autophagy related 7	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate inhibits the reaction [tyloxapol results in decreased expression of ATG7 protein]; PPARA protein affects the reaction [Fenofibrate results in increased expression of ATG7 mRNA]	PMID:21318169|PMID:36905866
1312481	ATG7	autophagy related 7	gene	CHEBI:50594	carbon nanotube	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ATG7 mRNA; Nanotubes, Carbon results in decreased expression of ATG7 mRNA	PMID:30138652|PMID:30802478
1312481	ATG7	autophagy related 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1304817	E	RGD:6480464	20220510	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ATG7 mRNA	PMID:32951350
1312481	ATG7	autophagy related 7	gene	CHEBI:50833	cadmium sulfide	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C034939	cadmium sulfide results in increased expression of ATG7 mRNA	PMID:27866839
1312481	ATG7	autophagy related 7	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ATG7 mRNA	PMID:35964746
1312481	ATG7	autophagy related 7	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1558502	E	RGD:6480464	20241105	CTD	MESH:D005485	Flutamide results in increased expression of ATG7 mRNA	PMID:32662666
1312481	ATG7	autophagy related 7	gene	CHEBI:5199	Fusaric acid	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D005669	Fusaric Acid results in increased expression of ATG7 mRNA	PMID:30582969
1312481	ATG7	autophagy related 7	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1558502	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ATG7 mRNA	PMID:19042947
1312481	ATG7	autophagy related 7	gene	CHEBI:53509	erlotinib hydrochloride	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069347	Erlotinib Hydrochloride results in increased expression of ATG7 protein	PMID:21655094
1312481	ATG7	autophagy related 7	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ATG7 protein	PMID:32959892
1312481	ATG7	autophagy related 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATG7 mRNA	PMID:39836092
1312481	ATG7	autophagy related 7	gene	CHEBI:63112	fingolimod hydrochloride	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:D000068876	Fingolimod Hydrochloride results in increased expression of ATG7 protein	PMID:25939952
1312481	ATG7	autophagy related 7	gene	CHEBI:64213	cantharidin	increases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D002193	Cantharidin results in increased expression of ATG7 protein	PMID:35398186
1312481	ATG7	autophagy related 7	gene	CHEBI:64213	cantharidin	increases expression	ISO	RGD:1304817	E	RGD:6480464	20221206	CTD	MESH:D002193	Cantharidin results in increased expression of ATG7 protein	PMID:35398186
1312481	ATG7	autophagy related 7	gene	CHEBI:6432	levamisole	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200714	CTD	MESH:D007978	Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of ATG7 protein]	PMID:32151603
1312481	ATG7	autophagy related 7	gene	CHEBI:6437	levetiracetam	decreases expression	ISO	RGD:1304817	E	RGD:6480464	20240109	CTD	MESH:D000077287	Levetiracetam results in decreased expression of ATG7 protein	PMID:37098359
1312481	ATG7	autophagy related 7	gene	CHEBI:6437	levetiracetam	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20240109	CTD	MESH:D000077287	Quercetin inhibits the reaction [Levetiracetam results in decreased expression of ATG7 protein]	PMID:37098359
1312481	ATG7	autophagy related 7	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20221004	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of ATG7 protein]	PMID:35568058
1312481	ATG7	autophagy related 7	gene	CHEBI:65899	flavokawain B	affects response to substance	EXP		E	RGD:6480464	20200331	CTD	MESH:C452039	ATG7 protein affects the susceptibility to flavokawain B	PMID:30025493
1312481	ATG7	autophagy related 7	gene	CHEBI:65899	flavokawain B	multiple interactions	EXP		E	RGD:6480464	20200331	CTD	MESH:C452039	[ATG7 protein affects the susceptibility to flavokawain B] which affects the cleavage of CASP3 protein; [ATG7 protein affects the susceptibility to flavokawain B] which affects the cleavage of PARP1 protein; ATG7 protein affects the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form]	PMID:30025493
1312481	ATG7	autophagy related 7	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D002185	Cannabidiol results in increased expression of ATG7 protein	PMID:38583854
1312481	ATG7	autophagy related 7	gene	CHEBI:6950	mirtazapine	increases expression	ISO	RGD:1304817	E	RGD:6480464	20221206	CTD	MESH:C035133	Mirtazapine results in increased expression of ATG7 mRNA	PMID:35066094
1312481	ATG7	autophagy related 7	gene	CHEBI:6950	mirtazapine	increases expression	ISO	RGD:1558502	E	RGD:6480464	20221206	CTD	MESH:C035133	Mirtazapine results in increased expression of ATG7 mRNA	PMID:35066094
1312481	ATG7	autophagy related 7	gene	CHEBI:6950	mirtazapine	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20221206	CTD	MESH:C035133	Ethanol promotes the reaction [Mirtazapine results in increased expression of ATG7 mRNA]; HMGB1 protein affects the reaction [Ethanol promotes the reaction [Mirtazapine results in increased expression of ATG7 mRNA]]; HMGB1 protein affects the reaction [Mirtazapine results in increased expression of ATG7 mRNA]	PMID:35066094
1312481	ATG7	autophagy related 7	gene	CHEBI:6950	mirtazapine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20221206	CTD	MESH:C035133	Ethanol promotes the reaction [Mirtazapine results in increased expression of ATG7 mRNA]	PMID:35066094
1312481	ATG7	autophagy related 7	gene	CHEBI:70436	platycodin D	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C108953	platycodin D results in increased expression of ATG7 protein	PMID:26078792
1312481	ATG7	autophagy related 7	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of ATG7 gene	PMID:33148267
1312481	ATG7	autophagy related 7	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ATG7 mRNA	PMID:31758290
1312481	ATG7	autophagy related 7	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ATG7 protein	PMID:34186270
1312481	ATG7	autophagy related 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATG7 mRNA	PMID:22206623
1312481	ATG7	autophagy related 7	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:C051752	nefazodone results in increased expression of ATG7 mRNA	PMID:32152650
1312481	ATG7	autophagy related 7	gene	CHEBI:7494	nefazodone	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:C051752	[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATG7 mRNA	PMID:32152650
1312481	ATG7	autophagy related 7	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [ATG7 protein results in decreased expression of SQSTM1 protein]	PMID:27629431
1312481	ATG7	autophagy related 7	gene	CHEBI:7602	nobiletin	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in increased expression of ATG7 protein]	PMID:38348393
1312481	ATG7	autophagy related 7	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C025589	ochratoxin A results in increased expression of ATG7 protein	PMID:38896176
1312481	ATG7	autophagy related 7	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C025589	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine promotes the reaction [ochratoxin A results in increased expression of ATG7 protein]; ferrostatin-1 inhibits the reaction [ochratoxin A results in increased expression of ATG7 protein]; tetrahydro-N, N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride inhibits the reaction [ochratoxin A results in increased expression of ATG7 protein]	PMID:38896176
1312481	ATG7	autophagy related 7	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1304817	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ATG7 mRNA	PMID:21346803
1312481	ATG7	autophagy related 7	gene	CHEBI:78510	dorsomorphin	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C516138	dorsomorphin results in increased expression of ATG7 protein	PMID:31900833
1312481	ATG7	autophagy related 7	gene	CHEBI:78708	Nonidet P-40	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C010615	Nonidet P-40 results in decreased expression of ATG7 mRNA	PMID:26552463
1312481	ATG7	autophagy related 7	gene	CHEBI:7939	parthenolide	multiple interactions	ISO	RGD:1558502	E	RGD:6480464	20240206	CTD	MESH:C002669	parthenolide inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of ATG7 protein]	PMID:37858773
1312481	ATG7	autophagy related 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1558502	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ATG7 mRNA	PMID:23091169
1312481	ATG7	autophagy related 7	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1304817	E	RGD:6480464	20230801	CTD	MESH:D010634	Phenobarbital inhibits the reaction [Dietary Fats results in increased expression of ATG7 mRNA]	PMID:36657701
1312481	ATG7	autophagy related 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ATG7 protein	PMID:31675489
1312481	ATG7	autophagy related 7	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ATG7 protein	PMID:31675489
1312481	ATG7	autophagy related 7	gene	CHEBI:84070	sodium arsenate	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in increased expression of ATG7 protein	PMID:38348393
1312481	ATG7	autophagy related 7	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	ATG7 protein affects the reaction [[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of HMOX1 protein]; nobiletin inhibits the reaction [sodium arsenate results in increased expression of ATG7 protein]	PMID:32525701|PMID:38348393
1312481	ATG7	autophagy related 7	gene	CHEBI:8461	promethazine	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D011398	Promethazine results in decreased expression of ATG7 protein	PMID:31682805
1312481	ATG7	autophagy related 7	gene	CHEBI:8630	pterostilbene	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C107773	ATG7 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]	PMID:34405320
1312481	ATG7	autophagy related 7	gene	CHEBI:8687	pyrvinium	increases expression	EXP		E	RGD:6480464	20260602	CTD	MESH:C024631	pyrvinium results in increased expression of ATG7 mRNA; pyrvinium results in increased expression of ATG7 protein	PMID:40976863
1312481	ATG7	autophagy related 7	gene	CHEBI:8899	rottlerin	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C085746	rottlerin results in increased expression of ATG7 protein	PMID:22902833
1312481	ATG7	autophagy related 7	gene	CHEBI:8899	rottlerin	multiple interactions	EXP		E	RGD:6480464	20140408	CTD	MESH:C085746	3-methyladenine inhibits the reaction [rottlerin results in increased expression of ATG7 protein]	PMID:22902833
1312481	ATG7	autophagy related 7	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D020123	[Sirolimus co-treated with TNF protein] results in increased expression of ATG7 mRNA	PMID:31676321
1312481	ATG7	autophagy related 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304817	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ATG7 mRNA	PMID:21346803
1312481	ATG7	autophagy related 7	gene	CHEBI:92519	1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C093337	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine results in increased expression of ATG7 protein	PMID:38896176
1312481	ATG7	autophagy related 7	gene	CHEBI:92519	1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C093337	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine promotes the reaction [ochratoxin A results in increased expression of ATG7 protein]	PMID:38896176
1312481	ATG7	autophagy related 7	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1558502	E	RGD:6480464	20170613	CTD	MESH:C001899	triptolide results in increased expression of ATG7 protein	PMID:26990902
1312481	ATG7	autophagy related 7	gene	CHEBI:9936	Vasicinone	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C052548	3-methyladenine inhibits the reaction [vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG7 protein]]; vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG7 protein]	PMID:32517337
1312481	ATG7	autophagy related 7	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304817	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ATG7 mRNA	PMID:23034163
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of HECA mRNA	PMID:38218311
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:132098	methoxyacetic acid	increases expression	ISO	RGD:1304818	E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in increased expression of HECA mRNA	PMID:20864626
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of HECA mRNA	PMID:23724009
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1615528	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of HECA mRNA	PMID:30319688
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of HECA mRNA	PMID:31614463
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HECA mRNA	PMID:37042841
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of HECA mRNA	PMID:23649840
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1615528	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of HECA mRNA	PMID:28973375
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of HECA mRNA	PMID:33359661
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304818	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of HECA mRNA	PMID:26577399
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304818	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of HECA mRNA	PMID:22061828
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of HECA mRNA	PMID:28818685
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1615528	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HECA mRNA	PMID:36331819
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1615528	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HECA mRNA	PMID:37236586
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of HECA mRNA	PMID:19549813
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of HECA mRNA	PMID:23649840
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HECA mRNA	PMID:21641981
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of HECA mRNA	PMID:23649840
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of HECA mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of HECA mRNA	PMID:35430440|PMID:41430723
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1615528	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of HECA mRNA	PMID:27339419
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:27732	caffeine	increases expression	ISO	RGD:1304818	E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in increased expression of HECA mRNA	PMID:20864626
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304818	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of HECA mRNA	PMID:31881176
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304818	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HECA mRNA	PMID:34747641
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615528	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HECA mRNA	PMID:21570461
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1304818	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in increased expression of HECA mRNA	PMID:20864626
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HECA mRNA	PMID:33212167
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of HECA mRNA	PMID:20044591
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HECA mRNA	PMID:38568856
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1615528	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HECA mRNA	PMID:20883709
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HECA promoter	PMID:27901495
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1304818	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HECA mRNA	PMID:21839799
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of HECA mRNA	PMID:27131904
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of HECA mRNA	PMID:25895662
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HECA mRNA	PMID:20458559
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1304818	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of HECA mRNA	PMID:24136188
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of HECA mRNA	PMID:20813756
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HECA mRNA	PMID:19710929
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of HECA mRNA	PMID:38479592
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304818	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of HECA mRNA	PMID:25181051
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1615528	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of HECA mRNA	PMID:40036665
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of HECA mRNA	PMID:39298647
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1615528	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of HECA mRNA	PMID:38685157
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304818	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of HECA mRNA	PMID:21266533
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1615528	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of HECA mRNA	PMID:21266533
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HECA mRNA	PMID:37042841
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HECA mRNA	PMID:38568856
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1615528	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of HECA mRNA	PMID:20883709
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1304818	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of HECA promoter	PMID:22457795
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1615528	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HECA mRNA	PMID:37236586
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of HECA mRNA	PMID:31533062
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of HECA mRNA	PMID:27153767
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1615528	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HECA mRNA	PMID:36331819
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HECA mRNA	PMID:25979313
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of HECA mRNA	PMID:19101580|PMID:23179753|PMID:24935251|PMID:27188386|PMID:29154799
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of HECA mRNA	PMID:20106945
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of HECA mRNA	PMID:24935251
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of HECA mRNA	PMID:29067470
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of HECA mRNA	PMID:22079256
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of HECA mRNA	PMID:18175754
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HECA mRNA	PMID:20458559
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of HECA mRNA; Nanotubes, Carbon results in decreased expression of HECA mRNA	PMID:25554681
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1615528	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of HECA mRNA	PMID:20003209
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HECA mRNA	PMID:22206623
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of HECA mRNA	PMID:22079256
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of HECA mRNA	PMID:22079256
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of HECA mRNA	PMID:19159669
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1615528	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of HECA mRNA	PMID:23091169
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of HECA mRNA	PMID:21278054
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304818	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of HECA mRNA	PMID:24780913
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1304818	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in increased expression of HECA mRNA	PMID:20864626
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of HECA mRNA	PMID:27131904
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of HECA mRNA	PMID:38568856
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of HECA mRNA	PMID:29301935
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1615528	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of HECA mRNA	PMID:28973697
1312483	HECA	HECA ribonucleoprotein granule regulator	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304818	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of HECA mRNA	PMID:19015723
1312484	CDC23	cell division cycle 23	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312485	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CDC23 mRNA	PMID:33045310
1312484	CDC23	cell division cycle 23	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CDC23 mRNA	PMID:33167477
1312484	CDC23	cell division cycle 23	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312485	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of CDC23 protein	PMID:31494107
1312484	CDC23	cell division cycle 23	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1304819	E	RGD:6480464	20120522	CTD	MESH:D004958	Estradiol results in increased expression of CDC23 mRNA	PMID:20068009
1312484	CDC23	cell division cycle 23	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304819	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CDC23 mRNA	PMID:33387578
1312484	CDC23	cell division cycle 23	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CDC23 mRNA	PMID:37042841
1312484	CDC23	cell division cycle 23	gene	CHEBI:17315	D-glucosamine	decreases expression	ISO	RGD:1304819	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of CDC23 mRNA	PMID:17109745
1312484	CDC23	cell division cycle 23	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312485	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CDC23 mRNA	PMID:34319233
1312484	CDC23	cell division cycle 23	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CDC23 protein	PMID:37730182
1312484	CDC23	cell division cycle 23	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	ISO	RGD:1304819	E	RGD:6480464	20120522	CTD	MESH:D005944	Glucosamine results in decreased expression of CDC23 mRNA	PMID:17109745
1312484	CDC23	cell division cycle 23	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDC23 mRNA	PMID:35301059
1312484	CDC23	cell division cycle 23	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CDC23 mRNA	PMID:19549813
1312484	CDC23	cell division cycle 23	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304819	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of CDC23 mRNA	PMID:30779732
1312484	CDC23	cell division cycle 23	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CDC23 mRNA	PMID:19244175
1312484	CDC23	cell division cycle 23	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CDC23 mRNA	PMID:23557933
1312484	CDC23	cell division cycle 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312485	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC23 mRNA	PMID:21570461
1312484	CDC23	cell division cycle 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304819	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC23 mRNA	PMID:33387578
1312484	CDC23	cell division cycle 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312485	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC23 mRNA	PMID:19770486
1312484	CDC23	cell division cycle 23	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	ISO	RGD:1304819	E	RGD:6480464	20120522	CTD	MESH:D005944	Glucosamine results in decreased expression of CDC23 mRNA	PMID:17109745
1312484	CDC23	cell division cycle 23	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDC23 mRNA	PMID:29803840
1312484	CDC23	cell division cycle 23	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CDC23 promoter	PMID:27901495
1312484	CDC23	cell division cycle 23	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CDC23 mRNA	PMID:20862710
1312484	CDC23	cell division cycle 23	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312485	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDC23 gene	PMID:35295148
1312484	CDC23	cell division cycle 23	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304819	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CDC23 mRNA	PMID:25181051
1312484	CDC23	cell division cycle 23	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304819	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC23 mRNA	PMID:36041667
1312484	CDC23	cell division cycle 23	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1304819	E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of CDC23 mRNA	PMID:27914987
1312484	CDC23	cell division cycle 23	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304819	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC23 mRNA	PMID:36041667
1312484	CDC23	cell division cycle 23	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304819	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC23 mRNA	PMID:36041667
1312484	CDC23	cell division cycle 23	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312485	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CDC23 mRNA	PMID:20350560
1312484	CDC23	cell division cycle 23	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1304819	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of CDC23 mRNA	PMID:22546817
1312484	CDC23	cell division cycle 23	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312485	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CDC23 mRNA	PMID:21266533
1312484	CDC23	cell division cycle 23	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1304819	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CDC23 mRNA	PMID:22546817
1312484	CDC23	cell division cycle 23	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of CDC23 mRNA	PMID:17312168
1312484	CDC23	cell division cycle 23	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDC23 mRNA	PMID:37042841
1312484	CDC23	cell division cycle 23	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDC23 mRNA	PMID:35301059
1312484	CDC23	cell division cycle 23	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CDC23 mRNA	PMID:19244175
1312484	CDC23	cell division cycle 23	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CDC23 mRNA	PMID:28302478
1312484	CDC23	cell division cycle 23	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CDC23 mRNA	PMID:31533062
1312484	CDC23	cell division cycle 23	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CDC23 mRNA	PMID:23179753|PMID:25979313
1312484	CDC23	cell division cycle 23	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CDC23 mRNA	PMID:25562108
1312484	CDC23	cell division cycle 23	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CDC23 mRNA	PMID:27188386
1312484	CDC23	cell division cycle 23	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312485	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CDC23 mRNA	PMID:17562736
1312484	CDC23	cell division cycle 23	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDC23 mRNA	PMID:21420995
1312484	CDC23	cell division cycle 23	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304819	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDC23 mRNA	PMID:33387578
1312484	CDC23	cell division cycle 23	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000082	Acetaminophen results in increased expression of CDC23 mRNA	PMID:38614205
1312484	CDC23	cell division cycle 23	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	ISO	RGD:1304819	E	RGD:6480464	20120522	CTD	MESH:D005944	Glucosamine results in decreased expression of CDC23 mRNA	PMID:17109745
1312484	CDC23	cell division cycle 23	gene	CHEBI:48707	(-)-citrinin	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D002953	Citrinin results in decreased expression of CDC23 mRNA	PMID:30428381
1312484	CDC23	cell division cycle 23	gene	CHEBI:48707	(-)-citrinin	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D002953	[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC23 mRNA	PMID:30428381
1312484	CDC23	cell division cycle 23	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CDC23 mRNA	PMID:20862710
1312484	CDC23	cell division cycle 23	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of CDC23 mRNA	PMID:20977926
1312484	CDC23	cell division cycle 23	gene	CHEBI:6382	Lasiocarpine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in increased expression of CDC23 mRNA	PMID:33884520
1312484	CDC23	cell division cycle 23	gene	CHEBI:63924	riddelliine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of CDC23 mRNA	PMID:33884520
1312484	CDC23	cell division cycle 23	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312485	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CDC23 mRNA	PMID:23650126
1312484	CDC23	cell division cycle 23	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of CDC23 mRNA	PMID:28988120
1312484	CDC23	cell division cycle 23	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312485	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CDC23 mRNA	PMID:22206623
1312484	CDC23	cell division cycle 23	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of CDC23 protein	PMID:31285264
1312484	CDC23	cell division cycle 23	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025589	ochratoxin A results in decreased expression of CDC23 mRNA	PMID:30428381
1312484	CDC23	cell division cycle 23	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C025589	[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC23 mRNA	PMID:30428381
1312484	CDC23	cell division cycle 23	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CDC23 gene]	PMID:28238834
1312484	CDC23	cell division cycle 23	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1304819	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CDC23 mRNA	PMID:23914054
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1622983	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ALG12 mRNA	PMID:33045310
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304826	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ALG12 mRNA]	PMID:31150632
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:137392	chlormequat chloride	decreases expression	ISO	RGD:1304826	E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in decreased expression of ALG12 protein	PMID:34958886
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1622983	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ALG12 mRNA	PMID:39241906
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1622983	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ALG12 mRNA	PMID:39298647
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in decreased expression of ALG12 mRNA	PMID:17178593
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:17315	D-glucosamine	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of ALG12 mRNA	PMID:17178593
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in decreased expression of ALG12 mRNA	PMID:17178593
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304826	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ALG12 mRNA	PMID:22061828|PMID:33387578
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of ALG12 mRNA	PMID:17178593
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ALG12 mRNA	PMID:35301059
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:24897	isoindoles	affects response to substance	EXP		E	RGD:6480464	20170303	CTD	MESH:D054833	ALG12 gene SNP affects the susceptibility to Isoindoles analog	PMID:25622337
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of ALG12 mRNA	PMID:19774075
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304826	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ALG12 mRNA	PMID:31150632
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304826	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ALG12 mRNA]	PMID:31150632
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622983	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ALG12 mRNA	PMID:21570461
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ALG12 mRNA	PMID:19465110
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304826	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALG12 mRNA	PMID:33387578
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1622983	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALG12 mRNA	PMID:28213091
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1622983	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ALG12 gene]	PMID:28213091
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of ALG12 mRNA	PMID:17178593
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304826	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ALG12 mRNA	PMID:28959563
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ALG12 mRNA	PMID:29803840
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ALG12 mRNA	PMID:34032870
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1622983	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ALG12 mRNA	PMID:22228805
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ALG12 5' UTR	PMID:27901495
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1622983	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ALG12 mRNA	PMID:23221170
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ALG12 gene	PMID:31601247
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304826	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of ALG12 mRNA	PMID:24136188
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622983	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ALG12 gene; titanium dioxide results in decreased methylation of ALG12 promoter alternative form	PMID:35295148
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304826	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ALG12 mRNA	PMID:23411599|PMID:34492290
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304826	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ALG12 mRNA	PMID:25181051
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304826	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ALG12 mRNA	PMID:30816183|PMID:32145629|PMID:32528016
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ALG12 mRNA	PMID:29275510
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1622983	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ALG12 mRNA	PMID:39298647
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ALG12 mRNA	PMID:38685157
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ALG12 gene	PMID:31601247
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304826	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ALG12 mRNA	PMID:32680482
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ALG12 mRNA	PMID:37042841
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ALG12 mRNA	PMID:35301059
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:1304826	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of ALG12 mRNA	PMID:27638505
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1622983	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ALG12 mRNA	PMID:40194260
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ALG12 mRNA	PMID:31533062
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1622983	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ALG12 mRNA	PMID:17292431
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ALG12 mRNA	PMID:29154799
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ALG12 gene	PMID:29154799
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in decreased expression of ALG12 mRNA	PMID:17178593
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1304826	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of ALG12 mRNA	PMID:24136188
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622983	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ALG12 mRNA	PMID:17562736
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of ALG12 mRNA	PMID:17178593
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1622983	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ALG12 mRNA	PMID:35436446
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1622983	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ALG12 mRNA	PMID:25620056
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304826	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ALG12 mRNA	PMID:24136188
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1622983	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ALG12 mRNA	PMID:22206623
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1304826	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ALG12 mRNA	PMID:24136188
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1304826	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ALG12 mRNA	PMID:21346803
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:78160	bleomycin A5	decreases expression	EXP		E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in decreased expression of ALG12 mRNA	PMID:21040473
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1622983	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ALG12 mRNA	PMID:30294300
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1622983	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of ALG12 mRNA	PMID:21278054
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304826	E	RGD:6480464	20120522	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ALG12 mRNA	PMID:21346803
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ALG12 mRNA	PMID:38568856
1312492	ALG12	ALG12 alpha-1,6-mannosyltransferase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304826	E	RGD:6480464	20120522	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ALG12 mRNA	PMID:21346803
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ADGRA2 mRNA	PMID:26272509
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRA2 mRNA	PMID:27188386
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ADGRA2 mRNA	PMID:23724009|PMID:33167477
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1619926	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of ADGRA2 mRNA	PMID:30951980
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C018475	butyraldehyde results in increased expression of ADGRA2 mRNA	PMID:26079696
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:2323365	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of ADGRA2 mRNA	PMID:36841081
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of ADGRA2 mRNA	PMID:22574217
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1619926	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of ADGRA2 mRNA	PMID:19484750
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ADGRA2 mRNA	PMID:30165855
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C005556	propionaldehyde results in increased expression of ADGRA2 mRNA	PMID:26079696
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1619926	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRA2 mRNA	PMID:37992649
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1619926	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRA2 mRNA	PMID:37992649
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1619926	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of ADGRA2 mRNA	PMID:37748715
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of ADGRA2 intron	PMID:30157460
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:181932	3-Nitrobenzanthrone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C117220	3-nitrobenzanthrone results in increased expression of ADGRA2 mRNA	PMID:34036453
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADGRA2 mRNA	PMID:39836092
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1619926	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRA2 mRNA	PMID:29950665
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ADGRA2 mRNA	PMID:23649840
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of ADGRA2 intron	PMID:30157460
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ADGRA2 mRNA	PMID:23649840
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:25710	organophosphorus compound	multiple interactions	ISO	RGD:2323365	E	RGD:6480464	20250401	CTD	MESH:D009943	[Dust results in increased abundance of Organophosphorus Compounds] which results in increased expression of ADGRA2 mRNA	PMID:39658253
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADGRA2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ADGRA2 mRNA	PMID:39836092
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ADGRA2 mRNA	PMID:25583101
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1619926	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADGRA2 mRNA	PMID:21570461
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:2323365	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADGRA2 mRNA	PMID:33387578
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ADGRA2 mRNA	PMID:33212167
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADGRA2 mRNA	PMID:29803840
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1619926	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRA2 mRNA	PMID:37992649
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADGRA2 mRNA	PMID:28595984|PMID:34032870|PMID:37939567
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADGRA2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ADGRA2 mRNA	PMID:39836092
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADGRA2 intron	PMID:30157460
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADGRA2 mRNA	PMID:32234424
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADGRA2 exon	PMID:27901495
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:2323365	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of ADGRA2 mRNA	PMID:25729387
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:2323365	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of ADGRA2 mRNA	PMID:25729387
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1619926	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADGRA2 gene; titanium dioxide results in decreased methylation of ADGRA2 promoter	PMID:35295148
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1619926	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ADGRA2 gene	PMID:35295148
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1619926	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRA2 mRNA	PMID:29950665
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:2323365	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ADGRA2 mRNA	PMID:34492290
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2323365	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRA2 mRNA	PMID:30816183|PMID:38750585
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased expression of ADGRA2 mRNA	PMID:32028606
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1619926	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ADGRA2 mRNA	PMID:30951980
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:C006780	bisphenol A results in decreased expression of and results in decreased methylation of ADGRA2 mRNA	PMID:38354435
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1619926	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ADGRA2 gene	PMID:31683443
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1619926	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ADGRA2 mRNA	PMID:40203079
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1619926	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ADGRA2 exon	PMID:33297965
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1619926	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ADGRA2 mRNA	PMID:30951980
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ADGRA2 intron	PMID:30157460
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1619926	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ADGRA2 mRNA	PMID:30951980
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1619926	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of ADGRA2 mRNA	PMID:30951980
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1619926	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRA2 mRNA	PMID:29950665
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADGRA2 mRNA	PMID:39836092
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ADGRA2 mRNA	PMID:24449571
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ADGRA2 mRNA	PMID:25979313
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:2323365	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of ADGRA2 mRNA	PMID:29427782
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D014635	Valproic Acid results in increased expression of ADGRA2 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1619926	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of ADGRA2 mRNA	PMID:24896083
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ADGRA2 gene	PMID:29154799
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRA2 mRNA	PMID:27188386
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1619926	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ADGRA2 mRNA	PMID:28973697
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1619926	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRA2 mRNA	PMID:37992649
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ADGRA2 mRNA	PMID:38832940
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1619926	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ADGRA2 mRNA	PMID:17562736
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADGRA2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ADGRA2 mRNA	PMID:39836092
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of ADGRA2 mRNA	PMID:31838189
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1619926	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ADGRA2 mRNA; Nanotubes, Carbon results in increased expression of ADGRA2 mRNA	PMID:25554681
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of ADGRA2 mRNA	PMID:20436886
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADGRA2 mRNA	PMID:39836092
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:2323365	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of ADGRA2 mRNA	PMID:25729387
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:2323365	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of ADGRA2 mRNA	PMID:25729387
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:6456	lidocaine	decreases expression	ISO	RGD:2323365	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in decreased expression of ADGRA2 mRNA	PMID:35283115
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ADGRA2 intron	PMID:30157460
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1619926	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADGRA2 mRNA	PMID:27935865
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRA2 mRNA	PMID:27188386
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C046012	pentanal results in increased expression of ADGRA2 mRNA	PMID:26079696
1312494	ADGRA2	adhesion G protein-coupled receptor A2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADGRA2 mRNA	PMID:27188386
1312495	MED13	mediator complex subunit 13	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312496	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of MED13 mRNA	PMID:16324150
1312495	MED13	mediator complex subunit 13	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312496	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MED13 mRNA	PMID:36331819
1312495	MED13	mediator complex subunit 13	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MED13 mRNA	PMID:26079696
1312495	MED13	mediator complex subunit 13	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of MED13 mRNA	PMID:40945087
1312495	MED13	mediator complex subunit 13	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of MED13 protein	PMID:35688186
1312495	MED13	mediator complex subunit 13	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304829	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of MED13 mRNA	PMID:32145629
1312495	MED13	mediator complex subunit 13	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MED13 mRNA	PMID:37042841
1312495	MED13	mediator complex subunit 13	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312496	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MED13 mRNA	PMID:23892564
1312495	MED13	mediator complex subunit 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MED13 mRNA	PMID:33754040
1312495	MED13	mediator complex subunit 13	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MED13 protein	PMID:37730182
1312495	MED13	mediator complex subunit 13	gene	CHEBI:17823	calcitriol	increases expression	ISO	RGD:1312496	E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of MED13 mRNA	PMID:16324150
1312495	MED13	mediator complex subunit 13	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304829	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MED13 mRNA	PMID:33387578
1312495	MED13	mediator complex subunit 13	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312496	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MED13 mRNA	PMID:19770486
1312495	MED13	mediator complex subunit 13	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of MED13 mRNA	PMID:41430723
1312495	MED13	mediator complex subunit 13	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1304829	E	RGD:6480464	20120613	CTD	MESH:C011559	tributyltin results in increased expression of MED13 mRNA	PMID:21683754
1312495	MED13	mediator complex subunit 13	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312496	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MED13 mRNA	PMID:31919559
1312495	MED13	mediator complex subunit 13	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MED13 protein	PMID:35688186
1312495	MED13	mediator complex subunit 13	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1304829	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of MED13 mRNA	PMID:25905778
1312495	MED13	mediator complex subunit 13	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of MED13 mRNA	PMID:19921347
1312495	MED13	mediator complex subunit 13	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MED13 mRNA	PMID:30912803
1312495	MED13	mediator complex subunit 13	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of MED13 mRNA	PMID:32186404
1312495	MED13	mediator complex subunit 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312496	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MED13 mRNA	PMID:21570461
1312495	MED13	mediator complex subunit 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304829	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MED13 mRNA	PMID:33387578
1312495	MED13	mediator complex subunit 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304829	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MED13 mRNA	PMID:32109520
1312495	MED13	mediator complex subunit 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312496	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MED13 mRNA	PMID:17942748
1312495	MED13	mediator complex subunit 13	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1304829	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of MED13 mRNA	PMID:19013527
1312495	MED13	mediator complex subunit 13	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MED13 mRNA	PMID:28001369
1312495	MED13	mediator complex subunit 13	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MED13 mRNA	PMID:33212167
1312495	MED13	mediator complex subunit 13	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of MED13 mRNA	PMID:32763439
1312495	MED13	mediator complex subunit 13	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MED13 mRNA	PMID:29803840
1312495	MED13	mediator complex subunit 13	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of MED13 protein	PMID:35688186
1312495	MED13	mediator complex subunit 13	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MED13 mRNA	PMID:38568856
1312495	MED13	mediator complex subunit 13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MED13 intron	PMID:30157460
1312495	MED13	mediator complex subunit 13	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MED13 mRNA]	PMID:32406909
1312495	MED13	mediator complex subunit 13	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MED13 mRNA	PMID:27131904
1312495	MED13	mediator complex subunit 13	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MED13 mRNA	PMID:19150397
1312495	MED13	mediator complex subunit 13	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312496	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MED13 mRNA	PMID:35676786
1312495	MED13	mediator complex subunit 13	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304829	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of MED13 mRNA	PMID:30047161
1312495	MED13	mediator complex subunit 13	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of MED13 mRNA	PMID:35295148
1312495	MED13	mediator complex subunit 13	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312496	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MED13 gene; titanium dioxide results in decreased methylation of MED13 promoter	PMID:35295148
1312495	MED13	mediator complex subunit 13	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304829	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MED13 mRNA	PMID:23411599|PMID:34492290
1312495	MED13	mediator complex subunit 13	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of MED13 mRNA	PMID:23811191
1312495	MED13	mediator complex subunit 13	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1304829	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of MED13 mRNA	PMID:19167457
1312495	MED13	mediator complex subunit 13	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304829	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of MED13 mRNA	PMID:32145629
1312495	MED13	mediator complex subunit 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of MED13 mRNA	PMID:26063408
1312495	MED13	mediator complex subunit 13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304829	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MED13 mRNA	PMID:30816183|PMID:33296240
1312495	MED13	mediator complex subunit 13	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of MED13 mRNA	PMID:24752500
1312495	MED13	mediator complex subunit 13	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C005290	oxybenzone results in increased expression of MED13 mRNA	PMID:36581016
1312495	MED13	mediator complex subunit 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312496	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of MED13 mRNA	PMID:39298647
1312495	MED13	mediator complex subunit 13	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MED13 intron	PMID:30157460
1312495	MED13	mediator complex subunit 13	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312496	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of MED13 mRNA	PMID:38685157
1312495	MED13	mediator complex subunit 13	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of MED13 mRNA	PMID:28392331
1312495	MED13	mediator complex subunit 13	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of MED13 mRNA	PMID:17312168
1312495	MED13	mediator complex subunit 13	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MED13 mRNA	PMID:37042841
1312495	MED13	mediator complex subunit 13	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MED13 mRNA	PMID:38174414
1312495	MED13	mediator complex subunit 13	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of MED13 mRNA	PMID:19320972|PMID:19376846
1312495	MED13	mediator complex subunit 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312496	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MED13 mRNA	PMID:36331819
1312495	MED13	mediator complex subunit 13	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MED13 mRNA	PMID:25979313
1312495	MED13	mediator complex subunit 13	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304829	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of MED13 mRNA	PMID:29427782
1312495	MED13	mediator complex subunit 13	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of MED13 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1312495	MED13	mediator complex subunit 13	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MED13 gene	PMID:29154799
1312495	MED13	mediator complex subunit 13	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304829	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of MED13 mRNA	PMID:30047161
1312495	MED13	mediator complex subunit 13	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MED13 mRNA	PMID:25562108
1312495	MED13	mediator complex subunit 13	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MED13 mRNA	PMID:27188386
1312495	MED13	mediator complex subunit 13	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of MED13 mRNA	PMID:24935251
1312495	MED13	mediator complex subunit 13	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of MED13 mRNA	PMID:22077320
1312495	MED13	mediator complex subunit 13	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of MED13 mRNA	PMID:24752500
1312495	MED13	mediator complex subunit 13	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304829	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MED13 mRNA	PMID:29097150
1312495	MED13	mediator complex subunit 13	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312496	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MED13 mRNA	PMID:17942748
1312495	MED13	mediator complex subunit 13	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312496	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MED13 mRNA	PMID:17942748
1312495	MED13	mediator complex subunit 13	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312496	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MED13 mRNA	PMID:35676786
1312495	MED13	mediator complex subunit 13	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of MED13 mRNA	PMID:26705709
1312495	MED13	mediator complex subunit 13	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312496	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MED13 mRNA	PMID:21641980
1312495	MED13	mediator complex subunit 13	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MED13 intron	PMID:30157460
1312495	MED13	mediator complex subunit 13	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of MED13 mRNA	PMID:27462272
1312495	MED13	mediator complex subunit 13	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MED13 mRNA	PMID:22206623
1312495	MED13	mediator complex subunit 13	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of MED13 mRNA	PMID:18927307
1312495	MED13	mediator complex subunit 13	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of MED13 mRNA	PMID:19095052
1312495	MED13	mediator complex subunit 13	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312496	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of MED13 mRNA	PMID:21795629
1312495	MED13	mediator complex subunit 13	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304829	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MED13 mRNA	PMID:30047161
1312495	MED13	mediator complex subunit 13	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1312496	E	RGD:6480464	20230905	CTD	MESH:D011441	Propylthiouracil results in increased expression of MED13 protein	PMID:30769017
1312495	MED13	mediator complex subunit 13	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of MED13 mRNA	PMID:24921660
1312495	MED13	mediator complex subunit 13	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MED13 mRNA	PMID:27131904
1312495	MED13	mediator complex subunit 13	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304829	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of MED13 mRNA	PMID:19281266
1312495	MED13	mediator complex subunit 13	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MED13 mRNA	PMID:38568856
1312495	MED13	mediator complex subunit 13	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MED13 mRNA	PMID:27188386
1312495	MED13	mediator complex subunit 13	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312496	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of MED13 mRNA	PMID:28973697
1312495	MED13	mediator complex subunit 13	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304829	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MED13 mRNA	PMID:23555832
1312497	OTOP2	otopetrin 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of OTOP2 mRNA	PMID:38218311
1312497	OTOP2	otopetrin 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623762	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of OTOP2 mRNA	PMID:33045310
1312497	OTOP2	otopetrin 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of OTOP2 mRNA	PMID:31614463
1312497	OTOP2	otopetrin 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304830	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of OTOP2 mRNA	PMID:33387578
1312497	OTOP2	otopetrin 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1623762	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of OTOP2 mRNA	PMID:31919559
1312497	OTOP2	otopetrin 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of OTOP2 mRNA	PMID:23557933
1312497	OTOP2	otopetrin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623762	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of OTOP2 mRNA	PMID:21570461
1312497	OTOP2	otopetrin 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304830	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OTOP2 mRNA	PMID:26033743
1312497	OTOP2	otopetrin 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of OTOP2 mRNA	PMID:38568856
1312497	OTOP2	otopetrin 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of OTOP2 exon	PMID:30157460
1312497	OTOP2	otopetrin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of OTOP2 5' UTR; Benzo(a)pyrene results in increased methylation of OTOP2 promoter	PMID:27901495
1312497	OTOP2	otopetrin 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304830	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OTOP2 mRNA	PMID:26033743
1312497	OTOP2	otopetrin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304830	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of OTOP2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312497	OTOP2	otopetrin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1623762	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of OTOP2 gene	PMID:31683443
1312497	OTOP2	otopetrin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1623762	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of OTOP2 exon	PMID:33297965
1312497	OTOP2	otopetrin 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of OTOP2 intron	PMID:30157460
1312497	OTOP2	otopetrin 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of OTOP2 gene	PMID:22964155
1312497	OTOP2	otopetrin 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623762	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of OTOP2 mRNA	PMID:17562736
1312497	OTOP2	otopetrin 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of OTOP2 mRNA	PMID:22230336
1312497	OTOP2	otopetrin 2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of OTOP2 intron	PMID:30157460
1312497	OTOP2	otopetrin 2	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1623762	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of OTOP2 mRNA	PMID:27935865
1312497	OTOP2	otopetrin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304830	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of OTOP2 mRNA	PMID:24780913
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312499	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of IL4I1 mRNA	PMID:37995155
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IL4I1 gene	PMID:20938992
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of IL4I1 mRNA	PMID:26079696
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IL4I1 mRNA	PMID:35811015
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IL4I1 mRNA	PMID:35811015
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:C031721	naphthalene results in increased expression of IL4I1 mRNA	PMID:18978301
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IL4I1 gene	PMID:20938992
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of IL4I1 mRNA	PMID:26079696
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of IL4I1 mRNA	PMID:36314267
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of IL4I1 mRNA	PMID:19549813
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of IL4I1 mRNA	PMID:35430440
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304831	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of IL4I1 mRNA	PMID:30779732
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IL4I1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of IL4I1 gene	PMID:20938992|PMID:22206623
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1304831	E	RGD:6480464	20140722	CTD	MESH:D003042	Cocaine results in decreased expression of IL4I1 mRNA	PMID:17898221
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IL4I1 mRNA	PMID:25583101
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IL4I1 mRNA	PMID:21570461
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304831	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IL4I1 mRNA	PMID:33387578
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IL4I1 mRNA	PMID:17942748
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D012402	Rotenone results in increased expression of IL4I1 mRNA	PMID:23186747
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312499	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of IL4I1 protein	PMID:28918527
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the expression of IL4I1 mRNA	PMID:20816728
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IL4I1 promoter	PMID:27901495
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IL4I1 mRNA	PMID:22316170
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of IL4I1 mRNA	PMID:19073995
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IL4I1 mRNA	PMID:26345256|PMID:38811393
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:30746	benzoic acid	decreases activity	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D019817	Benzoic Acid results in decreased activity of IL4I1 protein	PMID:15383589
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:30753	4-aminobenzoic acid	decreases activity	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D010129	4-Aminobenzoic Acid results in decreased activity of IL4I1 protein	PMID:15383589
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:31642	gadodiamide hydrate	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C064925	gadodiamide results in increased expression of IL4I1 mRNA	PMID:20959327
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:C009495	titanium dioxide results in decreased expression of IL4I1 mRNA	PMID:23131501
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312499	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IL4I1 gene	PMID:35295148
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:C009495	titanium dioxide results in increased expression of IL4I1 mRNA	PMID:19464567|PMID:21259345|PMID:23557971
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312499	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IL4I1 gene	PMID:35295148
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of IL4I1 mRNA	PMID:30951980
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of IL4I1 mRNA	PMID:27685785
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312499	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of IL4I1 gene	PMID:31683443
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of IL4I1 intron	PMID:30157460
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of IL4I1 mRNA	PMID:30951980
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1304831	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of IL4I1 mRNA	PMID:35163327
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IL4I1 mRNA	PMID:24449571
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D002994	Clofibrate results in decreased expression of IL4I1 mRNA	PMID:17585979
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of IL4I1 mRNA	PMID:40434365
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of IL4I1 mRNA	PMID:29038090
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of IL4I1 gene	PMID:29154799
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D013629	Tamoxifen affects the expression of IL4I1 mRNA	PMID:17555576
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IL4I1 mRNA	PMID:38832940
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D000082	Acetaminophen results in increased expression of IL4I1 mRNA	PMID:17585979
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of IL4I1 mRNA	PMID:24714768
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of IL4I1 mRNA	PMID:35811015
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of IL4I1 mRNA	PMID:17331233
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of IL4I1 mRNA	PMID:17555576
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of IL4I1 mRNA	PMID:17942748
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IL4I1 mRNA	PMID:17942748
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IL4I1 mRNA; Nanotubes, Carbon results in increased expression of IL4I1 mRNA; Nanotubes, Carbon results in increased expression of IL4I1 protein	PMID:25554681|PMID:27106021
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:50819	ferric oxide	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:C000499	ferric oxide analog results in decreased expression of IL4I1 mRNA	PMID:25086211
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:C030935	benz(a)anthracene results in increased expression of IL4I1 mRNA	PMID:26377693
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL4I1 mRNA	PMID:21641980
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of IL4I1 intron	PMID:30157460
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312499	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IL4I1 mRNA	PMID:22206623
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IL4I1 mRNA	PMID:22206623
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1304831	E	RGD:6480464	20211012	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of IL4I1 mRNA	PMID:33945839
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312499	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of IL4I1 mRNA	PMID:38648751
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of IL4I1 mRNA	PMID:26079696
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312499	E	RGD:6480464	20171212	CTD	MESH:C009277	sodium arsenate results in decreased expression of IL4I1 mRNA	PMID:21795629
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:95077	GSK-J4	multiple interactions	ISO	RGD:1312499	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of IL4I1 mRNA]; GSK-J4 inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of IL4I1 protein]	PMID:36537648
1312498	IL4I1	interleukin 4 induced 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304831	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of IL4I1 mRNA	PMID:23555832
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of AARS1 protein	PMID:39638853
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D015025	Zearalenone results in decreased expression of AARS1 protein	PMID:25058043|PMID:36252740
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of AARS1 mRNA	PMID:25596134
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of AARS1 mRNA	PMID:35967413
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of AARS1 mRNA	PMID:26272509
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AARS1 mRNA	PMID:27188386
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of AARS1 protein]	PMID:38195004
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D014212	Tretinoin results in decreased expression of AARS1 mRNA	PMID:33167477
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of AARS1 mRNA	PMID:25596134
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:15545	prostaglandin A1	increases metabolic processing	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C100573	prostaglandin A1 analog results in increased metabolism of AARS1 protein	PMID:19800325
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D000431	Ethanol affects the splicing of AARS1 mRNA	PMID:30319688
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312501	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of AARS1 mRNA	PMID:39241906
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of AARS1 mRNA	PMID:35877022
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D004958	Estradiol results in increased expression of AARS1 mRNA	PMID:32145629
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312501	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of AARS1 mRNA	PMID:39298647
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D014241	Trichloroethylene results in increased expression of AARS1 mRNA	PMID:33387578
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of AARS1 mRNA	PMID:37042841
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of AARS1 protein	PMID:32044396
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:177387	brequinar	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C046943	brequinar results in increased expression of AARS1 mRNA	PMID:39900124
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of AARS1 protein	PMID:37730182
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D005839	Gentamicins results in increased expression of AARS1 mRNA	PMID:22061828|PMID:33387578
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:180654	N(4)-hydroxycytidine	increases expression	ISO	RGD:1312501	E	RGD:6480464	20250805	CTD	MESH:C010737	N(4)-hydroxycytidine results in increased expression of AARS1 mRNA	PMID:37748715
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AARS1 mRNA	PMID:36331819
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304832	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of AARS1 protein	PMID:34915118
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of AARS1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AARS1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of AARS1 protein	PMID:35301059|PMID:38195004
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of AARS1 protein	PMID:23301498
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of AARS1 mRNA	PMID:27776689
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of AARS1 mRNA	PMID:19770486
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of AARS1 protein	PMID:38598786
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of AARS1 mRNA	PMID:22171008
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of AARS1 mRNA]	PMID:22206623
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AARS1 mRNA	PMID:40504410
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of AARS1 protein	PMID:35688186
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C024565	ethylene dichloride results in decreased expression of AARS1 mRNA	PMID:28960355
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of AARS1 mRNA	PMID:25596134
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of AARS1 mRNA	PMID:23300844
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of AARS1 mRNA	PMID:25596134
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin affects the reaction [Piroxicam results in decreased expression of AARS1 mRNA]	PMID:21858171
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D014414	Tungsten results in decreased expression of AARS1 mRNA	PMID:30912803
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of AARS1 mRNA	PMID:26865667
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of AARS1 mRNA	PMID:23195993
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AARS1 mRNA	PMID:21570461
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AARS1 mRNA	PMID:33387578
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AARS1 mRNA	PMID:16467188|PMID:17942748
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AARS1 mRNA	PMID:17942748
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of AARS1 mRNA	PMID:33512557
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of AARS1 mRNA	PMID:24690739
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:29073	L-ascorbic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D001205	Ascorbic Acid results in decreased expression of AARS1 mRNA	PMID:19197388
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of AARS1 mRNA	PMID:28595984|PMID:34032870|PMID:38568856
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of AARS1 mRNA	PMID:39719251
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AARS1 mRNA	PMID:40504410
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of AARS1 mRNA; Tunicamycin results in increased expression of AARS1 protein	PMID:22378314|PMID:29453283|PMID:33545341|PMID:36586010|PMID:38498338|PMID:39900124
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of AARS1 3' UTR; Benzo(a)pyrene affects the methylation of AARS1 intron; Benzo(a)pyrene affects the methylation of AARS1 promoter	PMID:27901495|PMID:30157460
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AARS1 protein	PMID:32717239
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to AARS1 protein]	PMID:32406909
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of AARS1 mRNA	PMID:24690739
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of AARS1 mRNA	PMID:22171008
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of AARS1 protein	PMID:19364129
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:C008261	lead acetate results in increased expression of AARS1 mRNA	PMID:11578147
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of AARS1 mRNA	PMID:31745603
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C009495	titanium dioxide results in increased expression of AARS1 mRNA	PMID:23557971|PMID:27760801
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304832	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of AARS1 mRNA	PMID:34492290
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C006253	pirinixic acid affects the expression of AARS1 mRNA	PMID:17950772
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C006253	pirinixic acid results in decreased expression of AARS1 mRNA	PMID:23811191
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C006780	bisphenol A affects the expression of AARS1 mRNA	PMID:30903817
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of AARS1 protein	PMID:31675489|PMID:37567409
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304832	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of AARS1 mRNA	PMID:33296240|PMID:34947998
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C006780	bisphenol A results in decreased expression of AARS1 mRNA	PMID:33221593
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C006780	bisphenol A results in decreased methylation of AARS1 promoter	PMID:27312807
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of AARS1 mRNA; bisphenol A results in increased expression of AARS1 protein	PMID:29275510|PMID:33670352|PMID:34186270
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:C006780	bisphenol A results in increased expression of AARS1 mRNA	PMID:25181051|PMID:32145629
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312501	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of AARS1 mRNA	PMID:38074096
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:33418	graphite	affects expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D006108	Graphite affects the expression of AARS1 mRNA	PMID:29933104
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of AARS1 mRNA	PMID:25979313
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:C016340	o,p'-DDT results in increased expression of AARS1 mRNA	PMID:24096037
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C016340	o,p'-DDT results in increased expression of AARS1 mRNA	PMID:24096037
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312501	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of AARS1 mRNA	PMID:39298647
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of AARS1 protein	PMID:34186270
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of AARS1 protein	PMID:34186270
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of AARS1 mRNA	PMID:37019170
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of AARS1 mRNA	PMID:21266533
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20230801	CTD	MESH:D004137	Dinitrochlorobenzene binds to AARS1 protein	PMID:32991956
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D005284	Fenthion results in decreased expression of AARS1 mRNA	PMID:34813904
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C005828	methidathion results in decreased expression of AARS1 mRNA	PMID:34813904
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D010269	Paraquat results in decreased expression of AARS1 protein	PMID:34064677
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D010269	Paraquat results in increased expression of AARS1 mRNA	PMID:32680482
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C005445	triphenyl phosphate affects the expression of AARS1 mRNA	PMID:37042841
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:35456	cadmium dichloride	affects localization	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the localization of AARS1 protein	PMID:18261755
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of AARS1 mRNA	PMID:25596134|PMID:38568856
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of AARS1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AARS1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of AARS1 protein	PMID:35301059|PMID:38195004
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of AARS1 protein	PMID:26879310
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of AARS1 mRNA	PMID:19320972
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:C018021	cobaltous chloride results in increased expression of AARS1 protein	PMID:24386269
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of AARS1 mRNA	PMID:25596134
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D003024	Clozapine results in increased expression of AARS1 protein	PMID:34122009
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of AARS1 mRNA	PMID:32588087
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of AARS1 mRNA	PMID:31533062
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of AARS1 mRNA	PMID:19167446
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of AARS1 mRNA	PMID:26352163
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of AARS1 mRNA	PMID:36864359|PMID:40419075
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AARS1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of AARS1 mRNA	PMID:36331819
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of AARS1 mRNA	PMID:17198877
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AARS1 mRNA	PMID:25979313
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of AARS1 mRNA	PMID:20106945|PMID:21632981|PMID:22147139|PMID:25224403|PMID:25562108|PMID:25596134|PMID:27989131
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D016572	Cyclosporine results in increased expression of AARS1 mRNA	PMID:25596134
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D016572	Cyclosporine results in increased expression of AARS1 mRNA	PMID:25224403
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of AARS1 mRNA	PMID:33512557
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:41500	4-phenylbutyric acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C075773	4-phenylbutyric acid results in decreased expression of AARS1 mRNA	PMID:14583596
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:41500	4-phenylbutyric acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C075773	4-phenylbutyric acid results in increased expression of AARS1 mRNA	PMID:14583596
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D003907	Dexamethasone results in decreased expression of AARS1 mRNA	PMID:22733784
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D000082	Acetaminophen affects the expression of AARS1 mRNA	PMID:17562736
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of AARS1 mRNA	PMID:29067470
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D000082	Acetaminophen results in increased expression of AARS1 mRNA	PMID:33387578
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of AARS1 mRNA]	PMID:15016801
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	Zoledronic Acid results in decreased expression of AARS1 mRNA	PMID:25596134
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of AARS1 mRNA	PMID:24690739
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AARS1 mRNA	PMID:40504410
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D004008	Diclofenac results in decreased expression of AARS1 mRNA	PMID:35537566
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D004726	Endosulfan results in increased expression of AARS1 mRNA	PMID:29391264
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of AARS1 mRNA	PMID:26865667
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AARS1 mRNA	PMID:24096037
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AARS1 mRNA	PMID:16467188|PMID:17942748|PMID:24096037
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AARS1 mRNA	PMID:17942748
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of AARS1 protein	PMID:19364129
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D011345	Fenofibrate results in increased expression of AARS1 mRNA	PMID:25596134
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of AARS1 mRNA	PMID:23300844
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of AARS1 mRNA; Nanotubes, Carbon results in increased expression of AARS1 mRNA	PMID:25554681
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of AARS1 mRNA	PMID:35964746
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D005485	Flutamide results in increased expression of AARS1 mRNA	PMID:24136188
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C015559	trimellitic anhydride results in increased expression of AARS1 mRNA	PMID:19042947
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AARS1 protein	PMID:32959892
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:63630	tolcapone	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:C066340	Tolcapone results in increased expression of AARS1 mRNA	PMID:24136188
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C017096	n-butoxyethanol results in increased expression of AARS1 mRNA	PMID:19812364
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of AARS1 mRNA	PMID:23650126
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of AARS1 mRNA	PMID:24810058
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1304832	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of AARS1 mRNA	PMID:37269647
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D008687	Metformin results in increased expression of AARS1 mRNA	PMID:25596134
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of AARS1 protein	PMID:34186270
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of AARS1 mRNA	PMID:22206623
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of AARS1 mRNA]	PMID:22206623
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of AARS1 protein	PMID:37664457
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of AARS1 mRNA	PMID:30559759
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AARS1 mRNA	PMID:27188386
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:80491	pinostrobin	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C411294	pinostrobin results in increased expression of AARS1 mRNA	PMID:37777166
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of AARS1 mRNA	PMID:19159669
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of AARS1 protein	PMID:31675489
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of AARS1 mRNA	PMID:19095052
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of AARS1 mRNA	PMID:33512557
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:C013418	bromfenacoum results in increased expression of AARS1 protein	PMID:28903499
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of AARS1 mRNA	PMID:21858171
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin affects the reaction [Piroxicam results in decreased expression of AARS1 mRNA]	PMID:21858171
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of AARS1 mRNA	PMID:33512557
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of AARS1 mRNA	PMID:19013360
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of AARS1 protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AARS1 mRNA	PMID:27188386|PMID:37664457
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D013605	T-2 Toxin results in decreased expression of AARS1 mRNA	PMID:34581912
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:D013605	T-2 Toxin results in decreased expression of AARS1 mRNA	PMID:26141394
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of AARS1 mRNA	PMID:29301935
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1304832	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of AARS1 protein	PMID:35544339
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:D019284	Thapsigargin results in increased expression of AARS1 protein	PMID:24648495
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of AARS1 protein	PMID:38598786
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312501	E	RGD:6480464	20230801	CTD	MESH:C080163	trovafloxacin results in decreased expression of AARS1 mRNA	PMID:35537566
1312500	AARS1	alanyl-tRNA synthetase 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304832	E	RGD:6480464	20230801	CTD	MESH:C025643	vinclozolin results in decreased expression of AARS1 mRNA	PMID:23034163
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:135947	bazedoxifene	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C447119	bazedoxifene results in decreased expression of RC3H2 mRNA	PMID:19914376
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of RC3H2 mRNA	PMID:23019147
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1304833	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of RC3H2 mRNA	PMID:32145629
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of RC3H2 mRNA	PMID:27664576
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RC3H2 mRNA	PMID:28818685
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312503	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RC3H2 mRNA	PMID:19770486
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RC3H2 gene	PMID:27153756
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RC3H2 mRNA	PMID:23649840
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312503	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RC3H2 mRNA	PMID:40504410
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of RC3H2 protein	PMID:35688186
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RC3H2 mRNA	PMID:23557933
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304833	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RC3H2 mRNA	PMID:22298810
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312503	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RC3H2 mRNA	PMID:21354282
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RC3H2 mRNA	PMID:28001369
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of RC3H2 protein	PMID:35688186
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312503	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RC3H2 mRNA	PMID:40504410
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1304833	E	RGD:6480464	20200915	CTD	MESH:D008627	Mercuric Chloride results in increased expression of RC3H2 mRNA	PMID:32599119
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304833	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RC3H2 mRNA	PMID:34492290
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304833	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RC3H2 mRNA	PMID:25181051
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304833	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of RC3H2 mRNA	PMID:32145629
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312503	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RC3H2 mRNA	PMID:38685157
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RC3H2 mRNA	PMID:37042841
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RC3H2 mRNA	PMID:38568856
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312503	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of RC3H2 mRNA	PMID:18353800
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RC3H2 mRNA	PMID:31533062
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RC3H2 mRNA	PMID:23179753|PMID:25979313
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304833	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of RC3H2 mRNA	PMID:29427782
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of RC3H2 mRNA	PMID:24935251|PMID:27188386
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1304833	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of RC3H2 mRNA	PMID:29427782
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1304833	E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of RC3H2 mRNA	PMID:27281708
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of RC3H2 mRNA	PMID:24935251
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304833	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RC3H2 mRNA	PMID:33387578
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312503	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of RC3H2 mRNA	PMID:29279043
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312503	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RC3H2 mRNA	PMID:40504410
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of RC3H2 mRNA	PMID:20436886
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RC3H2 protein	PMID:32959892
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RC3H2 mRNA	PMID:26378955
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312503	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RC3H2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RC3H2 mRNA	PMID:21641980|PMID:26378955
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312503	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of RC3H2 mRNA	PMID:23091169
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312503	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of RC3H2 mRNA	PMID:21795629
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312503	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of RC3H2 mRNA	PMID:21795629
1312502	RC3H2	ring finger and CCCH-type domains 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RC3H2 mRNA	PMID:38568856
1312504	RTKN2	rhotekin 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RTKN2 mRNA	PMID:38218311
1312504	RTKN2	rhotekin 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312505	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RTKN2 mRNA	PMID:33045310
1312504	RTKN2	rhotekin 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RTKN2 mRNA	PMID:33167477
1312504	RTKN2	rhotekin 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312505	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RTKN2 mRNA	PMID:30529165
1312504	RTKN2	rhotekin 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RTKN2 mRNA	PMID:26079696
1312504	RTKN2	rhotekin 2	gene	CHEBI:15756	hexadecanoic acid	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of RTKN2 mRNA	PMID:39506029
1312504	RTKN2	rhotekin 2	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of RTKN2 mRNA	PMID:21592394
1312504	RTKN2	rhotekin 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of RTKN2 mRNA	PMID:21592394
1312504	RTKN2	rhotekin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RTKN2 mRNA	PMID:32235866
1312504	RTKN2	rhotekin 2	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of RTKN2 mRNA	PMID:21592394
1312504	RTKN2	rhotekin 2	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of RTKN2 mRNA	PMID:21592394
1312504	RTKN2	rhotekin 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RTKN2 mRNA	PMID:39836092
1312504	RTKN2	rhotekin 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RTKN2 mRNA	PMID:19549813
1312504	RTKN2	rhotekin 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RTKN2 mRNA	PMID:21641981
1312504	RTKN2	rhotekin 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1304834	E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in decreased expression of RTKN2 mRNA	PMID:28623178
1312504	RTKN2	rhotekin 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of RTKN2 mRNA	PMID:17095637
1312504	RTKN2	rhotekin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RTKN2 mRNA	PMID:39836092
1312504	RTKN2	rhotekin 2	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312505	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of RTKN2 mRNA	PMID:35897073
1312504	RTKN2	rhotekin 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RTKN2 mRNA	PMID:28960355
1312504	RTKN2	rhotekin 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304834	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RTKN2 mRNA	PMID:31881176
1312504	RTKN2	rhotekin 2	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of RTKN2 promoter	PMID:22847954
1312504	RTKN2	rhotekin 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RTKN2 mRNA	PMID:24768652|PMID:25583101
1312504	RTKN2	rhotekin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304834	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RTKN2 mRNA	PMID:32109520
1312504	RTKN2	rhotekin 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RTKN2 mRNA	PMID:23179753
1312504	RTKN2	rhotekin 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312505	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of RTKN2 mRNA	PMID:30807115
1312504	RTKN2	rhotekin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RTKN2 mRNA	PMID:39836092
1312504	RTKN2	rhotekin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RTKN2 mRNA	PMID:21632981
1312504	RTKN2	rhotekin 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RTKN2 mRNA	PMID:25895662
1312504	RTKN2	rhotekin 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of RTKN2 mRNA	PMID:23557971
1312504	RTKN2	rhotekin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312505	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RTKN2 gene	PMID:35295148
1312504	RTKN2	rhotekin 2	gene	CHEBI:32234	titanium dioxide	increases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in increased methylation of RTKN2 promoter	PMID:34973136
1312504	RTKN2	rhotekin 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312505	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RTKN2 promoter	PMID:35295148
1312504	RTKN2	rhotekin 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312505	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RTKN2 mRNA	PMID:20813756
1312504	RTKN2	rhotekin 2	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of RTKN2 mRNA	PMID:30690063
1312504	RTKN2	rhotekin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304834	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RTKN2 mRNA	PMID:25181051|PMID:34947998
1312504	RTKN2	rhotekin 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304834	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RTKN2 gene	PMID:28505145
1312504	RTKN2	rhotekin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of RTKN2 mRNA	PMID:40203079
1312504	RTKN2	rhotekin 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RTKN2 intron	PMID:30157460
1312504	RTKN2	rhotekin 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RTKN2 mRNA	PMID:37019170
1312504	RTKN2	rhotekin 2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1304834	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of RTKN2 mRNA	PMID:32680482
1312504	RTKN2	rhotekin 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RTKN2 mRNA	PMID:37042841
1312504	RTKN2	rhotekin 2	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of RTKN2 mRNA	PMID:26678675
1312504	RTKN2	rhotekin 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RTKN2 mRNA	PMID:39836092
1312504	RTKN2	rhotekin 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RTKN2 mRNA	PMID:38568856
1312504	RTKN2	rhotekin 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RTKN2 mRNA	PMID:36326898
1312504	RTKN2	rhotekin 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RTKN2 mRNA	PMID:28302478
1312504	RTKN2	rhotekin 2	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of RTKN2 promoter	PMID:22847954
1312504	RTKN2	rhotekin 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RTKN2 mRNA	PMID:31533062
1312504	RTKN2	rhotekin 2	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of RTKN2 promoter	PMID:22847954
1312504	RTKN2	rhotekin 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of RTKN2 mRNA	PMID:39529242
1312504	RTKN2	rhotekin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RTKN2 mRNA	PMID:40419075
1312504	RTKN2	rhotekin 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of RTKN2 mRNA	PMID:23179753|PMID:24935251|PMID:27188386|PMID:28001369
1312504	RTKN2	rhotekin 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RTKN2 gene	PMID:29154799
1312504	RTKN2	rhotekin 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of RTKN2 mRNA	PMID:24449571
1312504	RTKN2	rhotekin 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RTKN2 mRNA	PMID:38832940
1312504	RTKN2	rhotekin 2	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RTKN2 mRNA	PMID:28542535
1312504	RTKN2	rhotekin 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of RTKN2 mRNA	PMID:26272509
1312504	RTKN2	rhotekin 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RTKN2 mRNA	PMID:27188386
1312504	RTKN2	rhotekin 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RTKN2 mRNA	PMID:22230336
1312504	RTKN2	rhotekin 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304834	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RTKN2 mRNA	PMID:33387578
1312504	RTKN2	rhotekin 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RTKN2 mRNA	PMID:39836092
1312504	RTKN2	rhotekin 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RTKN2 mRNA	PMID:22079256
1312504	RTKN2	rhotekin 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312505	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of RTKN2 mRNA	PMID:25554681
1312504	RTKN2	rhotekin 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RTKN2 mRNA	PMID:25554681
1312504	RTKN2	rhotekin 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RTKN2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RTKN2 mRNA	PMID:39836092
1312504	RTKN2	rhotekin 2	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of RTKN2 mRNA	PMID:28988120
1312504	RTKN2	rhotekin 2	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of RTKN2 mRNA	PMID:26307267
1312504	RTKN2	rhotekin 2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of RTKN2 intron	PMID:30157460
1312504	RTKN2	rhotekin 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304834	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RTKN2 gene	PMID:35440735
1312504	RTKN2	rhotekin 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RTKN2 mRNA	PMID:22079256|PMID:22714537
1312504	RTKN2	rhotekin 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RTKN2 mRNA	PMID:22079256
1312504	RTKN2	rhotekin 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of RTKN2 mRNA	PMID:29522793
1312504	RTKN2	rhotekin 2	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of RTKN2 protein	PMID:31285264
1312504	RTKN2	rhotekin 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RTKN2 mRNA	PMID:27188386
1312504	RTKN2	rhotekin 2	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of RTKN2 mRNA	PMID:30928695
1312504	RTKN2	rhotekin 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RTKN2 gene]	PMID:28238834
1312504	RTKN2	rhotekin 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of RTKN2 mRNA	PMID:32234424
1312504	RTKN2	rhotekin 2	gene	CHEBI:85014	2,5-hexanedione	increases expression	ISO	RGD:1304834	E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione results in increased expression of RTKN2 mRNA	PMID:22952946
1312504	RTKN2	rhotekin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304834	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RTKN2 mRNA	PMID:25825206
1312504	RTKN2	rhotekin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304834	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RTKN2 mRNA	PMID:24780913
1312504	RTKN2	rhotekin 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RTKN2 mRNA	PMID:27188386
1312504	RTKN2	rhotekin 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312505	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of RTKN2 mRNA	PMID:35537566
1312504	RTKN2	rhotekin 2	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1304834	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of RTKN2 gene	PMID:31682807
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:10022	deoxynivalenol	affects phosphorylation	ISO	RGD:1312510	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol affects the phosphorylation of HDAC2 protein	PMID:23352502
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of HDAC2 protein	PMID:39638853
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:619976	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of HDAC2 mRNA	PMID:21551480
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:132098	methoxyacetic acid	decreases activity	EXP		E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased activity of HDAC2 protein	PMID:15103026
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:132106	sodium propionate	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20230404	CTD	MESH:C514135	sodium propionate inhibits the reaction [Ethanol results in increased expression of HDAC2 mRNA]; sodium propionate inhibits the reaction [Ethanol results in increased expression of HDAC2 protein]	PMID:35639301
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of HDAC2 mRNA	PMID:33045310
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312510	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of HDAC2 mRNA	PMID:37995155
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:144804	nickel subsulfide	increases expression	ISO	RGD:619976	E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide results in increased expression of HDAC2 mRNA	PMID:21086188
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HDAC2 gene	PMID:20938992
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:15366	acetic acid	increases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:D019342	Acetic Acid results in increased expression of HDAC2 mRNA	PMID:35750087
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of HDAC2 mRNA	PMID:33167477
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:15368	acrolein	affects binding	EXP		E	RGD:6480464	20160210	CTD	MESH:D000171	Acrolein binds to HDAC2 protein	PMID:26481333
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of HDAC2 mRNA	PMID:26079696
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:15864	luteolin	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20260113	CTD	MESH:D047311	Luteolin inhibits the reaction [Cyclophosphamide results in increased expression of HDAC2 mRNA]; Luteolin inhibits the reaction [Cyclophosphamide results in increased expression of HDAC2 protein]	PMID:40555171
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:16118	berberine	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D001599	Berberine results in decreased expression of HDAC2 mRNA	PMID:27311644
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312510	E	RGD:6480464	20230404	CTD	MESH:D000431	Ethanol results in increased expression of HDAC2 mRNA; Ethanol results in increased expression of HDAC2 protein	PMID:35639301
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20230404	CTD	MESH:D000431	sodium propionate inhibits the reaction [Ethanol results in increased expression of HDAC2 mRNA]; sodium propionate inhibits the reaction [Ethanol results in increased expression of HDAC2 protein]	PMID:35639301
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:16240	hydrogen peroxide	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in decreased activity of HDAC2 protein	PMID:18421014
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Curcumin inhibits the reaction [Hydrogen Peroxide results in decreased activity of HDAC2 protein]	PMID:18421014
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312510	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HDAC2 mRNA	PMID:39241906
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol affects the expression of HDAC2 mRNA	PMID:22952798
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol inhibits the reaction [sodium arsenite results in increased expression of HDAC2 mRNA]	PMID:22952798
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HDAC2 gene	PMID:20938992
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HDAC2 mRNA	PMID:37042841
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:16708	adenine	decreases expression	ISO	RGD:619976	E	RGD:6480464	20221101	CTD	MESH:D000225	Adenine results in decreased expression of HDAC2 protein	PMID:35753429
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:16995	oxalic acid	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D019815	Oxalic Acid results in increased expression of HDAC2 mRNA	PMID:37414240
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:16995	oxalic acid	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D019815	Butyric Acid inhibits the reaction [Oxalic Acid results in increased expression of HDAC2 mRNA]	PMID:37414240
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:17489	3',5'-cyclic AMP	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20120412	CTD	MESH:D000242	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of HDAC2 mRNA]	PMID:19414516
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C031927	hydroquinone results in increased expression of HDAC2 mRNA; hydroquinone results in increased expression of HDAC2 protein	PMID:27220438|PMID:30448557
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:17594	hydroquinone	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C031927	trichostatin A inhibits the reaction [hydroquinone results in increased expression of HDAC2 mRNA]	PMID:27220438
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20200804	CTD	MESH:D009538	Nicotine results in decreased expression of HDAC2 protein	PMID:31507073
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of HDAC2 mRNA	PMID:24709674
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:619976	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of HDAC2 mRNA; Nicotine results in increased expression of HDAC2 protein	PMID:24709674|PMID:31846720|PMID:34245815
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20211012	CTD	MESH:D009538	SNAI1 protein affects the reaction [Nicotine results in increased expression of HDAC2 mRNA]; SNAI1 protein affects the reaction [Nicotine results in increased expression of HDAC2 protein]	PMID:34245815
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:619976	E	RGD:6480464	20150310	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of HDAC2 protein	PMID:25280772
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of HDAC2 protein	PMID:37730182
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:1784	biphenyl-4-amine	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C006757	4-biphenylamine results in decreased expression of HDAC2 mRNA	PMID:32905825
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:1784	biphenyl-4-amine	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C006757	TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of HDAC2 mRNA]	PMID:32905825
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HDAC2 mRNA	PMID:36331819
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20200804	CTD	MESH:D009538	Nicotine results in decreased expression of HDAC2 protein	PMID:31507073
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of HDAC2 mRNA	PMID:24709674
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:619976	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of HDAC2 mRNA; Nicotine results in increased expression of HDAC2 protein	PMID:24709674|PMID:31846720|PMID:34245815
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20211012	CTD	MESH:D009538	SNAI1 protein affects the reaction [Nicotine results in increased expression of HDAC2 mRNA]; SNAI1 protein affects the reaction [Nicotine results in increased expression of HDAC2 protein]	PMID:34245815
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:197437	mocetinostat	decreases expression	EXP		E	RGD:6480464	20231107	CTD	MESH:C523184	mocetinostat results in decreased expression of HDAC2 protein	PMID:26378038
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HDAC2 mRNA	PMID:37236586
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HDAC2 mRNA	PMID:39012411
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HDAC2 protein	PMID:23301498
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:619976	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of HDAC2 protein	PMID:33236894
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:24650	hydroxamic acid	multiple interactions	EXP		E	RGD:6480464	20170103	CTD	MESH:D006877	Hydroxamic Acids analog binds to and results in decreased activity of HDAC2 protein	PMID:19084294
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20140812	CTD	MESH:C016517	indole-3-carbinol inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC2 mRNA]	PMID:24200994
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of HDAC2 mRNA	PMID:19770486
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:619976	E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in decreased expression of HDAC2 mRNA	PMID:35737395
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312510	E	RGD:6480464	20230704	CTD	MESH:D010126	[Ozone results in increased expression of HIF1A] which results in increased expression of HDAC2	PMID:24040961
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20230704	CTD	MESH:D010126	[Ovalbumin co-treated with Ozone] results in decreased expression of HDAC2 protein; [Ozone results in increased phosphorylation of and results in increased carboxylation of HDAC2 protein] which results in decreased expression of and results in increased activity of HDAC2 protein; Ozone results in increased phosphorylation of and results in increased carboxylation of HDAC2 protein	PMID:24040961|PMID:34760922
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:25863	pelargonidin	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20190910	CTD	MESH:C066957	pelargonidin results in decreased expression of HDAC2 protein	PMID:31181187
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312510	E	RGD:6480464	20170516	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of HDAC2 mRNA; Carbon Tetrachloride results in increased expression of HDAC2 protein	PMID:27396813|PMID:31919559
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20170516	CTD	MESH:D002251	Carbon Tetrachloride deficiency inhibits the reaction [Carbon Tetrachloride results in increased expression of HDAC2 mRNA]; Carbon Tetrachloride deficiency inhibits the reaction [Carbon Tetrachloride results in increased expression of HDAC2 protein]	PMID:27396813
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HDAC2 gene	PMID:20938992
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of HDAC2 mRNA; [Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of HDAC2 gene	PMID:39164771|PMID:40512198
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HDAC2 mRNA	PMID:40504410
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:2762	antimycin A	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of HDAC2 mRNA	PMID:33512557
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:27732	caffeine	increases expression	ISO	RGD:619976	E	RGD:6480464	20140909	CTD	MESH:D002110	Caffeine results in increased expression of HDAC2 mRNA	PMID:24717552
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:619976	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of HDAC2 mRNA	PMID:25905778
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:27881	resveratrol	increases metabolic processing	EXP		E	RGD:6480464	20150127	CTD	MESH:C059514	resveratrol results in increased metabolism of HDAC2 protein	PMID:23463510
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of HDAC2 mRNA	PMID:23557933
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of HDAC2 mRNA	PMID:28903495
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:619976	E	RGD:6480464	20180515	CTD	MESH:D007854	Lead results in increased expression of HDAC2 mRNA; Lead results in increased expression of HDAC2 protein	PMID:29301062
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20180515	CTD	MESH:D007854	[HDAC1 protein co-treated with HDAC2 protein] inhibits the reaction [Lead results in decreased expression of NOTCH2 protein]; EZH2 protein inhibits the reaction [Lead results in increased expression of HDAC2 mRNA]; EZH2 protein inhibits the reaction [Lead results in increased expression of HDAC2 protein]; Lead promotes the reaction [HDAC1 protein binds to HDAC2 protein]	PMID:29301062
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of HDAC2 mRNA	PMID:40618947
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20190702	CTD	MESH:D019833	Genistein results in decreased expression of HDAC2 mRNA	PMID:29899271
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:D019833	[Genistein co-treated with sulforaphane] results in decreased expression of HDAC2 mRNA	PMID:29899271
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312510	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HDAC2 mRNA	PMID:21570461
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HDAC2 mRNA	PMID:19770486|PMID:24058054
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:619976	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HDAC2 mRNA	PMID:33387578
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312510	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HDAC2 mRNA	PMID:17942748
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HDAC2 mRNA	PMID:17942748
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28177	theophylline	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in increased expression of HDAC2 protein	PMID:15337792
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of HDAC2 mRNA	PMID:29955902|PMID:33512557
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HDAC2 mRNA	PMID:33212167
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HDAC2 mRNA	PMID:29803840
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:619976	E	RGD:6480464	20191210	CTD	MESH:D004317	Doxorubicin results in decreased expression of HDAC2 protein	PMID:31545955
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004317	Doxorubicin inhibits the reaction [HDAC2 protein binds to CCNE1 promoter]; Doxorubicin promotes the reaction [HDAC2 protein binds to TP73 promoter]; SETD7 protein promotes the reaction [Doxorubicin inhibits the reaction [HDAC2 protein binds to CCNE1 promoter]]; SETD7 protein promotes the reaction [Doxorubicin promotes the reaction [HDAC2 protein binds to TP73 promoter]]	PMID:25124555
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of HDAC2 protein	PMID:35688186
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of HDAC2 mRNA	PMID:20044591
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28925	mechlorethamine	increases expression	ISO	RGD:619976	E	RGD:6480464	20170725	CTD	MESH:D008466	Mechlorethamine results in increased expression of HDAC2 protein	PMID:28184907|PMID:33971176
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:28925	mechlorethamine	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20170725	CTD	MESH:D008466	Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of HDAC2 protein]	PMID:28184907
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of HDAC2 mRNA	PMID:38568856
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HDAC2 mRNA	PMID:22952798
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312510	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HDAC2 mRNA	PMID:19822182
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of HDAC2 mRNA; Estradiol inhibits the reaction [sodium arsenite results in increased expression of HDAC2 mRNA]	PMID:22952798|PMID:40512198
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HDAC2 mRNA	PMID:40504410
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HDAC2 3' UTR	PMID:27901495
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HDAC2 mRNA	PMID:15894712
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HDAC2 mRNA	PMID:33411230
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312510	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HDAC2 mRNA	PMID:22228805
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20120412	CTD	MESH:D001564	[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of HDAC2 mRNA	PMID:15894712
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of HDAC2 mRNA	PMID:15894712
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20120412	CTD	MESH:C015001	[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of HDAC2 mRNA	PMID:15894712
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:30621	diarsenic trioxide	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide affects the expression of HDAC2 mRNA	PMID:25574600
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:30621	diarsenic trioxide	increases methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased methylation of HDAC2 promoter	PMID:26046465
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:30742	ethylene glycol	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20231031	CTD	MESH:D019855	[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC2 mRNA; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC2 mRNA]	PMID:37414240
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:30772	butyric acid	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D020148	Butyric Acid inhibits the reaction [Oxalic Acid results in increased expression of HDAC2 mRNA]	PMID:37414240
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:30772	butyric acid	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20231031	CTD	MESH:D020148	Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC2 mRNA]	PMID:37414240
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:619976	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of HDAC2 mRNA	PMID:16483693
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:31206	ammonium chloride	increases expression	ISO	RGD:619976	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride results in increased expression of HDAC2 protein	PMID:16483693
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:619976	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of HDAC2 mRNA	PMID:24136188
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312510	E	RGD:6480464	20240305	CTD	MESH:C008261	lead acetate results in increased expression of HDAC2 protein	PMID:37797690
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20240305	CTD	MESH:C008261	HDAC2 protein promotes the reaction [lead acetate results in decreased expression of CKM mRNA]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of CKM protein]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYH4 mRNA]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYH4 protein]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYOD1 mRNA]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYOD1 protein]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYOG mRNA]; HDAC2 protein promotes the reaction [lead acetate results in decreased expression of MYOG protein]	PMID:37797690
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312510	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HDAC2 gene; titanium dioxide results in decreased methylation of HDAC2 promoter	PMID:35295148
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:619976	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of HDAC2 mRNA	PMID:19167457
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A affects the expression of HDAC2 mRNA	PMID:33670352
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312510	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of HDAC2 promoter	PMID:27334623
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of HDAC2 protein	PMID:37567409
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of HDAC2 mRNA	PMID:33221593
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:619976	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HDAC2 mRNA	PMID:25181051
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312510	E	RGD:6480464	20140715	CTD	MESH:C006780	bisphenol A results in increased expression of HDAC2 mRNA; bisphenol A results in increased expression of HDAC2 protein	PMID:24333847|PMID:28496034|PMID:34655688|PMID:40036665
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:619976	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of HDAC2 mRNA; bisphenol A results in increased expression of HDAC2 protein	PMID:30816183|PMID:34838597
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20220705	CTD	MESH:C006780	HDAC2 protein affects the reaction [bisphenol A results in decreased expression of CCND1 mRNA]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of CCND1 protein]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of CHAT protein]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of CTNNB1 mRNA]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of CTNNB1 protein]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of DLG4 mRNA]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of DLG4 protein]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of FURIN protein]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of GRIN1 mRNA]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of GRIN1 protein]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of MYC mRNA]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of MYC protein]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of NTRK1 protein]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of SLC17A6 mRNA]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of SLC17A6 protein]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of SPN mRNA]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of SPN protein]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of SYP mRNA]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of SYP protein]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of WNT3A mRNA]; HDAC2 protein affects the reaction [bisphenol A results in decreased expression of WNT3A protein]; HDAC2 protein affects the reaction [bisphenol A results in increased activity of and results in decreased phosphorylation of GSK3B protein]; HDAC2 protein affects the reaction [bisphenol A results in increased expression of ACHE mRNA alternative form]; HDAC2 protein affects the reaction [bisphenol A results in increased expression of ACHE mRNA]; HDAC2 protein affects the reaction [bisphenol A results in increased expression of and results in decreased metabolism of NGF protein]; HDAC2 protein affects the reaction [bisphenol A results in increased expression of NGF mRNA]; HDAC2 protein affects the reaction [bisphenol A results in increased expression of NGFR protein]	PMID:34655688|PMID:37372067
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HDAC2 mRNA; HDAC2 mutant form inhibits the reaction [bisphenol A results in decreased expression of SLC12A5 mRNA]; trichostatin A inhibits the reaction [bisphenol A results in increased expression of HDAC2 protein]	PMID:23440186|PMID:34838597|PMID:36041667
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:3374	capsaicin	increases expression	ISO	RGD:619976	E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin results in increased expression of HDAC2 mRNA	PMID:16278290
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20120412	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of HDAC2 mRNA]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of HDAC2 mRNA]	PMID:19414516
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:34159	15-deoxy-Delta(12,14)-prostaglandin J2	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C097240	15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of HDAC2 mRNA	PMID:21957481
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:34283	oxybenzone	increases expression	ISO	RGD:619976	E	RGD:6480464	20191112	CTD	MESH:C005290	oxybenzone results in increased expression of HDAC2 protein	PMID:31368502
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312510	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of HDAC2 mRNA	PMID:39298647
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HDAC2 mRNA	PMID:36041667
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of HDAC2 protein	PMID:34186270
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HDAC2 mRNA	PMID:36041667
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of HDAC2 protein	PMID:34186270
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HDAC2 mRNA	PMID:37019170
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of HDAC2 mRNA	PMID:34813904
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20170516	CTD	MESH:D015056	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] inhibits the reaction [TGFB1 protein results in increased expression of HDAC2 protein]	PMID:27396813
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of HDAC2 mRNA	PMID:38382870
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HDAC2 mRNA	PMID:37236586
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HDAC2 mRNA	PMID:39012411
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of HDAC2 protein	PMID:26879310
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:619976	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of HDAC2 gene	PMID:22079235
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of HDAC2 mRNA	PMID:28302478
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of HDAC2 mRNA	PMID:40419075
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HDAC2 mRNA	PMID:36331819
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D003474	Curcumin analog results in decreased expression of HDAC2 mRNA	PMID:26409325
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Hydrogen Peroxide results in decreased activity of HDAC2 protein]; Curcumin inhibits the reaction [Smoke results in decreased activity of HDAC2 protein]; Curcumin inhibits the reaction [Smoke results in increased degradation of and results in decreased expression of HDAC2 protein]	PMID:18421014
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:39827	fumaraldehyde	affects expression	EXP		E	RGD:6480464	20221206	CTD	MESH:C015977	malealdehyde affects the expression of HDAC2 mRNA	PMID:35750087
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:39867	valproic acid	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased activity of HDAC2 protein	PMID:15103026
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D014635	Valproic Acid results in decreased expression of HDAC2 mRNA; Valproic Acid results in decreased expression of HDAC2 protein	PMID:17653085|PMID:24200999
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:39867	valproic acid	increases degradation	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased degradation of HDAC2 protein	PMID:16294345
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Hydroxyurea promotes the reaction [Valproic Acid results in decreased expression of HDAC2 protein]	PMID:17653085
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20170725	CTD	MESH:D014635	Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of HDAC2 protein]	PMID:28184907
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:619976	E	RGD:6480464	20260113	CTD	MESH:D003520	Cyclophosphamide results in increased expression of HDAC2 mRNA; Cyclophosphamide results in increased expression of HDAC2 protein	PMID:40555171
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:4027	cyclophosphamide	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20260113	CTD	MESH:D003520	Luteolin inhibits the reaction [Cyclophosphamide results in increased expression of HDAC2 mRNA]; Luteolin inhibits the reaction [Cyclophosphamide results in increased expression of HDAC2 protein]	PMID:40555171
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of HDAC2 mRNA	PMID:19770486
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of HDAC2 mRNA	PMID:33512557
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312510	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of HDAC2 mRNA	PMID:17555576
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen promotes the reaction [HDAC2 protein binds to FOXM1 promoter]	PMID:20208560
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:619976	E	RGD:6480464	20191112	CTD	MESH:D003907	Dexamethasone results in increased expression of HDAC2 mRNA; Dexamethasone results in increased expression of HDAC2 protein	PMID:31518422|PMID:32791177
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20170516	CTD	MESH:D003907	[HDAC1 protein co-treated with HDAC2 protein] affects the reaction [Dexamethasone results in decreased expression of CDON mRNA]; [HDAC1 protein co-treated with HDAC2 protein] affects the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]; [HDAC1 protein co-treated with HDAC2 protein] affects the reaction [Dexamethasone results in decreased expression of MEX3A mRNA]; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] inhibits the reaction [TGFB1 protein results in increased expression of HDAC2 protein]	PMID:27396813|PMID:27645313
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20191112	CTD	MESH:D003907	Dexamethasone promotes the reaction [HDAC2 protein binds to BDNF promoter]; Dexamethasone promotes the reaction [NR3C1 protein binds to HDAC2 protein]; Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of HDAC2 protein]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of HDAC2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of HDAC2 protein]; romidepsin inhibits the reaction [Dexamethasone results in decreased expression of HDAC2 protein]	PMID:31518422|PMID:32791177
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1312510	E	RGD:6480464	20140513	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of HDAC2 mRNA	PMID:24316720
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:44423	hydroxyurea	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea promotes the reaction [Valproic Acid results in decreased expression of HDAC2 protein]	PMID:17653085
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:619976	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of HDAC2 mRNA	PMID:24136188
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HDAC2 mRNA	PMID:38832940
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of HDAC2 protein	PMID:18850582
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[vorinostat co-treated with monomethylarsonous acid] results in decreased expression of HDAC2 mRNA; vorinostat binds to and results in decreased activity of HDAC2 protein	PMID:19084294|PMID:23891734
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:45716	vorinostat	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20190910	CTD	MESH:C111237	Vorinostat inhibits the reaction [Sevoflurane results in increased expression of HDAC2 mRNA]; Vorinostat inhibits the reaction [Sevoflurane results in increased expression of HDAC2 protein]	PMID:30842370
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:46024	trichostatin A	decreases activity	EXP		E	RGD:6480464	20120501	CTD	MESH:C012589	trichostatin A results in decreased activity of HDAC2 protein	PMID:15103026|PMID:18421014|PMID:34973135
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C012589	trichostatin A inhibits the reaction [hydroquinone results in increased expression of HDAC2 mRNA]	PMID:27220438
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20220607	CTD	MESH:C012589	trichostatin A inhibits the reaction [bisphenol A results in increased expression of HDAC2 protein]	PMID:34838597
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:46345	5-fluorouracil	increases response to substance	EXP		E	RGD:6480464	20230404	CTD	MESH:D005472	HDAC2 protein results in increased susceptibility to Fluorouracil	PMID:35608750
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20141223	CTD	MESH:D005472	[HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA]]; [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of OLIG2 mRNA]]; Fluorouracil inhibits the reaction [TCF7L2 protein binds to HDAC2 protein]	PMID:25178657
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of HDAC2 mRNA; [Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of HDAC2 gene	PMID:39164771|PMID:40512198
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HDAC2 mRNA	PMID:40504410
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of HDAC2 mRNA	PMID:29899271|PMID:30684530
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:47807	sulforaphane	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:C016766	[Genistein co-treated with sulforaphane] results in decreased expression of HDAC2 mRNA	PMID:29899271
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D004726	Endosulfan results in decreased expression of HDAC2 mRNA	PMID:30090376
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312510	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of HDAC2 mRNA	PMID:17555576
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312510	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of HDAC2 mRNA	PMID:17942748
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HDAC2 mRNA	PMID:17942748
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:49900	arsenous acid	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide affects the expression of HDAC2 mRNA	PMID:25574600
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:49900	arsenous acid	increases methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased methylation of HDAC2 promoter	PMID:26046465
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:5011	fenpyroximate	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of HDAC2 mRNA	PMID:33512557
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of HDAC2 mRNA	PMID:17908484
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:50182	3,3'-diindolylmethane	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:C016392	3,3'-diindolylmethane results in decreased expression of HDAC2 protein	PMID:22800507
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:50182	3,3'-diindolylmethane	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20140812	CTD	MESH:C016392	3,3'-diindolylmethane inhibits the reaction [enterotoxin B, staphylococcal results in increased expression of HDAC2 mRNA]	PMID:24200994
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:50692	mifepristone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of HDAC2 mRNA	PMID:17584828
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:50692	mifepristone	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20191112	CTD	MESH:D015735	Mifepristone inhibits the reaction [Dexamethasone results in decreased expression of HDAC2 protein]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of HDAC2 mRNA]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of HDAC2 protein]	PMID:31518422|PMID:32791177
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:619976	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of HDAC2 mRNA	PMID:19162173
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:5118	fluoxetine	increases expression	ISO	RGD:619976	E	RGD:6480464	20120918	CTD	MESH:D005473	Fluoxetine results in increased expression of HDAC2 mRNA; Fluoxetine results in increased expression of HDAC2 protein	PMID:16670375
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:5118	fluoxetine	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20150310	CTD	MESH:D005473	Fluoxetine affects the reaction [sodium arsenate affects the expression of HDAC2 protein]	PMID:24952232
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:5759	Honokiol	multiple interactions	EXP		E	RGD:6480464	20221004	CTD	MESH:C005499	honokiol binds to and results in decreased activity of HDAC2 protein	PMID:34973135
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:60579	calcium oxalate	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20231031	CTD	MESH:D002129	[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC2 mRNA; Butyric Acid inhibits the reaction [[Ethylene Glycol co-treated with Calcium Oxalate] results in increased expression of HDAC2 mRNA]	PMID:37414240
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HDAC2 protein	PMID:32959892
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:61080	romidepsin	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20191112	CTD	MESH:C087123	romidepsin inhibits the reaction [Dexamethasone results in decreased expression of HDAC2 protein]	PMID:31518422
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:619976	E	RGD:6480464	20180703	CTD	MESH:C025340	manganese chloride results in increased expression of HDAC2 mRNA	PMID:29155171
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:619976	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of HDAC2 mRNA	PMID:24136188
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of HDAC2 mRNA	PMID:23650126
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:64317	isoprenaline	increases phosphorylation	ISO	RGD:1312510	E	RGD:6480464	20190910	CTD	MESH:D007545	Isoproterenol results in increased phosphorylation of HDAC2 protein	PMID:31009642
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:64317	isoprenaline	increases phosphorylation	ISO	RGD:619976	E	RGD:6480464	20190910	CTD	MESH:D007545	Isoproterenol results in increased phosphorylation of HDAC2 protein	PMID:31009642
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20190910	CTD	MESH:D007545	plantamajoside inhibits the reaction [Isoproterenol results in increased phosphorylation of HDAC2 protein]; Valsartan inhibits the reaction [Isoproterenol results in increased phosphorylation of HDAC2 protein]	PMID:31009642
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20190910	CTD	MESH:D007545	plantamajoside inhibits the reaction [Isoproterenol results in increased phosphorylation of HDAC2 protein]; Valsartan inhibits the reaction [Isoproterenol results in increased phosphorylation of HDAC2 protein]	PMID:31009642
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:619976	E	RGD:6480464	20201006	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HDAC2 mRNA	PMID:32387197
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:619976	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of HDAC2 mRNA	PMID:24136188
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases ubiquitination	EXP		E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of HDAC2 protein	PMID:18421014
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:C072553	[SOD2 protein co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in decreased expression of HDAC2 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Smoke results in increased degradation of and results in decreased expression of HDAC2 protein]; CAT protein inhibits the reaction [[SOD2 protein co-treated with benzyloxycarbonylleucyl-leucyl-leucine aldehyde] results in decreased expression of HDAC2 protein]	PMID:18421014|PMID:24973648
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of HDAC2 protein	PMID:31285264
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:77147	(20S)-ginsenoside Rh2	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C055305	ginsenoside Rh2 results in decreased expression of HDAC2 protein	PMID:26482938
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:79516	Nonylphenol	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:C025256	nonylphenol results in increased expression of HDAC2 mRNA; nonylphenol results in increased expression of HDAC2 protein	PMID:34974051
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:79516	Nonylphenol	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C025256	AHR protein affects the reaction [nonylphenol results in increased expression of HDAC2 mRNA]; AHR protein affects the reaction [nonylphenol results in increased expression of HDAC2 protein]; HDAC2 protein affects the reaction [nonylphenol results in decreased expression of and results in decreased acetylation of HNF4A protein]; HDAC2 protein affects the reaction [nonylphenol results in decreased expression of TNFSF15 mRNA]; HDAC2 protein affects the reaction [nonylphenol results in increased expression of PECAM1 protein]	PMID:34974051
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HDAC2 gene]	PMID:28238834
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312510	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of HDAC2 mRNA	PMID:30294300
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:619976	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of HDAC2 protein	PMID:28903499
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:8256	Plantamajoside	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20190910	CTD	MESH:C421173	plantamajoside inhibits the reaction [Isoproterenol results in increased phosphorylation of HDAC2 protein]	PMID:31009642
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:8256	Plantamajoside	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20190910	CTD	MESH:C421173	plantamajoside inhibits the reaction [Isoproterenol results in increased phosphorylation of HDAC2 protein]	PMID:31009642
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of HDAC2 mRNA	PMID:33512557
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:84070	sodium arsenate	affects expression	ISO	RGD:1312510	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate affects the expression of HDAC2 protein	PMID:24952232
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of HDAC2 mRNA	PMID:21795629
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312510	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of HDAC2 mRNA; sodium arsenate results in increased expression of HDAC2 protein	PMID:21795629|PMID:26193056
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20170303	CTD	MESH:C009277	Fluoxetine affects the reaction [sodium arsenate affects the expression of HDAC2 protein]	PMID:24952232
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:9130	sevoflurane	increases expression	ISO	RGD:619976	E	RGD:6480464	20190910	CTD	MESH:C009250	Sevoflurane results in increased expression of HDAC2 mRNA; Sevoflurane results in increased expression of HDAC2 protein	PMID:30842370
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:9130	sevoflurane	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20190910	CTD	MESH:C009250	Vorinostat inhibits the reaction [Sevoflurane results in increased expression of HDAC2 mRNA]; Vorinostat inhibits the reaction [Sevoflurane results in increased expression of HDAC2 protein]	PMID:30842370
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:91429	4-hydroxy-3-[4-(2-hydroxyphenyl)phenyl]-6-oxo-7H-thieno[2,3-b]pyridine-5-carbonitrile	affects localization	EXP		E	RGD:6480464	20260804	CTD	MESH:C512408	4-hydroxy-3-(4-(2-hydroxyphenyl)phenyl)-6-oxo-7H-thieno(2,3-b)pyridine-5-carbonitrile affects the localization of HDAC2 protein	PMID:26471090
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:9400	tangeretin	decreases expression	ISO	RGD:1312510	E	RGD:6480464	20231003	CTD	MESH:C059006	tangeretin metabolite results in decreased expression of HDAC2 protein; tangeretin results in decreased expression of HDAC2 protein	PMID:37517432
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:9405	tartrazine	increases expression	ISO	RGD:1312510	E	RGD:6480464	20250506	CTD	MESH:D013645	Tartrazine results in increased expression of HDAC2 mRNA	PMID:37447272
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:9422	tebufenpyrad	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of HDAC2 mRNA	PMID:33512557
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:619976	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of HDAC2 protein	PMID:32519852
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:9927	valsartan	multiple interactions	ISO	RGD:1312510	E	RGD:6480464	20190910	CTD	MESH:C081489	Valsartan inhibits the reaction [Isoproterenol results in increased phosphorylation of HDAC2 protein]	PMID:31009642
1312509	HDAC2	histone deacetylase 2	gene	CHEBI:9927	valsartan	multiple interactions	ISO	RGD:619976	E	RGD:6480464	20190910	CTD	MESH:C081489	Valsartan inhibits the reaction [Isoproterenol results in increased phosphorylation of HDAC2 protein]	PMID:31009642
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:10929	E	RGD:6480464	20230704	CTD	MESH:C084079	triptonide results in increased expression of MUC17 mRNA	PMID:33045310
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:3124	E	RGD:6480464	20250401	CTD	MESH:D001280	Atrazine affects the methylation of MUC17 gene	PMID:35440735
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of MUC17 mRNA	PMID:31614463
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MUC17 exon	PMID:30157460
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:10929	E	RGD:6480464	20260303	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MUC17 mRNA	PMID:40389097
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:10929	E	RGD:6480464	20230704	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MUC17 mRNA	PMID:26377647
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MUC17 promoter	PMID:27901495
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of MUC17 gene	PMID:25435355
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:10929	E	RGD:6480464	20230704	CTD	MESH:C009495	titanium dioxide results in increased expression of MUC17 mRNA	PMID:29264374
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:10929	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of MUC17 mRNA	PMID:39298647
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:10929	E	RGD:6480464	20241001	CTD	MESH:C543008	bisphenol S results in increased expression of MUC17 mRNA	PMID:38908815
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:10929	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MUC17 mRNA	PMID:38685157
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:3124	E	RGD:6480464	20250401	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MUC17 mRNA	PMID:34075131
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:3639	chlorothalonil	multiple interactions	ISO	RGD:10929	E	RGD:6480464	20230704	CTD	MESH:C005806	[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of MUC17 mRNA	PMID:33246813
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:10929	E	RGD:6480464	20230704	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of MUC17 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MUC17 mRNA]	PMID:17585979
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MUC17 gene	PMID:29154799
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:10929	E	RGD:6480464	20230704	CTD	MESH:D000082	Acetaminophen affects the expression of MUC17 mRNA	PMID:17562736
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:10929	E	RGD:6480464	20230704	CTD	MESH:D000082	Acetaminophen results in increased expression of MUC17 mRNA	PMID:29246445
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:10929	E	RGD:6480464	20230704	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of MUC17 mRNA; PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of MUC17 mRNA]; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MUC17 mRNA]	PMID:17585979|PMID:29246445
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	decreases expression	ISO	RGD:3124	E	RGD:6480464	20250401	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in decreased expression of MUC17 mRNA	PMID:17375077
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:3124	E	RGD:6480464	20250401	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of MUC17 mRNA	PMID:17449585
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:3124	E	RGD:6480464	20250401	CTD	MESH:D014302	Active Hexose Correlated Compound inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MUC17 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MUC17 mRNA]	PMID:17449585
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:3124	E	RGD:6480464	20250401	CTD	MESH:D008731	Methoxychlor affects the methylation of MUC17 gene	PMID:35440735
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:10929	E	RGD:6480464	20230704	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MUC17 mRNA	PMID:22206623
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:81927	enilconazole	decreases expression	ISO	RGD:10929	E	RGD:6480464	20230704	CTD	MESH:C017435	enilconazole results in decreased expression of MUC17 mRNA	PMID:32814239
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:82036	prothioconazole	increases expression	ISO	RGD:10929	E	RGD:6480464	20250401	CTD	MESH:C550005	prothioconazole results in increased expression of MUC17 mRNA	PMID:36007749
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:8450	procymidone	decreases expression	ISO	RGD:10929	E	RGD:6480464	20230704	CTD	MESH:C035988	procymidone results in decreased expression of MUC17 mRNA	PMID:36764477
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:8450	procymidone	increases expression	ISO	RGD:10929	E	RGD:6480464	20230704	CTD	MESH:C035988	procymidone results in increased expression of MUC17 mRNA	PMID:33246813
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:8450	procymidone	multiple interactions	ISO	RGD:10929	E	RGD:6480464	20230704	CTD	MESH:C035988	[tetrachloroisophthalonitrile co-treated with procymidone] results in increased expression of MUC17 mRNA	PMID:33246813
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:9334	sulfasalazine	multiple interactions	ISO	RGD:3124	E	RGD:6480464	20250401	CTD	MESH:D012460	Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MUC17 mRNA]	PMID:17449585
1312511	MUC17	mucin 17, cell surface associated	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:3124	E	RGD:6480464	20250401	CTD	MESH:C025643	vinclozolin results in decreased methylation of MUC17 gene	PMID:31079544
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ERCC4 mRNA	PMID:37042841
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:17148	putrescine	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D011700	Putrescine results in increased expression of ERCC4 mRNA	PMID:40086645
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D005947	Glucose results in increased expression of ERCC4 mRNA; Glucose results in increased expression of ERCC4 protein	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D005947	3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 protein]	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ERCC4 mRNA	PMID:33359661
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D005947	Glucose results in increased expression of ERCC4 mRNA; Glucose results in increased expression of ERCC4 protein	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D005947	3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 protein]	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:17642	pentachlorophenol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010416	Pentachlorophenol results in increased expression of ERCC4 mRNA	PMID:18486366
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1560340	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ERCC4 mRNA	PMID:27523638
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ERCC4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ERCC4 mRNA	PMID:39836092
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of ERCC4 mRNA	PMID:24376830
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312518	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ERCC4 mRNA	PMID:19770486
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1312518	E	RGD:6480464	20240206	CTD	MESH:D009151	Mustard Gas results in decreased expression of ERCC4 mRNA	PMID:19778212
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in increased expression of ERCC4 mRNA	PMID:28652203
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312518	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ERCC4 mRNA	PMID:22206623
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of ERCC4 mRNA	PMID:12569548
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ERCC4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 protein; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ERCC4 mRNA; trichostatin A inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 mRNA]; trichostatin A inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 protein]	PMID:32031413|PMID:39836092
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312518	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ERCC4 mRNA	PMID:40504410
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:27638	cobalt atom	increases expression	ISO	RGD:1312518	E	RGD:6480464	20120717	CTD	MESH:D003035	Cobalt results in increased expression of ERCC4 mRNA	PMID:22147119
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:27656	camptothecin	decreases response to substance	EXP		E	RGD:6480464	20120501	CTD	MESH:D002166	ERCC4 protein results in decreased susceptibility to Camptothecin	PMID:21227924
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:27656	camptothecin	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D002166	ERCC4 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AX protein]]	PMID:21227924
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of ERCC4 protein	PMID:35688186
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ERCC4 mRNA	PMID:23557933
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	ERCC4 mRNA results in decreased susceptibility to Cisplatin	PMID:21452186
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of ERCC4 mRNA; Cisplatin results in increased expression of ERCC4 protein	PMID:21996734
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[ERCC1 protein binds to ERCC4 protein] which results in decreased susceptibility to Cisplatin; DUSP6 inhibits the reaction [Cisplatin results in increased expression of ERCC4 mRNA]	PMID:21357694|PMID:21996734
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312518	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ERCC4 mRNA	PMID:21570461
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312518	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ERCC4 mRNA	PMID:19770486
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ERCC4 mRNA	PMID:28001369
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:28509	chloroethene	affects response to substance	EXP		E	RGD:6480464	20121113	CTD	MESH:D014752	ERCC4 5' UTR SNP affects the susceptibility to Vinyl Chloride	PMID:21216194
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ERCC4 mRNA	PMID:29803840
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ERCC4 protein	PMID:35688186
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1312518	E	RGD:6480464	20120412	CTD	MESH:D001205	[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC4 mRNA	PMID:17917374
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of ERCC4 mRNA	PMID:37762697
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ERCC4 mRNA	PMID:22714537
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ERCC4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 protein; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ERCC4 mRNA; trichostatin A inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 mRNA]; trichostatin A inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 protein]	PMID:32031413|PMID:39836092
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312518	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ERCC4 mRNA	PMID:40504410
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312518	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ERCC4 mRNA	PMID:19770486
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312518	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ERCC4 3' UTR; Benzo(a)pyrene results in decreased methylation of ERCC4 exon	PMID:27901495
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ERCC4 mRNA	PMID:28461126
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ERCC4 mRNA	PMID:28593498
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ERCC4 mRNA	PMID:17530438
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ERCC4 gene	PMID:31601247
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:31941	oxaliplatin	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	ERCC4 protein affects the susceptibility to oxaliplatin	PMID:16773204
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312518	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ERCC4 gene	PMID:35295148
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:33007	chromium(6+)	affects expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ERCC4 mRNA	PMID:30690063
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1560340	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ERCC4 mRNA	PMID:19167457
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1560340	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ERCC4 mRNA	PMID:25181051
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ERCC4 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ERCC4 mRNA	PMID:28628672|PMID:31601247
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERCC4 mRNA	PMID:28628672
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ERCC4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERCC4 mRNA	PMID:28628672
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312518	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC4 mRNA	PMID:17917374
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ERCC4 mRNA	PMID:37042841
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:351346	phenethyl isothiocyanate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in increased expression of ERCC4 mRNA	PMID:20442190
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ERCC4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ERCC4 mRNA	PMID:39836092
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1560340	E	RGD:6480464	20120613	CTD	MESH:D002994	Clofibrate results in increased expression of ERCC4 mRNA	PMID:12851107
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:38211	potassium bromate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C019536	potassium bromate results in decreased expression of ERCC4 mRNA	PMID:22539617
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D003474	Curcumin results in decreased expression of ERCC4 mRNA; Curcumin results in decreased expression of ERCC4 protein	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D003474	Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 protein]	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1560340	E	RGD:6480464	20180313	CTD	MESH:D003474	Curcumin inhibits the reaction [Streptozocin results in increased expression of ERCC4 mRNA]	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ERCC4 mRNA	PMID:28001369
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of ERCC4 mRNA	PMID:24935251
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ERCC4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERCC4 mRNA	PMID:28628672
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D005947	Glucose results in increased expression of ERCC4 mRNA; Glucose results in increased expression of ERCC4 protein	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D005947	3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 protein]	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:43572	kojic acid	multiple interactions	ISO	RGD:1312518	E	RGD:6480464	20120412	CTD	MESH:C011890	[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC4 mRNA	PMID:17917374
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:C012589	trichostatin A results in decreased expression of ERCC4 mRNA	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ERCC4 mRNA	PMID:24935251
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:C012589	trichostatin A inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 mRNA]; trichostatin A inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 protein]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 protein]	PMID:22228707|PMID:32031413
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312518	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ERCC4 mRNA	PMID:17562736
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of ERCC4 mRNA	PMID:26690555
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of ERCC4 mRNA	PMID:12569548
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ERCC4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 protein; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ERCC4 mRNA; trichostatin A inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 mRNA]; trichostatin A inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ERCC4 protein]	PMID:32031413|PMID:39836092
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312518	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ERCC4 mRNA	PMID:40504410
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:472805	ouabain	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D010042	Ouabain results in decreased expression of ERCC4 mRNA	PMID:24124520
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016766	sulforaphane results in increased expression of ERCC4 mRNA	PMID:20442190
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ERCC4 mRNA; epigallocatechin gallate inhibits the reaction [potassium chromate(VI) results in decreased expression of ERCC4 mRNA]	PMID:22079256
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312518	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ERCC4 mRNA	PMID:17555576
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ERCC4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ERCC4 mRNA	PMID:28628672
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ERCC4 mRNA	PMID:17530438
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:50102	N-methyl-N-nitrosourea	decreases expression	ISO	RGD:1312518	E	RGD:6480464	20120412	CTD	MESH:D008770	Methylnitrosourea results in decreased expression of ERCC4 mRNA	PMID:16616109
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1312518	E	RGD:6480464	20120412	CTD	MESH:D008770	Methylnitrosourea results in increased expression of ERCC4 mRNA	PMID:16616109
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:52717	bortezomib	increases response to substance	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	ERCC4 gene SNP results in increased susceptibility to Bortezomib	PMID:20864405
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:62880	veliparib	multiple interactions	EXP		E	RGD:6480464	20170103	CTD	MESH:C521013	ERCC4 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AX protein]]	PMID:21227924
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ERCC4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ERCC4 mRNA	PMID:39836092
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:64042	3-aminobenzamide	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:C025160	3-aminobenzamide results in decreased expression of ERCC4 mRNA; 3-aminobenzamide results in decreased expression of ERCC4 protein	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:64042	3-aminobenzamide	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:C025160	3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 protein]	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:64042	3-aminobenzamide	multiple interactions	ISO	RGD:1560340	E	RGD:6480464	20180313	CTD	MESH:C025160	3-aminobenzamide inhibits the reaction [Streptozocin results in increased expression of ERCC4 mRNA]	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1560340	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ERCC4 mRNA; 1-Methyl-4-phenylpyridinium results in increased expression of ERCC4 protein	PMID:20101267|PMID:28801915
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312518	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ERCC4 mRNA	PMID:22206623
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ERCC4 mRNA	PMID:22079256
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ERCC4 mRNA	PMID:22714537
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ERCC4 mRNA; epigallocatechin gallate inhibits the reaction [potassium chromate(VI) results in decreased expression of ERCC4 mRNA]	PMID:22079256
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:75270	nimustine	decreases response to substance	EXP		E	RGD:6480464	20160119	CTD	MESH:D015376	ERCC4 protein results in decreased susceptibility to Nimustine	PMID:26418950
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ERCC4 protein	PMID:31285264
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of ERCC4 mRNA	PMID:23726867
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:88249	PD 0325901	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C506614	mirdametinib results in increased expression of ERCC4 mRNA	PMID:21996734
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1560340	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ERCC4 mRNA	PMID:19281266
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1560340	E	RGD:6480464	20180313	CTD	MESH:D013311	Streptozocin results in increased expression of ERCC4 mRNA; Streptozocin results in increased expression of ERCC4 protein	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1560340	E	RGD:6480464	20180313	CTD	MESH:D013311	3-aminobenzamide inhibits the reaction [Streptozocin results in increased expression of ERCC4 mRNA]; Curcumin inhibits the reaction [Streptozocin results in increased expression of ERCC4 mRNA]	PMID:22228707
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ERCC4 mRNA	PMID:38568856
1312517	ERCC4	ERCC excision repair 4, endonuclease catalytic subunit	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ERCC4 mRNA	PMID:29301935
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550044	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZFP444 mRNA	PMID:33045310
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1304847	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ZFP444 mRNA	PMID:30071829
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550044	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP444 gene	PMID:20938992
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFP444 mRNA	PMID:39241906
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ZNF444 mRNA	PMID:31614463
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ZNF444 mRNA	PMID:38568856
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550044	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP444 gene	PMID:20938992
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF444 mRNA	PMID:37042841
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZNF444 protein	PMID:37730182
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304847	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP444 mRNA	PMID:33387578
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZNF444 mRNA	PMID:28818685
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZNF444 gene	PMID:27153756
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550044	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP444 gene	PMID:20938992
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF444 gene	PMID:25304211
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ZNF444 mRNA	PMID:23557933
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP444 mRNA	PMID:19770486
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304847	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP444 mRNA	PMID:33387578
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:28794	coumarin	increases expression	ISO	RGD:1304847	E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of ZFP444 mRNA	PMID:18480146
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF444 mRNA	PMID:38568856|PMID:39719251
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZNF444 mRNA	PMID:32234424
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1304847	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZFP444 mRNA	PMID:21839799
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZFP444 mRNA	PMID:19770486|PMID:27195522
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1550044	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of ZFP444 gene	PMID:35295148
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550044	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of ZFP444 mRNA	PMID:29264374
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304847	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZFP444 mRNA	PMID:34492290
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ZFP444 mRNA	PMID:20813756
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:32687	piperonyl butoxide	increases expression	ISO	RGD:1304847	E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of ZFP444 mRNA	PMID:22484513
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1550044	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ZFP444 promoter	PMID:27334623
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304847	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZNF444 mRNA	PMID:25181051
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304847	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP444 mRNA	PMID:34947998
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550044	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP444 mRNA	PMID:33221593
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1304847	E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of ZNF444 mRNA	PMID:23829299
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550044	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ZFP444 gene	PMID:31683443
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ZFP444 mRNA	PMID:39298647
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550044	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ZFP444 mRNA	PMID:37019170
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1550044	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ZFP444 mRNA	PMID:34813904
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZNF444 mRNA	PMID:38174414|PMID:38568856
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ZFP444 mRNA	PMID:17585979
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ZNF444 mRNA	PMID:31533062
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF444 mRNA	PMID:22083351
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZFP444 mRNA	PMID:21427059
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZNF444 gene	PMID:29154799
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1550044	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of ZFP444 mRNA	PMID:21427059
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZNF444 mRNA	PMID:20106945
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZFP444 mRNA	PMID:19770486
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550044	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ZNF444 mRNA	PMID:28973697
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ZNF444 mRNA	PMID:38832940
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZNF444 mRNA	PMID:22230336|PMID:29067470
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF444 gene	PMID:25304211
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1550044	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZFP444 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP444 mRNA	PMID:21641980|PMID:26378955
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1304847	E	RGD:6480464	20180220	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ZFP444 mRNA	PMID:27840820
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:755208	eprenetapopt	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of ZNF444 mRNA	PMID:19946333
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of ZNF444 mRNA]	PMID:19946333
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304847	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ZFP444 mRNA	PMID:21346803
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ZNF444 mRNA	PMID:38568856
1312520	ZNF444	zinc finger protein 444	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304847	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ZFP444 mRNA	PMID:21346803
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of ATAD2 protein	PMID:39638853
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ATAD2 mRNA	PMID:38218311
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:110423	clodronic acid	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in increased expression of ATAD2 mRNA	PMID:25596134
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of ATAD2 mRNA	PMID:16249480|PMID:33167477
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of ATAD2 mRNA	PMID:25596134
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of ATAD2 mRNA	PMID:29018328
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of ATAD2 mRNA	PMID:29581250
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312523	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATAD2 mRNA	PMID:39241906
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ATAD2 mRNA	PMID:30510588
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:D004958	Estradiol results in increased expression of ATAD2 mRNA	PMID:16474171|PMID:18310284|PMID:19167446
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of ATAD2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ATAD2 mRNA	PMID:17404688|PMID:20660070
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ATAD2 mRNA	PMID:38568856
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:16602	trichloroethene	decreases methylation	ISO	RGD:1304849	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of ATAD2 gene	PMID:27618143
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of ATAD2 mRNA	PMID:17404688
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of ATAD2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ATAD2 mRNA	PMID:17404688|PMID:20660070
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ATAD2 mRNA	PMID:21179406
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:17270	glycerol 2-phosphate	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:C031463	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of ATAD2 mRNA	PMID:26424790
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ATAD2 mRNA	PMID:33754040
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304849	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ATAD2 mRNA	PMID:27523638
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ATAD2 protein	PMID:37730182
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304849	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ATAD2 mRNA	PMID:22061828
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ATAD2 mRNA	PMID:28818685
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ATAD2 mRNA	PMID:19549813
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304849	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ATAD2 mRNA	PMID:21396975
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ATAD2 protein	PMID:39638853
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ATAD2 mRNA	PMID:23649840
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312523	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of ATAD2 mRNA	PMID:32553695
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ATAD2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ATAD2 mRNA	PMID:34911549
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312523	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ATAD2 mRNA	PMID:27339419|PMID:31919559
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATAD2 gene	PMID:25304211
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ATAD2 protein	PMID:35688186
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304849	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ATAD2 mRNA	PMID:31881176
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:27871	chloroacetaldehyde	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde affects the expression of ATAD2 mRNA	PMID:25596134
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in increased expression of ATAD2 mRNA	PMID:19167446
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of ATAD2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of ATAD2 mRNA	PMID:19167446|PMID:23557933
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ATAD2 mRNA	PMID:27392435
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1304849	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ATAD2 mRNA	PMID:22023808
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:27899	cisplatin	decreases phosphorylation	ISO	RGD:1312523	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased phosphorylation of ATAD2 protein	PMID:22006019
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in increased expression of ATAD2 mRNA	PMID:25596134|PMID:27594783
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ATAD2 mRNA	PMID:27392435
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ATAD2 mRNA	PMID:30912803
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of ATAD2 mRNA	PMID:16474171
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ATAD2 mRNA	PMID:25583101
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATAD2 mRNA	PMID:22574217
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312523	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATAD2 mRNA	PMID:21570461|PMID:24680724
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATAD2 mRNA	PMID:20106945|PMID:21632981|PMID:21802500
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304849	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATAD2 mRNA	PMID:32109520
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304849	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATAD2 mRNA	PMID:34747641
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ATAD2 mRNA	PMID:25975270
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ATAD2 mRNA	PMID:28001369
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of ATAD2 mRNA	PMID:23649840
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ATAD2 mRNA	PMID:20971185
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATAD2 mRNA	PMID:29803840
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ATAD2 protein	PMID:35688186
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D001205	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of ATAD2 mRNA	PMID:26424790
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of ATAD2 mRNA	PMID:22623647
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATAD2 mRNA	PMID:29301061
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of ATAD2 mRNA	PMID:34032870
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATAD2 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:21802500
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATAD2 mRNA	PMID:19770486
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312523	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATAD2 mRNA	PMID:20713471
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20201006	CTD	MESH:D001564	[Benzo(a)pyrene results in increased activity of AHR protein] which results in decreased expression of ATAD2 mRNA	PMID:32553695
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ATAD2 mRNA]	PMID:32406909
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ATAD2 mRNA	PMID:20971185
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ATAD2 mRNA	PMID:23806026
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ATAD2 mRNA	PMID:19150397|PMID:20382639
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ATAD2 mRNA	PMID:26238291
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATAD2 mRNA	PMID:29266867
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Dasatinib co-treated with Arsenic Trioxide] results in decreased expression of ATAD2 mRNA	PMID:29266867
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:31175	adefovir pivoxil	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of ATAD2 mRNA	PMID:25596134
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATAD2 gene	PMID:31601247
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of ATAD2 mRNA	PMID:38568856
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1304849	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ATAD2 mRNA	PMID:25729387
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304849	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ATAD2 mRNA	PMID:25729387
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312523	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATAD2 promoter alternative form	PMID:35295148
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312523	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ATAD2 gene	PMID:35295148
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304849	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ATAD2 mRNA	PMID:34492290
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ATAD2 mRNA	PMID:19710929
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312523	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ATAD2 mRNA	PMID:28472532
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ATAD2 mRNA	PMID:38479592
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ATAD2 mRNA	PMID:30903817
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ATAD2 mRNA	PMID:29275510
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304849	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ATAD2 mRNA	PMID:25181051
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ATAD2 mRNA	PMID:26063408
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of ATAD2 mRNA	PMID:16474171
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304849	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of ATAD2 mRNA	PMID:32145629
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of ATAD2 protein; [bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATAD2 gene	PMID:31601247|PMID:33376534
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312523	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of ATAD2 mRNA	PMID:26682919
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312523	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of ATAD2 mRNA	PMID:20713471
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ATAD2 mRNA	PMID:39298647|PMID:40203079
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ATAD2 mRNA	PMID:37019170
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ATAD2 mRNA	PMID:17361019|PMID:21266533
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of ATAD2 mRNA	PMID:36117858
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1304849	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of ATAD2 gene	PMID:33148267
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATAD2 mRNA	PMID:37042841
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1304849	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of ATAD2 mRNA	PMID:18500788
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride affects the expression of ATAD2 mRNA	PMID:25596134
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ATAD2 protein	PMID:26879310
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ATAD2 mRNA	PMID:19376846
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:3696	cidofovir anhydrous	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in increased expression of ATAD2 mRNA	PMID:25596134
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ATAD2 mRNA	PMID:32588087
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ATAD2 mRNA	PMID:40194260
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ATAD2 mRNA	PMID:28302478
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ATAD2 mRNA	PMID:31533062
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ATAD2 mRNA	PMID:19167446
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of ATAD2 mRNA	PMID:19167446
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312523	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ATAD2 mRNA	PMID:39529242
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ATAD2 mRNA	PMID:40419075
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312523	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ATAD2 mRNA	PMID:17292431
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATAD2 mRNA	PMID:27188386
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATAD2 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D003907	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of ATAD2 mRNA	PMID:26424790
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312523	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ATAD2 mRNA	PMID:28973697
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of ATAD2 mRNA	PMID:23649840
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ATAD2 mRNA	PMID:38832940
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of ATAD2 mRNA	PMID:26272509
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD2 mRNA	PMID:27188386
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ATAD2 mRNA	PMID:22230336
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304849	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ATAD2 mRNA	PMID:33387578
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATAD2 gene	PMID:25304211
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of ATAD2 mRNA	PMID:36621641
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATAD2 mRNA	PMID:29266867
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Dasatinib co-treated with Arsenic Trioxide] results in decreased expression of ATAD2 mRNA	PMID:29266867
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of ATAD2 mRNA	PMID:21148553
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of ATAD2 mRNA	PMID:36117858
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312523	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ATAD2 mRNA	PMID:19042947
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ATAD2 protein	PMID:32959892
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATAD2 mRNA	PMID:21641980
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304849	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ATAD2 mRNA	PMID:25729387
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ATAD2 mRNA	PMID:15336504
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ATAD2 mRNA	PMID:24810058
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1304849	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ATAD2 mRNA	PMID:37269647
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312523	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of ATAD2 mRNA	PMID:20003209
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1304849	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of ATAD2 mRNA	PMID:35283115
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1304849	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of ATAD2 gene	PMID:33148267
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of ATAD2 mRNA	PMID:29522793
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ATAD2 mRNA	PMID:37199045
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:754906	afuresertib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of ATAD2 mRNA	PMID:28960945
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ATAD2 protein	PMID:31285264
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:76989	phytoestrogen	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:D048789	Phytoestrogens results in increased expression of ATAD2 mRNA	PMID:18310284
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD2 mRNA	PMID:27188386
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATAD2 gene]	PMID:28238834
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312523	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ATAD2 mRNA	PMID:23091169
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312523	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ATAD2 mRNA	PMID:19482888
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312523	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ATAD2 mRNA]	PMID:19482888
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:81555	Enterolactone	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of ATAD2 mRNA	PMID:19167446
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATAD2 mRNA	PMID:19167446
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of ATAD2 mRNA	PMID:21858171
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1304849	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of ATAD2 mRNA	PMID:24780913
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304849	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ATAD2 mRNA	PMID:25825206
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1304849	E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of ATAD2 mRNA	PMID:32419051
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATAD2 mRNA	PMID:27188386
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:9111	Senkirkine	increases expression	ISO	RGD:1304849	E	RGD:6480464	20200915	CTD	MESH:C009238	senkirkine results in increased expression of ATAD2 mRNA	PMID:32419051
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of ATAD2 mRNA	PMID:22378314
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312523	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of ATAD2 protein	PMID:24648495
1312522	ATAD2	ATPase family AAA domain containing 2	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304849	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of ATAD2 mRNA	PMID:23034163
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of SMARCC1 protein	PMID:39638853
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SMARCC1 mRNA	PMID:33045310
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SMARCC1 mRNA	PMID:26251327
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of SMARCC1 mRNA	PMID:15498508|PMID:33167477
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014212	Tretinoin results in increased expression of SMARCC1 mRNA	PMID:22906706
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312525	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SMARCC1 mRNA	PMID:30319688
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312525	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SMARCC1 mRNA	PMID:39298647
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SMARCC1 mRNA	PMID:38568856
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304850	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SMARCC1 mRNA	PMID:33387578
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SMARCC1 mRNA	PMID:37042841
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312525	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SMARCC1 mRNA	PMID:23892564
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SMARCC1 mRNA	PMID:33754040
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SMARCC1 protein	PMID:37730182
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304850	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SMARCC1 mRNA	PMID:33387578
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SMARCC1 protein	PMID:23301498
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of SMARCC1 protein	PMID:19845377
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304850	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SMARCC1 mRNA	PMID:30779732
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of SMARCC1 mRNA	PMID:15672453
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of SMARCC1 mRNA	PMID:18414638
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312525	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMARCC1 mRNA	PMID:40504410
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SMARCC1 mRNA	PMID:19244175
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of SMARCC1 mRNA	PMID:19244175
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27690	acetazolamide	increases expression	ISO	RGD:1312525	E	RGD:6480464	20120717	CTD	MESH:D000086	Acetazolamide results in increased expression of SMARCC1 mRNA	PMID:19274763
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of SMARCC1 protein	PMID:35688186
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of SMARCC1 protein	PMID:37208198
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SMARCC1 mRNA	PMID:28903495
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of SMARCC1 mRNA	PMID:27594783
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SMARCC1 mRNA	PMID:30912803
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312525	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMARCC1 mRNA	PMID:21570461
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304850	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMARCC1 mRNA	PMID:33387578
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312525	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCC1 mRNA	PMID:17942748
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SMARCC1 mRNA	PMID:33212167
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SMARCC1 mRNA	PMID:39709020
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304850	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SMARCC1 mRNA	PMID:28959563
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312525	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SMARCC1 protein	PMID:28918527
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SMARCC1 protein	PMID:35688186
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312525	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMARCC1 mRNA	PMID:40504410
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMARCC1 mRNA	PMID:20064835
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMARCC1 mRNA	PMID:19770486
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:30621	diarsenic trioxide	increases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	SMARCC1 protein results in increased susceptibility to Arsenic Trioxide	PMID:20707922
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:31638	fulvestrant	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C070081	fulvestrant results in increased expression of SMARCC1 protein	PMID:24169358
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304850	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SMARCC1 mRNA	PMID:25729387
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:32181	tamibarotene	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of SMARCC1 mRNA	PMID:15498508
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1312525	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of SMARCC1 promoter	PMID:35295148
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SMARCC1 mRNA	PMID:33221593
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304850	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SMARCC1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304850	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SMARCC1 gene	PMID:28505145
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SMARCC1 mRNA	PMID:19244175
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of SMARCC1 mRNA	PMID:19244175
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1304850	E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of SMARCC1 mRNA	PMID:23829299
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of SMARCC1 gene	PMID:31601247
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312525	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SMARCC1 mRNA	PMID:38685157
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SMARCC1 mRNA	PMID:28392331
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SMARCC1 mRNA	PMID:37019170
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SMARCC1 mRNA	PMID:21266533
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SMARCC1 mRNA	PMID:37042841
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SMARCC1 mRNA	PMID:19320972|PMID:19376846
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:C018021	cobaltous chloride promotes the reaction [TP53 protein mutant form binds to SMARCC1 protein]	PMID:30381462
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1304850	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of SMARCC1 mRNA	PMID:25380136
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SMARCC1 mRNA	PMID:19244175
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of SMARCC1 mRNA	PMID:19244175
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SMARCC1 mRNA	PMID:25979313
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMARCC1 mRNA	PMID:19101580|PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMARCC1 mRNA	PMID:19136453
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of SMARCC1 mRNA	PMID:17183730
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of SMARCC1 mRNA	PMID:33512557
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312525	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SMARCC1 mRNA	PMID:17562736
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304850	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMARCC1 mRNA	PMID:33387578
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of SMARCC1 mRNA	PMID:18414638
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312525	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMARCC1 mRNA	PMID:40504410
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of SMARCC1 mRNA	PMID:36621641
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SMARCC1 mRNA	PMID:35436446
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312525	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SMARCC1 mRNA	PMID:17942748
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312525	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCC1 mRNA	PMID:17942748
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of SMARCC1 mRNA	PMID:23228038
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:49900	arsenous acid	increases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	SMARCC1 protein results in increased susceptibility to Arsenic Trioxide	PMID:20707922
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304850	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of SMARCC1 mRNA	PMID:24793618
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312525	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SMARCC1 mRNA	PMID:19042947
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of SMARCC1 mRNA	PMID:17183730
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304850	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SMARCC1 mRNA	PMID:25729387
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:6382	Lasiocarpine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SMARCC1 mRNA	PMID:33884520
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:63924	riddelliine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of SMARCC1 mRNA	PMID:33884520
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SMARCC1 mRNA	PMID:23650126
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SMARCC1 mRNA	PMID:15336504
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1304850	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SMARCC1 mRNA	PMID:28801915
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:6980	monocrotaline	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of SMARCC1 mRNA	PMID:33884520
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SMARCC1 mRNA	PMID:31758290
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312525	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SMARCC1 mRNA	PMID:22206623
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of SMARCC1 mRNA	PMID:31558096
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304850	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SMARCC1 mRNA	PMID:24780913
1312524	SMARCC1	SWI/SNF related BAF chromatin remodeling complex subunit C1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312525	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SMARCC1 mRNA	PMID:28973697
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312527	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CDK10 mRNA	PMID:33045310
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin affects the expression of CDK10 mRNA	PMID:15498508
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CDK10 mRNA	PMID:26079696
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of CDK10 mRNA	PMID:12419474
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D011794	Quercetin results in decreased expression of CDK10 mRNA	PMID:30152185
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312527	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CDK10 mRNA	PMID:39241906
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D004958	Estradiol affects the expression of CDK10 mRNA	PMID:21826169
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CDK10 mRNA	PMID:37042841
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CDK10 mRNA	PMID:26079696
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CDK10 mRNA	PMID:31163220
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CDK10 protein	PMID:37730182
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CDK10 mRNA	PMID:28818685
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDK10 mRNA	PMID:39836092
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312527	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CDK10 mRNA]	PMID:22206623
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDK10 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CDK10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDK10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK10 mRNA	PMID:39836092|PMID:40512198
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CDK10 mRNA	PMID:19244175
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA	PMID:19244175
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CDK10 mRNA	PMID:23557933
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of CDK10 promoter	PMID:22847954
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312527	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDK10 mRNA	PMID:21570461
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304851	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDK10 mRNA	PMID:33387578
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of CDK10 mRNA	PMID:23649840
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CDK10 mRNA	PMID:32763439
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of CDK10 mRNA	PMID:29803840
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of CDK10 mRNA	PMID:16404146
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CDK10 mRNA	PMID:29432896
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDK10 mRNA	PMID:38568856
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CDK10 mRNA	PMID:39719251
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDK10 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CDK10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDK10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK10 mRNA	PMID:39836092|PMID:40512198
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CDK10 promoter	PMID:27901495
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312527	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDK10 mRNA	PMID:22228805
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312527	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CDK10 mRNA	PMID:39716349
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CDK10 gene	PMID:31601247
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:32181	tamibarotene	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of CDK10 mRNA	PMID:15498508
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312527	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDK10 gene	PMID:35295148
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304851	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CDK10 mRNA	PMID:34492290
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A affects the expression of CDK10 mRNA	PMID:21826169
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304851	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CDK10 mRNA	PMID:30816183|PMID:32528016|PMID:33296240
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA	PMID:19244175
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312527	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CDK10 exon	PMID:33297965
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312527	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of CDK10 mRNA	PMID:40203079
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312527	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CDK10 mRNA	PMID:38685157
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of CDK10 mRNA	PMID:29024780
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDK10 mRNA	PMID:39836092
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1304851	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of CDK10 mRNA	PMID:30723492
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CDK10 mRNA	PMID:38174414|PMID:38568856
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1304851	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CDK10 mRNA	PMID:24386269
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CDK10 mRNA	PMID:19244175
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA	PMID:19244175
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312527	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CDK10 mRNA	PMID:40194260
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of CDK10 promoter	PMID:22847954
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CDK10 mRNA	PMID:31533062
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of CDK10 promoter	PMID:22847954
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CDK10 mRNA	PMID:40419075
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CDK10 mRNA	PMID:29154799
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CDK10 mRNA	PMID:15766595
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:43572	kojic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of CDK10 mRNA	PMID:16595896
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CDK10 mRNA	PMID:38832940
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CDK10 mRNA	PMID:28542535
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312527	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CDK10 mRNA	PMID:17562736
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CDK10 mRNA	PMID:22230336
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDK10 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CDK10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDK10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK10 mRNA	PMID:39836092|PMID:40512198
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:48707	(-)-citrinin	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D002953	[Citrinin co-treated with ochratoxin A] results in decreased expression of CDK10 mRNA	PMID:30428381
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312527	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CDK10 mRNA	PMID:39716349
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304851	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of CDK10 mRNA	PMID:24793618
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of CDK10 mRNA	PMID:22714537
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDK10 mRNA	PMID:39836092
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CDK10 mRNA	PMID:12419474
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1304851	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of CDK10 mRNA	PMID:19564919
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304851	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CDK10 mRNA	PMID:30467583
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312527	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CDK10 mRNA	PMID:22206623
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312527	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CDK10 mRNA]	PMID:22206623
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CDK10 mRNA	PMID:22714537
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of CDK10 mRNA	PMID:11830524
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025589	ochratoxin A results in decreased expression of CDK10 mRNA	PMID:30428381
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C025589	[Citrinin co-treated with ochratoxin A] results in decreased expression of CDK10 mRNA	PMID:30428381
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of CDK10 mRNA	PMID:26079696
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312527	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CDK10 mRNA	PMID:21278054
1312526	CDK10	cyclin dependent kinase 10	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312527	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CDK10 mRNA	PMID:35537566
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312530	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DLX2 mRNA	PMID:33045310
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	EXP		E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of DLX2 mRNA	PMID:23792671
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312530	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of DLX2 protein	PMID:17551590
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of DLX2 mRNA	PMID:21934132
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312530	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of DLX2 protein	PMID:16806298|PMID:17064353
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312530	E	RGD:6480464	20120412	CTD	MESH:D014212	DKK1 protein promotes the reaction [Tretinoin results in increased expression of DLX2 protein]	PMID:17064353
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of DLX2 mRNA	PMID:26079696
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of DLX2 mRNA	PMID:22378314
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of DLX2 mRNA	PMID:21632981
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of DLX2 mRNA	PMID:29581250
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DLX2 mRNA	PMID:19619570
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DLX2 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of DLX2 mRNA	PMID:19619570|PMID:30165855
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of DLX2 mRNA	PMID:20655997|PMID:23649840
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of DLX2 mRNA	PMID:21795739
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of DLX2 mRNA	PMID:26079696
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of DLX2 mRNA	PMID:33647349
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:17579	beta-carotene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019207	beta Carotene results in increased expression of DLX2 mRNA	PMID:17034753
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:17750	glycine betaine	increases expression	ISO	RGD:1304853	E	RGD:6480464	20151215	CTD	MESH:D001622	Betaine results in increased expression of DLX2 mRNA	PMID:26391144
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304853	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of DLX2 mRNA	PMID:27523638
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304853	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DLX2 mRNA	PMID:33387578
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DLX2 mRNA	PMID:28818685
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	multiple interactions	ISO	RGD:1312530	E	RGD:6480464	20231205	CTD	MESH:D014284	[pyriproxyfen metabolite co-treated with Triiodothyronine] results in increased expression of DLX2 mRNA	PMID:34289950
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DLX2 mRNA	PMID:39836092
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DLX2 mRNA	PMID:35301059
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DLX2 mRNA	PMID:19549813
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DLX2 mRNA	PMID:21641981
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312530	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of DLX2 mRNA	PMID:15674843
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DLX2 mRNA	PMID:18593933
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312530	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DLX2 mRNA	PMID:25629700
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DLX2 mRNA; [Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of DLX2 gene	PMID:39164771|PMID:39836092
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of DLX2 mRNA	PMID:26272509
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA	PMID:27188386
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DLX2 protein	PMID:35688186
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of DLX2 mRNA	PMID:23557933
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312530	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of DLX2 mRNA	PMID:21151649
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of DLX2 mRNA	PMID:19561079
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of DLX2 mRNA	PMID:24768652
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312530	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DLX2 mRNA	PMID:21570461
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DLX2 mRNA	PMID:16704738|PMID:19619570|PMID:20106945|PMID:21632981|PMID:22903824
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304853	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DLX2 mRNA	PMID:33387578
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312530	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DLX2 mRNA	PMID:17586704|PMID:24058054
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DLX2 mRNA	PMID:19619570
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of DLX2 mRNA	PMID:29955902
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of DLX2 mRNA	PMID:28001369
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DLX2 mRNA	PMID:33212167
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of DLX2 mRNA	PMID:39719251
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DLX2 mRNA	PMID:16966095|PMID:28595984|PMID:34032870|PMID:38568856
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DLX2 mRNA; TP53 protein promotes the reaction [sodium arsenite results in increased expression of DLX2 mRNA]	PMID:16966095|PMID:39836092
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DLX2 3' UTR	PMID:27901495
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DLX2 mRNA	PMID:20106945|PMID:21632981|PMID:21714911
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of DLX2 promoter	PMID:23974009
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DLX2 mRNA	PMID:18593933
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of DLX2 mRNA	PMID:26014281
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of DLX2 mRNA; Silicon Dioxide results in increased expression of DLX2 mRNA	PMID:22300531|PMID:23806026|PMID:25351596|PMID:25895662
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of DLX2 mRNA	PMID:20382639
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1304853	E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in decreased expression of DLX2 mRNA	PMID:33150645
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:30966	glycidol	increases methylation	ISO	RGD:1304853	E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in increased methylation of DLX2 promoter	PMID:33150595
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1304853	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of DLX2 mRNA	PMID:16483693
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of DLX2 mRNA	PMID:38568856
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312530	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of DLX2 mRNA	PMID:22609695
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in decreased expression of DLX2 mRNA	PMID:34973136
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312530	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DLX2 gene	PMID:35295148
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312530	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of DLX2 mRNA	PMID:28329830
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1304853	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of DLX2 mRNA	PMID:19167457
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312530	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of DLX2 promoter	PMID:27334623
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312530	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of DLX2 mRNA	PMID:30951980
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of DLX2 mRNA	PMID:33476716
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:33418	graphite	affects expression	ISO	RGD:1304853	E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of DLX2 mRNA	PMID:29933104
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312530	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of DLX2 mRNA	PMID:30951980
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312530	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of DLX2 mRNA	PMID:40203079
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312530	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of DLX2 mRNA	PMID:30951980
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C008745	bisphenol F results in increased expression of DLX2 mRNA	PMID:33476716
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312530	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DLX2 mRNA	PMID:38685157
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DLX2 mRNA	PMID:39836092
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DLX2 mRNA	PMID:35301059
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DLX2 mRNA	PMID:19167446
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:39260	pyriproxyfen	increases expression	ISO	RGD:1312530	E	RGD:6480464	20231205	CTD	MESH:C055613	pyriproxyfen metabolite results in increased expression of DLX2 mRNA	PMID:34289950
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:39260	pyriproxyfen	multiple interactions	ISO	RGD:1312530	E	RGD:6480464	20231205	CTD	MESH:C055613	[pyriproxyfen metabolite co-treated with Triiodothyronine] results in increased expression of DLX2 mRNA	PMID:34289950
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DLX2 mRNA	PMID:25979313
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of DLX2 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA	PMID:27188386
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DLX2 mRNA	PMID:25562108
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DLX2 mRNA	PMID:38832940
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA	PMID:27188386
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of DLX2 mRNA	PMID:24935251|PMID:26272509
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA	PMID:27188386
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of DLX2 mRNA	PMID:22230336
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304853	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DLX2 mRNA	PMID:33387578
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DLX2 mRNA	PMID:18687144
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DLX2 mRNA; [Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of DLX2 gene	PMID:39164771|PMID:39836092
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of DLX2 mRNA	PMID:21856257
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of DLX2 mRNA	PMID:22714537
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:53154	8'-apo-beta,psi-caroten-8'-al	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004984	apocarotenal results in increased expression of DLX2 mRNA	PMID:17034753
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of DLX2 mRNA	PMID:31629900
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DLX2 mRNA	PMID:39836092
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of DLX2 mRNA	PMID:29432895
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1312530	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of DLX2 mRNA	PMID:14729362
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA	PMID:27188386
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DLX2 mRNA	PMID:19167446
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1304853	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DLX2 mRNA	PMID:21394737
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of DLX2 mRNA	PMID:24921660
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX2 mRNA	PMID:27188386
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of DLX2 mRNA	PMID:26014281
1312529	DLX2	distal-less homeobox 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DLX2 mRNA	PMID:38568856
1312532	CAPN7	calpain 7	gene	CHEBI:101381	aloxistatin	multiple interactions	EXP		E	RGD:6480464	20200331	CTD	MESH:C108192	aloxistatin inhibits the reaction [CAPN7 protein results in increased degradation of and results in decreased expression of SMN2 protein alternative form]	PMID:30910806
1312532	CAPN7	calpain 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312533	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CAPN7 mRNA	PMID:33045310
1312532	CAPN7	calpain 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312533	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CAPN7 mRNA	PMID:37995155
1312532	CAPN7	calpain 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CAPN7 mRNA	PMID:36331819
1312532	CAPN7	calpain 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CAPN7 mRNA	PMID:37042841
1312532	CAPN7	calpain 7	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CAPN7 mRNA	PMID:23649840
1312532	CAPN7	calpain 7	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CAPN7 mRNA	PMID:16002434
1312532	CAPN7	calpain 7	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304855	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CAPN7 mRNA	PMID:22061828
1312532	CAPN7	calpain 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CAPN7 mRNA	PMID:19549813
1312532	CAPN7	calpain 7	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CAPN7 mRNA	PMID:23649840
1312532	CAPN7	calpain 7	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CAPN7 mRNA	PMID:23649840
1312532	CAPN7	calpain 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CAPN7 mRNA	PMID:25629700
1312532	CAPN7	calpain 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CAPN7 mRNA	PMID:22206623
1312532	CAPN7	calpain 7	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CAPN7 mRNA	PMID:19244175
1312532	CAPN7	calpain 7	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CAPN7 mRNA	PMID:28960355
1312532	CAPN7	calpain 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312533	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CAPN7 mRNA	PMID:21570461
1312532	CAPN7	calpain 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312533	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CAPN7 mRNA	PMID:15034205
1312532	CAPN7	calpain 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CAPN7 mRNA]	PMID:15034205
1312532	CAPN7	calpain 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CAPN7 mRNA	PMID:28001369
1312532	CAPN7	calpain 7	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CAPN7 mRNA	PMID:29803840
1312532	CAPN7	calpain 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312533	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CAPN7 mRNA	PMID:15034205
1312532	CAPN7	calpain 7	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of CAPN7 mRNA]	PMID:15034205
1312532	CAPN7	calpain 7	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CAPN7 mRNA	PMID:19073995
1312532	CAPN7	calpain 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CAPN7 mRNA	PMID:19150397
1312532	CAPN7	calpain 7	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304855	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CAPN7 mRNA	PMID:30047161
1312532	CAPN7	calpain 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312533	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CAPN7 gene	PMID:35295148
1312532	CAPN7	calpain 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312533	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CAPN7 promoter	PMID:35295148
1312532	CAPN7	calpain 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CAPN7 mRNA	PMID:19710929
1312532	CAPN7	calpain 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of CAPN7 protein	PMID:31675489
1312532	CAPN7	calpain 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CAPN7 mRNA	PMID:33221593
1312532	CAPN7	calpain 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304855	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CAPN7 mRNA	PMID:25181051
1312532	CAPN7	calpain 7	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CAPN7 protein	PMID:31675489
1312532	CAPN7	calpain 7	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of CAPN7 mRNA	PMID:19244175
1312532	CAPN7	calpain 7	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CAPN7 mRNA	PMID:37019170
1312532	CAPN7	calpain 7	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of CAPN7 mRNA]	PMID:19030233
1312532	CAPN7	calpain 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CAPN7 mRNA	PMID:37042841
1312532	CAPN7	calpain 7	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CAPN7 mRNA	PMID:24449571
1312532	CAPN7	calpain 7	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CAPN7 mRNA	PMID:19244175
1312532	CAPN7	calpain 7	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of CAPN7 mRNA	PMID:17585979
1312532	CAPN7	calpain 7	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CAPN7 mRNA	PMID:28302478
1312532	CAPN7	calpain 7	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CAPN7 mRNA	PMID:31533062
1312532	CAPN7	calpain 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CAPN7 mRNA	PMID:36331819
1312532	CAPN7	calpain 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of CAPN7 mRNA	PMID:23179753
1312532	CAPN7	calpain 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of CAPN7 mRNA	PMID:29154799
1312532	CAPN7	calpain 7	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304855	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CAPN7 mRNA	PMID:30047161
1312532	CAPN7	calpain 7	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CAPN7 mRNA	PMID:20106945
1312532	CAPN7	calpain 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304855	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CAPN7 mRNA	PMID:33387578
1312532	CAPN7	calpain 7	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CAPN7 mRNA	PMID:29523930
1312532	CAPN7	calpain 7	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of CAPN7 mRNA	PMID:31675489
1312532	CAPN7	calpain 7	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAPN7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CAPN7 mRNA	PMID:21641980|PMID:26378955
1312532	CAPN7	calpain 7	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CAPN7 mRNA	PMID:15336504
1312532	CAPN7	calpain 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CAPN7 mRNA	PMID:22206623
1312532	CAPN7	calpain 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312533	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CAPN7 mRNA	PMID:22206623
1312532	CAPN7	calpain 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CAPN7 gene]	PMID:28238834
1312532	CAPN7	calpain 7	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of CAPN7 mRNA	PMID:19363144
1312532	CAPN7	calpain 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CAPN7 protein	PMID:31675489
1312532	CAPN7	calpain 7	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of CAPN7 mRNA	PMID:21858171
1312532	CAPN7	calpain 7	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CAPN7 mRNA	PMID:19363144
1312532	CAPN7	calpain 7	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1304855	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of CAPN7 mRNA	PMID:30047161
1312532	CAPN7	calpain 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304855	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CAPN7 mRNA	PMID:30047161
1312532	CAPN7	calpain 7	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1312533	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon results in decreased expression of CAPN7 mRNA	PMID:19363144
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of SLF1 mRNA	PMID:26516004
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312536	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SLF1 mRNA	PMID:39241906
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304857	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SLF1 mRNA	PMID:33387578
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:16602	trichloroethene	decreases methylation	ISO	RGD:1304857	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of SLF1 gene	PMID:27618143
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLF1 mRNA	PMID:37042841
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SLF1 mRNA	PMID:21179406
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304857	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of SLF1 mRNA	PMID:26577399
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312536	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of SLF1 mRNA	PMID:37236586
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SLF1 mRNA	PMID:19549813
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SLF1 mRNA	PMID:23649840
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SLF1 protein	PMID:20106945
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161115	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLF1 gene	PMID:27153756
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SLF1 mRNA	PMID:23649840
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312536	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SLF1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLF1 mRNA	PMID:34911549
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLF1 gene	PMID:25304211
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SLF1 mRNA	PMID:26272509
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161115	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLF1 mRNA	PMID:27188386
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:C010974	Glyphosate results in increased expression of SLF1 mRNA	PMID:40294809
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312536	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SLF1 mRNA	PMID:28960355
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of SLF1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of SLF1 mRNA	PMID:19167446|PMID:23557933
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SLF1 mRNA	PMID:27392435
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SLF1 mRNA	PMID:27594783
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D009532	Nickel results in increased expression of SLF1 mRNA	PMID:25583101
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLF1 mRNA	PMID:20106945|PMID:21632981
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312536	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLF1 mRNA	PMID:19770486
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:28854	2,4-D	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in increased expression of SLF1 mRNA	PMID:40294809
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of SLF1 mRNA	PMID:22623647
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of SLF1 gene	PMID:28589171
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLF1 5' UTR	PMID:27901495
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SLF1 mRNA	PMID:19150397|PMID:20382639
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304857	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SLF1 mRNA	PMID:25181051
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312536	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of SLF1 mRNA	PMID:25594700
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312536	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SLF1 mRNA	PMID:21266533
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312536	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of SLF1 mRNA	PMID:36117858
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304857	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLF1 mRNA	PMID:33453195
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312536	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of SLF1 mRNA	PMID:37236586
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SLF1 mRNA	PMID:28302478
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SLF1 mRNA	PMID:31533062
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SLF1 mRNA	PMID:19167446
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLF1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of SLF1 mRNA	PMID:19167446
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312536	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of SLF1 mRNA	PMID:39529242
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SLF1 mRNA	PMID:40419075
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLF1 mRNA	PMID:25979313
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312536	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SLF1 mRNA	PMID:17963808
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D014635	Valproic Acid results in decreased expression of SLF1 mRNA	PMID:23179753|PMID:26272509|PMID:27188386|PMID:28001369
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304857	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of SLF1 mRNA	PMID:41580965
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of SLF1 mRNA	PMID:25562108
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLF1 mRNA	PMID:20106945|PMID:21632981
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312536	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SLF1 mRNA	PMID:28973697
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SLF1 mRNA	PMID:38832940
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C012589	trichostatin A results in decreased expression of SLF1 mRNA	PMID:24935251|PMID:26272509
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161115	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLF1 mRNA	PMID:27188386
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SLF1 mRNA	PMID:22230336
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLF1 gene	PMID:25304211
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of SLF1 mRNA	PMID:31838189
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:48981	quinolin-8-ol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of SLF1 mRNA	PMID:21632981
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312536	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of SLF1 mRNA	PMID:36117858
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312536	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLF1 mRNA	PMID:21641980
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312536	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SLF1 mRNA	PMID:23650126
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SLF1 mRNA	PMID:24810058
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SLF1 mRNA	PMID:31758290
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312536	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLF1 mRNA	PMID:22206623
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SLF1 mRNA	PMID:22714537
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of SLF1 protein	PMID:31285264
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLF1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLF1 mRNA	PMID:27188386
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLF1 gene]	PMID:28238834
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLF1 mRNA	PMID:19167446
1312535	SLF1	SMC5/6 complex localization factor 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLF1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLF1 mRNA	PMID:27188386
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of VPS39 mRNA	PMID:38218311
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of VPS39 mRNA	PMID:37995155
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312538	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of VPS39 mRNA	PMID:30319688
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1304858	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of VPS39 mRNA	PMID:17103110
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of VPS39 mRNA	PMID:39241906
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of VPS39 mRNA	PMID:39298647
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of VPS39 mRNA	PMID:20823114
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of VPS39 mRNA	PMID:21179406
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312538	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of VPS39 mRNA	PMID:34319233
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of VPS39 mRNA	PMID:17103032
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304858	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of VPS39 protein	PMID:34915118
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of VPS39 gene	PMID:27153756
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of VPS39 mRNA	PMID:19244175
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of VPS39 mRNA	PMID:19244175
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of VPS39 mRNA	PMID:30912803
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312538	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VPS39 mRNA	PMID:21570461
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of VPS39 mRNA	PMID:30851411
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:28869	menadione	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20150127	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of VPS39 mRNA	PMID:25270620
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of VPS39 mRNA	PMID:38568856
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of VPS39 promoter	PMID:27901495
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312538	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VPS39 mRNA	PMID:27858113
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of VPS39 mRNA	PMID:35676786
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312538	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VPS39 gene	PMID:35295148
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of VPS39 mRNA	PMID:29275510
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304858	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of VPS39 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304858	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of VPS39 mRNA	PMID:36041667
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of VPS39 mRNA	PMID:19244175
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of VPS39 mRNA	PMID:19244175
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of VPS39 mRNA	PMID:28628672
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304858	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of VPS39 mRNA	PMID:36041667
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1312538	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VPS39 mRNA	PMID:27858113
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VPS39 mRNA	PMID:28628672
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304858	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of VPS39 mRNA	PMID:36041667
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1304858	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of VPS39 mRNA	PMID:21241498
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312538	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of VPS39 mRNA	PMID:28392331
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of VPS39 mRNA	PMID:37019170
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VPS39 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of VPS39 mRNA	PMID:28628672
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of VPS39 mRNA	PMID:37042841
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:36015	1,1,1-trichloroethane	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20150127	CTD	MESH:C024566	1,1,1-trichloroethane results in decreased expression of VPS39 mRNA	PMID:25270620
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of VPS39 mRNA	PMID:19244175
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of VPS39 mRNA	PMID:19244175
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VPS39 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of VPS39 mRNA	PMID:28628672
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of VPS39 mRNA	PMID:38832940
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of VPS39 mRNA	PMID:22230336
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of VPS39 mRNA	PMID:35436446
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VPS39 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of VPS39 mRNA	PMID:28628672
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312538	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of VPS39 mRNA	PMID:35676786
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of VPS39 mRNA	PMID:20823114
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1312538	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VPS39 mRNA	PMID:27858113
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1312538	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of VPS39 mRNA	PMID:27858113
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of VPS39 protein	PMID:32959892
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of VPS39 mRNA	PMID:20823114
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312538	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of VPS39 mRNA	PMID:22206623
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of VPS39 mRNA	PMID:30851411
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to VPS39 gene]	PMID:28238834
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of VPS39 mRNA	PMID:39904859
1312537	VPS39	VPS39 subunit of HOPS complex	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304858	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of VPS39 mRNA	PMID:23034163
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312540	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SH3GLB1 mRNA	PMID:33045310
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases methylation	ISO	RGD:1312540	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased methylation of SH3GLB1 promoter	PMID:26251327
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312540	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SH3GLB1 mRNA	PMID:26251327
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of SH3GLB1 mRNA	PMID:23724009
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312540	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SH3GLB1 mRNA	PMID:22629407
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of SH3GLB1 mRNA]	PMID:22629407
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of SH3GLB1 mRNA	PMID:40945087
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SH3GLB1 mRNA	PMID:39241906
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D014260	Triclosan results in decreased expression of SH3GLB1 mRNA	PMID:34681664
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304859	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SH3GLB1 protein	PMID:32145629
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in decreased expression of SH3GLB1 mRNA	PMID:22467019|PMID:39298647
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304859	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SH3GLB1 gene	PMID:27618143
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D002635	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of SH3GLB1 mRNA	PMID:21592394
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SH3GLB1 mRNA	PMID:21592394
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006000	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SH3GLB1 mRNA	PMID:33754040
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SH3GLB1 mRNA	PMID:21592394
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SH3GLB1 mRNA	PMID:21592394
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SH3GLB1 mRNA	PMID:37236586
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SH3GLB1 mRNA	PMID:19549813
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SH3GLB1 protein	PMID:23301498
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SH3GLB1 mRNA	PMID:19770486
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SH3GLB1 mRNA	PMID:23649840
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SH3GLB1 mRNA	PMID:25629700
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006002	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SH3GLB1 mRNA	PMID:40504410
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SH3GLB1 mRNA	PMID:26272509
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1304859	E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of SH3GLB1 mRNA	PMID:25905778
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312540	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of SH3GLB1 mRNA	PMID:21151649
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304859	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SH3GLB1 mRNA	PMID:34747641
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312540	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SH3GLB1 mRNA	PMID:21570461
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SH3GLB1 mRNA	PMID:17942748
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304859	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of SH3GLB1 mRNA	PMID:28374803
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SH3GLB1 mRNA	PMID:30851411
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of SH3GLB1 protein	PMID:29385562
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of SH3GLB1 mRNA	PMID:26873546
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D003840	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SH3GLB1 mRNA	PMID:38568856
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SH3GLB1 mRNA	PMID:40504410
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SH3GLB1 mRNA	PMID:19770486
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SH3GLB1 mRNA	PMID:26238291
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SH3GLB1 promoter	PMID:27901495
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SH3GLB1 mRNA	PMID:27131904
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:31243	atazanavir sulfate	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D000069446	Atazanavir Sulfate results in increased expression of SH3GLB1 mRNA	PMID:32152650
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D000069446	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of SH3GLB1 protein	PMID:31675489
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304859	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SH3GLB1 mRNA; bisphenol A results in decreased expression of SH3GLB1 protein	PMID:32145629|PMID:34947998
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312540	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SH3GLB1 promoter	PMID:27312807
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of SH3GLB1 protein	PMID:34186270
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304859	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SH3GLB1 mRNA	PMID:25181051|PMID:30816183
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of SH3GLB1 protein	PMID:31675489
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of SH3GLB1 mRNA	PMID:24752500
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312540	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SH3GLB1 mRNA	PMID:26682919
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:34283	oxybenzone	increases expression	ISO	RGD:1304859	E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of SH3GLB1 mRNA	PMID:30316929
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SH3GLB1 mRNA	PMID:39298647
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SH3GLB1 protein	PMID:34186270
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312540	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of SH3GLB1 exon	PMID:33297965
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SH3GLB1 protein	PMID:34186270
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SH3GLB1 mRNA	PMID:28392331
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1304859	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of SH3GLB1 mRNA	PMID:22546817
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304859	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SH3GLB1 mRNA	PMID:21266533
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SH3GLB1 mRNA	PMID:37042841
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1304859	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SH3GLB1 mRNA	PMID:30589522
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SH3GLB1 mRNA	PMID:37236586
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SH3GLB1 protein	PMID:26879310
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of SH3GLB1 mRNA	PMID:19376846
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SH3GLB1 mRNA	PMID:24449571
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D005999	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of SH3GLB1 mRNA	PMID:17585979
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SH3GLB1 mRNA	PMID:31533062
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SH3GLB1 mRNA	PMID:36331819
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SH3GLB1 mRNA	PMID:25979313
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304859	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of SH3GLB1 mRNA	PMID:29427782
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SH3GLB1 mRNA	PMID:23179753
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SH3GLB1 mRNA	PMID:19770486
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SH3GLB1 mRNA	PMID:20106945|PMID:25562108|PMID:32152650|PMID:34681664
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SH3GLB1 mRNA	PMID:28973697
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of SH3GLB1 mRNA	PMID:33512557
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of SH3GLB1 mRNA	PMID:25704631|PMID:29067470
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SH3GLB1 mRNA	PMID:40504410
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of SH3GLB1 mRNA	PMID:24752500
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of SH3GLB1 mRNA	PMID:31675489
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312540	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SH3GLB1 mRNA	PMID:35436446
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SH3GLB1 mRNA	PMID:17942748
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304859	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of SH3GLB1 mRNA	PMID:24136188
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SH3GLB1 protein	PMID:32959892
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312540	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SH3GLB1 mRNA	PMID:21641980
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SH3GLB1 mRNA	PMID:23650126
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SH3GLB1 mRNA	PMID:28988120|PMID:29427785
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SH3GLB1 mRNA	PMID:15336504
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:64648	enniatin	decreases expression	ISO	RGD:1304859	E	RGD:6480464	20170228	CTD	MESH:C100264	enniatins results in decreased expression of SH3GLB1 mRNA	PMID:27163883
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:6773	Mesaconitine	decreases expression	ISO	RGD:1304859	E	RGD:6480464	20231031	CTD	MESH:C019470	mesaconitine results in decreased expression of SH3GLB1 protein	PMID:37182599
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SH3GLB1 protein	PMID:34186270
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:C051752	nefazodone results in increased expression of SH3GLB1 mRNA	PMID:32152650
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:7494	nefazodone	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:C051752	[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of SH3GLB1 mRNA	PMID:32152650
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SH3GLB1 mRNA	PMID:30851411
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SH3GLB1 mRNA	PMID:19159669
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SH3GLB1 protein	PMID:31675489
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SH3GLB1 protein	PMID:31675489
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of SH3GLB1 mRNA	PMID:21858171
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of SH3GLB1 protein	PMID:38348393
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312540	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SH3GLB1 mRNA	PMID:21795629
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312540	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SH3GLB1 mRNA	PMID:27131904
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304859	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SH3GLB1 mRNA	PMID:19281266
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304859	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SH3GLB1 mRNA	PMID:21346803
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1304859	E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of SH3GLB1 mRNA	PMID:25905778
1312539	SH3GLB1	SH3 domain containing GRB2 like, endophilin B1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SH3GLB1 mRNA	PMID:38568856
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of UBE2G2 mRNA	PMID:38218311
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:110423	clodronic acid	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in increased expression of UBE2G2 mRNA	PMID:25596134
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304860	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBE2G2 mRNA]	PMID:31150632
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of UBE2G2 mRNA	PMID:33167477
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of UBE2G2 mRNA	PMID:25596134
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of UBE2G2 mRNA	PMID:22378314
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312542	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of UBE2G2 mRNA	PMID:39241906
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of UBE2G2 mRNA	PMID:31614463
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312542	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of UBE2G2 mRNA	PMID:39298647
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of UBE2G2 mRNA	PMID:38568856
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:17115	L-serine	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D012694	Serine results in decreased expression of UBE2G2 mRNA	PMID:29098664
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304860	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of UBE2G2 mRNA	PMID:33387578
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of UBE2G2 mRNA	PMID:28818685
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312542	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of UBE2G2 mRNA	PMID:27462272
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of UBE2G2 mRNA	PMID:23649840
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312542	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of UBE2G2 mRNA	PMID:19770486
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of UBE2G2 mRNA	PMID:23649840
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304860	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBE2G2 mRNA	PMID:31150632
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312542	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBE2G2 mRNA	PMID:31919559
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304860	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBE2G2 mRNA]	PMID:31150632
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to UBE2G2 promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of UBE2G2 protein	PMID:35625704
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312542	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of UBE2G2 mRNA	PMID:28960355
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312542	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of UBE2G2 mRNA	PMID:22610192
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in increased expression of UBE2G2 mRNA	PMID:25596134
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304860	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2G2 mRNA	PMID:34747641
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312542	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2G2 mRNA	PMID:21570461
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304860	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBE2G2 mRNA	PMID:21215274
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBE2G2 mRNA	PMID:22903824
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304860	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBE2G2 mRNA	PMID:33387578
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1304860	E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of UBE2G2 mRNA]	PMID:21215274
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2G2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of UBE2G2 mRNA	PMID:17942748|PMID:25975270
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304860	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of UBE2G2 mRNA	PMID:28959563
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of UBE2G2 mRNA	PMID:36057382
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of UBE2G2 mRNA	PMID:38568856
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312542	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of UBE2G2 mRNA	PMID:22228805
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of UBE2G2 5' UTR	PMID:27901495
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312542	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBE2G2 mRNA	PMID:21569818
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of UBE2G2 mRNA	PMID:36057382
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of UBE2G2 gene	PMID:31601247
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304860	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of UBE2G2 mRNA	PMID:24136188
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312542	E	RGD:6480464	20180515	CTD	MESH:C009495	titanium dioxide results in decreased expression of UBE2G2 mRNA	PMID:29128614|PMID:29264374
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312542	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBE2G2 gene	PMID:35295148
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304860	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of UBE2G2 mRNA	PMID:34492290
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of UBE2G2 mRNA	PMID:18445702
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2G2 mRNA	PMID:29275510
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304860	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2G2 mRNA	PMID:32145629
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304860	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UBE2G2 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of UBE2G2 gene	PMID:31601247
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of UBE2G2 mRNA	PMID:19925653
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312542	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of UBE2G2 mRNA	PMID:39298647
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312542	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of UBE2G2 mRNA	PMID:38685157
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of UBE2G2 protein	PMID:34186270
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:34679	Di-n-octyl phthalate	decreases expression	ISO	RGD:1312542	E	RGD:6480464	20240305	CTD	MESH:C010715	di-n-octyl phthalate results in decreased expression of UBE2G2 mRNA	PMID:37810885
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBE2G2 mRNA	PMID:37042841
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:35176	zinc sulfate	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of UBE2G2 mRNA	PMID:12756304
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of UBE2G2 mRNA	PMID:25596134|PMID:38568856
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1304860	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of UBE2G2 promoter	PMID:22457795
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBE2G2 mRNA	PMID:26472689
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304860	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBE2G2 mRNA	PMID:33453195
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of UBE2G2 mRNA	PMID:19320972
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of UBE2G2 mRNA	PMID:24449571
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:3696	cidofovir anhydrous	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in increased expression of UBE2G2 mRNA	PMID:25596134
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of UBE2G2 mRNA	PMID:28302478
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UBE2G2 mRNA	PMID:25979313
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of UBE2G2 mRNA	PMID:17292431
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in decreased expression of UBE2G2 mRNA	PMID:23527032
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of UBE2G2 gene	PMID:29154799
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of UBE2G2 mRNA	PMID:23179753|PMID:27188386
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of UBE2G2 mRNA	PMID:25596134
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UBE2G2 mRNA	PMID:17562736
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304860	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of UBE2G2 mRNA	PMID:33387578
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of UBE2G2 mRNA	PMID:29523930
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to UBE2G2 promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of UBE2G2 protein	PMID:35625704
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304860	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of UBE2G2 mRNA	PMID:29391264|PMID:31464424
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1312542	E	RGD:6480464	20130416	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of UBE2G2 mRNA	PMID:22246474
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UBE2G2 mRNA	PMID:17942748
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312542	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2G2 mRNA	PMID:17942748
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:5001	fenofibrate	affects expression	ISO	RGD:1304860	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate affects the expression of UBE2G2 mRNA	PMID:25596134
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312542	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of UBE2G2 mRNA	PMID:25554681|PMID:25620056
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304860	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBE2G2 mRNA	PMID:24136188
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:5864	ifosfamide	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in increased expression of UBE2G2 mRNA	PMID:25596134
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:63952	arsenic trichloride	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to UBE2G2 promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of UBE2G2 protein	PMID:35625704
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	affects expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium affects the expression of UBE2G2 mRNA	PMID:25234470
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1304860	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of UBE2G2 mRNA	PMID:25596134
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312542	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of UBE2G2 mRNA	PMID:22206623
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to UBE2G2 gene]	PMID:28238834
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312542	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of UBE2G2 mRNA	PMID:31388691
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304860	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of UBE2G2 mRNA	PMID:21346803
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of UBE2G2 mRNA	PMID:38568856
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312542	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of UBE2G2 mRNA	PMID:28973697
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312542	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of UBE2G2 mRNA	PMID:35537566
1312541	UBE2G2	ubiquitin conjugating enzyme E2 G2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304860	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of UBE2G2 mRNA	PMID:18042343
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:116509	diuron	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in increased expression of LINC00520 mRNA	PMID:24172598
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of LINC00520 mRNA	PMID:26079696
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC00520 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC00520 mRNA	PMID:35811015
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:16767	3,4-dichloroaniline	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in increased expression of LINC00520 mRNA	PMID:24172598
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of LINC00520 mRNA	PMID:26079696
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:177387	brequinar	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C046943	brequinar results in increased expression of LINC00520 mRNA	PMID:39900124
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of LINC00520 mRNA	PMID:25583101
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:28358	rac-lactic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of LINC00520 mRNA	PMID:30851411
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of LINC00520 mRNA	PMID:20971185
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LINC00520 mRNA	PMID:38568856
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LINC00520 mRNA	PMID:38568856
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of LINC00520 mRNA	PMID:20971185
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LINC00520 gene	PMID:31601247
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LINC00520 gene	PMID:31601247
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LINC00520 mRNA	PMID:38382870
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LINC00520 mRNA	PMID:38568856
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LINC00520 mRNA	PMID:38832940
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of LINC00520 mRNA	PMID:35811015
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LINC00520 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LINC00520 mRNA	PMID:35811015
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of LINC00520 mRNA	PMID:30851411
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of LINC00520 mRNA	PMID:26079696
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of LINC00520 mRNA	PMID:17440010
1312543	LINC00520	long independently transcribed non-coding RNA 520	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LINC00520 mRNA	PMID:38568856
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1584992	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PARD3B mRNA]	PMID:31150632
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1623941	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PARD3B mRNA	PMID:20188158
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PARD3B mRNA	PMID:26079696
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1584992	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of PARD3B gene	PMID:35440735
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1623941	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PARD3B mRNA	PMID:30319688
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1623941	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PARD3B mRNA	PMID:39241906
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1584992	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of PARD3B mRNA	PMID:32145629
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1623941	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PARD3B mRNA	PMID:39298647
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of PARD3B mRNA	PMID:30165855
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PARD3B mRNA	PMID:38568856
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PARD3B protein	PMID:37730182
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1584992	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PARD3B mRNA	PMID:33387578
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PARD3B mRNA	PMID:28818685
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PARD3B intron	PMID:30157460
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1623941	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PARD3B mRNA	PMID:37236586
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PARD3B mRNA	PMID:22100608|PMID:32234424
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1623941	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PARD3B mRNA	PMID:19770486
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PARD3B gene; Aflatoxin B1 results in decreased methylation of PARD3B intron	PMID:27153756|PMID:30157460
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1584992	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PARD3B mRNA	PMID:31150632
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1584992	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PARD3B mRNA]	PMID:31150632
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1623941	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PARD3B mRNA	PMID:28189721|PMID:28960355
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1584992	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PARD3B mRNA	PMID:31881176
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PARD3B mRNA	PMID:27392435
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1623941	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in decreased expression of PARD3B mRNA	PMID:25270620
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PARD3B mRNA	PMID:27392435
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of PARD3B mRNA	PMID:24768652
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623941	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PARD3B mRNA	PMID:21570461
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1584992	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PARD3B mRNA	PMID:32109520
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1623941	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PARD3B mRNA	PMID:28922406
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PARD3B mRNA	PMID:33212167
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1623941	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in increased expression of PARD3B mRNA	PMID:35032568
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PARD3B mRNA	PMID:29803840
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PARD3B mRNA	PMID:21871943|PMID:32234424
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1623941	E	RGD:6480464	20140408	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PARD3B mRNA	PMID:19770486
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of PARD3B gene	PMID:31601247
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1623941	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of PARD3B mRNA	PMID:35295148
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1584992	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of PARD3B mRNA	PMID:23411599|PMID:34492290
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1623941	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of PARD3B mRNA	PMID:18648102
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1584992	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PARD3B mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PARD3B gene	PMID:31601247
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1584992	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of PARD3B mRNA	PMID:32145629
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1584992	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PARD3B gene	PMID:28505145
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of PARD3B gene	PMID:31601247
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1623941	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PARD3B mRNA	PMID:39298647
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PARD3B intron	PMID:30157460
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1623941	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PARD3B mRNA	PMID:28392331
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1623941	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of PARD3B mRNA	PMID:24535843
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1584992	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of PARD3B gene	PMID:33148267
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PARD3B mRNA	PMID:38568856
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1623941	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PARD3B mRNA	PMID:18974090
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1623941	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PARD3B mRNA	PMID:37236586
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PARD3B mRNA	PMID:24449571
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1623941	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PARD3B mRNA	PMID:40194260
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PARD3B mRNA	PMID:31533062
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1623941	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of PARD3B mRNA	PMID:39529242
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1623941	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PARD3B mRNA	PMID:28973697
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of PARD3B mRNA	PMID:24449571
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PARD3B mRNA	PMID:38832940
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PARD3B mRNA	PMID:27188386
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1584992	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PARD3B mRNA	PMID:33387578
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1584992	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PARD3B mRNA	PMID:29391264
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of PARD3B mRNA	PMID:32234424
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of PARD3B mRNA	PMID:38825487
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1623941	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PARD3B mRNA	PMID:23608068
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1584992	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PARD3B mRNA	PMID:28801915
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of PARD3B intron	PMID:30157460
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1584992	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PARD3B gene	PMID:35440735
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of PARD3B mRNA	PMID:27714895
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1584992	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of PARD3B gene	PMID:33148267
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PARD3B mRNA	PMID:37199045
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of PARD3B mRNA	PMID:36318118
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PARD3B mRNA	PMID:27188386
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of PARD3B mRNA	PMID:30928695
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1623941	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of PARD3B mRNA	PMID:23091169
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1623941	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PARD3B mRNA	PMID:39847705
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1584992	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PARD3B mRNA	PMID:24780913
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PARD3B mRNA	PMID:27188386
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PARD3B mRNA	PMID:38568856
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1623941	E	RGD:6480464	20140715	CTD	MESH:D013849	Thimerosal results in increased expression of PARD3B mRNA	PMID:24675092
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1623941	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of PARD3B mRNA	PMID:32835833
1312545	PARD3B	par-3 family cell polarity regulator beta	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1584992	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PARD3B mRNA	PMID:23034163
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:119915	fentanyl	increases expression	ISO	RGD:1598208	E	RGD:6480464	20241001	CTD	MESH:D005283	Fentanyl results in increased expression of TNFRSF9 mRNA	PMID:36032789
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312547	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TNFRSF9 mRNA	PMID:33045310
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TNFRSF9 mRNA	PMID:39752319
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TNFRSF9 mRNA	PMID:33167477
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1598208	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of TNFRSF9 mRNA	PMID:20488242
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TNFRSF9 mRNA	PMID:26079696
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1312547	E	RGD:6480464	20161213	CTD	MESH:D019308	Palmitic Acid results in increased expression of TNFRSF9 mRNA	PMID:25614714
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20161213	CTD	MESH:D019308	Quercetin inhibits the reaction [Palmitic Acid results in increased expression of TNFRSF9 mRNA]	PMID:25614714
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D000431	Ethanol promotes the reaction [FOXO3 protein results in increased expression of TNFRSF9 mRNA]	PMID:26470730
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin inhibits the reaction [Dietary Fats results in increased expression of TNFRSF9 mRNA]; Quercetin inhibits the reaction [Palmitic Acid results in increased expression of TNFRSF9 mRNA]	PMID:25614714
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFRSF9 mRNA	PMID:35811015
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TNFRSF9 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TNFRSF9 mRNA	PMID:35811015
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D014260	Triclosan results in increased expression of TNFRSF9 mRNA	PMID:34681664
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:164200	triclosan	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D014260	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in increased expression of TNFRSF9 mRNA	PMID:33819548
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of TNFRSF9 mRNA	PMID:20106945
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1598208	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of TNFRSF9 mRNA	PMID:26496021
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TNFRSF9 mRNA	PMID:25510870
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1598208	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TNFRSF9 mRNA	PMID:33387578
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D002635	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in increased expression of TNFRSF9 mRNA	PMID:33819548
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TNFRSF9 mRNA	PMID:23649840
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TNFRSF9 mRNA	PMID:26079696
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFRSF9 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFRSF9 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TNFRSF9 mRNA	PMID:37567420|PMID:37992649
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TNFRSF9 mRNA	PMID:39752319
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:17579	beta-carotene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019207	beta Carotene results in increased expression of TNFRSF9 mRNA	PMID:17034753
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C031927	hydroquinone results in increased expression of TNFRSF9 mRNA	PMID:22723965
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFRSF9 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFRSF9 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TNFRSF9 mRNA	PMID:37567420|PMID:37992649
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D006000	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in increased expression of TNFRSF9 mRNA	PMID:33819548
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:177406	Bardoxolone methyl	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C445068	bardoxolone methyl results in increased expression of TNFRSF9 mRNA	PMID:35724838
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20210608	CTD	MESH:D004051	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of TNFRSF9 mRNA	PMID:33484791
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1598208	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TNFRSF9 mRNA	PMID:26577399
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1598208	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TNFRSF9 mRNA	PMID:22061828|PMID:33387578
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:17907	styrene oxide	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C013690	styrene oxide results in increased expression of TNFRSF9 mRNA	PMID:22723965
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014284	Triiodothyronine results in increased expression of TNFRSF9 mRNA; Triiodothyronine results in increased expression of TNFRSF9 protein	PMID:14761676
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014284	4-OH-2',3,3',4',5'-pentachlorobiphenyl inhibits the reaction [Triiodothyronine results in increased expression of TNFRSF9 mRNA]; Polychlorinated Biphenyls inhibits the reaction [Triiodothyronine results in increased expression of TNFRSF9 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of TNFRSF9 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of TNFRSF9 protein]	PMID:14761676
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TNFRSF9 mRNA	PMID:39836092
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1598208	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TNFRSF9 mRNA	PMID:28522335
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:188851	Muraglitazar	increases expression	ISO	RGD:1598208	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of TNFRSF9 mRNA	PMID:21515302
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TNFRSF9 mRNA	PMID:25510870
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TNFRSF9 mRNA	PMID:25510870
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1598208	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TNFRSF9 mRNA	PMID:23630614|PMID:25378103|PMID:33354967
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:25187	p-menthan-3-ol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of TNFRSF9 mRNA	PMID:26760959
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	Ozone results in increased expression of TNFRSF9 mRNA	PMID:31476115
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	[Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF9 mRNA	PMID:31476115
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TNFRSF9 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TNFRSF9 mRNA	PMID:27106289|PMID:34911549
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1598208	E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in decreased expression of TNFRSF9 mRNA	PMID:31129395
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of TNFRSF9 mRNA	PMID:15672453
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:27363	zinc atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of TNFRSF9 mRNA	PMID:16979875
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TNFRSF9 mRNA; [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TNFRSF9 mRNA	PMID:16979875|PMID:18593933
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1598208	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TNFRSF9 mRNA	PMID:31150632
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20140408	CTD	MESH:D005492	[Folic Acid affects the susceptibility to Pemetrexed] which affects the expression of TNFRSF9 mRNA; [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of TNFRSF9 mRNA	PMID:22975265|PMID:24657277
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D006002	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in increased expression of TNFRSF9 mRNA	PMID:33819548
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TNFRSF9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TNFRSF9 mRNA	PMID:39836092
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFRSF9 mRNA]	PMID:37992649
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312547	E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol results in increased expression of TNFRSF9 mRNA	PMID:25761413
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D002945	Cisplatin results in increased expression of TNFRSF9 mRNA	PMID:18483502
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D002945	[Cisplatin co-treated with CDKN1A protein] results in increased expression of TNFRSF9 mRNA; [Cisplatin co-treated with jinfukang] results in decreased expression of TNFRSF9 mRNA	PMID:18483502|PMID:27392435
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312547	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of TNFRSF9 mRNA	PMID:32186404
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TNFRSF9 mRNA	PMID:22298810
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312547	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TNFRSF9 mRNA	PMID:21570461|PMID:26377647
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1598208	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TNFRSF9 mRNA	PMID:22298810|PMID:34747641
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFRSF9 mRNA	PMID:14761676
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312547	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFRSF9 mRNA	PMID:15310856
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1598208	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFRSF9 mRNA	PMID:33387578
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of TNFRSF9 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of TNFRSF9 protein]	PMID:14761676
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TNFRSF9 mRNA	PMID:33212167
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of TNFRSF9 mRNA	PMID:23649840
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1598208	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TNFRSF9 mRNA	PMID:26033743
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TNFRSF9 mRNA	PMID:29803840
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20231031	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFRSF9 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFRSF9 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TNFRSF9 mRNA	PMID:37567420|PMID:37992649
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28794	coumarin	decreases expression	ISO	RGD:1598208	E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in decreased expression of TNFRSF9 mRNA	PMID:18480146
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D003840	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in increased expression of TNFRSF9 mRNA	PMID:33819548
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFRSF9 mRNA]	PMID:37992649
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:28940	calciol	increases expression	ISO	RGD:1312547	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in increased expression of TNFRSF9 mRNA	PMID:17170073
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:29014	cordycepin	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C058120	cordycepin affects the expression of TNFRSF9 mRNA	PMID:28099944
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TNFRSF9 mRNA	PMID:38568856
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TNFRSF9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TNFRSF9 mRNA	PMID:39836092
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D014415	Tunicamycin results in increased expression of TNFRSF9 mRNA	PMID:38498338
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TNFRSF9 promoter	PMID:27901495
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TNFRSF9 mRNA	PMID:19181443|PMID:32234424
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312547	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TNFRSF9 intron	PMID:27901495
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:29866	arsenite(3-)	affects expression	EXP		E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of TNFRSF9 mRNA	PMID:22959463
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1598208	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TNFRSF9 mRNA	PMID:26033743
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:30185	zinc(0)	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of TNFRSF9 mRNA	PMID:16979875
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TNFRSF9 mRNA; [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TNFRSF9 mRNA	PMID:16979875|PMID:18593933
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:3020	benzalkonium chloride	increases expression	ISO	RGD:1312547	E	RGD:6480464	20190219	CTD	MESH:D001548	Benzalkonium Compounds results in increased expression of TNFRSF9 mRNA	PMID:30171875
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TNFRSF9 mRNA; Silicon Dioxide results in increased expression of TNFRSF9 mRNA	PMID:23806026|PMID:25351596|PMID:25895662
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312547	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TNFRSF9 mRNA	PMID:29341224|PMID:36403901|PMID:38811393
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:30621	diarsenic trioxide	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide affects the expression of TNFRSF9 mRNA	PMID:17530438
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TNFRSF9 mRNA; Arsenic Trioxide results in increased expression of TNFRSF9 protein	PMID:16010437|PMID:27829220
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1598208	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of TNFRSF9 mRNA	PMID:24915197
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:31236	aripiprazole	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:C094645	[Aripiprazole co-treated with Ozone] results in increased expression of TNFRSF9 mRNA	PMID:31476115
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TNFRSF9 gene	PMID:31601247
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1598208	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of TNFRSF9 mRNA	PMID:24136188
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:32195	Tesaglitazar	increases expression	ISO	RGD:1598208	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of TNFRSF9 mRNA	PMID:21515302
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312547	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TNFRSF9 mRNA	PMID:29264374
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312547	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TNFRSF9 mRNA	PMID:23557971
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1598208	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of TNFRSF9 mRNA	PMID:30012374
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1598208	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TNFRSF9 mRNA	PMID:25181051
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312547	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in decreased expression of TNFRSF9 mRNA	PMID:35479511
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1598208	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TNFRSF9 mRNA	PMID:30816183|PMID:32528016
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312547	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of TNFRSF9 promoter	PMID:27312807
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C006780	bisphenol A results in increased expression of TNFRSF9 mRNA	PMID:33312107
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312547	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of TNFRSF9 mRNA	PMID:26063408
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312547	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TNFRSF9 promoter	PMID:27312807
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TNFRSF9 gene	PMID:31601247
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1598208	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of TNFRSF9 mRNA	PMID:26496021
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TNFRSF9 mRNA	PMID:25510870
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TNFRSF9 mRNA	PMID:25510870
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1312547	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of TNFRSF9 mRNA	PMID:20713471
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34260	anthracen-2-amine	increases expression	ISO	RGD:1598208	E	RGD:6480464	20130312	CTD	MESH:C006593	2-anthramine results in increased expression of TNFRSF9 mRNA	PMID:23038007
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TNFRSF9 mRNA	PMID:35618242
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312547	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of TNFRSF9 mRNA	PMID:20713471
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C543008	bisphenol S results in increased expression of TNFRSF9 mRNA	PMID:33312107
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312547	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TNFRSF9 mRNA	PMID:30951980
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1312547	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of TNFRSF9 mRNA	PMID:26377693
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34575	bisphenol F	decreases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C008745	bisphenol F results in decreased expression of TNFRSF9 mRNA	PMID:33312107
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C008745	bisphenol F results in increased expression of TNFRSF9 mRNA	PMID:33312107
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312547	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of TNFRSF9 intron	PMID:28392331
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20180515	CTD	MESH:D015056	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of TNFRSF9 mRNA	PMID:29288687
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of TNFRSF9 mRNA	PMID:18836921
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1598208	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of TNFRSF9 mRNA	PMID:32680482
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TNFRSF9 mRNA	PMID:37042841
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TNFRSF9 mRNA	PMID:39836092
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TNFRSF9 mRNA	PMID:38382870
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of TNFRSF9 mRNA	PMID:36326898
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TNFRSF9 mRNA	PMID:17553155
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1598208	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TNFRSF9 mRNA	PMID:24386269
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of TNFRSF9 mRNA	PMID:17553155
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D005999	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFRSF9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in increased expression of TNFRSF9 mRNA	PMID:33819548
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:37144	epichlorohydrin	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004811	Epichlorohydrin results in increased expression of TNFRSF9 mRNA	PMID:22723965
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of TNFRSF9 mRNA	PMID:16979875
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:38319	usnic acid	increases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in increased expression of TNFRSF9 mRNA	PMID:32508146
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TNFRSF9 mRNA	PMID:32588087
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312547	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of TNFRSF9 mRNA	PMID:39529242
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1598208	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of TNFRSF9 mRNA	PMID:38685447
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1598208	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of TNFRSF9 mRNA	PMID:41580965
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of TNFRSF9 mRNA	PMID:20106945|PMID:27989131|PMID:34681664
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20180515	CTD	MESH:D003907	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of TNFRSF9 mRNA	PMID:29288687
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1312547	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of TNFRSF9 mRNA	PMID:16510352
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFRSF9 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFRSF9 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TNFRSF9 mRNA	PMID:37567420|PMID:37992649
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of TNFRSF9 mRNA	PMID:23649840
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of TNFRSF9 mRNA	PMID:17400583
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of TNFRSF9 mRNA	PMID:18483502|PMID:24657277
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:44185	methotrexate	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	[Folic Acid deficiency co-treated with Methotrexate] results in increased expression of TNFRSF9 mRNA; [Methotrexate co-treated with CDKN1A protein] results in increased expression of TNFRSF9 mRNA	PMID:18483502|PMID:24657277
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TNFRSF9 mRNA	PMID:38832940
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of TNFRSF9 mRNA	PMID:29309887
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312547	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TNFRSF9 mRNA	PMID:17562736
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of TNFRSF9 mRNA	PMID:29067470
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D000082	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of TNFRSF9 mRNA	PMID:33819548
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of TNFRSF9 mRNA	PMID:19036117
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of TNFRSF9 mRNA	PMID:24714768
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TNFRSF9 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TNFRSF9 mRNA	PMID:35811015
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of TNFRSF9 mRNA	PMID:24160326
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1312547	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of TNFRSF9 mRNA	PMID:23917077
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TNFRSF9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TNFRSF9 mRNA	PMID:39836092
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:47426	furosemide	affects expression	ISO	RGD:1598208	E	RGD:6480464	20120412	CTD	MESH:D005665	Furosemide affects the expression of TNFRSF9 mRNA	PMID:17497460
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1598208	E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in decreased expression of TNFRSF9 mRNA	PMID:36653537
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C016766	sulforaphane results in increased expression of TNFRSF9 mRNA	PMID:35724838
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1598208	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of TNFRSF9 mRNA	PMID:29391264
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TNFRSF9 mRNA	PMID:22079256
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of TNFRSF9 mRNA	PMID:18175754
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of TNFRSF9 mRNA	PMID:32234424
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:49900	arsenous acid	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide affects the expression of TNFRSF9 mRNA	PMID:17530438
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TNFRSF9 mRNA; Arsenic Trioxide results in increased expression of TNFRSF9 protein	PMID:16010437|PMID:27829220
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312547	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of TNFRSF9 mRNA	PMID:23845593
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312547	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TNFRSF9 mRNA; Nanotubes, Carbon results in increased expression of TNFRSF9 mRNA	PMID:25554681
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:52261	rose bengal	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:D012395	Rose Bengal inhibits the reaction [TNFRSF9 protein binds to TNFSF9 protein]	PMID:21219880
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:52717	bortezomib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	[BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased expression of TNFRSF9 mRNA	PMID:25522274
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:5299	Geniposide	decreases expression	ISO	RGD:1312547	E	RGD:6480464	20220111	CTD	MESH:C007835	geniposide results in decreased expression of TNFRSF9 mRNA	PMID:34718029
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312547	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TNFRSF9 mRNA	PMID:19042947
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:53154	8'-apo-beta,psi-caroten-8'-al	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004984	apocarotenal results in increased expression of TNFRSF9 mRNA	PMID:17034753
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312547	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TNFRSF9 mRNA	PMID:38701926
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:61000	erythrosin B	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:D004923	Erythrosine inhibits the reaction [TNFRSF9 protein binds to TNFSF9 protein]	PMID:21219880
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1598208	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of TNFRSF9 mRNA	PMID:28801915
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TNFRSF9 mRNA	PMID:39836092
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:63598	levofloxacin	decreases expression	ISO	RGD:1598208	E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of TNFRSF9 mRNA	PMID:24136188
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:63616	pemetrexed	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C085586	[Folic Acid affects the susceptibility to Pemetrexed] which affects the expression of TNFRSF9 mRNA	PMID:22975265
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1312547	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of TNFRSF9 mRNA	PMID:15003993
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:6451	Licarin A	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20180515	CTD	MESH:C432503	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of TNFRSF9 mRNA	PMID:29288687
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:65408	andrographolide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C030419	andrographolide results in increased expression of TNFRSF9 mRNA	PMID:35724838
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of TNFRSF9 mRNA	PMID:29309887
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D002185	Cannabidiol results in decreased expression of TNFRSF9 mRNA	PMID:39894194
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20201215	CTD	MESH:D002185	Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of TNFRSF9 mRNA]	PMID:27256343
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TNFRSF9 mRNA	PMID:39752319
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TNFRSF9 mRNA	PMID:31758290
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TNFRSF9 mRNA	PMID:22079256
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TNFRSF9 mRNA	PMID:22079256
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TNFRSF9 mRNA	PMID:37567420
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:75701	sarin	increases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of TNFRSF9 mRNA	PMID:19522546
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of TNFRSF9 mRNA	PMID:32858204
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:78886	2-tert-butylhydroquinone	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C018855	2-tert-butylhydroquinone results in increased expression of TNFRSF9 mRNA	PMID:35724838
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TNFRSF9 gene]	PMID:28238834
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1312547	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of TNFRSF9 mRNA	PMID:26655953
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1312547	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of TNFRSF9 mRNA	PMID:22434021
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312547	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TNFRSF9 mRNA	PMID:38648751
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1598208	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TNFRSF9 mRNA	PMID:27291303
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of TNFRSF9 mRNA	PMID:32234424
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:82538	Sunset Yellow FCF	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:C005842	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of TNFRSF9 mRNA	PMID:33819548
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of TNFRSF9 mRNA	PMID:26079696
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312547	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of TNFRSF9 mRNA	PMID:39847705
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1598208	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TNFRSF9 mRNA	PMID:24780913|PMID:25825206
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TNFRSF9 mRNA	PMID:39752319
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1598208	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TNFRSF9 mRNA	PMID:19281266
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312547	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of TNFRSF9 mRNA	PMID:33484791
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:9405	tartrazine	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D013645	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of TNFRSF9 mRNA	PMID:33819548
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TNFRSF9 mRNA	PMID:38568856
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TNFRSF9 mRNA	PMID:29301935
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1598208	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in decreased expression of TNFRSF9 mRNA	PMID:21515302
1312546	TNFRSF9	TNF receptor superfamily member 9	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312547	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TNFRSF9 mRNA	PMID:35537566
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of MUC20 mRNA	PMID:27188386
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of MUC20 mRNA	PMID:23830798
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MUC20 mRNA	PMID:22378314
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of MUC20 mRNA	PMID:30165855
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312551	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of MUC20 mRNA	PMID:33711761
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304865	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MUC20 mRNA	PMID:33387578
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304865	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of MUC20 gene	PMID:27618143
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of MUC20 mRNA	PMID:22238285
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of MUC20 mRNA	PMID:33647349
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MUC20 mRNA	PMID:28818685
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1304865	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of MUC20 mRNA	PMID:28522335
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1304865	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of MUC20 mRNA	PMID:30779732
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MUC20 mRNA	PMID:21867686
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312551	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of MUC20 mRNA	PMID:25629700
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312551	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MUC20 mRNA	PMID:22206623
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MUC20 mRNA	PMID:40512198
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of MUC20 mRNA	PMID:32186404
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MUC20 mRNA	PMID:25583101
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MUC20 mRNA	PMID:28001369
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MUC20 mRNA	PMID:33212167
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:29014	cordycepin	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C058120	cordycepin results in increased expression of MUC20 mRNA	PMID:34858524
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:2948	azathioprine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of MUC20 mRNA	PMID:22623647
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MUC20 mRNA	PMID:37682722
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MUC20 mRNA	PMID:38568856
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MUC20 mRNA	PMID:40512198
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312551	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of MUC20 mRNA	PMID:17127020
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MUC20 mRNA	PMID:21569818
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MUC20 promoter	PMID:27901495
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312551	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of MUC20 mRNA	PMID:23557971
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1304865	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of MUC20 mRNA	PMID:30012374
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of MUC20 mRNA	PMID:31715268
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304865	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of MUC20 mRNA	PMID:32145629
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of MUC20 mRNA	PMID:38074096
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased expression of MUC20 mRNA	PMID:22576693
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MUC20 mRNA	PMID:24449571
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of MUC20 mRNA	PMID:29038090
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MUC20 gene	PMID:29154799
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MUC20 mRNA	PMID:25562108
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MUC20 mRNA	PMID:38832940
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MUC20 mRNA	PMID:21420995
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MUC20 mRNA	PMID:40512198
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of MUC20 mRNA	PMID:25554681
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312551	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MUC20 mRNA	PMID:25554681
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312551	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MUC20 mRNA	PMID:21641980
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312551	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MUC20 mRNA	PMID:22206623
1312550	MUC20	mucin 20, cell surface associated	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312551	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MUC20 mRNA	PMID:22206623
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312553	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of LRRTM3 mRNA	PMID:36189433
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRTM3 mRNA	PMID:36189433
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312553	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of LRRTM3 mRNA	PMID:30319688
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LRRTM3 mRNA	PMID:35811015
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRRTM3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LRRTM3 mRNA	PMID:35811015
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of LRRTM3 mRNA	PMID:30510588
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LRRTM3 mRNA	PMID:25510870
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304866	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of LRRTM3 mRNA	PMID:33387578
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LRRTM3 mRNA	PMID:36189433
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LRRTM3 mRNA	PMID:25510870
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LRRTM3 mRNA	PMID:25510870
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of LRRTM3 mRNA	PMID:22100608
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LRRTM3 gene	PMID:27153756
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312553	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LRRTM3 mRNA	PMID:28960355
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304866	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRRTM3 mRNA	PMID:32109520
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312553	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of LRRTM3 mRNA	PMID:36209798
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of LRRTM3 mRNA	PMID:25895662
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304866	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRTM3 mRNA	PMID:25181051|PMID:27178563
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312553	E	RGD:6480464	20140513	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRTM3 mRNA	PMID:24465770
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LRRTM3 mRNA	PMID:25510870
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of LRRTM3 mRNA	PMID:25510870
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312553	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of LRRTM3 exon	PMID:33297965
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LRRTM3 intron	PMID:30157460
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312553	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LRRTM3 intron	PMID:28392331
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312553	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LRRTM3 mRNA	PMID:32715474
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of LRRTM3 mRNA	PMID:36117858
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312553	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of LRRTM3 mRNA	PMID:28962523
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LRRTM3 mRNA	PMID:31533062
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRRTM3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LRRTM3 mRNA	PMID:35811015
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:46666	crocidolite asbestos	affects methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite affects the methylation of LRRTM3 5' UTR; Asbestos, Crocidolite affects the methylation of LRRTM3 exon	PMID:29523930
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312553	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of LRRTM3 mRNA	PMID:36117858
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LRRTM3 intron	PMID:30157460
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in decreased expression of LRRTM3 mRNA	PMID:19084549
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304866	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of LRRTM3 mRNA	PMID:32109520
1312552	LRRTM3	leucine rich repeat transmembrane neuronal 3	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304866	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of LRRTM3 mRNA	PMID:19015723
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of PSMG2 protein	PMID:36252740
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PSMG2 mRNA	PMID:38218311
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312555	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PSMG2 mRNA	PMID:39241906
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312555	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PSMG2 mRNA	PMID:39298647
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PSMG2 mRNA	PMID:37042841
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of PSMG2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PSMG2 mRNA]	PMID:20230807
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1312555	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PSMG2 mRNA	PMID:20230807
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20120501	CTD	MESH:D015632	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of PSMG2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PSMG2 mRNA]	PMID:20230807
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of PSMG2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PSMG2 mRNA]	PMID:20230807
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMG2 mRNA	PMID:37236586
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PSMG2 gene	PMID:27153756
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PSMG2 mRNA	PMID:35430440
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PSMG2 mRNA	PMID:34911549
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304867	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PSMG2 mRNA	PMID:31150632
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMG2 mRNA	PMID:22206623
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312555	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSMG2 mRNA	PMID:21570461
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304867	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PSMG2 mRNA	PMID:32109520
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMG2 mRNA	PMID:17942748
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PSMG2 mRNA	PMID:30851411
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304867	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PSMG2 mRNA	PMID:28959563
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PSMG2 mRNA	PMID:16014739
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312555	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PSMG2 mRNA	PMID:22228805
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PSMG2 mRNA	PMID:19150397
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PSMG2 mRNA	PMID:29264374
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PSMG2 mRNA	PMID:18445702
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312555	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PSMG2 mRNA	PMID:23811191
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312555	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PSMG2 mRNA	PMID:28472532
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PSMG2 mRNA; bisphenol A results in decreased expression of PSMG2 protein	PMID:29275510|PMID:37567409
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304867	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PSMG2 mRNA	PMID:30816183|PMID:32528016
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304867	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PSMG2 gene	PMID:28505145
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PSMG2 mRNA	PMID:28628672
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312555	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PSMG2 mRNA	PMID:39298647
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312555	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PSMG2 mRNA	PMID:37019170
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PSMG2 mRNA	PMID:21266533
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PSMG2 mRNA	PMID:34813904
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PSMG2 mRNA	PMID:28628672
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of PSMG2 mRNA	PMID:34813904
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304867	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PSMG2 mRNA	PMID:35163327
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PSMG2 mRNA	PMID:38382870
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMG2 mRNA	PMID:37236586
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304867	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PSMG2 mRNA	PMID:35163327
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PSMG2 gene	PMID:29154799
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304867	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in increased expression of PSMG2 mRNA	PMID:38685447
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PSMG2 mRNA	PMID:28628672
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1304867	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of PSMG2 mRNA	PMID:24136188
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312555	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PSMG2 mRNA	PMID:17562736
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PSMG2 mRNA	PMID:21420995
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304867	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PSMG2 mRNA	PMID:33387578
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of PSMG2 mRNA	PMID:29523930
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMG2 mRNA	PMID:17942748
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PSMG2 mRNA	PMID:28628672
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PSMG2 mRNA	PMID:35964746
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304867	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PSMG2 mRNA	PMID:24136188
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312555	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PSMG2 mRNA	PMID:19042947
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:6030	isoniazide	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of PSMG2 protein	PMID:40015660
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PSMG2 protein	PMID:32959892
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312555	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMG2 mRNA	PMID:22206623
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:749301	potassium perchlorate	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of PSMG2 mRNA	PMID:29673971
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1304867	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PSMG2 mRNA	PMID:24136188
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PSMG2 mRNA	PMID:30851411
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312555	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of PSMG2 mRNA	PMID:19270015
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1312555	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of PSMG2 mRNA	PMID:40826991
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304867	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PSMG2 mRNA	PMID:19281266
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304867	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PSMG2 mRNA	PMID:21346803
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312555	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of PSMG2 protein	PMID:24648495
1312554	PSMG2	proteasome assembly chaperone 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304867	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PSMG2 mRNA	PMID:21346803
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312557	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DPH7 mRNA	PMID:33045310
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DPH7 mRNA	PMID:33167477
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312557	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DPH7 mRNA	PMID:36331819
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH7 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of DPH7 mRNA	PMID:39836092
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DPH7 mRNA	PMID:19549813
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DPH7 intron	PMID:30157460
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DPH7 gene	PMID:27153756
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150825	CTD	MESH:D001151	Arsenic affects the methylation of DPH7 gene	PMID:25304211
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH7 mRNA	PMID:39836092
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312557	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DPH7 mRNA	PMID:20702594|PMID:21570461
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304868	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DPH7 mRNA	PMID:33387578
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1304868	E	RGD:6480464	20141014	CTD	MESH:D012402	Rotenone results in decreased expression of DPH7 mRNA	PMID:19013527
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of DPH7 mRNA	PMID:29803840
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DPH7 mRNA	PMID:38568856
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH7 mRNA	PMID:39836092
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DPH7 promoter	PMID:27901495
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312557	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of DPH7 mRNA	PMID:29264374
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312557	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DPH7 gene	PMID:35295148
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DPH7 mRNA	PMID:19710929
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312557	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DPH7 mRNA	PMID:19710929
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304868	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of DPH7 mRNA	PMID:30816183
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304868	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of DPH7 mRNA	PMID:25181051
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312557	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DPH7 mRNA	PMID:21266533
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH7 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of DPH7 mRNA	PMID:39836092
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DPH7 mRNA	PMID:31533062
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312557	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DPH7 mRNA	PMID:36331819
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DPH7 mRNA	PMID:25979313
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312557	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of DPH7 mRNA	PMID:21427059
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in increased expression of DPH7 mRNA	PMID:37505509
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of DPH7 mRNA	PMID:20106945
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150825	CTD	MESH:D001151	Arsenic affects the methylation of DPH7 gene	PMID:25304211
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH7 mRNA	PMID:39836092
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1304868	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of DPH7 mRNA	PMID:30307764
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of DPH7 mRNA	PMID:31629900
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DPH7 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of DPH7 mRNA	PMID:39836092
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1312557	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of DPH7 mRNA	PMID:27462272
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1312557	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of DPH7 mRNA	PMID:20702594
1312556	DPH7	diphthamide biosynthesis 7	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of DPH7 mRNA	PMID:29301935
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of RGS20 mRNA	PMID:26272509|PMID:27188386
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGS20 mRNA	PMID:27188386
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RGS20 protein]	PMID:38195004
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of RGS20 mRNA	PMID:23724009|PMID:33167477
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312561	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RGS20 mRNA	PMID:30319688
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RGS20 mRNA	PMID:29432896
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RGS20 mRNA	PMID:21632981
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RGS20 mRNA	PMID:35811015
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RGS20 mRNA	PMID:35811015
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1586146	E	RGD:6480464	20140715	CTD	MESH:D004958	Estradiol results in increased expression of RGS20 mRNA modified form; Estradiol results in increased expression of RGS20 protein modified form	PMID:22265196
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of RGS20 mRNA	PMID:23649840
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RGS20 mRNA	PMID:28818685
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in increased expression of RGS20 mRNA	PMID:21172416
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RGS20 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RGS20 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RGS20 protein	PMID:35301059|PMID:38195004
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RGS20 mRNA	PMID:19549813
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of RGS20 protein	PMID:20106945
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RGS20 mRNA	PMID:21632981|PMID:21641981|PMID:22100608
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RGS20 mRNA	PMID:23649840
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RGS20 mRNA	PMID:18593933
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of RGS20 mRNA	PMID:26272509
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS20 mRNA	PMID:27188386
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of RGS20 mRNA	PMID:41028656
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of RGS20 mRNA	PMID:23300844
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1312561	E	RGD:6480464	20120412	CTD	MESH:D003042	HDAC5 affects the reaction [Cocaine affects the expression of RGS20 mRNA]	PMID:17988634
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RGS20 mRNA	PMID:25583101
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1586146	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RGS20 mRNA	PMID:33387578
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RGS20 mRNA	PMID:20106945|PMID:21632981
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1586146	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RGS20 mRNA	PMID:32109520
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RGS20 mRNA	PMID:30851411
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:28680	cytarabine	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of RGS20 mRNA	PMID:21198554
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of RGS20 mRNA	PMID:41028656
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RGS20 mRNA	PMID:29432896
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of RGS20 mRNA	PMID:29301061
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RGS20 intron	PMID:30157460
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RGS20 mRNA	PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170|PMID:32234424
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of RGS20 promoter	PMID:23974009
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RGS20 mRNA]	PMID:32406909
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of RGS20 mRNA	PMID:41028656
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RGS20 mRNA	PMID:18593933
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of RGS20 mRNA; Silicon Dioxide results in increased expression of RGS20 mRNA	PMID:25351596|PMID:25895662
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:30778	gallic acid	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of RGS20 mRNA	PMID:34408198
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of RGS20 gene	PMID:31601247
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1586146	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of RGS20 mRNA	PMID:32479839
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312561	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RGS20 gene	PMID:35295148
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312561	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of RGS20 mRNA	PMID:30951980
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1586146	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of RGS20 mRNA	PMID:41034487
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RGS20 gene	PMID:31601247
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1586146	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RGS20 mRNA	PMID:25181051|PMID:36779543
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1586146	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RGS20 gene	PMID:28505145
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1312561	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of RGS20 mRNA	PMID:25172293
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312561	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of RGS20 mRNA	PMID:24535843
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312561	E	RGD:6480464	20170613	CTD	MESH:D010269	Paraquat results in increased expression of RGS20 mRNA	PMID:28366735
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1586146	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RGS20 mRNA	PMID:35163327
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1586146	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of RGS20 promoter	PMID:22457795
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1586146	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RGS20 mRNA	PMID:30917596
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RGS20 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RGS20 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of RGS20 protein	PMID:35301059|PMID:38195004
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1586146	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RGS20 mRNA	PMID:35163327
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312561	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RGS20 mRNA	PMID:40194260
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of RGS20 mRNA	PMID:28001369
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RGS20 gene	PMID:29154799
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RGS20 mRNA	PMID:21632981|PMID:25562108
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1586146	E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RGS20 mRNA	PMID:36653537
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of RGS20 mRNA	PMID:23649840
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RGS20 mRNA	PMID:38832940
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1586146	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RGS20 mRNA	PMID:33387578
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RGS20 mRNA	PMID:29432896
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RGS20 mRNA	PMID:35811015
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of RGS20 mRNA	PMID:18175754
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of RGS20 mRNA	PMID:38568856
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of RGS20 mRNA	PMID:23300844
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	RGS20 protein affects the susceptibility to Topotecan	PMID:16217747
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:64163	diquat	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004178	Diquat results in increased expression of RGS20 mRNA	PMID:21172416
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:6887	methylphenidate	decreases expression	ISO	RGD:1312561	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in decreased expression of RGS20 mRNA	PMID:22470460
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of RGS20 mRNA	PMID:31758290
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases methylation	ISO	RGD:1586146	E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in decreased methylation of RGS20 promoter	PMID:27415467
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of RGS20 mRNA	PMID:19737606
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:7719	ochratoxin A	decreases methylation	ISO	RGD:1586146	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased methylation of RGS20 gene	PMID:37162024
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1586146	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased expression of RGS20 mRNA	PMID:37162024
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RGS20 mRNA	PMID:30851411
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGS20 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS20 mRNA	PMID:27188386
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of RGS20 mRNA	PMID:26705709
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGS20 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RGS20 mRNA	PMID:27188386
1312560	RGS20	regulator of G protein signaling 20	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312561	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of RGS20 mRNA	PMID:35537566
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:10110	zidovudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with IFNA1 protein] results in increased expression of IFIT1 mRNA	PMID:20370541
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of IFIT1 mRNA	PMID:38218311
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of IFIT1 mRNA	PMID:20188158
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:141319	metam	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C008435	methyldithiocarbamate inhibits the reaction [Lipopolysaccharides affects the expression of IFIT1 mRNA]	PMID:24056979
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of IFIT1 mRNA	PMID:21934132
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of IFIT1 mRNA	PMID:15894607|PMID:23830798|PMID:33167477
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:15767	dichloromethane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008752	Methylene Chloride results in increased expression of IFIT1 mRNA	PMID:20359517
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D001280	Atrazine results in decreased expression of IFIT1 mRNA	PMID:40945087
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16101	ethylbenzene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004912	ethylbenzene results in increased expression of IFIT1 mRNA	PMID:20359517
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of IFIT1 mRNA	PMID:20044591
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of IFIT1 mRNA	PMID:21632981
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16412	lipopolysaccharide	affects expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D008070	Lipopolysaccharides affects the expression of IFIT1 mRNA	PMID:28070326
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16412	lipopolysaccharide	affects expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D008070	Lipopolysaccharides affects the expression of IFIT1 mRNA	PMID:24056979
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IFIT1 mRNA	PMID:15860229|PMID:27385120|PMID:35811015
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IFIT1 mRNA; Lipopolysaccharides results in increased expression of IFIT1BL1 mRNA	PMID:25890327|PMID:26582142|PMID:27339419|PMID:39241906
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of IFIT1 mRNA; Plant Extracts affects the reaction [Lipopolysaccharides affects the expression of IFIT1 mRNA]; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IFIT1 mRNA]	PMID:28070326|PMID:35811015
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D008070	(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of IFIT1 mRNA]; [Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFIT1 mRNA]; [Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFIT1BL1 mRNA]; methyldithiocarbamate inhibits the reaction [Lipopolysaccharides affects the expression of IFIT1 mRNA]	PMID:24056979|PMID:25890327|PMID:39241906
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:164200	triclosan	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D014260	[Triclosan co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of IFIT1 mRNA	PMID:34589561
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D004958	Estradiol affects the expression of IFIT1 mRNA	PMID:15598610
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of IFIT1 mRNA	PMID:20106945|PMID:31614463
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D004958	Estradiol results in decreased expression of IFIT1 mRNA	PMID:39298647
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of IFIT1 mRNA	PMID:19484750|PMID:19619570|PMID:21185374
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D004958	Estradiol results in increased expression of IFIT1 mRNA; Estradiol results in increased expression of IFIT1BL1 mRNA	PMID:15289156|PMID:19484750|PMID:30077407
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of IFIT1 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of IFIT1 mRNA	PMID:19619570|PMID:30165855
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D004958	[Polyphenols co-treated with Estradiol] results in increased expression of IFIT1BL1 mRNA	PMID:30077407
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D014241	Trichloroethylene results in decreased expression of IFIT1 mRNA	PMID:22407948
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of IFIT1 mRNA	PMID:20359517
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in increased expression of IFIT1 mRNA	PMID:20359517|PMID:33064461
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D002635	[Triclosan co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of IFIT1 mRNA	PMID:34589561
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of IFIT1 mRNA	PMID:20864642
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of IFIT1 mRNA	PMID:26079696
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT1 mRNA	PMID:37567420
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of IFIT1 mRNA	PMID:36695872
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D005944	Glucosamine results in increased expression of IFIT1 mRNA	PMID:17178593
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of IFIT1 mRNA	PMID:21475673
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014050	Toluene results in increased expression of IFIT1 mRNA	PMID:20359517
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:175901	gemcitabine	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in increased expression of IFIT1 mRNA	PMID:17039268
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of IFIT1 mRNA	PMID:31256213
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT1 mRNA	PMID:37567420
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D010416	Pentachlorophenol results in increased expression of IFIT1 mRNA	PMID:23892564
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D006000	[Triclosan co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of IFIT1 mRNA	PMID:34589561
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20200310	CTD	MESH:D009538	Nicotine inhibits the reaction [Poly I-C results in increased expression of IFIT1 mRNA]	PMID:31154625
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IFIT1 mRNA	PMID:27405655
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160510	CTD	MESH:D002117	Calcitriol results in decreased expression of IFIT1 mRNA	PMID:12040012|PMID:16002434
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of IFIT1 mRNA	PMID:28818685
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IFIT1 mRNA	PMID:36331819
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014284	Triiodothyronine results in decreased expression of IFIT1 mRNA	PMID:23397585
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20200310	CTD	MESH:D009538	Nicotine inhibits the reaction [Poly I-C results in increased expression of IFIT1 mRNA]	PMID:31154625
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:193591	Didecyldimethylammonium	decreases expression	EXP		E	RGD:6480464	20221018	CTD	MESH:C027118	didecyldimethylammonium results in decreased expression of IFIT1 mRNA	PMID:32763356
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D005944	Glucosamine results in increased expression of IFIT1 mRNA	PMID:17178593
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D002104	Cadmium results in decreased expression of IFIT1 mRNA	PMID:31082426
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IFIT1 mRNA	PMID:37236586
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:232141	chlorophyllin	multiple interactions	EXP		E	RGD:6480464	20241119	CTD	MESH:C007020	chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of IFIT1 mRNA]	PMID:19152381
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of IFIT1 mRNA	PMID:19549813
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of IFIT1 mRNA	PMID:23876855
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:23808	dimethylarsinous acid	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C472511	dimethylarsinous acid results in increased expression of IFIT1 mRNA	PMID:20886546
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of IFIT1 mRNA	PMID:27153756
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IFIT1 mRNA	PMID:19770486
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of IFIT1 mRNA	PMID:23649840
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of IFIT1 mRNA	PMID:25102026
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D010126	Ozone results in decreased expression of IFIT1 mRNA	PMID:16183385
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of IFIT1 mRNA; [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of IFIT1BL1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of IFIT1 mRNA	PMID:34911549
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of IFIT1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of IFIT1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of IFIT1 protein	PMID:38598786
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IFIT1 mRNA	PMID:31919559
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IFIT1 mRNA; [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IFIT1BL1 mRNA	PMID:22206623
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D006002	[Triclosan co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of IFIT1 mRNA	PMID:34589561
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of IFIT1 mRNA	PMID:33512557
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of IFIT1 mRNA	PMID:38460933
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of IFIT1 mRNA	PMID:38460933
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of IFIT1 mRNA	PMID:38460933
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of IFIT1 mRNA	PMID:26272509
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFIT1 mRNA	PMID:27188386
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C010974	Glyphosate results in decreased expression of IFIT1 mRNA	PMID:35489704
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT1 mRNA	PMID:37567420
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of IFIT1 mRNA	PMID:27392435
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of IFIT1 mRNA	PMID:27392435
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28063	o-xylene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C026114	2-xylene results in increased expression of IFIT1 mRNA	PMID:20359517
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in decreased expression of IFIT1 mRNA	PMID:26865667
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D019833	Genistein results in increased expression of IFIT1 mRNA	PMID:15289156
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IFIT1 mRNA	PMID:21570461
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IFIT1 mRNA	PMID:12377990|PMID:19619570
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IFIT1 mRNA	PMID:19770486
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IFIT1 mRNA	PMID:16704738
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of IFIT1 mRNA	PMID:19619570
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of IFIT1 mRNA	PMID:23179753
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of IFIT1 mRNA	PMID:30851411
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D005944	Glucosamine results in increased expression of IFIT1 mRNA	PMID:17178593
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of IFIT1 mRNA	PMID:21198554
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of IFIT1 mRNA	PMID:24690739
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IFIT1 mRNA	PMID:29803840|PMID:30031762
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D004317	Doxorubicin results in decreased expression of IFIT1 mRNA	PMID:39631538
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D004317	Doxorubicin results in increased expression of IFIT1 mRNA	PMID:31768571
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT1 mRNA	PMID:37567420
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D003840	[Triclosan co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of IFIT1 mRNA	PMID:34589561
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of IFIT1 mRNA	PMID:29432896
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:28984	aluminium atom	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D000535	Aluminum results in decreased expression of IFIT1 mRNA	PMID:37544489
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D001379	Azathioprine results in decreased expression of IFIT1 mRNA	PMID:19192274|PMID:22623647
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of IFIT1 mRNA	PMID:12727804|PMID:23876855|PMID:25493608|PMID:38568856
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C017947	sodium arsenite results in decreased expression of IFIT1BL1 mRNA	PMID:37682722
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of IFIT1 mRNA	PMID:22714537
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	[sodium arsenite co-treated with FTO] results in increased expression of IFIT1 mRNA	PMID:39265400
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D014415	Tunicamycin results in increased expression of IFIT1 mRNA	PMID:38498338
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IFIT1 mRNA	PMID:21632981|PMID:26238291
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IFIT1 mRNA	PMID:19770486|PMID:20713471|PMID:21569818|PMID:39111554
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IFIT1 mRNA	PMID:19152381
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IFIT1 mRNA; Benzo(a)pyrene results in increased expression of IFIT1BL1 mRNA	PMID:23735875|PMID:32417428
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IFIT1 promoter	PMID:27901495
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of IFIT1 mRNA]	PMID:19152381
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to IFIT1 promoter]	PMID:19654925
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to IFIT1 mRNA]	PMID:32406909
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of IFIT1 mRNA	PMID:24690739
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of IFIT1 mRNA	PMID:25075043
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D012834	Silver affects the expression of IFIT1 mRNA	PMID:27131904
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of IFIT1 mRNA	PMID:25895662
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IFIT1 mRNA	PMID:22300531
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IFIT1 mRNA	PMID:23221170|PMID:29341224
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:3090	bicalutamide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in decreased expression of IFIT1 mRNA	PMID:15638997
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:31642	gadodiamide hydrate	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C064925	gadodiamide results in increased expression of IFIT1 mRNA	PMID:20959327
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C008261	lead acetate results in decreased expression of IFIT1 mRNA	PMID:22609695
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C009495	titanium dioxide results in increased expression of IFIT1 mRNA	PMID:23557971|PMID:27760801
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of IFIT1 mRNA	PMID:18648102
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C006253	pirinixic acid results in decreased expression of IFIT1 mRNA	PMID:23811191
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of IFIT1 mRNA	PMID:19710929
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of IFIT1 mRNA	PMID:19191707
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of IFIT1 protein	PMID:31675489
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in decreased expression of IFIT1 mRNA	PMID:35598803
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of IFIT1 mRNA	PMID:29275510
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in increased expression of IFIT1 mRNA; bisphenol A results in increased expression of IFIT1BL1 mRNA	PMID:32156529
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of IFIT1 protein	PMID:31675489
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:33629	aluminium(0)	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D000535	Aluminum results in decreased expression of IFIT1 mRNA	PMID:37544489
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C029297	vinylidene chloride results in decreased expression of IFIT1 mRNA	PMID:26682919
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of IFIT1 mRNA	PMID:23146750
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	IFIT1 mRNA affects the susceptibility to Carmustine	PMID:16365179
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of IFIT1 mRNA	PMID:20713471
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C543008	bisphenol S affects the expression of IFIT1 mRNA	PMID:39298647
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C543008	bisphenol S results in increased expression of IFIT1 mRNA; bisphenol S results in increased expression of IFIT1BL1 mRNA	PMID:39298647|PMID:40203079
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C008745	bisphenol F results in decreased expression of IFIT1 mRNA	PMID:38685157
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D004390	Chlorpyrifos results in increased expression of IFIT1 mRNA; Chlorpyrifos results in increased expression of IFIT1BL1 mRNA	PMID:37019170
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of IFIT1 mRNA	PMID:19647056
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of IFIT1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of IFIT1 protein	PMID:38598786
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D015056	[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IFIT1 mRNA	PMID:16054899
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:34905	paraquat	affects expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D010269	Paraquat affects the expression of IFIT1 mRNA	PMID:34097952
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of IFIT1 mRNA	PMID:37047231
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFIT1 mRNA]; [Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFIT1BL1 mRNA]	PMID:39241906
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IFIT1 mRNA	PMID:37042841
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IFIT1 mRNA	PMID:38174414|PMID:38568856
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IFIT1 mRNA	PMID:37236586
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of IFIT1 mRNA	PMID:37738295
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D005999	[Triclosan co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of IFIT1 mRNA	PMID:34589561
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of IFIT1 mRNA	PMID:28962523
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D002994	Clofibrate results in decreased expression of IFIT1 mRNA	PMID:23811191
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D002994	Clofibrate results in increased expression of IFIT1 mRNA	PMID:17585979
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:37699	protein kinase inhibitor	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors results in decreased expression of IFIT1 mRNA	PMID:28003376
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:37699	protein kinase inhibitor	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D047428	Protein Kinase Inhibitors results in decreased expression of IFIT1 mRNA	PMID:28003376
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	[Prednisolone results in increased susceptibility to Protein Kinase Inhibitors] inhibits the reaction [Antigens, Viral results in increased expression of IFIT1 mRNA]; [Prednisolone results in increased susceptibility to Protein Kinase Inhibitors] inhibits the reaction [CpG ODN 2216 results in increased expression of IFIT1 mRNA]; [Protein Kinase Inhibitors results in increased susceptibility to Prednisolone] inhibits the reaction [Antigens, Viral results in increased expression of IFIT1 mRNA]; [Protein Kinase Inhibitors results in increased susceptibility to Prednisolone] inhibits the reaction [CpG ODN 2216 results in increased expression of IFIT1 mRNA]	PMID:28003376
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IFIT1 mRNA	PMID:40194260
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of IFIT1 mRNA	PMID:28302478
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of IFIT1 mRNA	PMID:31533062
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of IFIT1 mRNA	PMID:40419075
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IFIT1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of IFIT1 mRNA	PMID:36331819
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IFIT1 mRNA	PMID:25979313
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of IFIT1 mRNA	PMID:24935251|PMID:28001369|PMID:29154799
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of IFIT1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D016572	Cyclosporine results in decreased expression of IFIT1 mRNA	PMID:19770486
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D013629	Tamoxifen affects the expression of IFIT1 mRNA	PMID:20937368
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D013629	Tamoxifen results in decreased expression of IFIT1 mRNA	PMID:25123088
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:41774	tamoxifen	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of IFIT1 mRNA	PMID:19155303
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D003907	[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of IFIT1 mRNA	PMID:16054899
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of IFIT1 mRNA	PMID:15289156
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT1 mRNA	PMID:37567420
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of IFIT1 mRNA	PMID:23649840
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of IFIT1 mRNA	PMID:38832940
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of IFIT1 mRNA	PMID:28542535
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of IFIT1 mRNA	PMID:24935251
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of IFIT1 mRNA	PMID:21420995|PMID:29067470
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of IFIT1 mRNA	PMID:17039268
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of IFIT1 mRNA	PMID:24690739
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of IFIT1 mRNA	PMID:33725128
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of IFIT1 mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IFIT1 mRNA]	PMID:35811015
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of IFIT1 mRNA	PMID:24160326
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of IFIT1 mRNA	PMID:25351596
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:46680	serpentine asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased expression of IFIT1 mRNA	PMID:29523930
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of IFIT1 mRNA	PMID:24160326
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of IFIT1 mRNA	PMID:38460933
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:47344	alvocidib	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C077990	alvocidib inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to IFIT1 promoter]]; alvocidib inhibits the reaction [IFNB1 protein promotes the reaction [SUPT5H protein binds to IFIT1 promoter]]	PMID:23589332
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:47381	diclofenac	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D004008	Diclofenac results in decreased expression of IFIT1 mRNA	PMID:19192274
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of IFIT1 mRNA	PMID:31675489
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of IFIT1 mRNA	PMID:31838189
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D005944	Glucosamine results in increased expression of IFIT1 mRNA	PMID:17178593
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of IFIT1 mRNA	PMID:32512070
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IFIT1 mRNA	PMID:22079256
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C109476	epoxiconazole results in decreased expression of IFIT1BL1 mRNA	PMID:35436446
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of IFIT1 mRNA	PMID:17211630
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:49852	5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D004004	Dichlororibofuranosylbenzimidazole inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to IFIT1 promoter]]	PMID:23589332
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:50035	alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of IFIT1 mRNA	PMID:25075043
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of IFIT1 mRNA; Nanotubes, Carbon results in decreased expression of IFIT1 mRNA	PMID:25620056
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IFIT1 mRNA; Nanotubes, Carbon results in increased expression of IFIT1 mRNA	PMID:25554681
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D000069059	Atorvastatin results in decreased expression of IFIT1 mRNA	PMID:40234311
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of IFIT1 mRNA	PMID:26377693
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in decreased expression of IFIT1 mRNA	PMID:18651567
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of IFIT1 mRNA	PMID:22714537
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of IFIT1 mRNA	PMID:17982090
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D010081	Oxazolone results in increased expression of IFIT1 mRNA	PMID:19647056
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of IFIT1 mRNA	PMID:19647056
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:5516	sodium aurothiomalate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D006052	Gold Sodium Thiomalate results in decreased expression of IFIT1 mRNA	PMID:19192274
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C082359	imidacloprid results in increased expression of IFIT1 mRNA; imidacloprid results in increased expression of IFIT1BL1 mRNA	PMID:38701926
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFIT1 mRNA	PMID:21641980
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of IFIT1 mRNA	PMID:28988120
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of IFIT1 mRNA	PMID:15336504
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases response to substance	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D020122	IFIT1 protein results in decreased susceptibility to tert-Butylhydroperoxide	PMID:15003993
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of IFIT1 mRNA	PMID:14729362|PMID:15003993|PMID:15336504
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D004178	Diquat results in decreased expression of IFIT1 mRNA	PMID:36851058
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:66919	ruxolitinib	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C540383	ruxolitinib results in decreased expression of IFIT1 mRNA	PMID:22941906
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:66919	ruxolitinib	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C540383	ruxolitinib inhibits the reaction [TNF protein results in increased expression of IFIT1 mRNA]	PMID:22941906
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:6888	6alpha-methylprednisolone	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008775	Methylprednisolone results in decreased expression of IFIT1 mRNA	PMID:19192274
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D002185	Cannabidiol results in increased expression of IFIT1 mRNA	PMID:39894194
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:71200	tofacitinib	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C479163	tofacitinib results in decreased expression of IFIT1 mRNA	PMID:22941906|PMID:25487280
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:71200	tofacitinib	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C479163	tofacitinib inhibits the reaction [TNF protein results in increased expression of IFIT1 mRNA]	PMID:22941906
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	IFIT1 mRNA affects the susceptibility to temozolomide	PMID:16365179
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of IFIT1 mRNA	PMID:31758290
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of IFIT1 mRNA	PMID:22206623
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IFIT1 mRNA; [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IFIT1BL1 mRNA	PMID:22206623
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of IFIT1 mRNA	PMID:22079256
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IFIT1 mRNA	PMID:22079256
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of IFIT1 mRNA	PMID:37567420
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of IFIT1 mRNA	PMID:30851411
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of IFIT1 mRNA	PMID:34995734
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFIT1 mRNA	PMID:27188386
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:79089	ceric oxide	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C030583	ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IFIT1 mRNA]	PMID:29792201
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:79997	GW 4064	decreases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C412815	GW 4064 results in decreased expression of IFIT1 mRNA; GW 4064 results in decreased expression of IFIT1BL1 mRNA	PMID:26655953
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D010634	Phenobarbital affects the expression of IFIT1 mRNA	PMID:23091169
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of IFIT1 mRNA	PMID:38648751
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of IFIT1 mRNA	PMID:30294300
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IFIT1 protein	PMID:31675489
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of IFIT1 mRNA	PMID:23146750
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of IFIT1 protein	PMID:31675489
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:8378	prednisolone	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D011239	Prednisolone results in decreased expression of IFIT1 mRNA	PMID:19192274
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:8378	prednisolone	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D011239	[Prednisolone results in increased susceptibility to Protein Kinase Inhibitors] inhibits the reaction [Antigens, Viral results in increased expression of IFIT1 mRNA]; [Prednisolone results in increased susceptibility to Protein Kinase Inhibitors] inhibits the reaction [CpG ODN 2216 results in increased expression of IFIT1 mRNA]; [Protein Kinase Inhibitors results in increased susceptibility to Prednisolone] inhibits the reaction [Antigens, Viral results in increased expression of IFIT1 mRNA]; [Protein Kinase Inhibitors results in increased susceptibility to Prednisolone] inhibits the reaction [CpG ODN 2216 results in increased expression of IFIT1 mRNA]	PMID:28003376
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of IFIT1 mRNA	PMID:26079696
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C009277	sodium arsenate results in increased expression of IFIT1 mRNA	PMID:39847705
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:84491	poly(I:C)	increases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:D011070	Poly I-C results in increased expression of IFIT1 mRNA	PMID:31154625
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20200310	CTD	MESH:D011070	IRF7 protein mutant form inhibits the reaction [Poly I-C results in increased expression of IFIT1 mRNA]; Nicotine inhibits the reaction [Poly I-C results in increased expression of IFIT1 mRNA]	PMID:31154625
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C045950	propiconazole results in increased expression of IFIT1 mRNA	PMID:21278054
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFIT1 mRNA]; [Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFIT1BL1 mRNA]	PMID:39241906
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C035534	florfenicol results in increased expression of IFIT1 mRNA	PMID:40826991
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFIT1 mRNA	PMID:27188386
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:D012834	Silver affects the expression of IFIT1 mRNA	PMID:27131904
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of IFIT1 mRNA	PMID:29301935
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of IFIT1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of IFIT1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of IFIT1 protein	PMID:38598786
1312562	IFIT1	interferon induced protein with tetratricopeptide repeats 1	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1620177	E	RGD:6480464	20260811	CTD	MESH:C080163	trovafloxacin results in increased expression of IFIT1 mRNA	PMID:35537566
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of MRTFA mRNA	PMID:27188386
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312565	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MRTFA mRNA	PMID:33045310
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312565	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of MRTFA mRNA	PMID:37995155
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of MKL1 mRNA; Tretinoin results in increased expression of MRTFA mRNA	PMID:23724009|PMID:33167477
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D010100	Oxygen results in increased expression of MRTFA mRNA	PMID:23517783
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D010100	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Oxygen affects the localization of MRTFA protein]; Cytochalasin D inhibits the reaction [Oxygen affects the localization of MRTFA protein]; exoenzyme C3, Clostridium botulinum inhibits the reaction [Oxygen affects the localization of MRTFA protein]; MRTFA protein affects the reaction [Oxygen results in increased expression of ACTA2 mRNA]; MRTFA protein affects the reaction [Oxygen results in increased expression of ACTA2 protein]; Oxygen promotes the reaction [MRTFA protein binds to ACTA2 promoter]; Oxygen results in increased expression of and affects the localization of MRTFA protein	PMID:23517783
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of MRTFA mRNA	PMID:24763279
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MRTFA mRNA	PMID:26079696
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:15756	hexadecanoic acid	affects localization	EXP		E	RGD:6480464	20160412	CTD	MESH:D019308	Palmitic Acid affects the localization of MRTFA protein	PMID:21393865
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D019308	CCG 1423 inhibits the reaction [Palmitic Acid affects the localization of MRTFA protein]	PMID:21393865
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of MKL1 mRNA	PMID:30319688
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MRTFA mRNA	PMID:20044591
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312565	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MRTFA mRNA	PMID:39241906
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MRTFA mRNA]	PMID:39241906
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of MRTFA mRNA	PMID:20655997
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304873	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of MRTFA mRNA]	PMID:20032058
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MRTFA protein	PMID:37730182
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304873	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MRTFA mRNA	PMID:22061828
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MRTFA mRNA	PMID:28818685
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MRTFA mRNA	PMID:35301059
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MRTFA mRNA	PMID:19549813
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of MRTFA intron	PMID:30157460
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MRTFA mRNA	PMID:23649840
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304873	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MKL1 mRNA	PMID:30779732
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312565	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MRTFA mRNA	PMID:17484886
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRTFA mRNA	PMID:22206623
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRTFA mRNA	PMID:40504410
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MRTFA protein	PMID:35688186
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of MRTFA mRNA	PMID:23557933
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of MRTFA mRNA	PMID:27392435|PMID:27594783
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of MRTFA mRNA	PMID:27392435
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312565	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MKL1 mRNA	PMID:30912803
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312565	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRTFA mRNA	PMID:21570461
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects localization	EXP		E	RGD:6480464	20170207	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the localization of MRTFA protein	PMID:27697457
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304873	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRTFA mRNA	PMID:32109520
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of MRTFA mRNA	PMID:29803840
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of MRTFA protein	PMID:35688186
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRTFA mRNA	PMID:40504410
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MKL1 promoter; Benzo(a)pyrene affects the methylation of MRTFA intron	PMID:27901495|PMID:30157460
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MKL1 5' UTR	PMID:27901495
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MRTFA gene	PMID:31601247
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304873	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRTFA mRNA	PMID:25181051
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MRTFA gene	PMID:31601247
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MRTFA gene	PMID:31601247
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312565	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of MRTFA promoter	PMID:33297965
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of MRTFA intron	PMID:30157460
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1304873	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of MRTFA mRNA	PMID:22546817
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1304873	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of MRTFA mRNA	PMID:22546817
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MRTFA mRNA]	PMID:39241906
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MRTFA mRNA	PMID:37042841
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MRTFA mRNA	PMID:35301059
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of MRTFA mRNA	PMID:28302478
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MRTFA mRNA	PMID:31533062
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312565	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of MRTFA mRNA	PMID:29038090
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of MRTFA mRNA	PMID:26272509
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MRTFA mRNA	PMID:27188386
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MRTFA mRNA	PMID:25562108
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1304873	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in decreased expression of MRTFA mRNA	PMID:20032058
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1304873	E	RGD:6480464	20120412	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of MRTFA mRNA]	PMID:20032058
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312565	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MRTFA mRNA	PMID:17562736
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MRTFA mRNA	PMID:22230336
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of MRTFA mRNA	PMID:24714768
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRTFA mRNA	PMID:40504410
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:472805	ouabain	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D010042	Ouabain results in decreased expression of MRTFA mRNA	PMID:28795476
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of MRTFA mRNA	PMID:18175754
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:529996	cytochalasin D	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D015638	Cytochalasin D inhibits the reaction [Oxygen affects the localization of MRTFA protein]	PMID:23517783
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:66104	jaspamide	affects localization	EXP		E	RGD:6480464	20160822	CTD	MESH:C057531	jasplakinolide affects the localization of MRTFA protein	PMID:23517783
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of MRTFA intron	PMID:30157460
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304873	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MRTFA gene	PMID:35440735
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRTFA mRNA	PMID:22206623
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1304873	E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in increased expression of MRTFA mRNA	PMID:23358140
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MRTFA mRNA	PMID:27188386
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MKL1 gene]	PMID:28238834
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1304873	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of MRTFA mRNA	PMID:32109520
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312565	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MRTFA mRNA]	PMID:39241906
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MRTFA mRNA	PMID:27188386
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304873	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of MRTFA mRNA	PMID:19281266
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304873	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MRTFA mRNA	PMID:21346803
1312564	MRTFA	myocardin related transcription factor A	gene	CHEBI:9607	Tiron	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D014013	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Oxygen affects the localization of MRTFA protein]	PMID:23517783
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312568	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DLX3 mRNA	PMID:33045310
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312568	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of DLX3 mRNA	PMID:37995155
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of DLX3 mRNA	PMID:26079696
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304875	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of DLX3 gene	PMID:28931070
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DLX3 mRNA	PMID:35811015
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DLX3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of DLX3 mRNA	PMID:35811015
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of DLX3 mRNA	PMID:30165855
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:177802	Cuprizon	affects expression	ISO	RGD:1304875	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of DLX3 mRNA	PMID:27523638
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:17833	gentamycin	affects expression	ISO	RGD:1304875	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins affects the expression of DLX3 mRNA	PMID:33387578
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312568	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of DLX3 mRNA	PMID:27106289
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312568	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DLX3 mRNA	PMID:25629700
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DLX3 mRNA	PMID:32525701
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of DLX3 mRNA	PMID:26272509
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of DLX3 mRNA	PMID:23557933
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312568	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DLX3 mRNA	PMID:21570461
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304875	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DLX3 mRNA	PMID:33387578
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DLX3 mRNA	PMID:23152189
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312568	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DLX3 mRNA	PMID:24058054
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DLX3 mRNA	PMID:30851411
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of DLX3 mRNA	PMID:26272509
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of DLX3 mRNA	PMID:34032870
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DLX3 3' UTR	PMID:30157460
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DLX3 3' UTR; Benzo(a)pyrene results in increased methylation of DLX3 exon	PMID:27901495
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312568	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of DLX3 mRNA	PMID:27131904
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DLX3 mRNA	PMID:20458559
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:32095	retinyl acetate	increases expression	ISO	RGD:1312568	E	RGD:6480464	20120412	CTD	MESH:C009166	retinol acetate results in increased expression of DLX3 mRNA	PMID:16772331
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1312568	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of DLX3 gene	PMID:35295148
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312568	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of DLX3 promoter	PMID:27334623
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304875	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DLX3 mRNA	PMID:36041667
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:34283	oxybenzone	affects expression	ISO	RGD:1304875	E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone affects the expression of DLX3 mRNA	PMID:30316929
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312568	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of DLX3 mRNA	PMID:30951980
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304875	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DLX3 mRNA	PMID:36041667
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312568	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DLX3 mRNA	PMID:38685157
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304875	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DLX3 mRNA	PMID:36041667
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1304875	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of DLX3 mRNA	PMID:35163327
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304875	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of DLX3 mRNA	PMID:35163327
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304875	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DLX3 mRNA	PMID:21297351
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304875	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of DLX3 mRNA	PMID:35163327
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DLX3 mRNA	PMID:25979313
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of DLX3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of DLX3 promoter	PMID:27989131
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1304875	E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of DLX3 mRNA	PMID:21658437
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of DLX3 mRNA	PMID:24935251|PMID:26272509
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of DLX3 mRNA	PMID:22230336
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of DLX3 mRNA	PMID:35811015
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DLX3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of DLX3 mRNA	PMID:35811015
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312568	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DLX3 mRNA	PMID:19446018
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DLX3 mRNA	PMID:32525701
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of DLX3 mRNA	PMID:31838189
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of DLX3 mRNA	PMID:26272509
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DLX3 mRNA	PMID:20458559
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304875	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of DLX3 mRNA	PMID:30307764
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of DLX3 mRNA	PMID:31629900
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1304875	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DLX3 mRNA	PMID:28801915
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DLX3 mRNA	PMID:30851411
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DLX3 gene]	PMID:28238834
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1304875	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DLX3 mRNA	PMID:27291303
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of DLX3 mRNA	PMID:32525701
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of DLX3 mRNA	PMID:26272509
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DLX3 mRNA	PMID:27188386
1312567	DLX3	distal-less homeobox 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312568	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of DLX3 mRNA	PMID:27131904
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of GGCT mRNA	PMID:38218311
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1304876	E	RGD:6480464	20130618	CTD	MESH:D004237	Diuron results in decreased expression of GGCT mRNA	PMID:21551480
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304876	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GGCT mRNA]	PMID:31150632
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GGCT mRNA	PMID:33167477
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GGCT mRNA	PMID:30529165
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:2302840	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GGCT mRNA	PMID:39241906
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304876	E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of GGCT mRNA	PMID:35192832
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of GGCT mRNA	PMID:38568856
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304876	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GGCT mRNA	PMID:33387578
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GGCT mRNA	PMID:37042841
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGCT mRNA	PMID:37992649
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of GGCT mRNA	PMID:28973375
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGCT mRNA	PMID:37992649
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:17688	(S)-nicotine	increases splicing	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased splicing of GGCT mRNA alternative form	PMID:23825647
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1304876	E	RGD:6480464	20230704	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of GGCT mRNA	PMID:36005737
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20180116	CTD	MESH:D004051	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of GGCT mRNA	PMID:28433925
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of GGCT protein	PMID:34122009
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304876	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GGCT mRNA	PMID:33387578
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GGCT mRNA	PMID:36331819
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1304876	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of GGCT mRNA	PMID:28522335
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:18723	nicotine	increases splicing	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased splicing of GGCT mRNA alternative form	PMID:23825647
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GGCT mRNA	PMID:29950665
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of GGCT mRNA	PMID:23649840
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304876	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GGCT mRNA	PMID:33354967
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GGCT mRNA	PMID:23649840
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D014747	GGCT protein affects the susceptibility to Vinblastine	PMID:16217747
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304876	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GGCT mRNA	PMID:31150632
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:2302840	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GGCT mRNA	PMID:31919559
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304876	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GGCT mRNA]	PMID:31150632
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGCT mRNA	PMID:32525701
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:2302840	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of GGCT mRNA	PMID:28960355
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304876	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of GGCT mRNA	PMID:31881176
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of GGCT mRNA	PMID:27392435
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of GGCT mRNA	PMID:27392435
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:2302840	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GGCT mRNA	PMID:26377647
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304876	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GGCT mRNA	PMID:34747641
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304876	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GGCT mRNA	PMID:33387578
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20180116	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of GGCT mRNA	PMID:28433925
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1304876	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of GGCT mRNA	PMID:28374803
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of GGCT mRNA	PMID:23186747
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304876	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of GGCT mRNA	PMID:28959563
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GGCT mRNA	PMID:20971185
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGCT mRNA	PMID:37992649
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of GGCT mRNA	PMID:37956786|PMID:38100851|PMID:38568856
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:2302840	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of GGCT mRNA	PMID:37682722
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:2302840	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GGCT mRNA	PMID:23735875
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GGCT promoter	PMID:27901495
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to GGCT mRNA]	PMID:32406909
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GGCT mRNA	PMID:20971185
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of GGCT protein	PMID:34122009
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1304876	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of GGCT mRNA	PMID:38458666
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304876	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of GGCT mRNA	PMID:24136188
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:2302840	E	RGD:6480464	20130618	CTD	MESH:C008261	lead acetate results in increased expression of GGCT mRNA	PMID:22609695
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of GGCT mRNA	PMID:29264374
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:2302840	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GGCT gene	PMID:35295148
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GGCT mRNA	PMID:29950665
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304876	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GGCT mRNA	PMID:34492290
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20130618	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of GGCT mRNA	PMID:18648102
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:2302840	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of GGCT mRNA	PMID:20813756|PMID:23811191
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:2302840	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of GGCT mRNA	PMID:28472532
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304876	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of GGCT mRNA	PMID:25181051
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of GGCT mRNA; bisphenol A results in decreased expression of GGCT protein	PMID:29275510|PMID:34186270|PMID:37664457
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304876	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of GGCT mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20180116	CTD	MESH:C006780	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of GGCT mRNA	PMID:28433925
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of GGCT mRNA	PMID:26682919
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20180116	CTD	MESH:C014024	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of GGCT mRNA	PMID:28433925
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of GGCT protein	PMID:34186270
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:2302840	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of GGCT mRNA	PMID:39298647
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of GGCT protein	PMID:34186270
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of GGCT protein	PMID:34186270
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:2302840	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of GGCT mRNA	PMID:28392331
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GGCT mRNA	PMID:29950665
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1304876	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of GGCT mRNA	PMID:38458666
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GGCT mRNA	PMID:38568856
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304876	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GGCT mRNA	PMID:33453195
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1304876	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of GGCT mRNA	PMID:25539665
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304876	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of GGCT mRNA	PMID:24386269
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in decreased expression of GGCT protein	PMID:17152098
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of GGCT mRNA	PMID:28302478
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of GGCT mRNA	PMID:31533062
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGCT mRNA	PMID:19167446
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GGCT mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of GGCT mRNA	PMID:36331819
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GGCT mRNA	PMID:25979313
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of GGCT mRNA	PMID:24383497|PMID:29154799
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of GGCT mRNA	PMID:25562108
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:2302840	E	RGD:6480464	20130618	CTD	MESH:D013629	Tamoxifen affects the expression of GGCT mRNA	PMID:17555576|PMID:20937368
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:2302840	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of GGCT mRNA	PMID:25123088
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:2302840	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GGCT mRNA	PMID:37992649
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1304876	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of GGCT mRNA	PMID:24136188
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of GGCT mRNA	PMID:26690555
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGCT mRNA	PMID:32525701
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304876	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GGCT mRNA	PMID:29391264
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:2302840	E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of GGCT mRNA	PMID:17555576
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GGCT mRNA	PMID:25620056
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:2302840	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GGCT mRNA; Nanotubes, Carbon results in increased expression of GGCT mRNA	PMID:25554681
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1304876	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of GGCT mRNA	PMID:23962444
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304876	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of GGCT mRNA	PMID:24136188
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:2302840	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of GGCT mRNA	PMID:38701926
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GGCT protein	PMID:32959892
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1304876	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of GGCT mRNA	PMID:25729387
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of GGCT mRNA	PMID:36851058
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:2302840	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of GGCT mRNA	PMID:27462272
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of GGCT mRNA	PMID:31758290
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of GGCT protein	PMID:34186270
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GGCT mRNA	PMID:22206623
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:76290	PhIP	decreases expression	ISO	RGD:1304876	E	RGD:6480464	20211012	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of GGCT mRNA	PMID:33945839
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:76326	N-nitrosomorpholine	decreases expression	ISO	RGD:1304876	E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in decreased expression of GGCT protein	PMID:19716841
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of GGCT protein	PMID:39638853
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:2302840	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital affects the expression of GGCT mRNA	PMID:23091169
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GGCT mRNA	PMID:19167446
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of GGCT mRNA	PMID:32525701
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304876	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GGCT mRNA	PMID:24780913
1312569	GGCT	gamma-glutamylcyclotransferase	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:2302840	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of GGCT protein	PMID:24648495
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of TRIM44 mRNA	PMID:37995155
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1621436	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TRIM44 mRNA	PMID:20188158
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TRIM44 mRNA	PMID:26079696
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of TRIM44 mRNA	PMID:30319688
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D006861	Hydrogen Peroxide promotes the reaction [TRIM44 protein promotes the reaction [SQSTM1 protein binds to SQSTM1 protein]]	PMID:39152142
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1621436	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TRIM44 mRNA	PMID:39241906
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TRIM44 mRNA]	PMID:39241906
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TRIM44 mRNA	PMID:39298647
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRIM44 mRNA	PMID:37042841
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TRIM44 mRNA	PMID:33754040
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TRIM44 mRNA	PMID:36331819
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:22689	bafilomycin A1	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C040929	bafilomycin A1 promotes the reaction [TRIM44 protein promotes the reaction [SQSTM1 protein binds to SQSTM1 protein]]	PMID:39152142
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TRIM44 intron	PMID:30157460
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304877	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TRIM44 mRNA	PMID:30779732
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TRIM44 mRNA	PMID:22206623
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRIM44 gene	PMID:25304211
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM44 mRNA	PMID:40504410
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304877	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TRIM44 mRNA	PMID:31881176
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of TRIM44 mRNA	PMID:27594783
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TRIM44 mRNA	PMID:30912803
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304877	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRIM44 mRNA	PMID:22298810
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621436	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRIM44 mRNA	PMID:21570461
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304877	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TRIM44 mRNA	PMID:33387578
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRIM44 mRNA	PMID:29803840
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [TRIM44 protein promotes the reaction [SQSTM1 protein binds to SQSTM1 protein]]	PMID:39152142
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TRIM44 mRNA	PMID:38568856
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM44 mRNA	PMID:40504410
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TRIM44 intron	PMID:30157460
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TRIM44 mRNA	PMID:20064835
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TRIM44 mRNA	PMID:19770486|PMID:21715664
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRIM44 promoter	PMID:27901495
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TRIM44 mRNA	PMID:19150397
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TRIM44 mRNA	PMID:39716349
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20251007	CTD	MESH:C006632	TRIM44 protein results in decreased susceptibility to Arsenic Trioxide	PMID:39152142
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C006632	[TRIM44 protein results in decreased susceptibility to Arsenic Trioxide] which results in increased expression of TXN mRNA; Arsenic Trioxide inhibits the reaction [TRIM44 protein results in increased lipidation of MAP1LC3B protein]; PRKACA protein affects the reaction [TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]]; PRKACA protein affects the reaction [TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of TXN mRNA]]; TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of TXN mRNA]; TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of SQSTM1 protein]	PMID:39152142
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621436	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRIM44 promoter	PMID:35295148
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TRIM44 mRNA	PMID:30903817
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304877	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRIM44 mRNA	PMID:25181051
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304877	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIM44 mRNA	PMID:34947998
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIM44 mRNA	PMID:33221593
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304877	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of TRIM44 mRNA	PMID:29097150|PMID:32145629
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304877	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TRIM44 gene	PMID:28505145
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304877	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TRIM44 mRNA	PMID:36041667
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of TRIM44 mRNA	PMID:19244175
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TRIM44 mRNA	PMID:39298647
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304877	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TRIM44 mRNA	PMID:36041667
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TRIM44 intron	PMID:30157460
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1621436	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TRIM44 mRNA	PMID:38685157
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304877	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TRIM44 mRNA	PMID:36041667
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TRIM44 mRNA]	PMID:39241906
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRIM44 mRNA	PMID:37042841
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:3638	chloroquine	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D002738	Chloroquine promotes the reaction [TRIM44 protein promotes the reaction [SQSTM1 protein binds to SQSTM1 protein]]	PMID:39152142
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TRIM44 mRNA	PMID:36331819
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304877	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of TRIM44 mRNA	PMID:29427782
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TRIM44 gene	PMID:29154799
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TRIM44 mRNA	PMID:28973697
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TRIM44 mRNA	PMID:28542535
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRIM44 mRNA	PMID:21420995
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304877	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRIM44 mRNA	PMID:33387578
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRIM44 gene	PMID:25304211
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM44 mRNA	PMID:40504410
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRIM44 mRNA	PMID:22079256
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TRIM44 mRNA	PMID:39716349
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20251007	CTD	MESH:C032793	TRIM44 protein results in decreased susceptibility to Arsenic Trioxide	PMID:39152142
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C032793	[TRIM44 protein results in decreased susceptibility to Arsenic Trioxide] which results in increased expression of TXN mRNA; Arsenic Trioxide inhibits the reaction [TRIM44 protein results in increased lipidation of MAP1LC3B protein]; PRKACA protein affects the reaction [TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]]; PRKACA protein affects the reaction [TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of TXN mRNA]]; TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 mRNA]; TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased expression of TXN mRNA]; TRIM44 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of SQSTM1 protein]	PMID:39152142
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TRIM44 mRNA	PMID:35964746
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304877	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of TRIM44 mRNA	PMID:24793618
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRIM44 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRIM44 mRNA	PMID:21641980|PMID:26378955
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1621436	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TRIM44 mRNA	PMID:23650126
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TRIM44 intron	PMID:30157460
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TRIM44 mRNA	PMID:22206623
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TRIM44 mRNA	PMID:22079256
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TRIM44 mRNA	PMID:22079256
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1621436	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TRIM44 mRNA]	PMID:39241906
1312571	TRIM44	tripartite motif containing 44	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TRIM44 mRNA	PMID:38568856
1312572	ATG2B	autophagy related 2B	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ATG2B mRNA	PMID:37995155
1312572	ATG2B	autophagy related 2B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ATG2B mRNA	PMID:26251327
1312572	ATG2B	autophagy related 2B	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ATG2B mRNA	PMID:26079696
1312572	ATG2B	autophagy related 2B	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312573	E	RGD:6480464	20201103	CTD	MESH:D001280	Atrazine results in increased expression of ATG2B mRNA	PMID:30360616
1312572	ATG2B	autophagy related 2B	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1312573	E	RGD:6480464	20201103	CTD	MESH:D001280	Lycopene inhibits the reaction [Atrazine results in increased expression of ATG2B mRNA]	PMID:30360616
1312572	ATG2B	autophagy related 2B	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1312573	E	RGD:6480464	20201103	CTD	MESH:C015329	Lycopene inhibits the reaction [Atrazine results in increased expression of ATG2B mRNA]	PMID:30360616
1312572	ATG2B	autophagy related 2B	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312573	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ATG2B mRNA	PMID:30319688
1312572	ATG2B	autophagy related 2B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ATG2B mRNA	PMID:39298647
1312572	ATG2B	autophagy related 2B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATG2B mRNA	PMID:37042841
1312572	ATG2B	autophagy related 2B	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of ATG2B mRNA	PMID:18070364
1312572	ATG2B	autophagy related 2B	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ATG2B protein	PMID:37730182
1312572	ATG2B	autophagy related 2B	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304878	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATG2B mRNA	PMID:33387578
1312572	ATG2B	autophagy related 2B	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ATG2B mRNA	PMID:28818685
1312572	ATG2B	autophagy related 2B	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ATG2B mRNA	PMID:39836092
1312572	ATG2B	autophagy related 2B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG2B mRNA	PMID:35301059
1312572	ATG2B	autophagy related 2B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312573	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATG2B mRNA	PMID:37236586
1312572	ATG2B	autophagy related 2B	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ATG2B mRNA	PMID:19549813
1312572	ATG2B	autophagy related 2B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATG2B gene	PMID:27153756
1312572	ATG2B	autophagy related 2B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312573	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ATG2B mRNA	PMID:19770486
1312572	ATG2B	autophagy related 2B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ATG2B mRNA	PMID:23649840
1312572	ATG2B	autophagy related 2B	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304878	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ATG2B mRNA	PMID:31150632
1312572	ATG2B	autophagy related 2B	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ATG2B protein	PMID:35688186
1312572	ATG2B	autophagy related 2B	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ATG2B mRNA	PMID:23557933
1312572	ATG2B	autophagy related 2B	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ATG2B mRNA	PMID:27594783
1312572	ATG2B	autophagy related 2B	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1304878	E	RGD:6480464	20141014	CTD	MESH:D003042	Cocaine affects the expression of ATG2B mRNA	PMID:20187946
1312572	ATG2B	autophagy related 2B	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ATG2B mRNA	PMID:30912803
1312572	ATG2B	autophagy related 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312573	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATG2B mRNA	PMID:21570461
1312572	ATG2B	autophagy related 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304878	E	RGD:6480464	20141014	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATG2B mRNA	PMID:21215274
1312572	ATG2B	autophagy related 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312573	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ATG2B mRNA	PMID:25975270
1312572	ATG2B	autophagy related 2B	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304878	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of ATG2B mRNA	PMID:28374803
1312572	ATG2B	autophagy related 2B	gene	CHEBI:2825	aristolochic acid A	multiple interactions	ISO	RGD:1304878	E	RGD:6480464	20241001	CTD	MESH:C000228	[aristolochic acid I co-treated with Probenecid] results in decreased expression of ATG2B protein	PMID:38428544
1312572	ATG2B	autophagy related 2B	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304878	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ATG2B mRNA	PMID:28959563
1312572	ATG2B	autophagy related 2B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATG2B mRNA	PMID:29803840
1312572	ATG2B	autophagy related 2B	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ATG2B protein	PMID:35688186
1312572	ATG2B	autophagy related 2B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312573	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ATG2B intron	PMID:27901495
1312572	ATG2B	autophagy related 2B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312573	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATG2B mRNA	PMID:22228805
1312572	ATG2B	autophagy related 2B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATG2B 3' UTR	PMID:27901495
1312572	ATG2B	autophagy related 2B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ATG2B mRNA]	PMID:32406909
1312572	ATG2B	autophagy related 2B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ATG2B mRNA	PMID:26238291
1312572	ATG2B	autophagy related 2B	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1304878	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of ATG2B mRNA	PMID:24136188
1312572	ATG2B	autophagy related 2B	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1304878	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of ATG2B mRNA	PMID:24136188
1312572	ATG2B	autophagy related 2B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312573	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATG2B gene	PMID:35295148
1312572	ATG2B	autophagy related 2B	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304878	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ATG2B mRNA	PMID:34492290
1312572	ATG2B	autophagy related 2B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312573	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ATG2B mRNA	PMID:19710929
1312572	ATG2B	autophagy related 2B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304878	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ATG2B mRNA	PMID:25181051
1312572	ATG2B	autophagy related 2B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304878	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ATG2B mRNA	PMID:30816183|PMID:32145629|PMID:34947998
1312572	ATG2B	autophagy related 2B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ATG2B mRNA	PMID:29275510
1312572	ATG2B	autophagy related 2B	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C005290	oxybenzone results in increased expression of ATG2B mRNA	PMID:36581016
1312572	ATG2B	autophagy related 2B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ATG2B mRNA	PMID:39298647
1312572	ATG2B	autophagy related 2B	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ATG2B mRNA	PMID:34813904
1312572	ATG2B	autophagy related 2B	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ATG2B mRNA	PMID:34813904
1312572	ATG2B	autophagy related 2B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATG2B mRNA	PMID:37042841
1312572	ATG2B	autophagy related 2B	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ATG2B mRNA	PMID:39836092
1312572	ATG2B	autophagy related 2B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATG2B mRNA	PMID:35301059
1312572	ATG2B	autophagy related 2B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312573	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATG2B mRNA	PMID:37236586
1312572	ATG2B	autophagy related 2B	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ATG2B mRNA	PMID:31533062
1312572	ATG2B	autophagy related 2B	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATG2B mRNA	PMID:25979313
1312572	ATG2B	autophagy related 2B	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ATG2B gene	PMID:29154799
1312572	ATG2B	autophagy related 2B	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312573	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ATG2B mRNA	PMID:17555576
1312572	ATG2B	autophagy related 2B	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1304878	E	RGD:6480464	20141014	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ATG2B mRNA	PMID:21658437
1312572	ATG2B	autophagy related 2B	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of ATG2B mRNA	PMID:24449571
1312572	ATG2B	autophagy related 2B	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATG2B mRNA	PMID:21420995
1312572	ATG2B	autophagy related 2B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312573	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ATG2B mRNA	PMID:17555576
1312572	ATG2B	autophagy related 2B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ATG2B mRNA; Nanotubes, Carbon results in decreased expression of ATG2B mRNA	PMID:25554681
1312572	ATG2B	autophagy related 2B	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304878	E	RGD:6480464	20141014	CTD	MESH:D008713	Methimazole results in increased expression of ATG2B mRNA	PMID:22504374
1312572	ATG2B	autophagy related 2B	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ATG2B mRNA	PMID:39836092
1312572	ATG2B	autophagy related 2B	gene	CHEBI:63598	levofloxacin	increases expression	ISO	RGD:1304878	E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in increased expression of ATG2B mRNA	PMID:24136188
1312572	ATG2B	autophagy related 2B	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312573	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ATG2B mRNA	PMID:22206623
1312572	ATG2B	autophagy related 2B	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312573	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ATG2B mRNA	PMID:31388691
1312572	ATG2B	autophagy related 2B	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1304878	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ATG2B mRNA	PMID:23914054
1312572	ATG2B	autophagy related 2B	gene	CHEBI:8426	probenecid	multiple interactions	ISO	RGD:1304878	E	RGD:6480464	20241001	CTD	MESH:D011339	[aristolochic acid I co-treated with Probenecid] results in decreased expression of ATG2B protein	PMID:38428544
1312572	ATG2B	autophagy related 2B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304878	E	RGD:6480464	20141014	CTD	MESH:D011441	Propylthiouracil results in increased expression of ATG2B mRNA	PMID:22504374
1312572	ATG2B	autophagy related 2B	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of ATG2B mRNA	PMID:29301935
1312572	ATG2B	autophagy related 2B	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of ATG2B mRNA	PMID:27188386
1312572	ATG2B	autophagy related 2B	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312573	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ATG2B mRNA	PMID:28973697
1312572	ATG2B	autophagy related 2B	gene	CHEBI:9763	trovafloxacin	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C080163	trovafloxacin results in increased expression of ATG2B mRNA	PMID:33609687
1312572	ATG2B	autophagy related 2B	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304878	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of ATG2B mRNA	PMID:23034163
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of SCUBE3 mRNA	PMID:26272509
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA	PMID:27188386
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614840	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SCUBE3 mRNA	PMID:33045310
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SCUBE3 mRNA	PMID:21934132
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SCUBE3 mRNA	PMID:37992649
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of SCUBE3 mRNA	PMID:22017230
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SCUBE3 mRNA	PMID:37992649
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304880	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SCUBE3 mRNA	PMID:33387578
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:2208	purine-6-thiol	increases expression	ISO	RGD:1304880	E	RGD:6480464	20130806	CTD	MESH:D015122	Mercaptopurine results in increased expression of SCUBE3 mRNA	PMID:23358152
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1614840	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of SCUBE3 mRNA	PMID:39984025
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1304880	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SCUBE3 mRNA	PMID:33354967
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SCUBE3 mRNA	PMID:34911549
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304880	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SCUBE3 mRNA	PMID:31150632
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SCUBE3 gene	PMID:25304211
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1614840	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of SCUBE3 mRNA	PMID:28960355
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304880	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SCUBE3 mRNA	PMID:31881176
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of SCUBE3 mRNA	PMID:24768652|PMID:25583101
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304880	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SCUBE3 mRNA	PMID:33387578
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SCUBE3 mRNA	PMID:33956508
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SCUBE3 mRNA	PMID:28001369
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of SCUBE3 mRNA	PMID:30807115
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SCUBE3 mRNA	PMID:37992649
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SCUBE3 mRNA	PMID:37682722
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SCUBE3 promoter	PMID:27901495
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614840	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SCUBE3 mRNA	PMID:22228805|PMID:27195522
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:3139	bleomycin A2	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:D001761	Bleomycin results in decreased expression of SCUBE3 mRNA	PMID:40645554
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:3139	bleomycin A2	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20211207	CTD	MESH:D001761	Bleomycin results in decreased expression of SCUBE3 mRNA	PMID:30825431
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20211207	CTD	MESH:D001761	Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of SCUBE3 mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of SCUBE3 mRNA]	PMID:30825431
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614840	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SCUBE3 promoter	PMID:35295148
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1614840	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SCUBE3 promoter	PMID:35295148
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304880	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SCUBE3 mRNA	PMID:25181051
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304880	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SCUBE3 mRNA	PMID:34947998
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SCUBE3 mRNA	PMID:25172293
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SCUBE3 mRNA	PMID:26682919
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of SCUBE3 mRNA	PMID:36804509
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1304880	E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of SCUBE3 mRNA	PMID:32119087
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1614840	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SCUBE3 gene	PMID:31683443
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of SCUBE3 mRNA	PMID:30951980
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1614840	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SCUBE3 exon	PMID:33297965
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SCUBE3 mRNA	PMID:28628672
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of SCUBE3 mRNA	PMID:30951980
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1614840	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SCUBE3 intron	PMID:28392331
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1614840	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SCUBE3 mRNA	PMID:37019170
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SCUBE3 gene	PMID:22964155
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SCUBE3 mRNA	PMID:28628672
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SCUBE3 mRNA	PMID:37042841
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SCUBE3 mRNA	PMID:35776891
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of SCUBE3 mRNA	PMID:26377693
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1304880	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased expression of SCUBE3 mRNA	PMID:27387713
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1614840	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SCUBE3 mRNA	PMID:40194260
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SCUBE3 mRNA	PMID:31533062
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SCUBE3 mRNA	PMID:25979313
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of SCUBE3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA	PMID:27188386
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SCUBE3 mRNA	PMID:28628672
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SCUBE3 mRNA	PMID:37992649
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA	PMID:27188386
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SCUBE3 mRNA	PMID:24935251|PMID:26272509
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304880	E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in decreased expression of SCUBE3 mRNA	PMID:30723492|PMID:33387578
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SCUBE3 gene	PMID:25304211
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SCUBE3 mRNA	PMID:28628672
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:50667	mercaptopurine	increases expression	ISO	RGD:1304880	E	RGD:6480464	20130806	CTD	MESH:D015122	Mercaptopurine results in increased expression of SCUBE3 mRNA	PMID:23358152
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:53050	trimellitic anhydride	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of SCUBE3 mRNA	PMID:40645554
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SCUBE3 mRNA	PMID:24810058
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1614840	E	RGD:6480464	20130514	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SCUBE3 mRNA	PMID:17475336
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of SCUBE3 mRNA]	PMID:30825431
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:748998	lenabasum	multiple interactions	ISO	RGD:1614840	E	RGD:6480464	20260714	CTD	MESH:C471849	lenabasum inhibits the reaction [Bleomycin results in decreased expression of SCUBE3 mRNA]	PMID:30825431
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of SCUBE3 mRNA	PMID:29522793
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1304880	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of SCUBE3 mRNA	PMID:33484710
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of SCUBE3 mRNA	PMID:34995734
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA	PMID:27188386
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SCUBE3 gene]	PMID:28238834
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SCUBE3 mRNA	PMID:27188386
1312575	SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	ISO	RGD:1304880	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of SCUBE3 mRNA	PMID:23358152
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in decreased expression of CLPX mRNA	PMID:33227293
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CLPX mRNA	PMID:21632981
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1304883	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of CLPX mRNA	PMID:32145629
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312579	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CLPX mRNA	PMID:39298647
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CLPX mRNA	PMID:37992649
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CLPX mRNA	PMID:37992649
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CLPX mRNA	PMID:33754040
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CLPX mRNA	PMID:36331819
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1304883	E	RGD:6480464	20170516	CTD	MESH:D000517	alpha-Chlorohydrin analog results in decreased expression of CLPX protein	PMID:26597043
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304883	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CLPX protein	PMID:34915118
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:188851	Muraglitazar	increases expression	ISO	RGD:1304883	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of CLPX mRNA	PMID:21515302
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CLPX mRNA	PMID:37236586
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312579	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of CLPX mRNA	PMID:24535564
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in decreased expression of CLPX mRNA	PMID:31939706
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CLPX mRNA	PMID:27339419
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CLPX mRNA	PMID:25629700
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLPX mRNA	PMID:22206623
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CLPX protein	PMID:37208198
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312579	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of CLPX mRNA	PMID:28189721|PMID:28960355
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CLPX mRNA	PMID:23557933
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of CLPX mRNA	PMID:34813904
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312579	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLPX mRNA	PMID:21570461|PMID:28922406
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLPX mRNA	PMID:17101203
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20150825	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLPX mRNA	PMID:25975270
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304883	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CLPX mRNA	PMID:33387578
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1304883	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of CLPX mRNA	PMID:28374803
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of CLPX mRNA	PMID:33512557
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304883	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of CLPX mRNA	PMID:28374803
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CLPX mRNA	PMID:30851411
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312579	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of CLPX mRNA	PMID:25896364|PMID:39631538
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CLPX mRNA	PMID:37992649
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in decreased expression of CLPX mRNA	PMID:39095385
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLPX mRNA	PMID:19770486
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312579	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CLPX mRNA	PMID:22228805
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CLPX mRNA]	PMID:32406909
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CLPX mRNA	PMID:19150397
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1304883	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of CLPX mRNA	PMID:24136188
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:31739	josamycin	affects response to substance	EXP		E	RGD:6480464	20200609	CTD	MESH:D015570	CLPX protein affects the susceptibility to Josamycin	PMID:31915244
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312579	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CLPX gene	PMID:35295148
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C009495	titanium dioxide results in increased expression of CLPX protein	PMID:30910687
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CLPX mRNA	PMID:18648102
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312579	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CLPX mRNA	PMID:18445702|PMID:20813756|PMID:23811191
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CLPX mRNA	PMID:19710929
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CLPX mRNA	PMID:38479592
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304883	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CLPX mRNA	PMID:30903817
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of CLPX protein	PMID:34186270|PMID:37567409
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304883	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of CLPX mRNA	PMID:32145629
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of CLPX mRNA	PMID:26063408
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312579	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CLPX exon	PMID:33297965
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312579	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of CLPX mRNA	PMID:33297965|PMID:39298647
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CLPX protein	PMID:34186270
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312579	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CLPX mRNA	PMID:38685157
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CLPX protein	PMID:34186270
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CLPX mRNA	PMID:37019170
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304883	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CLPX mRNA	PMID:21266533
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304883	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLPX mRNA	PMID:18164116
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312579	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in increased expression of CLPX mRNA	PMID:21371552
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1304883	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CLPX mRNA	PMID:30589522
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of CLPX mRNA	PMID:26377693
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1304883	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of CLPX mRNA	PMID:30723492
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CLPX mRNA	PMID:38568856
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CLPX mRNA	PMID:37236586
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1304883	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of CLPX gene	PMID:22079235
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CLPX mRNA	PMID:21139344
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of CLPX mRNA	PMID:17585979
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CLPX mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CLPX mRNA	PMID:36331819
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CLPX mRNA	PMID:25979313
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CLPX mRNA	PMID:17963808
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CLPX mRNA	PMID:23179753|PMID:27188386
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312579	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of CLPX mRNA	PMID:24535564
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of CLPX mRNA	PMID:19770486
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CLPX mRNA	PMID:25562108
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CLPX mRNA	PMID:37992649
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of CLPX mRNA	PMID:33512557
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of CLPX mRNA	PMID:18502557
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1304883	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of CLPX mRNA	PMID:24136188
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of CLPX protein	PMID:15907983
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CLPX mRNA	PMID:28542535
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CLPX mRNA	PMID:17562736
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLPX mRNA	PMID:21420995|PMID:22230336|PMID:25704631|PMID:29067470
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304883	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLPX mRNA	PMID:33387578
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1312579	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of CLPX mRNA	PMID:35436446
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312579	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CLPX mRNA	PMID:25620056
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CLPX mRNA	PMID:23608068
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of CLPX mRNA	PMID:20436886
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CLPX protein	PMID:32959892
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLPX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CLPX mRNA	PMID:21641980|PMID:26378955
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CLPX mRNA	PMID:23650126
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312579	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CLPX protein	PMID:26558463
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1304883	E	RGD:6480464	20120412	CTD	MESH:D008694	Methamphetamine results in increased expression of CLPX mRNA	PMID:19149911
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304883	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CLPX mRNA	PMID:30467583
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:6887	methylphenidate	increases expression	ISO	RGD:1312579	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in increased expression of CLPX mRNA	PMID:22470460
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CLPX protein	PMID:34186270
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CLPX mRNA	PMID:22206623
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CLPX mRNA	PMID:22206623
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CLPX protein	PMID:37664457
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1304883	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CLPX mRNA	PMID:18164116
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1304883	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased expression of CLPX mRNA	PMID:37162024
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:7719	ochratoxin A	increases methylation	ISO	RGD:1304883	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased methylation of CLPX gene	PMID:37162024
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CLPX mRNA	PMID:30851411
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of CLPX mRNA	PMID:19270015|PMID:19482888
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of CLPX mRNA]	PMID:19482888
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1304883	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of CLPX protein	PMID:28903499
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of CLPX mRNA	PMID:33512557
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of CLPX mRNA	PMID:39847705
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312579	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of CLPX mRNA	PMID:21795629
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312579	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CLPX mRNA	PMID:21278054
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CLPX protein	PMID:37664457
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304883	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CLPX mRNA	PMID:21346803
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:9747	Triptolide	affects expression	ISO	RGD:1312579	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide affects the expression of CLPX mRNA	PMID:32835833
1312578	CLPX	caseinolytic mitochondrial matrix peptidase chaperone subunit X	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1304883	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of CLPX mRNA	PMID:21515302
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of DSCAML1 mRNA	PMID:34925699
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of DSCAML1 mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DSCAML1 mRNA	PMID:30951980|PMID:36189433
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DSCAML1 mRNA	PMID:26079696
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304887	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of DSCAML1 gene	PMID:35440735
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312584	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of DSCAML1 mRNA	PMID:30319688
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of DSCAML1 mRNA	PMID:30510588
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DSCAML1 mRNA	PMID:25510870
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304887	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DSCAML1 mRNA	PMID:33387578
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of DSCAML1 mRNA	PMID:26079696
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA	PMID:37567420
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DSCAML1 mRNA	PMID:36189433
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:17303	morphine	increases expression	ISO	RGD:1312584	E	RGD:6480464	20120412	CTD	MESH:D009020	Morphine results in increased expression of DSCAML1 mRNA	PMID:20144693
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA	PMID:37567420
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DSCAML1 mRNA	PMID:31163220
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of DSCAML1 intron	PMID:30157460
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:18291	manganese atom	increases expression	ISO	RGD:1304887	E	RGD:6480464	20161115	CTD	MESH:D008345	Manganese results in increased expression of DSCAML1 mRNA	PMID:26745496
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of DSCAML1 mRNA	PMID:24376830
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DSCAML1 mRNA	PMID:25510870
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DSCAML1 mRNA	PMID:25510870
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of DSCAML1 intron	PMID:30157460
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DSCAML1 gene	PMID:28458013
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:2564	aldrin	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D000452	Aldrin results in increased expression of DSCAML1 mRNA	PMID:38723972
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312584	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of DSCAML1 mRNA	PMID:25629700
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases methylation	ISO	RGD:1304887	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased methylation of DSCAML1 gene	PMID:26431795
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DSCAML1 mRNA	PMID:33212167
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:28748	doxorubicin	affects methylation	ISO	RGD:1304887	E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of DSCAML1 gene	PMID:28962528
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA	PMID:37567420
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in increased expression of DSCAML1 mRNA	PMID:35954277
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DSCAML1 exon; Benzo(a)pyrene affects the methylation of DSCAML1 intron; Benzo(a)pyrene affects the methylation of DSCAML1 promoter	PMID:27901495|PMID:30157460
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DSCAML1 mRNA	PMID:21871943
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DSCAML1 3' UTR	PMID:27901495
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312584	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DSCAML1 intron	PMID:27901495
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DSCAML1 exon	PMID:27901495
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in increased expression of DSCAML1 mRNA	PMID:26551752
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of DSCAML1 mRNA	PMID:25895662
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DSCAML1 gene	PMID:31601247
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312584	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DSCAML1 gene	PMID:35295148
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304887	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of DSCAML1 mRNA	PMID:30816183
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312584	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of DSCAML1 mRNA	PMID:30951980|PMID:32156529
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DSCAML1 gene	PMID:31601247
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of DSCAML1 mRNA	PMID:31715268
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304887	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DSCAML1 gene	PMID:28505145
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DSCAML1 gene	PMID:31601247
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304887	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DSCAML1 mRNA	PMID:36041667
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DSCAML1 mRNA	PMID:25510870
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of DSCAML1 mRNA	PMID:25510870
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312584	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of DSCAML1 gene	PMID:31683443
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312584	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of DSCAML1 mRNA	PMID:30951980
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304887	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DSCAML1 mRNA	PMID:36041667
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of DSCAML1 mRNA	PMID:30951980
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of DSCAML1 exon; benzo(e)pyrene results in increased methylation of DSCAML1 intron	PMID:30157460
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312584	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of DSCAML1 mRNA	PMID:30951980
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304887	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of DSCAML1 mRNA	PMID:36041667
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1304887	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of DSCAML1 gene	PMID:33148267
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of DSCAML1 mRNA	PMID:29024780
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:35154	manganese(0)	increases expression	ISO	RGD:1304887	E	RGD:6480464	20161115	CTD	MESH:D008345	Manganese results in increased expression of DSCAML1 mRNA	PMID:26745496
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DSCAML1 mRNA	PMID:25979313
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1304887	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of DSCAML1 mRNA	PMID:29427782
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DSCAML1 gene	PMID:29154799
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA	PMID:37567420
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312584	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DSCAML1 mRNA	PMID:17562736
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:53444	potassium dichromate	affects expression	ISO	RGD:1312584	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate affects the expression of DSCAML1 mRNA	PMID:23608068
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:53578	hexamethylene diisocyanate	increases methylation	EXP		E	RGD:6480464	20150414	CTD	MESH:C015262	1,6-hexamethylene diisocyanate results in increased methylation of DSCAML1 gene	PMID:25445006
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1304887	E	RGD:6480464	20161115	CTD	MESH:C025340	manganese chloride results in increased expression of DSCAML1 mRNA	PMID:26745496
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of DSCAML1 exon; Methapyrilene results in increased methylation of DSCAML1 intron	PMID:30157460
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304887	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DSCAML1 gene	PMID:35440735
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:69478	cannabidiol	increases methylation	ISO	RGD:1312584	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased methylation of DSCAML1 gene	PMID:32579259
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1304887	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of DSCAML1 gene	PMID:33148267
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312584	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA	PMID:37567420
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1304887	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of DSCAML1 mRNA	PMID:26720608
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DSCAML1 gene]	PMID:28238834
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1304887	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DSCAML1 mRNA	PMID:21394737
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of DSCAML1 mRNA	PMID:26079696
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304887	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of DSCAML1 mRNA	PMID:24780913
1312583	DSCAML1	DS cell adhesion molecule like 1	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in increased expression of DSCAML1 mRNA	PMID:26551752
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of TRPM3 mRNA	PMID:26272509
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPM3 mRNA	PMID:27188386
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312586	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TRPM3 mRNA	PMID:33045310
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of TRPM3 mRNA	PMID:21934132
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312586	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of TRPM3 mRNA	PMID:36189433
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312586	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TRPM3 mRNA	PMID:36189433
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304888	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of TRPM3 gene	PMID:35440735
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312586	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TRPM3 mRNA	PMID:30319688
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312586	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of TRPM3 mRNA	PMID:33711761
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of TRPM3 mRNA	PMID:26079696
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312586	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TRPM3 mRNA	PMID:36189433
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TRPM3 mRNA	PMID:31163220
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304888	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TRPM3 mRNA	PMID:26577399|PMID:27523638
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TRPM3 gene	PMID:27153756
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304888	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRPM3 mRNA	PMID:33354967
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TRPM3 intron	PMID:30157460
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:2682	amphotericin B	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of TRPM3 mRNA	PMID:28534445
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TRPM3 mRNA	PMID:22171008
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:1304888	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of TRPM3 gene	PMID:31011160
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312586	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TRPM3 mRNA	PMID:28960355
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of TRPM3 mRNA	PMID:41028656
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312586	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of TRPM3 mRNA	PMID:32186404
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312586	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRPM3 mRNA	PMID:21570461
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312586	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TRPM3 mRNA	PMID:33956508
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304888	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRPM3 mRNA	PMID:33387578
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TRPM3 mRNA	PMID:28001369
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TRPM3 mRNA	PMID:23179753|PMID:27188386
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TRPM3 mRNA	PMID:41028656
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1304888	E	RGD:6480464	20200714	CTD	MESH:D004317	Doxorubicin results in increased expression of TRPM3 mRNA	PMID:32289291
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:28777	liquiritigenin	decreases activity	ISO	RGD:1312586	E	RGD:6480464	20190702	CTD	MESH:C083152	liquiritigenin results in decreased activity of TRPM3 protein	PMID:25361167
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite affects the expression of TRPM3 mRNA	PMID:29301061
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312586	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRPM3 mRNA	PMID:36209798
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TRPM3 promoter	PMID:27901495
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312586	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRPM3 intron	PMID:27901495
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312586	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TRPM3 mRNA	PMID:27195522
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TRPM3 mRNA	PMID:41028656
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TRPM3 mRNA	PMID:22171008
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TRPM3 mRNA	PMID:20458559
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TRPM3 gene	PMID:31601247
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1304888	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of TRPM3 mRNA	PMID:32479839
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304888	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TRPM3 mRNA	PMID:30047161
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312586	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRPM3 gene	PMID:35295148
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312586	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TRPM3 promoter	PMID:35295148
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304888	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TRPM3 mRNA	PMID:34492290
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304888	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRPM3 mRNA	PMID:25181051
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304888	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TRPM3 mRNA	PMID:34947998|PMID:41034487
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312586	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of TRPM3 mRNA	PMID:35598803
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of TRPM3 gene	PMID:31601247
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TRPM3 gene	PMID:31601247
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TRPM3 mRNA	PMID:25979313
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of TRPM3 mRNA	PMID:36804509
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312586	E	RGD:6480464	20121113	CTD	MESH:D010269	Paraquat results in increased expression of TRPM3 mRNA	PMID:22563483
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312586	E	RGD:6480464	20121113	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of TRPM3 mRNA; [Paraquat co-treated with Maneb] affects the expression of TRPM3 mRNA	PMID:22563483|PMID:36117858
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:35420	pregnenolone sulfate	multiple interactions	ISO	RGD:1312586	E	RGD:6480464	20190702	CTD	MESH:C018370	pregnenolone sulfate binds to and results in increased activity of TRPM3 protein	PMID:30883612
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TRPM3 mRNA	PMID:24449571
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:38626	pyridaben	increases expression	ISO	RGD:1312586	E	RGD:6480464	20121113	CTD	MESH:C428725	pyridaben results in increased expression of TRPM3 mRNA	PMID:22563483
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312586	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of TRPM3 mRNA	PMID:39529242
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304888	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of TRPM3 mRNA	PMID:29427782
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRPM3 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312586	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRPM3 mRNA	PMID:24896083
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TRPM3 mRNA	PMID:23179753|PMID:27188386
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPM3 mRNA	PMID:27188386
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304888	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TRPM3 mRNA	PMID:30047161
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in increased expression of TRPM3 mRNA	PMID:22147139
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TRPM3 mRNA	PMID:38832940
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of TRPM3 mRNA	PMID:26272509
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRPM3 mRNA	PMID:27188386
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of TRPM3 mRNA	PMID:24935251
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TRPM3 mRNA	PMID:24935251
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRPM3 mRNA	PMID:29067470
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304888	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRPM3 mRNA	PMID:32479839
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of TRPM3 mRNA	PMID:40706910
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304888	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TRPM3 mRNA	PMID:29391264
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TRPM3 mRNA	PMID:20458559
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312586	E	RGD:6480464	20121113	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of TRPM3 mRNA; [Paraquat co-treated with Maneb] affects the expression of TRPM3 mRNA	PMID:22563483|PMID:36117858
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312586	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TRPM3 mRNA	PMID:38701926
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:6809	methamphetamine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008694	TRPM3 gene SNP affects the susceptibility to Methamphetamine	PMID:18316681
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304888	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TRPM3 gene	PMID:35440735
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:75701	sarin	increases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of TRPM3 mRNA	PMID:19522546
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPM3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPM3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRPM3 mRNA	PMID:27188386
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRPM3 gene]	PMID:28238834
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304888	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TRPM3 mRNA	PMID:24780913|PMID:30047161
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPM3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRPM3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRPM3 mRNA	PMID:27188386
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of TRPM3 mRNA	PMID:27188386
1312585	TRPM3	transient receptor potential cation channel subfamily M member 3	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1304888	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of TRPM3 gene	PMID:31682807
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ATP5IF1 mRNA	PMID:35967413
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP5IF1 mRNA	PMID:20938992
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	[IFNB1 protein co-treated with Tretinoin] results in increased expression of ATP5IF1 protein	PMID:16826196
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C029424	hydrazine results in decreased expression of ATP5IF1 mRNA	PMID:15370871
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D000431	Ethanol affects the expression of ATP5IF1 mRNA	PMID:30319688
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D000431	Ethanol results in increased expression of ATP5IF1 mRNA	PMID:30319688
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ATP5IF1 mRNA	PMID:31059760
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552540	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATP5IF1 mRNA	PMID:39241906
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5IF1 mRNA	PMID:31059760
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of ATP5IF1 mRNA	PMID:23019147
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552540	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ATP5IF1 mRNA	PMID:39298647
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D014241	Trichloroethylene results in increased expression of ATP5IF1 mRNA	PMID:19448997
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP5IF1 mRNA	PMID:20938992
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ATP5IF1 mRNA	PMID:37992649
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D013739	Testosterone deficiency results in increased expression of ATP5IF1 mRNA	PMID:33848595
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of ATP5IF1 mRNA]	PMID:33848595
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ATP5IF1 mRNA	PMID:37992649
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ATP5IF1 mRNA; Diethylhexyl Phthalate results in increased expression of ATPIF1 mRNA	PMID:19850644|PMID:33754040
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ATP5IF1 mRNA]	PMID:19850644
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D014520	Urethane results in increased expression of ATP5IF1 mRNA	PMID:16289808
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATP5IF1 mRNA	PMID:36331819
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ATP5IF1 mRNA	PMID:19549813
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C016517	indole-3-carbinol affects the expression of ATP5IF1 mRNA	PMID:21396975
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:2181	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ATP5IF1 mRNA	PMID:23630614|PMID:25378103|PMID:33354967
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of ATP5IF1 mRNA	PMID:12376462
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ATP5IF1 mRNA	PMID:34911549
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of ATP5IF1 protein	PMID:38598786
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of ATP5IF1 mRNA	PMID:31919559
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ATP5IF1 mRNA	PMID:16239168
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:2181	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ATP5IF1 mRNA	PMID:31150632
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP5IF1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ATP5IF1 mRNA	PMID:20938992|PMID:22206623
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of ATP5IF1 protein	PMID:37834424
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATP5IF1 mRNA	PMID:40504410
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ATP5IF1 mRNA	PMID:26272509
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP5IF1 mRNA	PMID:27188386
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:2181	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ATP5IF1 mRNA	PMID:31881176
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:C059514	Resveratrol results in decreased expression of ATP5IF1 protein	PMID:25505154
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of ATP5IF1 mRNA	PMID:23300844
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D014414	Tungsten results in increased expression of ATP5IF1 mRNA	PMID:30912803
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:2181	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATP5IF1 mRNA	PMID:34747641
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATP5IF1 mRNA	PMID:28213091
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D019344	Lactic Acid results in decreased expression of ATP5IF1 mRNA	PMID:30851411
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D020106	Acrylamide affects the expression of ATP5IF1 mRNA	PMID:28959563
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATP5IF1 mRNA	PMID:29803840
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D004317	Doxorubicin results in increased expression of ATP5IF1 mRNA	PMID:26873546
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ATP5IF1 mRNA	PMID:37992649
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:28794	coumarin	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C030123	coumarin results in increased expression of ATP5IF1 mRNA	PMID:18480146
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ATP5IF1 mRNA	PMID:20044591
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATP5IF1 mRNA	PMID:38568856
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATP5IF1 mRNA	PMID:40504410
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATP5IF1 mRNA	PMID:19770486
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ATP5IF1 mRNA]	PMID:22228805
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ATP5IF1 mRNA]	PMID:32406909
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ATP5IF1 mRNA	PMID:19422848
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATP5IF1 mRNA	PMID:20458559
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D000643	Ammonium Chloride affects the expression of ATP5IF1 mRNA	PMID:16483693
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D001761	Bleomycin results in increased expression of ATP5IF1 protein	PMID:25933445
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of ATP5IF1 gene	PMID:31601247
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in decreased expression of ATP5IF1 mRNA	PMID:38568856
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552540	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATPIF1 gene	PMID:35295148
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ATP5IF1 mRNA	PMID:28943392
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ATP5IF1 mRNA	PMID:18648102
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:C006253	pirinixic acid affects the expression of ATP5IF1 mRNA	PMID:23811191
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:C006253	pirinixic acid results in decreased expression of ATP5IF1 mRNA	PMID:18445702
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:C006253	pirinixic acid results in increased expression of ATP5IF1 mRNA	PMID:18301758|PMID:20059764
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C006253	pirinixic acid results in increased expression of ATP5IF1 mRNA	PMID:19162173
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ATP5IF1 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of ATP5IF1 mRNA]	PMID:19710929|PMID:20059764
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:32888	gamma-hexachlorocyclohexane	decreases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D001556	Hexachlorocyclohexane results in decreased expression of ATP5IF1 mRNA	PMID:17785943
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C006780	bisphenol A affects the expression of ATP5IF1 mRNA	PMID:30903817
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C006780	bisphenol A results in decreased expression of ATP5IF1 mRNA	PMID:29275510
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:C006780	bisphenol A results in decreased expression of ATP5IF1 mRNA	PMID:33221593
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ATP5IF1 gene	PMID:31601247
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C006780	bisphenol A results in increased expression of ATP5IF1 mRNA	PMID:25181051|PMID:32145629
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ATP5IF1 mRNA	PMID:23196670
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of ATP5IF1 gene	PMID:31601247
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ATP5IF1 protein	PMID:34186270
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of ATP5IF1 gene	PMID:22964155
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ATP5IF1 mRNA	PMID:17361019|PMID:21266533
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ATP5IF1 mRNA	PMID:19638242
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ATP5IF1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ATP5IF1 promoter; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ATP5IF1 mRNA	PMID:25374375|PMID:28943392
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C039281	furan results in increased expression of ATP5IF1 mRNA	PMID:26194646
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ATP5IF1 mRNA	PMID:19162173
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:37825	p-toluidine	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C029370	4-toluidine results in increased expression of ATP5IF1 mRNA	PMID:27638505
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ATP5IF1 mRNA	PMID:32588087
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATP5IF1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ATP5IF1 mRNA	PMID:36331819
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATP5IF1 mRNA	PMID:25979313
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ATP5IF1 mRNA	PMID:23179753|PMID:27188386
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20230704	CTD	MESH:D014635	Valproic Acid results in increased methylation of ATP5IF1 gene	PMID:29154799
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:2181	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ATP5IF1 mRNA	PMID:41580965
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATP5IF1 mRNA	PMID:20106945|PMID:25562108
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D017313	Fenretinide results in increased expression of ATP5IF1 mRNA	PMID:28973697
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ATP5IF1 mRNA	PMID:37992649
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C012655	nimesulide results in increased expression of ATP5IF1 mRNA	PMID:24136188
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D014303	Trinitrotoluene affects the expression of ATP5IF1 mRNA	PMID:21346803
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATP5IF1 mRNA	PMID:25704631|PMID:31059760
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:2181	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATP5IF1 mRNA	PMID:33387578
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5IF1 mRNA	PMID:31059760
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of ATP5IF1 protein	PMID:37834424
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATP5IF1 mRNA	PMID:40504410
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:2181	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ATP5IF1 mRNA	PMID:29391264
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:49747	methylmercury(1+)	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C030957	methylmercury II results in increased expression of ATP5IF1 mRNA	PMID:17905399
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ATP5IF1 mRNA	PMID:19422848
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATP5IF1 mRNA	PMID:20458559
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ATP5IF1 mRNA	PMID:23300844
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ATP5IF1 mRNA; Nanotubes, Carbon results in decreased expression of ATP5IF1 mRNA	PMID:25554681|PMID:25620056
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D018120	Finasteride results in increased expression of ATP5IF1 mRNA	PMID:24136188
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:2181	E	RGD:6480464	20200519	CTD	MESH:C082360	fipronil results in increased expression of ATP5IF1 mRNA	PMID:31881178
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D005485	Flutamide results in increased expression of ATP5IF1 mRNA	PMID:24136188
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ATP5IF1 protein	PMID:32959892
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:C017096	n-butoxyethanol results in increased expression of ATP5IF1 mRNA	PMID:19812364
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of ATP5IF1 mRNA	PMID:37939859
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ATP5IF1 mRNA	PMID:22206623
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP5IF1 mRNA	PMID:22206623
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C051752	nefazodone results in increased expression of ATP5IF1 mRNA	PMID:24136188
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of ATP5IF1 mRNA	PMID:12376462
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D019344	Lactic Acid results in decreased expression of ATP5IF1 mRNA	PMID:30851411
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP5IF1 mRNA	PMID:27188386
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D010634	Phenobarbital results in increased expression of ATP5IF1 mRNA	PMID:19162173
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ATP5IF1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ATP5IF1 promoter	PMID:25374375
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1552540	E	RGD:6480464	20230704	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ATP5IF1 mRNA	PMID:31388691
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1552540	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of ATP5IF1 protein	PMID:35357534
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP5IF1 mRNA	PMID:27188386
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ATP5IF1 mRNA	PMID:21346803
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ATP5IF1 mRNA	PMID:38568856
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ATP5IF1 mRNA	PMID:29301935
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of ATP5IF1 mRNA	PMID:27188386
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of ATP5IF1 protein	PMID:38598786
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ATP5IF1 mRNA	PMID:21346803
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of ATP5IF1 mRNA	PMID:19140230
1312589	ATP5IF1	ATP synthase inhibitory factor subunit 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:2181	E	RGD:6480464	20230704	CTD	MESH:C025643	vinclozolin results in increased expression of ATP5IF1 mRNA	PMID:23034163
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1304892	E	RGD:6480464	20160210	CTD	MESH:D004237	Diuron results in decreased expression of KAT6A mRNA	PMID:25152437
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:136004	linsidomine	increases oxidation	ISO	RGD:1304892	E	RGD:6480464	20180220	CTD	MESH:C002385	linsidomine results in increased oxidation of KAT6A protein	PMID:28086193
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of KAT6A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of KAT6A mRNA	PMID:32699268
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312591	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of KAT6A mRNA	PMID:30319688
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KAT6A mRNA	PMID:39241906
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304892	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of KAT6A mRNA	PMID:20068009|PMID:32145629
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KAT6A mRNA	PMID:37042841
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of KAT6A mRNA	PMID:19162166
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of KAT6A mRNA	PMID:20655997
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KAT6A mRNA	PMID:33754040
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KAT6A protein	PMID:37730182
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304892	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of KAT6A mRNA	PMID:22061828
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KAT6A mRNA	PMID:19549813
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of KAT6A protein	PMID:23301498
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KAT6A gene	PMID:27153756
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of KAT6A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of KAT6A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of KAT6A mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of KAT6A mRNA	PMID:32699268|PMID:41430723
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of KAT6A mRNA	PMID:26272509
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA	PMID:27188386
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of KAT6A protein	PMID:35688186
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of KAT6A mRNA	PMID:27594783
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1312591	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of KAT6A protein	PMID:22006019
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of KAT6A mRNA	PMID:30912803
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304892	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KAT6A mRNA	PMID:33387578
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304892	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KAT6A mRNA	PMID:32109520|PMID:34747641
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of KAT6A mRNA	PMID:26272509
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA	PMID:27188386
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of KAT6A protein	PMID:35688186
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312591	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of KAT6A mRNA	PMID:36209798
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to KAT6A mRNA]	PMID:32406909
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KAT6A mRNA	PMID:19150397
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of KAT6A mRNA	PMID:26238291
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of KAT6A mRNA	PMID:34408198
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of KAT6A gene	PMID:31601247
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of KAT6A gene	PMID:31601247
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312591	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of KAT6A mRNA	PMID:20542052
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of KAT6A mRNA	PMID:27188386
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304892	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of KAT6A mRNA	PMID:25729387
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312591	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KAT6A promoter	PMID:35295148
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304892	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of KAT6A mRNA	PMID:34492290
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304892	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of KAT6A mRNA	PMID:32145629
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304892	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KAT6A mRNA	PMID:25181051
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in decreased expression of KAT6A mRNA	PMID:40036665
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of KAT6A gene	PMID:31601247
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of KAT6A mRNA	PMID:36232920
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304892	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of KAT6A mRNA	PMID:30816183|PMID:32528016|PMID:34947998|PMID:36803626
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of KAT6A gene	PMID:31601247
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1304892	E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of KAT6A mRNA	PMID:23829299
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of KAT6A mRNA	PMID:39298647
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312591	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of KAT6A mRNA	PMID:38685157
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of KAT6A mRNA	PMID:37019170
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304892	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KAT6A mRNA	PMID:21266533
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of KAT6A mRNA	PMID:34813904
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of KAT6A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of KAT6A mRNA	PMID:32699268
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of KAT6A mRNA	PMID:28302478
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of KAT6A mRNA	PMID:19167446
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312591	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of KAT6A mRNA	PMID:36331819
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1304892	E	RGD:6480464	20130723	CTD	MESH:D002737	Chloroprene results in increased expression of KAT6A mRNA	PMID:23125180
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304892	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of KAT6A mRNA	PMID:29427782
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D014635	Valproic Acid results in decreased expression of KAT6A mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of KAT6A gene	PMID:29154799
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of KAT6A mRNA	PMID:33512557
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C012589	trichostatin A results in decreased expression of KAT6A mRNA	PMID:24935251
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of KAT6A mRNA	PMID:29523930
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of KAT6A mRNA	PMID:26272509
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA	PMID:27188386
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of KAT6A mRNA	PMID:25554681
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of KAT6A mRNA	PMID:26705709
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1304892	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of KAT6A mRNA	PMID:25729387
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304892	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of KAT6A mRNA	PMID:25729387
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312591	E	RGD:6480464	20160210	CTD	MESH:D008694	Methamphetamine results in increased expression of KAT6A mRNA	PMID:26307267
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304892	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of KAT6A mRNA	PMID:30467583
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA	PMID:27188386
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:80799	Bufotalin	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of KAT6A mRNA	PMID:39904859
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312591	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of KAT6A mRNA	PMID:31388691
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1304892	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of KAT6A mRNA	PMID:27291303
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1312591	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of KAT6A mRNA	PMID:31558096
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1304892	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of KAT6A mRNA	PMID:23640034
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1304892	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of KAT6A mRNA	PMID:23640034
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA	PMID:27188386
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of KAT6A mRNA	PMID:12756304
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT6A mRNA	PMID:27188386
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304892	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of KAT6A mRNA	PMID:19281266
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of KAT6A mRNA	PMID:27188386
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304892	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of KAT6A mRNA	PMID:21346803
1312590	KAT6A	lysine acetyltransferase 6A	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312591	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of KAT6A mRNA	PMID:28973697
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of CCR8 mRNA	PMID:39245080
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CCR8 intron	PMID:30157460
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:18227	sterigmatocystin	increases expression	ISO	RGD:1312593	E	RGD:6480464	20120501	CTD	MESH:D013241	Sterigmatocystin results in increased expression of CCR8 mRNA	PMID:19818335
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:211551	TMC-120A	increases expression	ISO	RGD:1312593	E	RGD:6480464	20231219	CTD	MESH:C402696	TMC 120A results in increased expression of CCR8 mRNA	PMID:19818335
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:22984	calcium atom	affects abundance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	CCR8 protein affects the abundance of Calcium	PMID:12055238
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312593	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR8 mRNA	PMID:29950665
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312593	E	RGD:6480464	20180116	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CCR8 mRNA	PMID:28789997
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CCR8 intron	PMID:30157460
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:25442	mycotoxin	increases expression	ISO	RGD:1312593	E	RGD:6480464	20170228	CTD	MESH:D009183	Mycotoxins results in increased expression of CCR8 mRNA	PMID:19818335
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D001151	Arsenic affects the expression of CCR8 protein	PMID:24675094
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312593	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of CCR8 mRNA	PMID:28960355
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of CCR8 promoter	PMID:22847954
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304893	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CCR8 mRNA	PMID:26033743
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1304893	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CCR8 mRNA	PMID:26033743
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:29320	calcium(0)	affects abundance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	CCR8 protein affects the abundance of Calcium	PMID:12055238
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312593	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCR8 mRNA	PMID:21911445
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCR8 promoter	PMID:27901495
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304893	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CCR8 mRNA	PMID:26033743
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1304893	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CCR8 mRNA	PMID:26033743
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CCR8 mRNA	PMID:19428942
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312593	E	RGD:6480464	20250401	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CCR8 mRNA	PMID:38811393
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CCR8 mRNA	PMID:27829220
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312593	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of CCR8 mRNA	PMID:22609695
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312593	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CCR8 mRNA	PMID:29264374
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312593	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR8 mRNA	PMID:29950665
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304893	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CCR8 mRNA	PMID:25181051
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:34107	1-nitropyrene	decreases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in decreased expression of CCR8 mRNA	PMID:19428942
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CCR8 intron	PMID:30157460
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312593	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR8 mRNA	PMID:29950665
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312593	E	RGD:6480464	20180828	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CCR8 mRNA	PMID:29408670
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CCR8 mRNA	PMID:24449571
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of CCR8 promoter	PMID:22847954
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of CCR8 promoter	PMID:22847954
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:4027	cyclophosphamide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of CCR8 mRNA	PMID:17403535
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of CCR8 promoter	PMID:27989131
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of CCR8 protein	PMID:24675094
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312593	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CCR8 mRNA	PMID:35436446
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1312593	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of CCR8 mRNA	PMID:15885639
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CCR8 mRNA	PMID:27829220
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:49976	zinc dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C016837	zinc chloride results in decreased expression of CCR8 mRNA	PMID:19428942
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312593	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CCR8 mRNA	PMID:25620056
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:53001	nickel sulfate	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate affects the expression of CCR8 mRNA	PMID:18202158
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029938	nickel sulfate results in increased expression of CCR8 mRNA	PMID:11145678
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312593	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CCR8 mRNA	PMID:38701926
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CCR8 intron	PMID:30157460
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:75832	iron(2+) sulfate (anhydrous)	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C020748	ferrous sulfate results in decreased expression of CCR8 mRNA	PMID:19428942
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CCR8 gene]	PMID:28238834
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312593	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CCR8 mRNA	PMID:31388691
1312592	CCR8	C-C motif chemokine receptor 8	gene	CHEBI:8207	(+)-pilocarpine	decreases expression	ISO	RGD:1312593	E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in decreased expression of CCR8 mRNA; Pilocarpine results in decreased expression of CCR8 protein	PMID:17181556
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552051	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CLCA2 mRNA	PMID:33045310
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CLCA2 mRNA	PMID:25812627
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLCA2 mRNA	PMID:20938992
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1304894	E	RGD:6480464	20140408	CTD	MESH:D010100	Oxygen results in increased expression of CLCA2 mRNA	PMID:22911455
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CLCA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CLCA2 mRNA	PMID:35811015
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552051	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CLCA2 mRNA	PMID:19484750
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CLCA2 mRNA	PMID:30165855
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304894	E	RGD:6480464	20200211	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of CLCA2 mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA2 mRNA	PMID:26496021|PMID:32741896
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304894	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CLCA2 mRNA	PMID:33387578
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304894	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of CLCA2 gene	PMID:27618143
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLCA2 mRNA	PMID:20938992
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of CLCA2 mRNA	PMID:28937961
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CLCA2 mRNA	PMID:23649840
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304894	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA2 mRNA	PMID:32741896
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CLCA2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLCA2 mRNA]	PMID:20230807
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304894	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CLCA2 mRNA	PMID:33387578
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1552051	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLCA2 mRNA	PMID:20230807
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20120501	CTD	MESH:D015632	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CLCA2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLCA2 mRNA]	PMID:20230807
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of CLCA2 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLCA2 mRNA]	PMID:20230807
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of CLCA2 mRNA	PMID:21120746
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CLCA2 mRNA	PMID:23649840
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CLCA2 mRNA	PMID:22100608
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CLCA2 mRNA	PMID:23649840
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1304894	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CLCA2 mRNA	PMID:30779732
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLCA2 mRNA	PMID:20938992
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1552051	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of CLCA2 mRNA	PMID:19654921
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of CLCA2 mRNA	PMID:38460933
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CLCA2 mRNA	PMID:27392435
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CLCA2 mRNA	PMID:27392435
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of CLCA2 promoter	PMID:22847954
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552051	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLCA2 mRNA	PMID:18691609
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304894	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CLCA2 mRNA	PMID:33387578
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304894	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CLCA2 mRNA	PMID:26033743
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CLCA2 mRNA	PMID:15467011
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CLCA2 mRNA	PMID:38568856
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of CLCA2 mRNA	PMID:34032870|PMID:39719251
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CLCA2 mRNA	PMID:22316170|PMID:32234424
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of CLCA2 gene	PMID:25435355
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304894	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CLCA2 mRNA	PMID:26033743
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1552051	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of CLCA2 mRNA	PMID:15467011
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CLCA2 mRNA	PMID:26705709
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1304894	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CLCA2 mRNA	PMID:16483693
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of CLCA2 mRNA	PMID:38568856
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552051	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of CLCA2 mRNA	PMID:27760801
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552051	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CLCA2 mRNA	PMID:17426115
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CLCA2 mRNA	PMID:38479592
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304894	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CLCA2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552051	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CLCA2 mRNA	PMID:32156529
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1552051	E	RGD:6480464	20200211	CTD	MESH:C006780	bisphenol A results in increased methylation of CLCA2 promoter	PMID:27312807
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304894	E	RGD:6480464	20200211	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of CLCA2 mRNA	PMID:26496021
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:3392	carbendazim	multiple interactions	ISO	RGD:1304894	E	RGD:6480464	20121106	CTD	MESH:C006698	[carbendazim co-treated with 2,5-hexanedione] results in decreased expression of CLCA2 mRNA	PMID:22382377
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of CLCA2 mRNA	PMID:36804509
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1552051	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of CLCA2 mRNA	PMID:26377693
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1304894	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CLCA2 mRNA	PMID:30589522
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CLCA2 mRNA	PMID:38568856
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304894	E	RGD:6480464	20200211	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CLCA2 mRNA	PMID:25993096
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CLCA2 mRNA	PMID:25812627
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304894	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CLCA2 mRNA	PMID:27387713
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552051	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CLCA2 mRNA	PMID:40194260
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of CLCA2 promoter	PMID:22847954
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of CLCA2 promoter	PMID:22847954
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CLCA2 mRNA	PMID:40419075
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1304894	E	RGD:6480464	20200211	CTD	MESH:C016104	sodium bichromate results in decreased expression of CLCA2 mRNA	PMID:25993096
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304894	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CLCA2 mRNA	PMID:30047161
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CLCA2 mRNA	PMID:38832940
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1304894	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of CLCA2 mRNA	PMID:33387578
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552051	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CLCA2 mRNA	PMID:17562736
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CLCA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CLCA2 mRNA	PMID:35811015
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:46742	Nutlin-3	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of CLCA2 mRNA	PMID:38460933
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of CLCA2 mRNA	PMID:38460933
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1552051	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of CLCA2 mRNA	PMID:19654921
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304894	E	RGD:6480464	20200211	CTD	MESH:D004726	Endosulfan results in increased expression of CLCA2 mRNA	PMID:29391264
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of CLCA2 mRNA	PMID:38568856
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CLCA2 mRNA	PMID:26705709
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552051	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CLCA2 mRNA; Nanotubes, Carbon results in increased expression of CLCA2 mRNA	PMID:25554681|PMID:25620056
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304894	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CLCA2 mRNA	PMID:30047161
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:51052	lucanthone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in increased expression of CLCA2 mRNA	PMID:21148553
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:67251	beta-damascenone	increases expression	ISO	RGD:1552051	E	RGD:6480464	20161213	CTD	MESH:C075388	beta-damascenone results in increased expression of CLCA2 mRNA	PMID:22982537
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:75170	zaragozic acid A	increases expression	ISO	RGD:1304894	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of CLCA2 mRNA	PMID:27225895
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:75170	zaragozic acid A	increases expression	ISO	RGD:1552051	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of CLCA2 mRNA	PMID:27225895
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of CLCA2 mRNA	PMID:29522793
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1304894	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA2 mRNA	PMID:32741896
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:85014	2,5-hexanedione	multiple interactions	ISO	RGD:1304894	E	RGD:6480464	20150303	CTD	MESH:C011269	[carbendazim co-treated with 2,5-hexanedione] results in decreased expression of CLCA2 mRNA	PMID:22382377
1312594	CLCA2	chloride channel accessory 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304894	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CLCA2 mRNA	PMID:30047161
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:132098	methoxyacetic acid	decreases expression	ISO	RGD:1304895	E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of DDX31 mRNA	PMID:20864626
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304895	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX31 mRNA]	PMID:31150632
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DDX31 mRNA	PMID:33167477
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312597	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DDX31 mRNA	PMID:39241906
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of DDX31 mRNA	PMID:31614463
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DDX31 mRNA	PMID:37042841
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312597	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DDX31 mRNA	PMID:34319233
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304895	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of DDX31 mRNA	PMID:26577399
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DDX31 mRNA	PMID:28818685
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DDX31 mRNA	PMID:39836092
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DDX31 protein	PMID:23301498
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DDX31 mRNA	PMID:22100608
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312597	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DDX31 mRNA	PMID:19770486
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DDX31 gene	PMID:27153756
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of DDX31 mRNA	PMID:19774075
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304895	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DDX31 mRNA	PMID:31150632
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304895	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX31 mRNA]	PMID:31150632
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312597	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DDX31 mRNA	PMID:22206623
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DDX31 gene	PMID:25304211
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX31 mRNA	PMID:39836092
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:1304895	E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of DDX31 mRNA	PMID:20864626
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304895	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DDX31 mRNA	PMID:33387578
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1304895	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DDX31 mRNA	PMID:20864626
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of DDX31 mRNA	PMID:29803840
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:28794	coumarin	decreases expression	ISO	RGD:1304895	E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in decreased expression of DDX31 mRNA	PMID:18480146
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of DDX31 protein	PMID:35688186
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DDX31 mRNA	PMID:38568856
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX31 mRNA	PMID:39836092
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of DDX31 mRNA	PMID:25075043
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of DDX31 gene	PMID:31601247
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304895	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DDX31 mRNA	PMID:23411599|PMID:34492290
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312597	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DDX31 mRNA	PMID:19710929
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304895	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DDX31 mRNA	PMID:25181051
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304895	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DDX31 mRNA	PMID:30816183|PMID:32528016
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312597	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DDX31 mRNA	PMID:33221593
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304895	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DDX31 gene	PMID:28505145
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312597	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DDX31 mRNA	PMID:37019170
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304895	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of DDX31 mRNA	PMID:32680482
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DDX31 mRNA	PMID:37042841
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DDX31 mRNA	PMID:39836092
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DDX31 mRNA	PMID:38568856
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DDX31 mRNA	PMID:26472689
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of DDX31 mRNA	PMID:24449571
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DDX31 mRNA	PMID:23179753
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1304895	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of DDX31 mRNA	PMID:21346803
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312597	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DDX31 mRNA	PMID:17562736
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DDX31 gene	PMID:25304211
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX31 mRNA	PMID:39836092
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312597	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of DDX31 mRNA	PMID:35436446
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:50035	alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of DDX31 mRNA	PMID:25075043
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1304895	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of DDX31 mRNA	PMID:20080153
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DDX31 mRNA	PMID:39836092
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312597	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DDX31 mRNA	PMID:22206623
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DDX31 gene]	PMID:28238834
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1304895	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of DDX31 mRNA	PMID:20864626
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304895	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DDX31 mRNA	PMID:21346803
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of DDX31 mRNA	PMID:29301935
1312596	DDX31	DEAD-box helicase 31	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304895	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of DDX31 mRNA	PMID:23034163
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1550053	E	RGD:6480464	20190219	CTD	MESH:D015025	Zearalenone results in decreased expression of RPL23A mRNA	PMID:30138655
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL23A mRNA	PMID:39752319
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:15368	acrolein	increases expression	ISO	RGD:1304897	E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein results in increased expression of RPL23A mRNA	PMID:38090360
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RPL23A mRNA	PMID:36331819
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550053	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RPL23A mRNA	PMID:39241906
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of RPL23A mRNA	PMID:35877022
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL23A mRNA	PMID:39752319
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550053	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RPL23A mRNA	PMID:33754040
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RPL23A protein	PMID:37730182
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL23A mRNA	PMID:36331819
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:207229	dihydroartemisinin	affects binding	EXP		E	RGD:6480464	20170303	CTD	MESH:C039060	artenimol analog binds to RPL23A protein	PMID:26340163
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RPL23A mRNA	PMID:19549813
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPL23A protein	PMID:23301498
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of RPL23A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RPL23A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RPL23A protein	PMID:38598786
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL23A mRNA	PMID:22206623
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RPL23A mRNA	PMID:28903495
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RPL23A mRNA	PMID:27392435
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of RPL23A mRNA	PMID:27392435
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1550053	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of RPL23A mRNA	PMID:34813904
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550053	E	RGD:6480464	20150728	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RPL23A mRNA	PMID:19465110|PMID:19770486
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304897	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RPL23A mRNA	PMID:33387578|PMID:34747641
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20150728	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of RPL23A mRNA	PMID:16214954
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of RPL23A protein	PMID:39603559
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RPL23A mRNA; aristolochic acid I results in decreased expression of RPL23A protein	PMID:33212167
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RPL23A mRNA	PMID:30851411
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550053	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of RPL23A protein	PMID:28918527
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RPL23A mRNA; sodium arsenite results in decreased expression of RPL23A protein	PMID:38228842|PMID:38568856|PMID:39719251
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of RPL23A mRNA	PMID:21457566
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of and results in increased activity of RPL23A protein	PMID:30528433
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550053	E	RGD:6480464	20150728	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RPL23A mRNA	PMID:19770486
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RPL23A mRNA]; arsenite promotes the reaction [G3BP1 protein binds to RPL23A protein]	PMID:32406909
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1304897	E	RGD:6480464	20150728	CTD	MESH:D000643	Ammonium Chloride affects the expression of RPL23A mRNA	PMID:16483693
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304897	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of RPL23A mRNA	PMID:24136188
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304897	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RPL23A mRNA	PMID:34492290
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550053	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RPL23A mRNA	PMID:28472532
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304897	E	RGD:6480464	20150728	CTD	MESH:C006780	bisphenol A affects the expression of RPL23A mRNA	PMID:25181051
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL23A protein	PMID:34186270|PMID:37567409
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of RPL23A protein	PMID:34186270
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550053	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RPL23A mRNA	PMID:39298647
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RPL23A protein	PMID:34186270
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RPL23A protein	PMID:34186270
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:1304897	E	RGD:6480464	20150728	CTD	MESH:D002995	Clofibric Acid affects the expression of RPL23A mRNA	PMID:17602206
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RPL23A protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RPL23A protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of RPL23A protein	PMID:38598786
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1304897	E	RGD:6480464	20150728	CTD	MESH:D002509	Cephaloridine results in increased expression of RPL23A mRNA	PMID:18500788
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of RPL23A protein	PMID:26879310
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304897	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of RPL23A mRNA	PMID:26194646
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RPL23A mRNA	PMID:24449571
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of RPL23A mRNA	PMID:26352163
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL23A mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RPL23A mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of RPL23A mRNA	PMID:36331819
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RPL23A gene	PMID:29154799
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RPL23A mRNA	PMID:17183730
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	RPL23A protein affects the susceptibility to Methotrexate	PMID:16217747
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:45863	paclitaxel	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	RPL23A mRNA results in decreased susceptibility to Paclitaxel	PMID:16322897
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550053	E	RGD:6480464	20150728	CTD	MESH:D000082	Acetaminophen affects the expression of RPL23A mRNA	PMID:17562736
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of RPL23A protein	PMID:31195006
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1304897	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in increased expression of RPL23A mRNA	PMID:36868495
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1550053	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of RPL23A protein	PMID:21135415
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304897	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RPL23A mRNA	PMID:24136188
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RPL23A mRNA	PMID:17183730
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RPL23A protein	PMID:32959892
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL23A mRNA	PMID:39752319
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RPL23A protein	PMID:34186270
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL23A mRNA	PMID:22206623
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL23A protein	PMID:37664457
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of RPL23A protein	PMID:31285264
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RPL23A mRNA	PMID:30851411
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1550053	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RPL23A mRNA	PMID:40826991
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1550053	E	RGD:6480464	20180703	CTD	MESH:C089595	cylindrospermopsin results in increased expression of RPL23A mRNA	PMID:20936652
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1550053	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of RPL23A mRNA	PMID:39752319
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL23A protein	PMID:37664457
1312599	RPL23A	ribosomal protein L23a	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RPL23A protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RPL23A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RPL23A protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RPL23A protein	PMID:38598786
1312601	PRTN3	proteinase 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312602	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PRTN3 mRNA	PMID:33045310
1312601	PRTN3	proteinase 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRTN3 gene	PMID:20938992
1312601	PRTN3	proteinase 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of PRTN3 mRNA; Tretinoin results in decreased expression of PRTN3 protein	PMID:26892147
1312601	PRTN3	proteinase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of PRTN3 mRNA	PMID:17218384|PMID:33167477
1312601	PRTN3	proteinase 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	arsenic trioxide promotes the reaction [Tretinoin results in decreased expression of PRTN3 mRNA]	PMID:26892147
1312601	PRTN3	proteinase 3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001280	Atrazine results in increased expression of PRTN3 mRNA	PMID:18585445
1312601	PRTN3	proteinase 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312602	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PRTN3 mRNA	PMID:12057914|PMID:27339419
1312601	PRTN3	proteinase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312602	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of PRTN3 mRNA	PMID:19484750|PMID:39298647
1312601	PRTN3	proteinase 3	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312602	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of PRTN3 mRNA	PMID:18978301
1312601	PRTN3	proteinase 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20180116	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PRTN3 mRNA	PMID:28973375
1312601	PRTN3	proteinase 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304898	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PRTN3 mRNA	PMID:33387578
1312601	PRTN3	proteinase 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312602	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of PRTN3 mRNA	PMID:15363585|PMID:25549359
1312601	PRTN3	proteinase 3	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20120412	CTD	MESH:D014241	PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of PRTN3 protein]	PMID:15363585
1312601	PRTN3	proteinase 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRTN3 gene	PMID:20938992
1312601	PRTN3	proteinase 3	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of PRTN3 mRNA	PMID:24530881
1312601	PRTN3	proteinase 3	gene	CHEBI:16971	benzene-1,2,4-triol	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:C013038	4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in decreased expression of PRTN3 mRNA]	PMID:24530881
1312601	PRTN3	proteinase 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA	PMID:37567420
1312601	PRTN3	proteinase 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA	PMID:37567420
1312601	PRTN3	proteinase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20210608	CTD	MESH:D004051	Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of PRTN3 mRNA]	PMID:33484791
1312601	PRTN3	proteinase 3	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304898	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PRTN3 mRNA	PMID:26577399
1312601	PRTN3	proteinase 3	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRTN3 mRNA	PMID:36139627
1312601	PRTN3	proteinase 3	gene	CHEBI:18185	gamma-tocopherol	increases expression	ISO	RGD:1312602	E	RGD:6480464	20180116	CTD	MESH:D024505	Tocopherols results in increased expression of PRTN3 mRNA	PMID:17056531
1312601	PRTN3	proteinase 3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PRTN3 exon	PMID:30157460
1312601	PRTN3	proteinase 3	gene	CHEBI:18248	iron atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in decreased expression of PRTN3 mRNA	PMID:20368581
1312601	PRTN3	proteinase 3	gene	CHEBI:233355	4-aminobenzohydrazide	multiple interactions	EXP		E	RGD:6480464	20250408	CTD	MESH:C034343	4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in decreased expression of PRTN3 mRNA]	PMID:24530881
1312601	PRTN3	proteinase 3	gene	CHEBI:24527	herbicide	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20231031	CTD	MESH:D006540	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA	PMID:37567420
1312601	PRTN3	proteinase 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PRTN3 mRNA	PMID:22100608
1312601	PRTN3	proteinase 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PRTN3 mRNA	PMID:22100608
1312601	PRTN3	proteinase 3	gene	CHEBI:27013	tocopherol	increases expression	ISO	RGD:1312602	E	RGD:6480464	20120412	CTD	MESH:D024505	Tocopherols results in increased expression of PRTN3 mRNA	PMID:17056531
1312601	PRTN3	proteinase 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312602	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PRTN3 mRNA	PMID:27339419|PMID:31919559
1312601	PRTN3	proteinase 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PRTN3 gene	PMID:20938992
1312601	PRTN3	proteinase 3	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D012643	Selenium results in increased expression of PRTN3 protein	PMID:37834424
1312601	PRTN3	proteinase 3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of PRTN3 mRNA	PMID:27594783
1312601	PRTN3	proteinase 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312602	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of PRTN3 mRNA	PMID:40618947
1312601	PRTN3	proteinase 3	gene	CHEBI:27958	cocaine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the reaction [Antibodies, Antineutrophil Cytoplasmic binds to PRTN3 protein]	PMID:18438818
1312601	PRTN3	proteinase 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PRTN3 mRNA	PMID:30912803
1312601	PRTN3	proteinase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312602	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRTN3 mRNA	PMID:21570461|PMID:28922406
1312601	PRTN3	proteinase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PRTN3 mRNA	PMID:19465110
1312601	PRTN3	proteinase 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304898	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PRTN3 mRNA	PMID:28959563
1312601	PRTN3	proteinase 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA	PMID:37567420
1312601	PRTN3	proteinase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of PRTN3 mRNA	PMID:33933676
1312601	PRTN3	proteinase 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRTN3 3' UTR; Benzo(a)pyrene affects the methylation of PRTN3 promoter	PMID:27901495
1312601	PRTN3	proteinase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PRTN3 mRNA	PMID:32417428
1312601	PRTN3	proteinase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PRTN3 mRNA	PMID:22316170
1312601	PRTN3	proteinase 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PRTN3 mRNA	PMID:25895662
1312601	PRTN3	proteinase 3	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of PRTN3 mRNA]	PMID:26892147
1312601	PRTN3	proteinase 3	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1304898	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of PRTN3 mRNA	PMID:16483693
1312601	PRTN3	proteinase 3	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C061133	tamibarotene results in increased expression of PRTN3 mRNA	PMID:17229644
1312601	PRTN3	proteinase 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PRTN3 mRNA	PMID:29264374
1312601	PRTN3	proteinase 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PRTN3 mRNA	PMID:18648102
1312601	PRTN3	proteinase 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PRTN3 mRNA	PMID:19710929
1312601	PRTN3	proteinase 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304898	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PRTN3 mRNA	PMID:25181051
1312601	PRTN3	proteinase 3	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312602	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of PRTN3 mRNA	PMID:26682919
1312601	PRTN3	proteinase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312602	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PRTN3 gene	PMID:31683443
1312601	PRTN3	proteinase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PRTN3 mRNA	PMID:39298647
1312601	PRTN3	proteinase 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PRTN3 mRNA	PMID:38685157
1312601	PRTN3	proteinase 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PRTN3 mRNA	PMID:28392331
1312601	PRTN3	proteinase 3	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312602	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PRTN3 mRNA	PMID:24535843
1312601	PRTN3	proteinase 3	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312602	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of PRTN3 protein	PMID:39748354
1312601	PRTN3	proteinase 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1304898	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PRTN3 promoter	PMID:22457795
1312601	PRTN3	proteinase 3	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of PRTN3 mRNA	PMID:28962523
1312601	PRTN3	proteinase 3	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D012643	Selenium results in increased expression of PRTN3 protein	PMID:37834424
1312601	PRTN3	proteinase 3	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1312602	E	RGD:6480464	20260303	CTD	MESH:C473478	Sunitinib results in increased expression of PRTN3 protein	PMID:40449751
1312601	PRTN3	proteinase 3	gene	CHEBI:38940	sunitinib	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20260303	CTD	MESH:C473478	2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of PRTN3 protein]; N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of PRTN3 protein]]	PMID:40449751
1312601	PRTN3	proteinase 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PRTN3 mRNA	PMID:39529242
1312601	PRTN3	proteinase 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PRTN3 gene	PMID:29154799
1312601	PRTN3	proteinase 3	gene	CHEBI:4027	cyclophosphamide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of PRTN3 mRNA	PMID:17403535
1312601	PRTN3	proteinase 3	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1312602	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of PRTN3 mRNA	PMID:25123088
1312601	PRTN3	proteinase 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA	PMID:37567420
1312601	PRTN3	proteinase 3	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of PRTN3 mRNA	PMID:17400583
1312601	PRTN3	proteinase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312602	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PRTN3 mRNA	PMID:17562736
1312601	PRTN3	proteinase 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRTN3 mRNA	PMID:22230336
1312601	PRTN3	proteinase 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312602	E	RGD:6480464	20220705	CTD	MESH:D000082	Acetaminophen results in increased expression of PRTN3 mRNA	PMID:34724096
1312601	PRTN3	proteinase 3	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1312602	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of PRTN3 mRNA	PMID:26934552
1312601	PRTN3	proteinase 3	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in decreased expression of PRTN3 mRNA	PMID:26833863
1312601	PRTN3	proteinase 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PRTN3 mRNA	PMID:35436446
1312601	PRTN3	proteinase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312602	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PRTN3 mRNA	PMID:12072388
1312601	PRTN3	proteinase 3	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide promotes the reaction [Tretinoin results in decreased expression of PRTN3 mRNA]	PMID:26892147
1312601	PRTN3	proteinase 3	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312602	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of PRTN3 mRNA	PMID:25620056
1312601	PRTN3	proteinase 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312602	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PRTN3 mRNA	PMID:25620056
1312601	PRTN3	proteinase 3	gene	CHEBI:50694	minocycline	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008911	Minocycline results in increased expression of PRTN3 protein	PMID:12900849
1312601	PRTN3	proteinase 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312602	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of PRTN3 mRNA	PMID:38701926
1312601	PRTN3	proteinase 3	gene	CHEBI:71219	pazopanib	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C516667	pazopanib results in increased expression of PRTN3 protein	PMID:33271325
1312601	PRTN3	proteinase 3	gene	CHEBI:72754	bisphenol AF	decreases expression	ISO	RGD:1304898	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in decreased expression of PRTN3 mRNA	PMID:27567155
1312601	PRTN3	proteinase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312602	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PRTN3 mRNA	PMID:22206623
1312601	PRTN3	proteinase 3	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of PRTN3 mRNA	PMID:37567420
1312601	PRTN3	proteinase 3	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRTN3 mRNA	PMID:36139627
1312601	PRTN3	proteinase 3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312602	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PRTN3 mRNA	PMID:38648751
1312601	PRTN3	proteinase 3	gene	CHEBI:82664	iron(0)	decreases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in decreased expression of PRTN3 mRNA	PMID:20368581
1312601	PRTN3	proteinase 3	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312602	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of PRTN3 mRNA; Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of PRTN3 mRNA]	PMID:33484791
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312604	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MYT1 mRNA	PMID:33045310
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312604	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of MYT1 mRNA	PMID:16169686
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of MYT1 mRNA	PMID:26079696
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:15743	butanal	increases methylation	EXP		E	RGD:6480464	20190611	CTD	MESH:C018475	butyraldehyde results in increased methylation of MYT1 gene	PMID:30002397
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304899	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of MYT1 gene	PMID:35440735
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of MYT1 mRNA	PMID:17268063
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1312604	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of MYT1 mRNA	PMID:18978301
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312604	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYT1 mRNA	PMID:25510870
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MYT1 mRNA	PMID:21179406
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of MYT1 mRNA	PMID:26079696
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:17153	propanal	increases methylation	EXP		E	RGD:6480464	20190611	CTD	MESH:C005556	propionaldehyde results in increased methylation of MYT1 gene	PMID:30002397
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304899	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MYT1 mRNA	PMID:26577399
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:17935	octanal	increases methylation	EXP		E	RGD:6480464	20190611	CTD	MESH:C031639	caprylic aldehyde results in increased methylation of MYT1 gene	PMID:30002397
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of MYT1 intron	PMID:30157460
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312604	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYT1 mRNA	PMID:25510870
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312604	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYT1 mRNA	PMID:25510870
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	decreases expression	ISO	RGD:1312604	E	RGD:6480464	20171010	CTD	MESH:D005038	Ethylnitrosourea results in decreased expression of MYT1 protein	PMID:28549617
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MYT1 intron	PMID:30157460
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MYT1 gene	PMID:27153756
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312604	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MYT1 mRNA	PMID:27106289
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312604	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MYT1 mRNA	PMID:25629700
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of MYT1 mRNA	PMID:26272509
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYT1 mRNA	PMID:27188386
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:27882	(S)-colchicine	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D003078	Colchicine results in increased phosphorylation of MYT1 protein	PMID:16611024
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MYT1 mRNA	PMID:28903495
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of MYT1 mRNA	PMID:19921347
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312604	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MYT1 mRNA	PMID:24058054
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MYT1 mRNA	PMID:33212167
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304899	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MYT1 mRNA	PMID:28959563
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304899	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of MYT1 mRNA	PMID:26033743
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1304899	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of MYT1 mRNA	PMID:26033743
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:28748	doxorubicin	increases phosphorylation	ISO	RGD:1312604	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased phosphorylation of MYT1 protein	PMID:15861398
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of MYT1 mRNA	PMID:29301061|PMID:32844245
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312604	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of MYT1 mRNA	PMID:36209798
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:29678	sodium arsenite	increases methylation	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in increased methylation of MYT1 intron	PMID:32844245
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MYT1 5' UTR; Benzo(a)pyrene affects the methylation of MYT1 exon; Benzo(a)pyrene affects the methylation of MYT1 intron; Benzo(a)pyrene affects the methylation of MYT1 promoter	PMID:27901495|PMID:30157460
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MYT1 mRNA	PMID:16120219
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of MYT1 promoter	PMID:23974009
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304899	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of MYT1 mRNA	PMID:26033743
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1304899	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of MYT1 mRNA	PMID:26033743
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312604	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of MYT1 promoter	PMID:27334623
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304899	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MYT1 mRNA	PMID:25181051
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312604	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of MYT1 mRNA	PMID:32156529
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of MYT1 mRNA	PMID:17268063
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312604	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYT1 mRNA	PMID:25510870
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312604	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYT1 mRNA	PMID:25510870
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312604	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MYT1 gene	PMID:31683443
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312604	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of MYT1 mRNA	PMID:30951980
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312604	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of MYT1 exon	PMID:33297965
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of MYT1 intron	PMID:30157460
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:34787	heptanal	increases methylation	EXP		E	RGD:6480464	20190611	CTD	MESH:C046204	heptanal results in increased methylation of MYT1 gene	PMID:30002397
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:34892	nocodazole	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D015739	Nocodazole results in increased phosphorylation of MYT1 protein	PMID:16611024
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of MYT1 mRNA	PMID:37047231
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312604	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MYT1 mRNA	PMID:40194260
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:3930	cryptolepine	decreases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C024015	cryptolepine results in decreased expression of MYT1 mRNA	PMID:16120219
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MYT1 mRNA	PMID:25979313
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MYT1 gene	PMID:29154799
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MYT1 mRNA	PMID:27188386
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1312604	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of MYT1 mRNA	PMID:31099283
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:4911	etoposide	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D005047	Etoposide results in decreased expression of MYT1 mRNA	PMID:16120219
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312604	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of MYT1 mRNA	PMID:38701926
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:6076	itraconazole	increases expression	ISO	RGD:1312604	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of MYT1 mRNA	PMID:31099283
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1304899	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of MYT1 mRNA	PMID:19564919
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of MYT1 intron	PMID:30157460
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYT1 mRNA	PMID:27188386
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MYT1 gene]	PMID:28238834
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of MYT1 mRNA	PMID:26079696
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:84069	pentanal	increases methylation	EXP		E	RGD:6480464	20190611	CTD	MESH:C046012	pentanal results in increased methylation of MYT1 gene	PMID:30002397
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:84268	nonanal	increases methylation	EXP		E	RGD:6480464	20190611	CTD	MESH:C008664	nonanal results in increased methylation of MYT1 gene	PMID:30002397
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304899	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MYT1 mRNA	PMID:24780913
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:88528	hexanal	increases methylation	EXP		E	RGD:6480464	20190611	CTD	MESH:C010463	n-hexanal results in increased methylation of MYT1 gene	PMID:30002397
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYT1 mRNA	PMID:27188386
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304899	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of MYT1 mRNA	PMID:19281266
1312603	MYT1	myelin transcription factor 1	gene	CHEBI:94366	2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one	increases expression	ISO	RGD:1312604	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of MYT1 mRNA	PMID:31099283
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ZNF598 mRNA	PMID:38218311
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312606	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of ZFP598 mRNA	PMID:40945087
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ZNF598 mRNA	PMID:31614463
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312606	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ZFP598 mRNA	PMID:39298647
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ZNF598 mRNA	PMID:38568856
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304900	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP598 mRNA	PMID:22061828
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304900	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ZFP598 mRNA	PMID:33387578
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312606	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP598 mRNA	PMID:36331819
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ZNF598 protein	PMID:23301498
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ZNF598 mRNA	PMID:35430440
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304900	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ZFP598 mRNA	PMID:31150632
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF598 gene	PMID:25304211
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ZNF598 protein	PMID:35688186
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1304900	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA	PMID:33854195
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312606	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of ZFP598 mRNA	PMID:28189721|PMID:28960355
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304900	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP598 mRNA	PMID:33387578
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZNF598 mRNA	PMID:33212167
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF598 mRNA	PMID:29803840
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ZNF598 mRNA	PMID:29432896
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF598 protein	PMID:30528433
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF598 mRNA	PMID:38568856
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ZNF598 mRNA]	PMID:32406909
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of ZNF598 mRNA	PMID:38568856
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:32063	propylparaben	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C006068	propylparaben results in increased expression of ZNF598 mRNA	PMID:38568856
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312606	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP598 gene	PMID:35295148
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312606	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ZFP598 mRNA	PMID:23811191
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304900	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF598 mRNA	PMID:25181051
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304900	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP598 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312606	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ZFP598 mRNA	PMID:39298647
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312606	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ZFP598 mRNA	PMID:37019170
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1304900	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA	PMID:33854195
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZNF598 mRNA	PMID:38568856
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312606	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of ZFP598 mRNA	PMID:17585979|PMID:23811191
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ZNF598 mRNA	PMID:31533062
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312606	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP598 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ZFP598 mRNA	PMID:36331819
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312606	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ZFP598 mRNA	PMID:17292431
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF598 mRNA	PMID:25562108
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1304900	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA	PMID:33854195
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1304900	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA	PMID:33854195
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ZNF598 mRNA	PMID:29067470
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304900	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZFP598 mRNA	PMID:33387578
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF598 gene	PMID:25304211
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304900	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ZFP598 mRNA	PMID:29391264
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of ZNF598 mRNA	PMID:38568856
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1304900	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA	PMID:33854195
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ZNF598 protein	PMID:32959892
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ZNF598 mRNA	PMID:31758290
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1304900	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ZFP598 mRNA	PMID:24136188
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:80799	Bufotalin	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of ZNF598 mRNA	PMID:39904859
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304900	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ZFP598 mRNA	PMID:21346803
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ZNF598 mRNA	PMID:38568856
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304900	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ZFP598 mRNA	PMID:21346803
1312605	ZNF598	zinc finger protein 598, E3 ubiquitin ligase	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304900	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ZNF598 mRNA	PMID:23034163
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312608	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TRPM1 mRNA	PMID:33045310
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:136004	linsidomine	increases oxidation	ISO	RGD:1597140	E	RGD:6480464	20180220	CTD	MESH:C002385	linsidomine results in increased oxidation of TRPM1 protein	PMID:28086193
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:136185	VX nerve agent	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C009680	VX-agent results in increased expression of TRPM1 mRNA	PMID:38555327
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRPM1 mRNA	PMID:35811015
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1597140	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TRPM1 mRNA	PMID:33387578
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1597140	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TRPM1 mRNA	PMID:33387578
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of TRPM1 intron	PMID:30157460
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:18291	manganese atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of TRPM1 mRNA	PMID:17175027
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TRPM1 mRNA	PMID:35301059
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312608	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of TRPM1 mRNA	PMID:29950665
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TRPM1 gene; Aflatoxin B1 results in increased methylation of TRPM1 intron	PMID:27153756|PMID:30157460
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1597140	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of TRPM1 mRNA	PMID:30779732
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312608	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TRPM1 mRNA	PMID:25629700
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of TRPM1 mRNA	PMID:23557933
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312608	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRPM1 mRNA	PMID:21570461
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1597140	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRPM1 mRNA	PMID:33387578
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1597140	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TRPM1 mRNA	PMID:26033743
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TRPM1 5' UTR	PMID:27901495
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRPM1 promoter	PMID:27901495
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1597140	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TRPM1 mRNA	PMID:26033743
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TRPM1 gene	PMID:31601247
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1597140	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of TRPM1 mRNA	PMID:22641619
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312608	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TRPM1 mRNA	PMID:29264374
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312608	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of TRPM1 mRNA	PMID:29950665
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1597140	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TRPM1 mRNA	PMID:25181051
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TRPM1 gene	PMID:31601247
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TRPM1 gene	PMID:31601247
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312608	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TRPM1 gene	PMID:31683443
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312608	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TRPM1 mRNA	PMID:40203079
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TRPM1 gene	PMID:31601247
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TRPM1 intron	PMID:30157460
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312608	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TRPM1 intron	PMID:28392331
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312608	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TRPM1 mRNA	PMID:37019170
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312608	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of TRPM1 mRNA	PMID:29950665
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312608	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of TRPM1 mRNA	PMID:17942915
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312608	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of TRPM1 mRNA]	PMID:17942915
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:35154	manganese(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of TRPM1 mRNA	PMID:17175027
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TRPM1 mRNA	PMID:35301059
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1597140	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of TRPM1 mRNA	PMID:25539665
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TRPM1 gene	PMID:29154799
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1597140	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TRPM1 mRNA	PMID:33387578
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of TRPM1 mRNA	PMID:35811015
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRPM1 mRNA	PMID:35811015
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312608	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of TRPM1 mRNA	PMID:29279043
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1597140	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TRPM1 mRNA	PMID:29391264
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312608	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TRPM1 mRNA; Nanotubes, Carbon results in decreased expression of TRPM1 mRNA	PMID:25554681
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in increased expression of TRPM1 mRNA	PMID:17175027
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TRPM1 intron	PMID:30157460
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1597140	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TRPM1 gene	PMID:35440735
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1312608	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of TRPM1 mRNA	PMID:27858113
1312607	TRPM1	transient receptor potential cation channel subfamily M member 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRPM1 gene]	PMID:28238834
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:16118	berberine	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D001599	Berberine results in decreased expression of H2AC15 mRNA	PMID:27311644
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of H2AC15 mRNA	PMID:39709020
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of H2AC15 mRNA	PMID:35811015
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of H2AC15 mRNA	PMID:19167446
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of H2AC15 gene	PMID:27153756
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of H2AC15 mRNA	PMID:33512557
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of H2AC15 mRNA	PMID:21570461|PMID:24680724
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of H2AC15 mRNA	PMID:26290441
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:28177	theophylline	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in decreased expression of H2AC15 mRNA	PMID:18951874
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of H2AC15 mRNA	PMID:23179753
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of H2AC15 mRNA	PMID:39709020
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of H2AC15 mRNA	PMID:30851411
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of H2AC15 mRNA	PMID:32763439
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1618820	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of H2AC15 mRNA	PMID:37682722
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of H2AC15 mRNA	PMID:22316170
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:D012822	Silicon Dioxide results in increased expression of H2AC15 mRNA	PMID:26345256
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:C009495	titanium dioxide results in increased expression of H2AC15 mRNA	PMID:23557971
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:C074702	chromium hexavalent ion affects the expression of H2AC15 mRNA	PMID:28472532
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of H2AC15 mRNA	PMID:29275510
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1618820	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of H2AC15 mRNA	PMID:40203079
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of H2AC15 mRNA	PMID:26377693
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of H2AC15 mRNA	PMID:26377693
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of H2AC15 mRNA	PMID:19320972
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of H2AC15 mRNA	PMID:28962523
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of H2AC15 mRNA	PMID:33512557
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of H2AC15 mRNA	PMID:19167446
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of H2AC15 mRNA	PMID:33512557
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of H2AC15 mRNA	PMID:29067470
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of H2AC15 mRNA	PMID:35811015
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of H2AC15 mRNA	PMID:35811015
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:5011	fenpyroximate	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of H2AC15 mRNA	PMID:33512557
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of H2AC15 mRNA; Nanotubes, Carbon results in increased expression of H2AC15 mRNA	PMID:25554681
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:C015559	trimellitic anhydride results in increased expression of H2AC15 mRNA	PMID:19042947
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of H2AC15 mRNA	PMID:31629900
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of H2AC15 mRNA	PMID:23650126
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of H2AC15 mRNA	PMID:22078008
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:C072553	[MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of H2AC15 mRNA	PMID:25566086
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of H2AC15 mRNA	PMID:30851411
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of H2AC15 mRNA	PMID:33512557
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of H2AC15 mRNA	PMID:33512557
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1618820	E	RGD:6480464	20200825	CTD	MESH:D013792	Thalidomide results in decreased expression of H2AC15 mRNA	PMID:26217789
1312612	H2AC15	H2A clustered histone 15	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1618820	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of H2AC15 mRNA	PMID:35537566
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of COG2 mRNA	PMID:33167477
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of COG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of COG2 mRNA	PMID:32699268
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of COG2 mRNA	PMID:22378314
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of COG2 gene	PMID:33872906
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312616	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of COG2 mRNA	PMID:34319233
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of COG2 gene	PMID:33872906
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of COG2 mRNA	PMID:28818685
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COG2 mRNA	PMID:35301059
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COG2 mRNA	PMID:19549813
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of COG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of COG2 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of COG2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of COG2 mRNA	PMID:32699268|PMID:35430440
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312616	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COG2 mRNA	PMID:40504410
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:2762	antimycin A	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of COG2 mRNA	PMID:33512557
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of COG2 mRNA	PMID:23557933
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of COG2 mRNA	PMID:19921347
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of COG2 mRNA	PMID:23195993
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312616	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COG2 mRNA	PMID:21570461
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of COG2 mRNA	PMID:33212167
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of COG2 mRNA	PMID:39709020
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of COG2 mRNA	PMID:30851411
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of COG2 mRNA; sodium arsenite results in decreased expression of COG2 protein	PMID:30528433|PMID:38568856
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312616	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COG2 mRNA	PMID:40504410
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312616	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of COG2 mRNA	PMID:22228805
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312616	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COG2 promoter	PMID:27901495
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312616	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of COG2 protein	PMID:37955338
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to COG2 mRNA]	PMID:32406909
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of COG2 gene	PMID:31601247
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1589822	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of COG2 mRNA	PMID:25181051
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of COG2 gene	PMID:31601247
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312616	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of COG2 mRNA	PMID:33221593
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1589822	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of COG2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1589822	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of COG2 gene	PMID:28505145
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of COG2 gene	PMID:31601247
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of COG2 protein	PMID:31675489
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of COG2 protein	PMID:34186270
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of COG2 mRNA	PMID:37042841
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of COG2 mRNA	PMID:38174414|PMID:38568856
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1589822	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COG2 mRNA	PMID:33453195
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COG2 mRNA	PMID:35301059
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of COG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of COG2 mRNA	PMID:32699268
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of COG2 mRNA	PMID:28302478
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of COG2 mRNA	PMID:31533062
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of COG2 mRNA	PMID:29154799
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1589822	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of COG2 mRNA	PMID:33387578
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312616	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COG2 mRNA	PMID:40504410
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of COG2 mRNA	PMID:31675489
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of COG2 mRNA	PMID:22079256
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312616	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of COG2 mRNA	PMID:35436446
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of COG2 protein	PMID:32959892
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of COG2 mRNA	PMID:22079256
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of COG2 mRNA	PMID:22079256
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of COG2 mRNA	PMID:30851411
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COG2 gene]	PMID:28238834
1312615	COG2	component of oligomeric golgi complex 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312616	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of COG2 mRNA	PMID:30294300
1312617	CENPH	centromere protein H	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312618	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CENPH mRNA	PMID:20188158
1312617	CENPH	centromere protein H	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CENPH mRNA	PMID:20938992
1312617	CENPH	centromere protein H	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of CENPH mRNA	PMID:21934132|PMID:33167477
1312617	CENPH	centromere protein H	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in decreased expression of CENPH mRNA	PMID:23378141
1312617	CENPH	centromere protein H	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CENPH mRNA	PMID:20044591
1312617	CENPH	centromere protein H	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312618	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CENPH mRNA	PMID:39241906
1312617	CENPH	centromere protein H	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312618	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CENPH mRNA	PMID:39298647
1312617	CENPH	centromere protein H	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312618	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of CENPH mRNA	PMID:25210133
1312617	CENPH	centromere protein H	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in increased expression of CENPH mRNA]	PMID:25210133
1312617	CENPH	centromere protein H	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPH mRNA	PMID:25510870
1312617	CENPH	centromere protein H	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CENPH mRNA	PMID:38568856
1312617	CENPH	centromere protein H	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CENPH mRNA	PMID:20938992
1312617	CENPH	centromere protein H	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CENPH mRNA	PMID:26079696
1312617	CENPH	centromere protein H	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CENPH mRNA	PMID:37992649
1312617	CENPH	centromere protein H	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of CENPH mRNA	PMID:21592394
1312617	CENPH	centromere protein H	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of CENPH mRNA	PMID:21592394
1312617	CENPH	centromere protein H	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CENPH mRNA	PMID:37992649
1312617	CENPH	centromere protein H	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1583506	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CENPH mRNA	PMID:26577399
1312617	CENPH	centromere protein H	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of CENPH mRNA	PMID:21592394
1312617	CENPH	centromere protein H	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of CENPH mRNA	PMID:21592394
1312617	CENPH	centromere protein H	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of CENPH mRNA	PMID:39836092
1312617	CENPH	centromere protein H	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPH mRNA	PMID:25510870
1312617	CENPH	centromere protein H	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPH mRNA	PMID:25510870
1312617	CENPH	centromere protein H	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CENPH protein	PMID:20106945
1312617	CENPH	centromere protein H	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CENPH mRNA	PMID:35430440
1312617	CENPH	centromere protein H	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CENPH mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CENPH mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of CENPH mRNA	PMID:25658374|PMID:27106289|PMID:34911549
1312617	CENPH	centromere protein H	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312618	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CENPH mRNA	PMID:31919559
1312617	CENPH	centromere protein H	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CENPH mRNA	PMID:20938992
1312617	CENPH	centromere protein H	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CENPH mRNA	PMID:40504410
1312617	CENPH	centromere protein H	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CENPH mRNA	PMID:26272509
1312617	CENPH	centromere protein H	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CENPH mRNA	PMID:27188386
1312617	CENPH	centromere protein H	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of CENPH mRNA	PMID:19167446
1312617	CENPH	centromere protein H	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of CENPH mRNA	PMID:27392435
1312617	CENPH	centromere protein H	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312618	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of CENPH mRNA	PMID:30912803
1312617	CENPH	centromere protein H	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312618	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CENPH mRNA	PMID:21570461
1312617	CENPH	centromere protein H	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1583506	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CENPH mRNA	PMID:34747641
1312617	CENPH	centromere protein H	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CENPH mRNA	PMID:33212167
1312617	CENPH	centromere protein H	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CENPH mRNA	PMID:37992649
1312617	CENPH	centromere protein H	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of CENPH mRNA	PMID:22623647
1312617	CENPH	centromere protein H	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CENPH mRNA	PMID:38568856
1312617	CENPH	centromere protein H	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312618	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CENPH mRNA	PMID:17998272
1312617	CENPH	centromere protein H	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of CENPH mRNA	PMID:29301061
1312617	CENPH	centromere protein H	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CENPH mRNA	PMID:40504410
1312617	CENPH	centromere protein H	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CENPH mRNA	PMID:20064835
1312617	CENPH	centromere protein H	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CENPH 3' UTR	PMID:27901495
1312617	CENPH	centromere protein H	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CENPH mRNA	PMID:32234424
1312617	CENPH	centromere protein H	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312618	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CENPH mRNA	PMID:20713471
1312617	CENPH	centromere protein H	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CENPH promoter	PMID:27901495
1312617	CENPH	centromere protein H	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312618	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of CENPH mRNA	PMID:18929588
1312617	CENPH	centromere protein H	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CENPH mRNA]	PMID:32406909
1312617	CENPH	centromere protein H	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312618	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CENPH mRNA	PMID:29341224
1312617	CENPH	centromere protein H	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312618	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CENPH gene	PMID:35295148
1312617	CENPH	centromere protein H	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312618	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CENPH mRNA	PMID:23557971
1312617	CENPH	centromere protein H	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1583506	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of CENPH mRNA	PMID:30012374
1312617	CENPH	centromere protein H	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1583506	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of CENPH mRNA	PMID:34492290
1312617	CENPH	centromere protein H	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312618	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CENPH mRNA	PMID:20813756
1312617	CENPH	centromere protein H	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of CENPH mRNA	PMID:20813756
1312617	CENPH	centromere protein H	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of CENPH mRNA	PMID:38479592
1312617	CENPH	centromere protein H	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312618	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of CENPH mRNA	PMID:26063408
1312617	CENPH	centromere protein H	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CENPH mRNA	PMID:25979313
1312617	CENPH	centromere protein H	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPH mRNA	PMID:25510870
1312617	CENPH	centromere protein H	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CENPH mRNA	PMID:25510870
1312617	CENPH	centromere protein H	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312618	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of CENPH mRNA	PMID:20713471
1312617	CENPH	centromere protein H	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1312618	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of CENPH mRNA	PMID:36464114
1312617	CENPH	centromere protein H	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312618	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CENPH mRNA	PMID:37019170
1312617	CENPH	centromere protein H	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312618	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CENPH mRNA	PMID:17361019|PMID:21266533
1312617	CENPH	centromere protein H	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CENPH mRNA	PMID:37042841
1312617	CENPH	centromere protein H	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of CENPH mRNA	PMID:39836092
1312617	CENPH	centromere protein H	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1583506	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of CENPH mRNA	PMID:30723492
1312617	CENPH	centromere protein H	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312618	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CENPH mRNA	PMID:22698814
1312617	CENPH	centromere protein H	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312618	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CENPH mRNA	PMID:40194260
1312617	CENPH	centromere protein H	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312618	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CENPH mRNA	PMID:40194260
1312617	CENPH	centromere protein H	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CENPH mRNA	PMID:31533062
1312617	CENPH	centromere protein H	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of CENPH mRNA	PMID:19167446
1312617	CENPH	centromere protein H	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPH mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CENPH mRNA	PMID:19167446
1312617	CENPH	centromere protein H	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312618	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of CENPH mRNA	PMID:39529242
1312617	CENPH	centromere protein H	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1312618	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of CENPH mRNA	PMID:29038090
1312617	CENPH	centromere protein H	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CENPH mRNA	PMID:25979313
1312617	CENPH	centromere protein H	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of CENPH mRNA	PMID:23179753|PMID:28001369
1312617	CENPH	centromere protein H	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of CENPH mRNA	PMID:25562108
1312617	CENPH	centromere protein H	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of CENPH mRNA	PMID:20106945|PMID:21632981
1312617	CENPH	centromere protein H	gene	CHEBI:40909	azoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of CENPH mRNA	PMID:33512557
1312617	CENPH	centromere protein H	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CENPH mRNA	PMID:37992649
1312617	CENPH	centromere protein H	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CENPH mRNA	PMID:27188386
1312617	CENPH	centromere protein H	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1583506	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CENPH mRNA	PMID:33387578
1312617	CENPH	centromere protein H	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312618	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CENPH mRNA	PMID:40504410
1312617	CENPH	centromere protein H	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312618	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of CENPH mRNA	PMID:25554681
1312617	CENPH	centromere protein H	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312618	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CENPH mRNA	PMID:25554681
1312617	CENPH	centromere protein H	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312618	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CENPH mRNA	PMID:19042947
1312617	CENPH	centromere protein H	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312618	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CENPH mRNA	PMID:38701926
1312617	CENPH	centromere protein H	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of CENPH mRNA	PMID:39836092
1312617	CENPH	centromere protein H	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1312618	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of CENPH mRNA	PMID:19812364
1312617	CENPH	centromere protein H	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312618	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CENPH mRNA	PMID:23650126
1312617	CENPH	centromere protein H	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1583506	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CENPH mRNA	PMID:37269647
1312617	CENPH	centromere protein H	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1583506	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of CENPH mRNA	PMID:35283115
1312617	CENPH	centromere protein H	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1583506	E	RGD:6480464	20170725	CTD	MESH:D008694	Methamphetamine results in decreased expression of CENPH mRNA	PMID:28341135
1312617	CENPH	centromere protein H	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of CENPH mRNA	PMID:27918106
1312617	CENPH	centromere protein H	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1312618	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of CENPH mRNA	PMID:36464114
1312617	CENPH	centromere protein H	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312618	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CENPH mRNA	PMID:22206623
1312617	CENPH	centromere protein H	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of CENPH mRNA	PMID:29522793
1312617	CENPH	centromere protein H	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CENPH mRNA	PMID:37199045
1312617	CENPH	centromere protein H	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CENPH mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CENPH mRNA	PMID:27188386
1312617	CENPH	centromere protein H	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CENPH mRNA	PMID:19167446
1312617	CENPH	centromere protein H	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CENPH mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CENPH mRNA	PMID:27188386
1312617	CENPH	centromere protein H	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of CENPH mRNA	PMID:29301935
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of DDX42 protein	PMID:39638853
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of DDX42 mRNA	PMID:37995155
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304909	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX42 mRNA]	PMID:31150632
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DDX42 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DDX42 mRNA	PMID:32699268
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312620	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DDX42 mRNA	PMID:30319688
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of DDX42 mRNA	PMID:12414654
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of DDX42 protein	PMID:35688186
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304909	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DDX42 mRNA	PMID:33387578
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DDX42 mRNA	PMID:37042841
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DDX42 mRNA	PMID:21179406
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DDX42 mRNA	PMID:33754040
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312620	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DDX42 mRNA	PMID:34319233
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DDX42 protein	PMID:37730182
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DDX42 mRNA	PMID:28818685
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DDX42 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DDX42 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DDX42 mRNA	PMID:32699268
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304909	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DDX42 mRNA	PMID:31150632
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304909	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX42 mRNA]	PMID:31150632
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX42 protein	PMID:35072517
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DDX42 protein	PMID:38460933
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of DDX42 protein	PMID:35688186
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of DDX42 mRNA	PMID:28960355
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of DDX42 protein	PMID:25505154
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DDX42 mRNA	PMID:23557933
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of DDX42 mRNA	PMID:19921347
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of DDX42 mRNA	PMID:30912803
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312620	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DDX42 mRNA	PMID:17942748
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of DDX42 mRNA	PMID:33512557
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of DDX42 protein	PMID:35688186
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:28869	menadione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 results in increased expression of DDX42 mRNA	PMID:12414654
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX42 protein	PMID:35072517
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1304909	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DDX42 mRNA	PMID:21839799
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to DDX42 protein]	PMID:32406909
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312620	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DDX42 gene; titanium dioxide results in decreased methylation of DDX42 promoter alternative form	PMID:35295148
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of DDX42 mRNA	PMID:23811191
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DDX42 mRNA	PMID:33221593
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DDX42 gene	PMID:31601247
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of DDX42 protein	PMID:34186270
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304909	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DDX42 mRNA	PMID:25181051|PMID:30816183
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312620	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of DDX42 mRNA	PMID:40036665
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304909	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DDX42 gene	PMID:28505145
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312620	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of DDX42 gene	PMID:31683443
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of DDX42 protein	PMID:34186270
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312620	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of DDX42 mRNA	PMID:28392331
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DDX42 mRNA	PMID:37019170
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DDX42 mRNA	PMID:37042841
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304909	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DDX42 mRNA	PMID:33453195
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312620	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of DDX42 mRNA	PMID:18353800
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DDX42 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DDX42 mRNA	PMID:32699268
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:38604	pyrimidifen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of DDX42 mRNA	PMID:33512557
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DDX42 protein	PMID:26178269
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DDX42 mRNA	PMID:25979313
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DDX42 gene	PMID:29154799
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:41774	tamoxifen	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of DDX42 mRNA	PMID:15604281
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of DDX42 mRNA	PMID:27188386
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of DDX42 mRNA	PMID:20977926
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DDX42 protein	PMID:38460933
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX42 protein	PMID:35072517
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312620	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DDX42 mRNA	PMID:17942748
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312620	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DDX42 mRNA	PMID:17942748
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1304909	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of DDX42 mRNA	PMID:19162173
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of DDX42 mRNA	PMID:26705709
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DDX42 protein	PMID:32959892
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of DDX42 mRNA	PMID:12414654
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312620	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DDX42 protein	PMID:26558463
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312620	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of DDX42 mRNA	PMID:22206623
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:76604	MeIQx	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of DDX42 mRNA	PMID:20816883
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DDX42 protein	PMID:38348393
1312619	DDX42	DEAD-box helicase 42	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304909	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of DDX42 mRNA	PMID:20566332
1312623	LIPM	lipase family member M	gene	CHEBI:2208	purine-6-thiol	increases expression	ISO	RGD:1304912	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of LIPM mRNA	PMID:23358152
1312623	LIPM	lipase family member M	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of LIPM mRNA	PMID:41430723
1312623	LIPM	lipase family member M	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LIPM mRNA	PMID:32525701
1312623	LIPM	lipase family member M	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LIPM mRNA	PMID:30851411
1312623	LIPM	lipase family member M	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552056	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of LIPM mRNA	PMID:37682722
1312623	LIPM	lipase family member M	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of LIPM mRNA	PMID:27685785
1312623	LIPM	lipase family member M	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1552056	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of LIPM mRNA	PMID:26377693
1312623	LIPM	lipase family member M	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1304912	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of LIPM mRNA	PMID:35163327
1312623	LIPM	lipase family member M	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304912	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of LIPM mRNA	PMID:35163327
1312623	LIPM	lipase family member M	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304912	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of LIPM mRNA	PMID:35163327
1312623	LIPM	lipase family member M	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LIPM mRNA	PMID:32525701
1312623	LIPM	lipase family member M	gene	CHEBI:50667	mercaptopurine	increases expression	ISO	RGD:1304912	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of LIPM mRNA	PMID:23358152
1312623	LIPM	lipase family member M	gene	CHEBI:53050	trimellitic anhydride	increases methylation	ISO	RGD:1552056	E	RGD:6480464	20140610	CTD	MESH:C015559	trimellitic anhydride results in increased methylation of LIPM promoter	PMID:24675093
1312623	LIPM	lipase family member M	gene	CHEBI:67251	beta-damascenone	increases expression	ISO	RGD:1552056	E	RGD:6480464	20161213	CTD	MESH:C075388	beta-damascenone results in increased expression of LIPM mRNA	PMID:22982537
1312623	LIPM	lipase family member M	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LIPM mRNA	PMID:30851411
1312623	LIPM	lipase family member M	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LIPM gene]	PMID:28238834
1312623	LIPM	lipase family member M	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of LIPM mRNA	PMID:32525701
1312623	LIPM	lipase family member M	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	ISO	RGD:1304912	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of LIPM mRNA	PMID:23358152
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312626	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MRPL45 mRNA	PMID:33045310
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPL45 mRNA	PMID:33167477
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL45 mRNA	PMID:30529165
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL45 mRNA	PMID:36331819
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRPL45 mRNA	PMID:22378314
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1304913	E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of MRPL45 mRNA	PMID:17347304
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312626	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPL45 mRNA	PMID:39241906
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL45 mRNA	PMID:31059760
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of MRPL45 mRNA]	PMID:19442820
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of MRPL45 mRNA]	PMID:19442820
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304913	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MRPL45 mRNA	PMID:33387578
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL45 mRNA	PMID:36331819
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MRPL45 mRNA	PMID:35430440
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL45 mRNA	PMID:40504410
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MRPL45 mRNA	PMID:28903495
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312626	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPL45 mRNA	PMID:21570461
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304913	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPL45 mRNA	PMID:32109520
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304913	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPL45 mRNA	PMID:33387578
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL45 mRNA	PMID:17942748
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of MRPL45 mRNA	PMID:32763439
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MRPL45 mRNA	PMID:24690739
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPL45 mRNA; sodium arsenite results in decreased expression of MRPL45 protein	PMID:39571964|PMID:39719251
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL45 mRNA	PMID:40504410
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of MRPL45 mRNA	PMID:22378314
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MRPL45 promoter	PMID:27901495
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MRPL45 mRNA]	PMID:32406909
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MRPL45 mRNA	PMID:24690739
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of MRPL45 mRNA	PMID:25075043
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312626	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of MRPL45 mRNA	PMID:18648102
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312626	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MRPL45 mRNA	PMID:18301758|PMID:23811191
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL45 mRNA	PMID:29275510
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304913	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL45 mRNA	PMID:24988533|PMID:25181051
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312626	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL45 mRNA	PMID:33221593
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312626	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPL45 mRNA	PMID:39298647
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of MRPL45 protein	PMID:34186270
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312626	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MRPL45 mRNA	PMID:37019170
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MRPL45 mRNA	PMID:38568856
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304913	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MRPL45 mRNA	PMID:33453195
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of MRPL45 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MRPL45 mRNA]	PMID:17585979
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MRPL45 mRNA	PMID:31533062
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL45 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL45 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MRPL45 mRNA	PMID:36331819
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRPL45 mRNA	PMID:25979313
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of MRPL45 mRNA	PMID:23179753|PMID:27188386
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL45 mRNA	PMID:17183730
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312626	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MRPL45 mRNA	PMID:17562736
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL45 mRNA	PMID:31059760
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304913	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL45 mRNA	PMID:33387578
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL45 mRNA	PMID:31059760
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of MRPL45 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MRPL45 mRNA]	PMID:17585979
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of MRPL45 mRNA	PMID:24690739
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL45 mRNA	PMID:40504410
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of MRPL45 mRNA	PMID:18175754
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312626	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MRPL45 mRNA	PMID:17942748
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312626	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL45 mRNA	PMID:17942748
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:50035	alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of MRPL45 mRNA	PMID:25075043
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1304913	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MRPL45 mRNA	PMID:24136188
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304913	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MRPL45 mRNA	PMID:24136188
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312626	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MRPL45 mRNA	PMID:19042947
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of MRPL45 mRNA	PMID:17183730
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MRPL45 protein	PMID:32959892
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1312626	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of MRPL45 mRNA	PMID:20003209
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1304913	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of MRPL45 mRNA	PMID:30467583
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312626	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MRPL45 mRNA	PMID:22206623
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:7602	nobiletin	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of MRPL45 protein]	PMID:38348393
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MRPL45 gene]	PMID:28238834
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312626	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MRPL45 mRNA	PMID:31388691
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1304913	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MRPL45 mRNA	PMID:23640034
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of MRPL45 protein	PMID:38348393
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of MRPL45 protein]	PMID:38348393
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304913	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MRPL45 mRNA	PMID:21346803
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of MRPL45 mRNA	PMID:22378314
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:9516	thapsigargin	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019284	4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in decreased expression of MRPL45 mRNA]; caffeic acid promotes the reaction [Thapsigargin results in decreased expression of MRPL45 mRNA]; Drugs, Chinese Herbal promotes the reaction [Thapsigargin results in decreased expression of MRPL45 mRNA]	PMID:19442820
1312625	MRPL45	mitochondrial ribosomal protein L45	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304913	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MRPL45 mRNA	PMID:21346803
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ADGRA3 mRNA	PMID:33045310
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550058	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ADGRA3 mRNA	PMID:30319688
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ADGRA3 mRNA	PMID:21632981
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550058	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ADGRA3 mRNA	PMID:39241906
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of ADGRA3 mRNA	PMID:22574217
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304914	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ADGRA3 mRNA	PMID:32145629
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550058	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ADGRA3 mRNA	PMID:39298647
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADGRA3 mRNA	PMID:37042841
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ADGRA3 mRNA	PMID:23649840
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013739	Testosterone results in decreased expression of ADGRA3 mRNA	PMID:33359661
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of ADGRA3 mRNA	PMID:37748715
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550058	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ADGRA3 mRNA	PMID:36331819
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADGRA3 mRNA	PMID:35301059
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ADGRA3 mRNA	PMID:19549813
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ADGRA3 mRNA	PMID:19770486
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ADGRA3 mRNA	PMID:23649840
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304914	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADGRA3 mRNA	PMID:31150632
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550058	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ADGRA3 mRNA	PMID:22206623
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1304914	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ADGRA3 mRNA	PMID:22023808
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADGRA3 mRNA	PMID:20106945|PMID:21632981
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304914	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADGRA3 mRNA	PMID:21215274|PMID:33387578
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ADGRA3 mRNA	PMID:33212167
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304914	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ADGRA3 mRNA	PMID:28959563
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADGRA3 mRNA	PMID:29803840
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ADGRA3 mRNA	PMID:20044591
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADGRA3 mRNA	PMID:38568856
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADGRA3 mRNA	PMID:20064835
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20260707	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ADGRA3 exon	PMID:27901495
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ADGRA3 mRNA	PMID:19150397
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ADGRA3 gene	PMID:31601247
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ADGRA3 gene; [bisphenol S co-treated with Fulvestrant] affects the methylation of ADGRA3 gene	PMID:31601247
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550058	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADGRA3 gene	PMID:35295148
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550058	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in increased methylation of ADGRA3 gene; titanium dioxide results in increased methylation of ADGRA3 promoter	PMID:35295148
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304914	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ADGRA3 mRNA	PMID:34492290
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ADGRA3 mRNA	PMID:18445702
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550058	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ADGRA3 mRNA	PMID:18301758
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304914	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRA3 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ADGRA3 gene	PMID:31601247
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ADGRA3 mRNA	PMID:29275510
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ADGRA3 gene	PMID:31601247
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ADGRA3 mRNA	PMID:26682919
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] affects the methylation of ADGRA3 gene	PMID:31601247
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1550058	E	RGD:6480464	20160822	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of ADGRA3 mRNA	PMID:26377693
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550058	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ADGRA3 mRNA	PMID:38685157
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ADGRA3 mRNA	PMID:28392331
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1550058	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ADGRA3 intron	PMID:28392331
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550058	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ADGRA3 mRNA	PMID:37019170
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1304914	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of ADGRA3 gene	PMID:33148267
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADGRA3 mRNA	PMID:37042841
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304914	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADGRA3 mRNA	PMID:35163327
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ADGRA3 mRNA	PMID:38568856
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADGRA3 mRNA	PMID:35301059
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304914	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADGRA3 mRNA	PMID:35163327
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ADGRA3 mRNA	PMID:40194260
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550058	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ADGRA3 mRNA	PMID:36331819
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ADGRA3 mRNA	PMID:17183730
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D016572	Cyclosporine results in decreased expression of ADGRA3 mRNA	PMID:20106945|PMID:25562108
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of ADGRA3 mRNA	PMID:22733784
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ADGRA3 mRNA	PMID:38832940
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550058	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ADGRA3 mRNA	PMID:17562736
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ADGRA3 mRNA	PMID:26690555
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304914	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ADGRA3 mRNA	PMID:29391264
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ADGRA3 mRNA; Nanotubes, Carbon results in decreased expression of ADGRA3 mRNA	PMID:25554681
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ADGRA3 mRNA	PMID:17183730
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304914	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ADGRA3 gene	PMID:35440735
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1304914	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of ADGRA3 gene	PMID:33148267
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550058	E	RGD:6480464	20260707	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADGRA3 mRNA	PMID:22206623
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550058	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ADGRA3 mRNA	PMID:22206623
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ADGRA3 gene]	PMID:28238834
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ADGRA3 mRNA	PMID:19159669
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1304914	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ADGRA3 mRNA	PMID:27291303
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1304914	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ADGRA3 mRNA	PMID:23640034
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:8772	raloxifene	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of ADGRA3 mRNA	PMID:19429434
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of ADGRA3 mRNA	PMID:24921660
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304914	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ADGRA3 mRNA	PMID:19281266
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ADGRA3 mRNA	PMID:38568856
1312627	ADGRA3	adhesion G protein-coupled receptor A3	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1304914	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of ADGRA3 gene	PMID:31682807
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MRPL42 mRNA	PMID:38218311
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1616786	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MRPL42 mRNA	PMID:37995155
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPL42 mRNA	PMID:21934132|PMID:33167477
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MRPL42 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MRPL42 mRNA	PMID:32699268
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRPL42 mRNA	PMID:22378314
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MRPL42 mRNA	PMID:20044591
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1616786	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPL42 mRNA	PMID:39241906
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MRPL42 mRNA	PMID:39298647
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MRPL42 mRNA	PMID:37042841
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MRPL42 mRNA	PMID:21179406
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1304915	E	RGD:6480464	20141007	CTD	MESH:D014050	Toluene results in decreased expression of MRPL42 mRNA	PMID:22967744
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1616786	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MRPL42 mRNA	PMID:33754040
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1616786	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL42 mRNA	PMID:36331819
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1304915	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of MRPL42 mRNA	PMID:28522335
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MRPL42 mRNA	PMID:27153756
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MRPL42 mRNA	PMID:23649840
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MRPL42 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MRPL42 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of MRPL42 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of MRPL42 mRNA	PMID:32699268|PMID:35430440
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MRPL42 mRNA	PMID:25629700
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1616786	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL42 mRNA	PMID:22206623
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304915	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MRPL42 mRNA	PMID:31881176
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304915	E	RGD:6480464	20141007	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPL42 mRNA	PMID:21215274
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of MRPL42 mRNA	PMID:39709020
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPL42 mRNA	PMID:38568856|PMID:39719251
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MRPL42 mRNA	PMID:22378314
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MRPL42 mRNA]	PMID:32406909
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MRPL42 mRNA	PMID:20458559
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL42 mRNA	PMID:29275510
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304915	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL42 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL42 mRNA	PMID:33221593
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304915	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL42 mRNA	PMID:25181051
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1616786	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPL42 mRNA	PMID:39298647
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20250311	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of MRPL42 mRNA	PMID:32308655
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MRPL42 mRNA	PMID:17361019|PMID:21266533
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MRPL42 protein	PMID:26879310
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MRPL42 mRNA	PMID:19320972
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MRPL42 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MRPL42 mRNA	PMID:32699268
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MRPL42 mRNA	PMID:28302478
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1616786	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL42 mRNA	PMID:36331819
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRPL42 mRNA	PMID:25979313
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of MRPL42 mRNA	PMID:23179753|PMID:27188386
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1616786	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MRPL42 mRNA	PMID:17562736
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL42 mRNA	PMID:31059760
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304915	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MRPL42 mRNA	PMID:33387578
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MRPL42 mRNA	PMID:29279043
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1616786	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of MRPL42 mRNA	PMID:35436446
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of MRPL42 mRNA	PMID:18175754
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MRPL42 mRNA	PMID:20458559
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1616786	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MRPL42 mRNA; Nanotubes, Carbon results in increased expression of MRPL42 mRNA	PMID:25554681
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1304915	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MRPL42 mRNA	PMID:24136188
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304915	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MRPL42 mRNA	PMID:24136188
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MRPL42 mRNA	PMID:31758290
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MRPL42 mRNA	PMID:22206623
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1616786	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL42 mRNA	PMID:22206623
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MRPL42 gene]	PMID:28238834
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1616786	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of MRPL42 mRNA	PMID:30953684
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of MRPL42 mRNA	PMID:24921660
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1616786	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of MRPL42 protein	PMID:35357534
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304915	E	RGD:6480464	20141007	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MRPL42 mRNA	PMID:21346803
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:9288	streptozocin	affects expression	ISO	RGD:1616786	E	RGD:6480464	20120501	CTD	MESH:D013311	Streptozocin affects the expression of MRPL42 mRNA	PMID:18583417
1312629	MRPL42	mitochondrial ribosomal protein L42	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304915	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of MRPL42 mRNA	PMID:23034163
1312631	OPTC	opticin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of OPTC mRNA	PMID:36189433
1312631	OPTC	opticin	gene	CHEBI:15379	dioxygen	increases degradation	EXP		E	RGD:6480464	20151013	CTD	MESH:D010100	Oxygen deficiency results in increased degradation of OPTC protein	PMID:22534113
1312631	OPTC	opticin	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D010100	Edetic Acid inhibits the reaction [Oxygen deficiency results in increased degradation of OPTC protein]	PMID:22534113
1312631	OPTC	opticin	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of OPTC mRNA	PMID:31614463
1312631	OPTC	opticin	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312632	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of OPTC mRNA	PMID:33711761
1312631	OPTC	opticin	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304916	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of OPTC mRNA	PMID:33387578
1312631	OPTC	opticin	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of OPTC mRNA	PMID:26079696
1312631	OPTC	opticin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of OPTC mRNA	PMID:36189433
1312631	OPTC	opticin	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of OPTC mRNA	PMID:36706583
1312631	OPTC	opticin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of OPTC mRNA	PMID:31163220
1312631	OPTC	opticin	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of OPTC mRNA	PMID:36331819
1312631	OPTC	opticin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OPTC mRNA	PMID:28111341
1312631	OPTC	opticin	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304916	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of OPTC mRNA	PMID:30779732
1312631	OPTC	opticin	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304916	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of OPTC mRNA	PMID:31881176
1312631	OPTC	opticin	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of OPTC mRNA	PMID:23557933
1312631	OPTC	opticin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304916	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OPTC mRNA	PMID:32109520
1312631	OPTC	opticin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of OPTC 3' UTR; Benzo(a)pyrene results in increased methylation of OPTC promoter	PMID:27901495
1312631	OPTC	opticin	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312632	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of OPTC mRNA	PMID:27131904
1312631	OPTC	opticin	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of OPTC mRNA	PMID:37690743
1312631	OPTC	opticin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312632	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of OPTC mRNA	PMID:18648102
1312631	OPTC	opticin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304916	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of OPTC mRNA	PMID:25181051
1312631	OPTC	opticin	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of OPTC gene	PMID:31601247
1312631	OPTC	opticin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312632	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of OPTC mRNA	PMID:32156529
1312631	OPTC	opticin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312632	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of OPTC mRNA	PMID:30951980
1312631	OPTC	opticin	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1304916	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of OPTC promoter	PMID:22457795
1312631	OPTC	opticin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OPTC mRNA	PMID:28111341
1312631	OPTC	opticin	gene	CHEBI:35696	cobalt dichloride	increases degradation	EXP		E	RGD:6480464	20151013	CTD	MESH:C018021	cobaltous chloride results in increased degradation of OPTC protein	PMID:22534113
1312631	OPTC	opticin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of OPTC mRNA	PMID:36331819
1312631	OPTC	opticin	gene	CHEBI:4735	ethylenediaminetetraacetic acid	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:D004492	Edetic Acid inhibits the reaction [Oxygen deficiency results in increased degradation of OPTC protein]; Edetic Acid inhibits the reaction [VEGFA protein results in increased degradation of OPTC protein]	PMID:22534113
1312631	OPTC	opticin	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of OPTC mRNA	PMID:18175754
1312631	OPTC	opticin	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304916	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of OPTC mRNA	PMID:30307764
1312631	OPTC	opticin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312632	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of OPTC mRNA	PMID:25554681
1312631	OPTC	opticin	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304916	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of OPTC gene	PMID:35440735
1312631	OPTC	opticin	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312632	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of OPTC mRNA	PMID:22206623
1312631	OPTC	opticin	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to OPTC gene]	PMID:28238834
1312631	OPTC	opticin	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1304916	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of OPTC mRNA	PMID:32109520
1312631	OPTC	opticin	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of OPTC mRNA	PMID:27935865
1312631	OPTC	opticin	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1312632	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of OPTC mRNA	PMID:36706583
1312631	OPTC	opticin	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312632	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of OPTC mRNA	PMID:27131904
1312633	ARSL	arylsulfatase L	gene	CHEBI:10033	warfarin	decreases activity	EXP		E	RGD:6480464	20191112	CTD	MESH:D014859	Warfarin results in decreased activity of ARSL protein	PMID:7720070
1312633	ARSL	arylsulfatase L	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ARSL mRNA	PMID:21632981
1312633	ARSL	arylsulfatase L	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ARSL mRNA	PMID:30510588
1312633	ARSL	arylsulfatase L	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304917	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ARSE mRNA	PMID:33387578
1312633	ARSL	arylsulfatase L	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304917	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ARSE mRNA	PMID:33387578
1312633	ARSL	arylsulfatase L	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ARSL mRNA	PMID:19549813
1312633	ARSL	arylsulfatase L	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ARSL protein	PMID:20106945
1312633	ARSL	arylsulfatase L	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ARSL mRNA	PMID:27153756
1312633	ARSL	arylsulfatase L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304917	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARSL mRNA	PMID:32109520
1312633	ARSL	arylsulfatase L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304917	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARSE mRNA	PMID:33387578
1312633	ARSL	arylsulfatase L	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ARSL mRNA	PMID:23179753
1312633	ARSL	arylsulfatase L	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ARSL mRNA	PMID:38568856
1312633	ARSL	arylsulfatase L	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARSL mRNA	PMID:32234424
1312633	ARSL	arylsulfatase L	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20211207	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ARSL 3' UTR; Benzo(a)pyrene results in decreased methylation of ARSL 5' UTR	PMID:27901495
1312633	ARSL	arylsulfatase L	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ARSL gene	PMID:25435355
1312633	ARSL	arylsulfatase L	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ARSL mRNA	PMID:25895662
1312633	ARSL	arylsulfatase L	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of ARSL mRNA	PMID:37690743
1312633	ARSL	arylsulfatase L	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1304917	E	RGD:6480464	20211207	CTD	MESH:C069837	fullerene C60 results in increased expression of ARSL mRNA	PMID:19167457
1312633	ARSL	arylsulfatase L	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304917	E	RGD:6480464	20211207	CTD	MESH:C006780	bisphenol A results in decreased expression of ARSE mRNA; bisphenol A results in decreased expression of ARSL mRNA	PMID:25181051|PMID:32145629
1312633	ARSL	arylsulfatase L	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1304917	E	RGD:6480464	20211207	CTD	MESH:C005445	triphenyl phosphate results in increased expression of ARSL mRNA	PMID:30589522
1312633	ARSL	arylsulfatase L	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1304917	E	RGD:6480464	20211207	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ARSL mRNA	PMID:24386269
1312633	ARSL	arylsulfatase L	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARSL mRNA	PMID:25979313
1312633	ARSL	arylsulfatase L	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARSL mRNA	PMID:29154799|PMID:29501571
1312633	ARSL	arylsulfatase L	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of ARSL mRNA	PMID:24935251
1312633	ARSL	arylsulfatase L	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ARSL mRNA	PMID:20106945|PMID:25562108
1312633	ARSL	arylsulfatase L	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ARSL mRNA	PMID:38832940
1312633	ARSL	arylsulfatase L	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304917	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ARSE mRNA	PMID:33387578
1312633	ARSL	arylsulfatase L	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ARSL protein	PMID:32959892
1312633	ARSL	arylsulfatase L	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of ARSL mRNA	PMID:17547211
1312633	ARSL	arylsulfatase L	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ARSL mRNA	PMID:19159669
1312633	ARSL	arylsulfatase L	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304917	E	RGD:6480464	20211207	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ARSL mRNA	PMID:21346803
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312635	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ASF1B mRNA	PMID:33045310
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ASF1B mRNA	PMID:39752319
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ASF1B; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ASF1B gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ASF1B mRNA	PMID:20938992
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of ASF1B mRNA	PMID:16249480|PMID:33167477
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of ASF1B mRNA	PMID:26516004
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ASF1B mRNA	PMID:21632981
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ASF1B mRNA	PMID:39241906
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ASF1B mRNA	PMID:30510588
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1304918	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of ASF1B mRNA	PMID:32145629
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASF1B mRNA	PMID:25510870
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ASF1B mRNA	PMID:38568856
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312635	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of ASF1B mRNA	PMID:25549359
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304918	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ASF1B gene	PMID:27618143
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ASF1B; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ASF1B gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ASF1B mRNA	PMID:20938992
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of ASF1B mRNA	PMID:26079696
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASF1B mRNA	PMID:37992649
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ASF1B mRNA	PMID:39752319
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of ASF1B mRNA	PMID:21592394
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of ASF1B mRNA	PMID:21592394
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASF1B mRNA	PMID:37992649
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of ASF1B mRNA	PMID:21592394
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of ASF1B mRNA	PMID:21592394
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304918	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ASF1B mRNA	PMID:33387578
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ASF1B mRNA	PMID:28818685
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ASF1B intron	PMID:30157460
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASF1B mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASF1B mRNA	PMID:39836092
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASF1B mRNA	PMID:25510870
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASF1B mRNA	PMID:25510870
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ASF1B protein	PMID:20106945
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304918	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ASF1B mRNA	PMID:23630614|PMID:25378103
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ASF1B mRNA	PMID:19770486
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ASF1B gene; Aflatoxin B1 results in increased methylation of ASF1B intron	PMID:27153756|PMID:30157460
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ASF1B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ASF1B mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of ASF1B mRNA; TTPA protein affects the reaction [Ozone results in increased expression of ASF1B mRNA]	PMID:19555225|PMID:25658374|PMID:27106289|PMID:34911549
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ASF1B mRNA	PMID:17484886|PMID:31919559
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ASF1B mRNA	PMID:25629700
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D005492	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of ASF1B mRNA	PMID:24657277
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ASF1B; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ASF1B gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ASF1B mRNA	PMID:20938992
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASF1B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASF1B mRNA	PMID:39836092
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304918	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ASF1B mRNA	PMID:31881176
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of ASF1B mRNA	PMID:19167446
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1304918	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ASF1B mRNA	PMID:22023808
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of ASF1B mRNA	PMID:40618947
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ASF1B mRNA	PMID:27594783|PMID:38498338
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ASF1B mRNA	PMID:25583101
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASF1B mRNA	PMID:22574217
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312635	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASF1B mRNA	PMID:21570461
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304918	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ASF1B mRNA	PMID:34747641
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304918	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ASF1B mRNA	PMID:33387578
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312635	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ASF1B mRNA	PMID:26290441
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASF1B mRNA	PMID:17942748
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of ASF1B mRNA	PMID:33512557
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ASF1B mRNA	PMID:33212167
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ASF1B mRNA	PMID:32763439
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304918	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ASF1B mRNA	PMID:28959563
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ASF1B mRNA	PMID:20971185
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ASF1B mRNA	PMID:30031762
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASF1B mRNA	PMID:37992649
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of ASF1B mRNA	PMID:34032870
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ASF1B mRNA	PMID:38568856
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of ASF1B mRNA	PMID:28595984|PMID:29301061
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASF1B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASF1B mRNA; sodium arsenite promotes the reaction [ASF1B protein binds to CAPRIN1 protein]	PMID:33939924|PMID:39836092
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of ASF1B mRNA	PMID:22378314
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ASF1B intron	PMID:30157460
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASF1B mRNA	PMID:32234424
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASF1B mRNA	PMID:20504355
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of ASF1B mRNA	PMID:18929588
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ASF1B mRNA]	PMID:32406909
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ASF1B mRNA	PMID:20971185
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312635	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ASF1B mRNA	PMID:29341224
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ASF1B mRNA	PMID:20382639
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1304918	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ASF1B mRNA	PMID:25729387
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304918	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ASF1B mRNA	PMID:25729387
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304918	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ASF1B mRNA	PMID:30047161
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312635	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ASF1B gene; titanium dioxide results in decreased methylation of ASF1B promoter	PMID:35295148
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1304918	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of ASF1B mRNA	PMID:30012374
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312635	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ASF1B mRNA	PMID:23557971
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304918	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ASF1B mRNA	PMID:34492290
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1304918	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of ASF1B mRNA	PMID:12832660|PMID:19162173
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ASF1B mRNA	PMID:17950772|PMID:18301758
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of ASF1B mRNA]	PMID:17950772
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of ASF1B mRNA	PMID:19191707
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of ASF1B mRNA	PMID:19191707
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ASF1B mRNA	PMID:38479592
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ASF1B mRNA	PMID:30903817
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304918	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ASF1B mRNA	PMID:32145629
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ASF1B mRNA	PMID:29275510
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304918	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ASF1B mRNA	PMID:25181051
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ASF1B mRNA	PMID:26063408
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of ASF1B mRNA	PMID:20739668|PMID:30951980
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ASF1B mRNA	PMID:25979313
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASF1B mRNA	PMID:25510870
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ASF1B mRNA	PMID:25510870
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1312635	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of ASF1B mRNA	PMID:20713471
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of ASF1B mRNA	PMID:20713471
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312635	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ASF1B mRNA	PMID:30951980
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312635	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of ASF1B mRNA	PMID:26377693
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ASF1B intron	PMID:30157460
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312635	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ASF1B mRNA	PMID:30951980
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ASF1B mRNA	PMID:17361019|PMID:21266533
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ASF1B mRNA	PMID:36828243
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D003993	N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of ASF1B mRNA]	PMID:36828243
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ASF1B mRNA	PMID:17854601
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ASF1B mRNA]	PMID:17854601
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D010269	Paraquat results in decreased expression of ASF1B mRNA	PMID:35182771
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ASF1B mRNA	PMID:37042841
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASF1B mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASF1B mRNA	PMID:39836092
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312635	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of ASF1B mRNA	PMID:26377693
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1304918	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of ASF1B mRNA	PMID:18500788
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304918	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ASF1B mRNA	PMID:30723492
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ASF1B mRNA	PMID:26472689
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ASF1B mRNA	PMID:36326898
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304918	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ASF1B mRNA	PMID:25539665
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1304918	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ASF1B mRNA	PMID:30047161
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312635	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ASF1B mRNA	PMID:22698814
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ASF1B mRNA	PMID:19320972|PMID:19376846
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304918	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ASF1B mRNA	PMID:24386269
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ASF1B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ASF1B mRNA]	PMID:17585979
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ASF1B mRNA	PMID:40194260
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ASF1B mRNA	PMID:31533062
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ASF1B mRNA	PMID:19167446
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASF1B mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ASF1B mRNA	PMID:19167446
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ASF1B mRNA	PMID:39529242
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1304918	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of ASF1B mRNA	PMID:22110744
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of ASF1B mRNA	PMID:21427059
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in increased expression of ASF1B mRNA	PMID:19136453|PMID:21427059
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304918	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of ASF1B mRNA	PMID:41580965
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304918	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ASF1B mRNA	PMID:30047161
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ASF1B mRNA	PMID:19159671|PMID:20106945|PMID:21632981|PMID:25562108
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of ASF1B mRNA	PMID:33512557
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ASF1B mRNA	PMID:17555576
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ASF1B mRNA	PMID:28973697
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312635	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ASF1B mRNA	PMID:28973697
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASF1B mRNA	PMID:37992649
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of ASF1B mRNA	PMID:33512557
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of ASF1B mRNA	PMID:24657277
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:44185	methotrexate	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of ASF1B mRNA	PMID:24657277
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ASF1B mRNA	PMID:38832940
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ASF1B mRNA	PMID:28542535
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ASF1B mRNA	PMID:22230336
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ASF1B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ASF1B mRNA]	PMID:17585979
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASF1B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASF1B mRNA	PMID:39836092
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304918	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ASF1B mRNA	PMID:29391264
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312635	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ASF1B mRNA	PMID:35436446
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ASF1B mRNA	PMID:17555576
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ASF1B mRNA	PMID:17942748
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASF1B mRNA	PMID:17942748
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312635	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ASF1B mRNA; Nanotubes, Carbon results in increased expression of ASF1B mRNA	PMID:25554681
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304918	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ASF1B mRNA	PMID:30047161
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312635	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ASF1B mRNA	PMID:19042947
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ASF1B protein	PMID:23718831
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312635	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ASF1B mRNA	PMID:38701926
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ASF1B protein	PMID:32959892
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASF1B mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASF1B mRNA	PMID:39836092
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1304918	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of ASF1B mRNA	PMID:25729387
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304918	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ASF1B mRNA	PMID:25729387
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ASF1B mRNA	PMID:28988120
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ASF1B mRNA	PMID:15336504
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ASF1B mRNA	PMID:24810058
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1304918	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ASF1B mRNA	PMID:37269647
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ASF1B intron	PMID:30157460
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1304918	E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in increased expression of ASF1B mRNA	PMID:21161181
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ASF1B mRNA	PMID:39752319
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1312635	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of ASF1B mRNA	PMID:27858113
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:754906	afuresertib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of ASF1B mRNA	PMID:28960945
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of ASF1B mRNA	PMID:28284560
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ASF1B gene]	PMID:28238834
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1304918	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ASF1B mRNA	PMID:12832660
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312635	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of ASF1B mRNA	PMID:19482888|PMID:20403969|PMID:23091169
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ASF1B mRNA]	PMID:19482888
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312635	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ASF1B mRNA	PMID:31388691
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ASF1B mRNA	PMID:19167446
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1312635	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of ASF1B mRNA	PMID:21195148
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1312635	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of ASF1B mRNA	PMID:21195148
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1304918	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of ASF1B mRNA	PMID:30047161
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304918	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ASF1B mRNA	PMID:24780913|PMID:30047161
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:85993	palbociclib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of ASF1B mRNA	PMID:22869556
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:87368	diethyl malate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C058705	diethyl malate results in increased expression of ASF1B mRNA	PMID:38498338
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312635	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of ASF1B mRNA	PMID:39752319
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ASF1B mRNA	PMID:38568856
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ASF1B mRNA	PMID:29301935
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of ASF1B mRNA	PMID:22378314
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1312635	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of ASF1B mRNA	PMID:21195148
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312635	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of ASF1B mRNA	PMID:28973697
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312635	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ASF1B mRNA	PMID:35537566
1312634	ASF1B	anti-silencing function 1B histone chaperone	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304918	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of ASF1B mRNA	PMID:23555832
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of S100A13 mRNA	PMID:38218311
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of S100A13 mRNA	PMID:27188386
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of S100A13 mRNA	PMID:33167477
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of S100A13 mRNA	PMID:24763279
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304919	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of S100A13 gene	PMID:28931070
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of S100A13 mRNA	PMID:20044591
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of S100A13 mRNA	PMID:21632981
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of S100A13 mRNA	PMID:23019147
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312637	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of S100A13 mRNA	PMID:39298647
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304919	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of S100A13 mRNA	PMID:33387578
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1304919	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of S100A13 mRNA	PMID:22967744
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of S100A13 protein	PMID:37730182
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304919	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of S100A13 mRNA	PMID:33387578
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:22984	calcium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	[Calcium co-treated with Copper] binds to and affects the folding of S100A13 protein; Calcium binds to and affects the folding of S100A13 protein	PMID:16766622
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of S100A13 mRNA	PMID:19549813
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304919	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of S100A13 mRNA	PMID:21396975
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of S100A13 protein	PMID:20106945
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of S100A13 gene	PMID:27153756
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of S100A13 mRNA	PMID:23649840
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1304919	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of S100A13 mRNA	PMID:41580963
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of S100A13 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of S100A13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of S100A13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of S100A13 protein	PMID:38598786
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of S100A13 mRNA	PMID:18356318
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312637	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of S100A13 mRNA	PMID:17484886
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304919	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of S100A13 mRNA	PMID:33387578
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312637	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of S100A13 mRNA	PMID:31919559
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of S100A13 gene	PMID:25304211
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of S100A13 mRNA	PMID:40504410
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of S100A13 mRNA	PMID:33512557
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of S100A13 protein	PMID:38460933
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of S100A13 protein	PMID:35688186
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312637	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of S100A13 protein	PMID:37208198
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of S100A13 mRNA	PMID:23300844
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312637	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of S100A13 mRNA	PMID:30912803
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304919	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of S100A13 mRNA	PMID:34747641
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312637	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of S100A13 mRNA	PMID:21570461
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1312637	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone affects the expression of S100A13 mRNA	PMID:23186747
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of S100A13 protein	PMID:39603559
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of S100A13 mRNA	PMID:33512557
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of S100A13 mRNA	PMID:23179753|PMID:27188386
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of S100A13 mRNA	PMID:33212167
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of S100A13 mRNA	PMID:24834073
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	[Calcium co-treated with Copper] binds to and affects the folding of S100A13 protein; Copper affects the secretion of [FGF1 protein binds to SYT1 protein binds to S100A13 protein]	PMID:16262243|PMID:16766622
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of S100A13 protein	PMID:29385562
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of S100A13 mRNA	PMID:29803840
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Aspartame] affects the expression of S100A13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A13 mRNA	PMID:23783067
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:28851	phenanthrene	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C031181	phenanthrene results in decreased expression of S100A13 mRNA	PMID:38568856
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:29320	calcium(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	[Calcium co-treated with Copper] binds to and affects the folding of S100A13 protein; Calcium binds to and affects the folding of S100A13 protein	PMID:16766622
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of S100A13 protein	PMID:30528433
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of S100A13 mRNA	PMID:28595984|PMID:34032870
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1304919	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of S100A13 mRNA	PMID:21297353
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of S100A13 mRNA	PMID:40504410
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of S100A13 intron	PMID:30157460
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of S100A13 mRNA	PMID:20106945|PMID:21632981|PMID:32234424
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003300	[Calcium co-treated with Copper] binds to and affects the folding of S100A13 protein; Copper affects the secretion of [FGF1 protein binds to SYT1 protein binds to S100A13 protein]	PMID:16262243|PMID:16766622
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of S100A13 mRNA	PMID:18356318
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of S100A13 mRNA	PMID:20018196
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of S100A13 mRNA	PMID:19150397
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1304919	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of S100A13 mRNA	PMID:24915197
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304919	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of S100A13 mRNA	PMID:25729387
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1312637	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of S100A13 mRNA	PMID:18648102
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312637	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of S100A13 mRNA	PMID:18301758|PMID:23811191
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:3312	calcium dichloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002122	[Calcium Chloride co-treated with cuprous chloride] binds to and affects the folding of S100A13 protein; Calcium Chloride binds to and affects the folding of S100A13 protein	PMID:16766622
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312637	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of S100A13 mRNA	PMID:35598803
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of S100A13 protein	PMID:37567409
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312637	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of S100A13 mRNA	PMID:26682919
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312637	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of S100A13 mRNA	PMID:39298647
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312637	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of S100A13 mRNA	PMID:37019170
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304919	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of S100A13 mRNA	PMID:21266533
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312637	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of S100A13 mRNA	PMID:34813904
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of S100A13 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of S100A13 protein	PMID:38598786
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304919	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of S100A13 mRNA	PMID:35163327
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of S100A13 mRNA	PMID:38568856
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of S100A13 protein	PMID:26879310
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304919	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of S100A13 mRNA	PMID:35163327
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of S100A13 mRNA	PMID:24449571
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312637	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of S100A13 mRNA	PMID:17585979
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of S100A13 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of S100A13 mRNA]	PMID:17585979
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of S100A13 mRNA	PMID:33512557
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of S100A13 mRNA	PMID:28302478
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312637	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in increased expression of S100A13 mRNA	PMID:19136453|PMID:21427059
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of S100A13 mRNA	PMID:25562108
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312637	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of S100A13 mRNA	PMID:17555576
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312637	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of S100A13 mRNA	PMID:17562736
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of S100A13 mRNA	PMID:21420995
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304919	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of S100A13 mRNA	PMID:33387578
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of S100A13 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of S100A13 mRNA]	PMID:17585979
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of S100A13 mRNA	PMID:29523930
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of S100A13 protein	PMID:38460933
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of S100A13 gene	PMID:25304211
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of S100A13 mRNA	PMID:40504410
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:472805	ouabain	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010042	Ouabain affects the expression of S100A13 protein	PMID:17268060
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304919	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of S100A13 mRNA	PMID:29391264
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312637	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of S100A13 mRNA	PMID:17555576
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:5011	fenpyroximate	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of S100A13 mRNA	PMID:33512557
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of S100A13 mRNA	PMID:23300844
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:53472	copper(I) chloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C028419	[Calcium Chloride co-treated with cuprous chloride] binds to and affects the folding of S100A13 protein; cuprous chloride binds to and affects the folding of S100A13 protein	PMID:16766622
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of S100A13 protein	PMID:32959892
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304919	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of S100A13 mRNA	PMID:25729387
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1312637	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of S100A13 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of S100A13 mRNA	PMID:23783067
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:69355	casticin	increases expression	ISO	RGD:1312637	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in increased expression of S100A13 mRNA	PMID:28444820
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of S100A13 protein	PMID:34186270
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to S100A13 gene]	PMID:28238834
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312637	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of S100A13 mRNA	PMID:40826991
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304919	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of S100A13 mRNA	PMID:21346803
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of S100A13 mRNA	PMID:38568856
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019284	Thapsigargin results in increased expression of S100A13 mRNA	PMID:19442820
1312636	S100A13	S100 calcium binding protein A13	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of S100A13 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of S100A13 protein	PMID:38598786
1312638	UBQLN3	ubiquilin 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of UBQLN3 mRNA	PMID:31163220
1312638	UBQLN3	ubiquilin 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of UBQLN3 mRNA	PMID:41028656
1312638	UBQLN3	ubiquilin 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of UBQLN3 mRNA	PMID:41028656
1312638	UBQLN3	ubiquilin 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of UBQLN3 mRNA	PMID:29301061
1312638	UBQLN3	ubiquilin 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of UBQLN3 promoter	PMID:27901495
1312638	UBQLN3	ubiquilin 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of UBQLN3 3' UTR	PMID:27901495
1312638	UBQLN3	ubiquilin 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of UBQLN3 mRNA	PMID:41028656
1312638	UBQLN3	ubiquilin 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1615636	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of UBQLN3 mRNA	PMID:35295148
1312638	UBQLN3	ubiquilin 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304920	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of UBQLN3 mRNA	PMID:25181051
1312638	UBQLN3	ubiquilin 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1615636	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of UBQLN3 mRNA	PMID:32715474
1312638	UBQLN3	ubiquilin 3	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of UBQLN3 mRNA	PMID:17400583
1312638	UBQLN3	ubiquilin 3	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304920	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of UBQLN3 mRNA	PMID:30307764
1312639	CDC27	cell division cycle 27	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of CDC27 mRNA	PMID:21934132
1312639	CDC27	cell division cycle 27	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CDC27 mRNA	PMID:22378314
1312639	CDC27	cell division cycle 27	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of CDC27 protein	PMID:31494107
1312639	CDC27	cell division cycle 27	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CDC27 mRNA	PMID:21632981
1312639	CDC27	cell division cycle 27	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312640	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CDC27 mRNA	PMID:39298647
1312639	CDC27	cell division cycle 27	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CDC27 mRNA	PMID:23649840
1312639	CDC27	cell division cycle 27	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in decreased expression of CDC27 protein	PMID:20463053
1312639	CDC27	cell division cycle 27	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304921	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of CDC27 mRNA	PMID:26496021
1312639	CDC27	cell division cycle 27	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CDC27 protein	PMID:37730182
1312639	CDC27	cell division cycle 27	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CDC27 intron	PMID:30157460
1312639	CDC27	cell division cycle 27	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDC27 mRNA	PMID:28111341
1312639	CDC27	cell division cycle 27	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312640	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CDC27 mRNA	PMID:19770486
1312639	CDC27	cell division cycle 27	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CDC27 gene	PMID:27153756
1312639	CDC27	cell division cycle 27	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CDC27 mRNA	PMID:23649840
1312639	CDC27	cell division cycle 27	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CDC27 mRNA	PMID:22206623
1312639	CDC27	cell division cycle 27	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC27 mRNA	PMID:40504410
1312639	CDC27	cell division cycle 27	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CDC27 protein	PMID:35688186
1312639	CDC27	cell division cycle 27	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in decreased expression of CDC27 mRNA; resveratrol results in decreased expression of CDC27 protein	PMID:15767336|PMID:18089832
1312639	CDC27	cell division cycle 27	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312640	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of CDC27 protein	PMID:25505154
1312639	CDC27	cell division cycle 27	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of CDC27 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CDC27 mRNA	PMID:19167446|PMID:23557933
1312639	CDC27	cell division cycle 27	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CDC27 mRNA	PMID:28903495
1312639	CDC27	cell division cycle 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312640	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC27 mRNA	PMID:21570461
1312639	CDC27	cell division cycle 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304921	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDC27 mRNA	PMID:32109520
1312639	CDC27	cell division cycle 27	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CDC27 protein	PMID:33212167
1312639	CDC27	cell division cycle 27	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304921	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CDC27 mRNA	PMID:28959563
1312639	CDC27	cell division cycle 27	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of CDC27 mRNA	PMID:30911355
1312639	CDC27	cell division cycle 27	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312640	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of CDC27 mRNA	PMID:27862939
1312639	CDC27	cell division cycle 27	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDC27 mRNA	PMID:29803840
1312639	CDC27	cell division cycle 27	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of CDC27 protein	PMID:35688186
1312639	CDC27	cell division cycle 27	gene	CHEBI:29678	sodium arsenite	increases phosphorylation	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased phosphorylation of CDC27 protein	PMID:18501396
1312639	CDC27	cell division cycle 27	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [CDC27 protein binds to CAPRIN1 protein]	PMID:33939924
1312639	CDC27	cell division cycle 27	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC27 mRNA	PMID:40504410
1312639	CDC27	cell division cycle 27	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1312640	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of CDC27 mRNA	PMID:17127020
1312639	CDC27	cell division cycle 27	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312640	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDC27 mRNA	PMID:20504355
1312639	CDC27	cell division cycle 27	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of CDC27 mRNA	PMID:30911355
1312639	CDC27	cell division cycle 27	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CDC27 mRNA	PMID:20018196
1312639	CDC27	cell division cycle 27	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Arsenic Trioxide co-treated with Paclitaxel] results in increased expression of CDC27 protein modified form	PMID:19781537
1312639	CDC27	cell division cycle 27	gene	CHEBI:31206	ammonium chloride	increases expression	ISO	RGD:1304921	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride results in increased expression of CDC27 protein	PMID:16483693
1312639	CDC27	cell division cycle 27	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304921	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CDC27 mRNA	PMID:34492290
1312639	CDC27	cell division cycle 27	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312640	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CDC27 mRNA	PMID:18301758|PMID:23811191
1312639	CDC27	cell division cycle 27	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304921	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CDC27 mRNA	PMID:25181051
1312639	CDC27	cell division cycle 27	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304921	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CDC27 mRNA	PMID:30816183|PMID:32145629
1312639	CDC27	cell division cycle 27	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304921	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CDC27 gene	PMID:28505145
1312639	CDC27	cell division cycle 27	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304921	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of CDC27 mRNA	PMID:26496021
1312639	CDC27	cell division cycle 27	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of CDC27 mRNA	PMID:19244175
1312639	CDC27	cell division cycle 27	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312640	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CDC27 mRNA	PMID:39298647
1312639	CDC27	cell division cycle 27	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CDC27 intron	PMID:30157460
1312639	CDC27	cell division cycle 27	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312640	E	RGD:6480464	20190219	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CDC27 mRNA	PMID:29156651
1312639	CDC27	cell division cycle 27	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1304921	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CDC27 mRNA	PMID:22546817
1312639	CDC27	cell division cycle 27	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDC27 mRNA	PMID:37042841
1312639	CDC27	cell division cycle 27	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Cadmium Chloride promotes the reaction [CDC20 protein binds to CDC27 protein binds to MAD2L1 protein]]; Cadmium Chloride promotes the reaction [CDC20 protein binds to CDC27 protein binds to MAD2L1 protein]; CDC27 mutant form inhibits the reaction [Cadmium Chloride results in increased ubiquitination of and results in increased degradation of CDC20 protein]	PMID:20054826
1312639	CDC27	cell division cycle 27	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CDC27 mRNA	PMID:28111341
1312639	CDC27	cell division cycle 27	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CDC27 protein	PMID:26879310
1312639	CDC27	cell division cycle 27	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of CDC27 mRNA	PMID:19167446
1312639	CDC27	cell division cycle 27	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC27 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CDC27 mRNA	PMID:19167446
1312639	CDC27	cell division cycle 27	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of CDC27 mRNA	PMID:23179753|PMID:28001369
1312639	CDC27	cell division cycle 27	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312640	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of CDC27 mRNA	PMID:21427059
1312639	CDC27	cell division cycle 27	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CDC27 mRNA	PMID:20106945|PMID:25562108
1312639	CDC27	cell division cycle 27	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of CDC27 mRNA	PMID:27188386
1312639	CDC27	cell division cycle 27	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	[arsenic trioxide co-treated with Paclitaxel] results in increased expression of CDC27 protein modified form	PMID:19781537
1312639	CDC27	cell division cycle 27	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CDC27 mRNA	PMID:24935251|PMID:26272509
1312639	CDC27	cell division cycle 27	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC27 mRNA	PMID:27188386
1312639	CDC27	cell division cycle 27	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304921	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDC27 mRNA	PMID:33387578
1312639	CDC27	cell division cycle 27	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CDC27 mRNA	PMID:22230336|PMID:38614205
1312639	CDC27	cell division cycle 27	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC27 mRNA	PMID:40504410
1312639	CDC27	cell division cycle 27	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDC27 mRNA	PMID:22079256
1312639	CDC27	cell division cycle 27	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Arsenic Trioxide co-treated with Paclitaxel] results in increased expression of CDC27 protein modified form	PMID:19781537
1312639	CDC27	cell division cycle 27	gene	CHEBI:50161	motexafin gadolinium	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of CDC27 mRNA	PMID:16357179
1312639	CDC27	cell division cycle 27	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] affects the expression of CDC27 mRNA	PMID:16357179
1312639	CDC27	cell division cycle 27	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of CDC27 mRNA	PMID:26705709
1312639	CDC27	cell division cycle 27	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CDC27 protein	PMID:23718831
1312639	CDC27	cell division cycle 27	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CDC27 protein	PMID:32959892
1312639	CDC27	cell division cycle 27	gene	CHEBI:62984	zinc acetate	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in increased expression of CDC27 mRNA	PMID:16357179
1312639	CDC27	cell division cycle 27	gene	CHEBI:62984	zinc acetate	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] affects the expression of CDC27 mRNA	PMID:16357179
1312639	CDC27	cell division cycle 27	gene	CHEBI:63618	pravastatin	affects expression	ISO	RGD:1304921	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin affects the expression of CDC27 mRNA	PMID:27225895
1312639	CDC27	cell division cycle 27	gene	CHEBI:63618	pravastatin	increases expression	ISO	RGD:1312640	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of CDC27 mRNA	PMID:27225895
1312639	CDC27	cell division cycle 27	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of CDC27 mRNA	PMID:15336504
1312639	CDC27	cell division cycle 27	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D015655	U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of CDC27 mRNA]	PMID:12710931
1312639	CDC27	cell division cycle 27	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CDC27 intron	PMID:30157460
1312639	CDC27	cell division cycle 27	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312640	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CDC27 mRNA	PMID:22206623
1312639	CDC27	cell division cycle 27	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312640	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CDC27 mRNA	PMID:22206623
1312639	CDC27	cell division cycle 27	gene	CHEBI:75170	zaragozic acid A	affects expression	ISO	RGD:1312640	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 affects the expression of CDC27 mRNA	PMID:27225895
1312639	CDC27	cell division cycle 27	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1304921	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of CDC27 mRNA	PMID:27225895
1312639	CDC27	cell division cycle 27	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CDC27 mRNA	PMID:22079256
1312639	CDC27	cell division cycle 27	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDC27 mRNA	PMID:22079256
1312639	CDC27	cell division cycle 27	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC27 mRNA	PMID:27188386
1312639	CDC27	cell division cycle 27	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CDC27 gene]	PMID:28238834
1312639	CDC27	cell division cycle 27	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CDC27 mRNA	PMID:19159669
1312639	CDC27	cell division cycle 27	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDC27 mRNA	PMID:19167446
1312639	CDC27	cell division cycle 27	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC27 mRNA	PMID:27188386
1312639	CDC27	cell division cycle 27	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304921	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CDC27 mRNA	PMID:21346803
1312639	CDC27	cell division cycle 27	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of CDC27 mRNA	PMID:27188386
1312639	CDC27	cell division cycle 27	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304921	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CDC27 mRNA	PMID:21346803
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:10110	zidovudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with IFNA1 protein] results in increased expression of IRF2 mRNA	PMID:20370541
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of IRF2 mRNA	PMID:37995155
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of IRF2 mRNA	PMID:20188158
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of IRF2 mRNA	PMID:33167477
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:15422	ATP	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D000255	[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IRF2 mRNA; Hirudins inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IRF2 mRNA]	PMID:34212273
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of IRF2 mRNA	PMID:22378314
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of IRF2 mRNA	PMID:39241906
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312642	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IRF2 mRNA	PMID:10975854
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IRF2 mRNA; Hirudins inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IRF2 mRNA]; IRF2 protein affects the reaction [IFNG protein promotes the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA]]; IRF2 protein affects the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA]; IRF2 protein affects the reaction [Lipopolysaccharides results in increased secretion of [IL12A protein binds to IL12B protein]]; IRF2 protein affects the reaction [Lipopolysaccharides results in increased secretion of IL12B protein]	PMID:10415056|PMID:34212273
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of IRF2 mRNA	PMID:31614463
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of IRF2 mRNA	PMID:39298647
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304922	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of IRF2 gene	PMID:27618143
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D005947	Glucose results in increased expression of IRF2 mRNA	PMID:34212273
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D005947	Hirudins inhibits the reaction [Glucose results in increased expression of IRF2 mRNA]; IRF2 protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of GSDMD mRNA]	PMID:34212273
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1312642	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of IRF2 mRNA	PMID:28973375
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D005947	Glucose results in increased expression of IRF2 mRNA	PMID:34212273
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D005947	Hirudins inhibits the reaction [Glucose results in increased expression of IRF2 mRNA]; IRF2 protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of GSDMD mRNA]	PMID:34212273
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304922	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of IRF2 mRNA	PMID:33387578
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of IRF2 gene; Aflatoxin B1 results in increased methylation of IRF2 intron	PMID:27153756|PMID:30157460
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of IRF2 mRNA	PMID:23649840
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of IRF2 mRNA	PMID:35430440
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of IRF2 mRNA	PMID:34911549
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IRF2 mRNA	PMID:31919559
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of IRF2 mRNA	PMID:25629700
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IRF2 mRNA	PMID:22206623
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304922	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of IRF2 mRNA	PMID:31881176
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of IRF2 mRNA	PMID:27392435
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of IRF2 mRNA	PMID:30912803
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of IRF2 mRNA	PMID:23195993
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312642	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IRF2 mRNA	PMID:21570461
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304922	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IRF2 mRNA	PMID:33387578|PMID:34747641
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312642	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IRF2 mRNA	PMID:24058054
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304922	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of IRF2 mRNA	PMID:28959563
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IRF2 mRNA	PMID:29803840
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:28876	melphalan	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of IRF2 mRNA	PMID:22363485
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of IRF2 mRNA	PMID:38568856
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IRF2 5' UTR	PMID:27901495
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312642	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IRF2 mRNA	PMID:22228805
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of IRF2 mRNA	PMID:25895662
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of IRF2 mRNA	PMID:19073995
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of IRF2 mRNA	PMID:19150397|PMID:20382639
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304922	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of IRF2 mRNA	PMID:25729387
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312642	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IRF2 gene	PMID:35295148
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312642	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IRF2 gene	PMID:35295148
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of IRF2 mRNA	PMID:18648102
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1312642	E	RGD:6480464	20120814	CTD	MESH:C006253	pirinixic acid affects the expression of IRF2 mRNA	PMID:17950772|PMID:19136022
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of IRF2 mRNA	PMID:17950772|PMID:23811191
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20120412	CTD	MESH:C006253	NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of IRF2 mRNA]	PMID:17950772
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of IRF2 mRNA	PMID:28329830
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312642	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of IRF2 promoter	PMID:27334623
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304922	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IRF2 mRNA	PMID:25181051|PMID:34947998
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304922	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of IRF2 mRNA	PMID:32145629
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of IRF2 gene	PMID:31601247
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of IRF2 mRNA	PMID:39298647
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of IRF2 intron	PMID:30157460
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312642	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of IRF2 mRNA	PMID:34813904
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of IRF2 mRNA	PMID:17312168
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IRF2 mRNA	PMID:37042841
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of IRF2 mRNA	PMID:29024780
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IRF2 mRNA	PMID:38568856
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1304922	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of IRF2 promoter	PMID:22457795
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of IRF2 mRNA	PMID:23811191
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of IRF2 mRNA	PMID:29038090
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IRF2 mRNA	PMID:25979313
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of IRF2 mRNA	PMID:23179753|PMID:29154799
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of IRF2 gene	PMID:29154799
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of IRF2 mRNA	PMID:20106945|PMID:25562108
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312642	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of IRF2 mRNA	PMID:22733784
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D005947	Glucose results in increased expression of IRF2 mRNA	PMID:34212273
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D005947	Hirudins inhibits the reaction [Glucose results in increased expression of IRF2 mRNA]; IRF2 protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of GSDMD protein]; IRF2 protein affects the reaction [Glucose results in increased expression of GSDMD mRNA]	PMID:34212273
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of IRF2 mRNA]	PMID:21233418
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of IRF2 mRNA	PMID:38832940
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of IRF2 mRNA	PMID:21420995|PMID:27761495
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of IRF2 mRNA	PMID:22230336
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304922	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of IRF2 mRNA	PMID:33387578
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of IRF2 mRNA	PMID:24714768
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IRF2 mRNA	PMID:22079256
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1304922	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of IRF2 mRNA	PMID:28801915
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304922	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of IRF2 mRNA	PMID:25729387
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1304922	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of IRF2 mRNA	PMID:28801915
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of IRF2 intron	PMID:30157460
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1304922	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of IRF2 gene	PMID:35440735
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:6842	methoxychlor	increases methylation	ISO	RGD:1304922	E	RGD:6480464	20130611	CTD	MESH:D008731	Methoxychlor results in increased methylation of IRF2 gene	PMID:23303685
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:72544	flavonoids	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in increased expression of IRF2 mRNA	PMID:15465739
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312642	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of IRF2 mRNA	PMID:22206623
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IRF2 mRNA	PMID:22206623
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of IRF2 mRNA	PMID:22079256
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IRF2 mRNA	PMID:22079256
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:753160	lard	decreases expression	ISO	RGD:1304922	E	RGD:6480464	20260714	CTD	MESH:C029310	lard results in decreased expression of IRF2 mRNA	PMID:26115784
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of IRF2 mRNA	PMID:37199045
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of IRF2 protein	PMID:31285264
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:75701	sarin	decreases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of IRF2 mRNA	PMID:19522546
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1304922	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of IRF2 mRNA	PMID:21346803
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IRF2 gene]	PMID:28238834
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312642	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of IRF2 mRNA	PMID:19136022
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:82577	Fusarenone X	increases expression	ISO	RGD:1312642	E	RGD:6480464	20150310	CTD	MESH:C002469	fusarenon-X results in increased expression of IRF2 mRNA	PMID:24983900
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304922	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of IRF2 mRNA	PMID:19281266
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D013311	Streptozocin results in increased expression of IRF2 mRNA	PMID:34212273
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312642	E	RGD:6480464	20211109	CTD	MESH:D013311	Hirudins inhibits the reaction [Streptozocin results in increased expression of IRF2 mRNA]	PMID:34212273
1312641	IRF2	interferon regulatory factor 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of IRF2 mRNA	PMID:38568856
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of BATF mRNA	PMID:25596134
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312644	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of BATF mRNA	PMID:37995155
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BATF mRNA	PMID:20938992
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of BATF mRNA	PMID:33167477
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BATF mRNA	PMID:30529165
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of BATF mRNA	PMID:39506029
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312644	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of BATF mRNA	PMID:39241906
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BATF mRNA	PMID:20938992
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BATF mRNA	PMID:37042841
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BATF mRNA	PMID:37992649
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BATF mRNA	PMID:37992649
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1304923	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BATF promoter	PMID:23359474
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of BATF mRNA	PMID:28818685
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of BATF mRNA	PMID:19549813
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:234430	gardiquimod	increases expression	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in increased expression of BATF mRNA	PMID:28003376
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:234430	gardiquimod	multiple interactions	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BATF mRNA]	PMID:28003376
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BATF mRNA	PMID:27153756
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of BATF mRNA	PMID:23033980
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BATF mRNA	PMID:20938992
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BATF mRNA	PMID:19244175
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304923	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of BATF mRNA	PMID:31881176
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312644	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of BATF mRNA	PMID:32186404
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of BATF mRNA	PMID:24768652|PMID:25583101
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312644	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BATF mRNA	PMID:24058054
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304923	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BATF mRNA	PMID:34747641
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BATF mRNA	PMID:22903824
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312644	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BATF mRNA	PMID:37172768
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of BATF mRNA	PMID:23649840
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BATF mRNA	PMID:37992649
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:28869	menadione	increases expression	ISO	RGD:1312644	E	RGD:6480464	20150127	CTD	MESH:D024483	Vitamin K 3 results in increased expression of BATF mRNA	PMID:25270620
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BATF promoter	PMID:27901495
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of BATF 5' UTR	PMID:27901495
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BATF mRNA	PMID:21871943|PMID:22316170
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BATF mRNA	PMID:27858113
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of BATF mRNA	PMID:23806026
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1304923	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of BATF mRNA	PMID:22431001
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312644	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of BATF mRNA	PMID:29341224
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312644	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of BATF mRNA	PMID:35295148
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1304923	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of BATF mRNA	PMID:30012374
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312644	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of BATF mRNA	PMID:23557971
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304923	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of BATF mRNA	PMID:34492290
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312644	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of BATF mRNA	PMID:18648102
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312644	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of BATF mRNA	PMID:20813756
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304923	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of BATF mRNA	PMID:25181051
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312644	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of BATF promoter	PMID:27334623
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304923	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of BATF mRNA	PMID:34947998
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304923	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of BATF mRNA	PMID:30816183
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304923	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BATF promoter	PMID:23359474
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of BATF mRNA	PMID:19244175
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312644	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of BATF mRNA	PMID:30951980
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BATF mRNA	PMID:27858113
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312644	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of BATF promoter	PMID:28392331
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312644	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of BATF mRNA	PMID:28392331
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312644	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of BATF intron	PMID:28392331
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312644	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of BATF mRNA	PMID:37019170
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1304923	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BATF promoter	PMID:23359474
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304923	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of BATF mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of BATF mRNA	PMID:35163327
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1312644	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of BATF mRNA	PMID:26377693
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1304923	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of BATF mRNA	PMID:18500788
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304923	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of BATF mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of BATF mRNA	PMID:35163327
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of BATF mRNA	PMID:24449571
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BATF mRNA	PMID:19244175
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of BATF mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BATF mRNA]	PMID:17585979
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BATF mRNA]	PMID:28003376
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312644	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of BATF mRNA	PMID:40194260
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of BATF mRNA	PMID:29154799
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of BATF mRNA	PMID:25562108
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BATF mRNA	PMID:37992649
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of BATF mRNA	PMID:38832940
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of BATF mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of BATF mRNA]	PMID:17585979
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312644	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of BATF mRNA; Nanotubes, Carbon results in increased expression of BATF mRNA	PMID:25554681
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of BATF mRNA	PMID:35964746
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BATF mRNA	PMID:27858113
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BATF mRNA	PMID:27858113
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312644	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of BATF mRNA	PMID:19042947
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312644	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of BATF mRNA	PMID:38701926
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312644	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of BATF mRNA	PMID:22206623
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases methylation	ISO	RGD:1304923	E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in decreased methylation of BATF promoter	PMID:27415467
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BATF gene]	PMID:28238834
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312644	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of BATF mRNA	PMID:38648751
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	multiple interactions	ISO	RGD:1312644	E	RGD:6480464	20230704	CTD	MESH:C041508	[indeno(1,2,3-cd)pyrene co-treated with Antigens, Dermatophagoides] results in increased expression of BATF mRNA	PMID:36975775
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312644	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of BATF mRNA	PMID:39847705
1312643	BATF	basic leucine zipper ATF-like transcription factor	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of BATF mRNA	PMID:24921660
1312646	PHF3	PHD finger protein 3	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PHF3 mRNA	PMID:38218311
1312646	PHF3	PHD finger protein 3	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of PHF3 mRNA	PMID:35967413
1312646	PHF3	PHD finger protein 3	gene	CHEBI:16130	DDT	decreases methylation	ISO	RGD:1304925	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased methylation of PHF3 gene	PMID:30207508
1312646	PHF3	PHD finger protein 3	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of PHF3 protein	PMID:35688186
1312646	PHF3	PHD finger protein 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PHF3 mRNA	PMID:39241906
1312646	PHF3	PHD finger protein 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PHF3 mRNA	PMID:37042841
1312646	PHF3	PHD finger protein 3	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of PHF3 mRNA	PMID:16949557
1312646	PHF3	PHD finger protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PHF3 mRNA	PMID:33754040
1312646	PHF3	PHD finger protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312647	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PHF3 mRNA	PMID:34319233
1312646	PHF3	PHD finger protein 3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PHF3 protein	PMID:37730182
1312646	PHF3	PHD finger protein 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304925	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PHF3 mRNA	PMID:33387578
1312646	PHF3	PHD finger protein 3	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of PHF3 mRNA	PMID:16949557
1312646	PHF3	PHD finger protein 3	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of PHF3 mRNA	PMID:27462272
1312646	PHF3	PHD finger protein 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PHF3 protein	PMID:23301498
1312646	PHF3	PHD finger protein 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312647	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PHF3 mRNA	PMID:19770486
1312646	PHF3	PHD finger protein 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PHF3 mRNA	PMID:41430723
1312646	PHF3	PHD finger protein 3	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PHF3 mRNA	PMID:19244175
1312646	PHF3	PHD finger protein 3	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PHF3 protein	PMID:35688186
1312646	PHF3	PHD finger protein 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PHF3 mRNA	PMID:23557933
1312646	PHF3	PHD finger protein 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PHF3 mRNA	PMID:30912803
1312646	PHF3	PHD finger protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304925	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHF3 mRNA	PMID:32109520
1312646	PHF3	PHD finger protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312647	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHF3 mRNA	PMID:19465110
1312646	PHF3	PHD finger protein 3	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304925	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of PHF3 mRNA	PMID:19013527
1312646	PHF3	PHD finger protein 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PHF3 mRNA; aristolochic acid I results in decreased expression of PHF3 protein	PMID:33212167
1312646	PHF3	PHD finger protein 3	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of PHF3 mRNA	PMID:27862939
1312646	PHF3	PHD finger protein 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PHF3 mRNA	PMID:29803840
1312646	PHF3	PHD finger protein 3	gene	CHEBI:28876	melphalan	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of PHF3 mRNA	PMID:22363485
1312646	PHF3	PHD finger protein 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PHF3 promoter	PMID:27901495
1312646	PHF3	PHD finger protein 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PHF3 mRNA]	PMID:32406909
1312646	PHF3	PHD finger protein 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PHF3 mRNA	PMID:19150397|PMID:26238291
1312646	PHF3	PHD finger protein 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PHF3 gene	PMID:31601247
1312646	PHF3	PHD finger protein 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312647	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of PHF3 mRNA	PMID:23557971
1312646	PHF3	PHD finger protein 3	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of PHF3 mRNA	PMID:38479592
1312646	PHF3	PHD finger protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PHF3 mRNA	PMID:33221593
1312646	PHF3	PHD finger protein 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of PHF3 mRNA	PMID:29275510
1312646	PHF3	PHD finger protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304925	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PHF3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312646	PHF3	PHD finger protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312647	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PHF3 mRNA	PMID:26063408
1312646	PHF3	PHD finger protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PHF3 gene	PMID:31601247
1312646	PHF3	PHD finger protein 3	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of PHF3 mRNA	PMID:19244175
1312646	PHF3	PHD finger protein 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1304925	E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of PHF3 mRNA	PMID:23829299
1312646	PHF3	PHD finger protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PHF3 mRNA	PMID:39298647
1312646	PHF3	PHD finger protein 3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1304925	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of PHF3 gene	PMID:33148267
1312646	PHF3	PHD finger protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PHF3 mRNA	PMID:38568856
1312646	PHF3	PHD finger protein 3	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1304925	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PHF3 mRNA	PMID:24386269
1312646	PHF3	PHD finger protein 3	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PHF3 mRNA	PMID:19244175
1312646	PHF3	PHD finger protein 3	gene	CHEBI:3763	clorgyline	increases expression	EXP		E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of PHF3 mRNA	PMID:19691856
1312646	PHF3	PHD finger protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PHF3 mRNA	PMID:27153767
1312646	PHF3	PHD finger protein 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312647	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PHF3 mRNA	PMID:17963808
1312646	PHF3	PHD finger protein 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHF3 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1312646	PHF3	PHD finger protein 3	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1312647	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine affects the expression of PHF3 mRNA	PMID:19770486
1312646	PHF3	PHD finger protein 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PHF3 mRNA	PMID:26272509
1312646	PHF3	PHD finger protein 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in increased expression of PHF3 mRNA	PMID:28542535
1312646	PHF3	PHD finger protein 3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF3 mRNA	PMID:27188386
1312646	PHF3	PHD finger protein 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PHF3 mRNA; Nanotubes, Carbon results in decreased expression of PHF3 mRNA	PMID:25554681
1312646	PHF3	PHD finger protein 3	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1304925	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PHF3 mRNA	PMID:24136188
1312646	PHF3	PHD finger protein 3	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312647	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHF3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PHF3 mRNA	PMID:21641980|PMID:26378955
1312646	PHF3	PHD finger protein 3	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of PHF3 mRNA	PMID:28988120
1312646	PHF3	PHD finger protein 3	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312647	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of PHF3 mRNA	PMID:20003209
1312646	PHF3	PHD finger protein 3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1304925	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of PHF3 gene	PMID:33148267
1312646	PHF3	PHD finger protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312647	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of PHF3 mRNA	PMID:22206623
1312646	PHF3	PHD finger protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312647	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PHF3 mRNA	PMID:22206623
1312646	PHF3	PHD finger protein 3	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PHF3 protein	PMID:31285264
1312646	PHF3	PHD finger protein 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF3 mRNA	PMID:27188386
1312646	PHF3	PHD finger protein 3	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of PHF3 mRNA	PMID:19159669
1312646	PHF3	PHD finger protein 3	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of PHF3 protein	PMID:38348393
1312646	PHF3	PHD finger protein 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF3 mRNA	PMID:27188386
1312646	PHF3	PHD finger protein 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304925	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PHF3 mRNA	PMID:21346803
1312646	PHF3	PHD finger protein 3	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of PHF3 mRNA	PMID:17440010
1312646	PHF3	PHD finger protein 3	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PHF3 mRNA	PMID:29301935
1312646	PHF3	PHD finger protein 3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312647	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PHF3 mRNA	PMID:28973697
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:132606	mono(2-ethyl-5-oxohexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C080276	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:132607	mono(2-ethyl-5-hydroxyhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C479069	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:132611	mono(5-carboxy-2-ethylpentyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C051450	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C103325	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PFAS mRNA	PMID:33167477
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of PFAS mRNA	PMID:26516004
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PFAS mRNA	PMID:22378314
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614154	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PFAS mRNA	PMID:39241906
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of PFAS mRNA	PMID:23019147|PMID:31614463
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in decreased expression of PFAS mRNA	PMID:17404688
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PFAS mRNA	PMID:38568856
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PFAS mRNA	PMID:23649840
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of PFAS mRNA	PMID:17404688
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C016599	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of PFAS mRNA	PMID:21592394
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of PFAS mRNA	PMID:21592394
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of PFAS mRNA	PMID:21592394
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of PFAS mRNA	PMID:21592394
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304926	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PFAS mRNA	PMID:33387578
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PFAS mRNA	PMID:28818685
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PFAS protein	PMID:23301498
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PFAS mRNA	PMID:23649840
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PFAS gene	PMID:27153756
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PFAS mRNA	PMID:23649840
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of PFAS mRNA	PMID:25102026
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304926	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PFAS mRNA	PMID:30779732
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1614154	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PFAS mRNA	PMID:31919559
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PFAS mRNA	PMID:25629700
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PFAS gene	PMID:25304211
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1614154	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PFAS mRNA	PMID:40504410
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1614154	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PFAS mRNA	PMID:28960355
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of PFAS mRNA	PMID:23300844
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of PFAS mRNA	PMID:27594783
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PFAS mRNA	PMID:28001369
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of PFAS mRNA	PMID:23649840
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PFAS mRNA	PMID:32763439
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PFAS mRNA	PMID:20971185
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	increases expression	ISO	RGD:1304926	E	RGD:6480464	20150303	CTD	MESH:D019328	Buthionine Sulfoximine results in increased expression of PFAS protein	PMID:23736079
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PFAS mRNA	PMID:29803840
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1614154	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of PFAS mRNA	PMID:39631538
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29073	L-ascorbic acid	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D001205	Ascorbic Acid results in increased expression of PFAS mRNA	PMID:25555879
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D001205	[arsenic trioxide co-treated with Ascorbic Acid] results in increased expression of PFAS mRNA	PMID:25555879
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PFAS mRNA	PMID:38568856
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of PFAS mRNA	PMID:34032870
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1614154	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PFAS mRNA	PMID:40504410
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of PFAS mRNA	PMID:22378314
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PFAS mRNA	PMID:20064835
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PFAS mRNA]	PMID:32406909
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PFAS mRNA	PMID:20971185
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PFAS mRNA	PMID:25895662
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PFAS mRNA	PMID:25555879
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of PFAS mRNA	PMID:25555879
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1304926	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of PFAS mRNA	PMID:25729387
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304926	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PFAS mRNA	PMID:25729387
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614154	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PFAS gene	PMID:35295148
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304926	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PFAS mRNA	PMID:34492290
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1304926	E	RGD:6480464	20150303	CTD	MESH:C069837	fullerene C60 results in decreased expression of PFAS mRNA	PMID:19167457
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304926	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PFAS mRNA	PMID:25181051
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PFAS mRNA; bisphenol A results in decreased expression of PFAS protein	PMID:29275510|PMID:31675489|PMID:37567409
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304926	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PFAS mRNA	PMID:30816183|PMID:32528016
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304926	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of PFAS mRNA	PMID:32145629
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1614154	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PFAS mRNA	PMID:33221593
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of PFAS protein	PMID:31675489
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PFAS mRNA	PMID:39298647
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1614154	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PFAS promoter	PMID:33297965
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PFAS protein	PMID:34186270
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PFAS protein	PMID:34186270
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PFAS mRNA	PMID:28392331
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PFAS mRNA	PMID:37019170
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PFAS mRNA	PMID:17361019|PMID:21266533
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of PFAS mRNA	PMID:34813904
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of PFAS mRNA	PMID:17312168
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PFAS mRNA	PMID:37042841
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1304926	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of PFAS mRNA	PMID:25539665
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PFAS mRNA	PMID:19376846
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:37825	p-toluidine	increases expression	ISO	RGD:1304926	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of PFAS mRNA	PMID:27638505
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PFAS mRNA	PMID:28302478
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PFAS mRNA	PMID:31533062
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of PFAS mRNA	PMID:29154799
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PFAS mRNA	PMID:23179753
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PFAS mRNA	PMID:25562108
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of PFAS mRNA	PMID:23649840
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	PFAS gene mutant form affects the susceptibility to Methotrexate	PMID:19426680
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PFAS mRNA	PMID:21420995
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304926	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PFAS mRNA	PMID:33387578
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PFAS gene	PMID:25304211
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1614154	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PFAS mRNA	PMID:40504410
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of PFAS mRNA	PMID:31675489
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:48707	(-)-citrinin	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D002953	[Citrinin co-treated with ochratoxin A] results in increased expression of PFAS protein	PMID:39638853
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PFAS mRNA	PMID:25555879
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of PFAS mRNA	PMID:25555879
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of PFAS mRNA	PMID:23300844
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1614154	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PFAS mRNA	PMID:25554681
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1614154	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PFAS mRNA	PMID:19042947
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PFAS protein	PMID:32959892
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304926	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PFAS mRNA	PMID:25729387
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C581825	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PFAS mRNA	PMID:31758290
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PFAS protein	PMID:34186270
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PFAS mRNA	PMID:22206623
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PFAS protein	PMID:37664457
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PFAS mRNA	PMID:22714537
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	[Citrinin co-treated with ochratoxin A] results in increased expression of PFAS protein	PMID:39638853
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PFAS gene]	PMID:28238834
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1614154	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of PFAS mRNA	PMID:31388691
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PFAS protein	PMID:31675489
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of PFAS protein	PMID:31675489
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304926	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PFAS mRNA	PMID:30047161
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C028577	[mono(2-ethyl-5-hydroxyhexyl) phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono(2-ethyl-5-oxohexyl)phthalate co-treated with 2-ethyl-5-carboxypentyl phthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate co-treated with monoethyl phthalate co-treated with monobutyl phthalate] affects the expression of PFAS mRNA	PMID:37160244
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PFAS protein	PMID:37664457
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PFAS mRNA	PMID:29301935
1312648	PFAS	phosphoribosylformylglycinamidine synthase	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of PFAS mRNA	PMID:22378314
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of FAM135A mRNA	PMID:22378314
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312651	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FAM135A mRNA	PMID:30319688
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1312651	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of FAM135A mRNA	PMID:29018328
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of FAM135A mRNA	PMID:21632981
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with resveratrol] results in decreased expression of FAM135A mRNA	PMID:26667767
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304927	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of FAM135A mRNA	PMID:32145629
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312651	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FAM135A mRNA	PMID:39298647
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FAM135A mRNA	PMID:37042841
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FAM135A protein	PMID:37730182
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312651	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FAM135A mRNA	PMID:37236586
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of FAM135A mRNA	PMID:19549813
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FAM135A gene	PMID:27153756
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312651	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FAM135A mRNA	PMID:19770486
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of FAM135A mRNA	PMID:23649840
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1304927	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of FAM135A mRNA	PMID:30779732
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304927	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FAM135A mRNA	PMID:31150632
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312651	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FAM135A mRNA	PMID:31919559
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312651	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FAM135A mRNA	PMID:25629700
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of FAM135A protein	PMID:35688186
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1304927	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA	PMID:33854195
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[Lipopolysaccharides co-treated with resveratrol] results in decreased expression of FAM135A mRNA	PMID:26667767
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of FAM135A mRNA	PMID:27392435
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of FAM135A mRNA	PMID:27594783
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of FAM135A mRNA	PMID:27392435
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312651	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FAM135A mRNA	PMID:24680724
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304927	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FAM135A mRNA	PMID:33387578
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FAM135A mRNA	PMID:33212167
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FAM135A mRNA	PMID:30851411
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of FAM135A mRNA	PMID:29301061
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FAM135A mRNA	PMID:38568856
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FAM135A 5' UTR	PMID:27901495
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FAM135A mRNA	PMID:26238291
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312651	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FAM135A mRNA	PMID:20127859
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of FAM135A mRNA	PMID:27188386
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312651	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FAM135A gene	PMID:35295148
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304927	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FAM135A mRNA	PMID:34492290
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304927	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM135A mRNA	PMID:32145629
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of FAM135A mRNA	PMID:29275510
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304927	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FAM135A mRNA	PMID:25181051
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312651	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of FAM135A mRNA	PMID:39298647
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1304927	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA	PMID:33854195
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FAM135A mRNA	PMID:37042841
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312651	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FAM135A mRNA	PMID:24982889
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312651	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FAM135A mRNA	PMID:37236586
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FAM135A mRNA	PMID:31533062
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of FAM135A mRNA	PMID:24383497|PMID:26272509
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of FAM135A mRNA	PMID:24935251|PMID:29154799
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM135A mRNA	PMID:27188386
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FAM135A mRNA	PMID:25562108
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of FAM135A promoter	PMID:27989131
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1304927	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA	PMID:33854195
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of FAM135A mRNA	PMID:38832940
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:45716	vorinostat	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat affects the expression of FAM135A mRNA	PMID:27188386
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1304927	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA	PMID:33854195
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of FAM135A mRNA	PMID:24935251
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of FAM135A mRNA	PMID:21420995
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of FAM135A mRNA	PMID:40706910
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312651	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of FAM135A mRNA	PMID:35436446
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1312651	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of FAM135A mRNA	PMID:26377693
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312651	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of FAM135A mRNA	PMID:19042947
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312651	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of FAM135A mRNA	PMID:23608068
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1304927	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA	PMID:33854195
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312651	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FAM135A mRNA	PMID:22206623
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1304927	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of FAM135A mRNA	PMID:33484710
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FAM135A mRNA	PMID:30851411
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM135A mRNA	PMID:27188386
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM135A mRNA	PMID:27188386
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:9546	thimerosal	affects expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal affects the expression of FAM135A mRNA	PMID:27188386
1312650	FAM135A	family with sequence similarity 135 member A	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304927	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of FAM135A mRNA	PMID:23034163
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of HMX1 mRNA	PMID:34925699
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of HMX1 mRNA	PMID:26079696
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of HMX1 mRNA	PMID:27905399
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of HMX1 mRNA	PMID:26079696
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of HMX1 intron	PMID:30157460
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of HMX1 intron	PMID:30157460
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of HMX1 mRNA	PMID:19244175
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:28112	nickel atom	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel affects the expression of HMX1 mRNA	PMID:14575637
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D009532	trichostatin A inhibits the reaction [Nickel affects the expression of HMX1 mRNA]	PMID:14575637
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312653	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HMX1 mRNA	PMID:24058054|PMID:26377647
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304928	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HMX1 mRNA	PMID:32109520
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312653	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HMX1 mRNA	PMID:37172768
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of HMX1 mRNA	PMID:34089799
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of HMX1 mRNA	PMID:22378314
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HMX1 intron	PMID:30157460
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312653	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of HMX1 mRNA	PMID:27131904
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312653	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of HMX1 mRNA	PMID:22609695
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304928	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of HMX1 mRNA	PMID:30047161
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312653	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of HMX1 mRNA	PMID:35295148
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312653	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HMX1 enhancer; titanium dioxide results in decreased methylation of HMX1 gene; titanium dioxide results in decreased methylation of HMX1 promoter	PMID:35295148
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304928	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of HMX1 mRNA	PMID:34492290
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304928	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of HMX1 mRNA	PMID:25181051
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312653	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of HMX1 promoter	PMID:27334623
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of HMX1 intron; benzo(e)pyrene results in increased methylation of HMX1 polyA tail	PMID:30157460
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312653	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of HMX1 mRNA	PMID:32715474
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of HMX1 mRNA	PMID:19244175
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of HMX1 gene	PMID:29154799
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304928	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of HMX1 mRNA	PMID:30047161
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C012589	trichostatin A inhibits the reaction [Nickel affects the expression of HMX1 mRNA]	PMID:14575637
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:1304928	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of HMX1 gene	PMID:37958445
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304928	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of HMX1 mRNA	PMID:30047161
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of HMX1 intron; Methapyrilene results in increased methylation of HMX1 polyA tail	PMID:30157460
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:80630	irinotecan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in increased expression of HMX1 mRNA	PMID:20185912
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1304928	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HMX1 mRNA	PMID:27291303
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of HMX1 mRNA	PMID:30458266
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1304928	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of HMX1 mRNA	PMID:23640034
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of HMX1 mRNA	PMID:26079696
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304928	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of HMX1 mRNA	PMID:25825206|PMID:30047161
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312653	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of HMX1 mRNA	PMID:27131904
1312652	HMX1	H6 family homeobox 1	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of HMX1 mRNA	PMID:22378314
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D015025	Zearalenone results in increased expression of RUBCNL mRNA	PMID:36828454
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RUBCNL mRNA	PMID:27188386
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of RUBCNL mRNA	PMID:21934132|PMID:33167477
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1304929	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of RUBCNL mRNA	PMID:33729688
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1304929	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of RUBCNL mRNA	PMID:36841081
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:16170	mercury(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of RUBCNL mRNA	PMID:16823088
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312655	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RUBCNL mRNA	PMID:39241906
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of RUBCNL mRNA	PMID:21795739|PMID:31614463|PMID:36828454
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RUBCNL mRNA	PMID:37042841
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RUBCNL mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA	PMID:37567420|PMID:37992649
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RUBCNL mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA	PMID:37567420|PMID:37992649
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304929	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of RUBCNL mRNA	PMID:27523638
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of RUBCNL mRNA	PMID:26485663
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304929	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RUBCNL mRNA	PMID:33387578
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of RUBCNL promoter	PMID:30157460
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RUBCNL intron	PMID:30157460
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:25195	mercury atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of RUBCNL mRNA	PMID:16823088
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RUBCNL mRNA	PMID:41430723
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RUBCNL mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RUBCNL mRNA	PMID:34911549
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of RUBCNL mRNA	PMID:26272509
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA	PMID:27188386
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RUBCNL mRNA	PMID:24768652|PMID:25583101
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304929	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RUBCNL mRNA	PMID:32109520
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RUBCNL mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA	PMID:37567420|PMID:37992649
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RUBCNL mRNA	PMID:38568856
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA	PMID:34876320
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA	PMID:34876320
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RUBCNL promoter	PMID:27901495
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of RUBCNL mRNA	PMID:25075043
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of RUBCNL mRNA	PMID:28959546
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:30563	silicon dioxide	affects expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog affects the expression of RUBCNL mRNA	PMID:23806026
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of RUBCNL mRNA	PMID:20170705
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304929	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RUBCNL mRNA	PMID:25181051
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of RUBCNL mRNA	PMID:36828454
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of RUBCNL gene	PMID:31601247
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RUBCNL mRNA	PMID:37042841
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1304929	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of RUBCNL mRNA	PMID:35163327
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RUBCNL mRNA	PMID:38568856
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RUBCNL mRNA	PMID:36326898
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RUBCNL mRNA	PMID:24449571
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312655	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of RUBCNL mRNA	PMID:39529242
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312655	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of RUBCNL mRNA	PMID:29038090
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RUBCNL mRNA	PMID:25979313
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RUBCNL mRNA	PMID:23179753|PMID:26272509
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA	PMID:27188386
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RUBCNL mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA	PMID:37567420|PMID:37992649
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304929	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RUBCNL mRNA	PMID:33387578
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304929	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RUBCNL mRNA	PMID:29391264
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA	PMID:34876320
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RUBCNL mRNA	PMID:20170705
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:50035	alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of RUBCNL mRNA	PMID:25075043
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RUBCNL mRNA	PMID:35964746
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312655	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RUBCNL mRNA	PMID:38701926
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RUBCNL mRNA	PMID:37567420
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA	PMID:27188386
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312655	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of RUBCNL mRNA	PMID:34876320
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RUBCNL mRNA	PMID:27188386
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of RUBCNL mRNA	PMID:28959546
1312654	RUBCNL	rubicon like autophagy enhancer	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312655	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of RUBCNL mRNA	PMID:35537566
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of HAUS3 mRNA	PMID:38218311
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312659	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of HAUS3 mRNA	PMID:33045310
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312659	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of HAUS3 mRNA	PMID:37995155
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of HAUS3 mRNA	PMID:21632981
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312659	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HAUS3 mRNA	PMID:39241906
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of HAUS3 mRNA	PMID:22574217
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of HAUS3 mRNA	PMID:28818685
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HAUS3 mRNA	PMID:19549813
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of HAUS3 protein	PMID:20106945
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312659	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HAUS3 mRNA	PMID:19770486
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312659	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of HAUS3 mRNA	PMID:31919559
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of HAUS3 mRNA	PMID:18414638
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of HAUS3 mRNA	PMID:19244175
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of HAUS3 mRNA	PMID:19244175
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312659	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of HAUS3 mRNA	PMID:28960355
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312659	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of HAUS3 mRNA	PMID:30912803
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1591723	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HAUS3 mRNA	PMID:33387578
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of HAUS3 protein	PMID:39603559
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of HAUS3 mRNA	PMID:39709020
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of HAUS3 mRNA	PMID:38568856
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of HAUS3 mRNA	PMID:19150397
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of HAUS3 gene	PMID:31601247
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312659	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HAUS3 gene	PMID:35295148
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1591723	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of HAUS3 mRNA	PMID:23411599|PMID:34492290
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1591723	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of HAUS3 mRNA	PMID:25181051
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1591723	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of HAUS3 mRNA	PMID:34947998
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of HAUS3 gene	PMID:31601247
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1591723	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of HAUS3 mRNA	PMID:30816183|PMID:32528016
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of HAUS3 gene	PMID:31601247
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of HAUS3 mRNA	PMID:19244175
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of HAUS3 mRNA	PMID:19244175
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312659	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of HAUS3 mRNA	PMID:38685157
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HAUS3 mRNA	PMID:37042841
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of HAUS3 mRNA	PMID:19244175
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of HAUS3 mRNA	PMID:19244175
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312659	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of HAUS3 mRNA	PMID:39529242
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of HAUS3 mRNA	PMID:23179753|PMID:27188386
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HAUS3 gene	PMID:29154799
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of HAUS3 mRNA	PMID:21632981
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312659	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of HAUS3 mRNA	PMID:19770486
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of HAUS3 mRNA	PMID:25562108
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of HAUS3 mRNA	PMID:21420995
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1591723	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HAUS3 mRNA	PMID:33387578
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of HAUS3 mRNA	PMID:18414638
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1591723	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of HAUS3 mRNA	PMID:29391264
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of HAUS3 mRNA	PMID:18175754
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:48981	quinolin-8-ol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of HAUS3 mRNA	PMID:21632981
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312659	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of HAUS3 mRNA	PMID:25554681
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1591723	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of HAUS3 mRNA	PMID:24793618
1312658	HAUS3	HAUS augmin like complex subunit 3	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of HAUS3 mRNA	PMID:26079696
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312668	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of EXOC1 mRNA	PMID:33045310
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312668	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of EXOC1 mRNA	PMID:30529165
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:16136	hydrogen sulfide	decreases expression	ISO	RGD:1312668	E	RGD:6480464	20181113	CTD	MESH:D006862	Hydrogen Sulfide results in decreased expression of EXOC1 protein	PMID:29932956
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of EXOC1 mRNA	PMID:19162166
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1304939	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of EXOC1 mRNA	PMID:22967744
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of EXOC1 protein	PMID:37730182
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304939	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EXOC1 mRNA	PMID:33387578
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of EXOC1 mRNA	PMID:23649840
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312668	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of EXOC1 mRNA	PMID:25629700
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EXOC1 mRNA	PMID:40512198
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of EXOC1 protein	PMID:35688186
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of EXOC1 mRNA	PMID:23557933
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1304939	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of EXOC1 gene	PMID:28505145
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of EXOC1 mRNA	PMID:23195993
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304939	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EXOC1 mRNA	PMID:21724226
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EXOC1 mRNA	PMID:33212167
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EXOC1 mRNA	PMID:30851411
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of EXOC1 protein	PMID:30528433
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EXOC1 mRNA	PMID:40512198
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EXOC1 promoter	PMID:27901495
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of EXOC1 mRNA	PMID:26238291
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304939	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of EXOC1 mRNA	PMID:30816183
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312668	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of EXOC1 mRNA	PMID:32156529
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of EXOC1 gene	PMID:31601247
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304939	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of EXOC1 gene	PMID:28505145
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of EXOC1 protein	PMID:31675489
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312668	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of EXOC1 gene	PMID:31683443
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312668	E	RGD:6480464	20200519	CTD	MESH:C543008	bisphenol S results in increased expression of EXOC1 mRNA	PMID:31881267|PMID:39298647
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to EXOC1 protein	PMID:32991956
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of EXOC1 mRNA	PMID:28302478
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312668	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of EXOC1 mRNA	PMID:36331819
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of EXOC1 gene	PMID:29154799
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of EXOC1 mRNA	PMID:25562108
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312668	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EXOC1 mRNA	PMID:17562736
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of EXOC1 mRNA	PMID:22230336
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1304939	E	RGD:6480464	20130806	CTD	MESH:C005219	methyl cellosolve results in increased expression of EXOC1 mRNA	PMID:21061450
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EXOC1 mRNA	PMID:40512198
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1312668	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of EXOC1 mRNA	PMID:30529165
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EXOC1 mRNA	PMID:22079256
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312668	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of EXOC1 mRNA	PMID:35436446
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312668	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of EXOC1 mRNA	PMID:23608068
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EXOC1 protein	PMID:32959892
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312668	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of EXOC1 mRNA	PMID:23650126
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304939	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of EXOC1 mRNA	PMID:30467583
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312668	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EXOC1 mRNA	PMID:22206623
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of EXOC1 mRNA	PMID:22079256
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EXOC1 mRNA	PMID:22079256
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EXOC1 mRNA	PMID:30851411
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of EXOC1 protein	PMID:31675489
1312667	EXOC1	exocyst complex component 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304939	E	RGD:6480464	20130806	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EXOC1 mRNA	PMID:21346803
1312669	ATF7	activating transcription factor 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312670	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ATF7 mRNA	PMID:33045310
1312669	ATF7	activating transcription factor 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312670	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ATF7 mRNA	PMID:20188158
1312669	ATF7	activating transcription factor 7	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of ATF7 protein	PMID:28073184
1312669	ATF7	activating transcription factor 7	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312670	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of ATF7 mRNA	PMID:40945087
1312669	ATF7	activating transcription factor 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304940	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ATF7 mRNA	PMID:32145629
1312669	ATF7	activating transcription factor 7	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ATF7 protein	PMID:37730182
1312669	ATF7	activating transcription factor 7	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304940	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ATF7 mRNA	PMID:33387578
1312669	ATF7	activating transcription factor 7	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATF7 mRNA; ATF7 promotes the reaction [Cadmium results in increased expression of MT1A mRNA]	PMID:28632756|PMID:35301059
1312669	ATF7	activating transcription factor 7	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ATF7 protein	PMID:23301498
1312669	ATF7	activating transcription factor 7	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304940	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ATF7 mRNA	PMID:30779732
1312669	ATF7	activating transcription factor 7	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304940	E	RGD:6480464	20240903	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with baicalein] results in increased expression of ATF7 protein	PMID:33779329
1312669	ATF7	activating transcription factor 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312670	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ATF7 mRNA	PMID:22206623
1312669	ATF7	activating transcription factor 7	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of ATF7 protein	PMID:35688186
1312669	ATF7	activating transcription factor 7	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ATF7 mRNA	PMID:23557933
1312669	ATF7	activating transcription factor 7	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1312670	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of ATF7 mRNA	PMID:15681117
1312669	ATF7	activating transcription factor 7	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ATF7 mRNA	PMID:25583101
1312669	ATF7	activating transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304940	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATF7 mRNA	PMID:22298810
1312669	ATF7	activating transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312670	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATF7 mRNA	PMID:21570461
1312669	ATF7	activating transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304940	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATF7 mRNA	PMID:33387578
1312669	ATF7	activating transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312670	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATF7 mRNA	PMID:24058054
1312669	ATF7	activating transcription factor 7	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ATF7 mRNA	PMID:30851411
1312669	ATF7	activating transcription factor 7	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATF7 mRNA	PMID:29803840
1312669	ATF7	activating transcription factor 7	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ATF7 protein	PMID:35688186
1312669	ATF7	activating transcription factor 7	gene	CHEBI:2979	baicalein	multiple interactions	ISO	RGD:1304940	E	RGD:6480464	20240903	CTD	MESH:C006680	[Carbon Tetrachloride co-treated with baicalein] results in increased expression of ATF7 protein	PMID:33779329
1312669	ATF7	activating transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATF7 promoter	PMID:27901495
1312669	ATF7	activating transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATF7 5' UTR	PMID:27901495
1312669	ATF7	activating transcription factor 7	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312670	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of ATF7 mRNA	PMID:22609695
1312669	ATF7	activating transcription factor 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312670	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATF7 promoter	PMID:35295148
1312669	ATF7	activating transcription factor 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304940	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ATF7 mRNA	PMID:25181051|PMID:30816183|PMID:32145629
1312669	ATF7	activating transcription factor 7	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ATF7 gene	PMID:31601247
1312669	ATF7	activating transcription factor 7	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of ATF7 mRNA	PMID:29024780
1312669	ATF7	activating transcription factor 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ATF7 mRNA	PMID:38568856
1312669	ATF7	activating transcription factor 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATF7 mRNA	PMID:35301059
1312669	ATF7	activating transcription factor 7	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ATF7 mRNA	PMID:28302478
1312669	ATF7	activating transcription factor 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312670	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ATF7 mRNA	PMID:17963808
1312669	ATF7	activating transcription factor 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATF7 mRNA	PMID:24935251
1312669	ATF7	activating transcription factor 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ATF7 mRNA	PMID:23179753
1312669	ATF7	activating transcription factor 7	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ATF7 gene	PMID:29154799
1312669	ATF7	activating transcription factor 7	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of ATF7 promoter	PMID:27989131
1312669	ATF7	activating transcription factor 7	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ATF7 mRNA	PMID:27188386
1312669	ATF7	activating transcription factor 7	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ATF7 mRNA	PMID:24935251
1312669	ATF7	activating transcription factor 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312670	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ATF7 mRNA	PMID:17562736
1312669	ATF7	activating transcription factor 7	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312670	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of ATF7 mRNA	PMID:25554681
1312669	ATF7	activating transcription factor 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312670	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ATF7 mRNA	PMID:25554681
1312669	ATF7	activating transcription factor 7	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1304940	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ATF7 mRNA	PMID:28801915
1312669	ATF7	activating transcription factor 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312670	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ATF7 mRNA	PMID:22206623
1312669	ATF7	activating transcription factor 7	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ATF7 protein	PMID:31285264
1312669	ATF7	activating transcription factor 7	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ATF7 mRNA	PMID:30851411
1312669	ATF7	activating transcription factor 7	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1312670	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of ATF7 mRNA	PMID:31388691
1312669	ATF7	activating transcription factor 7	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304940	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ATF7 mRNA	PMID:19281266
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of HIPK1 mRNA	PMID:33045310
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of HIPK1 mRNA	PMID:15498508
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312672	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of HIPK1 mRNA	PMID:30319688
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312672	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of HIPK1 mRNA	PMID:30319688
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HIPK1 protein	PMID:36052886
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D008070	HIPK1 protein inhibits the reaction [MIR335 mRNA inhibits the reaction [Lipopolysaccharides results in decreased expression of CCND1 protein]]; HIPK1 protein inhibits the reaction [MIR335 mRNA inhibits the reaction [Lipopolysaccharides results in increased expression of BAX protein]]; HIPK1 protein inhibits the reaction [MIR335 mRNA inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; HIPK1 protein inhibits the reaction [MIR335 mRNA inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; MIR335 mRNA inhibits the reaction [Lipopolysaccharides results in increased expression of HIPK1 protein]; ZNF644 mRNA alternative form inhibits the reaction [MIR335 mRNA inhibits the reaction [Lipopolysaccharides results in increased expression of HIPK1 protein]]; ZNF644 mRNA alternative form promotes the reaction [Lipopolysaccharides results in increased expression of HIPK1 protein]	PMID:36052886
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of HIPK1 mRNA	PMID:22574217
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of HIPK1 mRNA	PMID:39298647
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of HIPK1 mRNA	PMID:23019147
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HIPK1 mRNA	PMID:37042841
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1312672	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of HIPK1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of HIPK1 mRNA]	PMID:20230807
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of HIPK1 protein	PMID:37730182
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1312672	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of HIPK1 mRNA	PMID:20230807
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1312672	E	RGD:6480464	20120501	CTD	MESH:D015632	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of HIPK1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of HIPK1 mRNA]	PMID:20230807
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of HIPK1 mRNA	PMID:28818685
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of HIPK1 mRNA	PMID:39836092
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1312672	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of HIPK1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of HIPK1 mRNA]	PMID:20230807
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of HIPK1 mRNA	PMID:19549813
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of HIPK1 mRNA	PMID:23649840
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:2682	amphotericin B	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of HIPK1 mRNA	PMID:28534445
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HIPK1 gene	PMID:25304211
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of HIPK1 mRNA	PMID:39836092
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1304941	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of HIPK1 mRNA	PMID:25905778
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of HIPK1 mRNA	PMID:30912803
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312672	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HIPK1 mRNA	PMID:21570461
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304941	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HIPK1 mRNA	PMID:33387578
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304941	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HIPK1 mRNA	PMID:34747641
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312672	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of HIPK1 mRNA	PMID:25896364|PMID:39631538
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of HIPK1 protein	PMID:35688186
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HIPK1 mRNA	PMID:38568856
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of HIPK1 mRNA; [sodium arsenite results in increased stability of and affects the localization of HIPK1 protein] which results in increased phosphorylation of CREB1 protein; sodium arsenite results in increased stability of and affects the localization of HIPK1 protein	PMID:27884605|PMID:39836092
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HIPK1 3' UTR	PMID:27901495
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HIPK1 5' UTR	PMID:27901495
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:29866	arsenite(3-)	affects expression	EXP		E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of HIPK1 mRNA	PMID:22959463
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to HIPK1 mRNA]	PMID:32406909
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HIPK1 mRNA	PMID:20018196
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HIPK1 mRNA	PMID:20458559
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HIPK1 gene	PMID:31601247
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304941	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HIPK1 mRNA	PMID:25729387
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of HIPK1 mRNA	PMID:15498508
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312672	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of HIPK1 mRNA	PMID:17656681
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of HIPK1 mRNA	PMID:29264374
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312672	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HIPK1 gene; titanium dioxide results in decreased methylation of HIPK1 promoter	PMID:35295148
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304941	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of HIPK1 mRNA	PMID:25181051
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HIPK1 gene	PMID:31601247
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of HIPK1 mRNA	PMID:39298647
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HIPK1 mRNA	PMID:28628672
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312672	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of HIPK1 mRNA	PMID:21266533
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1304941	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of HIPK1 mRNA	PMID:22546817
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of HIPK1 mRNA	PMID:34813904
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HIPK1 mRNA	PMID:28628672
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of HIPK1 mRNA	PMID:34813904
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1304941	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of HIPK1 mRNA	PMID:22546817
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of HIPK1 mRNA	PMID:39836092
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HIPK1 mRNA	PMID:38568856
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of HIPK1 mRNA	PMID:19320972
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of HIPK1 mRNA	PMID:31533062
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of HIPK1 mRNA	PMID:19167446
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304941	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of HIPK1 mRNA	PMID:29427782
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of HIPK1 mRNA	PMID:23179753
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of HIPK1 mRNA	PMID:19136453
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HIPK1 gene	PMID:29154799
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304941	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of HIPK1 mRNA	PMID:41580965
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of HIPK1 mRNA	PMID:25562108
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HIPK1 mRNA	PMID:28628672
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312672	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HIPK1 mRNA	PMID:17562736
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312672	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in increased expression of HIPK1 mRNA	PMID:17585979
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HIPK1 gene	PMID:25304211
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of HIPK1 mRNA	PMID:39836092
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HIPK1 mRNA	PMID:28628672
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HIPK1 mRNA	PMID:20458559
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:50161	motexafin gadolinium	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of HIPK1 mRNA	PMID:16357179
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of HIPK1 mRNA]	PMID:16357179
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:62984	zinc acetate	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in increased expression of HIPK1 mRNA	PMID:16357179
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:62984	zinc acetate	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of HIPK1 mRNA]	PMID:16357179
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of HIPK1 mRNA	PMID:39836092
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1304941	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of HIPK1 mRNA	PMID:25729387
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304941	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HIPK1 mRNA	PMID:25729387
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312672	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of HIPK1 mRNA	PMID:23650126
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312672	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of HIPK1 mRNA	PMID:20003209
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304941	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of HIPK1 mRNA	PMID:30467583
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of HIPK1 mRNA	PMID:37199045
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of HIPK1 protein	PMID:31285264
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HIPK1 gene]	PMID:28238834
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304941	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HIPK1 mRNA	PMID:24780913
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of HIPK1 mRNA	PMID:17440010
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of HIPK1 mRNA	PMID:38568856
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of HIPK1 mRNA	PMID:29301935
1312671	HIPK1	homeodomain interacting protein kinase 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304941	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of HIPK1 mRNA	PMID:23869203
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of ABCF2 protein	PMID:39638853
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:10110	zidovudine	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D015215	Zidovudine results in increased expression of ABCF2 mRNA	PMID:24292225
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312674	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ABCF2 mRNA	PMID:20188158
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ABCF2 gene	PMID:20938992
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ABCF2 mRNA	PMID:33167477
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ABCF2 mRNA	PMID:20044591
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312674	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ABCF2 mRNA	PMID:39241906
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ABCF2 mRNA	PMID:31614463
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ABCF2 mRNA	PMID:38568856
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:16602	trichloroethene	decreases methylation	ISO	RGD:1304942	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of ABCF2 gene	PMID:27618143
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ABCF2 gene	PMID:20938992
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ABCF2 mRNA	PMID:37042841
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ABCF2 mRNA	PMID:23649840
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:17558	quercitrin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of ABCF2 mRNA	PMID:25193878
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ABCF2 mRNA	PMID:36331819
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ABCF2 protein]	PMID:32272095
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ABCF2 mRNA	PMID:23649840
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ABCF2 mRNA	PMID:22100608
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ABCF2 mRNA	PMID:23649840
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of ABCF2 mRNA	PMID:15672453
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of ABCF2 mRNA	PMID:18356318
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ABCF2 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ABCF2 mRNA]	PMID:20938992|PMID:22206623
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ABCF2 gene	PMID:25304211
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABCF2 mRNA	PMID:40504410
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312674	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ABCF2 protein	PMID:25505154
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ABCF2 mRNA	PMID:23195993
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ABCF2 mRNA	PMID:24768652|PMID:25583101
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312674	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABCF2 mRNA	PMID:21570461
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304942	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABCF2 mRNA	PMID:33387578
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABCF2 mRNA	PMID:17942748
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABCF2 mRNA	PMID:17942748
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ABCF2 protein	PMID:39603559
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ABCF2 mRNA	PMID:33212167
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:28618	1,4-dichlorobenzene	increases expression	ISO	RGD:1312674	E	RGD:6480464	20171114	CTD	MESH:C018511	4-dichlorobenzene results in increased expression of ABCF2 mRNA	PMID:26975756
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ABCF2 mRNA	PMID:20971185
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of ABCF2 mRNA	PMID:34032870
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABCF2 mRNA; sodium arsenite results in decreased expression of ABCF2 protein	PMID:30528433|PMID:38568856
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABCF2 mRNA	PMID:40504410
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312674	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABCF2 mRNA	PMID:22228805
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ABCF2 promoter	PMID:27901495
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ABCF2 mRNA	PMID:20971185
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of ABCF2 mRNA	PMID:18356318
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ABCF2 mRNA	PMID:20018196
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312674	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ABCF2 gene	PMID:35295148
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ABCF2 mRNA	PMID:30903817
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304942	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ABCF2 mRNA	PMID:25181051
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCF2 protein	PMID:37567409
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ABCF2 protein	PMID:34186270
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1304942	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCF2 mRNA	PMID:17602206
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1312674	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of ABCF2 protein	PMID:32272095
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ABCF2 protein]	PMID:32272095
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304942	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ABCF2 mRNA	PMID:17602206
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCF2 mRNA	PMID:17917374
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304942	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ABCF2 mRNA	PMID:33453195
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1304942	E	RGD:6480464	20130806	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of ABCF2 promoter	PMID:22457795
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ABCF2 mRNA	PMID:19376846
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312674	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ABCF2 mRNA	PMID:40194260
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ABCF2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ABCF2 mRNA	PMID:36331819
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ABCF2 mRNA	PMID:25979313
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in increased expression of ABCF2 mRNA	PMID:22147139
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:41423	celecoxib	affects expression	ISO	RGD:1312674	E	RGD:6480464	20170303	CTD	MESH:C105934	Celecoxib affects the expression of ABCF2 mRNA	PMID:20562220
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ABCF2 mRNA	PMID:17555576
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:43572	kojic acid	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:C011890	[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCF2 mRNA	PMID:17917374
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of ABCF2 mRNA	PMID:24449571
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ABCF2 mRNA	PMID:38832940
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ABCF2 mRNA	PMID:17562736
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304942	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ABCF2 mRNA	PMID:33387578
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ABCF2 gene	PMID:25304211
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABCF2 mRNA	PMID:40504410
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304942	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ABCF2 mRNA	PMID:29391264
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312674	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ABCF2 mRNA	PMID:35436446
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ABCF2 mRNA	PMID:17555576
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ABCF2 mRNA	PMID:17942748
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABCF2 mRNA	PMID:17942748
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312674	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ABCF2 mRNA; Nanotubes, Carbon results in increased expression of ABCF2 mRNA	PMID:25554681
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304942	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ABCF2 mRNA	PMID:30047161
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304942	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ABCF2 mRNA	PMID:24136188
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312674	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ABCF2 mRNA	PMID:19042947
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ABCF2 protein	PMID:32959892
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312674	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ABCF2 protein	PMID:26558463
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312674	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ABCF2 mRNA	PMID:22206623
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312674	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ABCF2 mRNA]	PMID:22206623
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ABCF2 protein	PMID:31285264
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:75701	sarin	decreases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of ABCF2 mRNA	PMID:19522546
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:75701	sarin	increases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of ABCF2 mRNA	PMID:19522546
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1304942	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ABCF2 mRNA	PMID:21346803
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ABCF2 gene]	PMID:28238834
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304942	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ABCF2 mRNA	PMID:30047161
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304942	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ABCF2 mRNA	PMID:21346803
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ABCF2 mRNA	PMID:38568856
1312673	ABCF2	ATP binding cassette subfamily F member 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304942	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ABCF2 mRNA	PMID:21346803
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA	PMID:27188386
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:132098	methoxyacetic acid	increases expression	ISO	RGD:1304943	E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in increased expression of LRP12 mRNA	PMID:18199887
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304943	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LRP12 mRNA]	PMID:31150632
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:142921	3-phenylprop-2-enal	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased expression of LRP12 mRNA	PMID:19524605
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550067	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LRP12 mRNA	PMID:20938992
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of LRP12 mRNA	PMID:32845096
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550067	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRP12 mRNA	PMID:30529165
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550067	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of LRP12 mRNA	PMID:30319688
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550067	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LRP12 mRNA	PMID:39241906
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LRP12 mRNA	PMID:39298647
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of LRP12 mRNA	PMID:31614463
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of LRP12 mRNA	PMID:30165855
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550067	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LRP12 mRNA	PMID:20938992
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of LRP12 protein	PMID:37730182
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of LRP12 mRNA	PMID:28818685
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP12 mRNA	PMID:39836092
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRP12 mRNA	PMID:35301059
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304943	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRP12 mRNA	PMID:39012411
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LRP12 mRNA	PMID:19549813
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of LRP12 protein	PMID:20106945
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LRP12 mRNA	PMID:27153756
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of LRP12 mRNA	PMID:32845096
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550067	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LRP12 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LRP12 mRNA	PMID:34911549
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1304943	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of LRP12 mRNA	PMID:30779732
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304943	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LRP12 mRNA	PMID:31150632
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550067	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LRP12 mRNA	PMID:27339419|PMID:31919559
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304943	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LRP12 mRNA]	PMID:31150632
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LRP12 mRNA	PMID:25629700
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550067	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRP12 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LRP12 mRNA	PMID:20938992|PMID:22206623
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRP12 mRNA	PMID:39836092
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of LRP12 mRNA	PMID:27594783
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550067	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRP12 mRNA	PMID:21570461
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LRP12 mRNA	PMID:28001369
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LRP12 mRNA	PMID:29803840
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LRP12 mRNA	PMID:38568856
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRP12 mRNA	PMID:39836092
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550067	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LRP12 mRNA	PMID:22228805
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1550067	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LRP12 mRNA	PMID:29203145
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of LRP12 mRNA	PMID:29264374
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550067	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of LRP12 mRNA	PMID:23557971|PMID:27760801
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550067	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LRP12 gene	PMID:35295148
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304943	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LRP12 mRNA	PMID:34492290
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550067	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of LRP12 mRNA	PMID:28472532
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LRP12 mRNA	PMID:33221593
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304943	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LRP12 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304943	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LRP12 gene	PMID:28505145
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:34093	1-Hydroxypyrene	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C033146	1-hydroxypyrene results in decreased expression of LRP12 mRNA	PMID:21854004
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LRP12 mRNA	PMID:39298647
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of LRP12 mRNA	PMID:37019170
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LRP12 mRNA	PMID:37042841
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP12 mRNA	PMID:39836092
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304943	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LRP12 mRNA	PMID:21297351
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LRP12 mRNA	PMID:35301059
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304943	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRP12 mRNA	PMID:39012411
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LRP12 mRNA	PMID:40194260
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LRP12 mRNA	PMID:31533062
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:39472	1,3,4-thiadiazole	affects expression	ISO	RGD:1304943	E	RGD:6480464	20250204	CTD	MESH:C058949	1,3,4-thiadiazole analog affects the expression of LRP12 mRNA	PMID:30905023
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550067	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of LRP12 mRNA	PMID:17292431
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRP12 mRNA	PMID:24935251
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LRP12 gene	PMID:29154799
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of LRP12 mRNA	PMID:24935251|PMID:29154799
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304943	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of LRP12 mRNA	PMID:38685447
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of LRP12 mRNA	PMID:20106945
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LRP12 mRNA	PMID:38832940
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of LRP12 mRNA	PMID:24935251|PMID:26272509
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA	PMID:27188386
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of LRP12 mRNA	PMID:29067470
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304943	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LRP12 mRNA	PMID:33387578
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRP12 mRNA	PMID:39836092
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of LRP12 mRNA	PMID:26833863
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304943	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of LRP12 mRNA	PMID:29391264
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of LRP12 mRNA	PMID:18175754
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of LRP12 mRNA	PMID:23228038
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550067	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LRP12 mRNA; Nanotubes, Carbon results in increased expression of LRP12 mRNA	PMID:25554681
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1550067	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of LRP12 mRNA	PMID:26377693
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of LRP12 mRNA	PMID:22714537
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP12 mRNA	PMID:39836092
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550067	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LRP12 mRNA	PMID:22206623
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550067	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRP12 mRNA	PMID:22206623
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of LRP12 mRNA	PMID:22714537
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA	PMID:27188386
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LRP12 gene]	PMID:28238834
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of LRP12 mRNA	PMID:26272509
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA	PMID:27188386
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP12 mRNA	PMID:27188386
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304943	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of LRP12 mRNA	PMID:19281266
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304943	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LRP12 mRNA	PMID:21346803
1312675	LRP12	LDL receptor related protein 12	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304943	E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of LRP12 mRNA	PMID:22615374
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1620590	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CIB3 mRNA	PMID:33045310
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1620590	E	RGD:6480464	20170516	CTD	MESH:D011794	[Dietary Fats co-treated with Quercetin] affects the expression of CIB3 mRNA	PMID:25047408
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1620590	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CIB3 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CIB3 mRNA]	PMID:37992649
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1620590	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of CIB3 mRNA	PMID:28973375
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1620590	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CIB3 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CIB3 mRNA]	PMID:37992649
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1620590	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CIB3 mRNA	PMID:36331819
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of CIB3 mRNA	PMID:24376830
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1620590	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CIB3 mRNA	PMID:31919559
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1620590	E	RGD:6480464	20260707	CTD	MESH:C010974	Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CIB3 mRNA]	PMID:37992649
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1620590	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CIB3 mRNA	PMID:28189721|PMID:28960355
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620590	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CIB3 mRNA	PMID:28922406
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1620590	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CIB3 mRNA	PMID:26290441
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1620590	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CIB3 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CIB3 mRNA]	PMID:37992649
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CIB3 promoter	PMID:27901495
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CIB3 3' UTR	PMID:27901495
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1620590	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CIB3 mRNA	PMID:27131904
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1590245	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CIB3 mRNA	PMID:25181051
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of CIB3 mRNA	PMID:31715268
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1620590	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CIB3 mRNA	PMID:39298647
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1620590	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CIB3 mRNA	PMID:32715474
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1620590	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CIB3 mRNA	PMID:17942915
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1620590	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of CIB3 mRNA]	PMID:17942915
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:35176	zinc sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of CIB3 mRNA	PMID:16330358
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1590245	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of CIB3 mRNA	PMID:25539665
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CIB3 mRNA	PMID:24449571
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620590	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CIB3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CIB3 mRNA	PMID:36331819
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1620590	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of CIB3 mRNA	PMID:25123088
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1620590	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CIB3 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CIB3 mRNA]	PMID:37992649
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1620590	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in decreased expression of CIB3 mRNA	PMID:29246445
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1620590	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of CIB3 mRNA]	PMID:29246445
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of CIB3 mRNA	PMID:35811015
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of CIB3 mRNA	PMID:18175754
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1620590	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of CIB3 mRNA	PMID:25620056
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620590	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CIB3 mRNA	PMID:25620056
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1620590	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of CIB3 mRNA	PMID:26377693
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1620590	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of CIB3 mRNA	PMID:19270015|PMID:19482888|PMID:23091169
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1620590	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CIB3 mRNA]	PMID:19482888
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1620590	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CIB3 mRNA	PMID:38648751
1312677	CIB3	calcium and integrin binding family member 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1620590	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CIB3 mRNA	PMID:27131904
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of DDX17 protein	PMID:39638853
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DDX17 mRNA	PMID:38218311
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DDX17 mRNA	PMID:38218311
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of DDX17 mRNA	PMID:25596134
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of DDX17 mRNA	PMID:27188386
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in decreased expression of DDX17 mRNA	PMID:33227293
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of DDX17 mRNA	PMID:10718294
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20130806	CTD	MESH:D014212	Tretinoin results in decreased expression of DDX17 mRNA	PMID:10718294
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:15367	all-trans-retinoic acid	increases acetylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D014212	Tretinoin results in increased acetylation of DDX17 protein	PMID:28053092
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of DDX17 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of and results in increased oxidation of DDX17 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of DDX17 mRNA	PMID:32699268|PMID:32845096
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of DDX17 mRNA	PMID:25596134
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DDX17 mRNA	PMID:36331819
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DDX17 mRNA	PMID:26079696
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of DDX17 protein	PMID:28073184
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DDX17 mRNA	PMID:21179406
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of DDX17 mRNA	PMID:21632981
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DDX17 mRNA	PMID:39241906
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of DDX17 mRNA	PMID:21795739
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of DDX17 mRNA	PMID:32145629
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DDX17 mRNA	PMID:39298647
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1550068	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of DDX17 mRNA	PMID:33711761
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DDX17 mRNA	PMID:33387578
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DDX17 mRNA	PMID:37042841
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DDX17 mRNA	PMID:21179406
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of DDX17 mRNA	PMID:16949557
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DDX17 mRNA	PMID:33754040
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of DDX17 protein	PMID:34122009
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of DDX17 protein	PMID:37730182
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304945	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of DDX17 mRNA	PMID:22061828
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DDX17 mRNA	PMID:28818685
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DDX17 mRNA	PMID:36331819
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of DDX17 mRNA	PMID:16949557
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DDX17 mRNA	PMID:28111341|PMID:37325564
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of DDX17 mRNA	PMID:23487506
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DDX17 protein	PMID:23301498
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DDX17 mRNA	PMID:23649840
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of DDX17 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of and results in increased oxidation of DDX17 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of DDX17 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of DDX17 mRNA	PMID:32699268|PMID:32845096
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of DDX17 mRNA	PMID:19774075
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in decreased expression of DDX17 mRNA	PMID:18593933
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DDX17 mRNA	PMID:22206623
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:27563	arsenic atom	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	DDX17 mRNA results in decreased susceptibility to Arsenic	PMID:17976673
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DDX17 mRNA	PMID:19244175
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of DDX17 mRNA	PMID:19244175
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of DDX17 protein	PMID:35688186
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550068	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of DDX17 mRNA	PMID:28960355
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of DDX17 mRNA	PMID:25596134
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of DDX17 protein	PMID:25505154
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of DDX17 mRNA	PMID:28903495
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of DDX17 mRNA	PMID:25596134|PMID:27594783
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1304945	E	RGD:6480464	20200519	CTD	MESH:D009532	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of DDX17 mRNA	PMID:31734292
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DDX17 mRNA	PMID:22574217
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550068	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DDX17 mRNA	PMID:21570461
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DDX17 mRNA	PMID:15328365
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304945	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DDX17 mRNA	PMID:34747641
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to DDX17 promoter]	PMID:19654925
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of DDX17 mRNA	PMID:29955902
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of DDX17 mRNA	PMID:26272509
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DDX17 mRNA	PMID:33212167
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304945	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of DDX17 mRNA	PMID:30556269
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of DDX17 protein	PMID:28918527
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of DDX17 protein	PMID:35688186
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DDX17 mRNA; sodium arsenite results in decreased expression of DDX17 protein	PMID:38228842|PMID:38568856
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550068	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of DDX17 mRNA	PMID:36209798
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DDX17 mRNA; Benzo(a)pyrene results in decreased expression of DDX17 protein	PMID:20064835|PMID:20106945|PMID:21632981|PMID:33278487
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to DDX17 protein]	PMID:32406909
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304945	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of DDX17 mRNA	PMID:30556269
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in decreased expression of DDX17 mRNA	PMID:18593933
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of DDX17 protein	PMID:34122009
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DDX17 mRNA	PMID:19150397|PMID:20018196
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of DDX17 mRNA	PMID:27760801
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550068	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DDX17 gene	PMID:35295148
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550068	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of DDX17 mRNA	PMID:29264374
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of DDX17 mRNA	PMID:18445702
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304945	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of DDX17 mRNA	PMID:32145629
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DDX17 mRNA	PMID:25181051
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in decreased expression of DDX17 mRNA	PMID:40036665
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304945	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DDX17 gene	PMID:28505145
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DDX17 mRNA	PMID:28628672
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DDX17 protein	PMID:31675489
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of DDX17 mRNA	PMID:19244175
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of DDX17 mRNA	PMID:19244175
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1550068	E	RGD:6480464	20180515	CTD	MESH:D008748	Methylcholanthrene results in increased expression of DDX17 mRNA	PMID:25926378
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C543008	bisphenol S results in decreased expression of DDX17 mRNA	PMID:25912373
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DDX17 mRNA	PMID:39298647
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of DDX17 mRNA	PMID:28628672
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of DDX17 gene	PMID:22964155
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20150127	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DDX17 mRNA	PMID:24893172
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550068	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DDX17 mRNA	PMID:21266533
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of DDX17 mRNA	PMID:34813904
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DDX17 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of DDX17 mRNA	PMID:28628672
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of DDX17 mRNA	PMID:17312168
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DDX17 mRNA	PMID:25596134
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DDX17 mRNA	PMID:28111341|PMID:37325564
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of DDX17 mRNA	PMID:25868421
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1304945	E	RGD:6480464	20130806	CTD	MESH:C039281	furan results in increased methylation of DDX17 gene	PMID:22079235
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DDX17 mRNA	PMID:19320972
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of DDX17 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of DDX17 mRNA	PMID:32699268
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DDX17 mRNA	PMID:19244175
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of DDX17 mRNA	PMID:19244175
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of DDX17 mRNA	PMID:25596134
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of DDX17 mRNA	PMID:23811191
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DDX17 mRNA	PMID:31533062
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DDX17 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DDX17 mRNA	PMID:36331819
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550068	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DDX17 mRNA	PMID:17292431
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of DDX17 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDX17 mRNA	PMID:27188386
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of DDX17 mRNA	PMID:30047161
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of DDX17 mRNA	PMID:25562108
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of DDX17 mRNA	PMID:21163907
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DDX17 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of DDX17 mRNA	PMID:28628672
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550068	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DDX17 mRNA	PMID:28973697
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of DDX17 mRNA	PMID:23649840
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of DDX17 mRNA	PMID:24136188
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019319	Okadaic Acid results in decreased expression of DDX17 protein	PMID:19397276
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of DDX17 mRNA	PMID:22083351|PMID:27188386
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of DDX17 mRNA	PMID:28542535
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of DDX17 mRNA	PMID:24935251|PMID:26272509
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDX17 mRNA	PMID:27188386
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550068	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DDX17 mRNA	PMID:17562736
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of DDX17 mRNA	PMID:21420995
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DDX17 mRNA	PMID:33387578
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:47217	arsane	decreases response to substance	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	DDX17 mRNA results in decreased susceptibility to Arsenic	PMID:17976673
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of DDX17 mRNA	PMID:31675489
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DDX17 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of DDX17 mRNA	PMID:28628672
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304945	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of DDX17 mRNA	PMID:30307764
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DDX17 mRNA; Nanotubes, Carbon results in decreased expression of DDX17 mRNA	PMID:25554681|PMID:25620056
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1304945	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of DDX17 mRNA	PMID:34044035
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of DDX17 mRNA	PMID:30047161
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DDX17 mRNA	PMID:35964746
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of DDX17 mRNA	PMID:24136188
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of DDX17 mRNA	PMID:26377693
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of DDX17 mRNA	PMID:26705709
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:53001	nickel sulfate	multiple interactions	ISO	RGD:1304945	E	RGD:6480464	20200519	CTD	MESH:C029938	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of DDX17 mRNA	PMID:31734292
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:5864	ifosfamide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of DDX17 mRNA	PMID:25596134
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DDX17 protein	PMID:32959892
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DDX17 mRNA	PMID:23650126
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DDX17 mRNA	PMID:24810058
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1304945	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of DDX17 mRNA	PMID:25596134
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1550068	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of DDX17 mRNA	PMID:26307267
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of DDX17 mRNA	PMID:30467583
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of DDX17 mRNA	PMID:31758290
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:72754	bisphenol AF	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in decreased expression of DDX17 mRNA	PMID:25912373
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DDX17 mRNA	PMID:22206623
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DDX17 mRNA	PMID:22206623
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DDX17 protein	PMID:37664457
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of DDX17 mRNA	PMID:24136188
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of DDX17 protein	PMID:31285264
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDX17 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDX17 mRNA	PMID:27188386
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DDX17 gene]	PMID:28238834
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in decreased expression of DDX17 mRNA	PMID:20185912
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of DDX17 mRNA	PMID:30047161
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DDX17 protein	PMID:31675489
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304945	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DDX17 mRNA	PMID:30047161
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of DDX17 mRNA	PMID:40826991
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DDX17 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDX17 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DDX17 mRNA	PMID:27188386|PMID:37664457
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of DDX17 mRNA	PMID:17440010
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1550068	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of DDX17 mRNA	PMID:32835833
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550068	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of DDX17 mRNA	PMID:28973697
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1550068	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of DDX17 mRNA	PMID:18930950
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304945	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of DDX17 mRNA	PMID:19015723
1312679	DDX17	DEAD-box helicase 17	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304945	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of DDX17 mRNA	PMID:23034163
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of EZH2 mRNA	PMID:33045310
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014212	Tretinoin results in decreased expression of EZH2 mRNA	PMID:22906706|PMID:33167477
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312684	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of EZH2 mRNA	PMID:17198874
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D010100	Oxygen deficiency promotes the reaction [EZH2 protein binds to DICER1 promoter]	PMID:25351418
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of EZH2 mRNA	PMID:39506029
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312684	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of EZH2 mRNA	PMID:30319688
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:D000431	Ethanol results in decreased expression of EZH2 mRNA	PMID:35149083
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of EZH2 mRNA	PMID:20044591|PMID:21179406
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:D006861	Acetylcysteine inhibits the reaction [Hydrogen Peroxide affects the localization of EZH2 protein]; Hydrogen Peroxide results in increased phosphorylation of and affects the localization of EZH2 protein	PMID:24582688
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of EZH2 protein	PMID:35688186
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EZH2 mRNA	PMID:35811015
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312684	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EZH2 mRNA	PMID:39241906
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EZH2 mRNA	PMID:35811015
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1595860	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of EZH2 mRNA	PMID:32145629
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16469	17beta-estradiol	increases acetylation	EXP		E	RGD:6480464	20150825	CTD	MESH:D004958	Estradiol results in increased acetylation of EZH2 promoter	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004958	Estradiol results in increased expression of EZH2 mRNA; Estradiol results in increased expression of EZH2 protein	PMID:25088689|PMID:32030086
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1595860	E	RGD:6480464	20150825	CTD	MESH:D004958	Estradiol results in increased expression of EZH2 mRNA; Estradiol results in increased expression of EZH2 protein	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16469	17beta-estradiol	increases methylation	EXP		E	RGD:6480464	20150825	CTD	MESH:D004958	Estradiol results in increased methylation of EZH2 promoter	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:D004958	Estradiol promotes the reaction [CREBBP protein binds to EZH2 promoter]; Estradiol promotes the reaction [EP300 protein binds to EZH2 promoter]; Estradiol promotes the reaction [ESR1 protein binds to EZH2 promoter]; Estradiol promotes the reaction [ESR2 protein binds to EZH2 promoter]; Estradiol promotes the reaction [KMT2C protein binds to EZH2 promoter]; Estradiol promotes the reaction [KMT2D protein binds to EZH2 promoter]; KMT2C mutant form inhibits the reaction [Estradiol results in increased expression of EZH2 mRNA]; KMT2D mutant form inhibits the reaction [Estradiol promotes the reaction [CREBBP protein binds to EZH2 promoter]]; KMT2D mutant form inhibits the reaction [Estradiol promotes the reaction [EP300 protein binds to EZH2 promoter]]; KMT2D mutant form inhibits the reaction [Estradiol results in increased acetylation of EZH2 promoter]; KMT2D mutant form inhibits the reaction [Estradiol results in increased expression of EZH2 mRNA]; KMT2D mutant form inhibits the reaction [Estradiol results in increased methylation of EZH2 promoter]	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1595860	E	RGD:6480464	20150825	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of EZH2 mRNA; [bisphenol A co-treated with Estradiol] results in increased expression of EZH2 protein; [Diethylstilbestrol co-treated with Estradiol] results in increased expression of EZH2 mRNA; [Diethylstilbestrol co-treated with Estradiol] results in increased expression of EZH2 protein	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EZH2 mRNA	PMID:25510870
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312684	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone results in increased expression of EZH2 mRNA	PMID:31084621
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1595860	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of EZH2 mRNA	PMID:33387578
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:167693	GSK343	decreases activity	EXP		E	RGD:6480464	20210406	CTD	MESH:C586265	GSK343 results in decreased activity of EZH2 protein	PMID:23759589|PMID:24900432
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16827	corticosterone	decreases expression	ISO	RGD:1595860	E	RGD:6480464	20120412	CTD	MESH:D003345	Corticosterone results in decreased expression of EZH2 mRNA	PMID:15755911
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20241001	CTD	MESH:D005557	Formaldehyde results in decreased expression of EZH2 mRNA; Formaldehyde results in decreased expression of EZH2 protein	PMID:33233951
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of EZH2 mRNA	PMID:23649840
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of EZH2 mRNA	PMID:18070364
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of EZH2 mRNA	PMID:21179406
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17270	glycerol 2-phosphate	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:C031463	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of EZH2 mRNA; [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of EZH2 protein; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA]; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA]; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of SATB2 mRNA]; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of TNFRSF11B mRNA]	PMID:26424790
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17303	morphine	affects expression	ISO	RGD:1312684	E	RGD:6480464	20220111	CTD	MESH:D009020	Morphine affects the expression of EZH2 mRNA	PMID:33891991
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17303	morphine	multiple interactions	ISO	RGD:1595860	E	RGD:6480464	20160315	CTD	MESH:D009020	Morphine promotes the reaction [EZH2 protein binds to BDNF promoter]	PMID:25643298
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of EZH2 mRNA	PMID:21592394
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of EZH2 mRNA	PMID:21592394
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17401	myo-inositol hexakisphosphate	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20141223	CTD	MESH:D010833	Phytic Acid inhibits the reaction [Urethane results in increased expression of EZH2 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of EZH2 protein]	PMID:25168426
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of EZH2 mRNA	PMID:27683099
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C031927	hydroquinone results in decreased expression of EZH2 protein	PMID:27979589
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312684	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of EZH2 mRNA	PMID:23892564
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of EZH2 mRNA	PMID:36232341
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1595860	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of EZH2 mRNA	PMID:26577399
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of EZH2 protein	PMID:37730182
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of EZH2 mRNA	PMID:21592394
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of EZH2 mRNA	PMID:21592394
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of EZH2 mRNA	PMID:28818685
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17967	urethane	increases expression	ISO	RGD:1312684	E	RGD:6480464	20141223	CTD	MESH:D014520	Urethane results in increased expression of EZH2 mRNA; Urethane results in increased expression of EZH2 protein	PMID:25168426
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:17967	urethane	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20141223	CTD	MESH:D014520	Phytic Acid inhibits the reaction [Urethane results in increased expression of EZH2 mRNA]; Phytic Acid inhibits the reaction [Urethane results in increased expression of EZH2 protein]	PMID:25168426
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of EZH2 intron	PMID:30157460
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH2 mRNA	PMID:39836092
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1595860	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EZH2 mRNA	PMID:39012411
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:23	(+)-Eudesmin	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C105875	eudesmin results in decreased expression of EZH2 mRNA; eudesmin results in decreased expression of EZH2 protein	PMID:31026422
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EZH2 mRNA	PMID:25510870
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EZH2 mRNA	PMID:25510870
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of EZH2 protein	PMID:20106945
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of EZH2 mRNA	PMID:23649840
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20221101	CTD	MESH:D015127	[sodium arsenite results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate]] which results in increased expression of EZH2 protein	PMID:35364107
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of EZH2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of EZH2 mRNA	PMID:34911549
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312684	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EZH2 mRNA	PMID:17484886|PMID:27339419|PMID:31919559
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27563	arsenic atom	affects localization	ISO	RGD:1312684	E	RGD:6480464	20121009	CTD	MESH:D001151	Arsenic affects the localization of EZH2 protein	PMID:22426358
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1312684	E	RGD:6480464	20140311	CTD	MESH:D001151	Arsenic results in increased expression of EZH2 protein	PMID:22426358|PMID:22843710
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH2 mRNA; Acetylcysteine inhibits the reaction [Arsenic analog results in increased phosphorylation of EZH2 protein]; Arsenic analog results in increased phosphorylation of and affects the localization of EZH2 protein	PMID:24582688|PMID:39836092
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20121009	CTD	MESH:D001151	[[Arsenic results in decreased expression of IGF1 mRNA] co-treated with [Arsenic affects the localization of and results in increased expression of EZH2 protein]] results in decreased expression of MYOG; [Arsenic inhibits the reaction [EZH2 protein binds to TNF promoter]] promotes the reaction [[CREBBP protein binds to TNF promoter] which results in increased expression of TNF protein]; [Arsenic inhibits the reaction [EZH2 protein binds to TNF promoter]] promotes the reaction [[JUN protein binds to TNF promoter] which results in increased expression of TNF protein]; [Arsenic promotes the reaction [EZH2 protein binds to MYOG promoter]] which results in decreased expression of MYOG mRNA; Arsenic inhibits the reaction [EZH2 protein binds to IGF2R promoter]; Arsenic inhibits the reaction [EZH2 protein binds to TNF promoter]; Arsenic promotes the reaction [EZH2 protein binds to MYOG promoter]	PMID:22426358|PMID:38299738|PMID:39098089
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:C010974	Glyphosate results in increased expression of EZH2 mRNA	PMID:40578477
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of EZH2 protein	PMID:25505154
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol results in increased expression of EZH2 mRNA; resveratrol results in increased expression of EZH2 protein	PMID:26934322
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27881	resveratrol	increases response to substance	EXP		E	RGD:6480464	20161025	CTD	MESH:C059514	EZH2 mRNA results in increased susceptibility to resveratrol	PMID:26934322
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of EZH2 mRNA; EZH2 mRNA promotes the reaction [resveratrol results in decreased expression of ACTA2 mRNA]; EZH2 mRNA promotes the reaction [resveratrol results in decreased expression of ZEB1 mRNA]	PMID:19167446|PMID:26934322
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20160822	CTD	MESH:C059514	MIR137 mRNA affects the reaction [resveratrol results in decreased expression of EZH2 protein]	PMID:25505154
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of EZH2 mRNA	PMID:28903495
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1595860	E	RGD:6480464	20180515	CTD	MESH:D007854	Lead results in decreased expression of EZH2 protein	PMID:29301062
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1595860	E	RGD:6480464	20180515	CTD	MESH:D007854	EZH2 protein inhibits the reaction [Lead results in increased expression of HDAC2 mRNA]; EZH2 protein inhibits the reaction [Lead results in increased expression of HDAC2 protein]	PMID:29301062
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of EZH2 mRNA	PMID:40618947
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of EZH2 mRNA	PMID:27594783
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28088	genistein	increases phosphorylation	ISO	RGD:1595860	E	RGD:6480464	20130122	CTD	MESH:D019833	Genistein results in increased phosphorylation of EZH2 protein	PMID:22504913
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EZH2 mRNA	PMID:22574217
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312684	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EZH2 mRNA	PMID:21570461
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1595860	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EZH2 mRNA	PMID:34747641
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EZH2 mRNA; [Tetrachlorodibenzodioxin results in decreased expression of MIR101A] which results in increased expression of EZH2 protein	PMID:17942748|PMID:21602190
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D012402	Rotenone results in decreased expression of EZH2 mRNA	PMID:33157086
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:C004925	methylmercuric chloride affects the reaction [[Doxycycline co-treated with Bucladesine co-treated with GDNF protein] affects the reaction [EZH2 protein binds to NR4A1 promoter]]	PMID:36565944
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EZH2 mRNA	PMID:33212167
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1595860	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of EZH2 mRNA	PMID:28959563
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1595860	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of EZH2 mRNA	PMID:30556269
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of EZH2 mRNA	PMID:29803840
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	EZH2 protein affects the susceptibility to Doxorubicin	PMID:16217747
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of EZH2 protein	PMID:35688186
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28812	(aminomethyl)phosphonic acid	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:C036423	1-aminomethylphosphonic acid results in increased expression of EZH2 mRNA	PMID:40578477
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of EZH2 mRNA	PMID:20044591
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] inhibits the reaction [EZH2 protein binds to CDKN2A promoter]]; Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of EZH2 protein]; Acetylcysteine inhibits the reaction [Arsenic analog results in increased phosphorylation of EZH2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide affects the localization of EZH2 protein]	PMID:24582688|PMID:31551408
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20200310	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of EZH2 protein]	PMID:31551408
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D001205	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of EZH2 mRNA; [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of EZH2 protein; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA]; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA]; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of SATB2 mRNA]; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of TNFRSF11B mRNA]	PMID:26424790
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:29323	methylazoxymethanol	increases expression	ISO	RGD:1312684	E	RGD:6480464	20120412	CTD	MESH:C030667	methylazoxymethanol results in increased expression of EZH2 mRNA	PMID:17107856
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of EZH2 mRNA	PMID:22623647
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of EZH2 mRNA	PMID:36989763
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EZH2 mRNA; sodium arsenite results in increased expression of EZH2 protein	PMID:38146662|PMID:38568856
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312684	E	RGD:6480464	20221101	CTD	MESH:C017947	sodium arsenite results in increased expression of EZH2 mRNA	PMID:35364107
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH2 mRNA	PMID:39836092
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20221101	CTD	MESH:C017947	[sodium arsenite results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate]] which results in increased expression of EZH2 protein; GSK-2816126 promotes the reaction [sodium arsenite results in increased expression of EZH2 mRNA]; sodium arsenite inhibits the reaction [EZH2 protein binds to CXCL2 5' UTR]; sodium arsenite inhibits the reaction [EZH2 protein binds to IL1A 5' UTR]; sodium arsenite inhibits the reaction [EZH2 protein binds to IL1B 5' UTR]; sodium arsenite inhibits the reaction [EZH2 protein binds to TNF 5' UTR]; sodium arsenite inhibits the reaction [EZH2 protein binds to TRP73 5' UTR]	PMID:35364107
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EZH2 intron	PMID:30157460
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EZH2 mRNA	PMID:21632981|PMID:22316170
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EZH2 mRNA	PMID:17942131
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EZH2 mRNA	PMID:32234424
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1595860	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of EZH2 mRNA	PMID:30556269
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of EZH2 mRNA	PMID:20382639
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of EZH2 mRNA; Arsenic Trioxide results in decreased expression of EZH2 protein	PMID:30612216|PMID:35467087
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	EZH2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:26592252
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of EZH2 protein	PMID:26592252
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [EZH2 protein binds to RELA protein]	PMID:30612216
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1595860	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of EZH2 mRNA	PMID:25729387
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1595860	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of EZH2 mRNA	PMID:25729387
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1312684	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of EZH2 gene	PMID:35295148
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1595860	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EZH2 mRNA	PMID:34492290
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of EZH2 mRNA	PMID:38479592
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20250603	CTD	MESH:C074702	[potassium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of EZH2 mRNA	PMID:40016168
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the expression of EZH2 mRNA	PMID:28765096
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1595860	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of EZH2 mRNA	PMID:32145629
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of EZH2 mRNA	PMID:29275510
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of EZH2 mRNA	PMID:30015891|PMID:36508816
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	increases acetylation	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased acetylation of EZH2 promoter	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of EZH2 mRNA; bisphenol A results in increased expression of EZH2 protein	PMID:21761357|PMID:25088689|PMID:32030086
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312684	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased expression of EZH2 protein	PMID:21761357
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1595860	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of EZH2 mRNA; bisphenol A results in increased expression of EZH2 protein	PMID:25088689|PMID:26898831|PMID:27697584|PMID:30816183
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased methylation of EZH2 promoter	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312684	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased methylation of EZH2 gene; bisphenol A results in increased methylation of EZH2 promoter	PMID:30841672|PMID:36508816
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A promotes the reaction [CREBBP protein binds to EZH2 promoter]; bisphenol A promotes the reaction [EP300 protein binds to EZH2 promoter]; bisphenol A promotes the reaction [ESR1 protein binds to EZH2 promoter]; bisphenol A promotes the reaction [ESR2 protein binds to EZH2 promoter]; bisphenol A promotes the reaction [KMT2C protein binds to EZH2 promoter]; bisphenol A promotes the reaction [KMT2D protein binds to EZH2 promoter]; KMT2C mutant form inhibits the reaction [bisphenol A results in increased expression of EZH2 mRNA]; KMT2D mutant form inhibits the reaction [bisphenol A promotes the reaction [CREBBP protein binds to EZH2 promoter]]; KMT2D mutant form inhibits the reaction [bisphenol A promotes the reaction [EP300 protein binds to EZH2 promoter]]; KMT2D mutant form inhibits the reaction [bisphenol A results in increased acetylation of EZH2 promoter]; KMT2D mutant form inhibits the reaction [bisphenol A results in increased expression of EZH2 mRNA]; KMT2D mutant form inhibits the reaction [bisphenol A results in increased methylation of EZH2 promoter]	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1595860	E	RGD:6480464	20150825	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of EZH2 mRNA; [bisphenol A co-treated with Estradiol] results in increased expression of EZH2 protein	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312684	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of EZH2 mRNA	PMID:26682919
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EZH2 mRNA	PMID:25510870
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of EZH2 mRNA	PMID:25510870
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:3423	carmustine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of EZH2 mRNA	PMID:15980968
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EZH2 mRNA; bisphenol S results in increased expression of EZH2 protein	PMID:39032682
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of EZH2 intron	PMID:30157460
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1595860	E	RGD:6480464	20210406	CTD	MESH:D000487	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EZH2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of EZH2 mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of EZH2 mRNA	PMID:28392331
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EZH2 mRNA	PMID:21266533
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1595860	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EZH2 mRNA	PMID:21266533
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:34785	heptachlor	increases expression	ISO	RGD:1595860	E	RGD:6480464	20141014	CTD	MESH:D006533	Heptachlor results in increased expression of EZH2 mRNA	PMID:23153324
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312684	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of EZH2 mRNA	PMID:17854601
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of EZH2 mRNA]	PMID:17854601
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EZH2 mRNA	PMID:37042841
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH2 mRNA	PMID:39836092
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EZH2 mRNA	PMID:26472689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1595860	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EZH2 mRNA	PMID:39012411
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EZH2 mRNA	PMID:19320972
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:C018021	EZH2 mRNA promotes the reaction [cobaltous chloride deficiency results in decreased expression of DICER1 mRNA]	PMID:25351418
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20221101	CTD	MESH:D013755	[sodium arsenite results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate]] which results in increased expression of EZH2 protein	PMID:35364107
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:3763	clorgyline	decreases expression	EXP		E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in decreased expression of EZH2 mRNA	PMID:19691856
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of EZH2 mRNA	PMID:31533062
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of EZH2 mRNA	PMID:19167446
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EZH2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of EZH2 mRNA	PMID:19167446
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1595860	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of EZH2 mRNA	PMID:34896426
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:39098	pyrethrins	increases expression	ISO	RGD:1595860	E	RGD:6480464	20230704	CTD	MESH:D011722	Pyrethrins results in increased expression of EZH2 mRNA	PMID:36053783
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of EZH2 mRNA	PMID:39529242
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:39175	thiacloprid	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20260804	CTD	MESH:C417209	thiacloprid results in decreased expression of EZH2 mRNA	PMID:38844538
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:39178	clothianidin	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in decreased expression of EZH2 mRNA	PMID:31626844
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312684	E	RGD:6480464	20150414	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of EZH2 mRNA; perfluorooctane sulfonic acid results in increased expression of EZH2 protein	PMID:25510869
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1312684	E	RGD:6480464	20141223	CTD	MESH:C031763	1,3-butadiene results in increased expression of EZH2 mRNA	PMID:25237060
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1595860	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of EZH2 mRNA	PMID:22110744
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EZH2 mRNA	PMID:25979313
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312684	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of EZH2 mRNA	PMID:17963808
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of EZH2 mRNA	PMID:29154799
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1595860	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of EZH2 mRNA	PMID:41580965
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of EZH2 mRNA	PMID:17942131
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of EZH2 mRNA	PMID:20106945
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1595860	E	RGD:6480464	20210406	CTD	MESH:C037304	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EZH2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of EZH2 mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1595860	E	RGD:6480464	20210406	CTD	MESH:C017160	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EZH2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of EZH2 mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[EZH2 protein results in decreased expression of ESR1 protein] which results in decreased susceptibility to Tamoxifen	PMID:20306127
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D003907	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of EZH2 mRNA; [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of EZH2 protein; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA]; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of RUNX2 mRNA]; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of SATB2 mRNA]; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of TNFRSF11B mRNA]	PMID:26424790
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1595860	E	RGD:6480464	20230606	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of EZH2 mRNA	PMID:37077353
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:41922	diethylstilbestrol	increases acetylation	EXP		E	RGD:6480464	20150825	CTD	MESH:D004054	Diethylstilbestrol results in increased acetylation of EZH2 promoter	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of EZH2 mRNA; Diethylstilbestrol results in increased expression of EZH2 protein	PMID:21761357|PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1312684	E	RGD:6480464	20130122	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of EZH2 mRNA; Diethylstilbestrol results in increased expression of EZH2 protein	PMID:21761357
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1595860	E	RGD:6480464	20150825	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of EZH2 mRNA; Diethylstilbestrol results in increased expression of EZH2 protein	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:41922	diethylstilbestrol	increases methylation	EXP		E	RGD:6480464	20150825	CTD	MESH:D004054	Diethylstilbestrol results in increased methylation of EZH2 promoter	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:41922	diethylstilbestrol	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:D004054	Diethylstilbestrol promotes the reaction [CREBBP protein binds to EZH2 promoter]; Diethylstilbestrol promotes the reaction [EP300 protein binds to EZH2 promoter]; Diethylstilbestrol promotes the reaction [ESR1 protein binds to EZH2 promoter]; Diethylstilbestrol promotes the reaction [ESR2 protein binds to EZH2 promoter]; Diethylstilbestrol promotes the reaction [KMT2C protein binds to EZH2 promoter]; Diethylstilbestrol promotes the reaction [KMT2D protein binds to EZH2 promoter]; KMT2C mutant form inhibits the reaction [Diethylstilbestrol results in increased expression of EZH2 mRNA]; KMT2D mutant form inhibits the reaction [Diethylstilbestrol promotes the reaction [CREBBP protein binds to EZH2 promoter]]; KMT2D mutant form inhibits the reaction [Diethylstilbestrol promotes the reaction [EP300 protein binds to EZH2 promoter]]; KMT2D mutant form inhibits the reaction [Diethylstilbestrol results in increased acetylation of EZH2 promoter]; KMT2D mutant form inhibits the reaction [Diethylstilbestrol results in increased expression of EZH2 mRNA]; KMT2D mutant form inhibits the reaction [Diethylstilbestrol results in increased methylation of EZH2 promoter]	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:41922	diethylstilbestrol	multiple interactions	ISO	RGD:1595860	E	RGD:6480464	20150825	CTD	MESH:D004054	[Diethylstilbestrol co-treated with Estradiol] results in increased expression of EZH2 mRNA; [Diethylstilbestrol co-treated with Estradiol] results in increased expression of EZH2 protein	PMID:25088689
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of EZH2 protein	PMID:21114963
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of EZH2 mRNA	PMID:38832940
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of EZH2 protein	PMID:21114963
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D000082	Acetaminophen affects the expression of EZH2 mRNA	PMID:25458485
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in decreased expression of EZH2 mRNA	PMID:17942131
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of EZH2 mRNA	PMID:21420995|PMID:22230336|PMID:29067470
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1595860	E	RGD:6480464	20180703	CTD	MESH:D000082	Acetaminophen results in increased expression of EZH2 mRNA	PMID:29665328
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EZH2 mRNA	PMID:35811015
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:47217	arsane	affects localization	ISO	RGD:1312684	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the localization of EZH2 protein	PMID:22426358
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1312684	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased expression of EZH2 protein	PMID:22426358|PMID:22843710
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20160607	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH2 mRNA; Acetylcysteine inhibits the reaction [Arsenic analog results in increased phosphorylation of EZH2 protein]; Arsenic analog results in increased phosphorylation of and affects the localization of EZH2 protein	PMID:24582688|PMID:39836092
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20140805	CTD	MESH:D001151	[[Arsenic results in decreased expression of IGF1 mRNA] co-treated with [Arsenic affects the localization of and results in increased expression of EZH2 protein]] results in decreased expression of MYOG; [Arsenic inhibits the reaction [EZH2 protein binds to TNF promoter]] promotes the reaction [[CREBBP protein binds to TNF promoter] which results in increased expression of TNF protein]; [Arsenic inhibits the reaction [EZH2 protein binds to TNF promoter]] promotes the reaction [[JUN protein binds to TNF promoter] which results in increased expression of TNF protein]; [Arsenic promotes the reaction [EZH2 protein binds to MYOG promoter]] which results in decreased expression of MYOG mRNA; Arsenic inhibits the reaction [EZH2 protein binds to IGF2R promoter]; Arsenic inhibits the reaction [EZH2 protein binds to TNF promoter]; Arsenic promotes the reaction [EZH2 protein binds to MYOG promoter]	PMID:22426358|PMID:38299738|PMID:39098089
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1595860	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in decreased expression of EZH2 mRNA	PMID:37077353
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1595860	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of EZH2 mRNA	PMID:29391264
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004726	Endosulfan results in increased expression of EZH2 mRNA	PMID:29054638
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:4791	endosulfan	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004726	Endosulfan results in increased expression of and results in increased activity of EZH2 protein	PMID:29054638
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EZH2 mRNA	PMID:17942748
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of EZH2 mRNA; Arsenic Trioxide results in decreased expression of EZH2 protein	PMID:30612216|PMID:35467087
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	EZH2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:26592252
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of EZH2 protein	PMID:26592252
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [EZH2 protein binds to RELA protein]	PMID:30612216
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D003994	[Doxycycline co-treated with Bucladesine co-treated with GDNF protein] affects the reaction [EZH2 protein binds to NR4A1 promoter]; methylmercuric chloride affects the reaction [[Doxycycline co-treated with Bucladesine co-treated with GDNF protein] affects the reaction [EZH2 protein binds to NR4A1 promoter]]	PMID:36565944
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1595860	E	RGD:6480464	20210406	CTD	MESH:C017690	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EZH2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of EZH2 mRNA	PMID:33051911|PMID:33396045|PMID:34896426|PMID:36053783
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312684	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of EZH2 mRNA; Nanotubes, Carbon results in increased expression of EZH2 mRNA	PMID:25554681
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:50845	doxycycline	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D004318	[Doxycycline co-treated with Bucladesine co-treated with GDNF protein] affects the reaction [EZH2 protein binds to NR4A1 promoter]; methylmercuric chloride affects the reaction [[Doxycycline co-treated with Bucladesine co-treated with GDNF protein] affects the reaction [EZH2 protein binds to NR4A1 promoter]]	PMID:36565944
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:50924	sorafenib	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C471405	EZH2 protein affects the reaction [MIR600 affects the susceptibility to Sorafenib]	PMID:38229326
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of EZH2 mRNA	PMID:21148553
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312684	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of EZH2 mRNA	PMID:19042947
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D011192	Potassium Dichromate results in increased expression of EZH2 protein	PMID:29391238
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:53444	potassium dichromate	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D011192	EZH2 protein promotes the reaction [Potassium Dichromate results in increased expression of H2AX protein modified form]	PMID:29391238
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:5855	ibuprofen	increases expression	ISO	RGD:1595860	E	RGD:6480464	20180703	CTD	MESH:D007052	Ibuprofen results in increased expression of EZH2 mRNA	PMID:29665328
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1595860	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of EZH2 mRNA	PMID:20080153
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:61710	4-\{[4-(dimethylamino)phenyl]diazenyl\}phenyl-beta-lactoside	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20230704	CTD	MESH:C009765	lac dye inhibits the reaction [Dietary Fats results in decreased expression of EZH2 mRNA]	PMID:36828244
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH2 mRNA	PMID:39836092
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	EZH2 protein affects the susceptibility to Topotecan	PMID:16217747
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1595860	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of EZH2 mRNA	PMID:25729387
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1595860	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of EZH2 mRNA	PMID:25729387
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:63637	vemurafenib	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:C551177	[(+)-JQ1 compound co-treated with vemurafenib] results in decreased expression of EZH2 mRNA	PMID:27169980
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of EZH2 mRNA	PMID:15336504
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of EZH2 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of EZH2 protein	PMID:21903722
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:64211	8-Br-cAMP	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D015124	[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in decreased expression of EZH2 mRNA; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in decreased expression of EZH2 protein; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA]; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA]	PMID:21903722
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:65408	andrographolide	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C030419	andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EZH2 protein]; IL6 protein promotes the reaction [andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EZH2 protein]]	PMID:31128153
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:65408	andrographolide	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20190910	CTD	MESH:C030419	andrographolide inhibits the reaction [Tobacco Smoke Pollution results in increased expression of EZH2 protein]	PMID:31128153
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:6716	medroxyprogesterone acetate	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in decreased expression of EZH2 mRNA; Medroxyprogesterone Acetate results in decreased expression of EZH2 protein	PMID:21903722
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D017258	[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in decreased expression of EZH2 mRNA; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in decreased expression of EZH2 protein; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA]; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA]	PMID:21903722
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of EZH2 intron	PMID:30157460
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:68534	enzalutamide	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C540278	enzalutamide results in decreased expression of EZH2 protein	PMID:32805266
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:68534	enzalutamide	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:C540278	[enzalutamide co-treated with GSK-2816126] inhibits the reaction [AR protein binds to [EZH2 protein binds to SUZ12 protein binds to EED protein]]	PMID:32805266
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:75249	potassium chromate	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20250603	CTD	MESH:C027373	[potassium chromate(VI) results in increased abundance of chromium hexavalent ion] which results in decreased expression of EZH2 mRNA	PMID:40016168
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of EZH2 mRNA	PMID:29522793
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of EZH2 mRNA	PMID:37199045
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EZH2 gene]	PMID:28238834
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of EZH2 mRNA	PMID:17942131
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EZH2 mRNA	PMID:19167446
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312684	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of EZH2 mRNA	PMID:38648751
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of EZH2 mRNA	PMID:21858171
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1595860	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of EZH2 mRNA	PMID:24780913
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:85993	palbociclib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of EZH2 mRNA; palbociclib results in decreased expression of EZH2 protein	PMID:20948315|PMID:22869556|PMID:24736461
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:86989	stattic	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C517409	stattic inhibits the reaction [Arsenicals results in increased phosphorylation of EZH2 protein]	PMID:23255093
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [Arsenicals results in increased phosphorylation of EZH2 protein]	PMID:23255093
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1595860	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of EZH2 mRNA	PMID:19281266
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312684	E	RGD:6480464	20191008	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of EZH2 mRNA; [Streptozocin co-treated with Dietary Fats] results in increased expression of EZH2 protein	PMID:29127188
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of EZH2 mRNA	PMID:38568856
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:9747	Triptolide	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C001899	triptolide results in decreased expression of EZH2 protein	PMID:19879315
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of EZH2 mRNA	PMID:19140230
1312683	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312684	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of EZH2 mRNA	PMID:35537566
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CARD10 mRNA	PMID:27188386
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CARD10 gene	PMID:20938992
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of CARD10 mRNA	PMID:21934132
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CARD10 mRNA	PMID:22378314
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CARD10 mRNA	PMID:20044591
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CARD10 mRNA	PMID:35811015
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CARD10 mRNA; CARD10 protein affects the reaction [Lipopolysaccharides results in increased localization of RELA protein]	PMID:24863965|PMID:35811015
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D004958	Estradiol results in decreased expression of CARD10 mRNA	PMID:19426747|PMID:23373633
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CARD10 mRNA	PMID:39298647
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of CARD10 mRNA	PMID:23019147|PMID:31614463
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol inhibits the reaction [Etoposide results in increased expression of CARD10 mRNA]	PMID:19426747
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:16598	DDE	affects expression	ISO	RGD:1304949	E	RGD:6480464	20140909	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene affects the expression of CARD10 mRNA	PMID:24576310
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304949	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CARD10 mRNA	PMID:33387578
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CARD10 gene	PMID:20938992
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CARD10 mRNA	PMID:37992649
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CARD10 mRNA	PMID:37992649
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CARD10 protein	PMID:37730182
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of CARD10 mRNA	PMID:26485663
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304949	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CARD10 mRNA	PMID:33387578
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20150310	CTD	MESH:D015632	[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased expression of CARD10 mRNA	PMID:25406165
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CARD10 mRNA	PMID:39836092
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:188106	Myrtucommulone A	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20220104	CTD	MESH:C455139	myrtucommulone A results in decreased expression of CARD10 mRNA	PMID:26032814
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CARD10 mRNA	PMID:35301059
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CARD10 mRNA	PMID:37325564
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312686	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CARD10 mRNA	PMID:19770486
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CARD10 intron	PMID:30157460
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of CARD10 mRNA	PMID:26760959
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CARD10 mRNA	PMID:34911549
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CARD10 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CARD10 mRNA]	PMID:20938992|PMID:22206623
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:27563	arsenic atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased expression of CARD10 mRNA	PMID:19945496
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CARD10 mRNA	PMID:39836092
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CARD10 mRNA	PMID:40504410
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312686	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of CARD10 mRNA	PMID:35897073
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312686	E	RGD:6480464	20160210	CTD	MESH:D002945	Cisplatin results in increased expression of CARD10 mRNA	PMID:26546572
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CARD10 mRNA	PMID:27392435
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20160210	CTD	MESH:D002945	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Cisplatin results in increased expression of CARD10 mRNA]	PMID:26546572
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of CARD10 mRNA	PMID:23019147|PMID:26865667
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304949	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CARD10 mRNA	PMID:22298810
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312686	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CARD10 mRNA	PMID:21570461
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CARD10 mRNA	PMID:19933214
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CARD10 mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CARD10 mRNA	PMID:17942748
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CARD10 mRNA	PMID:33212167
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of CARD10 mRNA	PMID:30911355
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CARD10 mRNA	PMID:37992649
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CARD10 mRNA	PMID:29432896
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CARD10 mRNA	PMID:34032870
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CARD10 mRNA	PMID:39719251
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CARD10 mRNA	PMID:39836092
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CARD10 mRNA	PMID:40504410
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CARD10 promoter	PMID:27901495
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CARD10 mRNA	PMID:20064835
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of CARD10 mRNA	PMID:30911355
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CARD10 mRNA	PMID:34766707
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CARD10 mRNA	PMID:19150397
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312686	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of CARD10 mRNA	PMID:17656681
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CARD10 mRNA	PMID:23557971
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312686	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CARD10 gene	PMID:35295148
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1304949	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of CARD10 mRNA	PMID:19167457
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304949	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CARD10 mRNA	PMID:25181051
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of CARD10 mRNA	PMID:23019147|PMID:27685785
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312686	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CARD10 mRNA	PMID:32156529
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304949	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CARD10 gene	PMID:28505145
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CARD10 mRNA	PMID:25172293
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	ISO	RGD:1304949	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of CARD10 mRNA	PMID:22937105
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CARD10 mRNA	PMID:39298647
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CARD10 mRNA	PMID:38685157
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312686	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CARD10 mRNA	PMID:37019170
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CARD10 mRNA	PMID:28628672
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CARD10 mRNA	PMID:18691550
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D004052	IKBKB protein inhibits the reaction [Diethylnitrosamine results in increased expression of CARD10 mRNA]; MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CARD10 mRNA]	PMID:18691550
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1304949	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CARD10 mRNA	PMID:22546817
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CARD10 mRNA	PMID:39836092
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CARD10 mRNA	PMID:35301059
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CARD10 mRNA	PMID:37325564
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304949	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased expression of CARD10 mRNA	PMID:22079235
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CARD10 mRNA	PMID:24449571
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CARD10 mRNA	PMID:40419075
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CARD10 mRNA	PMID:25979313
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of CARD10 mRNA	PMID:19101580|PMID:23179753|PMID:28001369
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CARD10 mRNA	PMID:20106945
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CARD10 mRNA	PMID:17555576
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CARD10 mRNA	PMID:28628672
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CARD10 mRNA	PMID:37992649
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CARD10 mRNA	PMID:17562736
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CARD10 mRNA	PMID:21420995
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304949	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CARD10 mRNA	PMID:33387578
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304949	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of CARD10 mRNA	PMID:32479839
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of CARD10 mRNA	PMID:24714768
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CARD10 mRNA	PMID:29432896
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CARD10 mRNA	PMID:35811015
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:47217	arsane	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased expression of CARD10 mRNA	PMID:19945496
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CARD10 mRNA	PMID:39836092
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CARD10 mRNA	PMID:40504410
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1304949	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of CARD10 mRNA	PMID:29391264
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CARD10 mRNA	PMID:17555576
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CARD10 mRNA	PMID:17942748
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CARD10 mRNA	PMID:17942748
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of CARD10 mRNA	PMID:19426747
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:4911	etoposide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Estradiol inhibits the reaction [Etoposide results in increased expression of CARD10 mRNA]	PMID:19426747
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CARD10 mRNA	PMID:28628672
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CARD10 mRNA	PMID:25554681|PMID:25620056
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:51081	nitrates	decreases expression	ISO	RGD:1304949	E	RGD:6480464	20200915	CTD	MESH:D009566	Nitrates results in decreased expression of CARD10 mRNA	PMID:30022042
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of CARD10 mRNA	PMID:18651567
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of CARD10 mRNA	PMID:19042947
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of CARD10 mRNA	PMID:27188386
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CARD10 mRNA	PMID:39836092
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:63933	Aroclor 1254	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CARD10 mRNA	PMID:16934159
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1304949	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CARD10 mRNA	PMID:37269647
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20190910	CTD	MESH:C581157	XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CARD10 mRNA]	PMID:29891994
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312686	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CARD10 mRNA	PMID:22206623
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CARD10 mRNA]	PMID:22206623
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:755208	eprenetapopt	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt results in increased expression of CARD10 mRNA	PMID:19946333
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt results in increased expression of CARD10 mRNA]	PMID:19946333
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CARD10 gene]	PMID:28238834
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of CARD10 mRNA	PMID:19482888
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CARD10 mRNA]	PMID:19482888
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:82288	o-anisidine	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C003898	2-anisidine results in decreased expression of CARD10 mRNA	PMID:28089782
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:8426	probenecid	multiple interactions	ISO	RGD:1312686	E	RGD:6480464	20150310	CTD	MESH:D011339	[1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine co-treated with Probenecid] results in increased expression of CARD10 mRNA	PMID:25406165
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312686	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CARD10 mRNA	PMID:21278054
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of CARD10 mRNA	PMID:14699072
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:8922	Rutecarpine	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C028632	rutecarpine results in increased expression of CARD10 mRNA	PMID:34955744
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304949	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CARD10 mRNA	PMID:21346803
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of CARD10 mRNA	PMID:27188386
1312685	CARD10	caspase recruitment domain family member 10	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1304949	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of CARD10 gene	PMID:31079544
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in increased expression of IL21R mRNA; [bisphenol F co-treated with Tretinoin] results in increased expression of IL21R mRNA; [bisphenol S co-treated with Tretinoin] results in increased expression of IL21R mRNA	PMID:30951980
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of IL21R mRNA	PMID:26079696
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of IL21R mRNA]	PMID:19442820
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304950	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL21R mRNA	PMID:32741896
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304950	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of IL21R mRNA	PMID:33387578
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of IL21R mRNA	PMID:37042841
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of IL21R mRNA	PMID:19162166
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of IL21R mRNA	PMID:23649840
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of IL21R mRNA	PMID:26079696
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL21R mRNA	PMID:37992649
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304950	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL21R mRNA	PMID:32741896
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of IL21R mRNA]	PMID:19442820
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL21R mRNA	PMID:37992649
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312688	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IL21R mRNA	PMID:35550907
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304950	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of IL21R mRNA	PMID:27523638
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL21R mRNA	PMID:37325564
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of IL21R mRNA	PMID:23649840
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of IL21R intron	PMID:30157460
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IL21R mRNA	PMID:32234424
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304950	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of IL21R mRNA	PMID:30779732
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304950	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IL21R mRNA	PMID:31150632
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304950	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of IL21R mRNA	PMID:31881176
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312688	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of IL21R mRNA	PMID:32186404
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IL21R mRNA	PMID:25583101
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304950	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IL21R mRNA	PMID:33387578
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304950	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of IL21R mRNA	PMID:26033743
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL21R mRNA	PMID:37992649
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of IL21R mRNA	PMID:29301061|PMID:38568856
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL21R mRNA	PMID:34876320
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL21R mRNA	PMID:34876320
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IL21R 3' UTR; Benzo(a)pyrene affects the methylation of IL21R promoter	PMID:27901495
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IL21R mRNA	PMID:32234424
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312688	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IL21R mRNA	PMID:32417428
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304950	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of IL21R mRNA	PMID:26033743
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of IL21R mRNA	PMID:25895662
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312688	E	RGD:6480464	20250401	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IL21R mRNA	PMID:38811393
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of IL21R gene	PMID:31601247
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304950	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of IL21R mRNA	PMID:34492290
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1304950	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of IL21R mRNA	PMID:19167457
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304950	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IL21R mRNA	PMID:25181051
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20250204	CTD	MESH:C006780	bisphenol A results in decreased methylation of IL21R gene	PMID:38338858
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312688	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of IL21R mRNA	PMID:38701888
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of IL21R gene	PMID:31601247
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in increased expression of IL21R mRNA	PMID:30951980
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20250204	CTD	MESH:C543008	bisphenol S results in decreased methylation of IL21R gene	PMID:38338858
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C543008	bisphenol S results in increased expression of IL21R mRNA	PMID:33476716
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in increased expression of IL21R mRNA	PMID:30951980
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:34575	bisphenol F	decreases methylation	EXP		E	RGD:6480464	20250204	CTD	MESH:C008745	bisphenol F results in decreased methylation of IL21R gene	PMID:38338858
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in increased expression of IL21R mRNA	PMID:30951980
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312688	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of IL21R mRNA	PMID:37019170
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IL21R mRNA	PMID:37042841
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1304950	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of IL21R mRNA	PMID:35163327
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL21R mRNA	PMID:37325564
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of IL21R mRNA	PMID:36326898
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IL21R mRNA	PMID:24449571
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312688	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of IL21R mRNA	PMID:29038090
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of IL21R gene	PMID:29154799
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of IL21R promoter	PMID:27989131
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of IL21R mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of IL21R mRNA	PMID:25047013
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL21R mRNA	PMID:37992649
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of IL21R mRNA	PMID:24449571
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IL21R mRNA	PMID:38832940
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304950	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of IL21R mRNA	PMID:29391264
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL21R mRNA	PMID:34876320
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312688	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of IL21R mRNA	PMID:23845593
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312688	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IL21R mRNA; Nanotubes, Carbon results in increased expression of IL21R mRNA	PMID:25554681
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of IL21R mRNA	PMID:35964746
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312688	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IL21R mRNA	PMID:38701926
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312688	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of IL21R mRNA	PMID:36851058
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1304950	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL21R mRNA	PMID:32741896
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of IL21R mRNA	PMID:32234424
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312688	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL21R mRNA	PMID:34876320
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:9516	thapsigargin	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019284	4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in decreased expression of IL21R mRNA]; caffeic acid promotes the reaction [Thapsigargin results in decreased expression of IL21R mRNA]; Drugs, Chinese Herbal promotes the reaction [Thapsigargin results in decreased expression of IL21R mRNA]	PMID:19442820
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312688	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of IL21R mRNA	PMID:35537566
1312687	IL21R	interleukin 21 receptor	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1304950	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of IL21R gene	PMID:31682807
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of POLD2 mRNA	PMID:33045310
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of POLD2 mRNA	PMID:33167477
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of POLD2 mRNA	PMID:26516004
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16170	mercury(0)	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury affects the expression of POLD2 mRNA	PMID:16823088
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16235	guanine	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:D006147	Guanine metabolite results in decreased activity of [POLD1 protein binds to POLD2 protein binds to POLD3 protein binds to POLD4 protein]; Guanine metabolite results in decreased activity of [POLD1 protein binds to POLD2 protein binds to POLD4 protein]	PMID:26010525
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of POLD2 mRNA; chromium histidinate inhibits the reaction [Hydrogen Peroxide results in increased expression of POLD2 mRNA]	PMID:19902159|PMID:21751221
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of POLD2 mRNA	PMID:15309432
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312694	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POLD2 mRNA	PMID:39241906
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of POLD2 mRNA]	PMID:39241906
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of POLD2 mRNA	PMID:19167446
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of POLD2 mRNA	PMID:38568856
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304954	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of POLD2 mRNA	PMID:33387578
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of POLD2 mRNA	PMID:37042841
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of POLD2 mRNA	PMID:38160208
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:17521	(-)-quinic acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:D011801	[Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of POLD2 mRNA	PMID:21751221
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of POLD2 mRNA	PMID:19850644
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of POLD2 mRNA]	PMID:19850644
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304954	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of POLD2 mRNA	PMID:26577399
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of POLD2 mRNA	PMID:36331819
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of POLD2 mRNA	PMID:19770486
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304954	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of POLD2 mRNA	PMID:23630614
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:25195	mercury atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury affects the expression of POLD2 mRNA	PMID:16823088
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304954	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of POLD2 mRNA	PMID:31881176
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of POLD2 mRNA	PMID:19167446
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312694	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLD2 mRNA	PMID:21570461
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304954	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POLD2 mRNA	PMID:21215274
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304954	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POLD2 mRNA	PMID:33387578
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POLD2 mRNA	PMID:17942748
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1304954	E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of POLD2 mRNA]	PMID:21215274
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLD2 mRNA	PMID:17942748
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of POLD2 protein	PMID:39603559
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of POLD2 protein	PMID:33212167
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of POLD2 mRNA	PMID:32763439
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:28794	coumarin	increases expression	ISO	RGD:1304954	E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of POLD2 mRNA	PMID:18480146
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of POLD2 mRNA	PMID:38568856
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1304954	E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of POLD2 mRNA	PMID:35314868
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of POLD2 mRNA	PMID:39719251
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of POLD2 promoter	PMID:27901495
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1304954	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of POLD2 mRNA	PMID:25729387
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312694	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of POLD2 promoter	PMID:35295148
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304954	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of POLD2 mRNA	PMID:23411599|PMID:34492290
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of POLD2 mRNA	PMID:18648102
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of POLD2 mRNA	PMID:18445702
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of POLD2 mRNA	PMID:17950772|PMID:18301758
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of POLD2 mRNA]	PMID:17950772
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304954	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of POLD2 mRNA	PMID:25181051|PMID:32145629
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of POLD2 mRNA	PMID:29275510
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304954	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of POLD2 mRNA	PMID:34947998
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of POLD2 mRNA	PMID:40203079
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of POLD2 exon	PMID:30157460
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1312694	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of POLD2 mRNA	PMID:36464114
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of POLD2 mRNA	PMID:17361019|PMID:21266533
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312694	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of POLD2 mRNA	PMID:34813904
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312694	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of POLD2 mRNA	PMID:34813904
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of POLD2 mRNA]	PMID:39241906
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in decreased expression of POLD2 mRNA]	PMID:19030233
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1304954	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of POLD2 mRNA	PMID:35163327
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304954	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of POLD2 mRNA	PMID:25539665
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1304954	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of POLD2 gene	PMID:22079235
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of POLD2 mRNA	PMID:19320972|PMID:19376846
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of POLD2 mRNA	PMID:19167446
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of POLD2 mRNA	PMID:19167446
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of POLD2 mRNA	PMID:39529242
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of POLD2 mRNA	PMID:36331819
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1304954	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of POLD2 mRNA	PMID:22110744|PMID:25993096
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of POLD2 mRNA	PMID:17555576
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of POLD2 mRNA	PMID:17562736
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304954	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of POLD2 mRNA	PMID:33387578
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of POLD2 mRNA	PMID:17555576
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of POLD2 mRNA	PMID:17942748
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLD2 mRNA	PMID:17942748
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312694	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of POLD2 mRNA; Nanotubes, Carbon results in increased expression of POLD2 mRNA	PMID:25554681
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:50692	mifepristone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in decreased expression of POLD2 mRNA	PMID:17584828
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of POLD2 mRNA	PMID:35964746
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312694	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of POLD2 mRNA	PMID:19042947
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of POLD2 protein	PMID:32959892
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1304954	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of POLD2 mRNA	PMID:25729387
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of POLD2 exon	PMID:30157460
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1312694	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of POLD2 mRNA	PMID:27462272
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1312694	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of POLD2 mRNA	PMID:36464114
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312694	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of POLD2 mRNA	PMID:22206623
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of POLD2 protein	PMID:37664457
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of POLD2 protein	PMID:31285264
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of POLD2 mRNA	PMID:19167446
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312694	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of POLD2 mRNA	PMID:30294300
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of POLD2 protein	PMID:38348393
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312694	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of POLD2 mRNA]	PMID:39241906
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of POLD2 protein	PMID:37664457
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:9168	sirolimus	decreases expression	ISO	RGD:1312694	E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in decreased expression of POLD2 mRNA	PMID:11355896
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304954	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of POLD2 mRNA	PMID:21346803
1312693	POLD2	DNA polymerase delta 2, accessory subunit	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of POLD2 mRNA	PMID:38568856
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:15368	acrolein	decreases expression	ISO	RGD:2319961	E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein results in decreased expression of ARMC3 mRNA	PMID:38090360
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312696	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARMC3 mRNA	PMID:39241906
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ARMC3 mRNA	PMID:31614463
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:2319961	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ARMC3 mRNA	PMID:33387578
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ARMC3 mRNA	PMID:26079696
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312696	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ARMC3 mRNA	PMID:34319233
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of ARMC3 intron	PMID:30157460
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARMC3 mRNA	PMID:35301059
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ARMC3 gene	PMID:27153756
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312696	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ARMC3 mRNA	PMID:34911549
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:2319961	E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of ARMC3 mRNA	PMID:38314887
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:2319961	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ARMC3 mRNA	PMID:31881176
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARMC3 mRNA	PMID:33212167
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312696	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARMC3 mRNA	PMID:36209798
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARMC3 mRNA	PMID:22316170
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312696	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARMC3 mRNA	PMID:27195522
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ARMC3 3' UTR; Benzo(a)pyrene results in increased methylation of ARMC3 5' UTR; Benzo(a)pyrene results in increased methylation of ARMC3 promoter	PMID:27901495
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ARMC3 gene	PMID:31601247
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312696	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of ARMC3 mRNA	PMID:23557971
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARMC3 mRNA	PMID:19710929
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2319961	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ARMC3 mRNA	PMID:30816183
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312696	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ARMC3 mRNA	PMID:30951980|PMID:35598803
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2319961	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ARMC3 mRNA	PMID:34947998
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312696	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ARMC3 gene	PMID:31683443
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312696	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ARMC3 mRNA	PMID:30951980
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312696	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ARMC3 mRNA	PMID:30951980
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312696	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ARMC3 intron	PMID:28392331
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312696	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ARMC3 mRNA	PMID:28392331
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312696	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ARMC3 exon	PMID:28392331
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARMC3 mRNA	PMID:37042841
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARMC3 mRNA	PMID:35301059
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312696	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ARMC3 mRNA	PMID:23125180
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ARMC3 gene	PMID:29154799
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312696	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ARMC3 mRNA	PMID:29279043
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312696	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARMC3 mRNA; Nanotubes, Carbon results in decreased expression of ARMC3 mRNA	PMID:25554681
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312696	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ARMC3 mRNA	PMID:38701926
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:6651	malathion	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in decreased expression of ARMC3 mRNA	PMID:37047231
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312696	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ARMC3 mRNA	PMID:22206623
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARMC3 gene]	PMID:28238834
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:2319961	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ARMC3 mRNA	PMID:32109520
1312695	ARMC3	armadillo repeat containing 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:2319961	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ARMC3 mRNA	PMID:24780913
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312699	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ATOH7 mRNA	PMID:33045310
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312699	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ATOH7 mRNA	PMID:20188158
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ATOH7 mRNA	PMID:30510588
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1304957	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ATOH7 mRNA	PMID:33387578
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases methylation	ISO	RGD:1304957	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of ATOH7 gene	PMID:33923623
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATOH7 gene	PMID:27153756
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312699	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of ATOH7 mRNA	PMID:15674844
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312699	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ATOH7 mRNA	PMID:25629700
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312699	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of ATOH7 mRNA	PMID:40618947
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312699	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of ATOH7 mRNA	PMID:32186404
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312699	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATOH7 mRNA	PMID:22228805
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATOH7 exon; Benzo(a)pyrene results in increased methylation of ATOH7 promoter	PMID:27901495
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1304957	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of ATOH7 mRNA	PMID:24395379
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312699	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ATOH7 mRNA	PMID:18648102
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304957	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ATOH7 mRNA	PMID:25181051
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312699	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ATOH7 mRNA	PMID:37019170
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312699	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ATOH7 mRNA	PMID:40194260
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:38626	pyridaben	decreases expression	ISO	RGD:1312699	E	RGD:6480464	20121113	CTD	MESH:C428725	pyridaben results in decreased expression of ATOH7 mRNA	PMID:22563483
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATOH7 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATOH7 mRNA	PMID:27188386
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ATOH7 mRNA	PMID:26272509
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATOH7 mRNA	PMID:27188386
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ATOH7 mRNA	PMID:24935251
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304957	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of ATOH7 mRNA	PMID:22504374
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATOH7 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATOH7 mRNA	PMID:27188386
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATOH7 gene]	PMID:28238834
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304957	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ATOH7 mRNA	PMID:24780913
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304957	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of ATOH7 mRNA	PMID:22504374
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATOH7 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATOH7 mRNA	PMID:27188386
1312698	ATOH7	atonal bHLH transcription factor 7	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304957	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ATOH7 mRNA	PMID:19281266
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312702	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of RDH13 mRNA]	PMID:19467301
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RDH13 mRNA	PMID:26516004
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312702	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RDH13 mRNA	PMID:36331819
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304959	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of RDH13 gene	PMID:28931070
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of RDH13 mRNA	PMID:38568856
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RDH13 mRNA	PMID:37042841
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of RDH13 mRNA	PMID:33359661
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:18009	NADP(+)	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D009249	NADP binds to and results in increased activity of RDH13 protein	PMID:25526675
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of RDH13 mRNA	PMID:39836092
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312702	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RDH13 mRNA	PMID:19770486
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1304959	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of RDH13 mRNA	PMID:30779732
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304959	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RDH13 mRNA	PMID:31150632
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:27385	tetrachloromethane	increases response to substance	ISO	RGD:1312702	E	RGD:6480464	20170516	CTD	MESH:D002251	RDH13 results in increased susceptibility to Carbon Tetrachloride	PMID:27865848
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1312702	E	RGD:6480464	20170516	CTD	MESH:D002251	RDH13 protein promotes the reaction [Carbon Tetrachloride results in increased expression of ACTA2 protein]; RDH13 protein promotes the reaction [Carbon Tetrachloride results in increased expression of COL1A1 mRNA]; RDH13 protein promotes the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA]; RDH13 protein promotes the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]; RDH13 protein promotes the reaction [Carbon Tetrachloride results in increased expression of TIMP1 protein]	PMID:27865848
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312702	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of RDH13 protein	PMID:25505154
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of RDH13 mRNA	PMID:19921347
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312702	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of RDH13 mRNA	PMID:32186404
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304959	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RDH13 mRNA	PMID:32109520
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304959	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RDH13 mRNA	PMID:33387578
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312702	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RDH13 mRNA	PMID:25975270
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RDH13 mRNA	PMID:33212167
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RDH13 mRNA	PMID:38568856
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RDH13 exon; Benzo(a)pyrene affects the methylation of RDH13 intron; Benzo(a)pyrene affects the methylation of RDH13 promoter	PMID:27901495|PMID:30157460
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RDH13 mRNA	PMID:19150397
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:31767	lead diacetate	increases methylation	ISO	RGD:1304959	E	RGD:6480464	20180828	CTD	MESH:C008261	lead acetate results in increased methylation of RDH13 gene	PMID:29571894
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304959	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RDH13 mRNA	PMID:34492290
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312702	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RDH13 mRNA	PMID:19710929
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which affects the expression of RDH13 mRNA	PMID:38479592
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RDH13 protein	PMID:33376534|PMID:34186270
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304959	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RDH13 mRNA	PMID:25181051|PMID:30816183
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312702	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RDH13 mRNA	PMID:33221593
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RDH13 mRNA	PMID:28628672
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312702	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of RDH13 mRNA	PMID:40203079
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312702	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RDH13 mRNA	PMID:39298647
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RDH13 mRNA	PMID:28628672
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RDH13 intron	PMID:30157460
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RDH13 protein	PMID:34186270
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RDH13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RDH13 mRNA	PMID:28628672
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of RDH13 mRNA	PMID:39836092
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1304959	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RDH13 mRNA	PMID:33453195
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of RDH13 mRNA	PMID:19167446
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312702	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RDH13 mRNA	PMID:36331819
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RDH13 mRNA	PMID:25979313
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312702	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RDH13 mRNA	PMID:17963808
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RDH13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RDH13 mRNA	PMID:28628672
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:44409	NADP zwitterion	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D009249	NADP binds to and results in increased activity of RDH13 protein	PMID:25526675
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RDH13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RDH13 mRNA	PMID:28628672
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of RDH13 mRNA	PMID:20977926
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of RDH13 mRNA	PMID:39836092
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of RDH13 intron	PMID:30157460
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312702	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RDH13 mRNA	PMID:22206623
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of RDH13 protein	PMID:39638853
1312701	RDH13	retinol dehydrogenase 13	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of RDH13 protein	PMID:38348393
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of GDAP1L1 mRNA	PMID:26272509
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDAP1L1 mRNA	PMID:27188386
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623785	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GDAP1L1 mRNA	PMID:33045310
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:16136	hydrogen sulfide	decreases expression	ISO	RGD:1623785	E	RGD:6480464	20181113	CTD	MESH:D006862	Hydrogen Sulfide results in decreased expression of GDAP1L1 protein	PMID:29932956
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1623785	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of GDAP1L1 mRNA	PMID:30319688
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D004958	Estradiol results in decreased expression of GDAP1L1 protein	PMID:33181973
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA	PMID:37567420
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1623785	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of GDAP1L1 mRNA	PMID:26445464
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA	PMID:37567420
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1304960	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GDAP1L1 mRNA	PMID:39012411
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of GDAP1L1 mRNA	PMID:26272509
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA	PMID:27188386
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA	PMID:37567420
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of GDAP1L1 mRNA	PMID:23557933
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of GDAP1L1 promoter	PMID:22847954
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1304960	E	RGD:6480464	20160412	CTD	MESH:D003042	Cocaine results in decreased expression of GDAP1L1 protein	PMID:25100957
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1623785	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of GDAP1L1 mRNA	PMID:32186404
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304960	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of GDAP1L1 mRNA	PMID:26033743
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA	PMID:37567420
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of GDAP1L1 gene	PMID:28589171
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GDAP1L1 mRNA	PMID:38568856
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GDAP1L1 promoter	PMID:27901495
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304960	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of GDAP1L1 mRNA	PMID:26033743
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of GDAP1L1 mRNA	PMID:37690743
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304960	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of GDAP1L1 mRNA	PMID:30047161
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623785	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GDAP1L1 gene	PMID:35295148
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1623785	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of GDAP1L1 mRNA	PMID:32156529
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304960	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GDAP1L1 mRNA	PMID:25181051|PMID:34947998
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of GDAP1L1 mRNA	PMID:19244175
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623785	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of GDAP1L1 mRNA	PMID:30951980
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of GDAP1L1 mRNA	PMID:36117858
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1304960	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GDAP1L1 mRNA	PMID:39012411
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of GDAP1L1 promoter	PMID:22847954
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of GDAP1L1 promoter	PMID:22847954
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1623785	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of GDAP1L1 mRNA	PMID:39529242
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GDAP1L1 mRNA	PMID:25979313
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of GDAP1L1 mRNA	PMID:24935251|PMID:28001369
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304960	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of GDAP1L1 mRNA	PMID:30047161
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA	PMID:37567420
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623785	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GDAP1L1 mRNA	PMID:17562736
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:1304960	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of GDAP1L1 gene	PMID:37958445
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA	PMID:27188386
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304960	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of GDAP1L1 mRNA	PMID:30047161
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of GDAP1L1 mRNA	PMID:36117858
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of GDAP1L1 mRNA	PMID:20436886
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDAP1L1 mRNA	PMID:27188386
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1304960	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of GDAP1L1 mRNA	PMID:20080153
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1623785	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of GDAP1L1 mRNA	PMID:19751817
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1623785	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GDAP1L1 mRNA	PMID:22776087
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1623785	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA	PMID:37567420
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDAP1L1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDAP1L1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA	PMID:27188386
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GDAP1L1 gene]	PMID:28238834
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304960	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GDAP1L1 mRNA	PMID:30047161
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDAP1L1 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GDAP1L1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GDAP1L1 mRNA	PMID:27188386
1312703	GDAP1L1	ganglioside induced differentiation associated protein 1 like 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304960	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of GDAP1L1 mRNA	PMID:23869203
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of WBP1 mRNA	PMID:38218311
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1304961	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of WBP1 mRNA	PMID:21551480
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312706	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of WBP1 mRNA	PMID:20188158
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of WBP1 mRNA	PMID:23724009
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of WBP1 mRNA	PMID:30951980
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of WBP1 mRNA	PMID:30529165
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of WBP1 mRNA	PMID:36331819
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of WBP1 mRNA	PMID:39241906
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20161228	CTD	MESH:D008070	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of WBP1 gene	PMID:21212295
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of WBP1 mRNA	PMID:39298647
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of WBP1 mRNA	PMID:17251523
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312706	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of WBP1 mRNA	PMID:33754040
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of WBP1 protein	PMID:37730182
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304961	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of WBP1 mRNA	PMID:22061828
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of WBP1 mRNA	PMID:19549813
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of WBP1 mRNA	PMID:19376150
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304961	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of WBP1 mRNA	PMID:31150632
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of WBP1 mRNA	PMID:31919559
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of WBP1 mRNA	PMID:22206623
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of WBP1 mRNA	PMID:40512198
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of WBP1 mRNA	PMID:28960355
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of WBP1 mRNA	PMID:23557933
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:28112	nickel atom	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel affects the expression of WBP1 mRNA	PMID:14575637
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D009532	trichostatin A inhibits the reaction [Nickel affects the expression of WBP1 mRNA]	PMID:14575637
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312706	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WBP1 mRNA	PMID:21570461
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases methylation	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased methylation of WBP1 gene	PMID:21212295
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of WBP1 gene	PMID:21212295
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1304961	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of WBP1 mRNA	PMID:30556269
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of WBP1 mRNA	PMID:20044591
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of WBP1 mRNA	PMID:40512198
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of WBP1 promoter	PMID:27901495
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1304961	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of WBP1 mRNA	PMID:30556269
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of WBP1 mRNA	PMID:25895662
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of WBP1 mRNA	PMID:23811191
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of WBP1 mRNA	PMID:19710929
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of WBP1 mRNA	PMID:28329830
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of WBP1 mRNA	PMID:30903817
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304961	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of WBP1 mRNA	PMID:25181051
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of WBP1 mRNA	PMID:25912373
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304961	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of WBP1 mRNA	PMID:30816183|PMID:38750585
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of WBP1 mRNA	PMID:29275510
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of WBP1 mRNA	PMID:28628672
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of WBP1 mRNA	PMID:30951980
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of WBP1 mRNA	PMID:28628672
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of WBP1 mRNA	PMID:17361019|PMID:21266533
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312706	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of WBP1 mRNA	PMID:34813904
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of WBP1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of WBP1 mRNA	PMID:28628672
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of WBP1 mRNA	PMID:37042841
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304961	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of WBP1 mRNA	PMID:35163327
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304961	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of WBP1 mRNA	PMID:35163327
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1304961	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of WBP1 mRNA	PMID:24386269
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of WBP1 mRNA	PMID:23811191
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of WBP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of WBP1 mRNA]	PMID:17585979
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of WBP1 mRNA	PMID:28302478
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of WBP1 mRNA	PMID:31533062
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of WBP1 mRNA	PMID:19167446
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of WBP1 mRNA	PMID:36331819
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of WBP1 mRNA	PMID:17292431
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304961	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of WBP1 mRNA	PMID:41580965
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of WBP1 mRNA	PMID:25562108
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of WBP1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of WBP1 mRNA	PMID:28628672
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C012589	trichostatin A inhibits the reaction [Nickel affects the expression of WBP1 mRNA]	PMID:14575637
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312706	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of WBP1 mRNA	PMID:17562736
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of WBP1 mRNA	PMID:22230336
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of WBP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of WBP1 mRNA]	PMID:17585979
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of WBP1 mRNA	PMID:40512198
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of WBP1 mRNA	PMID:35436446
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of WBP1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of WBP1 mRNA	PMID:28628672
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of WBP1 mRNA; Nanotubes, Carbon results in decreased expression of WBP1 mRNA	PMID:25554681|PMID:25620056
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of WBP1 mRNA	PMID:22206623
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312706	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of WBP1 mRNA	PMID:22206623
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of WBP1 mRNA	PMID:28960945
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304961	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of WBP1 mRNA	PMID:24780913
1312705	WBP1	WW domain binding protein 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312706	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of WBP1 mRNA	PMID:40826991
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of LARS1 mRNA	PMID:35967413
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LARS1 mRNA]	PMID:31150632
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LARS1 protein]	PMID:38195004
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of LARS1 mRNA	PMID:23724009|PMID:33167477
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304962	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of LARS1 gene	PMID:35440735
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of LARS1 mRNA	PMID:21179406
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550076	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LARS1 mRNA	PMID:39241906
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of LARS1 mRNA	PMID:28973375
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:17750	glycine betaine	decreases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D001622	Betaine results in decreased expression of LARS1 mRNA	PMID:26391144
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D005839	Gentamicins results in increased expression of LARS1 mRNA	PMID:22061828
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304962	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of LARS1 protein	PMID:34915118
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LARS1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LARS1 protein	PMID:38195004
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LARS1 protein	PMID:23301498
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LARS1 intron	PMID:30157460
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of LARS1 mRNA	PMID:23649840
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of LARS1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of LARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of LARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of LARS1 protein	PMID:38598786
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LARS1 mRNA	PMID:31150632
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LARS1 mRNA	PMID:27339419|PMID:31919559
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LARS1 mRNA]	PMID:31150632
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of LARS1 protein	PMID:38460933
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of LARS1 protein	PMID:35688186
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of LARS1 mRNA	PMID:25596134
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of LARS1 mRNA	PMID:23557933
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of LARS1 mRNA	PMID:25596134
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LARS1 mRNA	PMID:21570461
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LARS1 mRNA	PMID:20106945|PMID:21632981
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304962	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LARS1 mRNA	PMID:34747641
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LARS1 mRNA	PMID:28001369
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LARS1 mRNA	PMID:33212167
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LARS1 mRNA	PMID:22228805
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to LARS1 mRNA]	PMID:32406909
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LARS1 mRNA	PMID:20018196
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:C006253	pirinixic acid results in decreased expression of LARS1 mRNA	PMID:16940010
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:C006253	pirinixic acid results in increased expression of LARS1 mRNA	PMID:18301758
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:C074702	chromium hexavalent ion affects the expression of LARS1 mRNA	PMID:28472532
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of LARS1 mRNA	PMID:30903817
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of LARS1 protein	PMID:34186270|PMID:37567409
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304962	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of LARS1 mRNA	PMID:30816183|PMID:32528016
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:C006780	bisphenol A results in increased expression of LARS1 mRNA	PMID:25181051
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of LARS1 mRNA	PMID:25979313
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of LARS1 protein	PMID:34186270
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of LARS1 protein	PMID:34186270
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of LARS1 mRNA	PMID:37019170
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LARS1 mRNA	PMID:24893172
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D005284	Fenthion results in decreased expression of LARS1 mRNA	PMID:34813904
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of LARS1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of LARS1 protein	PMID:38598786
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:C005828	methidathion results in increased expression of LARS1 mRNA	PMID:34813904
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D010269	Paraquat results in increased expression of LARS1 mRNA	PMID:32680482
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of LARS1 mRNA	PMID:17616710
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D002509	Cephaloridine results in decreased expression of LARS1 mRNA	PMID:18500788
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LARS1 mRNA	PMID:25596134
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LARS1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LARS1 protein	PMID:38195004
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of LARS1 mRNA	PMID:25596134
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LARS1 mRNA	PMID:31533062
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of LARS1 mRNA	PMID:36864359
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LARS1 mRNA	PMID:25979313
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of LARS1 mRNA	PMID:23179753|PMID:26272509
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	PMID:27188386
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of LARS1 mRNA	PMID:20106945|PMID:25562108|PMID:25596134|PMID:27989131
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D016572	Cyclosporine results in increased expression of LARS1 mRNA	PMID:25596134
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D003907	Dexamethasone results in decreased expression of LARS1 mRNA	PMID:22733784
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	Vorinostat results in decreased expression of LARS1 mRNA	PMID:27188386
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of LARS1 mRNA	PMID:26272509
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	PMID:27188386
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D000082	Acetaminophen affects the expression of LARS1 mRNA	PMID:17562736
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of LARS1 mRNA	PMID:29279043
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of LARS1 mRNA	PMID:29523930
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of LARS1 protein	PMID:38460933
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of LARS1 mRNA	PMID:23228038
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D011345	Fenofibrate results in decreased expression of LARS1 mRNA	PMID:25596134
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of LARS1 mRNA	PMID:25596134
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LARS1 mRNA; Nanotubes, Carbon results in increased expression of LARS1 mRNA	PMID:25620056
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D005485	Flutamide results in decreased expression of LARS1 mRNA	PMID:24793618
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D005485	Flutamide results in increased expression of LARS1 mRNA	PMID:24136188
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C001277	geldanamycin results in increased expression of LARS1 mRNA	PMID:26705709
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:5855	ibuprofen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of LARS1 mRNA	PMID:25596134
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LARS1 protein	PMID:32959892
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of LARS1 mRNA	PMID:28801915
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D008687	Metformin results in increased expression of LARS1 mRNA	PMID:25596134
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D008701	Methapyrilene results in decreased expression of LARS1 mRNA	PMID:30467583
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of LARS1 mRNA	PMID:31758290
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LARS1 protein	PMID:34186270
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of LARS1 protein	PMID:37664457
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of LARS1 protein	PMID:31285264
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of LARS1 mRNA	PMID:30559759
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	PMID:27188386
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LARS1 gene]	PMID:28238834
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of LARS1 protein	PMID:31675489
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of LARS1 mRNA	PMID:23914054
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of LARS1 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LARS1 mRNA	PMID:27188386|PMID:37664457
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:D013605	T-2 Toxin results in decreased expression of LARS1 mRNA	PMID:26141394
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of LARS1 mRNA	PMID:27188386
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of LARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of LARS1 protein	PMID:38598786
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LARS1 mRNA	PMID:21346803
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550076	E	RGD:6480464	20230801	CTD	MESH:C080163	trovafloxacin results in decreased expression of LARS1 mRNA	PMID:35537566
1312707	LARS1	leucyl-tRNA synthetase 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1304962	E	RGD:6480464	20230801	CTD	MESH:C025643	vinclozolin affects the expression of LARS1 mRNA	PMID:23034163
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:110423	clodronic acid	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid affects the expression of AIFM2 mRNA	PMID:25596134
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of AIFM2 mRNA	PMID:37995155
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of AIFM2 mRNA]	PMID:19467301
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of AIFM2 mRNA	PMID:25596134
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of AIFM2 mRNA	PMID:36331819
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312710	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of AIFM2 mRNA	PMID:30319688
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of AIFM2 mRNA	PMID:20044591
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16240	hydrogen peroxide	increases secretion	ISO	RGD:1304964	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased secretion of AIFM2 protein	PMID:14987999
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1304964	E	RGD:6480464	20120412	CTD	MESH:D006861	Butylated Hydroxytoluene inhibits the reaction [Hydrogen Peroxide results in increased secretion of AIFM2 protein]	PMID:14987999
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of AIFM2 mRNA	PMID:39298647
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of AIFM2 mRNA	PMID:30165855
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312710	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of AIFM2 mRNA	PMID:33711761
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312710	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of AIFM2 mRNA	PMID:25549359
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of AIFM2 mRNA	PMID:37042841
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:17158	methylglyoxal	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D011765	Pyruvaldehyde results in increased expression of AIFM2 mRNA	PMID:30447388
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of AIFM2 mRNA	PMID:22017230
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:173086	ferrostatin-1	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C573944	ferrostatin-1 results in increased expression of AIFM2 protein	PMID:38896176
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:173086	ferrostatin-1	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C573944	ferrostatin-1 inhibits the reaction [ochratoxin A results in decreased expression of AIFM2 protein]	PMID:38896176
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of AIFM2 mRNA	PMID:31256213
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1304964	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of AIFM2 mRNA	PMID:26577399
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of AIFM2 mRNA	PMID:28818685
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AIFM2 mRNA	PMID:36331819
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AIFM2 mRNA	PMID:39836092
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of AIFM2 mRNA	PMID:24067728
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AIFM2 mRNA	PMID:35301059
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AIFM2 mRNA	PMID:37236586
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of AIFM2 mRNA	PMID:19549813
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of AIFM2 mRNA	PMID:23649840
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1304964	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of AIFM2 mRNA	PMID:33354967
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of AIFM2 mRNA	PMID:23649840
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:2564	aldrin	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in decreased expression of AIFM2 mRNA	PMID:18579281
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1312710	E	RGD:6480464	20141014	CTD	MESH:C011559	tributyltin results in increased expression of AIFM2 mRNA	PMID:24848799
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304964	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AIFM2 mRNA	PMID:31150632
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AIFM2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AIFM2 mRNA	PMID:39836092
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AIFM2 mRNA	PMID:40504410
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of AIFM2 protein	PMID:38460933
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of AIFM2 mRNA	PMID:26272509
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIFM2 mRNA	PMID:27188386
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27871	chloroacetaldehyde	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in increased expression of AIFM2 mRNA	PMID:25596134
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1304964	E	RGD:6480464	20250311	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of AIFM2 mRNA	PMID:39276841
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of AIFM2 mRNA; Cisplatin results in decreased expression of AIFM2 protein	PMID:25596134|PMID:40654249
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20260602	CTD	MESH:D002945	Cisplatin results in decreased expression of AIFM2 protein	PMID:40654249
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of AIFM2 mRNA; Cisplatin results in increased expression of AIFM2 protein	PMID:27392435
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of AIFM2 mRNA; [Cisplatin co-treated with jinfukang] results in increased expression of AIFM2 protein; Cisplatin promotes the reaction [jinfukang results in increased expression of AIFM2 mRNA]; Cisplatin promotes the reaction [jinfukang results in increased expression of AIFM2 protein]; erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]; jinfukang promotes the reaction [Cisplatin results in increased expression of AIFM2 mRNA]; jinfukang promotes the reaction [Cisplatin results in increased expression of AIFM2 protein]	PMID:27392435|PMID:40654249
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20260602	CTD	MESH:D002945	erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]; IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]; ML385 inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]	PMID:40654249
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:D003042	Cocaine affects the expression of AIFM2 mRNA	PMID:15681117
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312710	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AIFM2 mRNA	PMID:21570461
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AIFM2 mRNA	PMID:19770486
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AIFM2 mRNA	PMID:20106945|PMID:21632981
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304964	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AIFM2 mRNA	PMID:34747641
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AIFM2 mRNA	PMID:17942748
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1304964	E	RGD:6480464	20171010	CTD	MESH:D012402	Rotenone results in decreased expression of AIFM2 mRNA	PMID:19013527
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of AIFM2 mRNA	PMID:33212167
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of AIFM2 mRNA	PMID:32763439
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of AIFM2 mRNA	PMID:20971185
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1304964	E	RGD:6480464	20171010	CTD	MESH:D004317	Doxorubicin results in decreased expression of AIFM2 mRNA	PMID:19915844
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:28783	zinc protoporphyrin	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20260602	CTD	MESH:C017803	zinc protoporphyrin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of AIFM2 protein]	PMID:39959930
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of AIFM2 mRNA	PMID:21281968|PMID:25493608|PMID:38568856|PMID:39900124
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AIFM2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AIFM2 mRNA	PMID:39836092
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AIFM2 mRNA	PMID:40504410
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D014415	Tunicamycin results in increased expression of AIFM2 mRNA	PMID:39900124
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of AIFM2 intron	PMID:30157460
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AIFM2 mRNA	PMID:21632981|PMID:26238291
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AIFM2 5' UTR	PMID:27901495
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of AIFM2 mRNA	PMID:20971185
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of AIFM2 gene	PMID:31601247
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of AIFM2 mRNA	PMID:38568856
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1304964	E	RGD:6480464	20250311	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of AIFM2 mRNA	PMID:39276841
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304964	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of AIFM2 mRNA	PMID:30047161
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of AIFM2 mRNA	PMID:23557971
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312710	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AIFM2 promoter	PMID:35295148
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312710	E	RGD:6480464	20131220	CTD	MESH:C006253	pirinixic acid results in increased expression of AIFM2 mRNA	PMID:18301758|PMID:20813756|PMID:23811191
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1304964	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of AIFM2 mRNA	PMID:19167457
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of AIFM2 mRNA	PMID:30903817
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1304964	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of AIFM2 promoter	PMID:27415467
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of AIFM2 protein	PMID:33376534
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of AIFM2 protein	PMID:34186270
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304964	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of AIFM2 mRNA	PMID:25181051
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	[ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of AIFM2 protein]	PMID:33376534
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	multiple interactions	ISO	RGD:1304964	E	RGD:6480464	20120412	CTD	MESH:D002084	Butylated Hydroxytoluene inhibits the reaction [ganglioside, GD3 results in increased secretion of AIFM2 protein]; Butylated Hydroxytoluene inhibits the reaction [Hydrogen Peroxide results in increased secretion of AIFM2 protein]	PMID:14987999
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of AIFM2 mRNA	PMID:39298647
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312710	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of AIFM2 exon; bisphenol S results in decreased methylation of AIFM2 promoter	PMID:33297965
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of AIFM2 protein	PMID:34186270
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of AIFM2 protein	PMID:34186270
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of AIFM2 protein	PMID:34186270
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312710	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of AIFM2 mRNA	PMID:37019170
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304964	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of AIFM2 mRNA	PMID:21266533
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1304964	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of AIFM2 mRNA	PMID:22546817
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20141014	CTD	MESH:D015056	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of AIFM2 mRNA	PMID:24848799
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1304964	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of AIFM2 mRNA	PMID:22546817
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AIFM2 mRNA	PMID:37042841
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AIFM2 mRNA	PMID:39836092
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312710	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of AIFM2 mRNA	PMID:26377693
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of AIFM2 mRNA	PMID:25596134
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AIFM2 mRNA	PMID:38174414
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AIFM2 mRNA	PMID:35301059
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AIFM2 mRNA	PMID:37236586
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1304964	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of AIFM2 mRNA	PMID:19162173|PMID:30047161
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of AIFM2 mRNA	PMID:19320972
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312710	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of AIFM2 mRNA	PMID:28962523
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of AIFM2 mRNA	PMID:40194260
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of AIFM2 mRNA	PMID:31533062
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AIFM2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of AIFM2 mRNA	PMID:36331819
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312710	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of AIFM2 mRNA	PMID:17292431
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20260602	CTD	MESH:D014635	Valproic Acid results in decreased expression of AIFM2 protein	PMID:40990894
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20260602	CTD	MESH:D014635	Valproic Acid results in decreased expression of AIFM2 protein	PMID:40990894
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304964	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of AIFM2 mRNA	PMID:30047161
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304964	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of AIFM2 mRNA	PMID:41580965
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1304964	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of AIFM2 mRNA	PMID:25596134
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of AIFM2 mRNA	PMID:20106945|PMID:25562108|PMID:25596134
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of AIFM2 mRNA	PMID:25047013
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20141014	CTD	MESH:D003907	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of AIFM2 mRNA	PMID:24848799
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of AIFM2 mRNA	PMID:28973697
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:D008727	Methotrexate affects the expression of AIFM2 mRNA	PMID:18502557
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of AIFM2 mRNA	PMID:38832940
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of AIFM2 mRNA	PMID:25704631|PMID:26690555
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of AIFM2 protein	PMID:38460933
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AIFM2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AIFM2 mRNA	PMID:39836092
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AIFM2 mRNA	PMID:40504410
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in increased expression of AIFM2 mRNA	PMID:26722802
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312710	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of AIFM2 mRNA	PMID:35436446
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AIFM2 mRNA	PMID:17942748
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20171010	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AIFM2 mRNA	PMID:17942748
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of AIFM2 mRNA	PMID:38568856
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of AIFM2 mRNA	PMID:25596134
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1304964	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of AIFM2 mRNA	PMID:25596134
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304964	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of AIFM2 mRNA	PMID:30047161
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:50833	cadmium sulfide	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C034939	cadmium sulfide results in increased expression of AIFM2 mRNA	PMID:27866839
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of AIFM2 mRNA	PMID:20977926
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:5855	ibuprofen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of AIFM2 mRNA	PMID:25596134
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:5855	ibuprofen	increases expression	ISO	RGD:1304964	E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of AIFM2 mRNA	PMID:25596134
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of AIFM2 mRNA	PMID:39836092
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1304964	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of AIFM2 mRNA	PMID:25596134
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:69832	osthole	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:C046627	osthol results in decreased expression of AIFM2 protein	PMID:40446951
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:69832	osthole	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C046627	TFRC protein promotes the reaction [osthol results in decreased expression of AIFM2 protein]	PMID:40446951
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of AIFM2 protein	PMID:34186270
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:76004	dimethyl fumarate	multiple interactions	ISO	RGD:1304964	E	RGD:6480464	20250603	CTD	MESH:C056020	Dimethyl Fumarate inhibits the reaction [Matrines results in decreased expression of AIFM2 mRNA]; Dimethyl Fumarate inhibits the reaction [Matrines results in decreased expression of AIFM2 protein]	PMID:38723914
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of AIFM2 protein	PMID:39638853
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C025589	ochratoxin A results in decreased expression of AIFM2 protein	PMID:38896176
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C025589	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine promotes the reaction [ochratoxin A results in decreased expression of AIFM2 protein]; ferrostatin-1 inhibits the reaction [ochratoxin A results in decreased expression of AIFM2 protein]; tetrahydro-N, N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride inhibits the reaction [ochratoxin A results in decreased expression of AIFM2 protein]	PMID:38896176
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIFM2 mRNA	PMID:27188386
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AIFM2 gene]	PMID:28238834
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1304964	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of AIFM2 mRNA	PMID:19162173
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304964	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of AIFM2 mRNA	PMID:30047161
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304964	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of AIFM2 mRNA	PMID:24780913
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIFM2 mRNA	PMID:27188386
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:92519	1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C093337	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine results in decreased expression of AIFM2 protein	PMID:38896176
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:92519	1-[2-(3,4-dichlorophenyl)ethyl]-4-methylpiperazine	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C093337	1-(2-(3,4-dichlorophenyl)ethyl)-4-methylpiperazine promotes the reaction [ochratoxin A results in decreased expression of AIFM2 protein]	PMID:38896176
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in increased expression of AIFM2 mRNA	PMID:11906190
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:94287	erastin	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:C477224	erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]	PMID:40654249
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:94287	erastin	multiple interactions	ISO	RGD:1312710	E	RGD:6480464	20260602	CTD	MESH:C477224	erastin inhibits the reaction [IFI35 protein affects the reaction [Cisplatin results in decreased expression of AIFM2 protein]]	PMID:40654249
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of AIFM2 mRNA	PMID:29301935
1312709	AIFM2	AIF family member 2, ferroptosis suppressor	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1304964	E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in increased expression of AIFM2 mRNA	PMID:25596134
1312711	RHOC	ras homolog family member C	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RHOC mRNA	PMID:38218311
1312711	RHOC	ras homolog family member C	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of RHOC mRNA	PMID:35967413
1312711	RHOC	ras homolog family member C	gene	CHEBI:141524	ochratoxin B	affects binding	EXP		E	RGD:6480464	20260505	CTD	MESH:C045354	RHOC protein binds to ochratoxin B	PMID:40952447
1312711	RHOC	ras homolog family member C	gene	CHEBI:144400	dinophysistoxin 1	increases expression	EXP		E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in increased expression of RHOC mRNA	PMID:28939011
1312711	RHOC	ras homolog family member C	gene	CHEBI:149906	Tanshinone I	increases expression	EXP		E	RGD:6480464	20200602	CTD	MESH:C021751	tanshinone results in increased expression of RHOC mRNA	PMID:15849732
1312711	RHOC	ras homolog family member C	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RHOC mRNA	PMID:20938992
1312711	RHOC	ras homolog family member C	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of RHOC mRNA	PMID:23724009
1312711	RHOC	ras homolog family member C	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of RHOC protein	PMID:39571964
1312711	RHOC	ras homolog family member C	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of RHOC mRNA	PMID:30951980
1312711	RHOC	ras homolog family member C	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RHOC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RHOC mRNA	PMID:32699268
1312711	RHOC	ras homolog family member C	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RHOC mRNA	PMID:30529165
1312711	RHOC	ras homolog family member C	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RHOC mRNA	PMID:36331819
1312711	RHOC	ras homolog family member C	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of RHOC mRNA	PMID:22378314
1312711	RHOC	ras homolog family member C	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RHOC mRNA	PMID:21632981
1312711	RHOC	ras homolog family member C	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RHOC mRNA	PMID:39241906
1312711	RHOC	ras homolog family member C	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312712	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of RHOC mRNA	PMID:15598610
1312711	RHOC	ras homolog family member C	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1304965	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of RHOC protein	PMID:32145629
1312711	RHOC	ras homolog family member C	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312712	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RHOC mRNA	PMID:39298647
1312711	RHOC	ras homolog family member C	gene	CHEBI:16482	naphthalene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of RHOC mRNA	PMID:22579512
1312711	RHOC	ras homolog family member C	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312712	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of RHOC mRNA	PMID:33711761
1312711	RHOC	ras homolog family member C	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RHOC mRNA	PMID:20938992
1312711	RHOC	ras homolog family member C	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RHOC mRNA	PMID:37042841
1312711	RHOC	ras homolog family member C	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of RHOC mRNA	PMID:23649840
1312711	RHOC	ras homolog family member C	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHOC mRNA	PMID:37992649
1312711	RHOC	ras homolog family member C	gene	CHEBI:17315	D-glucosamine	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine analog results in decreased expression of RHOC mRNA	PMID:16142878
1312711	RHOC	ras homolog family member C	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHOC mRNA	PMID:37992649
1312711	RHOC	ras homolog family member C	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RHOC mRNA	PMID:28818685
1312711	RHOC	ras homolog family member C	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RHOC mRNA	PMID:36331819
1312711	RHOC	ras homolog family member C	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine analog results in decreased expression of RHOC mRNA	PMID:16142878
1312711	RHOC	ras homolog family member C	gene	CHEBI:22977	cadmium atom	increases oxidation	ISO	RGD:1312712	E	RGD:6480464	20150310	CTD	MESH:D002104	Cadmium results in increased oxidation of RHOC protein	PMID:24077948
1312711	RHOC	ras homolog family member C	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RHOC mRNA	PMID:19549813
1312711	RHOC	ras homolog family member C	gene	CHEBI:24229	geranylgeraniol	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:C017338	geranylgeraniol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein]	PMID:24587105
1312711	RHOC	ras homolog family member C	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of RHOC protein	PMID:20106945
1312711	RHOC	ras homolog family member C	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RHOC mRNA	PMID:21632981|PMID:21641981|PMID:27153756
1312711	RHOC	ras homolog family member C	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1304965	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RHOC mRNA	PMID:23630614|PMID:25378103|PMID:33354967
1312711	RHOC	ras homolog family member C	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RHOC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RHOC mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RHOC mRNA	PMID:32699268
1312711	RHOC	ras homolog family member C	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1304965	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RHOC mRNA	PMID:30779732
1312711	RHOC	ras homolog family member C	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312712	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RHOC mRNA	PMID:27339419|PMID:31919559
1312711	RHOC	ras homolog family member C	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid affects the reaction [Cisplatin affects the expression of RHOC mRNA]	PMID:16898872
1312711	RHOC	ras homolog family member C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RHOC mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RHOC mRNA	PMID:20938992|PMID:22206623
1312711	RHOC	ras homolog family member C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RHOC mRNA	PMID:40504410
1312711	RHOC	ras homolog family member C	gene	CHEBI:27641	cycloheximide	decreases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:D003513	Cycloheximide results in decreased expression of RHOC protein	PMID:34873829
1312711	RHOC	ras homolog family member C	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20220809	CTD	MESH:D003513	RNF168 protein promotes the reaction [Cycloheximide results in decreased expression of RHOC protein]	PMID:34873829
1312711	RHOC	ras homolog family member C	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of RHOC mRNA	PMID:38460933
1312711	RHOC	ras homolog family member C	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of RHOC mRNA	PMID:38460933
1312711	RHOC	ras homolog family member C	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of RHOC mRNA	PMID:38460933
1312711	RHOC	ras homolog family member C	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of RHOC mRNA	PMID:26272509
1312711	RHOC	ras homolog family member C	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOC mRNA	PMID:27188386
1312711	RHOC	ras homolog family member C	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304965	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RHOC mRNA	PMID:31881176
1312711	RHOC	ras homolog family member C	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312712	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of RHOC protein	PMID:25505154
1312711	RHOC	ras homolog family member C	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RHOC mRNA	PMID:28903495
1312711	RHOC	ras homolog family member C	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of RHOC mRNA	PMID:23300844
1312711	RHOC	ras homolog family member C	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Folic Acid affects the reaction [Cisplatin affects the expression of RHOC mRNA]	PMID:16898872
1312711	RHOC	ras homolog family member C	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of RHOC mRNA	PMID:18930951
1312711	RHOC	ras homolog family member C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304965	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RHOC mRNA	PMID:34747641
1312711	RHOC	ras homolog family member C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312712	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RHOC mRNA	PMID:21570461
1312711	RHOC	ras homolog family member C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RHOC mRNA	PMID:20106945|PMID:21632981
1312711	RHOC	ras homolog family member C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312712	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RHOC mRNA	PMID:19770486
1312711	RHOC	ras homolog family member C	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine analog results in decreased expression of RHOC mRNA	PMID:16142878
1312711	RHOC	ras homolog family member C	gene	CHEBI:28600	farnesol	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:D005204	Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein]	PMID:24587105
1312711	RHOC	ras homolog family member C	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1304965	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of RHOC mRNA	PMID:28959563
1312711	RHOC	ras homolog family member C	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of RHOC mRNA	PMID:21198554
1312711	RHOC	ras homolog family member C	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RHOC mRNA	PMID:29803840
1312711	RHOC	ras homolog family member C	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHOC mRNA	PMID:37992649
1312711	RHOC	ras homolog family member C	gene	CHEBI:28851	phenanthrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C031181	phenanthrene results in increased expression of RHOC mRNA	PMID:22579512
1312711	RHOC	ras homolog family member C	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of RHOC mRNA	PMID:20044591
1312711	RHOC	ras homolog family member C	gene	CHEBI:2948	azathioprine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of RHOC mRNA	PMID:22623647
1312711	RHOC	ras homolog family member C	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of RHOC mRNA	PMID:20886546|PMID:38568856
1312711	RHOC	ras homolog family member C	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in increased expression of RHOC protein	PMID:39571964
1312711	RHOC	ras homolog family member C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RHOC mRNA	PMID:40504410
1312711	RHOC	ras homolog family member C	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of RHOC mRNA	PMID:29453283
1312711	RHOC	ras homolog family member C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RHOC mRNA	PMID:19770486
1312711	RHOC	ras homolog family member C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RHOC mRNA	PMID:21632981|PMID:22316170|PMID:22579512|PMID:26238291
1312711	RHOC	ras homolog family member C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312712	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RHOC mRNA	PMID:22228805
1312711	RHOC	ras homolog family member C	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312712	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RHOC mRNA	PMID:19073995|PMID:33720480
1312711	RHOC	ras homolog family member C	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of RHOC mRNA	PMID:26238599
1312711	RHOC	ras homolog family member C	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1304965	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of RHOC mRNA	PMID:16483693
1312711	RHOC	ras homolog family member C	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1304965	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of RHOC mRNA	PMID:25729387
1312711	RHOC	ras homolog family member C	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304965	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RHOC mRNA	PMID:25729387
1312711	RHOC	ras homolog family member C	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304965	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RHOC mRNA	PMID:30047161
1312711	RHOC	ras homolog family member C	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312712	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of RHOC mRNA	PMID:23557971
1312711	RHOC	ras homolog family member C	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312712	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RHOC promoter	PMID:35295148
1312711	RHOC	ras homolog family member C	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304965	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RHOC mRNA	PMID:23411599|PMID:34492290
1312711	RHOC	ras homolog family member C	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1304965	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RHOC mRNA	PMID:30723492
1312711	RHOC	ras homolog family member C	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312712	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of RHOC mRNA	PMID:18301758|PMID:23811191
1312711	RHOC	ras homolog family member C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RHOC mRNA	PMID:29275510
1312711	RHOC	ras homolog family member C	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312712	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of RHOC promoter	PMID:27312807
1312711	RHOC	ras homolog family member C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304965	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RHOC mRNA; bisphenol A results in increased expression of RHOC protein	PMID:25181051|PMID:32145629
1312711	RHOC	ras homolog family member C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312712	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RHOC mRNA	PMID:32156529|PMID:34585602
1312711	RHOC	ras homolog family member C	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RHOC mRNA	PMID:28628672
1312711	RHOC	ras homolog family member C	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of RHOC protein	PMID:31675489
1312711	RHOC	ras homolog family member C	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312712	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of RHOC mRNA	PMID:26682919
1312711	RHOC	ras homolog family member C	gene	CHEBI:34342	3-methylcholanthrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008748	Methylcholanthrene results in increased expression of RHOC mRNA	PMID:22579512
1312711	RHOC	ras homolog family member C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312712	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of RHOC mRNA	PMID:39298647
1312711	RHOC	ras homolog family member C	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312712	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of RHOC mRNA	PMID:26377693
1312711	RHOC	ras homolog family member C	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of RHOC mRNA	PMID:22579512
1312711	RHOC	ras homolog family member C	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RHOC protein	PMID:34186270
1312711	RHOC	ras homolog family member C	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312712	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RHOC mRNA	PMID:30951980
1312711	RHOC	ras homolog family member C	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHOC mRNA	PMID:28628672
1312711	RHOC	ras homolog family member C	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of RHOC mRNA	PMID:30951980
1312711	RHOC	ras homolog family member C	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312712	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RHOC intron	PMID:28392331
1312711	RHOC	ras homolog family member C	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312712	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RHOC mRNA	PMID:37019170
1312711	RHOC	ras homolog family member C	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304965	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RHOC mRNA	PMID:21266533
1312711	RHOC	ras homolog family member C	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of RHOC mRNA	PMID:16314067
1312711	RHOC	ras homolog family member C	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312712	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of RHOC mRNA	PMID:34813904
1312711	RHOC	ras homolog family member C	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RHOC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHOC mRNA	PMID:28628672
1312711	RHOC	ras homolog family member C	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312712	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of RHOC mRNA	PMID:24535843
1312711	RHOC	ras homolog family member C	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of RHOC mRNA	PMID:29024780
1312711	RHOC	ras homolog family member C	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of RHOC mRNA	PMID:22579512
1312711	RHOC	ras homolog family member C	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312712	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of RHOC mRNA	PMID:26377693
1312711	RHOC	ras homolog family member C	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304965	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of RHOC mRNA	PMID:30723492
1312711	RHOC	ras homolog family member C	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RHOC mRNA	PMID:26238599
1312711	RHOC	ras homolog family member C	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RHOC mRNA	PMID:38568856
1312711	RHOC	ras homolog family member C	gene	CHEBI:35559	furan	decreases methylation	ISO	RGD:1304965	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of RHOC gene	PMID:27387713
1312711	RHOC	ras homolog family member C	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304965	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of RHOC mRNA	PMID:26194646|PMID:27387713
1312711	RHOC	ras homolog family member C	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RHOC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RHOC mRNA	PMID:32699268
1312711	RHOC	ras homolog family member C	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of RHOC mRNA	PMID:17585979
1312711	RHOC	ras homolog family member C	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1312712	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 results in increased expression of RHOC mRNA	PMID:16221962
1312711	RHOC	ras homolog family member C	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RHOC mRNA	PMID:31533062
1312711	RHOC	ras homolog family member C	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of RHOC mRNA	PMID:26352163
1312711	RHOC	ras homolog family member C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RHOC protein	PMID:26178269
1312711	RHOC	ras homolog family member C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RHOC mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RHOC mRNA	PMID:36331819
1312711	RHOC	ras homolog family member C	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of RHOC mRNA	PMID:28001369
1312711	RHOC	ras homolog family member C	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304965	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RHOC mRNA	PMID:30047161
1312711	RHOC	ras homolog family member C	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RHOC mRNA	PMID:25562108
1312711	RHOC	ras homolog family member C	gene	CHEBI:41423	celecoxib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C105934	Celecoxib promotes the reaction [Atorvastatin results in decreased localization of RHOC protein]; Celecoxib promotes the reaction [Atorvastatin results in increased expression of RHOC protein]	PMID:18172863
1312711	RHOC	ras homolog family member C	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RHOC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHOC mRNA	PMID:28628672
1312711	RHOC	ras homolog family member C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312712	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RHOC mRNA	PMID:28973697
1312711	RHOC	ras homolog family member C	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHOC mRNA	PMID:37992649
1312711	RHOC	ras homolog family member C	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RHOC protein	PMID:38832940
1312711	RHOC	ras homolog family member C	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312712	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RHOC mRNA	PMID:17562736
1312711	RHOC	ras homolog family member C	gene	CHEBI:46557	zoledronic acid	affects localization	EXP		E	RGD:6480464	20180116	CTD	MESH:C088658	zoledronic acid affects the localization of RHOC protein	PMID:28871336
1312711	RHOC	ras homolog family member C	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of RHOC mRNA	PMID:38460933
1312711	RHOC	ras homolog family member C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RHOC mRNA	PMID:40504410
1312711	RHOC	ras homolog family member C	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of RHOC mRNA	PMID:31675489
1312711	RHOC	ras homolog family member C	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1304965	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RHOC mRNA	PMID:29391264
1312711	RHOC	ras homolog family member C	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine analog results in decreased expression of RHOC mRNA	PMID:16142878
1312711	RHOC	ras homolog family member C	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RHOC mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHOC mRNA	PMID:28628672
1312711	RHOC	ras homolog family member C	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of RHOC mRNA	PMID:26238599
1312711	RHOC	ras homolog family member C	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of RHOC mRNA	PMID:23300844
1312711	RHOC	ras homolog family member C	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312712	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RHOC mRNA; Nanotubes, Carbon results in increased expression of RHOC mRNA	PMID:25554681
1312711	RHOC	ras homolog family member C	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304965	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RHOC mRNA	PMID:30047161
1312711	RHOC	ras homolog family member C	gene	CHEBI:50686	atorvastatin calcium	decreases localization	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069059	Atorvastatin results in decreased localization of RHOC protein	PMID:18172863
1312711	RHOC	ras homolog family member C	gene	CHEBI:50686	atorvastatin calcium	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069059	Atorvastatin results in increased expression of RHOC protein	PMID:18172863
1312711	RHOC	ras homolog family member C	gene	CHEBI:50686	atorvastatin calcium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069059	Celecoxib promotes the reaction [Atorvastatin results in decreased localization of RHOC protein]; Celecoxib promotes the reaction [Atorvastatin results in increased expression of RHOC protein]	PMID:18172863
1312711	RHOC	ras homolog family member C	gene	CHEBI:51348	tetraphene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C030935	benz(a)anthracene results in increased expression of RHOC mRNA	PMID:22579512
1312711	RHOC	ras homolog family member C	gene	CHEBI:51687	chrysene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C031180	chrysene results in increased expression of RHOC mRNA	PMID:22579512
1312711	RHOC	ras homolog family member C	gene	CHEBI:52288	1-octadec-9-enoylglycero-3-phosphate	increases activity	EXP		E	RGD:6480464	20190702	CTD	MESH:C032881	lysophosphatidic acid results in increased activity of RHOC protein	PMID:24587105
1312711	RHOC	ras homolog family member C	gene	CHEBI:52288	1-octadec-9-enoylglycero-3-phosphate	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:C032881	Farnesol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein]; geranylgeraniol analog inhibits the reaction [lysophosphatidic acid results in increased activity of RHOC protein]	PMID:24587105
1312711	RHOC	ras homolog family member C	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of RHOC mRNA	PMID:16314067
1312711	RHOC	ras homolog family member C	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RHOC protein	PMID:32959892
1312711	RHOC	ras homolog family member C	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RHOC mRNA	PMID:21641980
1312711	RHOC	ras homolog family member C	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1304965	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of RHOC mRNA	PMID:25729387
1312711	RHOC	ras homolog family member C	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304965	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RHOC mRNA	PMID:25729387
1312711	RHOC	ras homolog family member C	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1312712	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in increased expression of RHOC mRNA	PMID:17654400
1312711	RHOC	ras homolog family member C	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RHOC mRNA	PMID:22206623
1312711	RHOC	ras homolog family member C	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312712	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RHOC mRNA	PMID:22206623
1312711	RHOC	ras homolog family member C	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	EXP		E	RGD:6480464	20220809	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [RNF168 protein results in decreased expression of RHOC protein]	PMID:34873829
1312711	RHOC	ras homolog family member C	gene	CHEBI:7719	ochratoxin A	affects binding	EXP		E	RGD:6480464	20260505	CTD	MESH:C025589	RHOC protein binds to ochratoxin A	PMID:40952447
1312711	RHOC	ras homolog family member C	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1304965	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of RHOC mRNA	PMID:23665939
1312711	RHOC	ras homolog family member C	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOC mRNA	PMID:27188386
1312711	RHOC	ras homolog family member C	gene	CHEBI:81525	2,3,3',4,4',5,5'-Heptachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C034559	2,2',3,3',4,4',5-heptachlorobiphenyl results in decreased expression of RHOC mRNA	PMID:26238599
1312711	RHOC	ras homolog family member C	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RHOC protein	PMID:31675489
1312711	RHOC	ras homolog family member C	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1304965	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of RHOC mRNA	PMID:21394737
1312711	RHOC	ras homolog family member C	gene	CHEBI:81758	cyproconazole	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C093628	cyproconazole results in decreased expression of RHOC mRNA	PMID:26238599
1312711	RHOC	ras homolog family member C	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in increased expression of RHOC mRNA	PMID:22579512
1312711	RHOC	ras homolog family member C	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of RHOC protein	PMID:31675489
1312711	RHOC	ras homolog family member C	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1312712	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of RHOC mRNA	PMID:27029645
1312711	RHOC	ras homolog family member C	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312712	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RHOC mRNA	PMID:39847705
1312711	RHOC	ras homolog family member C	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304965	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RHOC mRNA	PMID:30047161
1312711	RHOC	ras homolog family member C	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RHOC mRNA	PMID:40826991
1312711	RHOC	ras homolog family member C	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1312712	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of RHOC protein	PMID:20553848
1312711	RHOC	ras homolog family member C	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHOC mRNA	PMID:27188386
1312711	RHOC	ras homolog family member C	gene	CHEBI:9150	simvastatin	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of RHOC mRNA	PMID:14630613
1312711	RHOC	ras homolog family member C	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304965	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RHOC mRNA	PMID:19281266
1312711	RHOC	ras homolog family member C	gene	CHEBI:9448	terbinafine	increases localization	EXP		E	RGD:6480464	20161213	CTD	MESH:C041359	terbinafine results in increased localization of RHOC protein	PMID:17172416
1312711	RHOC	ras homolog family member C	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C032910	triadimefon analog results in decreased expression of RHOC mRNA; triadimefon results in decreased expression of RHOC mRNA	PMID:26238599
1312711	RHOC	ras homolog family member C	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304965	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of RHOC mRNA	PMID:23034163
1312713	CUTC	cutC copper transporter	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CUTC mRNA	PMID:21632981
1312713	CUTC	cutC copper transporter	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304966	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of CUTC gene	PMID:27618143
1312713	CUTC	cutC copper transporter	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CUTC mRNA	PMID:23649840
1312713	CUTC	cutC copper transporter	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312714	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CUTC mRNA	PMID:34319233
1312713	CUTC	cutC copper transporter	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304966	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CUTC mRNA	PMID:33387578
1312713	CUTC	cutC copper transporter	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CUTC mRNA	PMID:36331819
1312713	CUTC	cutC copper transporter	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CUTC mRNA	PMID:37236586
1312713	CUTC	cutC copper transporter	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CUTC mRNA	PMID:19549813|PMID:20599845
1312713	CUTC	cutC copper transporter	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CUTC protein	PMID:23301498
1312713	CUTC	cutC copper transporter	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CUTC mRNA	PMID:23649840
1312713	CUTC	cutC copper transporter	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312714	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CUTC mRNA	PMID:31919559
1312713	CUTC	cutC copper transporter	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CUTC mRNA	PMID:19244175
1312713	CUTC	cutC copper transporter	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of CUTC mRNA	PMID:19244175
1312713	CUTC	cutC copper transporter	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CUTC mRNA	PMID:27392435
1312713	CUTC	cutC copper transporter	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1312714	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of CUTC mRNA	PMID:34813904
1312713	CUTC	cutC copper transporter	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312714	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CUTC mRNA	PMID:21570461
1312713	CUTC	cutC copper transporter	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CUTC mRNA	PMID:17942748
1312713	CUTC	cutC copper transporter	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CUTC mRNA	PMID:33212167
1312713	CUTC	cutC copper transporter	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1312714	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CUTC mRNA	PMID:27862939
1312713	CUTC	cutC copper transporter	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312714	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of CUTC mRNA	PMID:39631538
1312713	CUTC	cutC copper transporter	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CUTC mRNA	PMID:38568856
1312713	CUTC	cutC copper transporter	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of CUTC mRNA	PMID:17879257
1312713	CUTC	cutC copper transporter	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312714	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CUTC mRNA	PMID:21715664|PMID:22228805
1312713	CUTC	cutC copper transporter	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CUTC mRNA	PMID:25351596
1312713	CUTC	cutC copper transporter	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CUTC mRNA	PMID:20382639
1312713	CUTC	cutC copper transporter	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312714	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CUTC gene	PMID:35295148
1312713	CUTC	cutC copper transporter	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312714	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CUTC gene	PMID:35295148
1312713	CUTC	cutC copper transporter	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304966	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CUTC mRNA	PMID:34492290
1312713	CUTC	cutC copper transporter	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304966	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CUTC mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1312713	CUTC	cutC copper transporter	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CUTC mRNA	PMID:28628672
1312713	CUTC	cutC copper transporter	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of CUTC mRNA	PMID:19244175
1312713	CUTC	cutC copper transporter	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of CUTC mRNA	PMID:19244175
1312713	CUTC	cutC copper transporter	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CUTC mRNA	PMID:21266533
1312713	CUTC	cutC copper transporter	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CUTC mRNA	PMID:28628672
1312713	CUTC	cutC copper transporter	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CUTC mRNA	PMID:37042841
1312713	CUTC	cutC copper transporter	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CUTC mRNA	PMID:38568856
1312713	CUTC	cutC copper transporter	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CUTC mRNA	PMID:37236586
1312713	CUTC	cutC copper transporter	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1304966	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CUTC mRNA	PMID:24386269
1312713	CUTC	cutC copper transporter	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CUTC mRNA	PMID:19244175
1312713	CUTC	cutC copper transporter	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of CUTC mRNA	PMID:19244175
1312713	CUTC	cutC copper transporter	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CUTC mRNA	PMID:28302478
1312713	CUTC	cutC copper transporter	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CUTC mRNA	PMID:31533062
1312713	CUTC	cutC copper transporter	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CUTC mRNA	PMID:36331819
1312713	CUTC	cutC copper transporter	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1304966	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of CUTC mRNA	PMID:22110744
1312713	CUTC	cutC copper transporter	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of CUTC mRNA	PMID:29154799
1312713	CUTC	cutC copper transporter	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of CUTC promoter	PMID:27989131
1312713	CUTC	cutC copper transporter	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CUTC mRNA	PMID:17555576
1312713	CUTC	cutC copper transporter	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of CUTC mRNA	PMID:25047013
1312713	CUTC	cutC copper transporter	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CUTC mRNA	PMID:28628672
1312713	CUTC	cutC copper transporter	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CUTC mRNA	PMID:28542535
1312713	CUTC	cutC copper transporter	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CUTC mRNA	PMID:17562736
1312713	CUTC	cutC copper transporter	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of CUTC mRNA	PMID:29067470
1312713	CUTC	cutC copper transporter	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304966	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CUTC mRNA	PMID:33387578
1312713	CUTC	cutC copper transporter	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	CUTC protein affects the susceptibility to Fluorouracil	PMID:16217747
1312713	CUTC	cutC copper transporter	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of CUTC mRNA]	PMID:15016801
1312713	CUTC	cutC copper transporter	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304966	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CUTC mRNA	PMID:29391264
1312713	CUTC	cutC copper transporter	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CUTC mRNA	PMID:17555576
1312713	CUTC	cutC copper transporter	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CUTC mRNA	PMID:17942748
1312713	CUTC	cutC copper transporter	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CUTC mRNA	PMID:17942748
1312713	CUTC	cutC copper transporter	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CUTC mRNA	PMID:28628672
1312713	CUTC	cutC copper transporter	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312714	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CUTC mRNA	PMID:35964746
1312713	CUTC	cutC copper transporter	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304966	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of CUTC mRNA	PMID:24793618
1312713	CUTC	cutC copper transporter	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304966	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CUTC mRNA	PMID:24136188
1312713	CUTC	cutC copper transporter	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1304966	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of CUTC mRNA	PMID:21983209
1312713	CUTC	cutC copper transporter	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CUTC protein	PMID:32959892
1312713	CUTC	cutC copper transporter	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of CUTC mRNA	PMID:28988120
1312713	CUTC	cutC copper transporter	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312714	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CUTC mRNA	PMID:22206623
1312713	CUTC	cutC copper transporter	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304966	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CUTC mRNA	PMID:21346803
1312713	CUTC	cutC copper transporter	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CUTC mRNA	PMID:38568856
1312713	CUTC	cutC copper transporter	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304966	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CUTC mRNA	PMID:21346803
1312713	CUTC	cutC copper transporter	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312714	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CUTC mRNA	PMID:35537566
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LSM1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LSM1 mRNA	PMID:32699268
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of LSM1 mRNA	PMID:20044591
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1558112	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of LSM1 mRNA	PMID:39298647
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LSM1 mRNA	PMID:37042841
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LSM1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LSM1 mRNA	PMID:39836092
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LSM1 mRNA	PMID:35301059
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LSM1 gene	PMID:27153756
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LSM1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LSM1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of LSM1 mRNA	PMID:32699268
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1558112	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LSM1 mRNA	PMID:25629700
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM1 mRNA	PMID:22206623
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LSM1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LSM1 mRNA	PMID:39836092
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LSM1 mRNA	PMID:40504410
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1558112	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LSM1 mRNA	PMID:17949056
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of LSM1 mRNA	PMID:33512557
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LSM1 mRNA	PMID:33212167
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of LSM1 mRNA	PMID:32763439
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1558112	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of LSM1 mRNA	PMID:27862939
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of LSM1 mRNA	PMID:29432896
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LSM1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LSM1 mRNA	PMID:39836092
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LSM1 mRNA	PMID:40504410
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to LSM1 mRNA]	PMID:32406909
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1558112	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of LSM1 mRNA	PMID:27131904
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1558112	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LSM1 mRNA	PMID:18301758
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of LSM1 mRNA	PMID:29275510
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304967	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LSM1 mRNA	PMID:25181051
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1558112	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of LSM1 mRNA	PMID:39298647
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in increased expression of LSM1 mRNA alternative form	PMID:17064354
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LSM1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LSM1 mRNA	PMID:39836092
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LSM1 mRNA	PMID:35301059
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of LSM1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of LSM1 mRNA	PMID:32699268
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of LSM1 mRNA	PMID:17010196
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of LSM1 mRNA	PMID:28302478
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LSM1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LSM1 mRNA	PMID:39836092
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LSM1 mRNA	PMID:40504410
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1558112	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of LSM1 mRNA	PMID:25554681
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1304967	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of LSM1 mRNA	PMID:34044035
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LSM1 mRNA	PMID:35964746
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304967	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of LSM1 mRNA	PMID:24136188
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of LSM1 protein	PMID:23718831
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LSM1 protein	PMID:32959892
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LSM1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LSM1 mRNA	PMID:39836092
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSM1 mRNA	PMID:21641980
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:6437	levetiracetam	increases expression	ISO	RGD:1304967	E	RGD:6480464	20181113	CTD	MESH:D000077287	Levetiracetam results in increased expression of LSM1 mRNA	PMID:20345932
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1558112	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM1 mRNA	PMID:22206623
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:8107	phenytoin	decreases expression	ISO	RGD:1304967	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in decreased expression of LSM1 mRNA	PMID:20345932
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1558112	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of LSM1 mRNA	PMID:30294300
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of LSM1 protein	PMID:38348393
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1558112	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of LSM1 mRNA	PMID:27131904
1312715	LSM1	LSM1 homolog, mRNA degradation associated	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304967	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LSM1 mRNA	PMID:21346803
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1621184	E	RGD:6480464	20231003	CTD	MESH:C084079	triptonide results in decreased expression of H2BC26 mRNA	PMID:33045310
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of H2BC26 mRNA	PMID:26516004
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of H2BC26 mRNA	PMID:20044591
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of H2BC26 mRNA	PMID:35811015
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1583885	E	RGD:6480464	20220809	CTD	MESH:D014241	Trichloroethylene results in decreased expression of H2BC26 mRNA	PMID:33387578
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of H2BC26 mRNA	PMID:19549813
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1583885	E	RGD:6480464	20220809	CTD	MESH:D000157	Aconitine results in increased expression of H2BC26 protein	PMID:33236894
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of H2BC26 mRNA	PMID:21867686
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of H2BC26 mRNA	PMID:27594783
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:28112	nickel atom	decreases methylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in decreased methylation of H2BC26 protein	PMID:16870173
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:28112	nickel atom	decreases ubiquitination	EXP		E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in decreased ubiquitination of H2BC26 protein	PMID:16870173
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:28112	nickel atom	increases methylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in increased methylation of H2BC26 protein	PMID:16870173
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:28112	nickel atom	increases ubiquitination	EXP		E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in increased ubiquitination of H2BC26 protein	PMID:16870173
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of H2BC26 mRNA	PMID:30851411
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1621184	E	RGD:6480464	20231003	CTD	MESH:D020106	Acrylamide results in increased expression of H2BC26 mRNA	PMID:30807115
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of H2BC26 mRNA	PMID:20044591
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1621184	E	RGD:6480464	20231003	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of H2BC26 mRNA	PMID:22610609
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of H2BC26 mRNA	PMID:23806026
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of H2BC26 mRNA	PMID:35984750
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1583885	E	RGD:6480464	20250902	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of H2BC27 mRNA	PMID:30047161
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1621184	E	RGD:6480464	20231003	CTD	MESH:C009495	titanium dioxide results in decreased expression of H2BC26 mRNA	PMID:29264374
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1621184	E	RGD:6480464	20231003	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of H2BC26 mRNA	PMID:18648102
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1621184	E	RGD:6480464	20231003	CTD	MESH:C006253	pirinixic acid results in increased expression of H2BC26 mRNA	PMID:23811191
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1583885	E	RGD:6480464	20250902	CTD	MESH:C006780	bisphenol A affects the expression of H2BC27 mRNA	PMID:25181051
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1583885	E	RGD:6480464	20250902	CTD	MESH:C006780	bisphenol A results in increased expression of H2BC27 protein	PMID:32145629
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:34750	Ethylenethiourea	decreases expression	ISO	RGD:1583885	E	RGD:6480464	20250902	CTD	MESH:D005031	Ethylenethiourea results in decreased expression of H2BC27 mRNA	PMID:27905518
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:34887	nickel dichloride	decreases acetylation	EXP		E	RGD:6480464	20120412	CTD	MESH:C022838	nickel chloride results in decreased acetylation of H2BC26 protein	PMID:16522665
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:34887	nickel dichloride	increases ubiquitination	EXP		E	RGD:6480464	20120412	CTD	MESH:C022838	nickel chloride results in increased ubiquitination of H2BC26 protein	PMID:16522665
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of H2BC26 mRNA	PMID:38382870
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1621184	E	RGD:6480464	20231003	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of H2BC26 mRNA	PMID:28962523
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of H2BC26 mRNA	PMID:31533062
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:3962	curcumin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in increased expression of H2BC26 mRNA	PMID:15713895
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of H2BC26 gene	PMID:29154799
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1583885	E	RGD:6480464	20250902	CTD	MESH:D000640	Amitrole results in decreased expression of H2BC27 mRNA	PMID:30047161
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of H2BC26 mRNA	PMID:28542535
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of H2BC26 mRNA	PMID:35811015
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of H2BC26 mRNA	PMID:35701726
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1583885	E	RGD:6480464	20250902	CTD	MESH:D008713	Methimazole results in decreased expression of H2BC27 mRNA	PMID:30047161
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1583885	E	RGD:6480464	20250902	CTD	MESH:C025340	manganese chloride results in decreased expression of H2BC27 mRNA	PMID:28801915
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:641	N-methyl-4-phenylpyridinium	affects expression	ISO	RGD:1583885	E	RGD:6480464	20250902	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium affects the expression of H2BC27 mRNA	PMID:28801915
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of H2BC26 mRNA	PMID:30851411
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of H2BC26 mRNA	PMID:24834073
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1583885	E	RGD:6480464	20250902	CTD	MESH:D011441	Propylthiouracil results in decreased expression of H2BC27 mRNA	PMID:30047161
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1583885	E	RGD:6480464	20250902	CTD	MESH:D011441	Propylthiouracil results in increased expression of H2BC27 mRNA	PMID:24780913
1312718	H2BC26	H2B clustered histone 26	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D013893	Thiram results in increased expression of H2BC26 mRNA	PMID:38568856
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SYNE2 mRNA	PMID:38218311
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of SYNE2 mRNA	PMID:35967413
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1615570	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SYNE2 mRNA	PMID:33045310
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:142921	3-phenylprop-2-enal	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in decreased expression of SYNE2 mRNA	PMID:24211530
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:15368	acrolein	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D000171	Acrolein results in decreased expression of SYNE2 mRNA	PMID:24211530
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYNE2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of SYNE2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SYNE2 mRNA	PMID:32699268|PMID:32845096
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SYNE2 mRNA	PMID:30529165
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SYNE2 mRNA	PMID:26079696
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16130	DDT	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of SYNE2 mRNA	PMID:30207508
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of SYNE2 protein	PMID:31494107
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of SYNE2 protein	PMID:35688186
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SYNE2 mRNA	PMID:39241906
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SYNE2 mRNA	PMID:39298647
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SYNE2 mRNA	PMID:25510870
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SYNE2 mRNA	PMID:38568856
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of SYNE2 mRNA	PMID:27664576
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SYNE2 mRNA	PMID:21179406
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of SYNE2 gene	PMID:33872906
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SYNE2 mRNA	PMID:33754040
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1615570	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SYNE2 mRNA	PMID:34319233
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of SYNE2 gene	PMID:33872906
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305248	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SYNE2 mRNA	PMID:26577399
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SYNE2 protein	PMID:37730182
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of SYNE2 intron	PMID:30157460
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SYNE2 mRNA	PMID:39836092
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of SYNE2 mRNA	PMID:27462272
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:2255	7beta-aminocephalosporanic acid	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:C030735	7-aminocephalosporanic acid results in decreased expression of SYNE2 mRNA	PMID:24211530
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SYNE2 mRNA	PMID:25510870
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SYNE2 mRNA	PMID:25510870
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SYNE2 mRNA	PMID:23649840
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1615570	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of SYNE2 intron	PMID:27776689
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1615570	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SYNE2 mRNA	PMID:19770486
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SYNE2 intron	PMID:30157460
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SYNE2 mRNA	PMID:23649840
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYNE2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of SYNE2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SYNE2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of SYNE2 mRNA	PMID:32699268|PMID:32845096
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SYNE2 mRNA	PMID:27106289
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SYNE2 mRNA	PMID:30723492
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SYNE2 mRNA	PMID:25629700
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SYNE2 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SYNE2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SYNE2 mRNA	PMID:39836092|PMID:40512198
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SYNE2 protein	PMID:35688186
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SYNE2 mRNA	PMID:28960355
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of SYNE2 mRNA	PMID:28903495
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of SYNE2 mRNA	PMID:27392435
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SYNE2 mRNA	PMID:27392435
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SYNE2 mRNA	PMID:33956508
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1615570	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SYNE2 mRNA	PMID:19933214
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of SYNE2 mRNA; Rotenone results in decreased expression of SYNE2 protein	PMID:33512557|PMID:39603559
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of SYNE2 mRNA	PMID:28374803
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SYNE2 mRNA	PMID:28001369
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SYNE2 mRNA; aristolochic acid I results in decreased expression of SYNE2 protein	PMID:33212167
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of SYNE2 mRNA	PMID:23649840
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SYNE2 mRNA	PMID:29803840
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SYNE2 mRNA	PMID:38568856
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1615570	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of SYNE2 mRNA	PMID:36209798
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SYNE2 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SYNE2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SYNE2 mRNA	PMID:39836092|PMID:40512198
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SYNE2 3' UTR; Benzo(a)pyrene affects the methylation of SYNE2 intron	PMID:27901495|PMID:30157460
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SYNE2 mRNA	PMID:22316170|PMID:26238291
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SYNE2 mRNA	PMID:21715664
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SYNE2 promoter	PMID:27901495
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1615570	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SYNE2 exon; Benzo(a)pyrene results in decreased methylation of SYNE2 intron	PMID:27901495
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SYNE2 5' UTR; Benzo(a)pyrene results in increased methylation of SYNE2 exon	PMID:27901495
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA	PMID:27858113
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SYNE2 mRNA	PMID:19150397|PMID:26238291
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of SYNE2 mRNA	PMID:24395379
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of SYNE2 gene	PMID:31601247
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of SYNE2 mRNA	PMID:24136188
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:32063	propylparaben	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C006068	propylparaben results in decreased expression of SYNE2 mRNA	PMID:38568856
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of SYNE2 mRNA	PMID:30047161
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1615570	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SYNE2 gene	PMID:35295148
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1615570	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of SYNE2 mRNA	PMID:29264374
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1615570	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SYNE2 gene	PMID:35295148
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SYNE2 mRNA	PMID:18445702
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305248	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SYNE2 mRNA	PMID:25181051
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SYNE2 protein	PMID:33376534|PMID:37567409
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SYNE2 mRNA	PMID:30816183|PMID:34947998
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of SYNE2 gene	PMID:31601247
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of SYNE2 gene	PMID:31601247
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SYNE2 protein	PMID:31675489
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SYNE2 mRNA	PMID:25510870
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SYNE2 mRNA	PMID:25510870
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34292	1,3-benzothiazole-2-thiol	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:C005563	captax results in decreased expression of SYNE2 mRNA	PMID:24211530
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1615570	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SYNE2 gene	PMID:31683443
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SYNE2 mRNA	PMID:39298647
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of SYNE2 gene	PMID:31601247
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of SYNE2 mRNA	PMID:26377693
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA	PMID:27858113
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SYNE2 intron	PMID:30157460
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1615570	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of SYNE2 protein	PMID:35362542
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SYNE2 protein]	PMID:35362542
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SYNE2 mRNA	PMID:37042841
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SYNE2 mRNA	PMID:39836092
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20140729	CTD	MESH:D002509	Cephaloridine results in decreased expression of SYNE2 mRNA	PMID:18500788
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SYNE2 mRNA	PMID:38568856
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1615570	E	RGD:6480464	20250603	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SYNE2 mRNA	PMID:39778857
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYNE2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SYNE2 mRNA	PMID:32699268
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:37144	epichlorohydrin	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D004811	Epichlorohydrin results in decreased expression of SYNE2 mRNA	PMID:24211530
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:3764	clotrimazole	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of SYNE2 mRNA	PMID:30047161
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SYNE2 mRNA	PMID:31533062
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SYNE2 mRNA	PMID:19167446
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:C100187	chloropicrin results in decreased expression of SYNE2 mRNA	PMID:24211530
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SYNE2 mRNA	PMID:23179753|PMID:28001369
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of SYNE2 mRNA	PMID:29427782
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1615570	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SYNE2 mRNA	PMID:20937368
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1615570	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SYNE2 mRNA	PMID:28973697
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of SYNE2 mRNA	PMID:23649840
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SYNE2 mRNA	PMID:27188386
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of SYNE2 mRNA	PMID:24935251
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNE2 mRNA	PMID:27188386
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SYNE2 mRNA	PMID:21420995
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SYNE2 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SYNE2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SYNE2 mRNA	PMID:39836092|PMID:40512198
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of SYNE2 mRNA	PMID:22079256
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SYNE2 mRNA	PMID:22079256
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1615570	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SYNE2 mRNA	PMID:17555576
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SYNE2 protein]	PMID:35362542
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of SYNE2 mRNA	PMID:38568856
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SYNE2 mRNA; Nanotubes, Carbon results in decreased expression of SYNE2 mRNA	PMID:25554681
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305248	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of SYNE2 mRNA	PMID:24136188
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SYNE2 mRNA	PMID:30047161
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of SYNE2 mRNA	PMID:24136188
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of SYNE2 mRNA	PMID:26377693
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA	PMID:27858113
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1615570	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA	PMID:27858113
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:53578	hexamethylene diisocyanate	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:C015262	1,6-hexamethylene diisocyanate results in decreased expression of SYNE2 mRNA	PMID:24211530
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:59604	ammonium hexachloroplatinate	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:C018453	ammonium hexachloroplatinate results in decreased expression of SYNE2 mRNA	PMID:24211530
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SYNE2 protein	PMID:32959892
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SYNE2 mRNA	PMID:39836092
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1615570	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SYNE2 protein	PMID:26558463
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SYNE2 intron	PMID:30157460
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305248	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SYNE2 gene	PMID:35440735
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1615570	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SYNE2 mRNA	PMID:22206623
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SYNE2 protein	PMID:37664457
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of SYNE2 mRNA	PMID:24136188
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SYNE2 mRNA	PMID:22079256
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SYNE2 mRNA	PMID:22079256
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of SYNE2 mRNA	PMID:27858113
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SYNE2 mRNA	PMID:37199045
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of SYNE2 mRNA	PMID:34995734
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNE2 mRNA	PMID:27188386
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SYNE2 gene]	PMID:28238834
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1615570	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SYNE2 mRNA	PMID:38648751
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SYNE2 protein	PMID:31675489
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SYNE2 protein	PMID:31675489
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of SYNE2 mRNA	PMID:33512557
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305248	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SYNE2 mRNA	PMID:30047161
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305248	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SYNE2 mRNA	PMID:24780913
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SYNE2 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNE2 mRNA	PMID:27188386|PMID:37664457
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:9422	tebufenpyrad	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of SYNE2 mRNA	PMID:33512557
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D013893	Thiram results in decreased expression of SYNE2 mRNA	PMID:24211530
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SYNE2 mRNA	PMID:29301935
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SYNE2 mRNA	PMID:27188386
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SYNE2 mRNA	PMID:28973697
1312719	SYNE2	spectrin repeat containing nuclear envelope protein 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1615570	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SYNE2 mRNA	PMID:35537566
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of STIL mRNA	PMID:38218311
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312721	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of STIL mRNA	PMID:33045310
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of STIL mRNA	PMID:33167477
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of STIL mRNA	PMID:26516004
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of STIL mRNA	PMID:24763279
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of STIL mRNA	PMID:21632981
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312721	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of STIL mRNA	PMID:39241906
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of STIL mRNA	PMID:19167446|PMID:20106945
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312721	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of STIL mRNA	PMID:25210133
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1304972	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of STIL mRNA	PMID:26496021
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in increased expression of STIL mRNA]	PMID:25210133
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STIL mRNA	PMID:25510870
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of STIL mRNA	PMID:20655997
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of STIL mRNA	PMID:21592394
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of STIL mRNA	PMID:21592394
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:176335	SP2509	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C000594309	SP2509 results in decreased expression of STIL mRNA	PMID:29581250
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of STIL mRNA	PMID:21592394
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of STIL mRNA	PMID:21592394
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of STIL mRNA	PMID:28818685
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of STIL mRNA	PMID:37748715
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of STIL mRNA	PMID:36331819
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STIL mRNA	PMID:25510870
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STIL mRNA	PMID:25510870
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of STIL protein	PMID:20106945
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of STIL mRNA	PMID:23649840
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of STIL mRNA	PMID:25102026
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20140408	CTD	MESH:D010126	Ozone results in decreased expression of STIL mRNA	PMID:24336422
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312721	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of STIL mRNA	PMID:33026818
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of STIL mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of STIL mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of STIL mRNA	PMID:25658374|PMID:34911549
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312721	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of STIL mRNA	PMID:31919559
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of STIL mRNA	PMID:25629700
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of STIL mRNA	PMID:15767336
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of STIL mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of STIL mRNA	PMID:19167446|PMID:23557933
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of STIL mRNA	PMID:30912803
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STIL mRNA	PMID:22574217
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of STIL mRNA	PMID:20106945|PMID:21632981|PMID:21802500
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304972	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of STIL mRNA	PMID:32109520
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of STIL mRNA	PMID:33212167
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of STIL mRNA	PMID:22623647
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of STIL mRNA	PMID:17998272
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STIL intron; Benzo(a)pyrene affects the methylation of STIL promoter	PMID:30157460
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STIL mRNA	PMID:21802500
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STIL mRNA	PMID:32234424
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312721	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STIL mRNA	PMID:32417428
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to STIL mRNA]	PMID:32406909
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312721	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of STIL mRNA	PMID:29341224
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of STIL mRNA	PMID:20382639
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of STIL mRNA	PMID:35295148
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312721	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STIL gene; titanium dioxide results in decreased methylation of STIL promoter	PMID:35295148
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312721	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of STIL mRNA	PMID:23557971
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of STIL mRNA	PMID:20813756
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312721	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of STIL mRNA	PMID:20059764
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of STIL mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of STIL mRNA]	PMID:19710929|PMID:20059764
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of STIL mRNA	PMID:38479592
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of STIL mRNA	PMID:29275510
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304972	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STIL mRNA	PMID:25181051
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304972	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of STIL mRNA	PMID:32145629
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of STIL gene	PMID:31601247
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304972	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STIL mRNA; [bisphenol A co-treated with Estradiol] results in increased expression of STIL mRNA	PMID:26496021|PMID:36041667
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STIL mRNA	PMID:25510870
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of STIL mRNA	PMID:25510870
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of STIL mRNA	PMID:40203079
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304972	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STIL mRNA	PMID:36041667
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304972	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STIL mRNA	PMID:36041667
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1304972	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of STIL mRNA	PMID:30723492
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of STIL mRNA	PMID:38174414
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312721	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of STIL mRNA	PMID:28962523
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of STIL mRNA	PMID:40194260
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312721	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of STIL mRNA	PMID:40194260
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of STIL mRNA	PMID:31533062
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of STIL mRNA	PMID:19167446
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STIL mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of STIL mRNA	PMID:19167446
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of STIL mRNA	PMID:39529242
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of STIL mRNA	PMID:40419075
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312721	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of STIL mRNA	PMID:36331819
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312721	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of STIL mRNA	PMID:23125180
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of STIL mRNA	PMID:20106945|PMID:21632981
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of STIL mRNA	PMID:38832940
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of STIL mRNA	PMID:22230336
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1304972	E	RGD:6480464	20190507	CTD	MESH:D004008	Diclofenac results in increased expression of STIL mRNA	PMID:30723492
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in decreased expression of STIL mRNA	PMID:24383545
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:48981	quinolin-8-ol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of STIL mRNA	PMID:21632981
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312721	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of STIL mRNA; Nanotubes, Carbon results in increased expression of STIL mRNA	PMID:25554681
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312721	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of STIL mRNA	PMID:19042947
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312721	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of STIL mRNA	PMID:38701926
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1304972	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of STIL mRNA	PMID:37269647
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of STIL mRNA	PMID:36851058
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1304972	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of STIL mRNA	PMID:35283115
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of STIL mRNA	PMID:29522793
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of STIL mRNA	PMID:37199045
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of STIL mRNA	PMID:34995734
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of STIL mRNA	PMID:19167446
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:85993	palbociclib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of STIL mRNA	PMID:22869556
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1304972	E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of STIL mRNA	PMID:32419051
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of STIL mRNA	PMID:19140230
1312720	STIL	STIL centriolar assembly protein	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312721	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of STIL mRNA	PMID:35537566
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MOSPD3 mRNA	PMID:38218311
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of MOSPD3 mRNA	PMID:35967413
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312723	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MOSPD3 mRNA	PMID:33045310
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304973	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MOSPD3 mRNA]	PMID:31150632
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:137392	chlormequat chloride	decreases expression	ISO	RGD:1304973	E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in decreased expression of MOSPD3 protein	PMID:34958886
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MOSPD3 mRNA	PMID:20938992
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MOSPD3 mRNA	PMID:22378314
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of MOSPD3 mRNA	PMID:31614463
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304973	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of MOSPD3 gene	PMID:27618143
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MOSPD3 mRNA	PMID:20938992
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MOSPD3 mRNA	PMID:37042841
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MOSPD3 mRNA	PMID:36331819
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MOSPD3 mRNA	PMID:35430440
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304973	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MOSPD3 mRNA	PMID:31150632
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304973	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MOSPD3 mRNA]	PMID:31150632
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MOSPD3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MOSPD3 mRNA	PMID:20938992|PMID:22206623
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of MOSPD3 mRNA	PMID:23557933
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MOSPD3 mRNA	PMID:27392435
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312723	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MOSPD3 mRNA	PMID:21570461
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304973	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of MOSPD3 mRNA	PMID:28374803
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MOSPD3 mRNA	PMID:38568856
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MOSPD3 promoter	PMID:27901495
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312723	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of MOSPD3 mRNA	PMID:27131904
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of MOSPD3 mRNA	PMID:25895662
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304973	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of MOSPD3 mRNA	PMID:24136188
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312723	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MOSPD3 gene	PMID:35295148
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304973	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MOSPD3 mRNA	PMID:34492290
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of MOSPD3 mRNA	PMID:28329830
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304973	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MOSPD3 mRNA	PMID:25181051
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312723	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in decreased expression of MOSPD3 mRNA	PMID:21932408
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MOSPD3 mRNA	PMID:28628672
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312723	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MOSPD3 mRNA	PMID:25172293
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312723	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MOSPD3 mRNA	PMID:38685157
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312723	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of MOSPD3 intron	PMID:28392331
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312723	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MOSPD3 mRNA	PMID:37019170
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304973	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MOSPD3 mRNA	PMID:21266533
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312723	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MOSPD3 mRNA	PMID:34813904
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MOSPD3 mRNA	PMID:28628672
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312723	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of MOSPD3 mRNA	PMID:34813904
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MOSPD3 mRNA	PMID:37042841
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20121009	CTD	MESH:D019256	MT3 affects the reaction [Cadmium Chloride affects the expression of MOSPD3 mRNA]	PMID:20371981
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MOSPD3 mRNA	PMID:32588087
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MOSPD3 mRNA	PMID:31533062
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MOSPD3 mRNA	PMID:36331819
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MOSPD3 mRNA	PMID:25979313
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of MOSPD3 mRNA	PMID:20106945
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MOSPD3 mRNA	PMID:28628672
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312723	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MOSPD3 mRNA	PMID:17562736
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1312723	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of MOSPD3 mRNA	PMID:29279043
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of MOSPD3 mRNA	PMID:38568856
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MOSPD3 mRNA	PMID:28628672
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MOSPD3 mRNA	PMID:35964746
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312723	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of MOSPD3 mRNA	PMID:23650126
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1304973	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of MOSPD3 mRNA	PMID:24136188
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312723	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MOSPD3 mRNA	PMID:22206623
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312723	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MOSPD3 mRNA	PMID:22206623
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1304973	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of MOSPD3 mRNA	PMID:24136188
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312723	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of MOSPD3 mRNA	PMID:27131904
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MOSPD3 mRNA	PMID:38568856
1312722	MOSPD3	motile sperm domain containing 3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MOSPD3 mRNA	PMID:29301935
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RAD52 mRNA	PMID:38218311
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1304975	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of RAD52 mRNA	PMID:36841081
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RAD52 mRNA	PMID:12057914|PMID:39241906
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304975	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RAD52 mRNA	PMID:33387578
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RAD52 mRNA	PMID:37042841
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20230502	CTD	MESH:D001554	Benzene results in decreased expression of RAD52 mRNA	PMID:35963423
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1312726	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of RAD52 mRNA	PMID:17945193
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RAD52 mRNA	PMID:39836092
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RAD52 mRNA	PMID:23649840
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312726	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RAD52 mRNA	PMID:19770486
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RAD52 gene	PMID:27153756
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RAD52 mRNA	PMID:19799994|PMID:23649840
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20240206	CTD	MESH:D009151	Mustard Gas results in decreased expression of RAD52 mRNA	PMID:19778212
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RAD52 mRNA	PMID:33387578
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAD52 mRNA	PMID:39836092
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312726	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAD52 mRNA	PMID:40504410
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RAD52 mRNA	PMID:28960355
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20210608	CTD	MESH:C059514	Resveratrol results in decreased expression of RAD52 mRNA	PMID:33775663
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312726	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAD52 mRNA	PMID:21570461
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304975	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAD52 mRNA	PMID:33387578
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of RAD52 mRNA	PMID:29955902
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312726	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of RAD52 mRNA	PMID:39631538
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of RAD52 gene	PMID:28589171
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RAD52 mRNA	PMID:38568856
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAD52 mRNA	PMID:39836092
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312726	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAD52 mRNA	PMID:40504410
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RAD52 mRNA	PMID:20504355
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312726	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RAD52 mRNA	PMID:22228805
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RAD52 5' UTR; Benzo(a)pyrene results in increased methylation of RAD52 promoter	PMID:27901495
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RAD52 mRNA]	PMID:32406909
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RAD52 mRNA	PMID:19073995
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of RAD52 mRNA	PMID:15073043
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304975	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RAD52 mRNA	PMID:25729387
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RAD52 mRNA	PMID:30047161
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312726	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RAD52 mRNA	PMID:18648102
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220607	CTD	MESH:C006780	bisphenol A affects the methylation of RAD52 gene	PMID:33391824
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of RAD52 mRNA	PMID:32156529
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304975	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RAD52 mRNA	PMID:25181051
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312726	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RAD52 mRNA	PMID:26063408
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304975	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RAD52 gene	PMID:28505145
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RAD52 mRNA	PMID:28628672
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RAD52 mRNA	PMID:38685157
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1312726	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of RAD52 mRNA	PMID:36464114
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RAD52 mRNA	PMID:21266533
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RAD52 mRNA	PMID:28628672
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1304975	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of RAD52 mRNA	PMID:22110744
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:35019	tributyl phosphate	increases expression	ISO	RGD:1312726	E	RGD:6480464	20260303	CTD	MESH:C009524	tributyl phosphate results in increased expression of RAD52 mRNA	PMID:40389058
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RAD52 mRNA	PMID:37042841
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	increases expression	ISO	RGD:1312726	E	RGD:6480464	20260303	CTD	MESH:C031324	tris(chloroethyl)phosphate results in increased expression of RAD52 mRNA	PMID:40389058
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RAD52 mRNA	PMID:39836092
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of RAD52 mRNA	PMID:16269432
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20121009	CTD	MESH:C039281	furan results in decreased expression of RAD52 mRNA	PMID:22507866
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RAD52 mRNA	PMID:24449571
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of RAD52 mRNA	PMID:17585979
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RAD52 mRNA	PMID:24383497
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RAD52 mRNA	PMID:30047161
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of RAD52 promoter	PMID:27989131
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RAD52 mRNA	PMID:28628672
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312726	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RAD52 mRNA	PMID:28973697
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RAD52 mRNA	PMID:38832940
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312726	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RAD52 mRNA	PMID:17562736
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304975	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RAD52 mRNA	PMID:33387578
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAD52 mRNA	PMID:39836092
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312726	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAD52 mRNA	PMID:40504410
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of RAD52 mRNA; Etoposide results in increased expression of RAD52 protein	PMID:16417649|PMID:19799994
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:4911	etoposide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	BRCA1 protein mutant form inhibits the reaction [Etoposide results in increased expression of RAD52 protein]	PMID:16417649
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20120412	CTD	MESH:C005223	methyleugenol results in decreased expression of RAD52 mRNA	PMID:21659616
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RAD52 mRNA	PMID:28628672
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of RAD52 mRNA	PMID:15073043
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RAD52 mRNA	PMID:30047161
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RAD52 mRNA	PMID:39836092
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304975	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RAD52 mRNA	PMID:25729387
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312726	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of RAD52 mRNA	PMID:20003209
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of RAD52 mRNA	PMID:19564919
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1312726	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of RAD52 mRNA	PMID:36464114
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312726	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RAD52 mRNA	PMID:22206623
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RAD52 mRNA	PMID:37199045
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of RAD52 mRNA	PMID:19162173
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312726	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of RAD52 mRNA	PMID:30294300
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of RAD52 mRNA	PMID:30047161
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RAD52 mRNA	PMID:30047161
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RAD52 mRNA	PMID:19281266
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304975	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RAD52 mRNA	PMID:21346803
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312726	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of RAD52 mRNA	PMID:28973697
1312725	RAD52	RAD52 DNA repair protein	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304975	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of RAD52 mRNA	PMID:23869203
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of USP8 mRNA	PMID:33045310
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304979	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of USP8 mRNA]	PMID:31150632
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of USP8 gene	PMID:20938992
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312731	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of USP8 mRNA	PMID:30319688
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of USP8 mRNA	PMID:39298647
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of USP8 gene	PMID:20938992
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of USP8 mRNA	PMID:37042841
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of USP8 mRNA	PMID:33754040
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of USP8 protein	PMID:37730182
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1304979	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of USP8 protein	PMID:34915118
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:22689	bafilomycin A1	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:C040929	[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] promotes the reaction [bafilomycin A1 results in increased cleavage of PARP1 protein]; bafilomycin A1 promotes the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein]	PMID:35022897
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of USP8 mRNA	PMID:28111341
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:229924	pifithrin-alpha hydrobromide	multiple interactions	EXP		E	RGD:6480464	20240409	CTD	MESH:C121565	pifithrin inhibits the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein]; pifithrin inhibits the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased expression of BAX protein]; pifithrin inhibits the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased expression of BBC3 protein]; pifithrin inhibits the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased expression of CDKN1A protein]; pifithrin inhibits the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased expression of PMAIP1 protein]	PMID:35022897
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of USP8 mRNA	PMID:23649840
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of USP8 mRNA	PMID:41430723
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1304979	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of USP8 mRNA	PMID:31150632
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304979	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of USP8 mRNA]	PMID:31150632
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of USP8 gene	PMID:20938992
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP8 mRNA	PMID:40504410
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of USP8 protein	PMID:35688186
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of USP8 mRNA	PMID:23557933
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of USP8 mRNA	PMID:30912803
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312731	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of USP8 mRNA	PMID:21570461
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304979	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of USP8 mRNA	PMID:34747641
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of USP8 mRNA	PMID:30851411
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of USP8 mRNA	PMID:29803840
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of USP8 protein	PMID:35688186
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:29019	nonanoic acid	increases expression	ISO	RGD:1312731	E	RGD:6480464	20120412	CTD	MESH:C008776	pelargonic acid results in increased expression of USP8 mRNA	PMID:11379042
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of USP8 mRNA	PMID:12016162|PMID:38568856
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP8 mRNA	PMID:40504410
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of USP8 mRNA	PMID:17879257
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312731	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of USP8 gene	PMID:35295148
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312731	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of USP8 promoter	PMID:27334623
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of USP8 mRNA	PMID:33221593
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304979	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of USP8 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of USP8 mRNA	PMID:28628672
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of USP8 mRNA	PMID:28628672
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of USP8 mRNA	PMID:28111341
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:3638	chloroquine	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:D002738	[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] promotes the reaction [Chloroquine results in increased cleavage of PARP1 protein]; Chloroquine promotes the reaction [[Cysteine Proteinase Inhibitors results in decreased activity of USP8 protein] which results in increased cleavage of PARP1 protein]	PMID:35022897
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of USP8 mRNA	PMID:28302478
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of USP8 mRNA	PMID:25979313
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312731	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of USP8 mRNA	PMID:17555576
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of USP8 mRNA	PMID:28628672
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312731	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of USP8 mRNA	PMID:17562736
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304979	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of USP8 mRNA	PMID:33387578
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312731	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP8 mRNA	PMID:40504410
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312731	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of USP8 mRNA	PMID:17555576
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of USP8 mRNA	PMID:28628672
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	decreases expression	ISO	RGD:1304979	E	RGD:6480464	20150512	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in decreased expression of USP8 mRNA	PMID:23537331
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:53556	toluene 2,4-diisocyanate	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20120412	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in decreased expression of USP8 mRNA	PMID:11379042
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of USP8 mRNA	PMID:23650126
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1304979	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of USP8 mRNA	PMID:30467583
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of USP8 mRNA	PMID:22206623
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of USP8 mRNA	PMID:30851411
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of USP8 mRNA	PMID:21795629
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312731	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of USP8 mRNA	PMID:21795629
1312730	USP8	ubiquitin specific peptidase 8	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1312731	E	RGD:6480464	20230801	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of USP8 mRNA	PMID:33269387
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MAPKAPK3 mRNA	PMID:38218311
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:132098	methoxyacetic acid	affects expression	ISO	RGD:1304980	E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid affects the expression of MAPKAPK3 mRNA	PMID:20864626
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of MAPKAPK3 mRNA	PMID:15928584
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MAPKAPK3 mRNA	PMID:33167477
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MAPKAPK3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MAPKAPK3 mRNA	PMID:32699268
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAPKAPK3 mRNA	PMID:36331819
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MAPKAPK3 mRNA	PMID:39241906
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20161228	CTD	MESH:D008070	MAPKAPK3 protein affects the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA]; MAPKAPK3 protein affects the reaction [MAPKAPK2 protein affects the reaction [Lipopolysaccharides affects the localization of RELA protein]]; MAPKAPK3 protein affects the reaction [MAPKAPK2 protein affects the reaction [Lipopolysaccharides results in increased activity of STAT3 protein]]; MAPKAPK3 protein affects the reaction [MAPKAPK2 protein affects the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]]	PMID:21586572
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MAPKAPK3 mRNA	PMID:38568856
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D002635	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650|PMID:33819548
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAPKAPK3 mRNA	PMID:37992649
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MAPKAPK3 mRNA	PMID:22401849
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1304980	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of MAPKAPK3 mRNA	PMID:22967744
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAPKAPK3 mRNA	PMID:37992649
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006000	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650|PMID:33819548
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MAPKAPK3 mRNA	PMID:34319233
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304980	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MAPKAPK3 mRNA	PMID:33387578
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MAPKAPK3 mRNA	PMID:28818685
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of MAPKAPK3 mRNA	PMID:24067728
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304980	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of MAPKAPK3 mRNA	PMID:21396975
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1304980	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA]	PMID:22129741
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MAPKAPK3 mRNA	PMID:22100608
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552084	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MAPKAPK3 mRNA	PMID:19770486
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MAPKAPK3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MAPKAPK3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of MAPKAPK3 mRNA	PMID:32699268
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552084	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAPKAPK3 mRNA	PMID:31919559
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MAPKAPK3 mRNA	PMID:25629700
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006002	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650|PMID:33819548
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:27504	mitomycin C	increases expression	ISO	RGD:1552084	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in increased expression of MAPKAPK3 mRNA	PMID:25270620
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAPKAPK3 mRNA	PMID:40504410
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:27641	cycloheximide	affects response to substance	EXP		E	RGD:6480464	20150609	CTD	MESH:D003513	MAPKAPK3 gene SNP affects the susceptibility to Cycloheximide	PMID:25622337
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:27698	vanadium atom	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of MAPKAPK3 mRNA	PMID:19000753
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MAPKAPK3 protein	PMID:35688186
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1304980	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of MAPKAPK3 gene	PMID:35440735
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of MAPKAPK3 mRNA	PMID:27392435
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1552084	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in increased expression of MAPKAPK3 mRNA	PMID:25270620
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MAPKAPK3 mRNA	PMID:27392435
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MAPKAPK3 mRNA	PMID:25583101
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552084	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAPKAPK3 mRNA	PMID:21570461
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304980	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MAPKAPK3 mRNA	PMID:21215274
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304980	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAPKAPK3 mRNA	PMID:32109520|PMID:33387578
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304980	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of MAPKAPK3 mRNA	PMID:19013527
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MAPKAPK3 mRNA	PMID:28001369
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MAPKAPK3 mRNA	PMID:33212167
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MAPKAPK3 mRNA	PMID:32763439
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MAPKAPK3 mRNA	PMID:30911355
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of MAPKAPK3 mRNA	PMID:39631538
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAPKAPK3 mRNA	PMID:37992649
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D003840	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650|PMID:33819548
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1304980	E	RGD:6480464	20121009	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA]	PMID:22129741
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MAPKAPK3 mRNA	PMID:12760830|PMID:38568856
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MAPKAPK3 mRNA	PMID:37682722
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:29678	sodium arsenite	increases activity	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased activity of MAPKAPK3 protein	PMID:12547826
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	SB 203580 inhibits the reaction [sodium arsenite results in increased activity of MAPKAPK3 protein]	PMID:12547826
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAPKAPK3 mRNA	PMID:40504410
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAPKAPK3 mRNA	PMID:22228805
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAPKAPK3 mRNA	PMID:32234424
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552084	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAPKAPK3 mRNA	PMID:19770486
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of MAPKAPK3 protein	PMID:37955338
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MAPKAPK3 mRNA	PMID:30911355
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:31243	atazanavir sulfate	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D000069446	Atazanavir Sulfate results in increased expression of MAPKAPK3 mRNA	PMID:32152650
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D000069446	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of MAPKAPK3 gene	PMID:31601247
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1304980	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of MAPKAPK3 mRNA	PMID:32479839
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552084	E	RGD:6480464	20180515	CTD	MESH:C009495	titanium dioxide results in increased expression of MAPKAPK3 mRNA	PMID:29128614|PMID:29264374
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304980	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MAPKAPK3 mRNA	PMID:34492290
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1304980	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of MAPKAPK3 mRNA	PMID:19167457
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of MAPKAPK3 mRNA	PMID:29275510
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304980	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MAPKAPK3 mRNA	PMID:25181051|PMID:30816183
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1304980	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of MAPKAPK3 mRNA	PMID:23196670
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MAPKAPK3 gene	PMID:31601247
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1552084	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of MAPKAPK3 exon	PMID:33297965
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of MAPKAPK3 gene	PMID:31601247
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1304980	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAPKAPK3 mRNA	PMID:17602206
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of MAPKAPK3 gene	PMID:22964155
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304980	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MAPKAPK3 mRNA	PMID:21266533
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304980	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAPKAPK3 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MAPKAPK3 mRNA]	PMID:17602206|PMID:22129741
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1304980	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MAPKAPK3 mRNA	PMID:32680482
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MAPKAPK3 mRNA	PMID:37042841
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:35170	vanadium(0)	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of MAPKAPK3 mRNA	PMID:19000753
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MAPKAPK3 mRNA	PMID:24449571
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D005999	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of MAPKAPK3 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650|PMID:33819548
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of MAPKAPK3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of MAPKAPK3 mRNA	PMID:32699268
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MAPKAPK3 mRNA	PMID:39529242
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAPKAPK3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of MAPKAPK3 mRNA	PMID:36331819
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1552084	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of MAPKAPK3 mRNA	PMID:31558096
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MAPKAPK3 mRNA	PMID:25979313
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MAPKAPK3 mRNA	PMID:19101580|PMID:23179753
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MAPKAPK3 mRNA	PMID:20106945|PMID:32152650|PMID:34681664
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1552084	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of MAPKAPK3 mRNA	PMID:19770486
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MAPKAPK3 mRNA	PMID:37992649
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552084	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAPKAPK3 mRNA	PMID:17562736
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MAPKAPK3 mRNA	PMID:21420995
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304980	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MAPKAPK3 mRNA	PMID:33387578
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D000082	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of MAPKAPK3 mRNA	PMID:33819548
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of MAPKAPK3 mRNA	PMID:24714768
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552084	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAPKAPK3 mRNA	PMID:40504410
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1552084	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of MAPKAPK3 mRNA	PMID:26934552
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304980	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of MAPKAPK3 mRNA	PMID:29391264
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1304980	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MAPKAPK3 mRNA	PMID:15576828
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1552084	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of MAPKAPK3 mRNA	PMID:25270620
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of MAPKAPK3 mRNA	PMID:25620056
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:5130	flurbiprofen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005480	MAPKAPK3 protein promotes the reaction [Flurbiprofen results in increased expression of NGFR protein]	PMID:18056468
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of MAPKAPK3 mRNA	PMID:18651567
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D011192	Potassium Dichromate results in increased expression of MAPKAPK3 mRNA	PMID:11678601
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:5855	ibuprofen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D007052	MAPKAPK3 protein promotes the reaction [Ibuprofen results in increased expression of NGFR protein]	PMID:18056468
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of MAPKAPK3 mRNA	PMID:31758290
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552084	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MAPKAPK3 mRNA	PMID:22206623
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:C051752	nefazodone results in increased expression of MAPKAPK3 mRNA	PMID:32152650
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:7494	nefazodone	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:C051752	[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAPKAPK3 mRNA	PMID:32152650
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1304980	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MAPKAPK3 mRNA	PMID:27291303
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1304980	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MAPKAPK3 mRNA	PMID:23640034
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1552084	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of MAPKAPK3 mRNA	PMID:27029645
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:90705	SB 203580	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C093642	SB 203580 inhibits the reaction [sodium arsenite results in increased activity of MAPKAPK3 protein]	PMID:12547826
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304980	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of MAPKAPK3 mRNA	PMID:19281266
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304980	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MAPKAPK3 mRNA	PMID:21346803
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:9405	tartrazine	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D013645	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAPKAPK3 mRNA	PMID:33819548
1312732	MAPKAPK3	MAPK activated protein kinase 3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MAPKAPK3 mRNA	PMID:29301935
1312734	LPXN	leupaxin	gene	CHEBI:10022	deoxynivalenol	decreases phosphorylation	ISO	RGD:1312735	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in decreased phosphorylation of LPXN protein	PMID:23352502
1312734	LPXN	leupaxin	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of LPXN mRNA	PMID:35967413
1312734	LPXN	leupaxin	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312735	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LPXN mRNA	PMID:33045310
1312734	LPXN	leupaxin	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1312735	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in increased expression of LPXN mRNA	PMID:33227293
1312734	LPXN	leupaxin	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LPXN mRNA	PMID:20938992
1312734	LPXN	leupaxin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of LPXN mRNA	PMID:33167477
1312734	LPXN	leupaxin	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of LPXN mRNA	PMID:22378314
1312734	LPXN	leupaxin	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of LPXN mRNA	PMID:21632981
1312734	LPXN	leupaxin	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of LPXN mRNA	PMID:29581250
1312734	LPXN	leupaxin	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LPXN mRNA	PMID:39241906
1312734	LPXN	leupaxin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of LPXN mRNA]	PMID:39241906
1312734	LPXN	leupaxin	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of LPXN mRNA	PMID:31614463
1312734	LPXN	leupaxin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of LPXN mRNA	PMID:30165855
1312734	LPXN	leupaxin	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304981	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LPXN mRNA	PMID:33387578
1312734	LPXN	leupaxin	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LPXN mRNA	PMID:20938992
1312734	LPXN	leupaxin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LPXN mRNA	PMID:37042841
1312734	LPXN	leupaxin	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of LPXN mRNA	PMID:19162166
1312734	LPXN	leupaxin	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of LPXN mRNA	PMID:23649840
1312734	LPXN	leupaxin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LPXN mRNA	PMID:37992649
1312734	LPXN	leupaxin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LPXN mRNA	PMID:37992649
1312734	LPXN	leupaxin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312735	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LPXN mRNA	PMID:34319233
1312734	LPXN	leupaxin	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of LPXN protein	PMID:37730182
1312734	LPXN	leupaxin	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304981	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of LPXN mRNA	PMID:22061828|PMID:33387578
1312734	LPXN	leupaxin	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LPXN mRNA	PMID:19549813
1312734	LPXN	leupaxin	gene	CHEBI:234430	gardiquimod	decreases expression	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in decreased expression of LPXN mRNA	PMID:28003376
1312734	LPXN	leupaxin	gene	CHEBI:234430	gardiquimod	multiple interactions	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of LPXN mRNA]	PMID:28003376
1312734	LPXN	leupaxin	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of LPXN mRNA	PMID:23649840
1312734	LPXN	leupaxin	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LPXN mRNA	PMID:22100608|PMID:27153756
1312734	LPXN	leupaxin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312735	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LPXN mRNA	PMID:19770486
1312734	LPXN	leupaxin	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of LPXN mRNA	PMID:23649840
1312734	LPXN	leupaxin	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of LPXN mRNA	PMID:35430440
1312734	LPXN	leupaxin	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312735	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LPXN mRNA	PMID:27339419|PMID:31919559
1312734	LPXN	leupaxin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LPXN mRNA	PMID:20938992
1312734	LPXN	leupaxin	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of LPXN mRNA	PMID:40512198
1312734	LPXN	leupaxin	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LPXN mRNA]	PMID:11007951
1312734	LPXN	leupaxin	gene	CHEBI:27810	resorcinol	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in decreased expression of LPXN mRNA	PMID:22623647
1312734	LPXN	leupaxin	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1304981	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of LPXN mRNA	PMID:31881176
1312734	LPXN	leupaxin	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of LPXN mRNA	PMID:19921347
1312734	LPXN	leupaxin	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of LPXN mRNA	PMID:23195993
1312734	LPXN	leupaxin	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of LPXN mRNA	PMID:24768652|PMID:25583101
1312734	LPXN	leupaxin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312735	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LPXN mRNA	PMID:21570461
1312734	LPXN	leupaxin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LPXN mRNA	PMID:11007951|PMID:20106945|PMID:21632981
1312734	LPXN	leupaxin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304981	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LPXN mRNA	PMID:33387578|PMID:34747641
1312734	LPXN	leupaxin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312735	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LPXN mRNA	PMID:26290441
1312734	LPXN	leupaxin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of LPXN mRNA]	PMID:11007951
1312734	LPXN	leupaxin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LPXN mRNA	PMID:17942748
1312734	LPXN	leupaxin	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LPXN mRNA	PMID:28001369
1312734	LPXN	leupaxin	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LPXN mRNA	PMID:33212167
1312734	LPXN	leupaxin	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of LPXN mRNA	PMID:32763439
1312734	LPXN	leupaxin	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of LPXN mRNA	PMID:20971185
1312734	LPXN	leupaxin	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312735	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of LPXN mRNA	PMID:39631538
1312734	LPXN	leupaxin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LPXN mRNA	PMID:37992649
1312734	LPXN	leupaxin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312735	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of LPXN mRNA	PMID:39515575
1312734	LPXN	leupaxin	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of LPXN mRNA	PMID:22714537|PMID:38568856
1312734	LPXN	leupaxin	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of LPXN mRNA	PMID:40512198
1312734	LPXN	leupaxin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LPXN mRNA	PMID:34876320
1312734	LPXN	leupaxin	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of LPXN mRNA	PMID:22378314
1312734	LPXN	leupaxin	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LPXN mRNA	PMID:34876320
1312734	LPXN	leupaxin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LPXN mRNA	PMID:20106945|PMID:21632981|PMID:30453624
1312734	LPXN	leupaxin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312735	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LPXN mRNA	PMID:22228805
1312734	LPXN	leupaxin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LPXN 3' UTR	PMID:27901495
1312734	LPXN	leupaxin	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of LPXN mRNA]	PMID:22228805
1312734	LPXN	leupaxin	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of LPXN promoter	PMID:23974009
1312734	LPXN	leupaxin	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to LPXN mRNA]	PMID:32406909
1312734	LPXN	leupaxin	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of LPXN mRNA	PMID:20971185
1312734	LPXN	leupaxin	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1312735	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LPXN mRNA	PMID:27131904
1312734	LPXN	leupaxin	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312735	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LPXN mRNA	PMID:29341224
1312734	LPXN	leupaxin	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of LPXN mRNA	PMID:35984750
1312734	LPXN	leupaxin	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1312735	E	RGD:6480464	20211207	CTD	MESH:D001761	Bleomycin results in increased expression of LPXN mRNA	PMID:30825431
1312734	LPXN	leupaxin	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20211207	CTD	MESH:D001761	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of LPXN mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of LPXN mRNA]	PMID:30825431
1312734	LPXN	leupaxin	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of LPXN mRNA	PMID:38568856
1312734	LPXN	leupaxin	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1304981	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of LPXN mRNA	PMID:25729387
1312734	LPXN	leupaxin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312735	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of LPXN mRNA	PMID:23557971|PMID:27760801
1312734	LPXN	leupaxin	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304981	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of LPXN mRNA	PMID:23411599|PMID:34492290
1312734	LPXN	leupaxin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1304981	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of LPXN mRNA	PMID:25380136
1312734	LPXN	leupaxin	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LPXN mRNA	PMID:19710929
1312734	LPXN	leupaxin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of LPXN mRNA	PMID:29275510
1312734	LPXN	leupaxin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304981	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LPXN mRNA	PMID:25181051
1312734	LPXN	leupaxin	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LPXN mRNA	PMID:28628672
1312734	LPXN	leupaxin	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LPXN mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of LPXN mRNA	PMID:28628672
1312734	LPXN	leupaxin	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of LPXN mRNA]	PMID:39241906
1312734	LPXN	leupaxin	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1304981	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of LPXN mRNA	PMID:35163327
1312734	LPXN	leupaxin	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LPXN mRNA	PMID:38174414|PMID:38568856
1312734	LPXN	leupaxin	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1304981	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of LPXN mRNA	PMID:27387713
1312734	LPXN	leupaxin	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1304981	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of LPXN mRNA	PMID:25380136
1312734	LPXN	leupaxin	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LPXN mRNA	PMID:24449571
1312734	LPXN	leupaxin	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of LPXN mRNA]	PMID:28003376
1312734	LPXN	leupaxin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312735	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LPXN mRNA	PMID:40194260
1312734	LPXN	leupaxin	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of LPXN mRNA	PMID:26352163
1312734	LPXN	leupaxin	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C100187	chloropicrin results in decreased expression of LPXN mRNA	PMID:28476498
1312734	LPXN	leupaxin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312735	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of LPXN mRNA	PMID:17292431
1312734	LPXN	leupaxin	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of LPXN mRNA	PMID:29154799
1312734	LPXN	leupaxin	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of LPXN mRNA	PMID:25562108|PMID:27989131
1312734	LPXN	leupaxin	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LPXN mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of LPXN mRNA	PMID:28628672
1312734	LPXN	leupaxin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LPXN mRNA	PMID:37992649
1312734	LPXN	leupaxin	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of LPXN mRNA	PMID:23649840
1312734	LPXN	leupaxin	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of LPXN mRNA	PMID:27188386
1312734	LPXN	leupaxin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312735	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LPXN mRNA	PMID:17562736
1312734	LPXN	leupaxin	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of LPXN mRNA	PMID:21420995
1312734	LPXN	leupaxin	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304981	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LPXN mRNA	PMID:33387578
1312734	LPXN	leupaxin	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	LPXN protein affects the susceptibility to Fluorouracil	PMID:15548681
1312734	LPXN	leupaxin	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of LPXN mRNA	PMID:40512198
1312734	LPXN	leupaxin	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304981	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of LPXN mRNA	PMID:29391264
1312734	LPXN	leupaxin	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LPXN mRNA	PMID:34876320
1312734	LPXN	leupaxin	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of LPXN mRNA	PMID:24383545
1312734	LPXN	leupaxin	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LPXN mRNA	PMID:17942748
1312734	LPXN	leupaxin	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LPXN mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of LPXN mRNA	PMID:28628672
1312734	LPXN	leupaxin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of LPXN mRNA	PMID:19194470
1312734	LPXN	leupaxin	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312735	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LPXN mRNA; Nanotubes, Carbon results in increased expression of LPXN mRNA	PMID:25554681
1312734	LPXN	leupaxin	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1304981	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of LPXN mRNA	PMID:34044035
1312734	LPXN	leupaxin	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312735	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of LPXN mRNA	PMID:19042947
1312734	LPXN	leupaxin	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of LPXN mRNA	PMID:31629900
1312734	LPXN	leupaxin	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of LPXN mRNA	PMID:38701926
1312734	LPXN	leupaxin	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1304981	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of LPXN mRNA	PMID:25729387
1312734	LPXN	leupaxin	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1312735	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of LPXN mRNA	PMID:19751817
1312734	LPXN	leupaxin	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1304981	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of LPXN mRNA	PMID:35283115
1312734	LPXN	leupaxin	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1304981	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of LPXN mRNA	PMID:19564919
1312734	LPXN	leupaxin	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of LPXN mRNA]	PMID:30825431
1312734	LPXN	leupaxin	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of LPXN mRNA	PMID:31758290
1312734	LPXN	leupaxin	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312735	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LPXN mRNA	PMID:22206623
1312734	LPXN	leupaxin	gene	CHEBI:748998	lenabasum	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260714	CTD	MESH:C471849	lenabasum inhibits the reaction [Bleomycin results in increased expression of LPXN mRNA]	PMID:30825431
1312734	LPXN	leupaxin	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of LPXN mRNA	PMID:22714537
1312734	LPXN	leupaxin	gene	CHEBI:753051	incobotulinumtoxina	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA affects the expression of LPXN mRNA	PMID:29522793
1312734	LPXN	leupaxin	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of LPXN mRNA	PMID:37199045
1312734	LPXN	leupaxin	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1304981	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of LPXN mRNA	PMID:21346803
1312734	LPXN	leupaxin	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of LPXN mRNA	PMID:19095052
1312734	LPXN	leupaxin	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LPXN mRNA	PMID:34876320
1312734	LPXN	leupaxin	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312735	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of LPXN mRNA]	PMID:39241906
1312734	LPXN	leupaxin	gene	CHEBI:88249	PD 0325901	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C506614	mirdametinib results in decreased expression of LPXN mRNA	PMID:25119042
1312734	LPXN	leupaxin	gene	CHEBI:88249	PD 0325901	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C506614	[(+)-JQ1 compound co-treated with mirdametinib] results in decreased expression of LPXN mRNA	PMID:25119042
1312734	LPXN	leupaxin	gene	CHEBI:8922	Rutecarpine	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C028632	rutecarpine results in increased expression of LPXN mRNA	PMID:34955744
1312734	LPXN	leupaxin	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1312735	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LPXN mRNA	PMID:27131904
1312734	LPXN	leupaxin	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LPXN mRNA	PMID:38568856
1312734	LPXN	leupaxin	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312735	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of LPXN mRNA	PMID:32835833
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312739	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SEC63 mRNA	PMID:33045310
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of SEC63 mRNA	PMID:16604517
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SEC63 mRNA	PMID:26079696
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312739	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SEC63 mRNA	PMID:30319688
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312739	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SEC63 mRNA	PMID:39241906
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312739	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SEC63 mRNA	PMID:39298647
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SEC63 mRNA	PMID:37042841
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SEC63 mRNA	PMID:23649840
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SEC63 mRNA	PMID:33848595
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SEC63 mRNA	PMID:33754040
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SEC63 protein	PMID:37730182
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SEC63 mRNA	PMID:36331819
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SEC63 mRNA	PMID:19549813
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SEC63 protein	PMID:23301498
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of SEC63 mRNA	PMID:19376150
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SEC63 mRNA	PMID:21641981
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SEC63 mRNA	PMID:19770486
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SEC63 mRNA	PMID:39836092
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SEC63 protein	PMID:35688186
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SEC63 mRNA	PMID:23557933
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312739	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEC63 mRNA	PMID:21570461
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SEC63 mRNA	PMID:18796159
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEC63 mRNA	PMID:17942748
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SEC63 mRNA	PMID:33212167
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304984	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SEC63 mRNA	PMID:28959563
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SEC63 mRNA	PMID:29803840
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312739	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of SEC63 mRNA	PMID:39631538
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of SEC63 mRNA	PMID:20044591
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of SEC63 mRNA	PMID:28595984|PMID:34032870
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SEC63 mRNA	PMID:38568856
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SEC63 mRNA	PMID:39836092
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of SEC63 mRNA; Tunicamycin results in increased expression of SEC63 protein	PMID:22378314|PMID:29453283
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SEC63 mRNA	PMID:19770486|PMID:20127859
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SEC63 mRNA	PMID:22228805
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:3048	benzatropine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in increased expression of SEC63 protein	PMID:34122009
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SEC63 mRNA	PMID:19073995
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1304984	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of SEC63 mRNA	PMID:24136188
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312739	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SEC63 gene; titanium dioxide results in decreased methylation of SEC63 promoter	PMID:35295148
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312739	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of SEC63 mRNA	PMID:35295148
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304984	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SEC63 mRNA	PMID:34492290
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of SEC63 mRNA	PMID:21318169|PMID:23811191
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of SEC63 mRNA]	PMID:21318169
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of SEC63 protein	PMID:37567409
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304984	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SEC63 mRNA	PMID:34947998
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SEC63 mRNA	PMID:33221593
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304984	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SEC63 mRNA	PMID:25181051
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SEC63 mRNA	PMID:28628672
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SEC63 mRNA	PMID:19244175
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SEC63 protein	PMID:34186270
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312739	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SEC63 mRNA	PMID:39298647
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of SEC63 protein	PMID:34186270
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SEC63 protein	PMID:34186270
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1304984	E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SEC63 mRNA	PMID:18668222
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of SEC63 mRNA	PMID:34813904
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SEC63 mRNA	PMID:28628672
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of SEC63 mRNA]	PMID:19030233
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SEC63 mRNA	PMID:37042841
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of SEC63 mRNA	PMID:17585979
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of SEC63 protein	PMID:34122009
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SEC63 mRNA	PMID:31533062
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SEC63 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SEC63 mRNA	PMID:36331819
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SEC63 mRNA	PMID:23179753
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of SEC63 mRNA	PMID:21427059
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SEC63 mRNA	PMID:25562108
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in increased expression of SEC63 mRNA	PMID:20106945|PMID:21632981|PMID:27989131
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312739	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in increased expression of SEC63 mRNA	PMID:25270620
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SEC63 mRNA	PMID:17555576
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SEC63 mRNA	PMID:28628672
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1304984	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of SEC63 mRNA	PMID:24136188
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SEC63 mRNA	PMID:28939011
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SEC63 mRNA	PMID:39836092
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304984	E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in increased expression of SEC63 mRNA	PMID:31464424
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of SEC63 mRNA	PMID:18175754
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SEC63 mRNA	PMID:17555576
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SEC63 mRNA	PMID:17942748
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEC63 mRNA	PMID:17942748
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of SEC63 mRNA	PMID:16984733
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SEC63 mRNA	PMID:28628672
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1312739	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of SEC63 mRNA	PMID:21318169
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1312739	E	RGD:6480464	20120613	CTD	MESH:D011345	[PPARA protein affects the susceptibility to Fenofibrate] which affects the expression of SEC63 mRNA	PMID:21318169
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312739	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of SEC63 mRNA	PMID:25554681
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312739	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SEC63 mRNA	PMID:25554681
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1304984	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of SEC63 mRNA	PMID:24136188
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:5613	haloperidol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in increased expression of SEC63 protein	PMID:34122009
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:6030	isoniazide	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in decreased expression of SEC63 protein	PMID:40015660
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SEC63 protein	PMID:32959892
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SEC63 mRNA	PMID:23650126
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SEC63 protein	PMID:34186270
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312739	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SEC63 mRNA	PMID:22206623
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1304984	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of SEC63 mRNA	PMID:24136188
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of SEC63 mRNA	PMID:30928695
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312739	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SEC63 mRNA	PMID:23091169
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312739	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of SEC63 mRNA	PMID:30953684
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304984	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SEC63 mRNA	PMID:19281266
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304984	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SEC63 mRNA	PMID:21346803
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:9352	sulindac	decreases expression	ISO	RGD:1304984	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of SEC63 mRNA	PMID:24136188
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of SEC63 mRNA	PMID:22378314
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304984	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SEC63 mRNA	PMID:21346803
1312738	SEC63	SEC63 protein translocation regulator	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304984	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SEC63 mRNA	PMID:23034163
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:165219	PCB138	increases expression	ISO	RGD:1304986	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of WFDC5 mRNA	PMID:23829299
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of WFDC5 mRNA	PMID:23649840
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of WFDC5 mRNA	PMID:23649840
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of WFDC5 mRNA	PMID:21867686
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WFDC5 mRNA	PMID:32525701
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of WFDC5 mRNA	PMID:38460933
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of WFDC5 mRNA	PMID:30851411
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1304986	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of WFDC5 mRNA	PMID:28959563
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550079	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of WFDC5 mRNA	PMID:37682722
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of WFDC5 promoter	PMID:27901495
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WFDC5 3' UTR	PMID:27901495
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of WFDC5 mRNA	PMID:25895662
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304986	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of WFDC5 mRNA	PMID:25181051
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304986	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of WFDC5 mRNA	PMID:41034487
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550079	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of WFDC5 3' UTR	PMID:28392331
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of WFDC5 mRNA	PMID:24714768
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of WFDC5 mRNA	PMID:38460933
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WFDC5 mRNA	PMID:32525701
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1304986	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of WFDC5 mRNA	PMID:30307764
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1550079	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of WFDC5 mRNA	PMID:22078008
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of WFDC5 mRNA	PMID:30851411
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to WFDC5 gene]	PMID:28238834
1312741	WFDC5	WAP four-disulfide core domain 5	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WFDC5 mRNA	PMID:32525701
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of WNT10B mRNA	PMID:25812627
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of WNT10B mRNA	PMID:39752319
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of WNT10B mRNA	PMID:33167477
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:15640	5-formyltetrahydrofolic acid	multiple interactions	ISO	RGD:1304988	E	RGD:6480464	20151013	CTD	MESH:D002955	[Methotrexate co-treated with Leucovorin] results in increased expression of WNT10B mRNA	PMID:25187349
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of WNT10B mRNA	PMID:26079696
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304988	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of WNT10B gene	PMID:28931070
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of WNT10B mRNA	PMID:12437293|PMID:23019147|PMID:31614463
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312745	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of WNT10B mRNA	PMID:25210133
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in increased expression of WNT10B mRNA]	PMID:25210133
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of WNT10B mRNA	PMID:39752319
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:17351	linoleic acid	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20170303	CTD	MESH:D019787	Linoleic Acid results in decreased expression of WNT10B mRNA	PMID:12021203
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1304988	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of WNT10B promoter	PMID:23359474
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1304988	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of WNT10B mRNA	PMID:26577399
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of WNT10B mRNA	PMID:36139627
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:2038	5-azacytidine	increases expression	ISO	RGD:1304988	E	RGD:6480464	20180116	CTD	MESH:D001374	Azacitidine results in increased expression of WNT10B mRNA	PMID:27415467
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:2208	purine-6-thiol	decreases expression	ISO	RGD:1304988	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of WNT10B mRNA	PMID:23358152
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT10B mRNA	PMID:35301059
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WNT10B mRNA	PMID:22100608
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in decreased expression of WNT10B mRNA	PMID:33026818
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of WNT10B mRNA	PMID:27106289
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20130122	CTD	MESH:D015032	[Zinc deficiency promotes the reaction [TRP53 gene mutant form results in increased susceptibility to nitrosobenzylmethylamine]] which results in decreased expression of WNT10B mRNA	PMID:12517797
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT10B mRNA	PMID:40504410
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312745	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of WNT10B mRNA	PMID:28960355
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20191008	CTD	MESH:C059514	[Dietary Fats co-treated with Resveratrol] results in increased expression of WNT10B mRNA	PMID:29197120
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of WNT10B mRNA	PMID:28903495
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of WNT10B mRNA	PMID:27392435
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1304988	E	RGD:6480464	20140408	CTD	MESH:D019833	Genistein results in decreased expression of WNT10B mRNA	PMID:24361872
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:28088	genistein	increases methylation	ISO	RGD:1304988	E	RGD:6480464	20140408	CTD	MESH:D019833	Genistein results in increased methylation of WNT10B promoter	PMID:24361872
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312745	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WNT10B mRNA	PMID:21570461
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to WNT10B promoter]	PMID:19654925
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of WNT10B mRNA; [NSC 689534 binds to Copper] which results in decreased expression of WNT10B mRNA	PMID:20971185|PMID:30911355
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312745	E	RGD:6480464	20181016	CTD	MESH:D012969	Sodium Fluoride results in increased expression of WNT10B mRNA	PMID:29447955
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:1304988	E	RGD:6480464	20181016	CTD	MESH:D012969	PTH protein promotes the reaction [Sodium Fluoride results in increased expression of WNT10B mRNA]	PMID:29447955
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20181016	CTD	MESH:D012969	PTH protein promotes the reaction [Sodium Fluoride results in increased expression of WNT10B mRNA]; Sodium Fluoride affects the reaction [PTH protein results in increased expression of WNT10B mRNA]	PMID:29447955
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312745	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of WNT10B mRNA	PMID:37682722
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT10B mRNA	PMID:40504410
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of WNT10B promoter	PMID:27901495
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WNT10B mRNA	PMID:32234424
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of WNT10B mRNA; [NSC 689534 binds to Copper] which results in decreased expression of WNT10B mRNA	PMID:20971185|PMID:30911355
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20130122	CTD	MESH:D015032	[Zinc deficiency promotes the reaction [TRP53 gene mutant form results in increased susceptibility to nitrosobenzylmethylamine]] which results in decreased expression of WNT10B mRNA	PMID:12517797
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of WNT10B mRNA	PMID:25895662
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of WNT10B mRNA	PMID:19150397
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C006632	[Arsenic Trioxide co-treated with apatinib] results in decreased expression of WNT10B mRNA	PMID:39223679
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1312745	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of WNT10B gene; titanium dioxide affects the methylation of WNT10B promoter	PMID:35295148
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of WNT10B mRNA	PMID:29264374
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304988	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of WNT10B mRNA	PMID:25181051
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of WNT10B mRNA	PMID:30951980|PMID:32156529
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1304988	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of WNT10B gene	PMID:28505145
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304988	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of WNT10B promoter	PMID:23359474
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of WNT10B mRNA	PMID:25979313
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:34159	15-deoxy-Delta(12,14)-prostaglandin J2	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20170303	CTD	MESH:C097240	15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of WNT10B mRNA	PMID:12021203
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of WNT10B gene	PMID:31601247
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of WNT10B mRNA	PMID:26377693
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of WNT10B mRNA	PMID:26377693
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:34572	allethrin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000487	Allethrins results in increased expression of WNT10B mRNA	PMID:12437293
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of WNT10B mRNA	PMID:30951980
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:34631	chlorpyrifos	affects expression	ISO	RGD:1304988	E	RGD:6480464	20120412	CTD	MESH:D004390	Chlorpyrifos affects the expression of WNT10B mRNA	PMID:18502319
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1304988	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of WNT10B promoter	PMID:23359474
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20171010	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT10B mRNA; APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT10B protein]	PMID:28242765
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D026023	Permethrin results in increased expression of WNT10B mRNA	PMID:12437293
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:34916	phenothrin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C006166	phenothrin results in increased expression of WNT10B mRNA	PMID:12437293
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20120918	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of WNT10B mRNA	PMID:19818801
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT10B mRNA	PMID:35301059
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of WNT10B mRNA	PMID:25812627
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of WNT10B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of WNT10B mRNA]	PMID:17585979
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of WNT10B mRNA	PMID:25812627
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312745	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of WNT10B mRNA	PMID:40194260
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of WNT10B mRNA	PMID:25812627
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312745	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of WNT10B mRNA	PMID:17292431
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:41774	tamoxifen	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of WNT10B mRNA	PMID:15590111
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20171010	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT10B mRNA; APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT10B protein]	PMID:28242765
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312745	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of WNT10B mRNA	PMID:18502557
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:44185	methotrexate	multiple interactions	ISO	RGD:1304988	E	RGD:6480464	20151013	CTD	MESH:D008727	[Methotrexate co-treated with Leucovorin] results in increased expression of WNT10B mRNA	PMID:25187349
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of WNT10B mRNA	PMID:38832940
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of WNT10B mRNA	PMID:24935251
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of WNT10B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of WNT10B mRNA]	PMID:17585979
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:4629	diosgenin	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20151215	CTD	MESH:D004144	Diosgenin results in decreased expression of WNT10B mRNA	PMID:26408789
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT10B mRNA	PMID:40504410
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of WNT10B mRNA	PMID:32234424
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C032793	[Arsenic Trioxide co-treated with apatinib] results in decreased expression of WNT10B mRNA	PMID:39223679
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:5014	fenvalerate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C017690	fenvalerate results in increased expression of WNT10B mRNA	PMID:12437293
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of WNT10B mRNA; Nanotubes, Carbon results in decreased expression of WNT10B mRNA	PMID:25554681
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:50667	mercaptopurine	decreases expression	ISO	RGD:1304988	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of WNT10B mRNA	PMID:23358152
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1304988	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of WNT10B mRNA	PMID:28801915
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of WNT10B mRNA	PMID:39752319
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:755665	etc-159	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000620782	ETC-159 results in decreased expression of WNT10B mRNA	PMID:39647516
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of WNT10B mRNA	PMID:36139627
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases methylation	ISO	RGD:1304988	E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in decreased methylation of WNT10B promoter	PMID:27415467
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases expression	ISO	RGD:1304988	E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased expression of WNT10B mRNA	PMID:27415467
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:78030	LGK974	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C586458	LGK974 results in decreased expression of WNT10B mRNA	PMID:39647516
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:78030	LGK974	decreases expression	ISO	RGD:1312745	E	RGD:6480464	20250902	CTD	MESH:C586458	LGK974 results in decreased expression of WNT10B mRNA	PMID:39647516
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT10B mRNA	PMID:27188386
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:80799	Bufotalin	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:C004600	bufotalin inhibits the reaction [TGFB1 protein results in increased expression of WNT10B mRNA]	PMID:38158113
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of WNT10B mRNA	PMID:32234424
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1304988	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of WNT10B mRNA	PMID:24780913
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of WNT10B mRNA	PMID:26272509
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT10B mRNA	PMID:27188386
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312745	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of WNT10B mRNA	PMID:39752319
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT10B mRNA	PMID:27188386
1312744	WNT10B	Wnt family member 10B	gene	CHEBI:94796	3,7-dihydropurine-6-thione	decreases expression	ISO	RGD:1304988	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in decreased expression of WNT10B mRNA	PMID:23358152
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:10106	zearalenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in decreased expression of TNFRSF25 mRNA	PMID:19371625
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of TNFRSF25 mRNA	PMID:38218311
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:113532	thymoquinone	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:C003466	thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF25 protein]	PMID:31935363
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1598206	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TNFRSF25 mRNA]	PMID:31150632
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:133296	microcystin RR	decreases expression	EXP		E	RGD:6480464	20161004	CTD	MESH:C063855	microcystin RR results in decreased expression of TNFRSF25 protein	PMID:19111056
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:136185	VX nerve agent	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C009680	VX-agent results in increased expression of TNFRSF25 mRNA	PMID:38555327
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312747	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TNFRSF25 mRNA	PMID:20188158
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1598206	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TNFRSF25 mRNA	PMID:30071829
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312747	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TNFRSF25 gene	PMID:20938992
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:15365	acetylsalicylic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D001241	Aspirin results in increased expression of TNFRSF25 mRNA	PMID:20457246
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TNFRSF25 mRNA	PMID:33167477
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TNFRSF25 mRNA	PMID:20044591
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFRSF25 protein	PMID:31935363
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:D008070	2,5-dimethyl-4-benzoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF25 protein]; 2-tert-butyl-4-quinone inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF25 protein]; phenylbenzoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF25 protein]; thymoquinone inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF25 protein]	PMID:31935363
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of TNFRSF25 mRNA	PMID:19429434
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of TNFRSF25 mRNA	PMID:35192832
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of TNFRSF25 mRNA	PMID:23019147
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TNFRSF25 mRNA	PMID:33387578
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1598206	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TNFRSF25 gene	PMID:27618143
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312747	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TNFRSF25 gene	PMID:20938992
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1312747	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of TNFRSF25 mRNA	PMID:31525975
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:174541	Licochalcone A	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C070840	licochalcone A results in increased expression of TNFRSF25 mRNA	PMID:30055311
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C031927	hydroquinone results in decreased expression of TNFRSF25 mRNA	PMID:15452088
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1312747	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of TNFRSF25 mRNA	PMID:31525975
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of TNFRSF25 mRNA	PMID:26577399
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TNFRSF25 mRNA	PMID:33387578
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TNFRSF25 mRNA	PMID:28818685
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:18291	manganese atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of TNFRSF25 mRNA	PMID:17175027
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of TNFRSF25 mRNA	PMID:12634122
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased expression of TNFRSF25 mRNA	PMID:22562489
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TNFRSF25 mRNA	PMID:19549813
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of TNFRSF25 mRNA	PMID:26760959
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312747	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of TNFRSF25 mRNA	PMID:27106289
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TNFRSF25 mRNA	PMID:30779732
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TNFRSF25 mRNA	PMID:31150632
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1598206	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TNFRSF25 mRNA]	PMID:31150632
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312747	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TNFRSF25 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TNFRSF25 gene	PMID:20938992|PMID:22206623
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of TNFRSF25 mRNA	PMID:19962721
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TNFRSF25 mRNA; [Arsenic co-treated with Fluorides] results in decreased expression of TNFRSF25 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TNFRSF25 mRNA	PMID:19962721|PMID:40512198
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1598206	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TNFRSF25 mRNA	PMID:31881176
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin promotes the reaction [jinfukang results in increased expression of TNFRSF25 mRNA]; jinfukang promotes the reaction [Cisplatin results in increased expression of TNFRSF25 mRNA]	PMID:27392435
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of TNFRSF25 promoter	PMID:22847954
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1312747	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of TNFRSF25 mRNA	PMID:15681117
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1312747	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of TNFRSF25 mRNA	PMID:20056891
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1312747	E	RGD:6480464	20120412	CTD	MESH:D003042	EHMT2 inhibits the reaction [Cocaine results in increased expression of TNFRSF25 mRNA]	PMID:20056891
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of TNFRSF25 mRNA	PMID:19371625
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of TNFRSF25 mRNA	PMID:23019147
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TNFRSF25 mRNA	PMID:18762178
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TNFRSF25 mRNA	PMID:33387578
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312747	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFRSF25 mRNA	PMID:15328365
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1598206	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFRSF25 mRNA	PMID:32109520
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TNFRSF25 mRNA	PMID:33212167
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TNFRSF25 mRNA	PMID:32763439
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312747	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TNFRSF25 mRNA	PMID:27862939
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of TNFRSF25 mRNA	PMID:16705698
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:28775	hesperidin	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D006569	Hesperidin results in increased expression of TNFRSF25 mRNA	PMID:24633329
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:29014	cordycepin	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C058120	cordycepin results in increased expression of TNFRSF25 protein	PMID:23941773
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TNFRSF25 mRNA	PMID:38568856
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TNFRSF25 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TNFRSF25 mRNA	PMID:40512198
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312747	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TNFRSF25 mRNA	PMID:34876320
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312747	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TNFRSF25 mRNA	PMID:34876320
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TNFRSF25 exon	PMID:27901495
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TNFRSF25 mRNA	PMID:15761015|PMID:17530438
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TNFRSF25 mRNA	PMID:19730151
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:32063	propylparaben	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C006068	propylparaben results in increased expression of TNFRSF25 mRNA	PMID:24481588
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312747	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TNFRSF25 mRNA	PMID:29264374|PMID:35295148
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TNFRSF25 mRNA	PMID:34492290
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:33007	chromium(6+)	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of TNFRSF25 mRNA	PMID:17382205
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1598206	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TNFRSF25 mRNA	PMID:25181051
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of TNFRSF25 mRNA; bisphenol A results in decreased expression of TNFRSF25 protein	PMID:19371625|PMID:33181973
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312747	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TNFRSF25 mRNA	PMID:32156529|PMID:38074096
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312747	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of TNFRSF25 promoter	PMID:27312807
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A results in increased expression of TNFRSF25 mRNA	PMID:23019147|PMID:33312107
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1598206	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of TNFRSF25 mRNA	PMID:35192832
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220607	CTD	MESH:C006780	bisphenol A results in increased methylation of TNFRSF25 promoter	PMID:32763279
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1598206	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TNFRSF25 gene	PMID:28505145
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312747	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of TNFRSF25 mRNA	PMID:25172293
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:3374	capsaicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002211	Capsaicin results in increased expression of TNFRSF25 mRNA	PMID:19502594
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of TNFRSF25 mRNA	PMID:36804509
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C543008	bisphenol S results in increased expression of TNFRSF25 mRNA	PMID:33312107
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312747	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TNFRSF25 mRNA	PMID:38685157
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C008745	bisphenol F results in increased expression of TNFRSF25 mRNA	PMID:33312107
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312747	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TNFRSF25 mRNA	PMID:28392331
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312747	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TNFRSF25 mRNA	PMID:37019170
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of TNFRSF25 gene	PMID:22964155
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in decreased expression of TNFRSF25 mRNA	PMID:18836921
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:35154	manganese(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of TNFRSF25 mRNA	PMID:17175027
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of TNFRSF25 mRNA	PMID:25539665
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of TNFRSF25 promoter	PMID:22847954
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TNFRSF25 mRNA	PMID:31533062
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of TNFRSF25 promoter	PMID:22847954
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011722	Pyrethrins results in decreased expression of TNFRSF25 mRNA	PMID:35321623
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of TNFRSF25 mRNA	PMID:23125180
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TNFRSF25 mRNA	PMID:25979313
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TNFRSF25 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TNFRSF25 gene	PMID:29154799
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TNFRSF25 mRNA	PMID:27188386
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TNFRSF25 mRNA	PMID:30047161
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TNFRSF25 mRNA	PMID:25562108
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of TNFRSF25 mRNA	PMID:19371625
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1312747	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of TNFRSF25 mRNA	PMID:16510352
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312747	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TNFRSF25 mRNA	PMID:28973697
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1312747	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of TNFRSF25 mRNA	PMID:31525975
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of TNFRSF25 mRNA	PMID:21678067
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of TNFRSF25 mRNA	PMID:27188386
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in increased expression of TNFRSF25 mRNA	PMID:29309887
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TNFRSF25 mRNA	PMID:33387578
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of TNFRSF25 mRNA	PMID:19036117
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of TNFRSF25 mRNA	PMID:19962721
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TNFRSF25 mRNA; [Arsenic co-treated with Fluorides] results in decreased expression of TNFRSF25 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TNFRSF25 mRNA	PMID:19962721|PMID:40512198
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:47426	furosemide	affects expression	ISO	RGD:1598206	E	RGD:6480464	20120412	CTD	MESH:D005665	Furosemide affects the expression of TNFRSF25 mRNA	PMID:17497460
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312747	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TNFRSF25 mRNA	PMID:34876320
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of TNFRSF25 mRNA	PMID:16705456
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TNFRSF25 mRNA	PMID:15761015|PMID:17530438
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TNFRSF25 mRNA	PMID:19730151
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1312747	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of TNFRSF25 mRNA	PMID:27915011
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:50182	3,3'-diindolylmethane	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C016392	3,3'-diindolylmethane results in decreased expression of TNFRSF25 mRNA	PMID:22514694
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:50385	hemin	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D006427	Hemin results in increased expression of TNFRSF25 protein	PMID:39486598
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312747	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TNFRSF25 mRNA; Nanotubes, Carbon results in decreased expression of TNFRSF25 mRNA	PMID:25554681
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1598206	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TNFRSF25 mRNA	PMID:30047161
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:C029938	nickel sulfate results in increased expression of TNFRSF25 mRNA	PMID:17382205
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312747	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of TNFRSF25 mRNA	PMID:19042947
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases response to substance	ISO	RGD:1312747	E	RGD:6480464	20150512	CTD	MESH:D014302	TNFRSF25 protein results in increased susceptibility to Trinitrobenzenesulfonic Acid	PMID:20980995
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in increased expression of TNFRSF25 mRNA	PMID:17175027
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:63948	trimethyltin	increases expression	ISO	RGD:1312747	E	RGD:6480464	20121113	CTD	MESH:C046488	trimethyltin results in increased expression of TNFRSF25 mRNA	PMID:21435392
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:6736	melittin	affects response to substance	EXP		E	RGD:6480464	20140902	CTD	MESH:D008555	TNFRSF25 protein affects the susceptibility to Melitten	PMID:22027265
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:6736	melittin	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D008555	Melitten results in increased expression of TNFRSF25 mRNA	PMID:22027265
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:6736	melittin	multiple interactions	EXP		E	RGD:6480464	20140902	CTD	MESH:D008555	TNFRSF25 protein affects the reaction [Melitten results in decreased phosphorylation of STAT3 protein]	PMID:22027265
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in increased expression of TNFRSF25 mRNA	PMID:29309887
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312747	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TNFRSF25 mRNA	PMID:22206623
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:74023	dioscin	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C019357	dioscin results in increased expression of TNFRSF25 mRNA	PMID:29990575|PMID:33359023
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:749301	potassium perchlorate	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of TNFRSF25 mRNA	PMID:29673971
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:75092	morin	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C008548	morin results in increased expression of TNFRSF25 mRNA	PMID:28689916
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of TNFRSF25 mRNA	PMID:17382205
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:75253	phenylarsine oxide	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C029341	oxophenylarsine results in increased expression of TNFRSF25 protein	PMID:25417048
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:75253	phenylarsine oxide	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:C029341	oxophenylarsine promotes the reaction [Viper Venoms results in increased expression of TNFRSF25 protein]; Viper Venoms promotes the reaction [oxophenylarsine results in increased expression of TNFRSF25 protein]	PMID:25417048
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:77012	methylseleninic acid	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of TNFRSF25 mRNA	PMID:11830524
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:78505	venom	increases expression	EXP		E	RGD:6480464	20170124	CTD	MESH:D014757	Viper Venoms results in increased expression of TNFRSF25 protein	PMID:25417048
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:78505	venom	multiple interactions	EXP		E	RGD:6480464	20170124	CTD	MESH:D014757	oxophenylarsine promotes the reaction [Viper Venoms results in increased expression of TNFRSF25 protein]; Viper Venoms promotes the reaction [oxophenylarsine results in increased expression of TNFRSF25 protein]	PMID:25417048
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TNFRSF25 mRNA	PMID:27188386
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:80770	Brevetoxin B	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C043466	brevetoxin 2 results in increased expression of TNFRSF25 mRNA	PMID:20498034
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TNFRSF25 mRNA	PMID:27589474
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases methylation	ISO	RGD:1598206	E	RGD:6480464	20260407	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased methylation of TNFRSF25 gene	PMID:40889571
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312747	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TNFRSF25 mRNA	PMID:34876320
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of TNFRSF25 mRNA	PMID:19429434
1312746	TNFRSF25	TNF receptor superfamily member 25	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TNFRSF25 mRNA	PMID:27188386
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1304990	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of KCTD5 mRNA	PMID:21551480
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KCTD5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KCTD5 mRNA	PMID:32699268
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of KCTD5 mRNA	PMID:24763279
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312749	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of KCTD5 mRNA	PMID:30319688
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of KCTD5 mRNA	PMID:21179406
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of KCTD5 mRNA	PMID:33647349
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KCTD5 protein	PMID:37730182
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KCTD5 mRNA	PMID:28818685
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312749	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of KCTD5 mRNA	PMID:27462272
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KCTD5 mRNA	PMID:19549813
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KCTD5 intron	PMID:30157460
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KCTD5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KCTD5 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of KCTD5 mRNA	PMID:32699268
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of KCTD5 mRNA	PMID:22171008
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of KCTD5 mRNA	PMID:18593933
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20150127	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of KCTD5 mRNA	PMID:25270620
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KCTD5 mRNA	PMID:25629700
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of KCTD5 mRNA	PMID:23557933
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of KCTD5 mRNA	PMID:40618947
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of KCTD5 mRNA	PMID:25583101
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312749	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KCTD5 mRNA	PMID:21570461
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KCTD5 mRNA	PMID:19770486
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of KCTD5 mRNA	PMID:33512557
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of KCTD5 mRNA	PMID:33212167
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of KCTD5 mRNA	PMID:32763439
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KCTD5 mRNA	PMID:38568856
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KCTD5 promoter	PMID:27901495
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of KCTD5 mRNA	PMID:22171008
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of KCTD5 mRNA	PMID:18593933
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KCTD5 mRNA	PMID:19150397
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to KCTD5 protein]	PMID:26598702
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1304990	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of KCTD5 mRNA	PMID:30047161
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1304990	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of KCTD5 mRNA	PMID:24136188
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312749	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KCTD5 promoter	PMID:35295148
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of KCTD5 mRNA	PMID:18648102
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312749	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of KCTD5 mRNA	PMID:28472532
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of KCTD5 mRNA	PMID:29275510
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304990	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KCTD5 mRNA	PMID:25181051
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304990	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of KCTD5 mRNA	PMID:30816183|PMID:34947998
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1304990	E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of KCTD5 mRNA	PMID:27914987
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of KCTD5 mRNA	PMID:20713471
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312749	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of KCTD5 promoter	PMID:33297965
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of KCTD5 intron	PMID:30157460
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KCTD5 mRNA	PMID:37042841
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1304990	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of KCTD5 promoter	PMID:22457795
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KCTD5 mRNA	PMID:38174414|PMID:38568856
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of KCTD5 mRNA	PMID:19320972|PMID:19376846
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KCTD5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KCTD5 mRNA	PMID:32699268
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of KCTD5 mRNA	PMID:21427059
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KCTD5 gene	PMID:29154799
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1304990	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of KCTD5 mRNA	PMID:30047161
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312749	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of KCTD5 mRNA	PMID:19770486
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of KCTD5 mRNA	PMID:20106945
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1304990	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of KCTD5 mRNA	PMID:24136188
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KCTD5 mRNA	PMID:38832940
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312749	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KCTD5 mRNA	PMID:17562736
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of KCTD5 mRNA	PMID:20977926
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to KCTD5 protein]	PMID:26598702
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1304990	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of KCTD5 mRNA	PMID:24136188
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304990	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of KCTD5 mRNA	PMID:30047161
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312749	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of KCTD5 mRNA	PMID:35964746
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304990	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KCTD5 mRNA	PMID:24136188
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312749	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of KCTD5 mRNA	PMID:19042947
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of KCTD5 protein	PMID:32959892
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of KCTD5 intron	PMID:30157460
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1304990	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of KCTD5 mRNA	PMID:24136188
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1304990	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of KCTD5 mRNA	PMID:21346803
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KCTD5 gene]	PMID:28238834
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304990	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of KCTD5 mRNA	PMID:30047161
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304990	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of KCTD5 mRNA	PMID:21346803
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1304990	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of KCTD5 mRNA	PMID:24136188
1312748	KCTD5	potassium channel tetramerization domain containing 5	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KCTD5 mRNA	PMID:38568856
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FKBP3 gene	PMID:20938992
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of FKBP3 protein	PMID:39571964
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312752	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FKBP3 mRNA	PMID:39241906
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of FKBP3 mRNA]	PMID:39241906
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of FKBP3 mRNA	PMID:23019147
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20250805	CTD	MESH:D004958	Estradiol results in decreased expression of FKBP3 protein	PMID:26903627
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FKBP3 gene	PMID:20938992
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FKBP3 mRNA	PMID:37042841
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of FKBP3 mRNA	PMID:21179406
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FKBP3 protein	PMID:37730182
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of FKBP3 mRNA	PMID:28860664
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FKBP3 mRNA	PMID:19549813
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FKBP3 protein	PMID:23301498
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304992	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of FKBP3 mRNA	PMID:21396975
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FKBP3 gene	PMID:27153756
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of FKBP3 mRNA	PMID:15674844
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312752	E	RGD:6480464	20250401	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of FKBP3 protein	PMID:39910959
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:2567	alendronic acid	affects expression	ISO	RGD:1304992	E	RGD:6480464	20120412	CTD	MESH:D019386	Alendronate affects the expression of FKBP3 mRNA	PMID:16079270
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of FKBP3 mRNA	PMID:35430440
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of FKBP3 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of FKBP3 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of FKBP3 protein	PMID:38598786
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1304992	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of FKBP3 mRNA	PMID:16140947
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1304992	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of FKBP3 mRNA]	PMID:16140947
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FKBP3 mRNA	PMID:31919559
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FKBP3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FKBP3 gene	PMID:20938992|PMID:22206623
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of FKBP3 gene	PMID:39164771
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of FKBP3 mRNA	PMID:40504410
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of FKBP3 mRNA	PMID:19244175
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of FKBP3 protein	PMID:38460933
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of FKBP3 protein	PMID:35688186
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1304992	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FKBP3 mRNA	PMID:31881176
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of FKBP3 protein	PMID:25505154
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312752	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FKBP3 mRNA	PMID:24680724
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304992	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FKBP3 mRNA	PMID:33387578
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312752	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FKBP3 mRNA	PMID:15034205|PMID:17942748
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FKBP3 mRNA; AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FKBP3 mRNA]	PMID:15034205|PMID:17942748
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FKBP3 mRNA	PMID:33212167
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FKBP3 mRNA	PMID:30851411
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of FKBP3 protein	PMID:35688186
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of FKBP3 mRNA; sodium arsenite results in decreased expression of FKBP3 protein	PMID:30528433|PMID:38568856
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in increased expression of FKBP3 protein	PMID:39571964
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of FKBP3 mRNA	PMID:40504410
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FKBP3 mRNA	PMID:15034205
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of FKBP3 mRNA]	PMID:15034205
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:30145	lithium atom	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of FKBP3 protein	PMID:40770094
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:30146	lithium hydride	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of FKBP3 protein	PMID:40770094
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1304992	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of FKBP3 mRNA	PMID:16140947
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1304992	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of FKBP3 mRNA]	PMID:16140947
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of FKBP3 mRNA	PMID:18648102
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of FKBP3 mRNA	PMID:18445702
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:32888	gamma-hexachlorocyclohexane	affects expression	ISO	RGD:1304992	E	RGD:6480464	20120412	CTD	MESH:D001556	Hexachlorocyclohexane affects the expression of FKBP3 mRNA	PMID:17785943
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of FKBP3 mRNA	PMID:30903817
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304992	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FKBP3 mRNA	PMID:25181051
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of FKBP3 mRNA	PMID:29275510
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of FKBP3 protein	PMID:34186270
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of FKBP3 protein	PMID:34186270
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:1304992	E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of FKBP3 mRNA	PMID:17602206
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of FKBP3 protein	PMID:38598786
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of FKBP3 mRNA]	PMID:39241906
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FKBP3 mRNA	PMID:37042841
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FKBP3 protein	PMID:33830842
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of and results in increased methylation of FKBP3 mRNA	PMID:33830842
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FKBP3 mRNA	PMID:19320972|PMID:19376846
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of FKBP3 mRNA	PMID:19244175
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312752	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of FKBP3 mRNA	PMID:17585979
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of FKBP3 mRNA	PMID:28302478
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FKBP3 mRNA	PMID:31533062
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:39096	alpha-hexachlorocyclohexane	increases expression	ISO	RGD:1304992	E	RGD:6480464	20120412	CTD	MESH:C040534	alpha-hexachlorocyclohexane results in increased expression of FKBP3 mRNA	PMID:17785943
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FKBP3 gene	PMID:29154799
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304992	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of FKBP3 mRNA	PMID:41580965
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FKBP3 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of FKBP3 mRNA	PMID:12929121
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1304992	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of FKBP3 mRNA	PMID:24136188
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1312752	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of FKBP3 mRNA	PMID:12929121
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1304992	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FKBP3 mRNA	PMID:33387578
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of FKBP3 protein	PMID:38460933
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of FKBP3 gene	PMID:39164771
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of FKBP3 mRNA	PMID:40504410
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312752	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of FKBP3 mRNA	PMID:35436446
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1304992	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FKBP3 mRNA	PMID:16079270
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1304992	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of FKBP3 mRNA	PMID:17557909
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FKBP3 mRNA	PMID:17942748
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FKBP3 mRNA	PMID:17942748
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1304992	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of FKBP3 mRNA	PMID:24136188
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304992	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of FKBP3 mRNA	PMID:24136188
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1312752	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of FKBP3 mRNA	PMID:26377693
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FKBP3 protein	PMID:32959892
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1304992	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of FKBP3 mRNA	PMID:24136188
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of FKBP3 protein	PMID:34186270
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FKBP3 mRNA	PMID:22206623
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FKBP3 mRNA	PMID:22206623
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1304992	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of FKBP3 mRNA	PMID:24136188
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FKBP3 mRNA	PMID:30851411
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:82388	p-anisidine	increases expression	ISO	RGD:1312752	E	RGD:6480464	20141111	CTD	MESH:C013813	4-anisidine results in increased expression of FKBP3 mRNA	PMID:12929121
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312752	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of FKBP3 mRNA]	PMID:39241906
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:8772	raloxifene	affects expression	ISO	RGD:1304992	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of FKBP3 mRNA	PMID:16079270
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304992	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FKBP3 mRNA	PMID:21346803
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of FKBP3 mRNA	PMID:38568856
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312752	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of FKBP3 protein	PMID:24648495
1312751	FKBP3	FKBP prolyl isomerase 3	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of FKBP3 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of FKBP3 protein	PMID:38598786
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DRG1 mRNA	PMID:38218311
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312754	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DRG1 mRNA	PMID:30319688
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312754	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of DRG1 mRNA	PMID:30319688
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312754	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DRG1 mRNA	PMID:39241906
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1304993	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DRG1 mRNA	PMID:20068009
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DRG1 mRNA	PMID:37042841
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of DRG1 promoter	PMID:33872906
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312754	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DRG1 mRNA	PMID:33754040
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of DRG1 promoter	PMID:33872906
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DRG1 mRNA	PMID:19549813
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DRG1 protein	PMID:23301498
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304993	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of DRG1 mRNA	PMID:21396975
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DRG1 mRNA	PMID:35430440
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312754	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DRG1 mRNA	PMID:25629700
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312754	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DRG1 mRNA	PMID:22206623
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DRG1 protein	PMID:38460933
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:27812	Se-methyl-L-selenocysteine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C002979	[selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of DRG1	PMID:15897249
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of DRG1 mRNA	PMID:27392435
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312754	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DRG1 mRNA	PMID:21570461
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1304993	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DRG1 mRNA	PMID:21215274
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1304993	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DRG1 mRNA	PMID:33387578
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312754	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DRG1 mRNA	PMID:17942748
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of DRG1 protein	PMID:30528433
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite inhibits the reaction [DRG1 protein binds to Ribonucleotides]	PMID:30528433
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312754	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DRG1 mRNA	PMID:22228805
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to DRG1 mRNA]	PMID:32406909
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1312754	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DRG1 mRNA	PMID:39716349
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312754	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DRG1 gene	PMID:35295148
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of DRG1 protein	PMID:37567409
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312754	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of DRG1 mRNA	PMID:29161229
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304993	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DRG1 mRNA	PMID:25181051
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DRG1 protein	PMID:31675489
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312754	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DRG1 mRNA	PMID:39298647
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of DRG1 protein	PMID:34186270
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of DRG1 protein	PMID:26879310
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312754	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of DRG1 mRNA	PMID:28903501
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DRG1 mRNA	PMID:28302478
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312754	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DRG1 mRNA	PMID:17292431
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304993	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of DRG1 mRNA	PMID:38685447|PMID:41580965
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DRG1 protein	PMID:38460933
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312754	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DRG1 mRNA	PMID:17942748
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312754	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DRG1 mRNA	PMID:17942748
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1312754	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DRG1 mRNA	PMID:39716349
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1304993	E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of DRG1 mRNA	PMID:38685447|PMID:41580965
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1304993	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of DRG1 mRNA	PMID:24793618
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304993	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DRG1 mRNA	PMID:24136188
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DRG1 protein	PMID:32959892
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of DRG1 mRNA	PMID:31758290
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DRG1 protein	PMID:34186270
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312754	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DRG1 mRNA	PMID:22206623
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DRG1 protein	PMID:37664457
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:80630	irinotecan	multiple interactions	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	[selenomethylselenocysteine co-treated with Irinotecan] results in decreased expression of DRG1	PMID:15897249
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DRG1 protein	PMID:31675489
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:9068	Se-methylselenocysteine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C002979	[selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of DRG1	PMID:15897249
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DRG1 protein	PMID:37664457
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DRG1 mRNA	PMID:38568856
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of DRG1 mRNA	PMID:29301935
1312753	DRG1	developmentally regulated GTP binding protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1304993	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of DRG1 mRNA	PMID:23555832
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CEBPZ mRNA	PMID:26272509
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPZ mRNA	PMID:27188386
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1304994	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CEBPZ mRNA]	PMID:31150632
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of CEBPZ mRNA	PMID:16054129
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in increased expression of CEBPZ mRNA	PMID:15894607
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312756	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CEBPZ mRNA	PMID:39241906
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312756	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of CEBPZ mRNA	PMID:15598610
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of CEBPZ mRNA	PMID:31614463
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CEBPZ mRNA	PMID:20823114
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CEBPZ mRNA	PMID:38568856
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312756	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of and results in increased activity of CEBPZ protein	PMID:35842051
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CEBPZ protein	PMID:37730182
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1304994	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CEBPZ mRNA	PMID:22061828|PMID:33387578
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312756	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPZ mRNA	PMID:37236586
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1304994	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CEBPZ mRNA	PMID:31150632
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1304994	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CEBPZ mRNA]	PMID:31150632
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CEBPZ mRNA	PMID:25629700
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:27656	camptothecin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002166	Camptothecin results in decreased expression of CEBPZ mRNA	PMID:17374387
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CEBPZ mRNA	PMID:30912803
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CEBPZ mRNA	PMID:19684285
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312756	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CEBPZ mRNA	PMID:17942748|PMID:19684285
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312756	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CEBPZ mRNA	PMID:17942748
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CEBPZ mRNA	PMID:33212167
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312756	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of CEBPZ mRNA	PMID:39631538
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CEBPZ mRNA	PMID:20458559
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312756	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CEBPZ gene	PMID:35295148
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1304994	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CEBPZ mRNA	PMID:23411599|PMID:34492290
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312756	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CEBPZ mRNA	PMID:18648102
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312756	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CEBPZ mRNA	PMID:23811191
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312756	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of CEBPZ mRNA	PMID:28329830
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of CEBPZ protein	PMID:37567409
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304994	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CEBPZ mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312756	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CEBPZ mRNA	PMID:39298647
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CEBPZ mRNA	PMID:37019170
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to CEBPZ protein	PMID:32991956
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1304994	E	RGD:6480464	20120814	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CEBPZ mRNA	PMID:19041683
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CEBPZ mRNA	PMID:37042841
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CEBPZ mRNA	PMID:38568856
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1304994	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CEBPZ promoter	PMID:22457795
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312756	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CEBPZ mRNA	PMID:18974090
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312756	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPZ mRNA	PMID:37236586
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CEBPZ mRNA	PMID:24449571
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CEBPZ mRNA	PMID:28302478
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1304994	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of CEBPZ mRNA	PMID:25993096
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CEBPZ mRNA	PMID:23179753|PMID:27188386
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of CEBPZ mRNA	PMID:21427059
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CEBPZ mRNA	PMID:20106945|PMID:25562108
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:41977	daunorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003630	Daunorubicin results in decreased expression of CEBPZ mRNA	PMID:17374387
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in decreased expression of CEBPZ mRNA	PMID:22334560
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312756	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CEBPZ mRNA	PMID:17942748
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312756	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CEBPZ mRNA	PMID:17942748
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:4911	etoposide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in decreased expression of CEBPZ mRNA	PMID:17374387
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CEBPZ mRNA	PMID:20458559
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CEBPZ mRNA	PMID:20823114
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304994	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CEBPZ mRNA	PMID:24136188
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CEBPZ protein	PMID:32959892
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of CEBPZ mRNA	PMID:20823114
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CEBPZ mRNA	PMID:31758290
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312756	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CEBPZ mRNA	PMID:22206623
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CEBPZ protein	PMID:37664457
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of CEBPZ protein	PMID:31285264
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1304994	E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in decreased expression of CEBPZ mRNA	PMID:18417182
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPZ mRNA	PMID:27188386
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of CEBPZ mRNA	PMID:30928695
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in decreased expression of CEBPZ mRNA	PMID:22334560
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312756	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in decreased expression of CEBPZ mRNA	PMID:22334560
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CEBPZ protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CEBPZ mRNA	PMID:27188386|PMID:37664457
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:9150	simvastatin	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin inhibits the reaction [CEBPZ binds to COL1A1 promoter]	PMID:16575855
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1304994	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of CEBPZ mRNA	PMID:19281266
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304994	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CEBPZ mRNA	PMID:21346803
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1304994	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CEBPZ mRNA	PMID:21346803
1312755	CEBPZ	CCAAT enhancer binding protein zeta	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304994	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of CEBPZ mRNA	PMID:23555832
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NEK4 gene	PMID:20938992
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NEK4 mRNA	PMID:33167477
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NEK4 mRNA	PMID:36331819
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of NEK4 mRNA	PMID:26079696
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of NEK4 mRNA	PMID:21632981
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of NEK4 mRNA	PMID:22574217
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NEK4 gene	PMID:20938992
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of NEK4 mRNA	PMID:27905399
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of NEK4 protein	PMID:37730182
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304995	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NEK4 mRNA	PMID:33387578
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NEK4 mRNA	PMID:39836092
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NEK4 mRNA	PMID:37236586
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NEK4 mRNA	PMID:19549813
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1304995	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of NEK4 mRNA	PMID:21396975
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1304995	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NEK4 mRNA	PMID:22129741
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312758	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NEK4 mRNA	PMID:19770486
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NEK4 mRNA	PMID:23649840
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of NEK4 mRNA	PMID:35430440
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NEK4 mRNA	PMID:25629700
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NEK4 gene	PMID:20938992
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NEK4 gene	PMID:25304211
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NEK4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NEK4 mRNA	PMID:39836092
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of NEK4 protein	PMID:35688186
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NEK4 mRNA	PMID:23557933
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in decreased expression of NEK4 mRNA	PMID:19031421
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NEK4 mRNA	PMID:11007951|PMID:17101203
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NEK4 mRNA	PMID:19770486
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NEK4 mRNA	PMID:17942748
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NEK4 mRNA	PMID:17942748
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1304995	E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NEK4 mRNA	PMID:22129741
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of NEK4 mRNA	PMID:16014739
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NEK4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NEK4 mRNA	PMID:39836092
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NEK4 mRNA	PMID:20504355
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NEK4 mRNA	PMID:26238291
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312758	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NEK4 gene	PMID:35295148
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1304995	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of NEK4 mRNA	PMID:34492290
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304995	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NEK4 mRNA	PMID:25181051
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304995	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of NEK4 mRNA	PMID:30816183|PMID:32528016
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NEK4 mRNA	PMID:33221593
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NEK4 mRNA	PMID:37019170
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NEK4 mRNA	PMID:21266533
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1304995	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NEK4 mRNA	PMID:22129741
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NEK4 mRNA	PMID:37042841
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NEK4 mRNA	PMID:39836092
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1312758	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride affects the expression of NEK4 mRNA	PMID:18974090
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NEK4 mRNA	PMID:37236586
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312758	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of NEK4 mRNA	PMID:18353800
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NEK4 mRNA	PMID:36331819
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of NEK4 mRNA	PMID:29154799
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of NEK4 mRNA	PMID:27989131
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of NEK4 mRNA	PMID:17555576
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NEK4 mRNA	PMID:17562736
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304995	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NEK4 mRNA	PMID:33387578
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NEK4 mRNA	PMID:22230336
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of NEK4 mRNA	PMID:16709241
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NEK4 gene	PMID:25304211
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NEK4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NEK4 mRNA	PMID:39836092
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NEK4 mRNA	PMID:17555576
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NEK4 mRNA	PMID:17942748
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NEK4 mRNA	PMID:17942748
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1304995	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of NEK4 mRNA	PMID:22504374
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NEK4 mRNA	PMID:39836092
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of NEK4 mRNA	PMID:19031421
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1304995	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of NEK4 mRNA	PMID:21346803
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NEK4 gene]	PMID:28238834
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312758	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of NEK4 mRNA	PMID:21278054
1312757	NEK4	NIMA related kinase 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304995	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of NEK4 mRNA	PMID:22504374
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of KIF1A mRNA	PMID:38218311
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of KIF1A mRNA	PMID:26272509
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312760	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of KIF1A mRNA	PMID:33045310
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312760	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of KIF1A mRNA	PMID:26251327
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312760	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF1A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of KIF1A gene	PMID:20938992
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of KIF1A mRNA	PMID:21934132
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of KIF1A mRNA	PMID:25014914|PMID:26079696
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1304996	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of KIF1A gene	PMID:28931070
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1304996	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of KIF1A mRNA	PMID:36841081
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312760	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of KIF1A mRNA	PMID:30319688
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of KIF1A mRNA	PMID:29018328
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312760	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of KIF1A mRNA	PMID:30319688
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of KIF1A mRNA	PMID:30510588
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1304996	E	RGD:6480464	20130806	CTD	MESH:D004958	Estradiol results in decreased expression of KIF1A mRNA	PMID:20068009
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of KIF1A mRNA	PMID:39298647
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312760	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of KIF1A mRNA	PMID:33711761
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1304996	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KIF1A mRNA	PMID:33387578
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312760	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF1A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of KIF1A gene	PMID:20938992
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of KIF1A mRNA	PMID:21179406
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of KIF1A mRNA	PMID:25014914|PMID:26079696
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1304996	E	RGD:6480464	20140211	CTD	MESH:D005947	Glucose results in increased expression of KIF1A protein	PMID:23776493
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1304996	E	RGD:6480464	20130806	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of KIF1A mRNA]	PMID:20032058
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1304996	E	RGD:6480464	20140211	CTD	MESH:D005947	Glucose results in increased expression of KIF1A protein	PMID:23776493
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1304996	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of KIF1A mRNA	PMID:22061828
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20150714	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of KIF1A mRNA	PMID:15329391
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KIF1A gene; Aflatoxin B1 results in increased methylation of KIF1A intron	PMID:27153756|PMID:30157460
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of KIF1A mRNA	PMID:21527772
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in decreased expression of KIF1A mRNA	PMID:15674843
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of KIF1A mRNA	PMID:21527772
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312760	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of KIF1A mRNA	PMID:17484886
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312760	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF1A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of KIF1A gene	PMID:20938992
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in increased expression of KIF1A mRNA	PMID:21527772
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of KIF1A mRNA	PMID:26272509
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312760	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of KIF1A mRNA	PMID:28960355
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of KIF1A promoter	PMID:22847954
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1304996	E	RGD:6480464	20130806	CTD	MESH:D012402	Rotenone results in increased expression of KIF1A mRNA	PMID:19013527
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of KIF1A mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of KIF1A mRNA	PMID:26272509
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KIF1A mRNA	PMID:29803840
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:29323	methylazoxymethanol	increases expression	ISO	RGD:1312760	E	RGD:6480464	20120412	CTD	MESH:C030667	methylazoxymethanol results in increased expression of KIF1A mRNA	PMID:17107856
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KIF1A mRNA	PMID:38568856
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KIF1A 5' UTR; Benzo(a)pyrene affects the methylation of KIF1A intron	PMID:27901495|PMID:30157460
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KIF1A 3' UTR	PMID:27901495
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312760	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KIF1A intron	PMID:27901495
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312760	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KIF1A mRNA	PMID:22610609
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KIF1A promoter	PMID:27901495
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312760	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to KIF1A promoter]	PMID:19654925
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312760	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KIF1A gene	PMID:35295148
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312760	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KIF1A promoter	PMID:35295148
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1304996	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KIF1A mRNA	PMID:25181051
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of KIF1A mRNA	PMID:32156529
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of KIF1A gene	PMID:31601247
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of KIF1A mRNA	PMID:25912373
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304996	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of KIF1A mRNA	PMID:29097150
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1304996	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of KIF1A mRNA	PMID:36041667
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1304996	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of KIF1A mRNA	PMID:36041667
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of KIF1A intron	PMID:30157460
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of KIF1A mRNA	PMID:38685157
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1304996	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of KIF1A mRNA	PMID:36041667
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312760	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of KIF1A intron	PMID:28392331
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1304996	E	RGD:6480464	20130806	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KIF1A mRNA	PMID:21266533
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312760	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KIF1A mRNA	PMID:21266533
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of KIF1A mRNA	PMID:21527772
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KIF1A mRNA	PMID:38568856
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312760	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of KIF1A mRNA	PMID:17585979
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of KIF1A promoter	PMID:22847954
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of KIF1A mRNA	PMID:31533062
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of KIF1A promoter	PMID:22847954
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KIF1A mRNA	PMID:25979313
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312760	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of KIF1A mRNA	PMID:17292431
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1304996	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of KIF1A mRNA	PMID:29427782
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of KIF1A mRNA	PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KIF1A gene	PMID:29154799
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1304996	E	RGD:6480464	20130806	CTD	MESH:D003907	Dexamethasone results in decreased expression of KIF1A mRNA	PMID:20032058
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1304996	E	RGD:6480464	20130806	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of KIF1A mRNA]	PMID:20032058
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:41977	daunorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D003630	KIF1A affects the susceptibility to Daunorubicin	PMID:17545624
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1304996	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in increased expression of KIF1A protein	PMID:23776493
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of KIF1A mRNA	PMID:27188386
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304996	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of KIF1A mRNA	PMID:29391264
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of KIF1A mRNA	PMID:21527772
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of KIF1A protein	PMID:23718831
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312760	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of KIF1A mRNA	PMID:23608068
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of KIF1A intron	PMID:30157460
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1312760	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of KIF1A mRNA	PMID:25566086
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1312760	E	RGD:6480464	20160315	CTD	MESH:C072553	MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of KIF1A mRNA]	PMID:25566086
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312760	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of KIF1A mRNA	PMID:19482888
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312760	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of KIF1A mRNA]	PMID:19482888
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1304996	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of KIF1A mRNA	PMID:23914054
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of KIF1A mRNA	PMID:25014914|PMID:26079696
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIF1A mRNA	PMID:27188386
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1304996	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of KIF1A protein	PMID:35544339
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of KIF1A mRNA	PMID:27188386
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of KIF1A mRNA	PMID:19140230
1312759	KIF1A	kinesin family member 1A	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1304996	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of KIF1A mRNA	PMID:22570695
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:10022	deoxynivalenol	decreases phosphorylation	ISO	RGD:1312762	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in decreased phosphorylation of SEC61B protein	PMID:23352502
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SEC61B mRNA	PMID:38218311
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61B mRNA	PMID:39752319
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of SEC61B mRNA	PMID:17218384
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SEC61B mRNA	PMID:36331819
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of SEC61B mRNA	PMID:29581250
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312762	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SEC61B mRNA	PMID:39241906
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312762	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SEC61B mRNA	PMID:39298647
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1304997	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SEC61B mRNA	PMID:32145629
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61B mRNA	PMID:39752319
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1312762	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SEC61B mRNA	PMID:28973375
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312762	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SEC61B mRNA	PMID:33754040
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SEC61B protein	PMID:37730182
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SEC61B mRNA	PMID:36331819
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SEC61B mRNA	PMID:39836092
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312762	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of SEC61B mRNA	PMID:27462272
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:211238	Torularhodin	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20250506	CTD	MESH:C078923	torularhodin inhibits the reaction [Dietary Fats results in decreased expression of SEC61B protein]	PMID:36234935
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SEC61B mRNA	PMID:35301059
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SEC61B mRNA	PMID:37236586
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SEC61B protein	PMID:23301498
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SEC61B protein	PMID:38598786
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1304997	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of SEC61B mRNA	PMID:30779732
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SEC61B mRNA	PMID:22206623
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SEC61B mRNA	PMID:40504410
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SEC61B protein	PMID:35688186
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SEC61B mRNA	PMID:27392435|PMID:27594783
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1312762	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of SEC61B mRNA	PMID:34813904
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312762	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SEC61B mRNA	PMID:30912803
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of SEC61B mRNA	PMID:26865667
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1304997	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEC61B mRNA	PMID:34747641
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312762	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEC61B mRNA	PMID:21570461|PMID:24680724
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312762	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SEC61B mRNA	PMID:19770486
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1304997	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of SEC61B mRNA	PMID:28374803
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SEC61B mRNA	PMID:30851411
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1304997	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SEC61B mRNA	PMID:30556269
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SEC61B mRNA	PMID:24690739
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SEC61B mRNA	PMID:38568856
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312762	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of SEC61B mRNA	PMID:37682722
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SEC61B mRNA	PMID:40504410
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of SEC61B mRNA	PMID:22378314|PMID:29453283
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1304997	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SEC61B mRNA	PMID:30556269
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SEC61B mRNA	PMID:24690739
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:3048	benzatropine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in increased expression of SEC61B protein	PMID:34122009
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1304997	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SEC61B mRNA	PMID:24136188
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312762	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SEC61B mRNA	PMID:23557971
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of SEC61B protein	PMID:34186270
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SEC61B protein	PMID:33376534
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1304997	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SEC61B mRNA	PMID:25181051|PMID:32145629
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312762	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SEC61B mRNA	PMID:33221593|PMID:38074096
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312762	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SEC61B mRNA	PMID:39298647|PMID:40203079
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of SEC61B protein	PMID:34186270
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312762	E	RGD:6480464	20230207	CTD	MESH:C008745	bisphenol F results in increased expression of SEC61B mRNA	PMID:35387338
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SEC61B protein	PMID:34186270
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312762	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SEC61B mRNA	PMID:37019170
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SEC61B mRNA	PMID:37042841
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1304997	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SEC61B mRNA	PMID:35163327
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SEC61B mRNA	PMID:39836092
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304997	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SEC61B mRNA	PMID:33453195
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SEC61B mRNA	PMID:38568856
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SEC61B mRNA	PMID:35301059
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SEC61B mRNA	PMID:37236586
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1304997	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SEC61B mRNA	PMID:35163327
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1304997	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SEC61B gene	PMID:22079235
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312762	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of SEC61B mRNA	PMID:17585979
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of SEC61B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SEC61B mRNA]	PMID:17585979
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of SEC61B protein	PMID:34122009
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SEC61B mRNA	PMID:31533062
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of SEC61B mRNA	PMID:26352163
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SEC61B mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SEC61B mRNA	PMID:36331819
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SEC61B gene	PMID:29154799
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SEC61B mRNA	PMID:23179753|PMID:26272509
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEC61B mRNA	PMID:27188386
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SEC61B mRNA	PMID:20106945|PMID:25562108
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312762	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in increased expression of SEC61B mRNA	PMID:19770486|PMID:25270620
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312762	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SEC61B mRNA	PMID:17562736
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304997	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SEC61B mRNA	PMID:33387578
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of SEC61B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SEC61B mRNA]	PMID:17585979
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of SEC61B mRNA	PMID:24690739
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SEC61B mRNA	PMID:40504410
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1304997	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SEC61B mRNA	PMID:29391264|PMID:31464424
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312762	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of SEC61B mRNA	PMID:22334560
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1304997	E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SEC61B mRNA	PMID:26865667
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312762	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SEC61B mRNA	PMID:17942748
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SEC61B mRNA	PMID:38568856
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312762	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SEC61B mRNA; Nanotubes, Carbon results in increased expression of SEC61B mRNA	PMID:25554681
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1312762	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of SEC61B mRNA	PMID:26377693
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of SEC61B mRNA	PMID:18651567
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SEC61B protein	PMID:32959892
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SEC61B mRNA	PMID:39836092
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of SEC61B protein	PMID:34122009
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61B mRNA	PMID:39752319
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SEC61B protein	PMID:34186270
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SEC61B mRNA	PMID:22206623
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SEC61B protein	PMID:37664457
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SEC61B mRNA	PMID:30851411
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEC61B mRNA	PMID:27188386
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312762	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SEC61B mRNA	PMID:38648751
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312762	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SEC61B mRNA	PMID:30294300
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1312762	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of SEC61B mRNA	PMID:22334560
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312762	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in increased expression of SEC61B mRNA	PMID:21278054|PMID:22334560
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312762	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61B mRNA	PMID:39752319
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SEC61B protein; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEC61B mRNA	PMID:27188386|PMID:37664457
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1304997	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SEC61B mRNA	PMID:21346803
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SEC61B mRNA	PMID:38568856
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of SEC61B mRNA	PMID:22378314
1312761	SEC61B	SEC61 translocon subunit beta	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SEC61B protein	PMID:38598786
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:10022	deoxynivalenol	decreases phosphorylation	ISO	RGD:1312764	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in decreased phosphorylation of DDX21 protein	PMID:23352502|PMID:23811945
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of DDX21 protein	PMID:39638853
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:1224	2-nitrofluorene	increases expression	ISO	RGD:1307306	E	RGD:6480464	20160119	CTD	MESH:C019499	2-nitrofluorene results in increased expression of DDX21 mRNA	PMID:15890375
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1307306	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX21 mRNA]	PMID:31150632
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D014212	Tretinoin results in decreased expression of DDX21 mRNA	PMID:15498508|PMID:16054129
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312764	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of DDX21 mRNA	PMID:16604517
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312764	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX21 mRNA	PMID:30529165
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DDX21 mRNA	PMID:35811015
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312764	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DDX21 mRNA	PMID:39241906
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of DDX21 mRNA; [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DDX21 mRNA	PMID:26667767|PMID:35811015
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312764	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of DDX21 mRNA]	PMID:39241906
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312764	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of DDX21 mRNA	PMID:15598610
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of DDX21 mRNA	PMID:16514628|PMID:23019147|PMID:31614463|PMID:32387340
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of DDX21 mRNA	PMID:38568856
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DDX21 mRNA	PMID:37042841
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1312764	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of DDX21 mRNA	PMID:17251523
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312764	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of DDX21 mRNA	PMID:23892564
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312764	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DDX21 mRNA	PMID:33754040
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of DDX21 protein	PMID:37730182
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1307306	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of DDX21 mRNA	PMID:22061828
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DDX21 mRNA	PMID:28818685
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312764	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DDX21 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DDX21 mRNA	PMID:37236586|PMID:37325564
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DDX21 protein	PMID:23301498
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DDX21 mRNA	PMID:22100608|PMID:27153756
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1307306	E	RGD:6480464	20160119	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DDX21 mRNA	PMID:15890375
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DDX21 mRNA	PMID:23649840
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312764	E	RGD:6480464	20240604	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of DDX21 protein	PMID:38307155
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of DDX21 mRNA	PMID:41430723
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DDX21 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DDX21 protein	PMID:38598786
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1307306	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of DDX21 mRNA	PMID:30779732
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1307306	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DDX21 mRNA	PMID:31150632
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312764	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DDX21 mRNA	PMID:27339419|PMID:31919559
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1307306	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX21 mRNA]	PMID:31150632
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DDX21 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX21 mRNA	PMID:39836092|PMID:40512198
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DDX21 protein	PMID:35688186
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1307306	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of DDX21 mRNA	PMID:25905778
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312764	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of DDX21 protein	PMID:25505154
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of DDX21 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of DDX21 mRNA	PMID:23557933|PMID:26667767
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of DDX21 mRNA	PMID:27594783
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1312764	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of DDX21 mRNA	PMID:34813904
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312764	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of DDX21 mRNA	PMID:30912803
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of DDX21 mRNA	PMID:25583101
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312764	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DDX21 mRNA	PMID:21570461
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DDX21 mRNA	PMID:20106945|PMID:21632981
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DDX21 mRNA	PMID:18061397|PMID:22903824
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of DDX21 protein	PMID:39603559
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1307306	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of DDX21 mRNA	PMID:28374803
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DDX21 mRNA	PMID:33212167
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1312764	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of DDX21 protein	PMID:21146535
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of DDX21 protein	PMID:35688186
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:29014	cordycepin	decreases expression	ISO	RGD:1312764	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in decreased expression of DDX21 mRNA	PMID:32042022
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DDX21 mRNA	PMID:38568856
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DDX21 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX21 mRNA	PMID:39836092|PMID:40512198
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DDX21 mRNA	PMID:18061397
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312764	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DDX21 mRNA	PMID:22228805
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1312764	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of DDX21 protein	PMID:21146535
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:30145	lithium atom	multiple interactions	ISO	RGD:1307306	E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium inhibits the reaction [Methamphetamine results in decreased expression of DDX21 mRNA]	PMID:19149911
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:30146	lithium hydride	multiple interactions	ISO	RGD:1307306	E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium inhibits the reaction [Methamphetamine results in decreased expression of DDX21 mRNA]	PMID:19149911
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DDX21 mRNA	PMID:26238291
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DDX21 protein	PMID:25419056
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:31638	fulvestrant	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of DDX21 mRNA	PMID:16514628
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1307306	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of DDX21 mRNA	PMID:30047161
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of DDX21 mRNA	PMID:15498508
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312764	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DDX21 gene	PMID:35295148
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312764	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of DDX21 mRNA	PMID:27760801
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1307306	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DDX21 mRNA	PMID:23411599|PMID:34492290
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1307306	E	RGD:6480464	20160119	CTD	MESH:C006253	pirinixic acid results in increased expression of DDX21 mRNA	PMID:15890375|PMID:19162173
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DDX21 mRNA	PMID:19710929
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:32687	piperonyl butoxide	increases expression	ISO	RGD:1307306	E	RGD:6480464	20160119	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of DDX21 mRNA	PMID:15890375
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	increases expression	ISO	RGD:1307306	E	RGD:6480464	20160119	CTD	MESH:C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of DDX21 mRNA	PMID:15890375
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312764	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of DDX21 mRNA	PMID:28472532
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of DDX21 mRNA	PMID:30903817
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of DDX21 mRNA; bisphenol A results in decreased expression of DDX21 protein	PMID:20678512|PMID:37567409
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1307306	E	RGD:6480464	20160119	CTD	MESH:C006780	bisphenol A results in decreased expression of DDX21 mRNA	PMID:25181051
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C006780	bisphenol A analog results in increased expression of DDX21 mRNA	PMID:32387340
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1307306	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DDX21 mRNA	PMID:25181051|PMID:32145629
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1307306	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DDX21 gene	PMID:28505145
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of DDX21 protein	PMID:31675489
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312764	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DDX21 mRNA	PMID:39298647
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312764	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DDX21 mRNA	PMID:37019170
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1307306	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DDX21 mRNA	PMID:17602206
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1307306	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DDX21 mRNA	PMID:21266533
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of DDX21 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DDX21 protein	PMID:38598786
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312764	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of DDX21 mRNA	PMID:34813904
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1307306	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of DDX21 mRNA	PMID:17602206
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1307306	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of DDX21 mRNA	PMID:32680482
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312764	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of DDX21 mRNA]	PMID:39241906
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1307306	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of DDX21 mRNA	PMID:30589522
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312764	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DDX21 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DDX21 mRNA	PMID:37236586|PMID:37325564
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1307306	E	RGD:6480464	20160119	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of DDX21 mRNA	PMID:19162173
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1312764	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of DDX21 mRNA	PMID:24183702
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1307306	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of DDX21 mRNA	PMID:30047161
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312764	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of DDX21 mRNA	PMID:28903501
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DDX21 mRNA	PMID:19320972|PMID:22202117
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C018021	zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of DDX21 mRNA]	PMID:22202117
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1307306	E	RGD:6480464	20160119	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of DDX21 mRNA	PMID:15890375
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of DDX21 mRNA	PMID:24449571
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DDX21 mRNA	PMID:32588087
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DDX21 mRNA	PMID:31533062
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of DDX21 mRNA	PMID:26352163|PMID:28476498
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1307306	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of DDX21 mRNA	PMID:25993096
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DDX21 mRNA	PMID:25979313
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312764	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DDX21 mRNA	PMID:17292431
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of DDX21 mRNA	PMID:19101580
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DDX21 mRNA	PMID:23179753
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1307306	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of DDX21 mRNA	PMID:41580965
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1307306	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of DDX21 mRNA	PMID:30047161
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DDX21 mRNA	PMID:20106945|PMID:25562108
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of DDX21 mRNA	PMID:14699072
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1307306	E	RGD:6480464	20160119	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of DDX21 mRNA	PMID:15890375
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312764	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of DDX21 mRNA	PMID:18502557
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:44616	afimoxifene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of DDX21 mRNA	PMID:16514628
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of DDX21 mRNA]	PMID:21233418
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DDX21 mRNA; Okadaic Acid results in increased expression of DDX21 protein	PMID:38832940
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1307306	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of DDX21 mRNA	PMID:32479839
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DDX21 mRNA	PMID:35811015
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DDX21 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX21 mRNA	PMID:39836092|PMID:40512198
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of DDX21 mRNA	PMID:31675489
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DDX21 protein	PMID:25419056
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:49976	zinc dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C016837	zinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of DDX21 mRNA]	PMID:22202117
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312764	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DDX21 mRNA; Nanotubes, Carbon results in increased expression of DDX21 mRNA	PMID:25554681|PMID:25620056
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1307306	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of DDX21 mRNA	PMID:30047161
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1307306	E	RGD:6480464	20160119	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of DDX21 mRNA	PMID:19162173
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1307306	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DDX21 mRNA	PMID:24136188
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312764	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DDX21 mRNA	PMID:19042947
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of DDX21 protein	PMID:23718831
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DDX21 protein	PMID:32959892
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of DDX21 mRNA	PMID:19606018
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of DDX21 mRNA	PMID:28988120
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of DDX21 mRNA	PMID:15336504
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312764	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of DDX21 protein	PMID:26558463
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1307306	E	RGD:6480464	20120412	CTD	MESH:D008694	Methamphetamine results in decreased expression of DDX21 mRNA	PMID:19149911
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1307306	E	RGD:6480464	20120412	CTD	MESH:D008694	Lithium inhibits the reaction [Methamphetamine results in decreased expression of DDX21 mRNA]	PMID:19149911
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1307306	E	RGD:6480464	20160119	CTD	MESH:D008701	Methapyrilene results in increased expression of DDX21 mRNA	PMID:15890375
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of DDX21 mRNA	PMID:31758290
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DDX21 protein	PMID:34186270
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312764	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DDX21 mRNA	PMID:22206623
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DDX21 protein	PMID:37664457
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1307306	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of DDX21 mRNA	PMID:24136188
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:75175	3',5'-cyclic UMP	affects binding	EXP		E	RGD:6480464	20220405	CTD	MESH:C045338	DDX21 protein binds to cyclic 3',5'-uridine monophosphate	PMID:30528433
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:754906	afuresertib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of DDX21 mRNA	PMID:28960945
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of DDX21 protein	PMID:31285264
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:7599	Nivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of DDX21 protein	PMID:39638853
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of DDX21 protein	PMID:39638853
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:7719	ochratoxin A	decreases acetylation	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased acetylation of DDX21 promoter	PMID:29098329
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased expression of DDX21 mRNA	PMID:29098329
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	[ochratoxin A results in decreased acetylation of DDX21 promoter] which results in decreased expression of DDX21 mRNA	PMID:29098329
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1307306	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of DDX21 mRNA	PMID:21346803
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D010634	Phenobarbital results in decreased expression of DDX21 protein	PMID:35881160
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1307306	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of DDX21 mRNA	PMID:19162173
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312764	E	RGD:6480464	20230502	CTD	MESH:D010634	Phenobarbital results in increased expression of DDX21 protein	PMID:35881160
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1312764	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of DDX21 protein	PMID:19552622
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:81543	Tributyltin oxide	decreases phosphorylation	ISO	RGD:1312764	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased phosphorylation of DDX21 protein	PMID:22174045
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312764	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of DDX21 mRNA	PMID:30294300
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of DDX21 protein	PMID:31675489
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of DDX21 mRNA	PMID:35688559
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312764	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of DDX21 mRNA	PMID:21278054
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1307306	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of DDX21 mRNA	PMID:30047161
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312764	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of DDX21 mRNA]	PMID:39241906
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of DDX21 mRNA	PMID:16514628
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DDX21 protein	PMID:37664457
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1307306	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DDX21 mRNA	PMID:21346803
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1307306	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of DDX21 protein	PMID:35544339
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of DDX21 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DDX21 protein	PMID:38598786
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1307306	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DDX21 mRNA	PMID:21346803
1312763	DDX21	DExD-box helicase 21	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1307306	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of DDX21 mRNA	PMID:23034163
1312766	CLDN19	claudin 19	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of CLDN19 mRNA	PMID:31016361
1312766	CLDN19	claudin 19	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of CLDN19 mRNA	PMID:34925699
1312766	CLDN19	claudin 19	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CLDN19 mRNA	PMID:30165855
1312766	CLDN19	claudin 19	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305000	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CLDN19 mRNA	PMID:33387578
1312766	CLDN19	claudin 19	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of CLDN19 mRNA	PMID:33647349
1312766	CLDN19	claudin 19	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305000	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CLDN19 mRNA	PMID:26577399
1312766	CLDN19	claudin 19	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305000	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CLDN19 mRNA	PMID:33387578
1312766	CLDN19	claudin 19	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CLDN19 mRNA	PMID:19549813
1312766	CLDN19	claudin 19	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CLDN19 mRNA	PMID:23557933
1312766	CLDN19	claudin 19	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of CLDN19 promoter	PMID:22847954
1312766	CLDN19	claudin 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLDN19 mRNA	PMID:26238291
1312766	CLDN19	claudin 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305000	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLDN19 mRNA	PMID:33387578
1312766	CLDN19	claudin 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312767	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CLDN19 promoter]	PMID:19654925
1312766	CLDN19	claudin 19	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305000	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CLDN19 mRNA	PMID:26033743
1312766	CLDN19	claudin 19	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312767	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of CLDN19 mRNA	PMID:36209798
1312766	CLDN19	claudin 19	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CLDN19 exon	PMID:27901495
1312766	CLDN19	claudin 19	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLDN19 mRNA	PMID:22316170|PMID:26238291|PMID:32234424
1312766	CLDN19	claudin 19	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312767	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLDN19 mRNA	PMID:22228805
1312766	CLDN19	claudin 19	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CLDN19 promoter	PMID:27901495
1312766	CLDN19	claudin 19	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305000	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CLDN19 mRNA	PMID:26033743
1312766	CLDN19	claudin 19	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1305000	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of CLDN19 mRNA	PMID:38458666
1312766	CLDN19	claudin 19	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305000	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of CLDN19 mRNA	PMID:24395379
1312766	CLDN19	claudin 19	gene	CHEBI:31767	lead diacetate	affects expression	ISO	RGD:1305000	E	RGD:6480464	20120918	CTD	MESH:C008261	lead acetate affects the expression of CLDN19 mRNA	PMID:21864555
1312766	CLDN19	claudin 19	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312767	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CLDN19 mRNA	PMID:35295148
1312766	CLDN19	claudin 19	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312767	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CLDN19 mRNA	PMID:20813756
1312766	CLDN19	claudin 19	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CLDN19 mRNA	PMID:30903817
1312766	CLDN19	claudin 19	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305000	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CLDN19 mRNA	PMID:25181051
1312766	CLDN19	claudin 19	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312767	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of CLDN19 promoter	PMID:27312807
1312766	CLDN19	claudin 19	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305000	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CLDN19 gene	PMID:28505145
1312766	CLDN19	claudin 19	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1305000	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of CLDN19 mRNA	PMID:38458666
1312766	CLDN19	claudin 19	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of CLDN19 mRNA	PMID:29024780
1312766	CLDN19	claudin 19	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305000	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of CLDN19 mRNA	PMID:25539665
1312766	CLDN19	claudin 19	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312767	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CLDN19 mRNA	PMID:40194260
1312766	CLDN19	claudin 19	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of CLDN19 promoter	PMID:22847954
1312766	CLDN19	claudin 19	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of CLDN19 promoter	PMID:22847954
1312766	CLDN19	claudin 19	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CLDN19 gene	PMID:29154799
1312766	CLDN19	claudin 19	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CLDN19 mRNA	PMID:38832940
1312766	CLDN19	claudin 19	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305000	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLDN19 mRNA	PMID:33387578
1312769	CCNG2	cyclin G2	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007262	deoxynivalenol results in increased expression of CCNG2 mRNA	PMID:30169763
1312769	CCNG2	cyclin G2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CCNG2 mRNA	PMID:38218311
1312769	CCNG2	cyclin G2	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of CCNG2 mRNA	PMID:25596134
1312769	CCNG2	cyclin G2	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CCNG2 mRNA	PMID:26272509
1312769	CCNG2	cyclin G2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1312769	CCNG2	cyclin G2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CCNG2 mRNA	PMID:33045310
1312769	CCNG2	cyclin G2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312770	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CCNG2 mRNA	PMID:37995155
1312769	CCNG2	cyclin G2	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of CCNG2 mRNA	PMID:31016361
1312769	CCNG2	cyclin G2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CCNG2 mRNA	PMID:26251327
1312769	CCNG2	cyclin G2	gene	CHEBI:144804	nickel subsulfide	affects expression	ISO	RGD:1312770	E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide affects the expression of CCNG2 mRNA	PMID:12729255
1312769	CCNG2	cyclin G2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CCNG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CCNG2 mRNA	PMID:32699268
1312769	CCNG2	cyclin G2	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CCNG2 mRNA	PMID:20042640|PMID:24236059|PMID:25596134
1312769	CCNG2	cyclin G2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312770	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CCNG2 mRNA	PMID:20880076
1312769	CCNG2	cyclin G2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CCNG2 mRNA	PMID:26079696
1312769	CCNG2	cyclin G2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312770	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CCNG2 mRNA	PMID:30319688
1312769	CCNG2	cyclin G2	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in increased expression of CCNG2 mRNA	PMID:23378141
1312769	CCNG2	cyclin G2	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	[Ethanol co-treated with Folic Acid] results in increased expression of CCNG2 mRNA	PMID:23378141
1312769	CCNG2	cyclin G2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CCNG2 mRNA	PMID:21632981
1312769	CCNG2	cyclin G2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CCNG2 mRNA	PMID:39241906
1312769	CCNG2	cyclin G2	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CCNG2 mRNA	PMID:30510588
1312769	CCNG2	cyclin G2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of CCNG2 mRNA	PMID:22574217
1312769	CCNG2	cyclin G2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of CCNG2 mRNA	PMID:15598610
1312769	CCNG2	cyclin G2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	Estradiol results in decreased expression of CCNG2 mRNA	PMID:26865669|PMID:28711546|PMID:31614463|PMID:32387340
1312769	CCNG2	cyclin G2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of CCNG2 mRNA	PMID:14664709|PMID:39298647
1312769	CCNG2	cyclin G2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of CCNG2 mRNA	PMID:19619570
1312769	CCNG2	cyclin G2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D004958	[Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CCNG2 mRNA; Estradiol inhibits the reaction [NCOA3 protein binds to CCNG2 promoter]; FOXA1 protein affects the reaction [[Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA]; FOXA1 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA]]; Tetrachlorodibenzodioxin inhibits the reaction [[Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Estradiol inhibits the reaction [NCOA3 protein binds to CCNG2 promoter]]	PMID:19619570|PMID:22596188
1312769	CCNG2	cyclin G2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CCNG2 mRNA	PMID:38568856
1312769	CCNG2	cyclin G2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CCNG2 mRNA	PMID:37042841
1312769	CCNG2	cyclin G2	gene	CHEBI:16836	4-nitrophenol	increases expression	ISO	RGD:1312770	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in increased expression of CCNG2 mRNA	PMID:34673133
1312769	CCNG2	cyclin G2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CCNG2 mRNA	PMID:23649840
1312769	CCNG2	cyclin G2	gene	CHEBI:17263	estrone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004970	Estrone results in decreased expression of CCNG2 mRNA	PMID:26865669
1312769	CCNG2	cyclin G2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1312770	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of CCNG2 mRNA	PMID:28973375
1312769	CCNG2	cyclin G2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305002	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of CCNG2 mRNA	PMID:26496021
1312769	CCNG2	cyclin G2	gene	CHEBI:175901	gemcitabine	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in increased expression of CCNG2 mRNA	PMID:17039268
1312769	CCNG2	cyclin G2	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CCNG2 mRNA	PMID:23416264
1312769	CCNG2	cyclin G2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CCNG2 mRNA	PMID:31163220
1312769	CCNG2	cyclin G2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CCNG2 mRNA	PMID:16002434
1312769	CCNG2	cyclin G2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CCNG2 mRNA	PMID:33387578
1312769	CCNG2	cyclin G2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305002	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CCNG2 mRNA	PMID:22061828
1312769	CCNG2	cyclin G2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CCNG2 mRNA	PMID:28818685
1312769	CCNG2	cyclin G2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCNG2 mRNA	PMID:36331819
1312769	CCNG2	cyclin G2	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in increased expression of CCNG2 mRNA	PMID:20368581
1312769	CCNG2	cyclin G2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CCNG2 mRNA	PMID:39836092
1312769	CCNG2	cyclin G2	gene	CHEBI:18320	1,4-dithiothreitol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004229	Dithiothreitol results in increased expression of CCNG2 mRNA	PMID:17332266
1312769	CCNG2	cyclin G2	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of CCNG2 mRNA	PMID:23416264
1312769	CCNG2	cyclin G2	gene	CHEBI:2038	5-azacytidine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D001374	Azacitidine results in decreased expression of CCNG2 mRNA	PMID:21245298
1312769	CCNG2	cyclin G2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCNG2 mRNA	PMID:37236586
1312769	CCNG2	cyclin G2	gene	CHEBI:229924	pifithrin-alpha hydrobromide	multiple interactions	EXP		E	RGD:6480464	20240409	CTD	MESH:C121565	[pifithrin co-treated with Arsenic Trioxide] results in increased expression of CCNG2 mRNA	PMID:35030298
1312769	CCNG2	cyclin G2	gene	CHEBI:23115	chlorohydrocarbon	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:D006843	Hydrocarbons, Chlorinated results in increased expression of CCNG2 mRNA	PMID:14757120
1312769	CCNG2	cyclin G2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CCNG2 mRNA	PMID:19549813
1312769	CCNG2	cyclin G2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CCNG2 mRNA	PMID:23649840
1312769	CCNG2	cyclin G2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CCNG2 protein	PMID:20106945
1312769	CCNG2	cyclin G2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CCNG2 gene	PMID:27153756
1312769	CCNG2	cyclin G2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CCNG2 mRNA	PMID:23649840
1312769	CCNG2	cyclin G2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of CCNG2 mRNA	PMID:15674843
1312769	CCNG2	cyclin G2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CCNG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CCNG2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CCNG2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of CCNG2 mRNA	PMID:32699268|PMID:41430723
1312769	CCNG2	cyclin G2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CCNG2 mRNA	PMID:27106289
1312769	CCNG2	cyclin G2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CCNG2 mRNA	PMID:31150632
1312769	CCNG2	cyclin G2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCNG2 mRNA	PMID:17484886|PMID:31919559
1312769	CCNG2	cyclin G2	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D005492	[Ethanol co-treated with Folic Acid] results in increased expression of CCNG2 mRNA	PMID:23378141
1312769	CCNG2	cyclin G2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCNG2 mRNA	PMID:22206623
1312769	CCNG2	cyclin G2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CCNG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCNG2 mRNA	PMID:39836092
1312769	CCNG2	cyclin G2	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of CCNG2 mRNA	PMID:38460933
1312769	CCNG2	cyclin G2	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of CCNG2 mRNA	PMID:38460933
1312769	CCNG2	cyclin G2	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of CCNG2 mRNA	PMID:38460933
1312769	CCNG2	cyclin G2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CCNG2 mRNA	PMID:26272509
1312769	CCNG2	cyclin G2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1312769	CCNG2	cyclin G2	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of CCNG2 mRNA	PMID:25596134
1312769	CCNG2	cyclin G2	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	CCNG2 protein affects the susceptibility to Cisplatin	PMID:16217747
1312769	CCNG2	cyclin G2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of CCNG2 mRNA	PMID:25596134
1312769	CCNG2	cyclin G2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CCNG2 mRNA	PMID:27594783
1312769	CCNG2	cyclin G2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CCNG2 mRNA	PMID:27392435
1312769	CCNG2	cyclin G2	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312770	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of CCNG2 mRNA	PMID:30912803
1312769	CCNG2	cyclin G2	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D019833	Genistein results in decreased expression of CCNG2 mRNA	PMID:26865669
1312769	CCNG2	cyclin G2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CCNG2 mRNA	PMID:24768652|PMID:25583101
1312769	CCNG2	cyclin G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305002	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCNG2 mRNA	PMID:22298810
1312769	CCNG2	cyclin G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312770	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCNG2 mRNA	PMID:21570461
1312769	CCNG2	cyclin G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCNG2 mRNA; Tetrachlorodibenzodioxin results in increased expression of CCNG2 protein	PMID:19574409|PMID:19619570|PMID:20348232|PMID:22596188
1312769	CCNG2	cyclin G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305002	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCNG2 mRNA	PMID:34747641
1312769	CCNG2	cyclin G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCNG2 mRNA]; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CCNG2 mRNA; AHR protein promotes the reaction [Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CCNG2 gene]]; ESR1 protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CCNG2 mRNA]; FOXA1 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA]]; FOXA1 protein affects the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CCNG2 promoter]]; FOXA1 protein affects the reaction [Tetrachlorodibenzodioxin promotes the reaction [NCOA3 protein binds to CCNG2 promoter]]; FOXA1 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CCNG2 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [[Estradiol binds to ESR1 protein] which results in decreased expression of CCNG2 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Estradiol inhibits the reaction [NCOA3 protein binds to CCNG2 promoter]]; Tetrachlorodibenzodioxin promotes the reaction [[[AHR protein binds to FOXA1 protein] which binds to CCNG2 promoter] which results in increased expression of CCNG2 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [[[AHR protein binds to NCOA3 protein binds to FOXA1 protein] which binds to CCNG2 promoter] which results in increased expression of CCNG2 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [[[AHR protein binds to NCOA3 protein binds to FOXA1 protein] which binds to CCNG2 promoter] which results in increased expression of CCNG2 protein]; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CCNG2 gene]; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CCNG2 promoter]; Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to CCNG2 gene]; Tetrachlorodibenzodioxin promotes the reaction [FOXA1 protein binds to CCNG2 enhancer]; Tetrachlorodibenzodioxin promotes the reaction [FOXA1 protein binds to CCNG2 promoter]; Tetrachlorodibenzodioxin promotes the reaction [NCOA3 protein binds to CCNG2 promoter]	PMID:19574409|PMID:19619570|PMID:22596188
1312769	CCNG2	cyclin G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CCNG2 mRNA	PMID:25975270
1312769	CCNG2	cyclin G2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CCNG2 mRNA	PMID:28001369
1312769	CCNG2	cyclin G2	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CCNG2 mRNA	PMID:30851411
1312769	CCNG2	cyclin G2	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of CCNG2 mRNA	PMID:26272509
1312769	CCNG2	cyclin G2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1312769	CCNG2	cyclin G2	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1305002	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of CCNG2 mRNA	PMID:28959563
1312769	CCNG2	cyclin G2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CCNG2 mRNA	PMID:30911355
1312769	CCNG2	cyclin G2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312770	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of CCNG2 mRNA	PMID:39631538
1312769	CCNG2	cyclin G2	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D004317	Doxorubicin inhibits the reaction [NR1I3 protein results in increased expression of CCNG2 mRNA]	PMID:21557330
1312769	CCNG2	cyclin G2	gene	CHEBI:28940	calciol	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in increased expression of CCNG2 mRNA	PMID:16508948
1312769	CCNG2	cyclin G2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCNG2 mRNA	PMID:34032870
1312769	CCNG2	cyclin G2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of CCNG2 mRNA	PMID:20886546|PMID:38568856
1312769	CCNG2	cyclin G2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CCNG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCNG2 mRNA	PMID:39836092
1312769	CCNG2	cyclin G2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CCNG2 promoter	PMID:27901495
1312769	CCNG2	cyclin G2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCNG2 mRNA	PMID:30453624
1312769	CCNG2	cyclin G2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCNG2 mRNA	PMID:20504355|PMID:22228805
1312769	CCNG2	cyclin G2	gene	CHEBI:3000	beauvericin	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C004456	[beauvericin co-treated with enniatins] results in decreased expression of CCNG2 mRNA	PMID:31100301
1312769	CCNG2	cyclin G2	gene	CHEBI:30045	divanadium pentaoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C066075	vanadium pentoxide results in decreased expression of CCNG2 mRNA	PMID:17459161
1312769	CCNG2	cyclin G2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CCNG2 mRNA	PMID:30911355
1312769	CCNG2	cyclin G2	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of CCNG2 mRNA	PMID:25075043
1312769	CCNG2	cyclin G2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CCNG2 mRNA	PMID:27131904
1312769	CCNG2	cyclin G2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CCNG2 mRNA	PMID:25895662
1312769	CCNG2	cyclin G2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CCNG2 mRNA	PMID:20018196
1312769	CCNG2	cyclin G2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CCNG2 mRNA	PMID:26238291
1312769	CCNG2	cyclin G2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CCNG2 mRNA	PMID:20458559|PMID:24356939|PMID:25424538
1312769	CCNG2	cyclin G2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C006632	[pifithrin co-treated with Arsenic Trioxide] results in increased expression of CCNG2 mRNA	PMID:35030298
1312769	CCNG2	cyclin G2	gene	CHEBI:3090	bicalutamide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of CCNG2 mRNA	PMID:15790403
1312769	CCNG2	cyclin G2	gene	CHEBI:31638	fulvestrant	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C070081	fulvestrant results in increased expression of CCNG2 mRNA	PMID:26865669
1312769	CCNG2	cyclin G2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of CCNG2 mRNA	PMID:24136188
1312769	CCNG2	cyclin G2	gene	CHEBI:31669	hexestrol	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D006589	Hexestrol results in decreased expression of CCNG2 mRNA	PMID:26865669
1312769	CCNG2	cyclin G2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CCNG2 mRNA	PMID:30047161
1312769	CCNG2	cyclin G2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of CCNG2 mRNA	PMID:27760801
1312769	CCNG2	cyclin G2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312770	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CCNG2 gene	PMID:35295148
1312769	CCNG2	cyclin G2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305002	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CCNG2 mRNA	PMID:34492290
1312769	CCNG2	cyclin G2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CCNG2 mRNA	PMID:18648102
1312769	CCNG2	cyclin G2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312770	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CCNG2 mRNA	PMID:18301758|PMID:20059764|PMID:23811191
1312769	CCNG2	cyclin G2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CCNG2 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of CCNG2 mRNA]	PMID:19710929|PMID:20059764
1312769	CCNG2	cyclin G2	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of CCNG2 mRNA	PMID:19191707
1312769	CCNG2	cyclin G2	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of CCNG2 mRNA	PMID:24356939
1312769	CCNG2	cyclin G2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312770	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CCNG2 mRNA	PMID:28472532
1312769	CCNG2	cyclin G2	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CCNG2 mRNA	PMID:38479592
1312769	CCNG2	cyclin G2	gene	CHEBI:33090	picene	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C056699	picene results in increased expression of CCNG2 mRNA	PMID:32251684
1312769	CCNG2	cyclin G2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C006780	bisphenol A results in decreased expression of CCNG2 mRNA	PMID:28711546
1312769	CCNG2	cyclin G2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of CCNG2 mRNA	PMID:26982218
1312769	CCNG2	cyclin G2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of CCNG2 mRNA	PMID:29275510
1312769	CCNG2	cyclin G2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305002	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CCNG2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1312769	CCNG2	cyclin G2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312770	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CCNG2 mRNA	PMID:33221593
1312769	CCNG2	cyclin G2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305002	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of CCNG2 mRNA	PMID:26496021
1312769	CCNG2	cyclin G2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CCNG2 mRNA	PMID:25172293
1312769	CCNG2	cyclin G2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CCNG2 mRNA	PMID:25979313
1312769	CCNG2	cyclin G2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	affects expression	ISO	RGD:1312770	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT affects the expression of CCNG2 mRNA	PMID:18925944
1312769	CCNG2	cyclin G2	gene	CHEBI:34342	3-methylcholanthrene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene results in increased expression of CCNG2 mRNA	PMID:20348232
1312769	CCNG2	cyclin G2	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to CCNG2 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to CCNG2 promoter]; Methylcholanthrene promotes the reaction [Methylcholanthrene results in increased expression of CCNG2 mRNA]	PMID:20348232
1312769	CCNG2	cyclin G2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CCNG2 mRNA	PMID:39298647
1312769	CCNG2	cyclin G2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312770	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of CCNG2 mRNA	PMID:40203079
1312769	CCNG2	cyclin G2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312770	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of CCNG2 mRNA	PMID:28392331
1312769	CCNG2	cyclin G2	gene	CHEBI:34682	diazinon	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D003976	Diazinon results in increased expression of CCNG2 mRNA	PMID:24356939
1312769	CCNG2	cyclin G2	gene	CHEBI:34709	Diisodecyl phthalate	increases expression	ISO	RGD:1312770	E	RGD:6480464	20150127	CTD	MESH:C042080	diisodecyl phthalate results in increased expression of CCNG2 mRNA	PMID:25270620
1312769	CCNG2	cyclin G2	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305002	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CCNG2 mRNA	PMID:22546817
1312769	CCNG2	cyclin G2	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C022838	nickel chloride results in increased expression of CCNG2 mRNA	PMID:17312168|PMID:21455298
1312769	CCNG2	cyclin G2	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of CCNG2 mRNA	PMID:12729255
1312769	CCNG2	cyclin G2	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20120717	CTD	MESH:C022838	HIF1A affects the reaction [nickel chloride results in increased expression of CCNG2 mRNA]	PMID:12729255
1312769	CCNG2	cyclin G2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CCNG2 mRNA	PMID:37042841
1312769	CCNG2	cyclin G2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1305002	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of CCNG2 mRNA	PMID:30589522
1312769	CCNG2	cyclin G2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CCNG2 mRNA	PMID:39836092
1312769	CCNG2	cyclin G2	gene	CHEBI:35456	cadmium dichloride	affects methylation	ISO	RGD:1305002	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the methylation of CCNG2 promoter	PMID:22457795
1312769	CCNG2	cyclin G2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CCNG2 mRNA	PMID:25596134|PMID:38568856
1312769	CCNG2	cyclin G2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCNG2 mRNA	PMID:37236586
1312769	CCNG2	cyclin G2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C018021	cobaltous chloride results in increased expression of CCNG2 mRNA	PMID:19376846|PMID:22202117|PMID:24356939
1312769	CCNG2	cyclin G2	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C018021	zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CCNG2 mRNA]	PMID:22202117
1312769	CCNG2	cyclin G2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CCNG2 mRNA	PMID:24449571
1312769	CCNG2	cyclin G2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of CCNG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of CCNG2 mRNA	PMID:32699268
1312769	CCNG2	cyclin G2	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of CCNG2 mRNA	PMID:25596134
1312769	CCNG2	cyclin G2	gene	CHEBI:3752	clomiphene	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D002996	Clomiphene results in increased expression of CCNG2 mRNA	PMID:26865669
1312769	CCNG2	cyclin G2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CCNG2 mRNA	PMID:28302478
1312769	CCNG2	cyclin G2	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of CCNG2 mRNA	PMID:19167446
1312769	CCNG2	cyclin G2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CCNG2 mRNA	PMID:40419075
1312769	CCNG2	cyclin G2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCNG2 mRNA	PMID:36331819
1312769	CCNG2	cyclin G2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of CCNG2 mRNA	PMID:25993096
1312769	CCNG2	cyclin G2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CCNG2 mRNA	PMID:25979313
1312769	CCNG2	cyclin G2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CCNG2 mRNA	PMID:17292431
1312769	CCNG2	cyclin G2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CCNG2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1312769	CCNG2	cyclin G2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1312769	CCNG2	cyclin G2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CCNG2 mRNA	PMID:30047161
1312769	CCNG2	cyclin G2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CCNG2 mRNA	PMID:25562108|PMID:25596134|PMID:27989131
1312769	CCNG2	cyclin G2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CCNG2 mRNA	PMID:20106945
1312769	CCNG2	cyclin G2	gene	CHEBI:41977	daunorubicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003630	Daunorubicin results in increased expression of CCNG2 mRNA	PMID:18754885
1312769	CCNG2	cyclin G2	gene	CHEBI:42106	L-1,4-dithiothreitol	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D004229	Dithiothreitol results in increased expression of CCNG2 mRNA	PMID:17332266
1312769	CCNG2	cyclin G2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CCNG2 mRNA	PMID:28973697
1312769	CCNG2	cyclin G2	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of CCNG2 mRNA	PMID:23649840
1312769	CCNG2	cyclin G2	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of CCNG2 mRNA	PMID:12929121
1312769	CCNG2	cyclin G2	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of CCNG2 mRNA]	PMID:21233418
1312769	CCNG2	cyclin G2	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1312770	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of CCNG2 mRNA	PMID:12929121
1312769	CCNG2	cyclin G2	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of CCNG2 mRNA	PMID:29309887
1312769	CCNG2	cyclin G2	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CCNG2 mRNA	PMID:28542535
1312769	CCNG2	cyclin G2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CCNG2 mRNA	PMID:24935251|PMID:26272509
1312769	CCNG2	cyclin G2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1312769	CCNG2	cyclin G2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312770	E	RGD:6480464	20120613	CTD	MESH:D000082	Acetaminophen affects the expression of CCNG2 mRNA	PMID:15606129|PMID:17562736
1312769	CCNG2	cyclin G2	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	CCNG2 affects the susceptibility to Fluorouracil	PMID:15067352
1312769	CCNG2	cyclin G2	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20121009	CTD	MESH:D005472	Fluorouracil results in decreased expression of CCNG2 mRNA	PMID:19272435
1312769	CCNG2	cyclin G2	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D005472	Fluorouracil results in increased expression of CCNG2 mRNA	PMID:16510598|PMID:16557594|PMID:17039268|PMID:18754885
1312769	CCNG2	cyclin G2	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of CCNG2 mRNA	PMID:38460933
1312769	CCNG2	cyclin G2	gene	CHEBI:46936	nonivamide	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C040937	nonivamide results in increased expression of CCNG2 mRNA	PMID:17332266
1312769	CCNG2	cyclin G2	gene	CHEBI:46936	nonivamide	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C040937	[nonivamide binds to and results in increased activity of TRPV1 protein] which results in increased expression of CCNG2 mRNA	PMID:17332266
1312769	CCNG2	cyclin G2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CCNG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCNG2 mRNA	PMID:39836092
1312769	CCNG2	cyclin G2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CCNG2 mRNA	PMID:29391264
1312769	CCNG2	cyclin G2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of CCNG2 mRNA	PMID:18851785
1312769	CCNG2	cyclin G2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312770	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CCNG2 mRNA	PMID:35436446
1312769	CCNG2	cyclin G2	gene	CHEBI:48607	lithium chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in decreased expression of CCNG2 mRNA	PMID:15711924
1312769	CCNG2	cyclin G2	gene	CHEBI:48607	lithium chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in increased expression of CCNG2 mRNA	PMID:17440966
1312769	CCNG2	cyclin G2	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of CCNG2 mRNA	PMID:18754885
1312769	CCNG2	cyclin G2	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of CCNG2 mRNA	PMID:26272509
1312769	CCNG2	cyclin G2	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1312769	CCNG2	cyclin G2	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of CCNG2 mRNA	PMID:16984733
1312769	CCNG2	cyclin G2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CCNG2 mRNA	PMID:20458559|PMID:24356939|PMID:25424538
1312769	CCNG2	cyclin G2	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C032793	[pifithrin co-treated with Arsenic Trioxide] results in increased expression of CCNG2 mRNA	PMID:35030298
1312769	CCNG2	cyclin G2	gene	CHEBI:49976	zinc dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C016837	zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CCNG2 mRNA]	PMID:22202117
1312769	CCNG2	cyclin G2	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of CCNG2 mRNA	PMID:25596134
1312769	CCNG2	cyclin G2	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1305002	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of CCNG2 mRNA	PMID:25596134
1312769	CCNG2	cyclin G2	gene	CHEBI:50035	alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of CCNG2 mRNA	PMID:25075043
1312769	CCNG2	cyclin G2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CCNG2 mRNA	PMID:25554681
1312769	CCNG2	cyclin G2	gene	CHEBI:50594	carbon nanotube	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CCNG2 mRNA	PMID:15585362
1312769	CCNG2	cyclin G2	gene	CHEBI:50845	doxycycline	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:D004318	Doxycycline inhibits the reaction [Isoproterenol results in increased expression of CCNG2 mRNA]	PMID:18089841
1312769	CCNG2	cyclin G2	gene	CHEBI:5118	fluoxetine	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D005473	Fluoxetine results in increased expression of CCNG2 mRNA	PMID:24356939
1312769	CCNG2	cyclin G2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of CCNG2 mRNA	PMID:24136188
1312769	CCNG2	cyclin G2	gene	CHEBI:52717	bortezomib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	[BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in decreased expression of CCNG2 mRNA	PMID:25522274
1312769	CCNG2	cyclin G2	gene	CHEBI:5864	ifosfamide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of CCNG2 mRNA	PMID:25596134
1312769	CCNG2	cyclin G2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CCNG2 mRNA	PMID:39836092
1312769	CCNG2	cyclin G2	gene	CHEBI:63112	fingolimod hydrochloride	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:D000068876	Fingolimod Hydrochloride results in increased expression of CCNG2 mRNA	PMID:24356939
1312769	CCNG2	cyclin G2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCNG2 mRNA	PMID:21641980
1312769	CCNG2	cyclin G2	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	CCNG2 protein affects the susceptibility to Topotecan	PMID:16217747
1312769	CCNG2	cyclin G2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of CCNG2 mRNA	PMID:19812364
1312769	CCNG2	cyclin G2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CCNG2 mRNA	PMID:15336504
1312769	CCNG2	cyclin G2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CCNG2 mRNA	PMID:28801915
1312769	CCNG2	cyclin G2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312770	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of CCNG2 mRNA	PMID:18089841|PMID:20003209
1312769	CCNG2	cyclin G2	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20120515	CTD	MESH:D007545	Doxycycline inhibits the reaction [Isoproterenol results in increased expression of CCNG2 mRNA]	PMID:18089841
1312769	CCNG2	cyclin G2	gene	CHEBI:64648	enniatin	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C100264	[beauvericin co-treated with enniatins] results in decreased expression of CCNG2 mRNA	PMID:31100301
1312769	CCNG2	cyclin G2	gene	CHEBI:6784	mestranol	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D008656	Mestranol results in decreased expression of CCNG2 mRNA	PMID:26865669
1312769	CCNG2	cyclin G2	gene	CHEBI:6801	metformin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of CCNG2 mRNA	PMID:25596134
1312769	CCNG2	cyclin G2	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of CCNG2 mRNA	PMID:25596134
1312769	CCNG2	cyclin G2	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of CCNG2 mRNA	PMID:29309887
1312769	CCNG2	cyclin G2	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in increased expression of CCNG2 mRNA	PMID:22101062
1312769	CCNG2	cyclin G2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CCNG2 mRNA	PMID:22206623
1312769	CCNG2	cyclin G2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312770	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCNG2 mRNA	PMID:22206623
1312769	CCNG2	cyclin G2	gene	CHEBI:747853	Gedatolisib	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C549060	gedatolisib inhibits the reaction [PIK3CA protein modified form results in decreased expression of CCNG2 mRNA]	PMID:27542212
1312769	CCNG2	cyclin G2	gene	CHEBI:7507	neomycin	increases expression	ISO	RGD:1312770	E	RGD:6480464	20190507	CTD	MESH:D009355	Neomycin results in increased expression of CCNG2 mRNA	PMID:30626089
1312769	CCNG2	cyclin G2	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of CCNG2 mRNA	PMID:36318118
1312769	CCNG2	cyclin G2	gene	CHEBI:7553	niclosamide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide inhibits the reaction [PIK3CA protein modified form results in decreased expression of CCNG2 mRNA]	PMID:27542212
1312769	CCNG2	cyclin G2	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C025589	ochratoxin A results in decreased expression of CCNG2 mRNA	PMID:24356939
1312769	CCNG2	cyclin G2	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CCNG2 mRNA	PMID:30851411
1312769	CCNG2	cyclin G2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1312769	CCNG2	cyclin G2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CCNG2 gene]	PMID:28238834
1312769	CCNG2	cyclin G2	gene	CHEBI:80630	irinotecan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in increased expression of CCNG2 mRNA	PMID:18927307
1312769	CCNG2	cyclin G2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312770	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CCNG2 mRNA	PMID:23091169
1312769	CCNG2	cyclin G2	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of CCNG2 mRNA	PMID:18958704
1312769	CCNG2	cyclin G2	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1312770	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of CCNG2 mRNA	PMID:21195148
1312769	CCNG2	cyclin G2	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1312770	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of CCNG2 mRNA	PMID:21195148
1312769	CCNG2	cyclin G2	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in increased expression of CCNG2 mRNA	PMID:32251684
1312769	CCNG2	cyclin G2	gene	CHEBI:82388	p-anisidine	increases expression	ISO	RGD:1312770	E	RGD:6480464	20141111	CTD	MESH:C013813	4-anisidine results in increased expression of CCNG2 mRNA	PMID:12929121
1312769	CCNG2	cyclin G2	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of CCNG2 mRNA	PMID:20368581
1312769	CCNG2	cyclin G2	gene	CHEBI:8378	prednisolone	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D011239	Prednisolone results in increased expression of CCNG2 mRNA	PMID:24356939
1312769	CCNG2	cyclin G2	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of CCNG2 mRNA	PMID:26079696
1312769	CCNG2	cyclin G2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CCNG2 mRNA	PMID:30047161
1312769	CCNG2	cyclin G2	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of CCNG2 mRNA	PMID:26272509
1312769	CCNG2	cyclin G2	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1312769	CCNG2	cyclin G2	gene	CHEBI:8687	pyrvinium	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C024631	pyrvinium inhibits the reaction [PIK3CA protein modified form results in decreased expression of CCNG2 mRNA]	PMID:27542212
1312769	CCNG2	cyclin G2	gene	CHEBI:8772	raloxifene	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of CCNG2 mRNA	PMID:16497877|PMID:26865669
1312769	CCNG2	cyclin G2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CCNG2 mRNA	PMID:27188386
1312769	CCNG2	cyclin G2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CCNG2 mRNA	PMID:27131904
1312769	CCNG2	cyclin G2	gene	CHEBI:9168	sirolimus	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D020123	Sirolimus results in increased expression of CCNG2 mRNA	PMID:24356939
1312769	CCNG2	cyclin G2	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	[cotylenin A co-treated with Sirolimus] results in increased expression of CCNG2 mRNA; Sirolimus inhibits the reaction [PIK3CA protein modified form results in decreased expression of CCNG2 mRNA]; Sirolimus inhibits the reaction [TP73 protein results in increased expression of CCNG2 mRNA]	PMID:18754885|PMID:21245298|PMID:27542212
1312769	CCNG2	cyclin G2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CCNG2 mRNA	PMID:19281266
1312769	CCNG2	cyclin G2	gene	CHEBI:92658	kenpaullone	decreases expression	ISO	RGD:1305002	E	RGD:6480464	20211109	CTD	MESH:C119620	kenpaullone results in decreased expression of CCNG2 mRNA	PMID:17993264
1312769	CCNG2	cyclin G2	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in decreased expression of CCNG2 mRNA	PMID:34581912
1312769	CCNG2	cyclin G2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CCNG2 mRNA	PMID:38568856
1312769	CCNG2	cyclin G2	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of CCNG2 mRNA	PMID:29301935
1312769	CCNG2	cyclin G2	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019284	Thapsigargin results in increased expression of CCNG2 mRNA	PMID:17332266
1312769	CCNG2	cyclin G2	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1312770	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of CCNG2 mRNA	PMID:21195148
1312769	CCNG2	cyclin G2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312770	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CCNG2 mRNA	PMID:35537566
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312772	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of PKNOX1 mRNA	PMID:33045310
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305003	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PKNOX1 mRNA]	PMID:31150632
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312772	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PKNOX1 mRNA	PMID:26251327
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312772	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PKNOX1 mRNA	PMID:20188158
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1312772	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of PKNOX1 promoter	PMID:26251327
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312772	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PKNOX1 mRNA	PMID:30319688
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312772	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PKNOX1 mRNA	PMID:39241906
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PKNOX1 mRNA	PMID:37042841
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:17303	morphine	increases expression	ISO	RGD:1312772	E	RGD:6480464	20120412	CTD	MESH:D009020	Morphine results in increased expression of PKNOX1 mRNA	PMID:21178816
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312772	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PKNOX1 mRNA	PMID:23892564
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PKNOX1 protein	PMID:37730182
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305003	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PKNOX1 mRNA	PMID:33387578
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PKNOX1 mRNA	PMID:28818685
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PKNOX1 mRNA	PMID:23649840
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PKNOX1 promoter	PMID:30157460
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PKNOX1 mRNA	PMID:18593933
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312772	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PKNOX1 mRNA	PMID:17484886
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305003	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PKNOX1 mRNA	PMID:31150632
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305003	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PKNOX1 mRNA]	PMID:31150632
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312772	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PKNOX1 mRNA	PMID:25629700
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PKNOX1 mRNA	PMID:23557933
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312772	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PKNOX1 mRNA	PMID:21570461|PMID:24058054
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PKNOX1 mRNA	PMID:32763439
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PKNOX1 mRNA	PMID:38568856
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312772	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PKNOX1 mRNA	PMID:22228805
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PKNOX1 mRNA	PMID:18593933
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PKNOX1 mRNA	PMID:15761015
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312772	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PKNOX1 gene; titanium dioxide results in decreased methylation of PKNOX1 promoter	PMID:35295148
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312772	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PKNOX1 mRNA	PMID:18648102
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312772	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of PKNOX1 mRNA	PMID:23811191
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PKNOX1 gene	PMID:31601247
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305003	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of PKNOX1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312772	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PKNOX1 mRNA	PMID:26063408
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312772	E	RGD:6480464	20240206	CTD	MESH:C543008	bisphenol S results in increased expression of PKNOX1 mRNA	PMID:37611474
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1312772	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride affects the expression of PKNOX1 mRNA	PMID:18974090
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305003	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PKNOX1 promoter	PMID:22457795
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PKNOX1 mRNA	PMID:19320972
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PKNOX1 mRNA	PMID:25979313
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312772	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PKNOX1 mRNA	PMID:28973697
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of PKNOX1 mRNA	PMID:21420995
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305003	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PKNOX1 mRNA	PMID:33387578
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PKNOX1 mRNA	PMID:15761015
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1305003	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of PKNOX1 mRNA	PMID:30307764
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:64213	cantharidin	increases expression	ISO	RGD:1312772	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in increased expression of PKNOX1 mRNA	PMID:36907384
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:6980	monocrotaline	decreases expression	ISO	RGD:1312772	E	RGD:6480464	20171114	CTD	MESH:D016686	Monocrotaline results in decreased expression of PKNOX1 mRNA	PMID:28818515
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312772	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PKNOX1 mRNA	PMID:22206623
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of PKNOX1 mRNA	PMID:19737606
1312771	PKNOX1	PBX/knotted 1 homeobox 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312772	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PKNOX1 mRNA	PMID:28973697
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312774	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SFSWAP mRNA	PMID:33045310
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312774	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SFSWAP mRNA	PMID:39241906
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SFSWAP mRNA	PMID:37042841
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312774	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SFSWAP mRNA	PMID:34319233
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SFSWAP protein	PMID:37730182
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of SFSWAP intron	PMID:30157460
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SFSWAP protein	PMID:23301498
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SFSWAP intron	PMID:30157460
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312774	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SFSWAP mRNA	PMID:25629700
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312774	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFSWAP mRNA	PMID:40504410
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SFSWAP protein	PMID:35688186
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312774	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SFSWAP mRNA	PMID:21570461
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305004	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SFSWAP mRNA	PMID:33387578
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SFSWAP mRNA	PMID:19933214
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFSWAP mRNA	PMID:17942748
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SFSWAP mRNA	PMID:29803840
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SFSWAP protein	PMID:35688186
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SFSWAP mRNA	PMID:38568856
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312774	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFSWAP mRNA	PMID:40504410
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SFSWAP intron	PMID:30157460
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of SFSWAP gene	PMID:31601247
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312774	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SFSWAP gene	PMID:35295148
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312774	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SFSWAP mRNA	PMID:23557971
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SFSWAP mRNA	PMID:18648102
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305004	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SFSWAP mRNA	PMID:25181051|PMID:34947998
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305004	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SFSWAP gene	PMID:28505145
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SFSWAP mRNA	PMID:28628672
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SFSWAP mRNA	PMID:19244175
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312774	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SFSWAP mRNA	PMID:39298647
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SFSWAP mRNA	PMID:28628672
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312774	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SFSWAP mRNA	PMID:38685157
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312774	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of SFSWAP intron	PMID:28392331
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SFSWAP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SFSWAP mRNA	PMID:28628672
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SFSWAP mRNA	PMID:38568856
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312774	E	RGD:6480464	20121009	CTD	MESH:D019256	MT3 affects the reaction [Cadmium Chloride affects the expression of SFSWAP mRNA]	PMID:20371981
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of SFSWAP mRNA	PMID:19376846
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SFSWAP mRNA	PMID:17292431
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SFSWAP mRNA	PMID:23179753
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SFSWAP gene	PMID:29154799
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SFSWAP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SFSWAP mRNA	PMID:28628672
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of SFSWAP mRNA	PMID:18502557
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SFSWAP mRNA	PMID:27188386
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305004	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SFSWAP mRNA	PMID:33387578
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:46680	serpentine asbestos	decreases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of SFSWAP gene	PMID:29523930
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312774	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFSWAP mRNA	PMID:40504410
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SFSWAP mRNA	PMID:17942748
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312774	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFSWAP mRNA	PMID:17942748
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SFSWAP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SFSWAP mRNA	PMID:28628672
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312774	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of SFSWAP mRNA	PMID:25554681
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SFSWAP protein	PMID:32959892
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312774	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SFSWAP mRNA	PMID:22206623
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of SFSWAP protein	PMID:31285264
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SFSWAP mRNA	PMID:19159669
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312774	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SFSWAP mRNA	PMID:23091169
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305004	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SFSWAP mRNA	PMID:23640034
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SFSWAP mRNA	PMID:38568856
1312773	SFSWAP	splicing factor SWAP	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305004	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of SFSWAP gene	PMID:31682807
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of LAMTOR5 mRNA	PMID:33167477
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312776	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LAMTOR5 mRNA	PMID:39298647
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LAMTOR5 mRNA	PMID:37042841
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312776	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LAMTOR5 mRNA	PMID:33754040
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of LAMTOR5 protein	PMID:37730182
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312776	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of LAMTOR5 mRNA	PMID:27462272
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of LAMTOR5 mRNA	PMID:23369406
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LAMTOR5 mRNA	PMID:35301059
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of LAMTOR5 mRNA	PMID:19549813
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LAMTOR5 mRNA	PMID:22206623
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LAMTOR5 mRNA	PMID:39836092
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LAMTOR5 mRNA	PMID:40504410
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of LAMTOR5 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of LAMTOR5 mRNA	PMID:23557933
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305005	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LAMTOR5 mRNA	PMID:32109520
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of LAMTOR5 mRNA]; MT2 affects the reaction [Copper results in increased expression of LAMTOR5 mRNA]	PMID:16629173
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of LAMTOR5 mRNA	PMID:28595984|PMID:34032870|PMID:38568856
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LAMTOR5 mRNA	PMID:39836092
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LAMTOR5 mRNA	PMID:40504410
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of LAMTOR5 mRNA]; MT2 affects the reaction [Copper results in increased expression of LAMTOR5 mRNA]	PMID:16629173
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of LAMTOR5 mRNA	PMID:20458559
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in decreased expression of LAMTOR5 mRNA	PMID:38568856
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312776	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LAMTOR5 gene	PMID:35295148
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312776	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of LAMTOR5 mRNA	PMID:18445702
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312776	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of LAMTOR5 mRNA	PMID:35598803
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of LAMTOR5 protein	PMID:37567409
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305005	E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of LAMTOR5 mRNA	PMID:25181051
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LAMTOR5 mRNA	PMID:28628672
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LAMTOR5 mRNA	PMID:28628672
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312776	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LAMTOR5 mRNA	PMID:37019170
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312776	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of LAMTOR5 mRNA	PMID:17361019
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LAMTOR5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LAMTOR5 mRNA	PMID:28628672
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LAMTOR5 mRNA	PMID:37042841
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305005	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LAMTOR5 mRNA	PMID:33453195
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305005	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of LAMTOR5 promoter	PMID:22457795
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LAMTOR5 mRNA	PMID:35301059
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:36791	escitalopram	increases expression	ISO	RGD:1305005	E	RGD:6480464	20250204	CTD	MESH:D000089983	Escitalopram results in increased expression of LAMTOR5 mRNA	PMID:28467792
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:3723	citalopram	increases expression	ISO	RGD:1305005	E	RGD:6480464	20250204	CTD	MESH:D015283	Citalopram results in increased expression of LAMTOR5 mRNA	PMID:28467792
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312776	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of LAMTOR5 mRNA	PMID:17585979
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LAMTOR5 mRNA	PMID:25812627
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of LAMTOR5 mRNA	PMID:28302478
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C100187	chloropicrin results in increased expression of LAMTOR5 mRNA	PMID:26352163
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of LAMTOR5 mRNA	PMID:25812627
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LAMTOR5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LAMTOR5 mRNA	PMID:28628672
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305005	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LAMTOR5 mRNA	PMID:33387578
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LAMTOR5 mRNA	PMID:39836092
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LAMTOR5 mRNA	PMID:40504410
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305005	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of LAMTOR5 mRNA	PMID:29097150
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LAMTOR5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LAMTOR5 mRNA	PMID:28628672
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of LAMTOR5 mRNA	PMID:20458559
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305005	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of LAMTOR5 mRNA	PMID:24136188
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LAMTOR5 mRNA	PMID:35964746
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LAMTOR5 protein	PMID:32959892
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312776	E	RGD:6480464	20161025	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of LAMTOR5 mRNA	PMID:23650126
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312776	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LAMTOR5 mRNA	PMID:22206623
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312776	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LAMTOR5 mRNA	PMID:22206623
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of LAMTOR5 protein	PMID:37664457
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of LAMTOR5 protein	PMID:31285264
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:77397	1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile	increases expression	ISO	RGD:1305005	E	RGD:6480464	20250204	CTD	MESH:D015283	Citalopram results in increased expression of LAMTOR5 mRNA	PMID:28467792
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:78492	diallyl trisulfide	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C042577	diallyl trisulfide results in increased expression of LAMTOR5 mRNA	PMID:11925594
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of LAMTOR5 protein	PMID:37664457
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305005	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LAMTOR5 mRNA	PMID:21346803
1312775	LAMTOR5	late endosomal/lysosomal adaptor, MAPK and MTOR activator 5	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305005	E	RGD:6480464	20161025	CTD	MESH:C025643	vinclozolin results in increased expression of LAMTOR5 mRNA	PMID:23034163|PMID:23869203
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SUCLG2 mRNA	PMID:38218311
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SUCLG2 mRNA	PMID:20938992
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SUCLG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SUCLG2 mRNA	PMID:32699268
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SUCLG2 mRNA	PMID:36331819
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SUCLG2 mRNA	PMID:22378314
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312780	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SUCLG2 mRNA	PMID:30319688
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SUCLG2 mRNA	PMID:21632981
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312780	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SUCLG2 mRNA	PMID:39241906
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305008	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SUCLG2 mRNA	PMID:32145629
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305008	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of SUCLG2 mRNA	PMID:26496021
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SUCLG2 mRNA	PMID:20938992
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SUCLG2 mRNA	PMID:23649840
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312780	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of SUCLG2 mRNA	PMID:33848595
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of SUCLG2 mRNA]	PMID:33848595
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:17712	9H-xanthine	multiple interactions	ISO	RGD:1305008	E	RGD:6480464	20120717	CTD	MESH:D019820	[Xanthine co-treated with XDH protein] results in decreased expression of SUCLG2 protein	PMID:19464573
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SUCLG2 mRNA	PMID:39150890
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305008	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SUCLG2 mRNA; Gentamicins results in increased expression of SUCLG2 protein	PMID:22061828
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SUCLG2 mRNA	PMID:28818685
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SUCLG2 mRNA	PMID:36331819
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SUCLG2 mRNA	PMID:39836092
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1312780	E	RGD:6480464	20151110	CTD	MESH:D002104	Cadmium results in increased expression of SUCLG2 mRNA	PMID:26187450
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SUCLG2 mRNA	PMID:35301059
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SUCLG2 mRNA	PMID:29950665
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of SUCLG2 mRNA	PMID:23649840
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SUCLG2 protein	PMID:20106945
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SUCLG2 mRNA	PMID:19770486
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SUCLG2 gene	PMID:27153756
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SUCLG2 mRNA	PMID:23649840
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SUCLG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SUCLG2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of SUCLG2 mRNA	PMID:32699268
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SUCLG2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of SUCLG2 protein	PMID:38598786
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305008	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SUCLG2 mRNA	PMID:31150632
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SUCLG2 mRNA	PMID:31919559
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SUCLG2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SUCLG2 mRNA	PMID:20938992|PMID:22206623
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SUCLG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SUCLG2 mRNA	PMID:39836092
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SUCLG2 mRNA	PMID:26272509
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUCLG2 mRNA	PMID:27188386
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1305008	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of SUCLG2 mRNA	PMID:26302742
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305008	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SUCLG2 mRNA	PMID:31881176
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312780	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of SUCLG2 protein	PMID:25505154
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form] results in decreased expression of SUCLG2 mRNA	PMID:23625948
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312780	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SUCLG2 mRNA	PMID:21570461
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312780	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SUCLG2 mRNA	PMID:19465110
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SUCLG2 mRNA	PMID:33212167
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SUCLG2 mRNA	PMID:32763439
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SUCLG2 mRNA	PMID:29803840
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of SUCLG2 mRNA; Doxorubicin results in decreased expression of SUCLG2 protein	PMID:21251210|PMID:26873546
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20151013	CTD	MESH:D004317	sodium nitrate inhibits the reaction [Doxorubicin results in decreased expression of SUCLG2 protein]	PMID:21251210
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:28918	(R)-adrenaline	increases expression	ISO	RGD:1305008	E	RGD:6480464	20120717	CTD	MESH:D004837	Epinephrine results in increased expression of SUCLG2 protein	PMID:19464573
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:29073	L-ascorbic acid	affects expression	ISO	RGD:1312780	E	RGD:6480464	20120501	CTD	MESH:D001205	Ascorbic Acid affects the expression of SUCLG2 protein	PMID:19224539
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SUCLG2 mRNA	PMID:38568856
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SUCLG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SUCLG2 mRNA	PMID:39836092
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SUCLG2 mRNA	PMID:21632981
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312780	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SUCLG2 mRNA	PMID:22228805
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to SUCLG2 mRNA]	PMID:32406909
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SUCLG2 mRNA	PMID:19150397
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SUCLG2 mRNA	PMID:29633893
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SUCLG2 protein	PMID:25419056
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:32195	Tesaglitazar	increases expression	ISO	RGD:1305008	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of SUCLG2 mRNA	PMID:21515302
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312780	E	RGD:6480464	20180515	CTD	MESH:C009495	titanium dioxide results in increased expression of SUCLG2 mRNA	PMID:29128614|PMID:29264374
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SUCLG2 mRNA	PMID:29950665
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305008	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SUCLG2 mRNA	PMID:34492290
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312780	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SUCLG2 mRNA	PMID:18301758|PMID:23811191
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SUCLG2 mRNA	PMID:30903817
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312780	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SUCLG2 promoter	PMID:27334623
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305008	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SUCLG2 mRNA	PMID:34947998
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SUCLG2 protein	PMID:37567409
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305008	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SUCLG2 mRNA	PMID:25181051
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305008	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of SUCLG2 mRNA	PMID:26496021
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SUCLG2 protein	PMID:34186270
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of SUCLG2 protein	PMID:34186270
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SUCLG2 protein	PMID:34186270
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SUCLG2 mRNA	PMID:39150890
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305008	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SUCLG2 mRNA	PMID:17602206
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SUCLG2 mRNA	PMID:29950665
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305008	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SUCLG2 mRNA	PMID:21266533
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SUCLG2 mRNA	PMID:17361019|PMID:21266533
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SUCLG2 mRNA	PMID:39150890
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SUCLG2 mRNA	PMID:39150890
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SUCLG2 protein	PMID:38598786
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305008	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SUCLG2 mRNA	PMID:17602206
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SUCLG2 mRNA	PMID:37042841
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:351346	phenethyl isothiocyanate	affects binding	EXP		E	RGD:6480464	20120717	CTD	MESH:C058305	SUCLG2 protein binds to phenethyl isothiocyanate	PMID:21838287
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SUCLG2 mRNA	PMID:39836092
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SUCLG2 mRNA	PMID:38568856
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SUCLG2 protein	PMID:24527689
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SUCLG2 mRNA	PMID:35301059
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SUCLG2 mRNA	PMID:39150890
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SUCLG2 mRNA	PMID:19376846
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SUCLG2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SUCLG2 mRNA	PMID:32699268
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1305008	E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate results in increased expression of SUCLG2 protein	PMID:16470657
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:38221	fumonisin B1	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 results in decreased expression of SUCLG2 mRNA	PMID:16221962
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SUCLG2 mRNA	PMID:31533062
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:39096	alpha-hexachlorocyclohexane	increases expression	ISO	RGD:1305008	E	RGD:6480464	20120412	CTD	MESH:C040534	alpha-hexachlorocyclohexane results in increased expression of SUCLG2 mRNA	PMID:16940010
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SUCLG2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SUCLG2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SUCLG2 mRNA	PMID:36331819
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SUCLG2 mRNA	PMID:25979313
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SUCLG2 mRNA	PMID:23179753|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29501571
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SUCLG2 gene	PMID:29501571
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUCLG2 mRNA	PMID:27188386
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of SUCLG2 mRNA	PMID:20106945
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of SUCLG2 mRNA	PMID:25047013
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312780	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SUCLG2 mRNA	PMID:28973697
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	SUCLG2 protein affects the susceptibility to Methotrexate	PMID:16217747
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SUCLG2 mRNA	PMID:38832940
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SUCLG2 mRNA	PMID:25270620
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312780	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SUCLG2 mRNA	PMID:17562736
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of SUCLG2 mRNA	PMID:25704631|PMID:29067470
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305008	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SUCLG2 mRNA	PMID:33387578
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1312780	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of SUCLG2 mRNA	PMID:19446018
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SUCLG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SUCLG2 mRNA	PMID:39836092
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:48517	7H-xanthine	multiple interactions	ISO	RGD:1305008	E	RGD:6480464	20121218	CTD	MESH:D019820	[Xanthine co-treated with XDH protein] results in decreased expression of SUCLG2 protein	PMID:19464573
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SUCLG2 mRNA	PMID:29633893
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SUCLG2 protein	PMID:25419056
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:6030	isoniazide	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of SUCLG2 protein	PMID:40015660
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SUCLG2 protein	PMID:32959892
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:63005	sodium nitrate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20151013	CTD	MESH:C031618	sodium nitrate inhibits the reaction [Doxorubicin results in decreased expression of SUCLG2 protein]	PMID:21251210
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SUCLG2 mRNA	PMID:39836092
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:6382	Lasiocarpine	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in decreased expression of SUCLG2 mRNA	PMID:40054833
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305008	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of SUCLG2 protein	PMID:30467583
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of SUCLG2 mRNA	PMID:17383702
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SUCLG2 mRNA	PMID:31758290
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SUCLG2 protein	PMID:34186270
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SUCLG2 mRNA	PMID:22206623
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SUCLG2 mRNA	PMID:22206623
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:75249	potassium chromate	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SUCLG2 protein	PMID:22144121
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:7602	nobiletin	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of SUCLG2 protein]	PMID:38348393
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:76326	N-nitrosomorpholine	affects expression	ISO	RGD:1305008	E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine affects the expression of SUCLG2 protein	PMID:19716841
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUCLG2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUCLG2 mRNA	PMID:27188386
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1312780	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SUCLG2 mRNA	PMID:39150890
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of SUCLG2 mRNA	PMID:22538082
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of SUCLG2 protein	PMID:38348393
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of SUCLG2 protein]	PMID:38348393
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:86204	chromium trinitrate	decreases expression	ISO	RGD:1312780	E	RGD:6480464	20170228	CTD	MESH:C041167	chromium nitrate results in decreased expression of SUCLG2 protein	PMID:22144121
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:90633	perfluorododecanoic acid	increases expression	ISO	RGD:1305008	E	RGD:6480464	20170303	CTD	MESH:C522391	perfluorododecanoic acid results in increased expression of SUCLG2 protein	PMID:26168851
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1312780	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of SUCLG2 protein	PMID:35357534
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUCLG2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUCLG2 mRNA	PMID:27188386
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305008	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SUCLG2 mRNA	PMID:21346803
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:94688	5-methyl-4-oxido-2-pyrazin-4-iumcarboxylic acid	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C027696	acipimox results in decreased expression of SUCLG2 mRNA	PMID:25352640
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SUCLG2 mRNA	PMID:38568856
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of SUCLG2 protein	PMID:38598786
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305008	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SUCLG2 mRNA	PMID:21346803
1312779	SUCLG2	succinate-CoA ligase GDP-forming subunit beta	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305008	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of SUCLG2 gene	PMID:31079544
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312782	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of DNAJC9 mRNA	PMID:37995155
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:132844	glycidyl methacrylate	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of DNAJC9 protein	PMID:36641056
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of DNAJC9 mRNA	PMID:26516004
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of DNAJC9 mRNA	PMID:24763279
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of DNAJC9 mRNA	PMID:22378314
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312782	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DNAJC9 mRNA	PMID:39241906
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305009	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of DNAJC9 mRNA	PMID:32145629
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of DNAJC9 mRNA	PMID:20660070
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of DNAJC9 mRNA	PMID:38568856
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305009	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DNAJC9 mRNA	PMID:33387578
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D002635	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA	PMID:32152650|PMID:33819548
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of DNAJC9 mRNA	PMID:20660070
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of DNAJC9 mRNA	PMID:21592394
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of DNAJC9 mRNA	PMID:21592394
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006000	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA	PMID:32152650|PMID:33819548
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of DNAJC9 mRNA	PMID:21592394
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of DNAJC9 mRNA	PMID:21592394
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DNAJC9 mRNA	PMID:39836092
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJC9 mRNA	PMID:35301059
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DNAJC9 mRNA	PMID:19549813
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DNAJC9 protein	PMID:23301498
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312782	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DNAJC9 mRNA	PMID:19770486
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DNAJC9 mRNA	PMID:23649840
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of DNAJC9 mRNA	PMID:25102026
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312782	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of DNAJC9 mRNA	PMID:32553695
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of DNAJC9 mRNA	PMID:34911549
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of DNAJC9 mRNA	PMID:15672453
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312782	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DNAJC9 mRNA	PMID:27339419
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DNAJC9 mRNA	PMID:22206623
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006002	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA	PMID:32152650|PMID:33819548
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27504	mitomycin C	increases expression	ISO	RGD:1312782	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in increased expression of DNAJC9 mRNA	PMID:25270620
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DNAJC9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DNAJC9 mRNA	PMID:39836092
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJC9 mRNA	PMID:40504410
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DNAJC9 mRNA	PMID:19244175
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of DNAJC9 mRNA	PMID:19167446
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312782	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in increased expression of DNAJC9 mRNA	PMID:25270620
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin inhibits the reaction [Piroxicam results in increased expression of DNAJC9 mRNA]	PMID:21858171
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DNAJC9 mRNA	PMID:22574217
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305009	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DNAJC9 mRNA	PMID:34747641
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312782	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of DNAJC9 protein	PMID:28918527
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of DNAJC9 mRNA	PMID:29803840
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of DNAJC9 protein	PMID:35688186
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D003840	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA	PMID:32152650|PMID:33819548
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DNAJC9 mRNA	PMID:38568856
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DNAJC9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DNAJC9 mRNA	PMID:39836092
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJC9 mRNA	PMID:40504410
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNAJC9 mRNA	PMID:32234424
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312782	E	RGD:6480464	20120717	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of DNAJC9 mRNA; Benzo(a)pyrene results in increased expression of DNAJC9 mRNA	PMID:19770486|PMID:21715664|PMID:32553695
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DNAJC9 mRNA	PMID:20382639
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DNAJC9 mRNA	PMID:15761015
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:31243	atazanavir sulfate	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D000069446	Atazanavir Sulfate results in increased expression of DNAJC9 mRNA	PMID:32152650
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305009	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of DNAJC9 mRNA	PMID:25729387
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305009	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DNAJC9 mRNA	PMID:25729387
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305009	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of DNAJC9 mRNA	PMID:24136188
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312782	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DNAJC9 gene	PMID:35295148
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312782	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of DNAJC9 mRNA	PMID:18301758|PMID:21318169|PMID:23811191
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of DNAJC9 mRNA]	PMID:21318169
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305009	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJC9 mRNA	PMID:34947998
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312782	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJC9 mRNA	PMID:26063408
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305009	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DNAJC9 mRNA	PMID:25181051|PMID:32145629
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305009	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DNAJC9 gene	PMID:28505145
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of DNAJC9 mRNA	PMID:24752500
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312782	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of DNAJC9 mRNA	PMID:20713471
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312782	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DNAJC9 mRNA	PMID:39298647
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312782	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DNAJC9 mRNA	PMID:37019170
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312782	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DNAJC9 mRNA	PMID:21266533
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312782	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of DNAJC9 mRNA	PMID:17854601
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DNAJC9 mRNA]	PMID:17854601
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DNAJC9 mRNA	PMID:37042841
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DNAJC9 mRNA	PMID:39836092
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35456	cadmium dichloride	affects methylation	ISO	RGD:1305009	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the methylation of DNAJC9 promoter	PMID:22457795
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DNAJC9 protein	PMID:33830842
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35456	cadmium dichloride	increases methylation	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of DNAJC9 mRNA	PMID:33830842
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJC9 mRNA	PMID:35301059
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35459	diisononyl phthalate	increases expression	ISO	RGD:1312782	E	RGD:6480464	20250204	CTD	MESH:C012125	diisononyl phthalate results in increased expression of DNAJC9 mRNA	PMID:33391822
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of DNAJC9 protein	PMID:26879310
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D005999	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of DNAJC9 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA	PMID:32152650|PMID:33819548
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DNAJC9 mRNA	PMID:19244175
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DNAJC9 mRNA	PMID:28302478
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of DNAJC9 mRNA	PMID:31533062
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of DNAJC9 mRNA	PMID:19167446
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNAJC9 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DNAJC9 mRNA	PMID:19167446
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312782	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of DNAJC9 mRNA	PMID:39529242
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DNAJC9 mRNA	PMID:23179753
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305009	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of DNAJC9 mRNA	PMID:41580965
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D016572	Cyclosporine results in decreased expression of DNAJC9 mRNA	PMID:32152650
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of DNAJC9 mRNA	PMID:32152650
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312782	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DNAJC9 mRNA	PMID:28973697
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DNAJC9 mRNA	PMID:38832940
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312782	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DNAJC9 mRNA	PMID:17562736
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAJC9 mRNA	PMID:22230336
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305009	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAJC9 mRNA	PMID:33387578
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312782	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of DNAJC9 mRNA	PMID:29279043
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DNAJC9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DNAJC9 mRNA	PMID:39836092
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJC9 mRNA	PMID:40504410
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of DNAJC9 mRNA	PMID:24752500
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DNAJC9 mRNA	PMID:15761015
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DNAJC9 mRNA	PMID:35964746
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:6030	isoniazide	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in decreased expression of DNAJC9 protein	PMID:40015660
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DNAJC9 protein	PMID:32959892
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DNAJC9 mRNA	PMID:39836092
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:63598	levofloxacin	decreases expression	ISO	RGD:1305009	E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of DNAJC9 mRNA	PMID:24136188
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305009	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DNAJC9 mRNA	PMID:25729387
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1305009	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of DNAJC9 mRNA	PMID:24136188
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312782	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DNAJC9 mRNA	PMID:22206623
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312782	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DNAJC9 mRNA	PMID:22206623
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DNAJC9 protein	PMID:37664457
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of DNAJC9 mRNA	PMID:37199045
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of DNAJC9 mRNA	PMID:36318118
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312782	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DNAJC9 mRNA	PMID:23091169
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNAJC9 mRNA	PMID:19167446
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:8249	piroxicam	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of DNAJC9 mRNA	PMID:21858171
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in increased expression of DNAJC9 mRNA]	PMID:21858171
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:82538	Sunset Yellow FCF	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:C005842	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of DNAJC9 mRNA	PMID:33819548
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DNAJC9 protein	PMID:38348393
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DNAJC9 protein	PMID:37664457
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305009	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of DNAJC9 mRNA	PMID:19281266
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:9405	tartrazine	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D013645	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of DNAJC9 mRNA	PMID:33819548
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DNAJC9 mRNA	PMID:38568856
1312781	DNAJC9	DnaJ heat shock protein family (Hsp40) member C9	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305009	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DNAJC9 mRNA	PMID:21346803
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of C1QTNF3 mRNA	PMID:21934132
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of C1QTNF3 mRNA	PMID:30529165
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of C1QTNF3 mRNA	PMID:36331819
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:C029424	hydrazine results in decreased expression of C1QTNF3 mRNA	PMID:15282401
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of C1QTNF3 mRNA	PMID:26079696
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of C1QTNF3 mRNA	PMID:20044591
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of C1QTNF3 mRNA	PMID:30510588
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of C1QTNF3 mRNA	PMID:31614463
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312784	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of C1QTNF3 mRNA	PMID:19484750
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of C1QTNF3 mRNA	PMID:31525975
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305010	E	RGD:6480464	20130115	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of C1QTNF3 mRNA]	PMID:20032058
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of C1QTNF3 mRNA	PMID:31525975
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305010	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of C1QTNF3 mRNA	PMID:26577399
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of C1QTNF3 mRNA	PMID:28818685
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of C1QTNF3 mRNA	PMID:37325564
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of C1QTNF3 mRNA	PMID:19549813
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of C1QTNF3 mRNA	PMID:27153756
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of C1QTNF3 mRNA	PMID:27106289
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312784	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of C1QTNF3 mRNA	PMID:25629700
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1305010	E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of C1QTNF3 mRNA	PMID:38314887
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312784	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of C1QTNF3 mRNA	PMID:28960355
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:D014640	Vancomycin results in increased expression of C1QTNF3 mRNA	PMID:18930951
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312784	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of C1QTNF3 mRNA	PMID:32186404
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of C1QTNF3 mRNA	PMID:24768652|PMID:25583101
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305010	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of C1QTNF3 mRNA	PMID:32109520
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305010	E	RGD:6480464	20130115	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of C1QTNF3 mRNA	PMID:22808131
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of C1QTNF3 mRNA	PMID:19933214
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305010	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of C1QTNF3 mRNA	PMID:28959563
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of C1QTNF3 mRNA	PMID:34032870
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of C1QTNF3 mRNA	PMID:37682722
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of C1QTNF3 mRNA	PMID:29301061
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of C1QTNF3 mRNA	PMID:34876320
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of C1QTNF3 mRNA	PMID:34876320
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of C1QTNF3 mRNA	PMID:32234424
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305010	E	RGD:6480464	20130115	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of C1QTNF3 mRNA	PMID:21839799
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of C1QTNF3 mRNA	PMID:22228805
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312784	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of C1QTNF3 mRNA	PMID:23735875
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C1QTNF3 promoter	PMID:27901495
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312784	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C1QTNF3 3' UTR; Benzo(a)pyrene results in increased methylation of C1QTNF3 exon; Benzo(a)pyrene results in increased methylation of C1QTNF3 intron	PMID:27901495
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of C1QTNF3 mRNA]	PMID:22228805
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:3000	beauvericin	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C004456	beauvericin results in decreased expression of C1QTNF3 mRNA	PMID:29203277
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:C006253	pirinixic acid results in increased expression of C1QTNF3 mRNA	PMID:18301758
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of C1QTNF3 gene	PMID:23968726
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of C1QTNF3 protein	PMID:31675489
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305010	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of C1QTNF3 mRNA	PMID:25181051|PMID:38750585
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of C1QTNF3 mRNA	PMID:37105096
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305010	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of C1QTNF3 mRNA	PMID:33296240
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of C1QTNF3 protein	PMID:31675489
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312784	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of C1QTNF3 exon; bisphenol S results in decreased methylation of C1QTNF3 promoter	PMID:33297965
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312784	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of C1QTNF3 promoter	PMID:28392331
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of C1QTNF3 mRNA	PMID:21266533
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of C1QTNF3 gene	PMID:23968726
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1305010	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of C1QTNF3 mRNA	PMID:35163327
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305010	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of C1QTNF3 mRNA	PMID:35163327
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of C1QTNF3 mRNA	PMID:37325564
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305010	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of C1QTNF3 mRNA	PMID:35163327
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305010	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of C1QTNF3 mRNA	PMID:25539665
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312784	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of C1QTNF3 mRNA	PMID:40194260
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of C1QTNF3 mRNA	PMID:31533062
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of C1QTNF3 mRNA	PMID:36331819
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of C1QTNF3 mRNA	PMID:29038090
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of C1QTNF3 mRNA	PMID:29154799
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305010	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of C1QTNF3 mRNA	PMID:30047161
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1305010	E	RGD:6480464	20130115	CTD	MESH:D003907	Dexamethasone results in decreased expression of C1QTNF3 mRNA	PMID:20032058
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1305010	E	RGD:6480464	20130115	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of C1QTNF3 mRNA]	PMID:20032058
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of C1QTNF3 mRNA	PMID:31525975
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of C1QTNF3 mRNA	PMID:38832940
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of C1QTNF3 mRNA	PMID:27188386
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of C1QTNF3 mRNA	PMID:26690555
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of C1QTNF3 mRNA	PMID:31675489
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1305010	E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of C1QTNF3 mRNA	PMID:37567419
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of C1QTNF3 mRNA	PMID:34876320
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312784	E	RGD:6480464	20130115	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of C1QTNF3 mRNA	PMID:17942748
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305010	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of C1QTNF3 mRNA	PMID:30047161
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of C1QTNF3 mRNA	PMID:36851058
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305010	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of C1QTNF3 gene	PMID:35440735
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312784	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of C1QTNF3 mRNA	PMID:22206623
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:748790	exenatide	increases expression	ISO	RGD:1312784	E	RGD:6480464	20260714	CTD	MESH:D000077270	Exenatide results in increased expression of C1QTNF3 mRNA	PMID:36152787
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of C1QTNF3 mRNA	PMID:29522793
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:76290	PhIP	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of C1QTNF3 mRNA	PMID:20816883
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1312784	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of C1QTNF3 mRNA	PMID:26655953
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305010	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of C1QTNF3 mRNA	PMID:32109520
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of C1QTNF3 protein	PMID:31675489
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of C1QTNF3 protein	PMID:31675489
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of C1QTNF3 mRNA	PMID:26079696
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312784	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of C1QTNF3 mRNA	PMID:34876320
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305010	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of C1QTNF3 mRNA	PMID:24780913|PMID:30047161
1312783	C1QTNF3	C1q and TNF related 3	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of C1QTNF3 mRNA	PMID:27188386
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of H2BC10 mRNA	PMID:22574217
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in increased expression of H2BC10 mRNA	PMID:17404688
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of H2BC10 mRNA	PMID:23649840
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in increased expression of H2BC10 mRNA	PMID:17404688
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of H2BC10 mRNA	PMID:19549813
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of H2BC10 protein	PMID:20106945
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of H2BC10 gene	PMID:27153756
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of H2BC10 mRNA	PMID:27153756
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of H2BC10 mRNA	PMID:23649840
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of H2BC10 mRNA	PMID:17101203
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of H2BC10 protein	PMID:39603559
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of H2BC10 mRNA	PMID:23649840
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of H2BC10 mRNA	PMID:20971185
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of H2BC10 mRNA	PMID:30031762
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of H2BC10 mRNA	PMID:24516582
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of H2BC10 3' UTR; Benzo(a)pyrene results in decreased methylation of H2BC10 exon; Benzo(a)pyrene results in decreased methylation of H2BC10 promoter	PMID:27901495
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of H2BC10 mRNA	PMID:20106945
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of H2BC10 mRNA	PMID:20971185
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of H2BC10 mRNA; Silicon Dioxide results in increased expression of H2BC10 mRNA	PMID:23806026|PMID:25351596
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of H2BC10 mRNA	PMID:20382639
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of H2BC10 mRNA	PMID:19710929
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of H2BC10 mRNA	PMID:29275510
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:34093	1-Hydroxypyrene	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C033146	1-hydroxypyrene results in decreased expression of H2BC10 mRNA	PMID:21854004
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of H2BC10 mRNA	PMID:26678675
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of H2BC10 mRNA	PMID:38568856
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of H2BC10 mRNA	PMID:19167446
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of H2BC10 mRNA	PMID:28001369
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of H2BC10 mRNA	PMID:27989131
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of H2BC10 mRNA	PMID:23649840
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of H2BC10 mRNA	PMID:25351596
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of H2BC10 mRNA	PMID:18175754
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of H2BC10 mRNA	PMID:31629900
1312785	H2BC10	H2B clustered histone 10	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of H2BC10 mRNA	PMID:29522793
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1312788	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in decreased expression of IRAK1BP1 mRNA	PMID:33227293
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of IRAK1BP1 mRNA	PMID:33167477
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312788	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of IRAK1BP1 mRNA	PMID:30319688
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of IRAK1BP1 mRNA	PMID:21632981
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of IRAK1BP1 mRNA	PMID:30165855
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305012	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of IRAK1BP1 mRNA	PMID:32741896
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305012	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of IRAK1BP1 mRNA	PMID:33387578
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305012	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of IRAK1BP1 mRNA	PMID:32741896
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305012	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of IRAK1BP1 mRNA	PMID:33387578
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1312788	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of IRAK1BP1 mRNA	PMID:37748715
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IRAK1BP1 mRNA	PMID:36331819
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of IRAK1BP1 mRNA	PMID:23649840
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of IRAK1BP1 mRNA	PMID:34911549
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of IRAK1BP1 mRNA	PMID:18593933
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of IRAK1BP1 mRNA	PMID:40504410
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of IRAK1BP1 mRNA	PMID:26272509
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRAK1BP1 mRNA	PMID:27188386
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:27810	resorcinol	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in decreased expression of IRAK1BP1 mRNA	PMID:22623647
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of IRAK1BP1 mRNA	PMID:28903495
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305012	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IRAK1BP1 mRNA	PMID:33387578
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IRAK1BP1 mRNA	PMID:25975270
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305012	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of IRAK1BP1 mRNA	PMID:19013527
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of IRAK1BP1 mRNA	PMID:33212167
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of IRAK1BP1 mRNA	PMID:32763439
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305012	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of IRAK1BP1 mRNA	PMID:30556269
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IRAK1BP1 mRNA	PMID:29803840
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of IRAK1BP1 mRNA	PMID:22623647
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of IRAK1BP1 gene	PMID:28589171
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of IRAK1BP1 mRNA	PMID:38568856
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of IRAK1BP1 mRNA	PMID:40504410
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IRAK1BP1 mRNA	PMID:20106945|PMID:21632981
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312788	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IRAK1BP1 mRNA	PMID:19770486|PMID:22228805
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305012	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of IRAK1BP1 mRNA	PMID:30556269
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of IRAK1BP1 mRNA	PMID:18593933
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312788	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IRAK1BP1 gene	PMID:35295148
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312788	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of IRAK1BP1 mRNA	PMID:18648102
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312788	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of IRAK1BP1 mRNA	PMID:20813756
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of IRAK1BP1 mRNA	PMID:19710929
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:33007	chromium(6+)	affects expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of IRAK1BP1 mRNA	PMID:30690063
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305012	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of IRAK1BP1 mRNA	PMID:19167457
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305012	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of IRAK1BP1 mRNA	PMID:34947998|PMID:41034487
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C006780	bisphenol A results in increased expression of IRAK1BP1 mRNA	PMID:32387340
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312788	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of IRAK1BP1 mRNA	PMID:32156529
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1305012	E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of IRAK1BP1 mRNA	PMID:18668222
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IRAK1BP1 mRNA	PMID:37042841
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1305012	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of IRAK1BP1 mRNA	PMID:30589522
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305012	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IRAK1BP1 mRNA	PMID:33453195
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305012	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of IRAK1BP1 mRNA	PMID:25539665
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of IRAK1BP1 mRNA	PMID:24449571
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of IRAK1BP1 mRNA	PMID:31533062
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IRAK1BP1 mRNA	PMID:36331819
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of IRAK1BP1 mRNA	PMID:38832940
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of IRAK1BP1 mRNA	PMID:26272509
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRAK1BP1 mRNA	PMID:27188386
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305012	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of IRAK1BP1 mRNA	PMID:33387578
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305012	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of IRAK1BP1 mRNA	PMID:32479839
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312788	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of IRAK1BP1 mRNA	PMID:29279043
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312788	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of IRAK1BP1 mRNA	PMID:40504410
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IRAK1BP1 mRNA	PMID:22079256
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:48981	quinolin-8-ol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of IRAK1BP1 mRNA	PMID:21632981
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:52774	pentane-2,3-dione	decreases expression	ISO	RGD:1305012	E	RGD:6480464	20150512	CTD	MESH:C013186	2,3-pentanedione results in decreased expression of IRAK1BP1 mRNA	PMID:25710175
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305012	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of IRAK1BP1 gene	PMID:35440735
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of IRAK1BP1 mRNA	PMID:22079256
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of IRAK1BP1 mRNA	PMID:22714537
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IRAK1BP1 mRNA	PMID:22079256
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305012	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of IRAK1BP1 mRNA	PMID:32741896
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRAK1BP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRAK1BP1 mRNA	PMID:27188386
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IRAK1BP1 gene]	PMID:28238834
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:82288	o-anisidine	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C003898	2-anisidine results in decreased expression of IRAK1BP1 mRNA	PMID:28089782
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312788	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of IRAK1BP1 mRNA	PMID:39847705
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1312788	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of IRAK1BP1 mRNA	PMID:40826991
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRAK1BP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IRAK1BP1 mRNA	PMID:27188386
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305012	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of IRAK1BP1 mRNA	PMID:19281266
1312787	IRAK1BP1	interleukin 1 receptor associated kinase 1 binding protein 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of IRAK1BP1 mRNA	PMID:38568856
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of C10ORF88 mRNA	PMID:33167477
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305014	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of C1H10ORF88 mRNA	PMID:33387578
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of C10ORF88 mRNA	PMID:19549813
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of C10ORF88 mRNA	PMID:23649840
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of C10ORF88 mRNA	PMID:23649840
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of C10ORF88 mRNA	PMID:23557933
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of C10ORF88 mRNA	PMID:33212167
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of C10ORF88 mRNA	PMID:30851411
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of C10ORF88 mRNA	PMID:29803840
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of C10ORF88 mRNA	PMID:38568856
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of C10ORF88 mRNA	PMID:20106945|PMID:21632981
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C10ORF88 promoter	PMID:27901495
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305014	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of C1H10ORF88 mRNA	PMID:34492290
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305014	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of C10ORF88 mRNA	PMID:25181051
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of C10ORF88 gene	PMID:31601247
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of C10ORF88 mRNA	PMID:37042841
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of C10ORF88 mRNA	PMID:28302478
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of C10ORF88 mRNA	PMID:25979313
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of C10ORF88 mRNA	PMID:23179753|PMID:24935251
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of C10ORF88 mRNA	PMID:26690555
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305014	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of C1H10ORF88 mRNA	PMID:33387578
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305014	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of C1H10ORF88 gene	PMID:35440735
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of C10ORF88 mRNA	PMID:30851411
1312790	C10orf88	chromosome 10 open reading frame 88	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305014	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of C1H10ORF88 mRNA	PMID:23034163
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of PABPC4 mRNA	PMID:35967413
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305015	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PABPC4 mRNA]	PMID:31150632
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:137392	chlormequat chloride	increases expression	ISO	RGD:1305015	E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of PABPC4 protein	PMID:34958886
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PABPC4 mRNA	PMID:26251327
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PABPC4 mRNA	PMID:33167477
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312793	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PABPC4 mRNA	PMID:30529165
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312793	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PABPC4 mRNA	PMID:39298647
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1312793	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of PABPC4 mRNA	PMID:19448997
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PABPC4 mRNA	PMID:37042841
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1312793	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of PABPC4 mRNA	PMID:28973375
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305015	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PABPC4 mRNA	PMID:26577399
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PABPC4 mRNA	PMID:28818685
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305015	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of PABPC4 protein	PMID:34915118
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312793	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PABPC4 mRNA	PMID:28111341|PMID:37236586
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:232796	cadmium acetate	decreases expression	EXP		E	RGD:6480464	20250107	CTD	MESH:C028031	cadmium acetate results in decreased expression of PABPC4 mRNA	PMID:18155341
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PABPC4 mRNA	PMID:19549813
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PABPC4 protein	PMID:23301498
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PABPC4 mRNA	PMID:23649840
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1305015	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of PABPC4 protein	PMID:33236894
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PABPC4 mRNA	PMID:23649840
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:2663	amiodarone	affects expression	ISO	RGD:1305015	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of PABPC4 mRNA	PMID:19483382
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305015	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PABPC4 mRNA	PMID:31150632
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305015	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PABPC4 mRNA]	PMID:31150632
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312793	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PABPC4 mRNA	PMID:40504410
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312793	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PABPC4 mRNA	PMID:21570461
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305015	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PABPC4 mRNA	PMID:34747641
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305015	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of PABPC4 mRNA	PMID:19013527|PMID:28374803
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PABPC4 mRNA	PMID:33212167
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of PABPC4 mRNA	PMID:39709020
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PABPC4 mRNA	PMID:30851411
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305015	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PABPC4 mRNA	PMID:28959563
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PABPC4 mRNA; sodium arsenite results in decreased expression of PABPC4 protein	PMID:25879800|PMID:30528433|PMID:38568856
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PABPC4 mRNA	PMID:25270620
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [PABPC4 protein binds to CAPRIN1 protein]	PMID:33939924
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312793	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PABPC4 mRNA	PMID:40504410
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PABPC4 mRNA	PMID:21632981
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PABPC4 mRNA	PMID:22228805
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:3023	benzbromarone	affects expression	ISO	RGD:1305015	E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of PABPC4 mRNA	PMID:19483382
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PABPC4 protein]	PMID:26598702
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of PABPC4 mRNA	PMID:31745603
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305015	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of PABPC4 mRNA	PMID:25729387
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305015	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PABPC4 mRNA	PMID:25729387
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1305015	E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of PABPC4 mRNA	PMID:19483382
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305015	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PABPC4 mRNA	PMID:34492290
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312793	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PABPC4 mRNA	PMID:18648102
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1305015	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of PABPC4 mRNA	PMID:19483382
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312793	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PABPC4 mRNA	PMID:18301758
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of PABPC4 protein	PMID:34186270
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305015	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PABPC4 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:41034487
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305015	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PABPC4 gene	PMID:28505145
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of PABPC4 gene	PMID:31601247
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of PABPC4 protein	PMID:34186270
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312793	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PABPC4 mRNA	PMID:39298647|PMID:40203079
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PABPC4 protein	PMID:34186270
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PABPC4 protein	PMID:34186270
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PABPC4 mRNA	PMID:28392331
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PABPC4 mRNA	PMID:37019170
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305015	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of PABPC4 mRNA	PMID:32680482
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1305015	E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of PABPC4 mRNA	PMID:17616710
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PABPC4 mRNA	PMID:38174414
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312793	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PABPC4 mRNA	PMID:28111341|PMID:37236586
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305015	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of PABPC4 mRNA	PMID:26194646
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:3750	clofibrate	affects expression	ISO	RGD:1305015	E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of PABPC4 mRNA	PMID:19483382
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PABPC4 mRNA	PMID:28302478
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of PABPC4 mRNA	PMID:26352163
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PABPC4 mRNA	PMID:40419075
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305015	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of PABPC4 mRNA	PMID:25993096
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PABPC4 mRNA	PMID:25979313
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312793	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PABPC4 mRNA	PMID:17292431
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of PABPC4 mRNA	PMID:19101580
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PABPC4 gene	PMID:29154799
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312793	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of PABPC4 mRNA	PMID:18502557
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of PABPC4 mRNA	PMID:29067470
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305015	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PABPC4 mRNA	PMID:33387578
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312793	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PABPC4 mRNA	PMID:40504410
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of PABPC4 mRNA	PMID:40706910
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PABPC4 mRNA	PMID:22079256
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:4886	L-ethionine	affects expression	ISO	RGD:1305015	E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of PABPC4 mRNA	PMID:19483382
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to PABPC4 protein]	PMID:26598702
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312793	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PABPC4 mRNA	PMID:25554681
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312793	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PABPC4 mRNA	PMID:19042947
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PABPC4 protein	PMID:32959892
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305015	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of PABPC4 mRNA	PMID:25729387
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305015	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PABPC4 mRNA	PMID:25729387
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PABPC4 protein	PMID:26558463
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305015	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PABPC4 gene	PMID:35440735
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PABPC4 protein	PMID:34186270
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PABPC4 mRNA	PMID:22079256
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PABPC4 mRNA	PMID:22079256
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PABPC4 protein	PMID:31285264
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of PABPC4 protein	PMID:39638853
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	ISO	RGD:1305015	E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of PABPC4 mRNA	PMID:19483382
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305015	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of PABPC4 mRNA	PMID:21346803
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:7772	omeprazole	affects expression	ISO	RGD:1305015	E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of PABPC4 mRNA	PMID:19483382
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PABPC4 mRNA	PMID:30851411
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312793	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PABPC4 mRNA	PMID:30294300
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PABPC4 protein	PMID:31675489
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305015	E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of PABPC4 mRNA	PMID:19483382
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305015	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PABPC4 mRNA	PMID:24780913
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312793	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PABPC4 mRNA	PMID:40826991
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305015	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PABPC4 mRNA	PMID:21346803
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305015	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PABPC4 mRNA	PMID:21346803
1312792	PABPC4	poly(A) binding protein cytoplasmic 4	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305015	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PABPC4 mRNA	PMID:23034163
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312795	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of PARD6G mRNA	PMID:37995155
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305016	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of PARD6G mRNA	PMID:26496021
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of PARD6G gene	PMID:30521419
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PARD6G intron	PMID:30157460
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312795	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PARD6G mRNA	PMID:32553695
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312795	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PARD6G mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PARD6G mRNA	PMID:34911549
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PARD6G mRNA	PMID:18593933
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PARD6G gene	PMID:25304211
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of PARD6G mRNA	PMID:38460933
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312795	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of PARD6G mRNA	PMID:40618947
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PARD6G mRNA	PMID:27392435
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PARD6G mRNA	PMID:27392435
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312795	E	RGD:6480464	20201006	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PARD6G mRNA	PMID:32553695
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PARD6G mRNA	PMID:33212167
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PARD6G mRNA	PMID:30851411
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PARD6G mRNA	PMID:32763439
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PARD6G intron	PMID:30157460
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312795	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of PARD6G mRNA	PMID:32553695
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312795	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of PARD6G mRNA	PMID:18191166
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PARD6G mRNA	PMID:18593933
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312795	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of PARD6G mRNA	PMID:23557971
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312795	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PARD6G gene	PMID:35295148
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of PARD6G mRNA	PMID:22576693
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305016	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PARD6G mRNA	PMID:25181051
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of PARD6G mRNA	PMID:29275510
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312795	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in increased expression of PARD6G mRNA	PMID:35479511
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of PARD6G gene	PMID:22576693|PMID:31601247
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305016	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of PARD6G mRNA	PMID:26496021
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of PARD6G gene	PMID:31601247
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305016	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PARD6G mRNA	PMID:35163327
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305016	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PARD6G mRNA	PMID:35163327
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PARD6G mRNA	PMID:31533062
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PARD6G mRNA	PMID:25979313
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PARD6G gene	PMID:29154799
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PARD6G mRNA	PMID:22230336
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of PARD6G mRNA	PMID:38460933
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PARD6G gene	PMID:25304211
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312795	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PARD6G mRNA; Nanotubes, Carbon results in decreased expression of PARD6G mRNA	PMID:25554681
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305016	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of PARD6G mRNA	PMID:20080153
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:6809	methamphetamine	affects expression	ISO	RGD:1305016	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine affects the expression of PARD6G mRNA	PMID:19564919
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1305016	E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] affects the expression of PARD6G mRNA	PMID:19564919
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:73297	SCH 23390	affects expression	ISO	RGD:1305016	E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 affects the expression of PARD6G mRNA	PMID:19564919
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:73297	SCH 23390	multiple interactions	ISO	RGD:1305016	E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] affects the expression of PARD6G mRNA	PMID:19564919
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PARD6G mRNA	PMID:30851411
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PARD6G gene]	PMID:28238834
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1305016	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of PARD6G mRNA	PMID:20345932
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1305016	E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of PARD6G mRNA	PMID:26923065
1312794	PARD6G	par-6 family cell polarity regulator gamma	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305016	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PARD6G mRNA	PMID:24780913
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of WNT9A mRNA	PMID:31016361
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:144804	nickel subsulfide	decreases expression	ISO	RGD:1305018	E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide results in decreased expression of WNT9A mRNA	PMID:24952340
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of WNT9A mRNA	PMID:20880076
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312798	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of WNT9A mRNA	PMID:30319688
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of WNT9A mRNA	PMID:30510588
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of WNT9A mRNA	PMID:30165855
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of WNT9A mRNA	PMID:38568856
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of WNT9A gene	PMID:30521419
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20240305	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of WNT9A protein	PMID:37364752
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of WNT9A mRNA	PMID:21592394
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of WNT9A mRNA	PMID:21592394
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of WNT9A mRNA	PMID:33647349
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of WNT9A mRNA	PMID:36706583
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of WNT9A mRNA	PMID:40323316
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of WNT9A mRNA	PMID:21592394
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of WNT9A mRNA	PMID:21592394
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305018	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of WNT9A mRNA	PMID:33387578
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT9A mRNA	PMID:37325564
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312798	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WNT9A mRNA	PMID:19770486
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:26523	reactive oxygen species	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017382	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of WNT9A mRNA	PMID:33656867
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312798	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of WNT9A mRNA	PMID:17484886
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:27504	mitomycin C	increases expression	ISO	RGD:1312798	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in increased expression of WNT9A mRNA	PMID:25270620
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of WNT9A mRNA	PMID:38460933
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of WNT9A mRNA	PMID:35897073
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of WNT9A mRNA	PMID:28960355
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of WNT9A mRNA	PMID:27392435
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of WNT9A mRNA	PMID:27392435
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:28112	nickel atom	affects expression	ISO	RGD:1305018	E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel affects the expression of WNT9A mRNA	PMID:19130878
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312798	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WNT9A mRNA	PMID:21570461|PMID:36222588
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WNT9A mRNA	PMID:19933214
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305018	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WNT9A mRNA	PMID:32109520|PMID:33387578
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the reaction [AHR protein binds to WNT9A promoter]	PMID:19654925
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of WNT9A mRNA	PMID:33212167
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of WNT9A mRNA	PMID:30911355
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:28741	sodium fluoride	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D012969	Sodium Fluoride results in increased expression of WNT9A mRNA; Sodium Fluoride results in increased expression of WNT9A protein	PMID:33982124
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of WNT9A mRNA	PMID:38568856
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of WNT9A intron	PMID:30157460
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312798	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WNT9A mRNA	PMID:19770486
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WNT9A 3' UTR; Benzo(a)pyrene results in increased methylation of WNT9A promoter	PMID:27901495
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene affects the reaction [AHR protein binds to WNT9A promoter]	PMID:19654925
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of WNT9A mRNA	PMID:30911355
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305018	E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in decreased expression of WNT9A mRNA	PMID:33150645
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:30966	glycidol	increases methylation	ISO	RGD:1305018	E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in increased methylation of WNT9A promoter	PMID:33150595
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1312798	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of WNT9A mRNA	PMID:36087614
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20130423	CTD	MESH:C008261	lead acetate results in decreased expression of WNT9A mRNA	PMID:22609695
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312798	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of WNT9A promoter	PMID:35295148
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305018	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of WNT9A mRNA	PMID:34492290
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:33083	fluoranthene	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20170725	CTD	MESH:C007738	fluoranthene results in decreased expression of WNT9A mRNA	PMID:28329830
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of WNT9A mRNA	PMID:28329830
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305018	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of WNT9A mRNA	PMID:25181051
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of WNT9A mRNA	PMID:33670352
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305018	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of WNT9A mRNA	PMID:34947998
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312798	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of WNT9A mRNA	PMID:30951980|PMID:32156529
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of WNT9A mRNA	PMID:25172293
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312798	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of WNT9A gene	PMID:31683443
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312798	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of WNT9A mRNA	PMID:30951980|PMID:40203079
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1312798	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of WNT9A exon	PMID:33297965
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of WNT9A 3' UTR	PMID:30157460
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312798	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of WNT9A mRNA	PMID:30951980
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of WNT9A intron	PMID:28392331
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of WNT9A mRNA	PMID:40323316
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1305018	E	RGD:6480464	20120412	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of WNT9A mRNA	PMID:18502319
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305018	E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon affects the expression of WNT9A mRNA	PMID:19130878
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:34682	diazinon	decreases expression	ISO	RGD:1305018	E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon results in decreased expression of WNT9A mRNA	PMID:18502319
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of WNT9A mRNA	PMID:40323316
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305018	E	RGD:6480464	20120412	CTD	MESH:D004026	Dieldrin affects the expression of WNT9A mRNA	PMID:19130878
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of WNT9A mRNA	PMID:40323316
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312798	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of WNT9A mRNA	PMID:20478370
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT9A mRNA	PMID:37325564
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of WNT9A mRNA	PMID:40323316
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312798	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of WNT9A mRNA	PMID:17292431
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of WNT9A gene	PMID:29154799
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312798	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of WNT9A mRNA	PMID:28973697
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:C107676	deguelin results in decreased expression of WNT9A mRNA	PMID:19861542
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of WNT9A mRNA	PMID:33656867
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305018	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of WNT9A mRNA	PMID:33387578
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of WNT9A mRNA	PMID:38460933
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312798	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of WNT9A mRNA	PMID:35436446
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1312798	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of WNT9A mRNA	PMID:27915011
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1312798	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of WNT9A mRNA	PMID:25554681
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312798	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of WNT9A mRNA	PMID:23608068
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of WNT9A 3' UTR	PMID:30157460
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20250805	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of WNT9A mRNA	PMID:40323316
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1312798	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of WNT9A mRNA	PMID:27029645
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305018	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of WNT9A mRNA	PMID:25825206|PMID:33150595
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:8502	6-propyl-2-thiouracil	increases methylation	ISO	RGD:1305018	E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in increased methylation of WNT9A promoter	PMID:33150595
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1312798	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of WNT9A mRNA	PMID:36706583
1312797	WNT9A	Wnt family member 9A	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305018	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of WNT9A mRNA	PMID:19281266
1312799	CERK	ceramide kinase	gene	CHEBI:132446	perfluorobutanesulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C539348	perfluorobutanesulfonic acid results in increased expression of CERK mRNA	PMID:40885241
1312799	CERK	ceramide kinase	gene	CHEBI:13956	ceramide 1-phosphate	affects abundance	EXP		E	RGD:6480464	20170303	CTD	MESH:C065576	CERK protein affects the abundance of ceramide 1-phosphate	PMID:15899891
1312799	CERK	ceramide kinase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CERK mRNA	PMID:36331819
1312799	CERK	ceramide kinase	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CERK mRNA	PMID:22378314
1312799	CERK	ceramide kinase	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of CERK mRNA	PMID:39709020
1312799	CERK	ceramide kinase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CERK mRNA	PMID:39241906
1312799	CERK	ceramide kinase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of CERK mRNA	PMID:20660070
1312799	CERK	ceramide kinase	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CERK mRNA	PMID:38568856
1312799	CERK	ceramide kinase	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of CERK mRNA	PMID:19162166
1312799	CERK	ceramide kinase	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of CERK mRNA	PMID:20660070
1312799	CERK	ceramide kinase	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CERK mRNA	PMID:21179406
1312799	CERK	ceramide kinase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CERK mRNA	PMID:37992649
1312799	CERK	ceramide kinase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CERK mRNA	PMID:37992649
1312799	CERK	ceramide kinase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA	PMID:39150890
1312799	CERK	ceramide kinase	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305019	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CERK mRNA	PMID:33387578
1312799	CERK	ceramide kinase	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of CERK mRNA	PMID:39836092
1312799	CERK	ceramide kinase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305019	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CERK mRNA	PMID:39012411
1312799	CERK	ceramide kinase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CERK mRNA	PMID:37776818
1312799	CERK	ceramide kinase	gene	CHEBI:22984	calcium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium affects the reaction [CERK protein results in increased phosphorylation of Ceramides]	PMID:16269826
1312799	CERK	ceramide kinase	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CERK mRNA	PMID:19549813
1312799	CERK	ceramide kinase	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1312800	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of CERK mRNA	PMID:19376150
1312799	CERK	ceramide kinase	gene	CHEBI:25107	magnesium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008274	Magnesium affects the reaction [CERK protein results in increased phosphorylation of Ceramides]	PMID:16269826
1312799	CERK	ceramide kinase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CERK mRNA	PMID:23649840
1312799	CERK	ceramide kinase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312800	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CERK mRNA	PMID:27339419
1312799	CERK	ceramide kinase	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the expression of CERK mRNA	PMID:25304211
1312799	CERK	ceramide kinase	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CERK gene	PMID:25304211
1312799	CERK	ceramide kinase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CERK mRNA	PMID:39836092
1312799	CERK	ceramide kinase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CERK mRNA	PMID:40504410
1312799	CERK	ceramide kinase	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1305019	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of CERK gene	PMID:35440735
1312799	CERK	ceramide kinase	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1305019	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA	PMID:33854195
1312799	CERK	ceramide kinase	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305019	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CERK mRNA	PMID:31881176
1312799	CERK	ceramide kinase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CERK mRNA	PMID:23557933
1312799	CERK	ceramide kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305019	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CERK mRNA	PMID:34747641
1312799	CERK	ceramide kinase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of CERK mRNA	PMID:29955902
1312799	CERK	ceramide kinase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1312800	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of CERK mRNA	PMID:32937126
1312799	CERK	ceramide kinase	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of CERK mRNA	PMID:39709020
1312799	CERK	ceramide kinase	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CERK mRNA	PMID:30851411
1312799	CERK	ceramide kinase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CERK mRNA	PMID:37992649
1312799	CERK	ceramide kinase	gene	CHEBI:29320	calcium(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium affects the reaction [CERK protein results in increased phosphorylation of Ceramides]	PMID:16269826
1312799	CERK	ceramide kinase	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1312800	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in decreased methylation of CERK gene	PMID:32068019
1312799	CERK	ceramide kinase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CERK mRNA	PMID:39836092
1312799	CERK	ceramide kinase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CERK mRNA	PMID:40504410
1312799	CERK	ceramide kinase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CERK 3' UTR; Benzo(a)pyrene affects the methylation of CERK intron	PMID:27901495|PMID:30157460
1312799	CERK	ceramide kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312800	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CERK mRNA	PMID:19770486
1312799	CERK	ceramide kinase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to CERK mRNA]	PMID:32406909
1312799	CERK	ceramide kinase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312800	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CERK gene	PMID:35295148
1312799	CERK	ceramide kinase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305019	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CERK mRNA	PMID:34492290
1312799	CERK	ceramide kinase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305019	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CERK mRNA	PMID:25380136
1312799	CERK	ceramide kinase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312800	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CERK mRNA	PMID:17426115
1312799	CERK	ceramide kinase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312800	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CERK mRNA	PMID:23811191
1312799	CERK	ceramide kinase	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CERK mRNA	PMID:19710929
1312799	CERK	ceramide kinase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305019	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CERK mRNA	PMID:25181051
1312799	CERK	ceramide kinase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312800	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of CERK mRNA	PMID:26063408|PMID:32156529
1312799	CERK	ceramide kinase	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of CERK mRNA	PMID:19244175
1312799	CERK	ceramide kinase	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312800	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of CERK mRNA	PMID:26682919
1312799	CERK	ceramide kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312800	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CERK gene	PMID:31683443
1312799	CERK	ceramide kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312800	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CERK exon	PMID:33297965
1312799	CERK	ceramide kinase	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CERK intron	PMID:30157460
1312799	CERK	ceramide kinase	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA	PMID:39150890
1312799	CERK	ceramide kinase	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1305019	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA	PMID:33854195
1312799	CERK	ceramide kinase	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305019	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CERK mRNA	PMID:21266533
1312799	CERK	ceramide kinase	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA	PMID:39150890
1312799	CERK	ceramide kinase	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA	PMID:39150890
1312799	CERK	ceramide kinase	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305019	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of CERK gene	PMID:33148267
1312799	CERK	ceramide kinase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CERK mRNA	PMID:37042841
1312799	CERK	ceramide kinase	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of CERK mRNA	PMID:39836092
1312799	CERK	ceramide kinase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305019	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CERK mRNA	PMID:39012411
1312799	CERK	ceramide kinase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CERK mRNA	PMID:37776818
1312799	CERK	ceramide kinase	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA	PMID:39150890
1312799	CERK	ceramide kinase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312800	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CERK mRNA	PMID:40194260
1312799	CERK	ceramide kinase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CERK mRNA	PMID:36331819
1312799	CERK	ceramide kinase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CERK mRNA	PMID:25979313
1312799	CERK	ceramide kinase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CERK mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1312799	CERK	ceramide kinase	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CERK mRNA	PMID:27188386
1312799	CERK	ceramide kinase	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305019	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CERK mRNA	PMID:30047161
1312799	CERK	ceramide kinase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CERK mRNA	PMID:20106945
1312799	CERK	ceramide kinase	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1305019	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA	PMID:33854195
1312799	CERK	ceramide kinase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CERK mRNA	PMID:37992649
1312799	CERK	ceramide kinase	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CERK mRNA	PMID:38832940
1312799	CERK	ceramide kinase	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1305019	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA	PMID:33854195
1312799	CERK	ceramide kinase	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CERK mRNA	PMID:24935251|PMID:26272509
1312799	CERK	ceramide kinase	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CERK mRNA	PMID:27188386
1312799	CERK	ceramide kinase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312800	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CERK mRNA	PMID:17562736
1312799	CERK	ceramide kinase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CERK mRNA	PMID:21420995
1312799	CERK	ceramide kinase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305019	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CERK mRNA	PMID:33387578
1312799	CERK	ceramide kinase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CERK mRNA	PMID:22230336
1312799	CERK	ceramide kinase	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the expression of CERK mRNA	PMID:25304211
1312799	CERK	ceramide kinase	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CERK gene	PMID:25304211
1312799	CERK	ceramide kinase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CERK mRNA	PMID:39836092
1312799	CERK	ceramide kinase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CERK mRNA	PMID:40504410
1312799	CERK	ceramide kinase	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305019	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CERK mRNA	PMID:29391264
1312799	CERK	ceramide kinase	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305019	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CERK mRNA	PMID:30047161
1312799	CERK	ceramide kinase	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CERK mRNA	PMID:35964746
1312799	CERK	ceramide kinase	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1305019	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA	PMID:33854195
1312799	CERK	ceramide kinase	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of CERK mRNA	PMID:39836092
1312799	CERK	ceramide kinase	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CERK mRNA	PMID:21641980
1312799	CERK	ceramide kinase	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312800	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CERK mRNA	PMID:23650126
1312799	CERK	ceramide kinase	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CERK intron	PMID:30157460
1312799	CERK	ceramide kinase	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305019	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CERK gene	PMID:35440735
1312799	CERK	ceramide kinase	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305019	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of CERK gene	PMID:33148267
1312799	CERK	ceramide kinase	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CERK mRNA	PMID:31758290
1312799	CERK	ceramide kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312800	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CERK mRNA	PMID:22206623
1312799	CERK	ceramide kinase	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CERK mRNA	PMID:30851411
1312799	CERK	ceramide kinase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CERK mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CERK mRNA	PMID:27188386
1312799	CERK	ceramide kinase	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1312800	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CERK mRNA	PMID:39150890
1312799	CERK	ceramide kinase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305019	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CERK mRNA	PMID:30047161
1312799	CERK	ceramide kinase	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of CERK mRNA	PMID:31734321
1312799	CERK	ceramide kinase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CERK mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CERK mRNA	PMID:27188386
1312799	CERK	ceramide kinase	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305019	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CERK mRNA	PMID:23034163
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PPFIA2 mRNA	PMID:27188386
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305021	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPFIA2 mRNA]	PMID:31150632
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1621980	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PPFIA2 mRNA	PMID:30319688
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PPFIA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PPFIA2 mRNA	PMID:35811015
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305021	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of PPFIA2 mRNA	PMID:26496021
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1621980	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PPFIA2 mRNA	PMID:34319233
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PPFIA2 mRNA	PMID:28818685
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PPFIA2 gene	PMID:27153756
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305021	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PPFIA2 mRNA	PMID:31150632
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305021	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPFIA2 mRNA]	PMID:31150632
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PPFIA2 mRNA	PMID:28903495
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1621980	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PPFIA2 mRNA	PMID:32186404
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1621980	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PPFIA2 mRNA	PMID:39631538
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PPFIA2 gene	PMID:28589171
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1621980	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPFIA2 mRNA	PMID:36209798|PMID:37682722
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PPFIA2 5' UTR; Benzo(a)pyrene affects the methylation of PPFIA2 promoter	PMID:27901495
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PPFIA2 mRNA	PMID:32234424
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PPFIA2 3' UTR	PMID:27901495
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PPFIA2 mRNA	PMID:22316170
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PPFIA2 exon	PMID:27901495
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1621980	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PPFIA2 mRNA	PMID:20813756
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305021	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PPFIA2 mRNA	PMID:19167457
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305021	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PPFIA2 mRNA	PMID:25181051|PMID:30816183|PMID:41034487
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1621980	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of PPFIA2 mRNA	PMID:32156529
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305021	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of PPFIA2 mRNA	PMID:26496021
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305021	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of PPFIA2 mRNA	PMID:25539665
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1621980	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PPFIA2 mRNA	PMID:40194260
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of PPFIA2 mRNA	PMID:26690555
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of PPFIA2 mRNA	PMID:35811015
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PPFIA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PPFIA2 mRNA	PMID:35811015
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305021	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PPFIA2 mRNA	PMID:29391264
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of PPFIA2 mRNA	PMID:32234424
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305021	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PPFIA2 mRNA	PMID:30307764
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305021	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PPFIA2 gene	PMID:35440735
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of PPFIA2 mRNA	PMID:30879928
1312803	PPFIA2	PPFI scaffold protein A2	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of PPFIA2 mRNA	PMID:32234424
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of HEYL mRNA	PMID:39752319
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HEYL mRNA	PMID:20938992
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312806	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of HEYL mRNA	PMID:30319688
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of HEYL mRNA	PMID:20044591
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of HEYL mRNA	PMID:30510588
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312806	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of HEYL mRNA	PMID:25210133
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305022	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HEYL mRNA	PMID:32741896
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305022	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HEYL mRNA	PMID:33387578
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HEYL mRNA	PMID:20938992
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HEYL mRNA	PMID:37992649
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of HEYL mRNA	PMID:39752319
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305022	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HEYL mRNA	PMID:32741896
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1305022	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of HEYL mRNA	PMID:22967744
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HEYL mRNA	PMID:37992649
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of HEYL mRNA	PMID:31163220
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305022	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of HEYL mRNA	PMID:26577399|PMID:27523638
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HEYL mRNA	PMID:36139627
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HEYL mRNA	PMID:35301059
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305022	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HEYL mRNA	PMID:33354967
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HEYL mRNA	PMID:20938992
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of HEYL mRNA	PMID:38460933
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HEYL mRNA	PMID:27188386
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305022	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of HEYL mRNA	PMID:31881176
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of HEYL mRNA	PMID:27392435
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of HEYL mRNA	PMID:30912803
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305022	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HEYL mRNA	PMID:22298810
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312806	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HEYL mRNA	PMID:24058054
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305022	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HEYL mRNA	PMID:34747641
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of HEYL mRNA	PMID:28001369
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20180410	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of HEYL mRNA	PMID:29104120
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HEYL mRNA	PMID:29803840
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of HEYL mRNA	PMID:39631538
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HEYL mRNA	PMID:37992649
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HEYL 3' UTR	PMID:27901495
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312806	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HEYL mRNA	PMID:22228805|PMID:32417428
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HEYL exon; Benzo(a)pyrene results in increased methylation of HEYL promoter	PMID:27901495
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of HEYL mRNA	PMID:37690743
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in decreased expression of HEYL mRNA	PMID:22613225
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305022	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of HEYL mRNA	PMID:30047161
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of HEYL mRNA	PMID:29264374
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312806	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of HEYL mRNA	PMID:23557971
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of HEYL mRNA	PMID:27685785
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305022	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HEYL mRNA	PMID:25181051|PMID:34947998
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of HEYL gene	PMID:31601247
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305022	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of HEYL mRNA	PMID:30816183|PMID:32528016
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312806	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of HEYL mRNA	PMID:30951980
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305022	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HEYL mRNA	PMID:36041667
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312806	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of HEYL mRNA	PMID:30951980
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305022	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HEYL mRNA	PMID:36041667
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312806	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of HEYL mRNA	PMID:30951980
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305022	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of HEYL mRNA	PMID:36041667
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312806	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of HEYL promoter	PMID:28392331
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of HEYL gene	PMID:22964155
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312806	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of HEYL mRNA	PMID:17361019|PMID:21266533
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20130416	CTD	MESH:D010269	[SNCA protein co-treated with Maneb co-treated with Paraquat] results in decreased expression of HEYL mRNA	PMID:23017109
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312806	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of HEYL mRNA	PMID:26377693
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HEYL mRNA	PMID:35301059
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of HEYL mRNA	PMID:29038090
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of HEYL mRNA	PMID:23179753
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305022	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of HEYL mRNA	PMID:30047161
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312806	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of HEYL mRNA	PMID:17555576
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HEYL mRNA	PMID:37992649
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of HEYL mRNA	PMID:27188386
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in increased expression of HEYL mRNA	PMID:28542535
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of HEYL mRNA	PMID:38460933
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312806	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of HEYL mRNA	PMID:17555576
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of HEYL mRNA	PMID:25620056
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312806	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of HEYL mRNA	PMID:25554681
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20130416	CTD	MESH:D008344	[SNCA protein co-treated with Maneb co-treated with Paraquat] results in decreased expression of HEYL mRNA	PMID:23017109
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of HEYL mRNA	PMID:23608068
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of HEYL mRNA	PMID:36907384
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1312806	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of HEYL mRNA	PMID:22078008
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of HEYL mRNA	PMID:39752319
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305022	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of HEYL mRNA	PMID:33484710
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HEYL mRNA	PMID:36139627
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305022	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HEYL mRNA	PMID:32741896
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HEYL mRNA	PMID:27188386
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HEYL gene]	PMID:28238834
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1312806	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of HEYL mRNA	PMID:26655953
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305022	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HEYL mRNA	PMID:24780913
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305022	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of HEYL mRNA	PMID:30047161
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312806	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of HEYL mRNA	PMID:39752319
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HEYL mRNA	PMID:27188386
1312805	HEYL	hes related family bHLH transcription factor with YRPW motif like	gene	CHEBI:9130	sevoflurane	decreases methylation	ISO	RGD:1312806	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in decreased methylation of HEYL mRNA	PMID:35249202
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623055	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZFP575 mRNA	PMID:33045310
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZNF575 mRNA	PMID:26079696
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF575 mRNA	PMID:37042841
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1305025	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of ZNF575 mRNA	PMID:22967744
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZNF575 mRNA	PMID:19549813
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ZNF575 mRNA	PMID:22100608
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ZNF575 mRNA	PMID:23557933
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ZNF575 mRNA	PMID:27392435
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:29678	sodium arsenite	decreases methylation	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ZNF575 gene	PMID:24570342
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF575 mRNA	PMID:24570342
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZNF575 5' UTR	PMID:27901495
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1623055	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ZFP575 mRNA	PMID:27131904
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623055	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP575 promoter	PMID:35295148
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ZNF575 mRNA	PMID:19710929
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305025	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ZFP575 mRNA	PMID:19167457
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305025	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF575 mRNA	PMID:25181051
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305025	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP575 mRNA	PMID:30816183|PMID:34947998
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305025	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP575 mRNA	PMID:36041667
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1623055	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ZFP575 exon	PMID:33297965
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305025	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP575 mRNA	PMID:36041667
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305025	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP575 mRNA	PMID:36041667
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZNF575 mRNA	PMID:38382870
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ZNF575 mRNA	PMID:24449571
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:46905	(R)-pantothenic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010205	Pantothenic Acid results in decreased expression of ZNF575 mRNA	PMID:19397697
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF575 gene]	PMID:28238834
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305025	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ZFP575 mRNA	PMID:24780913
1312810	ZNF575	zinc finger protein 575	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1623055	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ZFP575 mRNA	PMID:27131904
1312811	TNKS2	tankyrase 2	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:D004237	Diuron results in increased expression of TNKS2 mRNA	PMID:21551480
1312811	TNKS2	tankyrase 2	gene	CHEBI:132098	methoxyacetic acid	increases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:C013598	methoxyacetic acid results in increased expression of TNKS2 mRNA	PMID:20864626
1312811	TNKS2	tankyrase 2	gene	CHEBI:134689	rucaparib	affects binding	EXP		E	RGD:6480464	20200211	CTD	MESH:C531549	rucaparib binds to TNKS2 protein	PMID:28001384
1312811	TNKS2	tankyrase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552096	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TNKS2 mRNA	PMID:30319688
1312811	TNKS2	tankyrase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of TNKS2 mRNA	PMID:19484750
1312811	TNKS2	tankyrase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TNKS2 mRNA	PMID:37042841
1312811	TNKS2	tankyrase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TNKS2 mRNA	PMID:33754040|PMID:34319233
1312811	TNKS2	tankyrase 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:D005839	Gentamicins results in increased expression of TNKS2 mRNA	PMID:22061828
1312811	TNKS2	tankyrase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552096	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TNKS2 mRNA	PMID:36331819
1312811	TNKS2	tankyrase 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TNKS2 mRNA	PMID:28522335
1312811	TNKS2	tankyrase 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TNKS2 mRNA	PMID:23649840
1312811	TNKS2	tankyrase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TNKS2 gene	PMID:27153756
1312811	TNKS2	tankyrase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552096	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TNKS2 mRNA	PMID:19770486
1312811	TNKS2	tankyrase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TNKS2 mRNA	PMID:23649840
1312811	TNKS2	tankyrase 2	gene	CHEBI:27732	caffeine	increases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:D002110	Caffeine results in increased expression of TNKS2 mRNA	PMID:20864626
1312811	TNKS2	tankyrase 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TNKS2 mRNA	PMID:23557933
1312811	TNKS2	tankyrase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1552096	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of TNKS2 mRNA	PMID:21151649
1312811	TNKS2	tankyrase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TNKS2 mRNA	PMID:17101203
1312811	TNKS2	tankyrase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TNKS2 mRNA	PMID:21215274
1312811	TNKS2	tankyrase 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305026	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TNKS2 mRNA	PMID:28374803
1312811	TNKS2	tankyrase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TNKS2 mRNA	PMID:26272509
1312811	TNKS2	tankyrase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TNKS2 mRNA	PMID:20864626
1312811	TNKS2	tankyrase 2	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNKS2 mRNA	PMID:27188386
1312811	TNKS2	tankyrase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TNKS2 mRNA	PMID:30851411
1312811	TNKS2	tankyrase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of TNKS2 mRNA	PMID:28595984|PMID:39719251
1312811	TNKS2	tankyrase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TNKS2 mRNA	PMID:38568856
1312811	TNKS2	tankyrase 2	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of TNKS2 gene	PMID:25435355
1312811	TNKS2	tankyrase 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TNKS2 mRNA]	PMID:32406909
1312811	TNKS2	tankyrase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TNKS2 mRNA	PMID:19150397
1312811	TNKS2	tankyrase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1552096	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TNKS2 mRNA	PMID:35676786
1312811	TNKS2	tankyrase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552096	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TNKS2 gene	PMID:35295148
1312811	TNKS2	tankyrase 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of TNKS2 mRNA	PMID:38479592
1312811	TNKS2	tankyrase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305026	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TNKS2 mRNA	PMID:34947998
1312811	TNKS2	tankyrase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:C006780	bisphenol A results in increased expression of TNKS2 mRNA	PMID:25181051
1312811	TNKS2	tankyrase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TNKS2 mRNA	PMID:39298647
1312811	TNKS2	tankyrase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552096	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TNKS2 intron	PMID:28392331
1312811	TNKS2	tankyrase 2	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TNKS2 mRNA	PMID:17602206
1312811	TNKS2	tankyrase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TNKS2 mRNA	PMID:21266533
1312811	TNKS2	tankyrase 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TNKS2 mRNA	PMID:34813904
1312811	TNKS2	tankyrase 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of TNKS2 mRNA	PMID:34813904
1312811	TNKS2	tankyrase 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TNKS2 mRNA	PMID:17602206
1312811	TNKS2	tankyrase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TNKS2 mRNA	PMID:37042841
1312811	TNKS2	tankyrase 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of TNKS2 mRNA	PMID:19162173
1312811	TNKS2	tankyrase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of TNKS2 mRNA	PMID:19162173
1312811	TNKS2	tankyrase 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TNKS2 mRNA	PMID:28302478
1312811	TNKS2	tankyrase 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TNKS2 mRNA	PMID:31533062
1312811	TNKS2	tankyrase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552096	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TNKS2 mRNA	PMID:36331819
1312811	TNKS2	tankyrase 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TNKS2 gene	PMID:29154799
1312811	TNKS2	tankyrase 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of TNKS2 mRNA	PMID:20106945
1312811	TNKS2	tankyrase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552096	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TNKS2 mRNA	PMID:17562736
1312811	TNKS2	tankyrase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in decreased expression of TNKS2 mRNA	PMID:22334560
1312811	TNKS2	tankyrase 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1552096	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TNKS2 mRNA	PMID:35676786
1312811	TNKS2	tankyrase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552096	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TNKS2 mRNA	PMID:25554681
1312811	TNKS2	tankyrase 2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of TNKS2 mRNA	PMID:19162173
1312811	TNKS2	tankyrase 2	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of TNKS2 mRNA	PMID:26705709
1312811	TNKS2	tankyrase 2	gene	CHEBI:62878	XAV939	multiple interactions	EXP		E	RGD:6480464	20200211	CTD	MESH:C544261	XAV939 binds to and results in decreased activity of TNKS2 protein	PMID:28001384
1312811	TNKS2	tankyrase 2	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNKS2 mRNA	PMID:26378955
1312811	TNKS2	tankyrase 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1305026	E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of TNKS2 mRNA	PMID:39938710
1312811	TNKS2	tankyrase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TNKS2 mRNA	PMID:22206623
1312811	TNKS2	tankyrase 2	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1305026	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in increased expression of TNKS2 mRNA	PMID:26720608
1312811	TNKS2	tankyrase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TNKS2 mRNA	PMID:30851411
1312811	TNKS2	tankyrase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNKS2 mRNA	PMID:27188386
1312811	TNKS2	tankyrase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552096	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TNKS2 mRNA	PMID:23091169
1312811	TNKS2	tankyrase 2	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in decreased expression of TNKS2 mRNA	PMID:22334560
1312811	TNKS2	tankyrase 2	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1305026	E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of TNKS2 mRNA	PMID:26923065
1312811	TNKS2	tankyrase 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in decreased expression of TNKS2 mRNA	PMID:21278054|PMID:22334560
1312811	TNKS2	tankyrase 2	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:C028577	monobutyl phthalate results in increased expression of TNKS2 mRNA	PMID:20864626
1312811	TNKS2	tankyrase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNKS2 mRNA	PMID:27188386
1312811	TNKS2	tankyrase 2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:D012999	Soman results in decreased expression of TNKS2 mRNA	PMID:19281266
1312811	TNKS2	tankyrase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TNKS2 mRNA	PMID:21346803
1312811	TNKS2	tankyrase 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552096	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of TNKS2 mRNA	PMID:28973697
1312811	TNKS2	tankyrase 2	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305026	E	RGD:6480464	20180626	CTD	MESH:C025643	vinclozolin results in increased expression of TNKS2 mRNA	PMID:20566332
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SFMBT2 mRNA	PMID:26272509|PMID:27188386
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SFMBT2 mRNA	PMID:33045310
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SFMBT2 mRNA	PMID:25812627
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1616410	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SFMBT2 gene	PMID:20938992
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of SFMBT2 mRNA	PMID:23724009
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SFMBT2 mRNA	PMID:26516004
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SFMBT2 mRNA	PMID:26079696
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SFMBT2 mRNA	PMID:22378314
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of SFMBT2 mRNA	PMID:24758408
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein inhibits the reaction [Estradiol results in decreased expression of SFMBT2 mRNA]	PMID:24758408
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1616410	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SFMBT2 gene	PMID:20938992
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SFMBT2 mRNA	PMID:26079696
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305027	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SFMBT2 mRNA	PMID:33387578
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SFMBT2 mRNA	PMID:28818685
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of SFMBT2 intron	PMID:30157460
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFMBT2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of SFMBT2 mRNA	PMID:39836092
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SFMBT2 intron	PMID:30157460
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SFMBT2 mRNA	PMID:41430723
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1616410	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SFMBT2 mRNA	PMID:34911549
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SFMBT2 mRNA	PMID:25629700
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1616410	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SFMBT2 gene	PMID:20938992
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFMBT2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SFMBT2 mRNA	PMID:39836092
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SFMBT2 mRNA	PMID:26272509
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:27690	acetazolamide	increases expression	ISO	RGD:1616410	E	RGD:6480464	20120717	CTD	MESH:D000086	Acetazolamide results in increased expression of SFMBT2 mRNA	PMID:19274763
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SFMBT2 mRNA	PMID:28960355
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SFMBT2 mRNA	PMID:28903495
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SFMBT2 mRNA	PMID:24768652|PMID:25583101
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SFMBT2 mRNA	PMID:29704546
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SFMBT2 mRNA	PMID:19933214|PMID:27913140
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of SFMBT2 mRNA	PMID:29704546
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SFMBT2 mRNA	PMID:32763439
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305027	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SFMBT2 mRNA	PMID:26033743
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SFMBT2 mRNA	PMID:29803840
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of SFMBT2 mRNA	PMID:39719251
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of SFMBT2 mRNA	PMID:36209798
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1616410	E	RGD:6480464	20180410	CTD	MESH:C017947	sodium arsenite results in increased expression of SFMBT2	PMID:29121352
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFMBT2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SFMBT2 mRNA	PMID:39836092
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SFMBT2 promoter	PMID:27901495
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SFMBT2 5' UTR	PMID:27901495
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305027	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SFMBT2 mRNA	PMID:26033743
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SFMBT2 mRNA	PMID:19150397
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of SFMBT2 mRNA	PMID:35984750
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SFMBT2 gene	PMID:31601247
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1616410	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SFMBT2 gene	PMID:35295148
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1616410	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SFMBT2 mRNA	PMID:20813756
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305027	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SFMBT2 mRNA	PMID:25181051
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305027	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of SFMBT2 mRNA	PMID:32145629|PMID:41034487
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1616410	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SFMBT2 mRNA	PMID:26063408|PMID:35598803
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305027	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SFMBT2 gene	PMID:28505145
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SFMBT2 gene	PMID:31601247
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1616410	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SFMBT2 mRNA	PMID:30951980
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SFMBT2 intron	PMID:30157460
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SFMBT2 mRNA	PMID:32715474
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SFMBT2 mRNA	PMID:37042841
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFMBT2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of SFMBT2 mRNA	PMID:39836092
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SFMBT2 mRNA	PMID:25812627
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SFMBT2 mRNA	PMID:25812627
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SFMBT2 mRNA	PMID:31533062
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SFMBT2 mRNA	PMID:25812627
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of SFMBT2 mRNA	PMID:21427059
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SFMBT2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SFMBT2 mRNA	PMID:26272509|PMID:27188386
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in increased expression of SFMBT2 mRNA	PMID:24935251|PMID:26272509|PMID:27188386
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1616410	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SFMBT2 mRNA	PMID:17562736
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305027	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SFMBT2 mRNA	PMID:33387578
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFMBT2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SFMBT2 mRNA	PMID:39836092
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of SFMBT2 mRNA	PMID:40706910
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305027	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SFMBT2 mRNA	PMID:29391264
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SFMBT2 mRNA; Nanotubes, Carbon results in decreased expression of SFMBT2 mRNA	PMID:25554681
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305027	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of SFMBT2 mRNA	PMID:24793618
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:53444	potassium dichromate	affects expression	ISO	RGD:1616410	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate affects the expression of SFMBT2 mRNA	PMID:23608068
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1616410	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SFMBT2 mRNA	PMID:38701926
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of SFMBT2 mRNA	PMID:26272509
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFMBT2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of SFMBT2 mRNA	PMID:39836092
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SFMBT2 mRNA	PMID:24810058
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SFMBT2 intron	PMID:30157460
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SFMBT2 mRNA	PMID:31758290
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1616410	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SFMBT2 mRNA	PMID:22206623
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SFMBT2 mRNA	PMID:22714537
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SFMBT2 mRNA	PMID:37199045
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of SFMBT2 mRNA	PMID:26079696
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of SFMBT2 mRNA	PMID:26272509
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFMBT2 mRNA	PMID:27188386
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1616410	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of SFMBT2 protein	PMID:24648495
1312812	SFMBT2	Scm like with four mbt domains 2	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305027	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of SFMBT2 gene	PMID:31079544
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305028	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of EZH1 mRNA	PMID:25152437
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:16170	mercury(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of EZH1 mRNA	PMID:16823088
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of EZH1 mRNA	PMID:39241906
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of EZH1 mRNA]	PMID:39241906
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312814	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of EZH1 mRNA	PMID:15598610
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:16480	nitric oxide	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide deficiency results in decreased expression of EZH1 mRNA	PMID:15878706
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305028	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of EZH1 gene	PMID:27618143
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EZH1 mRNA	PMID:37042841
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:17270	glycerol 2-phosphate	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:C031463	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of EZH1 mRNA	PMID:26424790
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of EZH1 protein	PMID:37730182
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EZH1 mRNA	PMID:28818685
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH1 mRNA	PMID:39836092
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of EZH1 mRNA	PMID:23649840
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:25195	mercury atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of EZH1 mRNA	PMID:16823088
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of EZH1 mRNA	PMID:34911549
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of EZH1 mRNA	PMID:17484886
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of EZH1 mRNA	PMID:25629700
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EZH1 mRNA	PMID:22206623
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EZH1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EZH1 mRNA	PMID:39836092|PMID:40512198
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of EZH1 mRNA	PMID:26272509
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA	PMID:27188386
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of EZH1 mRNA	PMID:12002526
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of EZH1 mRNA	PMID:27594783
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of EZH1 mRNA	PMID:27392435
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of EZH1 mRNA	PMID:30912803
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of EZH1 mRNA	PMID:25583101
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312814	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EZH1 mRNA	PMID:21570461
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305028	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EZH1 mRNA	PMID:32109520
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20120412	CTD	MESH:D019328	Buthionine Sulfoximine results in decreased expression of EZH1 mRNA	PMID:15878706
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EZH1 mRNA	PMID:29803840
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312814	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of EZH1 mRNA	PMID:39631538
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D001205	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of EZH1 mRNA	PMID:26424790
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of EZH1 mRNA	PMID:39719251
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312814	E	RGD:6480464	20221101	CTD	MESH:C017947	sodium arsenite results in increased expression of EZH1 mRNA	PMID:35364107
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EZH1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EZH1 mRNA	PMID:39836092|PMID:40512198
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20221101	CTD	MESH:C017947	GSK-2816126 promotes the reaction [sodium arsenite results in increased expression of EZH1 mRNA]	PMID:35364107
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EZH1 promoter	PMID:27901495
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305028	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EZH1 mRNA	PMID:21839799
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EZH1 mRNA	PMID:22228805
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305028	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of EZH1 mRNA	PMID:30047161
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312814	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EZH1 gene	PMID:35295148
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312814	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of EZH1 mRNA	PMID:29264374
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305028	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of EZH1 mRNA	PMID:23411599
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of EZH1 mRNA	PMID:20170705
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305028	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of EZH1 mRNA	PMID:25181051|PMID:30816183
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of EZH1 mRNA	PMID:29275510
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of EZH1 mRNA	PMID:19244175
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of EZH1 mRNA	PMID:37019170
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305028	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of EZH1 mRNA	PMID:21266533
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312814	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of EZH1 mRNA	PMID:21266533
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of EZH1 mRNA]	PMID:39241906
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EZH1 mRNA	PMID:37042841
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH1 mRNA	PMID:39836092
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of EZH1 mRNA	PMID:38568856
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EZH1 mRNA	PMID:38174414
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of EZH1 mRNA	PMID:24449571
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EZH1 mRNA	PMID:25979313
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of EZH1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA	PMID:27188386
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305028	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of EZH1 mRNA	PMID:30047161
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305028	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of EZH1 mRNA	PMID:41580965
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of EZH1 mRNA	PMID:25562108
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D003907	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of EZH1 mRNA	PMID:26424790
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1305028	E	RGD:6480464	20230606	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of EZH1 mRNA	PMID:37077353
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of EZH1 mRNA	PMID:38832940
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of EZH1 mRNA	PMID:24935251
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of EZH1 mRNA	PMID:29279043
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EZH1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EZH1 mRNA	PMID:39836092|PMID:40512198
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1305028	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of EZH1 mRNA	PMID:37077353
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:4775	ellagic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004610	Ellagic Acid results in increased expression of EZH1 mRNA	PMID:12002526
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of EZH1 mRNA	PMID:18175754
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312814	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of EZH1 mRNA; Nanotubes, Carbon results in decreased expression of EZH1 mRNA	PMID:25554681
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305028	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of EZH1 mRNA	PMID:30047161
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EZH1 mRNA	PMID:35964746
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of EZH1 mRNA	PMID:27188386
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1305028	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of EZH1 mRNA	PMID:20080153
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of EZH1 mRNA	PMID:39836092
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20200317	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in decreased expression of EZH1 mRNA	PMID:22078008
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312814	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of EZH1 mRNA	PMID:20003209
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305028	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of EZH1 mRNA	PMID:30467583
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312814	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of EZH1 mRNA	PMID:22206623
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EZH1 mRNA	PMID:22206623
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA	PMID:27188386
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305028	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EZH1 mRNA	PMID:30047161
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312814	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of EZH1 mRNA]	PMID:39241906
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EZH1 mRNA	PMID:27188386
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305028	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of EZH1 mRNA	PMID:21346803
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of EZH1 mRNA	PMID:38568856
1312813	EZH1	enhancer of zeste 1 polycomb repressive complex 2 subunit	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305028	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EZH1 mRNA	PMID:21346803
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:10110	zidovudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in increased expression of IL27RA mRNA	PMID:15784690
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of IL27RA mRNA	PMID:26272509|PMID:27188386
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA	PMID:27188386
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312816	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of IL27RA mRNA	PMID:33045310
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312816	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of IL27RA mRNA	PMID:36189433
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of IL27RA mRNA	PMID:36189433
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of IL27RA mRNA	PMID:22378314
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of IL27RA mRNA	PMID:30510588
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of IL27RA mRNA	PMID:19619570|PMID:21185374|PMID:31614463
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of IL27RA mRNA	PMID:19619570
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305029	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL27RA mRNA	PMID:32741896
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of IL27RA mRNA	PMID:37042841
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL27RA mRNA	PMID:37992649
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312816	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of IL27RA mRNA	PMID:22401849
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of IL27RA mRNA	PMID:36189433
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305029	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL27RA mRNA	PMID:32741896
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL27RA mRNA	PMID:37992649
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312816	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IL27RA mRNA	PMID:35550907
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305029	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of IL27RA mRNA	PMID:27523638
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305029	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of IL27RA mRNA	PMID:22061828
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IL27RA mRNA	PMID:39836092
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of IL27RA mRNA	PMID:21120746
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of IL27RA mRNA	PMID:19549813
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of IL27RA intron	PMID:30157460
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305029	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of IL27RA mRNA	PMID:30779732
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IL27RA mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL27RA mRNA	PMID:39836092
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in increased expression of IL27RA mRNA	PMID:21527772
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of IL27RA mRNA	PMID:23557933
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of IL27RA mRNA	PMID:23300844
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of IL27RA mRNA	PMID:27594783
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IL27RA mRNA	PMID:25583101
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312816	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IL27RA mRNA	PMID:21570461|PMID:26377647
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IL27RA mRNA	PMID:19619570
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of IL27RA mRNA	PMID:19619570
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IL27RA mRNA	PMID:29803840
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL27RA mRNA	PMID:37992649
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:28939	N-acetyl-L-cysteine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine results in decreased expression of IL27RA mRNA	PMID:16084531
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of IL27RA mRNA	PMID:34032870
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of IL27RA mRNA	PMID:38568856|PMID:39719251
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312816	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of IL27RA mRNA	PMID:37682722
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IL27RA mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL27RA mRNA	PMID:39836092
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL27RA mRNA	PMID:34876320
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL27RA mRNA	PMID:34876320
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IL27RA 3' UTR	PMID:27901495
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of IL27RA promoter	PMID:27901495
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IL27RA mRNA	PMID:32234424
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312816	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IL27RA mRNA	PMID:29341224
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of IL27RA mRNA	PMID:19128835
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312816	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IL27RA gene	PMID:35295148
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305029	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IL27RA mRNA	PMID:25181051
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305029	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of IL27RA mRNA	PMID:30816183|PMID:32528016
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312816	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of IL27RA mRNA	PMID:38701888
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of IL27RA mRNA	PMID:25979313
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1312816	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of IL27RA mRNA	PMID:28392331
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:34674	dextran sulfate	decreases response to substance	ISO	RGD:1312816	E	RGD:6480464	20120412	CTD	MESH:D016264	IL27RA protein results in decreased susceptibility to Dextran Sulfate	PMID:16306766
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IL27RA mRNA	PMID:37042841
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305029	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of IL27RA mRNA	PMID:35163327
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IL27RA mRNA	PMID:39836092
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IL27RA mRNA	PMID:38568856
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20210309	CTD	MESH:C023036	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of IL27RA mRNA	PMID:33325755
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IL27RA mRNA	PMID:24449571
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312816	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IL27RA mRNA	PMID:40194260
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:38757	isoflavones	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones affects the expression of IL27RA mRNA	PMID:16365062
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of IL27RA mRNA	PMID:31533062
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of IL27RA mRNA	PMID:40419075
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312816	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of IL27RA mRNA	PMID:29038090
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IL27RA mRNA	PMID:25979313
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312816	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of IL27RA mRNA	PMID:17292431
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of IL27RA mRNA	PMID:29154799
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of IL27RA mRNA	PMID:27989131
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in increased expression of IL27RA mRNA	PMID:22147139
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IL27RA mRNA	PMID:37992649
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of IL27RA mRNA	PMID:24935251|PMID:26272509
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA	PMID:27188386
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	IL27RA protein affects the susceptibility to Fluorouracil	PMID:16217747
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IL27RA mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL27RA mRNA	PMID:39836092
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305029	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of IL27RA mRNA	PMID:29391264
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of IL27RA mRNA	PMID:16084531
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of IL27RA mRNA	PMID:22079256
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL27RA mRNA	PMID:34876320
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of IL27RA mRNA	PMID:38568856
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of IL27RA mRNA	PMID:19128835
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of IL27RA mRNA	PMID:23300844
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312816	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IL27RA mRNA	PMID:38701926
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IL27RA mRNA	PMID:39836092
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:63577	lamivudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in increased expression of IL27RA mRNA	PMID:15784690
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL27RA mRNA	PMID:22079614
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of IL27RA mRNA	PMID:31758290
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312816	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IL27RA mRNA	PMID:22206623
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of IL27RA mRNA	PMID:22079256
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of IL27RA mRNA	PMID:22079256
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:75701	sarin	increases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of IL27RA mRNA	PMID:19522546
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:76989	phytoestrogen	multiple interactions	EXP		E	RGD:6480464	20210309	CTD	MESH:D048789	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of IL27RA mRNA	PMID:33325755
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305029	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of IL27RA mRNA	PMID:32741896
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA	PMID:27188386
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of IL27RA mRNA	PMID:32234424
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312816	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of IL27RA mRNA	PMID:34876320
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of IL27RA mRNA	PMID:26272509
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA	PMID:27188386
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL27RA mRNA	PMID:27188386
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of IL27RA mRNA	PMID:38568856
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of IL27RA mRNA	PMID:29301935
1312815	IL27RA	interleukin 27 receptor subunit alpha	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of IL27RA mRNA	PMID:27188386
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312818	E	RGD:6480464	20160712	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACBD6 gene	PMID:20938992
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ACBD6 mRNA	PMID:33167477
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1305030	E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in decreased expression of ACBD6 protein	PMID:40631627
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312818	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of ACBD6 mRNA	PMID:40945087
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ACBD6 mRNA	PMID:21632981
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312818	E	RGD:6480464	20160712	CTD	MESH:D004958	Estradiol results in decreased expression of ACBD6 mRNA	PMID:19484750
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312818	E	RGD:6480464	20160712	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACBD6 gene	PMID:20938992
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACBD6 mRNA	PMID:37042841
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1305030	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of ACBD6 protein	PMID:40631627
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:17558	quercitrin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in decreased expression of ACBD6 mRNA	PMID:25193878
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1305030	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of ACBD6 protein	PMID:40631627
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ACBD6 mRNA	PMID:39836092
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312818	E	RGD:6480464	20160712	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACBD6 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACBD6 gene	PMID:20938992|PMID:22206623
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ACBD6 mRNA	PMID:39836092
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ACBD6 mRNA	PMID:23557933
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312818	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of ACBD6 mRNA	PMID:30912803
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312818	E	RGD:6480464	20160712	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACBD6 mRNA	PMID:21570461
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305030	E	RGD:6480464	20160712	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACBD6 mRNA	PMID:21215274
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACBD6 mRNA	PMID:20106945
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305030	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACBD6 mRNA	PMID:33387578
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ACBD6 mRNA	PMID:33212167
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ACBD6 mRNA	PMID:39836092
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACBD6 mRNA	PMID:20064835
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312818	E	RGD:6480464	20160712	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACBD6 mRNA	PMID:21715664
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACBD6 mRNA	PMID:21632981
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305030	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ACBD6 mRNA	PMID:25729387
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305030	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ACBD6 mRNA	PMID:34947998
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ACBD6 mRNA	PMID:25047013
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312818	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ACBD6 mRNA	PMID:32156529
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1305030	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ACBD6 mRNA	PMID:21241498
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312818	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ACBD6 mRNA	PMID:34813904
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312818	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ACBD6 mRNA	PMID:34813904
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ACBD6 mRNA	PMID:39836092
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ACBD6 mRNA	PMID:25979313
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ACBD6 mRNA	PMID:29154799
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ACBD6 mRNA	PMID:20106945
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1305030	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of ACBD6 protein	PMID:40631627
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ACBD6 mRNA	PMID:39836092
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305030	E	RGD:6480464	20160712	CTD	MESH:D005485	Flutamide results in decreased expression of ACBD6 mRNA	PMID:24136188
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ACBD6 protein	PMID:23718831
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ACBD6 mRNA	PMID:39836092
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305030	E	RGD:6480464	20160712	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ACBD6 mRNA	PMID:25729387
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305030	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of ACBD6 mRNA	PMID:24136188
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312818	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACBD6 mRNA	PMID:22206623
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ACBD6 mRNA	PMID:37199045
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ACBD6 gene]	PMID:28238834
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312818	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ACBD6 mRNA	PMID:40826991
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1305030	E	RGD:6480464	20160822	CTD	MESH:D013311	Streptozocin results in increased expression of ACBD6 mRNA	PMID:25905778
1312817	ACBD6	acyl-CoA binding domain containing 6	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ACBD6 mRNA	PMID:38568856
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of VTA1 mRNA	PMID:22378314
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552739	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of VTA1 mRNA	PMID:39241906
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of VTA1 mRNA	PMID:37042841
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552739	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of VTA1 mRNA	PMID:33754040
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of VTA1 mRNA	PMID:19549813
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of VTA1 gene	PMID:27153756
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of VTA1 mRNA	PMID:15672453
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of VTA1 mRNA	PMID:22171008
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552739	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of VTA1 mRNA	PMID:25629700
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of VTA1 protein	PMID:37834424
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1552739	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of VTA1 mRNA	PMID:28960355
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305031	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VTA1 mRNA	PMID:33387578
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of VTA1 mRNA	PMID:29803840
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of VTA1 mRNA	PMID:39719251
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to VTA1 mRNA]	PMID:32406909
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of VTA1 mRNA	PMID:22171008
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of VTA1 gene	PMID:31601247
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305031	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of VTA1 mRNA	PMID:30047161
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552739	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VTA1 gene; titanium dioxide results in decreased methylation of VTA1 promoter	PMID:35295148
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of VTA1 mRNA	PMID:29275510
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of VTA1 protein	PMID:37567409
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305031	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of VTA1 mRNA	PMID:25181051|PMID:34947998
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of VTA1 gene	PMID:31601247
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305031	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of VTA1 mRNA	PMID:36041667
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of VTA1 protein	PMID:34186270
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552739	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of VTA1 mRNA	PMID:39298647
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305031	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of VTA1 mRNA	PMID:36041667
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of VTA1 protein	PMID:34186270
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VTA1 mRNA	PMID:28628672
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305031	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of VTA1 mRNA	PMID:36041667
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1305031	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of VTA1 mRNA	PMID:21241498
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VTA1 mRNA	PMID:28628672
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305031	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of VTA1 promoter	PMID:22457795
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305031	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of VTA1 mRNA	PMID:30047161
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1552739	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of VTA1 mRNA	PMID:17585979
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in decreased expression of VTA1 protein	PMID:17152098
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of VTA1 mRNA	PMID:28302478
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552739	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of VTA1 mRNA	PMID:17292431
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1552739	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of VTA1 mRNA	PMID:21427059
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1552739	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of VTA1 mRNA	PMID:21427059
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305031	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of VTA1 mRNA	PMID:30047161
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of VTA1 mRNA	PMID:25562108
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VTA1 mRNA	PMID:28628672
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	Arsenic results in decreased expression of VTA1 protein	PMID:37834424
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of VTA1 mRNA	PMID:40706910
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of VTA1 mRNA	PMID:28628672
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552739	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of VTA1 mRNA; Nanotubes, Carbon results in increased expression of VTA1 mRNA	PMID:25554681
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305031	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of VTA1 mRNA	PMID:30047161
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305031	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of VTA1 mRNA	PMID:24136188
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of VTA1 protein	PMID:32959892
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of VTA1 mRNA	PMID:31758290
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of VTA1 protein	PMID:31675489
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of VTA1 protein	PMID:31675489
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305031	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of VTA1 mRNA	PMID:30047161
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of VTA1 mRNA	PMID:24921660
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of VTA1 protein	PMID:21469165
1312819	VTA1	vesicle trafficking 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of VTA1 mRNA	PMID:38568856
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of TMPRSS4 mRNA	PMID:38218311
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMPRSS4 mRNA	PMID:20938992
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of TMPRSS4 mRNA	PMID:23830798
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TMPRSS4 mRNA	PMID:26079696
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of TMPRSS4 mRNA	PMID:19619570|PMID:21185374
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TMPRSS4 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of TMPRSS4 mRNA	PMID:19619570|PMID:30165855
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305033	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMPRSS4 mRNA	PMID:33387578
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMPRSS4 mRNA	PMID:20938992
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]	PMID:37992649
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]	PMID:37992649
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMPRSS4 mRNA	PMID:36331819
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMPRSS4 mRNA	PMID:37236586|PMID:37325564
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TMPRSS4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TMPRSS4 mRNA	PMID:34911549
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1312822	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of TMPRSS4 mRNA	PMID:31939706
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMPRSS4 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TMPRSS4 mRNA	PMID:20938992|PMID:22206623
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]	PMID:37992649
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:28088	genistein	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein affects the expression of TMPRSS4 mRNA	PMID:26865667
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TMPRSS4 mRNA	PMID:25583101
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312822	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMPRSS4 mRNA	PMID:26377647
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312822	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMPRSS4 mRNA	PMID:20159946
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMPRSS4 mRNA	PMID:19619570
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TMPRSS4 mRNA	PMID:19619570
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TMPRSS4 mRNA	PMID:17942748
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1305033	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of TMPRSS4 mRNA	PMID:30556269
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305033	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TMPRSS4 mRNA	PMID:26033743
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]	PMID:37992649
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]	PMID:37992649
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312822	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMPRSS4 mRNA	PMID:37682722
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TMPRSS4 promoter	PMID:27901495
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TMPRSS4 5' UTR	PMID:27901495
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1305033	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of TMPRSS4 mRNA	PMID:30556269
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305033	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TMPRSS4 mRNA	PMID:26033743
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312822	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of TMPRSS4 mRNA	PMID:22609695
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1305033	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of TMPRSS4 mRNA	PMID:30012374
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312822	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TMPRSS4 mRNA	PMID:23557971|PMID:27760801
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TMPRSS4 mRNA	PMID:19710929
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305033	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TMPRSS4 mRNA	PMID:25181051
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312822	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of TMPRSS4 mRNA	PMID:32156529
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:34283	oxybenzone	increases expression	ISO	RGD:1305033	E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of TMPRSS4 mRNA	PMID:30316929
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312822	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TMPRSS4 mRNA	PMID:40203079
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312822	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of TMPRSS4 mRNA	PMID:26377693
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305033	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of TMPRSS4 mRNA	PMID:32680482
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMPRSS4 mRNA	PMID:37236586|PMID:37325564
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305033	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TMPRSS4 mRNA	PMID:27387713
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TMPRSS4 mRNA	PMID:36331819
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TMPRSS4 mRNA	PMID:24383497
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1312822	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of TMPRSS4 mRNA	PMID:25123088
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA; Glyphosate inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TMPRSS4 mRNA]	PMID:37992649
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312822	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of TMPRSS4 mRNA	PMID:18502557
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TMPRSS4 mRNA	PMID:38832940
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312822	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TMPRSS4 mRNA	PMID:17562736
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1312822	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of TMPRSS4 mRNA	PMID:29279043
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312822	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TMPRSS4 mRNA	PMID:35436446
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TMPRSS4 mRNA	PMID:26865667
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TMPRSS4 mRNA	PMID:17942748
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312822	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TMPRSS4 mRNA	PMID:25620056
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312822	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TMPRSS4 mRNA; Nanotubes, Carbon results in increased expression of TMPRSS4 mRNA	PMID:25554681
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C082360	fipronil results in increased expression of TMPRSS4 mRNA	PMID:27091632
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:5855	ibuprofen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007052	Ibuprofen affects the expression of TMPRSS4 mRNA	PMID:17070997
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TMPRSS4 mRNA	PMID:26378955
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:67251	beta-damascenone	increases expression	ISO	RGD:1312822	E	RGD:6480464	20161213	CTD	MESH:C075388	beta-damascenone results in increased expression of TMPRSS4 mRNA	PMID:22982537
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312822	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TMPRSS4 mRNA	PMID:22206623
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312822	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMPRSS4 mRNA	PMID:22206623
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TMPRSS4 gene]	PMID:28238834
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:80491	pinostrobin	increases phosphorylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C411294	pinostrobin results in increased phosphorylation of TMPRSS4 protein	PMID:37164308
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:82036	prothioconazole	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in decreased expression of TMPRSS4 mRNA	PMID:35048155
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:8887	rofecoxib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C116926	rofecoxib results in increased expression of TMPRSS4 mRNA	PMID:17070997
1312821	TMPRSS4	transmembrane serine protease 4	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305033	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of TMPRSS4 mRNA	PMID:23869203
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NET1 mRNA	PMID:33167477
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of NET1 mRNA	PMID:16249480|PMID:21934132
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305034	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of NET1 mRNA	PMID:33729688
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:15940	nicotinic acid	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20161213	CTD	MESH:D009525	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of NET1 mRNA]	PMID:16940432
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of NET1 mRNA	PMID:21632981
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312824	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NET1 mRNA	PMID:39241906
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of NET1 mRNA	PMID:15598610
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305034	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of NET1 mRNA	PMID:32145629
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312824	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of NET1 mRNA	PMID:39298647
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of NET1 mRNA	PMID:30165855
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305034	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NET1 mRNA	PMID:33387578
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of NET1 mRNA	PMID:16002434
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NET1 mRNA	PMID:39836092
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in increased expression of NET1 mRNA	PMID:23369406
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NET1 mRNA	PMID:37236586
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NET1 mRNA	PMID:19549813
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D005038	Ethylnitrosourea results in increased expression of NET1 mRNA	PMID:19100860
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of NET1 mRNA	PMID:22100608
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NET1 gene	PMID:27153756
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312824	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NET1 mRNA	PMID:19770486
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of NET1 mRNA	PMID:12763052
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305034	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NET1 mRNA	PMID:31150632
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312824	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NET1 mRNA	PMID:31919559
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NET1 mRNA	PMID:22206623
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NET1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NET1 mRNA	PMID:39836092
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D002945	Cisplatin results in increased expression of NET1 mRNA	PMID:38498338
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:28073	chromium atom	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D002857	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of NET1 mRNA]	PMID:16940432
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312824	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NET1 mRNA	PMID:21570461
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NET1 mRNA	PMID:20106945|PMID:21632981
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305034	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NET1 mRNA	PMID:21215274
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NET1 mRNA	PMID:19933214|PMID:28922406
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of NET1 mRNA	PMID:39709020
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NET1 mRNA	PMID:29803840
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of NET1 mRNA	PMID:20044591
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NET1 mRNA	PMID:38568856
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NET1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NET1 mRNA	PMID:39836092
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NET1 mRNA	PMID:20106945|PMID:21632981
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NET1 mRNA	PMID:19770486
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312824	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NET1 exon; Benzo(a)pyrene results in decreased methylation of NET1 intron	PMID:27901495
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312824	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NET1 mRNA	PMID:15034205|PMID:27195522
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NET1 promoter	PMID:27901495
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of NET1 mRNA]	PMID:15034205
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1305034	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NET1 mRNA	PMID:22431001
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NET1 mRNA	PMID:20382639
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1305034	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of NET1 mRNA	PMID:22641619
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305034	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of NET1 mRNA	PMID:25729387
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305034	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NET1 mRNA	PMID:25729387
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312824	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NET1 gene	PMID:35295148
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305034	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of NET1 mRNA	PMID:23411599|PMID:34492290
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of NET1 mRNA	PMID:16221962|PMID:18301758
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NET1 mRNA	PMID:30903817
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305034	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NET1 mRNA	PMID:30903817
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305034	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NET1 mRNA	PMID:25181051|PMID:32145629
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305034	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of NET1 mRNA	PMID:30816183|PMID:32528016|PMID:33296240
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312824	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of NET1 promoter	PMID:33297965
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312824	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of NET1 mRNA	PMID:30951980|PMID:33297965|PMID:39298647
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of NET1 mRNA	PMID:28628672
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312824	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of NET1 mRNA	PMID:30951980
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312824	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of NET1 promoter	PMID:28392331
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1312824	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of NET1 mRNA	PMID:31558096
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:34682	diazinon	decreases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of NET1 gene	PMID:22964155
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305034	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NET1 mRNA	PMID:21266533
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:34709	Diisodecyl phthalate	increases expression	ISO	RGD:1312824	E	RGD:6480464	20150127	CTD	MESH:C042080	diisodecyl phthalate results in increased expression of NET1 mRNA	PMID:25270620
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of NET1 mRNA	PMID:28628672
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of NET1 mRNA	PMID:19100860
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of NET1 mRNA	PMID:36117858
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NET1 mRNA	PMID:37042841
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:35036	fentin chloride	increases expression	ISO	RGD:1305034	E	RGD:6480464	20231205	CTD	MESH:C012594	triphenyltin chloride results in increased expression of NET1 mRNA	PMID:37156404
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1305034	E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of NET1 mRNA	PMID:17616710
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NET1 mRNA	PMID:39836092
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of NET1 mRNA	PMID:26377693
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305034	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NET1 mRNA	PMID:25993096
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NET1 mRNA	PMID:37236586
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305034	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of NET1 mRNA	PMID:25539665
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of NET1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NET1 mRNA]	PMID:17585979
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312824	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NET1 mRNA	PMID:40194260
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NET1 mRNA	PMID:31533062
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of NET1 mRNA	PMID:26352163
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NET1 mRNA	PMID:27153767
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1312824	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of NET1 mRNA	PMID:31558096
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NET1 mRNA	PMID:25979313
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NET1 mRNA	PMID:17963808
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of NET1 mRNA	PMID:21427059
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of NET1 gene	PMID:29154799
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of NET1 mRNA	PMID:23179753
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312824	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of NET1 mRNA	PMID:24896083
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in decreased expression of NET1 mRNA	PMID:17183730
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NET1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312824	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of NET1 mRNA	PMID:22733784
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of NET1 mRNA	PMID:28628672
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of NET1 mRNA	PMID:36621641
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of NET1 mRNA	PMID:28973697
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of NET1 mRNA	PMID:18502557
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of NET1 mRNA	PMID:22230336|PMID:29067470
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305034	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NET1 mRNA	PMID:33387578
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of NET1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NET1 mRNA]	PMID:17585979
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NET1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NET1 mRNA	PMID:39836092
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of NET1 mRNA	PMID:36621641
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305034	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of NET1 mRNA	PMID:29391264
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312824	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of NET1 mRNA	PMID:35436446
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of NET1 mRNA	PMID:18175754
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305034	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NET1 mRNA	PMID:17108234
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of NET1 mRNA	PMID:16984733
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of NET1 mRNA	PMID:28628672
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of NET1 mRNA; Nanotubes, Carbon results in decreased expression of NET1 mRNA	PMID:25554681
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312824	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of NET1 mRNA	PMID:25620056
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305034	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of NET1 mRNA	PMID:34044035
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of NET1 mRNA	PMID:36117858
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of NET1 mRNA	PMID:16780908
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of NET1 mRNA	PMID:23608068
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in decreased expression of NET1 mRNA	PMID:17183730
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NET1 mRNA	PMID:39836092
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305034	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of NET1 mRNA	PMID:25729387
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305034	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NET1 mRNA	PMID:25729387
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of NET1 mRNA	PMID:28988120
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305034	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of NET1 mRNA	PMID:30467583
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in increased expression of NET1 mRNA	PMID:17654400
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of NET1 mRNA	PMID:31758290
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NET1 mRNA	PMID:22206623
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305034	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of NET1 mRNA	PMID:24136188
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of NET1 mRNA	PMID:29522793
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NET1 mRNA	PMID:37199045
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of NET1 protein	PMID:31285264
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of NET1 mRNA	PMID:19482888
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312824	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NET1 mRNA]	PMID:19482888
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1312824	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of NET1 mRNA	PMID:31558096
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of NET1 mRNA	PMID:21858171
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312824	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of NET1 mRNA	PMID:39847705
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312824	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of NET1 mRNA	PMID:21795629
1312823	NET1	neuroepithelial cell transforming 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305034	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of NET1 mRNA	PMID:19015723
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of MMAA mRNA	PMID:26272509
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAA mRNA	PMID:27188386
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MMAA mRNA	PMID:26079696
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MMAA mRNA	PMID:39241906
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MMAA mRNA	PMID:39298647
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MMAA mRNA	PMID:37042841
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of MMAA mRNA	PMID:20655997
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MMAA mRNA	PMID:28085963
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305035	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MMAA mRNA	PMID:33387578
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MMAA mRNA	PMID:28818685
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MMAA mRNA	PMID:19549813
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MMAA mRNA	PMID:23649840
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MMAA gene	PMID:27153756
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MMAA mRNA	PMID:23649840
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312826	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MMAA mRNA	PMID:22206623
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MMAA protein	PMID:35688186
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312826	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of MMAA mRNA	PMID:28960355
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of MMAA mRNA	PMID:27594783
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of MMAA mRNA	PMID:27392435
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MMAA mRNA	PMID:24768652|PMID:25583101
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305035	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MMAA mRNA	PMID:21215274
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305035	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MMAA mRNA	PMID:33387578
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312826	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MMAA mRNA	PMID:21354282
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MMAA mRNA	PMID:28001369
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MMAA mRNA	PMID:33212167
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MMAA mRNA	PMID:30851411
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MMAA mRNA	PMID:29803840
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MMAA 5' UTR	PMID:27901495
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312826	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MMAA promoter	PMID:35295148
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305035	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MMAA mRNA	PMID:34492290
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of MMAA mRNA	PMID:38479592
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305035	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MMAA mRNA	PMID:30816183
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312826	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of MMAA mRNA	PMID:40203079
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MMAA mRNA	PMID:38685157
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of MMAA protein	PMID:34186270
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MMAA mRNA	PMID:37042841
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MMAA mRNA	PMID:38568856
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305035	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MMAA mRNA	PMID:24386269
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312826	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MMAA mRNA	PMID:40194260
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MMAA mRNA	PMID:31533062
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MMAA mRNA	PMID:25979313
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312826	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MMAA mRNA	PMID:17292431
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of MMAA mRNA	PMID:23179753|PMID:24935251
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of MMAA mRNA	PMID:28001369
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305035	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of MMAA mRNA	PMID:41580965
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of MMAA mRNA	PMID:24935251
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1305035	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of MMAA mRNA	PMID:21346803
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312826	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MMAA mRNA	PMID:17562736
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MMAA mRNA	PMID:21420995
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305035	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MMAA mRNA	PMID:33387578
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MMAA mRNA	PMID:29279043
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MMAA mRNA	PMID:25620056
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of MMAA mRNA	PMID:40234311
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312826	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of MMAA mRNA	PMID:38701926
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312826	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MMAA mRNA	PMID:22206623
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MMAA mRNA	PMID:30851411
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAA mRNA	PMID:27188386
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of MMAA mRNA	PMID:31734321
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MMAA mRNA	PMID:27188386
1312825	MMAA	metabolism of cobalamin associated A	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305035	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MMAA mRNA	PMID:21346803
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1552099	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of BAZ2A mRNA	PMID:33045310
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BAZ2A gene	PMID:20938992
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of BAZ2A mRNA	PMID:33167477
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of BAZ2A mRNA	PMID:20044591
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552099	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of BAZ2A mRNA	PMID:39241906
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of BAZ2A mRNA	PMID:16705744
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305037	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of BAZ2A mRNA	PMID:32145629
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BAZ2A gene	PMID:20938992
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BAZ2A mRNA	PMID:37042841
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of BAZ2A mRNA	PMID:33359661
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of BAZ2A protein	PMID:37730182
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of BAZ2A mRNA	PMID:16002434
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of BAZ2A mRNA	PMID:28818685
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of BAZ2A mRNA	PMID:39836092
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of BAZ2A mRNA	PMID:35430440
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305037	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of BAZ2A mRNA	PMID:30779732
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305037	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of BAZ2A mRNA	PMID:31129395
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552099	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of BAZ2A mRNA	PMID:25629700
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of BAZ2A gene	PMID:20938992
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAZ2A mRNA	PMID:40504410
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of BAZ2A protein	PMID:35688186
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1305037	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of BAZ2A mRNA	PMID:26302742
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of BAZ2A mRNA	PMID:27594783
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1552099	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of BAZ2A mRNA	PMID:30912803
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of BAZ2A mRNA	PMID:16705744
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552099	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BAZ2A mRNA	PMID:21570461|PMID:24680724
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BAZ2A mRNA	PMID:21296121
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BAZ2A mRNA	PMID:17942748
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of BAZ2A protein	PMID:35688186
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1305037	E	RGD:6480464	20240305	CTD	MESH:C017947	sodium arsenite results in increased expression of BAZ2A mRNA; sodium arsenite results in increased expression of BAZ2A protein	PMID:37757915|PMID:39354181
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552099	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of BAZ2A mRNA	PMID:36209798
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1305037	E	RGD:6480464	20251007	CTD	MESH:C017947	Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of BAZ2A mRNA]; Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of BAZ2A protein]	PMID:39354181
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAZ2A mRNA	PMID:40504410
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552099	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BAZ2A gene	PMID:35295148
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552099	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of BAZ2A mRNA	PMID:23557971
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552099	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of BAZ2A gene	PMID:35295148
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305037	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of BAZ2A mRNA	PMID:19167457
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305037	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of BAZ2A mRNA	PMID:25181051|PMID:30816183|PMID:32145629
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552099	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of BAZ2A mRNA	PMID:26063408
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305037	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BAZ2A mRNA; [bisphenol A co-treated with tributyltin] results in increased expression of BAZ2A mRNA	PMID:31129395|PMID:36041667
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305037	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BAZ2A mRNA	PMID:36041667
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BAZ2A mRNA	PMID:28628672
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305037	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of BAZ2A mRNA	PMID:36041667
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BAZ2A mRNA	PMID:28628672
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1552099	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of BAZ2A mRNA	PMID:34813904
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of BAZ2A mRNA	PMID:39836092
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305037	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of BAZ2A promoter	PMID:22457795
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of BAZ2A protein	PMID:26879310
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of BAZ2A mRNA	PMID:28302478
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of BAZ2A mRNA	PMID:31533062
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of BAZ2A mRNA	PMID:19167446
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BAZ2A mRNA	PMID:28628672
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAZ2A mRNA	PMID:40504410
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:48843	disodium selenite	multiple interactions	ISO	RGD:1305037	E	RGD:6480464	20251007	CTD	MESH:D018038	Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of BAZ2A mRNA]; Sodium Selenite inhibits the reaction [sodium arsenite results in increased expression of BAZ2A protein]	PMID:39354181
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552099	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BAZ2A mRNA	PMID:17942748
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of BAZ2A mRNA	PMID:28628672
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of BAZ2A mRNA	PMID:39836092
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1552099	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of BAZ2A mRNA	PMID:26307267
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of BAZ2A protein	PMID:31285264
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305037	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of BAZ2A mRNA	PMID:26720608
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:81980	triticonazole	increases expression	ISO	RGD:1305037	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in increased expression of BAZ2A mRNA	PMID:36084822
1312828	BAZ2A	bromodomain adjacent to zinc finger domain 2A	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305037	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of BAZ2A gene	PMID:31079544
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312831	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ICAM5 mRNA	PMID:33045310
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ICAM5 gene	PMID:20938992
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305039	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ICAM5 mRNA	PMID:33729688
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ICAM5 mRNA	PMID:26079696
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of ICAM5 mRNA	PMID:30319688
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ICAM5 mRNA	PMID:30510588
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20160705	CTD	MESH:D004958	Estradiol results in decreased expression of ICAM5 mRNA	PMID:26789235
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305039	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ICAM5 mRNA	PMID:32741896
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20160705	CTD	MESH:D004958	bisphenol A inhibits the reaction [Estradiol results in decreased expression of ICAM5 mRNA]; fulvestrant inhibits the reaction [Estradiol results in decreased expression of ICAM5 mRNA]	PMID:26789235
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ICAM5 gene	PMID:20938992
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ICAM5 mRNA	PMID:26079696
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of ICAM5 mRNA	PMID:33448797
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICAM5 mRNA]	PMID:33448797
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305039	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ICAM5 mRNA	PMID:32741896
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of ICAM5 mRNA	PMID:33448797
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICAM5 mRNA]	PMID:33448797
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305039	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ICAM5 mRNA	PMID:26577399
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1305039	E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ICAM5 mRNA	PMID:25378103
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ICAM5 gene	PMID:28458013
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ICAM5 mRNA	PMID:41430723
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ICAM5 gene	PMID:20938992
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D001151	Arsenic affects the expression of ICAM5 mRNA; Arsenic affects the expression of ICAM5 protein	PMID:24675094|PMID:28793237
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D001151	[Arsenic results in increased abundance of Arsenicals] which affects the expression of ICAM5 mRNA; [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of ICAM5 mRNA	PMID:28793237
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ICAM5 mRNA	PMID:28903495
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305039	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ICAM5 mRNA	PMID:33387578
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ICAM5 mRNA	PMID:33212167
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ICAM5 mRNA	PMID:32763439
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312831	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ICAM5 mRNA	PMID:27862939
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ICAM5 mRNA	PMID:38568856|PMID:39719251
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ICAM5 3' UTR; Benzo(a)pyrene affects the methylation of ICAM5 promoter	PMID:27901495
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ICAM5 exon	PMID:27901495
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ICAM5 mRNA	PMID:32234424
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of ICAM5 promoter	PMID:23974009
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ICAM5 mRNA	PMID:23806026
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ICAM5 mRNA	PMID:37690743
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20160705	CTD	MESH:C070081	fulvestrant inhibits the reaction [Estradiol results in decreased expression of ICAM5 mRNA]	PMID:26789235
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312831	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ICAM5 promoter	PMID:35295148
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312831	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ICAM5 gene	PMID:35295148
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305039	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ICAM5 mRNA	PMID:34492290
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ICAM5 protein	PMID:33376534
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305039	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ICAM5 mRNA	PMID:30816183|PMID:34947998|PMID:35192832
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ICAM5 mRNA	PMID:26789235
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305039	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ICAM5 mRNA	PMID:25181051|PMID:32145629
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305039	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ICAM5 gene	PMID:28505145
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305039	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ICAM5 mRNA	PMID:36041667
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A inhibits the reaction [Estradiol results in decreased expression of ICAM5 mRNA]	PMID:26789235
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:3423	carmustine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of ICAM5 mRNA	PMID:15980968
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ICAM5 mRNA	PMID:23146750
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312831	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ICAM5 gene	PMID:31683443
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1312831	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ICAM5 exon	PMID:33297965
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305039	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ICAM5 mRNA	PMID:36041667
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305039	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ICAM5 mRNA	PMID:36041667
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:34682	diazinon	decreases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of ICAM5 gene	PMID:22964155
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305039	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of ICAM5 mRNA	PMID:30723492
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305039	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ICAM5 mRNA	PMID:33453195
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312831	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ICAM5 mRNA	PMID:24982889
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ICAM5 mRNA	PMID:31533062
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ICAM5 mRNA	PMID:39529242
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of ICAM5 mRNA	PMID:33448797
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICAM5 mRNA]	PMID:33448797
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305039	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ICAM5 mRNA	PMID:33387578
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:46680	serpentine asbestos	decreases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of ICAM5 5' UTR	PMID:29523930
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of ICAM5 mRNA; Arsenic affects the expression of ICAM5 protein	PMID:24675094|PMID:28793237
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D001151	[Arsenic results in increased abundance of Arsenicals] which affects the expression of ICAM5 mRNA; [Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of ICAM5 mRNA	PMID:28793237
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D002101	[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of ICAM5 mRNA	PMID:28793237
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:5118	fluoxetine	decreases expression	ISO	RGD:1305039	E	RGD:6480464	20120717	CTD	MESH:D005473	Fluoxetine results in decreased expression of ICAM5 mRNA	PMID:17033635
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1312831	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in decreased expression of ICAM5 mRNA]	PMID:33448797
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1305039	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of ICAM5 mRNA	PMID:20080153
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ICAM5 mRNA	PMID:24810058
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:6682	mangiferin	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20120412	CTD	MESH:C013592	mangiferin results in decreased expression of ICAM5 mRNA	PMID:15135318
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312831	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ICAM5 mRNA	PMID:22206623
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of ICAM5 mRNA	PMID:36318118
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305039	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ICAM5 mRNA	PMID:32741896
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1312831	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of ICAM5 mRNA	PMID:26655953
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305039	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ICAM5 mRNA	PMID:24780913
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305039	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ICAM5 mRNA	PMID:19281266
1312830	ICAM5	intercellular adhesion molecule 5	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305039	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ICAM5 mRNA	PMID:19015723
1312832	SIX5	SIX homeobox 5	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SIX5 mRNA	PMID:38218311
1312832	SIX5	SIX homeobox 5	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SIX5 mRNA	PMID:38218311
1312832	SIX5	SIX homeobox 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SIX5 gene	PMID:20938992
1312832	SIX5	SIX homeobox 5	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SIX5 mRNA	PMID:30529165
1312832	SIX5	SIX homeobox 5	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SIX5 mRNA	PMID:26079696
1312832	SIX5	SIX homeobox 5	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of SIX5 mRNA	PMID:22574217
1312832	SIX5	SIX homeobox 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312833	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SIX5 mRNA	PMID:39298647
1312832	SIX5	SIX homeobox 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SIX5 gene	PMID:20938992
1312832	SIX5	SIX homeobox 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SIX5 mRNA	PMID:37042841
1312832	SIX5	SIX homeobox 5	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SIX5 mRNA	PMID:21179406
1312832	SIX5	SIX homeobox 5	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1312833	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SIX5 mRNA	PMID:28973375
1312832	SIX5	SIX homeobox 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305040	E	RGD:6480464	20130806	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SIX5 promoter	PMID:23359474
1312832	SIX5	SIX homeobox 5	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305040	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SIX5 mRNA	PMID:26577399
1312832	SIX5	SIX homeobox 5	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305040	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of SIX5 mRNA	PMID:22061828
1312832	SIX5	SIX homeobox 5	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SIX5 mRNA	PMID:28818685
1312832	SIX5	SIX homeobox 5	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of SIX5 mRNA	PMID:21120746
1312832	SIX5	SIX homeobox 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SIX5 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SIX5 mRNA	PMID:37236586|PMID:37325564
1312832	SIX5	SIX homeobox 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SIX5 gene	PMID:20938992
1312832	SIX5	SIX homeobox 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIX5 mRNA	PMID:40504410
1312832	SIX5	SIX homeobox 5	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SIX5 mRNA	PMID:26272509
1312832	SIX5	SIX homeobox 5	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA	PMID:27188386
1312832	SIX5	SIX homeobox 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SIX5 mRNA	PMID:23557933
1312832	SIX5	SIX homeobox 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312833	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SIX5 mRNA	PMID:21570461|PMID:24058054
1312832	SIX5	SIX homeobox 5	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SIX5 mRNA	PMID:29803840
1312832	SIX5	SIX homeobox 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIX5 mRNA	PMID:40504410
1312832	SIX5	SIX homeobox 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312833	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SIX5 mRNA	PMID:23735875
1312832	SIX5	SIX homeobox 5	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SIX5 mRNA]	PMID:22228805
1312832	SIX5	SIX homeobox 5	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of SIX5 mRNA	PMID:35984750
1312832	SIX5	SIX homeobox 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312833	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SIX5 gene	PMID:35295148
1312832	SIX5	SIX homeobox 5	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SIX5 mRNA	PMID:19710929
1312832	SIX5	SIX homeobox 5	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312833	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SIX5 promoter	PMID:27334623
1312832	SIX5	SIX homeobox 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of SIX5 mRNA	PMID:23146750
1312832	SIX5	SIX homeobox 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305040	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SIX5 mRNA	PMID:30816183
1312832	SIX5	SIX homeobox 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305040	E	RGD:6480464	20130806	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SIX5 promoter	PMID:23359474
1312832	SIX5	SIX homeobox 5	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312833	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SIX5 mRNA	PMID:25172293
1312832	SIX5	SIX homeobox 5	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of SIX5 mRNA	PMID:23146750
1312832	SIX5	SIX homeobox 5	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of SIX5 mRNA	PMID:23146750
1312832	SIX5	SIX homeobox 5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305040	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SIX5 mRNA	PMID:21266533
1312832	SIX5	SIX homeobox 5	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305040	E	RGD:6480464	20130806	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SIX5 promoter	PMID:23359474
1312832	SIX5	SIX homeobox 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SIX5 mRNA	PMID:37042841
1312832	SIX5	SIX homeobox 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SIX5 mRNA	PMID:38568856
1312832	SIX5	SIX homeobox 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SIX5 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SIX5 mRNA	PMID:37236586|PMID:37325564
1312832	SIX5	SIX homeobox 5	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SIX5 mRNA	PMID:23146750
1312832	SIX5	SIX homeobox 5	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SIX5 mRNA	PMID:24449571
1312832	SIX5	SIX homeobox 5	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of SIX5 mRNA	PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799
1312832	SIX5	SIX homeobox 5	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA	PMID:27188386
1312832	SIX5	SIX homeobox 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312833	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SIX5 mRNA	PMID:17562736
1312832	SIX5	SIX homeobox 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312833	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIX5 mRNA	PMID:40504410
1312832	SIX5	SIX homeobox 5	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of SIX5 mRNA	PMID:26272509
1312832	SIX5	SIX homeobox 5	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA	PMID:27188386
1312832	SIX5	SIX homeobox 5	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312833	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of SIX5 mRNA	PMID:19042947
1312832	SIX5	SIX homeobox 5	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312833	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of SIX5 mRNA	PMID:38701926
1312832	SIX5	SIX homeobox 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312833	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SIX5 mRNA	PMID:22206623
1312832	SIX5	SIX homeobox 5	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of SIX5 mRNA	PMID:36318118
1312832	SIX5	SIX homeobox 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA	PMID:27188386
1312832	SIX5	SIX homeobox 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SIX5 gene]	PMID:28238834
1312832	SIX5	SIX homeobox 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SIX5 mRNA	PMID:23146750
1312832	SIX5	SIX homeobox 5	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1312833	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of SIX5 mRNA	PMID:40826991
1312832	SIX5	SIX homeobox 5	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SIX5 mRNA	PMID:27188386
1312832	SIX5	SIX homeobox 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305040	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SIX5 mRNA	PMID:21346803
1312832	SIX5	SIX homeobox 5	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of SIX5 mRNA	PMID:22378314
1312832	SIX5	SIX homeobox 5	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SIX5 mRNA	PMID:27188386
1312832	SIX5	SIX homeobox 5	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312833	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of SIX5 mRNA	PMID:35537566
1312835	SNX22	sorting nexin 22	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SNX22 mRNA	PMID:37995155
1312835	SNX22	sorting nexin 22	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1614769	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNX22 gene	PMID:20938992
1312835	SNX22	sorting nexin 22	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SNX22 mRNA	PMID:23724009
1312835	SNX22	sorting nexin 22	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1614769	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SNX22 mRNA	PMID:24205000
1312835	SNX22	sorting nexin 22	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SNX22 mRNA	PMID:26079696
1312835	SNX22	sorting nexin 22	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614769	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SNX22 mRNA	PMID:39241906
1312835	SNX22	sorting nexin 22	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305042	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SNX22 mRNA	PMID:33387578
1312835	SNX22	sorting nexin 22	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1614769	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNX22 gene	PMID:20938992
1312835	SNX22	sorting nexin 22	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNX22 mRNA	PMID:37042841
1312835	SNX22	sorting nexin 22	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SNX22 mRNA	PMID:26079696
1312835	SNX22	sorting nexin 22	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SNX22 mRNA	PMID:28973375
1312835	SNX22	sorting nexin 22	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1614769	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SNX22 mRNA	PMID:23892564
1312835	SNX22	sorting nexin 22	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SNX22 mRNA	PMID:28818685
1312835	SNX22	sorting nexin 22	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1614769	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of SNX22 mRNA	PMID:39984025
1312835	SNX22	sorting nexin 22	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614769	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNX22 gene	PMID:20938992
1312835	SNX22	sorting nexin 22	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of SNX22 mRNA	PMID:38460933
1312835	SNX22	sorting nexin 22	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of SNX22 mRNA	PMID:38460933
1312835	SNX22	sorting nexin 22	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of SNX22 mRNA	PMID:40618947
1312835	SNX22	sorting nexin 22	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of SNX22 mRNA	PMID:27392435
1312835	SNX22	sorting nexin 22	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1614769	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SNX22 mRNA	PMID:30912803
1312835	SNX22	sorting nexin 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305042	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SNX22 mRNA	PMID:32109520
1312835	SNX22	sorting nexin 22	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNX22 mRNA	PMID:34032870
1312835	SNX22	sorting nexin 22	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SNX22 mRNA	PMID:40419235
1312835	SNX22	sorting nexin 22	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614769	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNX22 gene	PMID:35295148
1312835	SNX22	sorting nexin 22	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1614769	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of SNX22 mRNA	PMID:29264374
1312835	SNX22	sorting nexin 22	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1614769	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SNX22 gene	PMID:35295148
1312835	SNX22	sorting nexin 22	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305042	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SNX22 mRNA	PMID:25181051
1312835	SNX22	sorting nexin 22	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of SNX22 mRNA	PMID:29161229|PMID:32156529
1312835	SNX22	sorting nexin 22	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305042	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SNX22 mRNA	PMID:34947998
1312835	SNX22	sorting nexin 22	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SNX22 mRNA	PMID:36326898
1312835	SNX22	sorting nexin 22	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SNX22 mRNA	PMID:31533062
1312835	SNX22	sorting nexin 22	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SNX22 mRNA	PMID:25979313
1312835	SNX22	sorting nexin 22	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SNX22 mRNA	PMID:38832940
1312835	SNX22	sorting nexin 22	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614769	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNX22 mRNA	PMID:17562736
1312835	SNX22	sorting nexin 22	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of SNX22 mRNA	PMID:38460933
1312835	SNX22	sorting nexin 22	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of SNX22 mRNA]	PMID:21095227
1312835	SNX22	sorting nexin 22	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SNX22 mRNA	PMID:25554681
1312835	SNX22	sorting nexin 22	gene	CHEBI:6887	methylphenidate	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in decreased expression of SNX22 mRNA	PMID:22470460
1312835	SNX22	sorting nexin 22	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1614769	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SNX22 mRNA	PMID:22206623
1312835	SNX22	sorting nexin 22	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SNX22 gene]	PMID:28238834
1312835	SNX22	sorting nexin 22	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1614769	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SNX22 mRNA	PMID:38648751
1312835	SNX22	sorting nexin 22	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1614769	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of SNX22 mRNA	PMID:35537566
1312837	ZAN	zonadhesin	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312838	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZAN mRNA	PMID:33045310
1312837	ZAN	zonadhesin	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305044	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZAN mRNA]	PMID:31150632
1312837	ZAN	zonadhesin	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312838	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ZAN mRNA	PMID:20188158
1312837	ZAN	zonadhesin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312838	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ZAN mRNA	PMID:22401849
1312837	ZAN	zonadhesin	gene	CHEBI:17558	quercitrin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of ZAN mRNA	PMID:25193878
1312837	ZAN	zonadhesin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312838	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ZAN mRNA	PMID:34319233
1312837	ZAN	zonadhesin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312838	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZAN mRNA	PMID:37325564
1312837	ZAN	zonadhesin	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305044	E	RGD:6480464	20140729	CTD	MESH:C016517	indole-3-carbinol affects the expression of ZAN mRNA	PMID:21396975
1312837	ZAN	zonadhesin	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZAN intron	PMID:30157460
1312837	ZAN	zonadhesin	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305044	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ZAN mRNA	PMID:31150632
1312837	ZAN	zonadhesin	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305044	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZAN mRNA]	PMID:31150632
1312837	ZAN	zonadhesin	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ZAN mRNA	PMID:23557933
1312837	ZAN	zonadhesin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312838	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZAN mRNA	PMID:21570461
1312837	ZAN	zonadhesin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312838	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ZAN promoter]	PMID:19654925
1312837	ZAN	zonadhesin	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of ZAN mRNA	PMID:27188386
1312837	ZAN	zonadhesin	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312838	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ZAN protein	PMID:28918527
1312837	ZAN	zonadhesin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312838	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZAN mRNA	PMID:36209798
1312837	ZAN	zonadhesin	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312838	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of ZAN mRNA	PMID:37682722
1312837	ZAN	zonadhesin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312838	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZAN mRNA	PMID:20504355
1312837	ZAN	zonadhesin	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ZAN gene	PMID:25435355
1312837	ZAN	zonadhesin	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305044	E	RGD:6480464	20140729	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZAN mRNA	PMID:23411599
1312837	ZAN	zonadhesin	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZAN mRNA	PMID:28628672
1312837	ZAN	zonadhesin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312838	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ZAN gene	PMID:31683443
1312837	ZAN	zonadhesin	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZAN mRNA	PMID:28628672
1312837	ZAN	zonadhesin	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1312838	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZAN mRNA	PMID:24982889
1312837	ZAN	zonadhesin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312838	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZAN mRNA	PMID:37325564
1312837	ZAN	zonadhesin	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ZAN mRNA	PMID:24449571
1312837	ZAN	zonadhesin	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312838	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of ZAN mRNA	PMID:28962523
1312837	ZAN	zonadhesin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312838	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ZAN mRNA	PMID:40194260
1312837	ZAN	zonadhesin	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ZAN mRNA	PMID:28302478
1312837	ZAN	zonadhesin	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312838	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ZAN mRNA	PMID:39529242
1312837	ZAN	zonadhesin	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312838	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of ZAN mRNA	PMID:29038090
1312837	ZAN	zonadhesin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312838	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ZAN mRNA	PMID:17963808
1312837	ZAN	zonadhesin	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZAN mRNA	PMID:28628672
1312837	ZAN	zonadhesin	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZAN mRNA	PMID:28628672
1312837	ZAN	zonadhesin	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312838	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ZAN mRNA	PMID:19042947
1312837	ZAN	zonadhesin	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305044	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of ZAN mRNA	PMID:24136188
1312837	ZAN	zonadhesin	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305044	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ZAN mRNA	PMID:28801915
1312837	ZAN	zonadhesin	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312838	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ZAN mRNA	PMID:35537566
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of EMC7 mRNA	PMID:38218311
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312840	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of EMC7 mRNA	PMID:37995155
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312840	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of EMC7 mRNA	PMID:30319688
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312840	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EMC7 mRNA	PMID:33754040|PMID:34319233
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305045	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of EMC7 protein	PMID:34915118
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312840	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of EMC7 mRNA	PMID:27462272
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EMC7 mRNA	PMID:27153756
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312840	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EMC7 mRNA	PMID:22206623
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EMC7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EMC7 mRNA	PMID:39836092|PMID:40512198
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312840	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EMC7 mRNA	PMID:40504410
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1305045	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of EMC7 mRNA	PMID:26302742
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of EMC7 protein	PMID:39603559
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of EMC7 mRNA	PMID:33212167
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EMC7 mRNA	PMID:30851411
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305045	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of EMC7 mRNA	PMID:28959563
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in decreased expression of EMC7 protein	PMID:39571964
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EMC7 mRNA	PMID:38568856
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EMC7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EMC7 mRNA	PMID:39836092|PMID:40512198
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312840	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EMC7 mRNA	PMID:40504410
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to EMC7 mRNA]	PMID:32406909
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of EMC7 mRNA	PMID:38479592
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of EMC7 mRNA	PMID:30903817
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of EMC7 protein	PMID:34186270
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312840	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of EMC7 mRNA	PMID:26512966
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305045	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EMC7 mRNA	PMID:25181051
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312840	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of EMC7 mRNA	PMID:40203079
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of EMC7 protein	PMID:34186270
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of EMC7 protein	PMID:34186270
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305045	E	RGD:6480464	20141014	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EMC7 mRNA	PMID:21266533
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EMC7 mRNA	PMID:37042841
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of EMC7 protein	PMID:26879310
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of EMC7 mRNA	PMID:31533062
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of EMC7 mRNA	PMID:26352163
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EMC7 mRNA	PMID:23179753|PMID:29154799
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305045	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of EMC7 mRNA	PMID:24136188
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of EMC7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EMC7 mRNA	PMID:39836092|PMID:40512198
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312840	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EMC7 mRNA	PMID:40504410
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305045	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of EMC7 mRNA	PMID:24136188
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EMC7 protein	PMID:32959892
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312840	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EMC7 mRNA	PMID:22206623
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305045	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of EMC7 mRNA	PMID:24136188
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:78160	bleomycin A5	decreases expression	EXP		E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in decreased expression of EMC7 mRNA	PMID:21040473
1312839	EMC7	ER membrane protein complex subunit 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EMC7 mRNA	PMID:30851411
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312842	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of STK11IP mRNA	PMID:33045310
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of STK11IP; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STK11IP gene	PMID:20938992
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of STK11IP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of STK11IP mRNA	PMID:32699268
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:16130	DDT	increases methylation	ISO	RGD:1305046	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of STK11IP gene	PMID:30207508
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312842	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of STK11IP mRNA	PMID:30319688
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312842	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of STK11IP mRNA	PMID:39241906
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of STK11IP mRNA]	PMID:39241906
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of STK11IP; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STK11IP gene	PMID:20938992
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312842	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of STK11IP mRNA	PMID:34319233
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of STK11IP protein	PMID:37730182
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305046	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of STK11IP mRNA	PMID:33387578
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of STK11IP intron	PMID:30157460
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of STK11IP mRNA	PMID:23649840
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of STK11IP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of STK11IP mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of STK11IP mRNA	PMID:32699268
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312842	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of STK11IP mRNA	PMID:17484886
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STK11IP mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of STK11IP; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of STK11IP gene	PMID:20938992|PMID:22206623
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STK11IP mRNA	PMID:40512198
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STK11IP mRNA	PMID:40504410
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of STK11IP protein	PMID:35688186
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of STK11IP mRNA	PMID:23300844
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of STK11IP mRNA	PMID:27392435
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305046	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STK11IP mRNA	PMID:22298810
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312842	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STK11IP mRNA	PMID:21570461
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to STK11IP promoter]	PMID:19654925
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of STK11IP mRNA	PMID:29803840
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of STK11IP protein	PMID:35688186
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STK11IP mRNA	PMID:40512198
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STK11IP mRNA	PMID:40504410
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312842	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of STK11IP mRNA	PMID:35295148
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312842	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STK11IP gene	PMID:35295148
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305046	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of STK11IP mRNA	PMID:23411599
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305046	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of STK11IP mRNA	PMID:25181051
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312842	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of STK11IP mRNA	PMID:38685157
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of STK11IP mRNA]	PMID:39241906
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of STK11IP mRNA	PMID:37042841
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of STK11IP mRNA	PMID:38568856
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305046	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of STK11IP mRNA	PMID:24386269
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of STK11IP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of STK11IP mRNA	PMID:32699268
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312842	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of STK11IP mRNA	PMID:23811191
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312842	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of STK11IP mRNA	PMID:40194260
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312842	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of STK11IP mRNA	PMID:17963808
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of STK11IP mRNA	PMID:29154799
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312842	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of STK11IP mRNA	PMID:17562736
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STK11IP mRNA	PMID:40512198
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STK11IP mRNA	PMID:40504410
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305046	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of STK11IP mRNA	PMID:29391264
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of STK11IP mRNA	PMID:23300844
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312842	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of STK11IP mRNA	PMID:26307267
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STK11IP mRNA	PMID:22206623
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312842	E	RGD:6480464	20200519	CTD	MESH:D010634	Phenobarbital results in decreased expression of STK11IP mRNA	PMID:31836555
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312842	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of STK11IP mRNA]	PMID:39241906
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305046	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of STK11IP mRNA	PMID:21346803
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of STK11IP mRNA	PMID:29301935
1312841	STK11IP	serine/threonine kinase 11 interacting protein	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305046	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of STK11IP mRNA	PMID:23034163
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1550093	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of GCN1 mRNA	PMID:37995155
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550093	E	RGD:6480464	20190611	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GCN1 mRNA	PMID:20188158
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550093	E	RGD:6480464	20190611	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GCN1 gene	PMID:20938992
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550093	E	RGD:6480464	20190611	CTD	MESH:D000431	Ethanol affects the splicing of GCN1 mRNA	PMID:30319688
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550093	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GCN1 mRNA	PMID:39241906
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1593434	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of GCN1L1 protein	PMID:32145629
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of GCN1 mRNA	PMID:31614463
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550093	E	RGD:6480464	20190611	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GCN1 gene	PMID:20938992
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550093	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GCN1L1 mRNA	PMID:36331819
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1593434	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of GCN1 protein	PMID:34915118
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1550093	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of GCN1 mRNA	PMID:27462272
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550093	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCN1 mRNA	PMID:37236586
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GCN1 protein	PMID:23301498
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1550093	E	RGD:6480464	20190611	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GCN1 mRNA	PMID:19770486
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of GCN1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of GCN1 protein	PMID:38598786
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1593434	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of GCN1 mRNA	PMID:30779732
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550093	E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of GCN1 mRNA	PMID:17484886
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550093	E	RGD:6480464	20190611	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of GCN1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GCN1 gene	PMID:20938992|PMID:22206623
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of GCN1 mRNA	PMID:18414638
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550093	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCN1 mRNA	PMID:40504410
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D002945	Cisplatin results in decreased expression of GCN1 mRNA	PMID:27594783
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550093	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of GCN1 mRNA	PMID:30912803
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1593434	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GCN1 mRNA	PMID:33387578
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of GCN1 protein	PMID:39603559
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of GCN1 mRNA	PMID:39719251
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550093	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCN1 mRNA	PMID:40504410
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to GCN1 mRNA]	PMID:32406909
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1593434	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of GCN1L1 mRNA	PMID:30047161
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550093	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GCN1L1 gene	PMID:35295148
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1593434	E	RGD:6480464	20190611	CTD	MESH:C006253	pirinixic acid results in increased expression of GCN1 mRNA	PMID:19162173
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:33216	bisphenol A	affects binding	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A binds to GCN1 protein	PMID:23227178
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1593434	E	RGD:6480464	20190611	CTD	MESH:C006780	bisphenol A affects the expression of GCN1 mRNA	PMID:25181051
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of GCN1 protein	PMID:37567409
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1593434	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of GCN1 mRNA	PMID:33296240
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of GCN1 protein	PMID:34186270
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1593434	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of GCN1 mRNA	PMID:30816183
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1593434	E	RGD:6480464	20190611	CTD	MESH:C006780	bisphenol A results in increased methylation of GCN1 gene	PMID:28505145
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of GCN1 protein	PMID:31945527
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550093	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GCN1 mRNA	PMID:39298647
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of GCN1 protein	PMID:34186270
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of GCN1 protein	PMID:34186270
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of GCN1 protein	PMID:34186270
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of GCN1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of GCN1 protein	PMID:38598786
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GCN1 mRNA	PMID:37042841
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550093	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCN1 mRNA	PMID:37236586
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of GCN1 mRNA	PMID:19376846
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C000944	dicrotophos results in increased expression of GCN1 mRNA	PMID:28302478
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C100187	chloropicrin results in increased expression of GCN1 mRNA	PMID:26352163
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550093	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GCN1L1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of GCN1L1 mRNA	PMID:36331819
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GCN1 mRNA	PMID:25979313
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1593434	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of GCN1L1 mRNA	PMID:30047161
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of GCN1 mRNA	PMID:36621641
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550093	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of GCN1 mRNA	PMID:28973697
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008727	Methotrexate results in decreased expression of GCN1 mRNA	PMID:24449571
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of GCN1 mRNA	PMID:21420995
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1593434	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GCN1 mRNA	PMID:33387578
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of GCN1 mRNA	PMID:18414638
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550093	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCN1 mRNA	PMID:40504410
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1550093	E	RGD:6480464	20190611	CTD	MESH:C031180	chrysene results in increased expression of GCN1 mRNA	PMID:26377693
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1550093	E	RGD:6480464	20190611	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of GCN1 mRNA	PMID:23608068
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GCN1 protein	PMID:32959892
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:64227	ciglitazone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C039671	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of GCN1 mRNA	PMID:16197558
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1593434	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of GCN1 gene	PMID:35440735
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of GCN1 protein	PMID:34186270
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550093	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GCN1 mRNA	PMID:22206623
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550093	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of GCN1 mRNA	PMID:22206623
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of GCN1 protein	PMID:37664457
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1593434	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of GCN1L1 mRNA	PMID:30047161
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of GCN1 protein	PMID:37664457
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of GCN1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of GCN1 protein	PMID:38598786
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550093	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of GCN1 mRNA	PMID:28973697
1312843	GCN1	GCN1 activator of EIF2AK4	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1593434	E	RGD:6480464	20190611	CTD	MESH:C025643	vinclozolin results in decreased expression of GCN1 mRNA	PMID:23034163
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CYFIP2 mRNA	PMID:38218311
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312846	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CYFIP2 mRNA	PMID:33045310
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CYFIP2 mRNA	PMID:39752319
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYFIP2 mRNA	PMID:20938992
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of CYFIP2 mRNA	PMID:15894607|PMID:23724009|PMID:33167477
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in increased expression of CYFIP2 mRNA	PMID:15894607
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CYFIP2 mRNA	PMID:22378314
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of CYFIP2 mRNA	PMID:30319688
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of CYFIP2 mRNA; Hydrogen Peroxide results in increased expression of CYFIP2 protein	PMID:39667565
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:D006861	CYFIP2 protein inhibits the reaction [epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein]]; CYFIP2 protein inhibits the reaction [epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT2 protein]]; CYFIP2 protein inhibits the reaction [epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT3 protein]]; CYFIP2 protein promotes the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein]; CYFIP2 protein promotes the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT2 protein]; CYFIP2 protein promotes the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT3 protein]; epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in increased expression of CYFIP2 mRNA]; epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in increased expression of CYFIP2 protein]	PMID:39667565
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312846	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CYFIP2 mRNA	PMID:39241906
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of CYFIP2 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of CYFIP2 mRNA	PMID:20660070|PMID:30165855
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of CYFIP2 mRNA	PMID:33711761
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CYFIP2 mRNA	PMID:38568856
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYFIP2 mRNA	PMID:20938992
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CYFIP2 mRNA	PMID:23649840
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of CYFIP2 mRNA	PMID:20864642
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of CYFIP2 mRNA	PMID:20660070
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CYFIP2 mRNA	PMID:21179406
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CYFIP2 mRNA	PMID:26079696
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of CYFIP2 mRNA	PMID:39922521
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CYFIP2 mRNA	PMID:39752319
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of CYFIP2 mRNA	PMID:39922521
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305048	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CYFIP2 mRNA	PMID:22061828
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CYFIP2 intron	PMID:30157460
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1305048	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of CYFIP2 mRNA	PMID:28522335
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:211249	Ampullosporin	multiple interactions	ISO	RGD:1305048	E	RGD:6480464	20240806	CTD	MESH:C109004	[ampullosporin co-treated with Ketamine] results in decreased expression of CYFIP2 mRNA	PMID:16635253
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYFIP2 mRNA	PMID:29950665
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CYFIP2 mRNA	PMID:23649840
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305048	E	RGD:6480464	20130806	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYFIP2 mRNA	PMID:22129741
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CYFIP2 protein	PMID:20106945
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CYFIP2 mRNA	PMID:21632981|PMID:21641981
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CYFIP2 gene; Aflatoxin B1 results in increased methylation of CYFIP2 intron	PMID:27153756|PMID:30157460
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CYFIP2 mRNA	PMID:23649840
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYFIP2 mRNA	PMID:20938992
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYFIP2 mRNA	PMID:32525701
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of CYFIP2 protein	PMID:38460933
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305048	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CYFIP2 mRNA	PMID:31881176
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of CYFIP2 mRNA	PMID:27594783
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CYFIP2 mRNA	PMID:27392435
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in decreased expression of CYFIP2 mRNA	PMID:21858171
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CYFIP2 mRNA	PMID:30912803
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312846	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of CYFIP2 mRNA	PMID:18930951
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CYFIP2 mRNA	PMID:24768652|PMID:25583101
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312846	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CYFIP2 mRNA	PMID:26377647
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305048	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CYFIP2 mRNA	PMID:34747641
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305048	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYFIP2 mRNA	PMID:20959002|PMID:21215274|PMID:32109520
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312846	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYFIP2 mRNA	PMID:19759094|PMID:19770486|PMID:19933214|PMID:25270620|PMID:26290441
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of CYFIP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CYFIP2 mRNA; AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYFIP2 mRNA]	PMID:16214954|PMID:19759094|PMID:25975270
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305048	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of CYFIP2 mRNA	PMID:28374803
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CYFIP2 mRNA	PMID:28001369
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20180703	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CYFIP2 mRNA	PMID:29261810
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CYFIP2 mRNA	PMID:33212167
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20180703	CTD	MESH:D020106	Acrylamide results in decreased expression of CYFIP2 mRNA	PMID:29261810
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305048	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CYFIP2 mRNA	PMID:28959563
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CYFIP2 mRNA	PMID:29803840
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of CYFIP2 mRNA; sodium arsenite results in decreased expression of CYFIP2 protein	PMID:30528433|PMID:38568856
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CYFIP2 5' UTR; Benzo(a)pyrene affects the methylation of CYFIP2 promoter	PMID:27901495
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CYFIP2 exon	PMID:27901495
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CYFIP2 mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312846	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CYFIP2 mRNA	PMID:19770486|PMID:21715664|PMID:32417428
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of CYFIP2 mRNA	PMID:25075043
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312846	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CYFIP2 mRNA	PMID:29203145
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CYFIP2 mRNA	PMID:20382639
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CYFIP2 mRNA	PMID:15894607
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of CYFIP2 mRNA	PMID:38568856
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305048	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CYFIP2 mRNA	PMID:25729387
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1305048	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of CYFIP2 mRNA	PMID:30012374
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYFIP2 mRNA	PMID:29950665
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305048	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CYFIP2 mRNA	PMID:23411599|PMID:34492290
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1305048	E	RGD:6480464	20130806	CTD	MESH:C006253	pirinixic acid results in increased expression of CYFIP2 mRNA	PMID:19162173
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312846	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CYFIP2 mRNA	PMID:20813756
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYFIP2 mRNA	PMID:19710929
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305048	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CYFIP2 mRNA	PMID:25181051
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305048	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of CYFIP2 mRNA; bisphenol A results in decreased expression of CYFIP2 protein	PMID:24552547|PMID:35192832
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in decreased expression of CYFIP2 mRNA	PMID:39742910
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CYFIP2 gene	PMID:31601247
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305048	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of CYFIP2 mRNA	PMID:32145629
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305048	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CYFIP2 gene	PMID:28505145
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CYFIP2 mRNA	PMID:25979313
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of CYFIP2 mRNA	PMID:26682919
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305048	E	RGD:6480464	20130806	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYFIP2 mRNA	PMID:20959002
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of CYFIP2 intron	PMID:30157460
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYFIP2 mRNA	PMID:29950665
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305048	E	RGD:6480464	20130806	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CYFIP2 mRNA	PMID:22129741
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305048	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of CYFIP2 gene	PMID:33148267
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CYFIP2 mRNA	PMID:37042841
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305048	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CYFIP2 mRNA	PMID:30589522
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305048	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of CYFIP2 mRNA	PMID:35163327
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CYFIP2 mRNA	PMID:38568856
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CYFIP2 mRNA	PMID:19320972
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CYFIP2 mRNA	PMID:24449571
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312846	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CYFIP2 mRNA	PMID:40194260
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:38922	dibenzofurans	increases expression	ISO	RGD:1312846	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in increased expression of CYFIP2 mRNA	PMID:34254344
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of CYFIP2 mRNA	PMID:19167446
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of CYFIP2 mRNA	PMID:29038090
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CYFIP2 mRNA	PMID:25979313
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CYFIP2 mRNA	PMID:19101580|PMID:23179753|PMID:27188386
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312846	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of CYFIP2 mRNA	PMID:21427059
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CYFIP2 gene	PMID:29154799
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of CYFIP2 mRNA	PMID:17183730
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CYFIP2 mRNA	PMID:25562108|PMID:27989131
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in increased expression of CYFIP2 mRNA	PMID:19159671|PMID:22147139
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of CYFIP2 mRNA	PMID:39922521
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CYFIP2 mRNA	PMID:26272509
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYFIP2 mRNA	PMID:27188386
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CYFIP2 mRNA	PMID:22230336
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	CYFIP2 protein affects the susceptibility to Fluorouracil	PMID:16217747
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of CYFIP2 mRNA	PMID:17039268|PMID:17982676
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of CYFIP2 mRNA]	PMID:15016801|PMID:17982676
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of CYFIP2 mRNA	PMID:24714768
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46742	Nutlin-3	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of CYFIP2 mRNA	PMID:38460933
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of CYFIP2 protein	PMID:38460933
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYFIP2 mRNA	PMID:32525701
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1312846	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of CYFIP2 mRNA	PMID:30529165
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305048	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CYFIP2 mRNA	PMID:29391264
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20250805	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of CYFIP2 mRNA	PMID:39667565
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:C045651	CYFIP2 protein inhibits the reaction [epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT1 protein]]; CYFIP2 protein inhibits the reaction [epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT2 protein]]; CYFIP2 protein inhibits the reaction [epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of AKT3 protein]]; epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in increased expression of CYFIP2 mRNA]; epigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in increased expression of CYFIP2 protein]	PMID:39667565
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CYFIP2 mRNA	PMID:35436446
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1305048	E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of CYFIP2 mRNA	PMID:37567419
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in decreased expression of CYFIP2 mRNA	PMID:17211630|PMID:38568856
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of CYFIP2 mRNA	PMID:15894607
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:50035	alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of CYFIP2 mRNA	PMID:25075043
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CYFIP2 mRNA; Nanotubes, Carbon results in decreased expression of CYFIP2 mRNA	PMID:25554681
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312846	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CYFIP2 mRNA	PMID:19042947
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of CYFIP2 mRNA	PMID:17183730
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CYFIP2 protein	PMID:32959892
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:6121	ketamine	multiple interactions	ISO	RGD:1305048	E	RGD:6480464	20240806	CTD	MESH:D007649	[ampullosporin co-treated with Ketamine] results in decreased expression of CYFIP2 mRNA	PMID:16635253
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305048	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CYFIP2 mRNA	PMID:25729387
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of CYFIP2 mRNA	PMID:19812364
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312846	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of CYFIP2 mRNA	PMID:25270620
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305048	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of CYFIP2 mRNA	PMID:24136188
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of CYFIP2 intron	PMID:30157460
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305048	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of CYFIP2 gene	PMID:33148267
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CYFIP2 mRNA	PMID:39752319
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312846	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CYFIP2 mRNA	PMID:22206623
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CYFIP2 mRNA	PMID:22714537
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of CYFIP2 mRNA	PMID:32858204
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYFIP2 mRNA	PMID:27188386
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CYFIP2 gene]	PMID:28238834
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312846	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of CYFIP2 mRNA	PMID:19482888
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in decreased expression of CYFIP2 mRNA	PMID:21858171
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CYFIP2 mRNA	PMID:32525701
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1305048	E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of CYFIP2 mRNA	PMID:26923065
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305048	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CYFIP2 mRNA	PMID:24780913
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312846	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of CYFIP2 mRNA	PMID:39752319
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYFIP2 mRNA	PMID:27188386
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CYFIP2 mRNA	PMID:38568856
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305048	E	RGD:6480464	20130806	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CYFIP2 mRNA	PMID:21346803
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312846	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CYFIP2 mRNA	PMID:35537566
1312845	CYFIP2	cytoplasmic FMR1 interacting protein 2	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305048	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of CYFIP2 mRNA	PMID:23869203
1312847	FBXO16	F-box protein 16	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of FBXO16 mRNA	PMID:27188386
1312847	FBXO16	F-box protein 16	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312848	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FBXO16 mRNA	PMID:33045310
1312847	FBXO16	F-box protein 16	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FBXO16 mRNA	PMID:33167477
1312847	FBXO16	F-box protein 16	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of FBXO16 mRNA	PMID:26079696
1312847	FBXO16	F-box protein 16	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FBXO16 mRNA	PMID:35811015
1312847	FBXO16	F-box protein 16	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FBXO16 mRNA	PMID:35811015
1312847	FBXO16	F-box protein 16	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of FBXO16 mRNA	PMID:31614463
1312847	FBXO16	F-box protein 16	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305049	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FBXO16 mRNA	PMID:32741896
1312847	FBXO16	F-box protein 16	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1312848	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of FBXO16 mRNA	PMID:33711761
1312847	FBXO16	F-box protein 16	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305049	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FBXO16 mRNA	PMID:33387578
1312847	FBXO16	F-box protein 16	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of FBXO16 mRNA	PMID:27905399
1312847	FBXO16	F-box protein 16	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305049	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FBXO16 mRNA	PMID:32741896
1312847	FBXO16	F-box protein 16	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305049	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of FBXO16 mRNA	PMID:26577399
1312847	FBXO16	F-box protein 16	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of FBXO16 mRNA	PMID:17103032
1312847	FBXO16	F-box protein 16	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FBXO16 mRNA	PMID:19549813
1312847	FBXO16	F-box protein 16	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of FBXO16 mRNA	PMID:23649840
1312847	FBXO16	F-box protein 16	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FBXO16 mRNA	PMID:22100608
1312847	FBXO16	F-box protein 16	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FBXO16 mRNA	PMID:23649840
1312847	FBXO16	F-box protein 16	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of FBXO16 mRNA	PMID:19774075
1312847	FBXO16	F-box protein 16	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA	PMID:27188386
1312847	FBXO16	F-box protein 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305049	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXO16 mRNA	PMID:22298810
1312847	FBXO16	F-box protein 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305049	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBXO16 mRNA	PMID:33387578
1312847	FBXO16	F-box protein 16	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FBXO16 mRNA	PMID:28001369
1312847	FBXO16	F-box protein 16	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1305049	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of FBXO16 mRNA	PMID:27257137
1312847	FBXO16	F-box protein 16	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of FBXO16 mRNA	PMID:34032870
1312847	FBXO16	F-box protein 16	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312848	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXO16 mRNA	PMID:37682722
1312847	FBXO16	F-box protein 16	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of FBXO16 mRNA	PMID:22378314
1312847	FBXO16	F-box protein 16	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of FBXO16 gene	PMID:31601247
1312847	FBXO16	F-box protein 16	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312848	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of FBXO16 mRNA	PMID:18648102
1312847	FBXO16	F-box protein 16	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FBXO16 gene	PMID:31601247
1312847	FBXO16	F-box protein 16	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305049	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FBXO16 gene	PMID:28505145
1312847	FBXO16	F-box protein 16	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of FBXO16 gene	PMID:31601247
1312847	FBXO16	F-box protein 16	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312848	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of FBXO16 intron	PMID:28392331
1312847	FBXO16	F-box protein 16	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312848	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of FBXO16 mRNA	PMID:21266533
1312847	FBXO16	F-box protein 16	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXO16 mRNA	PMID:38382870
1312847	FBXO16	F-box protein 16	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FBXO16 mRNA	PMID:31533062
1312847	FBXO16	F-box protein 16	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FBXO16 mRNA	PMID:25979313
1312847	FBXO16	F-box protein 16	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXO16 mRNA	PMID:23179753|PMID:26272509
1312847	FBXO16	F-box protein 16	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FBXO16 gene	PMID:29154799
1312847	FBXO16	F-box protein 16	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXO16 mRNA	PMID:29154799
1312847	FBXO16	F-box protein 16	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA	PMID:27188386
1312847	FBXO16	F-box protein 16	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FBXO16 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1312847	FBXO16	F-box protein 16	gene	CHEBI:43572	kojic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of FBXO16 mRNA	PMID:16595896
1312847	FBXO16	F-box protein 16	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of FBXO16 mRNA	PMID:26272509
1312847	FBXO16	F-box protein 16	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA	PMID:27188386
1312847	FBXO16	F-box protein 16	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of FBXO16 mRNA	PMID:28542535
1312847	FBXO16	F-box protein 16	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of FBXO16 mRNA	PMID:24935251|PMID:26272509
1312847	FBXO16	F-box protein 16	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA	PMID:27188386
1312847	FBXO16	F-box protein 16	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305049	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of FBXO16 mRNA	PMID:33387578
1312847	FBXO16	F-box protein 16	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FBXO16 mRNA	PMID:35811015
1312847	FBXO16	F-box protein 16	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305049	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of FBXO16 mRNA	PMID:29391264
1312847	FBXO16	F-box protein 16	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312848	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of FBXO16 mRNA	PMID:38701926
1312847	FBXO16	F-box protein 16	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305049	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of FBXO16 mRNA	PMID:32741896
1312847	FBXO16	F-box protein 16	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA	PMID:27188386
1312847	FBXO16	F-box protein 16	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of FBXO16 mRNA	PMID:19095052
1312847	FBXO16	F-box protein 16	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1305049	E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of FBXO16 mRNA	PMID:29162477
1312847	FBXO16	F-box protein 16	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO16 mRNA	PMID:27188386
1312847	FBXO16	F-box protein 16	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305049	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of FBXO16 mRNA	PMID:22570695
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ARHGAP18 mRNA	PMID:33045310
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of ARHGAP18 mRNA	PMID:21934132
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ARHGAP18 mRNA	PMID:33167477
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312853	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ARHGAP18 mRNA	PMID:30319688
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ARHGAP18 mRNA	PMID:18951874
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ARHGAP18 mRNA	PMID:21632981
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARHGAP18 mRNA	PMID:35811015
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARHGAP18 mRNA	PMID:39241906
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARHGAP18 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ARHGAP18 mRNA	PMID:35811015
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ARHGAP18 mRNA	PMID:31614463
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of ARHGAP18 mRNA	PMID:20404318
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312853	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ARHGAP18 mRNA	PMID:33711761
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1305053	E	RGD:6480464	20120412	CTD	MESH:D014241	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ARHGAP18 mRNA	PMID:17905399
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARHGAP18 mRNA	PMID:37042841
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:16716	benzene	multiple interactions	ISO	RGD:1305053	E	RGD:6480464	20120412	CTD	MESH:D001554	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ARHGAP18 mRNA	PMID:17905399
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ARHGAP18 mRNA	PMID:23649840
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of ARHGAP18 mRNA	PMID:20864642
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ARHGAP18 mRNA	PMID:33359661
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ARHGAP18 mRNA	PMID:34319233
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ARHGAP18 mRNA; Diethylhexyl Phthalate results in increased expression of ARHGAP18 protein	PMID:31163220
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA	PMID:39150890
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305053	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ARHGAP18 mRNA	PMID:22061828
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ARHGAP18 mRNA	PMID:19549813
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ARHGAP18 mRNA	PMID:23649840
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305053	E	RGD:6480464	20130312	CTD	MESH:C016517	indole-3-carbinol affects the expression of ARHGAP18 mRNA	PMID:21396975
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ARHGAP18 mRNA	PMID:23649840
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305053	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of ARHGAP18 mRNA	PMID:30779732
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ARHGAP18 mRNA	PMID:17484886
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP18 mRNA	PMID:39836092
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ARHGAP18 mRNA	PMID:26272509
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ARHGAP18 protein	PMID:35688186
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ARHGAP18 mRNA	PMID:30912803
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of ARHGAP18 mRNA	PMID:18930951
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28088	genistein	decreases methylation	ISO	RGD:1305053	E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in decreased methylation of ARHGAP18 gene	PMID:28505145
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28088	genistein	increases methylation	ISO	RGD:1305053	E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of ARHGAP18 gene	PMID:28505145
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305053	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGAP18 mRNA	PMID:34747641
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGAP18 mRNA	PMID:20106945
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGAP18 mRNA	PMID:19933214
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ARHGAP18 mRNA	PMID:17942748
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ARHGAP18 mRNA	PMID:28001369
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of ARHGAP18 mRNA	PMID:23649840
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1305053	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of ARHGAP18 mRNA	PMID:30556269
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARHGAP18 mRNA	PMID:29803840
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARHGAP18 mRNA	PMID:39631538
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of ARHGAP18 protein	PMID:35688186
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:28876	melphalan	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of ARHGAP18 mRNA	PMID:22363485
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARHGAP18 mRNA	PMID:20371982|PMID:38568856
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGAP18 mRNA	PMID:22714537
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP18 mRNA	PMID:39836092
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARHGAP18 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1305053	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of ARHGAP18 mRNA	PMID:30556269
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ARHGAP18 mRNA	PMID:25895662
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of ARHGAP18 mRNA	PMID:20382639
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ARHGAP18 mRNA	PMID:19150397
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ARHGAP18 mRNA	PMID:27829220
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ARHGAP18 gene	PMID:31601247
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305053	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of ARHGAP18 mRNA	PMID:24136188
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305053	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ARHGAP18 mRNA	PMID:34492290
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305053	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ARHGAP18 mRNA	PMID:23411599
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARHGAP18 mRNA	PMID:19710929
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312853	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ARHGAP18 mRNA	PMID:28472532
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ARHGAP18 mRNA	PMID:30903817
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305053	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARHGAP18 mRNA	PMID:25181051
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of ARHGAP18 gene	PMID:31601247
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP18 mRNA	PMID:29275510
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305053	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP18 mRNA	PMID:34947998
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGAP18 protein	PMID:34186270
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312853	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGAP18 mRNA	PMID:34585602
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305053	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ARHGAP18 gene	PMID:28505145
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ARHGAP18 gene	PMID:31601247
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ARHGAP18 mRNA	PMID:25979313
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA	PMID:39150890
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305053	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARHGAP18 mRNA	PMID:21266533
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312853	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARHGAP18 mRNA	PMID:17361019|PMID:21266533
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA	PMID:39150890
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA	PMID:39150890
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARHGAP18 mRNA	PMID:37042841
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARHGAP18 mRNA	PMID:26472689
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA	PMID:39150890
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ARHGAP18 protein	PMID:26879310
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305053	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ARHGAP18 mRNA	PMID:25539665
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ARHGAP18 mRNA	PMID:19320972
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305053	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ARHGAP18 mRNA	PMID:24386269
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ARHGAP18 mRNA	PMID:24449571
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:37825	p-toluidine	increases expression	ISO	RGD:1305053	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of ARHGAP18 mRNA	PMID:27638505
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312853	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ARHGAP18 mRNA	PMID:40194260
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ARHGAP18 mRNA	PMID:28302478
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ARHGAP18 mRNA	PMID:31533062
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARHGAP18 mRNA	PMID:25979313
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ARHGAP18 mRNA	PMID:23179753|PMID:23527032|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ARHGAP18 mRNA	PMID:25562108
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ARHGAP18 mRNA	PMID:17555576
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312853	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ARHGAP18 mRNA	PMID:28973697
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of ARHGAP18 mRNA	PMID:23649840
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ARHGAP18 mRNA	PMID:26272509|PMID:27188386
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ARHGAP18 mRNA	PMID:24935251|PMID:26272509
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGAP18 mRNA	PMID:21420995
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305053	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGAP18 mRNA	PMID:33387578
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of ARHGAP18 mRNA	PMID:20977926
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARHGAP18 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ARHGAP18 mRNA	PMID:35811015
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP18 mRNA	PMID:39836092
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305053	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ARHGAP18 mRNA	PMID:29391264
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGAP18 mRNA	PMID:22079256
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ARHGAP18 mRNA	PMID:17555576
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARHGAP18 mRNA	PMID:17942748
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ARHGAP18 mRNA	PMID:17942748
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of ARHGAP18 mRNA	PMID:26272509
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:49747	methylmercury(1+)	multiple interactions	ISO	RGD:1305053	E	RGD:6480464	20120412	CTD	MESH:C030957	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ARHGAP18 mRNA	PMID:17905399
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ARHGAP18 mRNA	PMID:27829220
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARHGAP18 mRNA; Nanotubes, Carbon results in decreased expression of ARHGAP18 mRNA	PMID:25620056
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ARHGAP18 mRNA	PMID:22714537
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ARHGAP18 protein	PMID:32959892
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARHGAP18 mRNA	PMID:21641980
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of ARHGAP18 mRNA	PMID:20003209
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305053	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ARHGAP18 gene	PMID:35440735
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ARHGAP18 protein	PMID:34186270
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ARHGAP18 mRNA	PMID:22206623
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ARHGAP18 mRNA	PMID:22079256
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ARHGAP18 mRNA	PMID:22079256
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1305053	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of ARHGAP18 mRNA	PMID:33484710
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1312853	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ARHGAP18 mRNA	PMID:39150890
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312853	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ARHGAP18 mRNA	PMID:23091169
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1312853	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of ARHGAP18 mRNA	PMID:31388691
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1312853	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of ARHGAP18 mRNA	PMID:27029645
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of ARHGAP18 mRNA	PMID:26272509
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP18 mRNA	PMID:27188386
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305053	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ARHGAP18 mRNA	PMID:21346803
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1305053	E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in decreased expression of ARHGAP18 mRNA	PMID:26141394
1312852	ARHGAP18	Rho GTPase activating protein 18	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of ARHGAP18 mRNA	PMID:27188386
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312855	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DNTT mRNA	PMID:33045310
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DNTT mRNA	PMID:36331819
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DNTT mRNA	PMID:39298647
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of DNTT mRNA	PMID:37992649
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of DNTT mRNA	PMID:21669218
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of DNTT mRNA	PMID:37992649
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DNTT mRNA	PMID:36331819
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of DNTT mRNA	PMID:15674844
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of DNTT mRNA	PMID:12763052
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of DNTT mRNA	PMID:40618947
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312855	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DNTT mRNA	PMID:26377647
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20130416	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNTT mRNA	PMID:16102516|PMID:8122269
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNTT mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to DNTT promoter]	PMID:17942748|PMID:19654925
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of DNTT mRNA	PMID:37992649
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DNTT 3' UTR; Benzo(a)pyrene results in increased methylation of DNTT promoter	PMID:27901495
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of DNTT gene	PMID:31601247
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in decreased expression of DNTT mRNA	PMID:22609695
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of DNTT mRNA	PMID:27760801
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of DNTT mRNA	PMID:20813756|PMID:23811191
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of DNTT mRNA	PMID:20813756
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305054	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DNTT mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DNTT mRNA	PMID:39298647
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of DNTT gene	PMID:31601247
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of DNTT mRNA	PMID:28392331
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312855	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of DNTT mRNA	PMID:24535843
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of DNTT mRNA	PMID:17585979
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312855	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DNTT mRNA	PMID:40194260
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DNTT mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DNTT mRNA	PMID:36331819
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20120515	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of DNTT mRNA	PMID:21041162
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of DNTT mRNA	PMID:25123088
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of DNTT mRNA	PMID:21041162
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of DNTT mRNA	PMID:21041162
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of DNTT mRNA	PMID:37992649
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DNTT mRNA	PMID:17942748
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNTT mRNA	PMID:17942748
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312855	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DNTT mRNA	PMID:25620056
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:5277	gardenoside	decreases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:C056587	gardenoside results in decreased expression of DNTT mRNA	PMID:37588187
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:5277	gardenoside	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C056587	gardenoside inhibits the reaction [FOXO3A protein binds to DNTT promoter]	PMID:37588187
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20180703	CTD	MESH:D010081	Oxazolone results in decreased expression of DNTT mRNA	PMID:21404309
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:53556	toluene 2,4-diisocyanate	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20180703	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in decreased expression of DNTT mRNA	PMID:21404309
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of DNTT mRNA	PMID:19812364
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DNTT gene]	PMID:28238834
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of DNTT mRNA	PMID:19482888
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312855	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of DNTT mRNA]	PMID:19482888
1312854	DNTT	DNA nucleotidylexotransferase	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312855	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DNTT mRNA	PMID:38648751
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ATP6V0A4 mRNA	PMID:38218311
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ATP6V0A4 mRNA	PMID:38218311
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ATP6V0A4 mRNA	PMID:36189433
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of ATP6V0A4 mRNA	PMID:25321415|PMID:31614463
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305055	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ATP6V0A4 mRNA	PMID:33387578
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ATP6V0A4 mRNA	PMID:26079696
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ATP6V0A4 mRNA	PMID:36189433
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ATP6V0A4 mRNA	PMID:36189433
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of ATP6V0A4 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of ATP6V0A4 mRNA]	PMID:20230807
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305055	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ATP6V0A4 mRNA	PMID:27523638
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305055	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ATP6V0A4 mRNA	PMID:26577399
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305055	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ATP6V0A4 mRNA	PMID:22061828
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of ATP6V0A4 mRNA	PMID:20230807
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20120501	CTD	MESH:D015632	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of ATP6V0A4 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of ATP6V0A4 mRNA]	PMID:20230807
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATP6V0A4 mRNA	PMID:36331819
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of ATP6V0A4 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of ATP6V0A4 mRNA]	PMID:20230807
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V0A4 mRNA	PMID:29950665
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ATP6V0A4 gene; Aflatoxin B1 results in increased methylation of ATP6V0A4 promoter	PMID:27153756|PMID:30157460
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:27470	folic acid	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of ATP6V0A4 mRNA	PMID:21867686
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ATP6V0A4 mRNA	PMID:23557933
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of ATP6V0A4 mRNA	PMID:32186404
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ATP6V0A4 mRNA	PMID:24768652|PMID:25583101
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012402	Rotenone results in increased expression of ATP6V0A4 mRNA	PMID:31648047
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ATP6V0A4 mRNA	PMID:33212167
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATP6V0A4 mRNA	PMID:37682722
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ATP6V0A4 mRNA	PMID:29301061|PMID:38568856
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATP6V0A4 5' UTR; Benzo(a)pyrene affects the methylation of ATP6V0A4 intron	PMID:27901495|PMID:30157460
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ATP6V0A4 exon	PMID:27901495
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312857	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ATP6V0A4 exon; Benzo(a)pyrene results in decreased methylation of ATP6V0A4 intron	PMID:27901495
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312857	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of ATP6V0A4 mRNA	PMID:35295148
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V0A4 mRNA	PMID:29950665
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312857	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ATP6V0A4 mRNA	PMID:20813756
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305055	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ATP6V0A4 mRNA	PMID:25181051
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in decreased expression of ATP6V0A4 mRNA	PMID:38701888
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305055	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ATP6V0A4 mRNA	PMID:34947998
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312857	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ATP6V0A4 mRNA	PMID:32156529
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305055	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ATP6V0A4 gene	PMID:28505145
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ATP6V0A4 mRNA	PMID:26682919
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ATP6V0A4 mRNA	PMID:40203079
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in decreased expression of ATP6V0A4 mRNA]	PMID:40203079
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ATP6V0A4 intron	PMID:30157460
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1312857	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of ATP6V0A4 mRNA	PMID:26377693
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V0A4 mRNA	PMID:29950665
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate results in increased expression of ATP6V0A4 mRNA	PMID:29024780
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20210309	CTD	MESH:C023036	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of ATP6V0A4 mRNA	PMID:33325755
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312857	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ATP6V0A4 mRNA	PMID:28903501
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312857	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ATP6V0A4 mRNA	PMID:40194260
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ATP6V0A4 mRNA	PMID:39529242
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312857	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATP6V0A4 mRNA	PMID:36331819
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ATP6V0A4 mRNA	PMID:24383497|PMID:26272509
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0A4 mRNA	PMID:27188386
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305055	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ATP6V0A4 mRNA	PMID:41580965
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ATP6V0A4 mRNA	PMID:24935251
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of ATP6V0A4 mRNA	PMID:24714768
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of ATP6V0A4 mRNA	PMID:40706910
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:1312857	E	RGD:6480464	20200804	CTD	MESH:D002101	Cacodylic Acid results in increased expression of ATP6V0A4 mRNA	PMID:32052077
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:4911	etoposide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	ATP6V0A4 protein affects the susceptibility to Etoposide	PMID:16217747
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305055	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ATP6V0A4 mRNA	PMID:30307764
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312857	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ATP6V0A4 mRNA; Nanotubes, Carbon results in increased expression of ATP6V0A4 mRNA	PMID:25554681
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1312857	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of ATP6V0A4 mRNA	PMID:26377693
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312857	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ATP6V0A4 mRNA	PMID:23608068
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312857	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of ATP6V0A4 mRNA	PMID:36851058
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ATP6V0A4 intron	PMID:30157460
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305055	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ATP6V0A4 gene	PMID:35440735
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ATP6V0A4 mRNA	PMID:22714537
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:75253	phenylarsine oxide	increases expression	ISO	RGD:1312857	E	RGD:6480464	20251007	CTD	MESH:C029341	oxophenylarsine results in increased expression of ATP6V0A4 mRNA	PMID:37699712
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:76989	phytoestrogen	multiple interactions	EXP		E	RGD:6480464	20210309	CTD	MESH:D048789	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of ATP6V0A4 mRNA	PMID:33325755
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0A4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0A4 mRNA	PMID:27188386
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATP6V0A4 gene]	PMID:28238834
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312857	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ATP6V0A4 mRNA	PMID:38648751
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305055	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ATP6V0A4 mRNA	PMID:24780913
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of ATP6V0A4 mRNA	PMID:26272509
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0A4 mRNA	PMID:27188386
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0A4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0A4 mRNA	PMID:27188386
1312856	ATP6V0A4	ATPase H+ transporting V0 subunit a4	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1305055	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of ATP6V0A4 protein	PMID:32519852
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of NAGK mRNA	PMID:38218311
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312860	E	RGD:6480464	20171010	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of NAGK mRNA	PMID:28558994
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of NAGK mRNA	PMID:33167477
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NAGK mRNA	PMID:36331819
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of NAGK mRNA	PMID:39241906
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of NAGK mRNA]	PMID:39241906
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of NAGK mRNA	PMID:23649840
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAGK mRNA	PMID:37992649
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAGK mRNA	PMID:37992649
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312860	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of NAGK mRNA	PMID:23892564
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of NAGK protein	PMID:37730182
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305057	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NAGK mRNA	PMID:33387578
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NAGK mRNA	PMID:36331819
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NAGK mRNA	PMID:19549813
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of NAGK mRNA	PMID:23649840
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NAGK mRNA	PMID:23649840
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of NAGK protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of NAGK protein	PMID:38598786
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312860	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NAGK mRNA	PMID:31919559
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NAGK mRNA	PMID:40504410
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of NAGK mRNA	PMID:19244175
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of NAGK mRNA	PMID:26272509
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAGK mRNA	PMID:27188386
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NAGK mRNA	PMID:23557933
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of NAGK mRNA	PMID:27594783
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of NAGK mRNA	PMID:23195993
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312860	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NAGK mRNA	PMID:21570461
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305057	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NAGK mRNA	PMID:32109520
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NAGK mRNA	PMID:20106945|PMID:21632981
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305057	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NAGK mRNA	PMID:33387578
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NAGK mRNA	PMID:17942748
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305057	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of NAGK protein	PMID:35544339
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312860	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of NAGK mRNA	PMID:30807115
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAGK mRNA	PMID:37992649
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of NAGK protein	PMID:35688186
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NAGK mRNA	PMID:38568856
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NAGK mRNA	PMID:40504410
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NAGK promoter	PMID:27901495
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NAGK mRNA	PMID:21632981
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312860	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NAGK mRNA	PMID:20713471|PMID:22228805
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to NAGK promoter]	PMID:19654925
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312860	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NAGK gene; titanium dioxide results in decreased methylation of NAGK promoter	PMID:35295148
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305057	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of NAGK mRNA	PMID:34492290
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305057	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of NAGK mRNA	PMID:25380136
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312860	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NAGK mRNA	PMID:18301758|PMID:23811191
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NAGK mRNA	PMID:19710929
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305057	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of NAGK mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of NAGK protein	PMID:37567409
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305057	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NAGK mRNA	PMID:25181051
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of NAGK mRNA	PMID:19244175
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:1305057	E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of NAGK mRNA	PMID:17602206
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1312860	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of NAGK protein	PMID:35362542
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of NAGK protein]	PMID:35362542
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305057	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NAGK mRNA	PMID:21266533
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312860	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NAGK mRNA	PMID:17361019
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to NAGK protein	PMID:32991956
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of NAGK protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of NAGK protein	PMID:38598786
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of NAGK mRNA]	PMID:39241906
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NAGK mRNA	PMID:37042841
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305057	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of NAGK mRNA	PMID:25380136
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1312860	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of NAGK mRNA	PMID:28558994
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20171010	CTD	MESH:C023036	PPARA protein affects the reaction [perfluorooctanoic acid results in increased expression of NAGK mRNA]	PMID:28558994
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NAGK mRNA	PMID:19376846
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1305057	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of NAGK mRNA	PMID:25380136
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of NAGK mRNA	PMID:19244175
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312860	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NAGK mRNA	PMID:28558994|PMID:40194260
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NAGK mRNA	PMID:40419075
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1312860	E	RGD:6480464	20171010	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NAGK mRNA	PMID:28558994
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NAGK mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NAGK mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NAGK mRNA	PMID:36331819
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NAGK mRNA	PMID:25979313
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312860	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NAGK mRNA	PMID:17963808
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of NAGK mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAGK mRNA	PMID:27188386
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305057	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of NAGK mRNA	PMID:41580965
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of NAGK mRNA	PMID:20106945
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAGK mRNA	PMID:37992649
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NAGK mRNA	PMID:38832940
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312860	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NAGK mRNA	PMID:17562736
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NAGK mRNA	PMID:22230336
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NAGK mRNA	PMID:40504410
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NAGK mRNA	PMID:22079256
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312860	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of NAGK mRNA	PMID:22334560
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NAGK mRNA	PMID:17942748
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of NAGK protein]	PMID:35362542
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312860	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of NAGK mRNA	PMID:25620056
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305057	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of NAGK mRNA	PMID:24136188
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305057	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of NAGK mRNA	PMID:24793618
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NAGK protein	PMID:32959892
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of NAGK mRNA	PMID:28988120
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312860	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of NAGK mRNA	PMID:22776087
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of NAGK protein	PMID:34186270
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312860	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NAGK mRNA	PMID:22206623
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of NAGK mRNA	PMID:22079256
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NAGK mRNA	PMID:22079256
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of NAGK mRNA	PMID:22124623
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1305057	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of NAGK mRNA	PMID:22124623
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAGK mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAGK mRNA	PMID:27188386
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312860	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of NAGK mRNA	PMID:19482888
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NAGK mRNA]	PMID:19482888
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1312860	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of NAGK mRNA	PMID:22334560
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312860	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in increased expression of NAGK mRNA	PMID:22334560
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312860	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of NAGK mRNA]	PMID:39241906
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAGK mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAGK mRNA	PMID:27188386
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305057	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of NAGK mRNA	PMID:19281266
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of NAGK protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of NAGK protein	PMID:38598786
1312859	NAGK	N-acetylglucosamine kinase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305057	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of NAGK mRNA	PMID:21346803
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312862	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of RAB34 mRNA	PMID:33045310
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312862	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of RAB34 mRNA	PMID:37995155
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RAB34 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of RAB34 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RAB34 mRNA	PMID:32699268|PMID:32845096
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RAB34 mRNA	PMID:36331819
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312862	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RAB34 mRNA	PMID:39241906
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312862	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RAB34 mRNA	PMID:39298647
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305058	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of RAB34 mRNA	PMID:26496021
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RAB34 mRNA	PMID:37992649
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RAB34 mRNA	PMID:37992649
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RAB34 protein	PMID:37730182
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305058	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of RAB34 mRNA	PMID:22061828
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1305058	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of RAB34 protein	PMID:34915118
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of RAB34 mRNA	PMID:23369406
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RAB34 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of RAB34 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RAB34 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RAB34 mRNA	PMID:32699268|PMID:32845096
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312862	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RAB34 mRNA	PMID:31919559
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RAB34 mRNA	PMID:22206623
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RAB34 gene	PMID:25304211
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305058	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RAB34 mRNA	PMID:31881176
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312862	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAB34 mRNA	PMID:21570461
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305058	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RAB34 mRNA	PMID:34747641
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312862	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RAB34 mRNA	PMID:23238561
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305058	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAB34 mRNA	PMID:23238561|PMID:33387578
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RAB34 mRNA	PMID:33212167
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305058	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of RAB34 mRNA	PMID:28959563
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RAB34 mRNA	PMID:37992649
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RAB34 mRNA	PMID:38568856
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312862	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RAB34 mRNA	PMID:22228805
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305058	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of RAB34 mRNA	PMID:24136188
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312862	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of RAB34 mRNA	PMID:20542052
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305058	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of RAB34 mRNA	PMID:25729387
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305058	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RAB34 mRNA	PMID:25729387
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1305058	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of RAB34 mRNA	PMID:24136188
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312862	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RAB34 gene	PMID:35295148
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305058	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RAB34 mRNA	PMID:34492290
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1305058	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RAB34 mRNA	PMID:12832660
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312862	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of RAB34 mRNA	PMID:18301758|PMID:20813756|PMID:23811191
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:32888	gamma-hexachlorocyclohexane	affects expression	ISO	RGD:1305058	E	RGD:6480464	20120412	CTD	MESH:D001556	Hexachlorocyclohexane affects the expression of RAB34 mRNA	PMID:17785943
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305058	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RAB34 mRNA	PMID:25181051
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305058	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RAB34 mRNA	PMID:34947998
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312862	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RAB34 mRNA	PMID:33221593
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305058	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RAB34 gene	PMID:28505145
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305058	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of RAB34 mRNA	PMID:26496021
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of RAB34 mRNA	PMID:25979313
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:34107	1-nitropyrene	decreases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in decreased expression of RAB34 mRNA	PMID:19041380
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312862	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RAB34 mRNA	PMID:39298647
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305058	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RAB34 mRNA	PMID:21266533
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312862	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of RAB34 mRNA	PMID:24535843
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RAB34 mRNA	PMID:37042841
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RAB34 mRNA	PMID:38568856
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RAB34 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RAB34 mRNA	PMID:32699268
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RAB34 mRNA	PMID:36331819
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RAB34 mRNA	PMID:25979313
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of RAB34 mRNA	PMID:23179753|PMID:24935251
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RAB34 gene	PMID:29154799
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RAB34 mRNA	PMID:37992649
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1312862	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of RAB34 mRNA	PMID:12929121
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305058	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of RAB34 mRNA	PMID:24136188
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1312862	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of RAB34 mRNA	PMID:12929121
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312862	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RAB34 mRNA	PMID:17562736
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305058	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RAB34 mRNA	PMID:33387578
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RAB34 gene	PMID:25304211
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312862	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RAB34 mRNA	PMID:25620056
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305058	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RAB34 mRNA	PMID:24136188
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RAB34 protein	PMID:32959892
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305058	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of RAB34 mRNA	PMID:25729387
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305058	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RAB34 mRNA	PMID:25729387
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305058	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of RAB34 mRNA	PMID:24136188
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312862	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RAB34 mRNA	PMID:22206623
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RAB34 protein	PMID:37664457
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305058	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of RAB34 mRNA	PMID:24136188
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:77850	toxaphene	decreases expression	ISO	RGD:1305058	E	RGD:6480464	20141014	CTD	MESH:D014112	Toxaphene results in decreased expression of RAB34 mRNA	PMID:23153324
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1312862	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of RAB34 mRNA	PMID:31388691
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:82388	p-anisidine	decreases expression	ISO	RGD:1312862	E	RGD:6480464	20141111	CTD	MESH:C013813	4-anisidine results in decreased expression of RAB34 mRNA	PMID:12929121
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312862	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RAB34 mRNA	PMID:39847705
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RAB34 protein	PMID:37664457
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305058	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RAB34 mRNA	PMID:19281266
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RAB34 mRNA	PMID:38568856
1312861	RAB34	RAB34, member RAS oncogene family	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305058	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of RAB34 mRNA	PMID:23034163
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305059	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of RBM5 mRNA	PMID:21551480
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312864	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RBM5 mRNA	PMID:33045310
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of RBM5 mRNA	PMID:31016361
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RBM5 mRNA	PMID:36331819
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312864	E	RGD:6480464	20161025	CTD	MESH:D000431	Ethanol affects the expression of RBM5 mRNA	PMID:26730594
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312864	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RBM5 mRNA	PMID:30319688
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RBM5 mRNA	PMID:39241906
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RBM5 mRNA]	PMID:39241906
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RBM5 mRNA	PMID:39298647
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:16990	bilirubin IXalpha	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin results in decreased expression of RBM5 mRNA	PMID:20196124
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RBM5 protein	PMID:37730182
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305059	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of RBM5 mRNA	PMID:22061828|PMID:33387578
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RBM5 mRNA	PMID:36331819
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RBM5 mRNA	PMID:37325564
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RBM5 mRNA	PMID:19549813
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312864	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RBM5 mRNA	PMID:19770486
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312864	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of RBM5 mRNA	PMID:25629700
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RBM5 gene	PMID:25304211
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RBM5 mRNA	PMID:40504410
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of RBM5 mRNA	PMID:19244175
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of RBM5 protein	PMID:35688186
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1305059	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of RBM5 mRNA	PMID:25905778
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of RBM5 protein	PMID:25505154
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RBM5 mRNA	PMID:23557933
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of RBM5 mRNA	PMID:28903495
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RBM5 mRNA	PMID:30912803
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312864	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RBM5 mRNA	PMID:21570461|PMID:26377647
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305059	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RBM5 mRNA	PMID:34747641
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20131210	CTD	MESH:D013749	RBM5 promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]	PMID:23997114
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of RBM5 mRNA	PMID:23649840
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305059	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RBM5 mRNA	PMID:30556269
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312864	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of RBM5 protein	PMID:28918527
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RBM5 mRNA	PMID:29803840
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312864	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of RBM5 mRNA	PMID:25896364
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RBM5 mRNA	PMID:40504410
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312864	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RBM5 mRNA	PMID:20504355|PMID:22228805
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RBM5 promoter	PMID:27901495
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305059	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RBM5 mRNA	PMID:30556269
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of RBM5 mRNA	PMID:26014281
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305059	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RBM5 mRNA	PMID:30047161
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of RBM5 mRNA	PMID:23557971
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312864	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RBM5 gene	PMID:35295148
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1312864	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of RBM5 mRNA	PMID:18648102
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RBM5 mRNA	PMID:18445702
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305059	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RBM5 mRNA	PMID:25181051|PMID:30816183
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of RBM5 mRNA	PMID:32156529
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RBM5 gene	PMID:31601247
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305059	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of RBM5 mRNA	PMID:27571134
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312864	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of RBM5 mRNA	PMID:40036665
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of RBM5 mRNA	PMID:19244175
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:3374	capsaicin	increases expression	ISO	RGD:1305059	E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin results in increased expression of RBM5 mRNA	PMID:20349343
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of RBM5 protein	PMID:31945527
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RBM5 mRNA	PMID:38685157
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RBM5 mRNA	PMID:20350560|PMID:37019170
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305059	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RBM5 mRNA	PMID:21266533
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of RBM5 mRNA	PMID:34813904
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RBM5 mRNA]	PMID:39241906
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RBM5 mRNA	PMID:37042841
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305059	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of RBM5 mRNA	PMID:30723492
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RBM5 mRNA	PMID:37325564
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RBM5 mRNA	PMID:24449571
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of RBM5 mRNA	PMID:19244175
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RBM5 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RBM5 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of RBM5 mRNA	PMID:36331819
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1305059	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of RBM5 mRNA	PMID:23125180
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RBM5 mRNA	PMID:25979313
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in decreased expression of RBM5 mRNA	PMID:22083351|PMID:23179753|PMID:29154799
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305059	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of RBM5 mRNA	PMID:24136188
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of RBM5 mRNA	PMID:22083351
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RBM5 mRNA	PMID:28542535
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1305059	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of RBM5 mRNA	PMID:21346803
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305059	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RBM5 mRNA	PMID:33387578
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	RBM5 protein affects the susceptibility to Fluorouracil	PMID:15548681
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RBM5 mRNA	PMID:29432896
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RBM5 gene	PMID:25304211
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RBM5 mRNA	PMID:40504410
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305059	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of RBM5 mRNA	PMID:17557909
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RBM5 mRNA; Nanotubes, Carbon results in decreased expression of RBM5 mRNA	PMID:25554681
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305059	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RBM5 mRNA	PMID:30047161
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305059	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of RBM5 mRNA	PMID:24136188
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:53074	diphenylcyclopropenone	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:C029402	diphenylcyclopropenone results in decreased expression of RBM5 mRNA	PMID:25236440
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of RBM5 protein	PMID:23718831
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RBM5 protein	PMID:32959892
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RBM5 mRNA	PMID:21641980|PMID:26378955
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305059	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of RBM5 mRNA	PMID:24136188
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:6809	methamphetamine	decreases methylation	ISO	RGD:1312864	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased methylation of RBM5 promoter	PMID:26307267
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312864	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of RBM5 mRNA	PMID:26307267
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RBM5 mRNA	PMID:22206623
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of RBM5 mRNA	PMID:23091169
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312864	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of RBM5 mRNA	PMID:21795629|PMID:39847705
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312864	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of RBM5 mRNA	PMID:21795629
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305059	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RBM5 mRNA	PMID:30047161
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312864	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RBM5 mRNA]	PMID:39241906
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of RBM5 mRNA	PMID:26014281
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305059	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RBM5 mRNA	PMID:19281266
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of RBM5 mRNA	PMID:29301935
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1312864	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of RBM5 protein	PMID:24648495
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305059	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RBM5 mRNA	PMID:19015723
1312863	RBM5	RNA binding motif protein 5	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305059	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of RBM5 mRNA	PMID:20566332|PMID:23034163
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CTNNA2 mRNA	PMID:26272509
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNNA2 mRNA	PMID:27188386
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTNNA2 protein]	PMID:38195004
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1619285	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CTNNA2 mRNA	PMID:20938992
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin affects the expression of CTNNA2 mRNA	PMID:16211290
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:16130	DDT	decreases expression	ISO	RGD:1305060	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of CTNNA2 mRNA	PMID:30207508
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of CTNNA2 mRNA	PMID:29581250
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of CTNNA2 mRNA	PMID:30510588
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1619285	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CTNNA2 mRNA	PMID:19484750
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of CTNNA2 mRNA	PMID:20660070
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305060	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CTNNA2 mRNA	PMID:33387578
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1619285	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CTNNA2 mRNA	PMID:20938992
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of CTNNA2 gene	PMID:30521419
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:16899	D-mannitol	decreases expression	ISO	RGD:1619285	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in decreased expression of CTNNA2 mRNA	PMID:25270620
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of CTNNA2 mRNA	PMID:20660070
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of CTNNA2 mRNA	PMID:21592394
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of CTNNA2 mRNA	PMID:21592394
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CTNNA2 mRNA	PMID:31163220
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CTNNA2 protein	PMID:37730182
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CTNNA2 mRNA	PMID:21592394
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of CTNNA2 mRNA	PMID:21592394
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTNNA2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTNNA2 protein	PMID:38195004
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CTNNA2 gene	PMID:27153756
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of CTNNA2 mRNA	PMID:15674843
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of CTNNA2 mRNA	PMID:12763052
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1619285	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CTNNA2 mRNA	PMID:27106289
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CTNNA2 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of CTNNA2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CTNNA2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CTNNA2 protein	PMID:38598786
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1619285	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CTNNA2 mRNA	PMID:20938992
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNNA2 mRNA	PMID:27188386
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CTNNA2 protein	PMID:35688186
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1305060	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of CTNNA2 gene	PMID:35440735
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305060	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CTNNA2 mRNA	PMID:22298810
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1619285	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CTNNA2 mRNA	PMID:21570461
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNA2 mRNA	PMID:17942748
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of CTNNA2 protein	PMID:39603559
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CTNNA2 mRNA	PMID:28001369
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of CTNNA2 gene	PMID:28589171
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CTNNA2 mRNA	PMID:38568856
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CTNNA2 5' UTR; Benzo(a)pyrene affects the methylation of CTNNA2 promoter	PMID:27901495
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CTNNA2 exon	PMID:27901495
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of CTNNA2 gene	PMID:25435355
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C006632	[Arsenic Trioxide co-treated with apatinib] results in increased expression of CTNNA2 mRNA	PMID:39223679
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of CTNNA2 gene; [bisphenol F co-treated with Fulvestrant] results in decreased methylation of CTNNA2 gene	PMID:31601247
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1619285	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CTNNA2 promoter	PMID:35295148
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1619285	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CTNNA2 gene	PMID:35295148
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CTNNA2 mRNA	PMID:18648102
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305060	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CTNNA2 mRNA	PMID:25181051
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of CTNNA2 gene	PMID:31601247
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of CTNNA2 protein	PMID:31675489
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1619285	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CTNNA2 mRNA	PMID:32156529
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305060	E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of CTNNA2 mRNA	PMID:38750585
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of CTNNA2 gene	PMID:31601247
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of CTNNA2 protein	PMID:31675489
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of CTNNA2 gene	PMID:31601247
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of CTNNA2 gene	PMID:31601247
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1619285	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CTNNA2 intron	PMID:28392331
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305060	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CTNNA2 mRNA	PMID:21266533
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to CTNNA2 protein	PMID:32991956
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CTNNA2 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CTNNA2 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of CTNNA2 protein	PMID:38598786
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CTNNA2 protein	PMID:24527689
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305060	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CTNNA2 mRNA	PMID:30917596
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTNNA2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTNNA2 protein	PMID:38195004
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305060	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of CTNNA2 mRNA	PMID:25539665
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1619285	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CTNNA2 mRNA	PMID:40194260
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CTNNA2 mRNA	PMID:25979313
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CTNNA2 gene	PMID:29154799
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of CTNNA2 mRNA	PMID:23179753
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CTNNA2 protein	PMID:38832940
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of CTNNA2 mRNA	PMID:22230336
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of CTNNA2 mRNA	PMID:31675489
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305060	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CTNNA2 mRNA	PMID:29391264
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:1305060	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of CTNNA2 gene	PMID:37958445
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CTNNA2 mRNA	PMID:17942748
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1619285	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CTNNA2 mRNA	PMID:17942748
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C032793	[Arsenic Trioxide co-treated with apatinib] results in increased expression of CTNNA2 mRNA	PMID:39223679
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1619285	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CTNNA2 mRNA	PMID:38701926
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1619285	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of CTNNA2 mRNA	PMID:36851058
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CTNNA2 mRNA	PMID:22079614
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305060	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CTNNA2 gene	PMID:35440735
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:756894	tak-243	affects sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 affects the sumoylation of CTNNA2 protein	PMID:31285264
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNNA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNNA2 mRNA	PMID:27188386
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CTNNA2 gene]	PMID:28238834
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CTNNA2 protein	PMID:31675489
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNNA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTNNA2 mRNA	PMID:27188386
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305060	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CTNNA2 mRNA	PMID:19281266
1312865	CTNNA2	catenin alpha 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CTNNA2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CTNNA2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CTNNA2 protein	PMID:38598786
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:132098	methoxyacetic acid	decreases expression	ISO	RGD:1305062	E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of RWDD2B mRNA	PMID:20864626
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RWDD2B mRNA	PMID:21632981
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312869	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RWDD2B mRNA	PMID:39241906
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RWDD2B mRNA	PMID:37042841
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of RWDD2B mRNA	PMID:33359661
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312869	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RWDD2B mRNA	PMID:34319233
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RWDD2B protein	PMID:37730182
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RWDD2B mRNA	PMID:28818685
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RWDD2B mRNA	PMID:19549813
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312869	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RWDD2B mRNA	PMID:25629700
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312869	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RWDD2B mRNA	PMID:22206623
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RWDD2B mRNA	PMID:39836092
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:1305062	E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of RWDD2B mRNA	PMID:20864626
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305062	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RWDD2B mRNA	PMID:31881176
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RWDD2B mRNA	PMID:27392435
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of RWDD2B mRNA	PMID:27392435
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312869	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RWDD2B mRNA	PMID:21570461
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305062	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RWDD2B mRNA	PMID:32109520
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312869	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RWDD2B mRNA	PMID:18796159
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312869	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of RWDD2B mRNA	PMID:16214954
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305062	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of RWDD2B mRNA	PMID:19013527
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1305062	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RWDD2B mRNA	PMID:20864626
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RWDD2B mRNA	PMID:30851411
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RWDD2B mRNA	PMID:29803840
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RWDD2B mRNA	PMID:38568856
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RWDD2B mRNA	PMID:39836092
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RWDD2B mRNA	PMID:21632981
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RWDD2B promoter	PMID:27901495
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RWDD2B mRNA]	PMID:32406909
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RWDD2B mRNA	PMID:25351596
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312869	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RWDD2B mRNA	PMID:17426115
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305062	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RWDD2B mRNA	PMID:25181051
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305062	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RWDD2B mRNA	PMID:30816183|PMID:32528016
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305062	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of RWDD2B mRNA	PMID:32145629
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305062	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of RWDD2B mRNA	PMID:17602206
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305062	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of RWDD2B mRNA	PMID:17602206
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RWDD2B mRNA	PMID:37042841
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305062	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of RWDD2B promoter	PMID:22457795
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RWDD2B mRNA	PMID:19320972
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RWDD2B mRNA	PMID:24449571
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:38845	profenofos	increases expression	ISO	RGD:1305062	E	RGD:6480464	20130514	CTD	MESH:C024273	profenofos results in increased expression of RWDD2B mRNA	PMID:17569032
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of RWDD2B mRNA	PMID:29154799
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1312869	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of RWDD2B mRNA	PMID:21427059
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RWDD2B mRNA	PMID:25562108
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1305062	E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RWDD2B mRNA	PMID:21658437
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RWDD2B mRNA	PMID:38832940
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312869	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RWDD2B mRNA	PMID:17562736
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305062	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RWDD2B mRNA	PMID:33387578
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RWDD2B mRNA	PMID:39836092
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312869	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RWDD2B mRNA; Nanotubes, Carbon results in increased expression of RWDD2B mRNA	PMID:25554681
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312869	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of RWDD2B mRNA	PMID:19042947
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312869	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RWDD2B mRNA	PMID:22206623
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312869	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RWDD2B mRNA	PMID:22206623
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RWDD2B mRNA	PMID:30851411
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:82036	prothioconazole	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in increased expression of RWDD2B mRNA	PMID:35048155
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1305062	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of RWDD2B mRNA	PMID:20864626
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of RWDD2B mRNA	PMID:31734321
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305062	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RWDD2B mRNA	PMID:19281266
1312868	RWDD2B	RWD domain containing 2B	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of RWDD2B mRNA	PMID:29301935
1312871	SCRN3	secernin 3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SCRN3 mRNA	PMID:38218311
1312871	SCRN3	secernin 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of SCRN3 mRNA	PMID:23724009
1312871	SCRN3	secernin 3	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305064	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of SCRN3 gene	PMID:28931070
1312871	SCRN3	secernin 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550100	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SCRN3 mRNA	PMID:30319688
1312871	SCRN3	secernin 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SCRN3 mRNA	PMID:39241906
1312871	SCRN3	secernin 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305064	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SCRN3 mRNA	PMID:32145629
1312871	SCRN3	secernin 3	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SCRN3 mRNA	PMID:23649840
1312871	SCRN3	secernin 3	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SCRN3 mRNA	PMID:33359661
1312871	SCRN3	secernin 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305064	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SCRN3 mRNA	PMID:33387578
1312871	SCRN3	secernin 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550100	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SCRN3 mRNA	PMID:36331819
1312871	SCRN3	secernin 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SCRN3 mRNA	PMID:39836092
1312871	SCRN3	secernin 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550100	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SCRN3 mRNA	PMID:37236586
1312871	SCRN3	secernin 3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SCRN3 mRNA	PMID:23649840
1312871	SCRN3	secernin 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550100	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SCRN3 mRNA	PMID:27106289
1312871	SCRN3	secernin 3	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550100	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SCRN3 mRNA	PMID:17484886
1312871	SCRN3	secernin 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SCRN3 mRNA	PMID:31919559
1312871	SCRN3	secernin 3	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1550100	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of SCRN3 mRNA	PMID:18930951
1312871	SCRN3	secernin 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SCRN3 mRNA	PMID:28001369
1312871	SCRN3	secernin 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SCRN3 protein	PMID:33212167
1312871	SCRN3	secernin 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SCRN3 mRNA	PMID:29803840
1312871	SCRN3	secernin 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SCRN3 mRNA	PMID:32234424
1312871	SCRN3	secernin 3	gene	CHEBI:30145	lithium atom	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of SCRN3 protein	PMID:40770094
1312871	SCRN3	secernin 3	gene	CHEBI:30146	lithium hydride	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of SCRN3 protein	PMID:40770094
1312871	SCRN3	secernin 3	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of SCRN3 mRNA	PMID:34408198
1312871	SCRN3	secernin 3	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1305064	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of SCRN3 mRNA	PMID:22641619
1312871	SCRN3	secernin 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305064	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SCRN3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1312871	SCRN3	secernin 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of SCRN3 mRNA	PMID:35598803
1312871	SCRN3	secernin 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305064	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of SCRN3 mRNA	PMID:32145629
1312871	SCRN3	secernin 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550100	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of SCRN3 mRNA	PMID:25594700|PMID:40036665
1312871	SCRN3	secernin 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550100	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SCRN3 mRNA	PMID:39298647
1312871	SCRN3	secernin 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SCRN3 mRNA	PMID:21266533
1312871	SCRN3	secernin 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SCRN3 mRNA	PMID:39836092
1312871	SCRN3	secernin 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305064	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of SCRN3 mRNA	PMID:30723492
1312871	SCRN3	secernin 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SCRN3 mRNA	PMID:24982889
1312871	SCRN3	secernin 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550100	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SCRN3 mRNA	PMID:37236586
1312871	SCRN3	secernin 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SCRN3 mRNA	PMID:24449571
1312871	SCRN3	secernin 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550100	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SCRN3 mRNA	PMID:36331819
1312871	SCRN3	secernin 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SCRN3 mRNA	PMID:19770486
1312871	SCRN3	secernin 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SCRN3 mRNA	PMID:28973697
1312871	SCRN3	secernin 3	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SCRN3 mRNA	PMID:38832940
1312871	SCRN3	secernin 3	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SCRN3 mRNA	PMID:27188386
1312871	SCRN3	secernin 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SCRN3 mRNA	PMID:26272509
1312871	SCRN3	secernin 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550100	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SCRN3 mRNA	PMID:17562736
1312871	SCRN3	secernin 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SCRN3 mRNA	PMID:21420995|PMID:29067470
1312871	SCRN3	secernin 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SCRN3 mRNA	PMID:22079256
1312871	SCRN3	secernin 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SCRN3 mRNA; Nanotubes, Carbon results in decreased expression of SCRN3 mRNA	PMID:25554681
1312871	SCRN3	secernin 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550100	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SCRN3 mRNA; Nanotubes, Carbon results in increased expression of SCRN3 mRNA	PMID:25620056
1312871	SCRN3	secernin 3	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305064	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of SCRN3 mRNA	PMID:23962444
1312871	SCRN3	secernin 3	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of SCRN3 mRNA	PMID:26705709
1312871	SCRN3	secernin 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SCRN3 mRNA	PMID:39836092
1312871	SCRN3	secernin 3	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1550100	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of SCRN3 mRNA	PMID:19812364
1312871	SCRN3	secernin 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550100	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SCRN3 mRNA	PMID:22206623
1312871	SCRN3	secernin 3	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SCRN3 mRNA	PMID:22079256
1312871	SCRN3	secernin 3	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SCRN3 mRNA	PMID:22079256
1312871	SCRN3	secernin 3	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of SCRN3 mRNA	PMID:26079696
1312871	SCRN3	secernin 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550100	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SCRN3 mRNA	PMID:39847705
1312871	SCRN3	secernin 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SCRN3 mRNA	PMID:38568856
1312871	SCRN3	secernin 3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SCRN3 mRNA	PMID:29301935
1312871	SCRN3	secernin 3	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SCRN3 mRNA	PMID:27188386
1312871	SCRN3	secernin 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305064	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SCRN3 mRNA	PMID:21346803
1312871	SCRN3	secernin 3	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305064	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of SCRN3 mRNA	PMID:22570695
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNRPD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNRPD2 mRNA	PMID:32699268
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312874	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SNRPD2 mRNA	PMID:39241906
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1593018	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of SNRPD2 mRNA	PMID:22967744
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312874	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SNRPD2 mRNA	PMID:33754040
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SNRPD2 protein	PMID:37730182
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312874	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNRPD2 mRNA	PMID:36331819
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312874	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of SNRPD2 mRNA	PMID:27462272
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:207229	dihydroartemisinin	affects binding	EXP		E	RGD:6480464	20170303	CTD	MESH:C039060	artenimol analog binds to SNRPD2 protein	PMID:26340163
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SNRPD2 mRNA	PMID:19549813
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SNRPD2 protein	PMID:23301498
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SNRPD2 mRNA	PMID:23649840
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1593018	E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in decreased expression of SNRPD2 protein	PMID:33146391
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNRPD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNRPD2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of SNRPD2 mRNA	PMID:32699268
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312874	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SNRPD2 mRNA	PMID:34911549
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312874	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of SNRPD2 mRNA	PMID:25629700
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312874	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNRPD2 mRNA	PMID:22206623
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312874	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SNRPD2 mRNA	PMID:40504410
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of SNRPD2 protein	PMID:38460933
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312874	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of SNRPD2 protein	PMID:25505154
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312874	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SNRPD2 mRNA	PMID:30912803
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312874	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNRPD2 mRNA	PMID:21570461
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1593018	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNRPD2 mRNA	PMID:34747641
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312874	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SNRPD2 mRNA	PMID:15034205
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1593018	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SNRPD2 mRNA	PMID:32109520
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1593018	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNRPD2 mRNA	PMID:33387578
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312874	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SNRPD2 mRNA]	PMID:15034205
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1312874	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of SNRPD2 protein	PMID:21146535
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNRPD2 mRNA; sodium arsenite results in decreased expression of SNRPD2 protein	PMID:38228842|PMID:38568856
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of SNRPD2 mRNA	PMID:34032870
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312874	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SNRPD2 mRNA	PMID:40504410
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312874	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SNRPD2 mRNA	PMID:15034205
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312874	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNRPD2 mRNA	PMID:22228805
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312874	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SNRPD2 mRNA]; AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of SNRPD2 mRNA]	PMID:15034205|PMID:22228805
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to SNRPD2 mRNA]	PMID:32406909
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:3000	beauvericin	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C004456	[beauvericin co-treated with enniatins] results in increased expression of SNRPD2 protein	PMID:32407736
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1312874	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of SNRPD2 protein	PMID:21146535
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of SNRPD2 mRNA	PMID:25075043
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:3048	benzatropine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in increased expression of SNRPD2 protein	PMID:34122009
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1593018	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SNRPD2 mRNA	PMID:24136188
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in decreased expression of SNRPD2 mRNA	PMID:38568856
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1593018	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SNRPD2 mRNA	PMID:25729387
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312874	E	RGD:6480464	20150310	CTD	MESH:C009495	titanium dioxide analog results in decreased expression of SNRPD2 mRNA	PMID:25111187
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312874	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNRPD2 gene	PMID:35295148
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312874	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SNRPD2 mRNA	PMID:28472532
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SNRPD2 mRNA	PMID:30903817
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1593018	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SNRPD2 mRNA	PMID:25181051
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A results in decreased expression of SNRPD2 mRNA	PMID:38568856
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312874	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of SNRPD2 mRNA	PMID:35598803
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312874	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SNRPD2 mRNA	PMID:33221593
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of SNRPD2 protein	PMID:31945527
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SNRPD2 protein	PMID:34186270
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312874	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SNRPD2 mRNA	PMID:39298647
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312874	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SNRPD2 mRNA	PMID:38685157
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312874	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SNRPD2 mRNA	PMID:17361019|PMID:21266533
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SNRPD2 mRNA	PMID:37042841
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1593018	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of SNRPD2 promoter	PMID:22457795
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312874	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SNRPD2 mRNA	PMID:24982889
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SNRPD2 protein	PMID:26879310
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNRPD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNRPD2 mRNA	PMID:32699268
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1312874	E	RGD:6480464	20120412	CTD	MESH:D003024	Clozapine results in increased expression of SNRPD2 mRNA	PMID:14647396
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of SNRPD2 mRNA	PMID:26352163
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312874	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNRPD2 mRNA	PMID:36331819
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SNRPD2 gene	PMID:29154799
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPD2 mRNA	PMID:17183730
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of SNRPD2 protein	PMID:38460933
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312874	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SNRPD2 mRNA	PMID:40504410
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1312874	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SNRPD2 mRNA	PMID:35436446
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:50035	alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of SNRPD2 mRNA	PMID:25075043
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312874	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SNRPD2 mRNA	PMID:35964746
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1593018	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SNRPD2 mRNA	PMID:24136188
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1312874	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SNRPD2 mRNA	PMID:19042947
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:5613	haloperidol	increases expression	ISO	RGD:1312874	E	RGD:6480464	20120412	CTD	MESH:D006220	Haloperidol results in increased expression of SNRPD2 mRNA	PMID:14647396
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:5721	hinokiflavone	increases sumoylation	EXP		E	RGD:6480464	20200519	CTD	MESH:C060299	hinokiflavone results in increased sumoylation of SNRPD2 protein	PMID:28884683
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of SNRPD2 mRNA	PMID:17183730
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SNRPD2 protein	PMID:32959892
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1593018	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SNRPD2 mRNA	PMID:25729387
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1312874	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of SNRPD2 mRNA	PMID:23650126
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1312874	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SNRPD2 protein	PMID:26558463
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:64648	enniatin	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C100264	[beauvericin co-treated with enniatins] results in increased expression of SNRPD2 protein	PMID:32407736
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312874	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SNRPD2 mRNA	PMID:22206623
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312874	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNRPD2 mRNA	PMID:22206623
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of SNRPD2 protein	PMID:31285264
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1312874	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SNRPD2 mRNA	PMID:30294300
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SNRPD2 mRNA	PMID:38568856
1312873	SNRPD2	small nuclear ribonucleoprotein D2 polypeptide	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1593018	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SNRPD2 mRNA	PMID:23034163
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TNFSF18 mRNA	PMID:39241906
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312876	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFSF18 protein	PMID:21951872
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:16412	lipopolysaccharide	increases response to substance	ISO	RGD:1312876	E	RGD:6480464	20161228	CTD	MESH:D008070	TNFSF18 results in increased susceptibility to Lipopolysaccharides	PMID:21951872
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20161228	CTD	MESH:D008070	Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of TNFSF18 protein]; TNFSF18 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]; TNFSF18 mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]	PMID:21951872
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305066	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TNFSF18 mRNA	PMID:33387578
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of TNFSF18 mRNA	PMID:34673133
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF18 mRNA	PMID:37992649
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF18 mRNA	PMID:37992649
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305066	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TNFSF18 mRNA	PMID:33387578
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TNFSF18 mRNA	PMID:40288432
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:25187	p-menthan-3-ol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of TNFSF18 mRNA	PMID:26760959
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	Ozone results in increased expression of TNFSF18 mRNA	PMID:31476115
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	[Aripiprazole co-treated with Ozone] results in increased expression of TNFSF18 mRNA	PMID:31476115
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of TNFSF18 mRNA	PMID:27106289
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305066	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFSF18 mRNA	PMID:33387578
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TNFSF18 mRNA	PMID:20971185
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF18 mRNA	PMID:37992649
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TNFSF18 mRNA	PMID:34032870
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TNFSF18 mRNA	PMID:38568856
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TNFSF18 mRNA	PMID:20971185
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TNFSF18 mRNA	PMID:23806026
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TNFSF18 mRNA	PMID:17530438|PMID:21461292
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:31236	aripiprazole	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:C094645	[Aripiprazole co-treated with Ozone] results in increased expression of TNFSF18 mRNA	PMID:31476115
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305066	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TNFSF18 mRNA	PMID:34492290
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305066	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in decreased expression of TNFSF18 mRNA	PMID:29552716
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:37415	alpha-amanitin	affects expression	ISO	RGD:1312876	E	RGD:6480464	20240903	CTD	MESH:D053959	Alpha-Amanitin affects the expression of TNFSF18 mRNA	PMID:38531469
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TNFSF18 mRNA	PMID:40194260
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of TNFSF18 protein]	PMID:21951872
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312876	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF18 mRNA	PMID:37992649
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TNFSF18 mRNA	PMID:38832940
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305066	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TNFSF18 mRNA	PMID:33387578
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of TNFSF18 mRNA	PMID:35811015
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of TNFSF18 mRNA	PMID:35537566
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1305066	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of TNFSF18 mRNA	PMID:29391264
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TNFSF18 mRNA	PMID:35436446
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of TNFSF18 mRNA	PMID:24383545
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TNFSF18 mRNA	PMID:17530438|PMID:21461292
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312876	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TNFSF18 mRNA; Nanotubes, Carbon results in increased expression of TNFSF18 mRNA	PMID:25554681
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TNFSF18 mRNA	PMID:38701926
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:63618	pravastatin	affects expression	ISO	RGD:1305066	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin affects the expression of TNFSF18 mRNA	PMID:27225895
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:63618	pravastatin	affects expression	ISO	RGD:1312876	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin affects the expression of TNFSF18 mRNA	PMID:27225895
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1305066	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of TNFSF18 mRNA	PMID:27225895
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of TNFSF18 mRNA	PMID:27225895
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of TNFSF18 mRNA	PMID:29522793
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:93751	PF-3758309	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C550923	PF 3758309 results in decreased expression of TNFSF18 mRNA	PMID:29048629
1312875	TNFSF18	TNF superfamily member 18	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312876	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TNFSF18 mRNA	PMID:35537566
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of UBE2J1 mRNA	PMID:26272509
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA	PMID:27188386
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305067	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBE2J1 mRNA]	PMID:31150632
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2J1 mRNA	PMID:39752319
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of UBE2J1 mRNA	PMID:21934132|PMID:33167477
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of UBE2J1 mRNA	PMID:26079696
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of UBE2J1 mRNA	PMID:22378314
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of UBE2J1 mRNA	PMID:29581250
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312878	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of UBE2J1 mRNA	PMID:39241906
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312878	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of UBE2J1 mRNA	PMID:39298647
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305067	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of UBE2J1 gene	PMID:27618143
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of UBE2J1 mRNA	PMID:23649840
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2J1 mRNA	PMID:39752319
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305067	E	RGD:6480464	20140729	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in increased expression of UBE2J1 mRNA]	PMID:20032058
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of UBE2J1 protein	PMID:31163220
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of UBE2J1 protein	PMID:37730182
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305067	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of UBE2J1 mRNA	PMID:22061828
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305067	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of UBE2J1 mRNA	PMID:22061828
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of UBE2J1 mRNA	PMID:28818685
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1312878	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of UBE2J1 mRNA	PMID:24067728
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of UBE2J1 mRNA	PMID:37236586
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of UBE2J1 mRNA	PMID:23649840
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305067	E	RGD:6480464	20260811	CTD	MESH:C016517	indole-3-carbinol affects the expression of KRTAP5-2 mRNA	PMID:21396975
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of UBE2J1 mRNA	PMID:23649840
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of UBE2J1 mRNA	PMID:22171008
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305067	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of UBE2J1 mRNA	PMID:33387578
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305067	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBE2J1 mRNA	PMID:31150632
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312878	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBE2J1 mRNA	PMID:31919559
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305067	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBE2J1 mRNA]	PMID:31150632
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312878	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of UBE2J1 mRNA	PMID:25629700
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:27470	folic acid	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of UBE2J1 mRNA	PMID:27293554
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2J1 mRNA	PMID:22206623
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of UBE2J1 mRNA	PMID:40504410
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312878	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2J1 mRNA	PMID:21570461
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2J1 mRNA	PMID:17942748
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1312878	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in increased expression of UBE2J1 mRNA	PMID:20061341
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UBE2J1 mRNA	PMID:30851411
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of UBE2J1 mRNA	PMID:26272509
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA	PMID:27188386
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of UBE2J1 mRNA	PMID:23649840
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of UBE2J1 mRNA	PMID:15467011
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312878	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of UBE2J1 protein	PMID:28918527
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of UBE2J1 protein	PMID:35688186
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UBE2J1 mRNA	PMID:38568856|PMID:39719251
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of UBE2J1 mRNA	PMID:40504410
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of UBE2J1 mRNA	PMID:22378314|PMID:29453283
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312878	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBE2J1 mRNA	PMID:22228805
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of UBE2J1 mRNA	PMID:15467011
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of UBE2J1 mRNA	PMID:22171008
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:31429	colforsin daropate hydrochloride	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D005576	Colforsin results in increased expression of UBE2J1 mRNA	PMID:16751804
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305067	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of UBE2J1 mRNA	PMID:24136188
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312878	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of UBE2J1 mRNA	PMID:27760801
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305067	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of UBE2J1 mRNA	PMID:34492290
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of UBE2J1 mRNA	PMID:30903817
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305067	E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in decreased expression of KRTAP5-4 mRNA	PMID:25181051
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312878	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2J1 mRNA	PMID:26063408
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305067	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of UBE2J1 mRNA	PMID:29097150
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of UBE2J1 mRNA	PMID:25979313
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312878	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of UBE2J1 mRNA	PMID:39298647
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305067	E	RGD:6480464	20140729	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of UBE2J1 mRNA	PMID:21266533
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1312878	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBE2J1 mRNA	PMID:20061341
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of UBE2J1 mRNA	PMID:37236586
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of UBE2J1 mRNA	PMID:19320972
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305067	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of UBE2J1 mRNA	PMID:24386269
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1305067	E	RGD:6480464	20140729	CTD	MESH:D002994	Clofibrate results in decreased expression of UBE2J1 mRNA	PMID:12851107
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of UBE2J1 mRNA	PMID:16751804
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2J1 mRNA	PMID:19167446
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UBE2J1 mRNA	PMID:25979313
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of UBE2J1 mRNA	PMID:23179753|PMID:27188386
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of UBE2J1 mRNA	PMID:23179753
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of UBE2J1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312878	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of UBE2J1 mRNA	PMID:17555576
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1305067	E	RGD:6480464	20140729	CTD	MESH:D003907	Dexamethasone results in increased expression of UBE2J1 mRNA	PMID:20032058
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1305067	E	RGD:6480464	20140729	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in increased expression of UBE2J1 mRNA]	PMID:20032058
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of UBE2J1 mRNA	PMID:36621641
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of UBE2J1 mRNA	PMID:23649840
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of UBE2J1 mRNA	PMID:26272509
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA	PMID:27188386
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312878	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UBE2J1 mRNA	PMID:17562736
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of UBE2J1 mRNA	PMID:29432896
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of UBE2J1 mRNA	PMID:40504410
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305067	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of UBE2J1 mRNA	PMID:29391264
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312878	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of UBE2J1 mRNA	PMID:17555576
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305067	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UBE2J1 mRNA	PMID:29097150
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312878	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UBE2J1 mRNA	PMID:17942748
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2J1 mRNA	PMID:17942748
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1305067	E	RGD:6480464	20140729	CTD	MESH:D008770	Methylnitrosourea results in increased expression of UBE2J1 mRNA	PMID:17412507
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312878	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of UBE2J1 mRNA; Nanotubes, Carbon results in increased expression of UBE2J1 mRNA	PMID:25554681
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305067	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBE2J1 mRNA	PMID:24136188
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2J1 mRNA	PMID:39752319
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of UBE2J1 mRNA	PMID:31758290
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2J1 mRNA	PMID:22206623
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UBE2J1 mRNA	PMID:30851411
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA	PMID:27188386
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of UBE2J1 mRNA	PMID:19167446
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1312878	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of UBE2J1 mRNA	PMID:21278054
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312878	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2J1 mRNA	PMID:39752319
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UBE2J1 mRNA	PMID:27188386
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305067	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of UBE2J1 mRNA	PMID:19281266
1312877	UBE2J1	ubiquitin conjugating enzyme E2 J1	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of UBE2J1 mRNA	PMID:22378314
1312880	SMAD6	SMAD family member 6	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SMAD6 mRNA	PMID:38218311
1312880	SMAD6	SMAD family member 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SMAD6 gene	PMID:20938992
1312880	SMAD6	SMAD family member 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of SMAD6 protein	PMID:19058293
1312880	SMAD6	SMAD family member 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SMAD6 mRNA	PMID:21934132
1312880	SMAD6	SMAD family member 6	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of SMAD6 mRNA	PMID:30951980
1312880	SMAD6	SMAD family member 6	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1305069	E	RGD:6480464	20161213	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SMAD6 mRNA	PMID:26476374
1312880	SMAD6	SMAD family member 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305069	E	RGD:6480464	20161213	CTD	MESH:D010100	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of SMAD6 mRNA]	PMID:26476374
1312880	SMAD6	SMAD family member 6	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1305069	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of SMAD6 mRNA	PMID:36841081
1312880	SMAD6	SMAD family member 6	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1305069	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of SMAD6 mRNA]	PMID:26476374
1312880	SMAD6	SMAD family member 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides results in increased phosphorylation of SMAD3 protein] promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; IRAK1 protein promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]; MAP2K1 protein promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; MAPK1 protein promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; MAPK3 protein promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; SMAD3 protein modified form promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; TLR4 protein promotes the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]; U 0126 inhibits the reaction [Lipopolysaccharides inhibits the reaction [TGFB1 protein results in increased expression of SMAD6 mRNA]]	PMID:21295571
1312880	SMAD6	SMAD family member 6	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of SMAD6 mRNA	PMID:30510588
1312880	SMAD6	SMAD family member 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SMAD6 mRNA	PMID:30165855
1312880	SMAD6	SMAD family member 6	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305069	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SMAD6 gene	PMID:27618143
1312880	SMAD6	SMAD family member 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SMAD6 gene	PMID:20938992
1312880	SMAD6	SMAD family member 6	gene	CHEBI:16716	benzene	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20120412	CTD	MESH:D001554	TRP53 protein inhibits the reaction [Benzene results in increased expression of SMAD6]	PMID:15935813
1312880	SMAD6	SMAD family member 6	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of SMAD6 mRNA	PMID:21795739
1312880	SMAD6	SMAD family member 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of SMAD6 mRNA	PMID:36695872
1312880	SMAD6	SMAD family member 6	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of SMAD6 mRNA	PMID:27683099
1312880	SMAD6	SMAD family member 6	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of SMAD6 mRNA	PMID:16002434
1312880	SMAD6	SMAD family member 6	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305069	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SMAD6 mRNA	PMID:33387578
1312880	SMAD6	SMAD family member 6	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMAD6 mRNA	PMID:39836092
1312880	SMAD6	SMAD family member 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SMAD6 intron	PMID:30157460
1312880	SMAD6	SMAD family member 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SMAD6 gene	PMID:27153756
1312880	SMAD6	SMAD family member 6	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1312881	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of SMAD6 mRNA	PMID:15674844
1312880	SMAD6	SMAD family member 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SMAD6 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SMAD6 mRNA	PMID:34911549
1312880	SMAD6	SMAD family member 6	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SMAD6 mRNA	PMID:18356318
1312880	SMAD6	SMAD family member 6	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312881	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SMAD6 mRNA	PMID:17484886
1312880	SMAD6	SMAD family member 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SMAD6 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SMAD6 gene	PMID:20938992|PMID:22206623
1312880	SMAD6	SMAD family member 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMAD6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMAD6 mRNA	PMID:39836092
1312880	SMAD6	SMAD family member 6	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SMAD6 mRNA	PMID:27392435
1312880	SMAD6	SMAD family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312881	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMAD6 mRNA	PMID:21570461|PMID:24058054
1312880	SMAD6	SMAD family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMAD6 mRNA	PMID:19933214
1312880	SMAD6	SMAD family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305069	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SMAD6 mRNA	PMID:33387578
1312880	SMAD6	SMAD family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312881	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SMAD6 mRNA	PMID:37172768
1312880	SMAD6	SMAD family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SMAD6 promoter]	PMID:19654925
1312880	SMAD6	SMAD family member 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SMAD6 mRNA	PMID:23179753
1312880	SMAD6	SMAD family member 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SMAD6 mRNA	PMID:33212167
1312880	SMAD6	SMAD family member 6	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305069	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SMAD6 mRNA	PMID:28959563
1312880	SMAD6	SMAD family member 6	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of SMAD6 mRNA	PMID:21198554
1312880	SMAD6	SMAD family member 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SMAD6 mRNA	PMID:38568856|PMID:39719251
1312880	SMAD6	SMAD family member 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of SMAD6 mRNA	PMID:12016162|PMID:16966095|PMID:28595984|PMID:34032870
1312880	SMAD6	SMAD family member 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMAD6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMAD6 mRNA	PMID:39836092
1312880	SMAD6	SMAD family member 6	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of SMAD6 mRNA	PMID:29453283
1312880	SMAD6	SMAD family member 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMAD6 mRNA	PMID:35870112
1312880	SMAD6	SMAD family member 6	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SMAD6 mRNA	PMID:18356318
1312880	SMAD6	SMAD family member 6	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SMAD6 mRNA	PMID:20458559
1312880	SMAD6	SMAD family member 6	gene	CHEBI:30769	citric acid	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D019343	Citric Acid results in increased expression of SMAD6 mRNA	PMID:37149095
1312880	SMAD6	SMAD family member 6	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of SMAD6 mRNA	PMID:35984750
1312880	SMAD6	SMAD family member 6	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305069	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SMAD6 mRNA	PMID:25729387
1312880	SMAD6	SMAD family member 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SMAD6 mRNA	PMID:23557971
1312880	SMAD6	SMAD family member 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312881	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SMAD6 promoter	PMID:35295148
1312880	SMAD6	SMAD family member 6	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of SMAD6 mRNA	PMID:30690063
1312880	SMAD6	SMAD family member 6	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of SMAD6 mRNA	PMID:28329830
1312880	SMAD6	SMAD family member 6	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305069	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of SMAD6 mRNA	PMID:19167457
1312880	SMAD6	SMAD family member 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of SMAD6 mRNA	PMID:20170705
1312880	SMAD6	SMAD family member 6	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312881	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SMAD6 promoter	PMID:27334623
1312880	SMAD6	SMAD family member 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305069	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SMAD6 mRNA	PMID:26982218|PMID:30816183
1312880	SMAD6	SMAD family member 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SMAD6 mRNA	PMID:29275510
1312880	SMAD6	SMAD family member 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305069	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SMAD6 mRNA	PMID:25181051
1312880	SMAD6	SMAD family member 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312881	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of SMAD6 mRNA	PMID:32156529
1312880	SMAD6	SMAD family member 6	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SMAD6 mRNA	PMID:25172293
1312880	SMAD6	SMAD family member 6	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of SMAD6 mRNA	PMID:36804509
1312880	SMAD6	SMAD family member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312881	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SMAD6 mRNA	PMID:30951980
1312880	SMAD6	SMAD family member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of SMAD6 mRNA	PMID:30951980
1312880	SMAD6	SMAD family member 6	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SMAD6 intron	PMID:30157460
1312880	SMAD6	SMAD family member 6	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1312881	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of SMAD6 mRNA	PMID:26377693
1312880	SMAD6	SMAD family member 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312881	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SMAD6 mRNA	PMID:30951980
1312880	SMAD6	SMAD family member 6	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312881	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SMAD6 intron	PMID:28392331
1312880	SMAD6	SMAD family member 6	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312881	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SMAD6 mRNA	PMID:37019170
1312880	SMAD6	SMAD family member 6	gene	CHEBI:34905	paraquat	affects expression	ISO	RGD:1305069	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat affects the expression of SMAD6 mRNA	PMID:16854511
1312880	SMAD6	SMAD family member 6	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMAD6 mRNA	PMID:39836092
1312880	SMAD6	SMAD family member 6	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305069	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of SMAD6 mRNA	PMID:26194646
1312880	SMAD6	SMAD family member 6	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of SMAD6 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SMAD6 mRNA]	PMID:17585979
1312880	SMAD6	SMAD family member 6	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SMAD6 mRNA	PMID:40194260
1312880	SMAD6	SMAD family member 6	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SMAD6 mRNA	PMID:31533062
1312880	SMAD6	SMAD family member 6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMAD6 mRNA	PMID:28001369
1312880	SMAD6	SMAD family member 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of SMAD6 mRNA	PMID:24935251
1312880	SMAD6	SMAD family member 6	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SMAD6 gene	PMID:29154799
1312880	SMAD6	SMAD family member 6	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of SMAD6 mRNA	PMID:27989131
1312880	SMAD6	SMAD family member 6	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of SMAD6 mRNA	PMID:24449571
1312880	SMAD6	SMAD family member 6	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SMAD6 mRNA	PMID:38832940
1312880	SMAD6	SMAD family member 6	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SMAD6 mRNA	PMID:24935251
1312880	SMAD6	SMAD family member 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305069	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMAD6 mRNA	PMID:33387578
1312880	SMAD6	SMAD family member 6	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of SMAD6 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SMAD6 mRNA]	PMID:17585979
1312880	SMAD6	SMAD family member 6	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SMAD6 mRNA	PMID:23634900
1312880	SMAD6	SMAD family member 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMAD6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMAD6 mRNA	PMID:39836092
1312880	SMAD6	SMAD family member 6	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMAD6 mRNA	PMID:22079256
1312880	SMAD6	SMAD family member 6	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SMAD6 mRNA	PMID:35436446
1312880	SMAD6	SMAD family member 6	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SMAD6 mRNA	PMID:20170705
1312880	SMAD6	SMAD family member 6	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of SMAD6 mRNA	PMID:38568856
1312880	SMAD6	SMAD family member 6	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SMAD6 mRNA	PMID:20458559
1312880	SMAD6	SMAD family member 6	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003994	Bucladesine inhibits the reaction [BMP4 protein results in increased expression of SMAD6 mRNA]	PMID:20522807
1312880	SMAD6	SMAD family member 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SMAD6 mRNA; Nanotubes, Carbon results in decreased expression of SMAD6 mRNA	PMID:25554681
1312880	SMAD6	SMAD family member 6	gene	CHEBI:5262	galangin	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:C037032	galangin results in decreased expression of SMAD6 mRNA	PMID:25268046
1312880	SMAD6	SMAD family member 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMAD6 mRNA	PMID:39836092
1312880	SMAD6	SMAD family member 6	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMAD6 mRNA	PMID:26378955
1312880	SMAD6	SMAD family member 6	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMAD6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMAD6 mRNA	PMID:21641980|PMID:26378955
1312880	SMAD6	SMAD family member 6	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305069	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SMAD6 mRNA	PMID:25729387
1312880	SMAD6	SMAD family member 6	gene	CHEBI:63916	iloprost	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016285	Iloprost inhibits the reaction [BMP4 protein results in increased expression of SMAD6 mRNA]	PMID:20522807
1312880	SMAD6	SMAD family member 6	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SMAD6 intron	PMID:30157460
1312880	SMAD6	SMAD family member 6	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305069	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SMAD6 gene	PMID:35440735
1312880	SMAD6	SMAD family member 6	gene	CHEBI:72312	pasireotide	decreases expression	ISO	RGD:1305069	E	RGD:6480464	20170103	CTD	MESH:C517782	pasireotide results in decreased expression of SMAD6 mRNA	PMID:23137853
1312880	SMAD6	SMAD family member 6	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SMAD6 mRNA	PMID:31758290
1312880	SMAD6	SMAD family member 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SMAD6 mRNA	PMID:22206623
1312880	SMAD6	SMAD family member 6	gene	CHEBI:7507	neomycin	increases expression	ISO	RGD:1312881	E	RGD:6480464	20190507	CTD	MESH:D009355	Neomycin results in increased expression of SMAD6 mRNA	PMID:30626089
1312880	SMAD6	SMAD family member 6	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SMAD6 mRNA	PMID:22079256|PMID:22714537
1312880	SMAD6	SMAD family member 6	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMAD6 mRNA	PMID:22079256
1312880	SMAD6	SMAD family member 6	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of SMAD6 mRNA	PMID:32858204
1312880	SMAD6	SMAD family member 6	gene	CHEBI:7726	octreotide	decreases expression	ISO	RGD:1305069	E	RGD:6480464	20141111	CTD	MESH:D015282	Octreotide results in decreased expression of SMAD6 mRNA	PMID:23137853
1312880	SMAD6	SMAD family member 6	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1305069	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of SMAD6 mRNA	PMID:23665939
1312880	SMAD6	SMAD family member 6	gene	CHEBI:78420	icariin	multiple interactions	ISO	RGD:1312881	E	RGD:6480464	20140520	CTD	MESH:C056599	SMAD6 protein inhibits the reaction [icariin results in increased expression of BGLAP mRNA]; SMAD6 protein inhibits the reaction [icariin results in increased expression of SPP1 mRNA]	PMID:18295595
1312880	SMAD6	SMAD family member 6	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SMAD6 gene]	PMID:28238834
1312880	SMAD6	SMAD family member 6	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of SMAD6 mRNA	PMID:21278054
1312880	SMAD6	SMAD family member 6	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1305069	E	RGD:6480464	20120412	CTD	MESH:D013311	Streptozocin results in increased expression of SMAD6 protein	PMID:17437042
1312880	SMAD6	SMAD family member 6	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in decreased expression of SMAD6 mRNA	PMID:29453283
1312880	SMAD6	SMAD family member 6	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312881	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of SMAD6 mRNA	PMID:28973697
1312880	SMAD6	SMAD family member 6	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312881	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SMAD6 mRNA	PMID:35537566
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312883	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GOLGA7B mRNA	PMID:33045310
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312883	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of GOLGA7B mRNA	PMID:37995155
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of GOLGA7B mRNA	PMID:26079696
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GOLGA7B mRNA	PMID:35811015
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of GOLGA7B mRNA	PMID:30510588
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of GOLGA7B mRNA	PMID:38568856
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GOLGA7B mRNA	PMID:37042841
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of GOLGA7B mRNA	PMID:26079696
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of GOLGA7B mRNA	PMID:28903495
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of GOLGA7B mRNA	PMID:35954277
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312883	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of GOLGA7B mRNA	PMID:37682722
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GOLGA7B promoter	PMID:27901495
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312883	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GOLGA7B exon; Benzo(a)pyrene results in increased methylation of GOLGA7B intron	PMID:27901495
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312883	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GOLGA7B gene	PMID:35295148
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1583839	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GOLGA7B mRNA	PMID:25181051
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of GOLGA7B mRNA	PMID:31715268
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1583839	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GOLGA7B mRNA	PMID:34947998
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312883	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of GOLGA7B mRNA	PMID:40203079
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1312883	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of GOLGA7B mRNA	PMID:26377693
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312883	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of GOLGA7B mRNA	PMID:38685157
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312883	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of GOLGA7B mRNA	PMID:21266533
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1583839	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of GOLGA7B mRNA	PMID:35163327
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1583839	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of GOLGA7B mRNA	PMID:35163327
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GOLGA7B mRNA	PMID:38174414
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1583839	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of GOLGA7B mRNA	PMID:35163327
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312883	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GOLGA7B mRNA	PMID:40194260
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GOLGA7B gene	PMID:29154799
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312883	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of GOLGA7B mRNA	PMID:28973697
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GOLGA7B mRNA	PMID:38832940
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GOLGA7B mRNA	PMID:35811015
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312883	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of GOLGA7B mRNA	PMID:23608068
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1583839	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of GOLGA7B gene	PMID:35440735
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of GOLGA7B mRNA	PMID:26079696
1312882	GOLGA7B	golgin A7 family member B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1583839	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GOLGA7B mRNA	PMID:24780913
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312887	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYP4V3 mRNA	PMID:30529165
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CYP4V2 mRNA	PMID:26079696
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CYP4V2 mRNA	PMID:22378314
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1312887	E	RGD:6480464	20230404	CTD	MESH:D001280	Atrazine results in increased expression of CYP4V3 mRNA	PMID:36216167
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1312887	E	RGD:6480464	20230404	CTD	MESH:D001280	Lycopene inhibits the reaction [Atrazine results in increased expression of CYP4V3 mRNA]	PMID:36216167
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:15948	lycopene	increases expression	ISO	RGD:1312887	E	RGD:6480464	20230404	CTD	MESH:C015329	Lycopene results in increased expression of CYP4V3 mRNA	PMID:36216167
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1312887	E	RGD:6480464	20230404	CTD	MESH:C015329	Lycopene inhibits the reaction [Atrazine results in increased expression of CYP4V3 mRNA]	PMID:36216167
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312887	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CYP4V3 mRNA	PMID:30319688
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312887	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CYP4V3 mRNA	PMID:30319688
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CYP4V3 mRNA	PMID:39241906
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CYP4V3 mRNA	PMID:39298647
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:708530	E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of CYP4V3 mRNA	PMID:35192832
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of CYP4V2 mRNA	PMID:30165855
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CYP4V3 mRNA	PMID:19448997|PMID:25549359
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:708530	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CYP4V3 mRNA	PMID:33387578
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CYP4V2 mRNA	PMID:21179406
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:17241	1H-pyrazole	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in decreased expression of CYP4V3 mRNA	PMID:17945193
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CYP4V2 mRNA	PMID:31163220
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:708530	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CYP4V3 mRNA	PMID:33387578
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CYP4V2 mRNA	PMID:28818685
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312887	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYP4V3 mRNA	PMID:36331819
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:708530	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of CYP4V3 mRNA	PMID:28522335
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYP4V2 mRNA	PMID:35301059
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CYP4V2 mRNA	PMID:19549813
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CYP4V2 protein	PMID:20106945
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CYP4V2 mRNA	PMID:27153756
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:708530	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CYP4V3 mRNA	PMID:33354967
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CYP4V3 mRNA	PMID:17484886|PMID:27339419|PMID:31919559
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CYP4V3 mRNA	PMID:25629700
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYP4V2 mRNA	PMID:39836092
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CYP4V3 mRNA	PMID:28189721|PMID:28960355
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:708530	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of CYP4V3 mRNA	PMID:31881176
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312887	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CYP4V3 mRNA	PMID:21570461
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:708530	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CYP4V3 mRNA	PMID:22298810
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CYP4V3 mRNA	PMID:19770486|PMID:28213091
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:708530	E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CYP4V3 mRNA	PMID:21724226
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYP4V2 mRNA	PMID:20106945
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:708530	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYP4V3 mRNA	PMID:33387578
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312887	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP4V3 gene]	PMID:28213091
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of CYP4V2 mRNA	PMID:23649840
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CYP4V2 mRNA	PMID:29803840
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CYP4V2 mRNA	PMID:34032870
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYP4V2 mRNA	PMID:39836092
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CYP4V2 mRNA	PMID:32234424
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312887	E	RGD:6480464	20220111	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CYP4V2 protein	PMID:34472326
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of CYP4V3 mRNA	PMID:18191166
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:708530	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CYP4V3 mRNA	PMID:16483693
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of CYP4V2 gene	PMID:31601247
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:708530	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CYP4V3 mRNA	PMID:34492290
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CYP4V3 mRNA	PMID:18648102
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CYP4V3 mRNA	PMID:20813756
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312887	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYP4V3 mRNA	PMID:19710929
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1312887	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CYP4V3 mRNA	PMID:28472532
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CYP4V3 mRNA	PMID:33221593
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:708530	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CYP4V2 mRNA; bisphenol A results in decreased expression of CYP4V3 mRNA	PMID:25181051|PMID:34947998
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of CYP4V2 mRNA	PMID:27685785|PMID:29275510|PMID:31715268
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312887	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of CYP4V3 mRNA	PMID:38701888
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:708530	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of CYP4V3 mRNA	PMID:33296240|PMID:35192832
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CYP4V2 gene	PMID:31601247
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CYP4V3 mRNA	PMID:39298647
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1312887	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of CYP4V3 mRNA]	PMID:19030233
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CYP4V2 mRNA	PMID:37042841
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of CYP4V2 mRNA	PMID:29024780
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:708530	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of CYP4V3 mRNA	PMID:30723492
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CYP4V2 mRNA	PMID:38568856
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYP4V2 mRNA	PMID:35301059
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CYP4V2 mRNA	PMID:36326898
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of CYP4V3 mRNA	PMID:28903501
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of CYP4V3 mRNA	PMID:28962523
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CYP4V2 mRNA	PMID:31533062
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312887	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of CYP4V3 mRNA	PMID:39529242
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312887	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYP4V3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CYP4V3 mRNA	PMID:36331819
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:708530	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of CYP4V3 mRNA	PMID:25993096
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:39567	12-hydroxylauric acid	increases chemical synthesis	EXP		E	RGD:6480464	20180116	CTD	MESH:C031263	CYP4V2 protein results in increased chemical synthesis of 12-hydroxydodecanoic acid	PMID:28729181
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:39567	12-hydroxylauric acid	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C031263	2-chloro-5-nitrobenzanilide inhibits the reaction [CYP4V2 protein results in increased chemical synthesis of 12-hydroxydodecanoic acid]	PMID:28729181
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CYP4V2 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:29154799
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYP4V2 mRNA	PMID:27188386
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:708530	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of CYP4V3 mRNA	PMID:41580965
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CYP4V2 mRNA	PMID:20106945|PMID:25562108
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of CYP4V3 mRNA	PMID:19770486
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CYP4V2 mRNA	PMID:28973697
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of CYP4V2 mRNA	PMID:23649840
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of CYP4V2 mRNA	PMID:17400583
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CYP4V2 mRNA	PMID:38832940
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of CYP4V2 mRNA	PMID:24935251
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:708530	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CYP4V3 mRNA	PMID:33387578
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYP4V2 mRNA	PMID:39836092
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in decreased expression of CYP4V3 mRNA	PMID:26934552
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:708530	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CYP4V3 mRNA	PMID:29391264
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:708530	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of CYP4V3 mRNA	PMID:30307764
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CYP4V3 mRNA; Nanotubes, Carbon results in decreased expression of CYP4V3 mRNA	PMID:25554681
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C082360	fipronil results in decreased expression of CYP4V2 mRNA	PMID:27091632
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of CYP4V2 mRNA	PMID:27091632
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:708530	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of CYP4V3 mRNA	PMID:24136188|PMID:24793618
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312887	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP4V3 mRNA	PMID:26378955
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:708530	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CYP4V3 mRNA	PMID:30467583
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of CYP4V2 mRNA	PMID:27091632
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CYP4V2 mRNA	PMID:31758290
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312887	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CYP4V3 mRNA	PMID:22206623
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYP4V2 mRNA	PMID:27188386
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312887	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CYP4V3 mRNA	PMID:23091169
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312887	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CYP4V3 mRNA	PMID:38648751
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:708530	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CYP4V3 mRNA	PMID:23640034
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:708530	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CYP4V3 mRNA	PMID:25825206
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYP4V2 mRNA	PMID:27188386
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:708530	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of CYP4V3 mRNA	PMID:19281266
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of CYP4V2 mRNA	PMID:29301935
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of CYP4V2 mRNA	PMID:22378314
1312886	CYP4V2	cytochrome P450 family 4 subfamily V member 2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312887	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of CYP4V2 mRNA	PMID:28973697
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TRIM69 mRNA	PMID:26272509
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA	PMID:27188386
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312889	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TRIM69 mRNA	PMID:33045310
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of TRIM69 mRNA	PMID:31016361
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:149681	methcathinone	increases expression	EXP		E	RGD:6480464	20200602	CTD	MESH:C047806	monomethylpropion results in increased expression of TRIM69 mRNA	PMID:22303338
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TRIM69 mRNA	PMID:33167477
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of TRIM69 mRNA	PMID:25596134
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TRIM69 mRNA	PMID:35811015
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRIM69 mRNA	PMID:35811015
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of TRIM69 mRNA	PMID:30510588
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of TRIM69 mRNA	PMID:30165855
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRIM69 mRNA	PMID:37042841
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TRIM69 mRNA	PMID:37567420
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of TRIM69 mRNA	PMID:33359661
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TRIM69 mRNA	PMID:37567420
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305074	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TRIM69 mRNA	PMID:33387578
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRIM69 mRNA	PMID:21641981
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1305074	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of TRIM69 mRNA	PMID:41580963
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of TRIM69 mRNA	PMID:41430723
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of TRIM69 mRNA	PMID:26272509
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA	PMID:27188386
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312889	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of TRIM69 mRNA	PMID:28189721|PMID:28960355
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305074	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TRIM69 mRNA	PMID:31881176
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:27871	chloroacetaldehyde	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in increased expression of TRIM69 mRNA	PMID:25596134
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TRIM69 mRNA	PMID:24768652|PMID:25583101
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20151110	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM69 mRNA	PMID:17942748
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TRIM69 mRNA	PMID:28001369
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312889	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TRIM69 protein	PMID:28918527
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRIM69 mRNA	PMID:29803840
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TRIM69 mRNA	PMID:37567420
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRIM69 mRNA	PMID:38568856
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312889	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of TRIM69 mRNA	PMID:37682722
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRIM69 5' UTR	PMID:27901495
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRIM69 promoter	PMID:27901495
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TRIM69 mRNA]	PMID:32406909
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of TRIM69 mRNA	PMID:37690743
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIM69 mRNA	PMID:22576693
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305074	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIM69 mRNA	PMID:25181051
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TRIM69 gene	PMID:31601247
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of TRIM69 gene	PMID:22576693
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRIM69 mRNA	PMID:38568856
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305074	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of TRIM69 mRNA	PMID:25539665
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312889	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TRIM69 mRNA	PMID:40194260
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TRIM69 mRNA	PMID:26272509
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA	PMID:27188386
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TRIM69 mRNA	PMID:37567420
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TRIM69 mRNA	PMID:24935251
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312889	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TRIM69 mRNA	PMID:17562736
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRIM69 mRNA	PMID:21420995
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305074	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRIM69 mRNA	PMID:33387578
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TRIM69 mRNA	PMID:35811015
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312889	E	RGD:6480464	20151110	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TRIM69 mRNA	PMID:17942748
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20151110	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM69 mRNA	PMID:17942748
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of TRIM69 mRNA	PMID:38825487
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1312889	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TRIM69 mRNA	PMID:37567420
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305074	E	RGD:6480464	20151110	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of TRIM69 mRNA	PMID:21346803
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA	PMID:27188386
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRIM69 gene]	PMID:28238834
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of TRIM69 mRNA	PMID:26272509
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA	PMID:27188386
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRIM69 mRNA	PMID:27188386
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TRIM69 mRNA	PMID:29301935
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305074	E	RGD:6480464	20151110	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TRIM69 mRNA	PMID:21346803
1312888	TRIM69	tripartite motif containing 69	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312889	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of TRIM69 mRNA	PMID:32835833
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RHBDF1 mRNA	PMID:38218311
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of RHBDF1 mRNA	PMID:23724009
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of RHBDF1 mRNA	PMID:22378314
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312891	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RHBDF1 mRNA	PMID:30319688
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312891	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RHBDF1 mRNA	PMID:39241906
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	Estradiol results in decreased expression of RHBDF1 mRNA	PMID:19167446|PMID:26865669|PMID:28711546
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312891	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RHBDF1 mRNA	PMID:39298647
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RHBDF1 mRNA	PMID:21179406
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHBDF1 mRNA	PMID:37992649
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:17263	estrone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004970	Estrone results in decreased expression of RHBDF1 mRNA	PMID:26865669
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHBDF1 mRNA	PMID:37992649
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312891	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RHBDF1 mRNA	PMID:23892564
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of RHBDF1 protein	PMID:37730182
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RHBDF1 mRNA	PMID:28818685
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RHBDF1 mRNA	PMID:36331819
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RHBDF1 mRNA	PMID:37236586
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RHBDF1 mRNA	PMID:19549813
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RHBDF1 mRNA	PMID:21641981
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312891	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RHBDF1 mRNA	PMID:19770486
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RHBDF1 mRNA	PMID:34911549
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305075	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RHBDF1 mRNA	PMID:31150632
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312891	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RHBDF1 mRNA	PMID:27339419|PMID:31919559
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of RHBDF1 promoter	PMID:21291286
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of RHBDF1 mRNA	PMID:40512198
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RHBDF1 mRNA	PMID:40504410
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of RHBDF1 mRNA	PMID:26272509
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHBDF1 mRNA	PMID:27188386
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RHBDF1 protein	PMID:35688186
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in decreased expression of RHBDF1 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of RHBDF1 mRNA	PMID:19167446|PMID:23557933
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D019833	Genistein results in decreased expression of RHBDF1 mRNA	PMID:26865669
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312891	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RHBDF1 mRNA	PMID:21570461
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305075	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RHBDF1 mRNA	PMID:32109520
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305075	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RHBDF1 mRNA	PMID:33387578
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of RHBDF1 mRNA	PMID:29955902
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305075	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of RHBDF1 mRNA	PMID:28959563
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of RHBDF1 mRNA	PMID:24690739
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RHBDF1 mRNA	PMID:29803840
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHBDF1 mRNA	PMID:37992649
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of RHBDF1 mRNA	PMID:29319823
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RHBDF1 mRNA	PMID:38568856|PMID:39719251
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of RHBDF1 mRNA	PMID:40512198
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RHBDF1 mRNA	PMID:40504410
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of RHBDF1 mRNA	PMID:22378314
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RHBDF1 5' UTR	PMID:27901495
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RHBDF1 mRNA	PMID:32234424
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312891	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RHBDF1 mRNA	PMID:22228805
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RHBDF1 promoter	PMID:27901495
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of RHBDF1 mRNA	PMID:24690739
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:31638	fulvestrant	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C070081	fulvestrant results in increased expression of RHBDF1 mRNA	PMID:26865669
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312891	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RHBDF1 gene	PMID:35295148
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305075	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RHBDF1 mRNA	PMID:34492290
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312891	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RHBDF1 mRNA	PMID:18648102
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312891	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of RHBDF1 mRNA	PMID:17426115|PMID:18301758|PMID:20813756|PMID:23811191
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C006780	bisphenol A results in decreased expression of RHBDF1 mRNA	PMID:28711546
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305075	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RHBDF1 mRNA	PMID:25181051
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312891	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RHBDF1 mRNA	PMID:39298647
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312891	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RHBDF1 mRNA	PMID:38685157
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHBDF1 mRNA	PMID:28628672
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1305075	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of RHBDF1 mRNA	PMID:21241498
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312891	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RHBDF1 mRNA	PMID:21266533
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312891	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of RHBDF1 mRNA	PMID:34813904
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHBDF1 mRNA	PMID:28628672
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312891	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of RHBDF1 mRNA	PMID:34813904
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312891	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of RHBDF1 mRNA	PMID:24535843
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305075	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of RHBDF1 promoter	PMID:22457795
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20121009	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RHBDF1 mRNA; MT3 affects the reaction [Cadmium Chloride affects the expression of RHBDF1 mRNA]	PMID:20371981|PMID:37236586
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of RHBDF1 mRNA	PMID:19376846
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RHBDF1 mRNA	PMID:24449571
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RHBDF1 mRNA	PMID:31533062
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of RHBDF1 mRNA	PMID:19167446
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHBDF1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of RHBDF1 mRNA	PMID:19167446
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RHBDF1 mRNA	PMID:36331819
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RHBDF1 mRNA	PMID:25979313
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of RHBDF1 mRNA	PMID:28001369
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RHBDF1 gene	PMID:29154799
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RHBDF1 mRNA	PMID:25562108
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of RHBDF1 mRNA	PMID:25047013
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHBDF1 mRNA	PMID:28628672
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of RHBDF1 mRNA	PMID:26865669
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RHBDF1 mRNA	PMID:37992649
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of RHBDF1 mRNA]	PMID:21233418
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of RHBDF1 mRNA	PMID:24935251|PMID:26272509
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHBDF1 mRNA	PMID:27188386
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RHBDF1 mRNA	PMID:22230336
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of RHBDF1 mRNA	PMID:24690739
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of RHBDF1 promoter	PMID:21291286
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of RHBDF1 mRNA	PMID:40512198
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RHBDF1 mRNA	PMID:40504410
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305075	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RHBDF1 mRNA	PMID:29391264
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RHBDF1 mRNA	PMID:28628672
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1305075	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of RHBDF1 mRNA	PMID:30307764
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RHBDF1 mRNA	PMID:24810058
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:6784	mestranol	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D008656	Mestranol results in decreased expression of RHBDF1 mRNA	PMID:26865669
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1305075	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of RHBDF1 mRNA	PMID:19564919
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1305075	E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of RHBDF1 mRNA	PMID:19564919
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:73297	SCH 23390	decreases expression	ISO	RGD:1305075	E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 results in decreased expression of RHBDF1 mRNA	PMID:19564919
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:73297	SCH 23390	multiple interactions	ISO	RGD:1305075	E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of RHBDF1 mRNA	PMID:19564919
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312891	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RHBDF1 mRNA	PMID:22206623
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305075	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of RHBDF1 mRNA	PMID:21346803
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHBDF1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHBDF1 mRNA	PMID:27188386
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312891	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of RHBDF1 mRNA	PMID:19482888
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312891	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RHBDF1 mRNA]	PMID:19482888
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312891	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of RHBDF1 mRNA	PMID:31388691
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RHBDF1 mRNA	PMID:19167446
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305075	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RHBDF1 mRNA	PMID:24780913|PMID:25825206
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:8772	raloxifene	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of RHBDF1 mRNA	PMID:26865669
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of RHBDF1 mRNA	PMID:31734321
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHBDF1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RHBDF1 mRNA	PMID:27188386
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RHBDF1 mRNA	PMID:38568856
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of RHBDF1 mRNA	PMID:22378314
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312891	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of RHBDF1 mRNA	PMID:35537566
1312890	RHBDF1	rhomboid 5 homolog 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305075	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of RHBDF1 mRNA	PMID:22570695
1312892	CDC16	cell division cycle 16	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CDC16 mRNA	PMID:38218311
1312892	CDC16	cell division cycle 16	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CDC16 mRNA	PMID:30529165
1312892	CDC16	cell division cycle 16	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312893	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CDC16 mRNA	PMID:30319688
1312892	CDC16	cell division cycle 16	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CDC16 mRNA	PMID:20044591
1312892	CDC16	cell division cycle 16	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of CDC16 mRNA	PMID:14715546
1312892	CDC16	cell division cycle 16	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CDC16 protein	PMID:37730182
1312892	CDC16	cell division cycle 16	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305076	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CDC16 protein	PMID:34915118
1312892	CDC16	cell division cycle 16	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDC16 mRNA	PMID:37236586
1312892	CDC16	cell division cycle 16	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312893	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CDC16 mRNA	PMID:31919559
1312892	CDC16	cell division cycle 16	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CDC16 gene	PMID:25304211
1312892	CDC16	cell division cycle 16	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC16 mRNA	PMID:39836092
1312892	CDC16	cell division cycle 16	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CDC16 mRNA	PMID:19244175
1312892	CDC16	cell division cycle 16	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CDC16 protein	PMID:35688186
1312892	CDC16	cell division cycle 16	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312893	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of CDC16 mRNA	PMID:28960355
1312892	CDC16	cell division cycle 16	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of CDC16 mRNA	PMID:28903495
1312892	CDC16	cell division cycle 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312893	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC16 mRNA	PMID:21570461
1312892	CDC16	cell division cycle 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDC16 mRNA	PMID:17942748
1312892	CDC16	cell division cycle 16	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CDC16 mRNA	PMID:30911355
1312892	CDC16	cell division cycle 16	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDC16 mRNA	PMID:29803840
1312892	CDC16	cell division cycle 16	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312893	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDC16 mRNA	PMID:16014739
1312892	CDC16	cell division cycle 16	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC16 mRNA; sodium arsenite promotes the reaction [CDC16 protein binds to CAPRIN1 protein]	PMID:33939924|PMID:39836092
1312892	CDC16	cell division cycle 16	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312893	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDC16 mRNA	PMID:22228805
1312892	CDC16	cell division cycle 16	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of CDC16 mRNA	PMID:30911355
1312892	CDC16	cell division cycle 16	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of CDC16 mRNA	PMID:31745603
1312892	CDC16	cell division cycle 16	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312893	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CDC16 mRNA	PMID:18648102
1312892	CDC16	cell division cycle 16	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CDC16 mRNA	PMID:30903817
1312892	CDC16	cell division cycle 16	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305076	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CDC16 mRNA	PMID:25181051
1312892	CDC16	cell division cycle 16	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of CDC16 mRNA	PMID:19244175
1312892	CDC16	cell division cycle 16	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CDC16 mRNA	PMID:25979313
1312892	CDC16	cell division cycle 16	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312893	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CDC16 mRNA	PMID:39298647
1312892	CDC16	cell division cycle 16	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312893	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CDC16 mRNA	PMID:37019170
1312892	CDC16	cell division cycle 16	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:1305076	E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of CDC16 mRNA	PMID:17602206
1312892	CDC16	cell division cycle 16	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305076	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CDC16 mRNA	PMID:21266533
1312892	CDC16	cell division cycle 16	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312893	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of CDC16 mRNA	PMID:34813904
1312892	CDC16	cell division cycle 16	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDC16 mRNA	PMID:37042841
1312892	CDC16	cell division cycle 16	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305076	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CDC16 mRNA	PMID:33453195
1312892	CDC16	cell division cycle 16	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDC16 mRNA	PMID:37236586
1312892	CDC16	cell division cycle 16	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CDC16 mRNA	PMID:24449571
1312892	CDC16	cell division cycle 16	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CDC16 mRNA	PMID:19244175
1312892	CDC16	cell division cycle 16	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312893	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of CDC16 mRNA	PMID:17585979
1312892	CDC16	cell division cycle 16	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CDC16 mRNA	PMID:28302478
1312892	CDC16	cell division cycle 16	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CDC16 mRNA	PMID:25979313
1312892	CDC16	cell division cycle 16	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CDC16 mRNA	PMID:20106945|PMID:25562108
1312892	CDC16	cell division cycle 16	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of CDC16 mRNA	PMID:29309887
1312892	CDC16	cell division cycle 16	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305076	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDC16 mRNA	PMID:33387578
1312892	CDC16	cell division cycle 16	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D000082	Acetaminophen results in increased expression of CDC16 mRNA	PMID:38614205
1312892	CDC16	cell division cycle 16	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CDC16 gene	PMID:25304211
1312892	CDC16	cell division cycle 16	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC16 mRNA	PMID:39836092
1312892	CDC16	cell division cycle 16	gene	CHEBI:4744	Echimidine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C000615871	[CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of CDC16 mRNA	PMID:33884520
1312892	CDC16	cell division cycle 16	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CDC16 mRNA	PMID:30529165
1312892	CDC16	cell division cycle 16	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312893	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CDC16 mRNA	PMID:17942748
1312892	CDC16	cell division cycle 16	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDC16 mRNA	PMID:17942748
1312892	CDC16	cell division cycle 16	gene	CHEBI:50161	motexafin gadolinium	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in decreased expression of CDC16 mRNA	PMID:16357179
1312892	CDC16	cell division cycle 16	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDC16 mRNA	PMID:16357179
1312892	CDC16	cell division cycle 16	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312893	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CDC16 mRNA	PMID:35964746
1312892	CDC16	cell division cycle 16	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305076	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CDC16 mRNA	PMID:24136188
1312892	CDC16	cell division cycle 16	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1305076	E	RGD:6480464	20121009	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of CDC16 mRNA	PMID:22841810
1312892	CDC16	cell division cycle 16	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CDC16 protein	PMID:32959892
1312892	CDC16	cell division cycle 16	gene	CHEBI:62984	zinc acetate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in decreased expression of CDC16 mRNA	PMID:16357179
1312892	CDC16	cell division cycle 16	gene	CHEBI:62984	zinc acetate	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CDC16 mRNA	PMID:16357179
1312892	CDC16	cell division cycle 16	gene	CHEBI:6382	Lasiocarpine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of CDC16 mRNA	PMID:33884520
1312892	CDC16	cell division cycle 16	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312893	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CDC16 mRNA	PMID:23650126
1312892	CDC16	cell division cycle 16	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CDC16 mRNA	PMID:15336504
1312892	CDC16	cell division cycle 16	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of CDC16 mRNA	PMID:29309887
1312892	CDC16	cell division cycle 16	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CDC16 mRNA	PMID:31758290
1312892	CDC16	cell division cycle 16	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312893	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CDC16 mRNA	PMID:22206623
1312892	CDC16	cell division cycle 16	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of CDC16 protein	PMID:31285264
1312892	CDC16	cell division cycle 16	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305076	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CDC16 mRNA	PMID:21346803
1312892	CDC16	cell division cycle 16	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305076	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CDC16 mRNA	PMID:21346803
1312892	CDC16	cell division cycle 16	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1305076	E	RGD:6480464	20141111	CTD	MESH:C001899	triptolide results in decreased expression of CDC16 mRNA	PMID:23639586
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305077	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of PIBF1 mRNA	PMID:25152437
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1624034	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PIBF1 mRNA	PMID:39241906
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PIBF1 mRNA	PMID:37042841
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of PIBF1 mRNA; Progesterone results in increased expression of PIBF1 protein	PMID:17701593
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PIBF1 mRNA	PMID:19549813
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305077	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of PIBF1 mRNA	PMID:21396975
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PIBF1 mRNA	PMID:23649840
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PIBF1 gene	PMID:25304211
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1305077	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of PIBF1 gene	PMID:35440735
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1624034	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PIBF1 mRNA	PMID:28960355
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PIBF1 mRNA	PMID:27392435
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PIBF1 mRNA	PMID:27392435
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1624034	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PIBF1 mRNA	PMID:21570461
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1624034	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PIBF1 mRNA	PMID:15034205
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PIBF1 mRNA	PMID:33212167
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PIBF1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1624034	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PIBF1 mRNA	PMID:15034205
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:31527	dydrogesterone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004394	Dydrogesterone affects the expression of PIBF1 protein	PMID:15760377
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:31527	dydrogesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004394	Dydrogesterone results in increased expression of PIBF1 protein	PMID:16045524
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1305077	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of PIBF1 mRNA	PMID:22641619
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1624034	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PIBF1 promoter	PMID:35295148
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305077	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PIBF1 mRNA	PMID:34492290
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305077	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PIBF1 mRNA	PMID:25181051
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305077	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of PIBF1 mRNA	PMID:41034487
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of PIBF1 gene	PMID:31601247
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1624034	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of PIBF1 mRNA	PMID:36464114
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PIBF1 mRNA	PMID:37042841
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PIBF1 mRNA	PMID:28302478
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PIBF1 mRNA	PMID:25979313
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of PIBF1 mRNA	PMID:23179753
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PIBF1 gene	PMID:29154799
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PIBF1 mRNA	PMID:20106945|PMID:25562108
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PIBF1 mRNA	PMID:21420995
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PIBF1 gene	PMID:25304211
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PIBF1 mRNA	PMID:22079256
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:50692	mifepristone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in decreased expression of PIBF1 mRNA; Mifepristone results in decreased expression of PIBF1 protein	PMID:17701593
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305077	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of PIBF1 mRNA	PMID:20080153
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305077	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PIBF1 gene	PMID:35440735
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1624034	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of PIBF1 mRNA	PMID:36464114
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1624034	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PIBF1 mRNA	PMID:22206623
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PIBF1 mRNA	PMID:22079256
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PIBF1 mRNA	PMID:22079256
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of PIBF1 mRNA	PMID:30928695
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1624034	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of PIBF1 mRNA	PMID:31388691
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1624034	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of PIBF1 mRNA	PMID:40826991
1312894	PIBF1	progesterone immunomodulatory binding factor 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305077	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PIBF1 mRNA	PMID:23034163
1312895	SULF2	sulfatase 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SULF2 mRNA	PMID:38218311
1312895	SULF2	sulfatase 2	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305078	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SULF2 mRNA]	PMID:31150632
1312895	SULF2	sulfatase 2	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SULF2 mRNA	PMID:39752319
1312895	SULF2	sulfatase 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of SULF2 mRNA]	PMID:19467301
1312895	SULF2	sulfatase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SULF2 mRNA	PMID:23724009
1312895	SULF2	sulfatase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SULF2 mRNA	PMID:21934132|PMID:33167477
1312895	SULF2	sulfatase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1305078	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of SULF2 mRNA	PMID:20488242
1312895	SULF2	sulfatase 2	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20150825	CTD	MESH:D010100	[Oxygen deficiency co-treated with Oxygen] results in decreased expression of SULF2 mRNA; SULT1E1 protein promotes the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of SULF2 mRNA]	PMID:25922074
1312895	SULF2	sulfatase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SULF2 mRNA	PMID:36331819
1312895	SULF2	sulfatase 2	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of SULF2 mRNA	PMID:39506029
1312895	SULF2	sulfatase 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1305078	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of SULF2 mRNA	PMID:36841081
1312895	SULF2	sulfatase 2	gene	CHEBI:16037	2-nitropropane	increases expression	ISO	RGD:1305078	E	RGD:6480464	20120412	CTD	MESH:C016617	2-nitropropane results in increased expression of SULF2 mRNA	PMID:17070881
1312895	SULF2	sulfatase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312896	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SULF2 mRNA	PMID:30319688
1312895	SULF2	sulfatase 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312896	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SULF2 mRNA	PMID:30319688
1312895	SULF2	sulfatase 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of SULF2 mRNA	PMID:21632981
1312895	SULF2	sulfatase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SULF2 mRNA	PMID:39241906
1312895	SULF2	sulfatase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SULF2 mRNA	PMID:32145629
1312895	SULF2	sulfatase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SULF2 mRNA	PMID:39298647
1312895	SULF2	sulfatase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in increased expression of SULF2 mRNA	PMID:20106945|PMID:21632981
1312895	SULF2	sulfatase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SULF2 mRNA	PMID:30165855
1312895	SULF2	sulfatase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305078	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SULF2 mRNA	PMID:32741896
1312895	SULF2	sulfatase 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312896	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of SULF2 mRNA	PMID:33711761
1312895	SULF2	sulfatase 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SULF2 mRNA	PMID:38568856
1312895	SULF2	sulfatase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SULF2 mRNA	PMID:37042841
1312895	SULF2	sulfatase 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of SULF2 mRNA	PMID:28937961
1312895	SULF2	sulfatase 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SULF2 mRNA	PMID:23649840
1312895	SULF2	sulfatase 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of SULF2 mRNA	PMID:20864642
1312895	SULF2	sulfatase 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SULF2 mRNA	PMID:21179406
1312895	SULF2	sulfatase 2	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SULF2 mRNA	PMID:26079696
1312895	SULF2	sulfatase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SULF2 mRNA	PMID:37992649
1312895	SULF2	sulfatase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SULF2 mRNA	PMID:39752319
1312895	SULF2	sulfatase 2	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of SULF2 mRNA	PMID:21592394
1312895	SULF2	sulfatase 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SULF2 mRNA	PMID:21592394
1312895	SULF2	sulfatase 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305078	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SULF2 mRNA	PMID:32741896
1312895	SULF2	sulfatase 2	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1305078	E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of SULF2 mRNA	PMID:17070881
1312895	SULF2	sulfatase 2	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1312896	E	RGD:6480464	20121113	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of SULF2 mRNA	PMID:21607683
1312895	SULF2	sulfatase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SULF2 mRNA	PMID:37992649
1312895	SULF2	sulfatase 2	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SULF2 mRNA	PMID:36139627
1312895	SULF2	sulfatase 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SULF2 mRNA	PMID:21592394
1312895	SULF2	sulfatase 2	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SULF2 mRNA	PMID:21592394
1312895	SULF2	sulfatase 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of SULF2 intron	PMID:30157460
1312895	SULF2	sulfatase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SULF2 mRNA	PMID:36331819
1312895	SULF2	sulfatase 2	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in increased expression of SULF2 mRNA	PMID:20368581
1312895	SULF2	sulfatase 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SULF2 mRNA	PMID:39836092
1312895	SULF2	sulfatase 2	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in decreased expression of SULF2 mRNA	PMID:28860664
1312895	SULF2	sulfatase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SULF2 mRNA	PMID:37236586
1312895	SULF2	sulfatase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SULF2 mRNA	PMID:19549813
1312895	SULF2	sulfatase 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SULF2 mRNA	PMID:23649840
1312895	SULF2	sulfatase 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SULF2 protein	PMID:20106945
1312895	SULF2	sulfatase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SULF2 mRNA	PMID:21632981|PMID:21641981
1312895	SULF2	sulfatase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305078	E	RGD:6480464	20121113	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SULF2 mRNA	PMID:22484513|PMID:33354967
1312895	SULF2	sulfatase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312896	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SULF2 mRNA	PMID:19770486
1312895	SULF2	sulfatase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SULF2 gene; Aflatoxin B1 results in increased methylation of SULF2 intron	PMID:27153756|PMID:30157460
1312895	SULF2	sulfatase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SULF2 mRNA	PMID:23649840
1312895	SULF2	sulfatase 2	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312896	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SULF2 mRNA	PMID:32553695
1312895	SULF2	sulfatase 2	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20201006	CTD	MESH:D015127	[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of SULF2 mRNA	PMID:32553695
1312895	SULF2	sulfatase 2	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312896	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of SULF2 mRNA	PMID:24535564
1312895	SULF2	sulfatase 2	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305078	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of SULF2 mRNA	PMID:30779732
1312895	SULF2	sulfatase 2	gene	CHEBI:27300	vitamin D	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D014807	Vitamin D affects the expression of SULF2 mRNA	PMID:20368581
1312895	SULF2	sulfatase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SULF2 mRNA	PMID:31150632
1312895	SULF2	sulfatase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305078	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SULF2 mRNA]	PMID:31150632
1312895	SULF2	sulfatase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SULF2 mRNA]	PMID:22206623
1312895	SULF2	sulfatase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SULF2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SULF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SULF2 mRNA	PMID:32525701|PMID:39836092
1312895	SULF2	sulfatase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SULF2 mRNA	PMID:40504410
1312895	SULF2	sulfatase 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SULF2 mRNA	PMID:26272509
1312895	SULF2	sulfatase 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA	PMID:27188386
1312895	SULF2	sulfatase 2	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1305078	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of SULF2 gene	PMID:31011160
1312895	SULF2	sulfatase 2	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C059514	resveratrol results in increased expression of SULF2 mRNA	PMID:25888808
1312895	SULF2	sulfatase 2	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of SULF2 mRNA	PMID:23300844
1312895	SULF2	sulfatase 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of SULF2 mRNA	PMID:27392435
1312895	SULF2	sulfatase 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SULF2 mRNA; [Cisplatin co-treated with panobinostat] affects the expression of SULF2 mRNA	PMID:21791302|PMID:27392435
1312895	SULF2	sulfatase 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of SULF2 mRNA	PMID:18847459
1312895	SULF2	sulfatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305078	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SULF2 mRNA	PMID:34747641
1312895	SULF2	sulfatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312896	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SULF2 mRNA	PMID:28213091
1312895	SULF2	sulfatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SULF2 mRNA	PMID:21215274
1312895	SULF2	sulfatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SULF2 mRNA	PMID:26290441
1312895	SULF2	sulfatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SULF2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SULF2 gene]	PMID:17942748|PMID:28213091
1312895	SULF2	sulfatase 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of SULF2 mRNA	PMID:29955902
1312895	SULF2	sulfatase 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305078	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of SULF2 mRNA	PMID:28374803
1312895	SULF2	sulfatase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SULF2 mRNA	PMID:23179753|PMID:26272509
1312895	SULF2	sulfatase 2	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA	PMID:27188386
1312895	SULF2	sulfatase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SULF2 mRNA	PMID:33212167
1312895	SULF2	sulfatase 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SULF2 mRNA	PMID:32763439
1312895	SULF2	sulfatase 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of SULF2 mRNA	PMID:20971185
1312895	SULF2	sulfatase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of SULF2 mRNA	PMID:39631538
1312895	SULF2	sulfatase 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SULF2 mRNA	PMID:29803840|PMID:30031762
1312895	SULF2	sulfatase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SULF2 mRNA	PMID:37992649
1312895	SULF2	sulfatase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of SULF2 mRNA	PMID:20371982|PMID:38568856
1312895	SULF2	sulfatase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SULF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SULF2 mRNA	PMID:39836092
1312895	SULF2	sulfatase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SULF2 mRNA	PMID:40504410
1312895	SULF2	sulfatase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SULF2 mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1312895	SULF2	sulfatase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312896	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of SULF2 mRNA; Benzo(a)pyrene results in increased expression of SULF2 mRNA	PMID:19770486|PMID:22610609|PMID:32553695
1312895	SULF2	sulfatase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SULF2 promoter	PMID:27901495
1312895	SULF2	sulfatase 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of SULF2 mRNA	PMID:20971185
1312895	SULF2	sulfatase 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SULF2 mRNA	PMID:25895662
1312895	SULF2	sulfatase 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SULF2 mRNA	PMID:22521957
1312895	SULF2	sulfatase 2	gene	CHEBI:31175	adefovir pivoxil	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305078	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SULF2 mRNA	PMID:30047161
1312895	SULF2	sulfatase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SULF2 mRNA	PMID:23557971
1312895	SULF2	sulfatase 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SULF2 mRNA	PMID:34492290
1312895	SULF2	sulfatase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312896	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SULF2 mRNA	PMID:17426115|PMID:18301758|PMID:18445702|PMID:20813756|PMID:23811191
1312895	SULF2	sulfatase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SULF2 mRNA	PMID:19710929
1312895	SULF2	sulfatase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305078	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SULF2 mRNA	PMID:25181051
1312895	SULF2	sulfatase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SULF2 mRNA	PMID:25047013
1312895	SULF2	sulfatase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of SULF2 mRNA	PMID:32145629
1312895	SULF2	sulfatase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SULF2 mRNA	PMID:33221593
1312895	SULF2	sulfatase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312896	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in increased expression of SULF2 mRNA	PMID:35479511
1312895	SULF2	sulfatase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312896	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SULF2 promoter	PMID:27312807
1312895	SULF2	sulfatase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SULF2 mRNA	PMID:28628672
1312895	SULF2	sulfatase 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SULF2 mRNA	PMID:25979313
1312895	SULF2	sulfatase 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312896	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SULF2 mRNA	PMID:26682919
1312895	SULF2	sulfatase 2	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1305078	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of SULF2 mRNA	PMID:17070881
1312895	SULF2	sulfatase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SULF2 mRNA	PMID:39298647
1312895	SULF2	sulfatase 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312896	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of SULF2 mRNA	PMID:26377693
1312895	SULF2	sulfatase 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SULF2 intron	PMID:30157460
1312895	SULF2	sulfatase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SULF2 mRNA	PMID:28628672
1312895	SULF2	sulfatase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312896	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SULF2 intron	PMID:28392331
1312895	SULF2	sulfatase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SULF2 mRNA	PMID:21266533
1312895	SULF2	sulfatase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SULF2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SULF2 mRNA	PMID:28628672
1312895	SULF2	sulfatase 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312896	E	RGD:6480464	20121113	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of SULF2 mRNA	PMID:21607683
1312895	SULF2	sulfatase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SULF2 mRNA	PMID:37042841
1312895	SULF2	sulfatase 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of SULF2 mRNA	PMID:29024780
1312895	SULF2	sulfatase 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305078	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SULF2 mRNA	PMID:35163327
1312895	SULF2	sulfatase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SULF2 mRNA	PMID:39836092
1312895	SULF2	sulfatase 2	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1312896	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of SULF2 mRNA	PMID:26377693
1312895	SULF2	sulfatase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SULF2 mRNA	PMID:37236586
1312895	SULF2	sulfatase 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305078	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SULF2 mRNA	PMID:35163327
1312895	SULF2	sulfatase 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305078	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of SULF2 mRNA	PMID:26194646
1312895	SULF2	sulfatase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312896	E	RGD:6480464	20161025	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SULF2 mRNA	PMID:27413110|PMID:28903501
1312895	SULF2	sulfatase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SULF2 mRNA	PMID:19320972
1312895	SULF2	sulfatase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SULF2 mRNA	PMID:24386269
1312895	SULF2	sulfatase 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SULF2 mRNA	PMID:24449571
1312895	SULF2	sulfatase 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1312896	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of SULF2 mRNA	PMID:28962523
1312895	SULF2	sulfatase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312896	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of SULF2 mRNA	PMID:18353800
1312895	SULF2	sulfatase 2	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312896	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of SULF2 mRNA	PMID:17585979
1312895	SULF2	sulfatase 2	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SULF2 mRNA	PMID:28302478
1312895	SULF2	sulfatase 2	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SULF2 mRNA	PMID:19167446
1312895	SULF2	sulfatase 2	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SULF2 mRNA	PMID:19167446
1312895	SULF2	sulfatase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SULF2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SULF2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SULF2 mRNA	PMID:36331819
1312895	SULF2	sulfatase 2	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SULF2 mRNA]	PMID:18200517
1312895	SULF2	sulfatase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SULF2 mRNA	PMID:25979313
1312895	SULF2	sulfatase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SULF2 mRNA	PMID:17963808
1312895	SULF2	sulfatase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SULF2 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1312895	SULF2	sulfatase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312896	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of SULF2 mRNA	PMID:24535564
1312895	SULF2	sulfatase 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305078	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SULF2 mRNA	PMID:30047161
1312895	SULF2	sulfatase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SULF2 mRNA	PMID:25562108|PMID:25596134|PMID:27989131
1312895	SULF2	sulfatase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SULF2 mRNA	PMID:17555576
1312895	SULF2	sulfatase 2	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1312896	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of SULF2 mRNA	PMID:25123088
1312895	SULF2	sulfatase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SULF2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SULF2 mRNA	PMID:28628672
1312895	SULF2	sulfatase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SULF2 mRNA	PMID:28973697
1312895	SULF2	sulfatase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SULF2 mRNA	PMID:37992649
1312895	SULF2	sulfatase 2	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of SULF2 mRNA	PMID:23649840
1312895	SULF2	sulfatase 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SULF2 mRNA	PMID:38832940
1312895	SULF2	sulfatase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SULF2 mRNA	PMID:22230336
1312895	SULF2	sulfatase 2	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:46680	serpentine asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased expression of SULF2 mRNA	PMID:29523930
1312895	SULF2	sulfatase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SULF2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SULF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SULF2 mRNA	PMID:32525701|PMID:39836092
1312895	SULF2	sulfatase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SULF2 mRNA	PMID:40504410
1312895	SULF2	sulfatase 2	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of SULF2 mRNA	PMID:26833863
1312895	SULF2	sulfatase 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SULF2 mRNA	PMID:29391264
1312895	SULF2	sulfatase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SULF2 mRNA	PMID:17555576
1312895	SULF2	sulfatase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SULF2 mRNA	PMID:17942748
1312895	SULF2	sulfatase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SULF2 mRNA	PMID:17942748
1312895	SULF2	sulfatase 2	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of SULF2 mRNA	PMID:26272509
1312895	SULF2	sulfatase 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA	PMID:27188386
1312895	SULF2	sulfatase 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SULF2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SULF2 mRNA	PMID:28628672
1312895	SULF2	sulfatase 2	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SULF2 mRNA	PMID:22521957
1312895	SULF2	sulfatase 2	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SULF2 mRNA	PMID:23300844
1312895	SULF2	sulfatase 2	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305078	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SULF2 mRNA	PMID:30307764
1312895	SULF2	sulfatase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SULF2 mRNA; Nanotubes, Carbon results in decreased expression of SULF2 mRNA	PMID:25620056
1312895	SULF2	sulfatase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312896	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SULF2 mRNA	PMID:25554681
1312895	SULF2	sulfatase 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305078	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SULF2 mRNA	PMID:30047161
1312895	SULF2	sulfatase 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1312896	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of SULF2 mRNA	PMID:40234311
1312895	SULF2	sulfatase 2	gene	CHEBI:51052	lucanthone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in increased expression of SULF2 mRNA	PMID:21148553
1312895	SULF2	sulfatase 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of SULF2 mRNA	PMID:24136188
1312895	SULF2	sulfatase 2	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of SULF2 mRNA	PMID:22714537
1312895	SULF2	sulfatase 2	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of SULF2 mRNA	PMID:18200517
1312895	SULF2	sulfatase 2	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20120412	CTD	MESH:D014302	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of SULF2 mRNA]	PMID:18200517
1312895	SULF2	sulfatase 2	gene	CHEBI:5855	ibuprofen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in decreased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:5864	ifosfamide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SULF2 mRNA	PMID:39836092
1312895	SULF2	sulfatase 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SULF2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SULF2 mRNA	PMID:21641980|PMID:26378955
1312895	SULF2	sulfatase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305078	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SULF2 mRNA	PMID:28801915
1312895	SULF2	sulfatase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases methylation	ISO	RGD:1305078	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased methylation of SULF2 gene	PMID:28801915
1312895	SULF2	sulfatase 2	gene	CHEBI:67116	4-nitro-1,2-phenylenediamine	affects expression	ISO	RGD:1305078	E	RGD:6480464	20120904	CTD	MESH:C012277	1,2-diamino-4-nitrobenzene affects the expression of SULF2 mRNA	PMID:17070881
1312895	SULF2	sulfatase 2	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SULF2 intron	PMID:30157460
1312895	SULF2	sulfatase 2	gene	CHEBI:68508	diethyl maleate	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in decreased expression of SULF2 mRNA	PMID:21161181
1312895	SULF2	sulfatase 2	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SULF2 mRNA	PMID:39752319
1312895	SULF2	sulfatase 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SULF2 mRNA	PMID:31758290
1312895	SULF2	sulfatase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1305078	E	RGD:6480464	20180220	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SULF2 mRNA	PMID:27840820
1312895	SULF2	sulfatase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312896	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SULF2 mRNA	PMID:22206623
1312895	SULF2	sulfatase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SULF2 mRNA]	PMID:22206623
1312895	SULF2	sulfatase 2	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of SULF2 mRNA	PMID:24136188
1312895	SULF2	sulfatase 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SULF2 mRNA	PMID:22714537
1312895	SULF2	sulfatase 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SULF2 mRNA	PMID:37199045
1312895	SULF2	sulfatase 2	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SULF2 mRNA	PMID:36139627
1312895	SULF2	sulfatase 2	gene	CHEBI:76261	1-nitropropane	increases expression	ISO	RGD:1305078	E	RGD:6480464	20161220	CTD	MESH:C035314	1-nitropropane results in increased expression of SULF2 mRNA	PMID:17070881
1312895	SULF2	sulfatase 2	gene	CHEBI:76288	2,6-diaminotoluene	increases expression	ISO	RGD:1305078	E	RGD:6480464	20140107	CTD	MESH:C025235	2,6-diaminotoluene results in increased expression of SULF2 mRNA	PMID:17070881
1312895	SULF2	sulfatase 2	gene	CHEBI:76343	4-acetylaminofluorene	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20140107	CTD	MESH:C028676	4-acetylaminofluorene results in decreased expression of SULF2 mRNA	PMID:17070881
1312895	SULF2	sulfatase 2	gene	CHEBI:76394	2-nitro-p-phenylenediamine	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20140107	CTD	MESH:C014706	2-nitro-4-phenylenediamine results in decreased expression of SULF2 mRNA	PMID:17070881
1312895	SULF2	sulfatase 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305078	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SULF2 mRNA	PMID:32741896
1312895	SULF2	sulfatase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA	PMID:27188386
1312895	SULF2	sulfatase 2	gene	CHEBI:7852	oxycodone	increases expression	ISO	RGD:1305078	E	RGD:6480464	20161025	CTD	MESH:D010098	Oxycodone results in increased expression of SULF2 mRNA	PMID:23439660
1312895	SULF2	sulfatase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SULF2 gene]	PMID:28238834
1312895	SULF2	sulfatase 2	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SULF2 mRNA	PMID:19159669
1312895	SULF2	sulfatase 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312896	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SULF2 mRNA	PMID:31388691
1312895	SULF2	sulfatase 2	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SULF2 mRNA	PMID:19167446
1312895	SULF2	sulfatase 2	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of SULF2 mRNA	PMID:20368581
1312895	SULF2	sulfatase 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of SULF2 mRNA	PMID:26079696
1312895	SULF2	sulfatase 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312896	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of SULF2 mRNA	PMID:30953684
1312895	SULF2	sulfatase 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312896	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SULF2 mRNA	PMID:39847705
1312895	SULF2	sulfatase 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SULF2 mRNA	PMID:32525701
1312895	SULF2	sulfatase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SULF2 mRNA	PMID:25825206
1312895	SULF2	sulfatase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305078	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SULF2 mRNA	PMID:30047161
1312895	SULF2	sulfatase 2	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[Cisplatin co-treated with panobinostat] affects the expression of SULF2 mRNA	PMID:21791302
1312895	SULF2	sulfatase 2	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1312896	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SULF2 mRNA	PMID:39752319
1312895	SULF2	sulfatase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULF2 mRNA	PMID:27188386
1312895	SULF2	sulfatase 2	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1305078	E	RGD:6480464	20260804	CTD	MESH:D013605	T-2 Toxin results in increased expression of SULF2 mRNA	PMID:42167635
1312895	SULF2	sulfatase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305078	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SULF2 mRNA	PMID:21346803
1312895	SULF2	sulfatase 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1305078	E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of SULF2 mRNA	PMID:25596134
1312895	SULF2	sulfatase 2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1312896	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of SULF2 mRNA	PMID:28973697
1312895	SULF2	sulfatase 2	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1312896	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of SULF2 mRNA	PMID:35537566
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of DSE mRNA	PMID:33167477
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of DSE mRNA	PMID:21632981
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of DSE mRNA	PMID:22574217
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312898	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DSE mRNA	PMID:39298647
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305079	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DSE mRNA	PMID:33387578
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of DSE mRNA	PMID:23649840
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DSE mRNA	PMID:21179406
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DSE mRNA	PMID:37992649
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of DSE gene	PMID:33872906
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DSE mRNA	PMID:37992649
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312898	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DSE mRNA	PMID:34319233
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of DSE gene	PMID:33872906
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305079	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DSE mRNA	PMID:39012411
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of DSE protein	PMID:20106945
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DSE gene	PMID:27153756
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DSE mRNA	PMID:22100608
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of DSE mRNA	PMID:41430723
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312898	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DSE mRNA	PMID:31919559
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:27504	mitomycin C	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	DSE protein affects the susceptibility to Mitomycin	PMID:16217747
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DSE mRNA	PMID:40504410
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DSE mRNA	PMID:19244175
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312898	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of DSE mRNA	PMID:28960355
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305079	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DSE mRNA	PMID:31881176
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of DSE mRNA	PMID:27392435|PMID:27594783
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305079	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DSE mRNA	PMID:33387578
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305079	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DSE mRNA	PMID:34747641
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of DSE mRNA	PMID:29955902
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DSE mRNA	PMID:33212167
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DSE mRNA	PMID:32763439
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of DSE mRNA	PMID:24690739
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DSE mRNA	PMID:37992649
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DSE mRNA	PMID:38568856
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DSE mRNA	PMID:40504410
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of DSE mRNA	PMID:20106945
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DSE 5' UTR; Benzo(a)pyrene affects the methylation of DSE promoter	PMID:27901495
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DSE mRNA	PMID:21632981|PMID:21871943
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DSE mRNA	PMID:32234424
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of DSE mRNA	PMID:24690739
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DSE mRNA	PMID:19150397
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:31348	capecitabine	decreases response to substance	EXP		E	RGD:6480464	20170228	CTD	MESH:C110904	DSE protein results in decreased susceptibility to Capecitabine	PMID:16734730
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:31521	doxifluridine	decreases response to substance	EXP		E	RGD:6480464	20130806	CTD	MESH:C025034	DSE protein results in decreased susceptibility to doxifluridine	PMID:16734730
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312898	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of DSE mRNA	PMID:35295148
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305079	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of DSE mRNA	PMID:34492290
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1312898	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DSE mRNA	PMID:18648102
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305079	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DSE mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305079	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of DSE mRNA	PMID:41034487
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of DSE mRNA	PMID:25979313
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312898	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of DSE mRNA	PMID:26682919
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312898	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DSE mRNA	PMID:39298647
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of DSE gene	PMID:31601247
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312898	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of DSE mRNA	PMID:30951980
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312898	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of DSE mRNA	PMID:30951980
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene results in decreased expression of DSE mRNA	PMID:17374397
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of DSE mRNA	PMID:29024780
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305079	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DSE mRNA	PMID:39012411
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:35842	antirheumatic drug	affects expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents affects the expression of DSE mRNA	PMID:24449571
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DSE mRNA	PMID:19244175
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DSE mRNA	PMID:40419075
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DSE mRNA	PMID:25979313
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of DSE mRNA	PMID:29154799
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of DSE mRNA	PMID:20106945
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312898	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of DSE mRNA	PMID:28973697
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DSE mRNA	PMID:37992649
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305079	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DSE mRNA	PMID:33387578
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of DSE mRNA	PMID:22230336|PMID:29067470
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of DSE mRNA	PMID:24714768
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of DSE mRNA	PMID:24690739
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312898	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DSE mRNA	PMID:40504410
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305079	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of DSE mRNA	PMID:29391264
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DSE mRNA	PMID:22079256
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:48981	quinolin-8-ol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in increased expression of DSE mRNA	PMID:21632981
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305079	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of DSE mRNA	PMID:23962444
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C029938	nickel sulfate results in decreased expression of DSE mRNA	PMID:17374397
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010081	Oxazolone results in decreased expression of DSE mRNA	PMID:17374397
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	DSE protein affects the susceptibility to Topotecan	PMID:16217747
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DSE mRNA	PMID:22079256
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DSE mRNA	PMID:22079256
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DSE gene]	PMID:28238834
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312898	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DSE mRNA	PMID:23091169
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312898	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of DSE mRNA	PMID:31388691
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DSE mRNA	PMID:38568856
1312897	DSE	dermatan sulfate epimerase	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1312898	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of DSE protein	PMID:24648495
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1305080	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CDKL1 mRNA	PMID:30071829
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312900	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CDKL1 mRNA	PMID:22629407
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CDKL1 mRNA]	PMID:22629407
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1312900	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of CDKL1 mRNA	PMID:17556502
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20120412	CTD	MESH:D011374	NCOA2 protein affects the reaction [Progesterone results in decreased expression of CDKL1 mRNA]	PMID:17556502
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312900	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CDKL1 mRNA	PMID:34319233
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CDKL1 protein	PMID:37730182
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CDKL1 mRNA	PMID:28818685
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CDKL1 mRNA	PMID:19549813
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305080	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CDKL1 mRNA	PMID:33354967
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CDKL1 mRNA	PMID:26272509
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDKL1 mRNA	PMID:27188386
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305080	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CDKL1 mRNA	PMID:31881176
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CDKL1 mRNA	PMID:27392435
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312900	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of CDKL1 mRNA	PMID:18930951
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:28009	N-acetyl-beta-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in decreased expression of CDKL1 mRNA	PMID:18047607
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312900	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDKL1 mRNA	PMID:21570461
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305080	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDKL1 mRNA	PMID:33387578
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312900	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of CDKL1 mRNA	PMID:39631538
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDKL1 mRNA	PMID:38568856
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CDKL1 mRNA	PMID:34876320
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CDKL1 mRNA	PMID:34876320
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDKL1 mRNA	PMID:32234424
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CDKL1 exon	PMID:27901495
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of CDKL1 mRNA	PMID:37690743
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1305080	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of CDKL1 mRNA	PMID:16507785
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305080	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CDKL1 mRNA	PMID:30047161
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312900	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CDKL1 mRNA	PMID:23557971|PMID:29264374
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305080	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CDKL1 mRNA	PMID:25181051|PMID:30816183
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of CDKL1 mRNA	PMID:29275510
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312900	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CDKL1 mRNA	PMID:32156529
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305080	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDKL1 mRNA	PMID:36041667
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1312900	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of CDKL1 mRNA	PMID:26682919
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312900	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CDKL1 gene	PMID:31683443
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312900	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of CDKL1 mRNA	PMID:40203079
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305080	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDKL1 mRNA	PMID:36041667
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305080	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDKL1 mRNA	PMID:36041667
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDKL1 mRNA	PMID:37042841
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1305080	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of CDKL1 mRNA	PMID:18500788
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305080	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of CDKL1 mRNA	PMID:25539665
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305080	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of CDKL1 gene	PMID:22079235
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CDKL1 mRNA	PMID:31533062
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305080	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CDKL1 mRNA	PMID:30047161
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312900	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CDKL1 mRNA	PMID:28973697
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CDKL1 mRNA	PMID:38832940
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305080	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CDKL1 mRNA	PMID:33387578
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CDKL1 mRNA	PMID:34876320
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312900	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CDKL1 mRNA	PMID:25554681
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:506227	N-acetyl-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in decreased expression of CDKL1 mRNA	PMID:18047607
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305080	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CDKL1 mRNA	PMID:30047161
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of CDKL1 mRNA	PMID:11830524
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDKL1 mRNA	PMID:27188386
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305080	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CDKL1 mRNA	PMID:32109520
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CDKL1 mRNA	PMID:27935865
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:82436	decabromodiphenyl ether	multiple interactions	ISO	RGD:1305080	E	RGD:6480464	20200714	CTD	MESH:C010902	[Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in decreased expression of CDKL1 mRNA	PMID:32207525
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312900	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CDKL1 mRNA	PMID:34876320
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305080	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CDKL1 mRNA	PMID:30047161
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305080	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CDKL1 mRNA	PMID:24780913
1312899	CDKL1	cyclin dependent kinase like 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDKL1 mRNA	PMID:27188386
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312902	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of AIF1L mRNA	PMID:37995155
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of AIF1L mRNA	PMID:31016361
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:15365	acetylsalicylic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of AIF1L mRNA	PMID:11906190
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of AIF1L mRNA	PMID:21934132
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1305081	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of AIF1L mRNA	PMID:20488242
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of AIF1L mRNA	PMID:30529165
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AIF1L mRNA	PMID:36331819
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of AIF1L mRNA	PMID:26079696
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:15756	hexadecanoic acid	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of AIF1L mRNA	PMID:39506029
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312902	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of AIF1L mRNA	PMID:30319688
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312902	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of AIF1L mRNA	PMID:19484750
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of AIF1L mRNA	PMID:30165855
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of AIF1L mRNA	PMID:38568856
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305081	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of AIF1L mRNA	PMID:33387578
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of AIF1L mRNA	PMID:26079696
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1312902	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of AIF1L mRNA	PMID:33848595
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of AIF1L mRNA]	PMID:33848595
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305081	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of AIF1L mRNA	PMID:26577399
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of AIF1L protein	PMID:37730182
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305081	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of AIF1L mRNA	PMID:33387578
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of AIF1L mRNA	PMID:28818685
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305081	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AIF1L mRNA	PMID:39012411
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of AIF1L mRNA	PMID:19549813
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of AIF1L protein	PMID:23301498
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of AIF1L mRNA	PMID:21641981
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1312902	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of AIF1L mRNA	PMID:18579281
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of AIF1L protein	PMID:35688186
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1312902	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of AIF1L protein	PMID:25505154
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305081	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of AIF1L mRNA	PMID:22023808
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of AIF1L mRNA	PMID:27392435
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of AIF1L mRNA	PMID:27392435
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of AIF1L mRNA	PMID:15009677
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305081	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AIF1L mRNA	PMID:32109520|PMID:33387578
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312902	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AIF1L mRNA	PMID:16611356
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of AIF1L mRNA	PMID:32763439
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305081	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of AIF1L mRNA	PMID:28959563
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:28680	cytarabine	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of AIF1L mRNA	PMID:21198554
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of AIF1L mRNA	PMID:20971185
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of AIF1L mRNA	PMID:15467011
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of AIF1L protein	PMID:35688186
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of AIF1L mRNA	PMID:29432896
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of AIF1L mRNA	PMID:38568856
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of AIF1L mRNA	PMID:29301061
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of AIF1L intron	PMID:30157460
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AIF1L mRNA	PMID:26238291
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312902	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AIF1L mRNA	PMID:21569818
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AIF1L promoter	PMID:27901495
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of AIF1L mRNA	PMID:20971185
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of AIF1L mRNA	PMID:15467011
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of AIF1L gene	PMID:31601247
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of AIF1L mRNA	PMID:38568856
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312902	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of AIF1L mRNA	PMID:29264374
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312902	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AIF1L gene	PMID:35295148
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312902	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of AIF1L mRNA	PMID:27760801
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of AIF1L protein	PMID:37567409
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305081	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of AIF1L mRNA	PMID:25181051|PMID:30816183
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305081	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of AIF1L mRNA	PMID:33296240
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305081	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of AIF1L gene	PMID:28505145
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of AIF1L gene	PMID:31601247
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C543008	bisphenol S results in increased expression of AIF1L mRNA	PMID:25912373
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305081	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of AIF1L mRNA	PMID:35163327
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AIF1L mRNA	PMID:38174414
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305081	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AIF1L mRNA	PMID:39012411
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of AIF1L protein	PMID:26879310
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305081	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of AIF1L mRNA	PMID:35163327
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of AIF1L mRNA	PMID:24449571
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312902	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of AIF1L mRNA	PMID:40194260
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of AIF1L mRNA	PMID:31533062
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of AIF1L mRNA	PMID:40419075
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AIF1L mRNA	PMID:36331819
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AIF1L mRNA	PMID:25979313
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of AIF1L mRNA	PMID:28001369
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of AIF1L mRNA	PMID:19101580|PMID:26272509
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of AIF1L gene	PMID:29154799
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIF1L mRNA	PMID:27188386
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305081	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of AIF1L mRNA	PMID:38685447|PMID:41580965
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of AIF1L mRNA	PMID:25562108
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1305081	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of AIF1L mRNA	PMID:21865292
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312902	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of AIF1L mRNA	PMID:22733784
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1305081	E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of AIF1L mRNA	PMID:36653537
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305081	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of AIF1L mRNA	PMID:33387578
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305081	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of AIF1L mRNA	PMID:29391264
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of AIF1L mRNA	PMID:18175754
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305081	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of AIF1L mRNA	PMID:30307764
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312902	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of AIF1L mRNA	PMID:25554681
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305081	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of AIF1L mRNA	PMID:41580965
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1312902	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of AIF1L mRNA	PMID:23608068
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312902	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AIF1L mRNA	PMID:26378955
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of AIF1L mRNA	PMID:24810058
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of AIF1L mRNA	PMID:31758290
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of AIF1L mRNA	PMID:25912373
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312902	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of AIF1L mRNA	PMID:22206623
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of AIF1L protein	PMID:37664457
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIF1L mRNA	PMID:27188386
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of AIF1L mRNA	PMID:26079696
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305081	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of AIF1L mRNA	PMID:30047161
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of AIF1L protein; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AIF1L mRNA	PMID:27188386|PMID:37664457
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in decreased expression of AIF1L mRNA	PMID:11906190
1312901	AIF1L	allograft inflammatory factor 1 like	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of AIF1L mRNA	PMID:38568856
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of RO60 mRNA	PMID:25596134
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RO60 gene	PMID:20938992
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TROVE2 mRNA	PMID:33167477
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of RO60 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of RO60 mRNA	PMID:32699268
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RO60 mRNA	PMID:25596134
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of RO60 mRNA	PMID:40945087
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of RO60 mRNA	PMID:21179406
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RO60 mRNA	PMID:39241906
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RO60 gene	PMID:20938992
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RO60 mRNA	PMID:21179406
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305083	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RO60 mRNA	PMID:27523638
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:177802	Cuprizon	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	Cuprizone results in increased expression of TROVE2 protein	PMID:34122009
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RO60 protein	PMID:37730182
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305083	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TROVE2 mRNA	PMID:33387578
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RO60 mRNA	PMID:28818685
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of RO60 mRNA	PMID:27462272
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RO60 protein	PMID:23301498
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1305083	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RO60 mRNA	PMID:33354967
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RO60 gene	PMID:27153756
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RO60 mRNA	PMID:19770486
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1305083	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of RO60 mRNA	PMID:41580963
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of RO60 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of RO60 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of RO60 mRNA	PMID:32699268
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of RO60 mRNA	PMID:15226459
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TROVE2 mRNA	PMID:25629700
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RO60 gene	PMID:20938992
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RO60 gene	PMID:25304211
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RO60 mRNA	PMID:40504410
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of RO60 mRNA	PMID:19244175
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of RO60 protein	PMID:38460933
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305083	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RO60 mRNA	PMID:31881176
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of RO60 mRNA	PMID:25596134
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RO60 mRNA	PMID:23557933
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of RO60 mRNA	PMID:25596134
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1305083	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of RO60 mRNA	PMID:17898221
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RO60 mRNA	PMID:21570461
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305083	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RO60 mRNA; Tetrachlorodibenzodioxin results in decreased expression of TROVE2 mRNA	PMID:32109520|PMID:33387578
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RO60 mRNA	PMID:19465110
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RO60 mRNA	PMID:28001369
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305083	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of RO60 mRNA	PMID:28959563
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of RO60 mRNA	PMID:25523186
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RO60 mRNA	PMID:40504410
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of RO60 mRNA	PMID:25523186
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of RO60 mRNA	PMID:15226459
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of RO60 mRNA	PMID:35984750
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305083	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RO60 mRNA	PMID:34492290
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305083	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RO60 mRNA	PMID:25181051
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305083	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RO60 mRNA	PMID:30816183|PMID:34947998
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of RO60 protein	PMID:37567409
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305083	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of RO60 mRNA	PMID:29097150|PMID:33296240
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of RO60 mRNA	PMID:19244175
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RO60 mRNA	PMID:39298647
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RO60 protein	PMID:34186270
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1624075	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RO60 mRNA	PMID:38685157
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RO60 mRNA	PMID:37019170
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of RO60 mRNA	PMID:17312168
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TROVE2 mRNA	PMID:37042841
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:35176	zinc sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of RO60 mRNA	PMID:15226459
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RO60 mRNA	PMID:38568856
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RO60 protein	PMID:24527689
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:36009	omega-6 fatty acid	decreases expression	EXP		E	RGD:6480464	20170117	CTD	MESH:D043371	Fatty Acids, Omega-6 results in decreased expression of RO60 mRNA	PMID:16823509
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of RO60 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of RO60 mRNA	PMID:32699268
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of RO60 mRNA	PMID:19244175
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of RO60 mRNA	PMID:25596134
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RO60 mRNA	PMID:40194260
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RO60 mRNA	PMID:28302478
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1305083	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of RO60 mRNA	PMID:23125180
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305083	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of RO60 mRNA	PMID:29427782
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RO60 mRNA	PMID:23179753
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305083	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of RO60 mRNA	PMID:29427782
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RO60 gene	PMID:29154799
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RO60 mRNA	PMID:25596134
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:41607	crotonaldehyde	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in decreased expression of RO60 mRNA	PMID:20471460
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of RO60 mRNA	PMID:24935251
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of RO60 protein	PMID:38460933
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RO60 gene	PMID:25304211
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RO60 mRNA	PMID:40504410
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305083	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RO60 mRNA	PMID:29097150
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of RO60 mRNA	PMID:16984733
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of RO60 mRNA	PMID:25596134
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of TROVE2 mRNA	PMID:26705709
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:5864	ifosfamide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of RO60 mRNA	PMID:25596134
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of RO60 mRNA	PMID:20436886
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RO60 protein	PMID:32959892
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] affects the expression of RO60 mRNA	PMID:26378955
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D007545	Isoproterenol results in increased expression of RO60 mRNA	PMID:20003209
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:6801	metformin	affects expression	ISO	RGD:1305083	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin affects the expression of RO60 mRNA	PMID:25596134
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of RO60 mRNA	PMID:27462272
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1624075	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TROVE2 mRNA	PMID:22206623
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RO60 protein	PMID:37664457
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:757488	omega-3 fatty acids	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:D015525	Fatty Acids, Omega-3 results in increased expression of RO60 mRNA	PMID:16823509
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:D010634	Phenobarbital affects the expression of RO60 mRNA	PMID:23091169
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305083	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RO60 mRNA	PMID:32109520
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of RO60 protein	PMID:38348393
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1624075	E	RGD:6480464	20190409	CTD	MESH:C009277	sodium arsenate results in increased expression of RO60 mRNA	PMID:21795629
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RO60 protein	PMID:37664457
1312904	RO60	Ro60, Y RNA binding protein	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305083	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of RO60 mRNA	PMID:23555832
1312907	MATN3	matrilin 3	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in decreased expression of MATN3 mRNA	PMID:24172598
1312907	MATN3	matrilin 3	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of MATN3 mRNA	PMID:26272509|PMID:27188386
1312907	MATN3	matrilin 3	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN3 mRNA	PMID:27188386
1312907	MATN3	matrilin 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MATN3 mRNA	PMID:25812627
1312907	MATN3	matrilin 3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MATN3 mRNA	PMID:22378314
1312907	MATN3	matrilin 3	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000431	Ethanol results in decreased expression of MATN3 protein	PMID:20621659
1312907	MATN3	matrilin 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MATN3 mRNA	PMID:20044591
1312907	MATN3	matrilin 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MATN3 mRNA	PMID:30165855
1312907	MATN3	matrilin 3	gene	CHEBI:16767	3,4-dichloroaniline	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in decreased expression of MATN3 mRNA	PMID:24172598
1312907	MATN3	matrilin 3	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of MATN3 mRNA	PMID:21592394
1312907	MATN3	matrilin 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of MATN3 mRNA	PMID:21592394
1312907	MATN3	matrilin 3	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of MATN3 mRNA	PMID:21592394
1312907	MATN3	matrilin 3	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of MATN3 mRNA	PMID:21592394
1312907	MATN3	matrilin 3	gene	CHEBI:18088	formononetin	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C007768	formononetin results in decreased expression of MATN3 mRNA	PMID:37793997
1312907	MATN3	matrilin 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN3 mRNA	PMID:39836092
1312907	MATN3	matrilin 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MATN3 mRNA	PMID:19549813
1312907	MATN3	matrilin 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MATN3 mRNA	PMID:21632981
1312907	MATN3	matrilin 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MATN3 gene	PMID:25304211
1312907	MATN3	matrilin 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MATN3 mRNA	PMID:39836092
1312907	MATN3	matrilin 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of MATN3 mRNA	PMID:19167446
1312907	MATN3	matrilin 3	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of MATN3 promoter	PMID:22847954
1312907	MATN3	matrilin 3	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of MATN3 mRNA	PMID:26865667
1312907	MATN3	matrilin 3	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MATN3 mRNA	PMID:24768652|PMID:25583101
1312907	MATN3	matrilin 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MATN3 mRNA	PMID:20106945|PMID:21632981
1312907	MATN3	matrilin 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305085	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MATN3 mRNA	PMID:32109520
1312907	MATN3	matrilin 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MATN3 mRNA	PMID:33212167
1312907	MATN3	matrilin 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305085	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MATN3 mRNA	PMID:28959563
1312907	MATN3	matrilin 3	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of MATN3 mRNA	PMID:22623647
1312907	MATN3	matrilin 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of MATN3 mRNA	PMID:34032870
1312907	MATN3	matrilin 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MATN3 mRNA	PMID:39836092
1312907	MATN3	matrilin 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MATN3 intron	PMID:30157460
1312907	MATN3	matrilin 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MATN3 mRNA	PMID:21632981
1312907	MATN3	matrilin 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MATN3 mRNA	PMID:22316170
1312907	MATN3	matrilin 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of MATN3 mRNA	PMID:25895662
1312907	MATN3	matrilin 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of MATN3 gene	PMID:31601247
1312907	MATN3	matrilin 3	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305085	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of MATN3 mRNA	PMID:25729387
1312907	MATN3	matrilin 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305085	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of MATN3 mRNA	PMID:25729387
1312907	MATN3	matrilin 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312908	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of MATN3 mRNA	PMID:18648102
1312907	MATN3	matrilin 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MATN3 mRNA	PMID:30903817
1312907	MATN3	matrilin 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305085	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MATN3 mRNA	PMID:25181051
1312907	MATN3	matrilin 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305085	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MATN3 mRNA	PMID:34947998
1312907	MATN3	matrilin 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305085	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MATN3 gene	PMID:28505145
1312907	MATN3	matrilin 3	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MATN3 intron	PMID:30157460
1312907	MATN3	matrilin 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of MATN3 gene	PMID:31601247
1312907	MATN3	matrilin 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN3 mRNA	PMID:39836092
1312907	MATN3	matrilin 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MATN3 mRNA	PMID:26472689|PMID:38568856
1312907	MATN3	matrilin 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305085	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MATN3 mRNA	PMID:24386269
1312907	MATN3	matrilin 3	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312908	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of MATN3 mRNA	PMID:17585979
1312907	MATN3	matrilin 3	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MATN3 mRNA	PMID:28302478
1312907	MATN3	matrilin 3	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of MATN3 promoter	PMID:22847954
1312907	MATN3	matrilin 3	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of MATN3 promoter	PMID:22847954
1312907	MATN3	matrilin 3	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of MATN3 mRNA	PMID:19167446
1312907	MATN3	matrilin 3	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MATN3 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of MATN3 mRNA	PMID:19167446
1312907	MATN3	matrilin 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312908	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MATN3 mRNA	PMID:39529242
1312907	MATN3	matrilin 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MATN3 mRNA	PMID:25812627
1312907	MATN3	matrilin 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MATN3 mRNA	PMID:25979313
1312907	MATN3	matrilin 3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MATN3 gene	PMID:29154799
1312907	MATN3	matrilin 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MATN3 mRNA	PMID:26272509|PMID:28001369
1312907	MATN3	matrilin 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN3 mRNA	PMID:27188386
1312907	MATN3	matrilin 3	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of MATN3 mRNA	PMID:25562108
1312907	MATN3	matrilin 3	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of MATN3 mRNA	PMID:24714768
1312907	MATN3	matrilin 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MATN3 gene	PMID:25304211
1312907	MATN3	matrilin 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MATN3 mRNA	PMID:39836092
1312907	MATN3	matrilin 3	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of MATN3 mRNA	PMID:22714537
1312907	MATN3	matrilin 3	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1305085	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of MATN3 mRNA	PMID:28801915
1312907	MATN3	matrilin 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN3 mRNA	PMID:39836092
1312907	MATN3	matrilin 3	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305085	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of MATN3 mRNA	PMID:25729387
1312907	MATN3	matrilin 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305085	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of MATN3 mRNA	PMID:25729387
1312907	MATN3	matrilin 3	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MATN3 intron	PMID:30157460
1312907	MATN3	matrilin 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN3 mRNA	PMID:27188386
1312907	MATN3	matrilin 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305085	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of MATN3 mRNA	PMID:32109520
1312907	MATN3	matrilin 3	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MATN3 mRNA	PMID:19167446
1312907	MATN3	matrilin 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN3 mRNA	PMID:27188386
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1619021	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of KBTBD7 mRNA	PMID:37995155
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KBTBD7 mRNA	PMID:19074003
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of KBTBD7 mRNA	PMID:21632981
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KBTBD7 mRNA	PMID:35811015
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KBTBD7 mRNA	PMID:35811015
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:6501695	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KBTBD7 mRNA	PMID:33387578
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in decreased expression of KBTBD7 mRNA	PMID:20655997|PMID:27664576
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of KBTBD7 mRNA	PMID:21179406
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of KBTBD7 mRNA	PMID:31256213
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1619021	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KBTBD7 mRNA	PMID:34319233
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of KBTBD7 mRNA	PMID:28818685
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of KBTBD7 mRNA	PMID:19549813
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of KBTBD7 mRNA	PMID:27153756
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of KBTBD7 mRNA	PMID:26272509
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of KBTBD7 protein	PMID:35688186
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of KBTBD7 mRNA	PMID:23300844
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of KBTBD7 mRNA	PMID:27392435
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1619021	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KBTBD7 mRNA	PMID:21570461
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KBTBD7 mRNA	PMID:28001369
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of KBTBD7 mRNA	PMID:33212167
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of KBTBD7 mRNA	PMID:22623647
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KBTBD7 mRNA	PMID:21632981|PMID:26238291
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KBTBD7 promoter	PMID:27901495
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1619021	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to KBTBD7 promoter]	PMID:19654925
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of KBTBD7 mRNA	PMID:35984750
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1619021	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of KBTBD7 mRNA	PMID:33221593
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:6501695	E	RGD:6480464	20180220	CTD	MESH:C006780	bisphenol A results in increased expression of KBTBD7 mRNA	PMID:27178563|PMID:30816183|PMID:32528016|PMID:33296240
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KBTBD7 mRNA	PMID:28628672
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of KBTBD7 mRNA	PMID:25979313
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1619021	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of KBTBD7 mRNA	PMID:39298647
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1619021	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of KBTBD7 mRNA	PMID:38685157
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KBTBD7 mRNA	PMID:28628672
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of KBTBD7 mRNA	PMID:23179753|PMID:28001369
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of KBTBD7 gene	PMID:29154799
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of KBTBD7 mRNA	PMID:20106945|PMID:25562108
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KBTBD7 mRNA	PMID:28628672
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of KBTBD7 mRNA	PMID:29067470
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of KBTBD7 mRNA	PMID:35811015
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of KBTBD7 mRNA	PMID:28628672
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of KBTBD7 mRNA	PMID:23300844
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1619021	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KBTBD7 mRNA	PMID:21641980
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:6443	levonorgestrel	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KBTBD7 mRNA	PMID:19074003
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1619021	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KBTBD7 mRNA	PMID:22206623
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1619021	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of KBTBD7 mRNA	PMID:23091169
1312909	KBTBD7	kelch repeat and BTB domain containing 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1619021	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of KBTBD7 mRNA	PMID:28973697
1312911	PURG	purine rich element binding protein G	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PURG mRNA	PMID:26272509
1312911	PURG	purine rich element binding protein G	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1312911	PURG	purine rich element binding protein G	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PURG mRNA	PMID:20938992
1312911	PURG	purine rich element binding protein G	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PURG mRNA	PMID:23724009
1312911	PURG	purine rich element binding protein G	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of PURG mRNA	PMID:26516004
1312911	PURG	purine rich element binding protein G	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PURG mRNA	PMID:30529165
1312911	PURG	purine rich element binding protein G	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PURG mRNA	PMID:26079696
1312911	PURG	purine rich element binding protein G	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1305088	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PURG mRNA	PMID:23829299
1312911	PURG	purine rich element binding protein G	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PURG mRNA	PMID:20938992
1312911	PURG	purine rich element binding protein G	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PURG mRNA	PMID:31163220
1312911	PURG	purine rich element binding protein G	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PURG mRNA	PMID:37325564
1312911	PURG	purine rich element binding protein G	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312912	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PURG mRNA	PMID:19770486
1312911	PURG	purine rich element binding protein G	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PURG mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PURG mRNA	PMID:20938992|PMID:22206623
1312911	PURG	purine rich element binding protein G	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1312911	PURG	purine rich element binding protein G	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312912	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PURG mRNA	PMID:28960355
1312911	PURG	purine rich element binding protein G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312912	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PURG mRNA	PMID:21570461
1312911	PURG	purine rich element binding protein G	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305088	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PURG mRNA	PMID:33387578
1312911	PURG	purine rich element binding protein G	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of PURG mRNA	PMID:29301061
1312911	PURG	purine rich element binding protein G	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PURG 3' UTR; Benzo(a)pyrene affects the methylation of PURG promoter	PMID:27901495
1312911	PURG	purine rich element binding protein G	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PURG mRNA	PMID:32234424
1312911	PURG	purine rich element binding protein G	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PURG exon	PMID:27901495
1312911	PURG	purine rich element binding protein G	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PURG mRNA	PMID:15761015
1312911	PURG	purine rich element binding protein G	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305088	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PURG mRNA	PMID:30047161
1312911	PURG	purine rich element binding protein G	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312912	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of PURG mRNA	PMID:23557971
1312911	PURG	purine rich element binding protein G	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312912	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PURG promoter alternative form	PMID:35295148
1312911	PURG	purine rich element binding protein G	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312912	E	RGD:6480464	20150127	CTD	MESH:C006253	pirinixic acid results in increased expression of PURG mRNA	PMID:25270620
1312911	PURG	purine rich element binding protein G	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305088	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PURG mRNA	PMID:19167457
1312911	PURG	purine rich element binding protein G	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312912	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of PURG mRNA	PMID:35598803
1312911	PURG	purine rich element binding protein G	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305088	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PURG gene	PMID:28505145
1312911	PURG	purine rich element binding protein G	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	affects expression	ISO	RGD:1305088	E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl affects the expression of PURG mRNA	PMID:23829299
1312911	PURG	purine rich element binding protein G	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312912	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PURG gene	PMID:31683443
1312911	PURG	purine rich element binding protein G	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312912	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PURG mRNA	PMID:37019170
1312911	PURG	purine rich element binding protein G	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PURG mRNA	PMID:37325564
1312911	PURG	purine rich element binding protein G	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PURG mRNA	PMID:31533062
1312911	PURG	purine rich element binding protein G	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1312912	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of PURG mRNA	PMID:39529242
1312911	PURG	purine rich element binding protein G	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PURG mRNA	PMID:25979313
1312911	PURG	purine rich element binding protein G	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305088	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PURG mRNA	PMID:29427782
1312911	PURG	purine rich element binding protein G	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PURG mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:28001369
1312911	PURG	purine rich element binding protein G	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PURG gene	PMID:29154799
1312911	PURG	purine rich element binding protein G	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of PURG mRNA	PMID:24935251
1312911	PURG	purine rich element binding protein G	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1312911	PURG	purine rich element binding protein G	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305088	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PURG mRNA	PMID:30047161
1312911	PURG	purine rich element binding protein G	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PURG mRNA	PMID:28542535
1312911	PURG	purine rich element binding protein G	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PURG mRNA	PMID:24935251|PMID:26272509
1312911	PURG	purine rich element binding protein G	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PURG mRNA	PMID:24935251
1312911	PURG	purine rich element binding protein G	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1312911	PURG	purine rich element binding protein G	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305088	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PURG mRNA	PMID:33387578
1312911	PURG	purine rich element binding protein G	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of PURG mRNA]	PMID:15016801
1312911	PURG	purine rich element binding protein G	gene	CHEBI:48607	lithium chloride	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in decreased expression of PURG mRNA	PMID:23527032
1312911	PURG	purine rich element binding protein G	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PURG mRNA	PMID:15761015
1312911	PURG	purine rich element binding protein G	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305088	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PURG mRNA	PMID:30307764
1312911	PURG	purine rich element binding protein G	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312912	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PURG mRNA	PMID:25554681
1312911	PURG	purine rich element binding protein G	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305088	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PURG mRNA	PMID:30047161
1312911	PURG	purine rich element binding protein G	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312912	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PURG mRNA	PMID:22206623
1312911	PURG	purine rich element binding protein G	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1312911	PURG	purine rich element binding protein G	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of PURG mRNA	PMID:30458266
1312911	PURG	purine rich element binding protein G	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305088	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PURG mRNA	PMID:30047161
1312911	PURG	purine rich element binding protein G	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of PURG mRNA	PMID:26272509
1312911	PURG	purine rich element binding protein G	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1312911	PURG	purine rich element binding protein G	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PURG mRNA	PMID:27188386
1312911	PURG	purine rich element binding protein G	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305088	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of PURG mRNA	PMID:23555832
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRORP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRORP mRNA	PMID:32699268
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312914	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of PRORP mRNA	PMID:40945087
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PRORP mRNA	PMID:21632981
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D004958	Estradiol results in decreased expression of PRORP protein	PMID:33181973
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1305089	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PRORP mRNA	PMID:23829299
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PRORP mRNA	PMID:28818685
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PRORP mRNA	PMID:19549813
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PRORP protein	PMID:20106945
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRORP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRORP mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PRORP mRNA	PMID:32699268
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312914	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PRORP mRNA	PMID:34911549
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PRORP mRNA	PMID:21867686
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of PRORP protein	PMID:39603559
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305089	E	RGD:6480464	20191008	CTD	MESH:D020106	Acrylamide results in increased expression of PRORP mRNA	PMID:28959563
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PRORP mRNA	PMID:29803840
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of PRORP mRNA	PMID:22378314
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRORP intron	PMID:30157460
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PRORP mRNA	PMID:20064835|PMID:21632981
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305089	E	RGD:6480464	20191008	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in decreased expression of PRORP mRNA	PMID:25729387
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305089	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PRORP mRNA	PMID:34492290
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312914	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PRORP mRNA	PMID:32156529|PMID:33221593
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305089	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PRORP mRNA	PMID:25181051
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305089	E	RGD:6480464	20191008	CTD	MESH:C006780	bisphenol A results in increased methylation of PRORP gene	PMID:28505145
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1305089	E	RGD:6480464	20191008	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of PRORP mRNA	PMID:23829299
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PRORP intron	PMID:30157460
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312914	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PRORP mRNA	PMID:34813904
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PRORP mRNA	PMID:38568856
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305089	E	RGD:6480464	20191008	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PRORP promoter	PMID:22457795
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305089	E	RGD:6480464	20191008	CTD	MESH:C039281	furan results in increased methylation of PRORP gene	PMID:22079235
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PRORP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PRORP mRNA	PMID:32699268
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PRORP mRNA	PMID:28302478
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PRORP mRNA	PMID:20106945
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PRORP mRNA	PMID:25562108
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRORP mRNA	PMID:21420995|PMID:25704631|PMID:29067470
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305089	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRORP mRNA	PMID:33387578
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PRORP mRNA	PMID:22079256
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305089	E	RGD:6480464	20191008	CTD	MESH:D018120	Finasteride results in increased expression of PRORP mRNA	PMID:24136188
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:51876	auramine O	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D001576	Benzophenoneidum results in increased expression of PRORP protein	PMID:28722353
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305089	E	RGD:6480464	20191008	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in decreased expression of PRORP mRNA	PMID:25729387
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of PRORP mRNA	PMID:37939859
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PRORP intron	PMID:30157460
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PRORP mRNA	PMID:22079256
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PRORP mRNA	PMID:22079256
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in decreased expression of PRORP protein	PMID:39638853
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1305089	E	RGD:6480464	20191008	CTD	MESH:D013467	Sulindac results in increased expression of PRORP mRNA	PMID:24136188
1312913	PRORP	protein only RNase P catalytic subunit	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of PRORP mRNA	PMID:22378314
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MSRB1 mRNA	PMID:38218311
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MSRB1 mRNA	PMID:38218311
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312917	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MSRB1 mRNA	PMID:33045310
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312917	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of MSRB1 mRNA]	PMID:19467301
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MSRB1 mRNA	PMID:33167477
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D001280	Atrazine results in decreased expression of MSRB1 mRNA	PMID:22378314
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1312917	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of MSRB1 mRNA	PMID:20362636
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312917	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MSRB1 mRNA	PMID:30319688
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol affects the expression of MSRB1 mRNA	PMID:22574217
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MSRB1 mRNA	PMID:39298647
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1583243	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of MSRB1 mRNA	PMID:26496021
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MSRB1 mRNA	PMID:37042841
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D005557	Formaldehyde results in decreased expression of MSRB1 mRNA	PMID:23649840
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C044887	beta-methylcholine affects the expression of MSRB1 mRNA	PMID:21179406
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of MSRB1 mRNA	PMID:33848595
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MSRB1 mRNA	PMID:34319233
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1583243	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MSRB1 mRNA	PMID:22061828
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312917	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MSRB1 mRNA	PMID:36331819
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1583243	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of MSRB1 protein	PMID:34915118
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312917	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MSRB1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MSRB1 mRNA	PMID:37236586|PMID:37325564
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MSRB1 mRNA	PMID:23649840
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of MSRB1 mRNA	PMID:19376150
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MSRB1 protein	PMID:20106945
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MSRB1 mRNA	PMID:22100608
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MSRB1 mRNA	PMID:19770486
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MSRB1 mRNA	PMID:23649840
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312917	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MSRB1 mRNA	PMID:34911549
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of MSRB1 mRNA	PMID:15672453
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312917	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MSRB1 mRNA	PMID:17484886
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MSRB1 mRNA	PMID:27339419|PMID:31919559
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:27568	selenium atom	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium deficiency results in decreased expression of MSRB1 mRNA	PMID:12792026
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1312917	E	RGD:6480464	20120515	CTD	MESH:D012643	Selenium deficiency results in decreased expression of and results in decreased activity of MSRB1 protein	PMID:12792026|PMID:16170372
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:27812	Se-methyl-L-selenocysteine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C002979	selenomethylselenocysteine results in increased expression of MSRB1 mRNA	PMID:18514395
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1583243	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MSRB1 mRNA	PMID:31881176
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MSRB1 mRNA	PMID:28903495
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D009532	Nickel results in decreased expression of MSRB1 mRNA	PMID:23195993
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1583243	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MSRB1 mRNA	PMID:21215274|PMID:32109520
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1583243	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MSRB1 mRNA	PMID:34747641
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MSRB1 mRNA	PMID:33212167
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1312917	E	RGD:6480464	20230606	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of MSRB1 mRNA]	PMID:36315628
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MSRB1 mRNA	PMID:32234424
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MSRB1 mRNA	PMID:23735875
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312917	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MSRB1 mRNA	PMID:22228805
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SEPX1 promoter	PMID:27901495
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MSRB1 mRNA]	PMID:32406909
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:30621	diarsenic trioxide	affects expression	ISO	RGD:1312917	E	RGD:6480464	20210810	CTD	MESH:C006632	Arsenic Trioxide affects the expression of MSRB1 mRNA; Arsenic Trioxide affects the expression of MSRB1 protein	PMID:31473893
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of MSRB1 mRNA	PMID:22687993|PMID:25594700
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1583243	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of MSRB1 mRNA	PMID:33296240
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312917	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of MSRB1 mRNA	PMID:36315628
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1583243	E	RGD:6480464	20160210	CTD	MESH:C006780	bisphenol A results in increased expression of MSRB1 mRNA	PMID:25181051
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1312917	E	RGD:6480464	20230606	CTD	MESH:C006780	Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of MSRB1 mRNA]	PMID:36315628
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1583243	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of MSRB1 mRNA	PMID:26496021
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1583243	E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MSRB1 mRNA	PMID:27914987
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312917	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of MSRB1 mRNA	PMID:39298647
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312917	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MSRB1 mRNA	PMID:37019170
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20121218	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MSRB1 mRNA	PMID:17361019
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312917	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MSRB1 mRNA	PMID:34813904
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312917	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of MSRB1 mRNA	PMID:34813904
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312917	E	RGD:6480464	20130723	CTD	MESH:D010269	Paraquat results in increased expression of MSRB1 mRNA	PMID:21371552
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MSRB1 mRNA	PMID:37042841
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1583243	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of MSRB1 promoter	PMID:22457795
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312917	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MSRB1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MSRB1 mRNA	PMID:37236586|PMID:37325564
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:36904	elemental selenium	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium deficiency results in decreased expression of MSRB1 mRNA	PMID:12792026
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1312917	E	RGD:6480464	20120515	CTD	MESH:D012643	Selenium deficiency results in decreased expression of and results in decreased activity of MSRB1 protein	PMID:12792026|PMID:16170372
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:38221	fumonisin B1	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 results in decreased expression of MSRB1 mRNA	PMID:16221962
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MSRB1 mRNA	PMID:31533062
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312917	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MSRB1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of MSRB1 mRNA	PMID:36331819
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MSRB1 mRNA	PMID:25979313
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MSRB1 mRNA	PMID:23179753
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MSRB1 gene	PMID:29154799
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1583243	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of MSRB1 mRNA	PMID:41580965
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of MSRB1 mRNA	PMID:20106945
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312917	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MSRB1 mRNA	PMID:17562736
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MSRB1 mRNA	PMID:21420995|PMID:29067470
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of MSRB1 gene	PMID:29523930
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:46680	serpentine asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of MSRB1 gene	PMID:29523930
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of MSRB1 mRNA	PMID:26833863
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312917	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MSRB1 mRNA	PMID:17942748
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of MSRB1 mRNA	PMID:17211630
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:49900	arsenous acid	affects expression	ISO	RGD:1312917	E	RGD:6480464	20210810	CTD	MESH:C032793	Arsenic Trioxide affects the expression of MSRB1 mRNA; Arsenic Trioxide affects the expression of MSRB1 protein	PMID:31473893
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312917	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MSRB1 mRNA	PMID:25554681
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1583243	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of MSRB1 mRNA	PMID:34044035
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312917	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MSRB1 mRNA	PMID:38701926
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of MSRB1 mRNA	PMID:20436886
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of MSRB1 mRNA	PMID:28988120
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	MSRB1 protein results in decreased susceptibility to tert-Butylhydroperoxide	PMID:15914630
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1312917	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of MSRB1 mRNA	PMID:15003993
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of MSRB1 mRNA	PMID:17654400
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MSRB1 mRNA	PMID:31758290
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312917	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of MSRB1 mRNA	PMID:38648751
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312917	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of MSRB1 mRNA	PMID:39847705
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:9068	Se-methylselenocysteine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C002979	selenomethylselenocysteine results in increased expression of MSRB1 mRNA	PMID:18514395
1312916	MSRB1	methionine sulfoxide reductase B1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MSRB1 mRNA	PMID:38568856
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305093	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MXD4 mRNA]	PMID:31150632
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MXD4 mRNA	PMID:20188158
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010100	Oxygen affects the reaction [AHR protein results in decreased expression of MXD4 mRNA]	PMID:27103661
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305093	E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MXD4 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MXD4 mRNA	PMID:33729688
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MXD4 mRNA	PMID:26079696
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312920	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MXD4 mRNA	PMID:30319688
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312920	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MXD4 mRNA	PMID:30319688
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MXD4 mRNA	PMID:39241906
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MXD4 mRNA]	PMID:39241906
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1312920	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of MXD4 mRNA	PMID:15598610
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of MXD4 mRNA	PMID:16474171|PMID:31614463
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of MXD4 mRNA	PMID:14664709|PMID:39298647
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of MXD4 mRNA	PMID:38568856
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:17447	geraniol	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of MXD4 mRNA	PMID:27683099
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305093	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MXD4 mRNA	PMID:33387578
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MXD4 mRNA	PMID:28818685
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MXD4 mRNA	PMID:36331819
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305093	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MXD4 mRNA	PMID:39012411
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MXD4 mRNA	PMID:19549813
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MXD4 mRNA	PMID:23649840
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312920	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MXD4 mRNA	PMID:19770486
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MXD4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MXD4 mRNA	PMID:34911549
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305093	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of MXD4 mRNA	PMID:31129395
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312920	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MXD4 mRNA	PMID:17484886
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305093	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MXD4 mRNA	PMID:31150632
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305093	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MXD4 mRNA]	PMID:31150632
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MXD4 mRNA	PMID:22206623
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MXD4 mRNA	PMID:40504410
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of MXD4 mRNA	PMID:28189721|PMID:28960355
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MXD4 mRNA	PMID:27392435
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of MXD4 mRNA	PMID:16474171
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312920	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MXD4 mRNA	PMID:21570461|PMID:24680724
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305093	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MXD4 mRNA	PMID:33387578|PMID:34747641
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305093	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MXD4 mRNA	PMID:32109520
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of MXD4 mRNA	PMID:29955902
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MXD4 mRNA	PMID:33212167
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of MXD4 mRNA	PMID:39709020
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312920	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of MXD4 mRNA	PMID:39631538
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MXD4 mRNA	PMID:29432896
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MXD4 mRNA	PMID:38568856
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of MXD4 mRNA	PMID:39719251
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MXD4 mRNA	PMID:40504410
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312920	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MXD4 mRNA	PMID:19770486
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MXD4 promoter	PMID:27901495
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MXD4 mRNA	PMID:27131904
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of MXD4 mRNA	PMID:25895662
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of MXD4 mRNA	PMID:29203145
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of MXD4 mRNA	PMID:38568856
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312920	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MXD4 gene	PMID:35295148
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305093	E	RGD:6480464	20170221	CTD	MESH:D013853	Thioacetamide results in decreased expression of MXD4 mRNA	PMID:23411599
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of MXD4 mRNA	PMID:18648102
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MXD4 mRNA	PMID:30903817
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of MXD4 mRNA	PMID:16474171
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305093	E	RGD:6480464	20170221	CTD	MESH:C006780	bisphenol A results in decreased expression of MXD4 mRNA	PMID:25181051
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of MXD4 mRNA	PMID:20678512|PMID:29275510
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305093	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of MXD4 mRNA	PMID:31129395
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MXD4 mRNA	PMID:25172293
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C543008	bisphenol S results in decreased expression of MXD4 mRNA	PMID:25912373
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of MXD4 mRNA	PMID:39298647
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MXD4 mRNA	PMID:28628672
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of MXD4 gene	PMID:22964155
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312920	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MXD4 mRNA	PMID:21266533
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MXD4 mRNA	PMID:34813904
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MXD4 mRNA	PMID:28628672
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of MXD4 mRNA	PMID:34813904
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1312920	E	RGD:6480464	20210209	CTD	MESH:D010269	Paraquat results in increased expression of MXD4 mRNA	PMID:21463325
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MXD4 mRNA]	PMID:39241906
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MXD4 mRNA	PMID:37042841
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of MXD4 mRNA	PMID:29024780
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MXD4 mRNA	PMID:38568856
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305093	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MXD4 mRNA	PMID:39012411
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1305093	E	RGD:6480464	20170221	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MXD4 mRNA	PMID:19162173
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MXD4 mRNA	PMID:24449571
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of MXD4 mRNA	PMID:23811191
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of MXD4 mRNA	PMID:40434365
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of MXD4 mRNA	PMID:19167446
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MXD4 mRNA	PMID:19167446
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MXD4 mRNA	PMID:36331819
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1312920	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of MXD4 mRNA	PMID:29038090
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312920	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of MXD4 mRNA	PMID:23125180
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312920	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MXD4 mRNA	PMID:17963808
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of MXD4 mRNA	PMID:23527032|PMID:24935251|PMID:29154799
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MXD4 gene	PMID:29154799
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MXD4 mRNA	PMID:25562108
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312920	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of MXD4 mRNA	PMID:22733784
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MXD4 mRNA	PMID:28628672
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of MXD4 mRNA	PMID:15171707
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MXD4 mRNA	PMID:27188386
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305093	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MXD4 mRNA	PMID:33387578
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of MXD4 mRNA	PMID:29279043
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MXD4 mRNA	PMID:40504410
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of MXD4 mRNA	PMID:31838189
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305093	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MXD4 mRNA	PMID:29391264
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of MXD4 mRNA	PMID:38568856
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MXD4 mRNA	PMID:28628672
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of MXD4 mRNA	PMID:25554681
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1305093	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of MXD4 mRNA	PMID:28801915
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MXD4 mRNA	PMID:21641980
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305093	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of MXD4 mRNA	PMID:28801915
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in decreased expression of MXD4 mRNA	PMID:36914120
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:70778	GW 7647	decreases expression	ISO	RGD:1305093	E	RGD:6480464	20200519	CTD	MESH:C453899	GW 7647 results in decreased expression of MXD4 mRNA	PMID:31628012
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:72754	bisphenol AF	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in decreased expression of MXD4 mRNA	PMID:25912373
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MXD4 mRNA	PMID:22206623
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MXD4 mRNA	PMID:22714537
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MXD4 mRNA	PMID:37199045
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of MXD4 mRNA	PMID:28960945
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MXD4 gene]	PMID:28238834
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MXD4 mRNA	PMID:19167446
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312920	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MXD4 mRNA	PMID:39847705
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:85993	palbociclib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in increased expression of MXD4 mRNA	PMID:22869556
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312920	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MXD4 mRNA]	PMID:39241906
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1312920	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MXD4 mRNA	PMID:27131904
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305093	E	RGD:6480464	20170221	CTD	MESH:D012999	Soman results in decreased expression of MXD4 mRNA	PMID:19281266
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of MXD4 mRNA	PMID:17440010
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MXD4 mRNA	PMID:38568856
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MXD4 mRNA	PMID:29301935
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of MXD4 mRNA	PMID:19140230
1312919	MXD4	MAX dimerization protein 4	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305093	E	RGD:6480464	20170221	CTD	MESH:C025643	vinclozolin affects the expression of MXD4 mRNA	PMID:19015723
1312922	FBXO24	F-box protein 24	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1312923	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of FBXO24 mRNA	PMID:33045310
1312922	FBXO24	F-box protein 24	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312923	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FBXO24 mRNA	PMID:39241906
1312922	FBXO24	F-box protein 24	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FBXO24 mRNA	PMID:35811015
1312922	FBXO24	F-box protein 24	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of FBXO24 mRNA	PMID:30510588
1312922	FBXO24	F-box protein 24	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of FBXO24 mRNA	PMID:31614463
1312922	FBXO24	F-box protein 24	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of FBXO24 mRNA	PMID:38568856
1312922	FBXO24	F-box protein 24	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305095	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of FBXO24 mRNA	PMID:33387578
1312922	FBXO24	F-box protein 24	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of FBXO24 mRNA	PMID:26079696
1312922	FBXO24	F-box protein 24	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FBXO24 mRNA	PMID:28818685
1312922	FBXO24	F-box protein 24	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FBXO24 mRNA	PMID:22100608
1312922	FBXO24	F-box protein 24	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312923	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of FBXO24 mRNA	PMID:25629700
1312922	FBXO24	F-box protein 24	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312923	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of FBXO24 mRNA	PMID:28960355
1312922	FBXO24	F-box protein 24	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312923	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXO24 mRNA	PMID:34876320
1312922	FBXO24	F-box protein 24	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312923	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXO24 mRNA	PMID:34876320
1312922	FBXO24	F-box protein 24	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of FBXO24 gene	PMID:31601247
1312922	FBXO24	F-box protein 24	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312923	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of FBXO24 mRNA	PMID:29264374
1312922	FBXO24	F-box protein 24	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312923	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of FBXO24 mRNA	PMID:21318169
1312922	FBXO24	F-box protein 24	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312923	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of FBXO24 mRNA]	PMID:21318169
1312922	FBXO24	F-box protein 24	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXO24 mRNA	PMID:23146750
1312922	FBXO24	F-box protein 24	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305095	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXO24 mRNA	PMID:25181051
1312922	FBXO24	F-box protein 24	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305095	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of FBXO24 mRNA	PMID:30816183|PMID:32528016
1312922	FBXO24	F-box protein 24	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of FBXO24 mRNA	PMID:23146750
1312922	FBXO24	F-box protein 24	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of FBXO24 mRNA	PMID:23146750
1312922	FBXO24	F-box protein 24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312923	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of FBXO24 gene	PMID:31683443
1312922	FBXO24	F-box protein 24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312923	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of FBXO24 mRNA	PMID:40203079
1312922	FBXO24	F-box protein 24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of FBXO24 gene	PMID:31601247
1312922	FBXO24	F-box protein 24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of FBXO24 gene	PMID:31601247
1312922	FBXO24	F-box protein 24	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305095	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXO24 mRNA	PMID:33453195
1312922	FBXO24	F-box protein 24	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of FBXO24 mRNA	PMID:23146750
1312922	FBXO24	F-box protein 24	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FBXO24 gene	PMID:29154799
1312922	FBXO24	F-box protein 24	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of FBXO24 mRNA	PMID:20106945
1312922	FBXO24	F-box protein 24	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FBXO24 mRNA	PMID:38832940
1312922	FBXO24	F-box protein 24	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXO24 mRNA	PMID:26690555
1312922	FBXO24	F-box protein 24	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FBXO24 mRNA	PMID:35811015
1312922	FBXO24	F-box protein 24	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of FBXO24 mRNA	PMID:40706910
1312922	FBXO24	F-box protein 24	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305095	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of FBXO24 mRNA	PMID:29391264
1312922	FBXO24	F-box protein 24	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312923	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXO24 mRNA	PMID:34876320
1312922	FBXO24	F-box protein 24	gene	CHEBI:53444	potassium dichromate	affects expression	ISO	RGD:1312923	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate affects the expression of FBXO24 mRNA	PMID:23608068
1312922	FBXO24	F-box protein 24	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FBXO24 mRNA	PMID:23146750
1312922	FBXO24	F-box protein 24	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312923	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of FBXO24 mRNA	PMID:34876320
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RUFY1 mRNA	PMID:38218311
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312930	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RUFY1 mRNA	PMID:26251327
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUFY1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUFY1 mRNA	PMID:32699268
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312930	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RUFY1 mRNA	PMID:30319688
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RUFY1 mRNA	PMID:21632981
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312930	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RUFY1 mRNA	PMID:39298647
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RUFY1 mRNA	PMID:37042841
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:16716	benzene	decreases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in decreased expression of RUFY1 mRNA	PMID:19162166
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of RUFY1 mRNA	PMID:38685446
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312930	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RUFY1 mRNA	PMID:34319233
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305099	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RUFY1 mRNA	PMID:33387578
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of RUFY1 intron	PMID:30157460
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of RUFY1 mRNA	PMID:24376830
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RUFY1 mRNA	PMID:19549813
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RUFY1 protein	PMID:23301498
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RUFY1 intron	PMID:30157460
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUFY1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUFY1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the methylation of RUFY1 gene; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RUFY1 mRNA	PMID:32699268|PMID:35835166
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312930	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of RUFY1 mRNA]	PMID:22206623
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RUFY1 gene	PMID:25304211
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RUFY1 mRNA	PMID:40512198
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of RUFY1 protein	PMID:35688186
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of RUFY1 mRNA	PMID:28903495
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of RUFY1 mRNA	PMID:19921347
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312930	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RUFY1 mRNA	PMID:21570461
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305099	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RUFY1 mRNA	PMID:33387578
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312930	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RUFY1 mRNA	PMID:19933214
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of RUFY1 protein	PMID:39603559
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RUFY1 mRNA	PMID:33212167
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305099	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of RUFY1 mRNA	PMID:28959563
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RUFY1 mRNA	PMID:29803840
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RUFY1 mRNA	PMID:40512198
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RUFY1 3' UTR; Benzo(a)pyrene results in increased methylation of RUFY1 promoter	PMID:27901495
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305099	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RUFY1 mRNA	PMID:25181051
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of RUFY1 mRNA	PMID:22576693
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312930	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RUFY1 mRNA	PMID:33221593
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1305099	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of RUFY1 gene	PMID:28505145
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of RUFY1 gene	PMID:22576693
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305099	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RUFY1 gene	PMID:28505145
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of RUFY1 mRNA	PMID:19244175
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of RUFY1 gene	PMID:31601247
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312930	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RUFY1 intron	PMID:28392331
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RUFY1 mRNA	PMID:37042841
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305099	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RUFY1 mRNA	PMID:33453195
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305099	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RUFY1 mRNA	PMID:24386269
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RUFY1 mRNA	PMID:24449571
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUFY1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUFY1 mRNA	PMID:32699268
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RUFY1 mRNA	PMID:31533062
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RUFY1 mRNA	PMID:25979313
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RUFY1 mRNA	PMID:23179753
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312930	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RUFY1 mRNA	PMID:28973697
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305099	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RUFY1 mRNA	PMID:33387578
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RUFY1 gene	PMID:25304211
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RUFY1 mRNA	PMID:40512198
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RUFY1 mRNA	PMID:22079256
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305099	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of RUFY1 mRNA	PMID:29097150
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312930	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RUFY1 mRNA	PMID:35964746
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RUFY1 protein	PMID:32959892
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1312930	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RUFY1 mRNA	PMID:23650126
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312930	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RUFY1 mRNA	PMID:22206623
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312930	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of RUFY1 mRNA]	PMID:22206623
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RUFY1 mRNA	PMID:22079256
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RUFY1 mRNA	PMID:22079256
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RUFY1 mRNA	PMID:37199045
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of RUFY1 mRNA	PMID:22124623
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RUFY1 gene]	PMID:28238834
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1312930	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in increased expression of RUFY1 protein	PMID:26903627
1312929	RUFY1	RUN and FYVE domain containing 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305099	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RUFY1 mRNA	PMID:21346803
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312932	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of LPAR2 mRNA	PMID:37995155
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1561336	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LPAR2 mRNA]	PMID:31150632
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of LPAR2 mRNA	PMID:23724009
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of LPAR2 mRNA	PMID:33167477
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312932	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LPAR2 mRNA; Lipopolysaccharides results in increased expression of LPAR2 protein	PMID:21821728
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312932	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LPAR2 mRNA	PMID:25510870
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1561336	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LPAR2 mRNA	PMID:33387578
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of LPAR2 gene	PMID:30521419
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1312932	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of LPAR2 mRNA	PMID:28973375
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1561336	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of LPAR2 mRNA	PMID:26577399
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1561336	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LPAR2 mRNA	PMID:33387578
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312932	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LPAR2 mRNA	PMID:29950665
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312932	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LPAR2 mRNA	PMID:25510870
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312932	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LPAR2 mRNA	PMID:25510870
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of LPAR2 mRNA	PMID:35430440
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312932	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LPAR2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LPAR2 mRNA	PMID:34911549
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1561336	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LPAR2 mRNA	PMID:31150632
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1561336	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LPAR2 mRNA]	PMID:31150632
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of LPAR2 mRNA	PMID:19244175
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1561336	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of LPAR2 mRNA	PMID:31881176
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of LPAR2 mRNA	PMID:28903495
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of LPAR2 mRNA	PMID:16705744
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312932	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LPAR2 mRNA	PMID:21570461
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LPAR2 mRNA	PMID:21296121
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312932	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to LPAR2 promoter]	PMID:19654925
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LPAR2 mRNA	PMID:33212167
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of LPAR2 mRNA	PMID:30911355
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D001205	Ascorbic Acid inhibits the reaction [Benzo(a)pyrene results in decreased methylation of LPAR2 promoter]; Ascorbic Acid inhibits the reaction [Benzo(a)pyrene results in increased expression of LPAR2 mRNA]	PMID:27901495
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LPAR2 5' UTR; Benzo(a)pyrene results in decreased methylation of LPAR2 promoter	PMID:27901495
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LPAR2 mRNA	PMID:27901495
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Ascorbic Acid inhibits the reaction [Benzo(a)pyrene results in decreased methylation of LPAR2 promoter]; Ascorbic Acid inhibits the reaction [Benzo(a)pyrene results in increased expression of LPAR2 mRNA]; Vitamin B 6 inhibits the reaction [Benzo(a)pyrene results in increased expression of LPAR2 mRNA]	PMID:27901495
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of LPAR2 mRNA	PMID:30911355
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	LPAR2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312932	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of LPAR2 mRNA	PMID:35295148
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312932	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LPAR2 mRNA	PMID:29950665
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1561336	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of LPAR2 mRNA	PMID:25181051
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312932	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LPAR2 mRNA	PMID:32156529
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1561336	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of LPAR2 mRNA	PMID:34947998|PMID:36779543
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of LPAR2 mRNA	PMID:19244175
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312932	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of LPAR2 mRNA	PMID:26682919
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312932	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LPAR2 mRNA	PMID:25510870
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312932	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of LPAR2 mRNA	PMID:25510870
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312932	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LPAR2 mRNA	PMID:37019170
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312932	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LPAR2 mRNA	PMID:29950665
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LPAR2 mRNA	PMID:37042841
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LPAR2 mRNA	PMID:38174414
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LPAR2 mRNA	PMID:24449571
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of LPAR2 mRNA	PMID:19244175
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LPAR2 mRNA	PMID:25979313
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of LPAR2 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR2 mRNA	PMID:27188386
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1561336	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of LPAR2 mRNA	PMID:30047161
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of LPAR2 mRNA	PMID:33512557
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of LPAR2 mRNA	PMID:33512557
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	LPAR2 protein affects the susceptibility to Methotrexate	PMID:16217747
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of LPAR2 mRNA	PMID:27188386
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	LPAR2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1561336	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of LPAR2 mRNA	PMID:30047161
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1312932	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of LPAR2 mRNA	PMID:38701926
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1312932	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of LPAR2 mRNA	PMID:36851058
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of LPAR2 mRNA	PMID:31758290
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1561336	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LPAR2 mRNA	PMID:27567155
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR2 mRNA	PMID:27188386
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1561336	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of LPAR2 mRNA	PMID:30047161
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1312932	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of LPAR2 mRNA	PMID:38995820
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of LPAR2 mRNA	PMID:33512557
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1561336	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of LPAR2 mRNA	PMID:30047161
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1561336	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of LPAR2 mRNA	PMID:24780913
1312931	LPAR2	lysophosphatidic acid receptor 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LPAR2 mRNA	PMID:27188386
1312935	SCEL	sciellin	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SCEL mRNA	PMID:38218311
1312935	SCEL	sciellin	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in decreased expression of SCEL mRNA	PMID:24172598
1312935	SCEL	sciellin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of SCEL mRNA	PMID:16249480
1312935	SCEL	sciellin	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of SCEL mRNA	PMID:23019147
1312935	SCEL	sciellin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of SCEL mRNA	PMID:30165855
1312935	SCEL	sciellin	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1312936	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of SCEL mRNA	PMID:33711761
1312935	SCEL	sciellin	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305102	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SCEL mRNA	PMID:33387578
1312935	SCEL	sciellin	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of SCEL mRNA	PMID:16002434
1312935	SCEL	sciellin	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of SCEL mRNA	PMID:21120746
1312935	SCEL	sciellin	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SCEL mRNA	PMID:19549813
1312935	SCEL	sciellin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SCEL mRNA	PMID:34911549
1312935	SCEL	sciellin	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SCEL protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SCEL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SCEL protein	PMID:38598786
1312935	SCEL	sciellin	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312936	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SCEL mRNA	PMID:17484886
1312935	SCEL	sciellin	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of SCEL mRNA	PMID:19654921
1312935	SCEL	sciellin	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1312936	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of SCEL mRNA	PMID:38723480
1312935	SCEL	sciellin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in increased expression of SCEL mRNA]	PMID:38723480
1312935	SCEL	sciellin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCEL mRNA	PMID:27188386
1312935	SCEL	sciellin	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in decreased expression of SCEL mRNA	PMID:23019147
1312935	SCEL	sciellin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312936	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SCEL mRNA	PMID:21570461
1312935	SCEL	sciellin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305102	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SCEL mRNA	PMID:33387578
1312935	SCEL	sciellin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312936	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SCEL mRNA	PMID:17035482|PMID:19933214
1312935	SCEL	sciellin	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SCEL mRNA; aristolochic acid I results in decreased expression of SCEL protein	PMID:33212167
1312935	SCEL	sciellin	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305102	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SCEL mRNA	PMID:28959563
1312935	SCEL	sciellin	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of SCEL mRNA	PMID:20971185
1312935	SCEL	sciellin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of SCEL mRNA	PMID:28595984|PMID:34032870
1312935	SCEL	sciellin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SCEL mRNA	PMID:37682722
1312935	SCEL	sciellin	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SCEL mRNA	PMID:39719251
1312935	SCEL	sciellin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCEL mRNA	PMID:34876320
1312935	SCEL	sciellin	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCEL mRNA	PMID:34876320
1312935	SCEL	sciellin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20260415	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SCEL mRNA	PMID:40419235
1312935	SCEL	sciellin	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SCEL promoter	PMID:27901495
1312935	SCEL	sciellin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SCEL 3' UTR	PMID:27901495
1312935	SCEL	sciellin	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of SCEL mRNA	PMID:20971185
1312935	SCEL	sciellin	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SCEL mRNA	PMID:29203145
1312935	SCEL	sciellin	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of SCEL mRNA	PMID:37690743
1312935	SCEL	sciellin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1305102	E	RGD:6480464	20170613	CTD	MESH:C009495	titanium dioxide results in decreased expression of SCEL mRNA	PMID:28181387
1312935	SCEL	sciellin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SCEL mRNA	PMID:23557971
1312935	SCEL	sciellin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305102	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SCEL mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1312935	SCEL	sciellin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SCEL mRNA	PMID:29275510
1312935	SCEL	sciellin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312936	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of SCEL mRNA	PMID:32156529
1312935	SCEL	sciellin	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305102	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SCEL gene	PMID:28505145
1312935	SCEL	sciellin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312936	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of SCEL mRNA	PMID:40203079
1312935	SCEL	sciellin	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of SCEL mRNA	PMID:26377693
1312935	SCEL	sciellin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312936	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SCEL mRNA	PMID:30951980
1312935	SCEL	sciellin	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312936	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SCEL intron	PMID:28392331
1312935	SCEL	sciellin	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312936	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SCEL mRNA	PMID:37019170
1312935	SCEL	sciellin	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SCEL protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SCEL protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SCEL protein	PMID:38598786
1312935	SCEL	sciellin	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312936	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of SCEL mRNA	PMID:24535843
1312935	SCEL	sciellin	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SCEL mRNA	PMID:38174414
1312935	SCEL	sciellin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312936	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SCEL mRNA	PMID:40194260
1312935	SCEL	sciellin	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SCEL mRNA	PMID:27188386
1312935	SCEL	sciellin	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of SCEL mRNA	PMID:16144937
1312935	SCEL	sciellin	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SCEL mRNA	PMID:38832940
1312935	SCEL	sciellin	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305102	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SCEL mRNA	PMID:33387578
1312935	SCEL	sciellin	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of SCEL mRNA	PMID:24714768
1312935	SCEL	sciellin	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SCEL mRNA	PMID:29279043
1312935	SCEL	sciellin	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of SCEL mRNA	PMID:19654921
1312935	SCEL	sciellin	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1312936	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of SCEL mRNA	PMID:38723480
1312935	SCEL	sciellin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in increased expression of SCEL mRNA]	PMID:38723480
1312935	SCEL	sciellin	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of SCEL mRNA	PMID:30529165
1312935	SCEL	sciellin	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCEL mRNA	PMID:34876320
1312935	SCEL	sciellin	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305102	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SCEL mRNA	PMID:30307764
1312935	SCEL	sciellin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SCEL mRNA; Nanotubes, Carbon results in decreased expression of SCEL mRNA	PMID:25554681
1312935	SCEL	sciellin	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	ISO	RGD:1305102	E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of SCEL promoter	PMID:27415467
1312935	SCEL	sciellin	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCEL mRNA	PMID:27188386
1312935	SCEL	sciellin	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SCEL gene]	PMID:28238834
1312935	SCEL	sciellin	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1305102	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SCEL mRNA	PMID:27291303
1312935	SCEL	sciellin	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305102	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SCEL mRNA	PMID:23640034
1312935	SCEL	sciellin	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312936	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SCEL mRNA	PMID:34876320
1312935	SCEL	sciellin	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305102	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SCEL mRNA	PMID:24780913
1312935	SCEL	sciellin	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of SCEL mRNA	PMID:24921660
1312935	SCEL	sciellin	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SCEL mRNA	PMID:27188386
1312935	SCEL	sciellin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SCEL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SCEL protein	PMID:38598786
1312935	SCEL	sciellin	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1312936	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SCEL mRNA	PMID:35537566
1312935	SCEL	sciellin	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305102	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of SCEL gene	PMID:31079544
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312938	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CSMD1 mRNA	PMID:33045310
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CSMD1 mRNA	PMID:37995155
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305103	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CSMD1 mRNA]	PMID:31150632
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CSMD1 mRNA	PMID:19074003
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CSMD1 mRNA	PMID:20188158
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305103	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CSMD1 gene	PMID:28931070|PMID:35440735
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of CSMD1 mRNA	PMID:29018328
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312938	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CSMD1 mRNA	PMID:30319688
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305103	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CSMD1 mRNA	PMID:33387578
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of CSMD1 intron	PMID:30157460
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305103	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of CSMD1 mRNA	PMID:21396975
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305103	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CSMD1 mRNA	PMID:22129741
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CSMD1 gene	PMID:27153756
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305103	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CSMD1 mRNA	PMID:23630614|PMID:25378103
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CSMD1 intron	PMID:30157460
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305103	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CSMD1 mRNA	PMID:31150632
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305103	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CSMD1 mRNA]	PMID:31150632
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CSMD1 mRNA	PMID:24768652|PMID:25583101
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312938	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CSMD1 mRNA	PMID:21570461
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of CSMD1 mRNA	PMID:36209798
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CSMD1 exon; Benzo(a)pyrene affects the methylation of CSMD1 intron	PMID:30157460
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CSMD1 3' UTR; Benzo(a)pyrene results in decreased methylation of CSMD1 promoter	PMID:27901495
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of CSMD1 gene	PMID:25435355
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312938	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CSMD1 mRNA	PMID:29341224|PMID:38811393
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of CSMD1 gene	PMID:31601247
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CSMD1 gene; [bisphenol F co-treated with Fulvestrant] results in decreased methylation of CSMD1 gene	PMID:31601247
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1305103	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of CSMD1 mRNA	PMID:32479839
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1305103	E	RGD:6480464	20200915	CTD	MESH:D008627	Mercuric Chloride results in increased expression of CSMD1 mRNA	PMID:32599119
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CSMD1 mRNA	PMID:29264374
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312938	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CSMD1 gene	PMID:35295148
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of CSMD1 gene	PMID:31601247
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305103	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CSMD1 mRNA	PMID:25181051|PMID:30816183
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CSMD1 mRNA	PMID:32156529
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312938	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of CSMD1 mRNA	PMID:35598803
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305103	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CSMD1 gene	PMID:28505145
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CSMD1 gene	PMID:31601247
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of CSMD1 intron	PMID:30157460
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of CSMD1 gene	PMID:31601247
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305103	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CSMD1 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CSMD1 mRNA	PMID:18164116|PMID:22129741
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305103	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CSMD1 promoter	PMID:22457795
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305103	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of CSMD1 mRNA	PMID:25539665
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of CSMD1 mRNA	PMID:31626844
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305103	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of CSMD1 mRNA	PMID:29427782
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305103	E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in increased expression of CSMD1 mRNA	PMID:30723492
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305103	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CSMD1 mRNA	PMID:29391264
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:63618	pravastatin	decreases expression	ISO	RGD:1305103	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of CSMD1 mRNA	PMID:27225895
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:63618	pravastatin	decreases expression	ISO	RGD:1312938	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of CSMD1 mRNA	PMID:27225895
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:6443	levonorgestrel	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CSMD1 mRNA	PMID:19074003
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:6809	methamphetamine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008694	CSMD1 gene SNP affects the susceptibility to Methamphetamine	PMID:18316681
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of CSMD1 intron	PMID:30157460
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:75170	zaragozic acid A	affects expression	ISO	RGD:1312938	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 affects the expression of CSMD1 mRNA	PMID:27225895
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:75170	zaragozic acid A	increases expression	ISO	RGD:1305103	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of CSMD1 mRNA	PMID:27225895
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of CSMD1 mRNA	PMID:35486664
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1305103	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CSMD1 mRNA	PMID:18164116
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1305103	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of CSMD1 mRNA	PMID:23665939
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CSMD1 gene]	PMID:28238834
1312937	CSMD1	CUB and Sushi multiple domains 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305103	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CSMD1 mRNA	PMID:24780913|PMID:25825206
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312940	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ANKRD2 mRNA	PMID:33045310
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of ANKRD2 mRNA	PMID:23830798
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305104	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ANKRD2 mRNA	PMID:33729688
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ANKRD2 mRNA	PMID:26079696
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:15746	spermine	increases expression	ISO	RGD:1312940	E	RGD:6480464	20120412	CTD	MESH:D013096	Spermine results in increased expression of ANKRD2 mRNA	PMID:18673383
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ANKRD2 mRNA	PMID:31614463
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ANKRD2 mRNA	PMID:30165855
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in decreased expression of ANKRD2 mRNA	PMID:27664576
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ANKRD2 mRNA	PMID:26079696
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20260707	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA	PMID:37992649
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of ANKRD2 mRNA	PMID:21475673
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20260707	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA	PMID:37992649
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20210608	CTD	MESH:D004051	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of ANKRD2 mRNA	PMID:33484791
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ANKRD2 mRNA	PMID:36139627
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305104	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ANKRD2 mRNA	PMID:33387578
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ANKRD2 promoter	PMID:30157460
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ANKRD2 mRNA	PMID:32234424
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ANKRD2 gene	PMID:27153756
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1312940	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in increased expression of ANKRD2 mRNA	PMID:31626304
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ANKRD2 mRNA	PMID:27392435
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312940	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ANKRD2 mRNA	PMID:26377647
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312940	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ANKRD2 mRNA	PMID:26290441
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305104	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ANKRD2 mRNA	PMID:33387578
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ANKRD2 promoter]	PMID:19654925
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ANKRD2 mRNA	PMID:33212167
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ANKRD2 mRNA	PMID:30851411
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312940	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of ANKRD2 mRNA	PMID:30807115
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ANKRD2 mRNA	PMID:29803840
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312940	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of ANKRD2 mRNA	PMID:36227756
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20260707	CTD	MESH:D005632	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA	PMID:37992649
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20260707	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA]	PMID:37992649
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ANKRD2 mRNA	PMID:38568856
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ANKRD2 mRNA	PMID:39719251
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ANKRD2 promoter	PMID:27901495
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to ANKRD2 promoter]	PMID:19654925
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312940	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ANKRD2 mRNA	PMID:23221170
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	ANKRD2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:3160	Botulinum toxin type A	increases expression	ISO	RGD:1305104	E	RGD:6480464	20170117	CTD	MESH:D019274	Botulinum Toxins, Type A results in increased expression of ANKRD2 mRNA	PMID:18603602
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of ANKRD2 mRNA	PMID:38568856
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312940	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ANKRD2 mRNA	PMID:35295148
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305104	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ANKRD2 mRNA	PMID:25181051
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ANKRD2 gene	PMID:31601247
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305104	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ANKRD2 gene	PMID:28505145
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312940	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ANKRD2 mRNA	PMID:30951980
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312940	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ANKRD2 mRNA	PMID:37019170
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1312940	E	RGD:6480464	20120918	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of ANKRD2 mRNA	PMID:19647056
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312940	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ANKRD2 mRNA	PMID:40194260
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ANKRD2 mRNA	PMID:40419075
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ANKRD2 mRNA	PMID:27153767
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ANKRD2 mRNA	PMID:36331819
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ANKRD2 gene	PMID:29154799
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of ANKRD2 mRNA	PMID:27989131
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1312940	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in increased expression of ANKRD2 mRNA	PMID:40633821
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20260707	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ANKRD2 mRNA	PMID:37992649
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ANKRD2 mRNA	PMID:38832940
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of ANKRD2 mRNA	PMID:31838189
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ANKRD2 mRNA	PMID:32234424
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	ANKRD2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312940	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ANKRD2 mRNA; Nanotubes, Carbon results in increased expression of ANKRD2 mRNA	PMID:25620056
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1305104	E	RGD:6480464	20140513	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of ANKRD2 protein	PMID:24140754
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1312940	E	RGD:6480464	20120918	CTD	MESH:D010081	Oxazolone results in increased expression of ANKRD2 mRNA	PMID:19647056
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1312940	E	RGD:6480464	20120918	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of ANKRD2 mRNA	PMID:19647056
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ANKRD2 protein	PMID:32959892
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:60799	esketamine	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C000629870	Esketamine results in decreased expression of ANKRD2 mRNA	PMID:38219984
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ANKRD2 mRNA	PMID:15336504
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:64310	crizotinib	increases expression	ISO	RGD:1312940	E	RGD:6480464	20260303	CTD	MESH:C551994	Crizotinib results in increased expression of ANKRD2 mRNA; Crizotinib results in increased expression of ANKRD2 protein	PMID:41183147
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ANKRD2 mRNA	PMID:36139627
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:7719	ochratoxin A	decreases methylation	ISO	RGD:1305104	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased methylation of ANKRD2 gene	PMID:37162024
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305104	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased expression of ANKRD2 mRNA	PMID:37162024
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ANKRD2 mRNA	PMID:30851411
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of ANKRD2 mRNA	PMID:32234424
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ANKRD2 mRNA	PMID:26079696
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312940	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in decreased expression of ANKRD2 mRNA	PMID:33484791
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ANKRD2 mRNA	PMID:17440010
1312939	ANKRD2	ankyrin repeat domain 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ANKRD2 mRNA	PMID:38568856
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552115	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SMYD1 mRNA	PMID:33045310
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:15746	spermine	increases expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:D013096	Spermine results in increased expression of SMYD1 mRNA	PMID:18673383
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of SMYD1 mRNA	PMID:30510588
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552115	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SMYD1 mRNA	PMID:39298647
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [SMYD1 protein binds to ESR1 protein]	PMID:27156127
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMYD1 mRNA	PMID:25510870
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:16643	L-methionine	increases expression	ISO	RGD:1552115	E	RGD:6480464	20221206	CTD	MESH:D008715	Methionine deficiency results in increased expression of SMYD1 mRNA	PMID:35314295
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of SMYD1 mRNA	PMID:31525975
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of SMYD1 mRNA	PMID:31525975
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305105	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SMYD1 mRNA	PMID:33387578
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SMYD1 mRNA	PMID:36331819
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of SMYD1 mRNA	PMID:39984025
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMYD1 mRNA	PMID:25510870
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMYD1 mRNA	PMID:25510870
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of SMYD1 mRNA	PMID:19376150
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1552115	E	RGD:6480464	20160119	CTD	MESH:D009151	Mustard Gas results in increased expression of SMYD1 mRNA	PMID:26392148
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SMYD1 mRNA	PMID:34911549
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:27470	folic acid	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D005492	Folic Acid results in increased expression of SMYD1 mRNA	PMID:34742744
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SMYD1 mRNA	PMID:22206623
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SMYD1 mRNA	PMID:28189721|PMID:28960355
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMYD1 mRNA	PMID:18343893
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305105	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMYD1 mRNA	PMID:32109520
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMYD1 mRNA	PMID:19770486
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305105	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of SMYD1 mRNA	PMID:28374803
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SMYD1 mRNA	PMID:29803840
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SMYD1 promoter	PMID:27901495
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SMYD1 mRNA	PMID:29264374
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SMYD1 mRNA	PMID:18301758
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305105	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SMYD1 mRNA	PMID:25181051
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SMYD1 protein	PMID:37567409
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305105	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of SMYD1 mRNA	PMID:41034487
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552115	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SMYD1 mRNA	PMID:30951980|PMID:32156529
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305105	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SMYD1 gene	PMID:28505145
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMYD1 mRNA	PMID:25510870
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SMYD1 mRNA	PMID:25510870
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of SMYD1 mRNA	PMID:40203079
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552115	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SMYD1 mRNA	PMID:30951980|PMID:39298647
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552115	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SMYD1 mRNA	PMID:30951980
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1305105	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of SMYD1 mRNA	PMID:35163327
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305105	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SMYD1 mRNA	PMID:35163327
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1305105	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of SMYD1 mRNA	PMID:18500788
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305105	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SMYD1 mRNA	PMID:35163327
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SMYD1 mRNA	PMID:31533062
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of SMYD1 mRNA	PMID:39529242
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1305105	E	RGD:6480464	20121009	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SMYD1 mRNA	PMID:22237054
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SMYD1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SMYD1 mRNA	PMID:36331819
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMYD1 mRNA	PMID:15799026
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SMYD1 mRNA	PMID:28001369
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1305105	E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in increased expression of SMYD1 mRNA	PMID:35594946
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of SMYD1 mRNA	PMID:31525975
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SMYD1 mRNA	PMID:17562736
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1552115	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of SMYD1 mRNA	PMID:30529165
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305105	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of SMYD1 mRNA	PMID:22504374
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:50845	doxycycline	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:D004318	Doxycycline inhibits the reaction [Isoproterenol results in decreased expression of SMYD1 mRNA]	PMID:18089841
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of SMYD1 mRNA	PMID:36907384
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of SMYD1 mRNA	PMID:18089841|PMID:20003209
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20120515	CTD	MESH:D007545	Doxycycline inhibits the reaction [Isoproterenol results in decreased expression of SMYD1 mRNA]	PMID:18089841
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SMYD1 mRNA	PMID:22206623
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552115	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SMYD1 mRNA	PMID:22206623
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of SMYD1 mRNA	PMID:29522793
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SMYD1 gene]	PMID:28238834
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1552115	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of SMYD1 mRNA	PMID:18343893
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305105	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SMYD1 mRNA	PMID:32109520
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305105	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SMYD1 mRNA	PMID:23914054
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1552115	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SMYD1 mRNA	PMID:21278054
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305105	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SMYD1 mRNA	PMID:24780913
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305105	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of SMYD1 mRNA	PMID:22504374
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1552115	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of SMYD1 mRNA	PMID:26006729|PMID:26217789
1312941	SMYD1	SET and MYND domain containing 1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1552115	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of SMYD1 mRNA	PMID:32835833
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of CIDEA mRNA	PMID:25152437
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:136185	VX nerve agent	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C009680	VX-agent results in increased expression of CIDEA mRNA	PMID:38555327
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20191008	CTD	MESH:D002794	[Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of CIDEA mRNA	PMID:29127188
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of CIDEA mRNA	PMID:16604517|PMID:16788091|PMID:36189433
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CIDEA mRNA	PMID:36189433
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1312943	E	RGD:6480464	20140610	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CIDEA mRNA	PMID:23539316
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CIDEA mRNA	PMID:36331819
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20260407	CTD	MESH:D019308	Palmitic Acid results in decreased expression of CIDEA mRNA	PMID:40449640
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:15940	nicotinic acid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20161213	CTD	MESH:D009525	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of CIDEA mRNA]	PMID:16940432
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:15956	biotin	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D001710	[acetyl methyl tetramethyl tetralin co-treated with Biotin co-treated with Pantothenic Acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Thyroxine co-treated with TF protein] results in decreased expression of CIDEA mRNA	PMID:34323617
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of CIDEA mRNA	PMID:19484750
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of CIDEA mRNA	PMID:26496021
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305106	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of CIDEA mRNA	PMID:17905399
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20191008	CTD	MESH:D008715	[Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of CIDEA mRNA	PMID:29127188
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1312943	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of CIDEA mRNA	PMID:39922521
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CIDEA mRNA	PMID:37992649
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1312943	E	RGD:6480464	20200915	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of CIDEA mRNA	PMID:32522588
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CIDEA mRNA	PMID:36189433
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in increased expression of CIDEA mRNA]	PMID:20032058
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:17488	scopoletin	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20150825	CTD	MESH:D012603	Scopoletin inhibits the reaction [Alcohols affects the expression of CIDEA mRNA]	PMID:26115886
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1312943	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of CIDEA mRNA	PMID:39922521
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CIDEA mRNA	PMID:37992649
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20210504	CTD	MESH:D009538	Nicotine results in decreased expression of CIDEA mRNA	PMID:33091441
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CIDEA mRNA	PMID:31706747|PMID:34319233
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305106	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CIDEA mRNA	PMID:26577399
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:1784	biphenyl-4-amine	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C006757	4-biphenylamine results in decreased expression of CIDEA mRNA	PMID:24857880
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20210504	CTD	MESH:D009538	Nicotine results in decreased expression of CIDEA mRNA	PMID:33091441
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:23115	chlorohydrocarbon	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20210112	CTD	MESH:D006843	[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of CIDEA mRNA	PMID:30744511
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305106	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of CIDEA mRNA	PMID:21396975
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CIDEA mRNA	PMID:22129741
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CIDEA mRNA	PMID:33354967
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CIDEA intron	PMID:30157460
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CIDEA gene	PMID:27153756
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:25187	p-menthan-3-ol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of CIDEA mRNA	PMID:26760959
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20210112	CTD	MESH:D010126	[Ozone co-treated with Fructose] results in decreased expression of CIDEA mRNA; [Particulate Matter co-treated with Ozone co-treated with Fructose] results in decreased expression of CIDEA mRNA	PMID:23968387
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CIDEA mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CIDEA mRNA	PMID:34911549
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1305106	E	RGD:6480464	20260407	CTD	MESH:D000638	Amiodarone results in increased expression of CIDEA mRNA	PMID:40216313
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1312943	E	RGD:6480464	20171114	CTD	MESH:D000638	Amiodarone results in increased expression of CIDEA mRNA	PMID:28962527
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:2663	amiodarone	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20171114	CTD	MESH:D000638	1-(3,4-dihydroxyphenyl)-2-thiocyanate-ethanone inhibits the reaction [Amiodarone results in increased expression of CIDEA mRNA]; DDIT3 gene mutant form inhibits the reaction [Amiodarone results in increased expression of CIDEA mRNA]	PMID:28962527
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1312943	E	RGD:6480464	20141014	CTD	MESH:C011559	tributyltin results in increased expression of CIDEA mRNA	PMID:24848799
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20191008	CTD	MESH:D005492	[Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of CIDEA mRNA	PMID:29127188
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of CIDEA mRNA	PMID:19962721
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	[Arsenic co-treated with Fluorides] results in decreased expression of CIDEA mRNA	PMID:19962721
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CIDEA mRNA	PMID:28960355
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305106	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CIDEA mRNA	PMID:31881176
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312943	E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol results in increased expression of CIDEA mRNA	PMID:25761413
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of CIDEA mRNA	PMID:25905778
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:C059514	PRKAA1 gene mutant form inhibits the reaction [resveratrol results in increased expression of CIDEA mRNA]; resveratrol inhibits the reaction [Dietary Fats affects the expression of CIDEA mRNA]	PMID:17086191|PMID:25761413
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of CIDEA mRNA	PMID:15681117
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28073	chromium atom	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:D002857	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in decreased expression of CIDEA mRNA]	PMID:16940432
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of CIDEA mRNA	PMID:24768652
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CIDEA mRNA	PMID:21215274
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CIDEA mRNA	PMID:17942748
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28121	harmine	increases expression	ISO	RGD:1312943	E	RGD:6480464	20171114	CTD	MESH:D006247	Harmine results in increased expression of CIDEA protein	PMID:27805061
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28121	harmine	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20171114	CTD	MESH:D006247	Harmine affects the reaction [Dietary Fats affects the expression of CIDEA mRNA]	PMID:27805061
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305106	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of CIDEA mRNA	PMID:28374803
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20210112	CTD	MESH:C004925	[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of CIDEA mRNA	PMID:30744511
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CIDEA mRNA	PMID:30851411
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28436	delphinidin	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C017185	delphinidin results in increased expression of CIDEA mRNA	PMID:19182879
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312943	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of CIDEA mRNA	PMID:39631538
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28757	fructose	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20210112	CTD	MESH:D005632	Fructose results in decreased expression of CIDEA mRNA	PMID:23968387
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20210112	CTD	MESH:D005632	[Ozone co-treated with Fructose] results in decreased expression of CIDEA mRNA; [Particulate Matter co-treated with Fructose] results in decreased expression of CIDEA mRNA; [Particulate Matter co-treated with Ozone co-treated with Fructose] results in decreased expression of CIDEA mRNA	PMID:23968387
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CIDEA mRNA	PMID:37992649
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of CIDEA mRNA	PMID:29301061
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CIDEA mRNA	PMID:22316170
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CIDEA mRNA	PMID:21839799
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312943	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CIDEA mRNA	PMID:22610609
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CIDEA promoter	PMID:27901495
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CIDEA promoter	PMID:23974009
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CIDEA mRNA	PMID:17530438
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:30660	thyroxine	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D013974	[acetyl methyl tetramethyl tetralin co-treated with Biotin co-treated with Pantothenic Acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Thyroxine co-treated with TF protein] results in decreased expression of CIDEA mRNA	PMID:34323617
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:30879	alcohol	affects expression	ISO	RGD:1305106	E	RGD:6480464	20170228	CTD	MESH:D000438	Alcohols affects the expression of CIDEA mRNA	PMID:26115886
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:30879	alcohol	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20170228	CTD	MESH:D000438	Scopoletin inhibits the reaction [Alcohols affects the expression of CIDEA mRNA]	PMID:26115886
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of CIDEA mRNA	PMID:24915197
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CIDEA mRNA	PMID:30047161
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CIDEA mRNA	PMID:23557971
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312943	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CIDEA gene	PMID:35295148
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305106	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CIDEA mRNA	PMID:23411599
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305106	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CIDEA mRNA	PMID:25380136
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1305106	E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of CIDEA mRNA	PMID:19162173|PMID:22484513
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312943	E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of CIDEA mRNA; pirinixic acid results in increased expression of CIDEA protein	PMID:12727805|PMID:17690133|PMID:17950772|PMID:18301758|PMID:20059764
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CIDEA mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of CIDEA mRNA]	PMID:17950772|PMID:19710929|PMID:20059764
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:32687	piperonyl butoxide	increases expression	ISO	RGD:1305106	E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of CIDEA mRNA	PMID:22484513
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:32888	gamma-hexachlorocyclohexane	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20120412	CTD	MESH:D001556	Hexachlorocyclohexane results in decreased expression of CIDEA mRNA	PMID:17785943
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CIDEA mRNA	PMID:34947998|PMID:35192832
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of CIDEA mRNA	PMID:30245210|PMID:39537008
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305106	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CIDEA mRNA	PMID:25181051
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305106	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CIDEA gene	PMID:28505145
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of CIDEA mRNA	PMID:26496021
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:33418	graphite	increases expression	ISO	RGD:1312943	E	RGD:6480464	20180515	CTD	MESH:D006108	Graphite results in increased expression of CIDEA mRNA	PMID:27440207
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of CIDEA mRNA	PMID:22937105
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1305106	E	RGD:6480464	20130122	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CIDEA mRNA	PMID:16984957|PMID:20959002
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20130122	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CIDEA mRNA	PMID:20959002
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CIDEA mRNA	PMID:37019170
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305106	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of CIDEA mRNA	PMID:22546817
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312943	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CIDEA mRNA	PMID:17361019|PMID:21266533
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305106	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CIDEA mRNA	PMID:22546817
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D015056	[acetyl methyl tetramethyl tetralin co-treated with Biotin co-treated with Pantothenic Acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Thyroxine co-treated with TF protein] results in decreased expression of CIDEA mRNA; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone co-treated with bisphenol AF] results in increased expression of CIDEA mRNA; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of CIDEA mRNA	PMID:31596606|PMID:34323617
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20141014	CTD	MESH:D015056	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CIDEA mRNA; [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of CIDEA mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Roscovitine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of CIDEA mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEA mRNA	PMID:24848799|PMID:29288687|PMID:32417366|PMID:34323617
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1312943	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CIDEA mRNA	PMID:24535843
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CIDEA mRNA	PMID:22129741
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305106	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CIDEA mRNA	PMID:22546817
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of CIDEA mRNA	PMID:18836921
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of CIDEA gene	PMID:33148267
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305106	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of CIDEA mRNA	PMID:30589522
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CIDEA mRNA	PMID:35163327
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305106	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of CIDEA mRNA	PMID:25380136
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CIDEA mRNA	PMID:38174414
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CIDEA mRNA	PMID:25812627
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305106	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CIDEA mRNA	PMID:19162173
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CIDEA mRNA	PMID:35163327
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305106	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CIDEA mRNA	PMID:19162173
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312943	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CIDEA mRNA	PMID:18353800
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1312943	E	RGD:6480464	20210608	CTD	MESH:D002994	Clofibrate results in increased expression of CIDEA mRNA	PMID:33549593
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:38319	usnic acid	increases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in increased expression of CIDEA mRNA	PMID:32508146
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CIDEA mRNA	PMID:25812627
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312943	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CIDEA mRNA	PMID:40194260
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:38397	perfluorononanoic acid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20220111	CTD	MESH:C101816	[Dietary Fats co-treated with perfluoro-n-nonanoic acid] results in increased expression of CIDEA mRNA	PMID:33483757
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1305106	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CIDEA mRNA	PMID:19162173
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20210209	CTD	MESH:C076994	[Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of CIDEA mRNA; [perfluorooctane sulfonic acid co-treated with Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of CIDEA mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CIDEA mRNA	PMID:32979393|PMID:32991729|PMID:36331819
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of CIDEA mRNA	PMID:35594946
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CIDEA mRNA	PMID:30047161
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305106	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of CIDEA mRNA	PMID:41580965
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D003907	Dexamethasone results in increased expression of CIDEA mRNA	PMID:19853017
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1305106	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of CIDEA mRNA	PMID:20032058
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D003907	[acetyl methyl tetramethyl tetralin co-treated with Biotin co-treated with Pantothenic Acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Thyroxine co-treated with TF protein] results in decreased expression of CIDEA mRNA; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone co-treated with bisphenol AF] results in increased expression of CIDEA mRNA; [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone] results in increased expression of CIDEA mRNA	PMID:31596606|PMID:34323617
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20120412	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in increased expression of CIDEA mRNA]	PMID:20032058
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20141014	CTD	MESH:D003907	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CIDEA mRNA; [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of CIDEA mRNA; [mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Roscovitine co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of CIDEA mRNA; [Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA; [Rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CIDEA mRNA	PMID:24848799|PMID:29288687|PMID:32417366|PMID:34323617
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1305106	E	RGD:6480464	20230606	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CIDEA mRNA	PMID:36653537|PMID:37077353
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:42017	2,4-dinitrophenol	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20150127	CTD	MESH:D019297	[2,4-Dinitrophenol co-treated with Dietary Fats] affects the expression of CIDEA mRNA	PMID:24872412
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312943	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CIDEA mRNA	PMID:28973697
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1312943	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of CIDEA mRNA	PMID:39922521
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CIDEA mRNA	PMID:37992649
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305106	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CIDEA mRNA	PMID:24136188
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:46905	(R)-pantothenic acid	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D010205	[acetyl methyl tetramethyl tetralin co-treated with Biotin co-treated with Pantothenic Acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Thyroxine co-treated with TF protein] results in decreased expression of CIDEA mRNA	PMID:34323617
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of CIDEA mRNA	PMID:19962721
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	[Arsenic co-treated with Fluorides] results in decreased expression of CIDEA mRNA	PMID:19962721
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:47426	furosemide	affects expression	ISO	RGD:1305106	E	RGD:6480464	20120412	CTD	MESH:D005665	Furosemide affects the expression of CIDEA mRNA	PMID:17497460
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1305106	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of CIDEA mRNA	PMID:36653537|PMID:37077353
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1312943	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of CIDEA mRNA	PMID:30529165
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CIDEA mRNA	PMID:17942748
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CIDEA mRNA	PMID:17530438
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased methylation of CIDEA promoter	PMID:18033804
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of CIDEA mRNA	PMID:18033804
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine promotes the reaction [SP1 protein binds to CIDEA promoter]; Decitabine promotes the reaction [SP3 protein binds to CIDEA promoter]	PMID:18033804
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CIDEA mRNA	PMID:25620056
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312943	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CIDEA mRNA	PMID:25620056
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305106	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of CIDEA mRNA	PMID:23962444
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CIDEA mRNA	PMID:30047161
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305106	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CIDEA mRNA	PMID:24136188
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:5299	Geniposide	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20220111	CTD	MESH:C007835	geniposide results in decreased expression of CIDEA mRNA	PMID:34718029
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:53001	nickel sulfate	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20150609	CTD	MESH:C029938	nickel sulfate results in decreased expression of CIDEA mRNA	PMID:23126276
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:53001	nickel sulfate	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20150609	CTD	MESH:C029938	[nickel sulfate co-treated with Particulate Matter] results in decreased expression of CIDEA mRNA	PMID:23126276
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20240702	CTD	MESH:C082359	[imidacloprid co-treated with Dietary Fats] results in increased expression of CIDEA mRNA	PMID:33487623
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:6015	isoflurane	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20120412	CTD	MESH:D007530	Isoflurane results in decreased expression of CIDEA mRNA	PMID:16978161
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of CIDEA mRNA	PMID:20436886
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:63630	tolcapone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C066340	tolcapone results in increased expression of CIDEA mRNA	PMID:29688484
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CIDEA mRNA	PMID:22079614
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20200331	CTD	MESH:D012970	[Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CIDEA mRNA	PMID:19001666
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:6451	Licarin A	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20180515	CTD	MESH:C432503	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of CIDEA mRNA	PMID:29288687
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:6682	mangiferin	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20200915	CTD	MESH:C013592	[mangiferin co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CIDEA mRNA	PMID:32417366
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1305106	E	RGD:6480464	20170725	CTD	MESH:D008694	Methamphetamine results in increased expression of CIDEA mRNA; Methamphetamine results in increased expression of CIDEA protein	PMID:28341135
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of CIDEA gene	PMID:33148267
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:72754	bisphenol AF	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Rosiglitazone co-treated with bisphenol AF] results in increased expression of CIDEA mRNA	PMID:31596606
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305106	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CIDEA mRNA	PMID:24136188
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CIDEA mRNA	PMID:25566086
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1305106	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of CIDEA mRNA	PMID:23665939
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:7823	oxazepam	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20120412	CTD	MESH:D010076	Oxazepam results in decreased expression of CIDEA mRNA	PMID:12727805
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CIDEA mRNA	PMID:30851411
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CIDEA gene]	PMID:28238834
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305106	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of CIDEA mRNA	PMID:19162173
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1312943	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of CIDEA mRNA	PMID:18958704
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1312943	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of CIDEA mRNA	PMID:26377693
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305106	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CIDEA mRNA	PMID:25825206|PMID:30047161
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305106	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CIDEA mRNA	PMID:24780913
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1305106	E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of CIDEA mRNA	PMID:25905778
1312942	CIDEA	cell death inducing DFFA like effector a	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1312943	E	RGD:6480464	20191008	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of CIDEA mRNA	PMID:29127188
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of SRPK2 mRNA	PMID:16788091
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of SRPK2 protein	PMID:39571964
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312945	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SRPK2 mRNA	PMID:12057914
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305107	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SRPK2 mRNA	PMID:32145629
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305107	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SRPK2 gene	PMID:27618143
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SRPK2 mRNA	PMID:37042841
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1305107	E	RGD:6480464	20120918	CTD	MESH:D014050	Toluene results in decreased expression of SRPK2 mRNA	PMID:22166486
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1305107	E	RGD:6480464	20120918	CTD	MESH:D014050	Toluene results in increased expression of SRPK2 mRNA	PMID:22166486
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305107	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SRPK2 mRNA	PMID:22061828
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20150714	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SRPK2 mRNA	PMID:15329391
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPK2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SRPK2 mRNA	PMID:39836092
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312945	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SRPK2 mRNA	PMID:28111341
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SRPK2 protein	PMID:23301498
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SRPK2 mRNA	PMID:19770486
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in decreased expression of SRPK2 mRNA	PMID:15674843
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1312945	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SRPK2 mRNA	PMID:20857495
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312945	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SRPK2 mRNA	PMID:17484886
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SRPK2 gene	PMID:25304211
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRPK2 mRNA	PMID:39836092
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of SRPK2 protein	PMID:35688186
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SRPK2 mRNA	PMID:28903495
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:27899	cisplatin	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin affects the localization of SRPK2 protein	PMID:21157427
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin affects the localization of SRPK2 protein] which results in increased phosphorylation of SRSF2 protein; Cisplatin affects the localization of and results in increased phosphorylation of SRPK2 protein	PMID:21157427|PMID:23613995
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SRPK2 mRNA	PMID:30912803
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305107	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SRPK2 mRNA	PMID:34747641
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SRPK2 mRNA	PMID:33212167
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20250401	CTD	MESH:D004317	Doxorubicin results in decreased expression of SRPK2 mRNA; Doxorubicin results in decreased expression of SRPK2 protein	PMID:38244039|PMID:39631538
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of SRPK2 protein	PMID:35688186
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of SRPK2 protein	PMID:30528433
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of SRPK2 mRNA	PMID:36209798
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SRPK2 mRNA	PMID:38568856
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312945	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased expression of SRPK2 mRNA	PMID:32068019
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPK2 mRNA; [sodium arsenite co-treated with Tretinoin] results in increased expression of SRPK2 protein; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRPK2 mRNA; sodium arsenite inhibits the reaction [SRPK2 protein binds to Ribonucleotides]	PMID:30528433|PMID:39571964|PMID:39836092
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SRPK2 mRNA	PMID:20064835|PMID:20106945
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of SRPK2 protein	PMID:37955338
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:29866	arsenite(3-)	decreases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased methylation of SRPK2 promoter	PMID:23974009
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1312945	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of SRPK2 mRNA	PMID:20857495
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SRPK2 mRNA	PMID:19150397
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:30772	butyric acid	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:D020148	Butyric Acid affects the localization of SRPK2 protein	PMID:21555914
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of SRPK2 gene	PMID:31601247
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305107	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SRPK2 mRNA	PMID:34492290
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1312945	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of SRPK2 mRNA	PMID:19191707
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305107	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SRPK2 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998|PMID:41034487
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SRPK2 mRNA	PMID:33221593
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SRPK2 gene	PMID:31601247
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305107	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SRPK2 mRNA	PMID:25181051
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312945	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of SRPK2 mRNA	PMID:25594700
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305107	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SRPK2 gene	PMID:28505145
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of SRPK2 gene	PMID:31601247
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SRPK2 mRNA	PMID:19244175
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1312945	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SRPK2 gene	PMID:31683443
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SRPK2 mRNA	PMID:39298647
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SRPK2 mRNA	PMID:38685157
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1312945	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SRPK2 intron	PMID:28392331
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1305107	E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SRPK2 mRNA	PMID:18668222
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SRPK2 mRNA	PMID:37019170
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of SRPK2 mRNA	PMID:21527772
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20140408	CTD	MESH:D010269	Paraquat affects the localization of and results in increased phosphorylation of SRPK2 protein; SRPK2 protein affects the reaction [Paraquat results in increased phosphorylation of SRSF3 protein]; SRPK2 protein affects the reaction [Paraquat results in increased phosphorylation of SRSF5 protein]; SRPK2 protein affects the reaction [Paraquat results in increased phosphorylation of SRSF6 protein]	PMID:23613995
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SRPK2 mRNA	PMID:37042841
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305107	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SRPK2 mRNA	PMID:30589522
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPK2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SRPK2 mRNA	PMID:39836092
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SRPK2 mRNA	PMID:26472689
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312945	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SRPK2 mRNA	PMID:28111341
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SRPK2 mRNA	PMID:24449571
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1312945	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of SRPK2 mRNA	PMID:18353800
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1305107	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of SRPK2 mRNA	PMID:23125180
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SRPK2 mRNA	PMID:25979313
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SRPK2 gene	PMID:29154799
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SRPK2 mRNA	PMID:19101580|PMID:23179753
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SRPK2 mRNA	PMID:28973697
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of SRPK2 mRNA	PMID:24449571
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SRPK2 mRNA	PMID:22230336
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SRPK2 mRNA	PMID:29279043
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SRPK2 gene	PMID:25304211
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SRPK2 mRNA	PMID:39836092
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SRPK2 mRNA	PMID:22079256
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of SRPK2 mRNA	PMID:25554681
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305107	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SRPK2 mRNA	PMID:24136188
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1312945	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of SRPK2 mRNA	PMID:23608068
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SRPK2 protein	PMID:32959892
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SRPK2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SRPK2 mRNA	PMID:39836092
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1312945	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SRPK2 mRNA	PMID:21641980
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SRPK2 mRNA	PMID:15336504
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305107	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SRPK2 gene	PMID:35440735
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of SRPK2 mRNA	PMID:27462272
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in increased expression of SRPK2 mRNA	PMID:22101062
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312945	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SRPK2 mRNA	PMID:22206623
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:7438	N-methylformamide	increases expression	ISO	RGD:1312945	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide analog results in increased expression of SRPK2 mRNA; methylformamide results in increased expression of SRPK2 mRNA	PMID:17040096
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SRPK2 mRNA	PMID:22079256
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SRPK2 mRNA	PMID:22079256
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1305107	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of SRPK2 mRNA	PMID:22124623
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SRPK2 mRNA	PMID:19159669
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of SRPK2 mRNA	PMID:23091169
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312945	E	RGD:6480464	20150127	CTD	MESH:D010634	Phenobarbital results in increased expression of SRPK2 mRNA	PMID:25270620
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of SRPK2 mRNA	PMID:21278054
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:8772	raloxifene	affects expression	ISO	RGD:1305107	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of SRPK2 mRNA	PMID:16079270
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305107	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SRPK2 mRNA	PMID:21346803
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of SRPK2 mRNA	PMID:17440010
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305107	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SRPK2 mRNA	PMID:21346803
1312944	SRPK2	SRSF protein kinase 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312945	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SRPK2 mRNA	PMID:28973697
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552117	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PCDHGA7 mRNA	PMID:30319688
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PCDHGA7 mRNA	PMID:35811015
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305108	E	RGD:6480464	20260811	CTD	MESH:D014241	Trichloroethylene results in increased expression of PCDHGB4 mRNA	PMID:33387578
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDHGA7 gene	PMID:27153756
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PCDHGA7 mRNA	PMID:27392435
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PCDHGA7 mRNA	PMID:27392435
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PCDHGA7 mRNA	PMID:33212167
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PCDHGA7 mRNA	PMID:32763439
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:28748	doxorubicin	affects methylation	ISO	RGD:1305108	E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of PCDHGA7 gene	PMID:28962528
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PCDHGA7 mRNA	PMID:29803840
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552117	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PCDHGA7 mRNA	PMID:22228805
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1305108	E	RGD:6480464	20160712	CTD	MESH:C004312	glycidol results in increased expression of PCDHGA7 mRNA	PMID:24915197
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305108	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PCDHGA7 mRNA	PMID:30047161
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1552117	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of PCDHGA7 mRNA	PMID:23557971
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305108	E	RGD:6480464	20160712	CTD	MESH:C006780	bisphenol A affects the expression of PCDHGA7 mRNA	PMID:25181051
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PCDHGA7 gene	PMID:29154799
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305108	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PCDHGA7 mRNA	PMID:30047161
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PCDHGA7 mRNA	PMID:38832940
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of PCDHGA7 mRNA	PMID:35811015
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PCDHGA7 mRNA	PMID:35811015
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of PCDHGA7 promoter	PMID:29626692
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of PCDHGA7 promoter	PMID:29626692
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of PCDHGA7 mRNA	PMID:38825487
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305108	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PCDHGA7 mRNA	PMID:30047161
1312946	PCDHGA7	protocadherin gamma subfamily A, 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305108	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PCDHGA7 mRNA	PMID:30047161
1312947	STOM	stomatin	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of STOM protein	PMID:39638853
1312947	STOM	stomatin	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of STOM mRNA	PMID:35967413
1312947	STOM	stomatin	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305109	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of STOM mRNA	PMID:21551480
1312947	STOM	stomatin	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of STOM protein	PMID:36641056
1312947	STOM	stomatin	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550119	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of STOM mRNA	PMID:20188158
1312947	STOM	stomatin	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of STOM mRNA	PMID:23830798
1312947	STOM	stomatin	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1305109	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of STOM mRNA	PMID:36841081
1312947	STOM	stomatin	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of STOM mRNA	PMID:39241906
1312947	STOM	stomatin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550119	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of STOM mRNA	PMID:39298647
1312947	STOM	stomatin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of STOM mRNA	PMID:30165855
1312947	STOM	stomatin	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1305109	E	RGD:6480464	20120412	CTD	MESH:D014241	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of STOM mRNA	PMID:17905399
1312947	STOM	stomatin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of STOM mRNA	PMID:37042841
1312947	STOM	stomatin	gene	CHEBI:16716	benzene	multiple interactions	ISO	RGD:1305109	E	RGD:6480464	20120412	CTD	MESH:D001554	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of STOM mRNA	PMID:17905399
1312947	STOM	stomatin	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of STOM mRNA	PMID:23649840
1312947	STOM	stomatin	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of STOM mRNA	PMID:21669218
1312947	STOM	stomatin	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1305109	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of STOM mRNA	PMID:22967744
1312947	STOM	stomatin	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of STOM mRNA	PMID:23892564
1312947	STOM	stomatin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550119	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of STOM mRNA	PMID:34319233
1312947	STOM	stomatin	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of STOM protein	PMID:37730182
1312947	STOM	stomatin	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of STOM mRNA	PMID:36139627
1312947	STOM	stomatin	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305109	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of STOM mRNA	PMID:33387578
1312947	STOM	stomatin	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of STOM mRNA	PMID:19549813
1312947	STOM	stomatin	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of STOM mRNA	PMID:23649840
1312947	STOM	stomatin	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of STOM protein	PMID:20106945
1312947	STOM	stomatin	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of STOM gene	PMID:27153756
1312947	STOM	stomatin	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of STOM mRNA; Aflatoxin B1 results in increased expression of STOM protein	PMID:21632981|PMID:39638853
1312947	STOM	stomatin	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in increased expression of STOM protein	PMID:39638853
1312947	STOM	stomatin	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of STOM mRNA	PMID:21527772|PMID:23649840
1312947	STOM	stomatin	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of STOM mRNA	PMID:17484886
1312947	STOM	stomatin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550119	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STOM mRNA	PMID:22206623
1312947	STOM	stomatin	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of STOM mRNA	PMID:19654921
1312947	STOM	stomatin	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in increased expression of STOM mRNA	PMID:21527772
1312947	STOM	stomatin	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of STOM mRNA	PMID:26272509
1312947	STOM	stomatin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STOM mRNA	PMID:27188386
1312947	STOM	stomatin	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of STOM mRNA	PMID:28960355
1312947	STOM	stomatin	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305109	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of STOM mRNA	PMID:31881176
1312947	STOM	stomatin	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1305109	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of STOM mRNA	PMID:25905778
1312947	STOM	stomatin	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of STOM mRNA	PMID:40618947
1312947	STOM	stomatin	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1305109	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of STOM gene	PMID:28505145
1312947	STOM	stomatin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305109	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STOM mRNA	PMID:34747641
1312947	STOM	stomatin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550119	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to STOM promoter]	PMID:19654925
1312947	STOM	stomatin	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of STOM mRNA	PMID:39709020
1312947	STOM	stomatin	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305109	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of STOM mRNA	PMID:28959563
1312947	STOM	stomatin	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of STOM mRNA	PMID:21198554
1312947	STOM	stomatin	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1550119	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of STOM mRNA	PMID:27862939
1312947	STOM	stomatin	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of STOM mRNA	PMID:29803840
1312947	STOM	stomatin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of STOM mRNA	PMID:38568856|PMID:39719251
1312947	STOM	stomatin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of STOM mRNA	PMID:39515575
1312947	STOM	stomatin	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of STOM mRNA	PMID:34032870
1312947	STOM	stomatin	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550119	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of STOM mRNA; sodium arsenite results in increased expression of STOM protein	PMID:29044176|PMID:39095385
1312947	STOM	stomatin	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of STOM mRNA	PMID:12634122
1312947	STOM	stomatin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STOM mRNA	PMID:19770486
1312947	STOM	stomatin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STOM mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1312947	STOM	stomatin	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of STOM mRNA	PMID:18929588
1312947	STOM	stomatin	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in decreased expression of STOM mRNA]	PMID:18929588
1312947	STOM	stomatin	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1305109	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of STOM mRNA	PMID:38458666
1312947	STOM	stomatin	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of STOM mRNA	PMID:25895662
1312947	STOM	stomatin	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of STOM mRNA	PMID:20382639|PMID:26238291
1312947	STOM	stomatin	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1550119	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of STOM mRNA	PMID:22609695
1312947	STOM	stomatin	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C008261	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of STOM mRNA	PMID:12634122
1312947	STOM	stomatin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of STOM mRNA	PMID:23557971
1312947	STOM	stomatin	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550119	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STOM gene	PMID:35295148
1312947	STOM	stomatin	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305109	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of STOM mRNA	PMID:34492290
1312947	STOM	stomatin	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of STOM mRNA	PMID:17426115
1312947	STOM	stomatin	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of STOM mRNA	PMID:18301758
1312947	STOM	stomatin	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of STOM mRNA	PMID:38479592
1312947	STOM	stomatin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of STOM protein	PMID:31675489|PMID:34186270
1312947	STOM	stomatin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305109	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STOM mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1312947	STOM	stomatin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of STOM mRNA	PMID:20739668
1312947	STOM	stomatin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305109	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of STOM gene	PMID:28505145
1312947	STOM	stomatin	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of STOM mRNA	PMID:19244175
1312947	STOM	stomatin	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of STOM mRNA	PMID:25979313
1312947	STOM	stomatin	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1550119	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of STOM mRNA	PMID:26682919
1312947	STOM	stomatin	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of STOM mRNA	PMID:19925653
1312947	STOM	stomatin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of STOM mRNA	PMID:39298647
1312947	STOM	stomatin	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of STOM protein	PMID:34186270
1312947	STOM	stomatin	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of STOM protein	PMID:34186270
1312947	STOM	stomatin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305109	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of STOM mRNA	PMID:21266533
1312947	STOM	stomatin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550119	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of STOM mRNA	PMID:17361019|PMID:21266533
1312947	STOM	stomatin	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of STOM mRNA	PMID:37042841
1312947	STOM	stomatin	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1305109	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of STOM mRNA	PMID:38458666
1312947	STOM	stomatin	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of STOM mRNA	PMID:29024780
1312947	STOM	stomatin	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305109	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of STOM mRNA	PMID:35163327
1312947	STOM	stomatin	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of STOM mRNA	PMID:38568856
1312947	STOM	stomatin	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of STOM mRNA	PMID:26472689
1312947	STOM	stomatin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of STOM mRNA	PMID:12634122
1312947	STOM	stomatin	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305109	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of STOM mRNA	PMID:35163327
1312947	STOM	stomatin	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of STOM mRNA	PMID:23811191
1312947	STOM	stomatin	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of STOM mRNA	PMID:40434365
1312947	STOM	stomatin	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STOM mRNA	PMID:25979313
1312947	STOM	stomatin	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of STOM mRNA	PMID:29154799
1312947	STOM	stomatin	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of STOM mRNA	PMID:23179753|PMID:24935251
1312947	STOM	stomatin	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of STOM mRNA	PMID:21527772
1312947	STOM	stomatin	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of STOM mRNA	PMID:25562108|PMID:27989131
1312947	STOM	stomatin	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of STOM mRNA	PMID:17555576
1312947	STOM	stomatin	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of STOM mRNA	PMID:25047013
1312947	STOM	stomatin	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of STOM mRNA]	PMID:21233418
1312947	STOM	stomatin	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of STOM mRNA	PMID:18769122
1312947	STOM	stomatin	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of STOM mRNA	PMID:24935251
1312947	STOM	stomatin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of STOM mRNA	PMID:17562736
1312947	STOM	stomatin	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of STOM mRNA	PMID:29067470
1312947	STOM	stomatin	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of STOM mRNA	PMID:22230336
1312947	STOM	stomatin	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305109	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of STOM mRNA	PMID:33387578
1312947	STOM	stomatin	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D005472	Fluorouracil results in decreased expression of STOM mRNA	PMID:24737281
1312947	STOM	stomatin	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of STOM mRNA	PMID:29279043
1312947	STOM	stomatin	gene	CHEBI:46680	serpentine asbestos	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in decreased expression of STOM mRNA	PMID:21148743
1312947	STOM	stomatin	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of STOM mRNA	PMID:19654921
1312947	STOM	stomatin	gene	CHEBI:48242	dichromium trioxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C023600	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of STOM mRNA	PMID:12634122
1312947	STOM	stomatin	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of STOM mRNA	PMID:24383545
1312947	STOM	stomatin	gene	CHEBI:48981	quinolin-8-ol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in increased expression of STOM mRNA	PMID:21632981
1312947	STOM	stomatin	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550119	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of STOM mRNA	PMID:17555576
1312947	STOM	stomatin	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of STOM mRNA	PMID:21527772
1312947	STOM	stomatin	gene	CHEBI:49747	methylmercury(1+)	multiple interactions	ISO	RGD:1305109	E	RGD:6480464	20120412	CTD	MESH:C030957	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of STOM mRNA	PMID:17905399
1312947	STOM	stomatin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of STOM mRNA; Nanotubes, Carbon results in decreased expression of STOM mRNA	PMID:25620056
1312947	STOM	stomatin	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550119	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of STOM mRNA	PMID:35964746
1312947	STOM	stomatin	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of STOM protein	PMID:32959892
1312947	STOM	stomatin	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1550119	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of STOM protein	PMID:26558463
1312947	STOM	stomatin	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1550119	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of STOM mRNA	PMID:36907384
1312947	STOM	stomatin	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of STOM mRNA	PMID:18497975
1312947	STOM	stomatin	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of STOM protein	PMID:34186270
1312947	STOM	stomatin	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550119	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STOM mRNA	PMID:22206623
1312947	STOM	stomatin	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of STOM mRNA	PMID:36139627
1312947	STOM	stomatin	gene	CHEBI:77012	methylseleninic acid	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of STOM mRNA	PMID:18548127
1312947	STOM	stomatin	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in increased expression of STOM protein	PMID:39638853
1312947	STOM	stomatin	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STOM mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STOM mRNA	PMID:27188386
1312947	STOM	stomatin	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550119	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of STOM mRNA	PMID:31388691
1312947	STOM	stomatin	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STOM mRNA	PMID:27188386
1312947	STOM	stomatin	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STOM mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STOM mRNA	PMID:27188386
1312947	STOM	stomatin	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305109	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of STOM mRNA	PMID:19281266
1312947	STOM	stomatin	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of STOM mRNA	PMID:38568856
1312947	STOM	stomatin	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of STOM mRNA	PMID:29301935
1312947	STOM	stomatin	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305109	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of STOM mRNA	PMID:19015723
1312947	STOM	stomatin	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305109	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of STOM mRNA	PMID:23034163
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ARHGEF12 mRNA	PMID:33045310
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	affects methylation	ISO	RGD:1312951	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine affects the methylation of ARHGEF12 promoter	PMID:26251327
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312951	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ARHGEF12 mRNA	PMID:20188158|PMID:26251327
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ARHGEF12 mRNA	PMID:26079696
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:15756	hexadecanoic acid	affects phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid affects the phosphorylation of ARHGEF12 protein	PMID:28073184
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of ARHGEF12 mRNA	PMID:40945087
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312951	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ARHGEF12 mRNA	PMID:30319688
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1312951	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ARHGEF12 mRNA	PMID:30319688
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ARHGEF12 mRNA	PMID:39298647
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ARHGEF12 mRNA	PMID:33754040
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ARHGEF12 protein	PMID:37730182
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305111	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ARHGEF12 mRNA	PMID:22061828
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGEF12 mRNA	PMID:29950665
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ARHGEF12 gene	PMID:27153756
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARHGEF12 mRNA	PMID:34911549
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ARHGEF12 mRNA	PMID:22206623
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:27563	arsenic atom	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	ARHGEF12 mRNA results in increased susceptibility to Arsenic	PMID:17976673
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ARHGEF12 protein	PMID:35688186
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:1305111	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of ARHGEF12 gene	PMID:31011160
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of ARHGEF12 mRNA	PMID:28903495
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ARHGEF12 mRNA	PMID:24768652
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305111	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARHGEF12 mRNA	PMID:33387578
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305111	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARHGEF12 mRNA	PMID:32109520
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGEF12 mRNA	PMID:17942748
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARHGEF12 mRNA	PMID:33212167
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305111	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ARHGEF12 mRNA	PMID:30556269
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of ARHGEF12 protein	PMID:35688186
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ARHGEF12 gene	PMID:28589171
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGEF12 mRNA	PMID:38568856
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ARHGEF12 mRNA]	PMID:32406909
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305111	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ARHGEF12 mRNA	PMID:30556269
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of ARHGEF12 mRNA	PMID:25075043
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ARHGEF12 gene; [bisphenol S co-treated with Fulvestrant] results in decreased methylation of ARHGEF12 gene	PMID:31601247
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305111	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ARHGEF12 mRNA	PMID:30047161
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1312951	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of ARHGEF12 mRNA	PMID:17656681
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312951	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARHGEF12 gene; titanium dioxide results in decreased methylation of ARHGEF12 promoter	PMID:35295148
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGEF12 mRNA	PMID:29950665
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ARHGEF12 mRNA	PMID:19710929
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305111	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ARHGEF12 mRNA	PMID:19167457
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305111	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ARHGEF12 mRNA	PMID:32145629
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305111	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGEF12 mRNA	PMID:25181051
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARHGEF12 gene	PMID:31601247
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305111	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ARHGEF12 gene	PMID:28505145
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ARHGEF12 mRNA	PMID:25979313
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ARHGEF12 mRNA	PMID:39298647
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ARHGEF12 gene	PMID:31601247
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312951	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ARHGEF12 mRNA	PMID:40203079
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of ARHGEF12 gene	PMID:31601247
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312951	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ARHGEF12 mRNA	PMID:38685157
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ARHGEF12 gene	PMID:31601247
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ARHGEF12 mRNA	PMID:28392331
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1312951	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ARHGEF12 intron	PMID:28392331
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGEF12 mRNA	PMID:29950665
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312951	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARHGEF12 mRNA	PMID:21266533
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305111	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of ARHGEF12 gene	PMID:33148267
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34967	rimonabant	affects expression	ISO	RGD:1312951	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant affects the expression of ARHGEF12 mRNA	PMID:19030233
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of ARHGEF12 mRNA]	PMID:19030233
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARHGEF12 mRNA	PMID:37042841
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305111	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ARHGEF12 mRNA	PMID:30047161
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ARHGEF12 mRNA	PMID:40194260
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:38561	fluvastatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C065180	[zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF12 mRNA	PMID:16996129
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGEF12 mRNA	PMID:17183730
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305111	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ARHGEF12 mRNA	PMID:30047161
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ARHGEF12 mRNA	PMID:19770486
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ARHGEF12 mRNA	PMID:28542535
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGEF12 mRNA	PMID:21420995
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:46557	zoledronic acid	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	[zoledronic acid co-treated with fluvastatin] results in increased expression of ARHGEF12 mRNA	PMID:16996129
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:47217	arsane	increases response to substance	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	ARHGEF12 mRNA results in increased susceptibility to Arsenic	PMID:17976673
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305111	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ARHGEF12 mRNA	PMID:29391264
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312951	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARHGEF12 mRNA	PMID:17942748
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGEF12 mRNA	PMID:17942748
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:50035	alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of ARHGEF12 mRNA	PMID:25075043
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARHGEF12 mRNA; Nanotubes, Carbon results in decreased expression of ARHGEF12 mRNA	PMID:25554681
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305111	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ARHGEF12 mRNA	PMID:30047161
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGEF12 mRNA	PMID:17183730
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ARHGEF12 protein	PMID:32959892
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305111	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of ARHGEF12 gene	PMID:33148267
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ARHGEF12 mRNA	PMID:31758290
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312951	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ARHGEF12 mRNA	PMID:22206623
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of ARHGEF12 mRNA	PMID:18927307
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:8093	phenylephrine	decreases expression	ISO	RGD:1305111	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in decreased expression of ARHGEF12 mRNA	PMID:18158353
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ARHGEF12 mRNA	PMID:26079696
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312951	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ARHGEF12 mRNA	PMID:39847705
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1305111	E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of ARHGEF12 mRNA	PMID:26923065
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305111	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARHGEF12 mRNA	PMID:30047161
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305111	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ARHGEF12 mRNA	PMID:19281266
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ARHGEF12 mRNA	PMID:38568856
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of ARHGEF12 mRNA	PMID:27188386
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305111	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ARHGEF12 mRNA	PMID:21346803
1312950	ARHGEF12	Rho guanine nucleotide exchange factor 12	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312951	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ARHGEF12 mRNA	PMID:28973697
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1312954	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of NUBP2 protein	PMID:36252740
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NUBP2 mRNA	PMID:38218311
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001241	Aspirin results in decreased expression of NUBP2 mRNA	PMID:15456535|PMID:15928584
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NUBP2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of NUBP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NUBP2 mRNA	PMID:32699268|PMID:32845096
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312954	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NUBP2 mRNA	PMID:39241906
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312954	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of NUBP2 mRNA	PMID:39298647
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of NUBP2 protein	PMID:20109541
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NUBP2 mRNA	PMID:37042841
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of NUBP2 gene	PMID:33872906
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of NUBP2 gene	PMID:33872906
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1312954	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of NUBP2 mRNA	PMID:27462272
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUBP2 mRNA	PMID:37236586
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NUBP2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of NUBP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NUBP2 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of NUBP2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of NUBP2 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NUBP2 mRNA	PMID:34911549
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312954	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NUBP2 mRNA	PMID:31919559
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUBP2 mRNA	PMID:22206623
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUBP2 mRNA	PMID:40504410
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312954	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of NUBP2 protein	PMID:25505154
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312954	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUBP2 mRNA	PMID:21570461
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305113	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NUBP2 mRNA	PMID:33387578
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of NUBP2 protein	PMID:39603559
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NUBP2 mRNA	PMID:33212167
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305113	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of NUBP2 mRNA	PMID:28959563
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NUBP2 mRNA	PMID:38568856
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUBP2 mRNA	PMID:40504410
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305113	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of NUBP2 mRNA	PMID:25729387
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305113	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of NUBP2 mRNA	PMID:30047161
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312954	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NUBP2 gene	PMID:35295148
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305113	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NUBP2 mRNA	PMID:25181051
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of NUBP2 protein	PMID:31675489
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305113	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of NUBP2 mRNA	PMID:33296240
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305113	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of NUBP2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305113	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NUBP2 gene	PMID:28505145
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of NUBP2 protein	PMID:31675489
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312954	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NUBP2 mRNA	PMID:39298647
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312954	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NUBP2 mRNA	PMID:21266533
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NUBP2 mRNA	PMID:38568856
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUBP2 mRNA	PMID:37236586
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of NUBP2 mRNA	PMID:25812627
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NUBP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NUBP2 mRNA	PMID:32699268
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of NUBP2 mRNA	PMID:25812627
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NUBP2 mRNA	PMID:25812627
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NUBP2 gene	PMID:29154799
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305113	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NUBP2 mRNA	PMID:30047161
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305113	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of NUBP2 mRNA	PMID:24136188
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUBP2 mRNA	PMID:40504410
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of NUBP2 mRNA	PMID:31675489
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of NUBP2 mRNA	PMID:18175754
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of NUBP2 mRNA	PMID:17908484
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312954	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NUBP2 mRNA; Nanotubes, Carbon results in increased expression of NUBP2 mRNA	PMID:25554681
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305113	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NUBP2 mRNA	PMID:30047161
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:50692	mifepristone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of NUBP2 mRNA	PMID:17584828
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NUBP2 mRNA	PMID:35964746
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305113	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NUBP2 mRNA	PMID:24136188
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NUBP2 protein	PMID:32959892
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305113	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of NUBP2 mRNA	PMID:25729387
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305113	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of NUBP2 mRNA	PMID:24136188
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1312954	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of NUBP2 protein	PMID:36851058
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1312954	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of NUBP2 mRNA	PMID:27462272
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312954	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUBP2 mRNA	PMID:22206623
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305113	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of NUBP2 mRNA	PMID:24136188
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NUBP2 protein	PMID:31675489
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of NUBP2 protein	PMID:31675489
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305113	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of NUBP2 mRNA	PMID:30047161
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305113	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NUBP2 mRNA	PMID:21346803
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NUBP2 mRNA	PMID:38568856
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305113	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of NUBP2 mRNA	PMID:21346803
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1312954	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of NUBP2 mRNA	PMID:32835833
1312953	NUBP2	NUBP iron-sulfur cluster assembly factor 2, cytosolic	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305113	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of NUBP2 mRNA	PMID:22570695
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305114	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of MOB1B mRNA	PMID:25152437
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D011794	Quercetin results in decreased expression of MOB1B mRNA	PMID:21632981
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305114	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of MOB1B mRNA	PMID:32145629
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D014050	Toluene results in increased expression of MOB1B mRNA	PMID:28245982
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MOB1B protein	PMID:37730182
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305114	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MOB1B mRNA	PMID:33387578
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MOB1B mRNA	PMID:28818685
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1617540	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MOB1B mRNA	PMID:36331819
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1617540	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MOB1B mRNA	PMID:37236586
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MOB1B mRNA	PMID:19549813
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MOB1B mRNA	PMID:23649840
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1617540	E	RGD:6480464	20141111	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MOB1B mRNA	PMID:19770486
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MOB1B mRNA	PMID:23649840
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MOB1B mRNA	PMID:25629700
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305114	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MOB1B mRNA	PMID:31881176
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305114	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MOB1B mRNA	PMID:32109520|PMID:33387578
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MOB1B mRNA	PMID:33212167
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MOB1B mRNA	PMID:29803840
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of MOB1B mRNA	PMID:25523186
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MOB1B mRNA	PMID:37682722
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MOB1B mRNA	PMID:21457566
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of MOB1B mRNA	PMID:25523186
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MOB1B mRNA	PMID:27131904
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MOB1B mRNA	PMID:19150397
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of MOB1B gene	PMID:31601247
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1617540	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MOB1B gene; titanium dioxide results in increased methylation of MOB1B promoter	PMID:35295148
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305114	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MOB1B mRNA	PMID:34492290
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305114	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of MOB1B mRNA	PMID:32145629
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of MOB1B protein	PMID:34186270
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305114	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MOB1B mRNA	PMID:25181051
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MOB1B gene	PMID:31601247
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of MOB1B protein	PMID:34186270
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1617540	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of MOB1B mRNA	PMID:38685157
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of MOB1B mRNA	PMID:28392331
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to MOB1B protein	PMID:32991956
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MOB1B mRNA	PMID:37042841
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305114	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MOB1B mRNA	PMID:33453195
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1617540	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MOB1B mRNA	PMID:37236586
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1617540	E	RGD:6480464	20230307	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MOB1B mRNA	PMID:36152675
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:3763	clorgyline	increases expression	EXP		E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of MOB1B mRNA	PMID:19691856
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MOB1B mRNA	PMID:40194260
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MOB1B mRNA	PMID:40419075
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1617540	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MOB1B mRNA	PMID:36331819
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1305114	E	RGD:6480464	20141111	CTD	MESH:D002737	Chloroprene results in increased expression of MOB1B mRNA	PMID:23125180
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of MOB1B mRNA	PMID:23179753
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:41607	crotonaldehyde	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C012796	2-butenal results in decreased expression of MOB1B mRNA	PMID:20471460
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1305114	E	RGD:6480464	20141111	CTD	MESH:C005219	methyl cellosolve results in increased expression of MOB1B mRNA	PMID:21061450
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1617540	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MOB1B mRNA	PMID:17555576
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305114	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MOB1B mRNA	PMID:29097150
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305114	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of MOB1B mRNA	PMID:25729387
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MOB1B mRNA	PMID:22206623
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1617540	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of MOB1B mRNA	PMID:21795629
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1617540	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of MOB1B mRNA	PMID:40826991
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1617540	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MOB1B mRNA	PMID:27131904
1312955	MOB1B	MOB kinase activator 1B	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305114	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of MOB1B mRNA	PMID:19281266
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of HBE1 mRNA	PMID:27188386
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of HBE1 mRNA	PMID:21934132
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of HBE1 mRNA	PMID:26079696
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305115	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of HBE1 gene	PMID:35440735
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of HBE1 mRNA	PMID:30510588
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305115	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of HBE1 mRNA	PMID:32145629
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1305115	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of HBE1 mRNA	PMID:23829299
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305115	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HBE1 mRNA	PMID:33387578
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:16602	trichloroethene	decreases methylation	ISO	RGD:1305115	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of HBE1 gene	PMID:27618143
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of HBE1 mRNA	PMID:23649840|PMID:27905399
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of HBE1 mRNA	PMID:26079696
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HBE1 gene	PMID:27153756
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of HBE1 mRNA	PMID:21867686
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550121	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of HBB-Y mRNA	PMID:28960355
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305115	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of HBE1 mRNA	PMID:31881176
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305115	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HBE1 mRNA	PMID:33387578
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1305115	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of HBE1 protein	PMID:29459688
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550121	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of HBB-Y mRNA	PMID:37682722
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HBE1 promoter	PMID:27901495
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HBE1 exon	PMID:27901495
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of HBE1 mRNA	PMID:20382639
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1305115	E	RGD:6480464	20140722	CTD	MESH:D000643	Ammonium Chloride affects the expression of HBE1 mRNA	PMID:16483693
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of HBE1 gene; [bisphenol F co-treated with Fulvestrant] results in decreased methylation of HBE1 gene	PMID:31601247
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305115	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of HBE1 mRNA	PMID:25729387
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1550121	E	RGD:6480464	20131220	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of HBB-Y mRNA	PMID:18648102
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305115	E	RGD:6480464	20140722	CTD	MESH:C069837	fullerene C60 results in decreased expression of HBE1 mRNA	PMID:19167457
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305115	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HBE1 mRNA	PMID:25181051|PMID:32145629
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305115	E	RGD:6480464	20140722	CTD	MESH:C006780	bisphenol A results in increased expression of HBE1 mRNA	PMID:15901920
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1550121	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HBB-Y promoter	PMID:27312807
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of HBE1 gene	PMID:31601247
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1305115	E	RGD:6480464	20140722	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of HBE1 mRNA	PMID:23829299
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550121	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of HBB-Y mRNA	PMID:30951980
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of HBE1 gene	PMID:31601247
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550121	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of HBB-Y mRNA	PMID:30951980
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of HBE1 gene	PMID:31601247
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305115	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of HBE1 mRNA	PMID:32680482
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of HBE1 mRNA	PMID:29024780
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1550121	E	RGD:6480464	20131220	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of HBB-Y mRNA	PMID:19429403
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1550121	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of HBB-Y mRNA	PMID:28962523
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1550121	E	RGD:6480464	20131220	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of HBB-Y mRNA	PMID:19429403
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of HBE1 mRNA	PMID:28001369
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305115	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of HBE1 mRNA	PMID:41580965
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1550121	E	RGD:6480464	20131220	CTD	MESH:D008727	Methotrexate affects the expression of HBB-Y mRNA	PMID:18502557
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of HBE1 mRNA	PMID:38832940
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HBE1 protein	PMID:38832940
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550121	E	RGD:6480464	20131220	CTD	MESH:D000082	Acetaminophen affects the expression of HBB-Y mRNA	PMID:17562736
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of HBE1 mRNA	PMID:26690555
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	HBE1 protein affects the susceptibility to Fluorouracil	PMID:15352031
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of HBE1 protein	PMID:15352031
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of HBE1 mRNA	PMID:18175754
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305115	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of HBE1 mRNA	PMID:30307764
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550121	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in decreased expression of HBB-Y mRNA	PMID:35964746
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of HBE1 mRNA	PMID:27188386
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1550121	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HBB-Y mRNA	PMID:26378955
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305115	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of HBE1 mRNA	PMID:25729387
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305115	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of HBE1 mRNA	PMID:25729387
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of HBE1 mRNA	PMID:31758290
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of HBE1 mRNA	PMID:37199045
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1305115	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of HBE1 mRNA	PMID:33484710
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HBE1 gene]	PMID:28238834
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1550121	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of HBE1 mRNA	PMID:30294300
1312957	HBE1	hemoglobin subunit epsilon 1	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305115	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of HBE1 gene	PMID:31682807
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305116	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of CHURC1 mRNA	PMID:21551480
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CHURC1 gene	PMID:20938992
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1550122	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of CHURC1 mRNA	PMID:40945087
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHURC1 mRNA	PMID:25510870
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CHURC1 gene	PMID:20938992
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1305116	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of CHURC1 mRNA	PMID:22967744
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CHURC1 mRNA	PMID:28818685
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHURC1 mRNA	PMID:25510870
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHURC1 mRNA	PMID:25510870
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:27214	uranium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium results in increased expression of CHURC1 mRNA	PMID:15672453
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305116	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CHURC1 mRNA	PMID:33387578
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550122	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CHURC1 mRNA	PMID:25629700
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHURC1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CHURC1 gene	PMID:20938992|PMID:22206623
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CHURC1 mRNA	PMID:40504410
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:27808	heroin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003932	Heroin results in decreased expression of CHURC1 mRNA	PMID:16710320
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305116	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of CHURC1 mRNA	PMID:31881176
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of CHURC1 mRNA	PMID:15009677|PMID:16710320
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1550122	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of CHURC1 mRNA	PMID:30912803
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550122	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHURC1 mRNA	PMID:21570461
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305116	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHURC1 mRNA	PMID:34747641
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CHURC1 mRNA	PMID:28001369
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CHURC1 mRNA	PMID:33212167
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CHURC1 mRNA	PMID:40504410
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHURC1 promoter	PMID:27901495
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of CHURC1 mRNA	PMID:31745603
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1305116	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of CHURC1 mRNA	PMID:24136188
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550122	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CHURC1 gene; titanium dioxide results in decreased methylation of CHURC1 promoter	PMID:35295148
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305116	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CHURC1 mRNA	PMID:34492290
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305116	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CHURC1 mRNA	PMID:25181051
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550122	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CHURC1 mRNA	PMID:32156529
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550122	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CHURC1 mRNA	PMID:33221593|PMID:38074096
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHURC1 mRNA	PMID:25510870
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CHURC1 mRNA	PMID:25510870
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550122	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CHURC1 mRNA	PMID:39298647
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550122	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CHURC1 mRNA	PMID:40194260
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CHURC1 mRNA	PMID:31533062
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CHURC1 mRNA	PMID:25979313
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CHURC1 mRNA	PMID:23179753|PMID:27188386
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305116	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CHURC1 mRNA	PMID:24136188
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CHURC1 mRNA	PMID:38832940
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1550122	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of CHURC1 mRNA	PMID:29279043
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CHURC1 mRNA	PMID:40504410
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of CHURC1 mRNA	PMID:18175754
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1550122	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of CHURC1 mRNA	PMID:40234311
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305116	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of CHURC1 mRNA	PMID:19162173
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:1305116	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of CHURC1 mRNA	PMID:24136188
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305116	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of CHURC1 mRNA	PMID:24136188
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550122	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CHURC1 mRNA	PMID:22206623
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550122	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHURC1 mRNA	PMID:22206623
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305116	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CHURC1 mRNA	PMID:24136188
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CHURC1 gene]	PMID:28238834
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1550122	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of CHURC1 mRNA	PMID:40826991
1312958	CHURC1	churchill domain containing 1	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1550122	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of CHURC1 mRNA	PMID:26217789
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of JPT2 mRNA	PMID:37995155
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of JPT2 mRNA	PMID:30529165
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312961	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of JPT2 mRNA	PMID:39241906
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312961	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of JPT2 mRNA	PMID:39298647
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:D004958	Estradiol promotes the reaction [JPT2 protein binds to ESR1 protein]	PMID:27156127
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of JPT2 protein	PMID:20109541
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305117	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of JPT2 gene	PMID:27618143
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of JPT2 mRNA	PMID:37042841
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:17558	quercitrin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of JPT2 mRNA	PMID:25193878
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312961	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of JPT2 mRNA	PMID:23892564
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:177802	Cuprizon	affects expression	ISO	RGD:1305117	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of JPT2 mRNA	PMID:26577399
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in increased expression of JPT2 protein	PMID:34122009
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of JPT2 protein	PMID:37730182
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of JPT2 protein	PMID:23301498
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of JPT2 gene	PMID:27153756
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312961	E	RGD:6480464	20250401	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of JPT2 protein	PMID:39910959
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312961	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of JPT2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of JPT2 mRNA	PMID:34911549
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of JPT2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of JPT2 protein	PMID:38598786
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305117	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of JPT2 mRNA	PMID:31150632
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312961	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of JPT2 mRNA	PMID:27339419|PMID:31919559
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:D005492	Folic Acid results in decreased expression of JPT2 mRNA	PMID:25629700
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of JPT2 gene	PMID:25304211
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:C024565	ethylene dichloride results in increased expression of JPT2 mRNA	PMID:28960355
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the expression of JPT2 mRNA	PMID:28903495
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312961	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of JPT2 mRNA	PMID:21570461|PMID:24680724
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305117	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of JPT2 mRNA	PMID:33387578
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of JPT2 mRNA	PMID:30851411
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of JPT2 mRNA	PMID:20971185
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of JPT2 mRNA	PMID:29803840
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of JPT2 mRNA	PMID:39631538
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of JPT2 mRNA	PMID:38568856
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of JPT2 promoter	PMID:27901495
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of JPT2 mRNA	PMID:20971185
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in increased expression of JPT2 protein	PMID:34122009
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305117	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of JPT2 mRNA	PMID:24915197
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305117	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of JPT2 mRNA	PMID:24136188
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in decreased expression of JPT2 mRNA	PMID:22613225
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305117	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of HN1L mRNA	PMID:30047161
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305117	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of JPT2 mRNA	PMID:24136188
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:C009495	titanium dioxide results in decreased expression of JPT2 mRNA	PMID:29264374
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312961	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HN1L gene; titanium dioxide results in decreased methylation of HN1L promoter	PMID:35295148
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312961	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of JPT2 mRNA	PMID:23557971
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of JPT2 protein	PMID:37567409
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of JPT2 mRNA	PMID:20678512
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305117	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of JPT2 mRNA	PMID:25181051
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of JPT2 mRNA	PMID:25979313
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305117	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of JPT2 mRNA	PMID:23196670
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of JPT2 mRNA	PMID:40203079
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312961	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of JPT2 mRNA	PMID:39298647
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312961	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of JPT2 mRNA	PMID:38685157
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of JPT2 gene	PMID:22964155
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of JPT2 mRNA	PMID:21266533
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of JPT2 protein	PMID:38598786
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of JPT2 mRNA	PMID:37042841
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305117	E	RGD:6480464	20230307	CTD	MESH:C005445	triphenyl phosphate results in increased expression of JPT2 mRNA	PMID:30589522
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of JPT2 mRNA	PMID:38568856
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305117	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of JPT2 promoter	PMID:22457795
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305117	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of JPT2 mRNA	PMID:35163327
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305117	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of JPT2 gene	PMID:22079235
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of JPT2 mRNA	PMID:31533062
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of JPT2 mRNA	PMID:39529242
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of JPT2 mRNA	PMID:25979313
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of JPT2 mRNA	PMID:26272509
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPT2 mRNA	PMID:27188386
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305117	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of HN1L mRNA	PMID:30047161
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of JPT2 mRNA	PMID:25562108
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312961	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of JPT2 mRNA	PMID:28973697
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of JPT2 mRNA	PMID:24449571
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305117	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of JPT2 mRNA	PMID:24136188
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of JPT2 mRNA	PMID:24935251|PMID:26272509
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPT2 mRNA	PMID:27188386
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312961	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of JPT2 mRNA	PMID:17562736
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:D000082	Acetaminophen results in increased expression of JPT2 mRNA	PMID:29246445
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of JPT2 mRNA]	PMID:29246445
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of JPT2 gene	PMID:25304211
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of JPT2 mRNA	PMID:23228038
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312961	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of JPT2 mRNA; Nanotubes, Carbon results in increased expression of JPT2 mRNA	PMID:25554681
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1305117	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of JPT2 mRNA	PMID:34044035
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305117	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of HN1L mRNA	PMID:30047161
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312961	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of JPT2 mRNA	PMID:35964746
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305117	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of JPT2 mRNA	PMID:24136188
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of JPT2 protein	PMID:32959892
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	JPT2 protein affects the susceptibility to Topotecan	PMID:16217747
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of JPT2 mRNA	PMID:15336504
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305117	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of JPT2 protein	PMID:30467583
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1312961	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of JPT2 mRNA	PMID:27462272
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of JPT2 protein	PMID:37664457
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of JPT2 mRNA	PMID:29522793
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of JPT2 protein	PMID:39638853
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of JPT2 mRNA	PMID:30851411
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPT2 mRNA	PMID:27188386
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305117	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of HN1L mRNA	PMID:30047161
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312961	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of JPT2 mRNA	PMID:19270015
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312961	E	RGD:6480464	20230307	CTD	MESH:C009277	sodium arsenate results in increased expression of JPT2 mRNA	PMID:30953684
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305117	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of HN1L mRNA; Propylthiouracil results in increased expression of JPT2 mRNA	PMID:24780913|PMID:30047161
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of JPT2 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPT2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of JPT2 mRNA	PMID:27188386|PMID:37664457
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of JPT2 mRNA	PMID:38568856
1312960	JPT2	Jupiter microtubule associated homolog 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of JPT2 protein	PMID:38598786
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in increased expression of ITPK1 mRNA	PMID:19371625
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ITPK1 mRNA	PMID:38218311
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1312968	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ITPK1 mRNA	PMID:37995155
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312968	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ITPK1 mRNA	PMID:20188158
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ITPK1 mRNA	PMID:33167477
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ITPK1 mRNA	PMID:22378314
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312968	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ITPK1 mRNA	PMID:30319688
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1312968	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of ITPK1 mRNA	PMID:30517762
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of ITPK1 mRNA	PMID:16474171|PMID:23019147
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312968	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ITPK1 mRNA	PMID:39298647
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1595691	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ITPK1 mRNA	PMID:33387578
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ITPK1 mRNA	PMID:37042841
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1595691	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of ITPK1 mRNA	PMID:26496021
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312968	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of ITPK1 mRNA	PMID:23892564
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of ITPK1 intron	PMID:30157460
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	ISO	RGD:1312968	E	RGD:6480464	20141223	CTD	MESH:D014284	Triiodothyronine results in increased expression of ITPK1 mRNA	PMID:25172293
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ITPK1 mRNA	PMID:39836092
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1595691	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ITPK1 mRNA	PMID:33354967
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ITPK1 intron	PMID:30157460
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1312968	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of ITPK1 mRNA	PMID:30517762
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312968	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ITPK1 mRNA]	PMID:22206623
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	ITPK1 inhibits the reaction [[Cycloheximide co-treated with TNF] results in increased activity of CASP9 protein]; ITPK1 inhibits the reaction [[Cycloheximide co-treated with TNF] results in increased cleavage of and results in increased activity of CASP3 protein]; ITPK1 inhibits the reaction [[Cycloheximide co-treated with TNF] results in increased cleavage of and results in increased activity of CASP8 protein]; ITPK1 inhibits the reaction [[Cycloheximide co-treated with TNF] results in increased cleavage of BID protein]; ITPK1 inhibits the reaction [[Cycloheximide co-treated with TNF] results in increased cleavage of PARP1 protein]; ITPK1 mutant form promotes the reaction [[Cycloheximide co-treated with TNF protein] results in increased cleavage of BID protein]; ITPK1 mutant form promotes the reaction [[Cycloheximide co-treated with TNF protein] results in increased cleavage of PARP1 protein]; ITPK1 mutant form results in increased susceptibility to [Cycloheximide co-treated with TNF protein]	PMID:12925536
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1312968	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of ITPK1 mRNA	PMID:35897073
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1595691	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ITPK1 mRNA	PMID:31881176
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ITPK1 mRNA	PMID:28903495
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of ITPK1 mRNA	PMID:16474171
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ITPK1 mRNA	PMID:22298810
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312968	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ITPK1 mRNA	PMID:21570461
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1595691	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ITPK1 mRNA	PMID:22298810
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1595691	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ITPK1 mRNA	PMID:32109520
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ITPK1 mRNA	PMID:17555868|PMID:20106945|PMID:21632981
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1595691	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ITPK1 mRNA	PMID:33387578
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ITPK1 mRNA	PMID:33212167
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ITPK1 mRNA	PMID:29803840
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312968	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of ITPK1 mRNA	PMID:39631538
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ITPK1 mRNA	PMID:38568856
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312968	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ITPK1 mRNA	PMID:25270620
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ITPK1 mRNA	PMID:39719251
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of ITPK1 mRNA	PMID:22378314
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ITPK1 intron	PMID:30157460
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ITPK1 mRNA	PMID:20064835
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ITPK1 3' UTR	PMID:27901495
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1312968	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ITPK1 intron	PMID:27901495
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312968	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to ITPK1 promoter]	PMID:19654925
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ITPK1 mRNA	PMID:26238291
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ITPK1 gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of ITPK1 gene	PMID:31601247
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1312968	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of ITPK1 mRNA	PMID:29264374
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312968	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ITPK1 promoter	PMID:35295148
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312968	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ITPK1 mRNA	PMID:18445702
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1595691	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ITPK1 mRNA	PMID:25181051
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ITPK1 gene	PMID:31601247
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1312968	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ITPK1 promoter	PMID:27312807
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of ITPK1 mRNA	PMID:16474171
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1595691	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of ITPK1 mRNA	PMID:41034487
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1312968	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ITPK1 promoter	PMID:27312807
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ITPK1 gene	PMID:31601247
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1595691	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of ITPK1 mRNA	PMID:26496021
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of ITPK1 gene	PMID:31601247
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ITPK1 mRNA	PMID:28628672
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of ITPK1 intron	PMID:30157460
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ITPK1 gene	PMID:31601247
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312968	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ITPK1 mRNA	PMID:21266533
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ITPK1 mRNA	PMID:28628672
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ITPK1 mRNA	PMID:37042841
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ITPK1 mRNA	PMID:39836092
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:1595691	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of ITPK1 mRNA	PMID:27638505
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1312968	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ITPK1 mRNA	PMID:40194260
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ITPK1 mRNA	PMID:28302478
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ITPK1 mRNA	PMID:23179753
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1312968	E	RGD:6480464	20120918	CTD	MESH:D014635	Valproic Acid results in increased expression of ITPK1 mRNA	PMID:20546886|PMID:21427059
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of ITPK1 mRNA	PMID:20106945
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ITPK1 mRNA	PMID:28628672
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ITPK1 mRNA	PMID:19371625
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:44616	afimoxifene	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	ITPK1 results in decreased susceptibility to afimoxifene	PMID:21233418
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in decreased expression of ITPK1 mRNA	PMID:28542535
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1595691	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ITPK1 mRNA	PMID:33387578
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1595691	E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan affects the expression of ITPK1 mRNA	PMID:31464424
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1595691	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ITPK1 mRNA	PMID:29391264
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ITPK1 mRNA	PMID:28628672
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:53070	2,4-dinitrobenzenesulfonic acid	decreases expression	ISO	RGD:1312968	E	RGD:6480464	20190910	CTD	MESH:C001073	2,4-dinitrobenzenesulfonic acid results in decreased expression of ITPK1 mRNA	PMID:30116771
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:53070	2,4-dinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1312968	E	RGD:6480464	20190910	CTD	MESH:C001073	[2,4-dinitrobenzenesulfonic acid co-treated with GR 159897] results in increased expression of ITPK1 mRNA	PMID:30116771
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ITPK1 mRNA	PMID:39836092
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of ITPK1 intron	PMID:30157460
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1595691	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ITPK1 gene	PMID:35440735
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of ITPK1 mRNA	PMID:22101062
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ITPK1 mRNA	PMID:31758290
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312968	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ITPK1 mRNA	PMID:22206623
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312968	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ITPK1 mRNA]	PMID:22206623
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ITPK1 mRNA	PMID:22714537
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:80491	pinostrobin	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C411294	pinostrobin results in increased expression of ITPK1 mRNA	PMID:37777166
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1595691	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ITPK1 mRNA	PMID:32109520
1312967	ITPK1	inositol-tetrakisphosphate 1-kinase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1312968	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of ITPK1 mRNA	PMID:38995820
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305123	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TBRG1 mRNA]	PMID:31150632
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312970	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TBRG1 mRNA	PMID:20188158
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of TBRG1 mRNA	PMID:29581250
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312970	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TBRG1 mRNA	PMID:39298647
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TBRG1 mRNA	PMID:37042841
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1312970	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of TBRG1 mRNA	PMID:23892564
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TBRG1 protein	PMID:37730182
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305123	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TBRG1 mRNA	PMID:22061828
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TBRG1 gene	PMID:27153756
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TBRG1 mRNA	PMID:23649840
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305123	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TBRG1 mRNA	PMID:31150632
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312970	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TBRG1 mRNA	PMID:27339419|PMID:31919559
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305123	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TBRG1 mRNA]	PMID:31150632
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312970	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TBRG1 mRNA	PMID:40504410
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of TBRG1 protein	PMID:35688186
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TBRG1 mRNA	PMID:28903495
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of TBRG1 mRNA	PMID:19921347
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312970	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TBRG1 mRNA	PMID:21570461
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305123	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBRG1 mRNA	PMID:34747641
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312970	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBRG1 mRNA	PMID:19465110
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312970	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TBRG1 mRNA	PMID:17942748
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TBRG1 mRNA	PMID:28001369
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TBRG1 mRNA	PMID:28001369
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TBRG1 mRNA	PMID:39709020
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TBRG1 mRNA	PMID:20971185
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TBRG1 mRNA	PMID:29803840
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TBRG1 mRNA	PMID:38568856
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312970	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TBRG1 mRNA	PMID:40504410
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312970	E	RGD:6480464	20150714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TBRG1 mRNA	PMID:25908611
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312970	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TBRG1 mRNA	PMID:22228805
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312970	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of TBRG1 mRNA]	PMID:22228805
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TBRG1 mRNA	PMID:20971185
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312970	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of TBRG1 mRNA	PMID:20542052
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312970	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TBRG1 gene	PMID:35295148
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305123	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TBRG1 mRNA	PMID:23411599
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312970	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TBRG1 mRNA	PMID:18445702
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305123	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TBRG1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312970	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TBRG1 mRNA	PMID:33221593
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305123	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TBRG1 mRNA	PMID:25181051
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305123	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TBRG1 gene	PMID:28505145
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TBRG1 mRNA	PMID:25979313
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312970	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TBRG1 mRNA	PMID:39298647
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1312970	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of TBRG1 mRNA	PMID:34813904
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1312970	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of TBRG1 mRNA	PMID:34813904
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305123	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TBRG1 mRNA	PMID:33453195
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TBRG1 mRNA	PMID:38568856
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1312970	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of TBRG1 mRNA	PMID:25908611
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312970	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of TBRG1 mRNA	PMID:17585979
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TBRG1 mRNA	PMID:32588087
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TBRG1 mRNA	PMID:31533062
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of TBRG1 mRNA	PMID:40419075
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305123	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of TBRG1 mRNA	PMID:25993096
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TBRG1 mRNA	PMID:23179753
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TBRG1 gene	PMID:29154799
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of TBRG1 mRNA	PMID:17183730
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TBRG1 mRNA	PMID:20106945|PMID:25562108
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of TBRG1 mRNA	PMID:27188386
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312970	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TBRG1 mRNA	PMID:17562736
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305123	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TBRG1 mRNA	PMID:33387578
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312970	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TBRG1 mRNA	PMID:40504410
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of TBRG1 mRNA	PMID:36621641
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305123	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TBRG1 mRNA	PMID:29391264
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1312970	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TBRG1 mRNA	PMID:35436446
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312970	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TBRG1 mRNA	PMID:17942748
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312970	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TBRG1 mRNA; Nanotubes, Carbon results in increased expression of TBRG1 mRNA	PMID:25554681|PMID:25620056
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305123	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TBRG1 mRNA	PMID:24136188
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of TBRG1 mRNA	PMID:31629900
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of TBRG1 mRNA	PMID:17183730
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1312970	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of TBRG1 mRNA	PMID:14729362
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in increased expression of TBRG1 mRNA	PMID:22101062
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305123	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TBRG1 mRNA	PMID:21346803
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305123	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TBRG1 mRNA	PMID:21346803
1312969	TBRG1	transforming growth factor beta regulator 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305123	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TBRG1 mRNA	PMID:23034163
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312972	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CILP mRNA	PMID:33045310
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CILP mRNA	PMID:35811015
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of CILP mRNA	PMID:23019147
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312972	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CILP mRNA	PMID:19484750
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of CILP mRNA	PMID:20660070
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CILP mRNA	PMID:25510870
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CILP mRNA	PMID:33387578
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of CILP mRNA	PMID:20660070
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312972	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CILP mRNA	PMID:34319233
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of CILP mRNA	PMID:26485663
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CILP mRNA	PMID:33387578
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CILP mRNA	PMID:25510870
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CILP mRNA	PMID:25510870
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CILP gene	PMID:27153756
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CILP mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CILP mRNA	PMID:27106289|PMID:34911549
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1312972	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of CILP mRNA	PMID:25629700
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of CILP mRNA	PMID:38314887
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CILP mRNA	PMID:23557933
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	CILP protein affects the susceptibility to Cisplatin	PMID:16217747
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1312972	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of CILP mRNA	PMID:32186404
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of CILP mRNA	PMID:19371625|PMID:23019147
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CILP mRNA	PMID:24768652|PMID:25583101
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CILP mRNA	PMID:33387578
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305124	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CILP mRNA	PMID:34747641
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CILP mRNA	PMID:28001369
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CILP mRNA	PMID:28959563
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CILP mRNA	PMID:24690739
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CILP mRNA	PMID:29803840
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CILP mRNA	PMID:38568856
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CILP mRNA	PMID:34876320
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CILP mRNA	PMID:34876320
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to CILP promoter]	PMID:19654925
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of CILP mRNA	PMID:24690739
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1312972	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CILP mRNA	PMID:29341224|PMID:38811393
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of CILP mRNA	PMID:24395379
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305124	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CILP mRNA	PMID:30047161
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CILP mRNA	PMID:34492290
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CILP mRNA	PMID:19710929
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CILP mRNA	PMID:25181051|PMID:34947998
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A results in increased expression of CILP mRNA	PMID:23019147
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312972	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of CILP mRNA	PMID:30951980|PMID:32156529
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CILP mRNA	PMID:28628672
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CILP mRNA	PMID:25510870
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CILP mRNA	PMID:25510870
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1312972	E	RGD:6480464	20241001	CTD	MESH:C543008	bisphenol S results in decreased expression of CILP mRNA	PMID:38908815
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312972	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CILP mRNA	PMID:30951980
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CILP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CILP mRNA	PMID:28628672
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of CILP mRNA	PMID:32680482
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305124	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CILP mRNA	PMID:35163327
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of CILP mRNA	PMID:18500788
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CILP mRNA	PMID:30917596
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CILP mRNA	PMID:25812627
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305124	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CILP mRNA	PMID:35163327
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305124	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CILP mRNA	PMID:27387713
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CILP mRNA	PMID:25812627
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CILP gene	PMID:29154799
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305124	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CILP mRNA	PMID:30047161
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of CILP mRNA	PMID:25047013
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CILP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CILP mRNA	PMID:28628672
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CILP mRNA	PMID:19371625
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312972	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CILP mRNA	PMID:28973697
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CILP mRNA	PMID:33387578
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of CILP mRNA	PMID:26690555
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of CILP mRNA	PMID:24690739
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CILP mRNA	PMID:35811015
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CILP mRNA	PMID:34876320
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CILP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of CILP mRNA	PMID:28628672
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305124	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CILP mRNA	PMID:30047161
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312972	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of CILP mRNA	PMID:20003209
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:6716	medroxyprogesterone acetate	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in decreased expression of CILP mRNA	PMID:20843944
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1305124	E	RGD:6480464	20220111	CTD	MESH:C057862	cyanoginosin LR results in increased expression of CILP mRNA	PMID:34740672
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312972	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CILP mRNA	PMID:22206623
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1312972	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CILP mRNA	PMID:38648751
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:81980	triticonazole	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of CILP mRNA	PMID:36084822
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1312972	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of CILP mRNA	PMID:34876320
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305124	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CILP mRNA	PMID:24780913
1312971	CILP	cartilage intermediate layer protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305124	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CILP mRNA	PMID:30047161
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of ATL2 protein	PMID:39638853
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ATL2 mRNA	PMID:38218311
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ATL2 mRNA	PMID:38218311
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of ATL2 mRNA]	PMID:19467301
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ATL2 mRNA	PMID:33167477
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ATL2 mRNA	PMID:36331819
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ATL2 mRNA	PMID:22378314
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1312974	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ATL2 mRNA	PMID:30319688
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ATL2 mRNA	PMID:21632981
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of ATL2 protein	PMID:35688186
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1312974	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATL2 mRNA	PMID:39241906
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ATL2 mRNA	PMID:39298647
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305125	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of ATL2 mRNA	PMID:32145629
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATL2 mRNA	PMID:37042841
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305125	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ATL2 mRNA	PMID:26577399
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305125	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATL2 mRNA	PMID:33387578
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATL2 mRNA	PMID:36331819
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of ATL2 mRNA	PMID:33914522
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATL2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATL2 mRNA	PMID:37236586|PMID:37325564
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ATL2 mRNA	PMID:19549813
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ATL2 mRNA	PMID:23649840
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATL2 mRNA	PMID:39836092
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ATL2 protein	PMID:35688186
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305125	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ATL2 mRNA	PMID:31881176
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1312974	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ATL2 protein	PMID:25505154
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ATL2 mRNA	PMID:23557933
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1312974	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of ATL2 mRNA	PMID:30912803
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312974	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATL2 mRNA	PMID:24680724
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305125	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATL2 mRNA	PMID:21215274|PMID:33387578
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305125	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATL2 mRNA	PMID:34747641
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312974	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATL2 mRNA	PMID:15034205
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of ATL2 mRNA]	PMID:15034205
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1305125	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of ATL2 mRNA	PMID:28959563
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATL2 mRNA	PMID:15467011
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATL2 mRNA	PMID:29803840
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:29021	hexane	decreases methylation	ISO	RGD:1305125	E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of ATL2 promoter	PMID:23740543
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ATL2 mRNA	PMID:25523186
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATL2 mRNA	PMID:38568856
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATL2 mRNA	PMID:39836092
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of ATL2 mRNA	PMID:29453283
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATL2 mRNA	PMID:22228805
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312974	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATL2 mRNA	PMID:15034205|PMID:20127859|PMID:22228805
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of ATL2 mRNA]	PMID:15034205
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of ATL2 protein	PMID:37955338
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ATL2 mRNA	PMID:25523186
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATL2 mRNA	PMID:15467011
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ATL2 mRNA	PMID:19150397|PMID:20382639
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305125	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of ATL2 mRNA	PMID:24136188
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305125	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ATL2 mRNA	PMID:25729387
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305125	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ATL2 mRNA	PMID:25729387
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1305125	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of ATL2 mRNA	PMID:24136188
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312974	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATL2 gene; titanium dioxide results in decreased methylation of ATL2 promoter	PMID:35295148
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305125	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ATL2 mRNA	PMID:34492290
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1312974	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of ATL2 mRNA	PMID:18648102
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312974	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ATL2 mRNA	PMID:18445702
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1312974	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of ATL2 mRNA	PMID:33914522
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ATL2 protein	PMID:31675489|PMID:33376534|PMID:37567409
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ATL2 protein	PMID:34186270
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305125	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ATL2 mRNA	PMID:25181051|PMID:32145629
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305125	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ATL2 gene	PMID:28505145
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	[ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of ATL2 protein]	PMID:33376534
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ATL2 mRNA	PMID:25979313
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1312974	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of ATL2 mRNA	PMID:39298647
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1312974	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ATL2 mRNA	PMID:38685157
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305125	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATL2 mRNA	PMID:17602206
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1312974	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ATL2 mRNA	PMID:17361019|PMID:21266533
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305125	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATL2 mRNA	PMID:17602206
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATL2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATL2 mRNA	PMID:37236586|PMID:37325564
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ATL2 protein	PMID:26879310
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1312974	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ATL2 mRNA	PMID:28903501
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ATL2 mRNA	PMID:24449571
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ATL2 mRNA	PMID:17585979
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312974	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATL2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ATL2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ATL2 mRNA	PMID:36331819
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATL2 mRNA	PMID:25979313
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ATL2 gene	PMID:29154799
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATL2 mRNA	PMID:25562108
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATL2 mRNA	PMID:19770486
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ATL2 mRNA	PMID:28973697
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312974	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of ATL2 mRNA	PMID:18502557
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305125	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of ATL2 mRNA	PMID:24136188
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312974	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ATL2 mRNA	PMID:17562736
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:46661	asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001194	Asbestos affects the expression of ATL2 mRNA	PMID:17297452
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATL2 mRNA	PMID:39836092
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of ATL2 mRNA	PMID:31675489
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312974	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ATL2 mRNA; Nanotubes, Carbon results in increased expression of ATL2 mRNA	PMID:25620056
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:6078	ivermectin	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of ATL2 protein	PMID:32959892
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305125	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of ATL2 mRNA	PMID:25729387
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305125	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ATL2 mRNA	PMID:25729387
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ATL2 mRNA	PMID:31758290
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312974	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ATL2 mRNA	PMID:22206623
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ATL2 protein	PMID:37664457
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305125	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ATL2 mRNA	PMID:24136188
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of ATL2 protein	PMID:39638853
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:80630	irinotecan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in increased expression of ATL2 mRNA	PMID:18927307
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312974	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ATL2 mRNA	PMID:23091169
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1312974	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ATL2 mRNA	PMID:19270015
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ATL2 protein	PMID:31675489
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ATL2 protein	PMID:31675489
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1312974	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of ATL2 mRNA	PMID:40826991
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ATL2 protein	PMID:37664457
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of ATL2 mRNA	PMID:29301935
1312973	ATL2	atlastin GTPase 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1312974	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ATL2 mRNA	PMID:28973697
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1312976	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of KIF21A mRNA	PMID:33045310
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:15365	acetylsalicylic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of KIF21A mRNA	PMID:11906190
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1312976	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of KIF21A mRNA	PMID:30319688
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of KIF21A mRNA	PMID:21179406
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of KIF21A mRNA	PMID:21632981
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of KIF21A mRNA	PMID:30510588
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of KIF21A mRNA	PMID:31614463
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol promotes the reaction [ESR2 protein affects the expression of KIF21A mRNA]	PMID:20404318
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305126	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of KIF21A mRNA	PMID:26496021
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of KIF21A mRNA	PMID:22017230
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305126	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of KIF21A mRNA	PMID:26496021
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KIF21A protein	PMID:37730182
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305126	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of KIF21A mRNA	PMID:33387578
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KIF21A mRNA	PMID:35301059
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:232105	dicyclanil	increases expression	ISO	RGD:1312976	E	RGD:6480464	20241119	CTD	MESH:C121718	dicyclanil results in increased expression of KIF21A mRNA	PMID:15664270
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1305126	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of KIF21A mRNA	PMID:33354967
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KIF21A gene; Aflatoxin B1 results in increased methylation of KIF21A intron	PMID:28458013|PMID:30157460
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1312976	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of KIF21A mRNA	PMID:32553695
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of KIF21A mRNA	PMID:27106289
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KIF21A mRNA	PMID:22206623
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KIF21A mRNA	PMID:40504410
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of KIF21A protein	PMID:35688186
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of KIF21A mRNA	PMID:28903495
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of KIF21A mRNA	PMID:27594783
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1312976	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of KIF21A mRNA	PMID:18930951
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1312976	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of KIF21A mRNA	PMID:32186404
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312976	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KIF21A mRNA	PMID:18343893|PMID:21570461
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312976	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KIF21A mRNA	PMID:17337447
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312976	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KIF21A mRNA	PMID:18691609|PMID:32553695
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KIF21A mRNA	PMID:17942748
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of KIF21A mRNA	PMID:33212167
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KIF21A mRNA	PMID:29803840
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of KIF21A protein	PMID:35688186
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of KIF21A mRNA	PMID:29301061
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KIF21A mRNA	PMID:40504410
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312976	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KIF21A mRNA	PMID:22228805
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312976	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KIF21A mRNA	PMID:15034205|PMID:20713471
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KIF21A promoter	PMID:27901495
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of KIF21A mRNA]	PMID:22228805
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1312976	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of KIF21A protein	PMID:37955338
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KIF21A mRNA	PMID:19150397
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of KIF21A mRNA	PMID:31745603
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312976	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KIF21A gene; titanium dioxide results in decreased methylation of KIF21A promoter	PMID:35295148
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312976	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KIF21A promoter	PMID:35295148
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305126	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of KIF21A mRNA	PMID:30816183
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305126	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of KIF21A mRNA	PMID:32145629
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312976	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of KIF21A mRNA	PMID:33221593
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of KIF21A mRNA	PMID:27685785
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305126	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of KIF21A mRNA; [bisphenol A co-treated with Testosterone] results in increased expression of KIF21A mRNA	PMID:26496021
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1312976	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of KIF21A mRNA	PMID:28392331
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305126	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of KIF21A gene	PMID:33148267
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KIF21A mRNA	PMID:37042841
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305126	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of KIF21A mRNA	PMID:30589522
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KIF21A mRNA	PMID:35301059
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of KIF21A mRNA	PMID:19320972
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312976	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of KIF21A mRNA	PMID:40194260
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of KIF21A mRNA	PMID:27153767
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KIF21A mRNA	PMID:20106945|PMID:25562108
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KIF21A mRNA	PMID:38832940
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of KIF21A mRNA	PMID:26272509
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF21A mRNA	PMID:27188386
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305126	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KIF21A mRNA	PMID:33387578
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1305126	E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of KIF21A mRNA	PMID:21061450
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KIF21A mRNA	PMID:40504410
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KIF21A mRNA	PMID:17942748
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312976	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of KIF21A mRNA; Nanotubes, Carbon results in decreased expression of KIF21A mRNA	PMID:25554681
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305126	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of KIF21A mRNA	PMID:24136188
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305126	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KIF21A mRNA	PMID:24136188
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of KIF21A protein	PMID:32959892
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305126	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of KIF21A mRNA	PMID:24136188
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305126	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of KIF21A gene	PMID:33148267
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1312976	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of KIF21A mRNA	PMID:22206623
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KIF21A mRNA	PMID:22206623
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of KIF21A protein	PMID:37664457
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of KIF21A mRNA	PMID:37199045
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF21A mRNA	PMID:27188386
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1312976	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of KIF21A mRNA	PMID:18343893
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of KIF21A mRNA	PMID:26705709
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1312976	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of KIF21A mRNA	PMID:38995820
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1305126	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of KIF21A protein	PMID:28903499
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of KIF21A protein	PMID:38348393
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312976	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of KIF21A mRNA	PMID:21795629|PMID:30953684
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of KIF21A protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KIF21A mRNA	PMID:27188386|PMID:37664457
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KIF21A mRNA	PMID:38568856
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305126	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of KIF21A mRNA	PMID:21346803
1312975	KIF21A	kinesin family member 21A	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1305126	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of KIF21A protein	PMID:32519852
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312979	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of POLG2 mRNA	PMID:33045310
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305128	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of POLG2 mRNA]	PMID:31150632
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of POLG2 mRNA	PMID:22378314
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of POLG2 mRNA	PMID:39241906
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of POLG2 mRNA	PMID:31059760
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20150609	CTD	MESH:D004958	Estradiol results in decreased expression of POLG2 mRNA	PMID:25575267|PMID:39298647
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305128	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of POLG2 mRNA	PMID:33387578
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of POLG2 intron	PMID:30157460
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of POLG2 mRNA	PMID:19549813
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312979	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of POLG2 mRNA	PMID:19770486
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of POLG2 intron	PMID:30157460
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305128	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of POLG2 mRNA	PMID:31150632
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of POLG2 mRNA	PMID:31919559
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305128	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of POLG2 mRNA]	PMID:31150632
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of POLG2 mRNA	PMID:39836092
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of POLG2 mRNA	PMID:28960355
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305128	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of POLG2 mRNA	PMID:31881176
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of POLG2 mRNA	PMID:23557933
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D002945	Cisplatin results in increased expression of POLG2 mRNA	PMID:33545341|PMID:38498338
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:27974	estriol	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20150609	CTD	MESH:D004964	Estriol results in decreased expression of POLG2 mRNA	PMID:25575267
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312979	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLG2 mRNA	PMID:21570461
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305128	E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POLG2 mRNA	PMID:21215274|PMID:21724226
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305128	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POLG2 mRNA	PMID:33387578
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312979	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLG2 mRNA	PMID:17942748
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of POLG2 mRNA	PMID:33212167
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of POLG2 mRNA	PMID:32763439
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of POLG2 mRNA	PMID:29803840
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of POLG2 protein	PMID:35688186
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of POLG2 mRNA	PMID:38568856
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of POLG2 mRNA	PMID:39836092
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of POLG2 mRNA	PMID:22378314
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of POLG2 intron	PMID:30157460
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of POLG2 promoter	PMID:27901495
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of POLG2 mRNA	PMID:23221170
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of POLG2 mRNA	PMID:20382639
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of POLG2 mRNA	PMID:27829220
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:31341	calcium dihydroxide	affects expression	ISO	RGD:1312979	E	RGD:6480464	20190507	CTD	MESH:D002126	Calcium Hydroxide affects the expression of POLG2 mRNA	PMID:30615914
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1305128	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of POLG2 mRNA	PMID:32479839
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of POLG2 mRNA	PMID:31745603
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305128	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of POLG2 mRNA	PMID:25729387
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1305128	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of POLG2 mRNA	PMID:24136188
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312979	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of POLG2 promoter	PMID:35295148
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305128	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of POLG2 mRNA	PMID:34492290
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1305128	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of POLG2 mRNA	PMID:19162173
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312979	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of POLG2 mRNA	PMID:17426115
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	ISO	RGD:1305128	E	RGD:6480464	20120412	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of POLG2 mRNA	PMID:17785943
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305128	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of POLG2 mRNA	PMID:32145629|PMID:34947998
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20150609	CTD	MESH:C006780	bisphenol A results in decreased expression of POLG2 mRNA	PMID:25575267
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20150609	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in decreased expression of POLG2 mRNA	PMID:25575267
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	POLG2 mRNA affects the susceptibility to Carmustine	PMID:16365179
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1305128	E	RGD:6480464	20130122	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of POLG2 mRNA	PMID:20959002
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305128	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of POLG2 mRNA	PMID:17602206
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305128	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of POLG2 mRNA	PMID:17602206
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of POLG2 mRNA	PMID:37042841
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of POLG2 mRNA	PMID:38568856
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305128	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of POLG2 mRNA	PMID:19162173
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of POLG2 mRNA	PMID:19376846
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of POLG2 mRNA	PMID:23811191
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of POLG2 mRNA	PMID:28302478
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312979	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of POLG2 mRNA	PMID:17292431
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of POLG2 mRNA	PMID:23179753
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of POLG2 mRNA	PMID:29154799
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20150609	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of POLG2 mRNA	PMID:25575267
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305128	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of POLG2 mRNA	PMID:33387578
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in decreased expression of POLG2 mRNA	PMID:17585979
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of POLG2 mRNA	PMID:22230336|PMID:31059760
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305128	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of POLG2 mRNA	PMID:32479839
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of POLG2 mRNA	PMID:31059760
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of POLG2 mRNA	PMID:39836092
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305128	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of POLG2 mRNA	PMID:29391264
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312979	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of POLG2 mRNA	PMID:17942748
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312979	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLG2 mRNA	PMID:17942748
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of POLG2 mRNA	PMID:27829220
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of POLG2 mRNA; Nanotubes, Carbon results in decreased expression of POLG2 mRNA	PMID:25554681
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305128	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of POLG2 mRNA	PMID:19162173
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305128	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of POLG2 mRNA	PMID:24793618
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1312979	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of POLG2 mRNA	PMID:26377693
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of POLG2 mRNA	PMID:31629900
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:63598	levofloxacin	increases expression	ISO	RGD:1305128	E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in increased expression of POLG2 mRNA	PMID:24136188
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305128	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of POLG2 mRNA	PMID:25729387
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305128	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of POLG2 mRNA	PMID:25729387
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	POLG2 mRNA affects the susceptibility to temozolomide	PMID:16365179
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of POLG2 mRNA	PMID:31758290
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of POLG2 mRNA	PMID:22206623
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305128	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of POLG2 mRNA	PMID:24136188
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:76004	dimethyl fumarate	increases expression	ISO	RGD:1312979	E	RGD:6480464	20180220	CTD	MESH:C056020	Dimethyl Fumarate results in increased expression of POLG2 mRNA	PMID:27277809
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:76004	dimethyl fumarate	multiple interactions	ISO	RGD:1312979	E	RGD:6480464	20180220	CTD	MESH:C056020	NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of POLG2 mRNA]	PMID:27277809
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:76326	N-nitrosomorpholine	decreases expression	ISO	RGD:1305128	E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in decreased expression of POLG2 mRNA	PMID:19716841
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1305128	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of POLG2 mRNA	PMID:23665939
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305128	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of POLG2 mRNA	PMID:19162173
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312979	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of POLG2 mRNA	PMID:39847705
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1312979	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of POLG2 mRNA	PMID:21278054
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305128	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of POLG2 mRNA	PMID:21346803
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:9288	streptozocin	affects expression	ISO	RGD:1312979	E	RGD:6480464	20120501	CTD	MESH:D013311	Streptozocin affects the expression of POLG2 mRNA	PMID:18583417
1312978	POLG2	DNA polymerase gamma 2, accessory subunit	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305128	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of POLG2 mRNA	PMID:21346803
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305129	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of MAMDC2 mRNA	PMID:25152437
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of MAMDC2 mRNA	PMID:26272509
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA	PMID:27188386
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312981	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MAMDC2 mRNA	PMID:37995155
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in decreased expression of MAMDC2 mRNA	PMID:33227293
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAMDC2 mRNA	PMID:20938992
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MAMDC2 mRNA	PMID:30529165
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAMDC2 mRNA	PMID:36331819
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MAMDC2 mRNA	PMID:30165855
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAMDC2 mRNA	PMID:20938992
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of MAMDC2 mRNA	PMID:39245080
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of MAMDC2 mRNA	PMID:21795739
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of MAMDC2 mRNA	PMID:31525975|PMID:33448797
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:17234	glucose	increases methylation	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased methylation of MAMDC2 gene	PMID:33448797
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAMDC2 mRNA]	PMID:33448797
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MAMDC2 mRNA	PMID:22017230
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MAMDC2 mRNA	PMID:26445464
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of MAMDC2 mRNA	PMID:31525975|PMID:33448797
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:17634	D-glucose	increases methylation	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased methylation of MAMDC2 gene	PMID:33448797
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAMDC2 mRNA]	PMID:33448797
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAMDC2 mRNA	PMID:37325564
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MAMDC2 intron	PMID:30157460
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in decreased expression of MAMDC2 mRNA	PMID:33026818
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAMDC2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MAMDC2 mRNA	PMID:27106289|PMID:34911549
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1312981	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MAMDC2 mRNA	PMID:17484886
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MAMDC2 mRNA	PMID:25629700
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAMDC2 mRNA	PMID:20938992
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MAMDC2 mRNA	PMID:26272509
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAMDC2 mRNA	PMID:27188386
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of MAMDC2 mRNA	PMID:40618947
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MAMDC2 mRNA	PMID:25583101
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305129	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAMDC2 mRNA	PMID:34747641
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to MAMDC2 promoter]	PMID:19654925
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MAMDC2 mRNA	PMID:28001369
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of MAMDC2 mRNA	PMID:29803840
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of MAMDC2 mRNA	PMID:34032870|PMID:39719251
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAMDC2 mRNA	PMID:22316170
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312981	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAMDC2 mRNA	PMID:27195522
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MAMDC2 exon	PMID:27901495
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to MAMDC2 promoter]	PMID:19654925
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1305129	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of MAMDC2 mRNA	PMID:22431001
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of MAMDC2 mRNA	PMID:23221170
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MAMDC2 mRNA	PMID:20382639
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MAMDC2 mRNA	PMID:26705709
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305129	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of MAMDC2 mRNA	PMID:24395379
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of MAMDC2 mRNA	PMID:37690743
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of MAMDC2 gene	PMID:31601247
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1305129	E	RGD:6480464	20130806	CTD	MESH:C008261	lead acetate results in increased expression of MAMDC2 mRNA	PMID:22641619
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of MAMDC2 mRNA	PMID:23557971|PMID:27760801
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305129	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MAMDC2 mRNA	PMID:34492290
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1312981	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of MAMDC2 mRNA	PMID:19136022
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of MAMDC2 mRNA	PMID:20813756|PMID:23811191
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MAMDC2 mRNA	PMID:19710929
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of MAMDC2 mRNA	PMID:27685785|PMID:31715268
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305129	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MAMDC2 mRNA	PMID:25181051|PMID:30816183
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of MAMDC2 mRNA	PMID:32156529
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of MAMDC2 gene	PMID:31601247
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MAMDC2 mRNA	PMID:25979313
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C543008	bisphenol S results in increased expression of MAMDC2 mRNA	PMID:25912373
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312981	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of MAMDC2 mRNA	PMID:40203079
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in increased expression of MAMDC2 mRNA]	PMID:40203079
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1312981	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MAMDC2 mRNA	PMID:26377693
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MAMDC2 mRNA	PMID:28628672
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MAMDC2 mRNA	PMID:28628672
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of MAMDC2 mRNA	PMID:24535843
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of MAMDC2 mRNA	PMID:24535843
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305129	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of MAMDC2 mRNA	PMID:32680482
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305129	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of MAMDC2 mRNA	PMID:30589522
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305129	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of MAMDC2 mRNA	PMID:30723492
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAMDC2 mRNA	PMID:37325564
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312981	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MAMDC2 mRNA	PMID:40194260
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MAMDC2 mRNA	PMID:40419075
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAMDC2 mRNA	PMID:36331819
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MAMDC2 mRNA	PMID:25979313
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of MAMDC2 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of MAMDC2 mRNA	PMID:23179753|PMID:27188386
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA	PMID:27188386
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MAMDC2 mRNA	PMID:28628672
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in decreased expression of MAMDC2 mRNA	PMID:31525975|PMID:33448797
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	increases methylation	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased methylation of MAMDC2 gene	PMID:33448797
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAMDC2 mRNA]	PMID:33448797
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MAMDC2 mRNA	PMID:38832940
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of MAMDC2 mRNA	PMID:27188386
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of MAMDC2 mRNA	PMID:24935251|PMID:26272509
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA	PMID:27188386
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312981	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAMDC2 mRNA	PMID:17562736
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of MAMDC2 mRNA	PMID:16510598
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MAMDC2 mRNA	PMID:29279043
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of MAMDC2 mRNA	PMID:31838189
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305129	E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of MAMDC2 mRNA	PMID:17351261|PMID:17557909
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MAMDC2 mRNA	PMID:28628672
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MAMDC2 mRNA	PMID:26705709
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MAMDC2 mRNA; Nanotubes, Carbon results in decreased expression of MAMDC2 mRNA	PMID:25554681
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in decreased expression of MAMDC2 mRNA]	PMID:33448797
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of MAMDC2 mRNA	PMID:19042947
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305129	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of MAMDC2 mRNA	PMID:37269647
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MAMDC2 mRNA	PMID:22079614
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MAMDC2 mRNA	PMID:31758290
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MAMDC2 mRNA	PMID:25912373
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:753051	incobotulinumtoxina	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA affects the expression of MAMDC2 mRNA	PMID:29522793
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAMDC2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA	PMID:27188386
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MAMDC2 gene]	PMID:28238834
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312981	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MAMDC2 mRNA	PMID:19136022|PMID:23091169
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1312981	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of MAMDC2 mRNA	PMID:19482888
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1312981	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of MAMDC2 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of MAMDC2 mRNA]	PMID:19482888|PMID:24535843
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of MAMDC2 mRNA	PMID:26705709
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1312981	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MAMDC2 mRNA	PMID:39847705
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305129	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MAMDC2 mRNA	PMID:24780913
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAMDC2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAMDC2 mRNA	PMID:27188386
1312980	MAMDC2	MAM domain containing 2	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C032910	triadimefon results in decreased expression of MAMDC2 mRNA	PMID:26705709
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZKSCAN6 mRNA	PMID:36331819
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of ZNF18 mRNA	PMID:29581250
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312983	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZKSCAN6 mRNA	PMID:39241906
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ZNF18 mRNA	PMID:33359661
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZNF18 mRNA	PMID:28818685
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZKSCAN6 mRNA	PMID:36331819
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZNF18 mRNA	PMID:19549813
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF18 mRNA	PMID:27188386
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ZNF18 mRNA	PMID:27392435
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ZNF18 mRNA	PMID:27392435
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312983	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZKSCAN6 mRNA	PMID:21570461
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312983	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZKSCAN6 mRNA	PMID:24058054
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZKSCAN6 mRNA	PMID:17942748
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305130	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ZFP18 mRNA	PMID:28959563
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF18 mRNA	PMID:29803840
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF18 mRNA	PMID:38568856
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312983	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZKSCAN6 promoter	PMID:35295148
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1312983	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ZKSCAN6 promoter	PMID:27334623
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305130	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP18 mRNA	PMID:34947998
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF18 mRNA	PMID:37042841
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZNF18 mRNA	PMID:38568856
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ZNF18 mRNA	PMID:36326898
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ZKSCAN6 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ZKSCAN6 mRNA]	PMID:17585979
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:39178	clothianidin	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in decreased expression of ZNF18 mRNA	PMID:31626844
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZKSCAN6 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZKSCAN6 mRNA	PMID:36331819
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1312983	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ZKSCAN6 mRNA	PMID:17963808
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF18 mRNA	PMID:23179753
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in decreased expression of ZNF18 mRNA	PMID:17183730
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312983	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZKSCAN6 mRNA	PMID:17562736
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ZKSCAN6 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ZKSCAN6 mRNA]	PMID:17585979
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1312983	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ZKSCAN6 mRNA	PMID:17942748
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZKSCAN6 mRNA	PMID:17942748
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate affects the reaction [MTF1 affects the expression of ZKSCAN6 mRNA]	PMID:16221973
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312983	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ZKSCAN6 mRNA	PMID:35964746
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305130	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of ZFP18 mRNA	PMID:24793618
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in decreased expression of ZNF18 mRNA	PMID:17183730
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of ZNF18 mRNA	PMID:36318118
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF18 protein	PMID:31285264
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF18 mRNA	PMID:27188386
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF18 gene]	PMID:28238834
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1312983	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of ZKSCAN6 mRNA	PMID:39847705
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF18 mRNA	PMID:27188386
1312982	ZNF18	zinc finger protein 18	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305130	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ZNF18 mRNA	PMID:21346803
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1312985	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TWF2 mRNA	PMID:33045310
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1312985	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TWF2 mRNA	PMID:20188158
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TWF2 mRNA	PMID:20938992
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in increased expression of TWF2 mRNA	PMID:15498508|PMID:33167477
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:16170	mercury(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of TWF2 mRNA	PMID:16823088
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1312985	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TWF2 mRNA	PMID:39241906
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of TWF2 mRNA]	PMID:39241906
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of TWF2 mRNA	PMID:14699072
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1312985	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TWF2 mRNA	PMID:39298647
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TWF2 mRNA	PMID:20938992
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TWF2 mRNA	PMID:37042841
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TWF2 mRNA	PMID:21179406
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TWF2 mRNA	PMID:37992649
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TWF2 mRNA	PMID:37992649
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1312985	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of TWF2 mRNA	PMID:17997037
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312985	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TWF2 mRNA	PMID:34319233
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of TWF2 protein; [Cuprizone co-treated with Cannabidiol] results in decreased expression of TWF2 protein	PMID:34122009
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1591460	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TWF2 mRNA	PMID:33387578
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1312985	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of TWF2 mRNA	PMID:17997037
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TWF2 mRNA	PMID:37236586
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TWF2 mRNA	PMID:19549813
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TWF2 protein	PMID:23301498
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TWF2 mRNA	PMID:21641981|PMID:22100608
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312985	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TWF2 mRNA	PMID:19770486
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:25195	mercury atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of TWF2 mRNA	PMID:16823088
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1312985	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TWF2 mRNA	PMID:31919559
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TWF2 mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TWF2 mRNA]	PMID:20938992|PMID:22206623
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TWF2 mRNA	PMID:39836092
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TWF2 mRNA	PMID:40504410
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1591460	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TWF2 mRNA	PMID:31881176
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1591460	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of TWF2 mRNA	PMID:25905778
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TWF2 mRNA	PMID:27392435|PMID:27594783
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TWF2 mRNA	PMID:27392435
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1591460	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TWF2 mRNA	PMID:34747641
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1591460	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TWF2 mRNA	PMID:33387578
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1591460	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of TWF2 mRNA	PMID:28374803
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1591460	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of TWF2 mRNA	PMID:28959563
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TWF2 mRNA	PMID:32763439
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TWF2 mRNA	PMID:20971185
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1312985	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of TWF2 protein	PMID:28918527
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TWF2 mRNA	PMID:29803840
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TWF2 mRNA	PMID:37992649
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:28869	menadione	decreases expression	ISO	RGD:1312985	E	RGD:6480464	20150127	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of TWF2 mRNA	PMID:25270620
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TWF2 mRNA	PMID:39836092
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TWF2 mRNA	PMID:40504410
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TWF2 mRNA	PMID:21632981
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TWF2 promoter	PMID:27901495
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TWF2 mRNA	PMID:20971185
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of TWF2 protein	PMID:34122009
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TWF2 gene	PMID:31601247
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:32181	tamibarotene	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of TWF2 mRNA	PMID:15498508
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312985	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TWF2 gene	PMID:35295148
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1591460	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TWF2 mRNA	PMID:34492290
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312985	E	RGD:6480464	20150127	CTD	MESH:C006253	pirinixic acid results in decreased expression of TWF2 mRNA	PMID:17950772|PMID:25270620
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312985	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TWF2 mRNA	PMID:23811191
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20120412	CTD	MESH:C006253	NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of TWF2 mRNA]	PMID:17950772
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TWF2 mRNA	PMID:30903817
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of TWF2 protein	PMID:31675489
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1312985	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of TWF2 mRNA	PMID:30245210
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TWF2 gene	PMID:31601247
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1591460	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TWF2 mRNA	PMID:36041667
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of TWF2 protein	PMID:31675489
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1312985	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of TWF2 mRNA	PMID:26682919
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1312985	E	RGD:6480464	20250805	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of TWF2 protein; 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of TWF2 protein alternative form	PMID:26903627
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of TWF2 protein	PMID:34186270
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1591460	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TWF2 mRNA	PMID:36041667
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of TWF2 protein	PMID:34186270
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1591460	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TWF2 mRNA	PMID:36041667
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TWF2 protein	PMID:34186270
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1312985	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TWF2 mRNA	PMID:37019170
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312985	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TWF2 mRNA	PMID:21266533
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D003993	[Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of TWF2 protein	PMID:30218697
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of TWF2 mRNA]	PMID:39241906
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TWF2 mRNA	PMID:37042841
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1591460	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TWF2 mRNA	PMID:35163327
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TWF2 mRNA	PMID:37236586
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1591460	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TWF2 mRNA	PMID:35163327
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of TWF2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TWF2 mRNA]	PMID:17585979
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D013755	[Dibutyl Phthalate co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of TWF2 protein	PMID:30218697
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TWF2 mRNA	PMID:25562108
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TWF2 mRNA	PMID:14699072
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TWF2 mRNA	PMID:37992649
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312985	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TWF2 mRNA	PMID:17562736
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of TWF2 mRNA	PMID:29067470
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1591460	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TWF2 mRNA	PMID:33387578
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of TWF2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TWF2 mRNA]	PMID:17585979
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TWF2 mRNA	PMID:39836092
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TWF2 mRNA	PMID:40504410
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of TWF2 mRNA	PMID:31675489
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1591460	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TWF2 mRNA	PMID:29391264
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TWF2 protein	PMID:32959892
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1312985	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of TWF2 mRNA	PMID:36907384
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of TWF2 protein	PMID:34122009
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TWF2 protein	PMID:34186270
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1312985	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TWF2 mRNA	PMID:22206623
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TWF2 mRNA]	PMID:22206623
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1312985	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of TWF2 mRNA	PMID:31388691
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TWF2 protein	PMID:31675489
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of TWF2 protein	PMID:31675489
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of TWF2 mRNA	PMID:33512557
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1312985	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of TWF2 mRNA]	PMID:39241906
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of TWF2 mRNA	PMID:14699072
1312984	TWF2	twinfilin actin binding protein 2	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of TWF2 mRNA	PMID:17440010
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20230404	CTD	MESH:D000431	[2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Ethanol co-treated with Benzo(a)pyrene]] which results in increased expression of SLC25A28 mRNA; [Ethanol co-treated with Benzo(a)pyrene] results in increased expression of SLC25A28 mRNA	PMID:35412187
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SLC25A28 mRNA	PMID:35811015
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC25A28 mRNA	PMID:35811015
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1584155	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SLC25A28 mRNA	PMID:32145629
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1312989	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SLC25A28 mRNA	PMID:39298647
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1584155	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC25A28 mRNA	PMID:33387578
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLC25A28 mRNA	PMID:37042841
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1312989	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SLC25A28 mRNA	PMID:33754040
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1584155	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SLC25A28 mRNA	PMID:22061828
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SLC25A28 mRNA	PMID:28818685
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312989	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC25A28 mRNA	PMID:37236586
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1312989	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of SLC25A28 mRNA	PMID:19376150
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLC25A28 gene	PMID:27153756
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1312989	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLC25A28 mRNA	PMID:19770486
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312989	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SLC25A28 mRNA	PMID:34911549
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312989	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A28 mRNA	PMID:22206623
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1312989	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SLC25A28 mRNA	PMID:28960355
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SLC25A28 mRNA	PMID:23557933
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SLC25A28 mRNA	PMID:25583101
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312989	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC25A28 mRNA	PMID:20702594|PMID:21570461|PMID:26377647
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312989	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC25A28 mRNA	PMID:19770486|PMID:28213091
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1312989	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of SLC25A28 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC25A28 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SLC25A28 gene]	PMID:16214954|PMID:25975270|PMID:28213091
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC25A28 mRNA	PMID:33212167
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312989	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of SLC25A28 mRNA	PMID:39631538
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC25A28 mRNA	PMID:34032870
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of SLC25A28 mRNA	PMID:22378314
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SLC25A28 promoter	PMID:27901495
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC25A28 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20230404	CTD	MESH:D001564	[2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Ethanol co-treated with Benzo(a)pyrene]] which results in increased expression of SLC25A28 mRNA; [Ethanol co-treated with Benzo(a)pyrene] results in increased expression of SLC25A28 mRNA	PMID:35412187
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SLC25A28 mRNA	PMID:20458559
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SLC25A28	PMID:25256833
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1312989	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of SLC25A28 mRNA	PMID:21829687
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1312989	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC25A28 gene; titanium dioxide results in decreased methylation of SLC25A28 promoter	PMID:35295148
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1312989	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SLC25A28 gene	PMID:35295148
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1584155	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SLC25A28 mRNA	PMID:23411599
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1312989	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SLC25A28 mRNA	PMID:18648102
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in increased methylation of SLC25A28 gene; [Vehicle Emissions results in increased abundance of Nitrogen Dioxide] which results in increased methylation of SLC25A28 gene	PMID:27448387
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC25A28 mRNA; bisphenol A results in decreased expression of SLC25A28 protein	PMID:22576693|PMID:33376534
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1584155	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC25A28 mRNA	PMID:32145629
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1584155	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SLC25A28 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of SLC25A28 gene	PMID:22576693
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1312989	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SLC25A28 mRNA	PMID:39298647
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1312989	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in increased expression of SLC25A28 mRNA	PMID:35093514
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1312989	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SLC25A28 mRNA	PMID:21266533
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC25A28 mRNA	PMID:37042841
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1584155	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SLC25A28 mRNA	PMID:30589522
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SLC25A28 mRNA	PMID:38174414
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1584155	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLC25A28 mRNA	PMID:33453195
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312989	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC25A28 mRNA	PMID:37236586
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SLC25A28 mRNA	PMID:24449571
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1312989	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of SLC25A28 mRNA	PMID:23811191
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1312989	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLC25A28 mRNA	PMID:40194260
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SLC25A28 gene	PMID:29154799
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1312989	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of SLC25A28 mRNA	PMID:19770486
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1312989	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of SLC25A28 mRNA	PMID:18502557
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of SLC25A28 mRNA]	PMID:21233418
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC25A28 mRNA	PMID:26690555
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC25A28 mRNA	PMID:25704631
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1584155	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC25A28 mRNA	PMID:33387578
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC25A28 mRNA	PMID:35811015
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SLC25A28 mRNA	PMID:20458559
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SLC25A28	PMID:25256833
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1312989	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SLC25A28 mRNA	PMID:35964746
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:53578	hexamethylene diisocyanate	increases methylation	EXP		E	RGD:6480464	20150414	CTD	MESH:C015262	1,6-hexamethylene diisocyanate results in increased methylation of SLC25A28 gene	PMID:25445006
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1312989	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of SLC25A28 mRNA	PMID:26307267
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1312989	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A28 mRNA	PMID:22206623
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC25A28 gene]	PMID:28238834
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1312989	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of SLC25A28 mRNA	PMID:20702594
1312988	SLC25A28	solute carrier family 25 member 28	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1584155	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of SLC25A28 mRNA	PMID:25825206
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20210112	CTD	MESH:C118739	entinostat results in increased expression of GALNT15 mRNA	PMID:32870474
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1312993	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of GALNT15 mRNA	PMID:37995155
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1312993	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in decreased expression of GALNT15 mRNA	PMID:33227293
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312993	E	RGD:6480464	20161115	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of GALNT15 mRNA	PMID:26251327
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GALNT15 mRNA	PMID:20938992
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of GALNT15 mRNA	PMID:26516004
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1312993	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of GALNT15 mRNA	PMID:40945087
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of GALNT15 mRNA	PMID:30165855
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GALNT15 mRNA	PMID:25510870
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GALNT15 mRNA	PMID:20938992
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of GALNT15 mRNA	PMID:27905399
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALNT15 mRNA	PMID:37992649
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1312993	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of GALNT15 mRNA	PMID:28973375
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALNT15 mRNA	PMID:37992649
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GALNT15 mRNA	PMID:36331819
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT15 mRNA	PMID:29950665
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GALNT15 mRNA	PMID:25510870
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GALNT15 mRNA	PMID:25510870
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of GALNT15 gene	PMID:27153756
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1312993	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in decreased expression of GALNT15 mRNA	PMID:33026818
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GALNT15 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of GALNT15 mRNA	PMID:34911549
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GALNT15 mRNA	PMID:20938992
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C040641	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of GALNT15 mRNA	PMID:27424125
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20160210	CTD	MESH:D001151	Arsenic affects the methylation of GALNT15 gene	PMID:25304211
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:2322081	E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in increased expression of GALNT15 mRNA	PMID:38314887
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of GALNT15 mRNA	PMID:23557933
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of GALNT15 mRNA	PMID:28903495
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312993	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of GALNT15 mRNA	PMID:40618947
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D019833	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of GALNT15 mRNA	PMID:27424125
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312993	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GALNT15 mRNA	PMID:28922406
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:2322081	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GALNT15 mRNA	PMID:34747641
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:28197	daidzein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C004742	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of GALNT15 mRNA	PMID:27424125
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of GALNT15 mRNA	PMID:29955902|PMID:32870474
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1312993	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in increased expression of GALNT15 mRNA	PMID:35032568
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1312993	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of GALNT15 mRNA	PMID:39631538
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALNT15 mRNA	PMID:37992649
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GALNT15 mRNA	PMID:38568856
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1312993	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of GALNT15 mRNA	PMID:37682722
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1312993	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GALNT15 mRNA	PMID:22610609|PMID:32417428
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GALNT15 promoter	PMID:27901495
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312993	E	RGD:6480464	20120717	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GALNT15 mRNA	PMID:20713471|PMID:21569818
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of GALNT15 mRNA	PMID:38568856
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1312993	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of GALNT15 mRNA	PMID:23557971
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT15 mRNA	PMID:29950665
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1312993	E	RGD:6480464	20141111	CTD	MESH:C006253	pirinixic acid results in increased expression of GALNT15 mRNA	PMID:23811191
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of GALNT15 mRNA	PMID:22576693|PMID:27685785
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2322081	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of GALNT15 mRNA	PMID:30816183|PMID:32528016
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of GALNT15 gene	PMID:22576693|PMID:31601247
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GALNT15 mRNA	PMID:25510870
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of GALNT15 mRNA	PMID:25510870
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	GALNT15 mRNA affects the susceptibility to Carmustine	PMID:16365179
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1312993	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of GALNT15 mRNA	PMID:20713471
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of GALNT15 gene	PMID:31601247
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1312993	E	RGD:6480464	20160210	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of GALNT15 mRNA	PMID:26377693
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT15 mRNA	PMID:29950665
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:34778	glycitein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C086566	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of GALNT15 mRNA	PMID:27424125
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of GALNT15 mRNA	PMID:28628672
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GALNT15 mRNA	PMID:38568856
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1312993	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of GALNT15 mRNA	PMID:39529242
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GALNT15 mRNA	PMID:36331819
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1312993	E	RGD:6480464	20141111	CTD	MESH:D002737	Chloroprene results in increased expression of GALNT15 mRNA	PMID:23125180
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1312993	E	RGD:6480464	20180220	CTD	MESH:C016104	sodium bichromate results in increased expression of GALNT15 mRNA	PMID:27859739
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312993	E	RGD:6480464	20141111	CTD	MESH:D003907	Dexamethasone results in increased expression of GALNT15 mRNA	PMID:22733784
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of GALNT15 mRNA	PMID:28628672
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C013908	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of GALNT15 mRNA	PMID:27424125
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1312993	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALNT15 mRNA	PMID:37992649
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of GALNT15 mRNA	PMID:38832940
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312993	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GALNT15 mRNA	PMID:17562736
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of GALNT15 mRNA	PMID:29067470
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:2322081	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GALNT15 mRNA	PMID:33387578
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20160210	CTD	MESH:D001151	Arsenic affects the methylation of GALNT15 gene	PMID:25304211
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of GALNT15 mRNA	PMID:38568856
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of GALNT15 mRNA	PMID:28628672
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1312993	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GALNT15 mRNA; Nanotubes, Carbon results in decreased expression of GALNT15 mRNA	PMID:25554681
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1312993	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GALNT15 mRNA; Nanotubes, Carbon results in increased expression of GALNT15 mRNA	PMID:25620056
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1312993	E	RGD:6480464	20160210	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of GALNT15 mRNA	PMID:26377693
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1312993	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of GALNT15 mRNA	PMID:19042947
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20210112	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GALNT15 mRNA	PMID:32870474
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1312993	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of GALNT15 mRNA	PMID:20003209
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of GALNT15 mRNA	PMID:20843944
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	GALNT15 mRNA affects the susceptibility to temozolomide	PMID:16365179
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GALNT15 gene]	PMID:28238834
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:80373	glycitin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C433283	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of GALNT15 mRNA	PMID:27424125
1312992	GALNT15	polypeptide N-acetylgalactosaminyltransferase 15	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of GALNT15 mRNA	PMID:38568856
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ZFP281 mRNA	PMID:26251327
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of ZNF281 mRNA	PMID:22574217
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305139	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ZFP281 mRNA	PMID:32145629
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF281 mRNA	PMID:37042841
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ZNF281 mRNA	PMID:33359661
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:17447	geraniol	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of ZNF281 mRNA	PMID:27683099
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZNF281 protein	PMID:37730182
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZNF281 mRNA	PMID:28818685
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1312997	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZFP281 mRNA	PMID:37236586
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ZNF281 mRNA	PMID:19549813
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1305139	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ZFP281 mRNA	PMID:33354967
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ZNF281 mRNA	PMID:41430723
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305139	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of ZFP281 mRNA	PMID:31129395
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:27504	mitomycin C	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	ZNF281 protein affects the susceptibility to Mitomycin	PMID:16217747
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1312997	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZFP281 mRNA	PMID:40504410
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ZNF281 protein	PMID:35688186
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1312997	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of ZFP281 mRNA	PMID:40618947
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1312997	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP281 mRNA	PMID:21570461|PMID:24058054
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP281 mRNA	PMID:19770486
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1312997	E	RGD:6480464	20150127	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP281 mRNA	PMID:25270620
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of ZNF281 mRNA	PMID:29955902
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZNF281 mRNA	PMID:33212167
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF281 mRNA	PMID:38568856
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1312997	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of ZFP281 mRNA	PMID:36209798
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1312997	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZFP281 mRNA	PMID:40504410
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1312997	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZFP281 mRNA	PMID:22228805
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of ZNF281 mRNA	PMID:26014281
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:30621	diarsenic trioxide	increases sumoylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased sumoylation of ZNF281 protein	PMID:28318385
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ZFP281 mRNA	PMID:18445702
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305139	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ZFP281 mRNA	PMID:32145629
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of ZNF281 protein	PMID:31675489
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305139	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZNF281 mRNA	PMID:25181051
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1312997	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP281 mRNA	PMID:33221593
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305139	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of ZFP281 mRNA	PMID:31129395
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of ZNF281 protein	PMID:31675489
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to ZNF281 promoter]	PMID:20348232
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF281 mRNA	PMID:28628672
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZFP281 mRNA	PMID:37019170
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF281 mRNA	PMID:28628672
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF281 mRNA	PMID:37042841
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1312997	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZFP281 mRNA	PMID:37236586
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ZNF281 mRNA	PMID:31533062
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF281 mRNA	PMID:23179753
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZNF281 gene	PMID:29154799
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZFP281 mRNA	PMID:19770486
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1312997	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of ZFP281 mRNA	PMID:22733784
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF281 mRNA	PMID:28628672
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1312997	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ZNF281 mRNA	PMID:28973697
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1312997	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZFP281 mRNA	PMID:17562736
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZNF281 mRNA	PMID:21420995
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ZFP281 mRNA	PMID:29279043
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1312997	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZFP281 mRNA	PMID:40504410
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of ZNF281 mRNA	PMID:31675489
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ZNF281 mRNA	PMID:28628672
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:49900	arsenous acid	increases sumoylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased sumoylation of ZNF281 protein	PMID:28318385
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305139	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ZFP281 mRNA	PMID:24136188
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1312997	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of ZFP281 mRNA	PMID:40234311
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:6456	lidocaine	decreases expression	ISO	RGD:1305139	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in decreased expression of ZFP281 mRNA	PMID:35283115
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF281 protein	PMID:31285264
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1312997	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ZFP281 mRNA	PMID:23091169
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ZNF281 protein	PMID:31675489
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ZNF281 protein	PMID:31675489
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of ZNF281 mRNA	PMID:26014281
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305139	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ZFP281 mRNA	PMID:19281266
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305139	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ZFP281 mRNA	PMID:21346803
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1305139	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of ZFP281 mRNA	PMID:24136188
1312996	ZNF281	zinc finger protein 281	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305139	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ZFP281 mRNA	PMID:21346803
1313000	TBL3	transducin beta like 3	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of TBL3 protein	PMID:39638853
1313000	TBL3	transducin beta like 3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TBL3 mRNA	PMID:38218311
1313000	TBL3	transducin beta like 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313001	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TBL3 mRNA	PMID:33045310
1313000	TBL3	transducin beta like 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305142	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TBL3 mRNA]	PMID:31150632
1313000	TBL3	transducin beta like 3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBL3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TBL3 mRNA	PMID:32699268
1313000	TBL3	transducin beta like 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313001	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of TBL3 mRNA	PMID:30529165
1313000	TBL3	transducin beta like 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313001	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TBL3 mRNA	PMID:39241906
1313000	TBL3	transducin beta like 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313001	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TBL3 mRNA	PMID:39298647
1313000	TBL3	transducin beta like 3	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TBL3 mRNA	PMID:38568856
1313000	TBL3	transducin beta like 3	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TBL3 mRNA	PMID:23649840
1313000	TBL3	transducin beta like 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305142	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TBL3 protein	PMID:34915118
1313000	TBL3	transducin beta like 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TBL3 mRNA	PMID:19549813
1313000	TBL3	transducin beta like 3	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TBL3 mRNA	PMID:23649840
1313000	TBL3	transducin beta like 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TBL3 intron	PMID:30157460
1313000	TBL3	transducin beta like 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TBL3 mRNA	PMID:23649840
1313000	TBL3	transducin beta like 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBL3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TBL3 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of TBL3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TBL3 mRNA	PMID:32699268|PMID:35430440
1313000	TBL3	transducin beta like 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305142	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TBL3 mRNA	PMID:31150632
1313000	TBL3	transducin beta like 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305142	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TBL3 mRNA]	PMID:31150632
1313000	TBL3	transducin beta like 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313001	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TBL3 mRNA	PMID:25629700
1313000	TBL3	transducin beta like 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TBL3 gene	PMID:25304211
1313000	TBL3	transducin beta like 3	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TBL3 mRNA	PMID:19244175
1313000	TBL3	transducin beta like 3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of TBL3 mRNA	PMID:27594783
1313000	TBL3	transducin beta like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313001	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TBL3 mRNA	PMID:21570461
1313000	TBL3	transducin beta like 3	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TBL3 mRNA	PMID:39709020
1313000	TBL3	transducin beta like 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TBL3 mRNA	PMID:32763439
1313000	TBL3	transducin beta like 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313001	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of TBL3 mRNA]; MT2 affects the reaction [Copper results in increased expression of TBL3 mRNA]	PMID:16629173
1313000	TBL3	transducin beta like 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TBL3 mRNA	PMID:38568856
1313000	TBL3	transducin beta like 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TBL3 mRNA	PMID:34032870|PMID:39719251
1313000	TBL3	transducin beta like 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313001	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of TBL3 mRNA]; MT2 affects the reaction [Copper results in increased expression of TBL3 mRNA]	PMID:16629173
1313000	TBL3	transducin beta like 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313001	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of TBL3 mRNA	PMID:27760801
1313000	TBL3	transducin beta like 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305142	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TBL3 mRNA	PMID:23411599|PMID:34492290
1313000	TBL3	transducin beta like 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of TBL3 protein	PMID:37567409
1313000	TBL3	transducin beta like 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305142	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of TBL3 mRNA	PMID:33296240
1313000	TBL3	transducin beta like 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TBL3 gene	PMID:31601247
1313000	TBL3	transducin beta like 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305142	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TBL3 mRNA	PMID:25181051|PMID:34947998
1313000	TBL3	transducin beta like 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305142	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TBL3 gene	PMID:28505145
1313000	TBL3	transducin beta like 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of TBL3 protein	PMID:31945527
1313000	TBL3	transducin beta like 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313001	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TBL3 mRNA	PMID:39298647
1313000	TBL3	transducin beta like 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313001	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TBL3 intron	PMID:28392331
1313000	TBL3	transducin beta like 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313001	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TBL3 mRNA	PMID:37019170
1313000	TBL3	transducin beta like 3	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305142	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TBL3 mRNA	PMID:17602206
1313000	TBL3	transducin beta like 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305142	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TBL3 mRNA	PMID:17602206
1313000	TBL3	transducin beta like 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TBL3 mRNA	PMID:37042841
1313000	TBL3	transducin beta like 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TBL3 mRNA	PMID:19376846
1313000	TBL3	transducin beta like 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBL3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TBL3 mRNA	PMID:32699268
1313000	TBL3	transducin beta like 3	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TBL3 mRNA	PMID:19244175
1313000	TBL3	transducin beta like 3	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313001	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of TBL3 mRNA	PMID:17585979
1313000	TBL3	transducin beta like 3	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of TBL3 protein	PMID:34122009
1313000	TBL3	transducin beta like 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TBL3 mRNA	PMID:31533062
1313000	TBL3	transducin beta like 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313001	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid affects the expression of TBL3 mRNA	PMID:17292431|PMID:17963808
1313000	TBL3	transducin beta like 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TBL3 gene	PMID:29154799
1313000	TBL3	transducin beta like 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TBL3 mRNA	PMID:25562108
1313000	TBL3	transducin beta like 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TBL3 mRNA	PMID:21420995
1313000	TBL3	transducin beta like 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305142	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TBL3 mRNA	PMID:33387578
1313000	TBL3	transducin beta like 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TBL3 gene	PMID:25304211
1313000	TBL3	transducin beta like 3	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313001	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of TBL3 mRNA	PMID:30529165
1313000	TBL3	transducin beta like 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313001	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TBL3 mRNA; Nanotubes, Carbon results in increased expression of TBL3 mRNA	PMID:25554681
1313000	TBL3	transducin beta like 3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305142	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TBL3 mRNA	PMID:24136188
1313000	TBL3	transducin beta like 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313001	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TBL3 mRNA	PMID:19042947
1313000	TBL3	transducin beta like 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TBL3 protein	PMID:32959892
1313000	TBL3	transducin beta like 3	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305142	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of TBL3 mRNA	PMID:24136188
1313000	TBL3	transducin beta like 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313001	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TBL3 mRNA	PMID:22206623
1313000	TBL3	transducin beta like 3	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of TBL3 protein	PMID:31285264
1313000	TBL3	transducin beta like 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305142	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of TBL3 mRNA	PMID:32109520
1313000	TBL3	transducin beta like 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305142	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TBL3 mRNA	PMID:21346803
1313000	TBL3	transducin beta like 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305142	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TBL3 mRNA	PMID:21346803
1313000	TBL3	transducin beta like 3	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313001	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TBL3 mRNA	PMID:35537566
1313000	TBL3	transducin beta like 3	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305142	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TBL3 mRNA	PMID:23034163
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550129	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SDHAF3 mRNA	PMID:30319688
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SDHAF3 mRNA	PMID:21179406
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SDHAF3 mRNA	PMID:28818685
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1305143	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of SDHAF3 mRNA	PMID:28522335
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SDHAF3 mRNA	PMID:19549813
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SDHAF3 gene	PMID:27153756
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305143	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SDHAF3 mRNA	PMID:33387578
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550129	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SDHAF3 mRNA	PMID:25629700
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SDHAF3 gene	PMID:25304211
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305143	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SDHAF3 mRNA	PMID:31881176
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SDHAF3 mRNA	PMID:27392435
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1550129	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SDHAF3 mRNA	PMID:30912803
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550129	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SDHAF3 mRNA	PMID:21570461
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SDHAF3 mRNA	PMID:20106945|PMID:21632981
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305143	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SDHAF3 mRNA	PMID:21215274
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SDHAF3 mRNA	PMID:30851411
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28618	1,4-dichlorobenzene	increases expression	ISO	RGD:1550129	E	RGD:6480464	20171114	CTD	MESH:C018511	4-dichlorobenzene results in increased expression of SDHAF3 mRNA	PMID:26975756
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305143	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SDHAF3 mRNA	PMID:28959563
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SDHAF3 mRNA	PMID:29803840
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SDHAF3 mRNA	PMID:29432896
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SDHAF3 mRNA	PMID:38568856
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1305143	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SDHAF3 mRNA	PMID:21839799
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to SDHAF3 mRNA]	PMID:32406909
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550129	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ACN9 gene	PMID:35295148
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305143	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SDHAF3 mRNA	PMID:34492290
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1550129	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of SDHAF3 mRNA	PMID:18648102
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1305143	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SDHAF3 mRNA	PMID:30723492
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305143	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SDHAF3 mRNA	PMID:25181051
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of SDHAF3 mRNA	PMID:36232920
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550129	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SDHAF3 mRNA	PMID:33221593
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SDHAF3 mRNA	PMID:28628672
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SDHAF3 mRNA	PMID:28628672
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550129	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SDHAF3 mRNA	PMID:37019170
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305143	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SDHAF3 mRNA	PMID:21266533
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SDHAF3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SDHAF3 mRNA	PMID:28628672
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SDHAF3 mRNA	PMID:19376846
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305143	E	RGD:6480464	20221206	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SDHAF3 mRNA	PMID:24386269
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550129	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SDHAF3 mRNA	PMID:36331819
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SDHAF3 mRNA	PMID:25979313
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SDHAF3 gene	PMID:29154799
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SDHAF3 mRNA	PMID:23179753|PMID:28001369|PMID:29154799|PMID:37505509
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of SDHAF3 mRNA	PMID:17183730
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of SDHAF3 mRNA	PMID:20106945|PMID:25562108
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SDHAF3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SDHAF3 mRNA	PMID:28628672
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SDHAF3 mRNA	PMID:27188386
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305143	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SDHAF3 mRNA	PMID:33387578
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SDHAF3 gene	PMID:25304211
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SDHAF3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SDHAF3 mRNA	PMID:28628672
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305143	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of SDHAF3 mRNA	PMID:24136188
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1550129	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of SDHAF3 mRNA	PMID:40234311
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305143	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SDHAF3 mRNA	PMID:24136188
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of SDHAF3 mRNA	PMID:17183730
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of SDHAF3 mRNA	PMID:37939859
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SDHAF3 mRNA	PMID:31758290
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550129	E	RGD:6480464	20221206	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SDHAF3 mRNA	PMID:22206623
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SDHAF3 mRNA	PMID:30851411
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SDHAF3 mRNA	PMID:19159669
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550129	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SDHAF3 mRNA	PMID:31388691
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305143	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of SDHAF3 mRNA	PMID:19281266
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1305143	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of SDHAF3 mRNA	PMID:24136188
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SDHAF3 mRNA	PMID:38568856
1313002	SDHAF3	succinate dehydrogenase complex assembly factor 3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SDHAF3 mRNA	PMID:29301935
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RPS6KB2 mRNA	PMID:38218311
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313004	E	RGD:6480464	20130618	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RPS6KB2 mRNA	PMID:20188158
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of RPS6KB2 mRNA	PMID:22378314
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:16337	phosphatidic acid	increases activity	EXP		E	RGD:6480464	20170103	CTD	MESH:D010712	Phosphatidic Acids results in increased activity of RPS6KB2 protein	PMID:12087098
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:16337	phosphatidic acid	multiple interactions	EXP		E	RGD:6480464	20170103	CTD	MESH:D010712	MTOR protein affects the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein]; Sirolimus inhibits the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein]; Wortmannin inhibits the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein]	PMID:12087098
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313004	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RPS6KB2 mRNA	PMID:39298647
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313004	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of RPS6KB2 mRNA	PMID:28973375
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1305144	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of RPS6KB2 mRNA	PMID:11478936
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of RPS6KB2 protein	PMID:37730182
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305144	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RPS6KB2 mRNA	PMID:33387578
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:18152	myricetin	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:C040015	myricetin results in increased expression of RPS6KB2 protein	PMID:29698783
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313004	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of RPS6KB2 mRNA	PMID:33914522
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305144	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of RPS6KB2 protein	PMID:34915118
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1305144	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of RPS6KB2 mRNA	PMID:11478936
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313004	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RPS6KB2 mRNA	PMID:37236586
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313004	E	RGD:6480464	20130618	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of RPS6KB2 mRNA	PMID:19376150
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313004	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of RPS6KB2 mRNA	PMID:32186404
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313004	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPS6KB2 mRNA	PMID:21570461
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313004	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RPS6KB2 mRNA	PMID:19770486
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of RPS6KB2 mRNA	PMID:30911355
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:28748	doxorubicin	decreases phosphorylation	ISO	RGD:1305144	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased phosphorylation of RPS6KB2 protein	PMID:19801490
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1305144	E	RGD:6480464	20120412	CTD	MESH:D004317	NRG1 protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of RPS6KB2 protein]	PMID:19801490
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of RPS6KB2 protein	PMID:35688186
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:28885	butan-1-ol	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D020001	1-Butanol results in decreased activity of RPS6KB2 protein	PMID:12087098
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RPS6KB2 mRNA	PMID:29432896
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of RPS6KB2 gene	PMID:28589171
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of RPS6KB2 mRNA	PMID:34032870|PMID:39719251
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RPS6KB2 3' UTR	PMID:27901495
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of RPS6KB2 mRNA	PMID:30911355
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RPS6KB2 protein]	PMID:26598702
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RPS6KB2 gene	PMID:31601247
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305144	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RPS6KB2 mRNA	PMID:30047161
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313004	E	RGD:6480464	20130618	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RPS6KB2 mRNA	PMID:19710929
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305144	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RPS6KB2 mRNA	PMID:18180321|PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313004	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in increased expression of RPS6KB2 mRNA	PMID:29165653
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RPS6KB2 gene	PMID:31601247
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313004	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S results in decreased methylation of RPS6KB2 gene	PMID:31683443
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313004	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RPS6KB2 mRNA	PMID:38685157
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313004	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RPS6KB2 mRNA	PMID:37019170
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RPS6KB2 mRNA	PMID:37042841
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313004	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RPS6KB2 mRNA	PMID:37236586
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:3764	clotrimazole	decreases expression	ISO	RGD:1305144	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of RPS6KB2 mRNA	PMID:30047161
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313004	E	RGD:6480464	20130618	CTD	MESH:D014635	Valproic Acid affects the expression of RPS6KB2 mRNA	PMID:17963808
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RPS6KB2 gene	PMID:29154799
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305144	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RPS6KB2 mRNA	PMID:30047161
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:41072	3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione	multiple interactions	ISO	RGD:1305144	E	RGD:6480464	20141111	CTD	MESH:C070515	bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]	PMID:12720544
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305144	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RPS6KB2 mRNA	PMID:33387578
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of RPS6KB2 mRNA	PMID:18175754
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RPS6KB2 protein]	PMID:26598702
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305144	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RPS6KB2 mRNA	PMID:30047161
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:52289	wortmannin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin inhibits the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein]	PMID:12087098
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:52646	leptomycin B	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C038753	leptomycin B results in decreased activity of RPS6KB2 protein	PMID:12087098
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of RPS6KB2 mRNA	PMID:18651567
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RPS6KB2 protein	PMID:32959892
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:6482	linuron	decreases expression	ISO	RGD:1305144	E	RGD:6480464	20171114	CTD	MESH:D008044	Linuron results in decreased expression of RPS6KB2 mRNA	PMID:28705778
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:6651	malathion	decreases expression	ISO	RGD:1313004	E	RGD:6480464	20260804	CTD	MESH:D008294	Malathion results in decreased expression of RPS6KB2 mRNA	PMID:39476999
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1305144	E	RGD:6480464	20200714	CTD	MESH:D008694	Methamphetamine results in decreased expression of RPS6KB2 mRNA	PMID:32035215
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cannabidiol co-treated with moringin] results in increased expression of RPS6KB2 mRNA	PMID:30096889
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of RPS6KB2 mRNA	PMID:31758290
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313004	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RPS6KB2 mRNA	PMID:22206623
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:8093	phenylephrine	multiple interactions	ISO	RGD:1305144	E	RGD:6480464	20120412	CTD	MESH:D010656	bisindolylmaleimide I inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]; Prazosin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]; rottlerin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]	PMID:12720544
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:8364	prazosin	multiple interactions	ISO	RGD:1305144	E	RGD:6480464	20120412	CTD	MESH:D011224	Prazosin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]	PMID:12720544
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1305144	E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in increased expression of RPS6KB2 mRNA	PMID:26923065
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305144	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RPS6KB2 mRNA	PMID:30047161
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:8899	rottlerin	decreases activity	ISO	RGD:1305144	E	RGD:6480464	20131008	CTD	MESH:C085746	rottlerin results in decreased activity of RPS6KB2 protein	PMID:12720544
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:8899	rottlerin	multiple interactions	ISO	RGD:1305144	E	RGD:6480464	20131008	CTD	MESH:C085746	rottlerin inhibits the reaction [Phenylephrine results in increased activity of RPS6KB2 protein]	PMID:12720544
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:9168	sirolimus	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in decreased activity of RPS6KB2 protein	PMID:12087098
1313003	RPS6KB2	ribosomal protein S6 kinase B2	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	MTOR protein inhibits the reaction [Sirolimus results in decreased activity of RPS6KB2 protein]; Sirolimus inhibits the reaction [Phosphatidic Acids results in increased activity of RPS6KB2 protein]	PMID:12087098
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of IL15RA mRNA	PMID:38218311
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of IL15RA mRNA	PMID:33045310
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of IL15RA mRNA	PMID:26079696
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305149	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of IL15RA gene	PMID:28931070
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20250401	CTD	MESH:D011794	[Quercetin co-treated with Lipopolysaccharides] results in decreased expression of IL15RA mRNA	PMID:38823456
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IL15RA mRNA	PMID:35811015
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313010	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IL15RA mRNA	PMID:26582142|PMID:39241906
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of IL15RA mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IL15RA mRNA]	PMID:35811015
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20161228	CTD	MESH:D008070	(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of IL15RA mRNA]; [Quercetin co-treated with Lipopolysaccharides] results in decreased expression of IL15RA mRNA	PMID:26582142|PMID:38823456
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of IL15RA mRNA	PMID:39298647
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of IL15RA mRNA	PMID:24758408|PMID:31614463
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in increased expression of IL15RA mRNA; EGF protein promotes the reaction [Estradiol results in increased expression of IL15RA mRNA]	PMID:18692832|PMID:24758408
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305149	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of IL15RA mRNA	PMID:33387578
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in increased expression of IL15RA mRNA	PMID:18692832
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:17489	3',5'-cyclic AMP	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D000242	Cyclic AMP results in decreased expression of IL15RA mRNA	PMID:22117073
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:17489	3',5'-cyclic AMP	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D000242	[Metformin co-treated with Cyclic AMP] results in decreased expression of IL15RA mRNA; PPARGC1A mutant form inhibits the reaction [Cyclic AMP results in decreased expression of IL15RA mRNA]	PMID:22117073
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IL15RA mRNA	PMID:36331819
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of IL15RA mRNA	PMID:33914522
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL15RA mRNA	PMID:35301059
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL15RA mRNA	PMID:37236586
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IL15RA mRNA	PMID:19770486
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of IL15RA mRNA	PMID:23649840
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of IL15RA mRNA	PMID:34911549
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of IL15RA mRNA	PMID:17484886
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IL15RA mRNA	PMID:31919559
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IL15RA gene	PMID:25304211
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of IL15RA mRNA	PMID:28960355
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form] results in decreased expression of IL15RA mRNA	PMID:23625948
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IL15RA mRNA	PMID:24768652|PMID:25583101
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305149	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IL15RA mRNA	PMID:34747641
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IL15RA mRNA	PMID:21570461
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IL15RA mRNA	PMID:25975270
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IL15RA mRNA	PMID:29803840
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of IL15RA mRNA	PMID:38568856
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of IL15RA mRNA	PMID:37682722
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313010	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of IL15RA gene	PMID:39894169
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IL15RA promoter	PMID:27901495
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IL15RA mRNA	PMID:22228805
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of IL15RA mRNA	PMID:35295148
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305149	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of IL15RA mRNA	PMID:23411599
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of IL15RA mRNA	PMID:20813756|PMID:23811191
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:C006253	pirinixic acid results in increased expression of IL15RA mRNA	PMID:18301758
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of IL15RA mRNA	PMID:33914522
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305149	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of IL15RA mRNA	PMID:25181051
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1313010	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of IL15RA mRNA	PMID:37894381
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:C006780	bisphenol A results in decreased expression of IL15RA mRNA	PMID:21932408|PMID:32156529
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20250204	CTD	MESH:C006780	bisphenol A results in decreased methylation of IL15RA gene	PMID:38338858
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313010	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of IL15RA mRNA	PMID:38074096
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305149	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of IL15RA mRNA	PMID:36041667
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20250204	CTD	MESH:C543008	bisphenol S results in decreased methylation of IL15RA gene	PMID:38338858
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305149	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of IL15RA mRNA	PMID:36041667
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of IL15RA mRNA	PMID:38685157
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:34575	bisphenol F	decreases methylation	EXP		E	RGD:6480464	20250204	CTD	MESH:C008745	bisphenol F results in decreased methylation of IL15RA gene	PMID:38338858
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305149	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of IL15RA mRNA	PMID:36041667
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313010	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of IL15RA intron	PMID:28392331
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of IL15RA mRNA	PMID:37047231
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305149	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of IL15RA gene	PMID:33148267
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IL15RA mRNA	PMID:37042841
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL15RA mRNA	PMID:35301059
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL15RA mRNA	PMID:37236586
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313010	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of IL15RA mRNA	PMID:28903501
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IL15RA mRNA	PMID:24449571
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IL15RA mRNA	PMID:32588087
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313010	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IL15RA mRNA	PMID:40194260
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IL15RA mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of IL15RA mRNA	PMID:36331819
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D003520	Cyclophosphamide results in increased expression of IL15RA mRNA	PMID:21041162
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of IL15RA mRNA	PMID:20106945
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313010	E	RGD:6480464	20140114	CTD	MESH:D016572	Cyclosporine results in increased expression of IL15RA mRNA	PMID:23958496
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D003907	Dexamethasone results in increased expression of IL15RA mRNA	PMID:21041162
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of IL15RA mRNA	PMID:21041162
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313010	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of IL15RA mRNA	PMID:28973697
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of IL15RA mRNA	PMID:17400583|PMID:24449571
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of IL15RA mRNA	PMID:21420995
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of IL15RA mRNA	PMID:29067470
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305149	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of IL15RA mRNA	PMID:33387578
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of IL15RA mRNA	PMID:33725128
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of IL15RA mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of IL15RA mRNA]	PMID:35811015
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IL15RA gene	PMID:25304211
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305149	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of IL15RA mRNA	PMID:29391264
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol inhibits the reaction [IL1B protein results in increased expression of IL15RA mRNA]	PMID:12072388
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of IL15RA mRNA	PMID:25620056
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:53049	1-fluoro-2,4-dinitrobenzene	increases response to substance	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D004139	IL15RA protein results in increased susceptibility to Dinitrofluorobenzene	PMID:15719370
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313010	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IL15RA mRNA	PMID:38701926
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1313010	E	RGD:6480464	20140114	CTD	MESH:D016559	Tacrolimus results in increased expression of IL15RA mRNA	PMID:23958496
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D008687	Metformin results in decreased expression of IL15RA mRNA	PMID:22117073
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D008687	[Metformin co-treated with Cyclic AMP] results in decreased expression of IL15RA mRNA; Metformin promotes the reaction [GCG protein results in decreased expression of IL15RA mRNA]	PMID:22117073
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305149	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of IL15RA gene	PMID:33148267
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:7438	N-methylformamide	decreases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:C002950	methylformamide analog results in decreased expression of IL15RA mRNA; methylformamide results in decreased expression of IL15RA mRNA	PMID:17040096
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IL15RA gene]	PMID:28238834
1313009	IL15RA	interleukin 15 receptor subunit alpha	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313010	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital results in increased expression of IL15RA mRNA	PMID:19270015
1313011	CEP43	centrosomal protein 43	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1558504	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CEP43 mRNA	PMID:33045310
1313011	CEP43	centrosomal protein 43	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1583370	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CEP43 mRNA]	PMID:31150632
1313011	CEP43	centrosomal protein 43	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CEP43 mRNA	PMID:22378314
1313011	CEP43	centrosomal protein 43	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CEP43 mRNA	PMID:20044591
1313011	CEP43	centrosomal protein 43	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CEP43 protein	PMID:37730182
1313011	CEP43	centrosomal protein 43	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of CEP43 mRNA	PMID:12634122
1313011	CEP43	centrosomal protein 43	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CEP43 mRNA	PMID:19549813
1313011	CEP43	centrosomal protein 43	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of CEP43 mRNA	PMID:19376150
1313011	CEP43	centrosomal protein 43	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CEP43 mRNA	PMID:19770486
1313011	CEP43	centrosomal protein 43	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CEP43 gene	PMID:28458013
1313011	CEP43	centrosomal protein 43	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CEP43 mRNA	PMID:23649840
1313011	CEP43	centrosomal protein 43	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1558504	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CEP43 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CEP43 mRNA	PMID:34911549
1313011	CEP43	centrosomal protein 43	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1583370	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CEP43 mRNA	PMID:31150632
1313011	CEP43	centrosomal protein 43	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1583370	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CEP43 mRNA]	PMID:31150632
1313011	CEP43	centrosomal protein 43	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1558504	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CEP43 mRNA	PMID:22206623
1313011	CEP43	centrosomal protein 43	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CEP43 protein	PMID:35688186
1313011	CEP43	centrosomal protein 43	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1583370	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of CEP43 gene	PMID:35440735
1313011	CEP43	centrosomal protein 43	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CEP43 mRNA	PMID:23557933
1313011	CEP43	centrosomal protein 43	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CEP43 mRNA	PMID:27392435
1313011	CEP43	centrosomal protein 43	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:D014414	Tungsten results in increased expression of CEP43 mRNA	PMID:30912803
1313011	CEP43	centrosomal protein 43	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CEP43 mRNA	PMID:21570461
1313011	CEP43	centrosomal protein 43	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of CEP43 mRNA	PMID:29955902
1313011	CEP43	centrosomal protein 43	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CEP43 mRNA	PMID:28001369
1313011	CEP43	centrosomal protein 43	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CEP43 mRNA	PMID:32763439
1313011	CEP43	centrosomal protein 43	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CEP43 promoter	PMID:28476633
1313011	CEP43	centrosomal protein 43	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CEP43 mRNA	PMID:26238291
1313011	CEP43	centrosomal protein 43	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CEP43 mRNA	PMID:22228805
1313011	CEP43	centrosomal protein 43	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CEP43 mRNA	PMID:25895662
1313011	CEP43	centrosomal protein 43	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:C009495	titanium dioxide results in increased expression of CEP43 mRNA	PMID:23557971
1313011	CEP43	centrosomal protein 43	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CEP43 mRNA	PMID:18648102
1313011	CEP43	centrosomal protein 43	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CEP43 mRNA	PMID:28472532
1313011	CEP43	centrosomal protein 43	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CEP43 mRNA	PMID:29275510
1313011	CEP43	centrosomal protein 43	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of CEP43 mRNA	PMID:20713471
1313011	CEP43	centrosomal protein 43	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1558504	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CEP43 mRNA	PMID:39298647
1313011	CEP43	centrosomal protein 43	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CEP43 mRNA	PMID:21266533
1313011	CEP43	centrosomal protein 43	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20250204	CTD	MESH:C005445	triphenyl phosphate affects the expression of CEP43 mRNA	PMID:37042841
1313011	CEP43	centrosomal protein 43	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1583370	E	RGD:6480464	20250204	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CEP43 mRNA	PMID:35163327
1313011	CEP43	centrosomal protein 43	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1583370	E	RGD:6480464	20250204	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CEP43 mRNA	PMID:35163327
1313011	CEP43	centrosomal protein 43	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases methylation	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased methylation of CEP43 promoter	PMID:28476633
1313011	CEP43	centrosomal protein 43	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CEP43 mRNA	PMID:28302478
1313011	CEP43	centrosomal protein 43	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CEP43 mRNA	PMID:31533062
1313011	CEP43	centrosomal protein 43	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CEP43 mRNA	PMID:25979313
1313011	CEP43	centrosomal protein 43	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of CEP43 mRNA	PMID:23179753
1313011	CEP43	centrosomal protein 43	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:D014635	Valproic Acid results in decreased expression of CEP43 mRNA	PMID:21427059
1313011	CEP43	centrosomal protein 43	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CEP43 gene	PMID:29154799
1313011	CEP43	centrosomal protein 43	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CEP43 mRNA	PMID:25562108
1313011	CEP43	centrosomal protein 43	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CEP43 mRNA	PMID:25554681
1313011	CEP43	centrosomal protein 43	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1558504	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of CEP43 mRNA	PMID:40234311
1313011	CEP43	centrosomal protein 43	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CEP43 protein	PMID:32959892
1313011	CEP43	centrosomal protein 43	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of CEP43 mRNA	PMID:15336504
1313011	CEP43	centrosomal protein 43	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1558504	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CEP43 mRNA	PMID:22206623
1313011	CEP43	centrosomal protein 43	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CEP43 mRNA	PMID:37199045
1313011	CEP43	centrosomal protein 43	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1558504	E	RGD:6480464	20200331	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of CEP43 mRNA	PMID:25270620
1313011	CEP43	centrosomal protein 43	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1558504	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of CEP43 mRNA	PMID:40826991
1313011	CEP43	centrosomal protein 43	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:D013893	Thiram results in decreased expression of CEP43 mRNA	PMID:38568856
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:138858	Azaspiracid	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C406592	azaspiracid results in increased expression of B3GNT3 mRNA	PMID:28939011
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of B3GNT3 mRNA	PMID:36331819
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of B3GNT3 mRNA	PMID:20044591
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of B3GNT3 mRNA	PMID:35811015
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313013	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of B3GNT3 mRNA	PMID:39241906
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B3GNT3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of B3GNT3 mRNA	PMID:35811015
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of B3GNT3 mRNA	PMID:38568856
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305151	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of B3GNT3 mRNA	PMID:33387578
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GNT3 mRNA	PMID:37992649
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GNT3 mRNA	PMID:37992649
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305151	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of B3GNT3 mRNA	PMID:27523638
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1313013	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of B3GNT3 mRNA	PMID:39984025
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of B3GNT3 mRNA	PMID:29950665
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of B3GNT3 mRNA	PMID:19549813
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1313013	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of B3GNT3 mRNA	PMID:31939706
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313013	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of B3GNT3 mRNA	PMID:25629700
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of B3GNT3 mRNA	PMID:23557933
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of B3GNT3 mRNA	PMID:27392435
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313013	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of B3GNT3 mRNA	PMID:32186404
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of B3GNT3 mRNA	PMID:30851411
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313013	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of B3GNT3 mRNA	PMID:30807115
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1305151	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of B3GNT3 mRNA	PMID:30556269
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GNT3 mRNA	PMID:37992649
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of B3GNT3 mRNA	PMID:29301061|PMID:32844245|PMID:38568856
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of B3GNT3 mRNA	PMID:39719251
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29678	sodium arsenite	increases methylation	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in increased methylation of B3GNT3 intron	PMID:32844245
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of B3GNT3 5' UTR; Benzo(a)pyrene affects the methylation of B3GNT3 promoter	PMID:27901495
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of B3GNT3 mRNA	PMID:22316170|PMID:26238291
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313013	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of B3GNT3 mRNA	PMID:32417428
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of B3GNT3 3' UTR	PMID:27901495
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1305151	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of B3GNT3 mRNA	PMID:30556269
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of B3GNT3 mRNA	PMID:25895662
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	B3GNT3 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of B3GNT3 mRNA	PMID:38568856
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313013	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of B3GNT3 gene	PMID:35295148
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313013	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of B3GNT3 gene	PMID:35295148
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of B3GNT3 mRNA	PMID:29950665
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305151	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of B3GNT3 mRNA	PMID:25181051
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313013	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of B3GNT3 mRNA	PMID:34585602
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:34440	4-nonylphenol	multiple interactions	EXP		E	RGD:6480464	20140311	CTD	MESH:C041594	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of B3GNT3 mRNA	PMID:23626723
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C105260	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of B3GNT3 mRNA	PMID:23626723
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of B3GNT3 mRNA	PMID:29950665
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of B3GNT3 mRNA	PMID:29024780
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C019566	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of B3GNT3 mRNA	PMID:23626723
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of B3GNT3 mRNA	PMID:38382870
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of B3GNT3 mRNA	PMID:36331819
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of B3GNT3 mRNA	PMID:25562108
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313013	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B3GNT3 mRNA	PMID:37992649
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	B3GNT3 protein affects the susceptibility to Methotrexate	PMID:16217747
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of B3GNT3 mRNA	PMID:29067470
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305151	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of B3GNT3 mRNA	PMID:33387578
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B3GNT3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of B3GNT3 mRNA	PMID:35811015
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313013	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of B3GNT3 mRNA	PMID:35436446
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305151	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of B3GNT3 mRNA	PMID:17557909
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of B3GNT3 mRNA	PMID:32234424
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	B3GNT3 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313013	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of B3GNT3 mRNA; Nanotubes, Carbon results in increased expression of B3GNT3 mRNA	PMID:25554681
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313013	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of B3GNT3 mRNA	PMID:38701926
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of B3GNT3 mRNA	PMID:28988120
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of B3GNT3 mRNA	PMID:30851411
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of B3GNT3 mRNA	PMID:31734321
1313012	B3GNT3	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of B3GNT3 mRNA	PMID:38568856
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in decreased expression of ITGA10 mRNA	PMID:31863870
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313015	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ITGA10 mRNA	PMID:33045310
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ITGA10 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of ITGA10 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ITGA10 mRNA	PMID:32699268|PMID:32845096
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ITGA10 mRNA	PMID:26079696
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ITGA10 mRNA	PMID:22378314
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ITGA10 mRNA	PMID:21632981
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ITGA10 mRNA	PMID:30510588
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305152	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ITGA10 mRNA	PMID:33387578
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ITGA10 mRNA	PMID:37042841
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of ITGA10 mRNA	PMID:34673133
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of ITGA10 mRNA	PMID:20864642|PMID:21795739
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ITGA10 mRNA	PMID:22017230
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:17650	cortisol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006854	Hydrocortisone results in increased expression of ITGA10 mRNA	PMID:21267416
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305152	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ITGA10 mRNA	PMID:26577399|PMID:27523638
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ITGA10 mRNA	PMID:36139627
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of ITGA10 mRNA	PMID:26485663
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ITGA10 mRNA	PMID:29950665
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313015	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ITGA10 mRNA	PMID:19770486
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ITGA10 gene	PMID:27153756
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ITGA10 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of ITGA10 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ITGA10 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of ITGA10 mRNA	PMID:32699268|PMID:32845096
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of ITGA10 gene] which results in increased expression of ITGA10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of ITGA10 gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ITGA10 mRNA	PMID:40504410
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:27698	vanadium atom	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of ITGA10 mRNA	PMID:19000753
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313015	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of ITGA10 mRNA	PMID:40618947
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ITGA10 mRNA	PMID:20106945|PMID:21632981
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ITGA10 mRNA	PMID:33956508
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ITGA10 mRNA	PMID:16704738
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of ITGA10 mRNA	PMID:29955902
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ITGA10 mRNA	PMID:33212167
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305152	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ITGA10 mRNA	PMID:26033743
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ITGA10 mRNA	PMID:30911355
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ITGA10 mRNA	PMID:30031762
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ITGA10 mRNA	PMID:29803840
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ITGA10 mRNA	PMID:24431212|PMID:38568856
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20220405	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of ITGA10 gene] which results in increased expression of ITGA10 mRNA; [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ITGA10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of ITGA10 gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ITGA10 mRNA	PMID:34876320|PMID:40504410
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ITGA10 mRNA	PMID:34876320
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305152	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ITGA10 mRNA	PMID:26033743
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ITGA10 mRNA	PMID:30911355
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1305152	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of ITGA10 mRNA	PMID:24915197
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ITGA10 mRNA	PMID:29264374
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ITGA10 mRNA	PMID:29950665
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305152	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ITGA10 mRNA	PMID:34492290
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305152	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ITGA10 mRNA	PMID:25181051|PMID:31129395|PMID:34947998
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ITGA10 mRNA	PMID:32156529|PMID:37894381|PMID:38074096
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313015	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of ITGA10 mRNA	PMID:20713471
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ITGA10 mRNA	PMID:39298647
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1313015	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of ITGA10 mRNA	PMID:26377693
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ITGA10 mRNA	PMID:38685157
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ITGA10 mRNA	PMID:29950665
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:35170	vanadium(0)	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of ITGA10 mRNA	PMID:19000753
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ITGA10 mRNA	PMID:38568856
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ITGA10 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ITGA10 mRNA	PMID:32699268
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of ITGA10 mRNA	PMID:20106945
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313015	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of ITGA10 mRNA	PMID:22733784
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ITGA10 mRNA	PMID:38832940
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of ITGA10 gene] which results in increased expression of ITGA10 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased methylation of ITGA10 gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ITGA10 mRNA	PMID:40504410
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ITGA10 mRNA	PMID:34876320
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:50091	S-nitrosoglutathione	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione affects the expression of ITGA10 mRNA	PMID:38825487
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313015	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ITGA10 mRNA	PMID:38701926
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305152	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of ITGA10 mRNA	PMID:28801915
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305152	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ITGA10 mRNA	PMID:37269647
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of ITGA10 mRNA	PMID:35486664
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ITGA10 mRNA	PMID:36139627
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313015	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ITGA10 mRNA	PMID:34876320
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305152	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of ITGA10 mRNA	PMID:24780913
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of ITGA10 mRNA	PMID:31863870
1313014	ITGA10	integrin subunit alpha 10	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ITGA10 mRNA	PMID:29301935
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ASB7 mRNA	PMID:26251327
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of ASB7 mRNA	PMID:20655997
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305154	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ASB7 mRNA	PMID:33387578
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ASB7 intron	PMID:30157460
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1619902	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ASB7 mRNA	PMID:36331819
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASB7 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ASB7 mRNA	PMID:39836092
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ASB7 mRNA	PMID:19549813
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1619902	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ASB7 mRNA	PMID:19770486
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of ASB7 mRNA	PMID:19774075
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ASB7 gene	PMID:25304211
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASB7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ASB7 mRNA	PMID:39836092
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1305154	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA	PMID:33854195
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ASB7 mRNA	PMID:23557933
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of ASB7 mRNA	PMID:32186404
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1619902	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASB7 mRNA	PMID:21570461
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ASB7 mRNA	PMID:30851411
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305154	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ASB7 mRNA	PMID:26033743
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1305154	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of ASB7 mRNA	PMID:26033743
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ASB7 mRNA	PMID:29803840
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASB7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ASB7 mRNA	PMID:39836092
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305154	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ASB7 mRNA	PMID:26033743
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1305154	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of ASB7 mRNA	PMID:26033743
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1619902	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of ASB7 mRNA	PMID:35295148
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ASB7 mRNA	PMID:18648102
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1619902	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of ASB7 mRNA	PMID:19136022
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in decreased expression of ASB7 mRNA	PMID:21318169
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1619902	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of ASB7 mRNA]	PMID:21318169
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ASB7 gene	PMID:31601247
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305154	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of ASB7 mRNA	PMID:32145629
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ASB7 mRNA	PMID:39298647
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ASB7 mRNA	PMID:28628672
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ASB7 intron	PMID:30157460
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASB7 mRNA	PMID:28628672
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1305154	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA	PMID:33854195
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASB7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ASB7 mRNA	PMID:28628672
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASB7 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ASB7 mRNA	PMID:39836092
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305154	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ASB7 gene	PMID:22079235
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1619902	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ASB7 mRNA	PMID:36331819
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1619902	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ASB7 mRNA	PMID:17292431
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ASB7 mRNA	PMID:23179753
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ASB7 mRNA	PMID:17183730
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1305154	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA	PMID:33854195
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASB7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ASB7 mRNA	PMID:28628672
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1619902	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of ASB7 mRNA	PMID:18502557
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1305154	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA	PMID:33854195
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ASB7 mRNA	PMID:21420995
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ASB7 mRNA	PMID:29279043
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ASB7 gene	PMID:25304211
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASB7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ASB7 mRNA	PMID:39836092
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ASB7 mRNA	PMID:35436446
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASB7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ASB7 mRNA	PMID:28628672
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1619902	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ASB7 mRNA	PMID:25554681
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ASB7 mRNA	PMID:17183730
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1305154	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA	PMID:33854195
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ASB7 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ASB7 mRNA	PMID:39836092
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ASB7 intron	PMID:30157460
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ASB7 mRNA	PMID:22206623
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ASB7 mRNA	PMID:30851411
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1619902	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ASB7 mRNA	PMID:19136022|PMID:23091169
1313017	ASB7	ankyrin repeat and SOCS box containing 7	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1619902	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of ASB7 mRNA	PMID:21278054
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:119915	fentanyl	affects expression	ISO	RGD:1305155	E	RGD:6480464	20241001	CTD	MESH:D005283	Fentanyl affects the expression of ADAMTSL3 mRNA	PMID:36032789
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ADAMTSL3 mRNA	PMID:27188386
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313019	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAMTSL3 mRNA	PMID:36331819
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ADAMTSL3 mRNA	PMID:26079696
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313019	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ADAMTSL3 mRNA	PMID:30319688
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of ADAMTSL3 protein	PMID:18951874
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ADAMTSL3 mRNA	PMID:30510588
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of ADAMTSL3 mRNA	PMID:26079696
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313019	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL3 mRNA	PMID:37992649
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased expression of ADAMTSL3 mRNA	PMID:26717081
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:17578	toluene	increases methylation	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased methylation of ADAMTSL3 gene	PMID:26717081
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313019	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL3 mRNA	PMID:37992649
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ADAMTSL3 mRNA	PMID:34319233
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305155	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ADAMTSL3 mRNA	PMID:33387578
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ADAMTSL3 intron	PMID:30157460
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ADAMTSL3 mRNA	PMID:19549813
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ADAMTSL3 mRNA	PMID:22100608
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ADAMTSL3 mRNA	PMID:40512198
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1305155	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene	PMID:33854195
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of ADAMTSL3 mRNA	PMID:41028656
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of ADAMTSL3 mRNA	PMID:40618947
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of ADAMTSL3 protein	PMID:18951874
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ADAMTSL3 mRNA	PMID:41028656
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADAMTSL3 mRNA	PMID:29803840
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADAMTSL3 mRNA	PMID:39631538
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313019	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL3 mRNA	PMID:37992649
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAMTSL3 mRNA	PMID:22714537|PMID:29301061
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAMTSL3 mRNA	PMID:37682722
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ADAMTSL3 mRNA	PMID:40512198
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADAMTSL3 intron	PMID:30157460
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADAMTSL3 mRNA	PMID:32234424
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADAMTSL3 3' UTR; Benzo(a)pyrene results in increased methylation of ADAMTSL3 5' UTR; Benzo(a)pyrene results in increased methylation of ADAMTSL3 exon; Benzo(a)pyrene results in increased methylation of ADAMTSL3 promoter	PMID:27901495
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ADAMTSL3 mRNA]	PMID:32406909
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ADAMTSL3 mRNA	PMID:41028656
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ADAMTSL3 mRNA	PMID:27131904
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ADAMTSL3 mRNA	PMID:26705709
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313019	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADAMTSL3 gene; titanium dioxide results in decreased methylation of ADAMTSL3 promoter	PMID:35295148
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313019	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of ADAMTSL3 mRNA	PMID:35295148
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313019	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ADAMTSL3 promoter	PMID:35295148
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305155	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAMTSL3 mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305155	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ADAMTSL3 gene	PMID:28505145
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305155	E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ADAMTSL3 mRNA	PMID:32119087
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313019	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ADAMTSL3 gene	PMID:31683443
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313019	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ADAMTSL3 mRNA	PMID:30951980
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ADAMTSL3 intron	PMID:30157460
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313019	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ADAMTSL3 mRNA	PMID:30951980
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313019	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ADAMTSL3 intron	PMID:28392331
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1305155	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene	PMID:33854195
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305155	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ADAMTSL3 mRNA	PMID:32680482
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305155	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of ADAMTSL3 gene	PMID:33148267
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ADAMTSL3 mRNA	PMID:38382870
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ADAMTSL3 mRNA	PMID:40194260
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313019	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAMTSL3 mRNA	PMID:36331819
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ADAMTSL3 gene	PMID:29154799
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1305155	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene	PMID:33854195
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ADAMTSL3 mRNA	PMID:28973697
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313019	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL3 mRNA	PMID:37992649
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1305155	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene	PMID:33854195
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADAMTSL3 mRNA	PMID:21420995
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305155	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADAMTSL3 mRNA	PMID:33387578
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of ADAMTSL3 mRNA	PMID:24714768
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of ADAMTSL3 mRNA	PMID:40512198
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305155	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ADAMTSL3 mRNA	PMID:29391264
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ADAMTSL3 mRNA	PMID:32234424
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ADAMTSL3 mRNA	PMID:26705709
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of ADAMTSL3 mRNA	PMID:22714537
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of ADAMTSL3 mRNA	PMID:19042947
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1305155	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene	PMID:33854195
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of ADAMTSL3 mRNA	PMID:22078008
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ADAMTSL3 intron	PMID:30157460
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305155	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of ADAMTSL3 gene	PMID:33148267
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ADAMTSL3 mRNA	PMID:22714537
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ADAMTSL3 gene]	PMID:28238834
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of ADAMTSL3 mRNA	PMID:32234424
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305155	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ADAMTSL3 mRNA	PMID:24780913
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of ADAMTSL3 mRNA	PMID:14699072
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313019	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ADAMTSL3 mRNA	PMID:27131904
1313018	ADAMTSL3	ADAMTS like 3	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ADAMTSL3 mRNA	PMID:17440010
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614364	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SMIM8 mRNA	PMID:33045310
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305158	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SMIM8 mRNA]	PMID:31150632
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SMIM8 mRNA	PMID:33167477
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D001280	Atrazine results in decreased expression of SMIM8 mRNA	PMID:22378314
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SMIM8 mRNA	PMID:37042841
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1614364	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SMIM8 mRNA	PMID:35716406
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305158	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SMIM8 mRNA	PMID:33387578
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SMIM8 mRNA	PMID:28818685
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SMIM8 mRNA	PMID:19549813
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SMIM8 gene	PMID:27153756
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1614364	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SMIM8 mRNA	PMID:34911549
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305158	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SMIM8 mRNA	PMID:31150632
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1614364	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SMIM8 mRNA	PMID:31919559
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305158	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SMIM8 mRNA]	PMID:31150632
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614364	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SMIM8 mRNA	PMID:22206623
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic affects the methylation of SMIM8 gene	PMID:25304211
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SMIM8 mRNA	PMID:23557933
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1614364	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SMIM8 mRNA	PMID:30912803
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of SMIM8 mRNA	PMID:25583101
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SMIM8 mRNA	PMID:28001369
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SMIM8 mRNA	PMID:30851411
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SMIM8 mRNA	PMID:29803840
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMIM8 mRNA	PMID:20064835
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SMIM8 promoter	PMID:27901495
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305158	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SMIM8 mRNA	PMID:25729387
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305158	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SMIM8 mRNA	PMID:34492290
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614364	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SMIM8 mRNA	PMID:33221593
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305158	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SMIM8 mRNA	PMID:36041667
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1614364	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SMIM8 mRNA	PMID:39298647
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305158	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SMIM8 mRNA	PMID:36041667
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305158	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SMIM8 mRNA	PMID:36041667
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1614364	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SMIM8 mRNA	PMID:37019170
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1614364	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of SMIM8 protein	PMID:39748354
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305158	E	RGD:6480464	20161018	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of SMIM8 promoter	PMID:22457795
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SMIM8 mRNA	PMID:24449571
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1614364	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SMIM8 mRNA	PMID:40194260
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SMIM8 mRNA	PMID:28302478
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SMIM8 mRNA	PMID:31533062
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SMIM8 mRNA	PMID:25979313
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SMIM8 mRNA	PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of SMIM8 mRNA	PMID:20106945
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:43572	kojic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of SMIM8 mRNA	PMID:16595896
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SMIM8 mRNA	PMID:27188386
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C012589	trichostatin A results in increased expression of SMIM8 mRNA	PMID:24935251
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMIM8 mRNA	PMID:27188386
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305158	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SMIM8 mRNA	PMID:33387578
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic affects the methylation of SMIM8 gene	PMID:25304211
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMIM8 mRNA	PMID:22079256
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1614364	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SMIM8 mRNA	PMID:35436446
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305158	E	RGD:6480464	20161018	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SMIM8 mRNA	PMID:25729387
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1614364	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SMIM8 mRNA	PMID:22206623
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SMIM8 mRNA	PMID:22079256
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMIM8 mRNA	PMID:22079256
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SMIM8 mRNA	PMID:30851411
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMIM8 mRNA	PMID:27188386
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1614364	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SMIM8 mRNA	PMID:31388691
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1614364	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of SMIM8 mRNA	PMID:40826991
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMIM8 mRNA	PMID:27188386
1313022	SMIM8	small integral membrane protein 8	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305158	E	RGD:6480464	20161018	CTD	MESH:C025643	vinclozolin results in increased expression of SMIM8 mRNA	PMID:23034163
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313026	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ATPAF2 mRNA	PMID:20188158
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin affects the expression of ATPAF2 mRNA	PMID:15498508
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of ATPAF2 protein	PMID:18951874
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313026	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATPAF2 mRNA	PMID:39241906
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313026	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of ATPAF2 mRNA	PMID:29980752
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATPAF2 mRNA	PMID:37042841
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305161	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATPAF2 mRNA	PMID:33387578
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313026	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATPAF2 mRNA	PMID:37236586
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1305161	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of ATPAF2 protein	PMID:33236894
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ATPAF2 mRNA	PMID:23649840
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313026	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ATPAF2 mRNA	PMID:25629700
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313026	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATPAF2 mRNA	PMID:22206623
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313026	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ATPAF2 protein	PMID:25505154
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313026	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATPAF2 mRNA	PMID:21570461
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313026	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATPAF2 mRNA	PMID:20399798
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305161	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATPAF2 mRNA	PMID:33387578
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of ATPAF2 protein	PMID:18951874
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313026	E	RGD:6480464	20121009	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ATPAF2 mRNA	PMID:21340527
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATPAF2 mRNA	PMID:29803840
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313026	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATPAF2 mRNA	PMID:26873546
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of ATPAF2 mRNA	PMID:34032870
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of ATPAF2 protein	PMID:39571964
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313026	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATPAF2 exon; Benzo(a)pyrene results in increased methylation of ATPAF2 intron	PMID:27901495
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305161	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ATPAF2 mRNA	PMID:30047161
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:32181	tamibarotene	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of ATPAF2 mRNA	PMID:15498508
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313026	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ATPAF2 mRNA	PMID:23811191
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ATPAF2 gene	PMID:31601247
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305161	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ATPAF2 mRNA	PMID:25181051
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313026	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ATPAF2 mRNA	PMID:39298647
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305161	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ATPAF2 mRNA	PMID:21266533
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313026	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ATPAF2 mRNA	PMID:34813904
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313026	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ATPAF2 mRNA	PMID:34813904
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATPAF2 mRNA	PMID:37042841
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313026	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATPAF2 mRNA	PMID:37236586
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:3764	clotrimazole	increases expression	ISO	RGD:1305161	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of ATPAF2 mRNA	PMID:30047161
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ATPAF2 gene	PMID:29154799
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ATPAF2 mRNA	PMID:23179753
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305161	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ATPAF2 mRNA	PMID:30047161
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ATPAF2 mRNA	PMID:38832940
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of ATPAF2 mRNA	PMID:25704631
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305161	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ATPAF2 mRNA	PMID:33387578
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305161	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ATPAF2 mRNA	PMID:30047161
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305161	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ATPAF2 mRNA	PMID:24793618
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305161	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ATPAF2 mRNA	PMID:24136188
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ATPAF2 protein	PMID:23718831
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of ATPAF2 mRNA	PMID:37939859
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313026	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATPAF2 mRNA	PMID:22206623
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATPAF2 gene]	PMID:28238834
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305161	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ATPAF2 mRNA	PMID:30047161
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1313026	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of ATPAF2 protein	PMID:35357534
1313025	ATPAF2	ATP synthase mitochondrial F1 complex assembly factor 2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305161	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ATPAF2 mRNA	PMID:19281266
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:16412	lipopolysaccharide	affects localization	ISO	RGD:1622291	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides affects the localization of PDIA2 protein	PMID:17475668
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1622291	E	RGD:6480464	20161228	CTD	MESH:D008070	Vaticanol B inhibits the reaction [Lipopolysaccharides affects the localization of PDIA2 protein]	PMID:17475668
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of PDIA2 mRNA	PMID:30510588
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1622291	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of PDIA2 mRNA	PMID:33711761
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PDIA2 mRNA	PMID:31163220
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1305164	E	RGD:6480464	20180828	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PDIA2 mRNA	PMID:29945229
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1622291	E	RGD:6480464	20250401	CTD	MESH:D004051	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of PDIA2 mRNA	PMID:31606821
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in decreased expression of PDIA2 protein	PMID:16440303
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of PDIA2 mRNA	PMID:36861143
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1622291	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PDIA2 mRNA	PMID:28960355
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PDIA2 mRNA	PMID:23557933
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PDIA2 mRNA	PMID:27392435
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1622291	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of PDIA2 mRNA	PMID:40618947
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PDIA2 mRNA	PMID:27392435
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1305164	E	RGD:6480464	20170613	CTD	MESH:D012402	Ellagic Acid inhibits the reaction [Rotenone results in increased nitrosation of and results in decreased activity of PDIA2 protein]; Rotenone results in increased nitrosation of and results in decreased activity of PDIA2 protein	PMID:25247703
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PDIA2 mRNA	PMID:32763439
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:29073	L-ascorbic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D001205	Ascorbic Acid results in decreased expression of PDIA2 mRNA	PMID:19197388
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PDIA2 protein	PMID:19294697
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1622291	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of PDIA2 mRNA	PMID:17127020
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PDIA2 5' UTR	PMID:27901495
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PDIA2 mRNA	PMID:22316170
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1622291	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of PDIA2 mRNA	PMID:35295148
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305164	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PDIA2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305164	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PDIA2 gene	PMID:28505145
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1622291	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of PDIA2 mRNA	PMID:40203079
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PDIA2 protein	PMID:16440303
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305164	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PDIA2 gene	PMID:22079235
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PDIA2 mRNA	PMID:24449571
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1622291	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of PDIA2 mRNA	PMID:18353800
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:3647	chlorpromazine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002746	Chlorpromazine analog results in increased expression of PDIA2 mRNA	PMID:15924885
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1305164	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of PDIA2 mRNA	PMID:22561333
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305164	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of PDIA2 mRNA	PMID:29427782
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PDIA2 gene	PMID:29154799
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PDIA2 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of PDIA2 mRNA	PMID:36861143
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:4775	ellagic acid	multiple interactions	ISO	RGD:1305164	E	RGD:6480464	20170613	CTD	MESH:D004610	Ellagic Acid inhibits the reaction [Rotenone results in increased nitrosation of and results in decreased activity of PDIA2 protein]	PMID:25247703
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of PDIA2 mRNA	PMID:40706910
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1622291	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of PDIA2 mRNA	PMID:25620056
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1622291	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PDIA2 mRNA; Nanotubes, Carbon results in decreased expression of PDIA2 mRNA	PMID:25554681|PMID:25620056
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1622291	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of PDIA2 mRNA	PMID:26377693
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:52722	lactacystin	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:C067713	lactacystin results in increased expression of PDIA2 mRNA; lactacystin results in increased expression of PDIA2 protein	PMID:15353226
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1622291	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PDIA2 mRNA	PMID:23608068
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1622291	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of PDIA2 mRNA	PMID:38701926
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305164	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of PDIA2 mRNA	PMID:20080153
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PDIA2 mRNA; 1-Methyl-4-phenylpyridinium results in increased expression of PDIA2 protein	PMID:15353226
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:6651	malathion	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in decreased expression of PDIA2 mRNA	PMID:37047231
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305164	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PDIA2 mRNA	PMID:24780913
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1622291	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of PDIA2 protein	PMID:35357534
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1622291	E	RGD:6480464	20250401	CTD	MESH:D013311	Streptozocin results in increased expression of PDIA2 mRNA	PMID:31606821
1313029	PDIA2	protein disulfide isomerase family A member 2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1622291	E	RGD:6480464	20250401	CTD	MESH:D013311	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of PDIA2 mRNA	PMID:31606821
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313032	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RANBP6 mRNA	PMID:33045310
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of RANBP6 mRNA	PMID:31016361
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313032	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RANBP6 gene	PMID:20938992
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of RANBP6 mRNA	PMID:22378314
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RANBP6 mRNA	PMID:21632981
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313032	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RANBP6 gene	PMID:20938992
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305165	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RANBP6 mRNA	PMID:26577399
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RANBP6 mRNA	PMID:28818685
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313032	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RANBP6 mRNA	PMID:36331819
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313032	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RANBP6 gene	PMID:20938992
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of RANBP6 mRNA	PMID:18414638
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RANBP6 mRNA	PMID:28960355
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RANBP6 mRNA	PMID:22574217
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of RANBP6 protein	PMID:39603559
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RANBP6 mRNA	PMID:28001369
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RANBP6 mRNA	PMID:30851411
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RANBP6 mRNA	PMID:38568856
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305165	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RANBP6 mRNA	PMID:30047161
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of RANBP6 mRNA	PMID:29264374
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313032	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RANBP6 promoter	PMID:35295148
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313032	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RANBP6 promoter	PMID:35295148
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RANBP6 mRNA	PMID:20813756
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of RANBP6 protein	PMID:31675489
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305165	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RANBP6 mRNA	PMID:25181051|PMID:29097150
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of RANBP6 protein	PMID:31675489
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of RANBP6 mRNA	PMID:19041380
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RANBP6 protein	PMID:34186270
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RANBP6 protein	PMID:34186270
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RANBP6 mRNA	PMID:37019170
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of RANBP6 mRNA	PMID:17312168
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RANBP6 mRNA	PMID:37042841
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RANBP6 mRNA	PMID:24982889
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305165	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of RANBP6 mRNA	PMID:25539665|PMID:26194646
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RANBP6 mRNA	PMID:40194260
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RANBP6 mRNA	PMID:28302478
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RANBP6 mRNA	PMID:31533062
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313032	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RANBP6 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of RANBP6 mRNA	PMID:36331819
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RANBP6 gene	PMID:29154799
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of RANBP6 mRNA	PMID:29154799
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305165	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RANBP6 mRNA	PMID:30047161
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of RANBP6 mRNA	PMID:19770486
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313032	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RANBP6 mRNA	PMID:17562736
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of RANBP6 mRNA	PMID:21420995
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of RANBP6 mRNA	PMID:18414638
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of RANBP6 mRNA	PMID:31675489
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305165	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RANBP6 mRNA	PMID:29097150
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1313032	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of RANBP6 mRNA	PMID:40234311
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of RANBP6 mRNA	PMID:22714537
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of RANBP6 mRNA	PMID:31629900
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RANBP6 protein	PMID:32959892
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305165	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of RANBP6 mRNA	PMID:30467583
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RANBP6 mRNA	PMID:30851411
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1305165	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of RANBP6 mRNA	PMID:20345932
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of RANBP6 protein	PMID:31675489
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of RANBP6 mRNA	PMID:26079696
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:84070	sodium arsenate	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in increased expression of RANBP6 protein	PMID:38348393
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1305165	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of RANBP6 mRNA	PMID:30047161
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305165	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RANBP6 mRNA	PMID:30047161|PMID:36843608
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305165	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RANBP6 mRNA	PMID:21346803
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RANBP6 mRNA	PMID:38568856
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of RANBP6 mRNA	PMID:29301935
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305165	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RANBP6 mRNA	PMID:21346803
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1305165	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of RANBP6 mRNA	PMID:30047161
1313031	RANBP6	RAN binding protein 6	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313032	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of RANBP6 mRNA	PMID:35537566
1313033	TCTN3	tectonic family member 3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TCTN3 mRNA	PMID:38218311
1313033	TCTN3	tectonic family member 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TCTN3 mRNA	PMID:33167477
1313033	TCTN3	tectonic family member 3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TCTN3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TCTN3 mRNA	PMID:32699268
1313033	TCTN3	tectonic family member 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313034	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TCTN3 mRNA	PMID:39241906
1313033	TCTN3	tectonic family member 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TCTN3 mRNA	PMID:37042841
1313033	TCTN3	tectonic family member 3	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313034	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of TCTN3 mRNA	PMID:33914522
1313033	TCTN3	tectonic family member 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TCTN3 mRNA	PMID:19549813
1313033	TCTN3	tectonic family member 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TCTN3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TCTN3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TCTN3 mRNA	PMID:32699268
1313033	TCTN3	tectonic family member 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313034	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of TCTN3 mRNA	PMID:27106289
1313033	TCTN3	tectonic family member 3	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305166	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of TCTN3 mRNA	PMID:30779732
1313033	TCTN3	tectonic family member 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313034	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TCTN3 mRNA	PMID:25629700
1313033	TCTN3	tectonic family member 3	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of TCTN3 mRNA	PMID:18414638
1313033	TCTN3	tectonic family member 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TCTN3 mRNA	PMID:23557933
1313033	TCTN3	tectonic family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313034	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TCTN3 mRNA	PMID:21570461|PMID:26377647
1313033	TCTN3	tectonic family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305166	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TCTN3 mRNA	PMID:33387578
1313033	TCTN3	tectonic family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313034	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TCTN3 mRNA	PMID:28922406
1313033	TCTN3	tectonic family member 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TCTN3 mRNA	PMID:25879800|PMID:38568856
1313033	TCTN3	tectonic family member 3	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of TCTN3 mRNA	PMID:25075043
1313033	TCTN3	tectonic family member 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313034	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TCTN3 promoter	PMID:35295148
1313033	TCTN3	tectonic family member 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305166	E	RGD:6480464	20150707	CTD	MESH:D013853	Thioacetamide results in increased expression of TCTN3 mRNA	PMID:23411599
1313033	TCTN3	tectonic family member 3	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1313034	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of TCTN3 mRNA	PMID:33914522
1313033	TCTN3	tectonic family member 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313034	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TCTN3 mRNA	PMID:38685157
1313033	TCTN3	tectonic family member 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313034	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TCTN3 mRNA	PMID:37019170
1313033	TCTN3	tectonic family member 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TCTN3 mRNA	PMID:37042841
1313033	TCTN3	tectonic family member 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TCTN3 mRNA	PMID:38174414
1313033	TCTN3	tectonic family member 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TCTN3 mRNA	PMID:19376846
1313033	TCTN3	tectonic family member 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TCTN3 mRNA	PMID:24449571
1313033	TCTN3	tectonic family member 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TCTN3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TCTN3 mRNA	PMID:32699268
1313033	TCTN3	tectonic family member 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313034	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TCTN3 mRNA	PMID:40194260
1313033	TCTN3	tectonic family member 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TCTN3 mRNA	PMID:31533062
1313033	TCTN3	tectonic family member 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TCTN3 mRNA	PMID:25979313
1313033	TCTN3	tectonic family member 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TCTN3 mRNA	PMID:23179753|PMID:29154799
1313033	TCTN3	tectonic family member 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TCTN3 mRNA	PMID:25562108
1313033	TCTN3	tectonic family member 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305166	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TCTN3 mRNA	PMID:33387578
1313033	TCTN3	tectonic family member 3	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of TCTN3 mRNA	PMID:18414638
1313033	TCTN3	tectonic family member 3	gene	CHEBI:50035	alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of TCTN3 mRNA	PMID:25075043
1313033	TCTN3	tectonic family member 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313034	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TCTN3 mRNA	PMID:19042947
1313033	TCTN3	tectonic family member 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TCTN3 mRNA	PMID:38568856
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:125472	N-(6-acetamidohexyl)acetamide	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20170228	CTD	MESH:C014026	hexamethylene bisacetamide results in decreased expression of MCM3 mRNA	PMID:26941288
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:132238	iron(III) nitrilotriacetate	increases expression	ISO	RGD:1305168	E	RGD:6480464	20160705	CTD	MESH:C020326	ferric nitrilotriacetate results in increased expression of MCM3 mRNA	PMID:23208426
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313037	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MCM3 mRNA	PMID:37995155
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MCM3 mRNA	PMID:39752319
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:134355	auraptene	affects expression	EXP		E	RGD:6480464	20170509	CTD	MESH:C105832	aurapten affects the expression of MCM3 mRNA	PMID:23320178
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:146207	palytoxin	increases expression	ISO	RGD:1313037	E	RGD:6480464	20200303	CTD	MESH:C010272	palytoxin results in increased expression of MCM3 protein	PMID:20025956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MCM3 mRNA	PMID:16054129|PMID:33167477
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D014212	Tretinoin results in increased expression of MCM3 protein	PMID:20025956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of MCM3 mRNA	PMID:26516004
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MCM3 mRNA	PMID:23410634
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of MCM3 mRNA	PMID:23727915
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:16359	cholic acid	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D019826	Cholic Acid results in increased expression of MCM3 protein	PMID:20025956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MCM3 mRNA	PMID:39241906
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of MCM3 mRNA	PMID:35877022
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305168	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of MCM3 mRNA	PMID:32145629
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:16469	17beta-estradiol	affects localization	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the localization of MCM3 protein	PMID:16966611
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of MCM3 mRNA	PMID:19167446|PMID:20049119|PMID:22494775
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305168	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MCM3 mRNA	PMID:32741896
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in decreased expression of MCM3 protein; Estradiol promotes the reaction [Progesterone affects the localization of MCM3 protein]	PMID:16966611
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM3 mRNA	PMID:25510870
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MCM3 mRNA	PMID:38568856
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MCM3 mRNA	PMID:37042841
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:16827	corticosterone	decreases expression	ISO	RGD:1305168	E	RGD:6480464	20120412	CTD	MESH:D003345	Corticosterone results in decreased expression of MCM3 mRNA	PMID:15755911
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of MCM3 mRNA	PMID:34673133
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17026	progesterone	affects localization	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the localization of MCM3 protein	PMID:16966611
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of MCM3 mRNA	PMID:16966611
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of MCM3 protein; Estradiol promotes the reaction [Progesterone affects the localization of MCM3 protein]	PMID:16966611
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of MCM3 mRNA	PMID:38160208
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM3 mRNA	PMID:37992649
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20250311	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MCM3 mRNA	PMID:33162236
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MCM3 mRNA	PMID:39752319
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MCM3 mRNA	PMID:21592394
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM3 mRNA	PMID:21592394
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305168	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MCM3 mRNA	PMID:32741896
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM3 mRNA	PMID:37992649
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313037	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MCM3 mRNA	PMID:23892564
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17750	glycine betaine	decreases expression	ISO	RGD:1305168	E	RGD:6480464	20151215	CTD	MESH:D001622	Betaine results in decreased expression of MCM3 mRNA	PMID:26391144
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305168	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MCM3 mRNA	PMID:26577399
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MCM3 protein	PMID:37730182
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MCM3 mRNA	PMID:21592394
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM3 mRNA	PMID:21592394
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17907	styrene oxide	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:C013690	styrene oxide results in increased expression of MCM3 protein	PMID:20025956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MCM3 mRNA	PMID:28818685
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MCM3 mRNA	PMID:39836092
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM3 mRNA	PMID:25510870
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM3 mRNA	PMID:25510870
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MCM3 mRNA	PMID:19549813
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MCM3 protein	PMID:23301498
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MCM3 mRNA	PMID:21641981
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MCM3 mRNA	PMID:19770486
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MCM3 mRNA	PMID:22100608
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305168	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MCM3 mRNA	PMID:23630614
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of MCM3 mRNA	PMID:25102026
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of MCM3 protein	PMID:19845377
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of MCM3 protein	PMID:20025956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MCM3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MCM3 mRNA	PMID:27106289|PMID:34911549
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:2654	aminoglutethimide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in decreased expression of MCM3 protein	PMID:26102013
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305168	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MCM3 mRNA	PMID:30779732
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313037	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MCM3 mRNA	PMID:27339419|PMID:31919559
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:2756	anthracene-1,8,9-triol	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D000875	Anthralin results in increased expression of MCM3 protein	PMID:20025956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MCM3 mRNA	PMID:39836092
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MCM3 mRNA	PMID:40504410
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:27732	caffeine	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D002110	Caffeine results in increased expression of MCM3 protein	PMID:20025956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of MCM3 mRNA	PMID:31295307
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305168	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MCM3 mRNA	PMID:31881176
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of MCM3 mRNA	PMID:19167446
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MCM3 mRNA	PMID:28903495
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of MCM3 mRNA	PMID:19921347
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305168	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of MCM3 mRNA	PMID:22023808
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of MCM3 mRNA	PMID:27594783
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:27928	parathion	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D010278	Parathion results in increased expression of MCM3 mRNA	PMID:17390078
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of MCM3 mRNA	PMID:23195993
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM3 mRNA	PMID:22574217
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313037	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM3 mRNA	PMID:21570461|PMID:26377647
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305168	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM3 mRNA	PMID:34747641
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM3 mRNA	PMID:19770486
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of MCM3 mRNA	PMID:33512557
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MCM3 mRNA	PMID:33212167
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of MCM3 mRNA	PMID:39709020
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MCM3 mRNA	PMID:32763439
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D020106	Acrylamide results in increased expression of MCM3 protein	PMID:20025956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305168	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of MCM3 mRNA	PMID:22465980
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MCM3 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of MCM3 mRNA	PMID:20971185|PMID:30911355
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313037	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of MCM3 protein	PMID:28918527
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20250204	CTD	MESH:D004317	[VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of MCM3 protein	PMID:38367682
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM3 mRNA	PMID:37992649
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28794	coumarin	increases expression	ISO	RGD:1305168	E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of MCM3 mRNA	PMID:18480146
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D024483	Vitamin K 3 affects the expression of MCM3 mRNA	PMID:20044591|PMID:23410634
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of MCM3 mRNA	PMID:22623647
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MCM3 mRNA	PMID:38568856
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313037	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in decreased methylation of MCM3 gene	PMID:32068019
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of MCM3 mRNA	PMID:28595984|PMID:34032870
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MCM3 mRNA	PMID:39836092
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MCM3 mRNA	PMID:40504410
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MCM3 mRNA	PMID:22378314
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCM3 mRNA	PMID:20064835
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCM3 mRNA	PMID:19770486
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MCM3 mRNA	PMID:32234424|PMID:33411230
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MCM3 mRNA	PMID:20713471
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305168	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of MCM3 mRNA	PMID:22465980
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MCM3 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of MCM3 mRNA	PMID:20971185|PMID:30911355
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of MCM3 mRNA	PMID:26014281
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MCM3 mRNA	PMID:20382639
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MCM3 mRNA	PMID:34413873
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:30808	iron trichloride	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:C024555	ferric chloride results in increased expression of MCM3 protein	PMID:20025956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:30812	iron dichloride	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:C029451	ferrous chloride results in increased expression of MCM3 protein	PMID:20025956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1305168	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of MCM3 mRNA	PMID:32479839
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305168	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of MCM3 mRNA	PMID:25729387
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305168	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM3 mRNA	PMID:25729387
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:32111	saccharin	increases expression	ISO	RGD:1313037	E	RGD:6480464	20121009	CTD	MESH:D012439	Saccharin results in increased expression of MCM3 mRNA	PMID:19000923
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:32130	silver(1+) nitrate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in decreased expression of MCM3 mRNA	PMID:22831968
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1313037	E	RGD:6480464	20121009	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MCM3 mRNA	PMID:19000923
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313037	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MCM3 mRNA	PMID:23557971
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305168	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MCM3 mRNA	PMID:23411599|PMID:34492290
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of MCM3 mRNA	PMID:19136022
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313037	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MCM3 mRNA	PMID:17950772|PMID:18301758|PMID:19136022|PMID:20813756|PMID:23811191
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of MCM3 mRNA]	PMID:17950772
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of MCM3 mRNA	PMID:38479592
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MCM3 mRNA	PMID:30903817
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305168	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of MCM3 mRNA	PMID:32145629
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MCM3 mRNA; bisphenol A results in decreased expression of MCM3 protein	PMID:29275510|PMID:31675489|PMID:37567409
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305168	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MCM3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A results in increased expression of MCM3 mRNA; bisphenol A results in increased expression of MCM3 protein	PMID:22494775|PMID:33516137
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MCM3 protein	PMID:31675489
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MCM3 mRNA	PMID:25979313
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of MCM3 mRNA	PMID:26682919
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM3 mRNA	PMID:25510870
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM3 mRNA	PMID:25510870
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of MCM3 mRNA	PMID:20713471
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	ISO	RGD:1313037	E	RGD:6480464	20121009	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of MCM3 mRNA	PMID:19000923
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of MCM3 mRNA	PMID:20713471
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MCM3 mRNA	PMID:40203079
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MCM3 mRNA	PMID:26377693
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D016264	Dextran Sulfate results in increased expression of MCM3 protein	PMID:20025956|PMID:35362542
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of MCM3 protein]	PMID:35362542
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MCM3 mRNA	PMID:17361019|PMID:21266533
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to MCM3 protein	PMID:32991956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20180703	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of MCM3 mRNA	PMID:21404309
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MCM3 mRNA	PMID:17854601
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MCM3 mRNA]	PMID:17854601
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of MCM3 protein	PMID:39748354
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MCM3 mRNA	PMID:37042841
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MCM3 mRNA	PMID:39836092
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313037	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MCM3 mRNA	PMID:26377693
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1305168	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of MCM3 mRNA	PMID:18500788
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305168	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MCM3 mRNA	PMID:30723492
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MCM3 mRNA	PMID:38174414|PMID:38568856
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MCM3 protein	PMID:26879310
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305168	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of MCM3 mRNA	PMID:25539665
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20140311	CTD	MESH:D011285	[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Pregnenolone Carbonitrile] results in increased expression of MCM3 mRNA	PMID:23626729
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MCM3 mRNA	PMID:19320972|PMID:19376846
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:3647	chlorpromazine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002746	Chlorpromazine analog results in decreased expression of MCM3 mRNA	PMID:15924885
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:37415	alpha-amanitin	affects expression	ISO	RGD:1313037	E	RGD:6480464	20240903	CTD	MESH:D053959	Alpha-Amanitin affects the expression of MCM3 mRNA	PMID:38531469
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	ISO	RGD:1313037	E	RGD:6480464	20121009	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of MCM3 mRNA	PMID:19000923
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MCM3 mRNA	PMID:40194260
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MCM3 mRNA	PMID:31533062
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of MCM3 mRNA	PMID:19167446
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of MCM3 mRNA	PMID:19167446
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MCM3 mRNA	PMID:39529242
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1305168	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of MCM3 mRNA	PMID:22110744
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of MCM3 mRNA	PMID:21427059
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of MCM3 mRNA	PMID:21427059
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305168	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of MCM3 mRNA	PMID:41580965
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MCM3 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313037	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MCM3 mRNA	PMID:28973697
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM3 mRNA	PMID:37992649
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of MCM3 mRNA	PMID:33512557
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C012589	trichostatin A results in decreased expression of MCM3 mRNA	PMID:19606018|PMID:23770000
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MCM3 mRNA	PMID:17562736
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305168	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of MCM3 mRNA	PMID:32479839|PMID:33387578
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MCM3 mRNA	PMID:22230336
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of MCM3 protein	PMID:20025956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of MCM3 mRNA	PMID:16709241
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of MCM3 mRNA]	PMID:15016801
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:47032	1,4-dioxane	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120918	CTD	MESH:C025223	1,4-dioxane results in increased expression of MCM3 protein	PMID:20025956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MCM3 mRNA	PMID:39836092
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MCM3 mRNA	PMID:40504410
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of MCM3 protein]	PMID:35362542
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MCM3 mRNA	PMID:34413873
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:49976	zinc dichloride	increases expression	ISO	RGD:1313037	E	RGD:6480464	20121009	CTD	MESH:C016837	zinc chloride results in increased expression of MCM3 mRNA	PMID:19000923
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313037	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MCM3 mRNA; Nanotubes, Carbon results in increased expression of MCM3 mRNA	PMID:25554681|PMID:25620056
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313037	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of MCM3 mRNA	PMID:40234311
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MCM3 mRNA	PMID:35964746
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313037	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MCM3 mRNA	PMID:19042947
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1313037	E	RGD:6480464	20180703	CTD	MESH:D010081	Oxazolone results in increased expression of MCM3 mRNA	PMID:21404309
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1313037	E	RGD:6480464	20180703	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of MCM3 mRNA	PMID:21404309
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313037	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MCM3 mRNA	PMID:38701926
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MCM3 protein	PMID:32959892
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of MCM3 mRNA	PMID:19606018
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305168	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of MCM3 mRNA	PMID:20080153
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MCM3 mRNA	PMID:39836092
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305168	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MCM3 mRNA	PMID:25729387
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305168	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM3 mRNA	PMID:25729387
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:64090	tert-butyl hydroperoxide	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D020122	tert-Butylhydroperoxide affects the expression of MCM3 mRNA	PMID:23410634
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MCM3 mRNA	PMID:15336504
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305168	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of MCM3 mRNA	PMID:35283115
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:6918	Mezerein	increases expression	ISO	RGD:1313037	E	RGD:6480464	20141111	CTD	MESH:C011309	mezerein results in increased expression of MCM3 mRNA	PMID:19000923
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313037	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of MCM3 mRNA	PMID:27462272
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D002185	Cannabidiol results in decreased expression of MCM3 mRNA	PMID:36519830
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of MCM3 mRNA	PMID:22101062
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MCM3 mRNA	PMID:39752319
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313037	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MCM3 mRNA	PMID:22206623
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MCM3 protein	PMID:37664457
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of MCM3 mRNA	PMID:29522793
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:754951	siponimod	increases expression	ISO	RGD:1313037	E	RGD:6480464	20260714	CTD	MESH:C578989	siponimod results in increased expression of MCM3 mRNA	PMID:29556671
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MCM3 protein	PMID:31285264
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305168	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MCM3 mRNA	PMID:32741896
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of MCM3 mRNA	PMID:12517777
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305168	E	RGD:6480464	20130312	CTD	MESH:C025589	ochratoxin A results in increased expression of MCM3 mRNA	PMID:23208426
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:78870	sodium nitrite	increases expression	ISO	RGD:1313037	E	RGD:6480464	20140708	CTD	MESH:D012977	Sodium Nitrite results in increased expression of MCM3 protein	PMID:20025956
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:79516	Nonylphenol	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C025256	nonylphenol results in increased expression of MCM3 mRNA; nonylphenol results in increased expression of MCM3 protein	PMID:33516137
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MCM3 gene]	PMID:28238834
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:79995	GW 3965	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C473027	GW 3965 results in decreased expression of MCM3 mRNA	PMID:31437187
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MCM3 mRNA	PMID:19159669
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313037	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of MCM3 mRNA	PMID:19136022
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313037	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of MCM3 mRNA	PMID:19136022|PMID:23091169
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1313037	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of MCM3 mRNA	PMID:18958704
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:81543	Tributyltin oxide	decreases phosphorylation	ISO	RGD:1313037	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased phosphorylation of MCM3 protein	PMID:22174045
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM3 mRNA	PMID:19167446
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MCM3 protein	PMID:31675489
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of MCM3 mRNA	PMID:21858171
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:82615	diminazene diaceturate	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C003915	diminazene aceturate results in decreased expression of MCM3 mRNA	PMID:37681557
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of MCM3 mRNA	PMID:33512557
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313037	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MCM3 mRNA	PMID:39847705
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305168	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MCM3 mRNA	PMID:24780913
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313037	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MCM3 mRNA	PMID:39752319
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:90724	AM-251	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C103505	AM 251 results in decreased expression of MCM3 mRNA	PMID:16500647
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1305168	E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of MCM3 mRNA	PMID:32419051
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MCM3 protein	PMID:37664457
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of MCM3 mRNA	PMID:26014281
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MCM3 mRNA	PMID:38568856
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of MCM3 mRNA	PMID:22378314
1313036	MCM3	minichromosome maintenance complex component 3	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of MCM3 mRNA	PMID:19140230
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313039	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of PANK2 mRNA	PMID:33045310
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1305169	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PANK2 mRNA	PMID:30071829
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of PANK2 mRNA	PMID:33167477
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PANK2 mRNA	PMID:21632981
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PANK2 mRNA	PMID:39836092
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:18388	apigenin	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20121113	CTD	MESH:D047310	Apigenin results in decreased expression of PANK2 mRNA	PMID:22359648
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313039	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PANK2 mRNA	PMID:37236586
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PANK2 mRNA	PMID:23649840
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PANK2 gene	PMID:27153756
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PANK2 mRNA	PMID:23649840
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PANK2 mRNA	PMID:35430440
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PANK2 mRNA	PMID:18593933
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PANK2 mRNA	PMID:25629700
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313039	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PANK2 mRNA	PMID:22206623
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PANK2 gene	PMID:25304211
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PANK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PANK2 mRNA	PMID:39836092
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of PANK2 protein	PMID:35688186
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of PANK2 mRNA	PMID:27594783
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PANK2 mRNA	PMID:24768652|PMID:25583101
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313039	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PANK2 mRNA	PMID:21570461
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313039	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PANK2 mRNA	PMID:17942748
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PANK2 mRNA	PMID:28001369
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PANK2 mRNA	PMID:33212167
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of PANK2 mRNA	PMID:23649840
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PANK2 mRNA	PMID:32763439
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PANK2 mRNA	PMID:38568856
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PANK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PANK2 mRNA	PMID:39836092
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PANK2 mRNA	PMID:18593933
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PANK2 mRNA	PMID:19150397
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313039	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PANK2 mRNA	PMID:39716349
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313039	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of PANK2 mRNA	PMID:17656681
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313039	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PANK2 promoter	PMID:35295148
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PANK2 mRNA	PMID:18648102
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313039	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PANK2 mRNA	PMID:18301758
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305169	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PANK2 mRNA	PMID:25181051|PMID:30816183
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PANK2 mRNA	PMID:25979313
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PANK2 mRNA	PMID:39298647
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PANK2 mRNA	PMID:21266533
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PANK2 mRNA	PMID:37042841
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PANK2 mRNA	PMID:39836092
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313039	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PANK2 mRNA	PMID:37236586
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PANK2 mRNA	PMID:19376846
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PANK2 mRNA	PMID:28302478
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PANK2 mRNA	PMID:31533062
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PANK2 mRNA	PMID:27188386
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PANK2 gene	PMID:29154799
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313039	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in increased expression of PANK2 mRNA	PMID:19136453
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of PANK2 mRNA	PMID:19770486
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of PANK2 mRNA	PMID:23649840
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PANK2 mRNA	PMID:27188386
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of PANK2 mRNA	PMID:25704631
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PANK2 gene	PMID:25304211
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PANK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PANK2 mRNA	PMID:39836092
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313039	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PANK2 mRNA	PMID:17942748
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313039	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PANK2 mRNA	PMID:39716349
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305169	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of PANK2 mRNA	PMID:34044035
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PANK2 mRNA	PMID:39836092
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PANK2 mRNA	PMID:31758290
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PANK2 mRNA	PMID:22206623
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313039	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PANK2 mRNA	PMID:22206623
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313039	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of PANK2 mRNA	PMID:31558096
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:8249	piroxicam	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of PANK2 mRNA	PMID:21858171
1313038	PANK2	pantothenate kinase 2	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of PANK2 mRNA	PMID:27188386
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313042	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PCDHB3 mRNA	PMID:37995155
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PCDHB3 mRNA	PMID:22378314
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305171	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PCDHB3 mRNA	PMID:33387578
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305171	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PCDHB3 mRNA	PMID:33387578
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDHB3 gene	PMID:27153756
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PCDHB3 exon	PMID:30157460
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313042	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PCDHB3 mRNA	PMID:25629700
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305171	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDHB3 mRNA	PMID:33387578
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of PCDHB3 mRNA	PMID:22378314
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDHB3 exon	PMID:27901495
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313042	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PCDHB3 mRNA	PMID:22228805
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PCDHB3 promoter	PMID:27901495
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1305171	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of PCDHB3 mRNA	PMID:32479839
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313042	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PCDHB3 mRNA	PMID:19710929
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305171	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PCDHB3 mRNA	PMID:19167457
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305171	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDHB3 mRNA	PMID:34947998
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305171	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PCDHB3 mRNA	PMID:25181051
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of PCDHB3 gene	PMID:31601247
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305171	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PCDHB3 gene	PMID:22079235
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PCDHB3 mRNA	PMID:31533062
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313042	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PCDHB3 mRNA	PMID:17292431
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PCDHB3 mRNA	PMID:38832940
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305171	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PCDHB3 mRNA	PMID:33387578
1313041	PCDHB3	protocadherin beta 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDHB3 gene]	PMID:28238834
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of SNAPC3 mRNA	PMID:26272509
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAPC3 mRNA	PMID:27188386
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313044	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SNAPC3 mRNA	PMID:33045310
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313044	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNAPC3 gene	PMID:20938992
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313044	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SNAPC3 mRNA	PMID:30529165
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SNAPC3 mRNA	PMID:22378314
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of SNAPC3 mRNA	PMID:18951874
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305172	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SNAPC3 mRNA	PMID:33387578
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313044	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNAPC3 gene	PMID:20938992
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SNAPC3 mRNA	PMID:16949557
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC3 mRNA	PMID:39836092
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SNAPC3 mRNA	PMID:16949557
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SNAPC3 gene	PMID:27153756
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SNAPC3 mRNA	PMID:27153756
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313044	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SNAPC3 mRNA	PMID:19770486
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SNAPC3 intron	PMID:30157460
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313044	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNAPC3 gene	PMID:20938992
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNAPC3 mRNA	PMID:39836092
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:27899	cisplatin	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	SNAPC3 protein results in increased susceptibility to Cisplatin	PMID:16734730
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:28088	genistein	increases methylation	ISO	RGD:1305172	E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of SNAPC3 gene	PMID:28505145
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of SNAPC3 mRNA	PMID:23195993
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313044	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNAPC3 mRNA	PMID:21570461
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313044	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNAPC3 mRNA	PMID:15034205|PMID:21354282
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SNAPC3 mRNA	PMID:28001369
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SNAPC3 mRNA	PMID:33212167
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SNAPC3 mRNA	PMID:39709020
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of SNAPC3 mRNA	PMID:23649840
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SNAPC3 mRNA	PMID:29803840
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of SNAPC3 mRNA	PMID:29319823
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNAPC3 mRNA	PMID:39836092
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313044	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SNAPC3 mRNA	PMID:15034205
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SNAPC3 promoter	PMID:27901495
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313044	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNAPC3 mRNA	PMID:22228805
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313044	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SNAPC3 mRNA	PMID:19073995
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in decreased expression of SNAPC3 mRNA	PMID:34973136
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313044	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNAPC3 gene	PMID:35295148
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305172	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SNAPC3 mRNA	PMID:34492290
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313044	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SNAPC3 mRNA	PMID:20813756
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313044	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of SNAPC3 mRNA	PMID:32156529
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305172	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNAPC3 mRNA	PMID:25181051|PMID:30816183
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:3423	carmustine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in increased expression of SNAPC3 mRNA	PMID:15980968
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SNAPC3 mRNA	PMID:28628672
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SNAPC3 mRNA	PMID:28628672
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SNAPC3 mRNA	PMID:37042841
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC3 mRNA	PMID:39836092
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SNAPC3 mRNA	PMID:24449571
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SNAPC3 mRNA	PMID:31533062
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of SNAPC3 mRNA	PMID:19167446
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of SNAPC3 mRNA	PMID:23179753|PMID:26272509
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in increased expression of SNAPC3 mRNA	PMID:25192806|PMID:28001369
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAPC3 mRNA	PMID:27188386
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SNAPC3 mRNA	PMID:28628672
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305172	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SNAPC3 mRNA	PMID:33387578
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313044	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SNAPC3 mRNA	PMID:29279043
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNAPC3 mRNA	PMID:39836092
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313044	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of SNAPC3 mRNA	PMID:30529165
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313044	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SNAPC3 mRNA	PMID:30529165
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SNAPC3 mRNA	PMID:28628672
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313044	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SNAPC3 mRNA; Nanotubes, Carbon results in increased expression of SNAPC3 mRNA	PMID:25554681
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1305172	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of SNAPC3 mRNA	PMID:23962444
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305172	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of SNAPC3 mRNA	PMID:20080153
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SNAPC3 mRNA	PMID:39836092
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SNAPC3 mRNA	PMID:31758290
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAPC3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAPC3 mRNA	PMID:27188386
1313043	SNAPC3	small nuclear RNA activating complex polypeptide 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAPC3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SNAPC3 mRNA	PMID:27188386
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of GTF3C5 mRNA	PMID:38218311
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313046	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GTF3C5 mRNA	PMID:39241906
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313046	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of GTF3C5 mRNA	PMID:34319233
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GTF3C5 mRNA	PMID:23649840
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313046	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GTF3C5 mRNA	PMID:22206623
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GTF3C5 mRNA	PMID:39836092
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of GTF3C5 protein	PMID:35688186
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of GTF3C5 mRNA	PMID:27594783
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313046	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GTF3C5 mRNA	PMID:21570461
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305173	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GTF3C5 mRNA	PMID:21215274
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of GTF3C5 mRNA	PMID:33212167
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of GTF3C5 protein	PMID:21925251
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite co-treated with lead acetate] results in decreased expression of GTF3C5 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GTF3C5 mRNA	PMID:38072110|PMID:39836092
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GTF3C5 promoter	PMID:27901495
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313046	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GTF3C5 exon; Benzo(a)pyrene results in increased methylation of GTF3C5 intron	PMID:27901495
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in decreased expression of GTF3C5 protein	PMID:38072110
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313046	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GTF3C5 gene	PMID:35295148
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313046	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of GTF3C5 mRNA	PMID:18648102
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305173	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of GTF3C5 mRNA	PMID:25181051
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313046	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of GTF3C5 mRNA	PMID:37019170
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GTF3C5 mRNA	PMID:37042841
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of GTF3C5 mRNA	PMID:31626844
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313046	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of GTF3C5 mRNA	PMID:17292431|PMID:17963808
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GTF3C5 gene	PMID:29154799
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GTF3C5 mRNA	PMID:38832940
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313046	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GTF3C5 mRNA	PMID:17562736
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of GTF3C5 mRNA	PMID:22230336
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GTF3C5 mRNA	PMID:39836092
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GTF3C5 protein	PMID:32959892
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313046	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GTF3C5 mRNA	PMID:22206623
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of GTF3C5 protein	PMID:37664457
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of GTF3C5 mRNA	PMID:30559759
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313046	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of GTF3C5 mRNA	PMID:30294300
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305173	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of GTF3C5 mRNA	PMID:23640034
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:90724	AM-251	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C103505	AM 251 results in decreased expression of GTF3C5 mRNA	PMID:16500647
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of GTF3C5 protein	PMID:37664457
1313045	GTF3C5	general transcription factor IIIC subunit 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305173	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GTF3C5 mRNA	PMID:21346803
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305174	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAGOH mRNA]	PMID:31150632
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of MAGOH mRNA	PMID:16249480|PMID:21934132
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313048	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MAGOH mRNA	PMID:30319688
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313048	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MAGOH mRNA	PMID:30319688
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313048	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MAGOH mRNA	PMID:39241906
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [MAGOH protein binds to ESR1 protein]	PMID:27156127
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305174	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MAGOH mRNA	PMID:33387578
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:166595	Yessotoxin	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in decreased expression of MAGOH mRNA	PMID:30679557
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313048	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MAGOH mRNA	PMID:23892564
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305174	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MAGOH mRNA	PMID:22061828
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAGOH mRNA	PMID:36331819
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MAGOH mRNA	PMID:39836092
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305174	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of MAGOH mRNA	PMID:21396975
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MAGOH mRNA	PMID:19770486
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305174	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAGOH mRNA	PMID:31150632
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313048	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAGOH mRNA	PMID:27339419|PMID:31919559
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305174	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAGOH mRNA]	PMID:31150632
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAGOH mRNA	PMID:22206623
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:27504	mitomycin C	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	MAGOH protein affects the susceptibility to Mitomycin	PMID:16217747
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MAGOH mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAGOH mRNA	PMID:39836092
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MAGOH mRNA	PMID:23557933
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313048	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of MAGOH mRNA	PMID:30912803
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313048	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAGOH mRNA	PMID:21570461
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MAGOH mRNA	PMID:17101203
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305174	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAGOH mRNA	PMID:34747641
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAGOH mRNA	PMID:17942748
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAGOH mRNA	PMID:17942748
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MAGOH mRNA	PMID:24690739
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MAGOH mRNA	PMID:38568856
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MAGOH mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAGOH mRNA	PMID:39836092
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAGOH mRNA	PMID:20504355
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MAGOH promoter	PMID:27901495
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAGOH mRNA	PMID:22228805
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MAGOH mRNA	PMID:24690739
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAGOH mRNA	PMID:20018196
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305174	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of MAGOH mRNA	PMID:24136188
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of MAGOH mRNA	PMID:21829687
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305174	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAGOH mRNA	PMID:25729387
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305174	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MAGOH mRNA	PMID:30047161
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313048	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MAGOH promoter	PMID:35295148
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305174	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MAGOH mRNA	PMID:34492290
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MAGOH mRNA	PMID:18648102
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MAGOH mRNA; bisphenol A results in decreased expression of MAGOH protein	PMID:29275510|PMID:31675489
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MAGOH mRNA	PMID:33221593
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of MAGOH protein	PMID:34186270
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305174	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MAGOH mRNA	PMID:25181051|PMID:32145629
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313048	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MAGOH mRNA	PMID:32156529
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of MAGOH protein	PMID:31675489
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of MAGOH protein	PMID:34186270
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313048	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MAGOH mRNA	PMID:39298647
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MAGOH mRNA	PMID:38685157
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MAGOH mRNA	PMID:37019170
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MAGOH mRNA	PMID:17361019
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313048	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MAGOH mRNA	PMID:34813904
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MAGOH mRNA	PMID:37042841
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MAGOH mRNA	PMID:39836092
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MAGOH mRNA	PMID:38568856
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MAGOH mRNA	PMID:19376846
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MAGOH mRNA	PMID:24449571
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MAGOH protein	PMID:26178269
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAGOH mRNA	PMID:36331819
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MAGOH mRNA	PMID:25979313
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of MAGOH mRNA	PMID:29154799
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305174	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MAGOH mRNA	PMID:30047161
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MAGOH mRNA	PMID:20106945
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MAGOH mRNA	PMID:17555576
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305174	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of MAGOH mRNA	PMID:24136188
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of MAGOH mRNA	PMID:27188386
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAGOH mRNA	PMID:17562736
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of MAGOH mRNA	PMID:24690739
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MAGOH mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAGOH mRNA	PMID:39836092
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of MAGOH mRNA	PMID:22077320
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of MAGOH mRNA	PMID:31675489
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313048	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of MAGOH mRNA	PMID:35436446
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MAGOH mRNA	PMID:17555576
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MAGOH mRNA	PMID:17942748
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAGOH mRNA	PMID:17942748
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305174	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MAGOH mRNA	PMID:24136188
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305174	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MAGOH mRNA	PMID:30047161
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MAGOH mRNA	PMID:35964746
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305174	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MAGOH mRNA	PMID:24136188
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MAGOH mRNA	PMID:19042947
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MAGOH mRNA	PMID:39836092
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:1305174	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of MAGOH mRNA	PMID:24136188
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305174	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAGOH mRNA	PMID:25729387
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1313048	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of MAGOH mRNA	PMID:28444820
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313048	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAGOH mRNA	PMID:22206623
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305174	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MAGOH mRNA	PMID:24136188
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313048	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of MAGOH mRNA	PMID:30294300
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MAGOH protein	PMID:31675489
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MAGOH protein	PMID:31675489
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:8249	piroxicam	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of MAGOH mRNA	PMID:21858171
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313048	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of MAGOH mRNA	PMID:21278054
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305174	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of MAGOH mRNA	PMID:30047161
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MAGOH mRNA	PMID:38568856
1313047	MAGOH	mago homolog, exon junction complex subunit	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1305174	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of MAGOH mRNA	PMID:30047161
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of C9ORF78 mRNA	PMID:22378314
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of C9ORF78 protein	PMID:35688186
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of C9ORF78 protein	PMID:37730182
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of C9ORF78 mRNA	PMID:28818685
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of C9ORF78 mRNA	PMID:39836092
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of C9ORF78 mRNA	PMID:22171008
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of C9ORF78 mRNA	PMID:39836092
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of C9ORF78 protein	PMID:35688186
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of C9ORF78 mRNA	PMID:27392435
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of C9ORF78 mRNA	PMID:33212167
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of C9ORF78 mRNA	PMID:39836092
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of C9ORF78 mRNA	PMID:22171008
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305178	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of C3H9ORF78 mRNA	PMID:34492290
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305178	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of C9ORF78 mRNA	PMID:25181051
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of C9ORF78 mRNA	PMID:39836092
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of C9ORF78 mRNA	PMID:28302478
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of C9ORF78 mRNA	PMID:31533062
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of C9ORF78 mRNA	PMID:25562108
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of C9ORF78 mRNA	PMID:22230336
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of C9ORF78 mRNA	PMID:39836092
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of C9ORF78 protein	PMID:32959892
1313051	C9orf78	chromosome 9 open reading frame 78	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of C9ORF78 mRNA	PMID:39836092
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of PBXIP1 protein	PMID:39638853
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313055	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PBXIP1 mRNA	PMID:33045310
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PBXIP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PBXIP1 mRNA	PMID:32699268
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313055	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PBXIP1 mRNA	PMID:36331819
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PBXIP1 mRNA	PMID:26079696
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313055	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PBXIP1 mRNA	PMID:30319688
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PBXIP1 mRNA	PMID:39241906
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of PBXIP1 mRNA	PMID:31614463
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313055	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PBXIP1 mRNA	PMID:39298647
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313055	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of PBXIP1 mRNA	PMID:33711761
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PBXIP1 mRNA	PMID:38568856
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PBXIP1 mRNA	PMID:23649840
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313055	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PBXIP1 mRNA	PMID:33754040
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305180	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PBXIP1 mRNA	PMID:22061828
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PBXIP1 mRNA	PMID:28818685
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PBXIP1 mRNA	PMID:39836092
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305180	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of PBXIP1 protein	PMID:34915118
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of PBXIP1 mRNA	PMID:27462272
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PBXIP1 mRNA	PMID:23649840
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305180	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of PBXIP1 mRNA	PMID:21396975
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305180	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PBXIP1 mRNA	PMID:22129741
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PBXIP1 mRNA	PMID:23649840
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PBXIP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PBXIP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PBXIP1 mRNA	PMID:32699268
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305180	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of PBXIP1 mRNA	PMID:30779732
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313055	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PBXIP1 mRNA	PMID:17484886
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305180	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PBXIP1 mRNA	PMID:31150632
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PBXIP1 mRNA	PMID:39836092
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of PBXIP1 protein	PMID:38460933
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in decreased expression of PBXIP1 protein	PMID:37834424
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PBXIP1 mRNA	PMID:27392435
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PBXIP1 mRNA	PMID:27392435
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PBXIP1 mRNA	PMID:30912803
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PBXIP1 mRNA	PMID:22298810
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305180	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PBXIP1 mRNA	PMID:21215274
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PBXIP1 mRNA	PMID:33956508
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305180	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PBXIP1 mRNA	PMID:34747641
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of PBXIP1 protein	PMID:39603559
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PBXIP1 protein	PMID:33212167
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of PBXIP1 mRNA	PMID:23649840
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PBXIP1 mRNA	PMID:32763439
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313055	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of PBXIP1 mRNA	PMID:39631538
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of PBXIP1 protein	PMID:35688186
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of PBXIP1 mRNA	PMID:29301061
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PBXIP1 mRNA	PMID:39836092
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PBXIP1 promoter	PMID:27901495
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PBXIP1 mRNA	PMID:25895662
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305180	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PBXIP1 mRNA	PMID:24136188
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:31767	lead diacetate	affects expression	ISO	RGD:1305180	E	RGD:6480464	20120918	CTD	MESH:C008261	lead acetate affects the expression of PBXIP1 mRNA	PMID:21864555
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305180	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of PBXIP1 mRNA	PMID:23411599|PMID:34492290
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PBXIP1 mRNA	PMID:18648102
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305180	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PBXIP1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of PBXIP1 protein	PMID:34186270
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of PBXIP1 mRNA	PMID:19244175
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of PBXIP1 protein	PMID:34186270
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PBXIP1 protein	PMID:34186270
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305180	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PBXIP1 mRNA	PMID:21266533
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305180	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of PBXIP1 mRNA	PMID:22129741
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in decreased expression of PBXIP1 protein	PMID:34064677
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PBXIP1 mRNA	PMID:37042841
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PBXIP1 mRNA	PMID:39836092
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PBXIP1 protein	PMID:26879310
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PBXIP1 mRNA	PMID:19376846
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PBXIP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PBXIP1 mRNA	PMID:32699268
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of PBXIP1 mRNA	PMID:23811191
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PBXIP1 mRNA	PMID:32588087
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PBXIP1 mRNA	PMID:28302478
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PBXIP1 mRNA	PMID:31533062
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313055	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PBXIP1 mRNA	PMID:36331819
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313055	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PBXIP1 mRNA	PMID:17292431
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PBXIP1 mRNA	PMID:23179753|PMID:26272509
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of PBXIP1 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313055	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in increased expression of PBXIP1 mRNA	PMID:20546886
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PBXIP1 mRNA	PMID:27188386
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305180	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of PBXIP1 mRNA	PMID:41580965
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PBXIP1 mRNA	PMID:20106945|PMID:25562108
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313055	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PBXIP1 mRNA	PMID:28973697
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of PBXIP1 mRNA	PMID:23649840
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305180	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of PBXIP1 mRNA	PMID:24136188
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PBXIP1 mRNA	PMID:38832940
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of PBXIP1 mRNA	PMID:24935251
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313055	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PBXIP1 mRNA	PMID:17562736
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of PBXIP1 protein	PMID:38460933
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PBXIP1 mRNA	PMID:39836092
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305180	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PBXIP1 mRNA	PMID:29391264
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of PBXIP1 mRNA	PMID:38568856
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PBXIP1 mRNA; Nanotubes, Carbon results in decreased expression of PBXIP1 mRNA	PMID:25554681
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305180	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of PBXIP1 mRNA	PMID:24136188
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PBXIP1 protein	PMID:23718831
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PBXIP1 protein	PMID:32959892
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PBXIP1 mRNA	PMID:39836092
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PBXIP1 mRNA	PMID:25270620
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of PBXIP1 mRNA	PMID:28988120
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313055	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PBXIP1 mRNA	PMID:22776087
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:67895	corosolic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of PBXIP1 mRNA	PMID:37939859
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313055	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of PBXIP1 mRNA	PMID:26307267
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PBXIP1 protein	PMID:34186270
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305180	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PBXIP1 mRNA	PMID:24136188
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of PBXIP1 mRNA	PMID:36318118
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PBXIP1 mRNA	PMID:27188386
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:80630	irinotecan	decreases response to substance	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	PBXIP1 protein results in decreased susceptibility to Irinotecan	PMID:16734730
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of PBXIP1 mRNA	PMID:26079696
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313055	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of PBXIP1 mRNA	PMID:21278054
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PBXIP1 mRNA	PMID:27188386
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305180	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PBXIP1 mRNA	PMID:19281266
1313054	PBXIP1	PBX homeobox interacting protein 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305180	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PBXIP1 mRNA	PMID:21346803
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A12 mRNA	PMID:18313992
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SLC25A12 mRNA	PMID:26272509
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313057	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SLC25A12 mRNA	PMID:33045310
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305181	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC25A12 mRNA]	PMID:31150632
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC25A12 mRNA	PMID:36331819
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SLC25A12 mRNA	PMID:22378314
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313057	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SLC25A12 mRNA	PMID:30319688
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SLC25A12 mRNA	PMID:21632981
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of SLC25A12 mRNA	PMID:30510588
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305181	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SLC25A12 mRNA	PMID:32145629
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313057	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SLC25A12 mRNA	PMID:39298647
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLC25A12 mRNA	PMID:37042841
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1305181	E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of SLC25A12 mRNA	PMID:24349266
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1305181	E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of SLC25A12 mRNA	PMID:24349266
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SLC25A12 protein	PMID:31163220
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313057	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SLC25A12 mRNA	PMID:19850644
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of SLC25A12 mRNA]	PMID:19850644
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305181	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SLC25A12 mRNA	PMID:22061828
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SLC25A12 mRNA	PMID:28818685
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC25A12 mRNA	PMID:36331819
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SLC25A12 mRNA	PMID:19549813
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1313057	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of SLC25A12 mRNA	PMID:19376150
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305181	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC25A12 mRNA	PMID:31150632
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313057	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SLC25A12 mRNA	PMID:31919559
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305181	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC25A12 mRNA]	PMID:31150632
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A12 mRNA	PMID:22206623
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SLC25A12 mRNA	PMID:19244175
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SLC25A12 mRNA	PMID:26272509
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin affects the reaction [Piroxicam results in decreased expression of SLC25A12 mRNA]	PMID:21858171
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313057	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC25A12 mRNA	PMID:21570461
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305181	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC25A12 mRNA	PMID:21215274
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305181	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC25A12 mRNA	PMID:33387578
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC25A12 mRNA	PMID:17942748
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SLC25A12 mRNA	PMID:33212167
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SLC25A12 mRNA	PMID:39709020
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305181	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SLC25A12 mRNA	PMID:28959563
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLC25A12 mRNA	PMID:29803840
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC25A12 mRNA; sodium arsenite results in decreased expression of SLC25A12 protein	PMID:38228842|PMID:38568856
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305181	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC25A12 protein	PMID:29459688
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC25A12 mRNA	PMID:34032870
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1305181	E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC25A12 protein	PMID:38266420
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC25A12 mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313057	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SLC25A12 intron	PMID:27901495
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SLC25A12 mRNA	PMID:19150397
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313057	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC25A12 gene	PMID:35295148
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305181	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC25A12 mRNA	PMID:34492290
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC25A12 mRNA	PMID:19710929
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305181	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SLC25A12 mRNA	PMID:25181051
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305181	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC25A12 mRNA	PMID:30816183
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of SLC25A12 protein	PMID:34186270|PMID:37567409
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SLC25A12 mRNA	PMID:19244175
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SLC25A12 mRNA	PMID:25979313
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313057	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SLC25A12 mRNA	PMID:39298647
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SLC25A12 intron	PMID:30157460
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC25A12 mRNA	PMID:37042841
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SLC25A12 mRNA	PMID:19320972
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SLC25A12 mRNA	PMID:19244175
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SLC25A12 mRNA	PMID:28302478
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313057	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SLC25A12 protein	PMID:26178269
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC25A12 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC25A12 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLC25A12 mRNA	PMID:36331819
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313057	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SLC25A12 mRNA	PMID:17292431
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC25A12 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:29154799
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC25A12 mRNA	PMID:25562108
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313057	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC25A12 mRNA	PMID:19770486
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313057	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SLC25A12 mRNA	PMID:28973697
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1305181	E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of SLC25A12 mRNA	PMID:24349266
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:43602	obeticholic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of SLC25A12 mRNA	PMID:27939613
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SLC25A12 mRNA	PMID:38832940
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SLC25A12 mRNA	PMID:24935251
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen affects the expression of SLC25A12 mRNA	PMID:25704631
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313057	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLC25A12 mRNA	PMID:17562736
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305181	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC25A12 mRNA	PMID:33387578
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305181	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SLC25A12 mRNA	PMID:29391264
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC25A12 mRNA	PMID:22079256
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313057	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SLC25A12 mRNA	PMID:35436446
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC25A12 mRNA	PMID:17942748
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313057	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SLC25A12 mRNA; Nanotubes, Carbon results in increased expression of SLC25A12 mRNA	PMID:25620056
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SLC25A12 protein	PMID:32959892
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in decreased expression of SLC25A12 mRNA	PMID:18313992
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305181	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of SLC25A12 mRNA	PMID:24136188
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20200331	CTD	MESH:D012970	[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in decreased expression of SLC25A12 mRNA	PMID:20111022
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SLC25A12 intron	PMID:30157460
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SLC25A12 mRNA	PMID:31758290
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SLC25A12 protein	PMID:34186270
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313057	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC25A12 mRNA	PMID:22206623
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313057	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A12 mRNA	PMID:22206623
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SLC25A12 mRNA	PMID:22079256
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC25A12 mRNA	PMID:22079256
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313057	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SLC25A12 mRNA	PMID:30294300
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1305181	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of SLC25A12 protein	PMID:28903499
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of SLC25A12 mRNA	PMID:21858171
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin affects the reaction [Piroxicam results in decreased expression of SLC25A12 mRNA]	PMID:21858171
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1305181	E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of SLC25A12 mRNA	PMID:26923065
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of SLC25A12 mRNA	PMID:26272509
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A12 mRNA	PMID:27188386
1313056	SLC25A12	solute carrier family 25 member 12	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SLC25A12 mRNA	PMID:38568856
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of COL8A2 mRNA	PMID:26272509|PMID:27188386
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL8A2 mRNA	PMID:27188386
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313059	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COL8A2 mRNA	PMID:33045310
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of COL8A2 gene	PMID:20938992
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of COL8A2 mRNA	PMID:15982314
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of COL8A2 mRNA	PMID:22378314
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of COL8A2 mRNA	PMID:30510588
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of COL8A2 gene	PMID:20938992
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in increased expression of COL8A2 mRNA	PMID:28937961
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of COL8A2 mRNA	PMID:18070364
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA	PMID:37567420
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1305182	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of COL8A2 mRNA	PMID:22967744
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA	PMID:37567420
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305182	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of COL8A2 mRNA	PMID:33387578
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of COL8A2 intron	PMID:30157460
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of COL8A2 intron	PMID:30157460
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of COL8A2 mRNA	PMID:41430723
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of COL8A2 mRNA	PMID:34911549
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of COL8A2 mRNA	PMID:19774075
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of COL8A2 gene	PMID:20938992
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of COL8A2 mRNA	PMID:32525701
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA	PMID:37567420
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305182	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COL8A2 mRNA	PMID:34747641
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313059	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in decreased expression of COL8A2 mRNA	PMID:35032568
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA	PMID:37567420
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of COL8A2 exon; Benzo(a)pyrene affects the methylation of COL8A2 intron	PMID:27901495|PMID:30157460
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313059	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COL8A2 3' UTR; Benzo(a)pyrene results in increased methylation of COL8A2 exon	PMID:27901495
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of COL8A2 mRNA	PMID:19128835|PMID:26705709
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1305182	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of COL8A2 mRNA	PMID:24395379
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305182	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of COL8A2 mRNA	PMID:25729387
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313059	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of COL8A2 mRNA	PMID:29264374
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313059	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of COL8A2 promoter	PMID:35295148
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313059	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of COL8A2 gene	PMID:35295148
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313059	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of COL8A2 mRNA	PMID:20813756
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305182	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of COL8A2 mRNA	PMID:25181051|PMID:34947998|PMID:38750585|PMID:41034487
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305182	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of COL8A2 mRNA	PMID:30816183|PMID:41034487
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313059	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of COL8A2 mRNA	PMID:30951980|PMID:32156529|PMID:35598803
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313059	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S affects the expression of COL8A2 mRNA	PMID:30951980
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of COL8A2 exon; benzo(e)pyrene results in increased methylation of COL8A2 intron	PMID:30157460
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:34575	bisphenol F	affects expression	ISO	RGD:1313059	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F affects the expression of COL8A2 mRNA	PMID:30951980
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1313059	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of COL8A2 intron	PMID:28392331
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:34682	diazinon	increases expression	ISO	RGD:1305182	E	RGD:6480464	20180410	CTD	MESH:D003976	Diazinon results in increased expression of COL8A2 mRNA	PMID:29108742
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of COL8A2 mRNA	PMID:28628672
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305182	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of COL8A2 mRNA	PMID:32680482
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of COL8A2 mRNA	PMID:39241906
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313059	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of COL8A2 mRNA	PMID:40194260
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COL8A2 mRNA	PMID:25979313
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of COL8A2 gene	PMID:29154799
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of COL8A2 mRNA	PMID:28628672
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA	PMID:37567420
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of COL8A2 mRNA	PMID:29523930
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of COL8A2 mRNA	PMID:32525701
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of COL8A2 mRNA	PMID:28628672
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of COL8A2 mRNA	PMID:19128835|PMID:26705709
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of COL8A2 mRNA	PMID:21856257
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313059	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of COL8A2 mRNA; Nanotubes, Carbon results in decreased expression of COL8A2 mRNA	PMID:25554681
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:50648	9-cis-retinoic acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in increased expression of COL8A2 mRNA	PMID:15982314
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313059	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of COL8A2 mRNA	PMID:23608068
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of COL8A2 mRNA	PMID:15982314
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of COL8A2 mRNA	PMID:15336504
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of COL8A2 exon; Methapyrilene results in increased methylation of COL8A2 intron	PMID:30157460
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA	PMID:37567420
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL8A2 mRNA	PMID:27188386
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:80656	all-trans-4-oxoretinoic acid	decreases expression	EXP		E	RGD:6480464	20150120	CTD	MESH:C002202	4-oxoretinoic acid results in decreased expression of COL8A2 mRNA	PMID:15982314
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313059	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of COL8A2 mRNA	PMID:38648751
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of COL8A2 mRNA	PMID:19095052
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of COL8A2 mRNA	PMID:32525701
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305182	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of COL8A2 mRNA	PMID:36843608
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313059	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of COL8A2 mRNA	PMID:39241906
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL8A2 mRNA	PMID:27188386
1313058	COL8A2	collagen type VIII alpha 2 chain	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of COL8A2 mRNA	PMID:29301935
1313060	CEP76	centrosomal protein 76	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CEP76 mRNA	PMID:38218311
1313060	CEP76	centrosomal protein 76	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313061	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CEP76 mRNA	PMID:26251327
1313060	CEP76	centrosomal protein 76	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1313061	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of CEP76 promoter	PMID:26251327
1313060	CEP76	centrosomal protein 76	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of CEP76 mRNA	PMID:21934132|PMID:33167477
1313060	CEP76	centrosomal protein 76	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313061	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CEP76 mRNA	PMID:22629407
1313060	CEP76	centrosomal protein 76	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313061	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of CEP76 mRNA]	PMID:22629407
1313060	CEP76	centrosomal protein 76	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313061	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CEP76 mRNA	PMID:30319688
1313060	CEP76	centrosomal protein 76	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313061	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CEP76 mRNA	PMID:39241906
1313060	CEP76	centrosomal protein 76	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313061	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of CEP76 mRNA	PMID:29980752
1313060	CEP76	centrosomal protein 76	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CEP76 mRNA	PMID:37042841
1313060	CEP76	centrosomal protein 76	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CEP76 mRNA	PMID:23649840
1313060	CEP76	centrosomal protein 76	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of CEP76 mRNA	PMID:18070364
1313060	CEP76	centrosomal protein 76	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CEP76 protein	PMID:37730182
1313060	CEP76	centrosomal protein 76	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305183	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CEP76 mRNA	PMID:33387578
1313060	CEP76	centrosomal protein 76	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CEP76 mRNA	PMID:28818685
1313060	CEP76	centrosomal protein 76	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CEP76 intron	PMID:30157460
1313060	CEP76	centrosomal protein 76	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313061	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEP76 mRNA	PMID:37325564
1313060	CEP76	centrosomal protein 76	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CEP76 mRNA	PMID:23649840
1313060	CEP76	centrosomal protein 76	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1313061	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of CEP76 mRNA	PMID:19376150
1313060	CEP76	centrosomal protein 76	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305183	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEP76 mRNA	PMID:22129741
1313060	CEP76	centrosomal protein 76	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CEP76 protein	PMID:20106945
1313060	CEP76	centrosomal protein 76	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CEP76 mRNA	PMID:21641981|PMID:22100608|PMID:27153756
1313060	CEP76	centrosomal protein 76	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305183	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CEP76 mRNA	PMID:23630614|PMID:25378103
1313060	CEP76	centrosomal protein 76	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313061	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CEP76 mRNA	PMID:19770486
1313060	CEP76	centrosomal protein 76	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CEP76 intron	PMID:30157460
1313060	CEP76	centrosomal protein 76	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CEP76 mRNA	PMID:23649840
1313060	CEP76	centrosomal protein 76	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CEP76 mRNA	PMID:35430440
1313060	CEP76	centrosomal protein 76	gene	CHEBI:2682	amphotericin B	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of CEP76 mRNA	PMID:28534445
1313060	CEP76	centrosomal protein 76	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305183	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of CEP76 mRNA	PMID:31129395
1313060	CEP76	centrosomal protein 76	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305183	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CEP76 mRNA	PMID:31150632
1313060	CEP76	centrosomal protein 76	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313061	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of CEP76 mRNA	PMID:40618947
1313060	CEP76	centrosomal protein 76	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CEP76 mRNA	PMID:27392435
1313060	CEP76	centrosomal protein 76	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CEP76 mRNA	PMID:27392435
1313060	CEP76	centrosomal protein 76	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CEP76 mRNA	PMID:30851411
1313060	CEP76	centrosomal protein 76	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305183	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CEP76 mRNA	PMID:28959563
1313060	CEP76	centrosomal protein 76	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of CEP76 protein	PMID:35688186
1313060	CEP76	centrosomal protein 76	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CEP76 mRNA	PMID:32234424
1313060	CEP76	centrosomal protein 76	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CEP76 mRNA	PMID:26238291
1313060	CEP76	centrosomal protein 76	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305183	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of CEP76 mRNA	PMID:25729387
1313060	CEP76	centrosomal protein 76	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305183	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CEP76 mRNA	PMID:25729387
1313060	CEP76	centrosomal protein 76	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313061	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CEP76 enhancer; titanium dioxide results in decreased methylation of CEP76 gene	PMID:35295148
1313060	CEP76	centrosomal protein 76	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305183	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CEP76 mRNA	PMID:23411599|PMID:34492290
1313060	CEP76	centrosomal protein 76	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313061	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CEP76 mRNA	PMID:19710929
1313060	CEP76	centrosomal protein 76	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305183	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CEP76 mRNA	PMID:25181051
1313060	CEP76	centrosomal protein 76	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305183	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CEP76 mRNA	PMID:30816183|PMID:32145629|PMID:32528016
1313060	CEP76	centrosomal protein 76	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305183	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of CEP76 mRNA	PMID:31129395
1313060	CEP76	centrosomal protein 76	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313061	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CEP76 mRNA	PMID:39298647
1313060	CEP76	centrosomal protein 76	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313061	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CEP76 mRNA	PMID:38685157
1313060	CEP76	centrosomal protein 76	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305183	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CEP76 mRNA	PMID:22129741
1313060	CEP76	centrosomal protein 76	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CEP76 mRNA	PMID:37042841
1313060	CEP76	centrosomal protein 76	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313061	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEP76 mRNA	PMID:37325564
1313060	CEP76	centrosomal protein 76	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CEP76 mRNA	PMID:19376846
1313060	CEP76	centrosomal protein 76	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CEP76 mRNA	PMID:31533062
1313060	CEP76	centrosomal protein 76	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CEP76 mRNA	PMID:25979313
1313060	CEP76	centrosomal protein 76	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CEP76 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1313060	CEP76	centrosomal protein 76	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CEP76 gene	PMID:29154799
1313060	CEP76	centrosomal protein 76	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CEP76 mRNA	PMID:38832940
1313060	CEP76	centrosomal protein 76	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CEP76 mRNA	PMID:28542535
1313060	CEP76	centrosomal protein 76	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CEP76 mRNA	PMID:22230336
1313060	CEP76	centrosomal protein 76	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305183	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CEP76 mRNA	PMID:33387578
1313060	CEP76	centrosomal protein 76	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305183	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CEP76 mRNA	PMID:29391264
1313060	CEP76	centrosomal protein 76	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313061	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CEP76 mRNA	PMID:35436446
1313060	CEP76	centrosomal protein 76	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of CEP76 mRNA	PMID:18175754
1313060	CEP76	centrosomal protein 76	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305183	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of CEP76 mRNA	PMID:30307764
1313060	CEP76	centrosomal protein 76	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313061	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CEP76 mRNA	PMID:25554681
1313060	CEP76	centrosomal protein 76	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305183	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CEP76 mRNA	PMID:30047161
1313060	CEP76	centrosomal protein 76	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305183	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of CEP76 mRNA	PMID:25729387
1313060	CEP76	centrosomal protein 76	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305183	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CEP76 mRNA	PMID:25729387
1313060	CEP76	centrosomal protein 76	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of CEP76 mRNA	PMID:28988120
1313060	CEP76	centrosomal protein 76	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1313061	E	RGD:6480464	20200317	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CEP76 mRNA	PMID:22078008
1313060	CEP76	centrosomal protein 76	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313061	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CEP76 mRNA	PMID:22206623
1313060	CEP76	centrosomal protein 76	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CEP76 mRNA	PMID:37199045
1313060	CEP76	centrosomal protein 76	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CEP76 mRNA	PMID:30851411
1313060	CEP76	centrosomal protein 76	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313061	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CEP76 mRNA	PMID:31388691
1313060	CEP76	centrosomal protein 76	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305183	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CEP76 mRNA	PMID:23914054
1313060	CEP76	centrosomal protein 76	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305183	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CEP76 mRNA	PMID:24780913
1313060	CEP76	centrosomal protein 76	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305183	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CEP76 mRNA	PMID:30047161
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DBNDD2 mRNA	PMID:38218311
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1323207	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of DBNDD2 mRNA	PMID:33045310
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1323207	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DBNDD2 mRNA	PMID:20938992
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of DBNDD2 mRNA	PMID:23724009
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of DBNDD2 mRNA	PMID:26079696
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of DBNDD2 mRNA	PMID:30510588
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of DBNDD2 mRNA	PMID:30165855
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1323207	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DBNDD2 mRNA	PMID:20938992
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of DBNDD2 mRNA	PMID:21795739
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1323207	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DBNDD2 mRNA	PMID:37992649
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1323207	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DBNDD2 mRNA	PMID:37992649
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1559521	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DBNDD2 mRNA	PMID:33387578
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DBNDD2 mRNA	PMID:28818685
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of DBNDD2 intron	PMID:30157460
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DBNDD2 mRNA	PMID:39836092
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1323207	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of DBNDD2 mRNA	PMID:24067728
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1323207	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of DBNDD2 mRNA	PMID:25629700
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1323207	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DBNDD2 mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of DBNDD2 mRNA]	PMID:20938992|PMID:22206623
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DBNDD2 mRNA	PMID:39836092
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1323207	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of DBNDD2 mRNA	PMID:28960355
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1559521	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DBNDD2 mRNA	PMID:31881176
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of DBNDD2 mRNA	PMID:28903495
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of DBNDD2 mRNA	PMID:23300844
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of DBNDD2 mRNA	PMID:27392435
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of DBNDD2 mRNA	PMID:18847459
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1323207	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DBNDD2 mRNA	PMID:21570461
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1559521	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DBNDD2 mRNA	PMID:22298810
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1559521	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DBNDD2 mRNA	PMID:21215274|PMID:34747641
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1559521	E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of DBNDD2 mRNA]	PMID:21215274
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of DBNDD2 mRNA	PMID:33512557
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1323207	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DBNDD2 mRNA	PMID:37992649
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DBNDD2 mRNA	PMID:39836092
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DBNDD2 promoter	PMID:27901495
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DBNDD2 5' UTR	PMID:27901495
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DBNDD2 mRNA	PMID:26238291
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1323207	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DBNDD2 mRNA	PMID:22228805
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:29866	arsenite(3-)	affects expression	EXP		E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of DBNDD2 mRNA	PMID:22959463
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of DBNDD2 mRNA	PMID:26238291
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1323207	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DBNDD2 promoter	PMID:35295148
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1559521	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DBNDD2 mRNA	PMID:23411599
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1559521	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DBNDD2 mRNA	PMID:25380136
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1323207	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of DBNDD2 mRNA	PMID:17426115
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:33128	C60 fullerene	affects expression	ISO	RGD:1559521	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 affects the expression of DBNDD2 mRNA	PMID:19167457
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1559521	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DBNDD2 mRNA	PMID:25181051|PMID:30816183
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1559521	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DBNDD2 mRNA	PMID:36041667
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1559521	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DBNDD2 mRNA	PMID:36041667
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1559521	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DBNDD2 mRNA	PMID:36041667
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1323207	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DBNDD2 mRNA	PMID:32715474
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DBNDD2 mRNA	PMID:39836092
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1559521	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of DBNDD2 mRNA	PMID:25380136
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1559521	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of DBNDD2 promoter	PMID:22457795
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1559521	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of DBNDD2 mRNA	PMID:25380136
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1559521	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of DBNDD2 mRNA	PMID:38685447
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D016572	Cyclosporine results in increased expression of DBNDD2 mRNA	PMID:33631201
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of DBNDD2 mRNA	PMID:33512557
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1323207	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DBNDD2 mRNA	PMID:28973697
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1323207	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DBNDD2 mRNA	PMID:37992649
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of DBNDD2 mRNA	PMID:33512557
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DBNDD2 mRNA	PMID:38832940
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1323207	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DBNDD2 mRNA	PMID:17562736
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1559521	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DBNDD2 mRNA	PMID:33387578
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	DBNDD2 protein affects the susceptibility to Fluorouracil	PMID:16217747
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DBNDD2 mRNA	PMID:39836092
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of DBNDD2 mRNA	PMID:23300844
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1323207	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DBNDD2 mRNA	PMID:25554681
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1559521	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of DBNDD2 mRNA	PMID:23962444
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DBNDD2 mRNA	PMID:39836092
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1323207	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of DBNDD2 mRNA	PMID:23650126
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1323207	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DBNDD2 mRNA	PMID:22206623
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1323207	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of DBNDD2 mRNA]	PMID:22206623
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of DBNDD2 mRNA	PMID:33512557
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of DBNDD2 mRNA	PMID:26079696
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1323207	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of DBNDD2 mRNA	PMID:39847705
1313063	DBNDD2	dysbindin domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1559521	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DBNDD2 mRNA	PMID:24780913|PMID:25825206
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of UBAP1 mRNA	PMID:38218311
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313065	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of UBAP1 mRNA	PMID:33045310
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305186	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBAP1 mRNA]	PMID:31150632
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBAP1 mRNA	PMID:19074003
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of UBAP1 mRNA	PMID:33167477
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313065	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of UBAP1 mRNA	PMID:36331819
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313065	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of UBAP1 mRNA	PMID:39241906
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of UBAP1 mRNA	PMID:38568856
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of UBAP1 mRNA	PMID:37042841
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1313065	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of UBAP1 mRNA	PMID:17945193
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313065	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of UBAP1 mRNA	PMID:23892564
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305186	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of UBAP1 mRNA	PMID:33387578
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313065	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of UBAP1 mRNA	PMID:28111341
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of UBAP1 mRNA	PMID:19549813
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of UBAP1 protein	PMID:23301498
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of UBAP1 mRNA	PMID:41430723
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of UBAP1 mRNA	PMID:18593933
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305186	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBAP1 mRNA	PMID:31150632
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313065	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBAP1 mRNA	PMID:31919559
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305186	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of UBAP1 mRNA]	PMID:31150632
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of UBAP1 protein	PMID:35688186
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1305186	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of UBAP1 gene	PMID:35440735
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313065	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBAP1 mRNA	PMID:21570461
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313065	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBAP1 mRNA	PMID:15328365
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of UBAP1 mRNA	PMID:29432896
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UBAP1 mRNA	PMID:38568856
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313065	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBAP1 mRNA	PMID:19770486
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of UBAP1 mRNA	PMID:18593933
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313065	E	RGD:6480464	20150127	CTD	MESH:C008261	lead acetate results in increased expression of UBAP1 mRNA	PMID:25270620
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313065	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBAP1 gene	PMID:35295148
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305186	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of UBAP1 mRNA	PMID:25181051
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of UBAP1 gene	PMID:31601247
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305186	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of UBAP1 mRNA	PMID:30816183|PMID:32528016
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of UBAP1 gene	PMID:31601247
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UBAP1 mRNA	PMID:28628672
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UBAP1 mRNA	PMID:28628672
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305186	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of UBAP1 mRNA	PMID:18164116
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBAP1 mRNA	PMID:37042841
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBAP1 mRNA	PMID:38568856
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305186	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of UBAP1 promoter	PMID:22457795
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313065	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of UBAP1 mRNA	PMID:28111341
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of UBAP1 mRNA	PMID:19376846
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313065	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of UBAP1 mRNA	PMID:28962523
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313065	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of UBAP1 mRNA	PMID:18353800
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of UBAP1 mRNA	PMID:31533062
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313065	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of UBAP1 mRNA	PMID:36331819
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UBAP1 mRNA	PMID:25979313
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313065	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of UBAP1 mRNA	PMID:17292431
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of UBAP1 mRNA	PMID:28001369
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of UBAP1 mRNA	PMID:25562108
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UBAP1 mRNA	PMID:28628672
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313065	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UBAP1 mRNA	PMID:17562736
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313065	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of UBAP1 mRNA	PMID:29279043
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305186	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of UBAP1 mRNA	PMID:29391264
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of UBAP1 mRNA	PMID:28628672
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313065	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of UBAP1 mRNA	PMID:35964746
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305186	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBAP1 mRNA	PMID:24136188|PMID:24793618
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305186	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of UBAP1 mRNA	PMID:20080153
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305186	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of UBAP1 mRNA	PMID:28801915
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313065	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of UBAP1 mRNA	PMID:23650126
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313065	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of UBAP1 mRNA	PMID:19751817
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:6443	levonorgestrel	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBAP1 mRNA	PMID:19074003
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:7438	N-methylformamide	affects expression	ISO	RGD:1313065	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide affects the expression of UBAP1 mRNA; methylformamide analog affects the expression of UBAP1 mRNA	PMID:17040096
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1305186	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of UBAP1 mRNA	PMID:18164116
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of UBAP1 mRNA	PMID:24921660
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305186	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of UBAP1 mRNA	PMID:21346803
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of UBAP1 mRNA	PMID:38568856
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of UBAP1 mRNA	PMID:29301935
1313064	UBAP1	ubiquitin associated protein 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305186	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of UBAP1 mRNA	PMID:21346803
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GPR31 mRNA	PMID:35811015
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1616350	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GPR31B mRNA	PMID:39241906
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GPR31 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of GPR31 mRNA	PMID:35811015
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305187	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR31 mRNA	PMID:32741896
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305187	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR31 mRNA	PMID:32741896
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1305187	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of GPR31 mRNA	PMID:28522335
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1616350	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of GPR31B mRNA	PMID:28189721|PMID:28960355
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305187	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of GPR31 mRNA	PMID:31881176
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of GPR31 mRNA	PMID:23557933
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of GPR31 gene	PMID:28589171
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GPR31 promoter	PMID:27901495
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1616350	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the expression of GPR31B mRNA	PMID:35295148
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305187	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GPR31 mRNA	PMID:34492290
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305187	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GPR31 mRNA	PMID:25181051
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305187	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GPR31 gene	PMID:28505145
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GPR31 mRNA	PMID:25562108
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GPR31 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of GPR31 mRNA	PMID:35811015
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305187	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of GPR31 mRNA	PMID:35283115
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305187	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GPR31 mRNA	PMID:32741896
1313066	GPR31	G protein-coupled receptor 31	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GPR31 gene]	PMID:28238834
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MGAT5B mRNA	PMID:38218311
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1618017	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MGAT5B mRNA	PMID:33045310
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1618017	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of MGAT5B mRNA	PMID:20188158
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MGAT5B mRNA	PMID:26079696
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1618017	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MGAT5B mRNA	PMID:30319688
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1618017	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of MGAT5B mRNA	PMID:30319688
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MGAT5B mRNA	PMID:30165855
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305188	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of MGAT5B mRNA	PMID:27523638
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305188	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MGAT5B mRNA	PMID:26577399
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305188	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MGAT5B mRNA	PMID:33387578
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1618017	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of MGAT5B intron	PMID:27776689
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT5B mRNA	PMID:27188386
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618017	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MGAT5B mRNA	PMID:21570461
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MGAT5B mRNA	PMID:32763439
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1618017	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of MGAT5B mRNA	PMID:39631538
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MGAT5B promoter	PMID:27901495
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MGAT5B 3' UTR	PMID:27901495
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MGAT5B exon	PMID:27901495
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of MGAT5B promoter	PMID:23974009
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1618017	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of MGAT5B mRNA	PMID:29264374
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1618017	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MGAT5B gene	PMID:35295148
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of MGAT5B gene	PMID:31601247
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305188	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MGAT5B mRNA	PMID:25181051
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1618017	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of MGAT5B mRNA	PMID:32156529
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of MGAT5B mRNA	PMID:27685785
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305188	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of MGAT5B mRNA	PMID:41034487
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305188	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MGAT5B gene	PMID:28505145
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1618017	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MGAT5B promoter	PMID:27312807
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1618017	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of MGAT5B intron	PMID:28392331
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of MGAT5B gene	PMID:22964155
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MGAT5B mRNA	PMID:40419075
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MGAT5B mRNA	PMID:23179753
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of MGAT5B promoter	PMID:27989131
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:46024	trichostatin A	increases expression	ISO	RGD:1618017	E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of MGAT5B mRNA	PMID:24619417
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D004726	Endosulfan results in increased expression of MGAT5B mRNA	PMID:30090376
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305188	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of MGAT5B mRNA	PMID:30307764
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1618017	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of MGAT5B mRNA	PMID:38701926
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305188	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of MGAT5B mRNA	PMID:28801915
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MGAT5B mRNA	PMID:26378955
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305188	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MGAT5B gene	PMID:35440735
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:6980	monocrotaline	increases expression	ISO	RGD:1618017	E	RGD:6480464	20171114	CTD	MESH:D016686	Monocrotaline results in increased expression of MGAT5B mRNA	PMID:28818515
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT5B mRNA	PMID:27188386
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MGAT5B gene]	PMID:28238834
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305188	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MGAT5B mRNA	PMID:24780913
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT5B mRNA	PMID:27188386
1313067	MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305188	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of MGAT5B gene	PMID:31682807
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of SLC25A51 mRNA	PMID:35967413
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305190	E	RGD:6480464	20211116	CTD	MESH:D004237	Diuron results in decreased expression of SLC25A51 mRNA	PMID:21551480
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305190	E	RGD:6480464	20220111	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC25A51 mRNA]	PMID:31150632
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of SLC25A51 mRNA]	PMID:19467301
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SLC25A51 mRNA	PMID:30529165
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D001280	Atrazine results in decreased expression of SLC25A51 mRNA	PMID:22378314
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:16136	hydrogen sulfide	increases expression	ISO	RGD:1623784	E	RGD:6480464	20181113	CTD	MESH:D006862	Hydrogen Sulfide results in increased expression of SLC25A51 protein	PMID:29932956
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SLC25A51 mRNA	PMID:21179406
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of SLC25A51 mRNA	PMID:18951874
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SLC25A51 mRNA	PMID:39298647
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC25A51 mRNA	PMID:38568856
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1623784	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SLC25A51 mRNA	PMID:23892564
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A51 mRNA	PMID:39150890
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305190	E	RGD:6480464	20211116	CTD	MESH:D005839	Gentamicins results in decreased expression of SLC25A51 mRNA	PMID:22061828|PMID:33387578
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SLC25A51 mRNA	PMID:19549813
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLC25A51 mRNA	PMID:21641981
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SLC25A51 mRNA	PMID:18593933
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305190	E	RGD:6480464	20220111	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC25A51 mRNA	PMID:31150632
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305190	E	RGD:6480464	20220111	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC25A51 mRNA]	PMID:31150632
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SLC25A51 mRNA	PMID:21867686
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A51 mRNA	PMID:22206623
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC25A51 mRNA	PMID:39836092
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SLC25A51 mRNA	PMID:28189721|PMID:28960355
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SLC25A51 mRNA	PMID:23557933
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305190	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC25A51 mRNA	PMID:33387578
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20220111	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC25A51 mRNA	PMID:25975270
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SLC25A51 mRNA	PMID:28001369
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLC25A51 mRNA	PMID:29803840
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC25A51 mRNA	PMID:39836092
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC25A51 mRNA	PMID:26238291
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of SLC25A51 protein	PMID:37955338
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SLC25A51 mRNA	PMID:18593933
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SLC25A51 mRNA	PMID:19073995
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623784	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC25A51 gene; titanium dioxide results in decreased methylation of SLC25A51 promoter	PMID:35295148
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305190	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC25A51 mRNA	PMID:34492290
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1623784	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SLC25A51 mRNA	PMID:18445702
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305190	E	RGD:6480464	20220111	CTD	MESH:C006780	bisphenol A results in increased expression of SLC25A51 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SLC25A51 mRNA	PMID:25979313
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SLC25A51 mRNA	PMID:26682919
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1623784	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of SLC25A51 mRNA	PMID:39298647
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SLC25A51 mRNA	PMID:28392331
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A51 mRNA	PMID:39150890
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1623784	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SLC25A51 mRNA	PMID:37019170
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A51 mRNA	PMID:39150890
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A51 mRNA	PMID:39150890
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:1623784	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of SLC25A51 mRNA	PMID:25270620
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305190	E	RGD:6480464	20211116	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of SLC25A51 promoter	PMID:22457795
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A51 mRNA	PMID:39150890
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305190	E	RGD:6480464	20211116	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SLC25A51 mRNA	PMID:19162173
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1623784	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SLC25A51 mRNA	PMID:28903501
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1623784	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of SLC25A51 mRNA	PMID:18353800
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of SLC25A51 mRNA	PMID:17585979
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C100187	chloropicrin results in increased expression of SLC25A51 mRNA	PMID:26352163|PMID:28476498
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305190	E	RGD:6480464	20211116	CTD	MESH:C016104	sodium bichromate results in increased expression of SLC25A51 mRNA	PMID:22561333
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SLC25A51 gene	PMID:29154799
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140722	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC25A51 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A51 mRNA	PMID:27188386
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D016572	Cyclosporine results in increased expression of SLC25A51 mRNA	PMID:25562108
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1623784	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SLC25A51 mRNA	PMID:20937368
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1623784	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SLC25A51 mRNA	PMID:28973697
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC25A51 mRNA	PMID:25704631
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SLC25A51 mRNA	PMID:29523930
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC25A51 mRNA	PMID:39836092
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of SLC25A51 mRNA	PMID:30529165
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of SLC25A51 mRNA	PMID:24383545
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305190	E	RGD:6480464	20220111	CTD	MESH:C082360	fipronil results in increased expression of SLC25A51 mRNA	PMID:23962444
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305190	E	RGD:6480464	20211116	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of SLC25A51 mRNA	PMID:19162173
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305190	E	RGD:6480464	20220111	CTD	MESH:D005485	Flutamide results in decreased expression of SLC25A51 mRNA	PMID:24136188
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:63613	nevirapine	increases expression	ISO	RGD:1623784	E	RGD:6480464	20240903	CTD	MESH:D019829	Nevirapine results in increased expression of SLC25A51 mRNA	PMID:38636494
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1305190	E	RGD:6480464	20220111	CTD	MESH:C045463	Leflunomide results in decreased expression of SLC25A51 mRNA	PMID:24136188
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SLC25A51 mRNA	PMID:31758290
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20220111	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC25A51 mRNA	PMID:22206623
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC25A51 mRNA	PMID:22206623
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SLC25A51 mRNA	PMID:22714537
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SLC25A51 mRNA	PMID:37199045
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A51 mRNA	PMID:27188386
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SLC25A51 mRNA	PMID:39150890
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC25A51 gene]	PMID:28238834
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of SLC25A51 mRNA	PMID:19482888
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305190	E	RGD:6480464	20211116	CTD	MESH:D010634	Phenobarbital results in increased expression of SLC25A51 mRNA	PMID:19162173
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1623784	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SLC25A51 mRNA]	PMID:19482888
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1623784	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of SLC25A51 mRNA	PMID:30953684
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1623784	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SLC25A51 mRNA	PMID:21278054
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC25A51 mRNA	PMID:27188386
1313070	SLC25A51	solute carrier family 25 member 51	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305190	E	RGD:6480464	20211116	CTD	MESH:C025643	vinclozolin results in increased methylation of SLC25A51 gene	PMID:31682807
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KIFAP3 mRNA	PMID:38218311
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of KIFAP3 mRNA	PMID:33167477
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of KIFAP3 mRNA	PMID:21934132
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1313073	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of KIFAP3 mRNA	PMID:20362636
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of KIFAP3 mRNA	PMID:21632981
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of KIFAP3 protein	PMID:35688186
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1305191	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of KIFAP3 mRNA	PMID:23829299
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KIFAP3 mRNA	PMID:37042841
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KIFAP3 mRNA	PMID:37992649
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313073	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of KIFAP3 protein	PMID:20463053
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in decreased expression of KIFAP3 protein	PMID:20463053
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KIFAP3 mRNA	PMID:37992649
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of KIFAP3 protein	PMID:37730182
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of KIFAP3 mRNA	PMID:16002434
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305191	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of KIFAP3 mRNA	PMID:22061828
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KIFAP3 mRNA	PMID:28818685
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305191	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KIFAP3 mRNA	PMID:39012411
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KIFAP3 gene	PMID:27153756
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313073	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in decreased expression of KIFAP3 mRNA	PMID:16377760
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20120412	CTD	MESH:D009151	Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of KIFAP3 mRNA]	PMID:16377760
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KIFAP3 mRNA	PMID:22206623
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KIFAP3 gene	PMID:25304211
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of KIFAP3 mRNA	PMID:23300844
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of KIFAP3 mRNA	PMID:27392435
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of KIFAP3 mRNA	PMID:27392435
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313073	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KIFAP3 mRNA	PMID:21570461|PMID:24680724
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305191	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KIFAP3 mRNA	PMID:33387578
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305191	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KIFAP3 mRNA	PMID:34747641
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KIFAP3 mRNA	PMID:28001369
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of KIFAP3 mRNA	PMID:39709020
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of KIFAP3 mRNA	PMID:29803840
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KIFAP3 mRNA	PMID:37992649
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313073	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KIFAP3 mRNA	PMID:19770486
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313073	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of KIFAP3 protein	PMID:37955338
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of KIFAP3 mRNA	PMID:30690063
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305191	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of KIFAP3 mRNA	PMID:30816183
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of KIFAP3 gene	PMID:31601247
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305191	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KIFAP3 mRNA	PMID:25181051
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1305191	E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of KIFAP3 mRNA	PMID:23829299
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313073	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of KIFAP3 mRNA	PMID:37019170
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KIFAP3 mRNA	PMID:37042841
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305191	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KIFAP3 mRNA	PMID:39012411
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305191	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of KIFAP3 mRNA	PMID:24386269
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of KIFAP3 mRNA	PMID:31533062
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of KIFAP3 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA	PMID:27188386
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1305191	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of KIFAP3 mRNA	PMID:21865292
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KIFAP3 mRNA	PMID:25562108
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KIFAP3 mRNA	PMID:37992649
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313073	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of KIFAP3 mRNA	PMID:18502557
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of KIFAP3 mRNA	PMID:24935251|PMID:26272509
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA	PMID:27188386
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313073	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KIFAP3 mRNA	PMID:17562736
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of KIFAP3 mRNA	PMID:21420995
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305191	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KIFAP3 mRNA	PMID:33387578
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KIFAP3 gene	PMID:25304211
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KIFAP3 mRNA	PMID:22079256
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1305191	E	RGD:6480464	20150825	CTD	MESH:D007213	Indomethacin results in decreased expression of KIFAP3 mRNA	PMID:25972201
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of KIFAP3 mRNA	PMID:23300844
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:51876	auramine O	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D001576	Benzophenoneidum results in increased expression of KIFAP3 protein	PMID:28722353
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of KIFAP3 mRNA	PMID:22714537
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:61057	tacrolimus hydrate	decreases expression	ISO	RGD:1305191	E	RGD:6480464	20120501	CTD	MESH:D016559	Tacrolimus results in decreased expression of KIFAP3 mRNA	PMID:21865292
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:64198	dimercaprol	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20120412	CTD	MESH:D004112	Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of KIFAP3 mRNA]	PMID:16377760
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313073	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KIFAP3 mRNA	PMID:22206623
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313073	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of KIFAP3 mRNA	PMID:22206623
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of KIFAP3 mRNA	PMID:22079256|PMID:22714537
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KIFAP3 mRNA	PMID:22079256
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305191	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of KIFAP3 mRNA	PMID:21346803
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA	PMID:27188386
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313073	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of KIFAP3 mRNA	PMID:23091169
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1305191	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of KIFAP3 protein	PMID:28903499
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305191	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of KIFAP3 mRNA	PMID:36843608
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of KIFAP3 mRNA	PMID:26272509
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA	PMID:27188386
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KIFAP3 mRNA	PMID:27188386
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:9168	sirolimus	increases expression	ISO	RGD:1305191	E	RGD:6480464	20120501	CTD	MESH:D020123	Sirolimus results in increased expression of KIFAP3 mRNA	PMID:21865292
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305191	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of KIFAP3 mRNA	PMID:19281266
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305191	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of KIFAP3 mRNA	PMID:21346803
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KIFAP3 mRNA	PMID:38568856
1313072	KIFAP3	kinesin associated protein 3	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305191	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of KIFAP3 gene	PMID:31079544
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SEMA7A mRNA	PMID:38218311
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305192	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SEMA7A mRNA]	PMID:31150632
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SEMA7A mRNA	PMID:20188158
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SEMA7A mRNA	PMID:33167477
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SEMA7A mRNA	PMID:26079696
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1305192	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of SEMA7A mRNA	PMID:36841081
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SEMA7A mRNA	PMID:39241906
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SEMA7A mRNA]	PMID:39241906
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of SEMA7A mRNA	PMID:30510588
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SEMA7A mRNA	PMID:31614463
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SEMA7A mRNA	PMID:30165855
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of SEMA7A mRNA	PMID:18978301
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305192	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SEMA7A mRNA	PMID:33387578
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of SEMA7A mRNA	PMID:28937961
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SEMA7A mRNA	PMID:37992649
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SEMA7A mRNA	PMID:36706583
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SEMA7A mRNA	PMID:37992649
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SEMA7A mRNA	PMID:34319233
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SEMA7A mRNA	PMID:39150890
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305192	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of SEMA7A mRNA	PMID:27523638
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SEMA7A mRNA	PMID:36139627
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305192	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SEMA7A mRNA	PMID:33387578
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SEMA7A mRNA	PMID:28818685
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:188855	Octicizer	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C018535	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in decreased expression of SEMA7A protein	PMID:42015365
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SEMA7A intron	PMID:30157460
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1305192	E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in increased expression of SEMA7A mRNA	PMID:28623178
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SEMA7A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SEMA7A mRNA	PMID:35430440|PMID:41430723
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SEMA7A mRNA	PMID:34911549
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305192	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SEMA7A mRNA	PMID:31150632
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305192	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SEMA7A mRNA]	PMID:31150632
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305192	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SEMA7A mRNA	PMID:31881176
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SEMA7A mRNA	PMID:27392435
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305192	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of SEMA7A mRNA	PMID:15691709
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313075	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEMA7A mRNA	PMID:24680724
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305192	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SEMA7A mRNA	PMID:33387578|PMID:34747641
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEMA7A mRNA	PMID:17942748
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SEMA7A mRNA	PMID:33212167
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SEMA7A mRNA	PMID:30851411
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SEMA7A mRNA	PMID:29803840
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SEMA7A mRNA	PMID:37992649
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SEMA7A mRNA	PMID:34032870|PMID:39719251
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SEMA7A mRNA	PMID:38568856
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SEMA7A mRNA	PMID:34876320
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SEMA7A mRNA	PMID:34876320
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SEMA7A promoter	PMID:27901495
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SEMA7A mRNA	PMID:21569818
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1305192	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SEMA7A mRNA	PMID:38458666
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SEMA7A mRNA	PMID:25895662
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SEMA7A mRNA	PMID:20382639
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SEMA7A mRNA	PMID:20458559|PMID:27829220
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:30660	thyroxine	increases expression	ISO	RGD:1305192	E	RGD:6480464	20210309	CTD	MESH:D013974	Thyroxine results in increased expression of SEMA7A mRNA	PMID:29901742
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305192	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SEMA7A mRNA	PMID:30047161
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313075	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of SEMA7A mRNA	PMID:27760801
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305192	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SEMA7A mRNA	PMID:34492290
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313075	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SEMA7A mRNA	PMID:18648102
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of SEMA7A mRNA	PMID:38479592
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:33083	fluoranthene	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20170725	CTD	MESH:C007738	fluoranthene results in decreased expression of SEMA7A mRNA	PMID:28329830
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305192	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SEMA7A mRNA	PMID:19167457
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305192	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SEMA7A mRNA	PMID:25181051
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of SEMA7A mRNA	PMID:29275510
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305192	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SEMA7A mRNA	PMID:30816183|PMID:34947998|PMID:38750585
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313075	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of SEMA7A mRNA	PMID:25172293
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of SEMA7A mRNA	PMID:20713471
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of SEMA7A mRNA	PMID:20713471
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313075	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SEMA7A exon	PMID:33297965
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313075	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SEMA7A mRNA	PMID:30951980
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of SEMA7A mRNA	PMID:26377693
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313075	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SEMA7A mRNA	PMID:30951980
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SEMA7A mRNA	PMID:39150890
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SEMA7A mRNA	PMID:20350560|PMID:37019170
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SEMA7A gene	PMID:22964155
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SEMA7A mRNA	PMID:39150890
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SEMA7A mRNA	PMID:39150890
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of SEMA7A mRNA	PMID:28628672
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305192	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of SEMA7A mRNA	PMID:32680482
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of SEMA7A protein	PMID:39748354
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SEMA7A mRNA]	PMID:39241906
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SEMA7A mRNA	PMID:37042841
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:35033	triphenyl phosphate	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C005445	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in decreased expression of SEMA7A protein	PMID:42015365
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1305192	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SEMA7A mRNA	PMID:38458666
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C031324	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in decreased expression of SEMA7A protein	PMID:42015365
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C013320	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in decreased expression of SEMA7A protein	PMID:42015365
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305192	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of SEMA7A mRNA	PMID:35163327
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305192	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SEMA7A mRNA	PMID:35163327
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SEMA7A mRNA	PMID:39150890
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305192	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SEMA7A mRNA	PMID:35163327
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305192	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SEMA7A mRNA	PMID:30047161
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313075	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SEMA7A mRNA	PMID:40194260
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SEMA7A mRNA	PMID:31533062
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of SEMA7A mRNA	PMID:29038090
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1313075	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of SEMA7A mRNA	PMID:23125180
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SEMA7A gene	PMID:29154799
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305192	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SEMA7A mRNA	PMID:30047161
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of SEMA7A mRNA	PMID:22733784
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of SEMA7A mRNA	PMID:28628672
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1305192	E	RGD:6480464	20230606	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SEMA7A mRNA	PMID:37077353
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313075	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SEMA7A mRNA	PMID:28973697
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SEMA7A mRNA	PMID:37992649
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of SEMA7A mRNA	PMID:21678067
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SEMA7A mRNA	PMID:38832940
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305192	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SEMA7A mRNA	PMID:33387578
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1305192	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of SEMA7A mRNA	PMID:37077353
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of SEMA7A mRNA	PMID:31838189
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SEMA7A mRNA	PMID:34876320
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313075	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SEMA7A mRNA	PMID:17942748
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEMA7A mRNA	PMID:17942748
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of SEMA7A mRNA	PMID:28628672
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SEMA7A mRNA	PMID:20458559|PMID:27829220
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313075	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SEMA7A mRNA; Nanotubes, Carbon results in increased expression of SEMA7A mRNA	PMID:25554681
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305192	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SEMA7A mRNA	PMID:30047161
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of SEMA7A mRNA	PMID:22714537
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of SEMA7A protein	PMID:23718831
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SEMA7A mRNA	PMID:38701926
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:5951	Iopanoic acid	decreases expression	ISO	RGD:1305192	E	RGD:6480464	20260303	CTD	MESH:D007480	Iopanoic Acid results in decreased expression of SEMA7A mRNA	PMID:41206128
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA7A mRNA	PMID:21641980
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of SEMA7A mRNA	PMID:28988120
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305192	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SEMA7A gene	PMID:35440735
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1305192	E	RGD:6480464	20230307	CTD	MESH:C057862	cyanoginosin LR results in increased expression of SEMA7A protein	PMID:22430071
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313075	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SEMA7A mRNA	PMID:22206623
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SEMA7A mRNA	PMID:22714537
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SEMA7A mRNA	PMID:37199045
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SEMA7A mRNA	PMID:36139627
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:77131	sinapic acid	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20230404	CTD	MESH:C073734	sinapinic acid analog results in decreased expression of SEMA7A mRNA	PMID:36279966
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SEMA7A mRNA	PMID:30851411
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SEMA7A mRNA	PMID:39150890
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305192	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SEMA7A mRNA	PMID:32109520
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1305192	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of SEMA7A protein	PMID:28903499
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:84070	sodium arsenate	affects methylation	ISO	RGD:1313075	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate affects the methylation of SEMA7A promoter	PMID:20667999
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313075	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SEMA7A mRNA	PMID:20667999
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SEMA7A mRNA	PMID:34876320
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305192	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SEMA7A mRNA	PMID:24780913|PMID:25825206|PMID:30085217
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305192	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SEMA7A mRNA	PMID:30047161
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SEMA7A mRNA	PMID:36706583
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313075	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SEMA7A mRNA]	PMID:39241906
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SEMA7A mRNA	PMID:38568856
1313074	SEMA7A	semaphorin 7A (JohnMiltonHagen blood group)	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313075	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SEMA7A mRNA	PMID:28973697
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of CYP2W1 protein	PMID:39638853
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CYP2W1 mRNA	PMID:38218311
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of CYP2W1 mRNA	PMID:16985168
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:15429	hydroxylamine	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D019811	[CYP2W1 protein results in increased oxidation of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole] which results in increased chemical synthesis of Hydroxylamine	PMID:22734839
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CYP2W1 mRNA	PMID:20044591
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CYP2W1 mRNA	PMID:30510588
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CYP2W1 mRNA	PMID:28818685
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CYP2W1 mRNA	PMID:19549813
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of CYP2W1 promoter	PMID:22847954
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYP2W1 mRNA	PMID:16985168
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CYP2W1 mRNA	PMID:33212167
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of CYP2W1 mRNA	PMID:39709020
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CYP2W1 promoter	PMID:27901495
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CYP2W1 mRNA	PMID:22316170|PMID:26238291
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CYP2W1 exon	PMID:27901495
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1614687	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CYP2W1 promoter	PMID:27901495
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1614687	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the expression of CYP2W1 mRNA	PMID:35295148
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CYP2W1 mRNA	PMID:30903817
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305193	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CYP2W1 mRNA	PMID:25181051
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1614687	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CYP2W1 gene	PMID:31683443
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of CYP2W1 gene	PMID:31601247
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CYP2W1 protein	PMID:26879310
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of CYP2W1 promoter	PMID:22847954
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of CYP2W1 promoter	PMID:22847954
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CYP2W1 gene	PMID:29154799
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CYP2W1 mRNA	PMID:25562108
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of CYP2W1 mRNA	PMID:22230336
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:46680	serpentine asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of CYP2W1 promoter	PMID:29626692
1313076	CYP2W1	cytochrome P450 family 2 subfamily W member 1	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of CYP2W1 mRNA; beta-Naphthoflavone results in decreased expression of CYP2W1 protein	PMID:16985168|PMID:39638853
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313078	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SPTA1 mRNA	PMID:33045310
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313078	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of SPTA1 mRNA	PMID:36189433
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPTA1 mRNA	PMID:36189433
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SPTA1 mRNA	PMID:26516004
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313078	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SPTA1 mRNA	PMID:22629407
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305194	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of SPTA1 mRNA	PMID:33729688
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20121113	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPTA1 mRNA; Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of SPTA1 mRNA]	PMID:22629407|PMID:30529165
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SPTA1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SPTA1 mRNA	PMID:35811015
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305194	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SPTA1 mRNA	PMID:32145629
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313078	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SPTA1 mRNA	PMID:39298647
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPTA1 mRNA	PMID:25510870
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:16602	trichloroethene	decreases methylation	ISO	RGD:1305194	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of SPTA1 gene	PMID:27618143
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305194	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SPTA1 mRNA	PMID:33387578
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA	PMID:37567420
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313078	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SPTA1 mRNA	PMID:22401849
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SPTA1 mRNA	PMID:36189433
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA	PMID:37567420
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305194	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SPTA1 mRNA	PMID:26577399|PMID:27523638
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305194	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of SPTA1 mRNA	PMID:22061828
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305194	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SPTA1 mRNA	PMID:22061828|PMID:33387578
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305194	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPTA1 mRNA	PMID:39012411
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPTA1 mRNA	PMID:25510870
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPTA1 mRNA	PMID:25510870
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305194	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SPTA1 mRNA	PMID:23630614
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SPTA1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SPTA1 mRNA	PMID:34911549
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313078	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SPTA1 mRNA	PMID:17484886
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305194	E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SPTA1 mRNA	PMID:30723492
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:27568	selenium atom	multiple interactions	ISO	RGD:1305194	E	RGD:6480464	20260804	CTD	MESH:D012643	[1-Methyl-4-phenylpyridinium co-treated with [Sodium Selenite results in increased abundance of Selenium]] results in increased expression of SPTA1 mRNA	PMID:37269647
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1313078	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of SPTA1 mRNA	PMID:28960355
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313078	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of SPTA1 mRNA	PMID:40618947
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313078	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPTA1 mRNA	PMID:21570461
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305194	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPTA1 mRNA	PMID:32109520
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305194	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPTA1 mRNA	PMID:33387578
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313078	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SPTA1 protein	PMID:28918527
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA	PMID:37567420
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20231031	CTD	MESH:D015084	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA	PMID:37567420
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPTA1 mRNA	PMID:34032870|PMID:39719251
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of SPTA1 gene	PMID:25435355
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1305194	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of SPTA1 mRNA	PMID:24395379
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305194	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of SPTA1 mRNA	PMID:25729387
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305194	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SPTA1 mRNA	PMID:25729387
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313078	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of SPTA1 mRNA	PMID:35295148
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SPTA1 mRNA	PMID:19710929
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305194	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SPTA1 mRNA	PMID:19167457
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of SPTA1 protein	PMID:31675489
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305194	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SPTA1 mRNA	PMID:30816183|PMID:32145629
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SPTA1 protein	PMID:31675489
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPTA1 mRNA	PMID:25510870
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPTA1 mRNA	PMID:25510870
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313078	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SPTA1 mRNA	PMID:21266533
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of SPTA1 mRNA	PMID:16314067
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305194	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SPTA1 mRNA	PMID:36928142
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305194	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPTA1 mRNA	PMID:39012411
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305194	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SPTA1 mRNA	PMID:24386269
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:36904	elemental selenium	multiple interactions	ISO	RGD:1305194	E	RGD:6480464	20260804	CTD	MESH:D012643	[1-Methyl-4-phenylpyridinium co-treated with [Sodium Selenite results in increased abundance of Selenium]] results in increased expression of SPTA1 mRNA	PMID:37269647
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313078	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SPTA1 mRNA	PMID:40194260
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305194	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of SPTA1 mRNA	PMID:41580965
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA	PMID:37567420
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SPTA1 mRNA	PMID:38832940
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1305194	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of SPTA1 mRNA	PMID:33387578
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of SPTA1 mRNA	PMID:35811015
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SPTA1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SPTA1 mRNA	PMID:35811015
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:48843	disodium selenite	multiple interactions	ISO	RGD:1305194	E	RGD:6480464	20260804	CTD	MESH:D018038	[1-Methyl-4-phenylpyridinium co-treated with [Sodium Selenite results in increased abundance of Selenium]] results in increased expression of SPTA1 mRNA	PMID:37269647
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1305194	E	RGD:6480464	20240806	CTD	MESH:C000499	ferric oxide analog results in increased expression of SPTA1 mRNA	PMID:38615722
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:51403	1,4-phenylenediamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029728	4-phenylenediamine results in increased expression of SPTA1 mRNA	PMID:16314067
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of SPTA1 mRNA	PMID:16314067
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305194	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SPTA1 mRNA	PMID:25729387
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305194	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SPTA1 mRNA	PMID:25729387
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1313078	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of SPTA1 mRNA	PMID:19812364
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:64090	tert-butyl hydroperoxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased degradation of [SPTA1 protein binds to SPTB protein]	PMID:15040847
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305194	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SPTA1 mRNA	PMID:37269647
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:1305194	E	RGD:6480464	20260804	CTD	MESH:D015655	[1-Methyl-4-phenylpyridinium co-treated with [Sodium Selenite results in increased abundance of Selenium]] results in increased expression of SPTA1 mRNA	PMID:37269647
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1313078	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of SPTA1 mRNA	PMID:20003209
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1313078	E	RGD:6480464	20150127	CTD	MESH:C014476	diethyl maleate results in increased expression of SPTA1 mRNA	PMID:25270620
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313078	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of SPTA1 mRNA	PMID:37567420
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:8093	phenylephrine	decreases expression	ISO	RGD:1305194	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in decreased expression of SPTA1 mRNA	PMID:18158353
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1305194	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of SPTA1 protein	PMID:28903499
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SPTA1 protein	PMID:31675489
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305194	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of SPTA1 mRNA	PMID:24780913
1313077	SPTA1	spectrin alpha, erythrocytic 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305194	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of SPTA1 mRNA	PMID:25825206
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RBM11 mRNA	PMID:27188386
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313080	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RBM11 mRNA	PMID:30319688
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313080	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RBM11 mRNA	PMID:30319688
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305195	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RBM11 mRNA	PMID:33387578
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313080	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RBM11 mRNA	PMID:39922521
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313080	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RBM11 mRNA	PMID:39922521
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305195	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RBM11 mRNA	PMID:30779732
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305195	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RBM11 mRNA	PMID:33387578
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of RBM11 mRNA	PMID:26272509
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBM11 mRNA	PMID:27188386
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RBM11 promoter	PMID:27901495
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305195	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RBM11 mRNA	PMID:25729387
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313080	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RBM11 gene	PMID:35295148
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305195	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of RBM11 mRNA	PMID:41034487
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313080	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RBM11 mRNA	PMID:37019170
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RBM11 mRNA	PMID:38382870
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of RBM11 mRNA	PMID:23179753|PMID:24935251|PMID:27188386
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313080	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RBM11 mRNA	PMID:39922521
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of RBM11 mRNA	PMID:27188386
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RBM11 mRNA	PMID:28542535
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RBM11 mRNA	PMID:24935251
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305195	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RBM11 mRNA	PMID:33387578
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305195	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RBM11 mRNA	PMID:29391264
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of RBM11 mRNA	PMID:38825487
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305195	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RBM11 mRNA	PMID:25729387
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RBM11 mRNA	PMID:22714537
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBM11 mRNA	PMID:27188386
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305195	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RBM11 mRNA	PMID:24780913
1313079	RBM11	RNA binding motif protein 11	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RBM11 mRNA	PMID:27188386
1313081	JPH2	junctophilin 2	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305196	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of JPH2 mRNA	PMID:21551480
1313081	JPH2	junctophilin 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313082	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of JPH2 mRNA	PMID:33045310
1313081	JPH2	junctophilin 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313082	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of JPH2 mRNA	PMID:37995155
1313081	JPH2	junctophilin 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1305196	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of JPH2 mRNA	PMID:36841081
1313081	JPH2	junctophilin 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of JPH2 mRNA	PMID:22378314
1313081	JPH2	junctophilin 2	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of JPH2 mRNA	PMID:30510588
1313081	JPH2	junctophilin 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313082	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of JPH2 mRNA	PMID:33711761
1313081	JPH2	junctophilin 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305196	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of JPH2 mRNA	PMID:33387578
1313081	JPH2	junctophilin 2	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1313082	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of JPH2 mRNA	PMID:39984025
1313081	JPH2	junctophilin 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of JPH2 mRNA	PMID:32234424
1313081	JPH2	junctophilin 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313082	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of JPH2 mRNA	PMID:34911549
1313081	JPH2	junctophilin 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313082	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of JPH2 mRNA	PMID:17484886
1313081	JPH2	junctophilin 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH2 mRNA	PMID:27188386
1313081	JPH2	junctophilin 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of JPH2 mRNA	PMID:27392435
1313081	JPH2	junctophilin 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of JPH2 mRNA	PMID:27392435
1313081	JPH2	junctophilin 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313082	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of JPH2 mRNA	PMID:32186404
1313081	JPH2	junctophilin 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of JPH2 mRNA	PMID:25583101
1313081	JPH2	junctophilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305196	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of JPH2 mRNA	PMID:32109520
1313081	JPH2	junctophilin 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of JPH2 mRNA	PMID:33212167
1313081	JPH2	junctophilin 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305196	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of JPH2 mRNA	PMID:28959563
1313081	JPH2	junctophilin 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305196	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of JPH2 mRNA	PMID:26033743
1313081	JPH2	junctophilin 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of JPH2 mRNA	PMID:29803840
1313081	JPH2	junctophilin 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of JPH2 mRNA	PMID:39631538
1313081	JPH2	junctophilin 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1305196	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of JPH2 mRNA	PMID:19915844
1313081	JPH2	junctophilin 2	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1305196	E	RGD:6480464	20120412	CTD	MESH:D004317	Razoxane inhibits the reaction [Doxorubicin results in increased expression of JPH2 mRNA]	PMID:19915844
1313081	JPH2	junctophilin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of JPH2 mRNA	PMID:38568856
1313081	JPH2	junctophilin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of JPH2 mRNA	PMID:37682722
1313081	JPH2	junctophilin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of JPH2 3' UTR	PMID:27901495
1313081	JPH2	junctophilin 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305196	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of JPH2 mRNA	PMID:26033743
1313081	JPH2	junctophilin 2	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of JPH2 mRNA	PMID:28959546
1313081	JPH2	junctophilin 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of JPH2 mRNA	PMID:25895662
1313081	JPH2	junctophilin 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of JPH2 mRNA	PMID:19150397
1313081	JPH2	junctophilin 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of JPH2 mRNA	PMID:20458559
1313081	JPH2	junctophilin 2	gene	CHEBI:3139	bleomycin A2	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:D001761	Bleomycin results in decreased expression of JPH2 mRNA	PMID:40645554
1313081	JPH2	junctophilin 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of JPH2 mRNA	PMID:23557971
1313081	JPH2	junctophilin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313082	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of JPH2 gene	PMID:35295148
1313081	JPH2	junctophilin 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of JPH2 mRNA	PMID:18648102
1313081	JPH2	junctophilin 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of JPH2 mRNA	PMID:38479592
1313081	JPH2	junctophilin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305196	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of JPH2 mRNA	PMID:41034487
1313081	JPH2	junctophilin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313082	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of JPH2 mRNA	PMID:30951980
1313081	JPH2	junctophilin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313082	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of JPH2 exon; bisphenol S affects the methylation of JPH2 gene	PMID:31683443|PMID:33297965
1313081	JPH2	junctophilin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313082	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of JPH2 mRNA	PMID:30951980
1313081	JPH2	junctophilin 2	gene	CHEBI:3441	carvedilol	increases expression	ISO	RGD:1313082	E	RGD:6480464	20120613	CTD	MESH:C043211	carvedilol results in increased expression of JPH2 protein	PMID:22375019
1313081	JPH2	junctophilin 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of JPH2 intron	PMID:30157460
1313081	JPH2	junctophilin 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313082	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of JPH2 mRNA	PMID:30951980
1313081	JPH2	junctophilin 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313082	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of JPH2 intron	PMID:28392331
1313081	JPH2	junctophilin 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313082	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of JPH2 mRNA	PMID:21266533
1313081	JPH2	junctophilin 2	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1305196	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of JPH2 mRNA	PMID:35163327
1313081	JPH2	junctophilin 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305196	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of JPH2 mRNA	PMID:35163327
1313081	JPH2	junctophilin 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of JPH2 mRNA	PMID:38568856
1313081	JPH2	junctophilin 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of JPH2 mRNA	PMID:38382870
1313081	JPH2	junctophilin 2	gene	CHEBI:35459	diisononyl phthalate	increases expression	ISO	RGD:1313082	E	RGD:6480464	20250204	CTD	MESH:C012125	diisononyl phthalate results in increased expression of JPH2 mRNA	PMID:33391822
1313081	JPH2	junctophilin 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305196	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of JPH2 mRNA	PMID:35163327
1313081	JPH2	junctophilin 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of JPH2 mRNA	PMID:40194260
1313081	JPH2	junctophilin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of JPH2 mRNA	PMID:40419075
1313081	JPH2	junctophilin 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of JPH2 mRNA	PMID:29038090
1313081	JPH2	junctophilin 2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of JPH2 mRNA	PMID:22155349
1313081	JPH2	junctophilin 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of JPH2 mRNA	PMID:26272509
1313081	JPH2	junctophilin 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of JPH2 gene	PMID:29154799
1313081	JPH2	junctophilin 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH2 mRNA	PMID:27188386
1313081	JPH2	junctophilin 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of JPH2 mRNA	PMID:38832940
1313081	JPH2	junctophilin 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1305196	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of JPH2 mRNA	PMID:33387578
1313081	JPH2	junctophilin 2	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of JPH2 mRNA	PMID:31838189
1313081	JPH2	junctophilin 2	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313082	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of JPH2 mRNA	PMID:30529165
1313081	JPH2	junctophilin 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of JPH2 mRNA	PMID:32234424
1313081	JPH2	junctophilin 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of JPH2 mRNA	PMID:20458559
1313081	JPH2	junctophilin 2	gene	CHEBI:50225	razoxane	multiple interactions	ISO	RGD:1305196	E	RGD:6480464	20120412	CTD	MESH:D011929	Razoxane inhibits the reaction [Doxorubicin results in increased expression of JPH2 mRNA]	PMID:19915844
1313081	JPH2	junctophilin 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of JPH2 mRNA	PMID:40645554
1313081	JPH2	junctophilin 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of JPH2 mRNA	PMID:23608068
1313081	JPH2	junctophilin 2	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of JPH2 mRNA	PMID:36907384
1313081	JPH2	junctophilin 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of JPH2 intron	PMID:30157460
1313081	JPH2	junctophilin 2	gene	CHEBI:6904	metoprolol	increases expression	ISO	RGD:1313082	E	RGD:6480464	20120613	CTD	MESH:D008790	Metoprolol results in increased expression of JPH2 protein	PMID:22375019
1313081	JPH2	junctophilin 2	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in decreased expression of JPH2 mRNA	PMID:33244087
1313081	JPH2	junctophilin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313082	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of JPH2 mRNA	PMID:22206623
1313081	JPH2	junctophilin 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH2 mRNA	PMID:27188386
1313081	JPH2	junctophilin 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to JPH2 gene]	PMID:28238834
1313081	JPH2	junctophilin 2	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1313082	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of JPH2 mRNA	PMID:26655953
1313081	JPH2	junctophilin 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313082	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of JPH2 mRNA	PMID:38648751
1313081	JPH2	junctophilin 2	gene	CHEBI:82036	prothioconazole	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in increased expression of JPH2 mRNA	PMID:35048155
1313081	JPH2	junctophilin 2	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313082	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of JPH2 mRNA	PMID:27935865
1313081	JPH2	junctophilin 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313082	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of JPH2 mRNA	PMID:21795629
1313081	JPH2	junctophilin 2	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of JPH2 mRNA	PMID:31734321
1313081	JPH2	junctophilin 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of JPH2 mRNA	PMID:27188386
1313081	JPH2	junctophilin 2	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of JPH2 mRNA	PMID:28959546
1313083	NRL	neural retina leucine zipper	gene	CHEBI:15367	all-trans-retinoic acid	affects binding	ISO	RGD:1313084	E	RGD:6480464	20120412	CTD	MESH:D014212	[Tretinoin binds to RARA protein] which binds to NRL promoter; [Tretinoin binds to RXRA protein] which binds to NRL promoter; [Tretinoin binds to RXRG protein] which binds to NRL promoter	PMID:16854989
1313083	NRL	neural retina leucine zipper	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of NRL mRNA; Tretinoin results in increased expression of NRL protein	PMID:16854989
1313083	NRL	neural retina leucine zipper	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1305197	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of NRL protein	PMID:16854989
1313083	NRL	neural retina leucine zipper	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313084	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of NRL mRNA	PMID:16854989
1313083	NRL	neural retina leucine zipper	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313084	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NRL mRNA	PMID:34319233
1313083	NRL	neural retina leucine zipper	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of NRL mRNA	PMID:28818685
1313083	NRL	neural retina leucine zipper	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1313084	E	RGD:6480464	20231205	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of NRL mRNA	PMID:28050121
1313083	NRL	neural retina leucine zipper	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of NRL mRNA	PMID:27392435
1313083	NRL	neural retina leucine zipper	gene	CHEBI:28077	rifampicin	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in increased expression of NRL mRNA	PMID:24552687
1313083	NRL	neural retina leucine zipper	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313084	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NRL mRNA	PMID:24058054
1313083	NRL	neural retina leucine zipper	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305197	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of NRL mRNA	PMID:26033743
1313083	NRL	neural retina leucine zipper	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of NRL gene	PMID:28589171
1313083	NRL	neural retina leucine zipper	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NRL mRNA	PMID:38568856
1313083	NRL	neural retina leucine zipper	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NRL 3' UTR	PMID:27901495
1313083	NRL	neural retina leucine zipper	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NRL mRNA	PMID:22316170|PMID:32234424
1313083	NRL	neural retina leucine zipper	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305197	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of NRL mRNA	PMID:26033743
1313083	NRL	neural retina leucine zipper	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1313084	E	RGD:6480464	20231205	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of NRL mRNA	PMID:28050121
1313083	NRL	neural retina leucine zipper	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313084	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of NRL promoter	PMID:27334623
1313083	NRL	neural retina leucine zipper	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305197	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NRL mRNA	PMID:25181051
1313083	NRL	neural retina leucine zipper	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of NRL gene	PMID:31601247
1313083	NRL	neural retina leucine zipper	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NRL mRNA	PMID:38568856
1313083	NRL	neural retina leucine zipper	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NRL mRNA	PMID:31533062
1313083	NRL	neural retina leucine zipper	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313084	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NRL mRNA	PMID:17963808
1313083	NRL	neural retina leucine zipper	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NRL mRNA	PMID:38832940
1313083	NRL	neural retina leucine zipper	gene	CHEBI:49668	gefitinib	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C419708	gefitinib results in decreased expression of NRL mRNA	PMID:16685379
1313083	NRL	neural retina leucine zipper	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305197	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of NRL mRNA	PMID:30307764
1313083	NRL	neural retina leucine zipper	gene	CHEBI:50648	9-cis-retinoic acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in increased expression of NRL mRNA; Alitretinoin results in increased expression of NRL protein	PMID:16854989
1313083	NRL	neural retina leucine zipper	gene	CHEBI:75261	arotinoid acid	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C038864	4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased expression of NRL mRNA; 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased expression of NRL protein	PMID:16854989
1313083	NRL	neural retina leucine zipper	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NRL gene]	PMID:28238834
1313083	NRL	neural retina leucine zipper	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of NRL mRNA	PMID:32234424
1313083	NRL	neural retina leucine zipper	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305197	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of NRL mRNA	PMID:24780913
1313083	NRL	neural retina leucine zipper	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305197	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of NRL gene	PMID:31682807
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MEIS2 mRNA	PMID:38218311
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MEIS2 mRNA	PMID:33045310
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in increased expression of MEIS2 mRNA	PMID:17034753|PMID:21934132
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1305198	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of MEIS2 mRNA	PMID:20488242
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D014212	[Tretinoin co-treated with bisphenol A] results in increased expression of MEIS2 mRNA	PMID:40359302
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305198	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MEIS2 gene	PMID:28931070
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in decreased expression of MEIS2 mRNA	PMID:28986285
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in increased expression of MEIS2 mRNA	PMID:23378141
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	[Ethanol co-treated with Folic Acid] results in increased expression of MEIS2 mRNA	PMID:23378141
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of MEIS2 mRNA	PMID:30319688
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MEIS2 mRNA	PMID:21632981
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MEIS2 mRNA	PMID:35811015
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MEIS2 mRNA	PMID:35811015
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of MEIS2 mRNA	PMID:22574217
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of MEIS2 mRNA	PMID:25210133
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MEIS2 mRNA	PMID:21179406
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:17336	all-trans-retinol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014801	Vitamin A results in increased expression of MEIS2 mRNA	PMID:17034753
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:17336	all-trans-retinol	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D014801	[RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS2 mRNA; RARG gene mutant form inhibits the reaction [[RARA gene mutant form co-treated with Vitamin A] results in increased expression of MEIS2 mRNA]	PMID:16397886
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:17579	beta-carotene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019207	beta Carotene results in increased expression of MEIS2 mRNA	PMID:17034753
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305198	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MEIS2 mRNA	PMID:26577399
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20260203	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MEIS2 mRNA	PMID:40850461
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MEIS2 mRNA	PMID:19549813
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1550144	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of MEIS2 mRNA	PMID:18579281
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MEIS2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MEIS2 mRNA	PMID:27106289|PMID:34911549
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D005492	[Ethanol co-treated with Folic Acid] results in increased expression of MEIS2 mRNA	PMID:23378141
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:27563	arsenic atom	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	MEIS2 mRNA results in increased susceptibility to Arsenic	PMID:17976673
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MEIS2 mRNA	PMID:39836092
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MEIS2 mRNA	PMID:26272509
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA	PMID:27188386
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MEIS2 protein	PMID:35688186
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1305198	E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of MEIS2 mRNA	PMID:38314887
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of MEIS2 mRNA	PMID:19561079
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MEIS2 mRNA	PMID:25583101
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MEIS2 mRNA	PMID:22298810
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305198	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MEIS2 mRNA	PMID:34747641
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550144	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MEIS2 mRNA	PMID:24058054|PMID:24680724|PMID:26377647
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305198	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MEIS2 mRNA	PMID:32109520
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MEIS2 mRNA	PMID:19465110|PMID:21889950
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MEIS2 mRNA	PMID:25975270
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MEIS2 mRNA	PMID:28001369
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MEIS2 mRNA	PMID:33212167
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305198	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of MEIS2 mRNA	PMID:30556269
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of MEIS2 mRNA	PMID:27862939
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MEIS2 mRNA	PMID:29803840
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of MEIS2 mRNA	PMID:39719251
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1550144	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of MEIS2 gene	PMID:39894169
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MEIS2 mRNA	PMID:39836092
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of MEIS2 mRNA	PMID:22342234
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MEIS2 promoter	PMID:27901495
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305198	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MEIS2 mRNA	PMID:21839799
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MEIS2 mRNA	PMID:21715664|PMID:27195522
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MEIS2 exon	PMID:27901495
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MEIS2 mRNA	PMID:20127859
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of MEIS2 promoter	PMID:23974009
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305198	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of MEIS2 mRNA	PMID:30556269
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of MEIS2 mRNA	PMID:25895662
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MEIS2 mRNA	PMID:19150397|PMID:20382639
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of MEIS2 mRNA	PMID:35984750
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MEIS2 gene	PMID:31601247
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305198	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of MEIS2 mRNA	PMID:30047161
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550144	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MEIS2 enhancer; titanium dioxide results in decreased methylation of MEIS2 gene	PMID:35295148
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550144	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MEIS2 mRNA	PMID:23557971
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MEIS2 mRNA	PMID:19710929
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of MEIS2 mRNA	PMID:28329830
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of MEIS2 gene	PMID:28843141
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1550144	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of MEIS2 promoter	PMID:27334623
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305198	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MEIS2 mRNA	PMID:25181051
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MEIS2 gene; [Tretinoin co-treated with bisphenol A] results in increased expression of MEIS2 mRNA	PMID:31601247|PMID:40359302
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of MEIS2 mRNA	PMID:26682919
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550144	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MEIS2 gene	PMID:31683443
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1550144	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of MEIS2 exon; bisphenol S results in decreased methylation of MEIS2 promoter	PMID:33297965
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1550144	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of MEIS2 mRNA	PMID:26377693
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550144	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of MEIS2 intron	PMID:28392331
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1550144	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of MEIS2 mRNA	PMID:31558096
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1305198	E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MEIS2 mRNA	PMID:18668222
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550144	E	RGD:6480464	20260203	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MEIS2 mRNA	PMID:40850461
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MEIS2 mRNA	PMID:24449571
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MEIS2 mRNA	PMID:40194260
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MEIS2 mRNA	PMID:31533062
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MEIS2 mRNA	PMID:25979313
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MEIS2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA	PMID:27188386
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of MEIS2 mRNA	PMID:20106945
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550144	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MEIS2 mRNA	PMID:28973697
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:44597	all-trans-4-oxoretinol	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C041819	4-oxoretinol results in increased expression of MEIS2 mRNA	PMID:17034753
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of MEIS2 mRNA	PMID:24935251|PMID:26272509
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA	PMID:27188386
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MEIS2 mRNA	PMID:21420995
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305198	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MEIS2 mRNA	PMID:33387578
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of MEIS2 mRNA	PMID:33725128
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MEIS2 mRNA	PMID:35811015
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:47217	arsane	increases response to substance	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	MEIS2 mRNA results in increased susceptibility to Arsenic	PMID:17976673
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MEIS2 mRNA	PMID:39836092
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305198	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of MEIS2 mRNA	PMID:29391264
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MEIS2 mRNA	PMID:22079256
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D018038	Sodium Selenite results in decreased expression of MEIS2 mRNA	PMID:23274088
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MEIS2 mRNA	PMID:17555576
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305198	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of MEIS2 mRNA	PMID:17557909
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MEIS2 mRNA; Nanotubes, Carbon results in decreased expression of MEIS2 mRNA	PMID:25554681
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:50648	9-cis-retinoic acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in increased expression of MEIS2 mRNA	PMID:17034753
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305198	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of MEIS2 mRNA	PMID:30047161
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of MEIS2 mRNA	PMID:22714537
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of MEIS2 mRNA	PMID:19042947
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:53154	8'-apo-beta,psi-caroten-8'-al	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004984	apocarotenal results in increased expression of MEIS2 mRNA	PMID:17034753
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:63791	lenalidomide	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C467567	lenalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein]	PMID:25043012
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of MEIS2 mRNA	PMID:28988120
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of MEIS2 mRNA	PMID:36851058
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:72690	pomalidomide	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:C467566	pomalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein]	PMID:25043012
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550144	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MEIS2 mRNA	PMID:22206623
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MEIS2 mRNA	PMID:22079256
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MEIS2 mRNA	PMID:22079256
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA	PMID:27188386
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MEIS2 gene]	PMID:28238834
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:80656	all-trans-4-oxoretinoic acid	increases expression	EXP		E	RGD:6480464	20150120	CTD	MESH:C002202	4-oxoretinoic acid results in increased expression of MEIS2 mRNA	PMID:17034753
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550144	E	RGD:6480464	20130806	CTD	MESH:D010634	Phenobarbital affects the expression of MEIS2 mRNA	PMID:23091169
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550144	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MEIS2 mRNA	PMID:31388691
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of MEIS2 mRNA	PMID:31558096
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of MEIS2 mRNA	PMID:21858171
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:82527	Ptaquiloside	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20141111	CTD	MESH:C043680	ptaquiloside results in decreased expression of MEIS2 mRNA	PMID:23274088
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of MEIS2 mRNA	PMID:30953684
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1305198	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of MEIS2 mRNA	PMID:30047161
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305198	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MEIS2 mRNA	PMID:30047161
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:85990	panobinostat	affects expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat affects the expression of MEIS2 mRNA	PMID:26733615
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	(+)-JQ1 compound promotes the reaction [panobinostat affects the expression of MEIS2 mRNA]; panobinostat promotes the reaction [(+)-JQ1 compound affects the expression of MEIS2 mRNA]	PMID:26733615
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEIS2 mRNA	PMID:27188386
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:9513	thalidomide	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D013792	Thalidomide inhibits the reaction [CRBN protein binds to and results in increased ubiquitination of and results in increased degradation of MEIS2 protein]	PMID:25043012
1313085	MEIS2	Meis homeobox 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550144	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of MEIS2 mRNA	PMID:28973697
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1619527	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TTLL2 mRNA	PMID:37995155
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TTLL2 mRNA	PMID:28818685
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TTLL2 intron	PMID:30157460
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of TTLL2 mRNA	PMID:41028656
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TTLL2 mRNA	PMID:41028656
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1619527	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL2 mRNA	PMID:34876320
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1619527	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL2 mRNA	PMID:34876320
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TTLL2 exon; Benzo(a)pyrene affects the methylation of TTLL2 promoter	PMID:27901495
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TTLL2 3' UTR	PMID:27901495
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TTLL2 mRNA	PMID:41028656
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305200	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of TTLL2 mRNA	PMID:24395379
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1619527	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of TTLL2 mRNA	PMID:35295148
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305200	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TTLL2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TTLL2 gene	PMID:31601247
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1305200	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of TTLL2 mRNA	PMID:18500788
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1619527	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TTLL2 mRNA	PMID:40194260
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TTLL2 gene	PMID:29154799
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1619527	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL2 mRNA	PMID:34876320
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TTLL2 gene]	PMID:28238834
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1619527	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of TTLL2 mRNA	PMID:34876320
1313087	TTLL2	tubulin tyrosine ligase like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305200	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of TTLL2 mRNA	PMID:24780913
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of DR1 mRNA	PMID:24763279
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DR1 mRNA	PMID:20044591
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313089	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DR1 mRNA	PMID:39241906
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305201	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DR1 mRNA	PMID:33387578
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DR1 mRNA	PMID:21179406
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of DR1 mRNA	PMID:27683099
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313089	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DR1 mRNA	PMID:33754040
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DR1 mRNA	PMID:28818685
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:18291	manganese atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of DR1 mRNA	PMID:17175027
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DR1 mRNA	PMID:37325564
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DR1 mRNA	PMID:19549813
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DR1 protein	PMID:23301498
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1313089	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of DR1 mRNA	PMID:19376150
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DR1 mRNA	PMID:27153756
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313089	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DR1 mRNA	PMID:19770486
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DR1 mRNA	PMID:23649840
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DR1 mRNA	PMID:35430440
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313089	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DR1 mRNA	PMID:31919559
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313089	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DR1 mRNA	PMID:25629700
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DR1 mRNA	PMID:40504410
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DR1 mRNA	PMID:19244175
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of DR1 protein	PMID:35688186
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DR1 mRNA	PMID:22298810
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DR1 mRNA	PMID:17101203
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305201	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DR1 mRNA	PMID:33387578
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DR1 mRNA	PMID:33212167
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DR1 mRNA	PMID:21457566
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DR1 mRNA	PMID:40504410
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313089	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DR1 mRNA	PMID:19770486
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1305201	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of DR1 mRNA	PMID:32479839
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313089	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DR1 gene	PMID:35295148
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305201	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of DR1 mRNA	PMID:34492290
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313089	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of DR1 mRNA	PMID:23811191
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313089	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of DR1 mRNA	PMID:28472532
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313089	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of DR1 promoter	PMID:27334623
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of DR1 mRNA	PMID:29275510
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of DR1 mRNA	PMID:19244175
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313089	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DR1 mRNA	PMID:37019170
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of DR1 mRNA]	PMID:19030233
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:35154	manganese(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of DR1 mRNA	PMID:17175027
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1313089	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride affects the expression of DR1 mRNA	PMID:18974090
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DR1 protein	PMID:24527689
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DR1 mRNA	PMID:37325564
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DR1 mRNA	PMID:19320972
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DR1 mRNA	PMID:19244175
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:3766	clozapine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of DR1 protein	PMID:34122009
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DR1 mRNA	PMID:31533062
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DR1 gene	PMID:29154799
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DR1 mRNA	PMID:23179753
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DR1 mRNA	PMID:20106945|PMID:25562108
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of DR1 mRNA	PMID:36621641
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313089	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DR1 mRNA	PMID:17562736
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DR1 mRNA	PMID:40504410
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305201	E	RGD:6480464	20150303	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of DR1 mRNA	PMID:17108234
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313089	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DR1 mRNA	PMID:35964746
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1305201	E	RGD:6480464	20150303	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of DR1 mRNA	PMID:21983209
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:5613	haloperidol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in decreased expression of DR1 protein	PMID:34122009
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of DR1 mRNA	PMID:17175027
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of DR1 mRNA	PMID:28988120
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313089	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DR1 mRNA	PMID:22206623
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DR1 protein	PMID:37664457
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305201	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of DR1 mRNA	PMID:24136188
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:755208	eprenetapopt	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of DR1 mRNA	PMID:19946333
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of DR1 mRNA]	PMID:19946333
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1305201	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of DR1 protein	PMID:28903499
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of DR1 protein	PMID:37664457
1313088	DR1	down-regulator of transcription 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305201	E	RGD:6480464	20150303	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DR1 mRNA	PMID:21346803
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305203	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of BAG1 mRNA	PMID:21551480
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BAG1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of BAG1 mRNA	PMID:32699268
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of BAG1 mRNA	PMID:24763279
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313092	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of BAG1 mRNA	PMID:39241906
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of BAG1 mRNA	PMID:39298647
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305203	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of BAG1 gene	PMID:27618143
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1305203	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in increased expression of BAG1 protein	PMID:18093815
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in decreased expression of BAG1 mRNA	PMID:23649840|PMID:27664576
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of BAG1 mRNA	PMID:18037150
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of BAG1 mRNA	PMID:31256213
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of BAG1 protein alternative form	PMID:12479363
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of BAG1 mRNA	PMID:12634122
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of BAG1 mRNA	PMID:24376830
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of BAG1 mRNA	PMID:19549813
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of BAG1 protein	PMID:23301498
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of BAG1 mRNA	PMID:26760959
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of BAG1 mRNA	PMID:23649840
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BAG1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of BAG1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of BAG1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of BAG1 mRNA	PMID:32699268|PMID:35430440
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of BAG1 mRNA	PMID:19774075
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of BAG1 mRNA	PMID:15226459
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of BAG1 mRNA	PMID:40512198
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313092	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of BAG1 mRNA	PMID:40504410
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BAG1 mRNA	PMID:19244175
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of BAG1 mRNA	PMID:19561079
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1313092	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of BAG1 mRNA	PMID:15681117
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313092	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BAG1 mRNA	PMID:21570461
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305203	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BAG1 mRNA	PMID:33387578|PMID:34747641
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of BAG1 protein	PMID:39603559
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of BAG1 mRNA	PMID:30851411
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of BAG1 mRNA	PMID:20971185
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of BAG1 mRNA	PMID:16439991
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	[Doxorubicin co-treated with Cyclophosphamide] affects the expression of BAG1 mRNA	PMID:16322899
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of BAG1 mRNA	PMID:12760830|PMID:20886546|PMID:38568856
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of BAG1 mRNA	PMID:14691202|PMID:36209798
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of BAG1 mRNA	PMID:10910055|PMID:34032870
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of BAG1 mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of BAG1 mRNA	PMID:12634122|PMID:40512198
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313092	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of BAG1 mRNA	PMID:40504410
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313092	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BAG1 mRNA	PMID:20504355
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:29866	arsenite(3-)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of BAG1 mRNA	PMID:18585952
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C015001	XPA protein affects the reaction [arsenite results in increased expression of BAG1 mRNA]	PMID:18585952
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of BAG1 mRNA	PMID:20971185
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:30145	lithium atom	increases expression	ISO	RGD:1305203	E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in increased expression of BAG1 mRNA; Lithium results in increased expression of BAG1 protein	PMID:15872096
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:30146	lithium hydride	increases expression	ISO	RGD:1305203	E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in increased expression of BAG1 mRNA; Lithium results in increased expression of BAG1 protein	PMID:15872096
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of BAG1 mRNA	PMID:15226459
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of BAG1 mRNA	PMID:25351596
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of BAG1 mRNA	PMID:20382639
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of BAG1 mRNA	PMID:17530438
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C008261	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of BAG1 mRNA	PMID:12634122
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313092	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BAG1 gene	PMID:35295148
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313092	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of BAG1 protein	PMID:10426811
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of BAG1 mRNA	PMID:38479592
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305203	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of BAG1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of BAG1 mRNA	PMID:33221593
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305203	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of BAG1 mRNA	PMID:25181051
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305203	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of BAG1 gene	PMID:28505145
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:3392	carbendazim	increases expression	ISO	RGD:1305203	E	RGD:6480464	20121113	CTD	MESH:C006698	carbendazim results in increased expression of BAG1 mRNA	PMID:22952946
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	ISO	RGD:1305203	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of BAG1 mRNA	PMID:22937105
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1305203	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of BAG1 mRNA	PMID:22937105
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1305203	E	RGD:6480464	20120412	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of BAG1 mRNA	PMID:17452286
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305203	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of BAG1 mRNA	PMID:22546817
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:34682	diazinon	decreases expression	ISO	RGD:1305203	E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon results in decreased expression of BAG1 mRNA	PMID:17452286
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of BAG1 mRNA	PMID:17361019|PMID:21266533
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305203	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of BAG1 mRNA	PMID:22546817
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of BAG1 mRNA	PMID:34813904
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305203	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of BAG1 mRNA	PMID:22546817
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of BAG1 mRNA	PMID:18836921
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BAG1 mRNA	PMID:37042841
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:35176	zinc sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of BAG1 mRNA	PMID:15226459
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of BAG1 mRNA; Cadmium Chloride results in decreased expression of BAG1 protein	PMID:12160620
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of BAG1 mRNA	PMID:15501611
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of BAG1 mRNA	PMID:38174414
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305203	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of BAG1 mRNA	PMID:33453195
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of BAG1 mRNA	PMID:12634122
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of BAG1 mRNA	PMID:17553155
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:C018021	cobaltous chloride results in increased expression of BAG1 mRNA	PMID:19320972|PMID:19376846|PMID:25281833
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:C018021	cobaltous chloride promotes the reaction [Chromium Alloys results in increased expression of BAG1 mRNA]	PMID:25281833
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of BAG1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of BAG1 mRNA	PMID:32699268
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BAG1 mRNA	PMID:19244175
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20130416	CTD	MESH:D013755	BAG1 protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of DUSP1 mRNA]; BAG1 protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MT2A mRNA]; BAG1 protein promotes the reaction [[Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of RELA protein]; BAG1 protein promotes the reaction [[Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein] which results in increased localization of and results in increased activity of NFKB1 protein]; BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of CXCL8 mRNA]; BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of FKBP5 mRNA]; BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP1 mRNA]; BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP3 mRNA]; BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 mRNA]; BAG1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased degradation of NFKBIA protein]	PMID:20858459
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:38319	usnic acid	decreases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in decreased expression of BAG1 mRNA	PMID:32508146
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of BAG1 mRNA	PMID:40434365
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:39098	pyrethrins	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D011722	Pyrethrins results in decreased expression of BAG1 mRNA	PMID:35321623
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BAG1 mRNA	PMID:25979313
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1305203	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of BAG1 mRNA; Valproic Acid results in increased expression of BAG1 protein	PMID:15872096
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of BAG1 mRNA	PMID:17183730
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:4027	cyclophosphamide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	[Doxorubicin co-treated with Cyclophosphamide] affects the expression of BAG1 mRNA	PMID:16322899
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:41774	tamoxifen	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	BAG1 protein affects the susceptibility to Tamoxifen	PMID:19066611
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1305203	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of BAG1 mRNA	PMID:17005392
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313092	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of BAG1 mRNA	PMID:21041162
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide affects the localization of BAG1 protein	PMID:17110918
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of BAG1 mRNA	PMID:29309887
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305203	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of BAG1 mRNA	PMID:33387578
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of BAG1 mRNA	PMID:19036117
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of BAG1 mRNA	PMID:40512198
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313092	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of BAG1 mRNA	PMID:40504410
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:47344	alvocidib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C077990	alvocidib results in decreased expression of BAG1 mRNA; alvocidib results in decreased expression of BAG1 protein; alvocidib results in decreased expression of BAG1 protein alternative form	PMID:10887097|PMID:15972445
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of BAG1 mRNA	PMID:31838189
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BAG1 mRNA	PMID:22079256
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313092	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of BAG1 mRNA	PMID:35436446
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:48242	dichromium trioxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C023600	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of BAG1 mRNA	PMID:12634122
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of BAG1 mRNA	PMID:38568856
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of BAG1 mRNA	PMID:17530438
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:50594	carbon nanotube	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of BAG1 mRNA	PMID:15585362
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of BAG1 mRNA	PMID:17183730
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20121113	CTD	MESH:D007545	Isoproterenol results in decreased expression of BAG1 mRNA	PMID:21335049
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of BAG1 mRNA	PMID:29309887
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305203	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of BAG1 mRNA	PMID:30467583
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:6954	Mitotane	increases expression	ISO	RGD:1305203	E	RGD:6480464	20191114	CTD	MESH:D008939	Mitotane results in increased expression of BAG1 mRNA	PMID:23485034
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of BAG1 mRNA	PMID:22101062
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of BAG1 mRNA	PMID:22079256
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of BAG1 mRNA	PMID:22079256
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:75701	sarin	decreases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of BAG1 mRNA	PMID:19522546
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:75701	sarin	increases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of BAG1 mRNA	PMID:19522546
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1305203	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of BAG1 mRNA	PMID:15215175
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of BAG1 mRNA	PMID:30851411
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1313092	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of BAG1 mRNA	PMID:22538082
1313091	BAG1	BAG cochaperone 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of BAG1 mRNA	PMID:29301935
1313095	IPO4	importin 4	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of IPO4 mRNA	PMID:38218311
1313095	IPO4	importin 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305206	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of IPO4 mRNA]	PMID:31150632
1313095	IPO4	importin 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of IPO4 mRNA	PMID:23724009|PMID:33167477
1313095	IPO4	importin 4	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of IPO4 mRNA	PMID:22378314
1313095	IPO4	importin 4	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313096	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of IPO4 mRNA	PMID:30319688
1313095	IPO4	importin 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of IPO4 mRNA	PMID:20044591
1313095	IPO4	importin 4	gene	CHEBI:16240	hydrogen peroxide	decreases secretion	ISO	RGD:1313096	E	RGD:6480464	20121218	CTD	MESH:D006861	Hydrogen Peroxide results in decreased secretion of IPO4 mRNA	PMID:21179422
1313095	IPO4	importin 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313096	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IPO4 mRNA	PMID:39241906
1313095	IPO4	importin 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305206	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of IPO4 mRNA	PMID:32145629
1313095	IPO4	importin 4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of IPO4 mRNA	PMID:23019147|PMID:31614463
1313095	IPO4	importin 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305206	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of IPO4 mRNA	PMID:26496021
1313095	IPO4	importin 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of IPO4 mRNA	PMID:37042841
1313095	IPO4	importin 4	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of IPO4 protein	PMID:32044396
1313095	IPO4	importin 4	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of IPO4 mRNA	PMID:23649840
1313095	IPO4	importin 4	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of IPO4 mRNA	PMID:18037150
1313095	IPO4	importin 4	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of IPO4 mRNA	PMID:33359661
1313095	IPO4	importin 4	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313096	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of IPO4 mRNA	PMID:23892564
1313095	IPO4	importin 4	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of IPO4 promoter	PMID:30157460
1313095	IPO4	importin 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IPO4 mRNA	PMID:36331819
1313095	IPO4	importin 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305206	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of IPO4 protein	PMID:34915118
1313095	IPO4	importin 4	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of IPO4 protein	PMID:23301498
1313095	IPO4	importin 4	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of IPO4 mRNA	PMID:23649840
1313095	IPO4	importin 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of IPO4 exon	PMID:30157460
1313095	IPO4	importin 4	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of IPO4 mRNA	PMID:23649840
1313095	IPO4	importin 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of IPO4 mRNA	PMID:35430440
1313095	IPO4	importin 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of IPO4 mRNA	PMID:34911549
1313095	IPO4	importin 4	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305206	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of IPO4 mRNA	PMID:30779732
1313095	IPO4	importin 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305206	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of IPO4 mRNA	PMID:31150632
1313095	IPO4	importin 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313096	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of IPO4 mRNA	PMID:27339419|PMID:31919559
1313095	IPO4	importin 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305206	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of IPO4 mRNA]	PMID:31150632
1313095	IPO4	importin 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IPO4 mRNA	PMID:22206623
1313095	IPO4	importin 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IPO4 mRNA	PMID:40504410
1313095	IPO4	importin 4	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of IPO4 mRNA	PMID:27594783
1313095	IPO4	importin 4	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of IPO4 mRNA	PMID:23019147
1313095	IPO4	importin 4	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IPO4 mRNA	PMID:24768652|PMID:25583101
1313095	IPO4	importin 4	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D009532	MT1 affects the reaction [Nickel affects the expression of IPO4 mRNA]; MT2 affects the reaction [Nickel affects the expression of IPO4 mRNA]	PMID:16166738
1313095	IPO4	importin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313096	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IPO4 mRNA	PMID:20702594|PMID:21570461
1313095	IPO4	importin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IPO4 mRNA	PMID:17942748|PMID:18796159
1313095	IPO4	importin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IPO4 mRNA	PMID:17942748
1313095	IPO4	importin 4	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of IPO4 protein	PMID:39603559
1313095	IPO4	importin 4	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305206	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of IPO4 mRNA	PMID:28374803
1313095	IPO4	importin 4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of IPO4 mRNA	PMID:32763439
1313095	IPO4	importin 4	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of IPO4 mRNA	PMID:29803840
1313095	IPO4	importin 4	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of IPO4 gene	PMID:28589171
1313095	IPO4	importin 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IPO4 mRNA	PMID:40504410
1313095	IPO4	importin 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IPO4 exon	PMID:30157460
1313095	IPO4	importin 4	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of IPO4 mRNA	PMID:25895662
1313095	IPO4	importin 4	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of IPO4 gene	PMID:31601247
1313095	IPO4	importin 4	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of IPO4 gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of IPO4 gene	PMID:31601247
1313095	IPO4	importin 4	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305206	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of IPO4 mRNA	PMID:24136188
1313095	IPO4	importin 4	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C009495	titanium dioxide results in decreased expression of IPO4 protein	PMID:30910687
1313095	IPO4	importin 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313096	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IPO4 gene; titanium dioxide results in decreased methylation of IPO4 promoter	PMID:35295148
1313095	IPO4	importin 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305206	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of IPO4 mRNA	PMID:23411599|PMID:34492290
1313095	IPO4	importin 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of IPO4 mRNA	PMID:18648102
1313095	IPO4	importin 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313096	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of IPO4 mRNA	PMID:23811191
1313095	IPO4	importin 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of IPO4 mRNA	PMID:19710929
1313095	IPO4	importin 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of IPO4 mRNA	PMID:30903817
1313095	IPO4	importin 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of IPO4 protein	PMID:37567409
1313095	IPO4	importin 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305206	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of IPO4 mRNA	PMID:30816183|PMID:33296240|PMID:34947998
1313095	IPO4	importin 4	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of IPO4 gene	PMID:31601247
1313095	IPO4	importin 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of IPO4 mRNA	PMID:17989879
1313095	IPO4	importin 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305206	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of IPO4 mRNA	PMID:25181051
1313095	IPO4	importin 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of IPO4 gene	PMID:31601247
1313095	IPO4	importin 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305206	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of IPO4 mRNA	PMID:26496021
1313095	IPO4	importin 4	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	IPO4 mRNA affects the susceptibility to Carmustine	PMID:16365179
1313095	IPO4	importin 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of IPO4 protein	PMID:34186270
1313095	IPO4	importin 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313096	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of IPO4 mRNA	PMID:39298647|PMID:40203079
1313095	IPO4	importin 4	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of IPO4 promoter	PMID:30157460
1313095	IPO4	importin 4	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of IPO4 gene	PMID:31601247
1313095	IPO4	importin 4	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of IPO4 protein	PMID:34186270
1313095	IPO4	importin 4	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313096	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of IPO4 mRNA	PMID:28392331
1313095	IPO4	importin 4	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305206	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of IPO4 mRNA	PMID:32680482
1313095	IPO4	importin 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of IPO4 protein	PMID:26879310
1313095	IPO4	importin 4	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305206	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of IPO4 gene	PMID:22079235
1313095	IPO4	importin 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of IPO4 mRNA	PMID:19320972|PMID:19376846
1313095	IPO4	importin 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IPO4 mRNA	PMID:32588087
1313095	IPO4	importin 4	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of IPO4 mRNA	PMID:28302478
1313095	IPO4	importin 4	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of IPO4 mRNA	PMID:31533062
1313095	IPO4	importin 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IPO4 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of IPO4 mRNA	PMID:36331819
1313095	IPO4	importin 4	gene	CHEBI:39426	perfluorobutyric acid	increases expression	ISO	RGD:1313096	E	RGD:6480464	20220308	CTD	MESH:C033094	perfluorobutyric acid results in increased expression of IPO4 mRNA	PMID:34474067
1313095	IPO4	importin 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IPO4 mRNA	PMID:25979313
1313095	IPO4	importin 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of IPO4 mRNA	PMID:17292431
1313095	IPO4	importin 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of IPO4 mRNA; Valproic Acid results in decreased expression of IPO4 protein	PMID:19101580|PMID:29501571
1313095	IPO4	importin 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of IPO4 mRNA	PMID:23179753
1313095	IPO4	importin 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of IPO4 gene	PMID:29154799
1313095	IPO4	importin 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of IPO4 mRNA	PMID:22147139
1313095	IPO4	importin 4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of IPO4 mRNA	PMID:20106945|PMID:25562108
1313095	IPO4	importin 4	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of IPO4 mRNA	PMID:17555576
1313095	IPO4	importin 4	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305206	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of IPO4 mRNA	PMID:24136188
1313095	IPO4	importin 4	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of IPO4 protein	PMID:38832940
1313095	IPO4	importin 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IPO4 mRNA	PMID:38832940
1313095	IPO4	importin 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IPO4 mRNA	PMID:17562736
1313095	IPO4	importin 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of IPO4 mRNA	PMID:21420995|PMID:22230336
1313095	IPO4	importin 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305206	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of IPO4 mRNA	PMID:33387578
1313095	IPO4	importin 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of IPO4 mRNA	PMID:19420014
1313095	IPO4	importin 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IPO4 mRNA	PMID:40504410
1313095	IPO4	importin 4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of IPO4 mRNA	PMID:17555576
1313095	IPO4	importin 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of IPO4 mRNA	PMID:17942748
1313095	IPO4	importin 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IPO4 mRNA	PMID:17942748
1313095	IPO4	importin 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313096	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IPO4 mRNA; Nanotubes, Carbon results in increased expression of IPO4 mRNA	PMID:25554681
1313095	IPO4	importin 4	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305206	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of IPO4 mRNA	PMID:24136188
1313095	IPO4	importin 4	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305206	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of IPO4 mRNA	PMID:24793618
1313095	IPO4	importin 4	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305206	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of IPO4 mRNA	PMID:24136188
1313095	IPO4	importin 4	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of IPO4 protein	PMID:32959892
1313095	IPO4	importin 4	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305206	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of IPO4 mRNA	PMID:24136188
1313095	IPO4	importin 4	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of IPO4 mRNA	PMID:15336504
1313095	IPO4	importin 4	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of IPO4 promoter	PMID:30157460
1313095	IPO4	importin 4	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305206	E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of IPO4 mRNA	PMID:28935588
1313095	IPO4	importin 4	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1313096	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of IPO4 mRNA	PMID:31052254
1313095	IPO4	importin 4	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	IPO4 mRNA affects the susceptibility to temozolomide	PMID:16365179
1313095	IPO4	importin 4	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of IPO4 protein	PMID:34186270
1313095	IPO4	importin 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313096	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IPO4 mRNA	PMID:22206623
1313095	IPO4	importin 4	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of IPO4 protein	PMID:37664457
1313095	IPO4	importin 4	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305206	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of IPO4 mRNA	PMID:24136188
1313095	IPO4	importin 4	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of IPO4 protein	PMID:39638853
1313095	IPO4	importin 4	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of IPO4 protein	PMID:39638853
1313095	IPO4	importin 4	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305206	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of IPO4 mRNA	PMID:21346803
1313095	IPO4	importin 4	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of IPO4 mRNA	PMID:30928695
1313095	IPO4	importin 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1313096	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of IPO4 mRNA	PMID:20702594
1313095	IPO4	importin 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of IPO4 protein	PMID:31675489
1313095	IPO4	importin 4	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of IPO4 protein	PMID:31675489
1313095	IPO4	importin 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313096	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of IPO4 mRNA	PMID:39847705
1313095	IPO4	importin 4	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313096	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of IPO4 mRNA	PMID:21278054
1313095	IPO4	importin 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of IPO4 protein	PMID:37664457
1313095	IPO4	importin 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305206	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of IPO4 mRNA	PMID:21346803
1313095	IPO4	importin 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305206	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of IPO4 mRNA	PMID:21346803
1313095	IPO4	importin 4	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305206	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of IPO4 mRNA	PMID:22570695
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1587105	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LDLRAD4 mRNA]	PMID:31150632
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313100	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of LDLRAD4 mRNA	PMID:26251327
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313100	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of LDLRAD4 mRNA	PMID:20188158
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of LDLRAD4 mRNA	PMID:23724009
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313100	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of LDLRAD4 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of LDLRAD4 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of LDLRAD4 mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LDLRAD4 mRNA	PMID:30951980|PMID:36189433
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1587105	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of LDLRAD4 gene	PMID:28931070|PMID:35440735
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313100	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of LDLRAD4 mRNA	PMID:40945087
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313100	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LDLRAD4 mRNA	PMID:39241906
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313100	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of LDLRAD4 mRNA]	PMID:39241906
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of LDLRAD4 mRNA	PMID:19619570
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LDLRAD4 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of LDLRAD4 mRNA	PMID:19619570|PMID:30165855
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313100	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of LDLRAD4 mRNA	PMID:33711761
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of LDLRAD4 mRNA	PMID:23649840
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of LDLRAD4 mRNA	PMID:17404688
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313100	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of LDLRAD4 mRNA	PMID:36189433
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of LDLRAD4 mRNA	PMID:33647349
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:17574	biochanin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004541	biochanin A results in decreased expression of LDLRAD4 mRNA	PMID:12111696
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LDLRAD4 mRNA	PMID:36139627
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1587105	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of LDLRAD4 mRNA	PMID:33387578
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of LDLRAD4 intron	PMID:30157460
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313100	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LDLRAD4 mRNA	PMID:36331819
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in increased expression of LDLRAD4 mRNA	PMID:34773240
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Selenium inhibits the reaction [Cadmium results in increased expression of LDLRAD4 mRNA]	PMID:34773240
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313100	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LDLRAD4 mRNA	PMID:37236586
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of LDLRAD4 mRNA	PMID:19549813
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of LDLRAD4 mRNA	PMID:23649840
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of LDLRAD4 protein	PMID:20106945
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of LDLRAD4 intron	PMID:30157460
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LDLRAD4 gene	PMID:27153756
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1587105	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of LDLRAD4 mRNA	PMID:30779732
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:2682	amphotericin B	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in increased expression of LDLRAD4 mRNA	PMID:28534445
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1587105	E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LDLRAD4 mRNA	PMID:30690589|PMID:31150632
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:27385	tetrachloromethane	increases methylation	ISO	RGD:1587105	E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in increased methylation of LDLRAD4 promoter	PMID:30690589
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1587105	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LDLRAD4 mRNA]	PMID:31150632
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of LDLRAD4 mRNA	PMID:19244175
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in increased expression of LDLRAD4 mRNA]	PMID:34773240
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313100	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LDLRAD4 mRNA	PMID:28189721
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1587105	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of LDLRAD4 mRNA	PMID:31881176
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313100	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of LDLRAD4 mRNA	PMID:40618947
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LDLRAD4 mRNA	PMID:19619570|PMID:20106945
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LDLRAD4 mRNA	PMID:21632981
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1587105	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LDLRAD4 mRNA	PMID:32109520|PMID:33387578
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LDLRAD4 mRNA	PMID:19619570
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of LDLRAD4 mRNA	PMID:29955902
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LDLRAD4 mRNA	PMID:33212167
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of LDLRAD4 mRNA	PMID:23649840
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1587105	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of LDLRAD4 mRNA	PMID:28959563
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LDLRAD4 mRNA	PMID:29803840
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of LDLRAD4 gene	PMID:28589171
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of LDLRAD4 mRNA	PMID:21714911
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LDLRAD4 5' UTR; Benzo(a)pyrene affects the methylation of LDLRAD4 intron; Benzo(a)pyrene affects the methylation of LDLRAD4 promoter	PMID:27901495|PMID:30157460
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LDLRAD4 mRNA	PMID:20064835|PMID:20106945|PMID:22316170|PMID:32234424
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313100	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LDLRAD4 mRNA	PMID:19770486
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LDLRAD4 exon	PMID:27901495
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313100	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LDLRAD4 intron	PMID:27901495
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of LDLRAD4 mRNA	PMID:25895662
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313100	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of LDLRAD4 mRNA	PMID:39716349
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313100	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of LDLRAD4 mRNA	PMID:22609695
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1587105	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of LDLRAD4 mRNA	PMID:30047161
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313100	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LDLRAD4 promoter	PMID:35295148
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1587105	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of LDLRAD4 mRNA	PMID:34492290
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1587105	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LDLRAD4 mRNA	PMID:34947998
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of LDLRAD4 mRNA	PMID:31715268
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313100	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of LDLRAD4 mRNA	PMID:30951980
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1587105	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LDLRAD4 mRNA	PMID:25181051
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1587105	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LDLRAD4 gene	PMID:28505145
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313100	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of LDLRAD4 mRNA	PMID:30951980
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313100	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of LDLRAD4 mRNA	PMID:25172293
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313100	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LDLRAD4 mRNA	PMID:30951980
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313100	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of LDLRAD4 mRNA	PMID:30951980
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LDLRAD4 intron	PMID:30157460
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313100	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of LDLRAD4 mRNA	PMID:30951980
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313100	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of LDLRAD4 mRNA	PMID:30951980
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313100	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LDLRAD4 intron	PMID:28392331
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313100	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of LDLRAD4 mRNA]	PMID:39241906
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1587105	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of LDLRAD4 gene	PMID:33148267
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LDLRAD4 mRNA	PMID:37042841
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of LDLRAD4 mRNA	PMID:29024780
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313100	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LDLRAD4 mRNA	PMID:37236586
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of LDLRAD4 mRNA	PMID:19244175
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in increased expression of LDLRAD4 mRNA]	PMID:34773240
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313100	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of LDLRAD4 mRNA	PMID:23811191
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of LDLRAD4 mRNA	PMID:31533062
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313100	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LDLRAD4 mRNA	PMID:36331819
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LDLRAD4 mRNA	PMID:25979313
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of LDLRAD4 mRNA	PMID:29154799
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of LDLRAD4 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1587105	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of LDLRAD4 mRNA	PMID:30047161
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of LDLRAD4 mRNA	PMID:20106945|PMID:27989131
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of LDLRAD4 promoter	PMID:27989131
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1313100	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of LDLRAD4 mRNA	PMID:40633821
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of LDLRAD4 mRNA	PMID:14699072
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in increased expression of LDLRAD4 mRNA	PMID:19059307
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of LDLRAD4 mRNA	PMID:25047013
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of LDLRAD4 mRNA	PMID:23649840
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LDLRAD4 mRNA	PMID:38832940
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of LDLRAD4 mRNA	PMID:29067470
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1587105	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LDLRAD4 mRNA	PMID:33387578
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:46680	serpentine asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of LDLRAD4 5' UTR	PMID:29523930
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1587105	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of LDLRAD4 mRNA	PMID:29391264
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of LDLRAD4 mRNA	PMID:32234424
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313100	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of LDLRAD4 mRNA	PMID:39716349
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1587105	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of LDLRAD4 mRNA	PMID:30047161
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1587105	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of LDLRAD4 mRNA	PMID:24793618
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313100	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of LDLRAD4 mRNA	PMID:23608068
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1587105	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of LDLRAD4 mRNA	PMID:28801915
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of LDLRAD4 mRNA	PMID:28988120
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of LDLRAD4 mRNA	PMID:24810058
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LDLRAD4 intron	PMID:30157460
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1587105	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LDLRAD4 gene	PMID:35440735
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1587105	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of LDLRAD4 gene	PMID:33148267
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313100	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LDLRAD4 mRNA	PMID:22206623
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1587105	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of LDLRAD4 mRNA	PMID:33484710
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LDLRAD4 mRNA	PMID:36139627
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313100	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of LDLRAD4 mRNA	PMID:23091169
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1313100	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of LDLRAD4 mRNA	PMID:38995820
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of LDLRAD4 mRNA	PMID:26079696
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313100	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of LDLRAD4 mRNA	PMID:39847705
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1587105	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of LDLRAD4 mRNA	PMID:30047161
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313100	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of LDLRAD4 mRNA]	PMID:39241906
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of LDLRAD4 mRNA	PMID:19059307
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of LDLRAD4 mRNA	PMID:29301935
1313099	LDLRAD4	low density lipoprotein receptor class A domain containing 4	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313100	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of LDLRAD4 mRNA	PMID:28973697
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1619154	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RIPOR3 mRNA	PMID:33045310
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1619154	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of RIPOR3 mRNA	PMID:36189433
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1619154	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RIPOR3 mRNA	PMID:36189433
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:15379	dioxygen	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency affects the expression of RIPOR3 mRNA	PMID:25596134
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of RIPOR3 mRNA	PMID:22378314|PMID:40865780
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RIPOR3 mRNA	PMID:35811015
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RIPOR3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RIPOR3 mRNA	PMID:35811015
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of FAM65C mRNA	PMID:30510588
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1619154	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RIPOR3 mRNA	PMID:36189433
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of RIPOR3 mRNA	PMID:33647349
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1619154	E	RGD:6480464	20170725	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RIPOR3 mRNA	PMID:27405655
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of RIPOR3 mRNA	PMID:16002434|PMID:26485663
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of RIPOR3 mRNA	PMID:16002434
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of FAM65C mRNA	PMID:28818685
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of RIPOR3 intron	PMID:30157460
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1619154	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RIPOR3 mRNA	PMID:36331819
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1619154	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RIPOR3 mRNA	PMID:37236586
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RIPOR3 gene	PMID:27153756
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RIPOR3 intron	PMID:30157460
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1619154	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of FAM65C mRNA	PMID:28960355
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RIPOR3 mRNA	PMID:25583101
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1587669	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RIPOR3 mRNA	PMID:32109520
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RIPOR3 mRNA	PMID:22903824
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1587669	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RIPOR3 mRNA	PMID:33387578
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RIPOR3 mRNA	PMID:23179753|PMID:28001369
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RIPOR3 mRNA	PMID:33212167
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RIPOR3 mRNA	PMID:30851411
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1587669	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of RIPOR3 mRNA	PMID:28959563
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1587669	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of RIPOR3 mRNA	PMID:26033743
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1619154	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of RIPOR3 mRNA	PMID:39515575
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of RIPOR3 mRNA	PMID:22316170
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1619154	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FAM65C 5' UTR; Benzo(a)pyrene results in decreased methylation of FAM65C exon; Benzo(a)pyrene results in decreased methylation of FAM65C intron	PMID:27901495
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FAM65C promoter	PMID:27901495
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1587669	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of RIPOR3 mRNA	PMID:26033743
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of RIPOR3 mRNA	PMID:20382639
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1587669	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of RIPOR3 mRNA	PMID:24395379
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1587669	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RIPOR3 mRNA	PMID:34492290
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of RIPOR3 mRNA	PMID:25912373
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1587669	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RIPOR3 mRNA	PMID:25181051
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1619154	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of RIPOR3 mRNA	PMID:38074096
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RIPOR3 gene	PMID:31601247
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of FAM65C mRNA	PMID:29275510
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1619154	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in increased expression of FAM65C mRNA	PMID:30245210
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of RIPOR3 mRNA; 2,5,2',5'-tetrachlorobiphenyl results in decreased expression of RIPOR3 mRNA	PMID:36804509
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C543008	bisphenol S results in decreased expression of RIPOR3 mRNA	PMID:25912373
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1619154	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RIPOR3 mRNA	PMID:38685157
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1587669	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RIPOR3 mRNA	PMID:35163327
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1619154	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RIPOR3 mRNA	PMID:37236586
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1587669	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RIPOR3 mRNA	PMID:35163327
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1587669	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RIPOR3 mRNA	PMID:35163327
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1619154	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RIPOR3 mRNA	PMID:36331819
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RIPOR3 mRNA	PMID:25979313
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FAM65C gene	PMID:29154799
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of RIPOR3 mRNA	PMID:25047013
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RIPOR3 mRNA	PMID:38832940
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of RIPOR3 mRNA	PMID:24714768
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of RIPOR3 mRNA	PMID:35811015
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RIPOR3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RIPOR3 mRNA	PMID:35811015
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1587669	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RIPOR3 mRNA	PMID:29391264
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1619154	E	RGD:6480464	20170725	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of RIPOR3 mRNA	PMID:19042947
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1619154	E	RGD:6480464	20170725	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of RIPOR3 mRNA	PMID:23608068
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1587669	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of FAM65C mRNA	PMID:28801915
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of RIPOR3 mRNA	PMID:28988120
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:72754	bisphenol AF	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in decreased expression of RIPOR3 mRNA	PMID:25912373
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in increased expression of FAM65C mRNA	PMID:28284560
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RIPOR3 mRNA	PMID:30851411
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1587669	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RIPOR3 mRNA	PMID:24780913|PMID:25825206
1313101	RIPOR3	RIPOR family member 3	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1619154	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of FAM65C mRNA	PMID:35537566
1313103	POLI	DNA polymerase iota	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of POLI gene	PMID:20938992
1313103	POLI	DNA polymerase iota	gene	CHEBI:16235	guanine	decreases activity	EXP		E	RGD:6480464	20150825	CTD	MESH:D006147	Guanine metabolite results in decreased activity of POLI protein	PMID:26010525
1313103	POLI	DNA polymerase iota	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of POLI mRNA	PMID:39298647
1313103	POLI	DNA polymerase iota	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305212	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of POLI gene	PMID:27618143
1313103	POLI	DNA polymerase iota	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of POLI gene	PMID:20938992
1313103	POLI	DNA polymerase iota	gene	CHEBI:17256	2'-deoxyadenosine	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:C058118	[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLI protein; POLN protein inhibits the reaction [[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLI protein]	PMID:26098310
1313103	POLI	DNA polymerase iota	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305212	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of POLI mRNA	PMID:33387578
1313103	POLI	DNA polymerase iota	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of POLI mRNA	PMID:28818685
1313103	POLI	DNA polymerase iota	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POLI mRNA	PMID:37236586
1313103	POLI	DNA polymerase iota	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of POLI mRNA	PMID:19549813
1313103	POLI	DNA polymerase iota	gene	CHEBI:23704	diepoxybutane	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:C007366	[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLI protein; POLN protein inhibits the reaction [[diepoxybutane binds to 2'-deoxyadenosine] which results in decreased activity of POLI protein]	PMID:26098310
1313103	POLI	DNA polymerase iota	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305212	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of POLI mRNA	PMID:30779732
1313103	POLI	DNA polymerase iota	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305212	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of POLI mRNA	PMID:31150632
1313103	POLI	DNA polymerase iota	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of POLI gene	PMID:20938992
1313103	POLI	DNA polymerase iota	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of POLI mRNA	PMID:26272509
1313103	POLI	DNA polymerase iota	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	PMID:27188386
1313103	POLI	DNA polymerase iota	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of POLI protein	PMID:35688186
1313103	POLI	DNA polymerase iota	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of POLI mRNA	PMID:28189721|PMID:28960355
1313103	POLI	DNA polymerase iota	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1305212	E	RGD:6480464	20210608	CTD	MESH:C059514	Resveratrol results in decreased expression of POLI mRNA	PMID:33775663
1313103	POLI	DNA polymerase iota	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in decreased expression of POLI mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of POLI mRNA	PMID:19167446|PMID:23557933
1313103	POLI	DNA polymerase iota	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in decreased expression of POLI mRNA	PMID:22228119
1313103	POLI	DNA polymerase iota	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305212	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLI mRNA	PMID:22298810
1313103	POLI	DNA polymerase iota	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313104	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLI mRNA	PMID:21570461
1313103	POLI	DNA polymerase iota	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POLI mRNA	PMID:19770486
1313103	POLI	DNA polymerase iota	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305212	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POLI mRNA	PMID:33387578
1313103	POLI	DNA polymerase iota	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to POLI promoter]	PMID:19654925
1313103	POLI	DNA polymerase iota	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of POLI mRNA	PMID:28001369
1313103	POLI	DNA polymerase iota	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of POLI mRNA	PMID:39709020
1313103	POLI	DNA polymerase iota	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305212	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of POLI mRNA	PMID:28959563
1313103	POLI	DNA polymerase iota	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313104	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of POLI mRNA	PMID:27862939
1313103	POLI	DNA polymerase iota	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of POLI mRNA	PMID:29803840
1313103	POLI	DNA polymerase iota	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of POLI mRNA	PMID:34032870
1313103	POLI	DNA polymerase iota	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POLI mRNA	PMID:40419235
1313103	POLI	DNA polymerase iota	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of POLI mRNA	PMID:19073995|PMID:33720480
1313103	POLI	DNA polymerase iota	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of POLI mRNA	PMID:26238291
1313103	POLI	DNA polymerase iota	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of POLI mRNA	PMID:31745603
1313103	POLI	DNA polymerase iota	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305212	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of POLI mRNA	PMID:23411599
1313103	POLI	DNA polymerase iota	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of POLI mRNA	PMID:19710929
1313103	POLI	DNA polymerase iota	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305212	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of POLI mRNA	PMID:30816183|PMID:34947998
1313103	POLI	DNA polymerase iota	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of POLI mRNA	PMID:19244175
1313103	POLI	DNA polymerase iota	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of POLI mRNA	PMID:39298647
1313103	POLI	DNA polymerase iota	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of POLI mRNA	PMID:38685157
1313103	POLI	DNA polymerase iota	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1313104	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of POLI mRNA	PMID:36464114
1313103	POLI	DNA polymerase iota	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of POLI mRNA	PMID:17361019|PMID:21266533
1313103	POLI	DNA polymerase iota	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of POLI mRNA	PMID:34813904
1313103	POLI	DNA polymerase iota	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of POLI mRNA	PMID:37042841
1313103	POLI	DNA polymerase iota	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POLI mRNA	PMID:37236586
1313103	POLI	DNA polymerase iota	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305212	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased expression of POLI mRNA	PMID:22079235
1313103	POLI	DNA polymerase iota	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of POLI mRNA	PMID:24449571
1313103	POLI	DNA polymerase iota	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of POLI mRNA	PMID:28302478
1313103	POLI	DNA polymerase iota	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in decreased expression of POLI mRNA	PMID:19167446
1313103	POLI	DNA polymerase iota	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of POLI mRNA	PMID:27153767
1313103	POLI	DNA polymerase iota	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313104	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of POLI mRNA	PMID:36331819
1313103	POLI	DNA polymerase iota	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of POLI mRNA	PMID:25979313
1313103	POLI	DNA polymerase iota	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of POLI mRNA	PMID:23179753
1313103	POLI	DNA polymerase iota	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1313104	E	RGD:6480464	20130416	CTD	MESH:C017160	cypermethrin results in increased expression of POLI mRNA	PMID:21142847
1313103	POLI	DNA polymerase iota	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of POLI mRNA	PMID:38832940
1313103	POLI	DNA polymerase iota	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313104	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of POLI mRNA	PMID:17562736
1313103	POLI	DNA polymerase iota	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of POLI mRNA	PMID:22077320
1313103	POLI	DNA polymerase iota	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of POLI mRNA	PMID:22079256
1313103	POLI	DNA polymerase iota	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of POLI mRNA	PMID:35436446
1313103	POLI	DNA polymerase iota	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:1313104	E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in increased expression of POLI mRNA	PMID:17441966
1313103	POLI	DNA polymerase iota	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313104	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of POLI mRNA; Nanotubes, Carbon results in decreased expression of POLI mRNA	PMID:25554681
1313103	POLI	DNA polymerase iota	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1313104	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of POLI mRNA	PMID:22078008
1313103	POLI	DNA polymerase iota	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1313104	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of POLI mRNA	PMID:36464114
1313103	POLI	DNA polymerase iota	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313104	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of POLI mRNA	PMID:22206623
1313103	POLI	DNA polymerase iota	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of POLI mRNA	PMID:22079256
1313103	POLI	DNA polymerase iota	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of POLI mRNA	PMID:22079256
1313103	POLI	DNA polymerase iota	gene	CHEBI:75390	3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid	decreases activity	EXP		E	RGD:6480464	20161213	CTD	MESH:C060893	MK-886 results in decreased activity of POLI protein	PMID:23305233
1313103	POLI	DNA polymerase iota	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	PMID:27188386
1313103	POLI	DNA polymerase iota	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of POLI mRNA	PMID:30928695
1313103	POLI	DNA polymerase iota	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313104	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of POLI mRNA	PMID:21278054
1313103	POLI	DNA polymerase iota	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of POLI mRNA	PMID:26272509
1313103	POLI	DNA polymerase iota	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	PMID:27188386
1313103	POLI	DNA polymerase iota	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of POLI mRNA	PMID:27188386
1313103	POLI	DNA polymerase iota	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305212	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of POLI mRNA	PMID:23034163
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of PNN protein	PMID:39638853
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of PNN mRNA	PMID:21551480
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of PNN mRNA	PMID:15498508
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:15882	phenol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019800	Phenol results in decreased expression of PNN mRNA	PMID:17547211
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PNN mRNA	PMID:35953652
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of PNN mRNA; Lipopolysaccharides inhibits the reaction [Propofol results in decreased expression of PNN mRNA]; Lipopolysaccharides inhibits the reaction [Sevoflurane results in decreased expression of PNN mRNA]	PMID:35877022|PMID:35953652
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of PNN mRNA	PMID:32145629|PMID:35192832
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PNN mRNA	PMID:38568856
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PNN mRNA	PMID:33387578
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PNN mRNA	PMID:37042841
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of PNN protein	PMID:32044396
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313106	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PNN mRNA	PMID:23892564
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313106	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PNN mRNA	PMID:33754040
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313106	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PNN mRNA	PMID:34319233
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PNN protein	PMID:37730182
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313106	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PNN mRNA	PMID:37236586
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PNN mRNA	PMID:19549813
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PNN protein	PMID:23301498
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PNN gene	PMID:27153756
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313106	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PNN mRNA	PMID:19770486
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PNN mRNA	PMID:18593933
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313106	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PNN mRNA	PMID:22206623
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of PNN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PNN mRNA	PMID:39836092|PMID:40512198
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313106	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PNN mRNA	PMID:40504410
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PNN protein	PMID:35688186
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1597086	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of PNN mRNA	PMID:26302742
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:27810	resorcinol	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in increased expression of PNN mRNA	PMID:22623647
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of PNN mRNA	PMID:25905778
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin affects the reaction [Piroxicam results in decreased expression of PNN mRNA]	PMID:21858171
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313106	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PNN mRNA	PMID:30912803
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of PNN mRNA	PMID:16963248
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313106	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PNN mRNA	PMID:21570461
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1597086	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PNN mRNA	PMID:34747641
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PNN mRNA	PMID:20106945|PMID:21632981
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PNN mRNA	PMID:22808131|PMID:33387578
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313106	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PNN mRNA	PMID:28922406
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:28197	daidzein	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C004742	[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of PNN mRNA	PMID:16963248
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of PNN mRNA	PMID:29955902
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PNN mRNA	PMID:28001369
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PNN mRNA	PMID:33212167
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1597086	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of PNN mRNA	PMID:30556269
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of PNN protein	PMID:35688186
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of PNN mRNA	PMID:20044591
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PNN mRNA; sodium arsenite results in decreased expression of PNN protein	PMID:38228842|PMID:38568856
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of PNN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PNN mRNA	PMID:39836092|PMID:40512198
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313106	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PNN mRNA	PMID:40504410
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PNN mRNA	PMID:20106945|PMID:21632981
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313106	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PNN mRNA	PMID:19770486
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:29866	arsenite(3-)	affects expression	EXP		E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of PNN mRNA	PMID:22959463
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313106	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of PNN protein	PMID:37955338
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1597086	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of PNN mRNA	PMID:30556269
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PNN mRNA	PMID:18593933
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PNN mRNA	PMID:19150397|PMID:20018196
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of PNN mRNA	PMID:35984750
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of PNN mRNA	PMID:15498508
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313106	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PNN gene	PMID:35295148
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PNN mRNA	PMID:19162173
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PNN mRNA	PMID:29275510
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313106	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PNN mRNA	PMID:32156529|PMID:33221593
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of PNN mRNA	PMID:32145629|PMID:35192832
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1597086	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PNN mRNA	PMID:25181051|PMID:34947998
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PNN protein	PMID:34186270
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:34778	glycitein	multiple interactions	EXP		E	RGD:6480464	20141104	CTD	MESH:C086566	[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of PNN mRNA	PMID:16963248
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of PNN mRNA	PMID:17312168
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PNN mRNA	PMID:38568856
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PNN protein	PMID:33830842
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of and results in decreased methylation of PNN mRNA	PMID:33830842
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313106	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PNN mRNA	PMID:37236586
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of PNN mRNA	PMID:30047161
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PNN mRNA	PMID:19376846
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PNN mRNA	PMID:24449571
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PNN mRNA	PMID:27153767
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313106	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PNN protein	PMID:26178269
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1597086	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of PNN mRNA	PMID:23125180
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PNN mRNA	PMID:25979313
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PNN mRNA	PMID:19101580|PMID:23179753|PMID:26272509|PMID:27188386
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PNN mRNA	PMID:27188386
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PNN mRNA	PMID:30047161|PMID:41580965
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:44915	propofol	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D015742	Propofol results in decreased expression of PNN mRNA	PMID:35953652
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:44915	propofol	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D015742	Lipopolysaccharides inhibits the reaction [Propofol results in decreased expression of PNN mRNA]	PMID:35953652
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313106	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PNN mRNA	PMID:17562736
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of PNN mRNA	PMID:26690555
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PNN mRNA	PMID:29523930
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of PNN mRNA	PMID:25351596
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of PNN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PNN mRNA	PMID:39836092|PMID:40512198
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313106	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PNN mRNA	PMID:40504410
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PNN mRNA	PMID:22079256
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1597086	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PNN mRNA	PMID:30307764
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PNN mRNA	PMID:30047161
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1597086	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in increased expression of PNN mRNA	PMID:41580965
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of PNN mRNA	PMID:19162173
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313106	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PNN mRNA	PMID:35964746
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1597086	E	RGD:6480464	20120814	CTD	MESH:D005485	Flutamide results in increased expression of PNN mRNA	PMID:20566332
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1313106	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of PNN mRNA	PMID:26377693
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PNN protein	PMID:32959892
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313106	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PNN mRNA	PMID:21641980
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313106	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PNN mRNA	PMID:23650126
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of PNN mRNA	PMID:28988120
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:64153	tanespimycin	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C112765	tanespimycin results in increased expression of PNN mRNA	PMID:19514085
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PNN mRNA	PMID:31758290
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PNN protein	PMID:34186270
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313106	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PNN mRNA	PMID:22206623
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PNN mRNA	PMID:24136188
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PNN mRNA	PMID:22079256
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of PNN mRNA	PMID:22079256
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PNN protein	PMID:31285264
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PNN mRNA	PMID:27188386
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PNN gene]	PMID:28238834
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313106	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of PNN mRNA	PMID:23091169
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of PNN mRNA	PMID:30047161
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1597086	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of PNN mRNA	PMID:20345932
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PNN mRNA	PMID:27291303
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1597086	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of PNN protein	PMID:28903499
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of PNN mRNA	PMID:23914054
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of PNN mRNA	PMID:21858171
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin affects the reaction [Piroxicam results in decreased expression of PNN mRNA]	PMID:21858171
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PNN mRNA	PMID:30047161
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1597086	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PNN mRNA	PMID:24780913
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PNN mRNA	PMID:27188386
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:9130	sevoflurane	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C009250	Sevoflurane results in increased expression of PNN mRNA	PMID:35953652
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:9130	sevoflurane	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:C009250	Lipopolysaccharides inhibits the reaction [Sevoflurane results in decreased expression of PNN mRNA]	PMID:35953652
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1597086	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of PNN mRNA	PMID:30047161
1313105	PNN	pinin, desmosome associated protein	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1597086	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PNN mRNA	PMID:23034163
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550148	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of NT5DC1 mRNA	PMID:33045310
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NT5DC1 mRNA	PMID:33167477
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550148	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NT5DC1 mRNA	PMID:36331819
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1550148	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of NT5DC1 mRNA	PMID:23892564
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1305214	E	RGD:6480464	20180116	CTD	MESH:D009538	Nicotine results in increased expression of NT5DC1 mRNA	PMID:27782041
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1305214	E	RGD:6480464	20180116	CTD	MESH:D009538	Nicotine results in increased expression of NT5DC1 mRNA	PMID:27782041
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NT5DC1 mRNA	PMID:19549813
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NT5DC1 protein	PMID:23301498
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of NT5DC1 mRNA	PMID:27153756
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NT5DC1 protein	PMID:38460933
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of NT5DC1 mRNA	PMID:27392435
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of NT5DC1 mRNA	PMID:27392435
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:28088	genistein	increases methylation	ISO	RGD:1305214	E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of NT5DC1 gene	PMID:28505145
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550148	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NT5DC1 mRNA	PMID:21570461
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550148	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NT5DC1 mRNA	PMID:33956508
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305214	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NT5DC1 mRNA	PMID:33387578
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NT5DC1 mRNA	PMID:28001369
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NT5DC1 mRNA	PMID:33212167
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NT5DC1 protein	PMID:33212167
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of NT5DC1 mRNA	PMID:39709020
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NT5DC1 mRNA	PMID:29803840
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NT5DC1 mRNA	PMID:38568856
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550148	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of NT5DC1 mRNA	PMID:36209798
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NT5DC1 mRNA	PMID:26238291|PMID:32234424
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1550148	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NT5DC1 intron	PMID:27901495
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1550148	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of NT5DC1 protein	PMID:37955338
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NT5DC1 mRNA	PMID:20018196|PMID:26238291
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305214	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NT5DC1 mRNA	PMID:25729387
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550148	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of NT5DC1 mRNA	PMID:29264374
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550148	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NT5DC1 gene	PMID:35295148
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550148	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NT5DC1 mRNA	PMID:18301758|PMID:23811191
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of NT5DC1 protein	PMID:37567409
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305214	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NT5DC1 mRNA	PMID:25181051
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of NT5DC1 protein	PMID:34186270
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305214	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NT5DC1 gene	PMID:28505145
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550148	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NT5DC1 mRNA	PMID:39298647
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of NT5DC1 protein	PMID:34186270
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550148	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of NT5DC1 mRNA	PMID:38685157
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of NT5DC1 protein	PMID:34186270
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1550148	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of NT5DC1 mRNA	PMID:28392331
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550148	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NT5DC1 mRNA	PMID:37019170
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to NT5DC1 protein	PMID:32991956
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NT5DC1 mRNA	PMID:38568856
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:3763	clorgyline	increases expression	EXP		E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of NT5DC1 mRNA	PMID:19691856
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D015741	Metribolone results in increased expression of NT5C2L1 protein	PMID:17152098
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of NT5DC1 mRNA	PMID:28302478
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NT5DC1 mRNA	PMID:31533062
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550148	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NT5DC1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NT5DC1 mRNA	PMID:36331819
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NT5DC1 mRNA	PMID:25979313
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of NT5DC1 mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of NT5DC1 gene	PMID:29154799
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NT5DC1 mRNA	PMID:20106945|PMID:25562108
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NT5DC1 mRNA	PMID:38832940
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of NT5DC1 mRNA	PMID:24935251|PMID:26272509
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NT5DC1 mRNA	PMID:27188386
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305214	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NT5DC1 mRNA	PMID:33387578
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NT5DC1 protein	PMID:38460933
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305214	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of NT5DC1 mRNA	PMID:29391264
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D018038	Sodium Selenite results in increased expression of NT5C2L1 mRNA	PMID:18175754
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305214	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of NT5DC1 mRNA	PMID:23962444
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305214	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of NT5DC1 mRNA	PMID:24793618
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NT5DC1 protein	PMID:32959892
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305214	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NT5DC1 mRNA	PMID:25729387
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305214	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of NT5DC1 mRNA	PMID:24136188
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305214	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of NT5DC1 mRNA	PMID:24136188
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305214	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of NT5DC1 mRNA	PMID:30467583
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550148	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NT5DC1 mRNA	PMID:22206623
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NT5DC1 protein	PMID:37664457
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NT5DC1 mRNA	PMID:27188386
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1305214	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of NT5DC1 mRNA	PMID:20345932
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1550148	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of NT5DC1 mRNA	PMID:40826991
1313107	NT5DC1	5'-nucleotidase domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NT5DC1 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NT5DC1 mRNA	PMID:27188386|PMID:37664457
1313110	SIRT6	sirtuin 6	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SIRT6 mRNA	PMID:38218311
1313110	SIRT6	sirtuin 6	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SIRT6 mRNA	PMID:37995155
1313110	SIRT6	sirtuin 6	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313111	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SIRT6 mRNA	PMID:30319688
1313110	SIRT6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	affects response to substance	ISO	RGD:1305216	E	RGD:6480464	20190312	CTD	MESH:D006861	SIRT6 protein affects the susceptibility to Hydrogen Peroxide	PMID:30660577
1313110	SIRT6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	decreases abundance	EXP		E	RGD:6480464	20230704	CTD	MESH:D006861	SIRT6 protein results in decreased abundance of Hydrogen Peroxide	PMID:36356655
1313110	SIRT6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1305216	E	RGD:6480464	20190312	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of SIRT6 mRNA; Hydrogen Peroxide results in decreased expression of SIRT6 protein	PMID:30660577
1313110	SIRT6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of SIRT6 mRNA; Hydrogen Peroxide results in increased expression of SIRT6 protein	PMID:36356655
1313110	SIRT6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1313111	E	RGD:6480464	20230704	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of SIRT6 mRNA; Hydrogen Peroxide results in increased expression of SIRT6 protein	PMID:36356655
1313110	SIRT6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1305216	E	RGD:6480464	20190312	CTD	MESH:D006861	BACH1 protein inhibits the reaction [SIRT6 protein inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]]; NFE2L2 protein promotes the reaction [SIRT6 protein inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]]; SIRT6 protein inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; SIRT6 protein inhibits the reaction [Hydrogen Peroxide results in increased expression of BACH1 protein]	PMID:30660577
1313110	SIRT6	sirtuin 6	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313111	E	RGD:6480464	20230704	CTD	MESH:D006861	SIRT6 protein affects the reaction [Hydrogen Peroxide affects the expression of NFE2L2 protein]	PMID:36356655
1313110	SIRT6	sirtuin 6	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:D011794	Quercetin results in increased expression of SIRT6 mRNA; Quercetin results in increased expression of SIRT6 protein	PMID:34219513
1313110	SIRT6	sirtuin 6	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313111	E	RGD:6480464	20150714	CTD	MESH:D011794	Quercetin results in increased expression of SIRT6 mRNA	PMID:25862958
1313110	SIRT6	sirtuin 6	gene	CHEBI:16509	1,4-benzoquinone	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C004532	quinone results in decreased expression of SIRT6 mRNA	PMID:39357595
1313110	SIRT6	sirtuin 6	gene	CHEBI:16509	1,4-benzoquinone	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:C004532	TUG1 inhibits the reaction [quinone results in decreased expression of SIRT6 mRNA]	PMID:39357595
1313110	SIRT6	sirtuin 6	gene	CHEBI:16814	dehydroepiandrosterone sulfate	increases expression	ISO	RGD:1305216	E	RGD:6480464	20150714	CTD	MESH:D019314	Dehydroepiandrosterone Sulfate results in increased expression of SIRT6 protein	PMID:25786523
1313110	SIRT6	sirtuin 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20190910	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT6 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT6 protein	PMID:31016965
1313110	SIRT6	sirtuin 6	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of SIRT6 mRNA	PMID:33359661
1313110	SIRT6	sirtuin 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SIRT6 mRNA	PMID:33908429
1313110	SIRT6	sirtuin 6	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SIRT6 protein	PMID:37730182
1313110	SIRT6	sirtuin 6	gene	CHEBI:197221	NORCANTHARIDIN	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C069741	norcantharidin results in decreased expression of SIRT6 mRNA	PMID:34272796
1313110	SIRT6	sirtuin 6	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SIRT6 mRNA	PMID:19549813
1313110	SIRT6	sirtuin 6	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SIRT6 mRNA	PMID:35430440
1313110	SIRT6	sirtuin 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313111	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIRT6 mRNA	PMID:40504410
1313110	SIRT6	sirtuin 6	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of SIRT6 protein	PMID:25533949
1313110	SIRT6	sirtuin 6	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	PARP1 protein affects the reaction [resveratrol results in increased expression of SIRT6 protein]; STF-118804 inhibits the reaction [resveratrol results in increased expression of SIRT6 protein]	PMID:25533949
1313110	SIRT6	sirtuin 6	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D002945	[Cisplatin co-treated with hesperetin] results in increased expression of SIRT6 protein	PMID:31153982
1313110	SIRT6	sirtuin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313111	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SIRT6 mRNA	PMID:21570461
1313110	SIRT6	sirtuin 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305216	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SIRT6 mRNA	PMID:33387578
1313110	SIRT6	sirtuin 6	gene	CHEBI:28230	hesperetin	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C013015	hesperetin results in increased expression of SIRT6 protein	PMID:31153982
1313110	SIRT6	sirtuin 6	gene	CHEBI:28230	hesperetin	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C013015	[Cisplatin co-treated with hesperetin] results in increased expression of SIRT6 protein	PMID:31153982
1313110	SIRT6	sirtuin 6	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SIRT6 mRNA	PMID:33212167
1313110	SIRT6	sirtuin 6	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SIRT6 mRNA	PMID:32763439
1313110	SIRT6	sirtuin 6	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SIRT6 mRNA	PMID:24690739
1313110	SIRT6	sirtuin 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1305216	E	RGD:6480464	20220510	CTD	MESH:D004317	Doxorubicin results in decreased expression of SIRT6 mRNA; Doxorubicin results in decreased expression of SIRT6 protein	PMID:34713381|PMID:38395252
1313110	SIRT6	sirtuin 6	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20220510	CTD	MESH:D004317	Doxorubicin results in decreased expression of SIRT6 mRNA; Doxorubicin results in decreased expression of SIRT6 protein	PMID:34713381|PMID:38395252
1313110	SIRT6	sirtuin 6	gene	CHEBI:28748	doxorubicin	increases response to substance	ISO	RGD:1313111	E	RGD:6480464	20220510	CTD	MESH:D004317	SIRT6 gene mutant form results in increased susceptibility to Doxorubicin	PMID:34713381
1313110	SIRT6	sirtuin 6	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1305216	E	RGD:6480464	20220510	CTD	MESH:D004317	Doxorubicin inhibits the reaction [SIRT6 protein binds to FAS promoter]; Doxorubicin inhibits the reaction [SIRT6 protein binds to FASLG promoter]; Doxorubicin promotes the reaction [SIRT6 protein binds to TP53 protein]; Doxorubicin results in decreased expression of and results in decreased activity of SIRT6 protein; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN1A mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN2A mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL1B mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL6 mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TNF mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TP53 mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of IL1B protein]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of IL6 protein]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of TNF protein]]; SIRT6 protein inhibits the reaction [Doxorubicin promotes the reaction [TP53 protein binds to FAS promoter]]; SIRT6 protein inhibits the reaction [Doxorubicin promotes the reaction [TP53 protein binds to FASLG promoter]]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of ACADL mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of ACADM mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CAT mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CAT protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CD36 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CPT1A mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of GPX1 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of HMGB1 protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of PRDX5 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of SOD2 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased acetylation of TP53 protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased cleavage of CASP3 protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased cleavage of CASP8 protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN1A mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN2A mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of FADD protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of FAS mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of FAS protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of FASLG mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of FASLG protein modified form]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of FASLG protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL1B mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL6 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of PDK4 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of RIPK1 protein modified form]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of RIPK3 protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TNF mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TP53 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of IL1B protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of IL6 protein]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of TNF protein]	PMID:34713381|PMID:38395252
1313110	SIRT6	sirtuin 6	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313111	E	RGD:6480464	20220510	CTD	MESH:D004317	Doxorubicin results in decreased expression of and results in decreased activity of SIRT6 protein; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of CAT mRNA]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of CAT protein]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of FAS mRNA]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of FASL mRNA]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of GPX1 mRNA]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of PRDX5 mRNA]; SIRT6 gene mutant form promotes the reaction [Doxorubicin results in increased expression of SOD2 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of ACADL mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of ACADM mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CD36 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of CPT1A mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN1A mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN2A mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL1B mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL6 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of PDK4 mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TNF mRNA]; SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TRP53 mRNA]; SIRT6 protein promotes the reaction [Doxorubicin results in decreased expression of RIPK1 protein]	PMID:34713381|PMID:38395252
1313110	SIRT6	sirtuin 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305216	E	RGD:6480464	20220208	CTD	MESH:C017947	sodium arsenite results in decreased expression of SIRT6 protein	PMID:31874112
1313110	SIRT6	sirtuin 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SIRT6 mRNA	PMID:38568856|PMID:39719251
1313110	SIRT6	sirtuin 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313111	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIRT6 mRNA	PMID:40504410
1313110	SIRT6	sirtuin 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SIRT6 mRNA	PMID:22228805
1313110	SIRT6	sirtuin 6	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SIRT6 mRNA	PMID:24690739
1313110	SIRT6	sirtuin 6	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305216	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of SIRT6 mRNA	PMID:19167457
1313110	SIRT6	sirtuin 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305216	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SIRT6 mRNA	PMID:25181051|PMID:34947998
1313110	SIRT6	sirtuin 6	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305216	E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SIRT6 mRNA	PMID:17316808
1313110	SIRT6	sirtuin 6	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SIRT6 mRNA	PMID:38685157
1313110	SIRT6	sirtuin 6	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313111	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SIRT6 mRNA	PMID:37019170
1313110	SIRT6	sirtuin 6	gene	CHEBI:34905	paraquat	decreases response to substance	EXP		E	RGD:6480464	20201215	CTD	MESH:D010269	SIRT6 protein results in decreased susceptibility to Paraquat	PMID:31216030
1313110	SIRT6	sirtuin 6	gene	CHEBI:34905	paraquat	decreases response to substance	ISO	RGD:1313111	E	RGD:6480464	20230704	CTD	MESH:D010269	SIRT6 protein results in decreased susceptibility to Paraquat	PMID:36356655
1313110	SIRT6	sirtuin 6	gene	CHEBI:34905	paraquat	decreases stability	ISO	RGD:1313111	E	RGD:6480464	20201215	CTD	MESH:D010269	Paraquat results in decreased stability of SIRT6 protein mutant form	PMID:31216030
1313110	SIRT6	sirtuin 6	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313111	E	RGD:6480464	20230704	CTD	MESH:D010269	Paraquat results in increased expression of SIRT6 mRNA; Paraquat results in increased expression of SIRT6 protein	PMID:36356655
1313110	SIRT6	sirtuin 6	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D010269	[SIRT6 protein results in decreased susceptibility to Paraquat] inhibits the reaction [NFE2L2 protein binds to HMOX1 enhancer]; NFE2L2 mRNA promotes the reaction [Paraquat promotes the reaction [SIRT6 protein binds to HMOX1 gene]]; Paraquat promotes the reaction [SIRT6 protein binds to HMOX1 gene]	PMID:31216030
1313110	SIRT6	sirtuin 6	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313111	E	RGD:6480464	20201215	CTD	MESH:D010269	[SIRT6 protein mutant form results in decreased activity of SIRT6 protein] inhibits the reaction [Paraquat promotes the reaction [SMARCA4 protein binds to HMOX1 enhancer]]; [SIRT6 protein mutant form results in decreased activity of SIRT6 protein] inhibits the reaction [Paraquat results in increased expression of HMOX1 mRNA]; Paraquat promotes the reaction [SIRT6 protein binds to HMOX1 gene]; Paraquat promotes the reaction [SMARCC2 protein binds to SIRT6 protein]; SIRT6 promotes the reaction [Paraquat results in increased expression of GCLC mRNA]; SIRT6 promotes the reaction [Paraquat results in increased expression of GCLM mRNA]; SIRT6 promotes the reaction [Paraquat results in increased expression of GSS mRNA]; SIRT6 promotes the reaction [Paraquat results in increased expression of HMOX1 mRNA]; SIRT6 promotes the reaction [Paraquat results in increased expression of HSF1 mRNA]; SIRT6 promotes the reaction [Paraquat results in increased expression of NQO1 mRNA]; SIRT6 promotes the reaction [Paraquat results in increased expression of TXNRD1 mRNA]; SIRT6 protein affects the reaction [Paraquat results in increased cleavage of CASP3 protein]; SIRT6 protein promotes the reaction [Paraquat promotes the reaction [POLR2A protein modified form binds to HMOX1 gene]]; SIRT6 protein promotes the reaction [Paraquat promotes the reaction [SMARCA4 protein binds to HMOX1 enhancer]]; SIRT6 protein promotes the reaction [Paraquat promotes the reaction [SMARCC2 protein binds to HMOX1 enhancer]]	PMID:31216030|PMID:36356655
1313110	SIRT6	sirtuin 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SIRT6 mRNA	PMID:37042841
1313110	SIRT6	sirtuin 6	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SIRT6 mRNA	PMID:38174414
1313110	SIRT6	sirtuin 6	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313111	E	RGD:6480464	20190910	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SIRT6 mRNA	PMID:31016965
1313110	SIRT6	sirtuin 6	gene	CHEBI:37647	xanthone	multiple interactions	ISO	RGD:1305216	E	RGD:6480464	20230704	CTD	MESH:C009689	xanthone inhibits the reaction [Isoproterenol results in decreased expression of SIRT6 mRNA]	PMID:36414029
1313110	SIRT6	sirtuin 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313111	E	RGD:6480464	20190910	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SIRT6 mRNA	PMID:31016965
1313110	SIRT6	sirtuin 6	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D003474	Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in decreased expression of SIRT6 mRNA]; Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in decreased expression of SIRT6 protein]; SIRT6 protein promotes the reaction [Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in decreased expression of ABCA1 mRNA]]; SIRT6 protein promotes the reaction [Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in decreased expression of ABCA1 protein]]; SIRT6 protein promotes the reaction [Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of CCL2 protein]]; SIRT6 protein promotes the reaction [Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of IL6 protein]]; SIRT6 protein promotes the reaction [Curcumin inhibits the reaction [malondialdehyde-low density lipoprotein, human results in increased expression of TNF protein]]	PMID:33952798
1313110	SIRT6	sirtuin 6	gene	CHEBI:42567	fisetin	affects expression	ISO	RGD:1305216	E	RGD:6480464	20240903	CTD	MESH:C017875	fisetin affects the expression of SIRT6 protein	PMID:38278314
1313110	SIRT6	sirtuin 6	gene	CHEBI:42567	fisetin	multiple interactions	ISO	RGD:1305216	E	RGD:6480464	20240903	CTD	MESH:C017875	fisetin inhibits the reaction [IL1B protein results in decreased expression of SIRT6 protein]	PMID:38278314
1313110	SIRT6	sirtuin 6	gene	CHEBI:45863	paclitaxel	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D017239	Paclitaxel results in decreased expression of SIRT6 mRNA	PMID:34272796
1313110	SIRT6	sirtuin 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305216	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SIRT6 mRNA	PMID:33387578
1313110	SIRT6	sirtuin 6	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of SIRT6 mRNA	PMID:24690739
1313110	SIRT6	sirtuin 6	gene	CHEBI:46661	asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001194	Asbestos affects the expression of SIRT6 mRNA	PMID:17297452
1313110	SIRT6	sirtuin 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313111	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIRT6 mRNA	PMID:40504410
1313110	SIRT6	sirtuin 6	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of SIRT6 mRNA	PMID:22077320
1313110	SIRT6	sirtuin 6	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1305216	E	RGD:6480464	20230704	CTD	MESH:D007545	Isoproterenol results in decreased expression of SIRT6 mRNA	PMID:36414029
1313110	SIRT6	sirtuin 6	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1305216	E	RGD:6480464	20230704	CTD	MESH:D007545	xanthone inhibits the reaction [Isoproterenol results in decreased expression of SIRT6 mRNA]	PMID:36414029
1313110	SIRT6	sirtuin 6	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1305216	E	RGD:6480464	20180220	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SIRT6 protein affects the phosphorylation of EP300 protein]	PMID:27094368
1313110	SIRT6	sirtuin 6	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1305216	E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in decreased expression of SIRT6 mRNA	PMID:25452209
1313110	SIRT6	sirtuin 6	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1305216	E	RGD:6480464	20180220	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [SIRT6 protein results in decreased expression of EP300 protein]	PMID:27094368
1313110	SIRT6	sirtuin 6	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of SIRT6 protein	PMID:31285264
1313110	SIRT6	sirtuin 6	gene	CHEBI:79989	GW 6471	multiple interactions	ISO	RGD:1305216	E	RGD:6480464	20240806	CTD	MESH:C449302	GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN1A mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of CDKN2A mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL1B mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of IL6 mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TNF mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased expression of TP53 mRNA]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of IL1B protein]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of IL6 protein]]; GW 6471 inhibits the reaction [SIRT6 protein inhibits the reaction [Doxorubicin results in increased secretion of TNF protein]]	PMID:38395252
1313110	SIRT6	sirtuin 6	gene	CHEBI:8093	phenylephrine	multiple interactions	ISO	RGD:1305216	E	RGD:6480464	20180220	CTD	MESH:D010656	[SIRT6 protein co-treated with EP300 protein] affects the reaction [Phenylephrine results in increased expression of NPPA mRNA]; [SIRT6 protein co-treated with EP300 protein] affects the reaction [Phenylephrine results in increased expression of NPPB mRNA]; Phenylephrine results in decreased expression of and results in decreased activity of SIRT6 protein; SIRT6 protein affects the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of EP300 protein]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]; SIRT6 protein inhibits the reaction [Phenylephrine results in increased expression of NPPB mRNA]	PMID:27094368
1313110	SIRT6	sirtuin 6	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313111	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of SIRT6 mRNA	PMID:40826991
1313110	SIRT6	sirtuin 6	gene	CHEBI:90369	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide	decreases activity	EXP		E	RGD:6480464	20200211	CTD	MESH:C550547	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased activity of SIRT6 protein	PMID:26518726
1313110	SIRT6	sirtuin 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305216	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SIRT6 mRNA	PMID:21346803
1313110	SIRT6	sirtuin 6	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SIRT6 mRNA	PMID:38568856
1313112	FOXB1	forkhead box B1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313113	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXB1 gene	PMID:20938992
1313112	FOXB1	forkhead box B1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of FOXB1 mRNA	PMID:30510588
1313112	FOXB1	forkhead box B1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313113	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXB1 gene	PMID:20938992
1313112	FOXB1	forkhead box B1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXB1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of FOXB1 mRNA	PMID:39836092
1313112	FOXB1	forkhead box B1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313113	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of FOXB1 mRNA	PMID:15674843|PMID:15674844
1313112	FOXB1	forkhead box B1	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of FOXB1 mRNA	PMID:18356318
1313112	FOXB1	forkhead box B1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313113	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FOXB1 gene	PMID:20938992
1313112	FOXB1	forkhead box B1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FOXB1 mRNA	PMID:39836092
1313112	FOXB1	forkhead box B1	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313113	E	RGD:6480464	20240604	CTD	MESH:C010974	Glyphosate results in decreased expression of FOXB1 mRNA	PMID:33713393
1313112	FOXB1	forkhead box B1	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of FOXB1 promoter	PMID:22847954
1313112	FOXB1	forkhead box B1	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D019833	Genistein results in decreased expression of FOXB1 mRNA	PMID:25136773
1313112	FOXB1	forkhead box B1	gene	CHEBI:28112	nickel atom	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel affects the expression of FOXB1 mRNA	PMID:14575637
1313112	FOXB1	forkhead box B1	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D009532	trichostatin A inhibits the reaction [Nickel affects the expression of FOXB1 mRNA]	PMID:14575637
1313112	FOXB1	forkhead box B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313113	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FOXB1 mRNA	PMID:24058054
1313112	FOXB1	forkhead box B1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313113	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the reaction [AHR protein binds to FOXB1 promoter]	PMID:19654925
1313112	FOXB1	forkhead box B1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of FOXB1 mRNA	PMID:34032870
1313112	FOXB1	forkhead box B1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FOXB1 mRNA	PMID:39836092
1313112	FOXB1	forkhead box B1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FOXB1 5' UTR; Benzo(a)pyrene results in increased methylation of FOXB1 promoter	PMID:27901495
1313112	FOXB1	forkhead box B1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313113	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene affects the reaction [AHR protein binds to FOXB1 promoter]	PMID:19654925
1313112	FOXB1	forkhead box B1	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of FOXB1 promoter	PMID:23974009
1313112	FOXB1	forkhead box B1	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of FOXB1 mRNA	PMID:18356318
1313112	FOXB1	forkhead box B1	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of FOXB1 mRNA	PMID:35984750
1313112	FOXB1	forkhead box B1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305217	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of FOXB1 mRNA	PMID:30047161
1313112	FOXB1	forkhead box B1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313113	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FOXB1 gene; titanium dioxide results in decreased methylation of FOXB1 promoter	PMID:35295148
1313112	FOXB1	forkhead box B1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305217	E	RGD:6480464	20130806	CTD	MESH:C069837	fullerene C60 results in decreased expression of FOXB1 mRNA	PMID:19167457
1313112	FOXB1	forkhead box B1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305217	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FOXB1 mRNA	PMID:25181051
1313112	FOXB1	forkhead box B1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313113	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of FOXB1 promoter	PMID:27334623
1313112	FOXB1	forkhead box B1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FOXB1 gene	PMID:31601247
1313112	FOXB1	forkhead box B1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305217	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of FOXB1 mRNA	PMID:41034487
1313112	FOXB1	forkhead box B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of FOXB1 gene	PMID:31601247
1313112	FOXB1	forkhead box B1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXB1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of FOXB1 mRNA	PMID:39836092
1313112	FOXB1	forkhead box B1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313113	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FOXB1 mRNA	PMID:40194260
1313112	FOXB1	forkhead box B1	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of FOXB1 promoter	PMID:22847954
1313112	FOXB1	forkhead box B1	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of FOXB1 promoter	PMID:22847954
1313112	FOXB1	forkhead box B1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305217	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of FOXB1 mRNA	PMID:30047161
1313112	FOXB1	forkhead box B1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C012589	trichostatin A inhibits the reaction [Nickel affects the expression of FOXB1 mRNA]	PMID:14575637
1313112	FOXB1	forkhead box B1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313113	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FOXB1 mRNA	PMID:17562736
1313112	FOXB1	forkhead box B1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FOXB1 mRNA	PMID:39836092
1313112	FOXB1	forkhead box B1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305217	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of FOXB1 mRNA	PMID:30047161
1313112	FOXB1	forkhead box B1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FOXB1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of FOXB1 mRNA	PMID:39836092
1313112	FOXB1	forkhead box B1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305217	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of FOXB1 mRNA	PMID:32109520
1313112	FOXB1	forkhead box B1	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1313113	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of FOXB1 mRNA	PMID:21195148
1313112	FOXB1	forkhead box B1	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1313113	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of FOXB1 mRNA	PMID:21195148
1313112	FOXB1	forkhead box B1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305217	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FOXB1 mRNA	PMID:30047161
1313112	FOXB1	forkhead box B1	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1313113	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of FOXB1 mRNA	PMID:21195148
1313112	FOXB1	forkhead box B1	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1305217	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of FOXB1 mRNA	PMID:30047161
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MCM8 mRNA	PMID:38218311
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313115	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MCM8 mRNA	PMID:33045310
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MCM8 mRNA	PMID:33167477
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of MCM8 mRNA	PMID:26516004
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313115	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MCM8 mRNA	PMID:36331819
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MCM8 mRNA	PMID:21179406
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313115	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MCM8 mRNA	PMID:39241906
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MCM8 mRNA	PMID:21179406
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of MCM8 mRNA	PMID:38160208
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MCM8 mRNA	PMID:21592394
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM8 mRNA	PMID:21592394
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MCM8 mRNA	PMID:21592394
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM8 mRNA	PMID:21592394
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:1784	biphenyl-4-amine	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C006757	4-biphenylamine results in decreased expression of MCM8 protein	PMID:32433928
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:1784	biphenyl-4-amine	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C006757	Acetylcysteine inhibits the reaction [4-biphenylamine results in decreased expression of MCM8 protein]	PMID:32433928
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of MCM8 mRNA	PMID:17103032
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MCM8 mRNA	PMID:35301059
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313115	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MCM8 mRNA	PMID:28111341
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MCM8 mRNA	PMID:22100608
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305218	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MCM8 mRNA	PMID:23630614
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:2504	aflatoxin B1	increases mutagenesis	ISO	RGD:1305218	E	RGD:6480464	20240109	CTD	MESH:D016604	Aflatoxin B1 results in increased mutagenesis of MCM8 gene	PMID:36908029
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MCM8 mRNA	PMID:23649840
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MCM8 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MCM8 mRNA	PMID:35430440|PMID:41430723
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313115	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MCM8 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MCM8 mRNA	PMID:34911549
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313115	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MCM8 mRNA	PMID:31919559
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MCM8 gene	PMID:25304211
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MCM8 protein	PMID:35688186
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305218	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MCM8 mRNA	PMID:31881176
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of MCM8 mRNA	PMID:19167446
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MCM8 mRNA	PMID:28903495
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of MCM8 mRNA	PMID:27594783
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM8 mRNA	PMID:22574217
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313115	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM8 mRNA	PMID:21570461
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305218	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM8 mRNA	PMID:33387578
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of MCM8 protein	PMID:35688186
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MCM8 mRNA	PMID:29432896
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [4-biphenylamine results in decreased expression of MCM8 protein]	PMID:32433928
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MCM8 mRNA	PMID:22714537
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MCM8 mRNA	PMID:38568856
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCM8 mRNA	PMID:16120219|PMID:20064835
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MCM8 mRNA	PMID:32234424
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MCM8 mRNA	PMID:20018196
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MCM8 mRNA	PMID:26238291
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of MCM8 mRNA	PMID:38568856
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305218	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM8 mRNA	PMID:25729387
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305218	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MCM8 mRNA	PMID:34492290
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313115	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MCM8 mRNA	PMID:17950772|PMID:20813756|PMID:23811191
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313115	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of MCM8 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of MCM8 mRNA]	PMID:17950772|PMID:20813756
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of MCM8 mRNA	PMID:38479592
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MCM8 mRNA	PMID:30903817
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305218	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MCM8 mRNA	PMID:25181051
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MCM8 mRNA	PMID:29275510|PMID:33670352
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305218	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MCM8 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of MCM8 gene	PMID:31601247
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313115	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MCM8 mRNA	PMID:37019170
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MCM8 mRNA	PMID:37042841
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1305218	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of MCM8 mRNA	PMID:18500788
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MCM8 mRNA	PMID:38568856
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MCM8 mRNA	PMID:35301059
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313115	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MCM8 mRNA	PMID:28111341
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305218	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of MCM8 mRNA	PMID:25539665
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305218	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of MCM8 mRNA	PMID:24386269
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313115	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of MCM8 mRNA	PMID:23811191
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313115	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MCM8 mRNA	PMID:40194260
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MCM8 mRNA	PMID:31533062
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of MCM8 mRNA	PMID:19167446
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM8 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of MCM8 mRNA	PMID:19167446
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of MCM8 mRNA	PMID:26352163
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:3930	cryptolepine	decreases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C024015	cryptolepine results in decreased expression of MCM8 mRNA	PMID:16120219
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313115	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MCM8 mRNA	PMID:36331819
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1305218	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of MCM8 mRNA	PMID:22110744
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MCM8 gene	PMID:29154799
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of MCM8 mRNA	PMID:25562108
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of MCM8 mRNA	PMID:20106945|PMID:21632981
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MCM8 mRNA	PMID:38832940
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MCM8 mRNA	PMID:22230336
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305218	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MCM8 mRNA	PMID:33387578
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MCM8 mRNA	PMID:29523930
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MCM8 gene	PMID:25304211
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:4911	etoposide	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D005047	Etoposide results in decreased expression of MCM8 mRNA	PMID:16120219
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of MCM8 mRNA	PMID:38568856
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of MCM8 mRNA	PMID:21148553
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of MCM8 mRNA	PMID:22714537
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313115	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MCM8 mRNA	PMID:19042947
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305218	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MCM8 mRNA	PMID:25729387
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305218	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM8 mRNA	PMID:25729387
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1305218	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of MCM8 mRNA	PMID:19564919
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1305218	E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of MCM8 mRNA	PMID:19564919
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D002185	Cannabidiol results in decreased expression of MCM8 mRNA	PMID:36519830
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:73297	SCH 23390	decreases expression	ISO	RGD:1305218	E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 results in decreased expression of MCM8 mRNA	PMID:19564919
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:73297	SCH 23390	multiple interactions	ISO	RGD:1305218	E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of MCM8 mRNA	PMID:19564919
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313115	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MCM8 mRNA	PMID:22206623
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of MCM8 mRNA	PMID:29522793
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MCM8 mRNA	PMID:16120219
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MCM8 gene]	PMID:28238834
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM8 mRNA	PMID:19167446
1313114	MCM8	minichromosome maintenance 8 homologous recombination repair factor	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313115	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of MCM8 mRNA	PMID:35537566
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313117	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CDK20 mRNA	PMID:20188158
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDK20 gene	PMID:20938992
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:16236	ethanol	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D000431	CDK20 gene SNP affects the susceptibility to Ethanol	PMID:18438686
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313117	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CDK20 mRNA	PMID:39241906
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDK20 gene	PMID:20938992
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CDK20 mRNA	PMID:21179406
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313117	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CDK20 mRNA	PMID:34319233
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313117	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CDK20 mRNA	PMID:19770486
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDK20 gene	PMID:20938992
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK20 mRNA	PMID:40504410
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CDK20 mRNA	PMID:23557933
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305219	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDK20 mRNA	PMID:22298810
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313117	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDK20 mRNA	PMID:21570461
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK20 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CDK20 mRNA	PMID:17942748|PMID:25975270
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305219	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of CDK20 mRNA	PMID:19013527
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDK20 mRNA	PMID:29803840
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDK20 mRNA	PMID:19615344|PMID:39719251
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of CDK20 mRNA]	PMID:19615344
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK20 mRNA	PMID:40504410
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDK20 mRNA	PMID:20064835|PMID:22316170
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313117	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDK20 mRNA	PMID:22228805
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1305219	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of CDK20 mRNA	PMID:16507785
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305219	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CDK20 mRNA	PMID:23411599|PMID:34492290
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CDK20 mRNA	PMID:19710929
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305219	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CDK20 mRNA	PMID:25181051
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313117	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CDK20 mRNA	PMID:33221593
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313117	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CDK20 mRNA	PMID:39298647
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305219	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of CDK20 mRNA	PMID:22546817
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313117	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CDK20 mRNA	PMID:21266533
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305219	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CDK20 mRNA	PMID:22546817
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CDK20 mRNA	PMID:40419075
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of CDK20 mRNA	PMID:29154799
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:45285	pyrazinecarboxamide	decreases expression	ISO	RGD:1305219	E	RGD:6480464	20180703	CTD	MESH:D011718	Pyrazinamide results in decreased expression of CDK20 mRNA	PMID:22431067
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:45863	paclitaxel	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of CDK20 mRNA	PMID:18058816
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305219	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDK20 mRNA	PMID:33387578
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CDK20 mRNA	PMID:40504410
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313117	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK20 mRNA	PMID:17942748
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of CDK20 mRNA	PMID:25572481
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313117	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CDK20 mRNA	PMID:25620056
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:63933	Aroclor 1254	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of CDK20 mRNA	PMID:16934159
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305219	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of CDK20 mRNA	PMID:24136188
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313117	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CDK20 mRNA	PMID:22206623
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of CDK20 mRNA	PMID:39904859
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1305219	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of CDK20 mRNA	PMID:32109520
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313117	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CDK20 mRNA	PMID:31388691
1313116	CDK20	cyclin dependent kinase 20	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305219	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CDK20 mRNA	PMID:21346803
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PPM1L mRNA	PMID:39752319
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPM1L mRNA	PMID:20938992
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PPM1L mRNA	PMID:33167477
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PPM1L mRNA	PMID:22378314
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313119	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PPM1L mRNA	PMID:30319688
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PPM1L mRNA	PMID:39241906
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPM1L mRNA	PMID:20938992
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D002635	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PPM1L mRNA	PMID:34589561
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PPM1L mRNA	PMID:39752319
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PPM1L mRNA	PMID:33359661
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:17578	toluene	affects expression	ISO	RGD:1305220	E	RGD:6480464	20121113	CTD	MESH:D014050	Toluene affects the expression of PPM1L mRNA	PMID:21827849
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D006000	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PPM1L mRNA	PMID:34589561
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PPM1L mRNA	PMID:28818685
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPM1L mRNA	PMID:36331819
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PPM1L mRNA	PMID:39836092
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PPM1L mRNA	PMID:19770486
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PPM1L gene	PMID:27153756
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PPM1L intron	PMID:30157460
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PPM1L mRNA	PMID:32553695
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313119	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PPM1L mRNA	PMID:17484886
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPM1L mRNA	PMID:20938992
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D006002	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PPM1L mRNA	PMID:34589561
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PPM1L mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PPM1L mRNA	PMID:39836092
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305220	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PPM1L mRNA	PMID:31881176
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PPM1L mRNA	PMID:27392435
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PPM1L mRNA	PMID:27392435
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PPM1L mRNA	PMID:24768652|PMID:25583101
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305220	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPM1L mRNA	PMID:22298810|PMID:34747641
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313119	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPM1L mRNA	PMID:26377647
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305220	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPM1L mRNA	PMID:23238561|PMID:32109520|PMID:33387578
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPM1L mRNA	PMID:19770486|PMID:23238561|PMID:26290441|PMID:32553695
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313119	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPM1L mRNA	PMID:19933214
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305220	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of PPM1L mRNA	PMID:28374803
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PPM1L mRNA	PMID:28001369
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D003840	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PPM1L mRNA	PMID:34589561
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PPM1L mRNA	PMID:22714537|PMID:28336213
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:29678	sodium arsenite	increases methylation	EXP		E	RGD:6480464	20170613	CTD	MESH:C017947	sodium arsenite results in increased methylation of PPM1L gene	PMID:28336213
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20170613	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PPM1L mRNA; [sodium arsenite co-treated with sodium arsenite deficiency] results in increased methylation of PPM1L gene; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PPM1L mRNA; sodium arsenite deficiency inhibits the reaction [sodium arsenite results in increased expression of PPM1L mRNA]	PMID:28336213|PMID:39836092
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PPM1L mRNA	PMID:32234424
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in decreased expression of PPM1L mRNA; Benzo(a)pyrene results in decreased expression of PPM1L mRNA	PMID:19770486|PMID:21715664|PMID:22228805|PMID:23735875|PMID:32553695
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PPM1L 3' UTR	PMID:27901495
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313119	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PPM1L intron	PMID:27901495
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PPM1L mRNA	PMID:27131904
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305220	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of PPM1L mRNA	PMID:25729387
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305220	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPM1L mRNA	PMID:25729387
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:3207	budesonide	increases expression	ISO	RGD:1313119	E	RGD:6480464	20250506	CTD	MESH:D019819	Budesonide results in increased expression of PPM1L protein	PMID:39714734
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313119	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PPM1L gene; titanium dioxide results in decreased methylation of PPM1L promoter	PMID:35295148
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313119	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PPM1L mRNA	PMID:18648102
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of PPM1L mRNA	PMID:23811191
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305220	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PPM1L mRNA	PMID:25181051
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305220	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PPM1L mRNA	PMID:30816183|PMID:32528016
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of PPM1L mRNA	PMID:27685785|PMID:33670352
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305220	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of PPM1L mRNA	PMID:29097150|PMID:32145629
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of PPM1L gene	PMID:31601247
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313119	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of PPM1L mRNA	PMID:39298647
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313119	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PPM1L exon	PMID:33297965
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313119	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of PPM1L mRNA	PMID:40203079
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of PPM1L mRNA	PMID:26377693
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313119	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of PPM1L mRNA	PMID:38685157
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PPM1L mRNA	PMID:37019170
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313119	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PPM1L mRNA	PMID:21266533
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305220	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of PPM1L mRNA	PMID:32680482
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPM1L mRNA	PMID:37042841
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PPM1L mRNA	PMID:39836092
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PPM1L mRNA	PMID:36326898
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305220	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PPM1L mRNA	PMID:24386269
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D005999	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PPM1L mRNA	PMID:34589561
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PPM1L mRNA	PMID:40194260
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PPM1L mRNA	PMID:32588087
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PPM1L mRNA	PMID:31533062
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313119	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of PPM1L mRNA	PMID:39529242
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPM1L mRNA	PMID:36331819
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of PPM1L mRNA	PMID:28001369
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PPM1L mRNA	PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PPM1L gene	PMID:29154799
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1L mRNA	PMID:27188386
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:4021	Cyclopamine	increases expression	ISO	RGD:1313119	E	RGD:6480464	20250506	CTD	MESH:C000541	cyclopamine results in increased expression of PPM1L protein	PMID:39714734
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of PPM1L mRNA	PMID:20106945
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of PPM1L mRNA	PMID:29067470
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305220	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PPM1L mRNA	PMID:33387578
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D000082	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PPM1L mRNA	PMID:34589561
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PPM1L mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PPM1L mRNA	PMID:39836092
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:4744	Echimidine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C000615871	[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PPM1L mRNA	PMID:33884520
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PPM1L mRNA	PMID:35436446
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305220	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PPM1L mRNA	PMID:29097150
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PPM1L mRNA; Nanotubes, Carbon results in decreased expression of PPM1L mRNA	PMID:25554681
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313119	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PPM1L mRNA	PMID:25620056
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PPM1L mRNA	PMID:39836092
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305220	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPM1L mRNA	PMID:25729387
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:63924	riddelliine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PPM1L mRNA	PMID:33884520
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305220	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PPM1L mRNA	PMID:28801915
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305220	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of PPM1L mRNA	PMID:30467583
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:6980	monocrotaline	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of PPM1L mRNA	PMID:33884520
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PPM1L mRNA	PMID:39752319
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:71418	triamcinolone acetonide	increases expression	ISO	RGD:1313119	E	RGD:6480464	20250506	CTD	MESH:D014222	Triamcinolone Acetonide results in increased expression of PPM1L protein	PMID:39714734
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313119	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PPM1L mRNA	PMID:22206623
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1L mRNA	PMID:27188386
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of PPM1L mRNA	PMID:30928695
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PPM1L gene]	PMID:28238834
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313119	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of PPM1L mRNA	PMID:23091169
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of PPM1L mRNA	PMID:19482888
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of PPM1L mRNA]	PMID:19482888
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of PPM1L mRNA	PMID:31388691
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313119	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PPM1L mRNA	PMID:39752319
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1L mRNA	PMID:27188386
1313118	PPM1L	protein phosphatase, Mg2+/Mn2+ dependent 1L	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313119	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PPM1L mRNA	PMID:27131904
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552149	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SLC66A2 mRNA	PMID:33045310
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552149	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of SLC66A2 mRNA	PMID:37995155
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC66A2 gene	PMID:20938992
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D014212	Tretinoin results in decreased expression of SLC66A2 mRNA	PMID:33167477
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SLC66A2 mRNA	PMID:26079696
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of SLC66A2 mRNA	PMID:39506029
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305223	E	RGD:6480464	20241105	CTD	MESH:D004958	Estradiol results in increased expression of SLC66A2 mRNA	PMID:32145629
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552149	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SLC66A2 mRNA	PMID:39298647
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC66A2 gene	PMID:20938992
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SLC66A2 protein	PMID:37730182
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SLC66A2 mRNA	PMID:28818685
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20241105	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC66A2 mRNA	PMID:36331819
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC66A2 mRNA	PMID:37236586
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SLC66A2 mRNA	PMID:27153756
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1305223	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SLC66A2 mRNA	PMID:33354967
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:2663	amiodarone	affects expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D000638	Amiodarone affects the expression of SLC66A2 mRNA	PMID:19483382
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D000661	Amphetamine results in increased expression of SLC66A2 mRNA	PMID:30779732
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC66A2 gene	PMID:20938992
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SLC66A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC66A2 mRNA	PMID:40512198
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305223	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SLC66A2 mRNA	PMID:31881176
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D003042	Cocaine affects the expression of SLC66A2 mRNA	PMID:20187946
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC66A2 mRNA	PMID:22298810
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC66A2 mRNA	PMID:22298810
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC66A2 mRNA	PMID:18343893|PMID:21570461
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC66A2 mRNA	PMID:21215274
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305223	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC66A2 mRNA	PMID:34747641
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC66A2 mRNA	PMID:15328365|PMID:18796159|PMID:21889950|PMID:23994337|PMID:25975270
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of SLC66A2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC66A2 mRNA	PMID:16214954|PMID:25975270
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC66A2 mRNA	PMID:38568856
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC66A2 mRNA	PMID:39719251
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SLC66A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC66A2 mRNA	PMID:40512198
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC66A2 intron	PMID:30157460
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC66A2 mRNA	PMID:32234424
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC66A2 mRNA	PMID:22228805
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:3023	benzbromarone	affects expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D001553	Benzbromarone affects the expression of SLC66A2 mRNA	PMID:19483382
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SLC66A2 mRNA	PMID:23221170
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D005897	Glafenine results in decreased expression of SLC66A2 mRNA	PMID:24136188
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552149	E	RGD:6480464	20241105	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC66A2 gene	PMID:35295148
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D013853	Thioacetamide affects the expression of SLC66A2 mRNA	PMID:19483382
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC66A2 mRNA	PMID:23411599
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:C006253	pirinixic acid affects the expression of SLC66A2 mRNA	PMID:19483382
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:C006253	pirinixic acid results in decreased expression of SLC66A2 mRNA	PMID:18445702
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305223	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SLC66A2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552149	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SLC66A2 mRNA	PMID:33221593
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:C006780	bisphenol A results in increased methylation of SLC66A2 gene	PMID:28505145
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SLC66A2 mRNA	PMID:25979313
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SLC66A2 mRNA	PMID:23994337
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1552149	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of SLC66A2 mRNA	PMID:39298647
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1552149	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of SLC66A2 promoter	PMID:33297965
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552149	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SLC66A2 mRNA	PMID:37019170
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SLC66A2 mRNA	PMID:21266533
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SLC66A2 mRNA	PMID:21266533
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:34696	dieldrin	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D004026	Dieldrin results in increased expression of SLC66A2 mRNA	PMID:38723972
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20241105	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC66A2 mRNA	PMID:37042841
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC66A2 mRNA	PMID:37236586
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D002922	Ciguatoxins affects the expression of SLC66A2 mRNA	PMID:18353800
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:3750	clofibrate	affects expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D002994	Clofibrate affects the expression of SLC66A2 mRNA	PMID:19483382
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D002994	Clofibrate results in decreased expression of SLC66A2 mRNA	PMID:17585979
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552149	E	RGD:6480464	20241105	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC66A2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLC66A2 mRNA	PMID:36331819
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC66A2 mRNA	PMID:19136453|PMID:20546886
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SLC66A2 gene	PMID:29154799
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC66A2 mRNA	PMID:20106945|PMID:25562108
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SLC66A2 mRNA	PMID:38832940
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D000082	Acetaminophen affects the expression of SLC66A2 mRNA	PMID:17562736
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SLC66A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC66A2 mRNA	PMID:40512198
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552149	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SLC66A2 mRNA	PMID:35436446
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:4886	L-ethionine	affects expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D005001	Ethionine affects the expression of SLC66A2 mRNA	PMID:19483382
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D005485	Flutamide results in decreased expression of SLC66A2 mRNA	PMID:24136188
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of SLC66A2 mRNA	PMID:23608068
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305223	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SLC66A2 gene	PMID:35440735
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:C051752	nefazodone results in decreased expression of SLC66A2 mRNA	PMID:24136188
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of SLC66A2 mRNA	PMID:23994337
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D009853	Omeprazole affects the expression of SLC66A2 mRNA	PMID:19483382
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:7772	omeprazole	affects expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D009853	Omeprazole affects the expression of SLC66A2 mRNA	PMID:19483382
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of SLC66A2 mRNA	PMID:18343893
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1552149	E	RGD:6480464	20200114	CTD	MESH:C045950	propiconazole results in decreased expression of SLC66A2 mRNA	PMID:21278054
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D011441	Propylthiouracil affects the expression of SLC66A2 mRNA	PMID:19483382
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SLC66A2 mRNA	PMID:24780913
1313123	SLC66A2	solute carrier family 66 member 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305223	E	RGD:6480464	20200114	CTD	MESH:C025643	vinclozolin results in decreased expression of SLC66A2 mRNA	PMID:23034163
1313124	SLN	sarcolipin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D014212	Tretinoin results in increased expression of SLN mRNA	PMID:30416051
1313124	SLN	sarcolipin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305224	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of SLN mRNA	PMID:33729688
1313124	SLN	sarcolipin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313125	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLN mRNA	PMID:30529165
1313124	SLN	sarcolipin	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of SLN mRNA	PMID:15282401
1313124	SLN	sarcolipin	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SLN mRNA	PMID:26079696
1313124	SLN	sarcolipin	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of SLN mRNA	PMID:30510588
1313124	SLN	sarcolipin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305224	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SLN mRNA	PMID:32145629
1313124	SLN	sarcolipin	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SLN mRNA	PMID:26079696
1313124	SLN	sarcolipin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SLN mRNA	PMID:31163220
1313124	SLN	sarcolipin	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLN mRNA	PMID:35301059
1313124	SLN	sarcolipin	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305224	E	RGD:6480464	20130806	CTD	MESH:C016517	indole-3-carbinol affects the expression of SLN mRNA	PMID:21396975
1313124	SLN	sarcolipin	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLN gene	PMID:27153756
1313124	SLN	sarcolipin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313125	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SLN mRNA	PMID:34911549
1313124	SLN	sarcolipin	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1305224	E	RGD:6480464	20130806	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SLN mRNA	PMID:19111725
1313124	SLN	sarcolipin	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SLN mRNA	PMID:28903495
1313124	SLN	sarcolipin	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SLN mRNA	PMID:27392435
1313124	SLN	sarcolipin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305224	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLN mRNA	PMID:21215274|PMID:32109520
1313124	SLN	sarcolipin	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SLN mRNA	PMID:23179753
1313124	SLN	sarcolipin	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305224	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SLN mRNA	PMID:28959563
1313124	SLN	sarcolipin	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of SLN mRNA	PMID:21198554
1313124	SLN	sarcolipin	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305224	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of SLN mRNA	PMID:30556269
1313124	SLN	sarcolipin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLN mRNA	PMID:29301061
1313124	SLN	sarcolipin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLN promoter	PMID:27901495
1313124	SLN	sarcolipin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLN mRNA	PMID:22228805|PMID:22610609
1313124	SLN	sarcolipin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLN 5' UTR	PMID:27901495
1313124	SLN	sarcolipin	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305224	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of SLN mRNA	PMID:30556269
1313124	SLN	sarcolipin	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1305224	E	RGD:6480464	20130806	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SLN mRNA	PMID:19111725
1313124	SLN	sarcolipin	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SLN mRNA	PMID:25895662
1313124	SLN	sarcolipin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SLN mRNA	PMID:23557971
1313124	SLN	sarcolipin	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1313125	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of SLN mRNA	PMID:19136022
1313124	SLN	sarcolipin	gene	CHEBI:33128	C60 fullerene	affects expression	ISO	RGD:1305224	E	RGD:6480464	20130806	CTD	MESH:C069837	fullerene C60 affects the expression of SLN mRNA	PMID:19167457
1313124	SLN	sarcolipin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305224	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLN mRNA	PMID:25181051|PMID:32145629
1313124	SLN	sarcolipin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313125	E	RGD:6480464	20140513	CTD	MESH:C006780	bisphenol A results in increased expression of SLN mRNA	PMID:24465770
1313124	SLN	sarcolipin	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of SLN gene	PMID:31601247
1313124	SLN	sarcolipin	gene	CHEBI:33418	graphite	increases expression	ISO	RGD:1313125	E	RGD:6480464	20180515	CTD	MESH:D006108	Graphite results in increased expression of SLN mRNA	PMID:27440207
1313124	SLN	sarcolipin	gene	CHEBI:3374	capsaicin	increases expression	ISO	RGD:1313125	E	RGD:6480464	20250603	CTD	MESH:D002211	Capsaicin results in increased expression of SLN mRNA; Capsaicin results in increased expression of SLN protein	PMID:39800145
1313124	SLN	sarcolipin	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of SLN mRNA	PMID:26377693
1313124	SLN	sarcolipin	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1313125	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of SLN mRNA	PMID:26377693
1313124	SLN	sarcolipin	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1305224	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of SLN mRNA	PMID:35163327
1313124	SLN	sarcolipin	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305224	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SLN mRNA	PMID:35163327
1313124	SLN	sarcolipin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLN mRNA	PMID:35301059
1313124	SLN	sarcolipin	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305224	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SLN mRNA	PMID:35163327
1313124	SLN	sarcolipin	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305224	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of SLN mRNA	PMID:25539665
1313124	SLN	sarcolipin	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SLN mRNA	PMID:26272509|PMID:28001369
1313124	SLN	sarcolipin	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLN mRNA	PMID:27188386
1313124	SLN	sarcolipin	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR1 protein] results in decreased expression of SLN mRNA	PMID:19059307
1313124	SLN	sarcolipin	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SLN mRNA	PMID:38832940
1313124	SLN	sarcolipin	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SLN mRNA	PMID:24935251
1313124	SLN	sarcolipin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313125	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLN mRNA	PMID:17562736
1313124	SLN	sarcolipin	gene	CHEBI:4744	Echimidine	decreases expression	ISO	RGD:1305224	E	RGD:6480464	20211109	CTD	MESH:C000615871	echimidine results in decreased expression of SLN mRNA	PMID:34185104
1313124	SLN	sarcolipin	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305224	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SLN mRNA	PMID:30307764
1313124	SLN	sarcolipin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SLN mRNA; Nanotubes, Carbon results in decreased expression of SLN mRNA	PMID:25554681|PMID:25620056
1313124	SLN	sarcolipin	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313125	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SLN mRNA; Nanotubes, Carbon results in increased expression of SLN mRNA	PMID:25554681|PMID:25620056
1313124	SLN	sarcolipin	gene	CHEBI:53227	poly(ethylene)	multiple interactions	ISO	RGD:1313125	E	RGD:6480464	20260602	CTD	MESH:D020959	[Polyethylene results in increased abundance of Microplastics] which results in decreased expression of SLN mRNA	PMID:40262053
1313124	SLN	sarcolipin	gene	CHEBI:5643	Heliotrine	decreases expression	ISO	RGD:1305224	E	RGD:6480464	20211109	CTD	MESH:C010178	heliotrine results in decreased expression of SLN mRNA	PMID:34185104
1313124	SLN	sarcolipin	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of SLN mRNA	PMID:20843944
1313124	SLN	sarcolipin	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1313125	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLN mRNA	PMID:27935865
1313124	SLN	sarcolipin	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of SLN mRNA	PMID:25566086
1313124	SLN	sarcolipin	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of SLN mRNA	PMID:29522793
1313124	SLN	sarcolipin	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1305224	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of SLN mRNA	PMID:33484710
1313124	SLN	sarcolipin	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLN mRNA	PMID:27188386
1313124	SLN	sarcolipin	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313125	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of SLN mRNA	PMID:19136022
1313124	SLN	sarcolipin	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313125	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SLN mRNA	PMID:27935865
1313124	SLN	sarcolipin	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1313125	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of SLN mRNA	PMID:26377693
1313124	SLN	sarcolipin	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of SLN mRNA	PMID:26079696
1313124	SLN	sarcolipin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305224	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SLN mRNA	PMID:24780913
1313124	SLN	sarcolipin	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR1 protein] results in decreased expression of SLN mRNA	PMID:19059307
1313124	SLN	sarcolipin	gene	CHEBI:88522	Monobutylphthalate	affects expression	ISO	RGD:1313125	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate affects the expression of SLN mRNA	PMID:19162170
1313124	SLN	sarcolipin	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLN mRNA	PMID:27188386
1313124	SLN	sarcolipin	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SLN mRNA	PMID:38568856
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SMC2 mRNA	PMID:33167477
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SMC2 mRNA	PMID:21632981
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SMC2 mRNA	PMID:39241906
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305227	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SMC2 mRNA	PMID:32145629
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of SMC2 mRNA	PMID:16474171|PMID:19167446|PMID:36581016
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMC2 mRNA	PMID:25510870
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SMC2 mRNA	PMID:38568856
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305227	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SMC2 mRNA	PMID:33387578
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20120501	CTD	MESH:D001554	Benzene results in decreased expression of SMC2 mRNA	PMID:20018183
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of SMC2 mRNA	PMID:18070364
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of SMC2 mRNA	PMID:26079696
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SMC2 mRNA	PMID:37992649
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of SMC2 mRNA	PMID:21592394
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of SMC2 mRNA	PMID:21592394
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SMC2 mRNA	PMID:37992649
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of SMC2 mRNA	PMID:21592394
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of SMC2 mRNA	PMID:21592394
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305227	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SMC2 mRNA	PMID:22061828
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMC2 mRNA	PMID:39836092
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SMC2 mRNA	PMID:37236586
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMC2 mRNA	PMID:25510870
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMC2 mRNA	PMID:25510870
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SMC2 protein	PMID:23301498
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SMC2 protein	PMID:20106945
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SMC2 mRNA	PMID:23649840
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of SMC2 mRNA	PMID:12763052
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SMC2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SMC2 mRNA	PMID:34911549
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313129	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SMC2 mRNA	PMID:27339419|PMID:31919559
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SMC2 mRNA	PMID:25629700
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMC2 mRNA	PMID:39836092
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305227	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SMC2 mRNA	PMID:31881176
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1305227	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of SMC2 mRNA	PMID:25905778
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of SMC2 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of SMC2 mRNA	PMID:19167446|PMID:23557933
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SMC2 mRNA	PMID:27392435
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SMC2 mRNA	PMID:30912803
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of SMC2 mRNA	PMID:16474171
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SMC2 mRNA	PMID:25583101
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305227	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMC2 mRNA	PMID:34747641
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313129	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMC2 mRNA	PMID:21570461|PMID:26377647
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMC2 mRNA	PMID:21802500
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305227	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMC2 mRNA	PMID:32109520|PMID:33387578
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMC2 mRNA	PMID:17942748
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305227	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of SMC2 mRNA	PMID:28374803
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SMC2 mRNA	PMID:33212167
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SMC2 mRNA	PMID:39709020
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in increased expression of SMC2 mRNA	PMID:17205981
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SMC2 mRNA	PMID:15467011
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SMC2 mRNA	PMID:29803840
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SMC2 mRNA	PMID:37992649
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of SMC2 mRNA	PMID:22623647
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SMC2 mRNA	PMID:38568856
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313129	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased expression of SMC2 mRNA	PMID:32068019
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMC2 mRNA	PMID:39836092
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMC2 mRNA	PMID:21802500
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SMC2 mRNA	PMID:32234424
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SMC2 promoter	PMID:27901495
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in increased expression of SMC2 mRNA	PMID:17205981
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of SMC2 mRNA	PMID:15467011
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313129	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SMC2 mRNA	PMID:29341224
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SMC2 mRNA	PMID:20382639
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305227	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of SMC2 mRNA	PMID:25729387
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305227	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SMC2 mRNA	PMID:25729387
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313129	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SMC2 gene	PMID:35295148
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305227	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SMC2 mRNA	PMID:34492290
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305227	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SMC2 mRNA	PMID:25380136
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SMC2 mRNA	PMID:18648102
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of SMC2 mRNA	PMID:19136022
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SMC2 mRNA	PMID:17426115
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of SMC2 mRNA	PMID:17950772|PMID:18301758|PMID:20813756
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of SMC2 mRNA]	PMID:17950772
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of SMC2 mRNA	PMID:27793765
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305227	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SMC2 mRNA	PMID:25181051|PMID:26982218|PMID:30816183|PMID:32528016|PMID:34947998
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of SMC2 mRNA	PMID:16474171
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305227	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of SMC2 mRNA	PMID:32145629
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313129	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SMC2 mRNA	PMID:26682919
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMC2 mRNA	PMID:25510870
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMC2 mRNA	PMID:25510870
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SMC2 mRNA	PMID:39298647|PMID:40203079
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313129	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of SMC2 mRNA	PMID:26377693
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SMC2 mRNA	PMID:37019170
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of SMC2 mRNA	PMID:17854601
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of SMC2 mRNA]	PMID:17854601
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SMC2 mRNA	PMID:37042841
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305227	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SMC2 mRNA	PMID:30589522
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMC2 mRNA	PMID:39836092
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305227	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of SMC2 mRNA	PMID:25380136|PMID:30723492
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SMC2 mRNA	PMID:37236586
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SMC2 protein	PMID:26879310
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SMC2 mRNA	PMID:19376846
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1305227	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of SMC2 mRNA	PMID:25380136
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:3766	clozapine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of SMC2 protein	PMID:34122009
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SMC2 mRNA	PMID:28302478
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SMC2 mRNA	PMID:31533062
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SMC2 mRNA	PMID:19167446
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of SMC2 mRNA	PMID:19167446
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of SMC2 mRNA	PMID:39529242
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SMC2 mRNA	PMID:27153767|PMID:40419075
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SMC2 mRNA	PMID:25979313
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMC2 mRNA	PMID:23179753|PMID:27188386
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SMC2 gene	PMID:29154799
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of SMC2 mRNA	PMID:29154799
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SMC2 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1305227	E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of SMC2 mRNA	PMID:21658437
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313129	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SMC2 mRNA	PMID:28973697
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SMC2 mRNA	PMID:37992649
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMC2 mRNA	PMID:29067470
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SMC2 mRNA	PMID:22230336
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305227	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SMC2 mRNA	PMID:33387578
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMC2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SMC2 mRNA	PMID:39836092
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMC2 mRNA	PMID:22079256
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SMC2 mRNA	PMID:17942748
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMC2 mRNA	PMID:17942748
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313129	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SMC2 mRNA; Nanotubes, Carbon results in increased expression of SMC2 mRNA	PMID:25554681
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SMC2 mRNA	PMID:19042947
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of SMC2 mRNA	PMID:17982090
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313129	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SMC2 mRNA	PMID:38701926
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SMC2 protein	PMID:32959892
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SMC2 mRNA	PMID:39836092
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313129	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMC2 mRNA	PMID:21641980
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305227	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SMC2 mRNA	PMID:25729387
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305227	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SMC2 mRNA	PMID:25729387
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1313129	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of SMC2 mRNA	PMID:19812364
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:6437	levetiracetam	increases expression	ISO	RGD:1305227	E	RGD:6480464	20181113	CTD	MESH:D000077287	Levetiracetam results in increased expression of SMC2 mRNA	PMID:20345932
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305227	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of SMC2 mRNA	PMID:35283115
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305227	E	RGD:6480464	20130312	CTD	MESH:D008701	Methapyrilene results in increased expression of SMC2 mRNA	PMID:22584684
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SMC2 mRNA	PMID:22079256
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMC2 mRNA	PMID:22079256
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of SMC2 mRNA	PMID:29522793
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of SMC2 mRNA	PMID:30928695
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313129	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SMC2 mRNA	PMID:19136022|PMID:23091169
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1305227	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of SMC2 mRNA	PMID:20345932
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SMC2 mRNA	PMID:19167446
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313129	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SMC2 mRNA	PMID:38648751
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of SMC2 mRNA	PMID:32234424
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of SMC2 mRNA	PMID:21858171
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of SMC2 protein	PMID:38348393
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313129	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of SMC2 mRNA	PMID:30953684|PMID:39847705
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1305227	E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of SMC2 mRNA	PMID:32419051
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:9111	Senkirkine	increases expression	ISO	RGD:1305227	E	RGD:6480464	20200915	CTD	MESH:C009238	senkirkine results in increased expression of SMC2 mRNA	PMID:32419051
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of SMC2 mRNA	PMID:17440010
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of SMC2 mRNA	PMID:19140230
1313128	SMC2	structural maintenance of chromosomes 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313129	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SMC2 mRNA	PMID:35537566
1313130	PHF2	PHD finger protein 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PHF2 mRNA	PMID:33167477
1313130	PHF2	PHD finger protein 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PHF2 mRNA	PMID:26079696
1313130	PHF2	PHD finger protein 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313131	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PHF2 mRNA	PMID:30319688
1313130	PHF2	PHD finger protein 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313131	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of PHF2 protein	PMID:31494107
1313130	PHF2	PHD finger protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PHF2 mRNA	PMID:37042841
1313130	PHF2	PHD finger protein 2	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of PHF2 mRNA	PMID:26079696
1313130	PHF2	PHD finger protein 2	gene	CHEBI:17270	glycerol 2-phosphate	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:C031463	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of PHF2 mRNA	PMID:26424790
1313130	PHF2	PHD finger protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313131	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PHF2 mRNA	PMID:34319233
1313130	PHF2	PHD finger protein 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PHF2 protein	PMID:37730182
1313130	PHF2	PHD finger protein 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305228	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PHF2 mRNA	PMID:22061828
1313130	PHF2	PHD finger protein 2	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313131	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of PHF2 intron	PMID:27776689
1313130	PHF2	PHD finger protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PHF2 mRNA	PMID:23649840
1313130	PHF2	PHD finger protein 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313131	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PHF2 mRNA	PMID:25629700
1313130	PHF2	PHD finger protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHF2 mRNA	PMID:39836092
1313130	PHF2	PHD finger protein 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PHF2 protein	PMID:35688186
1313130	PHF2	PHD finger protein 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313131	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PHF2 mRNA	PMID:30912803
1313130	PHF2	PHD finger protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313131	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PHF2 mRNA	PMID:21570461
1313130	PHF2	PHD finger protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305228	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PHF2 mRNA	PMID:33387578
1313130	PHF2	PHD finger protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PHF2 mRNA	PMID:33212167
1313130	PHF2	PHD finger protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PHF2 mRNA	PMID:29803840
1313130	PHF2	PHD finger protein 2	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of PHF2 protein	PMID:35688186
1313130	PHF2	PHD finger protein 2	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D001205	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of PHF2 mRNA	PMID:26424790
1313130	PHF2	PHD finger protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of PHF2 mRNA	PMID:39719251
1313130	PHF2	PHD finger protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHF2 mRNA	PMID:39836092
1313130	PHF2	PHD finger protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PHF2 promoter	PMID:27901495
1313130	PHF2	PHD finger protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313131	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PHF2 mRNA	PMID:22228805
1313130	PHF2	PHD finger protein 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PHF2 mRNA]	PMID:32406909
1313130	PHF2	PHD finger protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305228	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PHF2 mRNA	PMID:25729387
1313130	PHF2	PHD finger protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305228	E	RGD:6480464	20180220	CTD	MESH:C006780	bisphenol A results in decreased expression of PHF2 mRNA	PMID:27178563
1313130	PHF2	PHD finger protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PHF2 mRNA; bisphenol A results in increased expression of PHF2 protein	PMID:25047013|PMID:33376534
1313130	PHF2	PHD finger protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305228	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PHF2 mRNA	PMID:25181051|PMID:41034487
1313130	PHF2	PHD finger protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PHF2 mRNA	PMID:28628672
1313130	PHF2	PHD finger protein 2	gene	CHEBI:34093	1-Hydroxypyrene	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C033146	1-hydroxypyrene results in increased expression of PHF2 mRNA	PMID:21854004
1313130	PHF2	PHD finger protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313131	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PHF2 mRNA	PMID:39298647
1313130	PHF2	PHD finger protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313131	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PHF2 exon	PMID:33297965
1313130	PHF2	PHD finger protein 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PHF2 mRNA	PMID:28628672
1313130	PHF2	PHD finger protein 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313131	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of PHF2 mRNA	PMID:34813904
1313130	PHF2	PHD finger protein 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305228	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of PHF2 gene	PMID:33148267
1313130	PHF2	PHD finger protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PHF2 mRNA	PMID:37042841
1313130	PHF2	PHD finger protein 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PHF2 mRNA	PMID:24449571
1313130	PHF2	PHD finger protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313131	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PHF2 mRNA	PMID:36331819
1313130	PHF2	PHD finger protein 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PHF2 mRNA	PMID:25979313
1313130	PHF2	PHD finger protein 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHF2 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1313130	PHF2	PHD finger protein 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF2 mRNA	PMID:27188386
1313130	PHF2	PHD finger protein 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D003907	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of PHF2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PHF2 mRNA	PMID:26424790|PMID:28628672
1313130	PHF2	PHD finger protein 2	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PHF2 mRNA	PMID:28542535
1313130	PHF2	PHD finger protein 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305228	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PHF2 mRNA	PMID:33387578
1313130	PHF2	PHD finger protein 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHF2 mRNA	PMID:39836092
1313130	PHF2	PHD finger protein 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PHF2 mRNA	PMID:28628672
1313130	PHF2	PHD finger protein 2	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1305228	E	RGD:6480464	20140513	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of PHF2 mRNA	PMID:21983209|PMID:24140754
1313130	PHF2	PHD finger protein 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305228	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PHF2 mRNA	PMID:25729387
1313130	PHF2	PHD finger protein 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of PHF2 mRNA	PMID:15336504
1313130	PHF2	PHD finger protein 2	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305228	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of PHF2 mRNA	PMID:30467583
1313130	PHF2	PHD finger protein 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305228	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PHF2 gene	PMID:35440735
1313130	PHF2	PHD finger protein 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305228	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of PHF2 gene	PMID:33148267
1313130	PHF2	PHD finger protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF2 mRNA	PMID:27188386
1313130	PHF2	PHD finger protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF2 mRNA	PMID:27188386
1313130	PHF2	PHD finger protein 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313131	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PHF2 mRNA	PMID:28973697
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of FRMPD1 mRNA	PMID:37995155
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313133	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of FRMPD1 mRNA	PMID:40945087
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313133	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FRMPD1 mRNA	PMID:30319688
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313133	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FRMPD1 mRNA	PMID:30319688
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of FRMPD1 mRNA	PMID:30510588
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305229	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FRMPD1 mRNA	PMID:33387578
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20250114	CTD	MESH:D001554	Benzene results in decreased expression of FRMPD1 mRNA	PMID:37084897
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of FRMPD1 mRNA	PMID:34319233
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of FRMPD1 mRNA	PMID:27462272
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FRMPD1 exon	PMID:30157460
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313133	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FRMPD1 mRNA	PMID:27106289
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305229	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FRMPD1 mRNA	PMID:31150632
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FRMPD1 mRNA	PMID:32525701
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of FRMPD1 mRNA	PMID:38460933
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305229	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FRMPD1 mRNA	PMID:32109520
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305229	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FRMPD1 mRNA	PMID:33387578
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FRMPD1 mRNA	PMID:30851411
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FRMPD1 mRNA	PMID:29803840
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of FRMPD1 mRNA	PMID:37682722
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FRMPD1 mRNA	PMID:38568856
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FRMPD1 5' UTR	PMID:27901495
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FRMPD1 3' UTR	PMID:27901495
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of FRMPD1 mRNA	PMID:35984750
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FRMPD1 gene	PMID:31601247
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of FRMPD1 mRNA	PMID:29264374
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of FRMPD1 gene	PMID:31601247
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of FRMPD1 mRNA	PMID:30951980
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FRMPD1 gene	PMID:31601247
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313133	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of FRMPD1 gene	PMID:31683443
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of FRMPD1 intron	PMID:30157460
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of FRMPD1 mRNA	PMID:28392331
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305229	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of FRMPD1 promoter	PMID:22457795
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305229	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of FRMPD1 mRNA	PMID:25539665
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FRMPD1 mRNA	PMID:31533062
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305229	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FRMPD1 mRNA	PMID:33387578
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of FRMPD1 mRNA	PMID:38460933
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FRMPD1 mRNA	PMID:32525701
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FRMPD1 mRNA; Nanotubes, Carbon results in decreased expression of FRMPD1 mRNA	PMID:25554681
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of FRMPD1 intron	PMID:30157460
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313133	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FRMPD1 mRNA	PMID:22206623
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of FRMPD1 mRNA	PMID:29522793
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FRMPD1 mRNA	PMID:30851411
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FRMPD1 mRNA	PMID:32525701
1313132	FRMPD1	FERM and PDZ domain containing 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313133	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of FRMPD1 mRNA	PMID:40826991
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313135	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of REEP1 mRNA	PMID:33045310
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:144400	dinophysistoxin 1	decreases expression	EXP		E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in decreased expression of REEP1 mRNA	PMID:28939011
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of REEP1 mRNA	PMID:23830798
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313135	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of REEP1 mRNA	PMID:16604517
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313135	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of REEP1 mRNA	PMID:20880076
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of REEP1 mRNA	PMID:26079696
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313135	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of REEP1 mRNA	PMID:30319688
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of REEP1 mRNA	PMID:30510588
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of REEP1 mRNA	PMID:19619570
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of REEP1 mRNA	PMID:24758408
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of REEP1 mRNA; EGF protein inhibits the reaction [Estradiol results in increased expression of REEP1 mRNA]	PMID:19619570|PMID:24758408
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305230	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of REEP1 mRNA	PMID:33387578
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313135	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of REEP1 mRNA	PMID:39922521
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313135	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of REEP1 mRNA	PMID:39922521
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of REEP1 mRNA	PMID:34319233
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of REEP1 mRNA	PMID:36139627
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305230	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of REEP1 mRNA	PMID:33387578
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of REEP1 mRNA	PMID:39836092
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of REEP1 mRNA	PMID:24376830
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of REEP1 mRNA	PMID:35301059
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of REEP1 protein	PMID:20106945
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of REEP1 mRNA	PMID:27153756
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of REEP1 exon	PMID:30157460
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of REEP1 mRNA	PMID:15672453
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of REEP1 mRNA	PMID:25629700
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of REEP1 mRNA	PMID:22206623
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of REEP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of REEP1 mRNA	PMID:39836092
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305230	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of REEP1 mRNA	PMID:31881176
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of REEP1 mRNA	PMID:24768652|PMID:25583101
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of REEP1 mRNA	PMID:19619570
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305230	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of REEP1 mRNA	PMID:34747641
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305230	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of REEP1 mRNA	PMID:33387578
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of REEP1 mRNA	PMID:19619570
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305230	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of REEP1 mRNA	PMID:28959563
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of REEP1 mRNA	PMID:29803840
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of REEP1 mRNA	PMID:39631538
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of REEP1 mRNA	PMID:20044591
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:29021	hexane	decreases methylation	ISO	RGD:1305230	E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of REEP1 promoter	PMID:23740543
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of REEP1 mRNA	PMID:29301061
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of REEP1 mRNA	PMID:39719251
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of REEP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of REEP1 mRNA	PMID:39836092
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of REEP1 intron; Benzo(a)pyrene affects the methylation of REEP1 promoter	PMID:27901495|PMID:30157460
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313135	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of REEP1 mRNA	PMID:22610609
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP1 mRNA	PMID:27858113
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of REEP1 mRNA	PMID:19150397|PMID:20018196
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305230	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of REEP1 mRNA	PMID:30047161
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313135	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of REEP1 mRNA	PMID:23557971
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of REEP1 mRNA	PMID:29264374
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313135	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of REEP1 gene	PMID:35295148
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313135	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of REEP1 gene; titanium dioxide results in increased methylation of REEP1 promoter	PMID:35295148
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305230	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of REEP1 mRNA	PMID:34492290
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305230	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of REEP1 mRNA	PMID:25181051|PMID:34947998
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of REEP1 gene	PMID:31601247
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of REEP1 mRNA	PMID:19244175
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313135	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of REEP1 mRNA	PMID:26377693
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP1 mRNA	PMID:27858113
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of REEP1 intron	PMID:30157460
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of REEP1 mRNA	PMID:21266533
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1305230	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of REEP1 mRNA	PMID:35163327
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305230	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of REEP1 mRNA	PMID:35163327
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of REEP1 mRNA	PMID:39836092
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313135	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of REEP1 mRNA	PMID:26377693
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305230	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of REEP1 mRNA	PMID:33453195
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of REEP1 mRNA	PMID:35301059
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305230	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of REEP1 mRNA	PMID:35163327
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305230	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of REEP1 mRNA	PMID:25539665
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of REEP1 mRNA	PMID:24449571
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of REEP1 mRNA	PMID:40194260
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of REEP1 mRNA	PMID:31533062
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of REEP1 mRNA	PMID:25979313
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of REEP1 gene	PMID:29154799
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of REEP1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:28001369|PMID:29154799
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP1 mRNA	PMID:27188386
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305230	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of REEP1 mRNA	PMID:30047161
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of REEP1 mRNA	PMID:20106945|PMID:27989131
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of REEP1 mRNA	PMID:28973697
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313135	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of REEP1 mRNA	PMID:39922521
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of REEP1 mRNA	PMID:38832940
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of REEP1 mRNA	PMID:24935251
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313135	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of REEP1 mRNA	PMID:17562736
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of REEP1 mRNA	PMID:25704631
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305230	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of REEP1 mRNA	PMID:33387578
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of REEP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of REEP1 mRNA	PMID:39836092
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313135	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of REEP1 mRNA	PMID:35436446
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of REEP1 mRNA	PMID:32234424
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of REEP1 mRNA	PMID:38825487
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305230	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of REEP1 mRNA	PMID:30307764
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313135	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of REEP1 mRNA	PMID:25554681
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305230	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of REEP1 mRNA	PMID:30047161
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP1 mRNA	PMID:27858113
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of REEP1 mRNA	PMID:27858113
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of REEP1 mRNA	PMID:39836092
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:63618	pravastatin	affects expression	ISO	RGD:1305230	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin affects the expression of REEP1 mRNA	PMID:27225895
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:63618	pravastatin	increases expression	ISO	RGD:1313135	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of REEP1 mRNA	PMID:27225895
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of REEP1 mRNA	PMID:36907384
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1313135	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of REEP1 mRNA	PMID:20003209
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of REEP1 intron	PMID:30157460
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305230	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of REEP1 gene	PMID:35440735
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313135	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of REEP1 mRNA	PMID:22206623
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of REEP1 mRNA	PMID:22206623
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:75170	zaragozic acid A	affects expression	ISO	RGD:1313135	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 affects the expression of REEP1 mRNA	PMID:27225895
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1305230	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of REEP1 mRNA	PMID:27225895
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of REEP1 mRNA	PMID:22714537
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1313135	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of REEP1 mRNA	PMID:27858113
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of REEP1 mRNA	PMID:36139627
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:77012	methylseleninic acid	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of REEP1 mRNA	PMID:18548127
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP1 mRNA	PMID:27188386
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313135	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of REEP1 mRNA	PMID:19482888
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313135	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of REEP1 mRNA]	PMID:19482888
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305230	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of REEP1 mRNA	PMID:32109520
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of REEP1 mRNA	PMID:32234424
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of REEP1 mRNA	PMID:26079696
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305230	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of REEP1 mRNA	PMID:30047161
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305230	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of REEP1 mRNA	PMID:36843608
1313134	REEP1	receptor accessory protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP1 mRNA	PMID:27188386
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of USP42 mRNA	PMID:20655997
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of USP42 mRNA	PMID:21179406
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1623119	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of USP42 mRNA	PMID:23892564
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of USP42 protein	PMID:37730182
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of USP42 mRNA	PMID:28818685
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of USP42 mRNA	PMID:36331819
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of USP42 mRNA	PMID:19549813
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP42 mRNA	PMID:40504410
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of USP42 protein	PMID:35688186
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of USP42 mRNA	PMID:27594783
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1623119	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of USP42 mRNA	PMID:30912803
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305231	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of USP42 mRNA	PMID:34747641
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1623119	E	RGD:6480464	20150127	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of USP42 mRNA	PMID:25270620
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of USP42 mRNA	PMID:17942748
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of USP42 mRNA	PMID:33212167
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305231	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of USP42 mRNA	PMID:28959563
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of USP42 mRNA	PMID:29803840
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of USP42 protein	PMID:35688186
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305231	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of USP42 mRNA	PMID:21297353
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP42 mRNA	PMID:40504410
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of USP42 3' UTR	PMID:27901495
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of USP42 promoter	PMID:27901495
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to USP42 mRNA]	PMID:32406909
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1623119	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of USP42 mRNA	PMID:20542052
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623119	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of USP42 promoter	PMID:35295148
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305231	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of USP42 mRNA	PMID:34492290
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1623119	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in decreased expression of USP42 mRNA	PMID:21318169
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of USP42 mRNA]	PMID:21318169
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305231	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of USP42 mRNA	PMID:25181051
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305231	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of USP42 mRNA	PMID:30816183|PMID:32528016|PMID:34947998|PMID:41034487
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of USP42 mRNA	PMID:28628672
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1623119	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of USP42 intron	PMID:28392331
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1623119	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of USP42 mRNA	PMID:37019170
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of USP42 mRNA	PMID:28628672
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of USP42 mRNA	PMID:37042841
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of USP42 mRNA	PMID:36331819
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of USP42 mRNA	PMID:25979313
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of USP42 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of USP42 gene	PMID:29154799
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA	PMID:27188386
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305231	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of USP42 mRNA	PMID:38685447|PMID:41580965
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of USP42 mRNA	PMID:20106945|PMID:25562108
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of USP42 mRNA	PMID:28628672
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of USP42 mRNA	PMID:26272509
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA	PMID:27188386
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623119	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of USP42 mRNA	PMID:17562736
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of USP42 mRNA	PMID:21420995
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP42 mRNA	PMID:40504410
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1623119	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of USP42 mRNA	PMID:17942748
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of USP42 mRNA	PMID:23228038
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of USP42 mRNA	PMID:28628672
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305231	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of USP42 mRNA	PMID:41580965
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of USP42 mRNA	PMID:31758290
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1623119	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of USP42 mRNA	PMID:22206623
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305231	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of USP42 mRNA	PMID:33484710
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA	PMID:27188386
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:81980	triticonazole	decreases expression	ISO	RGD:1305231	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of USP42 mRNA	PMID:36084822
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP42 mRNA	PMID:27188386
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305231	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of USP42 mRNA	PMID:21346803
1313136	USP42	ubiquitin specific peptidase 42	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of USP42 mRNA	PMID:38568856
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SLC5A10 mRNA	PMID:33167477
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313139	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SLC5A10 mRNA	PMID:39241906
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of SLC5A10 mRNA]	PMID:39241906
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305232	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC5A10 mRNA	PMID:33387578
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SLC5A10 mRNA	PMID:26079696
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A10 mRNA	PMID:37567420
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of SLC5A10 mRNA	PMID:36314267
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A10 mRNA	PMID:37567420
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SLC5A10 gene	PMID:27153756
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SLC5A10 mRNA	PMID:18593933
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of SLC5A10 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC5A10 mRNA	PMID:23557933|PMID:41028656
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305232	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SLC5A10 mRNA	PMID:26033743
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SLC5A10 mRNA	PMID:41028656
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A10 mRNA	PMID:37567420
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC5A10 mRNA	PMID:34032870
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC5A10 mRNA	PMID:38568856
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC5A10 intron	PMID:30157460
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313139	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLC5A10 intron	PMID:27901495
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305232	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SLC5A10 mRNA	PMID:26033743
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SLC5A10 mRNA	PMID:41028656
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SLC5A10 mRNA	PMID:18593933
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1305232	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SLC5A10 mRNA	PMID:38458666
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SLC5A10 mRNA	PMID:25895662
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of SLC5A10 gene	PMID:31601247
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313139	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SLC5A10 mRNA	PMID:29264374
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305232	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC5A10 mRNA	PMID:25181051
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of SLC5A10 gene	PMID:31601247
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SLC5A10 intron	PMID:30157460
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of SLC5A10 mRNA]	PMID:39241906
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1305232	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SLC5A10 mRNA	PMID:38458666
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305232	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SLC5A10 mRNA	PMID:33453195
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLC5A10 mRNA	PMID:38568856
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313139	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLC5A10 mRNA	PMID:40194260
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SLC5A10 gene	PMID:29154799
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A10 mRNA	PMID:37567420
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313139	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLC5A10 mRNA	PMID:17562736
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of SLC5A10 mRNA	PMID:40706910
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305232	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SLC5A10 mRNA	PMID:29391264
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313139	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of SLC5A10 mRNA	PMID:36851058
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SLC5A10 intron	PMID:30157460
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313139	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC5A10 mRNA	PMID:22206623
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SLC5A10 mRNA	PMID:37567420
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1305232	E	RGD:6480464	20190219	CTD	MESH:C025589	ochratoxin A results in decreased expression of SLC5A10 mRNA	PMID:30449730
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC5A10 gene]	PMID:28238834
1313138	SLC5A10	solute carrier family 5 member 10	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313139	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of SLC5A10 mRNA]	PMID:39241906
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HAVCR2 mRNA	PMID:20938992
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of HAVCR2 mRNA	PMID:33167477
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305233	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of HAVCR2 mRNA	PMID:33729688
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of HAVCR2 mRNA	PMID:36331819
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20130122	CTD	MESH:D002392	[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of HAVCR2 mRNA	PMID:16806235
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313141	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of HAVCR2 mRNA	PMID:30319688
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313141	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of HAVCR2 mRNA	PMID:30319688
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of HAVCR2 mRNA	PMID:30517762
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HAVCR2 mRNA	PMID:35811015
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HAVCR2 mRNA	PMID:39241906
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HAVCR2 mRNA	PMID:35811015
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of HAVCR2 mRNA]	PMID:39241906
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20140805	CTD	MESH:C040048	[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of HAVCR2 mRNA	PMID:16806235
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] promotes the reaction [NCOA2 protein binds to HAVCR2 promoter]; Estradiol promotes the reaction [ESR2 protein affects the expression of HAVCR2 mRNA]	PMID:20404318
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HAVCR2 mRNA	PMID:20938992
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HAVCR2 mRNA	PMID:37042841
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HAVCR2 mRNA	PMID:37992649
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20130122	CTD	MESH:C040048	[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of HAVCR2 mRNA	PMID:16806235
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:17558	quercitrin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of HAVCR2 mRNA	PMID:25193878
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HAVCR2 mRNA	PMID:37992649
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of HAVCR2 mRNA	PMID:26485663
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HAVCR2 mRNA	PMID:36331819
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HAVCR2 intron	PMID:30157460
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1305233	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of HAVCR2 mRNA	PMID:41580963
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of HAVCR2 mRNA	PMID:34911549
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305233	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of HAVCR2 mRNA	PMID:30779732
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of HAVCR2 mRNA	PMID:30517762
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HAVCR2 mRNA	PMID:20938992
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:27744	glyphosate	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of HAVCR2 gene	PMID:35377194
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20130122	CTD	MESH:C059514	[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of HAVCR2 mRNA	PMID:16806235
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of HAVCR2 mRNA	PMID:23195993
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305233	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HAVCR2 mRNA	PMID:34747641
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305233	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HAVCR2 mRNA	PMID:32109520
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HAVCR2 mRNA	PMID:33212167
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305233	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of HAVCR2 mRNA	PMID:26033743
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HAVCR2 mRNA	PMID:37992649
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313141	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of HAVCR2 mRNA	PMID:37682722
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HAVCR2 mRNA	PMID:38568856
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HAVCR2 mRNA	PMID:20064835
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HAVCR2 promoter	PMID:27901495
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313141	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HAVCR2 mRNA	PMID:22228805
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of HAVCR2 mRNA]	PMID:22228805
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305233	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of HAVCR2 mRNA	PMID:26033743
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of HAVCR2 mRNA	PMID:23806026
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of HAVCR2 mRNA	PMID:25895662
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HAVCR2 mRNA	PMID:20458559
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313141	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of HAVCR2 mRNA	PMID:17656681
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313141	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of HAVCR2 mRNA	PMID:29264374
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313141	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of HAVCR2 mRNA	PMID:23557971
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305233	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of HAVCR2 mRNA	PMID:34492290
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	EXP		E	RGD:6480464	20250708	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of HAVCR2 gene	PMID:38723642
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305233	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of HAVCR2 mRNA	PMID:19167457
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305233	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of HAVCR2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of HAVCR2 mRNA	PMID:27685785
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305233	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HAVCR2 gene	PMID:28505145
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305233	E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of HAVCR2 mRNA	PMID:32119087
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of HAVCR2 mRNA	PMID:22905168
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of HAVCR2 mRNA]	PMID:39241906
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HAVCR2 mRNA	PMID:37042841
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of HAVCR2 mRNA	PMID:29024780
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305233	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of HAVCR2 promoter	PMID:22457795
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of HAVCR2 mRNA	PMID:24449571
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HAVCR2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of HAVCR2 mRNA	PMID:36331819
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HAVCR2 mRNA	PMID:37992649
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HAVCR2 mRNA	PMID:38832940
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313141	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HAVCR2 mRNA	PMID:17562736
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HAVCR2 mRNA	PMID:35811015
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313141	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of HAVCR2 mRNA	PMID:35436446
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of HAVCR2 mRNA	PMID:32234424
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HAVCR2 mRNA	PMID:20458559
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313141	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of HAVCR2 mRNA; Nanotubes, Carbon results in increased expression of HAVCR2 mRNA	PMID:25554681
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305233	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of HAVCR2 mRNA	PMID:24136188
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of HAVCR2 mRNA	PMID:38701926
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HAVCR2 mRNA	PMID:21641980
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313141	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of HAVCR2 mRNA	PMID:36851058
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305233	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of HAVCR2 mRNA	PMID:35283115
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of HAVCR2 mRNA	PMID:20843944
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313141	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of HAVCR2 mRNA	PMID:22206623
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HAVCR2 gene]	PMID:28238834
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313141	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of HAVCR2 mRNA	PMID:38648751
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313141	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of HAVCR2 mRNA]	PMID:39241906
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305233	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of HAVCR2 mRNA	PMID:21346803
1313140	HAVCR2	hepatitis A virus cellular receptor 2	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of HAVCR2 mRNA	PMID:22378314
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of YTHDF3 mRNA	PMID:33167477
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313143	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of YTHDF3 mRNA	PMID:30319688
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of YTHDF3 mRNA	PMID:37042841
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of YTHDF3 mRNA	PMID:23649840
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313143	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of YTHDF3 mRNA	PMID:36174712
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of YTHDF3 protein	PMID:37730182
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305234	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of YTHDF3 mRNA	PMID:22061828
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of YTHDF3 mRNA	PMID:28818685
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of YTHDF3 mRNA	PMID:24376830
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of YTHDF3 mRNA; [Cadmium co-treated with Dietary Fats] results in increased expression of YTHDF3 mRNA; [Cadmium co-treated with Dietary Fats] results in increased expression of YTHDF3 protein	PMID:36084736|PMID:37236586
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of YTHDF3 mRNA	PMID:19549813
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of YTHDF3 intron	PMID:30157460
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of YTHDF3 mRNA	PMID:15672453
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313143	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of YTHDF3 mRNA	PMID:25629700
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of YTHDF3 mRNA	PMID:22206623
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27563	arsenic atom	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:D001151	Arsenic results in increased expression of YTHDF3	PMID:35363433
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of YTHDF3 mRNA	PMID:40504410
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of YTHDF3 protein	PMID:38460933
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313143	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of YTHDF3 protein	PMID:36173347
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of YTHDF3 mRNA	PMID:23557933
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305234	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of YTHDF3 mRNA	PMID:32109520
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313143	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of YTHDF3 mRNA	PMID:21570461
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305234	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of YTHDF3 mRNA	PMID:33387578
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of YTHDF3 mRNA	PMID:33212167
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of YTHDF3 mRNA	PMID:23649840
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of YTHDF3 mRNA	PMID:32763439
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite results in decreased expression of YTHDF3 mRNA	PMID:37061066
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of YTHDF3 mRNA	PMID:38568856
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of and results in increased activity of YTHDF3 protein	PMID:30528433
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of YTHDF3 mRNA	PMID:40504410
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313143	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of YTHDF3 mRNA	PMID:22228805
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of YTHDF3 mRNA	PMID:19150397|PMID:20018196
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:3090	bicalutamide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of YTHDF3 mRNA	PMID:16631469
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313143	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of YTHDF3 gene; titanium dioxide results in decreased methylation of YTHDF3 promoter	PMID:35295148
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313143	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of YTHDF3 mRNA	PMID:18445702
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305234	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of YTHDF3 mRNA	PMID:25181051
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of YTHDF3 mRNA; bisphenol A results in decreased expression of YTHDF3 protein	PMID:37567409|PMID:38354435
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305234	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of YTHDF3 mRNA	PMID:30816183
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313143	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of YTHDF3 mRNA	PMID:39298647
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305234	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of YTHDF3 mRNA	PMID:33453195
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of YTHDF3 mRNA	PMID:38174414|PMID:38568856
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of YTHDF3 mRNA	PMID:37236586
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:38221	fumonisin B1	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C056933	fumonisin B1 results in increased expression of YTHDF3 mRNA	PMID:33496827
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of YTHDF3 gene	PMID:29154799
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of YTHDF3 mRNA	PMID:27989131
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of YTHDF3 mRNA	PMID:23649840
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of YTHDF3 mRNA	PMID:20977926
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of YTHDF3 protein	PMID:38460933
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:47217	arsane	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:D001151	Arsenic results in increased expression of YTHDF3	PMID:35363433
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of YTHDF3 mRNA	PMID:40504410
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of YTHDF3 mRNA	PMID:38157273
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of YTHDF3 mRNA	PMID:16984733
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:50292	cadmium sulfate	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C037123	cadmium sulfate results in increased expression of YTHDF3 mRNA	PMID:35794303
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305234	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of YTHDF3 mRNA	PMID:24136188
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305234	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of YTHDF3 mRNA	PMID:19162173
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of YTHDF3 protein	PMID:32959892
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:64310	crizotinib	decreases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:C551994	Crizotinib results in decreased expression of YTHDF3 mRNA	PMID:41183147
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:64310	crizotinib	decreases expression	ISO	RGD:1313143	E	RGD:6480464	20260303	CTD	MESH:C551994	Crizotinib results in decreased expression of YTHDF3 mRNA	PMID:41183147
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305234	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of YTHDF3 gene	PMID:35440735
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of YTHDF3 protein	PMID:34186270
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313143	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of YTHDF3 mRNA	PMID:22206623
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313143	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of YTHDF3 mRNA	PMID:22206623
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of YTHDF3 protein	PMID:37664457
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to YTHDF3 gene]	PMID:28238834
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305234	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of YTHDF3 mRNA	PMID:32109520
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:81927	enilconazole	affects expression	ISO	RGD:1313143	E	RGD:6480464	20260804	CTD	MESH:C017435	enilconazole affects the expression of YTHDF3 mRNA	PMID:38232526
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of YTHDF3 protein	PMID:37664457
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:9130	sevoflurane	increases expression	ISO	RGD:1313143	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased expression of YTHDF3 protein	PMID:35249202
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305234	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of YTHDF3 mRNA	PMID:21346803
1313142	YTHDF3	YTH N6-methyladenosine RNA binding protein F3	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1305234	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of YTHDF3 mRNA	PMID:24136188
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DCPH1 mRNA	PMID:38218311
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:C084079	triptonide results in decreased expression of DCPH1 mRNA	PMID:33045310
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1305235	E	RGD:6480464	20260707	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of DCPH1 mRNA	PMID:30071829
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DCPH1 mRNA	PMID:33167477
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D000431	Ethanol results in increased expression of DCPH1 mRNA	PMID:30319688
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DCPH1 mRNA	PMID:20044591
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of DCPH1 mRNA	PMID:21632981
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DCPH1 mRNA	PMID:37042841
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D005947	Glucose results in increased expression of DCPH1 mRNA	PMID:39922521
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D005947	Glucose results in increased expression of DCPH1 mRNA	PMID:39922521
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DCPH1 mRNA	PMID:37236586
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DCPH1 mRNA	PMID:19549813
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DCPH1 mRNA	PMID:35430440
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DCPH1 mRNA	PMID:39836092
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DCPH1 mRNA	PMID:23557933
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of DCPH1 mRNA	PMID:27594783
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of DCPH1 mRNA	PMID:23195993
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DCPH1 protein	PMID:33212167
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DCPH1 mRNA	PMID:32763439
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DCPH1 mRNA	PMID:29803840
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D004317	Doxorubicin results in increased expression of DCPH1 mRNA	PMID:39631538
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DCPH1 mRNA	PMID:39836092
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:3048	benzatropine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in increased expression of DCPH1 protein	PMID:34122009
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305235	E	RGD:6480464	20260707	CTD	MESH:D002065	Buspirone results in decreased expression of DCPH1 mRNA	PMID:24136188
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in increased expression of DCPH1 mRNA	PMID:35295148
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305235	E	RGD:6480464	20260707	CTD	MESH:C006780	bisphenol A results in decreased expression of DCPH1 mRNA	PMID:34947998
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of DCPH1 protein	PMID:34186270
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DCPH1 mRNA	PMID:37236586
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of DCPH1 protein	PMID:34122009
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DCPH1 mRNA	PMID:28302478
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DCPH1 mRNA	PMID:27153767|PMID:40419075
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014635	Valproic Acid affects the expression of DCPH1 mRNA	PMID:25979313
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DCPH1 gene	PMID:29154799
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DCPH1 mRNA	PMID:19101580|PMID:23179753
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of DCPH1 mRNA	PMID:20106945|PMID:25562108
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313145	E	RGD:6480464	20260707	CTD	MESH:D005947	Glucose results in increased expression of DCPH1 mRNA	PMID:39922521
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DCPH1 mRNA	PMID:39836092
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DCPH1 protein	PMID:32959892
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DCPH1 protein	PMID:34186270
1313144	DCPH1	damage control phosphatase 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1305235	E	RGD:6480464	20260707	CTD	MESH:C080163	trovafloxacin results in decreased expression of DCPH1 mRNA	PMID:24136188
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1313147	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of PSMD13 protein	PMID:36252740
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PSMD13 mRNA	PMID:38218311
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313147	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PSMD13 mRNA	PMID:20188158
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in increased expression of PSMD13 mRNA	PMID:15894607
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313147	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PSMD13 mRNA	PMID:39241906
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313147	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PSMD13 mRNA	PMID:39298647
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of PSMD13 mRNA	PMID:38685446
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1305236	E	RGD:6480464	20260203	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of PSMD13 protein	PMID:40089264
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1305236	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PSMD13 mRNA	PMID:21318169
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313147	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PSMD13 mRNA	PMID:21318169
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305236	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of PSMD13 mRNA	PMID:22061828
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMD13 mRNA	PMID:36331819
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of PSMD13 mRNA	PMID:17103032
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313147	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of PSMD13 mRNA	PMID:27462272
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD13 mRNA	PMID:37236586|PMID:37325564
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PSMD13 mRNA	PMID:19549813
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PSMD13 protein	PMID:23301498
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313147	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of PSMD13 intron	PMID:27776689
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD13 protein	PMID:38598786
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313147	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PSMD13 mRNA	PMID:31919559
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PSMD13 mRNA	PMID:22206623
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in decreased expression of PSMD13 protein	PMID:25110733
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD13 mRNA	PMID:35809665
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PSMD13 mRNA	PMID:40504410
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of PSMD13 mRNA	PMID:28903495
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20181016	CTD	MESH:D002945	[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of PSMD13 protein	PMID:29733421
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313147	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSMD13 mRNA	PMID:21570461
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313147	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PSMD13 mRNA	PMID:19465110
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMD13 mRNA	PMID:17942748
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305236	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PSMD13 mRNA	PMID:28959563
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313147	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of PSMD13 protein	PMID:28918527
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PSMD13 mRNA	PMID:29803840
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PSMD13 gene	PMID:28589171
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of PSMD13 mRNA	PMID:34032870
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313147	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PSMD13 mRNA	PMID:16014739
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PSMD13 mRNA	PMID:40504410
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to PSMD13 mRNA]	PMID:32406909
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:30145	lithium atom	increases expression	ISO	RGD:1305236	E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in increased expression of PSMD13 protein	PMID:18296634
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:30146	lithium hydride	increases expression	ISO	RGD:1305236	E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in increased expression of PSMD13 protein	PMID:18296634
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PSMD13 mRNA	PMID:15894607
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20181016	CTD	MESH:D001761	[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of PSMD13 protein	PMID:29733421
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1305236	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of PSMD13 mRNA	PMID:19162173|PMID:21318169
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313147	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PSMD13 mRNA	PMID:21318169|PMID:23811191
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of PSMD13 mRNA]	PMID:21318169
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:32687	piperonyl butoxide	increases expression	ISO	RGD:1305236	E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of PSMD13 mRNA	PMID:22484513
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305236	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PSMD13 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305236	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PSMD13 gene	PMID:28505145
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313147	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PSMD13 promoter	PMID:27312807
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305236	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PSMD13 mRNA	PMID:36041667
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313147	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PSMD13 mRNA	PMID:39298647
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305236	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PSMD13 mRNA	PMID:36041667
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313147	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of PSMD13 mRNA	PMID:38685157
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305236	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PSMD13 mRNA	PMID:36041667
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PSMD13 protein	PMID:34186270
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313147	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PSMD13 mRNA	PMID:37019170
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313147	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PSMD13 mRNA	PMID:17361019|PMID:21266533
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313147	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PSMD13 mRNA	PMID:34813904
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD13 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD13 protein	PMID:38598786
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313147	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of PSMD13 mRNA	PMID:34813904
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PSMD13 mRNA	PMID:37042841
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35456	cadmium dichloride	affects localization	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the localization of PSMD13 protein	PMID:18261755
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD13 mRNA	PMID:37236586|PMID:37325564
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1313147	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of PSMD13 mRNA	PMID:19429403
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305236	E	RGD:6480464	20120814	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PSMD13 mRNA	PMID:19162173|PMID:21318169
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305236	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of PSMD13 mRNA	PMID:19162173
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PSMD13 mRNA	PMID:19320972
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305236	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PSMD13 mRNA	PMID:24386269
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of PSMD13 mRNA	PMID:40434365
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1313147	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of PSMD13 mRNA	PMID:19429403
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313147	E	RGD:6480464	20130416	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PSMD13 mRNA	PMID:20936131
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20130416	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMD13 mRNA; PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of PSMD13 mRNA]	PMID:20936131|PMID:36331819
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PSMD13 gene	PMID:29154799
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PSMD13 mRNA	PMID:23179753|PMID:29154799
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1305236	E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in increased expression of PSMD13 mRNA	PMID:21318169
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PSMD13 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305236	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of PSMD13 mRNA	PMID:24136188
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in decreased expression of PSMD13 protein	PMID:25110733
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD13 mRNA	PMID:35809665
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PSMD13 mRNA	PMID:40504410
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of PSMD13 mRNA	PMID:36621641
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313147	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PSMD13 mRNA	PMID:17942748
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMD13 mRNA	PMID:17942748
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:4911	etoposide	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20181016	CTD	MESH:D005047	[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of PSMD13 protein	PMID:29733421
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of PSMD13 mRNA	PMID:17211630
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PSMD13 mRNA	PMID:15894607
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305236	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PSMD13 mRNA	PMID:24136188
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PSMD13 mRNA	PMID:35964746
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305236	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PSMD13 mRNA	PMID:24136188
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of PSMD13 mRNA	PMID:20977926
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313147	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PSMD13 mRNA	PMID:19042947
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PSMD13 protein	PMID:32959892
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305236	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of PSMD13 mRNA	PMID:24136188
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:63952	arsenic trichloride	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD13 mRNA	PMID:35809665
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305236	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of PSMD13 mRNA	PMID:24136188
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1305236	E	RGD:6480464	20211109	CTD	MESH:D007545	[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD13 mRNA	PMID:30303030
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313147	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PSMD13 mRNA	PMID:22206623
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313147	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PSMD13 mRNA	PMID:22206623
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305236	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PSMD13 mRNA	PMID:24136188
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PSMD13 mRNA	PMID:31806706
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20140204	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of PSMD13 mRNA; beta-Naphthoflavone results in increased expression of PSMD13 protein	PMID:19737606|PMID:39638853
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PSMD13 gene]	PMID:28238834
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305236	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of PSMD13 mRNA	PMID:19162173
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313147	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PSMD13 mRNA	PMID:30294300
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1313147	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of PSMD13 protein	PMID:26903627
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PSMD13 mRNA	PMID:38568856
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD13 protein	PMID:38598786
1313146	PSMD13	proteasome 26S subunit, non-ATPase 13	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305236	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PSMD13 mRNA	PMID:21346803
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of TATDN1 mRNA	PMID:21934132
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TATDN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TATDN1 mRNA	PMID:32699268
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TATDN1 mRNA	PMID:21179406
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313149	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TATDN1 mRNA	PMID:25510870
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313149	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TATDN1 mRNA	PMID:25510870
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313149	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TATDN1 mRNA	PMID:25510870
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313149	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TATDN1 mRNA	PMID:19770486
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TATDN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TATDN1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of TATDN1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TATDN1 mRNA	PMID:32699268|PMID:35430440
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313149	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TATDN1 mRNA	PMID:19770486
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1585145	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TATDN1 mRNA	PMID:33387578
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of TATDN1 mRNA	PMID:24834073
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TATDN1 mRNA	PMID:32763439
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of TATDN1 protein	PMID:38228842
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of TATDN1 mRNA	PMID:22378314
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to TATDN1 mRNA]	PMID:32406909
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313149	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TATDN1 gene; titanium dioxide results in decreased methylation of TATDN1 promoter alternative form	PMID:35295148
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1585145	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TATDN1 mRNA	PMID:34492290
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TATDN1 mRNA	PMID:30903817
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313149	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TATDN1 mRNA	PMID:25510870
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313149	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TATDN1 mRNA	PMID:25510870
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313149	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TATDN1 mRNA	PMID:39298647
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TATDN1 protein	PMID:34186270
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313149	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of TATDN1 intron	PMID:28392331
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TATDN1 mRNA	PMID:24449571
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TATDN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TATDN1 mRNA	PMID:32699268
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1313149	E	RGD:6480464	20120412	CTD	MESH:D003024	Clozapine results in increased expression of TATDN1 mRNA	PMID:14647396
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TATDN1 mRNA	PMID:32588087
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TATDN1 mRNA	PMID:23179753
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313149	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TATDN1 mRNA	PMID:28973697
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of TATDN1 mRNA	PMID:27188386
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1585145	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TATDN1 mRNA	PMID:33387578
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313149	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TATDN1 mRNA	PMID:35436446
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:5613	haloperidol	increases expression	ISO	RGD:1313149	E	RGD:6480464	20120412	CTD	MESH:D006220	Haloperidol results in increased expression of TATDN1 mRNA	PMID:14647396
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TATDN1 protein	PMID:32959892
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1313149	E	RGD:6480464	20150127	CTD	MESH:D016559	Tacrolimus results in increased expression of TATDN1 mRNA	PMID:25270620
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313149	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of TATDN1 protein	PMID:36851058
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TATDN1 mRNA	PMID:31758290
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of TATDN1 mRNA	PMID:30928695
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in increased expression of TATDN1 mRNA	PMID:31863870
1313148	TATDN1	TatD DNase domain containing 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TATDN1 mRNA	PMID:38568856
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313151	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TRIM32 mRNA	PMID:30319688
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRIM32 mRNA	PMID:37042841
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:16708	adenine	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D000225	Adenine results in decreased expression of TRIM32 mRNA	PMID:24211769
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of TRIM32 mRNA	PMID:20655997
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TRIM32 mRNA	PMID:23649840
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TRIM32 mRNA	PMID:21179406
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TRIM32 protein	PMID:37730182
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:17967	urethane	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane affects the expression of TRIM32 mRNA	PMID:28818685
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313151	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of TRIM32 mRNA	PMID:37748715
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TRIM32 mRNA	PMID:19549813
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TRIM32 mRNA	PMID:24211769
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TRIM32 mRNA	PMID:23649840
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TRIM32 gene	PMID:27153756
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313151	E	RGD:6480464	20130618	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRIM32 mRNA	PMID:19770486
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TRIM32 mRNA	PMID:24211769
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TRIM32 mRNA	PMID:23649840
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305238	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TRIM32 mRNA	PMID:30779732
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TRIM32 mRNA	PMID:22206623
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:27504	mitomycin C	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D016685	Mitomycin results in decreased expression of TRIM32 mRNA	PMID:24211769
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRIM32 mRNA	PMID:40512198
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TRIM32 protein	PMID:35688186
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:27882	(S)-colchicine	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D003078	Colchicine results in decreased expression of TRIM32 mRNA	PMID:24211769
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin results in decreased expression of TRIM32 mRNA	PMID:24211769
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TRIM32 mRNA	PMID:27392435
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313151	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRIM32 mRNA	PMID:21570461
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305238	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TRIM32 mRNA	PMID:33387578
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305238	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRIM32 mRNA	PMID:21215274
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20130618	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM32 mRNA	PMID:17942748
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313151	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of TRIM32 mRNA	PMID:23186747
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TRIM32 mRNA	PMID:33212167
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TRIM32 mRNA	PMID:30851411
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRIM32 mRNA	PMID:38568856
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRIM32 mRNA	PMID:40512198
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of TRIM32 promoter	PMID:23974009
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313151	E	RGD:6480464	20250603	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TRIM32 mRNA; Silicon Dioxide results in decreased expression of TRIM32 protein	PMID:39742911
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20250603	CTD	MESH:D012822	MIR6236 promotes the reaction [Silicon Dioxide results in decreased expression of TRIM32 mRNA]; MIR6236 promotes the reaction [Silicon Dioxide results in decreased expression of TRIM32 protein]; TRIM32 protein inhibits the reaction [Silicon Dioxide results in increased cleavage of CASP3 protein]; TRIM32 protein inhibits the reaction [Silicon Dioxide results in increased cleavage of CASP9 protein]	PMID:39742911
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313151	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRIM32 gene; titanium dioxide results in decreased methylation of TRIM32 promoter	PMID:35295148
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305238	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TRIM32 mRNA	PMID:23411599|PMID:34492290
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1305238	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TRIM32 mRNA	PMID:19162173
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305238	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRIM32 mRNA	PMID:25181051
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313151	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIM32 mRNA	PMID:26063408
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305238	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of TRIM32 mRNA	PMID:30816183|PMID:32528016
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313151	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TRIM32 mRNA	PMID:38685157
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TRIM32 mRNA	PMID:28628672
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305238	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TRIM32 mRNA	PMID:17602206
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TRIM32 mRNA	PMID:28628672
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305238	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TRIM32 mRNA	PMID:17602206
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of TRIM32 mRNA	PMID:36117858
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRIM32 mRNA	PMID:37042841
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRIM32 mRNA	PMID:38568856
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TRIM32 mRNA	PMID:24449571
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TRIM32 mRNA	PMID:32588087
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRIM32 mRNA	PMID:24383497|PMID:24935251
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TRIM32 gene	PMID:29154799
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1305238	E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in increased expression of TRIM32 mRNA	PMID:27281708
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TRIM32 mRNA	PMID:28628672
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:44423	hydroxyurea	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D006918	Hydroxyurea results in decreased expression of TRIM32 mRNA	PMID:24211769
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TRIM32 mRNA	PMID:22230336
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRIM32 mRNA	PMID:40512198
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313151	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TRIM32 mRNA	PMID:35436446
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313151	E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TRIM32 mRNA	PMID:17942748
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20130618	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM32 mRNA	PMID:17942748
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TRIM32 mRNA	PMID:28628672
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305238	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of TRIM32 mRNA	PMID:23962444
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305238	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of TRIM32 mRNA	PMID:24793618
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305238	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TRIM32 mRNA	PMID:24136188
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of TRIM32 mRNA	PMID:36117858
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in decreased expression of TRIM32 mRNA	PMID:16780908
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TRIM32 protein	PMID:32959892
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TRIM32 mRNA	PMID:28988120
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313151	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TRIM32 mRNA	PMID:22206623
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TRIM32 mRNA	PMID:30851411
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313151	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital results in increased expression of TRIM32 mRNA	PMID:19270015
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305238	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of TRIM32 mRNA	PMID:19281266
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305238	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TRIM32 mRNA	PMID:21346803
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TRIM32 mRNA	PMID:38568856
1313150	TRIM32	tripartite motif containing 32	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305238	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TRIM32 mRNA	PMID:23034163
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SLC39A1 mRNA	PMID:38218311
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305241	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of SLC39A1 mRNA	PMID:21551480
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1557571	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SLC39A1 mRNA	PMID:26251327
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:144804	nickel subsulfide	increases expression	ISO	RGD:1305241	E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide results in increased expression of SLC39A1 mRNA	PMID:21086188
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SLC39A1 mRNA	PMID:33167477
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1305241	E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of SLC39A1 mRNA	PMID:17347304
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1557571	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SLC39A1 mRNA	PMID:39241906
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1557571	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SLC39A1 mRNA	PMID:39298647
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1557571	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SLC39A1 mRNA	PMID:34319233
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1557571	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SLC39A1 mRNA	PMID:33754040
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:D002117	Calcitriol results in decreased expression of SLC39A1 mRNA	PMID:20089671
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1557571	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of SLC39A1 mRNA	PMID:27462272
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of SLC39A1 mRNA	PMID:24284285
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SLC39A1 protein	PMID:20106945
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLC39A1 mRNA	PMID:22100608
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	affects expression	ISO	RGD:1557571	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of SLC39A1 mRNA	PMID:17085522
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	affects metabolic processing	ISO	RGD:1557571	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A1 protein affects the metabolism of Zinc	PMID:16652366
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of SLC39A1 mRNA	PMID:15226459
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A1 protein results in increased transport of Zinc	PMID:18326752
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	increases uptake	EXP		E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A1 protein results in increased uptake of Zinc	PMID:11301334|PMID:12888280
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	increases uptake	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:D015032	SLC39A1 protein results in increased uptake of Zinc	PMID:14525987|PMID:15322118|PMID:25089007
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D015032	Zinc deficiency promotes the reaction [ochratoxin A results in decreased expression of SLC39A1 mRNA]	PMID:19720134
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:D015032	Cadmium Chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]; cobaltous chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]; ferrous chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]; nickel chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]	PMID:25089007
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1557571	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SLC39A1 mRNA	PMID:31919559
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of SLC39A1 mRNA	PMID:19244175
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27584	aldosterone	increases expression	ISO	RGD:1305241	E	RGD:6480464	20130212	CTD	MESH:D000450	Aldosterone results in increased expression of SLC39A1 mRNA	PMID:19333130
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27584	aldosterone	multiple interactions	ISO	RGD:1305241	E	RGD:6480464	20130212	CTD	MESH:D000450	Spironolactone inhibits the reaction [Aldosterone results in increased expression of SLC39A1 mRNA]	PMID:19333130
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27698	vanadium atom	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of SLC39A1 mRNA	PMID:19000753
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20200331	CTD	MESH:D002945	[Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of SLC39A1 mRNA	PMID:30871063
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557571	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC39A1 mRNA	PMID:21570461
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC39A1 mRNA	PMID:23152189
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305241	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC39A1 mRNA	PMID:16054898|PMID:34747641
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC39A1 mRNA	PMID:33212167
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC39A1 mRNA	PMID:20106945|PMID:32234424
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLC39A1 5' UTR	PMID:27901495
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	affects expression	ISO	RGD:1557571	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of SLC39A1 mRNA	PMID:17085522
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	affects metabolic processing	ISO	RGD:1557571	E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A1 protein affects the metabolism of Zinc	PMID:16652366
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased expression of SLC39A1 mRNA	PMID:15226459
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A1 protein results in increased transport of Zinc	PMID:18326752
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	increases uptake	EXP		E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A1 protein results in increased uptake of Zinc	PMID:11301334|PMID:12888280
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	increases uptake	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:D015032	SLC39A1 protein results in increased uptake of Zinc	PMID:14525987|PMID:15322118|PMID:25089007
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D015032	Zinc deficiency promotes the reaction [ochratoxin A results in decreased expression of SLC39A1 mRNA]	PMID:19720134
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:D015032	Cadmium Chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]; cobaltous chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]; ferrous chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]; nickel chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]	PMID:25089007
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:30812	iron dichloride	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:C029451	ferrous chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]	PMID:25089007
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305241	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SLC39A1 mRNA	PMID:25729387
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557571	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC39A1 gene	PMID:35295148
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1557571	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of SLC39A1 mRNA	PMID:27760801
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1557571	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SLC39A1 mRNA	PMID:18648102
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305241	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SLC39A1 mRNA	PMID:19167457
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305241	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SLC39A1 mRNA	PMID:25181051
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305241	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC39A1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305241	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SLC39A1 gene	PMID:28505145
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305241	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SLC39A1 mRNA	PMID:36041667
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of SLC39A1 mRNA	PMID:19244175
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of SLC39A1 mRNA	PMID:19244175
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305241	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SLC39A1 mRNA	PMID:36041667
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305241	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SLC39A1 mRNA	PMID:36041667
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1557571	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SLC39A1 mRNA	PMID:37019170
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:C022838	nickel chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]	PMID:25089007
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:35170	vanadium(0)	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of SLC39A1 mRNA	PMID:19000753
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:35176	zinc sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of SLC39A1 mRNA; Zinc Sulfate results in decreased expression of SLC39A1 protein	PMID:15226459|PMID:25162517
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:35176	zinc sulfate	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:D019287	Zinc Sulfate results in increased expression of SLC39A1 mRNA	PMID:25162517
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLC39A1 mRNA	PMID:27647474
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:D019256	Cadmium Chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]	PMID:25089007
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SLC39A1 mRNA	PMID:19376846
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20151013	CTD	MESH:C018021	cobaltous chloride inhibits the reaction [SLC39A1 protein results in increased uptake of Zinc]	PMID:25089007
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of SLC39A1 mRNA	PMID:19244175
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305241	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of SLC39A1 mRNA	PMID:38685447|PMID:41580965
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:41879	dexamethasone	affects expression	ISO	RGD:1305241	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone affects the expression of SLC39A1 mRNA	PMID:15102944
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557571	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLC39A1 mRNA	PMID:17562736
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of SLC39A1 mRNA	PMID:20471814
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1557571	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SLC39A1 mRNA	PMID:35436446
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:49976	zinc dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C016837	zinc chloride inhibits the reaction [Grape Seed Proanthocyanidins results in increased expression of SLC39A1 mRNA]	PMID:20471814
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557571	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SLC39A1 mRNA; Nanotubes, Carbon results in increased expression of SLC39A1 mRNA	PMID:25554681|PMID:25620056
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305241	E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of SLC39A1 mRNA	PMID:38685447|PMID:41580965
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1557571	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SLC39A1 mRNA	PMID:35964746
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1557571	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SLC39A1 mRNA	PMID:38701926
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305241	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SLC39A1 mRNA	PMID:25729387
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:72544	flavonoids	decreases expression	ISO	RGD:1305241	E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in decreased expression of SLC39A1 mRNA	PMID:18035473
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of SLC39A1 mRNA	PMID:19720134
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	Zinc deficiency promotes the reaction [ochratoxin A results in decreased expression of SLC39A1 mRNA]	PMID:19720134
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of SLC39A1 mRNA	PMID:34995734
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:80799	Bufotalin	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of SLC39A1 mRNA	PMID:39904859
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1557571	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SLC39A1 mRNA	PMID:31388691
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A1 mRNA	PMID:17622302
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305241	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SLC39A1 mRNA	PMID:19281266
1313154	SLC39A1	solute carrier family 39 member 1	gene	CHEBI:9241	spironolactone	multiple interactions	ISO	RGD:1305241	E	RGD:6480464	20130212	CTD	MESH:D013148	Spironolactone inhibits the reaction [Aldosterone results in increased expression of SLC39A1 mRNA]	PMID:19333130
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313156	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZKSCAN7 mRNA	PMID:33045310
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ZKSCAN7 mRNA	PMID:19074003
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313156	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ZKSCAN7 mRNA	PMID:36331819
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313156	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZKSCAN7 mRNA	PMID:39241906
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of ZKSCAN7 mRNA	PMID:20655997
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313156	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ZKSCAN7 mRNA	PMID:34319233
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ZKSCAN7 mRNA	PMID:16002434
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZKSCAN7 mRNA	PMID:28818685
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of ZKSCAN7 mRNA	PMID:17103032
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZKSCAN7 mRNA	PMID:19549813
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZKSCAN7 gene	PMID:27153756
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305242	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of ZKSCAN7 mRNA	PMID:31129395
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20161115	CTD	MESH:D001151	Arsenic affects the methylation of ZKSCAN7 gene	PMID:25304211
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of ZKSCAN7 protein	PMID:35688186
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305242	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZKSCAN7 mRNA	PMID:33387578
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313156	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZKSCAN7 intron	PMID:27901495
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZKSCAN7 5' UTR; Benzo(a)pyrene results in increased methylation of ZKSCAN7 exon	PMID:27901495
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20141111	CTD	MESH:C015001	arsenite results in increased methylation of ZKSCAN7 promoter	PMID:23974009
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:3048	benzatropine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in decreased expression of ZKSCAN7 protein	PMID:34122009
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ZKSCAN7 mRNA	PMID:25351596
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313156	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZKSCAN7 enhancer; titanium dioxide results in decreased methylation of ZKSCAN7 promoter	PMID:35295148
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305242	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZKSCAN7 mRNA	PMID:34492290
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:32588	potassium chloride	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D011189	[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of ZKSCAN7 mRNA	PMID:29691375
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305242	E	RGD:6480464	20161115	CTD	MESH:C006780	bisphenol A results in decreased expression of ZKSCAN7 mRNA	PMID:25181051
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313156	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ZKSCAN7 mRNA	PMID:32156529
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZKSCAN7 gene	PMID:31601247
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305242	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of ZKSCAN7 mRNA	PMID:31129395
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313156	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of ZKSCAN7 mRNA	PMID:39298647
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZKSCAN7 mRNA	PMID:37042841
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313156	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ZKSCAN7 mRNA	PMID:28903501
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ZKSCAN7 mRNA	PMID:31533062
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of ZKSCAN7 mRNA	PMID:31626844
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313156	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ZKSCAN7 mRNA	PMID:36331819
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZKSCAN7 gene	PMID:29154799
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305242	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZKSCAN7 mRNA	PMID:33387578
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20161115	CTD	MESH:D001151	Arsenic affects the methylation of ZKSCAN7 gene	PMID:25304211
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313156	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ZKSCAN7 mRNA	PMID:35436446
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:6443	levonorgestrel	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ZKSCAN7 mRNA	PMID:19074003
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased expression of ZKSCAN7 protein	PMID:34122009
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ZKSCAN7 mRNA	PMID:37199045
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:755208	eprenetapopt	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of ZKSCAN7 mRNA	PMID:19946333
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of ZKSCAN7 mRNA]	PMID:19946333
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZKSCAN7 gene]	PMID:28238834
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1305242	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ZKSCAN7 mRNA	PMID:27291303
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305242	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ZKSCAN7 mRNA	PMID:23640034
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZKSCAN7 mRNA	PMID:29301935
1313155	ZKSCAN7	zinc finger with KRAB and SCAN domains 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313156	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ZKSCAN7 mRNA	PMID:28973697
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PLEKHA3 mRNA	PMID:26272509
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA	PMID:27188386
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313159	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PLEKHA3 mRNA	PMID:30319688
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313159	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PLEKHA3 mRNA	PMID:30319688
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313159	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PLEKHA3 mRNA	PMID:39241906
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PLEKHA3 mRNA	PMID:33359661
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PLEKHA3 protein	PMID:37730182
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305244	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PLEKHA3 mRNA	PMID:22061828|PMID:33387578
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PLEKHA3 mRNA	PMID:28818685
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLEKHA3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEKHA3 mRNA	PMID:28111341|PMID:37451636
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PLEKHA3 mRNA	PMID:19549813
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PLEKHA3 mRNA	PMID:23649840
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLEKHA3 mRNA	PMID:22206623
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLEKHA3 mRNA	PMID:39836092
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of PLEKHA3 protein	PMID:35688186
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313159	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLEKHA3 mRNA	PMID:21570461
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313159	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLEKHA3 mRNA	PMID:15034205
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLEKHA3 mRNA; AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PLEKHA3 mRNA]	PMID:15034205|PMID:17942748
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305244	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of PLEKHA3 mRNA	PMID:19013527
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PLEKHA3 mRNA; aristolochic acid I results in increased expression of PLEKHA3 protein	PMID:33212167
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of PLEKHA3 mRNA	PMID:26272509
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA	PMID:27188386
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PLEKHA3 mRNA	PMID:38568856
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLEKHA3 mRNA	PMID:39836092
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313159	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLEKHA3 mRNA	PMID:15034205|PMID:22228805
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of PLEKHA3 mRNA]	PMID:15034205
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PLEKHA3 mRNA	PMID:27131904
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313159	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLEKHA3 gene	PMID:35295148
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305244	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PLEKHA3 mRNA	PMID:34492290
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305244	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PLEKHA3 mRNA	PMID:25181051
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305244	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PLEKHA3 gene	PMID:28505145
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313159	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PLEKHA3 mRNA	PMID:39298647
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:34679	Di-n-octyl phthalate	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20240305	CTD	MESH:C010715	di-n-octyl phthalate results in decreased expression of PLEKHA3 mRNA	PMID:37810885
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305244	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PLEKHA3 mRNA	PMID:21266533
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305244	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PLEKHA3 mRNA	PMID:21266533
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:34709	Diisodecyl phthalate	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20240305	CTD	MESH:C042080	diisodecyl phthalate results in decreased expression of PLEKHA3 mRNA	PMID:37810885
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PLEKHA3 mRNA	PMID:37042841
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305244	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PLEKHA3 mRNA	PMID:33453195
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLEKHA3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEKHA3 mRNA	PMID:28111341|PMID:37451636
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PLEKHA3 mRNA	PMID:28302478
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLEKHA3 mRNA	PMID:25979313
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLEKHA3 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLEKHA3 mRNA	PMID:21427059
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of PLEKHA3 mRNA	PMID:29154799
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA	PMID:27188386
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305244	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of PLEKHA3 mRNA	PMID:38685447|PMID:41580965
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PLEKHA3 mRNA	PMID:25562108
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PLEKHA3 mRNA	PMID:24935251|PMID:26272509
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA	PMID:27188386
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305244	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PLEKHA3 mRNA	PMID:33387578
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLEKHA3 mRNA	PMID:39836092
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305244	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLEKHA3 mRNA	PMID:29391264
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PLEKHA3 mRNA	PMID:35436446
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313159	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PLEKHA3 mRNA	PMID:17942748
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLEKHA3 mRNA	PMID:17942748
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305244	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of PLEKHA3 mRNA	PMID:41580965
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PLEKHA3 mRNA	PMID:23650126
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PLEKHA3 mRNA	PMID:31758290
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PLEKHA3 mRNA	PMID:22206623
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313159	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLEKHA3 mRNA	PMID:22206623
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA	PMID:27188386
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLEKHA3 mRNA	PMID:27188386
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313159	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PLEKHA3 mRNA	PMID:27131904
1313158	PLEKHA3	pleckstrin homology domain containing A3	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PLEKHA3 mRNA	PMID:29301935
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FAM171A1 protein]	PMID:38195004
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313161	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of FAM171A1 mRNA	PMID:16788091
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1594172	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of FAM171A1 gene	PMID:35440735
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313161	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FAM171A1 mRNA	PMID:30319688
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of FAM171A1 mRNA	PMID:21632981
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313161	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FAM171A1 mRNA	PMID:39241906
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of FAM171A1 mRNA	PMID:30165855
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FAM171A1 mRNA	PMID:37042841
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of FAM171A1 protein	PMID:37730182
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of FAM171A1 mRNA	PMID:28818685
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FAM171A1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FAM171A1 protein	PMID:38195004
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FAM171A1 intron	PMID:30157460
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:27504	mitomycin C	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	FAM171A1 protein affects the susceptibility to Mitomycin	PMID:16217747
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FAM171A1 gene	PMID:25304211
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313161	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FAM171A1 mRNA	PMID:40504410
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of FAM171A1 protein	PMID:35688186
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:1594172	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of FAM171A1 gene	PMID:31011160
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313161	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of FAM171A1 mRNA	PMID:28960355
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of FAM171A1 mRNA	PMID:19561079
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1594172	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of FAM171A1 mRNA	PMID:22023808
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of FAM171A1 mRNA	PMID:27392435
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313161	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FAM171A1 mRNA	PMID:21570461|PMID:26377647
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FAM171A1 mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FAM171A1 mRNA	PMID:33212167
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	FAM171A1 protein affects the susceptibility to Doxorubicin	PMID:16217747
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of FAM171A1 mRNA	PMID:39719251
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313161	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FAM171A1 mRNA	PMID:40504410
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FAM171A1 intron	PMID:30157460
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FAM171A1 mRNA	PMID:22316170
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313161	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FAM171A1 mRNA	PMID:22228805|PMID:32417428
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of FAM171A1 gene	PMID:25435355
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of FAM171A1 promoter	PMID:23974009
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1594172	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FAM171A1 mRNA	PMID:34492290
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313161	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of FAM171A1 mRNA	PMID:23811191
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313161	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FAM171A1 mRNA	PMID:19710929
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313161	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of FAM171A1 mRNA	PMID:28472532
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1594172	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FAM171A1 mRNA	PMID:25181051
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FAM171A1 mRNA	PMID:28628672
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of FAM171A1 intron	PMID:30157460
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FAM171A1 mRNA	PMID:28628672
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313161	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of FAM171A1 mRNA	PMID:24535843
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FAM171A1 mRNA	PMID:37042841
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FAM171A1 mRNA	PMID:38568856
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FAM171A1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FAM171A1 protein	PMID:38195004
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1594172	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FAM171A1 mRNA	PMID:24386269
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FAM171A1 mRNA	PMID:24449571
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FAM171A1 mRNA	PMID:25979313
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of FAM171A1 mRNA	PMID:28001369|PMID:29154799
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FAM171A1 gene	PMID:29154799
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FAM171A1 mRNA	PMID:25562108
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FAM171A1 mRNA	PMID:28628672
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313161	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FAM171A1 mRNA	PMID:28973697
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	FAM171A1 protein affects the susceptibility to Methotrexate	PMID:16217747
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of FAM171A1 mRNA	PMID:21420995
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	FAM171A1 protein affects the susceptibility to Fluorouracil	PMID:16217747
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313161	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FAM171A1 mRNA	PMID:29279043
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FAM171A1 gene	PMID:25304211
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313161	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FAM171A1 mRNA	PMID:40504410
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313161	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of FAM171A1 mRNA	PMID:35436446
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:4911	etoposide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	FAM171A1 protein affects the susceptibility to Etoposide	PMID:16217747
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of FAM171A1 mRNA	PMID:28628672
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1594172	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of FAM171A1 mRNA	PMID:30307764
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313161	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FAM171A1 mRNA; Nanotubes, Carbon results in decreased expression of FAM171A1 mRNA	PMID:25554681
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1594172	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of FAM171A1 mRNA	PMID:23962444
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:50693	milrinone	decreases expression	ISO	RGD:1594172	E	RGD:6480464	20180703	CTD	MESH:D020105	Milrinone results in decreased expression of FAM171A1 mRNA	PMID:22936366
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313161	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of FAM171A1 mRNA	PMID:19042947
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	FAM171A1 protein affects the susceptibility to Topotecan	PMID:16217747
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of FAM171A1 mRNA	PMID:28988120
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of FAM171A1 mRNA	PMID:29432895
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of FAM171A1 intron	PMID:30157460
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1594172	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FAM171A1 gene	PMID:35440735
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of FAM171A1 mRNA	PMID:31758290
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313161	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of FAM171A1 mRNA	PMID:23091169
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313161	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of FAM171A1 mRNA	PMID:19270015|PMID:19482888
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313161	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of FAM171A1 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FAM171A1 mRNA]	PMID:19482888|PMID:24535843
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313161	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of FAM171A1 mRNA	PMID:21278054
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1594172	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of FAM171A1 mRNA	PMID:24780913
1313160	FAM171A1	family with sequence similarity 171 member A1	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of FAM171A1 mRNA	PMID:31734321
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305246	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ABHD17B mRNA]	PMID:31150632
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ABHD17B mRNA	PMID:26251327
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ABHD17B mRNA	PMID:39298647
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of ABHD17B mRNA	PMID:19167446
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305246	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of ABHD17B mRNA	PMID:26496021
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ABHD17B mRNA	PMID:37042841
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of ABHD17B mRNA	PMID:20655997
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ABHD17B protein	PMID:37730182
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ABHD17B mRNA	PMID:28818685
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABHD17B mRNA	PMID:37236586
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ABHD17B mRNA	PMID:19549813
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ABHD17B gene	PMID:27153756
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313163	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ABHD17B mRNA	PMID:19770486
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305246	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ABHD17B mRNA	PMID:31150632
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305246	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ABHD17B mRNA]	PMID:31150632
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABHD17B mRNA	PMID:22206623
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABHD17B mRNA	PMID:40512198
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ABHD17B mRNA	PMID:40504410
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ABHD17B mRNA	PMID:26272509
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD17B mRNA	PMID:27188386
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ABHD17B mRNA	PMID:28189721|PMID:28960355
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313163	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABHD17B mRNA	PMID:21570461
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305246	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ABHD17B mRNA	PMID:33387578
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305246	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABHD17B mRNA	PMID:34747641
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of ABHD17B mRNA	PMID:29704546
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD17B mRNA	PMID:30851411
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ABHD17B mRNA	PMID:29803840
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABHD17B mRNA	PMID:40512198
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ABHD17B mRNA	PMID:40504410
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313163	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABHD17B mRNA	PMID:22228805
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313163	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ABHD17B promoter alternative form	PMID:35295148
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313163	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ABHD17B gene	PMID:35295148
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305246	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ABHD17B mRNA	PMID:34492290
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ABHD17B mRNA	PMID:20813756|PMID:23811191
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ABHD17B mRNA	PMID:26063408
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305246	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of ABHD17B mRNA	PMID:33296240
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305246	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ABHD17B gene	PMID:28505145
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305246	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ABHD17B mRNA; [bisphenol A co-treated with Estradiol] results in increased expression of ABHD17B mRNA	PMID:26496021|PMID:36041667
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313163	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ABHD17B mRNA	PMID:39298647
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305246	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ABHD17B mRNA	PMID:36041667
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305246	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ABHD17B mRNA	PMID:36041667
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313163	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ABHD17B intron	PMID:28392331
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313163	E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of ABHD17B mRNA	PMID:21371552
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ABHD17B mRNA	PMID:37042841
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305246	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ABHD17B mRNA	PMID:35163327
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABHD17B mRNA	PMID:37236586
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305246	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ABHD17B mRNA	PMID:35163327
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313163	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ABHD17B mRNA	PMID:22698814
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313163	E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in increased expression of ABHD17B mRNA	PMID:21139344
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ABHD17B mRNA	PMID:24449571
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ABHD17B mRNA	PMID:31533062
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ABHD17B mRNA	PMID:25979313
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ABHD17B mRNA	PMID:23179753|PMID:26272509
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ABHD17B gene	PMID:29154799
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD17B mRNA	PMID:27188386
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D016572	Cyclosporine results in decreased expression of ABHD17B mRNA	PMID:25562108
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ABHD17B mRNA	PMID:38832940
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ABHD17B mRNA	PMID:28542535
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C012589	trichostatin A results in decreased expression of ABHD17B mRNA	PMID:24935251
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of ABHD17B mRNA	PMID:21420995
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305246	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ABHD17B mRNA	PMID:33387578
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABHD17B mRNA	PMID:40512198
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ABHD17B mRNA	PMID:40504410
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305246	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ABHD17B mRNA	PMID:29391264
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of ABHD17B mRNA	PMID:31629900
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ABHD17B mRNA	PMID:22206623
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313163	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABHD17B mRNA	PMID:22206623
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD17B mRNA	PMID:30851411
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD17B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD17B mRNA	PMID:27188386
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313163	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of ABHD17B mRNA	PMID:23091169
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305246	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ABHD17B mRNA	PMID:32109520
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313163	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of ABHD17B mRNA	PMID:40826991
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD17B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABHD17B mRNA	PMID:27188386
1313162	ABHD17B	abhydrolase domain containing 17B, depalmitoylase	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of ABHD17B mRNA	PMID:27188386
1313164	PRDM7	PR/SET domain 7	gene	CHEBI:15414	S-adenosyl-L-methionine	affects binding	EXP		E	RGD:6480464	20170516	CTD	MESH:D012436	S-Adenosylmethionine binds to PRDM7 protein	PMID:27129774
1313164	PRDM7	PR/SET domain 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PRDM7 mRNA	PMID:35811015
1313164	PRDM7	PR/SET domain 7	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PRDM7 mRNA	PMID:19549813
1313164	PRDM7	PR/SET domain 7	gene	CHEBI:27899	cisplatin	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	PRDM7 results in increased susceptibility to Cisplatin	PMID:21755009
1313164	PRDM7	PR/SET domain 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRDM7 promoter	PMID:27901495
1313164	PRDM7	PR/SET domain 7	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PRDM7 mRNA	PMID:38568856
1313164	PRDM7	PR/SET domain 7	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PRDM7 mRNA	PMID:38832940
1313164	PRDM7	PR/SET domain 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRDM7 mRNA	PMID:26690555
1313164	PRDM7	PR/SET domain 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of PRDM7 mRNA	PMID:35811015
1313164	PRDM7	PR/SET domain 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PRDM7 mRNA	PMID:35811015
1313164	PRDM7	PR/SET domain 7	gene	CHEBI:67040	S-adenosyl-L-methioninate	affects binding	EXP		E	RGD:6480464	20170516	CTD	MESH:D012436	S-Adenosylmethionine binds to PRDM7 protein	PMID:27129774
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313168	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SNRPE mRNA	PMID:33045310
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313168	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SNRPE mRNA	PMID:39241906
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of SNRPE protein	PMID:20109541
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SNRPE mRNA	PMID:38568856
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:166595	Yessotoxin	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in decreased expression of SNRPE mRNA	PMID:30679557
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313168	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SNRPE mRNA	PMID:19850644
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313168	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SNRPE mRNA]	PMID:19850644
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:2321675	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SNRPE mRNA	PMID:33387578
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:2321675	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SNRPE mRNA	PMID:22061828
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SNRPE mRNA	PMID:28818685
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNRPE mRNA	PMID:35301059
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SNRPE protein	PMID:23301498
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313168	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SNRPE mRNA	PMID:34911549
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SNRPE mRNA	PMID:18356318
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:2321675	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SNRPE mRNA	PMID:33387578
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313168	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNRPE mRNA	PMID:22206623
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SNRPE mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SNRPE mRNA	PMID:40512198
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313168	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SNRPE mRNA	PMID:40504410
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313168	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of SNRPE protein	PMID:25505154
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313168	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of SNRPE mRNA	PMID:21151649
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313168	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SNRPE mRNA	PMID:30912803
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:2321675	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNRPE mRNA	PMID:34747641
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313168	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNRPE mRNA	PMID:15034205
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313168	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNRPE mRNA; AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of SNRPE mRNA]	PMID:15034205|PMID:17942748
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SNRPE mRNA	PMID:28001369
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SNRPE mRNA	PMID:33212167
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SNRPE mRNA	PMID:30851411
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1313168	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of SNRPE protein	PMID:21146535
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of SNRPE protein	PMID:29385562
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNRPE mRNA	PMID:38568856|PMID:39719251
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of SNRPE mRNA; sodium arsenite results in increased expression of SNRPE protein	PMID:34032870|PMID:38228842
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SNRPE mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SNRPE mRNA	PMID:40512198
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313168	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SNRPE mRNA	PMID:40504410
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313168	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SNRPE mRNA	PMID:15034205
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313168	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of SNRPE mRNA]	PMID:15034205
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to SNRPE mRNA]	PMID:32406909
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1313168	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of SNRPE protein	PMID:21146535
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SNRPE mRNA	PMID:18356318
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313168	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SNRPE mRNA	PMID:39716349
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SNRPE mRNA	PMID:20458559
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:30621	diarsenic trioxide	increases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	SNRPE protein results in increased susceptibility to Arsenic Trioxide	PMID:20707922
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in decreased expression of SNRPE mRNA	PMID:38568856
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313168	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNRPE gene	PMID:35295148
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313168	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of SNRPE mRNA	PMID:18648102
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313168	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SNRPE mRNA	PMID:28472532
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SNRPE mRNA	PMID:30903817
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of SNRPE mRNA	PMID:29275510|PMID:38568856
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:2321675	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SNRPE gene	PMID:28505145
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SNRPE protein	PMID:33376534
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313168	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SNRPE mRNA; bisphenol A results in increased expression of SNRPE protein	PMID:26903627|PMID:33221593
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2321675	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNRPE mRNA	PMID:25181051|PMID:30816183
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	[ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in increased expression of SNRPE protein]	PMID:33376534
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313168	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SNRPE mRNA	PMID:39298647
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SNRPE mRNA	PMID:28628672
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of SNRPE protein	PMID:34186270
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPE mRNA	PMID:28628672
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SNRPE protein	PMID:34186270
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1313168	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of SNRPE mRNA	PMID:31558096
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313168	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SNRPE mRNA	PMID:17361019
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPE mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SNRPE mRNA	PMID:28628672
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313168	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of SNRPE protein	PMID:39748354
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNRPE mRNA	PMID:35301059
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SNRPE mRNA	PMID:24449571
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SNRPE mRNA	PMID:28302478
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313168	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of SNRPE mRNA	PMID:39529242
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of SNRPE mRNA	PMID:23179753|PMID:24935251
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313168	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SNRPE mRNA	PMID:17555576
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPE mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SNRPE mRNA	PMID:28628672
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313168	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SNRPE mRNA	PMID:28973697
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of SNRPE mRNA	PMID:24935251
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313168	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNRPE mRNA	PMID:17562736
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SNRPE mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SNRPE mRNA	PMID:40512198
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313168	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SNRPE mRNA	PMID:40504410
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313168	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SNRPE mRNA	PMID:35436446
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313168	E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SNRPE mRNA	PMID:17555576|PMID:17942748
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313168	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNRPE mRNA	PMID:17942748
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPE mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SNRPE mRNA	PMID:28628672
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313168	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SNRPE mRNA	PMID:39716349
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SNRPE mRNA	PMID:20458559
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:49900	arsenous acid	increases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	SNRPE protein results in increased susceptibility to Arsenic Trioxide	PMID:20707922
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313168	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SNRPE mRNA	PMID:25554681
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1313168	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of SNRPE mRNA	PMID:40234311
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SNRPE protein	PMID:32959892
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:2321675	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of SNRPE mRNA	PMID:24136188
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313168	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SNRPE protein	PMID:26558463
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313168	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNRPE mRNA	PMID:22206623
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:749016	gossypol acetic acid	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in increased expression of SNRPE protein	PMID:29938581
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:2321675	E	RGD:6480464	20140729	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of SNRPE mRNA	PMID:15215175
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SNRPE mRNA	PMID:30851411
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SNRPE mRNA	PMID:19159669
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313168	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SNRPE mRNA	PMID:30294300
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313168	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of SNRPE mRNA	PMID:31558096
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313168	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of SNRPE mRNA	PMID:40826991
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1313168	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of SNRPE protein	PMID:26903627
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of SNRPE mRNA	PMID:17440010
1313167	SNRPE	small nuclear ribonucleoprotein polypeptide E	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SNRPE mRNA	PMID:38568856
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313170	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PDZRN3 mRNA	PMID:37995155
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PDZRN3 mRNA	PMID:26251327
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PDZRN3 gene	PMID:20938992
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PDZRN3 mRNA	PMID:21934132|PMID:23724009
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PDZRN3 mRNA	PMID:36331819
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PDZRN3 mRNA	PMID:22378314
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of PDZRN3 mRNA	PMID:36841081
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PDZRN3 mRNA	PMID:20044591
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of PDZRN3 mRNA	PMID:29581250
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313170	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PDZRN3 mRNA	PMID:27339419
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PDZRN3 mRNA	PMID:32145629
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PDZRN3 gene	PMID:20938992
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PDZRN3 mRNA	PMID:33359661
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA	PMID:39150890
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PDZRN3 protein	PMID:37730182
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of PDZRN3 mRNA	PMID:26485663
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PDZRN3 mRNA	PMID:28818685
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PDZRN3 mRNA	PMID:28818685
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PDZRN3 mRNA	PMID:36331819
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PDZRN3 intron	PMID:30157460
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1313170	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of PDZRN3 mRNA	PMID:24535564
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PDZRN3 mRNA	PMID:31150632
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313170	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of PDZRN3 mRNA	PMID:25629700
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PDZRN3 gene	PMID:20938992
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PDZRN3 mRNA	PMID:31881176
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20231003	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased methylation of PDZRN3 intron	PMID:33445541
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of PDZRN3 mRNA	PMID:22023808
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313170	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PDZRN3 mRNA	PMID:20702594|PMID:21570461|PMID:26377647
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PDZRN3 mRNA	PMID:21215274|PMID:32109520
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PDZRN3 mRNA	PMID:18691609
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305250	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PDZRN3 mRNA	PMID:23238561
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313170	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PDZRN3 mRNA	PMID:18796159|PMID:23238561|PMID:26290441
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of PDZRN3 mRNA	PMID:16214954
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PDZRN3 mRNA	PMID:23179753|PMID:26272509|PMID:34089799
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDZRN3 mRNA	PMID:27188386
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PDZRN3 mRNA	PMID:28959563
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305250	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of PDZRN3 mRNA	PMID:30556269
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PDZRN3 gene	PMID:28589171
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PDZRN3 mRNA	PMID:37682722
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PDZRN3 mRNA	PMID:19770486
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313170	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PDZRN3 mRNA	PMID:22228805
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PDZRN3 promoter	PMID:27901495
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of PDZRN3 promoter	PMID:23974009
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305250	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of PDZRN3 mRNA	PMID:30556269
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PDZRN3 mRNA	PMID:27131904
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PDZRN3 gene	PMID:31601247
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PDZRN3 mRNA	PMID:24136188
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20231003	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased methylation of PDZRN3 intron	PMID:33445541
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PDZRN3 mRNA	PMID:30047161
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313170	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of PDZRN3 mRNA	PMID:29264374
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313170	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PDZRN3 promoter	PMID:35295148
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of PDZRN3 mRNA	PMID:23411599
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PDZRN3 mRNA	PMID:25380136
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313170	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PDZRN3 mRNA	PMID:18301758|PMID:18445702|PMID:23811191
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PDZRN3 mRNA	PMID:19710929
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PDZRN3 mRNA	PMID:25181051|PMID:32145629
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in decreased expression of PDZRN3 mRNA	PMID:39742910
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PDZRN3 gene	PMID:31601247
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313170	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of PDZRN3 promoter	PMID:27312807
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of PDZRN3 mRNA	PMID:29275510
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305250	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of PDZRN3 mRNA	PMID:41034487
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313170	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of PDZRN3 mRNA	PMID:30951980|PMID:34585602
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305250	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PDZRN3 gene	PMID:28505145
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PDZRN3 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PDZRN3 mRNA	PMID:28628672|PMID:31601247
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1313170	E	RGD:6480464	20120412	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of PDZRN3 mRNA	PMID:20702594
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PDZRN3 exon	PMID:30157460
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1313170	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of PDZRN3 intron	PMID:28392331
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA	PMID:39150890
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PDZRN3 mRNA	PMID:37019170
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA	PMID:39150890
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA	PMID:39150890
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PDZRN3 mRNA	PMID:28628672
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of PDZRN3 mRNA	PMID:24535843
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305250	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of PDZRN3 mRNA	PMID:30589522
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of PDZRN3 mRNA	PMID:25380136|PMID:30723492
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA	PMID:39150890
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of PDZRN3 mRNA	PMID:25539665
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of PDZRN3 mRNA	PMID:25380136
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PDZRN3 mRNA	PMID:40194260
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:38845	profenofos	increases expression	ISO	RGD:1305250	E	RGD:6480464	20130514	CTD	MESH:C024273	profenofos results in increased expression of PDZRN3 mRNA	PMID:17569032
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:38922	dibenzofurans	increases expression	ISO	RGD:1313170	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in increased expression of PDZRN3 mRNA	PMID:34254344
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PDZRN3 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PDZRN3 mRNA	PMID:36331819
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of PDZRN3 mRNA	PMID:23125180
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PDZRN3 mRNA	PMID:25979313
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313170	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of PDZRN3 mRNA	PMID:24535564
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PDZRN3 mRNA	PMID:30047161
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of PDZRN3 mRNA	PMID:22733784
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PDZRN3 mRNA	PMID:28628672
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of PDZRN3 mRNA	PMID:24935251
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of PDZRN3 mRNA	PMID:24935251|PMID:26272509
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDZRN3 mRNA	PMID:27188386
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PDZRN3 mRNA	PMID:28628672
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PDZRN3 mRNA	PMID:30047161
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of PDZRN3 mRNA	PMID:24136188
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313170	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PDZRN3 mRNA	PMID:23608068
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:5613	haloperidol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in decreased expression of PDZRN3 protein	PMID:34122009
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PDZRN3 mRNA	PMID:22079614
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:65408	andrographolide	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20121218	CTD	MESH:C030419	[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of PDZRN3 mRNA	PMID:19737545
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PDZRN3 exon	PMID:30157460
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305250	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PDZRN3 gene	PMID:35440735
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PDZRN3 mRNA	PMID:31758290
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20180220	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PDZRN3 mRNA	PMID:27840820
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20140204	CTD	MESH:D019324	[andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of PDZRN3 mRNA	PMID:19737545
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDZRN3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDZRN3 mRNA	PMID:27188386
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313170	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PDZRN3 mRNA	PMID:39150890
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PDZRN3 gene]	PMID:28238834
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:8064	phenformin	increases expression	ISO	RGD:1305250	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in increased expression of PDZRN3 mRNA	PMID:31324951
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1313170	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of PDZRN3 mRNA	PMID:20702594
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305250	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PDZRN3 mRNA	PMID:32109520
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313170	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of PDZRN3 mRNA	PMID:21795629
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305250	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PDZRN3 mRNA	PMID:24780913
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:9079	Securinine	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C000785	securinine results in decreased expression of PDZRN3 mRNA	PMID:32662633
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of PDZRN3 protein	PMID:35357534
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDZRN3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PDZRN3 mRNA	PMID:27188386
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313170	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PDZRN3 mRNA	PMID:27131904
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305250	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PDZRN3 mRNA	PMID:19281266
1313169	PDZRN3	PDZ domain containing ring finger 3	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305250	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of PDZRN3 gene	PMID:31682807
1313171	RNF152	ring finger protein 152	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305251	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNF152 mRNA]	PMID:31150632
1313171	RNF152	ring finger protein 152	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of RNF152 mRNA	PMID:34925699
1313171	RNF152	ring finger protein 152	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RNF152 mRNA	PMID:20188158
1313171	RNF152	ring finger protein 152	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of RNF152 mRNA	PMID:36189433
1313171	RNF152	ring finger protein 152	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of RNF152 mRNA	PMID:23724009
1313171	RNF152	ring finger protein 152	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550154	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RNF152 mRNA	PMID:36189433
1313171	RNF152	ring finger protein 152	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of RNF152 mRNA	PMID:26079696
1313171	RNF152	ring finger protein 152	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of RNF152 mRNA	PMID:39506029
1313171	RNF152	ring finger protein 152	gene	CHEBI:16130	DDT	increases methylation	ISO	RGD:1305251	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of RNF152 gene	PMID:30207508
1313171	RNF152	ring finger protein 152	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RNF152 mRNA	PMID:35811015
1313171	RNF152	ring finger protein 152	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305251	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of RNF152 mRNA	PMID:32145629
1313171	RNF152	ring finger protein 152	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RNF152 mRNA	PMID:39298647
1313171	RNF152	ring finger protein 152	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305251	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RNF152 mRNA	PMID:33387578
1313171	RNF152	ring finger protein 152	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550154	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of RNF152 mRNA	PMID:36189433
1313171	RNF152	ring finger protein 152	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305251	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of RNF152 mRNA	PMID:26496021
1313171	RNF152	ring finger protein 152	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RNF152 mRNA	PMID:31163220
1313171	RNF152	ring finger protein 152	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550154	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RNF152 mRNA	PMID:28085963
1313171	RNF152	ring finger protein 152	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305251	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RNF152 mRNA	PMID:33387578
1313171	RNF152	ring finger protein 152	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RNF152 mRNA	PMID:28818685
1313171	RNF152	ring finger protein 152	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550154	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RNF152 mRNA	PMID:36331819
1313171	RNF152	ring finger protein 152	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1550154	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in increased expression of RNF152 mRNA	PMID:18579281
1313171	RNF152	ring finger protein 152	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RNF152 exon; Aflatoxin B1 results in decreased methylation of RNF152 gene; Aflatoxin B1 results in decreased methylation of RNF152 intron	PMID:27153756|PMID:30157460
1313171	RNF152	ring finger protein 152	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305251	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RNF152 mRNA	PMID:31150632
1313171	RNF152	ring finger protein 152	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RNF152 mRNA	PMID:27339419|PMID:31919559
1313171	RNF152	ring finger protein 152	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305251	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNF152 mRNA]	PMID:31150632
1313171	RNF152	ring finger protein 152	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305251	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RNF152 mRNA	PMID:31881176
1313171	RNF152	ring finger protein 152	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550154	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF152 mRNA	PMID:26377647|PMID:28922406
1313171	RNF152	ring finger protein 152	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305251	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNF152 mRNA	PMID:32109520|PMID:33387578
1313171	RNF152	ring finger protein 152	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of RNF152 mRNA	PMID:24834073
1313171	RNF152	ring finger protein 152	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RNF152 mRNA	PMID:30851411
1313171	RNF152	ring finger protein 152	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNF152 mRNA	PMID:29803840
1313171	RNF152	ring finger protein 152	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of RNF152 mRNA	PMID:29301061|PMID:39719251
1313171	RNF152	ring finger protein 152	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of RNF152 mRNA	PMID:34032870
1313171	RNF152	ring finger protein 152	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RNF152 mRNA	PMID:32234424
1313171	RNF152	ring finger protein 152	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RNF152 mRNA	PMID:19770486
1313171	RNF152	ring finger protein 152	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550154	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RNF152 mRNA	PMID:27195522
1313171	RNF152	ring finger protein 152	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RNF152 exon; Benzo(a)pyrene results in increased methylation of RNF152 promoter	PMID:27901495
1313171	RNF152	ring finger protein 152	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of RNF152 promoter	PMID:23974009
1313171	RNF152	ring finger protein 152	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RNF152 mRNA	PMID:23221170
1313171	RNF152	ring finger protein 152	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of RNF152 mRNA	PMID:37690743
1313171	RNF152	ring finger protein 152	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550154	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RNF152 gene	PMID:35295148
1313171	RNF152	ring finger protein 152	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305251	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RNF152 mRNA	PMID:34492290
1313171	RNF152	ring finger protein 152	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550154	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RNF152 mRNA	PMID:28472532
1313171	RNF152	ring finger protein 152	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305251	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of RNF152 mRNA	PMID:32145629
1313171	RNF152	ring finger protein 152	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305251	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF152 mRNA	PMID:25181051|PMID:34947998
1313171	RNF152	ring finger protein 152	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF152 mRNA	PMID:34585602
1313171	RNF152	ring finger protein 152	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305251	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of RNF152 mRNA	PMID:29097150|PMID:30816183|PMID:33296240
1313171	RNF152	ring finger protein 152	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF152 gene	PMID:31601247
1313171	RNF152	ring finger protein 152	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305251	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RNF152 mRNA; [bisphenol A co-treated with Testosterone] results in decreased expression of RNF152 mRNA	PMID:26496021|PMID:36041667
1313171	RNF152	ring finger protein 152	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of RNF152 mRNA	PMID:26682919
1313171	RNF152	ring finger protein 152	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in decreased expression of RNF152 mRNA	PMID:30616060
1313171	RNF152	ring finger protein 152	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of RNF152 mRNA	PMID:30951980|PMID:39298647
1313171	RNF152	ring finger protein 152	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305251	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RNF152 mRNA	PMID:36041667
1313171	RNF152	ring finger protein 152	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of RNF152 mRNA	PMID:30951980
1313171	RNF152	ring finger protein 152	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305251	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RNF152 mRNA	PMID:36041667
1313171	RNF152	ring finger protein 152	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RNF152 mRNA	PMID:38382870
1313171	RNF152	ring finger protein 152	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305251	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of RNF152 promoter	PMID:22457795
1313171	RNF152	ring finger protein 152	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of RNF152 mRNA	PMID:28903501
1313171	RNF152	ring finger protein 152	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RNF152 mRNA	PMID:32588087
1313171	RNF152	ring finger protein 152	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RNF152 mRNA	PMID:40194260
1313171	RNF152	ring finger protein 152	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550154	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RNF152 mRNA	PMID:36331819
1313171	RNF152	ring finger protein 152	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RNF152 gene	PMID:29154799
1313171	RNF152	ring finger protein 152	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RNF152 mRNA	PMID:17183730
1313171	RNF152	ring finger protein 152	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of RNF152 promoter	PMID:27989131
1313171	RNF152	ring finger protein 152	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550154	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RNF152 mRNA	PMID:28973697
1313171	RNF152	ring finger protein 152	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RNF152 mRNA	PMID:38832940
1313171	RNF152	ring finger protein 152	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550154	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RNF152 mRNA	PMID:17562736
1313171	RNF152	ring finger protein 152	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305251	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RNF152 mRNA	PMID:33387578
1313171	RNF152	ring finger protein 152	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RNF152 mRNA	PMID:35811015
1313171	RNF152	ring finger protein 152	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550154	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RNF152 mRNA	PMID:35436446
1313171	RNF152	ring finger protein 152	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305251	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RNF152 mRNA	PMID:29097150
1313171	RNF152	ring finger protein 152	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of RNF152 mRNA	PMID:32234424
1313171	RNF152	ring finger protein 152	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of RNF152 mRNA	PMID:23228038
1313171	RNF152	ring finger protein 152	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1550154	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of RNF152 mRNA	PMID:25620056
1313171	RNF152	ring finger protein 152	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of RNF152 mRNA	PMID:25620056
1313171	RNF152	ring finger protein 152	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of RNF152 mRNA	PMID:31629900
1313171	RNF152	ring finger protein 152	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RNF152 mRNA	PMID:17183730
1313171	RNF152	ring finger protein 152	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of RNF152 mRNA	PMID:24810058
1313171	RNF152	ring finger protein 152	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305251	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RNF152 gene	PMID:35440735
1313171	RNF152	ring finger protein 152	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RNF152 mRNA	PMID:22206623
1313171	RNF152	ring finger protein 152	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RNF152 mRNA	PMID:30851411
1313171	RNF152	ring finger protein 152	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1550154	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of RNF152 mRNA	PMID:26655953
1313171	RNF152	ring finger protein 152	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of RNF152 mRNA	PMID:23091169
1313171	RNF152	ring finger protein 152	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305251	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RNF152 mRNA	PMID:32109520
1313171	RNF152	ring finger protein 152	gene	CHEBI:82436	decabromodiphenyl ether	multiple interactions	ISO	RGD:1305251	E	RGD:6480464	20200714	CTD	MESH:C010902	[Flame Retardants co-treated with pentabromodiphenyl ether co-treated with decabromobiphenyl ether co-treated with hexabromocyclododecane] results in decreased expression of RNF152 mRNA	PMID:32207525
1313171	RNF152	ring finger protein 152	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305251	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RNF152 mRNA	PMID:24780913
1313171	RNF152	ring finger protein 152	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RNF152 mRNA	PMID:38568856
1313171	RNF152	ring finger protein 152	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1550154	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of RNF152 mRNA	PMID:32835833
1313173	RNF135	ring finger protein 135	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552157	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RNF135 mRNA	PMID:33045310
1313173	RNF135	ring finger protein 135	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305252	E	RGD:6480464	20220920	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNF135 mRNA]	PMID:31150632
1313173	RNF135	ring finger protein 135	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of RNF135 mRNA	PMID:21934132
1313173	RNF135	ring finger protein 135	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNF135 mRNA	PMID:39241906
1313173	RNF135	ring finger protein 135	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552157	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RNF135 mRNA	PMID:27339419
1313173	RNF135	ring finger protein 135	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of RNF135 mRNA	PMID:22217510
1313173	RNF135	ring finger protein 135	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1305252	E	RGD:6480464	20220920	CTD	MESH:D011374	Progesterone results in decreased expression of RNF135 mRNA	PMID:21770760
1313173	RNF135	ring finger protein 135	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1552157	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RNF135 mRNA	PMID:23892564
1313173	RNF135	ring finger protein 135	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RNF135 mRNA	PMID:34319233
1313173	RNF135	ring finger protein 135	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of RNF135 mRNA	PMID:24376830
1313173	RNF135	ring finger protein 135	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552157	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RNF135 mRNA	PMID:37236586
1313173	RNF135	ring finger protein 135	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305252	E	RGD:6480464	20220920	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RNF135 mRNA	PMID:31150632
1313173	RNF135	ring finger protein 135	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305252	E	RGD:6480464	20220920	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RNF135 mRNA]	PMID:31150632
1313173	RNF135	ring finger protein 135	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of RNF135 mRNA	PMID:26272509
1313173	RNF135	ring finger protein 135	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RNF135 mRNA	PMID:27188386
1313173	RNF135	ring finger protein 135	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of RNF135 protein	PMID:35688186
1313173	RNF135	ring finger protein 135	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of RNF135 mRNA	PMID:19921347
1313173	RNF135	ring finger protein 135	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RNF135 mRNA	PMID:27392435|PMID:27594783
1313173	RNF135	ring finger protein 135	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of RNF135 mRNA	PMID:27392435
1313173	RNF135	ring finger protein 135	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of RNF135 mRNA	PMID:34813904
1313173	RNF135	ring finger protein 135	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNF135 mRNA	PMID:33212167
1313173	RNF135	ring finger protein 135	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNF135 mRNA	PMID:29803840
1313173	RNF135	ring finger protein 135	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RNF135 mRNA	PMID:38568856
1313173	RNF135	ring finger protein 135	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552157	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RNF135 mRNA	PMID:21715664|PMID:22228805
1313173	RNF135	ring finger protein 135	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RNF135 promoter	PMID:27901495
1313173	RNF135	ring finger protein 135	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF135 mRNA	PMID:22576693
1313173	RNF135	ring finger protein 135	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305252	E	RGD:6480464	20220920	CTD	MESH:C006780	bisphenol A results in increased expression of RNF135 mRNA	PMID:25181051
1313173	RNF135	ring finger protein 135	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552157	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RNF135 mRNA	PMID:33221593
1313173	RNF135	ring finger protein 135	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF135 gene	PMID:22576693
1313173	RNF135	ring finger protein 135	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305252	E	RGD:6480464	20220920	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF135 gene	PMID:28505145
1313173	RNF135	ring finger protein 135	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of RNF135 mRNA	PMID:40203079
1313173	RNF135	ring finger protein 135	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552157	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RNF135 mRNA	PMID:39298647
1313173	RNF135	ring finger protein 135	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RNF135 mRNA	PMID:21266533
1313173	RNF135	ring finger protein 135	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of RNF135 mRNA	PMID:34813904
1313173	RNF135	ring finger protein 135	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RNF135 mRNA	PMID:37042841
1313173	RNF135	ring finger protein 135	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RNF135 mRNA	PMID:38568856
1313173	RNF135	ring finger protein 135	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552157	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RNF135 mRNA	PMID:37236586
1313173	RNF135	ring finger protein 135	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552157	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of RNF135 mRNA	PMID:36331819
1313173	RNF135	ring finger protein 135	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RNF135 mRNA	PMID:25979313
1313173	RNF135	ring finger protein 135	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of RNF135 mRNA	PMID:27989131
1313173	RNF135	ring finger protein 135	gene	CHEBI:44658	okadaic acid	decreases expression	ISO	RGD:1552157	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RNF135 mRNA	PMID:25270620
1313173	RNF135	ring finger protein 135	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RNF135 mRNA	PMID:28542535
1313173	RNF135	ring finger protein 135	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552157	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RNF135 mRNA	PMID:17562736
1313173	RNF135	ring finger protein 135	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552157	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RNF135 mRNA	PMID:35436446
1313173	RNF135	ring finger protein 135	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552157	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of RNF135 mRNA	PMID:25554681
1313173	RNF135	ring finger protein 135	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RNF135 mRNA	PMID:27188386
1313173	RNF135	ring finger protein 135	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1305252	E	RGD:6480464	20220920	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of RNF135 mRNA	PMID:29162477
1313173	RNF135	ring finger protein 135	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RNF135 mRNA	PMID:27188386
1313173	RNF135	ring finger protein 135	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RNF135 mRNA	PMID:38568856
1313174	OTOR	otoraplin	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of OTOR mRNA	PMID:34925699
1313174	OTOR	otoraplin	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of OTOR mRNA	PMID:23724009
1313174	OTOR	otoraplin	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305253	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of OTOR mRNA	PMID:33387578
1313174	OTOR	otoraplin	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1313175	E	RGD:6480464	20241001	CTD	MESH:D005557	Formaldehyde results in increased expression of OTOR mRNA	PMID:33233951
1313174	OTOR	otoraplin	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1313175	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of OTOR mRNA	PMID:32553695
1313174	OTOR	otoraplin	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313175	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of OTOR mRNA	PMID:40618947
1313174	OTOR	otoraplin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313175	E	RGD:6480464	20201006	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of OTOR mRNA	PMID:32553695
1313174	OTOR	otoraplin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OTOR mRNA	PMID:20106945|PMID:21632981
1313174	OTOR	otoraplin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305253	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of OTOR mRNA	PMID:33387578
1313174	OTOR	otoraplin	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305253	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OTOR mRNA	PMID:26033743
1313174	OTOR	otoraplin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313175	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in decreased expression of OTOR mRNA	PMID:32553695
1313174	OTOR	otoraplin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of OTOR promoter	PMID:27901495
1313174	OTOR	otoraplin	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305253	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OTOR mRNA	PMID:26033743
1313174	OTOR	otoraplin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313175	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of OTOR mRNA	PMID:35295148
1313174	OTOR	otoraplin	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305253	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of OTOR mRNA	PMID:23411599|PMID:34492290
1313174	OTOR	otoraplin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305253	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of OTOR mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313174	OTOR	otoraplin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305253	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of OTOR mRNA	PMID:41034487
1313174	OTOR	otoraplin	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313175	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of OTOR mRNA	PMID:37019170
1313174	OTOR	otoraplin	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313175	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of OTOR mRNA	PMID:21266533
1313174	OTOR	otoraplin	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305253	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of OTOR mRNA	PMID:30047161
1313174	OTOR	otoraplin	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of OTOR mRNA	PMID:37199045
1313174	OTOR	otoraplin	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305253	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of OTOR mRNA	PMID:30047161
1313174	OTOR	otoraplin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305253	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of OTOR mRNA	PMID:24780913
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621437	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CEMIP mRNA	PMID:33045310
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of CEMIP mRNA	PMID:26079696
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:15756	hexadecanoic acid	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of CEMIP mRNA	PMID:39506029
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of CEMIP mRNA	PMID:40865780
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:16130	DDT	decreases expression	ISO	RGD:1305254	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of CEMIP mRNA	PMID:30207508
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:16243	quercetin	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin affects the expression of CEMIP mRNA	PMID:21632981
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CEMIP mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CEMIP mRNA	PMID:35811015
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CEMIP mRNA	PMID:30510588
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of CEMIP mRNA	PMID:24758408
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CEMIP mRNA	PMID:21795739|PMID:31614463
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein inhibits the reaction [Estradiol results in decreased expression of CEMIP mRNA]; Progesterone inhibits the reaction [Estradiol results in increased expression of CEMIP mRNA]	PMID:21795739|PMID:24758408
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEMIP mRNA	PMID:25510870
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CEMIP mRNA	PMID:38568856
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305254	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CEMIP mRNA	PMID:33387578
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CEMIP mRNA	PMID:37042841
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of CEMIP mRNA	PMID:39245080
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone inhibits the reaction [Estradiol results in increased expression of CEMIP mRNA]	PMID:21795739
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C005556	propionaldehyde results in increased expression of CEMIP mRNA	PMID:25014914|PMID:26079696
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of CEMIP mRNA	PMID:33448797
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in increased expression of CEMIP mRNA]	PMID:33448797
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of CEMIP mRNA	PMID:22017230
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of CEMIP mRNA	PMID:31256213
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of CEMIP mRNA	PMID:33448797
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in increased expression of CEMIP mRNA]	PMID:33448797
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of CEMIP mRNA	PMID:16002434|PMID:26485663
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305254	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CEMIP mRNA	PMID:33387578
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:17935	octanal	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C031639	caprylic aldehyde results in increased expression of CEMIP mRNA	PMID:25014914
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305254	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CEMIP mRNA	PMID:28522335
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:188736	Archazolid B	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C519728	archazolid B results in increased expression of CEMIP mRNA	PMID:25218289
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1621437	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of CEMIP mRNA	PMID:39984025
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEMIP mRNA	PMID:25510870
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEMIP mRNA	PMID:25510870
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CEMIP mRNA	PMID:32234424
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CEMIP gene	PMID:27153756
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEMIP mRNA	PMID:32525701
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of CEMIP mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of CEMIP mRNA	PMID:23557933|PMID:41028656
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of CEMIP mRNA	PMID:19561079
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of CEMIP mRNA	PMID:40618947
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1621437	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of CEMIP mRNA	PMID:32186404
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CEMIP mRNA	PMID:25583101
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305254	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CEMIP mRNA	PMID:32109520
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CEMIP mRNA	PMID:20106945|PMID:21632981|PMID:26238291|PMID:29704546
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CEMIP mRNA	PMID:33212167
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CEMIP mRNA	PMID:30851411
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of CEMIP mRNA	PMID:21198554
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CEMIP mRNA; [Disulfiram binds to Copper] which results in increased expression of CEMIP mRNA; [NSC 689534 binds to Copper] which results in decreased expression of CEMIP mRNA	PMID:20971185|PMID:24690739|PMID:41028656
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CEMIP mRNA	PMID:29803840
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CEMIP mRNA	PMID:25493608
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of CEMIP mRNA	PMID:34032870|PMID:38568856
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1621437	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of CEMIP mRNA	PMID:39515575
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CEMIP mRNA	PMID:20064835|PMID:21632981
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CEMIP promoter	PMID:27901495
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CEMIP mRNA	PMID:26238291
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CEMIP 3' UTR; Benzo(a)pyrene results in increased methylation of CEMIP 5' UTR	PMID:27901495
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CEMIP mRNA; [Disulfiram binds to Copper] which results in increased expression of CEMIP mRNA; [NSC 689534 binds to Copper] which results in decreased expression of CEMIP mRNA	PMID:20971185|PMID:24690739|PMID:41028656
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of CEMIP mRNA	PMID:26014281
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CEMIP mRNA	PMID:27131904
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CEMIP mRNA	PMID:25895662
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CEMIP mRNA	PMID:26238291
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CEMIP gene	PMID:31601247
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1305254	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of CEMIP mRNA	PMID:32479839
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1621437	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CEMIP mRNA	PMID:35295148
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:33083	fluoranthene	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20170725	CTD	MESH:C007738	fluoranthene results in decreased expression of CEMIP mRNA	PMID:28329830
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305254	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CEMIP mRNA	PMID:25181051|PMID:34947998|PMID:38750585
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of CEMIP mRNA	PMID:26063408|PMID:37105096
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CEMIP gene	PMID:31601247
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CEMIP gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEMIP mRNA	PMID:28628672|PMID:31601247
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:34093	1-Hydroxypyrene	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C033146	[Metals, Heavy co-treated with 1-hydroxypyrene] results in decreased methylation of CEMIP gene	PMID:39164771
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of CEMIP mRNA	PMID:23146750
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEMIP mRNA	PMID:25510870
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEMIP mRNA	PMID:25510870
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of CEMIP mRNA	PMID:40203079
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621437	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CEMIP mRNA	PMID:30951980
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of CEMIP intron	PMID:30157460
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:34787	heptanal	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C046204	heptanal results in increased expression of CEMIP mRNA	PMID:25014914
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEMIP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CEMIP mRNA	PMID:28628672
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CEMIP mRNA	PMID:37042841
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of CEMIP mRNA	PMID:29024780
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305254	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CEMIP mRNA	PMID:35163327
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305254	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of CEMIP mRNA	PMID:30723492
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305254	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CEMIP mRNA	PMID:28511854
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305254	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CEMIP mRNA	PMID:35163327
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CEMIP mRNA	PMID:40194260
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CEMIP mRNA	PMID:28302478
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of CEMIP mRNA	PMID:39529242
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of CEMIP mRNA	PMID:31626844
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305254	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of CEMIP mRNA	PMID:29427782
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CEMIP mRNA	PMID:25562108
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of CEMIP mRNA	PMID:25047013
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEMIP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CEMIP mRNA	PMID:28628672
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in increased expression of CEMIP mRNA	PMID:33448797
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in increased expression of CEMIP mRNA]	PMID:33448797
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CEMIP mRNA	PMID:38832940
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CEMIP mRNA	PMID:22230336|PMID:29067470
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305254	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of CEMIP mRNA	PMID:32479839
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of CEMIP mRNA	PMID:24690739
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of CEMIP mRNA	PMID:35811015
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CEMIP mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of CEMIP mRNA	PMID:35811015
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CEMIP mRNA	PMID:29279043
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of CEMIP mRNA	PMID:29523930
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEMIP mRNA	PMID:32525701
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305254	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CEMIP mRNA	PMID:29391264
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:1621437	E	RGD:6480464	20200804	CTD	MESH:D002101	Cacodylic Acid results in increased expression of CEMIP mRNA	PMID:32052077
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CEMIP mRNA	PMID:32234424
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CEMIP mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of CEMIP mRNA	PMID:28628672
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:507499	tricetin	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C469689	tricetin results in decreased expression of CEMIP mRNA	PMID:38654487
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in increased expression of CEMIP mRNA]	PMID:33448797
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of CEMIP mRNA	PMID:31629900
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1621437	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CEMIP mRNA	PMID:38701926
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CEMIP mRNA	PMID:28988120
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of CEMIP intron	PMID:30157460
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1621437	E	RGD:6480464	20231031	CTD	MESH:C057862	cyanoginosin LR results in increased expression of CEMIP mRNA	PMID:37342990
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CEMIP mRNA	PMID:31758290
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of CEMIP mRNA	PMID:29522793
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CEMIP mRNA	PMID:30851411
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305254	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CEMIP mRNA	PMID:32109520
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of CEMIP mRNA	PMID:19095052
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CEMIP mRNA	PMID:23146750
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1621437	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in increased expression of CEMIP mRNA	PMID:27935865
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1621437	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of CEMIP mRNA	PMID:27029645
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C046012	pentanal results in increased expression of CEMIP mRNA	PMID:25014914|PMID:26079696
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEMIP mRNA	PMID:32525701
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305254	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CEMIP mRNA	PMID:24780913
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of CEMIP mRNA	PMID:26014281
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1621437	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CEMIP mRNA	PMID:27131904
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:9355	sulfuretin	decreases activity	ISO	RGD:1621437	E	RGD:6480464	20241105	CTD	MESH:C054989	sulfuretin results in decreased activity of CEMIP protein	PMID:39454959
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CEMIP mRNA	PMID:38568856
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of CEMIP mRNA	PMID:29301935
1313176	CEMIP	cell migration inducing hyaluronidase 1	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305254	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of CEMIP gene	PMID:31682807
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313179	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LRRN4 mRNA	PMID:33045310
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin affects the expression of LRRN4 mRNA	PMID:31600526
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of LRRN4 mRNA	PMID:21934132
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313179	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRRN4 mRNA	PMID:37992649
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of LRRN4 mRNA	PMID:33647349
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313179	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRRN4 mRNA	PMID:37992649
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LRRN4 mRNA	PMID:31163220
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305256	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of LRRN4 mRNA	PMID:26577399
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305256	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of LRRN4 mRNA	PMID:33387578
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of LRRN4 mRNA	PMID:28818685
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of LRRN4 mRNA	PMID:19549813
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1305256	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of LRRN4 protein	PMID:33236894
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305256	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LRRN4 mRNA	PMID:22129741
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LRRN4 mRNA	PMID:28960355
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313179	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of LRRN4 mRNA	PMID:32186404
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313179	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRRN4 mRNA	PMID:21570461|PMID:26377647
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305256	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRRN4 mRNA	PMID:33387578
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRRN4 mRNA	PMID:20106945|PMID:21632981
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313179	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to LRRN4 promoter]	PMID:19654925
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of LRRN4 mRNA	PMID:21198554
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LRRN4 mRNA	PMID:29803840
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313179	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRRN4 mRNA	PMID:37992649
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:28854	2,4-D	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of LRRN4 mRNA	PMID:40294809
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313179	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of LRRN4 mRNA	PMID:37682722
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LRRN4 5' UTR	PMID:27901495
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LRRN4 promoter	PMID:27901495
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313179	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LRRN4 intron	PMID:27901495
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LRRN4 mRNA	PMID:20106945|PMID:21632981|PMID:21871943
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313179	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to LRRN4 promoter]	PMID:19654925
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of LRRN4 mRNA	PMID:27131904
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of LRRN4 mRNA	PMID:35676786
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313179	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of LRRN4 mRNA	PMID:23557971
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313179	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRRN4 gene	PMID:35295148
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LRRN4 mRNA	PMID:19710929
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305256	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRN4 mRNA	PMID:25181051
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRN4 mRNA	PMID:26063408
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313179	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LRRN4 mRNA	PMID:32156529
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of LRRN4 gene	PMID:31601247
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313179	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LRRN4 mRNA	PMID:30951980
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1313179	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of LRRN4 mRNA	PMID:26377693
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313179	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of LRRN4 mRNA	PMID:38685157
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305256	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LRRN4 mRNA	PMID:22129741
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of LRRN4 mRNA	PMID:31533062
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of LRRN4 mRNA	PMID:39529242
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of LRRN4 mRNA	PMID:40419075
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1305256	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of LRRN4 mRNA	PMID:23125180
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LRRN4 mRNA	PMID:25979313
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of LRRN4 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LRRN4 gene	PMID:29154799
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRRN4 mRNA	PMID:27188386
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of LRRN4 mRNA	PMID:19159671
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of LRRN4 mRNA	PMID:28973697
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313179	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRRN4 mRNA	PMID:37992649
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LRRN4 mRNA	PMID:38832940
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of LRRN4 mRNA	PMID:24935251
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305256	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LRRN4 mRNA	PMID:33387578
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305256	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of LRRN4 mRNA	PMID:29391264
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1305256	E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of LRRN4 mRNA	PMID:37567419
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of LRRN4 mRNA	PMID:26272509
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of LRRN4 mRNA	PMID:35676786
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LRRN4 mRNA; Nanotubes, Carbon results in decreased expression of LRRN4 mRNA	PMID:25554681
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313179	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of LRRN4 mRNA	PMID:40234311
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of LRRN4 mRNA	PMID:26377693
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1313179	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of LRRN4 mRNA	PMID:26377693
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:53578	hexamethylene diisocyanate	increases methylation	EXP		E	RGD:6480464	20150414	CTD	MESH:C015262	1,6-hexamethylene diisocyanate results in increased methylation of LRRN4 gene	PMID:25445006
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1305256	E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in increased expression of LRRN4 mRNA	PMID:21161181
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1305256	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of LRRN4 mRNA	PMID:23665939
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRRN4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRRN4 mRNA	PMID:27188386
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313179	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of LRRN4 mRNA	PMID:38648751
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of LRRN4 mRNA	PMID:26377693
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRRN4 mRNA	PMID:27188386
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRRN4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRRN4 mRNA	PMID:27188386
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313179	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of LRRN4 mRNA	PMID:27131904
1313178	LRRN4	leucine rich repeat neuronal 4	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305256	E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in decreased expression of LRRN4 mRNA	PMID:22615374
1313180	VN1R3	vomeronasal 1 receptor 3	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of VN1R3 mRNA	PMID:24763279
1313180	VN1R3	vomeronasal 1 receptor 3	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1359155	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of VOM1R30 mRNA	PMID:27523638
1313180	VN1R3	vomeronasal 1 receptor 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1318566	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of VMN1R70 mRNA	PMID:25629700
1313180	VN1R3	vomeronasal 1 receptor 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of VN1R3 mRNA	PMID:23557933
1313180	VN1R3	vomeronasal 1 receptor 3	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1359155	E	RGD:6480464	20160705	CTD	MESH:C039281	furan results in decreased expression of VOM1R30 mRNA	PMID:25539665
1313180	VN1R3	vomeronasal 1 receptor 3	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1318566	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of VMN1R70 mRNA	PMID:35436446
1313180	VN1R3	vomeronasal 1 receptor 3	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of VN1R3 mRNA	PMID:18175754
1313180	VN1R3	vomeronasal 1 receptor 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to VN1R3 gene]	PMID:28238834
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of AFG3L2 mRNA]	PMID:19467301
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313184	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of AFG3L2 mRNA	PMID:26251327
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1313184	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of AFG3L2 promoter	PMID:26251327
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of AFG3L2 mRNA	PMID:33167477
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of AFG3L2 protein	PMID:39571964
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of AFG3L2 mRNA	PMID:22378314
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313184	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of AFG3L2 mRNA	PMID:30319688
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313184	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of AFG3L2 mRNA	PMID:39241906
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of AFG3L2 mRNA	PMID:21179406
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AFG3L2 mRNA	PMID:36331819
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:18388	apigenin	increases expression	ISO	RGD:1313184	E	RGD:6480464	20121113	CTD	MESH:D047310	Apigenin results in increased expression of AFG3L2 mRNA	PMID:22359648
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305259	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of AFG3L2 protein	PMID:34915118
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of AFG3L2 mRNA	PMID:22206623
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of AFG3L2 mRNA	PMID:23557933
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313184	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AFG3L2 mRNA	PMID:21570461
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313184	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AFG3L2 mRNA	PMID:15034205
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313184	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of AFG3L2 mRNA	PMID:26873546
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of AFG3L2 mRNA	PMID:29803840
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of AFG3L2 mRNA	PMID:38568856
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	[sodium arsenite co-treated with lead acetate] results in increased expression of AFG3L2 protein; [sodium arsenite co-treated with Tretinoin] results in increased expression of AFG3L2 protein	PMID:38072110|PMID:39571964
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313184	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AFG3L2 mRNA	PMID:15034205
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in increased expression of AFG3L2 protein	PMID:38072110
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313184	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AFG3L2 promoter	PMID:35295148
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305259	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of AFG3L2 mRNA	PMID:23411599
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313184	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of AFG3L2 mRNA	PMID:18301758
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305259	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of AFG3L2 mRNA	PMID:30816183|PMID:32528016
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of AFG3L2 protein	PMID:34186270|PMID:37567409
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305259	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of AFG3L2 mRNA	PMID:25181051
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305259	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of AFG3L2 gene	PMID:28505145
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AFG3L2 mRNA	PMID:28628672
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of AFG3L2 protein	PMID:34186270
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AFG3L2 mRNA	PMID:28628672
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of AFG3L2 protein	PMID:34186270
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AFG3L2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AFG3L2 mRNA	PMID:28628672
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of AFG3L2 mRNA	PMID:36117858
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AFG3L2 mRNA	PMID:37042841
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305259	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of AFG3L2 mRNA	PMID:24386269
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AFG3L2 mRNA	PMID:36331819
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AFG3L2 mRNA	PMID:25979313
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313184	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of AFG3L2 mRNA	PMID:21427059
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of AFG3L2 mRNA	PMID:17183730
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AFG3L2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AFG3L2 mRNA	PMID:28628672
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of AFG3L2 mRNA	PMID:24935251
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of AFG3L2 mRNA	PMID:25704631|PMID:26690555
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305259	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of AFG3L2 mRNA	PMID:29391264
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313184	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of AFG3L2 mRNA	PMID:35436446
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AFG3L2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AFG3L2 mRNA	PMID:28628672
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of AFG3L2 mRNA	PMID:35964746
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305259	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of AFG3L2 mRNA	PMID:24136188
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of AFG3L2 mRNA	PMID:36117858
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of AFG3L2 mRNA	PMID:17183730
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AFG3L2 protein	PMID:32959892
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313184	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of AFG3L2 mRNA	PMID:23650126
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of AFG3L2 mRNA	PMID:37939859
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of AFG3L2 protein	PMID:34186270
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313184	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of AFG3L2 mRNA	PMID:22206623
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313184	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of AFG3L2 mRNA	PMID:22206623
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of AFG3L2 protein	PMID:37664457
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305259	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of AFG3L2 mRNA	PMID:24136188
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305259	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of AFG3L2 mRNA	PMID:21346803
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313184	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of AFG3L2 mRNA	PMID:31388691
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of AFG3L2 protein	PMID:37664457
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of AFG3L2 mRNA	PMID:38568856
1313183	AFG3L2	AFG3 like matrix AAA peptidase subunit 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305259	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of AFG3L2 mRNA	PMID:21346803
1313187	GOLGA3	golgin A3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305262	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GOLGA3 mRNA]	PMID:31150632
1313187	GOLGA3	golgin A3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of GOLGA3 mRNA	PMID:23724009
1313187	GOLGA3	golgin A3	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20150127	CTD	MESH:D008628	Mercury analog results in decreased expression of GOLGA3 mRNA	PMID:25056781
1313187	GOLGA3	golgin A3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313188	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of GOLGA3 mRNA	PMID:30319688
1313187	GOLGA3	golgin A3	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D011794	Quercetin results in decreased expression of GOLGA3 protein	PMID:14750173
1313187	GOLGA3	golgin A3	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of GOLGA3 mRNA	PMID:38568856
1313187	GOLGA3	golgin A3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GOLGA3 mRNA	PMID:37042841
1313187	GOLGA3	golgin A3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of GOLGA3 mRNA	PMID:33848595
1313187	GOLGA3	golgin A3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of GOLGA3 mRNA]	PMID:33848595
1313187	GOLGA3	golgin A3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of GOLGA3 protein	PMID:37730182
1313187	GOLGA3	golgin A3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305262	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GOLGA3 mRNA	PMID:33387578
1313187	GOLGA3	golgin A3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305262	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of GOLGA3 protein	PMID:34915118
1313187	GOLGA3	golgin A3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GOLGA3 mRNA	PMID:37236586
1313187	GOLGA3	golgin A3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GOLGA3 protein	PMID:23301498
1313187	GOLGA3	golgin A3	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20150127	CTD	MESH:D008628	Mercury analog results in decreased expression of GOLGA3 mRNA	PMID:25056781
1313187	GOLGA3	golgin A3	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GOLGA3 mRNA	PMID:18593933
1313187	GOLGA3	golgin A3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305262	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GOLGA3 mRNA	PMID:31150632
1313187	GOLGA3	golgin A3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305262	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GOLGA3 mRNA]	PMID:31150632
1313187	GOLGA3	golgin A3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GOLGA3 mRNA	PMID:25629700
1313187	GOLGA3	golgin A3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GOLGA3 gene	PMID:25304211
1313187	GOLGA3	golgin A3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GOLGA3 mRNA	PMID:40504410
1313187	GOLGA3	golgin A3	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of GOLGA3 mRNA	PMID:19244175
1313187	GOLGA3	golgin A3	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA	PMID:19244175
1313187	GOLGA3	golgin A3	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of GOLGA3 protein	PMID:35688186
1313187	GOLGA3	golgin A3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of GOLGA3 mRNA	PMID:27594783
1313187	GOLGA3	golgin A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313188	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GOLGA3 mRNA	PMID:21570461
1313187	GOLGA3	golgin A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305262	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GOLGA3 mRNA	PMID:32109520
1313187	GOLGA3	golgin A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20140408	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GOLGA3 mRNA	PMID:23994337
1313187	GOLGA3	golgin A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GOLGA3 mRNA	PMID:25975270
1313187	GOLGA3	golgin A3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20250401	CTD	MESH:D004317	Doxorubicin results in decreased expression of GOLGA3 protein	PMID:38244039
1313187	GOLGA3	golgin A3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313188	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of GOLGA3 mRNA	PMID:39631538
1313187	GOLGA3	golgin A3	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of GOLGA3 protein	PMID:35688186
1313187	GOLGA3	golgin A3	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of GOLGA3 mRNA	PMID:20044591
1313187	GOLGA3	golgin A3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GOLGA3 mRNA	PMID:38568856
1313187	GOLGA3	golgin A3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GOLGA3 mRNA	PMID:40504410
1313187	GOLGA3	golgin A3	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of GOLGA3 mRNA	PMID:22378314
1313187	GOLGA3	golgin A3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GOLGA3 promoter	PMID:27901495
1313187	GOLGA3	golgin A3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to GOLGA3 mRNA]	PMID:32406909
1313187	GOLGA3	golgin A3	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GOLGA3 mRNA	PMID:18593933
1313187	GOLGA3	golgin A3	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313188	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of GOLGA3 mRNA	PMID:23221170
1313187	GOLGA3	golgin A3	gene	CHEBI:30778	gallic acid	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of GOLGA3 mRNA	PMID:34408198
1313187	GOLGA3	golgin A3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GOLGA3 gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of GOLGA3 gene	PMID:31601247
1313187	GOLGA3	golgin A3	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of GOLGA3 mRNA	PMID:31745603
1313187	GOLGA3	golgin A3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of GOLGA3 mRNA	PMID:29264374
1313187	GOLGA3	golgin A3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313188	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GOLGA3 gene	PMID:35295148
1313187	GOLGA3	golgin A3	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305262	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of GOLGA3 mRNA	PMID:19167457
1313187	GOLGA3	golgin A3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305262	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GOLGA3 mRNA	PMID:34947998
1313187	GOLGA3	golgin A3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of GOLGA3 gene	PMID:31601247
1313187	GOLGA3	golgin A3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305262	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GOLGA3 mRNA	PMID:25181051
1313187	GOLGA3	golgin A3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GOLGA3 gene	PMID:31601247
1313187	GOLGA3	golgin A3	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of GOLGA3 mRNA	PMID:19244175
1313187	GOLGA3	golgin A3	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA	PMID:19244175
1313187	GOLGA3	golgin A3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of GOLGA3 mRNA	PMID:23994337
1313187	GOLGA3	golgin A3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GOLGA3 mRNA	PMID:39298647
1313187	GOLGA3	golgin A3	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of GOLGA3 intron	PMID:30157460
1313187	GOLGA3	golgin A3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313188	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of GOLGA3 mRNA	PMID:38685157
1313187	GOLGA3	golgin A3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of GOLGA3 gene	PMID:31601247
1313187	GOLGA3	golgin A3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of GOLGA3 mRNA	PMID:37019170
1313187	GOLGA3	golgin A3	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313188	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of GOLGA3 protein	PMID:35362542
1313187	GOLGA3	golgin A3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GOLGA3 protein]	PMID:35362542
1313187	GOLGA3	golgin A3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GOLGA3 mRNA	PMID:37042841
1313187	GOLGA3	golgin A3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305262	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GOLGA3 mRNA	PMID:33453195
1313187	GOLGA3	golgin A3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GOLGA3 mRNA	PMID:37236586
1313187	GOLGA3	golgin A3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of GOLGA3 mRNA	PMID:23146750
1313187	GOLGA3	golgin A3	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of GOLGA3 mRNA	PMID:19244175
1313187	GOLGA3	golgin A3	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA	PMID:19244175
1313187	GOLGA3	golgin A3	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of GOLGA3 protein	PMID:34122009
1313187	GOLGA3	golgin A3	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of GOLGA3 mRNA	PMID:28302478
1313187	GOLGA3	golgin A3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GOLGA3 mRNA	PMID:25979313
1313187	GOLGA3	golgin A3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313188	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of GOLGA3 mRNA	PMID:17292431
1313187	GOLGA3	golgin A3	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305262	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of GOLGA3 mRNA	PMID:29427782
1313187	GOLGA3	golgin A3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GOLGA3 mRNA	PMID:20106945|PMID:25562108
1313187	GOLGA3	golgin A3	gene	CHEBI:42223	emodin	increases expression	ISO	RGD:1313188	E	RGD:6480464	20180703	CTD	MESH:D004642	Emodin results in increased expression of GOLGA3 mRNA	PMID:21319176
1313187	GOLGA3	golgin A3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GOLGA3 mRNA	PMID:38832940
1313187	GOLGA3	golgin A3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of GOLGA3 mRNA	PMID:21420995
1313187	GOLGA3	golgin A3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GOLGA3 gene	PMID:25304211
1313187	GOLGA3	golgin A3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GOLGA3 mRNA	PMID:40504410
1313187	GOLGA3	golgin A3	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of GOLGA3 mRNA	PMID:36621641
1313187	GOLGA3	golgin A3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of GOLGA3 mRNA	PMID:35436446
1313187	GOLGA3	golgin A3	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313188	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GOLGA3 protein]	PMID:35362542
1313187	GOLGA3	golgin A3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GOLGA3 protein	PMID:32959892
1313187	GOLGA3	golgin A3	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of GOLGA3 intron	PMID:30157460
1313187	GOLGA3	golgin A3	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1305262	E	RGD:6480464	20230307	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of GOLGA3 protein	PMID:22430071
1313187	GOLGA3	golgin A3	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of GOLGA3 protein	PMID:34186270
1313187	GOLGA3	golgin A3	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313188	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of GOLGA3 mRNA	PMID:22206623
1313187	GOLGA3	golgin A3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of GOLGA3 mRNA	PMID:37199045
1313187	GOLGA3	golgin A3	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of GOLGA3 mRNA	PMID:23994337
1313187	GOLGA3	golgin A3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305262	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GOLGA3 mRNA	PMID:21346803
1313187	GOLGA3	golgin A3	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of GOLGA3 mRNA	PMID:38568856
1313187	GOLGA3	golgin A3	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of GOLGA3 mRNA	PMID:22378314
1313187	GOLGA3	golgin A3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305262	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of GOLGA3 mRNA	PMID:21346803
1313187	GOLGA3	golgin A3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313188	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of GOLGA3 mRNA	PMID:28973697
1313187	GOLGA3	golgin A3	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305262	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of GOLGA3 mRNA	PMID:23034163
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623831	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ASAP2 mRNA	PMID:33045310
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305263	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ASAP2 mRNA]	PMID:31150632
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ASAP2 mRNA	PMID:22378314
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ASAP2 mRNA	PMID:21632981
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D004958	Estradiol affects the expression of ASAP2 mRNA	PMID:14699072
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D004958	Estradiol results in increased expression of ASAP2 mRNA	PMID:20106945
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1623831	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ASAP2 mRNA	PMID:39298647
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in decreased expression of ASAP2 mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of ASAP2 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of ASAP2 mRNA	PMID:20404318|PMID:20660070|PMID:30165855
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D011374	Progesterone results in increased expression of ASAP2 mRNA	PMID:18037150
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of ASAP2 mRNA	PMID:20660070
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305263	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ASAP2 mRNA	PMID:26577399
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ASAP2 protein	PMID:37730182
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ASAP2 intron	PMID:30157460
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1623831	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASAP2 mRNA	PMID:28111341|PMID:37236586|PMID:37325564
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ASAP2 mRNA	PMID:19549813
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305263	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ASAP2 mRNA	PMID:21396975
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ASAP2 intron	PMID:30157460
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1305263	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of ASAP2 mRNA	PMID:41580963
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1623831	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ASAP2 mRNA	PMID:34911549
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D014501	Uranium affects the expression of ASAP2 mRNA	PMID:15672453
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305263	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ASAP2 mRNA	PMID:31150632
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305263	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ASAP2 mRNA]	PMID:31150632
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ASAP2 gene	PMID:25304211
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ASAP2 protein	PMID:35688186
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1305263	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of ASAP2 gene	PMID:31011160
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D002945	Cisplatin results in decreased expression of ASAP2 mRNA	PMID:19561079
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305263	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASAP2 mRNA	PMID:22298810
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623831	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASAP2 mRNA	PMID:21570461|PMID:26377647|PMID:28922406
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ASAP2 mRNA	PMID:20106945|PMID:21632981
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ASAP2 mRNA	PMID:30851411
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1623831	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of ASAP2 mRNA	PMID:30807115
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ASAP2 mRNA	PMID:32763439
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ASAP2 gene	PMID:28589171
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of ASAP2 protein	PMID:38228842
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ASAP2 mRNA	PMID:38568856
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of ASAP2 mRNA	PMID:21632981
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ASAP2 3' UTR	PMID:27901495
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ASAP2 mRNA	PMID:20064835|PMID:20106945
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1623831	E	RGD:6480464	20151110	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ASAP2 mRNA	PMID:19770486
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ASAP2 promoter	PMID:27901495
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASAP2 mRNA	PMID:21871943
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1623831	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASAP2 mRNA	PMID:22610609
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ASAP2 gene	PMID:25435355
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ASAP2 mRNA]	PMID:32406909
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ASAP2 mRNA	PMID:19150397
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:3090	bicalutamide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of ASAP2 mRNA	PMID:16631469
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ASAP2 gene	PMID:31601247
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of ASAP2 mRNA	PMID:38568856
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305263	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of ASAP2 mRNA	PMID:24136188
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623831	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ASAP2 promoter	PMID:35295148
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1623831	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ASAP2 gene	PMID:35295148
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1623831	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ASAP2 mRNA	PMID:23811191
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1623831	E	RGD:6480464	20151110	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ASAP2 mRNA	PMID:19710929
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of ASAP2 mRNA	PMID:30690063
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1623831	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of ASAP2 mRNA	PMID:28329830
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305263	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A affects the expression of ASAP2 mRNA	PMID:34947998
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305263	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ASAP2 mRNA	PMID:25181051
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ASAP2 gene	PMID:31601247
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ASAP2 mRNA	PMID:25047013
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ASAP2 gene	PMID:31601247
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ASAP2 intron	PMID:30157460
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1623831	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ASAP2 mRNA	PMID:32715474
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ASAP2 mRNA	PMID:37042841
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1623831	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of ASAP2 mRNA	PMID:26377693
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1623831	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASAP2 mRNA	PMID:28111341|PMID:37236586|PMID:37325564
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C018021	cobaltous chloride results in increased expression of ASAP2 mRNA	PMID:19376846
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ASAP2 mRNA	PMID:31533062
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1305263	E	RGD:6480464	20180116	CTD	MESH:C464485	acetamiprid results in increased expression of ASAP2 mRNA	PMID:27782041
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ASAP2 mRNA	PMID:40419075
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623831	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ASAP2 mRNA	PMID:36331819
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305263	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of ASAP2 mRNA	PMID:29427782
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of ASAP2 mRNA	PMID:24935251|PMID:29154799
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ASAP2 gene	PMID:29154799
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D016572	Cyclosporine results in increased expression of ASAP2 mRNA	PMID:20106945|PMID:25562108
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305263	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of ASAP2 mRNA	PMID:24136188
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ASAP2 mRNA	PMID:38832940
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ASAP2 mRNA	PMID:24935251
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ASAP2 mRNA	PMID:29067470
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ASAP2 gene	PMID:25304211
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ASAP2 mRNA	PMID:22079256
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1623831	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ASAP2 mRNA	PMID:35436446
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of ASAP2 mRNA	PMID:38568856
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1623831	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ASAP2 mRNA	PMID:25554681|PMID:25620056
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1623831	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ASAP2 mRNA	PMID:25620056
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305263	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ASAP2 mRNA	PMID:24793618
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ASAP2 intron	PMID:30157460
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ASAP2 protein	PMID:34186270
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305263	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ASAP2 mRNA	PMID:24136188
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ASAP2 mRNA	PMID:22079256|PMID:22714537
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ASAP2 mRNA	PMID:22079256
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ASAP2 mRNA	PMID:30851411
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D010634	Phenobarbital affects the expression of ASAP2 mRNA	PMID:19159669
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305263	E	RGD:6480464	20151110	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ASAP2 mRNA	PMID:21346803
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ASAP2 mRNA	PMID:38568856
1313189	ASAP2	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1623831	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ASAP2 mRNA	PMID:28973697
1313192	PHF10	PHD finger protein 10	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PHF10 mRNA	PMID:33045310
1313192	PHF10	PHD finger protein 10	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PHF10 mRNA	PMID:26251327
1313192	PHF10	PHD finger protein 10	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1313193	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of PHF10 promoter	PMID:26251327
1313192	PHF10	PHD finger protein 10	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PHF10 mRNA	PMID:26079696
1313192	PHF10	PHD finger protein 10	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PHF10 mRNA	PMID:22378314
1313192	PHF10	PHD finger protein 10	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PHF10 mRNA	PMID:21632981
1313192	PHF10	PHD finger protein 10	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PHF10 mRNA	PMID:37042841
1313192	PHF10	PHD finger protein 10	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PHF10 mRNA	PMID:23649840
1313192	PHF10	PHD finger protein 10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PHF10 mRNA	PMID:33754040
1313192	PHF10	PHD finger protein 10	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PHF10 protein	PMID:37730182
1313192	PHF10	PHD finger protein 10	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PHF10 protein	PMID:23301498
1313192	PHF10	PHD finger protein 10	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PHF10 gene	PMID:27153756
1313192	PHF10	PHD finger protein 10	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PHF10 mRNA	PMID:23649840
1313192	PHF10	PHD finger protein 10	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PHF10 mRNA	PMID:35430440
1313192	PHF10	PHD finger protein 10	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of PHF10 mRNA	PMID:15672453
1313192	PHF10	PHD finger protein 10	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313193	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PHF10 mRNA	PMID:31919559
1313192	PHF10	PHD finger protein 10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313193	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PHF10 mRNA	PMID:22206623
1313192	PHF10	PHD finger protein 10	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PHF10 protein	PMID:35688186
1313192	PHF10	PHD finger protein 10	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305266	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PHF10 mRNA	PMID:31881176
1313192	PHF10	PHD finger protein 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHF10 mRNA	PMID:21632981
1313192	PHF10	PHD finger protein 10	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PHF10 mRNA	PMID:33212167
1313192	PHF10	PHD finger protein 10	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PHF10 mRNA	PMID:30851411
1313192	PHF10	PHD finger protein 10	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PHF10 mRNA	PMID:20971185
1313192	PHF10	PHD finger protein 10	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of PHF10 protein	PMID:35688186
1313192	PHF10	PHD finger protein 10	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of PHF10 mRNA	PMID:20044591
1313192	PHF10	PHD finger protein 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of PHF10 protein	PMID:29044176
1313192	PHF10	PHD finger protein 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PHF10 promoter	PMID:27901495
1313192	PHF10	PHD finger protein 10	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PHF10 mRNA	PMID:20971185
1313192	PHF10	PHD finger protein 10	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PHF10 mRNA	PMID:25895662
1313192	PHF10	PHD finger protein 10	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313193	E	RGD:6480464	20150127	CTD	MESH:C008261	lead acetate results in increased expression of PHF10 mRNA	PMID:25270620
1313192	PHF10	PHD finger protein 10	gene	CHEBI:31767	lead diacetate	increases methylation	ISO	RGD:1305266	E	RGD:6480464	20180828	CTD	MESH:C008261	lead acetate results in increased methylation of PHF10 gene	PMID:29571894
1313192	PHF10	PHD finger protein 10	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of PHF10 mRNA	PMID:31745603
1313192	PHF10	PHD finger protein 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313193	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PHF10 gene; titanium dioxide results in decreased methylation of PHF10 promoter	PMID:35295148
1313192	PHF10	PHD finger protein 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305266	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PHF10 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313192	PHF10	PHD finger protein 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PHF10 mRNA	PMID:33221593
1313192	PHF10	PHD finger protein 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305266	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PHF10 mRNA	PMID:25181051
1313192	PHF10	PHD finger protein 10	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305266	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PHF10 gene	PMID:28505145
1313192	PHF10	PHD finger protein 10	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PHF10 mRNA	PMID:37019170
1313192	PHF10	PHD finger protein 10	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PHF10 mRNA	PMID:34813904
1313192	PHF10	PHD finger protein 10	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20190219	CTD	MESH:D010269	Paraquat results in decreased expression of PHF10 mRNA	PMID:28012437
1313192	PHF10	PHD finger protein 10	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PHF10 mRNA	PMID:37042841
1313192	PHF10	PHD finger protein 10	gene	CHEBI:35546	perfluorodecanoic acid	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C036567	perfluorodecanoic acid results in increased expression of PHF10 mRNA	PMID:38568856
1313192	PHF10	PHD finger protein 10	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PHF10 mRNA	PMID:19376846
1313192	PHF10	PHD finger protein 10	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of PHF10 mRNA	PMID:19167446
1313192	PHF10	PHD finger protein 10	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PHF10 mRNA	PMID:25979313
1313192	PHF10	PHD finger protein 10	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHF10 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1313192	PHF10	PHD finger protein 10	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF10 mRNA	PMID:27188386
1313192	PHF10	PHD finger protein 10	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PHF10 mRNA	PMID:25562108
1313192	PHF10	PHD finger protein 10	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of PHF10 mRNA	PMID:22733784
1313192	PHF10	PHD finger protein 10	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of PHF10 mRNA	PMID:23649840
1313192	PHF10	PHD finger protein 10	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	PHF10 protein affects the susceptibility to Methotrexate	PMID:16217747
1313192	PHF10	PHD finger protein 10	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PHF10 mRNA	PMID:38832940
1313192	PHF10	PHD finger protein 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313193	E	RGD:6480464	20120626	CTD	MESH:D000082	Acetaminophen affects the expression of PHF10 mRNA	PMID:17562736
1313192	PHF10	PHD finger protein 10	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of PHF10 mRNA	PMID:35537566
1313192	PHF10	PHD finger protein 10	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313193	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PHF10 mRNA	PMID:25620056
1313192	PHF10	PHD finger protein 10	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305266	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of PHF10 mRNA	PMID:24793618
1313192	PHF10	PHD finger protein 10	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305266	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of PHF10 mRNA	PMID:28801915
1313192	PHF10	PHD finger protein 10	gene	CHEBI:6382	Lasiocarpine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PHF10 mRNA	PMID:33884520
1313192	PHF10	PHD finger protein 10	gene	CHEBI:63924	riddelliine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PHF10 mRNA	PMID:33884520
1313192	PHF10	PHD finger protein 10	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PHF10 mRNA	PMID:23650126
1313192	PHF10	PHD finger protein 10	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305266	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PHF10 mRNA	PMID:28801915
1313192	PHF10	PHD finger protein 10	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of PHF10 mRNA	PMID:28444820
1313192	PHF10	PHD finger protein 10	gene	CHEBI:6980	monocrotaline	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of PHF10 mRNA	PMID:33884520
1313192	PHF10	PHD finger protein 10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313193	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PHF10 mRNA	PMID:22206623
1313192	PHF10	PHD finger protein 10	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PHF10 mRNA	PMID:30851411
1313192	PHF10	PHD finger protein 10	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF10 mRNA	PMID:27188386
1313192	PHF10	PHD finger protein 10	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF10 mRNA	PMID:27188386
1313192	PHF10	PHD finger protein 10	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305266	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PHF10 mRNA	PMID:19281266
1313192	PHF10	PHD finger protein 10	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1305266	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of PHF10 protein	PMID:35544339
1313192	PHF10	PHD finger protein 10	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313193	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of PHF10 mRNA	PMID:35537566
1313192	PHF10	PHD finger protein 10	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305266	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of PHF10 gene	PMID:31682807
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313197	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of AMOTL1 gene	PMID:20938992
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of AMOTL1 mRNA	PMID:23724009|PMID:33167477
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313197	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of AMOTL1 mRNA	PMID:30319688
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of AMOTL1 mRNA	PMID:22574217
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305268	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of AMOTL1 mRNA	PMID:32145629
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305268	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of AMOTL1 mRNA	PMID:26496021
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:165210	Mono-carboxy isooctyl phthalate	affects expression	EXP		E	RGD:6480464	20220906	CTD	MESH:C573544	mono(carboxy-isooctyl)phthalate affects the expression of AMOTL1 mRNA	PMID:34478338
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313197	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of AMOTL1 gene	PMID:20938992
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of AMOTL1 gene	PMID:30521419
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of AMOTL1 mRNA	PMID:23649840
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of AMOTL1 mRNA	PMID:26079696
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of AMOTL1 mRNA	PMID:31163220
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of AMOTL1 protein	PMID:37730182
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AMOTL1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of AMOTL1 mRNA	PMID:39836092
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AMOTL1 mRNA	PMID:35301059
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313197	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of AMOTL1 mRNA	PMID:19376150
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:24828	indoles	decreases expression	ISO	RGD:1305268	E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in decreased expression of AMOTL1 mRNA	PMID:20521778
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:24828	indoles	increases expression	ISO	RGD:1305268	E	RGD:6480464	20170303	CTD	MESH:D007211	Indoles results in increased expression of AMOTL1 mRNA	PMID:20521778
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of AMOTL1 promoter	PMID:30157460
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of AMOTL1 mRNA	PMID:22100608
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313197	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of AMOTL1 mRNA	PMID:34911549
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313197	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of AMOTL1 gene	PMID:20938992
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AMOTL1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AMOTL1 mRNA	PMID:39836092
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of AMOTL1 mRNA	PMID:26272509
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMOTL1 mRNA	PMID:27188386
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1305268	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of AMOTL1 gene	PMID:31011160
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C059514	resveratrol results in increased expression of AMOTL1 mRNA	PMID:23750556
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of AMOTL1 mRNA	PMID:27392435|PMID:27594783
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of AMOTL1 mRNA	PMID:27392435
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of AMOTL1 mRNA	PMID:29803840
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of AMOTL1 mRNA	PMID:30031762
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of AMOTL1 protein	PMID:35688186
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of AMOTL1 mRNA	PMID:25879800
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AMOTL1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AMOTL1 mRNA	PMID:39836092
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to AMOTL1 mRNA]	PMID:32406909
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313197	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of AMOTL1 mRNA	PMID:27131904
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313197	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AMOTL1 gene; titanium dioxide results in decreased methylation of AMOTL1 promoter	PMID:35295148
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:32293	verteporfin	decreases response to substance	EXP		E	RGD:6480464	20220405	CTD	MESH:C098350	Verteporfin results in decreased susceptibility to AMOTL1 protein	PMID:34480788
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:32293	verteporfin	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C098350	Verteporfin inhibits the reaction [AMOTL1 protein results in increased activity of YAP1 protein]	PMID:34480788
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313197	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of AMOTL1 mRNA	PMID:20813756
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of AMOTL1 gene	PMID:31601247
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305268	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of AMOTL1 mRNA	PMID:32145629
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313197	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of AMOTL1 mRNA	PMID:26063408
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305268	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of AMOTL1 mRNA	PMID:26496021
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of AMOTL1 mRNA	PMID:25979313
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313197	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of AMOTL1 exon	PMID:33297965
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313197	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of AMOTL1 mRNA	PMID:40203079
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of AMOTL1 gene	PMID:31601247
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313197	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of AMOTL1 mRNA	PMID:37019170
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AMOTL1 mRNA	PMID:37042841
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1305268	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of AMOTL1 mRNA	PMID:35163327
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AMOTL1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of AMOTL1 mRNA	PMID:39836092
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305268	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of AMOTL1 mRNA	PMID:30917596
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AMOTL1 mRNA	PMID:25851441
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AMOTL1 mRNA	PMID:35301059
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of AMOTL1 mRNA	PMID:19320972
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of AMOTL1 mRNA	PMID:24449571
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of AMOTL1 mRNA	PMID:24383497|PMID:24935251|PMID:28001369
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of AMOTL1 mRNA	PMID:38832940
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of AMOTL1 mRNA	PMID:21420995
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AMOTL1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AMOTL1 mRNA	PMID:39836092
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of AMOTL1 mRNA	PMID:31838189
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of AMOTL1 mRNA	PMID:32234424
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of AMOTL1 mRNA	PMID:23228038
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of AMOTL1 mRNA	PMID:38568856
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:50729	mitoxantrone	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	AMOTL1 mRNA affects the susceptibility to Mitoxantrone	PMID:16044152
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of AMOTL1 mRNA	PMID:26705709
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of AMOTL1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of AMOTL1 mRNA	PMID:39836092
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305268	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of AMOTL1 gene	PMID:35440735
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMOTL1 mRNA	PMID:27188386
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of AMOTL1 mRNA	PMID:30458266
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1313197	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of AMOTL1 mRNA	PMID:27029645
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AMOTL1 mRNA	PMID:27188386
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313197	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of AMOTL1 mRNA	PMID:27131904
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:9466	Testosterone propionate	increases expression	ISO	RGD:1313197	E	RGD:6480464	20141111	CTD	MESH:D043343	Testosterone Propionate results in increased expression of AMOTL1 mRNA	PMID:15601916
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313197	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of AMOTL1 mRNA	PMID:28973697
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313197	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of AMOTL1 mRNA	PMID:35537566
1313196	AMOTL1	angiomotin like 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305268	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of AMOTL1 mRNA	PMID:19015723
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TOPORS mRNA	PMID:38218311
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TOPORS mRNA	PMID:33167477
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TOPORS protein	PMID:37730182
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305270	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TOPORS mRNA	PMID:33387578
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TOPORS mRNA	PMID:28818685
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOPORS mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TOPORS mRNA	PMID:39836092
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TOPORS mRNA	PMID:23649840
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TOPORS mRNA	PMID:23649840
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOPORS mRNA	PMID:39836092
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313200	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOPORS mRNA	PMID:40504410
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TOPORS protein	PMID:35688186
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TOPORS mRNA	PMID:23557933
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of TOPORS mRNA	PMID:27594783
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313200	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TOPORS mRNA	PMID:21570461
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305270	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TOPORS mRNA	PMID:21215274|PMID:33387578
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TOPORS mRNA	PMID:19770486
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TOPORS mRNA	PMID:17942748
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of TOPORS mRNA	PMID:33512557
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TOPORS mRNA	PMID:32763439
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of TOPORS protein	PMID:35688186
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313200	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of TOPORS mRNA	PMID:36209798
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOPORS mRNA	PMID:39836092
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313200	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOPORS mRNA	PMID:40504410
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:30563	silicon dioxide	increases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased methylation of TOPORS gene	PMID:34973136
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313200	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TOPORS gene	PMID:35295148
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305270	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TOPORS mRNA	PMID:34492290
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TOPORS mRNA	PMID:33221593|PMID:38074096
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305270	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of TOPORS mRNA	PMID:33296240|PMID:41034487
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TOPORS mRNA	PMID:39298647
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TOPORS mRNA	PMID:37019170
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TOPORS mRNA	PMID:37042841
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOPORS mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TOPORS mRNA	PMID:39836092
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TOPORS mRNA	PMID:38568856
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305270	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of TOPORS promoter	PMID:22457795
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TOPORS mRNA	PMID:28302478
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TOPORS mRNA	PMID:31533062
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of TOPORS mRNA	PMID:23179753|PMID:27188386
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in decreased expression of TOPORS mRNA	PMID:20546886
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of TOPORS mRNA	PMID:19770486
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TOPORS mRNA	PMID:17555576
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TOPORS mRNA	PMID:17562736
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TOPORS mRNA	PMID:29279043
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOPORS mRNA	PMID:39836092
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313200	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TOPORS mRNA	PMID:40504410
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TOPORS mRNA	PMID:17555576
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TOPORS mRNA	PMID:17942748
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TOPORS mRNA	PMID:17942748
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1313200	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of TOPORS mRNA	PMID:21318169
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1313200	E	RGD:6480464	20120613	CTD	MESH:D011345	[PPARA protein affects the susceptibility to Fenofibrate] which affects the expression of TOPORS mRNA	PMID:21318169
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313200	E	RGD:6480464	20180515	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TOPORS mRNA	PMID:25926378
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TOPORS mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TOPORS mRNA	PMID:39836092
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TOPORS mRNA	PMID:22206623
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:7438	N-methylformamide	increases expression	ISO	RGD:1313200	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide analog results in increased expression of TOPORS mRNA; methylformamide results in increased expression of TOPORS mRNA	PMID:17040096
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of TOPORS protein	PMID:31285264
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of TOPORS mRNA; Irinotecan results in decreased expression of TOPORS mRNA	PMID:15956246
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313200	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TOPORS mRNA	PMID:23091169
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:84070	sodium arsenate	affects methylation	ISO	RGD:1313200	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate affects the methylation of TOPORS promoter	PMID:20667999
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of TOPORS mRNA	PMID:20667999
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1313200	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of TOPORS protein	PMID:35357534
1313199	TOPORS	TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305270	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of TOPORS mRNA	PMID:23869203
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SNAPC5 mRNA	PMID:26079696
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:15891	taurine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013654	Taurine results in increased expression of SNAPC5 mRNA	PMID:16579726
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313203	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SNAPC5 mRNA	PMID:39298647
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNAPC5 mRNA	PMID:37042841
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1582813	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SNAPC5 mRNA	PMID:33387578
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SNAPC5 mRNA	PMID:19549813
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SNAPC5 mRNA	PMID:35430440
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313203	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNAPC5 mRNA	PMID:22206623
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SNAPC5 mRNA	PMID:23557933
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313203	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNAPC5 mRNA	PMID:21570461|PMID:24680724
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1582813	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNAPC5 mRNA	PMID:22298810
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1582813	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SNAPC5 mRNA	PMID:33387578
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SNAPC5 mRNA	PMID:33212167
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1582813	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SNAPC5 mRNA	PMID:28959563
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of SNAPC5 mRNA	PMID:17879257
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:30563	silicon dioxide	decreases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased methylation of SNAPC5 gene	PMID:34973136
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SNAPC5 mRNA	PMID:20458559
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313203	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SNAPC5 mRNA	PMID:23557971
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313203	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNAPC5 gene	PMID:35295148
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:32497	thioacetamide	increases methylation	ISO	RGD:1582813	E	RGD:6480464	20170516	CTD	MESH:D013853	Thioacetamide results in increased methylation of SNAPC5 promoter	PMID:27914986
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313203	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of SNAPC5 mRNA	PMID:18648102
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1313203	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of SNAPC5 mRNA	PMID:19191707
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313203	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SNAPC5 promoter	PMID:27334623
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1582813	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SNAPC5 mRNA	PMID:25181051
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313203	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SNAPC5 mRNA	PMID:26063408
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1582813	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SNAPC5 mRNA	PMID:31129395
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313203	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SNAPC5 mRNA	PMID:39298647|PMID:40203079
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SNAPC5 mRNA	PMID:28628672
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313203	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of SNAPC5 mRNA	PMID:28392331
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SNAPC5 mRNA	PMID:28628672
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SNAPC5 mRNA	PMID:26472689
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of SNAPC5 mRNA	PMID:40434365
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SNAPC5 mRNA	PMID:31533062
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313203	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of SNAPC5 mRNA	PMID:39529242
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SNAPC5 mRNA	PMID:23179753
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SNAPC5 mRNA	PMID:28628672
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of SNAPC5 mRNA	PMID:28542535
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313203	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNAPC5 mRNA	PMID:17562736
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1582813	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SNAPC5 mRNA	PMID:29391264
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of SNAPC5 mRNA	PMID:28628672
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SNAPC5 mRNA	PMID:20458559
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313203	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SNAPC5 mRNA	PMID:35964746
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313203	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SNAPC5 mRNA	PMID:22206623
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313203	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNAPC5 mRNA	PMID:22206623
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313203	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SNAPC5 mRNA	PMID:31388691
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313203	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SNAPC5 mRNA	PMID:30294300
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of SNAPC5 mRNA	PMID:26079696
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1582813	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SNAPC5 mRNA	PMID:24780913
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1582813	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of SNAPC5 mRNA	PMID:19281266
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SNAPC5 mRNA	PMID:29301935
1313202	SNAPC5	small nuclear RNA activating complex polypeptide 5	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1582813	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of SNAPC5 mRNA	PMID:19015723
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305273	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of LIMS2 mRNA	PMID:21551480
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313205	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of LIMS2 mRNA	PMID:20188158
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LIMS2 mRNA	PMID:36189433
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of LIMS2 mRNA	PMID:26079696
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of LIMS2 mRNA	PMID:25056781
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of LIMS2 mRNA	PMID:30510588
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of LIMS2 mRNA	PMID:32145629
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LIMS2 mRNA	PMID:39298647
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of LIMS2 mRNA	PMID:33711761
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305273	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LIMS2 mRNA	PMID:33387578
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of LIMS2 mRNA	PMID:26079696
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313205	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LIMS2 mRNA	PMID:39922521
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of LIMS2 mRNA	PMID:36189433
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1313205	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of LIMS2 mRNA	PMID:28973375
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313205	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LIMS2 mRNA	PMID:39922521
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LIMS2 intron	PMID:30157460
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of LIMS2 mRNA	PMID:33914522
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305273	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of LIMS2 mRNA	PMID:28522335
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LIMS2 mRNA	PMID:35301059
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LIMS2 mRNA	PMID:19549813
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of LIMS2 mRNA	PMID:22100608
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LIMS2 intron	PMID:30157460
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of LIMS2 mRNA	PMID:25056781
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of LIMS2 mRNA	PMID:31626304
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of LIMS2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of LIMS2 mRNA	PMID:34911549
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313205	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of LIMS2 mRNA	PMID:17484886
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LIMS2 mRNA	PMID:31150632
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of LIMS2 mRNA	PMID:22206623
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of LIMS2 mRNA	PMID:27392435
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of LIMS2 mRNA	PMID:22023808
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of LIMS2 mRNA	PMID:27392435
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305273	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of LIMS2 mRNA	PMID:20187946
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305273	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LIMS2 mRNA	PMID:22298810|PMID:34747641
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313205	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LIMS2 mRNA	PMID:21570461
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LIMS2 mRNA	PMID:21215274
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305273	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LIMS2 mRNA	PMID:33387578
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313205	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LIMS2 mRNA	PMID:18796159
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of LIMS2 mRNA	PMID:28374803
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LIMS2 mRNA	PMID:19770486
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313205	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LIMS2 mRNA	PMID:22228805
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LIMS2 promoter	PMID:27901495
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to LIMS2 promoter]	PMID:19654925
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LIMS2 mRNA	PMID:34973136
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313205	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LIMS2 mRNA	PMID:29203145
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of LIMS2 mRNA	PMID:20382639
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1305273	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of LIMS2 mRNA	PMID:22641619
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of LIMS2 mRNA	PMID:30047161
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of LIMS2 mRNA	PMID:30012374
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of LIMS2 mRNA	PMID:19464567|PMID:23557971
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LIMS2 promoter	PMID:34973136
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in increased expression of LIMS2 mRNA	PMID:34973136
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of LIMS2 mRNA	PMID:23411599|PMID:34492290
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313205	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LIMS2 mRNA	PMID:18301758
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of LIMS2 mRNA	PMID:38479592
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1313205	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of LIMS2 mRNA	PMID:33914522
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LIMS2 mRNA	PMID:25181051|PMID:30816183
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305273	E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in increased expression of LIMS4 mRNA	PMID:25181051
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LIMS2 mRNA	PMID:39298647
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313205	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LIMS2 mRNA	PMID:30951980
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LIMS2 intron	PMID:30157460
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of LIMS2 mRNA	PMID:38685157
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313205	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of LIMS2 mRNA	PMID:30951980
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313205	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LIMS2 mRNA	PMID:37019170
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:34656	cumene	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20120412	CTD	MESH:C015763	cumene results in decreased expression of LIMS2 mRNA	PMID:18648096
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305273	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LIMS2 mRNA	PMID:35163327
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LIMS2 mRNA	PMID:33453195
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LIMS2 mRNA	PMID:35301059
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305273	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LIMS2 mRNA	PMID:35163327
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LIMS2 mRNA	PMID:19320972
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of LIMS2 mRNA	PMID:24449571
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:3764	clotrimazole	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of LIMS2 mRNA	PMID:30047161
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313205	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LIMS2 mRNA	PMID:40194260
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LIMS2 mRNA	PMID:31533062
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of LIMS2 mRNA	PMID:40419075
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1313205	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of LIMS2 mRNA	PMID:29038090
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of LIMS2 mRNA	PMID:29154799
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of LIMS2 mRNA	PMID:30047161
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305273	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of LIMS2 mRNA	PMID:41580965
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of LIMS2 promoter	PMID:27989131
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of LIMS2 mRNA	PMID:25047013
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313205	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of LIMS2 mRNA	PMID:22733784
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313205	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of LIMS2 mRNA	PMID:28973697
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313205	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LIMS2 mRNA	PMID:39922521
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LIMS2 mRNA	PMID:38832940
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of LIMS2 mRNA	PMID:29279043
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of LIMS2 mRNA	PMID:30529165
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of LIMS2 mRNA	PMID:29391264
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of LIMS2 mRNA	PMID:35436446
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313205	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LIMS2 mRNA; Nanotubes, Carbon results in decreased expression of LIMS2 mRNA	PMID:25554681
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of LIMS2 mRNA	PMID:30047161
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1313205	E	RGD:6480464	20141223	CTD	MESH:C000499	ferric oxide analog results in increased expression of LIMS2 mRNA	PMID:25086211
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of LIMS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LIMS2 mRNA	PMID:21641980|PMID:26378955
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313205	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of LIMS2 mRNA	PMID:26307267
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of LIMS2 mRNA	PMID:30467583
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LIMS2 intron	PMID:30157460
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313205	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LIMS2 mRNA	PMID:22206623
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313205	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of LIMS2 mRNA	PMID:22206623
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of LIMS2 mRNA	PMID:24136188
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LIMS2 gene]	PMID:28238834
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of LIMS2 mRNA	PMID:26079696
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of LIMS2 mRNA	PMID:35688559
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305273	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of LIMS2 mRNA	PMID:24780913|PMID:30047161
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of LIMS2 mRNA	PMID:29301935
1313204	LIMS2	LIM zinc finger domain containing 2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305273	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of LIMS2 mRNA	PMID:19015723
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313208	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ROR2 mRNA	PMID:33045310
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313208	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ROR2 mRNA	PMID:37995155
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305275	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ROR2 mRNA]	PMID:31150632
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ROR2 mRNA	PMID:33167477
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of ROR2 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of ROR2 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of ROR2 mRNA	PMID:30951980
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of ROR2 mRNA	PMID:24763279
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ROR2 mRNA	PMID:26079696
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305275	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of ROR2 gene	PMID:35440735
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ROR2 mRNA	PMID:30165855
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ROR2 mRNA	PMID:36139627
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305275	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ROR2 mRNA	PMID:21396975
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ROR2 exon	PMID:30157460
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313208	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ROR2 mRNA	PMID:34911549
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305275	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ROR2 mRNA	PMID:31150632
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305275	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ROR2 mRNA]	PMID:31150632
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ROR2 mRNA	PMID:23557933
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313208	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ROR2 mRNA	PMID:24680724
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313208	E	RGD:6480464	20141223	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ROR2 mRNA	PMID:24928892
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ROR2 mRNA	PMID:12377990
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313208	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ROR2 mRNA	PMID:17586704
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ROR2 mRNA	PMID:29803840
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of ROR2 mRNA	PMID:34032870
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ROR2 intron	PMID:30157460
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ROR2 mRNA	PMID:32234424
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ROR2 promoter	PMID:27901495
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1313208	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of ROR2 gene	PMID:35295148
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:32497	thioacetamide	affects methylation	ISO	RGD:1305275	E	RGD:6480464	20141223	CTD	MESH:D013853	Thioacetamide affects the methylation of ROR2 promoter	PMID:25151969
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:33007	chromium(6+)	affects expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ROR2 mRNA	PMID:30690063
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305275	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ROR2 mRNA	PMID:25181051
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of ROR2 mRNA	PMID:15223131
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305275	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ROR2 mRNA	PMID:34947998
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ROR2 mRNA	PMID:30951980
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305275	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ROR2 gene	PMID:28505145
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of ROR2 mRNA	PMID:30951980
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ROR2 mRNA	PMID:30951980
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of ROR2 mRNA	PMID:30951980
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ROR2 intron	PMID:30157460
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ROR2 mRNA	PMID:30951980
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313208	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of ROR2 mRNA	PMID:30951980
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313208	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ROR2 intron	PMID:28392331
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313208	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of ROR2 protein	PMID:39748354
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305275	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ROR2 promoter	PMID:22457795
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ROR2 mRNA	PMID:25812627
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305275	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of ROR2 mRNA	PMID:27387713
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ROR2 mRNA	PMID:31533062
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ROR2 mRNA	PMID:25812627
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ROR2 mRNA	PMID:25979313
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ROR2 mRNA	PMID:28001369
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ROR2 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313208	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of ROR2 mRNA	PMID:24896083
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ROR2 gene	PMID:29154799
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ROR2 mRNA	PMID:27188386
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1305275	E	RGD:6480464	20250401	CTD	MESH:D003907	Dexamethasone results in increased expression of ROR2 mRNA	PMID:38971901
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ROR2 mRNA	PMID:38832940
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ROR2 mRNA	PMID:24935251|PMID:26272509
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ROR2 mRNA	PMID:27188386
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305275	E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in decreased expression of ROR2 mRNA	PMID:30723492
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ROR2 mRNA	PMID:29067470
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ROR2 mRNA	PMID:22079256
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:1305275	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of ROR2 gene	PMID:37958445
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313208	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ROR2 mRNA; Nanotubes, Carbon results in increased expression of ROR2 mRNA	PMID:25554681
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ROR2 intron	PMID:30157460
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305275	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ROR2 gene	PMID:35440735
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ROR2 mRNA	PMID:22079256
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ROR2 mRNA	PMID:22714537
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ROR2 mRNA	PMID:22079256
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ROR2 mRNA	PMID:36139627
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ROR2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ROR2 mRNA	PMID:27188386
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ROR2 gene]	PMID:28238834
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313208	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ROR2 mRNA	PMID:38648751
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ROR2 mRNA	PMID:26079696
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313208	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of ROR2 mRNA	PMID:30953684
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305275	E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ROR2 mRNA	PMID:33150595
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305275	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ROR2 mRNA	PMID:24780913
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases methylation	ISO	RGD:1305275	E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in increased methylation of ROR2 promoter	PMID:33150595
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:8687	pyrvinium	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:C024631	pyrvinium inhibits the reaction [ROR2 protein results in decreased expression of CDH1 protein]; pyrvinium inhibits the reaction [ROR2 protein results in increased expression of CDH2 protein]; pyrvinium inhibits the reaction [ROR2 protein results in increased expression of VIM protein]	PMID:39428718
1313207	ROR2	ROR family WNT receptor 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ROR2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ROR2 mRNA	PMID:27188386
1313209	RELL2	RELT like 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RELL2 mRNA	PMID:38218311
1313209	RELL2	RELT like 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313210	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RELL2 mRNA	PMID:20188158
1313209	RELL2	RELT like 2	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of RELL2 mRNA	PMID:30510588
1313209	RELL2	RELT like 2	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1305276	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of RELL2 mRNA	PMID:23829299
1313209	RELL2	RELT like 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RELL2 mRNA	PMID:25510870
1313209	RELL2	RELT like 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305276	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RELL2 mRNA	PMID:33387578
1313209	RELL2	RELT like 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RELL2 mRNA	PMID:37042841
1313209	RELL2	RELT like 2	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of RELL2 mRNA	PMID:33647349
1313209	RELL2	RELT like 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305276	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RELL2 mRNA	PMID:33387578
1313209	RELL2	RELT like 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RELL2 mRNA	PMID:28818685
1313209	RELL2	RELT like 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RELL2 mRNA	PMID:25510870
1313209	RELL2	RELT like 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RELL2 mRNA	PMID:25510870
1313209	RELL2	RELT like 2	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305276	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of RELL2 mRNA	PMID:30779732
1313209	RELL2	RELT like 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313210	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RELL2 mRNA	PMID:25629700
1313209	RELL2	RELT like 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RELL2 mRNA	PMID:40512198
1313209	RELL2	RELT like 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313210	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of RELL2 mRNA	PMID:28960355
1313209	RELL2	RELT like 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305276	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RELL2 mRNA	PMID:31881176
1313209	RELL2	RELT like 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RELL2 mRNA	PMID:23557933
1313209	RELL2	RELT like 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of RELL2 mRNA	PMID:27392435
1313209	RELL2	RELT like 2	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305276	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of RELL2 mRNA	PMID:20187946
1313209	RELL2	RELT like 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313210	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of RELL2 mRNA	PMID:32186404
1313209	RELL2	RELT like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305276	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RELL2 mRNA	PMID:22298810
1313209	RELL2	RELT like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305276	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RELL2 mRNA	PMID:32109520
1313209	RELL2	RELT like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305276	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RELL2 mRNA	PMID:33387578
1313209	RELL2	RELT like 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of RELL2 mRNA	PMID:32763439
1313209	RELL2	RELT like 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of RELL2 mRNA]; MT2 affects the reaction [Copper results in increased expression of RELL2 mRNA]	PMID:16629173
1313209	RELL2	RELT like 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RELL2 mRNA	PMID:38568856
1313209	RELL2	RELT like 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RELL2 mRNA	PMID:40512198
1313209	RELL2	RELT like 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RELL2 mRNA	PMID:34876320
1313209	RELL2	RELT like 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RELL2 mRNA	PMID:34876320
1313209	RELL2	RELT like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305276	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RELL2 mRNA	PMID:21839799
1313209	RELL2	RELT like 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RELL2 exon	PMID:27901495
1313209	RELL2	RELT like 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to RELL2 promoter]	PMID:19654925
1313209	RELL2	RELT like 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of RELL2 mRNA]; MT2 affects the reaction [Copper results in increased expression of RELL2 mRNA]	PMID:16629173
1313209	RELL2	RELT like 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313210	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RELL2 gene	PMID:35295148
1313209	RELL2	RELT like 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305276	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RELL2 mRNA	PMID:23411599|PMID:34492290
1313209	RELL2	RELT like 2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305276	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of RELL2 mRNA	PMID:19167457
1313209	RELL2	RELT like 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305276	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RELL2 mRNA	PMID:25181051
1313209	RELL2	RELT like 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305276	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RELL2 mRNA	PMID:34947998
1313209	RELL2	RELT like 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RELL2 mRNA	PMID:25510870
1313209	RELL2	RELT like 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1305276	E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of RELL2 mRNA	PMID:23829299
1313209	RELL2	RELT like 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RELL2 mRNA	PMID:25510870
1313209	RELL2	RELT like 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313210	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RELL2 mRNA	PMID:28392331
1313209	RELL2	RELT like 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305276	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RELL2 mRNA	PMID:21266533
1313209	RELL2	RELT like 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of RELL2 mRNA	PMID:29024780
1313209	RELL2	RELT like 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RELL2 mRNA	PMID:38174414
1313209	RELL2	RELT like 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305276	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of RELL2 mRNA	PMID:25539665
1313209	RELL2	RELT like 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313210	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RELL2 mRNA	PMID:40194260
1313209	RELL2	RELT like 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RELL2 mRNA	PMID:31533062
1313209	RELL2	RELT like 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of RELL2 mRNA	PMID:29154799
1313209	RELL2	RELT like 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305276	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RELL2 mRNA	PMID:30047161
1313209	RELL2	RELT like 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RELL2 mRNA	PMID:38832940
1313209	RELL2	RELT like 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of RELL2 mRNA	PMID:29067470
1313209	RELL2	RELT like 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RELL2 mRNA	PMID:40512198
1313209	RELL2	RELT like 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305276	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RELL2 mRNA	PMID:29391264
1313209	RELL2	RELT like 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RELL2 mRNA	PMID:34876320
1313209	RELL2	RELT like 2	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305276	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of RELL2 mRNA	PMID:34044035
1313209	RELL2	RELT like 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305276	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RELL2 mRNA	PMID:30047161
1313209	RELL2	RELT like 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313210	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RELL2 mRNA	PMID:38701926
1313209	RELL2	RELT like 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305276	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RELL2 mRNA	PMID:28801915
1313209	RELL2	RELT like 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313210	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of RELL2 mRNA	PMID:34876320
1313209	RELL2	RELT like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305276	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RELL2 mRNA	PMID:24780913
1313209	RELL2	RELT like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305276	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RELL2 mRNA	PMID:30047161
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305278	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of ADAM33 mRNA	PMID:25152437
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:132606	mono(2-ethyl-5-oxohexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C080276	[[Endocrine Disruptors results in increased abundance of mono(2-ethyl-5-oxohexyl)phthalate] which results in increased methylation of ADAM33 intron] which results in increased expression of ADAM33 mRNA	PMID:30226539
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:132607	mono(2-ethyl-5-hydroxyhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C479069	[[Endocrine Disruptors results in increased abundance of mono(2-ethyl-5-hydroxyhexyl) phthalate] which results in increased methylation of ADAM33 intron] which results in increased expression of ADAM33 mRNA	PMID:30226539
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:132611	mono(5-carboxy-2-ethylpentyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C051450	[[Endocrine Disruptors results in increased abundance of 2-ethyl-5-carboxypentyl phthalate] which results in increased methylation of ADAM33 intron] which results in increased expression of ADAM33 mRNA	PMID:30226539
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of ADAM33 mRNA	PMID:34925699
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:15365	acetylsalicylic acid	affects response to substance	EXP		E	RGD:6480464	20120501	CTD	MESH:D001241	ADAM33 SNP affects the susceptibility to Aspirin	PMID:17061022
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313213	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of ADAM33 mRNA	PMID:36189433
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADAM33 mRNA	PMID:36189433
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313213	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ADAM33 mRNA	PMID:39241906
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ADAM33 mRNA	PMID:30510588
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313213	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ADAM33 mRNA	PMID:33711761
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of ADAM33 mRNA	PMID:26079696
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADAM33 mRNA	PMID:36189433
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of ADAM33 mRNA	PMID:26485663
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ADAM33 mRNA	PMID:34911549
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313213	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ADAM33 mRNA	PMID:25629700
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADAM33 mRNA	PMID:40504410
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313213	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ADAM33 mRNA	PMID:28960355
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAM33 mRNA	PMID:23557933
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ADAM33 mRNA	PMID:24768652|PMID:25583101
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313213	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADAM33 mRNA	PMID:21570461
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305278	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADAM33 mRNA	PMID:33387578
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305278	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADAM33 mRNA	PMID:32109520
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of ADAM33 mRNA]	PMID:29753051
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313213	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAM33 mRNA	PMID:37682722
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADAM33 mRNA	PMID:40504410
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ADAM33 promoter	PMID:27901495
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ADAM33 mRNA]	PMID:22228805
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:3015	benomyl	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D001542	Benomyl results in increased expression of ADAM33 protein	PMID:27784618
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:3015	benomyl	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D001542	ORMDL3 protein affects the reaction [Benomyl results in increased expression of ADAM33 protein]	PMID:27784618
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ADAM33 mRNA	PMID:37690743
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305278	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ADAM33 mRNA	PMID:30047161
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313213	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ADAM33 mRNA	PMID:23557971
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313213	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ADAM33 gene	PMID:35295148
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313213	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in increased expression of ADAM33 mRNA	PMID:30245210
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313213	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of ADAM33 exon; bisphenol S affects the methylation of ADAM33 promoter	PMID:33297965
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313213	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ADAM33 mRNA	PMID:38685157
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305278	E	RGD:6480464	20150127	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ADAM33 mRNA	PMID:24893172
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305278	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ADAM33 mRNA	PMID:32680482
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ADAM33 mRNA	PMID:24449571
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313213	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ADAM33 mRNA	PMID:39529242
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305278	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of ADAM33 mRNA	PMID:29427782
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ADAM33 gene	PMID:29154799
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305278	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ADAM33 mRNA	PMID:30047161
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADAM33 mRNA	PMID:22230336
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305278	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADAM33 mRNA	PMID:33387578
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313213	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ADAM33 mRNA	PMID:29279043
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313213	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADAM33 mRNA	PMID:40504410
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of ADAM33 mRNA	PMID:31838189
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305278	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of ADAM33 mRNA	PMID:17557909
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	EXP		E	RGD:6480464	20211207	CTD	MESH:C014347	Decitabine results in decreased methylation of ADAM33 promoter	PMID:34534549
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305278	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ADAM33 mRNA	PMID:30047161
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1313213	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of ADAM33 mRNA	PMID:26377693
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313213	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ADAM33 mRNA	PMID:23608068
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ADAM33 mRNA	PMID:24810058
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:71193	liraglutide	decreases methylation	EXP		E	RGD:6480464	20211207	CTD	MESH:D000069450	Liraglutide results in decreased methylation of ADAM33 promoter	PMID:34534549
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:71193	liraglutide	decreases methylation	ISO	RGD:1313213	E	RGD:6480464	20211207	CTD	MESH:D000069450	Liraglutide results in decreased methylation of ADAM33 promoter	PMID:34534549
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:71193	liraglutide	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D000069450	Liraglutide results in increased expression of ADAM33 mRNA; Liraglutide results in increased expression of ADAM33 protein	PMID:34534549
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:71193	liraglutide	increases expression	ISO	RGD:1313213	E	RGD:6480464	20211207	CTD	MESH:D000069450	Liraglutide results in increased expression of ADAM33 mRNA; Liraglutide results in increased expression of ADAM33 protein	PMID:34534549
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313213	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ADAM33 mRNA	PMID:22206623
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1305278	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of ADAM33 mRNA	PMID:32109520
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313213	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ADAM33 mRNA	PMID:38648751
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313213	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ADAM33 mRNA	PMID:21795629
1313212	ADAM33	ADAM metallopeptidase domain 33	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313213	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of ADAM33 mRNA	PMID:35537566
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of CHERP protein	PMID:39638853
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313215	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CHERP mRNA	PMID:33045310
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305279	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CHERP mRNA]	PMID:31150632
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313215	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CHERP mRNA	PMID:24205000
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313215	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CHERP mRNA	PMID:30319688
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of CHERP mRNA	PMID:31614463
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CHERP protein	PMID:37730182
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CHERP protein]	PMID:32272095
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CHERP protein	PMID:23301498
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305279	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CHERP mRNA	PMID:31150632
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305279	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CHERP mRNA]	PMID:31150632
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHERP mRNA	PMID:22206623
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHERP mRNA	PMID:40504410
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CHERP protein	PMID:35688186
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of CHERP mRNA	PMID:27594783
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313215	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CHERP mRNA	PMID:30912803
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHERP mRNA	PMID:22574217
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313215	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHERP mRNA	PMID:21570461
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313215	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CHERP mRNA	PMID:19465110
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of CHERP mRNA	PMID:33512557
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CHERP mRNA	PMID:33212167
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	increases expression	ISO	RGD:1305279	E	RGD:6480464	20140610	CTD	MESH:D019328	Buthionine Sulfoximine results in increased expression of CHERP protein	PMID:23736079
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Aspartame] affects the expression of CHERP mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CHERP mRNA	PMID:23783067
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHERP mRNA	PMID:40504410
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313215	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CHERP exon; Benzo(a)pyrene results in decreased methylation of CHERP intron	PMID:27901495
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305279	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CHERP mRNA	PMID:34492290
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CHERP gene	PMID:31601247
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305279	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CHERP mRNA	PMID:25181051
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1305279	E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of CHERP mRNA	PMID:27914987
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313215	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CHERP gene	PMID:31683443
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305279	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHERP mRNA	PMID:17602206
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313215	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of CHERP protein	PMID:32272095
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CHERP protein]	PMID:32272095
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305279	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHERP mRNA	PMID:17602206
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CHERP mRNA	PMID:37042841
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CHERP mRNA	PMID:38382870
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CHERP mRNA	PMID:19376846
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CHERP mRNA	PMID:28302478
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CHERP mRNA	PMID:25979313
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CHERP gene	PMID:29154799
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of CHERP mRNA	PMID:24449571
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313215	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CHERP mRNA	PMID:17562736
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313215	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CHERP mRNA	PMID:19446018
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHERP mRNA	PMID:40504410
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CHERP mRNA	PMID:35964746
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305279	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CHERP mRNA	PMID:24136188
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CHERP protein	PMID:32959892
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CHERP mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of CHERP mRNA	PMID:23783067
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313215	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of CHERP mRNA	PMID:26307267
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CHERP mRNA	PMID:31758290
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313215	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHERP mRNA	PMID:22206623
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:7599	Nivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of CHERP protein	PMID:39638853
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:7599	Nivalenol	increases expression	ISO	RGD:1313215	E	RGD:6480464	20220607	CTD	MESH:C038405	nivalenol results in increased expression of CHERP mRNA	PMID:35016910
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305279	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CHERP mRNA	PMID:21346803
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CHERP mRNA	PMID:38568856
1313214	CHERP	calcium homeostasis endoplasmic reticulum protein	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305279	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CHERP mRNA	PMID:21346803
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DAZAP1 mRNA	PMID:38218311
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DAZAP1 mRNA	PMID:38218311
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:15882	phenol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019800	Phenol results in increased expression of DAZAP1 mRNA	PMID:17547211
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313217	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DAZAP1 mRNA	PMID:39241906
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DAZAP1 mRNA	PMID:39298647
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305280	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of DAZAP1 mRNA	PMID:32145629
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of DAZAP1 mRNA	PMID:23649840
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in increased expression of DAZAP1 protein	PMID:34122009
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DAZAP1 mRNA	PMID:36331819
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DAZAP1 mRNA	PMID:37236586
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DAZAP1 protein	PMID:23301498
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DAZAP1 mRNA	PMID:23649840
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of DAZAP1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of DAZAP1 protein	PMID:38598786
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of DAZAP1 mRNA]	PMID:22206623
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DAZAP1 gene	PMID:25304211
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAZAP1 mRNA	PMID:40504410
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000966	Antimony Potassium Tartrate results in increased expression of DAZAP1 mRNA	PMID:17547211
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DAZAP1 protein	PMID:38460933
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DAZAP1 protein	PMID:35688186
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of DAZAP1 mRNA	PMID:28903495
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305280	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of DAZAP1 mRNA	PMID:20187946
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313217	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DAZAP1 mRNA	PMID:20702594|PMID:21570461
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305280	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DAZAP1 mRNA	PMID:33387578
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DAZAP1 mRNA	PMID:17942748
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of DAZAP1 mRNA	PMID:23179753|PMID:26272509
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAZAP1 mRNA	PMID:27188386
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of DAZAP1 mRNA	PMID:39709020
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DAZAP1 mRNA	PMID:29803840
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DAZAP1 mRNA	PMID:38568856
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAZAP1 mRNA	PMID:40504410
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DAZAP1 promoter	PMID:27901495
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313217	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DAZAP1 mRNA	PMID:20504355|PMID:22228805
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313217	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of DAZAP1 protein	PMID:37955338
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:30304	antimony(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000965	Antimony results in increased expression of DAZAP1 mRNA	PMID:17547211
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in increased expression of DAZAP1 protein	PMID:34122009
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DAZAP1 mRNA	PMID:39716349
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DAZAP1 mRNA	PMID:20458559
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DAZAP1 gene	PMID:31601247
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:31739	josamycin	affects response to substance	EXP		E	RGD:6480464	20200609	CTD	MESH:D015570	DAZAP1 protein affects the susceptibility to Josamycin	PMID:31915244
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of DAZAP1 mRNA	PMID:38568856
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305280	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DAZAP1 mRNA	PMID:25729387
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313217	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of DAZAP1 mRNA	PMID:29264374
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313217	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of DAZAP1 promoter alternative form	PMID:35295148
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of DAZAP1 mRNA	PMID:29275510
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DAZAP1 mRNA	PMID:33221593
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305280	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DAZAP1 mRNA	PMID:25181051|PMID:32145629
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of DAZAP1 gene	PMID:31601247
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:34093	1-Hydroxypyrene	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C033146	1-hydroxypyrene results in decreased expression of DAZAP1 mRNA	PMID:21854004
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of DAZAP1 gene	PMID:31601247
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1305280	E	RGD:6480464	20210406	CTD	MESH:D000487	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA	PMID:33051911|PMID:33396045|PMID:34896426
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of DAZAP1 mRNA	PMID:38685157
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of DAZAP1 protein	PMID:34186270
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313217	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DAZAP1 intron	PMID:28392331
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313217	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DAZAP1 mRNA	PMID:37019170
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of DAZAP1 protein	PMID:38598786
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305280	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DAZAP1 mRNA	PMID:33453195
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305280	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of DAZAP1 promoter	PMID:22457795
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DAZAP1 mRNA	PMID:37236586
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:39098	pyrethrins	affects expression	ISO	RGD:1305280	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins affects the expression of DAZAP1 mRNA	PMID:34896426
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DAZAP1 mRNA	PMID:36331819
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DAZAP1 mRNA	PMID:17963808
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of DAZAP1 mRNA	PMID:21427059
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of DAZAP1 mRNA	PMID:21427059
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DAZAP1 gene	PMID:29154799
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1305280	E	RGD:6480464	20210406	CTD	MESH:C037304	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA	PMID:33051911|PMID:33396045|PMID:34896426
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1305280	E	RGD:6480464	20210406	CTD	MESH:C017160	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA	PMID:33051911|PMID:33396045|PMID:34896426
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of DAZAP1 mRNA	PMID:17555576
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305280	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of DAZAP1 mRNA	PMID:24136188
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DAZAP1 mRNA	PMID:17562736
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DAZAP1 protein	PMID:38460933
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DAZAP1 gene	PMID:25304211
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAZAP1 mRNA	PMID:40504410
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DAZAP1 mRNA	PMID:17555576
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DAZAP1 mRNA	PMID:17942748
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DAZAP1 mRNA	PMID:17942748
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DAZAP1 mRNA	PMID:39716349
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DAZAP1 mRNA	PMID:20458559
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1305280	E	RGD:6480464	20210406	CTD	MESH:C017690	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA	PMID:33051911|PMID:33396045|PMID:34896426
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DAZAP1 protein	PMID:32959892
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305280	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DAZAP1 mRNA	PMID:25729387
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313217	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DAZAP1 mRNA	PMID:22206623
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313217	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of DAZAP1 mRNA]	PMID:22206623
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DAZAP1 protein	PMID:37664457
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAZAP1 mRNA	PMID:27188386
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1313217	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of DAZAP1 mRNA	PMID:20702594
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of DAZAP1 mRNA	PMID:26079696
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DAZAP1 protein	PMID:38348393
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313217	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of DAZAP1 mRNA	PMID:40826991
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DAZAP1 protein; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAZAP1 mRNA	PMID:27188386|PMID:37664457
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305280	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of DAZAP1 mRNA	PMID:19281266
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DAZAP1 mRNA	PMID:38568856
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of DAZAP1 protein	PMID:38598786
1313216	DAZAP1	DAZ associated protein 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305280	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DAZAP1 mRNA	PMID:21346803
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313219	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SLC72A1 mRNA	PMID:30319688
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313219	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SLC72A1 mRNA	PMID:39241906
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:9294064	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC71A1 mRNA	PMID:33387578
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLC71A1 mRNA	PMID:37042841
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of SLC71A1 promoter	PMID:33872906
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SLC71A1 mRNA	PMID:33359661
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of SLC71A1 promoter	PMID:33872906
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:9294064	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SLC71A1 mRNA	PMID:22061828|PMID:33387578
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313219	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC72A1 mRNA	PMID:37236586
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of SLC71A1 mRNA	PMID:23195993
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:9294064	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC71A1 mRNA	PMID:33387578
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:9294064	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC71A1 mRNA	PMID:33387578
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of SLC71A1 mRNA	PMID:33512557
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SLC71A1 mRNA	PMID:30851411
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313219	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SLC72A1 gene	PMID:35295148
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:9294064	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SLC71A1 mRNA	PMID:34492290
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313219	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SLC72A1 mRNA	PMID:18648102
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of SLC71A1 mRNA	PMID:38479592
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:9294064	E	RGD:6480464	20161018	CTD	MESH:C006780	bisphenol A results in increased expression of SLC71A1 mRNA	PMID:25181051
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313219	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SLC72A1 mRNA	PMID:39298647
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:9294064	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] affects the expression of SLC71A1 mRNA	PMID:35163327
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:9294064	E	RGD:6480464	20260811	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of TPTE promoter	PMID:22457795
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313219	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC72A1 mRNA	PMID:37236586
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:9294064	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] affects the expression of SLC71A1 mRNA	PMID:35163327
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SLC71A1 mRNA	PMID:31533062
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLC71A1 mRNA	PMID:25979313
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SLC71A1 mRNA	PMID:23179753
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of SLC71A1 mRNA	PMID:33512557
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:9294064	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC71A1 mRNA	PMID:33387578
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SLC71A1 mRNA	PMID:29523930
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:9294064	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SLC71A1 mRNA	PMID:29391264
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:9294064	E	RGD:6480464	20161018	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of SLC71A1 mRNA	PMID:19162173
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SLC71A1 protein	PMID:32959892
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313219	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC72A1 mRNA	PMID:22206623
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SLC71A1 mRNA	PMID:30851411
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC71A1 gene]	PMID:28238834
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313219	E	RGD:6480464	20160315	CTD	MESH:C045950	propiconazole results in increased expression of SLC72A1 mRNA	PMID:21278054
1313218	SLC71A1	solute carrier family 71 member 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:9294064	E	RGD:6480464	20260811	CTD	MESH:C025643	vinclozolin results in increased expression of TPTE mRNA	PMID:22615374
1313223	POSTN	periostin	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of POSTN mRNA	PMID:25152437
1313223	POSTN	periostin	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of POSTN mRNA	PMID:26272509
1313223	POSTN	periostin	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1313223	POSTN	periostin	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of POSTN mRNA	PMID:20938992
1313223	POSTN	periostin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of POSTN mRNA	PMID:21934132
1313223	POSTN	periostin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of POSTN mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of POSTN mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of POSTN mRNA	PMID:30951980
1313223	POSTN	periostin	gene	CHEBI:15379	dioxygen	decreases response to substance	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D010100	POSTN gene mutant form results in decreased susceptibility to Oxygen	PMID:22363622
1313223	POSTN	periostin	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20140211	CTD	MESH:D010100	Oxygen deficiency results in increased expression of POSTN protein	PMID:23728938
1313223	POSTN	periostin	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen results in increased expression of POSTN mRNA; Oxygen results in increased expression of POSTN protein	PMID:22363622
1313223	POSTN	periostin	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20140211	CTD	MESH:D010100	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of POSTN protein]; POSTN protein affects the reaction [Oxygen deficiency results in increased expression of VEGFA mRNA]; POSTN protein affects the reaction [Oxygen deficiency results in increased secretion of VEGFA protein]	PMID:23728938
1313223	POSTN	periostin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D010100	[POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of ACTA2 mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CCL4 mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CXCL1 mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of CXCL2 mRNA; [POSTN gene mutant form results in decreased susceptibility to Oxygen] which results in decreased expression of ELN mRNA; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CCL4 mRNA]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CXCL1 mRNA]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of CXCL2 mRNA]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of ELN mRNA]; POSTN gene mutant form inhibits the reaction [Oxygen results in increased expression of POSTN mRNA]	PMID:22363622
1313223	POSTN	periostin	gene	CHEBI:156259	PD-166866	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20200908	CTD	MESH:C113399	PD 166866 inhibits the reaction [FGF1 protein results in increased expression of POSTN mRNA]	PMID:15121739
1313223	POSTN	periostin	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of POSTN mRNA	PMID:36841081
1313223	POSTN	periostin	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of POSTN mRNA	PMID:30517762
1313223	POSTN	periostin	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in decreased expression of POSTN mRNA	PMID:17023530
1313223	POSTN	periostin	gene	CHEBI:16359	cholic acid	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:D019826	Cholic Acid results in decreased expression of POSTN mRNA	PMID:37813191
1313223	POSTN	periostin	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313224	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POSTN mRNA	PMID:23585870
1313223	POSTN	periostin	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of POSTN mRNA	PMID:30510588
1313223	POSTN	periostin	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of POSTN mRNA	PMID:21795739
1313223	POSTN	periostin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313224	E	RGD:6480464	20250805	CTD	MESH:D004958	Estradiol results in increased expression of POSTN protein; Estradiol results in increased expression of POSTN protein alternative form	PMID:26903627
1313223	POSTN	periostin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of POSTN mRNA	PMID:32741896
1313223	POSTN	periostin	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of POSTN mRNA	PMID:20938992
1313223	POSTN	periostin	gene	CHEBI:16865	gamma-aminobutyric acid	affects expression	ISO	RGD:1305285	E	RGD:6480464	20140513	CTD	MESH:D005680	gamma-Aminobutyric Acid affects the expression of POSTN mRNA	PMID:24098073
1313223	POSTN	periostin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of POSTN mRNA	PMID:37992649
1313223	POSTN	periostin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of POSTN mRNA	PMID:36695872
1313223	POSTN	periostin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of and results in increased methylation of POSTN mRNA	PMID:36314267
1313223	POSTN	periostin	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of POSTN mRNA	PMID:32741896
1313223	POSTN	periostin	gene	CHEBI:173719	Curcumol	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C022801	curcumol results in decreased expression of POSTN mRNA	PMID:32344006
1313223	POSTN	periostin	gene	CHEBI:173719	Curcumol	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C022801	curcumol results in decreased expression of and results in decreased secretion of POSTN protein; POSTN protein affects the reaction [curcumol results in decreased expression of ICAM1 protein]; POSTN protein affects the reaction [curcumol results in decreased expression of VCAM1 protein]	PMID:32344006
1313223	POSTN	periostin	gene	CHEBI:173719	Curcumol	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20210706	CTD	MESH:C022801	curcumol inhibits the reaction [Carbon Tetrachloride results in increased expression of POSTN protein]	PMID:32344006
1313223	POSTN	periostin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of POSTN mRNA	PMID:37992649
1313223	POSTN	periostin	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of POSTN mRNA	PMID:36331819
1313223	POSTN	periostin	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of POSTN mRNA	PMID:39836092
1313223	POSTN	periostin	gene	CHEBI:194147	aristolochic acids	increases expression	ISO	RGD:1305285	E	RGD:6480464	20230103	CTD	MESH:D034341	Aristolochic Acids results in increased expression of POSTN mRNA	PMID:19717638
1313223	POSTN	periostin	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in decreased expression of POSTN mRNA	PMID:15120970
1313223	POSTN	periostin	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of POSTN mRNA	PMID:29741670
1313223	POSTN	periostin	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of POSTN protein]	PMID:32272095
1313223	POSTN	periostin	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of POSTN protein	PMID:20106945
1313223	POSTN	periostin	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of POSTN mRNA	PMID:22100608
1313223	POSTN	periostin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of POSTN mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of POSTN mRNA	PMID:27106289|PMID:34911549
1313223	POSTN	periostin	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313224	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of POSTN mRNA; Carbon Tetrachloride results in increased expression of POSTN protein	PMID:27339419|PMID:29987408|PMID:31919559|PMID:32344006
1313223	POSTN	periostin	gene	CHEBI:27385	tetrachloromethane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D002251	POSTN protein promotes the reaction [Carbon Tetrachloride results in increased expression of GPT protein]	PMID:32344006
1313223	POSTN	periostin	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of POSTN mRNA; curcumol inhibits the reaction [Carbon Tetrachloride results in increased expression of POSTN protein]	PMID:30517762|PMID:32344006
1313223	POSTN	periostin	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of POSTN mRNA	PMID:25629700
1313223	POSTN	periostin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of POSTN mRNA	PMID:20938992
1313223	POSTN	periostin	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D001151	Arsenic results in decreased expression of POSTN mRNA	PMID:38036231
1313223	POSTN	periostin	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of POSTN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of POSTN mRNA	PMID:39836092
1313223	POSTN	periostin	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of POSTN mRNA	PMID:19244175
1313223	POSTN	periostin	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of POSTN mRNA	PMID:26272509
1313223	POSTN	periostin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1313223	POSTN	periostin	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of POSTN mRNA	PMID:38314887
1313223	POSTN	periostin	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313224	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of POSTN protein	PMID:37208198
1313223	POSTN	periostin	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of POSTN mRNA	PMID:28903495
1313223	POSTN	periostin	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20151013	CTD	MESH:D002945	POSTN mRNA results in decreased susceptibility to Cisplatin	PMID:25199881
1313223	POSTN	periostin	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of POSTN mRNA	PMID:12075121
1313223	POSTN	periostin	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of POSTN mRNA	PMID:24768652|PMID:25583101
1313223	POSTN	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POSTN mRNA	PMID:36370075
1313223	POSTN	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305285	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POSTN mRNA	PMID:34747641
1313223	POSTN	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POSTN mRNA	PMID:33387578
1313223	POSTN	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POSTN mRNA	PMID:33956508
1313223	POSTN	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305285	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POSTN mRNA	PMID:32109520
1313223	POSTN	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313224	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POSTN mRNA	PMID:21889950
1313223	POSTN	periostin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of POSTN mRNA]	PMID:15667827
1313223	POSTN	periostin	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of POSTN mRNA	PMID:28374803
1313223	POSTN	periostin	gene	CHEBI:28445	vincristine	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	POSTN mRNA results in decreased susceptibility to Vincristine	PMID:25199881
1313223	POSTN	periostin	gene	CHEBI:28509	chloroethene	increases expression	ISO	RGD:1313224	E	RGD:6480464	20230606	CTD	MESH:D014752	Vinyl Chloride results in increased expression of POSTN protein	PMID:36892438
1313223	POSTN	periostin	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of POSTN mRNA	PMID:28959563
1313223	POSTN	periostin	gene	CHEBI:28659	phosphorus atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010758	[Phosphorus co-treated with paricalcitol] results in decreased expression of POSTN mRNA	PMID:17715259
1313223	POSTN	periostin	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of POSTN mRNA	PMID:21198554
1313223	POSTN	periostin	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305285	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of POSTN mRNA	PMID:30556269
1313223	POSTN	periostin	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of POSTN mRNA	PMID:24690739
1313223	POSTN	periostin	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of POSTN mRNA	PMID:15467011
1313223	POSTN	periostin	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin results in decreased expression of POSTN mRNA	PMID:28940058
1313223	POSTN	periostin	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of POSTN mRNA	PMID:17888722|PMID:39631538
1313223	POSTN	periostin	gene	CHEBI:28748	doxorubicin	decreases response to substance	EXP		E	RGD:6480464	20151013	CTD	MESH:D004317	POSTN mRNA results in decreased susceptibility to Doxorubicin	PMID:25199881
1313223	POSTN	periostin	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of POSTN mRNA	PMID:29803840
1313223	POSTN	periostin	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1305285	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of POSTN mRNA	PMID:19915844
1313223	POSTN	periostin	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313224	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of POSTN mRNA	PMID:36227756
1313223	POSTN	periostin	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20120412	CTD	MESH:D004317	Razoxane inhibits the reaction [Doxorubicin results in increased expression of POSTN mRNA]	PMID:19915844
1313223	POSTN	periostin	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D004317	DMD protein affects the reaction [Doxorubicin results in decreased expression of POSTN mRNA]	PMID:17888722
1313223	POSTN	periostin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of POSTN mRNA	PMID:37992649
1313223	POSTN	periostin	gene	CHEBI:28939	N-acetyl-L-cysteine	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D000111	Acetylcysteine results in decreased expression of POSTN mRNA	PMID:32947957
1313223	POSTN	periostin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of POSTN mRNA	PMID:35954277
1313223	POSTN	periostin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20190219	CTD	MESH:C017947	sodium arsenite results in decreased expression of POSTN mRNA	PMID:30130555|PMID:37682722
1313223	POSTN	periostin	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of POSTN mRNA	PMID:22714537|PMID:38568856
1313223	POSTN	periostin	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of POSTN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of POSTN mRNA	PMID:39836092
1313223	POSTN	periostin	gene	CHEBI:29852	methylarsonic acid	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:C020300	monomethylarsonic acid results in decreased expression of POSTN mRNA	PMID:37813191
1313223	POSTN	periostin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of POSTN mRNA	PMID:20713471
1313223	POSTN	periostin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POSTN mRNA	PMID:22316170|PMID:32234424
1313223	POSTN	periostin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313224	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POSTN mRNA	PMID:21964900
1313223	POSTN	periostin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of POSTN exon; Benzo(a)pyrene results in increased methylation of POSTN promoter	PMID:27901495
1313223	POSTN	periostin	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305285	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of POSTN mRNA	PMID:30556269
1313223	POSTN	periostin	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of POSTN mRNA	PMID:24690739
1313223	POSTN	periostin	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of POSTN mRNA	PMID:15467011
1313223	POSTN	periostin	gene	CHEBI:30207	phosphorus(.)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010758	[Phosphorus co-treated with paricalcitol] results in decreased expression of POSTN mRNA	PMID:17715259
1313223	POSTN	periostin	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of POSTN mRNA	PMID:27131904
1313223	POSTN	periostin	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of POSTN mRNA	PMID:22431001
1313223	POSTN	periostin	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of POSTN mRNA	PMID:26705709
1313223	POSTN	periostin	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of POSTN gene	PMID:31601247
1313223	POSTN	periostin	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of POSTN mRNA	PMID:38568856
1313223	POSTN	periostin	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of POSTN mRNA	PMID:25729387
1313223	POSTN	periostin	gene	CHEBI:32345	gamma-Oryzanol (TN)	affects expression	ISO	RGD:1305285	E	RGD:6480464	20141111	CTD	MESH:C013172	gamma-oryzanol affects the expression of POSTN mRNA	PMID:24098073
1313223	POSTN	periostin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305285	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of POSTN mRNA	PMID:30723492
1313223	POSTN	periostin	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of POSTN mRNA	PMID:19136022
1313223	POSTN	periostin	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313224	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of POSTN mRNA	PMID:23811191
1313223	POSTN	periostin	gene	CHEBI:3312	calcium dichloride	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D002122	Calcium Chloride results in decreased expression of POSTN protein	PMID:25824407
1313223	POSTN	periostin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of POSTN mRNA	PMID:36232920
1313223	POSTN	periostin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of POSTN mRNA	PMID:12075121|PMID:25181051|PMID:30816183|PMID:34947998
1313223	POSTN	periostin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of POSTN protein	PMID:34186270
1313223	POSTN	periostin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305285	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of POSTN mRNA	PMID:29097150|PMID:32145629
1313223	POSTN	periostin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of POSTN mRNA; bisphenol A results in increased expression of POSTN protein; bisphenol A results in increased expression of POSTN protein alternative form	PMID:26903627|PMID:30951980|PMID:38701888
1313223	POSTN	periostin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of POSTN mRNA	PMID:30951980
1313223	POSTN	periostin	gene	CHEBI:338412	(-)-anisomycin	increases expression	ISO	RGD:1305285	E	RGD:6480464	20120412	CTD	MESH:D000841	Anisomycin results in increased expression of POSTN mRNA	PMID:15121739
1313223	POSTN	periostin	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313224	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of POSTN mRNA	PMID:26682919
1313223	POSTN	periostin	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of POSTN mRNA	PMID:20713471
1313223	POSTN	periostin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S affects the expression of POSTN mRNA	PMID:30951980
1313223	POSTN	periostin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of POSTN mRNA	PMID:40203079
1313223	POSTN	periostin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313224	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of POSTN mRNA	PMID:39298647
1313223	POSTN	periostin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of POSTN gene	PMID:31601247
1313223	POSTN	periostin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of POSTN mRNA	PMID:30951980
1313223	POSTN	periostin	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313224	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of POSTN mRNA	PMID:26377693
1313223	POSTN	periostin	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of POSTN protein	PMID:34186270
1313223	POSTN	periostin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of POSTN mRNA	PMID:30951980
1313223	POSTN	periostin	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of POSTN mRNA	PMID:30951980
1313223	POSTN	periostin	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of POSTN protein	PMID:34186270
1313223	POSTN	periostin	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of POSTN protein	PMID:32272095
1313223	POSTN	periostin	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of POSTN protein]	PMID:32272095
1313223	POSTN	periostin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305285	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of POSTN mRNA	PMID:21266533
1313223	POSTN	periostin	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in increased expression of POSTN protein	PMID:34064677
1313223	POSTN	periostin	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of POSTN mRNA	PMID:35163327
1313223	POSTN	periostin	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of POSTN mRNA	PMID:35163327
1313223	POSTN	periostin	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of POSTN mRNA	PMID:39836092
1313223	POSTN	periostin	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305285	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of POSTN mRNA	PMID:30723492
1313223	POSTN	periostin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of POSTN mRNA	PMID:29741670
1313223	POSTN	periostin	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of POSTN mRNA	PMID:35163327
1313223	POSTN	periostin	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305285	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of POSTN mRNA	PMID:27387713
1313223	POSTN	periostin	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of POSTN mRNA	PMID:24386269
1313223	POSTN	periostin	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of POSTN mRNA	PMID:19244175
1313223	POSTN	periostin	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in decreased expression of POSTN mRNA	PMID:37813191
1313223	POSTN	periostin	gene	CHEBI:37918	fluorescein 5-isothiocyanate	affects binding	EXP		E	RGD:6480464	20180116	CTD	MESH:D016650	Fluorescein-5-isothiocyanate binds to POSTN protein	PMID:27129696
1313223	POSTN	periostin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313224	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of POSTN mRNA	PMID:40194260
1313223	POSTN	periostin	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of POSTN mRNA	PMID:31533062
1313223	POSTN	periostin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of POSTN mRNA	PMID:27153767
1313223	POSTN	periostin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of POSTN mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of POSTN mRNA	PMID:36331819
1313223	POSTN	periostin	gene	CHEBI:3962	curcumin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in increased expression of POSTN mRNA	PMID:21594647
1313223	POSTN	periostin	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of POSTN gene	PMID:29154799
1313223	POSTN	periostin	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of POSTN mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:29154799
1313223	POSTN	periostin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313224	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of POSTN mRNA	PMID:24896083
1313223	POSTN	periostin	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1313223	POSTN	periostin	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of POSTN mRNA	PMID:15331540
1313223	POSTN	periostin	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of POSTN mRNA	PMID:17555576
1313223	POSTN	periostin	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of POSTN mRNA	PMID:25047013
1313223	POSTN	periostin	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20250204	CTD	MESH:D003907	Dexamethasone inhibits the reaction [Particulate Matter results in increased expression of POSTN mRNA]	PMID:35335934
1313223	POSTN	periostin	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20250204	CTD	MESH:D003907	Dexamethasone inhibits the reaction [[Ovalbumin co-treated with Particulate Matter] results in increased expression of POSTN mRNA]	PMID:35335934
1313223	POSTN	periostin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313224	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of POSTN mRNA	PMID:28973697
1313223	POSTN	periostin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of POSTN mRNA	PMID:37992649
1313223	POSTN	periostin	gene	CHEBI:44185	methotrexate	decreases response to substance	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	POSTN mRNA results in decreased susceptibility to Methotrexate	PMID:25199881
1313223	POSTN	periostin	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of POSTN mRNA	PMID:38832940
1313223	POSTN	periostin	gene	CHEBI:45863	paclitaxel	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	POSTN mRNA results in decreased susceptibility to Paclitaxel	PMID:25199881
1313223	POSTN	periostin	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of POSTN mRNA	PMID:19682730
1313223	POSTN	periostin	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of POSTN mRNA	PMID:24935251|PMID:26272509
1313223	POSTN	periostin	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1313223	POSTN	periostin	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of POSTN mRNA	PMID:21420995|PMID:29067470
1313223	POSTN	periostin	gene	CHEBI:46345	5-fluorouracil	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	POSTN protein results in decreased susceptibility to Fluorouracil	PMID:15731169
1313223	POSTN	periostin	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of POSTN mRNA	PMID:24690739
1313223	POSTN	periostin	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D001151	Arsenic results in decreased expression of POSTN mRNA	PMID:38036231
1313223	POSTN	periostin	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of POSTN mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of POSTN mRNA	PMID:39836092
1313223	POSTN	periostin	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313224	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of POSTN mRNA	PMID:17555576
1313223	POSTN	periostin	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20120717	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of POSTN mRNA	PMID:12075121|PMID:17351261|PMID:17557909
1313223	POSTN	periostin	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D005047	Etoposide results in increased expression of POSTN mRNA	PMID:29397400
1313223	POSTN	periostin	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1313223	POSTN	periostin	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of POSTN mRNA	PMID:26705709
1313223	POSTN	periostin	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of POSTN mRNA	PMID:38825487
1313223	POSTN	periostin	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305285	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of POSTN mRNA	PMID:30307764
1313223	POSTN	periostin	gene	CHEBI:50225	razoxane	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20120412	CTD	MESH:D011929	Razoxane inhibits the reaction [Doxorubicin results in increased expression of POSTN mRNA]	PMID:19915844
1313223	POSTN	periostin	gene	CHEBI:50693	milrinone	increases expression	ISO	RGD:1305285	E	RGD:6480464	20180703	CTD	MESH:D020105	Milrinone results in increased expression of POSTN mRNA	PMID:22936366
1313223	POSTN	periostin	gene	CHEBI:52289	wortmannin	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin inhibits the reaction [AGT protein results in increased expression of POSTN mRNA]; wortmannin inhibits the reaction [FGF1 protein results in increased expression of POSTN mRNA]	PMID:15121739
1313223	POSTN	periostin	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of POSTN mRNA	PMID:22714537
1313223	POSTN	periostin	gene	CHEBI:53050	trimellitic anhydride	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of POSTN mRNA	PMID:40645554
1313223	POSTN	periostin	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of POSTN protein	PMID:32959892
1313223	POSTN	periostin	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of POSTN mRNA	PMID:39836092
1313223	POSTN	periostin	gene	CHEBI:63632	topotecan	decreases response to substance	EXP		E	RGD:6480464	20151013	CTD	MESH:D019772	POSTN mRNA results in decreased susceptibility to Topotecan	PMID:25199881
1313223	POSTN	periostin	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of POSTN mRNA	PMID:25729387
1313223	POSTN	periostin	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of POSTN mRNA	PMID:36851058
1313223	POSTN	periostin	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313224	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of POSTN mRNA	PMID:20003209
1313223	POSTN	periostin	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20211109	CTD	MESH:D007545	[Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADL mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADM mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADS mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADVL mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACSL1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of AKT1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5F1A mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5F1D mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5MC1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5PO mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP6AP2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of AZI2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of BAG4 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of BIRC2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CASP7 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CDC37 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CHUK mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of COPS3 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CPT1A mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CPT2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of CUL1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of DMAC2L mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ELP1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of GCLM mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of GLG1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of GPX1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of HADHA mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of JUN mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of KCNQ1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of KEAP1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of KPNA3 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of KPNA6 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of LRPPRC mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of MAP2K4 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of MAP3K2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NCSTN mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFA10L1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFA11 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFB2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFB5 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFB8 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS3 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS4 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFS8 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFV1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFV2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NFE2L2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NFKB1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NFKBIA mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NKIRAS2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NOTCH1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NQO1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of NSMAF mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PEBP1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PECR mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PRKACA mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMA7 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMB1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMB5 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMB8 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMC5 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMC6 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD11 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD13 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD5 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of SLC25A20 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of SOD2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of STAT1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of STAT3 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of TBK1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of TXNRD2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of UBA1 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of USP2 mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of XDH mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of YWHAG mRNA; [Isoproterenol co-treated with POSTN protein] results in decreased expression of ZFAND5 mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of ATP5ME mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of ATP5PD mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of BCL2 mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of DAP mRNA; [Isoproterenol co-treated with POSTN protein] results in increased expression of TNF mRNA	PMID:30303030
1313223	POSTN	periostin	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305285	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of POSTN mRNA	PMID:35283115
1313223	POSTN	periostin	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [AGT protein results in increased expression of POSTN mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FGF1 protein results in increased expression of POSTN mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TGFB1 protein results in increased expression of POSTN mRNA]	PMID:15121739|PMID:16325820
1313223	POSTN	periostin	gene	CHEBI:6541	losartan	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D019808	Losartan results in decreased expression of POSTN mRNA	PMID:32947957
1313223	POSTN	periostin	gene	CHEBI:6541	losartan	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20120501	CTD	MESH:D019808	Losartan results in decreased expression of POSTN mRNA	PMID:21641384
1313223	POSTN	periostin	gene	CHEBI:6541	losartan	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20120412	CTD	MESH:D019808	Losartan inhibits the reaction [AGT protein results in increased expression of POSTN mRNA]	PMID:15121739
1313223	POSTN	periostin	gene	CHEBI:67895	corosolic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of POSTN mRNA	PMID:37939859
1313223	POSTN	periostin	gene	CHEBI:6918	Mezerein	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20260707	CTD	MESH:C011309	mezerein results in decreased expression of POSTN mRNA	PMID:37813191
1313223	POSTN	periostin	gene	CHEBI:6980	monocrotaline	increases expression	ISO	RGD:1305285	E	RGD:6480464	20160315	CTD	MESH:D016686	Monocrotaline results in increased expression of POSTN protein	PMID:24947524
1313223	POSTN	periostin	gene	CHEBI:72754	bisphenol AF	decreases expression	ISO	RGD:1305285	E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in decreased expression of POSTN mRNA	PMID:39938710
1313223	POSTN	periostin	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of POSTN protein	PMID:34186270
1313223	POSTN	periostin	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of POSTN mRNA	PMID:22714537
1313223	POSTN	periostin	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of POSTN mRNA	PMID:32741896
1313223	POSTN	periostin	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305285	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of POSTN mRNA	PMID:19717638
1313223	POSTN	periostin	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1313223	POSTN	periostin	gene	CHEBI:79	(-)-Arctigenin	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:C071942	arctigenin inhibits the reaction [[IL4 protein co-treated with IL13 protein] results in increased secretion of POSTN protein]; BIRC3 protein affects the reaction [KLF5 protein inhibits the reaction [arctigenin inhibits the reaction [[IL4 protein co-treated with IL13 protein] results in increased secretion of POSTN protein]]]; KLF5 protein inhibits the reaction [arctigenin inhibits the reaction [[IL4 protein co-treated with IL13 protein] results in increased secretion of POSTN protein]]; TNFSF12 protein affects the reaction [BIRC3 protein affects the reaction [KLF5 protein inhibits the reaction [arctigenin inhibits the reaction [[IL4 protein co-treated with IL13 protein] results in increased secretion of POSTN protein]]]]	PMID:40803538
1313223	POSTN	periostin	gene	CHEBI:7931	paricalcitol	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C084656	[Phosphorus co-treated with paricalcitol] results in decreased expression of POSTN mRNA	PMID:17715259
1313223	POSTN	periostin	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313224	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of POSTN mRNA	PMID:19136022|PMID:23091169
1313223	POSTN	periostin	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in decreased expression of POSTN mRNA	PMID:19084549
1313223	POSTN	periostin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313224	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of POSTN mRNA	PMID:38648751
1313223	POSTN	periostin	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305285	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of POSTN mRNA	PMID:23914054
1313223	POSTN	periostin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305285	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of POSTN mRNA	PMID:24780913
1313223	POSTN	periostin	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of POSTN mRNA; Raloxifene Hydrochloride results in decreased expression of POSTN protein	PMID:32947957
1313223	POSTN	periostin	gene	CHEBI:8887	rofecoxib	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C116926	rofecoxib affects the expression of POSTN mRNA	PMID:17070997
1313223	POSTN	periostin	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20170303	CTD	MESH:C093642	SB 203580 inhibits the reaction [AGT protein results in increased expression of POSTN mRNA]; SB 203580 inhibits the reaction [FGF1 protein results in increased expression of POSTN mRNA]	PMID:15121739|PMID:17485602
1313223	POSTN	periostin	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POSTN mRNA	PMID:27188386
1313223	POSTN	periostin	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313224	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of POSTN mRNA	PMID:27131904
1313223	POSTN	periostin	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus inhibits the reaction [FGF1 protein results in increased expression of POSTN mRNA]	PMID:15121739
1313223	POSTN	periostin	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of POSTN mRNA	PMID:38568856
1313223	POSTN	periostin	gene	CHEBI:9927	valsartan	multiple interactions	ISO	RGD:1305285	E	RGD:6480464	20170303	CTD	MESH:C081489	Valsartan inhibits the reaction [AGT protein results in increased expression of POSTN mRNA]	PMID:17485602
1313223	POSTN	periostin	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305285	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of POSTN mRNA	PMID:19015723
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1305286	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PLAG1 mRNA	PMID:30071829
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313226	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PLAG1 mRNA	PMID:20188158
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of PLAG1 mRNA	PMID:33167477
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PLAG1 mRNA	PMID:26079696
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PLAG1 mRNA	PMID:21632981
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305286	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of PLAG1 mRNA	PMID:26496021
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PLAG1 mRNA	PMID:20655997
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of PLAG1 mRNA	PMID:26079696
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLAG1 mRNA	PMID:36139627
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PLAG1 mRNA	PMID:28818685
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PLAG1 intron	PMID:30157460
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305286	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PLAG1 mRNA	PMID:30779732
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PLAG1 mRNA	PMID:26272509
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLAG1 mRNA	PMID:27188386
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PLAG1 mRNA	PMID:27392435
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PLAG1 mRNA	PMID:24768652|PMID:25583101
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305286	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLAG1 mRNA	PMID:33387578
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PLAG1 mRNA	PMID:28001369
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PLAG1 mRNA	PMID:33212167
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PLAG1 mRNA	PMID:29803840
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of PLAG1 mRNA	PMID:34032870
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PLAG1 mRNA	PMID:38568856
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLAG1 intron	PMID:30157460
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PLAG1 mRNA	PMID:21632981
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PLAG1 mRNA	PMID:25895662
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305286	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PLAG1 mRNA	PMID:30047161
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313226	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLAG1 gene	PMID:35295148
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313226	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of PLAG1 mRNA	PMID:18648102
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLAG1 mRNA	PMID:19710929
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305286	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PLAG1 mRNA	PMID:25181051
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313226	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of PLAG1 promoter	PMID:27334623
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PLAG1 mRNA	PMID:33670352
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of PLAG1 gene	PMID:31601247
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305286	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of PLAG1 mRNA	PMID:26496021
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PLAG1 intron	PMID:30157460
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PLAG1 mRNA	PMID:37042841
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:35456	cadmium dichloride	affects methylation	ISO	RGD:1305286	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the methylation of PLAG1 promoter	PMID:22457795
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PLAG1 mRNA	PMID:31533062
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLAG1 mRNA	PMID:25979313
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305286	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PLAG1 mRNA	PMID:29427782
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLAG1 mRNA	PMID:23179753|PMID:24935251|PMID:25192806|PMID:28001369
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305286	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLAG1 mRNA	PMID:29427782
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PLAG1 gene	PMID:29154799
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of PLAG1 mRNA	PMID:19101580
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305286	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PLAG1 mRNA	PMID:30047161|PMID:41580965
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PLAG1 mRNA	PMID:25562108
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of PLAG1 promoter	PMID:27989131
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of PLAG1 mRNA	PMID:16144937
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PLAG1 mRNA	PMID:38832940
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305286	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PLAG1 mRNA	PMID:33387578
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1305286	E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in decreased expression of PLAG1 mRNA	PMID:36653537
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305286	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PLAG1 mRNA	PMID:30047161|PMID:41580965
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of PLAG1 mRNA	PMID:28988120
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PLAG1 intron	PMID:30157460
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of PLAG1 mRNA	PMID:29522793
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PLAG1 mRNA	PMID:37199045
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLAG1 mRNA	PMID:36139627
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLAG1 mRNA	PMID:27188386
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of PLAG1 mRNA	PMID:26079696
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305286	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PLAG1 mRNA	PMID:24780913|PMID:30047161
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLAG1 mRNA	PMID:27188386
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PLAG1 mRNA	PMID:29301935
1313225	PLAG1	PLAG1 zinc finger	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305286	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of PLAG1 mRNA	PMID:23555832
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of HAUS4 mRNA	PMID:38218311
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of HAUS4 mRNA	PMID:25812627
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313229	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of HAUS4 mRNA	PMID:26251327
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of HAUS4 mRNA	PMID:22378314
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313229	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HAUS4 mRNA	PMID:39241906
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of HAUS4 mRNA	PMID:23019147|PMID:31614463
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305288	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of HAUS4 mRNA	PMID:32145629
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313229	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of HAUS4 mRNA	PMID:39298647
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of HAUS4 mRNA	PMID:22217510
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of HAUS4 mRNA	PMID:23649840
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of HAUS4 mRNA	PMID:21592394|PMID:33359661
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of HAUS4 mRNA	PMID:21592394
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of HAUS4 mRNA	PMID:21592394
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of HAUS4 mRNA	PMID:21592394
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HAUS4 mRNA	PMID:19549813
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of HAUS4 mRNA	PMID:19376150
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313229	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of HAUS4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of HAUS4 mRNA	PMID:34911549
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313229	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of HAUS4 mRNA	PMID:31919559
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313229	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HAUS4 mRNA	PMID:22206623
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of HAUS4 mRNA	PMID:19244175
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of HAUS4 mRNA	PMID:26272509
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HAUS4 mRNA	PMID:27188386
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of HAUS4 protein	PMID:35688186
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305288	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of HAUS4 mRNA	PMID:31881176
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of HAUS4 gene	PMID:31636367
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of HAUS4 mRNA	PMID:27392435
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313229	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of HAUS4 mRNA	PMID:30912803
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305288	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HAUS4 mRNA	PMID:34747641
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305288	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HAUS4 mRNA	PMID:33387578
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of HAUS4 mRNA	PMID:28001369
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305288	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of HAUS4 mRNA	PMID:28959563
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HAUS4 mRNA	PMID:29803840
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of HAUS4 mRNA	PMID:38568856
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of HAUS4 mRNA	PMID:29453283
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HAUS4 mRNA	PMID:20106945
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HAUS4 protein	PMID:32717239
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of HAUS4 mRNA	PMID:23221170
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305288	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of HAUS4 mRNA	PMID:25729387
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305288	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HAUS4 mRNA	PMID:25729387
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305288	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of HAUS4 mRNA	PMID:30047161
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305288	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of HAUS4 mRNA	PMID:24136188
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305288	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of HAUS4 mRNA	PMID:23411599|PMID:34492290
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313229	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of HAUS4 mRNA	PMID:18301758
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HAUS4 mRNA	PMID:19710929
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313229	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HAUS4 mRNA	PMID:19710929
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of HAUS4 mRNA	PMID:30903817
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305288	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HAUS4 mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:32528016
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of HAUS4 gene	PMID:31601247
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305288	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HAUS4 gene	PMID:28505145
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HAUS4 mRNA	PMID:28628672
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of HAUS4 mRNA	PMID:19244175
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305288	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of HAUS4 mRNA	PMID:23196670
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313229	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of HAUS4 mRNA	PMID:39298647
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305288	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of HAUS4 mRNA	PMID:21266533
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of HAUS4 mRNA	PMID:21266533
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HAUS4 mRNA	PMID:28628672
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HAUS4 mRNA	PMID:37042841
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305288	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of HAUS4 mRNA	PMID:30723492
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HAUS4 mRNA	PMID:38382870
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305288	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of HAUS4 mRNA	PMID:25539665
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305288	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of HAUS4 mRNA	PMID:30047161
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of HAUS4 mRNA	PMID:19244175
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:37825	p-toluidine	increases expression	ISO	RGD:1305288	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of HAUS4 mRNA	PMID:27638505
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313229	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of HAUS4 mRNA	PMID:40194260
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of HAUS4 mRNA	PMID:28302478
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS4 mRNA	PMID:19167446
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of HAUS4 mRNA	PMID:39529242
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of HAUS4 mRNA	PMID:25812627|PMID:40419075
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HAUS4 mRNA	PMID:25979313
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313229	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of HAUS4 mRNA	PMID:17963808
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in decreased expression of HAUS4 mRNA	PMID:23179753|PMID:25192806|PMID:28001369
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305288	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of HAUS4 mRNA	PMID:30047161
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of HAUS4 mRNA	PMID:20106945|PMID:25562108
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of HAUS4 mRNA	PMID:27989131
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HAUS4 mRNA	PMID:28628672
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313229	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of HAUS4 mRNA	PMID:28973697
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of HAUS4 mRNA	PMID:24449571
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of HAUS4 mRNA	PMID:38832940
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of HAUS4 mRNA	PMID:21420995
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305288	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HAUS4 mRNA	PMID:33387578
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HAUS4 mRNA	PMID:28628672
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of HAUS4 mRNA	PMID:25620056
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313229	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of HAUS4 mRNA	PMID:25554681
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305288	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of HAUS4 mRNA	PMID:30047161
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1313229	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of HAUS4 mRNA	PMID:26377693
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:63598	levofloxacin	decreases expression	ISO	RGD:1305288	E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of HAUS4 mRNA	PMID:24136188
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305288	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of HAUS4 mRNA	PMID:25729387
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305288	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HAUS4 mRNA	PMID:25729387
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1305288	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of HAUS4 mRNA	PMID:24136188
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313229	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HAUS4 mRNA	PMID:22206623
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of HAUS4 mRNA	PMID:22714537
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HAUS4 mRNA	PMID:27188386
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313229	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of HAUS4 mRNA	PMID:31388691
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HAUS4 mRNA	PMID:19167446
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313229	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of HAUS4 mRNA	PMID:39847705
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of HAUS4 mRNA	PMID:21278054
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305288	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HAUS4 mRNA	PMID:25825206
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305288	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of HAUS4 mRNA	PMID:30047161
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HAUS4 mRNA	PMID:27188386
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of HAUS4 mRNA	PMID:38568856
1313228	HAUS4	HAUS augmin like complex subunit 4	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313229	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of HAUS4 mRNA	PMID:35537566
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TUBAL3 mRNA	PMID:26079696
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of TUBAL3 mRNA	PMID:39506029
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305289	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TUBAL3 gene	PMID:27618143
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TUBAL3 mRNA	PMID:26079696
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:17833	gentamycin	multiple interactions	ISO	RGD:1305289	E	RGD:6480464	20191112	CTD	MESH:D005839	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein	PMID:30545405
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TUBAL3 mRNA	PMID:18356318
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:27732	caffeine	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D002110	Caffeine results in increased expression of TUBAL3 protein	PMID:31195006
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:28001	vancomycin	multiple interactions	ISO	RGD:1305289	E	RGD:6480464	20191112	CTD	MESH:D014640	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein	PMID:30545405
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:28971	ampicillin	multiple interactions	ISO	RGD:1305289	E	RGD:6480464	20191112	CTD	MESH:D000667	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein	PMID:30545405
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1619822	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TUBAL3 mRNA	PMID:37682722
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of TUBAL3 mRNA	PMID:29301061|PMID:39719251
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TUBAL3 promoter	PMID:27901495
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TUBAL3 mRNA	PMID:18356318
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TUBAL3 mRNA	PMID:25895662
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305289	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TUBAL3 mRNA	PMID:25181051
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of TUBAL3 mRNA	PMID:31715268
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1619822	E	RGD:6480464	20220607	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TUBAL3 protein	PMID:34864091
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305289	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of TUBAL3 mRNA	PMID:25539665|PMID:27387713
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of TUBAL3 protein	PMID:34122009
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1619822	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TUBAL3 mRNA	PMID:40194260
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1619822	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TUBAL3 mRNA	PMID:17963808
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TUBAL3 mRNA	PMID:38832940
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of TUBAL3 protein	PMID:31195006
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TUBAL3 protein	PMID:32959892
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:6909	metronidazole	multiple interactions	ISO	RGD:1305289	E	RGD:6480464	20191112	CTD	MESH:D008795	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein	PMID:30545405
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:7507	neomycin	multiple interactions	ISO	RGD:1305289	E	RGD:6480464	20191112	CTD	MESH:D009355	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein	PMID:30545405
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C025589	ochratoxin A results in decreased expression of TUBAL3 mRNA	PMID:30763683
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of TUBAL3 mRNA	PMID:26079696
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1305289	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of TUBAL3 protein	PMID:32519852
1313230	TUBAL3	tubulin alpha like 3	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305289	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of TUBAL3 gene	PMID:31682807
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RPP25 mRNA	PMID:26272509|PMID:27188386
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA	PMID:27188386
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of RPP25 mRNA	PMID:30510588
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of RPP25 mRNA	PMID:31614463
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313232	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of RPP25 mRNA	PMID:19484750
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RPP25 mRNA	PMID:37042841
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313232	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RPP25 mRNA	PMID:37992649
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313232	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of RPP25 mRNA	PMID:22401849
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313232	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RPP25 mRNA	PMID:37992649
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313232	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RPP25 mRNA	PMID:33754040
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305290	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RPP25 mRNA	PMID:26577399
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RPP25 mRNA	PMID:22100608
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305290	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RPP25 mRNA	PMID:30779732
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313232	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of RPP25 mRNA	PMID:17484886
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of RPP25 mRNA	PMID:18414638
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of RPP25 mRNA	PMID:26272509
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RPP25 mRNA	PMID:27188386
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313232	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of RPP25 mRNA	PMID:32186404
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305290	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPP25 mRNA	PMID:22298810
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313232	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPP25 mRNA	PMID:21570461
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305290	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RPP25 mRNA	PMID:32109520|PMID:33387578
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RPP25 mRNA	PMID:23179753
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of RPP25 mRNA	PMID:21198554
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RPP25 mRNA	PMID:29803840
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313232	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RPP25 mRNA	PMID:37992649
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of RPP25 mRNA	PMID:34032870
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of RPP25 gene	PMID:28589171
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of RPP25 mRNA	PMID:28595984
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RPP25 mRNA	PMID:32234424
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RPP25 3' UTR; Benzo(a)pyrene results in increased methylation of RPP25 exon; Benzo(a)pyrene results in increased methylation of RPP25 promoter	PMID:27901495
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of RPP25 mRNA	PMID:35984750
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313232	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RPP25 gene	PMID:35295148
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305290	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RPP25 mRNA	PMID:23411599|PMID:34492290
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305290	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RPP25 mRNA	PMID:25181051
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313232	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of RPP25 mRNA	PMID:30951980
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1313232	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of RPP25 mRNA	PMID:26377693
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of RPP25 gene	PMID:22964155
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305290	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RPP25 mRNA	PMID:21266533
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313232	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RPP25 mRNA	PMID:21266533
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305290	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RPP25 mRNA	PMID:35163327
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305290	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RPP25 mRNA	PMID:35163327
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305290	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of RPP25 gene	PMID:22079235
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313232	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of RPP25 mRNA	PMID:39529242
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RPP25 mRNA	PMID:25979313
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313232	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of RPP25 mRNA	PMID:21427059
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RPP25 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA	PMID:27188386
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313232	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RPP25 mRNA	PMID:37992649
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of RPP25 mRNA]	PMID:21233418
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RPP25 mRNA	PMID:38832940
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of RPP25 mRNA	PMID:26690555
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of RPP25 mRNA	PMID:29067470
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of RPP25 mRNA	PMID:18414638
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1313232	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of RPP25 mRNA	PMID:31099283
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305290	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RPP25 mRNA	PMID:29391264
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RPP25 mRNA	PMID:22079256
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305290	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of RPP25 mRNA	PMID:24793618
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of RPP25 mRNA	PMID:31629900
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:6076	itraconazole	increases expression	ISO	RGD:1313232	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of RPP25 mRNA	PMID:31099283
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of RPP25 mRNA	PMID:31758290
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313232	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RPP25 mRNA	PMID:22206623
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RPP25 mRNA	PMID:22079256
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RPP25 mRNA	PMID:22079256
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RPP25 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA	PMID:27188386
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of RPP25 mRNA	PMID:30458266
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305290	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RPP25 mRNA	PMID:24780913
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of RPP25 mRNA	PMID:26272509
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA	PMID:27188386
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RPP25 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPP25 mRNA	PMID:27188386
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305290	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RPP25 mRNA	PMID:19281266
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of RPP25 mRNA	PMID:34581912
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:94366	2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one	increases expression	ISO	RGD:1313232	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of RPP25 mRNA	PMID:31099283
1313231	RPP25	ribonuclease P/MRP subunit p25	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305290	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of RPP25 mRNA	PMID:20566332
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASIP1 gene	PMID:20938992
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of RASIP1 mRNA	PMID:26079696
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of RASIP1 mRNA	PMID:22378314
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RASIP1 mRNA	PMID:29432896
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of RASIP1 mRNA	PMID:20044591
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of RASIP1 mRNA	PMID:38568856
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305291	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RASIP1 mRNA	PMID:33387578
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASIP1 gene	PMID:20938992
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASIP1 mRNA	PMID:37992649
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASIP1 mRNA	PMID:37992649
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RASIP1 protein	PMID:37730182
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305291	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of RASIP1 mRNA	PMID:22061828|PMID:33387578
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RASIP1 mRNA	PMID:37236586
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RASIP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of RASIP1 mRNA	PMID:34911549
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of RASIP1 mRNA	PMID:18356318
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASIP1 gene	PMID:20938992
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RASIP1 gene	PMID:25304211
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RASIP1 mRNA	PMID:40504410
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305291	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASIP1 mRNA	PMID:22298810
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305291	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RASIP1 mRNA	PMID:34747641
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305291	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RASIP1 mRNA	PMID:33387578
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASIP1 mRNA	PMID:37992649
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RASIP1 mRNA	PMID:29432896
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of RASIP1 mRNA	PMID:34032870
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RASIP1 mRNA	PMID:38568856
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RASIP1 mRNA	PMID:40504410
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RASIP1 promoter	PMID:27901495
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313234	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RASIP1 mRNA	PMID:21964900|PMID:32417428
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of RASIP1 mRNA	PMID:18356318
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:31991	phenol red	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D010637	[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of RASIP1 protein	PMID:31629898
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305291	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RASIP1 mRNA	PMID:30047161
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313234	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RASIP1 gene	PMID:35295148
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305291	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RASIP1 mRNA	PMID:25181051
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305291	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RASIP1 mRNA	PMID:30816183
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C006780	bisphenol A analog results in increased expression of RASIP1 mRNA	PMID:32387340
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313234	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of RASIP1 mRNA	PMID:30951980|PMID:32156529|PMID:33221593
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of RASIP1 protein	PMID:31629898
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313234	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of RASIP1 gene	PMID:31683443
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313234	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of RASIP1 exon	PMID:33297965
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313234	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of RASIP1 mRNA	PMID:30951980
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313234	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RASIP1 mRNA	PMID:38685157
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313234	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RASIP1 mRNA	PMID:30951980
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313234	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RASIP1 mRNA	PMID:37019170
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305291	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RASIP1 mRNA	PMID:21266533
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305291	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of RASIP1 mRNA	PMID:35163327
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305291	E	RGD:6480464	20130806	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of RASIP1 promoter	PMID:22457795
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RASIP1 mRNA	PMID:37236586
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305291	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of RASIP1 mRNA	PMID:35163327
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:3764	clotrimazole	increases expression	ISO	RGD:1305291	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of RASIP1 mRNA	PMID:30047161
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313234	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RASIP1 mRNA	PMID:40194260
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RASIP1 mRNA	PMID:31533062
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313234	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of RASIP1 mRNA	PMID:39529242
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305291	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RASIP1 mRNA	PMID:30047161
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313234	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RASIP1 mRNA	PMID:17555576
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313234	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RASIP1 mRNA	PMID:28973697
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASIP1 mRNA	PMID:37992649
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of RASIP1 mRNA	PMID:27188386
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313234	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RASIP1 mRNA	PMID:17562736
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RASIP1 mRNA	PMID:29432896
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RASIP1 gene	PMID:25304211
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313234	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RASIP1 mRNA	PMID:40504410
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305291	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RASIP1 mRNA	PMID:29391264
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313234	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RASIP1 mRNA	PMID:17555576
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:4911	etoposide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	RASIP1 protein affects the susceptibility to Etoposide	PMID:16217747
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305291	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RASIP1 mRNA	PMID:30047161
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313234	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of RASIP1 mRNA	PMID:19042947
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RASIP1 mRNA	PMID:22079614
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313234	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RASIP1 mRNA	PMID:22206623
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RASIP1 gene]	PMID:28238834
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305291	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RASIP1 mRNA	PMID:30047161
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313234	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of RASIP1 mRNA	PMID:17569031
1313233	RASIP1	Ras interacting protein 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305291	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RASIP1 mRNA	PMID:19015723
1313235	INCENP	inner centromere protein	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of INCENP mRNA	PMID:39752319
1313235	INCENP	inner centromere protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552170	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of INCENP mRNA	PMID:26251327
1313235	INCENP	inner centromere protein	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of INCENP mRNA	PMID:20938992
1313235	INCENP	inner centromere protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of INCENP mRNA	PMID:33167477
1313235	INCENP	inner centromere protein	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of INCENP mRNA	PMID:22378314
1313235	INCENP	inner centromere protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of INCENP mRNA	PMID:20044591
1313235	INCENP	inner centromere protein	gene	CHEBI:16240	hydrogen peroxide	affects localization	EXP		E	RGD:6480464	20200211	CTD	MESH:D006861	Hydrogen Peroxide affects the localization of INCENP protein	PMID:28343997
1313235	INCENP	inner centromere protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of INCENP mRNA	PMID:39241906
1313235	INCENP	inner centromere protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INCENP mRNA	PMID:25510870
1313235	INCENP	inner centromere protein	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305292	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of INCENP mRNA	PMID:33387578
1313235	INCENP	inner centromere protein	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of INCENP mRNA	PMID:20938992
1313235	INCENP	inner centromere protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of INCENP mRNA	PMID:37042841
1313235	INCENP	inner centromere protein	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of INCENP mRNA	PMID:37992649
1313235	INCENP	inner centromere protein	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of INCENP mRNA	PMID:39752319
1313235	INCENP	inner centromere protein	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of INCENP mRNA	PMID:21592394
1313235	INCENP	inner centromere protein	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of INCENP mRNA	PMID:21592394
1313235	INCENP	inner centromere protein	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of INCENP mRNA	PMID:37992649
1313235	INCENP	inner centromere protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552170	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of INCENP mRNA	PMID:34319233
1313235	INCENP	inner centromere protein	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of INCENP protein	PMID:37730182
1313235	INCENP	inner centromere protein	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of INCENP mRNA	PMID:21592394
1313235	INCENP	inner centromere protein	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of INCENP mRNA	PMID:21592394
1313235	INCENP	inner centromere protein	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305292	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of INCENP mRNA	PMID:22061828|PMID:33387578
1313235	INCENP	inner centromere protein	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of INCENP mRNA	PMID:28818685
1313235	INCENP	inner centromere protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INCENP mRNA	PMID:25510870
1313235	INCENP	inner centromere protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INCENP mRNA	PMID:25510870
1313235	INCENP	inner centromere protein	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of INCENP mRNA	PMID:19549813
1313235	INCENP	inner centromere protein	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of INCENP protein	PMID:39638853
1313235	INCENP	inner centromere protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305292	E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of INCENP mRNA	PMID:25378103
1313235	INCENP	inner centromere protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of INCENP exon	PMID:30157460
1313235	INCENP	inner centromere protein	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1552170	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of INCENP mRNA	PMID:33026818
1313235	INCENP	inner centromere protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of INCENP mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of INCENP mRNA	PMID:34911549
1313235	INCENP	inner centromere protein	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of INCENP mRNA	PMID:17484886
1313235	INCENP	inner centromere protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305292	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of INCENP mRNA	PMID:31150632
1313235	INCENP	inner centromere protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552170	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of INCENP mRNA	PMID:31919559
1313235	INCENP	inner centromere protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of INCENP mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of INCENP mRNA]	PMID:20938992|PMID:22206623
1313235	INCENP	inner centromere protein	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in decreased expression of INCENP mRNA	PMID:25270620
1313235	INCENP	inner centromere protein	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of INCENP gene	PMID:25304211
1313235	INCENP	inner centromere protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of INCENP mRNA	PMID:40504410
1313235	INCENP	inner centromere protein	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of INCENP protein	PMID:35688186
1313235	INCENP	inner centromere protein	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of INCENP mRNA	PMID:28960355
1313235	INCENP	inner centromere protein	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305292	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of INCENP mRNA	PMID:31881176
1313235	INCENP	inner centromere protein	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of INCENP protein	PMID:25505154
1313235	INCENP	inner centromere protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of INCENP mRNA	PMID:19167446
1313235	INCENP	inner centromere protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of INCENP mRNA	PMID:30912803
1313235	INCENP	inner centromere protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552170	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of INCENP mRNA	PMID:21570461
1313235	INCENP	inner centromere protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305292	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of INCENP mRNA	PMID:33387578|PMID:34747641
1313235	INCENP	inner centromere protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of INCENP mRNA	PMID:15667827
1313235	INCENP	inner centromere protein	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of INCENP mRNA	PMID:32763439
1313235	INCENP	inner centromere protein	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305292	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of INCENP mRNA	PMID:28959563
1313235	INCENP	inner centromere protein	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of INCENP mRNA	PMID:29803840
1313235	INCENP	inner centromere protein	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of INCENP mRNA	PMID:37992649
1313235	INCENP	inner centromere protein	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of INCENP protein	PMID:35688186
1313235	INCENP	inner centromere protein	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of INCENP mRNA	PMID:29301061|PMID:34032870
1313235	INCENP	inner centromere protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of INCENP mRNA	PMID:40504410
1313235	INCENP	inner centromere protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of INCENP mRNA	PMID:17942131
1313235	INCENP	inner centromere protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552170	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of INCENP mRNA	PMID:19770486|PMID:20504355
1313235	INCENP	inner centromere protein	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of INCENP mRNA	PMID:18929588
1313235	INCENP	inner centromere protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to INCENP mRNA]	PMID:32406909
1313235	INCENP	inner centromere protein	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of INCENP mRNA	PMID:25895662
1313235	INCENP	inner centromere protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1552170	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of INCENP mRNA	PMID:29341224
1313235	INCENP	inner centromere protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of INCENP mRNA	PMID:20382639
1313235	INCENP	inner centromere protein	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:C015358	methylparaben results in increased expression of INCENP mRNA	PMID:17121429
1313235	INCENP	inner centromere protein	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305292	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of INCENP mRNA	PMID:25729387
1313235	INCENP	inner centromere protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305292	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of INCENP mRNA	PMID:25729387
1313235	INCENP	inner centromere protein	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305292	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of INCENP mRNA	PMID:30047161
1313235	INCENP	inner centromere protein	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1552170	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of INCENP mRNA	PMID:17656681
1313235	INCENP	inner centromere protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552170	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of INCENP gene	PMID:35295148
1313235	INCENP	inner centromere protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552170	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of INCENP mRNA	PMID:23557971
1313235	INCENP	inner centromere protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305292	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of INCENP mRNA; Thioacetamide results in increased expression of INCENP protein	PMID:23411599
1313235	INCENP	inner centromere protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of INCENP mRNA	PMID:18648102
1313235	INCENP	inner centromere protein	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of INCENP mRNA	PMID:17426115
1313235	INCENP	inner centromere protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552170	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of INCENP mRNA	PMID:17950772|PMID:18301758|PMID:23811191
1313235	INCENP	inner centromere protein	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of INCENP mRNA]	PMID:17950772
1313235	INCENP	inner centromere protein	gene	CHEBI:32687	piperonyl butoxide	increases expression	ISO	RGD:1305292	E	RGD:6480464	20140408	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of INCENP protein	PMID:23411599
1313235	INCENP	inner centromere protein	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of INCENP mRNA	PMID:38479592
1313235	INCENP	inner centromere protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of INCENP mRNA; bisphenol A results in decreased expression of INCENP protein	PMID:29275510|PMID:33376534
1313235	INCENP	inner centromere protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305292	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of INCENP mRNA	PMID:25181051
1313235	INCENP	inner centromere protein	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of INCENP gene	PMID:31601247
1313235	INCENP	inner centromere protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305292	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of INCENP mRNA	PMID:30816183
1313235	INCENP	inner centromere protein	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1552170	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of INCENP mRNA	PMID:26682919
1313235	INCENP	inner centromere protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INCENP mRNA	PMID:25510870
1313235	INCENP	inner centromere protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of INCENP mRNA	PMID:25510870
1313235	INCENP	inner centromere protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of INCENP mRNA	PMID:39298647|PMID:40203079
1313235	INCENP	inner centromere protein	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1552170	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of INCENP mRNA	PMID:26377693
1313235	INCENP	inner centromere protein	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of INCENP mRNA	PMID:37019170
1313235	INCENP	inner centromere protein	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of INCENP mRNA	PMID:17361019|PMID:21266533
1313235	INCENP	inner centromere protein	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of INCENP mRNA	PMID:17854601
1313235	INCENP	inner centromere protein	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of INCENP mRNA]	PMID:17854601
1313235	INCENP	inner centromere protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of INCENP mRNA	PMID:37042841
1313235	INCENP	inner centromere protein	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305292	E	RGD:6480464	20140408	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of INCENP mRNA; 1-Naphthylisothiocyanate results in increased expression of INCENP protein	PMID:23411599|PMID:30723492
1313235	INCENP	inner centromere protein	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of INCENP mRNA	PMID:36326898
1313235	INCENP	inner centromere protein	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305292	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of INCENP mRNA	PMID:25539665
1313235	INCENP	inner centromere protein	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305292	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of INCENP mRNA	PMID:30047161
1313235	INCENP	inner centromere protein	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1552170	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of INCENP mRNA	PMID:22698814
1313235	INCENP	inner centromere protein	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of INCENP mRNA	PMID:32588087
1313235	INCENP	inner centromere protein	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of INCENP mRNA	PMID:40194260
1313235	INCENP	inner centromere protein	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of INCENP mRNA	PMID:28302478
1313235	INCENP	inner centromere protein	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of INCENP mRNA	PMID:31533062
1313235	INCENP	inner centromere protein	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of INCENP mRNA	PMID:19167446
1313235	INCENP	inner centromere protein	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INCENP mRNA; [Coumestrol co-treated with Resveratrol] results in increased expression of INCENP mRNA	PMID:19167446
1313235	INCENP	inner centromere protein	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of INCENP mRNA	PMID:39529242
1313235	INCENP	inner centromere protein	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305292	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of INCENP mRNA	PMID:30047161
1313235	INCENP	inner centromere protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of INCENP mRNA	PMID:17942131
1313235	INCENP	inner centromere protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552170	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of INCENP mRNA	PMID:28973697
1313235	INCENP	inner centromere protein	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of INCENP mRNA	PMID:37992649
1313235	INCENP	inner centromere protein	gene	CHEBI:43572	kojic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of INCENP mRNA	PMID:16595896
1313235	INCENP	inner centromere protein	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of INCENP mRNA	PMID:38832940
1313235	INCENP	inner centromere protein	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in decreased expression of INCENP mRNA	PMID:19606018
1313235	INCENP	inner centromere protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of INCENP mRNA	PMID:17562736
1313235	INCENP	inner centromere protein	gene	CHEBI:46195	paracetamol	affects response to substance	ISO	RGD:1305292	E	RGD:6480464	20160119	CTD	MESH:D000082	INCENP mRNA affects the susceptibility to Acetaminophen	PMID:26512990
1313235	INCENP	inner centromere protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305292	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of INCENP mRNA	PMID:33387578
1313235	INCENP	inner centromere protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in decreased expression of INCENP mRNA	PMID:17942131
1313235	INCENP	inner centromere protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305292	E	RGD:6480464	20140408	CTD	MESH:D000082	Acetaminophen results in increased expression of INCENP protein	PMID:23411599
1313235	INCENP	inner centromere protein	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of INCENP gene	PMID:25304211
1313235	INCENP	inner centromere protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of INCENP mRNA	PMID:40504410
1313235	INCENP	inner centromere protein	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1305292	E	RGD:6480464	20140408	CTD	MESH:C005223	methyleugenol results in increased expression of INCENP protein	PMID:23411599
1313235	INCENP	inner centromere protein	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305292	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of INCENP mRNA	PMID:30307764
1313235	INCENP	inner centromere protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552170	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of INCENP mRNA; Nanotubes, Carbon results in increased expression of INCENP mRNA	PMID:25554681
1313235	INCENP	inner centromere protein	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305292	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of INCENP mRNA	PMID:22504374|PMID:30047161
1313235	INCENP	inner centromere protein	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1552170	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of INCENP mRNA	PMID:40234311
1313235	INCENP	inner centromere protein	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552170	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of INCENP mRNA	PMID:19042947
1313235	INCENP	inner centromere protein	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552170	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of INCENP mRNA	PMID:38701926
1313235	INCENP	inner centromere protein	gene	CHEBI:6015	isoflurane	decreases methylation	ISO	RGD:1552170	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in decreased methylation of INCENP mRNA	PMID:35249202
1313235	INCENP	inner centromere protein	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of INCENP protein	PMID:32959892
1313235	INCENP	inner centromere protein	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of INCENP mRNA	PMID:19606018
1313235	INCENP	inner centromere protein	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305292	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of INCENP mRNA	PMID:25729387
1313235	INCENP	inner centromere protein	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305292	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of INCENP mRNA	PMID:25729387
1313235	INCENP	inner centromere protein	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of INCENP mRNA	PMID:28988120
1313235	INCENP	inner centromere protein	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of INCENP mRNA	PMID:39752319
1313235	INCENP	inner centromere protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552170	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of INCENP mRNA	PMID:22206623
1313235	INCENP	inner centromere protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of INCENP mRNA]	PMID:22206623
1313235	INCENP	inner centromere protein	gene	CHEBI:749301	potassium perchlorate	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in increased expression of INCENP mRNA	PMID:29673971
1313235	INCENP	inner centromere protein	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of INCENP mRNA	PMID:37199045
1313235	INCENP	inner centromere protein	gene	CHEBI:754951	siponimod	increases expression	ISO	RGD:1552170	E	RGD:6480464	20260714	CTD	MESH:C578989	siponimod results in increased expression of INCENP mRNA	PMID:29556671
1313235	INCENP	inner centromere protein	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of INCENP protein	PMID:31285264
1313235	INCENP	inner centromere protein	gene	CHEBI:76604	MeIQx	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of INCENP mRNA	PMID:20816883
1313235	INCENP	inner centromere protein	gene	CHEBI:77092	fenbendazole	increases expression	ISO	RGD:1305292	E	RGD:6480464	20140408	CTD	MESH:D005273	Fenbendazole results in increased expression of INCENP protein	PMID:23411599
1313235	INCENP	inner centromere protein	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of INCENP mRNA	PMID:34995734
1313235	INCENP	inner centromere protein	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1552170	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of INCENP mRNA	PMID:23091169
1313235	INCENP	inner centromere protein	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of INCENP mRNA	PMID:17942131|PMID:18958704
1313235	INCENP	inner centromere protein	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of INCENP mRNA	PMID:19167446
1313235	INCENP	inner centromere protein	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1552170	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of INCENP mRNA	PMID:38648751
1313235	INCENP	inner centromere protein	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of INCENP mRNA	PMID:32234424
1313235	INCENP	inner centromere protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305292	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of INCENP mRNA	PMID:22504374|PMID:30047161
1313235	INCENP	inner centromere protein	gene	CHEBI:85993	palbociclib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of INCENP mRNA	PMID:22869556
1313235	INCENP	inner centromere protein	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of INCENP mRNA	PMID:40826991
1313235	INCENP	inner centromere protein	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1552170	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of INCENP mRNA	PMID:39752319
1313235	INCENP	inner centromere protein	gene	CHEBI:88542	Butylparaben	increases expression	EXP		E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in increased expression of INCENP mRNA	PMID:17121429
1313235	INCENP	inner centromere protein	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1552170	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of INCENP protein	PMID:24648495
1313235	INCENP	inner centromere protein	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552170	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of INCENP mRNA	PMID:35537566
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of FKBP7 mRNA	PMID:38218311
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of FKBP7 mRNA	PMID:27188386
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of FKBP7 protein	PMID:39571964
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313237	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FKBP7 mRNA	PMID:39241906
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313237	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FKBP7 mRNA	PMID:37992649
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313237	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FKBP7 mRNA	PMID:37992649
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305293	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FKBP7 mRNA	PMID:33387578
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of FKBP7 mRNA	PMID:28818685
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305293	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FKBP7 mRNA	PMID:39012411
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FKBP7 mRNA	PMID:19549813
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313237	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FKBP7 mRNA	PMID:19770486
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FKBP7 mRNA	PMID:17484886|PMID:31919559
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313237	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FKBP7 mRNA	PMID:25629700
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313237	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of FKBP7 mRNA	PMID:28960355
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:27856	acetamide	affects expression	ISO	RGD:1305293	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide affects the expression of FKBP7 mRNA	PMID:31881176
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in decreased expression of FKBP7 protein	PMID:37834424
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of FKBP7 mRNA	PMID:27392435
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305293	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FKBP7 mRNA	PMID:34747641
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313237	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FKBP7 mRNA	PMID:21570461
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305293	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FKBP7 mRNA	PMID:32109520
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FKBP7 mRNA	PMID:17942748
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FKBP7 mRNA	PMID:17942748
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1305293	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of FKBP7 mRNA	PMID:30556269
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of FKBP7 mRNA	PMID:20971185
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FKBP7 mRNA	PMID:29803840
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313237	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FKBP7 mRNA	PMID:37992649
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FKBP7 mRNA	PMID:38568856|PMID:39719251
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of FKBP7 mRNA	PMID:22714537
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in increased expression of FKBP7 protein	PMID:39571964
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313237	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FKBP7 mRNA	PMID:22228805
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1305293	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of FKBP7 mRNA	PMID:30556269
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of FKBP7 mRNA	PMID:20971185
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313237	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of FKBP7 mRNA	PMID:39716349
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305293	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of FKBP7 mRNA	PMID:25729387
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FKBP7 mRNA	PMID:19710929
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305293	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FKBP7 mRNA	PMID:30816183|PMID:34947998
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313237	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of FKBP7 mRNA	PMID:26063408|PMID:30951980
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305293	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FKBP7 gene	PMID:28505145
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FKBP7 mRNA	PMID:28628672
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of FKBP7 protein	PMID:34186270
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313237	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FKBP7 mRNA	PMID:30951980
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of FKBP7 protein	PMID:34186270
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313237	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of FKBP7 mRNA	PMID:30951980
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP7 mRNA	PMID:28628672
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of FKBP7 protein	PMID:34186270
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FKBP7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP7 mRNA	PMID:28628672
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305293	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FKBP7 mRNA	PMID:39012411
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of FKBP7 protein	PMID:26879310
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305293	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of FKBP7 mRNA	PMID:27387713
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313237	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FKBP7 mRNA	PMID:40194260
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FKBP7 mRNA	PMID:31533062
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FKBP7 mRNA	PMID:25979313
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of FKBP7 mRNA	PMID:17292431
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of FKBP7 mRNA	PMID:23179753|PMID:24935251|PMID:28001369|PMID:29154799
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FKBP7 mRNA	PMID:20106945|PMID:25562108
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FKBP7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP7 mRNA	PMID:28628672
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313237	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FKBP7 mRNA	PMID:37992649
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FKBP7 mRNA	PMID:38832940
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of FKBP7 mRNA	PMID:27188386
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of FKBP7 mRNA	PMID:24935251
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313237	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FKBP7 mRNA	PMID:29279043
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:472805	ouabain	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010042	Ouabain results in increased expression of FKBP7 mRNA	PMID:16412265
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of FKBP7 mRNA	PMID:22077320
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305293	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of FKBP7 mRNA	PMID:29391264
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313237	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of FKBP7 mRNA	PMID:35436446
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FKBP7 mRNA	PMID:17555576
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305293	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of FKBP7 mRNA	PMID:17557909
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FKBP7 mRNA	PMID:17942748
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313237	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FKBP7 mRNA	PMID:17942748
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FKBP7 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FKBP7 mRNA	PMID:28628672
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313237	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of FKBP7 mRNA	PMID:39716349
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305293	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of FKBP7 mRNA	PMID:24793618
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305293	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of FKBP7 mRNA	PMID:25729387
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of FKBP7 mRNA	PMID:28988120
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of FKBP7 protein	PMID:34186270
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FKBP7 gene]	PMID:28238834
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1313237	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of FKBP7 mRNA	PMID:18958704
1313236	FKBP7	FKBP prolyl isomerase 7	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305293	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of FKBP7 mRNA	PMID:19281266
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of EIF4G2 protein	PMID:39638853
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313239	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EIF4G2 mRNA	PMID:33045310
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1305294	E	RGD:6480464	20120412	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of EIF4G2 mRNA	PMID:10336889
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313239	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of EIF4G2 mRNA	PMID:20188158
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of EIF4G2 mRNA	PMID:18491231
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	PDCD4 protein promotes the reaction [Tretinoin results in increased expression of EIF4G2 protein]; Tretinoin results in increased expression of and results in increased localization of EIF4G2 protein	PMID:17259349|PMID:18491231
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of EIF4G2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of EIF4G2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of EIF4G2 mRNA	PMID:32699268|PMID:32845096
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305294	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of EIF4G2 gene	PMID:28931070
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of EIF4G2 mRNA	PMID:22378314
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of EIF4G2 mRNA	PMID:30319688
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of EIF4G2 mRNA	PMID:21179406
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313239	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of EIF4G2 mRNA	PMID:15598610
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313239	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EIF4G2 mRNA	PMID:39298647
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:166520	3,4-Methylenedioxyamphetamine	increases expression	ISO	RGD:1305294	E	RGD:6480464	20201208	CTD	MESH:D015104	3,4-Methylenedioxyamphetamine results in increased expression of EIF4G2 mRNA	PMID:10336889
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1305294	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in increased expression of EIF4G2 mRNA	PMID:15878777
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20140408	CTD	MESH:D008550	Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EIF4G2 mRNA]	PMID:23963992
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of EIF4G2 mRNA	PMID:21179406
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in decreased expression of EIF4G2 protein	PMID:20463053
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313239	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of EIF4G2 mRNA	PMID:23892564
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of EIF4G2 mRNA	PMID:33754040
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of EIF4G2 protein	PMID:37730182
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of EIF4G2 protein	PMID:18491231
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305294	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of EIF4G2 mRNA	PMID:22061828
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EIF4G2 mRNA	PMID:36331819
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EIF4G2 mRNA	PMID:28111341|PMID:37236586
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of EIF4G2 mRNA	PMID:26760959
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:254496	7,12-dimethyltetraphene	affects expression	ISO	RGD:1313239	E	RGD:6480464	20120501	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene affects the expression of EIF4G2 mRNA	PMID:21785161
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of EIF4G2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of EIF4G2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of EIF4G2 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of EIF4G2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of EIF4G2 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of EIF4G2 protein	PMID:38598786
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EIF4G2 mRNA	PMID:22206623
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in decreased expression of EIF4G2 protein	PMID:18089832
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002945	Cisplatin results in increased expression of EIF4G2 mRNA	PMID:25450742
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305294	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EIF4G2 mRNA	PMID:34747641
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313239	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EIF4G2 mRNA	PMID:21570461|PMID:24680724
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313239	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EIF4G2 mRNA	PMID:19465110
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of EIF4G2 protein	PMID:18491231
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of EIF4G2 mRNA]; MT2 affects the reaction [Copper results in increased expression of EIF4G2 mRNA]	PMID:16629173
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EIF4G2 mRNA	PMID:29803840
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of EIF4G2 mRNA	PMID:20044591
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of and results in increased activity of EIF4G2 protein	PMID:30528433
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313239	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of EIF4G2 mRNA	PMID:22342234
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of EIF4G2 mRNA]; MT2 affects the reaction [Copper results in increased expression of EIF4G2 mRNA]	PMID:16629173
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:30621	diarsenic trioxide	increases cleavage	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased cleavage of EIF4G2 protein	PMID:18491231
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313239	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of EIF4G2 mRNA	PMID:20542052
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305294	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of EIF4G2 mRNA	PMID:30047161
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:32234	titanium dioxide	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C009495	titanium dioxide results in decreased expression of EIF4G2 protein	PMID:30910687
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313239	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EIF4G2 gene	PMID:35295148
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305294	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EIF4G2 mRNA	PMID:34492290
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313239	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of EIF4G2 mRNA	PMID:18648102
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of EIF4G2 mRNA	PMID:30903817
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305294	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of EIF4G2 mRNA	PMID:25181051
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of EIF4G2 protein	PMID:31675489|PMID:37567409
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of EIF4G2 mRNA	PMID:33221593
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305294	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of EIF4G2 mRNA	PMID:41034487
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313239	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in increased expression of EIF4G2 mRNA	PMID:21932408
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of EIF4G2 protein	PMID:31675489
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313239	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EIF4G2 mRNA	PMID:39298647
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of EIF4G2 protein	PMID:34186270
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313239	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of EIF4G2 mRNA	PMID:38685157
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G2 mRNA	PMID:28628672
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of EIF4G2 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of EIF4G2 protein	PMID:38598786
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G2 mRNA	PMID:28628672
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20140408	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of EIF4G2 mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EIF4G2 mRNA]	PMID:23963992
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of EIF4G2 mRNA]	PMID:19030233
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EIF4G2 mRNA	PMID:37042841
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313239	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EIF4G2 mRNA	PMID:18974090
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EIF4G2 mRNA	PMID:28111341|PMID:37236586
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EIF4G2 mRNA	PMID:19320972
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of EIF4G2 mRNA	PMID:25908611
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of EIF4G2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of EIF4G2 mRNA	PMID:32699268
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of EIF4G2 protein	PMID:18491231
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of EIF4G2 protein	PMID:24301089
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EIF4G2 mRNA	PMID:36331819
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EIF4G2 mRNA	PMID:25979313
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of EIF4G2 mRNA	PMID:19136453
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305294	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of EIF4G2 mRNA	PMID:30047161
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G2 mRNA	PMID:28628672
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of EIF4G2 mRNA	PMID:36621641
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:4469	(S)-amphetamine	increases expression	ISO	RGD:1305294	E	RGD:6480464	20120412	CTD	MESH:D003913	Dextroamphetamine results in increased expression of EIF4G2 mRNA	PMID:10336889
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in decreased expression of EIF4G2 mRNA	PMID:19606018
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of EIF4G2 mRNA	PMID:31675489
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in decreased expression of EIF4G2 mRNA	PMID:22334560
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of EIF4G2 mRNA	PMID:18175754
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G2 mRNA	PMID:28628672
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:49900	arsenous acid	increases cleavage	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased cleavage of EIF4G2 protein	PMID:18491231
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305294	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of EIF4G2 mRNA	PMID:30047161
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305294	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of EIF4G2 mRNA	PMID:19162173
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EIF4G2 mRNA	PMID:35964746
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20140408	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of EIF4G2 mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of EIF4G2 mRNA]	PMID:23963992
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EIF4G2 protein	PMID:32959892
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of EIF4G2 mRNA	PMID:19606018
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:65329	LY294002	increases expression	EXP		E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of EIF4G2 protein	PMID:18491231
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1305294	E	RGD:6480464	20120412	CTD	MESH:D008694	Methamphetamine results in increased expression of EIF4G2 mRNA	PMID:10336889
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of EIF4G2 protein	PMID:34186270
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EIF4G2 mRNA	PMID:22206623
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313239	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EIF4G2 mRNA	PMID:22206623
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:7599	Nivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of EIF4G2 protein	PMID:39638853
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of EIF4G2 mRNA	PMID:12517777
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of EIF4G2 protein	PMID:39638853
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EIF4G2 gene]	PMID:28238834
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of EIF4G2 mRNA	PMID:39904859
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305294	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of EIF4G2 mRNA	PMID:20056577
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in decreased expression of EIF4G2 mRNA	PMID:22334560
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313239	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in decreased expression of EIF4G2 mRNA	PMID:22334560
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305294	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of EIF4G2 mRNA	PMID:30047161
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:9168	sirolimus	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in increased expression of EIF4G2 protein	PMID:18491231
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of EIF4G2 protein	PMID:38598786
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305294	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EIF4G2 mRNA	PMID:21346803
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305294	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of EIF4G2 mRNA	PMID:19015723
1313238	EIF4G2	eukaryotic translation initiation factor 4 gamma 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305294	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of EIF4G2 mRNA	PMID:23034163
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305295	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of WFDC3 mRNA	PMID:25152437
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of WFDC3 mRNA	PMID:27188386
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1621504	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of WFDC3 mRNA	PMID:33045310
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621504	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of WFDC3 mRNA	PMID:33045310
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1621504	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of WFDC3 mRNA	PMID:37995155
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of WFDC3 mRNA	PMID:26516004
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of WFDC3 mRNA	PMID:36331819
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305295	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of WFDC3 gene	PMID:27618143
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of WFDC3 mRNA	PMID:37992649
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1621504	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of WFDC3 mRNA	PMID:33848595
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of WFDC3 mRNA]	PMID:33848595
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of WFDC3 mRNA	PMID:37992649
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of WFDC3 mRNA	PMID:36331819
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:19452	2-amino-4,6-dinitrotoluene	affects expression	ISO	RGD:1305295	E	RGD:6480464	20140304	CTD	MESH:C035208	2-amino-4,6-dinitrotoluene affects the expression of WFDC3 mRNA	PMID:21346803
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1305295	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of WFDC3 mRNA	PMID:41580963
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of WFDC3 mRNA	PMID:35430440
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of WFDC3 mRNA	PMID:34911549
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1621504	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of WFDC3 mRNA	PMID:27339419|PMID:31919559
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of WFDC3 mRNA	PMID:32525701
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305295	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of WFDC3 mRNA	PMID:31881176
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1621504	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of WFDC3 mRNA	PMID:32186404
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305295	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WFDC3 mRNA	PMID:21215274
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of WFDC3 mRNA	PMID:33212167
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305295	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of WFDC3 mRNA	PMID:28959563
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of WFDC3 mRNA	PMID:21198554
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of WFDC3 mRNA	PMID:37992649
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:C028473	WFDC3 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine	PMID:21177773
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1621504	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of WFDC3 mRNA	PMID:37682722
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of WFDC3 mRNA	PMID:38568856
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WFDC3 5' UTR; Benzo(a)pyrene results in increased methylation of WFDC3 promoter	PMID:27901495
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305295	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of WFDC3 mRNA	PMID:30047161
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1621504	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of WFDC3 mRNA	PMID:23557971
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305295	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of WFDC3 mRNA	PMID:34492290
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of WFDC3 mRNA	PMID:19710929
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305295	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of WFDC3 mRNA	PMID:25181051
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621504	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of WFDC3 mRNA	PMID:40203079
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in increased expression of WFDC3 mRNA]	PMID:40203079
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1621504	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of WFDC3 mRNA	PMID:32715474
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305295	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of WFDC3 mRNA	PMID:35163327
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305295	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of WFDC3 mRNA	PMID:30723492
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305295	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of WFDC3 promoter	PMID:22457795
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305295	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of WFDC3 mRNA	PMID:35163327
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of WFDC3 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of WFDC3 mRNA	PMID:36331819
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1621504	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of WFDC3 mRNA	PMID:23125180
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305295	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of WFDC3 mRNA	PMID:30047161
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1621504	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of WFDC3 mRNA	PMID:37992649
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1305295	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of WFDC3 mRNA	PMID:21346803
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of WFDC3 mRNA	PMID:32525701
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1621504	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of WFDC3 mRNA	PMID:27106021
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305295	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of WFDC3 mRNA	PMID:24136188
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305295	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of WFDC3 mRNA	PMID:30047161
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1621504	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of WFDC3 mRNA	PMID:38701926
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1621504	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of WFDC3 mRNA	PMID:22206623
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to WFDC3 gene]	PMID:28238834
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of WFDC3 mRNA	PMID:32525701
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305295	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of WFDC3 mRNA	PMID:30047161
1313240	WFDC3	WAP four-disulfide core domain 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305295	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of WFDC3 mRNA	PMID:21346803
1313241	R3HDML	R3H domain containing like	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305296	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of R3HDML mRNA	PMID:33387578
1313241	R3HDML	R3H domain containing like	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305296	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of R3HDML gene	PMID:27618143
1313241	R3HDML	R3H domain containing like	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA	PMID:37567420
1313241	R3HDML	R3H domain containing like	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA	PMID:37567420
1313241	R3HDML	R3H domain containing like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:2293981	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of R3HDML mRNA	PMID:33754040
1313241	R3HDML	R3H domain containing like	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of R3HDML exon	PMID:30157460
1313241	R3HDML	R3H domain containing like	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of R3HDML mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of R3HDML mRNA	PMID:34911549
1313241	R3HDML	R3H domain containing like	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of R3HDML promoter	PMID:22847954
1313241	R3HDML	R3H domain containing like	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA	PMID:37567420
1313241	R3HDML	R3H domain containing like	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20231031	CTD	MESH:D015084	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA	PMID:37567420
1313241	R3HDML	R3H domain containing like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:2293981	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of R3HDML mRNA	PMID:37682722|PMID:39232337
1313241	R3HDML	R3H domain containing like	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of R3HDML 5' UTR	PMID:27901495
1313241	R3HDML	R3H domain containing like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of R3HDML 3' UTR; Benzo(a)pyrene results in increased methylation of R3HDML promoter	PMID:27901495
1313241	R3HDML	R3H domain containing like	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of R3HDML gene	PMID:25435355
1313241	R3HDML	R3H domain containing like	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of R3HDML mRNA	PMID:25895662
1313241	R3HDML	R3H domain containing like	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305296	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of R3HDML mRNA	PMID:34492290
1313241	R3HDML	R3H domain containing like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305296	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of R3HDML mRNA	PMID:25181051
1313241	R3HDML	R3H domain containing like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:2293981	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of R3HDML mRNA	PMID:40203079
1313241	R3HDML	R3H domain containing like	gene	CHEBI:34575	bisphenol F	affects expression	ISO	RGD:2293981	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F affects the expression of R3HDML mRNA	PMID:38685157
1313241	R3HDML	R3H domain containing like	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305296	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of R3HDML mRNA	PMID:33453195
1313241	R3HDML	R3H domain containing like	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of R3HDML promoter	PMID:22847954
1313241	R3HDML	R3H domain containing like	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of R3HDML promoter	PMID:22847954
1313241	R3HDML	R3H domain containing like	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of R3HDML gene	PMID:29154799
1313241	R3HDML	R3H domain containing like	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA	PMID:37567420
1313241	R3HDML	R3H domain containing like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of R3HDML mRNA	PMID:26690555
1313241	R3HDML	R3H domain containing like	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:2293981	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of R3HDML mRNA	PMID:37567420
1313242	RLF	RLF zinc finger	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RLF mRNA	PMID:33167477
1313242	RLF	RLF zinc finger	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RLF mRNA	PMID:24236059|PMID:25596134
1313242	RLF	RLF zinc finger	gene	CHEBI:16130	DDT	decreases expression	ISO	RGD:1305297	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of RLF mRNA	PMID:30207508
1313242	RLF	RLF zinc finger	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RLF mRNA	PMID:21632981
1313242	RLF	RLF zinc finger	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of RLF protein	PMID:35688186
1313242	RLF	RLF zinc finger	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552172	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RLF mRNA	PMID:39241906
1313242	RLF	RLF zinc finger	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RLF mRNA	PMID:37042841
1313242	RLF	RLF zinc finger	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of RLF mRNA	PMID:20655997
1313242	RLF	RLF zinc finger	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of RLF mRNA	PMID:16949557
1313242	RLF	RLF zinc finger	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305297	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RLF mRNA	PMID:33387578
1313242	RLF	RLF zinc finger	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RLF mRNA	PMID:39836092
1313242	RLF	RLF zinc finger	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of RLF mRNA	PMID:16949557
1313242	RLF	RLF zinc finger	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RLF mRNA	PMID:19549813
1313242	RLF	RLF zinc finger	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RLF gene	PMID:27153756
1313242	RLF	RLF zinc finger	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552172	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RLF mRNA	PMID:19770486
1313242	RLF	RLF zinc finger	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RLF mRNA	PMID:41430723
1313242	RLF	RLF zinc finger	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305297	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RLF mRNA	PMID:30779732
1313242	RLF	RLF zinc finger	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552172	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RLF mRNA	PMID:31919559
1313242	RLF	RLF zinc finger	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RLF mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RLF mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RLF mRNA	PMID:32525701|PMID:39836092|PMID:40512198
1313242	RLF	RLF zinc finger	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552172	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RLF mRNA	PMID:40504410
1313242	RLF	RLF zinc finger	gene	CHEBI:27871	chloroacetaldehyde	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde affects the expression of RLF mRNA	PMID:25596134
1313242	RLF	RLF zinc finger	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of RLF mRNA	PMID:27392435
1313242	RLF	RLF zinc finger	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in increased expression of RLF mRNA	PMID:25596134
1313242	RLF	RLF zinc finger	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RLF mRNA	PMID:27392435
1313242	RLF	RLF zinc finger	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1552172	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RLF mRNA	PMID:30912803
1313242	RLF	RLF zinc finger	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of RLF mRNA	PMID:23195993
1313242	RLF	RLF zinc finger	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305297	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RLF mRNA	PMID:21215274|PMID:34747641
1313242	RLF	RLF zinc finger	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552172	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RLF mRNA	PMID:19770486
1313242	RLF	RLF zinc finger	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RLF mRNA	PMID:33212167
1313242	RLF	RLF zinc finger	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of RLF mRNA	PMID:39709020
1313242	RLF	RLF zinc finger	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RLF mRNA	PMID:30851411
1313242	RLF	RLF zinc finger	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RLF mRNA	PMID:29803840
1313242	RLF	RLF zinc finger	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of RLF mRNA	PMID:39719251
1313242	RLF	RLF zinc finger	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RLF mRNA	PMID:38568856
1313242	RLF	RLF zinc finger	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RLF mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RLF mRNA	PMID:39836092|PMID:40512198
1313242	RLF	RLF zinc finger	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552172	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RLF mRNA	PMID:40504410
1313242	RLF	RLF zinc finger	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RLF promoter	PMID:27901495
1313242	RLF	RLF zinc finger	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RLF mRNA]	PMID:32406909
1313242	RLF	RLF zinc finger	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RLF mRNA	PMID:25351596
1313242	RLF	RLF zinc finger	gene	CHEBI:32234	titanium dioxide	increases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in increased methylation of RLF gene	PMID:34973136
1313242	RLF	RLF zinc finger	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305297	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RLF mRNA	PMID:34492290
1313242	RLF	RLF zinc finger	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of RLF mRNA	PMID:38479592
1313242	RLF	RLF zinc finger	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of RLF gene	PMID:31601247
1313242	RLF	RLF zinc finger	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1552172	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of RLF promoter	PMID:27334623
1313242	RLF	RLF zinc finger	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305297	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RLF mRNA	PMID:25181051
1313242	RLF	RLF zinc finger	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305297	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of RLF mRNA	PMID:30816183
1313242	RLF	RLF zinc finger	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552172	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of RLF mRNA	PMID:35598803
1313242	RLF	RLF zinc finger	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1305297	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RLF mRNA	PMID:21241498
1313242	RLF	RLF zinc finger	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552172	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RLF mRNA	PMID:37019170
1313242	RLF	RLF zinc finger	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305297	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of RLF mRNA	PMID:22110744
1313242	RLF	RLF zinc finger	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RLF mRNA	PMID:39836092
1313242	RLF	RLF zinc finger	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RLF mRNA	PMID:38568856
1313242	RLF	RLF zinc finger	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305297	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RLF mRNA	PMID:33453195
1313242	RLF	RLF zinc finger	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1552172	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of RLF mRNA	PMID:28903501
1313242	RLF	RLF zinc finger	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of RLF mRNA	PMID:19320972|PMID:19376846
1313242	RLF	RLF zinc finger	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305297	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of RLF mRNA	PMID:24386269
1313242	RLF	RLF zinc finger	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of RLF mRNA	PMID:25596134
1313242	RLF	RLF zinc finger	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RLF mRNA	PMID:31533062
1313242	RLF	RLF zinc finger	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RLF mRNA	PMID:27153767|PMID:40419075
1313242	RLF	RLF zinc finger	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of RLF mRNA	PMID:23179753|PMID:27188386
1313242	RLF	RLF zinc finger	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1305297	E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RLF mRNA	PMID:21658437
1313242	RLF	RLF zinc finger	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552172	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RLF mRNA	PMID:17562736
1313242	RLF	RLF zinc finger	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of RLF mRNA	PMID:21420995
1313242	RLF	RLF zinc finger	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552172	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of RLF mRNA	PMID:29279043
1313242	RLF	RLF zinc finger	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of RLF mRNA	PMID:18687144
1313242	RLF	RLF zinc finger	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RLF mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RLF mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RLF mRNA	PMID:32525701|PMID:39836092|PMID:40512198
1313242	RLF	RLF zinc finger	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552172	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RLF mRNA	PMID:40504410
1313242	RLF	RLF zinc finger	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of RLF mRNA	PMID:22077320
1313242	RLF	RLF zinc finger	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RLF mRNA	PMID:22079256
1313242	RLF	RLF zinc finger	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1305297	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of RLF mRNA	PMID:25596134
1313242	RLF	RLF zinc finger	gene	CHEBI:5864	ifosfamide	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in increased expression of RLF mRNA	PMID:25596134
1313242	RLF	RLF zinc finger	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of RLF mRNA	PMID:39836092
1313242	RLF	RLF zinc finger	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1552172	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RLF mRNA	PMID:23650126
1313242	RLF	RLF zinc finger	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1305297	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of RLF mRNA	PMID:25596134
1313242	RLF	RLF zinc finger	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1305297	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of RLF mRNA	PMID:19564919
1313242	RLF	RLF zinc finger	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RLF mRNA	PMID:31758290
1313242	RLF	RLF zinc finger	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RLF mRNA	PMID:22079256
1313242	RLF	RLF zinc finger	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RLF mRNA	PMID:22079256
1313242	RLF	RLF zinc finger	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of RLF protein	PMID:31285264
1313242	RLF	RLF zinc finger	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RLF mRNA	PMID:30851411
1313242	RLF	RLF zinc finger	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of RLF mRNA	PMID:19159669
1313242	RLF	RLF zinc finger	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552172	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of RLF mRNA	PMID:30953684
1313242	RLF	RLF zinc finger	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RLF mRNA	PMID:32525701
1313242	RLF	RLF zinc finger	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1552172	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of RLF mRNA	PMID:21278054
1313242	RLF	RLF zinc finger	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305297	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RLF mRNA	PMID:19281266
1313242	RLF	RLF zinc finger	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RLF mRNA	PMID:38568856
1313242	RLF	RLF zinc finger	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of RLF mRNA	PMID:29301935
1313242	RLF	RLF zinc finger	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305297	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RLF mRNA	PMID:21346803
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313246	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ARID3A mRNA	PMID:37995155
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313246	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ARID3A; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARID3A gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARID3A mRNA	PMID:20938992
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305299	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ARID3A mRNA	PMID:33729688
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1313246	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of ARID3A mRNA	PMID:15282401
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ARID3A mRNA	PMID:22378314
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ARID3A mRNA	PMID:23410634
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313246	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARID3A mRNA	PMID:39241906
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313246	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ARID3A mRNA	PMID:39298647
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ARID3A mRNA	PMID:30165855
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ARID3A mRNA	PMID:38568856
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313246	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ARID3A; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARID3A gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARID3A mRNA	PMID:20938992
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ARID3A mRNA	PMID:21179406
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305299	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ARID3A mRNA	PMID:26577399
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ARID3A protein	PMID:37730182
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313246	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARID3A mRNA	PMID:36331819
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ARID3A mRNA	PMID:39836092
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ARID3A mRNA	PMID:19549813
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARID3A mRNA	PMID:22100608
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ARID3A intron	PMID:30157460
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ARID3A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ARID3A mRNA	PMID:35430440|PMID:41430723
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of ARID3A mRNA	PMID:22171008
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313246	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of ARID3A; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ARID3A gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARID3A mRNA	PMID:20938992
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ARID3A mRNA	PMID:26272509
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID3A mRNA	PMID:27188386
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of ARID3A protein	PMID:35688186
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1313246	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of ARID3A mRNA	PMID:28960355
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313246	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ARID3A mRNA	PMID:30912803
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313246	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARID3A mRNA	PMID:28922406|PMID:37172768
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305299	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARID3A mRNA	PMID:34747641
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313246	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARID3A mRNA	PMID:24058054
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ARID3A mRNA	PMID:23179753
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARID3A mRNA	PMID:33212167
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:28534	1,2-dibromoethane	increases expression	ISO	RGD:1313246	E	RGD:6480464	20120412	CTD	MESH:D015946	Ethylene Dibromide results in increased expression of ARID3A mRNA	PMID:15612046
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305299	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ARID3A mRNA	PMID:26033743
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARID3A mRNA	PMID:29803840
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D024483	Vitamin K 3 affects the expression of ARID3A mRNA	PMID:20044591|PMID:23410634
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARID3A mRNA	PMID:29301061
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ARID3A mRNA	PMID:38568856
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARID3A intron	PMID:30157460
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313246	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ARID3A intron	PMID:27901495
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARID3A mRNA	PMID:32234424
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ARID3A 3' UTR; Benzo(a)pyrene results in increased methylation of ARID3A 5' UTR; Benzo(a)pyrene results in increased methylation of ARID3A promoter	PMID:27901495
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305299	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ARID3A mRNA	PMID:26033743
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of ARID3A mRNA	PMID:22171008
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1313246	E	RGD:6480464	20120412	CTD	MESH:C004312	glycidol results in increased expression of ARID3A mRNA	PMID:15612046
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305299	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ARID3A mRNA	PMID:30047161
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313246	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARID3A promoter	PMID:35295148
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313246	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of ARID3A mRNA	PMID:27760801
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:32588	potassium chloride	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D011189	[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of ARID3A mRNA	PMID:29691375
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:33098	2-nitrotoluene	increases expression	ISO	RGD:1313246	E	RGD:6480464	20120412	CTD	MESH:C029955	2-nitrotoluene results in increased expression of ARID3A mRNA	PMID:15612046
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313246	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ARID3A promoter	PMID:27334623
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ARID3A protein	PMID:31675489|PMID:33376534
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305299	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ARID3A mRNA	PMID:25181051
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARID3A gene	PMID:31601247
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313246	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ARID3A mRNA	PMID:39298647|PMID:40203079
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313246	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in increased expression of ARID3A mRNA]	PMID:40203079
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ARID3A intron	PMID:30157460
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARID3A mRNA	PMID:37042841
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ARID3A mRNA	PMID:39836092
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305299	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of ARID3A promoter	PMID:22457795
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305299	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ARID3A mRNA	PMID:30047161
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ARID3A mRNA	PMID:28302478
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ARID3A mRNA	PMID:31533062
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313246	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARID3A mRNA	PMID:36331819
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARID3A mRNA	PMID:29154799
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ARID3A mRNA	PMID:23179753
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ARID3A gene	PMID:29154799
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305299	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ARID3A mRNA	PMID:30047161
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:42223	emodin	increases expression	ISO	RGD:1313246	E	RGD:6480464	20120412	CTD	MESH:D004642	Emodin results in increased expression of ARID3A mRNA	PMID:15612046
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ARID3A mRNA	PMID:38832940
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313246	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARID3A mRNA	PMID:17562736
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305299	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARID3A mRNA	PMID:33387578
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ARID3A mRNA	PMID:22230336
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of ARID3A mRNA	PMID:31838189
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305299	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ARID3A mRNA	PMID:29391264
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:48981	quinolin-8-ol	increases expression	ISO	RGD:1313246	E	RGD:6480464	20120412	CTD	MESH:D015125	Oxyquinoline results in increased expression of ARID3A mRNA	PMID:15612046
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313246	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ARID3A mRNA	PMID:25554681|PMID:25620056
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305299	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of ARID3A mRNA	PMID:22504374
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:50845	doxycycline	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:D004318	Doxycycline promotes the reaction [erastin results in increased expression of ARID3A mRNA]	PMID:38115220
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313246	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ARID3A mRNA	PMID:38701926
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305299	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of ARID3A mRNA	PMID:28801915
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ARID3A mRNA	PMID:39836092
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:64090	tert-butyl hydroperoxide	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D020122	tert-Butylhydroperoxide affects the expression of ARID3A mRNA	PMID:23410634
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ARID3A intron	PMID:30157460
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ARID3A protein	PMID:31285264
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:76606	methyl carbamate	increases expression	ISO	RGD:1313246	E	RGD:6480464	20140107	CTD	MESH:C036868	methyl carbamate results in increased expression of ARID3A mRNA	PMID:15612046
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of ARID3A protein	PMID:39638853
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID3A mRNA	PMID:27188386
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of ARID3A mRNA	PMID:32234424
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305299	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ARID3A mRNA	PMID:23914054
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305299	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of ARID3A mRNA	PMID:22504374
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARID3A mRNA	PMID:27188386
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:94287	erastin	increases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C477224	erastin results in increased expression of ARID3A mRNA	PMID:38115220
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:94287	erastin	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:C477224	Doxycycline promotes the reaction [erastin results in increased expression of ARID3A mRNA]	PMID:38115220
1313245	ARID3A	AT-rich interaction domain 3A	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ARID3A mRNA	PMID:38568856
1313247	KRT32	keratin 32	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of KRT32 mRNA	PMID:23830798
1313247	KRT32	keratin 32	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1359701	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of KRT32 mRNA	PMID:26496021
1313247	KRT32	keratin 32	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313248	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of KRT32 mRNA	PMID:33711761
1313247	KRT32	keratin 32	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1359701	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KRT32 mRNA	PMID:33387578
1313247	KRT32	keratin 32	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313248	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of KRT32 mRNA	PMID:23892564
1313247	KRT32	keratin 32	gene	CHEBI:2038	5-azacytidine	increases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of KRT32 mRNA	PMID:20823114
1313247	KRT32	keratin 32	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of KRT32 mRNA	PMID:38460933
1313247	KRT32	keratin 32	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of KRT32 mRNA	PMID:23557933
1313247	KRT32	keratin 32	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313248	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KRT32 mRNA	PMID:21570461
1313247	KRT32	keratin 32	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of KRT32 mRNA	PMID:34032870
1313247	KRT32	keratin 32	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313248	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of KRT32 mRNA	PMID:16014739
1313247	KRT32	keratin 32	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KRT32 3' UTR	PMID:27901495
1313247	KRT32	keratin 32	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KRT32 promoter	PMID:27901495
1313247	KRT32	keratin 32	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1359701	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT32 mRNA	PMID:25181051
1313247	KRT32	keratin 32	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1359701	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of KRT32 mRNA	PMID:26496021
1313247	KRT32	keratin 32	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1313248	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of KRT32 mRNA	PMID:26377693
1313247	KRT32	keratin 32	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1359701	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KRT32 mRNA	PMID:35163327
1313247	KRT32	keratin 32	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1359701	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT32 mRNA	PMID:35163327
1313247	KRT32	keratin 32	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1359701	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT32 mRNA	PMID:35163327
1313247	KRT32	keratin 32	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of KRT32 mRNA	PMID:24449571
1313247	KRT32	keratin 32	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KRT32 gene]	PMID:28238834
1313247	KRT32	keratin 32	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of KRT32 mRNA	PMID:24834073
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305301	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ABCE1 mRNA]	PMID:31150632
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ABCE1 mRNA	PMID:16140955|PMID:23724009|PMID:33167477
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Thiophenes analog promotes the reaction [Tretinoin results in decreased expression of ABCE1 mRNA]	PMID:16140955
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABCE1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABCE1 mRNA	PMID:32699268
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:15756	hexadecanoic acid	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019308	Palmitic Acid results in increased expression of ABCE1 protein	PMID:24651439
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ABCE1 mRNA	PMID:22378314
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313250	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ABCE1 mRNA	PMID:39241906
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of ABCE1 mRNA]	PMID:39241906
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305301	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ABCE1 protein	PMID:32145629
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of ABCE1 mRNA	PMID:24758408|PMID:31614463
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313250	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ABCE1 mRNA	PMID:39298647
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein promotes the reaction [Estradiol results in increased expression of ABCE1 mRNA]	PMID:24758408
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ABCE1 mRNA	PMID:38568856
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305301	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ABCE1 mRNA	PMID:33387578
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ABCE1 mRNA	PMID:21179406
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:17323	trans-pinosylvin	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C049032	pinosylvin results in decreased expression of ABCE1 mRNA	PMID:23333577
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305301	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ABCE1 mRNA	PMID:22061828|PMID:33387578
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ABCE1 mRNA	PMID:28818685
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABCE1 mRNA	PMID:39836092
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ABCE1 mRNA	PMID:37236586
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:232105	dicyclanil	increases expression	ISO	RGD:1313250	E	RGD:6480464	20241119	CTD	MESH:C121718	dicyclanil results in increased expression of ABCE1 mRNA	PMID:15664270
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ABCE1 protein	PMID:23301498
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ABCE1 mRNA	PMID:23649840
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ABCE1 mRNA	PMID:23649840
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABCE1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABCE1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ABCE1 mRNA	PMID:32699268
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ABCE1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ABCE1 protein	PMID:38598786
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:26961	thiophenes	multiple interactions	EXP		E	RGD:6480464	20170103	CTD	MESH:D013876	Thiophenes analog promotes the reaction [Tretinoin results in decreased expression of ABCE1 mRNA]	PMID:16140955
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ABCE1 mRNA	PMID:17484886
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305301	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ABCE1 mRNA	PMID:31150632
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313250	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ABCE1 mRNA	PMID:27339419|PMID:31919559
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305301	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ABCE1 mRNA]	PMID:31150632
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ABCE1 mRNA	PMID:22206623
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABCE1 mRNA	PMID:39836092
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ABCE1 mRNA	PMID:27392435
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABCE1 mRNA	PMID:22298810
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313250	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABCE1 mRNA	PMID:21570461
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313250	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABCE1 mRNA	PMID:15034205
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABCE1 mRNA; AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of ABCE1 mRNA]	PMID:15034205|PMID:17942748
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ABCE1 mRNA	PMID:33212167
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of ABCE1 mRNA	PMID:39709020
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ABCE1 mRNA	PMID:29803840
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABCE1 mRNA	PMID:38568856
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABCE1 mRNA	PMID:39836092
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of ABCE1 mRNA	PMID:17127020
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313250	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABCE1 mRNA	PMID:15034205|PMID:22228805
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of ABCE1 mRNA]	PMID:15034205
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ABCE1 mRNA	PMID:25895662
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1305301	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of ABCE1 mRNA	PMID:11578147
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of ABCE1 mRNA	PMID:31745603
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305301	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ABCE1 mRNA	PMID:30047161
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305301	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ABCE1 mRNA	PMID:34492290
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313250	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ABCE1 mRNA	PMID:28472532
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305301	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ABCE1 mRNA	PMID:19167457
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCE1 protein	PMID:31675489|PMID:37567409
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313250	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCE1 mRNA	PMID:33221593
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305301	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ABCE1 mRNA	PMID:25181051
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of ABCE1 mRNA	PMID:19041380
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313250	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ABCE1 mRNA	PMID:39298647
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ABCE1 protein	PMID:34186270
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:34575	bisphenol F	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	bisphenol F results in increased methylation of ABCE1 gene	PMID:31601247
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ABCE1 protein	PMID:34186270
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313250	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ABCE1 mRNA	PMID:37019170
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ABCE1 protein	PMID:38598786
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305301	E	RGD:6480464	20150512	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ABCE1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ABCE1 promoter	PMID:25374375
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305301	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ABCE1 mRNA	PMID:32680482
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of ABCE1 mRNA]	PMID:39241906
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ABCE1 mRNA	PMID:37042841
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABCE1 mRNA	PMID:39836092
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ABCE1 mRNA	PMID:38174414|PMID:38568856
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ABCE1 mRNA	PMID:37236586
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313250	E	RGD:6480464	20240206	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ABCE1 protein	PMID:37422089
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ABCE1 mRNA	PMID:24449571
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:36011	pinosylvin	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C049032	pinosylvin results in decreased expression of ABCE1 mRNA	PMID:23333577
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABCE1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABCE1 mRNA	PMID:32699268
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of ABCE1 protein	PMID:34122009
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ABCE1 mRNA	PMID:32588087
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ABCE1 mRNA	PMID:28302478
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ABCE1 mRNA	PMID:31533062
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ABCE1 mRNA	PMID:19167446
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ABCE1 mRNA	PMID:17292431
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ABCE1 mRNA	PMID:23179753|PMID:27188386
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305301	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ABCE1 mRNA	PMID:30047161
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313250	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of ABCE1 mRNA	PMID:19770486
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305301	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of ABCE1 mRNA	PMID:24136188
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ABCE1 mRNA	PMID:17562736
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of ABCE1 mRNA	PMID:21420995|PMID:25704631
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305301	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ABCE1 mRNA	PMID:33387578
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABCE1 mRNA	PMID:39836092
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ABCE1 mRNA	PMID:22079256
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABCE1 mRNA	PMID:17942748
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313250	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ABCE1 mRNA	PMID:25554681
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305301	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ABCE1 mRNA	PMID:24136188
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305301	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ABCE1 mRNA	PMID:30047161
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ABCE1 mRNA	PMID:35964746
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305301	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ABCE1 mRNA	PMID:24136188
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ABCE1 protein	PMID:32959892
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ABCE1 mRNA	PMID:39836092
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ABCE1 mRNA	PMID:26378955
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ABCE1 mRNA	PMID:26378955
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313250	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ABCE1 mRNA	PMID:23650126
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305301	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ABCE1 mRNA	PMID:30467583
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ABCE1 mRNA	PMID:22206623
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ABCE1 protein	PMID:37664457
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305301	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ABCE1 mRNA	PMID:24136188
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ABCE1 mRNA	PMID:22079256
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ABCE1 mRNA	PMID:22079256
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:755540	docetaxel	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	[Docetaxel results in decreased susceptibility to Docetaxel] which results in decreased expression of ABCE1 mRNA	PMID:19944135
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of ABCE1 mRNA; beta-Naphthoflavone results in increased expression of ABCE1 protein	PMID:32858204|PMID:39638853
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305301	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ABCE1 mRNA	PMID:21346803
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305301	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of ABCE1 mRNA	PMID:30047161
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1305301	E	RGD:6480464	20150512	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ABCE1 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of ABCE1 promoter	PMID:25374375
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313250	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ABCE1 mRNA	PMID:30294300
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ABCE1 protein	PMID:31675489
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of ABCE1 protein	PMID:38348393
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1305301	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of ABCE1 mRNA	PMID:30047161
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313250	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of ABCE1 mRNA	PMID:21278054
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305301	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ABCE1 mRNA	PMID:30047161
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313250	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of ABCE1 mRNA]	PMID:39241906
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ABCE1 protein	PMID:37664457
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305301	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ABCE1 mRNA	PMID:21346803
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ABCE1 mRNA	PMID:38568856
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ABCE1 protein	PMID:38598786
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305301	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ABCE1 mRNA	PMID:21346803
1313249	ABCE1	ATP binding cassette subfamily E member 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305301	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of ABCE1 mRNA	PMID:23555832
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of IRAK4 mRNA	PMID:27188386
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of IRAK4 protein	PMID:36641056
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of IRAK4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of IRAK4 mRNA	PMID:32699268
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of IRAK4 mRNA	PMID:26079696
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of IRAK4 mRNA; Ethanol results in increased expression of IRAK4 protein	PMID:28964808
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313253	E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of IRAK4 protein	PMID:28964808
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D000431	[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 mRNA; [Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 protein; acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 mRNA]; acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 protein]; acanthoic acid inhibits the reaction [Ethanol results in increased expression of IRAK4 protein]; PRKAA1 protein promotes the reaction [acanthoic acid inhibits the reaction [Ethanol results in increased expression of IRAK4 protein]]	PMID:28964808
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20180515	CTD	MESH:D000431	acanthoic acid inhibits the reaction [Ethanol results in increased expression of IRAK4 protein]	PMID:28964808
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:16412	lipopolysaccharide	increases degradation	ISO	RGD:1313253	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased degradation of IRAK4 protein	PMID:22849695
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IRAK4 protein	PMID:28964808
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:16412	lipopolysaccharide	increases phosphorylation	ISO	RGD:1313253	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased phosphorylation of IRAK4 protein	PMID:25294874
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D008070	[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 mRNA; [Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 protein; acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 mRNA]; acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 protein]	PMID:28964808
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1305303	E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Titanium] results in decreased expression of IRAK4 mRNA	PMID:21308757
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20161228	CTD	MESH:D008070	ginsenoside Re inhibits the reaction [Lipopolysaccharides results in increased degradation of IRAK4 protein]; iberin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IRAK4 protein]	PMID:22849695|PMID:25294874
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313253	E	RGD:6480464	20211109	CTD	MESH:D014241	Trichloroethylene results in increased expression of IRAK4 protein	PMID:33007382
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20211109	CTD	MESH:D014241	sulforaphane inhibits the reaction [Trichloroethylene results in increased expression of IRAK4 protein]	PMID:33007382
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of IRAK4 protein	PMID:17701593
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of IRAK4 mRNA	PMID:33359661
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305303	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of IRAK4 mRNA	PMID:33387578
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20241203	CTD	MESH:D001397	[Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of IRAK4 protein	PMID:34273909
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:233299	(-)-acanthoic acid	multiple interactions	EXP		E	RGD:6480464	20250408	CTD	MESH:C099958	acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 mRNA]; acanthoic acid inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in increased expression of IRAK4 protein]; acanthoic acid inhibits the reaction [Ethanol results in increased expression of IRAK4 protein]; PRKAA1 protein promotes the reaction [acanthoic acid inhibits the reaction [Ethanol results in increased expression of IRAK4 protein]]	PMID:28964808
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:233299	(-)-acanthoic acid	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20250408	CTD	MESH:C099958	acanthoic acid inhibits the reaction [Ethanol results in increased expression of IRAK4 protein]	PMID:28964808
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of IRAK4 gene	PMID:27153756
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of IRAK4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of IRAK4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of IRAK4 mRNA	PMID:32699268
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:26710	sodium chloride	increases phosphorylation	EXP		E	RGD:6480464	20260113	CTD	MESH:D012965	Sodium Chloride results in increased phosphorylation of IRAK4 protein	PMID:40447172
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D012965	IRAK4 protein affects the reaction [Sodium Chloride results in decreased expression of ARG1 protein]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in decreased expression of ARG1 protein]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of ACTA2 protein]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of HAVCR1 mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of IL1B mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of IL6 mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of LCN2 mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of TGFB1 protein]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of TNF mRNA]]; IRAK4 protein promotes the reaction [Sodium Chloride results in decreased expression of IL10 mRNA]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of ACTA2 protein]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of HAVCR1 mRNA]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of IL1B mRNA]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of IL6 mRNA]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of LCN2 mRNA]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of TNF mRNA]; IRAK4 protein promotes the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]; liquiritigenin inhibits the reaction [IRAK4 protein affects the reaction [Sodium Chloride results in decreased expression of ARG1 protein]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in decreased expression of IL10 mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of ACTA2 protein]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of IL1B mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of IL6 mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of LCN2 mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of TNF mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]]	PMID:40447172
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IRAK4 gene	PMID:25304211
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:1305303	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of IRAK4 gene	PMID:31011160
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of IRAK4 mRNA	PMID:27392435
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313253	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of IRAK4 mRNA	PMID:30912803
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305303	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IRAK4 mRNA	PMID:22298810
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313253	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IRAK4 mRNA	PMID:24680724
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IRAK4 mRNA	PMID:29803840
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:28777	liquiritigenin	affects binding	EXP		E	RGD:6480464	20260113	CTD	MESH:C083152	liquiritigenin binds to IRAK4 protein	PMID:40447172
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:28777	liquiritigenin	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C083152	IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in decreased expression of ARG1 protein]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of ACTA2 protein]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of HAVCR1 mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of IL1B mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of IL6 mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of LCN2 mRNA]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of TGFB1 protein]]; IRAK4 protein inhibits the reaction [liquiritigenin inhibits the reaction [Sodium Chloride results in increased expression of TNF mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein affects the reaction [Sodium Chloride results in decreased expression of ARG1 protein]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in decreased expression of IL10 mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of ACTA2 protein]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of IL1B mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of IL6 mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of LCN2 mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased expression of TNF mRNA]]; liquiritigenin inhibits the reaction [IRAK4 protein promotes the reaction [Sodium Chloride results in increased phosphorylation of MAPK8 protein]]	PMID:40447172
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:28777	liquiritigenin	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20260113	CTD	MESH:C083152	liquiritigenin inhibits the reaction [Sodium Chloride, Dietary results in increased phosphorylation of IRAK4 protein]	PMID:40447172
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313253	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of IRAK4 mRNA	PMID:39515575
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IRAK4 5' UTR	PMID:27901495
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of IRAK4 mRNA; Silicon Dioxide results in decreased expression of IRAK4 mRNA	PMID:25351596|PMID:25895662
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313253	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IRAK4 gene	PMID:35295148
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305303	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of IRAK4 mRNA	PMID:34492290
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313253	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of IRAK4 mRNA	PMID:28472532
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305303	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IRAK4 mRNA	PMID:25181051|PMID:34947998
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313253	E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A results in increased expression of IRAK4 protein modified form	PMID:33706241
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:33341	titanium atom	multiple interactions	ISO	RGD:1305303	E	RGD:6480464	20120515	CTD	MESH:D014025	[Lipopolysaccharides co-treated with Titanium] results in decreased expression of IRAK4 mRNA	PMID:21308757
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20220308	CTD	MESH:D016264	[Azoxymethane co-treated with Dextran Sulfate] results in increased phosphorylation of IRAK4 protein	PMID:34273909
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313253	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of IRAK4 mRNA	PMID:21266533
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C022838	nickel chloride results in increased expression of IRAK4 protein	PMID:21473897
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313253	E	RGD:6480464	20171010	CTD	MESH:D010269	Paraquat results in increased expression of IRAK4 protein modified form	PMID:28363843
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20171010	CTD	MESH:D010269	Phosphorothioate Oligonucleotides inhibits the reaction [Paraquat results in increased expression of IRAK4 protein modified form]	PMID:28363843
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305303	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of IRAK4 mRNA	PMID:33453195
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of IRAK4 mRNA	PMID:36326898
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305303	E	RGD:6480464	20151013	CTD	MESH:C018021	cobaltous chloride results in increased expression of IRAK4 mRNA; cobaltous chloride results in increased expression of IRAK4 protein	PMID:21925238
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IRAK4 mRNA	PMID:24449571
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:36706	resiquimod	increases phosphorylation	EXP		E	RGD:6480464	20180515	CTD	MESH:C402365	resiquimod results in increased phosphorylation of IRAK4 protein	PMID:28924041
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:36706	resiquimod	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C402365	[Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod promotes the reaction [IRF5 protein binds to CXCL10 promoter]]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod promotes the reaction [IRF5 protein binds to TNF promoter]]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod results in increased expression of IL6 protein]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod results in increased expression of TNF protein]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod results in increased phosphorylation of IKBKB protein]	PMID:28924041
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of IRAK4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of IRAK4 mRNA	PMID:32699268
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:37699	protein kinase inhibitor	decreases activity	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors results in decreased activity of IRAK4 protein	PMID:28003376
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:37699	protein kinase inhibitor	decreases activity	ISO	RGD:1313253	E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors results in decreased activity of IRAK4 protein	PMID:28003376
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D047428	[Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod promotes the reaction [IRF5 protein binds to CXCL10 promoter]]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod promotes the reaction [IRF5 protein binds to TNF promoter]]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod results in increased expression of IL6 protein]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod results in increased expression of TNF protein]; [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod results in increased phosphorylation of IKBKB protein]; Protein Kinase Inhibitors results in decreased phosphorylation of and results in decreased activity of IRAK4 protein	PMID:28924041
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of IRAK4 gene	PMID:29154799
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of IRAK4 mRNA	PMID:25562108|PMID:27989131
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of IRAK4 mRNA	PMID:17400583
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1313253	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of IRAK4 mRNA	PMID:29279043
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IRAK4 gene	PMID:25304211
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1313253	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of IRAK4 mRNA	PMID:26934552
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20211109	CTD	MESH:C016766	sulforaphane inhibits the reaction [Trichloroethylene results in increased expression of IRAK4 protein]	PMID:33007382
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of IRAK4 mRNA	PMID:18175754
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:50692	mifepristone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in decreased expression of IRAK4 protein	PMID:17701593
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:50924	sorafenib	increases expression	ISO	RGD:1313253	E	RGD:6480464	20260203	CTD	MESH:C471405	Sorafenib results in increased expression of IRAK4 mRNA	PMID:40518001
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:51081	nitrates	increases expression	ISO	RGD:1305303	E	RGD:6480464	20200915	CTD	MESH:D009566	Nitrates results in increased expression of IRAK4 mRNA	PMID:30022042
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:5199	Fusaric acid	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D005669	Fusaric Acid results in decreased expression of IRAK4 protein	PMID:30582969
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313253	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IRAK4 mRNA	PMID:38701926
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:61668	oroxylin A	multiple interactions	ISO	RGD:1305303	E	RGD:6480464	20201006	CTD	MESH:C080669	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [endotoxin, Escherichia coli results in increased expression of IRAK4 protein]	PMID:32464219
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:6541	losartan	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20260113	CTD	MESH:D019808	Losartan inhibits the reaction [Sodium Chloride, Dietary results in increased phosphorylation of IRAK4 protein]	PMID:40447172
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:69355	casticin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C054133	casticin results in increased expression of IRAK4 mRNA	PMID:27862857
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:77148	ginsenoside Re	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20140408	CTD	MESH:C049864	ginsenoside Re inhibits the reaction [Lipopolysaccharides results in increased degradation of IRAK4 protein]	PMID:22849695
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:89494	iberin	multiple interactions	ISO	RGD:1313253	E	RGD:6480464	20151103	CTD	MESH:C082585	iberin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IRAK4 protein]	PMID:25294874
1313252	IRAK4	interleukin 1 receptor associated kinase 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305303	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of IRAK4 mRNA	PMID:21346803
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in increased expression of ETNK2 mRNA	PMID:19371625
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313255	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ETNK2 mRNA	PMID:33045310
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305304	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ETNK2 mRNA]	PMID:31150632
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ETNK2 mRNA	PMID:26079696
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ETNK2 mRNA	PMID:22378314
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of ETNK2 mRNA	PMID:20106945
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ETNK2 mRNA	PMID:39298647
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ETNK2 mRNA	PMID:38568856
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ETNK2 mRNA	PMID:26079696
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ETNK2 mRNA	PMID:34319233
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313255	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ETNK2 mRNA	PMID:33754040
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ETNK2 mRNA	PMID:16002434
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305304	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ETNK2 mRNA	PMID:33387578
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ETNK2 mRNA	PMID:36331819
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ETNK2 mRNA	PMID:37236586
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ETNK2 protein	PMID:20106945
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ETNK2 mRNA	PMID:27153756
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ETNK2 mRNA	PMID:19770486
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ETNK2 exon	PMID:30157460
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305304	E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ETNK2 mRNA	PMID:30690589|PMID:31150632
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ETNK2 mRNA	PMID:27339419|PMID:31919559
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:27385	tetrachloromethane	increases methylation	ISO	RGD:1305304	E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in increased methylation of ETNK2 promoter	PMID:30690589
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305304	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ETNK2 mRNA]	PMID:31150632
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ETNK2 mRNA	PMID:28189721|PMID:28960355
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of ETNK2 mRNA	PMID:19371625
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ETNK2 mRNA	PMID:28903495
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1313255	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of ETNK2 mRNA	PMID:34813904
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of ETNK2 mRNA	PMID:19371625
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1305304	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of ETNK2 gene	PMID:28505145
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313255	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ETNK2 mRNA	PMID:24680724
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ETNK2 mRNA	PMID:20106945
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305304	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ETNK2 mRNA	PMID:32109520|PMID:33387578
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ETNK2 mRNA	PMID:28213091
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ETNK2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ETNK2 gene]	PMID:25975270|PMID:28213091
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313255	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of ETNK2 mRNA	PMID:30807115
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ETNK2 mRNA	PMID:29803840
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:29132	N-acetyl-1,4-benzoquinone imine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:C028473	ETNK2 gene SNP affects the susceptibility to N-acetyl-4-benzoquinoneimine	PMID:21177773
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ETNK2 mRNA	PMID:38568856
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313255	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ETNK2 gene	PMID:39894169
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ETNK2 mRNA	PMID:34876320
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ETNK2 mRNA	PMID:34876320
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ETNK2 exon	PMID:30157460
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ETNK2 mRNA	PMID:20106945|PMID:32234424
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ETNK2 3' UTR; Benzo(a)pyrene results in decreased methylation of ETNK2 exon; Benzo(a)pyrene results in decreased methylation of ETNK2 promoter	PMID:27901495
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ETNK2 mRNA	PMID:22316170
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1305304	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of ETNK2 mRNA	PMID:38458666
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ETNK2 mRNA	PMID:34973136
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:30772	butyric acid	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D020148	Butyric Acid results in increased expression of ETNK2 mRNA	PMID:34581912
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of ETNK2 mRNA	PMID:38568856
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in decreased expression of ETNK2 mRNA	PMID:38568856
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:32063	propylparaben	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C006068	propylparaben results in decreased expression of ETNK2 mRNA	PMID:38568856
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1305304	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of ETNK2 mRNA	PMID:24136188
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305304	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of ETNK2 mRNA	PMID:23411599
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ETNK2 mRNA	PMID:20813756|PMID:23811191
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ETNK2 mRNA	PMID:30903817
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305304	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ETNK2 mRNA	PMID:25181051
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1313255	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A affects the expression of ETNK2 mRNA	PMID:39742910
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A results in decreased expression of ETNK2 mRNA	PMID:38568856
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305304	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ETNK2 mRNA	PMID:34947998
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of ETNK2 mRNA	PMID:19371625
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305304	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of ETNK2 mRNA	PMID:32145629
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305304	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ETNK2 gene	PMID:28505145
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305304	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of ETNK2 gene	PMID:28505145
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20241001	CTD	MESH:C006780	[Dietary Fats co-treated with bisphenol A] results in decreased expression of ETNK2 mRNA	PMID:36632902
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of ETNK2 mRNA	PMID:19371625
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313255	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of ETNK2 mRNA	PMID:39298647
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313255	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ETNK2 gene	PMID:31683443
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C543008	bisphenol S results in decreased expression of ETNK2 mRNA	PMID:38568856
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of ETNK2 mRNA	PMID:33297965
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ETNK2 gene	PMID:31601247
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:34575	bisphenol F	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008745	bisphenol F results in decreased expression of ETNK2 mRNA	PMID:38568856
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20241001	CTD	MESH:C008745	[Dietary Fats co-treated with bisphenol F] results in decreased expression of ETNK2 mRNA	PMID:36632902
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ETNK2 mRNA	PMID:37019170
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313255	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ETNK2 mRNA	PMID:32715474
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1305304	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of ETNK2 mRNA	PMID:38458666
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ETNK2 mRNA	PMID:38568856
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ETNK2 mRNA	PMID:37236586
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313255	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ETNK2 mRNA	PMID:28903501
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305304	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ETNK2 mRNA	PMID:24386269
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ETNK2 mRNA	PMID:24449571
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313255	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of ETNK2 mRNA	PMID:18353800
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of ETNK2 mRNA	PMID:23811191
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:38922	dibenzofurans	increases expression	ISO	RGD:1313255	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in increased expression of ETNK2 mRNA	PMID:34254344
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ETNK2 mRNA	PMID:31533062
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ETNK2 mRNA	PMID:36331819
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of ETNK2 mRNA	PMID:28001369|PMID:29154799
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of ETNK2 mRNA	PMID:20106945
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1313255	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of ETNK2 mRNA	PMID:25123088
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1305304	E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of ETNK2 mRNA	PMID:36653537
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ETNK2 mRNA; Okadaic Acid results in decreased expression of ETNK2 protein	PMID:38832940
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313255	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ETNK2 mRNA	PMID:17562736
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ETNK2 mRNA	PMID:29067470
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of ETNK2 mRNA	PMID:31838189
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ETNK2 mRNA	PMID:35436446
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ETNK2 mRNA	PMID:34876320
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ETNK2 mRNA	PMID:32234424
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of ETNK2 mRNA	PMID:38568856
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of ETNK2 mRNA	PMID:25572481
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313255	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ETNK2 mRNA	PMID:25620056
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305304	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of ETNK2 mRNA	PMID:34044035
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313255	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ETNK2 mRNA	PMID:23608068
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313255	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ETNK2 mRNA	PMID:23091169
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305304	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ETNK2 mRNA	PMID:32109520
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313255	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ETNK2 mRNA	PMID:38648751
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ETNK2 mRNA	PMID:26079696
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313255	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of ETNK2 mRNA	PMID:34876320
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305304	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ETNK2 mRNA	PMID:19281266
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ETNK2 mRNA	PMID:38568856
1313254	ETNK2	ethanolamine kinase 2	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of ETNK2 mRNA	PMID:25572481
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of UBE2Q1 mRNA	PMID:25812627
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552177	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE2Q1 gene	PMID:20938992
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of UBE2Q1 mRNA	PMID:33167477
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of UBE2Q1 mRNA	PMID:22378314
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552177	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE2Q1 gene	PMID:20938992
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of UBE2Q1 mRNA	PMID:19162166
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1552177	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of UBE2Q1 mRNA	PMID:23892564
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552177	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of UBE2Q1 mRNA	PMID:33754040
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552177	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2Q1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBE2Q1 gene	PMID:20938992|PMID:22206623
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2Q1 mRNA	PMID:39836092
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552177	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of UBE2Q1 mRNA	PMID:28960355
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552177	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2Q1 mRNA	PMID:21570461
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1552177	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of UBE2Q1 mRNA	PMID:23186747
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of UBE2Q1 mRNA	PMID:33212167
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of UBE2Q1 mRNA	PMID:29803840
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2Q1 mRNA	PMID:39836092
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of UBE2Q1 mRNA	PMID:29453283
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552177	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBE2Q1 mRNA	PMID:22228805
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552177	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of UBE2Q1 promoter alternative form	PMID:35295148
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2Q1 mRNA	PMID:22576693
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305305	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2Q1 mRNA	PMID:34947998
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552177	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of UBE2Q1 mRNA	PMID:26063408
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of UBE2Q1 gene	PMID:22576693
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552177	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of UBE2Q1 mRNA	PMID:37019170
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of UBE2Q1 gene	PMID:22964155
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552177	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of UBE2Q1 mRNA	PMID:34813904
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBE2Q1 mRNA	PMID:37042841
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1552177	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBE2Q1 mRNA	PMID:20061341
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of UBE2Q1 mRNA	PMID:25812627
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of UBE2Q1 mRNA	PMID:25812627
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of UBE2Q1 mRNA	PMID:25812627
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of UBE2Q1 mRNA	PMID:23179753
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of UBE2Q1 mRNA	PMID:28542535
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552177	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UBE2Q1 mRNA	PMID:17562736
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305305	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of UBE2Q1 mRNA	PMID:33387578
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2Q1 mRNA	PMID:39836092
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552177	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of UBE2Q1 mRNA	PMID:17555576
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552177	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of UBE2Q1 mRNA	PMID:35964746
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UBE2Q1 protein	PMID:32959892
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1552177	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of UBE2Q1 mRNA	PMID:22206623
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552177	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBE2Q1 mRNA	PMID:22206623
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305305	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of UBE2Q1 mRNA	PMID:22124623
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1552177	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in increased expression of UBE2Q1 mRNA	PMID:22538082
1313256	UBE2Q1	ubiquitin conjugating enzyme E2 Q1	gene	CHEBI:9944	venlafaxine hydrochloride	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069470	Venlafaxine Hydrochloride results in decreased expression of UBE2Q1 mRNA	PMID:16341940
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313259	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EPB42 mRNA	PMID:33045310
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:D010100	Oxygen deficiency results in increased expression of EPB42 mRNA	PMID:22629407
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of EPB42 mRNA]	PMID:22629407
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of EPB42 mRNA	PMID:30510588
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305306	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of EPB42 mRNA	PMID:32145629
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313259	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EPB42 mRNA	PMID:39298647
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPB42 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA	PMID:37567420|PMID:37992649
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPB42 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA	PMID:37567420|PMID:37992649
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305306	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EPB42 mRNA	PMID:33387578
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1313259	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in increased expression of EPB42 mRNA	PMID:29279043
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1305306	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of EPB42 protein	PMID:33236894
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EPB42 gene	PMID:27153756
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313259	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of EPB42 mRNA	PMID:40618947
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:D019833	Genistein results in decreased expression of EPB42 mRNA	PMID:21048042
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305306	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPB42 mRNA	PMID:33387578
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313259	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPB42 mRNA	PMID:28213091
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305306	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of EPB42 mRNA	PMID:28959563
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPB42 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA	PMID:37567420|PMID:37992649
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313259	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EPB42 exon; Benzo(a)pyrene results in decreased methylation of EPB42 intron	PMID:27901495
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EPB42 promoter	PMID:27901495
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305306	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of EPB42 mRNA	PMID:25729387
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305306	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of EPB42 mRNA; [Topotecan co-treated with oxaliplatin] results in decreased expression of EPB42 mRNA	PMID:25729387
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305306	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EPB42 mRNA	PMID:34492290
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of EPB42 mRNA	PMID:18648102
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305306	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EPB42 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305306	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of EPB42 mRNA	PMID:32145629|PMID:34947998
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305306	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EPB42 mRNA	PMID:36041667
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20200915	CTD	MESH:C014024	[NR1I2 protein affects the susceptibility to 2,4,5,2',4',5'-hexachlorobiphenyl] which affects the expression of EPB42 mRNA	PMID:32352317
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305306	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EPB42 mRNA	PMID:36041667
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305306	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EPB42 mRNA	PMID:36041667
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313259	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of EPB42 mRNA	PMID:37019170
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of EPB42 mRNA	PMID:21266533
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:D014635	Valproic Acid affects the expression of EPB42 mRNA	PMID:17292431
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305306	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of EPB42 mRNA	PMID:41580965
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPB42 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA	PMID:37567420|PMID:37992649
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305306	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EPB42 mRNA	PMID:33387578
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305306	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of EPB42 mRNA	PMID:25729387
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305306	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of EPB42 mRNA; [Topotecan co-treated with oxaliplatin] results in decreased expression of EPB42 mRNA	PMID:25729387
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1313259	E	RGD:6480464	20151110	CTD	MESH:C017096	n-butoxyethanol results in increased expression of EPB42 mRNA	PMID:19812364
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases degradation	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased degradation of EPB42 protein	PMID:15040847
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313259	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA	PMID:37567420
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1305306	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of EPB42 mRNA	PMID:33484710
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EPB42 gene]	PMID:28238834
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305306	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EPB42 mRNA	PMID:24780913
1313258	EPB42	erythrocyte membrane protein band 4.2	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of EPB42 mRNA	PMID:34581912
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313261	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CHML mRNA	PMID:37995155
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of CHML mRNA	PMID:31016361
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313261	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CHML mRNA	PMID:20188158
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of CHML mRNA	PMID:21934132|PMID:23724009|PMID:33167477
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CHML mRNA	PMID:21632981
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of CHML mRNA	PMID:31614463
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of CHML mRNA	PMID:30165855
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CHML mRNA	PMID:38568856
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CHML mRNA	PMID:37042841
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CHML mRNA	PMID:23649840
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CHML mRNA	PMID:28818685
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CHML mRNA	PMID:19549813
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CHML mRNA	PMID:23649840
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CHML mRNA	PMID:27153756
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313261	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CHML mRNA	PMID:19770486
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CHML mRNA	PMID:23649840
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CHML mRNA	PMID:41430723
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of CHML mRNA	PMID:18414638
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1596201	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CHML mRNA	PMID:31881176
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CHML mRNA	PMID:23557933
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313261	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHML mRNA	PMID:19933214
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CHML mRNA	PMID:33212167
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of CHML mRNA	PMID:23649840
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CHML mRNA	PMID:32763439
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CHML mRNA	PMID:38568856
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313261	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CHML mRNA	PMID:37682722
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1313261	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased methylation of CHML gene	PMID:32068019
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CHML promoter	PMID:27901495
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CHML mRNA	PMID:25895662
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CHML mRNA	PMID:19150397
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CHML mRNA	PMID:20458559
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CHML gene	PMID:31601247
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313261	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CHML promoter	PMID:35295148
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1596201	E	RGD:6480464	20160209	CTD	MESH:D013853	Thioacetamide results in increased expression of CHML mRNA	PMID:23411599
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1313261	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of CHML mRNA	PMID:19191707
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CHML mRNA; bisphenol A results in decreased expression of CHML protein	PMID:29275510|PMID:33376534
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1596201	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CHML mRNA	PMID:34947998
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CHML gene	PMID:31601247
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313261	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of CHML promoter	PMID:27312807
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1596201	E	RGD:6480464	20160209	CTD	MESH:C006780	bisphenol A results in increased expression of CHML mRNA	PMID:25181051
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1596201	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CHML gene	PMID:28505145
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CHML gene	PMID:31601247
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313261	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CHML mRNA	PMID:37019170
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CHML mRNA	PMID:37042841
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CHML mRNA	PMID:38568856
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CHML mRNA	PMID:38382870
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CHML mRNA	PMID:19320972
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CHML mRNA	PMID:24449571
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of CHML mRNA	PMID:40434365
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CHML mRNA	PMID:25979313
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CHML gene	PMID:29154799
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of CHML mRNA	PMID:28001369|PMID:29154799
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CHML mRNA	PMID:20106945|PMID:27989131
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CHML mRNA	PMID:25562108
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313261	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CHML mRNA	PMID:28973697
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of CHML mRNA	PMID:23649840
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CHML mRNA	PMID:27188386
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of CHML mRNA	PMID:18414638
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of CHML mRNA	PMID:18175754
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of CHML mRNA	PMID:23228038
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CHML mRNA	PMID:20458559
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1596201	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of CHML mRNA	PMID:28801915
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1313261	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of CHML mRNA	PMID:27462272
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313261	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CHML mRNA	PMID:22206623
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1596201	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of CHML mRNA	PMID:33484710
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CHML gene]	PMID:28238834
1313260	CHML	CHM like Rab escort protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1596201	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CHML mRNA	PMID:25825206
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313265	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NETO2 mRNA	PMID:33045310
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of NETO2 mRNA	PMID:23724009|PMID:33167477
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NETO2 mRNA	PMID:24236059
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NETO2 mRNA	PMID:22378314
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of NETO2 mRNA	PMID:21632981
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313265	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NETO2 mRNA	PMID:39241906
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of NETO2 mRNA	PMID:31614463
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313265	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of NETO2 mRNA	PMID:37992649
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313265	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of NETO2 mRNA	PMID:37992649
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305310	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NETO2 mRNA	PMID:33387578
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NETO2 mRNA	PMID:39836092
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305310	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NETO2 mRNA	PMID:22129741
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NETO2 gene	PMID:27153756
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NETO2 mRNA	PMID:27153756
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NETO2 mRNA	PMID:21527772
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of NETO2 mRNA	PMID:21527772
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NETO2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NETO2 mRNA	PMID:39836092
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in increased expression of NETO2 mRNA	PMID:21527772
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313265	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of NETO2 mRNA	PMID:28189721|PMID:28960355
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of NETO2 mRNA	PMID:15009677
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of NETO2 mRNA	PMID:25583101
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305310	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NETO2 mRNA	PMID:33387578
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313265	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NETO2 mRNA	PMID:19933214
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313265	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NETO2 mRNA	PMID:19465110
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NETO2 mRNA	PMID:30851411
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313265	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of NETO2 mRNA	PMID:27862939
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NETO2 mRNA	PMID:29803840
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313265	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of NETO2 mRNA	PMID:37992649
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NETO2 mRNA	PMID:38568856
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313265	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of NETO2 mRNA	PMID:36209798
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NETO2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NETO2 mRNA	PMID:39836092
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NETO2 mRNA	PMID:22378314
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NETO2 promoter	PMID:27901495
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NETO2 mRNA	PMID:26238291
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1313265	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of NETO2 mRNA	PMID:27131904
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1305310	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of NETO2 mRNA	PMID:38458666
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NETO2 mRNA	PMID:19150397|PMID:20382639
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NETO2 mRNA	PMID:26238291
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of NETO2 mRNA	PMID:25258189
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305310	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of NETO2 mRNA	PMID:25729387
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313265	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NETO2 promoter	PMID:35295148
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305310	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of NETO2 mRNA	PMID:34492290
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313265	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of NETO2 mRNA	PMID:20813756
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305310	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NETO2 mRNA	PMID:25181051
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313265	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of NETO2 mRNA	PMID:32156529
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of NETO2 mRNA	PMID:25047013|PMID:31715268
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305310	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of NETO2 mRNA	PMID:29097150
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NETO2 mRNA	PMID:28628672
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of NETO2 mRNA	PMID:25979313
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313265	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of NETO2 mRNA	PMID:28392331
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NETO2 mRNA	PMID:28628672
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of NETO2 mRNA	PMID:21527772
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305310	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NETO2 mRNA	PMID:22129741
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305310	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of NETO2 mRNA	PMID:32680482
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1305310	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of NETO2 mRNA	PMID:38458666
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NETO2 mRNA	PMID:39836092
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NETO2 mRNA	PMID:38568856
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305310	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NETO2 mRNA	PMID:25993096
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305310	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of NETO2 promoter	PMID:22457795
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NETO2 mRNA	PMID:19320972
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of NETO2 mRNA	PMID:24449571
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313265	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of NETO2 mRNA	PMID:28962523
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313265	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of NETO2 mRNA	PMID:40194260
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NETO2 mRNA	PMID:31533062
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of NETO2 mRNA	PMID:19167446
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NETO2 mRNA	PMID:40419075
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NETO2 mRNA	PMID:25979313
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of NETO2 mRNA	PMID:23179753|PMID:23527032|PMID:27188386|PMID:28001369
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NETO2 gene	PMID:29154799
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of NETO2 mRNA	PMID:21527772
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NETO2 mRNA	PMID:25562108
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NETO2 mRNA	PMID:28628672
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313265	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of NETO2 mRNA	PMID:37992649
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NETO2 mRNA	PMID:22230336
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305310	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NETO2 mRNA	PMID:33387578
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	NETO2 protein affects the susceptibility to Fluorouracil	PMID:16217747
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NETO2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NETO2 mRNA	PMID:39836092
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NETO2 mRNA	PMID:28628672
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of NETO2 mRNA	PMID:25258189
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of NETO2 mRNA	PMID:20977926
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of NETO2 mRNA	PMID:26272509|PMID:27188386
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NETO2 mRNA	PMID:27188386
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of NETO2 mRNA	PMID:39836092
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305310	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of NETO2 mRNA	PMID:25729387
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:6887	methylphenidate	increases expression	ISO	RGD:1313265	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in increased expression of NETO2 mRNA	PMID:22470460
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of NETO2 mRNA	PMID:31758290
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313265	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NETO2 mRNA	PMID:22206623
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of NETO2 mRNA	PMID:22714537
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of NETO2 mRNA	PMID:29522793
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NETO2 mRNA	PMID:37199045
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:7719	ochratoxin A	increases acetylation	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in increased acetylation of NETO2 promoter	PMID:29098329
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NETO2 mRNA	PMID:30851411
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NETO2 mRNA	PMID:27188386
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NETO2 gene]	PMID:28238834
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305310	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of NETO2 mRNA	PMID:36843608
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NETO2 mRNA	PMID:27188386
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1313265	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of NETO2 mRNA	PMID:27131904
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of NETO2 mRNA	PMID:22378314
1313264	NETO2	neuropilin and tolloid like 2	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313265	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of NETO2 mRNA	PMID:32835833
1313267	NRSN2	neurensin 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614172	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NRSN2 mRNA	PMID:33045310
1313267	NRSN2	neurensin 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NRSN2 mRNA	PMID:33167477
1313267	NRSN2	neurensin 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1614172	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of NRSN2 mRNA	PMID:36189433
1313267	NRSN2	neurensin 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1614172	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NRSN2 mRNA	PMID:36189433
1313267	NRSN2	neurensin 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of NRSN2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of NRSN2 mRNA	PMID:32699268
1313267	NRSN2	neurensin 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1614172	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NRSN2 mRNA	PMID:36189433
1313267	NRSN2	neurensin 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1586322	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of NRSN2 mRNA	PMID:26577399
1313267	NRSN2	neurensin 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1586322	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of NRSN2 mRNA	PMID:22061828
1313267	NRSN2	neurensin 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of NRSN2 mRNA	PMID:28818685
1313267	NRSN2	neurensin 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NRSN2 mRNA	PMID:35301059
1313267	NRSN2	neurensin 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of NRSN2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of NRSN2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of NRSN2 mRNA	PMID:32699268
1313267	NRSN2	neurensin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NRSN2 mRNA	PMID:39836092|PMID:40512198
1313267	NRSN2	neurensin 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of NRSN2 mRNA	PMID:23557933
1313267	NRSN2	neurensin 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of NRSN2 mRNA	PMID:32763439
1313267	NRSN2	neurensin 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NRSN2 mRNA	PMID:29803840
1313267	NRSN2	neurensin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NRSN2 mRNA	PMID:39836092|PMID:40512198
1313267	NRSN2	neurensin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NRSN2 promoter	PMID:27901495
1313267	NRSN2	neurensin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1586322	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NRSN2 mRNA	PMID:25181051|PMID:30816183|PMID:34947998|PMID:41034487
1313267	NRSN2	neurensin 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NRSN2 mRNA	PMID:28628672
1313267	NRSN2	neurensin 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NRSN2 mRNA	PMID:28628672
1313267	NRSN2	neurensin 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NRSN2 mRNA	PMID:35301059
1313267	NRSN2	neurensin 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of NRSN2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of NRSN2 mRNA	PMID:32699268
1313267	NRSN2	neurensin 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1614172	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NRSN2 mRNA	PMID:40194260
1313267	NRSN2	neurensin 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NRSN2 mRNA	PMID:31533062
1313267	NRSN2	neurensin 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1586322	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of NRSN2 mRNA	PMID:41580965
1313267	NRSN2	neurensin 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1586322	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in increased expression of NRSN2 mRNA	PMID:38685447
1313267	NRSN2	neurensin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NRSN2 mRNA	PMID:25562108
1313267	NRSN2	neurensin 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NRSN2 mRNA	PMID:28628672
1313267	NRSN2	neurensin 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NRSN2 mRNA	PMID:38832940
1313267	NRSN2	neurensin 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1586322	E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in decreased expression of NRSN2 mRNA	PMID:30723492
1313267	NRSN2	neurensin 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NRSN2 mRNA	PMID:39836092|PMID:40512198
1313267	NRSN2	neurensin 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NRSN2 mRNA	PMID:28628672
1313267	NRSN2	neurensin 2	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of NRSN2 mRNA	PMID:22714537
1313267	NRSN2	neurensin 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1614172	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of NRSN2 mRNA	PMID:38701926
1313267	NRSN2	neurensin 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of NRSN2 mRNA	PMID:31758290
1313267	NRSN2	neurensin 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1586322	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of NRSN2 mRNA	PMID:32109520
1313267	NRSN2	neurensin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1586322	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of NRSN2 mRNA	PMID:24780913|PMID:25825206
1313267	NRSN2	neurensin 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NRSN2 mRNA	PMID:38568856
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313269	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CNOT7 mRNA	PMID:20188158
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313269	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CNOT7 gene	PMID:20938992
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D004958	Estradiol results in decreased expression of CNOT7 mRNA	PMID:21453500
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of CNOT7 mRNA	PMID:21453500
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313269	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CNOT7 gene	PMID:20938992
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CNOT7 mRNA	PMID:23649840
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of CNOT7 mRNA	PMID:21453500
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CNOT7 mRNA	PMID:21179406
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305313	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CNOT7 mRNA	PMID:22061828
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305313	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNOT7 mRNA	PMID:39012411
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CNOT7 mRNA	PMID:23649840
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313269	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CNOT7 mRNA	PMID:19770486
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CNOT7 mRNA	PMID:23649840
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of CNOT7 mRNA	PMID:19774075
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313269	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CNOT7 gene	PMID:20938992
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CNOT7 mRNA	PMID:39836092
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1305313	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CNOT7 mRNA	PMID:26302742
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1305313	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of CNOT7 mRNA	PMID:25905778
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of CNOT7 mRNA	PMID:24768652
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313269	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CNOT7 mRNA	PMID:21570461|PMID:24680724
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305313	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CNOT7 mRNA	PMID:33387578
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of CNOT7 mRNA	PMID:18191903
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CNOT7 mRNA	PMID:28001369
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CNOT7 mRNA	PMID:33212167
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of CNOT7 mRNA	PMID:25523186
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CNOT7 mRNA	PMID:39836092
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of CNOT7 mRNA	PMID:25523186
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CNOT7 mRNA	PMID:19150397
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:30778	gallic acid	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of CNOT7 mRNA	PMID:34408198
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CNOT7 gene	PMID:31601247
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313269	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CNOT7 gene; titanium dioxide results in decreased methylation of CNOT7 promoter alternative form	PMID:35295148
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305313	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CNOT7 mRNA	PMID:25181051
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305313	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CNOT7 mRNA	PMID:30816183|PMID:34947998|PMID:41034487
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313269	E	RGD:6480464	20150127	CTD	MESH:C006780	bisphenol A results in increased expression of CNOT7 mRNA	PMID:25270620
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CNOT7 gene	PMID:31601247
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313269	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CNOT7 mRNA	PMID:39298647
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313269	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CNOT7 mRNA	PMID:38685157
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:1313269	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of CNOT7 mRNA	PMID:25270620
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313269	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of CNOT7 mRNA	PMID:34813904
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CNOT7 mRNA	PMID:37042841
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305313	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNOT7 mRNA	PMID:39012411
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305313	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of CNOT7 gene	PMID:22079235
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CNOT7 mRNA	PMID:28302478
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CNOT7 mRNA	PMID:31533062
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CNOT7 mRNA	PMID:25979313
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of CNOT7 mRNA	PMID:23179753
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313269	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of CNOT7 mRNA	PMID:18502557
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CNOT7 mRNA	PMID:27188386
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CNOT7 mRNA	PMID:24935251
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CNOT7 mRNA	PMID:21420995
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313269	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CNOT7 mRNA	PMID:29279043
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CNOT7 mRNA	PMID:39836092
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CNOT7 protein	PMID:32959892
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CNOT7 mRNA	PMID:26378955
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313269	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of CNOT7 mRNA	PMID:25270620
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313269	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of CNOT7 protein	PMID:36851058
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313269	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CNOT7 mRNA	PMID:22206623
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CNOT7 gene]	PMID:28238834
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1305313	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of CNOT7 mRNA	PMID:20345932
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1313269	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in increased expression of CNOT7 protein	PMID:26903627
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of CNOT7 mRNA	PMID:27188386
1313268	CNOT7	CCR4-NOT transcription complex subunit 7	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305313	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CNOT7 mRNA	PMID:23034163
1313271	RNF115	ring finger protein 115	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313272	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RNF115 mRNA	PMID:33045310
1313271	RNF115	ring finger protein 115	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin affects the expression of RNF115 mRNA	PMID:15498508
1313271	RNF115	ring finger protein 115	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of RNF115 mRNA	PMID:22378314
1313271	RNF115	ring finger protein 115	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of RNF115 mRNA	PMID:22574217
1313271	RNF115	ring finger protein 115	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RNF115 mRNA	PMID:37042841
1313271	RNF115	ring finger protein 115	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of RNF115 mRNA	PMID:33359661
1313271	RNF115	ring finger protein 115	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313272	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RNF115 mRNA	PMID:23892564
1313271	RNF115	ring finger protein 115	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305315	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RNF115 mRNA	PMID:33387578
1313271	RNF115	ring finger protein 115	gene	CHEBI:18112	2-aminophenol	affects response to substance	EXP		E	RGD:6480464	20150609	CTD	MESH:C027667	RNF115 gene SNP affects the susceptibility to 2-aminophenol	PMID:25622337
1313271	RNF115	ring finger protein 115	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313272	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RNF115 mRNA	PMID:37325564
1313271	RNF115	ring finger protein 115	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RNF115 mRNA	PMID:19549813
1313271	RNF115	ring finger protein 115	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1313272	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of RNF115 mRNA	PMID:19376150
1313271	RNF115	ring finger protein 115	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RNF115 mRNA	PMID:27153756
1313271	RNF115	ring finger protein 115	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RNF115 mRNA	PMID:23649840
1313271	RNF115	ring finger protein 115	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305315	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of RNF115 mRNA	PMID:31129395
1313271	RNF115	ring finger protein 115	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313272	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNF115 mRNA	PMID:22206623
1313271	RNF115	ring finger protein 115	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305315	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RNF115 mRNA	PMID:31881176
1313271	RNF115	ring finger protein 115	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313272	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF115 mRNA	PMID:21570461
1313271	RNF115	ring finger protein 115	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNF115 mRNA	PMID:33212167
1313271	RNF115	ring finger protein 115	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313272	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of RNF115 mRNA	PMID:27862939
1313271	RNF115	ring finger protein 115	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNF115 mRNA	PMID:29803840
1313271	RNF115	ring finger protein 115	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RNF115 mRNA	PMID:29432896
1313271	RNF115	ring finger protein 115	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNF115 mRNA	PMID:38568856|PMID:39719251
1313271	RNF115	ring finger protein 115	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RNF115 mRNA	PMID:19150397
1313271	RNF115	ring finger protein 115	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313272	E	RGD:6480464	20150127	CTD	MESH:C008261	lead acetate results in increased expression of RNF115 mRNA	PMID:25270620
1313271	RNF115	ring finger protein 115	gene	CHEBI:32181	tamibarotene	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of RNF115 mRNA	PMID:15498508
1313271	RNF115	ring finger protein 115	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of RNF115 mRNA	PMID:30690063
1313271	RNF115	ring finger protein 115	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305315	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RNF115 mRNA	PMID:25181051
1313271	RNF115	ring finger protein 115	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305315	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of RNF115 mRNA	PMID:31129395
1313271	RNF115	ring finger protein 115	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF115 mRNA	PMID:28628672
1313271	RNF115	ring finger protein 115	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313272	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RNF115 mRNA	PMID:37019170
1313271	RNF115	ring finger protein 115	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF115 mRNA	PMID:28628672
1313271	RNF115	ring finger protein 115	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313272	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RNF115 mRNA	PMID:37325564
1313271	RNF115	ring finger protein 115	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of RNF115 mRNA	PMID:19376846
1313271	RNF115	ring finger protein 115	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RNF115 mRNA	PMID:31533062
1313271	RNF115	ring finger protein 115	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RNF115 mRNA	PMID:25979313
1313271	RNF115	ring finger protein 115	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RNF115 mRNA	PMID:23179753
1313271	RNF115	ring finger protein 115	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RNF115 mRNA	PMID:25562108
1313271	RNF115	ring finger protein 115	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF115 mRNA	PMID:28628672
1313271	RNF115	ring finger protein 115	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RNF115 mRNA	PMID:36621641
1313271	RNF115	ring finger protein 115	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of RNF115 mRNA	PMID:36621641
1313271	RNF115	ring finger protein 115	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RNF115 mRNA	PMID:22079256
1313271	RNF115	ring finger protein 115	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RNF115 mRNA	PMID:28628672
1313271	RNF115	ring finger protein 115	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305315	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RNF115 mRNA	PMID:24136188
1313271	RNF115	ring finger protein 115	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313272	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RNF115 mRNA	PMID:23650126
1313271	RNF115	ring finger protein 115	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RNF115 mRNA	PMID:31758290
1313271	RNF115	ring finger protein 115	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313272	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNF115 mRNA	PMID:22206623
1313271	RNF115	ring finger protein 115	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305315	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of RNF115 mRNA	PMID:24136188
1313271	RNF115	ring finger protein 115	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RNF115 mRNA	PMID:22079256|PMID:22714537
1313271	RNF115	ring finger protein 115	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RNF115 mRNA	PMID:22079256
1313271	RNF115	ring finger protein 115	gene	CHEBI:755208	eprenetapopt	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of RNF115 mRNA	PMID:19946333
1313271	RNF115	ring finger protein 115	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1305315	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of RNF115 mRNA	PMID:20345932
1313271	RNF115	ring finger protein 115	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313272	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of RNF115 mRNA	PMID:31388691
1313271	RNF115	ring finger protein 115	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313272	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of RNF115 mRNA	PMID:21278054
1313273	BTD	biotinidase	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of BTD mRNA	PMID:38218311
1313273	BTD	biotinidase	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313274	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of BTD mRNA	PMID:37995155
1313273	BTD	biotinidase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305316	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BTD mRNA]	PMID:31150632
1313273	BTD	biotinidase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313274	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of BTD mRNA	PMID:20188158
1313273	BTD	biotinidase	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of BTD mRNA	PMID:26079696
1313273	BTD	biotinidase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of BTD mRNA	PMID:39241906
1313273	BTD	biotinidase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313274	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of BTD mRNA	PMID:39298647
1313273	BTD	biotinidase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BTD mRNA	PMID:37042841
1313273	BTD	biotinidase	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of BTD mRNA	PMID:19693291
1313273	BTD	biotinidase	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in decreased expression of BTD mRNA	PMID:19693291
1313273	BTD	biotinidase	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305316	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of BTD mRNA	PMID:33387578
1313273	BTD	biotinidase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313274	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BTD mRNA	PMID:36331819
1313273	BTD	biotinidase	gene	CHEBI:188851	Muraglitazar	increases expression	ISO	RGD:1305316	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of BTD mRNA	PMID:21515302
1313273	BTD	biotinidase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of BTD mRNA	PMID:19549813
1313273	BTD	biotinidase	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of BTD protein	PMID:20106945
1313273	BTD	biotinidase	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of BTD mRNA	PMID:19770486
1313273	BTD	biotinidase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of BTD mRNA	PMID:35430440
1313273	BTD	biotinidase	gene	CHEBI:27385	tetrachloromethane	decreases activity	ISO	RGD:1305316	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased activity of BTD protein	PMID:12867299
1313273	BTD	biotinidase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305316	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of BTD mRNA	PMID:31150632
1313273	BTD	biotinidase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305316	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of BTD mRNA]	PMID:31150632
1313273	BTD	biotinidase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313274	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BTD mRNA	PMID:22206623
1313273	BTD	biotinidase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BTD mRNA	PMID:39836092
1313273	BTD	biotinidase	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313274	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of BTD mRNA	PMID:28189721|PMID:28960355
1313273	BTD	biotinidase	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of BTD mRNA	PMID:27392435
1313273	BTD	biotinidase	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of BTD mRNA	PMID:27392435
1313273	BTD	biotinidase	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of BTD mRNA	PMID:24768652|PMID:25583101
1313273	BTD	biotinidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313274	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BTD mRNA	PMID:21570461
1313273	BTD	biotinidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305316	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BTD mRNA	PMID:34747641
1313273	BTD	biotinidase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of BTD mRNA	PMID:32763439
1313273	BTD	biotinidase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of BTD mRNA	PMID:29803840
1313273	BTD	biotinidase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of BTD mRNA	PMID:38568856
1313273	BTD	biotinidase	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1313274	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased methylation of BTD gene	PMID:24118411
1313273	BTD	biotinidase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BTD mRNA	PMID:39836092
1313273	BTD	biotinidase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of BTD mRNA	PMID:32234424
1313273	BTD	biotinidase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BTD 3' UTR	PMID:27901495
1313273	BTD	biotinidase	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305316	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of BTD mRNA	PMID:30047161
1313273	BTD	biotinidase	gene	CHEBI:32195	Tesaglitazar	increases expression	ISO	RGD:1305316	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of BTD mRNA	PMID:21515302
1313273	BTD	biotinidase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313274	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BTD promoter alternative form	PMID:35295148
1313273	BTD	biotinidase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305316	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of BTD mRNA	PMID:23411599|PMID:34492290
1313273	BTD	biotinidase	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313274	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of BTD mRNA	PMID:28472532
1313273	BTD	biotinidase	gene	CHEBI:33007	chromium(6+)	affects localization	EXP		E	RGD:6480464	20150310	CTD	MESH:C074702	chromium hexavalent ion affects the localization of BTD protein	PMID:24858232
1313273	BTD	biotinidase	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of BTD mRNA; chromium hexavalent ion results in decreased expression of BTD protein	PMID:21641978
1313273	BTD	biotinidase	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:C074702	trichostatin A inhibits the reaction [chromium hexavalent ion results in decreased expression of BTD protein]	PMID:21641978
1313273	BTD	biotinidase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305316	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of BTD mRNA	PMID:25181051
1313273	BTD	biotinidase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305316	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of BTD mRNA	PMID:30816183|PMID:32528016
1313273	BTD	biotinidase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BTD mRNA	PMID:28628672
1313273	BTD	biotinidase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305316	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:36041667
1313273	BTD	biotinidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313274	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of BTD mRNA	PMID:39298647
1313273	BTD	biotinidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:28628672
1313273	BTD	biotinidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305316	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:36041667
1313273	BTD	biotinidase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305316	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:36041667
1313273	BTD	biotinidase	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313274	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of BTD intron	PMID:28392331
1313273	BTD	biotinidase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of BTD mRNA	PMID:37019170
1313273	BTD	biotinidase	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313274	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of BTD mRNA	PMID:34813904
1313273	BTD	biotinidase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BTD mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:28628672
1313273	BTD	biotinidase	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305316	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of BTD mRNA	PMID:22110744
1313273	BTD	biotinidase	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313274	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of BTD protein	PMID:39748354
1313273	BTD	biotinidase	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305316	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of BTD gene	PMID:22079235
1313273	BTD	biotinidase	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305316	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of BTD mRNA	PMID:24386269
1313273	BTD	biotinidase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of BTD mRNA	PMID:17585979
1313273	BTD	biotinidase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of BTD mRNA	PMID:40419075
1313273	BTD	biotinidase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313274	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BTD mRNA	PMID:36331819
1313273	BTD	biotinidase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BTD mRNA	PMID:25979313
1313273	BTD	biotinidase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of BTD mRNA	PMID:23179753
1313273	BTD	biotinidase	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305316	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of BTD mRNA	PMID:30047161
1313273	BTD	biotinidase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of BTD mRNA	PMID:20106945|PMID:25562108
1313273	BTD	biotinidase	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of BTD promoter	PMID:27989131
1313273	BTD	biotinidase	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BTD mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:28628672
1313273	BTD	biotinidase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of BTD mRNA	PMID:28973697
1313273	BTD	biotinidase	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C012589	trichostatin A results in increased expression of BTD protein	PMID:21641978
1313273	BTD	biotinidase	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:C012589	trichostatin A inhibits the reaction [chromium hexavalent ion results in decreased expression of BTD protein]	PMID:21641978
1313273	BTD	biotinidase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of BTD mRNA	PMID:29067470
1313273	BTD	biotinidase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305316	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of BTD mRNA	PMID:33387578
1313273	BTD	biotinidase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BTD mRNA	PMID:39836092
1313273	BTD	biotinidase	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BTD mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of BTD mRNA	PMID:28628672
1313273	BTD	biotinidase	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305316	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of BTD mRNA	PMID:30047161
1313273	BTD	biotinidase	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305316	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of BTD mRNA	PMID:19162173
1313273	BTD	biotinidase	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305316	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of BTD mRNA	PMID:24793618
1313273	BTD	biotinidase	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of BTD mRNA	PMID:20436886
1313273	BTD	biotinidase	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of BTD mRNA	PMID:15336504
1313273	BTD	biotinidase	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305316	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of BTD mRNA	PMID:28801915
1313273	BTD	biotinidase	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of BTD mRNA	PMID:27918106
1313273	BTD	biotinidase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313274	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of BTD mRNA	PMID:22206623
1313273	BTD	biotinidase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313274	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BTD mRNA	PMID:22206623
1313273	BTD	biotinidase	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305316	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of BTD mRNA	PMID:30047161
1313273	BTD	biotinidase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases methylation	ISO	RGD:1305316	E	RGD:6480464	20260407	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased methylation of BTD gene	PMID:40889571
1313273	BTD	biotinidase	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305316	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of BTD mRNA	PMID:23914054
1313273	BTD	biotinidase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305316	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of BTD mRNA	PMID:30047161
1313273	BTD	biotinidase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305316	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of BTD mRNA	PMID:21346803
1313273	BTD	biotinidase	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of BTD mRNA	PMID:17440010
1313273	BTD	biotinidase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of BTD mRNA	PMID:38568856
1313273	BTD	biotinidase	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1305316	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of BTD mRNA	PMID:30047161
1313275	CNTRL	centriolin	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of CNTRL mRNA	PMID:35967413
1313275	CNTRL	centriolin	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CNTRL mRNA	PMID:27188386
1313275	CNTRL	centriolin	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CNTRL mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CNTRL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CNTRL mRNA	PMID:32699268|PMID:32845096
1313275	CNTRL	centriolin	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C018475	butyraldehyde results in decreased expression of CNTRL mRNA	PMID:26079696
1313275	CNTRL	centriolin	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305317	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CNTRL gene	PMID:28931070
1313275	CNTRL	centriolin	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D011794	Quercetin results in decreased expression of CNTRL mRNA	PMID:21632981
1313275	CNTRL	centriolin	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CNTRL mRNA	PMID:39241906
1313275	CNTRL	centriolin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CNTRL mRNA	PMID:39298647
1313275	CNTRL	centriolin	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNTRL mRNA	PMID:25510870
1313275	CNTRL	centriolin	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CNTRL mRNA	PMID:38568856
1313275	CNTRL	centriolin	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305317	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CNTRL mRNA	PMID:33387578
1313275	CNTRL	centriolin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CNTRL mRNA	PMID:37042841
1313275	CNTRL	centriolin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of CNTRL mRNA	PMID:22401849
1313275	CNTRL	centriolin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1557555	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CNTRL mRNA	PMID:34319233
1313275	CNTRL	centriolin	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305317	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CNTRL mRNA	PMID:26577399
1313275	CNTRL	centriolin	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CNTRL mRNA	PMID:36331819
1313275	CNTRL	centriolin	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CNTRL mRNA	PMID:35301059
1313275	CNTRL	centriolin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNTRL mRNA	PMID:37236586
1313275	CNTRL	centriolin	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNTRL mRNA	PMID:25510870
1313275	CNTRL	centriolin	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNTRL mRNA	PMID:25510870
1313275	CNTRL	centriolin	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CNTRL mRNA	PMID:23649840
1313275	CNTRL	centriolin	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CNTRL mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CNTRL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CNTRL mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of CNTRL mRNA	PMID:32699268|PMID:32845096
1313275	CNTRL	centriolin	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CNTRL mRNA	PMID:26272509
1313275	CNTRL	centriolin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTRL mRNA	PMID:27188386
1313275	CNTRL	centriolin	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CNTRL mRNA	PMID:23557933
1313275	CNTRL	centriolin	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CNTRL mRNA	PMID:28903495
1313275	CNTRL	centriolin	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of CNTRL mRNA	PMID:27392435
1313275	CNTRL	centriolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305317	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CNTRL mRNA	PMID:34747641
1313275	CNTRL	centriolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305317	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CNTRL mRNA	PMID:33387578
1313275	CNTRL	centriolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CNTRL mRNA	PMID:19933214
1313275	CNTRL	centriolin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CNTRL mRNA	PMID:25975270
1313275	CNTRL	centriolin	gene	CHEBI:28680	cytarabine	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D003561	Cytarabine results in increased expression of CNTRL mRNA	PMID:21198554
1313275	CNTRL	centriolin	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:D004317	Doxorubicin results in increased expression of CNTRL mRNA	PMID:25896364
1313275	CNTRL	centriolin	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CNTRL mRNA	PMID:27131904
1313275	CNTRL	centriolin	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305317	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CNTRL mRNA	PMID:30047161
1313275	CNTRL	centriolin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1557555	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of CNTRL mRNA	PMID:29264374
1313275	CNTRL	centriolin	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305317	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CNTRL mRNA	PMID:34492290
1313275	CNTRL	centriolin	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:C006253	pirinixic acid results in decreased expression of CNTRL mRNA	PMID:23811191
1313275	CNTRL	centriolin	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:C006253	pirinixic acid results in increased expression of CNTRL mRNA	PMID:18301758
1313275	CNTRL	centriolin	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305317	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of CNTRL mRNA	PMID:30816183
1313275	CNTRL	centriolin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CNTRL protein	PMID:33376534
1313275	CNTRL	centriolin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305317	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased expression of CNTRL mRNA	PMID:29097150
1313275	CNTRL	centriolin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CNTRL mRNA	PMID:32156529|PMID:33221593
1313275	CNTRL	centriolin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305317	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased expression of CNTRL mRNA	PMID:32145629|PMID:32528016
1313275	CNTRL	centriolin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1557555	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of CNTRL mRNA	PMID:26063408
1313275	CNTRL	centriolin	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNTRL mRNA	PMID:25510870
1313275	CNTRL	centriolin	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CNTRL mRNA	PMID:25510870
1313275	CNTRL	centriolin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of CNTRL mRNA	PMID:40203079
1313275	CNTRL	centriolin	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of CNTRL mRNA	PMID:26377693
1313275	CNTRL	centriolin	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1557555	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of CNTRL mRNA	PMID:28392331
1313275	CNTRL	centriolin	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CNTRL mRNA	PMID:37019170
1313275	CNTRL	centriolin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CNTRL mRNA	PMID:17361019
1313275	CNTRL	centriolin	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CNTRL mRNA	PMID:37042841
1313275	CNTRL	centriolin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CNTRL mRNA	PMID:35301059
1313275	CNTRL	centriolin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CNTRL mRNA	PMID:37236586
1313275	CNTRL	centriolin	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305317	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CNTRL mRNA	PMID:24386269
1313275	CNTRL	centriolin	gene	CHEBI:35861	dibenzo[a,l]pyrene	increases expression	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:C041517	dibenzo(a,l)pyrene results in increased expression of CNTRL mRNA	PMID:25908611
1313275	CNTRL	centriolin	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:D002922	Ciguatoxins affects the expression of CNTRL mRNA	PMID:18353800
1313275	CNTRL	centriolin	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CNTRL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CNTRL mRNA	PMID:32699268
1313275	CNTRL	centriolin	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:D002994	Clofibrate results in increased expression of CNTRL mRNA	PMID:17585979|PMID:23811191
1313275	CNTRL	centriolin	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CNTRL mRNA	PMID:31533062
1313275	CNTRL	centriolin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CNTRL mRNA	PMID:27153767
1313275	CNTRL	centriolin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CNTRL mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CNTRL mRNA	PMID:36331819
1313275	CNTRL	centriolin	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CNTRL mRNA	PMID:25979313
1313275	CNTRL	centriolin	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CNTRL mRNA	PMID:23179753|PMID:24935251|PMID:27188386|PMID:28001369
1313275	CNTRL	centriolin	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305317	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CNTRL mRNA	PMID:30047161
1313275	CNTRL	centriolin	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CNTRL mRNA	PMID:25562108
1313275	CNTRL	centriolin	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CNTRL mRNA	PMID:26272509
1313275	CNTRL	centriolin	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTRL mRNA	PMID:27188386
1313275	CNTRL	centriolin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:D000082	Acetaminophen affects the expression of CNTRL mRNA	PMID:17562736
1313275	CNTRL	centriolin	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305317	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CNTRL mRNA	PMID:33387578
1313275	CNTRL	centriolin	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305317	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CNTRL mRNA	PMID:29391264
1313275	CNTRL	centriolin	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of CNTRL protein	PMID:31195006
1313275	CNTRL	centriolin	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305317	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of CNTRL mRNA	PMID:29097150
1313275	CNTRL	centriolin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of CNTRL mRNA	PMID:19363521
1313275	CNTRL	centriolin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	TP53 protein affects the reaction [Decitabine results in decreased expression of CNTRL mRNA]	PMID:19363521
1313275	CNTRL	centriolin	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1557555	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of CNTRL mRNA	PMID:25620056
1313275	CNTRL	centriolin	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305317	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CNTRL mRNA	PMID:30047161
1313275	CNTRL	centriolin	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1557555	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CNTRL mRNA	PMID:35964746
1313275	CNTRL	centriolin	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1557555	E	RGD:6480464	20160210	CTD	MESH:C030935	benz(a)anthracene results in increased expression of CNTRL mRNA	PMID:26377693
1313275	CNTRL	centriolin	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20140715	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CNTRL mRNA	PMID:23608068
1313275	CNTRL	centriolin	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CNTRL mRNA	PMID:22206623
1313275	CNTRL	centriolin	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTRL mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTRL mRNA	PMID:27188386
1313275	CNTRL	centriolin	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CNTRL gene]	PMID:28238834
1313275	CNTRL	centriolin	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C046012	pentanal results in decreased expression of CNTRL mRNA	PMID:26079696
1313275	CNTRL	centriolin	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305317	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CNTRL mRNA	PMID:30047161
1313275	CNTRL	centriolin	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of CNTRL protein	PMID:35357534
1313275	CNTRL	centriolin	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTRL mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CNTRL mRNA	PMID:27188386
1313275	CNTRL	centriolin	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CNTRL mRNA	PMID:27131904
1313275	CNTRL	centriolin	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CNTRL mRNA	PMID:38568856
1313275	CNTRL	centriolin	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1557555	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CNTRL mRNA	PMID:35537566
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of RCL1 mRNA	PMID:23724009|PMID:33167477
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305320	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of RCL1 mRNA	PMID:33729688
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of RCL1 mRNA	PMID:22378314
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of RCL1 mRNA	PMID:20044591
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313279	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RCL1 mRNA	PMID:39241906
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RCL1 mRNA	PMID:39298647
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	Estradiol results in increased expression of RCL1 mRNA	PMID:26865669|PMID:28711546|PMID:31614463
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:17263	estrone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004970	Estrone results in increased expression of RCL1 mRNA	PMID:26865669
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1313279	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of RCL1 mRNA	PMID:28973375
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305320	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RCL1 mRNA	PMID:33387578
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305320	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of RCL1 mRNA	PMID:22061828
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of RCL1 intron	PMID:30157460
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RCL1 mRNA	PMID:36331819
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RCL1 mRNA	PMID:39836092
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305320	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of RCL1 protein	PMID:34915118
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RCL1 mRNA	PMID:37236586
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RCL1 mRNA	PMID:19549813
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313279	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RCL1 mRNA	PMID:19770486
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RCL1 intron	PMID:30157460
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of RCL1 protein	PMID:39638853
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313279	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RCL1 mRNA	PMID:31919559
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RCL1 mRNA	PMID:25629700
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RCL1 mRNA; [Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of RCL1 gene	PMID:39164771|PMID:39836092
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305320	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RCL1 mRNA	PMID:31881176
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D019833	Genistein results in increased expression of RCL1 mRNA	PMID:26865669
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313279	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RCL1 mRNA	PMID:21570461
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RCL1 mRNA	PMID:11489354|PMID:20106945|PMID:21632981
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305320	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RCL1 mRNA	PMID:33387578
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RCL1 mRNA	PMID:17942748
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RCL1 mRNA	PMID:29803840
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of RCL1 mRNA	PMID:29301061|PMID:38568856
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RCL1 mRNA	PMID:39836092
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313279	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RCL1 exon; Benzo(a)pyrene results in decreased methylation of RCL1 intron	PMID:27901495
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RCL1 mRNA	PMID:17879257
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RCL1 promoter	PMID:27901495
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of RCL1 mRNA	PMID:25075043
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of RCL1 mRNA	PMID:25258189
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:31638	fulvestrant	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C070081	fulvestrant results in decreased expression of RCL1 mRNA	PMID:26865669
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RCL1 gene	PMID:31601247
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305320	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of RCL1 mRNA	PMID:24136188
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:31669	hexestrol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D006589	Hexestrol results in increased expression of RCL1 mRNA	PMID:26865669
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1305320	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of RCL1 mRNA	PMID:24136188
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RCL1 mRNA	PMID:19710929
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313279	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RCL1 mRNA	PMID:28472532
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of RCL1 mRNA	PMID:30903817
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305320	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RCL1 mRNA	PMID:25181051
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of RCL1 protein	PMID:37567409
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C006780	bisphenol A results in increased expression of RCL1 mRNA	PMID:28711546
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RCL1 gene	PMID:31601247
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of RCL1 protein	PMID:31945527
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RCL1 mRNA	PMID:39298647
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RCL1 intron	PMID:30157460
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RCL1 mRNA	PMID:37019170
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1305320	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of RCL1 mRNA	PMID:19638242
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305320	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of RCL1 mRNA	PMID:32680482
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305320	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of RCL1 gene	PMID:33148267
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RCL1 mRNA	PMID:37042841
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RCL1 mRNA	PMID:39836092
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RCL1 mRNA	PMID:38174414
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RCL1 mRNA	PMID:37236586
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RCL1 mRNA	PMID:24449571
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313279	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of RCL1 mRNA	PMID:18353800
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of RCL1 mRNA	PMID:17585979
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of RCL1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RCL1 mRNA]	PMID:17585979
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:3752	clomiphene	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D002996	Clomiphene results in decreased expression of RCL1 mRNA	PMID:26865669
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RCL1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of RCL1 mRNA	PMID:36331819
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1313279	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of RCL1 mRNA	PMID:22155349
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RCL1 mRNA	PMID:25979313
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RCL1 gene	PMID:29154799
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RCL1 mRNA	PMID:23179753
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RCL1 mRNA	PMID:17183730
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RCL1 mRNA	PMID:25562108
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RCL1 mRNA	PMID:26865669
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of RCL1 mRNA]	PMID:21233418
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313279	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RCL1 mRNA	PMID:17562736
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of RCL1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RCL1 mRNA]	PMID:17585979
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RCL1 mRNA; [Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of RCL1 gene	PMID:39164771|PMID:39836092
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RCL1 mRNA	PMID:22079256
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RCL1 mRNA	PMID:17942748
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of RCL1 mRNA	PMID:25258189
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:50035	alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of RCL1 mRNA	PMID:25075043
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313279	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of RCL1 mRNA	PMID:25554681
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313279	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RCL1 mRNA	PMID:35964746
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313279	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of RCL1 mRNA	PMID:19042947
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RCL1 mRNA	PMID:17183730
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RCL1 protein	PMID:32959892
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RCL1 mRNA	PMID:39836092
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313279	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RCL1 protein	PMID:26558463
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:6784	mestranol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D008656	Mestranol results in increased expression of RCL1 mRNA	PMID:26865669
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305320	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of RCL1 mRNA	PMID:30467583
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RCL1 intron	PMID:30157460
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305320	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of RCL1 gene	PMID:33148267
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RCL1 mRNA	PMID:31758290
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313279	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RCL1 mRNA	PMID:22206623
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RCL1 mRNA	PMID:22079256
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RCL1 mRNA	PMID:22079256
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RCL1 mRNA	PMID:37199045
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of RCL1 protein	PMID:39638853
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of RCL1 mRNA	PMID:19159669
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of RCL1 mRNA	PMID:21278054
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of RCL1 mRNA	PMID:26865669
1313278	RCL1	RNA terminal phosphate cyclase like 1	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1313279	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of RCL1 protein	PMID:35357534
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:10110	zidovudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in increased expression of MARS1 mRNA	PMID:15784690
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313281	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of MARS1 mRNA	PMID:33045310
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305321	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MARS1 mRNA]	PMID:31150632
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MARS1 gene	PMID:20938992
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MARS1 mRNA	PMID:22378314
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D000431	Ethanol affects the splicing of MARS1 mRNA	PMID:30319688
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313281	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MARS1 mRNA	PMID:39241906
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313281	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MARS1 mRNA	PMID:39298647
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MARS1 gene	PMID:20938992
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of MARS1 mRNA	PMID:18037150
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of MARS1 mRNA	PMID:22321834
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313281	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of MARS1 mRNA	PMID:33848595
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:175901	gemcitabine	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in increased expression of MARS1 mRNA	PMID:17039268
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MARS1 protein	PMID:37730182
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of MARS1 promoter	PMID:30157460
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305321	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of MARS1 protein	PMID:34915118
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MARS1 mRNA	PMID:19549813
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MARS1 mRNA	PMID:23649840
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of MARS1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of MARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of MARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of MARS1 protein	PMID:38598786
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305321	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MARS1 mRNA	PMID:31150632
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305321	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MARS1 mRNA]	PMID:31150632
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MARS1 gene	PMID:20938992
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MARS1 mRNA	PMID:40504410
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MARS1 mRNA	PMID:23557933
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MARS1 mRNA]	PMID:21858171
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MARS1 mRNA	PMID:25583101
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MARS1 mRNA	PMID:21570461
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MARS1 mRNA	PMID:20106945|PMID:21632981
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MARS1 mRNA	PMID:21354282
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of MARS1 mRNA	PMID:16214954
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MARS1 mRNA	PMID:28001369
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MARS1 mRNA	PMID:27188386
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of MARS1 mRNA	PMID:23649840
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	increases expression	ISO	RGD:1305321	E	RGD:6480464	20160712	CTD	MESH:D019328	Buthionine Sulfoximine results in increased expression of MARS1 protein	PMID:23736079
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MARS1 mRNA	PMID:29803840
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MARS1 mRNA	PMID:29432896
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MARS1 mRNA	PMID:38568856
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MARS1 mRNA	PMID:40504410
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of MARS1 mRNA	PMID:22378314|PMID:29453283
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MARS1 mRNA	PMID:22228805
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MARS1 mRNA	PMID:21569818|PMID:22228805
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of MARS1 mRNA	PMID:26014281
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1305321	E	RGD:6480464	20160712	CTD	MESH:C008261	lead acetate results in increased expression of MARS1 mRNA	PMID:11578147
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:C009495	titanium dioxide affects the expression of MARS1 mRNA	PMID:23557971
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:C009495	titanium dioxide results in increased expression of MARS1 mRNA	PMID:27760801
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MARS1 mRNA	PMID:28472532
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C006780	bisphenol A affects the expression of MARS1 mRNA	PMID:30903817
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of MARS1 protein	PMID:37567409
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305321	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MARS1 mRNA	PMID:30816183|PMID:32528016
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MARS1 mRNA; bisphenol A results in increased expression of MARS1 protein	PMID:33670352|PMID:34186270
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305321	E	RGD:6480464	20160712	CTD	MESH:C006780	bisphenol A results in increased expression of MARS1 mRNA	PMID:25181051
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MARS1 mRNA	PMID:25979313
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of MARS1 mRNA	PMID:19041380
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313281	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MARS1 mRNA	PMID:39298647
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of MARS1 protein	PMID:34186270
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of MARS1 protein	PMID:34186270
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313281	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MARS1 mRNA	PMID:37019170
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of MARS1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of MARS1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of MARS1 protein	PMID:38598786
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of MARS1 mRNA	PMID:17312168
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305321	E	RGD:6480464	20160712	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MARS1 mRNA	PMID:20551477
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MARS1 mRNA	PMID:24449571
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of MARS1 mRNA	PMID:26352163
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MARS1 mRNA	PMID:36864359
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MARS1 mRNA	PMID:23179753
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MARS1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MARS1 mRNA	PMID:38832940
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	Vorinostat results in decreased expression of MARS1 mRNA	PMID:27188386
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of MARS1 mRNA	PMID:29067470
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of MARS1 mRNA]	PMID:15016801
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of MARS1 mRNA	PMID:33725128
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of MARS1 mRNA	PMID:29523930
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MARS1 mRNA	PMID:40504410
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:48707	(-)-citrinin	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D002953	Citrinin results in increased expression of MARS1 protein	PMID:39638853
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MARS1 mRNA; Nanotubes, Carbon results in increased expression of MARS1 mRNA	PMID:25554681
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313281	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MARS1 mRNA	PMID:35964746
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313281	E	RGD:6480464	20200114	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MARS1 mRNA	PMID:19042947
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MARS1 protein	PMID:32959892
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:63577	lamivudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in increased expression of MARS1 mRNA	PMID:15784690
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305321	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of MARS1 mRNA	PMID:30467583
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MARS1 protein	PMID:34186270
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MARS1 protein	PMID:37664457
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of MARS1 protein	PMID:39638853
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of MARS1 mRNA	PMID:30559759
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MARS1 mRNA	PMID:27188386
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:80025	Salinomycin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of MARS1 mRNA	PMID:19682730
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MARS1 protein	PMID:31675489
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of MARS1 mRNA	PMID:19095052
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305321	E	RGD:6480464	20160712	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MARS1 mRNA	PMID:23640034
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305321	E	RGD:6480464	20160712	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MARS1 mRNA	PMID:23914054
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of MARS1 mRNA	PMID:21858171
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MARS1 mRNA]	PMID:21858171
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MARS1 protein; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MARS1 mRNA	PMID:27188386|PMID:37664457
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of MARS1 mRNA	PMID:26014281
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of MARS1 mRNA	PMID:22378314
1313280	MARS1	methionyl-tRNA synthetase 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of MARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of MARS1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of MARS1 protein	PMID:38598786
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of MAP4K4 mRNA	PMID:35967413
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of MAP4K4 mRNA	PMID:37995155
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305322	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP4K4 mRNA]	PMID:31150632
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K4 mRNA	PMID:20938992
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of MAP4K4 mRNA	PMID:15928584
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MAP4K4 mRNA	PMID:33167477
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MAP4K4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MAP4K4 mRNA	PMID:32699268
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAP4K4 mRNA	PMID:36331819
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D019308	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of MAP4K4 mRNA	PMID:30547786
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16196	oleic acid	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D019301	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of MAP4K4 mRNA	PMID:30547786
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313283	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MAP4K4 mRNA	PMID:30319688
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313283	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MAP4K4 mRNA	PMID:30319688
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20190507	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of MAP4K4 mRNA; Ethanol affects the expression of and affects the splicing of MAP4K4 mRNA	PMID:30319688|PMID:30517762
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MAP4K4 mRNA	PMID:21632981
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MAP4K4 mRNA	PMID:39241906
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MAP4K4 mRNA]	PMID:39241906
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of MAP4K4 mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of MAP4K4 mRNA	PMID:20660070|PMID:20823114
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K4 mRNA	PMID:20938992
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MAP4K4 mRNA	PMID:37042841
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of MAP4K4 mRNA	PMID:20655997
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of MAP4K4 mRNA	PMID:23649840
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of MAP4K4 mRNA	PMID:20660070
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	MAP4K4 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the localization of RELB protein]; MAP4K4 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CRH mRNA]; MAP4K4 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PTGS2 mRNA]	PMID:26751383
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MAP4K4 mRNA	PMID:33754040
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MAP4K4 protein	PMID:37730182
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAP4K4 mRNA	PMID:36331819
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MAP4K4 mRNA	PMID:19549813
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MAP4K4 mRNA	PMID:23649840
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1305322	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of MAP4K4 protein	PMID:33236894
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305322	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of MAP4K4 mRNA	PMID:21396975
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313283	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MAP4K4 mRNA	PMID:19770486
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MAP4K4 exon	PMID:30157460
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MAP4K4 mRNA	PMID:23649840
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MAP4K4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MAP4K4 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of MAP4K4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MAP4K4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of MAP4K4 mRNA	PMID:32699268|PMID:35430440|PMID:41430723
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305322	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MAP4K4 mRNA	PMID:30779732
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:26820	sulfates	affects methylation	EXP		E	RGD:6480464	20170303	CTD	MESH:D013431	Sulfates affects the methylation of MAP4K4 promoter	PMID:25395096
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:26820	sulfates	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D013431	[Soot co-treated with Sulfates] affects the methylation of MAP4K4 promoter	PMID:25395096
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27086	tributylstannane	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C011559	tributyltin results in decreased expression of MAP4K4 mRNA	PMID:27678064
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305322	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAP4K4 mRNA	PMID:31150632
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313283	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAP4K4 mRNA	PMID:31919559
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305322	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MAP4K4 mRNA]	PMID:31150632
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of MAP4K4 mRNA	PMID:30517762
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K4 mRNA	PMID:20938992
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of MAP4K4 gene	PMID:39164771
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27698	vanadium atom	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of MAP4K4 mRNA	PMID:19000753
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MAP4K4 protein	PMID:35688186
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305322	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MAP4K4 mRNA	PMID:31881176
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MAP4K4 mRNA	PMID:23557933
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of MAP4K4 mRNA	PMID:28903495
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of MAP4K4 mRNA	PMID:19561079
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MAP4K4 mRNA	PMID:30912803
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MAP4K4 mRNA	PMID:25583101
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305322	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAP4K4 mRNA	PMID:34747641
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313283	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAP4K4 mRNA	PMID:21570461
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MAP4K4 mRNA	PMID:20106945|PMID:21632981
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305322	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MAP4K4 mRNA	PMID:33387578
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of MAP4K4 mRNA	PMID:19465110
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MAP4K4 mRNA	PMID:23179753|PMID:28001369
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of MAP4K4 mRNA	PMID:23649840
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MAP4K4 mRNA	PMID:30911355
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of MAP4K4 mRNA	PMID:29803840
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of MAP4K4 protein	PMID:35688186
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of MAP4K4 mRNA	PMID:20044591
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MAP4K4 mRNA	PMID:18812580
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MAP4K4 mRNA	PMID:24431212|PMID:38568856
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MAP4K4 promoter	PMID:27901495
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAP4K4 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAP4K4 mRNA	PMID:32234424
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313283	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAP4K4 mRNA	PMID:19770486|PMID:22228805|PMID:22610609
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA	PMID:27858113
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MAP4K4 mRNA]	PMID:32406909
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MAP4K4 mRNA	PMID:30911355
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313283	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MAP4K4 mRNA	PMID:23221170
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAP4K4 mRNA	PMID:19150397
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of MAP4K4 mRNA	PMID:34408198
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of MAP4K4 gene	PMID:31601247
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of MAP4K4 mRNA	PMID:38568856
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313283	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of MAP4K4 mRNA	PMID:21829687
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305322	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of MAP4K4 mRNA	PMID:25729387
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305322	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of MAP4K4 mRNA	PMID:25729387
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313283	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MAP4K4 promoter	PMID:35295148
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305322	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MAP4K4 mRNA	PMID:23411599|PMID:34492290
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313283	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MAP4K4 mRNA	PMID:18301758|PMID:21318169|PMID:23811191
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of MAP4K4 mRNA]	PMID:21318169
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:32888	gamma-hexachlorocyclohexane	decreases expression	ISO	RGD:1305322	E	RGD:6480464	20120522	CTD	MESH:D001556	Hexachlorocyclohexane results in decreased expression of MAP4K4 mRNA	PMID:17785943
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MAP4K4 mRNA	PMID:30903817
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of MAP4K4 gene	PMID:31601247
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MAP4K4 protein	PMID:33376534
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305322	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of MAP4K4 mRNA	PMID:32145629
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of MAP4K4 mRNA	PMID:38074096
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of MAP4K4 protein	PMID:34186270
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305322	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MAP4K4 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305322	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MAP4K4 gene	PMID:28505145
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of MAP4K4 gene	PMID:31601247
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305322	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MAP4K4 mRNA	PMID:36041667
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of MAP4K4 mRNA	PMID:24752500
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313283	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of MAP4K4 mRNA	PMID:26682919
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of MAP4K4 protein	PMID:34186270
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313283	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of MAP4K4 mRNA	PMID:33297965|PMID:39298647|PMID:40203079
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305322	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MAP4K4 mRNA	PMID:36041667
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313283	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MAP4K4 mRNA	PMID:26377693
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA	PMID:27858113
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305322	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MAP4K4 mRNA	PMID:36041667
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313283	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of MAP4K4 intron	PMID:28392331
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of MAP4K4 mRNA	PMID:31558096
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MAP4K4 mRNA	PMID:34813904
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313283	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MAP4K4 mRNA	PMID:24535843
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MAP4K4 mRNA]	PMID:39241906
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MAP4K4 mRNA	PMID:37042841
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35170	vanadium(0)	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of MAP4K4 mRNA	PMID:19000753
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313283	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MAP4K4 mRNA	PMID:26377693
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MAP4K4 mRNA	PMID:38568856
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35458	cerium trichloride	increases expression	ISO	RGD:1313283	E	RGD:6480464	20121113	CTD	MESH:C026690	cerous chloride results in increased expression of MAP4K4 mRNA; cerous chloride results in increased expression of MAP4K4 protein	PMID:21656643
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305322	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of MAP4K4 gene	PMID:22079235
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MAP4K4 mRNA	PMID:24449571
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of MAP4K4 mRNA	PMID:25908611
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MAP4K4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MAP4K4 mRNA	PMID:32699268
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of MAP4K4 mRNA	PMID:19167446
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP4K4 mRNA	PMID:19167446
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAP4K4 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAP4K4 mRNA	PMID:36331819
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1305322	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of MAP4K4 mRNA	PMID:23125180
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MAP4K4 mRNA	PMID:25979313
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305322	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of MAP4K4 mRNA	PMID:29427782
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of MAP4K4 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MAP4K4 gene	PMID:29154799
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MAP4K4 mRNA	PMID:26272509
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305322	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of MAP4K4 mRNA	PMID:38685447|PMID:41580965
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MAP4K4 mRNA	PMID:25562108|PMID:27989131
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313283	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MAP4K4 mRNA	PMID:28973697
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of MAP4K4 mRNA	PMID:23649840
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of MAP4K4 mRNA	PMID:21678067
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MAP4K4 mRNA	PMID:38832940
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MAP4K4 mRNA	PMID:27188386
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of MAP4K4 mRNA	PMID:24935251|PMID:26272509
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP4K4 mRNA	PMID:27188386
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313283	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAP4K4 mRNA	PMID:17562736
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of MAP4K4 gene	PMID:39164771
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of MAP4K4 mRNA	PMID:24752500
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313283	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of MAP4K4 mRNA	PMID:35436446
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of MAP4K4 mRNA	PMID:38568856
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of MAP4K4 mRNA	PMID:26272509
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of MAP4K4 mRNA	PMID:16984733
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of MAP4K4 mRNA	PMID:20823114
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305322	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of MAP4K4 mRNA	PMID:30307764
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313283	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MAP4K4 mRNA	PMID:25554681
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:51081	nitrates	increases expression	ISO	RGD:1305322	E	RGD:6480464	20200915	CTD	MESH:D009566	Nitrates results in increased expression of MAP4K4 mRNA	PMID:30022042
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA	PMID:27858113
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MAP4K4 mRNA	PMID:27858113
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of MAP4K4 mRNA	PMID:20977926
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of MAP4K4 mRNA	PMID:23608068
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305322	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of MAP4K4 mRNA	PMID:25729387
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305322	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of MAP4K4 mRNA	PMID:25729387
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of MAP4K4 mRNA	PMID:24810058
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of MAP4K4 mRNA	PMID:20823114
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cannabidiol co-treated with moringin] results in decreased expression of MAP4K4 mRNA	PMID:30096889
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MAP4K4 protein	PMID:34186270
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1305322	E	RGD:6480464	20241105	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MAP4K4 mRNA	PMID:22242189
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313283	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MAP4K4 mRNA	PMID:22206623
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of MAP4K4 mRNA	PMID:30559759
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1305322	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of MAP4K4 mRNA	PMID:23665939
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP4K4 mRNA	PMID:27188386
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MAP4K4 mRNA	PMID:19167446
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313283	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of MAP4K4 mRNA	PMID:39847705
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313283	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of MAP4K4 mRNA	PMID:30953684
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305322	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MAP4K4 mRNA	PMID:24780913
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313283	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of MAP4K4 mRNA]	PMID:39241906
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP4K4 mRNA	PMID:27188386
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9123	sertraline	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D020280	Sertraline results in decreased expression of MAP4K4 mRNA	PMID:24865413
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9123	sertraline	multiple interactions	EXP		E	RGD:6480464	20140909	CTD	MESH:D020280	MAP4K4 mutant form inhibits the reaction [Sertraline results in increased cleavage of CASP4 protein]; MAP4K4 mutant form inhibits the reaction [Sertraline results in increased expression of DDIT3 protein]; MAP4K4 mutant form inhibits the reaction [Sertraline results in increased phosphorylation of EIF2AK3 protein]	PMID:24865413
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305322	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of MAP4K4 mRNA	PMID:19281266
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MAP4K4 mRNA	PMID:38568856
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313283	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of MAP4K4 mRNA	PMID:17569031
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305322	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of MAP4K4 mRNA	PMID:19015723
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305322	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MAP4K4 mRNA	PMID:23034163
1313282	MAP4K4	mitogen-activated protein kinase kinase kinase kinase 4	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305322	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MAP4K4 mRNA	PMID:20566332
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PLA2G3 mRNA	PMID:26272509
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G3 mRNA	PMID:27188386
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1305323	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of PLA2G3 mRNA	PMID:36841081
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of PLA2G3 mRNA	PMID:23019147
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:16482	naphthalene	decreases expression	ISO	RGD:1305323	E	RGD:6480464	20150127	CTD	MESH:C031721	naphthalene analog results in decreased expression of PLA2G3 mRNA	PMID:24976557
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552182	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PLA2G3 mRNA	PMID:34319233
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305323	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PLA2G3 mRNA	PMID:27523638
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305323	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PLA2G3 mRNA	PMID:33387578
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PLA2G3 mRNA	PMID:28818685
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305323	E	RGD:6480464	20260602	CTD	MESH:D002104	[cadmium sulfate results in increased abundance of Cadmium] which results in increased expression of PLA2G3 protein	PMID:30090467
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PLA2G3 mRNA	PMID:19549813
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PLA2G3 mRNA	PMID:21641981
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of PLA2G3 mRNA	PMID:25102026
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1305323	E	RGD:6480464	20200114	CTD	MESH:D010126	Ozone results in increased expression of PLA2G3 mRNA	PMID:31397875
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PLA2G3 mRNA	PMID:21867686
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1552182	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of PLA2G3 mRNA	PMID:35897073
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1552182	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PLA2G3 mRNA	PMID:28960355
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PLA2G3 mRNA	PMID:24768652|PMID:25583101
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PLA2G3 mRNA	PMID:30851411
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of PLA2G3 protein	PMID:35688186
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLA2G3 promoter	PMID:27901495
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552182	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLA2G3 mRNA	PMID:27195522
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552182	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to PLA2G3 promoter]	PMID:19654925
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:30966	glycidol	affects expression	ISO	RGD:1305323	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol affects the expression of PLA2G3 mRNA	PMID:24915197
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305323	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of PLA2G3 mRNA	PMID:24395379
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLA2G3 gene	PMID:31601247
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552182	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PLA2G3 mRNA	PMID:29264374|PMID:35295148
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305323	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PLA2G3 mRNA	PMID:34947998
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552182	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of PLA2G3 mRNA	PMID:32156529
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PLA2G3 gene	PMID:31601247
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLA2G3 gene	PMID:31601247
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PLA2G3 mRNA	PMID:25979313
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in decreased expression of PLA2G3 mRNA	PMID:19371625
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552182	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PLA2G3 gene	PMID:31683443
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:34757	fenitrothion	decreases expression	ISO	RGD:1305323	E	RGD:6480464	20181016	CTD	MESH:D005278	Fenitrothion results in decreased expression of PLA2G3 protein	PMID:29292090
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305323	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PLA2G3 promoter	PMID:22457795
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305323	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of PLA2G3 mRNA	PMID:25539665
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552182	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PLA2G3 mRNA	PMID:40194260
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:38683	4-nitro-m-cresol	decreases expression	ISO	RGD:1305323	E	RGD:6480464	20181016	CTD	MESH:C008636	4-nitro-3-cresol results in decreased expression of PLA2G3 protein	PMID:29292090
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PLA2G3 mRNA	PMID:31533062
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLA2G3 mRNA	PMID:25979313
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLA2G3 mRNA	PMID:23179753
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PLA2G3 mRNA	PMID:27188386
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305323	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLA2G3 mRNA	PMID:33387578
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1305323	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of PLA2G3 mRNA	PMID:37077353
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305323	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLA2G3 mRNA	PMID:29391264
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1305323	E	RGD:6480464	20260602	CTD	MESH:C037123	[cadmium sulfate results in increased abundance of Cadmium] which results in increased expression of PLA2G3 protein	PMID:30090467
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1552182	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PLA2G3 mRNA	PMID:23608068
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1552182	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of PLA2G3 mRNA	PMID:38701926
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PLA2G3 mRNA	PMID:24810058
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PLA2G3 mRNA	PMID:31758290
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552182	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PLA2G3 mRNA	PMID:22206623
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PLA2G3 mRNA	PMID:30851411
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G3 mRNA	PMID:27188386
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305323	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of PLA2G3 mRNA	PMID:25825206
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G3 mRNA	PMID:27188386
1313284	PLA2G3	phospholipase A2 group III	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1552182	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of PLA2G3 mRNA	PMID:32835833
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SPRY4 mRNA	PMID:38218311
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313287	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SPRY4 mRNA	PMID:33045310
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of SPRY4 mRNA	PMID:34925699
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of SPRY4 mRNA]	PMID:19467301
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SPRY4 mRNA	PMID:33167477
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SPRY4 mRNA	PMID:36189433
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SPRY4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SPRY4 mRNA	PMID:32699268
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305324	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of SPRY4 mRNA	PMID:33729688
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPRY4 mRNA	PMID:30529165
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1305324	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of SPRY4 mRNA	PMID:36841081
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	[Ethanol co-treated with Folic Acid] results in decreased expression of SPRY4 mRNA	PMID:23378141
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SPRY4 mRNA	PMID:23410634
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of SPRY4 mRNA	PMID:30510588
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SPRY4 mRNA	PMID:39298647
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of SPRY4 mRNA	PMID:23019147|PMID:30165855|PMID:31614463
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305324	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SPRY4 mRNA	PMID:32145629
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of SPRY4 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of SPRY4 mRNA	PMID:20660070|PMID:30165855
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:165219	PCB138	increases expression	ISO	RGD:1305324	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SPRY4 mRNA	PMID:23829299
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of SPRY4 mRNA	PMID:28937961
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of SPRY4 mRNA	PMID:39245080
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of SPRY4 mRNA	PMID:18037150
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of SPRY4 mRNA	PMID:20660070
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of SPRY4 mRNA	PMID:36314267
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SPRY4 mRNA	PMID:36695872
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1305324	E	RGD:6480464	20120412	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SPRY4 mRNA	PMID:16809437
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SPRY4 mRNA	PMID:36189433
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of SPRY4 mRNA	PMID:33647349
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of SPRY4 mRNA	PMID:31256213
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SPRY4 mRNA	PMID:19850644
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SPRY4 mRNA	PMID:31163220
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of SPRY4 mRNA]	PMID:19850644
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305324	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SPRY4 mRNA	PMID:27523638
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SPRY4 protein	PMID:37730182
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305324	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of SPRY4 mRNA	PMID:22061828
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305324	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SPRY4 mRNA	PMID:33387578
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SPRY4 mRNA	PMID:28818685
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:193591	Didecyldimethylammonium	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027118	didecyldimethylammonium results in increased expression of SPRY4 mRNA	PMID:39710153
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313287	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of SPRY4 mRNA	PMID:27462272
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305324	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPRY4 mRNA	PMID:39012411
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPRY4 mRNA	PMID:37236586
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SPRY4 mRNA	PMID:19549813
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SPRY4 mRNA	PMID:22100608
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305324	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SPRY4 mRNA	PMID:33354967
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313287	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of SPRY4 mRNA	PMID:15674844
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SPRY4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SPRY4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of SPRY4 mRNA	PMID:32699268
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SPRY4 mRNA	PMID:34911549
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SPRY4 mRNA	PMID:18593933
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SPRY4 mRNA	PMID:25629700
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D005492	[Ethanol co-treated with Folic Acid] results in decreased expression of SPRY4 mRNA	PMID:23378141
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SPRY4 mRNA	PMID:26272509
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA	PMID:27188386
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of SPRY4 protein	PMID:35688186
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SPRY4 mRNA	PMID:27392435
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1305324	E	RGD:6480464	20180313	CTD	MESH:D003042	Cocaine results in increased expression of SPRY4 mRNA	PMID:27899881
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313287	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPRY4 mRNA	PMID:21570461
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPRY4 mRNA	PMID:20106945|PMID:21632981
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305324	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPRY4 mRNA	PMID:33387578
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305324	E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPRY4 mRNA	PMID:26232522
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of SPRY4 mRNA	PMID:29955902
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SPRY4 mRNA	PMID:28001369
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SPRY4 mRNA	PMID:33212167
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305324	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SPRY4 mRNA	PMID:28959563
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SPRY4 mRNA	PMID:30031762
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D024483	Vitamin K 3 affects the expression of SPRY4 mRNA	PMID:23410634
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:2948	azathioprine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of SPRY4 mRNA	PMID:22623647
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SPRY4 mRNA	PMID:38568856
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRY4 mRNA	PMID:34876320
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRY4 mRNA	PMID:34876320
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPRY4 mRNA	PMID:21632981|PMID:21714911|PMID:26238291|PMID:32234424|PMID:35870112
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SPRY4 5' UTR	PMID:27901495
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of SPRY4 promoter	PMID:23974009
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SPRY4 mRNA	PMID:18593933
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SPRY4 mRNA	PMID:26014281
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313287	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SPRY4 mRNA	PMID:27131904
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SPRY4 mRNA	PMID:22300531|PMID:25351596
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SPRY4 mRNA	PMID:20382639
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SPRY4 mRNA	PMID:26238291
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305324	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of SPRY4 mRNA	PMID:24915197
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of SPRY4 mRNA	PMID:38568856
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305324	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SPRY4 mRNA	PMID:30047161
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305324	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SPRY4 mRNA	PMID:34492290
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of SPRY4 mRNA	PMID:23811191
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of SPRY4 mRNA	PMID:28329830
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305324	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SPRY4 mRNA	PMID:19167457
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305324	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SPRY4 mRNA	PMID:25181051|PMID:32145629
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of SPRY4 mRNA	PMID:29275510
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of SPRY4 mRNA	PMID:25594700
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313287	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SPRY4 mRNA	PMID:30951980|PMID:32156529
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313287	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of SPRY4 mRNA	PMID:25172293
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313287	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of SPRY4 mRNA	PMID:39298647
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313287	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SPRY4 gene	PMID:31683443
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of SPRY4 mRNA	PMID:33297965
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313287	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SPRY4 mRNA	PMID:30951980|PMID:40203079
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SPRY4 mRNA	PMID:28628672
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313287	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SPRY4 mRNA	PMID:30951980|PMID:38685157
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPRY4 mRNA	PMID:28628672
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313287	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SPRY4 mRNA	PMID:37019170
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305324	E	RGD:6480464	20230606	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SPRY4 mRNA	PMID:31050326
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305324	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SPRY4 mRNA	PMID:21266533
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313287	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SPRY4 mRNA	PMID:17361019|PMID:21266533
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPRY4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SPRY4 mRNA	PMID:28628672
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305324	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPRY4 mRNA	PMID:39012411
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SPRY4 mRNA	PMID:37236586
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SPRY4 protein	PMID:26879310
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305324	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SPRY4 mRNA	PMID:30047161
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of SPRY4 mRNA	PMID:28962523
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SPRY4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SPRY4 mRNA	PMID:32699268
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SPRY4 mRNA	PMID:28302478
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SPRY4 mRNA	PMID:40419075
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SPRY4 mRNA	PMID:36331819
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of SPRY4 mRNA	PMID:23125180
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPRY4 mRNA	PMID:25979313
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305324	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of SPRY4 mRNA	PMID:29427782
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of SPRY4 mRNA	PMID:21427059
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SPRY4 mRNA	PMID:28001369
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305324	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SPRY4 mRNA	PMID:30047161
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SPRY4 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPRY4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SPRY4 mRNA	PMID:28628672
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313287	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SPRY4 mRNA	PMID:28973697
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313287	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of SPRY4 mRNA	PMID:18502557
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SPRY4 mRNA	PMID:38832940
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of SPRY4 mRNA	PMID:21420995|PMID:29067470
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of SPRY4 mRNA	PMID:33725128
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of SPRY4 mRNA	PMID:25757056
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SPRY4 mRNA	PMID:18687144|PMID:25351596
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in decreased expression of SPRY4 mRNA	PMID:26934552
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of SPRY4 mRNA	PMID:31838189
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of SPRY4 mRNA	PMID:35701726
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SPRY4 mRNA	PMID:22079256
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRY4 mRNA	PMID:34876320
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SPRY4 mRNA	PMID:38568856
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA	PMID:27188386
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPRY4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SPRY4 mRNA	PMID:28628672
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:50594	carbon nanotube	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SPRY4 mRNA	PMID:25102311
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313287	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SPRY4 mRNA; Nanotubes, Carbon results in increased expression of SPRY4 mRNA	PMID:25554681
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305324	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SPRY4 mRNA	PMID:30047161
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313287	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of SPRY4 mRNA	PMID:40234311
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:507499	tricetin	increases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C469689	tricetin results in increased expression of SPRY4 mRNA	PMID:38654487
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of SPRY4 mRNA	PMID:31629900
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313287	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SPRY4 mRNA	PMID:38701926
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SPRY4 protein	PMID:32959892
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305324	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of SPRY4 mRNA	PMID:28801915
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SPRY4 mRNA	PMID:28988120
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:64090	tert-butyl hydroperoxide	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D020122	tert-Butylhydroperoxide affects the expression of SPRY4 mRNA	PMID:23410634
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305324	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SPRY4 mRNA	PMID:28801915
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1305324	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of SPRY4 mRNA	PMID:27840820
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of SPRY4 mRNA	PMID:22079256
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SPRY4 mRNA	PMID:22079256
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305324	E	RGD:6480464	20141111	CTD	MESH:C007350	nitrofen results in decreased expression of SPRY4 mRNA	PMID:23982388|PMID:26720608|PMID:33484710
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA	PMID:27188386
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of SPRY4 mRNA	PMID:32234424
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313287	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRY4 mRNA	PMID:34876320
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313287	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of SPRY4 mRNA	PMID:21278054
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305324	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of SPRY4 mRNA	PMID:24780913
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305324	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SPRY4 mRNA	PMID:30047161
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRY4 mRNA	PMID:27188386
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SPRY4 mRNA	PMID:26014281
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313287	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SPRY4 mRNA	PMID:27131904
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SPRY4 mRNA	PMID:38568856
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313287	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of SPRY4 mRNA	PMID:17569031
1313286	SPRY4	sprouty RTK signaling antagonist 4	gene	CHEBI:9907	ursodeoxycholic acid	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D014580	Ursodeoxycholic Acid affects the expression of SPRY4 mRNA	PMID:18422935
1313288	PLXNA2	plexin A2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313289	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PLXNA2 mRNA	PMID:33045310
1313288	PLXNA2	plexin A2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PLXNA2 mRNA	PMID:26251327
1313288	PLXNA2	plexin A2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PLXNA2 mRNA	PMID:21934132|PMID:23724009
1313288	PLXNA2	plexin A2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313289	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PLXNA2 mRNA	PMID:30319688
1313288	PLXNA2	plexin A2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313289	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PLXNA2 mRNA	PMID:30319688
1313288	PLXNA2	plexin A2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305325	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of PLXNA2 mRNA	PMID:32145629
1313288	PLXNA2	plexin A2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313289	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PLXNA2 mRNA	PMID:39298647
1313288	PLXNA2	plexin A2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PLXNA2 mRNA	PMID:30165855
1313288	PLXNA2	plexin A2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLXNA2 mRNA	PMID:25510870
1313288	PLXNA2	plexin A2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PLXNA2 mRNA	PMID:38568856
1313288	PLXNA2	plexin A2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PLXNA2 mRNA	PMID:37042841
1313288	PLXNA2	plexin A2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of PLXNA2 mRNA	PMID:36695872
1313288	PLXNA2	plexin A2	gene	CHEBI:17627	ferroheme b	increases expression	ISO	RGD:1313289	E	RGD:6480464	20120814	CTD	MESH:D006418	Heme metabolite results in increased expression of PLXNA2 mRNA	PMID:19191707
1313288	PLXNA2	plexin A2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PLXNA2 mRNA	PMID:19850644
1313288	PLXNA2	plexin A2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of PLXNA2 mRNA]	PMID:19850644
1313288	PLXNA2	plexin A2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PLXNA2 protein	PMID:37730182
1313288	PLXNA2	plexin A2	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PLXNA2 mRNA	PMID:36139627
1313288	PLXNA2	plexin A2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of PLXNA2 mRNA	PMID:16002434
1313288	PLXNA2	plexin A2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PLXNA2 mRNA	PMID:28818685
1313288	PLXNA2	plexin A2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of PLXNA2 intron	PMID:30157460
1313288	PLXNA2	plexin A2	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1313289	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of PLXNA2 mRNA	PMID:33914522
1313288	PLXNA2	plexin A2	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of PLXNA2 mRNA	PMID:27462272
1313288	PLXNA2	plexin A2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLXNA2 mRNA	PMID:25510870
1313288	PLXNA2	plexin A2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLXNA2 mRNA	PMID:25510870
1313288	PLXNA2	plexin A2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PLXNA2 mRNA	PMID:19549813
1313288	PLXNA2	plexin A2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PLXNA2 gene	PMID:27153756
1313288	PLXNA2	plexin A2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PLXNA2 intron	PMID:30157460
1313288	PLXNA2	plexin A2	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PLXNA2 mRNA	PMID:32553695
1313288	PLXNA2	plexin A2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D010126	pyrazolanthrone inhibits the reaction [Ozone results in increased expression of PLXNA2 mRNA]	PMID:17460151
1313288	PLXNA2	plexin A2	gene	CHEBI:26355	heme b	increases expression	ISO	RGD:1313289	E	RGD:6480464	20140805	CTD	MESH:D006418	Heme metabolite results in increased expression of PLXNA2 mRNA	PMID:19191707
1313288	PLXNA2	plexin A2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PLXNA2 mRNA	PMID:31150632
1313288	PLXNA2	plexin A2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PLXNA2 mRNA	PMID:31919559
1313288	PLXNA2	plexin A2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313289	E	RGD:6480464	20181016	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PLXNA2 mRNA	PMID:29987408
1313288	PLXNA2	plexin A2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PLXNA2 mRNA	PMID:25629700
1313288	PLXNA2	plexin A2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PLXNA2 gene	PMID:25304211
1313288	PLXNA2	plexin A2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PLXNA2 mRNA	PMID:26272509
1313288	PLXNA2	plexin A2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA	PMID:27188386
1313288	PLXNA2	plexin A2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313289	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PLXNA2 mRNA	PMID:28960355
1313288	PLXNA2	plexin A2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PLXNA2 mRNA	PMID:31881176
1313288	PLXNA2	plexin A2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20200211	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of PLXNA2 mRNA]	PMID:31298478
1313288	PLXNA2	plexin A2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PLXNA2 mRNA	PMID:27392435
1313288	PLXNA2	plexin A2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PLXNA2 mRNA	PMID:27392435
1313288	PLXNA2	plexin A2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313289	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of PLXNA2 mRNA	PMID:32186404
1313288	PLXNA2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305325	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLXNA2 mRNA	PMID:22298810
1313288	PLXNA2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313289	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLXNA2 mRNA	PMID:21570461
1313288	PLXNA2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLXNA2 mRNA	PMID:20106945
1313288	PLXNA2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLXNA2 mRNA	PMID:23238561|PMID:32109520|PMID:33387578
1313288	PLXNA2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLXNA2 mRNA	PMID:18796159|PMID:19465110|PMID:23238561|PMID:32553695
1313288	PLXNA2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305325	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLXNA2 mRNA	PMID:34747641
1313288	PLXNA2	plexin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of PLXNA2 mRNA; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA]	PMID:16054899|PMID:16214954
1313288	PLXNA2	plexin A2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of PLXNA2 mRNA	PMID:28374803
1313288	PLXNA2	plexin A2	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D004317	Doxorubicin affects the expression of PLXNA2 mRNA	PMID:25529476
1313288	PLXNA2	plexin A2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PLXNA2 mRNA	PMID:29803840
1313288	PLXNA2	plexin A2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PLXNA2 mRNA	PMID:22714537
1313288	PLXNA2	plexin A2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PLXNA2 mRNA	PMID:37682722
1313288	PLXNA2	plexin A2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PLXNA2 mRNA	PMID:38568856|PMID:39719251
1313288	PLXNA2	plexin A2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLXNA2 intron	PMID:30157460
1313288	PLXNA2	plexin A2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PLXNA2 mRNA	PMID:20106945|PMID:22316170|PMID:26238291
1313288	PLXNA2	plexin A2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in decreased expression of PLXNA2 mRNA	PMID:32553695
1313288	PLXNA2	plexin A2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PLXNA2 5' UTR	PMID:27901495
1313288	PLXNA2	plexin A2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313289	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLXNA2 mRNA	PMID:21569818|PMID:21964900|PMID:22610609|PMID:23735875
1313288	PLXNA2	plexin A2	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313289	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in increased expression of PLXNA2 mRNA	PMID:33053406
1313288	PLXNA2	plexin A2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313289	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of PLXNA2 mRNA	PMID:27131904
1313288	PLXNA2	plexin A2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PLXNA2 mRNA	PMID:25895662
1313288	PLXNA2	plexin A2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PLXNA2 mRNA	PMID:19150397|PMID:26238291
1313288	PLXNA2	plexin A2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLXNA2 gene	PMID:31601247
1313288	PLXNA2	plexin A2	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305325	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of PLXNA2 mRNA	PMID:24136188
1313288	PLXNA2	plexin A2	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of PLXNA2 mRNA	PMID:38568856
1313288	PLXNA2	plexin A2	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of PLXNA2 mRNA	PMID:32479839
1313288	PLXNA2	plexin A2	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of PLXNA2 mRNA	PMID:38568856
1313288	PLXNA2	plexin A2	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20190219	CTD	MESH:C030110	Oxaliplatin results in decreased expression of PLXNA2 protein	PMID:30031110
1313288	PLXNA2	plexin A2	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of PLXNA2 mRNA	PMID:24136188
1313288	PLXNA2	plexin A2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313289	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLXNA2 gene	PMID:35295148
1313288	PLXNA2	plexin A2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313289	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of PLXNA2 mRNA	PMID:27760801|PMID:31298478
1313288	PLXNA2	plexin A2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20200211	CTD	MESH:C009495	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of PLXNA2 mRNA]	PMID:31298478
1313288	PLXNA2	plexin A2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PLXNA2 mRNA	PMID:34492290
1313288	PLXNA2	plexin A2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PLXNA2 mRNA	PMID:19167457
1313288	PLXNA2	plexin A2	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1313289	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of PLXNA2 mRNA	PMID:33914522
1313288	PLXNA2	plexin A2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305325	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of PLXNA2 mRNA	PMID:32145629
1313288	PLXNA2	plexin A2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PLXNA2 mRNA	PMID:25181051|PMID:30816183
1313288	PLXNA2	plexin A2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PLXNA2 gene	PMID:31601247
1313288	PLXNA2	plexin A2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C006780	bisphenol A analog results in increased expression of PLXNA2 mRNA; bisphenol A results in increased expression of PLXNA2 mRNA	PMID:32387340|PMID:38568856
1313288	PLXNA2	plexin A2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313289	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in increased expression of PLXNA2 mRNA	PMID:30245210|PMID:35479511
1313288	PLXNA2	plexin A2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLXNA2 gene	PMID:31601247
1313288	PLXNA2	plexin A2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PLXNA2 mRNA	PMID:25979313
1313288	PLXNA2	plexin A2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLXNA2 mRNA	PMID:25510870
1313288	PLXNA2	plexin A2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PLXNA2 mRNA	PMID:25510870
1313288	PLXNA2	plexin A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PLXNA2 mRNA	PMID:39298647
1313288	PLXNA2	plexin A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313289	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PLXNA2 mRNA	PMID:30951980|PMID:33297965|PMID:40203079
1313288	PLXNA2	plexin A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of PLXNA2 gene	PMID:31601247
1313288	PLXNA2	plexin A2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313289	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PLXNA2 mRNA	PMID:26377693
1313288	PLXNA2	plexin A2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PLXNA2 intron	PMID:30157460
1313288	PLXNA2	plexin A2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313289	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PLXNA2 mRNA	PMID:30951980|PMID:38685157
1313288	PLXNA2	plexin A2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PLXNA2 mRNA	PMID:28392331
1313288	PLXNA2	plexin A2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313289	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PLXNA2 mRNA	PMID:37019170
1313288	PLXNA2	plexin A2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D015056	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA]	PMID:16054899
1313288	PLXNA2	plexin A2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of PLXNA2 mRNA	PMID:32680482
1313288	PLXNA2	plexin A2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PLXNA2 mRNA	PMID:37042841
1313288	PLXNA2	plexin A2	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305325	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of PLXNA2 mRNA	PMID:30589522
1313288	PLXNA2	plexin A2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of PLXNA2 mRNA	PMID:29024780
1313288	PLXNA2	plexin A2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PLXNA2 mRNA	PMID:38174414
1313288	PLXNA2	plexin A2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PLXNA2 mRNA	PMID:38382870
1313288	PLXNA2	plexin A2	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of PLXNA2 mRNA	PMID:26194646
1313288	PLXNA2	plexin A2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of PLXNA2 mRNA	PMID:28903501
1313288	PLXNA2	plexin A2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PLXNA2 mRNA	PMID:19320972
1313288	PLXNA2	plexin A2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313289	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of PLXNA2 mRNA	PMID:18353800
1313288	PLXNA2	plexin A2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PLXNA2 mRNA	PMID:38568856
1313288	PLXNA2	plexin A2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PLXNA2 mRNA	PMID:38568856
1313288	PLXNA2	plexin A2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PLXNA2 mRNA	PMID:40419075
1313288	PLXNA2	plexin A2	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1313289	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of PLXNA2 mRNA	PMID:29038090
1313288	PLXNA2	plexin A2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1313289	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of PLXNA2 mRNA	PMID:23125180
1313288	PLXNA2	plexin A2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLXNA2 mRNA	PMID:25979313
1313288	PLXNA2	plexin A2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305325	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PLXNA2 mRNA	PMID:29427782
1313288	PLXNA2	plexin A2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLXNA2 mRNA	PMID:29427782
1313288	PLXNA2	plexin A2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PLXNA2 gene	PMID:29154799
1313288	PLXNA2	plexin A2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PLXNA2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509
1313288	PLXNA2	plexin A2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA	PMID:27188386
1313288	PLXNA2	plexin A2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of PLXNA2 mRNA	PMID:27989131
1313288	PLXNA2	plexin A2	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of PLXNA2 promoter	PMID:27989131
1313288	PLXNA2	plexin A2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PLXNA2 mRNA	PMID:20106945|PMID:25562108
1313288	PLXNA2	plexin A2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D003907	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA]	PMID:16054899
1313288	PLXNA2	plexin A2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313289	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PLXNA2 mRNA	PMID:28973697
1313288	PLXNA2	plexin A2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of PLXNA2 mRNA	PMID:18502557
1313288	PLXNA2	plexin A2	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of PLXNA2 mRNA	PMID:24136188
1313288	PLXNA2	plexin A2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PLXNA2 mRNA	PMID:38832940
1313288	PLXNA2	plexin A2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of PLXNA2 mRNA	PMID:24935251|PMID:26272509
1313288	PLXNA2	plexin A2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA	PMID:27188386
1313288	PLXNA2	plexin A2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PLXNA2 mRNA	PMID:17562736
1313288	PLXNA2	plexin A2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLXNA2 mRNA	PMID:32479839
1313288	PLXNA2	plexin A2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of PLXNA2 mRNA	PMID:29067470
1313288	PLXNA2	plexin A2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305325	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PLXNA2 mRNA	PMID:33387578
1313288	PLXNA2	plexin A2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PLXNA2 gene	PMID:25304211
1313288	PLXNA2	plexin A2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLXNA2 mRNA	PMID:29391264
1313288	PLXNA2	plexin A2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLXNA2 mRNA	PMID:22079256
1313288	PLXNA2	plexin A2	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1313289	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of PLXNA2 mRNA	PMID:35436446
1313288	PLXNA2	plexin A2	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of PLXNA2 mRNA	PMID:38568856
1313288	PLXNA2	plexin A2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313289	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of PLXNA2 mRNA	PMID:25554681
1313288	PLXNA2	plexin A2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PLXNA2 mRNA	PMID:25620056
1313288	PLXNA2	plexin A2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313289	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PLXNA2 mRNA	PMID:25554681
1313288	PLXNA2	plexin A2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of PLXNA2 mRNA	PMID:26377693
1313288	PLXNA2	plexin A2	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of PLXNA2 mRNA	PMID:26705709
1313288	PLXNA2	plexin A2	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of PLXNA2 mRNA	PMID:22714537
1313288	PLXNA2	plexin A2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313289	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PLXNA2 mRNA	PMID:23608068
1313288	PLXNA2	plexin A2	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of PLXNA2 mRNA	PMID:20080153
1313288	PLXNA2	plexin A2	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of PLXNA2 mRNA	PMID:24136188
1313288	PLXNA2	plexin A2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PLXNA2 mRNA	PMID:15336504
1313288	PLXNA2	plexin A2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PLXNA2 mRNA	PMID:24810058
1313288	PLXNA2	plexin A2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of PLXNA2 intron	PMID:30157460
1313288	PLXNA2	plexin A2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PLXNA2 mRNA	PMID:22206623
1313288	PLXNA2	plexin A2	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PLXNA2 mRNA	PMID:24136188
1313288	PLXNA2	plexin A2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PLXNA2 mRNA	PMID:22079256
1313288	PLXNA2	plexin A2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLXNA2 mRNA	PMID:22079256
1313288	PLXNA2	plexin A2	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PLXNA2 mRNA	PMID:36139627
1313288	PLXNA2	plexin A2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305325	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of PLXNA2 mRNA	PMID:21346803
1313288	PLXNA2	plexin A2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA	PMID:27188386
1313288	PLXNA2	plexin A2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PLXNA2 gene]	PMID:28238834
1313288	PLXNA2	plexin A2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of PLXNA2 mRNA	PMID:19270015|PMID:23091169
1313288	PLXNA2	plexin A2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PLXNA2 mRNA	PMID:32109520
1313288	PLXNA2	plexin A2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313289	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PLXNA2 mRNA	PMID:24680724
1313288	PLXNA2	plexin A2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PLXNA2 mRNA	PMID:21394737
1313288	PLXNA2	plexin A2	gene	CHEBI:82299	3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone	affects response to substance	EXP		E	RGD:6480464	20150609	CTD	MESH:C054121	PLXNA2 gene SNP affects the susceptibility to 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone	PMID:25622337
1313288	PLXNA2	plexin A2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313289	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PLXNA2 mRNA	PMID:39847705
1313288	PLXNA2	plexin A2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of PLXNA2 mRNA	PMID:21278054
1313288	PLXNA2	plexin A2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PLXNA2 mRNA	PMID:24780913
1313288	PLXNA2	plexin A2	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of PLXNA2 mRNA	PMID:26272509
1313288	PLXNA2	plexin A2	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA	PMID:27188386
1313288	PLXNA2	plexin A2	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1313289	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [Ozone results in increased expression of PLXNA2 mRNA]	PMID:17460151
1313288	PLXNA2	plexin A2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA	PMID:27188386
1313288	PLXNA2	plexin A2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313289	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of PLXNA2 mRNA	PMID:27131904
1313288	PLXNA2	plexin A2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305325	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PLXNA2 mRNA	PMID:21346803
1313288	PLXNA2	plexin A2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PLXNA2 mRNA	PMID:38568856
1313288	PLXNA2	plexin A2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313289	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PLXNA2 mRNA	PMID:28973697
1313288	PLXNA2	plexin A2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305325	E	RGD:6480464	20191112	CTD	MESH:C025643	vinclozolin results in decreased expression of PLXNA2 mRNA	PMID:30207508
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:2323973	E	RGD:6480464	20120522	CTD	MESH:D004237	Diuron results in decreased expression of TXNDC5 mRNA	PMID:21551480
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:2323973	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TXNDC5 mRNA]	PMID:31150632
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313293	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TXNDC5 mRNA	PMID:26251327
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TXNDC5 mRNA	PMID:33167477
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D010100	[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of TXNDC5 mRNA; [cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of TXNDC5 protein	PMID:23326410
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313293	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TXNDC5 mRNA	PMID:39241906
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TXNDC5 mRNA	PMID:31614463
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313293	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TXNDC5 mRNA	PMID:39298647
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:16480	nitric oxide	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D009569	[NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which affects the expression of TXNDC5 protein	PMID:19320461
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313293	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of TXNDC5 mRNA	PMID:33848595
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:17362	quinoline	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C037219	quinoline analog results in decreased expression of TXNDC5 protein	PMID:18645022
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313293	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TXNDC5 mRNA	PMID:34319233
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313293	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TXNDC5 mRNA	PMID:33754040
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:17833	gentamycin	multiple interactions	ISO	RGD:2323973	E	RGD:6480464	20191112	CTD	MESH:D005839	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein	PMID:30545405
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNDC5 mRNA	PMID:35301059
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313293	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNDC5 mRNA	PMID:37236586
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TXNDC5 protein	PMID:23301498
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TXNDC5 mRNA	PMID:32234424
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313293	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TXNDC5 mRNA	PMID:19770486
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TXNDC5 gene	PMID:27153756
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of TXNDC5 mRNA	PMID:25102026
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of TXNDC5 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of TXNDC5 protein	PMID:38598786
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TXNDC5 mRNA	PMID:22171008
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313293	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TXNDC5 mRNA	PMID:31919559
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:2323973	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TXNDC5 mRNA	PMID:31150632
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:2323973	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TXNDC5 mRNA]	PMID:31150632
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313293	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TXNDC5 mRNA	PMID:25629700
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313293	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TXNDC5 mRNA]	PMID:22206623
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC5 mRNA	PMID:39836092
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313293	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC5 mRNA	PMID:40504410
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of TXNDC5 mRNA	PMID:33512557
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:28001	vancomycin	multiple interactions	ISO	RGD:2323973	E	RGD:6480464	20191112	CTD	MESH:D014640	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein	PMID:30545405
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313293	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TXNDC5 mRNA	PMID:21570461
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:2323973	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TXNDC5 mRNA	PMID:34747641
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:28971	ampicillin	multiple interactions	ISO	RGD:2323973	E	RGD:6480464	20191112	CTD	MESH:D000667	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein	PMID:30545405
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:29287	gold atom	multiple interactions	ISO	RGD:1313293	E	RGD:6480464	20150310	CTD	MESH:D006046	Gold analog results in decreased expression of and results in increased phosphorylation of TXNDC5 protein	PMID:24780912
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TXNDC5 mRNA	PMID:24516582|PMID:38568856
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of TXNDC5 protein	PMID:20050688
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC5 mRNA	PMID:39836092
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313293	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC5 mRNA	PMID:40504410
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TXNDC5 mRNA	PMID:32234424
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313293	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TXNDC5 mRNA	PMID:19770486
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:30050	gold(0)	multiple interactions	ISO	RGD:1313293	E	RGD:6480464	20150310	CTD	MESH:D006046	Gold analog results in decreased expression of and results in increased phosphorylation of TXNDC5 protein	PMID:24780912
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TXNDC5 mRNA	PMID:22171008
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313293	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TXNDC5 mRNA	PMID:29264374
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313293	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TXNDC5 gene	PMID:35295148
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313293	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of TXNDC5 mRNA	PMID:18648102
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313293	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TXNDC5 mRNA	PMID:18301758
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of TXNDC5 protein	PMID:34186270
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313293	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TXNDC5 protein	PMID:35999755
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2323973	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TXNDC5 mRNA	PMID:34947998
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:2323973	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TXNDC5 mRNA	PMID:36041667
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of TXNDC5 protein	PMID:31675489
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of TXNDC5 protein	PMID:34186270
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313293	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TXNDC5 mRNA	PMID:39298647
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:2323973	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TXNDC5 mRNA	PMID:36041667
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:2323973	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TXNDC5 mRNA	PMID:36041667
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313293	E	RGD:6480464	20220607	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TXNDC5 protein	PMID:34864091
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313293	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TXNDC5 mRNA	PMID:34813904
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of TXNDC5 protein	PMID:38598786
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNDC5 mRNA	PMID:35301059
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313293	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TXNDC5 mRNA	PMID:37236586
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TXNDC5 mRNA	PMID:19320972
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:C018021	[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of TXNDC5 mRNA; [cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of TXNDC5 protein	PMID:23326410
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of TXNDC5 mRNA	PMID:33512557
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313293	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of TXNDC5 mRNA	PMID:36331819
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TXNDC5 mRNA	PMID:25979313
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313293	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of TXNDC5 mRNA	PMID:21427059
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D016572	Cyclosporine results in increased expression of TXNDC5 mRNA	PMID:20106945|PMID:21163907
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313293	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in increased expression of TXNDC5 mRNA	PMID:25270620
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of TXNDC5 mRNA	PMID:33512557
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313293	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TXNDC5 mRNA	PMID:17562736
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:2323973	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TXNDC5 mRNA	PMID:33387578
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313293	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in increased expression of TXNDC5 mRNA	PMID:29246445
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313293	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of TXNDC5 mRNA]	PMID:29246445
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313293	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TXNDC5 mRNA	PMID:29279043
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC5 mRNA	PMID:39836092
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313293	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TXNDC5 mRNA	PMID:40504410
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of TXNDC5 mRNA	PMID:31675489
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:5011	fenpyroximate	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of TXNDC5 mRNA	PMID:33512557
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313293	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of TXNDC5 protein	PMID:21135415
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313293	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TXNDC5 mRNA	PMID:35964746
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:52646	leptomycin B	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C038753	leptomycin B results in increased expression of TXNDC5 mRNA	PMID:24515801
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:52646	leptomycin B	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C038753	1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane inhibits the reaction [leptomycin B results in increased expression of TXNDC5 mRNA]	PMID:24515801
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313293	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TXNDC5 mRNA	PMID:19042947
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:6030	isoniazide	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of TXNDC5 protein	PMID:40015660
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TXNDC5 protein	PMID:32959892
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1313293	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of TXNDC5 mRNA	PMID:20003209
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:6909	metronidazole	multiple interactions	ISO	RGD:2323973	E	RGD:6480464	20191112	CTD	MESH:D008795	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein	PMID:30545405
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TXNDC5 protein	PMID:34186270
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313293	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TXNDC5 mRNA	PMID:22206623
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313293	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TXNDC5 mRNA]	PMID:22206623
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TXNDC5 protein	PMID:37664457
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:7507	neomycin	multiple interactions	ISO	RGD:2323973	E	RGD:6480464	20191112	CTD	MESH:D009355	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein	PMID:30545405
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TXNDC5 gene]	PMID:28238834
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313293	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of TXNDC5 mRNA	PMID:31388691
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313293	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TXNDC5 mRNA	PMID:38648751
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:2323973	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of TXNDC5 mRNA	PMID:21394737
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of TXNDC5 mRNA	PMID:33512557
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of TXNDC5 protein	PMID:31675489
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:2323973	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TXNDC5 mRNA	PMID:36843608
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TXNDC5 protein	PMID:37664457
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:9123	sertraline	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D020280	Sertraline results in decreased expression of TXNDC5 mRNA	PMID:24865413
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of TXNDC5 mRNA	PMID:33512557
1313292	TXNDC5	thioredoxin domain containing 5	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of TXNDC5 protein	PMID:38598786
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313296	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ALOX12B mRNA	PMID:37995155
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:15843	arachidonic acid	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D016718	[TP53 protein results in increased expression of ALOX12B mRNA] which results in increased metabolism of Arachidonic Acid	PMID:30258081
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313296	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ALOX12B mRNA	PMID:30319688
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of ALOX12B mRNA	PMID:27664576
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313296	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ALOX12B mRNA	PMID:39922521
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of ALOX12B mRNA	PMID:31256213
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313296	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ALOX12B mRNA	PMID:39922521
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALOX12B mRNA	PMID:29950665
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ALOX12B mRNA	PMID:23649840
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ALOX12B mRNA	PMID:22100608
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ALOX12B gene	PMID:27153756
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ALOX12B mRNA	PMID:23649840
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ALOX12B mRNA	PMID:22206623
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ALOX12B mRNA	PMID:32525701
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of ALOX12B mRNA	PMID:38460933
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ALOX12B mRNA	PMID:38460933
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ALOX12B mRNA	PMID:27392435
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305330	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ALOX12B mRNA	PMID:32109520
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ALOX12B mRNA	PMID:15251184
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALOX12B mRNA	PMID:21296121|PMID:23152189
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313296	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALOX12B mRNA	PMID:17035482
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20120412	CTD	MESH:D013749	[decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ALOX12B mRNA	PMID:15251184
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ALOX12B mRNA	PMID:30851411
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D004317	Doxorubicin results in increased expression of ALOX12B mRNA	PMID:30258081
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D004317	TP53 gene mutant form inhibits the reaction [Doxorubicin results in increased expression of ALOX12B mRNA]; TP53 protein promotes the reaction [Doxorubicin results in increased expression of ALOX12B mRNA]	PMID:30258081
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ALOX12B gene	PMID:28589171
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ALOX12B mRNA	PMID:37682722
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ALOX12B intron	PMID:30157460
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ALOX12B mRNA	PMID:22228805
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ALOX12B 3' UTR; Benzo(a)pyrene results in decreased methylation of ALOX12B exon	PMID:27901495
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ALOX12B mRNA	PMID:32234424
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ALOX12B promoter	PMID:27901495
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ALOX12B mRNA	PMID:29264374
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALOX12B mRNA	PMID:29950665
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313296	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ALOX12B mRNA	PMID:20813756
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALOX12B mRNA	PMID:28628672
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ALOX12B mRNA	PMID:26377693
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALOX12B mRNA	PMID:29950665
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALOX12B mRNA	PMID:28628672
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313296	E	RGD:6480464	20190219	CTD	MESH:D010269	Paraquat results in increased expression of ALOX12B mRNA	PMID:28012437
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ALOX12B mRNA	PMID:17585979
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ALOX12B gene	PMID:29154799
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALOX12B mRNA	PMID:28628672
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313296	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ALOX12B mRNA	PMID:39922521
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ALOX12B mRNA	PMID:38832940
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313296	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ALOX12B mRNA	PMID:17562736
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ALOX12B mRNA	PMID:38460933
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ALOX12B mRNA	PMID:32525701
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D004726	Endosulfan results in increased expression of ALOX12B mRNA	PMID:28108160|PMID:40706910
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ALOX12B mRNA	PMID:28628672
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of ALOX12B mRNA	PMID:15251184
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ALOX12B mRNA	PMID:15251184
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313296	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ALOX12B mRNA	PMID:23608068
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:5855	ibuprofen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007052	Ibuprofen affects the expression of ALOX12B mRNA	PMID:17070997
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313296	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ALOX12B mRNA	PMID:22206623
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:7553	niclosamide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	ALOX12B protein results in decreased susceptibility to Niclosamide	PMID:30258081
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in increased expression of ALOX12B mRNA	PMID:30258081
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:7553	niclosamide	increases expression	ISO	RGD:1313296	E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in increased expression of ALOX12B mRNA	PMID:30258081
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:7553	niclosamide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	TP53 gene mutant form inhibits the reaction [Niclosamide results in increased expression of ALOX12B mRNA]; TP53 protein mutant form inhibits the reaction [Niclosamide results in increased expression of ALOX12B mRNA]	PMID:30258081
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ALOX12B mRNA	PMID:30851411
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ALOX12B gene]	PMID:28238834
1313295	ALOX12B	arachidonate 12-lipoxygenase, 12R type	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ALOX12B mRNA	PMID:32525701
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of TPST2 mRNA	PMID:35967413
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TPST2 mRNA	PMID:39752319
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TPST2 mRNA	PMID:21632981
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TPST2 mRNA	PMID:39241906
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20161228	CTD	MESH:D008070	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of TPST2 gene	PMID:21212295
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TPST2 mRNA	PMID:37042841
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TPST2 mRNA	PMID:21179406
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TPST2 mRNA	PMID:22401849
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TPST2 mRNA	PMID:39752319
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of TPST2 mRNA	PMID:33359661
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313298	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TPST2 mRNA	PMID:33754040
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TPST2 mRNA	PMID:28818685
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TPST2 mRNA	PMID:27153756
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TPST2 mRNA	PMID:34911549
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TPST2 mRNA	PMID:18593933
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TPST2 mRNA	PMID:22206623
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TPST2 mRNA	PMID:40504410
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313298	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TPST2 mRNA	PMID:21570461
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TPST2 mRNA	PMID:17949056
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305331	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TPST2 mRNA	PMID:33387578|PMID:34747641
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TPST2 mRNA	PMID:19933214
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases methylation	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased methylation of TPST2 gene	PMID:21212295
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TPST2 mRNA; [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of TPST2 gene	PMID:17942748|PMID:21212295
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TPST2 mRNA	PMID:23179753
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TPST2 mRNA	PMID:33212167
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TPST2 protein	PMID:28918527
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TPST2 mRNA	PMID:40504410
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TPST2 5' UTR	PMID:27901495
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TPST2 mRNA	PMID:32234424
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313298	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TPST2 exon; Benzo(a)pyrene results in decreased methylation of TPST2 intron	PMID:27901495
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TPST2 mRNA	PMID:18593933
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305331	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of TPST2 mRNA	PMID:24136188
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305331	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TPST2 mRNA	PMID:30047161
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TPST2 mRNA	PMID:29264374
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313298	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TPST2 gene	PMID:35295148
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1305331	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TPST2 mRNA	PMID:19162173
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305331	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of TPST2 mRNA	PMID:19167457
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305331	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TPST2 mRNA	PMID:25181051
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313298	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TPST2 promoter	PMID:27312807
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313298	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of TPST2 mRNA	PMID:39298647
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313298	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TPST2 gene	PMID:31683443
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1305331	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of TPST2 mRNA	PMID:21241498
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313298	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TPST2 mRNA	PMID:37019170
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TPST2 mRNA	PMID:17917374
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TPST2 mRNA	PMID:37042841
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305331	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of TPST2 mRNA	PMID:30589522
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TPST2 mRNA	PMID:40194260
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TPST2 mRNA	PMID:23179753|PMID:23527032
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305331	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TPST2 mRNA	PMID:30047161
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TPST2 mRNA	PMID:25562108
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TPST2 mRNA	PMID:14699072
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:43572	kojic acid	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:C011890	[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TPST2 mRNA	PMID:17917374
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305331	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of TPST2 mRNA	PMID:24136188
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of TPST2 mRNA	PMID:26272509
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPST2 mRNA	PMID:27188386
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TPST2 mRNA	PMID:17562736
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of TPST2 mRNA	PMID:29067470
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305331	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TPST2 mRNA	PMID:33387578
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TPST2 protein affects the susceptibility to Fluorouracil	PMID:16217747
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of TPST2 mRNA	PMID:24714768
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TPST2 mRNA	PMID:40504410
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305331	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TPST2 mRNA	PMID:29391264
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TPST2 mRNA	PMID:22079256
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TPST2 mRNA	PMID:17942748
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305331	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TPST2 mRNA	PMID:30047161
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305331	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of TPST2 mRNA	PMID:19162173
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TPST2 mRNA	PMID:35964746
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305331	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of TPST2 mRNA	PMID:24136188
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of TPST2 mRNA	PMID:15336504
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305331	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TPST2 gene	PMID:35440735
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TPST2 mRNA	PMID:39752319
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TPST2 mRNA	PMID:31758290
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313298	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TPST2 mRNA	PMID:22206623
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TPST2 mRNA	PMID:22206623
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TPST2 mRNA	PMID:22079256
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TPST2 mRNA	PMID:22079256
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPST2 mRNA	PMID:27188386
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305331	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TPST2 mRNA	PMID:19162173
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305331	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TPST2 mRNA	PMID:30047161
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313298	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TPST2 mRNA	PMID:39752319
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TPST2 mRNA	PMID:27188386
1313297	TPST2	tyrosylprotein sulfotransferase 2	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305331	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of TPST2 gene	PMID:31079544
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of MDM2 mRNA	PMID:31863870
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:10110	zidovudine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	Zidovudine results in increased expression of MDM2 protein	PMID:16797627
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:113532	thymoquinone	decreases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:C003466	thymoquinone results in decreased expression of MDM2 protein	PMID:31433961|PMID:34627931
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:119486	efavirenz	increases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:C098320	efavirenz results in increased expression of MDM2 mRNA	PMID:40582629
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:1224	2-nitrofluorene	increases expression	ISO	RGD:1305332	E	RGD:6480464	20130416	CTD	MESH:C019499	2-nitrofluorene results in increased expression of MDM2 mRNA	PMID:14600272|PMID:15890375|PMID:22484513|PMID:23052194
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313300	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of MDM2 mRNA	PMID:33045310
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MDM2 mRNA]	PMID:31150632
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of MDM2 mRNA	PMID:31016361
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:136609	theaflavin	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20180206	CTD	MESH:C056068	[theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]	PMID:23717041
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:142921	3-phenylprop-2-enal	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased expression of MDM2 mRNA	PMID:19000754
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MDM2 gene	PMID:20938992
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D001241	Aspirin results in decreased expression of MDM2 mRNA	PMID:20457246
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010100	Oxygen deficiency results in increased expression of MDM2 mRNA; Oxygen deficiency results in increased expression of MDM2 protein	PMID:19502547|PMID:19578757|PMID:19714248|PMID:25596134
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010100	[Cisplatin co-treated with eprenetapopt co-treated with Oxygen deficiency] results in increased expression of MDM2 mRNA; [Oxygen deficiency co-treated with eprenetapopt] results in increased expression of MDM2 mRNA; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]]; Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 protein]	PMID:19578757|PMID:29690507
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MDM2 mRNA	PMID:30529165
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:15600	(+)-catechin	decreases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D002392	Catechin results in decreased expression of MDM2 mRNA	PMID:23706674
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:15738	staurosporine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019311	Staurosporine inhibits the reaction [EGF protein inhibits the reaction [resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]]	PMID:15542774
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:15864	luteolin	increases expression	ISO	RGD:1305332	E	RGD:6480464	20210706	CTD	MESH:D047311	Luteolin results in increased expression of MDM2 mRNA	PMID:31201582
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:15864	luteolin	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20170110	CTD	MESH:D047311	Luteolin promotes the reaction [Hydrogen Peroxide results in increased expression of MDM2 mRNA]	PMID:27525270
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305332	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MDM2 gene	PMID:28931070|PMID:35440735
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16096	palmatine	affects binding	EXP		E	RGD:6480464	20230606	CTD	MESH:C005413	palmatine binds to MDM2 protein	PMID:35997646
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16130	DDT	increases expression	ISO	RGD:1313300	E	RGD:6480464	20140211	CTD	MESH:D003634	DDT results in increased expression of MDM2 mRNA; DDT results in increased expression of MDM2 protein	PMID:23684557
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16130	DDT	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20140211	CTD	MESH:D003634	Androstanols inhibits the reaction [DDT results in increased expression of MDM2 mRNA]	PMID:23684557
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20130416	CTD	MESH:D000431	Ethanol results in decreased expression of MDM2 mRNA	PMID:22535522
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of MDM2 protein	PMID:25005833
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of MDM2 mRNA	PMID:21751221
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1305332	E	RGD:6480464	20170110	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of MDM2 mRNA	PMID:14689451|PMID:27525270
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	EUK-134 inhibits the reaction [Hydrogen Peroxide results in decreased expression of MDM2 protein]; Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of MDM2 protein]; Hydrogen Peroxide promotes the reaction [TP53 protein binds to MDM2 promoter]; Hydrogen Peroxide promotes the reaction [TP53 protein results in increased expression of MDM2]	PMID:21552291|PMID:25005833
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20170110	CTD	MESH:D006861	[Quercetin co-treated with Hydrogen Peroxide] results in increased expression of MDM2 mRNA; Hydrogen Peroxide results in increased expression of and affects the localization of MDM2 protein; Luteolin promotes the reaction [Hydrogen Peroxide results in increased expression of MDM2 mRNA]	PMID:14689451|PMID:27525270
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide promotes the reaction [TRP53 protein results in increased expression of MDM2]	PMID:21552291
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D011794	Quercetin results in decreased expression of MDM2 protein	PMID:21933852
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D011794	Quercetin results in increased expression of MDM2 mRNA	PMID:21632981|PMID:23727915|PMID:24849437
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1305332	E	RGD:6480464	20210706	CTD	MESH:D011794	Quercetin results in increased expression of MDM2 mRNA	PMID:31201582
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of and results in decreased expression of MDM2 protein	PMID:17973296
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20170110	CTD	MESH:D011794	[Quercetin co-treated with Hydrogen Peroxide] results in increased expression of MDM2 mRNA	PMID:27525270
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MDM2 mRNA	PMID:35953652
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313300	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MDM2 mRNA	PMID:10975854|PMID:23107598
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20161228	CTD	MESH:D008070	Indirubin E804 inhibits the reaction [Lipopolysaccharides results in increased expression of MDM2 mRNA]	PMID:23107598
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16469	17beta-estradiol	decreases phosphorylation	ISO	RGD:1313300	E	RGD:6480464	20120717	CTD	MESH:D004958	Estradiol results in decreased phosphorylation of MDM2 protein	PMID:22314386
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of MDM2 mRNA alternative form; Estradiol results in increased expression of MDM2 protein	PMID:12168835
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20140211	CTD	MESH:D004958	Estradiol results in increased expression of MDM2 mRNA; Estradiol results in increased expression of MDM2 protein	PMID:23684557
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D004958	[Estradiol co-treated with Parathion] results in increased expression of MDM2 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of MDM2 mRNA	PMID:17622325|PMID:30165855
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:165199	Paraoxon-methyl	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C008480	methylparaoxon results in increased expression of MDM2 mRNA	PMID:18418871
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:165219	PCB138	increases phosphorylation	EXP		E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16602	trichloroethene	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene affects the expression of MDM2 mRNA	PMID:21135412
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305332	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MDM2 mRNA	PMID:33387578
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D014241	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of MDM2 mRNA	PMID:17905399
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MDM2 gene	PMID:20938992
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120918	CTD	MESH:D001554	Benzene results in increased expression of MDM2 mRNA	PMID:11896287|PMID:15342939|PMID:15935812
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16716	benzene	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:D001554	MDM2 gene polymorphism affects the reaction [CDKN2A gene polymorphism affects the susceptibility to Benzene]	PMID:19596022
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16716	benzene	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D001554	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of MDM2 mRNA	PMID:17905399
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16716	benzene	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D001554	TRP53 protein affects the reaction [Benzene results in increased expression of MDM2 mRNA]	PMID:11896287
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of MDM2 mRNA; Formaldehyde results in increased expression of MDM2 protein	PMID:18045764|PMID:23649840
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of MDM2 mRNA; Formaldehyde results in increased expression of MDM2 protein	PMID:18045764
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of MDM2 mRNA	PMID:26079696
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17154	nicotinamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009536	Niacinamide results in increased expression of MDM2 mRNA	PMID:16998810
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MDM2 protein	PMID:24706461
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313300	E	RGD:6480464	20250311	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of MDM2 mRNA	PMID:20463053|PMID:33162236
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MDM2 mRNA	PMID:20403060
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1305332	E	RGD:6480464	20140715	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of MDM2 mRNA; 2-Acetylaminofluorene results in increased expression of MDM2 protein	PMID:19167416|PMID:22213190|PMID:22584684
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20121113	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of MDM2 mRNA	PMID:21607683
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17356	2-acetamidofluorene	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D015073	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of MDM2 protein	PMID:11003613
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:174442	Carbadox	increases expression	ISO	RGD:1305332	E	RGD:6480464	20210706	CTD	MESH:D002218	Carbadox results in increased expression of MDM2 mRNA	PMID:26558467
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17580	linalool	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C018584	linalool results in increased expression of MDM2 mRNA	PMID:19922762
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:175901	gemcitabine	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in decreased expression of MDM2 mRNA	PMID:20103597
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:175901	gemcitabine	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in increased expression of MDM2 mRNA	PMID:17039268
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone results in increased expression of MDM2 mRNA	PMID:29221148
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MDM2 mRNA	PMID:23892564
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:D009538	[[Nicotine results in decreased expression of RPS27A protein] which results in increased phosphorylation of MDM2 protein] which results in increased ubiquitination of TP53 protein; [Nicotine results in decreased expression of RPS27A protein] which results in increased phosphorylation of MDM2 protein	PMID:30272249
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:177387	brequinar	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C046943	brequinar results in increased expression of MDM2 mRNA	PMID:39900124
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases phosphorylation	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased phosphorylation of MDM2 protein	PMID:31163220
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MDM2 mRNA	PMID:31163220
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MDM2 protein	PMID:37730182
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305332	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MDM2 mRNA	PMID:22061828|PMID:33387578
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:1784	biphenyl-4-amine	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C006757	4-biphenylamine results in increased expression of MDM2 mRNA	PMID:32905825
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:1784	biphenyl-4-amine	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C006757	TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of MDM2 mRNA]	PMID:32905825
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17846	(S)-naringenin	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C005273	naringenin metabolite results in increased expression of MDM2 mRNA	PMID:36235125
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17846	(S)-naringenin	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C005273	[naringenin co-treated with bisphenol A] results in increased expression of MDM2 mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of MDM2 mRNA	PMID:36235125
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:17967	urethane	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D014520	[Urethane co-treated with Freund's Adjuvant] results in increased expression of MDM2 mRNA	PMID:12400877
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:180692	EUK-134	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C433928	EUK-134 inhibits the reaction [Hydrogen Peroxide results in decreased expression of MDM2 protein]; EUK-134 inhibits the reaction [Vitamin K 3 results in decreased expression of MDM2 protein]	PMID:25005833
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:18088	formononetin	increases expression	ISO	RGD:1305332	E	RGD:6480464	20171010	CTD	MESH:C007768	formononetin results in increased expression of MDM2 protein	PMID:28414026
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:181416	Leucomalachite green	increases phosphorylation	ISO	RGD:1305332	E	RGD:6480464	20211109	CTD	MESH:C015320	leucomalachite green results in increased phosphorylation of MDM2 protein	PMID:26558467
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:18291	manganese atom	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20150825	CTD	MESH:D008345	Manganese results in decreased expression of MDM2 protein	PMID:25791630
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20150825	CTD	MESH:D008345	[Manganese co-treated with NGF protein] results in decreased expression of MDM2 protein; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of MDM2 protein]	PMID:25791630
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:184401	3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C045421	3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of MDM2 mRNA	PMID:23810796
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:D009538	[[Nicotine results in decreased expression of RPS27A protein] which results in increased phosphorylation of MDM2 protein] which results in increased ubiquitination of TP53 protein; [Nicotine results in decreased expression of RPS27A protein] which results in increased phosphorylation of MDM2 protein	PMID:30272249
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:188855	Octicizer	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C018535	2-ethylhexyldiphenylphosphate results in increased expression of MDM2 mRNA	PMID:30981936
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:195250	corn oil	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20230704	CTD	MESH:D003314	Corn Oil results in decreased expression of MDM2 mRNA	PMID:22760963
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:196991	4-hydroperoxycyclophosphamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011272	perfosfamide results in increased expression of MDM2	PMID:18034189
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:201674	icaritin	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C499403	icaritin results in decreased expression of MDM2 protein	PMID:38431053
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:2038	5-azacytidine	increases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of MDM2 mRNA	PMID:20823114
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of MDM2 mRNA	PMID:12634122
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120814	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of MDM2 protein	PMID:12135628
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120814	CTD	MESH:D008769	Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in increased expression of MDM2 protein]	PMID:12135628
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:229764	selinexor	increases expression	EXP		E	RGD:6480464	20240409	CTD	MESH:C585161	selinexor results in increased expression of MDM2 protein	PMID:37899423
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:229764	selinexor	multiple interactions	EXP		E	RGD:6480464	20240409	CTD	MESH:C585161	[INCB057643 co-treated with selinexor] results in increased expression of MDM2 protein	PMID:37899423
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20121009	CTD	MESH:D002104	Cadmium results in decreased expression of MDM2 mRNA	PMID:21467746
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313300	E	RGD:6480464	20121113	CTD	MESH:D002104	Cadmium results in increased expression of MDM2 mRNA	PMID:22666406
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[sulforaphane co-treated with Cadmium] results in increased expression of MDM2 mRNA	PMID:31035011
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:229924	pifithrin-alpha hydrobromide	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20240409	CTD	MESH:C121565	pifithrin inhibits the reaction [Arsenic Trioxide results in increased expression of MDM2 mRNA]	PMID:17487067
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:229924	pifithrin-alpha hydrobromide	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20240409	CTD	MESH:C121565	pifithrin inhibits the reaction [Doxorubicin results in increased expression of MDM2 mRNA]; pifithrin inhibits the reaction [Vehicle Emissions results in decreased expression of MDM2 protein]	PMID:14766674|PMID:18940243
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:231415	DENSPM	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C059685	N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein	PMID:15546879
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:231415	DENSPM	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:C059685	Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]; TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]]; TP53 protein promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]	PMID:15546879
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:232486	5-ethynyl-2'-deoxyuridine	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C031086	5-ethynyl-2'-deoxyuridine results in decreased expression of MDM2 protein	PMID:42178126
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:232796	cadmium acetate	increases expression	EXP		E	RGD:6480464	20250107	CTD	MESH:C028031	cadmium acetate results in increased expression of MDM2 protein	PMID:15450950
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	increases phosphorylation	EXP		E	RGD:6480464	20250408	CTD	MESH:C081766	2,4,4'-trichlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709|PMID:20840854
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20250408	CTD	MESH:C081766	2,4,4'-trichlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]	PMID:20840854
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	increases phosphorylation	EXP		E	RGD:6480464	20250408	CTD	MESH:C009828	2,4,5,2',5'-pentachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709|PMID:20840854
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	EXP		E	RGD:6480464	20250408	CTD	MESH:C009828	2,4,5,2',5'-pentachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; MDM2 mutant form inhibits the reaction [2,4,5,2',5'-pentachlorobiphenyl results in decreased phosphorylation of FOXO3 protein]	PMID:20840854
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:23704	diepoxybutane	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C007366	diepoxybutane inhibits the reaction [TP53 protein binds to MDM2 protein]	PMID:20024960
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MDM2 mRNA	PMID:23649840
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D005038	Ethylnitrosourea results in increased expression of MDM2 mRNA	PMID:15954086
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D005038	Ethylnitrosourea results in increased expression of MDM2 mRNA	PMID:19100860
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MDM2 protein	PMID:20106945
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MDM2 gene	PMID:27153756
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MDM2 mRNA	PMID:21632981|PMID:21641981|PMID:27153756|PMID:29445054|PMID:31555880|PMID:32234424
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305332	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MDM2 mRNA	PMID:14600272|PMID:15890375|PMID:22484513|PMID:23052194|PMID:23630614|PMID:25378103|PMID:33354967
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MDM2 mRNA	PMID:19770486
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MDM2 mRNA; Methyl Methanesulfonate results in increased expression of MDM2 protein	PMID:23649840|PMID:25078064
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of MDM2 mRNA	PMID:15651846
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D009151	Mustard Gas results in increased expression of MDM2 mRNA	PMID:33491125
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120501	CTD	MESH:D009151	Mustard Gas results in increased expression of MDM2 mRNA	PMID:15674843|PMID:18955075
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20140610	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of MDM2 mRNA; 9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA	PMID:23717041|PMID:32553695
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20140610	CTD	MESH:D015127	[epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]; [theaflavin co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]; theaflavin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]	PMID:23717041
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:2636	amifostine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004999	Amifostine results in decreased expression of MDM2 mRNA	PMID:14555708
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:26523	reactive oxygen species	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D017382	[[[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased phosphorylation of and results in increased stability of TP53 protein] which results in increased expression of MDM2 protein	PMID:27634759
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305332	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of MDM2 mRNA	PMID:30779732
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:2687	amsacrine	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D000677	MDM2 promoter SNP results in decreased susceptibility to Amsacrine	PMID:17575151
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27363	zinc atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of MDM2 protein	PMID:16636310
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27363	zinc atom	increases ubiquitination	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in increased ubiquitination of MDM2 protein	PMID:16965791
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc binds to and results in increased folding of MDM2 protein; Zinc promotes the reaction [MDM2 protein binds to MDM2 protein]; Zinc promotes the reaction [MDM2 protein binds to MDM4 protein]	PMID:16965791
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305332	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MDM2 mRNA	PMID:31150632
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313300	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MDM2 mRNA	PMID:31919559
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MDM2 mRNA]	PMID:31150632
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27470	folic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid affects the expression of MDM2 mRNA	PMID:16361273
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MDM2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MDM2 gene	PMID:20938992|PMID:22206623
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27504	mitomycin C	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016685	Mitomycin results in increased expression of MDM2 protein	PMID:18096571
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27504	mitomycin C	increases expression	ISO	RGD:1313300	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in increased expression of MDM2 mRNA	PMID:25270620
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27504	mitomycin C	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D016685	[Mitomycin results in increased stability of TP53 protein] which results in increased expression of MDM2 mRNA	PMID:20536192
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MDM2 gene	PMID:25304211
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27563	arsenic atom	affects response to substance	EXP		E	RGD:6480464	20120918	CTD	MESH:D001151	MDM2 SNP affects the susceptibility to Arsenic	PMID:21982800
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27563	arsenic atom	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	Arsenic results in increased expression of MDM2 protein	PMID:35821281
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MDM2 mRNA; USP7 protein affects the reaction [Arsenic results in increased expression of MDM2 protein]	PMID:35821281|PMID:39836092
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of MDM2 mRNA	PMID:33512557
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27638	cobalt atom	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D003035	Cobalt results in increased expression of MDM2 mRNA	PMID:24068677
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27638	cobalt atom	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:D003035	TP53 protein affects the reaction [Cobalt results in increased expression of MDM2 mRNA]	PMID:24068677
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002166	Camptothecin results in increased expression of MDM2 protein	PMID:17555331
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	Dactinomycin results in increased expression of MDM2 mRNA	PMID:38460933
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of MDM2 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of MDM2 protein	PMID:38460933
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MDM2 mRNA	PMID:26272509
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA	PMID:27188386
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MDM2 protein	PMID:35688186
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of MDM2 mRNA	PMID:31295307
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305332	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MDM2 mRNA	PMID:31881176
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27871	chloroacetaldehyde	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in increased expression of MDM2 mRNA	PMID:25596134
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27881	resveratrol	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol affects the expression of MDM2 protein	PMID:16369916
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C059514	resveratrol results in decreased expression of MDM2 mRNA; resveratrol results in decreased expression of MDM2 protein	PMID:16998810|PMID:19846903|PMID:20878097|PMID:25667456
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C059514	resveratrol results in increased expression of MDM2 mRNA	PMID:15280659|PMID:15767336|PMID:25888808
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of MDM2 mRNA; resveratrol results in increased expression of MDM2 protein	PMID:11245472|PMID:16081268|PMID:16369916
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MDM2 mRNA; Capsaicin promotes the reaction [Resveratrol results in decreased expression of MDM2 protein]; EGF protein inhibits the reaction [Resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]; Resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]; Resveratrol promotes the reaction [Capsaicin results in decreased expression of MDM2 protein]; Staurosporine inhibits the reaction [EGF protein inhibits the reaction [Resveratrol inhibits the reaction [TP53 protein binds to MDM2 protein]]]; TP53 affects the reaction [Resveratrol results in decreased expression of MDM2 protein]	PMID:15542774|PMID:19846903|PMID:23557933
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20121218	CTD	MESH:C059514	[resveratrol results in increased phosphorylation of TRP53 protein] inhibits the reaction [TRP53 protein binds to MDM2 protein]	PMID:11245472
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20230502	CTD	MESH:D002945	Cisplatin results in decreased expression of MDM2 mRNA; Cisplatin results in decreased expression of MDM2 protein	PMID:35842499
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of MDM2 mRNA; Cisplatin results in increased expression of MDM2 protein	PMID:16797627|PMID:24280081|PMID:25450742|PMID:25596134|PMID:32856486|PMID:33545341|PMID:38498338
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1305332	E	RGD:6480464	20141223	CTD	MESH:D002945	Cisplatin results in increased expression of MDM2 mRNA	PMID:24880025
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313300	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in increased expression of MDM2 mRNA; Cisplatin results in increased expression of MDM2 protein	PMID:21151649|PMID:24280081|PMID:25270620|PMID:32856486|PMID:35842499
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with eprenetapopt co-treated with Oxygen deficiency] results in increased expression of MDM2 mRNA; [Cisplatin co-treated with eprenetapopt] results in increased expression of MDM2 mRNA; [TP53 protein binds to MDM2 protein] which results in decreased susceptibility to Cisplatin; Cisplatin promotes the reaction [TP53 protein binds to MDM2 promoter]; Cisplatin promotes the reaction [TP53 protein results in increased expression of MDM2]; Cisplatin results in increased activity of and results in increased expression of MDM2 protein; MDM2 protein promotes the reaction [Cisplatin results in increased cleavage of CASP3 protein]; MDM2 protein promotes the reaction [Cisplatin results in increased expression of HES1 protein]; MDM2 protein promotes the reaction [Cisplatin results in increased expression of MDM2 protein]; NOTCH1 protein affects the reaction [MDM2 protein promotes the reaction [Cisplatin results in increased cleavage of CASP3 protein]]; NOTCH1 protein affects the reaction [MDM2 protein promotes the reaction [Cisplatin results in increased expression of HES1 protein]]; nutlin 3 promotes the reaction [Cisplatin results in increased activity of and results in increased expression of MDM2 protein]; TP53 affects the reaction [Cisplatin results in increased activity of and results in increased expression of MDM2 protein]; TP53 affects the reaction [nutlin 3 promotes the reaction [Cisplatin results in increased activity of and results in increased expression of MDM2 protein]]	PMID:21509038|PMID:21552291|PMID:21624110|PMID:29690507|PMID:32856486
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20230502	CTD	MESH:D002945	Cisplatin promotes the reaction [NFE2L2 protein results in increased expression of MDM2 mRNA]; NFE2L2 protein inhibits the reaction [Cisplatin results in decreased expression of MDM2 mRNA]; NFE2L2 protein inhibits the reaction [Cisplatin results in decreased expression of MDM2 protein]	PMID:35842499
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin promotes the reaction [TRP53 protein results in increased expression of MDM2]; NFE2L2 protein affects the reaction [Cisplatin results in increased expression of MDM2 mRNA]; NFE2L2 protein affects the reaction [Cisplatin results in increased expression of MDM2 protein]; nutlin 3 inhibits the reaction [Cisplatin results in increased expression of MDM2 protein]	PMID:21552291|PMID:32856486|PMID:35842499
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:27928	parathion	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D010278	[Estradiol co-treated with Parathion] results in increased expression of MDM2 mRNA	PMID:17622325
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28077	rifampicin	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D012293	[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of MDM2 mRNA	PMID:21224054
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of MDM2 mRNA	PMID:21048042
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D009532	Nickel results in increased expression of MDM2 mRNA	PMID:24068677
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:D009532	TP53 protein affects the reaction [Nickel results in increased expression of MDM2 mRNA]	PMID:24068677
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313300	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MDM2 mRNA	PMID:21570461
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MDM2 mRNA	PMID:16039398
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases degradation	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased degradation of MDM2 protein	PMID:15459018
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MDM2 mRNA	PMID:19578757
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305332	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MDM2 mRNA	PMID:33387578
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313300	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MDM2 mRNA	PMID:12167310|PMID:21041162|PMID:26290441
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased phosphorylation of MDM2 protein	PMID:19751709
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases phosphorylation	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased phosphorylation of MDM2 protein	PMID:15459018
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MDM2 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 protein]; Tetrachlorodibenzodioxin results in decreased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein modified form]; Tetrachlorodibenzodioxin results in decreased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein]	PMID:19578757|PMID:22044530
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin inhibits the reaction [Etoposide results in increased expression of MDM2 protein]; Tetrachlorodibenzodioxin results in increased expression of and results in increased phosphorylation of and results in increased activity of MDM2 protein	PMID:15459018
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MDM2 mRNA	PMID:17942748
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of MDM2 mRNA	PMID:33512557
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20140610	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MDM2 mRNA	PMID:23202902
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MDM2 mRNA	PMID:28001369
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28277	brassinolide	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C023623	brassinolide results in decreased expression of MDM2 protein	PMID:20833159
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of MDM2 mRNA	PMID:26272509
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA	PMID:27188386
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of MDM2 mRNA	PMID:16001973
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of MDM2 mRNA	PMID:23649840
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28509	chloroethene	affects response to substance	EXP		E	RGD:6480464	20140513	CTD	MESH:D014752	MDM2 polymorphism affects the susceptibility to Vinyl Chloride	PMID:24464562
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1313300	E	RGD:6480464	20130910	CTD	MESH:D003300	Copper results in increased expression of MDM2 mRNA	PMID:16629173
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MDM2 mRNA	PMID:30911355
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D004317	Doxorubicin affects the expression of MDM2 mRNA	PMID:25529476|PMID:29803840
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1313300	E	RGD:6480464	20180828	CTD	MESH:D004317	Doxorubicin affects the expression of MDM2 mRNA	PMID:29653124
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	decreases response to substance	EXP		E	RGD:6480464	20160119	CTD	MESH:D004317	MDM2 protein results in decreased susceptibility to Doxorubicin	PMID:26317544
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D004317	Doxorubicin results in increased expression of MDM2 mRNA; Doxorubicin results in increased expression of MDM2 protein	PMID:14665630|PMID:17653088|PMID:17959036|PMID:19074854|PMID:19560264|PMID:26317544
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1305332	E	RGD:6480464	20161025	CTD	MESH:D004317	Doxorubicin results in increased expression of MDM2 mRNA	PMID:12187937|PMID:27255381|PMID:34713381
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120501	CTD	MESH:D004317	Doxorubicin results in increased expression of MDM2 mRNA	PMID:14766674|PMID:16949053|PMID:34713381
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased phosphorylation of MDM2 protein	PMID:17935137
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin inhibits the reaction [TP53 protein binds to MDM2 protein]; Doxorubicin results in increased activity of and results in increased expression of MDM2 protein; IFNA1 protein promotes the reaction [Doxorubicin results in increased expression of MDM2 protein]; MDM2 protein inhibits the reaction [HIPK2 protein promotes the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein]]; MDM2 protein promotes the reaction [cobaltous chloride inhibits the reaction [HIPK2 protein promotes the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein]]]; nutlin 3 promotes the reaction [Doxorubicin results in increased activity of and results in increased expression of MDM2 protein]; SETD7 mutant form promotes the reaction [Doxorubicin results in increased expression of MDM2 mRNA]; SETD7 mutant form promotes the reaction [Doxorubicin results in increased expression of MDM2 protein]; TP53 affects the reaction [Doxorubicin results in increased activity of and results in increased expression of MDM2 protein]; TP53 affects the reaction [nutlin 3 promotes the reaction [Doxorubicin results in increased activity of and results in increased expression of MDM2 protein]]; wortmannin promotes the reaction [Doxorubicin results in increased phosphorylation of MDM2 protein]	PMID:17935137|PMID:17959036|PMID:19351845|PMID:19714248|PMID:21624110|PMID:26317544
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004317	pifithrin inhibits the reaction [Doxorubicin results in increased expression of MDM2 mRNA]	PMID:14766674
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MDM2 mRNA	PMID:23783067
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28794	coumarin	decreases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:C030123	coumarin analog results in decreased expression of MDM2 mRNA	PMID:32578917
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28830	chlorambucil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002699	Chlorambucil results in increased expression of MDM2 mRNA	PMID:17476690
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28863	flavanones	increases phosphorylation	EXP		E	RGD:6480464	20170303	CTD	MESH:D044950	Flavanones results in increased phosphorylation of MDM2 protein	PMID:21616090
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28869	menadione	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of MDM2 protein	PMID:25005833
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:28869	menadione	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D024483	EUK-134 inhibits the reaction [Vitamin K 3 results in decreased expression of MDM2 protein]	PMID:25005833
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20120918	CTD	MESH:D001205	Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of MDM2 protein]	PMID:21262251
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of MDM2 mRNA	PMID:36057382
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of MDM2 mRNA	PMID:29319823
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MDM2 protein	PMID:16166651
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MDM2 mRNA; sodium arsenite results in increased expression of MDM2 protein; sodium arsenite results in increased expression of MDM2 protein alternative form	PMID:11813266|PMID:12016162|PMID:19010883|PMID:20375080|PMID:28785074|PMID:29301061|PMID:29319823|PMID:32844245|PMID:39900124
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313300	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MDM2 mRNA	PMID:11353140|PMID:20477944|PMID:39232337
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased expression of MDM2 protein]; [sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MDM2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MDM2 mRNA; MAPK1 protein promotes the reaction [sodium arsenite results in increased expression of MDM2 protein]; TP53 protein mutant form inhibits the reaction [sodium arsenite results in increased expression of MDM2 mRNA]; TP53 protein promotes the reaction [sodium arsenite results in increased expression of MDM2 protein]	PMID:20375080|PMID:23192986|PMID:28785074|PMID:39836092
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20250805	CTD	MESH:C017947	Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in increased expression of MDM2 mRNA]	PMID:39232337
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D014415	Tunicamycin results in increased expression of MDM2 mRNA	PMID:39900124
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29852	methylarsonic acid	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:C020300	monomethylarsonic acid results in increased expression of MDM2 mRNA	PMID:17481689
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29852	methylarsonic acid	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:C020300	[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MDM2 mRNA	PMID:23192986
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MDM2 mRNA	PMID:30562542
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MDM2 protein	PMID:21467743
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MDM2 mRNA; Benzo(a)pyrene results in increased expression of MDM2 protein; Benzo(a)pyrene results in increased expression of MDM2 protein modified form	PMID:10837373|PMID:18418871|PMID:20106945|PMID:21632981|PMID:21871943|PMID:22044530|PMID:22316170|PMID:22889811|PMID:25690898|PMID:26238291|PMID:27694624|PMID:28461126|PMID:30562542|PMID:31555880|PMID:32234424|PMID:40280401
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of MDM2 mRNA; Benzo(a)pyrene results in increased expression of MDM2 mRNA	PMID:18656336|PMID:19146932|PMID:19770486|PMID:21569818|PMID:22228805|PMID:22610609|PMID:23735875|PMID:32553695|PMID:9006915
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	increases phosphorylation	EXP		E	RGD:6480464	20150609	CTD	MESH:D001564	Benzo(a)pyrene results in increased phosphorylation of MDM2 protein	PMID:20840854|PMID:25744307
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	2,4,4'-trichlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; 2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; 2,4,5,2',5'-pentachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; 3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of MDM2 mRNA; Benzo(a)pyrene promotes the reaction [TP53 protein binds to MDM2 protein]; Benzo(a)pyrene results in increased expression of and results in increased phosphorylation of MDM2 protein; Cadmium Chloride affects the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; MAPK3 mutant form inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; MDM2 mutant form promotes the reaction [Benzo(a)pyrene results in increased expression of TP53 protein]; Simvastatin promotes the reaction [Benzo(a)pyrene promotes the reaction [TP53 protein binds to MDM2 protein]]; TP53 affects the reaction [Benzo(a)pyrene results in increased expression of MDM2 mRNA]; U 0126 inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]	PMID:10837373|PMID:15625077|PMID:17690111|PMID:18096571|PMID:20840854|PMID:25744307|PMID:40280401
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:27858113
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29866	arsenite(3-)	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite results in increased expression of MDM2 mRNA; arsenite results in increased expression of MDM2 protein; arsenite results in increased expression of MDM2 protein modified form	PMID:30177839|PMID:34425169
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C015001	[[[arsenite results in increased activity of PRKDC protein] which results in increased phosphorylation of and results in increased activity of MAPK9 protein] promotes the reaction [MAPK9 protein binds to TP53 protein]] inhibits the reaction [MDM2 results in increased degradation of and results in decreased stability of TP53 protein]; arsenite inhibits the reaction [G3BP1 protein binds to MDM2 mRNA]; arsenite promotes the reaction [IKBKB protein binds to MDM2 protein]; DAPK1 protein inhibits the reaction [arsenite results in increased expression of MDM2 protein modified form]; DAPK1 protein inhibits the reaction [arsenite results in increased expression of MDM2 protein]; ETS1 protein inhibits the reaction [arsenite results in increased expression of MDM2 protein modified form]; ETS1 protein inhibits the reaction [arsenite results in increased expression of MDM2 protein]; IKBKB protein promotes the reaction [arsenite results in increased expression of MDM2 protein modified form]; IKBKB protein promotes the reaction [arsenite results in increased expression of MDM2 protein]; TP53 protein inhibits the reaction [arsenite results in increased expression of MDM2 protein modified form]; TP53 protein inhibits the reaction [arsenite results in increased expression of MDM2 protein]	PMID:22366412|PMID:30177839|PMID:32406909
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of MDM2 mRNA	PMID:36057382
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1313300	E	RGD:6480464	20130910	CTD	MESH:D003300	Copper results in increased expression of MDM2 mRNA	PMID:16629173
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MDM2 mRNA	PMID:30911355
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30185	zinc(0)	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of MDM2 protein	PMID:16636310
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30185	zinc(0)	increases ubiquitination	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in increased ubiquitination of MDM2 protein	PMID:16965791
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc binds to and results in increased folding of MDM2 protein; Zinc promotes the reaction [MDM2 protein binds to MDM2 protein]; Zinc promotes the reaction [MDM2 protein binds to MDM4 protein]	PMID:16965791
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of MDM2 mRNA	PMID:26014281
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30512	silver atom	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D012834	[Silver co-treated with Povidone] affects the expression of MDM2 protein; [Silver co-treated with Povidone] results in decreased expression of MDM2 mRNA	PMID:27387714
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MDM2 mRNA	PMID:19073995
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MDM2 mRNA	PMID:20382639|PMID:26238291|PMID:28593498
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1313300	E	RGD:6480464	20250603	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MDM2 mRNA	PMID:39826883
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MDM2 mRNA	PMID:20458559
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MDM2 mRNA; Arsenic Trioxide results in decreased expression of MDM2 protein	PMID:21145380|PMID:38070468
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MDM2 mRNA	PMID:20862710|PMID:25574600|PMID:26705709
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1305332	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MDM2 mRNA	PMID:17487067
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20191114	CTD	MESH:C006632	dapagliflozin inhibits the reaction [Arsenic Trioxide results in decreased expression of MDM2 mRNA]; pifithrin inhibits the reaction [Arsenic Trioxide results in increased expression of MDM2 mRNA]	PMID:17487067|PMID:38070468
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:30682	ruthenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012428	Ruthenium results in decreased expression of MDM2 protein	PMID:17210701
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:31175	adefovir pivoxil	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of MDM2 mRNA	PMID:25596134
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:31206	ammonium chloride	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride results in increased expression of MDM2 mRNA; Ammonium Chloride results in increased expression of MDM2 protein	PMID:12420312|PMID:16483693
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:31781	lopinavir	decreases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:D061466	Lopinavir results in decreased expression of MDM2 mRNA	PMID:40582629
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of MDM2 mRNA	PMID:23202902
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305332	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of MDM2 mRNA	PMID:25729387
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of MDM2 mRNA	PMID:25729387
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:32076	zinc pyrithione	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C010423	pyrithione zinc results in increased expression of MDM2 mRNA	PMID:21424779
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313300	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MDM2 gene	PMID:35295148
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C009495	titanium dioxide results in increased expression of MDM2 mRNA	PMID:21067279
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305332	E	RGD:6480464	20150127	CTD	MESH:D013853	Thioacetamide results in increased expression of MDM2 mRNA	PMID:18619722|PMID:22659510|PMID:23411599|PMID:25242409|PMID:26011634|PMID:34492290
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:32497	thioacetamide	increases phosphorylation	ISO	RGD:1305332	E	RGD:6480464	20160210	CTD	MESH:D013853	Thioacetamide results in increased phosphorylation of MDM2 protein	PMID:26558467
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MDM2 mRNA	PMID:18648102
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MDM2 mRNA	PMID:15890375|PMID:19162173
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:C006253	MDM2 protein affects the reaction [pirinixic acid results in increased activity of PPARA protein]; MDM2 protein promotes the reaction [[pirinixic acid results in increased activity of PPARA protein] which results in increased expression of ACOX1 mRNA]; MDM2 protein promotes the reaction [[pirinixic acid results in increased activity of PPARA protein] which results in increased expression of ANGPTL4 mRNA]; MDM2 protein promotes the reaction [[pirinixic acid results in increased activity of PPARA protein] which results in increased expression of CYP4A1 mRNA]; MDM2 protein promotes the reaction [[pirinixic acid results in increased activity of PPARA protein] which results in increased expression of EHHADH mRNA]; MDM2 protein promotes the reaction [[pirinixic acid results in increased activity of PPARA protein] which results in increased expression of FABP1 mRNA]; MDM2 protein promotes the reaction [pirinixic acid results in increased expression of PPARA protein]; pirinixic acid promotes the reaction [[PPARA protein binds to MDM2 protein] which binds to ACOX1 promoter]; pirinixic acid promotes the reaction [[PPARA protein binds to MDM2 protein] which binds to DBI promoter]; pirinixic acid promotes the reaction [MDM2 protein binds to PPARA protein]	PMID:19103650
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:32687	piperonyl butoxide	increases expression	ISO	RGD:1305332	E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of MDM2 mRNA	PMID:15890375|PMID:22484513
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	increases expression	ISO	RGD:1305332	E	RGD:6480464	20130416	CTD	MESH:C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MDM2 mRNA	PMID:14600272|PMID:15890375|PMID:22484513|PMID:23052194
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:33083	fluoranthene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:C007738	[Benzo(a)pyrene co-treated with fluoranthene] affects the expression of MDM2 mRNA	PMID:17690111
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MDM2 mRNA	PMID:30903817
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305332	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MDM2 mRNA	PMID:25181051
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of MDM2 mRNA	PMID:26982218
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A analog results in increased expression of MDM2 mRNA; bisphenol A results in increased expression of MDM2 mRNA	PMID:29275510|PMID:32387340
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305332	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MDM2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313300	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of MDM2 mRNA	PMID:26063408
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	increases phosphorylation	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased phosphorylation of MDM2 protein	PMID:24831732
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	[naringenin co-treated with bisphenol A] results in increased expression of MDM2 mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of MDM2 mRNA; Curcumin inhibits the reaction [bisphenol A results in increased phosphorylation of MDM2 protein]	PMID:24831732|PMID:36235125
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:3374	capsaicin	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin results in decreased expression of MDM2 protein	PMID:19846903
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:3374	capsaicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002211	Capsaicin results in increased expression of MDM2 mRNA	PMID:19502594
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:3374	capsaicin	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin promotes the reaction [Resveratrol results in decreased expression of MDM2 protein]; Resveratrol promotes the reaction [Capsaicin results in decreased expression of MDM2 protein]; TP53 affects the reaction [Capsaicin results in decreased expression of MDM2 protein]	PMID:19846903
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MDM2 mRNA	PMID:25979313
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	affects expression	ISO	RGD:1313300	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT affects the expression of MDM2 mRNA	PMID:18925944
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of MDM2 mRNA; 1-nitropyrene results in increased expression of MDM2 protein; 1-nitropyrene results in increased expression of MDM2 protein modified form	PMID:10837373|PMID:22044530
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34107	1-nitropyrene	multiple interactions	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	nutlin 3 results in increased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein modified form]; nutlin 3 results in increased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein]; Tetrachlorodibenzodioxin results in decreased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein modified form]; Tetrachlorodibenzodioxin results in decreased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein]; TP53 affects the reaction [1-nitropyrene results in increased expression of MDM2 mRNA]	PMID:10837373|PMID:22044530
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34199	2,2',3,3',6,6'-hexachlorobiphenyl	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:C010498	2,3,6,2',3',6'-hexachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases phosphorylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709|PMID:20840854
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]	PMID:20840854
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34204	2,2',4,4'-tetrachlorobiphenyl	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:C035976	2,4,2',4'-tetrachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34205	2,2',4,5-tetrachlorobiphenyl	increases phosphorylation	EXP		E	RGD:6480464	20170303	CTD	MESH:C042128	2,4,4',5-tetrachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases phosphorylation	EXP		E	RGD:6480464	20120918	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709|PMID:20840854
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; MDM2 mutant form inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased phosphorylation of FOXO3 protein]	PMID:20840854
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MDM2 mRNA	PMID:39298647
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313300	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of MDM2 promoter	PMID:33297965
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MDM2 mRNA	PMID:26377693
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:40280401
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:27858113
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313300	E	RGD:6480464	20230207	CTD	MESH:C008745	bisphenol F results in increased expression of MDM2 mRNA	PMID:35387338
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MDM2 mRNA	PMID:37019170
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34631	chlorpyrifos	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MDM2 mRNA	PMID:30981936
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305332	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of MDM2 mRNA	PMID:22546817
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305332	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of MDM2 mRNA	PMID:22546817
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1313300	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of MDM2 gene	PMID:38995845
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1305332	E	RGD:6480464	20150127	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MDM2 mRNA; Diethylnitrosamine results in increased expression of MDM2 protein	PMID:14555611|PMID:15459018|PMID:25242409
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MDM2 mRNA; Diethylnitrosamine results in increased expression of MDM2 protein	PMID:17854601|PMID:18506893|PMID:19100860|PMID:21607683
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of MDM2 protein; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MDM2 mRNA	PMID:11003613|PMID:18544905
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MDM2 mRNA]	PMID:17854601
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305332	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of MDM2 mRNA	PMID:22546817
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20140211	CTD	MESH:C022838	nickel chloride results in increased expression of MDM2 mRNA	PMID:23566959|PMID:28552779
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34887	nickel dichloride	multiple interactions	EXP		E	RGD:6480464	20140211	CTD	MESH:C022838	TP53 protein affects the reaction [nickel chloride results in increased expression of MDM2 mRNA]	PMID:23566959
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D010269	Paraquat results in increased expression of MDM2 mRNA	PMID:20883675|PMID:34097952
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305332	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MDM2 mRNA	PMID:32680482
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D010269	GPX1 protein affects the reaction [Paraquat affects the expression of MDM2 mRNA]	PMID:12654481
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MDM2 mRNA	PMID:37042841
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305332	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of MDM2 mRNA	PMID:30589522
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35154	manganese(0)	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20150825	CTD	MESH:D008345	Manganese results in decreased expression of MDM2 protein	PMID:25791630
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20150825	CTD	MESH:D008345	[Manganese co-treated with NGF protein] results in decreased expression of MDM2 protein; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of MDM2 protein]	PMID:25791630
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MDM2 mRNA	PMID:26377693
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1305332	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of MDM2 mRNA	PMID:22110744
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MDM2 mRNA	PMID:38568856
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20191008	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MDM2 mRNA	PMID:31077537
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	decreases phosphorylation	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased phosphorylation of MDM2 protein	PMID:28651161
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305332	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MDM2 mRNA	PMID:23405080
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120918	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MDM2 mRNA	PMID:11958953|PMID:20061341|PMID:22314386
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	increases phosphorylation	EXP		E	RGD:6480464	20150609	CTD	MESH:D019256	Cadmium Chloride results in increased phosphorylation of MDM2 protein	PMID:25744307
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	increases phosphorylation	ISO	RGD:1313300	E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in increased phosphorylation of MDM2 protein	PMID:20525538|PMID:22314386
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:D019256	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MDM2 protein]; Cadmium Chloride affects the reaction [Benzo(a)pyrene results in increased phosphorylation of MDM2 protein]; Cadmium Chloride affects the reaction [Etoposide results in increased phosphorylation of MDM2 protein]; Cadmium Chloride affects the reaction [Fluorouracil results in increased phosphorylation of MDM2 protein]; GJA1 promotes the reaction [Cadmium Chloride results in decreased phosphorylation of MDM2 protein]	PMID:25744307|PMID:28651161
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20191008	CTD	MESH:D019256	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of MDM2 mRNA	PMID:31077537
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in increased expression of MDM2 protein]; MT1 affects the reaction [Cadmium Chloride results in increased expression of MDM2 mRNA]; MT2 affects the reaction [Cadmium Chloride results in increased expression of MDM2 mRNA]	PMID:11958953|PMID:12135628
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35509	androstane	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20170131	CTD	MESH:D000732	Androstanols inhibits the reaction [DDT results in increased expression of MDM2 mRNA]	PMID:23684557
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MDM2 mRNA	PMID:19162173
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased expression of MDM2 mRNA	PMID:22079235
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of MDM2 mRNA	PMID:19162173
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of MDM2 protein	PMID:19714248
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305332	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of MDM2 mRNA	PMID:24386269
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	MDM2 protein promotes the reaction [cobaltous chloride inhibits the reaction [HIPK2 protein promotes the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of TP53 protein]]]	PMID:19714248
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of MDM2 mRNA	PMID:14600272|PMID:15890375
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35812	oxfendazole	decreases phosphorylation	ISO	RGD:1305332	E	RGD:6480464	20160210	CTD	MESH:C011030	oxfendazole results in decreased phosphorylation of MDM2 protein	PMID:26558467
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:35812	oxfendazole	increases expression	ISO	RGD:1305332	E	RGD:6480464	20160210	CTD	MESH:C011030	oxfendazole results in increased expression of MDM2 mRNA	PMID:26558467
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:3647	chlorpromazine	increases expression	ISO	RGD:1305332	E	RGD:6480464	20150825	CTD	MESH:D002746	Chlorpromazine results in increased expression of MDM2 mRNA	PMID:25596134
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:36791	escitalopram	increases expression	ISO	RGD:1305332	E	RGD:6480464	20250204	CTD	MESH:D000089983	Escitalopram results in increased expression of MDM2 mRNA	PMID:28467792
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:3696	cidofovir anhydrous	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir affects the expression of MDM2 mRNA	PMID:25596134
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:3723	citalopram	increases expression	ISO	RGD:1305332	E	RGD:6480464	20250204	CTD	MESH:D015283	Citalopram results in increased expression of MDM2 mRNA	PMID:28467792
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of MDM2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MDM2 mRNA]	PMID:17585979
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:38211	potassium bromate	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C019536	potassium bromate results in increased expression of MDM2 mRNA	PMID:30559759
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:38221	fumonisin B1	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 inhibits the reaction [AGT protein results in increased expression of MDM2 mRNA]; fumonisin B1 inhibits the reaction [AGT protein results in increased expression of MDM2 protein]	PMID:18206046
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:38746	parathion-methyl	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008743	Methyl Parathion results in increased expression of MDM2 mRNA	PMID:18418871
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MDM2 mRNA	PMID:31533062
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313300	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of MDM2 mRNA	PMID:39529242
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:39171	nitenpyram	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:C464843	nitenpyram results in increased expression of MDM2 mRNA	PMID:35568224
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:3930	cryptolepine	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C024015	cryptolepine results in increased expression of MDM2 mRNA; cryptolepine results in increased expression of MDM2 protein	PMID:16120219
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MDM2 mRNA	PMID:40419075
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of MDM2 mRNA	PMID:23125180
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1305332	E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate affects the expression of MDM2 mRNA	PMID:11960910|PMID:22110744
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305332	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of MDM2 mRNA	PMID:25993096
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	[Curcumin results in decreased expression of MDM2 protein] which results in decreased expression of CDKN1A mRNA; Curcumin results in decreased expression of MDM2 mRNA; Curcumin results in decreased expression of MDM2 protein	PMID:17332326
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:3962	curcumin	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D003474	Curcumin analog results in increased expression of MDM2 mRNA	PMID:26409325
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:D003474	Curcumin inhibits the reaction [bisphenol A results in increased phosphorylation of MDM2 protein]	PMID:24831732
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MDM2 mRNA	PMID:25979313
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of MDM2 mRNA	PMID:28001369
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MDM2 mRNA	PMID:23179753
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of MDM2 mRNA	PMID:38685447|PMID:41580965
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MDM2 mRNA	PMID:20106945|PMID:25562108|PMID:25596134
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:40909	azoxystrobin	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C087670	azoxystrobin results in increased expression of MDM2 protein	PMID:32339800
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MDM2 mRNA	PMID:17555576
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:41774	tamoxifen	decreases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:D013629	Tamoxifen results in decreased expression of MDM2 mRNA	PMID:34821461
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:41922	diethylstilbestrol	affects mutagenesis	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol affects the mutagenesis of MDM2 gene	PMID:7916985
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of MDM2 mRNA	PMID:21041162
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MDM2 mRNA	PMID:15890375
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MDM2 mRNA	PMID:15545218
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:41948	eflornithine	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20241105	CTD	MESH:D000518	Eflornithine results in decreased expression of MDM2 mRNA	PMID:11502571
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in decreased expression of MDM2 mRNA	PMID:16570282
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313300	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MDM2 mRNA	PMID:28973697
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4356	desferrioxamine B	increases expression	ISO	RGD:1305332	E	RGD:6480464	20240806	CTD	MESH:D003676	Deferoxamine results in increased expression of MDM2 protein	PMID:19950214
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of MDM2 mRNA	PMID:33512557
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:43572	kojic acid	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:C011890	[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MDM2 mRNA	PMID:18544905
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of MDM2 mRNA	PMID:23649840
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of MDM2 mRNA	PMID:18502557
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in increased expression of MDM2 mRNA; Methotrexate results in increased expression of MDM2 protein	PMID:17637740|PMID:21678067|PMID:24449571
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:44185	methotrexate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in increased activity of and results in increased expression of MDM2 protein; nutlin 3 promotes the reaction [Methotrexate results in increased activity of and results in increased expression of MDM2 protein]; TP53 affects the reaction [Methotrexate results in increased activity of and results in increased expression of MDM2 protein]; TP53 affects the reaction [nutlin 3 promotes the reaction [Methotrexate results in increased activity of and results in increased expression of MDM2 protein]]	PMID:21624110
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:44423	hydroxyurea	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea affects the expression of MDM2 protein	PMID:16356682
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:44423	hydroxyurea	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of MDM2 mRNA	PMID:18647660
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of MDM2 mRNA	PMID:16356682
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305332	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of MDM2 mRNA	PMID:24136188
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:44658	okadaic acid	decreases phosphorylation	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased phosphorylation of MDM2 protein	PMID:38832940
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4488	diallyl disulfide	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20191008	CTD	MESH:C028009	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of MDM2 mRNA	PMID:31077537
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:44975	1,10-phenanthroline	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C025205	1,10-phenanthroline results in increased expression of MDM2 mRNA	PMID:19502547
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MDM2 mRNA	PMID:27188386
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:45863	paclitaxel	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	MDM2 protein results in decreased susceptibility to Paclitaxel	PMID:13130078
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of MDM2 mRNA	PMID:28542535
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MDM2 mRNA	PMID:17562736
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MDM2 mRNA	PMID:21420995
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MDM2 mRNA	PMID:21807079
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MDM2 mRNA	PMID:22230336
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of MDM2 mRNA	PMID:17202762|PMID:33387578
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20160315	CTD	MESH:D000082	Acetaminophen results in increased expression of MDM2 mRNA	PMID:26056430
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	increases phosphorylation	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased phosphorylation of MDM2 protein	PMID:16330492
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen promotes the reaction [MDM2 protein binds to TP53 protein]	PMID:16330492
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of MDM2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MDM2 mRNA]	PMID:17585979
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D005472	Fluorouracil results in increased expression of MDM2 mRNA; Fluorouracil results in increased expression of MDM2 protein; Fluorouracil results in increased expression of MDM2 protein modified form	PMID:14665630|PMID:15546879|PMID:16557594|PMID:17982676|PMID:18096571|PMID:19098008|PMID:22525470|PMID:28785074|PMID:30177839
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of MDM2 mRNA	PMID:16949053
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46345	5-fluorouracil	increases phosphorylation	EXP		E	RGD:6480464	20150609	CTD	MESH:D005472	Fluorouracil results in increased phosphorylation of MDM2 protein	PMID:25744307
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Cadmium Chloride affects the reaction [Fluorouracil results in increased phosphorylation of MDM2 protein]; Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]; TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of MDM2 protein]]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of MDM2 mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of MDM2 protein]	PMID:15546879|PMID:17982676|PMID:25744307
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:465284	ganciclovir	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015774	Ganciclovir results in increased expression of MDM2 protein	PMID:15592511
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of MDM2 mRNA	PMID:36576512
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MDM2 mRNA	PMID:29279043
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46677	amphibole asbestos	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017636	Asbestos, Amphibole results in decreased expression of MDM2 protein	PMID:20855422
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46742	Nutlin-3	decreases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:C482205	nutlin 3 results in decreased expression of MDM2 protein	PMID:35213076
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46742	Nutlin-3	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C482205	nutlin 3 results in increased expression of MDM2 mRNA; nutlin 3 results in increased expression of MDM2 protein; nutlin 3 results in increased expression of MDM2 protein modified form	PMID:16014563|PMID:16439685|PMID:19098008|PMID:21109480|PMID:22044530|PMID:38460933
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46742	Nutlin-3	increases expression	ISO	RGD:1313300	E	RGD:6480464	20170303	CTD	MESH:C482205	nutlin 3 results in increased expression of MDM2 mRNA	PMID:16949053
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of MDM2 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of MDM2 protein; [nutlin 3 inhibits the reaction [TP53 protein binds to MDM2 protein]] which results in increased activity of TP53 protein; nutlin 3 inhibits the reaction [TP53 protein binds to MDM2 protein]; nutlin 3 inhibits the reaction [TP73 binds to MDM2]; nutlin 3 promotes the reaction [Cisplatin results in increased activity of and results in increased expression of MDM2 protein]; nutlin 3 promotes the reaction [Doxorubicin results in increased activity of and results in increased expression of MDM2 protein]; nutlin 3 promotes the reaction [Methotrexate results in increased activity of and results in increased expression of MDM2 protein]; nutlin 3 results in increased activity of and results in increased expression of MDM2 protein; nutlin 3 results in increased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein modified form]; nutlin 3 results in increased susceptibility to [1-nitropyrene results in increased expression of MDM2 protein]; PVT1 protein inhibits the reaction [nutlin 3 results in decreased expression of MDM2 protein]; TP53 affects the reaction [nutlin 3 promotes the reaction [Cisplatin results in increased activity of and results in increased expression of MDM2 protein]]; TP53 affects the reaction [nutlin 3 promotes the reaction [Doxorubicin results in increased activity of and results in increased expression of MDM2 protein]]; TP53 affects the reaction [nutlin 3 promotes the reaction [Methotrexate results in increased activity of and results in increased expression of MDM2 protein]]; TP53 affects the reaction [nutlin 3 results in increased activity of and results in increased expression of MDM2 protein]; TP53 protein affects the reaction [nutlin 3 results in increased expression of MDM2 protein]; TP53 protein promotes the reaction [nutlin 3 results in increased expression of MDM2 mRNA]; TP53 protein promotes the reaction [nutlin 3 results in increased expression of MDM2 protein]	PMID:16439685|PMID:20422343|PMID:21109480|PMID:21509038|PMID:21624110|PMID:22044530|PMID:22260869|PMID:35213076|PMID:38460933
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46742	Nutlin-3	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20241105	CTD	MESH:C482205	nutlin 3 inhibits the reaction [Cisplatin results in increased expression of MDM2 protein]	PMID:32856486
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:46979	N-acetylsphingosine	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C064769	N-acetylsphingosine results in decreased expression of MDM2 mRNA; N-acetylsphingosine results in decreased expression of MDM2 protein	PMID:18206046
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MDM2 gene	PMID:25304211
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:47217	arsane	affects response to substance	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	MDM2 SNP affects the susceptibility to Arsenic	PMID:21982800
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:47217	arsane	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	Arsenic results in increased expression of MDM2 protein	PMID:35821281
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MDM2 mRNA; USP7 protein affects the reaction [Arsenic results in increased expression of MDM2 protein]	PMID:35821281|PMID:39836092
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:472805	ouabain	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D010042	Ouabain results in decreased expression of and results in decreased phosphorylation of MDM2 protein	PMID:31436044
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:47344	alvocidib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C077990	alvocidib results in decreased expression of MDM2 mRNA; alvocidib results in decreased expression of MDM2 protein	PMID:12589031
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D004008	Diclofenac results in decreased expression of MDM2 mRNA	PMID:17202759
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:47426	furosemide	affects expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D005665	Furosemide affects the expression of MDM2 mRNA	PMID:17497460
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4776	ellipticine	decreases response to substance	EXP		E	RGD:6480464	20140415	CTD	MESH:C034192	MDM2 promoter SNP results in decreased susceptibility to ellipticine	PMID:17575151
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:47807	sulforaphane	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:C016766	[sulforaphane co-treated with Cadmium] results in increased expression of MDM2 mRNA	PMID:31035011
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305332	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of MDM2 mRNA	PMID:29391264
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20140610	CTD	MESH:C045651	[epigallocatechin gallate co-treated with polylactic acid-polyglycolic acid copolymer analog] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MDM2 mRNA]	PMID:23717041
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1305332	E	RGD:6480464	20180515	CTD	MESH:C109476	epoxiconazole results in increased expression of MDM2 mRNA	PMID:29038839
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4811	epoxiconazole	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20180515	CTD	MESH:C109476	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MDM2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MDM2 mRNA	PMID:29038839
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in increased expression of MDM2 mRNA	PMID:17481689
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D002101	[sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] affects the expression of MDM2 mRNA	PMID:23192986
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of MDM2 mRNA	PMID:24383545
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MDM2 mRNA	PMID:17555576
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MDM2 mRNA alternative form; Ethinyl Estradiol results in increased expression of MDM2 protein	PMID:12168835
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MDM2 mRNA	PMID:17942748
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MDM2 mRNA	PMID:17942748
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D005047	Etoposide results in decreased expression of MDM2 protein	PMID:26259609
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	MDM2 promoter SNP results in decreased susceptibility to Etoposide	PMID:17575151
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D005047	Etoposide results in increased expression of MDM2 mRNA; Etoposide results in increased expression of MDM2 protein; Etoposide results in increased expression of MDM2 protein modified form	PMID:16120219|PMID:18096571|PMID:25078064|PMID:30177839|PMID:31542801
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of MDM2 protein	PMID:15459018
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	increases phosphorylation	EXP		E	RGD:6480464	20150609	CTD	MESH:D005047	Etoposide results in increased phosphorylation of MDM2 protein	PMID:17935137|PMID:25744307
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Etoposide promotes the reaction [MDM2 protein binds to TOP2A protein]]; Cadmium Chloride affects the reaction [Etoposide results in increased phosphorylation of MDM2 protein]; Etoposide promotes the reaction [MDM2 protein binds to TOP2A protein]; IKBKB protein promotes the reaction [Etoposide results in increased expression of MDM2 protein modified form]; IKBKB protein promotes the reaction [Etoposide results in increased expression of MDM2 protein]; Wortmannin promotes the reaction [Etoposide results in increased phosphorylation of MDM2 protein]	PMID:17575151|PMID:17935137|PMID:25744307|PMID:30177839
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4911	etoposide	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D005047	Tetrachlorodibenzodioxin inhibits the reaction [Etoposide results in increased expression of MDM2 protein]	PMID:15459018
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1305332	E	RGD:6480464	20180515	CTD	MESH:C005223	methyleugenol results in increased expression of MDM2 mRNA	PMID:26011634
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of MDM2 mRNA	PMID:26272509
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA	PMID:27188386
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:49747	methylmercury(1+)	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:C030957	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of MDM2 mRNA	PMID:17905399
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MDM2 mRNA	PMID:20458559
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MDM2 mRNA; Arsenic Trioxide results in decreased expression of MDM2 protein	PMID:21145380|PMID:38070468
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MDM2 mRNA	PMID:20862710|PMID:25574600|PMID:26705709
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1305332	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MDM2 mRNA	PMID:17487067
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20191114	CTD	MESH:C032793	dapagliflozin inhibits the reaction [Arsenic Trioxide results in decreased expression of MDM2 mRNA]; pifithrin inhibits the reaction [Arsenic Trioxide results in increased expression of MDM2 mRNA]	PMID:17487067|PMID:38070468
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of MDM2 mRNA	PMID:25596134
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1305332	E	RGD:6480464	20171010	CTD	MESH:D008770	Methylnitrosourea results in increased expression of MDM2 mRNA	PMID:28688903
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of MDM2 mRNA	PMID:17145863
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:50161	motexafin gadolinium	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of MDM2 mRNA	PMID:16357179
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of MDM2 mRNA]	PMID:16357179
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:50182	3,3'-diindolylmethane	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20160210	CTD	MESH:C016392	3,3'-diindolylmethane analog results in decreased expression of MDM2 mRNA	PMID:26593444
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305332	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of MDM2 mRNA	PMID:23962444
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of MDM2 mRNA	PMID:41580965
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:50686	atorvastatin calcium	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D000069059	Atorvastatin results in increased expression of MDM2 protein	PMID:29630879
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:50692	mifepristone	increases expression	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of MDM2 mRNA	PMID:12605714
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:50729	mitoxantrone	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	MDM2 promoter SNP results in decreased susceptibility to Mitoxantrone	PMID:17575151
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:50924	sorafenib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C471405	sorafenib results in increased expression of MDM2 mRNA	PMID:26409325
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:5100	flucytosine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005437	Flucytosine results in increased expression of MDM2 protein	PMID:15592511
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305332	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MDM2 mRNA	PMID:24136188
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:51348	tetraphene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:40280401
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:27858113
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:51687	chrysene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:40280401
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MDM2 mRNA	PMID:27858113
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:52289	wortmannin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin promotes the reaction [Doxorubicin results in increased phosphorylation of MDM2 protein]; wortmannin promotes the reaction [Etoposide results in increased phosphorylation of MDM2 protein]	PMID:17935137
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:52492	mancozeb	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C013099	mancozeb results in increased expression of MDM2 mRNA	PMID:27235710
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:52492	mancozeb	multiple interactions	EXP		E	RGD:6480464	20171114	CTD	MESH:C013099	lupeol inhibits the reaction [mancozeb results in increased expression of MDM2 mRNA]	PMID:27235710
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:52646	leptomycin B	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C038753	leptomycin B results in increased expression of MDM2 mRNA	PMID:20803015
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:52717	bortezomib	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib affects the expression of MDM2 protein	PMID:12393500
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:52717	bortezomib	increases cleavage	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased cleavage of MDM2 protein	PMID:12393500
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:52717	bortezomib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	[CASP8 protein results in increased activity of CASP3 protein] affects the reaction [Bortezomib results in increased cleavage of MDM2 protein]; Bortezomib promotes the reaction [TP53 protein binds to MDM2 protein]	PMID:12393500
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of MDM2 mRNA	PMID:26705709
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:53248	poly(vinylpyrrolidone)	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D011205	[Silver co-treated with Povidone] affects the expression of MDM2 protein; [Silver co-treated with Povidone] results in decreased expression of MDM2 mRNA	PMID:27387714
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20120918	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of MDM2 protein	PMID:21262251
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:53444	potassium dichromate	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20120918	CTD	MESH:D011192	Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of MDM2 protein]	PMID:21262251
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:5864	ifosfamide	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in increased expression of MDM2 mRNA	PMID:25596134
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:6015	isoflurane	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D007530	Isoflurane results in decreased expression of MDM2 mRNA	PMID:16978161
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:61014	PD123319	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C073402	PD 123319 inhibits the reaction [AGT protein results in increased expression of MDM2 mRNA]; PD 123319 inhibits the reaction [AGT protein results in increased expression of MDM2 protein]	PMID:18206046
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:62984	zinc acetate	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in increased expression of MDM2 mRNA	PMID:16357179
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:62984	zinc acetate	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of MDM2 mRNA]	PMID:16357179
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305332	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of MDM2 mRNA	PMID:28801915
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:63618	pravastatin	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D017035	Pravastatin results in increased expression of MDM2 protein	PMID:15625077
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:63618	pravastatin	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D017035	Pravastatin results in increased phosphorylation of MDM2 protein	PMID:15625077
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:63618	pravastatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D017035	[Pravastatin results in increased phosphorylation of MDM2 protein] which results in increased degradation of TP53 protein; Sirolimus inhibits the reaction [Pravastatin results in increased phosphorylation of MDM2 protein]; U 0126 inhibits the reaction [Pravastatin results in increased phosphorylation of MDM2 protein]	PMID:15625077
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MDM2 mRNA	PMID:26378955
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305332	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of MDM2 mRNA	PMID:25729387
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:63632	topotecan	multiple interactions	EXP		E	RGD:6480464	20200211	CTD	MESH:D019772	[N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride co-treated with Topotecan] results in decreased expression of MDM2 protein	PMID:23376119
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of MDM2 mRNA	PMID:25729387
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305332	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of MDM2 mRNA	PMID:24136188
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:6382	Lasiocarpine	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in increased expression of MDM2 mRNA	PMID:40054833
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of MDM2 mRNA	PMID:28988120
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of MDM2 mRNA	PMID:27509014
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:64153	tanespimycin	increases degradation	EXP		E	RGD:6480464	20170228	CTD	MESH:C112765	tanespimycin results in increased degradation of MDM2 protein	PMID:17157164
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:64213	cantharidin	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D002193	Cantharidin results in decreased expression of MDM2 mRNA	PMID:31945315
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MDM2 mRNA	PMID:23783067
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:65329	LY294002	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of MDM2 protein	PMID:16412023
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:65345	PX-866	decreases phosphorylation	EXP		E	RGD:6480464	20230801	CTD	MESH:C496788	PX-866 results in decreased phosphorylation of MDM2 protein	PMID:27017931
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:65345	PX-866	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C496788	[Raloxifene Hydrochloride co-treated with PX-866] results in decreased phosphorylation of MDM2 protein	PMID:27017931
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:6570	lupeol	multiple interactions	EXP		E	RGD:6480464	20171114	CTD	MESH:C010480	lupeol inhibits the reaction [mancozeb results in increased expression of MDM2 mRNA]	PMID:27235710
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1305332	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of MDM2 mRNA	PMID:25596134
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20130312	CTD	MESH:D008701	Methapyrilene results in decreased expression of MDM2 mRNA	PMID:22584684
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305332	E	RGD:6480464	20160210	CTD	MESH:D008701	Methapyrilene results in increased expression of MDM2 mRNA	PMID:15890375|PMID:18619722|PMID:25242409|PMID:26558467|PMID:30467583
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:6820	methapyrilene	increases phosphorylation	ISO	RGD:1305332	E	RGD:6480464	20160210	CTD	MESH:D008701	Methapyrilene results in increased phosphorylation of MDM2 protein	PMID:26558467
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:6856	methyl caffeate	affects binding	EXP		E	RGD:6480464	20151110	CTD	MESH:C042405	methyl caffeate binds to MDM2 protein	PMID:26415618
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20191008	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of MDM2 protein	PMID:31157505
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20171010	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of MDM2 mRNA; cyanoginosin LR results in decreased expression of MDM2 protein	PMID:28414124
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of MDM2 mRNA	PMID:27932991|PMID:30713602
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1313300	E	RGD:6480464	20201215	CTD	MESH:D002185	Cannabidiol results in increased expression of MDM2 mRNA	PMID:30742662
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20201215	CTD	MESH:D002185	[lipopolysaccharide, E coli O55-B5 co-treated with Cannabidiol] results in increased expression of MDM2 mRNA	PMID:30742662
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:6980	monocrotaline	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D016686	[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of MDM2 mRNA	PMID:21224054
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:70436	platycodin D	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C108953	platycodin D results in decreased expression of MDM2 protein	PMID:25431082|PMID:27432230
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:70436	platycodin D	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C108953	MDM2 protein inhibits the reaction [platycodin D results in increased expression of FOXO3 protein]	PMID:25431082
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:72754	bisphenol AF	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	[bisphenol AF co-treated with cylindrospermopsin] results in increased expression of MDM2 mRNA	PMID:32244372
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:73726	GW 501516	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20170303	CTD	MESH:C425931	MDM2 protein inhibits the reaction [GW 501516 results in increased activity of PPARB protein]	PMID:19103650
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of MDM2 mRNA	PMID:22206623
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:749301	potassium perchlorate	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of MDM2 mRNA	PMID:29673971
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305332	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MDM2 mRNA	PMID:24136188
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1313300	E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MDM2 mRNA	PMID:20061341
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Etoposide promotes the reaction [MDM2 protein binds to TOP2A protein]]	PMID:17575151
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:75458	carbonyl cyanide p-trifluoromethoxyphenylhydrazone	decreases expression	EXP		E	RGD:6480464	20131008	CTD	MESH:D002259	Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of MDM2 mRNA	PMID:16039398
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	[Cisplatin co-treated with eprenetapopt co-treated with Oxygen deficiency] results in increased expression of MDM2 mRNA; [Cisplatin co-treated with eprenetapopt] results in increased expression of MDM2 mRNA; [Oxygen deficiency co-treated with eprenetapopt] results in increased expression of MDM2 mRNA	PMID:29690507
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:755540	docetaxel	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	Docetaxel results in increased expression of MDM2 protein	PMID:16080190|PMID:16797627
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MDM2 protein	PMID:31285264
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:757885	8-chloroadenosine	increases expression	ISO	RGD:1313300	E	RGD:6480464	20260714	CTD	MESH:C075440	8-chloroadenosine results in increased expression of MDM2 mRNA	PMID:31778309
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MDM2 protein	PMID:15635149
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	ISO	RGD:1305332	E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of MDM2 mRNA; N-nitrosomorpholine results in increased expression of MDM2 protein	PMID:14587038|PMID:19716841
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:76995	alpha-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:C011512	alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [Oxygen deficiency results in increased expression of MDM2 mRNA]]; alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of MDM2 mRNA]	PMID:19578757
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:77013	beta-naphthoflavone	increases phosphorylation	ISO	RGD:1305332	E	RGD:6480464	20160210	CTD	MESH:D019324	beta-Naphthoflavone results in increased phosphorylation of MDM2 protein	PMID:26558467
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:77092	fenbendazole	increases expression	ISO	RGD:1305332	E	RGD:6480464	20140408	CTD	MESH:D005273	Fenbendazole results in increased expression of MDM2 mRNA	PMID:23411599
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C025589	ochratoxin A results in decreased expression of MDM2 mRNA	PMID:30763683
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305332	E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in increased expression of MDM2 mRNA	PMID:23358140
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:77397	1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile	increases expression	ISO	RGD:1305332	E	RGD:6480464	20250204	CTD	MESH:D015283	Citalopram results in increased expression of MDM2 mRNA	PMID:28467792
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of MDM2 protein	PMID:24415872
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:78492	diallyl trisulfide	increases degradation	EXP		E	RGD:6480464	20170725	CTD	MESH:C042577	diallyl trisulfide results in increased degradation of MDM2 protein	PMID:23754639
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA	PMID:27188386
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of MDM2 mRNA	PMID:30928695
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:80043	Nodularin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C063998	nodularin results in increased expression of MDM2 mRNA	PMID:30562542
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:80630	irinotecan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in increased expression of MDM2 mRNA; Irinotecan results in increased expression of MDM2 mRNA	PMID:15956246
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305332	E	RGD:6480464	20141223	CTD	MESH:D010634	Phenobarbital results in increased expression of MDM2 mRNA	PMID:25145657
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313300	E	RGD:6480464	20141223	CTD	MESH:D010634	Phenobarbital results in increased expression of MDM2 mRNA	PMID:19482888|PMID:20816995|PMID:25145657
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:8069	phenobarbital	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased phosphorylation of MDM2 protein	PMID:19751709
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MDM2 mRNA]; NR1I3 protein promotes the reaction [Phenobarbital results in increased expression of MDM2 mRNA]	PMID:19482888
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:80774	tauroursodeoxycholic acid	increases expression	ISO	RGD:1305332	E	RGD:6480464	20141111	CTD	MESH:C031655	ursodoxicoltaurine results in increased expression of MDM2 mRNA	PMID:15885361
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:8107	phenytoin	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20120412	CTD	MESH:D010672	[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of MDM2 mRNA	PMID:21224054
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1313300	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of MDM2 mRNA	PMID:22538082
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:81395	10-Hydroxycamptothecin	affects response to substance	EXP		E	RGD:6480464	20170303	CTD	MESH:C028098	MDM2 protein affects the susceptibility to 10-hydroxycamptothecin	PMID:13130078
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:81525	2,3,3',4,4',5,5'-Heptachlorobiphenyl	increases phosphorylation	EXP		E	RGD:6480464	20170303	CTD	MESH:C034559	2,2',3,3',4,4',5-heptachlorobiphenyl results in increased phosphorylation of MDM2 protein	PMID:19751709
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:8163	phosphoramide mustard	increases expression	ISO	RGD:1305332	E	RGD:6480464	20160210	CTD	MESH:C030090	phosphoramide mustard results in increased expression of MDM2 mRNA	PMID:26708502
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:81758	cyproconazole	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20180515	CTD	MESH:C093628	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MDM2 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MDM2 mRNA	PMID:29038839
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:82285	ortho-Aminoazotoluene	increases expression	ISO	RGD:1313300	E	RGD:6480464	20141111	CTD	MESH:D009762	o-Aminoazotoluene results in increased expression of MDM2 mRNA	PMID:15346788
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in increased expression of MDM2 mRNA	PMID:32251684
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:82551	N-Vinyl-2-pyrrolidone	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20141111	CTD	MESH:C042670	[N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which affects the expression of MDM2 mRNA	PMID:22037397
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of MDM2 mRNA	PMID:33512557
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313300	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of MDM2 mRNA	PMID:11353140|PMID:39847705
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:8434	prochloraz	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20180515	CTD	MESH:C045362	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MDM2 mRNA	PMID:29038839
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:8450	procymidone	decreases expression	ISO	RGD:1305332	E	RGD:6480464	20141111	CTD	MESH:C035988	procymidone results in decreased expression of MDM2 mRNA	PMID:15686871
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:8461	promethazine	increases phosphorylation	ISO	RGD:1305332	E	RGD:6480464	20160210	CTD	MESH:D011398	Promethazine results in increased phosphorylation of MDM2 protein	PMID:26558467
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:85078	dapagliflozin	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20251007	CTD	MESH:C529054	dapagliflozin inhibits the reaction [Arsenic Trioxide results in decreased expression of MDM2 mRNA]	PMID:38070468
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:86193	DAPT	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C419410	N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of MDM2 protein	PMID:25005833
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:86193	DAPT	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:C419410	Hydrogen Peroxide inhibits the reaction [N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in increased expression of MDM2 protein]	PMID:25005833
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with PX-866] results in decreased phosphorylation of MDM2 protein	PMID:27017931
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of MDM2 mRNA	PMID:21607682
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:88046	cylindrospermopsin	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C089595	[bisphenol AF co-treated with cylindrospermopsin] results in increased expression of MDM2 mRNA	PMID:32244372
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of MDM2 mRNA	PMID:33645215
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MDM2 mRNA	PMID:27188386
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:91215	1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one	increases expression	EXP		E	RGD:6480464	20170221	CTD	MESH:C095284	1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in increased expression of MDM2 protein	PMID:16288207
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of MDM2 mRNA	PMID:26014281
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9141	silver(0)	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D012834	[Silver co-treated with Povidone] affects the expression of MDM2 protein; [Silver co-treated with Povidone] results in decreased expression of MDM2 mRNA	PMID:27387714
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9150	simvastatin	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D019821	Simvastatin results in increased phosphorylation of MDM2 protein	PMID:15625077
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9150	simvastatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019821	Simvastatin promotes the reaction [Benzo(a)pyrene promotes the reaction [TP53 protein binds to MDM2 protein]]	PMID:15625077
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9168	sirolimus	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in decreased expression of MDM2 protein	PMID:19560264
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	EIF4E protein inhibits the reaction [Sirolimus results in decreased expression of MDM2 protein]; Sirolimus inhibits the reaction [Pravastatin results in increased phosphorylation of MDM2 protein]; Sirolimus promotes the reaction [TP73 protein binds to MDM2 promoter]	PMID:15625077|PMID:19560264|PMID:21245298
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MDM2 mRNA	PMID:21346803
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in increased expression of MDM2 mRNA	PMID:31863870
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1305332	E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in increased expression of MDM2 mRNA	PMID:26141394
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9410	taurodeoxycholic acid	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20250805	CTD	MESH:D013657	Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in increased expression of MDM2 mRNA]	PMID:39232337
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of MDM2 mRNA	PMID:33512557
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:94995	2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C451219	2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one results in increased expression of MDM2	PMID:21647879
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MDM2 mRNA	PMID:29301935
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MDM2 mRNA	PMID:21346803
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9747	Triptolide	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C001899	triptolide results in decreased expression of MDM2 protein	PMID:36990132
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313300	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of MDM2 mRNA	PMID:32835833
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313300	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of MDM2 mRNA	PMID:35537566
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1313300	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of MDM2 mRNA	PMID:18930950
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9907	ursodeoxycholic acid	increases expression	ISO	RGD:1305332	E	RGD:6480464	20120613	CTD	MESH:D014580	Ursodeoxycholic Acid results in increased expression of MDM2 mRNA	PMID:15885361
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9907	ursodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014580	MDM2 mutant form inhibits the reaction [Ursodeoxycholic Acid results in increased ubiquitination of TP53 protein]	PMID:20807506
1313299	MDM2	MDM2 proto-oncogene	gene	CHEBI:9907	ursodeoxycholic acid	multiple interactions	ISO	RGD:1305332	E	RGD:6480464	20120412	CTD	MESH:D014580	[Ursodeoxycholic Acid promotes the reaction [TP53 protein binds to MDM2 protein]] which results in increased degradation of TP53 protein; MDM2 mutant form inhibits the reaction [Ursodeoxycholic Acid affects the localization of TP53 protein]; NR3C1 mutant form inhibits the reaction [Ursodeoxycholic Acid inhibits the reaction [TGFB1 protein results in decreased expression of MDM2 protein]]; NR3C2 mutant form inhibits the reaction [Ursodeoxycholic Acid inhibits the reaction [TGFB1 protein results in decreased expression of MDM2 protein]]; Ursodeoxycholic Acid inhibits the reaction [TGFB1 protein results in decreased expression of MDM2 protein]; Ursodeoxycholic Acid promotes the reaction [TP53 protein binds to MDM2 protein]	PMID:14514686|PMID:15222754|PMID:17881359
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621378	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GSC2 mRNA	PMID:33045310
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1621378	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of GSC2 mRNA	PMID:33711761
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of GSC2 mRNA	PMID:24376830
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1621378	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of GSC2 mRNA	PMID:28960355
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of GSC2 mRNA	PMID:23557933
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621378	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GSC2 mRNA	PMID:24058054
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1621378	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of GSC2 mRNA	PMID:27862939
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GSC2 promoter	PMID:27901495
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621378	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GSC2 gene; titanium dioxide results in decreased methylation of GSC2 promoter	PMID:35295148
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1621378	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of GSC2 promoter	PMID:27334623
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305333	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GSC2 mRNA	PMID:25181051
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305333	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GSC2 gene	PMID:28505145
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1621378	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of GSC2 gene	PMID:31683443
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1621378	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of GSC2 mRNA	PMID:30951980
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GSC2 gene	PMID:29154799
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1621378	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GSC2 mRNA	PMID:17562736
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of GSC2 promoter	PMID:29626692
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of GSC2 promoter	PMID:29626692
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1621378	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of GSC2 mRNA	PMID:35436446
1313301	GSC2	goosecoid homeobox 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1621378	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GSC2 mRNA	PMID:22206623
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1322974	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DNAH9 mRNA	PMID:33045310
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1322974	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of DNAH9 mRNA	PMID:20188158
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1322974	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DNAH9 mRNA	PMID:36189433
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:621799	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of DNAH9 gene	PMID:35440735
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1322974	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of DNAH9 mRNA	PMID:36189433
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of DNAH9 mRNA	PMID:33359661
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DNAH9 intron	PMID:30157460
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of DNAH9 gene	PMID:31636367
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1322974	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of DNAH9 mRNA	PMID:32186404
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:621799	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DNAH9 mRNA	PMID:32109520
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:621799	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of DNAH9 mRNA	PMID:28374803
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:621799	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of DNAH9 mRNA	PMID:28959563
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1322974	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of DNAH9 mRNA	PMID:36227756
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of DNAH9 protein	PMID:35688186
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DNAH9 promoter	PMID:27901495
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DNAH9 5' UTR	PMID:27901495
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1322974	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNAH9 mRNA	PMID:27195522
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:621799	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNAH9 mRNA	PMID:21839799
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DNAH9 exon	PMID:27901495
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of DNAH9 gene	PMID:25435355
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of DNAH9 promoter	PMID:23974009
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:621799	E	RGD:6480464	20130806	CTD	MESH:D000643	Ammonium Chloride affects the expression of DNAH9 mRNA	PMID:16483693
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1322974	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of DNAH9 mRNA	PMID:23557971
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:621799	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of DNAH9 mRNA	PMID:34492290
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:621799	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAH9 mRNA	PMID:25181051|PMID:29097150|PMID:30816183|PMID:32528016|PMID:34947998
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1322974	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of DNAH9 mRNA	PMID:30951980
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:621799	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of DNAH9 mRNA	PMID:41034487
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1322974	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of DNAH9 gene	PMID:31683443
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1322974	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of DNAH9 mRNA	PMID:30951980
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of DNAH9 intron	PMID:30157460
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1322974	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of DNAH9 mRNA	PMID:30951980
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1322974	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DNAH9 intron	PMID:28392331
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:621799	E	RGD:6480464	20130806	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of DNAH9 mRNA	PMID:18164116
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:621799	E	RGD:6480464	20130806	CTD	MESH:D002509	Cephaloridine results in decreased expression of DNAH9 mRNA	PMID:18500788
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of DNAH9 mRNA	PMID:24449571
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:621799	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of DNAH9 mRNA	PMID:29427782
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of DNAH9 mRNA	PMID:23179753|PMID:27188386
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:621799	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAH9 mRNA	PMID:33387578
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:621799	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of DNAH9 mRNA	PMID:29391264
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:621799	E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of DNAH9 mRNA	PMID:37567419
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1322974	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DNAH9 mRNA; Nanotubes, Carbon results in decreased expression of DNAH9 mRNA	PMID:25554681
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in decreased expression of DNAH9 mRNA	PMID:18651567
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1322974	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of DNAH9 mRNA	PMID:38701926
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:621799	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of DNAH9 mRNA	PMID:28801915
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of DNAH9 intron	PMID:30157460
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:621799	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DNAH9 gene	PMID:35440735
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:621799	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of DNAH9 mRNA	PMID:18164116
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DNAH9 gene]	PMID:28238834
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:621799	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of DNAH9 mRNA	PMID:24780913
1313302	DNAH9	dynein axonemal heavy chain 9	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:621799	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of DNAH9 mRNA	PMID:23869203
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CIZ1 mRNA	PMID:38218311
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CIZ1 mRNA	PMID:33045310
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CIZ1 mRNA	PMID:33167477
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of CIZ1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of CIZ1 mRNA	PMID:32699268
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313305	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CIZ1 mRNA	PMID:30319688
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CIZ1 mRNA	PMID:39241906
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305336	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CIZ1 mRNA	PMID:33387578
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CIZ1 protein	PMID:37730182
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CIZ1 mRNA	PMID:35301059
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CIZ1 protein	PMID:23301498
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CIZ1 intron	PMID:30157460
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CIZ1 gene	PMID:27153756
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of CIZ1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of CIZ1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of CIZ1 mRNA	PMID:32699268
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313305	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CIZ1 mRNA	PMID:40504410
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CIZ1 mRNA	PMID:19244175
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of CIZ1 mRNA	PMID:27594783
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin inhibits the reaction [Piroxicam results in increased expression of CIZ1 mRNA]	PMID:21858171
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:28077	rifampicin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in decreased expression of CIZ1 mRNA	PMID:24552687
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313305	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CIZ1 mRNA	PMID:21570461
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305336	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CIZ1 mRNA	PMID:33387578
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CIZ1 protein	PMID:33212167
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CIZ1 mRNA	PMID:29803840
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of CIZ1 protein	PMID:35688186
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CIZ1 mRNA	PMID:39719251
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313305	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CIZ1 mRNA	PMID:40504410
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CIZ1 5' UTR; Benzo(a)pyrene affects the methylation of CIZ1 promoter	PMID:27901495
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313305	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CIZ1 mRNA	PMID:22228805
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305336	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CIZ1 mRNA	PMID:30047161
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313305	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CIZ1 gene	PMID:35295148
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CIZ1 mRNA	PMID:33221593
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CIZ1 mRNA	PMID:33670352
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305336	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CIZ1 mRNA	PMID:25181051
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305336	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CIZ1 gene	PMID:28505145
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313305	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CIZ1 gene	PMID:31683443
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CIZ1 mRNA	PMID:39298647
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of CIZ1 gene	PMID:31601247
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CIZ1 mRNA	PMID:38685157
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIZ1 mRNA	PMID:28628672
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CIZ1 mRNA	PMID:37019170
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIZ1 mRNA	PMID:28628672
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305336	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CIZ1 mRNA	PMID:22546817
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305336	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CIZ1 mRNA	PMID:35163327
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CIZ1 mRNA	PMID:35301059
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305336	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CIZ1 mRNA	PMID:35163327
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CIZ1 mRNA	PMID:19376846
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of CIZ1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of CIZ1 mRNA	PMID:32699268
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CIZ1 mRNA	PMID:19244175
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of CIZ1 mRNA	PMID:23811191
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CIZ1 mRNA	PMID:28302478
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CIZ1 mRNA	PMID:31533062
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CIZ1 mRNA	PMID:29154799
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305336	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CIZ1 mRNA	PMID:30047161
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CIZ1 mRNA	PMID:20106945|PMID:25562108
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIZ1 mRNA	PMID:28628672
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	CIZ1 protein affects the susceptibility to Methotrexate	PMID:16217747
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of CIZ1 mRNA	PMID:29067470
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CIZ1 mRNA	PMID:29279043
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313305	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CIZ1 mRNA	PMID:40504410
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of CIZ1 mRNA	PMID:22079256
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313305	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CIZ1 mRNA	PMID:17942748
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIZ1 mRNA	PMID:28628672
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305336	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CIZ1 mRNA	PMID:30047161
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CIZ1 mRNA	PMID:22206623
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CIZ1 mRNA	PMID:22079256
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of CIZ1 mRNA	PMID:22079256
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of CIZ1 protein	PMID:31285264
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305336	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CIZ1 mRNA	PMID:27291303
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:8249	piroxicam	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of CIZ1 mRNA	PMID:21858171
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in increased expression of CIZ1 mRNA]	PMID:21858171
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CIZ1 mRNA	PMID:21278054
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305336	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CIZ1 mRNA	PMID:30047161
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of CIZ1 mRNA	PMID:40826991
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305336	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CIZ1 mRNA	PMID:21346803
1313304	CIZ1	CDKN1A interacting zinc finger protein 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313305	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CIZ1 mRNA	PMID:28973697
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HIC2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of HIC2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of HIC2 mRNA	PMID:32699268|PMID:32845096
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of HIC2 mRNA	PMID:22378314
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305338	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of HIC2 mRNA	PMID:32145629
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of HIC2 mRNA	PMID:20655997
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HIC2 mRNA	PMID:37992649
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of HIC2 mRNA	PMID:33647349
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HIC2 mRNA	PMID:37992649
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of HIC2 protein	PMID:37730182
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HIC2 mRNA	PMID:35301059
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HIC2 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of HIC2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of HIC2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of HIC2 mRNA	PMID:32699268|PMID:32845096
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HIC2 mRNA	PMID:22206623
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HIC2 gene	PMID:25304211
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of HIC2 protein	PMID:35688186
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of HIC2 mRNA	PMID:27392435
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of HIC2 mRNA	PMID:27392435
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313308	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HIC2 mRNA	PMID:21570461
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HIC2 mRNA	PMID:17942748
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HIC2 mRNA	PMID:17942748
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of HIC2 mRNA	PMID:23179753
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HIC2 mRNA	PMID:33212167
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305338	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of HIC2 mRNA	PMID:28959563
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HIC2 mRNA	PMID:29803840
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HIC2 mRNA	PMID:37992649
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of HIC2 mRNA	PMID:34032870
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HIC2 3' UTR	PMID:30157460
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HIC2 5' UTR	PMID:27901495
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305338	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of HIC2 mRNA	PMID:30047161
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313308	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of HIC2 mRNA	PMID:29264374
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313308	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HIC2 promoter	PMID:35295148
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313308	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of HIC2 promoter	PMID:35295148
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313308	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of HIC2 mRNA	PMID:18301758|PMID:23811191
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HIC2 mRNA	PMID:19710929
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305338	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of HIC2 mRNA	PMID:25181051
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305338	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of HIC2 mRNA; bisphenol A results in decreased expression of HIC2 protein	PMID:24552547|PMID:30816183|PMID:32528016
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313308	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of HIC2 mRNA	PMID:39298647
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313308	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of HIC2 exon	PMID:33297965
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HIC2 mRNA	PMID:35301059
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305338	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of HIC2 mRNA	PMID:30047161
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of HIC2 mRNA	PMID:24449571
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313308	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of HIC2 mRNA	PMID:28962523
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313308	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of HIC2 mRNA	PMID:18353800
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of HIC2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of HIC2 mRNA	PMID:32699268
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of HIC2 mRNA	PMID:28302478
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of HIC2 mRNA	PMID:31533062
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HIC2 mRNA	PMID:25979313
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of HIC2 mRNA	PMID:17292431
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305338	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of HIC2 mRNA	PMID:30047161
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of HIC2 mRNA	PMID:17555576
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HIC2 mRNA	PMID:37992649
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HIC2 mRNA	PMID:38832940
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of HIC2 mRNA	PMID:27188386
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of HIC2 mRNA	PMID:21420995|PMID:29067470
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	HIC2 protein affects the susceptibility to Fluorouracil	PMID:16217747
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HIC2 gene	PMID:25304211
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of HIC2 mRNA	PMID:31838189
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of HIC2 mRNA	PMID:17555576
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of HIC2 mRNA	PMID:17942748
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HIC2 mRNA	PMID:17942748
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	ISO	RGD:1313308	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased methylation of HIC2 gene	PMID:27923600
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305338	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of HIC2 mRNA	PMID:30047161
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313308	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HIC2 mRNA	PMID:22206623
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313308	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HIC2 mRNA	PMID:22206623
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HIC2 gene]	PMID:28238834
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305338	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HIC2 mRNA	PMID:30047161
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305338	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of HIC2 mRNA	PMID:24780913
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of HIC2 mRNA	PMID:12756304
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1313308	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of HIC2 protein	PMID:35357534
1313307	HIC2	HIC ZBTB transcriptional repressor 2	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305338	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of HIC2 mRNA	PMID:20566332
1313309	DAP3	death associated protein 3	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DAP3 mRNA	PMID:38218311
1313309	DAP3	death associated protein 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313310	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DAP3 mRNA	PMID:33045310
1313309	DAP3	death associated protein 3	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DAP3 mRNA	PMID:19074003
1313309	DAP3	death associated protein 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DAP3 mRNA	PMID:20938992
1313309	DAP3	death associated protein 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DAP3 mRNA	PMID:33167477
1313309	DAP3	death associated protein 3	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of DAP3 mRNA	PMID:24763279
1313309	DAP3	death associated protein 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313310	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DAP3 mRNA	PMID:39241906
1313309	DAP3	death associated protein 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313310	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DAP3 mRNA	PMID:39298647
1313309	DAP3	death associated protein 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DAP3 mRNA	PMID:20938992
1313309	DAP3	death associated protein 3	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20140408	CTD	MESH:D008550	Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of DAP3 mRNA]	PMID:23963992
1313309	DAP3	death associated protein 3	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313310	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of DAP3 mRNA	PMID:17251523
1313309	DAP3	death associated protein 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313310	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of DAP3 protein	PMID:20463053
1313309	DAP3	death associated protein 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in decreased expression of DAP3 protein	PMID:20463053
1313309	DAP3	death associated protein 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DAP3 mRNA	PMID:36331819
1313309	DAP3	death associated protein 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305339	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of DAP3 protein	PMID:34915118
1313309	DAP3	death associated protein 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DAP3 gene	PMID:27153756
1313309	DAP3	death associated protein 3	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of DAP3 mRNA	PMID:26760959
1313309	DAP3	death associated protein 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DAP3 mRNA	PMID:35430440
1313309	DAP3	death associated protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DAP3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DAP3 mRNA	PMID:20938992|PMID:22206623
1313309	DAP3	death associated protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAP3 mRNA	PMID:39836092
1313309	DAP3	death associated protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAP3 mRNA	PMID:40504410
1313309	DAP3	death associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313310	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DAP3 mRNA	PMID:21570461
1313309	DAP3	death associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305339	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DAP3 mRNA	PMID:33387578
1313309	DAP3	death associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DAP3 mRNA	PMID:17942748
1313309	DAP3	death associated protein 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DAP3 mRNA	PMID:33212167
1313309	DAP3	death associated protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313310	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DAP3 mRNA	PMID:16014739
1313309	DAP3	death associated protein 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DAP3 mRNA	PMID:38568856
1313309	DAP3	death associated protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAP3 mRNA	PMID:39836092
1313309	DAP3	death associated protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAP3 mRNA	PMID:40504410
1313309	DAP3	death associated protein 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DAP3 5' UTR	PMID:27901495
1313309	DAP3	death associated protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313310	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DAP3 mRNA	PMID:22228805
1313309	DAP3	death associated protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313310	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DAP3 promoter	PMID:35295148
1313309	DAP3	death associated protein 3	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of DAP3 mRNA	PMID:23777605
1313309	DAP3	death associated protein 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of DAP3 mRNA	PMID:30903817
1313309	DAP3	death associated protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of DAP3 protein	PMID:37567409
1313309	DAP3	death associated protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313310	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DAP3 mRNA; bisphenol A results in increased expression of DAP3 protein	PMID:26903627|PMID:33221593
1313309	DAP3	death associated protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313310	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DAP3 mRNA	PMID:39298647
1313309	DAP3	death associated protein 3	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of DAP3 protein	PMID:34186270
1313309	DAP3	death associated protein 3	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of DAP3 protein	PMID:34186270
1313309	DAP3	death associated protein 3	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305339	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of DAP3 mRNA	PMID:22546817
1313309	DAP3	death associated protein 3	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to DAP3 protein	PMID:32991956
1313309	DAP3	death associated protein 3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313310	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of DAP3 mRNA	PMID:34813904
1313309	DAP3	death associated protein 3	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305339	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of DAP3 mRNA	PMID:22546817
1313309	DAP3	death associated protein 3	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20140408	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of DAP3 mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of DAP3 mRNA]	PMID:23963992
1313309	DAP3	death associated protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DAP3 mRNA	PMID:37042841
1313309	DAP3	death associated protein 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DAP3 protein	PMID:24527689
1313309	DAP3	death associated protein 3	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of DAP3 mRNA	PMID:19320972|PMID:19376846
1313309	DAP3	death associated protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DAP3 mRNA	PMID:36331819
1313309	DAP3	death associated protein 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313310	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of DAP3 mRNA	PMID:21427059
1313309	DAP3	death associated protein 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DAP3 mRNA	PMID:20106945|PMID:25562108
1313309	DAP3	death associated protein 3	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1305339	E	RGD:6480464	20140513	CTD	MESH:C017160	cypermethrin results in increased expression of DAP3 mRNA	PMID:22528246
1313309	DAP3	death associated protein 3	gene	CHEBI:41423	celecoxib	affects expression	ISO	RGD:1313310	E	RGD:6480464	20170303	CTD	MESH:C105934	Celecoxib affects the expression of DAP3 mRNA	PMID:20562220
1313309	DAP3	death associated protein 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of DAP3 mRNA	PMID:25704631
1313309	DAP3	death associated protein 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAP3 mRNA	PMID:39836092
1313309	DAP3	death associated protein 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DAP3 mRNA	PMID:40504410
1313309	DAP3	death associated protein 3	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of DAP3 mRNA	PMID:18175754
1313309	DAP3	death associated protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DAP3 mRNA	PMID:17942748
1313309	DAP3	death associated protein 3	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1313310	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of DAP3 mRNA	PMID:40234311
1313309	DAP3	death associated protein 3	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20140408	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of DAP3 mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in increased expression of DAP3 mRNA]	PMID:23963992
1313309	DAP3	death associated protein 3	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of DAP3 mRNA	PMID:17659339
1313309	DAP3	death associated protein 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DAP3 protein	PMID:32959892
1313309	DAP3	death associated protein 3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313310	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of DAP3 mRNA	PMID:14729362
1313309	DAP3	death associated protein 3	gene	CHEBI:6443	levonorgestrel	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DAP3 mRNA	PMID:19074003
1313309	DAP3	death associated protein 3	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of DAP3 mRNA	PMID:37939859
1313309	DAP3	death associated protein 3	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1313310	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in increased expression of DAP3 mRNA	PMID:17654400
1313309	DAP3	death associated protein 3	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of DAP3 mRNA	PMID:31758290
1313309	DAP3	death associated protein 3	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DAP3 protein	PMID:34186270
1313309	DAP3	death associated protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313310	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of DAP3 mRNA	PMID:22206623
1313309	DAP3	death associated protein 3	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DAP3 protein	PMID:37664457
1313309	DAP3	death associated protein 3	gene	CHEBI:7602	nobiletin	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of DAP3 protein]	PMID:38348393
1313309	DAP3	death associated protein 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DAP3 gene]	PMID:28238834
1313309	DAP3	death associated protein 3	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010672	Phenytoin results in increased expression of DAP3 mRNA	PMID:14741686
1313309	DAP3	death associated protein 3	gene	CHEBI:8207	(+)-pilocarpine	increases expression	ISO	RGD:1305339	E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in increased expression of DAP3 mRNA	PMID:17971868
1313309	DAP3	death associated protein 3	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of DAP3 protein	PMID:38348393
1313309	DAP3	death associated protein 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of DAP3 protein]	PMID:38348393
1313309	DAP3	death associated protein 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DAP3 protein	PMID:37664457
1313309	DAP3	death associated protein 3	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DAP3 mRNA	PMID:38568856
1313309	DAP3	death associated protein 3	gene	CHEBI:9907	ursodeoxycholic acid	affects expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D014580	Ursodeoxycholic Acid affects the expression of DAP3 mRNA	PMID:18422935
1313309	DAP3	death associated protein 3	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305339	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of DAP3 mRNA	PMID:23034163
1313311	CEP55	centrosomal protein 55	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CEP55 mRNA	PMID:20938992
1313311	CEP55	centrosomal protein 55	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of CEP55 mRNA	PMID:23724009|PMID:33167477
1313311	CEP55	centrosomal protein 55	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305340	E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CEP55 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CEP55 mRNA	PMID:33729688
1313311	CEP55	centrosomal protein 55	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000431	Ethanol results in decreased expression of CEP55 protein	PMID:20621659
1313311	CEP55	centrosomal protein 55	gene	CHEBI:16243	quercetin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin affects the phosphorylation of CEP55 protein	PMID:35688186
1313311	CEP55	centrosomal protein 55	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of CEP55 mRNA	PMID:21632981
1313311	CEP55	centrosomal protein 55	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of CEP55 mRNA	PMID:35877022
1313311	CEP55	centrosomal protein 55	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of CEP55 mRNA	PMID:19167446
1313311	CEP55	centrosomal protein 55	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEP55 mRNA	PMID:25510870
1313311	CEP55	centrosomal protein 55	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305340	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CEP55 mRNA	PMID:33387578
1313311	CEP55	centrosomal protein 55	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305340	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of CEP55 gene	PMID:27618143
1313311	CEP55	centrosomal protein 55	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CEP55 mRNA	PMID:20938992
1313311	CEP55	centrosomal protein 55	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D002635	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CEP55 mRNA	PMID:34589561
1313311	CEP55	centrosomal protein 55	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of CEP55 mRNA	PMID:21795739
1313311	CEP55	centrosomal protein 55	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of CEP55 mRNA	PMID:18070364
1313311	CEP55	centrosomal protein 55	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CEP55 mRNA	PMID:21179406
1313311	CEP55	centrosomal protein 55	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA	PMID:37992649
1313311	CEP55	centrosomal protein 55	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of CEP55 mRNA	PMID:21592394
1313311	CEP55	centrosomal protein 55	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of CEP55 mRNA	PMID:21592394
1313311	CEP55	centrosomal protein 55	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA	PMID:37992649
1313311	CEP55	centrosomal protein 55	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D006000	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CEP55 mRNA	PMID:34589561
1313311	CEP55	centrosomal protein 55	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CEP55 mRNA	PMID:31163220
1313311	CEP55	centrosomal protein 55	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1623932	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CEP55 mRNA	PMID:34319233
1313311	CEP55	centrosomal protein 55	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305340	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CEP55 promoter	PMID:23359474
1313311	CEP55	centrosomal protein 55	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305340	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CEP55 mRNA	PMID:26577399
1313311	CEP55	centrosomal protein 55	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CEP55 protein	PMID:37730182
1313311	CEP55	centrosomal protein 55	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of CEP55 mRNA	PMID:21592394
1313311	CEP55	centrosomal protein 55	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of CEP55 mRNA	PMID:21592394
1313311	CEP55	centrosomal protein 55	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305340	E	RGD:6480464	20241001	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CEP55 mRNA	PMID:38301995
1313311	CEP55	centrosomal protein 55	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of CEP55 mRNA	PMID:21120746
1313311	CEP55	centrosomal protein 55	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEP55 mRNA	PMID:25510870
1313311	CEP55	centrosomal protein 55	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEP55 mRNA	PMID:25510870
1313311	CEP55	centrosomal protein 55	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CEP55 mRNA	PMID:19549813
1313311	CEP55	centrosomal protein 55	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CEP55 protein	PMID:23301498
1313311	CEP55	centrosomal protein 55	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CEP55 protein	PMID:20106945
1313311	CEP55	centrosomal protein 55	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CEP55 mRNA	PMID:19770486
1313311	CEP55	centrosomal protein 55	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305340	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CEP55 mRNA	PMID:23630614|PMID:25378103
1313311	CEP55	centrosomal protein 55	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of CEP55 mRNA	PMID:25102026
1313311	CEP55	centrosomal protein 55	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1623932	E	RGD:6480464	20150609	CTD	MESH:D010126	Ozone results in increased expression of CEP55 mRNA	PMID:25658374
1313311	CEP55	centrosomal protein 55	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CEP55 mRNA	PMID:41430723
1313311	CEP55	centrosomal protein 55	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CEP55 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CEP55 mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of CEP55 mRNA; TTPA protein affects the reaction [Ozone results in increased expression of CEP55 mRNA]	PMID:19555225|PMID:24381131|PMID:25658374|PMID:27106289|PMID:34911549
1313311	CEP55	centrosomal protein 55	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of CEP55 mRNA	PMID:17484886
1313311	CEP55	centrosomal protein 55	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1623932	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CEP55 mRNA	PMID:31919559
1313311	CEP55	centrosomal protein 55	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1623932	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of CEP55 mRNA	PMID:25629700
1313311	CEP55	centrosomal protein 55	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CEP55 mRNA	PMID:20938992
1313311	CEP55	centrosomal protein 55	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D006002	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CEP55 mRNA	PMID:34589561
1313311	CEP55	centrosomal protein 55	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CEP55 mRNA	PMID:40504410
1313311	CEP55	centrosomal protein 55	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of CEP55 mRNA	PMID:33512557
1313311	CEP55	centrosomal protein 55	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA]	PMID:37992649
1313311	CEP55	centrosomal protein 55	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305340	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CEP55 mRNA	PMID:31881176
1313311	CEP55	centrosomal protein 55	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of CEP55 mRNA	PMID:19167446
1313311	CEP55	centrosomal protein 55	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CEP55 mRNA	PMID:25583101
1313311	CEP55	centrosomal protein 55	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CEP55 mRNA	PMID:22298810
1313311	CEP55	centrosomal protein 55	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CEP55 mRNA	PMID:21802500
1313311	CEP55	centrosomal protein 55	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305340	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CEP55 mRNA	PMID:33387578|PMID:34747641
1313311	CEP55	centrosomal protein 55	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of CEP55 mRNA	PMID:33512557
1313311	CEP55	centrosomal protein 55	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CEP55 protein	PMID:33212167
1313311	CEP55	centrosomal protein 55	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CEP55 mRNA	PMID:32763439
1313311	CEP55	centrosomal protein 55	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CEP55 mRNA	PMID:30031762
1313311	CEP55	centrosomal protein 55	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA	PMID:37992649
1313311	CEP55	centrosomal protein 55	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D003840	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CEP55 mRNA	PMID:34589561
1313311	CEP55	centrosomal protein 55	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA]	PMID:37992649
1313311	CEP55	centrosomal protein 55	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of CEP55 mRNA	PMID:22623647
1313311	CEP55	centrosomal protein 55	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CEP55 mRNA	PMID:17998272
1313311	CEP55	centrosomal protein 55	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of CEP55 mRNA	PMID:29301061|PMID:39719251
1313311	CEP55	centrosomal protein 55	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1623932	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of CEP55 mRNA	PMID:39515575
1313311	CEP55	centrosomal protein 55	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CEP55 mRNA	PMID:40504410
1313311	CEP55	centrosomal protein 55	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of CEP55 mRNA	PMID:22378314|PMID:29453283
1313311	CEP55	centrosomal protein 55	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CEP55 mRNA	PMID:20064835|PMID:21802500
1313311	CEP55	centrosomal protein 55	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CEP55 mRNA	PMID:19770486
1313311	CEP55	centrosomal protein 55	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CEP55 mRNA	PMID:32234424
1313311	CEP55	centrosomal protein 55	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CEP55 mRNA	PMID:20713471|PMID:32417428
1313311	CEP55	centrosomal protein 55	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of CEP55 mRNA	PMID:18929588
1313311	CEP55	centrosomal protein 55	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1623932	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CEP55 mRNA	PMID:29341224
1313311	CEP55	centrosomal protein 55	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CEP55 mRNA	PMID:20382639
1313311	CEP55	centrosomal protein 55	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CEP55 mRNA	PMID:20458559
1313311	CEP55	centrosomal protein 55	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305340	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CEP55 mRNA	PMID:30047161
1313311	CEP55	centrosomal protein 55	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623932	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CEP55 gene; titanium dioxide results in decreased methylation of CEP55 promoter	PMID:35295148
1313311	CEP55	centrosomal protein 55	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1305340	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of CEP55 mRNA	PMID:30012374
1313311	CEP55	centrosomal protein 55	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1623932	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CEP55 mRNA	PMID:23557971
1313311	CEP55	centrosomal protein 55	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1623932	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CEP55 promoter	PMID:35295148
1313311	CEP55	centrosomal protein 55	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305340	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CEP55 mRNA	PMID:22659510|PMID:23411599|PMID:34492290
1313311	CEP55	centrosomal protein 55	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CEP55 mRNA	PMID:18301758
1313311	CEP55	centrosomal protein 55	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CEP55 mRNA	PMID:19710929
1313311	CEP55	centrosomal protein 55	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of CEP55 mRNA	PMID:38479592
1313311	CEP55	centrosomal protein 55	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CEP55 mRNA	PMID:29275510
1313311	CEP55	centrosomal protein 55	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305340	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CEP55 mRNA	PMID:25181051
1313311	CEP55	centrosomal protein 55	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305340	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of CEP55 mRNA	PMID:32145629
1313311	CEP55	centrosomal protein 55	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1623932	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of CEP55 mRNA	PMID:40036665
1313311	CEP55	centrosomal protein 55	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305340	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CEP55 promoter	PMID:23359474
1313311	CEP55	centrosomal protein 55	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1623932	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of CEP55 mRNA	PMID:26682919
1313311	CEP55	centrosomal protein 55	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEP55 mRNA	PMID:25510870
1313311	CEP55	centrosomal protein 55	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CEP55 mRNA	PMID:25510870
1313311	CEP55	centrosomal protein 55	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of CEP55 mRNA	PMID:20713471
1313311	CEP55	centrosomal protein 55	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CEP55 mRNA	PMID:39298647|PMID:40203079
1313311	CEP55	centrosomal protein 55	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of CEP55 gene	PMID:31601247
1313311	CEP55	centrosomal protein 55	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CEP55 mRNA	PMID:20350560
1313311	CEP55	centrosomal protein 55	gene	CHEBI:34687	dibutyl phthalate	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CEP55 mRNA	PMID:36828243
1313311	CEP55	centrosomal protein 55	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D003993	N-methyl-delta-3,3-dihydroindole-2,2 diketone inhibits the reaction [Dibutyl Phthalate results in increased expression of CEP55 mRNA]	PMID:36828243
1313311	CEP55	centrosomal protein 55	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305340	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CEP55 promoter	PMID:23359474
1313311	CEP55	centrosomal protein 55	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CEP55 mRNA	PMID:24535843
1313311	CEP55	centrosomal protein 55	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305340	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of CEP55 gene	PMID:33148267
1313311	CEP55	centrosomal protein 55	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305340	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of CEP55 mRNA	PMID:30723492
1313311	CEP55	centrosomal protein 55	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CEP55 mRNA	PMID:26472689
1313311	CEP55	centrosomal protein 55	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305340	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of CEP55 mRNA	PMID:25539665
1313311	CEP55	centrosomal protein 55	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305340	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CEP55 mRNA	PMID:30047161
1313311	CEP55	centrosomal protein 55	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CEP55 mRNA	PMID:19320972
1313311	CEP55	centrosomal protein 55	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D005999	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CEP55 mRNA	PMID:34589561
1313311	CEP55	centrosomal protein 55	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1623932	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of CEP55 mRNA	PMID:28962523
1313311	CEP55	centrosomal protein 55	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CEP55 mRNA	PMID:40194260
1313311	CEP55	centrosomal protein 55	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1623932	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CEP55 mRNA	PMID:40194260
1313311	CEP55	centrosomal protein 55	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CEP55 mRNA	PMID:28302478
1313311	CEP55	centrosomal protein 55	gene	CHEBI:38725	mevinphos	increases expression	ISO	RGD:1305340	E	RGD:6480464	20150714	CTD	MESH:D008799	Mevinphos results in increased expression of CEP55 mRNA; Mevinphos results in increased expression of CEP55 protein	PMID:25449601
1313311	CEP55	centrosomal protein 55	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CEP55 mRNA	PMID:31533062
1313311	CEP55	centrosomal protein 55	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of CEP55 mRNA	PMID:19167446
1313311	CEP55	centrosomal protein 55	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP55 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of CEP55 mRNA	PMID:19167446
1313311	CEP55	centrosomal protein 55	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of CEP55 mRNA	PMID:39529242
1313311	CEP55	centrosomal protein 55	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CEP55 mRNA	PMID:40419075
1313311	CEP55	centrosomal protein 55	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CEP55 mRNA	PMID:25979313
1313311	CEP55	centrosomal protein 55	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305340	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CEP55 mRNA	PMID:30047161
1313311	CEP55	centrosomal protein 55	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CEP55 mRNA	PMID:37992649
1313311	CEP55	centrosomal protein 55	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of CEP55 mRNA	PMID:33512557
1313311	CEP55	centrosomal protein 55	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CEP55 mRNA	PMID:38832940
1313311	CEP55	centrosomal protein 55	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CEP55 mRNA	PMID:27188386
1313311	CEP55	centrosomal protein 55	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CEP55 mRNA	PMID:28542535
1313311	CEP55	centrosomal protein 55	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CEP55 mRNA	PMID:22230336
1313311	CEP55	centrosomal protein 55	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of CEP55 mRNA	PMID:17039268
1313311	CEP55	centrosomal protein 55	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of CEP55 mRNA	PMID:24714768
1313311	CEP55	centrosomal protein 55	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CEP55 mRNA	PMID:40504410
1313311	CEP55	centrosomal protein 55	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of CEP55 mRNA	PMID:31838189
1313311	CEP55	centrosomal protein 55	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305340	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CEP55 mRNA	PMID:29391264
1313311	CEP55	centrosomal protein 55	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CEP55 mRNA	PMID:20458559
1313311	CEP55	centrosomal protein 55	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1623932	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CEP55 mRNA; Nanotubes, Carbon results in increased expression of CEP55 mRNA	PMID:25554681|PMID:25620056
1313311	CEP55	centrosomal protein 55	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305340	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CEP55 mRNA	PMID:30047161
1313311	CEP55	centrosomal protein 55	gene	CHEBI:50883	boron nitride	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017282	boron nitride results in decreased expression of CEP55 mRNA	PMID:30644070
1313311	CEP55	centrosomal protein 55	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of CEP55 mRNA	PMID:21148553
1313311	CEP55	centrosomal protein 55	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1623932	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CEP55 mRNA	PMID:19042947
1313311	CEP55	centrosomal protein 55	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1623932	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CEP55 mRNA	PMID:38701926
1313311	CEP55	centrosomal protein 55	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of CEP55 mRNA	PMID:19812364
1313311	CEP55	centrosomal protein 55	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CEP55 mRNA	PMID:24810058
1313311	CEP55	centrosomal protein 55	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305340	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CEP55 mRNA	PMID:37269647
1313311	CEP55	centrosomal protein 55	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305340	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of CEP55 mRNA	PMID:35283115
1313311	CEP55	centrosomal protein 55	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in decreased expression of CEP55 mRNA	PMID:25290377
1313311	CEP55	centrosomal protein 55	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305340	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of CEP55 gene	PMID:33148267
1313311	CEP55	centrosomal protein 55	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of CEP55 mRNA	PMID:29522793
1313311	CEP55	centrosomal protein 55	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CEP55 mRNA	PMID:37199045
1313311	CEP55	centrosomal protein 55	gene	CHEBI:754906	afuresertib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of CEP55 mRNA	PMID:28960945
1313311	CEP55	centrosomal protein 55	gene	CHEBI:76604	MeIQx	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CEP55 mRNA	PMID:20816883
1313311	CEP55	centrosomal protein 55	gene	CHEBI:7719	ochratoxin A	decreases acetylation	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased acetylation of CEP55 promoter	PMID:29098329
1313311	CEP55	centrosomal protein 55	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased expression of CEP55 mRNA	PMID:29098329
1313311	CEP55	centrosomal protein 55	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305340	E	RGD:6480464	20241001	CTD	MESH:C025589	ochratoxin A results in increased expression of CEP55 mRNA	PMID:38301995
1313311	CEP55	centrosomal protein 55	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	[ochratoxin A results in decreased acetylation of CEP55 promoter] which results in decreased expression of CEP55 mRNA	PMID:29098329
1313311	CEP55	centrosomal protein 55	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of CEP55 mRNA	PMID:34995734
1313311	CEP55	centrosomal protein 55	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of CEP55 mRNA	PMID:30928695
1313311	CEP55	centrosomal protein 55	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1623932	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CEP55 mRNA	PMID:23091169
1313311	CEP55	centrosomal protein 55	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1623932	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CEP55 mRNA	PMID:24535843
1313311	CEP55	centrosomal protein 55	gene	CHEBI:81555	Enterolactone	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of CEP55 mRNA	PMID:19167446
1313311	CEP55	centrosomal protein 55	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CEP55 mRNA	PMID:19167446
1313311	CEP55	centrosomal protein 55	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1623932	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CEP55 mRNA	PMID:38648751
1313311	CEP55	centrosomal protein 55	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of CEP55 mRNA	PMID:33512557
1313311	CEP55	centrosomal protein 55	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of CEP55 mRNA	PMID:32234424
1313311	CEP55	centrosomal protein 55	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of CEP55 mRNA	PMID:21858171
1313311	CEP55	centrosomal protein 55	gene	CHEBI:82538	Sunset Yellow FCF	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:C005842	[6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CEP55 mRNA	PMID:34589561
1313311	CEP55	centrosomal protein 55	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of CEP55 mRNA	PMID:33512557
1313311	CEP55	centrosomal protein 55	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305340	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of CEP55 mRNA	PMID:24780913
1313311	CEP55	centrosomal protein 55	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305340	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CEP55 mRNA	PMID:30047161
1313311	CEP55	centrosomal protein 55	gene	CHEBI:85993	palbociclib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of CEP55 mRNA	PMID:22869556
1313311	CEP55	centrosomal protein 55	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1623932	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CEP55 mRNA	PMID:35537566
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of LEMD2 mRNA	PMID:38568856
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305341	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LEMD2 mRNA	PMID:33387578
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Clozapine] results in increased expression of LEMD2 protein	PMID:34122009
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of LEMD2 protein	PMID:37730182
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of LEMD2 mRNA	PMID:28818685
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552183	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LEMD2 mRNA	PMID:19770486
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LEMD2 gene	PMID:27153756
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1552183	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of LEMD2 mRNA	PMID:25629700
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552183	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LEMD2 mRNA	PMID:40504410
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of LEMD2 protein	PMID:35688186
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552183	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LEMD2 mRNA	PMID:21570461
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305341	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LEMD2 mRNA	PMID:33387578
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of LEMD2 mRNA	PMID:24690739
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LEMD2 mRNA	PMID:29803840
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of LEMD2 protein	PMID:35688186
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LEMD2 mRNA	PMID:38568856
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552183	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LEMD2 mRNA	PMID:40504410
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305341	E	RGD:6480464	20130806	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LEMD2 mRNA	PMID:21839799
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LEMD2 5' UTR	PMID:27901495
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552183	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LEMD2 mRNA	PMID:22228805
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LEMD2 3' UTR; Benzo(a)pyrene results in increased methylation of LEMD2 promoter	PMID:27901495
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of LEMD2 mRNA	PMID:24690739
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552183	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LEMD2 promoter	PMID:35295148
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305341	E	RGD:6480464	20130806	CTD	MESH:C069837	fullerene C60 results in increased expression of LEMD2 mRNA	PMID:19167457
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305341	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LEMD2 mRNA	PMID:25181051
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LEMD2 gene	PMID:31601247
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of LEMD2 protein	PMID:34186270
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1552183	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of LEMD2 exon	PMID:33297965
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of LEMD2 protein	PMID:34186270
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LEMD2 mRNA	PMID:28628672
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of LEMD2 protein	PMID:34186270
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552183	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LEMD2 intron	PMID:28392331
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552183	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LEMD2 mRNA	PMID:37019170
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552183	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of LEMD2 mRNA	PMID:34813904
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LEMD2 mRNA	PMID:28628672
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1552183	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of LEMD2 mRNA	PMID:34813904
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LEMD2 mRNA	PMID:37042841
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1552183	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of LEMD2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LEMD2 mRNA]	PMID:17585979
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:3766	clozapine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	[Cuprizone co-treated with Clozapine] results in increased expression of LEMD2 protein	PMID:34122009
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LEMD2 mRNA	PMID:31533062
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LEMD2 gene	PMID:29154799
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of LEMD2 mRNA	PMID:20106945
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LEMD2 mRNA	PMID:28628672
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305341	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LEMD2 mRNA	PMID:33387578
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1552183	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of LEMD2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of LEMD2 mRNA]	PMID:17585979
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of LEMD2 mRNA	PMID:24690739
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552183	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LEMD2 mRNA	PMID:40504410
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LEMD2 mRNA	PMID:28628672
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:50729	mitoxantrone	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	LEMD2 mRNA affects the susceptibility to Mitoxantrone	PMID:16044152
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305341	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of LEMD2 mRNA	PMID:19162173
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305341	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of LEMD2 mRNA	PMID:24793618
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of LEMD2 protein	PMID:23718831
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LEMD2 protein	PMID:32959892
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305341	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of LEMD2 mRNA	PMID:28801915
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LEMD2 protein	PMID:34186270
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552183	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LEMD2 mRNA	PMID:22206623
1313312	LEMD2	LEM domain nuclear envelope protein 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LEMD2 mRNA	PMID:38568856
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ARHGAP9 mRNA	PMID:26272509
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP9 mRNA	PMID:27188386
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313315	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ARHGAP9 mRNA	PMID:33045310
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313315	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ARHGAP9 mRNA	PMID:26251327
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:15354	choline	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002794	Choline affects the expression of ARHGAP9 mRNA	PMID:17616785
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGAP9 mRNA	PMID:20938992
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in increased expression of ARHGAP9 mRNA	PMID:15894607|PMID:33167477
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1305342	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of ARHGAP9 mRNA	PMID:20488242
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in increased expression of ARHGAP9 mRNA	PMID:15894607
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ARHGAP9 mRNA	PMID:36189433
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARHGAP9 mRNA	PMID:39241906
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305342	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGAP9 mRNA	PMID:32741896
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGAP9 mRNA	PMID:20938992
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARHGAP9 mRNA	PMID:37042841
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGAP9 mRNA	PMID:37992649
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ARHGAP9 mRNA	PMID:36189433
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305342	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGAP9 mRNA	PMID:32741896
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGAP9 mRNA	PMID:37992649
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305342	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ARHGAP9 mRNA	PMID:22061828
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1313315	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of ARHGAP9 mRNA	PMID:39984025
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305342	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARHGAP9 mRNA	PMID:39012411
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ARHGAP9 mRNA	PMID:19549813
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ARHGAP9 intron	PMID:30157460
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ARHGAP9 mRNA	PMID:35430440
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of ARHGAP9 mRNA	PMID:19774075
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305342	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ARHGAP9 mRNA	PMID:31150632
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ARHGAP9 mRNA	PMID:20938992
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1305342	E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of ARHGAP9 mRNA	PMID:38314887
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305342	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ARHGAP9 mRNA	PMID:31881176
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1305342	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ARHGAP9 mRNA	PMID:25905778
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1305342	E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of ARHGAP9 mRNA	PMID:25905778
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of ARHGAP9 mRNA	PMID:23300844
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1305342	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of ARHGAP9 mRNA	PMID:17898221
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ARHGAP9 mRNA	PMID:25583101
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305342	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGAP9 mRNA	PMID:34747641
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ARHGAP9 mRNA	PMID:32763439
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGAP9 mRNA	PMID:37992649
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARHGAP9 mRNA	PMID:34032870
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGAP9 mRNA	PMID:38568856
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ARHGAP9 gene	PMID:25435355
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313315	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ARHGAP9 mRNA	PMID:27131904
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313315	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ARHGAP9 mRNA	PMID:29341224
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ARHGAP9 mRNA	PMID:15894607
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:C015358	methylparaben results in increased expression of ARHGAP9 mRNA	PMID:17121429
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313315	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARHGAP9 gene	PMID:35295148
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305342	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ARHGAP9 mRNA	PMID:34492290
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313315	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ARHGAP9 mRNA	PMID:18301758
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305342	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP9 mRNA	PMID:25181051|PMID:32145629
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313315	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARHGAP9 promoter	PMID:27312807
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313315	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGAP9 mRNA	PMID:32156529|PMID:38701888
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313315	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ARHGAP9 gene	PMID:31683443
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ARHGAP9 mRNA	PMID:38685157
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of ARHGAP9 mRNA	PMID:31558096
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARHGAP9 mRNA	PMID:37042841
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305342	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of ARHGAP9 mRNA	PMID:35163327
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305342	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ARHGAP9 mRNA	PMID:25380136
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ARHGAP9 mRNA	PMID:38382870
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305342	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARHGAP9 mRNA	PMID:39012411
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ARHGAP9 mRNA	PMID:24449571
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ARHGAP9 mRNA	PMID:31533062
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ARHGAP9 mRNA	PMID:39529242
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of ARHGAP9 mRNA	PMID:23125180
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of ARHGAP9 mRNA	PMID:31558096
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGAP9 mRNA	PMID:37992649
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of ARHGAP9 mRNA	PMID:33512557
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ARHGAP9 mRNA	PMID:38832940
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313315	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ARHGAP9 mRNA	PMID:29279043
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ARHGAP9 mRNA	PMID:15894607
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of ARHGAP9 mRNA	PMID:38825487
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:5011	fenpyroximate	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of ARHGAP9 mRNA	PMID:33512557
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ARHGAP9 mRNA	PMID:23300844
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313315	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ARHGAP9 mRNA	PMID:38701926
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of ARHGAP9 mRNA	PMID:36907384
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:6809	methamphetamine	increases methylation	ISO	RGD:1313315	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased methylation of ARHGAP9 promoter	PMID:26307267
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:68508	diethyl maleate	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C014476	diethyl maleate results in increased expression of ARHGAP9 mRNA	PMID:33545341
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313315	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ARHGAP9 mRNA	PMID:22206623
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305342	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ARHGAP9 mRNA	PMID:32741896
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP9 mRNA	PMID:27188386
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARHGAP9 gene]	PMID:28238834
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of ARHGAP9 mRNA	PMID:33512557
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313315	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of ARHGAP9 mRNA	PMID:31558096
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1305342	E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in increased expression of ARHGAP9 mRNA	PMID:26923065
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305342	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARHGAP9 mRNA	PMID:24780913
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:88542	Butylparaben	increases expression	EXP		E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in increased expression of ARHGAP9 mRNA	PMID:17121429
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGAP9 mRNA	PMID:27188386
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313315	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ARHGAP9 mRNA	PMID:27131904
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1305342	E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of ARHGAP9 mRNA	PMID:25905778
1313314	ARHGAP9	Rho GTPase activating protein 9	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of ARHGAP9 mRNA	PMID:33512557
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305343	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of EMILIN2 mRNA	PMID:25152437
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of EMILIN2 mRNA	PMID:27188386
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313317	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of EMILIN2 mRNA	PMID:37995155
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of EMILIN2 mRNA	PMID:20188158
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EMILIN2 mRNA	PMID:20938992
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of EMILIN2 mRNA	PMID:26079696
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:16130	DDT	increases expression	ISO	RGD:1305343	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased expression of EMILIN2 mRNA	PMID:30207508
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313317	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of EMILIN2 mRNA	PMID:19484750
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EMILIN2 mRNA	PMID:20938992
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EMILIN2 mRNA	PMID:37992649
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EMILIN2 mRNA	PMID:37992649
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305343	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of EMILIN2 mRNA	PMID:22061828
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305343	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of EMILIN2 mRNA	PMID:33387578
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EMILIN2 mRNA	PMID:36331819
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of EMILIN2 mRNA	PMID:19549813
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305343	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EMILIN2 mRNA	PMID:22129741
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of EMILIN2 mRNA	PMID:22100608
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EMILIN2 intron	PMID:30157460
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of EMILIN2 mRNA	PMID:41430723
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305343	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of EMILIN2 mRNA	PMID:30779732
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313317	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EMILIN2 mRNA	PMID:31919559
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of EMILIN2 mRNA	PMID:25629700
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EMILIN2 mRNA	PMID:20938992
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EMILIN2 gene	PMID:25304211
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of EMILIN2 mRNA	PMID:26272509
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EMILIN2 mRNA	PMID:27188386
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313317	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of EMILIN2 mRNA	PMID:35897073
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of EMILIN2 mRNA	PMID:23557933
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of EMILIN2 gene	PMID:31636367
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of EMILIN2 mRNA	PMID:27594783
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313317	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of EMILIN2 mRNA	PMID:21151649
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of EMILIN2 mRNA	PMID:24768652|PMID:25583101
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313317	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EMILIN2 mRNA	PMID:21570461
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313317	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of EMILIN2 mRNA	PMID:32937126
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of EMILIN2 mRNA	PMID:28001369
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of EMILIN2 mRNA	PMID:39631538
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of EMILIN2 mRNA	PMID:29803840
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EMILIN2 mRNA	PMID:37992649
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1305343	E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EMILIN2 mRNA	PMID:22129741
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of EMILIN2 mRNA	PMID:37682722|PMID:39515575
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EMILIN2 mRNA	PMID:38568856
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EMILIN2 promoter	PMID:27901495
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EMILIN2 mRNA	PMID:21569818|PMID:22228805
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EMILIN2 exon	PMID:27901495
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of EMILIN2 promoter	PMID:23974009
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313317	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of EMILIN2 mRNA	PMID:23221170
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313317	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of EMILIN2 gene	PMID:35295148
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305343	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EMILIN2 mRNA	PMID:34492290
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313317	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of EMILIN2 mRNA	PMID:26063408|PMID:32156529
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313317	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of EMILIN2 mRNA	PMID:26682919
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313317	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of EMILIN2 exon	PMID:33297965
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313317	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of EMILIN2 mRNA	PMID:30951980
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of EMILIN2 intron	PMID:30157460
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313317	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of EMILIN2 intron	PMID:28392331
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305343	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of EMILIN2 mRNA	PMID:22129741
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305343	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of EMILIN2 mRNA	PMID:35163327
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of EMILIN2 mRNA	PMID:24982889
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313317	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EMILIN2 mRNA	PMID:24982889
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305343	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of EMILIN2 mRNA	PMID:35163327
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of EMILIN2 mRNA	PMID:22698814
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of EMILIN2 mRNA	PMID:24449571
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of EMILIN2 mRNA	PMID:31533062
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EMILIN2 mRNA	PMID:36331819
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of EMILIN2 mRNA	PMID:23125180
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EMILIN2 mRNA	PMID:23179753
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313317	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of EMILIN2 mRNA	PMID:24896083
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of EMILIN2 gene	PMID:29154799
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of EMILIN2 mRNA	PMID:25047013
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of EMILIN2 mRNA	PMID:28973697
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313317	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EMILIN2 mRNA	PMID:37992649
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of EMILIN2 mRNA	PMID:38832940
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305343	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EMILIN2 mRNA	PMID:33387578
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EMILIN2 gene	PMID:25304211
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313317	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of EMILIN2 mRNA	PMID:25554681
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313317	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of EMILIN2 mRNA	PMID:25554681
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313317	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of EMILIN2 mRNA	PMID:40234311
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313317	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of EMILIN2 mRNA	PMID:19042947
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:5643	Heliotrine	increases expression	ISO	RGD:1305343	E	RGD:6480464	20211109	CTD	MESH:C010178	heliotrine results in increased expression of EMILIN2 mRNA	PMID:34185104
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313317	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of EMILIN2 mRNA	PMID:38701926
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of EMILIN2 intron	PMID:30157460
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of EMILIN2 mRNA	PMID:31758290
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313317	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of EMILIN2 mRNA	PMID:22206623
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1313317	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of EMILIN2 mRNA	PMID:27858113
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EMILIN2 mRNA	PMID:27188386
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313317	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of EMILIN2 mRNA	PMID:38648751
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of EMILIN2 mRNA	PMID:26079696
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313317	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of EMILIN2 mRNA	PMID:39847705
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313317	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of EMILIN2 mRNA	PMID:30953684
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1305343	E	RGD:6480464	20211109	CTD	MESH:C009237	senecionine results in increased expression of EMILIN2 mRNA	PMID:34185104
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EMILIN2 mRNA	PMID:27188386
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:9111	Senkirkine	increases expression	ISO	RGD:1305343	E	RGD:6480464	20211109	CTD	MESH:C009238	senkirkine results in increased expression of EMILIN2 mRNA	PMID:34185104
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of EMILIN2 mRNA	PMID:29301935
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in increased expression of EMILIN2 mRNA	PMID:29453283
1313316	EMILIN2	elastin microfibril interfacer 2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313317	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of EMILIN2 mRNA	PMID:28973697
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305346	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of FARP1 mRNA	PMID:21551480
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of FARP1 mRNA	PMID:26272509
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FARP1 mRNA	PMID:27188386
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of FARP1 mRNA	PMID:33045310
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FARP1 mRNA	PMID:36331819
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of FARP1 mRNA	PMID:26079696
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305346	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of FARP1 gene	PMID:28931070|PMID:35440735
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313321	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FARP1 mRNA	PMID:30319688
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of FARP1 mRNA	PMID:21632981
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of FARP1 protein	PMID:35688186
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305346	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of FARP1 mRNA	PMID:20068009
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313321	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FARP1 mRNA	PMID:39298647
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol inhibits the reaction [afimoxifene results in increased expression of FARP1 mRNA]	PMID:16849584
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FARP1 mRNA	PMID:37042841
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of FARP1 protein	PMID:37730182
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of FARP1 intron	PMID:30157460
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FARP1 mRNA	PMID:36331819
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305346	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of FARP1 protein	PMID:34915118
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FARP1 mRNA	PMID:37236586
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FARP1 mRNA	PMID:19549813
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FARP1 mRNA	PMID:19770486
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FARP1 gene	PMID:27153756
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FARP1 intron	PMID:30157460
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FARP1 mRNA	PMID:23649840
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1305346	E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in decreased expression of FARP1 mRNA	PMID:35737395
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FARP1 mRNA	PMID:25629700
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FARP1 mRNA	PMID:22206623
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20240702	CTD	MESH:D001151	Arsenic results in decreased expression of FARP1 mRNA	PMID:38150313
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FARP1 mRNA	PMID:40504410
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of FARP1 mRNA	PMID:19244175
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of FARP1 protein	PMID:35688186
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:1305346	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of FARP1 gene	PMID:31011160
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of FARP1 promoter	PMID:22847954
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in increased expression of FARP1 mRNA	PMID:20884965
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of FARP1 mRNA	PMID:25583101
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FARP1 mRNA	PMID:26290441
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FARP1 mRNA	PMID:28001369
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FARP1 mRNA	PMID:33212167
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305346	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of FARP1 mRNA	PMID:30556269
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of FARP1 mRNA	PMID:20971185
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FARP1 mRNA	PMID:15467011
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FARP1 mRNA	PMID:29803840
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of FARP1 protein	PMID:35688186
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of FARP1 mRNA	PMID:20044591
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of FARP1 gene	PMID:28589171
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of FARP1 mRNA	PMID:34032870
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FARP1 mRNA	PMID:38568856
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FARP1 mRNA	PMID:40504410
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FARP1 3' UTR; Benzo(a)pyrene affects the methylation of FARP1 5' UTR	PMID:27901495
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FARP1 mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FARP1 mRNA	PMID:19770486
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FARP1 promoter	PMID:27901495
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of FARP1 gene	PMID:25435355
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FARP1 mRNA	PMID:27858113
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to FARP1 mRNA]	PMID:32406909
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305346	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of FARP1 mRNA	PMID:30556269
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of FARP1 mRNA	PMID:20971185
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of FARP1 mRNA	PMID:15467011
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313321	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of FARP1 mRNA	PMID:23221170
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of FARP1 gene	PMID:31601247
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FARP1 gene; Fulvestrant inhibits the reaction [afimoxifene results in increased expression of FARP1 mRNA]	PMID:16849584|PMID:31601247
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313321	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FARP1 gene	PMID:35295148
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305346	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FARP1 mRNA	PMID:34492290
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313321	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of FARP1 mRNA	PMID:18648102
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305346	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of FARP1 mRNA	PMID:19167457
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of FARP1 mRNA	PMID:30903817
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305346	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FARP1 mRNA	PMID:25181051
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1305346	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of FARP1 promoter	PMID:27415467
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313321	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of FARP1 promoter	PMID:27334623
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of FARP1 mRNA	PMID:22576693
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of FARP1 mRNA	PMID:26063408
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313321	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of FARP1 mRNA	PMID:30951980
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of FARP1 gene	PMID:22576693
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305346	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FARP1 gene	PMID:28505145
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FARP1 gene	PMID:31601247
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S affects the methylation of FARP1 gene	PMID:31601247
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313321	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FARP1 mRNA	PMID:30951980|PMID:39298647
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FARP1 mRNA	PMID:27858113
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of FARP1 intron	PMID:30157460
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34568	Benzo[ghi]perylene	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in decreased expression of FARP1 mRNA	PMID:26377693
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1305346	E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FARP1 protein	PMID:34896426
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313321	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of FARP1 mRNA	PMID:30951980
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313321	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of FARP1 intron	PMID:28392331
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313321	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FARP1 mRNA	PMID:37019170
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305346	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of FARP1 gene	PMID:33148267
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FARP1 mRNA	PMID:37042841
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FARP1 mRNA	PMID:26472689
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FARP1 mRNA	PMID:38382870
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FARP1 mRNA	PMID:37236586
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313321	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of FARP1 mRNA	PMID:28903501
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FARP1 mRNA	PMID:19320972
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of FARP1 mRNA	PMID:19244175
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of FARP1 mRNA	PMID:28302478
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of FARP1 promoter	PMID:22847954
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of FARP1 promoter	PMID:22847954
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1305346	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of FARP1 protein	PMID:34896426
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FARP1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FARP1 mRNA	PMID:36331819
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FARP1 mRNA	PMID:23179753|PMID:25979313
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305346	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of FARP1 mRNA	PMID:29427782
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of FARP1 mRNA	PMID:24383497|PMID:26272509
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FARP1 gene	PMID:29154799
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FARP1 mRNA	PMID:27188386
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FARP1 mRNA	PMID:25562108|PMID:27989131
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1305346	E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FARP1 protein	PMID:34896426
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1305346	E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FARP1 protein	PMID:34896426
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of FARP1 mRNA	PMID:28973697
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313321	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FARP1 mRNA	PMID:28973697
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:44616	afimoxifene	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C016601	afimoxifene results in increased expression of FARP1 mRNA	PMID:16849584
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20200211	CTD	MESH:C016601	ESR2 protein inhibits the reaction [afimoxifene results in increased expression of FARP1 mRNA]; Estradiol inhibits the reaction [afimoxifene results in increased expression of FARP1 mRNA]; Fulvestrant inhibits the reaction [afimoxifene results in increased expression of FARP1 mRNA]	PMID:16849584
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of FARP1 mRNA	PMID:24935251
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313321	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FARP1 mRNA	PMID:17562736
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of FARP1 mRNA	PMID:21420995
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305346	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of FARP1 mRNA	PMID:33387578
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of FARP1 mRNA	PMID:29067470
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of FARP1 promoter	PMID:29626692
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of FARP1 promoter	PMID:29626692
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46680	serpentine asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of FARP1 promoter	PMID:29626692
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:46680	serpentine asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of FARP1 3' UTR	PMID:29523930
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20240702	CTD	MESH:D001151	Arsenic results in decreased expression of FARP1 mRNA	PMID:38150313
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FARP1 mRNA	PMID:40504410
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of FARP1 mRNA	PMID:31838189
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313321	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of FARP1 mRNA	PMID:35436446
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of FARP1 mRNA	PMID:18175754
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1305346	E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FARP1 protein	PMID:34896426
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FARP1 mRNA	PMID:25554681
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313321	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of FARP1 mRNA	PMID:25554681
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305346	E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in increased expression of FARP1 mRNA	PMID:38685447
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of FARP1 mRNA	PMID:26377693
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FARP1 mRNA	PMID:27858113
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FARP1 mRNA	PMID:27858113
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of FARP1 mRNA	PMID:16780908
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of FARP1 mRNA	PMID:19042947
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:53578	hexamethylene diisocyanate	increases methylation	EXP		E	RGD:6480464	20150414	CTD	MESH:C015262	1,6-hexamethylene diisocyanate results in increased methylation of FARP1 gene	PMID:25445006
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FARP1 protein	PMID:32959892
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of FARP1 mRNA	PMID:15336504
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313321	E	RGD:6480464	20121113	CTD	MESH:D007545	Isoproterenol results in increased expression of FARP1 mRNA	PMID:21335049
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of FARP1 intron	PMID:30157460
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305346	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FARP1 gene	PMID:35440735
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305346	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of FARP1 gene	PMID:33148267
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FARP1 mRNA	PMID:22206623
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of FARP1 protein	PMID:37664457
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FARP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FARP1 mRNA	PMID:27188386
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FARP1 gene]	PMID:28238834
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313321	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of FARP1 mRNA	PMID:19482888
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of FARP1 mRNA]	PMID:19482888
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313321	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of FARP1 mRNA	PMID:30294300
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1313321	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of FARP1 mRNA	PMID:38995820
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1305346	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of FARP1 protein	PMID:28903499
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of FARP1 protein	PMID:38348393
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305346	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of FARP1 mRNA	PMID:24780913
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of FARP1 protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FARP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FARP1 mRNA	PMID:27188386|PMID:37664457
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305346	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of FARP1 mRNA	PMID:19281266
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305346	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of FARP1 mRNA	PMID:19015723
1313320	FARP1	FERM, ARH/RhoGEF and pleckstrin domain protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305346	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of FARP1 mRNA	PMID:23034163
1313328	MATN2	matrilin 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305353	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of MATN2 mRNA	PMID:25152437
1313328	MATN2	matrilin 2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of MATN2 mRNA	PMID:26272509
1313328	MATN2	matrilin 2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN2 mRNA	PMID:27188386
1313328	MATN2	matrilin 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313329	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MATN2 mRNA	PMID:37995155
1313328	MATN2	matrilin 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313329	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of MATN2 mRNA	PMID:20188158
1313328	MATN2	matrilin 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MATN2 mRNA	PMID:20938992
1313328	MATN2	matrilin 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of MATN2 mRNA	PMID:16249480
1313328	MATN2	matrilin 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of MATN2 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of MATN2 mRNA	PMID:30951980
1313328	MATN2	matrilin 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MATN2 mRNA	PMID:26079696
1313328	MATN2	matrilin 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305353	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of MATN2 gene	PMID:35440735
1313328	MATN2	matrilin 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313329	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MATN2 mRNA	PMID:30319688
1313328	MATN2	matrilin 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313329	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in increased expression of MATN2 mRNA	PMID:29018328
1313328	MATN2	matrilin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of MATN2 mRNA	PMID:19619570
1313328	MATN2	matrilin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of MATN2 mRNA	PMID:14664709
1313328	MATN2	matrilin 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of MATN2 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MATN2 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of MATN2 mRNA	PMID:19619570|PMID:20660070|PMID:30165855
1313328	MATN2	matrilin 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305353	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of MATN2 mRNA	PMID:26496021
1313328	MATN2	matrilin 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305353	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MATN2 mRNA	PMID:33387578
1313328	MATN2	matrilin 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MATN2 mRNA	PMID:20938992
1313328	MATN2	matrilin 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of MATN2 mRNA	PMID:21795739
1313328	MATN2	matrilin 2	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of MATN2 mRNA	PMID:20660070
1313328	MATN2	matrilin 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MATN2 mRNA	PMID:37992649
1313328	MATN2	matrilin 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MATN2 mRNA	PMID:36314267
1313328	MATN2	matrilin 2	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1305353	E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of MATN2 mRNA; 2-Acetylaminofluorene results in increased expression of MATN2 protein	PMID:17513098
1313328	MATN2	matrilin 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MATN2 mRNA	PMID:37992649
1313328	MATN2	matrilin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313329	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MATN2 mRNA	PMID:33754040
1313328	MATN2	matrilin 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305353	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of MATN2 mRNA	PMID:26577399
1313328	MATN2	matrilin 2	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MATN2 mRNA	PMID:36139627
1313328	MATN2	matrilin 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305353	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MATN2 mRNA	PMID:33387578
1313328	MATN2	matrilin 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN2 mRNA	PMID:39836092
1313328	MATN2	matrilin 2	gene	CHEBI:193591	Didecyldimethylammonium	decreases expression	EXP		E	RGD:6480464	20221018	CTD	MESH:C027118	didecyldimethylammonium results in decreased expression of MATN2 mRNA	PMID:32763356
1313328	MATN2	matrilin 2	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in decreased expression of MATN2 mRNA	PMID:28860664
1313328	MATN2	matrilin 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MATN2 protein	PMID:20106945
1313328	MATN2	matrilin 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MATN2 mRNA	PMID:32234424
1313328	MATN2	matrilin 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MATN2 intron	PMID:30157460
1313328	MATN2	matrilin 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313329	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MATN2 mRNA	PMID:27339419|PMID:31919559
1313328	MATN2	matrilin 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MATN2 mRNA	PMID:20938992
1313328	MATN2	matrilin 2	gene	CHEBI:27504	mitomycin C	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	MATN2 protein affects the susceptibility to Mitomycin	PMID:16217747
1313328	MATN2	matrilin 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MATN2 gene	PMID:25304211
1313328	MATN2	matrilin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MATN2 mRNA	PMID:39836092
1313328	MATN2	matrilin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MATN2 mRNA	PMID:40504410
1313328	MATN2	matrilin 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN2 mRNA	PMID:27188386
1313328	MATN2	matrilin 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MATN2 mRNA	PMID:28903495
1313328	MATN2	matrilin 2	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20151013	CTD	MESH:D002945	MATN2 mRNA results in decreased susceptibility to Cisplatin	PMID:25199881
1313328	MATN2	matrilin 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D002945	[Cisplatin co-treated with Paclitaxel] results in decreased expression of MATN2 mRNA	PMID:20705681
1313328	MATN2	matrilin 2	gene	CHEBI:28077	rifampicin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D012293	Rifampin results in increased expression of MATN2 mRNA	PMID:27177772
1313328	MATN2	matrilin 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MATN2 mRNA	PMID:25583101
1313328	MATN2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MATN2 mRNA	PMID:22298810
1313328	MATN2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305353	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MATN2 mRNA	PMID:22298810
1313328	MATN2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313329	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MATN2 mRNA	PMID:26377647
1313328	MATN2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MATN2 mRNA	PMID:19619570|PMID:20106945
1313328	MATN2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305353	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MATN2 mRNA	PMID:33387578
1313328	MATN2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MATN2 mRNA	PMID:11007951
1313328	MATN2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MATN2 mRNA	PMID:17942748
1313328	MATN2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MATN2 mRNA	PMID:19619570
1313328	MATN2	matrilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MATN2 mRNA	PMID:17942748
1313328	MATN2	matrilin 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of MATN2 protein	PMID:39603559
1313328	MATN2	matrilin 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MATN2 mRNA	PMID:28001369
1313328	MATN2	matrilin 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MATN2 mRNA; aristolochic acid I results in decreased expression of MATN2 protein	PMID:33212167
1313328	MATN2	matrilin 2	gene	CHEBI:28445	vincristine	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	MATN2 mRNA results in decreased susceptibility to Vincristine	PMID:25199881
1313328	MATN2	matrilin 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305353	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MATN2 mRNA	PMID:28959563
1313328	MATN2	matrilin 2	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of MATN2 mRNA	PMID:21198554
1313328	MATN2	matrilin 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MATN2 mRNA; [NSC 689534 binds to Copper] which results in increased expression of MATN2 mRNA	PMID:20971185|PMID:31162603
1313328	MATN2	matrilin 2	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of MATN2 mRNA	PMID:29803840
1313328	MATN2	matrilin 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of MATN2 mRNA	PMID:15033991|PMID:28608983|PMID:39631538
1313328	MATN2	matrilin 2	gene	CHEBI:28748	doxorubicin	decreases response to substance	EXP		E	RGD:6480464	20151013	CTD	MESH:D004317	MATN2 mRNA results in decreased susceptibility to Doxorubicin	PMID:25199881
1313328	MATN2	matrilin 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MATN2 mRNA	PMID:37992649
1313328	MATN2	matrilin 2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313329	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite affects the methylation of MATN2 gene	PMID:39894169
1313328	MATN2	matrilin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of MATN2 mRNA	PMID:29301061
1313328	MATN2	matrilin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MATN2 mRNA	PMID:37682722
1313328	MATN2	matrilin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MATN2 mRNA	PMID:39836092
1313328	MATN2	matrilin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MATN2 mRNA	PMID:40504410
1313328	MATN2	matrilin 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MATN2 polyA tail; Benzo(a)pyrene affects the methylation of MATN2 promoter	PMID:27901495|PMID:30157460
1313328	MATN2	matrilin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MATN2 mRNA	PMID:20106945|PMID:21871943|PMID:22316170|PMID:32234424
1313328	MATN2	matrilin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MATN2 mRNA	PMID:20713471|PMID:22610609
1313328	MATN2	matrilin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1305353	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MATN2 mRNA	PMID:21839799
1313328	MATN2	matrilin 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MATN2 mRNA; [NSC 689534 binds to Copper] which results in increased expression of MATN2 mRNA	PMID:20971185|PMID:31162603
1313328	MATN2	matrilin 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of MATN2 mRNA	PMID:25895662
1313328	MATN2	matrilin 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of MATN2 mRNA	PMID:23806026
1313328	MATN2	matrilin 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of MATN2 mRNA	PMID:20382639
1313328	MATN2	matrilin 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MATN2 mRNA	PMID:26705709
1313328	MATN2	matrilin 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of MATN2 mRNA	PMID:23557971
1313328	MATN2	matrilin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313329	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MATN2 gene	PMID:35295148
1313328	MATN2	matrilin 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313329	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MATN2 promoter	PMID:35295148
1313328	MATN2	matrilin 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313329	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MATN2 mRNA	PMID:28472532
1313328	MATN2	matrilin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305353	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MATN2 mRNA	PMID:25181051
1313328	MATN2	matrilin 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C006780	bisphenol A results in increased expression of MATN2 mRNA	PMID:27177772
1313328	MATN2	matrilin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305353	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of MATN2 mRNA	PMID:41034487
1313328	MATN2	matrilin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313329	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MATN2 mRNA	PMID:33221593
1313328	MATN2	matrilin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MATN2 mRNA	PMID:28628672
1313328	MATN2	matrilin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305353	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of MATN2 mRNA	PMID:26496021
1313328	MATN2	matrilin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of MATN2 mRNA	PMID:30951980
1313328	MATN2	matrilin 2	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of MATN2 mRNA	PMID:20713471
1313328	MATN2	matrilin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MATN2 gene	PMID:31601247
1313328	MATN2	matrilin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of MATN2 mRNA	PMID:30951980
1313328	MATN2	matrilin 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of MATN2 intron	PMID:30157460
1313328	MATN2	matrilin 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MATN2 mRNA	PMID:28628672
1313328	MATN2	matrilin 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of MATN2 mRNA	PMID:36117858
1313328	MATN2	matrilin 2	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of MATN2 mRNA	PMID:26678675
1313328	MATN2	matrilin 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN2 mRNA	PMID:39836092
1313328	MATN2	matrilin 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313329	E	RGD:6480464	20190312	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MATN2 mRNA	PMID:30711707
1313328	MATN2	matrilin 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MATN2 mRNA	PMID:24449571
1313328	MATN2	matrilin 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MATN2 mRNA	PMID:31533062
1313328	MATN2	matrilin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MATN2 mRNA	PMID:40419075
1313328	MATN2	matrilin 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MATN2 mRNA	PMID:25979313
1313328	MATN2	matrilin 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of MATN2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:29154799
1313328	MATN2	matrilin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of MATN2 mRNA	PMID:20106945|PMID:27989131
1313328	MATN2	matrilin 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MATN2 mRNA	PMID:17555576
1313328	MATN2	matrilin 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MATN2 mRNA	PMID:28628672
1313328	MATN2	matrilin 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of MATN2 mRNA	PMID:28973697
1313328	MATN2	matrilin 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MATN2 mRNA	PMID:37992649
1313328	MATN2	matrilin 2	gene	CHEBI:44185	methotrexate	decreases response to substance	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	MATN2 mRNA results in decreased susceptibility to Methotrexate	PMID:25199881
1313328	MATN2	matrilin 2	gene	CHEBI:45863	paclitaxel	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	MATN2 mRNA results in decreased susceptibility to Paclitaxel	PMID:25199881
1313328	MATN2	matrilin 2	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	[Cisplatin co-treated with Paclitaxel] results in decreased expression of MATN2 mRNA	PMID:20705681
1313328	MATN2	matrilin 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of MATN2 mRNA	PMID:24935251
1313328	MATN2	matrilin 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MATN2 mRNA	PMID:17562736
1313328	MATN2	matrilin 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of MATN2 mRNA	PMID:26690555
1313328	MATN2	matrilin 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305353	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MATN2 mRNA	PMID:33387578
1313328	MATN2	matrilin 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MATN2 mRNA	PMID:29523930
1313328	MATN2	matrilin 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MATN2 mRNA	PMID:29279043
1313328	MATN2	matrilin 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MATN2 gene	PMID:25304211
1313328	MATN2	matrilin 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MATN2 mRNA	PMID:39836092
1313328	MATN2	matrilin 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MATN2 mRNA	PMID:40504410
1313328	MATN2	matrilin 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305353	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MATN2 mRNA	PMID:29391264
1313328	MATN2	matrilin 2	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1305353	E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of MATN2 mRNA	PMID:37567419
1313328	MATN2	matrilin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MATN2 mRNA	PMID:17555576
1313328	MATN2	matrilin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305353	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of MATN2 mRNA	PMID:17557909
1313328	MATN2	matrilin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MATN2 mRNA	PMID:17942748
1313328	MATN2	matrilin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MATN2 mRNA	PMID:17942748
1313328	MATN2	matrilin 2	gene	CHEBI:4911	etoposide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	MATN2 protein affects the susceptibility to Etoposide	PMID:16217747
1313328	MATN2	matrilin 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of MATN2 mRNA	PMID:32234424
1313328	MATN2	matrilin 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MATN2 mRNA	PMID:28628672
1313328	MATN2	matrilin 2	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MATN2 mRNA	PMID:26705709
1313328	MATN2	matrilin 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313329	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of MATN2 mRNA	PMID:25554681
1313328	MATN2	matrilin 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313329	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of MATN2 mRNA	PMID:36117858
1313328	MATN2	matrilin 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of MATN2 mRNA	PMID:19042947
1313328	MATN2	matrilin 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MATN2 mRNA	PMID:39836092
1313328	MATN2	matrilin 2	gene	CHEBI:63632	topotecan	decreases response to substance	EXP		E	RGD:6480464	20151013	CTD	MESH:D019772	MATN2 mRNA results in decreased susceptibility to Topotecan	PMID:25199881
1313328	MATN2	matrilin 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MATN2 mRNA	PMID:15336504
1313328	MATN2	matrilin 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313329	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of MATN2 mRNA	PMID:36851058
1313328	MATN2	matrilin 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of MATN2 intron	PMID:30157460
1313328	MATN2	matrilin 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of MATN2 mRNA	PMID:31758290
1313328	MATN2	matrilin 2	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of MATN2 mRNA	PMID:22714537
1313328	MATN2	matrilin 2	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MATN2 mRNA	PMID:36139627
1313328	MATN2	matrilin 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN2 mRNA	PMID:27188386
1313328	MATN2	matrilin 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MATN2 gene]	PMID:28238834
1313328	MATN2	matrilin 2	gene	CHEBI:80630	irinotecan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in increased expression of MATN2 mRNA	PMID:18927307
1313328	MATN2	matrilin 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305353	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MATN2 mRNA	PMID:27291303
1313328	MATN2	matrilin 2	gene	CHEBI:8922	Rutecarpine	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C028632	rutecarpine results in decreased expression of MATN2 mRNA	PMID:34955744
1313328	MATN2	matrilin 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MATN2 mRNA	PMID:27188386
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313331	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of LSM7 mRNA	PMID:33045310
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of LSM7 mRNA	PMID:22378314
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313331	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LSM7 mRNA	PMID:39241906
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LSM7 mRNA	PMID:37042841
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:166595	Yessotoxin	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in decreased expression of LSM7 mRNA	PMID:30679557
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305354	E	RGD:6480464	20130115	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of LSM7 mRNA]	PMID:20032058
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1305354	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of LSM7 mRNA	PMID:22967744
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313331	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LSM7 mRNA	PMID:33754040
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313331	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LSM7 mRNA	PMID:36331819
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313331	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LSM7 mRNA	PMID:37236586
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D014747	LSM7 protein affects the susceptibility to Vinblastine	PMID:16217747
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305354	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LSM7 mRNA	PMID:33387578
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313331	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM7 mRNA	PMID:22206623
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in increased expression of LSM7 protein	PMID:37834424
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305354	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LSM7 mRNA	PMID:32109520|PMID:33387578
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305354	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LSM7 mRNA	PMID:34747641
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LSM7 mRNA	PMID:30851411
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	LSM7 protein affects the susceptibility to Doxorubicin	PMID:16217747
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LSM7 mRNA	PMID:29803840
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LSM7 mRNA	PMID:38568856
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of LSM7 mRNA	PMID:28595984|PMID:34032870
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313331	E	RGD:6480464	20150922	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LSM7 mRNA	PMID:20504355
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1313331	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of LSM7 gene	PMID:35295148
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313331	E	RGD:6480464	20150922	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of LSM7 mRNA	PMID:18648102
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313331	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of LSM7 mRNA	PMID:28472532
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of LSM7 mRNA	PMID:30903817
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305354	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LSM7 mRNA	PMID:25181051
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of LSM7 mRNA	PMID:19244175
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313331	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of LSM7 promoter	PMID:33297965
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313331	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of LSM7 exon	PMID:33297965
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313331	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of LSM7 mRNA	PMID:38685157
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305354	E	RGD:6480464	20130115	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LSM7 mRNA	PMID:17602206
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of LSM7 gene	PMID:22964155
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313331	E	RGD:6480464	20150922	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of LSM7 mRNA	PMID:17361019|PMID:21266533
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305354	E	RGD:6480464	20130115	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of LSM7 mRNA	PMID:17602206
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313331	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LSM7 mRNA	PMID:37236586
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LSM7 mRNA	PMID:19320972|PMID:19376846
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of LSM7 mRNA	PMID:19167446
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313331	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LSM7 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of LSM7 mRNA	PMID:36331819
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LSM7 gene	PMID:29154799
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1305354	E	RGD:6480464	20130115	CTD	MESH:D003907	Dexamethasone results in decreased expression of LSM7 mRNA	PMID:20032058
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1305354	E	RGD:6480464	20130115	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of LSM7 mRNA]	PMID:20032058
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313331	E	RGD:6480464	20150922	CTD	MESH:D000082	Acetaminophen affects the expression of LSM7 mRNA	PMID:17562736
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305354	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LSM7 mRNA	PMID:33387578
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305354	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of LSM7 mRNA	PMID:24136188
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:1305354	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of LSM7 mRNA	PMID:24136188
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313331	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM7 mRNA	PMID:22206623
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of LSM7 protein	PMID:37664457
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LSM7 mRNA	PMID:30851411
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LSM7 gene]	PMID:28238834
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:80630	irinotecan	increases response to substance	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	LSM7 protein results in increased susceptibility to Irinotecan	PMID:16734730
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313331	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of LSM7 mRNA	PMID:31388691
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313331	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of LSM7 mRNA	PMID:30294300
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1305354	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of LSM7 protein	PMID:28903499
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of LSM7 protein	PMID:37664457
1313330	LSM7	LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305354	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of LSM7 mRNA	PMID:23034163|PMID:23555832
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313333	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of COL4A4 mRNA	PMID:36189433
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of COL4A4 mRNA	PMID:36189433
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of COL4A4 mRNA	PMID:30529165
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of COL4A4 mRNA	PMID:26079696
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D014260	Triclosan results in increased expression of COL4A4 mRNA	PMID:34681664
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of COL4A4 mRNA	PMID:38568856
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305355	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of COL4A4 gene	PMID:27618143
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D005947	Glucose results in increased expression of COL4A4 mRNA	PMID:33631230
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D005947	3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA]	PMID:33631230
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of COL4A4 mRNA	PMID:36189433
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D005947	Glucose results in increased expression of COL4A4 mRNA	PMID:33631230
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D005947	3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA]	PMID:33631230
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305355	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of COL4A4 mRNA	PMID:23630614
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of COL4A4 mRNA	PMID:23557933
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of COL4A4 mRNA	PMID:25583101
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1305355	E	RGD:6480464	20200519	CTD	MESH:D009532	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of COL4A4 mRNA	PMID:31734292
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313333	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COL4A4 mRNA	PMID:26377647
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305355	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COL4A4 mRNA	PMID:32109520|PMID:33387578|PMID:34747641
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COL4A4 mRNA	PMID:33956508
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COL4A4 mRNA	PMID:12377990
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313333	E	RGD:6480464	20170110	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COL4A4 mRNA	PMID:27562557
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of COL4A4 mRNA	PMID:30911355
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COL4A4 mRNA	PMID:29803840
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20130326	CTD	MESH:D004317	Doxorubicin results in decreased expression of COL4A4 mRNA	PMID:15033991|PMID:39631538
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004317	Doxorubicin results in increased expression of COL4A4 mRNA	PMID:37062353
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of COL4A4 mRNA	PMID:34032870
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of COL4A4 mRNA	PMID:36209798
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL4A4 mRNA	PMID:27858113
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of COL4A4 mRNA	PMID:30911355
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1313333	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of COL4A4 mRNA	PMID:36087614
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1305355	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of COL4A4 mRNA	PMID:11578147
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1305355	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of COL4A4 mRNA	PMID:16507785
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1305355	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of COL4A4 mRNA	PMID:30012374
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313333	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of COL4A4 mRNA	PMID:23557971
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305355	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of COL4A4 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of COL4A4 gene	PMID:31601247
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305355	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of COL4A4 mRNA	PMID:25181051
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of COL4A4 mRNA	PMID:26682919
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313333	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of COL4A4 gene	PMID:31683443
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of COL4A4 mRNA	PMID:26377693
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL4A4 mRNA	PMID:27858113
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313333	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of COL4A4 mRNA	PMID:37019170
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313333	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of COL4A4 mRNA	PMID:24535843
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305355	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of COL4A4 mRNA	PMID:32680482
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of COL4A4 mRNA	PMID:37042841
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305355	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of COL4A4 mRNA	PMID:35163327
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1305355	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of COL4A4 mRNA	PMID:18500788
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COL4A4 mRNA	PMID:38382870
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305355	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of COL4A4 mRNA	PMID:35163327
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305355	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of COL4A4 mRNA	PMID:29427782
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of COL4A4 mRNA	PMID:24935251
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of COL4A4 mRNA	PMID:28973697
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313333	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of COL4A4 mRNA	PMID:28973697
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D005947	Glucose results in increased expression of COL4A4 mRNA	PMID:33631230
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D005947	3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA]	PMID:33631230
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in increased expression of COL4A4 protein	PMID:8667468
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of COL4A4 mRNA	PMID:38832940
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of COL4A4 mRNA	PMID:26272509
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL4A4 mRNA	PMID:27188386
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of COL4A4 mRNA	PMID:24935251
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of COL4A4 mRNA	PMID:22230336
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305355	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COL4A4 mRNA	PMID:33387578
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305355	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of COL4A4 mRNA	PMID:29391264
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:4948	Evodiamine	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine results in decreased expression of COL4A4 mRNA	PMID:38878560
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of COL4A4 mRNA; Nanotubes, Carbon results in decreased expression of COL4A4 mRNA	PMID:25554681
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of COL4A4 mRNA	PMID:26377693
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL4A4 mRNA	PMID:27858113
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1313333	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of COL4A4 mRNA	PMID:26377693
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL4A4 mRNA	PMID:27858113
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:53001	nickel sulfate	multiple interactions	ISO	RGD:1305355	E	RGD:6480464	20200519	CTD	MESH:C029938	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of COL4A4 mRNA	PMID:31734292
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of COL4A4 mRNA	PMID:22079614
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL4A4 mRNA	PMID:27188386
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COL4A4 gene]	PMID:28238834
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of COL4A4 mRNA	PMID:18927307
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in decreased expression of COL4A4 mRNA	PMID:19084549
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305355	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of COL4A4 mRNA	PMID:24780913
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL4A4 mRNA	PMID:27188386
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D013311	Streptozocin results in increased expression of COL4A4 mRNA	PMID:33631230
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:D013311	3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Streptozocin results in increased expression of COL4A4 mRNA]; Valsartan inhibits the reaction [Streptozocin results in increased expression of COL4A4 mRNA]	PMID:33631230
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:9927	valsartan	multiple interactions	ISO	RGD:1313333	E	RGD:6480464	20210608	CTD	MESH:C081489	Valsartan inhibits the reaction [Streptozocin results in increased expression of COL4A4 mRNA]	PMID:33631230
1313332	COL4A4	collagen type IV alpha 4 chain	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305355	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of COL4A4 mRNA	PMID:23034163
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of B4GALT2 mRNA	PMID:38218311
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of B4GALT2 mRNA	PMID:27188386
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313337	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of B4GALT2 mRNA	PMID:33045310
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B4GALT2 mRNA	PMID:20938992
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of B4GALT2 mRNA	PMID:33167477
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B4GALT2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B4GALT2 mRNA	PMID:32699268
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313337	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of B4GALT2 mRNA	PMID:30319688
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B4GALT2 mRNA	PMID:35811015
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of B4GALT2 mRNA	PMID:31614463
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313337	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of B4GALT2 mRNA	PMID:39298647
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of B4GALT2 mRNA	PMID:38568856
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B4GALT2 mRNA	PMID:20938992
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313337	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of B4GALT2 mRNA	PMID:17251523
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of B4GALT2 mRNA	PMID:18037150
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B4GALT2 mRNA	PMID:37992649
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1305358	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of B4GALT2 mRNA	PMID:22967744
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B4GALT2 mRNA	PMID:37992649
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1313337	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of B4GALT2 mRNA	PMID:17997037
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305358	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of B4GALT2 promoter	PMID:23359474
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of B4GALT2 mRNA	PMID:28818685
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of B4GALT2 intron	PMID:30157460
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1313337	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of B4GALT2 mRNA	PMID:17997037
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:232796	cadmium acetate	increases expression	EXP		E	RGD:6480464	20250107	CTD	MESH:C028031	cadmium acetate results in increased expression of B4GALT2 mRNA	PMID:18155341
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of B4GALT2 mRNA	PMID:19549813
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of B4GALT2 gene	PMID:27153756
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B4GALT2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B4GALT2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of B4GALT2 mRNA	PMID:32699268
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B4GALT2 mRNA	PMID:20938992
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of B4GALT2 mRNA	PMID:39836092
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of B4GALT2 mRNA	PMID:40504410
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1305358	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of B4GALT2 gene	PMID:31011160
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of B4GALT2 mRNA	PMID:23557933
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of B4GALT2 mRNA	PMID:33212167
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of B4GALT2 mRNA	PMID:20971185
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of B4GALT2 mRNA	PMID:29803840
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B4GALT2 mRNA	PMID:37992649
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of B4GALT2 mRNA	PMID:38568856
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305358	E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of B4GALT2 mRNA	PMID:35314868
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313337	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of B4GALT2 mRNA	PMID:37682722
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of B4GALT2 mRNA	PMID:39719251
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of B4GALT2 mRNA	PMID:39836092
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of B4GALT2 mRNA	PMID:40504410
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of B4GALT2 5' UTR	PMID:27901495
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of B4GALT2 exon; Benzo(a)pyrene results in increased methylation of B4GALT2 promoter	PMID:27901495
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of B4GALT2 mRNA	PMID:20971185
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:31746	kainic acid	decreases expression	ISO	RGD:1313337	E	RGD:6480464	20120412	CTD	MESH:D007608	Kainic Acid results in decreased expression of B4GALT2 mRNA	PMID:17997037
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313337	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of B4GALT2 gene	PMID:35295148
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305358	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of B4GALT2 mRNA	PMID:23411599|PMID:34492290
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305358	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of B4GALT2 mRNA	PMID:19167457
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305358	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of B4GALT2 mRNA	PMID:25181051
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313337	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of B4GALT2 mRNA	PMID:26063408
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313337	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of B4GALT2 promoter	PMID:27312807
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305358	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of B4GALT2 mRNA; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of B4GALT2 promoter	PMID:23359474|PMID:36041667
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313337	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of B4GALT2 gene	PMID:31683443
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305358	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of B4GALT2 mRNA	PMID:36041667
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of B4GALT2 intron	PMID:30157460
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305358	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of B4GALT2 mRNA	PMID:36041667
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305358	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of B4GALT2 promoter	PMID:23359474
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of B4GALT2 mRNA	PMID:38174414|PMID:38568856
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305358	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of B4GALT2 mRNA	PMID:33453195
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of B4GALT2 mRNA	PMID:19320972|PMID:19376846
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of B4GALT2 mRNA	PMID:24449571
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of B4GALT2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of B4GALT2 mRNA	PMID:32699268
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of B4GALT2 mRNA	PMID:27153767|PMID:40419075
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of B4GALT2 mRNA	PMID:25979313
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of B4GALT2 mRNA	PMID:23179753|PMID:28001369
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of B4GALT2 gene	PMID:29154799
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305358	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of B4GALT2 mRNA	PMID:38685447
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D016572	Cyclosporine results in decreased expression of B4GALT2 mRNA	PMID:33631201
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313337	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of B4GALT2 mRNA	PMID:28973697
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of B4GALT2 mRNA	PMID:37992649
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of B4GALT2 mRNA	PMID:29067470
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B4GALT2 mRNA	PMID:35811015
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of B4GALT2 mRNA	PMID:39836092
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313337	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of B4GALT2 mRNA	PMID:40504410
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305358	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of B4GALT2 mRNA	PMID:29391264
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313337	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of B4GALT2 mRNA; Nanotubes, Carbon results in increased expression of B4GALT2 mRNA	PMID:25554681
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of B4GALT2 intron	PMID:30157460
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313337	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of B4GALT2 mRNA	PMID:22206623
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to B4GALT2 gene]	PMID:28238834
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305358	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of B4GALT2 mRNA	PMID:23914054
1313336	B4GALT2	beta-1,4-galactosyltransferase 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of B4GALT2 mRNA	PMID:38568856
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACAP1 mRNA	PMID:27188386
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313340	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ACAP1 mRNA	PMID:33045310
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ACAP1 mRNA	PMID:35811015
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACAP1 mRNA	PMID:35811015
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305360	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ACAP1 mRNA	PMID:32741896
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ACAP1 mRNA	PMID:38568856
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACAP1 mRNA	PMID:37042841
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313340	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ACAP1 mRNA	PMID:22401849
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305360	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ACAP1 mRNA	PMID:32741896
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305360	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ACAP1 mRNA	PMID:22061828|PMID:33387578
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	multiple interactions	ISO	RGD:1305360	E	RGD:6480464	20251007	CTD	MESH:D024502	[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in increased expression of ACAP1 mRNA]	PMID:39325335
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACAP1 mRNA	PMID:37236586
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ACAP1 mRNA	PMID:19549813
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1305360	E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in decreased expression of ACAP1 mRNA	PMID:28623178
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ACAP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ACAP1 mRNA	PMID:34911549
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACAP1 mRNA	PMID:17484886
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA	PMID:32525701
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA	PMID:40504410
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305360	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ACAP1 mRNA	PMID:31881176
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ACAP1 mRNA	PMID:27392435
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ACAP1 mRNA	PMID:25583101
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305360	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACAP1 mRNA	PMID:34747641
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305360	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACAP1 mRNA	PMID:33387578
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:28680	cytarabine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003561	Cytarabine results in increased expression of ACAP1 mRNA	PMID:19194470
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1305360	E	RGD:6480464	20251007	CTD	MESH:D001205	[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in increased expression of ACAP1 mRNA]	PMID:39325335
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ACAP1 mRNA	PMID:37682722
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1305360	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of ACAP1 mRNA	PMID:39325335
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1305360	E	RGD:6480464	20251007	CTD	MESH:C017947	[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in increased expression of ACAP1 mRNA]	PMID:39325335
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA	PMID:34876320|PMID:40504410
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA	PMID:34876320
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ACAP1 promoter	PMID:27901495
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313340	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ACAP1 mRNA	PMID:29341224
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305360	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ACAP1 mRNA	PMID:34492290
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of ACAP1 mRNA	PMID:36232920
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305360	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ACAP1 mRNA	PMID:25181051|PMID:34947998
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ACAP1 gene	PMID:31601247
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313340	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of ACAP1 mRNA	PMID:25172293
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ACAP1 mRNA	PMID:40203079
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313340	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ACAP1 exon	PMID:33297965
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ACAP1 mRNA	PMID:38685157
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313340	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ACAP1 mRNA	PMID:32715474
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ACAP1 mRNA	PMID:37042841
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305360	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of ACAP1 mRNA	PMID:35163327
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305360	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of ACAP1 mRNA	PMID:30723492
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACAP1 mRNA	PMID:37236586
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:35842	antirheumatic drug	affects expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents affects the expression of ACAP1 mRNA	PMID:24449571
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313340	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ACAP1 mRNA	PMID:40194260
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ACAP1 mRNA	PMID:31533062
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of ACAP1 mRNA	PMID:29038090
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of ACAP1 mRNA	PMID:23125180
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313340	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACAP1 mRNA	PMID:17562736
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACAP1 mRNA	PMID:35811015
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA	PMID:32525701
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA	PMID:40504410
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA	PMID:34876320
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of ACAP1 mRNA	PMID:38825487
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ACAP1 mRNA	PMID:23608068
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313340	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ACAP1 mRNA	PMID:38701926
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305360	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of ACAP1 mRNA	PMID:28801915
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACAP1 mRNA	PMID:21641980
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313340	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ACAP1 mRNA	PMID:22206623
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305360	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ACAP1 mRNA	PMID:32741896
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACAP1 mRNA	PMID:27188386
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of ACAP1 mRNA	PMID:39847705
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ACAP1 mRNA	PMID:32525701
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313340	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ACAP1 mRNA	PMID:34876320
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305360	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ACAP1 mRNA	PMID:24780913
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACAP1 mRNA	PMID:27188386
1313339	ACAP1	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313340	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ACAP1 mRNA	PMID:35537566
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of FAM114A2 mRNA	PMID:22378314
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313343	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FAM114A2 mRNA	PMID:39241906
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FAM114A2 protein	PMID:37730182
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FAM114A2 mRNA	PMID:19549813
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305362	E	RGD:6480464	20130806	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A2 mRNA	PMID:22129741
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FAM114A2 gene	PMID:27153756
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313343	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FAM114A2 mRNA	PMID:22206623
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of FAM114A2 protein	PMID:38460933
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of FAM114A2 protein	PMID:35688186
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of FAM114A2 mRNA	PMID:28903495
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FAM114A2 mRNA	PMID:28001369
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FAM114A2 mRNA	PMID:33212167
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of FAM114A2 mRNA	PMID:39709020
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FAM114A2 mRNA	PMID:29803840
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1305362	E	RGD:6480464	20130806	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A2 mRNA	PMID:22129741
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of FAM114A2 mRNA; sodium arsenite results in decreased expression of FAM114A2 protein	PMID:25879800|PMID:30528433
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FAM114A2 3' UTR	PMID:27901495
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313343	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FAM114A2 gene	PMID:35295148
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313343	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of FAM114A2 mRNA	PMID:29264374
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305362	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FAM114A2 mRNA	PMID:25181051
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM114A2 protein	PMID:33376534
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305362	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM114A2 mRNA	PMID:30816183
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of FAM114A2 protein	PMID:34186270
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of FAM114A2 protein	PMID:34186270
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FAM114A2 mRNA	PMID:28628672
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of FAM114A2 protein	PMID:34186270
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FAM114A2 mRNA	PMID:28628672
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305362	E	RGD:6480464	20130806	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of FAM114A2 mRNA	PMID:22129741
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FAM114A2 mRNA	PMID:37042841
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FAM114A2 mRNA	PMID:31533062
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FAM114A2 mRNA	PMID:25979313
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FAM114A2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FAM114A2 mRNA	PMID:28628672
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of FAM114A2 mRNA	PMID:22230336
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of FAM114A2 protein	PMID:38460933
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313343	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of FAM114A2 mRNA	PMID:35436446
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FAM114A2 mRNA	PMID:28628672
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of FAM114A2 protein	PMID:23718831
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FAM114A2 protein	PMID:32959892
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305362	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FAM114A2 gene	PMID:35440735
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313343	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FAM114A2 mRNA	PMID:22206623
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313343	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FAM114A2 mRNA	PMID:22206623
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of FAM114A2 protein	PMID:38348393
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of FAM114A2 mRNA	PMID:38568856
1313342	FAM114A2	family with sequence similarity 114 member A2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of FAM114A2 mRNA	PMID:29301935
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313345	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAPKAP1 mRNA	PMID:36331819
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MAPKAP1 mRNA	PMID:26079696
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305363	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MAPKAP1 gene	PMID:28931070
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MAPKAP1 mRNA	PMID:22378314
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of MAPKAP1 mRNA	PMID:18951874
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MAPKAP1 mRNA	PMID:37042841
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of MAPKAP1 mRNA	PMID:23649840
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313345	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MAPKAP1 mRNA	PMID:34319233
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MAPKAP1 protein	PMID:37730182
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305363	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of MAPKAP1 mRNA	PMID:22061828
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of MAPKAP1 intron	PMID:30157460
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MAPKAP1 mRNA	PMID:23649840
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of MAPKAP1 intron	PMID:30157460
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MAPKAP1 gene	PMID:27153756
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MAPKAP1 mRNA	PMID:23649840
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313345	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MAPKAP1 mRNA	PMID:25629700
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MAPKAP1 protein	PMID:35688186
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MAPKAP1 mRNA	PMID:23557933
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of MAPKAP1 mRNA	PMID:19561079|PMID:27594783
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313345	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of MAPKAP1 mRNA	PMID:21151649
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313345	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAPKAP1 mRNA	PMID:21570461
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MAPKAP1 intron	PMID:30157460
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAPKAP1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313345	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAPKAP1 mRNA	PMID:22228805
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313345	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MAPKAP1 intron	PMID:27901495
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313345	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MAPKAP1 mRNA]	PMID:22228805
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313345	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MAPKAP1 mRNA	PMID:39716349
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305363	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAPKAP1 mRNA	PMID:25729387
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305363	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MAPKAP1 mRNA	PMID:34492290
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305363	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MAPKAP1 mRNA	PMID:25181051|PMID:30816183
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313345	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MAPKAP1 mRNA	PMID:33221593
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305363	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MAPKAP1 gene	PMID:28505145
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MAPKAP1 mRNA	PMID:28628672
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MAPKAP1 mRNA	PMID:25979313
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to MAPKAP1 promoter]	PMID:20348232
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MAPKAP1 gene	PMID:31601247
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MAPKAP1 intron	PMID:30157460
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MAPKAP1 mRNA	PMID:28628672
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MAPKAP1 mRNA	PMID:19320972
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313345	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAPKAP1 mRNA	PMID:36331819
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MAPKAP1 gene	PMID:29154799
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MAPKAP1 mRNA	PMID:23179753|PMID:25192806|PMID:26272509|PMID:28001369
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313345	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of MAPKAP1 mRNA	PMID:21427059
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAPKAP1 mRNA	PMID:27188386
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MAPKAP1 mRNA	PMID:28628672
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MAPKAP1 mRNA	PMID:36621641
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313345	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MAPKAP1 mRNA	PMID:17562736
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MAPKAP1 mRNA	PMID:21420995
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of MAPKAP1 mRNA	PMID:16557594
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MAPKAP1 mRNA	PMID:28628672
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313345	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MAPKAP1 mRNA	PMID:39716349
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305363	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MAPKAP1 mRNA	PMID:24136188
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305363	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MAPKAP1 mRNA	PMID:24136188
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of MAPKAP1 mRNA	PMID:20977926
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305363	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MAPKAP1 mRNA	PMID:25729387
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313345	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of MAPKAP1 mRNA	PMID:23650126
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of MAPKAP1 mRNA	PMID:28988120
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MAPKAP1 intron	PMID:30157460
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305363	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MAPKAP1 gene	PMID:35440735
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of MAPKAP1 mRNA	PMID:27714895|PMID:27918106
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cannabidiol co-treated with moringin] results in increased expression of MAPKAP1 mRNA	PMID:30096889
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of MAPKAP1 mRNA	PMID:31758290
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313345	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of MAPKAP1 mRNA	PMID:22206623
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAPKAP1 mRNA	PMID:27188386
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313345	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of MAPKAP1 mRNA	PMID:30953684
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAPKAP1 mRNA	PMID:27188386
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305363	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MAPKAP1 mRNA	PMID:21346803
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MAPKAP1 mRNA	PMID:38568856
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313345	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of MAPKAP1 protein	PMID:24648495
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305363	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MAPKAP1 mRNA	PMID:23869203
1313344	MAPKAP1	MAPK associated protein 1	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305363	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of MAPKAP1 gene	PMID:31682807
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1618151	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CROCC mRNA	PMID:33045310
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1618151	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CROCC mRNA	PMID:30319688
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CROCC mRNA	PMID:37042841
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1618151	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CROCC mRNA	PMID:34319233
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305364	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CROCC mRNA	PMID:26577399
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CROCC mRNA	PMID:39836092
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1618151	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CROCC mRNA	PMID:37236586
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1305364	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of CROCC protein	PMID:33236894
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CROCC exon	PMID:30157460
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305364	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of CROCC mRNA	PMID:30779732
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of CROCC mRNA	PMID:18356318
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CROCC mRNA	PMID:21867686
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CROCC gene	PMID:25304211
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CROCC mRNA	PMID:39836092
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CROCC mRNA	PMID:27392435
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1305364	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of CROCC gene	PMID:28505145
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618151	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CROCC mRNA	PMID:21570461
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305364	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CROCC mRNA	PMID:33387578
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CROCC mRNA	PMID:39836092
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CROCC promoter	PMID:27901495
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1618151	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CROCC mRNA	PMID:22228805
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of CROCC gene	PMID:25435355
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of CROCC mRNA	PMID:18356318
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1305364	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of CROCC mRNA	PMID:16507785
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1618151	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CROCC promoter	PMID:35295148
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1618151	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CROCC gene; titanium dioxide results in increased methylation of CROCC promoter	PMID:35295148
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305364	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CROCC mRNA	PMID:34492290
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1618151	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CROCC mRNA	PMID:19710929
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1618151	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of CROCC promoter	PMID:27312807
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CROCC gene	PMID:31601247
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305364	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of CROCC gene	PMID:28505145
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1305364	E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CROCC mRNA	PMID:32119087
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1618151	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CROCC gene	PMID:31683443
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1618151	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CROCC mRNA	PMID:21266533
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to CROCC protein	PMID:32991956
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305364	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of CROCC gene	PMID:33148267
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CROCC mRNA	PMID:39836092
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305364	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CROCC mRNA	PMID:33453195
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CROCC mRNA	PMID:38568856
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1618151	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CROCC mRNA	PMID:37236586
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of CROCC mRNA	PMID:24449571
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CROCC mRNA	PMID:31533062
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1618151	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CROCC mRNA	PMID:17963808
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CROCC gene	PMID:29154799
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1618151	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CROCC mRNA	PMID:28973697
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305364	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CROCC mRNA	PMID:33387578
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CROCC gene	PMID:25304211
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CROCC mRNA	PMID:39836092
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of CROCC mRNA	PMID:19194470
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1618151	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CROCC mRNA; Nanotubes, Carbon results in decreased expression of CROCC mRNA	PMID:25554681
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305364	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of CROCC mRNA	PMID:22504374
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CROCC mRNA	PMID:39836092
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305364	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CROCC gene	PMID:35440735
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305364	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of CROCC gene	PMID:33148267
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1618151	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CROCC mRNA	PMID:22206623
1313346	CROCC	ciliary rootlet coiled-coil, rootletin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305364	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of CROCC mRNA	PMID:22504374
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:144441	triacsin C	decreases expression	EXP		E	RGD:6480464	20190903	CTD	MESH:C034613	triacsin C results in decreased expression of HS2ST1 mRNA	PMID:16704987
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of HS2ST1 mRNA	PMID:33167477
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313349	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HS2ST1 mRNA	PMID:30529165
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:15571	hydrazine	increases expression	ISO	RGD:1313349	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in increased expression of HS2ST1 mRNA	PMID:15282401
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:15843	arachidonic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D016718	Arachidonic Acid results in decreased expression of HS2ST1 mRNA	PMID:16704987
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of HS2ST1 mRNA	PMID:21632981
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313349	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HS2ST1 mRNA	PMID:25549359
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of HS2ST1 mRNA	PMID:23649840
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1305366	E	RGD:6480464	20250805	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of HS2ST1 mRNA	PMID:26516888
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HS2ST1 mRNA	PMID:19549813
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HS2ST1 gene	PMID:27153756
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of HS2ST1 mRNA	PMID:27392435
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin affects the reaction [Piroxicam results in decreased expression of HS2ST1 mRNA]	PMID:21858171
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HS2ST1 mRNA	PMID:22574217
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313349	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HS2ST1 mRNA	PMID:21570461
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305366	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HS2ST1 mRNA	PMID:33387578
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305366	E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HS2ST1 mRNA	PMID:26232522|PMID:34747641
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of HS2ST1 mRNA	PMID:33512557
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313349	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of HS2ST1 mRNA	PMID:32937126
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of HS2ST1 mRNA	PMID:28001369
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HS2ST1 mRNA	PMID:33212167
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of HS2ST1 mRNA	PMID:23649840
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HS2ST1 mRNA	PMID:29803840
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313349	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of HS2ST1 mRNA	PMID:19073829
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HS2ST1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313349	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HS2ST1 intron	PMID:27901495
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HS2ST1 mRNA	PMID:26238291
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305366	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HS2ST1 mRNA	PMID:25729387
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313349	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HS2ST1 gene	PMID:35295148
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305366	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of HS2ST1 mRNA	PMID:34492290
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305366	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of HS2ST1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of HS2ST1 mRNA	PMID:25979313
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313349	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of HS2ST1 mRNA	PMID:38685157
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HS2ST1 mRNA	PMID:37042841
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:35176	zinc sulfate	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of HS2ST1 mRNA	PMID:12756304
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of HS2ST1 mRNA	PMID:31533062
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of HS2ST1 mRNA	PMID:40419075
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1313349	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of HS2ST1 mRNA	PMID:31558096
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HS2ST1 mRNA	PMID:25979313
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in increased expression of HS2ST1 mRNA	PMID:23179753|PMID:25192806|PMID:29154799
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of HS2ST1 mRNA	PMID:25562108
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of HS2ST1 mRNA	PMID:23649840
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HS2ST1 mRNA	PMID:38832940
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1305366	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of HS2ST1 mRNA	PMID:29391264
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305366	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of HS2ST1 mRNA	PMID:24793618
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305366	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HS2ST1 mRNA	PMID:25729387
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1313349	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of HS2ST1 mRNA	PMID:20003209
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HS2ST1 gene]	PMID:28238834
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:80025	Salinomycin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of HS2ST1 mRNA	PMID:19682730
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313349	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of HS2ST1 mRNA	PMID:31388691
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313349	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of HS2ST1 mRNA	PMID:31558096
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of HS2ST1 mRNA	PMID:21858171
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin affects the reaction [Piroxicam results in decreased expression of HS2ST1 mRNA]	PMID:21858171
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of HS2ST1 protein	PMID:38348393
1313348	HS2ST1	heparan sulfate 2-O-sulfotransferase 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305366	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of HS2ST1 mRNA	PMID:19015723
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of GTPBP3 mRNA	PMID:38218311
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313351	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of GTPBP3 mRNA	PMID:33045310
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313351	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of GTPBP3; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GTPBP3 gene	PMID:20938992
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of GTPBP3 mRNA	PMID:26079696
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of GTPBP3 mRNA	PMID:22574217
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305367	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GTPBP3 mRNA	PMID:33387578
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313351	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of GTPBP3; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GTPBP3 gene	PMID:20938992
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GTPBP3 mRNA	PMID:37042841
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of GTPBP3 mRNA	PMID:21179406
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of GTPBP3 mRNA	PMID:28818685
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313351	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GTPBP3 mRNA	PMID:36331819
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1305367	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of GTPBP3 protein	PMID:34915118
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313351	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of GTPBP3 mRNA	PMID:24067728
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GTPBP3 mRNA	PMID:35301059
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of GTPBP3 mRNA	PMID:19549813
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313351	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of GTPBP3; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of GTPBP3 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of GTPBP3 mRNA]	PMID:20938992|PMID:22206623
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of GTPBP3 mRNA	PMID:18414638
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of GTPBP3 gene	PMID:31636367
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313351	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GTPBP3 mRNA	PMID:21570461
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305367	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GTPBP3 mRNA	PMID:33387578
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of GTPBP3 mRNA	PMID:29704546
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of GTPBP3 mRNA	PMID:23649840
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GTPBP3 mRNA	PMID:20971185
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313351	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of GTPBP3 mRNA	PMID:27862939
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of GTPBP3 mRNA	PMID:20044591
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GTPBP3 mRNA	PMID:38568856
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313351	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of GTPBP3 mRNA	PMID:20883709
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GTPBP3 mRNA	PMID:20971185
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of GTPBP3 mRNA	PMID:25895662
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313351	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GTPBP3 gene	PMID:35295148
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305367	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GTPBP3 mRNA	PMID:34492290
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305367	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GTPBP3 mRNA	PMID:25181051
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313351	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of GTPBP3 exon	PMID:33297965
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305367	E	RGD:6480464	20130618	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GTPBP3 mRNA	PMID:21266533
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GTPBP3 mRNA	PMID:38174414
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313351	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GTPBP3 mRNA	PMID:20883709
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GTPBP3 mRNA	PMID:35301059
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of GTPBP3 protein	PMID:26879310
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of GTPBP3 mRNA	PMID:28302478
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GTPBP3 mRNA	PMID:31533062
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313351	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GTPBP3 mRNA	PMID:36331819
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of GTPBP3 mRNA	PMID:23179753
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GTPBP3 gene	PMID:29154799
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of GTPBP3 mRNA	PMID:23649840
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305367	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GTPBP3 mRNA	PMID:33387578
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of GTPBP3 mRNA	PMID:18414638
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of GTPBP3 protein	PMID:23718831
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313351	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GTPBP3 mRNA	PMID:22206623
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313351	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of GTPBP3 mRNA]	PMID:22206623
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of GTPBP3 mRNA	PMID:37199045
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1305367	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of GTPBP3 mRNA	PMID:32109520
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of GTPBP3 mRNA	PMID:38568856
1313350	GTPBP3	GTP binding protein 3, mitochondrial	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GTPBP3 mRNA	PMID:29301935
1313352	KLHL40	kelch like family member 40	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313353	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of KLHL40 mRNA	PMID:33045310
1313352	KLHL40	kelch like family member 40	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313353	E	RGD:6480464	20161115	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of KLHL40 mRNA	PMID:26251327
1313352	KLHL40	kelch like family member 40	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1305368	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of KLHL40 mRNA	PMID:36841081
1313352	KLHL40	kelch like family member 40	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313353	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of KLHL40 mRNA	PMID:30319688
1313352	KLHL40	kelch like family member 40	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1305368	E	RGD:6480464	20190910	CTD	MESH:D000431	Ethanol results in decreased expression of KLHL40 mRNA	PMID:31078653
1313352	KLHL40	kelch like family member 40	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305368	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KLHL40 mRNA	PMID:33387578
1313352	KLHL40	kelch like family member 40	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305368	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of KLHL40 mRNA	PMID:22061828
1313352	KLHL40	kelch like family member 40	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305368	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of KLHL40 mRNA	PMID:33387578
1313352	KLHL40	kelch like family member 40	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of KLHL40 polyA tail	PMID:30157460
1313352	KLHL40	kelch like family member 40	gene	CHEBI:2208	purine-6-thiol	increases expression	ISO	RGD:1305368	E	RGD:6480464	20141111	CTD	MESH:D015122	Mercaptopurine results in increased expression of KLHL40 mRNA	PMID:23358152
1313352	KLHL40	kelch like family member 40	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20141111	CTD	MESH:D010278	Parathion results in increased methylation of KLHL40 promoter	PMID:22847954
1313352	KLHL40	kelch like family member 40	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313353	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of KLHL40 mRNA	PMID:32186404
1313352	KLHL40	kelch like family member 40	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305368	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KLHL40 mRNA	PMID:32109520|PMID:33387578
1313352	KLHL40	kelch like family member 40	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1305368	E	RGD:6480464	20120522	CTD	MESH:D004317	Doxorubicin results in increased expression of KLHL40 mRNA	PMID:20211217
1313352	KLHL40	kelch like family member 40	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KLHL40 exon	PMID:27901495
1313352	KLHL40	kelch like family member 40	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313353	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KLHL40 gene	PMID:35295148
1313352	KLHL40	kelch like family member 40	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313353	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KLHL40 gene	PMID:35295148
1313352	KLHL40	kelch like family member 40	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305368	E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in decreased expression of KLHL40 mRNA	PMID:25181051
1313352	KLHL40	kelch like family member 40	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313353	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of KLHL40 gene	PMID:31683443
1313352	KLHL40	kelch like family member 40	gene	CHEBI:34611	carbofuran	increases expression	ISO	RGD:1305368	E	RGD:6480464	20120522	CTD	MESH:D002235	Carbofuran results in increased expression of KLHL40 mRNA	PMID:20211217
1313352	KLHL40	kelch like family member 40	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305368	E	RGD:6480464	20120522	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of KLHL40 mRNA	PMID:21266533
1313352	KLHL40	kelch like family member 40	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1305368	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KLHL40 mRNA	PMID:35163327
1313352	KLHL40	kelch like family member 40	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305368	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KLHL40 mRNA	PMID:35163327
1313352	KLHL40	kelch like family member 40	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305368	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KLHL40 mRNA	PMID:35163327
1313352	KLHL40	kelch like family member 40	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1313353	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of KLHL40 mRNA	PMID:28962523
1313352	KLHL40	kelch like family member 40	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313353	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of KLHL40 mRNA	PMID:40194260
1313352	KLHL40	kelch like family member 40	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20141111	CTD	MESH:D004397	Fonofos results in increased methylation of KLHL40 promoter	PMID:22847954
1313352	KLHL40	kelch like family member 40	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20141111	CTD	MESH:C012568	terbufos results in increased methylation of KLHL40 promoter	PMID:22847954
1313352	KLHL40	kelch like family member 40	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KLHL40 mRNA	PMID:25979313
1313352	KLHL40	kelch like family member 40	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305368	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of KLHL40 mRNA	PMID:41580965
1313352	KLHL40	kelch like family member 40	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KLHL40 mRNA	PMID:38832940
1313352	KLHL40	kelch like family member 40	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305368	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KLHL40 mRNA	PMID:33387578
1313352	KLHL40	kelch like family member 40	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305368	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of KLHL40 mRNA	PMID:29391264
1313352	KLHL40	kelch like family member 40	gene	CHEBI:50667	mercaptopurine	increases expression	ISO	RGD:1305368	E	RGD:6480464	20141111	CTD	MESH:D015122	Mercaptopurine results in increased expression of KLHL40 mRNA	PMID:23358152
1313352	KLHL40	kelch like family member 40	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1313353	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of KLHL40 mRNA	PMID:19751817
1313352	KLHL40	kelch like family member 40	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1305368	E	RGD:6480464	20120522	CTD	MESH:D007545	Isoproterenol results in increased expression of KLHL40 mRNA	PMID:20211217
1313352	KLHL40	kelch like family member 40	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313353	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KLHL40 mRNA	PMID:27935865
1313352	KLHL40	kelch like family member 40	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	ISO	RGD:1305368	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of KLHL40 mRNA	PMID:23358152
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin affects the expression of NKX3-1 mRNA	PMID:31600526
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of NKX3-1 mRNA; Tretinoin results in increased expression of NKX3-1 protein	PMID:16817226
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of NKX3-1 mRNA	PMID:26079696
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of NKX3-1 mRNA	PMID:11238180
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D011794	Quercetin results in increased expression of NKX3-1 protein	PMID:25380086
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D011794	[Quercetin co-treated with arctigenin] results in increased expression of NKX3-1 protein	PMID:25380086
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in decreased expression of NKX3-1 mRNA	PMID:12711008
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of NKX3-1 mRNA	PMID:17131305|PMID:29581250
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013196	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Dihydrotestosterone results in increased expression of NKX3-1 mRNA]	PMID:17131305
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NKX3-1 mRNA	PMID:35811015
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NKX3-1 mRNA]	PMID:35811015
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of NKX3-1 mRNA	PMID:30510588
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of NKX3-1 mRNA	PMID:17131305|PMID:31614463
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased expression of NKX3-1 mRNA]; [Estradiol co-treated with TGFB1 protein] results in increased expression of NKX3-1 mRNA; AR protein affects the reaction [Estradiol results in increased expression of NKX3-1 mRNA]; ESR2 protein affects the reaction [Estradiol results in increased expression of NKX3-1 mRNA]; Fulvestrant inhibits the reaction [Estradiol results in increased expression of NKX3-1 mRNA]	PMID:17131305|PMID:30165855
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313355	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of NKX3-1 mRNA	PMID:33711761
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of NKX3-1 mRNA	PMID:38685446
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313355	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of NKX3-1 mRNA	PMID:33848595
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313355	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of NKX3-1 mRNA]	PMID:33848595
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of NKX3-1 mRNA	PMID:33647349
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NKX3-1 mRNA	PMID:28818685
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NKX3-1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of NKX3-1 mRNA	PMID:39836092
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NKX3-1 mRNA	PMID:22100608
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of NKX3-1 mRNA	PMID:18593933
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NKX3-1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NKX3-1 mRNA	PMID:39836092
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D000966	Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA; Antimony Potassium Tartrate results in increased expression of NKX3-1 protein	PMID:29462692
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000966	bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA]	PMID:29462692
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol results in decreased expression of NKX3-1 mRNA	PMID:18586690|PMID:22700762|PMID:25297617
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of NKX3-1 mRNA	PMID:19561079
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019833	Genistein results in decreased expression of NKX3-1 mRNA	PMID:15378649|PMID:16865672
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313355	E	RGD:6480464	20120515	CTD	MESH:D019833	Genistein results in increased expression of NKX3-1 mRNA	PMID:21810550
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1313355	E	RGD:6480464	20120515	CTD	MESH:D019833	fulvestrant inhibits the reaction [Genistein results in decreased expression of NKX3-1 mRNA]	PMID:21810550
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313355	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NKX3-1 mRNA	PMID:24058054
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:28197	daidzein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004742	daidzein results in decreased expression of NKX3-1 mRNA	PMID:16865672
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of NKX3-1 mRNA	PMID:28001369
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NKX3-1 mRNA	PMID:33212167
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305369	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of NKX3-1 mRNA	PMID:28959563
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of NKX3-1 mRNA	PMID:30911355
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313355	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of NKX3-1 mRNA	PMID:27862939
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NKX3-1 mRNA	PMID:29803840
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of NKX3-1 mRNA	PMID:39719251
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313355	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of NKX3-1 mRNA	PMID:36209798
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NKX3-1 mRNA	PMID:38568856
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NKX3-1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NKX3-1 mRNA	PMID:39836092
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NKX3-1 promoter	PMID:27901495
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of NKX3-1 mRNA	PMID:30911355
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of NKX3-1 mRNA	PMID:18593933
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of NKX3-1 mRNA	PMID:25351596
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NKX3-1 mRNA	PMID:19150397
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of NKX3-1 mRNA	PMID:35984750
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:3090	bicalutamide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in decreased expression of NKX3-1 mRNA	PMID:15638997|PMID:28500234
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:3090	bicalutamide	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	[Niclosamide co-treated with bicalutamide] results in decreased expression of NKX3-1 mRNA; bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA]; bicalutamide inhibits the reaction [Cadmium Chloride results in increased expression of NKX3-1 mRNA]; bicalutamide inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]	PMID:11751618|PMID:28500234|PMID:29462692
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant inhibits the reaction [Estradiol results in increased expression of NKX3-1 mRNA]	PMID:17131305
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313355	E	RGD:6480464	20120515	CTD	MESH:C070081	fulvestrant inhibits the reaction [Genistein results in decreased expression of NKX3-1 mRNA]	PMID:21810550
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313355	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NKX3-1 gene	PMID:35295148
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313355	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NKX3-1 promoter	PMID:35295148
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305369	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of NKX3-1 mRNA	PMID:19167457
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305369	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NKX3-1 mRNA	PMID:25181051
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313355	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of NKX3-1 promoter	PMID:27334623
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in increased expression of NKX3-1 mRNA	PMID:23146750
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313355	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of NKX3-1 mRNA	PMID:30951980
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:34240	2,4-Dihydroxybenzophenone	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C121479	2,4-dihydroxybenzophenone analog results in decreased expression of NKX3-1 mRNA	PMID:33684284
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313355	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of NKX3-1 mRNA	PMID:30951980
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313355	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of NKX3-1 mRNA	PMID:30951980
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:34741	equol	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D060754	Equol results in decreased expression of NKX3-1 mRNA	PMID:16865672
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:34849	mibolerone	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C100075	mibolerone results in increased expression of NKX3-1 mRNA	PMID:10537180
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:34849	mibolerone	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C100075	Flufenamic Acid inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA]; Piroxicam inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA]	PMID:10537180
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NKX3-1 mRNA	PMID:37042841
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NKX3-1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of NKX3-1 mRNA	PMID:39836092
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NKX3-1 mRNA	PMID:11751618|PMID:38568856
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D019256	bicalutamide inhibits the reaction [Cadmium Chloride results in increased expression of NKX3-1 mRNA]	PMID:11751618
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of NKX3-1 mRNA	PMID:24449571
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313355	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of NKX3-1 mRNA	PMID:17585979
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in decreased expression of NKX3-1 mRNA	PMID:12711008
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of NKX3-1 mRNA; Metribolone results in increased expression of NKX3-1 protein	PMID:11751618|PMID:17010675|PMID:17131305|PMID:17202838|PMID:17303007|PMID:19318562|PMID:21440447
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	bicalutamide inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]; Dapsone analog inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]; Metribolone promotes the reaction [AR protein binds to NKX3-1 enhancer]; Metribolone promotes the reaction [AR protein binds to NKX3-1 promoter]; Metribolone promotes the reaction [KDM3A protein binds to NKX3-1 enhancer]; Metribolone promotes the reaction [UXT protein binds to NKX3-1 promoter]; TP53 protein inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]; UXT protein affects the reaction [Metribolone results in increased expression of NKX3-1 mRNA]	PMID:11751618|PMID:16603237|PMID:17202838|PMID:19318562|PMID:21440447
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:38757	isoflavones	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones results in decreased expression of NKX3-1 mRNA	PMID:17374662
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:39397	tetramethrin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C009424	tetramethrin results in decreased expression of NKX3-1 mRNA	PMID:12711008
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of NKX3-1 mRNA; Curcumin results in decreased expression of NKX3-1 protein	PMID:17303007|PMID:18719366
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in increased expression of NKX3-1 mRNA	PMID:23179753|PMID:24935251|PMID:25192806
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313355	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of NKX3-1 mRNA	PMID:21427059
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of NKX3-1 mRNA	PMID:36621641
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:42638	flufenamic acid	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D005439	Flufenamic Acid inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA]	PMID:10537180
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:4325	dapsone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003622	Dapsone analog inhibits the reaction [Metribolone results in increased expression of NKX3-1 mRNA]	PMID:21440447
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NKX3-1 mRNA	PMID:38832940
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of NKX3-1 mRNA	PMID:21420995|PMID:29067470
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NKX3-1 mRNA]	PMID:35811015
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of NKX3-1 mRNA	PMID:24160326
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of NKX3-1 mRNA	PMID:25351596
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of NKX3-1 mRNA	PMID:18687144|PMID:25757056
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:46680	serpentine asbestos	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine affects the expression of NKX3-1 mRNA	PMID:24160326
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NKX3-1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NKX3-1 mRNA	PMID:39836092
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of NKX3-1 mRNA	PMID:16984733
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of NKX3-1 mRNA	PMID:18174752
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:50648	9-cis-retinoic acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in increased expression of NKX3-1 mRNA; Alitretinoin results in increased expression of NKX3-1 protein	PMID:16763719
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:5132	flutamide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005485	Flutamide results in decreased expression of NKX3-1 protein	PMID:17303007
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:5132	flutamide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005485	[Flutamide binds to and results in decreased activity of AR protein] which results in decreased expression of NKX3-1 protein	PMID:17303007
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of NKX3-1 mRNA	PMID:31629900
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NKX3-1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of NKX3-1 mRNA	PMID:39836092
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:63959	celastrol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C050414	celastrol results in decreased expression of NKX3-1 mRNA	PMID:17010675
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of NKX3-1 mRNA	PMID:15336504
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:65954	gedunin	decreases expression	EXP		E	RGD:6480464	20130305	CTD	MESH:C106014	gedunin results in decreased expression of NKX3-1 mRNA	PMID:17010675
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:68534	enzalutamide	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C540278	enzalutamide results in decreased expression of NKX3-1 mRNA	PMID:29581250|PMID:32184358
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:68534	enzalutamide	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:C540278	enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of NKX3-1 mRNA]; NVP-BHG712 promotes the reaction [enzalutamide results in decreased expression of NKX3-1 mRNA]	PMID:32184358
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1313355	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NKX3-1 mRNA	PMID:27935865
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:73158	sirtinol	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C439060	sirtinol results in decreased expression of NKX3-1 mRNA	PMID:22495798
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NKX3-1 mRNA	PMID:37199045
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of NKX3-1 mRNA	PMID:28500234
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:7553	niclosamide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	[Niclosamide co-treated with bicalutamide] results in decreased expression of NKX3-1 mRNA	PMID:28500234
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:77012	methylseleninic acid	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid affects the expression of NKX3-1 mRNA	PMID:14617803
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:79	(-)-Arctigenin	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:C071942	arctigenin results in increased expression of NKX3-1 protein	PMID:25380086
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:79	(-)-Arctigenin	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:C071942	[Quercetin co-treated with arctigenin] results in increased expression of NKX3-1 protein	PMID:25380086
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:81760	difenoconazole	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C115058	difenoconazole results in decreased expression of NKX3-1 mRNA	PMID:12711008
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:81918	fentin acetate	decreases expression	EXP		E	RGD:6480464	20141104	CTD	MESH:C011978	phentin acetate results in decreased expression of NKX3-1 mRNA	PMID:12711008
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313355	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NKX3-1 mRNA	PMID:27935865
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120613	CTD	MESH:D010894	Piroxicam inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA]	PMID:10537180
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:93751	PF-3758309	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C550923	PF 3758309 results in increased expression of NKX3-1 mRNA	PMID:29048629
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of NKX3-1 mRNA	PMID:38568856
1313354	NKX3-1	NK3 homeobox 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305369	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of NKX3-1 mRNA	PMID:18220299
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of IFT22 mRNA	PMID:38218311
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313357	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of IFT22 mRNA	PMID:33045310
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of IFT22 mRNA	PMID:23019147
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of IFT22 mRNA	PMID:23649840
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313357	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IFT22 mRNA	PMID:33754040
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305370	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of IFT22 mRNA	PMID:33387578
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313357	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IFT22 mRNA	PMID:37236586
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of IFT22 mRNA	PMID:19549813
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of IFT22 mRNA	PMID:23649840
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of IFT22 mRNA	PMID:23649840
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313357	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of IFT22 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of IFT22 mRNA	PMID:34911549
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313357	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of IFT22 mRNA	PMID:25629700
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D001151	Arsenic affects the methylation of IFT22 gene	PMID:25304211
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:1305370	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of IFT22 gene	PMID:31011160
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313357	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of IFT22 protein	PMID:25505154
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313357	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of IFT22 mRNA	PMID:30912803
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305370	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IFT22 mRNA	PMID:22298810
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313357	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IFT22 mRNA	PMID:21570461
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305370	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IFT22 mRNA	PMID:33387578
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of IFT22 mRNA	PMID:29955902
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305370	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of IFT22 mRNA	PMID:28959563
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of IFT22 mRNA	PMID:20044591
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to IFT22 mRNA]	PMID:32406909
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305370	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of IFT22 mRNA	PMID:23411599
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313357	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of IFT22 mRNA	PMID:18648102
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of IFT22 mRNA	PMID:38479592
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305370	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of IFT22 gene	PMID:28505145
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D002220	Carbamazepine affects the expression of IFT22 mRNA	PMID:25979313
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313357	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of IFT22 mRNA	PMID:37019170
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IFT22 mRNA	PMID:38568856
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313357	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IFT22 mRNA	PMID:37236586
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of IFT22 mRNA	PMID:24449571
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid affects the expression of IFT22 mRNA	PMID:25979313
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of IFT22 mRNA	PMID:19101580|PMID:23179753|PMID:28001369|PMID:29154799
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of IFT22 mRNA	PMID:17183730
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of IFT22 mRNA	PMID:20106945
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313357	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of IFT22 mRNA	PMID:28973697
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313357	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of IFT22 mRNA	PMID:28973697
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of IFT22 mRNA	PMID:23649840
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D001151	Arsenic affects the methylation of IFT22 gene	PMID:25304211
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305370	E	RGD:6480464	20161025	CTD	MESH:D005485	Flutamide results in decreased expression of IFT22 mRNA	PMID:24793618
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of IFT22 mRNA	PMID:17183730
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313357	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IFT22 mRNA	PMID:22206623
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313357	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of IFT22 mRNA	PMID:30953684
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of IFT22 mRNA	PMID:38568856
1313356	IFT22	intraflagellar transport 22	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305370	E	RGD:6480464	20161025	CTD	MESH:C025643	vinclozolin results in decreased expression of IFT22 mRNA	PMID:23034163
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:10119	ziprasidone	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:C092292	ziprasidone results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:145994	remdesivir	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20221101	CTD	MESH:C000606551	remdesivir results in decreased expression of SOX17 mRNA	PMID:35605700
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:15366	acetic acid	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20120717	CTD	MESH:D019342	Acetic Acid results in decreased expression of SOX17 protein	PMID:21296659
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin affects the expression of SOX17 mRNA	PMID:31600526
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:15367	all-trans-retinoic acid	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:D014212	Tretinoin results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of SOX17 mRNA	PMID:16236135
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D014212	[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] inhibits the reaction [Chir 99021 results in increased expression of SOX17 mRNA]	PMID:31711903
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SOX17 mRNA	PMID:26079696
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:15920	columbamine	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:C055786	columbamine results in decreased expression of SOX17 mRNA	PMID:23124089
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313359	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SOX17 mRNA	PMID:10975854
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of SOX17 mRNA	PMID:30510588
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of SOX17 mRNA	PMID:25210133
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in decreased expression of SOX17 mRNA]	PMID:25210133
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:C031721	naphthalene results in increased expression of SOX17 protein	PMID:16239640
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20170516	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SOX17 mRNA	PMID:28013219
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:16602	trichloroethene	decreases methylation	ISO	RGD:1305371	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of SOX17 gene	PMID:27618143
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305371	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SOX17 mRNA	PMID:33387578
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SOX17 mRNA	PMID:37992649
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SOX17 mRNA	PMID:28973375
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:17336	all-trans-retinol	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:D014801	[Vitamin A co-treated with INHBA protein] results in increased expression of SOX17 mRNA	PMID:17244017
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of SOX17 mRNA	PMID:33647349
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1305371	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of SOX17 mRNA	PMID:22967744
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SOX17 mRNA	PMID:37992649
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313359	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SOX17 mRNA	PMID:34319233
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305371	E	RGD:6480464	20160412	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of SOX17 mRNA	PMID:25031359
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:177802	Cuprizon	affects expression	ISO	RGD:1305371	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of SOX17 mRNA	PMID:27523638
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305371	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of SOX17 mRNA	PMID:26577399
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305371	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SOX17 mRNA	PMID:33387578
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:18300	maleic acid	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C030272	maleic acid results in increased expression of SOX17 mRNA	PMID:28392987
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SOX17 mRNA	PMID:22100608
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SOX17 gene	PMID:27153756
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305371	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SOX17 mRNA	PMID:33354967
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SOX17 mRNA	PMID:34911549
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SOX17 mRNA	PMID:25629700
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SOX17 mRNA	PMID:40504410
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:27656	camptothecin	increases methylation	EXP		E	RGD:6480464	20190409	CTD	MESH:D002166	Camptothecin results in increased methylation of SOX17 gene	PMID:30720231
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:27666	actinomycin D	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:D003609	Dactinomycin results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOX17 mRNA	PMID:27188386
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313359	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SOX17 mRNA	PMID:28960355
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305371	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SOX17 mRNA	PMID:31881176
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of SOX17 mRNA	PMID:19371625
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1305371	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of SOX17 mRNA	PMID:25905778
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D007854	Lead results in decreased expression of SOX17 mRNA	PMID:37467947
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of SOX17 mRNA; Genistein results in decreased expression of SOX17 protein	PMID:32186404
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1305371	E	RGD:6480464	20160412	CTD	MESH:D019833	[Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of SOX17 mRNA	PMID:25031359
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313359	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SOX17 mRNA	PMID:26377647
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305371	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SOX17 mRNA	PMID:34747641
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305371	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SOX17 mRNA	PMID:33387578
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313359	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SOX17 mRNA	PMID:19770486|PMID:24058054
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SOX17 mRNA	PMID:25975270
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of SOX17 mRNA	PMID:22105179
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:28748	doxorubicin	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:D004317	Doxorubicin results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313359	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of SOX17 mRNA	PMID:39631538
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SOX17 mRNA	PMID:37992649
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:329853329|PMID:32078435	20230614	RGD	MESH:D000111	N-acetyl-cysteine inhibits the reaction [angiotensin II decreases expression of SOX17 protein in retinal endothelial cells]	
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:28940	calciol	increases expression	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in increased expression of SOX17 mRNA; Cholecalciferol results in increased expression of SOX17 protein	PMID:17170073
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SOX17 mRNA	PMID:40504410
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305371	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SOX17 mRNA	PMID:21839799
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313359	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SOX17 mRNA	PMID:19770486|PMID:22228805|PMID:32417428
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SOX17 3' UTR; Benzo(a)pyrene results in increased methylation of SOX17 promoter	PMID:27901495
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA	PMID:27858113
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of SOX17 promoter	PMID:23974009
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SOX17 mRNA	PMID:25895662
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305371	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SOX17 mRNA	PMID:25729387
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313359	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SOX17 gene; titanium dioxide results in decreased methylation of SOX17 promoter	PMID:35295148
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313359	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SOX17 mRNA	PMID:23557971
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313359	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SOX17 gene	PMID:35295148
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305371	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SOX17 mRNA	PMID:34492290
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of SOX17 mRNA	PMID:18648102
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305371	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of SOX17 mRNA	PMID:19167457
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305371	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SOX17 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of SOX17 mRNA	PMID:27271280
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313359	E	RGD:6480464	20140311	CTD	MESH:C006780	bisphenol A results in increased expression of SOX17 mRNA	PMID:24090592|PMID:30951980
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305371	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SOX17 gene	PMID:28505145
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SOX17 mRNA	PMID:25979313
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SOX17 mRNA	PMID:26682919
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20140715	CTD	MESH:D008748	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SOX17 mRNA	PMID:23519560
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313359	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SOX17 mRNA	PMID:30951980
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313359	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of SOX17 mRNA	PMID:26377693
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA	PMID:27858113
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1313359	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of SOX17 mRNA	PMID:26377693
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SOX17 mRNA	PMID:38685157
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313359	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SOX17 mRNA	PMID:30951980
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313359	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SOX17 mRNA	PMID:34289071|PMID:37019170
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:34719	dinoseb	decreases localization	EXP		E	RGD:6480464	20141111	CTD	MESH:C018527	dinoseb results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of SOX17 mRNA	PMID:21527772
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in increased expression of SOX17 mRNA	PMID:12595580
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SOX17 mRNA	PMID:38382870
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20140715	CTD	MESH:D013755	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SOX17 mRNA	PMID:23519560
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313359	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SOX17 mRNA	PMID:40194260
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:38940	sunitinib	decreases localization	EXP		E	RGD:6480464	20170303	CTD	MESH:C473478	sunitinib results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20150414	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SOX17 mRNA	PMID:25510869
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of SOX17 mRNA	PMID:29038090
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of SOX17 mRNA	PMID:23125180
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SOX17 mRNA	PMID:25979313
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in decreased expression of SOX17 mRNA	PMID:37505509
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:39867	valproic acid	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:D014635	Valproic Acid results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:41922	diethylstilbestrol	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:D004054	Diethylstilbestrol results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SOX17 mRNA	PMID:19371625
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313359	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SOX17 mRNA	PMID:28973697
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SOX17 mRNA	PMID:37992649
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313359	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SOX17 mRNA	PMID:17562736
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of SOX17 mRNA	PMID:22230336
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D005472	Fluorouracil results in decreased expression of SOX17 mRNA	PMID:24737281
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20120717	CTD	MESH:D005472	Fluorouracil results in decreased expression of SOX17 protein	PMID:21296659
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:46345	5-fluorouracil	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:D005472	Fluorouracil results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of SOX17 mRNA	PMID:24714768
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SOX17 mRNA	PMID:40504410
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:472552	5-bromo-2'-deoxyuridine	decreases localization	EXP		E	RGD:6480464	20191114	CTD	MESH:D001973	Bromodeoxyuridine results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305371	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SOX17 mRNA	PMID:29391264
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:48432	angiotensin II	decreases expression	EXP		E	RGD:329853329|PMID:32078435	20230614	RGD	MESH:D000804	Angiotensin II decreases expression of SOX17 protein in retinal endothelial cells	
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:48432	angiotensin II	increases expression	EXP		E	RGD:329853320|PMID:36200131	20230614	RGD	MESH:D000804	Angiotensin II increases expression of SOX17 mRNA and protein in retinal microvascular endothelial cells	
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:49668	gefitinib	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:C419708	gefitinib results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:49960	vandetanib	decreases localization	EXP		E	RGD:6480464	20170110	CTD	MESH:C452423	vandetanib results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased methylation of SOX17 promoter	PMID:18413743
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of SOX17 mRNA; Decitabine results in increased expression of SOX17 protein	PMID:18413743
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305371	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SOX17 mRNA	PMID:30307764
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313359	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SOX17 mRNA; Nanotubes, Carbon results in increased expression of SOX17 mRNA	PMID:25554681
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:50692	mifepristone	decreases expression	ISO	RGD:1305371	E	RGD:6480464	20150825	CTD	MESH:D015735	Mifepristone results in decreased expression of SOX17 mRNA	PMID:25972201
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:50924	sorafenib	decreases localization	EXP		E	RGD:6480464	20170303	CTD	MESH:C471405	sorafenib results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:51137	mianserin	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:D008803	Mianserin results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1313359	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of SOX17 mRNA	PMID:26377693
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA	PMID:27858113
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313359	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA	PMID:27858113
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of SOX17 mRNA	PMID:19042947
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:6067	isotretinoin	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:D015474	Isotretinoin results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305371	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SOX17 mRNA	PMID:25729387
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1305371	E	RGD:6480464	20220208	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of SOX17 mRNA	PMID:34858468
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:64163	diquat	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:D004178	Diquat results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:64195	ritanserin	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:D016713	Ritanserin results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:64206	bromochloroacetic acid	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20120717	CTD	MESH:C099813	bromochloroacetic acid results in decreased expression of SOX17 protein	PMID:21296659
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313359	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of SOX17 mRNA	PMID:20003209
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1305371	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of SOX17 mRNA	PMID:19564919
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1305371	E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of SOX17 mRNA	PMID:19564919
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:6980	monocrotaline	decreases expression	ISO	RGD:1305371	E	RGD:329853317|PMID:36913491	20230614	RGD	MESH:D016686	Monocrotaline decreases expression of Sox17 protein in the lung	
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:73297	SCH 23390	multiple interactions	ISO	RGD:1305371	E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of SOX17 mRNA	PMID:19564919
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313359	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SOX17 mRNA	PMID:22206623
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:74514	6-aminonicotinamide	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:D015120	6-Aminonicotinamide results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:78510	dorsomorphin	decreases localization	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	dorsomorphin results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOX17 mRNA	PMID:27188386
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SOX17 gene]	PMID:28238834
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313359	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SOX17 mRNA	PMID:23091169
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:81766	hexaconazole	decreases localization	EXP		E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:81796	Chlorophacinone	decreases localization	EXP		E	RGD:6480464	20141111	CTD	MESH:C004662	chlorophacinone results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:81843	fluazinam	decreases localization	EXP		E	RGD:6480464	20141104	CTD	MESH:C075780	fluazinam results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:81913	diniconazole	decreases localization	EXP		E	RGD:6480464	20170303	CTD	MESH:C049346	diniconazole results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:81922	flusilazole	decreases localization	EXP		E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1313359	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of SOX17 mRNA	PMID:26377693
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305371	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SOX17 mRNA	PMID:24780913
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:91091	CHIR 99021	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C473711	Chir 99021 results in increased expression of SOX17 mRNA	PMID:31711903
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:91091	CHIR 99021	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C473711	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Chir 99021 results in increased expression of SOX17 mRNA]; [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] inhibits the reaction [Chir 99021 results in increased expression of SOX17 mRNA]	PMID:31711903
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:91108	SB 431542	decreases localization	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Chir 99021 results in increased expression of SOX17 mRNA]; [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] inhibits the reaction [Chir 99021 results in increased expression of SOX17 mRNA]; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOX17 mRNA	PMID:27188386|PMID:31711903
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:9513	thalidomide	decreases localization	EXP		E	RGD:6480464	20140211	CTD	MESH:D013792	Thalidomide results in decreased localization of SOX17 protein	PMID:24154490
1313358	SOX17	SRY-box transcription factor 17	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305371	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of SOX17 mRNA	PMID:19015723
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313361	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NCBP2 mRNA	PMID:33045310
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of NCBP2 mRNA	PMID:15498508
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1596188	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of NCBP2 mRNA	PMID:36841081
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1596188	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NCBP2 mRNA	PMID:33387578
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NCBP2 mRNA	PMID:37042841
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1596188	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of NCBP2 mRNA	PMID:22061828
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NCBP2 mRNA	PMID:35301059
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NCBP2 gene	PMID:27153756
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313361	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of NCBP2 mRNA	PMID:17095637
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NCBP2 mRNA	PMID:23557933
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of NCBP2 mRNA	PMID:19561079
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of NCBP2 mRNA	PMID:24768652
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313361	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NCBP2 mRNA	PMID:21570461
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1596188	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NCBP2 mRNA	PMID:32109520|PMID:33387578
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313361	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NCBP2 mRNA	PMID:15034205
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313361	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NCBP2 mRNA; AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NCBP2 mRNA]	PMID:15034205|PMID:17942748
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NCBP2 mRNA	PMID:33212167
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [NCBP2 protein binds to CAPRIN1 protein]	PMID:33939924
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313361	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NCBP2 mRNA	PMID:15034205|PMID:22228805
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313361	E	RGD:6480464	20130312	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NCBP2 mRNA; AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of NCBP2 mRNA]	PMID:15034205|PMID:27858113
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1596188	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of NCBP2 mRNA	PMID:38458666
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of NCBP2 mRNA	PMID:15498508
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313361	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NCBP2 gene	PMID:35295148
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313361	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of NCBP2 mRNA	PMID:18445702
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313361	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of NCBP2 mRNA	PMID:18301758
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of NCBP2 mRNA; bisphenol A results in decreased expression of NCBP2 protein	PMID:29275510|PMID:34186270
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1313361	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of NCBP2 mRNA	PMID:26377693
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313361	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NCBP2 mRNA	PMID:27858113
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of NCBP2 protein	PMID:34186270
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NCBP2 mRNA	PMID:37042841
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1596188	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of NCBP2 mRNA	PMID:38458666
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NCBP2 mRNA	PMID:35301059
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NCBP2 mRNA	PMID:19320972|PMID:19376846
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of NCBP2 mRNA	PMID:28302478
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NCBP2 mRNA	PMID:36864359
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NCBP2 mRNA	PMID:25562108
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of NCBP2 mRNA	PMID:36621641
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of NCBP2 mRNA	PMID:26272509
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NCBP2 mRNA	PMID:27188386
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313361	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NCBP2 mRNA	PMID:17562736
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of NCBP2 mRNA	PMID:22230336
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313361	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of NCBP2 mRNA	PMID:35436446
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313361	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NCBP2 mRNA	PMID:17942748
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1596188	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of NCBP2 mRNA	PMID:34044035
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1313361	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of NCBP2 mRNA	PMID:40234311
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1313361	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of NCBP2 mRNA	PMID:26377693
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313361	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NCBP2 mRNA	PMID:27858113
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313361	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of NCBP2 mRNA	PMID:27858113
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313361	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of NCBP2 mRNA	PMID:23650126
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of NCBP2 protein	PMID:34186270
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313361	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NCBP2 mRNA	PMID:22206623
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:78160	bleomycin A5	increases expression	EXP		E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in increased expression of NCBP2 mRNA	PMID:21040473
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NCBP2 mRNA	PMID:27188386
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313361	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of NCBP2 mRNA	PMID:30294300
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of NCBP2 mRNA	PMID:12756304
1313360	NCBP2	nuclear cap binding protein subunit 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NCBP2 mRNA	PMID:27188386
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of EIF6 mRNA; deoxynivalenol results in increased expression of EIF6 protein	PMID:39638853|PMID:40320232
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305373	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of EIF6 mRNA	PMID:21551480
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:125472	N-(6-acetamidohexyl)acetamide	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C014026	hexamethylene bisacetamide results in increased expression of EIF6 protein	PMID:17569113
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF6 protein]	PMID:38195004
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of EIF6 mRNA	PMID:40320232
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EIF6 mRNA	PMID:30529165
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313363	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of EIF6 mRNA	PMID:40945087
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EIF6 mRNA	PMID:29432896
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of EIF6 mRNA	PMID:39709020
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313363	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EIF6 mRNA	PMID:39241906
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of EIF6 mRNA	PMID:15598610
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313363	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EIF6 mRNA	PMID:39298647
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EIF6 mRNA	PMID:37042841
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313363	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of EIF6 protein	PMID:20463053
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in increased expression of EIF6 protein	PMID:20463053
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313363	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EIF6 mRNA	PMID:34319233
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of EIF6 protein	PMID:37730182
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305373	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of EIF6 mRNA	PMID:33387578
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305373	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of EIF6 protein	PMID:34915118
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313363	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of EIF6 mRNA	PMID:27462272
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF6 protein	PMID:38195004
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EIF6 protein	PMID:23301498
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of EIF6 mRNA	PMID:35430440
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EIF6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EIF6 protein	PMID:38598786
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305373	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EIF6 mRNA	PMID:31150632
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313363	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EIF6 mRNA	PMID:27339419|PMID:31919559
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIF6 mRNA	PMID:40504410
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of EIF6 mRNA	PMID:19244175
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of EIF6 mRNA	PMID:19244175
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of EIF6 mRNA	PMID:33512557
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of EIF6 protein	PMID:38460933
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of EIF6 protein	PMID:35688186
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313363	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of EIF6 protein	PMID:25505154
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of EIF6 mRNA	PMID:18930951
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313363	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EIF6 mRNA	PMID:21570461
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313363	E	RGD:6480464	20120717	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EIF6 mRNA	PMID:15328365|PMID:17942748|PMID:18796159
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of EIF6 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF6 mRNA	PMID:16214954|PMID:17942748
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305373	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of EIF6 protein	PMID:35544339
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of EIF6 mRNA; aristolochic acid I results in increased expression of EIF6 protein	PMID:33212167
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EIF6 mRNA	PMID:30851411
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:28694	copper atom	affects binding	EXP		E	RGD:6480464	20120918	CTD	MESH:D003300	EIF6 protein binds to Copper	PMID:14534351
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of EIF6 mRNA	PMID:15467011
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EIF6 mRNA	PMID:29432896
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIF6 mRNA	PMID:40504410
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EIF6 promoter	PMID:27901495
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313363	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EIF6 mRNA	PMID:23735875
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to EIF6 protein]	PMID:32406909
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:30052	copper(0)	affects binding	EXP		E	RGD:6480464	20120918	CTD	MESH:D003300	EIF6 protein binds to Copper	PMID:14534351
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of EIF6 mRNA	PMID:15467011
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:3048	benzatropine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in decreased expression of EIF6 protein	PMID:34122009
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of EIF6 mRNA	PMID:25895662
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of EIF6 protein	PMID:20416286
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305373	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of EIF6 mRNA	PMID:24136188
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313363	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EIF6 gene	PMID:35295148
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305373	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EIF6 mRNA	PMID:34492290
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305373	E	RGD:6480464	20130806	CTD	MESH:C069837	fullerene C60 results in decreased expression of EIF6 mRNA	PMID:19167457
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of EIF6 mRNA	PMID:30903817
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of EIF6 protein	PMID:34186270
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313363	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of EIF6 promoter	PMID:27312807
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305373	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EIF6 mRNA	PMID:25181051
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313363	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of EIF6 promoter	PMID:27312807
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF6 mRNA	PMID:28628672
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of EIF6 mRNA	PMID:19244175
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of EIF6 mRNA	PMID:19244175
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313363	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of EIF6 mRNA	PMID:26682919
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:3423	carmustine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of EIF6 mRNA	PMID:15980968
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of EIF6 protein	PMID:34186270
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313363	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EIF6 mRNA	PMID:39298647
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of EIF6 protein	PMID:34186270
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313363	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of EIF6 mRNA	PMID:38685157
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF6 mRNA	PMID:28628672
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of EIF6 protein	PMID:34186270
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313363	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of EIF6 mRNA	PMID:37019170
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313363	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EIF6 mRNA	PMID:17361019
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305373	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of EIF6 mRNA	PMID:21266533
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EIF6 protein	PMID:38598786
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF6 mRNA	PMID:28628672
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305373	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of EIF6 mRNA	PMID:32680482
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EIF6 mRNA	PMID:37042841
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305373	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EIF6 mRNA	PMID:33453195
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of EIF6 protein	PMID:38195004
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of EIF6 mRNA	PMID:19244175
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of EIF6 mRNA	PMID:19244175
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313363	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of EIF6 mRNA	PMID:17585979
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:3766	clozapine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of EIF6 protein	PMID:34122009
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 results in increased expression of EIF6 mRNA	PMID:16221962
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of EIF6 mRNA	PMID:32588087
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of EIF6 mRNA	PMID:26352163
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305373	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of EIF6 mRNA	PMID:25993096
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of EIF6 mRNA	PMID:17292431
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of EIF6 mRNA	PMID:19101580
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EIF6 mRNA	PMID:23179753
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of EIF6 gene	PMID:29154799
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of EIF6 mRNA	PMID:17555576
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF6 mRNA	PMID:28628672
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EIF6 mRNA	PMID:17562736
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of EIF6 protein	PMID:38460933
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIF6 mRNA	PMID:40504410
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313363	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of EIF6 mRNA	PMID:35436446
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of EIF6 mRNA	PMID:17555576
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EIF6 mRNA	PMID:17942748
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF6 mRNA	PMID:17942748
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF6 mRNA	PMID:28628672
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313363	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of EIF6 mRNA; Nanotubes, Carbon results in increased expression of EIF6 mRNA	PMID:25554681|PMID:25620056
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1305373	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of EIF6 mRNA	PMID:34044035
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	ISO	RGD:1313363	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of EIF6 mRNA	PMID:15375163
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EIF6 mRNA	PMID:35964746
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305373	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of EIF6 mRNA	PMID:24136188
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EIF6 protein	PMID:32959892
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1313363	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of EIF6 mRNA	PMID:19751817
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313363	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of EIF6 protein	PMID:26558463
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313363	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of EIF6 mRNA	PMID:36851058
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of EIF6 protein	PMID:34186270
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313363	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of EIF6 mRNA	PMID:22206623
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305373	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of EIF6 mRNA	PMID:24136188
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of EIF6 protein	PMID:31285264
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:7599	Nivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of EIF6 mRNA; nivalenol results in increased expression of EIF6 protein	PMID:39638853|PMID:40320232
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of EIF6 protein	PMID:39638853
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EIF6 mRNA	PMID:30851411
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313363	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of EIF6 mRNA	PMID:30294300
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of EIF6 protein	PMID:38348393
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305373	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of EIF6 mRNA	PMID:21346803
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:9381	T-2 toxin	affects expression	ISO	RGD:1305373	E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin affects the expression of EIF6 protein	PMID:26141394
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of EIF6 mRNA	PMID:38568856
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EIF6 protein	PMID:38598786
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305373	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EIF6 mRNA	PMID:21346803
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1313363	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of EIF6 mRNA	PMID:18930950
1313362	EIF6	eukaryotic translation initiation factor 6	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305373	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of EIF6 mRNA	PMID:23034163
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GNT8 mRNA	PMID:20938992
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of B3GNT8 mRNA	PMID:33167477
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of B3GNT8 mRNA	PMID:22378314
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of B3GNT8 mRNA	PMID:35811015
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of B3GNT8 mRNA	PMID:26582142|PMID:39241906
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B3GNT8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of B3GNT8 mRNA	PMID:35811015
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of B3GNT8 mRNA	PMID:30165855
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GNT8 mRNA	PMID:20938992
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305374	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of B3GNT8 mRNA	PMID:33387578
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of B3GNT8 mRNA	PMID:39984025
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of B3GNT8 mRNA	PMID:29950665
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of B3GNT8 mRNA	PMID:20938992
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of B3GNT8 mRNA	PMID:23557933
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of B3GNT8 mRNA	PMID:38568856
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of B3GNT8 5' UTR	PMID:27901495
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622061	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of B3GNT8 promoter	PMID:35295148
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of B3GNT8 mRNA	PMID:29950665
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305374	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of B3GNT8 mRNA	PMID:25181051|PMID:34947998
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of B3GNT8 mRNA	PMID:30245210
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305374	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of B3GNT8 mRNA	PMID:41034487
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1622061	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of B3GNT8 mRNA	PMID:32156529
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1622061	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of B3GNT8 gene	PMID:31683443
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1622061	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of B3GNT8 exon	PMID:33297965
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of B3GNT8 mRNA	PMID:29950665
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of B3GNT8 mRNA	PMID:21266533
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of B3GNT8 mRNA	PMID:37042841
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of B3GNT8 mRNA	PMID:24449571
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1622061	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of B3GNT8 mRNA	PMID:36331819
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of B3GNT8 mRNA	PMID:26272509|PMID:28001369
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of B3GNT8 gene	PMID:29154799
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GNT8 mRNA	PMID:27188386
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of B3GNT8 mRNA	PMID:28973697
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:44616	afimoxifene	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20230801	CTD	MESH:C016601	afimoxifene results in decreased expression of B3GNT8 mRNA	PMID:26879975
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622061	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of B3GNT8 mRNA	PMID:17562736
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of B3GNT8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of B3GNT8 mRNA	PMID:35811015
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305374	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of B3GNT8 mRNA	PMID:29391264
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1622061	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of B3GNT8 mRNA	PMID:38701926
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GNT8 mRNA	PMID:27188386
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1622061	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of B3GNT8 mRNA	PMID:39847705
1313364	B3GNT8	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of B3GNT8 mRNA	PMID:27188386
1313365	GALK1	galactokinase 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of GALK1 protein	PMID:39638853
1313365	GALK1	galactokinase 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of GALK1 mRNA	PMID:27188386
1313365	GALK1	galactokinase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GALK1 mRNA	PMID:33167477
1313365	GALK1	galactokinase 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:10617	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of GALK1 mRNA	PMID:20880076
1313365	GALK1	galactokinase 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GALK1 mRNA	PMID:36331819
1313365	GALK1	galactokinase 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of GALK1 mRNA	PMID:26079696
1313365	GALK1	galactokinase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:10617	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GALK1 mRNA	PMID:39241906
1313365	GALK1	galactokinase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:10617	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of GALK1 mRNA	PMID:39298647
1313365	GALK1	galactokinase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of GALK1 mRNA	PMID:30165855
1313365	GALK1	galactokinase 1	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of GALK1 protein	PMID:20109541
1313365	GALK1	galactokinase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GALK1 mRNA	PMID:37042841
1313365	GALK1	galactokinase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALK1 mRNA	PMID:37992649
1313365	GALK1	galactokinase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALK1 mRNA	PMID:37992649
1313365	GALK1	galactokinase 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of GALK1 mRNA	PMID:28818685
1313365	GALK1	galactokinase 1	gene	CHEBI:17973	alpha-D-galactose 1-phosphate	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:C029973	[Enzyme Inhibitors binds to and results in decreased activity of GALK1 protein] which results in decreased abundance of galactose-1-phosphate; [GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate	PMID:20696150
1313365	GALK1	galactokinase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GALK1 mRNA	PMID:36331819
1313365	GALK1	galactokinase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305375	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of GALK1 protein	PMID:34915118
1313365	GALK1	galactokinase 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:10617	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of GALK1 mRNA	PMID:27462272
1313365	GALK1	galactokinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GALK1 mRNA	PMID:37236586
1313365	GALK1	galactokinase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of GALK1 mRNA	PMID:19549813
1313365	GALK1	galactokinase 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors binds to and results in decreased activity of GALK1 protein] which results in decreased abundance of galactose-1-phosphate; Enzyme Inhibitors binds to and results in decreased activity of GALK1 protein	PMID:20696150
1313365	GALK1	galactokinase 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of GALK1 mRNA	PMID:19376150
1313365	GALK1	galactokinase 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of GALK1 protein	PMID:20106945
1313365	GALK1	galactokinase 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of GALK1 mRNA	PMID:25102026
1313365	GALK1	galactokinase 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of GALK1 protein	PMID:38598786
1313365	GALK1	galactokinase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:10617	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GALK1 mRNA	PMID:31919559
1313365	GALK1	galactokinase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GALK1 mRNA	PMID:22206623
1313365	GALK1	galactokinase 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GALK1 gene	PMID:25304211
1313365	GALK1	galactokinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GALK1 mRNA	PMID:39836092
1313365	GALK1	galactokinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GALK1 mRNA	PMID:40504410
1313365	GALK1	galactokinase 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of GALK1 protein	PMID:38460933
1313365	GALK1	galactokinase 1	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305375	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of GALK1 mRNA	PMID:31881176
1313365	GALK1	galactokinase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of GALK1 mRNA	PMID:27392435
1313365	GALK1	galactokinase 1	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305375	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of GALK1 mRNA	PMID:20187946
1313365	GALK1	galactokinase 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:10617	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of GALK1 mRNA	PMID:30912803
1313365	GALK1	galactokinase 1	gene	CHEBI:28061	alpha-D-galactose	increases metabolic processing	EXP		E	RGD:6480464	20140805	CTD	MESH:D005690	GALK1 protein results in increased metabolism of Galactose	PMID:20696150
1313365	GALK1	galactokinase 1	gene	CHEBI:28061	alpha-D-galactose	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:D005690	[GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate	PMID:20696150
1313365	GALK1	galactokinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:10617	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GALK1 mRNA	PMID:21570461
1313365	GALK1	galactokinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305375	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GALK1 mRNA	PMID:21215274|PMID:32109520
1313365	GALK1	galactokinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:10617	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GALK1 mRNA	PMID:26290441
1313365	GALK1	galactokinase 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of GALK1 protein	PMID:39603559
1313365	GALK1	galactokinase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305375	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of GALK1 mRNA	PMID:28374803
1313365	GALK1	galactokinase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GALK1 mRNA	PMID:33212167
1313365	GALK1	galactokinase 1	gene	CHEBI:28260	galactose	increases metabolic processing	EXP		E	RGD:6480464	20120501	CTD	MESH:D005690	GALK1 protein results in increased metabolism of Galactose	PMID:20696150
1313365	GALK1	galactokinase 1	gene	CHEBI:28260	galactose	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005690	[GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate	PMID:20696150
1313365	GALK1	galactokinase 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of GALK1 mRNA	PMID:32763439
1313365	GALK1	galactokinase 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305375	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of GALK1 mRNA	PMID:28959563
1313365	GALK1	galactokinase 1	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:10617	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper results in decreased expression of GALK1 protein	PMID:23882024
1313365	GALK1	galactokinase 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GALK1 mRNA	PMID:20971185
1313365	GALK1	galactokinase 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:10617	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of GALK1 protein	PMID:28918527
1313365	GALK1	galactokinase 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of GALK1 mRNA	PMID:29803840
1313365	GALK1	galactokinase 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALK1 mRNA	PMID:37992649
1313365	GALK1	galactokinase 1	gene	CHEBI:28940	calciol	decreases expression	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in decreased expression of GALK1 mRNA	PMID:16508948
1313365	GALK1	galactokinase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GALK1 mRNA	PMID:38568856
1313365	GALK1	galactokinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GALK1 mRNA	PMID:39836092
1313365	GALK1	galactokinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GALK1 mRNA	PMID:40504410
1313365	GALK1	galactokinase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GALK1 promoter	PMID:30157460
1313365	GALK1	galactokinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GALK1 mRNA	PMID:20106945|PMID:32234424
1313365	GALK1	galactokinase 1	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:10617	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper results in decreased expression of GALK1 protein	PMID:23882024
1313365	GALK1	galactokinase 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GALK1 mRNA	PMID:20971185
1313365	GALK1	galactokinase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of GALK1 protein	PMID:19364129
1313365	GALK1	galactokinase 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GALK1 protein]	PMID:26598702
1313365	GALK1	galactokinase 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305375	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of GALK1 mRNA	PMID:30047161
1313365	GALK1	galactokinase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:10617	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GALK1 gene	PMID:35295148
1313365	GALK1	galactokinase 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305375	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of GALK1 mRNA	PMID:34492290
1313365	GALK1	galactokinase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:10617	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of GALK1 mRNA	PMID:17426115|PMID:18301758|PMID:20059764|PMID:23811191
1313365	GALK1	galactokinase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GALK1 mRNA	PMID:19710929
1313365	GALK1	galactokinase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GALK1 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of GALK1 mRNA]	PMID:19710929|PMID:20059764
1313365	GALK1	galactokinase 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of GALK1 mRNA	PMID:38479592
1313365	GALK1	galactokinase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of GALK1 mRNA	PMID:30903817
1313365	GALK1	galactokinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305375	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of GALK1 mRNA	PMID:33296240
1313365	GALK1	galactokinase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of GALK1 gene	PMID:31601247
1313365	GALK1	galactokinase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of GALK1 protein	PMID:37567409
1313365	GALK1	galactokinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:10617	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GALK1 mRNA	PMID:32156529|PMID:33221593
1313365	GALK1	galactokinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305375	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GALK1 mRNA	PMID:25181051
1313365	GALK1	galactokinase 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305375	E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GALK1 mRNA	PMID:17316808
1313365	GALK1	galactokinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:10617	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of GALK1 mRNA	PMID:39298647
1313365	GALK1	galactokinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of GALK1 gene	PMID:31601247
1313365	GALK1	galactokinase 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:10617	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GALK1 mRNA	PMID:37019170
1313365	GALK1	galactokinase 1	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:10617	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of GALK1 protein	PMID:35362542
1313365	GALK1	galactokinase 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GALK1 protein]	PMID:35362542
1313365	GALK1	galactokinase 1	gene	CHEBI:34682	diazinon	decreases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of GALK1 gene	PMID:22964155
1313365	GALK1	galactokinase 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of GALK1 protein	PMID:38598786
1313365	GALK1	galactokinase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:D015056	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of GALK1 mRNA	PMID:16054899
1313365	GALK1	galactokinase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GALK1 mRNA	PMID:37042841
1313365	GALK1	galactokinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GALK1 protein	PMID:24527689
1313365	GALK1	galactokinase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GALK1 mRNA	PMID:37236586
1313365	GALK1	galactokinase 1	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of GALK1 mRNA	PMID:19429403
1313365	GALK1	galactokinase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of GALK1 mRNA	PMID:19320972
1313365	GALK1	galactokinase 1	gene	CHEBI:37480	D-galactopyranose 1-phosphate	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:C029973	[Enzyme Inhibitors binds to and results in decreased activity of GALK1 protein] which results in decreased abundance of galactose-1-phosphate; [GALK1 protein results in increased metabolism of Galactose] which results in increased abundance of galactose-1-phosphate	PMID:20696150
1313365	GALK1	galactokinase 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of GALK1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GALK1 mRNA]	PMID:17585979
1313365	GALK1	galactokinase 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of GALK1 mRNA	PMID:28302478
1313365	GALK1	galactokinase 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:10617	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of GALK1 mRNA	PMID:39529242
1313365	GALK1	galactokinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of GALK1 mRNA	PMID:19429403
1313365	GALK1	galactokinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GALK1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GALK1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of GALK1 mRNA	PMID:36331819
1313365	GALK1	galactokinase 1	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1305375	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of GALK1 mRNA	PMID:22110744
1313365	GALK1	galactokinase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of GALK1 mRNA	PMID:29154799
1313365	GALK1	galactokinase 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305375	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of GALK1 mRNA	PMID:41580965
1313365	GALK1	galactokinase 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305375	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of GALK1 mRNA	PMID:30047161
1313365	GALK1	galactokinase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of GALK1 mRNA	PMID:20106945|PMID:25562108
1313365	GALK1	galactokinase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:D003907	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of GALK1 mRNA	PMID:16054899
1313365	GALK1	galactokinase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:10617	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of GALK1 mRNA	PMID:28973697
1313365	GALK1	galactokinase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALK1 mRNA	PMID:37992649
1313365	GALK1	galactokinase 1	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305375	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of GALK1 mRNA	PMID:24136188
1313365	GALK1	galactokinase 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of GALK1 mRNA	PMID:38832940
1313365	GALK1	galactokinase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305375	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GALK1 mRNA	PMID:33387578
1313365	GALK1	galactokinase 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of GALK1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GALK1 mRNA]	PMID:17585979
1313365	GALK1	galactokinase 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of GALK1 protein	PMID:38460933
1313365	GALK1	galactokinase 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GALK1 gene	PMID:25304211
1313365	GALK1	galactokinase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GALK1 mRNA	PMID:39836092
1313365	GALK1	galactokinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GALK1 mRNA	PMID:40504410
1313365	GALK1	galactokinase 1	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	ISO	RGD:10617	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide analog results in decreased expression of GALK1 protein	PMID:23882024
1313365	GALK1	galactokinase 1	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of GALK1 protein]	PMID:35362542
1313365	GALK1	galactokinase 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of GALK1 protein	PMID:19364129
1313365	GALK1	galactokinase 1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to GALK1 protein]	PMID:26598702
1313365	GALK1	galactokinase 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305375	E	RGD:6480464	20210706	CTD	MESH:C017690	fenvalerate results in increased expression of GALK1 protein	PMID:33656234
1313365	GALK1	galactokinase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:10617	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GALK1 mRNA	PMID:25620056
1313365	GALK1	galactokinase 1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305375	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of GALK1 mRNA	PMID:24136188
1313365	GALK1	galactokinase 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305375	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of GALK1 mRNA	PMID:30047161
1313365	GALK1	galactokinase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of GALK1 mRNA	PMID:35964746
1313365	GALK1	galactokinase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:10617	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of GALK1 mRNA	PMID:19042947
1313365	GALK1	galactokinase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GALK1 protein	PMID:32959892
1313365	GALK1	galactokinase 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:10617	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of GALK1 mRNA	PMID:23650126
1313365	GALK1	galactokinase 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305375	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of GALK1 mRNA	PMID:24136188
1313365	GALK1	galactokinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GALK1 mRNA	PMID:24810058
1313365	GALK1	galactokinase 1	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:10617	E	RGD:6480464	20200331	CTD	MESH:D012970	Sodium Glutamate results in increased expression of GALK1 mRNA	PMID:20111022
1313365	GALK1	galactokinase 1	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20200331	CTD	MESH:D012970	[Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of GALK1 mRNA; [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of GALK1 mRNA	PMID:19001666|PMID:20111022
1313365	GALK1	galactokinase 1	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1305375	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of GALK1 mRNA	PMID:19564919
1313365	GALK1	galactokinase 1	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:10617	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of GALK1 mRNA	PMID:27462272
1313365	GALK1	galactokinase 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of GALK1 protein	PMID:34186270
1313365	GALK1	galactokinase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:10617	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GALK1 mRNA	PMID:22206623
1313365	GALK1	galactokinase 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305375	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of GALK1 mRNA	PMID:24136188
1313365	GALK1	galactokinase 1	gene	CHEBI:7599	Nivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in decreased expression of GALK1 protein	PMID:39638853
1313365	GALK1	galactokinase 1	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	ISO	RGD:1305375	E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of GALK1 protein	PMID:19716841
1313365	GALK1	galactokinase 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of GALK1 mRNA	PMID:19159669
1313365	GALK1	galactokinase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305375	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GALK1 mRNA	PMID:21394737
1313365	GALK1	galactokinase 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:10617	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of GALK1 mRNA	PMID:21278054
1313365	GALK1	galactokinase 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1305375	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of GALK1 mRNA	PMID:30047161
1313365	GALK1	galactokinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305375	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of GALK1 mRNA	PMID:30047161
1313365	GALK1	galactokinase 1	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1305375	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of GALK1 mRNA	PMID:24136188
1313365	GALK1	galactokinase 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of GALK1 mRNA	PMID:38568856
1313365	GALK1	galactokinase 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of GALK1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of GALK1 protein	PMID:38598786
1313365	GALK1	galactokinase 1	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:10617	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of GALK1 mRNA	PMID:32835833
1313366	SRP68	signal recognition particle 68	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305376	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SRP68 mRNA]	PMID:31150632
1313366	SRP68	signal recognition particle 68	gene	CHEBI:135741	testosterone undecanoate	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C010792	testosterone undecanoate results in increased expression of SRP68 mRNA	PMID:19074003
1313366	SRP68	signal recognition particle 68	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550190	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SRP68 mRNA	PMID:20188158
1313366	SRP68	signal recognition particle 68	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550190	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SRP68 mRNA	PMID:30319688
1313366	SRP68	signal recognition particle 68	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550190	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SRP68 mRNA	PMID:39298647
1313366	SRP68	signal recognition particle 68	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of SRP68 protein	PMID:20109541
1313366	SRP68	signal recognition particle 68	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SRP68 mRNA	PMID:37042841
1313366	SRP68	signal recognition particle 68	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SRP68 protein	PMID:37730182
1313366	SRP68	signal recognition particle 68	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305376	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SRP68 mRNA	PMID:22061828|PMID:33387578
1313366	SRP68	signal recognition particle 68	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SRP68 mRNA	PMID:19549813
1313366	SRP68	signal recognition particle 68	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SRP68 protein	PMID:23301498
1313366	SRP68	signal recognition particle 68	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1305376	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of SRP68 protein	PMID:33236894
1313366	SRP68	signal recognition particle 68	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SRP68 mRNA	PMID:23649840
1313366	SRP68	signal recognition particle 68	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SRP68 mRNA	PMID:35430440
1313366	SRP68	signal recognition particle 68	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SRP68 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SRP68 protein	PMID:38598786
1313366	SRP68	signal recognition particle 68	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305376	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SRP68 mRNA	PMID:31150632
1313366	SRP68	signal recognition particle 68	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550190	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SRP68 mRNA	PMID:31919559
1313366	SRP68	signal recognition particle 68	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305376	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SRP68 mRNA]	PMID:31150632
1313366	SRP68	signal recognition particle 68	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of SRP68 mRNA	PMID:16835338
1313366	SRP68	signal recognition particle 68	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SRP68 protein	PMID:35688186
1313366	SRP68	signal recognition particle 68	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1305376	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of SRP68 gene	PMID:35440735
1313366	SRP68	signal recognition particle 68	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1550190	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of SRP68 protein	PMID:25505154
1313366	SRP68	signal recognition particle 68	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SRP68 mRNA	PMID:23557933
1313366	SRP68	signal recognition particle 68	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550190	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SRP68 mRNA	PMID:30912803
1313366	SRP68	signal recognition particle 68	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550190	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SRP68 mRNA	PMID:21570461
1313366	SRP68	signal recognition particle 68	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305376	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SRP68 mRNA	PMID:32109520
1313366	SRP68	signal recognition particle 68	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550190	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SRP68 mRNA	PMID:17942748
1313366	SRP68	signal recognition particle 68	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of SRP68 protein	PMID:39603559
1313366	SRP68	signal recognition particle 68	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SRP68 mRNA	PMID:33212167
1313366	SRP68	signal recognition particle 68	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of SRP68 protein	PMID:30528433
1313366	SRP68	signal recognition particle 68	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SRP68 mRNA	PMID:38568856
1313366	SRP68	signal recognition particle 68	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of SRP68 mRNA	PMID:22378314
1313366	SRP68	signal recognition particle 68	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SRP68 promoter	PMID:27901495
1313366	SRP68	signal recognition particle 68	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305376	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SRP68 mRNA	PMID:24136188
1313366	SRP68	signal recognition particle 68	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1305376	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of SRP68 mRNA	PMID:32479839
1313366	SRP68	signal recognition particle 68	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550190	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SRP68 gene	PMID:35295148
1313366	SRP68	signal recognition particle 68	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305376	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SRP68 mRNA	PMID:19167457
1313366	SRP68	signal recognition particle 68	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1305376	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SRP68 gene	PMID:28505145
1313366	SRP68	signal recognition particle 68	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of SRP68 protein	PMID:34186270
1313366	SRP68	signal recognition particle 68	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305376	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SRP68 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1313366	SRP68	signal recognition particle 68	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305376	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SRP68 gene	PMID:28505145
1313366	SRP68	signal recognition particle 68	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550190	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SRP68 mRNA	PMID:39298647
1313366	SRP68	signal recognition particle 68	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1550190	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of SRP68 mRNA	PMID:26377693
1313366	SRP68	signal recognition particle 68	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SRP68 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SRP68 protein	PMID:38598786
1313366	SRP68	signal recognition particle 68	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SRP68 mRNA	PMID:37042841
1313366	SRP68	signal recognition particle 68	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305376	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SRP68 gene	PMID:22079235
1313366	SRP68	signal recognition particle 68	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550190	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of SRP68 mRNA	PMID:17585979
1313366	SRP68	signal recognition particle 68	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SRP68 mRNA	PMID:25979313
1313366	SRP68	signal recognition particle 68	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550190	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SRP68 mRNA	PMID:17292431
1313366	SRP68	signal recognition particle 68	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SRP68 gene	PMID:29154799
1313366	SRP68	signal recognition particle 68	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SRP68 mRNA	PMID:20106945|PMID:25562108
1313366	SRP68	signal recognition particle 68	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550190	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SRP68 mRNA	PMID:17562736
1313366	SRP68	signal recognition particle 68	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SRP68 mRNA	PMID:29523930
1313366	SRP68	signal recognition particle 68	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of SRP68 mRNA	PMID:16835338
1313366	SRP68	signal recognition particle 68	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305376	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SRP68 mRNA	PMID:29391264
1313366	SRP68	signal recognition particle 68	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550190	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SRP68 mRNA	PMID:17942748
1313366	SRP68	signal recognition particle 68	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305376	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of SRP68 mRNA	PMID:34044035
1313366	SRP68	signal recognition particle 68	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550190	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SRP68 mRNA	PMID:35964746
1313366	SRP68	signal recognition particle 68	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305376	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SRP68 mRNA	PMID:24136188
1313366	SRP68	signal recognition particle 68	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SRP68 protein	PMID:32959892
1313366	SRP68	signal recognition particle 68	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SRP68 protein	PMID:34186270
1313366	SRP68	signal recognition particle 68	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550190	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SRP68 mRNA	PMID:22206623
1313366	SRP68	signal recognition particle 68	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SRP68 gene]	PMID:28238834
1313366	SRP68	signal recognition particle 68	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1550190	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SRP68 mRNA	PMID:30294300
1313366	SRP68	signal recognition particle 68	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SRP68 protein	PMID:31675489
1313366	SRP68	signal recognition particle 68	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1305376	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of SRP68 protein	PMID:28903499
1313366	SRP68	signal recognition particle 68	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1550190	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SRP68 mRNA	PMID:21278054
1313366	SRP68	signal recognition particle 68	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of SRP68 mRNA	PMID:24921660
1313366	SRP68	signal recognition particle 68	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SRP68 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SRP68 protein	PMID:38598786
1313366	SRP68	signal recognition particle 68	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305376	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SRP68 mRNA	PMID:21346803
1313368	BEST2	bestrophin 2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of BEST2 mRNA	PMID:26272509
1313368	BEST2	bestrophin 2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BEST2 mRNA	PMID:27188386
1313368	BEST2	bestrophin 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313369	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of BEST2 mRNA	PMID:33045310
1313368	BEST2	bestrophin 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313369	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of BEST2 mRNA	PMID:30319688
1313368	BEST2	bestrophin 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of BEST2 mRNA	PMID:31614463
1313368	BEST2	bestrophin 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of BEST2 mRNA	PMID:38568856
1313368	BEST2	bestrophin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305377	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BEST2 promoter	PMID:23359474
1313368	BEST2	bestrophin 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305377	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of BEST2 mRNA	PMID:33387578
1313368	BEST2	bestrophin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313369	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BEST2 mRNA	PMID:21570461
1313368	BEST2	bestrophin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BEST2 mRNA	PMID:21296121
1313368	BEST2	bestrophin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313369	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BEST2 mRNA	PMID:21354282
1313368	BEST2	bestrophin 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of BEST2 mRNA	PMID:33212167
1313368	BEST2	bestrophin 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of BEST2 mRNA	PMID:38568856
1313368	BEST2	bestrophin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BEST2 exon	PMID:27901495
1313368	BEST2	bestrophin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313369	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BEST2 gene	PMID:35295148
1313368	BEST2	bestrophin 2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305377	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of BEST2 mRNA	PMID:19167457
1313368	BEST2	bestrophin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305377	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of BEST2 mRNA	PMID:41034487
1313368	BEST2	bestrophin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305377	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of BEST2 mRNA	PMID:25181051|PMID:41034487
1313368	BEST2	bestrophin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305377	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BEST2 promoter	PMID:23359474
1313368	BEST2	bestrophin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313369	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of BEST2 exon	PMID:33297965
1313368	BEST2	bestrophin 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BEST2 mRNA	PMID:28628672
1313368	BEST2	bestrophin 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305377	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of BEST2 promoter	PMID:23359474
1313368	BEST2	bestrophin 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BEST2 mRNA	PMID:28628672
1313368	BEST2	bestrophin 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305377	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of BEST2 mRNA	PMID:30047161
1313368	BEST2	bestrophin 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BEST2 mRNA	PMID:28628672
1313368	BEST2	bestrophin 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of BEST2 mRNA	PMID:38832940
1313368	BEST2	bestrophin 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BEST2 mRNA	PMID:28628672
1313368	BEST2	bestrophin 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305377	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of BEST2 mRNA	PMID:30047161
1313368	BEST2	bestrophin 2	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305377	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of BEST2 mRNA	PMID:35283115
1313368	BEST2	bestrophin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313369	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of BEST2 mRNA	PMID:22206623
1313368	BEST2	bestrophin 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BEST2 mRNA	PMID:27188386
1313368	BEST2	bestrophin 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BEST2 gene]	PMID:28238834
1313368	BEST2	bestrophin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305377	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of BEST2 mRNA	PMID:30047161
1313368	BEST2	bestrophin 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BEST2 mRNA	PMID:27188386
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313371	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MTMR6 gene	PMID:20938992
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of MTMR6 mRNA	PMID:15498508
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MTMR6 mRNA	PMID:33167477
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313371	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of MTMR6 mRNA	PMID:24205000
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313371	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of MTMR6 mRNA	PMID:30319688
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of MTMR6 protein	PMID:35688186
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313371	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MTMR6 gene	PMID:20938992
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MTMR6 mRNA	PMID:37042841
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MTMR6 mRNA	PMID:21179406
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1313371	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of MTMR6 mRNA	PMID:19376150
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313371	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MTMR6 mRNA	PMID:19770486
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313371	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTMR6 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MTMR6 gene	PMID:20938992|PMID:22206623
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MTMR6 protein	PMID:35688186
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MTMR6 mRNA	PMID:23557933
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of MTMR6 mRNA	PMID:27392435
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MTMR6 mRNA	PMID:22574217
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305378	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MTMR6 mRNA	PMID:33387578
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MTMR6 mRNA	PMID:22903824
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of MTMR6 protein	PMID:39603559
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MTMR6 mRNA	PMID:28001369
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MTMR6 mRNA	PMID:30851411
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of MTMR6 mRNA	PMID:25523186
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MTMR6 mRNA	PMID:38568856
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1313371	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MTMR6 intron	PMID:27901495
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MTMR6 promoter	PMID:27901495
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313371	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MTMR6 exon	PMID:27901495
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MTMR6 mRNA]	PMID:32406909
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of MTMR6 mRNA	PMID:25523186
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MTMR6 mRNA	PMID:19150397
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of MTMR6 mRNA	PMID:15498508
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313371	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MTMR6 gene	PMID:35295148
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313371	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MTMR6 mRNA	PMID:18648102
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313371	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MTMR6 mRNA	PMID:17426115
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MTMR6 mRNA	PMID:29275510
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305378	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MTMR6 mRNA	PMID:25181051
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305378	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MTMR6 gene	PMID:28505145
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313371	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of MTMR6 mRNA	PMID:38685157
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1313371	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MTMR6 mRNA	PMID:17681415
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MTMR6 mRNA	PMID:24449571
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MTMR6 mRNA	PMID:28302478
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MTMR6 mRNA	PMID:25979313
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MTMR6 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369|PMID:29154799
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTMR6 mRNA	PMID:27188386
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MTMR6 mRNA	PMID:25562108
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of MTMR6 mRNA	PMID:27188386
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of MTMR6 mRNA	PMID:19151715
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of MTMR6 mRNA	PMID:20977926
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MTMR6 protein	PMID:32959892
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1305378	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of MTMR6 mRNA	PMID:28801915
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313371	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of MTMR6 mRNA	PMID:23650126
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of MTMR6 mRNA	PMID:28988120
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313371	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MTMR6 mRNA	PMID:22206623
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313371	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTMR6 mRNA	PMID:22206623
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MTMR6 mRNA	PMID:22714537
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MTMR6 mRNA	PMID:30851411
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTMR6 mRNA	PMID:27188386
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MTMR6 mRNA	PMID:27188386
1313370	MTMR6	myotubularin related protein 6	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313371	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of MTMR6 protein	PMID:24648495
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CLCN6 mRNA	PMID:38218311
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CLCN6 protein]	PMID:38195004
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of CLCN6 mRNA	PMID:23724009|PMID:33167477
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313373	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CLCN6 mRNA	PMID:30319688
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313373	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CLCN6 mRNA	PMID:30319688
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CLCN6 mRNA	PMID:38568856
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305379	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CLCN6 mRNA	PMID:33387578
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CLCN6 mRNA	PMID:21179406
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305379	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CLCN6 mRNA	PMID:33387578
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLCN6 mRNA	PMID:39836092
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CLCN6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CLCN6 protein	PMID:38195004
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313373	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CLCN6 mRNA	PMID:19770486
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CLCN6 gene	PMID:27153756
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313373	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CLCN6 mRNA	PMID:34911549
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of CLCN6 mRNA	PMID:19774075
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305379	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CLCN6 mRNA	PMID:31150632
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLCN6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CLCN6 mRNA	PMID:39836092
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305379	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CLCN6 mRNA	PMID:31881176
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313373	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of CLCN6 mRNA	PMID:32186404
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305379	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLCN6 mRNA	PMID:22298810
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313373	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLCN6 mRNA	PMID:21570461
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305379	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CLCN6 mRNA	PMID:33387578
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305379	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CLCN6 mRNA	PMID:28959563
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CLCN6 mRNA	PMID:29803840
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CLCN6 mRNA	PMID:29432896
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of CLCN6 mRNA	PMID:29319823
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLCN6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CLCN6 mRNA	PMID:39836092
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLCN6 mRNA	PMID:26238291
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CLCN6 promoter	PMID:27901495
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CLCN6 gene	PMID:31601247
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313373	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CLCN6 mRNA	PMID:29264374
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313373	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of CLCN6 mRNA	PMID:18648102
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of CLCN6 gene	PMID:31601247
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305379	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of CLCN6 mRNA	PMID:32145629
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313373	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CLCN6 mRNA	PMID:32156529
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305379	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CLCN6 mRNA	PMID:25181051
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313373	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of CLCN6 mRNA	PMID:38074096
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CLCN6 gene	PMID:31601247
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313373	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of CLCN6 mRNA	PMID:26682919
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313373	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CLCN6 gene	PMID:31683443
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313373	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of CLCN6 mRNA	PMID:40203079
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of CLCN6 gene	PMID:31601247
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313373	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CLCN6 mRNA	PMID:37019170
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of CLCN6 gene	PMID:22964155
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305379	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CLCN6 mRNA	PMID:21266533
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CLCN6 mRNA	PMID:37042841
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLCN6 mRNA	PMID:39836092
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305379	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of CLCN6 mRNA	PMID:30723492
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CLCN6 mRNA	PMID:26472689
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305379	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CLCN6 mRNA	PMID:33453195
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CLCN6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CLCN6 protein	PMID:38195004
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305379	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of CLCN6 mRNA	PMID:26194646
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CLCN6 mRNA	PMID:28302478
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CLCN6 mRNA	PMID:31533062
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of CLCN6 mRNA	PMID:17198877
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CLCN6 mRNA	PMID:25562108
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305379	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLCN6 mRNA	PMID:33387578
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CLCN6 mRNA	PMID:29432896
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLCN6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CLCN6 mRNA	PMID:39836092
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of CLCN6 mRNA	PMID:22077320
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1313373	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of CLCN6 mRNA	PMID:35436446
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of CLCN6 mRNA	PMID:18175754
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:C029892	cupric chloride results in decreased expression of CLCN6 mRNA	PMID:34921933
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of CLCN6 mRNA	PMID:17211630
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305379	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of CLCN6 mRNA	PMID:24793618
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLCN6 mRNA	PMID:39836092
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:63618	pravastatin	increases expression	ISO	RGD:1305379	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of CLCN6 mRNA	PMID:27225895
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:63618	pravastatin	increases expression	ISO	RGD:1313373	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of CLCN6 mRNA	PMID:27225895
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313373	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of CLCN6 mRNA	PMID:26307267
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313373	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CLCN6 mRNA	PMID:22206623
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:75170	zaragozic acid A	increases expression	ISO	RGD:1305379	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of CLCN6 mRNA	PMID:27225895
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:75170	zaragozic acid A	increases expression	ISO	RGD:1313373	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of CLCN6 mRNA	PMID:27225895
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:8107	phenytoin	decreases expression	ISO	RGD:1305379	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in decreased expression of CLCN6 mRNA	PMID:20345932
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305379	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CLCN6 mRNA	PMID:27291303
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:8772	raloxifene	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of CLCN6 mRNA	PMID:16497877
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305379	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CLCN6 mRNA	PMID:21346803
1313372	CLCN6	Cl-/H+ antiporter 6	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305379	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CLCN6 mRNA	PMID:21346803
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:10110	zidovudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in decreased expression of RBL1 mRNA	PMID:15784690
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:132098	methoxyacetic acid	multiple interactions	ISO	RGD:1595511	E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased phosphorylation of and results in decreased expression of RBL1 protein	PMID:11313878
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RBL1 mRNA	PMID:33167477
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of RBL1 protein	PMID:15231690
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RBL1 mRNA	PMID:26079696
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:15930	atrazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001280	[Atrazine co-treated with Arsenates] results in increased expression of RBL1 mRNA	PMID:18585445
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:16240	hydrogen peroxide	decreases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein	PMID:12621062
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	calyculin A inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein]; Okadaic Acid inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein]	PMID:12621062
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of RBL1 mRNA	PMID:23727915
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1313375	E	RGD:6480464	20150714	CTD	MESH:D011794	Quercetin results in increased expression of RBL1 mRNA	PMID:25862958
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313375	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RBL1 mRNA	PMID:10975854|PMID:39241906
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of RBL1 mRNA	PMID:24758408
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein inhibits the reaction [Estradiol results in increased expression of RBL1 mRNA]	PMID:24758408
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RBL1 mRNA	PMID:25510870
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of RBL1 mRNA	PMID:34673133
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:16899	D-mannitol	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in decreased expression of RBL1 mRNA	PMID:25270620
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RBL1 mRNA	PMID:37992649
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of RBL1 mRNA	PMID:21592394
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of RBL1 mRNA	PMID:21592394
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RBL1 mRNA	PMID:37992649
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [RBL1 protein binds to CDC25A promoter]; Nicotine inhibits the reaction [RBL1 protein binds to CDC6 promoter]	PMID:16862215
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313375	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RBL1 mRNA	PMID:34319233
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of RBL1 protein	PMID:37730182
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of RBL1 mRNA	PMID:21592394
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of RBL1 mRNA	PMID:21592394
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1595511	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RBL1 mRNA	PMID:33387578
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [RBL1 protein binds to CDC25A promoter]; Nicotine inhibits the reaction [RBL1 protein binds to CDC6 promoter]	PMID:16862215
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RBL1 mRNA	PMID:25510870
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RBL1 mRNA	PMID:25510870
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RBL1 mRNA	PMID:19549813
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RBL1 mRNA	PMID:19770486
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D009151	Mustard Gas results in decreased expression of RBL1 mRNA	PMID:33491125
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of RBL1 mRNA	PMID:15674843
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1595511	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of RBL1 mRNA	PMID:41580963
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RBL1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of RBL1 mRNA	PMID:34911549
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1595511	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of RBL1 mRNA	PMID:30779732
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RBL1 mRNA; Carbon Tetrachloride results in increased expression of RBL1 protein	PMID:19887370|PMID:31919559
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RBL1 mRNA	PMID:25629700
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:27470	folic acid	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of RBL1 mRNA	PMID:21867686
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RBL1 mRNA	PMID:22206623
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20191105	CTD	MESH:D000968	Antimycin A results in decreased expression of RBL1 mRNA	PMID:19304788
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:27641	cycloheximide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D003513	Cycloheximide results in decreased expression of RBL1 protein	PMID:20100483
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA]; palbociclib promotes the reaction [Cycloheximide results in decreased expression of RBL1 protein]; RB1 protein affects the reaction [palbociclib promotes the reaction [Cycloheximide results in decreased expression of RBL1 protein]]	PMID:11007951|PMID:20100483
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:27656	camptothecin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002166	Camptothecin results in decreased expression of RBL1 protein	PMID:15585644
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of RBL1 protein	PMID:35688186
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of RBL1 mRNA	PMID:31295307
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1595511	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RBL1 mRNA	PMID:31881176
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1595511	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of RBL1 gene	PMID:28505145
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313375	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RBL1 mRNA	PMID:21570461
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RBL1 mRNA	PMID:23152189
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1595511	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RBL1 mRNA	PMID:32109520|PMID:33387578
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA	PMID:11007951
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA	PMID:15667827
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RBL1 mRNA]	PMID:11007951
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of RBL1 mRNA	PMID:19304788
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1595511	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of RBL1 mRNA	PMID:28374803
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RBL1 mRNA	PMID:28001369
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RBL1 mRNA	PMID:33212167
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of RBL1 mRNA	PMID:23649840
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of RBL1 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of RBL1 mRNA	PMID:20971185|PMID:30911355
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of RBL1 protein	PMID:16537896
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RBL1 mRNA	PMID:37992649
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RBL1 mRNA	PMID:38568856
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313375	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of RBL1 mRNA	PMID:16014739
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RBL1 mRNA	PMID:19770486
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RBL1 mRNA	PMID:32234424|PMID:33411230
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RBL1 promoter	PMID:27901495
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of RBL1 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of RBL1 mRNA	PMID:20971185|PMID:30911355
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of RBL1 mRNA	PMID:25895662
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RBL1 mRNA	PMID:20382639
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:30621	diarsenic trioxide	decreases methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased methylation of RBL1 promoter	PMID:29159499
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1595511	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of RBL1 mRNA	PMID:25729387
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1595511	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RBL1 mRNA	PMID:25729387
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:32130	silver(1+) nitrate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in increased expression of RBL1 mRNA; Silver Nitrate results in increased expression of RBL1 mRNA	PMID:22831968
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313375	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RBL1 promoter	PMID:35295148
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1595511	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RBL1 mRNA	PMID:23411599|PMID:34492290
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RBL1 mRNA	PMID:17950772|PMID:20813756
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of RBL1 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of RBL1 mRNA]	PMID:17950772|PMID:20813756
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1313375	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of RBL1 mRNA	PMID:19191707
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RBL1 mRNA	PMID:29275510
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1595511	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RBL1 mRNA	PMID:25181051
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RBL1 protein	PMID:32981897
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1595511	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of RBL1 mRNA	PMID:32145629
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1595511	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of RBL1 gene	PMID:28505145
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313375	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of RBL1 mRNA	PMID:26682919
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RBL1 mRNA	PMID:25510870
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RBL1 mRNA	PMID:25510870
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C005290	oxybenzone results in increased expression of RBL1 mRNA	PMID:36581016
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RBL1 mRNA	PMID:20350560
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RBL1 mRNA	PMID:17361019|PMID:21266533
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313375	E	RGD:6480464	20120613	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of RBL1 mRNA; Diethylnitrosamine results in increased expression of RBL1 protein	PMID:17854601|PMID:19887370
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RBL1 mRNA; RB1 protein affects the reaction [Diethylnitrosamine results in increased expression of RBL1 protein]; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of RBL1 mRNA]; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of RBL1 protein]	PMID:17854601|PMID:19887370|PMID:24535843
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RBL1 mRNA	PMID:37042841
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RBL1 mRNA	PMID:38174414
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1595511	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased expression of RBL1 mRNA	PMID:22079235
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20140311	CTD	MESH:D011285	[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Pregnenolone Carbonitrile] results in increased expression of RBL1 mRNA	PMID:23626729
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RBL1 mRNA	PMID:19320972|PMID:19376846
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RBL1 mRNA	PMID:24449571
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RBL1 mRNA	PMID:40194260
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RBL1 mRNA	PMID:31533062
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of RBL1 mRNA	PMID:39529242
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of RBL1 mRNA	PMID:23125180
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RBL1 mRNA	PMID:17963808
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of RBL1 mRNA	PMID:28001369
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RBL1 mRNA	PMID:17183730
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:41774	tamoxifen	increases phosphorylation	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased phosphorylation of RBL1 protein	PMID:15642790
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:41791	calyculin A	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C059041	calyculin A inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein]	PMID:12621062
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RBL1 mRNA	PMID:37992649
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of RBL1 mRNA	PMID:23649840
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of RBL1 mRNA	PMID:24449571
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:44658	okadaic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019319	Okadaic Acid inhibits the reaction [Hydrogen Peroxide results in decreased phosphorylation of RBL1 protein]	PMID:12621062
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:45409	ritonavir	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019438	Ritonavir results in increased expression of RBL1 mRNA	PMID:19386116
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RBL1 mRNA	PMID:22230336
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1595511	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RBL1 mRNA	PMID:33387578
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:47344	alvocidib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C077990	alvocidib results in decreased expression of RBL1 protein	PMID:9829756
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:49900	arsenous acid	decreases methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased methylation of RBL1 promoter	PMID:29159499
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of RBL1 mRNA	PMID:27915011
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313375	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RBL1 mRNA; Nanotubes, Carbon results in increased expression of RBL1 mRNA	PMID:25554681
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:D010081	Oxazolone results in increased expression of RBL1 mRNA	PMID:11379042
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of RBL1 mRNA	PMID:11379042
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RBL1 mRNA	PMID:17183730
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:63577	lamivudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in decreased expression of RBL1 mRNA	PMID:15784690
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBL1 mRNA	PMID:21641980
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1595511	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RBL1 mRNA	PMID:25729387
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:6382	Lasiocarpine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RBL1 mRNA	PMID:33884520
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:63924	riddelliine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RBL1 mRNA	PMID:33884520
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:6456	lidocaine	affects expression	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:D008012	Lidocaine affects the expression of RBL1 mRNA	PMID:18931217
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1595511	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of RBL1 mRNA	PMID:35283115
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:65329	LY294002	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of RBL1 protein	PMID:15601625
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D002185	Cannabidiol results in decreased expression of RBL1 mRNA	PMID:36519830
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:6980	monocrotaline	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of RBL1 mRNA	PMID:33884520
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RBL1 mRNA	PMID:22206623
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RBL1 mRNA	PMID:22206623
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of RBL1 protein	PMID:20100483
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases ubiquitination	EXP		E	RGD:6480464	20150414	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of RBL1 protein	PMID:20100483
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [palbociclib results in decreased expression of RBL1 protein]; palbociclib promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of RBL1 protein]	PMID:20100483
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of RBL1 mRNA	PMID:29522793
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RBL1 gene]	PMID:28238834
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:79995	GW 3965	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C473027	GW 3965 results in decreased expression of RBL1 mRNA	PMID:31437187
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of RBL1 mRNA; Irinotecan results in decreased expression of RBL1 mRNA	PMID:15956246
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313375	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of RBL1 mRNA	PMID:23091169
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of RBL1 mRNA	PMID:19482888
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313375	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RBL1 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RBL1 mRNA]	PMID:19482888|PMID:24535843
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1595511	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RBL1 mRNA	PMID:24780913
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:85993	palbociclib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of RBL1 mRNA; palbociclib results in decreased expression of RBL1 protein	PMID:20100483|PMID:20473330
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:85993	palbociclib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [palbociclib results in decreased expression of RBL1 protein]; palbociclib inhibits the reaction [RBL1 protein binds to CCNA2 promoter]; palbociclib inhibits the reaction [RBL1 protein binds to PLK1 promoter]; palbociclib inhibits the reaction [RBL1 protein binds to RNR2 promoter]; palbociclib promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of RBL1 protein]; palbociclib promotes the reaction [Cycloheximide results in decreased expression of RBL1 protein]; palbociclib results in decreased phosphorylation of and results in decreased expression of RBL1 protein; RB1 protein affects the reaction [palbociclib inhibits the reaction [RBL1 protein binds to CCNA2 promoter]]; RB1 protein affects the reaction [palbociclib inhibits the reaction [RBL1 protein binds to PLK1 promoter]]; RB1 protein affects the reaction [palbociclib inhibits the reaction [RBL1 protein binds to RNR2 promoter]]; RB1 protein affects the reaction [palbociclib promotes the reaction [Cycloheximide results in decreased expression of RBL1 protein]]; RB1 protein affects the reaction [palbociclib results in decreased expression of RBL1 protein]	PMID:20100483
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:8772	raloxifene	decreases phosphorylation	EXP		E	RGD:6480464	20230801	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased phosphorylation of RBL1 protein	PMID:26660119
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	[TGFB1 protein co-treated with Sirolimus] inhibits the reaction [[E2F4 protein binds to RBL1 protein] which binds to CDK2 protein]	PMID:12417722
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of RBL1 mRNA	PMID:29301935
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of RBL1 mRNA	PMID:19140230
1313374	RBL1	RB transcriptional corepressor like 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313375	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of RBL1 mRNA	PMID:35537566
1313376	RELT	RELT TNF receptor	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313377	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RELT mRNA	PMID:33045310
1313376	RELT	RELT TNF receptor	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RELT gene	PMID:20938992
1313376	RELT	RELT TNF receptor	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RELT mRNA	PMID:33167477
1313376	RELT	RELT TNF receptor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313377	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RELT mRNA	PMID:39241906
1313376	RELT	RELT TNF receptor	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of RELT mRNA	PMID:23019147|PMID:31614463
1313376	RELT	RELT TNF receptor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305381	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RELT mRNA	PMID:32741896
1313376	RELT	RELT TNF receptor	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305381	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RELT mRNA	PMID:33387578
1313376	RELT	RELT TNF receptor	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RELT gene	PMID:20938992
1313376	RELT	RELT TNF receptor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RELT mRNA	PMID:37042841
1313376	RELT	RELT TNF receptor	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RELT mRNA	PMID:37992649
1313376	RELT	RELT TNF receptor	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305381	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RELT mRNA	PMID:32741896
1313376	RELT	RELT TNF receptor	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of RELT mRNA	PMID:33647349
1313376	RELT	RELT TNF receptor	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RELT mRNA	PMID:37992649
1313376	RELT	RELT TNF receptor	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305381	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RELT mRNA	PMID:27523638
1313376	RELT	RELT TNF receptor	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RELT protein	PMID:37730182
1313376	RELT	RELT TNF receptor	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305381	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RELT mRNA	PMID:33387578
1313376	RELT	RELT TNF receptor	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RELT mRNA	PMID:28818685
1313376	RELT	RELT TNF receptor	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of RELT intron	PMID:30157460
1313376	RELT	RELT TNF receptor	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased expression of RELT mRNA	PMID:22562489
1313376	RELT	RELT TNF receptor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RELT mRNA	PMID:37325564
1313376	RELT	RELT TNF receptor	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RELT mRNA	PMID:19549813
1313376	RELT	RELT TNF receptor	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RELT mRNA	PMID:22100608
1313376	RELT	RELT TNF receptor	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RELT intron	PMID:30157460
1313376	RELT	RELT TNF receptor	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of RELT mRNA	PMID:35430440
1313376	RELT	RELT TNF receptor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RELT gene	PMID:20938992
1313376	RELT	RELT TNF receptor	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RELT mRNA	PMID:39836092
1313376	RELT	RELT TNF receptor	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305381	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RELT mRNA	PMID:31881176
1313376	RELT	RELT TNF receptor	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RELT mRNA	PMID:24768652|PMID:25583101
1313376	RELT	RELT TNF receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313377	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RELT mRNA	PMID:21570461
1313376	RELT	RELT TNF receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305381	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RELT mRNA	PMID:33387578
1313376	RELT	RELT TNF receptor	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RELT mRNA	PMID:28001369
1313376	RELT	RELT TNF receptor	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RELT mRNA	PMID:33212167
1313376	RELT	RELT TNF receptor	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305381	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of RELT mRNA	PMID:28959563
1313376	RELT	RELT TNF receptor	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RELT mRNA	PMID:29803840
1313376	RELT	RELT TNF receptor	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RELT mRNA	PMID:37992649
1313376	RELT	RELT TNF receptor	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of RELT mRNA	PMID:34032870
1313376	RELT	RELT TNF receptor	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RELT mRNA	PMID:38568856
1313376	RELT	RELT TNF receptor	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RELT mRNA	PMID:39836092
1313376	RELT	RELT TNF receptor	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RELT 5' UTR	PMID:27901495
1313376	RELT	RELT TNF receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RELT mRNA	PMID:26238291|PMID:32234424
1313376	RELT	RELT TNF receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313377	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RELT mRNA	PMID:22228805
1313376	RELT	RELT TNF receptor	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to RELT promoter]	PMID:19654925
1313376	RELT	RELT TNF receptor	gene	CHEBI:3000	beauvericin	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C004456	beauvericin results in decreased expression of RELT mRNA	PMID:29203277
1313376	RELT	RELT TNF receptor	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313377	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RELT mRNA	PMID:27131904
1313376	RELT	RELT TNF receptor	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305381	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RELT mRNA	PMID:34492290
1313376	RELT	RELT TNF receptor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RELT mRNA	PMID:29275510
1313376	RELT	RELT TNF receptor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305381	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RELT mRNA	PMID:25181051
1313376	RELT	RELT TNF receptor	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313377	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of RELT promoter	PMID:27312807
1313376	RELT	RELT TNF receptor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305381	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RELT mRNA	PMID:34947998
1313376	RELT	RELT TNF receptor	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RELT mRNA	PMID:37042841
1313376	RELT	RELT TNF receptor	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305381	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of RELT mRNA	PMID:35163327
1313376	RELT	RELT TNF receptor	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305381	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RELT mRNA	PMID:35163327
1313376	RELT	RELT TNF receptor	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RELT mRNA	PMID:38568856
1313376	RELT	RELT TNF receptor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RELT mRNA	PMID:37325564
1313376	RELT	RELT TNF receptor	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305381	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of RELT mRNA	PMID:35163327
1313376	RELT	RELT TNF receptor	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305381	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RELT mRNA	PMID:35163327
1313376	RELT	RELT TNF receptor	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RELT mRNA	PMID:24449571
1313376	RELT	RELT TNF receptor	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RELT mRNA	PMID:31533062
1313376	RELT	RELT TNF receptor	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RELT mRNA	PMID:25562108
1313376	RELT	RELT TNF receptor	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313377	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RELT mRNA	PMID:37992649
1313376	RELT	RELT TNF receptor	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313377	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of RELT mRNA	PMID:18502557
1313376	RELT	RELT TNF receptor	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RELT mRNA	PMID:38832940
1313376	RELT	RELT TNF receptor	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of RELT mRNA	PMID:29067470
1313376	RELT	RELT TNF receptor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305381	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RELT mRNA	PMID:33387578
1313376	RELT	RELT TNF receptor	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RELT mRNA	PMID:39836092
1313376	RELT	RELT TNF receptor	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of RELT mRNA	PMID:18175754
1313376	RELT	RELT TNF receptor	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313377	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RELT mRNA	PMID:38701926
1313376	RELT	RELT TNF receptor	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305381	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RELT gene	PMID:35440735
1313376	RELT	RELT TNF receptor	gene	CHEBI:754906	afuresertib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of RELT mRNA	PMID:28960945
1313376	RELT	RELT TNF receptor	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305381	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RELT mRNA	PMID:32741896
1313376	RELT	RELT TNF receptor	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313377	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of RELT mRNA	PMID:39847705
1313376	RELT	RELT TNF receptor	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305381	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RELT mRNA	PMID:24780913
1313376	RELT	RELT TNF receptor	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313377	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RELT mRNA	PMID:27131904
1313376	RELT	RELT TNF receptor	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305381	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RELT mRNA	PMID:19281266
1313376	RELT	RELT TNF receptor	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RELT mRNA	PMID:38568856
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of UBE2C mRNA	PMID:31863870
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of UBE2C mRNA	PMID:38218311
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313379	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of UBE2C mRNA	PMID:33045310
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2C mRNA	PMID:39752319
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of UBE2C mRNA	PMID:20938992
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of UBE2C mRNA	PMID:21934132
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D010100	Oxygen results in decreased expression of UBE2C mRNA	PMID:27103661
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:16170	mercury(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of UBE2C mRNA	PMID:17547211
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of UBE2C mRNA	PMID:12414654
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of UBE2C mRNA	PMID:35877022
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in increased expression of UBE2C mRNA]	PMID:19442820
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of UBE2C mRNA	PMID:16474171
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of UBE2C mRNA	PMID:20826375|PMID:27623287
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305382	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBE2C mRNA	PMID:32741896
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UBE2C mRNA	PMID:25510870
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of UBE2C mRNA	PMID:38568856
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of UBE2C mRNA	PMID:33387578
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of UBE2C mRNA	PMID:25549359
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of UBE2C mRNA	PMID:20938992
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:16827	corticosterone	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20120412	CTD	MESH:D003345	Corticosterone results in decreased expression of UBE2C mRNA	PMID:15755911
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of UBE2C mRNA	PMID:21179406
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of UBE2C mRNA	PMID:26079696
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UBE2C mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA	PMID:37567420|PMID:37992649
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2C mRNA	PMID:39752319
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of UBE2C mRNA	PMID:21592394
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of UBE2C mRNA	PMID:21592394
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305382	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBE2C mRNA	PMID:32741896
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1305382	E	RGD:6480464	20130312	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of UBE2C mRNA	PMID:22584684
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of UBE2C mRNA	PMID:17317680
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17356	2-acetamidofluorene	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D015073	TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of UBE2C mRNA]	PMID:17317680
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in increased expression of UBE2C mRNA]	PMID:19442820
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of UBE2C mRNA	PMID:27683099
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:174627	2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C088115	anacardic acid inhibits the reaction [[Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein]	PMID:27129209
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:175901	gemcitabine	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in decreased expression of UBE2C mRNA	PMID:17039268
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UBE2C mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA	PMID:37567420|PMID:37992649
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of UBE2C mRNA	PMID:16949557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of UBE2C mRNA	PMID:23825647
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Tubocurarine inhibits the reaction [Nicotine results in decreased expression of UBE2C mRNA]	PMID:16949557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1305382	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of UBE2C mRNA	PMID:33789034
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305382	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of UBE2C mRNA	PMID:26577399
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of UBE2C mRNA	PMID:21592394
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of UBE2C mRNA	PMID:21592394
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of UBE2C mRNA	PMID:22061828
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:17924	D-glucitol	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20240305	CTD	MESH:D013012	Sorbitol results in decreased expression of UBE2C mRNA	PMID:35678645
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of UBE2C mRNA	PMID:36331819
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305382	E	RGD:6480464	20241001	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of UBE2C mRNA	PMID:38301995
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of UBE2C mRNA	PMID:16949557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of UBE2C mRNA	PMID:23825647
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Tubocurarine inhibits the reaction [Nicotine results in decreased expression of UBE2C mRNA]	PMID:16949557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:2038	5-azacytidine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001374	[Azacitidine co-treated with Thalidomide] affects the expression of UBE2C mRNA	PMID:18720364
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of UBE2C mRNA	PMID:21120746
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UBE2C mRNA	PMID:25510870
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UBE2C mRNA	PMID:25510870
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of UBE2C mRNA	PMID:19549813
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305382	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UBE2C mRNA	PMID:22129741
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305382	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of UBE2C mRNA	PMID:23630614|PMID:25378103
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:25195	mercury atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of UBE2C mRNA	PMID:17547211
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of UBE2C mRNA	PMID:25102026
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of UBE2C mRNA	PMID:32553695
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of UBE2C mRNA	PMID:19555225
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of UBE2C mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of UBE2C mRNA	PMID:27106289|PMID:34911549
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:2687	amsacrine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D000677	Amsacrine results in decreased expression of UBE2C mRNA	PMID:17374387
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of UBE2C mRNA	PMID:22171008
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of UBE2C mRNA	PMID:17484886
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of UBE2C mRNA	PMID:31150632
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313379	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBE2C mRNA	PMID:27339419|PMID:29987408
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of UBE2C mRNA	PMID:25629700
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D005492	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of UBE2C mRNA	PMID:24657277
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of UBE2C mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of UBE2C mRNA]	PMID:20938992|PMID:22206623
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2C mRNA	PMID:39836092
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000966	Antimony Potassium Tartrate results in increased expression of UBE2C mRNA	PMID:17547211
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of UBE2C mRNA	PMID:33512557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA	PMID:37567420
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of UBE2C mRNA	PMID:28189721|PMID:28960355
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305382	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of UBE2C mRNA	PMID:31881176
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of UBE2C mRNA	PMID:27392435|PMID:27594783
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of UBE2C mRNA	PMID:22023808
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of UBE2C mRNA	PMID:40618947
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of UBE2C mRNA	PMID:21151649
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28073	chromium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002857	Chromium results in increased expression of UBE2C mRNA	PMID:17547211
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28088	genistein	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein affects the expression of UBE2C mRNA alternative form	PMID:18847459
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of UBE2C mRNA	PMID:16474171
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2C mRNA	PMID:22298810
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305382	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2C mRNA	PMID:34747641
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313379	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE2C mRNA	PMID:21570461
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBE2C mRNA	PMID:21802500
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBE2C mRNA	PMID:32109520|PMID:33387578
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBE2C mRNA	PMID:15034205
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBE2C mRNA	PMID:20106945|PMID:21496263
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305382	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBE2C mRNA	PMID:21215274
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313379	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBE2C mRNA	PMID:21496263|PMID:26290441
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2C mRNA; AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of UBE2C mRNA]	PMID:15034205|PMID:17942748
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of UBE2C mRNA	PMID:28374803
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of UBE2C mRNA	PMID:33512557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of UBE2C mRNA	PMID:20061341
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of UBE2C mRNA	PMID:24834073
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of UBE2C mRNA	PMID:23649840
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003561	Cytarabine results in decreased expression of UBE2C mRNA	PMID:17374387
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305382	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of UBE2C mRNA	PMID:30556269
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of UBE2C mRNA	PMID:20971185
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D004317	Doxorubicin results in decreased expression of UBE2C mRNA; Doxorubicin results in decreased expression of UBE2C protein	PMID:27129209|PMID:29803840|PMID:38447685
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of UBE2C mRNA	PMID:39631538
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D004317	[Doxorubicin results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein; TP53 protein inhibits the reaction [Doxorubicin results in decreased expression of UBE2C protein]	PMID:27129209
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UBE2C mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA	PMID:37567420|PMID:37992649
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:28869	menadione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of UBE2C mRNA	PMID:12414654
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of UBE2C mRNA	PMID:22623647
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of UBE2C mRNA	PMID:38568856
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of UBE2C mRNA	PMID:17998272
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2C mRNA; TP53 protein affects the reaction [sodium arsenite results in increased expression of UBE2C mRNA]	PMID:16966095|PMID:39836092
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of UBE2C mRNA	PMID:22378314
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of UBE2C mRNA	PMID:20064835|PMID:21802500
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of UBE2C mRNA	PMID:15034205
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBE2C mRNA	PMID:32417428|PMID:35678645
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of UBE2C mRNA]	PMID:15034205
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of UBE2C mRNA	PMID:18929588
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to UBE2C mRNA]	PMID:32406909
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in decreased expression of UBE2C mRNA]	PMID:18929588
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305382	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of UBE2C mRNA	PMID:30556269
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of UBE2C mRNA	PMID:20971185
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:30145	lithium atom	increases expression	ISO	RGD:1305382	E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in increased expression of UBE2C mRNA	PMID:21711903
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:30146	lithium hydride	increases expression	ISO	RGD:1305382	E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in increased expression of UBE2C mRNA	PMID:21711903
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of UBE2C mRNA	PMID:22171008
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:30304	antimony(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000965	Antimony results in increased expression of UBE2C mRNA	PMID:17547211
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313379	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of UBE2C mRNA	PMID:29341224
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of UBE2C mRNA	PMID:20382639|PMID:26238291
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of UBE2C mRNA	PMID:17547211
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:3090	bicalutamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C053541	[Niclosamide co-treated with bicalutamide] results in decreased expression of UBE2C mRNA	PMID:28500234
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305382	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of UBE2C mRNA	PMID:25729387
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305382	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of UBE2C mRNA	PMID:30047161
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of UBE2C mRNA	PMID:24136188
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313379	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBE2C promoter	PMID:35295148
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1305382	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of UBE2C mRNA	PMID:30012374
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313379	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of UBE2C mRNA	PMID:23557971
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313379	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of UBE2C promoter	PMID:35295148
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305382	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of UBE2C mRNA	PMID:34492290
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313379	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of UBE2C mRNA	PMID:18301758|PMID:21318169|PMID:23811191
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of UBE2C mRNA]	PMID:21318169
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of UBE2C mRNA	PMID:19191707
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of UBE2C mRNA	PMID:38479592
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of UBE2C mRNA	PMID:19490990|PMID:30903817
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2C mRNA; bisphenol A results in decreased expression of UBE2C protein	PMID:29275510|PMID:37567409
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE2C mRNA	PMID:25181051
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of UBE2C mRNA	PMID:16474171
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of UBE2C mRNA	PMID:20826375
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of UBE2C mRNA	PMID:20826375
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of UBE2C mRNA	PMID:26682919
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UBE2C mRNA	PMID:25510870
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UBE2C mRNA	PMID:25510870
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of UBE2C mRNA	PMID:20713471
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of UBE2C mRNA	PMID:20713471
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of UBE2C mRNA	PMID:39298647
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in increased expression of UBE2C mRNA	PMID:27685785
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of UBE2C mRNA	PMID:26377693
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305382	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of UBE2C mRNA	PMID:22546817
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34687	dibutyl phthalate	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of UBE2C mRNA	PMID:28973377
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305382	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of UBE2C mRNA	PMID:22546817
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305382	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UBE2C mRNA	PMID:22129741
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of UBE2C mRNA	PMID:24535843
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C022838	nickel chloride results in increased expression of UBE2C mRNA	PMID:17547211
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBE2C mRNA	PMID:37042841
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of UBE2C mRNA	PMID:26377693
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of UBE2C mRNA	PMID:18500788
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305382	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of UBE2C mRNA	PMID:30723492
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of UBE2C mRNA	PMID:25993096
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of UBE2C mRNA	PMID:20061341
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBE2C protein	PMID:26220685
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35459	diisononyl phthalate	increases expression	ISO	RGD:1313379	E	RGD:6480464	20250204	CTD	MESH:C012125	diisononyl phthalate results in increased expression of UBE2C mRNA	PMID:33391822
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of UBE2C mRNA	PMID:36326898
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313379	E	RGD:6480464	20240305	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of UBE2C mRNA	PMID:35678645
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305382	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of UBE2C mRNA	PMID:25539665
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305382	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of UBE2C mRNA	PMID:30047161
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313379	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of UBE2C mRNA	PMID:22698814
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of UBE2C mRNA	PMID:19320972
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of UBE2C mRNA	PMID:24386269
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of UBE2C mRNA	PMID:40194260
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of UBE2C mRNA	PMID:33512557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of UBE2C mRNA	PMID:31533062
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of UBE2C mRNA	PMID:39529242
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of UBE2C mRNA	PMID:36331819
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1313379	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of UBE2C mRNA	PMID:23125180
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of UBE2C mRNA	PMID:31558096
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D003474	Curcumin results in decreased expression of UBE2C mRNA; Curcumin results in decreased expression of UBE2C protein	PMID:22258452|PMID:38348716
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of UBE2C mRNA	PMID:41580965
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305382	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of UBE2C mRNA	PMID:30047161
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of UBE2C mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:40909	azoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of UBE2C mRNA	PMID:33512557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of UBE2C mRNA	PMID:17555576
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1305382	E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of UBE2C mRNA	PMID:21658437
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in decreased expression of UBE2C mRNA	PMID:16671099
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of UBE2C mRNA	PMID:28973697
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in increased expression of UBE2C mRNA	PMID:16570282
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313379	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of UBE2C mRNA	PMID:28973697
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UBE2C mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA	PMID:37567420|PMID:37992649
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of UBE2C mRNA	PMID:33512557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of UBE2C mRNA	PMID:23649840
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in decreased expression of UBE2C mRNA	PMID:17374387
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20160412	CTD	MESH:D008727	Methotrexate results in decreased expression of UBE2C mRNA	PMID:24136188
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:44185	methotrexate	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of UBE2C mRNA	PMID:24657277
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:44423	hydroxyurea	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in decreased expression of UBE2C mRNA	PMID:17374387
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of UBE2C mRNA	PMID:24136188
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of UBE2C mRNA	PMID:33387578
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of UBE2C mRNA	PMID:22230336
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of UBE2C mRNA; Fluorouracil results in decreased expression of UBE2C protein	PMID:16557594|PMID:17039268|PMID:17374387|PMID:27129209
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D005472	[Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein; anacardic acid inhibits the reaction [[Fluorouracil results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein]; CDKN1A protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; CDKN1A protein affects the reaction [Fluorouracil results in decreased expression of UBE2C protein]; Fluorouracil inhibits the reaction [NFYA protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [EP300 protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]; Fluorouracil promotes the reaction [TP53 protein mutant form binds to UBE2C promoter]; TP53 protein affects the reaction [Fluorouracil promotes the reaction [E2F4 protein binds to UBE2C promoter]]; TP53 protein affects the reaction [Fluorouracil results in decreased expression of UBE2C mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of UBE2C mRNA]; TP53 protein inhibits the reaction [Fluorouracil results in decreased expression of UBE2C protein]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYA protein binds to UBE2C promoter]]; TP53 protein mutant form affects the reaction [Fluorouracil promotes the reaction [NFYB protein binds to UBE2C promoter]]	PMID:27129209
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of UBE2C mRNA	PMID:24714768
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE2C mRNA	PMID:39836092
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in decreased expression of UBE2C mRNA	PMID:18175754|PMID:24383545
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of UBE2C mRNA	PMID:17555576
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UBE2C mRNA	PMID:17942748
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBE2C mRNA	PMID:17942748
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:4911	etoposide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in decreased expression of UBE2C mRNA; Etoposide results in decreased expression of UBE2C protein	PMID:17374387|PMID:27129209
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:4911	etoposide	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D005047	[Etoposide results in increased acetylation of TP53 protein mutant form] which results in increased expression of UBE2C protein; CDKN1A protein affects the reaction [Etoposide results in decreased expression of UBE2C protein]; TP53 protein affects the reaction [Etoposide results in decreased expression of UBE2C mRNA]; TP53 protein inhibits the reaction [Etoposide results in decreased expression of UBE2C protein]	PMID:27129209
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of UBE2C mRNA	PMID:17547211
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1313379	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of UBE2C mRNA	PMID:25270620
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:5011	fenpyroximate	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of UBE2C mRNA	PMID:33512557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313379	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of UBE2C mRNA; Nanotubes, Carbon results in increased expression of UBE2C mRNA	PMID:25554681
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305382	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of UBE2C mRNA	PMID:30047161
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20140513	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of UBE2C mRNA	PMID:24140754
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of UBE2C mRNA	PMID:19042947
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011192	Potassium Dichromate results in increased expression of UBE2C mRNA	PMID:17547211
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313379	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of UBE2C mRNA	PMID:38701926
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UBE2C protein	PMID:32959892
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of UBE2C mRNA	PMID:25729387
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305382	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of UBE2C mRNA	PMID:25729387
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of UBE2C mRNA	PMID:24136188
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of UBE2C mRNA	PMID:23650126
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of UBE2C mRNA	PMID:28988120
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of UBE2C mRNA	PMID:24136188
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of UBE2C mRNA	PMID:12414654
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of UBE2C mRNA	PMID:24810058
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of UBE2C mRNA	PMID:37269647
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of UBE2C mRNA	PMID:17547211
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305382	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of UBE2C mRNA	PMID:35283115
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of UBE2C mRNA	PMID:37939859
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20170725	CTD	MESH:D008694	Methamphetamine results in decreased expression of UBE2C mRNA	PMID:28341135
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305382	E	RGD:6480464	20130312	CTD	MESH:D008701	Methapyrilene results in increased expression of UBE2C mRNA	PMID:22484513|PMID:22584684
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:68534	enzalutamide	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:C540278	[enzalutamide co-treated with NVP-BHG712] results in decreased expression of UBE2C mRNA	PMID:32184358
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2C mRNA	PMID:39752319
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313379	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of UBE2C mRNA	PMID:22206623
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of UBE2C mRNA]	PMID:22206623
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of UBE2C protein	PMID:37664457
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:749016	gossypol acetic acid	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of UBE2C protein	PMID:29938581
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of UBE2C mRNA	PMID:20061341
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of UBE2C mRNA	PMID:27225895
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1313379	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of UBE2C mRNA	PMID:27225895
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of UBE2C mRNA	PMID:29522793
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of UBE2C mRNA	PMID:37567420
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1313379	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of UBE2C mRNA	PMID:27858113
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of UBE2C mRNA	PMID:28500234
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:7553	niclosamide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	[Niclosamide co-treated with bicalutamide] results in decreased expression of UBE2C mRNA	PMID:28500234
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1305382	E	RGD:6480464	20190219	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of UBE2C mRNA	PMID:29877212
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305382	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of UBE2C mRNA	PMID:32741896
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of UBE2C mRNA	PMID:32858204
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305382	E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in increased expression of UBE2C mRNA	PMID:23358140|PMID:38301995
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of UBE2C mRNA	PMID:34995734
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of UBE2C mRNA; Irinotecan results in decreased expression of UBE2C mRNA	PMID:15956246
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in decreased expression of UBE2C mRNA	PMID:20097248
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:8064	phenformin	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of UBE2C mRNA	PMID:31324951
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313379	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of UBE2C mRNA	PMID:19363144|PMID:19482888|PMID:20403969|PMID:23091169
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of UBE2C mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of UBE2C mRNA]	PMID:19482888|PMID:24535843
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313379	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of UBE2C mRNA	PMID:38648751
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of UBE2C mRNA	PMID:33512557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of UBE2C mRNA	PMID:24834073
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of UBE2C mRNA	PMID:33512557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313379	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of UBE2C mRNA	PMID:39847705
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313379	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of UBE2C mRNA	PMID:21278054
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305382	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of UBE2C mRNA	PMID:24780913|PMID:30047161
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:85993	palbociclib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of UBE2C mRNA	PMID:22869556
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313379	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of UBE2C mRNA	PMID:39752319
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of UBE2C protein	PMID:37664457
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305382	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of UBE2C mRNA	PMID:19281266
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of UBE2C mRNA	PMID:33512557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:9513	thalidomide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013792	[Azacitidine co-treated with Thalidomide] affects the expression of UBE2C mRNA	PMID:18720364
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019284	Thapsigargin results in increased expression of UBE2C mRNA	PMID:19442820
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:9516	thapsigargin	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019284	caffeic acid promotes the reaction [Thapsigargin results in increased expression of UBE2C mRNA]; Drugs, Chinese Herbal promotes the reaction [Thapsigargin results in increased expression of UBE2C mRNA]	PMID:19442820
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of UBE2C mRNA	PMID:19140230
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1305382	E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of UBE2C mRNA	PMID:24136188
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:9774	tubocurarine	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014403	Tubocurarine results in decreased expression of UBE2C mRNA	PMID:16949557
1313378	UBE2C	ubiquitin conjugating enzyme E2 C	gene	CHEBI:9774	tubocurarine	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D014403	Tubocurarine inhibits the reaction [Nicotine results in decreased expression of UBE2C mRNA]	PMID:16949557
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ARHGDIB mRNA	PMID:38218311
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ARHGDIB mRNA	PMID:35967413
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305383	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of ARHGDIB mRNA	PMID:21551480
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ARHGDIB mRNA	PMID:27188386
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of ARHGDIB mRNA	PMID:17218384|PMID:23830798|PMID:33167477
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ARHGDIB mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ARHGDIB mRNA	PMID:32699268
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:15555	prostaglandin D2	increases cleavage	EXP		E	RGD:6480464	20120412	CTD	MESH:D015230	Prostaglandin D2 results in increased cleavage of ARHGDIB protein	PMID:15843042
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of ARHGDIB mRNA	PMID:15282401
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ARHGDIB mRNA	PMID:26079696
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:16240	hydrogen peroxide	increases cleavage	ISO	RGD:1305383	E	RGD:6480464	20161213	CTD	MESH:D006861	Hydrogen Peroxide results in increased cleavage of ARHGDIB protein	PMID:16647178
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1305383	E	RGD:6480464	20161213	CTD	MESH:D006861	Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of ARHGDIB protein]	PMID:16647178
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:16243	quercetin	increases cleavage	EXP		E	RGD:6480464	20170110	CTD	MESH:D011794	Quercetin results in increased cleavage of ARHGDIB protein	PMID:12874837
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ARHGDIB mRNA	PMID:21632981
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	[Quercetin co-treated with Ascorbic Acid] results in increased expression of ARHGDIB mRNA	PMID:17639512
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1305383	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin inhibits the reaction [Hydrogen Peroxide results in increased cleavage of ARHGDIB protein]	PMID:16647178
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313381	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ARHGDIB mRNA	PMID:27339419|PMID:39241906
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ARHGDIB mRNA	PMID:30510588
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol affects the expression of ARHGDIB mRNA	PMID:25321415
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ARHGDIB mRNA	PMID:39298647
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of ARHGDIB mRNA	PMID:29980752
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ARHGDIB mRNA	PMID:23649840
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ARHGDIB mRNA	PMID:26079696
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of ARHGDIB mRNA	PMID:33448797
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGDIB mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of ARHGDIB mRNA]	PMID:33448797|PMID:37992649
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of ARHGDIB mRNA	PMID:33448797
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGDIB mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of ARHGDIB mRNA]	PMID:33448797|PMID:37992649
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ARHGDIB mRNA	PMID:31163220
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305383	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ARHGDIB mRNA	PMID:22061828
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:18152	myricetin	increases cleavage	EXP		E	RGD:6480464	20120412	CTD	MESH:C040015	myricetin results in increased cleavage of ARHGDIB protein	PMID:15748703
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARHGDIB mRNA	PMID:39836092
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305383	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ARHGDIB protein	PMID:34915118
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARHGDIB mRNA	PMID:31738976
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGDIB mRNA	PMID:29950665
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARHGDIB protein	PMID:21527772
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ARHGDIB mRNA	PMID:23649840
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ARHGDIB mRNA	PMID:21527772
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of ARHGDIB mRNA	PMID:21527772
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ARHGDIB mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ARHGDIB mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ARHGDIB mRNA	PMID:32699268
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARHGDIB mRNA	PMID:34911549
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313381	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ARHGDIB mRNA	PMID:27339419|PMID:31919559
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:27485	prostaglandin J2	increases cleavage	EXP		E	RGD:6480464	20120412	CTD	MESH:C037112	9-deoxy-delta-9-prostaglandin D2 results in increased cleavage of ARHGDIB protein	PMID:15843042
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ARHGDIB gene	PMID:25304211
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARHGDIB mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARHGDIB mRNA	PMID:39836092
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in increased expression of ARHGDIB mRNA	PMID:21527772
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ARHGDIB mRNA	PMID:26272509
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA	PMID:27188386
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305383	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ARHGDIB mRNA	PMID:31881176
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ARHGDIB mRNA	PMID:27594783
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ARHGDIB mRNA	PMID:27392435
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of ARHGDIB mRNA	PMID:18930951
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28009	N-acetyl-beta-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in decreased expression of ARHGDIB mRNA	PMID:18047607
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1305383	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of ARHGDIB gene	PMID:28505145
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ARHGDIB mRNA	PMID:25583101
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305383	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGDIB mRNA	PMID:34747641
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313381	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGDIB mRNA	PMID:21570461
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313381	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARHGDIB mRNA	PMID:31961203
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ARHGDIB mRNA	PMID:28001369
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of ARHGDIB mRNA	PMID:21198554
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1305383	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of ARHGDIB mRNA	PMID:30556269
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper results in decreased expression of ARHGDIB protein	PMID:23882024
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313381	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ARHGDIB protein	PMID:28918527
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARHGDIB mRNA	PMID:29803840
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARHGDIB mRNA	PMID:39631538
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGDIB mRNA	PMID:37992649
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:29073	L-ascorbic acid	increases expression	ISO	RGD:1313381	E	RGD:6480464	20120501	CTD	MESH:D001205	Ascorbic Acid results in increased expression of ARHGDIB protein	PMID:22139585
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001205	[Quercetin co-treated with Ascorbic Acid] results in increased expression of ARHGDIB mRNA	PMID:17639512
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARHGDIB mRNA	PMID:12634122|PMID:12727804|PMID:38568856|PMID:39719251
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARHGDIB mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARHGDIB mRNA; sodium arsenite results in decreased expression of and affects the splicing of ARHGDIB mRNA	PMID:25879800|PMID:39836092
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGDIB mRNA	PMID:34876320
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGDIB mRNA	PMID:34876320
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARHGDIB 5' UTR; Benzo(a)pyrene affects the methylation of ARHGDIB promoter	PMID:27901495
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARHGDIB mRNA	PMID:21569818
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313381	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARHGDIB mRNA	PMID:22228805
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ARHGDIB 3' UTR	PMID:27901495
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ARHGDIB mRNA]	PMID:22228805
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ARHGDIB mRNA]	PMID:32406909
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1305383	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of ARHGDIB mRNA	PMID:30556269
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper results in decreased expression of ARHGDIB protein	PMID:23882024
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313381	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ARHGDIB mRNA	PMID:27131904
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313381	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ARHGDIB mRNA	PMID:29341224
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ARHGDIB mRNA	PMID:20458559
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305383	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of ARHGDIB mRNA	PMID:24136188
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313381	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ARHGDIB mRNA	PMID:23557971
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGDIB mRNA	PMID:29950665
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305383	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ARHGDIB mRNA	PMID:34492290
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305383	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ARHGDIB mRNA	PMID:25380136
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ARHGDIB mRNA	PMID:17426115
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305383	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARHGDIB mRNA	PMID:25181051
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGDIB mRNA	PMID:29275510
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGDIB mRNA; bisphenol A results in decreased expression of ARHGDIB protein	PMID:33221593|PMID:35999755
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313381	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARHGDIB promoter	PMID:27312807
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305383	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGDIB mRNA	PMID:34947998
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313381	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGDIB mRNA	PMID:30951980|PMID:32156529
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305383	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of ARHGDIB gene	PMID:28505145
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ARHGDIB mRNA	PMID:39298647
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313381	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ARHGDIB mRNA	PMID:30951980
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ARHGDIB intron	PMID:30157460
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313381	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ARHGDIB mRNA	PMID:30951980
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313381	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ARHGDIB mRNA	PMID:28392331
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of ARHGDIB protein	PMID:35999755
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313381	E	RGD:6480464	20140211	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ARHGDIB mRNA	PMID:23894361
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGDIB mRNA	PMID:29950665
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305383	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARHGDIB mRNA	PMID:21266533
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313381	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ARHGDIB mRNA	PMID:34813904
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313381	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ARHGDIB mRNA	PMID:34813904
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARHGDIB mRNA	PMID:37042841
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305383	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of ARHGDIB mRNA	PMID:35163327
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of ARHGDIB mRNA	PMID:26678675
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARHGDIB mRNA	PMID:39836092
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305383	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ARHGDIB mRNA	PMID:33453195
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARHGDIB mRNA	PMID:38382870|PMID:38568856
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARHGDIB mRNA	PMID:31738976
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ARHGDIB mRNA	PMID:19320972
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1305383	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of ARHGDIB mRNA	PMID:25380136
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ARHGDIB mRNA	PMID:24449571
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ARHGDIB mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ARHGDIB mRNA	PMID:32699268
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:37187	lead nitrate	increases expression	ISO	RGD:1313381	E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate results in increased expression of ARHGDIB protein	PMID:20435106
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ARHGDIB mRNA	PMID:31533062
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of ARHGDIB mRNA	PMID:29038090
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of ARHGDIB mRNA	PMID:23125180
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ARHGDIB mRNA]	PMID:18200517
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARHGDIB mRNA	PMID:29154799
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ARHGDIB mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313381	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of ARHGDIB mRNA	PMID:24896083
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA	PMID:27188386
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305383	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ARHGDIB mRNA	PMID:41580965
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of ARHGDIB mRNA	PMID:21527772
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of ARHGDIB mRNA	PMID:15171707
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of ARHGDIB mRNA	PMID:33448797
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ARHGDIB mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of ARHGDIB mRNA]	PMID:33448797|PMID:37992649
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of ARHGDIB mRNA	PMID:17400583
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305383	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of ARHGDIB mRNA	PMID:24136188
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ARHGDIB mRNA	PMID:38832940
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:4488	diallyl disulfide	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C028009	diallyl disulfide results in decreased expression of ARHGDIB mRNA; diallyl disulfide results in decreased expression of ARHGDIB protein	PMID:36793247
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:4488	diallyl disulfide	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C028009	ARHGDIB protein affects the reaction [diallyl disulfide results in decreased expression of CD33 protein]; ARHGDIB protein affects the reaction [diallyl disulfide results in increased expression of ITGAM protein]; ARHGDIB protein inhibits the reaction [diallyl disulfide results in decreased expression of LIMK1 protein]; ARHGDIB protein inhibits the reaction [diallyl disulfide results in decreased expression of PAK1 protein]; ARHGDIB protein inhibits the reaction [diallyl disulfide results in decreased expression of RAC1 protein]	PMID:36793247
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of ARHGDIB protein	PMID:20543569
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARHGDIB mRNA	PMID:17562736
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGDIB mRNA	PMID:21420995
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305383	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGDIB mRNA	PMID:33387578
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:46345	5-fluorouracil	affects expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D005472	Fluorouracil affects the expression of ARHGDIB mRNA	PMID:34151400
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ARHGDIB gene	PMID:25304211
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARHGDIB mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARHGDIB mRNA	PMID:39836092
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide analog results in decreased expression of ARHGDIB protein	PMID:23882024
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of ARHGDIB mRNA	PMID:31838189
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGDIB mRNA	PMID:34876320
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305383	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARHGDIB mRNA	PMID:17557909
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of ARHGDIB mRNA	PMID:21527772
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA	PMID:27188386
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ARHGDIB mRNA	PMID:20458559
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of ARHGDIB mRNA	PMID:38825487
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313381	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of ARHGDIB protein; Nanotubes, Carbon analog affects the expression of ARHGDIB mRNA	PMID:21135415|PMID:25554681
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:506227	N-acetyl-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in decreased expression of ARHGDIB mRNA	PMID:18047607
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305383	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ARHGDIB mRNA	PMID:30047161
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ARHGDIB mRNA	PMID:35964746
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305383	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ARHGDIB mRNA	PMID:24136188
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in decreased expression of ARHGDIB mRNA]	PMID:33448797
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of ARHGDIB mRNA	PMID:18200517
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D014302	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of ARHGDIB mRNA]	PMID:18200517
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ARHGDIB protein	PMID:23718831
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313381	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ARHGDIB mRNA	PMID:38701926
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of ARHGDIB mRNA	PMID:20436886
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARHGDIB mRNA	PMID:39836092
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ARHGDIB mRNA	PMID:28988120
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313381	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ARHGDIB mRNA	PMID:22776087
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1305383	E	RGD:6480464	20211109	CTD	MESH:D007545	Isoproterenol results in increased expression of ARHGDIB mRNA	PMID:30303030
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ARHGDIB intron	PMID:30157460
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ARHGDIB mRNA	PMID:31758290
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ARHGDIB mRNA	PMID:25912373
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313381	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ARHGDIB mRNA	PMID:22206623
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ARHGDIB mRNA	PMID:22714537
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of ARHGDIB mRNA	PMID:36318118
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA	PMID:27188386
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:7852	oxycodone	decreases expression	ISO	RGD:1305383	E	RGD:6480464	20161025	CTD	MESH:D010098	Oxycodone results in decreased expression of ARHGDIB mRNA	PMID:23439660
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in decreased expression of ARHGDIB mRNA	PMID:19084549
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of ARHGDIB mRNA	PMID:19482888
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ARHGDIB mRNA]	PMID:19482888
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of ARHGDIB mRNA	PMID:26705709
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of ARHGDIB mRNA	PMID:12727804
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313381	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ARHGDIB mRNA	PMID:34876320
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305383	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ARHGDIB mRNA	PMID:30047161
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of ARHGDIB mRNA	PMID:20713136
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:90633	perfluorododecanoic acid	increases expression	ISO	RGD:1305383	E	RGD:6480464	20170303	CTD	MESH:C522391	perfluorododecanoic acid results in increased expression of ARHGDIB protein	PMID:19854247
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARHGDIB mRNA	PMID:27188386
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313381	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ARHGDIB mRNA	PMID:27131904
1313380	ARHGDIB	Rho GDP dissociation inhibitor beta	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305383	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ARHGDIB mRNA	PMID:19015723
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305384	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of CPT1C mRNA	PMID:21551480
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:131843	meldonium	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20201103	CTD	MESH:C050147	3-(2,2,2-trimethylhydrazine)propionate results in decreased expression of CPT1C mRNA	PMID:32389661
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CPT1C mRNA	PMID:20188158
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313383	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CPT1C mRNA	PMID:26251327
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1313383	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of CPT1C promoter	PMID:26251327
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of CPT1C mRNA	PMID:21934132
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CPT1C mRNA	PMID:30529165
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CPT1C mRNA	PMID:22378314
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20220705	CTD	MESH:D000431	Ethanol results in decreased expression of CPT1C mRNA	PMID:34995708
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CPT1C mRNA; withaferin A inhibits the reaction [Ethanol results in decreased expression of CPT1C mRNA]	PMID:30517762|PMID:34995708
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1305384	E	RGD:6480464	20260804	CTD	MESH:D011794	Quercetin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein]	PMID:33733575
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1305384	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CPT1C mRNA	PMID:23829299
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305384	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CPT1C mRNA	PMID:33387578
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CPT1C mRNA	PMID:26079696
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20250401	CTD	MESH:D004051	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of CPT1C mRNA	PMID:31606821
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305384	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CPT1C mRNA	PMID:33387578
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305384	E	RGD:6480464	20260804	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein; MIR21 promotes the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein]; Quercetin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein]	PMID:33733575
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CPT1C intron	PMID:30157460
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313383	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CPT1C mRNA	PMID:19770486
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of CPT1C mRNA	PMID:30517762
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313383	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of CPT1C mRNA	PMID:28960355
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CPT1C mRNA	PMID:23557933
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313383	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in increased expression of CPT1C mRNA	PMID:25270620
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313383	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CPT1C mRNA	PMID:21570461
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305384	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CPT1C mRNA	PMID:33387578
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPT1C mRNA	PMID:17942748
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CPT1C mRNA	PMID:33212167
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313383	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in increased expression of CPT1C mRNA	PMID:26873546
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20160607	CTD	MESH:D004317	[Doxorubicin co-treated with Dexrazoxane] results in decreased expression of CPT1C mRNA	PMID:26873546
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1C mRNA	PMID:23783067
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CPT1C mRNA	PMID:22714537
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of CPT1C mRNA	PMID:38359550
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20251007	CTD	MESH:C017947	Ketoglutaric Acids inhibits the reaction [sodium arsenite results in decreased expression of CPT1C mRNA]	PMID:38359550
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of CPT1C mRNA	PMID:22378314
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CPT1C mRNA	PMID:22228805
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CPT1C 5' UTR	PMID:27901495
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313383	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of CPT1C mRNA; Benzo(a)pyrene results in increased expression of CPT1C mRNA	PMID:19770486|PMID:22610609|PMID:32553695
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CPT1C promoter	PMID:27901495
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPT1C mRNA	PMID:27858113
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305384	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CPT1C mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of CPT1C mRNA	PMID:37105096
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of CPT1C mRNA	PMID:29275510
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305384	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CPT1C mRNA	PMID:25181051
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305384	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CPT1C gene	PMID:28505145
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305384	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CPT1C mRNA	PMID:36041667
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20250311	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CPT1C protein	PMID:39197524
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20250311	CTD	MESH:C023035	[Palm Oil co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in decreased expression of CPT1C protein	PMID:39197524
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313383	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CPT1C gene	PMID:31683443
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305384	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CPT1C mRNA	PMID:36041667
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPT1C mRNA	PMID:27858113
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of CPT1C exon	PMID:30157460
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CPT1C mRNA	PMID:38685157
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305384	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CPT1C mRNA	PMID:36041667
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305384	E	RGD:6480464	20260804	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein; MIR21 promotes the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein]; Quercetin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPT1C protein]	PMID:33733575
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313383	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CPT1C mRNA	PMID:40194260
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313383	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CPT1C mRNA	PMID:17963808
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CPT1C gene	PMID:29154799
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313383	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CPT1C mRNA	PMID:28973697
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CPT1C mRNA	PMID:28542535
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CPT1C mRNA	PMID:24935251|PMID:26272509
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPT1C mRNA	PMID:27188386
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305384	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CPT1C mRNA	PMID:33387578
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313383	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CPT1C mRNA	PMID:17555576
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CPT1C mRNA	PMID:17942748
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1313383	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of CPT1C mRNA	PMID:25270620
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:50223	(+)-dexrazoxane	increases expression	ISO	RGD:1313383	E	RGD:6480464	20170303	CTD	MESH:D064730	Dexrazoxane results in increased expression of CPT1C mRNA	PMID:26873546
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:50223	(+)-dexrazoxane	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20170303	CTD	MESH:D064730	[Doxorubicin co-treated with Dexrazoxane] results in decreased expression of CPT1C mRNA	PMID:26873546
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313383	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of CPT1C mRNA	PMID:40234311
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPT1C mRNA	PMID:27858113
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CPT1C mRNA	PMID:27858113
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:52717	bortezomib	increases response to substance	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	CPT1C gene SNP results in increased susceptibility to Bortezomib	PMID:20864405
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of CPT1C mRNA	PMID:22714537
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CPT1C mRNA	PMID:23783067
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of CPT1C exon	PMID:30157460
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:68656	raspberry ketone	increases expression	ISO	RGD:1313383	E	RGD:6480464	20230404	CTD	MESH:C035522	raspberry ketone results in increased expression of CPT1C mRNA	PMID:36460224
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:69120	withaferin A	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20220705	CTD	MESH:C009684	withaferin A inhibits the reaction [Ethanol results in decreased expression of CPT1C mRNA]	PMID:34995708
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CPT1C mRNA	PMID:31758290
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313383	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CPT1C mRNA	PMID:22206623
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPT1C mRNA	PMID:27188386
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CPT1C gene]	PMID:28238834
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of CPT1C mRNA	PMID:39904859
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305384	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CPT1C mRNA	PMID:23640034
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305384	E	RGD:6480464	20241105	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CPT1C mRNA	PMID:37926403
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313383	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of CPT1C mRNA	PMID:40826991
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:88249	PD 0325901	multiple interactions	ISO	RGD:1305384	E	RGD:6480464	20230502	CTD	MESH:C506614	mirdametinib inhibits the reaction [polyphyllin I inhibits the reaction [Dietary Fats results in decreased expression of CPT1C protein]]	PMID:36120828
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CPT1C mRNA	PMID:27188386
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305384	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CPT1C mRNA	PMID:19281266
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1313383	E	RGD:6480464	20250401	CTD	MESH:D013311	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of CPT1C mRNA	PMID:31606821
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of CPT1C mRNA	PMID:22378314
1313382	CPT1C	carnitine palmitoyltransferase 1C	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1305384	E	RGD:6480464	20230502	CTD	MESH:C032910	triadimefon results in decreased expression of CPT1C mRNA; triadimefon results in decreased expression of CPT1C protein	PMID:36179991
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313385	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ASB16 mRNA	PMID:33045310
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ASB16 mRNA	PMID:22378314
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1563878	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of ASB16 mRNA	PMID:17103110
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313385	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ASB16 mRNA	PMID:25510870
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1563878	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ASB16 mRNA	PMID:33387578
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1563878	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ASB16 gene	PMID:27618143
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313385	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASB16 mRNA	PMID:37992649
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313385	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASB16 mRNA	PMID:37992649
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313385	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ASB16 mRNA	PMID:36331819
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1563878	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ASB16 mRNA	PMID:39012411
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313385	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ASB16 mRNA	PMID:25510870
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313385	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ASB16 mRNA	PMID:25510870
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ASB16 mRNA	PMID:19549813
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ASB16 mRNA	PMID:27392435
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ASB16 mRNA	PMID:27392435
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1563878	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ASB16 mRNA	PMID:28959563
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313385	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASB16 mRNA	PMID:37992649
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ASB16 mRNA	PMID:29301061
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ASB16 promoter	PMID:27901495
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ASB16 gene	PMID:31601247
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313385	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ASB16 mRNA	PMID:29264374
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1563878	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ASB16 mRNA	PMID:25181051|PMID:34947998
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ASB16 gene	PMID:31601247
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1563878	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ASB16 mRNA	PMID:36041667
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313385	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ASB16 mRNA	PMID:25510870
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313385	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ASB16 mRNA	PMID:25510870
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1563878	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ASB16 mRNA	PMID:23196670
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1563878	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ASB16 mRNA	PMID:36041667
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1563878	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ASB16 mRNA	PMID:36041667
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1563878	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of ASB16 mRNA	PMID:35163327
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1563878	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ASB16 mRNA	PMID:35163327
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1563878	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of ASB16 promoter	PMID:22457795
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1563878	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ASB16 mRNA	PMID:39012411
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1563878	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ASB16 mRNA	PMID:35163327
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1563878	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ASB16 mRNA	PMID:35163327
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1563878	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ASB16 mRNA	PMID:25539665
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ASB16 mRNA	PMID:31533062
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313385	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ASB16 mRNA	PMID:36331819
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ASB16 gene	PMID:29154799
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313385	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASB16 mRNA	PMID:37992649
1313384	ASB16	ankyrin repeat and SOCS box containing 16	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1313385	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ASB16 mRNA	PMID:27935865
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in increased expression of IDH2 mRNA	PMID:18313992
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1597139	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of IDH2 mRNA	PMID:21551480
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of IDH2 mRNA	PMID:33045310
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IDH2 mRNA]	PMID:31150632
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of IDH2 protein]	PMID:38195004
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:136185	VX nerve agent	decreases activity	ISO	RGD:1597139	E	RGD:6480464	20170613	CTD	MESH:C009680	VX-agent results in decreased activity of IDH2 protein	PMID:28267914
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1557355	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of IDH2 mRNA	PMID:20188158
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:14336	glycerol 1-phosphate	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C029620	IDH2 protein mutant form results in increased abundance of alpha-glycerophosphoric acid	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:14336	glycerol 1-phosphate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C029620	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of alpha-glycerophosphoric acid]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:145829	trilobatin	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20200915	CTD	MESH:C000598619	trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased activity of IDH2 protein]; trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of IDH2 protein]	PMID:30104959
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of IDH2 gene	PMID:20938992
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of IDH2 mRNA	PMID:33167477
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of IDH2 mRNA	PMID:36331819
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15545	prostaglandin A1	increases metabolic processing	ISO	RGD:1557355	E	RGD:6480464	20120501	CTD	MESH:C100573	prostaglandin A1 analog results in increased metabolism of IDH2 protein	PMID:19800325
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15682	(N(omega)-L-arginino)succinic acid	decreases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D001125	IDH2 protein mutant form results in decreased abundance of Argininosuccinic Acid	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15682	(N(omega)-L-arginino)succinic acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D001125	Triazines inhibits the reaction [IDH2 protein mutant form results in decreased abundance of Argininosuccinic Acid]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15746	spermine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D013096	IDH2 protein mutant form results in increased abundance of Spermine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15746	spermine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D013096	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Spermine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15846	NAD(+)	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D009243	IDH2 protein mutant form results in increased abundance of NAD; IDH2 protein mutant form results in increased abundance of NAD metabolite	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15846	NAD(+)	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D009243	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of NAD metabolite]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of NAD]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15891	taurine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D013654	IDH2 protein mutant form results in increased abundance of Taurine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15891	taurine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D013654	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Taurine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15918	2'-deoxycytosine 5'-monophosphate	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D003843	IDH2 protein mutant form results in increased abundance of Deoxycytidine Monophosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:15918	2'-deoxycytosine 5'-monophosphate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D003843	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Deoxycytidine Monophosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16108	dihydroxyacetone phosphate	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D004099	IDH2 protein mutant form results in increased abundance of Dihydroxyacetone Phosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16108	dihydroxyacetone phosphate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D004099	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Dihydroxyacetone Phosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16136	hydrogen sulfide	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D006862	[GYY 4137 results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Hydrogen Peroxide results in decreased expression of IDH2 protein]; SIRT3 protein affects the reaction [[GYY 4137 results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Hydrogen Peroxide results in decreased expression of IDH2 protein]]	PMID:26422756
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16136	hydrogen sulfide	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20210209	CTD	MESH:D006862	[[sodium sulfide results in increased abundance of Hydrogen Sulfide] which co-treated with Paraquat] results in decreased expression of IDH2 protein; [sodium sulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Paraquat results in decreased expression of and results in decreased activity of IDH2 protein]	PMID:32064027
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16171	NMN zwitterion	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20260303	CTD	MESH:D009537	Nicotinamide Mononucleotide inhibits the reaction [Bleomycin results in decreased expression of IDH2 protein]	PMID:40840615
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16192	2'-deoxyguanosine 5'-monophosphate	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C007257	IDH2 protein mutant form results in increased abundance of 2'-deoxyguanosine 5'-phosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16192	2'-deoxyguanosine 5'-monophosphate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C007257	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of 2'-deoxyguanosine 5'-phosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16235	guanine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D006147	IDH2 protein mutant form results in increased abundance of Guanine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16235	guanine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D006147	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Guanine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1557355	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of IDH2 mRNA	PMID:30319688
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of IDH2 mRNA	PMID:29432896
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16240	hydrogen peroxide	decreases activity	ISO	RGD:1597139	E	RGD:6480464	20200915	CTD	MESH:D006861	Hydrogen Peroxide results in decreased activity of IDH2 protein	PMID:30104959
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of IDH2 protein	PMID:26422756
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20130514	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of IDH2 protein	PMID:23178681|PMID:30104959
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D006861	[GYY 4137 results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Hydrogen Peroxide results in decreased expression of IDH2 protein]; SIRT3 protein affects the reaction [[GYY 4137 results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Hydrogen Peroxide results in decreased expression of IDH2 protein]]	PMID:26422756
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20200915	CTD	MESH:D006861	Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of IDH2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of IDH2 protein]; trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased activity of IDH2 protein]; trilobatin inhibits the reaction [Hydrogen Peroxide results in decreased expression of IDH2 protein]	PMID:30104959
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16244	4-(trimethylammonio)butanoate	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C002889	IDH2 protein mutant form results in increased abundance of gamma-butyrobetaine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16244	4-(trimethylammonio)butanoate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C002889	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of gamma-butyrobetaine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16264	UDP-N-acetyl-alpha-D-glucosamine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D014537	IDH2 protein mutant form results in increased abundance of Uridine Diphosphate N-Acetylglucosamine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16264	UDP-N-acetyl-alpha-D-glucosamine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D014537	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Uridine Diphosphate N-Acetylglucosamine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16325	lithocholic acid	increases expression	ISO	RGD:1557355	E	RGD:6480464	20250114	CTD	MESH:D008095	Lithocholic Acid results in increased expression of IDH2 mRNA	PMID:39695227
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16335	adenosine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D000241	IDH2 protein mutant form results in increased abundance of Adenosine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16335	adenosine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D000241	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Adenosine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16336	hyaluronic acid	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20130514	CTD	MESH:D006820	Hyaluronic Acid analog results in decreased expression of IDH2 protein	PMID:23178681
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16347	(R)-carnitine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D002331	IDH2 protein mutant form results in increased abundance of Carnitine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16347	(R)-carnitine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D002331	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Carnitine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of IDH2 mRNA	PMID:39241906
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of IDH2 mRNA	PMID:39298647
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of IDH2 mRNA	PMID:26496021
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of IDH2 gene	PMID:20938992
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of IDH2 mRNA	PMID:37042841
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16704	uridine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D014529	IDH2 protein mutant form results in increased abundance of Uridine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16704	uridine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D014529	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Uridine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16737	creatinine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D003404	IDH2 protein mutant form results in increased abundance of Creatinine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16737	creatinine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D003404	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Creatinine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16761	ADP	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D000244	IDH2 protein mutant form results in increased abundance of Adenosine Diphosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16761	ADP	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D000244	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Adenosine Diphosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16856	glutathione	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D005978	IDH2 protein mutant form results in increased abundance of Glutathione	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16856	glutathione	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D005978	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Glutathione]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16905	keto-D-fructose 1,6-bisphosphate	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C029063	IDH2 protein mutant form results in increased abundance of fructose-1,6-diphosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16905	keto-D-fructose 1,6-bisphosphate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C029063	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of fructose-1,6-diphosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16977	L-alanine	decreases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D000409	IDH2 protein mutant form results in decreased abundance of Alanine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16977	L-alanine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D000409	Triazines inhibits the reaction [IDH2 protein mutant form results in decreased abundance of Alanine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:16990	bilirubin IXalpha	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin results in decreased expression of IDH2 mRNA	PMID:20196124
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17013	dTMP	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D013938	IDH2 protein mutant form results in increased abundance of Thymidine Monophosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17013	dTMP	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D013938	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Thymidine Monophosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17050	3-phosphoglyceric acid	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C005156	IDH2 protein mutant form results in increased abundance of 3-phosphoglycerate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17050	3-phosphoglyceric acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C005156	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of 3-phosphoglycerate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17084	2-hydroxyglutaric acid	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C019417	IDH2 protein mutant form results in increased abundance of alpha-hydroxyglutarate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17084	2-hydroxyglutaric acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C019417	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of alpha-hydroxyglutarate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IDH2 mRNA	PMID:37992649
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17489	3',5'-cyclic AMP	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D000242	IDH2 protein mutant form results in increased abundance of Cyclic AMP	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17489	3',5'-cyclic AMP	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D000242	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Cyclic AMP]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17509	5'-S-methyl-5'-thioadenosine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C008500	IDH2 protein mutant form results in increased abundance of 5'-methylthioadenosine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17509	5'-S-methyl-5'-thioadenosine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C008500	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of 5'-methylthioadenosine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:175358	Diosbulbin B	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20210706	CTD	MESH:C569454	diosbulbin B results in decreased expression of IDH2 mRNA	PMID:32148032
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17562	cytidine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D003562	IDH2 protein mutant form results in increased abundance of Cytidine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17562	cytidine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D003562	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Cytidine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:175936	8-Epidiosbulbin E acetate	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20210706	CTD	MESH:C534602	8-epidiosbulbin E acetate results in decreased expression of IDH2 mRNA	PMID:31626840
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17621	FMN	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D005486	IDH2 protein mutant form results in increased abundance of Flavin Mononucleotide	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17621	FMN	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D005486	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Flavin Mononucleotide]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IDH2 mRNA	PMID:37992649
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17659	UDP	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D014530	IDH2 protein mutant form results in increased abundance of Uridine Diphosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17659	UDP	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D014530	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Uridine Diphosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17712	9H-xanthine	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20120717	CTD	MESH:D019820	[Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of IDH2 protein; [Xanthine co-treated with XDH protein] results in decreased expression of IDH2 protein	PMID:19464573
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of IDH2 mRNA	PMID:34319233
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1557355	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IDH2 mRNA	PMID:21318169
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17750	glycine betaine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D001622	IDH2 protein mutant form results in increased abundance of Betaine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17750	glycine betaine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D001622	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Betaine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Clozapine] results in decreased expression of IDH2 protein	PMID:34122009
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17969	sedoheptulose 1,7-bisphosphate	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C022079	IDH2 protein mutant form results in increased abundance of sedoheptulose 1,7-bisphosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:17969	sedoheptulose 1,7-bisphosphate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C022079	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of sedoheptulose 1,7-bisphosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:18009	NADP(+)	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D009249	IDH2 protein mutant form results in increased abundance of NADP	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:18009	NADP(+)	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D009249	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of NADP]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IDH2 mRNA	PMID:36331819
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1557355	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of IDH2 mRNA	PMID:27462272
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:20995	aldehydo-D-glucosamine 6-phosphate	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C001293	IDH2 protein mutant form results in increased abundance of glucosamine 6-phosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:20995	aldehydo-D-glucosamine 6-phosphate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C001293	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of glucosamine 6-phosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:21949	O-butanoyl-L-carnitine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C427065	IDH2 protein mutant form results in increased abundance of butyrylcarnitine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:21949	O-butanoyl-L-carnitine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C427065	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of butyrylcarnitine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:22211	aconitic acid	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D000156	IDH2 protein mutant form results in increased abundance of Aconitic Acid	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:22211	aconitic acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D000156	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Aconitic Acid]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of IDH2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of IDH2 protein	PMID:38195004
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IDH2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased oxidation of IDH2 protein	PMID:30529385|PMID:37236586
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:231651	vosaroxin	increases activity	EXP		E	RGD:6480464	20240702	CTD	MESH:C485113	vosaroxin results in increased activity of IDH2 protein	PMID:29800573
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:231651	vosaroxin	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C485113	SIRT2 protein affects the reaction [vosaroxin results in increased activity of IDH2 protein]	PMID:29800573
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of IDH2 mRNA	PMID:19549813
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of IDH2 mRNA	PMID:27153756
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of IDH2 mRNA	PMID:19770486
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:2567	alendronic acid	affects expression	ISO	RGD:1597139	E	RGD:6480464	20120412	CTD	MESH:D019386	Alendronate affects the expression of IDH2 mRNA	PMID:16079270
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1597139	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of IDH2 mRNA	PMID:41580963
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of IDH2 mRNA	PMID:35430440
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1557355	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of IDH2 mRNA	PMID:24489787
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of IDH2 protein	PMID:38598786
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D014747	IDH2 protein affects the susceptibility to Vinblastine	PMID:16217747
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IDH2 mRNA	PMID:31919559
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of IDH2 mRNA	PMID:31150632
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of IDH2 mRNA]	PMID:31150632
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid deficiency results in decreased expression of IDH2 protein	PMID:28639913
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IDH2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of IDH2 gene	PMID:20938992|PMID:22206623
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IDH2 gene	PMID:25304211
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of IDH2 mRNA	PMID:39836092
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of IDH2 protein	PMID:37208198
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1597139	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of IDH2 mRNA	PMID:31881176
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1557355	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of IDH2 protein	PMID:25505154
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1597139	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of IDH2 mRNA	PMID:25905778
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:C059514	Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]; SIRT3 mutant form inhibits the reaction [Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]]	PMID:25522270
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of IDH2 mRNA	PMID:27392435|PMID:27594783
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of IDH2 mRNA	PMID:27392435
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28013	beta-D-fructofuranose 1,6-bisphosphate	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C029063	IDH2 protein mutant form results in increased abundance of fructose-1,6-diphosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28013	beta-D-fructofuranose 1,6-bisphosphate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C029063	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of fructose-1,6-diphosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557355	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IDH2 mRNA	PMID:21570461
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1597139	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IDH2 mRNA	PMID:34747641
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IDH2 mRNA	PMID:19770486
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IDH2 mRNA	PMID:21215274
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IDH2 mRNA	PMID:20106945|PMID:21632981
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of IDH2 protein	PMID:39603559
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1597139	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of IDH2 mRNA; Rotenone results in increased expression of IDH2 protein	PMID:28374803|PMID:35544339
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1557355	E	RGD:6480464	20191008	CTD	MESH:C000228	aristolochic acid I results in increased expression of IDH2 mRNA	PMID:31009690
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28358	rac-lactic acid	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D019344	IDH2 protein mutant form results in increased abundance of Lactic Acid	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28358	rac-lactic acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D019344	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Lactic Acid]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of IDH2 mRNA	PMID:32763439
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20250506	CTD	MESH:D020106	Acrylamide results in decreased expression of IDH2 protein	PMID:39082229
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of IDH2 mRNA; Sodium Fluoride results in decreased expression of IDH2 protein	PMID:27548804|PMID:27862939
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28741	sodium fluoride	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:D012969	[Sodium Fluoride results in increased abundance of Fluorides] which results in decreased activity of IDH2 protein; SIRT3 protein inhibits the reaction [[Sodium Fluoride results in increased abundance of Fluorides] which results in decreased activity of IDH2 protein]	PMID:34780879
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20220705	CTD	MESH:D012969	[Sodium Fluoride results in increased abundance of Fluorides] which results in decreased activity of IDH2 protein	PMID:34780879
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of IDH2 mRNA	PMID:26873546
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of IDH2 mRNA	PMID:29803840
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20120412	CTD	MESH:D004317	[docetaxel co-treated with Doxorubicin] results in decreased expression of IDH2 protein	PMID:20457137
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IDH2 mRNA	PMID:37992649
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Aspartame] affects the expression of IDH2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of IDH2 mRNA	PMID:23783067
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of IDH2 mRNA	PMID:29432896
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28918	(R)-adrenaline	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20120717	CTD	MESH:D004837	Epinephrine results in decreased expression of IDH2 protein	PMID:19464573
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28918	(R)-adrenaline	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20120717	CTD	MESH:D004837	[Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of IDH2 protein	PMID:19464573
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20200915	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased activity of IDH2 protein]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of IDH2 protein]	PMID:30104959
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:28984	aluminium atom	decreases activity	ISO	RGD:1597139	E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in decreased activity of IDH2 protein	PMID:15486972
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:29042	alpha-D-glucose 1-phosphate	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C031590	IDH2 protein mutant form results in increased abundance of glucose-1-phosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:29042	alpha-D-glucose 1-phosphate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C031590	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of glucose-1-phosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of IDH2 mRNA	PMID:38568856
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of IDH2 protein	PMID:38685555
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of IDH2 mRNA	PMID:34032870
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of IDH2 mRNA; sodium arsenite results in decreased expression of and affects the splicing of IDH2 mRNA	PMID:25879800|PMID:39836092
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014415	Tunicamycin results in decreased expression of IDH2 mRNA	PMID:20196124
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of IDH2 mRNA	PMID:29453283
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IDH2 mRNA	PMID:19770486
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1557355	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IDH2 mRNA	PMID:22228805
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of IDH2 mRNA]	PMID:22228805
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to IDH2 protein]	PMID:32406909
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of IDH2 mRNA	PMID:25895662
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of IDH2 mRNA	PMID:19150397
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of IDH2 mRNA	PMID:29223816
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of IDH2 protein	PMID:25419056
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:3139	bleomycin A2	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20260303	CTD	MESH:D001761	Bleomycin results in decreased expression of IDH2 protein	PMID:40840615
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:3139	bleomycin A2	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20151215	CTD	MESH:D001761	Bleomycin results in decreased expression of IDH2 protein	PMID:25933445
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20260303	CTD	MESH:D001761	Nicotinamide Mononucleotide inhibits the reaction [Bleomycin results in decreased expression of IDH2 protein]; SIRT3 protein affects the reaction [Bleomycin results in decreased expression of IDH2 protein]	PMID:40840615
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557355	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IDH2 promoter	PMID:35295148
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1557355	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IDH2 gene	PMID:35295148
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:32398	D-glyceric acid	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C042971	IDH2 protein mutant form results in increased abundance of glyceric acid	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:32398	D-glyceric acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C042971	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of glyceric acid]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:32497	thioacetamide	decreases activity	ISO	RGD:1597139	E	RGD:6480464	20210706	CTD	MESH:D013853	Thioacetamide results in decreased activity of IDH2 protein	PMID:33522075
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of IDH2 mRNA	PMID:34492290
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20210706	CTD	MESH:D013853	honokiol inhibits the reaction [Thioacetamide results in decreased activity of IDH2 protein]	PMID:33522075
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557355	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of IDH2 mRNA	PMID:21318169
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of IDH2 mRNA	PMID:19710929
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of IDH2 mRNA]	PMID:21318169
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:32816	pyruvic acid	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D019289	IDH2 protein mutant form results in increased abundance of Pyruvic Acid	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:32816	pyruvic acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D019289	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Pyruvic Acid]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1557355	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of IDH2 mRNA	PMID:28472532
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of IDH2 mRNA	PMID:38479592
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of IDH2 mRNA	PMID:30903817
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1597139	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of IDH2 mRNA	PMID:25181051
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of IDH2 protein	PMID:34186270
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of IDH2 mRNA	PMID:34947998
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of IDH2 protein	PMID:37567409
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of IDH2 mRNA	PMID:26496021
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:33508	glyceric acid	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C042971	IDH2 protein mutant form results in increased abundance of glyceric acid	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:33508	glyceric acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C042971	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of glyceric acid]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:33629	aluminium(0)	decreases activity	ISO	RGD:1597139	E	RGD:6480464	20120412	CTD	MESH:D000535	Aluminum results in decreased activity of IDH2 protein	PMID:15486972
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20120412	CTD	MESH:C014024	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of IDH2 mRNA	PMID:16984957
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34283	oxybenzone	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in decreased expression of IDH2 mRNA	PMID:30316929
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20120412	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of IDH2 mRNA	PMID:16984957
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20120412	CTD	MESH:C023035	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of IDH2 mRNA	PMID:16984957
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to IDH2 promoter]	PMID:20348232
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of IDH2 mRNA	PMID:39298647
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of IDH2 mRNA; bisphenol S results in increased expression of IDH2 protein	PMID:31121516|PMID:34186270
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of IDH2 protein	PMID:34186270
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1557355	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of IDH2 mRNA	PMID:38685157
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of IDH2 protein	PMID:34186270
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of IDH2 protein	PMID:38598786
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1557355	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of IDH2 mRNA	PMID:17854601
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of IDH2 mRNA]	PMID:17854601
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34887	nickel dichloride	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C022838	nickel chloride results in increased activity of IDH2 protein	PMID:17018869
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20210209	CTD	MESH:D010269	Paraquat results in decreased expression of IDH2 protein	PMID:32064027
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20210209	CTD	MESH:D010269	[[sodium sulfide results in increased abundance of Hydrogen Sulfide] which co-treated with Paraquat] results in decreased expression of IDH2 protein; [sodium sulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Paraquat results in decreased expression of and results in decreased activity of IDH2 protein]; Paraquat results in decreased expression of and results in decreased activity of IDH2 protein	PMID:32064027
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of IDH2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of IDH2 protein	PMID:38195004
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IDH2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased oxidation of IDH2 protein	PMID:30529385|PMID:37236586
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of IDH2 mRNA	PMID:19162173
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of IDH2 mRNA	PMID:28903501
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of IDH2 mRNA	PMID:19320972|PMID:19376846
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:3766	clozapine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	[Cuprizone co-treated with Clozapine] results in decreased expression of IDH2 protein	PMID:34122009
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:37736	D-fructofuranose 1,6-bisphosphate	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C029063	IDH2 protein mutant form results in increased abundance of fructose-1,6-diphosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:37736	D-fructofuranose 1,6-bisphosphate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C029063	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of fructose-1,6-diphosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:38102	triazines	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D014227	Triazines inhibits the reaction [IDH2 protein mutant form results in decreased abundance of Alanine]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased abundance of Argininosuccinic Acid]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased abundance of malic acid]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of AQP4 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of AS3MT mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of ASB5 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of CENPF mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of CHRM2 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of CLU mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of CNTN2 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of DBH mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of DOC2G mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of FGF16 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of GNMT mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of GSTK1 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of HK1 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of HOPX mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of IRX5 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of KBTBD13 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of KCNE1 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of LAMB3 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of LGI1 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of MTR mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of NAPRT mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of RANGRF mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of RPL3L mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of SEC31B mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of SLC17A7 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of SLC38A4 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of SLC47A1 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of SLC7A1 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of THBS4 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of TMOD4 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of WFIKKN2 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of 2'-deoxyguanosine 5'-phosphate]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of 3-dehydrocarnitine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of 3-phosphoglycerate]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of 5'-methylthioadenosine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of 6-phosphogluconic acid]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Acetylcarnitine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Aconitic Acid]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Adenosine Diphosphate]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Adenosine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of alpha-glycerophosphoric acid]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of alpha-hydroxyglutarate]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Betaine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of butyrylcarnitine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Carnitine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Creatinine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Cyclic AMP]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Cytidine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Deoxycytidine Monophosphate]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Dihydroxyacetone Phosphate]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of erythrose 4-phosphate]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Flavin Mononucleotide]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of fructose-1,6-diphosphate]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of gamma-butyrobetaine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of glucosamine 6-phosphate]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of glucose-1-phosphate]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Glutathione]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of glyceric acid]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Guanine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of guanosine diphosphate glucose]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Lactic Acid]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of N-methylnicotinamide]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of NAD metabolite]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of NAD]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of NADP]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Pantothenic Acid]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Pyruvic Acid]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of sedoheptulose 1,7-bisphosphate]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Spermine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Taurine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Thymidine Monophosphate]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Uridine Diphosphate N-Acetylglucosamine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Uridine Diphosphate]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Uridine]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of ACACA mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of ACTA1 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of CA3 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of CAMK2B mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of CCN5 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of CDH4 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of EPHB2 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of GDPD3 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of GSTA1 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of GSTA2 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of HDDC3 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of HSPA1A mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of HSPA1B mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of MET mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of MTTP mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of MYH4 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of NMRK2 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of PDE3B mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of SIX1 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of SNTB1 mRNA]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased expression of TNNC2 mRNA]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of IDH2 mRNA	PMID:32588087
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of IDH2 mRNA	PMID:31533062
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of IDH2 mRNA	PMID:39529242
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IDH2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of IDH2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of IDH2 mRNA	PMID:36331819
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of IDH2 mRNA	PMID:19101580|PMID:29154799|PMID:29501571
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of IDH2 mRNA	PMID:24383497
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of IDH2 gene	PMID:29501571
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1597139	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of IDH2 mRNA	PMID:30047161
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of IDH2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of IDH2 mRNA	PMID:14699072
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR1 protein] results in increased expression of IDH2 mRNA	PMID:19059307
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IDH2 mRNA	PMID:37992649
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:44215	NAD zwitterion	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D009243	IDH2 protein mutant form results in increased abundance of NAD; IDH2 protein mutant form results in increased abundance of NAD metabolite	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:44215	NAD zwitterion	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D009243	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of NAD metabolite]; Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of NAD]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:44409	NADP zwitterion	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D009249	IDH2 protein mutant form results in increased abundance of NADP	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:44409	NADP zwitterion	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D009249	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of NADP]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:45863	paclitaxel	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	IDH2 protein affects the susceptibility to Paclitaxel	PMID:16217747
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:45863	paclitaxel	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of IDH2 mRNA	PMID:15000894
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of IDH2 mRNA	PMID:25704631
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of IDH2 mRNA	PMID:24714768
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C088658	zoledronic acid results in increased expression of IDH2 protein	PMID:28871336
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:46905	(R)-pantothenic acid	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D010205	IDH2 protein mutant form results in increased abundance of Pantothenic Acid	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:46905	(R)-pantothenic acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D010205	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Pantothenic Acid]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IDH2 gene	PMID:25304211
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of IDH2 mRNA	PMID:39836092
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in decreased expression of IDH2 mRNA	PMID:26934552
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of IDH2 mRNA	PMID:29391264
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:47987	2-amino-2-deoxy-D-glucopyranose 6-phosphate	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C001293	IDH2 protein mutant form results in increased abundance of glucosamine 6-phosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:47987	2-amino-2-deoxy-D-glucopyranose 6-phosphate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C001293	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of glucosamine 6-phosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:48153	D-erythrose 4-phosphate	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C026959	IDH2 protein mutant form results in increased abundance of erythrose 4-phosphate	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:48153	D-erythrose 4-phosphate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C026959	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of erythrose 4-phosphate]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:48517	7H-xanthine	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20121218	CTD	MESH:D019820	[Epinephrine co-treated with Xanthine co-treated with XDH] results in decreased expression of IDH2 protein; [Xanthine co-treated with XDH protein] results in decreased expression of IDH2 protein	PMID:19464573
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1597139	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of IDH2 mRNA	PMID:16079270
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of IDH2 mRNA	PMID:17557909
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of IDH2 mRNA	PMID:36868495
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of IDH2 mRNA	PMID:29223816
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of IDH2 protein	PMID:25419056
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of IDH2 mRNA	PMID:25620056
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1597139	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of IDH2 mRNA	PMID:30047161
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	ISO	RGD:1597139	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of IDH2 mRNA	PMID:19162173
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of IDH2 mRNA	PMID:31629900
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:57589	O-acetyl-L-carnitine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D000108	IDH2 protein mutant form results in increased abundance of Acetylcarnitine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:57589	O-acetyl-L-carnitine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D000108	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Acetylcarnitine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:5759	Honokiol	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20210706	CTD	MESH:C005499	honokiol inhibits the reaction [Thioacetamide results in decreased activity of IDH2 protein]	PMID:33522075
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:57885	3-dehydrocarnitine	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C103930	IDH2 protein mutant form results in increased abundance of 3-dehydrocarnitine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:57885	3-dehydrocarnitine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C103930	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of 3-dehydrocarnitine]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:6030	isoniazide	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of IDH2 protein	PMID:40015660
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of IDH2 protein	PMID:32959892
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:62254	GDP-alpha-D-glucose	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C100085	IDH2 protein mutant form results in increased abundance of guanosine diphosphate glucose	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:62254	GDP-alpha-D-glucose	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C100085	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of guanosine diphosphate glucose]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in increased expression of IDH2 mRNA	PMID:18313992
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases activity	EXP		E	RGD:6480464	20151013	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased activity of IDH2 protein	PMID:25522270
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:64090	tert-butyl hydroperoxide	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D020122	resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]; SIRT3 mutant form inhibits the reaction [resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]]	PMID:25522270
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of IDH2 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of IDH2 mRNA; [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of IDH2 mRNA	PMID:20111022|PMID:23783067
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:64399	N-methylnicotinamide	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C008472	IDH2 protein mutant form results in increased abundance of N-methylnicotinamide	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:64399	N-methylnicotinamide	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C008472	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of N-methylnicotinamide]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:6650	malic acid	decreases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C030298	IDH2 protein mutant form results in decreased abundance of malic acid	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:6650	malic acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C030298	Triazines inhibits the reaction [IDH2 protein mutant form results in decreased abundance of malic acid]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of IDH2 mRNA	PMID:37939859
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of IDH2 mRNA	PMID:30467583
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20190910	CTD	MESH:C581157	XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IDH2 mRNA]	PMID:29891994
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of IDH2 mRNA	PMID:31758290
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of IDH2 protein	PMID:34186270
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1557355	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IDH2 mRNA	PMID:22206623
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of IDH2 mRNA	PMID:22206623
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of IDH2 protein	PMID:37664457
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of IDH2 mRNA	PMID:22714537
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of IDH2 mRNA	PMID:29522793
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:755540	docetaxel	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20260714	CTD	MESH:D000077143	[Docetaxel co-treated with Doxorubicin] results in decreased expression of IDH2 protein	PMID:20457137
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:76208	sodium sulfide (anhydrous)	multiple interactions	ISO	RGD:1597139	E	RGD:6480464	20210209	CTD	MESH:C033479	[[sodium sulfide results in increased abundance of Hydrogen Sulfide] which co-treated with Paraquat] results in decreased expression of IDH2 protein; [sodium sulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [Paraquat results in decreased expression of and results in decreased activity of IDH2 protein]	PMID:32064027
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1597139	E	RGD:6480464	20211012	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of IDH2 mRNA	PMID:33945839
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:76792	5-(hydroxymethyl)cytosine	decreases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:C011865	IDH2 protein mutant form results in decreased abundance of 5-hydroxymethylcytosine	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of IDH2 protein	PMID:39638853
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:78320	2-hydroxypropanoic acid	increases abundance	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D019344	IDH2 protein mutant form results in increased abundance of Lactic Acid	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:78320	2-hydroxypropanoic acid	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20180313	CTD	MESH:D019344	Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Lactic Acid]	PMID:27469509
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of IDH2 mRNA	PMID:19159669
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1557355	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of IDH2 mRNA	PMID:19482888
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1597139	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of IDH2 mRNA	PMID:19162173|PMID:30047161
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1557355	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of IDH2 mRNA]	PMID:19482888
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1557355	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in increased expression of IDH2 mRNA	PMID:22538082
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1557355	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of IDH2 mRNA	PMID:38648751
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1557355	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of IDH2 mRNA	PMID:30294300
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of IDH2 protein	PMID:38348393
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of IDH2 mRNA	PMID:36843608
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1597139	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of IDH2 mRNA	PMID:30047161
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of IDH2 mRNA	PMID:14699072
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:8772	raloxifene	affects expression	ISO	RGD:1597139	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of IDH2 mRNA	PMID:16079270
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of IDH2 mRNA; ESR1 protein affects the reaction [Raloxifene Hydrochloride results in increased expression of IDH2 mRNA]	PMID:14699072|PMID:19059307
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of IDH2 protein	PMID:37664457
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of IDH2 mRNA	PMID:19281266
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:9288	streptozocin	affects expression	ISO	RGD:1557355	E	RGD:6480464	20120501	CTD	MESH:D013311	Streptozocin affects the expression of IDH2 mRNA	PMID:18583417
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of IDH2 mRNA	PMID:38568856
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1557355	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of IDH2 mRNA	PMID:35537566
1313391	IDH2	isocitrate dehydrogenase (NADP(+)) 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1597139	E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of IDH2 mRNA	PMID:24136188
1313392	PLK4	polo like kinase 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313393	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PLK4 mRNA	PMID:33045310
1313392	PLK4	polo like kinase 4	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLK4 mRNA	PMID:39752319
1313392	PLK4	polo like kinase 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of PLK4 mRNA	PMID:15498508|PMID:33167477
1313392	PLK4	polo like kinase 4	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of PLK4 mRNA	PMID:26516004
1313392	PLK4	polo like kinase 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313393	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PLK4 mRNA	PMID:39241906
1313392	PLK4	polo like kinase 4	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in increased expression of PLK4 mRNA]	PMID:19442820
1313392	PLK4	polo like kinase 4	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of PLK4 mRNA	PMID:15598610
1313392	PLK4	polo like kinase 4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of PLK4 mRNA	PMID:16474171|PMID:19167446
1313392	PLK4	polo like kinase 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313393	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of PLK4 mRNA	PMID:25210133
1313392	PLK4	polo like kinase 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in increased expression of PLK4 mRNA]	PMID:25210133
1313392	PLK4	polo like kinase 4	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PLK4 mRNA	PMID:38568856
1313392	PLK4	polo like kinase 4	gene	CHEBI:16827	corticosterone	decreases expression	ISO	RGD:1305390	E	RGD:6480464	20120412	CTD	MESH:D003345	Corticosterone results in decreased expression of PLK4 mRNA	PMID:15755911
1313392	PLK4	polo like kinase 4	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of PLK4 mRNA	PMID:17251523
1313392	PLK4	polo like kinase 4	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PLK4 mRNA	PMID:21179406
1313392	PLK4	polo like kinase 4	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of PLK4 mRNA	PMID:26079696
1313392	PLK4	polo like kinase 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLK4 mRNA	PMID:37992649
1313392	PLK4	polo like kinase 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLK4 mRNA	PMID:39752319
1313392	PLK4	polo like kinase 4	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of PLK4 mRNA	PMID:21592394
1313392	PLK4	polo like kinase 4	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of PLK4 mRNA	PMID:21592394
1313392	PLK4	polo like kinase 4	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305390	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of PLK4 mRNA]	PMID:20032058
1313392	PLK4	polo like kinase 4	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in increased expression of PLK4 mRNA]	PMID:19442820
1313392	PLK4	polo like kinase 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLK4 mRNA	PMID:37992649
1313392	PLK4	polo like kinase 4	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305390	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PLK4 mRNA	PMID:26577399|PMID:27523638
1313392	PLK4	polo like kinase 4	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of PLK4 mRNA	PMID:21592394
1313392	PLK4	polo like kinase 4	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of PLK4 mRNA	PMID:21592394
1313392	PLK4	polo like kinase 4	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLK4 mRNA	PMID:39836092
1313392	PLK4	polo like kinase 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLK4 mRNA	PMID:28111341
1313392	PLK4	polo like kinase 4	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PLK4 mRNA	PMID:22100608
1313392	PLK4	polo like kinase 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305390	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PLK4 mRNA	PMID:23630614
1313392	PLK4	polo like kinase 4	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of PLK4 mRNA	PMID:25102026
1313392	PLK4	polo like kinase 4	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120501	CTD	MESH:D010126	Ozone results in increased expression of PLK4 mRNA	PMID:12763052|PMID:19555225
1313392	PLK4	polo like kinase 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PLK4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PLK4 mRNA	PMID:34911549
1313392	PLK4	polo like kinase 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313393	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PLK4 mRNA	PMID:31919559
1313392	PLK4	polo like kinase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLK4 mRNA	PMID:39836092
1313392	PLK4	polo like kinase 4	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305390	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PLK4 mRNA	PMID:31881176
1313392	PLK4	polo like kinase 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of PLK4 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of PLK4 mRNA	PMID:19167446|PMID:23557933
1313392	PLK4	polo like kinase 4	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin promotes the reaction [Piroxicam results in decreased expression of PLK4 mRNA]	PMID:21858171
1313392	PLK4	polo like kinase 4	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of PLK4 mRNA	PMID:16474171
1313392	PLK4	polo like kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313393	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLK4 mRNA	PMID:21570461
1313392	PLK4	polo like kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305390	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLK4 mRNA	PMID:33387578|PMID:34747641
1313392	PLK4	polo like kinase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLK4 mRNA	PMID:17942748
1313392	PLK4	polo like kinase 4	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305390	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of PLK4 mRNA	PMID:28374803
1313392	PLK4	polo like kinase 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PLK4 mRNA	PMID:33212167
1313392	PLK4	polo like kinase 4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PLK4 mRNA	PMID:32763439
1313392	PLK4	polo like kinase 4	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305390	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PLK4 mRNA	PMID:26033743
1313392	PLK4	polo like kinase 4	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1305390	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of PLK4 mRNA	PMID:26033743
1313392	PLK4	polo like kinase 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PLK4 mRNA	PMID:30031762
1313392	PLK4	polo like kinase 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLK4 mRNA	PMID:37992649
1313392	PLK4	polo like kinase 4	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PLK4 mRNA	PMID:29432896
1313392	PLK4	polo like kinase 4	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite affects the expression of PLK4 mRNA	PMID:29301061
1313392	PLK4	polo like kinase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PLK4 mRNA	PMID:38568856
1313392	PLK4	polo like kinase 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLK4 mRNA	PMID:39836092
1313392	PLK4	polo like kinase 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLK4 mRNA	PMID:32234424
1313392	PLK4	polo like kinase 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLK4 mRNA	PMID:20713471|PMID:32417428
1313392	PLK4	polo like kinase 4	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305390	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PLK4 mRNA	PMID:26033743
1313392	PLK4	polo like kinase 4	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1305390	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of PLK4 mRNA	PMID:26033743
1313392	PLK4	polo like kinase 4	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PLK4 mRNA	PMID:23806026
1313392	PLK4	polo like kinase 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PLK4 mRNA	PMID:20382639
1313392	PLK4	polo like kinase 4	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PLK4 mRNA	PMID:26705709
1313392	PLK4	polo like kinase 4	gene	CHEBI:30966	glycidol	affects expression	ISO	RGD:1305390	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol affects the expression of PLK4 mRNA	PMID:24395379
1313392	PLK4	polo like kinase 4	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of PLK4 mRNA	PMID:21829687
1313392	PLK4	polo like kinase 4	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1305390	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of PLK4 mRNA	PMID:22641619
1313392	PLK4	polo like kinase 4	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305390	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of PLK4 mRNA	PMID:25729387
1313392	PLK4	polo like kinase 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305390	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PLK4 mRNA	PMID:25729387
1313392	PLK4	polo like kinase 4	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of PLK4 mRNA	PMID:15498508
1313392	PLK4	polo like kinase 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313393	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLK4 gene	PMID:35295148
1313392	PLK4	polo like kinase 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305390	E	RGD:6480464	20121009	CTD	MESH:D013853	Thioacetamide results in increased expression of PLK4 mRNA	PMID:22659510|PMID:34492290
1313392	PLK4	polo like kinase 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1305390	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PLK4 mRNA	PMID:12832660
1313392	PLK4	polo like kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PLK4 mRNA	PMID:29275510
1313392	PLK4	polo like kinase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305390	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of PLK4 mRNA	PMID:26982218|PMID:30816183|PMID:32528016
1313392	PLK4	polo like kinase 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of PLK4 mRNA	PMID:16474171
1313392	PLK4	polo like kinase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305390	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PLK4 mRNA	PMID:25181051|PMID:32145629
1313392	PLK4	polo like kinase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313393	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PLK4 mRNA	PMID:26063408
1313392	PLK4	polo like kinase 4	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313393	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of PLK4 mRNA	PMID:26682919
1313392	PLK4	polo like kinase 4	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of PLK4 mRNA	PMID:20713471
1313392	PLK4	polo like kinase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of PLK4 mRNA	PMID:40203079
1313392	PLK4	polo like kinase 4	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PLK4 mRNA	PMID:37019170
1313392	PLK4	polo like kinase 4	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305390	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of PLK4 mRNA	PMID:22546817
1313392	PLK4	polo like kinase 4	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305390	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of PLK4 mRNA	PMID:22546817
1313392	PLK4	polo like kinase 4	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PLK4 mRNA	PMID:17854601
1313392	PLK4	polo like kinase 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of PLK4 mRNA]	PMID:17854601
1313392	PLK4	polo like kinase 4	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305390	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of PLK4 mRNA	PMID:22546817
1313392	PLK4	polo like kinase 4	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20190219	CTD	MESH:D010269	[ATG7 protein affects the susceptibility to Paraquat] which affects the expression of PLK4 mRNA	PMID:28012437
1313392	PLK4	polo like kinase 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PLK4 mRNA	PMID:37042841
1313392	PLK4	polo like kinase 4	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of PLK4 mRNA	PMID:26678675
1313392	PLK4	polo like kinase 4	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLK4 mRNA	PMID:39836092
1313392	PLK4	polo like kinase 4	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305390	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of PLK4 mRNA	PMID:30723492
1313392	PLK4	polo like kinase 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PLK4 mRNA	PMID:38174414
1313392	PLK4	polo like kinase 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PLK4 protein	PMID:38185225
1313392	PLK4	polo like kinase 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:D019256	Cadmium Chloride promotes the reaction [[CCDC85C protein binds to PLK4 protein] which results in increased localization of CCDC85C protein]; Cadmium Chloride promotes the reaction [[CCDC85C protein binds to PLK4 protein] which results in increased localization of PLK4 protein]; Cadmium Chloride promotes the reaction [CCDC85C protein binds to PLK4 protein]; Cadmium Chloride results in increased expression of and results in increased localization of PLK4 protein; CCDC85C protein promotes the reaction [Cadmium Chloride results in increased expression of PLK4 protein]; CCDC85C protein promotes the reaction [Cadmium Chloride results in increased localization of PLK4 protein]; GCLM protein promotes the reaction [Cadmium Chloride results in increased expression of PLK4 protein]; PLK4 protein promotes the reaction [Cadmium Chloride results in increased localization of PLK4 protein]	PMID:38185225
1313392	PLK4	polo like kinase 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLK4 mRNA	PMID:28111341
1313392	PLK4	polo like kinase 4	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PLK4 mRNA	PMID:36326898
1313392	PLK4	polo like kinase 4	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305390	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of PLK4 mRNA	PMID:25539665
1313392	PLK4	polo like kinase 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PLK4 mRNA	PMID:24449571
1313392	PLK4	polo like kinase 4	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PLK4 mRNA	PMID:40194260
1313392	PLK4	polo like kinase 4	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PLK4 mRNA	PMID:28302478
1313392	PLK4	polo like kinase 4	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PLK4 mRNA	PMID:31533062
1313392	PLK4	polo like kinase 4	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of PLK4 mRNA	PMID:19167446
1313392	PLK4	polo like kinase 4	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK4 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of PLK4 mRNA	PMID:19167446
1313392	PLK4	polo like kinase 4	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PLK4 mRNA	PMID:39529242
1313392	PLK4	polo like kinase 4	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1305390	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of PLK4 mRNA	PMID:22110744
1313392	PLK4	polo like kinase 4	gene	CHEBI:3962	curcumin	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D003474	Curcumin analog results in increased expression of PLK4 mRNA	PMID:26409325
1313392	PLK4	polo like kinase 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLK4 mRNA	PMID:25979313
1313392	PLK4	polo like kinase 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLK4 mRNA	PMID:23179753|PMID:27188386
1313392	PLK4	polo like kinase 4	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305390	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of PLK4 mRNA	PMID:41580965
1313392	PLK4	polo like kinase 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of PLK4 mRNA	PMID:20106945|PMID:21632981|PMID:22147139
1313392	PLK4	polo like kinase 4	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1305390	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in decreased expression of PLK4 mRNA	PMID:20032058
1313392	PLK4	polo like kinase 4	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1305390	E	RGD:6480464	20120412	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of PLK4 mRNA]	PMID:20032058
1313392	PLK4	polo like kinase 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PLK4 mRNA	PMID:28973697
1313392	PLK4	polo like kinase 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313393	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PLK4 mRNA	PMID:28973697
1313392	PLK4	polo like kinase 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLK4 mRNA	PMID:37992649
1313392	PLK4	polo like kinase 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of PLK4 mRNA	PMID:18502557
1313392	PLK4	polo like kinase 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PLK4 mRNA	PMID:38832940
1313392	PLK4	polo like kinase 4	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PLK4 mRNA	PMID:27188386
1313392	PLK4	polo like kinase 4	gene	CHEBI:45863	paclitaxel	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of PLK4 mRNA	PMID:15000894
1313392	PLK4	polo like kinase 4	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PLK4 mRNA	PMID:28542535
1313392	PLK4	polo like kinase 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLK4 mRNA	PMID:26690555
1313392	PLK4	polo like kinase 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305390	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLK4 mRNA	PMID:33387578
1313392	PLK4	polo like kinase 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PLK4 mRNA	PMID:22230336
1313392	PLK4	polo like kinase 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLK4 mRNA	PMID:39836092
1313392	PLK4	polo like kinase 4	gene	CHEBI:4744	Echimidine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C000615871	[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of PLK4 mRNA	PMID:33884520
1313392	PLK4	polo like kinase 4	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of PLK4 mRNA	PMID:40706910
1313392	PLK4	polo like kinase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1305390	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PLK4 mRNA	PMID:17351261
1313392	PLK4	polo like kinase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PLK4 mRNA	PMID:17942748
1313392	PLK4	polo like kinase 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLK4 mRNA	PMID:17942748
1313392	PLK4	polo like kinase 4	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PLK4 mRNA	PMID:26705709
1313392	PLK4	polo like kinase 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313393	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PLK4 mRNA; Nanotubes, Carbon results in increased expression of PLK4 mRNA	PMID:25554681
1313392	PLK4	polo like kinase 4	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305390	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of PLK4 mRNA	PMID:41580965
1313392	PLK4	polo like kinase 4	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of PLK4 mRNA	PMID:21148553
1313392	PLK4	polo like kinase 4	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PLK4 mRNA	PMID:19042947
1313392	PLK4	polo like kinase 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLK4 mRNA	PMID:39836092
1313392	PLK4	polo like kinase 4	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PLK4 mRNA	PMID:21641980
1313392	PLK4	polo like kinase 4	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305390	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of PLK4 mRNA	PMID:25729387
1313392	PLK4	polo like kinase 4	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305390	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PLK4 mRNA	PMID:25729387
1313392	PLK4	polo like kinase 4	gene	CHEBI:6382	Lasiocarpine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of PLK4 mRNA	PMID:33884520
1313392	PLK4	polo like kinase 4	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1313393	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of PLK4 mRNA	PMID:19812364
1313392	PLK4	polo like kinase 4	gene	CHEBI:63924	riddelliine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of PLK4 mRNA	PMID:33884520
1313392	PLK4	polo like kinase 4	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313393	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PLK4 mRNA	PMID:23650126
1313392	PLK4	polo like kinase 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305390	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PLK4 mRNA	PMID:37269647
1313392	PLK4	polo like kinase 4	gene	CHEBI:6980	monocrotaline	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of PLK4 mRNA	PMID:33884520
1313392	PLK4	polo like kinase 4	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLK4 mRNA	PMID:39752319
1313392	PLK4	polo like kinase 4	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of PLK4 mRNA	PMID:29522793
1313392	PLK4	polo like kinase 4	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PLK4 mRNA	PMID:37199045
1313392	PLK4	polo like kinase 4	gene	CHEBI:754906	afuresertib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of PLK4 mRNA	PMID:28960945
1313392	PLK4	polo like kinase 4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313393	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of PLK4 mRNA	PMID:23091169
1313392	PLK4	polo like kinase 4	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PLK4 mRNA	PMID:19167446
1313392	PLK4	polo like kinase 4	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of PLK4 mRNA	PMID:21858171
1313392	PLK4	polo like kinase 4	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin promotes the reaction [Piroxicam results in decreased expression of PLK4 mRNA]	PMID:21858171
1313392	PLK4	polo like kinase 4	gene	CHEBI:82615	diminazene diaceturate	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C003915	diminazene aceturate results in decreased expression of PLK4 mRNA	PMID:37681557
1313392	PLK4	polo like kinase 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305390	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PLK4 mRNA	PMID:24780913
1313392	PLK4	polo like kinase 4	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313393	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of PLK4 mRNA	PMID:39752319
1313392	PLK4	polo like kinase 4	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1305390	E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of PLK4 mRNA	PMID:32419051
1313392	PLK4	polo like kinase 4	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019284	Thapsigargin results in increased expression of PLK4 mRNA	PMID:19442820
1313392	PLK4	polo like kinase 4	gene	CHEBI:9516	thapsigargin	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019284	4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in increased expression of PLK4 mRNA]; caffeic acid promotes the reaction [Thapsigargin results in increased expression of PLK4 mRNA]; Drugs, Chinese Herbal promotes the reaction [Thapsigargin results in increased expression of PLK4 mRNA]	PMID:19442820
1313392	PLK4	polo like kinase 4	gene	CHEBI:9607	Tiron	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:D014013	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt results in increased expression of PLK4 protein	PMID:22785532
1313392	PLK4	polo like kinase 4	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of PLK4 mRNA	PMID:19140230
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313395	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NAP1L4 mRNA	PMID:33045310
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of NAP1L4 protein	PMID:35688186
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313395	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NAP1L4 mRNA	PMID:39241906
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of NAP1L4 mRNA	PMID:23019147
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305391	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NAP1L4 mRNA	PMID:33387578
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313395	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NAP1L4 mRNA	PMID:34319233
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NAP1L4 protein	PMID:37730182
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305391	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of NAP1L4 mRNA	PMID:22061828
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of NAP1L4 mRNA	PMID:39836092
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NAP1L4 3' UTR	PMID:30157460
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NAP1L4 mRNA	PMID:23649840
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of NAP1L4 protein	PMID:19845377
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313395	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of NAP1L4 mRNA	PMID:12763052
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313395	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NAP1L4 mRNA	PMID:34911549
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of NAP1L4 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of NAP1L4 protein	PMID:38598786
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305391	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of NAP1L4 mRNA	PMID:30779732
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NAP1L4 mRNA	PMID:25629700
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313395	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAP1L4 mRNA	PMID:22206623
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NAP1L4 gene	PMID:25304211
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313395	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NAP1L4 mRNA	PMID:40504410
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NAP1L4 protein	PMID:38460933
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NAP1L4 mRNA	PMID:23557933
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of NAP1L4 mRNA	PMID:27392435
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of NAP1L4 mRNA	PMID:16705744
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NAP1L4 mRNA	PMID:22574217
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313395	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NAP1L4 mRNA	PMID:21570461
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of NAP1L4 protein	PMID:29385562
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NAP1L4 mRNA	PMID:38568856
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313395	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of NAP1L4 protein	PMID:29044176
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313395	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NAP1L4 mRNA	PMID:40504410
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NAP1L4 5' UTR; Benzo(a)pyrene results in decreased methylation of NAP1L4 promoter	PMID:27901495
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NAP1L4 mRNA	PMID:19150397
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of NAP1L4 mRNA	PMID:34408198
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NAP1L4 gene	PMID:31601247
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313395	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NAP1L4 gene	PMID:35295148
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of NAP1L4 mRNA	PMID:18648102
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NAP1L4 mRNA	PMID:19710929
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of NAP1L4 mRNA; bisphenol A results in decreased expression of NAP1L4 protein	PMID:29275510|PMID:31675489
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305391	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NAP1L4 mRNA	PMID:34947998
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of NAP1L4 protein	PMID:37567409
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305391	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NAP1L4 mRNA	PMID:25181051|PMID:41034487
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313395	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of NAP1L4 mRNA	PMID:26063408
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NAP1L4 gene	PMID:31601247
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of NAP1L4 mRNA	PMID:25979313
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313395	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NAP1L4 mRNA	PMID:39298647
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of NAP1L4 mRNA	PMID:28628672
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of NAP1L4 3' UTR	PMID:30157460
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NAP1L4 mRNA	PMID:28628672
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NAP1L4 mRNA	PMID:17361019
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of NAP1L4 mRNA	PMID:34813904
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of NAP1L4 protein	PMID:38598786
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NAP1L4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of NAP1L4 mRNA	PMID:28628672
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of NAP1L4 mRNA	PMID:34813904
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of NAP1L4 mRNA	PMID:39836092
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NAP1L4 mRNA	PMID:26472689
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of NAP1L4 protein	PMID:34122009
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of NAP1L4 mRNA	PMID:19167446
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313395	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NAP1L4 mRNA	PMID:17292431
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NAP1L4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of NAP1L4 mRNA	PMID:28628672
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313395	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NAP1L4 mRNA	PMID:17562736
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of NAP1L4 protein	PMID:38460933
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NAP1L4 gene	PMID:25304211
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313395	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NAP1L4 mRNA	PMID:40504410
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:47286	CU-O LINKAGE	increases phosphorylation	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased phosphorylation of NAP1L4 protein	PMID:25470785
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of NAP1L4 mRNA	PMID:35436446
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313395	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NAP1L4 mRNA	PMID:17942748
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of NAP1L4 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of NAP1L4 mRNA	PMID:28628672
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305391	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NAP1L4 mRNA	PMID:24136188
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of NAP1L4 mRNA	PMID:26377693
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NAP1L4 protein	PMID:32959892
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of NAP1L4 mRNA	PMID:39836092
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313395	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NAP1L4 protein	PMID:26558463
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of NAP1L4 3' UTR	PMID:30157460
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313395	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of NAP1L4 mRNA	PMID:22206623
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313395	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NAP1L4 mRNA	PMID:22206623
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of NAP1L4 protein	PMID:37664457
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of NAP1L4 protein	PMID:39638853
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313395	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of NAP1L4 mRNA	PMID:31388691
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of NAP1L4 protein	PMID:37664457
1313394	NAP1L4	nucleosome assembly protein 1 like 4	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of NAP1L4 protein	PMID:38598786
1313396	CPNE6	copine 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313397	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CPNE6 mRNA	PMID:20938992
1313396	CPNE6	copine 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1583895	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CPNE6 mRNA	PMID:33729688
1313396	CPNE6	copine 6	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313397	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CPNE6 mRNA	PMID:30319688
1313396	CPNE6	copine 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313397	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CPNE6 mRNA	PMID:39241906
1313396	CPNE6	copine 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313397	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CPNE6 mRNA]	PMID:39241906
1313396	CPNE6	copine 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313397	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CPNE6 mRNA	PMID:20938992
1313396	CPNE6	copine 6	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1583895	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CPNE6 mRNA	PMID:26577399
1313396	CPNE6	copine 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1583895	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CPNE6 mRNA	PMID:39012411
1313396	CPNE6	copine 6	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CPNE6 mRNA	PMID:22100608|PMID:32234424
1313396	CPNE6	copine 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313397	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CPNE6 mRNA	PMID:20938992
1313396	CPNE6	copine 6	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1583895	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of CPNE6 mRNA	PMID:19013527
1313396	CPNE6	copine 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CPNE6 mRNA	PMID:38568856
1313396	CPNE6	copine 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CPNE6 promoter	PMID:27901495
1313396	CPNE6	copine 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CPNE6 mRNA	PMID:32234424
1313396	CPNE6	copine 6	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of CPNE6 gene	PMID:25435355
1313396	CPNE6	copine 6	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CPNE6 protein]	PMID:26598702
1313396	CPNE6	copine 6	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313397	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CPNE6 mRNA	PMID:19710929
1313396	CPNE6	copine 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313397	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CPNE6 mRNA	PMID:32156529
1313396	CPNE6	copine 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1583895	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CPNE6 mRNA	PMID:25181051|PMID:38750585
1313396	CPNE6	copine 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in decreased expression of CPNE6 mRNA	PMID:30616060
1313396	CPNE6	copine 6	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313397	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of CPNE6 mRNA	PMID:36117858
1313396	CPNE6	copine 6	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313397	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CPNE6 mRNA]	PMID:39241906
1313396	CPNE6	copine 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1583895	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CPNE6 mRNA	PMID:39012411
1313396	CPNE6	copine 6	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1583895	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of CPNE6 mRNA	PMID:25539665
1313396	CPNE6	copine 6	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of CPNE6 promoter	PMID:27989131
1313396	CPNE6	copine 6	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CPNE6 mRNA	PMID:38832940
1313396	CPNE6	copine 6	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CPNE6 mRNA	PMID:32234424
1313396	CPNE6	copine 6	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CPNE6 protein]	PMID:26598702
1313396	CPNE6	copine 6	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313397	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of CPNE6 mRNA	PMID:36117858
1313396	CPNE6	copine 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313397	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CPNE6 mRNA	PMID:22206623
1313396	CPNE6	copine 6	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CPNE6 gene]	PMID:28238834
1313396	CPNE6	copine 6	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1583895	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CPNE6 mRNA	PMID:32109520
1313396	CPNE6	copine 6	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1583895	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of CPNE6 protein	PMID:28903499
1313396	CPNE6	copine 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1583895	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CPNE6 mRNA	PMID:24780913
1313396	CPNE6	copine 6	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313397	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CPNE6 mRNA]	PMID:39241906
1313396	CPNE6	copine 6	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1583895	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of CPNE6 gene	PMID:31682807
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TIGD3 mRNA	PMID:38218311
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550196	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TIGD3 mRNA	PMID:30319688
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TIGD3 mRNA	PMID:20044591
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550196	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TIGD3 mRNA	PMID:39241906
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305393	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in increased expression of TIGD3 mRNA]	PMID:20032058
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of TIGD3 mRNA	PMID:33647349
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TIGD3 mRNA	PMID:34319233
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TIGD3 mRNA	PMID:19549813
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TIGD3 mRNA	PMID:21641981
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TIGD3 mRNA	PMID:27392435
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305393	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TIGD3 mRNA	PMID:33387578
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TIGD3 mRNA	PMID:19933214
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of TIGD3 mRNA	PMID:29955902
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TIGD3 mRNA	PMID:32763439
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of TIGD3 mRNA	PMID:36209798
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TIGD3 mRNA	PMID:23806026
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TIGD3 mRNA	PMID:35984750
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1305393	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of TIGD3 mRNA	PMID:24915197
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TIGD3 mRNA	PMID:29264374
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550196	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TIGD3 gene	PMID:35295148
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550196	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TIGD3 promoter	PMID:35295148
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305393	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TIGD3 mRNA	PMID:34492290
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305393	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of TIGD3 mRNA	PMID:19167457
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305393	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TIGD3 mRNA	PMID:25181051|PMID:30816183
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of TIGD3 mRNA	PMID:30951980
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TIGD3 mRNA	PMID:37042841
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of TIGD3 mRNA	PMID:39529242
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1550196	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of TIGD3 mRNA	PMID:40633821
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1305393	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of TIGD3 mRNA	PMID:20032058
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1305393	E	RGD:6480464	20120412	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in increased expression of TIGD3 mRNA]	PMID:20032058
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TIGD3 mRNA	PMID:38832940
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of TIGD3 mRNA	PMID:24935251
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305393	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TIGD3 mRNA	PMID:33387578
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TIGD3 mRNA	PMID:28988120
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of TIGD3 mRNA	PMID:36318118
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TIGD3 gene]	PMID:28238834
1313398	TIGD3	tigger transposable element derived 3	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1305393	E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of TIGD3 mRNA	PMID:29162477
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of JMJD6 mRNA	PMID:38218311
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313401	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of JMJD6 mRNA	PMID:33045310
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305395	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of JMJD6 mRNA]	PMID:31150632
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of JMJD6 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of JMJD6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of JMJD6 mRNA	PMID:32699268|PMID:32845096
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313401	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of JMJD6 mRNA	PMID:20880076
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of JMJD6 mRNA	PMID:30529165
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of JMJD6 protein	PMID:28073184
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of JMJD6 mRNA	PMID:29581250
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313401	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of JMJD6 mRNA	PMID:39241906
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313401	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of JMJD6 mRNA	PMID:15598610
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of JMJD6 mRNA	PMID:37042841
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of JMJD6 mRNA	PMID:20655997|PMID:23649840
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of JMJD6 mRNA	PMID:38685446
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of JMJD6 mRNA	PMID:33647349
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of JMJD6 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of JMJD6 mRNA]	PMID:20230807
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305395	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of JMJD6 mRNA	PMID:33387578
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1313401	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of JMJD6 mRNA	PMID:20230807
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20120501	CTD	MESH:D015632	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of JMJD6 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of JMJD6 mRNA]	PMID:20230807
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of JMJD6 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of JMJD6 mRNA]	PMID:20230807
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20120717	CTD	MESH:D008769	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of JMJD6 mRNA	PMID:19840844
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of JMJD6 mRNA	PMID:21120746
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of JMJD6 protein	PMID:23301498
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313401	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of JMJD6 mRNA	PMID:19770486
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of JMJD6 mRNA	PMID:23649840
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of JMJD6 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of JMJD6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of JMJD6 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of JMJD6 mRNA	PMID:32699268|PMID:32845096
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of JMJD6 mRNA	PMID:18593933
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305395	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of JMJD6 mRNA	PMID:31150632
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313401	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of JMJD6 mRNA	PMID:31919559
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305395	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of JMJD6 mRNA]	PMID:31150632
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of JMJD6 mRNA]	PMID:22206623
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of JMJD6 mRNA	PMID:18414638
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of JMJD6 gene	PMID:25304211
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of JMJD6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of JMJD6 mRNA	PMID:32525701|PMID:39836092
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of JMJD6 mRNA	PMID:33512557
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of JMJD6 mRNA	PMID:21151649
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313401	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of JMJD6 mRNA	PMID:30912803
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313401	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of JMJD6 mRNA	PMID:21570461|PMID:24680724
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305395	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of JMJD6 mRNA	PMID:32109520
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of JMJD6 mRNA	PMID:28001369
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of JMJD6 mRNA	PMID:33212167
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28358	rac-lactic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of JMJD6 mRNA	PMID:30851411
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28428	beta-hexachlorocyclohexane	increases expression	ISO	RGD:1313401	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in increased expression of JMJD6 mRNA	PMID:25270620
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of JMJD6 mRNA	PMID:32763439
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305395	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of JMJD6 mRNA	PMID:28959563
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of JMJD6 mRNA	PMID:29803840
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in decreased expression of JMJD6 protein	PMID:39571964
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of JMJD6 mRNA	PMID:34032870|PMID:36586010|PMID:38568856
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of JMJD6 mRNA	PMID:39836092
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of JMJD6 mRNA	PMID:18593933
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of JMJD6 mRNA	PMID:25351596
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of JMJD6 mRNA	PMID:19150397
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:31206	ammonium chloride	increases expression	ISO	RGD:1305395	E	RGD:6480464	20230117	CTD	MESH:D000643	Ammonium Chloride results in increased expression of JMJD6 protein	PMID:16483693
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305395	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of JMJD6 mRNA	PMID:24136188
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of JMJD6 mRNA	PMID:21829687
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:32195	Tesaglitazar	increases expression	ISO	RGD:1305395	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of JMJD6 mRNA	PMID:21515302
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313401	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of JMJD6 gene; titanium dioxide results in decreased methylation of JMJD6 promoter alternative form	PMID:35295148
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305395	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of JMJD6 mRNA	PMID:23411599|PMID:34492290
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of JMJD6 mRNA	PMID:19710929
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:32588	potassium chloride	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D011189	[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of JMJD6 mRNA	PMID:29691375
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305395	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of JMJD6 mRNA	PMID:25181051
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305395	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of JMJD6 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305395	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of JMJD6 gene	PMID:28505145
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305395	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of JMJD6 mRNA	PMID:23196670
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313401	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of JMJD6 exon	PMID:33297965
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313401	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of JMJD6 mRNA	PMID:39298647
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313401	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of JMJD6 mRNA	PMID:37019170
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305395	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of JMJD6 mRNA	PMID:22546817
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305395	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of JMJD6 mRNA	PMID:21266533
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305395	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of JMJD6 mRNA	PMID:22546817
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:1313401	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of JMJD6 mRNA	PMID:25270620
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20151215	CTD	MESH:D015056	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 mRNA; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 protein; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of CEBPA protein]; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]	PMID:26117538
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305395	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of JMJD6 mRNA	PMID:22546817
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:34887	nickel dichloride	increases expression	ISO	RGD:1305395	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of JMJD6 mRNA	PMID:22110744
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of JMJD6 mRNA	PMID:37042841
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of JMJD6 mRNA	PMID:38568856
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20120717	CTD	MESH:D019256	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of JMJD6 mRNA	PMID:19840844
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of JMJD6 mRNA	PMID:19320972|PMID:19376846
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305395	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of JMJD6 mRNA	PMID:24386269
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of JMJD6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of JMJD6 mRNA	PMID:32699268
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of JMJD6 mRNA	PMID:17585979
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of JMJD6 mRNA	PMID:33512557
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305395	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of JMJD6 mRNA	PMID:25993096
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of JMJD6 mRNA	PMID:25979313
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313401	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of JMJD6 mRNA	PMID:17292431|PMID:17963808
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of JMJD6 mRNA	PMID:19136453
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of JMJD6 mRNA	PMID:23179753|PMID:29154799
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305395	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of JMJD6 mRNA	PMID:30047161|PMID:41580965
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of JMJD6 mRNA	PMID:20106945|PMID:25562108
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:41607	crotonaldehyde	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in increased expression of JMJD6 mRNA	PMID:20471460
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20151215	CTD	MESH:D003907	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 mRNA; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 protein; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of CEBPA protein]; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]	PMID:26117538
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of JMJD6 mRNA	PMID:33512557
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of JMJD6 mRNA	PMID:38832940
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of JMJD6 mRNA	PMID:29279043
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of JMJD6 mRNA	PMID:25351596
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of JMJD6 mRNA	PMID:18414638
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of JMJD6 gene	PMID:25304211
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of JMJD6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of JMJD6 mRNA	PMID:32525701|PMID:39836092
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:5011	fenpyroximate	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of JMJD6 mRNA	PMID:33512557
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313401	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of JMJD6 mRNA; Nanotubes, Carbon results in increased expression of JMJD6 mRNA	PMID:25554681
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305395	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of JMJD6 mRNA	PMID:30047161
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of JMJD6 mRNA	PMID:40234311
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305395	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of JMJD6 mRNA	PMID:24136188
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:53001	nickel sulfate	increases expression	ISO	RGD:1313401	E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of JMJD6 mRNA	PMID:16166746
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of JMJD6 protein	PMID:32959892
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of JMJD6 mRNA	PMID:28988120
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased methylation of JMJD6 gene	PMID:29432895
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of JMJD6 mRNA	PMID:15336504
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:6809	methamphetamine	decreases methylation	ISO	RGD:1313401	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased methylation of JMJD6 promoter	PMID:26307267
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313401	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of JMJD6 mRNA	PMID:26307267
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313401	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of JMJD6 mRNA	PMID:22206623
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of JMJD6 mRNA]	PMID:22206623
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of JMJD6 mRNA	PMID:37199045
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:755208	eprenetapopt	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of JMJD6 mRNA	PMID:19946333
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of JMJD6 mRNA]	PMID:19946333
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of JMJD6 protein	PMID:31285264
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of JMJD6 protein	PMID:39638853
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of JMJD6 mRNA	PMID:22124623
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305395	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of JMJD6 mRNA	PMID:22124623
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305395	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of JMJD6 mRNA	PMID:21346803
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of JMJD6 mRNA	PMID:30851411
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to JMJD6 gene]	PMID:28238834
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1313401	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of JMJD6 mRNA	PMID:21195148
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of JMJD6 mRNA	PMID:33512557
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1313401	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of JMJD6 mRNA	PMID:21195148
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of JMJD6 mRNA	PMID:31558096
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:8249	piroxicam	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of JMJD6 mRNA	PMID:21858171
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of JMJD6 mRNA	PMID:32525701
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305395	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of JMJD6 mRNA	PMID:30047161
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313401	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of JMJD6 mRNA	PMID:40826991
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:87368	diethyl malate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C058705	diethyl malate results in increased expression of JMJD6 mRNA	PMID:38498338
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1313401	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of JMJD6 protein	PMID:35357534
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305395	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of JMJD6 mRNA	PMID:21346803
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of JMJD6 mRNA	PMID:33512557
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of JMJD6 mRNA	PMID:38568856
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of JMJD6 mRNA	PMID:29301935
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1313401	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of JMJD6 mRNA	PMID:21195148
1313400	JMJD6	jumonji domain containing 6, arginine demethylase and lysine hydroxylase	gene	CHEBI:9753	troglitazone	multiple interactions	ISO	RGD:1313401	E	RGD:6480464	20151215	CTD	MESH:C057693	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 mRNA; [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of JMJD6 protein; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of CEBPA protein]; JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]	PMID:26117538
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RSU1 mRNA	PMID:38218311
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313403	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of RSU1 mRNA	PMID:33045310
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313403	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of RSU1 mRNA	PMID:37995155
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RSU1 mRNA	PMID:33167477
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of RSU1 mRNA	PMID:19167446
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313403	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RSU1 mRNA	PMID:34319233
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1591781	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RSU1 mRNA	PMID:33387578
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313403	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RSU1 mRNA	PMID:37236586
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of RSU1 mRNA	PMID:23649840
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313403	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RSU1 mRNA	PMID:19770486
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of RSU1 mRNA	PMID:23649840
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of RSU1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RSU1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RSU1 protein	PMID:38598786
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313403	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RSU1 mRNA	PMID:31919559
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RSU1 mRNA	PMID:21867686
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313403	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RSU1 mRNA	PMID:40504410
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1591781	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of RSU1 gene	PMID:35440735
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in increased expression of RSU1 mRNA	PMID:21858171
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313403	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in decreased expression of RSU1 mRNA	PMID:12540486
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313403	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RSU1 mRNA	PMID:21570461
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1591781	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RSU1 mRNA	PMID:32109520
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of RSU1 protein	PMID:39603559
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RSU1 mRNA	PMID:33212167
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313403	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of RSU1 protein	PMID:28918527
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RSU1 mRNA	PMID:38568856
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313403	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RSU1 mRNA	PMID:40504410
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313403	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RSU1 mRNA	PMID:21715664
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313403	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RSU1 mRNA	PMID:22228805
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of RSU1 promoter	PMID:23974009
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of RSU1 mRNA	PMID:26705709
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of RSU1 gene	PMID:31601247
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313403	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of RSU1 mRNA	PMID:29264374
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313403	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RSU1 mRNA	PMID:18648102
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1591781	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RSU1 mRNA	PMID:25181051
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313403	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RSU1 mRNA; bisphenol A results in decreased expression of RSU1 protein	PMID:33221593|PMID:35999755
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1591781	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RSU1 mRNA	PMID:30816183|PMID:34947998
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of RSU1 protein	PMID:34186270|PMID:37567409
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1591781	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RSU1 gene	PMID:28505145
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of RSU1 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RSU1 mRNA	PMID:28628672|PMID:31601247
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313403	E	RGD:6480464	20200519	CTD	MESH:C543008	bisphenol S results in increased expression of RSU1 mRNA	PMID:31881267
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RSU1 protein	PMID:34186270
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313403	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RSU1 mRNA	PMID:37019170
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313403	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of RSU1 protein	PMID:35999755
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RSU1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of RSU1 protein	PMID:38598786
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RSU1 mRNA	PMID:28628672
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RSU1 mRNA	PMID:37042841
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313403	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RSU1 mRNA	PMID:37236586
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313403	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RSU1 mRNA	PMID:40194260
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of RSU1 mRNA	PMID:19167446
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RSU1 mRNA	PMID:19167446
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RSU1 mRNA	PMID:25979313
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313403	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RSU1 mRNA	PMID:17292431
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RSU1 mRNA	PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509|PMID:28001369
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RSU1 mRNA	PMID:27188386
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RSU1 mRNA	PMID:20106945|PMID:25562108
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313403	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RSU1 mRNA	PMID:17555576
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RSU1 mRNA	PMID:28628672
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RSU1 mRNA	PMID:38832940
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313403	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RSU1 mRNA	PMID:40504410
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1591781	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RSU1 mRNA	PMID:29391264
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313403	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RSU1 mRNA	PMID:17555576
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RSU1 mRNA	PMID:28628672
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of RSU1 mRNA	PMID:26705709
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:50594	carbon nanotube	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	[Nanotubes, Carbon co-treated with calfactant] results in decreased expression of RSU1 protein	PMID:23026733
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313403	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of RSU1 mRNA	PMID:40234311
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313403	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RSU1 mRNA	PMID:35964746
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of RSU1 mRNA	PMID:20977926
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RSU1 protein	PMID:32959892
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313403	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RSU1 mRNA	PMID:23650126
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of RSU1 mRNA	PMID:31758290
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313403	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RSU1 mRNA	PMID:22206623
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:749466	calfactant	multiple interactions	EXP		E	RGD:6480464	20260721	CTD	MESH:C117342	[Nanotubes, Carbon co-treated with calfactant] results in decreased expression of RSU1 protein	PMID:23026733
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RSU1 mRNA	PMID:27188386
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RSU1 gene]	PMID:28238834
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RSU1 mRNA	PMID:19167446
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in increased expression of RSU1 mRNA	PMID:21858171
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RSU1 mRNA	PMID:27188386
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RSU1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RSU1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of RSU1 protein	PMID:38598786
1313402	RSU1	Ras suppressor protein 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1591781	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RSU1 mRNA	PMID:19015723
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313405	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RBSN mRNA	PMID:33045310
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313405	E	RGD:6480464	20150310	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RBSN mRNA	PMID:20188158
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RBSN mRNA	PMID:37042841
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of RBSN mRNA	PMID:28973375
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RBSN protein	PMID:37730182
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305397	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RBSN mRNA	PMID:31150632
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313405	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RBSN mRNA	PMID:22206623
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RBSN protein	PMID:35688186
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RBSN mRNA	PMID:23557933
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of RBSN mRNA	PMID:27594783
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RBSN mRNA	PMID:30912803
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of RBSN mRNA	PMID:32186404
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313405	E	RGD:6480464	20150310	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RBSN mRNA	PMID:21570461
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305397	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RBSN mRNA	PMID:33387578
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313405	E	RGD:6480464	20160822	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RBSN mRNA	PMID:25975270
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of RBSN protein	PMID:35688186
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RBSN mRNA	PMID:38568856
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313405	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of RBSN protein	PMID:29044176
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RBSN 5' UTR; Benzo(a)pyrene results in increased methylation of RBSN promoter	PMID:27901495
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313405	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of RBSN protein	PMID:37955338
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20150310	CTD	MESH:C008261	lead acetate results in decreased expression of RBSN mRNA	PMID:21829687
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313405	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RBSN gene	PMID:35295148
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20150310	CTD	MESH:C006253	pirinixic acid results in decreased expression of RBSN mRNA	PMID:20813756
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305397	E	RGD:6480464	20160822	CTD	MESH:C006780	bisphenol A results in increased expression of RBSN mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313405	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RBSN mRNA	PMID:26063408
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to RBSN promoter]	PMID:20348232
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313405	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RBSN mRNA	PMID:38685157
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1305397	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of RBSN mRNA	PMID:21241498
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RBSN mRNA	PMID:37019170
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1305397	E	RGD:6480464	20150310	CTD	MESH:D002509	Cephaloridine results in decreased expression of RBSN mRNA	PMID:18500788
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C018021	cobaltous chloride results in increased expression of RBSN mRNA	PMID:19320972
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1305397	E	RGD:6480464	20150310	CTD	MESH:D002737	Chloroprene results in increased expression of RBSN mRNA	PMID:23125180
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RBSN gene	PMID:29154799
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D016572	Cyclosporine results in increased expression of RBSN mRNA	PMID:20106945
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of RBSN mRNA	PMID:29279043
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313405	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RBSN mRNA	PMID:22206623
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313405	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RBSN mRNA	PMID:22206623
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1305397	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of RBSN protein	PMID:28903499
1313404	RBSN	rabenosyn, RAB effector	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305397	E	RGD:6480464	20150310	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RBSN mRNA	PMID:21346803
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313407	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TAF13 mRNA	PMID:33045310
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of TAF13 mRNA	PMID:31016361
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of TAF13 mRNA	PMID:22574217
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TAF13 mRNA	PMID:31614463
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305398	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TAF13 mRNA	PMID:33387578
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TAF13 mRNA	PMID:37042841
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313407	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TAF13 mRNA	PMID:19850644
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313407	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TAF13 mRNA	PMID:33754040
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313407	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of TAF13 mRNA]	PMID:19850644
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305398	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of TAF13 mRNA	PMID:22061828
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TAF13 mRNA	PMID:28818685
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TAF13 promoter	PMID:30157460
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF13 mRNA	PMID:39836092
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TAF13 mRNA	PMID:19549813
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1305398	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of TAF13 mRNA	PMID:41580963
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:2682	amphotericin B	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of TAF13 mRNA	PMID:28534445
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF13 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF13 mRNA	PMID:39836092
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of TAF13 mRNA	PMID:26272509
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAF13 mRNA	PMID:27188386
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313407	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TAF13 mRNA	PMID:21570461|PMID:24680724
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305398	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TAF13 mRNA	PMID:32109520|PMID:33387578
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TAF13 mRNA	PMID:28001369
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TAF13 mRNA	PMID:39709020
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of TAF13 mRNA; [NSC 689534 binds to Copper] which results in increased expression of TAF13 mRNA	PMID:20971185|PMID:24690739
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TAF13 mRNA	PMID:38568856
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF13 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF13 mRNA	PMID:39836092
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TAF13 promoter	PMID:27901495
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF13 mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313407	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF13 mRNA	PMID:22228805
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of TAF13 mRNA; [NSC 689534 binds to Copper] which results in increased expression of TAF13 mRNA	PMID:20971185|PMID:24690739
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305398	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TAF13 mRNA	PMID:25729387
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305398	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TAF13 mRNA	PMID:30047161
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313407	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TAF13 mRNA	PMID:29264374
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313407	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of TAF13 mRNA	PMID:18648102
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TAF13 mRNA	PMID:19710929
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of TAF13 mRNA	PMID:38479592
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TAF13 mRNA	PMID:30903817
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313407	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TAF13 promoter	PMID:27334623
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF13 mRNA	PMID:29275510
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305398	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TAF13 mRNA	PMID:25181051
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305398	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TAF13 gene	PMID:28505145
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TAF13 mRNA	PMID:28628672
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF13 mRNA	PMID:28628672
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TAF13 mRNA	PMID:28628672
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313407	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TAF13 mRNA	PMID:28392331
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313407	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TAF13 mRNA	PMID:17361019|PMID:21266533
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TAF13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TAF13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF13 mRNA	PMID:28628672
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TAF13 mRNA	PMID:37042841
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF13 mRNA	PMID:39836092
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305398	E	RGD:6480464	20130806	CTD	MESH:C039281	furan results in increased methylation of TAF13 gene	PMID:22079235
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of TAF13 mRNA	PMID:28001369
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305398	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of TAF13 mRNA	PMID:38685447|PMID:41580965
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305398	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TAF13 mRNA	PMID:30047161
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TAF13 mRNA	PMID:20106945|PMID:25562108
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TAF13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TAF13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF13 mRNA	PMID:28628672
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305398	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TAF13 mRNA	PMID:24136188
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TAF13 mRNA	PMID:38832940
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305398	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TAF13 mRNA	PMID:33387578
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of TAF13 mRNA	PMID:24690739
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF13 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF13 mRNA	PMID:39836092
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of TAF13 mRNA	PMID:22077320
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TAF13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TAF13 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF13 mRNA	PMID:28628672
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305398	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of TAF13 mRNA	PMID:24136188
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305398	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of TAF13 mRNA	PMID:41580965
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305398	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TAF13 mRNA	PMID:30047161
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305398	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TAF13 mRNA	PMID:24136188
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF13 mRNA	PMID:39836092
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305398	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TAF13 mRNA	PMID:25729387
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313407	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TAF13 mRNA	PMID:22206623
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAF13 mRNA	PMID:27188386
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of TAF13 mRNA	PMID:30928695
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TAF13 gene]	PMID:28238834
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of TAF13 mRNA	PMID:19159669
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313407	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TAF13 mRNA	PMID:30294300
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313407	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TAF13 mRNA	PMID:39847705
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1305398	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of TAF13 mRNA	PMID:30047161
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305398	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TAF13 mRNA	PMID:30047161
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAF13 mRNA	PMID:27188386
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TAF13 mRNA	PMID:38568856
1313406	TAF13	TATA-box binding protein associated factor 13	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305398	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TAF13 mRNA	PMID:23034163
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1313409	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in decreased expression of IFNAR1 mRNA	PMID:17090620
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313409	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of IFNAR1 mRNA	PMID:33045310
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of IFNAR1 mRNA	PMID:33167477
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1305399	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of IFNAR1 mRNA	PMID:36841081
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of IFNAR1 mRNA	PMID:21632981
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313409	E	RGD:6480464	20161228	CTD	MESH:D008070	IFNAR1 protein affects the reaction [Lipopolysaccharides results in increased activity of STAT3 protein]	PMID:21586572
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313409	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of IFNAR1 mRNA	PMID:39298647
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:16830	methylamine	multiple interactions	ISO	RGD:1313409	E	RGD:6480464	20120412	CTD	MESH:C027451	methylamine inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of IFNAR1 protein]	PMID:18722370
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of IFNAR1 mRNA	PMID:18247414
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305399	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of IFNAR1 mRNA	PMID:22061828
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305399	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of IFNAR1 mRNA	PMID:22061828
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of IFNAR1 mRNA	PMID:18247414
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313409	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IFNAR1 mRNA	PMID:37325564
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of IFNAR1 mRNA	PMID:41430723
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:2618	amantadine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000547	Amantadine affects the expression of IFNAR1 mRNA	PMID:16756086
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of IFNAR1 mRNA	PMID:18316168
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of IFNAR1 mRNA	PMID:31295307
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:27878	2-naphthylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015081	2-Naphthylamine results in decreased expression of IFNAR1 mRNA	PMID:18247414
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in decreased expression of IFNAR1 mRNA	PMID:22228119
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of IFNAR1 mRNA	PMID:23195993
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305399	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IFNAR1 mRNA	PMID:33387578|PMID:34747641
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of IFNAR1 mRNA	PMID:28001369
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of IFNAR1 mRNA	PMID:30911355
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IFNAR1 mRNA	PMID:29803840
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of IFNAR1 mRNA	PMID:38568856
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IFNAR1 mRNA	PMID:18247414
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of IFNAR1 mRNA	PMID:30911355
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of IFNAR1 mRNA	PMID:18316168
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313409	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of IFNAR1 gene	PMID:35295148
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305399	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of IFNAR1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IFNAR1 mRNA	PMID:37042841
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313409	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IFNAR1 mRNA	PMID:37325564
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IFNAR1 mRNA	PMID:24449571
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313409	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of IFNAR1 mRNA	PMID:17585979
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin promotes the reaction [IFNA1 protein results in increased expression of IFNAR1 protein]; Curcumin promotes the reaction [IFNB1 protein results in increased expression of IFNAR1 protein]	PMID:17979888
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of IFNAR1 mRNA	PMID:23179753
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313409	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of IFNAR1 mRNA	PMID:21427059
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of IFNAR1 mRNA	PMID:25562108
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313409	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of IFNAR1 mRNA	PMID:28973697
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313409	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IFNAR1 mRNA	PMID:17562736
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of IFNAR1 mRNA	PMID:21420995
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of IFNAR1 mRNA; Fluorouracil results in increased expression of IFNAR1 protein	PMID:17088986
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313409	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IFNAR1 mRNA	PMID:25554681
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:5062	finasteride	decreases expression	ISO	RGD:1305399	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in decreased expression of IFNAR1 mRNA	PMID:24136188
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305399	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of IFNAR1 mRNA	PMID:24136188
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313409	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IFNAR1 mRNA	PMID:38701926
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:6482	linuron	increases expression	ISO	RGD:1313409	E	RGD:6480464	20210112	CTD	MESH:D008044	Linuron results in increased expression of IFNAR1 mRNA	PMID:30661753
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:6482	linuron	multiple interactions	ISO	RGD:1313409	E	RGD:6480464	20210112	CTD	MESH:D008044	SIGMAR1 gene promotes the reaction [Linuron results in increased expression of IFNAR1 mRNA]; XBP1 gene promotes the reaction [Linuron results in increased expression of IFNAR1 mRNA]	PMID:30661753
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305399	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of IFNAR1 mRNA	PMID:30467583
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:69478	cannabidiol	affects expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D002185	Cannabidiol affects the expression of IFNAR1 mRNA	PMID:39894194
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1313409	E	RGD:6480464	20250708	CTD	MESH:D002185	Cannabidiol results in increased expression of IFNAR1 mRNA	PMID:39894194
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:75934	vadimezan	multiple interactions	ISO	RGD:1313409	E	RGD:6480464	20260804	CTD	MESH:C066668	IFNAR1 protein affects the reaction [vadimezan results in increased expression of ACOD1 protein]	PMID:36862550
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313409	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of IFNAR1 mRNA	PMID:21795629
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:9352	sulindac	decreases expression	ISO	RGD:1305399	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of IFNAR1 mRNA	PMID:24136188
1313408	IFNAR1	interferon alpha and beta receptor subunit 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305399	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of IFNAR1 mRNA	PMID:20566332
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313414	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COMMD8 mRNA	PMID:33045310
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313414	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of COMMD8 gene	PMID:20938992
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of COMMD8 mRNA	PMID:20044591
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of COMMD8 mRNA	PMID:21632981
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313414	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of COMMD8 mRNA	PMID:39241906
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of COMMD8 mRNA	PMID:22574217
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313414	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of COMMD8 gene	PMID:20938992
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COMMD8 mRNA	PMID:37042841
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305402	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of COMMD8 mRNA	PMID:26496021
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COMMD8 mRNA	PMID:19549813
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of COMMD8 protein	PMID:20106945
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313414	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of COMMD8 gene	PMID:20938992
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313414	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of COMMD8 protein	PMID:25505154
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313414	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COMMD8 mRNA	PMID:21570461
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of COMMD8 mRNA	PMID:33212167
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of COMMD8 mRNA	PMID:30851411
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305402	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of COMMD8 mRNA	PMID:28959563
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of COMMD8 mRNA	PMID:25523186
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of COMMD8 mRNA	PMID:39719251
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313414	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of COMMD8 mRNA	PMID:37682722
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313414	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of COMMD8 mRNA	PMID:15034205
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313414	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of COMMD8 mRNA	PMID:22228805
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313414	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of COMMD8 mRNA]	PMID:15034205
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of COMMD8 mRNA	PMID:25523186
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305402	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of COMMD8 mRNA	PMID:30047161
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313414	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of COMMD8 mRNA	PMID:23811191
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305402	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of COMMD8 mRNA	PMID:25181051
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313414	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of COMMD8 mRNA	PMID:26063408
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305402	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of COMMD8 mRNA	PMID:30816183|PMID:32528016
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305402	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of COMMD8 gene	PMID:28505145
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305402	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of COMMD8 mRNA	PMID:26496021
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of COMMD8 mRNA	PMID:28302478
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of COMMD8 mRNA	PMID:27153767
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COMMD8 mRNA	PMID:25979313
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of COMMD8 gene	PMID:29154799
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of COMMD8 mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305402	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of COMMD8 mRNA	PMID:30047161
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of COMMD8 mRNA	PMID:36621641
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of COMMD8 mRNA	PMID:27188386
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of COMMD8 mRNA	PMID:18175754
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in decreased expression of COMMD8 mRNA	PMID:17211630
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305402	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of COMMD8 mRNA	PMID:24136188
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305402	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of COMMD8 mRNA	PMID:24136188
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of COMMD8 protein	PMID:32959892
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313414	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of COMMD8 mRNA	PMID:22206623
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of COMMD8 mRNA	PMID:30851411
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COMMD8 gene]	PMID:28238834
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305402	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of COMMD8 mRNA	PMID:30047161
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313414	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of COMMD8 mRNA	PMID:40826991
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1305402	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of COMMD8 mRNA	PMID:30047161
1313413	COMMD8	COMM domain containing 8	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305402	E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in decreased expression of COMMD8 mRNA	PMID:22615374
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305404	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LECT2 mRNA]	PMID:31150632
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of LECT2 mRNA]	PMID:19467301
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LECT2 mRNA	PMID:20938992
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LECT2 mRNA	PMID:39298647
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305404	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of LECT2 mRNA	PMID:32145629
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LECT2 mRNA	PMID:20938992
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of LECT2 mRNA	PMID:28973375
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305404	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of LECT2 mRNA	PMID:26496021
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LECT2 mRNA	PMID:31163220
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of LECT2 mRNA	PMID:27153756
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313417	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of LECT2 mRNA	PMID:31919559
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305404	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LECT2 mRNA	PMID:31150632
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305404	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LECT2 mRNA]	PMID:31150632
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LECT2 mRNA	PMID:20938992
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LECT2 mRNA	PMID:28189721|PMID:28960355
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LECT2 mRNA	PMID:22298810
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305404	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LECT2 mRNA	PMID:22298810
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313417	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LECT2 mRNA	PMID:26377647
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305404	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LECT2 mRNA	PMID:21215274
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of LECT2 mRNA	PMID:29955902
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of LECT2 mRNA	PMID:39631538
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of LECT2 mRNA	PMID:37682722
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313417	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LECT2 3' UTR; Benzo(a)pyrene results in increased methylation of LECT2 exon	PMID:27901495
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305404	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of LECT2 mRNA	PMID:23411599|PMID:34492290
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1305404	E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of LECT2 mRNA	PMID:28943392
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of LECT2 mRNA	PMID:20059764|PMID:23811191
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LECT2 mRNA	PMID:19710929
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of LECT2 mRNA]	PMID:20059764
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313417	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of LECT2 mRNA	PMID:28472532
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305404	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LECT2 mRNA	PMID:25181051
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305404	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LECT2 gene	PMID:28505145
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305404	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of LECT2 mRNA	PMID:26496021
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LECT2 mRNA	PMID:39298647|PMID:40203079
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of LECT2 mRNA	PMID:24535843
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305404	E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of LECT2 mRNA	PMID:28943392
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LECT2 mRNA	PMID:24535843
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305404	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of LECT2 mRNA	PMID:30589522
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305404	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LECT2 mRNA	PMID:35163327
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1305404	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of LECT2 mRNA	PMID:18500788
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305404	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LECT2 mRNA	PMID:35163327
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305404	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LECT2 mRNA	PMID:24386269
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of LECT2 mRNA	PMID:29038090
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of LECT2 mRNA	PMID:29154799
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of LECT2 mRNA	PMID:27989131
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313417	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of LECT2 mRNA	PMID:28973697
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305404	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of LECT2 mRNA	PMID:24136188
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313417	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LECT2 mRNA	PMID:17562736
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of LECT2 mRNA	PMID:26690555
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313417	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in increased expression of LECT2 mRNA	PMID:29246445
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of LECT2 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of LECT2 mRNA]	PMID:29246445|PMID:34546377
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305404	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LECT2 mRNA	PMID:17108234
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1305404	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of LECT2 mRNA	PMID:23962444
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305404	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of LECT2 mRNA	PMID:24136188
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305404	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of LECT2 mRNA	PMID:24136188
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1305404	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of LECT2 mRNA	PMID:33484710
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313417	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of LECT2 mRNA	PMID:19270015|PMID:19482888
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313417	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LECT2 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LECT2 mRNA]	PMID:19482888|PMID:24535843
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313417	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of LECT2 mRNA	PMID:38648751
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313417	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of LECT2 mRNA	PMID:21278054
1313416	LECT2	leukocyte cell derived chemotaxin 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305404	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LECT2 mRNA	PMID:21346803
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ZCWPW1 mRNA	PMID:38218311
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ZCWPW1 mRNA	PMID:22378314
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1617950	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZCWPW1 mRNA	PMID:39241906
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1617950	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ZCWPW1 mRNA	PMID:39298647
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305405	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ZCWPW1 mRNA	PMID:33387578
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZCWPW1 mRNA	PMID:37042841
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:19452	2-amino-4,6-dinitrotoluene	affects expression	ISO	RGD:1305405	E	RGD:6480464	20180918	CTD	MESH:C035208	2-amino-4,6-dinitrotoluene affects the expression of ZCWPW1 mRNA	PMID:21346803
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ZCWPW1 mRNA	PMID:19549813
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ZCWPW1 mRNA	PMID:19244175
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of ZCWPW1 mRNA	PMID:19244175
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1617950	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ZCWPW1 mRNA	PMID:30912803
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305405	E	RGD:6480464	20180918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZCWPW1 mRNA	PMID:22298810
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1617950	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZCWPW1 mRNA	PMID:21570461
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of ZCWPW1 mRNA	PMID:29955902
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZCWPW1 mRNA	PMID:33212167
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZCWPW1 mRNA	PMID:34032870
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of ZCWPW1 mRNA	PMID:29453283
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZCWPW1 mRNA	PMID:26238291
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1617950	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZCWPW1 mRNA	PMID:22228805
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZCWPW1 5' UTR	PMID:27901495
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1617950	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ZCWPW1 mRNA	PMID:27131904
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ZCWPW1 mRNA	PMID:25351596
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZCWPW1 mRNA	PMID:26238291
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1617950	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZCWPW1 gene	PMID:35295148
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1617950	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZCWPW1 promoter	PMID:27312807
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305405	E	RGD:6480464	20180918	CTD	MESH:C006780	bisphenol A results in increased expression of ZCWPW1 mRNA	PMID:25181051|PMID:36779543
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1617950	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of ZCWPW1 mRNA	PMID:20739668
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of ZCWPW1 mRNA	PMID:19244175
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of ZCWPW1 mRNA	PMID:19244175
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1617950	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ZCWPW1 intron	PMID:28392331
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZCWPW1 mRNA	PMID:37042841
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZCWPW1 mRNA	PMID:38382870
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ZCWPW1 mRNA	PMID:19244175
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of ZCWPW1 mRNA	PMID:19244175
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1617950	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ZCWPW1 mRNA	PMID:40194260
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ZCWPW1 mRNA	PMID:31533062
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ZCWPW1 mRNA	PMID:40419075
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZCWPW1 mRNA	PMID:25979313
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZCWPW1 gene	PMID:29154799
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305405	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZCWPW1 mRNA	PMID:33387578
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1617950	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ZCWPW1 mRNA	PMID:38648751
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1617950	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ZCWPW1 mRNA	PMID:27935865
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305405	E	RGD:6480464	20180918	CTD	MESH:D011441	Propylthiouracil results in increased expression of ZCWPW1 mRNA	PMID:24780913
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1617950	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ZCWPW1 mRNA	PMID:27131904
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of ZCWPW1 mRNA	PMID:22378314|PMID:29453283
1313418	ZCWPW1	zinc finger CW-type and PWWP domain containing 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1617950	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ZCWPW1 mRNA	PMID:35537566
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of SMARCD1 protein	PMID:39638853
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SMARCD1 mRNA	PMID:38218311
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313420	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SMARCD1 mRNA	PMID:37995155
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SMARCD1 mRNA	PMID:33167477
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SMARCD1 mRNA	PMID:26079696
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313420	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SMARCD1 mRNA	PMID:30319688
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313420	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SMARCD1 mRNA	PMID:39298647
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMARCD1 mRNA	PMID:25510870
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SMARCD1 mRNA	PMID:21179406
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313420	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SMARCD1 protein	PMID:20463053
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313420	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SMARCD1 mRNA	PMID:28973375
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMARCD1 mRNA	PMID:25510870
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMARCD1 mRNA	PMID:25510870
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of SMARCD1 gene] which results in increased expression of SMARCD1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMARCD1 mRNA	PMID:40504410
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:27698	vanadium atom	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of SMARCD1 mRNA	PMID:19000753
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SMARCD1 mRNA	PMID:28903495
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313420	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMARCD1 mRNA	PMID:21570461|PMID:24680724
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SMARCD1 mRNA	PMID:11489354
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCD1 mRNA	PMID:17942748
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SMARCD1 mRNA	PMID:33212167
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SMARCD1 mRNA	PMID:29803840
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of SMARCD1 gene] which results in increased expression of SMARCD1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMARCD1 mRNA	PMID:40504410
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313420	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SMARCD1 promoter	PMID:35295148
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305406	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SMARCD1 mRNA	PMID:23411599
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313420	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SMARCD1 mRNA	PMID:18648102
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305406	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SMARCD1 mRNA	PMID:25181051
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305406	E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of SMARCD1 mRNA	PMID:38750585
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305406	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SMARCD1 gene	PMID:28505145
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMARCD1 mRNA	PMID:25510870
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SMARCD1 mRNA	PMID:25510870
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:3423	carmustine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in increased expression of SMARCD1 mRNA	PMID:15980968
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313420	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SMARCD1 exon	PMID:33297965
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313420	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of SMARCD1 mRNA	PMID:33297965
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313420	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SMARCD1 mRNA	PMID:38685157
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCD1 mRNA	PMID:28628672
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1305406	E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SMARCD1 mRNA	PMID:18668222
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCD1 mRNA	PMID:28628672
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:35170	vanadium(0)	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of SMARCD1 mRNA	PMID:19000753
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SMARCD1 mRNA	PMID:38382870
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SMARCD1 mRNA	PMID:19320972
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313420	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of SMARCD1 mRNA	PMID:17585979
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMARCD1 mRNA	PMID:23179753
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCD1 mRNA	PMID:28628672
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of SMARCD1 gene] which results in increased expression of SMARCD1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMARCD1 mRNA	PMID:40504410
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313420	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCD1 mRNA	PMID:17942748
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCD1 mRNA	PMID:28628672
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313420	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of SMARCD1 mRNA	PMID:40234311
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of SMARCD1 protein	PMID:31285264
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1305406	E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of SMARCD1 mRNA	PMID:26923065
1313419	SMARCD1	SWI/SNF related BAF chromatin remodeling complex subunit D1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313420	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SMARCD1 mRNA	PMID:21278054
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313422	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KY mRNA	PMID:36189433
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305407	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KY mRNA	PMID:33729688
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:15746	spermine	increases expression	ISO	RGD:1313422	E	RGD:6480464	20120412	CTD	MESH:D013096	Spermine results in increased expression of KY mRNA	PMID:18673383
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313422	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of KY mRNA	PMID:30319688
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of KY mRNA	PMID:19484750
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305407	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KY mRNA	PMID:33387578
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KY mRNA	PMID:37042841
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313422	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KY mRNA	PMID:36189433
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of KY mRNA	PMID:20403060
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KY gene	PMID:27153756
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in decreased expression of KY mRNA	PMID:33026818
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of KY mRNA	PMID:31150632
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of KY mRNA	PMID:31881176
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of KY mRNA	PMID:17898221
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of KY mRNA	PMID:32186404
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of KY mRNA	PMID:24768652
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KY mRNA	PMID:32109520
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1305407	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of KY mRNA	PMID:28959563
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KY mRNA	PMID:29803840
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of KY mRNA	PMID:39631538
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KY promoter	PMID:27901495
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313422	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KY mRNA	PMID:27195522
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KY 3' UTR; Benzo(a)pyrene results in increased methylation of KY 5' UTR	PMID:27901495
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of KY gene	PMID:31601247
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313422	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of KY mRNA	PMID:20542052
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of KY mRNA	PMID:30047161
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of KY mRNA	PMID:19167457
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KY mRNA	PMID:25181051
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313422	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of KY exon	PMID:33297965
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of KY gene	PMID:31601247
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313422	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of KY intron	PMID:28392331
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305407	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of KY mRNA	PMID:21266533
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KY mRNA	PMID:37042841
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KY mRNA	PMID:35163327
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305407	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KY mRNA	PMID:35163327
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KY mRNA	PMID:38568856
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305407	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KY mRNA	PMID:35163327
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of KY mRNA	PMID:24449571
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:39175	thiacloprid	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20210608	CTD	MESH:C417209	thiacloprid results in decreased expression of KY mRNA	PMID:33426623
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:39175	thiacloprid	multiple interactions	ISO	RGD:1305407	E	RGD:6480464	20210608	CTD	MESH:C417209	[thiacloprid co-treated with clothianidin] results in decreased expression of KY mRNA; [thiacloprid co-treated with enilconazole] results in decreased expression of KY mRNA	PMID:33426623
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:39178	clothianidin	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20210608	CTD	MESH:C480342	clothianidin results in decreased expression of KY mRNA	PMID:33426623
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:39178	clothianidin	multiple interactions	ISO	RGD:1305407	E	RGD:6480464	20210608	CTD	MESH:C480342	[enilconazole co-treated with clothianidin] results in decreased expression of KY mRNA; [thiacloprid co-treated with clothianidin] results in decreased expression of KY mRNA	PMID:33426623
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of KY mRNA	PMID:30047161
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of KY mRNA	PMID:26690555
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of KY mRNA	PMID:38701926
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1313422	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of KY mRNA	PMID:20003209
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1313422	E	RGD:6480464	20160315	CTD	MESH:C072553	[MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of KY mRNA	PMID:25566086
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:753160	lard	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20260714	CTD	MESH:C029310	lard results in decreased expression of KY mRNA	PMID:26115784
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313422	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of KY mRNA	PMID:31388691
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:81927	enilconazole	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20210608	CTD	MESH:C017435	enilconazole results in decreased expression of KY mRNA	PMID:33426623
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:81927	enilconazole	multiple interactions	ISO	RGD:1305407	E	RGD:6480464	20210608	CTD	MESH:C017435	[enilconazole co-treated with clothianidin] results in decreased expression of KY mRNA; [thiacloprid co-treated with enilconazole] results in decreased expression of KY mRNA	PMID:33426623
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313422	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of KY mRNA	PMID:27935865
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305407	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KY mRNA	PMID:24780913|PMID:25825206|PMID:30047161
1313421	KY	kyphoscoliosis peptidase	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305407	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of KY mRNA	PMID:23869203
1313423	FOXK2	forkhead box K2	gene	CHEBI:137392	chlormequat chloride	decreases expression	ISO	RGD:1305408	E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in decreased expression of FOXK2 protein	PMID:34958886
1313423	FOXK2	forkhead box K2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1614344	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of FOXK2 mRNA	PMID:26251327
1313423	FOXK2	forkhead box K2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FOXK2 mRNA	PMID:33167477
1313423	FOXK2	forkhead box K2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614344	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FOXK2 mRNA	PMID:39241906
1313423	FOXK2	forkhead box K2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of FOXK2 mRNA	PMID:22574217
1313423	FOXK2	forkhead box K2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of FOXK2 mRNA	PMID:23019147|PMID:31614463
1313423	FOXK2	forkhead box K2	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of FOXK2 gene	PMID:30521419
1313423	FOXK2	forkhead box K2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1614344	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of FOXK2 mRNA	PMID:23892564
1313423	FOXK2	forkhead box K2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of FOXK2 protein	PMID:37730182
1313423	FOXK2	forkhead box K2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305408	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of FOXK2 mRNA	PMID:22061828
1313423	FOXK2	forkhead box K2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FOXK2 mRNA	PMID:28818685
1313423	FOXK2	forkhead box K2	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1614344	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of FOXK2 mRNA	PMID:37748715
1313423	FOXK2	forkhead box K2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1614344	E	RGD:6480464	20260113	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FOXK2 mRNA	PMID:37451636
1313423	FOXK2	forkhead box K2	gene	CHEBI:25187	p-menthan-3-ol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of FOXK2 mRNA	PMID:26760959
1313423	FOXK2	forkhead box K2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614344	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of FOXK2 mRNA]	PMID:22206623
1313423	FOXK2	forkhead box K2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FOXK2 gene	PMID:25304211
1313423	FOXK2	forkhead box K2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of FOXK2 protein	PMID:35688186
1313423	FOXK2	forkhead box K2	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of FOXK2 gene	PMID:31636367
1313423	FOXK2	forkhead box K2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1614344	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FOXK2 mRNA	PMID:24058054
1313423	FOXK2	forkhead box K2	gene	CHEBI:28177	theophylline	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in increased expression of FOXK2 mRNA	PMID:16083514
1313423	FOXK2	forkhead box K2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of FOXK2 mRNA	PMID:39709020
1313423	FOXK2	forkhead box K2	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of FOXK2 mRNA	PMID:23649840
1313423	FOXK2	forkhead box K2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305408	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of FOXK2 mRNA	PMID:28959563
1313423	FOXK2	forkhead box K2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1614344	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of FOXK2 mRNA	PMID:27862939
1313423	FOXK2	forkhead box K2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FOXK2 mRNA	PMID:29803840
1313423	FOXK2	forkhead box K2	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of FOXK2 protein	PMID:35688186
1313423	FOXK2	forkhead box K2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1305408	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of FOXK2 mRNA	PMID:21297353
1313423	FOXK2	forkhead box K2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FOXK2 mRNA	PMID:19150397
1313423	FOXK2	forkhead box K2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305408	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of FOXK2 mRNA	PMID:30047161
1313423	FOXK2	forkhead box K2	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1614344	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of FOXK2 mRNA	PMID:17656681
1313423	FOXK2	forkhead box K2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614344	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FOXK2 promoter	PMID:35295148
1313423	FOXK2	forkhead box K2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305408	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FOXK2 mRNA	PMID:34492290
1313423	FOXK2	forkhead box K2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of FOXK2 mRNA	PMID:30903817
1313423	FOXK2	forkhead box K2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305408	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FOXK2 mRNA	PMID:25181051
1313423	FOXK2	forkhead box K2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1614344	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of FOXK2 promoter	PMID:27334623
1313423	FOXK2	forkhead box K2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305408	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FOXK2 mRNA	PMID:30816183|PMID:32528016
1313423	FOXK2	forkhead box K2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FOXK2 gene	PMID:31601247
1313423	FOXK2	forkhead box K2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1614344	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of FOXK2 promoter	PMID:27312807
1313423	FOXK2	forkhead box K2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of FOXK2 mRNA	PMID:33670352
1313423	FOXK2	forkhead box K2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305408	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FOXK2 gene	PMID:28505145
1313423	FOXK2	forkhead box K2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of FOXK2 mRNA	PMID:25979313
1313423	FOXK2	forkhead box K2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1614344	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of FOXK2 mRNA	PMID:39298647
1313423	FOXK2	forkhead box K2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FOXK2 mRNA	PMID:37042841
1313423	FOXK2	forkhead box K2	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305408	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of FOXK2 mRNA	PMID:30589522
1313423	FOXK2	forkhead box K2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1614344	E	RGD:6480464	20260113	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FOXK2 mRNA	PMID:37451636
1313423	FOXK2	forkhead box K2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305408	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of FOXK2 mRNA	PMID:19162173
1313423	FOXK2	forkhead box K2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1614344	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of FOXK2 mRNA	PMID:18353800
1313423	FOXK2	forkhead box K2	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of FOXK2 mRNA	PMID:28302478
1313423	FOXK2	forkhead box K2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FOXK2 mRNA	PMID:31533062
1313423	FOXK2	forkhead box K2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of FOXK2 mRNA	PMID:29154799
1313423	FOXK2	forkhead box K2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FOXK2 gene	PMID:29154799
1313423	FOXK2	forkhead box K2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305408	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of FOXK2 mRNA	PMID:30047161
1313423	FOXK2	forkhead box K2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FOXK2 mRNA	PMID:20106945|PMID:25562108
1313423	FOXK2	forkhead box K2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1614344	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of FOXK2 mRNA	PMID:19770486
1313423	FOXK2	forkhead box K2	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of FOXK2 mRNA	PMID:23649840
1313423	FOXK2	forkhead box K2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of FOXK2 mRNA	PMID:24449571
1313423	FOXK2	forkhead box K2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614344	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FOXK2 mRNA	PMID:17562736
1313423	FOXK2	forkhead box K2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of FOXK2 mRNA	PMID:22230336
1313423	FOXK2	forkhead box K2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of FOXK2 mRNA	PMID:29067470
1313423	FOXK2	forkhead box K2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305408	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FOXK2 mRNA	PMID:33387578
1313423	FOXK2	forkhead box K2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1614344	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FOXK2 mRNA	PMID:29279043
1313423	FOXK2	forkhead box K2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FOXK2 gene	PMID:25304211
1313423	FOXK2	forkhead box K2	gene	CHEBI:50594	carbon nanotube	decreases methylation	EXP		E	RGD:6480464	20191008	CTD	MESH:D037742	Nanotubes, Carbon results in decreased methylation of FOXK2 gene	PMID:29426343
1313423	FOXK2	forkhead box K2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305408	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of FOXK2 mRNA	PMID:30047161
1313423	FOXK2	forkhead box K2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305408	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of FOXK2 mRNA	PMID:19162173
1313423	FOXK2	forkhead box K2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1614344	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FOXK2 mRNA	PMID:35964746
1313423	FOXK2	forkhead box K2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1614344	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of FOXK2 mRNA	PMID:19042947
1313423	FOXK2	forkhead box K2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1614344	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FOXK2 mRNA	PMID:22206623
1313423	FOXK2	forkhead box K2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1614344	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of FOXK2 mRNA]	PMID:22206623
1313423	FOXK2	forkhead box K2	gene	CHEBI:756894	tak-243	affects sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 affects the sumoylation of FOXK2 protein	PMID:31285264
1313423	FOXK2	forkhead box K2	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of FOXK2 mRNA	PMID:19159669
1313423	FOXK2	forkhead box K2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1614344	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of FOXK2 mRNA	PMID:23091169
1313423	FOXK2	forkhead box K2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305408	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of FOXK2 mRNA	PMID:30047161
1313423	FOXK2	forkhead box K2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1305408	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FOXK2 mRNA	PMID:27291303
1313423	FOXK2	forkhead box K2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305408	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of FOXK2 mRNA	PMID:30047161
1313423	FOXK2	forkhead box K2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305408	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FOXK2 mRNA	PMID:21346803
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1550206	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of TTC17 mRNA	PMID:33045310
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TTC17 mRNA	PMID:36331819
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TTC17 mRNA	PMID:21632981
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550206	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TTC17 mRNA	PMID:39298647
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of TTC17 mRNA	PMID:38568856
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305410	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TTC17 mRNA	PMID:33387578
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TTC17 mRNA	PMID:37042841
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TTC17 mRNA	PMID:23649840
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TTC17 mRNA	PMID:38685446
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305410	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TTC17 mRNA	PMID:22061828
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TTC17 mRNA	PMID:36331819
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1550206	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of TTC17 mRNA	PMID:27462272
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TTC17 mRNA	PMID:37236586
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TTC17 mRNA	PMID:19549813
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TTC17 mRNA	PMID:23649840
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TTC17 mRNA	PMID:23649840
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550206	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TTC17 mRNA	PMID:31919559
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTC17 mRNA	PMID:40504410
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TTC17 mRNA	PMID:19244175
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1305410	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of TTC17 gene	PMID:31011160
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550206	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TTC17 mRNA	PMID:28960355
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550206	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TTC17 mRNA	PMID:30912803
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305410	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTC17 mRNA	PMID:22298810
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550206	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTC17 mRNA	PMID:21570461
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305410	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TTC17 mRNA	PMID:18796159|PMID:32109520
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TTC17 mRNA	PMID:33212167
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TTC17 mRNA	PMID:20971185
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TTC17 mRNA	PMID:29803840
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTC17 mRNA	PMID:28595984|PMID:34032870
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TTC17 mRNA	PMID:38568856
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550206	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of TTC17 mRNA	PMID:36209798
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTC17 mRNA	PMID:40504410
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of TTC17 mRNA	PMID:29453283
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TTC17 promoter	PMID:27901495
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TTC17 mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of TTC17 mRNA	PMID:20971185
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TTC17 mRNA	PMID:25351596
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of TTC17 mRNA	PMID:31745603
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305410	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TTC17 mRNA	PMID:34492290
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550206	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TTC17 mRNA	PMID:33221593
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TTC17 gene	PMID:31601247
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TTC17 mRNA	PMID:28628672
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of TTC17 mRNA	PMID:19244175
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550206	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TTC17 mRNA	PMID:39298647
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTC17 mRNA	PMID:28628672
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1550206	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of TTC17 mRNA	PMID:31558096
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TTC17 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTC17 mRNA	PMID:28628672
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TTC17 mRNA	PMID:37042841
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TTC17 mRNA	PMID:37236586
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305410	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of TTC17 mRNA	PMID:25539665
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TTC17 mRNA	PMID:19244175
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TTC17 mRNA	PMID:31533062
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TTC17 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TTC17 mRNA	PMID:36331819
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1550206	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of TTC17 mRNA	PMID:31558096
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TTC17 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTC17 mRNA	PMID:27188386
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of TTC17 mRNA	PMID:25562108
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of TTC17 promoter	PMID:27989131
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550206	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TTC17 mRNA	PMID:17555576
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TTC17 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTC17 mRNA	PMID:28628672
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TTC17 mRNA	PMID:24935251
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TTC17 mRNA	PMID:21420995
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TTC17 mRNA	PMID:22230336
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305410	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TTC17 mRNA	PMID:33387578
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550206	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTC17 mRNA	PMID:40504410
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550206	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TTC17 mRNA	PMID:17555576
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of TTC17 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTC17 mRNA	PMID:28628672
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305410	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of TTC17 mRNA	PMID:24136188
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305410	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of TTC17 mRNA	PMID:30467583
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TTC17 mRNA	PMID:31758290
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550206	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TTC17 mRNA	PMID:22206623
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTC17 mRNA	PMID:27188386
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TTC17 gene]	PMID:28238834
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1550206	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of TTC17 mRNA	PMID:31558096
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTC17 mRNA	PMID:27188386
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305410	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TTC17 mRNA	PMID:19281266
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1550206	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of TTC17 protein	PMID:24648495
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305410	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TTC17 mRNA	PMID:21346803
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305410	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TTC17 mRNA	PMID:23034163
1313426	TTC17	tetratricopeptide repeat domain 17	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305410	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of TTC17 mRNA	PMID:23034163
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313429	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CDC34 mRNA	PMID:33045310
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDC34 gene	PMID:20938992
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15368	acrolein	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D000171	Acrolein results in decreased expression of CDC34 protein	PMID:24812010
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CDC34 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CDC34 mRNA	PMID:32699268
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313429	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CDC34 mRNA	PMID:24205000
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDC34 mRNA	PMID:30529165
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CDC34 mRNA	PMID:36331819
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of CDC34 mRNA	PMID:39506029
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313429	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of CDC34 mRNA	PMID:40945087
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1305411	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in decreased expression of CDC34 mRNA	PMID:15353170
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313429	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CDC34 mRNA	PMID:39241906
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D004958	Estradiol affects the expression of CDC34 mRNA	PMID:15598610
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:16602	trichloroethene	affects expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D014241	Trichloroethylene affects the expression of CDC34 mRNA	PMID:21135412
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDC34 gene	PMID:20938992
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CDC34 mRNA	PMID:21179406
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of CDC34 mRNA	PMID:33647349
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313429	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of CDC34 mRNA	PMID:23892564
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1305411	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CDC34 mRNA	PMID:21318169
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313429	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CDC34 mRNA	PMID:33754040
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305411	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of CDC34 mRNA	PMID:22061828
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CDC34 mRNA	PMID:28818685
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDC34 mRNA	PMID:36331819
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CDC34 mRNA	PMID:37236586
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CDC34 intron	PMID:30157460
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CDC34 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CDC34 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of CDC34 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of CDC34 mRNA	PMID:32699268|PMID:35430440
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CDC34 mRNA	PMID:34911549
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305411	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CDC34 mRNA	PMID:31150632
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313429	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of CDC34 mRNA	PMID:25629700
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CDC34 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDC34 gene	PMID:20938992|PMID:22206623
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305411	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC34 mRNA	PMID:34747641
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC34 mRNA	PMID:21570461
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC34 mRNA	PMID:21354282
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CDC34 mRNA	PMID:28001369
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CDC34 mRNA	PMID:33212167
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CDC34 mRNA	PMID:30851411
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305411	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CDC34 mRNA	PMID:28959563
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDC34 protein	PMID:30528433
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CDC34 mRNA	PMID:38568856
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CDC34 mRNA	PMID:16120219|PMID:20106945
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CDC34 mRNA	PMID:22228805
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CDC34 mRNA	PMID:20458559
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CDC34 mRNA	PMID:17530438
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1305411	E	RGD:6480464	20120412	CTD	MESH:C032036	bromobenzene results in increased expression of CDC34 mRNA	PMID:15056800
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313429	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CDC34 promoter	PMID:35295148
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CDC34 mRNA	PMID:18648102
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313429	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CDC34 mRNA	PMID:18301758|PMID:23811191
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CDC34 gene	PMID:23968726
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305411	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of CDC34 mRNA	PMID:33296240
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CDC34 gene	PMID:31601247
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305411	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CDC34 mRNA	PMID:25181051|PMID:32145629
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313429	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CDC34 mRNA	PMID:32156529
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDC34 mRNA	PMID:28628672
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305411	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:36041667
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313429	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CDC34 mRNA	PMID:39298647
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:28628672
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305411	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:36041667
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDC34 mRNA	PMID:28628672
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305411	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:36041667
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305411	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of CDC34 mRNA	PMID:22546817
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305411	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CDC34 mRNA	PMID:22546817
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313429	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of CDC34 mRNA	PMID:34813904
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:28628672
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of CDC34 gene	PMID:23968726
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDC34 mRNA	PMID:37042841
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305411	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of CDC34 promoter	PMID:22457795
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CDC34 mRNA	PMID:37236586
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305411	E	RGD:6480464	20120717	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CDC34 mRNA	PMID:19162173|PMID:21318169
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CDC34 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CDC34 mRNA	PMID:32699268
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D002994	Clofibrate results in increased expression of CDC34 mRNA	PMID:17585979
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of CDC34 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CDC34 mRNA]	PMID:17585979
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313429	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CDC34 mRNA	PMID:40194260
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CDC34 mRNA	PMID:31533062
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:3930	cryptolepine	decreases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C024015	cryptolepine results in decreased expression of CDC34 mRNA	PMID:16120219
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDC34 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CDC34 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CDC34 mRNA	PMID:36331819
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:C016104	sodium bichromate results in increased expression of CDC34 mRNA	PMID:22155349
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of CDC34 mRNA	PMID:29154799
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1305411	E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in increased expression of CDC34 mRNA	PMID:21318169
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CDC34 gene	PMID:29154799
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of CDC34 promoter	PMID:27989131
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D013629	Tamoxifen results in increased expression of CDC34 mRNA	PMID:17555576
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:28628672
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	CDC34 protein affects the susceptibility to Methotrexate	PMID:16217747
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CDC34 mRNA	PMID:38832940
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of CDC34 mRNA	PMID:29309887
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1305411	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of CDC34 mRNA	PMID:21346803
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of CDC34 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CDC34 mRNA]	PMID:17585979
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	CDC34 protein affects the susceptibility to Fluorouracil	PMID:16217747
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313429	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of CDC34 mRNA	PMID:22334560
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:48707	(-)-citrinin	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D002953	Citrinin results in decreased expression of CDC34 mRNA	PMID:30428381
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:48707	(-)-citrinin	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D002953	[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC34 mRNA	PMID:30428381
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:49553	copper(II) chloride	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride affects the expression of CDC34 mRNA	PMID:17211630
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDC34 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDC34 mRNA	PMID:28628672
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CDC34 mRNA	PMID:20458559
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CDC34 mRNA	PMID:17530438
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313429	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CDC34 mRNA	PMID:25620056
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305411	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CDC34 mRNA	PMID:24136188
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of CDC34 mRNA	PMID:20977926
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of CDC34 mRNA	PMID:18651567
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CDC34 mRNA	PMID:19042947
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CDC34 protein	PMID:32959892
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1305411	E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of CDC34 mRNA	PMID:18178546
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313429	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of CDC34 mRNA	PMID:23650126
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D015655	U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of CDC34 mRNA]	PMID:12710931
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313429	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of CDC34 mRNA	PMID:36851058
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of CDC34 mRNA	PMID:29309887
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305411	E	RGD:6480464	20120412	CTD	MESH:D008701	Methapyrilene results in increased expression of CDC34 mRNA	PMID:16393664
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313429	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CDC34 mRNA	PMID:22206623
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313429	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CDC34 mRNA	PMID:22206623
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CDC34 mRNA	PMID:37199045
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CDC34 mRNA	PMID:16120219
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C025589	ochratoxin A results in decreased expression of CDC34 mRNA	PMID:30428381
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C025589	[Citrinin co-treated with ochratoxin A] results in decreased expression of CDC34 mRNA	PMID:30428381
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CDC34 mRNA	PMID:30851411
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CDC34 mRNA	PMID:19159669
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital results in increased expression of CDC34 mRNA	PMID:19270015
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1313429	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of CDC34 mRNA	PMID:22334560
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313429	E	RGD:6480464	20130618	CTD	MESH:C045950	propiconazole results in increased expression of CDC34 mRNA	PMID:22334560
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305411	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CDC34 mRNA	PMID:21346803
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CDC34 mRNA	PMID:38568856
1313428	CDC34	cell division cycle 34, ubiquitin conjugating enzyme	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313429	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of CDC34 mRNA	PMID:35537566
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of UCHL5 mRNA	PMID:21934132|PMID:33167477
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1305414	E	RGD:6480464	20161025	CTD	MESH:D000431	Ethanol results in decreased expression of UCHL5 protein	PMID:19609968
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of UCHL5 mRNA	PMID:18951874
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313433	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of UCHL5 mRNA	PMID:39241906
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:16583	butane-2,3-dione	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D003931	Diacetyl results in increased expression of UCHL5 protein	PMID:34031698
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of UCHL5 mRNA	PMID:38568856
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of UCHL5 mRNA	PMID:23649840
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of UCHL5 mRNA	PMID:21179406
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of UCHL5 mRNA	PMID:28818685
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UCHL5 mRNA	PMID:37236586
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of UCHL5 mRNA	PMID:23649840
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of UCHL5 gene	PMID:27153756
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of UCHL5 mRNA	PMID:23649840
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of UCHL5 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of UCHL5 mRNA	PMID:34911549
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313433	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UCHL5 mRNA	PMID:31919559
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of UCHL5 mRNA	PMID:21867686
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UCHL5 mRNA	PMID:22206623
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UCHL5 mRNA	PMID:39836092
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin results in increased phosphorylation of TP63 protein alternative form] promotes the reaction [ADRM1 protein binds to UCHL5 protein binds to TP63 protein alternative form]; Cisplatin promotes the reaction [ADRM1 protein binds to UCHL5 protein binds to STK11 protein alternative form]; Cisplatin promotes the reaction [NOS2 protein binds to ADRM1 protein binds to UCHL5 protein]; TP63 protein promotes the reaction [Cisplatin promotes the reaction [NOS2 protein binds to ADRM1 protein binds to UCHL5 protein]]	PMID:20959455|PMID:21191146
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1305414	E	RGD:6480464	20150825	CTD	MESH:D019833	Genistein results in increased expression of UCHL5 protein	PMID:24552547
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313433	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UCHL5 mRNA	PMID:21570461
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305414	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UCHL5 mRNA	PMID:33387578
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of UCHL5 mRNA	PMID:23179753|PMID:26272509
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL5 mRNA	PMID:27188386
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of UCHL5 mRNA	PMID:33212167
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313433	E	RGD:6480464	20231205	CTD	MESH:C000228	aristolochic acid I results in increased expression of UCHL5 mRNA; aristolochic acid I results in increased expression of UCHL5 protein	PMID:26108275
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of UCHL5 mRNA	PMID:38568856
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UCHL5 mRNA	PMID:39836092
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1305414	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UCHL5 mRNA	PMID:21839799
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313433	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UCHL5 mRNA	PMID:22228805
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of UCHL5 mRNA	PMID:25895662
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of UCHL5 mRNA	PMID:20458559
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305414	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of UCHL5 mRNA	PMID:25729387
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313433	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UCHL5 gene	PMID:35295148
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305414	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of UCHL5 mRNA	PMID:34492290
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313433	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of UCHL5 mRNA	PMID:18648102
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of UCHL5 mRNA	PMID:33670352
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of UCHL5 gene	PMID:31601247
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of UCHL5 protein	PMID:34186270
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305414	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UCHL5 mRNA	PMID:25181051
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of UCHL5 protein	PMID:33376534
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305414	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of UCHL5 mRNA	PMID:23196670
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of UCHL5 protein	PMID:31945527
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of UCHL5 gene	PMID:31601247
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of UCHL5 protein	PMID:34186270
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1313433	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of UCHL5 mRNA	PMID:36464114
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of UCHL5 gene	PMID:22964155
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313433	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of UCHL5 mRNA	PMID:17361019|PMID:21266533
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to UCHL5 protein	PMID:32991956
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313433	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in increased expression of UCHL5 mRNA	PMID:21371552
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20130514	CTD	MESH:D010269	[Paraquat co-treated with Maneb] results in increased expression of UCHL5 mRNA	PMID:18386188
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UCHL5 mRNA	PMID:37042841
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305414	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of UCHL5 mRNA	PMID:33453195
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UCHL5 mRNA	PMID:37236586
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of UCHL5 mRNA	PMID:28302478
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of UCHL5 mRNA	PMID:19167446
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCHL5 mRNA	PMID:19167446
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1305414	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of UCHL5 mRNA	PMID:22110744
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UCHL5 mRNA	PMID:25979313
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of UCHL5 gene	PMID:29154799
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of UCHL5 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL5 mRNA	PMID:27188386
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of UCHL5 mRNA	PMID:20106945|PMID:27989131
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:1305414	E	RGD:6480464	20190910	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of UCHL5 protein]	PMID:30980806
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305414	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of UCHL5 mRNA	PMID:24136188
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1305414	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of UCHL5 mRNA	PMID:18754875
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of UCHL5 mRNA	PMID:24935251
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UCHL5 mRNA	PMID:39836092
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of UCHL5 mRNA	PMID:18175754
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of UCHL5 mRNA	PMID:20458559
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313433	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of UCHL5 mRNA	PMID:25554681
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305414	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of UCHL5 mRNA	PMID:24136188
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305414	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UCHL5 mRNA	PMID:24136188
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20130514	CTD	MESH:D008344	[Paraquat co-treated with Maneb] results in increased expression of UCHL5 mRNA	PMID:18386188
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313433	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of UCHL5 mRNA	PMID:19042947
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UCHL5 protein	PMID:32959892
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305414	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of UCHL5 mRNA	PMID:25729387
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313433	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of UCHL5 mRNA	PMID:23650126
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1313433	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of UCHL5 mRNA	PMID:36464114
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of UCHL5 protein	PMID:34186270
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313433	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of UCHL5 mRNA	PMID:22206623
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313433	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UCHL5 mRNA	PMID:22206623
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305414	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of UCHL5 mRNA	PMID:24136188
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL5 mRNA	PMID:27188386
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of UCHL5 mRNA; Irinotecan results in decreased expression of UCHL5 mRNA	PMID:15956246
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1313433	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of UCHL5 mRNA	PMID:22538082
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of UCHL5 mRNA	PMID:19167446
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of UCHL5 mRNA	PMID:21858171
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UCHL5 mRNA	PMID:27188386
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1305414	E	RGD:6480464	20190910	CTD	MESH:D013311	Streptozocin results in increased expression of UCHL5 protein	PMID:30980806
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1305414	E	RGD:6480464	20190910	CTD	MESH:D013311	4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of UCHL5 protein]	PMID:30980806
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of UCHL5 mRNA	PMID:38568856
1313432	UCHL5	ubiquitin C-terminal hydrolase L5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305414	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of UCHL5 mRNA	PMID:21346803
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:10106	zearalenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in decreased expression of ATPAF1 mRNA	PMID:19371625
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:132098	methoxyacetic acid	decreases expression	ISO	RGD:1305417	E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of ATPAF1 mRNA	PMID:20864626
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATPAF1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of ATPAF1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATPAF1 mRNA	PMID:32699268|PMID:32845096
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of ATPAF1 mRNA	PMID:24763279
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ATPAF1 mRNA	PMID:22378314
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATPAF1 mRNA	PMID:37042841
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ATPAF1 mRNA	PMID:23649840
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ATPAF1 mRNA	PMID:21179406
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1619843	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of ATPAF1 mRNA	PMID:23892564
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305417	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ATPAF1 mRNA	PMID:33387578
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ATPAF1 mRNA	PMID:28818685
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATPAF1 mRNA	PMID:35301059
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ATPAF1 protein	PMID:23301498
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305417	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ATPAF1 mRNA	PMID:21396975
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATPAF1 gene	PMID:27153756
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ATPAF1 mRNA	PMID:23649840
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATPAF1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of ATPAF1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATPAF1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of ATPAF1 mRNA	PMID:32699268|PMID:32845096
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ATPAF1 mRNA	PMID:21867686
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATPAF1 gene	PMID:25304211
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:1305417	E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of ATPAF1 mRNA	PMID:20864626
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1619843	E	RGD:6480464	20120412	CTD	MESH:D003042	[Cocaine co-treated with FOS protein mutant form] results in decreased expression of ATPAF1 mRNA	PMID:18355967
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATPAF1 mRNA	PMID:21632981
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1619843	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATPAF1 mRNA	PMID:20399798
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ATPAF1 mRNA	PMID:28001369
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1305417	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ATPAF1 mRNA	PMID:20864626
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ATPAF1 mRNA	PMID:33212167
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATPAF1 mRNA	PMID:29803840
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1619843	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATPAF1 mRNA	PMID:39631538
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ATPAF1 mRNA	PMID:29432896
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of ATPAF1 mRNA	PMID:29319823
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1619843	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of ATPAF1 mRNA	PMID:33053406
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1619843	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ATPAF1 mRNA	PMID:18648102
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ATPAF1 mRNA	PMID:30903817
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305417	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ATPAF1 mRNA	PMID:25181051
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ATPAF1 mRNA	PMID:33670352
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1619843	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ATPAF1 mRNA	PMID:38685157
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1619843	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ATPAF1 mRNA	PMID:21266533
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATPAF1 mRNA	PMID:35301059
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATPAF1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATPAF1 mRNA	PMID:32699268
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ATPAF1 mRNA	PMID:28302478
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ATPAF1 mRNA	PMID:31533062
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATPAF1 mRNA	PMID:25979313
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ATPAF1 mRNA	PMID:23179753|PMID:37505509
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATPAF1 mRNA	PMID:20106945|PMID:25562108
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATPAF1 gene	PMID:25304211
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305417	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ATPAF1 mRNA	PMID:29391264
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305417	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ATPAF1 mRNA	PMID:24136188
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1619843	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ATPAF1 mRNA	PMID:22206623
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:7602	nobiletin	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of ATPAF1 protein]	PMID:38348393
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in increased expression of ATPAF1 mRNA	PMID:30559759
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:8107	phenytoin	decreases expression	ISO	RGD:1305417	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in decreased expression of ATPAF1 mRNA	PMID:20345932
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of ATPAF1 mRNA	PMID:19095052
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of ATPAF1 protein	PMID:38348393
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of ATPAF1 protein]	PMID:38348393
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1619843	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of ATPAF1 mRNA	PMID:21278054
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1305417	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of ATPAF1 mRNA	PMID:20864626
1313436	ATPAF1	ATP synthase mitochondrial F1 complex assembly factor 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ATPAF1 mRNA	PMID:38568856
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of POLR2E protein	PMID:39638853
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313438	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of POLR2E gene	PMID:20938992
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313438	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of POLR2E mRNA	PMID:24205000
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of POLR2E mRNA	PMID:26079696
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313438	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of POLR2E mRNA	PMID:39298647
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313438	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of POLR2E gene	PMID:20938992
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of POLR2E mRNA	PMID:37042841
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313438	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of POLR2E mRNA	PMID:34319233
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313438	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of POLR2E mRNA	PMID:36331819
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313438	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of POLR2E mRNA	PMID:25629700
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313438	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of POLR2E gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of POLR2E mRNA]	PMID:20938992|PMID:22206623
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313438	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of POLR2E mRNA	PMID:40504410
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313438	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of POLR2E mRNA	PMID:22610192
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313438	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLR2E mRNA	PMID:21570461
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1589817	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POLR2E mRNA	PMID:33387578
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313438	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLR2E mRNA	PMID:17942748
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of POLR2E mRNA	PMID:33512557
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POLR2E mRNA	PMID:30851411
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of POLR2E mRNA	PMID:12727804|PMID:38568856
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of POLR2E mRNA	PMID:34032870
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [POLR2E protein binds to CAPRIN1 protein]	PMID:33939924
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313438	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of POLR2E mRNA	PMID:40504410
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POLR2E protein	PMID:33278487
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313438	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of POLR2E protein	PMID:37955338
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of POLR2E protein	PMID:25419056
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of POLR2E mRNA	PMID:17762391
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313438	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of POLR2E mRNA	PMID:23811191
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313438	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of POLR2E mRNA	PMID:28472532
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of POLR2E mRNA	PMID:30903817
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1589817	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of POLR2E mRNA	PMID:25181051
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of POLR2E protein	PMID:31675489|PMID:33376534|PMID:37567409
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313438	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of POLR2E mRNA	PMID:33221593
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1589817	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of POLR2E mRNA	PMID:30816183|PMID:41034487
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1589817	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of POLR2E mRNA	PMID:34947998
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of POLR2E protein	PMID:31675489
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:34107	1-nitropyrene	decreases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in decreased expression of POLR2E mRNA	PMID:19041380
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:3423	carmustine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of POLR2E mRNA	PMID:15980968
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313438	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of POLR2E mRNA	PMID:39298647|PMID:40203079
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313438	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of POLR2E mRNA	PMID:37019170
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of POLR2E mRNA	PMID:37042841
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of POLR2E mRNA	PMID:19376846
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of POLR2E mRNA	PMID:19167446
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313438	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of POLR2E mRNA	PMID:36331819
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of POLR2E mRNA	PMID:20106945|PMID:25562108
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of POLR2E mRNA	PMID:33512557
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of POLR2E mRNA	PMID:22230336
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313438	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of POLR2E mRNA	PMID:40504410
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of POLR2E mRNA	PMID:31675489
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313438	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of POLR2E mRNA	PMID:35436446
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313438	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of POLR2E mRNA	PMID:17942748
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313438	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLR2E mRNA	PMID:17942748
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of POLR2E protein	PMID:25419056
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313438	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of POLR2E mRNA	PMID:35964746
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of POLR2E protein	PMID:32959892
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of POLR2E mRNA	PMID:15336504
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of POLR2E protein	PMID:34186270
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313438	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of POLR2E mRNA	PMID:22206623
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313438	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of POLR2E mRNA]	PMID:22206623
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POLR2E mRNA	PMID:30851411
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313438	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of POLR2E mRNA	PMID:31388691
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1589817	E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of POLR2E protein	PMID:19954255
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313438	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of POLR2E mRNA	PMID:30294300
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of POLR2E protein	PMID:31675489
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of POLR2E protein	PMID:31675489
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of POLR2E mRNA	PMID:12727804
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313438	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of POLR2E mRNA	PMID:40826991
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of POLR2E mRNA	PMID:34581912
1313437	POLR2E	RNA polymerase II, I and III subunit E	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of POLR2E mRNA	PMID:38568856
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RARS2 mRNA	PMID:38218311
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of RARS2 protein	PMID:36641056
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313440	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RARS2 mRNA	PMID:36331819
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313440	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RARS2 mRNA	PMID:30319688
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RARS2 mRNA	PMID:31059760
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313440	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RARS2 mRNA	PMID:39241906
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of RARS2 mRNA	PMID:31059760
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of RARS2 mRNA	PMID:38568856
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RARS2 mRNA	PMID:37042841
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313440	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of RARS2 mRNA	PMID:17251523
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313440	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RARS2 mRNA	PMID:37236586
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RARS2 gene	PMID:27153756
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RARS2 mRNA	PMID:23557933
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313440	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RARS2 mRNA	PMID:21570461
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305419	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RARS2 mRNA	PMID:33387578
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RARS2 mRNA	PMID:33212167
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RARS2 mRNA	PMID:30851411
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of RARS2 mRNA	PMID:39719251
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RARS2 mRNA	PMID:38568856
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313440	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RARS2 mRNA	PMID:22228805
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313440	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of RARS2 protein	PMID:37955338
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RARS2 mRNA	PMID:20018196
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305419	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RARS2 mRNA	PMID:25729387
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305419	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RARS2 mRNA	PMID:34492290
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33146	vanadyl sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C034028	vanadyl sulfate results in increased expression of RARS2 mRNA	PMID:16330358
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305419	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RARS2 mRNA	PMID:30816183|PMID:32528016
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RARS2 mRNA	PMID:25047013
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305419	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RARS2 mRNA	PMID:25181051
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313440	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of RARS2 mRNA	PMID:26682919
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313440	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RARS2 mRNA	PMID:39298647
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313440	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RARS2 mRNA	PMID:17361019|PMID:21266533
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RARS2 mRNA	PMID:37042841
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313440	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RARS2 mRNA	PMID:37236586
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RARS2 mRNA	PMID:24449571
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RARS2 mRNA	PMID:28302478
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RARS2 mRNA	PMID:31533062
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313440	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RARS2 mRNA	PMID:36331819
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RARS2 mRNA	PMID:25979313
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RARS2 mRNA	PMID:23179753
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RARS2 gene	PMID:29154799
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of RARS2 mRNA	PMID:25704631|PMID:31059760
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305419	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RARS2 mRNA	PMID:33387578
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of RARS2 mRNA	PMID:31059760
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305419	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RARS2 mRNA	PMID:24136188
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305419	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RARS2 mRNA	PMID:25729387
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313440	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RARS2 mRNA	PMID:23650126
1313439	RARS2	arginyl-tRNA synthetase 2, mitochondrial	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RARS2 mRNA	PMID:30851411
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TRMO mRNA	PMID:38218311
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TRMO mRNA	PMID:22378314
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305420	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TRMO mRNA	PMID:33387578
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRMO mRNA	PMID:37042841
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305420	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TRMO mRNA	PMID:33387578
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TRMO mRNA	PMID:19549813
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305420	E	RGD:6480464	20160119	CTD	MESH:C016517	indole-3-carbinol affects the expression of TRMO mRNA	PMID:21396975
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TRMO mRNA	PMID:23649840
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRMO mRNA	PMID:39836092
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of TRMO mRNA	PMID:26272509
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRMO mRNA	PMID:27188386
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313442	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of TRMO mRNA	PMID:40618947
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305420	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRMO mRNA	PMID:33387578
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TRMO mRNA	PMID:30851411
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRMO mRNA	PMID:29803840
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TRMO mRNA	PMID:38568856
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRMO mRNA	PMID:39836092
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TRMO mRNA	PMID:35984750
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305420	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of TRMO mRNA	PMID:25729387
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305420	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TRMO mRNA	PMID:25729387
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313442	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TRMO mRNA	PMID:29264374
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305420	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRMO mRNA	PMID:25181051
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305420	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TRMO mRNA	PMID:34947998
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TRMO mRNA	PMID:25979313
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313442	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TRMO mRNA	PMID:38685157
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313442	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of TRMO mRNA	PMID:28392331
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRMO mRNA	PMID:37042841
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TRMO mRNA	PMID:38174414|PMID:38568856
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TRMO mRNA	PMID:28302478
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRMO mRNA	PMID:23179753
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of TRMO mRNA	PMID:20106945
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305420	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TRMO mRNA	PMID:33387578
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRMO mRNA	PMID:39836092
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305420	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of TRMO mRNA	PMID:25729387
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305420	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TRMO mRNA	PMID:25729387
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TRMO mRNA	PMID:30851411
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRMO mRNA	PMID:27188386
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of TRMO mRNA	PMID:24921660
1313441	TRMO	tRNA methyltransferase O	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TRMO mRNA	PMID:27188386
1313443	RFK	riboflavin kinase	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1558007	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of RFK protein	PMID:36252740
1313443	RFK	riboflavin kinase	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1558007	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of RFK mRNA]	PMID:19467301
1313443	RFK	riboflavin kinase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RFK mRNA	PMID:33167477
1313443	RFK	riboflavin kinase	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1558007	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RFK mRNA	PMID:22629407
1313443	RFK	riboflavin kinase	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1558007	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of RFK mRNA]	PMID:22629407
1313443	RFK	riboflavin kinase	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1558007	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RFK mRNA	PMID:30319688
1313443	RFK	riboflavin kinase	gene	CHEBI:16238	FAD	increases abundance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005182	RFK protein results in increased abundance of Flavin-Adenine Dinucleotide	PMID:21308351
1313443	RFK	riboflavin kinase	gene	CHEBI:16240	hydrogen peroxide	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	RFK protein results in decreased susceptibility to Hydrogen Peroxide	PMID:21308351
1313443	RFK	riboflavin kinase	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of RFK protein	PMID:18951874
1313443	RFK	riboflavin kinase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1558007	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RFK mRNA	PMID:39241906
1313443	RFK	riboflavin kinase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RFK mRNA	PMID:37042841
1313443	RFK	riboflavin kinase	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of RFK mRNA	PMID:23649840
1313443	RFK	riboflavin kinase	gene	CHEBI:16856	glutathione	increases abundance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005978	RFK protein results in increased abundance of Glutathione	PMID:21308351
1313443	RFK	riboflavin kinase	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1558007	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of RFK mRNA	PMID:21669218
1313443	RFK	riboflavin kinase	gene	CHEBI:17621	FMN	increases abundance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005486	RFK protein results in increased abundance of Flavin Mononucleotide	PMID:21308351
1313443	RFK	riboflavin kinase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1558007	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RFK mRNA	PMID:19850644
1313443	RFK	riboflavin kinase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1558007	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of RFK mRNA]	PMID:19850644
1313443	RFK	riboflavin kinase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1549748	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RFK mRNA	PMID:33387578
1313443	RFK	riboflavin kinase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1558007	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RFK mRNA	PMID:28111341
1313443	RFK	riboflavin kinase	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RFK mRNA	PMID:23649840
1313443	RFK	riboflavin kinase	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RFK intron	PMID:30157460
1313443	RFK	riboflavin kinase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RFK mRNA	PMID:23649840
1313443	RFK	riboflavin kinase	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of RFK mRNA	PMID:26272509
1313443	RFK	riboflavin kinase	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RFK mRNA	PMID:27188386
1313443	RFK	riboflavin kinase	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RFK mRNA	PMID:28903495
1313443	RFK	riboflavin kinase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1558007	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of RFK mRNA	PMID:21151649
1313443	RFK	riboflavin kinase	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	RFK protein results in decreased susceptibility to Cisplatin	PMID:21308351
1313443	RFK	riboflavin kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1549748	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RFK mRNA	PMID:32109520
1313443	RFK	riboflavin kinase	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of RFK protein	PMID:18951874
1313443	RFK	riboflavin kinase	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RFK mRNA	PMID:28001369
1313443	RFK	riboflavin kinase	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1549748	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of RFK mRNA	PMID:28959563
1313443	RFK	riboflavin kinase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RFK mRNA	PMID:29803840
1313443	RFK	riboflavin kinase	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of RFK mRNA	PMID:25523186
1313443	RFK	riboflavin kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of RFK protein	PMID:30528433
1313443	RFK	riboflavin kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1558007	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of RFK mRNA	PMID:37682722
1313443	RFK	riboflavin kinase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of RFK protein	PMID:38228842
1313443	RFK	riboflavin kinase	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1558007	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of RFK mRNA	PMID:17127020
1313443	RFK	riboflavin kinase	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of RFK mRNA	PMID:25523186
1313443	RFK	riboflavin kinase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of RFK mRNA	PMID:20382639|PMID:26238291
1313443	RFK	riboflavin kinase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1558007	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RFK gene; titanium dioxide results in decreased methylation of RFK promoter	PMID:35295148
1313443	RFK	riboflavin kinase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1549748	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RFK mRNA	PMID:34492290
1313443	RFK	riboflavin kinase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1558007	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RFK mRNA	PMID:18648102
1313443	RFK	riboflavin kinase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1558007	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RFK mRNA	PMID:17426115
1313443	RFK	riboflavin kinase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1558007	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of RFK mRNA	PMID:18301758|PMID:23811191
1313443	RFK	riboflavin kinase	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of RFK mRNA	PMID:38479592
1313443	RFK	riboflavin kinase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1549748	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RFK mRNA	PMID:25181051
1313443	RFK	riboflavin kinase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1558007	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of RFK mRNA	PMID:26063408
1313443	RFK	riboflavin kinase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1549748	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of RFK mRNA	PMID:33296240
1313443	RFK	riboflavin kinase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1549748	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RFK gene	PMID:28505145
1313443	RFK	riboflavin kinase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RFK mRNA	PMID:28628672
1313443	RFK	riboflavin kinase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1549748	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RFK mRNA	PMID:36041667
1313443	RFK	riboflavin kinase	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of RFK mRNA	PMID:25979313
1313443	RFK	riboflavin kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1558007	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RFK mRNA	PMID:39298647
1313443	RFK	riboflavin kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RFK mRNA	PMID:28628672
1313443	RFK	riboflavin kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1549748	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RFK mRNA	PMID:36041667
1313443	RFK	riboflavin kinase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1549748	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RFK mRNA	PMID:36041667
1313443	RFK	riboflavin kinase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1558007	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RFK mRNA	PMID:37019170
1313443	RFK	riboflavin kinase	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of RFK gene	PMID:22964155
1313443	RFK	riboflavin kinase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RFK mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RFK mRNA	PMID:28628672
1313443	RFK	riboflavin kinase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RFK mRNA	PMID:37042841
1313443	RFK	riboflavin kinase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RFK mRNA	PMID:38568856
1313443	RFK	riboflavin kinase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1558007	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RFK mRNA	PMID:28111341
1313443	RFK	riboflavin kinase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1558007	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of RFK mRNA	PMID:17585979
1313443	RFK	riboflavin kinase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RFK mRNA	PMID:25979313
1313443	RFK	riboflavin kinase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1558007	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RFK mRNA	PMID:17292431|PMID:17963808
1313443	RFK	riboflavin kinase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of RFK mRNA	PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1313443	RFK	riboflavin kinase	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RFK gene	PMID:29154799
1313443	RFK	riboflavin kinase	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1549748	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of RFK mRNA	PMID:38685447|PMID:41580965
1313443	RFK	riboflavin kinase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RFK mRNA	PMID:25562108
1313443	RFK	riboflavin kinase	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RFK mRNA	PMID:14699072
1313443	RFK	riboflavin kinase	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in increased expression of RFK mRNA	PMID:19059307
1313443	RFK	riboflavin kinase	gene	CHEBI:41791	calyculin A	increases expression	ISO	RGD:1558007	E	RGD:6480464	20150127	CTD	MESH:C059041	calyculin A results in increased expression of RFK mRNA	PMID:25270620
1313443	RFK	riboflavin kinase	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RFK mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RFK mRNA	PMID:28628672
1313443	RFK	riboflavin kinase	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of RFK mRNA	PMID:23649840
1313443	RFK	riboflavin kinase	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of RFK mRNA	PMID:26272509
1313443	RFK	riboflavin kinase	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RFK mRNA	PMID:27188386
1313443	RFK	riboflavin kinase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of RFK mRNA	PMID:22230336
1313443	RFK	riboflavin kinase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of RFK mRNA	PMID:29067470
1313443	RFK	riboflavin kinase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1549748	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RFK mRNA	PMID:33387578
1313443	RFK	riboflavin kinase	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of RFK mRNA	PMID:21148743
1313443	RFK	riboflavin kinase	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1549748	E	RGD:6480464	20131126	CTD	MESH:C005219	methyl cellosolve results in increased expression of RFK mRNA	PMID:21061450
1313443	RFK	riboflavin kinase	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1558007	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RFK mRNA	PMID:35436446
1313443	RFK	riboflavin kinase	gene	CHEBI:48958	1,1'-azobis(N,N-dimethylformamide)	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D003958	RFK protein results in decreased susceptibility to Diamide	PMID:21308351
1313443	RFK	riboflavin kinase	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RFK mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RFK mRNA	PMID:28628672
1313443	RFK	riboflavin kinase	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1549748	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of RFK mRNA	PMID:41580965
1313443	RFK	riboflavin kinase	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	ISO	RGD:1549748	E	RGD:6480464	20131126	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of RFK mRNA	PMID:19162173
1313443	RFK	riboflavin kinase	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1549748	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of RFK mRNA	PMID:24793618
1313443	RFK	riboflavin kinase	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of RFK mRNA	PMID:20436886
1313443	RFK	riboflavin kinase	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1549748	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of RFK mRNA	PMID:28801915
1313443	RFK	riboflavin kinase	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1558007	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RFK mRNA	PMID:23650126
1313443	RFK	riboflavin kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1558007	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RFK mRNA	PMID:22206623
1313443	RFK	riboflavin kinase	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1549748	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of RFK mRNA	PMID:24136188
1313443	RFK	riboflavin kinase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RFK mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RFK mRNA	PMID:27188386
1313443	RFK	riboflavin kinase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1549748	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RFK mRNA	PMID:32109520
1313443	RFK	riboflavin kinase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1549748	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RFK mRNA	PMID:30047161
1313443	RFK	riboflavin kinase	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of RFK mRNA	PMID:14699072
1313443	RFK	riboflavin kinase	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of RFK mRNA	PMID:19059307
1313443	RFK	riboflavin kinase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RFK mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RFK mRNA	PMID:27188386
1313443	RFK	riboflavin kinase	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1549748	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of RFK mRNA	PMID:23034163
1313443	RFK	riboflavin kinase	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1549748	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of RFK gene	PMID:31682807
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313450	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SUPT3 mRNA	PMID:33045310
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313450	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SUPT3H gene	PMID:20938992
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SUPT3H mRNA	PMID:33167477
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313450	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SUPT3 mRNA	PMID:36331819
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1591316	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SUPT3H mRNA	PMID:33387578
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313450	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SUPT3H gene	PMID:20938992
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SUPT3H mRNA	PMID:23649840
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313450	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SUPT3 mRNA	PMID:36331819
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SUPT3H mRNA	PMID:35301059
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1591316	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of SUPT3H mRNA	PMID:21396975
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SUPT3H protein	PMID:20106945
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SUPT3H mRNA	PMID:21641981
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313450	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SUPT3H mRNA	PMID:19770486
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SUPT3H gene	PMID:27153756
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313450	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SUPT3H mRNA	PMID:25629700
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313450	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SUPT3H gene	PMID:20938992
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SUPT3H mRNA	PMID:27392435
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SUPT3H mRNA	PMID:27392435
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313450	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SUPT3H mRNA	PMID:21570461
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313450	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SUPT3H mRNA	PMID:17942748
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1591316	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SUPT3H mRNA	PMID:33387578
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313450	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SUPT3H mRNA	PMID:17942748
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SUPT3H mRNA	PMID:33212167
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of SUPT3H mRNA	PMID:29319823
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SUPT3H mRNA	PMID:34032870
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:29678	sodium arsenite	decreases methylation	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased methylation of SUPT3H intron	PMID:32844245
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of SUPT3H mRNA	PMID:29301061|PMID:32844245
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SUPT3H mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291|PMID:32234424
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313450	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SUPT3H mRNA	PMID:19770486|PMID:21715664
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:30563	silicon dioxide	increases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased methylation of SUPT3H promoter	PMID:34973136
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SUPT3H mRNA	PMID:20382639|PMID:26238291
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313450	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SUPT3H gene	PMID:35295148
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313450	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SUPT3H promoter	PMID:35295148
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1591316	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SUPT3H mRNA	PMID:34492290
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313450	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SUPT3H mRNA	PMID:18301758
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313450	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SUPT3H mRNA	PMID:19710929
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313450	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SUPT3 mRNA	PMID:39298647
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313450	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SUPT3 mRNA	PMID:38685157
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313450	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SUPT3 mRNA	PMID:28392331
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313450	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SUPT3 mRNA	PMID:34813904
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SUPT3H mRNA	PMID:38382870
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SUPT3H mRNA	PMID:35301059
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SUPT3H mRNA	PMID:24449571
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:3766	clozapine	increases expression	ISO	RGD:1591316	E	RGD:6480464	20120522	CTD	MESH:D003024	Clozapine results in increased expression of SUPT3H mRNA	PMID:16715494
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SUPT3H mRNA	PMID:31533062
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313450	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SUPT3 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SUPT3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SUPT3 mRNA	PMID:36331819
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SUPT3H mRNA	PMID:23179753|PMID:27188386
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SUPT3H gene	PMID:29154799
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SUPT3H mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of SUPT3H mRNA	PMID:24449571
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of SUPT3H mRNA	PMID:22230336
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313450	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SUPT3 mRNA	PMID:29279043
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SUPT3H mRNA	PMID:22079256
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313450	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SUPT3 mRNA	PMID:35436446
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313450	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SUPT3H mRNA	PMID:17942748
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of SUPT3H mRNA	PMID:32234424
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:5613	haloperidol	increases expression	ISO	RGD:1591316	E	RGD:6480464	20120522	CTD	MESH:D006220	Haloperidol results in increased expression of SUPT3H mRNA	PMID:16715494
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313450	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SUPT3 mRNA	PMID:22206623
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SUPT3H mRNA	PMID:22079256
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SUPT3H mRNA	PMID:22079256
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of SUPT3H mRNA	PMID:36318118
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of SUPT3H protein	PMID:31285264
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of SUPT3H mRNA	PMID:30928695
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SUPT3H gene]	PMID:28238834
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of SUPT3H mRNA	PMID:32234424
1313449	SUPT3H	SPT3 homolog, SAGA and STAGA complex component	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313450	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SUPT3 mRNA	PMID:39847705
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SNRPF mRNA	PMID:33167477
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1616756	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SNRPF mRNA	PMID:39241906
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of SNRPF mRNA	PMID:35877022
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [SNRPF protein binds to ESR1 protein]	PMID:27156127
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:165219	PCB138	increases expression	ISO	RGD:1588229	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SNRPF mRNA	PMID:23829299
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SNRPF mRNA	PMID:38568856
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1588229	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SNRPF gene	PMID:27618143
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:166595	Yessotoxin	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in decreased expression of SNRPF mRNA	PMID:30679557
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:17347	testosterone	affects expression	ISO	RGD:1616756	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone affects the expression of SNRPF mRNA	PMID:20403060
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SNRPF mRNA	PMID:33359661
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1616756	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SNRPF mRNA	PMID:19850644
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1616756	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SNRPF mRNA	PMID:33754040
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1616756	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SNRPF mRNA]	PMID:19850644
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SNRPF protein	PMID:37730182
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1588229	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SNRPF mRNA	PMID:33387578
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1588229	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SNRPF mRNA	PMID:22061828
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of SNRPF mRNA	PMID:24284285
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNRPF mRNA	PMID:35301059
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SNRPF mRNA	PMID:35430440
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1616756	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SNRPF mRNA	PMID:34911549
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1616756	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SNRPF mRNA]	PMID:22206623
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNRPF mRNA	PMID:39836092
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SNRPF mRNA	PMID:23557933
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SNRPF mRNA	PMID:28903495
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SNRPF mRNA	PMID:27392435
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1616756	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SNRPF mRNA	PMID:30912803
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1588229	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNRPF mRNA	PMID:34747641
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1616756	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNRPF mRNA	PMID:15034205
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1616756	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of SNRPF mRNA]	PMID:15034205
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SNRPF mRNA	PMID:39709020
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1616756	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of SNRPF protein	PMID:21146535
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNRPF mRNA; sodium arsenite results in decreased expression of SNRPF protein	PMID:38228842|PMID:38568856
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of SNRPF mRNA	PMID:28595984|PMID:34032870
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNRPF mRNA	PMID:39836092
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SNRPF promoter	PMID:27901495
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1616756	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNRPF mRNA	PMID:15034205
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1616756	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in increased expression of SNRPF mRNA]	PMID:15034205
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to SNRPF mRNA]	PMID:32406909
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1616756	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of SNRPF protein	PMID:21146535
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SNRPF mRNA	PMID:20458559
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1588229	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SNRPF mRNA	PMID:24136188
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1588229	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of SNRPF mRNA	PMID:22641619
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1588229	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SNRPF mRNA	PMID:25729387
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1588229	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SNRPF mRNA	PMID:34492290
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SNRPF mRNA	PMID:30903817
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of SNRPF mRNA	PMID:29275510
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1588229	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SNRPF mRNA	PMID:25181051
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1616756	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SNRPF mRNA	PMID:33221593
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:34568	Benzo[ghi]perylene	decreases expression	ISO	RGD:1616756	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in decreased expression of SNRPF mRNA	PMID:26377693
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPF mRNA	PMID:28628672
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1616756	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SNRPF mRNA	PMID:37019170
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1616756	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of SNRPF protein	PMID:35362542
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1616756	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of SNRPF protein]	PMID:35362542
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPF mRNA	PMID:28628672
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNRPF mRNA	PMID:35301059
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SNRPF mRNA	PMID:19376846
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SNRPF mRNA	PMID:28302478
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SNRPF mRNA	PMID:31533062
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of SNRPF mRNA	PMID:26352163
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1588229	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of SNRPF mRNA	PMID:25993096
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SNRPF mRNA	PMID:25979313
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1588229	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of SNRPF mRNA	PMID:41580965
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SNRPF mRNA	PMID:25562108
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPF mRNA	PMID:28628672
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1616756	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNRPF mRNA	PMID:17562736
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:46680	serpentine asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of SNRPF 5' UTR	PMID:29523930
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNRPF mRNA	PMID:39836092
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:48707	(-)-citrinin	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D002953	[Citrinin co-treated with ochratoxin A] results in decreased expression of SNRPF protein	PMID:39638853
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of SNRPF mRNA	PMID:18175754
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1616756	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of SNRPF protein]	PMID:35362542
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPF mRNA	PMID:28628672
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SNRPF mRNA	PMID:20458559
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1588229	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SNRPF mRNA	PMID:24136188
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SNRPF protein	PMID:32959892
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:1588229	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of SNRPF mRNA	PMID:24136188
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1588229	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SNRPF mRNA	PMID:25729387
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1616756	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of SNRPF protein	PMID:36851058
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1616756	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of SNRPF mRNA	PMID:20003209
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:67895	corosolic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of SNRPF mRNA	PMID:37939859
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SNRPF mRNA	PMID:31758290
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SNRPF protein	PMID:34186270
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1616756	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SNRPF mRNA	PMID:22206623
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1616756	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SNRPF mRNA]	PMID:22206623
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1588229	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of SNRPF mRNA	PMID:15215175
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	[Citrinin co-treated with ochratoxin A] results in decreased expression of SNRPF protein	PMID:39638853
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:80630	irinotecan	increases response to substance	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	SNRPF protein results in increased susceptibility to Irinotecan	PMID:16734730
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1616756	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SNRPF mRNA	PMID:30294300
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1588229	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SNRPF mRNA	PMID:24780913
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:9381	T-2 toxin	affects expression	ISO	RGD:1588229	E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin affects the expression of SNRPF protein	PMID:26141394
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SNRPF mRNA	PMID:38568856
1313451	SNRPF	small nuclear ribonucleoprotein polypeptide F	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1588229	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of SNRPF mRNA	PMID:22570695
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KDM5A mRNA	PMID:38218311
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313453	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of KDM5A mRNA	PMID:33045310
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014212	Tretinoin results in increased expression of KDM5A mRNA	PMID:22906706|PMID:33167477
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of KDM5A mRNA	PMID:22378314
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:D000431	Ethanol results in decreased expression of KDM5A protein	PMID:35149083
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of KDM5A mRNA	PMID:20044591
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:16243	quercetin	affects expression	ISO	RGD:1305429	E	RGD:6480464	20120522	CTD	MESH:D011794	Quercetin affects the expression of KDM5A mRNA	PMID:18178720
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KDM5A mRNA	PMID:39241906
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20161228	CTD	MESH:D008070	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of KDM5A gene	PMID:21212295
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KDM5A mRNA	PMID:37042841
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KDM5A protein	PMID:37730182
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305429	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of KDM5A mRNA	PMID:22061828|PMID:33387578
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KDM5A mRNA	PMID:28818685
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KDM5A mRNA	PMID:35301059
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of KDM5A mRNA	PMID:37236586
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:232469	Crenigacestat	multiple interactions	EXP		E	RGD:6480464	20241203	CTD	MESH:C000654634	crenigacestat inhibits the reaction [Aconitine results in increased expression of KDM5A protein]	PMID:32234357
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KDM5A mRNA	PMID:19549813
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:2430	aconitine	increases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:D000157	Aconitine results in increased expression of KDM5A protein	PMID:32234357
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:2430	aconitine	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D000157	Aconitine promotes the reaction [NOTCH1 protein modified form binds to KDM5A protein]; crenigacestat inhibits the reaction [Aconitine results in increased expression of KDM5A protein]	PMID:32234357
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KDM5A gene	PMID:27153756
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313453	E	RGD:6480464	20120522	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KDM5A mRNA	PMID:19770486
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of KDM5A mRNA	PMID:26760959
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of KDM5A mRNA	PMID:23649840
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of KDM5A mRNA	PMID:41430723
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C040641	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA	PMID:27424125
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1305429	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of KDM5A gene	PMID:35440735
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in decreased expression of KDM5A mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of KDM5A mRNA	PMID:19167446|PMID:23557933
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of KDM5A mRNA	PMID:30912803
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D019833	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA	PMID:27424125
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305429	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KDM5A mRNA	PMID:33387578|PMID:34747641
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KDM5A mRNA	PMID:31961203
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20120522	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in increased methylation of KDM5A gene	PMID:21212295
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:28197	daidzein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C004742	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA	PMID:27424125
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of KDM5A mRNA	PMID:33512557
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KDM5A mRNA	PMID:28001369
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305429	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of KDM5A mRNA	PMID:28959563
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305429	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of KDM5A mRNA	PMID:38578163
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C017947	sodium arsenite results in increased expression of KDM5A mRNA; sodium arsenite results in increased expression of KDM5A protein	PMID:29148585|PMID:38568856
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KDM5A mRNA	PMID:19150397
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of KDM5A mRNA	PMID:26238291
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of KDM5A gene	PMID:31601247
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313453	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KDM5A gene; titanium dioxide results in decreased methylation of KDM5A promoter alternative form	PMID:35295148
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313453	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of KDM5A mRNA	PMID:29264374
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of KDM5A mRNA	PMID:28329830
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313453	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of KDM5A promoter	PMID:27334623
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305429	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KDM5A mRNA	PMID:25181051|PMID:30816183
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of KDM5A intron	PMID:30157460
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of KDM5A mRNA	PMID:37019170
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:34778	glycitein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C086566	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA	PMID:27424125
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of KDM5A mRNA	PMID:37047231
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KDM5A mRNA	PMID:37042841
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KDM5A mRNA	PMID:35301059
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of KDM5A mRNA	PMID:37236586
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of KDM5A mRNA	PMID:19376846
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305429	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of KDM5A mRNA	PMID:24386269
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of KDM5A mRNA	PMID:31533062
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of KDM5A mRNA	PMID:19167446
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in decreased expression of KDM5A mRNA	PMID:19167446
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1305429	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of KDM5A mRNA	PMID:23125180
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305429	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of KDM5A mRNA	PMID:29427782
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of KDM5A mRNA	PMID:23179753|PMID:27188386
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305429	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of KDM5A mRNA	PMID:29427782
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of KDM5A mRNA	PMID:25562108
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:41774	tamoxifen	increases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D013629	Tamoxifen results in increased expression of KDM5A mRNA	PMID:15590111
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C013908	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA	PMID:27424125
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313453	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of KDM5A mRNA	PMID:28973697
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313453	E	RGD:6480464	20120522	CTD	MESH:D000082	Acetaminophen affects the expression of KDM5A mRNA	PMID:17562736
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305429	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KDM5A mRNA	PMID:33387578
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D005472	Fluorouracil results in decreased expression of KDM5A mRNA	PMID:16557594
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D018038	Sodium Selenite results in decreased expression of KDM5A mRNA	PMID:16705456
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D018038	Sodium Selenite results in increased expression of KDM5A mRNA	PMID:18175754
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305429	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of KDM5A mRNA	PMID:24793618
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D011192	Potassium Dichromate results in increased expression of KDM5A mRNA	PMID:11678601
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] affects the expression of KDM5A mRNA	PMID:26378955
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of KDM5A mRNA	PMID:28988120
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of KDM5A intron	PMID:30157460
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KDM5A mRNA	PMID:22206623
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of KDM5A mRNA	PMID:37199045
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KDM5A gene]	PMID:28238834
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:80373	glycitin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C433283	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of KDM5A mRNA	PMID:27424125
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313453	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of KDM5A mRNA	PMID:23091169
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of KDM5A mRNA	PMID:23091169
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:81555	Enterolactone	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of KDM5A mRNA	PMID:19167446
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of KDM5A mRNA	PMID:33512557
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of KDM5A mRNA	PMID:17440010
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KDM5A mRNA	PMID:38568856
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:95077	GSK-J4	multiple interactions	ISO	RGD:1313453	E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of KDM5A mRNA]; GSK-J4 inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of KDM5A protein]	PMID:36537648
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313453	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of KDM5A mRNA	PMID:28973697
1313452	KDM5A	lysine demethylase 5A	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305429	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of KDM5A mRNA	PMID:18042343
1313454	CDH18	cadherin 18	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CDH18 mRNA	PMID:26272509
1313454	CDH18	cadherin 18	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1313454	CDH18	cadherin 18	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1615561	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CDH18 mRNA	PMID:37995155
1313454	CDH18	cadherin 18	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305430	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of CDH18 gene	PMID:35440735
1313454	CDH18	cadherin 18	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1615561	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CDH18 mRNA	PMID:30319688
1313454	CDH18	cadherin 18	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of CDH18 mRNA	PMID:17555868
1313454	CDH18	cadherin 18	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH18 mRNA	PMID:25510870
1313454	CDH18	cadherin 18	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305430	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CDH18 mRNA	PMID:33387578
1313454	CDH18	cadherin 18	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDH18 mRNA	PMID:37992649
1313454	CDH18	cadherin 18	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDH18 mRNA	PMID:37992649
1313454	CDH18	cadherin 18	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CDH18 mRNA	PMID:31163220
1313454	CDH18	cadherin 18	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH18 mRNA	PMID:25510870
1313454	CDH18	cadherin 18	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH18 mRNA	PMID:25510870
1313454	CDH18	cadherin 18	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CDH18 gene	PMID:27153756
1313454	CDH18	cadherin 18	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CDH18 intron	PMID:30157460
1313454	CDH18	cadherin 18	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1615561	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CDH18 mRNA	PMID:25629700
1313454	CDH18	cadherin 18	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of CDH18 mRNA	PMID:26272509
1313454	CDH18	cadherin 18	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1313454	CDH18	cadherin 18	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CDH18 mRNA	PMID:28903495
1313454	CDH18	cadherin 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615561	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDH18 mRNA	PMID:26377647
1313454	CDH18	cadherin 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305430	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CDH18 mRNA	PMID:33387578
1313454	CDH18	cadherin 18	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of CDH18 mRNA	PMID:29955902
1313454	CDH18	cadherin 18	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CDH18 mRNA	PMID:28001369
1313454	CDH18	cadherin 18	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDH18 mRNA	PMID:37992649
1313454	CDH18	cadherin 18	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CDH18 5' UTR; Benzo(a)pyrene affects the methylation of CDH18 promoter	PMID:27901495
1313454	CDH18	cadherin 18	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CDH18 3' UTR; Benzo(a)pyrene results in increased methylation of CDH18 exon	PMID:27901495
1313454	CDH18	cadherin 18	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CDH18 mRNA	PMID:23806026
1313454	CDH18	cadherin 18	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1305430	E	RGD:6480464	20230404	CTD	MESH:D000643	Ammonium Chloride affects the expression of CDH18 mRNA	PMID:16483693
1313454	CDH18	cadherin 18	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CDH18 gene	PMID:31601247
1313454	CDH18	cadherin 18	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of CDH18 mRNA	PMID:20170705
1313454	CDH18	cadherin 18	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of CDH18 gene	PMID:31601247
1313454	CDH18	cadherin 18	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305430	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CDH18 mRNA	PMID:34947998
1313454	CDH18	cadherin 18	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CDH18 gene	PMID:31601247
1313454	CDH18	cadherin 18	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305430	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDH18 mRNA	PMID:36041667
1313454	CDH18	cadherin 18	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH18 mRNA	PMID:25510870
1313454	CDH18	cadherin 18	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CDH18 mRNA	PMID:25510870
1313454	CDH18	cadherin 18	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305430	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDH18 mRNA	PMID:36041667
1313454	CDH18	cadherin 18	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of CDH18 intron	PMID:30157460
1313454	CDH18	cadherin 18	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305430	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CDH18 mRNA	PMID:36041667
1313454	CDH18	cadherin 18	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1615561	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CDH18 intron	PMID:28392331
1313454	CDH18	cadherin 18	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CDH18 mRNA	PMID:38568856
1313454	CDH18	cadherin 18	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of CDH18 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1313454	CDH18	cadherin 18	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1313454	CDH18	cadherin 18	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CDH18 mRNA	PMID:20106945
1313454	CDH18	cadherin 18	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1615561	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDH18 mRNA	PMID:37992649
1313454	CDH18	cadherin 18	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CDH18 mRNA	PMID:26272509
1313454	CDH18	cadherin 18	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1313454	CDH18	cadherin 18	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CDH18 mRNA	PMID:24935251
1313454	CDH18	cadherin 18	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305430	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CDH18 mRNA	PMID:33387578
1313454	CDH18	cadherin 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of CDH18 mRNA	PMID:33725128
1313454	CDH18	cadherin 18	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CDH18 mRNA	PMID:20170705
1313454	CDH18	cadherin 18	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of CDH18 mRNA	PMID:18936297
1313454	CDH18	cadherin 18	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of CDH18 mRNA	PMID:26272509
1313454	CDH18	cadherin 18	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CDH18 mRNA	PMID:24810058
1313454	CDH18	cadherin 18	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of CDH18 intron	PMID:30157460
1313454	CDH18	cadherin 18	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305430	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CDH18 gene	PMID:35440735
1313454	CDH18	cadherin 18	gene	CHEBI:72544	flavonoids	decreases expression	ISO	RGD:1305430	E	RGD:6480464	20230404	CTD	MESH:D005419	Flavonoids results in decreased expression of CDH18 mRNA	PMID:18035473
1313454	CDH18	cadherin 18	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1313454	CDH18	cadherin 18	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1615561	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of CDH18 mRNA	PMID:31388691
1313454	CDH18	cadherin 18	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of CDH18 mRNA	PMID:26272509
1313454	CDH18	cadherin 18	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1313454	CDH18	cadherin 18	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDH18 mRNA	PMID:27188386
1313456	UBL3	ubiquitin like 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313457	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of UBL3 mRNA	PMID:33045310
1313456	UBL3	ubiquitin like 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of UBL3 mRNA	PMID:33167477
1313456	UBL3	ubiquitin like 3	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of UBL3 mRNA	PMID:21632981
1313456	UBL3	ubiquitin like 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of UBL3 mRNA	PMID:39241906
1313456	UBL3	ubiquitin like 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of UBL3 mRNA	PMID:15289156
1313456	UBL3	ubiquitin like 3	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of UBL3 mRNA	PMID:38568856
1313456	UBL3	ubiquitin like 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of UBL3 mRNA	PMID:31163220
1313456	UBL3	ubiquitin like 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305431	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of UBL3 mRNA	PMID:22061828
1313456	UBL3	ubiquitin like 3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of UBL3 mRNA	PMID:28818685
1313456	UBL3	ubiquitin like 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UBL3 mRNA	PMID:35301059
1313456	UBL3	ubiquitin like 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of UBL3 mRNA	PMID:19549813
1313456	UBL3	ubiquitin like 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of UBL3 mRNA	PMID:22100608
1313456	UBL3	ubiquitin like 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of UBL3 gene	PMID:27153756
1313456	UBL3	ubiquitin like 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of UBL3 mRNA	PMID:19770486
1313456	UBL3	ubiquitin like 3	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305431	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of UBL3 mRNA	PMID:30779732
1313456	UBL3	ubiquitin like 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313457	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBL3 mRNA	PMID:22206623
1313456	UBL3	ubiquitin like 3	gene	CHEBI:27504	mitomycin C	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	UBL3 protein affects the susceptibility to Mitomycin	PMID:16217747
1313456	UBL3	ubiquitin like 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBL3 mRNA	PMID:39836092
1313456	UBL3	ubiquitin like 3	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of UBL3 mRNA	PMID:19244175
1313456	UBL3	ubiquitin like 3	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of UBL3 mRNA	PMID:28903495
1313456	UBL3	ubiquitin like 3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of UBL3 mRNA	PMID:27392435
1313456	UBL3	ubiquitin like 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of UBL3 mRNA	PMID:27392435
1313456	UBL3	ubiquitin like 3	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of UBL3 mRNA	PMID:15289156
1313456	UBL3	ubiquitin like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313457	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBL3 mRNA	PMID:21570461
1313456	UBL3	ubiquitin like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305431	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBL3 mRNA	PMID:21215274|PMID:32109520
1313456	UBL3	ubiquitin like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305431	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBL3 mRNA	PMID:34747641
1313456	UBL3	ubiquitin like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBL3 mRNA	PMID:17942748|PMID:19933214
1313456	UBL3	ubiquitin like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBL3 mRNA	PMID:17942748
1313456	UBL3	ubiquitin like 3	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of UBL3 mRNA	PMID:39709020
1313456	UBL3	ubiquitin like 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UBL3 mRNA	PMID:30851411
1313456	UBL3	ubiquitin like 3	gene	CHEBI:28680	cytarabine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003561	Cytarabine results in increased expression of UBL3 mRNA	PMID:19194470
1313456	UBL3	ubiquitin like 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UBL3 mRNA	PMID:38568856
1313456	UBL3	ubiquitin like 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBL3 mRNA	PMID:39836092
1313456	UBL3	ubiquitin like 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBL3 mRNA	PMID:22228805
1313456	UBL3	ubiquitin like 3	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of UBL3 mRNA	PMID:26014281
1313456	UBL3	ubiquitin like 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of UBL3 mRNA	PMID:35676786
1313456	UBL3	ubiquitin like 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313457	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBL3 promoter	PMID:35295148
1313456	UBL3	ubiquitin like 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305431	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of UBL3 mRNA	PMID:25181051
1313456	UBL3	ubiquitin like 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305431	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of UBL3 mRNA	PMID:34947998
1313456	UBL3	ubiquitin like 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of UBL3 gene	PMID:31601247
1313456	UBL3	ubiquitin like 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313457	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of UBL3 promoter	PMID:27312807
1313456	UBL3	ubiquitin like 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305431	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of UBL3 mRNA	PMID:33296240
1313456	UBL3	ubiquitin like 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305431	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of UBL3 mRNA	PMID:36041667
1313456	UBL3	ubiquitin like 3	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of UBL3 mRNA	PMID:19244175
1313456	UBL3	ubiquitin like 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313457	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of UBL3 mRNA	PMID:40203079
1313456	UBL3	ubiquitin like 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305431	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of UBL3 mRNA	PMID:36041667
1313456	UBL3	ubiquitin like 3	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of UBL3 mRNA	PMID:26377693
1313456	UBL3	ubiquitin like 3	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305431	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of UBL3 mRNA	PMID:36041667
1313456	UBL3	ubiquitin like 3	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305431	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UBL3 mRNA	PMID:17602206
1313456	UBL3	ubiquitin like 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305431	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of UBL3 mRNA	PMID:17602206
1313456	UBL3	ubiquitin like 3	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313457	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of UBL3 mRNA	PMID:26377693
1313456	UBL3	ubiquitin like 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UBL3 mRNA	PMID:38174414
1313456	UBL3	ubiquitin like 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UBL3 mRNA	PMID:35301059
1313456	UBL3	ubiquitin like 3	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of UBL3 mRNA	PMID:19376846
1313456	UBL3	ubiquitin like 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of UBL3 mRNA	PMID:24449571
1313456	UBL3	ubiquitin like 3	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of UBL3 mRNA	PMID:19244175
1313456	UBL3	ubiquitin like 3	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of UBL3 mRNA	PMID:28302478
1313456	UBL3	ubiquitin like 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of UBL3 mRNA	PMID:27153767|PMID:40419075
1313456	UBL3	ubiquitin like 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UBL3 mRNA	PMID:25979313
1313456	UBL3	ubiquitin like 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of UBL3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:29154799
1313456	UBL3	ubiquitin like 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBL3 mRNA	PMID:27188386
1313456	UBL3	ubiquitin like 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305431	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of UBL3 mRNA	PMID:38685447
1313456	UBL3	ubiquitin like 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of UBL3 mRNA	PMID:25562108
1313456	UBL3	ubiquitin like 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of UBL3 mRNA	PMID:17555576
1313456	UBL3	ubiquitin like 3	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of UBL3 mRNA	PMID:15289156
1313456	UBL3	ubiquitin like 3	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D017239	Paclitaxel results in increased expression of UBL3 mRNA	PMID:40481235
1313456	UBL3	ubiquitin like 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of UBL3 mRNA	PMID:24935251|PMID:26272509
1313456	UBL3	ubiquitin like 3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBL3 mRNA	PMID:27188386
1313456	UBL3	ubiquitin like 3	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of UBL3 mRNA	PMID:29279043
1313456	UBL3	ubiquitin like 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBL3 mRNA	PMID:39836092
1313456	UBL3	ubiquitin like 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of UBL3 mRNA	PMID:17555576
1313456	UBL3	ubiquitin like 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UBL3 mRNA	PMID:17942748
1313456	UBL3	ubiquitin like 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UBL3 mRNA	PMID:17942748
1313456	UBL3	ubiquitin like 3	gene	CHEBI:4911	etoposide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	UBL3 protein affects the susceptibility to Etoposide	PMID:16217747
1313456	UBL3	ubiquitin like 3	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of UBL3 mRNA	PMID:35676786
1313456	UBL3	ubiquitin like 3	gene	CHEBI:50729	mitoxantrone	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	UBL3 protein affects the susceptibility to Mitoxantrone	PMID:16217747
1313456	UBL3	ubiquitin like 3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305431	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBL3 mRNA	PMID:24136188
1313456	UBL3	ubiquitin like 3	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of UBL3 mRNA	PMID:22714537
1313456	UBL3	ubiquitin like 3	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of UBL3 mRNA	PMID:23650126
1313456	UBL3	ubiquitin like 3	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of UBL3 mRNA	PMID:31758290
1313456	UBL3	ubiquitin like 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of UBL3 mRNA	PMID:22206623
1313456	UBL3	ubiquitin like 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313457	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UBL3 mRNA	PMID:22206623
1313456	UBL3	ubiquitin like 3	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305431	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of UBL3 mRNA	PMID:24136188
1313456	UBL3	ubiquitin like 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UBL3 mRNA	PMID:30851411
1313456	UBL3	ubiquitin like 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBL3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBL3 mRNA	PMID:27188386
1313456	UBL3	ubiquitin like 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to UBL3 gene]	PMID:28238834
1313456	UBL3	ubiquitin like 3	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313457	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of UBL3 mRNA	PMID:19363144
1313456	UBL3	ubiquitin like 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305431	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of UBL3 mRNA	PMID:32109520
1313456	UBL3	ubiquitin like 3	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1313457	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of UBL3 protein	PMID:35357534
1313456	UBL3	ubiquitin like 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBL3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of UBL3 mRNA	PMID:27188386
1313456	UBL3	ubiquitin like 3	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of UBL3 mRNA	PMID:26014281
1313456	UBL3	ubiquitin like 3	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of UBL3 mRNA	PMID:38568856
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SIGLEC5 mRNA	PMID:20938992
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of SIGLECF mRNA	PMID:30517762
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313459	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SIGLECF mRNA	PMID:39241906
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SIGLEC5 mRNA	PMID:20938992
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SIGLEC5 mRNA	PMID:23649840
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313459	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SIGLECF mRNA	PMID:37992649
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313459	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SIGLECF mRNA	PMID:37992649
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SIGLEC5 mRNA	PMID:19850644
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of SIGLEC5 mRNA]	PMID:19850644
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SIGLEC5 mRNA	PMID:23649840
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SIGLEC5 mRNA	PMID:23649840
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SIGLEC5 mRNA	PMID:41430723
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313459	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SIGLECF mRNA	PMID:34911549
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of SIGLECF mRNA	PMID:30517762
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SIGLEC5 mRNA	PMID:20938992
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SIGLEC5 mRNA	PMID:27594783
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:D019833	Genistein results in increased expression of SIGLECF mRNA	PMID:32186404
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SIGLEC5 mRNA	PMID:26377647
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SIGLEC5 mRNA	PMID:19933214|PMID:23238561|PMID:26290441
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313459	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SIGLECF mRNA	PMID:37992649
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SIGLEC5 mRNA	PMID:25258189
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:C009495	titanium dioxide results in decreased expression of SIGLEC5 mRNA	PMID:21259345|PMID:23557971
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313459	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of SIGLECF mRNA	PMID:35295148
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313459	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SIGLECF mRNA	PMID:28392331
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SIGLEC5 mRNA	PMID:37042841
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:D002737	Chloroprene results in decreased expression of SIGLEC5 mRNA	PMID:23125180
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SIGLEC5 gene	PMID:29154799
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313459	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SIGLECF mRNA	PMID:37992649
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	[Dietary Carbohydrates co-treated with Acetaminophen] results in increased expression of SIGLEC5 mRNA	PMID:17093179
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:C016766	sulforaphane results in decreased expression of SIGLEC5 mRNA	PMID:30529165
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of SIGLEC5 mRNA	PMID:26833863
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SIGLEC5 mRNA	PMID:25258189
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SIGLEC5 mRNA; Nanotubes, Carbon results in decreased expression of SIGLEC5 mRNA	PMID:25554681
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SIGLEC5 mRNA	PMID:19042947
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313459	E	RGD:6480464	20210518	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SIGLEC5 mRNA	PMID:22206623
1313458	SIGLEC5	sialic acid binding Ig like lectin 5	gene	CHEBI:78160	bleomycin A5	decreases expression	EXP		E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in decreased expression of SIGLEC5 mRNA	PMID:21040473
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313465	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of RPP14 mRNA	PMID:37995155
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of RPP14 protein	PMID:36641056
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313465	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RPP14 mRNA	PMID:30319688
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RPP14 mRNA	PMID:37042841
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:17579	beta-carotene	multiple interactions	ISO	RGD:1313465	E	RGD:6480464	20140909	CTD	MESH:D019207	[BCO1 protein affects the susceptibility to beta Carotene] which affects the expression of RPP14 mRNA	PMID:24657404
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPP14 mRNA	PMID:35301059
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RPP14 mRNA	PMID:19549813
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPP14 protein	PMID:23301498
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of RPP14 mRNA	PMID:35430440
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305436	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RPP14 mRNA	PMID:33387578
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPP14 mRNA	PMID:39836092
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313465	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RPP14 mRNA	PMID:28960355
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RPP14 mRNA	PMID:23557933
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313465	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RPP14 mRNA	PMID:21354282
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313465	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPP14 mRNA	PMID:17942748
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of RPP14 protein	PMID:39603559
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RPP14 mRNA	PMID:33212167
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPP14 mRNA	PMID:39836092
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RPP14 promoter	PMID:27901495
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of RPP14 mRNA	PMID:25075043
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305436	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RPP14 mRNA	PMID:23411599
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305436	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RPP14 mRNA	PMID:25181051
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305436	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RPP14 mRNA	PMID:36041667
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305436	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RPP14 mRNA	PMID:36041667
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305436	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RPP14 mRNA	PMID:36041667
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313465	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RPP14 mRNA	PMID:21266533
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RPP14 mRNA	PMID:38568856
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPP14 mRNA	PMID:35301059
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RPP14 mRNA	PMID:28302478
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RPP14 mRNA	PMID:25979313
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RPP14 mRNA	PMID:25562108
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305436	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RPP14 mRNA	PMID:33387578
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPP14 mRNA	PMID:39836092
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313465	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of RPP14 mRNA	PMID:35436446
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313465	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RPP14 mRNA	PMID:17942748
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313465	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPP14 mRNA	PMID:17942748
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:50035	alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of RPP14 mRNA	PMID:25075043
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:6078	ivermectin	increases expression	ISO	RGD:1313465	E	RGD:6480464	20190219	CTD	MESH:D007559	Ivermectin results in increased expression of RPP14 mRNA	PMID:28942281
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RPP14 mRNA	PMID:37199045
1313464	RPP14	ribonuclease P/MRP subunit p14	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313465	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of RPP14 mRNA	PMID:30953684
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313467	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TEX14 mRNA	PMID:33045310
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:17489	3',5'-cyclic AMP	multiple interactions	ISO	RGD:1305437	E	RGD:6480464	20120412	CTD	MESH:D000242	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of TEX14 mRNA]	PMID:19414516
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TEX14 protein	PMID:37730182
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305437	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TEX14 mRNA	PMID:33387578
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TEX14 mRNA	PMID:28818685
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TEX14 intron	PMID:30157460
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313467	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of TEX14 mRNA	PMID:27106289
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TEX14 mRNA	PMID:21867686
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TEX14 gene	PMID:25304211
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TEX14 mRNA	PMID:33212167
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TEX14 mRNA	PMID:32763439
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313467	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TEX14 protein	PMID:28918527
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TEX14 5' UTR; Benzo(a)pyrene affects the methylation of TEX14 intron; Benzo(a)pyrene affects the methylation of TEX14 promoter	PMID:27901495|PMID:30157460
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TEX14 3' UTR	PMID:27901495
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TEX14 mRNA	PMID:23806026
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TEX14 mRNA	PMID:19710929
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305437	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TEX14 mRNA	PMID:25181051
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313467	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TEX14 mRNA	PMID:30951980
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	multiple interactions	ISO	RGD:1305437	E	RGD:6480464	20120412	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of TEX14 mRNA]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of TEX14 mRNA]	PMID:19414516
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1305437	E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TEX14 protein	PMID:34896426
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313467	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TEX14 mRNA	PMID:28392331
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TEX14 mRNA	PMID:38382870
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313467	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TEX14 mRNA	PMID:40194260
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1305437	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of TEX14 protein	PMID:34896426
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX14 mRNA	PMID:27188386
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1305437	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of TEX14 mRNA	PMID:21865292
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1305437	E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TEX14 protein	PMID:34896426
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1305437	E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TEX14 protein	PMID:34896426
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TEX14 mRNA	PMID:38832940
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TEX14 mRNA	PMID:28542535
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TEX14 gene	PMID:25304211
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1305437	E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TEX14 protein	PMID:34896426
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313467	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of TEX14 mRNA	PMID:23608068
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of TEX14 mRNA	PMID:31629900
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305437	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TEX14 gene	PMID:35440735
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:756028	mivebresib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in increased expression of TEX14 mRNA	PMID:35486664
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX14 mRNA	PMID:27188386
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TEX14 gene]	PMID:28238834
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313467	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of TEX14 mRNA	PMID:31388691
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:83784	galaxolide	decreases expression	ISO	RGD:1305437	E	RGD:6480464	20240305	CTD	MESH:C033119	galaxolide results in decreased expression of TEX14 mRNA	PMID:37797914
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of TEX14 mRNA	PMID:31734321
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TEX14 mRNA	PMID:27188386
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:9367	swainsonine	increases expression	ISO	RGD:1305437	E	RGD:6480464	20260407	CTD	MESH:D017026	Swainsonine results in increased expression of TEX14 mRNA	PMID:40381828
1313466	TEX14	testis expressed 14, intercellular bridge forming factor	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313467	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of TEX14 mRNA	PMID:32835833
1313468	CDH20	cadherin 20	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305438	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CDH20 mRNA	PMID:33729688
1313468	CDH20	cadherin 20	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313469	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CDH20 mRNA	PMID:30319688
1313468	CDH20	cadherin 20	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of CDH20 mRNA	PMID:30510588
1313468	CDH20	cadherin 20	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CDH20 mRNA	PMID:31163220
1313468	CDH20	cadherin 20	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CDH20 exon; Aflatoxin B1 results in decreased methylation of CDH20 gene; Aflatoxin B1 results in decreased methylation of CDH20 intron	PMID:27153756|PMID:30157460
1313468	CDH20	cadherin 20	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CDH20 mRNA	PMID:33212167
1313468	CDH20	cadherin 20	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305438	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CDH20 mRNA	PMID:26033743
1313468	CDH20	cadherin 20	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CDH20 exon; Benzo(a)pyrene results in increased methylation of CDH20 promoter	PMID:27901495
1313468	CDH20	cadherin 20	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305438	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CDH20 mRNA	PMID:26033743
1313468	CDH20	cadherin 20	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of CDH20 mRNA	PMID:35984750
1313468	CDH20	cadherin 20	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of CDH20 mRNA	PMID:37690743
1313468	CDH20	cadherin 20	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of CDH20 gene	PMID:31601247
1313468	CDH20	cadherin 20	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313469	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of CDH20 mRNA	PMID:35295148
1313468	CDH20	cadherin 20	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313469	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDH20 gene	PMID:35295148
1313468	CDH20	cadherin 20	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305438	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CDH20 mRNA	PMID:25181051|PMID:34947998
1313468	CDH20	cadherin 20	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CDH20 gene	PMID:31601247
1313468	CDH20	cadherin 20	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of CDH20 gene	PMID:31601247
1313468	CDH20	cadherin 20	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of CDH20 intron	PMID:30157460
1313468	CDH20	cadherin 20	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313469	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of CDH20 mRNA	PMID:30951980
1313468	CDH20	cadherin 20	gene	CHEBI:35004	Tetrachlorobisphenol A	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C041181	tetrachlorodian results in decreased expression of CDH20 mRNA	PMID:31326446
1313468	CDH20	cadherin 20	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305438	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CDH20 promoter	PMID:22457795
1313468	CDH20	cadherin 20	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDH20 mRNA	PMID:26690555
1313468	CDH20	cadherin 20	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of CDH20 mRNA	PMID:25757056
1313468	CDH20	cadherin 20	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313469	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CDH20 mRNA	PMID:35436446
1313468	CDH20	cadherin 20	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of CDH20 intron	PMID:30157460
1313470	BEST3	bestrophin 3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of BEST3 mRNA	PMID:22378314
1313470	BEST3	bestrophin 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of BEST3 gene	PMID:27153756
1313470	BEST3	bestrophin 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of BEST3 mRNA	PMID:27392435
1313470	BEST3	bestrophin 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305439	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BEST3 mRNA	PMID:33387578
1313470	BEST3	bestrophin 3	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1305439	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of BEST3 mRNA	PMID:27257137
1313470	BEST3	bestrophin 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550212	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of BEST3 mRNA	PMID:36209798
1313470	BEST3	bestrophin 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BEST3 intron; Benzo(a)pyrene affects the methylation of BEST3 promoter	PMID:27901495|PMID:30157460
1313470	BEST3	bestrophin 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of BEST3 3' UTR	PMID:27901495
1313470	BEST3	bestrophin 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BEST3 mRNA	PMID:22316170
1313470	BEST3	bestrophin 3	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of BEST3 mRNA	PMID:25895662
1313470	BEST3	bestrophin 3	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1305439	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of BEST3 mRNA	PMID:22641619
1313470	BEST3	bestrophin 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305439	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of BEST3 mRNA	PMID:34492290
1313470	BEST3	bestrophin 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305439	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of BEST3 mRNA	PMID:25181051|PMID:34973380
1313470	BEST3	bestrophin 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550212	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of BEST3 gene	PMID:31683443
1313470	BEST3	bestrophin 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of BEST3 mRNA	PMID:38568856
1313470	BEST3	bestrophin 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of BEST3 mRNA	PMID:36326898
1313470	BEST3	bestrophin 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550212	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of BEST3 mRNA	PMID:40194260
1313470	BEST3	bestrophin 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of BEST3 mRNA	PMID:31533062
1313470	BEST3	bestrophin 3	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1550212	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of BEST3 mRNA	PMID:29038090
1313470	BEST3	bestrophin 3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of BEST3 mRNA	PMID:38832940
1313470	BEST3	bestrophin 3	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of BEST3 mRNA	PMID:29522793
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313476	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PRRG2 mRNA	PMID:33045310
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313476	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PRRG2 mRNA	PMID:36331819
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313476	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PRRG2 mRNA	PMID:39241906
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313476	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of PRRG2 mRNA	PMID:29980752
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PRRG2 mRNA	PMID:38568856
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305444	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PRRG2 mRNA	PMID:33387578
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRRG2 mRNA	PMID:29093498
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305444	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PRRG2 mRNA	PMID:31150632
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313476	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRRG2 mRNA	PMID:22206623
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of PRRG2 mRNA	PMID:36861143
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PRRG2 mRNA	PMID:23557933
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PRRG2 mRNA	PMID:27392435
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313476	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRRG2 mRNA	PMID:21570461
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305444	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRRG2 mRNA	PMID:32109520|PMID:33387578
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of PRRG2 mRNA	PMID:29704546
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313476	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRRG2 mRNA	PMID:17942748
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PRRG2 promoter	PMID:27901495
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PRRG2 5' UTR	PMID:27901495
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313476	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of PRRG2 mRNA	PMID:22609695
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313476	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PRRG2 gene	PMID:35295148
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313476	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PRRG2 mRNA	PMID:23811191
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305444	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PRRG2 mRNA	PMID:34947998
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305444	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PRRG2 gene	PMID:28505145
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313476	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PRRG2 mRNA	PMID:37019170
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313476	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PRRG2 mRNA	PMID:21266533
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313476	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of PRRG2 mRNA	PMID:34813904
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313476	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of PRRG2 mRNA	PMID:34813904
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PRRG2 mRNA	PMID:38174414
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305444	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PRRG2 mRNA	PMID:33453195
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRRG2 mRNA	PMID:29093498
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313476	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of PRRG2 mRNA	PMID:17585979
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313476	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PRRG2 mRNA	PMID:40194260
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313476	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PRRG2 mRNA	PMID:36331819
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PRRG2 gene	PMID:29154799
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1305444	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of PRRG2 mRNA	PMID:21346803
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305444	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRRG2 mRNA	PMID:33387578
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in decreased expression of PRRG2 mRNA	PMID:36861143
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305444	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PRRG2 mRNA	PMID:29391264
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313476	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRRG2 mRNA	PMID:17942748
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:50292	cadmium sulfate	increases expression	ISO	RGD:1313476	E	RGD:6480464	20120717	CTD	MESH:C037123	cadmium sulfate results in increased expression of PRRG2 mRNA	PMID:19274763
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313476	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of PRRG2 mRNA	PMID:23650126
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313476	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PRRG2 mRNA	PMID:14729362
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313476	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRRG2 mRNA	PMID:22206623
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PRRG2 gene]	PMID:28238834
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305444	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PRRG2 mRNA	PMID:21346803
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PRRG2 mRNA	PMID:38568856
1313475	PRRG2	proline rich and Gla domain 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305444	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PRRG2 mRNA	PMID:21346803
1313477	LTF	lactotransferrin	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313478	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of LTF mRNA	PMID:37995155
1313477	LTF	lactotransferrin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	LTF protein inhibits the reaction [Tretinoin results in increased activity of CASP3 protein]	PMID:16168621
1313477	LTF	lactotransferrin	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of LTF mRNA	PMID:22378314
1313477	LTF	lactotransferrin	gene	CHEBI:16130	DDT	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D003634	DDT results in increased expression of LTF mRNA	PMID:9607801
1313477	LTF	lactotransferrin	gene	CHEBI:16170	mercury(0)	increases expression	ISO	RGD:1313478	E	RGD:6480464	20231031	CTD	MESH:D008628	Mercury results in increased expression of LTF protein	PMID:37137463
1313477	LTF	lactotransferrin	gene	CHEBI:16412	lipopolysaccharide	increases secretion	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased secretion of LTF protein	PMID:11302825
1313477	LTF	lactotransferrin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Thalidomide inhibits the reaction [Lipopolysaccharides results in increased secretion of LTF protein]	PMID:11302825
1313477	LTF	lactotransferrin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20161228	CTD	MESH:D008070	[LTF protein co-treated with Phosphatidylcholines co-treated with Phytosterols] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]	PMID:16141546
1313477	LTF	lactotransferrin	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of LTF mRNA	PMID:15598610|PMID:39298647
1313477	LTF	lactotransferrin	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D004958	Estradiol results in decreased expression of LTF mRNA	PMID:31646340
1313477	LTF	lactotransferrin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of LTF mRNA; Estradiol results in increased expression of LTF protein	PMID:10433208|PMID:11006360|PMID:11390168|PMID:15289156|PMID:16684588|PMID:17640991|PMID:19484750|PMID:19654927|PMID:24052564|PMID:25575267|PMID:32186404|PMID:9607801
1313477	LTF	lactotransferrin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	[Estradiol co-treated with ESR1 protein] results in increased expression of LTF mRNA; [Estradiol co-treated with ESR2 protein] results in increased expression of LTF mRNA; Fulvestrant inhibits the reaction [Estradiol results in decreased expression of LTF mRNA]	PMID:21783566|PMID:31646340
1313477	LTF	lactotransferrin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004958	AHR protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of LTF mRNA]]; ESR1 protein affects the reaction [Estradiol results in increased expression of LTF mRNA]; fulvestrant inhibits the reaction [Estradiol results in increased expression of LTF mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of LTF mRNA]	PMID:10433208|PMID:11006360|PMID:17640991|PMID:19654927|PMID:24052564|PMID:9607801
1313477	LTF	lactotransferrin	gene	CHEBI:16480	nitric oxide	decreases activity	ISO	RGD:1305445	E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide deficiency results in decreased activity of LTF protein	PMID:14563657
1313477	LTF	lactotransferrin	gene	CHEBI:16480	nitric oxide	increases chemical synthesis	ISO	RGD:1305445	E	RGD:6480464	20120412	CTD	MESH:D009569	LTF protein results in increased chemical synthesis of Nitric Oxide	PMID:14563657
1313477	LTF	lactotransferrin	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120501	CTD	MESH:D007631	Chlordecone results in increased expression of LTF mRNA	PMID:33711761|PMID:9371753|PMID:9607801
1313477	LTF	lactotransferrin	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D007631	fulvestrant inhibits the reaction [Chlordecone results in increased expression of LTF mRNA]	PMID:9607801
1313477	LTF	lactotransferrin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LTF mRNA	PMID:37042841
1313477	LTF	lactotransferrin	gene	CHEBI:16684	atropine	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D001285	Atropine inhibits the reaction [methylcholine results in increased secretion of LTF protein]	PMID:11112886
1313477	LTF	lactotransferrin	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of LTF mRNA	PMID:17251523
1313477	LTF	lactotransferrin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LTF mRNA	PMID:37992649
1313477	LTF	lactotransferrin	gene	CHEBI:17276	phloretin	increases expression	ISO	RGD:1305445	E	RGD:6480464	20150414	CTD	MESH:D010693	Phloretin results in increased expression of LTF protein	PMID:24487097
1313477	LTF	lactotransferrin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LTF mRNA	PMID:37992649
1313477	LTF	lactotransferrin	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of LTF mRNA	PMID:23825647
1313477	LTF	lactotransferrin	gene	CHEBI:17741	N,N-dimethylformamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004126	Dimethylformamide results in increased expression of LTF mRNA	PMID:18063697
1313477	LTF	lactotransferrin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1305445	E	RGD:6480464	20180828	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of LTF mRNA	PMID:29945229
1313477	LTF	lactotransferrin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20250401	CTD	MESH:D004051	[Streptozocin co-treated with Diethylhexyl Phthalate] results in increased expression of LTF mRNA	PMID:31606821
1313477	LTF	lactotransferrin	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of LTF mRNA	PMID:26485663
1313477	LTF	lactotransferrin	gene	CHEBI:18152	myricetin	increases expression	ISO	RGD:1305445	E	RGD:6480464	20150414	CTD	MESH:C040015	myricetin results in increased expression of LTF protein	PMID:24487097
1313477	LTF	lactotransferrin	gene	CHEBI:18388	apigenin	increases expression	ISO	RGD:1305445	E	RGD:6480464	20150414	CTD	MESH:D047310	Apigenin results in increased expression of LTF protein	PMID:24487097
1313477	LTF	lactotransferrin	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of LTF mRNA	PMID:23825647
1313477	LTF	lactotransferrin	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D002104	Cadmium results in decreased expression of LTF mRNA	PMID:31646340
1313477	LTF	lactotransferrin	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D002104	Fulvestrant inhibits the reaction [Cadmium results in decreased expression of LTF mRNA]	PMID:31646340
1313477	LTF	lactotransferrin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305445	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LTF mRNA	PMID:39012411
1313477	LTF	lactotransferrin	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LTF protein	PMID:23301498
1313477	LTF	lactotransferrin	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LTF intron	PMID:30157460
1313477	LTF	lactotransferrin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LTF mRNA	PMID:19770486
1313477	LTF	lactotransferrin	gene	CHEBI:25195	mercury atom	increases expression	ISO	RGD:1313478	E	RGD:6480464	20231031	CTD	MESH:D008628	Mercury results in increased expression of LTF protein	PMID:37137463
1313477	LTF	lactotransferrin	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of LTF mRNA	PMID:15674844
1313477	LTF	lactotransferrin	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of LTF mRNA	PMID:12763052|PMID:33026818
1313477	LTF	lactotransferrin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LTF mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LTF mRNA	PMID:34911549
1313477	LTF	lactotransferrin	gene	CHEBI:26125	phytosterols	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20170303	CTD	MESH:D010840	[LTF protein co-treated with Phosphatidylcholines co-treated with Phytosterols] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]	PMID:16141546
1313477	LTF	lactotransferrin	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1305445	E	RGD:6480464	20170303	CTD	MESH:D017382	LTF protein inhibits the reaction [Dexamethasone results in increased abundance of Reactive Oxygen Species]	PMID:24587916
1313477	LTF	lactotransferrin	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1313478	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of LTF mRNA	PMID:31939706
1313477	LTF	lactotransferrin	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120515	CTD	MESH:C040641	genistin results in increased expression of LTF mRNA	PMID:20049207
1313477	LTF	lactotransferrin	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic results in decreased expression of LTF protein	PMID:19167470
1313477	LTF	lactotransferrin	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased expression of LTF mRNA	PMID:19654921
1313477	LTF	lactotransferrin	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D002945	Cisplatin results in decreased expression of LTF mRNA	PMID:11099651
1313477	LTF	lactotransferrin	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of LTF promoter	PMID:22847954
1313477	LTF	lactotransferrin	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of LTF mRNA	PMID:30912803
1313477	LTF	lactotransferrin	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1305445	E	RGD:6480464	20150414	CTD	MESH:D019833	Genistein results in increased expression of LTF mRNA; Genistein results in increased expression of LTF protein	PMID:24487097|PMID:29217487
1313477	LTF	lactotransferrin	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313478	E	RGD:6480464	20140513	CTD	MESH:D019833	Genistein results in increased expression of LTF mRNA	PMID:15289156|PMID:22553218
1313477	LTF	lactotransferrin	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D019833	[Genistein co-treated with ESR1 protein] results in increased expression of LTF mRNA; [Genistein co-treated with ESR2 protein] results in increased expression of LTF mRNA	PMID:21783566
1313477	LTF	lactotransferrin	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of LTF mRNA	PMID:25583101
1313477	LTF	lactotransferrin	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in increased expression of LTF mRNA	PMID:12540486
1313477	LTF	lactotransferrin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313478	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LTF mRNA	PMID:26377647|PMID:28922406
1313477	LTF	lactotransferrin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LTF mRNA	PMID:15034205|PMID:28213091
1313477	LTF	lactotransferrin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313478	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LTF mRNA	PMID:37172768
1313477	LTF	lactotransferrin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LTF mRNA; AHR protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of LTF mRNA]]; Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of LTF mRNA]	PMID:11006360|PMID:17942748|PMID:24052564
1313477	LTF	lactotransferrin	gene	CHEBI:28177	theophylline	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013806	Theophylline results in decreased expression of LTF protein	PMID:12016098
1313477	LTF	lactotransferrin	gene	CHEBI:28640	lipoteichoic acid	increases secretion	EXP		E	RGD:6480464	20170303	CTD	MESH:C009900	lipoteichoic acid results in increased secretion of LTF protein	PMID:11302825
1313477	LTF	lactotransferrin	gene	CHEBI:28640	lipoteichoic acid	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C009900	Thalidomide inhibits the reaction [lipoteichoic acid results in increased secretion of LTF protein]	PMID:11302825
1313477	LTF	lactotransferrin	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313478	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of LTF protein	PMID:28918527
1313477	LTF	lactotransferrin	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313478	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of LTF mRNA	PMID:36227756
1313477	LTF	lactotransferrin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LTF mRNA	PMID:37992649
1313477	LTF	lactotransferrin	gene	CHEBI:2948	azathioprine	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D001379	Azathioprine results in decreased expression of LTF mRNA	PMID:21621594
1313477	LTF	lactotransferrin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LTF mRNA	PMID:38568856
1313477	LTF	lactotransferrin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of LTF mRNA	PMID:36209798|PMID:37682722|PMID:39515575
1313477	LTF	lactotransferrin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20161228	CTD	MESH:C017947	[Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of LTF mRNA	PMID:16452187
1313477	LTF	lactotransferrin	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313478	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of LTF mRNA	PMID:22342234
1313477	LTF	lactotransferrin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LTF promoter	PMID:27901495
1313477	LTF	lactotransferrin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LTF mRNA	PMID:15034205|PMID:22228805
1313477	LTF	lactotransferrin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LTF mRNA	PMID:19770486
1313477	LTF	lactotransferrin	gene	CHEBI:29866	arsenite(3-)	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:C015001	arsenite results in decreased expression of LTF mRNA	PMID:31646340
1313477	LTF	lactotransferrin	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C015001	Fulvestrant inhibits the reaction [arsenite results in decreased expression of LTF mRNA]	PMID:31646340
1313477	LTF	lactotransferrin	gene	CHEBI:3001	beclomethasone	decreases secretion	EXP		E	RGD:6480464	20130723	CTD	MESH:D001507	Beclomethasone results in decreased secretion of LTF protein	PMID:11112886
1313477	LTF	lactotransferrin	gene	CHEBI:3001	beclomethasone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D001507	Beclomethasone inhibits the reaction [methylcholine results in increased secretion of LTF protein]	PMID:11112886
1313477	LTF	lactotransferrin	gene	CHEBI:30187	aluminium oxide	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20150609	CTD	MESH:D000537	[Nanotubes, Carbon co-treated with Aluminum Oxide] results in increased secretion of LTF protein	PMID:25598225
1313477	LTF	lactotransferrin	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313478	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LTF mRNA	PMID:27131904
1313477	LTF	lactotransferrin	gene	CHEBI:31638	fulvestrant	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:C070081	Fulvestrant results in increased expression of LTF mRNA	PMID:31646340
1313477	LTF	lactotransferrin	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of LTF gene; Fulvestrant inhibits the reaction [arsenite results in decreased expression of LTF mRNA]; Fulvestrant inhibits the reaction [Cadmium results in decreased expression of LTF mRNA]; Fulvestrant inhibits the reaction [Estradiol results in decreased expression of LTF mRNA]	PMID:31601247|PMID:31646340
1313477	LTF	lactotransferrin	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20130514	CTD	MESH:C070081	fulvestrant inhibits the reaction [1,7-diphenyl-5-heptene-3-one results in increased expression of LTF mRNA]; fulvestrant inhibits the reaction [Chlordecone results in increased expression of LTF mRNA]; fulvestrant inhibits the reaction [Estradiol results in increased expression of LTF mRNA]; fulvestrant inhibits the reaction [o,p'-DDT results in increased expression of LTF mRNA]	PMID:10433208|PMID:17640991|PMID:19654927|PMID:9607801
1313477	LTF	lactotransferrin	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of LTF mRNA	PMID:38568856
1313477	LTF	lactotransferrin	gene	CHEBI:3207	budesonide	decreases secretion	EXP		E	RGD:6480464	20130723	CTD	MESH:D019819	Budesonide results in decreased secretion of LTF protein	PMID:11112886
1313477	LTF	lactotransferrin	gene	CHEBI:3207	budesonide	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D019819	Budesonide inhibits the reaction [methylcholine results in increased secretion of LTF protein]	PMID:11112886
1313477	LTF	lactotransferrin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of LTF mRNA	PMID:23557971|PMID:29264374
1313477	LTF	lactotransferrin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313478	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of LTF mRNA	PMID:27760801|PMID:35295148
1313477	LTF	lactotransferrin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305445	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LTF mRNA	PMID:25181051
1313477	LTF	lactotransferrin	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LTF gene	PMID:31601247
1313477	LTF	lactotransferrin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313478	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LTF mRNA	PMID:32156529
1313477	LTF	lactotransferrin	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305445	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LTF gene	PMID:28505145
1313477	LTF	lactotransferrin	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	[bisphenol A co-treated with ESR1 protein] results in increased expression of LTF mRNA; [bisphenol A co-treated with ESR2 protein] results in increased expression of LTF mRNA; [bisphenol A co-treated with Fulvestrant] results in decreased methylation of LTF gene	PMID:21783566|PMID:31601247
1313477	LTF	lactotransferrin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20230207	CTD	MESH:C006780	[Dextran Sulfate co-treated with bisphenol A] results in increased expression of LTF protein	PMID:35999755
1313477	LTF	lactotransferrin	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of LTF mRNA; tetrabromobisphenol A results in increased expression of LTF protein	PMID:25461914|PMID:31675489
1313477	LTF	lactotransferrin	gene	CHEBI:3374	capsaicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002211	Capsaicin results in increased expression of LTF protein	PMID:9537786
1313477	LTF	lactotransferrin	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of LTF mRNA; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of LTF protein	PMID:11390168|PMID:11908639
1313477	LTF	lactotransferrin	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1313478	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of LTF mRNA; o,p'-DDT results in increased expression of LTF protein	PMID:11390168|PMID:9607801
1313477	LTF	lactotransferrin	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20141111	CTD	MESH:C016340	fulvestrant inhibits the reaction [o,p'-DDT results in increased expression of LTF mRNA]	PMID:9607801
1313477	LTF	lactotransferrin	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of LTF mRNA	PMID:36804509
1313477	LTF	lactotransferrin	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1305445	E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of LTF mRNA	PMID:32119087
1313477	LTF	lactotransferrin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LTF mRNA	PMID:39298647
1313477	LTF	lactotransferrin	gene	CHEBI:34432	4-octylphenol	multiple interactions	EXP		E	RGD:6480464	20140204	CTD	MESH:C080417	[4-octylphenol co-treated with ESR1 protein] results in increased expression of LTF mRNA; [4-octylphenol co-treated with ESR2 protein] results in increased expression of LTF mRNA	PMID:21783566
1313477	LTF	lactotransferrin	gene	CHEBI:34440	4-nonylphenol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C041594	[4-nonylphenol co-treated with ESR1 protein] results in increased expression of LTF mRNA; [4-nonylphenol co-treated with ESR2 protein] results in increased expression of LTF mRNA	PMID:21783566
1313477	LTF	lactotransferrin	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of LTF mRNA	PMID:34289071
1313477	LTF	lactotransferrin	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of LTF protein	PMID:35999755
1313477	LTF	lactotransferrin	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20230207	CTD	MESH:D016264	[Dextran Sulfate co-treated with bisphenol A] results in increased expression of LTF protein	PMID:35999755
1313477	LTF	lactotransferrin	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of LTF gene	PMID:22964155
1313477	LTF	lactotransferrin	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313478	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of LTF protein	PMID:39748354
1313477	LTF	lactotransferrin	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LTF mRNA	PMID:37042841
1313477	LTF	lactotransferrin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305445	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LTF mRNA	PMID:39012411
1313477	LTF	lactotransferrin	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of LTF mRNA	PMID:17132714
1313477	LTF	lactotransferrin	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313478	E	RGD:6480464	20240206	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of LTF protein	PMID:37422089
1313477	LTF	lactotransferrin	gene	CHEBI:35852	transplatin	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C034697	transplatin results in decreased expression of LTF mRNA	PMID:11099651
1313477	LTF	lactotransferrin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313478	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LTF mRNA	PMID:40194260
1313477	LTF	lactotransferrin	gene	CHEBI:38626	pyridaben	increases expression	ISO	RGD:1313478	E	RGD:6480464	20121113	CTD	MESH:C428725	pyridaben results in increased expression of LTF mRNA	PMID:22563483
1313477	LTF	lactotransferrin	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of LTF promoter	PMID:22847954
1313477	LTF	lactotransferrin	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of LTF promoter	PMID:22847954
1313477	LTF	lactotransferrin	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of LTF mRNA	PMID:21621594
1313477	LTF	lactotransferrin	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in increased expression of LTF mRNA	PMID:21621594
1313477	LTF	lactotransferrin	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of LTF mRNA	PMID:17555576
1313477	LTF	lactotransferrin	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of LTF protein	PMID:11390168
1313477	LTF	lactotransferrin	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1305445	E	RGD:6480464	20150414	CTD	MESH:D013629	[Ethinyl Estradiol co-treated with Tamoxifen] results in increased expression of LTF protein	PMID:24487097
1313477	LTF	lactotransferrin	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1305445	E	RGD:6480464	20150825	CTD	MESH:D003907	LTF protein inhibits the reaction [Dexamethasone results in increased abundance of Reactive Oxygen Species]	PMID:24587916
1313477	LTF	lactotransferrin	gene	CHEBI:41922	diethylstilbestrol	affects methylation	ISO	RGD:1313478	E	RGD:6480464	20140513	CTD	MESH:D004054	Diethylstilbestrol affects the methylation of LTF promoter	PMID:24316720
1313477	LTF	lactotransferrin	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of LTF protein	PMID:15082075
1313477	LTF	lactotransferrin	gene	CHEBI:41922	diethylstilbestrol	decreases methylation	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased methylation of LTF promoter	PMID:9331098
1313477	LTF	lactotransferrin	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of LTF; Diethylstilbestrol results in increased expression of LTF mRNA; Diethylstilbestrol results in increased expression of LTF protein	PMID:11390168|PMID:15082075|PMID:15289156|PMID:15591538|PMID:16452187|PMID:16690809|PMID:17394237|PMID:22275727|PMID:25575267
1313477	LTF	lactotransferrin	gene	CHEBI:41922	diethylstilbestrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D004054	[Diethylstilbestrol co-treated with ESR1 protein] results in increased expression of LTF mRNA; [Diethylstilbestrol co-treated with ESR2 protein] results in increased expression of LTF mRNA	PMID:21783566
1313477	LTF	lactotransferrin	gene	CHEBI:41922	diethylstilbestrol	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004054	[Diethylstilbestrol co-treated with sodium arsenite] results in increased expression of LTF mRNA; ESR1 mutant form inhibits the reaction [Diethylstilbestrol affects the methylation of LTF promoter]; ESR1 protein affects the reaction [Diethylstilbestrol results in increased expression of LTF]	PMID:16452187|PMID:22275727|PMID:24316720
1313477	LTF	lactotransferrin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LTF mRNA	PMID:37992649
1313477	LTF	lactotransferrin	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D008727	Methotrexate results in decreased expression of LTF mRNA	PMID:21621594
1313477	LTF	lactotransferrin	gene	CHEBI:44616	afimoxifene	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in increased expression of LTF protein	PMID:11390168
1313477	LTF	lactotransferrin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LTF mRNA	PMID:17562736
1313477	LTF	lactotransferrin	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C088658	zoledronic acid results in increased expression of LTF protein	PMID:28871336
1313477	LTF	lactotransferrin	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1313478	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of LTF mRNA	PMID:29279043
1313477	LTF	lactotransferrin	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic results in decreased expression of LTF protein	PMID:19167470
1313477	LTF	lactotransferrin	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1313478	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased expression of LTF mRNA	PMID:19654921
1313477	LTF	lactotransferrin	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313478	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of LTF mRNA	PMID:30529165
1313477	LTF	lactotransferrin	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313478	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of LTF mRNA	PMID:35436446
1313477	LTF	lactotransferrin	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of LTF mRNA	PMID:18175754
1313477	LTF	lactotransferrin	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of LTF mRNA	PMID:17555576
1313477	LTF	lactotransferrin	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305445	E	RGD:6480464	20150414	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LTF protein	PMID:24487097
1313477	LTF	lactotransferrin	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LTF mRNA	PMID:17942748|PMID:30675821
1313477	LTF	lactotransferrin	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1305445	E	RGD:6480464	20150414	CTD	MESH:D004997	[Ethinyl Estradiol co-treated with Tamoxifen] results in increased expression of LTF protein	PMID:24487097
1313477	LTF	lactotransferrin	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LTF mRNA	PMID:17942748
1313477	LTF	lactotransferrin	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of LTF mRNA	PMID:38568856
1313477	LTF	lactotransferrin	gene	CHEBI:4998	fenarimol	decreases expression	ISO	RGD:1305445	E	RGD:6480464	20141111	CTD	MESH:C033789	fenarimol results in decreased expression of LTF mRNA	PMID:16324804
1313477	LTF	lactotransferrin	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313478	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LTF mRNA; Nanotubes, Carbon results in increased expression of LTF mRNA	PMID:25554681|PMID:27106021
1313477	LTF	lactotransferrin	gene	CHEBI:50594	carbon nanotube	increases secretion	ISO	RGD:1313478	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased secretion of LTF protein	PMID:25598225
1313477	LTF	lactotransferrin	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20161228	CTD	MESH:D037742	[Nanotubes, Carbon co-treated with Aluminum Oxide] results in increased secretion of LTF protein	PMID:25598225
1313477	LTF	lactotransferrin	gene	CHEBI:51214	diamminedichloroplatinum	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C034697	transplatin results in decreased expression of LTF mRNA	PMID:11099651
1313477	LTF	lactotransferrin	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313478	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of LTF mRNA	PMID:38701926
1313477	LTF	lactotransferrin	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D016559	Tacrolimus results in increased expression of LTF mRNA	PMID:21621594
1313477	LTF	lactotransferrin	gene	CHEBI:62845	4-hydroxy-17beta-estradiol	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:C014036	4-hydroxyestradiol results in increased expression of LTF mRNA	PMID:9371753|PMID:9607801
1313477	LTF	lactotransferrin	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of LTF mRNA	PMID:23650126
1313477	LTF	lactotransferrin	gene	CHEBI:64482	phosphatidylcholine	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20170228	CTD	MESH:D010713	[LTF protein co-treated with Phosphatidylcholines co-treated with Phytosterols] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]	PMID:16141546
1313477	LTF	lactotransferrin	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of LTF protein	PMID:35926579
1313477	LTF	lactotransferrin	gene	CHEBI:67895	corosolic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of LTF mRNA	PMID:37939859
1313477	LTF	lactotransferrin	gene	CHEBI:6842	methoxychlor	increases expression	ISO	RGD:1313478	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor metabolite results in increased expression of LTF mRNA; Methoxychlor metabolite results in increased expression of LTF protein; Methoxychlor results in increased expression of LTF mRNA; Methoxychlor results in increased expression of LTF protein	PMID:10433208|PMID:11390168|PMID:11908639
1313477	LTF	lactotransferrin	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1313478	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LTF mRNA	PMID:30675821
1313477	LTF	lactotransferrin	gene	CHEBI:7459	naloxone	decreases activity	ISO	RGD:1305445	E	RGD:6480464	20120412	CTD	MESH:D009270	Naloxone results in decreased activity of LTF protein	PMID:14563657
1313477	LTF	lactotransferrin	gene	CHEBI:7590	nitrofen	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20260804	CTD	MESH:C007350	[nitrofen co-treated with 4-phenylbenzoic acid] results in increased expression of LTF mRNA	PMID:39181781
1313477	LTF	lactotransferrin	gene	CHEBI:76604	MeIQx	multiple interactions	ISO	RGD:1305445	E	RGD:6480464	20140107	CTD	MESH:C036990	LTF protein inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 mRNA]; LTF protein inhibits the reaction [2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of CYP1A2 protein]	PMID:12079509
1313477	LTF	lactotransferrin	gene	CHEBI:78734	tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:D001285	Atropine inhibits the reaction [methylcholine results in increased secretion of LTF protein]	PMID:11112886
1313477	LTF	lactotransferrin	gene	CHEBI:79516	Nonylphenol	increases expression	ISO	RGD:1313478	E	RGD:6480464	20141111	CTD	MESH:C025256	nonylphenol results in increased expression of LTF protein	PMID:11390168
1313477	LTF	lactotransferrin	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of LTF mRNA; Irinotecan results in decreased expression of LTF mRNA	PMID:15956246
1313477	LTF	lactotransferrin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313478	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of LTF mRNA	PMID:38648751
1313477	LTF	lactotransferrin	gene	CHEBI:8378	prednisolone	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D011239	Prednisolone results in decreased expression of LTF mRNA	PMID:21621594
1313477	LTF	lactotransferrin	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1313478	E	RGD:6480464	20120918	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of LTF mRNA	PMID:21621594
1313477	LTF	lactotransferrin	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1313478	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of LTF protein	PMID:35357534
1313477	LTF	lactotransferrin	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313478	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LTF mRNA	PMID:27131904
1313477	LTF	lactotransferrin	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1313478	E	RGD:6480464	20250401	CTD	MESH:D013311	[Streptozocin co-treated with Diethylhexyl Phthalate] results in increased expression of LTF mRNA	PMID:31606821
1313477	LTF	lactotransferrin	gene	CHEBI:9513	thalidomide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013792	Thalidomide inhibits the reaction [Lipopolysaccharides results in increased secretion of LTF protein]; Thalidomide inhibits the reaction [lipoteichoic acid results in increased secretion of LTF protein]	PMID:11302825
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TRRAP mRNA	PMID:33045310
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:144804	nickel subsulfide	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide results in decreased expression of TRRAP mRNA	PMID:12760830
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of TRRAP mRNA	PMID:15498508|PMID:33167477
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in decreased expression of TRRAP protein	PMID:15894607
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRRAP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of TRRAP mRNA	PMID:32699268
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of TRRAP mRNA	PMID:29018328
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of TRRAP mRNA	PMID:30319688
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TRRAP mRNA	PMID:21179406
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TRRAP mRNA	PMID:21632981
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TRRAP mRNA	PMID:39241906
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20140610	CTD	MESH:D004958	Estradiol promotes the reaction [ESR1 protein binds to TRRAP protein mutant form]; Estradiol promotes the reaction [ESR1 protein binds to TRRAP protein]	PMID:23665804|PMID:32088792
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TRRAP mRNA	PMID:21179406
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550217	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TRRAP mRNA	PMID:34319233
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TRRAP protein	PMID:37730182
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of TRRAP mRNA	PMID:39836092
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of TRRAP mRNA	PMID:27462272
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRRAP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of TRRAP mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRRAP mRNA	PMID:32699268
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305446	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TRRAP mRNA	PMID:30779732
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRRAP gene	PMID:25304211
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRRAP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRRAP mRNA	PMID:39836092|PMID:40512198
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRRAP mRNA	PMID:40504410
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TRRAP mRNA	PMID:19244175
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TRRAP protein	PMID:35688186
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of TRRAP mRNA	PMID:19561079|PMID:27594783
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TRRAP mRNA	PMID:30912803
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of TRRAP protein	PMID:39603559
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TRRAP mRNA	PMID:39709020
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305446	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TRRAP mRNA	PMID:28959563
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20250204	CTD	MESH:D004317	[VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of TRRAP protein	PMID:38367682
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of TRRAP protein	PMID:35688186
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of TRRAP mRNA	PMID:20044591
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRRAP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRRAP mRNA	PMID:39836092|PMID:40512198
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRRAP mRNA	PMID:40504410
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TRRAP mRNA	PMID:20106945|PMID:21632981
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TRRAP mRNA	PMID:20504355
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRRAP 5' UTR; Benzo(a)pyrene results in decreased methylation of TRRAP promoter	PMID:27901495
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TRRAP mRNA]	PMID:32406909
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TRRAP mRNA	PMID:19150397|PMID:20018196
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of TRRAP protein	PMID:15894607
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of TRRAP gene	PMID:31601247
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of TRRAP mRNA	PMID:15498508
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550217	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRRAP promoter alternative form	PMID:35295148
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550217	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TRRAP gene	PMID:35295148
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1305446	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of TRRAP mRNA	PMID:16940010
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305446	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRRAP mRNA	PMID:25181051|PMID:30816183
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TRRAP protein	PMID:33376534
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305446	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TRRAP mRNA	PMID:26982218
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TRRAP gene	PMID:31601247
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550217	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TRRAP mRNA	PMID:33221593
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A binds to and affects the folding of AR protein] affects the reaction [AR protein modified form binds to TRRAP protein modified form]; [ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of TRRAP protein]; bisphenol A inhibits the reaction [ESR1 protein binds to TRRAP protein]	PMID:28751236|PMID:29389661|PMID:33376534
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TRRAP mRNA	PMID:39298647
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TRRAP gene	PMID:31601247
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550217	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of TRRAP mRNA	PMID:40203079
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TRRAP mRNA	PMID:37019170
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of TRRAP gene	PMID:22964155
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRRAP mRNA	PMID:37042841
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of TRRAP mRNA	PMID:39836092
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRRAP mRNA	PMID:38568856
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TRRAP mRNA	PMID:38382870
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of TRRAP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of TRRAP mRNA	PMID:32699268
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TRRAP mRNA	PMID:19244175
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550217	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of TRRAP mRNA	PMID:23811191
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015741	[Metribolone binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to TRRAP protein modified form]	PMID:28751236
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of TRRAP mRNA	PMID:28302478
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TRRAP mRNA	PMID:31533062
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016104	sodium bichromate results in decreased expression of TRRAP mRNA	PMID:12760830
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305446	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRRAP mRNA	PMID:29427782
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TRRAP gene	PMID:29154799
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20140610	CTD	MESH:D013629	Tamoxifen inhibits the reaction [ESR1 protein binds to TRRAP protein]	PMID:23665804
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRRAP mRNA	PMID:21420995
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:46680	serpentine asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of TRRAP gene	PMID:29523930
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TRRAP gene	PMID:25304211
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TRRAP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRRAP mRNA	PMID:39836092|PMID:40512198
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRRAP mRNA	PMID:40504410
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:47381	diclofenac	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20240702	CTD	MESH:D004008	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of TRRAP mRNA	PMID:37844793
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20240702	CTD	MESH:D004997	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of TRRAP mRNA	PMID:37844793
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of TRRAP protein	PMID:15894607
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of TRRAP mRNA	PMID:20977926
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of TRRAP protein	PMID:23718831
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:5855	ibuprofen	multiple interactions	ISO	RGD:1550217	E	RGD:6480464	20240702	CTD	MESH:D007052	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in increased expression of TRRAP mRNA	PMID:37844793
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TRRAP protein	PMID:32959892
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of TRRAP mRNA	PMID:39836092
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of TRRAP mRNA	PMID:15336504
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:6925	microcystin-LR	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C057862	cyanoginosin LR results in increased expression of TRRAP mRNA	PMID:29518473
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:72754	bisphenol AF	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	[bisphenol AF binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to TRRAP protein modified form]; bisphenol AF inhibits the reaction [ESR1 protein binds to TRRAP protein]	PMID:28751236|PMID:29389661
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550217	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TRRAP mRNA	PMID:22206623
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of TRRAP protein	PMID:31285264
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of TRRAP mRNA	PMID:19287073
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRRAP gene]	PMID:28238834
1313479	TRRAP	transformation/transcription domain associated protein	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305446	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of TRRAP mRNA	PMID:23034163
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of POMT2 mRNA	PMID:38218311
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313481	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POMT2 mRNA	PMID:39241906
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1586427	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of POMT2 mRNA	PMID:33387578
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313481	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of POMT2 mRNA	PMID:33848595
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313481	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of POMT2 mRNA]	PMID:33848595
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:17558	quercitrin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of POMT2 mRNA	PMID:25193878
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of POMT2 protein	PMID:37730182
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1586427	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of POMT2 mRNA	PMID:33387578
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313481	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of POMT2 mRNA	PMID:36331819
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of POMT2 intron	PMID:30157460
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1586427	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of POMT2 mRNA	PMID:30779732
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313481	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of POMT2 mRNA	PMID:17484886
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1586427	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of POMT2 mRNA	PMID:31150632
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313481	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of POMT2 mRNA	PMID:25629700
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of POMT2 mRNA	PMID:27392435
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313481	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POMT2 mRNA	PMID:21570461
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1586427	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POMT2 mRNA	PMID:33387578
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of POMT2 mRNA	PMID:16404146
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in increased expression of POMT2 mRNA; sodium arsenite results in increased expression of POMT2 protein	PMID:30528433|PMID:38100851
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	[Polystyrenes results in increased abundance of Microplastics] promotes the reaction [sodium arsenite results in increased expression of POMT2 mRNA]	PMID:38100851
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of POMT2 intron	PMID:30157460
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313481	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of POMT2 promoter	PMID:35295148
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1586427	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of POMT2 mRNA	PMID:25181051
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1586427	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of POMT2 mRNA	PMID:34947998
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313481	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of POMT2 mRNA	PMID:39298647
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313481	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of POMT2 mRNA	PMID:38685157
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of POMT2 mRNA	PMID:38174414
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313481	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of POMT2 mRNA	PMID:36331819
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of POMT2 mRNA	PMID:25979313
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of POMT2 mRNA	PMID:26272509
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of POMT2 gene	PMID:29154799
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POMT2 mRNA	PMID:27188386
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313481	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of POMT2 mRNA	PMID:35436446
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1586427	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of POMT2 mRNA	PMID:34044035
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1586427	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of POMT2 mRNA	PMID:20080153
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313481	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of POMT2 mRNA	PMID:22206623
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POMT2 mRNA	PMID:27188386
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of POMT2 mRNA	PMID:27188386
1313480	POMT2	protein O-mannosyltransferase 2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1586427	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of POMT2 mRNA	PMID:19281266
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313483	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TRIM11 mRNA	PMID:26251327
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TRIM11 gene	PMID:20938992
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TRIM11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of TRIM11 mRNA	PMID:32699268
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313483	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TRIM11 mRNA	PMID:30319688
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TRIM11 mRNA	PMID:21632981
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TRIM11 mRNA	PMID:39241906
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TRIM11 gene	PMID:20938992
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of TRIM11 mRNA	PMID:19162166
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313483	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TRIM11 mRNA	PMID:34319233
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305448	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TRIM11 mRNA	PMID:33387578
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TRIM11 mRNA	PMID:28818685
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TRIM11 3' UTR	PMID:30157460
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TRIM11 mRNA	PMID:19549813
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313483	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of TRIM11 gene	PMID:27776689
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313483	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TRIM11 mRNA	PMID:19770486
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TRIM11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of TRIM11 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of TRIM11 mRNA	PMID:32699268
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TRIM11 mRNA	PMID:18593933
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TRIM11 gene	PMID:20938992
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM11 mRNA	PMID:40504410
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of TRIM11 mRNA	PMID:19921347
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313483	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRIM11 mRNA	PMID:21570461
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305448	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRIM11 mRNA	PMID:32109520
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TRIM11 mRNA	PMID:17942748
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM11 mRNA	PMID:17942748
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TRIM11 mRNA	PMID:28001369
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TRIM11 mRNA	PMID:33212167
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313483	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of TRIM11 gene	PMID:39894169
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TRIM11 mRNA	PMID:38568856|PMID:39719251
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM11 mRNA	PMID:40504410
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of TRIM11 mRNA	PMID:22378314
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TRIM11 3' UTR	PMID:30157460
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313483	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TRIM11 mRNA	PMID:19770486|PMID:22228805|PMID:22610609
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRIM11 3' UTR	PMID:27901495
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TRIM11 mRNA	PMID:18593933
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of TRIM11 mRNA	PMID:38568856
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TRIM11 mRNA	PMID:29264374
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313483	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRIM11 gene; titanium dioxide results in decreased methylation of TRIM11 promoter	PMID:35295148
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of TRIM11 mRNA	PMID:18648102
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of TRIM11 mRNA	PMID:21318169|PMID:23811191
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of TRIM11 mRNA]	PMID:21318169
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305448	E	RGD:6480464	20130806	CTD	MESH:C069837	fullerene C60 results in increased expression of TRIM11 mRNA	PMID:19167457
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305448	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TRIM11 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305448	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TRIM11 mRNA	PMID:36041667
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313483	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TRIM11 gene	PMID:31683443
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TRIM11 gene	PMID:31601247
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305448	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TRIM11 mRNA	PMID:36041667
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313483	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of TRIM11 mRNA	PMID:26377693
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TRIM11 mRNA	PMID:38685157
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305448	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TRIM11 mRNA	PMID:36041667
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRIM11 mRNA	PMID:37042841
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRIM11 mRNA	PMID:38568856
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313483	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TRIM11 mRNA	PMID:28903501
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of TRIM11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of TRIM11 mRNA	PMID:32699268
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of TRIM11 mRNA	PMID:23811191
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TRIM11 mRNA	PMID:31533062
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313483	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of TRIM11 mRNA	PMID:39529242
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TRIM11 gene	PMID:29154799
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TRIM11 mRNA	PMID:25562108
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TRIM11 mRNA	PMID:17555576
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRIM11 mRNA	PMID:40504410
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TRIM11 mRNA	PMID:17555576
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TRIM11 mRNA	PMID:17942748
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TRIM11 mRNA	PMID:17942748
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TRIM11 mRNA; Nanotubes, Carbon results in decreased expression of TRIM11 mRNA	PMID:25554681
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1313483	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of TRIM11 mRNA	PMID:26377693
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1313483	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of TRIM11 mRNA	PMID:19812364
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313483	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TRIM11 mRNA	PMID:22206623
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	affects expression	ISO	RGD:1313483	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl affects the expression of TRIM11 mRNA	PMID:31388691
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305448	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TRIM11 mRNA	PMID:21346803
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TRIM11 mRNA	PMID:38568856
1313482	TRIM11	tripartite motif containing 11	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313483	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of TRIM11 mRNA	PMID:35537566
1313485	HOXC11	homeobox C11	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1620670	E	RGD:6480464	20140722	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HOXC11 gene	PMID:20938992
1313485	HOXC11	homeobox C11	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of HOXC11 mRNA	PMID:24763279
1313485	HOXC11	homeobox C11	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of HOXC11 mRNA	PMID:31614463
1313485	HOXC11	homeobox C11	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1620670	E	RGD:6480464	20140722	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HOXC11 gene	PMID:20938992
1313485	HOXC11	homeobox C11	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HOXC11 gene; Aflatoxin B1 results in decreased methylation of HOXC11 promoter	PMID:27153756|PMID:30157460
1313485	HOXC11	homeobox C11	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1620670	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of HOXC11 mRNA	PMID:25629700
1313485	HOXC11	homeobox C11	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620670	E	RGD:6480464	20140722	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HOXC11 gene	PMID:20938992
1313485	HOXC11	homeobox C11	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of HOXC11 mRNA	PMID:24768652
1313485	HOXC11	homeobox C11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620670	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HOXC11 mRNA	PMID:24058054
1313485	HOXC11	homeobox C11	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of HOXC11 mRNA	PMID:30851411
1313485	HOXC11	homeobox C11	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of HOXC11 gene	PMID:28589171
1313485	HOXC11	homeobox C11	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HOXC11 3' UTR; Benzo(a)pyrene affects the methylation of HOXC11 exon; Benzo(a)pyrene affects the methylation of HOXC11 promoter	PMID:27901495
1313485	HOXC11	homeobox C11	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of HOXC11 promoter	PMID:23974009
1313485	HOXC11	homeobox C11	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620670	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HOXC11 gene	PMID:35295148
1313485	HOXC11	homeobox C11	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1620670	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of HOXC11 gene	PMID:35295148
1313485	HOXC11	homeobox C11	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to HOXC11 promoter]	PMID:20348232
1313485	HOXC11	homeobox C11	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1620670	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HOXC11 mRNA	PMID:32715474
1313485	HOXC11	homeobox C11	gene	CHEBI:46345	5-fluorouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil affects the expression of HOXC11 protein	PMID:15331170
1313485	HOXC11	homeobox C11	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	HOXC11 protein affects the susceptibility to Fluorouracil	PMID:15331170
1313485	HOXC11	homeobox C11	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of HOXC11 promoter	PMID:29626692
1313485	HOXC11	homeobox C11	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of HOXC11 promoter	PMID:29626692
1313485	HOXC11	homeobox C11	gene	CHEBI:46680	serpentine asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of HOXC11 promoter	PMID:29626692
1313485	HOXC11	homeobox C11	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of HOXC11 mRNA	PMID:30851411
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of BHLHE22 mRNA	PMID:27188386
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313487	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BHLHE22 mRNA	PMID:30529165
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of BHLHE22 mRNA	PMID:24763279
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305451	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of BHLHE22 mRNA	PMID:33387578
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of BHLHE22 promoter; [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of BHLHE22 gene	PMID:33872906
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of BHLHE22 mRNA	PMID:31163220
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of BHLHE22 promoter; [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of BHLHE22 gene	PMID:33872906
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305451	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of BHLHE22 mRNA	PMID:26577399
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305451	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of BHLHE22 mRNA	PMID:27523638
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of BHLHE22 mRNA	PMID:23649840
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of BHLHE22 gene	PMID:27153756
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of BHLHE22 mRNA	PMID:23649840
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of BHLHE22 mRNA	PMID:41430723
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305451	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of BHLHE22 mRNA	PMID:30779732
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313487	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BHLHE22 mRNA	PMID:17484886
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313487	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of BHLHE22 mRNA	PMID:28960355
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1305451	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of BHLHE22 mRNA	PMID:17898221
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of BHLHE22 mRNA	PMID:24768652
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313487	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BHLHE22 promoter]	PMID:19654925
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:28680	cytarabine	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of BHLHE22 mRNA	PMID:21198554
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of BHLHE22 gene	PMID:28589171
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313487	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of BHLHE22 mRNA	PMID:37682722
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BHLHE22 promoter	PMID:27901495
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BHLHE22 exon	PMID:27901495
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of BHLHE22 promoter	PMID:23974009
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313487	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of BHLHE22 mRNA	PMID:27131904
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305451	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of BHLHE22 mRNA	PMID:24915197
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305451	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of BHLHE22 mRNA	PMID:30047161
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313487	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of BHLHE22 gene	PMID:35295148
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313487	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of BHLHE22 mRNA	PMID:20813756
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305451	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of BHLHE22 mRNA	PMID:25181051|PMID:34947998
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305451	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of BHLHE22 mRNA	PMID:33296240
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313487	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased expression of BHLHE22 mRNA	PMID:32365465
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of BHLHE22 gene	PMID:31601247
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:35559	furan	decreases methylation	ISO	RGD:1305451	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of BHLHE22 gene	PMID:27387713
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305451	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of BHLHE22 mRNA	PMID:27387713
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:3764	clotrimazole	decreases expression	ISO	RGD:1305451	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of BHLHE22 mRNA	PMID:30047161
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BHLHE22 mRNA	PMID:25979313
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of BHLHE22 mRNA	PMID:28001369
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of BHLHE22 gene	PMID:29154799
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305451	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of BHLHE22 mRNA	PMID:30047161
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313487	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of BHLHE22 mRNA	PMID:19446018
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313487	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of BHLHE22 mRNA	PMID:29279043
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305451	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of BHLHE22 mRNA	PMID:30047161
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313487	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of BHLHE22 mRNA	PMID:23608068
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305451	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of BHLHE22 mRNA	PMID:20080153
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases expression	ISO	RGD:1305451	E	RGD:6480464	20210406	CTD	MESH:C074283	estradiol 3-benzoate results in increased expression of BHLHE22 mRNA	PMID:32741896
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BHLHE22 gene]	PMID:28238834
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305451	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of BHLHE22 mRNA	PMID:30047161
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305451	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of BHLHE22 mRNA	PMID:24780913
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313487	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of BHLHE22 mRNA	PMID:27131904
1313486	BHLHE22	basic helix-loop-helix family member e22	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305451	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of BHLHE22 mRNA	PMID:19281266
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:10033	warfarin	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin results in decreased expression of CCT8 mRNA	PMID:20493250
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313489	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of CCT8 mRNA	PMID:33045310
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313489	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CCT8 mRNA	PMID:37995155
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305452	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCT8 mRNA]	PMID:31150632
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:133296	microcystin RR	increases expression	EXP		E	RGD:6480464	20161004	CTD	MESH:C063855	microcystin RR results in increased expression of CCT8 protein	PMID:19111056
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCT8 mRNA	PMID:30529165
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313489	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CCT8 mRNA	PMID:30319688
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313489	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CCT8 mRNA	PMID:39241906
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of CCT8 mRNA	PMID:35877022
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT8 mRNA]	PMID:39241906
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313489	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of CCT8 mRNA	PMID:15598610
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CCT8 mRNA	PMID:38568856
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:17296	aniline	multiple interactions	ISO	RGD:1305452	E	RGD:6480464	20120918	CTD	MESH:C023650	aniline results in increased nitrosation of and results in increased expression of CCT8 protein	PMID:21708182
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CCT8 mRNA	PMID:33754040
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of CCT8 protein; [Cuprizone co-treated with Cannabidiol] results in decreased expression of CCT8 protein; [Cuprizone co-treated with Haloperidol] results in decreased expression of CCT8 protein	PMID:34122009
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CCT8 protein	PMID:37730182
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of CCT8 mRNA	PMID:17103032
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCT8 mRNA	PMID:35301059
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CCT8 protein	PMID:23301498
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313489	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of CCT8 mRNA	PMID:27776689
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CCT8 mRNA	PMID:35430440
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CCT8 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CCT8 protein	PMID:38598786
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305452	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCT8 mRNA	PMID:31150632
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313489	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCT8 mRNA	PMID:31919559
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305452	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCT8 mRNA]	PMID:31150632
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCT8 mRNA	PMID:22206623
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27732	caffeine	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D002110	Caffeine results in decreased expression of CCT8 protein	PMID:31195006
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CCT8 protein	PMID:37208198
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CCT8 mRNA	PMID:23557933
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20181016	CTD	MESH:D002945	[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of CCT8 protein	PMID:29733421
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCT8 mRNA	PMID:22574217
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313489	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCT8 mRNA	PMID:21570461|PMID:24680724
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CCT8 mRNA	PMID:15056799
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CCT8 mRNA	PMID:19770486
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCT8 mRNA	PMID:17942748
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CCT8 mRNA	PMID:32763439
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CCT8 mRNA	PMID:29803840
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCT8 mRNA; sodium arsenite results in decreased expression of CCT8 protein	PMID:20050688|PMID:30528433|PMID:39719251
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313489	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCT8 mRNA	PMID:22228805
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CCT8 mRNA]; arsenite promotes the reaction [G3BP1 protein binds to CCT8 protein]	PMID:32406909
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of CCT8 protein	PMID:34122009
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CCT8 mRNA	PMID:20458559
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CCT8 protein]	PMID:26598702
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20181016	CTD	MESH:D001761	[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of CCT8 protein	PMID:29733421
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305452	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CCT8 mRNA	PMID:25729387
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305452	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CCT8 mRNA	PMID:30047161
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313489	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CCT8 gene	PMID:35295148
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305452	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CCT8 mRNA	PMID:34492290
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313489	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CCT8 mRNA	PMID:28472532
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of CCT8 protein	PMID:34186270
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305452	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CCT8 mRNA	PMID:25181051|PMID:41034487
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CCT8 protein	PMID:34186270
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313489	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CCT8 mRNA	PMID:39298647
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CCT8 protein	PMID:34186270
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CCT8 protein	PMID:34186270
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313489	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of CCT8 intron	PMID:28392331
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CCT8 protein	PMID:38598786
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT8 mRNA]	PMID:39241906
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305452	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CCT8 mRNA	PMID:33453195
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305452	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of CCT8 promoter	PMID:22457795
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCT8 mRNA	PMID:35301059
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CCT8 mRNA	PMID:24449571
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CCT8 mRNA	PMID:28302478
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of CCT8 mRNA	PMID:26352163
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305452	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of CCT8 mRNA	PMID:25993096
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305452	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CCT8 mRNA	PMID:30047161
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:40303	lovastatin	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20120814	CTD	MESH:D008148	Lovastatin results in decreased expression of CCT8 mRNA	PMID:20493250
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of CCT8 mRNA	PMID:21041162
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of CCT8 mRNA	PMID:21041162
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305452	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CCT8 mRNA	PMID:24136188
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of CCT8 protein	PMID:25470785
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCT8 mRNA	PMID:30529165
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of CCT8 protein	PMID:31195006
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313489	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CCT8 mRNA	PMID:35436446
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313489	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CCT8 mRNA	PMID:17942748
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCT8 mRNA	PMID:17942748
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:4911	etoposide	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20181016	CTD	MESH:D005047	[Etoposide co-treated with Cisplatin co-treated with Bleomycin] results in decreased expression of CCT8 protein	PMID:29733421
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CCT8 mRNA	PMID:20458559
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CCT8 protein]	PMID:26598702
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305452	E	RGD:6480464	20210706	CTD	MESH:C017690	fenvalerate results in increased expression of CCT8 protein	PMID:33656234
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313489	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CCT8 mRNA; Nanotubes, Carbon results in increased expression of CCT8 mRNA	PMID:25554681
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305452	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CCT8 mRNA	PMID:24136188
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305452	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CCT8 mRNA	PMID:30047161
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of CCT8 mRNA	PMID:40234311
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CCT8 mRNA	PMID:35964746
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305452	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CCT8 mRNA	PMID:24136188
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:5613	haloperidol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in decreased expression of CCT8 protein	PMID:34122009
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CCT8 protein	PMID:32959892
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305452	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CCT8 mRNA	PMID:25729387
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305452	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CCT8 mRNA	PMID:24136188
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313489	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CCT8 mRNA	PMID:23650126
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:64153	tanespimycin	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:C112765	[tanespimycin co-treated with VER 155008] results in decreased expression of CCT8 protein	PMID:31370342
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313489	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of CCT8 mRNA	PMID:27462272
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of CCT8 protein	PMID:34122009
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CCT8 protein	PMID:34186270
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCT8 mRNA	PMID:22206623
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305452	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CCT8 mRNA	PMID:24136188
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of CCT8 protein	PMID:31285264
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1305452	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CCT8 mRNA	PMID:15215175
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	ISO	RGD:1305452	E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of CCT8 protein	PMID:19716841
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CCT8 protein	PMID:39638853
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:7719	ochratoxin A	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C025589	ochratoxin A affects the expression of CCT8 protein	PMID:26861962
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CCT8 gene]	PMID:28238834
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305452	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of CCT8 mRNA	PMID:30047161
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1305452	E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of CCT8 protein	PMID:19954255
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1305452	E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of CCT8 protein	PMID:19954255
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313489	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CCT8 mRNA	PMID:30294300
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1305452	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of CCT8 protein	PMID:28903499
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of CCT8 protein	PMID:38348393
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305452	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CCT8 mRNA	PMID:30047161
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313489	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT8 mRNA]	PMID:39241906
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305452	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CCT8 mRNA	PMID:19281266
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305452	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CCT8 mRNA	PMID:21346803
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CCT8 protein	PMID:38598786
1313488	CCT8	chaperonin containing TCP1 subunit 8	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305452	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of CCT8 mRNA	PMID:23034163
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PSMG1 mRNA	PMID:33167477
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PSMG1 mRNA	PMID:20044591
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PSMG1 mRNA	PMID:21632981
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313492	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PSMG1 mRNA	PMID:39241906
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305454	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of PSMG1 mRNA	PMID:32145629
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305454	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of PSMG1 gene	PMID:27618143
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PSMG1 mRNA	PMID:20655997
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1313492	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of PSMG1 mRNA	PMID:17997037
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305454	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PSMG1 mRNA	PMID:22061828
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PSMG1 mRNA	PMID:28818685
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313492	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMG1 mRNA	PMID:36331819
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:18291	manganese atom	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D008345	Manganese results in decreased expression of PSMG1 protein	PMID:37834424
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1313492	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of PSMG1 mRNA	PMID:17997037
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PSMG1 mRNA	PMID:19549813
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PSMG1 protein	PMID:23301498
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PSMG1 gene	PMID:27153756
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313492	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PSMG1 mRNA	PMID:34911549
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of PSMG1 mRNA	PMID:15672453
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305454	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PSMG1 mRNA	PMID:31150632
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313492	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PSMG1 mRNA	PMID:31919559
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313492	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMG1 mRNA	PMID:22206623
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PSMG1 protein	PMID:35688186
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313492	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of PSMG1 mRNA	PMID:30912803
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313492	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSMG1 mRNA	PMID:21570461
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305454	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PSMG1 mRNA	PMID:32109520
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313492	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PSMG1 mRNA	PMID:18796159
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of PSMG1 mRNA	PMID:33512557
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of PSMG1 mRNA	PMID:20044591
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PSMG1 mRNA	PMID:38568856
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313492	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of PSMG1 protein	PMID:37955338
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313492	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PSMG1 promoter	PMID:35295148
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305454	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PSMG1 mRNA	PMID:34492290
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313492	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of PSMG1 mRNA	PMID:18648102
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313492	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PSMG1 mRNA	PMID:18445702
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313492	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PSMG1 mRNA	PMID:28472532
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PSMG1 mRNA	PMID:29275510
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305454	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PSMG1 mRNA	PMID:34947998
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305454	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PSMG1 mRNA	PMID:25181051|PMID:32145629
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305454	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PSMG1 gene	PMID:28505145
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313492	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PSMG1 mRNA	PMID:39298647
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313492	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PSMG1 mRNA	PMID:21266533
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:35154	manganese(0)	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D008345	Manganese results in decreased expression of PSMG1 protein	PMID:37834424
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305454	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PSMG1 gene	PMID:22079235
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PSMG1 mRNA	PMID:19320972|PMID:19376846
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313492	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMG1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PSMG1 mRNA	PMID:36331819
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1313492	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of PSMG1 mRNA	PMID:31558096
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PSMG1 mRNA	PMID:25979313
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PSMG1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PSMG1 mRNA	PMID:27188386
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305454	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of PSMG1 mRNA	PMID:41580965
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of PSMG1 mRNA	PMID:20106945
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PSMG1 mRNA	PMID:38832940
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PSMG1 mRNA	PMID:24935251
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313492	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PSMG1 mRNA	PMID:17562736
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PSMG1 mRNA	PMID:21420995
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313492	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PSMG1 mRNA; Nanotubes, Carbon results in increased expression of PSMG1 mRNA	PMID:25554681
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305454	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PSMG1 mRNA	PMID:24136188
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313492	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PSMG1 mRNA	PMID:35964746
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305454	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of PSMG1 mRNA	PMID:24793618
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305454	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PSMG1 mRNA	PMID:24136188
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:6030	isoniazide	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in decreased expression of PSMG1 protein	PMID:40015660
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PSMG1 protein	PMID:32959892
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PSMG1 protein	PMID:34186270
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313492	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMG1 mRNA	PMID:22206623
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of PSMG1 protein	PMID:31285264
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PSMG1 mRNA	PMID:27188386
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PSMG1 gene]	PMID:28238834
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313492	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PSMG1 mRNA	PMID:30294300
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1313492	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of PSMG1 mRNA	PMID:31558096
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PSMG1 mRNA	PMID:27188386
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305454	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PSMG1 mRNA	PMID:19281266
1313491	PSMG1	proteasome assembly chaperone 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PSMG1 mRNA	PMID:38568856
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C007262	deoxynivalenol results in decreased expression of TFCP2L1 protein	PMID:33890134
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TFCP2L1 mRNA	PMID:26272509
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA	PMID:27188386
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552211	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TFCP2L1 mRNA	PMID:33045310
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305456	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TFCP2L1 mRNA]	PMID:31150632
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:132844	glycidyl methacrylate	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of TFCP2L1 protein	PMID:36641056
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:15366	acetic acid	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20120717	CTD	MESH:D019342	Acetic Acid results in decreased expression of TFCP2L1 protein	PMID:21296659
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TFCP2L1 mRNA	PMID:36189433
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TFCP2L1 mRNA	PMID:26079696
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552211	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TFCP2L1 mRNA	PMID:30319688
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of TFCP2L1 mRNA	PMID:28986285
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552211	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TFCP2L1 mRNA	PMID:30319688
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of TFCP2L1 mRNA	PMID:15598610
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TFCP2L1 mRNA	PMID:31614463
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305456	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of TFCP2L1 mRNA	PMID:26496021
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1552211	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of TFCP2L1 mRNA	PMID:33711761
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TFCP2L1 mRNA	PMID:38568856
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of TFCP2L1 mRNA	PMID:17251523
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of TFCP2L1 mRNA	PMID:21540246
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TFCP2L1 mRNA	PMID:26079696
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TFCP2L1 mRNA	PMID:36189433
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of TFCP2L1 mRNA	PMID:20403060
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TFCP2L1 mRNA	PMID:34319233
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of TFCP2L1 mRNA	PMID:26485663
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TFCP2L1 mRNA	PMID:28818685
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TFCP2L1 mRNA	PMID:36331819
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:2208	purine-6-thiol	decreases expression	ISO	RGD:1305456	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of TFCP2L1 mRNA	PMID:23358152
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TFCP2L1 mRNA	PMID:19549813
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of TFCP2L1 mRNA	PMID:23876855
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1552211	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of TFCP2L1 intron	PMID:27776689
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305456	E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TFCP2L1 mRNA	PMID:25378103
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TFCP2L1 mRNA	PMID:34911549
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305456	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TFCP2L1 mRNA	PMID:31150632
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305456	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TFCP2L1 mRNA]	PMID:31150632
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of TFCP2L1 mRNA	PMID:41028656
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1552211	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of TFCP2L1 mRNA	PMID:40618947
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TFCP2L1 mRNA	PMID:24768652|PMID:25583101
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305456	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TFCP2L1 mRNA	PMID:33387578
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TFCP2L1 mRNA	PMID:26290441
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305456	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TFCP2L1 mRNA	PMID:32109520
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin affects the methylation of TFCP2L1 intron] which results in decreased expression of TFCP2L1 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of TFCP2L1 mRNA	PMID:17942748|PMID:33017471
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1552211	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of TFCP2L1 mRNA	PMID:32937126
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TFCP2L1 mRNA	PMID:23903816
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TFCP2L1 mRNA	PMID:33212167
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TFCP2L1 mRNA	PMID:30851411
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305456	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TFCP2L1 mRNA	PMID:28959563
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TFCP2L1 mRNA	PMID:41028656
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552211	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of TFCP2L1 mRNA	PMID:39631538
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TFCP2L1 mRNA	PMID:38568856
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TFCP2L1 mRNA	PMID:37682722
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TFCP2L1 mRNA	PMID:34032870
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TFCP2L1 intron	PMID:30157460
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TFCP2L1 3' UTR	PMID:27901495
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA	PMID:27858113
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TFCP2L1 mRNA	PMID:41028656
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TFCP2L1 mRNA; Silicon Dioxide results in decreased expression of TFCP2L1 mRNA	PMID:25351596|PMID:25895662
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of TFCP2L1 mRNA	PMID:38568856
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1305456	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of TFCP2L1 mRNA	PMID:22641619
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552211	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TFCP2L1 mRNA	PMID:23557971|PMID:35295148
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552211	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TFCP2L1 gene	PMID:35295148
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305456	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TFCP2L1 mRNA	PMID:23411599|PMID:34492290
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305456	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TFCP2L1 mRNA	PMID:25181051
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1552211	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TFCP2L1 promoter	PMID:27334623
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TFCP2L1 gene	PMID:31601247
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552211	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of TFCP2L1 mRNA	PMID:32156529|PMID:35598803
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305456	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of TFCP2L1 mRNA	PMID:26496021
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TFCP2L1 mRNA	PMID:40203079
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of TFCP2L1 mRNA	PMID:26377693
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA	PMID:27858113
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552211	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TFCP2L1 mRNA	PMID:38685157
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TFCP2L1 mRNA	PMID:34813904
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305456	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TFCP2L1 mRNA	PMID:35163327
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of TFCP2L1 mRNA	PMID:26377693
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TFCP2L1 mRNA	PMID:38382870|PMID:38568856
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305456	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TFCP2L1 mRNA	PMID:35163327
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305456	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of TFCP2L1 mRNA	PMID:25539665
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305456	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of TFCP2L1 mRNA	PMID:24386269
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TFCP2L1 mRNA	PMID:24449571
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1552211	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of TFCP2L1 mRNA	PMID:18353800
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552211	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TFCP2L1 mRNA	PMID:40194260
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of TFCP2L1 mRNA	PMID:39529242
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TFCP2L1 mRNA	PMID:36331819
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TFCP2L1 mRNA	PMID:25979313
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TFCP2L1 mRNA	PMID:26272509|PMID:28001369
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA	PMID:27188386
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305456	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of TFCP2L1 mRNA	PMID:41580965
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TFCP2L1 mRNA	PMID:17555576
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of TFCP2L1 mRNA	PMID:25123088
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of TFCP2L1 mRNA	PMID:17394237
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552211	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TFCP2L1 mRNA	PMID:28973697
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1552211	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in increased expression of TFCP2L1 mRNA	PMID:25270620
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TFCP2L1 mRNA	PMID:24935251
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TFCP2L1 mRNA	PMID:17562736
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305456	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TFCP2L1 mRNA	PMID:33387578
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:46345	5-fluorouracil	increases expression	ISO	RGD:1552211	E	RGD:6480464	20120717	CTD	MESH:D005472	Fluorouracil results in increased expression of TFCP2L1 protein	PMID:21296659
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of TFCP2L1 mRNA	PMID:24714768
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305456	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TFCP2L1 mRNA	PMID:29391264
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TFCP2L1 mRNA	PMID:17555576
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TFCP2L1 mRNA	PMID:17942748
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of TFCP2L1 mRNA	PMID:17942748
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of TFCP2L1 mRNA	PMID:38568856
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TFCP2L1 mRNA; Nanotubes, Carbon results in decreased expression of TFCP2L1 mRNA	PMID:25554681
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:50667	mercaptopurine	decreases expression	ISO	RGD:1305456	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of TFCP2L1 mRNA	PMID:23358152
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of TFCP2L1 mRNA	PMID:26377693
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA	PMID:27858113
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TFCP2L1 mRNA	PMID:27858113
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1552211	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of TFCP2L1 mRNA	PMID:25270620
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552211	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TFCP2L1 mRNA	PMID:22206623
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:76290	PhIP	decreases expression	ISO	RGD:1305456	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of TFCP2L1 mRNA	PMID:15215175
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TFCP2L1 mRNA	PMID:30851411
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA	PMID:27188386
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TFCP2L1 gene]	PMID:28238834
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552211	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TFCP2L1 mRNA	PMID:23091169
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305456	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of TFCP2L1 mRNA	PMID:30047161
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TFCP2L1 mRNA	PMID:19270015|PMID:19482888
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1552211	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of TFCP2L1 mRNA]	PMID:19482888
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552211	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TFCP2L1 mRNA	PMID:30294300
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305456	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TFCP2L1 mRNA	PMID:30047161
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of TFCP2L1 mRNA	PMID:26272509
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA	PMID:27188386
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFCP2L1 mRNA	PMID:27188386
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:94796	3,7-dihydropurine-6-thione	decreases expression	ISO	RGD:1305456	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in decreased expression of TFCP2L1 mRNA	PMID:23358152
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TFCP2L1 mRNA	PMID:38568856
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305456	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin affects the expression of TFCP2L1 mRNA	PMID:23034163
1313494	TFCP2L1	transcription factor CP2 like 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305456	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of TFCP2L1 mRNA	PMID:20566332
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of PPM1D mRNA	PMID:31863870
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of PPM1D mRNA	PMID:25596134
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313499	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PPM1D mRNA	PMID:33045310
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313499	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of PPM1D mRNA	PMID:37995155
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:136185	VX nerve agent	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C009680	VX-agent results in increased expression of PPM1D mRNA	PMID:38555327
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPM1D gene	PMID:20938992
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PPM1D mRNA	PMID:23724009
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of PPM1D mRNA	PMID:25596134
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPM1D mRNA	PMID:36331819
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PPM1D mRNA	PMID:26079696
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:15882	phenol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019800	Phenol results in increased expression of PPM1D mRNA	PMID:17547211
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of PPM1D mRNA	PMID:12414654
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D011794	Quercetin results in increased expression of PPM1D mRNA; Quercetin results in increased expression of PPM1D protein	PMID:21632981|PMID:25078064
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of PPM1D mRNA	PMID:29581250
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of PPM1D mRNA	PMID:16514628
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:16480	nitric oxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide results in increased expression of PPM1D mRNA	PMID:15126337
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313499	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of PPM1D mRNA	PMID:33711761
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PPM1D mRNA	PMID:38568856
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305460	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of PPM1D gene	PMID:27618143
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPM1D gene	PMID:20938992
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:16708	adenine	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D000225	Adenine results in decreased expression of PPM1D mRNA	PMID:24211769
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1313499	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of PPM1D mRNA	PMID:34673133
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PPM1D mRNA	PMID:20655997
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PPM1D mRNA	PMID:23649840
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PPM1D mRNA	PMID:21179406
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PPM1D mRNA	PMID:33359661
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C031927	hydroquinone results in increased expression of PPM1D mRNA	PMID:23416264
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PPM1D protein	PMID:37730182
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305460	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PPM1D mRNA	PMID:33387578
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:17846	(S)-naringenin	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C005273	[naringenin co-treated with bisphenol A] results in increased expression of PPM1D mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of PPM1D mRNA	PMID:36235125
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:18291	manganese atom	decreases expression	ISO	RGD:1305460	E	RGD:6480464	20150825	CTD	MESH:D008345	Manganese results in decreased expression of PPM1D protein	PMID:25791630
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:18291	manganese atom	multiple interactions	ISO	RGD:1305460	E	RGD:6480464	20150825	CTD	MESH:D008345	[Manganese co-treated with NGF protein] results in decreased expression of PPM1D protein; PPM1D mutant form promotes the reaction [[Manganese co-treated with NGF protein] results in increased cleavage of PARP1 protein]; PPM1D mutant form promotes the reaction [[Manganese co-treated with NGF protein] results in increased phosphorylation of TP53 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased cleavage of PARP1 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of BCL2L1 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of MDM2 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in increased expression of BAX protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in increased phosphorylation of TP53 protein]	PMID:25791630
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:211249	Ampullosporin	multiple interactions	ISO	RGD:1305460	E	RGD:6480464	20240806	CTD	MESH:C109004	[ampullosporin co-treated with Ketamine] results in increased expression of PPM1D mRNA	PMID:16635253
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PPM1D mRNA	PMID:23649840
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PPM1D protein	PMID:20106945
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PPM1D mRNA	PMID:21632981|PMID:21641981|PMID:22100608|PMID:27153756
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313499	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PPM1D mRNA	PMID:19770486
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	TP53 protein affects the reaction [Aflatoxin B1 results in increased expression of PPM1D mRNA]	PMID:22100608
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PPM1D mRNA; Methyl Methanesulfonate results in increased expression of PPM1D protein	PMID:22100608|PMID:23649840|PMID:25078064
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313499	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of PPM1D mRNA	PMID:32553695
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PPM1D mRNA	PMID:41430723
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PPM1D mRNA	PMID:18593933
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPM1D gene	PMID:20938992
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPM1D gene	PMID:25304211
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of PPM1D mRNA	PMID:33512557
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of PPM1D mRNA	PMID:38460933
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of PPM1D mRNA	PMID:38460933
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PPM1D mRNA	PMID:26272509
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA	PMID:27188386
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of PPM1D protein	PMID:35688186
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313499	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PPM1D mRNA	PMID:28960355
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27871	chloroacetaldehyde	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde affects the expression of PPM1D mRNA	PMID:25596134
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1305460	E	RGD:6480464	20210608	CTD	MESH:C059514	Resveratrol results in decreased expression of PPM1D mRNA	PMID:33775663
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PPM1D mRNA	PMID:23557933
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27882	(S)-colchicine	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D003078	Colchicine results in decreased expression of PPM1D mRNA	PMID:24211769
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in increased expression of PPM1D mRNA	PMID:21532991|PMID:23300844|PMID:24280081|PMID:33545341
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313499	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in increased expression of PPM1D mRNA	PMID:24280081|PMID:25270620
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313499	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPM1D mRNA	PMID:21570461
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305460	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPM1D mRNA	PMID:33387578
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of PPM1D mRNA	PMID:33512557
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of PPM1D mRNA	PMID:39709020
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of PPM1D mRNA	PMID:26272509
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA	PMID:27188386
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of PPM1D mRNA	PMID:30911355
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004317	Doxorubicin results in increased expression of PPM1D mRNA	PMID:36634904
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D004317	[TP53 protein affects the susceptibility to Doxorubicin] which affects the expression of PPM1D mRNA	PMID:36634904
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of PPM1D protein	PMID:35688186
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:28869	menadione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 results in increased expression of PPM1D mRNA	PMID:12414654
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPM1D mRNA	PMID:39900124
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PPM1D mRNA	PMID:38568856
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1313499	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased methylation of PPM1D gene	PMID:39894169
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D014415	Tunicamycin results in decreased expression of PPM1D mRNA	PMID:39900124
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of PPM1D mRNA	PMID:21873647
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PPM1D mRNA; Benzo(a)pyrene results in increased expression of PPM1D protein	PMID:20106945|PMID:21632981|PMID:22316170|PMID:22409540|PMID:32234424|PMID:40280401
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313499	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of PPM1D mRNA; Benzo(a)pyrene results in increased expression of PPM1D mRNA	PMID:19770486|PMID:32553695
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPM1D mRNA	PMID:40280401
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PPM1D mRNA]	PMID:22228805
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of PPM1D mRNA	PMID:30911355
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PPM1D mRNA	PMID:18593933
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PPM1D mRNA	PMID:20382639|PMID:26238291|PMID:28593498
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:30621	diarsenic trioxide	affects activity	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide affects the activity of PPM1D	PMID:18482988
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PPM1D protein	PMID:21175813
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313499	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PPM1D mRNA	PMID:29095437
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	MIR29A protein affects the reaction [Arsenic Trioxide results in decreased expression of PPM1D protein]; PPM1D mutant form promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of CHEK2 protein]; PPM1D mutant form promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]	PMID:18482988|PMID:21175813
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20191114	CTD	MESH:C006632	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PPM1D mRNA]	PMID:29095437
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:31175	adefovir pivoxil	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of PPM1D mRNA	PMID:25596134
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:31638	fulvestrant	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of PPM1D mRNA	PMID:16514628
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305460	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPM1D mRNA	PMID:25729387
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313499	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PPM1D gene; titanium dioxide results in decreased methylation of PPM1D promoter	PMID:35295148
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305460	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PPM1D mRNA	PMID:34492290
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of PPM1D mRNA	PMID:38479592
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of PPM1D mRNA	PMID:36982678
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305460	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of PPM1D mRNA	PMID:41034487
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305460	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PPM1D mRNA	PMID:25181051|PMID:30816183|PMID:33296240|PMID:34947998
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPM1D mRNA; [naringenin co-treated with bisphenol A] results in increased expression of PPM1D mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of PPM1D mRNA	PMID:28628672|PMID:36235125
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:34342	3-methylcholanthrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D008748	Methylcholanthrene results in increased expression of PPM1D mRNA	PMID:22100608
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPM1D mRNA	PMID:40280401
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PPM1D mRNA	PMID:28628672
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1313499	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of PPM1D mRNA	PMID:31558096
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305460	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of PPM1D mRNA	PMID:22546817
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPM1D mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PPM1D mRNA	PMID:28628672
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPM1D mRNA	PMID:37042841
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of PPM1D mRNA	PMID:29024780
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:35154	manganese(0)	decreases expression	ISO	RGD:1305460	E	RGD:6480464	20150825	CTD	MESH:D008345	Manganese results in decreased expression of PPM1D protein	PMID:25791630
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:35154	manganese(0)	multiple interactions	ISO	RGD:1305460	E	RGD:6480464	20150825	CTD	MESH:D008345	[Manganese co-treated with NGF protein] results in decreased expression of PPM1D protein; PPM1D mutant form promotes the reaction [[Manganese co-treated with NGF protein] results in increased cleavage of PARP1 protein]; PPM1D mutant form promotes the reaction [[Manganese co-treated with NGF protein] results in increased phosphorylation of TP53 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased cleavage of PARP1 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of BCL2L1 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of MDM2 protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in increased expression of BAX protein]; PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in increased phosphorylation of TP53 protein]	PMID:25791630
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PPM1D mRNA	PMID:38568856
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PPM1D mRNA	PMID:25596134
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305460	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased expression of PPM1D mRNA	PMID:22079235
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PPM1D mRNA	PMID:19376846
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PPM1D mRNA	PMID:24449571
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:35861	dibenzo[a,l]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C041517	dibenzo(a,l)pyrene results in increased expression of PPM1D mRNA; dibenzo(a,l)pyrene results in increased expression of PPM1D protein	PMID:22409540
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:38211	potassium bromate	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C019536	potassium bromate results in increased expression of PPM1D mRNA	PMID:30559759
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of PPM1D mRNA	PMID:40434365
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PPM1D mRNA	PMID:31533062
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPM1D mRNA	PMID:36331819
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PPM1D mRNA	PMID:23179753|PMID:29154799
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPM1D mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PPM1D mRNA	PMID:28628672
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:42223	emodin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004642	Emodin results in increased expression of PPM1D mRNA	PMID:16045814
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of PPM1D mRNA	PMID:23649840
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:44423	hydroxyurea	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D006918	Hydroxyurea results in increased expression of PPM1D mRNA	PMID:24211769
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:44616	afimoxifene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of PPM1D mRNA	PMID:16514628
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PPM1D mRNA	PMID:38832940
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313499	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PPM1D mRNA	PMID:17562736
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PPM1D mRNA	PMID:21420995|PMID:22230336
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305460	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PPM1D mRNA	PMID:33387578
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of PPM1D mRNA; Fluorouracil results in increased expression of PPM1D protein	PMID:14665630|PMID:17982676
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in increased expression of PPM1D mRNA]; TP53 protein promotes the reaction [Fluorouracil results in increased expression of PPM1D mRNA]	PMID:15016801|PMID:17982676
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of PPM1D mRNA	PMID:18687144
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of PPM1D mRNA	PMID:38460933
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPM1D gene	PMID:25304211
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313499	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PPM1D mRNA	PMID:35436446
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of PPM1D mRNA	PMID:18175754
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D005047	Etoposide results in increased expression of PPM1D protein	PMID:25078064
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of PPM1D mRNA	PMID:26272509
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA	PMID:27188386
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PPM1D mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PPM1D mRNA	PMID:28628672
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:49900	arsenous acid	affects activity	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide affects the activity of PPM1D	PMID:18482988
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PPM1D protein	PMID:21175813
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313499	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PPM1D mRNA	PMID:29095437
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	MIR29A protein affects the reaction [Arsenic Trioxide results in decreased expression of PPM1D protein]; PPM1D mutant form promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of CHEK2 protein]; PPM1D mutant form promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]	PMID:18482988|PMID:21175813
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20191114	CTD	MESH:C032793	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PPM1D mRNA]	PMID:29095437
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1305460	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of PPM1D mRNA	PMID:25596134
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of PPM1D mRNA	PMID:23300844
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:50292	cadmium sulfate	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C037123	cadmium sulfate results in decreased expression of PPM1D mRNA	PMID:21783983
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PPM1D mRNA	PMID:35964746
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:51348	tetraphene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPM1D mRNA	PMID:40280401
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:51687	chrysene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PPM1D mRNA	PMID:40280401
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:52289	wortmannin	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:C009687	wortmannin inhibits the reaction [Soil Pollutants results in increased expression of PPM1D protein]	PMID:22409540
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:5864	ifosfamide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of PPM1D mRNA	PMID:25596134
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:6121	ketamine	multiple interactions	ISO	RGD:1305460	E	RGD:6480464	20240806	CTD	MESH:D007649	[ampullosporin co-treated with Ketamine] results in increased expression of PPM1D mRNA	PMID:16635253
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305460	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPM1D mRNA	PMID:25729387
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PPM1D mRNA	PMID:12414654
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1313499	E	RGD:6480464	20190219	CTD	MESH:D008687	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of PPM1D mRNA]	PMID:29095437
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1305460	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of PPM1D mRNA	PMID:19564919
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313499	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PPM1D mRNA	PMID:22206623
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in increased expression of PPM1D mRNA	PMID:30559759
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305460	E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in increased expression of PPM1D mRNA	PMID:23358140
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA	PMID:27188386
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:80630	irinotecan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in increased expression of PPM1D mRNA	PMID:18927307
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of PPM1D mRNA	PMID:32234424
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305460	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of PPM1D mRNA	PMID:23640034
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of PPM1D mRNA	PMID:26079696
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of PPM1D mRNA	PMID:16514628
1313498	PPM1D	protein phosphatase, Mg2+/Mn2+ dependent 1D	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPM1D mRNA	PMID:27188386
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TRP53BP2 mRNA	PMID:26251327
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRP53BP2 mRNA	PMID:30529165
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TRP53BP2 mRNA	PMID:36331819
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of TP53BP2 protein	PMID:28073184
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:16130	DDT	increases methylation	ISO	RGD:1305461	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of TP53BP2 gene	PMID:30207508
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313501	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TRP53BP2 mRNA	PMID:30319688
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313501	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TRP53BP2 mRNA	PMID:30319688
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of TP53BP2 protein	PMID:31494107
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of TP53BP2 mRNA	PMID:15309432
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TRP53BP2 mRNA	PMID:39298647
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of TP53BP2 mRNA	PMID:20106945
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305461	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TP53BP2 mRNA	PMID:33387578
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TP53BP2 mRNA	PMID:37042841
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TP53BP2 mRNA	PMID:21179406
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TP53BP2 protein	PMID:37730182
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:17846	(S)-naringenin	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C005273	[naringenin metabolite co-treated with bisphenol A] results in increased expression of TP53BP2 mRNA	PMID:36235125
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TP53BP2 mRNA	PMID:28818685
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TP53BP2 mRNA	PMID:35301059
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TP53BP2 intron	PMID:30157460
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:25187	p-menthan-3-ol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of TP53BP2 mRNA	PMID:26760959
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TP53BP2 mRNA	PMID:23649840
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in decreased expression of TRP53BP2 mRNA	PMID:18955075
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305461	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TP53BP2 mRNA	PMID:30779732
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313501	E	RGD:6480464	20200609	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TRP53BP2 protein	PMID:31513885
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:27385	tetrachloromethane	increases response to substance	ISO	RGD:1313501	E	RGD:6480464	20200609	CTD	MESH:D002251	TRP53BP2 protein results in increased susceptibility to Carbon Tetrachloride	PMID:31513885
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20200609	CTD	MESH:D002251	[TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of ATG5 protein; [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of ATG7 protein; [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of BECN1 protein; [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of IL1B mRNA; [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of IL6 mRNA; [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of SQSTM1 protein; [TRP53BP2 protein affects the susceptibility to Carbon Tetrachloride] which affects the expression of TNF mRNA; TRP53BP2 protein affects the reaction [Carbon Tetrachloride results in increased expression of GPT protein]; TRP53BP2 protein affects the reaction [Carbon Tetrachloride results in increased expression of SQSTM1 protein]	PMID:31513885
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of TP53BP2 protein	PMID:35688186
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in decreased expression of TP53BP2 protein	PMID:18089832
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1305461	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of TP53BP2 mRNA	PMID:25905778
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TP53BP2 mRNA	PMID:23557933
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TP53BP2 mRNA	PMID:28903495
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in decreased expression of TP53BP2 mRNA	PMID:12540486
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313501	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRP53BP2 mRNA	PMID:21570461
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305461	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TP53BP2 mRNA	PMID:33387578
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TP53BP2 mRNA	PMID:33212167
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of TP53BP2 protein	PMID:35688186
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in decreased expression of TP53BP2 mRNA	PMID:39900124
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TP53BP2 mRNA	PMID:38568856
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D014415	Tunicamycin results in decreased expression of TP53BP2 mRNA	PMID:39900124
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D014415	Tunicamycin results in increased expression of TP53BP2 mRNA	PMID:33545341
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TP53BP2 mRNA	PMID:26238291
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TP53BP2 promoter	PMID:27901495
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TP53BP2 mRNA]	PMID:32406909
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TP53BP2 mRNA	PMID:25351596
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TP53BP2 mRNA	PMID:19150397
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of TRP53BP2 mRNA	PMID:27760801
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313501	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRP53BP2 gene	PMID:35295148
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313501	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TRP53BP2 mRNA	PMID:18301758
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of TRP53BP2 mRNA	PMID:28329830
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TP53BP2 mRNA	PMID:36235125
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305461	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TP53BP2 mRNA	PMID:25181051
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TRP53BP2 mRNA	PMID:33221593
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C006780	bisphenol A results in increased expression of TP53BP2 mRNA	PMID:33312107
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305461	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of TP53BP2 mRNA	PMID:30816183
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313501	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of TRP53BP2 mRNA	PMID:32156529
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	[naringenin metabolite co-treated with bisphenol A] results in increased expression of TP53BP2 mRNA	PMID:36235125
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	ISO	RGD:1305461	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of TP53BP2 mRNA	PMID:22937105
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1305461	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of TP53BP2 mRNA	PMID:22937105
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of TRP53BP2 mRNA	PMID:26682919
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TRP53BP2 mRNA	PMID:39298647
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TP53BP2 gene	PMID:31601247
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C543008	bisphenol S results in increased expression of TP53BP2 mRNA	PMID:33312107
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TP53BP2 mRNA	PMID:28628672
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C008745	bisphenol F results in increased expression of TP53BP2 mRNA	PMID:33312107
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305461	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of TP53BP2 mRNA	PMID:22546817
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TP53BP2 mRNA	PMID:28628672
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in increased expression of TP53BP2 mRNA	PMID:18836921|PMID:19526292
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TP53BP2 mRNA	PMID:12160620
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TP53BP2 mRNA	PMID:35301059
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313501	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of TRP53BP2 mRNA	PMID:18353800
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:38635	3-methyladenine	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20200609	CTD	MESH:C025946	TRP53BP2 protein affects the reaction [3-methyladenine results in increased expression of GPT protein]; TRP53BP2 protein affects the reaction [3-methyladenine results in increased expression of IL1B mRNA]; TRP53BP2 protein affects the reaction [3-methyladenine results in increased expression of IL6 mRNA]	PMID:31513885
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313501	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TRP53BP2 mRNA	PMID:36331819
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TP53BP2 mRNA	PMID:25979313
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TP53BP2 mRNA	PMID:20106945|PMID:25562108
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313501	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TRP53BP2 mRNA	PMID:17555576
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TP53BP2 mRNA	PMID:28628672
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:43572	kojic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of TP53BP2 mRNA	PMID:16595896
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TP53BP2 mRNA	PMID:38832940
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of TP53BP2 mRNA	PMID:21420995
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305461	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TP53BP2 mRNA	PMID:33387578
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313501	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TRP53BP2 mRNA	PMID:17555576
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TP53BP2 mRNA	PMID:28628672
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313501	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TRP53BP2 mRNA; Nanotubes, Carbon results in decreased expression of TRP53BP2 mRNA	PMID:25554681
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:6954	Mitotane	increases expression	ISO	RGD:1305461	E	RGD:6480464	20191114	CTD	MESH:D008939	Mitotane results in increased expression of TP53BP2 mRNA	PMID:23485034
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313501	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TRP53BP2 mRNA	PMID:22206623
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TP53BP2 gene]	PMID:28238834
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of TP53BP2 mRNA	PMID:19159669
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1305461	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of TRP53BP2 mRNA	PMID:20345932
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305461	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TRP53BP2 mRNA	PMID:21346803
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TP53BP2 mRNA	PMID:38568856
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313501	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of TRP53BP2 protein	PMID:24648495
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305461	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TRP53BP2 mRNA	PMID:21346803
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305461	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TP53BP2 mRNA	PMID:23034163
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305461	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of TP53BP2 gene	PMID:31079544
1313500	TP53BP2	tumor protein p53 binding protein 2	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305461	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of TP53BP2 gene	PMID:31079544
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313503	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of GPT2 mRNA	PMID:37995155
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305462	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPT2 mRNA]	PMID:31150632
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313503	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of GPT2 mRNA]	PMID:19467301
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GPT2 mRNA	PMID:33167477
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313503	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GPT2 mRNA	PMID:36189433
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of GPT2 mRNA	PMID:22378314
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313503	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of GPT2 mRNA	PMID:30319688
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GPT2 mRNA	PMID:29432896
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of GPT2 mRNA	PMID:20044591
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of GPT2 mRNA	PMID:18951874
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of GPT2 mRNA	PMID:21632981
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GPT2 mRNA	PMID:35811015
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313503	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of GPT2 mRNA	PMID:39298647
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of GPT2 mRNA	PMID:20068009
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of GPT2 mRNA	PMID:19484750
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of GPT2 mRNA	PMID:38568856
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305462	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of GPT2 gene	PMID:27618143
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of GPT2 protein	PMID:32044396
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313503	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of GPT2 mRNA	PMID:36189433
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of GPT2 mRNA	PMID:34319233
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of GPT2 mRNA	PMID:26577399
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of GPT2 mRNA	PMID:26485663
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of GPT2 mRNA	PMID:37748715
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of GPT2 intron	PMID:30157460
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPT2 mRNA	PMID:35301059
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:23414	copper(II) sulfate	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of GPT2 mRNA	PMID:19549813
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of GPT2 intron	PMID:30157460
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GPT2 gene	PMID:27153756
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1305462	E	RGD:6480464	20150414	CTD	MESH:D016604	[sulforaphane co-treated with Aflatoxin B1] affects the expression of GPT2 mRNA	PMID:25450479
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1313503	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of GPT2 mRNA	PMID:24489787
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in decreased expression of GPT2 mRNA	PMID:31129395
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of GPT2 mRNA	PMID:31150632
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:27385	tetrachloromethane	increases activity	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased activity of GPT2 protein	PMID:19085960
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GPT2 mRNA; Carbon Tetrachloride results in increased expression of GPT2 protein	PMID:19085960|PMID:27339419|PMID:31919559
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305462	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of GPT2 mRNA]	PMID:31150632
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GPT2 mRNA	PMID:25629700
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313503	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GPT2 mRNA	PMID:22206623
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:27638	cobalt atom	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003035	[tungsten carbide co-treated with Cobalt] results in increased expression of GPT2 mRNA	PMID:23052192
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of GPT2 mRNA	PMID:31881176
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of GPT2 mRNA	PMID:27594783
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:27902	tetracycline	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20150127	CTD	MESH:D013752	Tetracycline results in decreased expression of GPT2 mRNA	PMID:24489787
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305462	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPT2 mRNA	PMID:22298810
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GPT2 mRNA	PMID:20106945|PMID:21632981
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GPT2 mRNA	PMID:21215274|PMID:32109520
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GPT2 mRNA	PMID:19770486
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313503	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GPT2 mRNA	PMID:25975270
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of GPT2 mRNA	PMID:28001369
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GPT2 mRNA	PMID:33212167
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of GPT2 mRNA	PMID:32763439
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305462	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of GPT2 mRNA	PMID:28959563
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of GPT2 mRNA; [Disulfiram binds to Copper] which results in increased expression of GPT2 mRNA	PMID:24690739|PMID:30911355
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GPT2 mRNA	PMID:29803840
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of GPT2 mRNA	PMID:20044591
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GPT2 mRNA	PMID:29432896
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of GPT2 mRNA	PMID:37682722
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GPT2 mRNA	PMID:38568856
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of GPT2 mRNA	PMID:22378314|PMID:29453283
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GPT2 intron	PMID:30157460
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in decreased expression of GPT2 mRNA; Benzo(a)pyrene results in decreased expression of GPT2 mRNA; Benzo(a)pyrene results in decreased expression of GPT2 protein	PMID:20064835|PMID:20106945|PMID:21632981|PMID:24356939|PMID:26238291|PMID:32234424|PMID:32717239
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GPT2 mRNA	PMID:21839799
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GPT2 mRNA	PMID:19770486
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GPT2 3' UTR; Benzo(a)pyrene results in decreased methylation of GPT2 promoter	PMID:27901495
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:29866	arsenite(3-)	affects expression	EXP		E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of GPT2 mRNA	PMID:22959463
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to GPT2 mRNA]	PMID:32406909
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of GPT2 mRNA; [Disulfiram binds to Copper] which results in increased expression of GPT2 mRNA	PMID:24690739|PMID:30911355
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20250603	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GPT2 mRNA	PMID:39826883
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of GPT2 mRNA	PMID:24356939
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of GPT2 mRNA	PMID:24136188
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of GPT2 mRNA	PMID:23557971
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313503	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GPT2 gene	PMID:35295148
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of GPT2 mRNA	PMID:18648102
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of GPT2 mRNA	PMID:23811191
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of GPT2 mRNA	PMID:18445702
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GPT2 mRNA	PMID:19710929
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of GPT2 mRNA	PMID:24356939
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305462	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of GPT2 mRNA	PMID:30903817
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GPT2 mRNA	PMID:25181051
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of GPT2 mRNA	PMID:25979313
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of GPT2 mRNA	PMID:19041380
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313503	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of GPT2 gene	PMID:31683443
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of GPT2 mRNA	PMID:33297965
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313503	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of GPT2 mRNA	PMID:39298647
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of GPT2 gene	PMID:31601247
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of GPT2 intron	PMID:30157460
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of GPT2 mRNA	PMID:35093514
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:34682	diazinon	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D003976	Diazinon results in increased expression of GPT2 mRNA	PMID:24356939
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of GPT2 gene	PMID:22964155
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GPT2 mRNA	PMID:38174414
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305462	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GPT2 mRNA	PMID:33453195
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GPT2 mRNA	PMID:35301059
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of GPT2 protein	PMID:26879310
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313503	E	RGD:6480464	20161025	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of GPT2 mRNA	PMID:27413110
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C018021	cobaltous chloride results in increased expression of GPT2 mRNA	PMID:24356939
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313503	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of GPT2 mRNA	PMID:18353800
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of GPT2 mRNA	PMID:23811191
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of GPT2 mRNA	PMID:40194260
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GPT2 mRNA	PMID:32588087
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GPT2 mRNA	PMID:31533062
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of GPT2 mRNA	PMID:26352163
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of GPT2 mRNA	PMID:40419075
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1313503	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of GPT2 mRNA	PMID:23125180
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of GPT2 mRNA	PMID:17292431
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GPT2 gene	PMID:29154799
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of GPT2 mRNA	PMID:29154799
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of GPT2 mRNA	PMID:38685447|PMID:41580965
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:4027	cyclophosphamide	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D003520	Cyclophosphamide metabolite results in decreased expression of GPT2 mRNA	PMID:24356939
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20140715	CTD	MESH:D016572	Cyclosporine results in decreased expression of GPT2 mRNA	PMID:19770486|PMID:23308384
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of GPT2 mRNA	PMID:20106945|PMID:27989131
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313503	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in increased expression of GPT2 mRNA	PMID:25224403
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of GPT2 mRNA	PMID:28973697
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of GPT2 mRNA	PMID:18502557
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of GPT2 mRNA	PMID:24136188
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of GPT2 mRNA	PMID:38832940
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GPT2 mRNA	PMID:17562736
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:46195	paracetamol	increases activity	ISO	RGD:1305462	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased activity of GPT2 protein	PMID:19085960
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305462	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of GPT2 protein	PMID:19085960
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of GPT2 mRNA	PMID:24690739
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of GPT2 mRNA	PMID:33725128
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GPT2 mRNA	PMID:35811015
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of GPT2 mRNA	PMID:35537566
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1305462	E	RGD:6480464	20150414	CTD	MESH:C016766	[sulforaphane co-treated with Aflatoxin B1] affects the expression of GPT2 mRNA	PMID:25450479
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of GPT2 mRNA	PMID:35436446
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1305462	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in increased expression of GPT2 mRNA	PMID:36868495
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of GPT2 mRNA	PMID:24356939
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:50161	motexafin gadolinium	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of GPT2 mRNA	PMID:16357179
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313503	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GPT2 mRNA; Nanotubes, Carbon results in increased expression of GPT2 mRNA	PMID:25620056
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of GPT2 mRNA	PMID:41580965
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of GPT2 mRNA	PMID:38701926
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:62984	zinc acetate	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in increased expression of GPT2 mRNA	PMID:16357179
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of GPT2 mRNA	PMID:24136188
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GPT2 mRNA	PMID:24810058
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305462	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GPT2 mRNA	PMID:28801915
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313503	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GPT2 mRNA	PMID:22776087
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of GPT2 protein	PMID:36851058
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:64307	2,4-diaminobutyric acid	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:C005959	[beta-N-methylamino-L-alanine co-treated with 2,4-diaminobutyric acid] results in increased expression of GPT2 mRNA	PMID:28634653
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:67895	corosolic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of GPT2 mRNA	PMID:37939859
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of GPT2 intron	PMID:30157460
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1313503	E	RGD:6480464	20141111	CTD	MESH:D002185	Cannabidiol results in increased expression of GPT2 mRNA	PMID:21542829
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of GPT2 mRNA	PMID:31758290
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of GPT2 protein	PMID:34186270
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GPT2 mRNA	PMID:22206623
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313503	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GPT2 mRNA	PMID:22206623
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:7507	neomycin	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20190507	CTD	MESH:D009355	Neomycin results in decreased expression of GPT2 mRNA	PMID:30626089
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of GPT2 mRNA	PMID:22714537
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C025589	ochratoxin A metabolite results in decreased expression of GPT2 mRNA	PMID:24356939
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:7852	oxycodone	increases expression	ISO	RGD:1305462	E	RGD:6480464	20161025	CTD	MESH:D010098	Oxycodone results in increased expression of GPT2 mRNA	PMID:23439660
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GPT2 gene]	PMID:28238834
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of GPT2 mRNA	PMID:19270015
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305462	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of GPT2 mRNA	PMID:32109520
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313503	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of GPT2 mRNA	PMID:38648751
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of GPT2 mRNA	PMID:26705709
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:82036	prothioconazole	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in increased expression of GPT2 mRNA	PMID:35048155
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:82283	Tungsten carbide	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C002802	[tungsten carbide co-treated with Cobalt] results in increased expression of GPT2 mRNA	PMID:23052192
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313503	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of GPT2 mRNA	PMID:39847705
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of GPT2 mRNA	PMID:21278054
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305462	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GPT2 mRNA	PMID:21346803
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of GPT2 mRNA	PMID:38568856
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GPT2 mRNA	PMID:29301935
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of GPT2 mRNA	PMID:22378314|PMID:29453283
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313503	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of GPT2 mRNA	PMID:35537566
1313502	GPT2	glutamic--pyruvic transaminase 2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305462	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of GPT2 mRNA	PMID:19015723
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of MAP4K1 mRNA	PMID:27188386
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K1 mRNA	PMID:20938992|PMID:33549593
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of MAP4K1 mRNA	PMID:15282401
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of MAP4K1 mRNA	PMID:15309432
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20140408	CTD	MESH:D004958	[Estradiol co-treated with IGF1R mutant form] results in increased expression of MAP4K1 mRNA	PMID:23094148
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K1 mRNA	PMID:20938992|PMID:33549593
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MAP4K1 mRNA	PMID:37042841
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:17439	cyanocob(III)alamin	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20210608	CTD	MESH:D014805	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA	PMID:33549593
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1305463	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MAP4K1 mRNA	PMID:21318169
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313505	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MAP4K1 mRNA	PMID:21318169
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:17750	glycine betaine	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20210608	CTD	MESH:D001622	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA	PMID:33549593
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MAP4K1 mRNA	PMID:36139627
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305463	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MAP4K1 mRNA	PMID:33387578
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305463	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MAP4K1 mRNA	PMID:22061828
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of MAP4K1 intron	PMID:30157460
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of MAP4K1 mRNA	PMID:39984025
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of MAP4K1 mRNA	PMID:19376150
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MAP4K1 gene; Aflatoxin B1 results in increased methylation of MAP4K1 intron	PMID:28458013|PMID:30157460
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MAP4K1 mRNA	PMID:23649840
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:26820	sulfates	affects methylation	EXP		E	RGD:6480464	20170303	CTD	MESH:D013431	Sulfates affects the methylation of MAP4K1 promoter	PMID:25395096
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:26820	sulfates	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D013431	[Soot co-treated with Sulfates] affects the methylation of MAP4K1 promoter	PMID:25395096
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20210608	CTD	MESH:D015032	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA	PMID:33549593
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305463	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MAP4K1 mRNA	PMID:31150632
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MAP4K1 mRNA	PMID:20938992|PMID:33549593
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP4K1 mRNA	PMID:40504410
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of MAP4K1 mRNA	PMID:26272509
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP4K1 mRNA	PMID:27188386
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305463	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MAP4K1 mRNA	PMID:31881176
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of MAP4K1 mRNA	PMID:19921347
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of MAP4K1 mRNA	PMID:23300844
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MAP4K1 mRNA	PMID:27392435
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:28017	starch	multiple interactions	ISO	RGD:1305463	E	RGD:6480464	20170516	CTD	MESH:D013213	Starch analog inhibits the reaction [Rapeseed Oil metabolite results in decreased expression of MAP4K1 mRNA]	PMID:27363782
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MAP4K1 mRNA	PMID:25583101
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305463	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAP4K1 mRNA	PMID:34747641
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP4K1 mRNA	PMID:17942748
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MAP4K1 mRNA	PMID:28001369
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305463	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of MAP4K1 mRNA	PMID:26033743
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP4K1 mRNA	PMID:34876320|PMID:40504410
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA	PMID:34876320
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MAP4K1 intron; Benzo(a)pyrene affects the methylation of MAP4K1 promoter	PMID:27901495|PMID:30157460
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAP4K1 mRNA	PMID:21569818|PMID:22610609
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313505	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MAP4K1 mRNA	PMID:32417428
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MAP4K1 exon	PMID:27901495
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305463	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of MAP4K1 mRNA	PMID:26033743
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20210608	CTD	MESH:D015032	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc] results in decreased expression of MAP4K1 mRNA	PMID:33549593
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313505	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of MAP4K1 mRNA	PMID:27131904
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C061133	tamibarotene results in increased expression of MAP4K1 mRNA	PMID:17229644
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of MAP4K1 mRNA	PMID:27760801
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313505	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MAP4K1 mRNA	PMID:23557971
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305463	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MAP4K1 mRNA	PMID:34492290
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313505	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MAP4K1 mRNA	PMID:20059764|PMID:23811191
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MAP4K1 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of MAP4K1 mRNA]	PMID:19710929|PMID:20059764
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305463	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MAP4K1 mRNA	PMID:25181051
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MAP4K1 mRNA	PMID:25979313
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313505	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MAP4K1 gene	PMID:31683443
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313505	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of MAP4K1 mRNA	PMID:28392331
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305463	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of MAP4K1 mRNA	PMID:30589522
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305463	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of MAP4K1 mRNA	PMID:35163327
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313505	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MAP4K1 mRNA	PMID:24982889
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MAP4K1 mRNA	PMID:25812627
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MAP4K1 mRNA	PMID:24449571
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MAP4K1 mRNA	PMID:25812627
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313505	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MAP4K1 mRNA	PMID:40194260
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MAP4K1 mRNA	PMID:31533062
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MAP4K1 mRNA	PMID:25812627
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of MAP4K1 mRNA	PMID:29038090
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MAP4K1 mRNA	PMID:25979313
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in increased expression of MAP4K1 mRNA	PMID:37505509
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MAP4K1 gene	PMID:29154799
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of MAP4K1 mRNA	PMID:21041162
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of MAP4K1 mRNA	PMID:14648872
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305463	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MAP4K1 mRNA	PMID:33387578
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of MAP4K1 mRNA	PMID:17331233
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP4K1 mRNA	PMID:40504410
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of MAP4K1 mRNA	PMID:35436446
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of MAP4K1 mRNA	PMID:17720352
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA	PMID:34876320
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MAP4K1 mRNA	PMID:17942748
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP4K1 mRNA	PMID:17942748
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of MAP4K1 mRNA	PMID:23300844
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313505	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of MAP4K1 mRNA	PMID:25554681
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of MAP4K1 mRNA	PMID:25554681
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MAP4K1 mRNA	PMID:35964746
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313505	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MAP4K1 mRNA	PMID:38701926
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of MAP4K1 mRNA	PMID:19812364
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in decreased expression of MAP4K1 mRNA	PMID:16982809
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1305463	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of MAP4K1 mRNA	PMID:28954212
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305463	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of MAP4K1 mRNA	PMID:35283115
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313505	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MAP4K1 mRNA	PMID:22206623
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MAP4K1 mRNA	PMID:37199045
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MAP4K1 mRNA	PMID:36139627
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP4K1 mRNA	PMID:27188386
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MAP4K1 gene]	PMID:28238834
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of MAP4K1 mRNA	PMID:39847705
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313505	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MAP4K1 mRNA	PMID:34876320
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313505	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of MAP4K1 mRNA	PMID:40826991
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAP4K1 mRNA	PMID:27188386
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313505	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of MAP4K1 mRNA	PMID:27131904
1313504	MAP4K1	mitogen-activated protein kinase kinase kinase kinase 1	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MAP4K1 mRNA	PMID:27188386
1313507	FBXO10	F-box protein 10	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313508	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FBXO10 mRNA	PMID:30319688
1313507	FBXO10	F-box protein 10	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of FBXO10 mRNA	PMID:21632981
1313507	FBXO10	F-box protein 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305465	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of FBXO10 mRNA	PMID:32145629
1313507	FBXO10	F-box protein 10	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	Estradiol results in increased expression of FBXO10 mRNA	PMID:30165855|PMID:31614463
1313507	FBXO10	F-box protein 10	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305465	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of FBXO10 mRNA	PMID:20068009
1313507	FBXO10	F-box protein 10	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of FBXO10 mRNA	PMID:39613055
1313507	FBXO10	F-box protein 10	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313508	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXO10 mRNA	PMID:37992649
1313507	FBXO10	F-box protein 10	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of FBXO10 mRNA	PMID:39613055
1313507	FBXO10	F-box protein 10	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313508	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXO10 mRNA	PMID:37992649
1313507	FBXO10	F-box protein 10	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305465	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of FBXO10 mRNA	PMID:26577399
1313507	FBXO10	F-box protein 10	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of FBXO10 protein	PMID:37730182
1313507	FBXO10	F-box protein 10	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305465	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of FBXO10 mRNA	PMID:22061828
1313507	FBXO10	F-box protein 10	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FBXO10 mRNA	PMID:39836092
1313507	FBXO10	F-box protein 10	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313508	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of FBXO10 mRNA	PMID:31626304
1313507	FBXO10	F-box protein 10	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO10 mRNA	PMID:39836092
1313507	FBXO10	F-box protein 10	gene	CHEBI:28009	N-acetyl-beta-D-glucosamine	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in increased expression of FBXO10 mRNA	PMID:18047607
1313507	FBXO10	F-box protein 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305465	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXO10 mRNA	PMID:22298810
1313507	FBXO10	F-box protein 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305465	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBXO10 mRNA	PMID:33387578
1313507	FBXO10	F-box protein 10	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FBXO10 mRNA	PMID:33212167
1313507	FBXO10	F-box protein 10	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBXO10 mRNA	PMID:30851411
1313507	FBXO10	F-box protein 10	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FBXO10 mRNA	PMID:29803840
1313507	FBXO10	F-box protein 10	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313508	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXO10 mRNA	PMID:37992649
1313507	FBXO10	F-box protein 10	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXO10 mRNA	PMID:38568856
1313507	FBXO10	F-box protein 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO10 mRNA	PMID:39836092
1313507	FBXO10	F-box protein 10	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBXO10 5' UTR	PMID:27901495
1313507	FBXO10	F-box protein 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FBXO10 promoter	PMID:27901495
1313507	FBXO10	F-box protein 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313508	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FBXO10 exon; Benzo(a)pyrene results in decreased methylation of FBXO10 intron	PMID:27901495
1313507	FBXO10	F-box protein 10	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305465	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FBXO10 mRNA	PMID:34492290
1313507	FBXO10	F-box protein 10	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313508	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of FBXO10 mRNA	PMID:18301758
1313507	FBXO10	F-box protein 10	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305465	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of FBXO10 mRNA	PMID:30816183
1313507	FBXO10	F-box protein 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305465	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXO10 mRNA	PMID:32145629
1313507	FBXO10	F-box protein 10	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FBXO10 gene	PMID:31601247
1313507	FBXO10	F-box protein 10	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305465	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXO10 mRNA	PMID:36041667
1313507	FBXO10	F-box protein 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305465	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXO10 mRNA	PMID:36041667
1313507	FBXO10	F-box protein 10	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305465	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXO10 mRNA	PMID:36041667
1313507	FBXO10	F-box protein 10	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305465	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of FBXO10 mRNA	PMID:32680482
1313507	FBXO10	F-box protein 10	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FBXO10 mRNA	PMID:39836092
1313507	FBXO10	F-box protein 10	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of FBXO10 mRNA	PMID:39613055
1313507	FBXO10	F-box protein 10	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313508	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXO10 mRNA	PMID:37992649
1313507	FBXO10	F-box protein 10	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305465	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXO10 mRNA	PMID:33387578
1313507	FBXO10	F-box protein 10	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO10 mRNA	PMID:39836092
1313507	FBXO10	F-box protein 10	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305465	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of FBXO10 mRNA	PMID:29391264
1313507	FBXO10	F-box protein 10	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305465	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of FBXO10 mRNA	PMID:30307764
1313507	FBXO10	F-box protein 10	gene	CHEBI:506227	N-acetyl-D-glucosamine	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in increased expression of FBXO10 mRNA	PMID:18047607
1313507	FBXO10	F-box protein 10	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of FBXO10 mRNA	PMID:39836092
1313507	FBXO10	F-box protein 10	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305465	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FBXO10 gene	PMID:35440735
1313507	FBXO10	F-box protein 10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1305465	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of FBXO10 mRNA	PMID:27840820
1313507	FBXO10	F-box protein 10	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1313508	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of FBXO10 mRNA	PMID:25566086
1313507	FBXO10	F-box protein 10	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1313508	E	RGD:6480464	20160315	CTD	MESH:C072553	MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of FBXO10 mRNA]	PMID:25566086
1313507	FBXO10	F-box protein 10	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBXO10 mRNA	PMID:30851411
1313507	FBXO10	F-box protein 10	gene	CHEBI:78492	diallyl trisulfide	increases expression	ISO	RGD:1305465	E	RGD:6480464	20240604	CTD	MESH:C042577	diallyl trisulfide results in increased expression of FBXO10 mRNA	PMID:34014027
1313507	FBXO10	F-box protein 10	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305465	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of FBXO10 mRNA	PMID:24780913
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PRPF8 mRNA	PMID:38218311
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PRPF8 mRNA	PMID:33045310
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of PRPF8 mRNA]	PMID:19467301
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PRPF8 mRNA	PMID:26251327
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PRPF8 gene	PMID:20938992
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in increased expression of PRPF8 mRNA	PMID:15894607
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in increased expression of PRPF8 mRNA	PMID:15894607
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313511	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PRPF8 mRNA	PMID:30319688
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PRPF8 mRNA	PMID:39298647
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305467	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PRPF8 mRNA	PMID:33387578
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PRPF8 gene	PMID:20938992
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PRPF8 mRNA	PMID:37042841
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of PRPF8 mRNA	PMID:19162166
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PRPF8 mRNA	PMID:21179406
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PRPF8 mRNA	PMID:33754040
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313511	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PRPF8 mRNA	PMID:34319233
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20241001	CTD	MESH:D004051	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of PRPF8 protein	PMID:38995844
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305467	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PRPF8 mRNA	PMID:22061828
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PRPF8 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of PRPF8 mRNA	PMID:39836092
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PRPF8 gene	PMID:20938992
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20210504	CTD	MESH:D001151	Arsenic affects the methylation of PRPF8 gene	PMID:32603190
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PRPF8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PRPF8 mRNA	PMID:39836092
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of PRPF8 mRNA	PMID:19244175
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1305467	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of PRPF8 mRNA	PMID:26302742
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of PRPF8 protein	PMID:25505154
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of PRPF8 mRNA	PMID:27594783
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PRPF8 mRNA	PMID:30912803
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of PRPF8 mRNA	PMID:16705744
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313511	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRPF8 mRNA	PMID:21570461
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305467	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PRPF8 mRNA	PMID:33387578
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313511	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRPF8 mRNA	PMID:19770486
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRPF8 mRNA	PMID:17942748
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PRPF8 mRNA	PMID:38568856
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313511	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of PRPF8 mRNA	PMID:36209798
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PRPF8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PRPF8 mRNA	PMID:39836092
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313511	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of PRPF8 mRNA	PMID:22342234
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313511	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PRPF8 mRNA	PMID:22228805
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PRPF8 mRNA]	PMID:32406909
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PRPF8 mRNA	PMID:15894607
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313511	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PRPF8 promoter	PMID:35295148
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of PRPF8 gene	PMID:23968726
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of PRPF8 protein	PMID:31675489
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PRPF8 mRNA; bisphenol A results in increased expression of PRPF8 protein	PMID:33670352|PMID:34186270
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305467	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PRPF8 mRNA	PMID:25181051|PMID:41034487
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313511	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of PRPF8 mRNA	PMID:40036665
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305467	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRPF8 mRNA	PMID:36041667
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1305467	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of PRPF8 mRNA	PMID:24096037
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1313511	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of PRPF8 mRNA	PMID:24096037
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PRPF8 mRNA	PMID:39298647
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305467	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRPF8 mRNA	PMID:36041667
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRPF8 mRNA	PMID:28628672
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305467	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRPF8 mRNA	PMID:36041667
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PRPF8 protein	PMID:34186270
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PRPF8 mRNA	PMID:28392331
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20241001	CTD	MESH:C027561	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of PRPF8 protein	PMID:38995844
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PRPF8 mRNA	PMID:37019170
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34687	dibutyl phthalate	affects expression	ISO	RGD:1305467	E	RGD:6480464	20190910	CTD	MESH:D003993	Dibutyl Phthalate affects the expression of PRPF8 mRNA	PMID:30934153
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20241001	CTD	MESH:D003993	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate] affects the expression of PRPF8 protein	PMID:38995844
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRPF8 mRNA	PMID:28628672
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of PRPF8 gene	PMID:23968726
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PRPF8 mRNA	PMID:37042841
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PRPF8 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of PRPF8 mRNA	PMID:39836092
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PRPF8 mRNA	PMID:38382870
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of PRPF8 mRNA	PMID:19244175
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:38221	fumonisin B1	decreases expression	ISO	RGD:1313511	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 results in decreased expression of PRPF8 mRNA	PMID:16221962
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PRPF8 mRNA	PMID:28302478
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PRPF8 mRNA	PMID:36331819
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313511	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PRPF8 mRNA	PMID:17555576
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRPF8 mRNA	PMID:28628672
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305467	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRPF8 mRNA	PMID:33387578
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of PRPF8 mRNA	PMID:29523930
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20210504	CTD	MESH:D001151	Arsenic affects the methylation of PRPF8 gene	PMID:32603190
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PRPF8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PRPF8 mRNA	PMID:39836092
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of PRPF8 mRNA	PMID:18175754
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313511	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PRPF8 mRNA	PMID:17555576
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305467	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PRPF8 mRNA	PMID:17108234|PMID:24096037
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313511	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PRPF8 mRNA	PMID:17942748|PMID:24096037
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRPF8 mRNA	PMID:17942748
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRPF8 mRNA	PMID:28628672
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of PRPF8 mRNA	PMID:15894607
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313511	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PRPF8 mRNA	PMID:35964746
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313511	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PRPF8 mRNA	PMID:19042947
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PRPF8 protein	PMID:32959892
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PRPF8 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of PRPF8 mRNA	PMID:39836092
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:63630	tolcapone	affects binding	ISO	RGD:1305467	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to PRPF8 protein	PMID:19783845
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313511	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PRPF8 protein	PMID:26558463
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305467	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of PRPF8 mRNA	PMID:30467583
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313511	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of PRPF8 mRNA	PMID:27462272
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PRPF8 mRNA	PMID:31758290
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PRPF8 protein	PMID:34186270
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313511	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PRPF8 mRNA	PMID:22206623
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of PRPF8 mRNA	PMID:36318118
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PRPF8 protein	PMID:31285264
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313511	E	RGD:6480464	20200519	CTD	MESH:D010634	Phenobarbital results in increased expression of PRPF8 mRNA	PMID:31836555
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PRPF8 protein	PMID:31675489
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:9130	sevoflurane	increases expression	ISO	RGD:1313511	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased expression of PRPF8 protein	PMID:35249202
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PRPF8 mRNA	PMID:38568856
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313511	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of PRPF8 protein	PMID:24648495
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305467	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of PRPF8 mRNA	PMID:23555832
1313510	PRPF8	pre-mRNA processing factor 8	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305467	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PRPF8 mRNA	PMID:23034163
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ALG8 mRNA	PMID:38218311
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313513	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ALG8 mRNA	PMID:33045310
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ALG8 mRNA	PMID:33167477
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of ALG8 mRNA	PMID:30951980
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313513	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ALG8 mRNA	PMID:39241906
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ALG8 mRNA	PMID:37042841
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ALG8 mRNA	PMID:21179406
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ALG8 mRNA	PMID:33359661
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305468	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ALG8 mRNA	PMID:33387578
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ALG8 mRNA	PMID:28818685
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ALG8 mRNA	PMID:36331819
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ALG8 mRNA	PMID:19549813
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ALG8 mRNA	PMID:35430440
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ALG8 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ALG8 mRNA	PMID:34911549
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305468	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of ALG8 mRNA	PMID:31129395
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313513	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ALG8 mRNA	PMID:31919559
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of ALG8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ALG8 mRNA	PMID:40512198
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALG8 mRNA	PMID:40504410
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313513	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of ALG8 mRNA	PMID:28189721|PMID:28960355
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313513	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ALG8 protein	PMID:25505154
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of ALG8 mRNA	PMID:19921347
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1305468	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of ALG8 gene	PMID:28505145
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313513	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ALG8 mRNA	PMID:21570461
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305468	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALG8 mRNA	PMID:33387578
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ALG8 mRNA	PMID:25975270
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of ALG8 mRNA	PMID:33512557
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ALG8 mRNA	PMID:29803840
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ALG8 mRNA	PMID:38568856|PMID:39719251
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of ALG8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ALG8 mRNA	PMID:40512198
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALG8 mRNA	PMID:40504410
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305468	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ALG8 mRNA	PMID:30047161
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313513	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ALG8 mRNA	PMID:32156529
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305468	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ALG8 mRNA	PMID:25181051
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305468	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of ALG8 gene; [bisphenol A co-treated with tributyltin] results in increased expression of ALG8 mRNA	PMID:28505145|PMID:31129395
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of ALG8 mRNA	PMID:30951980
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305468	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ALG8 mRNA	PMID:21266533
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ALG8 mRNA	PMID:37042841
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ALG8 mRNA	PMID:19376846
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313513	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ALG8 mRNA	PMID:40194260
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of ALG8 mRNA	PMID:33512557
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ALG8 mRNA	PMID:28302478
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ALG8 mRNA	PMID:19167446
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG8 mRNA	PMID:19167446
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ALG8 mRNA	PMID:36331819
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ALG8 mRNA	PMID:25979313
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313513	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ALG8 mRNA	PMID:17292431
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305468	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ALG8 mRNA	PMID:30047161
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ALG8 mRNA	PMID:20106945|PMID:25562108
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:45863	paclitaxel	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	ALG8 protein affects the susceptibility to Paclitaxel	PMID:16217747
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of ALG8 mRNA	PMID:26690555|PMID:29067470
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305468	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ALG8 mRNA	PMID:33387578
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of ALG8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ALG8 mRNA	PMID:40512198
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313513	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALG8 mRNA	PMID:40504410
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ALG8 mRNA	PMID:22079256
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313513	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ALG8 mRNA; Nanotubes, Carbon results in increased expression of ALG8 mRNA	PMID:25554681
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305468	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ALG8 mRNA	PMID:24793618
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ALG8 protein	PMID:32959892
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313513	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ALG8 mRNA	PMID:22206623
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ALG8 mRNA	PMID:22079256
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ALG8 mRNA	PMID:22079256
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of ALG8 mRNA	PMID:18548127
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ALG8 mRNA	PMID:19159669
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313513	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ALG8 mRNA	PMID:23091169
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ALG8 mRNA	PMID:19167446
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313513	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ALG8 mRNA	PMID:30294300
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of ALG8 mRNA	PMID:33512557
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1305468	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of ALG8 mRNA	PMID:30047161
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305468	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ALG8 mRNA	PMID:30047161
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ALG8 mRNA	PMID:38568856
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ALG8 mRNA	PMID:29301935
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305468	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ALG8 mRNA	PMID:21346803
1313512	ALG8	ALG8 alpha-1,3-glucosyltransferase	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305468	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ALG8 mRNA	PMID:23034163
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RNF19B mRNA	PMID:38218311
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1615038	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RNF19B mRNA	PMID:33045310
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RNF19B mRNA	PMID:33167477
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of RNF19B mRNA	PMID:24763279
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of RNF19B mRNA	PMID:26079696
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of RNF19B mRNA	PMID:22378314
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1615038	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RNF19B mRNA	PMID:30319688
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RNF19B mRNA	PMID:21632981
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNF19B mRNA	PMID:39241906
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RNF19B mRNA	PMID:35811015
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNF19B mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RNF19B mRNA	PMID:35811015
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RNF19B mRNA	PMID:39298647
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of RNF19B mRNA	PMID:20106945
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RNF19B mRNA	PMID:37042841
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:16708	adenine	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D000225	Adenine results in decreased expression of RNF19B mRNA	PMID:24211769
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of RNF19B mRNA	PMID:23649840
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of RNF19B mRNA	PMID:33647349
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305470	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RNF19B mRNA	PMID:27523638
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305470	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RNF19B mRNA	PMID:33387578
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RNF19B mRNA	PMID:28818685
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF19B mRNA	PMID:39836092
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002104	Cadmium results in increased expression of RNF19B mRNA	PMID:16439709
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RNF19B mRNA	PMID:19549813
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RNF19B mRNA	PMID:23649840
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RNF19B mRNA	PMID:27153756
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RNF19B mRNA	PMID:23649840
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RNF19B mRNA	PMID:41430723
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1615038	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of RNF19B mRNA	PMID:17484886
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1615038	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RNF19B mRNA	PMID:31919559
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF19B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RNF19B mRNA	PMID:39836092
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RNF19B mRNA	PMID:40504410
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of RNF19B mRNA	PMID:38460933
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RNF19B mRNA	PMID:28960355
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305470	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RNF19B mRNA	PMID:31881176
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:27882	(S)-colchicine	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D003078	Colchicine results in decreased expression of RNF19B mRNA	PMID:24211769
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RNF19B mRNA	PMID:28903495
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin results in decreased expression of RNF19B mRNA	PMID:24211769
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RNF19B mRNA	PMID:27392435|PMID:27594783
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RNF19B mRNA	PMID:23195993|PMID:25583101
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF19B mRNA	PMID:22574217
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305470	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNF19B mRNA	PMID:34747641
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNF19B mRNA	PMID:33212167
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of RNF19B mRNA	PMID:39709020
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RNF19B mRNA	PMID:30851411
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of RNF19B mRNA	PMID:23649840
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	RNF19B protein affects the susceptibility to Doxorubicin	PMID:16217747
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RNF19B mRNA	PMID:29432896
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D001379	Azathioprine results in decreased expression of RNF19B mRNA	PMID:19192274
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNF19B mRNA	PMID:38568856|PMID:39719251
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF19B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RNF19B mRNA	PMID:39836092
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RNF19B mRNA	PMID:40504410
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RNF19B mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RNF19B promoter	PMID:27901495
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RNF19B mRNA]	PMID:32406909
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of RNF19B mRNA	PMID:25075043
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of RNF19B mRNA	PMID:25895662
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1615038	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RNF19B gene; titanium dioxide results in decreased methylation of RNF19B promoter	PMID:35295148
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of RNF19B mRNA	PMID:17426115|PMID:18445702|PMID:21318169|PMID:23811191
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of RNF19B mRNA]	PMID:21318169
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of RNF19B mRNA	PMID:19191707
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1615038	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RNF19B mRNA	PMID:28472532
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of RNF19B mRNA	PMID:38479592
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of RNF19B mRNA	PMID:28329830
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305470	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF19B mRNA	PMID:25181051
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305470	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF19B gene	PMID:28505145
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305470	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RNF19B mRNA	PMID:36041667
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RNF19B mRNA	PMID:39298647
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of RNF19B gene	PMID:31601247
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305470	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RNF19B mRNA	PMID:36041667
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1615038	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RNF19B mRNA	PMID:38685157
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305470	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RNF19B mRNA	PMID:36041667
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305470	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RNF19B mRNA	PMID:21266533
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305470	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of RNF19B mRNA	PMID:32680482
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RNF19B mRNA	PMID:37042841
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF19B mRNA	PMID:39836092
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RNF19B mRNA	PMID:38568856
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of RNF19B mRNA	PMID:19376846
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1615038	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RNF19B mRNA	PMID:40194260
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RNF19B mRNA	PMID:31533062
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1615038	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of RNF19B mRNA	PMID:39529242
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RNF19B mRNA	PMID:25979313
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RNF19B gene	PMID:29154799
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RNF19B mRNA	PMID:20106945|PMID:25562108
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of RNF19B mRNA	PMID:28973697
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of RNF19B mRNA	PMID:23649840
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in decreased expression of RNF19B mRNA	PMID:19192274
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RNF19B mRNA	PMID:38832940
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RNF19B mRNA	PMID:28542535
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1615038	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RNF19B mRNA	PMID:17562736
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RNF19B mRNA	PMID:21420995|PMID:22230336|PMID:29067470
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305470	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RNF19B mRNA	PMID:33387578
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RNF19B mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RNF19B mRNA	PMID:35811015
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of RNF19B mRNA	PMID:24160326
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:46680	serpentine asbestos	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine affects the expression of RNF19B mRNA	PMID:24160326
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of RNF19B mRNA	PMID:38460933
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF19B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RNF19B mRNA	PMID:39836092
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RNF19B mRNA	PMID:40504410
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:47381	diclofenac	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D004008	Diclofenac results in decreased expression of RNF19B mRNA	PMID:19192274
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of RNF19B mRNA	PMID:35436446
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:50035	alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of RNF19B mRNA	PMID:25075043
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:50161	motexafin gadolinium	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of RNF19B mRNA	PMID:15867382
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of RNF19B mRNA	PMID:25620056
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1615038	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RNF19B mRNA; Nanotubes, Carbon results in increased expression of RNF19B mRNA	PMID:25554681
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RNF19B mRNA	PMID:35964746
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of RNF19B mRNA	PMID:31629900
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:5516	sodium aurothiomalate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D006052	Gold Sodium Thiomalate results in decreased expression of RNF19B mRNA	PMID:19192274
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1615038	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RNF19B mRNA	PMID:38701926
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RNF19B mRNA	PMID:39836092
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1615038	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RNF19B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF19B mRNA	PMID:21641980|PMID:26378955
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:6888	6alpha-methylprednisolone	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008775	Methylprednisolone results in decreased expression of RNF19B mRNA	PMID:19192274
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1615038	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of RNF19B mRNA	PMID:22206623
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RNF19B mRNA	PMID:30851411
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RNF19B gene]	PMID:28238834
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of RNF19B mRNA	PMID:19159669
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1615038	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of RNF19B mRNA	PMID:23091169
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1615038	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of RNF19B mRNA	PMID:19270015
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D010894	Piroxicam results in decreased expression of RNF19B mRNA	PMID:19192274
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:8378	prednisolone	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D011239	Prednisolone results in decreased expression of RNF19B mRNA	PMID:19192274
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305470	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RNF19B mRNA	PMID:24780913
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1615038	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RNF19B mRNA	PMID:40826991
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RNF19B mRNA	PMID:38568856
1313515	RNF19B	ring finger protein 19B	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of RNF19B mRNA	PMID:29301935
1313517	ATF6	activating transcription factor 6	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of ATF6 mRNA	PMID:20682335|PMID:22846391
1313517	ATF6	activating transcription factor 6	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313518	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of ATF6 protein	PMID:19336499
1313517	ATF6	activating transcription factor 6	gene	CHEBI:10022	deoxynivalenol	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20141111	CTD	MESH:C007262	ATF6 protein affects the reaction [deoxynivalenol results in increased expression of IL6 mRNA]	PMID:19336499
1313517	ATF6	activating transcription factor 6	gene	CHEBI:113532	thymoquinone	increases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:C003466	thymoquinone results in increased expression of ATF6 mRNA; thymoquinone results in increased expression of ATF6 protein	PMID:29981725
1313517	ATF6	activating transcription factor 6	gene	CHEBI:131923	salubrinal	increases expression	ISO	RGD:1313518	E	RGD:6480464	20170303	CTD	MESH:C496827	salubrinal results in increased expression of ATF6 mRNA	PMID:23958496
1313517	ATF6	activating transcription factor 6	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF6 mRNA]	PMID:31150632
1313517	ATF6	activating transcription factor 6	gene	CHEBI:134990	agomelatine	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220111	CTD	MESH:C084711	agomelatine inhibits the reaction [Dietary Fats results in increased expression of ATF6 protein]	PMID:34081941
1313517	ATF6	activating transcription factor 6	gene	CHEBI:135285	vildagliptin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220111	CTD	MESH:C502012	Vildagliptin inhibits the reaction [Dietary Fats results in increased expression of ATF6 protein]	PMID:34081941
1313517	ATF6	activating transcription factor 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313518	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ATF6 mRNA	PMID:20188158
1313517	ATF6	activating transcription factor 6	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	EXP		E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of ATF6 mRNA	PMID:20682335
1313517	ATF6	activating transcription factor 6	gene	CHEBI:146195	3-acetyldeoxynivalenol	increases expression	EXP		E	RGD:6480464	20200303	CTD	MESH:C043247	3-acetyldeoxynivalenol results in increased expression of ATF6 mRNA	PMID:20682335
1313517	ATF6	activating transcription factor 6	gene	CHEBI:146195	3-acetyldeoxynivalenol	increases expression	ISO	RGD:1313518	E	RGD:6480464	20221206	CTD	MESH:C043247	3-acetyldeoxynivalenol results in increased expression of ATF6 mRNA	PMID:35413383
1313517	ATF6	activating transcription factor 6	gene	CHEBI:146195	3-acetyldeoxynivalenol	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20221206	CTD	MESH:C043247	4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ATF6 mRNA]	PMID:35413383
1313517	ATF6	activating transcription factor 6	gene	CHEBI:146245	SR 144528	multiple interactions	EXP		E	RGD:6480464	20200407	CTD	MESH:C110630	[Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of ATF6 mRNA]	PMID:31054322
1313517	ATF6	activating transcription factor 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of ATF6 mRNA; Tretinoin results in increased expression of ATF6 protein	PMID:19960509|PMID:21934132
1313517	ATF6	activating transcription factor 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313518	E	RGD:6480464	20121009	CTD	MESH:D014212	Tretinoin results in increased expression of ATF6 mRNA; Tretinoin results in increased expression of ATF6 protein	PMID:22498432
1313517	ATF6	activating transcription factor 6	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313518	E	RGD:6480464	20150310	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ATF6 protein; Oxygen results in increased expression of ATF6 protein	PMID:24680926|PMID:32996202
1313517	ATF6	activating transcription factor 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20210406	CTD	MESH:D010100	1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone inhibits the reaction [Oxygen results in increased expression of ATF6 protein]; 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone inhibits the reaction [Oxygen results in increased expression of ATF6 protein]]	PMID:32996202
1313517	ATF6	activating transcription factor 6	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of ATF6 mRNA	PMID:24763279
1313517	ATF6	activating transcription factor 6	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1313518	E	RGD:6480464	20230404	CTD	MESH:D019308	Palmitic Acid results in increased expression of ATF6 mRNA	PMID:36030031
1313517	ATF6	activating transcription factor 6	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D019308	3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of ATF6 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of ATF6 mRNA	PMID:32369900
1313517	ATF6	activating transcription factor 6	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230404	CTD	MESH:D019308	[4-phenylbutyric acid co-treated with Palmitic Acid] results in decreased expression of ATF6 protein; [Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein; gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein]	PMID:36030031|PMID:39701215
1313517	ATF6	activating transcription factor 6	gene	CHEBI:15864	luteolin	multiple interactions	EXP		E	RGD:6480464	20201103	CTD	MESH:D047311	Luteolin inhibits the reaction [Thapsigargin results in increased expression of ATF6 protein modified form]; Luteolin inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein modified form]	PMID:32407927
1313517	ATF6	activating transcription factor 6	gene	CHEBI:15866	2-deoxy-D-glucose	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D003847	Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]]	PMID:39798073
1313517	ATF6	activating transcription factor 6	gene	CHEBI:15930	atrazine	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20231205	CTD	MESH:D001280	Atrazine results in increased cleavage of ATF6 protein	PMID:25259610
1313517	ATF6	activating transcription factor 6	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20231205	CTD	MESH:D001280	Melatonin inhibits the reaction [Atrazine results in increased cleavage of ATF6 protein]	PMID:25259610
1313517	ATF6	activating transcription factor 6	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20201006	CTD	MESH:C015329	Lycopene inhibits the reaction [Oxaliplatin results in increased expression of ATF6 mRNA]	PMID:32544411
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16015	L-glutamic acid	increases expression	ISO	RGD:1305471	E	RGD:6480464	20230801	CTD	MESH:D018698	Glutamic Acid results in increased expression of ATF6 protein	PMID:35028790
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16015	L-glutamic acid	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220906	CTD	MESH:D018698	shikonin inhibits the reaction [Glutamic Acid results in increased expression of ATF6 protein]	PMID:35028790
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16112	chlorogenic acid	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220510	CTD	MESH:D002726	Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]; Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]	PMID:34801538
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16196	oleic acid	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D019301	3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in increased expression of ATF6 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in increased expression of ATF6 mRNA	PMID:32369900
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16196	oleic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20220208	CTD	MESH:D019301	Oleic Acid inhibits the reaction [[Palmitates co-treated with bisphenol A] results in increased expression of ATF6 mRNA]	PMID:32976987
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16236	ethanol	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20180313	CTD	MESH:D000431	Ethanol results in increased cleavage of ATF6 protein	PMID:28119953
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1305471	E	RGD:6480464	20140513	CTD	MESH:D000431	Ethanol results in increased expression of ATF6 protein	PMID:24146112
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313518	E	RGD:6480464	20140513	CTD	MESH:D000431	Ethanol results in increased expression of ATF6 protein	PMID:24146112
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20140513	CTD	MESH:D000431	dioscin inhibits the reaction [Ethanol results in increased expression of ATF6 protein]	PMID:24146112
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20140513	CTD	MESH:D000431	dioscin inhibits the reaction [Ethanol results in increased expression of ATF6 protein]	PMID:24146112
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D011794	Quercetin results in increased expression of ATF6 protein	PMID:30152185
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20210406	CTD	MESH:D011794	Quercetin inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]; Quercetin inhibits the reaction [Cadmium results in increased expression of ATF6 protein]; Quercetin inhibits the reaction [cypermethrin results in increased expression of ATF6 mRNA]; Quercetin inhibits the reaction [Vincristine results in increased expression of ATF6 mRNA]	PMID:33038355|PMID:35714484|PMID:35876585
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16412	lipopolysaccharide	increases cleavage	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased cleavage of ATF6 protein	PMID:19675143
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATF6 protein	PMID:28245985|PMID:30918470
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATF6 mRNA	PMID:39241906
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20170613	CTD	MESH:D008070	4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of ATF6 protein]; ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in increased expression of ATF6 protein]	PMID:28245985|PMID:30918470
1313517	ATF6	activating transcription factor 6	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D014260	Triclosan results in decreased expression of ATF6 mRNA	PMID:34681664
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ATF6 mRNA	PMID:26496021
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16494	lipoic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20140211	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of ATF6 mRNA]	PMID:23892647
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16598	DDE	increases activity	EXP		E	RGD:6480464	20170207	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased activity of ATF6 protein	PMID:27589886
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305471	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ATF6 mRNA	PMID:33387578|PMID:36396003
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305471	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ATF6 gene	PMID:27618143
1313517	ATF6	activating transcription factor 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATF6 mRNA	PMID:37042841
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16738	2,4-dichlorophenol	increases expression	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:C004762	2,4-dichlorophenol results in increased expression of ATF6 mRNA; 2,4-dichlorophenol results in increased expression of ATF6 protein	PMID:25160872
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D002635	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20120412	CTD	MESH:D008550	Melatonin inhibits the reaction [Methamphetamine results in increased expression of ATF6 protein]; Melatonin inhibits the reaction [sodium arsenite results in increased activity of ATF6 protein]	PMID:18715270|PMID:28070110
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20231205	CTD	MESH:D008550	Melatonin inhibits the reaction [Atrazine results in increased cleavage of ATF6 protein]; Melatonin inhibits the reaction [bisphenol A results in increased expression of ATF6 protein]	PMID:25259610|PMID:38538260
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16856	glutathione	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:D005978	SOD1 gene mutant form inhibits the reaction [Glutathione results in increased expression of ATF6 protein modified form]	PMID:27349771
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16990	bilirubin IXalpha	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D001663	Bilirubin results in increased expression of ATF6 mRNA	PMID:27578021
1313517	ATF6	activating transcription factor 6	gene	CHEBI:16990	bilirubin IXalpha	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:D001663	4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of ATF6 mRNA]	PMID:27578021
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17115	L-serine	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D012694	Serine results in increased expression of ATF6 mRNA	PMID:29098664
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D005947	Glucose deficiency results in increased expression of ATF6 protein; Glucose results in increased expression of ATF6 mRNA; Glucose results in increased expression of ATF6 protein	PMID:31022492|PMID:39798073
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D005947	4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF6 protein]; ATF6 protein modified form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]	PMID:31022492|PMID:39798073
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220510	CTD	MESH:D005947	Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; Glucose results in increased expression of and affects the localization of ATF6 protein; Metformin inhibits the reaction [Glucose results in increased expression of and affects the localization of ATF6 protein]	PMID:34801538
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20260303	CTD	MESH:D005947	3-(indol-3-yl)propionic acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; [Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein; gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein]	PMID:39701215|PMID:40628365
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of ATF6 mRNA	PMID:17945193
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313518	E	RGD:6480464	20240305	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein	PMID:37692514
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20240305	CTD	MESH:C016599	4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]	PMID:37692514
1313517	ATF6	activating transcription factor 6	gene	CHEBI:173086	ferrostatin-1	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230704	CTD	MESH:C573944	ferrostatin-1 inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]	PMID:37075931
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of ATF6 mRNA	PMID:17178593
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:19383982|PMID:20165829|PMID:33812996
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1305471	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:20165829
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1313518	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 protein	PMID:30602124
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829|PMID:33812996
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20260203	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17315	D-glucosamine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20260203	CTD	MESH:D005944	ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]	PMID:30602124
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17447	geraniol	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of ATF6 mRNA	PMID:27683099
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17447	geraniol	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:C007836	geraniol inhibits the reaction [Rotenone results in increased expression of ATF6 protein]	PMID:30141137
1313517	ATF6	activating transcription factor 6	gene	CHEBI:174748	C.I. Natural Red 20	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220906	CTD	MESH:C016101	shikonin inhibits the reaction [Glutamic Acid results in increased expression of ATF6 protein]	PMID:35028790
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17515	L-gamma-glutamyl-L-cysteine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20260407	CTD	MESH:C017341	gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein]	PMID:39701215
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17573	glycyrrhetinate	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20230307	CTD	MESH:C119129	18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of ATF6 mRNA]	PMID:35699857
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C031927	hydroquinone results in decreased expression of ATF6 mRNA; hydroquinone results in decreased expression of ATF6 protein	PMID:37148176
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C031927	hydroquinone results in increased expression of ATF6 protein	PMID:36646296
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17594	hydroquinone	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:C031927	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of ATF6 protein]; [Sirolimus co-treated with hydroquinone] results in decreased expression of ATF6 protein; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; ATF6 protein affects the reaction [hydroquinone results in decreased phosphorylation of MTOR protein]; ATF6 protein affects the reaction [hydroquinone results in increased expression of BAX protein]; ATF6 protein affects the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]	PMID:36646296|PMID:37148176
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D005947	Glucose deficiency results in increased expression of ATF6 protein; Glucose results in increased expression of ATF6 mRNA; Glucose results in increased expression of ATF6 protein	PMID:31022492|PMID:39798073
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D005947	4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF6 protein]; ATF6 protein modified form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]	PMID:31022492|PMID:39798073
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220510	CTD	MESH:D005947	Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; Glucose results in increased expression of and affects the localization of ATF6 protein; Metformin inhibits the reaction [Glucose results in increased expression of and affects the localization of ATF6 protein]	PMID:34801538
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20260303	CTD	MESH:D005947	3-(indol-3-yl)propionic acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; [Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein; gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein]	PMID:39701215|PMID:40628365
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006000	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]	PMID:18477628
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1305471	E	RGD:6480464	20240305	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ATF6 protein	PMID:37692514
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ATF6 mRNA	PMID:34319233
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1305471	E	RGD:6480464	20150310	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ATF6 mRNA	PMID:21673306|PMID:25280772
1313517	ATF6	activating transcription factor 6	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of ATF6 protein	PMID:37730182
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ATF6 mRNA	PMID:16002434
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:D002117	[salinomycin co-treated with Calcitriol] results in increased expression of ATF6 mRNA	PMID:35914560
1313517	ATF6	activating transcription factor 6	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305471	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATF6 mRNA	PMID:33387578
1313517	ATF6	activating transcription factor 6	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of ATF6 mRNA	PMID:37748715
1313517	ATF6	activating transcription factor 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATF6 mRNA	PMID:36331819
1313517	ATF6	activating transcription factor 6	gene	CHEBI:18291	manganese atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of ATF6 mRNA	PMID:17175027
1313517	ATF6	activating transcription factor 6	gene	CHEBI:18388	apigenin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:D047310	Apigenin inhibits the reaction [Brefeldin A results in increased cleavage of ATF6 protein]; Apigenin inhibits the reaction [Thapsigargin results in increased cleavage of ATF6 protein]	PMID:20493918
1313517	ATF6	activating transcription factor 6	gene	CHEBI:18721	3-chloropropane-1,2-diol	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D000517	[4-phenylbutyric acid co-treated with alpha-Chlorohydrin] results in decreased expression of ATF6 protein	PMID:33651226
1313517	ATF6	activating transcription factor 6	gene	CHEBI:18721	3-chloropropane-1,2-diol	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20210706	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of and affects the cleavage of ATF6 protein	PMID:33651226
1313517	ATF6	activating transcription factor 6	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]	PMID:18477628
1313517	ATF6	activating transcription factor 6	gene	CHEBI:193416	Pendulone	increases cleavage	EXP		E	RGD:6480464	20221018	CTD	MESH:C569898	pendulone results in increased cleavage of ATF6 protein	PMID:35288263
1313517	ATF6	activating transcription factor 6	gene	CHEBI:201674	icaritin	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:C499403	icaritin inhibits the reaction [Thapsigargin results in increased expression of ATF6 mRNA]	PMID:36372277
1313517	ATF6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of ATF6 mRNA	PMID:17178593
1313517	ATF6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:19383982|PMID:20165829|PMID:33812996
1313517	ATF6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1305471	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:20165829
1313517	ATF6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1313518	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 protein	PMID:30602124
1313517	ATF6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829|PMID:33812996
1313517	ATF6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829
1313517	ATF6	activating transcription factor 6	gene	CHEBI:20993	aldehydo-D-glucosamine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20190312	CTD	MESH:D005944	ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]	PMID:30602124
1313517	ATF6	activating transcription factor 6	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of ATF6 mRNA	PMID:28860664
1313517	ATF6	activating transcription factor 6	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1305471	E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in increased expression of ATF6 mRNA; Cadmium results in increased expression of ATF6 protein	PMID:35714484|PMID:37453011|PMID:37886005|PMID:38238535
1313517	ATF6	activating transcription factor 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20251007	CTD	MESH:D002104	4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein; chrysin inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]; Gallic Acid inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]; morin inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]; Quercetin inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]; Quercetin inhibits the reaction [Cadmium results in increased expression of ATF6 protein]	PMID:35714484|PMID:37453011|PMID:37886005|PMID:38001299|PMID:38238535
1313517	ATF6	activating transcription factor 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230905	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATF6 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein	PMID:37236586|PMID:37261864
1313517	ATF6	activating transcription factor 6	gene	CHEBI:232991	Perhexiline maleate	increases expression	EXP		E	RGD:6480464	20250107	CTD	MESH:C023470	perhexiline maleate results in increased expression of ATF6 mRNA	PMID:33309543
1313517	ATF6	activating transcription factor 6	gene	CHEBI:232991	Perhexiline maleate	multiple interactions	EXP		E	RGD:6480464	20250107	CTD	MESH:C023470	[perhexiline maleate results in increased abundance of Perhexiline] which results in increased expression of ATF6 mRNA; CYP2D6 protein inhibits the reaction [[perhexiline maleate results in increased abundance of Perhexiline] which results in increased expression of ATF6 mRNA]	PMID:36083301
1313517	ATF6	activating transcription factor 6	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1305471	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ATF6 mRNA	PMID:33354967
1313517	ATF6	activating transcription factor 6	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ATF6 mRNA	PMID:19770486
1313517	ATF6	activating transcription factor 6	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20170303	CTD	MESH:D017382	[arsenic trioxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased cleavage of ATF6 protein	PMID:23892647
1313517	ATF6	activating transcription factor 6	gene	CHEBI:2663	amiodarone	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20171114	CTD	MESH:D000638	Amiodarone results in increased expression of and affects the localization of ATF6 protein	PMID:28962527
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27086	tributylstannane	increases cleavage	EXP		E	RGD:6480464	20140211	CTD	MESH:C011559	tributyltin results in increased cleavage of ATF6 protein	PMID:23743301
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305471	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ATF6 mRNA; Carbon Tetrachloride results in increased expression of ATF6 protein	PMID:31150632|PMID:33779329
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313518	E	RGD:6480464	20150714	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ATF6 mRNA	PMID:25827057|PMID:31919559
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20190910	CTD	MESH:D002251	baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF6 protein]; schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF6 mRNA]	PMID:31150632|PMID:33779329
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20150714	CTD	MESH:D002251	1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF6 mRNA]	PMID:25827057
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006002	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to ATF6 promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of and results in increased cleavage of ATF6 protein; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF6 protein; AKR1C3 protein promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF6 protein]; NFE2L2 protein affects the reaction [[arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6 mRNA]	PMID:35625704|PMID:40571110
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27616	psoralen	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D005363	Ficusin results in increased expression of ATF6 mRNA; Ficusin results in increased expression of ATF6 protein	PMID:31364909
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27616	psoralen	multiple interactions	EXP		E	RGD:6480464	20230606	CTD	MESH:D005363	4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF6 protein]	PMID:31364909
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305471	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ATF6 mRNA	PMID:31881176
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27869	chloroacetic acid	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20150414	CTD	MESH:C006972	chloroacetic acid results in increased cleavage of ATF6 protein	PMID:25451595
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27869	chloroacetic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20150414	CTD	MESH:C006972	Acetylcysteine inhibits the reaction [chloroacetic acid results in increased cleavage of ATF6 protein]	PMID:25451595
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:C059514	resveratrol results in increased expression of ATF6 protein	PMID:24264887
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C059514	resveratrol inhibits the reaction [arsenic trioxide results in increased expression of ATF6 protein]	PMID:25107562
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20200609	CTD	MESH:C059514	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]	PMID:31433112
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20200211	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in increased cleavage of ATF6 protein]	PMID:31298478
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313518	E	RGD:6480464	20240604	CTD	MESH:D002945	Cisplatin results in increased expression of ATF6 protein	PMID:38688426
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20240604	CTD	MESH:D002945	ATP2A2 protein inhibits the reaction [Cisplatin results in increased expression of ATF6 protein]	PMID:38688426
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305471	E	RGD:6480464	20140610	CTD	MESH:D003042	Cocaine affects the expression of ATF6 mRNA	PMID:23644055
1313517	ATF6	activating transcription factor 6	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ATF6 mRNA	PMID:30912803
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28077	rifampicin	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D012293	Rifampin results in increased expression of ATF6 mRNA	PMID:32535746
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20200519	CTD	MESH:D009532	[nickel sulfate results in increased abundance of Nickel] which results in increased expression of ATF6 mRNA	PMID:31734292
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313518	E	RGD:6480464	20230404	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATF6 mRNA	PMID:36222588
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305471	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATF6 mRNA	PMID:34747641
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases cleavage	ISO	RGD:1305471	E	RGD:6480464	20150310	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased cleavage of ATF6 protein	PMID:24932542
1313517	ATF6	activating transcription factor 6	gene	CHEBI:2814	arecoline	increases expression	ISO	RGD:1313518	E	RGD:6480464	20250506	CTD	MESH:D001115	Arecoline results in increased expression of ATF6 mRNA; Arecoline results in increased expression of ATF6 protein	PMID:38450909
1313517	ATF6	activating transcription factor 6	gene	CHEBI:2814	arecoline	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20250506	CTD	MESH:D001115	4-phenylbutyric acid inhibits the reaction [Arecoline results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [Arecoline results in increased expression of ATF6 protein]	PMID:38450909
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20190702	CTD	MESH:D012402	Rotenone results in increased expression of ATF6 protein	PMID:30141137
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305471	E	RGD:6480464	20230704	CTD	MESH:D012402	Rotenone results in increased expression of ATF6 protein	PMID:36538285|PMID:37105514
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313518	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of ATF6 mRNA	PMID:32189544
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:D012402	geraniol inhibits the reaction [Rotenone results in increased expression of ATF6 protein]	PMID:30141137
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20230704	CTD	MESH:D012402	repaglinide inhibits the reaction [Rotenone results in increased expression of ATF6 protein]; Roflumilast inhibits the reaction [Rotenone results in increased expression of ATF6 protein]	PMID:36538285|PMID:37105514
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20210907	CTD	MESH:D012402	Metformin inhibits the reaction [Rotenone results in increased expression of ATF6 mRNA]	PMID:32189544
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28216	methylmercury chloride	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20191210	CTD	MESH:C004925	methylmercuric chloride results in increased cleavage of ATF6 protein	PMID:31330229
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20191210	CTD	MESH:C004925	Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased cleavage of ATF6 protein]; AKT1 protein mutant form inhibits the reaction [methylmercuric chloride results in increased cleavage of ATF6 protein]	PMID:31330229
1313517	ATF6	activating transcription factor 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ATF6 mRNA	PMID:33212167
1313517	ATF6	activating transcription factor 6	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1313518	E	RGD:6480464	20260407	CTD	MESH:C000228	aristolochic acid I results in increased expression of ATF6 protein	PMID:40480416
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28299	quercetin 3-O-beta-D-glucofuranoside	increases expression	ISO	RGD:1305471	E	RGD:6480464	20190219	CTD	MESH:C016527	isoquercitrin results in increased expression of ATF6 mRNA	PMID:30365939
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28299	quercetin 3-O-beta-D-glucofuranoside	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20251104	CTD	MESH:C016527	isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]	PMID:38001299
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ATF6 mRNA	PMID:30851411
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of ATF6 mRNA	PMID:17178593
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:19383982|PMID:20165829|PMID:33812996
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1305471	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:20165829
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1313518	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 protein	PMID:30602124
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829|PMID:33812996
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28393	beta-D-glucosamine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20190312	CTD	MESH:D005944	ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]	PMID:30602124
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28445	vincristine	increases expression	ISO	RGD:1305471	E	RGD:6480464	20210406	CTD	MESH:D014750	Vincristine results in increased expression of ATF6 mRNA	PMID:33038355
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28445	vincristine	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20210406	CTD	MESH:D014750	Quercetin inhibits the reaction [Vincristine results in increased expression of ATF6 mRNA]	PMID:33038355
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28527	rutin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20251007	CTD	MESH:D012431	Rutin inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; Rutin inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]	PMID:30973085
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305471	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ATF6 mRNA	PMID:28959563
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28741	sodium fluoride	affects expression	ISO	RGD:1305471	E	RGD:6480464	20141223	CTD	MESH:D012969	Sodium Fluoride affects the expression of ATF6 mRNA	PMID:25132241
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1305471	E	RGD:6480464	20221206	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ATF6 mRNA	PMID:35413380
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313518	E	RGD:6480464	20140311	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ATF6 mRNA; Sodium Fluoride results in increased expression of ATF6 protein	PMID:21626649|PMID:38823497
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20221206	CTD	MESH:D012969	Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of ATF6 mRNA]	PMID:35413380
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATF6 mRNA	PMID:29803840
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1305471	E	RGD:6480464	20220705	CTD	MESH:D004317	Doxorubicin results in increased expression of ATF6 protein	PMID:35152301
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220705	CTD	MESH:D004317	sacubitril and valsartan sodium hydrate drug combination inhibits the reaction [Doxorubicin results in increased expression of ATF6 protein]	PMID:35152301
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220510	CTD	MESH:D005632	[dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]; [Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein; [Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein; Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]; Metformin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]	PMID:34801538|PMID:34939712
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28775	hesperidin	decreases expression	ISO	RGD:1305471	E	RGD:6480464	20230704	CTD	MESH:D006569	Hesperidin results in decreased expression of ATF6 mRNA	PMID:36966900
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28775	hesperidin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220405	CTD	MESH:D006569	Hesperidin inhibits the reaction [abamectin results in increased expression of ATF6 mRNA]; Hesperidin inhibits the reaction [Paclitaxel results in increased expression of ATF6 mRNA]; Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of ATF6 mRNA]	PMID:34748272|PMID:35413380|PMID:36966900
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28819	naringin	increases expression	EXP		E	RGD:6480464	20250506	CTD	MESH:C005274	naringin results in increased expression of ATF6 protein	PMID:39056589
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28819	naringin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20240806	CTD	MESH:C005274	naringin inhibits the reaction [Oxaliplatin results in increased expression of ATF6 mRNA]	PMID:38037725
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D003840	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28869	menadione	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D024483	Vitamin K 3 results in increased expression of ATF6 protein	PMID:19819344
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28869	menadione	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D024483	Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of ATF6 protein]; S 3483 promotes the reaction [Vitamin K 3 results in increased expression of ATF6 protein]	PMID:19819344
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]; Acetylcysteine results in increased metabolism of and results in increased activity of ATF6 protein	PMID:19722195|PMID:34520753|PMID:37148176
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20140513	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of ATF6 protein modified form]; Acetylcysteine inhibits the reaction [arsenite results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of ATF6 protein]	PMID:18077580|PMID:21198628|PMID:24291486
1313517	ATF6	activating transcription factor 6	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20121218	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Arecoline results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [chloroacetic acid results in increased cleavage of ATF6 protein]; Acetylcysteine inhibits the reaction [methylmercuric chloride results in increased cleavage of ATF6 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ATF6 protein]	PMID:21911445|PMID:25451595|PMID:31330229|PMID:37692514|PMID:38450909
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29287	gold atom	increases cleavage	EXP		E	RGD:6480464	20170516	CTD	MESH:D006046	Gold analog results in increased cleavage of ATF6 protein	PMID:26551149
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	affects localization	ISO	RGD:1313518	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the localization of ATF6 protein	PMID:21911445
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATF6 mRNA	PMID:28595984|PMID:34032870
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	increases activity	ISO	RGD:1305471	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased activity of ATF6 protein	PMID:18715270
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ATF6 mRNA	PMID:38568856
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1305471	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ATF6 mRNA	PMID:38897041
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313518	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ATF6 protein	PMID:21911445
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF6 protein; AKR1C3 protein promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF6 protein]	PMID:40571110
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20161228	CTD	MESH:C017947	Melatonin inhibits the reaction [sodium arsenite results in increased activity of ATF6 protein]; zingerone inhibits the reaction [sodium arsenite results in increased expression of ATF6 mRNA]	PMID:18715270|PMID:38897041
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20161228	CTD	MESH:C017947	Acetylcysteine inhibits the reaction [sodium arsenite results in increased expression of ATF6 protein]	PMID:21911445
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	decreases cleavage	EXP		E	RGD:6480464	20130416	CTD	MESH:D014415	Tunicamycin results in decreased cleavage of ATF6 protein	PMID:22959463
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	increases cleavage	EXP		E	RGD:6480464	20170516	CTD	MESH:D014415	Tunicamycin results in increased cleavage of ATF6 protein	PMID:26551149
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20160412	CTD	MESH:D014415	Tunicamycin results in increased cleavage of ATF6 protein	PMID:24648495
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of ATF6 mRNA; Tunicamycin results in increased expression of ATF6 protein; Tunicamycin results in increased expression of ATF6 protein modified form	PMID:22378314|PMID:29723631|PMID:30592132|PMID:32407927|PMID:39900124
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1305471	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of ATF6 protein	PMID:18477628|PMID:28399139|PMID:32740777
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313518	E	RGD:401842386|PMID:27813192	20231018	RGD	MESH:D014415	tunicamycin increases expression of Atf6 mRNA in liver	
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313518	E	RGD:6480464	20130416	CTD	MESH:D014415	Tunicamycin results in increased expression of ATF6 mRNA; Tunicamycin results in increased expression of ATF6 protein	PMID:22001960|PMID:22959925|PMID:25160872|PMID:29894845|PMID:36030031
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	multiple interactions	EXP		E	RGD:6480464	20201103	CTD	MESH:D014415	Luteolin inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein modified form]	PMID:32407927
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20120412	CTD	MESH:D014415	ibutilide inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]; Nicotine inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]	PMID:18477628|PMID:28399139
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	multiple interactions	ISO	RGD:1313518	E	RGD:401842386|PMID:27813192	20231018	RGD	MESH:D014415	naltrexone inhibits the reaction [tunicamycin increases expression of Atf6 mRNA in liver]	
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29699	tunicamycin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20160412	CTD	MESH:D014415	1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of ATF6 mRNA]; 3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]; EIF2AK3 gene mutant form inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]	PMID:22959925|PMID:24648495|PMID:29894845
1313517	ATF6	activating transcription factor 6	gene	CHEBI:2979	baicalein	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20240903	CTD	MESH:C006680	baicalein inhibits the reaction [Carbon Tetrachloride results in increased expression of ATF6 protein]	PMID:33779329
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATF6 3' UTR	PMID:27901495
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ATF6 mRNA	PMID:19770486
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ATF6 promoter	PMID:27901495
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1305471	E	RGD:6480464	20230704	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATF6 protein	PMID:36736873
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29866	arsenite(3-)	increases cleavage	EXP		E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite results in increased cleavage of ATF6 protein	PMID:22959463
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1305471	E	RGD:6480464	20121218	CTD	MESH:C015001	arsenite results in increased expression of ATF6 protein	PMID:18077580
1313517	ATF6	activating transcription factor 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20121218	CTD	MESH:C015001	Acetylcysteine inhibits the reaction [arsenite results in increased expression of ATF6 protein]	PMID:18077580
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30050	gold(0)	increases cleavage	EXP		E	RGD:6480464	20170516	CTD	MESH:D006046	Gold analog results in increased cleavage of ATF6 protein	PMID:26551149
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30314	(R)-lipoic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20140211	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of ATF6 mRNA]	PMID:23892647
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1305471	E	RGD:6480464	20191112	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ATF6 protein	PMID:31028789
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20230704	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ATF6 protein	PMID:37075931
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20191112	CTD	MESH:D012822	Poly G inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]	PMID:31028789
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230704	CTD	MESH:D012822	ferrostatin-1 inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]; KN 93 inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]; N-butyloxycarbonyl-methionyl-aspartyl-glycyl-cysteinyl-glutamyl-leucine inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]	PMID:37075931
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ATF6 mRNA	PMID:20018196
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ATF6 protein	PMID:23883479
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATF6 mRNA; Arsenic Trioxide results in increased expression of ATF6 protein	PMID:17963750|PMID:19176121|PMID:25107562|PMID:25258189
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATF6 mRNA	PMID:23892647|PMID:34091186
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30621	diarsenic trioxide	increases phosphorylation	EXP		E	RGD:6480464	20220111	CTD	MESH:C006632	Arsenic Trioxide results in increased phosphorylation of ATF6 protein	PMID:34560123
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide promotes the reaction [nilotinib results in decreased expression of ATF6 protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in increased expression of ATF6 protein]	PMID:23883479|PMID:25107562
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20191114	CTD	MESH:C006632	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; [Arsenic Trioxide co-treated with antimony trichloride] results in increased expression of ATF6 mRNA; [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased cleavage of ATF6 protein; Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of ATF6 mRNA]	PMID:23892647|PMID:34091186
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30778	gallic acid	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20251202	CTD	MESH:D005707	Gallic Acid inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]	PMID:37886005
1313517	ATF6	activating transcription factor 6	gene	CHEBI:30853	glycyrrhetinic acid	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20230307	CTD	MESH:C119129	18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of ATF6 mRNA]	PMID:35699857
1313517	ATF6	activating transcription factor 6	gene	CHEBI:31243	atazanavir sulfate	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D000069446	Atazanavir Sulfate results in increased expression of ATF6 mRNA	PMID:32152650
1313517	ATF6	activating transcription factor 6	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D000069446	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1313517	ATF6	activating transcription factor 6	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATF6 gene	PMID:31601247
1313517	ATF6	activating transcription factor 6	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1305471	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of ATF6 mRNA	PMID:11578147|PMID:38530053
1313517	ATF6	activating transcription factor 6	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313518	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of ATF6 mRNA	PMID:21829687
1313517	ATF6	activating transcription factor 6	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20250506	CTD	MESH:C008261	sinapinic acid inhibits the reaction [lead acetate results in increased expression of ATF6 mRNA]	PMID:38530053
1313517	ATF6	activating transcription factor 6	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1305471	E	RGD:6480464	20250506	CTD	MESH:D008627	Mercuric Chloride results in increased expression of ATF6 mRNA	PMID:39096083
1313517	ATF6	activating transcription factor 6	gene	CHEBI:31823	mercury dichloride	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20250506	CTD	MESH:D008627	syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of ATF6 mRNA]	PMID:39096083
1313517	ATF6	activating transcription factor 6	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305471	E	RGD:6480464	20201006	CTD	MESH:C030110	Oxaliplatin results in increased expression of ATF6 mRNA	PMID:32544411|PMID:38037725
1313517	ATF6	activating transcription factor 6	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20201006	CTD	MESH:C030110	Lycopene inhibits the reaction [Oxaliplatin results in increased expression of ATF6 mRNA]; naringin inhibits the reaction [Oxaliplatin results in increased expression of ATF6 mRNA]	PMID:32544411|PMID:38037725
1313517	ATF6	activating transcription factor 6	gene	CHEBI:32234	titanium dioxide	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20200211	CTD	MESH:C009495	titanium dioxide results in increased cleavage of ATF6 protein	PMID:31298478
1313517	ATF6	activating transcription factor 6	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C009495	titanium dioxide results in increased expression of ATF6 mRNA	PMID:39461655
1313517	ATF6	activating transcription factor 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20200609	CTD	MESH:C009495	titanium dioxide results in increased expression of ATF6 mRNA	PMID:31769605
1313517	ATF6	activating transcription factor 6	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20200211	CTD	MESH:C009495	4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased cleavage of ATF6 protein]; Resveratrol inhibits the reaction [titanium dioxide results in increased cleavage of ATF6 protein]; titanium dioxide results in increased expression of and results in increased cleavage of ATF6 protein	PMID:31298478|PMID:31769605
1313517	ATF6	activating transcription factor 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:D013853	Thioacetamide results in increased expression of ATF6 protein modified form	PMID:27349771
1313517	ATF6	activating transcription factor 6	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1305471	E	RGD:6480464	20140513	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of ATF6 protein modified form	PMID:24291486
1313517	ATF6	activating transcription factor 6	gene	CHEBI:32585	4-hydroxynon-2-enal	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20140513	CTD	MESH:C027576	Acetylcysteine inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of ATF6 protein modified form]	PMID:24291486
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20191112	CTD	MESH:C074702	[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ATF6 protein	PMID:30974164
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33118	boric acid	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:C032688	boric acid results in increased cleavage of and affects the localization of ATF6 protein	PMID:27587023
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33128	C60 fullerene	affects expression	ISO	RGD:1305471	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 affects the expression of ATF6 mRNA	PMID:19167457
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305471	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ATF6 mRNA	PMID:25181051
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313518	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ATF6 promoter	PMID:27334623
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of ATF6 mRNA	PMID:22576693
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ATF6 protein	PMID:35999755
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ATF6 gene	PMID:31601247
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C006780	bisphenol A results in increased expression of ATF6 mRNA	PMID:38134982
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305471	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ATF6 mRNA	PMID:30816183|PMID:32528016|PMID:34947998|PMID:35699857|PMID:41034487
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313518	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ATF6 mRNA; bisphenol A results in increased expression of ATF6 protein	PMID:32575098|PMID:35569583|PMID:38538260
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of ATF6 gene	PMID:22576693
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ATF6 gene	PMID:31601247
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20160705	CTD	MESH:C006780	18alpha-glycyrrhetinic acid inhibits the reaction [bisphenol A results in increased expression of ATF6 mRNA]; [bisphenol A co-treated with Estradiol] results in decreased expression of ATF6 mRNA	PMID:26496021|PMID:35699857
1313517	ATF6	activating transcription factor 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20220208	CTD	MESH:C006780	[Palmitates co-treated with bisphenol A] results in increased expression of ATF6 mRNA; Melatonin inhibits the reaction [bisphenol A results in increased expression of ATF6 protein]; Oleic Acid inhibits the reaction [[Palmitates co-treated with bisphenol A] results in increased expression of ATF6 mRNA]	PMID:32976987|PMID:38538260
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1313518	E	RGD:6480464	20240206	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of ATF6 mRNA	PMID:37080397
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ATF6 mRNA	PMID:39298647
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313518	E	RGD:6480464	20241105	CTD	MESH:C543008	bisphenol S results in increased expression of ATF6 mRNA	PMID:35569583
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34421	4-Hydroxybenzophenone	increases expression	ISO	RGD:1313518	E	RGD:6480464	20221101	CTD	MESH:C024292	4-hydroxybenzophenone results in increased expression of ATF6 protein	PMID:35476924
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34421	4-Hydroxybenzophenone	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20221101	CTD	MESH:C024292	CXCL1 protein promotes the reaction [4-hydroxybenzophenone results in increased expression of ATF6 protein]	PMID:35476924
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C008745	bisphenol F results in increased expression of ATF6 mRNA	PMID:38134982
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313518	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ATF6 mRNA	PMID:38685157
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATF6 mRNA	PMID:28628672
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ATF6 mRNA	PMID:37019170
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34631	chlorpyrifos	decreases methylation	ISO	RGD:1305471	E	RGD:6480464	20210907	CTD	MESH:D004390	Chlorpyrifos results in decreased methylation of ATF6 gene	PMID:32905263
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305471	E	RGD:6480464	20170516	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ATF6 protein	PMID:26804720
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ATF6 protein	PMID:26804720
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20170516	CTD	MESH:D003993	4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ATF6 protein]	PMID:26804720
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:D003993	4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ATF6 protein]	PMID:26804720
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATF6 mRNA	PMID:28628672
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34905	paraquat	increases cleavage	EXP		E	RGD:6480464	20180515	CTD	MESH:D010269	Paraquat results in increased cleavage of ATF6 protein	PMID:28986289
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D010269	Paraquat results in increased expression of ATF6 mRNA; Paraquat results in increased expression of ATF6 protein modified form	PMID:28986289|PMID:34097952
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305471	E	RGD:6480464	20121009	CTD	MESH:D010269	Paraquat results in increased expression of ATF6 protein	PMID:22245251
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20121009	CTD	MESH:D010269	Minocycline inhibits the reaction [Paraquat results in increased expression of ATF6 protein]	PMID:22245251
1313517	ATF6	activating transcription factor 6	gene	CHEBI:34967	rimonabant	multiple interactions	EXP		E	RGD:6480464	20210202	CTD	MESH:D000077285	[Rimonabant co-treated with SR 144528] inhibits the reaction [Dronabinol results in increased expression of ATF6 mRNA]	PMID:31054322
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATF6 mRNA	PMID:37042841
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305471	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of ATF6 mRNA	PMID:30589522
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35154	manganese(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of ATF6 mRNA	PMID:17175027
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20190702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATF6 mRNA; Cadmium Chloride results in increased expression of ATF6 protein	PMID:30796460
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305471	E	RGD:6480464	20200609	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATF6 mRNA; Cadmium Chloride results in increased expression of ATF6 protein	PMID:30973085|PMID:31433112
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313518	E	RGD:6480464	20150414	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATF6 mRNA; Cadmium Chloride results in increased expression of ATF6 protein	PMID:25409916|PMID:38242296|PMID:39038763
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:D019256	4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]	PMID:30796460
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20200609	CTD	MESH:D019256	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; 4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]; Rutin inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; Rutin inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]	PMID:30973085|PMID:31433112|PMID:38001299
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230905	CTD	MESH:D019256	4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATF6 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein	PMID:37236586|PMID:37261864|PMID:38242296
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ATF6 mRNA	PMID:36251517
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35553	perhexiline	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D010480	[perhexiline maleate results in increased abundance of Perhexiline] which results in increased expression of ATF6 mRNA; CYP2D6 protein inhibits the reaction [[perhexiline maleate results in increased abundance of Perhexiline] which results in increased expression of ATF6 mRNA]	PMID:36083301
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305471	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ATF6 gene	PMID:22079235
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305471	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ATF6 mRNA	PMID:24386269
1313517	ATF6	activating transcription factor 6	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ATF6 mRNA	PMID:24449571
1313517	ATF6	activating transcription factor 6	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D005999	[Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1313517	ATF6	activating transcription factor 6	gene	CHEBI:3682	chrysazin	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C004315	danthron results in increased expression of ATF6 protein	PMID:21126053
1313517	ATF6	activating transcription factor 6	gene	CHEBI:37288	gadolinium trichloride	affects expression	ISO	RGD:1305471	E	RGD:6480464	20120501	CTD	MESH:C038958	gadolinium chloride affects the expression of ATF6 mRNA	PMID:21198628
1313517	ATF6	activating transcription factor 6	gene	CHEBI:37288	gadolinium trichloride	increases expression	ISO	RGD:1305471	E	RGD:6480464	20120501	CTD	MESH:C038958	gadolinium chloride results in increased expression of ATF6 protein	PMID:21198628
1313517	ATF6	activating transcription factor 6	gene	CHEBI:37288	gadolinium trichloride	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20120501	CTD	MESH:C038958	Acetylcysteine inhibits the reaction [gadolinium chloride results in increased expression of ATF6 protein]	PMID:21198628
1313517	ATF6	activating transcription factor 6	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ATF6 mRNA	PMID:28302478
1313517	ATF6	activating transcription factor 6	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1313518	E	RGD:6480464	20250603	CTD	MESH:C473478	Sunitinib results in increased expression of ATF6 mRNA	PMID:39613054
1313517	ATF6	activating transcription factor 6	gene	CHEBI:39214	abamectin	increases expression	ISO	RGD:1305471	E	RGD:6480464	20220405	CTD	MESH:C048324	abamectin results in increased expression of ATF6 mRNA	PMID:34748272
1313517	ATF6	activating transcription factor 6	gene	CHEBI:39214	abamectin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220405	CTD	MESH:C048324	Hesperidin inhibits the reaction [abamectin results in increased expression of ATF6 mRNA]	PMID:34748272
1313517	ATF6	activating transcription factor 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ATF6 mRNA	PMID:40419075
1313517	ATF6	activating transcription factor 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1305471	E	RGD:6480464	20250401	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ATF6 mRNA	PMID:37955688
1313517	ATF6	activating transcription factor 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATF6 mRNA	PMID:36331819
1313517	ATF6	activating transcription factor 6	gene	CHEBI:39426	perfluorobutyric acid	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C033094	perfluorobutyric acid results in increased expression of ATF6 mRNA	PMID:36251517
1313517	ATF6	activating transcription factor 6	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1305471	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of ATF6 mRNA	PMID:22561333
1313517	ATF6	activating transcription factor 6	gene	CHEBI:3962	curcumin	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D003474	Curcumin results in increased expression of ATF6 mRNA	PMID:29723631
1313517	ATF6	activating transcription factor 6	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1313518	E	RGD:6480464	20140311	CTD	MESH:D003474	Curcumin results in increased expression of ATF6 protein	PMID:21793155
1313517	ATF6	activating transcription factor 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATF6 mRNA	PMID:25979313
1313517	ATF6	activating transcription factor 6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATF6 mRNA	PMID:23179753
1313517	ATF6	activating transcription factor 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of ATF6 mRNA	PMID:29154799
1313517	ATF6	activating transcription factor 6	gene	CHEBI:40279	allopurinol	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D000493	Allopurinol results in increased expression of ATF6 mRNA	PMID:32535746
1313517	ATF6	activating transcription factor 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ATF6 mRNA	PMID:20106945|PMID:24973091|PMID:25562108|PMID:27989131|PMID:32152650
1313517	ATF6	activating transcription factor 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313518	E	RGD:6480464	20140114	CTD	MESH:D016572	Cyclosporine results in increased expression of ATF6 mRNA	PMID:23958496
1313517	ATF6	activating transcription factor 6	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA; ATF6 protein affects the reaction [Cyclosporine results in increased expression of XBP1 protein alternative form]	PMID:32152650|PMID:35033536
1313517	ATF6	activating transcription factor 6	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1305471	E	RGD:6480464	20230704	CTD	MESH:C017160	cypermethrin results in increased expression of ATF6 mRNA	PMID:35876585
1313517	ATF6	activating transcription factor 6	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20230704	CTD	MESH:C017160	Quercetin inhibits the reaction [cypermethrin results in increased expression of ATF6 mRNA]	PMID:35876585
1313517	ATF6	activating transcription factor 6	gene	CHEBI:41500	4-phenylbutyric acid	decreases expression	EXP		E	RGD:6480464	20190702	CTD	MESH:C075773	4-phenylbutyric acid results in decreased expression of ATF6 protein	PMID:30796460
1313517	ATF6	activating transcription factor 6	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Ficusin results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Lipopolysaccharides results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [SFTPC protein mutant form results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]; [4-phenylbutyric acid co-treated with alpha-Chlorohydrin] results in decreased expression of ATF6 protein	PMID:20165829|PMID:27638906|PMID:28245985|PMID:30796460|PMID:31364909|PMID:33651226|PMID:34520753|PMID:36646296|PMID:37148176
1313517	ATF6	activating transcription factor 6	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20120501	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased cleavage of ATF6 protein]	PMID:20165829|PMID:26804720|PMID:30980806|PMID:38001299
1313517	ATF6	activating transcription factor 6	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20170516	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [3-acetyldeoxynivalenol results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Arecoline results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Bilirubin results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 mRNA]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [titanium dioxide results in increased cleavage of ATF6 protein]; [4-phenylbutyric acid co-treated with Palmitic Acid] results in decreased expression of ATF6 protein	PMID:26804720|PMID:27578021|PMID:31298478|PMID:35413383|PMID:36030031|PMID:37692514|PMID:38242296|PMID:38450909
1313517	ATF6	activating transcription factor 6	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATF6 mRNA	PMID:28628672
1313517	ATF6	activating transcription factor 6	gene	CHEBI:42567	fisetin	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C017875	fisetin results in increased expression of ATF6 protein	PMID:28181380
1313517	ATF6	activating transcription factor 6	gene	CHEBI:42567	fisetin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C017875	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of ATF6 protein]	PMID:28181380
1313517	ATF6	activating transcription factor 6	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D005947	Glucose deficiency results in increased expression of ATF6 protein; Glucose results in increased expression of ATF6 mRNA; Glucose results in increased expression of ATF6 protein	PMID:31022492|PMID:39798073
1313517	ATF6	activating transcription factor 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D005947	4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF6 protein]; ATF6 protein modified form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]	PMID:31022492|PMID:39798073
1313517	ATF6	activating transcription factor 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220510	CTD	MESH:D005947	Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; Glucose results in increased expression of and affects the localization of ATF6 protein; Metformin inhibits the reaction [Glucose results in increased expression of and affects the localization of ATF6 protein]	PMID:34801538
1313517	ATF6	activating transcription factor 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20260303	CTD	MESH:D005947	3-(indol-3-yl)propionic acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; [Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein; gamma-glutamylcysteine inhibits the reaction [[Glucose co-treated with Palmitic Acid] results in increased expression of ATF6 protein]	PMID:39701215|PMID:40628365
1313517	ATF6	activating transcription factor 6	gene	CHEBI:44241	metyrapone	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D008797	Metyrapone promotes the reaction [Vitamin K 3 results in increased expression of ATF6 protein]	PMID:19819344
1313517	ATF6	activating transcription factor 6	gene	CHEBI:44975	1,10-phenanthroline	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C025205	[1,10-phenanthroline results in decreased activity of MBTPS2 protein] which affects the localization of ATF6 protein; [1,10-phenanthroline results in decreased activity of MBTPS2 protein] which results in decreased cleavage of ATF6 protein	PMID:21355074
1313517	ATF6	activating transcription factor 6	gene	CHEBI:45285	pyrazinecarboxamide	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:D011718	Pyrazinamide results in increased expression of ATF6 mRNA	PMID:28063906
1313517	ATF6	activating transcription factor 6	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1305471	E	RGD:6480464	20230704	CTD	MESH:D017239	Paclitaxel results in increased expression of ATF6 mRNA	PMID:36966900
1313517	ATF6	activating transcription factor 6	gene	CHEBI:45863	paclitaxel	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20230704	CTD	MESH:D017239	Hesperidin inhibits the reaction [Paclitaxel results in increased expression of ATF6 mRNA]	PMID:36966900
1313517	ATF6	activating transcription factor 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ATF6 mRNA	PMID:17562736
1313517	ATF6	activating transcription factor 6	gene	CHEBI:46195	paracetamol	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20191210	CTD	MESH:D000082	Acetaminophen results in increased cleavage of ATF6 protein	PMID:31524377
1313517	ATF6	activating transcription factor 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305471	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ATF6 mRNA	PMID:33387578
1313517	ATF6	activating transcription factor 6	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased cleavage of and results in increased activity of ATF6 protein; Guanabenz inhibits the reaction [Acetaminophen results in increased cleavage of ATF6 protein]	PMID:19931551|PMID:31524377
1313517	ATF6	activating transcription factor 6	gene	CHEBI:46345	5-fluorouracil	affects expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D005472	Fluorouracil affects the expression of ATF6 mRNA	PMID:34151400
1313517	ATF6	activating transcription factor 6	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of ATF6 mRNA	PMID:17331233
1313517	ATF6	activating transcription factor 6	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of ATF6 protein	PMID:25324550
1313517	ATF6	activating transcription factor 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to ATF6 promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of and results in increased cleavage of ATF6 protein; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF6 protein; AKR1C3 protein promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF6 protein]; NFE2L2 protein affects the reaction [[arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6 mRNA]	PMID:35625704|PMID:40571110
1313517	ATF6	activating transcription factor 6	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1305471	E	RGD:6480464	20260602	CTD	MESH:D004008	Diclofenac results in increased expression of ATF6 mRNA	PMID:40534331
1313517	ATF6	activating transcription factor 6	gene	CHEBI:47381	diclofenac	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20260602	CTD	MESH:D004008	chrysin inhibits the reaction [Diclofenac results in increased expression of ATF6 mRNA]	PMID:40534331
1313517	ATF6	activating transcription factor 6	gene	CHEBI:47657	roflumilast	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20231031	CTD	MESH:C424423	Roflumilast inhibits the reaction [Rotenone results in increased expression of ATF6 protein]	PMID:37105514
1313517	ATF6	activating transcription factor 6	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305471	E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in decreased expression of ATF6 mRNA	PMID:31464424
1313517	ATF6	activating transcription factor 6	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305471	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ATF6 mRNA	PMID:29391264
1313517	ATF6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of ATF6 mRNA	PMID:17178593
1313517	ATF6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:19383982|PMID:20165829|PMID:33812996
1313517	ATF6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1305471	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 mRNA	PMID:20165829
1313517	ATF6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1313518	E	RGD:6480464	20190312	CTD	MESH:D005944	Glucosamine results in increased expression of ATF6 protein	PMID:30602124
1313517	ATF6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; NUS1 protein inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829|PMID:33812996
1313517	ATF6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20120501	CTD	MESH:D005944	4-phenylbutyric acid inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of MEF2A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of PPARGC1A protein]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 mRNA]; ATF6 mutant form inhibits the reaction [Glucosamine results in decreased expression of SLC2A4 protein]; ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829
1313517	ATF6	activating transcription factor 6	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20190312	CTD	MESH:D005944	ATF6 protein affects the reaction [Glucosamine results in increased expression of OSTN mRNA]	PMID:30602124
1313517	ATF6	activating transcription factor 6	gene	CHEBI:48080	brefeldin A	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:D020126	Apigenin inhibits the reaction [Brefeldin A results in increased cleavage of ATF6 protein]	PMID:20493918
1313517	ATF6	activating transcription factor 6	gene	CHEBI:4811	epoxiconazole	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20180515	CTD	MESH:C109476	[cyproconazole co-treated with epoxiconazole] results in increased expression of ATF6 mRNA	PMID:29038839
1313517	ATF6	activating transcription factor 6	gene	CHEBI:48347	triclocarban	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C009540	triclocarban results in increased expression of ATF6 mRNA; triclocarban results in increased expression of ATF6 protein	PMID:30592132
1313517	ATF6	activating transcription factor 6	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D018038	Sodium Selenite results in increased expression of ATF6 protein	PMID:34520753
1313517	ATF6	activating transcription factor 6	gene	CHEBI:48843	disodium selenite	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D018038	4-phenylbutyric acid inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [Sodium Selenite results in increased expression of ATF6 protein]	PMID:34520753
1313517	ATF6	activating transcription factor 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305471	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ATF6 mRNA	PMID:29097150
1313517	ATF6	activating transcription factor 6	gene	CHEBI:49662	indometacin	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased activity of ATF6 protein	PMID:17341418
1313517	ATF6	activating transcription factor 6	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D007213	Indomethacin results in increased expression of ATF6 mRNA	PMID:32535746
1313517	ATF6	activating transcription factor 6	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATF6 mRNA	PMID:28628672
1313517	ATF6	activating transcription factor 6	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ATF6 protein	PMID:23883479
1313517	ATF6	activating transcription factor 6	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATF6 mRNA; Arsenic Trioxide results in increased expression of ATF6 protein	PMID:17963750|PMID:19176121|PMID:25107562|PMID:25258189
1313517	ATF6	activating transcription factor 6	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313518	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATF6 mRNA	PMID:23892647|PMID:34091186
1313517	ATF6	activating transcription factor 6	gene	CHEBI:49900	arsenous acid	increases phosphorylation	EXP		E	RGD:6480464	20220111	CTD	MESH:C032793	Arsenic Trioxide results in increased phosphorylation of ATF6 protein	PMID:34560123
1313517	ATF6	activating transcription factor 6	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide promotes the reaction [nilotinib results in decreased expression of ATF6 protein]; Resveratrol inhibits the reaction [Arsenic Trioxide results in increased expression of ATF6 protein]	PMID:23883479|PMID:25107562
1313517	ATF6	activating transcription factor 6	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20191114	CTD	MESH:C032793	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; [Arsenic Trioxide co-treated with antimony trichloride] results in increased expression of ATF6 mRNA; [Arsenic Trioxide results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased cleavage of ATF6 protein; Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of and results in increased cleavage of ATF6 protein]; Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of ATF6 mRNA]	PMID:23892647|PMID:34091186
1313517	ATF6	activating transcription factor 6	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20240305	CTD	MESH:D011345	Fenofibrate inhibits the reaction [Dietary Fats results in increased expression of ATF6 mRNA]; Fenofibrate inhibits the reaction [Dietary Fats results in increased expression of ATF6 protein]	PMID:38216941
1313517	ATF6	activating transcription factor 6	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305471	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of ATF6 mRNA	PMID:34044035
1313517	ATF6	activating transcription factor 6	gene	CHEBI:50686	atorvastatin calcium	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220809	CTD	MESH:D000069059	[dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]	PMID:34939712
1313517	ATF6	activating transcription factor 6	gene	CHEBI:50694	minocycline	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20121009	CTD	MESH:D008911	Minocycline inhibits the reaction [Paraquat results in increased expression of ATF6 protein]	PMID:22245251
1313517	ATF6	activating transcription factor 6	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20130416	CTD	MESH:C049325	1,2-dithiol-3-thione inhibits the reaction [Tunicamycin results in increased expression of ATF6 mRNA]	PMID:22959925
1313517	ATF6	activating transcription factor 6	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20241105	CTD	MESH:D005485	Flutamide results in increased expression of ATF6 mRNA; Flutamide results in increased expression of ATF6 protein	PMID:32662666
1313517	ATF6	activating transcription factor 6	gene	CHEBI:52172	nilotinib	decreases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C498826	nilotinib results in decreased expression of ATF6 protein	PMID:23883479
1313517	ATF6	activating transcription factor 6	gene	CHEBI:52172	nilotinib	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:C498826	Arsenic Trioxide promotes the reaction [nilotinib results in decreased expression of ATF6 protein]	PMID:23883479
1313517	ATF6	activating transcription factor 6	gene	CHEBI:53001	nickel sulfate	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20200519	CTD	MESH:C029938	[nickel sulfate results in increased abundance of Nickel] which results in increased expression of ATF6 mRNA	PMID:31734292
1313517	ATF6	activating transcription factor 6	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313518	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ATF6 mRNA	PMID:19042947
1313517	ATF6	activating transcription factor 6	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313518	E	RGD:6480464	20150414	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ATF6 mRNA	PMID:25409916
1313517	ATF6	activating transcription factor 6	gene	CHEBI:53444	potassium dichromate	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20191112	CTD	MESH:D011192	[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ATF6 protein	PMID:30974164
1313517	ATF6	activating transcription factor 6	gene	CHEBI:5553	Guanabenz	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20191210	CTD	MESH:D006143	Guanabenz inhibits the reaction [Acetaminophen results in increased cleavage of ATF6 protein]	PMID:31524377
1313517	ATF6	activating transcription factor 6	gene	CHEBI:5856	Ibutilide	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20211109	CTD	MESH:C067192	ibutilide inhibits the reaction [Tunicamycin results in increased expression of ATF6 protein]	PMID:28399139
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6078	ivermectin	increases expression	ISO	RGD:1313518	E	RGD:6480464	20190219	CTD	MESH:D007559	Ivermectin results in increased expression of ATF6 mRNA	PMID:28942281
1313517	ATF6	activating transcription factor 6	gene	CHEBI:60799	esketamine	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C000629870	Esketamine results in increased expression of ATF6 mRNA	PMID:38219984
1313517	ATF6	activating transcription factor 6	gene	CHEBI:60888	BAPTA	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C025603	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid results in increased expression of ATF6 protein	PMID:28181380
1313517	ATF6	activating transcription factor 6	gene	CHEBI:60888	BAPTA	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C025603	1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [fisetin results in increased expression of ATF6 protein]	PMID:28181380
1313517	ATF6	activating transcription factor 6	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1313518	E	RGD:6480464	20140114	CTD	MESH:D016559	Tacrolimus results in increased expression of ATF6 mRNA	PMID:23958496
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1313518	E	RGD:6480464	20221206	CTD	MESH:D007649	Ketamine results in increased expression of ATF6 mRNA	PMID:35728656
1313517	ATF6	activating transcription factor 6	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of ATF6 mRNA	PMID:17175027
1313517	ATF6	activating transcription factor 6	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305471	E	RGD:6480464	20150714	CTD	MESH:C025340	manganese chloride results in increased expression of ATF6 protein	PMID:25732873
1313517	ATF6	activating transcription factor 6	gene	CHEBI:63621	saquinavir	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019258	Saquinavir results in increased expression of ATF6 protein	PMID:19147209
1313517	ATF6	activating transcription factor 6	gene	CHEBI:63952	arsenic trichloride	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] promotes the reaction [NFE2L2 protein binds to ATF6 promoter]; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of and results in increased cleavage of ATF6 protein; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6 mRNA; NFE2L2 protein affects the reaction [[arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of ATF6 mRNA]	PMID:35625704
1313517	ATF6	activating transcription factor 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305471	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ATF6 mRNA	PMID:28801915
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6413	letrozole	increases expression	ISO	RGD:1305471	E	RGD:6480464	20210706	CTD	MESH:C067431	Letrozole results in increased expression of ATF6 mRNA	PMID:33491863
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6413	letrozole	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20210706	CTD	MESH:C067431	ADM protein inhibits the reaction [Letrozole results in increased expression of ATF6 mRNA]	PMID:33491863
1313517	ATF6	activating transcription factor 6	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313518	E	RGD:6480464	20210907	CTD	MESH:D004178	Diquat results in increased expression of ATF6 mRNA	PMID:32536062
1313517	ATF6	activating transcription factor 6	gene	CHEBI:64213	cantharidin	increases cleavage	EXP		E	RGD:6480464	20170613	CTD	MESH:D002193	Cantharidin results in increased cleavage of ATF6 protein	PMID:27113412
1313517	ATF6	activating transcription factor 6	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20200609	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]	PMID:31433112
1313517	ATF6	activating transcription factor 6	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20150127	CTD	MESH:C085911	[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with HRAS protein] results in decreased expression of ATF6 protein	PMID:24898257
1313517	ATF6	activating transcription factor 6	gene	CHEBI:65347	carfilzomib	increases expression	EXP		E	RGD:6480464	20250506	CTD	MESH:C524865	carfilzomib results in increased expression of ATF6 protein	PMID:39645617
1313517	ATF6	activating transcription factor 6	gene	CHEBI:65737	demethoxycurcumin	multiple interactions	EXP		E	RGD:6480464	20160210	CTD	MESH:C050229	demethoxycurcumin analog inhibits the reaction [Thapsigargin results in increased expression of ATF6 protein]	PMID:26264395
1313517	ATF6	activating transcription factor 6	gene	CHEBI:67486	quercetin 3-O-beta-D-galactopyranoside	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C021304	hyperoside inhibits the reaction [Particulate Matter results in increased cleavage of ATF6 protein]	PMID:38848825
1313517	ATF6	activating transcription factor 6	gene	CHEBI:67987	ginsenoside Rg1	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C035054	ginsenoside Rg1 inhibits the reaction [Lipopolysaccharides results in increased expression of ATF6 protein]	PMID:30918470
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220510	CTD	MESH:D008687	Metformin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]; Metformin inhibits the reaction [Glucose results in increased expression of and affects the localization of ATF6 protein]	PMID:34801538
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20210907	CTD	MESH:D008687	Metformin inhibits the reaction [Rotenone results in increased expression of ATF6 mRNA]	PMID:32189544
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	affects localization	EXP		E	RGD:6480464	20180220	CTD	MESH:D008694	Methamphetamine affects the localization of ATF6 protein	PMID:27323860
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	increases cleavage	EXP		E	RGD:6480464	20180220	CTD	MESH:D008694	Methamphetamine results in increased cleavage of ATF6 protein	PMID:27323860
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:D008694	Methamphetamine results in increased cleavage of ATF6 protein	PMID:27323860
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20250506	CTD	MESH:D008694	Methamphetamine results in increased expression of ATF6 protein	PMID:38901802
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1305471	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ATF6 mRNA; Methamphetamine results in increased expression of ATF6 protein	PMID:19564919|PMID:28070110|PMID:34214594
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D008694	ATF6 protein affects the reaction [Methamphetamine results in increased cleavage of CASP3 protein]; ATF6 protein affects the reaction [Methamphetamine results in increased cleavage of CASP9 protein]; ATF6 protein affects the reaction [Methamphetamine results in increased expression of DDIT3 mRNA]; ATF6 protein affects the reaction [Methamphetamine results in increased expression of DDIT3 protein]; ATF6 protein affects the reaction [Methamphetamine results in increased expression of XBP1 mRNA]; ATF6 protein affects the reaction [Methamphetamine results in increased expression of XBP1 protein]; Methamphetamine results in decreased expression of and results in increased cleavage of ATF6 protein; Naltrexone inhibits the reaction [Methamphetamine results in increased cleavage of ATF6 protein]; norbinaltorphimine inhibits the reaction [Methamphetamine results in increased cleavage of ATF6 protein]; STIM1 protein affects the reaction [Methamphetamine results in increased expression of ATF6 protein]	PMID:27323860|PMID:38901802
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20170725	CTD	MESH:D008694	Melatonin inhibits the reaction [Methamphetamine results in increased expression of ATF6 protein]	PMID:28070110
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305471	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ATF6 mRNA	PMID:30467583
1313517	ATF6	activating transcription factor 6	gene	CHEBI:68329	syringic acid	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20250506	CTD	MESH:C001945	syringic acid inhibits the reaction [Mercuric Chloride results in increased expression of ATF6 mRNA]	PMID:39096083
1313517	ATF6	activating transcription factor 6	gene	CHEBI:68352	quercetin 3-O-beta-D-glucopyranoside	increases expression	ISO	RGD:1305471	E	RGD:6480464	20190219	CTD	MESH:C016527	isoquercitrin results in increased expression of ATF6 mRNA	PMID:30365939
1313517	ATF6	activating transcription factor 6	gene	CHEBI:68352	quercetin 3-O-beta-D-glucopyranoside	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20251104	CTD	MESH:C016527	isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 mRNA]; isoquercitrin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATF6 protein]	PMID:38001299
1313517	ATF6	activating transcription factor 6	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305471	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ATF6 gene	PMID:35440735
1313517	ATF6	activating transcription factor 6	gene	CHEBI:68657	zingerone	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20250805	CTD	MESH:C013738	zingerone inhibits the reaction [sodium arsenite results in increased expression of ATF6 mRNA]	PMID:38897041
1313517	ATF6	activating transcription factor 6	gene	CHEBI:69074	linderalactone	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20250708	CTD	MESH:C477965	linderalactone inhibits the reaction [Streptozocin results in increased expression of ATF6 protein]	PMID:37757635
1313517	ATF6	activating transcription factor 6	gene	CHEBI:69355	casticin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C054133	casticin results in increased expression of ATF6 protein	PMID:27862857
1313517	ATF6	activating transcription factor 6	gene	CHEBI:72959	N-hexadecanoylsphingosine	increases expression	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:C097760	N-palmitoylsphingosine results in increased expression of ATF6 mRNA	PMID:28223344
1313517	ATF6	activating transcription factor 6	gene	CHEBI:72959	N-hexadecanoylsphingosine	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:C097760	[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ATF6 mRNA; ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of ATF6 mRNA]	PMID:28223344
1313517	ATF6	activating transcription factor 6	gene	CHEBI:73278	poly(guanylic acid)	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20191112	CTD	MESH:D011068	Poly G inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]	PMID:31028789
1313517	ATF6	activating transcription factor 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ATF6 mRNA	PMID:22206623
1313517	ATF6	activating transcription factor 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of ATF6 mRNA	PMID:27840820
1313517	ATF6	activating transcription factor 6	gene	CHEBI:74023	dioscin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20140513	CTD	MESH:C019357	dioscin inhibits the reaction [Ethanol results in increased expression of ATF6 protein]	PMID:24146112
1313517	ATF6	activating transcription factor 6	gene	CHEBI:74023	dioscin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20140513	CTD	MESH:C019357	dioscin inhibits the reaction [Ethanol results in increased expression of ATF6 protein]	PMID:24146112
1313517	ATF6	activating transcription factor 6	gene	CHEBI:7465	naltrexone	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D009271	Naltrexone inhibits the reaction [Methamphetamine results in increased cleavage of ATF6 protein]	PMID:27323860
1313517	ATF6	activating transcription factor 6	gene	CHEBI:74856	antimony trichloride	increases expression	ISO	RGD:1313518	E	RGD:6480464	20231003	CTD	MESH:C054672	antimony trichloride results in increased expression of ATF6 mRNA	PMID:34091186
1313517	ATF6	activating transcription factor 6	gene	CHEBI:74856	antimony trichloride	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20231003	CTD	MESH:C054672	[Arsenic Trioxide co-treated with antimony trichloride] results in increased expression of ATF6 mRNA	PMID:34091186
1313517	ATF6	activating transcription factor 6	gene	CHEBI:7494	nefazodone	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:C051752	nefazodone results in increased expression of ATF6 mRNA	PMID:32152650
1313517	ATF6	activating transcription factor 6	gene	CHEBI:7494	nefazodone	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:C051752	[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of ATF6 mRNA	PMID:32152650
1313517	ATF6	activating transcription factor 6	gene	CHEBI:7496	nelfinavir	affects localization	EXP		E	RGD:6480464	20140708	CTD	MESH:D019888	Nelfinavir affects the localization of ATF6 protein	PMID:21355074
1313517	ATF6	activating transcription factor 6	gene	CHEBI:7496	nelfinavir	decreases cleavage	EXP		E	RGD:6480464	20140708	CTD	MESH:D019888	Nelfinavir results in decreased cleavage of ATF6 protein	PMID:21355074
1313517	ATF6	activating transcription factor 6	gene	CHEBI:7496	nelfinavir	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D019888	Nelfinavir results in decreased expression of ATF6 protein alternative form	PMID:21355074
1313517	ATF6	activating transcription factor 6	gene	CHEBI:7496	nelfinavir	increases stability	EXP		E	RGD:6480464	20140708	CTD	MESH:D019888	Nelfinavir results in increased stability of ATF6 protein	PMID:21355074
1313517	ATF6	activating transcription factor 6	gene	CHEBI:7496	nelfinavir	multiple interactions	EXP		E	RGD:6480464	20140708	CTD	MESH:D019888	Nelfinavir inhibits the reaction [MBTPS2 protein results in increased cleavage of and results in increased activity of ATF6 protein]	PMID:21355074
1313517	ATF6	activating transcription factor 6	gene	CHEBI:75092	morin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20251007	CTD	MESH:C008548	morin inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]	PMID:38238535
1313517	ATF6	activating transcription factor 6	gene	CHEBI:75095	chrysin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20260602	CTD	MESH:C043561	chrysin inhibits the reaction [Cadmium results in increased expression of ATF6 mRNA]; chrysin inhibits the reaction [Diclofenac results in increased expression of ATF6 mRNA]	PMID:37453011|PMID:40534331
1313517	ATF6	activating transcription factor 6	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of ATF6 protein	PMID:27638906
1313517	ATF6	activating transcription factor 6	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C072553	4-phenylbutyric acid inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of ATF6 protein]; ATF6 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ACE2 protein]; ATF6 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of CTSD protein]	PMID:27638906
1313517	ATF6	activating transcription factor 6	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ATF6 protein	PMID:31285264
1313517	ATF6	activating transcription factor 6	gene	CHEBI:7599	Nivalenol	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C038405	nivalenol results in increased expression of ATF6 mRNA	PMID:20682335
1313517	ATF6	activating transcription factor 6	gene	CHEBI:77012	methylseleninic acid	multiple interactions	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased cleavage of and results in increased activity of ATF6 protein	PMID:16205645
1313517	ATF6	activating transcription factor 6	gene	CHEBI:77131	sinapic acid	decreases expression	ISO	RGD:1305471	E	RGD:6480464	20250506	CTD	MESH:C073734	sinapinic acid results in decreased expression of ATF6 mRNA	PMID:38530053
1313517	ATF6	activating transcription factor 6	gene	CHEBI:77131	sinapic acid	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20250506	CTD	MESH:C073734	sinapinic acid inhibits the reaction [lead acetate results in increased expression of ATF6 mRNA]	PMID:38530053
1313517	ATF6	activating transcription factor 6	gene	CHEBI:77148	ginsenoside Re	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:C049864	Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]]; Deoxyglucose inhibits the reaction [ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 mRNA]; ginsenoside Re inhibits the reaction [Glucose results in increased expression of ATF6 protein]	PMID:39798073
1313517	ATF6	activating transcription factor 6	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in increased expression of ATF6 mRNA; ochratoxin A results in increased expression of ATF6 protein	PMID:30559759|PMID:36058351
1313517	ATF6	activating transcription factor 6	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305471	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ATF6 mRNA	PMID:21346803
1313517	ATF6	activating transcription factor 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ATF6 mRNA	PMID:30851411
1313517	ATF6	activating transcription factor 6	gene	CHEBI:78420	icariin	decreases expression	ISO	RGD:1305471	E	RGD:6480464	20260303	CTD	MESH:C056599	icariin results in decreased expression of ATF6 protein	PMID:34018553
1313517	ATF6	activating transcription factor 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20200609	CTD	MESH:C516138	dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]	PMID:31433112
1313517	ATF6	activating transcription factor 6	gene	CHEBI:78708	Nonidet P-40	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C010615	Nonidet P-40 results in increased expression of ATF6 mRNA	PMID:26552463
1313517	ATF6	activating transcription factor 6	gene	CHEBI:7959	D-penicillamine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010396	Penicillamine results in increased metabolism of and results in increased activity of ATF6 protein	PMID:19722195
1313517	ATF6	activating transcription factor 6	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:C412815	GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of ATF6 mRNA]	PMID:28223344
1313517	ATF6	activating transcription factor 6	gene	CHEBI:80025	Salinomycin	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C010327	salinomycin results in increased expression of ATF6 mRNA	PMID:35914560
1313517	ATF6	activating transcription factor 6	gene	CHEBI:80025	Salinomycin	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C010327	[salinomycin co-treated with Calcitriol] results in increased expression of ATF6 mRNA	PMID:35914560
1313517	ATF6	activating transcription factor 6	gene	CHEBI:8062	phenethyl caffeate	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:C055494	[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of ATF6 mRNA; GW 4064 inhibits the reaction [[caffeic acid phenethyl ester co-treated with Dietary Fats] results in decreased expression of ATF6 mRNA]	PMID:28223344
1313517	ATF6	activating transcription factor 6	gene	CHEBI:80774	tauroursodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20170207	CTD	MESH:C031655	ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829
1313517	ATF6	activating transcription factor 6	gene	CHEBI:80774	tauroursodeoxycholic acid	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20141111	CTD	MESH:C031655	ursodoxicoltaurine inhibits the reaction [Glucosamine results in increased expression of ATF6 mRNA]	PMID:20165829
1313517	ATF6	activating transcription factor 6	gene	CHEBI:80774	tauroursodeoxycholic acid	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:C031655	ursodoxicoltaurine inhibits the reaction [[N-palmitoylsphingosine co-treated with Dietary Fats] results in increased expression of ATF6 mRNA]; ursodoxicoltaurine inhibits the reaction [N-palmitoylsphingosine results in increased expression of ATF6 mRNA]	PMID:28223344
1313517	ATF6	activating transcription factor 6	gene	CHEBI:80885	Pachymic acid	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C102487	pachymic acid results in increased expression of ATF6 mRNA; pachymic acid results in increased expression of ATF6 protein	PMID:35524978
1313517	ATF6	activating transcription factor 6	gene	CHEBI:81068	Shikonin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220906	CTD	MESH:C016101	shikonin inhibits the reaction [Glutamic Acid results in increased expression of ATF6 protein]	PMID:35028790
1313517	ATF6	activating transcription factor 6	gene	CHEBI:81529	Norbinaltorphimine	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:C051844	norbinaltorphimine inhibits the reaction [Methamphetamine results in increased cleavage of ATF6 protein]	PMID:27323860
1313517	ATF6	activating transcription factor 6	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of ATF6 mRNA	PMID:22434021
1313517	ATF6	activating transcription factor 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305471	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ATF6 mRNA	PMID:27291303
1313517	ATF6	activating transcription factor 6	gene	CHEBI:81758	cyproconazole	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20180515	CTD	MESH:C093628	[cyproconazole co-treated with epoxiconazole] results in increased expression of ATF6 mRNA	PMID:29038839
1313517	ATF6	activating transcription factor 6	gene	CHEBI:82416	Chloroacetonitrile	increases expression	ISO	RGD:1313518	E	RGD:6480464	20230801	CTD	MESH:C069277	chloroacetonitrile results in increased expression of ATF6 protein	PMID:36940772
1313517	ATF6	activating transcription factor 6	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305471	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ATF6 mRNA	PMID:23640034
1313517	ATF6	activating transcription factor 6	gene	CHEBI:82445	Dibromoacetonitrile	increases expression	ISO	RGD:1313518	E	RGD:6480464	20240806	CTD	MESH:C051715	dibromoacetonitrile results in increased expression of ATF6 protein	PMID:38065397
1313517	ATF6	activating transcription factor 6	gene	CHEBI:82577	Fusarenone X	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C002469	fusarenon-X results in increased expression of ATF6 mRNA	PMID:20682335
1313517	ATF6	activating transcription factor 6	gene	CHEBI:8450	procymidone	increases expression	ISO	RGD:1313518	E	RGD:6480464	20230704	CTD	MESH:C035988	procymidone results in increased expression of ATF6 mRNA; procymidone results in increased expression of ATF6 protein	PMID:35913088
1313517	ATF6	activating transcription factor 6	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of ATF6 mRNA	PMID:21278054
1313517	ATF6	activating transcription factor 6	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305471	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil affects the expression of ATF6 mRNA	PMID:36038036
1313517	ATF6	activating transcription factor 6	gene	CHEBI:85078	dapagliflozin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20220809	CTD	MESH:C529054	[dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]	PMID:34939712
1313517	ATF6	activating transcription factor 6	gene	CHEBI:8653	pyocyanine	increases activity	ISO	RGD:1305471	E	RGD:6480464	20170516	CTD	MESH:D011710	Pyocyanine results in increased activity of ATF6 protein	PMID:27613716
1313517	ATF6	activating transcription factor 6	gene	CHEBI:8805	Repaglinide	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20230704	CTD	MESH:C072379	repaglinide inhibits the reaction [Rotenone results in increased expression of ATF6 protein]	PMID:36538285
1313517	ATF6	activating transcription factor 6	gene	CHEBI:88542	Butylparaben	increases expression	EXP		E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in increased expression of ATF6 protein	PMID:29319206
1313517	ATF6	activating transcription factor 6	gene	CHEBI:8863	Riluzole	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:D019782	Riluzole results in increased expression of ATF6 protein	PMID:30280407
1313517	ATF6	activating transcription factor 6	gene	CHEBI:90369	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20200609	CTD	MESH:C550547	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [Resveratrol inhibits the reaction [Cadmium Chloride results in increased expression of ATF6 protein]]	PMID:31433112
1313517	ATF6	activating transcription factor 6	gene	CHEBI:91460	KN-93	increases expression	ISO	RGD:1313518	E	RGD:6480464	20230704	CTD	MESH:C072105	KN 93 results in increased expression of ATF6 protein	PMID:37075931
1313517	ATF6	activating transcription factor 6	gene	CHEBI:91460	KN-93	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230704	CTD	MESH:C072105	KN 93 inhibits the reaction [Silicon Dioxide results in increased expression of ATF6 protein]	PMID:37075931
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9150	simvastatin	increases expression	ISO	RGD:1305471	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of ATF6 mRNA; Simvastatin results in increased expression of ATF6 protein	PMID:18807172
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20240109	CTD	MESH:D020123	[Sirolimus co-treated with hydroquinone] results in decreased expression of ATF6 protein	PMID:37148176
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9288	streptozocin	increases cleavage	ISO	RGD:1305471	E	RGD:6480464	20190910	CTD	MESH:D013311	Streptozocin results in increased cleavage of ATF6 protein	PMID:30980806
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1313518	E	RGD:156430337|PMID:36044268	20230228	RGD	MESH:D013311	streptozocin increases expression of Atf6 protein in heart	
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1313518	E	RGD:6480464	20250708	CTD	MESH:D013311	Streptozocin results in increased expression of ATF6 protein	PMID:37757635
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1305471	E	RGD:6480464	20190910	CTD	MESH:D013311	4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased cleavage of ATF6 protein]; [Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein; Chlorogenic Acid inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]; Metformin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Fructose] results in increased expression of ATF6 protein]	PMID:30980806|PMID:34801538
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20211109	CTD	MESH:D013311	[Dietary Fats co-treated with Streptozocin] results in increased expression of ATF6 mRNA; linderalactone inhibits the reaction [Streptozocin results in increased expression of ATF6 protein]; NUS1 protein inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of ATF6 mRNA]	PMID:33812996|PMID:37757635
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D013467	Sulindac results in increased expression of ATF6 mRNA	PMID:32535746
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases activity	EXP		E	RGD:6480464	20130611	CTD	MESH:D019284	Thapsigargin results in increased activity of ATF6 protein	PMID:23383089
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases cleavage	EXP		E	RGD:6480464	20230404	CTD	MESH:D019284	Thapsigargin results in increased cleavage of ATF6 protein	PMID:23741617
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases cleavage	ISO	RGD:1305471	E	RGD:6480464	20150714	CTD	MESH:D019284	Thapsigargin results in increased cleavage of ATF6 protein	PMID:24638036
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases cleavage	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:D019284	Thapsigargin results in increased cleavage of ATF6 protein	PMID:20493918
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of ATF6 mRNA; Thapsigargin results in increased expression of ATF6 protein; Thapsigargin results in increased expression of ATF6 protein modified form	PMID:17963750|PMID:22378314|PMID:23576437|PMID:26264395|PMID:30796460|PMID:32407927
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1305471	E	RGD:6480464	20120412	CTD	MESH:D019284	Thapsigargin results in increased expression of ATF6 protein	PMID:18477628
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1313518	E	RGD:6480464	20140211	CTD	MESH:D019284	Thapsigargin results in increased expression of ATF6 mRNA; Thapsigargin results in increased expression of ATF6 protein	PMID:23576437|PMID:28223344
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	multiple interactions	EXP		E	RGD:6480464	20140211	CTD	MESH:D019284	1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea inhibits the reaction [Thapsigargin results in increased expression of ATF6 protein]; ATF6 promotes the reaction [Thapsigargin results in increased expression of DDIT3 protein]; ATF6 promotes the reaction [Thapsigargin results in increased expression of HSPA5 protein]; demethoxycurcumin analog inhibits the reaction [Thapsigargin results in increased expression of ATF6 protein]; icaritin inhibits the reaction [Thapsigargin results in increased expression of ATF6 mRNA]; Luteolin inhibits the reaction [Thapsigargin results in increased expression of ATF6 protein modified form]; Thapsigargin results in increased cleavage of and affects the localization of ATF6 protein	PMID:23576437|PMID:26264395|PMID:27358234|PMID:27587023|PMID:32407927|PMID:36372277
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9516	thapsigargin	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20120412	CTD	MESH:D019284	1-(1-methanesulfonylpiperidin-4-yl)-3-(4-trifluoromethoxyphenyl)urea inhibits the reaction [Thapsigargin results in increased expression of ATF6 protein]; Apigenin inhibits the reaction [Thapsigargin results in increased cleavage of ATF6 protein]	PMID:20493918|PMID:23576437
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9607	Tiron	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20141111	CTD	MESH:D014013	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [arsenic trioxide results in increased expression of and results in increased cleavage of ATF6 protein]	PMID:23892647
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20170613	CTD	MESH:C001899	triptolide results in decreased expression of ATF6 protein	PMID:26990902
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313518	E	RGD:6480464	20230502	CTD	MESH:C001899	triptolide results in increased expression of ATF6 mRNA	PMID:36520315
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9747	Triptolide	multiple interactions	ISO	RGD:1313518	E	RGD:6480464	20230502	CTD	MESH:C001899	STING1 protein affects the reaction [triptolide results in increased expression of ATF6 mRNA]; STING1 protein affects the reaction [triptolide results in increased expression of ATF6 protein]	PMID:36520315
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313518	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ATF6 mRNA	PMID:28973697
1313517	ATF6	activating transcription factor 6	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C057693	Troglitazone results in increased expression of ATF6 mRNA	PMID:32535746
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614603	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CNTNAP5A mRNA	PMID:33045310
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1614603	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CNTNAP5A mRNA	PMID:36189433
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1565194	E	RGD:6480464	20250401	CTD	MESH:D001280	Atrazine affects the methylation of CNTNAP5B gene	PMID:28931070|PMID:35440735
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1565194	E	RGD:6480464	20250401	CTD	MESH:D014241	Trichloroethylene results in increased expression of CNTNAP5B mRNA	PMID:33387578
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1614603	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CNTNAP5A mRNA	PMID:37567420
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1614603	E	RGD:6480464	20130618	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of CNTNAP5A mRNA	PMID:22401849
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1614603	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CNTNAP5A mRNA	PMID:36189433
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1614603	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CNTNAP5A mRNA	PMID:37567420
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CNTNAP5 mRNA	PMID:31163220
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1614603	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CNTNAP5A mRNA	PMID:34319233
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:24527	herbicide	multiple interactions	ISO	RGD:1614603	E	RGD:6480464	20231031	CTD	MESH:D006540	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CNTNAP5A mRNA	PMID:37567420
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CNTNAP5 gene	PMID:27153756
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1565194	E	RGD:6480464	20250401	CTD	MESH:C010974	Glyphosate results in decreased expression of CNTNAP5B mRNA	PMID:38314887
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1565194	E	RGD:6480464	20250401	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CNTNAP5B mRNA	PMID:32109520
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of CNTNAP5 mRNA	PMID:29704546
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CNTNAP5 mRNA	PMID:32763439
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1614603	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CNTNAP5A mRNA	PMID:37567420
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CNTNAP5 promoter	PMID:27901495
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CNTNAP5 exon	PMID:27901495
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of CNTNAP5 gene	PMID:25435355
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CNTNAP5 promoter	PMID:23974009
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CNTNAP5 mRNA	PMID:25895662
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1565194	E	RGD:6480464	20250401	CTD	MESH:C004312	glycidol results in decreased expression of CNTNAP5B mRNA	PMID:24395379
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CNTNAP5 gene	PMID:31601247
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of CNTNAP5 gene	PMID:31601247
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1565194	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CNTNAP5 mRNA; bisphenol A results in decreased expression of CNTNAP5B mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:41034487
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1565194	E	RGD:6480464	20250401	CTD	MESH:C006780	bisphenol A results in increased methylation of CNTNAP5B gene	PMID:28505145
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CNTNAP5 gene	PMID:31601247
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in decreased expression of CNTNAP5 mRNA	PMID:30616060
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of CNTNAP5 gene	PMID:31601247
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1565194	E	RGD:6480464	20250401	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of CNTNAP5B promoter	PMID:22457795
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1565194	E	RGD:6480464	20250401	CTD	MESH:D014635	Valproic Acid results in decreased expression of CNTNAP5B mRNA	PMID:29427782
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1614603	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CNTNAP5A mRNA	PMID:37567420
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CNTNAP5 mRNA	PMID:38832940
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of CNTNAP5 mRNA	PMID:27188386
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of CNTNAP5 mRNA	PMID:26690555
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:6015	isoflurane	decreases methylation	ISO	RGD:1614603	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in decreased methylation of CNTNAP5 mRNA	PMID:35249202
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1614603	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of CNTNAP5A mRNA	PMID:36851058
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1614603	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of CNTNAP5A mRNA	PMID:26307267
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1614603	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CNTNAP5A mRNA	PMID:37567420
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CNTNAP5 gene]	PMID:28238834
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1565194	E	RGD:6480464	20250401	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CNTNAP5B mRNA	PMID:32109520
1313519	CNTNAP5	contactin associated protein family member 5	gene	CHEBI:9130	sevoflurane	decreases methylation	ISO	RGD:1614603	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in decreased methylation of CNTNAP5 mRNA	PMID:35249202
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SPAG7 mRNA	PMID:38218311
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313521	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SPAG7 mRNA	PMID:33045310
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of SPAG7 protein	PMID:28073184
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313521	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of SPAG7 mRNA	PMID:40945087
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in decreased expression of SPAG7 protein	PMID:34122009
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SPAG7 protein	PMID:37730182
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305473	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SPAG7 mRNA	PMID:33387578
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SPAG7 mRNA	PMID:28818685
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313521	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of SPAG7 mRNA	PMID:37748715
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SPAG7 mRNA	PMID:39836092
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SPAG7 mRNA	PMID:19549813
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SPAG7 protein	PMID:23301498
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313521	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SPAG7 mRNA	PMID:22206623
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SPAG7 protein	PMID:35688186
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in decreased expression of SPAG7 protein	PMID:37834424
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313521	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPAG7 mRNA	PMID:21570461
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305473	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPAG7 mRNA	PMID:21215274
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305473	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of SPAG7 mRNA	PMID:19013527
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of SPAG7 mRNA	PMID:33512557
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SPAG7 mRNA	PMID:39709020
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SPAG7 mRNA	PMID:30851411
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SPAG7 mRNA	PMID:29803840
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313521	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPAG7 mRNA	PMID:22228805
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305473	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SPAG7 mRNA	PMID:34492290
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SPAG7 mRNA	PMID:25047013
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313521	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SPAG7 mRNA	PMID:33221593
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SPAG7 protein	PMID:37567409
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305473	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SPAG7 mRNA	PMID:25181051
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of SPAG7 mRNA	PMID:19244175
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SPAG7 gene	PMID:22964155
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D010269	Paraquat results in increased expression of SPAG7 mRNA	PMID:35182771
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SPAG7 mRNA	PMID:39836092
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPAG7 mRNA	PMID:25979313
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SPAG7 mRNA	PMID:23179753|PMID:29154799
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of SPAG7 mRNA	PMID:25047013
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313521	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SPAG7 mRNA; Nanotubes, Carbon results in decreased expression of SPAG7 mRNA	PMID:25554681
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313521	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SPAG7 mRNA	PMID:35964746
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:6078	ivermectin	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of SPAG7 protein	PMID:32959892
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SPAG7 mRNA	PMID:39836092
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of SPAG7 protein	PMID:34122009
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313521	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SPAG7 mRNA	PMID:22206623
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313521	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SPAG7 mRNA	PMID:22206623
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SPAG7 mRNA	PMID:30851411
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SPAG7 gene]	PMID:28238834
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313521	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of SPAG7 mRNA	PMID:40826991
1313520	SPAG7	sperm associated antigen 7	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305473	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of SPAG7 mRNA	PMID:19281266
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305474	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of L3MBTL3 gene	PMID:35440735
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of L3MBTL3 mRNA	PMID:29581250
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of L3MBTL3 mRNA	PMID:39241906
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of L3MBTL3 mRNA	PMID:35811015
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305474	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of L3MBTL3 mRNA	PMID:20068009
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305474	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of L3MBTL3 mRNA	PMID:33387578
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305474	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of L3MBTL3 gene	PMID:27618143
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of L3MBTL3 protein	PMID:37730182
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of L3MBTL3 mRNA	PMID:16002434
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305474	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of L3MBTL3 mRNA	PMID:22061828
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of L3MBTL3 mRNA	PMID:28818685
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of L3MBTL3 mRNA	PMID:36331819
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:234430	gardiquimod	increases expression	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in increased expression of L3MBTL3 mRNA	PMID:28003376
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:234430	gardiquimod	multiple interactions	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of L3MBTL3 mRNA]	PMID:28003376
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of L3MBTL3 mRNA	PMID:23649840
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of L3MBTL3 mRNA	PMID:41430723
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305474	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of L3MBTL3 mRNA	PMID:30779732
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of L3MBTL3 mRNA	PMID:30912803
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313523	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of L3MBTL3 mRNA	PMID:21570461
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305474	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of L3MBTL3 mRNA	PMID:33387578
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305474	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of L3MBTL3 mRNA	PMID:28959563
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of L3MBTL3 mRNA	PMID:25879800
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA	PMID:34876320
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA	PMID:34876320
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of L3MBTL3 5' UTR; Benzo(a)pyrene affects the methylation of L3MBTL3 promoter	PMID:27901495
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1313523	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of L3MBTL3 intron	PMID:27901495
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305474	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of L3MBTL3 mRNA	PMID:25729387
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305474	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of L3MBTL3 mRNA	PMID:30047161
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313523	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of L3MBTL3 promoter	PMID:35295148
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305474	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of L3MBTL3 mRNA	PMID:34492290
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305474	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of L3MBTL3 mRNA	PMID:30816183
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of L3MBTL3 mRNA	PMID:31715268
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of L3MBTL3 mRNA	PMID:33221593
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of L3MBTL3 mRNA	PMID:29275510
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305474	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of L3MBTL3 mRNA	PMID:41034487
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313523	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in increased expression of L3MBTL3 mRNA	PMID:35479511
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of L3MBTL3 mRNA	PMID:28628672
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:34237	2,4-diaminotoluene	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in decreased expression of L3MBTL3 mRNA	PMID:20713471
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of L3MBTL3 mRNA	PMID:28628672
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of L3MBTL3 mRNA	PMID:37042841
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of L3MBTL3 mRNA	PMID:38174414
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305474	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of L3MBTL3 promoter	PMID:22457795
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of L3MBTL3 mRNA	PMID:19320972
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305474	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of L3MBTL3 mRNA	PMID:24386269
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of L3MBTL3 mRNA]	PMID:28003376
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:1305474	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of L3MBTL3 mRNA	PMID:27638505
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of L3MBTL3 mRNA	PMID:40194260
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of L3MBTL3 mRNA	PMID:36331819
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of L3MBTL3 mRNA	PMID:25979313
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of L3MBTL3 mRNA	PMID:23179753
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of L3MBTL3 mRNA	PMID:24935251|PMID:29154799
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of L3MBTL3 gene	PMID:29154799
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305474	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of L3MBTL3 mRNA	PMID:30047161
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of L3MBTL3 mRNA	PMID:28628672
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of L3MBTL3 mRNA	PMID:28973697
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of L3MBTL3 mRNA	PMID:38832940
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of L3MBTL3 mRNA	PMID:24935251
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313523	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of L3MBTL3 mRNA	PMID:17562736
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of L3MBTL3 mRNA	PMID:29067470
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305474	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of L3MBTL3 mRNA	PMID:33387578
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of L3MBTL3 mRNA	PMID:24714768
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of L3MBTL3 mRNA	PMID:35811015
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of L3MBTL3 mRNA	PMID:22079256
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA	PMID:34876320
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of L3MBTL3 mRNA	PMID:28628672
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305474	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of L3MBTL3 mRNA	PMID:30047161
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of L3MBTL3 mRNA	PMID:35964746
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305474	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of L3MBTL3 mRNA	PMID:24793618
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305474	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of L3MBTL3 mRNA	PMID:25729387
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of L3MBTL3 mRNA	PMID:22079614
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of L3MBTL3 mRNA	PMID:22079256
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of L3MBTL3 mRNA	PMID:22079256
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313523	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of L3MBTL3 mRNA	PMID:23091169
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313523	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of L3MBTL3 mRNA	PMID:39847705
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313523	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of L3MBTL3 mRNA	PMID:34876320
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305474	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of L3MBTL3 mRNA	PMID:30047161
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305474	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of L3MBTL3 mRNA	PMID:21346803
1313522	L3MBTL3	L3MBTL histone methyl-lysine binding protein 3	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305474	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of L3MBTL3 mRNA	PMID:23555832
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of MKI67 mRNA; deoxynivalenol results in increased expression of MKI67 protein	PMID:31863870|PMID:39638853
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C007262	deoxynivalenol results in increased expression of MKI67 protein	PMID:32416088
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:10022	deoxynivalenol	increases phosphorylation	ISO	RGD:1313526	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased phosphorylation of MKI67 protein	PMID:23352502|PMID:23811945
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:10022	deoxynivalenol	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C007262	Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of MKI67 protein]	PMID:32416088
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:10043	wogonin	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C085514	wogonin results in decreased expression of MKI67 protein	PMID:32671444
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D015025	Zearalenone results in increased expression of MKI67 mRNA	PMID:28965971
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:10335	2,2':5',2''-terthiophene	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C019101	alpha-terthienyl results in decreased expression of MKI67 mRNA	PMID:35691152
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:113532	thymoquinone	decreases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:C003466	thymoquinone results in decreased expression of MKI67 protein	PMID:31298468
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:131518	N,N-bis(2-hydroxypropyl)nitrosamine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20160405	CTD	MESH:C012457	[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein; [Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein; Copper deficiency inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; Indomethacin inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]; nimesulide inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]	PMID:19497425|PMID:22387750
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:132082	entinostat	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of MKI67 protein	PMID:21041383
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313526	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MKI67 mRNA	PMID:33045310
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:132446	perfluorobutanesulfonic acid	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C539348	[perfluorobutanesulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in increased expression of MKI67 protein	PMID:40334771
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:132448	perfluorohexanesulfonic acid	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C471071	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluorohexanesulfonic acid] results in increased expression of MKI67 protein	PMID:38603627
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:35861251
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of MKI67 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:31884101|PMID:39752319
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:133246	tetramethylpyrazine	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C017953	[evodiamine co-treated with tetramethylpyrazine] results in decreased expression of MKI67 protein	PMID:39486648
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:134609	nitrosobis(2-oxopropyl)amine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20190219	CTD	MESH:C013622	nitrosobis(2-oxopropyl)amine results in increased expression of MKI67 protein	PMID:29877212
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:134689	rucaparib	multiple interactions	EXP		E	RGD:6480464	20200211	CTD	MESH:C531549	[Irinotecan co-treated with rucaparib] results in decreased expression of MKI67 protein	PMID:30612311
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:134716	brexpiprazole	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C000591922	brexpiprazole results in decreased expression of MKI67 protein	PMID:37347510
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:135632	camostat	increases expression	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C034532	camostat results in increased expression of MKI67 protein	PMID:25104499
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:135632	camostat	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C034532	mirdametinib inhibits the reaction [camostat results in increased expression of MKI67 protein]	PMID:25104499
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:138236	oridonin	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C011959	oridonin analog results in decreased expression of MKI67 protein	PMID:31594861
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:145994	remdesivir	decreases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:C000606551	remdesivir results in decreased expression of MKI67 protein	PMID:35417658
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MKI67 mRNA	PMID:20938992|PMID:33549593
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15365	acetylsalicylic acid	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:D001241	Aspirin results in increased expression of MKI67 protein	PMID:38563870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15365	acetylsalicylic acid	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20180410	CTD	MESH:D001241	Aspirin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; Aspirin inhibits the reaction [Tartrazine results in increased expression of MKI67 mRNA]	PMID:29031619|PMID:31032366
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MKI67 mRNA; Tretinoin results in decreased expression of MKI67 protein	PMID:16249480|PMID:16461808|PMID:33167477
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120918	CTD	MESH:D014212	Tretinoin inhibits the reaction [sodium arsenite results in decreased expression of MKI67 protein]	PMID:21964460
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MKI67 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MKI67 mRNA	PMID:32699268
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313526	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of MKI67 mRNA	PMID:22629407|PMID:24205000
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MKI67 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MKI67 mRNA	PMID:33729688
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of MKI67 mRNA]	PMID:22629407
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15571	hydrazine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20231031	CTD	MESH:C029424	hydrazine results in increased expression of MKI67 protein	PMID:37527026
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MKI67 mRNA	PMID:26079696
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of MKI67 protein	PMID:28073184
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15864	luteolin	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:D047311	[CB-5083 co-treated with Luteolin] results in decreased expression of MKI67 protein	PMID:40194745
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D001280	Atrazine results in decreased expression of MKI67 mRNA	PMID:34146662
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15930	atrazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001280	[Atrazine co-treated with Arsenates] results in increased expression of MKI67 mRNA	PMID:18585445
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20210504	CTD	MESH:C015329	Lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of MKI67 protein]	PMID:33592256
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16037	2-nitropropane	increases expression	ISO	RGD:1305476	E	RGD:6480464	20231031	CTD	MESH:C016617	2-nitropropane results in increased expression of MKI67 protein	PMID:37527026
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16113	cholesterol	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002784	[[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with Silver Compounds] results in decreased expression of MKI67 protein; [[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with Silver Compounds] results in increased expression of MKI67 mRNA; [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the expression of MKI67 mRNA; [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [Silver Compounds affects the expression of MKI67 mRNA]; [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [Silver Compounds results in decreased expression of MKI67 protein]; [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] results in increased expression of MKI67 protein; [EGF protein co-treated with [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with Cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]]] inhibits the reaction [[EGF protein co-treated with Silver Compounds] results in decreased expression of MKI67 protein]	PMID:35385781
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D000431	Ethanol results in decreased expression of MKI67 protein	PMID:31226463
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20151215	CTD	MESH:D000431	Ethanol results in decreased expression of MKI67 protein	PMID:17067360|PMID:26188107|PMID:29548890|PMID:31226463
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1305476	E	RGD:6480464	20190910	CTD	MESH:D000431	Ethanol results in increased expression of MKI67 protein	PMID:29769550
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D000431	IGF1 protein inhibits the reaction [Ethanol results in decreased expression of MKI67 protein]	PMID:31226463
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:D000431	Ethanol promotes the reaction [4-Nitroquinoline-1-oxide results in increased expression of MKI67 protein]	PMID:37406968
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16243	quercetin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin affects the phosphorylation of MKI67 protein	PMID:35688186
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of MKI67 protein	PMID:15067354
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	[Cisplatin co-treated with Quercetin] results in decreased expression of MKI67 protein; [Quercetin co-treated with Ascorbic Acid] results in increased expression of MKI67 mRNA	PMID:16082193|PMID:17639512
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin promotes the reaction [Tamoxifen results in decreased expression of MKI67 protein]	PMID:15067354
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16335	adenosine	affects expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D000241	Adenosine affects the expression of MKI67 mRNA	PMID:34070360
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16335	adenosine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20250204	CTD	MESH:D000241	Adenosine results in increased expression of MKI67 protein	PMID:19638569
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16348	3-nitropropanoic acid	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20121009	CTD	MESH:C015392	3-nitropropionic acid results in decreased expression of MKI67 protein	PMID:21827787
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313526	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MKI67 mRNA	PMID:39241906
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of MKI67 mRNA	PMID:30510588
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:164200	triclosan	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250708	CTD	MESH:D014260	Triclosan inhibits the reaction [beta-Naphthoflavone results in increased expression of MKI67 mRNA]; Triclosan promotes the reaction [alpha-naphthoflavone results in increased expression of MKI67 mRNA]	PMID:39653182
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305476	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of MKI67 mRNA	PMID:32145629
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MKI67 mRNA	PMID:39298647
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D004958	Estradiol results in increased expression of MKI67 mRNA	PMID:18310284|PMID:19167446|PMID:27260121|PMID:28965971
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305476	E	RGD:6480464	20160607	CTD	MESH:D004958	Estradiol results in increased expression of MKI67 mRNA; Estradiol results in increased expression of MKI67 protein	PMID:16607101|PMID:20381596|PMID:23288143|PMID:26372666|PMID:26945725|PMID:31119341
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:D004958	Estradiol deficiency results in increased expression of MKI67 protein; Estradiol results in increased expression of MKI67 protein	PMID:15845746|PMID:19654927|PMID:21484412
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D004958	[Arsenic co-treated with Estradiol] results in increased expression of MKI67 mRNA; Fulvestrant inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA]	PMID:27260121|PMID:33047385
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D004958	9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MKI67 mRNA; [Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of MKI67 protein; Isoflavones inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA]; Methylcholanthrene inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA]; Methylcholanthrene inhibits the reaction [Estradiol results in increased expression of MKI67 protein]; Plant Preparations inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]]	PMID:16891317|PMID:20381596|PMID:23288143|PMID:26372666|PMID:26945725|PMID:32741896
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:D004958	fulvestrant inhibits the reaction [Estradiol results in increased expression of MKI67 protein]; Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]]; Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]; SOD2 protein affects the reaction [Estradiol deficiency results in increased expression of MKI67 protein]	PMID:15845746|PMID:19654927|PMID:21484412
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:165199	Paraoxon-methyl	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C008480	methylparaoxon results in decreased expression of MKI67 protein	PMID:18418871
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MKI67 mRNA	PMID:25510870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MKI67 mRNA	PMID:38568856
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MKI67 mRNA	PMID:33387578
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased expression of MKI67 mRNA	PMID:25549359|PMID:27618143
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MKI67 mRNA	PMID:20938992|PMID:33549593
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16716	benzene	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D001554	Benzene results in decreased expression of MKI67 mRNA	PMID:21843810
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20260203	CTD	MESH:D001554	Benzene results in decreased expression of MKI67 protein	PMID:40885242
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:167830	isorhapontigenin	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C432307	isorhapontigenin results in decreased expression of MKI67 protein	PMID:37619952
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16796	melatonin	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008550	Melatonin results in decreased expression of MKI67 mRNA; Melatonin results in decreased expression of MKI67 protein	PMID:21062352
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D008550	Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein]; Melatonin inhibits the reaction [Cyclophosphamide results in decreased expression of MKI67 protein]	PMID:19028472|PMID:36154502
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16907	4-nitroquinoline N-oxide	increases expression	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:D015112	4-Nitroquinoline-1-oxide results in increased expression of MKI67 protein	PMID:37406968
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:16907	4-nitroquinoline N-oxide	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:D015112	Ethanol promotes the reaction [4-Nitroquinoline-1-oxide results in increased expression of MKI67 protein]	PMID:37406968
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of MKI67 mRNA; Progesterone affects the expression of MKI67 protein	PMID:17251523|PMID:22238285
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of MKI67 mRNA	PMID:16966611
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of MKI67 mRNA	PMID:16888808
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D011374	Copper promotes the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein]; Lead inhibits the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein]	PMID:32004626
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D011374	[Estrogens co-treated with Progesterone] results in increased expression of MKI67 protein	PMID:16800253
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D011374	Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]]; Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]	PMID:15845746
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of MKI67 mRNA	PMID:26079696
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17234	glucose	affects expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose affects the expression of MKI67 protein	PMID:39613055
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17234	glucose	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in decreased expression of MKI67 mRNA	PMID:39613055
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250902	CTD	MESH:D005947	Glucose results in increased expression of MKI67 protein	PMID:40638403
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D005947	[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein]	PMID:25192544
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with 2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA; alanosine inhibits the reaction [imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]]; imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]	PMID:37567420|PMID:37992649|PMID:40638403
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17241	1H-pyrazole	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20210608	CTD	MESH:C031280	pyrazole results in decreased expression of MKI67 protein	PMID:33737021
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of MKI67 protein	PMID:36314267
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:35861251
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of MKI67 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:31884101|PMID:39752319
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17276	phloretin	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20220607	CTD	MESH:D010693	[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]	PMID:34896434
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17296	aniline	increases expression	ISO	RGD:1305476	E	RGD:6480464	20120918	CTD	MESH:C023650	aniline results in increased expression of MKI67 protein	PMID:21070798
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17315	D-glucosamine	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of MKI67 mRNA	PMID:17109745
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MKI67 mRNA	PMID:21592394
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of MKI67 mRNA	PMID:21592394
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MKI67 mRNA	PMID:32741896
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1305476	E	RGD:6480464	20160210	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of MKI67 protein	PMID:15565650|PMID:23665045|PMID:26338220
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of MKI67 mRNA	PMID:17317680
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17356	2-acetamidofluorene	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D015073	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein; Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein]; Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]	PMID:15565650|PMID:17393424|PMID:23665045
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17439	cyanocob(III)alamin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20210608	CTD	MESH:D014805	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA	PMID:33549593
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:174442	Carbadox	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20210706	CTD	MESH:D002218	Carbadox results in decreased expression of MKI67 protein	PMID:26558467
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of MKI67 mRNA	PMID:27683099
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17447	geraniol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20190611	CTD	MESH:C007836	geraniol results in decreased expression of MKI67 protein	PMID:26154255
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17509	5'-S-methyl-5'-thioadenosine	decreases expression	ISO	RGD:1313526	E	RGD:153297773|PMID:21209952	20220726	RGD	MESH:C008500	5'-S-methyl-5'-thioadenosine decreases expression of Ki-67 protein in Mdr2-/- mouse liver	
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:175111	Berberrubine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240402	CTD	MESH:C115958	berberrubine inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MKI67 protein]	PMID:37871880
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17574	biochanin A	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240702	CTD	MESH:C004541	biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of MKI67 protein]	PMID:38648921
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17579	beta-carotene	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20150414	CTD	MESH:D019207	[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA	PMID:23859036
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:175901	gemcitabine	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C056507	Gemcitabine results in decreased expression of MKI67 protein	PMID:38000456
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:175901	gemcitabine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230207	CTD	MESH:C056507	[Curcumin co-treated with Gemcitabine] results in decreased expression of MKI67 protein	PMID:17440100
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17634	D-glucose	affects expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose affects the expression of MKI67 protein	PMID:39613055
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17634	D-glucose	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in decreased expression of MKI67 mRNA	PMID:39613055
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250902	CTD	MESH:D005947	Glucose results in increased expression of MKI67 protein	PMID:40638403
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D005947	[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein]	PMID:25192544
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with 2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA; alanosine inhibits the reaction [imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]]; imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]	PMID:37567420|PMID:37992649|PMID:40638403
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20200114	CTD	MESH:D009538	Nicotine results in decreased expression of MKI67 protein	PMID:30959089
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20200519	CTD	MESH:D009538	Nicotine results in increased expression of MKI67 protein	PMID:31678612
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20180703	CTD	MESH:D009538	[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein; Hexamethonium inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]; methyllycaconitine inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]	PMID:29501575
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230801	CTD	MESH:D009538	[Nicotine co-treated with Quartz] results in increased expression of MKI67 protein	PMID:36868510
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1313526	E	RGD:6480464	20230801	CTD	MESH:D004051	Diethylhexyl Phthalate affects the expression of MKI67 mRNA	PMID:37059381
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20231031	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MKI67 protein	PMID:37258237
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MKI67 mRNA; Diethylhexyl Phthalate results in decreased expression of MKI67 protein	PMID:33754040|PMID:34492810|PMID:35716406|PMID:36209858
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313526	E	RGD:6480464	20140513	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MKI67 mRNA; Diethylhexyl Phthalate results in increased expression of MKI67 protein	PMID:24496636|PMID:34319233|PMID:37406783
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250805	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MKI67 protein	PMID:40323316
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17750	glycine betaine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20210608	CTD	MESH:D001622	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA	PMID:33549593
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:177631	Ulipristal	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20240604	CTD	MESH:C094854	ulipristal results in decreased expression of MKI67 protein	PMID:38458359
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305476	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MKI67 mRNA	PMID:26577399
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MKI67 protein	PMID:37730182
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MKI67 mRNA; Calcitriol results in decreased expression of MKI67 protein	PMID:21592394|PMID:8950452
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of MKI67 mRNA	PMID:21592394
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17948	(+)-taxifolin	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20220809	CTD	MESH:C003377	Fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]]; taxifolin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]; taxifolin promotes the reaction [Fluvastatin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]]	PMID:35465754
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17967	urethane	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D014520	Urethane affects the expression of MKI67 protein	PMID:15790490
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17967	urethane	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D014520	CYP2E1 gene mutant form inhibits the reaction [Urethane affects the expression of MKI67 protein]	PMID:15790490
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:17992	sucrose	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240109	CTD	MESH:D013395	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of MKI67 mRNA]; [Sucrose co-treated with Dietary Fats] results in increased expression of MKI67 mRNA	PMID:37516258
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:18088	formononetin	decreases expression	EXP		E	RGD:151357000|PMID:32276600	20220222	RGD	MESH:C007768	formononetin decreases expression of MKI67 protein in lung	
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:18135	catechol	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20140513	CTD	MESH:C034221	catechol results in decreased expression of MKI67 protein	PMID:23535288
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:18135	catechol	increases expression	ISO	RGD:1305476	E	RGD:6480464	20140513	CTD	MESH:C034221	catechol results in increased expression of MKI67 protein	PMID:23535288
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:181416	Leucomalachite green	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20211109	CTD	MESH:C015320	leucomalachite green results in decreased expression of MKI67 protein	PMID:26558467
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20150414	CTD	MESH:D024502	[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA	PMID:23859036
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	ISO	RGD:1313526	E	RGD:6480464	20180116	CTD	MESH:D014284	Triiodothyronine results in increased expression of MKI67 mRNA	PMID:28315333
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20180116	CTD	MESH:D014284	U 0126 inhibits the reaction [Triiodothyronine results in increased expression of MKI67 mRNA]	PMID:28315333
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKI67 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MKI67 mRNA	PMID:39836092
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of MKI67 mRNA	PMID:17103032
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:183735	Nitrosoheptamethyleneimine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20231031	CTD	MESH:C002148	N-nitrosoheptamethyleneimine results in increased expression of MKI67 protein	PMID:37527026
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20200114	CTD	MESH:D009538	Nicotine results in decreased expression of MKI67 protein	PMID:30959089
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20200519	CTD	MESH:D009538	Nicotine results in increased expression of MKI67 protein	PMID:31678612
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20180703	CTD	MESH:D009538	[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein; Hexamethonium inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]; methyllycaconitine inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]	PMID:29501575
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230801	CTD	MESH:D009538	[Nicotine co-treated with Quartz] results in increased expression of MKI67 protein	PMID:36868510
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:188855	Octicizer	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:C018535	2-ethylhexyldiphenylphosphate results in decreased expression of MKI67 protein	PMID:35503735
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:188855	Octicizer	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20221004	CTD	MESH:C018535	2-ethylhexyldiphenylphosphate results in decreased expression of MKI67 protein	PMID:35503735
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:18917	1,3-dichloropropan-2-ol	increases expression	ISO	RGD:1305476	E	RGD:6480464	20231205	CTD	MESH:C033489	1,3-dichloro-2-propanol results in increased expression of MKI67 protein	PMID:34269859
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:189471	pseudolaric acid B	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240109	CTD	MESH:C058391	pseudolaric acid B results in decreased expression of MKI67 protein	PMID:37244295
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:199329	Inotodiol	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C517091	inotodiol results in decreased expression of MKI67 mRNA	PMID:21359924
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:2038	5-azacytidine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001374	[Azacitidine co-treated with Thalidomide] affects the expression of MKI67 mRNA	PMID:18720364
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of MKI67 mRNA	PMID:27462272
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:205919	clobetasol	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260602	CTD	MESH:D002990	[Clobetasol co-treated with calcipotriene] inhibits the reaction [Imiquimod results in increased expression of MKI67 protein]	PMID:40568777
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of MKI67 mRNA	PMID:17109745
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of MKI67 protein	PMID:38563870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:22542	androstane-3,17-dione	increases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:C006576	androstane-3,17-dione results in increased expression of MKI67 protein	PMID:38122923
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:22542	androstane-3,17-dione	multiple interactions	EXP		E	RGD:6480464	20250204	CTD	MESH:C006576	apalutamide inhibits the reaction [androstane-3,17-dione results in increased expression of MKI67 protein]	PMID:38122923
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:22718	benzoates	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in decreased expression of MKI67 protein	PMID:29472718
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of MKI67 mRNA	PMID:21120746
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:D002104	Cadmium results in increased expression of MKI67 protein	PMID:38563870|PMID:39892737
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of MKI67 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 mRNA	PMID:29741670|PMID:36671501
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 protein; Grape Seed Extract inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 protein]	PMID:26935153
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:23115	chlorohydrocarbon	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:D006843	[Hydrocarbons, Fluorinated co-treated with Hydrocarbons, Brominated co-treated with Hydrocarbons, Chlorinated] results in increased expression of MKI67 protein	PMID:33333158
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:231344	talazoparib	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C586365	[talazoparib co-treated with darinaparsin] results in decreased expression of MKI67 protein	PMID:36253561
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:232159	silmitasertib	increases expression	EXP		E	RGD:6480464	20241119	CTD	MESH:C555142	silmitasertib results in increased expression of MKI67 protein	PMID:25798061
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:232521	CB-5083	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C000606272	[CB-5083 co-treated with Luteolin] results in decreased expression of MKI67 protein	PMID:40194745
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:232612	Azoxymethane	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:D001397	Azoxymethane results in increased expression of MKI67 protein	PMID:38563870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20241203	CTD	MESH:D001397	[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein; Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein]	PMID:19028472
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20241203	CTD	MESH:D001397	[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MKI67 protein; berberrubine inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MKI67 protein]; sinpeinine A inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein]	PMID:34273909|PMID:37871880|PMID:39551424
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MKI67 mRNA	PMID:25510870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MKI67 mRNA	PMID:25510870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:233362	Abemaciclib	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000590451	abemaciclib results in decreased expression of MKI67 protein	PMID:28620137
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:233362	Abemaciclib	multiple interactions	EXP		E	RGD:6480464	20250408	CTD	MESH:C000590451	RB1 protein affects the reaction [abemaciclib results in decreased expression of MKI67 protein]	PMID:28620137
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:23414	copper(II) sulfate	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of MKI67 mRNA	PMID:19549813
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:234265	SHP099	decreases expression	EXP		E	RGD:6480464	20250610	CTD	MESH:C000609471	SHP099 results in decreased expression of MKI67 protein	PMID:32417439
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:234265	SHP099	multiple interactions	EXP		E	RGD:6480464	20250610	CTD	MESH:C000609471	SHP099 promotes the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in decreased expression of MKI67 protein]	PMID:32417439
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:23480	cyclohexanols	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20170303	CTD	MESH:D003511	[Diethylnitrosamine co-treated with Cyclohexanols] results in increased expression of MKI67 protein	PMID:17393424
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MKI67 protein	PMID:23301498
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:25036	lignan	decreases expression	EXP		E	RGD:6480464	20170124	CTD	MESH:D017705	Lignans results in decreased expression of MKI67 protein	PMID:15897583
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MKI67 protein	PMID:20106945
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MKI67 mRNA	PMID:21641981
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MKI67 mRNA	PMID:19770486
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MKI67 protein	PMID:39638853
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305476	E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MKI67 mRNA	PMID:25378103
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MKI67 mRNA	PMID:23649840
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1305476	E	RGD:6480464	20220607	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein	PMID:34896434|PMID:39214269
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D015127	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; 9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]; [Estradiol co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in increased expression of MKI67 protein; [Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; Doxorubicin promotes the reaction [1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]]; Plant Preparations inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene promotes the reaction [Estradiol results in increased expression of MKI67 mRNA]]	PMID:16891317|PMID:26945725|PMID:34896434|PMID:39214269
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20140408	CTD	MESH:D010126	Ozone results in decreased expression of MKI67 mRNA	PMID:24336422
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313526	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of MKI67 protein	PMID:33026818
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MKI67 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MKI67 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of MKI67 mRNA	PMID:32699268
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MKI67 mRNA; [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MKI67 protein; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MKI67 mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which results in increased expression of MKI67 mRNA; TTPA protein affects the reaction [Ozone results in increased expression of MKI67 mRNA]	PMID:19555225|PMID:25658374|PMID:27106289|PMID:34911549
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:2676	amoxicillin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20231205	CTD	MESH:D000658	Amoxicillin results in decreased expression of MKI67 mRNA; Amoxicillin results in decreased expression of MKI67 protein	PMID:36529298
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:2704	anastrozole	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C090450	anastrozole results in decreased expression of MKI67 protein	PMID:15767642|PMID:16002280
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:2704	anastrozole	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C090450	[Tamoxifen co-treated with anastrozole] results in decreased expression of MKI67 protein	PMID:15767642
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20241105	CTD	MESH:C011559	tributyltin results in decreased expression of MKI67 protein	PMID:32783468
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20241105	CTD	MESH:C011559	Fatty Acids, Omega-3 inhibits the reaction [tributyltin results in decreased expression of MKI67 protein]	PMID:32783468
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20150414	CTD	MESH:D015032	[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA	PMID:23859036
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20210608	CTD	MESH:D015032	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA	PMID:33549593
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MKI67 mRNA	PMID:17484886
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MKI67 mRNA	PMID:31150632
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MKI67 protein	PMID:16325526
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313526	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MKI67 mRNA; Carbon Tetrachloride results in increased expression of MKI67 protein	PMID:27339419|PMID:29987408|PMID:31816328|PMID:36526012|PMID:38992766
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20181016	CTD	MESH:D002251	[calcipotriene co-treated with Carbon Tetrachloride] results in increased expression of MKI67 mRNA; ATM protein inhibits the reaction [Carbon Tetrachloride results in increased expression of MKI67 protein]; GANT 61 inhibits the reaction [Carbon Tetrachloride results in increased expression of MKI67 protein]; PANX1 protein affects the reaction [Carbon Tetrachloride results in increased expression of MKI67 mRNA]; Verteporfin inhibits the reaction [[calcipotriene co-treated with Carbon Tetrachloride] results in increased expression of MKI67 mRNA]; Verteporfin inhibits the reaction [Carbon Tetrachloride results in increased expression of MKI67 mRNA]	PMID:29987408|PMID:31816328|PMID:36526012|PMID:38992766
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27470	folic acid	affects expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid affects the expression of MKI67 protein	PMID:21349824
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MKI67 mRNA	PMID:20938992|PMID:33549593
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKI67 mRNA; [Arsenic co-treated with Estradiol] results in increased expression of MKI67 mRNA; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of MKI67 protein; [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of MKI67 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MKI67 mRNA	PMID:33047385|PMID:35809665|PMID:39836092
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MKI67 mRNA	PMID:40504410
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of MKI67 mRNA	PMID:33512557
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27698	vanadium atom	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D014639	Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]	PMID:15565650
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MKI67 protein	PMID:35688186
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20190910	CTD	MESH:D002110	Caffeine results in decreased expression of MKI67 protein	PMID:30528684
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20160119	CTD	MESH:D002110	Caffeine inhibits the reaction [aluminum chloride results in decreased expression of MKI67 protein]	PMID:26339337
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1305476	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of MKI67 protein	PMID:27486271
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA]; [Glyphosate co-treated with 2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA	PMID:37567420|PMID:37992649
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of MKI67 mRNA	PMID:28189721|PMID:28960355
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27812	Se-methyl-L-selenocysteine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C002979	selenomethylselenocysteine results in decreased expression of MKI67 protein	PMID:18855134
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27812	Se-methyl-L-selenocysteine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C002979	[selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein	PMID:18855134
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305476	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MKI67 mRNA; acetamide results in increased expression of MKI67 protein	PMID:31881176
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C059514	Resveratrol results in decreased expression of MKI67; Resveratrol results in decreased expression of MKI67 mRNA; Resveratrol results in decreased expression of MKI67 protein	PMID:15767336|PMID:17992120|PMID:21209944|PMID:21291235|PMID:24604232
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of MKI67 protein	PMID:25505154
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of MKI67 mRNA	PMID:15149879
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313526	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of MKI67 protein	PMID:22086758
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of MKI67 protein; [Coumestrol co-treated with Resveratrol] results in increased expression of MKI67 mRNA; Resveratrol results in decreased expression of and affects the localization of MKI67 protein; SIRT1 protein affects the reaction [Resveratrol results in decreased expression of MKI67 protein]	PMID:19167446|PMID:26959057|PMID:41028656
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20211109	CTD	MESH:C059514	Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein]; Resveratrol inhibits the reaction [MIR136 promotes the reaction [Paraquat results in decreased expression of MKI67 protein]]	PMID:33978298|PMID:35236239
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MKI67 mRNA	PMID:28903495
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D007854	Lead results in decreased expression of MKI67 protein	PMID:32004626
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:D007854	Lead results in increased expression of MKI67 protein	PMID:38563870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27889	lead(0)	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D007854	Lead inhibits the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein]	PMID:32004626
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20211109	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein]	PMID:33978298
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of MKI67 mRNA; Cisplatin results in decreased expression of MKI67 protein	PMID:27594783|PMID:39461470
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of MKI67 mRNA	PMID:40618947
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of MKI67 protein	PMID:20702592
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of MKI67 protein	PMID:22006019
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D002945	[Cisplatin co-treated with Quercetin] results in decreased expression of MKI67 protein; Cisplatin promotes the reaction [selenocystine results in decreased expression of MKI67 protein]; selenocystine promotes the reaction [Cisplatin results in decreased expression of MKI67 protein]	PMID:16082193|PMID:39461470
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of MKI67 protein	PMID:34813904
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MKI67 mRNA	PMID:30912803
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:27999	tolbutamide	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D014044	Tolbutamide results in decreased expression of MKI67 protein	PMID:16718685
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28077	rifampicin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D012293	[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein	PMID:21224054
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:D019833	Genistein results in decreased expression of MKI67 mRNA	PMID:31593742
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1305476	E	RGD:6480464	20120918	CTD	MESH:D019833	Genistein results in increased expression of MKI67 mRNA	PMID:20381596
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120918	CTD	MESH:D019833	Isoflavones inhibits the reaction [Genistein results in increased expression of MKI67 mRNA]	PMID:20381596
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MKI67 mRNA	PMID:25583101
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305476	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MKI67 mRNA	PMID:34747641
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313526	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MKI67 mRNA	PMID:18691609|PMID:26377647
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MKI67 mRNA	PMID:32109520|PMID:33387578
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MKI67 protein	PMID:32283119|PMID:39880321
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MKI67 mRNA	PMID:21846477
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [NFE2L2 gene mutant form results in increased expression of MKI67 protein]	PMID:21846477
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28172	harmaline	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230404	CTD	MESH:D006246	Harmaline results in decreased expression of MKI67 protein	PMID:35963316
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28201	rotenone	affects expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone affects the expression of MKI67 mRNA	PMID:33512557
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of MKI67 mRNA	PMID:28374803
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MKI67 mRNA	PMID:23179753|PMID:26272509
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MKI67 mRNA	PMID:27188386
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of MKI67 mRNA	PMID:17109745
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28445	vincristine	increases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	MKI67 gene SNP results in increased susceptibility to Vincristine	PMID:20864405
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28509	chloroethene	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240604	CTD	MESH:D014752	[Vinyl Chloride co-treated with Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of MKI67 protein	PMID:37061008
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28553	selenocystine	decreases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C009226	selenocystine results in decreased expression of MKI67 protein	PMID:39461470
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28553	selenocystine	multiple interactions	EXP		E	RGD:6480464	20241203	CTD	MESH:C009226	Cisplatin promotes the reaction [selenocystine results in decreased expression of MKI67 protein]; selenocystine promotes the reaction [Cisplatin results in decreased expression of MKI67 protein]	PMID:39461470
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D020106	Acrylamide results in decreased expression of MKI67 mRNA; Acrylamide results in decreased expression of MKI67 protein	PMID:20734998|PMID:32763439
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305476	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of MKI67 mRNA	PMID:28959563
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D003300	Copper results in decreased expression of MKI67 protein	PMID:32004626
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20150512	CTD	MESH:D003300	Copper deficiency results in decreased expression of MKI67 protein	PMID:24013775
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28694	copper atom	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:D003300	Copper results in increased expression of MKI67 protein	PMID:35809665
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305476	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of MKI67 mRNA	PMID:30556269
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of MKI67 protein; [Copper co-treated with Resveratrol] results in decreased expression of MKI67 protein; [NSC 689534 binds to Copper] which results in decreased expression of MKI67 mRNA; Copper promotes the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein]	PMID:20971185|PMID:32004626|PMID:35809665|PMID:41028656
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D003300	Copper deficiency inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]	PMID:19497425
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of MKI67 mRNA	PMID:15205334|PMID:29803840|PMID:30031762
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	[zoledronic acid co-treated with Doxorubicin] results in decreased expression of MKI67 protein; Doxorubicin promotes the reaction [palbociclib results in decreased expression of MKI67 protein]	PMID:18695136|PMID:22751436
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20250311	CTD	MESH:D004317	Doxorubicin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; Doxorubicin promotes the reaction [1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]]	PMID:39214269
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:D004317	Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]]	PMID:30482226
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20231031	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with 2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA	PMID:37567420|PMID:37992649
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of MKI67 protein	PMID:35688186
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240109	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Sucrose co-treated with Dietary Fats] results in increased expression of MKI67 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA]; [Glyphosate co-treated with 2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein	PMID:37516258|PMID:37992649
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [1,12-benzoperylene results in increased expression of MKI67 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of MKI67 protein]	PMID:31518672|PMID:32745510
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:28946	theobromine	multiple interactions	ISO	RGD:1305476	E	RGD:127229954|PMID:33360052	20210607	RGD	MESH:D013805	[Theobromine co-treated with Theanine] inhibits the reaction [1,2-dimethylhydrazine increases expression Mki67 protein in the colon]	
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29014	cordycepin	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C058120	cordycepin results in increased expression of MKI67 mRNA	PMID:34070360
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29014	cordycepin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230704	CTD	MESH:C058120	cordycepin inhibits the reaction [FGF9 protein results in increased expression of MKI67 protein]	PMID:33172093
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29019	nonanoic acid	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:C008776	pelargonic acid affects the expression of MKI67 mRNA	PMID:22302311
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29073	L-ascorbic acid	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D001205	Ascorbic Acid results in decreased expression of MKI67 protein	PMID:38160894
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001205	[Quercetin co-treated with Ascorbic Acid] results in increased expression of MKI67 mRNA; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of MKI67 protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein]	PMID:17639512|PMID:38160894
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20150414	CTD	MESH:D001205	[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA	PMID:23859036
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of MKI67 mRNA	PMID:36057382
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29287	gold atom	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which results in increased expression of MKI67 mRNA	PMID:28433809
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of MKI67 mRNA	PMID:22623647
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:2955	azithromycin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240109	CTD	MESH:D017963	Azithromycin results in decreased expression of MKI67 mRNA	PMID:37995777|PMID:39890031
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of MKI67 mRNA	PMID:34032870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MKI67 mRNA	PMID:38072110|PMID:38568856
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MKI67 protein	PMID:21964460
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of MKI67 mRNA	PMID:29301061|PMID:39719251
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1305476	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of MKI67 protein	PMID:38977090
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of MKI67 protein	PMID:37668303
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKI67 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MKI67 mRNA	PMID:39836092
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20161228	CTD	MESH:C017947	Methylnitrosourea promotes the reaction [sodium arsenite results in increased expression of MKI67 protein]; sodium arsenite promotes the reaction [Methylnitrosourea results in increased expression of MKI67 protein]; Tretinoin inhibits the reaction [sodium arsenite results in decreased expression of MKI67 protein]	PMID:21964460|PMID:38977090
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MKI67 mRNA	PMID:40504410
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MKI67 mRNA	PMID:22378314
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MKI67 mRNA	PMID:17942131|PMID:19770486|PMID:21569818
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MKI67 mRNA	PMID:20713471|PMID:32417428
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20170516	CTD	MESH:D001564	[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of MKI67 protein; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA	PMID:27858113|PMID:38237855
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:C015001	arsenite results in increased expression of MKI67 protein	PMID:38563870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MKI67 mRNA]	PMID:32406909
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of MKI67 mRNA	PMID:36057382
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30050	gold(0)	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which results in increased expression of MKI67 mRNA	PMID:28433809
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D003300	Copper results in decreased expression of MKI67 protein	PMID:32004626
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20150512	CTD	MESH:D003300	Copper deficiency results in decreased expression of MKI67 protein	PMID:24013775
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30052	copper(0)	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:D003300	Copper results in increased expression of MKI67 protein	PMID:35809665
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305476	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of MKI67 mRNA	PMID:30556269
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of MKI67 protein; [Copper co-treated with Resveratrol] results in decreased expression of MKI67 protein; [NSC 689534 binds to Copper] which results in decreased expression of MKI67 mRNA; Copper promotes the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein]	PMID:20971185|PMID:32004626|PMID:35809665|PMID:41028656
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D003300	Copper deficiency inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]	PMID:19497425
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30145	lithium atom	increases expression	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in increased expression of MKI67 mRNA	PMID:21711903
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30146	lithium hydride	increases expression	ISO	RGD:1305476	E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in increased expression of MKI67 mRNA	PMID:21711903
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20150414	CTD	MESH:D015032	[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA	PMID:23859036
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20210608	CTD	MESH:D015032	[Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA	PMID:33549593
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MKI67 mRNA	PMID:27131904
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30537	triphenylstannane	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20230905	CTD	MESH:C030665	triphenyltin results in decreased expression of MKI67 mRNA; triphenyltin results in decreased expression of MKI67 protein	PMID:35489455
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of MKI67 protein	PMID:35288261
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313526	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MKI67 mRNA	PMID:29341224
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MKI67 mRNA	PMID:20382639
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MKI67 mRNA; Arsenic Trioxide results in decreased expression of MKI67 protein	PMID:27318970|PMID:30091188|PMID:38160894
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20200114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MKI67 protein	PMID:31421153
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of MKI67 mRNA]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of MKI67 protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein]	PMID:27318970|PMID:38160894
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200114	CTD	MESH:C006632	FOXO3 protein affects the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein]	PMID:31421153
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30682	ruthenium atom	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20220607	CTD	MESH:D012428	[Ruthenium binds to Phloretin] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]	PMID:34896434
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:30772	butyric acid	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20241105	CTD	MESH:D020148	Butyric Acid promotes the reaction [erastin results in decreased expression of MKI67 protein]	PMID:37341073
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3086	betulin	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C002503	[Gefitinib co-treated with betulin] results in decreased expression of MKI67 protein	PMID:27447558
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3090	bicalutamide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in decreased expression of MKI67 mRNA	PMID:15638997
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:310312	isoliquiritigenin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20170516	CTD	MESH:C040920	isoliquiritigenin results in decreased expression of MKI67 mRNA; isoliquiritigenin results in decreased expression of MKI67 protein	PMID:27702603
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:31355	carboplatin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230606	CTD	MESH:D016190	Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; Carboplatin promotes the reaction [Pulsatilla saponin A inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]]; Pulsatilla saponin A promotes the reaction [Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]]	PMID:33190582
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3139	bleomycin A2	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:D001761	Bleomycin results in decreased expression of MKI67 mRNA	PMID:40645554
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C070081	fulvestrant inhibits the reaction [bisphenol A results in decreased expression of MKI67 mRNA]; fulvestrant inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA]; fulvestrant inhibits the reaction [nonylphenol results in increased expression of MKI67 mRNA]	PMID:27260121|PMID:28701262
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:31638	fulvestrant	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:C070081	fulvestrant inhibits the reaction [1,7-diphenyl-5-heptene-3-one results in increased expression of MKI67 protein]; fulvestrant inhibits the reaction [Estradiol results in increased expression of MKI67 protein]	PMID:19654927
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:31695	indigo carmine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20250805	CTD	MESH:D007203	[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in increased expression of MKI67 protein	PMID:24941295
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20211109	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein; Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein]	PMID:33978298
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:31832	methyl salicylate	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:C033069	methyl salicylate affects the expression of MKI67 mRNA	PMID:22302311
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of MKI67 mRNA; methylparaben results in increased expression of MKI67 protein	PMID:31745603|PMID:35174924
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of MKI67 mRNA	PMID:25729387
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MKI67 mRNA	PMID:25729387
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20140513	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MKI67 protein	PMID:22387750|PMID:23535288
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32161	sulfadimethoxine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120918	CTD	MESH:D013412	[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein; Indomethacin inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]; Indomethacin inhibits the reaction [Sulfadimethoxine results in increased expression of MKI67 protein]; nimesulide inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]	PMID:22387750
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C009495	titanium dioxide results in increased expression of MKI67 mRNA	PMID:32224134
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1305476	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of MKI67 mRNA	PMID:30012374
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313526	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MKI67 mRNA; titanium dioxide results in increased expression of MKI67 protein	PMID:23557971|PMID:29128614
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32234	titanium dioxide	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:C009495	[Vitallium analog binds to titanium dioxide] which results in decreased expression of MKI67 mRNA	PMID:23825117
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32293	verteporfin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230307	CTD	MESH:C098350	Verteporfin inhibits the reaction [[calcipotriene co-treated with Carbon Tetrachloride] results in increased expression of MKI67 mRNA]; Verteporfin inhibits the reaction [Carbon Tetrachloride results in increased expression of MKI67 mRNA]; Verteporfin inhibits the reaction [perfluorooctanoic acid results in increased expression of MKI67 protein]	PMID:36152675|PMID:38992766
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32297	Vinpocetine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20241105	CTD	MESH:C013983	vinpocetine inhibits the reaction [Thioacetamide results in increased expression of MKI67 protein]	PMID:32840391
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305476	E	RGD:6480464	20160210	CTD	MESH:D013853	Thioacetamide results in increased expression of MKI67 mRNA; Thioacetamide results in increased expression of MKI67 protein	PMID:23411599|PMID:26011634|PMID:26558467|PMID:32840391|PMID:34492290|PMID:37258237|PMID:39716576
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20241105	CTD	MESH:D013853	montelukast inhibits the reaction [Thioacetamide results in increased expression of MKI67 protein]; Trimetazidine inhibits the reaction [Thioacetamide results in increased expression of MKI67 protein]; vinpocetine inhibits the reaction [Thioacetamide results in increased expression of MKI67 protein]	PMID:32840391|PMID:39716576
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305476	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MKI67 mRNA	PMID:25380136
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1305476	E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of MKI67 mRNA	PMID:22484513|PMID:32741897
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313526	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MKI67 mRNA	PMID:17950772|PMID:23811191
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of MKI67 mRNA]	PMID:17950772
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of MKI67 mRNA	PMID:19191707
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MKI67 protein	PMID:21776270
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:33007	chromium(6+)	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250401	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of MKI67 protein	PMID:38563870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of MKI67 mRNA	PMID:38479592
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MKI67 mRNA	PMID:30903817
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased expression of MKI67 mRNA	PMID:28701262|PMID:29275510
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MKI67 mRNA	PMID:23146694|PMID:25181051|PMID:30816183
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A results in decreased expression of MKI67 protein	PMID:35278557
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305476	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of MKI67 mRNA; bisphenol A results in increased expression of MKI67 protein	PMID:26877094|PMID:32145629|PMID:35465754
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313526	E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased expression of MKI67 mRNA; bisphenol A results in increased expression of MKI67 protein	PMID:22875908
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	fulvestrant inhibits the reaction [bisphenol A results in decreased expression of MKI67 mRNA]	PMID:28701262
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20220809	CTD	MESH:C006780	Fluvastatin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]; Fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]]; taxifolin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]; taxifolin promotes the reaction [Fluvastatin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]]	PMID:35465754
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20241105	CTD	MESH:C006780	[ERBB2 protein results in increased susceptibility to bisphenol A] which results in increased expression of MKI67 protein	PMID:38892447
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3374	capsaicin	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20180515	CTD	MESH:D002211	Capsaicin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]	PMID:29155087
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MKI67 mRNA	PMID:25979313
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of MKI67 mRNA	PMID:26682919
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MKI67 mRNA	PMID:25510870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MKI67 mRNA	PMID:25510870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of MKI67 mRNA	PMID:20713471
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20151110	CTD	MESH:D008748	Methylcholanthrene inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA]; Methylcholanthrene inhibits the reaction [Estradiol results in increased expression of MKI67 protein]	PMID:26372666
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3437	carteolol	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D002354	Carteolol results in decreased expression of MKI67 protein	PMID:37120125
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313526	E	RGD:6480464	20180828	CTD	MESH:C543008	bisphenol S affects the expression of MKI67 protein	PMID:29526645
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of MKI67 mRNA	PMID:39298647|PMID:40203079
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S results in increased expression of MKI67 protein	PMID:31945527|PMID:38657712
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34421	4-Hydroxybenzophenone	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20221101	CTD	MESH:C024292	4-hydroxybenzophenone results in decreased expression of MKI67 protein	PMID:35476924
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34421	4-Hydroxybenzophenone	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20221101	CTD	MESH:C024292	CXCL1 protein promotes the reaction [4-hydroxybenzophenone results in decreased expression of MKI67 protein]	PMID:35476924
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34533	Amaranth	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20250805	CTD	MESH:D000548	[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in increased expression of MKI67 protein	PMID:24941295
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MKI67 protein	PMID:21776270
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MKI67 mRNA	PMID:26377693
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20170516	CTD	MESH:C006703	[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of MKI67 protein; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA	PMID:27858113|PMID:38237855
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34568	Benzo[ghi]perylene	decreases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:C006718	1,12-benzoperylene results in decreased expression of MKI67 protein	PMID:35182551
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of MKI67 protein	PMID:31518672
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34568	Benzo[ghi]perylene	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:C006718	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [1,12-benzoperylene results in decreased expression of MKI67 protein]; Acetylcysteine inhibits the reaction [1,12-benzoperylene results in increased expression of MKI67 protein]	PMID:31518672|PMID:35182551
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230404	CTD	MESH:C008745	bisphenol F results in decreased expression of MKI67 protein	PMID:35278557
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250805	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MKI67 protein	PMID:40323316
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240702	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of MKI67 protein	PMID:38648921
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D016264	[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein; Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein]	PMID:19028472
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20220308	CTD	MESH:D016264	[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MKI67 protein; berberrubine inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of MKI67 protein]; biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of MKI67 protein]; sinpeinine A inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein]	PMID:34273909|PMID:37871880|PMID:38648921|PMID:39551424
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305476	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of MKI67 mRNA	PMID:22546817
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MKI67 mRNA	PMID:21266533|PMID:31050326
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MKI67 protein	PMID:16916955
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250805	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MKI67 protein	PMID:40323316
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305476	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of MKI67 mRNA	PMID:22546817
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250805	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MKI67 protein	PMID:40323316
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to MKI67 protein	PMID:32991956
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene affects the expression of MKI67 mRNA	PMID:22302311
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34750	Ethylenethiourea	increases expression	ISO	RGD:1305476	E	RGD:6480464	20231031	CTD	MESH:D005031	Ethylenethiourea results in increased expression of MKI67 protein	PMID:37527026
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MKI67 protein	PMID:34813904
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MKI67 protein	PMID:21776270
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20140408	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MKI67 mRNA; Diethylnitrosamine results in increased expression of MKI67 protein	PMID:24012840|PMID:37527026|PMID:40882885
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MKI67 mRNA; Diethylnitrosamine results in increased expression of MKI67 protein	PMID:17854601|PMID:17942915
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein; [Diethylnitrosamine co-treated with Cyclohexanols] results in increased expression of MKI67 protein; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MKI67 protein; [Mirtazapine co-treated with Diethylnitrosamine] results in increased expression of MKI67 mRNA; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein]; Mirtazapine inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 mRNA]; Mirtazapine inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 protein]; Proliferating Cell Nuclear Antigen inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 protein]	PMID:17393424|PMID:17651763|PMID:23665045|PMID:24012840|PMID:40882885
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MKI67 mRNA; MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 protein]; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 mRNA]	PMID:17854601|PMID:17942915|PMID:24535843
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20230905	CTD	MESH:D010269	Paraquat results in decreased expression of MKI67 protein	PMID:35236239
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230905	CTD	MESH:D010269	Paraquat results in decreased expression of MKI67 protein	PMID:34811946
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20230905	CTD	MESH:D010269	MIR136 promotes the reaction [Paraquat results in decreased expression of MKI67 protein]; Resveratrol inhibits the reaction [MIR136 promotes the reaction [Paraquat results in decreased expression of MKI67 protein]]	PMID:35236239
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of MKI67 mRNA; ST2825 inhibits the reaction [Paraquat results in decreased expression of MKI67 protein]	PMID:34811946|PMID:36117858
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MKI67 mRNA	PMID:37042841
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305476	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of MKI67 mRNA	PMID:30589522
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of MKI67 mRNA	PMID:17616710
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:351346	phenethyl isothiocyanate	increases expression	ISO	RGD:1305476	E	RGD:6480464	20140513	CTD	MESH:C058305	phenethyl isothiocyanate results in increased expression of MKI67 protein	PMID:23535288
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKI67 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MKI67 mRNA	PMID:39836092
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35170	vanadium(0)	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D014639	Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]	PMID:15565650
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313526	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MKI67 mRNA	PMID:26377693
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of MKI67 mRNA	PMID:18500788
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35455	1-naphthyl isothiocyanate	affects expression	ISO	RGD:1305476	E	RGD:6480464	20180515	CTD	MESH:D015058	1-Naphthylisothiocyanate affects the expression of MKI67 protein	PMID:26011634
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305476	E	RGD:6480464	20140408	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MKI67 mRNA; 1-Naphthylisothiocyanate results in increased expression of MKI67 protein	PMID:23411599|PMID:30723492
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MKI67 mRNA	PMID:38568856
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MKI67 mRNA; Cadmium Chloride results in decreased expression of MKI67 protein	PMID:25993096|PMID:30506660
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MKI67 mRNA	PMID:24982889
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MKI67 mRNA	PMID:26472689|PMID:38382870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305476	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MKI67 protein	PMID:22081424|PMID:22457795
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of MKI67 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 mRNA	PMID:29741670|PMID:36671501
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120717	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 protein; Decitabine inhibits the reaction [Cadmium Chloride results in increased expression of MKI67 protein]; Grape Seed Extract inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 protein]	PMID:22457795|PMID:26935153
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35459	diisononyl phthalate	increases expression	ISO	RGD:1313526	E	RGD:6480464	20220111	CTD	MESH:C012125	diisononyl phthalate results in increased expression of MKI67 protein	PMID:34453847
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250805	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MKI67 protein	PMID:40323316
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MKI67 mRNA	PMID:36326898
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MKI67 protein	PMID:40334771
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313526	E	RGD:6480464	20230307	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MKI67 mRNA; perfluorooctanoic acid results in increased expression of MKI67 protein	PMID:36152675
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C023036	[perfluorobutanesulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in increased expression of MKI67 protein; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluorohexanesulfonic acid] results in increased expression of MKI67 protein	PMID:38603627|PMID:40334771
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230307	CTD	MESH:C023036	Verteporfin inhibits the reaction [perfluorooctanoic acid results in increased expression of MKI67 protein]	PMID:36152675
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305476	E	RGD:6480464	20121009	CTD	MESH:C039281	furan results in increased expression of MKI67 mRNA; furan results in increased expression of MKI67 protein	PMID:20562052|PMID:22507866|PMID:25539665
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of MKI67 mRNA	PMID:28903501
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313526	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of MKI67 mRNA	PMID:22698814
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20140311	CTD	MESH:D011285	[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Pregnenolone Carbonitrile] results in increased expression of MKI67 mRNA	PMID:23626729
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MKI67 mRNA	PMID:19320972|PMID:19376846
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:C018021	[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein]	PMID:25192544
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of MKI67 mRNA	PMID:25380136
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35812	oxfendazole	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20160210	CTD	MESH:C011030	oxfendazole results in decreased expression of MKI67 protein	PMID:26558467
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MKI67 mRNA	PMID:24449571
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of MKI67 mRNA	PMID:16269432
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3638	chloroquine	multiple interactions	EXP		E	RGD:6480464	20200331	CTD	MESH:D002738	[Chloroquine co-treated with flavokawain B] results in decreased expression of MKI67 protein	PMID:30025493
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:D002738	[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]]	PMID:30482226
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3647	chlorpromazine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002746	Chlorpromazine analog results in decreased expression of MKI67 mRNA	PMID:15924885
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:36704	imiquimod	increases expression	ISO	RGD:1313526	E	RGD:6480464	20260602	CTD	MESH:C056493	Imiquimod results in increased expression of MKI67 protein	PMID:40568777
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:36704	imiquimod	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260602	CTD	MESH:C056493	[Clobetasol co-treated with calcipotriene] inhibits the reaction [Imiquimod results in increased expression of MKI67 protein]; pyrimidin-2-one beta-ribofuranoside inhibits the reaction [Imiquimod results in increased expression of MKI67 protein]	PMID:40568777
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MKI67 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MKI67 mRNA	PMID:32699268
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1305476	E	RGD:6480464	20210406	CTD	MESH:D002994	Clofibrate results in increased expression of MKI67 mRNA	PMID:32741897
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	ISO	RGD:1313526	E	RGD:6480464	20130312	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of MKI67 protein	PMID:22981962
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MKI67 mRNA	PMID:32588087
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MKI67 mRNA	PMID:40194260
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:38561	fluvastatin	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20220809	CTD	MESH:C065180	Fluvastatin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]; Fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]]; taxifolin promotes the reaction [Fluvastatin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]]	PMID:35465754
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of MKI67 mRNA	PMID:28302478
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:38746	parathion-methyl	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008743	Methyl Parathion results in decreased expression of MKI67 protein	PMID:18418871
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:38757	isoflavones	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones results in decreased expression of MKI67 mRNA	PMID:23288143
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:38757	isoflavones	increases expression	ISO	RGD:1305476	E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones results in increased expression of MKI67 mRNA	PMID:23288143
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:38757	isoflavones	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA]; Isoflavones inhibits the reaction [Genistein results in increased expression of MKI67 mRNA]	PMID:20381596|PMID:23288143
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MKI67 mRNA	PMID:31533062
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:38940	sunitinib	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20231205	CTD	MESH:C473478	Sunitinib results in decreased expression of MKI67 protein	PMID:36797997
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of MKI67 mRNA	PMID:19167446
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MKI67 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of MKI67 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of MKI67 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of MKI67 mRNA]	PMID:18310284|PMID:19167446
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20201103	CTD	MESH:C464485	acetamiprid results in decreased expression of MKI67 mRNA	PMID:30103633|PMID:39529242
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:39175	thiacloprid	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:C417209	thiacloprid results in decreased expression of MKI67 mRNA; thiacloprid results in decreased expression of MKI67 protein	PMID:37468076
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MKI67 mRNA	PMID:40419075
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MKI67 protein	PMID:40334771
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C076994	[perfluorobutanesulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in increased expression of MKI67 protein; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluorohexanesulfonic acid] results in increased expression of MKI67 protein	PMID:38603627|PMID:40334771
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of MKI67 mRNA	PMID:22561333
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D003474	Curcumin results in decreased expression of MKI67 protein	PMID:18226269|PMID:19372569|PMID:38348716
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20240806	CTD	MESH:D003474	Curcumin inhibits the reaction [Lamotrigine results in decreased expression of MKI67 protein]	PMID:38050455
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D003474	[Curcumin co-treated with Gemcitabine] results in decreased expression of MKI67 protein	PMID:17440100
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MKI67 mRNA	PMID:25979313
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of MKI67 mRNA	PMID:28001369
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4021	Cyclopamine	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20141111	CTD	MESH:C000541	cyclopamine results in decreased expression of MKI67 protein	PMID:22923130
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20250506	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of MKI67 protein	PMID:39209270
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20210608	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of MKI67 protein	PMID:33737021|PMID:39952379
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1305476	E	RGD:6480464	20240806	CTD	MESH:D003520	Cyclophosphamide results in increased expression of MKI67 protein	PMID:36154502
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4027	cyclophosphamide	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20240806	CTD	MESH:D003520	coenzyme Q10 inhibits the reaction [Cyclophosphamide results in decreased expression of MKI67 protein]; Melatonin inhibits the reaction [Cyclophosphamide results in decreased expression of MKI67 protein]	PMID:36154502|PMID:39209270
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4031	cyclosporin A	affects expression	ISO	RGD:1305476	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of MKI67 mRNA	PMID:24971338
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MKI67 mRNA	PMID:19159671|PMID:20106945|PMID:21632981|PMID:25562108|PMID:27318970
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of MKI67 mRNA	PMID:17942131|PMID:19770486
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4042	cypermethrin	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C017160	cypermethrin results in decreased expression of MKI67 protein	PMID:36063984
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230704	CTD	MESH:C017160	cypermethrin results in decreased expression of MKI67 mRNA; cypermethrin results in decreased expression of MKI67 protein	PMID:37011868
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:40618	aminoguanidine	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C004479	pimagedine results in decreased expression of MKI67 mRNA	PMID:19266598
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41423	celecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C105934	Celecoxib results in decreased expression of MKI67	PMID:20697803
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41423	celecoxib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C105934	[FEC protocol co-treated with Celecoxib] results in decreased expression of MKI67 protein	PMID:16507397
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41423	celecoxib	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C105934	Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of MKI67 protein]	PMID:32416088
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41774	tamoxifen	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D013629	Tamoxifen results in decreased expression of MKI67 protein	PMID:15767642|PMID:16002280|PMID:18855134|PMID:20332317
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of MKI67 protein	PMID:15067354
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41774	tamoxifen	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of MKI67 protein	PMID:12627041
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of MKI67 protein	PMID:17219426
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein; [Tamoxifen co-treated with anastrozole] results in decreased expression of MKI67 protein	PMID:15767642|PMID:18855134
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D013629	Quercetin promotes the reaction [Tamoxifen results in decreased expression of MKI67 protein]	PMID:15067354
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41879	dexamethasone	affects expression	ISO	RGD:1313526	E	RGD:6480464	20260505	CTD	MESH:D003907	Dexamethasone affects the expression of MKI67 mRNA	PMID:40262731
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D003907	Dexamethasone results in decreased expression of MKI67 protein	PMID:22048647
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20180515	CTD	MESH:D003907	Dexamethasone results in decreased expression of MKI67 protein	PMID:29111458
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313526	E	RGD:6480464	20260505	CTD	MESH:D003907	Dexamethasone results in increased expression of MKI67 protein	PMID:40262731
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MKI67 protein	PMID:16468032
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313526	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MKI67 mRNA	PMID:28973697
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:42758	aldehydo-D-glucose	affects expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose affects the expression of MKI67 protein	PMID:39613055
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in decreased expression of MKI67 mRNA	PMID:39613055
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250902	CTD	MESH:D005947	Glucose results in increased expression of MKI67 protein	PMID:40638403
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D005947	[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA; [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein]	PMID:25192544
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 mRNA; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with 2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [Glyphosate co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MKI67 protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA; alanosine inhibits the reaction [imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]]; imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]	PMID:37567420|PMID:37992649|PMID:40638403
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C107676	deguelin results in decreased expression of MKI67 protein	PMID:22623043
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:43931	methyllycaconitine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20180703	CTD	MESH:C054634	methyllycaconitine inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]	PMID:29501575
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of MKI67 mRNA	PMID:24657277
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:44445	nimesulide	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120918	CTD	MESH:C012655	nimesulide inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]	PMID:22387750
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MKI67 mRNA; Okadaic Acid results in increased expression of MKI67 protein	PMID:38832940
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4489	Diallyl sulfide	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C038491	allyl sulfide results in decreased expression of MKI67 protein	PMID:37209385
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:44915	propofol	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D015742	Propofol results in decreased expression of MKI67 protein	PMID:36207479
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4512	Dictamnine	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C026398	dictamnine results in decreased expression of MKI67 protein	PMID:34861243
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MKI67 mRNA	PMID:27188386
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of MKI67 mRNA	PMID:28542535
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C012589	trichostatin A results in decreased expression of MKI67 mRNA	PMID:23770000
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1305476	E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen affects the expression of MKI67 protein	PMID:26011634
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313526	E	RGD:6480464	20260407	CTD	MESH:D000082	Acetaminophen affects the expression of MKI67 mRNA	PMID:40505803
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of MKI67 mRNA	PMID:29067470
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MKI67 mRNA	PMID:33387578
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in decreased expression of MKI67 mRNA	PMID:17942131
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MKI67 mRNA	PMID:22230336
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of MKI67 protein	PMID:17431590
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1313526	E	RGD:6480464	20240903	CTD	MESH:D000082	Acetaminophen results in increased expression of MKI67 mRNA	PMID:38657942
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46245	coenzyme Q10	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20250506	CTD	MESH:C024989	coenzyme Q10 inhibits the reaction [Cyclophosphamide results in decreased expression of MKI67 protein]	PMID:39209270
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4631	diosmin	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20141111	CTD	MESH:D004145	Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein]; Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein]	PMID:23665045
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1313526	E	RGD:6480464	20231031	CTD	MESH:D005472	Fluorouracil affects the expression of MKI67 protein	PMID:36203040
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	MKI67 mRNA affects the susceptibility to Fluorouracil; MKI67 protein affects the susceptibility to Fluorouracil	PMID:15548681|PMID:18286688
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of MKI67; Fluorouracil results in decreased expression of MKI67 mRNA	PMID:11300326|PMID:15205334|PMID:16709241|PMID:21594360
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20231031	CTD	MESH:D005472	Fluorouracil results in decreased expression of MKI67 protein	PMID:36203040
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46557	zoledronic acid	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	[zoledronic acid co-treated with Doxorubicin] results in decreased expression of MKI67 protein	PMID:18695136
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of MKI67 mRNA	PMID:29279043
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of MKI67 mRNA	PMID:29279043
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1313526	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of MKI67 protein	PMID:17200189
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46680	serpentine asbestos	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20170303	CTD	MESH:D017632	[MPO protein affects the susceptibility to Asbestos, Serpentine] which affects the expression of MKI67 protein; PRKDC protein affects the reaction [Asbestos, Serpentine results in increased expression of MKI67 protein]	PMID:16266986|PMID:17200189
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46727	quartz	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230801	CTD	MESH:D011791	[Nicotine co-treated with Quartz] results in increased expression of MKI67 protein	PMID:36868510
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:46938	zebularine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260602	CTD	MESH:C009131	pyrimidin-2-one beta-ribofuranoside inhibits the reaction [Imiquimod results in increased expression of MKI67 protein]	PMID:40568777
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKI67 mRNA; [Arsenic co-treated with Estradiol] results in increased expression of MKI67 mRNA; [arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of MKI67 protein; [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of MKI67 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MKI67 mRNA	PMID:33047385|PMID:35809665|PMID:39836092
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MKI67 mRNA	PMID:40504410
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4744	Echimidine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20200915	CTD	MESH:C000615871	echimidine results in increased expression of MKI67 mRNA	PMID:32419051
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1313526	E	RGD:6480464	20160412	CTD	MESH:D007654	Ketoconazole results in increased expression of MKI67 mRNA	PMID:25808816
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:47575	ABT-737	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C501332	ABT-737 results in decreased expression of MKI67 protein	PMID:19773376
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:47575	ABT-737	multiple interactions	EXP		E	RGD:6480464	20210504	CTD	MESH:C501332	[ABT-737 co-treated with Sirolimus] results in decreased expression of MKI67 protein	PMID:19773376
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4778	embelin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C010945	embelin results in decreased expression of MKI67 protein	PMID:24694877
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MKI67 mRNA	PMID:29391264
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305476	E	RGD:6480464	20180116	CTD	MESH:D004726	Endosulfan results in increased expression of MKI67 protein	PMID:28935589
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of MKI67 mRNA	PMID:17109745
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313526	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of MKI67 protein	PMID:22334560
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:48607	lithium chloride	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]]	PMID:15845746
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:1305476	E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in increased expression of MKI67 mRNA	PMID:37567419
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in decreased expression of MKI67 mRNA	PMID:24383545
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:48843	disodium selenite	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20150414	CTD	MESH:D018038	[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA	PMID:23859036
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MKI67 mRNA	PMID:17351261
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4918	O-methyleugenol	increases expression	ISO	RGD:1305476	E	RGD:6480464	20140408	CTD	MESH:C005223	methyleugenol results in increased expression of MKI67 protein	PMID:23411599|PMID:26011634
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4948	Evodiamine	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine results in decreased expression of MKI67 protein	PMID:37611839
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4948	Evodiamine	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C049639	[evodiamine co-treated with tetramethylpyrazine] results in decreased expression of MKI67 protein	PMID:39486648
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4953	exemestane	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C056516	exemestane results in decreased expression of MKI67 protein	PMID:16002280
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120918	CTD	MESH:D007213	Indomethacin inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein]; Indomethacin inhibits the reaction [Sulfadimethoxine results in increased expression of MKI67 protein]	PMID:22387750
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:49668	gefitinib	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C419708	[Gefitinib co-treated with betulin] results in decreased expression of MKI67 protein	PMID:27447558
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MKI67 mRNA; Arsenic Trioxide results in decreased expression of MKI67 protein	PMID:27318970|PMID:30091188|PMID:38160894
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20200114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MKI67 protein	PMID:31421153
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of MKI67 mRNA]; Arsenic Trioxide promotes the reaction [Ascorbic Acid results in decreased expression of MKI67 protein]; Ascorbic Acid promotes the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein]	PMID:27318970|PMID:38160894
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200114	CTD	MESH:C032793	FOXO3 protein affects the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein]	PMID:31421153
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:4994	Febrifugine	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C001207	febrifugine results in decreased expression of MKI67 protein	PMID:38431229
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1305476	E	RGD:6480464	20121113	CTD	MESH:D011345	Fenofibrate results in increased expression of MKI67 mRNA; Fenofibrate results in increased expression of MKI67 protein	PMID:17264098|PMID:32741897
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1313526	E	RGD:6480464	20241203	CTD	MESH:D011345	Fenofibrate results in increased expression of MKI67 protein	PMID:39442682
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:50095	bucladesine	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D003994	Bucladesine results in decreased expression of MKI67 protein	PMID:16718685
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1305476	E	RGD:6480464	20251007	CTD	MESH:D008770	Methylnitrosourea results in increased expression of MKI67 protein	PMID:38977090
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1313526	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of MKI67 mRNA	PMID:25270620
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:50102	N-methyl-N-nitrosourea	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20251007	CTD	MESH:D008770	Methylnitrosourea promotes the reaction [sodium arsenite results in increased expression of MKI67 protein]; sodium arsenite promotes the reaction [Methylnitrosourea results in increased expression of MKI67 protein]	PMID:38977090
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:5011	fenpyroximate	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of MKI67 mRNA	PMID:33512557
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Cadmium Chloride results in increased expression of MKI67 protein]	PMID:22457795
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:50207	sophoraflavanone B	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20170103	CTD	MESH:C119737	8-prenylnaringenin results in decreased expression of MKI67 mRNA	PMID:26372666
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313526	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of MKI67 mRNA; Nanotubes, Carbon analog affects the expression of MKI67 mRNA	PMID:25554681
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313526	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of MKI67 mRNA	PMID:40234311
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:50692	mifepristone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in decreased expression of MKI67 protein	PMID:18579510
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:50730	montelukast	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20250805	CTD	MESH:C093875	montelukast inhibits the reaction [Thioacetamide results in increased expression of MKI67 protein]	PMID:39716576
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:50749	calcipotriol	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250114	CTD	MESH:C055085	[calcipotriene co-treated with Carbon Tetrachloride] results in increased expression of MKI67 mRNA; [Clobetasol co-treated with calcipotriene] inhibits the reaction [Imiquimod results in increased expression of MKI67 protein]; Verteporfin inhibits the reaction [[calcipotriene co-treated with Carbon Tetrachloride] results in increased expression of MKI67 mRNA]	PMID:38992766|PMID:40568777
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of MKI67 mRNA	PMID:21148553
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:5118	fluoxetine	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20260303	CTD	MESH:D005473	Fluoxetine results in decreased expression of MKI67 mRNA; Fluoxetine results in decreased expression of MKI67 protein	PMID:39826770
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:51311	bromoethene	increases expression	ISO	RGD:1305476	E	RGD:6480464	20231031	CTD	MESH:C003763	vinyl bromide results in increased expression of MKI67 protein	PMID:37527026
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305476	E	RGD:6480464	20160210	CTD	MESH:D005485	Flutamide results in increased expression of MKI67 protein	PMID:26485406
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20170516	CTD	MESH:C030935	[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of MKI67 protein; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA	PMID:27858113|PMID:38237855
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20170516	CTD	MESH:C031180	[benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with Benzo(a)pyrene co-treated with chrysene] results in increased expression of MKI67 protein; [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA	PMID:27858113|PMID:38237855
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:5169	fraxetin	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C105671	fraxetin results in decreased expression of MKI67 protein	PMID:37867445
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:517248	bufalin	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C022777	bufalin results in decreased expression of MKI67 protein	PMID:36924737
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:51876	auramine O	increases expression	ISO	RGD:1305476	E	RGD:6480464	20231031	CTD	MESH:D001576	Benzophenoneidum results in increased expression of MKI67 protein	PMID:37527026
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of MKI67 mRNA	PMID:36117858
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of MKI67 protein	PMID:19372569
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:52717	bortezomib	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:D000069286	[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein; CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]; Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]]	PMID:30482226
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C029938	nickel sulfate results in increased expression of MKI67 protein	PMID:21776270
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:53050	trimellitic anhydride	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:C015559	trimellitic anhydride affects the expression of MKI67 mRNA	PMID:22302311
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:53050	trimellitic anhydride	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of MKI67 mRNA	PMID:40645554
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MKI67 mRNA	PMID:19042947
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of MKI67 mRNA	PMID:17982090
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:55365	alpha-hexylcinnamaldehyde	affects expression	ISO	RGD:1313526	E	RGD:6480464	20120515	CTD	MESH:C080043	hexyl cinnamic aldehyde affects the expression of MKI67 mRNA	PMID:22302311
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:5643	Heliotrine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20200915	CTD	MESH:C010178	heliotrine results in increased expression of MKI67 mRNA	PMID:32419051
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:5700	Hexamethonium	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20180703	CTD	MESH:D018738	Hexamethonium inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]	PMID:29501575
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313526	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MKI67 mRNA	PMID:38701926
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6039	isopimaric acid	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230704	CTD	MESH:C115138	isopimaric acid results in decreased expression of MKI67 protein	PMID:36754215
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MKI67 protein	PMID:32959892
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:61000	erythrosin B	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20250805	CTD	MESH:D004923	[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in increased expression of MKI67 protein	PMID:24941295
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6121	ketamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007649	Ketamine results in increased expression of MKI67 protein	PMID:19919587
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:61278	scutellarin	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:C484876	scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein]	PMID:25192544
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKI67 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MKI67 mRNA	PMID:39836092
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:63053	purmorphamine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20241203	CTD	MESH:C470893	purmorphamine inhibits the reaction [nonylphenol results in decreased expression of MKI67 protein]	PMID:39111523
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:63607	linezolid	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20170303	CTD	MESH:C098010	Linezolid results in decreased expression of MKI67 mRNA	PMID:21296123
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MKI67 mRNA	PMID:21641980
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MKI67 mRNA	PMID:25729387
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MKI67 mRNA	PMID:25729387
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:63637	vemurafenib	multiple interactions	EXP		E	RGD:6480464	20230404	CTD	MESH:C551177	[Vemurafenib co-treated with 3,5-bis((4-nitrophenyl)methylidene)-1-prop-2-enoylpiperidin-4-one] results in decreased expression of MKI67 protein	PMID:35648318
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6367	lamotrigine	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20240806	CTD	MESH:C047781	Lamotrigine results in decreased expression of MKI67 protein	PMID:38050455
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6367	lamotrigine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20240806	CTD	MESH:C047781	Curcumin inhibits the reaction [Lamotrigine results in decreased expression of MKI67 protein]	PMID:38050455
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6382	Lasiocarpine	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:C005136	lasiocarpine results in decreased expression of MKI67 mRNA	PMID:40956406
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6382	Lasiocarpine	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in increased expression of MKI67 mRNA	PMID:40054833
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6382	Lasiocarpine	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C005136	[CYP3A4 protein co-treated with lasiocarpine] results in decreased expression of MKI67 mRNA	PMID:40956406
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:63918	artesunate	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20180410	CTD	MESH:C039726	artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]	PMID:29031619
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1305476	E	RGD:6480464	20210504	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of MKI67 protein	PMID:33592256
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:63933	Aroclor 1254	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20210504	CTD	MESH:D020111	Lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of MKI67 protein]	PMID:33592256
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:63948	trimethyltin	increases expression	ISO	RGD:1313526	E	RGD:6480464	20160412	CTD	MESH:C046488	trimethyltin results in increased expression of MKI67 mRNA	PMID:24002884
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:63952	arsenic trichloride	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] which results in increased expression of MKI67 protein; [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in increased expression of MKI67 protein	PMID:35809665
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of MKI67 mRNA	PMID:28988120
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313526	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of MKI67 protein	PMID:26558463
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6413	letrozole	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C067431	letrozole results in decreased expression of MKI67 protein	PMID:16002280
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of MKI67 mRNA	PMID:36851058
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:64227	ciglitazone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C039671	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MKI67 mRNA	PMID:16197558
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6443	levonorgestrel	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016912	Levonorgestrel results in decreased expression of MKI67 protein	PMID:16019350
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20200331	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ANGPT2 protein results in increased expression of MKI67 protein]	PMID:31838054
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6570	lupeol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20130416	CTD	MESH:C010480	lupeol results in decreased expression of MKI67 mRNA	PMID:20732907
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:65899	flavokawain B	multiple interactions	EXP		E	RGD:6480464	20200331	CTD	MESH:C452039	[ATG5 protein affects the susceptibility to flavokawain B] which affects the expression of MKI67 protein; [Chloroquine co-treated with flavokawain B] results in decreased expression of MKI67 protein	PMID:30025493
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:66331	xanthohumol	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C104536	xanthohumol results in decreased expression of MKI67 protein	PMID:35259468
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:66790	Pulsatilla saponin D	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20250603	CTD	MESH:C000601508	Pulsatilla saponin D results in decreased expression of MKI67 protein	PMID:39954838
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:67991	(20S)-ginsenoside Rg3	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C097367	[ginsenoside Rg3 co-treated with osimertinib] results in decreased expression of MKI67 protein	PMID:31916386
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6809	methamphetamine	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in decreased expression of MKI67 mRNA	PMID:25290377
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20171010	CTD	MESH:D008694	Methamphetamine results in decreased expression of MKI67 mRNA	PMID:28619521
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305476	E	RGD:6480464	20160210	CTD	MESH:D008701	Methapyrilene results in increased expression of MKI67 protein	PMID:26558467
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:68233	(Z)-3-butylidenephthalide	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C026105	butylidenephthalide results in decreased expression of MKI67 protein	PMID:16987298
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:68233	(Z)-3-butylidenephthalide	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20130903	CTD	MESH:C026105	butylidenephthalide results in decreased expression of MKI67 protein	PMID:16987298
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1305476	E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in increased expression of MKI67 mRNA	PMID:21161181
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:68534	enzalutamide	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:C540278	enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of MKI67 protein]	PMID:32184358
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:68641	(-)-cotinine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20200519	CTD	MESH:D003367	Cotinine results in increased expression of MKI67 protein	PMID:31678612
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:68657	zingerone	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20190409	CTD	MESH:C013738	zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]	PMID:30720227
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of MKI67 mRNA	PMID:27462272
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:69236	falcarindiol	decreases expression	EXP		E	RGD:6480464	20260602	CTD	MESH:C034379	falcarindiol results in decreased expression of MKI67 protein	PMID:40901755
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1313526	E	RGD:6480464	20170613	CTD	MESH:C057862	cyanoginosin LR results in increased expression of MKI67 protein	PMID:28189720|PMID:36115647|PMID:36288207
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20200804	CTD	MESH:D002185	Cannabidiol results in decreased expression of MKI67 protein	PMID:24910342
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6950	mirtazapine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20260113	CTD	MESH:C035133	[Mirtazapine co-treated with Diethylnitrosamine] results in increased expression of MKI67 mRNA; Mirtazapine inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 mRNA]; Mirtazapine inhibits the reaction [Diethylnitrosamine results in increased expression of MKI67 protein]	PMID:40882885
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:6980	monocrotaline	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D016686	[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein	PMID:21224054
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:69832	osthole	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C046627	osthol results in decreased expression of MKI67 protein	PMID:31870840
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:70851	phthalaldehyde	affects expression	ISO	RGD:1313526	E	RGD:6480464	20121218	CTD	MESH:D009764	o-Phthalaldehyde affects the expression of MKI67 mRNA	PMID:22302311
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:35861251
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of MKI67 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:31884101|PMID:39752319
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:71019	omacetaxine mepesuccinate	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C001652	Homoharringtonine results in decreased expression of MKI67 protein	PMID:31726078
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:71418	triamcinolone acetonide	decreases expression	EXP		E	RGD:6480464	20130115	CTD	MESH:D014222	Triamcinolone Acetonide results in decreased expression of MKI67 protein	PMID:16029572
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:72821	1-methyltryptophan	multiple interactions	EXP		E	RGD:6480464	20230404	CTD	MESH:C525396	1-methyltryptophan inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]	PMID:35687267
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:73458	NS-398	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of MKI67 mRNA	PMID:27318970
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20180410	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MKI67 protein	PMID:29031619|PMID:29155087|PMID:30720227
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313526	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MKI67 mRNA; 1,2-Dimethylhydrazine results in increased expression of MKI67 protein	PMID:22206623|PMID:33190582|PMID:38563870
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20180410	CTD	MESH:D019813	Artesunate inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; Aspirin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; Capsaicin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; zingerone inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]	PMID:29031619|PMID:29155087|PMID:30720227
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20230606	CTD	MESH:D019813	Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; Carboplatin promotes the reaction [Pulsatilla saponin A inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]]; Pulsatilla saponin A inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]; Pulsatilla saponin A promotes the reaction [Carboplatin inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of MKI67 protein]]	PMID:33190582
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:74571	iodoacetic acid	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20200519	CTD	MESH:D019807	Iodoacetic Acid results in decreased expression of MKI67 mRNA	PMID:31693920
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:747353	darolutamide	decreases expression	EXP		E	RGD:6480464	20260224	CTD	MESH:C000607739	darolutamide results in decreased expression of MKI67 protein	PMID:39309439
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:747353	darolutamide	multiple interactions	EXP		E	RGD:6480464	20260224	CTD	MESH:C000607739	darolutamide promotes the reaction [RSL3 compound results in decreased expression of MKI67 protein]; RSL3 compound promotes the reaction [darolutamide results in decreased expression of MKI67 protein]	PMID:39309439
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone results in decreased expression of MKI67 mRNA	PMID:27318970
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of MKI67 mRNA]	PMID:27318970
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:748911	alanosine	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:C000082	alanosine inhibits the reaction [imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]]	PMID:40638403
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of MKI67 mRNA	PMID:29522793
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of MKI67 mRNA	PMID:37567420
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of MKI67 mRNA	PMID:27858113
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:75393	Y-27632	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C108830	Y 27632 results in decreased expression of MKI67 protein	PMID:32417439
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:75393	Y-27632	multiple interactions	EXP		E	RGD:6480464	20210504	CTD	MESH:C108830	Y 27632 promotes the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in decreased expression of MKI67 protein]	PMID:32417439
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MKI67 mRNA	PMID:37199045
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:754951	siponimod	increases expression	ISO	RGD:1305476	E	RGD:6480464	20260714	CTD	MESH:C578989	siponimod results in increased expression of MKI67 mRNA	PMID:29556671
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:754951	siponimod	increases expression	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:C578989	siponimod results in increased expression of MKI67 mRNA	PMID:29556671
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:755199	apalutamide	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C572045	apalutamide inhibits the reaction [androstane-3,17-dione results in increased expression of MKI67 protein]	PMID:38122923
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of MKI67 mRNA; Niclosamide results in decreased expression of MKI67 protein	PMID:28284560|PMID:35115509
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:755540	docetaxel	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:D000077143	Docetaxel results in decreased expression of MKI67 protein	PMID:38546343
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:755540	docetaxel	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	[Docetaxel co-treated with fatostatin] results in decreased expression of MKI67 protein; Docetaxel promotes the reaction [[TP53 protein mutant form results in increased susceptibility to fatostatin] which results in decreased expression of MKI67 protein]	PMID:26512780
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:755540	docetaxel	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:D000077143	METTL14 protein inhibits the reaction [Docetaxel results in decreased expression of MKI67 protein]	PMID:38546343
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:755599	epacadostat	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C000613752	epacadostat inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]	PMID:35687267
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:755912	aluminum chloride	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20260714	CTD	MESH:D000077410	Aluminum Chloride results in decreased expression of MKI67 protein	PMID:26339337
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:755912	aluminum chloride	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20260714	CTD	MESH:D000077410	Caffeine inhibits the reaction [Aluminum Chloride results in decreased expression of MKI67 protein]	PMID:26339337
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:756940	abbv-744	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000706695	ABBV-744 results in decreased expression of MKI67 protein	PMID:37769529
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:756996	imeglimin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20260714	CTD	MESH:C575881	alanosine inhibits the reaction [imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]]; imeglimin promotes the reaction [Glucose results in increased expression of MKI67 protein]	PMID:40638403
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:757488	omega-3 fatty acids	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20260714	CTD	MESH:D015525	Fatty Acids, Omega-3 inhibits the reaction [tributyltin results in decreased expression of MKI67 protein]	PMID:32783468
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20201103	CTD	MESH:C007350	nitrofen results in decreased expression of MKI67 protein	PMID:31843527
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:759101	me-344	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000597890	ME-344 results in decreased expression of MKI67 protein	PMID:31597662
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:7599	Nivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of MKI67 protein	PMID:39638853
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:75998	trametinib	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:C560077	[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of MKI67 protein	PMID:37116855
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:76016	vortioxetine	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C557874	Vortioxetine results in decreased expression of MKI67 protein	PMID:40972861
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:76290	PhIP	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20140513	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of MKI67 protein	PMID:23535288
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1305476	E	RGD:6480464	20190219	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MKI67 protein	PMID:29877212
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:76359	butylated hydroxyanisole	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20140513	CTD	MESH:D002083	Butylated Hydroxyanisole results in decreased expression of MKI67 protein	PMID:23535288
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:76359	butylated hydroxyanisole	increases expression	ISO	RGD:1305476	E	RGD:6480464	20140513	CTD	MESH:D002083	Butylated Hydroxyanisole results in increased expression of MKI67 protein	PMID:23535288
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:76604	MeIQx	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of MKI67 mRNA	PMID:20816883
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:76989	phytoestrogen	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:D048789	Phytoestrogens results in increased expression of MKI67 mRNA	PMID:18310284
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:76995	alpha-naphthoflavone	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250708	CTD	MESH:C011512	alpha-naphthoflavone results in increased expression of MKI67 mRNA	PMID:39653182
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:76995	alpha-naphthoflavone	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250708	CTD	MESH:C011512	Triclosan promotes the reaction [alpha-naphthoflavone results in increased expression of MKI67 mRNA]	PMID:39653182
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MKI67 mRNA	PMID:32741896
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of MKI67 mRNA	PMID:12517777
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313526	E	RGD:6480464	20250708	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of MKI67 mRNA	PMID:39653182
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250708	CTD	MESH:D019324	Triclosan inhibits the reaction [beta-Naphthoflavone results in increased expression of MKI67 mRNA]	PMID:39653182
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:77092	fenbendazole	increases expression	ISO	RGD:1305476	E	RGD:6480464	20140408	CTD	MESH:D005273	Fenbendazole results in increased expression of MKI67 protein	PMID:23411599
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in decreased expression of MKI67 protein	PMID:39638853
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in decreased expression of MKI67 mRNA	PMID:21703336
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120717	CTD	MESH:C025589	SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of MKI67 mRNA]	PMID:21703336
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:7735	olanzapine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20240702	CTD	MESH:C076029	Olanzapine results in increased expression of MKI67 protein	PMID:38437955
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of MKI67 mRNA	PMID:34995734
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MKI67 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MKI67 mRNA	PMID:27188386
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250805	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of MKI67 protein	PMID:40323316
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:79516	Nonylphenol	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20241203	CTD	MESH:C025256	nonylphenol results in decreased expression of MKI67 protein	PMID:39111523
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:79516	Nonylphenol	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20241203	CTD	MESH:C025256	nonylphenol results in decreased expression of MKI67 protein	PMID:39111523
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:79516	Nonylphenol	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C025256	nonylphenol results in increased expression of MKI67 mRNA	PMID:27260121
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:79516	Nonylphenol	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C025256	fulvestrant inhibits the reaction [nonylphenol results in increased expression of MKI67 mRNA]	PMID:27260121
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:79516	Nonylphenol	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20241203	CTD	MESH:C025256	purmorphamine inhibits the reaction [nonylphenol results in decreased expression of MKI67 protein]	PMID:39111523
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:80495	benzidine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20231031	CTD	MESH:C029876	benzidine results in increased expression of MKI67 protein	PMID:37527026
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:80630	irinotecan	multiple interactions	EXP		E	RGD:6480464	20200211	CTD	MESH:D000077146	[Irinotecan co-treated with rucaparib] results in decreased expression of MKI67 protein	PMID:30612311
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8064	phenformin	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of MKI67 mRNA	PMID:31324951
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305476	E	RGD:6480464	20141223	CTD	MESH:D010634	Phenobarbital results in increased expression of MKI67 mRNA	PMID:25145657
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313526	E	RGD:6480464	20141223	CTD	MESH:D010634	Phenobarbital results in increased expression of MKI67 mRNA; Phenobarbital results in increased expression of MKI67 protein	PMID:19363144|PMID:19482888|PMID:20403969|PMID:23091169|PMID:24690595|PMID:25145657|PMID:33549593|PMID:34813904
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MKI67 protein	PMID:17651763
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MKI67 mRNA; [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MKI67 mRNA]	PMID:19482888|PMID:24535843|PMID:33549593
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:80887	Phellopterin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240430	CTD	MESH:C104601	phellopterin results in decreased expression of MKI67 protein	PMID:37708916
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8107	phenytoin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:D010672	[Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein	PMID:21224054
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:81336	pectolinarigenin	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C528671	pectolinarigenin results in decreased expression of MKI67 protein	PMID:37393350
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of MKI67 mRNA	PMID:17942131|PMID:18958704
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MKI67 mRNA	PMID:19167446
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313526	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of MKI67 mRNA	PMID:38648751
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MKI67 mRNA	PMID:31173147
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:C511295	[2,2',4,4'-tetrabromodiphenyl ether co-treated with hexabrominated diphenyl ether 153 co-treated with pentabrominated diphenyl ether 100] results in increased expression of MKI67 protein	PMID:30796839
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1313526	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of MKI67 protein	PMID:22334560
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:81760	difenoconazole	increases expression	ISO	RGD:1305476	E	RGD:6480464	20230905	CTD	MESH:C115058	difenoconazole results in increased expression of MKI67 protein	PMID:34519103
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:81760	difenoconazole	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20230905	CTD	MESH:C115058	ginger extract inhibits the reaction [difenoconazole results in increased expression of MKI67 protein]	PMID:34519103
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:82119	Dimefox	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C012920	dimefox results in increased expression of MKI67 protein	PMID:18418871
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:82307	para-Cresidine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20160210	CTD	MESH:C013453	cresidine results in increased expression of MKI67 protein	PMID:26338220
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in increased expression of MKI67 mRNA; indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein	PMID:35687267
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	multiple interactions	EXP		E	RGD:6480464	20230404	CTD	MESH:C041508	1-methyltryptophan inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]; AHR protein promotes the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]; epacadostat inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased expression of MKI67 protein]	PMID:35687267
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:82357	N-Nitrosodiethanolamine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20231031	CTD	MESH:C014129	N-nitrosodiethanolamine results in increased expression of MKI67 protein	PMID:37527026
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:82360	N-Nitrosomethylethylamine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20231031	CTD	MESH:C017510	methylethylnitrosamine results in increased expression of MKI67 protein	PMID:37527026
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of MKI67 mRNA	PMID:32234424
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:82411	Brilliant Blue	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20250805	CTD	MESH:C006796	[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in increased expression of MKI67 protein	PMID:24941295
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MKI67 protein	PMID:26206603
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of MKI67 mRNA	PMID:21858171
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:82527	Ptaquiloside	increases expression	ISO	RGD:1313526	E	RGD:6480464	20141111	CTD	MESH:C043680	ptaquiloside results in increased expression of MKI67 mRNA	PMID:22143989
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:82538	Sunset Yellow FCF	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20250805	CTD	MESH:C005842	[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in increased expression of MKI67 protein	PMID:24941295
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:82615	diminazene diaceturate	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C003915	diminazene aceturate results in decreased expression of MKI67 mRNA	PMID:37681557
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:82619	icariside II	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C060988	baohuoside I results in decreased expression of MKI67 protein	PMID:25119583
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:83766	olaparib	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C531550	olaparib results in decreased expression of MKI67 protein	PMID:29567272
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:83766	olaparib	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:C531550	INCB054329 promotes the reaction [olaparib results in decreased expression of MKI67 protein]; olaparib promotes the reaction [INCB054329 results in decreased expression of MKI67 protein]	PMID:29567272
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8382	prednisone	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20240604	CTD	MESH:D011241	Prednisone results in decreased expression of MKI67 mRNA	PMID:38439560
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:84050	trabectedin	increases expression	ISO	RGD:1305476	E	RGD:6480464	20161025	CTD	MESH:C099150	trabectedin results in increased expression of MKI67 protein	PMID:12154027
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of MKI67 protein	PMID:38348393
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8461	promethazine	affects expression	ISO	RGD:1305476	E	RGD:6480464	20180515	CTD	MESH:D011398	Promethazine affects the expression of MKI67 protein	PMID:26011634
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8461	promethazine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20160210	CTD	MESH:D011398	Promethazine results in increased expression of MKI67 protein	PMID:26558467
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313526	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of MKI67 mRNA; propiconazole results in increased expression of MKI67 protein	PMID:21278054|PMID:22334560
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8499	propranolol	decreases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:D011433	Propranolol results in decreased expression of MKI67 protein	PMID:31838054
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8499	propranolol	multiple interactions	EXP		E	RGD:6480464	20200331	CTD	MESH:D011433	ANGPT2 protein inhibits the reaction [Propranolol results in decreased expression of MKI67 protein]	PMID:31838054
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20120412	CTD	MESH:D011441	[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein; Copper deficiency inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]; Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein]	PMID:19497425
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:85993	palbociclib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of MKI67 protein	PMID:15542782|PMID:22170262|PMID:22383795|PMID:22751436|PMID:23708653|PMID:26318986|PMID:28620137
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:85993	palbociclib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	Doxorubicin promotes the reaction [palbociclib results in decreased expression of MKI67 protein]; RB1 protein affects the reaction [palbociclib results in decreased expression of MKI67 protein]	PMID:22751436|PMID:28620137
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:86290	6-bromoindirubin-3'-oxime	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20240206	CTD	MESH:C483321	[trametinib co-treated with 6-bromoindirubin-3'-oxime] results in increased expression of MKI67 protein	PMID:37116855
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of MKI67 protein	PMID:11535548
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:88249	PD 0325901	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20200915	CTD	MESH:C506614	[mirdametinib affects the susceptibility to KRAS protein] affects the reaction [NVP-BKM120 results in decreased expression of MKI67 protein]; mirdametinib inhibits the reaction [camostat results in increased expression of MKI67 protein]	PMID:24576621|PMID:25104499
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:35861251
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA	PMID:39752319
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:8890	(S)-ropivacaine	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C037663	Ropivacaine results in decreased expression of MKI67 protein	PMID:36193553
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9068	Se-methylselenocysteine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C002979	selenomethylselenocysteine results in decreased expression of MKI67 protein	PMID:18855134
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9068	Se-methylselenocysteine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C002979	[selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein	PMID:18855134
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:90943	osimertinib	decreases expression	EXP		E	RGD:151357000|PMID:32276600	20220222	RGD	MESH:C000603933	osimertinib decreases expression of MKI67 protein in lung	
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:90943	osimertinib	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C000603933	[ginsenoside Rg3 co-treated with osimertinib] results in decreased expression of MKI67 protein	PMID:31916386
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of MKI67 mRNA	PMID:32419051
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MKI67 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MKI67 mRNA	PMID:27188386
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9111	Senkirkine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20200915	CTD	MESH:C009238	senkirkine results in increased expression of MKI67 mRNA	PMID:32419051
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:91275	N-butyl-N-(4-hydroxybutyl)nitrosamine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20180703	CTD	MESH:D002085	[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein; Hexamethonium inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]; methyllycaconitine inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein]	PMID:29501575
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9130	sevoflurane	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C009250	Sevoflurane results in increased expression of MKI67 protein	PMID:36207479
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MKI67 mRNA	PMID:27131904
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:91450	sapanisertib	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C572449	sapanisertib results in decreased expression of MKI67 protein	PMID:26536665
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:91450	sapanisertib	increases cleavage	EXP		E	RGD:6480464	20240702	CTD	MESH:C572449	sapanisertib results in increased cleavage of MKI67 protein	PMID:26536665
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9150	simvastatin	decreases expression	ISO	RGD:1305476	E	RGD:6480464	20160315	CTD	MESH:D019821	Simvastatin results in decreased expression of MKI67 protein	PMID:26577051
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9159	sinensetin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C059295	sinensetin results in decreased expression of MKI67 protein	PMID:39434434
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9159	sinensetin	multiple interactions	EXP		E	RGD:6480464	20250708	CTD	MESH:C059295	AKT activator SC79 inhibits the reaction [sinensetin results in decreased expression of MKI67 protein]	PMID:39434434
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9168	sirolimus	affects expression	ISO	RGD:1305476	E	RGD:6480464	20150825	CTD	MESH:D020123	Sirolimus affects the expression of MKI67 mRNA	PMID:24971338
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9168	sirolimus	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in decreased expression of MKI67 protein	PMID:19773376
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	[ABT-737 co-treated with Sirolimus] results in decreased expression of MKI67 protein	PMID:19773376
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9316	sufentanil	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D017409	Sufentanil results in decreased expression of MKI67 protein	PMID:38952040
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9316	sufentanil	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D017409	tilianin promotes the reaction [Sufentanil results in decreased expression of MKI67 protein]	PMID:38952040
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9405	tartrazine	increases expression	ISO	RGD:1305476	E	RGD:6480464	20250506	CTD	MESH:D013645	Tartrazine results in increased expression of MKI67 mRNA	PMID:31032366
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9405	tartrazine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20250506	CTD	MESH:D013645	[Erythrosine co-treated with ponceau 4R co-treated with Allura Red AC Dye co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Tartrazine co-treated with Amaranth Dye co-treated with brilliant blue co-treated with azo rubin S co-treated with Indigo Carmine] results in increased expression of MKI67 protein; Aspirin inhibits the reaction [Tartrazine results in increased expression of MKI67 mRNA]	PMID:24941295|PMID:31032366
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of MKI67 mRNA	PMID:33512557
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:94287	erastin	decreases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:C477224	erastin results in decreased expression of MKI67 protein	PMID:35234341
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:94287	erastin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20241105	CTD	MESH:C477224	erastin results in decreased expression of MKI67 protein	PMID:37341073
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:94287	erastin	multiple interactions	EXP		E	RGD:6480464	20220809	CTD	MESH:C477224	BGN mRNA alternative form inhibits the reaction [erastin results in decreased expression of MKI67 protein]	PMID:35234341
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:94287	erastin	multiple interactions	ISO	RGD:1313526	E	RGD:6480464	20241105	CTD	MESH:C477224	Butyric Acid promotes the reaction [erastin results in decreased expression of MKI67 protein]	PMID:37341073
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:94789	1-[(2,3,4-trimethoxyphenyl)methyl]piperazine	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20250805	CTD	MESH:D014292	Trimetazidine inhibits the reaction [Thioacetamide results in increased expression of MKI67 protein]	PMID:39716576
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9513	thalidomide	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D013792	Thalidomide results in decreased expression of MKI67 protein	PMID:34520751
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9513	thalidomide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013792	[Azacitidine co-treated with Thalidomide] affects the expression of MKI67 mRNA	PMID:18720364
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of MKI67 mRNA	PMID:22378314
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9607	Tiron	multiple interactions	ISO	RGD:1305476	E	RGD:6480464	20250311	CTD	MESH:D014013	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]; Doxorubicin promotes the reaction [1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of MKI67 protein]]	PMID:39214269
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9747	Triptolide	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C001899	triptolide results in decreased expression of MKI67 protein	PMID:24842335
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of MKI67 mRNA	PMID:19140230
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C057693	troglitazone results in increased expression of MKI67 protein	PMID:10097144
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313526	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of MKI67 mRNA	PMID:35537566
1313525	MKI67	marker of proliferation Ki-67	gene	CHEBI:9928	Valtratum	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C030127	valtrate results in decreased expression of MKI67 protein	PMID:36048842
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CTCFL mRNA	PMID:27188386
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:2321501	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CTCFL mRNA	PMID:33387578
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1620240	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CTCFL mRNA	PMID:37992649
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1620240	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CTCFL mRNA	PMID:37992649
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:2321501	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CTCFL mRNA	PMID:26577399
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CTCFL intron	PMID:30157460
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CTCFL gene	PMID:25304211
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1620240	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of CTCFL mRNA	PMID:21151649
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620240	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CTCFL mRNA	PMID:21570461
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1620240	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CTCFL mRNA	PMID:37172768
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTCFL mRNA	PMID:27188386
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1620240	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CTCFL mRNA	PMID:37992649
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1620240	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of CTCFL mRNA	PMID:36209798
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CTCFL intron	PMID:30157460
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CTCFL 3' UTR; Benzo(a)pyrene results in increased methylation of CTCFL promoter	PMID:27901495
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of CTCFL gene	PMID:25435355
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:2321501	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CTCFL mRNA	PMID:34492290
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1620240	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of CTCFL promoter	PMID:27312807
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CTCFL mRNA	PMID:25979313
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CTCFL intron	PMID:30157460
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1620240	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CTCFL mRNA	PMID:38685157
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1620240	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CTCFL mRNA	PMID:32715474
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CTCFL mRNA	PMID:25979313
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of CTCFL mRNA	PMID:28001369
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of CTCFL promoter	PMID:27989131
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1620240	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CTCFL mRNA	PMID:37992649
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CTCFL gene	PMID:25304211
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the methylation of CTCFL gene	PMID:17957795
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of CTCFL mRNA	PMID:21856257
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1620240	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CTCFL mRNA	PMID:25620056
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:2321501	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of CTCFL mRNA	PMID:34044035
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1620240	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of CTCFL mRNA	PMID:20829426
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1620240	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of CTCFL mRNA	PMID:36851058
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CTCFL intron	PMID:30157460
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:6842	methoxychlor	affects expression	ISO	RGD:1620240	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor affects the expression of CTCFL mRNA	PMID:20829426
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTCFL mRNA	PMID:27188386
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CTCFL gene]	PMID:28238834
1313529	CTCFL	CCCTC-binding factor like	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CTCFL mRNA	PMID:27188386
1313530	SNX7	sorting nexin 7	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305480	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SNX7 mRNA]	PMID:31150632
1313530	SNX7	sorting nexin 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX7 mRNA	PMID:36331819
1313530	SNX7	sorting nexin 7	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313531	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SNX7 mRNA	PMID:30319688
1313530	SNX7	sorting nexin 7	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SNX7 mRNA	PMID:20044591
1313530	SNX7	sorting nexin 7	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SNX7 mRNA	PMID:21632981
1313530	SNX7	sorting nexin 7	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313531	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SNX7 mRNA	PMID:39241906
1313530	SNX7	sorting nexin 7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313531	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SNX7 mRNA	PMID:39298647
1313530	SNX7	sorting nexin 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305480	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of SNX7 mRNA	PMID:26496021
1313530	SNX7	sorting nexin 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SNX7 mRNA	PMID:34319233
1313530	SNX7	sorting nexin 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313531	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SNX7 mRNA	PMID:19850644
1313530	SNX7	sorting nexin 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of SNX7 mRNA]	PMID:19850644
1313530	SNX7	sorting nexin 7	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305480	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SNX7 mRNA	PMID:26577399
1313530	SNX7	sorting nexin 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SNX7 mRNA	PMID:19549813
1313530	SNX7	sorting nexin 7	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313531	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in increased expression of SNX7 mRNA	PMID:18579281
1313530	SNX7	sorting nexin 7	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1313531	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of SNX7 mRNA	PMID:18579281
1313530	SNX7	sorting nexin 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SNX7 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SNX7 mRNA	PMID:34911549
1313530	SNX7	sorting nexin 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305480	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SNX7 mRNA	PMID:31150632
1313530	SNX7	sorting nexin 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313531	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SNX7 mRNA	PMID:31919559
1313530	SNX7	sorting nexin 7	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305480	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SNX7 mRNA]	PMID:31150632
1313530	SNX7	sorting nexin 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX7 mRNA	PMID:22206623
1313530	SNX7	sorting nexin 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SNX7 mRNA	PMID:40504410
1313530	SNX7	sorting nexin 7	gene	CHEBI:2762	antimycin A	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of SNX7 mRNA	PMID:33512557
1313530	SNX7	sorting nexin 7	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SNX7 mRNA	PMID:28960355
1313530	SNX7	sorting nexin 7	gene	CHEBI:27903	(2,4,5-trichlorophenoxy)acetic acid	increases expression	ISO	RGD:1313531	E	RGD:6480464	20130514	CTD	MESH:D015085	2,4,5-Trichlorophenoxyacetic Acid results in increased expression of SNX7 mRNA	PMID:18579281
1313530	SNX7	sorting nexin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313531	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX7 mRNA	PMID:21570461
1313530	SNX7	sorting nexin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313531	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNX7 mRNA	PMID:19465110
1313530	SNX7	sorting nexin 7	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of SNX7 protein	PMID:39603559
1313530	SNX7	sorting nexin 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SNX7 mRNA	PMID:30851411
1313530	SNX7	sorting nexin 7	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of SNX7 mRNA	PMID:27862939
1313530	SNX7	sorting nexin 7	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SNX7 mRNA	PMID:29803840
1313530	SNX7	sorting nexin 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNX7 mRNA	PMID:38568856|PMID:39719251
1313530	SNX7	sorting nexin 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SNX7 mRNA	PMID:40504410
1313530	SNX7	sorting nexin 7	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SNX7 promoter	PMID:27901495
1313530	SNX7	sorting nexin 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313531	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNX7 mRNA	PMID:22228805
1313530	SNX7	sorting nexin 7	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to SNX7 mRNA]	PMID:32406909
1313530	SNX7	sorting nexin 7	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SNX7 mRNA	PMID:29264374
1313530	SNX7	sorting nexin 7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313531	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SNX7 mRNA	PMID:23557971|PMID:27760801
1313530	SNX7	sorting nexin 7	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305480	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SNX7 mRNA	PMID:34492290
1313530	SNX7	sorting nexin 7	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of SNX7 mRNA	PMID:28329830
1313530	SNX7	sorting nexin 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305480	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNX7 mRNA	PMID:25181051
1313530	SNX7	sorting nexin 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305480	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of SNX7 mRNA	PMID:26496021
1313530	SNX7	sorting nexin 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313531	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SNX7 mRNA	PMID:30951980|PMID:39298647
1313530	SNX7	sorting nexin 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313531	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SNX7 mRNA	PMID:30951980|PMID:38685157
1313530	SNX7	sorting nexin 7	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1313531	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of SNX7 mRNA	PMID:31558096
1313530	SNX7	sorting nexin 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313531	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SNX7 mRNA	PMID:37019170
1313530	SNX7	sorting nexin 7	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1313531	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of SNX7 protein	PMID:39748354
1313530	SNX7	sorting nexin 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SNX7 mRNA	PMID:38568856
1313530	SNX7	sorting nexin 7	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305480	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of SNX7 mRNA	PMID:27387713
1313530	SNX7	sorting nexin 7	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305480	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SNX7 mRNA	PMID:24386269
1313530	SNX7	sorting nexin 7	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SNX7 mRNA	PMID:28302478
1313530	SNX7	sorting nexin 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SNX7 mRNA	PMID:40419075
1313530	SNX7	sorting nexin 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX7 mRNA	PMID:36331819
1313530	SNX7	sorting nexin 7	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1313531	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of SNX7 mRNA	PMID:31558096
1313530	SNX7	sorting nexin 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313531	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of SNX7 mRNA	PMID:24896083
1313530	SNX7	sorting nexin 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SNX7 mRNA	PMID:28973697
1313530	SNX7	sorting nexin 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313531	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNX7 mRNA	PMID:17562736
1313530	SNX7	sorting nexin 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305480	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SNX7 mRNA	PMID:33387578
1313530	SNX7	sorting nexin 7	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1313531	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of SNX7 mRNA	PMID:29279043
1313530	SNX7	sorting nexin 7	gene	CHEBI:46680	serpentine asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of SNX7 5' UTR	PMID:29523930
1313530	SNX7	sorting nexin 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SNX7 mRNA	PMID:40504410
1313530	SNX7	sorting nexin 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313531	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SNX7 mRNA; Nanotubes, Carbon results in increased expression of SNX7 mRNA	PMID:25554681|PMID:25620056
1313530	SNX7	sorting nexin 7	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305480	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SNX7 mRNA	PMID:24136188
1313530	SNX7	sorting nexin 7	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SNX7 mRNA	PMID:23650126
1313530	SNX7	sorting nexin 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313531	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SNX7 mRNA	PMID:22206623
1313530	SNX7	sorting nexin 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313531	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX7 mRNA	PMID:22206623
1313530	SNX7	sorting nexin 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SNX7 mRNA	PMID:30851411
1313530	SNX7	sorting nexin 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SNX7 gene]	PMID:28238834
1313530	SNX7	sorting nexin 7	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1313531	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of SNX7 mRNA	PMID:31558096
1313530	SNX7	sorting nexin 7	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313531	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SNX7 mRNA	PMID:21278054
1313530	SNX7	sorting nexin 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305480	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SNX7 mRNA	PMID:36843608
1313530	SNX7	sorting nexin 7	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1313531	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in increased expression of SNX7 protein	PMID:26903627
1313530	SNX7	sorting nexin 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305480	E	RGD:6480464	20150303	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SNX7 mRNA	PMID:21346803
1313530	SNX7	sorting nexin 7	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305480	E	RGD:6480464	20150303	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SNX7 mRNA	PMID:21346803
1313530	SNX7	sorting nexin 7	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305480	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of SNX7 gene	PMID:31079544
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of SFR1 mRNA	PMID:21934132
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SFR1 mRNA	PMID:26079696
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of SFR1 mRNA	PMID:18951874
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313533	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SFR1 mRNA	PMID:39241906
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of SFR1 mRNA	PMID:23019147
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313533	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SFR1 mRNA	PMID:39298647
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305481	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SFR1 mRNA	PMID:33387578
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SFR1 mRNA	PMID:37042841
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313533	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SFR1 mRNA	PMID:33754040
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305481	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SFR1 mRNA	PMID:33387578
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SFR1 mRNA	PMID:28818685
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313533	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SFR1 mRNA	PMID:37236586
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SFR1 mRNA	PMID:19549813
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313533	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SFR1 mRNA	PMID:31919559
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of SFR1 mRNA	PMID:19167446
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SFR1 mRNA	PMID:27594783
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313533	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SFR1 mRNA	PMID:24680724
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305481	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SFR1 mRNA	PMID:33387578|PMID:34747641
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313533	E	RGD:6480464	20140408	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SFR1 mRNA	PMID:23994337
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of SFR1 mRNA	PMID:29955902
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SFR1 mRNA	PMID:28001369
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SFR1 mRNA	PMID:32234424
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SFR1 mRNA	PMID:20382639
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305481	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SFR1 mRNA	PMID:25181051|PMID:34947998
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313533	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SFR1 mRNA	PMID:33221593
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305481	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of SFR1 mRNA	PMID:41034487
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313533	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of SFR1 mRNA	PMID:25594700
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1313533	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SFR1 mRNA	PMID:23994337
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of SFR1 gene	PMID:31601247
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in increased expression of SFR1 mRNA	PMID:27685785
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313533	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SFR1 mRNA	PMID:39298647
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SFR1 mRNA	PMID:38174414
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313533	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SFR1 mRNA	PMID:37236586
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SFR1 mRNA	PMID:24449571
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SFR1 mRNA	PMID:19167446
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of SFR1 mRNA	PMID:19167446
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SFR1 mRNA	PMID:40419075
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1305481	E	RGD:6480464	20260505	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SFR1 mRNA	PMID:40128328
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SFR1 mRNA	PMID:25979313
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313533	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SFR1 mRNA	PMID:17292431
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SFR1 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305481	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of SFR1 mRNA	PMID:41580965
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine affects the expression of SFR1 mRNA	PMID:20106945
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SFR1 mRNA	PMID:25562108|PMID:27989131
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313533	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of SFR1 mRNA	PMID:22733784
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SFR1 mRNA	PMID:27188386
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305481	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SFR1 mRNA	PMID:33387578
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1313533	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of SFR1 mRNA	PMID:26377693
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313533	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of SFR1 mRNA	PMID:27462272
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313533	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SFR1 mRNA	PMID:22206623
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SFR1 mRNA	PMID:37199045
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313533	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of SFR1 mRNA	PMID:23994337
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1305481	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of SFR1 mRNA	PMID:32109520
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313533	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of SFR1 mRNA	PMID:40826991
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1305481	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of SFR1 protein	PMID:35544339
1313532	SFR1	SWI5 dependent homologous recombination repair protein 1	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of SFR1 mRNA	PMID:27188386
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313535	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of LRRN2 mRNA	PMID:37995155
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LRRN2 gene	PMID:20938992
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of LRRN2 mRNA	PMID:30510588
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of LRRN2 mRNA	PMID:31614463
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305482	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of LRRN2 mRNA	PMID:33387578
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LRRN2 gene	PMID:20938992
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LRRN2 mRNA	PMID:37042841
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRN2 mRNA	PMID:37567420
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRN2 mRNA	PMID:37567420
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LRRN2 gene	PMID:20938992
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LRRN2 gene	PMID:25304211
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313535	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of LRRN2 mRNA	PMID:32186404
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LRRN2 mRNA	PMID:33212167
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of LRRN2 mRNA	PMID:21198554
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRN2 mRNA	PMID:37567420
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313535	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of LRRN2 mRNA	PMID:37682722
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LRRN2 3' UTR; Benzo(a)pyrene affects the methylation of LRRN2 5' UTR	PMID:27901495
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRRN2 mRNA	PMID:32234424
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LRRN2 promoter	PMID:27901495
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of LRRN2 mRNA	PMID:35984750
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313535	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRRN2 promoter	PMID:35295148
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313535	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LRRN2 gene	PMID:35295148
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LRRN2 mRNA	PMID:19710929
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRN2 mRNA	PMID:27685785
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305482	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRN2 mRNA	PMID:25181051
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305482	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of LRRN2 mRNA	PMID:30816183|PMID:34947998|PMID:38750585
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313535	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of LRRN2 gene	PMID:31683443
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313535	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of LRRN2 exon	PMID:33297965
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313535	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LRRN2 intron	PMID:28392331
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313535	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LRRN2 mRNA	PMID:37019170
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of LRRN2 mRNA	PMID:36117858
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRRN2 mRNA	PMID:29154799
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LRRN2 gene	PMID:29154799
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of LRRN2 mRNA	PMID:27989131
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRN2 mRNA	PMID:37567420
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LRRN2 mRNA	PMID:38832940
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of LRRN2 mRNA	PMID:22230336
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LRRN2 gene	PMID:25304211
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of LRRN2 mRNA	PMID:36117858
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305482	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LRRN2 gene	PMID:35440735
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313535	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LRRN2 mRNA	PMID:22206623
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313535	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of LRRN2 mRNA	PMID:37567420
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LRRN2 gene]	PMID:28238834
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305482	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of LRRN2 mRNA	PMID:27291303
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305482	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of LRRN2 mRNA	PMID:19281266
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of LRRN2 mRNA	PMID:29301935
1313534	LRRN2	leucine rich repeat neuronal 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305482	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of LRRN2 mRNA	PMID:23034163
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PMS2 mRNA	PMID:38218311
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313537	E	RGD:6480464	20260811	CTD	MESH:C084079	triptonide results in increased expression of RSPH10B mRNA	PMID:33045310
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PMS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PMS2 mRNA	PMID:32699268
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in decreased expression of PMS2 mRNA	PMID:11566570
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D004958	Estradiol results in decreased expression of PMS2 mRNA	PMID:22082530
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:16480	nitric oxide	increases expression	ISO	RGD:1313537	E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide deficiency results in increased expression of PMS2 mRNA	PMID:15878706
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PMS2 mRNA	PMID:37042841
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313537	E	RGD:6480464	20260811	CTD	MESH:D005947	Glucose results in increased expression of RSPH10B mRNA	PMID:39922521
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313537	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in increased expression of PMS2 protein	PMID:20463053
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313537	E	RGD:6480464	20260811	CTD	MESH:D005947	Glucose results in increased expression of RSPH10B mRNA	PMID:39922521
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305483	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PMS2 mRNA	PMID:33387578
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:196991	4-hydroperoxycyclophosphamide	decreases expression	ISO	RGD:1305483	E	RGD:6480464	20161025	CTD	MESH:C011272	perfosfamide results in decreased expression of PMS2 mRNA	PMID:11754170
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PMS2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PMS2 protein	PMID:31390735
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PMS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PMS2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PMS2 mRNA	PMID:32699268
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313537	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PMS2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PMS2 mRNA	PMID:34911549
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:27385	tetrachloromethane	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PMS2 mRNA	PMID:11566570
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313537	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PMS2 mRNA	PMID:28960355
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PMS2 mRNA	PMID:23557933
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:27899	cisplatin	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin affects the localization of PMS2 protein	PMID:21064154
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PMS2 mRNA	PMID:27392435
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PMS2 mRNA	PMID:27392435
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313537	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PMS2 mRNA	PMID:21570461
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313537	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PMS2 mRNA	PMID:25975270
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PMS2 mRNA	PMID:33212167
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PMS2 mRNA	PMID:38568856
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313537	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PMS2 mRNA	PMID:11353140
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PMS2 mRNA	PMID:28461126
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313537	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PMS2 mRNA	PMID:22228805
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PMS2 mRNA	PMID:22521957
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305483	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PMS2 mRNA	PMID:30047161
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313537	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PMS2 gene	PMID:35295148
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:33007	chromium(6+)	increases response to substance	ISO	RGD:1313537	E	RGD:6480464	20130723	CTD	MESH:C074702	PMS2 protein results in increased susceptibility to chromium hexavalent ion	PMID:15831465
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305483	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PMS2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1313537	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of PMS2 mRNA	PMID:36464114
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313537	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PMS2 mRNA	PMID:17361019|PMID:21266533
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35019	tributyl phosphate	increases expression	ISO	RGD:1313537	E	RGD:6480464	20260303	CTD	MESH:C009524	tributyl phosphate results in increased expression of PMS2 mRNA	PMID:40389058
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35019	tributyl phosphate	multiple interactions	ISO	RGD:1313537	E	RGD:6480464	20260303	CTD	MESH:C009524	4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline inhibits the reaction [tributyl phosphate results in increased expression of PMS2 mRNA]; U 0126 inhibits the reaction [tributyl phosphate results in increased expression of PMS2 mRNA]	PMID:40389058
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PMS2 mRNA	PMID:37042841
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	increases expression	ISO	RGD:1313537	E	RGD:6480464	20260303	CTD	MESH:C031324	tris(chloroethyl)phosphate results in increased expression of PMS2 mRNA	PMID:40389058
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313537	E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PMS2 mRNA	PMID:11958953
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PMS2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PMS2 protein	PMID:31390735
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313537	E	RGD:6480464	20120814	CTD	MESH:D019256	MT1 affects the reaction [Cadmium Chloride results in increased expression of PMS2 mRNA]; MT2 affects the reaction [Cadmium Chloride results in increased expression of PMS2 mRNA]	PMID:11958953
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305483	E	RGD:6480464	20130402	CTD	MESH:C039281	furan results in increased expression of PMS2 mRNA	PMID:22079235
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305483	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of PMS2 mRNA	PMID:30047161
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:36704	imiquimod	decreases expression	ISO	RGD:1313537	E	RGD:6480464	20120412	CTD	MESH:C056493	imiquimod results in decreased expression of PMS2 mRNA	PMID:21878529
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PMS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PMS2 mRNA	PMID:32699268
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PMS2 mRNA	PMID:32588087
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313537	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PMS2 mRNA	PMID:39529242
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1305483	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of PMS2 mRNA	PMID:11056294
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313537	E	RGD:6480464	20260811	CTD	MESH:D005947	Glucose results in increased expression of RSPH10B mRNA	PMID:39922521
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313537	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PMS2 mRNA	PMID:17562736
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1305483	E	RGD:6480464	20120412	CTD	MESH:C005223	methyleugenol results in decreased expression of PMS2 mRNA	PMID:21659616
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PMS2 mRNA	PMID:22521957
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:50102	N-methyl-N-nitrosourea	affects response to substance	ISO	RGD:1313537	E	RGD:6480464	20120412	CTD	MESH:D008770	PMS2 protein affects the susceptibility to Methylnitrosourea	PMID:12967659
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008770	PMS2 protein results in increased susceptibility to Methylnitrosourea	PMID:16426742
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:50102	N-methyl-N-nitrosourea	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008770	Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein]	PMID:16204460
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of PMS2 mRNA	PMID:22082530
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305483	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PMS2 mRNA	PMID:30047161
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313537	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of PMS2 mRNA	PMID:38701926
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:68234	myristicin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C005246	myristicin results in decreased expression of PMS2 mRNA	PMID:24792648
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:72564	temozolomide	affects response to substance	ISO	RGD:1313537	E	RGD:6480464	20130305	CTD	MESH:C047246	PMS2 protein affects the susceptibility to temozolomide	PMID:12967659
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:72564	temozolomide	multiple interactions	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	[temozolomide co-treated with O(6)-benzylguanine] affects the expression of PMS2 protein	PMID:20980775
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1313537	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of PMS2 mRNA	PMID:36464114
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:748866	6-o-benzylguanine	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C064976	[Temozolomide co-treated with O(6)-benzylguanine] affects the expression of PMS2 protein	PMID:20980775
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:77012	methylseleninic acid	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of PMS2 mRNA	PMID:12517777
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305483	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PMS2 mRNA	PMID:30047161
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:8772	raloxifene	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of PMS2 mRNA	PMID:16202921
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of PMS2 mRNA	PMID:24921660
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PMS2 mRNA	PMID:38568856
1313536	PMS2	PMS1 homolog 2, mismatch repair system component	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305483	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PMS2 mRNA	PMID:21346803
1313538	DPEP3	dipeptidase 3	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of DPEP3 mRNA	PMID:26272509
1313538	DPEP3	dipeptidase 3	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPEP3 mRNA	PMID:27188386
1313538	DPEP3	dipeptidase 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of DPEP3 mRNA	PMID:20404318
1313538	DPEP3	dipeptidase 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305484	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DPEP3 mRNA	PMID:33387578
1313538	DPEP3	dipeptidase 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DPEP3 mRNA	PMID:37042841
1313538	DPEP3	dipeptidase 3	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of DPEP3 mRNA	PMID:26079696
1313538	DPEP3	dipeptidase 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305484	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DPEP3 mRNA	PMID:33387578
1313538	DPEP3	dipeptidase 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DPEP3 mRNA	PMID:35430440
1313538	DPEP3	dipeptidase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DPEP3 promoter	PMID:27901495
1313538	DPEP3	dipeptidase 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313539	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of DPEP3 mRNA	PMID:29264374
1313538	DPEP3	dipeptidase 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313539	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DPEP3 gene	PMID:35295148
1313538	DPEP3	dipeptidase 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313539	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of DPEP3 mRNA	PMID:35295148
1313538	DPEP3	dipeptidase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305484	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DPEP3 mRNA	PMID:25181051
1313538	DPEP3	dipeptidase 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313539	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of DPEP3 promoter	PMID:27312807
1313538	DPEP3	dipeptidase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305484	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DPEP3 mRNA	PMID:30816183|PMID:32528016
1313538	DPEP3	dipeptidase 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DPEP3 mRNA	PMID:37042841
1313538	DPEP3	dipeptidase 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313539	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of DPEP3 mRNA	PMID:40194260
1313538	DPEP3	dipeptidase 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DPEP3 gene	PMID:29154799
1313538	DPEP3	dipeptidase 3	gene	CHEBI:4453	desogestrel	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D017135	[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of DPEP3 mRNA	PMID:18160741
1313538	DPEP3	dipeptidase 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305484	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DPEP3 mRNA	PMID:33387578
1313538	DPEP3	dipeptidase 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313539	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of DPEP3 mRNA	PMID:38701926
1313538	DPEP3	dipeptidase 3	gene	CHEBI:59224	cetrorelix	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C062876	[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of DPEP3 mRNA; [cetrorelix co-treated with testosterone enanthate] results in decreased expression of DPEP3 mRNA	PMID:18160741
1313538	DPEP3	dipeptidase 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPEP3 mRNA	PMID:27188386
1313538	DPEP3	dipeptidase 3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313539	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of DPEP3 mRNA	PMID:31388691
1313538	DPEP3	dipeptidase 3	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1305484	E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of DPEP3 mRNA	PMID:29162477
1313538	DPEP3	dipeptidase 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPEP3 mRNA	PMID:27188386
1313538	DPEP3	dipeptidase 3	gene	CHEBI:9464	testosterone enanthate	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of DPEP3 mRNA; [cetrorelix co-treated with testosterone enanthate] results in decreased expression of DPEP3 mRNA	PMID:18160741
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MPHOSPH9 mRNA	PMID:16249480
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MPHOSPH9 mRNA	PMID:26079696
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1598368	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MPHOSPH9 gene	PMID:28931070|PMID:35440735
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MPHOSPH9 mRNA	PMID:21632981
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of MPHOSPH9 mRNA	PMID:29581250
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of MPHOSPH9 mRNA	PMID:16474171
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MPHOSPH9 protein	PMID:37730182
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1618843	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MPHOSPH9 mRNA	PMID:36331819
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MPHOSPH9 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MPHOSPH9 mRNA	PMID:39836092
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MPHOSPH9 mRNA	PMID:35301059
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1618843	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MPHOSPH9 mRNA	PMID:19770486
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MPHOSPH9 gene	PMID:27153756
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MPHOSPH9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MPHOSPH9 mRNA	PMID:39836092
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MPHOSPH9 mRNA	PMID:27188386
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MPHOSPH9 protein	PMID:35688186
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1618843	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of MPHOSPH9 mRNA	PMID:28960355
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of MPHOSPH9 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of MPHOSPH9 mRNA	PMID:19167446|PMID:23557933
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MPHOSPH9 mRNA	PMID:28903495
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019833	Genistein results in increased expression of MPHOSPH9 mRNA	PMID:16474171|PMID:16705744
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MPHOSPH9 mRNA	PMID:25583101
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1598368	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MPHOSPH9 mRNA	PMID:33387578
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1618843	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MPHOSPH9 mRNA	PMID:19770486
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MPHOSPH9 mRNA	PMID:33212167
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1598368	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of MPHOSPH9 mRNA	PMID:28959563
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MPHOSPH9 mRNA	PMID:29803840
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MPHOSPH9 mRNA	PMID:38568856
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MPHOSPH9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MPHOSPH9 mRNA	PMID:39836092
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1618843	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MPHOSPH9 mRNA	PMID:19770486
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of MPHOSPH9 mRNA	PMID:25351596
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MPHOSPH9 gene	PMID:31601247
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1598368	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MPHOSPH9 mRNA	PMID:25181051|PMID:34947998
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1618843	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of MPHOSPH9 mRNA	PMID:32156529
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1618843	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of MPHOSPH9 promoter	PMID:27312807
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of MPHOSPH9 mRNA	PMID:16474171
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1598368	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MPHOSPH9 mRNA	PMID:30816183|PMID:32528016
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MPHOSPH9 gene	PMID:31601247
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1618843	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of MPHOSPH9 mRNA	PMID:26377693
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1618843	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MPHOSPH9 mRNA	PMID:37019170
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1618843	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MPHOSPH9 mRNA	PMID:17361019|PMID:21266533
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MPHOSPH9 mRNA	PMID:37042841
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MPHOSPH9 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MPHOSPH9 mRNA	PMID:39836092
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MPHOSPH9 mRNA	PMID:35301059
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of MPHOSPH9 mRNA	PMID:17010675
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MPHOSPH9 mRNA	PMID:28302478
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of MPHOSPH9 mRNA	PMID:19167446
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MPHOSPH9 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of MPHOSPH9 mRNA	PMID:19167446
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1618843	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MPHOSPH9 mRNA	PMID:36331819
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MPHOSPH9 mRNA	PMID:25979313
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of MPHOSPH9 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1618843	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of MPHOSPH9 mRNA	PMID:21427059
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MPHOSPH9 gene	PMID:29154799
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MPHOSPH9 mRNA	PMID:27188386
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of MPHOSPH9 mRNA	PMID:26272509
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MPHOSPH9 mRNA	PMID:22230336
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1598368	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MPHOSPH9 mRNA	PMID:33387578
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MPHOSPH9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MPHOSPH9 mRNA	PMID:39836092
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MPHOSPH9 mRNA	PMID:22079256
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1598368	E	RGD:6480464	20120412	CTD	MESH:D005485	Flutamide results in decreased expression of MPHOSPH9 mRNA	PMID:21525395
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1618843	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MPHOSPH9 mRNA	PMID:19042947
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MPHOSPH9 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MPHOSPH9 mRNA	PMID:39836092
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MPHOSPH9 mRNA	PMID:15336504
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1598368	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MPHOSPH9 gene	PMID:35440735
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1618843	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MPHOSPH9 mRNA	PMID:22206623
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:749301	potassium perchlorate	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in increased expression of MPHOSPH9 mRNA	PMID:29673971
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MPHOSPH9 mRNA	PMID:22079256
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MPHOSPH9 mRNA	PMID:22079256
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MPHOSPH9 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MPHOSPH9 mRNA	PMID:27188386
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of MPHOSPH9 mRNA	PMID:30928695
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1618843	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of MPHOSPH9 mRNA	PMID:23091169
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MPHOSPH9 mRNA	PMID:19167446
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1618843	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of MPHOSPH9 mRNA	PMID:21795629
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MPHOSPH9 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MPHOSPH9 mRNA	PMID:27188386
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in decreased expression of MPHOSPH9 mRNA	PMID:34581912
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of MPHOSPH9 mRNA	PMID:17440010
1313543	MPHOSPH9	M-phase phosphoprotein 9	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MPHOSPH9 mRNA	PMID:29301935
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of ACSS2 protein	PMID:39638853
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ACSS2 mRNA	PMID:38218311
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron results in decreased expression of ACSS2 mRNA	PMID:21551480|PMID:24172598
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:131762	dodecyldimethylamine N-oxide	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:C014518	dodecyldimethylamine oxide results in increased expression of ACSS2 mRNA	PMID:40571133
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1618386	E	RGD:6480464	20160822	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ACSS2 mRNA	PMID:21705711|PMID:37995155
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of ACSS2 protein	PMID:36641056
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of ACSS2 mRNA	PMID:31016361
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ACSS2 mRNA	PMID:20188158
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ACSS2 mRNA	PMID:33167477
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACSS2 mRNA	PMID:36189433
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ACSS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ACSS2 mRNA	PMID:32699268
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:15379	dioxygen	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D010100	Oxygen deficiency affects the expression of ACSS2 protein	PMID:26087400
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ACSS2 mRNA	PMID:24236059
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACSS2 mRNA	PMID:30529165
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACSS2 mRNA	PMID:36331819
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of ACSS2 mRNA	PMID:36841081
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:16130	DDT	increases expression	ISO	RGD:1305489	E	RGD:6480464	20190219	CTD	MESH:D003634	DDT results in increased expression of ACSS2 mRNA	PMID:29477483
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACSS2 mRNA	PMID:29432896
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of ACSS2 mRNA	PMID:30517762
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ACSS2 mRNA	PMID:27339419
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ACSS2 mRNA	PMID:32145629
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of ACSS2 mRNA	PMID:19484750|PMID:39298647
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1618386	E	RGD:6480464	20171010	CTD	MESH:D004958	Estradiol results in increased expression of ACSS2 mRNA	PMID:28476547
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305489	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of ACSS2 mRNA	PMID:26496021
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20171010	CTD	MESH:D004958	bisphenol A inhibits the reaction [Estradiol results in increased expression of ACSS2 mRNA]	PMID:28476547
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ACSS2 mRNA	PMID:38568856
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305489	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ACSS2 mRNA	PMID:33387578
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACSS2 mRNA	PMID:37042841
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:166595	Yessotoxin	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in increased expression of ACSS2 mRNA	PMID:30679557
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:16767	3,4-dichloroaniline	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in decreased expression of ACSS2 mRNA	PMID:24172598
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:168262	Ganoderic acid A	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20210504	CTD	MESH:C515005	[Dietary Fats co-treated with ganoderic acid A] affects the expression of ACSS2 mRNA	PMID:29852127
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D005947	Glucose results in increased expression of ACSS2 mRNA	PMID:36156098|PMID:39613055
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACSS2 mRNA	PMID:36189433
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1618386	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of ACSS2 mRNA	PMID:17178593
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:17336	all-trans-retinol	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20150512	CTD	MESH:D014801	Vitamin A deficiency results in decreased expression of ACSS2 mRNA	PMID:12163651
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of ACSS2 mRNA	PMID:16579987
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D005947	Glucose results in increased expression of ACSS2 mRNA	PMID:36156098|PMID:39613055
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ACSS2 protein	PMID:31163220
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ACSS2 mRNA	PMID:19850644
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D004051	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACSS2 mRNA; PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACSS2 mRNA]	PMID:19850644|PMID:28433925
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ACSS2 protein	PMID:37730182
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305489	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ACSS2 mRNA	PMID:22061828|PMID:33387578
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ACSS2 mRNA	PMID:28818685
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1618386	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of ACSS2 mRNA	PMID:27462272
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ACSS2 mRNA	PMID:17178593
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS2 mRNA	PMID:29950665
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ACSS2 mRNA	PMID:19549813
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of ACSS2 mRNA	PMID:23487506
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ACSS2 protein	PMID:20106945
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ACSS2 mRNA	PMID:21641981|PMID:22100608|PMID:27153756
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ACSS2 gene	PMID:27153756
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1618386	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of ACSS2 mRNA	PMID:18579281
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1618386	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of ACSS2 mRNA	PMID:33026818
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ACSS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ACSS2 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of ACSS2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of ACSS2 mRNA	PMID:32699268|PMID:35430440
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1305489	E	RGD:6480464	20230801	CTD	MESH:D000638	Amiodarone results in increased expression of ACSS2 mRNA	PMID:32084307|PMID:40216313
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1618386	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of ACSS2 mRNA	PMID:24535564
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACSS2 mRNA	PMID:31150632
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACSS2 mRNA	PMID:27339419|PMID:31919559
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of ACSS2 mRNA	PMID:30517762
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACSS2 mRNA	PMID:22206623
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS2 mRNA	PMID:32045263
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ACSS2 protein	PMID:35688186
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ACSS2 mRNA	PMID:28189721|PMID:28960355
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ACSS2 mRNA	PMID:31881176
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ACSS2 mRNA	PMID:27594783
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ACSS2 mRNA; [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of ACSS2 mRNA	PMID:27392435|PMID:30871063
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:27902	tetracycline	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20150127	CTD	MESH:D013752	Tetracycline results in decreased expression of ACSS2 mRNA	PMID:24489787
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of ACSS2 mRNA	PMID:18930951
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ACSS2 mRNA	PMID:24768652|PMID:25583101
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618386	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACSS2 mRNA	PMID:21570461|PMID:26377647
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACSS2 mRNA	PMID:20106945
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACSS2 mRNA	PMID:21215274|PMID:21724226
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACSS2 mRNA	PMID:19770486
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305489	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACSS2 mRNA	PMID:33387578
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20180116	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACSS2 mRNA	PMID:28433925
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1305489	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone affects the expression of ACSS2 mRNA	PMID:28374803
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of ACSS2 mRNA	PMID:29955902
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1618386	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of ACSS2 mRNA	PMID:32937126
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ACSS2 mRNA	PMID:33212167
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ACSS2 mRNA	PMID:17178593
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28509	chloroethene	increases expression	ISO	RGD:1618386	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in increased expression of ACSS2 mRNA	PMID:18579281
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ACSS2 mRNA	PMID:32763439
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of ACSS2 mRNA	PMID:24690739
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ACSS2 mRNA	PMID:29803840
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ACSS2 protein	PMID:35688186
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of ACSS2 mRNA	PMID:34032870|PMID:39719251
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1618386	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of ACSS2 mRNA	PMID:37682722
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20220208	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS2 mRNA	PMID:32045263
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACSS2 mRNA	PMID:22178795|PMID:26238291|PMID:32234424
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACSS2 mRNA	PMID:22228805
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1618386	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACSS2 mRNA	PMID:19770486|PMID:21964900
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ACSS2 promoter	PMID:27901495
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of ACSS2 mRNA	PMID:24690739
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of ACSS2 mRNA	PMID:25075043
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1305489	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of ACSS2 mRNA	PMID:38458666
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ACSS2 mRNA	PMID:25895662
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ACSS2 mRNA	PMID:27829220
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of ACSS2 mRNA	PMID:24136188
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of ACSS2 mRNA	PMID:32479839
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of ACSS2 mRNA	PMID:31745603
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:32138	sodium acetate trihydrate	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D019346	Sodium Acetate results in increased expression of ACSS2 mRNA	PMID:36156098
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACSS2 mRNA	PMID:23557971
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1618386	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ACSS2 promoter alternative form	PMID:35295148
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS2 mRNA	PMID:29950665
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ACSS2 mRNA	PMID:34492290
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ACSS2 mRNA	PMID:18648102
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ACSS2 mRNA	PMID:18445702
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ACSS2 mRNA	PMID:30903817
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305489	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ACSS2 mRNA	PMID:32145629
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ACSS2 gene	PMID:31601247
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ACSS2 protein	PMID:34186270
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305489	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ACSS2 mRNA	PMID:25181051
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1618386	E	RGD:6480464	20171010	CTD	MESH:C006780	bisphenol A results in increased expression of ACSS2 mRNA	PMID:28476547
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305489	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of ACSS2 mRNA	PMID:26496021
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20171010	CTD	MESH:C006780	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACSS2 mRNA; bisphenol A inhibits the reaction [Estradiol results in increased expression of ACSS2 mRNA]	PMID:28433925|PMID:28476547
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20180116	CTD	MESH:C014024	[Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACSS2 mRNA	PMID:28433925
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:34283	oxybenzone	increases expression	ISO	RGD:1305489	E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of ACSS2 mRNA	PMID:30316929
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1618386	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of ACSS2 mRNA	PMID:39298647
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ACSS2 mRNA	PMID:40203079
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ACSS2 protein	PMID:34186270
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ACSS2 protein	PMID:34186270
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1618386	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ACSS2 protein	PMID:35362542
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS2 mRNA; evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ACSS2 protein]	PMID:29950665|PMID:35362542
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ACSS2 mRNA	PMID:21266533
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ACSS2 mRNA	PMID:21266533
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSS2 mRNA	PMID:28628672
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ACSS2 mRNA	PMID:37042841
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1305489	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of ACSS2 mRNA	PMID:30589522
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1305489	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of ACSS2 mRNA	PMID:38458666
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305489	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ACSS2 mRNA	PMID:35163327
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305489	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ACSS2 mRNA	PMID:30723492
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ACSS2 mRNA	PMID:32588087
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1618386	E	RGD:6480464	20190507	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ACSS2 mRNA	PMID:30657992
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305489	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ACSS2 mRNA	PMID:35163327
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ACSS2 mRNA	PMID:28903501
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ACSS2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ACSS2 mRNA	PMID:32699268
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ACSS2 mRNA	PMID:32588087
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1618386	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ACSS2 mRNA	PMID:40194260
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ACSS2 mRNA	PMID:31533062
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ACSS2 mRNA	PMID:32588087|PMID:36864359|PMID:40419075
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACSS2 mRNA	PMID:36331819
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1618386	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ACSS2 mRNA	PMID:23125180
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of ACSS2 mRNA	PMID:25993096
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ACSS2 mRNA	PMID:25979313
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ACSS2 mRNA	PMID:17292431
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ACSS2 mRNA	PMID:29154799
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ACSS2 gene	PMID:29154799
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1618386	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of ACSS2 mRNA	PMID:21427059|PMID:24535564
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of ACSS2 mRNA	PMID:38685447
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:40303	lovastatin	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20181016	CTD	MESH:D008148	[Dietary Fats co-treated with Lovastatin] affects the expression of ACSS2 mRNA	PMID:29852127
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D016572	Cyclosporine results in decreased expression of ACSS2 mRNA	PMID:20106945|PMID:23830897
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ACSS2 mRNA	PMID:21865292
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20140408	CTD	MESH:D016572	Cyclosporine results in decreased expression of ACSS2 mRNA	PMID:23830897
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of ACSS2 mRNA	PMID:27989131
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ACSS2 mRNA	PMID:20937368
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of ACSS2 mRNA	PMID:25047013
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSS2 mRNA	PMID:28628672
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D005947	Glucose results in increased expression of ACSS2 mRNA	PMID:36156098|PMID:39613055
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of ACSS2 mRNA	PMID:17400583
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:44658	okadaic acid	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid affects the expression of ACSS2 protein	PMID:38832940
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:45409	ritonavir	affects expression	ISO	RGD:1305489	E	RGD:6480464	20170303	CTD	MESH:D019438	Ritonavir affects the expression of ACSS2 mRNA	PMID:17719200
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1618386	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACSS2 mRNA	PMID:17562736
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ACSS2 mRNA	PMID:29067470
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305489	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ACSS2 mRNA	PMID:33387578
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of ACSS2 mRNA	PMID:24714768
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of ACSS2 mRNA	PMID:24690739
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACSS2 mRNA	PMID:29432896
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS2 mRNA	PMID:32045263
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:47612	bezafibrate	affects expression	ISO	RGD:1305489	E	RGD:6480464	20120613	CTD	MESH:D001629	Bezafibrate affects the expression of ACSS2 mRNA	PMID:17719200
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1305489	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of ACSS2 mRNA	PMID:29391264
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1618386	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ACSS2 mRNA	PMID:17178593
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of ACSS2 mRNA	PMID:32512070
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ACSS2 mRNA	PMID:35436446
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ACSS2 mRNA	PMID:32234424
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ACSS2 protein]	PMID:35362542
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:C029892	cupric chloride results in decreased expression of ACSS2 mRNA	PMID:34921933|PMID:38568856
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of ACSS2 mRNA	PMID:36868495
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ACSS2 mRNA	PMID:28628672
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ACSS2 mRNA	PMID:27829220
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of ACSS2 mRNA	PMID:25572481
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:50035	alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of ACSS2 mRNA	PMID:25075043
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ACSS2 mRNA; Nanotubes, Carbon results in decreased expression of ACSS2 mRNA	PMID:25554681|PMID:25620056
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1618386	E	RGD:6480464	20141223	CTD	MESH:C000499	ferric oxide analog results in increased expression of ACSS2 mRNA	PMID:25086211
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:5118	fluoxetine	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D005473	Fluoxetine results in increased expression of ACSS2 mRNA	PMID:37386098
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ACSS2 mRNA	PMID:22714537
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ACSS2 protein	PMID:23718831
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ACSS2 protein	PMID:32959892
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of ACSS2 mRNA	PMID:28801915
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:63630	tolcapone	increases expression	ISO	RGD:1305489	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in increased expression of ACSS2 mRNA	PMID:24136188
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ACSS2 mRNA	PMID:28801915
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:65585	carnosic acid	increases expression	ISO	RGD:1618386	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in increased expression of ACSS2 protein	PMID:35926579
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1618386	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of ACSS2 mRNA	PMID:27462272
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ACSS2 mRNA	PMID:31758290
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ACSS2 protein	PMID:34186270
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ACSS2 mRNA	PMID:22206623
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1618386	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACSS2 mRNA	PMID:22206623
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ACSS2 mRNA	PMID:24136188
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of ACSS2 mRNA	PMID:28960945
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of ACSS2 mRNA	PMID:19717638
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of ACSS2 protein	PMID:39638853
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ACSS2 gene]	PMID:28238834
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ACSS2 protein	PMID:31675489
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305489	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ACSS2 mRNA	PMID:24780913
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305489	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ACSS2 mRNA	PMID:21346803
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ACSS2 mRNA	PMID:38568856
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305489	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ACSS2 mRNA	PMID:21346803
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of ACSS2 mRNA	PMID:32835833
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of ACSS2 mRNA	PMID:25572481
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1618386	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ACSS2 mRNA	PMID:35537566
1313544	ACSS2	acyl-CoA synthetase short chain family member 2	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305489	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of ACSS2 gene	PMID:31079544
1313548	RNF2	ring finger protein 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313549	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RNF2 mRNA	PMID:30319688
1313548	RNF2	ring finger protein 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313549	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RNF2 mRNA	PMID:30319688
1313548	RNF2	ring finger protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20260602	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNF2 mRNA; Lipopolysaccharides results in decreased expression of RNF2 protein	PMID:39241906|PMID:40465481
1313548	RNF2	ring finger protein 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20260602	CTD	MESH:D008070	naringenin inhibits the reaction [Lipopolysaccharides results in decreased expression of RNF2 protein]	PMID:40465481
1313548	RNF2	ring finger protein 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305491	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RNF2 mRNA	PMID:26577399
1313548	RNF2	ring finger protein 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RNF2 protein	PMID:37730182
1313548	RNF2	ring finger protein 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of RNF2 mRNA	PMID:16002434
1313548	RNF2	ring finger protein 2	gene	CHEBI:17846	(S)-naringenin	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20260602	CTD	MESH:C005273	naringenin inhibits the reaction [Lipopolysaccharides results in decreased expression of RNF2 protein]	PMID:40465481
1313548	RNF2	ring finger protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RNF2 mRNA	PMID:37236586
1313548	RNF2	ring finger protein 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RNF2 protein	PMID:23301498
1313548	RNF2	ring finger protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313549	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RNF2 mRNA	PMID:19770486
1313548	RNF2	ring finger protein 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313549	E	RGD:6480464	20160119	CTD	MESH:D009151	Mustard Gas results in increased expression of RNF2 mRNA	PMID:15674843|PMID:26392148
1313548	RNF2	ring finger protein 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RNF2 protein	PMID:35688186
1313548	RNF2	ring finger protein 2	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1313549	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of RNF2 protein	PMID:22006019
1313548	RNF2	ring finger protein 2	gene	CHEBI:27928	parathion	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in decreased methylation of RNF2 promoter	PMID:22847954
1313548	RNF2	ring finger protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313549	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF2 mRNA	PMID:24680724
1313548	RNF2	ring finger protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNF2 mRNA	PMID:19770486
1313548	RNF2	ring finger protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313549	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RNF2 mRNA	PMID:15034205
1313548	RNF2	ring finger protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RNF2 mRNA]	PMID:15034205
1313548	RNF2	ring finger protein 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305491	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of RNF2 protein	PMID:35544339
1313548	RNF2	ring finger protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RNF2 mRNA	PMID:33212167
1313548	RNF2	ring finger protein 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RNF2 mRNA	PMID:30851411
1313548	RNF2	ring finger protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNF2 mRNA	PMID:29803840
1313548	RNF2	ring finger protein 2	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of RNF2 mRNA	PMID:25523186
1313548	RNF2	ring finger protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RNF2 mRNA	PMID:15034205
1313548	RNF2	ring finger protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RNF2 promoter	PMID:27901495
1313548	RNF2	ring finger protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases response to substance	EXP		E	RGD:6480464	20140211	CTD	MESH:D001564	RNF2 protein results in decreased susceptibility to Benzo(a)pyrene	PMID:23712474
1313548	RNF2	ring finger protein 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of RNF2 mRNA]	PMID:15034205
1313548	RNF2	ring finger protein 2	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of RNF2 mRNA	PMID:25523186
1313548	RNF2	ring finger protein 2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RNF2 mRNA	PMID:27131904
1313548	RNF2	ring finger protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313549	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RNF2 promoter	PMID:35295148
1313548	RNF2	ring finger protein 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313549	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RNF2 gene	PMID:35295148
1313548	RNF2	ring finger protein 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305491	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RNF2 mRNA	PMID:34492290
1313548	RNF2	ring finger protein 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1305491	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RNF2 mRNA	PMID:30723492
1313548	RNF2	ring finger protein 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RNF2 mRNA	PMID:20059764
1313548	RNF2	ring finger protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of RNF2 mRNA]	PMID:20059764
1313548	RNF2	ring finger protein 2	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which results in decreased methylation of RNF2 5' UTR	PMID:28843141
1313548	RNF2	ring finger protein 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305491	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RNF2 mRNA	PMID:25181051
1313548	RNF2	ring finger protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RNF2 gene	PMID:31601247
1313548	RNF2	ring finger protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305491	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of RNF2 mRNA	PMID:30816183
1313548	RNF2	ring finger protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305491	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF2 gene	PMID:28505145
1313548	RNF2	ring finger protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313549	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RNF2 mRNA	PMID:39298647
1313548	RNF2	ring finger protein 2	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1305491	E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF2 protein	PMID:34896426
1313548	RNF2	ring finger protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313549	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RNF2 mRNA	PMID:28392331
1313548	RNF2	ring finger protein 2	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of RNF2 mRNA]	PMID:19030233
1313548	RNF2	ring finger protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313549	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RNF2 mRNA	PMID:37236586
1313548	RNF2	ring finger protein 2	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:1305491	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of RNF2 mRNA	PMID:27638505
1313548	RNF2	ring finger protein 2	gene	CHEBI:38689	fonofos	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in decreased methylation of RNF2 promoter	PMID:22847954
1313548	RNF2	ring finger protein 2	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1305491	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of RNF2 protein	PMID:34896426
1313548	RNF2	ring finger protein 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RNF2 gene	PMID:29154799
1313548	RNF2	ring finger protein 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of RNF2 mRNA	PMID:19770486
1313548	RNF2	ring finger protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of RNF2 mRNA	PMID:20106945
1313548	RNF2	ring finger protein 2	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1305491	E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF2 protein	PMID:34896426
1313548	RNF2	ring finger protein 2	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1305491	E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF2 protein	PMID:34896426
1313548	RNF2	ring finger protein 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RNF2 mRNA	PMID:36621641
1313548	RNF2	ring finger protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313549	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RNF2 mRNA	PMID:17562736
1313548	RNF2	ring finger protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RNF2 protein	PMID:22230336
1313548	RNF2	ring finger protein 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313549	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RNF2 mRNA	PMID:35436446
1313548	RNF2	ring finger protein 2	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1305491	E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF2 protein	PMID:34896426
1313548	RNF2	ring finger protein 2	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of RNF2 mRNA	PMID:20977926
1313548	RNF2	ring finger protein 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RNF2 protein	PMID:32959892
1313548	RNF2	ring finger protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RNF2 mRNA	PMID:22206623
1313548	RNF2	ring finger protein 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RNF2 protein	PMID:37664457
1313548	RNF2	ring finger protein 2	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305491	E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in increased expression of RNF2 mRNA	PMID:23358140
1313548	RNF2	ring finger protein 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RNF2 mRNA	PMID:30851411
1313548	RNF2	ring finger protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RNF2 gene]	PMID:28238834
1313548	RNF2	ring finger protein 2	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of RNF2 mRNA	PMID:19159669
1313548	RNF2	ring finger protein 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313549	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of RNF2 mRNA	PMID:31388691
1313548	RNF2	ring finger protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305491	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RNF2 mRNA	PMID:24780913
1313548	RNF2	ring finger protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RNF2 protein	PMID:37664457
1313548	RNF2	ring finger protein 2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313549	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RNF2 mRNA	PMID:27131904
1313548	RNF2	ring finger protein 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305491	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RNF2 mRNA	PMID:21346803
1313548	RNF2	ring finger protein 2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1305491	E	RGD:6480464	20181016	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of RNF2 mRNA	PMID:28946194
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SEMA6A mRNA	PMID:26272509
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA	PMID:27188386
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1617604	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SEMA6A mRNA	PMID:33045310
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SEMA6A mRNA	PMID:37995155
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:135937	enzacamene	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C038939	enzacamene results in increased expression of SEMA6A mRNA	PMID:30597193
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SEMA6A gene	PMID:20938992
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SEMA6A mRNA	PMID:23724009
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of SEMA6A mRNA	PMID:22378314
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1617604	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of SEMA6A mRNA	PMID:30319688
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1617604	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SEMA6A mRNA	PMID:30319688
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SEMA6A mRNA	PMID:35811015
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of SEMA6A mRNA	PMID:21185374
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SEMA6A mRNA	PMID:25510870
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SEMA6A gene	PMID:20938992
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SEMA6A mRNA	PMID:21179406
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20250902	CTD	MESH:D005947	[imeglimin co-treated with Glucose] results in increased expression of SEMA6A mRNA	PMID:34588186
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20250902	CTD	MESH:D005947	[imeglimin co-treated with Glucose] results in increased expression of SEMA6A mRNA	PMID:34588186
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SEMA6A protein	PMID:31163220
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of SEMA6A mRNA	PMID:37748715
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1305493	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of SEMA6A mRNA	PMID:28522335
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SEMA6A mRNA	PMID:25510870
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SEMA6A mRNA	PMID:25510870
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SEMA6A mRNA	PMID:22100608
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SEMA6A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SEMA6A mRNA	PMID:27106289|PMID:34911549
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:2666	amitriptyline	increases expression	ISO	RGD:1305493	E	RGD:6480464	20130416	CTD	MESH:D000639	Amitriptyline results in increased expression of SEMA6A mRNA	PMID:22341215
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SEMA6A gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of SEMA6A mRNA]	PMID:20938992|PMID:22206623
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SEMA6A mRNA	PMID:40504410
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA	PMID:27188386
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SEMA6A protein	PMID:35688186
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of SEMA6A mRNA	PMID:28903495
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of SEMA6A mRNA	PMID:19921347
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of SEMA6A promoter	PMID:22847954
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of SEMA6A mRNA	PMID:18000554
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1305493	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of SEMA6A mRNA	PMID:15691709
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305493	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEMA6A mRNA	PMID:22298810
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305493	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SEMA6A mRNA	PMID:33387578|PMID:34747641
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SEMA6A mRNA	PMID:19933214
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305493	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SEMA6A mRNA	PMID:32109520
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SEMA6A mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA	PMID:27188386
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SEMA6A mRNA	PMID:33212167
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of SEMA6A mRNA	PMID:26272509
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SEMA6A mRNA	PMID:32763439
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SEMA6A mRNA	PMID:29803840
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of SEMA6A protein	PMID:35688186
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of SEMA6A mRNA	PMID:20044591
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of and affects the splicing of SEMA6A mRNA	PMID:25879800
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SEMA6A mRNA	PMID:40504410
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SEMA6A 5' UTR	PMID:27901495
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SEMA6A mRNA	PMID:20106945
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SEMA6A mRNA	PMID:21569818
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SEMA6A exon	PMID:27901495
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of SEMA6A promoter	PMID:23974009
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of SEMA6A mRNA	PMID:26551752|PMID:28959546
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1305493	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SEMA6A mRNA	PMID:38458666
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:30563	silicon dioxide	decreases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased methylation of SEMA6A gene	PMID:34973136
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SEMA6A mRNA	PMID:34973136
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SEMA6A gene	PMID:31601247
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in decreased expression of SEMA6A mRNA	PMID:22613225
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1617604	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SEMA6A gene	PMID:35295148
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SEMA6A mRNA	PMID:18648102
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305493	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of SEMA6A mRNA	PMID:30816183
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of SEMA6A mRNA	PMID:23146750
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305493	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of SEMA6A mRNA	PMID:31129395
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1617604	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SEMA6A mRNA	PMID:34585602|PMID:35479511
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SEMA6A gene	PMID:31601247
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of SEMA6A mRNA	PMID:23146750
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SEMA6A mRNA	PMID:25510870
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SEMA6A mRNA	PMID:25510870
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of SEMA6A mRNA	PMID:23146750
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of SEMA6A mRNA	PMID:26377693
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SEMA6A mRNA	PMID:38685157
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1617604	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SEMA6A mRNA	PMID:37019170
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:34682	diazinon	increases expression	ISO	RGD:1305493	E	RGD:6480464	20180410	CTD	MESH:D003976	Diazinon results in increased expression of SEMA6A mRNA	PMID:29108742
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SEMA6A mRNA	PMID:37042841
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1305493	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SEMA6A mRNA	PMID:38458666
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SEMA6A mRNA	PMID:23146750
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305493	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SEMA6A mRNA	PMID:24386269
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305493	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SEMA6A mRNA	PMID:24386269
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SEMA6A mRNA	PMID:28302478
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of SEMA6A promoter	PMID:22847954
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SEMA6A mRNA	PMID:31533062
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of SEMA6A promoter	PMID:22847954
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SEMA6A mRNA	PMID:25979313
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1617604	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SEMA6A mRNA	PMID:17292431
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305493	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of SEMA6A mRNA	PMID:29427782
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SEMA6A mRNA	PMID:23179753
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of SEMA6A mRNA	PMID:19101580
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305493	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of SEMA6A mRNA	PMID:38685447|PMID:41580965
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SEMA6A mRNA	PMID:28973697
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20250902	CTD	MESH:D005947	[imeglimin co-treated with Glucose] results in increased expression of SEMA6A mRNA	PMID:34588186
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SEMA6A mRNA	PMID:27188386
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SEMA6A mRNA	PMID:24935251
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D000082	Acetaminophen affects the expression of SEMA6A mRNA	PMID:25458485
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1617604	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SEMA6A mRNA	PMID:17562736
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SEMA6A mRNA	PMID:22230336
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305493	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SEMA6A mRNA	PMID:33387578
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of SEMA6A mRNA	PMID:35811015
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SEMA6A mRNA	PMID:35811015
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:46680	serpentine asbestos	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in decreased expression of SEMA6A mRNA	PMID:21148743
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of SEMA6A mRNA	PMID:40504410
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305493	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SEMA6A mRNA	PMID:29391264
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305493	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SEMA6A mRNA	PMID:29097150
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of SEMA6A mRNA	PMID:26272509
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of SEMA6A mRNA	PMID:38825487
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SEMA6A mRNA; Nanotubes, Carbon results in decreased expression of SEMA6A mRNA	PMID:25554681
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1305493	E	RGD:6480464	20260203	CTD	MESH:C082359	imidacloprid results in increased expression of SEMA6A mRNA	PMID:40750069
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1305493	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of SEMA6A mRNA	PMID:28801915
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1617604	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SEMA6A mRNA	PMID:22206623
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of SEMA6A mRNA]	PMID:22206623
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of SEMA6A mRNA	PMID:29522793
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:756996	imeglimin	multiple interactions	ISO	RGD:1617604	E	RGD:6480464	20260714	CTD	MESH:C575881	[imeglimin co-treated with Glucose] results in increased expression of SEMA6A mRNA	PMID:34588186
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA	PMID:27188386
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SEMA6A gene]	PMID:28238834
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SEMA6A mRNA	PMID:23146750
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:81794	thifluzamide	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of SEMA6A mRNA	PMID:33512557
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:81980	triticonazole	decreases expression	ISO	RGD:1305493	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of SEMA6A mRNA	PMID:36084822
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA6A mRNA	PMID:27188386
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of SEMA6A mRNA	PMID:26551752|PMID:28959546
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SEMA6A mRNA	PMID:27188386
1313551	SEMA6A	semaphorin 6A	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305493	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of SEMA6A mRNA	PMID:19015723
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552220	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GTF2H3 mRNA	PMID:33045310
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of GTF2H3 mRNA	PMID:17045167|PMID:33167477
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GTF2H3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GTF2H3 mRNA	PMID:32699268
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GTF2H3 mRNA	PMID:36331819
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GTF2H3 mRNA	PMID:39241906
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of GTF2H3 mRNA	PMID:19167446
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of GTF2H3 mRNA	PMID:38568856
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GTF2H3 mRNA	PMID:37042841
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of GTF2H3 mRNA	PMID:33359661
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305494	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of GTF2H3 mRNA	PMID:33387578
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of GTF2H3 mRNA	PMID:28818685
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305494	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of GTF2H3 protein	PMID:34915118
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GTF2H3 mRNA	PMID:37236586
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of GTF2H3 gene	PMID:27153756
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GTF2H3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GTF2H3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of GTF2H3 mRNA	PMID:32699268
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GTF2H3 mRNA	PMID:25629700
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GTF2H3 mRNA	PMID:22206623
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GTF2H3 mRNA	PMID:39836092
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of GTF2H3 mRNA	PMID:31295307
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552220	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GTF2H3 mRNA	PMID:21570461
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GTF2H3 mRNA	PMID:15056799
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305494	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GTF2H3 mRNA	PMID:33387578
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GTF2H3 mRNA	PMID:39836092
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552220	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GTF2H3 mRNA	PMID:22228805
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to GTF2H3 promoter]	PMID:19654925
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GTF2H3 mRNA	PMID:20018196
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552220	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of GTF2H3 mRNA	PMID:28472532
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305494	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of GTF2H3 mRNA	PMID:25181051
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1552220	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of GTF2H3 promoter	PMID:27334623
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of GTF2H3 protein	PMID:31675489
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of GTF2H3 protein	PMID:31675489
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:1305494	E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of GTF2H3 mRNA	PMID:17602206
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305494	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GTF2H3 mRNA	PMID:21266533
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GTF2H3 mRNA	PMID:17361019|PMID:21266533
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of GTF2H3 mRNA	PMID:34813904
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of GTF2H3 mRNA	PMID:34813904
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GTF2H3 mRNA	PMID:37042841
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GTF2H3 mRNA	PMID:38568856
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305494	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GTF2H3 mRNA	PMID:33453195
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GTF2H3 mRNA	PMID:37236586
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:36704	imiquimod	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20120412	CTD	MESH:C056493	imiquimod results in decreased expression of GTF2H3 mRNA	PMID:21878529
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GTF2H3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GTF2H3 mRNA	PMID:32699268
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of GTF2H3 mRNA	PMID:28302478
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of GTF2H3 mRNA	PMID:36331819
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GTF2H3 gene	PMID:29154799
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305494	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of GTF2H3 mRNA	PMID:38685447|PMID:41580965
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of GTF2H3 mRNA	PMID:26690555
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GTF2H3 mRNA	PMID:39836092
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of GTF2H3 mRNA	PMID:31675489
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552220	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of GTF2H3 mRNA	PMID:35436446
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552220	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of GTF2H3 mRNA	PMID:25620056
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305494	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of GTF2H3 mRNA	PMID:41580965
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552220	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of GTF2H3 mRNA	PMID:19042947
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GTF2H3 protein	PMID:32959892
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305494	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of GTF2H3 mRNA	PMID:20080153
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552220	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GTF2H3 mRNA	PMID:22206623
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of GTF2H3 mRNA	PMID:37199045
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552220	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of GTF2H3 mRNA	PMID:30294300
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of GTF2H3 protein	PMID:31675489
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305494	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of GTF2H3 mRNA	PMID:19281266
1313552	GTF2H3	general transcription factor IIH subunit 3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GTF2H3 mRNA	PMID:29301935
1313554	PLXNB2	plexin B2	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of PLXNB2 protein	PMID:39638853
1313554	PLXNB2	plexin B2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PLXNB2 mRNA	PMID:38218311
1313554	PLXNB2	plexin B2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of PLXNB2 mRNA	PMID:25812627
1313554	PLXNB2	plexin B2	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLXNB2 protein]	PMID:38195004
1313554	PLXNB2	plexin B2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313555	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PLXNB2 mRNA	PMID:20188158
1313554	PLXNB2	plexin B2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PLXNB2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PLXNB2 mRNA	PMID:32699268
1313554	PLXNB2	plexin B2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313555	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of PLXNB2 mRNA	PMID:24205000
1313554	PLXNB2	plexin B2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PLXNB2 mRNA	PMID:36331819
1313554	PLXNB2	plexin B2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313555	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PLXNB2 mRNA	PMID:30319688
1313554	PLXNB2	plexin B2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PLXNB2 mRNA	PMID:21632981
1313554	PLXNB2	plexin B2	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of PLXNB2 mRNA	PMID:30510588
1313554	PLXNB2	plexin B2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of PLXNB2 mRNA	PMID:22574217
1313554	PLXNB2	plexin B2	gene	CHEBI:16708	adenine	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D000225	Adenine results in decreased expression of PLXNB2 mRNA	PMID:24211769
1313554	PLXNB2	plexin B2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PLXNB2 mRNA	PMID:23649840
1313554	PLXNB2	plexin B2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PLXNB2 mRNA	PMID:21179406
1313554	PLXNB2	plexin B2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305495	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PLXNB2 mRNA	PMID:26577399
1313554	PLXNB2	plexin B2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PLXNB2 intron	PMID:30157460
1313554	PLXNB2	plexin B2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLXNB2 mRNA	PMID:39836092
1313554	PLXNB2	plexin B2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLXNB2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLXNB2 protein	PMID:38195004
1313554	PLXNB2	plexin B2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLXNB2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLXNB2 mRNA	PMID:37236586|PMID:37325564
1313554	PLXNB2	plexin B2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PLXNB2 mRNA	PMID:23649840
1313554	PLXNB2	plexin B2	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313555	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of PLXNB2 intron; Ethylnitrosourea results in increased mutagenesis of PLXNB2 mRNA	PMID:27776689
1313554	PLXNB2	plexin B2	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of PLXNB2 mRNA	PMID:19376150
1313554	PLXNB2	plexin B2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PLXNB2 protein	PMID:20106945
1313554	PLXNB2	plexin B2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PLXNB2 mRNA	PMID:21632981
1313554	PLXNB2	plexin B2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PLXNB2 mRNA	PMID:23649840
1313554	PLXNB2	plexin B2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PLXNB2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PLXNB2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PLXNB2 mRNA	PMID:32699268
1313554	PLXNB2	plexin B2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PLXNB2 mRNA	PMID:34911549
1313554	PLXNB2	plexin B2	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of PLXNB2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PLXNB2 protein	PMID:38598786
1313554	PLXNB2	plexin B2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305495	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PLXNB2 mRNA	PMID:31150632
1313554	PLXNB2	plexin B2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PLXNB2 mRNA	PMID:22206623
1313554	PLXNB2	plexin B2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PLXNB2 gene	PMID:25304211
1313554	PLXNB2	plexin B2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLXNB2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLXNB2 mRNA	PMID:39836092
1313554	PLXNB2	plexin B2	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of PLXNB2 mRNA	PMID:19244175
1313554	PLXNB2	plexin B2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313555	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of PLXNB2 protein	PMID:25505154
1313554	PLXNB2	plexin B2	gene	CHEBI:27882	(S)-colchicine	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D003078	Colchicine results in decreased expression of PLXNB2 mRNA	PMID:24211769
1313554	PLXNB2	plexin B2	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of PLXNB2 mRNA	PMID:28903495
1313554	PLXNB2	plexin B2	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of PLXNB2 mRNA	PMID:19921347
1313554	PLXNB2	plexin B2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in increased expression of PLXNB2 mRNA	PMID:21858171
1313554	PLXNB2	plexin B2	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305495	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of PLXNB2 mRNA	PMID:20187946
1313554	PLXNB2	plexin B2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PLXNB2 mRNA	PMID:30912803
1313554	PLXNB2	plexin B2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of PLXNB2 mRNA	PMID:23195993
1313554	PLXNB2	plexin B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305495	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLXNB2 mRNA	PMID:34747641
1313554	PLXNB2	plexin B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLXNB2 mRNA	PMID:15652763|PMID:33956508
1313554	PLXNB2	plexin B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313555	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLXNB2 mRNA	PMID:17035482
1313554	PLXNB2	plexin B2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PLXNB2 mRNA	PMID:33212167
1313554	PLXNB2	plexin B2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PLXNB2 mRNA	PMID:32763439
1313554	PLXNB2	plexin B2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of PLXNB2 mRNA	PMID:24690739
1313554	PLXNB2	plexin B2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PLXNB2 mRNA	PMID:29803840
1313554	PLXNB2	plexin B2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of PLXNB2 mRNA	PMID:39719251
1313554	PLXNB2	plexin B2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313555	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of PLXNB2 mRNA	PMID:36209798
1313554	PLXNB2	plexin B2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLXNB2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLXNB2 mRNA	PMID:39836092
1313554	PLXNB2	plexin B2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLXNB2 5' UTR	PMID:27901495
1313554	PLXNB2	plexin B2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313555	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PLXNB2 5' UTR; Benzo(a)pyrene results in decreased methylation of PLXNB2 exon; Benzo(a)pyrene results in decreased methylation of PLXNB2 intron	PMID:27901495
1313554	PLXNB2	plexin B2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLXNB2 mRNA	PMID:21632981
1313554	PLXNB2	plexin B2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of PLXNB2 mRNA	PMID:33053406
1313554	PLXNB2	plexin B2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of PLXNB2 mRNA	PMID:24690739
1313554	PLXNB2	plexin B2	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	PLXNB2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1313554	PLXNB2	plexin B2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313555	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLXNB2 gene; titanium dioxide results in decreased methylation of PLXNB2 promoter	PMID:35295148
1313554	PLXNB2	plexin B2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313555	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of PLXNB2 mRNA	PMID:23557971
1313554	PLXNB2	plexin B2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313555	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PLXNB2 gene	PMID:35295148
1313554	PLXNB2	plexin B2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305495	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PLXNB2 mRNA	PMID:34492290
1313554	PLXNB2	plexin B2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PLXNB2 mRNA	PMID:18445702
1313554	PLXNB2	plexin B2	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305495	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of PLXNB2 mRNA	PMID:19167457
1313554	PLXNB2	plexin B2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PLXNB2 mRNA	PMID:30903817
1313554	PLXNB2	plexin B2	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of PLXNB2 gene	PMID:31601247
1313554	PLXNB2	plexin B2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of PLXNB2 protein	PMID:34186270
1313554	PLXNB2	plexin B2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305495	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PLXNB2 mRNA	PMID:25181051|PMID:32145629
1313554	PLXNB2	plexin B2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313555	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PLXNB2 mRNA	PMID:26063408|PMID:33221593
1313554	PLXNB2	plexin B2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PLXNB2 promoter	PMID:27271280
1313554	PLXNB2	plexin B2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305495	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PLXNB2 gene	PMID:28505145
1313554	PLXNB2	plexin B2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PLXNB2 mRNA	PMID:25979313
1313554	PLXNB2	plexin B2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of PLXNB2 protein	PMID:31945527
1313554	PLXNB2	plexin B2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PLXNB2 mRNA	PMID:39298647
1313554	PLXNB2	plexin B2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313555	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of PLXNB2 exon	PMID:33297965
1313554	PLXNB2	plexin B2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PLXNB2 intron	PMID:30157460
1313554	PLXNB2	plexin B2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PLXNB2 protein	PMID:34186270
1313554	PLXNB2	plexin B2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PLXNB2 protein	PMID:34186270
1313554	PLXNB2	plexin B2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PLXNB2 mRNA	PMID:34813904
1313554	PLXNB2	plexin B2	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of PLXNB2 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of PLXNB2 protein	PMID:38598786
1313554	PLXNB2	plexin B2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLXNB2 mRNA	PMID:39836092
1313554	PLXNB2	plexin B2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLXNB2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLXNB2 protein	PMID:38195004
1313554	PLXNB2	plexin B2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLXNB2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLXNB2 mRNA	PMID:37236586|PMID:37325564
1313554	PLXNB2	plexin B2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PLXNB2 mRNA	PMID:25812627
1313554	PLXNB2	plexin B2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PLXNB2 mRNA	PMID:24449571
1313554	PLXNB2	plexin B2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PLXNB2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PLXNB2 mRNA	PMID:32699268
1313554	PLXNB2	plexin B2	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of PLXNB2 mRNA	PMID:19244175
1313554	PLXNB2	plexin B2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PLXNB2 mRNA	PMID:25812627
1313554	PLXNB2	plexin B2	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of PLXNB2 mRNA	PMID:19167446
1313554	PLXNB2	plexin B2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PLXNB2 mRNA	PMID:25812627
1313554	PLXNB2	plexin B2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PLXNB2 mRNA	PMID:36331819
1313554	PLXNB2	plexin B2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLXNB2 mRNA	PMID:29154799
1313554	PLXNB2	plexin B2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PLXNB2 mRNA	PMID:23179753
1313554	PLXNB2	plexin B2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313555	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PLXNB2 mRNA	PMID:28973697
1313554	PLXNB2	plexin B2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLXNB2 mRNA	PMID:21420995|PMID:26690555
1313554	PLXNB2	plexin B2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PLXNB2 mRNA	PMID:22230336
1313554	PLXNB2	plexin B2	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of PLXNB2 mRNA	PMID:24690739
1313554	PLXNB2	plexin B2	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PLXNB2 mRNA	PMID:29432896
1313554	PLXNB2	plexin B2	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1313555	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of PLXNB2 mRNA	PMID:16251409
1313554	PLXNB2	plexin B2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PLXNB2 gene	PMID:25304211
1313554	PLXNB2	plexin B2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLXNB2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLXNB2 mRNA	PMID:39836092
1313554	PLXNB2	plexin B2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305495	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLXNB2 mRNA	PMID:29391264
1313554	PLXNB2	plexin B2	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	PLXNB2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1313554	PLXNB2	plexin B2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313555	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of PLXNB2 mRNA	PMID:25620056
1313554	PLXNB2	plexin B2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PLXNB2 protein	PMID:32959892
1313554	PLXNB2	plexin B2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PLXNB2 mRNA	PMID:39836092
1313554	PLXNB2	plexin B2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of PLXNB2 mRNA	PMID:15336504
1313554	PLXNB2	plexin B2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PLXNB2 intron	PMID:30157460
1313554	PLXNB2	plexin B2	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of PLXNB2 mRNA	PMID:22101062
1313554	PLXNB2	plexin B2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313555	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PLXNB2 mRNA	PMID:22206623
1313554	PLXNB2	plexin B2	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305495	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PLXNB2 mRNA	PMID:24136188
1313554	PLXNB2	plexin B2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of PLXNB2 protein	PMID:39638853
1313554	PLXNB2	plexin B2	gene	CHEBI:8107	phenytoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010672	Phenytoin results in decreased expression of PLXNB2 mRNA	PMID:14741686
1313554	PLXNB2	plexin B2	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in increased expression of PLXNB2 mRNA	PMID:21858171
1313554	PLXNB2	plexin B2	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1313555	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of PLXNB2 mRNA	PMID:27029645
1313554	PLXNB2	plexin B2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313555	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PLXNB2 mRNA	PMID:39847705
1313554	PLXNB2	plexin B2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305495	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PLXNB2 mRNA	PMID:24780913
1313554	PLXNB2	plexin B2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305495	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PLXNB2 mRNA	PMID:19281266
1313554	PLXNB2	plexin B2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of PLXNB2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PLXNB2 protein	PMID:38598786
1313554	PLXNB2	plexin B2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305495	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin affects the expression of PLXNB2 mRNA	PMID:23034163
1313556	MSC	musculin	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313557	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MSC mRNA	PMID:33045310
1313556	MSC	musculin	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313557	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MSC mRNA	PMID:37995155
1313556	MSC	musculin	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305496	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MSC mRNA]	PMID:31150632
1313556	MSC	musculin	gene	CHEBI:149681	methcathinone	increases expression	EXP		E	RGD:6480464	20200602	CTD	MESH:C047806	monomethylpropion results in increased expression of MSC mRNA	PMID:22303338
1313556	MSC	musculin	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MSC mRNA	PMID:16604517
1313556	MSC	musculin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MSC mRNA	PMID:36189433
1313556	MSC	musculin	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MSC mRNA	PMID:26079696
1313556	MSC	musculin	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MSC mRNA	PMID:35811015
1313556	MSC	musculin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MSC mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MSC mRNA	PMID:35811015
1313556	MSC	musculin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of MSC mRNA	PMID:25210133
1313556	MSC	musculin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MSC mRNA	PMID:30165855
1313556	MSC	musculin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305496	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MSC mRNA	PMID:32741896
1313556	MSC	musculin	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305496	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MSC mRNA	PMID:33387578
1313556	MSC	musculin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MSC mRNA	PMID:37042841
1313556	MSC	musculin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MSC mRNA	PMID:37992649
1313556	MSC	musculin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of MSC promoter	PMID:33872906
1313556	MSC	musculin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in increased expression of MSC mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MSC mRNA	PMID:20463053|PMID:36189433
1313556	MSC	musculin	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305496	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MSC mRNA	PMID:32741896
1313556	MSC	musculin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MSC mRNA	PMID:37992649
1313556	MSC	musculin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of MSC promoter	PMID:33872906
1313556	MSC	musculin	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305496	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MSC mRNA	PMID:33387578
1313556	MSC	musculin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305496	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MSC mRNA	PMID:39012411
1313556	MSC	musculin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MSC mRNA	PMID:37236586
1313556	MSC	musculin	gene	CHEBI:232105	dicyclanil	increases expression	ISO	RGD:1313557	E	RGD:6480464	20241119	CTD	MESH:C121718	dicyclanil results in increased expression of MSC mRNA	PMID:15664270
1313556	MSC	musculin	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MSC mRNA	PMID:23649840
1313556	MSC	musculin	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MSC gene	PMID:27153756
1313556	MSC	musculin	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MSC mRNA	PMID:23649840
1313556	MSC	musculin	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313557	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MSC mRNA	PMID:17484886
1313556	MSC	musculin	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305496	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MSC mRNA	PMID:31150632
1313556	MSC	musculin	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305496	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MSC mRNA]	PMID:31150632
1313556	MSC	musculin	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of MSC mRNA	PMID:27392435
1313556	MSC	musculin	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of MSC mRNA	PMID:32186404
1313556	MSC	musculin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MSC mRNA	PMID:17942748
1313556	MSC	musculin	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MSC mRNA	PMID:29803840
1313556	MSC	musculin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MSC mRNA	PMID:37992649
1313556	MSC	musculin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MSC mRNA	PMID:37682722
1313556	MSC	musculin	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MSC mRNA	PMID:22714537
1313556	MSC	musculin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MSC mRNA	PMID:22316170
1313556	MSC	musculin	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MSC exon; Benzo(a)pyrene results in decreased methylation of MSC promoter	PMID:27901495
1313556	MSC	musculin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MSC mRNA	PMID:20064835
1313556	MSC	musculin	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of MSC promoter	PMID:23974009
1313556	MSC	musculin	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313557	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MSC mRNA	PMID:29341224
1313556	MSC	musculin	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MSC mRNA	PMID:15761015
1313556	MSC	musculin	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of MSC mRNA	PMID:35984750
1313556	MSC	musculin	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305496	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of MSC mRNA	PMID:24395379
1313556	MSC	musculin	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of MSC gene	PMID:31601247
1313556	MSC	musculin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313557	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of MSC mRNA	PMID:35295148
1313556	MSC	musculin	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305496	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MSC mRNA	PMID:34492290
1313556	MSC	musculin	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220607	CTD	MESH:C006780	bisphenol A affects the methylation of MSC gene	PMID:33391824
1313556	MSC	musculin	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313557	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of MSC promoter	PMID:27334623
1313556	MSC	musculin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20150127	CTD	MESH:C006780	bisphenol A results in decreased expression of MSC mRNA	PMID:25270620
1313556	MSC	musculin	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of MSC gene	PMID:31601247
1313556	MSC	musculin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of MSC mRNA	PMID:29275510
1313556	MSC	musculin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305496	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MSC mRNA	PMID:25181051
1313556	MSC	musculin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313557	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of MSC mRNA	PMID:30951980
1313556	MSC	musculin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MSC gene	PMID:31601247
1313556	MSC	musculin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313557	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of MSC mRNA	PMID:30951980
1313556	MSC	musculin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313557	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of MSC mRNA	PMID:30951980
1313556	MSC	musculin	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305496	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MSC mRNA	PMID:32680482
1313556	MSC	musculin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305496	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MSC mRNA	PMID:39012411
1313556	MSC	musculin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MSC mRNA	PMID:37236586
1313556	MSC	musculin	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305496	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MSC mRNA	PMID:35163327
1313556	MSC	musculin	gene	CHEBI:3647	chlorpromazine	decreases expression	ISO	RGD:1305496	E	RGD:6480464	20150825	CTD	MESH:D002746	Chlorpromazine results in decreased expression of MSC mRNA	PMID:25596134
1313556	MSC	musculin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MSC mRNA	PMID:32588087
1313556	MSC	musculin	gene	CHEBI:40279	allopurinol	increases expression	ISO	RGD:1305496	E	RGD:6480464	20241203	CTD	MESH:D000493	Allopurinol results in increased expression of MSC mRNA	PMID:37876353
1313556	MSC	musculin	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MSC mRNA	PMID:20106945
1313556	MSC	musculin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313557	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MSC mRNA	PMID:28973697
1313556	MSC	musculin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MSC mRNA	PMID:37992649
1313556	MSC	musculin	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305496	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MSC mRNA	PMID:33387578
1313556	MSC	musculin	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of MSC mRNA	PMID:29067470
1313556	MSC	musculin	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MSC mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MSC mRNA	PMID:35811015
1313556	MSC	musculin	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of MSC mRNA	PMID:25757056
1313556	MSC	musculin	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of MSC mRNA	PMID:26833863
1313556	MSC	musculin	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305496	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MSC mRNA	PMID:29391264
1313556	MSC	musculin	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of MSC mRNA	PMID:24383545
1313556	MSC	musculin	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313557	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MSC mRNA	PMID:17942748
1313556	MSC	musculin	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313557	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MSC mRNA	PMID:17942748
1313556	MSC	musculin	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20150127	CTD	MESH:D005047	Etoposide results in decreased expression of MSC mRNA	PMID:25270620
1313556	MSC	musculin	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MSC mRNA	PMID:15761015
1313556	MSC	musculin	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1305496	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of MSC mRNA	PMID:25596134
1313556	MSC	musculin	gene	CHEBI:50102	N-methyl-N-nitrosourea	decreases expression	ISO	RGD:1313557	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in decreased expression of MSC mRNA	PMID:25270620
1313556	MSC	musculin	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313557	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of MSC mRNA	PMID:40234311
1313556	MSC	musculin	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of MSC mRNA	PMID:22714537
1313556	MSC	musculin	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1305496	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of MSC mRNA	PMID:25596134
1313556	MSC	musculin	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MSC mRNA	PMID:22714537
1313556	MSC	musculin	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305496	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MSC mRNA	PMID:32741896
1313556	MSC	musculin	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MSC gene]	PMID:28238834
1313556	MSC	musculin	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MSC mRNA	PMID:19159669
1313556	MSC	musculin	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MSC mRNA	PMID:23146750
1313556	MSC	musculin	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of MSC mRNA	PMID:26079696
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313559	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MIS18BP1 mRNA	PMID:39752319
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MIS18BP1 mRNA	PMID:21632981
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of MIS18BP1 protein	PMID:35688186
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313559	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MIS18BP1 mRNA	PMID:39241906
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1594757	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MIS18BP1 mRNA	PMID:33387578
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MIS18BP1 mRNA	PMID:37042841
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of MIS18BP1 mRNA	PMID:26079696
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313559	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIS18BP1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIS18BP1 mRNA	PMID:37992649
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313559	E	RGD:6480464	20250603	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in decreased expression of MIS18BP1 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MIS18BP1 mRNA	PMID:20463053|PMID:39752319
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MIS18BP1 mRNA	PMID:21592394|PMID:33359661
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of MIS18BP1 mRNA	PMID:21592394
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313559	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIS18BP1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIS18BP1 mRNA	PMID:37992649
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MIS18BP1 protein	PMID:37730182
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MIS18BP1 mRNA	PMID:21592394
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of MIS18BP1 mRNA	PMID:21592394
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1594757	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MIS18BP1 mRNA	PMID:33387578
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MIS18BP1 mRNA	PMID:19549813
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MIS18BP1 protein	PMID:20106945
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313559	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MIS18BP1 mRNA	PMID:19770486
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of MIS18BP1 mRNA	PMID:25102026
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313559	E	RGD:6480464	20140408	CTD	MESH:D010126	Ozone results in decreased expression of MIS18BP1 mRNA	PMID:24336422
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313559	E	RGD:6480464	20150609	CTD	MESH:D010126	Ozone results in increased expression of MIS18BP1 mRNA	PMID:25658374
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313559	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MIS18BP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MIS18BP1 mRNA	PMID:27106289|PMID:34911549
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313559	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MIS18BP1 mRNA	PMID:17484886|PMID:31919559
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1313559	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in decreased expression of MIS18BP1 mRNA	PMID:25270620
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of MIS18BP1 mRNA	PMID:26272509
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MIS18BP1 mRNA	PMID:27188386
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MIS18BP1 protein	PMID:35688186
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1313559	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIS18BP1 mRNA]	PMID:37992649
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1594757	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MIS18BP1 mRNA	PMID:31881176
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of MIS18BP1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of MIS18BP1 mRNA	PMID:19167446|PMID:23557933
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of MIS18BP1 mRNA	PMID:27392435
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313559	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in decreased expression of MIS18BP1 mRNA	PMID:25270620
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1313559	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of MIS18BP1 protein	PMID:22006019
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313559	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MIS18BP1 mRNA	PMID:30912803
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313559	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MIS18BP1 mRNA	PMID:21570461
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1594757	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MIS18BP1 mRNA	PMID:32109520|PMID:33387578
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313559	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MIS18BP1 mRNA	PMID:37172768
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1594757	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MIS18BP1 mRNA	PMID:34747641
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MIS18BP1 mRNA	PMID:33212167
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MIS18BP1 mRNA	PMID:32763439
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1594757	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of MIS18BP1 mRNA	PMID:28959563
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313559	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of MIS18BP1 mRNA	PMID:36227756
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313559	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIS18BP1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIS18BP1 mRNA	PMID:37992649
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of MIS18BP1 protein	PMID:35688186
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1313559	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIS18BP1 mRNA]	PMID:37992649
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of MIS18BP1 mRNA	PMID:22623647
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MIS18BP1 mRNA	PMID:38568856
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313559	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MIS18BP1 mRNA	PMID:17998272
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MIS18BP1 promoter	PMID:27901495
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313559	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MIS18BP1 mRNA	PMID:32417428
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MIS18BP1 mRNA]	PMID:32406909
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313559	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MIS18BP1 mRNA	PMID:29341224
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MIS18BP1 mRNA	PMID:19150397|PMID:20018196|PMID:20382639
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of MIS18BP1 gene	PMID:31601247
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313559	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the expression of MIS18BP1 mRNA	PMID:35295148
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313559	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MIS18BP1 promoter	PMID:35295148
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1594757	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MIS18BP1 mRNA	PMID:34492290
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1594757	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MIS18BP1 mRNA	PMID:25181051
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MIS18BP1 mRNA	PMID:29275510
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1594757	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MIS18BP1 mRNA	PMID:30816183|PMID:32528016
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1594757	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of MIS18BP1 mRNA	PMID:32145629
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313559	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of MIS18BP1 mRNA	PMID:26682919
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313559	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MIS18BP1 mRNA	PMID:40203079
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of MIS18BP1 gene	PMID:31601247
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313559	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MIS18BP1 mRNA	PMID:37019170
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313559	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MIS18BP1 mRNA	PMID:21266533
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1594757	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MIS18BP1 mRNA	PMID:30723492
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MIS18BP1 mRNA	PMID:38174414|PMID:38568856
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1594757	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of MIS18BP1 mRNA	PMID:25539665
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313559	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of MIS18BP1 mRNA	PMID:28962523
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313559	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MIS18BP1 mRNA	PMID:40194260
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MIS18BP1 mRNA	PMID:28302478
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MIS18BP1 mRNA	PMID:31533062
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of MIS18BP1 mRNA	PMID:19167446
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MIS18BP1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of MIS18BP1 mRNA	PMID:19167446
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313559	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MIS18BP1 mRNA	PMID:39529242
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MIS18BP1 mRNA	PMID:27153767|PMID:40419075
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of MIS18BP1 mRNA	PMID:23179753|PMID:28001369
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1594757	E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of MIS18BP1 mRNA	PMID:35594946
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of MIS18BP1 mRNA	PMID:21632981
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313559	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIS18BP1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MIS18BP1 mRNA	PMID:37992649
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MIS18BP1 mRNA	PMID:38832940
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MIS18BP1 mRNA	PMID:27188386
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of MIS18BP1 mRNA	PMID:26272509
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MIS18BP1 mRNA	PMID:27188386
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1594757	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MIS18BP1 mRNA	PMID:33387578
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1313559	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of MIS18BP1 mRNA	PMID:29279043
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313559	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of MIS18BP1 mRNA	PMID:25554681
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of MIS18BP1 mRNA	PMID:26705709
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313559	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MIS18BP1 mRNA	PMID:19042947
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313559	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MIS18BP1 mRNA	PMID:38701926
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1594757	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of MIS18BP1 mRNA	PMID:37269647
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1594757	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of MIS18BP1 mRNA	PMID:35283115
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313559	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MIS18BP1 mRNA	PMID:39752319
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MIS18BP1 protein	PMID:31285264
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in decreased expression of MIS18BP1 mRNA	PMID:30559759
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MIS18BP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MIS18BP1 mRNA	PMID:27188386
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of MIS18BP1 mRNA	PMID:30928695
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313559	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MIS18BP1 mRNA	PMID:23091169
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MIS18BP1 mRNA	PMID:19167446
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313559	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of MIS18BP1 mRNA	PMID:38648751
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:82272	Erionite	increases expression	ISO	RGD:1313559	E	RGD:6480464	20200915	CTD	MESH:C083174	erionite results in increased expression of MIS18BP1 mRNA	PMID:29279043
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of MIS18BP1 mRNA	PMID:32234424
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1594757	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MIS18BP1 mRNA	PMID:24780913
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313559	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of MIS18BP1 mRNA	PMID:40826991
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313559	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of MIS18BP1 mRNA	PMID:39752319
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MIS18BP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MIS18BP1 mRNA	PMID:27188386
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MIS18BP1 mRNA	PMID:27188386
1313558	MIS18BP1	MIS18 binding protein 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313559	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of MIS18BP1 mRNA	PMID:35537566
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313561	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COTL1 mRNA	PMID:33045310
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:132844	glycidyl methacrylate	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of COTL1 protein	PMID:36641056
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COTL1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of COTL1 gene	PMID:20938992
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in increased expression of COTL1 mRNA	PMID:15894607|PMID:33167477
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of COTL1 mRNA	PMID:16604517
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in increased expression of COTL1 mRNA	PMID:15894607
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of COTL1 mRNA	PMID:15282401
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of COTL1 mRNA	PMID:26079696
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of COTL1 mRNA	PMID:21632981
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313561	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of COTL1 mRNA	PMID:39241906
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305498	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of COTL1 mRNA	PMID:32145629
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of COTL1 mRNA	PMID:39298647
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of COTL1 mRNA	PMID:31614463
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313561	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of COTL1 mRNA	PMID:33711761
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305498	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of COTL1 mRNA	PMID:33387578
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COTL1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of COTL1 gene	PMID:20938992
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of COTL1 mRNA	PMID:18037150
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of COTL1 mRNA	PMID:26079696
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COTL1 mRNA	PMID:37992649
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COTL1 mRNA	PMID:37992649
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313561	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of COTL1 mRNA	PMID:23892564
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:17750	glycine betaine	decreases expression	ISO	RGD:1305498	E	RGD:6480464	20151215	CTD	MESH:D001622	Betaine results in decreased expression of COTL1 mRNA	PMID:26391144
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305498	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of COTL1 mRNA	PMID:22061828
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of COTL1 mRNA	PMID:28818685
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of COTL1 intron	PMID:30157460
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COTL1 mRNA	PMID:36331819
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313561	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of COTL1 mRNA	PMID:27462272
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COTL1 protein	PMID:33040242
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of COTL1 mRNA	PMID:23649840
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of COTL1 mRNA	PMID:19770486
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of COTL1 mRNA	PMID:22100608|PMID:27153756
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305498	E	RGD:6480464	20121113	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of COTL1 mRNA	PMID:22484513
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of COTL1 mRNA	PMID:23649840
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1305498	E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in increased expression of COTL1 protein	PMID:33146391
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of COTL1 mRNA	PMID:34911549
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of COTL1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of COTL1 protein	PMID:38598786
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313561	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of COTL1 mRNA	PMID:17484886|PMID:27339419|PMID:31919559
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COTL1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of COTL1 gene	PMID:20938992
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COTL1 mRNA	PMID:40504410
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of COTL1 mRNA	PMID:26272509
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA	PMID:27188386
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1305498	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of COTL1 gene	PMID:31011160
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305498	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of COTL1 mRNA	PMID:31881176
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1305498	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of COTL1 mRNA	PMID:25905778
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1305498	E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of COTL1 mRNA	PMID:25905778
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of COTL1 mRNA	PMID:27392435
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305498	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of COTL1 mRNA	PMID:22023808
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of COTL1 mRNA	PMID:27392435
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of COTL1 protein	PMID:20884965
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	ESR2 promotes the reaction [Genistein results in decreased expression of COTL1 protein]	PMID:20884965
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of COTL1 mRNA	PMID:25583101
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305498	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COTL1 mRNA	PMID:34747641
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313561	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COTL1 mRNA	PMID:16611356|PMID:21570461|PMID:24680724
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COTL1 mRNA	PMID:20106945|PMID:21632981
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COTL1 mRNA	PMID:19933214
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305498	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COTL1 mRNA	PMID:21215274
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305498	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of COTL1 protein	PMID:35544339
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of COTL1 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA	PMID:27188386
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of COTL1 mRNA	PMID:33212167
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of COTL1 protein	PMID:28918527
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of COTL1 protein	PMID:29385562
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COTL1 mRNA	PMID:29803840
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of COTL1 mRNA	PMID:19277126
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COTL1 mRNA	PMID:37992649
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of COTL1 mRNA	PMID:38568856
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of COTL1 mRNA	PMID:39719251
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COTL1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COTL1 mRNA	PMID:34876320|PMID:40504410
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COTL1 mRNA	PMID:34876320
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of COTL1 3' UTR	PMID:27901495
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of COTL1 mRNA	PMID:20106945|PMID:21632981
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20120814	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of COTL1 mRNA	PMID:19770486|PMID:20713471|PMID:21569818
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to COTL1 protein]	PMID:32406909
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:3000	beauvericin	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C004456	beauvericin results in decreased expression of COTL1 mRNA	PMID:29203277
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:30563	silicon dioxide	affects secretion	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog affects the secretion of COTL1 protein	PMID:25895662
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of COTL1 mRNA	PMID:25895662
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1305498	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of COTL1 mRNA	PMID:22431001
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313561	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of COTL1 mRNA	PMID:29341224
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of COTL1 mRNA	PMID:20382639
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of COTL1 mRNA	PMID:15894607
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305498	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of COTL1 mRNA	PMID:24136188
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313561	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of COTL1 mRNA	PMID:23557971
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305498	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of COTL1 mRNA	PMID:34492290
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1305498	E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of COTL1 mRNA	PMID:28943392
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305498	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of COTL1 mRNA	PMID:25380136
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313561	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of COTL1 mRNA	PMID:18301758|PMID:23811191
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of COTL1 mRNA	PMID:19710929
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313561	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of COTL1 mRNA	PMID:28472532
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305498	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of COTL1 mRNA	PMID:25181051
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of COTL1 protein	PMID:34186270|PMID:37664457
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305498	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of COTL1 mRNA	PMID:32145629
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of COTL1 protein	PMID:35999755
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of COTL1 protein	PMID:37567409
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305498	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of COTL1 protein	PMID:32145629
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313561	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of COTL1 mRNA	PMID:32156529|PMID:34585602|PMID:38701888
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COTL1 mRNA	PMID:28628672
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of COTL1 mRNA	PMID:25979313
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of COTL1 mRNA	PMID:20713471
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of COTL1 mRNA	PMID:39298647
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of COTL1 protein	PMID:34186270
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313561	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of COTL1 intron	PMID:28392331
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313561	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of COTL1 mRNA	PMID:37019170
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of COTL1 protein	PMID:35999755
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313561	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of COTL1 mRNA	PMID:34813904
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of COTL1 protein	PMID:38598786
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COTL1 mRNA	PMID:28628672
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313561	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of COTL1 mRNA	PMID:34813904
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305498	E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of COTL1 mRNA	PMID:28943392
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of COTL1 mRNA	PMID:37042841
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305498	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of COTL1 mRNA	PMID:30589522
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of COTL1 mRNA	PMID:29024780
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305498	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of COTL1 mRNA	PMID:25380136
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305498	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of COTL1 mRNA	PMID:33453195
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COTL1 protein	PMID:24527689
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305498	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COTL1 mRNA	PMID:25993096
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COTL1 protein	PMID:33040242
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of COTL1 mRNA	PMID:19320972
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1305498	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of COTL1 mRNA	PMID:25380136
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of COTL1 mRNA	PMID:24449571
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of COTL1 mRNA	PMID:31533062
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COTL1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of COTL1 mRNA	PMID:36331819
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COTL1 mRNA	PMID:25979313
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of COTL1 mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of COTL1 mRNA	PMID:21427059
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of COTL1 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of COTL1 mRNA	PMID:22733784
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COTL1 mRNA	PMID:28628672
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313561	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of COTL1 mRNA	PMID:28973697
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COTL1 mRNA	PMID:37992649
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of COTL1 mRNA	PMID:38832940
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of COTL1 mRNA	PMID:28542535
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D000082	Acetaminophen affects the expression of COTL1 mRNA	PMID:25458485
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313561	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of COTL1 mRNA	PMID:17562736
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305498	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of COTL1 mRNA	PMID:33387578
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of COTL1 mRNA	PMID:29432896
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of COTL1 mRNA	PMID:18687144
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COTL1 mRNA	PMID:40504410
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1313561	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of COTL1 mRNA	PMID:26934552
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305498	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of COTL1 mRNA	PMID:29391264
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of COTL1 mRNA	PMID:22079256
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COTL1 mRNA	PMID:34876320
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:4917	eugenol	decreases expression	ISO	RGD:1305498	E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in decreased expression of COTL1 protein	PMID:39793947
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of COTL1 mRNA	PMID:28628672
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of COTL1 mRNA	PMID:15894607
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate affects the reaction [MTF1 affects the expression of COTL1 mRNA]	PMID:16221973
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of COTL1 mRNA	PMID:25620056
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313561	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of COTL1 mRNA; Nanotubes, Carbon results in increased expression of COTL1 mRNA	PMID:25554681
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313561	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of COTL1 mRNA	PMID:40234311
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313561	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of COTL1 mRNA	PMID:38701926
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of COTL1 protein	PMID:32959892
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:63613	nevirapine	decreases expression	ISO	RGD:1305498	E	RGD:6480464	20140114	CTD	MESH:D019829	Nevirapine results in decreased expression of COTL1 mRNA	PMID:23947594
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313561	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of COTL1 mRNA	PMID:36851058
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of COTL1 mRNA	PMID:22078008
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of COTL1 mRNA	PMID:31758290
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of COTL1 protein	PMID:34186270
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of COTL1 mRNA	PMID:22206623
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of COTL1 protein	PMID:37664457
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of COTL1 mRNA	PMID:22079256
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of COTL1 mRNA	PMID:22079256
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1305498	E	RGD:6480464	20200609	CTD	MESH:C025589	ochratoxin A results in decreased expression of COTL1 protein	PMID:31369848
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA	PMID:27188386
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:7852	oxycodone	decreases expression	ISO	RGD:1305498	E	RGD:6480464	20161025	CTD	MESH:D010098	Oxycodone results in decreased expression of COTL1 mRNA	PMID:23439660
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of COTL1 mRNA	PMID:26079696
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313561	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of COTL1 mRNA	PMID:34876320
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305498	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of COTL1 mRNA	PMID:24780913
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of COTL1 protein; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COTL1 mRNA	PMID:27188386|PMID:37664457
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1305498	E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of COTL1 mRNA	PMID:25905778
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313561	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of COTL1 protein	PMID:24648495
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of COTL1 protein	PMID:38598786
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305498	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of COTL1 mRNA	PMID:19015723
1313560	COTL1	coactosin like F-actin binding protein 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305498	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of COTL1 mRNA	PMID:22570695|PMID:23869203
1313562	CALML3	calmodulin like 3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CALML3 mRNA	PMID:38218311
1313562	CALML3	calmodulin like 3	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305499	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of CALML3 mRNA	PMID:21551480
1313562	CALML3	calmodulin like 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313563	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CALML3 mRNA	PMID:19484750
1313562	CALML3	calmodulin like 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CALML3 mRNA	PMID:30165855
1313562	CALML3	calmodulin like 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305499	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CALML3 mRNA	PMID:33387578
1313562	CALML3	calmodulin like 3	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313563	E	RGD:6480464	20220308	CTD	MESH:D001554	Benzene results in increased expression of CALML3 mRNA	PMID:34624356
1313562	CALML3	calmodulin like 3	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of CALML3 mRNA	PMID:31256213
1313562	CALML3	calmodulin like 3	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of CALML3 mRNA	PMID:26485663
1313562	CALML3	calmodulin like 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305499	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CALML3 mRNA	PMID:33387578
1313562	CALML3	calmodulin like 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CALML3 mRNA	PMID:29741670
1313562	CALML3	calmodulin like 3	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313563	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of CALML3 mRNA	PMID:31626304
1313562	CALML3	calmodulin like 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313563	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CALML3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CALML3 mRNA	PMID:34911549
1313562	CALML3	calmodulin like 3	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305499	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CALML3 mRNA	PMID:30779732
1313562	CALML3	calmodulin like 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CALML3 mRNA	PMID:32525701
1313562	CALML3	calmodulin like 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313563	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CALML3 mRNA	PMID:28960355
1313562	CALML3	calmodulin like 3	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305499	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of CALML3 mRNA	PMID:31881176
1313562	CALML3	calmodulin like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305499	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CALML3 mRNA	PMID:33387578
1313562	CALML3	calmodulin like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313563	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CALML3 mRNA	PMID:17942748
1313562	CALML3	calmodulin like 3	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313563	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CALML3 protein	PMID:28918527
1313562	CALML3	calmodulin like 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313563	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CALML3 mRNA	PMID:37682722
1313562	CALML3	calmodulin like 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CALML3 3' UTR	PMID:27901495
1313562	CALML3	calmodulin like 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CALML3 mRNA	PMID:40419235
1313562	CALML3	calmodulin like 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CALML3 exon; Benzo(a)pyrene results in increased methylation of CALML3 promoter	PMID:27901495
1313562	CALML3	calmodulin like 3	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CALML3 promoter	PMID:23974009
1313562	CALML3	calmodulin like 3	gene	CHEBI:3139	bleomycin A2	decreases expression	ISO	RGD:1305499	E	RGD:6480464	20151215	CTD	MESH:D001761	Bleomycin results in decreased expression of CALML3 protein	PMID:25933445
1313562	CALML3	calmodulin like 3	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1305499	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of CALML3 mRNA	PMID:11578147
1313562	CALML3	calmodulin like 3	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1305499	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of CALML3 mRNA	PMID:32479839
1313562	CALML3	calmodulin like 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313563	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of CALML3 mRNA	PMID:23557971
1313562	CALML3	calmodulin like 3	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305499	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of CALML3 mRNA	PMID:19167457
1313562	CALML3	calmodulin like 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305499	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CALML3 mRNA	PMID:25181051
1313562	CALML3	calmodulin like 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305499	E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of CALML3 mRNA	PMID:36779543
1313562	CALML3	calmodulin like 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313563	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CALML3 mRNA	PMID:32156529
1313562	CALML3	calmodulin like 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CALML3 mRNA	PMID:29741670
1313562	CALML3	calmodulin like 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313563	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CALML3 mRNA	PMID:40194260
1313562	CALML3	calmodulin like 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CALML3 gene	PMID:29154799
1313562	CALML3	calmodulin like 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305499	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CALML3 mRNA	PMID:33387578
1313562	CALML3	calmodulin like 3	gene	CHEBI:46195	paracetamol	increases secretion	ISO	RGD:1313563	E	RGD:6480464	20180703	CTD	MESH:D000082	Acetaminophen results in increased secretion of CALML3 protein	PMID:24038040
1313562	CALML3	calmodulin like 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CALML3 mRNA	PMID:32525701
1313562	CALML3	calmodulin like 3	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1305499	E	RGD:6480464	20190507	CTD	MESH:D004008	Diclofenac results in increased expression of CALML3 mRNA	PMID:30723492
1313562	CALML3	calmodulin like 3	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313563	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of CALML3 mRNA	PMID:30529165
1313562	CALML3	calmodulin like 3	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313563	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of CALML3 mRNA; Nanotubes, Carbon analog affects the expression of CALML3 mRNA	PMID:25554681
1313562	CALML3	calmodulin like 3	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	ISO	RGD:1305499	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of CALML3 mRNA	PMID:21983209
1313562	CALML3	calmodulin like 3	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of CALML3 mRNA	PMID:20436886
1313562	CALML3	calmodulin like 3	gene	CHEBI:753160	lard	decreases expression	ISO	RGD:1305499	E	RGD:6480464	20260714	CTD	MESH:C029310	lard results in decreased expression of CALML3 mRNA	PMID:26115784
1313562	CALML3	calmodulin like 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CALML3 mRNA	PMID:37199045
1313562	CALML3	calmodulin like 3	gene	CHEBI:78420	icariin	affects expression	ISO	RGD:1313563	E	RGD:6480464	20260303	CTD	MESH:C056599	icariin affects the expression of CALML3 mRNA	PMID:31296789
1313562	CALML3	calmodulin like 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1305499	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CALML3 mRNA	PMID:27291303
1313562	CALML3	calmodulin like 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CALML3 mRNA	PMID:32525701
1313562	CALML3	calmodulin like 3	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1305499	E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of CALML3 mRNA	PMID:29162477
1313562	CALML3	calmodulin like 3	gene	CHEBI:9150	simvastatin	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of CALML3 mRNA	PMID:17428261
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FAM204A mRNA	PMID:37042841
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313565	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of FAM204A mRNA	PMID:33754040
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305500	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of FAM204A mRNA	PMID:33387578
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FAM204A mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of FAM204A mRNA	PMID:39836092
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313565	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FAM204A mRNA	PMID:19770486
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FAM204A mRNA	PMID:23649840
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of FAM204A mRNA	PMID:18356318
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FAM204A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FAM204A mRNA	PMID:39836092
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313565	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FAM204A mRNA	PMID:40504410
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of FAM204A mRNA	PMID:26272509
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM204A mRNA	PMID:27188386
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1305500	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA	PMID:33854195
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305500	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FAM204A mRNA	PMID:31881176
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305500	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FAM204A mRNA	PMID:34747641
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305500	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of FAM204A mRNA	PMID:19013527
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FAM204A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FAM204A mRNA	PMID:39836092
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313565	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FAM204A mRNA	PMID:40504410
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FAM204A mRNA	PMID:22316170
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of FAM204A mRNA	PMID:18356318
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313565	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FAM204A gene	PMID:35295148
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305500	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM204A mRNA	PMID:34947998
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313565	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM204A mRNA	PMID:33221593
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313565	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of FAM204A mRNA	PMID:26063408|PMID:29161229|PMID:40036665
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of FAM204A mRNA	PMID:25979313
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313565	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of FAM204A mRNA	PMID:39298647
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1305500	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA	PMID:33854195
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FAM204A mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of FAM204A mRNA	PMID:39836092
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FAM204A mRNA	PMID:38382870
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FAM204A mRNA	PMID:24449571
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FAM204A mRNA	PMID:32588087
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of FAM204A mRNA	PMID:28302478
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FAM204A mRNA	PMID:25979313
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of FAM204A mRNA	PMID:23179753
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of FAM204A mRNA	PMID:20106945
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1305500	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA	PMID:33854195
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313565	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FAM204A mRNA	PMID:28973697
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of FAM204A mRNA]	PMID:21233418
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1305500	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA	PMID:33854195
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313565	E	RGD:6480464	20140610	CTD	MESH:D000082	Acetaminophen affects the expression of FAM204A mRNA	PMID:17562736
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313565	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FAM204A mRNA	PMID:29279043
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FAM204A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FAM204A mRNA	PMID:39836092
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313565	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FAM204A mRNA	PMID:40504410
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1305500	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA	PMID:33854195
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FAM204A mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of FAM204A mRNA	PMID:39836092
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313565	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FAM204A mRNA	PMID:22206623
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM204A mRNA	PMID:27188386
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1305500	E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of FAM204A mRNA	PMID:29162477
1313564	FAM204A	family with sequence similarity 204 member A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM204A mRNA	PMID:27188386
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:10033	warfarin	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin results in decreased expression of TUFM mRNA	PMID:20493250
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552222	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TUFM mRNA	PMID:33045310
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552222	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TUFM mRNA	PMID:20188158
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of TUFM mRNA	PMID:16604517
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D019308	[Palmitic Acid co-treated with Oleic Acid] affects the expression of TUFM mRNA	PMID:30547786
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:16196	oleic acid	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D019301	[Palmitic Acid co-treated with Oleic Acid] affects the expression of TUFM mRNA	PMID:30547786
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552222	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TUFM mRNA	PMID:30319688
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of TUFM protein	PMID:19207037
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of TUFM protein	PMID:17292933
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552222	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TUFM mRNA	PMID:39241906
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of TUFM mRNA	PMID:31059760
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TUFM mRNA	PMID:39298647
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305501	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of TUFM protein	PMID:32145629
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TUFM mRNA	PMID:37042841
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of TUFM protein	PMID:32044396
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305501	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of TUFM mRNA; Gentamicins results in decreased expression of TUFM protein	PMID:22061828|PMID:33387578
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305501	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TUFM mRNA	PMID:22061828
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:18243	dopamine	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D004298	Dopamine results in increased expression of TUFM protein	PMID:24675778
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TUFM mRNA	PMID:36331819
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305501	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TUFM protein	PMID:34915118
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TUFM protein	PMID:23301498
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1305501	E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in increased expression of TUFM protein	PMID:33146391
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of TUFM protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of TUFM protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of TUFM protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of TUFM protein	PMID:38598786
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:27363	zinc atom	affects binding	EXP		E	RGD:6480464	20120918	CTD	MESH:D015032	TUFM protein binds to Zinc	PMID:14534351
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TUFM mRNA	PMID:40504410
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of TUFM protein	PMID:38460933
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1552222	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of TUFM protein	PMID:36173347
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:27827	paraoxon	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D010261	Paraoxon results in increased expression of TUFM protein	PMID:20931991
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1552222	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of TUFM protein	PMID:25505154
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TUFM mRNA	PMID:23557933
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552222	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TUFM mRNA	PMID:21570461
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TUFM mRNA	PMID:19770486
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TUFM mRNA	PMID:17942748
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of TUFM protein	PMID:39603559
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305501	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of TUFM protein	PMID:35544339
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TUFM mRNA	PMID:27862939
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1305501	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of TUFM mRNA	PMID:19915844
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of TUFM mRNA	PMID:29803840
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of TUFM protein	PMID:16144979
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Aspartame] affects the expression of TUFM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TUFM mRNA	PMID:23783067
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TUFM mRNA	PMID:29432896
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:29287	gold atom	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20150310	CTD	MESH:D006046	Gold analog results in decreased expression of and results in increased phosphorylation of TUFM protein	PMID:24780912
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TUFM mRNA	PMID:38568856
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TUFM mRNA	PMID:40504410
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TUFM protein	PMID:17292933
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:30050	gold(0)	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20150310	CTD	MESH:D006046	Gold analog results in decreased expression of and results in increased phosphorylation of TUFM protein	PMID:24780912
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:30185	zinc(0)	affects binding	EXP		E	RGD:6480464	20120918	CTD	MESH:D015032	TUFM protein binds to Zinc	PMID:14534351
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305501	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of TUFM mRNA	PMID:24136188
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552222	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TUFM gene; titanium dioxide results in decreased methylation of TUFM promoter	PMID:35295148
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552222	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TUFM mRNA	PMID:15375163|PMID:18301758|PMID:23811191
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of TUFM protein	PMID:34186270
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of TUFM protein	PMID:37567409
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305501	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TUFM mRNA; bisphenol A results in increased expression of TUFM protein	PMID:25181051|PMID:32145629
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305501	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TUFM gene	PMID:28505145
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	TUFM mRNA affects the susceptibility to Carmustine	PMID:16365179
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552222	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TUFM gene	PMID:31683443
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of TUFM protein	PMID:34186270
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of TUFM protein	PMID:34186270
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552222	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TUFM mRNA	PMID:38685157
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TUFM protein	PMID:34186270
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305501	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TUFM mRNA	PMID:17602206
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:34709	Diisodecyl phthalate	increases expression	ISO	RGD:1552222	E	RGD:6480464	20150127	CTD	MESH:C042080	diisodecyl phthalate results in increased expression of TUFM mRNA	PMID:25270620
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of TUFM protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of TUFM protein	PMID:38598786
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305501	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of TUFM mRNA	PMID:17602206
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305501	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TUFM protein	PMID:21699967
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1305501	E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate results in increased expression of TUFM protein	PMID:16470657
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TUFM mRNA	PMID:31533062
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TUFM mRNA	PMID:36331819
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TUFM mRNA	PMID:25979313
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TUFM mRNA	PMID:17292431
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TUFM mRNA	PMID:23179753
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:40303	lovastatin	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20120814	CTD	MESH:D008148	Lovastatin results in decreased expression of TUFM mRNA	PMID:20493250
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D016572	Cyclosporine results in decreased expression of TUFM mRNA	PMID:20106945|PMID:21163907
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of TUFM mRNA	PMID:19770486
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TUFM mRNA	PMID:17562736
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in increased expression of TUFM mRNA	PMID:31059760
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of TUFM mRNA	PMID:31059760
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of TUFM protein	PMID:38460933
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TUFM mRNA	PMID:40504410
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TUFM mRNA	PMID:22079256
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of TUFM mRNA	PMID:18175754
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TUFM mRNA	PMID:17942748
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TUFM mRNA	PMID:17942748
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20181016	CTD	MESH:D005047	Etoposide results in decreased expression of TUFM protein	PMID:29733421
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305501	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of TUFM mRNA	PMID:30307764
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TUFM mRNA	PMID:25620056
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552222	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TUFM mRNA; Nanotubes, Carbon results in increased expression of TUFM mRNA	PMID:25554681
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TUFM mRNA	PMID:35964746
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305501	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TUFM mRNA	PMID:24136188
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TUFM protein	PMID:32959892
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:63918	artesunate	decreases response to substance	EXP		E	RGD:6480464	20170228	CTD	MESH:C039726	TUFM mRNA results in decreased susceptibility to artesunate	PMID:20144594
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TUFM protein	PMID:24675778
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1552222	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of TUFM mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of TUFM mRNA	PMID:23783067
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1305501	E	RGD:6480464	20120412	CTD	MESH:D008694	Methamphetamine results in decreased expression of TUFM protein	PMID:19826936
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:68233	(Z)-3-butylidenephthalide	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C026105	butylidenephthalide results in increased expression of TUFM protein	PMID:23770345
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1305501	E	RGD:6480464	20230307	CTD	MESH:C057862	cyanoginosin LR results in increased expression of TUFM protein	PMID:22430071
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	TUFM mRNA affects the susceptibility to temozolomide	PMID:16365179
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TUFM protein	PMID:34186270
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of TUFM mRNA	PMID:22079256
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TUFM mRNA	PMID:22079256
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:79516	Nonylphenol	increases expression	ISO	RGD:1305501	E	RGD:6480464	20141111	CTD	MESH:C025256	nonylphenol results in increased expression of TUFM protein	PMID:19260726
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1305501	E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of TUFM protein	PMID:19954255
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552222	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TUFM mRNA	PMID:30294300
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1305501	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of TUFM protein	PMID:28903499
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:8493	Propiverine	affects binding	ISO	RGD:1305501	E	RGD:6480464	20180410	CTD	MESH:C015586	propiverine binds to TUFM protein	PMID:29273565
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1552222	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of TUFM mRNA	PMID:40826991
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305501	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TUFM mRNA	PMID:19281266
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:9381	T-2 toxin	affects expression	ISO	RGD:1305501	E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin affects the expression of TUFM protein	PMID:26141394
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TUFM mRNA	PMID:38568856
1313566	TUFM	Tu translation elongation factor, mitochondrial	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of TUFM protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of TUFM protein	PMID:38598786
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621868	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of XRRA1 mRNA	PMID:33045310
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305502	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of XRRA1 mRNA	PMID:33387578
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of XRRA1 mRNA	PMID:37042841
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305502	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of XRRA1 mRNA	PMID:26577399
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of XRRA1 mRNA	PMID:28818685
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the splicing of XRRA1 mRNA	PMID:35072517
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305502	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of XRRA1 mRNA	PMID:33387578
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of XRRA1 mRNA	PMID:39709020
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305502	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of XRRA1 mRNA	PMID:28959563
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of XRRA1 mRNA	PMID:29803840
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of XRRA1 mRNA	PMID:34032870
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1621868	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of XRRA1 mRNA	PMID:37682722
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the splicing of XRRA1 mRNA	PMID:35072517
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of XRRA1 5' UTR	PMID:27901495
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305502	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of XRRA1 mRNA	PMID:30047161
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621868	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of XRRA1 gene	PMID:35295148
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1621868	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of XRRA1 promoter alternative form	PMID:35295148
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305502	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of XRRA1 mRNA	PMID:25181051
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1621868	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of XRRA1 gene	PMID:31683443
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of XRRA1 mRNA	PMID:31533062
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of XRRA1 mRNA	PMID:40419075
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305502	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of XRRA1 mRNA	PMID:30047161
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of XRRA1 mRNA	PMID:20106945
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of XRRA1 mRNA	PMID:24449571
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of XRRA1 mRNA	PMID:28542535
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the splicing of XRRA1 mRNA	PMID:35072517
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305502	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of XRRA1 mRNA	PMID:30047161
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1621868	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of XRRA1 mRNA	PMID:23608068
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to XRRA1 gene]	PMID:28238834
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of XRRA1 mRNA	PMID:26079696
1313568	XRRA1	X-ray radiation resistance associated 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305502	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of XRRA1 mRNA	PMID:24780913
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ADCK5 mRNA	PMID:33045310
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of ADCK5 mRNA	PMID:25056781
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ADCK5 mRNA	PMID:20044591
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ADCK5 mRNA	PMID:39241906
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313571	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ADCK5 mRNA	PMID:39298647
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADCK5 mRNA	PMID:37042841
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313571	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of ADCK5 mRNA	PMID:33848595
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of ADCK5 mRNA	PMID:25056781
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADCK5 mRNA	PMID:31919559
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313571	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of ADCK5 mRNA	PMID:25629700
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADCK5 gene	PMID:25304211
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ADCK5 mRNA	PMID:28960355
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ADCK5 mRNA	PMID:27392435
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313571	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADCK5 mRNA	PMID:21570461
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305504	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADCK5 mRNA	PMID:21215274
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADCK5 mRNA	PMID:28922406
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305504	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADCK5 mRNA	PMID:33387578
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ADCK5 mRNA	PMID:32763439
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313571	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ADCK5 protein	PMID:28918527
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADCK5 mRNA	PMID:33145626
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313571	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of ADCK5 mRNA	PMID:39095385
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of ADCK5 protein	PMID:37955338
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ADCK5 mRNA	PMID:35984750
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305504	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of ADCK5 mRNA	PMID:24136188
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313571	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADCK5 gene	PMID:35295148
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305504	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ADCK5 mRNA	PMID:34492290
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313571	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ADCK5 mRNA	PMID:18301758|PMID:23811191
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313571	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ADCK5 mRNA	PMID:28472532
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1313571	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of ADCK5 mRNA	PMID:37894381
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305504	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADCK5 mRNA	PMID:25181051
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313571	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ADCK5 gene	PMID:31683443
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313571	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ADCK5 mRNA	PMID:39298647
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ADCK5 mRNA	PMID:38685157
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305504	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ADCK5 mRNA	PMID:21266533
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305504	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ADCK5 mRNA	PMID:30047161
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ADCK5 mRNA	PMID:28903501
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313571	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADCK5 mRNA	PMID:40194260
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313571	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ADCK5 mRNA	PMID:17292431
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305504	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ADCK5 mRNA	PMID:30047161
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313571	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ADCK5 mRNA	PMID:28973697
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305504	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of ADCK5 mRNA	PMID:24136188
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313571	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ADCK5 mRNA	PMID:17562736
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADCK5 gene	PMID:25304211
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305504	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ADCK5 mRNA	PMID:29391264
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ADCK5 mRNA	PMID:35436446
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ADCK5 mRNA	PMID:25620056
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305504	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ADCK5 mRNA	PMID:30047161
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1305504	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of ADCK5 mRNA	PMID:19564919
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADCK5 mRNA	PMID:22206623
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305504	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ADCK5 mRNA	PMID:24136188
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of ADCK5 mRNA	PMID:19270015
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313571	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of ADCK5 mRNA	PMID:21278054
1313570	ADCK5	aarF domain containing kinase 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305504	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ADCK5 mRNA	PMID:30047161
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KCTD15 mRNA	PMID:38218311
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of KCTD15 mRNA	PMID:27188386
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313573	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of KCTD15 mRNA	PMID:37995155
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313573	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KCTD15 gene	PMID:20938992
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of KCTD15 mRNA	PMID:33167477
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of KCTD15 mRNA	PMID:26079696
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of KCTD15 mRNA	PMID:22378314
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313573	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of KCTD15 mRNA	PMID:39298647
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313573	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KCTD15 mRNA	PMID:25510870
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313573	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of KCTD15 mRNA	PMID:33711761
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313573	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KCTD15 gene	PMID:20938992
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of KCTD15 mRNA	PMID:23649840
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of KCTD15 mRNA	PMID:26079696
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313573	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of KCTD15 mRNA	PMID:23892564
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of KCTD15 protein	PMID:37730182
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1583737	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KCTD15 mRNA	PMID:33387578
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of KCTD15 mRNA	PMID:28818685
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of KCTD15 3' UTR	PMID:30157460
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313573	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KCTD15 mRNA	PMID:25510870
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313573	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KCTD15 mRNA	PMID:25510870
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of KCTD15 protein	PMID:23301498
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of KCTD15 mRNA	PMID:23649840
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KCTD15 intron	PMID:30157460
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of KCTD15 mRNA	PMID:23649840
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313573	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of KCTD15 mRNA	PMID:17484886
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313573	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KCTD15 mRNA	PMID:31919559
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1583737	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KCTD15 mRNA	PMID:31150632
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313573	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of KCTD15 gene	PMID:20938992
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KCTD15 gene	PMID:25304211
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1583737	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of KCTD15 mRNA	PMID:31881176
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of KCTD15 mRNA	PMID:27392435
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1583737	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of KCTD15 mRNA	PMID:22023808
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313573	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of KCTD15 mRNA	PMID:32186404
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313573	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KCTD15 mRNA	PMID:21570461
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313573	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KCTD15 mRNA	PMID:19933214
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313573	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KCTD15 mRNA	PMID:17942748
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of KCTD15 mRNA	PMID:33212167
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1583737	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of KCTD15 mRNA	PMID:30556269
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KCTD15 mRNA	PMID:29803840
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of KCTD15 mRNA	PMID:29453283
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313573	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of KCTD15 mRNA	PMID:17127020
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KCTD15 intron	PMID:30157460
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313573	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KCTD15 mRNA	PMID:22228805
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of KCTD15 gene	PMID:25435355
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313573	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of KCTD15 mRNA]	PMID:22228805
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1583737	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of KCTD15 mRNA	PMID:30556269
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of KCTD15 mRNA	PMID:25351596
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:30768	propionic acid	decreases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C029658	propionic acid results in decreased expression of KCTD15 mRNA	PMID:31526819
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of KCTD15 gene	PMID:31601247
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1583737	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of KCTD15 mRNA	PMID:32479839
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1583737	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of KCTD15 mRNA	PMID:25729387
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1583737	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of KCTD15 mRNA	PMID:25729387
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313573	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KCTD15 promoter	PMID:35295148
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1583737	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of KCTD15 mRNA	PMID:34492290
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1583737	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of KCTD15 mRNA	PMID:25181051
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313573	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of KCTD15 mRNA	PMID:25594700
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1583737	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of KCTD15 mRNA	PMID:33296240
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1583737	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of KCTD15 mRNA	PMID:30816183|PMID:34947998
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of KCTD15 mRNA	PMID:19041380
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313573	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KCTD15 mRNA	PMID:25510870
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313573	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of KCTD15 mRNA	PMID:25510870
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of KCTD15 gene	PMID:31601247
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313573	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KCTD15 mRNA	PMID:37019170
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of KCTD15 gene	PMID:22964155
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1583737	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of KCTD15 mRNA	PMID:22110744
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1583737	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of KCTD15 gene	PMID:33148267
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KCTD15 mRNA	PMID:37042841
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1583737	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KCTD15 mRNA	PMID:35163327
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1583737	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KCTD15 mRNA	PMID:35163327
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1583737	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of KCTD15 mRNA	PMID:27387713
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of KCTD15 mRNA	PMID:24449571
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of KCTD15 mRNA	PMID:32588087
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of KCTD15 mRNA	PMID:28302478
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of KCTD15 mRNA	PMID:31533062
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1583737	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of KCTD15 mRNA	PMID:22110744
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KCTD15 mRNA	PMID:25979313
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of KCTD15 mRNA	PMID:19101580|PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313573	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in decreased expression of KCTD15 mRNA	PMID:20546886|PMID:21427059
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCTD15 mRNA	PMID:27188386
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of KCTD15 mRNA	PMID:20106945
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of KCTD15 mRNA	PMID:23649840
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of KCTD15 mRNA	PMID:27188386
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of KCTD15 mRNA	PMID:24935251
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313573	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KCTD15 mRNA	PMID:17562736
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1583737	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KCTD15 mRNA	PMID:33387578
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KCTD15 gene	PMID:25304211
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313573	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of KCTD15 mRNA	PMID:17942748
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313573	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KCTD15 mRNA	PMID:17942748
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of KCTD15 mRNA	PMID:32234424
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313573	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of KCTD15 mRNA; Nanotubes, Carbon results in increased expression of KCTD15 mRNA	PMID:25620056
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1313573	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of KCTD15 mRNA	PMID:26377693
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in decreased expression of KCTD15 mRNA	PMID:16780908
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313573	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of KCTD15 mRNA	PMID:38701926
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1583737	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of KCTD15 mRNA	PMID:25729387
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1583737	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of KCTD15 mRNA	PMID:25729387
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1583737	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of KCTD15 gene	PMID:35440735
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1583737	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of KCTD15 gene	PMID:33148267
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of KCTD15 mRNA	PMID:31758290
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of KCTD15 mRNA	PMID:22714537
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of KCTD15 protein	PMID:31285264
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCTD15 mRNA	PMID:27188386
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of KCTD15 mRNA	PMID:26079696
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCTD15 mRNA	PMID:27188386
1313572	KCTD15	potassium channel tetramerization domain containing 15	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KCTD15 mRNA	PMID:38568856
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DNPEP mRNA	PMID:38218311
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313576	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DNPEP mRNA	PMID:33045310
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313576	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DNPEP gene	PMID:20938992
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of DNPEP mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of DNPEP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of DNPEP mRNA	PMID:32699268|PMID:32845096
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of DNPEP mRNA	PMID:22378314
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:16240	hydrogen peroxide	decreases secretion	ISO	RGD:1313576	E	RGD:6480464	20121218	CTD	MESH:D006861	Hydrogen Peroxide results in decreased secretion of DNPEP mRNA	PMID:21179422
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313576	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DNPEP gene	PMID:20938992
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:16990	bilirubin IXalpha	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin results in decreased expression of DNPEP mRNA	PMID:20196124
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313576	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DNPEP mRNA	PMID:33754040
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1583848	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of DNPEP mRNA	PMID:22061828
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DNPEP mRNA	PMID:28818685
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of DNPEP mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of DNPEP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of DNPEP mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of DNPEP mRNA	PMID:32699268|PMID:32845096
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313576	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of DNPEP mRNA	PMID:34911549
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313576	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DNPEP gene	PMID:20938992
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313576	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNPEP mRNA	PMID:40504410
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DNPEP mRNA	PMID:19244175
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DNPEP protein	PMID:38460933
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of DNPEP mRNA	PMID:19921347
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of DNPEP protein	PMID:20884965
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	ESR2 promotes the reaction [Genistein results in decreased expression of DNPEP protein]	PMID:20884965
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313576	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DNPEP mRNA	PMID:21570461
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313576	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNPEP mRNA	PMID:21354282
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1583848	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNPEP mRNA	PMID:21215274
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1583848	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DNPEP mRNA	PMID:33387578|PMID:34747641
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of DNPEP protein	PMID:39603559
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313576	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of DNPEP protein	PMID:28918527
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DNPEP mRNA	PMID:29803840
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of DNPEP mRNA	PMID:29319823
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313576	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DNPEP mRNA	PMID:16014739
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1583848	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of DNPEP protein	PMID:29459688
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313576	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNPEP mRNA	PMID:40504410
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DNPEP promoter	PMID:27901495
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313576	E	RGD:6480464	20150127	CTD	MESH:C008261	lead acetate results in decreased expression of DNPEP mRNA	PMID:22609695|PMID:25270620
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313576	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of DNPEP mRNA	PMID:21829687
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313576	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DNPEP promoter	PMID:35295148
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313576	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of DNPEP mRNA	PMID:27760801
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DNPEP mRNA	PMID:19710929
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1583848	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of DNPEP mRNA	PMID:30816183|PMID:32528016
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1583848	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DNPEP mRNA	PMID:25181051
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1583848	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DNPEP mRNA	PMID:36041667
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1583848	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DNPEP mRNA	PMID:36041667
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313576	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DNPEP mRNA	PMID:38685157
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1583848	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DNPEP mRNA	PMID:36041667
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNPEP mRNA; Cadmium Chloride results in increased expression of DNPEP protein	PMID:24527689|PMID:26472689
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1583848	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of DNPEP mRNA	PMID:26194646
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of DNPEP mRNA	PMID:19320972
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of DNPEP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of DNPEP mRNA	PMID:32699268
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DNPEP mRNA	PMID:19244175
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313576	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of DNPEP mRNA	PMID:23811191
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of DNPEP mRNA	PMID:40419075
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313576	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DNPEP mRNA	PMID:17292431
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1583848	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of DNPEP mRNA	PMID:29427782
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of DNPEP mRNA; Valproic Acid results in decreased expression of DNPEP protein	PMID:29501571
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of DNPEP mRNA	PMID:20106945
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of DNPEP protein	PMID:38460933
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313576	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNPEP mRNA	PMID:40504410
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DNPEP mRNA	PMID:22079256
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313576	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of DNPEP mRNA	PMID:35436446
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of DNPEP mRNA	PMID:18175754
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:50102	N-methyl-N-nitrosourea	decreases activity	ISO	RGD:1583848	E	RGD:6480464	20120412	CTD	MESH:D008770	Methylnitrosourea results in decreased activity of DNPEP protein	PMID:16537183
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1583848	E	RGD:6480464	20210706	CTD	MESH:C017690	fenvalerate results in decreased expression of DNPEP protein	PMID:33656234
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313576	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DNPEP mRNA	PMID:25554681
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DNPEP protein	PMID:32959892
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313576	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DNPEP mRNA	PMID:22206623
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DNPEP mRNA	PMID:22079256
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DNPEP mRNA	PMID:22079256
1313575	DNPEP	aspartyl aminopeptidase	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1583848	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of DNPEP mRNA	PMID:19281266
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of SENP7 mRNA	PMID:26272509
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP7 mRNA	PMID:27188386
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1550234	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of SENP7 mRNA	PMID:33045310
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305510	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SENP7 mRNA]	PMID:31150632
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SENP7 mRNA	PMID:21632981
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of SENP7 mRNA	PMID:22574217
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305510	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SENP7 mRNA	PMID:32145629
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SENP7 mRNA	PMID:37042841
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SENP7 protein	PMID:37730182
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305510	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SENP7 mRNA	PMID:22061828
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SENP7 mRNA	PMID:39836092
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SENP7 mRNA	PMID:22100608
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SENP7 mRNA	PMID:23649840
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SENP7 mRNA	PMID:22171008
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305510	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SENP7 mRNA	PMID:31150632
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305510	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SENP7 mRNA]	PMID:31150632
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SENP7 mRNA	PMID:21867686
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of SENP7 mRNA	PMID:38723480
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SENP7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SENP7 mRNA	PMID:39836092
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550234	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SENP7 mRNA	PMID:40504410
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1305510	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of SENP7 mRNA	PMID:25905778
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SENP7 mRNA	PMID:23557933
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SENP7 mRNA	PMID:27392435
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SENP7 mRNA	PMID:27392435
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550234	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SENP7 mRNA	PMID:21570461
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305510	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SENP7 mRNA	PMID:21215274
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550234	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SENP7 mRNA	PMID:21354282
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SENP7 mRNA	PMID:28001369
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SENP7 mRNA	PMID:33212167
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SENP7 mRNA	PMID:32763439
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SENP7 mRNA	PMID:29803840
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of SENP7 mRNA	PMID:28595984|PMID:34032870
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SENP7 mRNA	PMID:38568856
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SENP7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SENP7 mRNA	PMID:39836092
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550234	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SENP7 mRNA	PMID:40504410
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of SENP7 mRNA	PMID:21714911
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SENP7 promoter	PMID:27901495
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SENP7 mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1305510	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SENP7 mRNA	PMID:21839799
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SENP7 mRNA	PMID:22171008
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SENP7 mRNA	PMID:34973136
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305510	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SENP7 mRNA	PMID:25729387
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305510	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of SENP7 mRNA	PMID:30047161
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550234	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SENP7 gene	PMID:35295148
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305510	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SENP7 mRNA	PMID:34492290
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550234	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SENP7 mRNA	PMID:19710929
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of SENP7 mRNA	PMID:27793765
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305510	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SENP7 mRNA	PMID:25181051
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305510	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of SENP7 mRNA	PMID:33296240|PMID:41034487
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305510	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SENP7 gene	PMID:28505145
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550234	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SENP7 mRNA	PMID:39298647
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550234	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SENP7 mRNA	PMID:20350560
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SENP7 mRNA	PMID:39836092
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:3763	clorgyline	increases expression	EXP		E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of SENP7 mRNA	PMID:19691856
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:3764	clotrimazole	decreases expression	ISO	RGD:1305510	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of SENP7 mRNA	PMID:30047161
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SENP7 mRNA	PMID:28302478
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SENP7 mRNA	PMID:31533062
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SENP7 mRNA	PMID:27153767|PMID:40419075
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1305510	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of SENP7 mRNA	PMID:22110744
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SENP7 mRNA	PMID:23179753|PMID:27188386
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305510	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SENP7 mRNA	PMID:30047161
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550234	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SENP7 mRNA	PMID:17562736
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SENP7 mRNA	PMID:29067470
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305510	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SENP7 mRNA	PMID:33387578
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1550234	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SENP7 mRNA	PMID:29279043
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in decreased expression of SENP7 mRNA	PMID:38723480
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SENP7 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SENP7 mRNA	PMID:39836092
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550234	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SENP7 mRNA	PMID:40504410
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SENP7 mRNA	PMID:22079256
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305510	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SENP7 mRNA	PMID:30047161
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305510	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of SENP7 mRNA	PMID:20080153
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SENP7 mRNA	PMID:39836092
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1550234	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SENP7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SENP7 mRNA	PMID:21641980|PMID:26378955
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305510	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SENP7 mRNA	PMID:25729387
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305510	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SENP7 mRNA	PMID:25729387
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1550234	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of SENP7 protein	PMID:36851058
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550234	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SENP7 mRNA	PMID:22206623
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SENP7 mRNA	PMID:22079256
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SENP7 mRNA	PMID:22079256
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP7 mRNA	PMID:27188386
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of SENP7 mRNA	PMID:30928695
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550234	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SENP7 mRNA	PMID:23091169
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1305510	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of SENP7 mRNA	PMID:20345932
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of SENP7 mRNA	PMID:26079696
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305510	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SENP7 mRNA	PMID:30047161
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SENP7 mRNA	PMID:27188386
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1550234	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of SENP7 protein	PMID:24648495
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of SENP7 mRNA	PMID:27188386
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550234	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SENP7 mRNA	PMID:28973697
1313579	SENP7	SUMO specific peptidase 7	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305510	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of SENP7 mRNA	PMID:23034163
1313581	PPL	periplakin	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305511	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of PPL mRNA	PMID:21551480
1313581	PPL	periplakin	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PPL mRNA	PMID:26272509
1313581	PPL	periplakin	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1313581	PPL	periplakin	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PPL mRNA	PMID:20188158
1313581	PPL	periplakin	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PPL mRNA	PMID:20938992
1313581	PPL	periplakin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of PPL mRNA	PMID:30951980
1313581	PPL	periplakin	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PPL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PPL mRNA	PMID:32699268
1313581	PPL	periplakin	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of PPL mRNA	PMID:24403227|PMID:26516004
1313581	PPL	periplakin	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D010100	1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of PPL mRNA]	PMID:24403227
1313581	PPL	periplakin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305511	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PPL mRNA	PMID:33729688
1313581	PPL	periplakin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPL mRNA	PMID:30529165
1313581	PPL	periplakin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PPL mRNA	PMID:35811015
1313581	PPL	periplakin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PPL mRNA	PMID:39298647
1313581	PPL	periplakin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of PPL mRNA	PMID:30165855
1313581	PPL	periplakin	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PPL mRNA	PMID:38568856
1313581	PPL	periplakin	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305511	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PPL mRNA	PMID:33387578
1313581	PPL	periplakin	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PPL mRNA	PMID:20938992
1313581	PPL	periplakin	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PPL mRNA	PMID:23649840|PMID:28937961
1313581	PPL	periplakin	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of PPL mRNA	PMID:18070364
1313581	PPL	periplakin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPL mRNA	PMID:37992649
1313581	PPL	periplakin	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PPL mRNA	PMID:33359661
1313581	PPL	periplakin	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in decreased expression of PPL mRNA	PMID:19693291
1313581	PPL	periplakin	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of PPL mRNA	PMID:21592394
1313581	PPL	periplakin	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of PPL mRNA	PMID:21592394
1313581	PPL	periplakin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPL mRNA	PMID:37992649
1313581	PPL	periplakin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PPL mRNA	PMID:33754040
1313581	PPL	periplakin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PPL mRNA	PMID:19850644
1313581	PPL	periplakin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of PPL mRNA]	PMID:19850644
1313581	PPL	periplakin	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305511	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PPL mRNA	PMID:27523638
1313581	PPL	periplakin	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of PPL mRNA	PMID:21592394|PMID:26485663
1313581	PPL	periplakin	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of PPL mRNA	PMID:21592394
1313581	PPL	periplakin	gene	CHEBI:181932	3-Nitrobenzanthrone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C117220	3-nitrobenzanthrone results in decreased expression of PPL mRNA	PMID:34036453
1313581	PPL	periplakin	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in decreased expression of PPL mRNA	PMID:28860664
1313581	PPL	periplakin	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of PPL mRNA	PMID:23487506
1313581	PPL	periplakin	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PPL mRNA	PMID:23649840
1313581	PPL	periplakin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305511	E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PPL mRNA	PMID:25378103
1313581	PPL	periplakin	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PPL intron; Aflatoxin B1 results in increased methylation of PPL polyA tail	PMID:30157460
1313581	PPL	periplakin	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PPL mRNA	PMID:23649840
1313581	PPL	periplakin	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PPL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PPL mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PPL mRNA	PMID:32699268
1313581	PPL	periplakin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PPL mRNA	PMID:34911549
1313581	PPL	periplakin	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of PPL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of PPL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of PPL protein	PMID:38598786
1313581	PPL	periplakin	gene	CHEBI:2682	amphotericin B	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of PPL mRNA	PMID:28534445
1313581	PPL	periplakin	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305511	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PPL mRNA	PMID:31150632
1313581	PPL	periplakin	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313582	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PPL mRNA	PMID:27339419
1313581	PPL	periplakin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PPL mRNA	PMID:20938992
1313581	PPL	periplakin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPL mRNA	PMID:40504410
1313581	PPL	periplakin	gene	CHEBI:2762	antimycin A	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20191105	CTD	MESH:D000968	Antimycin A results in decreased expression of PPL mRNA	PMID:19304788
1313581	PPL	periplakin	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PPL mRNA	PMID:26272509
1313581	PPL	periplakin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1313581	PPL	periplakin	gene	CHEBI:27779	griseofulvin	affects expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D006118	Griseofulvin affects the expression of PPL mRNA	PMID:12735108
1313581	PPL	periplakin	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305511	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PPL mRNA	PMID:31881176
1313581	PPL	periplakin	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in decreased expression of PPL mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of PPL mRNA	PMID:19167446|PMID:23557933
1313581	PPL	periplakin	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PPL mRNA	PMID:27392435
1313581	PPL	periplakin	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1305511	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of PPL mRNA	PMID:22023808
1313581	PPL	periplakin	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313582	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of PPL mRNA	PMID:40618947
1313581	PPL	periplakin	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of PPL protein	PMID:20884965
1313581	PPL	periplakin	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	ESR2 promotes the reaction [Genistein results in decreased expression of PPL protein]	PMID:20884965
1313581	PPL	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPL mRNA	PMID:22298810
1313581	PPL	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313582	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPL mRNA	PMID:21570461
1313581	PPL	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPL mRNA	PMID:20106945
1313581	PPL	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPL mRNA	PMID:19933214
1313581	PPL	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPL mRNA	PMID:23152189
1313581	PPL	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305511	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPL mRNA	PMID:33387578
1313581	PPL	periplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPL mRNA	PMID:17035482|PMID:28922406
1313581	PPL	periplakin	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of PPL mRNA	PMID:19304788
1313581	PPL	periplakin	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PPL mRNA	PMID:30851411
1313581	PPL	periplakin	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20200804	CTD	MESH:D004317	Doxorubicin results in decreased expression of PPL mRNA	PMID:31768571
1313581	PPL	periplakin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPL mRNA	PMID:37992649
1313581	PPL	periplakin	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PPL mRNA	PMID:29432896
1313581	PPL	periplakin	gene	CHEBI:29014	cordycepin	increases expression	ISO	RGD:1313582	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in increased expression of PPL mRNA	PMID:32042022
1313581	PPL	periplakin	gene	CHEBI:2948	azathioprine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of PPL mRNA	PMID:22623647
1313581	PPL	periplakin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPL mRNA	PMID:38568856
1313581	PPL	periplakin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPL mRNA	PMID:37682722
1313581	PPL	periplakin	gene	CHEBI:29678	sodium arsenite	decreases methylation	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased methylation of PPL gene	PMID:24570342
1313581	PPL	periplakin	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PPL mRNA	PMID:24570342|PMID:39719251
1313581	PPL	periplakin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPL mRNA	PMID:40504410
1313581	PPL	periplakin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PPL intron	PMID:30157460
1313581	PPL	periplakin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PPL mRNA	PMID:20106945
1313581	PPL	periplakin	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PPL 3' UTR; Benzo(a)pyrene results in decreased methylation of PPL promoter	PMID:27901495
1313581	PPL	periplakin	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to PPL promoter]	PMID:19654925
1313581	PPL	periplakin	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PPL mRNA]	PMID:32406909
1313581	PPL	periplakin	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PPL mRNA	PMID:25895662
1313581	PPL	periplakin	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PPL gene	PMID:31601247
1313581	PPL	periplakin	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of PPL mRNA	PMID:38568856
1313581	PPL	periplakin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1305511	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of PPL mRNA	PMID:30012374
1313581	PPL	periplakin	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of PPL mRNA	PMID:23557971
1313581	PPL	periplakin	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313582	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PPL gene	PMID:35295148
1313581	PPL	periplakin	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305511	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PPL mRNA	PMID:23411599|PMID:34492290
1313581	PPL	periplakin	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PPL mRNA	PMID:19710929
1313581	PPL	periplakin	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305511	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PPL mRNA	PMID:19167457
1313581	PPL	periplakin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of PPL protein	PMID:31675489
1313581	PPL	periplakin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305511	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PPL mRNA	PMID:30816183|PMID:32145629|PMID:32528016
1313581	PPL	periplakin	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PPL gene	PMID:31601247
1313581	PPL	periplakin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of PPL protein	PMID:37567409
1313581	PPL	periplakin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305511	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of PPL mRNA	PMID:35192832|PMID:36779543
1313581	PPL	periplakin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313582	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of PPL mRNA	PMID:25594700|PMID:32156529
1313581	PPL	periplakin	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PPL gene	PMID:31601247
1313581	PPL	periplakin	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of PPL protein	PMID:31675489
1313581	PPL	periplakin	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of PPL mRNA	PMID:19244175
1313581	PPL	periplakin	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PPL mRNA	PMID:25979313
1313581	PPL	periplakin	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PPL mRNA	PMID:19692669
1313581	PPL	periplakin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of PPL protein	PMID:31945527
1313581	PPL	periplakin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313582	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PPL mRNA	PMID:30951980
1313581	PPL	periplakin	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1313582	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of PPL mRNA	PMID:26377693
1313581	PPL	periplakin	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PPL protein	PMID:34186270
1313581	PPL	periplakin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313582	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PPL mRNA	PMID:30951980
1313581	PPL	periplakin	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of PPL mRNA	PMID:30951980
1313581	PPL	periplakin	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PPL protein	PMID:34186270
1313581	PPL	periplakin	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to PPL protein	PMID:32991956
1313581	PPL	periplakin	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of PPL protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of PPL protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of PPL protein	PMID:38598786
1313581	PPL	periplakin	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313582	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PPL mRNA	PMID:24535843
1313581	PPL	periplakin	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPL mRNA	PMID:37042841
1313581	PPL	periplakin	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305511	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of PPL mRNA	PMID:30589522
1313581	PPL	periplakin	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313582	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of PPL mRNA	PMID:26377693
1313581	PPL	periplakin	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305511	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of PPL mRNA	PMID:30723492
1313581	PPL	periplakin	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PPL mRNA	PMID:38382870
1313581	PPL	periplakin	gene	CHEBI:35546	perfluorodecanoic acid	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C036567	perfluorodecanoic acid results in decreased expression of PPL mRNA	PMID:38568856
1313581	PPL	periplakin	gene	CHEBI:35559	furan	decreases methylation	ISO	RGD:1305511	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of PPL gene	PMID:27387713
1313581	PPL	periplakin	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305511	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of PPL mRNA	PMID:25539665|PMID:27387713
1313581	PPL	periplakin	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1313582	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of PPL mRNA	PMID:24183702
1313581	PPL	periplakin	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of PPL mRNA	PMID:28903501
1313581	PPL	periplakin	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PPL mRNA	PMID:24449571
1313581	PPL	periplakin	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PPL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PPL mRNA	PMID:32699268
1313581	PPL	periplakin	gene	CHEBI:37825	p-toluidine	increases expression	ISO	RGD:1305511	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of PPL mRNA	PMID:27638505
1313581	PPL	periplakin	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of PPL mRNA	PMID:19167446
1313581	PPL	periplakin	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPL mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of PPL mRNA	PMID:19167446
1313581	PPL	periplakin	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313582	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of PPL mRNA	PMID:39529242
1313581	PPL	periplakin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PPL mRNA	PMID:40419075
1313581	PPL	periplakin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PPL mRNA	PMID:17292431
1313581	PPL	periplakin	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PPL mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1313581	PPL	periplakin	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of PPL mRNA	PMID:21427059
1313581	PPL	periplakin	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1313581	PPL	periplakin	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine affects the expression of PPL mRNA	PMID:20106945
1313581	PPL	periplakin	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PPL mRNA	PMID:21632981|PMID:25562108
1313581	PPL	periplakin	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1305511	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of PPL mRNA	PMID:21865292
1313581	PPL	periplakin	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of PPL mRNA	PMID:25123088
1313581	PPL	periplakin	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313582	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of PPL mRNA	PMID:22733784
1313581	PPL	periplakin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PPL mRNA	PMID:28973697
1313581	PPL	periplakin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPL mRNA	PMID:37992649
1313581	PPL	periplakin	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PPL mRNA	PMID:38832940
1313581	PPL	periplakin	gene	CHEBI:44658	okadaic acid	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of and results in increased phosphorylation of PPL protein	PMID:38832940
1313581	PPL	periplakin	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PPL mRNA	PMID:24935251
1313581	PPL	periplakin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PPL mRNA	PMID:17562736
1313581	PPL	periplakin	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PPL mRNA	PMID:21420995
1313581	PPL	periplakin	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305511	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PPL mRNA	PMID:33387578
1313581	PPL	periplakin	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of PPL mRNA	PMID:25704631
1313581	PPL	periplakin	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of PPL mRNA	PMID:24714768
1313581	PPL	periplakin	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of PPL mRNA	PMID:35811015
1313581	PPL	periplakin	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PPL mRNA	PMID:35811015
1313581	PPL	periplakin	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PPL mRNA	PMID:20831825
1313581	PPL	periplakin	gene	CHEBI:46677	amphibole asbestos	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017636	Asbestos, Amphibole results in decreased expression of PPL mRNA	PMID:20831825
1313581	PPL	periplakin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPL mRNA	PMID:40504410
1313581	PPL	periplakin	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of PPL mRNA	PMID:31675489
1313581	PPL	periplakin	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305511	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PPL mRNA	PMID:29391264
1313581	PPL	periplakin	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305511	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PPL mRNA	PMID:17557909
1313581	PPL	periplakin	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of PPL mRNA	PMID:38568856
1313581	PPL	periplakin	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of PPL mRNA	PMID:26272509
1313581	PPL	periplakin	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1313581	PPL	periplakin	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313582	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of PPL mRNA	PMID:25554681
1313581	PPL	periplakin	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313582	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PPL mRNA	PMID:25554681
1313581	PPL	periplakin	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305511	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of PPL mRNA	PMID:22504374
1313581	PPL	periplakin	gene	CHEBI:507499	tricetin	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C469689	tricetin results in decreased expression of PPL mRNA	PMID:38654487
1313581	PPL	periplakin	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313582	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of PPL mRNA	PMID:19042947
1313581	PPL	periplakin	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1305511	E	RGD:6480464	20120501	CTD	MESH:D016559	Tacrolimus results in increased expression of PPL mRNA	PMID:21865292
1313581	PPL	periplakin	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of PPL mRNA	PMID:15336504
1313581	PPL	periplakin	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PPL mRNA	PMID:15003993
1313581	PPL	periplakin	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PPL mRNA	PMID:24810058
1313581	PPL	periplakin	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of PPL protein	PMID:37788135
1313581	PPL	periplakin	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305511	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PPL gene	PMID:35440735
1313581	PPL	periplakin	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PPL protein	PMID:34186270
1313581	PPL	periplakin	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1313582	E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PPL mRNA	PMID:20061341
1313581	PPL	periplakin	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PPL mRNA	PMID:37199045
1313581	PPL	periplakin	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PPL mRNA	PMID:30851411
1313581	PPL	periplakin	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1313581	PPL	periplakin	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of PPL mRNA	PMID:19482888
1313581	PPL	periplakin	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313582	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PPL mRNA]	PMID:19482888
1313581	PPL	periplakin	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PPL mRNA	PMID:19167446
1313581	PPL	periplakin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313582	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PPL mRNA	PMID:38648751
1313581	PPL	periplakin	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PPL protein	PMID:31675489
1313581	PPL	periplakin	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305511	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PPL mRNA	PMID:24780913
1313581	PPL	periplakin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305511	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of PPL mRNA	PMID:22504374
1313581	PPL	periplakin	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of PPL mRNA	PMID:26272509
1313581	PPL	periplakin	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1313581	PPL	periplakin	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPL mRNA	PMID:27188386
1313581	PPL	periplakin	gene	CHEBI:9168	sirolimus	increases expression	ISO	RGD:1305511	E	RGD:6480464	20120501	CTD	MESH:D020123	Sirolimus results in increased expression of PPL mRNA	PMID:21865292
1313581	PPL	periplakin	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305511	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PPL mRNA	PMID:19281266
1313581	PPL	periplakin	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305511	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PPL mRNA	PMID:21346803
1313581	PPL	periplakin	gene	CHEBI:92181	lasalocid	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D007832	Lasalocid results in increased expression of PPL protein	PMID:37788135
1313581	PPL	periplakin	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PPL mRNA	PMID:38568856
1313581	PPL	periplakin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of PPL protein; [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of PPL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of PPL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of PPL protein	PMID:38598786
1313581	PPL	periplakin	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1305511	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of PPL protein	PMID:32519852
1313581	PPL	periplakin	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313582	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of PPL mRNA	PMID:28973697
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305512	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of FAM3D gene	PMID:28931070|PMID:35440735
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D004958	Estradiol results in increased expression of FAM3D mRNA	PMID:15289156|PMID:26879975
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of FAM3D mRNA	PMID:33711761
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313584	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FAM3D mRNA	PMID:34319233
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305512	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FAM3D mRNA	PMID:33387578
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of FAM3D mRNA	PMID:17103032
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305512	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of FAM3D mRNA	PMID:21396975
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313584	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FAM3D mRNA	PMID:34911549
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D005492	Folic Acid results in increased expression of FAM3D mRNA	PMID:25629700
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of FAM3D mRNA]	PMID:22206623
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM3D mRNA	PMID:23557933
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of FAM3D promoter	PMID:22847954
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D019833	Genistein results in increased expression of FAM3D mRNA	PMID:15289156
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FAM3D mRNA	PMID:17942748
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FAM3D mRNA	PMID:17942748
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:28436	delphinidin	decreases expression	ISO	RGD:1313584	E	RGD:6480464	20240604	CTD	MESH:C017185	delphinidin results in decreased expression of FAM3D mRNA; delphinidin results in decreased expression of FAM3D protein	PMID:38291899
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1305512	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of FAM3D mRNA	PMID:30556269
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313584	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of FAM3D mRNA	PMID:36209798
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:C017947	sodium arsenite results in increased expression of FAM3D mRNA	PMID:17350061
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FAM3D intron	PMID:30157460
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FAM3D 5' UTR	PMID:27901495
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1305512	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of FAM3D mRNA	PMID:30556269
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313584	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the expression of FAM3D mRNA	PMID:35295148
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:C009495	titanium dioxide results in decreased expression of FAM3D mRNA	PMID:23557971
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:C006253	pirinixic acid results in decreased expression of FAM3D mRNA	PMID:17426115
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305512	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM3D mRNA	PMID:25181051
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305512	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of FAM3D mRNA	PMID:41034487
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313584	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of FAM3D mRNA	PMID:32156529
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of FAM3D intron	PMID:30157460
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:C008745	bisphenol F results in increased expression of FAM3D mRNA	PMID:30951980
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305512	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of FAM3D mRNA	PMID:35163327
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305512	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of FAM3D mRNA	PMID:27387713
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of FAM3D promoter	PMID:22847954
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of FAM3D promoter	PMID:22847954
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FAM3D gene	PMID:29154799
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D013629	Tamoxifen affects the expression of FAM3D mRNA	PMID:17555576
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of FAM3D mRNA	PMID:15289156
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305512	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of FAM3D mRNA	PMID:33387578
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FAM3D mRNA	PMID:17555576
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305512	E	RGD:6480464	20210209	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FAM3D mRNA	PMID:17557909
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FAM3D mRNA	PMID:17942748
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FAM3D mRNA	PMID:17942748
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313584	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of FAM3D mRNA	PMID:38701926
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of FAM3D intron	PMID:30157460
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305512	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FAM3D gene	PMID:35440735
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FAM3D mRNA	PMID:22206623
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of FAM3D mRNA]	PMID:22206623
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FAM3D gene]	PMID:28238834
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313584	E	RGD:6480464	20210209	CTD	MESH:D010634	Phenobarbital affects the expression of FAM3D mRNA	PMID:23091169
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1305512	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FAM3D mRNA	PMID:27291303
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:81980	triticonazole	decreases expression	ISO	RGD:1305512	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of FAM3D mRNA	PMID:36084822
1313583	FAM3D	FAM3 metabolism regulating signaling molecule D	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305512	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of FAM3D mRNA	PMID:23640034
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1305515	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RGS17 mRNA	PMID:30071829
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS17 mRNA	PMID:20938992
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of RGS17 mRNA	PMID:21934132
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1305515	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in decreased expression of RGS17 mRNA	PMID:20488242
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1305515	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of RGS17 mRNA	PMID:36841081
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of RGS17 mRNA	PMID:30165855
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305515	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RGS17 mRNA	PMID:33387578
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS17 mRNA	PMID:20938992
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RGS17 mRNA	PMID:37042841
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:17303	morphine	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20130122	CTD	MESH:D009020	Morphine promotes the reaction [GNAI2 protein binds to RGS17 protein]; Morphine promotes the reaction [GNAZ protein binds to RGS17 protein]	PMID:18652891
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of RGS17 mRNA	PMID:21592394
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of RGS17 mRNA	PMID:21592394
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of RGS17 mRNA	PMID:31256213
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of RGS17 mRNA	PMID:21592394
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of RGS17 mRNA	PMID:21592394
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of RGS17 intron	PMID:30157460
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20130122	CTD	MESH:D015032	RGS17 protein affects the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]; Zinc promotes the reaction [OPRM1 protein binds to RGS17 protein]	PMID:18652891
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS17 mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of RGS17 mRNA]	PMID:20938992|PMID:22206623
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RGS17 gene	PMID:25304211
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of RGS17 mRNA	PMID:26272509
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGS17 mRNA	PMID:27188386
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RGS17 mRNA	PMID:28960355
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RGS17 mRNA	PMID:23557933
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of RGS17 mRNA	PMID:21044322|PMID:27392435
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:27899	cisplatin	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	RGS17 protein results in increased susceptibility to Cisplatin	PMID:21044322
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RGS17 mRNA	PMID:27392435
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of RGS17 promoter	PMID:22847954
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of RGS17 mRNA	PMID:32186404
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RGS17 mRNA	PMID:19933214
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RGS17 mRNA	PMID:33212167
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:28445	vincristine	increases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	RGS17 protein results in increased susceptibility to Vincristine	PMID:21044322
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305515	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of RGS17 mRNA	PMID:28959563
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313588	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of RGS17 mRNA	PMID:39631538
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of RGS17 mRNA	PMID:36209798
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RGS17 intron	PMID:30157460
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313588	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RGS17 mRNA	PMID:22228805
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RGS17 5' UTR; Benzo(a)pyrene results in increased methylation of RGS17 promoter	PMID:27901495
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20130122	CTD	MESH:D015032	RGS17 protein affects the reaction [Zinc promotes the reaction [OPRM1 protein binds to PRKCG protein]]; Zinc promotes the reaction [OPRM1 protein binds to RGS17 protein]	PMID:18652891
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RGS17 mRNA	PMID:25351596
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of RGS17 gene	PMID:31601247
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313588	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RGS17 gene	PMID:35295148
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RGS17 mRNA	PMID:18648102
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:33128	C60 fullerene	affects expression	ISO	RGD:1305515	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 affects the expression of RGS17 mRNA	PMID:19167457
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305515	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RGS17 mRNA	PMID:25181051
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of RGS17 mRNA	PMID:32156529
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305515	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of RGS17 mRNA	PMID:29097150
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313588	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of RGS17 mRNA	PMID:35598803
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305515	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RGS17 gene	PMID:28505145
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313588	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of RGS17 mRNA	PMID:30951980
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313588	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RGS17 mRNA	PMID:30951980
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:34682	diazinon	decreases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of RGS17 gene	PMID:22964155
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RGS17 mRNA	PMID:37042841
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RGS17 mRNA	PMID:26472689
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1305515	E	RGD:6480464	20220705	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RGS17 protein	PMID:34958885
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of RGS17 promoter	PMID:22847954
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of RGS17 promoter	PMID:22847954
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RGS17 mRNA	PMID:25979313
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of RGS17 mRNA	PMID:24935251
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RGS17 gene	PMID:29154799
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313588	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of RGS17 mRNA	PMID:22733784
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of RGS17 mRNA	PMID:24935251
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RGS17 mRNA	PMID:24935251
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305515	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RGS17 mRNA	PMID:33387578
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RGS17 mRNA	PMID:29432896
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of RGS17 gene	PMID:25304211
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305515	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RGS17 mRNA	PMID:29097150
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of RGS17 mRNA	PMID:19042947
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:6809	methamphetamine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008694	RGS17 gene SNP affects the susceptibility to Methamphetamine	PMID:18316681
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of RGS17 mRNA	PMID:31758290
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313588	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RGS17 mRNA	PMID:22206623
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1305515	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of RGS17 mRNA	PMID:27840820
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of RGS17 mRNA]	PMID:22206623
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RGS17 mRNA	PMID:37199045
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:755540	docetaxel	increases response to substance	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	RGS17 protein results in increased susceptibility to Docetaxel	PMID:21044322
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:77702	S-nitroso-N-acetyl-D-penicillamine	multiple interactions	ISO	RGD:1313588	E	RGD:6480464	20140415	CTD	MESH:D026423	S-Nitroso-N-Acetylpenicillamine promotes the reaction [OPRM1 protein binds to RGS17 protein]	PMID:18652891
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGS17 mRNA	PMID:27188386
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of RGS17 mRNA	PMID:26705709
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1305515	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RGS17 mRNA	PMID:27291303
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305515	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RGS17 mRNA	PMID:24780913
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RGS17 mRNA	PMID:27188386
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of RGS17 mRNA	PMID:29301935
1313587	RGS17	regulator of G protein signaling 17	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305515	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RGS17 mRNA	PMID:19015723
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in increased expression of CABLES1 mRNA	PMID:19371625|PMID:36828454
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313590	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CABLES1 mRNA	PMID:20188158
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of CABLES1 mRNA	PMID:23724009|PMID:33167477
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CABLES1 mRNA	PMID:36189433
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1305516	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of CABLES1 mRNA	PMID:36841081
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313590	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CABLES1 mRNA	PMID:30319688
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CABLES1 mRNA	PMID:20044591
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CABLES1 mRNA	PMID:21632981
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of CABLES1 protein	PMID:35688186
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CABLES1 mRNA	PMID:39241906
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of CABLES1 mRNA	PMID:23019147|PMID:36828454
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313590	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CABLES1 mRNA	PMID:39298647
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of CABLES1 mRNA	PMID:30165855
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313590	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of CABLES1 mRNA	PMID:25549359
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CABLES1 mRNA	PMID:36189433
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305516	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CABLES1 promoter	PMID:23359474
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CABLES1 protein	PMID:37730182
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CABLES1 intron	PMID:30157460
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305516	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CABLES1 mRNA	PMID:39012411
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CABLES1 mRNA	PMID:37325564
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CABLES1 mRNA	PMID:19549813
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CABLES1 mRNA	PMID:23649840
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305516	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of CABLES1 mRNA	PMID:21396975
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CABLES1 mRNA	PMID:23649840
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CABLES1 mRNA	PMID:34911549
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CABLES1 mRNA	PMID:22206623
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of CABLES1 gene	PMID:39164771
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CABLES1 protein	PMID:35688186
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of CABLES1 mRNA	PMID:23300844
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of CABLES1 mRNA	PMID:27392435
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of CABLES1 mRNA	PMID:19371625|PMID:23019147
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CABLES1 mRNA	PMID:24768652|PMID:25583101
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305516	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CABLES1 mRNA	PMID:32109520
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305516	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CABLES1 mRNA	PMID:21215274|PMID:33387578
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CABLES1 mRNA	PMID:28001369
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CABLES1 mRNA	PMID:33212167
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CABLES1 mRNA	PMID:20971185
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of CABLES1 protein	PMID:35688186
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of CABLES1 mRNA	PMID:20044591
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:28876	melphalan	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of CABLES1 mRNA	PMID:22363485
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CABLES1 mRNA	PMID:38568856
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of CABLES1 mRNA	PMID:36209798
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CABLES1 intron; Benzo(a)pyrene affects the methylation of CABLES1 promoter	PMID:27901495|PMID:30157460
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CABLES1 mRNA	PMID:32234424
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305516	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CABLES1 mRNA	PMID:21839799
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CABLES1 3' UTR	PMID:27901495
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CABLES1 mRNA	PMID:30453624
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CABLES1 exon	PMID:27901495
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of CABLES1 mRNA	PMID:18929588
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in decreased expression of CABLES1 mRNA]	PMID:18929588
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CABLES1 mRNA	PMID:20971185
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CABLES1 mRNA	PMID:25895662
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CABLES1 mRNA	PMID:19150397
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1305516	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of CABLES1 mRNA	PMID:22641619
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305516	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CABLES1 mRNA	PMID:30047161
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313590	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CABLES1 gene; titanium dioxide results in decreased methylation of CABLES1 promoter	PMID:35295148
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1305516	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of CABLES1 mRNA	PMID:34492290
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313590	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CABLES1 mRNA	PMID:20813756|PMID:23811191
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313590	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CABLES1 mRNA	PMID:28472532
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305516	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of CABLES1 mRNA	PMID:19167457
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305516	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CABLES1 mRNA	PMID:25181051
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of CABLES1 mRNA	PMID:19371625|PMID:29275510|PMID:36828454
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305516	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CABLES1 mRNA	PMID:30816183|PMID:34947998
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CABLES1 gene	PMID:31601247
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CABLES1 mRNA	PMID:28628672
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305516	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CABLES1 promoter	PMID:23359474
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of CABLES1 mRNA	PMID:19371625
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313590	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of CABLES1 mRNA	PMID:26377693
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of CABLES1 mRNA	PMID:28392331
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313590	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CABLES1 mRNA	PMID:37019170
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305516	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CABLES1 mRNA	PMID:21266533
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305516	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CABLES1 promoter	PMID:23359474
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305516	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CABLES1 mRNA	PMID:22546817
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CABLES1 mRNA	PMID:28628672
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of CABLES1 mRNA	PMID:21527772
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305516	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of CABLES1 gene	PMID:33148267
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313590	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CABLES1 mRNA	PMID:18974090
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305516	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of CABLES1 promoter	PMID:22457795
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305516	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CABLES1 mRNA	PMID:39012411
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CABLES1 mRNA	PMID:37325564
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CABLES1 mRNA	PMID:36326898
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CABLES1 mRNA	PMID:19320972
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313590	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CABLES1 mRNA	PMID:40194260
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CABLES1 mRNA	PMID:31533062
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313590	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CABLES1 mRNA	PMID:17292431
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305516	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CABLES1 mRNA	PMID:30047161
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CABLES1 mRNA	PMID:28628672
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CABLES1 mRNA	PMID:19371625
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CABLES1 mRNA	PMID:28973697
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313590	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CABLES1 mRNA	PMID:17562736
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of CABLES1 gene	PMID:39164771
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305516	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CABLES1 mRNA	PMID:29391264
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CABLES1 mRNA	PMID:28628672
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of CABLES1 mRNA	PMID:23300844
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the methylation of CABLES1 promoter	PMID:17982127
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CABLES1 mRNA; Nanotubes, Carbon results in decreased expression of CABLES1 mRNA	PMID:25554681
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305516	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CABLES1 mRNA	PMID:30047161
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of CABLES1 mRNA	PMID:22714537
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of CABLES1 mRNA	PMID:19042947
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of CABLES1 mRNA	PMID:27188386
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1305516	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of CABLES1 mRNA	PMID:28801915
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CABLES1 mRNA	PMID:28988120
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305516	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CABLES1 mRNA	PMID:28801915
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CABLES1 mRNA	PMID:22079614
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:6925	microcystin-LR	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C057862	cyanoginosin LR results in increased expression of CABLES1 mRNA	PMID:29518473
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305516	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of CABLES1 gene	PMID:33148267
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CABLES1 mRNA	PMID:31758290
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CABLES1 mRNA	PMID:22206623
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313590	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CABLES1 mRNA	PMID:22206623
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CABLES1 gene]	PMID:28238834
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CABLES1 mRNA	PMID:19159669
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:83537	1-benzylpiperazine	increases expression	ISO	RGD:1305516	E	RGD:6480464	20170221	CTD	MESH:C006737	N-benzylpiperazine results in increased expression of CABLES1 mRNA	PMID:26821219
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:84070	sodium arsenate	affects expression	ISO	RGD:1313590	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate affects the expression of CABLES1 mRNA	PMID:39847705
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305516	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CABLES1 mRNA	PMID:24780913|PMID:30047161
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305516	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of CABLES1 mRNA	PMID:25825206
1313589	CABLES1	Cdk5 and Abl enzyme substrate 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313590	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CABLES1 mRNA	PMID:28973697
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MRPS28 mRNA	PMID:38218311
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313592	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MRPS28 mRNA	PMID:37995155
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313592	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPS28 mRNA	PMID:36331819
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1597461	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MRPS28 gene	PMID:28931070
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRPS28 mRNA	PMID:22378314
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313592	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MRPS28 mRNA	PMID:30319688
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313592	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPS28 mRNA	PMID:39241906
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313592	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MRPS28 mRNA]	PMID:39241906
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MRPS28 mRNA	PMID:38568856
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of MRPS28 mRNA	PMID:18037150
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313592	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MRPS28 mRNA	PMID:35550907
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313592	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPS28 mRNA	PMID:36331819
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MRPS28 mRNA	PMID:23649840
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313592	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MRPS28 mRNA	PMID:19770486
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313592	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MRPS28 mRNA	PMID:17484886
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1597461	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MRPS28 mRNA	PMID:33387578
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313592	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS28 mRNA	PMID:22206623
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313592	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of MRPS28 mRNA	PMID:22610192
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1313592	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of MRPS28 protein	PMID:22006019
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313592	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPS28 mRNA	PMID:21570461
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MRPS28 protein	PMID:33212167
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MRPS28 mRNA	PMID:30851411
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1597461	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MRPS28 mRNA	PMID:28959563
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPS28 mRNA	PMID:38568856
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of MRPS28 mRNA	PMID:28595984|PMID:34032870
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MRPS28 mRNA	PMID:22378314
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MRPS28 protein	PMID:33278487
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313592	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MRPS28 mRNA	PMID:21715664
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MRPS28 mRNA]	PMID:32406909
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1597461	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MRPS28 mRNA	PMID:25729387
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313592	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MRPS28 gene	PMID:35295148
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313592	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of MRPS28 mRNA	PMID:18648102
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313592	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MRPS28 mRNA	PMID:18301758
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313592	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MRPS28 mRNA	PMID:28472532
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1597461	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MRPS28 mRNA	PMID:25181051
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPS28 protein	PMID:34186270
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1597461	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPS28 mRNA	PMID:34947998
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1597461	E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of MRPS28 mRNA	PMID:17316808
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPS28 mRNA	PMID:28628672
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPS28 mRNA	PMID:28628672
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313592	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MRPS28 mRNA]	PMID:39241906
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MRPS28 mRNA	PMID:37042841
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313592	E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in increased expression of MRPS28 mRNA	PMID:21139344
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313592	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of MRPS28 mRNA	PMID:17585979
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MRPS28 mRNA	PMID:31533062
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313592	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MRPS28 mRNA	PMID:39529242
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313592	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPS28 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPS28 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MRPS28 mRNA	PMID:36331819
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRPS28 mRNA	PMID:25979313
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPS28 mRNA	PMID:28628672
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1597461	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of MRPS28 mRNA	PMID:21346803
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPS28 mRNA	PMID:25704631
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1597461	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPS28 mRNA	PMID:33387578
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MRPS28 mRNA	PMID:28628672
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of MRPS28 mRNA	PMID:19194470
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313592	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MRPS28 mRNA	PMID:25554681
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1597461	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MRPS28 mRNA	PMID:25729387
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313592	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of MRPS28 mRNA	PMID:23650126
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of MRPS28 mRNA	PMID:27714895
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313592	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MRPS28 mRNA	PMID:22206623
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313592	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS28 mRNA	PMID:22206623
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MRPS28 protein	PMID:37664457
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:75701	sarin	decreases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of MRPS28 mRNA	PMID:19522546
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MRPS28 mRNA	PMID:30851411
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313592	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MRPS28 mRNA]	PMID:39241906
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MRPS28 protein	PMID:37664457
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1597461	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MRPS28 mRNA	PMID:21346803
1313591	MRPS28	mitochondrial ribosomal protein S28	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of MRPS28 mRNA	PMID:22378314
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MAML2 mRNA	PMID:38218311
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of MAML2 mRNA	PMID:26272509
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAML2 mRNA	PMID:27188386
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1615588	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MAML2 mRNA	PMID:30319688
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1615588	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MAML2 mRNA	PMID:39241906
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of MAML2 mRNA	PMID:31614463
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MAML2 mRNA	PMID:30165855
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1587536	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MAML2 mRNA	PMID:33387578
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MAML2 mRNA	PMID:37042841
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of MAML2 mRNA	PMID:20655997
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1615588	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of MAML2 mRNA	PMID:33848595
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1615588	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of MAML2 mRNA]	PMID:33848595
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:174733	Licochalcone B	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of MAML2 mRNA	PMID:33647349
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1587536	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MAML2 mRNA	PMID:33387578
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAML2 mRNA	PMID:39836092
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1587536	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of MAML2 mRNA	PMID:28522335
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAML2 mRNA	PMID:35301059
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MAML2 mRNA	PMID:23649840
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1615588	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAML2 mRNA	PMID:34911549
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1587536	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MAML2 mRNA	PMID:30779732
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MAML2 gene	PMID:25304211
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAML2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAML2 mRNA	PMID:39836092
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MAML2 mRNA	PMID:26272509
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAML2 mRNA	PMID:27188386
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MAML2 protein	PMID:35688186
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of MAML2 mRNA	PMID:21603599|PMID:27392435
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of MAML2 mRNA	PMID:27392435
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MAML2 mRNA	PMID:25583101
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MAML2 mRNA	PMID:20106945|PMID:21632981
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1587536	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MAML2 mRNA	PMID:32109520
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1587536	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MAML2 mRNA	PMID:33387578
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MAML2 mRNA	PMID:28001369
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MAML2 mRNA	PMID:33212167
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of MAML2 mRNA	PMID:20971185
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MAML2 mRNA	PMID:29803840
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of MAML2 mRNA	PMID:39719251
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAML2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAML2 mRNA	PMID:39836092
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAML2 mRNA	PMID:20106945|PMID:21632981|PMID:30453624
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1615588	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAML2 mRNA	PMID:21569818
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MAML2 5' UTR	PMID:27901495
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MAML2 promoter	PMID:27901495
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of MAML2 mRNA	PMID:20971185
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of MAML2 mRNA	PMID:20382639
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAML2 mRNA	PMID:19150397|PMID:20018196
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MAML2 mRNA	PMID:19710929
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of MAML2 gene	PMID:31601247
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1587536	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MAML2 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1615588	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of MAML2 mRNA	PMID:35598803
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1587536	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] affects the methylation of MAML2 gene	PMID:33148267
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of MAML2 mRNA	PMID:29024780
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1587536	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of MAML2 mRNA	PMID:35163327
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAML2 mRNA	PMID:39836092
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MAML2 mRNA	PMID:35301059
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1587536	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of MAML2 mRNA	PMID:35163327
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MAML2 mRNA	PMID:19320972
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MAML2 mRNA	PMID:31533062
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MAML2 mRNA	PMID:40419075
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of MAML2 mRNA	PMID:28001369
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of MAML2 mRNA	PMID:24935251
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MAML2 mRNA	PMID:25562108
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAML2 mRNA	PMID:27188386
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of MAML2 mRNA	PMID:26272509
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAML2 mRNA	PMID:27188386
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1587536	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MAML2 mRNA	PMID:33387578
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of MAML2 mRNA	PMID:16510598
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of MAML2 mRNA	PMID:17331233
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MAML2 gene	PMID:25304211
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAML2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MAML2 mRNA	PMID:39836092
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAML2 mRNA	PMID:22079256
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615588	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MAML2 mRNA; Nanotubes, Carbon results in decreased expression of MAML2 mRNA	PMID:25554681
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1615588	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MAML2 mRNA	PMID:35964746
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of MAML2 mRNA	PMID:31629900
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MAML2 mRNA	PMID:39836092
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of MAML2 mRNA	PMID:28988120
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1587536	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MAML2 gene	PMID:35440735
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1587536	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] affects the methylation of MAML2 gene	PMID:33148267
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MAML2 mRNA	PMID:22079256
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAML2 mRNA	PMID:22079256
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MAML2 protein	PMID:31285264
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAML2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAML2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAML2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAML2 mRNA	PMID:27188386
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1615588	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of MAML2 mRNA	PMID:39847705
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MAML2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAML2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAML2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAML2 mRNA	PMID:27188386
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1587536	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of MAML2 gene	PMID:31079544
1313593	MAML2	mastermind like transcriptional coactivator 2	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1587536	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of MAML2 gene	PMID:31079544
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of AAK1 mRNA	PMID:26272509
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA	PMID:27188386
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of AAK1 mRNA	PMID:40945087
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1618841	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of AAK1 mRNA	PMID:30319688
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of AAK1 protein	PMID:31494107
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of AAK1 mRNA	PMID:39241906
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of AAK1 mRNA	PMID:23649840
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of AAK1 protein	PMID:37730182
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of AAK1 mRNA	PMID:28818685
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of AAK1 intron	PMID:30157460
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of AAK1 mRNA	PMID:39836092
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AAK1 mRNA	PMID:35301059
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of AAK1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AAK1 mRNA	PMID:28111341|PMID:37236586
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of AAK1 mRNA	PMID:19549813
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of AAK1 protein	PMID:23301498
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of AAK1 mRNA	PMID:23649840
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1305520	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of AAK1 protein	PMID:33236894
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of AAK1 gene	PMID:27153756
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1618841	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of AAK1 mRNA	PMID:19770486
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of AAK1 intron	PMID:30157460
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of AAK1 mRNA	PMID:23649840
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of AAK1 protein	PMID:19845377
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:26523	reactive oxygen species	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017382	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of AAK1 mRNA	PMID:33656867
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of AAK1 mRNA	PMID:21867686
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of AAK1 mRNA	PMID:32525701
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AAK1 mRNA	PMID:40504410
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of AAK1 mRNA	PMID:26272509
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA	PMID:27188386
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of AAK1 protein	PMID:35688186
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of AAK1 mRNA	PMID:28711546
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1618841	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of AAK1 mRNA	PMID:21151649
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of AAK1 mRNA	PMID:30912803
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618841	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AAK1 mRNA	PMID:21570461
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305520	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AAK1 mRNA	PMID:33387578
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305520	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AAK1 mRNA	PMID:32109520
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of AAK1 protein	PMID:39603559
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of AAK1 protein	PMID:35688186
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1618841	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of AAK1 gene	PMID:39894169
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of AAK1 mRNA	PMID:38568856
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AAK1 mRNA	PMID:40504410
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1618841	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of AAK1 intron	PMID:27901495
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of AAK1 protein	PMID:37955338
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of AAK1 gene	PMID:31601247
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305520	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of AAK1 mRNA	PMID:25729387
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of AAK1 mRNA	PMID:30903817
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305520	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of AAK1 mRNA	PMID:25181051
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of AAK1 protein	PMID:31675489
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305520	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of AAK1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of AAK1 gene	PMID:31601247
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305520	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of AAK1 gene	PMID:28505145
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of AAK1 gene	PMID:31601247
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of AAK1 protein	PMID:31675489
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of AAK1 mRNA	PMID:25979313
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1618841	E	RGD:6480464	20250805	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of AAK1 protein; 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of AAK1 protein alternative form	PMID:26903627
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1618841	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of AAK1 intron	PMID:28392331
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of AAK1 mRNA	PMID:36117858
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AAK1 mRNA	PMID:37042841
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of AAK1 mRNA	PMID:39836092
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AAK1 mRNA	PMID:38382870
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305520	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AAK1 mRNA	PMID:33453195
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AAK1 mRNA	PMID:35301059
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of AAK1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of AAK1 mRNA	PMID:28111341|PMID:37236586
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of AAK1 mRNA; perfluorooctanoic acid results in increased expression of AAK1 protein	PMID:26879310|PMID:36326898
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of AAK1 mRNA	PMID:24449571
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of AAK1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of AAK1 mRNA]	PMID:17585979
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of AAK1 mRNA	PMID:28302478
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of AAK1 mRNA	PMID:31533062
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of AAK1 mRNA	PMID:40419075
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1305520	E	RGD:6480464	20130806	CTD	MESH:D002737	Chloroprene results in increased expression of AAK1 mRNA	PMID:23125180
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AAK1 mRNA	PMID:25979313
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of AAK1 mRNA	PMID:23179753|PMID:26272509|PMID:27188386|PMID:28001369
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA	PMID:27188386
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of AAK1 mRNA	PMID:25562108
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of AAK1 mRNA	PMID:38832940
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of AAK1 mRNA	PMID:27188386
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of AAK1 mRNA	PMID:24935251|PMID:26272509
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA	PMID:27188386
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of THY1-AS1 mRNA] which results in increased expression of AAK1 mRNA	PMID:33656867
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1618841	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of AAK1 mRNA	PMID:17562736
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of AAK1 mRNA	PMID:21420995
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of AAK1 mRNA	PMID:29067470
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of AAK1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of AAK1 mRNA]	PMID:17585979
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of AAK1 mRNA	PMID:32525701
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AAK1 mRNA	PMID:40504410
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of AAK1 mRNA	PMID:31675489
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of AAK1 mRNA	PMID:35436446
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305520	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of AAK1 mRNA	PMID:30307764
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1305520	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of AAK1 mRNA	PMID:34044035
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:5118	fluoxetine	decreases expression	ISO	RGD:1305520	E	RGD:6480464	20130806	CTD	MESH:D005473	Fluoxetine results in decreased expression of AAK1 mRNA	PMID:17033635
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1618841	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of AAK1 mRNA	PMID:36117858
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AAK1 protein	PMID:32959892
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of AAK1 mRNA	PMID:39836092
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305520	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of AAK1 mRNA	PMID:25729387
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of AAK1 mRNA	PMID:36907384
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1618841	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of AAK1 mRNA	PMID:22206623
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA	PMID:27188386
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AAK1 gene]	PMID:28238834
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305520	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of AAK1 mRNA	PMID:32109520
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:81543	Tributyltin oxide	decreases phosphorylation	ISO	RGD:1618841	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased phosphorylation of AAK1 protein	PMID:22174045
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of AAK1 protein	PMID:31675489
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1305520	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of AAK1 protein	PMID:28903499
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of AAK1 protein	PMID:31675489
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of AAK1 mRNA	PMID:32525701
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305520	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of AAK1 mRNA	PMID:24780913
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AAK1 mRNA	PMID:27188386
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of AAK1 mRNA	PMID:38568856
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:95341	baricitinib	decreases activity	EXP		E	RGD:6480464	20220104	CTD	MESH:C000596027	baricitinib results in decreased activity of AAK1 protein	PMID:32113509
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305520	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of AAK1 mRNA	PMID:19015723
1313595	AAK1	AP2 associated kinase 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305520	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of AAK1 mRNA	PMID:23034163
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of GNPDA2 mRNA	PMID:33167477
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313597	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GNPDA2 mRNA	PMID:39241906
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305521	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GNPDA2 mRNA	PMID:33387578
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of GNPDA2 mRNA	PMID:33359661
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of GNPDA2 mRNA	PMID:28818685
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNPDA2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of GNPDA2 mRNA	PMID:39836092
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in increased expression of GNPDA2 mRNA	PMID:23369406
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313597	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GNPDA2 mRNA	PMID:19770486
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of GNPDA2 intron	PMID:30157460
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GNPDA2 mRNA	PMID:23649840
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GNPDA2 gene	PMID:25304211
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNPDA2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNPDA2 mRNA	PMID:39836092
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1305521	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA	PMID:33854195
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305521	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of GNPDA2 mRNA	PMID:31881176
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313597	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of GNPDA2 mRNA	PMID:30912803
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305521	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GNPDA2 mRNA	PMID:34747641
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305521	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GNPDA2 mRNA	PMID:32109520|PMID:33387578
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313597	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GNPDA2 mRNA	PMID:17942748
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313597	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of GNPDA2 protein	PMID:28918527
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNPDA2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNPDA2 mRNA	PMID:39836092
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GNPDA2 intron	PMID:30157460
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313597	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GNPDA2 mRNA	PMID:22228805
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GNPDA2 promoter	PMID:27901495
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313597	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GNPDA2 gene; titanium dioxide results in decreased methylation of GNPDA2 promoter	PMID:35295148
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305521	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of GNPDA2 mRNA	PMID:34492290
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313597	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of GNPDA2 mRNA	PMID:18648102
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305521	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of GNPDA2 mRNA	PMID:30816183|PMID:34947998
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of GNPDA2 protein	PMID:34186270
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305521	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GNPDA2 mRNA	PMID:25181051|PMID:41034487
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313597	E	RGD:6480464	20131210	CTD	MESH:C006780	bisphenol A results in increased expression of GNPDA2 mRNA	PMID:23798566
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of GNPDA2 gene	PMID:31601247
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of GNPDA2 protein	PMID:34186270
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313597	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of GNPDA2 mRNA	PMID:28392331
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1305521	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA	PMID:33854195
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GNPDA2 mRNA	PMID:37042841
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNPDA2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of GNPDA2 mRNA	PMID:39836092
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GNPDA2 protein	PMID:24527689
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of GNPDA2 mRNA	PMID:24449571
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:3763	clorgyline	increases expression	EXP		E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of GNPDA2 mRNA	PMID:19691856
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of GNPDA2 mRNA	PMID:28302478
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GNPDA2 gene	PMID:29154799
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GNPDA2 mRNA	PMID:20106945|PMID:25562108
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1305521	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA	PMID:33854195
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1305521	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA	PMID:33854195
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of GNPDA2 mRNA	PMID:29067470
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305521	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GNPDA2 mRNA	PMID:33387578
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313597	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of GNPDA2 mRNA	PMID:29279043
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GNPDA2 gene	PMID:25304211
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNPDA2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNPDA2 mRNA	PMID:39836092
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305521	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GNPDA2 mRNA	PMID:29391264
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313597	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of GNPDA2 mRNA	PMID:35436446
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313597	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of GNPDA2 mRNA	PMID:17942748
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313597	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GNPDA2 mRNA	PMID:17942748
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1305521	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA	PMID:33854195
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GNPDA2 protein	PMID:32959892
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GNPDA2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of GNPDA2 mRNA	PMID:39836092
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of GNPDA2 mRNA	PMID:28988120
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313597	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GNPDA2 mRNA	PMID:22206623
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of GNPDA2 mRNA	PMID:22714537
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313597	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of GNPDA2 mRNA	PMID:23091169
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1305521	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of GNPDA2 mRNA	PMID:20345932
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1305521	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of GNPDA2 mRNA	PMID:32109520
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of GNPDA2 protein	PMID:38348393
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313597	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of GNPDA2 mRNA	PMID:30953684
1313596	GNPDA2	glucosamine-6-phosphate deaminase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305521	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GNPDA2 mRNA	PMID:21346803
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of FBXL14 mRNA	PMID:26272509
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FBXL14 mRNA	PMID:33167477
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of FBXL14 mRNA	PMID:40865780
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313600	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FBXL14 mRNA	PMID:39241906
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FBXL14 mRNA	PMID:37042841
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313600	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBXL14 mRNA	PMID:37236586
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FBXL14 mRNA	PMID:22100608
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FBXL14 intron	PMID:30157460
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FBXL14 mRNA	PMID:18593933
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313600	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FBXL14 mRNA	PMID:31919559
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of FBXL14 mRNA	PMID:26272509
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C010974	Glyphosate results in increased expression of FBXL14 mRNA	PMID:40865780
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of FBXL14 mRNA	PMID:27392435
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313600	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXL14 mRNA	PMID:21570461
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of FBXL14 mRNA	PMID:29955902
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FBXL14 mRNA	PMID:28001369
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of FBXL14 mRNA	PMID:26272509
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of FBXL14 mRNA	PMID:32763439
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FBXL14 promoter	PMID:27901495
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FBXL14 3' UTR; Benzo(a)pyrene results in increased methylation of FBXL14 exon	PMID:27901495
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FBXL14 mRNA	PMID:18593933
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of FBXL14 mRNA; Silicon Dioxide results in decreased expression of FBXL14 mRNA	PMID:25351596|PMID:25895662
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of FBXL14 mRNA	PMID:35984750
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1305523	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of FBXL14 mRNA	PMID:16483693
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313600	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXL14 gene; titanium dioxide results in decreased methylation of FBXL14 promoter	PMID:35295148
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305523	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXL14 mRNA	PMID:25181051
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313600	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of FBXL14 mRNA	PMID:32156529
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL14 mRNA	PMID:28628672
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of FBXL14 gene	PMID:22964155
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL14 mRNA	PMID:28628672
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FBXL14 mRNA	PMID:37042841
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXL14 mRNA	PMID:38568856
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FBXL14 mRNA	PMID:38174414
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313600	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBXL14 mRNA	PMID:37236586
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FBXL14 mRNA	PMID:31533062
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXL14 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FBXL14 gene	PMID:29154799
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXL14 mRNA	PMID:28001369
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL14 mRNA	PMID:28628672
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of FBXL14 mRNA	PMID:24935251|PMID:26272509
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313600	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FBXL14 mRNA	PMID:17562736
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313600	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of FBXL14 mRNA	PMID:29279043
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1305523	E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in decreased expression of FBXL14 mRNA	PMID:36653537
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL14 mRNA	PMID:28628672
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313600	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FBXL14 mRNA	PMID:35964746
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of FBXL14 mRNA	PMID:31629900
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305523	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FBXL14 gene	PMID:35440735
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of FBXL14 mRNA	PMID:37199045
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FBXL14 gene]	PMID:28238834
1313599	FBXL14	F-box and leucine rich repeat protein 14	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXL14 mRNA	PMID:27188386
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of FBXL12 mRNA	PMID:38218311
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550238	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FBXL12 mRNA	PMID:33045310
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of FBXL12 mRNA	PMID:37995155
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305528	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBXL12 mRNA]	PMID:31150632
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases methylation	ISO	RGD:1550238	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased methylation of FBXL12 promoter	PMID:26251327
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550238	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FBXL12 mRNA	PMID:26251327
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FBXL12 mRNA	PMID:39241906
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of FBXL12 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of FBXL12 mRNA]	PMID:20230807
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305528	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of FBXL12 mRNA	PMID:33387578
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of FBXL12 mRNA	PMID:20230807
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of FBXL12 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of FBXL12 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of FBXL12 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of FBXL12 mRNA]	PMID:20230807
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of FBXL12 mRNA	PMID:37748715
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of FBXL12 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of FBXL12 mRNA]	PMID:20230807
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1550238	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FBXL12 mRNA	PMID:19770486
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FBXL12 mRNA	PMID:23649840
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FBXL12 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FBXL12 mRNA	PMID:34911549
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FBXL12 mRNA	PMID:18593933
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305528	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FBXL12 mRNA	PMID:31150632
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550238	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FBXL12 mRNA	PMID:31919559
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305528	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBXL12 mRNA]	PMID:31150632
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of FBXL12 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of FBXL12 mRNA]	PMID:20230807
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20120412	CTD	MESH:D009532	MT1 affects the reaction [Nickel affects the expression of FBXL12 mRNA]; MT2 affects the reaction [Nickel affects the expression of FBXL12 mRNA]	PMID:16166738
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550238	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXL12 mRNA	PMID:21570461
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305528	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBXL12 mRNA	PMID:33387578
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550238	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBXL12 mRNA	PMID:26290441
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of FBXL12 mRNA	PMID:33512557
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FBXL12 mRNA	PMID:33212167
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:28358	rac-lactic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of FBXL12 mRNA	PMID:30851411
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXL12 mRNA	PMID:38568856
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550238	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FBXL12 mRNA	PMID:22228805
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550238	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of FBXL12 mRNA]	PMID:22228805
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of FBXL12 mRNA	PMID:18593933
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305528	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FBXL12 mRNA	PMID:34492290
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305528	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FBXL12 mRNA	PMID:25181051
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of FBXL12 mRNA	PMID:38685157
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FBXL12 mRNA	PMID:37042841
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FBXL12 mRNA	PMID:31533062
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FBXL12 mRNA	PMID:25562108
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550238	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of FBXL12 mRNA	PMID:17555576
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:46661	asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001194	Asbestos affects the expression of FBXL12 mRNA	PMID:17297452
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of FBXL12 mRNA	PMID:30529165
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305528	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of FBXL12 mRNA	PMID:29391264
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of FBXL12 mRNA	PMID:22079256
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of FBXL12 mRNA	PMID:18175754
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550238	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FBXL12 mRNA	PMID:17555576
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of FBXL12 mRNA	PMID:17942748
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FBXL12 mRNA; Nanotubes, Carbon results in decreased expression of FBXL12 mRNA	PMID:25554681
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1550238	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of FBXL12 mRNA	PMID:26377693
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of FBXL12 mRNA	PMID:19812364
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1550238	E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of FBXL12 mRNA	PMID:20061341
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of FBXL12 mRNA	PMID:22079256
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of FBXL12 mRNA	PMID:22079256
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of FBXL12 mRNA	PMID:30851411
1313605	FBXL12	F-box and leucine rich repeat protein 12	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1550238	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of FBXL12 mRNA	PMID:35537566
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in decreased expression of CCL25 mRNA	PMID:22968694
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1313609	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in increased expression of CCL25 mRNA	PMID:33227293
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313609	E	RGD:6480464	20171114	CTD	MESH:D000431	Ethanol results in increased expression of CCL25 protein	PMID:28843478
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:16240	hydrogen peroxide	increases secretion	EXP		E	RGD:6480464	20210608	CTD	MESH:D006861	Hydrogen Peroxide results in increased secretion of CCL25 protein	PMID:33491125
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CCL25 mRNA	PMID:30510588
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305530	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of CCL25 mRNA	PMID:26496021
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305530	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CCL25 mRNA	PMID:33387578
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:168396	mycophenolic acid	increases expression	ISO	RGD:1313609	E	RGD:6480464	20120501	CTD	MESH:D009173	Mycophenolic Acid results in increased expression of CCL25 mRNA	PMID:19818335
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CCL25 mRNA	PMID:35818422
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250708	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Asian ginseng] results in increased expression of CCL25 mRNA	PMID:35818422
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:18227	sterigmatocystin	increases expression	ISO	RGD:1313609	E	RGD:6480464	20120501	CTD	MESH:D013241	Sterigmatocystin results in increased expression of CCL25 mRNA	PMID:19818335
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCL25 mRNA	PMID:36331819
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:200715	Brevianamide A	increases expression	ISO	RGD:1313609	E	RGD:6480464	20231219	CTD	MESH:C006794	brevianamide A results in increased expression of CCL25 mRNA	PMID:19818335
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:211551	TMC-120A	increases expression	ISO	RGD:1313609	E	RGD:6480464	20231219	CTD	MESH:C402696	TMC 120A results in increased expression of CCL25 mRNA	PMID:19818335
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CCL25 mRNA	PMID:29950665
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases secretion	EXP		E	RGD:6480464	20210608	CTD	MESH:D009151	Mustard Gas results in increased secretion of CCL25 protein	PMID:33491125
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:25442	mycotoxin	increases expression	ISO	RGD:1313609	E	RGD:6480464	20170228	CTD	MESH:D009183	Mycotoxins results in increased expression of CCL25 mRNA	PMID:19818335
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20200310	CTD	MESH:D010126	Ozone results in decreased expression of CCL25 mRNA	PMID:26342085
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1313609	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of CCL25 mRNA	PMID:31939706
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20150512	CTD	MESH:D015032	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL25 mRNA	PMID:23503329
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20181016	CTD	MESH:D002251	[PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of CCL25 protein	PMID:29987408
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CCL25 mRNA	PMID:25629700
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:27638	cobalt atom	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20150512	CTD	MESH:D003035	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL25 mRNA	PMID:23503329
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1313609	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of CCL25 mRNA	PMID:28960355
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20150512	CTD	MESH:D009532	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL25 mRNA	PMID:23503329
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313609	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCL25 mRNA	PMID:21570461
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCL25 mRNA	PMID:21296121
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313609	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCL25 mRNA	PMID:21041162
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313609	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of CCL25 mRNA	PMID:39095385
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CCL25 promoter	PMID:27901495
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CCL25 mRNA	PMID:22228805
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20150512	CTD	MESH:D015032	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL25 mRNA	PMID:23503329
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305530	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CCL25 mRNA	PMID:30047161
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CCL25 mRNA	PMID:29950665
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313609	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CCL25 mRNA	PMID:18648102
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313609	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CCL25 mRNA	PMID:20813756
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CCL25 mRNA	PMID:19710929
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305530	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CCL25 mRNA	PMID:25181051
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CCL25 mRNA	PMID:32156529
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305530	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CCL25 gene	PMID:28505145
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305530	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of CCL25 mRNA	PMID:26496021
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CCL25 intron	PMID:30157460
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313609	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CCL25 intron	PMID:28392331
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313609	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CCL25 mRNA	PMID:37019170
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CCL25 mRNA	PMID:29950665
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20150512	CTD	MESH:D015056	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL25 mRNA	PMID:23503329
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305530	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of CCL25 promoter	PMID:22457795
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20200331	CTD	MESH:D002738	Chloroquine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL25 protein]	PMID:22341560
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313609	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CCL25 mRNA	PMID:40194260
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CCL25 mRNA	PMID:36331819
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305530	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of CCL25 mRNA	PMID:30047161
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20120515	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of CCL25 mRNA	PMID:21041162
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:41607	crotonaldehyde	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in increased expression of CCL25 mRNA	PMID:20471460
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of CCL25 mRNA	PMID:21041162
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20150512	CTD	MESH:D003907	[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCL25 mRNA	PMID:23503329
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of CCL25 mRNA	PMID:21041162
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of CCL25 mRNA	PMID:17400583
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1313609	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in increased expression of CCL25 mRNA	PMID:25270620
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CCL25 mRNA; Nanotubes, Carbon results in decreased expression of CCL25 mRNA	PMID:25554681|PMID:25620056
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305530	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CCL25 mRNA	PMID:30047161
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:52007	monodansylcadaverine	multiple interactions	ISO	RGD:1313609	E	RGD:6480464	20200331	CTD	MESH:C008542	monodansylcadaverine inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of CCL25 protein]	PMID:22341560
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313609	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CCL25 mRNA	PMID:38701926
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CCL25 intron	PMID:30157460
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:68792	asperentin	increases expression	ISO	RGD:1313609	E	RGD:6480464	20131008	CTD	MESH:C000488	cladosporin results in increased expression of CCL25 mRNA	PMID:19818335
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:68794	neoechinulin A	increases expression	ISO	RGD:1313609	E	RGD:6480464	20170228	CTD	MESH:C490266	neoechinulin A results in increased expression of CCL25 mRNA	PMID:19818335
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313609	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CCL25 mRNA	PMID:22206623
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:753435	ginseng, asian	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C000713447	[Diethylhexyl Phthalate co-treated with Asian ginseng] results in increased expression of CCL25 mRNA	PMID:35818422
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305530	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CCL25 mRNA	PMID:23640034
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305530	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CCL25 mRNA	PMID:30047161
1313608	CCL25	C-C motif chemokine ligand 25	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305530	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of CCL25 gene	PMID:31079544
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of HSPA12A mRNA	PMID:26272509
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA	PMID:27188386
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of HSPA12A mRNA	PMID:26251327
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HSPA12A gene	PMID:20938992
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of HSPA12A mRNA	PMID:23724009
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D019308	[Palmitic Acid co-treated with Arsenic] affects the expression of HSPA12A mRNA	PMID:33736254
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305531	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of HSPA12A gene	PMID:28931070
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313611	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of HSPA12A mRNA	PMID:30319688
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of HSPA12A mRNA	PMID:21632981
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HSPA12A mRNA	PMID:39241906
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of HSPA12A mRNA	PMID:31614463
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of HSPA12A mRNA	PMID:30165855
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305531	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of HSPA12A gene	PMID:27618143
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HSPA12A gene	PMID:20938992
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1305531	E	RGD:6480464	20160607	CTD	MESH:D005947	Glucose results in decreased expression of HSPA12A protein	PMID:22413817
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1305531	E	RGD:6480464	20160607	CTD	MESH:D005947	KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA12A protein]	PMID:22413817
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1305531	E	RGD:6480464	20160607	CTD	MESH:D005947	Glucose results in decreased expression of HSPA12A protein	PMID:22413817
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1305531	E	RGD:6480464	20160607	CTD	MESH:D005947	KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA12A protein]	PMID:22413817
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305531	E	RGD:6480464	20191112	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA	PMID:31199487
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of HSPA12A protein	PMID:37730182
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of HSPA12A intron	PMID:30157460
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA12A mRNA	PMID:35301059
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HSPA12A intron	PMID:30157460
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of HSPA12A mRNA	PMID:34911549
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of HSPA12A mRNA	PMID:25629700
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HSPA12A gene	PMID:20938992
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D001151	Arsenic affects the expression of HSPA12A mRNA	PMID:33736254
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HSPA12A gene	PMID:25304211
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D001151	[Palmitic Acid co-treated with Arsenic] affects the expression of HSPA12A mRNA	PMID:33736254
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HSPA12A mRNA	PMID:40504410
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1305531	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of HSPA12A gene	PMID:35440735
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of HSPA12A mRNA	PMID:23557933
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of HSPA12A mRNA	PMID:23300844
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of HSPA12A mRNA	PMID:27392435
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of HSPA12A mRNA	PMID:27392435
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28088	genistein	affects expression	ISO	RGD:1313611	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein affects the expression of HSPA12A mRNA	PMID:32186404
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HSPA12A mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305531	E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HSPA12A mRNA	PMID:26232522
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of HSPA12A mRNA	PMID:29955902
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of HSPA12A mRNA	PMID:26272509
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA	PMID:27188386
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HSPA12A mRNA	PMID:29803840
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of HSPA12A mRNA	PMID:39631538
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20120918	CTD	MESH:D004317	[[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of HSPA12A mRNA	PMID:21040762
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of HSPA12A gene	PMID:28589171
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of HSPA12A mRNA	PMID:37682722
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HSPA12A mRNA	PMID:40504410
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HSPA12A intron	PMID:30157460
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HSPA12A mRNA	PMID:20106945|PMID:21632981|PMID:26238291|PMID:32234424
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to HSPA12A mRNA]	PMID:32406909
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of HSPA12A mRNA	PMID:25351596
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HSPA12A mRNA	PMID:20382639
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HSPA12A gene	PMID:31601247
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1305531	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of HSPA12A mRNA	PMID:16507785
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:32130	silver(1+) nitrate	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in decreased expression of HSPA12A mRNA	PMID:22831968
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:3215	bupivacaine	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20220607	CTD	MESH:D002045	Bupivacaine results in decreased expression of HSPA12A protein	PMID:34793778
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:3215	bupivacaine	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20220607	CTD	MESH:D002045	HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of BCL2 protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of DNM1L protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of MFN1 protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of PINK1 protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of PPARGC1A protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of PRKN protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of SLC2A1 protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of SLC2A4 protein]; HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of TOMM20 protein]	PMID:34793778
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313611	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HSPA12A promoter	PMID:35295148
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of HSPA12A mRNA	PMID:18648102
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of HSPA12A mRNA	PMID:20813756
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of HSPA12A gene	PMID:31601247
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305531	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HSPA12A mRNA	PMID:25181051|PMID:30816183
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HSPA12A gene	PMID:31601247
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34093	1-Hydroxypyrene	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C033146	[Metals, Heavy co-treated with 1-hydroxypyrene] results in decreased methylation of HSPA12A gene	PMID:39164771
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313611	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of HSPA12A mRNA	PMID:40203079
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HSPA12A mRNA	PMID:28628672
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in increased expression of HSPA12A mRNA]	PMID:40203079
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of HSPA12A intron	PMID:30157460
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HSPA12A mRNA	PMID:28628672
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1305531	E	RGD:6480464	20191112	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA	PMID:31199487
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HSPA12A mRNA	PMID:37019170
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305531	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of HSPA12A mRNA	PMID:21266533
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305531	E	RGD:6480464	20191112	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA	PMID:31199487
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1305531	E	RGD:6480464	20191112	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA	PMID:31199487
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HSPA12A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HSPA12A mRNA	PMID:28628672
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305531	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of HSPA12A mRNA	PMID:32680482
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305531	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of HSPA12A mRNA	PMID:35163327
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HSPA12A mRNA	PMID:38382870
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305531	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HSPA12A mRNA	PMID:33453195
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HSPA12A mRNA	PMID:35301059
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1305531	E	RGD:6480464	20191112	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA	PMID:31199487
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305531	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of HSPA12A mRNA	PMID:35163327
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HSPA12A mRNA	PMID:25979313
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of HSPA12A mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA	PMID:27188386
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of HSPA12A mRNA	PMID:25562108
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HSPA12A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HSPA12A mRNA	PMID:28628672
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of HSPA12A mRNA	PMID:28973697
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1305531	E	RGD:6480464	20160607	CTD	MESH:D005947	Glucose results in decreased expression of HSPA12A protein	PMID:22413817
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1305531	E	RGD:6480464	20160607	CTD	MESH:D005947	KU-32 compound inhibits the reaction [Glucose results in decreased expression of HSPA12A protein]	PMID:22413817
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HSPA12A mRNA	PMID:38832940
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of HSPA12A mRNA	PMID:24935251
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of HSPA12A mRNA	PMID:29067470
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305531	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HSPA12A mRNA	PMID:33387578
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of HSPA12A mRNA	PMID:24714768
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of HSPA12A mRNA	PMID:29279043
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D001151	Arsenic affects the expression of HSPA12A mRNA	PMID:33736254
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HSPA12A gene	PMID:25304211
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D001151	[Palmitic Acid co-treated with Arsenic] affects the expression of HSPA12A mRNA	PMID:33736254
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313611	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HSPA12A mRNA	PMID:40504410
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:48607	lithium chloride	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in decreased expression of HSPA12A mRNA	PMID:23527032
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HSPA12A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HSPA12A mRNA	PMID:28628672
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of HSPA12A mRNA	PMID:23300844
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of HSPA12A mRNA	PMID:22714537
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of HSPA12A mRNA	PMID:23608068
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HSPA12A protein	PMID:32959892
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of HSPA12A mRNA	PMID:28988120
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of HSPA12A intron	PMID:30157460
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305531	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of HSPA12A gene	PMID:35440735
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of HSPA12A protein	PMID:34186270
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313611	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HSPA12A mRNA	PMID:22206623
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of HSPA12A mRNA	PMID:22714537
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of HSPA12A mRNA	PMID:32858204
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of HSPA12A protein	PMID:39638853
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of HSPA12A mRNA	PMID:34995734
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA	PMID:27188386
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1305531	E	RGD:6480464	20191112	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of HSPA12A mRNA	PMID:31199487
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305531	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HSPA12A mRNA	PMID:24780913
1313610	HSPA12A	heat shock protein family A (Hsp70) member 12A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HSPA12A mRNA	PMID:27188386
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of RBBP5 mRNA	PMID:19438726
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313613	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of RBBP5 mRNA	PMID:33045310
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305532	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RBBP5 mRNA]	PMID:31150632
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313613	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RBBP5 mRNA	PMID:26251327
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313613	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RBBP5 mRNA	PMID:20188158
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:D000431	Ethanol results in increased expression of RBBP5 protein	PMID:35149083
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RBBP5 mRNA	PMID:37042841
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:17303	morphine	decreases expression	ISO	RGD:1313613	E	RGD:6480464	20220111	CTD	MESH:D009020	Morphine results in decreased expression of RBBP5 mRNA	PMID:33891991
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1313613	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of RBBP5 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RBBP5 mRNA]	PMID:20230807
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RBBP5 protein	PMID:37730182
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1313613	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RBBP5 mRNA	PMID:20230807
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1313613	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of RBBP5 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of RBBP5 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RBBP5 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RBBP5 mRNA]	PMID:20230807
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RBBP5 mRNA	PMID:28818685
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313613	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RBBP5 mRNA	PMID:36331819
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1313613	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of RBBP5 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RBBP5 mRNA]	PMID:20230807
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of RBBP5 mRNA	PMID:12634122
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RBBP5 mRNA	PMID:19549813
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RBBP5 gene	PMID:27153756
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of RBBP5 mRNA	PMID:26760959
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:2682	amphotericin B	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of RBBP5 mRNA; Amphotericin B results in decreased expression of RBBP5 mRNA	PMID:28534445
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305532	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RBBP5 mRNA	PMID:31150632
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305532	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RBBP5 mRNA]	PMID:31150632
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of RBBP5 protein	PMID:35688186
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1313613	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of RBBP5 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RBBP5 mRNA]	PMID:20230807
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RBBP5 mRNA	PMID:23557933
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313613	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RBBP5 mRNA	PMID:21570461
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RBBP5 mRNA	PMID:29803840
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of RBBP5 protein	PMID:35688186
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of RBBP5 protein	PMID:38228842
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RBBP5 mRNA	PMID:38568856
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RBBP5 mRNA	PMID:20064835
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RBBP5 3' UTR	PMID:27901495
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313613	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RBBP5 mRNA	PMID:18648102
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313613	E	RGD:6480464	20150127	CTD	MESH:C006253	pirinixic acid results in decreased expression of RBBP5 mRNA	PMID:25270620
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305532	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RBBP5 mRNA	PMID:25181051
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313613	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of RBBP5 promoter	PMID:27312807
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305532	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RBBP5 mRNA	PMID:34947998
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of RBBP5 protein	PMID:33376534
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:34631	chlorpyrifos	affects expression	ISO	RGD:1313613	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos affects the expression of RBBP5 mRNA	PMID:37019170
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RBBP5 mRNA	PMID:37042841
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RBBP5 mRNA	PMID:31533062
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313613	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RBBP5 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of RBBP5 mRNA	PMID:36331819
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of RBBP5 mRNA	PMID:29154799
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:41791	calyculin A	decreases expression	ISO	RGD:1313613	E	RGD:6480464	20150127	CTD	MESH:C059041	calyculin A results in decreased expression of RBBP5 mRNA	PMID:25270620
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:41977	daunorubicin	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003630	Daunorubicin affects the expression of RBBP5 mRNA	PMID:12656675
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RBBP5 mRNA	PMID:38832940
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RBBP5 mRNA	PMID:28542535
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RBBP5 mRNA	PMID:22230336
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305532	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RBBP5 mRNA	PMID:24136188
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RBBP5 protein	PMID:32959892
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D015655	U 0126 affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of RBBP5 mRNA]	PMID:12710931
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313613	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RBBP5 mRNA	PMID:22206623
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RBBP5 protein	PMID:37664457
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RBBP5 gene]	PMID:28238834
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of RBBP5 mRNA; Irinotecan results in decreased expression of RBBP5 mRNA	PMID:15956246
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:80630	irinotecan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in increased expression of RBBP5 mRNA; Irinotecan results in increased expression of RBBP5 mRNA	PMID:15956246
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RBBP5 protein	PMID:37664457
1313612	RBBP5	RB binding protein 5, histone lysine methyltransferase complex subunit	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of RBBP5 mRNA	PMID:17440010
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313615	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TBCE mRNA	PMID:37995155
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TBCE mRNA	PMID:33167477
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TBCE mRNA	PMID:22378314
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TBCE mRNA	PMID:20044591
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313615	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TBCE mRNA	PMID:39298647
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1313615	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone promotes the reaction [Biomarkers metabolite binds to TBCE gene]	PMID:31084621
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305533	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TBCE mRNA	PMID:22061828
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBCE mRNA	PMID:39836092
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TBCE protein	PMID:23301498
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313615	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TBCE mRNA	PMID:19770486
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TBCE intron	PMID:30157460
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBCE mRNA	PMID:39836092
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305533	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBCE mRNA	PMID:33387578
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1313615	E	RGD:6480464	20120613	CTD	MESH:D012402	Rotenone affects the expression of TBCE mRNA	PMID:21893155
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1313615	E	RGD:6480464	20120613	CTD	MESH:D012402	TRP53 affects the reaction [Rotenone affects the expression of TBCE mRNA]	PMID:21893155
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TBCE mRNA	PMID:33212167
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313615	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of TBCE mRNA	PMID:25896364|PMID:39631538
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313615	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of TBCE mRNA	PMID:20883709
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBCE mRNA	PMID:39836092
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313615	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TBCE mRNA	PMID:19770486
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313615	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of TBCE protein	PMID:37955338
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to TBCE mRNA]	PMID:32406909
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313615	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TBCE gene	PMID:35295148
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313615	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of TBCE mRNA	PMID:18648102
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305533	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of TBCE mRNA	PMID:19167457
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TBCE protein	PMID:33376534
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305533	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TBCE mRNA	PMID:25181051
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305533	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TBCE mRNA	PMID:36041667
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313615	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TBCE mRNA	PMID:39298647
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305533	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TBCE mRNA	PMID:36041667
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313615	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TBCE mRNA	PMID:38685157
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of TBCE protein	PMID:34186270
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305533	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of TBCE mRNA	PMID:36041667
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TBCE protein	PMID:34186270
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313615	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TBCE mRNA	PMID:37019170
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBCE mRNA	PMID:39836092
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1313615	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride affects the expression of TBCE mRNA	PMID:20883709
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305533	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TBCE mRNA	PMID:19162173
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of TBCE mRNA	PMID:19376846
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313615	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of TBCE mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TBCE mRNA]	PMID:17585979
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TBCE mRNA	PMID:23179753|PMID:29154799
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TBCE mRNA	PMID:25562108
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313615	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TBCE mRNA	PMID:28973697
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305533	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TBCE mRNA	PMID:24136188
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313615	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TBCE mRNA	PMID:17562736
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313615	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in decreased expression of TBCE mRNA	PMID:17585979
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313615	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of TBCE mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TBCE mRNA]	PMID:17585979
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TBCE protein affects the susceptibility to Fluorouracil	PMID:16217747
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313615	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TBCE mRNA	PMID:29279043
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBCE mRNA	PMID:39836092
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305533	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of TBCE mRNA	PMID:29097150
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305533	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of TBCE mRNA	PMID:24136188
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305533	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TBCE mRNA	PMID:24136188
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TBCE protein	PMID:32959892
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBCE mRNA	PMID:39836092
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313615	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TBCE mRNA	PMID:23650126
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305533	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TBCE gene	PMID:35440735
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TBCE protein	PMID:34186270
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:748572	acyline	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C109238	acyline results in increased expression of TBCE mRNA	PMID:17510436
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305533	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TBCE mRNA	PMID:24136188
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305533	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TBCE mRNA	PMID:19162173
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of TBCE mRNA	PMID:39904859
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313615	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TBCE mRNA	PMID:30294300
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of TBCE protein	PMID:38348393
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305533	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TBCE mRNA	PMID:21346803
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305533	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TBCE mRNA	PMID:21346803
1313614	TBCE	tubulin folding cofactor E	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305533	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of TBCE mRNA	PMID:22570695
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1617233	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DOP1A mRNA	PMID:33045310
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DOP1A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DOP1A mRNA	PMID:32699268
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of DOP1A mRNA	PMID:24763279
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of DOP1A mRNA	PMID:26079696
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DOP1A mRNA	PMID:20044591
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of DOP1A mRNA	PMID:21632981
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1617233	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DOP1A mRNA	PMID:39298647
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DOP1A mRNA	PMID:37042841
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of DOP1A mRNA	PMID:19162166
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of DOP1A mRNA	PMID:23649840
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DOP1A protein	PMID:37730182
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DOP1A mRNA	PMID:28818685
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1617233	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DOP1A mRNA	PMID:36331819
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DOP1A mRNA	PMID:35301059
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1617233	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DOP1A mRNA	PMID:37236586
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of DOP1A mRNA	PMID:23649840
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DOP1A mRNA	PMID:23649840
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DOP1A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DOP1A mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of DOP1A mRNA	PMID:32699268
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of DOP1A protein	PMID:35688186
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1617233	E	RGD:6480464	20210209	CTD	MESH:C024565	ethylene dichloride affects the expression of DOP1A mRNA	PMID:28960355
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DOP1A mRNA	PMID:23557933
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305534	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DOP1A mRNA	PMID:34747641
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DOP1A mRNA	PMID:28001369
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DOP1A mRNA	PMID:33212167
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DOP1A mRNA	PMID:29803840
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20200114	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DOP1A exon	PMID:30157460
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1617233	E	RGD:6480464	20181113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DOP1A mRNA	PMID:21569818
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DOP1A gene	PMID:31601247
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1617233	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of DOP1A mRNA	PMID:35295148
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1617233	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DOP1A gene	PMID:35295148
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305534	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of DOP1A mRNA	PMID:30816183
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DOP1A gene	PMID:31601247
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1617233	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of DOP1A mRNA	PMID:35598803
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DOP1A gene	PMID:31601247
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DOP1A mRNA	PMID:37042841
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305534	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DOP1A mRNA	PMID:33453195
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DOP1A mRNA	PMID:35301059
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1617233	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DOP1A mRNA	PMID:37236586
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1617233	E	RGD:6480464	20181113	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of DOP1A mRNA	PMID:28903501
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of DOP1A mRNA	PMID:24449571
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DOP1A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DOP1A mRNA	PMID:32699268
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1617233	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DOP1A mRNA	PMID:36331819
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of DOP1A mRNA	PMID:24383497|PMID:28001369
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of DOP1A mRNA	PMID:20106945
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1617233	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of DOP1A mRNA	PMID:29279043
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1617233	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of DOP1A mRNA	PMID:35436446
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1305534	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of DOP1A mRNA	PMID:30307764
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305534	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DOP1A gene	PMID:35440735
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:80799	Bufotalin	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of DOP1A mRNA	PMID:39904859
1313616	DOP1A	DOP1 leucine zipper like protein A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1617233	E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of DOP1A mRNA	PMID:30294300
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313619	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ARL6 mRNA	PMID:33045310
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313619	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ARL6 mRNA	PMID:30319688
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313619	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ARL6 mRNA	PMID:30319688
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ARL6 mRNA	PMID:21632981
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of ARL6 mRNA	PMID:22574217
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305535	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ARL6 mRNA	PMID:33387578
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARL6 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARL6 mRNA; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CTNNB1 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LEF1 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RUNX2 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TCF7 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT3A protein]	PMID:32522577|PMID:35301059
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305535	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ARL6 mRNA	PMID:21396975
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313619	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARL6 mRNA	PMID:19770486
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313619	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ARL6 mRNA	PMID:34911549
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313619	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ARL6 mRNA	PMID:27339419|PMID:31919559
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313619	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ARL6 protein	PMID:25505154
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313619	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARL6 mRNA	PMID:21570461
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARL6 mRNA	PMID:33212167
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305535	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ARL6 mRNA	PMID:28959563
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313619	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARL6 promoter	PMID:35295148
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305535	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ARL6 mRNA	PMID:23411599|PMID:34492290
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of ARL6 mRNA	PMID:27685785
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARL6 mRNA	PMID:37042841
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305535	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ARL6 mRNA	PMID:30917596
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305535	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARL6 mRNA	PMID:33453195
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARL6 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARL6 mRNA; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CTNNB1 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LEF1 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RUNX2 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TCF7 protein]; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT3A protein]	PMID:32522577|PMID:35301059
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305535	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ARL6 mRNA	PMID:25539665
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ARL6 mRNA	PMID:31533062
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of ARL6 mRNA	PMID:31626844
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313619	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ARL6 mRNA	PMID:17963808
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of ARL6 mRNA	PMID:24935251|PMID:29154799
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ARL6 mRNA	PMID:20106945
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313619	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of ARL6 mRNA	PMID:19770486
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313619	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ARL6 mRNA	PMID:28973697
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ARL6 mRNA	PMID:24935251
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARL6 mRNA	PMID:26690555
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305535	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARL6 mRNA	PMID:33387578
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305535	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ARL6 mRNA	PMID:29391264
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313619	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ARL6 mRNA	PMID:35436446
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ARL6 protein	PMID:23718831
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305535	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of ARL6 mRNA	PMID:20080153
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARL6 gene]	PMID:28238834
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313619	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ARL6 mRNA	PMID:23091169
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305535	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ARL6 mRNA	PMID:24780913
1313618	ARL6	ARF like GTPase 6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305535	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ARL6 mRNA	PMID:21346803
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HECTD2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HECTD2 gene	PMID:20938992
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of HECTD2 mRNA	PMID:21934132
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HECTD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of HECTD2 mRNA	PMID:32699268
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of HECTD2 mRNA	PMID:21632981
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313621	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of HECTD2 mRNA	PMID:39298647
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of HECTD2 mRNA	PMID:30165855
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HECTD2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HECTD2 gene	PMID:20938992
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HECTD2 mRNA	PMID:37992649
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HECTD2 mRNA	PMID:37992649
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of HECTD2 mRNA	PMID:28818685
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HECTD2 mRNA	PMID:35301059
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305536	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HECTD2 mRNA	PMID:39012411
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HECTD2 mRNA	PMID:37236586
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of HECTD2 mRNA	PMID:19549813
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HECTD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of HECTD2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of HECTD2 mRNA	PMID:32699268
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1305536	E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in increased expression of HECTD2 mRNA	PMID:31129395
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305536	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of HECTD2 mRNA	PMID:31150632
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313621	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of HECTD2 mRNA	PMID:31919559
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of HECTD2 mRNA	PMID:25629700
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HECTD2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HECTD2 gene	PMID:20938992
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HECTD2 mRNA	PMID:40504410
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of HECTD2 mRNA	PMID:28189721|PMID:28960355
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305536	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HECTD2 mRNA	PMID:22298810
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313621	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HECTD2 mRNA	PMID:21570461
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HECTD2 mRNA	PMID:19933214|PMID:24680724
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313621	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HECTD2 mRNA	PMID:17949056|PMID:19770486
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of HECTD2 mRNA	PMID:16214954
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of HECTD2 mRNA	PMID:27862939
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HECTD2 mRNA	PMID:29803840
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HECTD2 mRNA	PMID:37992649
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HECTD2 mRNA	PMID:38568856
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HECTD2 mRNA	PMID:40504410
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313621	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HECTD2 mRNA	PMID:32417428
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:3016	Benoxacor	increases expression	ISO	RGD:1313621	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in increased expression of HECTD2 mRNA	PMID:34850242
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of HECTD2 mRNA	PMID:29264374
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313621	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HECTD2 gene; titanium dioxide results in decreased methylation of HECTD2 promoter	PMID:35295148
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305536	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of HECTD2 mRNA	PMID:34947998
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305536	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of HECTD2 mRNA	PMID:33296240
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of HECTD2 mRNA	PMID:38685157
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HECTD2 mRNA	PMID:37042841
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HECTD2 mRNA	PMID:35301059
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305536	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HECTD2 mRNA	PMID:39012411
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HECTD2 mRNA	PMID:37236586
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305536	E	RGD:6480464	20130806	CTD	MESH:C039281	furan results in increased methylation of HECTD2 gene	PMID:22079235
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of HECTD2 mRNA	PMID:28903501
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of HECTD2 mRNA	PMID:24449571
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313621	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of HECTD2 mRNA	PMID:18353800
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of HECTD2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of HECTD2 mRNA	PMID:32699268
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of HECTD2 mRNA	PMID:33512557
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of HECTD2 mRNA	PMID:31533062
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C480342	clothianidin results in increased expression of HECTD2 mRNA	PMID:29044138
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of HECTD2 mRNA	PMID:27153767
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HECTD2 mRNA	PMID:25979313
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of HECTD2 mRNA	PMID:23179753|PMID:27188386
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HECTD2 gene	PMID:29154799
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313621	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of HECTD2 mRNA	PMID:19770486
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of HECTD2 mRNA	PMID:37992649
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313621	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HECTD2 mRNA	PMID:17562736
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313621	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HECTD2 mRNA	PMID:40504410
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of HECTD2 mRNA	PMID:40706910
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in decreased expression of HECTD2 mRNA	PMID:22334560
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:48981	quinolin-8-ol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of HECTD2 mRNA	PMID:21632981
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of HECTD2 mRNA	PMID:25554681
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of HECTD2 mRNA	PMID:20977926
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313621	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of HECTD2 mRNA	PMID:19042947
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:53444	potassium dichromate	affects expression	ISO	RGD:1313621	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate affects the expression of HECTD2 mRNA	PMID:23608068
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HECTD2 mRNA	PMID:22206623
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of HECTD2 mRNA	PMID:18927307
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of HECTD2 mRNA	PMID:23091169
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in decreased expression of HECTD2 mRNA	PMID:22334560
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313621	E	RGD:6480464	20131210	CTD	MESH:C045950	propiconazole results in decreased expression of HECTD2 mRNA	PMID:21278054|PMID:22334560|PMID:23970803
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305536	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of HECTD2 mRNA	PMID:19281266
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of HECTD2 mRNA	PMID:38568856
1313620	HECTD2	HECT domain E3 ubiquitin protein ligase 2	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of HECTD2 mRNA	PMID:27188386
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305538	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANKK1 mRNA	PMID:32741896
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ANKK1 mRNA	PMID:37042841
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305538	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANKK1 mRNA	PMID:32741896
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ANKK1 mRNA	PMID:19549813
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ANKK1 exon	PMID:30157460
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1620554	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ANKK1 mRNA	PMID:27106289
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in increased methylation of ANKK1 gene	PMID:24525453
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305538	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ANKK1 mRNA	PMID:28959563
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305538	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ANKK1 mRNA	PMID:26033743
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ANKK1 mRNA	PMID:25879800
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ANKK1 promoter	PMID:27901495
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1620554	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ANKK1 mRNA	PMID:23735875
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ANKK1 exon	PMID:27901495
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305538	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ANKK1 mRNA	PMID:26033743
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ANKK1 mRNA	PMID:23806026
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1305538	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of ANKK1 mRNA	PMID:30012374
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305538	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ANKK1 mRNA	PMID:25181051
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ANKK1 mRNA	PMID:38382870
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620554	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ANKK1 mRNA	PMID:40194260
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in decreased expression of ANKK1 mRNA	PMID:23527032
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ANKK1 mRNA	PMID:38832940
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ANKK1 mRNA	PMID:26690555
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in increased methylation of ANKK1 gene	PMID:24525453
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1620554	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ANKK1 mRNA	PMID:23608068
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1620554	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ANKK1 mRNA	PMID:38701926
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305538	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ANKK1 mRNA	PMID:32741896
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of ANKK1 mRNA	PMID:32234424
1313623	ANKK1	ankyrin repeat and kinase domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305538	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ANKK1 mRNA	PMID:24780913
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PCDHB13 mRNA	PMID:38568856
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:174733	Licochalcone B	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of PCDHB13 mRNA	PMID:33647349
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PCDHB13 mRNA	PMID:28818685
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PCDHB13 mRNA	PMID:40288432
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDHB13 gene	PMID:27153756
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PCDHB13 exon	PMID:27901495
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PCDHB13 promoter	PMID:27901495
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PCDHB13 gene	PMID:31601247
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of PCDHB13 gene	PMID:31601247
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PCDHB13 mRNA	PMID:31533062
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PCDHB13 mRNA	PMID:23179753
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PCDHB13 mRNA	PMID:38832940
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of PCDHB13 mRNA	PMID:31629900
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of PCDHB13 mRNA	PMID:28988120
1313625	PCDHB13	protocadherin beta 13	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDHB13 gene]	PMID:28238834
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of FBL protein	PMID:39638853
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of FBL mRNA	PMID:38218311
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305542	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBL mRNA]	PMID:31150632
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313629	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FBL mRNA	PMID:20188158
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FBL mRNA	PMID:33167477
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313629	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FBL mRNA	PMID:39241906
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313629	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of FBL mRNA	PMID:15598610
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:165219	PCB138	increases expression	ISO	RGD:1305542	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of FBL mRNA	PMID:23829299
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of FBL mRNA	PMID:38568856
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of FBL protein	PMID:39245080
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:17574	biochanin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004541	biochanin A results in increased expression of FBL mRNA	PMID:12111696
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FBL protein	PMID:37730182
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305542	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of FBL mRNA	PMID:22061828
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	decreases expression	ISO	RGD:1305542	E	RGD:6480464	20161025	CTD	MESH:D024502	alpha-Tocopherol deficiency results in decreased expression of FBL protein	PMID:15247049
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FBL mRNA	PMID:36331819
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305542	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of FBL protein	PMID:34915118
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:193591	Didecyldimethylammonium	decreases expression	EXP		E	RGD:6480464	20221018	CTD	MESH:C027118	didecyldimethylammonium results in decreased expression of FBL protein	PMID:32763356
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313629	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of FBL mRNA	PMID:27462272
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBL mRNA	PMID:35301059
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:231511	Potassium hexachloropalladate(IV)	affects localization	EXP		E	RGD:6480464	20240702	CTD	MESH:C532828	potassium hexachloropalladate(IV) analog affects the localization of FBL protein	PMID:10942594
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of FBL protein	PMID:23301498
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of FBL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of FBL protein	PMID:38598786
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305542	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FBL mRNA	PMID:31150632
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305542	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBL mRNA]	PMID:31150632
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBL mRNA	PMID:22206623
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27504	mitomycin C	affects localization	EXP		E	RGD:6480464	20120814	CTD	MESH:D016685	Mitomycin analog affects the localization of FBL protein	PMID:10942594
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of FBL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBL mRNA	PMID:39836092|PMID:40512198
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of FBL mRNA	PMID:19684285
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27666	actinomycin D	affects localization	EXP		E	RGD:6480464	20120814	CTD	MESH:D003609	Dactinomycin analog affects the localization of FBL protein	PMID:10942594
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27899	cisplatin	affects localization	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin analog affects the localization of FBL protein	PMID:10942594
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313629	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of FBL mRNA	PMID:21151649
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBL mRNA	PMID:19684285
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305542	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBL mRNA	PMID:33387578
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of FBL mRNA	PMID:19684285
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of FBL mRNA; Rotenone results in increased expression of FBL protein	PMID:33512557|PMID:39603559
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305542	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of FBL protein	PMID:35544339
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313629	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of FBL protein	PMID:28918527
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FBL mRNA	PMID:29803840
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FBL mRNA	PMID:36989763|PMID:38568856
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of FBL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBL mRNA	PMID:39836092|PMID:40512198
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBL 3' UTR	PMID:27901495
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FBL promoter	PMID:27901495
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to FBL mRNA]	PMID:32406909
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FBL mRNA	PMID:20382639
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305542	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of FBL mRNA	PMID:24136188
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31767	lead diacetate	affects localization	EXP		E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate affects the localization of FBL protein	PMID:10942594
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31823	mercury dichloride	affects localization	EXP		E	RGD:6480464	20120814	CTD	MESH:D008627	Mercuric Chloride affects the localization of FBL protein	PMID:10942594
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31823	mercury dichloride	affects localization	ISO	RGD:1313629	E	RGD:6480464	20120918	CTD	MESH:D008627	Mercuric Chloride affects the localization of FBL protein	PMID:10942594|PMID:12388758
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31823	mercury dichloride	decreases activity	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D008627	Mercuric Chloride results in decreased activity of FBL protein	PMID:19077085
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31823	mercury dichloride	increases cleavage	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D008627	Mercuric Chloride results in increased cleavage of FBL protein	PMID:10925315
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:31823	mercury dichloride	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D008627	CD28 protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]; IFNG protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]; IL4 protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]; IL6 protein affects the reaction [Mercuric Chloride results in decreased activity of FBL protein]	PMID:19077085
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:32130	silver(1+) nitrate	decreases activity	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D012835	Silver Nitrate results in decreased activity of FBL protein	PMID:19077085
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:32130	silver(1+) nitrate	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D012835	CD28 protein affects the reaction [Silver Nitrate results in decreased activity of FBL protein]; IFNG protein affects the reaction [Silver Nitrate results in decreased activity of FBL protein]; IL4 protein affects the reaction [Silver Nitrate results in decreased activity of FBL protein]; IL6 protein affects the reaction [Silver Nitrate results in decreased activity of FBL protein]	PMID:19077085
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305542	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of FBL mRNA	PMID:30047161
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305542	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FBL mRNA	PMID:34492290
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313629	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of FBL mRNA	PMID:28472532
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of FBL mRNA	PMID:38479592
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of FBL mRNA; bisphenol A results in decreased expression of FBL protein	PMID:29275510|PMID:31675489|PMID:34186270
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305542	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FBL mRNA	PMID:25181051
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305542	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBL mRNA	PMID:36041667
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of FBL protein	PMID:31675489
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313629	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of FBL mRNA	PMID:39298647
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305542	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBL mRNA	PMID:36041667
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of FBL protein	PMID:34186270
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305542	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBL mRNA	PMID:36041667
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313629	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FBL mRNA	PMID:37019170
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313629	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of FBL mRNA	PMID:17361019
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of FBL protein	PMID:38598786
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in increased expression of FBL protein	PMID:34064677
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305542	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of FBL mRNA	PMID:32680482
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:35456	cadmium dichloride	affects localization	EXP		E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride affects the localization of FBL protein	PMID:10942594
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBL mRNA	PMID:35301059
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of FBL protein	PMID:26879310
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313629	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of FBL mRNA	PMID:17585979
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of FBL mRNA	PMID:33512557
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FBL mRNA	PMID:36331819
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305542	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of FBL mRNA	PMID:25993096
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313629	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of FBL mRNA	PMID:17292431
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FBL gene	PMID:29154799
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305542	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of FBL mRNA	PMID:41580965
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of FBL mRNA	PMID:20106945|PMID:27989131
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305542	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of FBL mRNA	PMID:24136188
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313629	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FBL mRNA	PMID:17562736
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of FBL mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBL mRNA	PMID:39836092|PMID:40512198
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of FBL mRNA	PMID:31675489
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of FBL mRNA	PMID:18175754
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:4911	etoposide	affects localization	EXP		E	RGD:6480464	20120814	CTD	MESH:D005047	Etoposide analog affects the localization of FBL protein	PMID:10942594
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:49852	5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole	affects localization	EXP		E	RGD:6480464	20250107	CTD	MESH:D004004	Dichlororibofuranosylbenzimidazole analog affects the localization of FBL protein	PMID:10942594
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:5011	fenpyroximate	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of FBL mRNA	PMID:33512557
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313629	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of FBL mRNA; Nanotubes, Carbon results in increased expression of FBL mRNA	PMID:25554681
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305542	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of FBL mRNA	PMID:30047161
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FBL mRNA	PMID:35964746
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305542	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of FBL mRNA	PMID:24136188
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of FBL protein	PMID:31629900
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:5516	sodium aurothiomalate	affects localization	EXP		E	RGD:6480464	20120814	CTD	MESH:D006052	Gold Sodium Thiomalate affects the localization of FBL protein	PMID:10942594
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:5516	sodium aurothiomalate	decreases activity	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D006052	Gold Sodium Thiomalate results in decreased activity of FBL protein	PMID:19077085
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:5516	sodium aurothiomalate	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20120814	CTD	MESH:D006052	CD28 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IFNG protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IL4 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]; IL6 protein affects the reaction [Gold Sodium Thiomalate results in decreased activity of FBL protein]	PMID:19077085
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FBL protein	PMID:32959892
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305542	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of FBL mRNA	PMID:20080153
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305542	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of FBL mRNA	PMID:24136188
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313629	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of FBL protein	PMID:26558463
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313629	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of FBL mRNA	PMID:27462272
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of FBL protein	PMID:34186270
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313629	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBL mRNA	PMID:22206623
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of FBL protein	PMID:37664457
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305542	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of FBL mRNA	PMID:24136188
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of FBL protein	PMID:31285264
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313629	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of FBL mRNA	PMID:30294300
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of FBL protein	PMID:31675489
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313629	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of FBL mRNA	PMID:31558096
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of FBL protein	PMID:31675489
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of FBL mRNA	PMID:33512557
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305542	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of FBL mRNA	PMID:30047161
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1313629	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of FBL protein	PMID:20553848
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of FBL protein	PMID:37664457
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305542	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of FBL mRNA	PMID:19281266
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of FBL mRNA	PMID:33512557
1313628	FBL	fibrillarin rRNA 2'-O-methyltransferase	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of FBL protein	PMID:38598786
1313630	WDR36	WD repeat domain 36	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of WDR36 protein	PMID:39638853
1313630	WDR36	WD repeat domain 36	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of WDR36 mRNA	PMID:33167477
1313630	WDR36	WD repeat domain 36	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of WDR36 mRNA	PMID:20044591
1313630	WDR36	WD repeat domain 36	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550247	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of WDR36 mRNA	PMID:39241906
1313630	WDR36	WD repeat domain 36	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550247	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of WDR36 mRNA	PMID:39298647
1313630	WDR36	WD repeat domain 36	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of WDR36 mRNA	PMID:23019147|PMID:31614463
1313630	WDR36	WD repeat domain 36	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of WDR36 mRNA	PMID:23649840
1313630	WDR36	WD repeat domain 36	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550247	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of WDR36 mRNA	PMID:33754040
1313630	WDR36	WD repeat domain 36	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of WDR36 protein	PMID:37730182
1313630	WDR36	WD repeat domain 36	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of WDR36 mRNA	PMID:16002434
1313630	WDR36	WD repeat domain 36	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1586463	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of WDR36 mRNA	PMID:33387578
1313630	WDR36	WD repeat domain 36	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of WDR36 mRNA	PMID:39836092
1313630	WDR36	WD repeat domain 36	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of WDR36 mRNA	PMID:35301059
1313630	WDR36	WD repeat domain 36	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550247	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WDR36 mRNA	PMID:37236586
1313630	WDR36	WD repeat domain 36	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of WDR36 mRNA	PMID:19549813
1313630	WDR36	WD repeat domain 36	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of WDR36 mRNA	PMID:23649840
1313630	WDR36	WD repeat domain 36	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of WDR36 gene	PMID:27153756
1313630	WDR36	WD repeat domain 36	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of WDR36 mRNA	PMID:23649840
1313630	WDR36	WD repeat domain 36	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550247	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of WDR36 mRNA	PMID:34911549
1313630	WDR36	WD repeat domain 36	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550247	E	RGD:6480464	20130618	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of WDR36 mRNA	PMID:17484886
1313630	WDR36	WD repeat domain 36	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550247	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of WDR36 mRNA	PMID:31919559
1313630	WDR36	WD repeat domain 36	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550247	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of WDR36 mRNA	PMID:25629700
1313630	WDR36	WD repeat domain 36	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550247	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of WDR36 mRNA]	PMID:22206623
1313630	WDR36	WD repeat domain 36	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of WDR36 gene	PMID:25304211
1313630	WDR36	WD repeat domain 36	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of WDR36 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WDR36 mRNA	PMID:39836092
1313630	WDR36	WD repeat domain 36	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of WDR36 mRNA	PMID:23557933
1313630	WDR36	WD repeat domain 36	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of WDR36 mRNA	PMID:27594783
1313630	WDR36	WD repeat domain 36	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550247	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WDR36 mRNA	PMID:17942748
1313630	WDR36	WD repeat domain 36	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550247	E	RGD:6480464	20130618	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WDR36 mRNA	PMID:17942748
1313630	WDR36	WD repeat domain 36	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of WDR36 mRNA	PMID:33212167
1313630	WDR36	WD repeat domain 36	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of WDR36 mRNA	PMID:29803840
1313630	WDR36	WD repeat domain 36	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of WDR36 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WDR36 mRNA	PMID:39836092
1313630	WDR36	WD repeat domain 36	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of WDR36 promoter	PMID:27901495
1313630	WDR36	WD repeat domain 36	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550247	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WDR36 mRNA	PMID:19770486
1313630	WDR36	WD repeat domain 36	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of WDR36 mRNA	PMID:19150397
1313630	WDR36	WD repeat domain 36	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of WDR36 mRNA	PMID:26238291
1313630	WDR36	WD repeat domain 36	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1586463	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of WDR36 mRNA	PMID:24136188
1313630	WDR36	WD repeat domain 36	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1586463	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of WDR36 mRNA	PMID:25729387
1313630	WDR36	WD repeat domain 36	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550247	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of WDR36 mRNA	PMID:29264374
1313630	WDR36	WD repeat domain 36	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1586463	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of WDR36 mRNA	PMID:34492290
1313630	WDR36	WD repeat domain 36	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1550247	E	RGD:6480464	20130618	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of WDR36 mRNA	PMID:18648102
1313630	WDR36	WD repeat domain 36	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550247	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of WDR36 mRNA	PMID:28472532
1313630	WDR36	WD repeat domain 36	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR36 protein	PMID:37567409
1313630	WDR36	WD repeat domain 36	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1586463	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of WDR36 mRNA	PMID:25181051
1313630	WDR36	WD repeat domain 36	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to WDR36 protein	PMID:32991956
1313630	WDR36	WD repeat domain 36	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of WDR36 mRNA	PMID:37042841
1313630	WDR36	WD repeat domain 36	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of WDR36 mRNA	PMID:39836092
1313630	WDR36	WD repeat domain 36	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of WDR36 mRNA	PMID:35301059
1313630	WDR36	WD repeat domain 36	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550247	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WDR36 mRNA	PMID:37236586
1313630	WDR36	WD repeat domain 36	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of WDR36 mRNA	PMID:31533062
1313630	WDR36	WD repeat domain 36	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1586463	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of WDR36 mRNA	PMID:25993096
1313630	WDR36	WD repeat domain 36	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550247	E	RGD:6480464	20130618	CTD	MESH:D014635	Valproic Acid affects the expression of WDR36 mRNA	PMID:17292431
1313630	WDR36	WD repeat domain 36	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of WDR36 mRNA	PMID:23179753|PMID:27188386
1313630	WDR36	WD repeat domain 36	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1586463	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of WDR36 mRNA	PMID:24136188
1313630	WDR36	WD repeat domain 36	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550247	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of WDR36 mRNA	PMID:17562736
1313630	WDR36	WD repeat domain 36	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of WDR36 mRNA	PMID:21420995
1313630	WDR36	WD repeat domain 36	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1586463	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of WDR36 mRNA	PMID:33387578
1313630	WDR36	WD repeat domain 36	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of WDR36 gene	PMID:25304211
1313630	WDR36	WD repeat domain 36	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of WDR36 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WDR36 mRNA	PMID:39836092
1313630	WDR36	WD repeat domain 36	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550247	E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of WDR36 mRNA	PMID:17942748
1313630	WDR36	WD repeat domain 36	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550247	E	RGD:6480464	20130618	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WDR36 mRNA	PMID:17942748
1313630	WDR36	WD repeat domain 36	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550247	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of WDR36 mRNA; Nanotubes, Carbon results in increased expression of WDR36 mRNA	PMID:25554681
1313630	WDR36	WD repeat domain 36	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1586463	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of WDR36 mRNA	PMID:24136188
1313630	WDR36	WD repeat domain 36	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1586463	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of WDR36 mRNA	PMID:24793618
1313630	WDR36	WD repeat domain 36	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1586463	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of WDR36 mRNA	PMID:24136188
1313630	WDR36	WD repeat domain 36	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of WDR36 protein	PMID:32959892
1313630	WDR36	WD repeat domain 36	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1586463	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of WDR36 mRNA	PMID:20080153
1313630	WDR36	WD repeat domain 36	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of WDR36 mRNA	PMID:39836092
1313630	WDR36	WD repeat domain 36	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1586463	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of WDR36 mRNA	PMID:25729387
1313630	WDR36	WD repeat domain 36	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550247	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of WDR36 mRNA	PMID:22206623
1313630	WDR36	WD repeat domain 36	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550247	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of WDR36 mRNA]	PMID:22206623
1313630	WDR36	WD repeat domain 36	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of WDR36 protein	PMID:37664457
1313630	WDR36	WD repeat domain 36	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1586463	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of WDR36 mRNA	PMID:24136188
1313630	WDR36	WD repeat domain 36	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of WDR36 protein	PMID:31285264
1313630	WDR36	WD repeat domain 36	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1586463	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of WDR36 mRNA	PMID:21346803
1313630	WDR36	WD repeat domain 36	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1586463	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of WDR36 mRNA	PMID:36843608
1313630	WDR36	WD repeat domain 36	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of WDR36 protein	PMID:37664457
1313630	WDR36	WD repeat domain 36	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1586463	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of WDR36 mRNA	PMID:21346803
1313630	WDR36	WD repeat domain 36	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1586463	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of WDR36 mRNA	PMID:21346803
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CDK14 mRNA	PMID:33045310
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CDK14 mRNA	PMID:30071829
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313633	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CDK14 mRNA	PMID:20188158
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDK14 mRNA	PMID:20938992
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of CDK14 mRNA	PMID:21934132
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of CDK14 mRNA	PMID:33167477
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDK14 mRNA	PMID:30529165
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305544	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CDK14 gene	PMID:28931070
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of CDK14 mRNA	PMID:30319688
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of CDK14 mRNA	PMID:30165855
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CDK14 mRNA	PMID:38568856
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDK14 mRNA	PMID:20938992
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CDK14 mRNA	PMID:37042841
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313633	E	RGD:6480464	20250114	CTD	MESH:D001554	Benzene results in increased expression of CDK14 mRNA	PMID:37084897
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:16836	4-nitrophenol	increases expression	ISO	RGD:1313633	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in increased expression of CDK14 mRNA	PMID:34673133
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CDK14 mRNA	PMID:23649840
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDK14 mRNA	PMID:37992649
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDK14 mRNA	PMID:37992649
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CDK14 mRNA	PMID:33754040
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305544	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CDK14 mRNA	PMID:33387578
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:181932	3-Nitrobenzanthrone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C117220	3-nitrobenzanthrone results in decreased expression of CDK14 mRNA	PMID:34036453
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CDK14 protein	PMID:20106945
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CDK14 mRNA	PMID:22100608
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CDK14 gene	PMID:27153756
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	ISO	RGD:1305544	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of CDK14 mRNA	PMID:15651846
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:2564	aldrin	increases expression	ISO	RGD:1313633	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in increased expression of CDK14 mRNA	PMID:18579281
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CDK14 mRNA	PMID:35430440
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of CDK14 mRNA	PMID:17484886
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDK14 mRNA	PMID:20938992
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1313633	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of CDK14 mRNA	PMID:28960355
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of CDK14 mRNA	PMID:22023808
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of CDK14 mRNA	PMID:27392435
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313633	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDK14 mRNA	PMID:24680724
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDK14 mRNA	PMID:32109520|PMID:33387578
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK14 mRNA	PMID:17942748
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CDK14 mRNA	PMID:33212167
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CDK14 mRNA	PMID:28959563
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDK14 mRNA	PMID:37992649
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of CDK14 protein	PMID:35688186
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDK14 mRNA	PMID:34032870
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CDK14 3' UTR; Benzo(a)pyrene affects the methylation of CDK14 intron; Benzo(a)pyrene affects the methylation of CDK14 promoter	PMID:27901495|PMID:30157460
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CDK14 mRNA	PMID:20064835|PMID:20106945|PMID:22316170
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CDK14 mRNA	PMID:15894712|PMID:21569818
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CDK14 exon	PMID:27901495
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:D001564	[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of CDK14 mRNA	PMID:15894712
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of CDK14 mRNA	PMID:15894712
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to CDK14 mRNA]	PMID:32406909
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:C015001	[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of CDK14 mRNA	PMID:15894712
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of CDK14 mRNA	PMID:27188386
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:31823	mercury dichloride	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in increased expression of CDK14 mRNA	PMID:27188386
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305544	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of CDK14 mRNA	PMID:25729387
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313633	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDK14 gene	PMID:35295148
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313633	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CDK14 mRNA	PMID:35295148
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of CDK14 mRNA	PMID:19167457
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of CDK14 gene	PMID:31601247
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CDK14 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305544	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of CDK14 mRNA	PMID:32145629
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313633	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of CDK14 mRNA	PMID:35598803
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313633	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CDK14 gene	PMID:31683443
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDK14 mRNA	PMID:28628672
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of CDK14 intron	PMID:30157460
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313633	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CDK14 mRNA	PMID:37019170
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDK14 mRNA	PMID:28628672
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305544	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of CDK14 gene	PMID:33148267
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CDK14 mRNA	PMID:30589522
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CDK14 mRNA	PMID:33453195
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CDK14 mRNA	PMID:24449571
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CDK14 mRNA	PMID:40194260
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CDK14 mRNA	PMID:40419075
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1305544	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of CDK14 mRNA	PMID:22110744
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CDK14 mRNA	PMID:25979313
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CDK14 mRNA	PMID:26272509
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CDK14 gene	PMID:29154799
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of CDK14 mRNA	PMID:38685447
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of CDK14 mRNA	PMID:22147139|PMID:27989131
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of CDK14 promoter	PMID:27989131
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDK14 mRNA	PMID:28628672
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CDK14 mRNA	PMID:28973697
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CDK14 mRNA	PMID:37992649
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of CDK14 mRNA	PMID:27188386
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CDK14 mRNA	PMID:26272509
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CDK14 mRNA	PMID:21420995
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CDK14 mRNA	PMID:29279043
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CDK14 mRNA	PMID:29391264
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313633	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CDK14 mRNA	PMID:35436446
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CDK14 mRNA	PMID:17942748
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313633	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDK14 mRNA	PMID:17942748
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CDK14 mRNA	PMID:32234424
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of CDK14 mRNA	PMID:23228038
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CDK14 mRNA	PMID:28628672
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CDK14 mRNA	PMID:25554681
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in decreased expression of CDK14 mRNA	PMID:22504374
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of CDK14 mRNA	PMID:21983209
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1313633	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of CDK14 mRNA	PMID:26377693
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of CDK14 mRNA	PMID:26705709
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of CDK14 mRNA	PMID:22714537
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of CDK14 mRNA	PMID:20080153
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305544	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of CDK14 mRNA	PMID:25729387
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of CDK14 intron	PMID:30157460
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305544	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CDK14 gene	PMID:35440735
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305544	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of CDK14 gene	PMID:33148267
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CDK14 mRNA	PMID:31758290
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:73295	WIN 55212-2	increases expression	ISO	RGD:1313633	E	RGD:6480464	20170303	CTD	MESH:C070417	(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in increased expression of CDK14 mRNA	PMID:12237329
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CDK14 mRNA	PMID:22714537
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:75253	phenylarsine oxide	increases expression	ISO	RGD:1313633	E	RGD:6480464	20251007	CTD	MESH:C029341	oxophenylarsine results in increased expression of CDK14 mRNA	PMID:37699712
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:7719	ochratoxin A	decreases acetylation	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased acetylation of CDK14 promoter	PMID:29098329
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased expression of CDK14 mRNA	PMID:29098329
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	[ochratoxin A results in decreased acetylation of CDK14 promoter] which results in decreased expression of CDK14 mRNA	PMID:29098329
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CDK14 gene]	PMID:28238834
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CDK14 mRNA	PMID:32109520
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313633	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CDK14 mRNA	PMID:38648751
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305544	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CDK14 mRNA	PMID:23914054
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305544	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CDK14 mRNA	PMID:22504374
1313632	CDK14	cyclin dependent kinase 14	gene	CHEBI:9546	thimerosal	affects expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal affects the expression of CDK14 mRNA	PMID:27188386
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313635	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of METAP1 mRNA	PMID:20188158
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of METAP1 mRNA	PMID:33167477
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of METAP1 mRNA	PMID:29432896
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313635	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of METAP1 mRNA	PMID:39241906
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313635	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of METAP1 mRNA	PMID:27462272
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of METAP1 mRNA	PMID:23649840
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313635	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of METAP1 mRNA]	PMID:22206623
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of METAP1 mRNA	PMID:22574217
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313635	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of METAP1 mRNA	PMID:21570461
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of METAP1 protein	PMID:39603559
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of METAP1 mRNA	PMID:33212167
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of METAP1 protein	PMID:33212167
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of METAP1 mRNA	PMID:39709020
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of METAP1 mRNA	PMID:29803840
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of METAP1 mRNA	PMID:20044591
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of METAP1 mRNA; sodium arsenite results in decreased expression of METAP1 protein	PMID:30528433|PMID:38568856
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite inhibits the reaction [METAP1 protein binds to Ribonucleotides]	PMID:30528433
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of METAP1 promoter	PMID:27901495
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313635	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of METAP1 protein	PMID:37955338
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:30145	lithium atom	decreases expression	ISO	RGD:1313635	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of METAP1 protein	PMID:40770094
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:30146	lithium hydride	decreases expression	ISO	RGD:1313635	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of METAP1 protein	PMID:40770094
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to METAP1 protein]	PMID:26598702
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305545	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of METAP1 mRNA	PMID:30047161
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313635	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of METAP1 promoter	PMID:35295148
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313635	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of METAP1 mRNA	PMID:18648102
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313635	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of METAP1 mRNA	PMID:23811191
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313635	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of METAP1 mRNA	PMID:33221593
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of METAP1 protein	PMID:34186270
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305545	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of METAP1 mRNA	PMID:25181051|PMID:34947998
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313635	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of METAP1 mRNA	PMID:39298647
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of METAP1 mRNA	PMID:37042841
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of METAP1 mRNA	PMID:38568856
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305545	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of METAP1 gene	PMID:22079235
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305545	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of METAP1 mRNA	PMID:30047161
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of METAP1 mRNA	PMID:19320972
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of METAP1 mRNA	PMID:25979313
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of METAP1 gene	PMID:29154799
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305545	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of METAP1 mRNA	PMID:30047161
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of METAP1 promoter	PMID:27989131
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313635	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of METAP1 mRNA	PMID:17562736
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:48635	fumagillin	decreases activity	EXP		E	RGD:6480464	20120814	CTD	MESH:C026211	fumagillin results in decreased activity of METAP1 protein	PMID:14534293
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:48635	fumagillin	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:C026211	[fumagillin results in decreased activity of [METAP1 protein co-treated with METAP2 protein]] which results in decreased metabolism of YWHAG protein	PMID:14534293
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to METAP1 protein]	PMID:26598702
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1305545	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of METAP1 mRNA	PMID:30307764
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313635	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of METAP1 mRNA; Nanotubes, Carbon results in increased expression of METAP1 mRNA	PMID:25554681
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305545	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of METAP1 mRNA	PMID:23962444
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305545	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of METAP1 mRNA	PMID:30047161
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305545	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of METAP1 mRNA	PMID:24136188
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of METAP1 protein	PMID:34186270
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313635	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of METAP1 mRNA	PMID:22206623
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313635	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of METAP1 mRNA]	PMID:22206623
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of METAP1 protein	PMID:37664457
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to METAP1 gene]	PMID:28238834
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305545	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of METAP1 mRNA	PMID:30047161
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of METAP1 protein	PMID:37664457
1313634	METAP1	methionyl aminopeptidase 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305545	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of METAP1 mRNA	PMID:19015723
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:15368	acrolein	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D000171	Acrolein results in decreased expression of ANAPC2 mRNA	PMID:26719373
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313637	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ANAPC2 mRNA	PMID:30319688
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ANAPC2 mRNA	PMID:39241906
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313637	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ANAPC2 mRNA	PMID:39298647
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ANAPC2 protein	PMID:37730182
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305546	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ANAPC2 mRNA	PMID:22061828
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of ANAPC2 intron	PMID:30157460
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ANAPC2 intron	PMID:30157460
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313637	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ANAPC2 mRNA	PMID:22206623
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313637	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANAPC2 mRNA	PMID:40504410
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ANAPC2 mRNA	PMID:19244175
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ANAPC2 protein	PMID:35688186
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of ANAPC2 mRNA	PMID:19921347
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313637	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ANAPC2 mRNA	PMID:21570461
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ANAPC2 mRNA	PMID:33212167
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ANAPC2 mRNA	PMID:30911355
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ANAPC2 mRNA	PMID:27862939
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:D004317	Doxorubicin promotes the reaction [CCAR1 protein binds to ANAPC2 protein]	PMID:21903591
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ANAPC2 protein	PMID:35688186
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ANAPC2 mRNA	PMID:16014739
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ANAPC2 mRNA	PMID:39719251
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313637	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANAPC2 mRNA	PMID:40504410
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ANAPC2 mRNA	PMID:30911355
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:3016	Benoxacor	increases expression	ISO	RGD:1313637	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in increased expression of ANAPC2 mRNA	PMID:34850242
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ANAPC2 gene	PMID:31601247
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ANAPC2 gene	PMID:31601247
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313637	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ANAPC2 gene	PMID:35295148
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ANAPC2 mRNA	PMID:18648102
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A affects the expression of ANAPC2 mRNA	PMID:35628146
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305546	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ANAPC2 mRNA	PMID:25181051|PMID:30816183
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313637	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ANAPC2 gene	PMID:31683443
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313637	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ANAPC2 mRNA	PMID:39298647
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ANAPC2 intron	PMID:30157460
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ANAPC2 gene	PMID:31601247
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ANAPC2 mRNA	PMID:34813904
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ANAPC2 mRNA	PMID:34813904
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:34892	nocodazole	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:D015739	Nocodazole promotes the reaction [CCAR1 protein binds to ANAPC2 protein]	PMID:21903591
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ANAPC2 mRNA	PMID:37042841
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of ANAPC2 mRNA	PMID:19376846
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ANAPC2 mRNA	PMID:19244175
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ANAPC2 mRNA	PMID:31533062
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ANAPC2 gene	PMID:29154799
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305546	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ANAPC2 mRNA	PMID:33387578
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313637	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANAPC2 mRNA	PMID:40504410
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:4744	Echimidine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C000615871	[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of ANAPC2 mRNA	PMID:33884520
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305546	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ANAPC2 mRNA	PMID:24136188
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313637	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ANAPC2 mRNA	PMID:35964746
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ANAPC2 protein	PMID:32959892
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:6382	Lasiocarpine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ANAPC2 mRNA	PMID:33884520
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ANAPC2 intron	PMID:30157460
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:6980	monocrotaline	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of ANAPC2 mRNA	PMID:33884520
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313637	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ANAPC2 mRNA	PMID:22206623
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313637	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ANAPC2 mRNA	PMID:22206623
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1313637	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of ANAPC2 mRNA	PMID:22538082
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1313637	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of ANAPC2 protein	PMID:35357534
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305546	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ANAPC2 mRNA	PMID:21346803
1313636	ANAPC2	anaphase promoting complex subunit 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305546	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ANAPC2 mRNA	PMID:21346803
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552231	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of STAC2 mRNA	PMID:37995155
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of STAC2 mRNA	PMID:34925699
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552231	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of STAC2 mRNA	PMID:20188158
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of STAC2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of STAC2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of STAC2 gene	PMID:20938992
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1552231	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of STAC2 mRNA	PMID:36189433
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of STAC2 mRNA	PMID:36189433
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of STAC2 mRNA	PMID:26079696
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552231	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of STAC2 mRNA	PMID:30319688
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552231	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of STAC2 mRNA	PMID:30319688
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of STAC2 mRNA	PMID:35811015
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of STAC2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of STAC2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of STAC2 gene	PMID:20938992
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of STAC2 mRNA	PMID:26079696
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STAC2 mRNA	PMID:37567420
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of STAC2 mRNA	PMID:36189433
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STAC2 mRNA	PMID:37567420
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305548	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of STAC2 mRNA	PMID:33387578
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of STAC2 mRNA	PMID:24376830
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of STAC2 mRNA	PMID:19549813
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of STAC2 mRNA	PMID:22100608|PMID:32234424
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:2666	amitriptyline	increases expression	ISO	RGD:1305548	E	RGD:6480464	20130416	CTD	MESH:D000639	Amitriptyline results in increased expression of STAC2 mRNA	PMID:22341215
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305548	E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of STAC2 mRNA	PMID:30723492
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of STAC2; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of STAC2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of STAC2 gene	PMID:20938992
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552231	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of STAC2 mRNA	PMID:28189721|PMID:28960355
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of STAC2 promoter	PMID:22847954
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of STAC2 mRNA	PMID:25583101
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305548	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of STAC2 mRNA	PMID:33387578
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of STAC2 mRNA	PMID:29955902
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STAC2 mRNA	PMID:37567420
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of STAC2 mRNA	PMID:22378314
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STAC2 promoter	PMID:27901495
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of STAC2 mRNA	PMID:25895662
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1552231	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of STAC2 mRNA	PMID:29203145|PMID:38811393
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of STAC2 mRNA	PMID:37690743
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of STAC2 mRNA	PMID:38568856
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552231	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STAC2 gene	PMID:35295148
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552231	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of STAC2 gene	PMID:35295148
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305548	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of STAC2 mRNA	PMID:19167457
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305548	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of STAC2 mRNA	PMID:34947998
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305548	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of STAC2 mRNA	PMID:25181051
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552231	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of STAC2 mRNA	PMID:32156529
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305548	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of STAC2 mRNA	PMID:32680482
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305548	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of STAC2 mRNA	PMID:30723492
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1305548	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of STAC2 mRNA	PMID:35163327
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1552231	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of STAC2 mRNA	PMID:28962523
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of STAC2 promoter	PMID:22847954
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of STAC2 promoter	PMID:22847954
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of STAC2 mRNA	PMID:31626844
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of STAC2 mRNA	PMID:40419075
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1552231	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of STAC2 mRNA	PMID:21427059
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STAC2 mRNA	PMID:37567420
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of STAC2 mRNA	PMID:38832940
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of STAC2 mRNA	PMID:29067470
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305548	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of STAC2 mRNA	PMID:33387578
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of STAC2 mRNA	PMID:35811015
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of STAC2 mRNA	PMID:31838189
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of STAC2 mRNA	PMID:38568856
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552231	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of STAC2 mRNA; Nanotubes, Carbon results in increased expression of STAC2 mRNA	PMID:25554681
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of STAC2 mRNA	PMID:35964746
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552231	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of STAC2 mRNA	PMID:38701926
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STAC2 mRNA	PMID:26378955
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of STAC2 mRNA	PMID:24810058
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1552231	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of STAC2 mRNA	PMID:37567420
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of STAC2 mRNA	PMID:36318118
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in decreased expression of STAC2 mRNA	PMID:19084549
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of STAC2 mRNA	PMID:26079696
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1552231	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of STAC2 mRNA	PMID:39847705
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305548	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of STAC2 mRNA	PMID:24780913
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305548	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of STAC2 mRNA	PMID:19281266
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of STAC2 mRNA	PMID:38568856
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305548	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of STAC2 mRNA	PMID:19015723
1313639	STAC2	SH3 and cysteine rich domain 2	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305548	E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of STAC2 mRNA	PMID:22615374
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305549	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of MS4A7 mRNA	PMID:25152437
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305549	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of MS4A7 mRNA	PMID:21551480
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552232	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MS4A7 mRNA	PMID:37995155
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MS4A7 mRNA	PMID:20938992
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of MS4A7 mRNA	PMID:24205000
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305549	E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MS4A7 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MS4A7 mRNA	PMID:33729688
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552232	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of MS4A7 mRNA	PMID:19484750
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305549	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A7 mRNA	PMID:32741896
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305549	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MS4A7 mRNA	PMID:33387578
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MS4A7 mRNA	PMID:20938992
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of MS4A7 mRNA	PMID:26079696
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA	PMID:37992649
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1552232	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of MS4A7 mRNA	PMID:33848595
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305549	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A7 mRNA	PMID:32741896
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of MS4A7 mRNA]	PMID:33848595
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA	PMID:37992649
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of MS4A7 mRNA	PMID:26485663
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:1305549	E	RGD:6480464	20120814	CTD	MESH:D007501	Iron deficiency results in increased expression of MS4A7 mRNA	PMID:16629162
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:194147	aristolochic acids	increases expression	ISO	RGD:1305549	E	RGD:6480464	20230103	CTD	MESH:D034341	Aristolochic Acids results in increased expression of MS4A7 mRNA	PMID:21834575
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MS4A7 mRNA	PMID:23649840
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MS4A7 gene	PMID:27153756
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MS4A7 mRNA	PMID:23649840
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MS4A7 mRNA	PMID:34911549
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552232	E	RGD:6480464	20181016	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MS4A7 mRNA	PMID:29987408|PMID:31919559
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MS4A7 mRNA	PMID:20938992
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MS4A7 mRNA	PMID:40504410
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA]	PMID:37992649
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of MS4A7 mRNA	PMID:28960355
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305549	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MS4A7 mRNA	PMID:31881176
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of MS4A7 mRNA	PMID:23195993
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MS4A7 mRNA	PMID:24768652|PMID:25583101
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305549	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MS4A7 mRNA	PMID:34747641
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552232	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MS4A7 mRNA	PMID:21570461|PMID:26377647
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305549	E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MS4A7 mRNA	PMID:26232522|PMID:32109520
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of MS4A7 mRNA	PMID:39631538
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA	PMID:37992649
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA]	PMID:37992649
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MS4A7 mRNA	PMID:40504410
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MS4A7 mRNA	PMID:20064835
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552232	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MS4A7 mRNA	PMID:22228805|PMID:23735875
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MS4A7 promoter	PMID:27901495
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MS4A7 mRNA]	PMID:22228805
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1552232	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MS4A7 mRNA	PMID:29341224|PMID:38811393
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305549	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of MS4A7 mRNA	PMID:25729387
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305549	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of MS4A7 mRNA	PMID:25729387
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of MS4A7 mRNA	PMID:29264374
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1305549	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of MS4A7 mRNA	PMID:30012374
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552232	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MS4A7 mRNA	PMID:19464567|PMID:21259345|PMID:23557971|PMID:27760801
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552232	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MS4A7 mRNA	PMID:23811191
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305549	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MS4A7 mRNA	PMID:25181051
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of MS4A7 mRNA	PMID:25594700
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1305549	E	RGD:6480464	20170613	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MS4A7 mRNA	PMID:28300664
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1552232	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of MS4A7 mRNA	PMID:26682919
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305549	E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of MS4A7 mRNA	PMID:32119087
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to MS4A7 promoter]	PMID:20348232
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1552232	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MS4A7 mRNA	PMID:26377693
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:34709	Diisodecyl phthalate	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20150127	CTD	MESH:C042080	diisodecyl phthalate results in decreased expression of MS4A7 mRNA	PMID:25270620
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of MS4A7 mRNA	PMID:17374397
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305549	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of MS4A7 mRNA	PMID:27387713
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MS4A7 mRNA	PMID:24449571
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1552232	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of MS4A7 mRNA	PMID:28973697
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MS4A7 mRNA	PMID:37992649
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of MS4A7 mRNA	PMID:23649840
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552232	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MS4A7 mRNA	PMID:17562736
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305549	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MS4A7 mRNA	PMID:33387578
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552232	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MS4A7 mRNA	PMID:40504410
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:4917	eugenol	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D005054	Eugenol results in increased expression of MS4A7 mRNA	PMID:17374397
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1305549	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of MS4A7 mRNA	PMID:30307764
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552232	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MS4A7 mRNA; Nanotubes, Carbon results in increased expression of MS4A7 mRNA	PMID:25554681
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C029938	nickel sulfate results in increased expression of MS4A7 mRNA	PMID:16780908|PMID:17374397
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552232	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MS4A7 mRNA	PMID:38701926
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:63613	nevirapine	decreases expression	ISO	RGD:1305549	E	RGD:6480464	20140114	CTD	MESH:D019829	Nevirapine results in decreased expression of MS4A7 mRNA	PMID:23947594
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305549	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of MS4A7 mRNA	PMID:25729387
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305549	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of MS4A7 mRNA	PMID:25729387
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1552232	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of MS4A7 mRNA	PMID:23650126
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:6925	microcystin-LR	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of MS4A7 mRNA	PMID:29518473
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305549	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MS4A7 mRNA	PMID:32741896
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MS4A7 gene]	PMID:28238834
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1552232	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of MS4A7 mRNA	PMID:38648751
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:8228	pioglitazone	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C060836	Pioglitazone results in increased expression of MS4A7 mRNA	PMID:30031879
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:1305549	E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of MS4A7 mRNA	PMID:16629162
1313641	MS4A7	membrane spanning 4-domains A7	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552232	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MS4A7 mRNA	PMID:39847705
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPS15 mRNA	PMID:20938992
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of EPS15 mRNA	PMID:26079696
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of EPS15 mRNA	PMID:21632981
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EPS15 mRNA	PMID:21370964
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	coenzyme Q10 inhibits the reaction [Lipopolysaccharides results in increased expression of EPS15 mRNA]	PMID:21370964
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313643	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EPS15 mRNA	PMID:39298647
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPS15 mRNA	PMID:20938992
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of EPS15 mRNA	PMID:23649840
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:17574	biochanin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004541	biochanin A results in decreased expression of EPS15 mRNA	PMID:12111696
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305550	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of EPS15 mRNA	PMID:27523638
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of EPS15 protein	PMID:37730182
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305550	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of EPS15 mRNA	PMID:22061828|PMID:33387578
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305550	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of EPS15 protein	PMID:34915118
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of EPS15 mRNA	PMID:19549813
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EPS15 protein	PMID:23301498
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EPS15 gene	PMID:27153756
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27214	uranium atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014501	Uranium affects the expression of EPS15 mRNA	PMID:15672453
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313643	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EPS15 mRNA	PMID:27339419
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EPS15 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPS15 mRNA	PMID:20938992|PMID:22206623
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EPS15 mRNA	PMID:40504410
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of EPS15 protein	PMID:35688186
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of EPS15 mRNA	PMID:12002526
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313643	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of EPS15 mRNA	PMID:30912803
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313643	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EPS15 mRNA	PMID:21570461|PMID:24680724
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPS15 mRNA	PMID:12377990
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305550	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPS15 mRNA	PMID:33387578|PMID:34747641
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305550	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPS15 mRNA	PMID:32109520
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:28177	theophylline	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in decreased expression of EPS15 mRNA	PMID:18951874
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EPS15 mRNA	PMID:33212167
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of EPS15 mRNA	PMID:32763439
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313643	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased expression of EPS15 mRNA	PMID:32068019
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EPS15 mRNA	PMID:40504410
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EPS15 promoter	PMID:27901495
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313643	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EPS15 mRNA	PMID:22228805
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:29866	arsenite(3-)	decreases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased methylation of EPS15 promoter	PMID:23974009
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313643	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EPS15 gene; titanium dioxide results in decreased methylation of EPS15 promoter	PMID:35295148
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313643	E	RGD:6480464	20150127	CTD	MESH:C006253	pirinixic acid results in increased expression of EPS15 mRNA	PMID:25270620
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of EPS15 mRNA	PMID:12419474
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of EPS15 protein	PMID:31675489|PMID:34186270
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305550	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of EPS15 mRNA	PMID:30816183
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of EPS15 gene	PMID:31601247
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313643	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of EPS15 promoter	PMID:27312807
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305550	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of EPS15 mRNA	PMID:29097150|PMID:32145629
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313643	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of EPS15 mRNA	PMID:33221593
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of EPS15 protein	PMID:31675489
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of EPS15 mRNA	PMID:25979313
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to EPS15 promoter]	PMID:20348232
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313643	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EPS15 mRNA	PMID:39298647
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313643	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of EPS15 mRNA	PMID:37019170
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313643	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EPS15 mRNA	PMID:21266533
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305550	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of EPS15 mRNA	PMID:18164116
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of EPS15 mRNA]	PMID:19030233
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EPS15 mRNA	PMID:37042841
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305550	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of EPS15 mRNA	PMID:30589522
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EPS15 mRNA	PMID:25979313
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of EPS15 mRNA	PMID:29154799
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of EPS15 mRNA	PMID:25562108
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of EPS15 mRNA	PMID:33512557
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313643	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EPS15 mRNA	PMID:17562736
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305550	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EPS15 mRNA	PMID:33387578
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:46245	coenzyme Q10	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C024989	coenzyme Q10 inhibits the reaction [Lipopolysaccharides results in increased expression of EPS15 mRNA]	PMID:21370964
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EPS15 mRNA	PMID:40504410
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:4775	ellagic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004610	Ellagic Acid results in increased expression of EPS15 mRNA	PMID:12002526
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305550	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EPS15 mRNA	PMID:29097150
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:49668	gefitinib	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C419708	gefitinib results in increased expression of EPS15 mRNA	PMID:16685379
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305550	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of EPS15 mRNA	PMID:24136188
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EPS15 protein	PMID:32959892
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EPS15 mRNA	PMID:26378955
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305550	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of EPS15 mRNA	PMID:30467583
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305550	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of EPS15 gene	PMID:35440735
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of EPS15 protein	PMID:34186270
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313643	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EPS15 mRNA	PMID:22206623
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313643	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EPS15 mRNA	PMID:22206623
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1305550	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of EPS15 mRNA	PMID:18164116
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EPS15 gene]	PMID:28238834
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313643	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of EPS15 mRNA	PMID:23091169
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313643	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of EPS15 mRNA	PMID:31388691
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of EPS15 protein	PMID:31675489
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of EPS15 mRNA	PMID:33512557
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1305550	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of EPS15 protein	PMID:28903499
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of EPS15 protein	PMID:31675489
1313642	EPS15	epidermal growth factor receptor pathway substrate 15	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305550	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EPS15 mRNA	PMID:24780913
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:10106	zearalenone	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D015025	Zearalenone results in decreased expression of RASSF2 mRNA	PMID:36828454
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313645	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of RASSF2 mRNA	PMID:37995155
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313645	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RASSF2 mRNA	PMID:20188158
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASSF2 gene	PMID:20938992
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of RASSF2 mRNA	PMID:23724009
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of RASSF2 mRNA	PMID:16788091
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of RASSF2 mRNA	PMID:23830798|PMID:33167477
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313645	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RASSF2 mRNA	PMID:30319688
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RASSF2 mRNA	PMID:39241906
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of RASSF2 mRNA	PMID:31614463|PMID:36828454
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305551	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RASSF2 mRNA	PMID:33387578
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASSF2 gene	PMID:20938992
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of RASSF2 mRNA	PMID:19162166
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of RASSF2 mRNA	PMID:26079696
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASSF2 mRNA	PMID:37992649
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:174733	Licochalcone B	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of RASSF2 mRNA	PMID:33647349
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASSF2 mRNA	PMID:37992649
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RASSF2 mRNA	PMID:34319233
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of RASSF2 protein	PMID:37730182
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305551	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RASSF2 mRNA	PMID:33387578
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RASSF2 mRNA	PMID:28818685
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of RASSF2 intron	PMID:30157460
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RASSF2 mRNA	PMID:19549813
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RASSF2 intron	PMID:30157460
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RASSF2 mRNA	PMID:22100608
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RASSF2 mRNA	PMID:26035830|PMID:41430723
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RASSF2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASSF2 gene	PMID:20938992|PMID:22206623
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RASSF2 mRNA	PMID:40504410
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RASSF2 mRNA	PMID:28960355
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305551	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RASSF2 mRNA	PMID:31881176
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RASSF2 mRNA	PMID:23557933
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RASSF2 mRNA	PMID:30912803
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1305551	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of RASSF2 mRNA	PMID:12075121
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RASSF2 mRNA	PMID:25583101
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313645	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASSF2 mRNA	PMID:26377647
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305551	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RASSF2 mRNA	PMID:32109520|PMID:33387578
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305551	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RASSF2 mRNA	PMID:34747641
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to RASSF2 promoter]	PMID:19654925
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RASSF2 mRNA	PMID:33212167
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:28680	cytarabine	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in increased expression of RASSF2 mRNA	PMID:21198554
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASSF2 mRNA	PMID:37992649
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of RASSF2 mRNA	PMID:39515575
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RASSF2 mRNA	PMID:38568856
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RASSF2 mRNA	PMID:40504410
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RASSF2 3' UTR; Benzo(a)pyrene affects the methylation of RASSF2 5' UTR	PMID:27901495
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RASSF2 mRNA; Benzo(a)pyrene results in increased expression of RASSF2 mRNA alternative form	PMID:25690898|PMID:32234424
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RASSF2 promoter	PMID:27901495
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of RASSF2 gene	PMID:25435355
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of RASSF2 mRNA	PMID:18929588
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RASSF2 mRNA]	PMID:32406909
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RASSF2 mRNA	PMID:19073995
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305551	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RASSF2 mRNA	PMID:30047161
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305551	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RASSF2 mRNA	PMID:34492290
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RASSF2 mRNA	PMID:17950772
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20120412	CTD	MESH:C006253	NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of RASSF2 mRNA]	PMID:17950772
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of RASSF2 mRNA	PMID:19191707
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305551	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RASSF2 mRNA	PMID:25181051
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of RASSF2 mRNA	PMID:36828454
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of RASSF2 mRNA	PMID:26063408
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RASSF2 gene	PMID:31601247
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305551	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of RASSF2 mRNA	PMID:12075121
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of RASSF2 mRNA	PMID:36804509
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of RASSF2 mRNA	PMID:40203079
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RASSF2 intron	PMID:30157460
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313645	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RASSF2 intron	PMID:28392331
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RASSF2 mRNA	PMID:37042841
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	decreases methylation	ISO	RGD:1313645	E	RGD:6480464	20200714	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in decreased methylation of RASSF2 gene	PMID:32135139
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20200714	CTD	MESH:D013755	corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased methylation of RASSF2 gene]	PMID:32135139
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RASSF2 mRNA	PMID:31533062
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RASSF2 mRNA	PMID:40419075
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:3962	curcumin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in increased expression of RASSF2 mRNA	PMID:17198877
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of RASSF2 mRNA	PMID:28001369
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of RASSF2 mRNA	PMID:19101580|PMID:24935251|PMID:29154799
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RASSF2 gene	PMID:29154799
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305551	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RASSF2 mRNA	PMID:30047161
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of RASSF2 mRNA	PMID:27989131
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RASSF2 mRNA	PMID:37992649
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RASSF2 mRNA	PMID:38832940
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of RASSF2 mRNA	PMID:26272509
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RASSF2 mRNA	PMID:24935251
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASSF2 mRNA	PMID:27188386
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313645	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RASSF2 mRNA	PMID:17562736
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305551	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RASSF2 mRNA	PMID:33387578
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RASSF2 mRNA	PMID:40504410
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of RASSF2 mRNA	PMID:31838189
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305551	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RASSF2 mRNA	PMID:29391264
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305551	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RASSF2 mRNA	PMID:12075121
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D007213	Indomethacin results in increased expression of RASSF2 mRNA	PMID:24737281
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of RASSF2 mRNA	PMID:38825487
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of RASSF2 mRNA	PMID:17013896
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305551	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RASSF2 mRNA	PMID:30047161
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RASSF2 mRNA	PMID:35964746
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313645	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RASSF2 mRNA	PMID:38701926
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of RASSF2 mRNA	PMID:20436886
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305551	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of RASSF2 mRNA	PMID:20080153
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASSF2 mRNA	PMID:21641980
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of RASSF2 mRNA	PMID:28988120
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:67895	corosolic acid	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20200714	CTD	MESH:C113861	corosolic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased methylation of RASSF2 gene]	PMID:32135139
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of RASSF2 intron	PMID:30157460
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RASSF2 mRNA	PMID:31758290
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313645	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of RASSF2 mRNA	PMID:22206623
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313645	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RASSF2 mRNA	PMID:22206623
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASSF2 mRNA	PMID:27188386
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RASSF2 gene]	PMID:28238834
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of RASSF2 mRNA	PMID:26079696
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305551	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RASSF2 mRNA	PMID:24780913|PMID:30047161
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASSF2 mRNA	PMID:27188386
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of RASSF2 mRNA	PMID:29301935
1313644	RASSF2	Ras association domain family member 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313645	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of RASSF2 mRNA	PMID:17569031
1313646	MED8	mediator complex subunit 8	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MED8 mRNA	PMID:38218311
1313646	MED8	mediator complex subunit 8	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MED8 mRNA	PMID:33045310
1313646	MED8	mediator complex subunit 8	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614251	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MED8 mRNA	PMID:39241906
1313646	MED8	mediator complex subunit 8	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1614251	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MED8 mRNA	PMID:39298647
1313646	MED8	mediator complex subunit 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MED8 mRNA	PMID:37042841
1313646	MED8	mediator complex subunit 8	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MED8 mRNA	PMID:39836092
1313646	MED8	mediator complex subunit 8	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MED8 mRNA	PMID:23649840
1313646	MED8	mediator complex subunit 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305552	E	RGD:6480464	20211221	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MED8 mRNA	PMID:33387578
1313646	MED8	mediator complex subunit 8	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MED8 mRNA	PMID:39836092
1313646	MED8	mediator complex subunit 8	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MED8 mRNA	PMID:23557933
1313646	MED8	mediator complex subunit 8	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of MED8 mRNA	PMID:34813904
1313646	MED8	mediator complex subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614251	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MED8 mRNA	PMID:21570461|PMID:24680724
1313646	MED8	mediator complex subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305552	E	RGD:6480464	20211221	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MED8 mRNA	PMID:21215274|PMID:33387578
1313646	MED8	mediator complex subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MED8 mRNA	PMID:29704546
1313646	MED8	mediator complex subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of MED8 mRNA	PMID:29704546
1313646	MED8	mediator complex subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1305552	E	RGD:6480464	20211221	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of MED8 mRNA]	PMID:21215274
1313646	MED8	mediator complex subunit 8	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MED8 mRNA	PMID:32763439
1313646	MED8	mediator complex subunit 8	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MED8 mRNA	PMID:29803840
1313646	MED8	mediator complex subunit 8	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MED8 mRNA	PMID:38568856
1313646	MED8	mediator complex subunit 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MED8 mRNA	PMID:39836092
1313646	MED8	mediator complex subunit 8	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of MED8 mRNA	PMID:22378314
1313646	MED8	mediator complex subunit 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614251	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MED8 mRNA	PMID:22228805
1313646	MED8	mediator complex subunit 8	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of MED8 mRNA	PMID:25895662
1313646	MED8	mediator complex subunit 8	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MED8 mRNA	PMID:20382639
1313646	MED8	mediator complex subunit 8	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of MED8 mRNA	PMID:29264374
1313646	MED8	mediator complex subunit 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614251	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MED8 gene	PMID:35295148
1313646	MED8	mediator complex subunit 8	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of MED8 mRNA	PMID:20170705
1313646	MED8	mediator complex subunit 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MED8 mRNA	PMID:33221593
1313646	MED8	mediator complex subunit 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305552	E	RGD:6480464	20211221	CTD	MESH:C006780	bisphenol A results in increased expression of MED8 mRNA	PMID:25181051
1313646	MED8	mediator complex subunit 8	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305552	E	RGD:6480464	20211221	CTD	MESH:C006780	bisphenol A results in increased methylation of MED8 gene	PMID:28505145
1313646	MED8	mediator complex subunit 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1614251	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MED8 mRNA	PMID:39298647
1313646	MED8	mediator complex subunit 8	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MED8 mRNA	PMID:17361019
1313646	MED8	mediator complex subunit 8	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MED8 mRNA	PMID:34813904
1313646	MED8	mediator complex subunit 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MED8 mRNA	PMID:37042841
1313646	MED8	mediator complex subunit 8	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MED8 mRNA	PMID:39836092
1313646	MED8	mediator complex subunit 8	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MED8 mRNA	PMID:38174414|PMID:38568856
1313646	MED8	mediator complex subunit 8	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MED8 mRNA	PMID:28302478
1313646	MED8	mediator complex subunit 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MED8 mRNA	PMID:40419075
1313646	MED8	mediator complex subunit 8	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MED8 mRNA	PMID:25979313
1313646	MED8	mediator complex subunit 8	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MED8 mRNA	PMID:23179753
1313646	MED8	mediator complex subunit 8	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of MED8 mRNA	PMID:17183730
1313646	MED8	mediator complex subunit 8	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MED8 mRNA	PMID:20106945|PMID:27989131
1313646	MED8	mediator complex subunit 8	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305552	E	RGD:6480464	20211221	CTD	MESH:D000082	Acetaminophen results in decreased expression of MED8 mRNA	PMID:33387578
1313646	MED8	mediator complex subunit 8	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1614251	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MED8 mRNA	PMID:29279043
1313646	MED8	mediator complex subunit 8	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MED8 mRNA	PMID:39836092
1313646	MED8	mediator complex subunit 8	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305552	E	RGD:6480464	20211221	CTD	MESH:D004726	Endosulfan results in increased expression of MED8 mRNA	PMID:29391264
1313646	MED8	mediator complex subunit 8	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MED8 mRNA	PMID:20170705
1313646	MED8	mediator complex subunit 8	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305552	E	RGD:6480464	20211221	CTD	MESH:D005485	Flutamide results in increased expression of MED8 mRNA	PMID:24136188
1313646	MED8	mediator complex subunit 8	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of MED8 mRNA	PMID:17183730
1313646	MED8	mediator complex subunit 8	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of MED8 mRNA	PMID:20436886
1313646	MED8	mediator complex subunit 8	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MED8 mRNA	PMID:39836092
1313646	MED8	mediator complex subunit 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1614251	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MED8 mRNA	PMID:22206623
1313646	MED8	mediator complex subunit 8	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MED8 protein	PMID:31285264
1313646	MED8	mediator complex subunit 8	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of MED8 mRNA	PMID:17440010
1313646	MED8	mediator complex subunit 8	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MED8 mRNA	PMID:38568856
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1617498	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PTAR1 mRNA	PMID:20938992
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PTAR1 mRNA	PMID:23724009
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1617498	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PTAR1 mRNA	PMID:30319688
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:16240	hydrogen peroxide	increases secretion	ISO	RGD:1617498	E	RGD:6480464	20121218	CTD	MESH:D006861	Hydrogen Peroxide results in increased secretion of PTAR1 mRNA	PMID:21179422
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1617498	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PTAR1 mRNA	PMID:20938992
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PTAR1 mRNA	PMID:37042841
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PTAR1 mRNA	PMID:28818685
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PTAR1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of PTAR1 mRNA	PMID:39836092
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1617498	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PTAR1 mRNA	PMID:37236586
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:708369	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of PTAR1 mRNA	PMID:21396975
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PTAR1 mRNA	PMID:23649840
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1617498	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PTAR1 mRNA	PMID:25629700
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1617498	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PTAR1 mRNA	PMID:20938992
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PTAR1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PTAR1 mRNA	PMID:39836092
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:27656	camptothecin	decreases response to substance	EXP		E	RGD:6480464	20160315	CTD	MESH:D002166	PTAR1 mRNA results in decreased susceptibility to Camptothecin	PMID:25269479
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PTAR1 mRNA	PMID:26272509
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTAR1 mRNA	PMID:27188386
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of PTAR1 protein	PMID:39603559
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PTAR1 mRNA	PMID:33212167
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PTAR1 mRNA	PMID:29803840
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PTAR1 mRNA	PMID:38568856
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PTAR1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PTAR1 mRNA	PMID:39836092
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1617498	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PTAR1 gene	PMID:35295148
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:708369	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PTAR1 mRNA	PMID:34492290
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:708369	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PTAR1 mRNA	PMID:34947998
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:708369	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PTAR1 mRNA	PMID:25181051
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PTAR1 mRNA	PMID:37042841
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PTAR1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of PTAR1 mRNA	PMID:39836092
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1617498	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PTAR1 mRNA	PMID:37236586
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PTAR1 mRNA	PMID:31533062
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:708369	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PTAR1 mRNA	PMID:29427782
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PTAR1 mRNA	PMID:23179753|PMID:27188386
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:708369	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of PTAR1 mRNA	PMID:29427782
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PTAR1 gene	PMID:29154799
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PTAR1 mRNA	PMID:26272509
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTAR1 mRNA	PMID:27188386
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1617498	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PTAR1 mRNA	PMID:17562736
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PTAR1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PTAR1 mRNA	PMID:39836092
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of PTAR1 mRNA	PMID:23228038
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1617498	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PTAR1 mRNA	PMID:25620056
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of PTAR1 mRNA	PMID:26705709
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PTAR1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of PTAR1 mRNA	PMID:39836092
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PTAR1 mRNA	PMID:31758290
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTAR1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTAR1 mRNA	PMID:27188386
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:708369	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PTAR1 mRNA	PMID:32109520
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:708369	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of PTAR1 mRNA	PMID:23640034
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1617498	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of PTAR1 mRNA	PMID:21795629
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:708369	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PTAR1 mRNA	PMID:24780913
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PTAR1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTAR1 mRNA	PMID:27188386
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:708369	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PTAR1 mRNA	PMID:21346803
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PTAR1 mRNA	PMID:38568856
1313649	PTAR1	protein prenyltransferase alpha subunit repeat containing 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:708369	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PTAR1 mRNA	PMID:23034163
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NELFA mRNA	PMID:38218311
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of NELFA mRNA	PMID:38218311
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NELFA gene	PMID:20938992
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NELFA mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of NELFA mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NELFA mRNA	PMID:32699268|PMID:32845096
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313652	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of NELFA mRNA	PMID:30319688
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NELFA gene	PMID:20938992
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NELFA mRNA	PMID:37042841
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NELFA protein	PMID:37730182
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305556	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of NELFA mRNA	PMID:22061828
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of NELFA intron	PMID:30157460
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313652	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of NELFA mRNA	PMID:24067728
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D002104	Cadmium results in increased expression of NELFA mRNA	PMID:24376830
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of NELFA protein	PMID:23301498
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NELFA intron	PMID:30157460
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NELFA mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of NELFA mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NELFA mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of NELFA mRNA	PMID:32699268|PMID:32845096
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NELFA gene	PMID:20938992
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic affects the methylation of NELFA gene	PMID:25304211
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of NELFA mRNA	PMID:19244175
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of NELFA mRNA	PMID:19244175
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of NELFA protein	PMID:35688186
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of NELFA mRNA	PMID:23557933
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313652	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NELFA mRNA	PMID:21570461
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305556	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NELFA mRNA	PMID:33387578
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NELFA mRNA	PMID:17942748
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305556	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of NELFA mRNA	PMID:19013527
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of NELFA protein	PMID:35688186
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NELFA intron	PMID:30157460
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20240702	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NELFA promoter	PMID:27901495
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NELFA gene	PMID:31601247
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313652	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of NELFA mRNA	PMID:21829687
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313652	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of NELFA mRNA	PMID:29264374
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313652	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NELFA gene; titanium dioxide results in decreased methylation of NELFA promoter	PMID:35295148
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NELFA protein	PMID:33376534
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305556	E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in increased expression of NELFA mRNA	PMID:25181051
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NELFA gene; [ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of NELFA protein]; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NELFA mRNA	PMID:28628672|PMID:31601247|PMID:33376534
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of NELFA mRNA	PMID:19244175
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313652	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NELFA mRNA	PMID:39298647
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of NELFA intron	PMID:30157460
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313652	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NELFA mRNA	PMID:37019170
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305556	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NELFA mRNA	PMID:21266533
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NELFA mRNA	PMID:28628672
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of NELFA mRNA	PMID:24449571
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NELFA mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NELFA mRNA	PMID:32699268
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of NELFA mRNA	PMID:19244175
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of NELFA mRNA	PMID:19244175
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of NELFA mRNA	PMID:31533062
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NELFA mRNA	PMID:25979313
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NELFA gene	PMID:29154799
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D016572	Cyclosporine results in increased expression of NELFA mRNA	PMID:25562108
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of NELFA mRNA	PMID:16144937
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NELFA mRNA	PMID:28628672
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313652	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of NELFA mRNA	PMID:18502557
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150714	CTD	MESH:D001151	Arsenic affects the methylation of NELFA gene	PMID:25304211
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:47344	alvocidib	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20170303	CTD	MESH:C077990	alvocidib inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to IFIT1 promoter]]; alvocidib inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to ISG15 promoter]]; alvocidib inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to MX1 promoter]]	PMID:23589332
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of NELFA mRNA	PMID:18175754
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313652	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NELFA mRNA	PMID:17942748
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NELFA mRNA	PMID:17942748
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NELFA mRNA	PMID:28628672
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:49852	5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole	multiple interactions	ISO	RGD:1313652	E	RGD:6480464	20250107	CTD	MESH:D004004	Dichlororibofuranosylbenzimidazole inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to IFIT1 promoter]]; Dichlororibofuranosylbenzimidazole inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to ISG15 promoter]]; Dichlororibofuranosylbenzimidazole inhibits the reaction [IFNB1 protein promotes the reaction [NELFA protein binds to MX1 promoter]]	PMID:23589332
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NELFA protein	PMID:32959892
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of NELFA intron	PMID:30157460
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313652	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of NELFA mRNA	PMID:19270015
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:8107	phenytoin	decreases expression	ISO	RGD:1305556	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in decreased expression of NELFA mRNA	PMID:20345932
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:81543	Tributyltin oxide	increases phosphorylation	ISO	RGD:1313652	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased phosphorylation of NELFA protein	PMID:22174045
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305556	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of NELFA mRNA	PMID:19281266
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305556	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NELFA mRNA	PMID:21346803
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of NELFA mRNA	PMID:29301935
1313651	NELFA	negative elongation factor complex member A	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305556	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of NELFA mRNA	PMID:21346803
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313654	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TMEM59L mRNA	PMID:33045310
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313654	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TMEM59L mRNA	PMID:20188158
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1305557	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of TMEM59L mRNA	PMID:20488242
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313654	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of TMEM59L mRNA	PMID:36189433
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313654	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TMEM59L mRNA	PMID:36189433
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of TMEM59L mRNA	PMID:22378314
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313654	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of TMEM59L mRNA	PMID:30319688
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305557	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMEM59L mRNA	PMID:33387578
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313654	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of TMEM59L mRNA	PMID:36189433
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of TMEM59L mRNA	PMID:17103032
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313654	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM59L mRNA	PMID:37325564
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TMEM59L mRNA	PMID:21867686
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TMEM59L gene	PMID:25304211
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TMEM59L mRNA	PMID:28903495
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of TMEM59L promoter	PMID:22847954
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313654	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM59L mRNA	PMID:21570461
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313654	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TMEM59L promoter]	PMID:19654925
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TMEM59L mRNA	PMID:32763439
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TMEM59L promoter	PMID:27901495
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TMEM59L mRNA	PMID:20106945
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TMEM59L mRNA	PMID:22316170
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	TMEM59L protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305557	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TMEM59L mRNA	PMID:30047161
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313654	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMEM59L promoter alternative form	PMID:35295148
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313654	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TMEM59L mRNA	PMID:23557971
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305557	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TMEM59L mRNA	PMID:25181051
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305557	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM59L mRNA	PMID:34947998
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313654	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TMEM59L mRNA	PMID:37019170
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305557	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of TMEM59L mRNA	PMID:32680482
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of TMEM59L mRNA	PMID:29024780
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305557	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of TMEM59L mRNA	PMID:30723492
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TMEM59L mRNA	PMID:38382870
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313654	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM59L mRNA	PMID:37325564
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305557	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of TMEM59L mRNA	PMID:30047161
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of TMEM59L promoter	PMID:22847954
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TMEM59L mRNA	PMID:31533062
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of TMEM59L promoter	PMID:22847954
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of TMEM59L mRNA	PMID:28001369
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305557	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TMEM59L mRNA	PMID:30047161
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:43572	kojic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of TMEM59L mRNA	PMID:16595896
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TMEM59L mRNA	PMID:28542535
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313654	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TMEM59L mRNA	PMID:17562736
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM59L mRNA	PMID:22230336
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TMEM59L gene	PMID:25304211
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	TMEM59L protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305557	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of TMEM59L mRNA	PMID:30307764
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305557	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TMEM59L mRNA	PMID:30047161
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305557	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of TMEM59L mRNA	PMID:28801915
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305557	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TMEM59L mRNA	PMID:28801915
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305557	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TMEM59L mRNA	PMID:30047161
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1305557	E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of TMEM59L mRNA	PMID:29162477
1313653	TMEM59L	transmembrane protein 59 like	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TMEM59L mRNA	PMID:38568856
1313655	TTK	TTK protein kinase	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of TTK mRNA	PMID:31863870
1313655	TTK	TTK protein kinase	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TTK mRNA	PMID:38218311
1313655	TTK	TTK protein kinase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313656	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TTK mRNA	PMID:33045310
1313655	TTK	TTK protein kinase	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTK gene	PMID:20938992
1313655	TTK	TTK protein kinase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TTK mRNA	PMID:33167477
1313655	TTK	TTK protein kinase	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TTK mRNA	PMID:21632981
1313655	TTK	TTK protein kinase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313656	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TTK mRNA	PMID:39241906
1313655	TTK	TTK protein kinase	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305558	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of TTK mRNA	PMID:32145629
1313655	TTK	TTK protein kinase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:D004958	Estradiol results in increased expression of TTK mRNA	PMID:18310284|PMID:19167446|PMID:20106945
1313655	TTK	TTK protein kinase	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TTK mRNA	PMID:25510870
1313655	TTK	TTK protein kinase	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TTK mRNA	PMID:38568856
1313655	TTK	TTK protein kinase	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305558	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TTK mRNA	PMID:33387578
1313655	TTK	TTK protein kinase	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305558	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TTK gene	PMID:27618143
1313655	TTK	TTK protein kinase	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTK gene	PMID:20938992
1313655	TTK	TTK protein kinase	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TTK mRNA	PMID:21179406
1313655	TTK	TTK protein kinase	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of TTK mRNA	PMID:26079696
1313655	TTK	TTK protein kinase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TTK mRNA	PMID:37567420|PMID:37992649
1313655	TTK	TTK protein kinase	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of TTK mRNA	PMID:21592394|PMID:33359661
1313655	TTK	TTK protein kinase	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of TTK mRNA	PMID:21592394
1313655	TTK	TTK protein kinase	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305558	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of TTK mRNA	PMID:26496021
1313655	TTK	TTK protein kinase	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of TTK mRNA	PMID:27683099
1313655	TTK	TTK protein kinase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TTK mRNA	PMID:37567420|PMID:37992649
1313655	TTK	TTK protein kinase	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20140408	CTD	MESH:D014527	Uric Acid results in decreased expression of TTK mRNA	PMID:23619996
1313655	TTK	TTK protein kinase	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20140408	CTD	MESH:D014527	NLRP3 gene mutant form inhibits the reaction [Uric Acid results in decreased expression of TTK mRNA]	PMID:23619996
1313655	TTK	TTK protein kinase	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305558	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TTK mRNA	PMID:26577399
1313655	TTK	TTK protein kinase	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of TTK protein	PMID:37730182
1313655	TTK	TTK protein kinase	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of TTK mRNA	PMID:21592394
1313655	TTK	TTK protein kinase	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of TTK mRNA	PMID:21592394
1313655	TTK	TTK protein kinase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TTK mRNA	PMID:36331819
1313655	TTK	TTK protein kinase	gene	CHEBI:2038	5-azacytidine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001374	[Azacitidine co-treated with Thalidomide] affects the expression of TTK mRNA	PMID:18720364
1313655	TTK	TTK protein kinase	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TTK mRNA	PMID:25510870
1313655	TTK	TTK protein kinase	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TTK mRNA	PMID:25510870
1313655	TTK	TTK protein kinase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TTK mRNA	PMID:19549813
1313655	TTK	TTK protein kinase	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of TTK protein	PMID:20106945
1313655	TTK	TTK protein kinase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305558	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TTK mRNA	PMID:23630614|PMID:25378103
1313655	TTK	TTK protein kinase	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of TTK mRNA	PMID:25102026
1313655	TTK	TTK protein kinase	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in decreased expression of TTK mRNA	PMID:18955075
1313655	TTK	TTK protein kinase	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of TTK mRNA	PMID:15674844
1313655	TTK	TTK protein kinase	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313656	E	RGD:6480464	20150609	CTD	MESH:D010126	Ozone results in increased expression of TTK mRNA	PMID:25658374
1313655	TTK	TTK protein kinase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TTK mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TTK mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of TTK mRNA	PMID:25658374|PMID:27106289|PMID:34911549
1313655	TTK	TTK protein kinase	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D014747	TTK protein affects the susceptibility to Vinblastine	PMID:16217747
1313655	TTK	TTK protein kinase	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of TTK mRNA	PMID:17484886
1313655	TTK	TTK protein kinase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313656	E	RGD:6480464	20181016	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TTK mRNA	PMID:29987408|PMID:31919559
1313655	TTK	TTK protein kinase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TTK gene	PMID:20938992
1313655	TTK	TTK protein kinase	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA]	PMID:37992649
1313655	TTK	TTK protein kinase	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305558	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TTK mRNA	PMID:31881176
1313655	TTK	TTK protein kinase	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of TTK mRNA	PMID:15767336
1313655	TTK	TTK protein kinase	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in increased expression of TTK mRNA	PMID:19167446
1313655	TTK	TTK protein kinase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of TTK mRNA	PMID:19167446
1313655	TTK	TTK protein kinase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305558	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of TTK mRNA	PMID:22023808
1313655	TTK	TTK protein kinase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of TTK mRNA	PMID:21151649
1313655	TTK	TTK protein kinase	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin promotes the reaction [Piroxicam results in decreased expression of TTK mRNA]	PMID:21858171
1313655	TTK	TTK protein kinase	gene	CHEBI:28088	genistein	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein affects the expression of TTK mRNA	PMID:18847459
1313655	TTK	TTK protein kinase	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TTK mRNA	PMID:25583101
1313655	TTK	TTK protein kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTK mRNA	PMID:22298810|PMID:22574217
1313655	TTK	TTK protein kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313656	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTK mRNA	PMID:26377647
1313655	TTK	TTK protein kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305558	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TTK mRNA	PMID:32109520
1313655	TTK	TTK protein kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305558	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TTK mRNA	PMID:34747641
1313655	TTK	TTK protein kinase	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305558	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TTK mRNA	PMID:28374803
1313655	TTK	TTK protein kinase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of TTK mRNA	PMID:33512557
1313655	TTK	TTK protein kinase	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TTK mRNA	PMID:33212167
1313655	TTK	TTK protein kinase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TTK mRNA	PMID:32763439
1313655	TTK	TTK protein kinase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305558	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TTK mRNA	PMID:28959563
1313655	TTK	TTK protein kinase	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	TTK protein affects the susceptibility to Doxorubicin	PMID:16217747
1313655	TTK	TTK protein kinase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20231031	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TTK mRNA	PMID:37567420|PMID:37992649
1313655	TTK	TTK protein kinase	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of TTK protein	PMID:35688186
1313655	TTK	TTK protein kinase	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA]	PMID:37992649
1313655	TTK	TTK protein kinase	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of TTK mRNA	PMID:22623647
1313655	TTK	TTK protein kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTK mRNA	PMID:38568856
1313655	TTK	TTK protein kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTK mRNA	PMID:17998272
1313655	TTK	TTK protein kinase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of TTK mRNA	PMID:29301061
1313655	TTK	TTK protein kinase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313656	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of TTK mRNA	PMID:39515575
1313655	TTK	TTK protein kinase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TTK promoter	PMID:27901495
1313655	TTK	TTK protein kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TTK mRNA	PMID:16120219|PMID:20064835|PMID:21632981
1313655	TTK	TTK protein kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TTK mRNA	PMID:19770486
1313655	TTK	TTK protein kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313656	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TTK intron	PMID:27901495
1313655	TTK	TTK protein kinase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TTK mRNA	PMID:33411230
1313655	TTK	TTK protein kinase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313656	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TTK mRNA	PMID:32417428
1313655	TTK	TTK protein kinase	gene	CHEBI:30145	lithium atom	increases expression	ISO	RGD:1305558	E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in increased expression of TTK mRNA	PMID:21711903
1313655	TTK	TTK protein kinase	gene	CHEBI:30146	lithium hydride	increases expression	ISO	RGD:1305558	E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in increased expression of TTK mRNA	PMID:21711903
1313655	TTK	TTK protein kinase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313656	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TTK mRNA	PMID:29341224
1313655	TTK	TTK protein kinase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TTK mRNA	PMID:20018196|PMID:20382639
1313655	TTK	TTK protein kinase	gene	CHEBI:31638	fulvestrant	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of TTK mRNA	PMID:19016759
1313655	TTK	TTK protein kinase	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	[fulvestrant co-treated with Sirolimus] results in decreased expression of TTK mRNA	PMID:19016759
1313655	TTK	TTK protein kinase	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305558	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of TTK mRNA	PMID:25729387
1313655	TTK	TTK protein kinase	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305558	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TTK mRNA	PMID:25729387
1313655	TTK	TTK protein kinase	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313656	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of TTK mRNA	PMID:17656681
1313655	TTK	TTK protein kinase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313656	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TTK gene; titanium dioxide results in decreased methylation of TTK promoter	PMID:35295148
1313655	TTK	TTK protein kinase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1305558	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of TTK mRNA	PMID:30012374
1313655	TTK	TTK protein kinase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305558	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of TTK mRNA	PMID:32145629
1313655	TTK	TTK protein kinase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TTK mRNA	PMID:29275510
1313655	TTK	TTK protein kinase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305558	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TTK mRNA	PMID:25181051
1313655	TTK	TTK protein kinase	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TTK gene	PMID:31601247
1313655	TTK	TTK protein kinase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305558	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of TTK mRNA	PMID:26496021
1313655	TTK	TTK protein kinase	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313656	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of TTK mRNA	PMID:26682919
1313655	TTK	TTK protein kinase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TTK mRNA	PMID:25510870
1313655	TTK	TTK protein kinase	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TTK mRNA	PMID:25510870
1313655	TTK	TTK protein kinase	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of TTK mRNA	PMID:20713471
1313655	TTK	TTK protein kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TTK mRNA	PMID:40203079
1313655	TTK	TTK protein kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313656	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of TTK mRNA	PMID:33297965
1313655	TTK	TTK protein kinase	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305558	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of TTK mRNA	PMID:22546817
1313655	TTK	TTK protein kinase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TTK mRNA	PMID:17361019|PMID:21266533
1313655	TTK	TTK protein kinase	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305558	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of TTK mRNA	PMID:22546817
1313655	TTK	TTK protein kinase	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of TTK mRNA	PMID:17854601
1313655	TTK	TTK protein kinase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of TTK mRNA; RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of TTK mRNA]	PMID:17854601|PMID:24535843
1313655	TTK	TTK protein kinase	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305558	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of TTK mRNA	PMID:22546817
1313655	TTK	TTK protein kinase	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305558	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of TTK mRNA	PMID:30589522
1313655	TTK	TTK protein kinase	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1305558	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of TTK mRNA	PMID:18500788
1313655	TTK	TTK protein kinase	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305558	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of TTK mRNA	PMID:30723492
1313655	TTK	TTK protein kinase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305558	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TTK mRNA	PMID:25993096
1313655	TTK	TTK protein kinase	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of TTK mRNA	PMID:36326898
1313655	TTK	TTK protein kinase	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305558	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of TTK mRNA	PMID:25539665
1313655	TTK	TTK protein kinase	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313656	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of TTK mRNA	PMID:28962523
1313655	TTK	TTK protein kinase	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA]	PMID:17585979
1313655	TTK	TTK protein kinase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TTK mRNA	PMID:32588087
1313655	TTK	TTK protein kinase	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of TTK mRNA	PMID:33512557
1313655	TTK	TTK protein kinase	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TTK mRNA	PMID:28302478
1313655	TTK	TTK protein kinase	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TTK mRNA	PMID:31533062
1313655	TTK	TTK protein kinase	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of TTK mRNA	PMID:19167446
1313655	TTK	TTK protein kinase	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TTK mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of TTK mRNA	PMID:19167446
1313655	TTK	TTK protein kinase	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of TTK mRNA	PMID:39529242
1313655	TTK	TTK protein kinase	gene	CHEBI:3930	cryptolepine	decreases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C024015	cryptolepine results in decreased expression of TTK mRNA	PMID:16120219
1313655	TTK	TTK protein kinase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of TTK mRNA	PMID:36331819
1313655	TTK	TTK protein kinase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of TTK mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1313655	TTK	TTK protein kinase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of TTK mRNA	PMID:20106945|PMID:21632981
1313655	TTK	TTK protein kinase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20231031	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TTK mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TTK mRNA	PMID:37567420|PMID:37992649
1313655	TTK	TTK protein kinase	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of TTK mRNA	PMID:33512557
1313655	TTK	TTK protein kinase	gene	CHEBI:43572	kojic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of TTK mRNA	PMID:16595896
1313655	TTK	TTK protein kinase	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TTK mRNA	PMID:38832940
1313655	TTK	TTK protein kinase	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of TTK mRNA	PMID:26272509
1313655	TTK	TTK protein kinase	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTK mRNA	PMID:27188386
1313655	TTK	TTK protein kinase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of TTK mRNA	PMID:26690555|PMID:29067470
1313655	TTK	TTK protein kinase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305558	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TTK mRNA	PMID:33387578
1313655	TTK	TTK protein kinase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TTK mRNA	PMID:22230336
1313655	TTK	TTK protein kinase	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TTK mRNA]	PMID:17585979
1313655	TTK	TTK protein kinase	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of TTK mRNA	PMID:24714768
1313655	TTK	TTK protein kinase	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of TTK mRNA	PMID:31838189
1313655	TTK	TTK protein kinase	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of TTK mRNA	PMID:40706910
1313655	TTK	TTK protein kinase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TTK mRNA	PMID:22079256
1313655	TTK	TTK protein kinase	gene	CHEBI:4911	etoposide	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D005047	Etoposide results in decreased expression of TTK mRNA	PMID:16120219
1313655	TTK	TTK protein kinase	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1313656	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of TTK mRNA	PMID:25270620
1313655	TTK	TTK protein kinase	gene	CHEBI:50594	carbon nanotube	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TTK mRNA	PMID:15585362
1313655	TTK	TTK protein kinase	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of TTK mRNA	PMID:21148553
1313655	TTK	TTK protein kinase	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313656	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TTK mRNA	PMID:19042947
1313655	TTK	TTK protein kinase	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313656	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TTK mRNA	PMID:38701926
1313655	TTK	TTK protein kinase	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305558	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of TTK mRNA	PMID:25729387
1313655	TTK	TTK protein kinase	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305558	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TTK mRNA	PMID:25729387
1313655	TTK	TTK protein kinase	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313656	E	RGD:6480464	20260113	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of TTK mRNA	PMID:40930398
1313655	TTK	TTK protein kinase	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TTK mRNA	PMID:28988120
1313655	TTK	TTK protein kinase	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TTK mRNA	PMID:24810058
1313655	TTK	TTK protein kinase	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305558	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TTK mRNA	PMID:37269647
1313655	TTK	TTK protein kinase	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305558	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of TTK mRNA	PMID:35283115
1313655	TTK	TTK protein kinase	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1305558	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of TTK mRNA	PMID:19564919
1313655	TTK	TTK protein kinase	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1305558	E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of TTK mRNA	PMID:19564919
1313655	TTK	TTK protein kinase	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305558	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TTK gene	PMID:35440735
1313655	TTK	TTK protein kinase	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D002185	Cannabidiol results in decreased expression of TTK mRNA	PMID:36519830
1313655	TTK	TTK protein kinase	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TTK mRNA	PMID:31758290
1313655	TTK	TTK protein kinase	gene	CHEBI:73297	SCH 23390	multiple interactions	ISO	RGD:1305558	E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of TTK mRNA	PMID:19564919
1313655	TTK	TTK protein kinase	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TTK mRNA	PMID:22079256
1313655	TTK	TTK protein kinase	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TTK mRNA	PMID:22079256
1313655	TTK	TTK protein kinase	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of TTK mRNA	PMID:29522793
1313655	TTK	TTK protein kinase	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of TTK mRNA	PMID:37567420
1313655	TTK	TTK protein kinase	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TTK mRNA	PMID:37199045
1313655	TTK	TTK protein kinase	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of TTK mRNA	PMID:16120219
1313655	TTK	TTK protein kinase	gene	CHEBI:76989	phytoestrogen	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:D048789	Phytoestrogens results in increased expression of TTK mRNA	PMID:18310284
1313655	TTK	TTK protein kinase	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of TTK mRNA	PMID:18548127
1313655	TTK	TTK protein kinase	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of TTK mRNA	PMID:34995734
1313655	TTK	TTK protein kinase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTK mRNA	PMID:27188386
1313655	TTK	TTK protein kinase	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of TTK mRNA	PMID:30928695
1313655	TTK	TTK protein kinase	gene	CHEBI:79997	GW 4064	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C412815	GW 4064 results in increased expression of TTK mRNA	PMID:31437187
1313655	TTK	TTK protein kinase	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of TTK mRNA; Irinotecan results in decreased expression of TTK mRNA	PMID:15956246
1313655	TTK	TTK protein kinase	gene	CHEBI:8064	phenformin	decreases expression	ISO	RGD:1305558	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of TTK mRNA	PMID:31324951
1313655	TTK	TTK protein kinase	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313656	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of TTK mRNA	PMID:23091169
1313655	TTK	TTK protein kinase	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313656	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of TTK mRNA	PMID:24535843
1313655	TTK	TTK protein kinase	gene	CHEBI:81555	Enterolactone	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of TTK mRNA	PMID:19167446
1313655	TTK	TTK protein kinase	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TTK mRNA	PMID:19167446
1313655	TTK	TTK protein kinase	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of TTK mRNA	PMID:33512557
1313655	TTK	TTK protein kinase	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of TTK mRNA	PMID:32234424
1313655	TTK	TTK protein kinase	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of TTK mRNA	PMID:21858171
1313655	TTK	TTK protein kinase	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin promotes the reaction [Piroxicam results in decreased expression of TTK mRNA]	PMID:21858171
1313655	TTK	TTK protein kinase	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of TTK mRNA	PMID:33512557
1313655	TTK	TTK protein kinase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305558	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of TTK mRNA	PMID:24780913
1313655	TTK	TTK protein kinase	gene	CHEBI:85993	palbociclib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of TTK mRNA	PMID:22869556
1313655	TTK	TTK protein kinase	gene	CHEBI:88046	cylindrospermopsin	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C089595	cylindrospermopsin results in decreased expression of TTK mRNA	PMID:30905859
1313655	TTK	TTK protein kinase	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1305558	E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of TTK mRNA	PMID:32419051
1313655	TTK	TTK protein kinase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TTK mRNA	PMID:27188386
1313655	TTK	TTK protein kinase	gene	CHEBI:9111	Senkirkine	increases expression	ISO	RGD:1305558	E	RGD:6480464	20200915	CTD	MESH:C009238	senkirkine results in increased expression of TTK mRNA	PMID:32419051
1313655	TTK	TTK protein kinase	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	[fulvestrant co-treated with Sirolimus] results in decreased expression of TTK mRNA	PMID:19016759
1313655	TTK	TTK protein kinase	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in decreased expression of TTK mRNA	PMID:34581912
1313655	TTK	TTK protein kinase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TTK mRNA	PMID:38568856
1313655	TTK	TTK protein kinase	gene	CHEBI:9513	thalidomide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013792	[Azacitidine co-treated with Thalidomide] affects the expression of TTK mRNA	PMID:18720364
1313655	TTK	TTK protein kinase	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019284	Thapsigargin results in increased expression of TTK mRNA	PMID:19442820
1313655	TTK	TTK protein kinase	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1305558	E	RGD:6480464	20141111	CTD	MESH:C001899	triptolide results in increased expression of TTK mRNA	PMID:23639586
1313655	TTK	TTK protein kinase	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of TTK mRNA	PMID:19140230
1313655	TTK	TTK protein kinase	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313656	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TTK mRNA	PMID:35537566
1313655	TTK	TTK protein kinase	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305558	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of TTK gene	PMID:31079544
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ADGRG5 mRNA	PMID:33167477
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ADGRG5 mRNA	PMID:18951874
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305559	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRG5 mRNA; [Testosterone co-treated with Estradiol] results in decreased expression of ADGRG5 mRNA	PMID:32741896
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305559	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ADGRG5 mRNA	PMID:33387578
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADGRG5 mRNA	PMID:37042841
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1550253	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ADGRG5 mRNA	PMID:39922521
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305559	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRG5 mRNA; [Testosterone co-treated with Estradiol] results in decreased expression of ADGRG5 mRNA	PMID:32741896
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1550253	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ADGRG5 mRNA	PMID:39922521
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305559	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ADGRG5 mRNA	PMID:27523638
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305559	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ADGRG5 mRNA	PMID:33354967
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ADGRG5 intron	PMID:30157460
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305559	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of ADGRG5 mRNA	PMID:30779732
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305559	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ADGRG5 mRNA	PMID:31881176
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305559	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADGRG5 mRNA	PMID:32109520
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ADGRG5 mRNA	PMID:28001369
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1550253	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ADGRG5 mRNA	PMID:19465457
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305559	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ADGRG5 mRNA	PMID:28959563
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:28854	2,4-D	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of ADGRG5 mRNA	PMID:40294809
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADGRG5 promoter	PMID:27901495
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADGRG5 3' UTR; Benzo(a)pyrene results in increased methylation of ADGRG5 exon	PMID:27901495
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20161115	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ADGRG5 gene	PMID:25435355
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1550253	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ADGRG5 mRNA	PMID:29341224
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1305559	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of ADGRG5 mRNA	PMID:32479839
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305559	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ADGRG5 mRNA	PMID:34492290
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305559	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRG5 mRNA	PMID:25181051
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550253	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ADGRG5 mRNA	PMID:26063408
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1550253	E	RGD:6480464	20180515	CTD	MESH:D008748	[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of ADGRG5 mRNA; [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of ADGRG5 mRNA	PMID:25926378
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADGRG5 mRNA	PMID:37042841
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1550253	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of ADGRG5 mRNA	PMID:29038090
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ADGRG5 mRNA	PMID:25979313
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in increased expression of ADGRG5 mRNA	PMID:23527032
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1550253	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ADGRG5 mRNA	PMID:39922521
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550253	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ADGRG5 mRNA	PMID:25554681
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1550253	E	RGD:6480464	20180515	CTD	MESH:D037742	[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of ADGRG5 mRNA; [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of ADGRG5 mRNA	PMID:25926378
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1550253	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ADGRG5 mRNA	PMID:38701926
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550253	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADGRG5 mRNA	PMID:22206623
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305559	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ADGRG5 mRNA	PMID:32741896
1313657	ADGRG5	adhesion G protein-coupled receptor G5	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ADGRG5 mRNA	PMID:29301935
1313660	SATB1	SATB homeobox 1	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of SATB1 mRNA	PMID:26272509
1313660	SATB1	SATB homeobox 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SATB1 mRNA	PMID:27188386
1313660	SATB1	SATB homeobox 1	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin affects the expression of SATB1 mRNA	PMID:31600526
1313660	SATB1	SATB homeobox 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SATB1 mRNA	PMID:26079696
1313660	SATB1	SATB homeobox 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SATB1 mRNA	PMID:22378314
1313660	SATB1	SATB homeobox 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313661	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SATB1 mRNA	PMID:30319688
1313660	SATB1	SATB homeobox 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of SATB1 mRNA	PMID:19484750|PMID:25210133
1313660	SATB1	SATB homeobox 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305561	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of SATB1 mRNA	PMID:26496021
1313660	SATB1	SATB homeobox 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SATB1 mRNA	PMID:37042841
1313660	SATB1	SATB homeobox 1	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in decreased expression of SATB1 mRNA	PMID:15120971
1313660	SATB1	SATB homeobox 1	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of SATB1 mRNA	PMID:33359661
1313660	SATB1	SATB homeobox 1	gene	CHEBI:17447	geraniol	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of SATB1 mRNA	PMID:27683099
1313660	SATB1	SATB homeobox 1	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of SATB1 mRNA	PMID:31256213
1313660	SATB1	SATB homeobox 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1305561	E	RGD:6480464	20230704	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SATB1 mRNA	PMID:36005737
1313660	SATB1	SATB homeobox 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SATB1 mRNA	PMID:34319233
1313660	SATB1	SATB homeobox 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SATB1 protein	PMID:37730182
1313660	SATB1	SATB homeobox 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305561	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SATB1 mRNA	PMID:22061828
1313660	SATB1	SATB homeobox 1	gene	CHEBI:2208	purine-6-thiol	decreases expression	ISO	RGD:1305561	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of SATB1 mRNA	PMID:23358152
1313660	SATB1	SATB homeobox 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D002104	Cadmium results in increased expression of SATB1 mRNA	PMID:31082426
1313660	SATB1	SATB homeobox 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SATB1 mRNA	PMID:35301059
1313660	SATB1	SATB homeobox 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SATB1 mRNA	PMID:27153756
1313660	SATB1	SATB homeobox 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SATB1 gene	PMID:27153756
1313660	SATB1	SATB homeobox 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313661	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SATB1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SATB1 mRNA	PMID:34911549
1313660	SATB1	SATB homeobox 1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305561	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SATB1 mRNA	PMID:30779732
1313660	SATB1	SATB homeobox 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305561	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SATB1 mRNA	PMID:31150632
1313660	SATB1	SATB homeobox 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313661	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SATB1 mRNA	PMID:22206623
1313660	SATB1	SATB homeobox 1	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SATB1 mRNA	PMID:19244175
1313660	SATB1	SATB homeobox 1	gene	CHEBI:2762	antimycin A	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of SATB1 mRNA	PMID:33512557
1313660	SATB1	SATB homeobox 1	gene	CHEBI:27690	acetazolamide	increases expression	ISO	RGD:1313661	E	RGD:6480464	20120717	CTD	MESH:D000086	Acetazolamide results in increased expression of SATB1 mRNA	PMID:19274763
1313660	SATB1	SATB homeobox 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305561	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SATB1 mRNA	PMID:31881176
1313660	SATB1	SATB homeobox 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SATB1 mRNA	PMID:28903495
1313660	SATB1	SATB homeobox 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of SATB1 mRNA	PMID:27594783
1313660	SATB1	SATB homeobox 1	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of SATB1 mRNA	PMID:18355967
1313660	SATB1	SATB homeobox 1	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D003042	FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of SATB1 mRNA]	PMID:18355967
1313660	SATB1	SATB homeobox 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SATB1 mRNA	PMID:30912803
1313660	SATB1	SATB homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SATB1 mRNA	PMID:22574217
1313660	SATB1	SATB homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313661	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SATB1 mRNA	PMID:24058054
1313660	SATB1	SATB homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305561	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SATB1 mRNA	PMID:32109520
1313660	SATB1	SATB homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SATB1 mRNA	PMID:17942748
1313660	SATB1	SATB homeobox 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of SATB1 mRNA	PMID:33512557
1313660	SATB1	SATB homeobox 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SATB1 mRNA	PMID:28001369
1313660	SATB1	SATB homeobox 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Thiosemicarbazones binds to Copper] which results in increased expression of SATB1 protein	PMID:20931265
1313660	SATB1	SATB homeobox 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SATB1 mRNA	PMID:29803840
1313660	SATB1	SATB homeobox 1	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of SATB1 gene	PMID:28589171
1313660	SATB1	SATB homeobox 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SATB1 mRNA; sodium arsenite results in decreased expression of SATB1 protein	PMID:34032870|PMID:39571964
1313660	SATB1	SATB homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SATB1 5' UTR; Benzo(a)pyrene affects the methylation of SATB1 promoter	PMID:27901495
1313660	SATB1	SATB homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SATB1 mRNA	PMID:30453624
1313660	SATB1	SATB homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SATB1 mRNA	PMID:21569818
1313660	SATB1	SATB homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SATB1 mRNA	PMID:22316170
1313660	SATB1	SATB homeobox 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Thiosemicarbazones binds to Copper] which results in increased expression of SATB1 protein	PMID:20931265
1313660	SATB1	SATB homeobox 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SATB1 mRNA	PMID:20382639
1313660	SATB1	SATB homeobox 1	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	SATB1 protein results in decreased susceptibility to Arsenic Trioxide	PMID:25317073
1313660	SATB1	SATB homeobox 1	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of SATB1 gene	PMID:31601247
1313660	SATB1	SATB homeobox 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305561	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SATB1 mRNA	PMID:25729387
1313660	SATB1	SATB homeobox 1	gene	CHEBI:32095	retinyl acetate	increases expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:C009166	retinol acetate results in increased expression of SATB1 mRNA	PMID:16772331
1313660	SATB1	SATB homeobox 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305561	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of SATB1 mRNA	PMID:30047161
1313660	SATB1	SATB homeobox 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313661	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SATB1 mRNA	PMID:23557971
1313660	SATB1	SATB homeobox 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313661	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SATB1 promoter	PMID:35295148
1313660	SATB1	SATB homeobox 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of SATB1 mRNA	PMID:18648102
1313660	SATB1	SATB homeobox 1	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of SATB1 mRNA	PMID:12419474
1313660	SATB1	SATB homeobox 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305561	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SATB1 mRNA	PMID:25181051
1313660	SATB1	SATB homeobox 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313661	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SATB1 promoter	PMID:27334623
1313660	SATB1	SATB homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SATB1 mRNA	PMID:29275510
1313660	SATB1	SATB homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305561	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of SATB1 mRNA	PMID:41034487
1313660	SATB1	SATB homeobox 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313661	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SATB1 mRNA	PMID:26063408
1313660	SATB1	SATB homeobox 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305561	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of SATB1 mRNA	PMID:26496021
1313660	SATB1	SATB homeobox 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SATB1 mRNA	PMID:19244175
1313660	SATB1	SATB homeobox 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313661	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SATB1 gene	PMID:31683443
1313660	SATB1	SATB homeobox 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SATB1 mRNA	PMID:37019170
1313660	SATB1	SATB homeobox 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SATB1 mRNA	PMID:37042841
1313660	SATB1	SATB homeobox 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305561	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of SATB1 mRNA	PMID:35163327
1313660	SATB1	SATB homeobox 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SATB1 mRNA	PMID:35301059
1313660	SATB1	SATB homeobox 1	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SATB1 mRNA	PMID:19244175
1313660	SATB1	SATB homeobox 1	gene	CHEBI:38604	pyrimidifen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of SATB1 mRNA	PMID:33512557
1313660	SATB1	SATB homeobox 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SATB1 mRNA	PMID:31533062
1313660	SATB1	SATB homeobox 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SATB1 mRNA	PMID:40419075
1313660	SATB1	SATB homeobox 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1305561	E	RGD:6480464	20121009	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SATB1 mRNA	PMID:22237054
1313660	SATB1	SATB homeobox 1	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of SATB1 mRNA	PMID:29038090
1313660	SATB1	SATB homeobox 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of SATB1 mRNA	PMID:23125180
1313660	SATB1	SATB homeobox 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SATB1 mRNA	PMID:25979313
1313660	SATB1	SATB homeobox 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SATB1 mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1313660	SATB1	SATB homeobox 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305561	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SATB1 mRNA	PMID:30047161
1313660	SATB1	SATB homeobox 1	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20120515	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of SATB1 mRNA	PMID:21041162
1313660	SATB1	SATB homeobox 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of SATB1 mRNA	PMID:20106945
1313660	SATB1	SATB homeobox 1	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of SATB1 mRNA	PMID:33512557
1313660	SATB1	SATB homeobox 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SATB1 mRNA	PMID:17555576
1313660	SATB1	SATB homeobox 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of SATB1 mRNA	PMID:21041162
1313660	SATB1	SATB homeobox 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of SATB1 mRNA	PMID:21041162
1313660	SATB1	SATB homeobox 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313661	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SATB1 mRNA	PMID:28973697
1313660	SATB1	SATB homeobox 1	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of SATB1 mRNA	PMID:33512557
1313660	SATB1	SATB homeobox 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SATB1 mRNA	PMID:38832940
1313660	SATB1	SATB homeobox 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SATB1 mRNA	PMID:21420995
1313660	SATB1	SATB homeobox 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of SATB1 mRNA	PMID:26690555
1313660	SATB1	SATB homeobox 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SATB1 mRNA	PMID:29279043
1313660	SATB1	SATB homeobox 1	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of SATB1 mRNA	PMID:21148743
1313660	SATB1	SATB homeobox 1	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of SATB1 mRNA	PMID:31838189
1313660	SATB1	SATB homeobox 1	gene	CHEBI:47807	sulforaphane	increases methylation	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased methylation of SATB1 gene	PMID:31838189
1313660	SATB1	SATB homeobox 1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of SATB1 mRNA	PMID:18175754
1313660	SATB1	SATB homeobox 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SATB1 mRNA	PMID:17555576
1313660	SATB1	SATB homeobox 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SATB1 mRNA	PMID:17942748
1313660	SATB1	SATB homeobox 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313661	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SATB1 mRNA	PMID:17942748
1313660	SATB1	SATB homeobox 1	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	SATB1 protein results in decreased susceptibility to Arsenic Trioxide	PMID:25317073
1313660	SATB1	SATB homeobox 1	gene	CHEBI:5011	fenpyroximate	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of SATB1 mRNA	PMID:33512557
1313660	SATB1	SATB homeobox 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SATB1 mRNA	PMID:17145863
1313660	SATB1	SATB homeobox 1	gene	CHEBI:50594	carbon nanotube	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of SATB1 mRNA	PMID:23634900
1313660	SATB1	SATB homeobox 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SATB1 mRNA; Nanotubes, Carbon results in decreased expression of SATB1 mRNA	PMID:25554681
1313660	SATB1	SATB homeobox 1	gene	CHEBI:50667	mercaptopurine	decreases expression	ISO	RGD:1305561	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of SATB1 mRNA	PMID:23358152
1313660	SATB1	SATB homeobox 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305561	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SATB1 mRNA	PMID:30047161
1313660	SATB1	SATB homeobox 1	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of SATB1 mRNA	PMID:16780908
1313660	SATB1	SATB homeobox 1	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	SATB1 protein affects the susceptibility to Topotecan	PMID:16217747
1313660	SATB1	SATB homeobox 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305561	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SATB1 mRNA	PMID:25729387
1313660	SATB1	SATB homeobox 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305561	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SATB1 mRNA	PMID:25729387
1313660	SATB1	SATB homeobox 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SATB1 mRNA	PMID:15336504
1313660	SATB1	SATB homeobox 1	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of SATB1 mRNA	PMID:36907384
1313660	SATB1	SATB homeobox 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313661	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SATB1 mRNA	PMID:22206623
1313660	SATB1	SATB homeobox 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313661	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SATB1 mRNA	PMID:22206623
1313660	SATB1	SATB homeobox 1	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of SATB1 mRNA	PMID:22714537
1313660	SATB1	SATB homeobox 1	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of SATB1 mRNA	PMID:36318118
1313660	SATB1	SATB homeobox 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SATB1 mRNA	PMID:27188386
1313660	SATB1	SATB homeobox 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SATB1 gene]	PMID:28238834
1313660	SATB1	SATB homeobox 1	gene	CHEBI:81794	thifluzamide	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of SATB1 mRNA	PMID:33512557
1313660	SATB1	SATB homeobox 1	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of SATB1 mRNA	PMID:33512557
1313660	SATB1	SATB homeobox 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313661	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of SATB1 mRNA	PMID:39847705
1313660	SATB1	SATB homeobox 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305561	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SATB1 mRNA	PMID:30047161
1313660	SATB1	SATB homeobox 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SATB1 mRNA	PMID:27188386
1313660	SATB1	SATB homeobox 1	gene	CHEBI:94796	3,7-dihydropurine-6-thione	decreases expression	ISO	RGD:1305561	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in decreased expression of SATB1 mRNA	PMID:23358152
1313660	SATB1	SATB homeobox 1	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305561	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of SATB1 gene	PMID:31682807
1313662	XPOT	exportin for tRNA	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305562	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of XPOT mRNA]	PMID:31150632
1313662	XPOT	exportin for tRNA	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of XPOT mRNA	PMID:15498508|PMID:18614847|PMID:33167477
1313662	XPOT	exportin for tRNA	gene	CHEBI:15571	hydrazine	increases expression	ISO	RGD:1313663	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in increased expression of XPOT mRNA	PMID:15282401
1313662	XPOT	exportin for tRNA	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of XPOT mRNA	PMID:21632981
1313662	XPOT	exportin for tRNA	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of XPOT mRNA	PMID:20106945|PMID:31614463
1313662	XPOT	exportin for tRNA	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313663	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of XPOT mRNA	PMID:39298647
1313662	XPOT	exportin for tRNA	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305562	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of XPOT mRNA	PMID:33387578
1313662	XPOT	exportin for tRNA	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313663	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of XPOT mRNA	PMID:17251523
1313662	XPOT	exportin for tRNA	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313663	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of XPOT mRNA	PMID:34319233
1313662	XPOT	exportin for tRNA	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D002117	Calcitriol results in decreased expression of XPOT mRNA	PMID:16847355|PMID:18614847
1313662	XPOT	exportin for tRNA	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305562	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of XPOT mRNA	PMID:22061828
1313662	XPOT	exportin for tRNA	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of XPOT protein	PMID:23301498
1313662	XPOT	exportin for tRNA	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of XPOT protein	PMID:20106945
1313662	XPOT	exportin for tRNA	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of XPOT mRNA	PMID:21632981
1313662	XPOT	exportin for tRNA	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305562	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of XPOT mRNA	PMID:31150632
1313662	XPOT	exportin for tRNA	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313663	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of XPOT mRNA	PMID:27339419|PMID:31919559
1313662	XPOT	exportin for tRNA	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305562	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of XPOT mRNA]	PMID:31150632
1313662	XPOT	exportin for tRNA	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of XPOT protein	PMID:38460933
1313662	XPOT	exportin for tRNA	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305562	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of XPOT mRNA	PMID:31881176
1313662	XPOT	exportin for tRNA	gene	CHEBI:28088	genistein	increases methylation	ISO	RGD:1305562	E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of XPOT gene	PMID:28505145
1313662	XPOT	exportin for tRNA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of XPOT mRNA	PMID:20106945|PMID:21632981
1313662	XPOT	exportin for tRNA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313663	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of XPOT mRNA	PMID:19465110
1313662	XPOT	exportin for tRNA	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313663	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of XPOT mRNA	PMID:16214954
1313662	XPOT	exportin for tRNA	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of XPOT mRNA	PMID:28001369
1313662	XPOT	exportin for tRNA	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of XPOT mRNA	PMID:33212167
1313662	XPOT	exportin for tRNA	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of XPOT mRNA	PMID:32763439
1313662	XPOT	exportin for tRNA	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of XPOT mRNA	PMID:28595984|PMID:34032870
1313662	XPOT	exportin for tRNA	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of XPOT mRNA; sodium arsenite results in increased expression of XPOT protein	PMID:38228842|PMID:38568856|PMID:39719251
1313662	XPOT	exportin for tRNA	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of XPOT mRNA; Tunicamycin results in increased expression of XPOT protein	PMID:22378314|PMID:29453283
1313662	XPOT	exportin for tRNA	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of XPOT mRNA	PMID:20106945|PMID:21632981
1313662	XPOT	exportin for tRNA	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of XPOT mRNA	PMID:17879257
1313662	XPOT	exportin for tRNA	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of XPOT 5' UTR	PMID:27901495
1313662	XPOT	exportin for tRNA	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to XPOT mRNA]	PMID:32406909
1313662	XPOT	exportin for tRNA	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of XPOT mRNA	PMID:25895662
1313662	XPOT	exportin for tRNA	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of XPOT protein	PMID:25419056
1313662	XPOT	exportin for tRNA	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1305562	E	RGD:6480464	20130806	CTD	MESH:C008261	lead acetate results in increased expression of XPOT mRNA	PMID:11578147
1313662	XPOT	exportin for tRNA	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of XPOT mRNA	PMID:31745603
1313662	XPOT	exportin for tRNA	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305562	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of XPOT mRNA	PMID:30047161
1313662	XPOT	exportin for tRNA	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of XPOT mRNA	PMID:15498508
1313662	XPOT	exportin for tRNA	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313663	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of XPOT mRNA	PMID:29264374
1313662	XPOT	exportin for tRNA	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313663	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of XPOT gene	PMID:35295148
1313662	XPOT	exportin for tRNA	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305562	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of XPOT mRNA	PMID:34492290
1313662	XPOT	exportin for tRNA	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of XPOT mRNA	PMID:30903817
1313662	XPOT	exportin for tRNA	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of XPOT protein	PMID:32981897|PMID:37567409
1313662	XPOT	exportin for tRNA	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313663	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of XPOT promoter	PMID:27312807
1313662	XPOT	exportin for tRNA	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of XPOT mRNA	PMID:29275510|PMID:33670352
1313662	XPOT	exportin for tRNA	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305562	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of XPOT mRNA	PMID:25181051
1313662	XPOT	exportin for tRNA	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of XPOT mRNA	PMID:25979313
1313662	XPOT	exportin for tRNA	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of XPOT mRNA	PMID:19041380
1313662	XPOT	exportin for tRNA	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313663	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of XPOT mRNA	PMID:39298647
1313662	XPOT	exportin for tRNA	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of XPOT protein	PMID:34186270
1313662	XPOT	exportin for tRNA	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of XPOT mRNA	PMID:28628672
1313662	XPOT	exportin for tRNA	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of XPOT protein	PMID:34186270
1313662	XPOT	exportin for tRNA	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313663	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of XPOT mRNA	PMID:28392331
1313662	XPOT	exportin for tRNA	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313663	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of XPOT mRNA	PMID:37019170
1313662	XPOT	exportin for tRNA	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313663	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of XPOT mRNA	PMID:34813904
1313662	XPOT	exportin for tRNA	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of XPOT mRNA	PMID:28628672
1313662	XPOT	exportin for tRNA	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313663	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of XPOT mRNA	PMID:34813904
1313662	XPOT	exportin for tRNA	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of XPOT mRNA	PMID:37042841
1313662	XPOT	exportin for tRNA	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of XPOT mRNA	PMID:38568856
1313662	XPOT	exportin for tRNA	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305562	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of XPOT mRNA	PMID:24386269
1313662	XPOT	exportin for tRNA	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of XPOT mRNA	PMID:24449571
1313662	XPOT	exportin for tRNA	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313663	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of XPOT mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of XPOT mRNA]	PMID:17585979
1313662	XPOT	exportin for tRNA	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of XPOT mRNA	PMID:32588087
1313662	XPOT	exportin for tRNA	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of XPOT mRNA	PMID:31533062
1313662	XPOT	exportin for tRNA	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of XPOT mRNA	PMID:40419075
1313662	XPOT	exportin for tRNA	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of XPOT mRNA	PMID:29154799
1313662	XPOT	exportin for tRNA	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305562	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of XPOT mRNA	PMID:30047161
1313662	XPOT	exportin for tRNA	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of XPOT mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1313662	XPOT	exportin for tRNA	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of XPOT mRNA	PMID:28628672
1313662	XPOT	exportin for tRNA	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305562	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of XPOT mRNA	PMID:24136188
1313662	XPOT	exportin for tRNA	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of XPOT mRNA	PMID:38832940
1313662	XPOT	exportin for tRNA	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of XPOT mRNA	PMID:22230336
1313662	XPOT	exportin for tRNA	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of XPOT mRNA	PMID:29067470
1313662	XPOT	exportin for tRNA	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313663	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of XPOT mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of XPOT mRNA]	PMID:17585979
1313662	XPOT	exportin for tRNA	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of XPOT protein	PMID:38460933
1313662	XPOT	exportin for tRNA	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of XPOT mRNA	PMID:36621641
1313662	XPOT	exportin for tRNA	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of XPOT mRNA	PMID:31838189
1313662	XPOT	exportin for tRNA	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305562	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of XPOT mRNA	PMID:29391264
1313662	XPOT	exportin for tRNA	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of XPOT mRNA	PMID:28628672
1313662	XPOT	exportin for tRNA	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of XPOT protein	PMID:25419056
1313662	XPOT	exportin for tRNA	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305562	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of XPOT mRNA	PMID:30047161
1313662	XPOT	exportin for tRNA	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305562	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of XPOT mRNA	PMID:24136188
1313662	XPOT	exportin for tRNA	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of XPOT protein	PMID:32959892
1313662	XPOT	exportin for tRNA	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305562	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of XPOT mRNA	PMID:24136188
1313662	XPOT	exportin for tRNA	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of XPOT mRNA	PMID:24810058
1313662	XPOT	exportin for tRNA	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305562	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of XPOT mRNA	PMID:28801915|PMID:37269647
1313662	XPOT	exportin for tRNA	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313663	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of XPOT protein	PMID:26558463
1313662	XPOT	exportin for tRNA	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305562	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of XPOT mRNA	PMID:30467583
1313662	XPOT	exportin for tRNA	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of XPOT protein	PMID:34186270
1313662	XPOT	exportin for tRNA	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305562	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of XPOT mRNA	PMID:24136188
1313662	XPOT	exportin for tRNA	gene	CHEBI:755208	eprenetapopt	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of XPOT mRNA	PMID:19946333
1313662	XPOT	exportin for tRNA	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of XPOT mRNA]	PMID:19946333
1313662	XPOT	exportin for tRNA	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of XPOT protein	PMID:39638853
1313662	XPOT	exportin for tRNA	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of XPOT protein	PMID:39638853
1313662	XPOT	exportin for tRNA	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of XPOT mRNA	PMID:19159669
1313662	XPOT	exportin for tRNA	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of XPOT mRNA	PMID:26705709
1313662	XPOT	exportin for tRNA	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of XPOT protein	PMID:31675489
1313662	XPOT	exportin for tRNA	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of XPOT mRNA	PMID:21858171
1313662	XPOT	exportin for tRNA	gene	CHEBI:84070	sodium arsenate	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in increased expression of XPOT protein	PMID:38348393
1313662	XPOT	exportin for tRNA	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305562	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of XPOT mRNA	PMID:30047161
1313662	XPOT	exportin for tRNA	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305562	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of XPOT mRNA	PMID:21346803
1313662	XPOT	exportin for tRNA	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of XPOT mRNA	PMID:22378314
1313662	XPOT	exportin for tRNA	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313663	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of XPOT mRNA	PMID:35537566
1313662	XPOT	exportin for tRNA	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305562	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of XPOT mRNA	PMID:23555832
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1305563	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of CPA2 mRNA	PMID:36841081
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1305563	E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of CPA2 mRNA	PMID:17347304
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CPA2 mRNA	PMID:25510870
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1614164	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of CPA2 mRNA	PMID:29980752
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305563	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CPA2 mRNA	PMID:33387578
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20250401	CTD	MESH:D004051	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of CPA2 mRNA	PMID:31606821
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CPA2 exon	PMID:30157460
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPA2 mRNA	PMID:37236586
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CPA2 mRNA	PMID:25510870
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CPA2 mRNA	PMID:25510870
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CPA2 gene	PMID:27153756
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CPA2 exon	PMID:30157460
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305563	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CPA2 mRNA	PMID:31150632
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614164	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CPA2 mRNA	PMID:26377647
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305563	E	RGD:6480464	20130122	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CPA2 mRNA	PMID:20959002
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305563	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CPA2 mRNA	PMID:33387578
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1614164	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of CPA2 mRNA	PMID:37682722
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of CPA2 promoter	PMID:18448484
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305563	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CPA2 mRNA	PMID:30085273
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1305563	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of CPA2 mRNA	PMID:16483693
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1614164	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of CPA2 mRNA	PMID:20542052|PMID:22609695
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1614164	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CPA2 mRNA	PMID:17426115
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305563	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of CPA2 mRNA	PMID:19167457
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305563	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CPA2 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305563	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CPA2 mRNA	PMID:35192832
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CPA2 mRNA	PMID:25510870
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CPA2 mRNA	PMID:25510870
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1305563	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CPA2 mRNA	PMID:20959002|PMID:23196670
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of CPA2 exon	PMID:30157460
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1614164	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CPA2 intron	PMID:28392331
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305563	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CPA2 mRNA	PMID:21266533
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305563	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CPA2 mRNA	PMID:35163327
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CPA2 mRNA	PMID:37236586
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305563	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CPA2 mRNA	PMID:35163327
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305563	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CPA2 mRNA	PMID:24386269
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1614164	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CPA2 mRNA	PMID:40194260
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1305563	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of CPA2 mRNA	PMID:22561333
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305563	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of CPA2 mRNA	PMID:22561333
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305563	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CPA2 mRNA	PMID:33387578
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1614164	E	RGD:6480464	20161213	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CPA2 mRNA	PMID:23917077
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1614164	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CPA2 mRNA	PMID:25620056
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1614164	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CPA2 mRNA	PMID:25620056
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1305563	E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CPA2 mRNA	PMID:18178546
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of CPA2 exon	PMID:30157460
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1614164	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CPA2 mRNA	PMID:22206623
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305563	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CPA2 mRNA	PMID:21346803
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1614164	E	RGD:6480464	20250401	CTD	MESH:D013311	Streptozocin results in increased expression of CPA2 mRNA	PMID:31606821
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1614164	E	RGD:6480464	20250401	CTD	MESH:D013311	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of CPA2 mRNA	PMID:31606821
1313664	CPA2	carboxypeptidase A2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305563	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CPA2 mRNA	PMID:21346803
1313665	KLHL7	kelch like family member 7	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of KLHL7 mRNA	PMID:38218311
1313665	KLHL7	kelch like family member 7	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of KLHL7 mRNA	PMID:27188386
1313665	KLHL7	kelch like family member 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313666	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of KLHL7 mRNA	PMID:37995155
1313665	KLHL7	kelch like family member 7	gene	CHEBI:137392	chlormequat chloride	decreases expression	ISO	RGD:1305564	E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in decreased expression of KLHL7 protein	PMID:34958886
1313665	KLHL7	kelch like family member 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of KLHL7 mRNA	PMID:21934132
1313665	KLHL7	kelch like family member 7	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of KLHL7 mRNA	PMID:21179406
1313665	KLHL7	kelch like family member 7	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of KLHL7 mRNA	PMID:18951874
1313665	KLHL7	kelch like family member 7	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of KLHL7 protein	PMID:18951874
1313665	KLHL7	kelch like family member 7	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of KLHL7 protein	PMID:19207037
1313665	KLHL7	kelch like family member 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313666	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KLHL7 mRNA	PMID:39241906
1313665	KLHL7	kelch like family member 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KLHL7 mRNA	PMID:37042841
1313665	KLHL7	kelch like family member 7	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of KLHL7 mRNA	PMID:21179406
1313665	KLHL7	kelch like family member 7	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305564	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of KLHL7 mRNA	PMID:22061828
1313665	KLHL7	kelch like family member 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305564	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLHL7 mRNA	PMID:39012411
1313665	KLHL7	kelch like family member 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313666	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLHL7 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KLHL7 mRNA	PMID:37236586|PMID:37325564
1313665	KLHL7	kelch like family member 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of KLHL7 mRNA	PMID:19549813
1313665	KLHL7	kelch like family member 7	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of KLHL7 mRNA	PMID:23649840
1313665	KLHL7	kelch like family member 7	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of KLHL7 mRNA	PMID:23649840
1313665	KLHL7	kelch like family member 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313666	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KLHL7 mRNA	PMID:31919559
1313665	KLHL7	kelch like family member 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313666	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KLHL7 mRNA	PMID:25629700
1313665	KLHL7	kelch like family member 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313666	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KLHL7 mRNA	PMID:40504410
1313665	KLHL7	kelch like family member 7	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1305564	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of KLHL7 mRNA	PMID:25905778
1313665	KLHL7	kelch like family member 7	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of KLHL7 mRNA	PMID:23557933
1313665	KLHL7	kelch like family member 7	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of KLHL7 mRNA	PMID:23300844
1313665	KLHL7	kelch like family member 7	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of KLHL7 mRNA	PMID:27392435|PMID:27594783
1313665	KLHL7	kelch like family member 7	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of KLHL7 protein	PMID:18951874
1313665	KLHL7	kelch like family member 7	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of KLHL7 mRNA	PMID:28001369
1313665	KLHL7	kelch like family member 7	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KLHL7 mRNA	PMID:29803840
1313665	KLHL7	kelch like family member 7	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313666	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of KLHL7 mRNA	PMID:25896364|PMID:39631538
1313665	KLHL7	kelch like family member 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313666	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KLHL7 mRNA	PMID:40504410
1313665	KLHL7	kelch like family member 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305564	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KLHL7 mRNA	PMID:21839799
1313665	KLHL7	kelch like family member 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313666	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KLHL7 mRNA	PMID:22228805
1313665	KLHL7	kelch like family member 7	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305564	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of KLHL7 mRNA	PMID:24136188
1313665	KLHL7	kelch like family member 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313666	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KLHL7 gene	PMID:35295148
1313665	KLHL7	kelch like family member 7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313666	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of KLHL7 mRNA	PMID:18301758|PMID:20813756|PMID:23811191
1313665	KLHL7	kelch like family member 7	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305564	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of KLHL7 mRNA	PMID:19167457
1313665	KLHL7	kelch like family member 7	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305564	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KLHL7 gene	PMID:28505145
1313665	KLHL7	kelch like family member 7	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313666	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of KLHL7 mRNA	PMID:28392331
1313665	KLHL7	kelch like family member 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313666	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KLHL7 mRNA	PMID:37019170
1313665	KLHL7	kelch like family member 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KLHL7 mRNA	PMID:37042841
1313665	KLHL7	kelch like family member 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305564	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KLHL7 mRNA	PMID:33453195
1313665	KLHL7	kelch like family member 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305564	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLHL7 mRNA	PMID:39012411
1313665	KLHL7	kelch like family member 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313666	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLHL7 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KLHL7 mRNA	PMID:37236586|PMID:37325564
1313665	KLHL7	kelch like family member 7	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305564	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of KLHL7 mRNA	PMID:24386269
1313665	KLHL7	kelch like family member 7	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of KLHL7 mRNA	PMID:19376846
1313665	KLHL7	kelch like family member 7	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C018021	[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of KLHL7 mRNA	PMID:18654764
1313665	KLHL7	kelch like family member 7	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of KLHL7 mRNA	PMID:24449571
1313665	KLHL7	kelch like family member 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313666	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of KLHL7 mRNA	PMID:36331819
1313665	KLHL7	kelch like family member 7	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KLHL7 mRNA	PMID:25979313
1313665	KLHL7	kelch like family member 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of KLHL7 mRNA	PMID:23179753|PMID:27188386
1313665	KLHL7	kelch like family member 7	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KLHL7 gene	PMID:29154799
1313665	KLHL7	kelch like family member 7	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of KLHL7 promoter	PMID:27989131
1313665	KLHL7	kelch like family member 7	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KLHL7 mRNA	PMID:25562108
1313665	KLHL7	kelch like family member 7	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KLHL7 mRNA	PMID:38832940
1313665	KLHL7	kelch like family member 7	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of KLHL7 mRNA	PMID:26272509
1313665	KLHL7	kelch like family member 7	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL7 mRNA	PMID:27188386
1313665	KLHL7	kelch like family member 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305564	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KLHL7 mRNA	PMID:33387578
1313665	KLHL7	kelch like family member 7	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	KLHL7 protein affects the susceptibility to Fluorouracil	PMID:16217747
1313665	KLHL7	kelch like family member 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313666	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KLHL7 mRNA	PMID:40504410
1313665	KLHL7	kelch like family member 7	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of KLHL7 mRNA	PMID:18175754
1313665	KLHL7	kelch like family member 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of KLHL7 mRNA	PMID:23300844
1313665	KLHL7	kelch like family member 7	gene	CHEBI:50292	cadmium sulfate	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C037123	[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of KLHL7 mRNA	PMID:18654764
1313665	KLHL7	kelch like family member 7	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305564	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of KLHL7 mRNA	PMID:20080153
1313665	KLHL7	kelch like family member 7	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313666	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of KLHL7 mRNA	PMID:23650126
1313665	KLHL7	kelch like family member 7	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313666	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of KLHL7 mRNA	PMID:20003209
1313665	KLHL7	kelch like family member 7	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305564	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of KLHL7 mRNA	PMID:30467583
1313665	KLHL7	kelch like family member 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313666	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KLHL7 mRNA	PMID:22206623
1313665	KLHL7	kelch like family member 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL7 mRNA	PMID:27188386
1313665	KLHL7	kelch like family member 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313666	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of KLHL7 mRNA	PMID:23091169
1313665	KLHL7	kelch like family member 7	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1305564	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of KLHL7 mRNA	PMID:20345932
1313665	KLHL7	kelch like family member 7	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1313666	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of KLHL7 mRNA	PMID:31388691
1313665	KLHL7	kelch like family member 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305564	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of KLHL7 mRNA	PMID:24780913
1313665	KLHL7	kelch like family member 7	gene	CHEBI:88212	lead(II) chloride	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029891	[cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of KLHL7 mRNA	PMID:18654764
1313665	KLHL7	kelch like family member 7	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL7 mRNA	PMID:27188386
1313665	KLHL7	kelch like family member 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305564	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of KLHL7 mRNA	PMID:21346803
1313665	KLHL7	kelch like family member 7	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305564	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of KLHL7 mRNA	PMID:20566332
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SUPV3L1 mRNA	PMID:33167477
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305565	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of SUPV3L1 gene	PMID:28931070
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SUPV3L1 mRNA	PMID:22378314
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1305565	E	RGD:6480464	20130514	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of SUPV3L1 protein	PMID:23178681
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313668	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SUPV3L1 mRNA	PMID:23892564
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SUPV3L1 protein	PMID:37730182
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305565	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SUPV3L1 mRNA	PMID:33387578
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313668	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SUPV3L1 mRNA	PMID:36331819
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SUPV3L1 mRNA	PMID:19549813
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313668	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SUPV3L1 mRNA	PMID:25629700
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1305565	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of SUPV3L1 gene	PMID:31011160
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1313668	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of SUPV3L1 protein	PMID:22006019
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313668	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SUPV3L1 mRNA	PMID:21570461
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305565	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SUPV3L1 mRNA	PMID:21215274
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of SUPV3L1 mRNA	PMID:33512557
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305565	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SUPV3L1 mRNA	PMID:28959563
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SUPV3L1 mRNA	PMID:29803840
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1305565	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of SUPV3L1 mRNA	PMID:19915844
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of SUPV3L1 mRNA	PMID:25075043
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SUPV3L1 mRNA	PMID:25895662
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1305565	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SUPV3L1 mRNA	PMID:19162173
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of SUPV3L1 mRNA	PMID:20678512
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305565	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SUPV3L1 mRNA	PMID:30816183|PMID:32528016
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of SUPV3L1 protein	PMID:34186270
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305565	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SUPV3L1 mRNA	PMID:25181051
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUPV3L1 mRNA	PMID:28628672
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of SUPV3L1 protein	PMID:34186270
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SUPV3L1 protein	PMID:34186270
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313668	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SUPV3L1 promoter	PMID:28392331
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313668	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of SUPV3L1 mRNA	PMID:34813904
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUPV3L1 mRNA	PMID:28628672
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313668	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SUPV3L1 mRNA	PMID:34813904
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305565	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SUPV3L1 mRNA	PMID:24386269
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SUPV3L1 mRNA	PMID:32588087
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313668	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SUPV3L1 mRNA	PMID:36331819
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SUPV3L1 mRNA	PMID:25979313
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SUPV3L1 mRNA	PMID:20106945|PMID:25562108
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUPV3L1 mRNA	PMID:28628672
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of SUPV3L1 mRNA	PMID:33512557
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of SUPV3L1 mRNA	PMID:25704631
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of SUPV3L1 mRNA	PMID:17039268
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUPV3L1 mRNA	PMID:28628672
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:50035	alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of SUPV3L1 mRNA	PMID:25075043
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313668	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SUPV3L1 mRNA; Nanotubes, Carbon results in increased expression of SUPV3L1 mRNA	PMID:25554681
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305565	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of SUPV3L1 mRNA	PMID:24136188
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305565	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SUPV3L1 mRNA	PMID:24136188
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SUPV3L1 protein	PMID:32959892
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SUPV3L1 mRNA	PMID:19159669
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of SUPV3L1 mRNA	PMID:33512557
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305565	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SUPV3L1 mRNA	PMID:21346803
1313667	SUPV3L1	Suv3 like RNA helicase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305565	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SUPV3L1 mRNA	PMID:21346803
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of UPP1 mRNA	PMID:38218311
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of UPP1 mRNA	PMID:35967413
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of UPP1 mRNA	PMID:23724009|PMID:23830798|PMID:33167477
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20140408	CTD	MESH:D010100	Oxygen inhibits the reaction [darinaparsin results in increased expression of UPP1 mRNA]	PMID:22535156
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of UPP1 mRNA	PMID:26079696
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of UPP1 mRNA	PMID:28986285
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of UPP1 mRNA	PMID:20044591
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16335	adenosine	increases metabolic processing	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D000241	UPP1 protein results in increased metabolism of Adenosine	PMID:15772079
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of UPP1 mRNA	PMID:39298647
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of UPP1 mRNA	PMID:20106945|PMID:31614463
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of UPP1 mRNA	PMID:20660070
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313670	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of UPP1 mRNA	PMID:33711761
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305566	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of UPP1 mRNA	PMID:33387578
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16704	uridine	affects abundance	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D014529	UPP1 protein affects the abundance of Uridine	PMID:15772079
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16704	uridine	increases metabolic processing	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D014529	UPP1 protein results in increased metabolism of Uridine	PMID:15772079
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16704	uridine	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D014529	[UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil; [UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Pentobarbital	PMID:15772079
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16750	guanosine	increases metabolic processing	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D006151	UPP1 protein results in increased metabolism of Guanosine	PMID:15772079
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D002635	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UPP1 mRNA	PMID:34589561
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of UPP1 mRNA	PMID:27664576
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1305566	E	RGD:6480464	20260505	CTD	MESH:D005557	Formaldehyde results in increased expression of UPP1 protein	PMID:40907675
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:16898	pyrimidine	increases metabolic processing	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:C030986	UPP1 protein results in increased metabolism of pyrimidine	PMID:15772079
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of UPP1 mRNA	PMID:20660070
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UPP1 mRNA	PMID:37992649
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of UPP1 mRNA	PMID:33647349
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:17562	cytidine	increases metabolic processing	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D003562	UPP1 protein results in increased metabolism of Cytidine	PMID:15772079
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of UPP1 mRNA	PMID:31256213
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UPP1 mRNA	PMID:37992649
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D006000	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UPP1 mRNA	PMID:34589561
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of UPP1 mRNA	PMID:23825647
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of UPP1 mRNA	PMID:31163220
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305566	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of UPP1 mRNA	PMID:26577399
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of UPP1 mRNA	PMID:28818685
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305566	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of UPP1 protein	PMID:34915118
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of UPP1 mRNA	PMID:23825647
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in increased expression of UPP1 mRNA	PMID:21172416
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of UPP1 mRNA	PMID:19549813
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1305566	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of UPP1 protein	PMID:33236894
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of UPP1 protein	PMID:20106945
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of UPP1 mRNA	PMID:27153756
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of UPP1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of UPP1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of UPP1 protein	PMID:38598786
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305566	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of UPP1 mRNA	PMID:30779732
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1313670	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of UPP1 mRNA	PMID:31939706
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D006002	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UPP1 mRNA	PMID:34589561
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of UPP1 gene	PMID:25304211
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of UPP1 mRNA	PMID:40512198
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305566	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of UPP1 mRNA	PMID:31881176
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1305566	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of UPP1 mRNA	PMID:25905778
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of UPP1 mRNA	PMID:23557933
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of UPP1 mRNA	PMID:27392435
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of UPP1 mRNA	PMID:27392435
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of UPP1 mRNA	PMID:24768652|PMID:25583101
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305566	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UPP1 mRNA	PMID:34747641
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313670	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UPP1 mRNA	PMID:21570461|PMID:26377647
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UPP1 mRNA	PMID:20106945|PMID:21632981
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UPP1 mRNA	PMID:16704738
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305566	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UPP1 mRNA	PMID:33387578
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313670	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UPP1 mRNA	PMID:26290441
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPP1 mRNA	PMID:17942748
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of UPP1 mRNA	PMID:28001369
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1305566	E	RGD:6480464	20200211	CTD	MESH:C004925	methylmercuric chloride results in increased expression of UPP1 mRNA	PMID:31378766
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of UPP1 mRNA	PMID:33212167
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UPP1 mRNA	PMID:30851411
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of UPP1 mRNA	PMID:20971185
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of UPP1 mRNA	PMID:18510171
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of UPP1 mRNA	PMID:29803840
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UPP1 mRNA	PMID:37992649
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D003840	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UPP1 mRNA	PMID:34589561
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of UPP1 mRNA	PMID:20044591
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28869	menadione	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20150127	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of UPP1 mRNA	PMID:25270620
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:28940	calciol	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in decreased expression of UPP1 mRNA	PMID:16508948
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:2948	azathioprine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of UPP1 mRNA	PMID:22623647
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UPP1 mRNA	PMID:38568856|PMID:39719251
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of UPP1 mRNA	PMID:40512198
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of UPP1 mRNA	PMID:29453283
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of UPP1 5' UTR	PMID:27901495
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UPP1 mRNA	PMID:21632981|PMID:26238291
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313670	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UPP1 mRNA	PMID:22228805|PMID:23735875|PMID:32417428
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of UPP1 mRNA	PMID:20971185
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of UPP1 mRNA	PMID:25895662
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313670	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of UPP1 mRNA	PMID:23221170
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of UPP1 mRNA	PMID:27829220
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:3090	bicalutamide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of UPP1 mRNA	PMID:15638997
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:31521	doxifluridine	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20130806	CTD	MESH:C025034	5-benzylacyclouridine inhibits the reaction [[TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine]; [TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine; [TNF protein results in increased expression of UPP1 mRNA] which results in increased susceptibility to doxifluridine	PMID:16397116
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1305566	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of UPP1 mRNA	PMID:16507785
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of UPP1 mRNA	PMID:31745603
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305566	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of UPP1 mRNA	PMID:25729387
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305566	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of UPP1 mRNA	PMID:30047161
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305566	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of UPP1 mRNA	PMID:34492290
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of UPP1 mRNA	PMID:18648102
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of UPP1 mRNA	PMID:17426115
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313670	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of UPP1 mRNA	PMID:18301758|PMID:20813756
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of UPP1 mRNA	PMID:20170705|PMID:30903817
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of UPP1 mRNA	PMID:20678512
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305566	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of UPP1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305566	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UPP1 mRNA	PMID:25181051|PMID:32145629
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UPP1 mRNA	PMID:28628672
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313670	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of UPP1 mRNA	PMID:25172293
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of UPP1 mRNA	PMID:25979313
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1313670	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of UPP1 mRNA	PMID:20713471
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of UPP1 mRNA	PMID:20713471
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of UPP1 mRNA	PMID:40203079
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313670	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of UPP1 mRNA	PMID:30951980
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313670	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of UPP1 mRNA	PMID:30951980
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of UPP1 protein	PMID:35362542
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of UPP1 protein]	PMID:35362542
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of UPP1 mRNA	PMID:21266533
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of UPP1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of UPP1 protein	PMID:38598786
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UPP1 mRNA	PMID:28628672
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305566	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of UPP1 mRNA	PMID:32680482
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UPP1 mRNA	PMID:37042841
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate results in increased expression of UPP1 mRNA	PMID:29024780
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305566	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of UPP1 mRNA	PMID:35163327
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1305566	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of UPP1 mRNA	PMID:18500788
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of UPP1 mRNA	PMID:38568856
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305566	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of UPP1 mRNA	PMID:35163327
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in increased expression of UPP1 mRNA	PMID:19320972|PMID:19376846|PMID:22941251
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of UPP1 mRNA	PMID:24449571
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D005999	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UPP1 mRNA	PMID:34589561
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of UPP1 mRNA	PMID:32588087
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313670	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of UPP1 mRNA	PMID:40194260
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of UPP1 mRNA	PMID:40434365
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of UPP1 mRNA	PMID:26352163
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of UPP1 mRNA	PMID:40419075
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of UPP1 mRNA	PMID:23125180
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of UPP1 mRNA	PMID:19136453
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of UPP1 mRNA	PMID:19101580|PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305566	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of UPP1 mRNA	PMID:30047161|PMID:41580965
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of UPP1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:41037	5-benzyl-1-(2-hydroxyethoxymethyl)uracil	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20161213	CTD	MESH:C034753	5-benzylacyclouridine inhibits the reaction [[TNF protein results in increased activity of UPP1 protein] which results in increased susceptibility to doxifluridine]	PMID:16397116
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:41607	crotonaldehyde	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in increased expression of UPP1 mRNA	PMID:20471460
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:41791	calyculin A	increases expression	ISO	RGD:1313670	E	RGD:6480464	20150127	CTD	MESH:C059041	calyculin A results in increased expression of UPP1 mRNA	PMID:25270620
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UPP1 mRNA	PMID:28628672
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313670	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of UPP1 mRNA	PMID:28973697
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UPP1 mRNA	PMID:37992649
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:43602	obeticholic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in increased expression of UPP1 mRNA	PMID:27939613
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of UPP1 mRNA	PMID:17379860
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of UPP1 mRNA	PMID:38832940
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:4488	diallyl disulfide	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C028009	diallyl disulfide inhibits the reaction [tobacco tar analog results in increased expression of UPP1 mRNA]	PMID:36758788
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of UPP1 mRNA	PMID:26272509
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UPP1 mRNA	PMID:27188386
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of UPP1 mRNA	PMID:29067470
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305566	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of UPP1 mRNA	PMID:33387578
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D000082	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of UPP1 mRNA	PMID:34589561
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	UPP1 affects the susceptibility to Fluorouracil	PMID:15067352
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:46345	5-fluorouracil	affects response to substance	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D005472	UPP1 protein affects the susceptibility to Fluorouracil	PMID:15772079
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of UPP1 mRNA; Fluorouracil results in increased expression of UPP1 protein	PMID:15109396|PMID:15331170|PMID:24737281
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D005472	[UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Fluorouracil	PMID:15772079
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of UPP1 mRNA	PMID:24714768
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of UPP1 mRNA	PMID:25757056
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of UPP1 gene	PMID:25304211
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of UPP1 mRNA	PMID:40512198
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of UPP1 mRNA	PMID:31838189
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in increased expression of UPP1 mRNA	PMID:26615145
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of UPP1 mRNA	PMID:24383545
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305566	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UPP1 mRNA	PMID:17557909
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UPP1 mRNA	PMID:17942748
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPP1 mRNA	PMID:17942748
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of UPP1 protein]	PMID:35362542
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of UPP1 mRNA	PMID:38568856
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of UPP1 mRNA	PMID:16984733
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1305566	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in increased expression of UPP1 mRNA	PMID:36868495
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of UPP1 mRNA	PMID:28628672
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of UPP1 mRNA	PMID:27829220
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:50102	N-methyl-N-nitrosourea	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in decreased expression of UPP1 mRNA	PMID:25270620
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1305566	E	RGD:6480464	20120412	CTD	MESH:D008770	Methylnitrosourea results in increased expression of UPP1 mRNA	PMID:17412507
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of UPP1 mRNA	PMID:25620056
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313670	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of UPP1 mRNA; Nanotubes, Carbon results in increased expression of UPP1 mRNA	PMID:25554681
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305566	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of UPP1 mRNA	PMID:30047161
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:52717	bortezomib	decreases activity	ISO	RGD:1313670	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased activity of UPP1 protein	PMID:16397116
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:52717	bortezomib	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib inhibits the reaction [TNF protein results in increased activity of UPP1 protein]; Bortezomib inhibits the reaction [TNF protein results in increased expression of UPP1 mRNA]	PMID:16397116
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of UPP1 mRNA	PMID:18651567
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1305566	E	RGD:6480464	20120613	CTD	MESH:C015559	trimellitic anhydride results in increased expression of UPP1 mRNA	PMID:21893156
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1305566	E	RGD:6480464	20120613	CTD	MESH:D010081	Oxazolone results in increased expression of UPP1 mRNA	PMID:21893156
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313670	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of UPP1 mRNA	PMID:38701926
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UPP1 protein	PMID:32959892
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305566	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of UPP1 mRNA	PMID:28801915
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of UPP1 mRNA	PMID:21641980
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305566	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of UPP1 mRNA	PMID:25729387
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305566	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of UPP1 mRNA	PMID:25729387
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of UPP1 mRNA	PMID:15336504
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305566	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of UPP1 mRNA	PMID:28801915
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:64163	diquat	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004178	Diquat results in increased expression of UPP1 mRNA	PMID:21172416
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1305566	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of UPP1 mRNA	PMID:19564919
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1305566	E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of UPP1 mRNA	PMID:19564919
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in increased expression of UPP1 mRNA	PMID:33244087
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:73297	SCH 23390	multiple interactions	ISO	RGD:1305566	E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of UPP1 mRNA	PMID:19564919
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:75408	sulindac sulfide	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C025462	sulindac sulfide results in increased expression of UPP1 mRNA	PMID:16184548
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:78160	bleomycin A5	decreases expression	EXP		E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in decreased expression of UPP1 mRNA	PMID:21040473
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UPP1 mRNA	PMID:30851411
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UPP1 mRNA	PMID:27188386
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:7983	pentobarbital	affects response to substance	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D010424	UPP1 protein affects the susceptibility to Pentobarbital	PMID:15772079
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:7983	pentobarbital	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20120412	CTD	MESH:D010424	[UPP1 protein results in increased metabolism of Uridine] which affects the susceptibility to Pentobarbital	PMID:15772079
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of UPP1 mRNA	PMID:19159669
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:8069	phenobarbital	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in increased expression of UPP1 mRNA	PMID:19084549
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of UPP1 mRNA	PMID:31173147
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of UPP1 mRNA	PMID:39847705
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:84070	sodium arsenate	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of UPP1 mRNA	PMID:12727804
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305566	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of UPP1 mRNA	PMID:24780913
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305566	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of UPP1 mRNA	PMID:30047161
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of UPP1 mRNA	PMID:24921660
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:88522	Monobutylphthalate	affects expression	ISO	RGD:1313670	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate affects the expression of UPP1 mRNA	PMID:19162170
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of UPP1 mRNA	PMID:27188386
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305566	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of UPP1 mRNA	PMID:21346803
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of UPP1 mRNA	PMID:38568856
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1313670	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of UPP1 mRNA	PMID:26217789
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013849	Thimerosal results in increased expression of UPP1 mRNA	PMID:16870260
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of UPP1 protein	PMID:38598786
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1305566	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of UPP1 protein	PMID:32519852
1313669	UPP1	uridine phosphorylase 1	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1313670	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of UPP1 mRNA	PMID:18930950
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide analog results in decreased expression of LRFN3 mRNA	PMID:33227293
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313672	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of LRFN3 mRNA	PMID:24205000
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LRFN3 mRNA	PMID:36331819
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313672	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of LRFN3 mRNA	PMID:30319688
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313672	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of LRFN3 mRNA	PMID:39298647
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of LRFN3 mRNA	PMID:38568856
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305567	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LRFN3 mRNA	PMID:33387578
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313672	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of LRFN3 mRNA	PMID:25549359
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LRFN3 mRNA	PMID:37042841
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313672	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LRFN3 mRNA	PMID:32235866
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305567	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of LRFN3 mRNA	PMID:33387578
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LRFN3 mRNA	PMID:36331819
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRFN3 mRNA	PMID:37236586
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of LRFN3 mRNA	PMID:19549813
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LRFN3 gene	PMID:27153756
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in decreased expression of LRFN3 mRNA	PMID:31939706
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRFN3 mRNA	PMID:22206623
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:27698	vanadium atom	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D014639	[Metals, Heavy results in increased abundance of Vanadium] which results in increased methylation of LRFN3 gene	PMID:39164771
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:1305567	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of LRFN3 gene	PMID:31011160
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313672	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of LRFN3 mRNA	PMID:28960355
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of LRFN3 mRNA	PMID:23557933
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313672	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRFN3 mRNA	PMID:28922406
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305567	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRFN3 mRNA	PMID:33387578
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LRFN3 mRNA	PMID:28001369
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of LRFN3 mRNA	PMID:32763439
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of LRFN3 mRNA	PMID:20044591
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:29021	hexane	decreases methylation	ISO	RGD:1305567	E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of LRFN3 promoter	PMID:23740543
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRFN3 mRNA	PMID:27195522
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313672	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LRFN3 mRNA	PMID:22228805
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to LRFN3 promoter]	PMID:19654925
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LRFN3 mRNA	PMID:34973136
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313672	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRFN3 gene	PMID:35295148
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313672	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LRFN3 gene	PMID:35295148
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305567	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of LRFN3 mRNA	PMID:34492290
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1313672	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of LRFN3 mRNA	PMID:17950772
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313672	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of LRFN3 mRNA	PMID:18301758|PMID:23811191
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LRFN3 mRNA	PMID:19710929
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305567	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LRFN3 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313672	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LRFN3 mRNA	PMID:32156529
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305567	E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LRFN3 mRNA	PMID:32119087
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313672	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LRFN3 mRNA	PMID:37019170
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of LRFN3 mRNA	PMID:34813904
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35170	vanadium(0)	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D014639	[Metals, Heavy results in increased abundance of Vanadium] which results in increased methylation of LRFN3 gene	PMID:39164771
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of LRFN3 mRNA	PMID:26377693
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LRFN3 mRNA	PMID:38568856
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LRFN3 mRNA	PMID:38382870
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRFN3 mRNA	PMID:37236586
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305567	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of LRFN3 mRNA	PMID:25539665|PMID:26194646|PMID:27387713
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305567	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased methylation of LRFN3 gene	PMID:27387713
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LRFN3 mRNA	PMID:19376846
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of LRFN3 mRNA	PMID:24449571
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313672	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of LRFN3 mRNA	PMID:28962523
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313672	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of LRFN3 mRNA	PMID:23811191
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LRFN3 mRNA	PMID:40194260
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of LRFN3 mRNA	PMID:28302478
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of LRFN3 mRNA	PMID:31533062
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LRFN3 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LRFN3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of LRFN3 mRNA	PMID:36331819
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313672	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of LRFN3 mRNA	PMID:17963808
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LRFN3 gene	PMID:29154799
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of LRFN3 mRNA	PMID:20106945
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of LRFN3 mRNA	PMID:19770486
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313672	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of LRFN3 mRNA	PMID:18502557
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305567	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LRFN3 mRNA	PMID:33387578
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1305567	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of LRFN3 mRNA	PMID:29391264
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of LRFN3 mRNA	PMID:18175754
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313672	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of LRFN3 mRNA	PMID:25620056
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313672	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of LRFN3 mRNA	PMID:19042947
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of LRFN3 mRNA	PMID:31758290
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313672	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LRFN3 mRNA	PMID:22206623
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305567	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of LRFN3 mRNA	PMID:21346803
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LRFN3 gene]	PMID:28238834
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305567	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LRFN3 mRNA	PMID:21346803
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of LRFN3 mRNA	PMID:29301935
1313671	LRFN3	leucine rich repeat and fibronectin type III domain containing 3	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305567	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of LRFN3 mRNA	PMID:20566332
1313673	PAX2	paired box 2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PAX2 mRNA	PMID:26272509
1313673	PAX2	paired box 2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX2 mRNA	PMID:27188386
1313673	PAX2	paired box 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313674	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PAX2 mRNA	PMID:33045310
1313673	PAX2	paired box 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of PAX2 mRNA	PMID:37995155
1313673	PAX2	paired box 2	gene	CHEBI:132889	graphene oxide	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide analog results in decreased expression of PAX2 mRNA	PMID:33227293
1313673	PAX2	paired box 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PAX2 mRNA	PMID:20188158
1313673	PAX2	paired box 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313674	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PAX2 gene	PMID:20938992
1313673	PAX2	paired box 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313674	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of PAX2 mRNA	PMID:36189433
1313673	PAX2	paired box 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313674	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PAX2 mRNA	PMID:36189433
1313673	PAX2	paired box 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305568	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of PAX2 gene	PMID:28931070|PMID:35440735
1313673	PAX2	paired box 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1305568	E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in decreased expression of PAX2 mRNA	PMID:29548890|PMID:31039417
1313673	PAX2	paired box 2	gene	CHEBI:16412	lipopolysaccharide	increases response to substance	ISO	RGD:1313674	E	RGD:6480464	20161228	CTD	MESH:D008070	PAX2 protein results in increased susceptibility to Lipopolysaccharides	PMID:21131441
1313673	PAX2	paired box 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PAX2 mRNA	PMID:25549359
1313673	PAX2	paired box 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313674	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PAX2 gene	PMID:20938992
1313673	PAX2	paired box 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313674	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of PAX2 mRNA	PMID:36189433
1313673	PAX2	paired box 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313674	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of PAX2 mRNA	PMID:36189433
1313673	PAX2	paired box 2	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PAX2 mRNA	PMID:33359661
1313673	PAX2	paired box 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1305568	E	RGD:6480464	20121009	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PAX2 mRNA	PMID:22677342
1313673	PAX2	paired box 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PAX2 intron	PMID:30157460
1313673	PAX2	paired box 2	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of PAX2 mRNA	PMID:21120746
1313673	PAX2	paired box 2	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of PAX2 mRNA	PMID:24376830
1313673	PAX2	paired box 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313674	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of PAX2 mRNA	PMID:25629700
1313673	PAX2	paired box 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313674	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PAX2 gene	PMID:20938992
1313673	PAX2	paired box 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PAX2 mRNA	PMID:28189721|PMID:28960355
1313673	PAX2	paired box 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PAX2 mRNA	PMID:28903495
1313673	PAX2	paired box 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313674	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PAX2 mRNA	PMID:21570461|PMID:24058054
1313673	PAX2	paired box 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305568	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PAX2 mRNA	PMID:32109520
1313673	PAX2	paired box 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PAX2 mRNA	PMID:21296121
1313673	PAX2	paired box 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PAX2 mRNA	PMID:33212167
1313673	PAX2	paired box 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313674	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of PAX2 mRNA	PMID:27862939
1313673	PAX2	paired box 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in increased expression of PAX2 mRNA	PMID:35954277
1313673	PAX2	paired box 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PAX2 3' UTR; Benzo(a)pyrene affects the methylation of PAX2 intron; Benzo(a)pyrene affects the methylation of PAX2 promoter	PMID:27901495|PMID:30157460
1313673	PAX2	paired box 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PAX2 mRNA	PMID:21803694
1313673	PAX2	paired box 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PAX2 gene	PMID:31601247
1313673	PAX2	paired box 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of PAX2 mRNA	PMID:35295148
1313673	PAX2	paired box 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313674	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PAX2 gene; titanium dioxide results in decreased methylation of PAX2 promoter	PMID:35295148
1313673	PAX2	paired box 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313674	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of PAX2 mRNA	PMID:29264374
1313673	PAX2	paired box 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313674	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PAX2 promoter	PMID:35295148
1313673	PAX2	paired box 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305568	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PAX2 mRNA	PMID:23411599
1313673	PAX2	paired box 2	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305568	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of PAX2 mRNA	PMID:19167457
1313673	PAX2	paired box 2	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of PAX2 gene	PMID:31601247
1313673	PAX2	paired box 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313674	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of PAX2 promoter	PMID:27334623
1313673	PAX2	paired box 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305568	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PAX2 mRNA	PMID:25181051
1313673	PAX2	paired box 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of PAX2 mRNA	PMID:30951980
1313673	PAX2	paired box 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313674	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of PAX2 mRNA	PMID:32156529
1313673	PAX2	paired box 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PAX2 gene	PMID:31601247
1313673	PAX2	paired box 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313674	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PAX2 gene	PMID:31683443
1313673	PAX2	paired box 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of PAX2 mRNA	PMID:30951980
1313673	PAX2	paired box 2	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of PAX2 mRNA	PMID:26377693
1313673	PAX2	paired box 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PAX2 intron	PMID:30157460
1313673	PAX2	paired box 2	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of PAX2 mRNA	PMID:26377693
1313673	PAX2	paired box 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of PAX2 mRNA	PMID:30951980
1313673	PAX2	paired box 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313674	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PAX2 mRNA	PMID:37019170
1313673	PAX2	paired box 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305568	E	RGD:6480464	20250805	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PAX2 mRNA	PMID:28415704
1313673	PAX2	paired box 2	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1313674	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of PAX2 gene	PMID:38995845
1313673	PAX2	paired box 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PAX2 mRNA	PMID:40194260
1313673	PAX2	paired box 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PAX2 mRNA	PMID:25979313
1313673	PAX2	paired box 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PAX2 gene	PMID:29154799
1313673	PAX2	paired box 2	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of PAX2 mRNA	PMID:25123088
1313673	PAX2	paired box 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PAX2 mRNA	PMID:24935251
1313673	PAX2	paired box 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305568	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PAX2 mRNA	PMID:33387578
1313673	PAX2	paired box 2	gene	CHEBI:46680	serpentine asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of PAX2 gene	PMID:29523930
1313673	PAX2	paired box 2	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:1305568	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of PAX2 gene	PMID:37958445
1313673	PAX2	paired box 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313674	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of PAX2 mRNA	PMID:25620056
1313673	PAX2	paired box 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313674	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PAX2 mRNA	PMID:25620056
1313673	PAX2	paired box 2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PAX2 intron	PMID:30157460
1313673	PAX2	paired box 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305568	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PAX2 gene	PMID:35440735
1313673	PAX2	paired box 2	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1313674	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PAX2 mRNA	PMID:25566086
1313673	PAX2	paired box 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX2 mRNA	PMID:27188386
1313673	PAX2	paired box 2	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of PAX2 mRNA	PMID:26272509
1313673	PAX2	paired box 2	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX2 mRNA	PMID:27188386
1313673	PAX2	paired box 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAX2 mRNA	PMID:27188386
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ARL5B mRNA	PMID:26272509
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARL5B mRNA	PMID:27188386
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313676	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ARL5B mRNA	PMID:33045310
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ARL5B mRNA	PMID:26251327
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	EXP		E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of ARL5B mRNA	PMID:23792671
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:15343	acetaldehyde	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D000079	Acetaldehyde results in increased expression of ARL5B mRNA	PMID:23416264
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ARL5B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ARL5B mRNA	PMID:32699268
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ARL5B mRNA	PMID:36331819
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ARL8 mRNA	PMID:20044591
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ARL5B mRNA	PMID:35811015
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARL5B mRNA	PMID:35811015
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305569	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of ARL5B mRNA	PMID:32145629
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ARL5B mRNA	PMID:39298647
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARL5B mRNA	PMID:37042841
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313676	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of ARL5B mRNA	PMID:17178593
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ARL5B mRNA	PMID:37992649
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313676	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of ARL5B mRNA	PMID:17178593
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ARL5B mRNA	PMID:37992649
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D002117	Calcitriol results in increased expression of ARL8 mRNA	PMID:16002434
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305569	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ARL5B mRNA	PMID:33387578
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARL5B mRNA	PMID:36331819
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ARL5B mRNA	PMID:39836092
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1313676	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of ARL5B mRNA	PMID:33914522
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305569	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARL5B mRNA	PMID:39012411
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ARL5B mRNA	PMID:19549813
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313676	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARL5B mRNA	PMID:19770486
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ARL5B mRNA	PMID:23649840
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ARL5B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ARL5B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ARL5B mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of ARL5B mRNA	PMID:32699268|PMID:41430723
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARL5B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ARL5B mRNA	PMID:34911549
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ARL5B mRNA	PMID:18593933
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313676	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ARL5B mRNA	PMID:31919559
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARL5B mRNA	PMID:40504410
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ARL5B mRNA	PMID:27392435
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ARL5B mRNA	PMID:27392435
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313676	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of ARL5B mRNA	PMID:30912803
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ARL5B mRNA	PMID:23195993|PMID:24768652|PMID:25583101
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313676	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARL5B mRNA	PMID:21570461
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305569	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARL5B mRNA	PMID:33387578
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ARL5B promoter]	PMID:19654925
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ARL5B mRNA	PMID:28001369
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ARL5B mRNA	PMID:28001369
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARL5B mRNA	PMID:33212167
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of ARL5B mRNA	PMID:23649840
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ARL5B mRNA	PMID:20971185
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARL5B mRNA	PMID:29803840
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ARL5B mRNA	PMID:37992649
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ARL5B mRNA	PMID:25523186
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARL5B mRNA	PMID:39719251
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ARL5B mRNA	PMID:38568856
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARL5B mRNA	PMID:40504410
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARL5B mRNA	PMID:20106945
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ARL5B mRNA	PMID:25523186
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ARL5B mRNA	PMID:20971185
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ARL5B mRNA	PMID:18593933
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ARL5B mRNA	PMID:27131904
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ARL5B mRNA	PMID:23806026
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ARL5B mRNA	PMID:26238291
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ARL5B mRNA	PMID:22521957
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1305569	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of ARL5B mRNA	PMID:16507785
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313676	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARL5B promoter alternative form	PMID:35295148
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305569	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ARL5B mRNA	PMID:23411599|PMID:34492290
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ARL5B mRNA	PMID:20813756
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ARL5B mRNA	PMID:19710929
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARL5B mRNA	PMID:19710929
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of ARL5B mRNA	PMID:28329830
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1313676	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of ARL5B mRNA	PMID:33914522
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305569	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ARL5B mRNA	PMID:32145629
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:33418	graphite	affects expression	ISO	RGD:1305569	E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of ARL5B mRNA	PMID:29933104
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ARL5B mRNA	PMID:39298647
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1305569	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ARL5B mRNA	PMID:21241498
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313676	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARL5B mRNA	PMID:21266533
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ARL5B mRNA	PMID:39836092
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARL5B mRNA	PMID:38174414|PMID:38568856
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305569	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ARL5B mRNA	PMID:39012411
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ARL5B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ARL5B mRNA	PMID:32699268
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ARL5B mRNA	PMID:27153767
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARL5B mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ARL5B mRNA	PMID:36331819
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARL5B mRNA	PMID:23179753|PMID:27188386
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ARL5B mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313676	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in increased expression of ARL5B mRNA	PMID:17178593
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ARL5B mRNA	PMID:37992649
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of ARL5B mRNA	PMID:23649840
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ARL5B mRNA	PMID:28542535
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ARL5B mRNA	PMID:26690555
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305569	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ARL5B mRNA	PMID:33387578
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20120412	CTD	MESH:D000082	MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ARL5B mRNA]	PMID:18700144
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of ARL5B mRNA	PMID:20977926
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ARL5B mRNA	PMID:35811015
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ARL5B mRNA	PMID:18687144
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARL5B mRNA	PMID:40504410
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305569	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ARL5B mRNA	PMID:29391264
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305569	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARL5B mRNA	PMID:29097150
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of ARL5B mRNA	PMID:23228038
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ARL5B mRNA	PMID:22521957
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARL5B mRNA; Nanotubes, Carbon results in decreased expression of ARL5B mRNA	PMID:25554681|PMID:25620056
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313676	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ARL5B mRNA	PMID:23608068
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ARL5B mRNA	PMID:39836092
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ARL5B mRNA	PMID:28988120
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305569	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ARL5B mRNA	PMID:28801915
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1305569	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ARL5B mRNA	PMID:19564919
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1305569	E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of ARL5B mRNA	PMID:19564919
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:73297	SCH 23390	increases expression	ISO	RGD:1305569	E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 results in increased expression of ARL5B mRNA	PMID:19564919
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:73297	SCH 23390	multiple interactions	ISO	RGD:1305569	E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of ARL5B mRNA	PMID:19564919
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ARL5B mRNA	PMID:22206623
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARL5B mRNA	PMID:27188386
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ARL5B mRNA	PMID:30928695
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARL5B gene]	PMID:28238834
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ARL5B mRNA	PMID:19159669
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of ARL5B mRNA	PMID:23091169
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of ARL5B mRNA	PMID:19095052
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1313676	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of ARL5B mRNA	PMID:38995820
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313676	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ARL5B mRNA	PMID:39847705
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARL5B mRNA	PMID:27188386
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313676	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ARL5B mRNA	PMID:27131904
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ARL5B mRNA	PMID:38568856
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of ARL5B mRNA	PMID:29301935
1313675	ARL5B	ARF like GTPase 5B	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305569	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of ARL5B mRNA	PMID:23869203
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of ZMPSTE24 mRNA	PMID:24236059
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ZMPSTE24 mRNA	PMID:22378314
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313678	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ZMPSTE24 mRNA	PMID:30319688
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ZMPSTE24 mRNA	PMID:20044591
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ZMPSTE24 mRNA	PMID:21632981
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313678	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZMPSTE24 mRNA	PMID:39241906
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305570	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZMPSTE24 mRNA	PMID:33387578
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZMPSTE24 mRNA	PMID:36331819
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZMPSTE24 mRNA	PMID:35301059
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZMPSTE24 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZMPSTE24 mRNA	PMID:37236586|PMID:37325564
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZMPSTE24 mRNA	PMID:19549813
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZMPSTE24 gene	PMID:27153756
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ZMPSTE24 mRNA	PMID:35430440
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZMPSTE24 mRNA	PMID:22206623
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZMPSTE24 mRNA	PMID:39836092
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305570	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ZMPSTE24 mRNA	PMID:31881176
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20141111	CTD	MESH:C059514	resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased acetylation of FOXO3 protein]; resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased expression of CAT protein]; resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased expression of GADD45A protein]; SIRT1 mutant form inhibits the reaction [resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased expression of CAT protein]]; SIRT1 mutant form inhibits the reaction [resveratrol inhibits the reaction [ZMPSTE24 gene mutant form results in increased expression of GADD45A protein]]	PMID:23217256
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ZMPSTE24 mRNA	PMID:28903495
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313678	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZMPSTE24 mRNA	PMID:20702594|PMID:21570461
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313678	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZMPSTE24 mRNA	PMID:31961203
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZMPSTE24 mRNA	PMID:17942748
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of ZMPSTE24 protein	PMID:39603559
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZMPSTE24 mRNA	PMID:32763439
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313678	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ZMPSTE24 protein	PMID:28918527
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ZMPSTE24 mRNA	PMID:25523186
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZMPSTE24 mRNA	PMID:39719251
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZMPSTE24 mRNA	PMID:39836092
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313678	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZMPSTE24 mRNA	PMID:22228805
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ZMPSTE24 mRNA	PMID:25523186
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ZMPSTE24 mRNA	PMID:20458559
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:31781	lopinavir	decreases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:D061466	Lopinavir results in decreased activity of ZMPSTE24 protein	PMID:18230615
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1313678	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of ZMPSTE24 mRNA	PMID:19136022
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313678	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in decreased expression of ZMPSTE24 mRNA	PMID:17426115|PMID:17950772
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of ZMPSTE24 mRNA]	PMID:17950772
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305570	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZMPSTE24 mRNA	PMID:25181051
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305570	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZMPSTE24 mRNA	PMID:34947998
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ZMPSTE24 protein	PMID:34186270
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313678	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZMPSTE24 promoter	PMID:27312807
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313678	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ZMPSTE24 mRNA	PMID:39298647
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ZMPSTE24 protein	PMID:34186270
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313678	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ZMPSTE24 protein	PMID:35362542
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ZMPSTE24 protein]	PMID:35362542
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZMPSTE24 mRNA	PMID:35301059
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZMPSTE24 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZMPSTE24 mRNA	PMID:37236586|PMID:37325564
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ZMPSTE24 mRNA	PMID:28302478
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZMPSTE24 mRNA	PMID:36331819
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZMPSTE24 mRNA	PMID:25979313
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ZMPSTE24 mRNA	PMID:23179753
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ZMPSTE24 mRNA	PMID:17183730
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZMPSTE24 mRNA	PMID:25562108
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ZMPSTE24 mRNA	PMID:38832940
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:45409	ritonavir	decreases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:D019438	Ritonavir results in decreased activity of ZMPSTE24 protein	PMID:18230615
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313678	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZMPSTE24 mRNA	PMID:17562736
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZMPSTE24 mRNA	PMID:39836092
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZMPSTE24 mRNA	PMID:17942748
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ZMPSTE24 protein]	PMID:35362542
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ZMPSTE24 mRNA	PMID:20458559
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ZMPSTE24 mRNA	PMID:17183730
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ZMPSTE24 protein	PMID:32959892
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313678	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZMPSTE24 mRNA	PMID:22206623
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313678	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZMPSTE24 mRNA	PMID:22206623
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZMPSTE24 gene]	PMID:28238834
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313678	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of ZMPSTE24 mRNA	PMID:19136022
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1313678	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of ZMPSTE24 mRNA	PMID:20702594
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of ZMPSTE24 mRNA	PMID:21858171
1313677	ZMPSTE24	zinc metallopeptidase STE24	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ZMPSTE24 mRNA	PMID:38568856
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313680	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CNNM4 mRNA	PMID:33045310
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D011794	Quercetin results in increased expression of CNNM4 mRNA	PMID:30152185
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313680	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CNNM4 mRNA	PMID:39241906
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CNNM4 mRNA	PMID:39298647
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CNNM4 mRNA	PMID:38568856
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305571	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CNNM4 mRNA	PMID:33387578
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of CNNM4 mRNA	PMID:33647349
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313680	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CNNM4 mRNA	PMID:34319233
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CNNM4 protein	PMID:37730182
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305571	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CNNM4 mRNA	PMID:33387578
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CNNM4 mRNA	PMID:28818685
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313680	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CNNM4 mRNA	PMID:36331819
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CNNM4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of CNNM4 mRNA	PMID:39836092
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305571	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CNNM4 protein	PMID:34915118
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:22984	calcium atom	affects expression	ISO	RGD:1305571	E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium affects the expression of CNNM4 mRNA	PMID:15913539
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CNNM4 mRNA	PMID:19549813
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CNNM4 gene	PMID:27153756
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CNNM4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CNNM4 mRNA	PMID:39836092
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313680	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CNNM4 mRNA	PMID:26377647
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CNNM4 mRNA	PMID:33212167
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CNNM4 mRNA	PMID:30851411
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305571	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CNNM4 mRNA	PMID:28959563
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CNNM4 mRNA	PMID:29803840
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:29320	calcium(0)	affects expression	ISO	RGD:1305571	E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium affects the expression of CNNM4 mRNA	PMID:15913539
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CNNM4 mRNA	PMID:38568856
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CNNM4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CNNM4 mRNA	PMID:39836092
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CNNM4 mRNA	PMID:19770486
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CNNM4 mRNA	PMID:20106945|PMID:21632981
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CNNM4 exon; Benzo(a)pyrene results in increased methylation of CNNM4 promoter	PMID:27901495
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	CNNM4 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CNNM4 protein]	PMID:26598702
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313680	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CNNM4 gene	PMID:35295148
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305571	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CNNM4 mRNA	PMID:34492290
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CNNM4 mRNA	PMID:18648102
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313680	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CNNM4 mRNA	PMID:18301758
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313680	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of CNNM4 mRNA	PMID:28329830
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305571	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CNNM4 mRNA	PMID:34947998
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305571	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CNNM4 mRNA	PMID:25181051
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1313680	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of CNNM4 mRNA	PMID:25172293
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CNNM4 mRNA	PMID:39298647
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313680	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CNNM4 intron	PMID:28392331
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CNNM4 mRNA	PMID:37042841
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CNNM4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of CNNM4 mRNA	PMID:39836092
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CNNM4 protein	PMID:26879310
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CNNM4 mRNA	PMID:40194260
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CNNM4 mRNA	PMID:28302478
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313680	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CNNM4 mRNA	PMID:36331819
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:39867	valproic acid	affects methylation	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid affects the methylation of CNNM4 gene	PMID:29501571
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of CNNM4 mRNA; Valproic Acid results in increased expression of CNNM4 protein	PMID:24935251|PMID:29154799|PMID:29501571
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CNNM4 gene	PMID:29154799
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CNNM4 mRNA	PMID:25562108|PMID:27989131
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313680	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of CNNM4 mRNA	PMID:18502557
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CNNM4 mRNA	PMID:38832940
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313680	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CNNM4 mRNA	PMID:17562736
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CNNM4 mRNA	PMID:21420995|PMID:22230336|PMID:29067470
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305571	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CNNM4 mRNA	PMID:33387578
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CNNM4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CNNM4 mRNA	PMID:39836092
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305571	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CNNM4 mRNA	PMID:29391264
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CNNM4 mRNA	PMID:35436446
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	CNNM4 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CNNM4 protein]	PMID:26598702
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313680	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CNNM4 mRNA	PMID:25554681
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CNNM4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of CNNM4 mRNA	PMID:39836092
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313680	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of CNNM4 mRNA	PMID:36851058
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313680	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CNNM4 mRNA	PMID:22206623
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CNNM4 mRNA	PMID:30851411
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CNNM4 mRNA	PMID:19159669
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in increased expression of CNNM4 mRNA	PMID:11906190
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CNNM4 mRNA	PMID:38568856
1313679	CNNM4	cyclin and CBS domain divalent metal cation transport mediator 4	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305571	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CNNM4 mRNA	PMID:23034163
1313682	RPL38	ribosomal protein L38	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RPL38 mRNA	PMID:38218311
1313682	RPL38	ribosomal protein L38	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of RPL38 mRNA	PMID:35967413
1313682	RPL38	ribosomal protein L38	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313683	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RPL38 mRNA	PMID:33045310
1313682	RPL38	ribosomal protein L38	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305573	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of RPL38 gene	PMID:35440735
1313682	RPL38	ribosomal protein L38	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313683	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RPL38 mRNA	PMID:30319688
1313682	RPL38	ribosomal protein L38	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313683	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RPL38 mRNA	PMID:39241906
1313682	RPL38	ribosomal protein L38	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of RPL38 mRNA	PMID:23019147
1313682	RPL38	ribosomal protein L38	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RPL38 mRNA	PMID:33754040
1313682	RPL38	ribosomal protein L38	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPL38 protein	PMID:23301498
1313682	RPL38	ribosomal protein L38	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305573	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RPL38 mRNA	PMID:30779732
1313682	RPL38	ribosomal protein L38	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of RPL38 mRNA	PMID:18356318
1313682	RPL38	ribosomal protein L38	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPL38 mRNA	PMID:39836092
1313682	RPL38	ribosomal protein L38	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of RPL38 mRNA	PMID:19244175
1313682	RPL38	ribosomal protein L38	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313683	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of RPL38 mRNA	PMID:30912803
1313682	RPL38	ribosomal protein L38	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of RPL38 protein	PMID:20884965
1313682	RPL38	ribosomal protein L38	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	ESR2 promotes the reaction [Genistein results in decreased expression of RPL38 protein]	PMID:20884965
1313682	RPL38	ribosomal protein L38	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313683	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPL38 mRNA	PMID:17949056|PMID:21570461
1313682	RPL38	ribosomal protein L38	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313683	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of RPL38 mRNA	PMID:17942748
1313682	RPL38	ribosomal protein L38	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RPL38 mRNA	PMID:34089799
1313682	RPL38	ribosomal protein L38	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RPL38 protein	PMID:33212167
1313682	RPL38	ribosomal protein L38	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of RPL38 mRNA	PMID:24690739
1313682	RPL38	ribosomal protein L38	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPL38 mRNA; sodium arsenite results in decreased expression of and results in increased activity of RPL38 protein	PMID:30528433|PMID:39836092
1313682	RPL38	ribosomal protein L38	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RPL38 protein	PMID:33278487
1313682	RPL38	ribosomal protein L38	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of RPL38 promoter	PMID:23974009
1313682	RPL38	ribosomal protein L38	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RPL38 mRNA]	PMID:32406909
1313682	RPL38	ribosomal protein L38	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of RPL38 mRNA	PMID:24690739
1313682	RPL38	ribosomal protein L38	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of RPL38 mRNA	PMID:18356318
1313682	RPL38	ribosomal protein L38	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RPL38 mRNA	PMID:20018196
1313682	RPL38	ribosomal protein L38	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of RPL38 mRNA	PMID:19150397
1313682	RPL38	ribosomal protein L38	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1305573	E	RGD:6480464	20160223	CTD	MESH:D000643	Ammonium Chloride affects the expression of RPL38 mRNA	PMID:16483693
1313682	RPL38	ribosomal protein L38	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in decreased expression of RPL38 mRNA	PMID:38568856
1313682	RPL38	ribosomal protein L38	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313683	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RPL38 gene; titanium dioxide results in decreased methylation of RPL38 promoter	PMID:35295148
1313682	RPL38	ribosomal protein L38	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RPL38 mRNA	PMID:18648102
1313682	RPL38	ribosomal protein L38	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of RPL38 mRNA	PMID:30903817
1313682	RPL38	ribosomal protein L38	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL38 mRNA	PMID:38568856
1313682	RPL38	ribosomal protein L38	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305573	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL38 mRNA	PMID:32145629
1313682	RPL38	ribosomal protein L38	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL38 mRNA	PMID:35598803
1313682	RPL38	ribosomal protein L38	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305573	E	RGD:6480464	20160223	CTD	MESH:C006780	bisphenol A results in increased expression of RPL38 mRNA	PMID:25181051
1313682	RPL38	ribosomal protein L38	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of RPL38 mRNA	PMID:19244175
1313682	RPL38	ribosomal protein L38	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of RPL38 mRNA	PMID:40203079
1313682	RPL38	ribosomal protein L38	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of RPL38 protein	PMID:34186270
1313682	RPL38	ribosomal protein L38	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313683	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RPL38 mRNA	PMID:39298647
1313682	RPL38	ribosomal protein L38	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RPL38 mRNA	PMID:38685157
1313682	RPL38	ribosomal protein L38	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RPL38 protein	PMID:34186270
1313682	RPL38	ribosomal protein L38	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1305573	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of RPL38 mRNA	PMID:21241498
1313682	RPL38	ribosomal protein L38	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313683	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RPL38 mRNA	PMID:37019170
1313682	RPL38	ribosomal protein L38	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313683	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of RPL38 mRNA	PMID:34813904
1313682	RPL38	ribosomal protein L38	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313683	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of RPL38 mRNA	PMID:34813904
1313682	RPL38	ribosomal protein L38	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305573	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of RPL38 gene	PMID:33148267
1313682	RPL38	ribosomal protein L38	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RPL38 mRNA	PMID:37042841
1313682	RPL38	ribosomal protein L38	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RPL38 mRNA	PMID:38568856
1313682	RPL38	ribosomal protein L38	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of RPL38 mRNA	PMID:19244175
1313682	RPL38	ribosomal protein L38	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RPL38 mRNA	PMID:38568856
1313682	RPL38	ribosomal protein L38	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RPL38 mRNA	PMID:31533062
1313682	RPL38	ribosomal protein L38	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of RPL38 mRNA	PMID:26352163
1313682	RPL38	ribosomal protein L38	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313683	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RPL38 mRNA	PMID:17555576
1313682	RPL38	ribosomal protein L38	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313683	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RPL38 mRNA	PMID:17562736
1313682	RPL38	ribosomal protein L38	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of RPL38 mRNA	PMID:24690739
1313682	RPL38	ribosomal protein L38	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RPL38 mRNA	PMID:39836092
1313682	RPL38	ribosomal protein L38	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313683	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RPL38 mRNA	PMID:35436446
1313682	RPL38	ribosomal protein L38	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313683	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RPL38 mRNA	PMID:17555576
1313682	RPL38	ribosomal protein L38	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of RPL38 mRNA	PMID:17942748
1313682	RPL38	ribosomal protein L38	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313683	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of RPL38 mRNA	PMID:17942748
1313682	RPL38	ribosomal protein L38	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305573	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RPL38 mRNA	PMID:30047161
1313682	RPL38	ribosomal protein L38	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D011192	Potassium Dichromate results in increased expression of RPL38 mRNA	PMID:11678601
1313682	RPL38	ribosomal protein L38	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RPL38 protein	PMID:32959892
1313682	RPL38	ribosomal protein L38	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of RPL38 protein	PMID:26558463
1313682	RPL38	ribosomal protein L38	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305573	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of RPL38 gene	PMID:33148267
1313682	RPL38	ribosomal protein L38	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RPL38 protein	PMID:34186270
1313682	RPL38	ribosomal protein L38	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL38 protein	PMID:37664457
1313682	RPL38	ribosomal protein L38	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of RPL38 protein	PMID:31285264
1313682	RPL38	ribosomal protein L38	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313683	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of RPL38 mRNA	PMID:30294300
1313682	RPL38	ribosomal protein L38	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305573	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RPL38 mRNA	PMID:30047161
1313682	RPL38	ribosomal protein L38	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313683	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RPL38 mRNA	PMID:40826991
1313682	RPL38	ribosomal protein L38	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1313683	E	RGD:6480464	20180703	CTD	MESH:C089595	cylindrospermopsin results in increased expression of RPL38 mRNA	PMID:20936652
1313682	RPL38	ribosomal protein L38	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL38 protein	PMID:37664457
1313682	RPL38	ribosomal protein L38	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1305573	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of RPL38 mRNA	PMID:30047161
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313686	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of OSGEPL1 mRNA	PMID:33045310
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313686	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of OSGEPL1 mRNA	PMID:37995155
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305575	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of OSGEPL1 mRNA]	PMID:31150632
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of OSGEPL1 mRNA	PMID:33167477
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of OSGEPL1 mRNA	PMID:21632981
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of OSGEPL1 mRNA	PMID:35811015
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of OSGEPL1 mRNA	PMID:35811015
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of OSGEPL1 mRNA	PMID:19484750
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313686	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of OSGEPL1 mRNA	PMID:39298647
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305575	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of OSGEPL1 mRNA	PMID:33387578
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of OSGEPL1 mRNA	PMID:37042841
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305575	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of OSGEPL1 mRNA	PMID:33387578
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of OSGEPL1 mRNA	PMID:28818685
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of OSGEPL1 mRNA	PMID:37748715
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305575	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of OSGEPL1 mRNA	PMID:21396975
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of OSGEPL1 mRNA	PMID:35430440
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305575	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of OSGEPL1 mRNA	PMID:31150632
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of OSGEPL1 mRNA	PMID:31919559
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305575	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of OSGEPL1 mRNA]	PMID:31150632
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313686	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of OSGEPL1 mRNA	PMID:22206623
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of OSGEPL1 gene	PMID:25304211
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313686	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of OSGEPL1 mRNA	PMID:40504410
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of OSGEPL1 mRNA	PMID:27594783
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of OSGEPL1 mRNA	PMID:27392435
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of OSGEPL1 mRNA	PMID:27392435
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313686	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of OSGEPL1 mRNA	PMID:21570461
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of OSGEPL1 mRNA	PMID:33212167
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:2896	astemizole	increases expression	ISO	RGD:1305575	E	RGD:6480464	20120412	CTD	MESH:D016589	Astemizole results in increased expression of OSGEPL1 mRNA	PMID:20221588
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:29191	hydroxyl	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of OSGEPL1-AS1 mRNA] which results in decreased expression of OSGEPL1 mRNA	PMID:33656867
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of OSGEPL1 mRNA	PMID:38568856
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313686	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of OSGEPL1 mRNA	PMID:40504410
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of OSGEPL1 promoter	PMID:27901495
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to OSGEPL1 mRNA]	PMID:32406909
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of OSGEPL1 mRNA	PMID:20458559
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305575	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of OSGEPL1 mRNA	PMID:23411599
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305575	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of OSGEPL1 mRNA	PMID:25181051
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of OSGEPL1 protein	PMID:33376534
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305575	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of OSGEPL1 mRNA	PMID:34947998
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of OSGEPL1 mRNA	PMID:33221593
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305575	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of OSGEPL1 mRNA	PMID:30816183|PMID:32528016
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313686	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of OSGEPL1 mRNA	PMID:39298647
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313686	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of OSGEPL1 mRNA	PMID:38685157
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of OSGEPL1 mRNA	PMID:21266533
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of OSGEPL1 mRNA	PMID:37042841
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305575	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of OSGEPL1 mRNA	PMID:25539665
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of OSGEPL1 mRNA	PMID:28302478
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of OSGEPL1 mRNA	PMID:31533062
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of OSGEPL1 mRNA	PMID:25979313
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of OSGEPL1 gene	PMID:29154799
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of OSGEPL1 mRNA	PMID:29154799
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of OSGEPL1 mRNA	PMID:20106945|PMID:25562108
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of OSGEPL1 mRNA	PMID:19770486
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of OSGEPL1 mRNA	PMID:38832940
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of OSGEPL1-AS1 mRNA] which results in decreased expression of OSGEPL1 mRNA	PMID:33656867
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of OSGEPL1 mRNA	PMID:29067470
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305575	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of OSGEPL1 mRNA	PMID:33387578
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of OSGEPL1 mRNA	PMID:20977926
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of OSGEPL1 mRNA	PMID:35811015
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of OSGEPL1 gene	PMID:25304211
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313686	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of OSGEPL1 mRNA	PMID:40504410
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of OSGEPL1 mRNA	PMID:22079256
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of OSGEPL1 mRNA	PMID:20458559
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of OSGEPL1 mRNA	PMID:28988120
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313686	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of OSGEPL1 mRNA	PMID:22206623
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313686	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of OSGEPL1 mRNA	PMID:22206623
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of OSGEPL1 mRNA	PMID:22079256
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of OSGEPL1 mRNA	PMID:22079256
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of OSGEPL1 mRNA	PMID:37199045
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313686	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of OSGEPL1 mRNA	PMID:39847705
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305575	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of OSGEPL1 mRNA	PMID:21346803
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of OSGEPL1 mRNA	PMID:38568856
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305575	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of OSGEPL1 mRNA	PMID:21346803
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305575	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of OSGEPL1 mRNA	PMID:19015723
1313685	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305575	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of OSGEPL1 mRNA	PMID:23034163
1313687	KIF9	kinesin family member 9	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313688	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF9 mRNA	PMID:20938992
1313687	KIF9	kinesin family member 9	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of KIF9 mRNA	PMID:33167477
1313687	KIF9	kinesin family member 9	gene	CHEBI:16130	DDT	increases methylation	ISO	RGD:1565187	E	RGD:6480464	20211012	CTD	MESH:D003634	DDT results in increased methylation of KIF9 gene	PMID:31682807
1313687	KIF9	kinesin family member 9	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313688	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KIF9 mRNA	PMID:39241906
1313687	KIF9	kinesin family member 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of KIF9 mRNA	PMID:30165855
1313687	KIF9	kinesin family member 9	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1565187	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of KIF9 mRNA	PMID:33387578
1313687	KIF9	kinesin family member 9	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313688	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF9 mRNA	PMID:20938992
1313687	KIF9	kinesin family member 9	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313688	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of KIF9 mRNA	PMID:39922521
1313687	KIF9	kinesin family member 9	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313688	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KIF9 mRNA	PMID:37992649
1313687	KIF9	kinesin family member 9	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313688	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of KIF9 mRNA	PMID:39922521
1313687	KIF9	kinesin family member 9	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313688	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KIF9 mRNA	PMID:37992649
1313687	KIF9	kinesin family member 9	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1565187	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of KIF9 mRNA	PMID:26577399
1313687	KIF9	kinesin family member 9	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of KIF9 intron	PMID:30157460
1313687	KIF9	kinesin family member 9	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of KIF9 mRNA	PMID:35430440
1313687	KIF9	kinesin family member 9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313688	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of KIF9 mRNA	PMID:20938992
1313687	KIF9	kinesin family member 9	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1565187	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of KIF9 mRNA	PMID:31881176
1313687	KIF9	kinesin family member 9	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313688	E	RGD:6480464	20140812	CTD	MESH:D002945	Cisplatin results in decreased expression of KIF9 mRNA	PMID:24865317
1313687	KIF9	kinesin family member 9	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313688	E	RGD:6480464	20140812	CTD	MESH:D002945	Lutein promotes the reaction [Cisplatin results in decreased expression of KIF9 mRNA]	PMID:24865317
1313687	KIF9	kinesin family member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1565187	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KIF9 mRNA	PMID:33387578
1313687	KIF9	kinesin family member 9	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of KIF9 mRNA	PMID:20971185
1313687	KIF9	kinesin family member 9	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313688	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of KIF9 protein	PMID:28918527
1313687	KIF9	kinesin family member 9	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313688	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KIF9 mRNA	PMID:37992649
1313687	KIF9	kinesin family member 9	gene	CHEBI:28838	lutein	increases expression	ISO	RGD:1313688	E	RGD:6480464	20140812	CTD	MESH:D014975	Lutein results in increased expression of KIF9 mRNA	PMID:24865317
1313687	KIF9	kinesin family member 9	gene	CHEBI:28838	lutein	multiple interactions	ISO	RGD:1313688	E	RGD:6480464	20140812	CTD	MESH:D014975	Lutein promotes the reaction [Cisplatin results in decreased expression of KIF9 mRNA]	PMID:24865317
1313687	KIF9	kinesin family member 9	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KIF9 3' UTR	PMID:27901495
1313687	KIF9	kinesin family member 9	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of KIF9 mRNA	PMID:20971185
1313687	KIF9	kinesin family member 9	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313688	E	RGD:6480464	20140513	CTD	MESH:D012834	Silver results in decreased expression of KIF9 mRNA	PMID:19429238|PMID:22576574
1313687	KIF9	kinesin family member 9	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313688	E	RGD:6480464	20211109	CTD	MESH:D012822	Silicon Dioxide results in increased expression of KIF9 mRNA	PMID:33720480
1313687	KIF9	kinesin family member 9	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of KIF9 gene	PMID:31601247
1313687	KIF9	kinesin family member 9	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313688	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of KIF9 mRNA	PMID:35295148
1313687	KIF9	kinesin family member 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1565187	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KIF9 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1313687	KIF9	kinesin family member 9	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of KIF9 gene	PMID:31601247
1313687	KIF9	kinesin family member 9	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1565187	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KIF9 gene	PMID:28505145
1313687	KIF9	kinesin family member 9	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of KIF9 gene	PMID:31601247
1313687	KIF9	kinesin family member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313688	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of KIF9 mRNA	PMID:30951980|PMID:40203079
1313687	KIF9	kinesin family member 9	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313688	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of KIF9 mRNA	PMID:30951980
1313687	KIF9	kinesin family member 9	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313688	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KIF9 mRNA	PMID:37019170
1313687	KIF9	kinesin family member 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KIF9 mRNA	PMID:37042841
1313687	KIF9	kinesin family member 9	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1565187	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of KIF9 mRNA	PMID:30723492
1313687	KIF9	kinesin family member 9	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KIF9 mRNA	PMID:38568856
1313687	KIF9	kinesin family member 9	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1565187	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of KIF9 mRNA	PMID:25539665
1313687	KIF9	kinesin family member 9	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313688	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of KIF9 mRNA	PMID:40194260
1313687	KIF9	kinesin family member 9	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of KIF9 mRNA	PMID:31533062
1313687	KIF9	kinesin family member 9	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KIF9 mRNA	PMID:25979313
1313687	KIF9	kinesin family member 9	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313688	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of KIF9 mRNA	PMID:17963808
1313687	KIF9	kinesin family member 9	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of KIF9 mRNA	PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1313687	KIF9	kinesin family member 9	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313688	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of KIF9 mRNA	PMID:21427059
1313687	KIF9	kinesin family member 9	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1313688	E	RGD:6480464	20130416	CTD	MESH:C017160	cypermethrin results in increased expression of KIF9 mRNA	PMID:21142847
1313687	KIF9	kinesin family member 9	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1313688	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of KIF9 mRNA	PMID:25123088
1313687	KIF9	kinesin family member 9	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313688	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of KIF9 mRNA	PMID:39922521
1313687	KIF9	kinesin family member 9	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313688	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of KIF9 mRNA	PMID:37992649
1313687	KIF9	kinesin family member 9	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of KIF9 mRNA	PMID:23649840
1313687	KIF9	kinesin family member 9	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313688	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of KIF9 mRNA	PMID:18502557
1313687	KIF9	kinesin family member 9	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1565187	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of KIF9 mRNA	PMID:29391264
1313687	KIF9	kinesin family member 9	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313688	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of KIF9 mRNA	PMID:25554681
1313687	KIF9	kinesin family member 9	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of KIF9 mRNA	PMID:20977926
1313687	KIF9	kinesin family member 9	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313688	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of KIF9 mRNA	PMID:19042947
1313687	KIF9	kinesin family member 9	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313688	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of KIF9 mRNA	PMID:38701926
1313687	KIF9	kinesin family member 9	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of KIF9 mRNA	PMID:28988120
1313687	KIF9	kinesin family member 9	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313688	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KIF9 mRNA	PMID:22206623
1313687	KIF9	kinesin family member 9	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of KIF9 mRNA	PMID:19159669
1313687	KIF9	kinesin family member 9	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313688	E	RGD:6480464	20140513	CTD	MESH:D012834	Silver results in decreased expression of KIF9 mRNA	PMID:19429238|PMID:22576574
1313687	KIF9	kinesin family member 9	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1565187	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of KIF9 mRNA	PMID:21346803
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MCM2 mRNA	PMID:38218311
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:125472	N-(6-acetamidohexyl)acetamide	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20170228	CTD	MESH:C014026	hexamethylene bisacetamide results in decreased expression of MCM2 mRNA	PMID:26941288
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313690	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MCM2 mRNA	PMID:37995155
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MCM2 mRNA	PMID:20938992
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MCM2 mRNA	PMID:16249480
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of MCM2 protein	PMID:39571964
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MCM2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MCM2 mRNA	PMID:32699268
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of MCM2 mRNA	PMID:26516004
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MCM2 mRNA	PMID:36331819
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16118	berberine	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20131008	CTD	MESH:D001599	Berberine inhibits the reaction [Dexamethasone results in increased expression of MCM2 mRNA]	PMID:20462044
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16170	mercury(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of MCM2 mRNA	PMID:17547211
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in decreased expression of MCM2 mRNA	PMID:23727915
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of MCM2 protein	PMID:35688186
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MCM2 mRNA	PMID:39241906
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of MCM2 mRNA	PMID:15598610
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	affects phosphorylation	EXP		E	RGD:6480464	20160607	CTD	MESH:D004958	Estradiol affects the phosphorylation of MCM2 protein	PMID:27026707
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of MCM2 mRNA	PMID:16474171|PMID:17268063|PMID:19167446|PMID:24758408
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305577	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of MCM2 mRNA	PMID:32145629
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313690	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of MCM2 mRNA	PMID:25210133
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein inhibits the reaction [Estradiol results in increased expression of MCM2 mRNA]	PMID:24758408
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20160315	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] affects the localization of MCM2 protein; [Progesterone co-treated with Estradiol] results in decreased expression of MCM2 protein; ESR1 protein promotes the reaction [Estradiol results in increased expression of MCM2 mRNA]	PMID:16966611|PMID:25210133
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM2 mRNA	PMID:25510870
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MCM2 mRNA	PMID:38568856
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16602	trichloroethene	decreases phosphorylation	EXP		E	RGD:6480464	20231205	CTD	MESH:D014241	Trichloroethylene results in decreased phosphorylation of MCM2 protein	PMID:26018768
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MCM2 mRNA	PMID:20938992
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of MCM2 mRNA	PMID:16966611
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] affects the localization of MCM2 protein; [Progesterone co-treated with Estradiol] results in decreased expression of MCM2 protein	PMID:16966611
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MCM2 mRNA	PMID:21179406
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of MCM2 mRNA	PMID:26079696
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of MCM2 mRNA	PMID:38160208
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM2 mRNA	PMID:37992649
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17296	aniline	increases expression	ISO	RGD:1305577	E	RGD:6480464	20120918	CTD	MESH:C023650	aniline results in increased expression of MCM2 protein	PMID:21070798
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of MCM2 mRNA	PMID:21592394
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM2 mRNA	PMID:21592394
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of MCM2 mRNA	PMID:27683099
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM2 mRNA	PMID:37992649
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313690	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MCM2 mRNA	PMID:23892564
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MCM2 protein	PMID:31163220
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305577	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MCM2 mRNA	PMID:26577399
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MCM2 protein	PMID:37730182
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MCM2 mRNA	PMID:21592394
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of MCM2 mRNA	PMID:21592394
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305577	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MCM2 mRNA	PMID:33387578
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305577	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MCM2 mRNA	PMID:22061828
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MCM2 mRNA	PMID:28818685
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in decreased expression of MCM2 mRNA	PMID:12634122
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120717	CTD	MESH:D008769	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MCM2 mRNA	PMID:19840844
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:22633	arsenite ion	multiple interactions	ISO	RGD:1305577	E	RGD:6480464	20170117	CTD	MESH:D018053	[AS3MT protein results in increased susceptibility to Arsenites] which affects the expression of MCM2 mRNA	PMID:19411561
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in increased expression of MCM2 mRNA	PMID:17547211
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM2 mRNA	PMID:25510870
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM2 mRNA	PMID:25510870
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MCM2 mRNA	PMID:19549813
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MCM2 protein	PMID:20106945
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MCM2 mRNA	PMID:22100608
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:25195	mercury atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of MCM2 mRNA	PMID:17547211
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of MCM2 mRNA	PMID:25102026
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MCM2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MCM2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of MCM2 mRNA	PMID:32699268
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MCM2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MCM2 mRNA	PMID:34911549
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305577	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MCM2 mRNA	PMID:30779732
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of MCM2 mRNA	PMID:22171008
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313690	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MCM2 mRNA	PMID:27339419|PMID:31919559
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MCM2 mRNA	PMID:25629700
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MCM2 mRNA	PMID:20938992
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MCM2 mRNA	PMID:40504410
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000966	Antimony Potassium Tartrate results in increased expression of MCM2 mRNA	PMID:17547211
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of MCM2 mRNA	PMID:26272509
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM2 mRNA	PMID:27188386
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MCM2 protein	PMID:35688186
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of MCM2 mRNA	PMID:31295307
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305577	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MCM2 mRNA	PMID:31881176
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of MCM2 mRNA	PMID:19167446
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of MCM2 mRNA	PMID:19921347
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of MCM2 mRNA	PMID:27392435
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of MCM2 mRNA	PMID:21151649|PMID:40618947
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of MCM2 mRNA	PMID:16061661|PMID:27594783
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27928	parathion	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D010278	Parathion results in increased expression of MCM2 mRNA	PMID:17390078
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:27928	parathion	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010278	[Parathion co-treated with Estrogens] results in increased expression of MCM2 mRNA	PMID:18204794
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28073	chromium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002857	Chromium results in increased expression of MCM2 mRNA	PMID:17547211
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of MCM2 mRNA	PMID:16474171
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MCM2 mRNA	PMID:25583101
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM2 mRNA	PMID:22574217
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313690	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MCM2 mRNA	PMID:21570461
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MCM2 mRNA	PMID:16611356
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM2 mRNA	PMID:20106945|PMID:21496263
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305577	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM2 mRNA	PMID:34747641
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313690	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MCM2 mRNA	PMID:15667827|PMID:21496263
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013749	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of MCM2 mRNA	PMID:26159488
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MCM2 mRNA	PMID:17942748
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of MCM2 protein	PMID:39603559
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305577	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of MCM2 mRNA	PMID:28959563
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305577	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of MCM2 mRNA	PMID:22465980|PMID:30556269
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MCM2 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of MCM2 mRNA	PMID:20971185|PMID:30911355
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MCM2 mRNA	PMID:29803840
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM2 mRNA	PMID:37992649
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of MCM2 protein	PMID:35688186
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:28794	coumarin	increases expression	ISO	RGD:1305577	E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of MCM2 mRNA	PMID:18480146
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of MCM2 mRNA	PMID:22623647
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MCM2 mRNA	PMID:12760830|PMID:38568856
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of MCM2 mRNA	PMID:28595984|PMID:29301061|PMID:34032870|PMID:39719251
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in decreased expression of MCM2 protein; MCM2 protein inhibits the reaction [sodium arsenite inhibits the reaction [H3-3A protein binds to MT1F promoter]]; MCM2 protein inhibits the reaction [sodium arsenite inhibits the reaction [H3-3A protein binds to NR4A1 promoter]]; sodium arsenite inhibits the reaction [H3-3A protein binds to MCM2 protein]	PMID:37734572|PMID:39571964
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MCM2 mRNA	PMID:40504410
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MCM2 mRNA	PMID:22378314
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MCM2 intron	PMID:30157460
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCM2 mRNA	PMID:16120219|PMID:21632981
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MCM2 mRNA	PMID:19770486
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313690	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MCM2 exon; Benzo(a)pyrene results in decreased methylation of MCM2 intron	PMID:27901495
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MCM2 mRNA	PMID:20106945|PMID:32234424
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to MCM2 promoter]	PMID:19654925
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305577	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of MCM2 mRNA	PMID:22465980|PMID:30556269
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MCM2 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of MCM2 mRNA	PMID:20971185|PMID:30911355
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of MCM2 mRNA	PMID:22171008
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:30304	antimony(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000965	Antimony results in increased expression of MCM2 mRNA	PMID:17547211
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MCM2 mRNA	PMID:20382639
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MCM2 mRNA; Arsenic Trioxide results in increased expression of MCM2 protein	PMID:17530438|PMID:17547211|PMID:25419056
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MCM2 protein]	PMID:26598702
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:3090	bicalutamide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in decreased expression of MCM2 mRNA	PMID:15638997
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MCM2 gene	PMID:31601247
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of MCM2 mRNA	PMID:21829687
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305577	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of MCM2 mRNA	PMID:25729387
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305577	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM2 mRNA	PMID:25729387
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313690	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MCM2 gene	PMID:35295148
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313690	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MCM2 mRNA	PMID:23557971
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313690	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MCM2 gene	PMID:35295148
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:32293	verteporfin	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20181113	CTD	MESH:C098350	Verteporfin inhibits the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of MCM2 mRNA]	PMID:29893953
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1305577	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of MCM2 mRNA	PMID:34492290
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305577	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MCM2 mRNA	PMID:30723492
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313690	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MCM2 mRNA	PMID:17950772|PMID:18301758|PMID:20813756|PMID:23626729|PMID:23811191
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of MCM2 mRNA; [pirinixic acid co-treated with Pregnenolone Carbonitrile] results in increased expression of MCM2 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of MCM2 mRNA]	PMID:17950772|PMID:20813756|PMID:23626729
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313690	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MCM2 mRNA	PMID:28472532
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of MCM2 mRNA	PMID:38479592
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305577	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of MCM2 mRNA	PMID:19167457
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MCM2 mRNA	PMID:30903817
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305577	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MCM2 mRNA	PMID:25181051|PMID:32145629
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313690	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of MCM2 promoter	PMID:27334623
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MCM2 mRNA; bisphenol A results in decreased expression of MCM2 protein	PMID:29275510|PMID:37567409
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305577	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MCM2 mRNA	PMID:34947998
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C006780	bisphenol A results in increased expression of MCM2 mRNA; bisphenol A results in increased expression of MCM2 protein	PMID:16474171|PMID:17268063|PMID:33516137
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305577	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MCM2 gene	PMID:28505145
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MCM2 gene	PMID:31601247
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MCM2 protein	PMID:31675489
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313690	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of MCM2 mRNA	PMID:26682919
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM2 mRNA	PMID:25510870
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MCM2 mRNA	PMID:25510870
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MCM2 mRNA	PMID:40203079
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MCM2 gene	PMID:31601247
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313690	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MCM2 mRNA	PMID:26377693
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MCM2 mRNA	PMID:28628672
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20250311	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of MCM2 mRNA	PMID:28392331|PMID:32308655
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34631	chlorpyrifos	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MCM2 protein	PMID:32171938
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305577	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MCM2 mRNA	PMID:21266533
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MCM2 mRNA	PMID:17361019|PMID:21266533
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to MCM2 protein	PMID:32991956
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1313690	E	RGD:6480464	20180703	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of MCM2 mRNA	PMID:21404309
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MCM2 mRNA	PMID:28628672
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1305577	E	RGD:6480464	20120814	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MCM2 mRNA	PMID:19041683
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313690	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MCM2 mRNA	PMID:17854601|PMID:24535843
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of MCM2 mRNA]	PMID:17854601
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of MCM2 mRNA	PMID:17312168
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34905	paraquat	affects expression	ISO	RGD:1313690	E	RGD:6480464	20160119	CTD	MESH:D010269	Paraquat affects the expression of MCM2 mRNA	PMID:26345256
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D010269	[Paraquat co-treated with Antigens, Dermatophagoides] results in decreased expression of MCM2 mRNA	PMID:34097952
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MCM2 mRNA	PMID:37042841
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305577	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of MCM2 mRNA	PMID:30589522
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of MCM2 mRNA	PMID:26678675
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313690	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MCM2 mRNA	PMID:26377693
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1305577	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of MCM2 mRNA	PMID:18500788
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305577	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MCM2 mRNA	PMID:30723492
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MCM2 mRNA	PMID:17547211
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120717	CTD	MESH:D019256	[Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of MCM2 mRNA	PMID:19840844
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305577	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MCM2 mRNA	PMID:35163327
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305577	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of MCM2 mRNA	PMID:20562052|PMID:22079235|PMID:25539665
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20140311	CTD	MESH:D011285	[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Pregnenolone Carbonitrile] results in increased expression of MCM2 mRNA; [Phenobarbital co-treated with Pregnenolone Carbonitrile] results in increased expression of MCM2 mRNA; [pirinixic acid co-treated with Pregnenolone Carbonitrile] results in increased expression of MCM2 mRNA	PMID:23626729
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MCM2 mRNA	PMID:19320972
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MCM2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MCM2 mRNA	PMID:32699268
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MCM2 mRNA	PMID:40194260
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MCM2 mRNA	PMID:31533062
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of MCM2 mRNA	PMID:19167446
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of MCM2 mRNA	PMID:19167446
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MCM2 mRNA	PMID:39529242
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:3930	cryptolepine	decreases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C024015	cryptolepine results in decreased expression of MCM2 mRNA	PMID:16120219
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MCM2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MCM2 mRNA	PMID:36331819
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1305577	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of MCM2 mRNA	PMID:22110744
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305577	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of MCM2 mRNA	PMID:25993096
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1305577	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of MCM2 mRNA	PMID:18299980
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MCM2 mRNA	PMID:17963808
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305577	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MCM2 mRNA	PMID:30047161
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of MCM2 mRNA	PMID:25562108
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of MCM2 mRNA	PMID:20106945|PMID:21632981
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MCM2 mRNA	PMID:17555576
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313690	E	RGD:6480464	20131008	CTD	MESH:D003907	Dexamethasone results in increased expression of MCM2 mRNA	PMID:20462044
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MCM2 mRNA	PMID:28628672
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20131008	CTD	MESH:D003907	Berberine inhibits the reaction [Dexamethasone results in increased expression of MCM2 mRNA]	PMID:20462044
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313690	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MCM2 mRNA	PMID:28973697
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MCM2 mRNA	PMID:37992649
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MCM2 mRNA	PMID:38832940
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C012589	trichostatin A results in decreased expression of MCM2 mRNA; trichostatin A results in decreased expression of MCM2 protein	PMID:23770000
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20140408	CTD	MESH:C012589	pyrazolanthrone inhibits the reaction [trichostatin A results in decreased expression of MCM2 protein]	PMID:23770000
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MCM2 mRNA	PMID:17562736
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	MCM2 protein affects the susceptibility to Fluorouracil	PMID:15548681
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of MCM2 protein	PMID:17562444|PMID:28871336
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:46557	zoledronic acid	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	[zoledronic acid co-treated with docetaxel] results in decreased expression of MCM2 protein	PMID:17562444
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:4659	disulfiram	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004221	Disulfiram results in decreased expression of MCM2 mRNA	PMID:19789329
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004221	cupric chloride promotes the reaction [Disulfiram results in decreased expression of MCM2 mRNA]	PMID:19789329
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MCM2 mRNA	PMID:40504410
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:47286	CU-O LINKAGE	decreases phosphorylation	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased phosphorylation of MCM2 protein	PMID:25470785
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:4791	endosulfan	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D004726	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of MCM2 mRNA	PMID:26159488
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:48607	lithium chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in decreased expression of MCM2 mRNA	PMID:17440966
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:48707	(-)-citrinin	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D002953	Citrinin results in increased expression of MCM2 protein	PMID:39638853
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MCM2 mRNA	PMID:17555576
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MCM2 mRNA	PMID:17942748
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MCM2 mRNA	PMID:17942748
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:4911	etoposide	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D005047	Etoposide results in decreased expression of MCM2 mRNA	PMID:16120219
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:49553	copper(II) chloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C029892	cupric chloride promotes the reaction [Disulfiram results in decreased expression of MCM2 mRNA]	PMID:19789329
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MCM2 mRNA	PMID:28628672
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MCM2 mRNA; Arsenic Trioxide results in increased expression of MCM2 protein	PMID:17530438|PMID:17547211|PMID:25419056
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to MCM2 protein]	PMID:26598702
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate affects the reaction [MTF1 affects the expression of MCM2 mRNA]	PMID:16221973
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313690	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MCM2 mRNA; Nanotubes, Carbon results in increased expression of MCM2 mRNA	PMID:25554681
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305577	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MCM2 mRNA	PMID:30047161
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313690	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of MCM2 mRNA	PMID:40234311
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313690	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MCM2 mRNA	PMID:19042947
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1313690	E	RGD:6480464	20180703	CTD	MESH:D010081	Oxazolone results in increased expression of MCM2 mRNA	PMID:21404309
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011192	Potassium Dichromate results in increased expression of MCM2 mRNA	PMID:17547211
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1313690	E	RGD:6480464	20180703	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of MCM2 mRNA	PMID:21404309
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313690	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MCM2 mRNA	PMID:38701926
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MCM2 protein	PMID:32959892
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305577	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MCM2 mRNA	PMID:25729387
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305577	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MCM2 mRNA	PMID:25729387
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:6382	Lasiocarpine	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:C005136	lasiocarpine results in decreased expression of MCM2 mRNA	PMID:40956406
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:6382	Lasiocarpine	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C005136	[CYP3A4 protein co-treated with lasiocarpine] results in decreased expression of MCM2 mRNA	PMID:40956406
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MCM2 mRNA	PMID:15336504
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of MCM2 mRNA	PMID:17547211
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305577	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of MCM2 mRNA	PMID:35283115
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:6651	malathion	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008294	Malathion results in increased expression of MCM2 mRNA	PMID:18204794
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:6651	malathion	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008294	[Malathion co-treated with Estrogens] results in increased expression of MCM2 mRNA	PMID:18204794
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1313690	E	RGD:6480464	20230404	CTD	MESH:C057862	cyanoginosin LR results in increased expression of MCM2 protein	PMID:36115647
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:6925	microcystin-LR	multiple interactions	EXP		E	RGD:6480464	20230404	CTD	MESH:C057862	cyanoginosin LR results in increased expression of and results in increased phosphorylation of MCM2 protein	PMID:36115647
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:6925	microcystin-LR	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20230404	CTD	MESH:C057862	cyanoginosin LR results in increased expression of and results in increased phosphorylation of MCM2 protein	PMID:36115647
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in decreased expression of MCM2 mRNA; Cannabidiol results in decreased expression of MCM2 protein	PMID:33244087|PMID:34122009|PMID:36519830
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of MCM2 mRNA	PMID:22101062
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313690	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MCM2 mRNA	PMID:22206623
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:749016	gossypol acetic acid	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of MCM2 protein	PMID:29938581
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1313690	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of MCM2 mRNA	PMID:27858113
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:75408	sulindac sulfide	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C025462	sulindac sulfide results in decreased expression of MCM2 mRNA	PMID:16184548
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of MCM2 mRNA; Niclosamide results in decreased expression of MCM2 protein	PMID:28284560|PMID:29031202
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:755540	docetaxel	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	[Zoledronic Acid co-treated with Docetaxel] results in decreased expression of MCM2 protein	PMID:17562444
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of MCM2 protein	PMID:31285264
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MCM2 mRNA	PMID:16120219
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:77012	methylseleninic acid	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid affects the expression of MCM2 mRNA	PMID:14617803
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of MCM2 protein	PMID:39638853
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:78160	bleomycin A5	increases expression	EXP		E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in increased expression of MCM2 mRNA	PMID:21040473
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM2 mRNA	PMID:27188386
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:79516	Nonylphenol	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C025256	nonylphenol results in increased expression of MCM2 mRNA; nonylphenol results in increased expression of MCM2 protein	PMID:33516137
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:79995	GW 3965	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C473027	GW 3965 results in decreased expression of MCM2 mRNA	PMID:31437187
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:79997	GW 4064	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C412815	GW 4064 results in increased expression of MCM2 mRNA	PMID:31437187
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MCM2 mRNA	PMID:19159669
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313690	E	RGD:6480464	20140311	CTD	MESH:D010634	Phenobarbital results in increased expression of MCM2 mRNA	PMID:19482888|PMID:23091169|PMID:23626729
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D010634	[Phenobarbital co-treated with Pregnenolone Carbonitrile] results in increased expression of MCM2 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MCM2 mRNA]	PMID:19482888|PMID:23626729
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1313690	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of MCM2 mRNA	PMID:18958704
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MCM2 mRNA	PMID:19167446
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313690	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of MCM2 mRNA	PMID:30294300
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MCM2 protein	PMID:31675489
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MCM2 protein	PMID:31675489
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1313690	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of MCM2 mRNA	PMID:27029645
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313690	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of MCM2 mRNA	PMID:30953684
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305577	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MCM2 mRNA	PMID:24780913|PMID:30047161
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [trichostatin A results in decreased expression of MCM2 protein]	PMID:23770000
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MCM2 mRNA	PMID:27188386
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1313690	E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus inhibits the reaction [IL2 protein results in increased expression of MCM2 mRNA]	PMID:11355896
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305577	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of MCM2 mRNA	PMID:19281266
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305577	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MCM2 mRNA	PMID:21346803
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MCM2 mRNA	PMID:38568856
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MCM2 mRNA	PMID:29301935
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of MCM2 mRNA	PMID:22378314
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of MCM2 mRNA	PMID:19140230
1313689	MCM2	minichromosome maintenance complex component 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305577	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MCM2 mRNA	PMID:23034163
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1619186	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of DIRAS2 mRNA	PMID:36189433
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DIRAS2 mRNA	PMID:36189433
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305580	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of DIRAS2 gene	PMID:35440735
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of DIRAS2 mRNA	PMID:22378314
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1619186	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of DIRAS2 mRNA	PMID:30319688
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1619186	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DIRAS2 mRNA	PMID:30319688
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DIRAS2 mRNA	PMID:35811015
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIRAS2 mRNA	PMID:25510870
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305580	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DIRAS2 mRNA	PMID:33387578
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA	PMID:37567420
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1619186	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of DIRAS2 mRNA	PMID:36189433
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DIRAS2 mRNA	PMID:36189433
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA	PMID:37567420
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1619186	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DIRAS2 mRNA	PMID:34319233
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DIRAS2 mRNA	PMID:37325564
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIRAS2 mRNA	PMID:25510870
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIRAS2 mRNA	PMID:25510870
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DIRAS2 intron	PMID:30157460
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of DIRAS2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of DIRAS2 mRNA	PMID:34911549
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:27563	arsenic atom	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in increased expression of DIRAS2 mRNA	PMID:36861143
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DIRAS2 mRNA	PMID:27188386
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA	PMID:37567420
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of DIRAS2 mRNA	PMID:23557933
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of DIRAS2 promoter	PMID:22847954
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305580	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DIRAS2 mRNA	PMID:32109520
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305580	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DIRAS2 mRNA	PMID:33387578
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA	PMID:37567420
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1619186	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of DIRAS2 mRNA	PMID:37682722
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DIRAS2 mRNA	PMID:34876320
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DIRAS2 mRNA	PMID:34876320
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DIRAS2 5' UTR	PMID:27901495
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DIRAS2 mRNA	PMID:22316170
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DIRAS2 promoter	PMID:27901495
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to DIRAS2 promoter]	PMID:19654925
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DIRAS2 gene	PMID:31601247
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1619186	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DIRAS2 gene	PMID:35295148
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DIRAS2 mRNA	PMID:19710929
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305580	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DIRAS2 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DIRAS2 gene	PMID:31601247
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIRAS2 mRNA	PMID:25510870
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DIRAS2 mRNA	PMID:25510870
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1619186	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of DIRAS2 mRNA	PMID:30951980
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1619186	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DIRAS2 mRNA	PMID:37019170
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1619186	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DIRAS2 mRNA	PMID:21266533
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DIRAS2 mRNA	PMID:37325564
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1619186	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DIRAS2 mRNA	PMID:40194260
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of DIRAS2 promoter	PMID:22847954
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of DIRAS2 promoter	PMID:22847954
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DIRAS2 gene	PMID:29154799
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of DIRAS2 mRNA	PMID:24383497|PMID:26272509|PMID:28001369
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of DIRAS2 mRNA	PMID:20106945
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1619186	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of DIRAS2 mRNA	PMID:22733784
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA	PMID:37567420
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DIRAS2 mRNA	PMID:35811015
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:47217	arsane	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in increased expression of DIRAS2 mRNA	PMID:36861143
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DIRAS2 mRNA	PMID:34876320
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1619186	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DIRAS2 mRNA; Nanotubes, Carbon results in decreased expression of DIRAS2 mRNA	PMID:25554681
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1619186	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of DIRAS2 mRNA	PMID:26377693
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA	PMID:37567420
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DIRAS2 mRNA	PMID:27188386
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DIRAS2 gene]	PMID:28238834
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of DIRAS2 mRNA	PMID:26705709
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1619186	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DIRAS2 mRNA	PMID:34876320
1313693	DIRAS2	DIRAS family GTPase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DIRAS2 mRNA	PMID:27188386
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313695	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of ITGB2 mRNA	PMID:22968694
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ITGB2 mRNA	PMID:35967413
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ITGB2 mRNA	PMID:33045310
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:132853	acteoside	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C058956	acteoside inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]; acteoside inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein]	PMID:16393473
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1313695	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide analog results in increased expression of ITGB2 mRNA; graphene oxide results in increased expression of ITGB2 mRNA	PMID:33227293
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:134926	drometrizole	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C033674	benazol P affects the expression of ITGB2 mRNA	PMID:36586167
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:142487	(20S)-ginsenoside Rh1	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C425564	ginsenoside Rh1 inhibits the reaction [TNF protein results in increased expression of [ITGAL protein binds to ITGB2 protein]]	PMID:21875580
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITGB2 mRNA	PMID:20938992
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:15365	acetylsalicylic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of [ITGA2B protein binds to ITGB2 protein]	PMID:15140583
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of ITGB2 mRNA; Tretinoin results in increased expression of ITGB2 protein	PMID:15498508|PMID:16322068|PMID:16581781|PMID:18055984|PMID:33167477
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	[GABPA protein binds to EP300 protein] promotes the reaction [Tretinoin results in increased expression of ITGB2 mRNA]; CSF3 protein promotes the reaction [Tretinoin results in increased expression of ITGB2 protein]; EP300 protein promotes the reaction [Tretinoin results in increased expression of ITGB2 mRNA]	PMID:16581781|PMID:18055984
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:15368	acrolein	increases expression	ISO	RGD:1313695	E	RGD:6480464	20121113	CTD	MESH:D000171	Acrolein results in increased expression of ITGB2 mRNA	PMID:18515264
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ITGB2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ITGB2 mRNA	PMID:32699268
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305581	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ITGB2 mRNA	PMID:33729688
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002392	Catechin inhibits the reaction [S100B protein results in increased expression of ITGB2 mRNA]	PMID:17103373
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:15647	leukotriene B4	increases expression	ISO	RGD:1305581	E	RGD:6480464	20120412	CTD	MESH:D007975	Leukotriene B4 results in increased expression of ITGB2 protein	PMID:14716214
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:15647	leukotriene B4	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D007975	Leukotriene B4 results in increased expression of [ITGAM protein binds to ITGB2 protein]; LY 255283 analog inhibits the reaction [Leukotriene B4 results in increased expression of [ITGAM protein binds to ITGB2 protein]]; LY 255283 inhibits the reaction [Leukotriene B4 results in increased expression of [ITGAM protein binds to ITGB2 protein]]; LY 293111 inhibits the reaction [Leukotriene B4 results in increased expression of [ITGAM protein binds to ITGB2 protein]]	PMID:7473568
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:15738	staurosporine	multiple interactions	EXP		E	RGD:6480464	20130212	CTD	MESH:D019311	Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein]	PMID:16393473
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ITGB2 mRNA	PMID:26079696
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305581	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of ITGB2 gene	PMID:35440735
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16112	chlorogenic acid	decreases expression	ISO	RGD:1305581	E	RGD:6480464	20171010	CTD	MESH:D002726	Chlorogenic Acid results in decreased expression of ITGB2 protein	PMID:21414398
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16112	chlorogenic acid	multiple interactions	ISO	RGD:1305581	E	RGD:6480464	20171010	CTD	MESH:D002726	Chlorogenic Acid inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of ITGB2 protein]	PMID:21414398
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313695	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ITGB2 mRNA	PMID:30319688
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ITGB2 mRNA	PMID:30517762
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin inhibits the reaction [S100B protein results in increased expression of ITGB2 mRNA]	PMID:17103373
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1305581	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ITGB2 protein	PMID:17655881
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313695	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ITGB2 mRNA	PMID:10975854|PMID:27339419|PMID:39241906
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	ITGB2 protein affects the reaction [Lipopolysaccharides results in increased expression of TNF protein]	PMID:12538815
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1305581	E	RGD:6480464	20161228	CTD	MESH:D008070	ginsenoside Rb1 inhibits the reaction [Lipopolysaccharides results in increased expression of ITGB2 protein]; notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of ITGB2 protein]	PMID:17655881
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ITGB2 mRNA	PMID:39298647
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ITGB2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ITGB2 mRNA	PMID:20226447|PMID:30165855
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305581	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGB2 mRNA	PMID:32741896
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16480	nitric oxide	increases abundance	ISO	RGD:1305581	E	RGD:6480464	20120412	CTD	MESH:D009569	ITGB2 protein results in increased abundance of Nitric Oxide	PMID:8600936
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16480	nitric oxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide promotes the reaction [ITGB2 protein results in increased activity of RAP1A protein]; Nitric Oxide promotes the reaction [ITGB2 protein results in increased activity of RAP2A protein]	PMID:16963453
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16480	nitric oxide	multiple interactions	ISO	RGD:1305581	E	RGD:6480464	20120412	CTD	MESH:D009569	[CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide; [ITGB2 protein results in increased susceptibility to Ozone] which results in increased abundance of Nitric Oxide; CSF2 protein promotes the reaction [ITGB2 protein results in increased abundance of Nitric Oxide]; Ozone promotes the reaction [[CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide]	PMID:8600936
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305581	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ITGB2 mRNA	PMID:33387578
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305581	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ITGB2 gene	PMID:27618143
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITGB2 mRNA	PMID:20938992
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16716	benzene	decreases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in decreased expression of ITGB2 mRNA	PMID:16188091|PMID:20036648
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16761	ADP	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:D000244	Cadmium promotes the reaction [Adenosine Diphosphate results in increased activity of [ITGB2 protein binds to ITGA3 protein]]	PMID:26023812
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ITGB2 mRNA	PMID:23649840
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of ITGB2 mRNA	PMID:17251523
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of ITGB2 mRNA	PMID:21540246
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in increased expression of ITGB2 mRNA	PMID:20226447
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB2 mRNA	PMID:37992649
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305581	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGB2 mRNA	PMID:32741896
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:C031927	hydroquinone results in decreased expression of ITGB2 mRNA	PMID:19148301
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:17594	hydroquinone	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:C031927	hydroquinone results in decreased expression of ITGB2 protein	PMID:17464197
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1313695	E	RGD:6480464	20120613	CTD	MESH:C031927	hydroquinone results in increased expression of ITGB2 protein	PMID:21664406
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB2 mRNA	PMID:37992649
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305581	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ITGB2 mRNA	PMID:27523638
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305581	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ITGB2 mRNA	PMID:22061828
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ITGB2 mRNA	PMID:36331819
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in increased expression of ITGB2 mRNA	PMID:20368581
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:183083	indirubin	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C027185	indirubin results in increased expression of ITGB2 protein	PMID:16115123
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1305581	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of ITGB2 mRNA	PMID:28522335
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:2038	5-azacytidine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001374	Azacitidine results in decreased expression of ITGB2 mRNA	PMID:19194470
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:211551	TMC-120A	increases expression	ISO	RGD:1313695	E	RGD:6480464	20231219	CTD	MESH:C402696	TMC 120A results in increased expression of ITGB2 mRNA	PMID:19818335
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:D002104	Cadmium promotes the reaction [Adenosine Diphosphate results in increased activity of [ITGB2 protein binds to ITGA3 protein]]	PMID:26023812
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGB2 mRNA	PMID:29950665
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ITGB2 protein]	PMID:32272095
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ITGB2 mRNA	PMID:22100608
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ITGB2 mRNA	PMID:23649840
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of ITGB2 mRNA	PMID:18955075
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:25442	mycotoxin	increases expression	ISO	RGD:1313695	E	RGD:6480464	20170228	CTD	MESH:D009183	Mycotoxins results in increased expression of ITGB2 mRNA	PMID:19818335
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:25812	ozone	increases response to substance	ISO	RGD:1305581	E	RGD:6480464	20120412	CTD	MESH:D010126	ITGB2 protein results in increased susceptibility to Ozone	PMID:8600936
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ITGB2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ITGB2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ITGB2 mRNA	PMID:32699268
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1305581	E	RGD:6480464	20120412	CTD	MESH:D010126	[ITGB2 protein results in increased susceptibility to Ozone] which results in increased abundance of Nitric Oxide; Ozone promotes the reaction [[CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide]	PMID:8600936
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ITGB2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ITGB2 mRNA	PMID:34911549
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27086	tributylstannane	affects localization	EXP		E	RGD:6480464	20240109	CTD	MESH:C011559	tributyltin affects the localization of ITGB2 protein	PMID:20883105
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27086	tributylstannane	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C011559	tributyltin results in increased expression of ITGB2 mRNA	PMID:26314263
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20240109	CTD	MESH:C011559	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tributyltin affects the localization of ITGB2 protein]	PMID:20883105
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27300	vitamin D	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D014807	Vitamin D results in increased expression of ITGB2 mRNA	PMID:20368581
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of ITGB2 mRNA	PMID:19071009
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313695	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ITGB2 mRNA	PMID:15056808|PMID:27339419|PMID:31919559
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ITGB2 mRNA	PMID:30517762
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ITGB2 mRNA	PMID:20938992
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ITGB2 mRNA	PMID:40504410
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27779	griseofulvin	affects expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D006118	Griseofulvin affects the expression of ITGB2 mRNA	PMID:12735108
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305581	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ITGB2 mRNA	PMID:31881176
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:C059514	resveratrol results in increased expression of ITGB2 mRNA	PMID:25888808
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol analog inhibits the reaction [formylmethionyl-leucyl-phenylalanine methyl ester results in increased expression of ITGB2 protein]	PMID:9605577
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1305581	E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of ITGB2 mRNA	PMID:25905778
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305581	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ITGB2 mRNA	PMID:22023808
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ITGB2 mRNA	PMID:25583101
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305581	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ITGB2 mRNA	PMID:34747641
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ITGB2 mRNA	PMID:16962184
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:28177	theophylline	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in increased expression of ITGB2 mRNA	PMID:16083514
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ITGB2 mRNA; aristolochic acid I results in increased expression of ITGB2 protein	PMID:33212167
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:28262	dimethyl sulfoxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004121	Dimethyl Sulfoxide promotes the reaction [alitretinoin results in increased expression of ITGB2 protein]	PMID:15964820
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ITGB2 mRNA	PMID:39631538
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB2 mRNA	PMID:37992649
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ITGB2 mRNA	PMID:14691202|PMID:37682722
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ITGB2 mRNA	PMID:29301061|PMID:34032870|PMID:36989763|PMID:38568856
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ITGB2 mRNA	PMID:40504410
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ITGB2 5' UTR; Benzo(a)pyrene affects the methylation of ITGB2 intron	PMID:27901495|PMID:30157460
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ITGB2 promoter	PMID:27901495
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of ITGB2 mRNA; Benzo(a)pyrene results in increased expression of ITGB2 mRNA	PMID:22316170|PMID:26314263
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313695	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ITGB2 mRNA	PMID:22228805
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of ITGB2 mRNA	PMID:19071009
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:30537	triphenylstannane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C030665	triphenyltin results in increased expression of ITGB2 mRNA; triphenyltin results in increased expression of ITGB2 protein	PMID:12788061
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ITGB2 mRNA	PMID:25895662
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313695	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ITGB2 mRNA	PMID:29341224
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ITGB2 mRNA	PMID:20458559
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1313695	E	RGD:6480464	20211207	CTD	MESH:D001761	Bleomycin results in increased expression of ITGB2 mRNA	PMID:30825431
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20211207	CTD	MESH:D001761	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of ITGB2 mRNA]; lenabasum inhibits the reaction [Bleomycin results in increased expression of ITGB2 mRNA]	PMID:30825431
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ITGB2 gene	PMID:31601247
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:31739	josamycin	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D015570	Josamycin results in decreased expression of ITGB2 protein	PMID:8096833
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:31739	josamycin	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:D015570	Ribomunyl inhibits the reaction [Josamycin results in decreased expression of ITGB2 protein]	PMID:8096833
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:32023	plaunotol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C047686	plaunotol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]	PMID:10215738
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:C061133	tamibarotene results in decreased expression of ITGB2 mRNA	PMID:27737899
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of ITGB2 mRNA	PMID:15498508
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:32181	tamibarotene	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:C061133	CSF3 protein inhibits the reaction [tamibarotene results in decreased expression of ITGB2 mRNA]; tamibarotene inhibits the reaction [CSF3 protein results in increased expression of ITGB2 mRNA]	PMID:27737899
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305581	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of ITGB2 mRNA	PMID:24136188
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGB2 mRNA	PMID:29950665
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305581	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ITGB2 mRNA	PMID:34492290
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305581	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ITGB2 mRNA	PMID:25380136
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ITGB2 mRNA	PMID:17426115
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ITGB2 mRNA	PMID:19710929
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:3305	Calcimycin	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D000001	Calcimycin results in increased expression of ITGB2 protein	PMID:8094364
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:33098	2-nitrotoluene	increases expression	ISO	RGD:1305581	E	RGD:6480464	20120412	CTD	MESH:C029955	2-nitrotoluene results in increased expression of ITGB2 mRNA	PMID:16460773
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305581	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ITGB2 mRNA	PMID:25181051
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of ITGB2 mRNA	PMID:25594700
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of ITGB2 mRNA; bisphenol A results in increased expression of ITGB2 protein	PMID:14555285
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305581	E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A results in increased expression of ITGB2 mRNA	PMID:34973380
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313695	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ITGB2 mRNA	PMID:32156529|PMID:38701888
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ITGB2 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ITGB2 mRNA	PMID:28628672|PMID:31601247
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of ITGB2 protein	PMID:21623697
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313695	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of ITGB2 mRNA	PMID:26682919
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ITGB2 mRNA	PMID:39298647|PMID:40203079
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313695	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ITGB2 mRNA	PMID:30951980
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of ITGB2 mRNA	PMID:30951980|PMID:38685157
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313695	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ITGB2 mRNA	PMID:32715474
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313695	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ITGB2 protein	PMID:32272095
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ITGB2 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ITGB2 protein]	PMID:29950665|PMID:32272095
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of ITGB2 gene	PMID:22964155
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ITGB2 mRNA	PMID:28628672
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ITGB2 mRNA	PMID:37042841
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305581	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of ITGB2 mRNA	PMID:30589522
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305581	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of ITGB2 mRNA	PMID:35163327
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305581	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ITGB2 mRNA	PMID:25380136
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases response to substance	ISO	RGD:1313695	E	RGD:6480464	20120918	CTD	MESH:D015058	ITGB2 protein results in increased susceptibility to 1-Naphthylisothiocyanate	PMID:16614373|PMID:21070799
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D015058	[1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of ITGB2 mRNA	PMID:27344345
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305581	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ITGB2 promoter	PMID:22457795
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ITGB2 mRNA	PMID:38568856
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ITGB2 protein	PMID:38758093
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305581	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ITGB2 mRNA	PMID:35163327
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:3558	cerivastatin	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:C086276	cerivastatin inhibits the reaction [TNF results in increased expression of ITGB2]	PMID:12615677
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C018021	cobaltous chloride results in increased expression of ITGB2 mRNA	PMID:26314263
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1305581	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of ITGB2 mRNA	PMID:25380136
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ITGB2 mRNA	PMID:24449571
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ITGB2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ITGB2 mRNA	PMID:32699268
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	affects localization	EXP		E	RGD:6480464	20240109	CTD	MESH:D013755	Tetradecanoylphorbol Acetate affects the localization of ITGB2 protein	PMID:20883105
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein	PMID:16393473
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20130212	CTD	MESH:D013755	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of ITGB2 protein]; acteoside inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein]; crenatoside inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein]; Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ITGB2 protein]	PMID:16393473|PMID:20883105
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313695	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ITGB2 mRNA	PMID:40194260
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of ITGB2 mRNA	PMID:40434365
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:38757	isoflavones	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones affects the expression of ITGB2 mRNA	PMID:16365062
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ITGB2 mRNA	PMID:36331819
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in increased expression of ITGB2 mRNA	PMID:23527032
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ITGB2 gene	PMID:29154799
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ITGB2 mRNA	PMID:25562108
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:41072	3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C070515	bisindolylmaleimide I inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein]	PMID:16963453
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ITGB2 mRNA	PMID:28628672
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ITGB2 mRNA	PMID:37992649
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of ITGB2 mRNA	PMID:21678067
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ITGB2 mRNA	PMID:38832940
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ITGB2 mRNA	PMID:17562736
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of ITGB2	PMID:15485462
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of ITGB2 mRNA	PMID:24714768
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:46661	asbestos	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001194	Asbestos results in decreased expression of ITGB2 mRNA	PMID:22398240
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ITGB2 mRNA	PMID:23634900
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ITGB2 mRNA	PMID:40504410
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1313695	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of ITGB2 mRNA	PMID:26934552
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of ITGB2 mRNA	PMID:26833863
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305581	E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan results in increased expression of ITGB2 mRNA	PMID:31464424
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ITGB2 mRNA	PMID:35436446
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D004997	[Ethinyl Estradiol co-treated with Cholic Acids] affects the expression of ITGB2 mRNA	PMID:27344345
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:49662	indometacin	affects response to substance	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D007213	ITGB2 protein affects the susceptibility to Indomethacin	PMID:10486359
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1305581	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in increased expression of ITGB2 mRNA	PMID:36868495
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ITGB2 mRNA	PMID:28628672
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of [ITGAM protein binds to ITGB2 protein]	PMID:10761979
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:49747	methylmercury(1+)	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C030957	methylmercury II results in increased expression of ITGB2 mRNA	PMID:26314263
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ITGB2 mRNA	PMID:20458559
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313695	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of ITGB2 mRNA	PMID:23845593
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313695	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ITGB2 mRNA; Nanotubes, Carbon results in increased expression of ITGB2 mRNA	PMID:25554681
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:50648	9-cis-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C103303	Dimethyl Sulfoxide promotes the reaction [Alitretinoin results in increased expression of ITGB2 protein]	PMID:15964820
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313695	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of ITGB2 mRNA	PMID:40234311
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:50686	atorvastatin calcium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069059	Atorvastatin inhibits the reaction [TNF results in increased expression of ITGB2]	PMID:12615677
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305581	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ITGB2 mRNA	PMID:24136188
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:5158	Formylmethionyl-leucyl-phenylalanine methyl ester	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C042932	formylmethionyl-leucyl-phenylalanine methyl ester results in increased expression of ITGB2 protein	PMID:9605577
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:5158	Formylmethionyl-leucyl-phenylalanine methyl ester	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C042932	resveratrol analog inhibits the reaction [formylmethionyl-leucyl-phenylalanine methyl ester results in increased expression of ITGB2 protein]	PMID:9605577
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:52289	wortmannin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein]	PMID:16963453
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:53490	N-formyl-L-methionyl-L-leucyl-L-phenylalanine	increases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:D009240	N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein	PMID:10215738|PMID:16393473
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:53490	N-formyl-L-methionyl-L-leucyl-L-phenylalanine	increases expression	ISO	RGD:1313695	E	RGD:6480464	20120613	CTD	MESH:D009240	N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein	PMID:21664406
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:53490	N-formyl-L-methionyl-L-leucyl-L-phenylalanine	multiple interactions	EXP		E	RGD:6480464	20130212	CTD	MESH:D009240	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]; acteoside inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]; crenatoside inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]; plaunotol inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of ITGB2 protein]	PMID:10215738|PMID:16393473
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:5643	Heliotrine	increases expression	ISO	RGD:1305581	E	RGD:6480464	20211109	CTD	MESH:C010178	heliotrine results in increased expression of ITGB2 mRNA	PMID:34185104
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313695	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ITGB2 mRNA	PMID:38701926
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of ITGB2 mRNA	PMID:20436886
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:64206	bromochloroacetic acid	increases expression	ISO	RGD:1305581	E	RGD:6480464	20120412	CTD	MESH:C099813	bromochloroacetic acid results in increased expression of ITGB2 mRNA	PMID:16460773
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:6456	lidocaine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008012	Lidocaine inhibits the reaction [TNF protein results in increased expression of [ITGAM protein binds to ITGB2 protein]]	PMID:9336308
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein]	PMID:16963453
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of ITGB2 protein	PMID:35926579
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:67989	ginsenoside Rb1	multiple interactions	ISO	RGD:1305581	E	RGD:6480464	20161228	CTD	MESH:C442759	ginsenoside Rb1 inhibits the reaction [Lipopolysaccharides results in increased expression of ITGB2 protein]	PMID:17655881
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305581	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ITGB2 gene	PMID:35440735
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:68794	neoechinulin A	increases expression	ISO	RGD:1313695	E	RGD:6480464	20170228	CTD	MESH:C490266	neoechinulin A results in increased expression of ITGB2 mRNA	PMID:19818335
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1305581	E	RGD:6480464	20230307	CTD	MESH:C057862	cyanoginosin LR results in increased expression of ITGB2 mRNA; cyanoginosin LR results in increased expression of ITGB2 protein	PMID:19360947
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of ITGB2 mRNA]	PMID:30825431
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313695	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ITGB2 mRNA	PMID:22206623
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:748998	lenabasum	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20260714	CTD	MESH:C471849	lenabasum inhibits the reaction [Bleomycin results in increased expression of ITGB2 mRNA]	PMID:30825431
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305581	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of ITGB2 mRNA	PMID:32741896
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:77146	ginsenoside C-K	multiple interactions	EXP		E	RGD:6480464	20170117	CTD	MESH:C112772	ginsenoside compound K inhibits the reaction [TNF protein results in increased expression of [ITGAL protein binds to ITGB2 protein]]	PMID:21875580
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:77149	notoginsenoside R1	decreases expression	ISO	RGD:1313695	E	RGD:6480464	20151110	CTD	MESH:C072936	notoginsenoside R1 results in decreased expression of ITGB2 protein	PMID:18176958
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:77149	notoginsenoside R1	multiple interactions	ISO	RGD:1305581	E	RGD:6480464	20151110	CTD	MESH:C072936	notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in increased expression of ITGB2 protein]	PMID:17655881
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C025589	ochratoxin A metabolite results in increased expression of ITGB2 mRNA; ochratoxin A results in increased expression of ITGB2 mRNA	PMID:26314263
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:7852	oxycodone	decreases expression	ISO	RGD:1305581	E	RGD:6480464	20161025	CTD	MESH:D010098	Oxycodone results in decreased expression of ITGB2 mRNA	PMID:23439660
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:79	(-)-Arctigenin	decreases secretion	EXP		E	RGD:6480464	20230404	CTD	MESH:C071942	arctigenin results in decreased secretion of ITGB2 protein	PMID:29740324
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:7986	Pentoxifylline	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D010431	Pentoxifylline affects the expression of ITGB2	PMID:1976392
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:81543	Tributyltin oxide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of ITGB2 mRNA	PMID:26314263
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:81555	Enterolactone	decreases secretion	EXP		E	RGD:6480464	20230404	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased secretion of ITGB2 protein	PMID:29740324
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313695	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ITGB2 mRNA	PMID:38648751
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305581	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ITGB2 mRNA	PMID:27291303
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of ITGB2 mRNA	PMID:38995820
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305581	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ITGB2 mRNA	PMID:23640034
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of ITGB2 mRNA	PMID:20368581
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ITGB2 mRNA	PMID:26079696
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:8427	probucol	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20130903	CTD	MESH:D011341	Probucol promotes the reaction [APOE gene mutant form results in increased expression of ITGB2 mRNA]	PMID:19394937
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:8890	(S)-ropivacaine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C037663	Ropivacaine inhibits the reaction [TNF protein results in increased expression of [ITGAM protein binds to ITGB2 protein]]	PMID:9336308
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:90721	N-[3-(aminomethyl)benzyl]acetamidine	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C104820	N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein]; N-(3-(aminomethyl)benzyl)acetamidine inhibits the reaction [ITGB2 protein results in increased activity of RAP2A protein]	PMID:16963453
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:9111	Senkirkine	increases expression	ISO	RGD:1305581	E	RGD:6480464	20211109	CTD	MESH:C009238	senkirkine results in increased expression of ITGB2 mRNA	PMID:34185104
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:91462	SU6656	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:C416927	SU 6656 inhibits the reaction [ITGB2 protein results in increased activity of RAP1A protein]	PMID:16963453
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:9150	simvastatin	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D019821	Simvastatin binds to [ITGAL protein binds to ITGB2 protein]	PMID:15041742
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:9150	simvastatin	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in decreased expression of ITGB2 mRNA	PMID:12615677
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:9150	simvastatin	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin inhibits the reaction [TNF results in increased expression of ITGB2]	PMID:12615677
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:9150	simvastatin	multiple interactions	ISO	RGD:1313695	E	RGD:6480464	20120412	CTD	MESH:D019821	Simvastatin results in decreased expression of [ITGAM protein binds to ITGB2 protein]	PMID:21330348
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305581	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ITGB2 mRNA	PMID:19281266
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1305581	E	RGD:6480464	20120412	CTD	MESH:D013311	Streptozocin results in increased expression of ITGB2 protein	PMID:16129698
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1305581	E	RGD:6480464	20120412	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of ITGB2 mRNA; KLK1 protein inhibits the reaction [Streptozocin results in increased expression of ITGB2 protein]	PMID:16129698|PMID:25905778
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:9334	sulfasalazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012460	Sulfasalazine inhibits the reaction [TNF protein results in increased expression of ITGB2 protein]	PMID:8094364
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ITGB2 mRNA	PMID:29301935
1313694	ITGB2	integrin subunit beta 2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305581	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ITGB2 mRNA	PMID:19015723
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MCM9 mRNA	PMID:38218311
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313697	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of MCM9 mRNA	PMID:33045310
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313697	E	RGD:6480464	20230404	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of MCM9 mRNA]	PMID:19467301
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MCM9 mRNA	PMID:33167477
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1560557	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MCM9 mRNA	PMID:33387578
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MCM9 mRNA	PMID:37042841
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of MCM9 mRNA	PMID:26079696
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MCM9 protein	PMID:37730182
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:2422	acetohydrazide	decreases expression	ISO	RGD:1313697	E	RGD:6480464	20230404	CTD	MESH:C014949	acetylhydrazine results in decreased expression of MCM9 mRNA	PMID:15282401
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MCM9 mRNA	PMID:23649840
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MCM9 protein	PMID:35688186
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1560557	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of MCM9 gene	PMID:31011160
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MCM9 mRNA	PMID:23557933
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1560557	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MCM9 mRNA	PMID:33387578
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MCM9 mRNA	PMID:28001369
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of MCM9 mRNA	PMID:32763439
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MCM9 mRNA	PMID:22714537
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MCM9 mRNA	PMID:19150397
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313697	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MCM9 gene	PMID:35295148
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1560557	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MCM9 mRNA	PMID:25181051
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1560557	E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MCM9 protein	PMID:34896426
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313697	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MCM9 mRNA	PMID:40194260
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1560557	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of MCM9 protein	PMID:34896426
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of MCM9 mRNA	PMID:28001369
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1560557	E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MCM9 protein	PMID:34896426
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1560557	E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MCM9 protein	PMID:34896426
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313697	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MCM9 mRNA	PMID:17562736
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1560557	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MCM9 mRNA	PMID:33387578
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in increased expression of MCM9 mRNA	PMID:26615145
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1560557	E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MCM9 protein	PMID:34896426
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of MCM9 mRNA	PMID:22714537
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313697	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MCM9 mRNA	PMID:22206623
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of MCM9 mRNA	PMID:22714537
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313697	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of MCM9 mRNA	PMID:35537566
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1560557	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MCM9 mRNA	PMID:23869203
1313696	MCM9	minichromosome maintenance 9 homologous recombination repair factor	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1560557	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of MCM9 gene	PMID:31682807
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RANBP3 mRNA	PMID:38218311
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RANBP3 mRNA	PMID:38218311
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RANBP3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RANBP3 mRNA	PMID:32699268
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of RANBP3 mRNA	PMID:22378314
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1557627	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RANBP3 mRNA	PMID:30319688
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:16240	hydrogen peroxide	increases phosphorylation	ISO	RGD:1557627	E	RGD:6480464	20200211	CTD	MESH:D006861	Hydrogen Peroxide results in increased phosphorylation of RANBP3 protein	PMID:31494107
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1557627	E	RGD:6480464	20200211	CTD	MESH:D006861	N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of RANBP3 protein]	PMID:31494107
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of RANBP3 mRNA	PMID:16202921
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1557627	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RANBP3 mRNA	PMID:23892564
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Haloperidol] results in decreased expression of RANBP3 protein	PMID:34122009
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RANBP3 protein	PMID:37730182
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RANBP3 mRNA	PMID:28818685
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of RANBP3 exon	PMID:30157460
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RANBP3 mRNA	PMID:19549813
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RANBP3 protein	PMID:23301498
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of RANBP3 protein	PMID:19845377
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RANBP3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RANBP3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RANBP3 mRNA	PMID:32699268
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1557627	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RANBP3 mRNA	PMID:22206623
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1557627	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RANBP3 mRNA	PMID:40504410
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of RANBP3 mRNA	PMID:19244175
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of RANBP3 protein	PMID:35688186
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in decreased expression of RANBP3 protein	PMID:18089832
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1557627	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of RANBP3 protein	PMID:25505154
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1557627	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of RANBP3 protein	PMID:22006019
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of RANBP3 protein	PMID:35688186
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of RANBP3 protein	PMID:38228842
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1557627	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RANBP3 mRNA	PMID:40504410
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RANBP3 3' UTR; Benzo(a)pyrene affects the methylation of RANBP3 intron	PMID:27901495|PMID:30157460
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1557627	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RANBP3 exon; Benzo(a)pyrene results in increased methylation of RANBP3 intron	PMID:27901495
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557627	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RANBP3 gene	PMID:35295148
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1589604	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of RANBP3 mRNA	PMID:30816183
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1557627	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RANBP3 mRNA	PMID:33221593
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1589604	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RANBP3 mRNA	PMID:25181051
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of RANBP3 mRNA	PMID:19244175
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RANBP3 exon	PMID:30157460
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1557627	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RANBP3 mRNA	PMID:38685157
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1557627	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of RANBP3 protein	PMID:35362542
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1557627	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of RANBP3 protein]	PMID:35362542
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RANBP3 mRNA	PMID:37042841
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RANBP3 mRNA	PMID:38568856
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RANBP3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RANBP3 mRNA	PMID:32699268
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of RANBP3 mRNA	PMID:19244175
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1557627	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of RANBP3 mRNA	PMID:17585979
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RANBP3 gene	PMID:29154799
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1557627	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of RANBP3 mRNA	PMID:29279043
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1557627	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RANBP3 mRNA	PMID:40504410
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1557627	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of RANBP3 protein]	PMID:35362542
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:5613	haloperidol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in decreased expression of RANBP3 protein	PMID:34122009
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RANBP3 protein	PMID:32959892
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1557627	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of RANBP3 mRNA	PMID:26307267
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of RANBP3 exon	PMID:30157460
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1557627	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RANBP3 mRNA	PMID:22206623
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1557627	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RANBP3 mRNA	PMID:22206623
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of RANBP3 protein	PMID:31285264
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of RANBP3 protein	PMID:39638853
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RANBP3 gene]	PMID:28238834
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1589604	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of RANBP3 protein	PMID:28903499
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1557627	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of RANBP3 mRNA	PMID:30953684
1313698	RANBP3	RAN binding protein 3	gene	CHEBI:9130	sevoflurane	increases expression	ISO	RGD:1557627	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased expression of RANBP3 protein	PMID:35249202
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in increased expression of DHRS3 mRNA	PMID:19371625
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of DHRS3 mRNA	PMID:21551480
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of DHRS3 mRNA	PMID:26272509
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA	PMID:27188386
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of DHRS3 mRNA	PMID:33045310
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305584	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of DHRS3 mRNA]	PMID:31150632
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of DHRS3 mRNA	PMID:26251327
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases abundance	ISO	RGD:1313700	E	RGD:6480464	20140610	CTD	MESH:D014212	DHRS3 gene mutant form results in increased abundance of Tretinoin	PMID:24005908
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of DHRS3 mRNA	PMID:15498508|PMID:16054129|PMID:16249480|PMID:17431108|PMID:21934132|PMID:23724009|PMID:23830798
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1305584	E	RGD:6480464	20121009	CTD	MESH:D014212	Tretinoin results in increased expression of DHRS3 mRNA	PMID:20488242|PMID:22262565|PMID:22664269
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1313700	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of DHRS3 mRNA	PMID:36189433
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20140610	CTD	MESH:D014212	[DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in decreased expression of ALDH1A1 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in decreased expression of ALDH1A2 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in decreased expression of ALDH1A3 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in decreased expression of HOXA13 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in decreased expression of HOXD13 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in decreased expression of RDH10 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in increased expression of CYP26A1 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in increased expression of HOXA1 mRNA; [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in increased expression of RARB mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DHRS3 mRNA	PMID:24005908|PMID:36189433
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D010100	Oxygen deficiency results in increased expression of DHRS3 mRNA	PMID:24403227
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D010100	1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of DHRS3 mRNA]	PMID:24403227
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DHRS3 mRNA	PMID:30529165
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DHRS3 mRNA	PMID:26079696
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1305584	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of DHRS3 mRNA	PMID:36841081
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313700	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of DHRS3 mRNA	PMID:40945087
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DHRS3 mRNA	PMID:20044591
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DHRS3 mRNA	PMID:39241906
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of DHRS3 mRNA	PMID:35811015
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:16422	androst-4-ene-3,17-dione	increases metabolic processing	EXP		E	RGD:6480464	20150414	CTD	MESH:D000735	DHRS3 protein results in increased metabolism of Androstenedione	PMID:25451588
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DHRS3 mRNA	PMID:39298647
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of DHRS3 mRNA	PMID:19619570|PMID:23019147
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of DHRS3 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DHRS3 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of DHRS3 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA]	PMID:19619570|PMID:20660070|PMID:23275455|PMID:30165855
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DHRS3 mRNA	PMID:19448997
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305584	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DHRS3 mRNA	PMID:33387578
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DHRS3 mRNA	PMID:37042841
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of DHRS3 mRNA	PMID:21540246
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D011374	7-propyl spirolactone inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; [Estradiol co-treated with Progesterone] results in decreased expression of DHRS3 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein; Aldosterone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; Mifepristone promotes the reaction [Progesterone affects the expression of DHRS3 mRNA]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA]	PMID:20660070|PMID:22414680|PMID:23275455
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of DHRS3 mRNA	PMID:36695872
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of DHRS3 mRNA	PMID:36189433
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17263	estrone	increases metabolic processing	EXP		E	RGD:6480464	20150414	CTD	MESH:D004970	DHRS3 protein results in increased metabolism of Estrone	PMID:25451588
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1313700	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of DHRS3 mRNA	PMID:28973375
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17336	all-trans-retinol	decreases abundance	ISO	RGD:1313700	E	RGD:6480464	20140610	CTD	MESH:D014801	DHRS3 gene mutant form results in decreased abundance of Vitamin A	PMID:24005908
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of DHRS3 mRNA	PMID:21592394
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of DHRS3 mRNA	PMID:21592394
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17378	D-glyceraldehyde	increases metabolic processing	EXP		E	RGD:6480464	20150414	CTD	MESH:D005985	DHRS3 protein results in increased metabolism of Glyceraldehyde	PMID:25451588
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of DHRS3 mRNA	PMID:23892564
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of DHRS3 mRNA	PMID:23825647
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305584	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DHRS3 promoter	PMID:23359474
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA	PMID:39150890
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of DHRS3 mRNA	PMID:16002434
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of DHRS3 mRNA	PMID:21592394
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of DHRS3 mRNA	PMID:21592394
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of DHRS3 mRNA	PMID:22061828
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DHRS3 mRNA	PMID:28818685
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:18009	NADP(+)	increases activity	EXP		E	RGD:6480464	20150414	CTD	MESH:D009249	NADP results in increased activity of DHRS3 protein	PMID:25451588
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:18009	NADP(+)	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D009249	NADP binds to and results in increased activity of DHRS3 protein	PMID:25526675
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of DHRS3 mRNA	PMID:23825647
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:188851	Muraglitazar	increases expression	ISO	RGD:1305584	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of DHRS3 mRNA	PMID:21515302
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:22718	benzoates	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in decreased expression of DHRS3 mRNA	PMID:29472718
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in decreased expression of DHRS3 mRNA	PMID:28860664
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DHRS3 mRNA	PMID:37236586
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of DHRS3 protein	PMID:20106945
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of DHRS3 mRNA	PMID:27153756
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of DHRS3 mRNA	PMID:19770486
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DHRS3 intron	PMID:30157460
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of DHRS3 mRNA	PMID:25102026
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DHRS3 mRNA	PMID:31150632
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DHRS3 mRNA	PMID:27339419|PMID:31919559
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DHRS3 mRNA	PMID:17484886
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305584	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of DHRS3 mRNA]	PMID:31150632
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of DHRS3 mRNA	PMID:18414638
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DHRS3 mRNA	PMID:40504410
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:27584	aldosterone	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D000450	Aldosterone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]	PMID:23275455
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of DHRS3 mRNA	PMID:26272509
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA	PMID:27188386
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of DHRS3 mRNA	PMID:19371625
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of DHRS3 mRNA	PMID:18930951
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28052	acetohexamide	increases metabolic processing	EXP		E	RGD:6480464	20150414	CTD	MESH:D000092	DHRS3 protein results in increased metabolism of Acetohexamide	PMID:25451588
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of DHRS3 mRNA	PMID:19371625|PMID:23019147|PMID:26865667
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D019833	[Dexamethasone co-treated with Genistein] results in increased expression of DHRS3 mRNA	PMID:25136773
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305584	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DHRS3 mRNA	PMID:22298810
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DHRS3 mRNA	PMID:18343893
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DHRS3 mRNA	PMID:21215274|PMID:21724226
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DHRS3 mRNA	PMID:19770486
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DHRS3 mRNA	PMID:19619570|PMID:20106945
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305584	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DHRS3 mRNA	PMID:33387578|PMID:34747641
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313700	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DHRS3 mRNA	PMID:15328365|PMID:15800033|PMID:16611356
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DHRS3 mRNA	PMID:19619570
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DHRS3 mRNA	PMID:34089799
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DHRS3 mRNA	PMID:33212167
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DHRS3 mRNA	PMID:30851411
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DHRS3 mRNA	PMID:32763439
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305584	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of DHRS3 mRNA	PMID:30556269
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of DHRS3 mRNA	PMID:24690739
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DHRS3 mRNA	PMID:15467011
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28735	4-nitroacetophenone	increases metabolic processing	EXP		E	RGD:6480464	20150414	CTD	MESH:C001972	DHRS3 protein results in increased metabolism of 4-nitroacetophenone	PMID:25451588
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of DHRS3 mRNA	PMID:30031762
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DHRS3 mRNA	PMID:12727804|PMID:38568856
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of DHRS3 mRNA	PMID:39719251
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DHRS3 mRNA	PMID:40504410
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of DHRS3 mRNA	PMID:22378314
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DHRS3 mRNA	PMID:32234424
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DHRS3 mRNA	PMID:15894712|PMID:19770486
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DHRS3 mRNA; Benzo(a)pyrene results in increased expression of DHRS3 protein	PMID:32717239|PMID:38036013
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D001564	[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of DHRS3 mRNA	PMID:15894712
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of DHRS3 mRNA	PMID:15894712
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of DHRS3 mRNA	PMID:18929588
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:C015001	[arsenite co-treated with Benzo(a)pyrene] results in decreased expression of DHRS3 mRNA; TRP53 protein affects the reaction [arsenite results in increased expression of DHRS3 mRNA]	PMID:15894712|PMID:18929588
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305584	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of DHRS3 mRNA	PMID:30556269
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of DHRS3 mRNA	PMID:24690739
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of DHRS3 mRNA	PMID:15467011
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of DHRS3 mRNA	PMID:27131904
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of DHRS3 mRNA	PMID:25895662
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of DHRS3 mRNA	PMID:19150397
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of DHRS3 mRNA	PMID:35984750
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DHRS3 gene	PMID:31601247
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of DHRS3 mRNA	PMID:24136188
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of DHRS3 mRNA	PMID:22641619
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of DHRS3 mRNA	PMID:38568856
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of DHRS3 mRNA	PMID:15498508
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of DHRS3 mRNA	PMID:23557971
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313700	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DHRS3 promoter	PMID:35295148
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of DHRS3 mRNA	PMID:34492290
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of DHRS3 mRNA	PMID:18648102
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of DHRS3 mRNA	PMID:18445702
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313700	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of DHRS3 mRNA	PMID:17426115|PMID:18301758
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	increases metabolic processing	EXP		E	RGD:6480464	20150414	CTD	MESH:C016583	DHRS3 protein results in increased metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone	PMID:25451588
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of DHRS3 mRNA	PMID:22576693
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A results in increased expression of DHRS3 mRNA	PMID:19371625|PMID:23019147|PMID:29275510|PMID:29718440|PMID:34831106
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305584	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DHRS3 mRNA	PMID:25181051|PMID:34947998
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313700	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of DHRS3 mRNA	PMID:30951980|PMID:35341816|PMID:37105096
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of DHRS3 gene	PMID:22576693
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DHRS3 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DHRS3 mRNA	PMID:28628672|PMID:31601247
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305584	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DHRS3 promoter	PMID:23359474
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DHRS3 mRNA	PMID:25172293
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of DHRS3 mRNA	PMID:19371625
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of DHRS3 mRNA	PMID:26682919
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of DHRS3 mRNA	PMID:36804509
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	DHRS3 mRNA affects the susceptibility to Carmustine	PMID:16365179
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DHRS3 mRNA	PMID:39298647
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of DHRS3 mRNA	PMID:34831106
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313700	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of DHRS3 mRNA	PMID:30951980|PMID:40203079
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of DHRS3 mRNA	PMID:34831106
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313700	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of DHRS3 mRNA	PMID:30951980
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of DHRS3 protein	PMID:34186270
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA	PMID:39150890
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:1305584	E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of DHRS3 mRNA	PMID:17602206
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DHRS3 mRNA	PMID:21266533
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305584	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DHRS3 promoter	PMID:23359474
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA	PMID:39150890
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA	PMID:39150890
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DHRS3 mRNA	PMID:28628672
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of DHRS3 mRNA	PMID:21527772
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of DHRS3 mRNA	PMID:25380136
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DHRS3 mRNA	PMID:26472689
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DHRS3 mRNA	PMID:37236586
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA	PMID:39150890
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313700	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DHRS3 mRNA	PMID:40194260
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DHRS3 mRNA	PMID:31533062
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of DHRS3 mRNA	PMID:38568856
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DHRS3 mRNA	PMID:25979313
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DHRS3 mRNA	PMID:17292431|PMID:17963808
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of DHRS3 mRNA	PMID:29154799
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DHRS3 gene	PMID:29154799
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of DHRS3 mRNA	PMID:24935251
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of DHRS3 mRNA	PMID:20106945
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DHRS3 mRNA	PMID:25562108|PMID:27989131
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of DHRS3 mRNA	PMID:17555576
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D003907	[Dexamethasone co-treated with Genistein] results in increased expression of DHRS3 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DHRS3 mRNA	PMID:25136773|PMID:28628672
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of DHRS3 mRNA	PMID:19371625
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in increased expression of DHRS3 mRNA	PMID:15958647
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:44409	NADP zwitterion	increases activity	EXP		E	RGD:6480464	20150414	CTD	MESH:D009249	NADP results in increased activity of DHRS3 protein	PMID:25451588
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:44409	NADP zwitterion	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D009249	NADP binds to and results in increased activity of DHRS3 protein	PMID:25526675
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of DHRS3 mRNA	PMID:38832940
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DHRS3 mRNA	PMID:17562736
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of DHRS3 mRNA	PMID:21420995|PMID:29067470
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in decreased expression of DHRS3 mRNA	PMID:29246445
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305584	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DHRS3 mRNA	PMID:33387578
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form promotes the reaction [Acetaminophen results in decreased expression of DHRS3 mRNA]	PMID:29246445
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of DHRS3 mRNA	PMID:24714768
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of DHRS3 mRNA	PMID:24690739
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of DHRS3 mRNA	PMID:33725128
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of DHRS3 mRNA	PMID:35811015
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of DHRS3 mRNA	PMID:18414638
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DHRS3 mRNA	PMID:40504410
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of DHRS3 mRNA	PMID:35537566
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1305584	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of DHRS3 mRNA	PMID:37077353
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1305584	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of DHRS3 mRNA	PMID:29391264
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313700	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DHRS3 mRNA	PMID:17555576
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of DHRS3 mRNA	PMID:17108234
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DHRS3 mRNA	PMID:18936297
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of DHRS3 mRNA	PMID:38568856
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DHRS3 mRNA	PMID:28628672
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:4998	fenarimol	increases expression	ISO	RGD:1305584	E	RGD:6480464	20171114	CTD	MESH:C033789	fenarimol results in increased expression of DHRS3 mRNA	PMID:28970091
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DHRS3 mRNA; Nanotubes, Carbon results in decreased expression of DHRS3 mRNA	PMID:25554681|PMID:25620056
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:50692	mifepristone	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D015735	Mifepristone promotes the reaction [Progesterone affects the expression of DHRS3 mRNA]	PMID:22414680
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:50859	bexarotene	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C095105	bexarotene results in increased expression of DHRS3 mRNA	PMID:17178900
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of DHRS3 mRNA	PMID:24793618
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:51507	benzil	increases metabolic processing	EXP		E	RGD:6480464	20150414	CTD	MESH:C006697	DHRS3 protein results in increased metabolism of benzil	PMID:25451588
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:5445	glyceraldehyde	increases metabolic processing	EXP		E	RGD:6480464	20150414	CTD	MESH:D005985	DHRS3 protein results in increased metabolism of Glyceraldehyde	PMID:25451588
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of DHRS3 mRNA	PMID:18769122
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of DHRS3 mRNA	PMID:28801915
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DHRS3 mRNA	PMID:28801915
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in increased expression of DHRS3 mRNA	PMID:16982809
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:64211	8-Br-cAMP	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D015124	7-propyl spirolactone inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein; Aldosterone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA]	PMID:23275455
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20121113	CTD	MESH:D007545	Isoproterenol results in decreased expression of DHRS3 mRNA	PMID:21335049
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:67895	corosolic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of DHRS3 mRNA	PMID:37939859
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313700	E	RGD:6480464	20181016	CTD	MESH:D008825	Miconazole results in increased expression of DHRS3 mRNA	PMID:29337257
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	DHRS3 mRNA affects the susceptibility to temozolomide	PMID:16365179
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of DHRS3 mRNA	PMID:31758290
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:72754	bisphenol AF	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in decreased expression of DHRS3 mRNA	PMID:25912373
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of DHRS3 mRNA	PMID:28960945
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of DHRS3 mRNA	PMID:36318118
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of DHRS3 mRNA	PMID:26720608
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DHRS3 mRNA	PMID:30851411
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of DHRS3 mRNA	PMID:34995734
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA	PMID:27188386
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313700	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of DHRS3 mRNA	PMID:39150890
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1313700	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of DHRS3 mRNA	PMID:18343893
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1305584	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of DHRS3 mRNA	PMID:22664269
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:81922	flusilazole	increases expression	ISO	RGD:1305584	E	RGD:6480464	20161025	CTD	MESH:C061365	flusilazole results in increased expression of DHRS3 mRNA	PMID:22664269|PMID:27094377|PMID:28263823
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:81922	flusilazole	increases expression	ISO	RGD:1313700	E	RGD:6480464	20181016	CTD	MESH:C061365	flusilazole results in increased expression of DHRS3 mRNA	PMID:29337257
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of DHRS3 mRNA	PMID:12727804
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305584	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DHRS3 mRNA	PMID:36843608
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of DHRS3 mRNA	PMID:26272509
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA	PMID:27188386
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:87368	diethyl malate	affects expression	ISO	RGD:1313700	E	RGD:6480464	20170303	CTD	MESH:C058705	diethyl malate affects the expression of DHRS3 mRNA	PMID:24814887
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20240430	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of DHRS3 mRNA	PMID:35278568
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DHRS3 mRNA	PMID:27188386
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of DHRS3 mRNA	PMID:27131904
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DHRS3 mRNA	PMID:38568856
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of DHRS3 mRNA	PMID:22378314
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1305584	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon results in increased expression of DHRS3 mRNA	PMID:22664269|PMID:28263823
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1305584	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of DHRS3 mRNA	PMID:21515302
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1313700	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of DHRS3 mRNA	PMID:12732648
1313699	DHRS3	dehydrogenase/reductase 3	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313700	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of DHRS3 mRNA	PMID:35537566
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in decreased expression of COL6A2 mRNA	PMID:31863870
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of COL6A2 mRNA	PMID:38218311
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305585	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of COL6A2 mRNA	PMID:25152437
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305585	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of COL6A2 mRNA	PMID:21551480
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313702	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COL6A2 mRNA	PMID:33045310
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of COL6A2 mRNA	PMID:30951980
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of COL6A2 mRNA	PMID:36331819
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of COL6A2 mRNA	PMID:22378314
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:16130	DDT	increases expression	ISO	RGD:1305585	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased expression of COL6A2 mRNA	PMID:30207508
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313702	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of COL6A2 mRNA	PMID:30319688
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313702	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of COL6A2 mRNA	PMID:16977382
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20161228	CTD	MESH:D008070	Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of COL6A2 mRNA]	PMID:16977382
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305585	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of COL6A2 mRNA	PMID:32145629
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313702	E	RGD:6480464	20130416	CTD	MESH:D004958	Estradiol results in increased expression of COL6A2 mRNA	PMID:23144751
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of COL6A2 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of COL6A2 mRNA	PMID:20823114|PMID:30165855
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305585	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL6A2 mRNA	PMID:32741896
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D004958	[bisphenol A results in increased susceptibility to Estradiol] which results in decreased expression of COL6A2 mRNA; Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of COL6A2 mRNA]	PMID:16977382|PMID:27312807
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of COL6A2 mRNA	PMID:26079696
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:17234	glucose	affects secretion	EXP		E	RGD:6480464	20160822	CTD	MESH:D005947	Glucose deficiency affects the secretion of COL6A2 protein	PMID:24802182
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL6A2 mRNA	PMID:37992649
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305585	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL6A2 mRNA	PMID:32741896
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of COL6A2 mRNA	PMID:33647349
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:17634	D-glucose	affects secretion	EXP		E	RGD:6480464	20160822	CTD	MESH:D005947	Glucose deficiency affects the secretion of COL6A2 protein	PMID:24802182
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL6A2 mRNA	PMID:37992649
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313702	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of COL6A2 mRNA	PMID:33754040
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA	PMID:39150890
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of COL6A2 mRNA	PMID:28818685
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of COL6A2 intron	PMID:30157460
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COL6A2 mRNA	PMID:36331819
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COL6A2 mRNA	PMID:29741670
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COL6A2 protein]	PMID:32272095
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of COL6A2 polyA tail	PMID:30157460
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of COL6A2 mRNA	PMID:18356318
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of COL6A2 mRNA]	PMID:22206623
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of COL6A2 gene] which results in increased expression of COL6A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COL6A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of COL6A2 gene	PMID:40504410
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of COL6A2 mRNA	PMID:19244175
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of COL6A2 mRNA	PMID:28960355
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305585	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of COL6A2 mRNA	PMID:31881176
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:27881	resveratrol	affects secretion	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol affects the secretion of COL6A2 protein	PMID:24802182
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in decreased expression of COL6A2 mRNA	PMID:23625948
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313702	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of COL6A2 mRNA	PMID:32186404
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305585	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COL6A2 mRNA	PMID:34747641
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313702	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COL6A2 mRNA	PMID:26377647
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305585	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COL6A2 mRNA	PMID:33387578
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL6A2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to COL6A2 promoter]	PMID:17942748|PMID:19654925
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305585	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of COL6A2 mRNA	PMID:28959563
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of COL6A2 mRNA	PMID:21198554
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1305585	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of COL6A2 mRNA	PMID:30556269
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of COL6A2 mRNA	PMID:30911355
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of COL6A2 protein	PMID:28918527
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1305585	E	RGD:6480464	20181113	CTD	MESH:D012969	Sodium Fluoride results in increased expression of COL6A2 protein	PMID:29653260
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of COL6A2 mRNA	PMID:29803840
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of COL6A2 mRNA	PMID:39631538
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20120918	CTD	MESH:D004317	[[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of COL6A2 mRNA	PMID:21040762
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL6A2 mRNA	PMID:37992649
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of COL6A2 gene	PMID:28589171
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of COL6A2 mRNA	PMID:18812580
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313702	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of COL6A2 gene	PMID:39894169
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of COL6A2 mRNA	PMID:38568856
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of COL6A2 mRNA	PMID:12634122
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of COL6A2 gene] which results in increased expression of COL6A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COL6A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of COL6A2 gene	PMID:40504410
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of COL6A2 intron; Benzo(a)pyrene affects the methylation of COL6A2 promoter	PMID:27901495|PMID:30157460
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of COL6A2 3' UTR	PMID:27901495
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COL6A2 5' UTR	PMID:27901495
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of COL6A2 mRNA	PMID:18929588
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in decreased expression of COL6A2 mRNA]	PMID:18929588
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1305585	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of COL6A2 mRNA	PMID:30556269
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of COL6A2 mRNA	PMID:30911355
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of COL6A2 mRNA	PMID:18356318
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of COL6A2 gene	PMID:31601247
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C008261	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of COL6A2 mRNA	PMID:12634122
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305585	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of COL6A2 mRNA	PMID:25729387
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305585	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of COL6A2 mRNA	PMID:25729387
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of COL6A2 mRNA	PMID:35295148
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313702	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of COL6A2 gene; titanium dioxide results in decreased methylation of COL6A2 promoter	PMID:35295148
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305585	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of COL6A2 mRNA	PMID:34492290
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305585	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of COL6A2 mRNA	PMID:25380136
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of COL6A2 mRNA	PMID:17426115
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of COL6A2 mRNA	PMID:20813756
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305585	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of COL6A2 mRNA	PMID:25181051
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of COL6A2 protein	PMID:34186270
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305585	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of COL6A2 mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998|PMID:38750585
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313702	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of COL6A2 mRNA	PMID:30951980|PMID:32156529|PMID:32370801
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305585	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of COL6A2 gene	PMID:28505145
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A results in increased susceptibility to Estradiol] which results in decreased expression of COL6A2 mRNA	PMID:27312807
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of COL6A2 mRNA	PMID:19244175
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of COL6A2 mRNA	PMID:40203079
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313702	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of COL6A2 mRNA	PMID:30951980
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of COL6A2 protein	PMID:34186270
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313702	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of COL6A2 mRNA	PMID:30951980
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of COL6A2 mRNA	PMID:30951980
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of COL6A2 protein	PMID:34186270
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA	PMID:39150890
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of COL6A2 mRNA	PMID:31558096
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of COL6A2 mRNA; Dextran Sulfate results in decreased expression of COL6A2 protein	PMID:32272095|PMID:35093514
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313702	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of COL6A2 protein	PMID:35362542
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COL6A2 protein]; evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of COL6A2 protein]	PMID:32272095|PMID:35362542
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA	PMID:39150890
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA	PMID:39150890
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305585	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL6A2 mRNA	PMID:18164116
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of COL6A2 mRNA	PMID:29024780
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305585	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of COL6A2 mRNA	PMID:25380136
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of COL6A2 mRNA	PMID:38568856
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COL6A2 mRNA; [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of COL6A2 mRNA	PMID:12634122|PMID:29741670
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA	PMID:39150890
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305585	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of COL6A2 mRNA	PMID:27387713
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of COL6A2 mRNA	PMID:19244175
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:3764	clotrimazole	increases expression	ISO	RGD:1305585	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of COL6A2 mRNA	PMID:30047161
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of COL6A2 mRNA	PMID:40434365
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of COL6A2 mRNA	PMID:31533062
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of COL6A2 mRNA	PMID:31626844
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COL6A2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of COL6A2 mRNA	PMID:36331819
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:39501	2,2,2-tetramine	multiple interactions	ISO	RGD:1305585	E	RGD:6480464	20120717	CTD	MESH:D014266	Trientine inhibits the reaction [Streptozocin results in increased expression of COL6A2 protein]	PMID:19634143
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of COL6A2 mRNA	PMID:17963808
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of COL6A2 mRNA	PMID:19101580|PMID:26272509
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of COL6A2 gene	PMID:29154799
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A2 mRNA	PMID:27188386
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305585	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of COL6A2 mRNA	PMID:30047161|PMID:41580965
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of COL6A2 mRNA	PMID:40633821
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of COL6A2 mRNA	PMID:25047013
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of COL6A2 mRNA	PMID:28973697
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:42758	aldehydo-D-glucose	affects secretion	EXP		E	RGD:6480464	20160822	CTD	MESH:D005947	Glucose deficiency affects the secretion of COL6A2 protein	PMID:24802182
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL6A2 mRNA	PMID:37992649
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of COL6A2 mRNA	PMID:38832940
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of COL6A2 mRNA	PMID:19682730
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of COL6A2 mRNA	PMID:17562736
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of COL6A2 gene] which results in increased expression of COL6A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COL6A2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of COL6A2 gene	PMID:40504410
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305585	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of COL6A2 mRNA	PMID:29391264
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:48242	dichromium trioxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C023600	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of COL6A2 mRNA	PMID:12634122
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of COL6A2 mRNA	PMID:18175754
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:48843	disodium selenite	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20130514	CTD	MESH:D018038	[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of COL6A2 mRNA	PMID:23274088
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of COL6A2 mRNA	PMID:17942748
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL6A2 mRNA	PMID:17942748
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:4917	eugenol	increases expression	ISO	RGD:1305585	E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in increased expression of COL6A2 protein	PMID:39793947
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of COL6A2 protein]	PMID:35362542
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of COL6A2 mRNA	PMID:20823114
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313702	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of COL6A2 mRNA; Nanotubes, Carbon results in increased expression of COL6A2 mRNA	PMID:25554681
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305585	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of COL6A2 mRNA	PMID:30047161
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:52774	pentane-2,3-dione	increases expression	ISO	RGD:1305585	E	RGD:6480464	20150512	CTD	MESH:C013186	2,3-pentanedione results in increased expression of COL6A2 mRNA	PMID:25710175
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of COL6A2 mRNA	PMID:20436886
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	COL6A2 protein affects the susceptibility to Topotecan	PMID:16217747
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305585	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of COL6A2 mRNA	PMID:25729387
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305585	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of COL6A2 mRNA	PMID:25729387
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1313702	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of COL6A2 mRNA	PMID:23650126
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of COL6A2 mRNA	PMID:15336504
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of COL6A2 mRNA	PMID:36907384
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:64648	enniatin	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C100264	enniatins results in decreased expression of COL6A2 mRNA	PMID:36016515
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of COL6A2 mRNA	PMID:20823114
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in decreased expression of COL6A2 mRNA	PMID:36914120
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of COL6A2 mRNA	PMID:31758290
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of COL6A2 protein	PMID:34186270
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313702	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of COL6A2 mRNA	PMID:22206623
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of COL6A2 mRNA]	PMID:22206623
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of COL6A2 mRNA	PMID:36318118
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305585	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of COL6A2 mRNA	PMID:32741896
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1305585	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of COL6A2 mRNA	PMID:18164116
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A2 mRNA	PMID:27188386
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of COL6A2 mRNA	PMID:39150890
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COL6A2 gene]	PMID:28238834
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010672	Phenytoin results in increased expression of COL6A2 mRNA	PMID:8224229
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313702	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of COL6A2 mRNA	PMID:38648751
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305585	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of COL6A2 mRNA	PMID:27291303
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of COL6A2 mRNA	PMID:38995820
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of COL6A2 mRNA	PMID:31558096
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305585	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of COL6A2 mRNA	PMID:23640034
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:82527	Ptaquiloside	decreases expression	ISO	RGD:1313702	E	RGD:6480464	20141111	CTD	MESH:C043680	ptaquiloside results in decreased expression of COL6A2 mRNA	PMID:23274088
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:82527	Ptaquiloside	multiple interactions	ISO	RGD:1313702	E	RGD:6480464	20141111	CTD	MESH:C043680	[ptaquiloside co-treated with Sodium Selenite] results in decreased expression of COL6A2 mRNA	PMID:23274088
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL6A2 mRNA	PMID:27188386
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:9150	simvastatin	increases expression	ISO	RGD:1313702	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of COL6A2 mRNA	PMID:16274305
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305585	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of COL6A2 mRNA	PMID:19281266
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1305585	E	RGD:6480464	20120717	CTD	MESH:D013311	Streptozocin results in increased expression of COL6A2 protein	PMID:19634143
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1305585	E	RGD:6480464	20120717	CTD	MESH:D013311	Trientine inhibits the reaction [Streptozocin results in increased expression of COL6A2 protein]	PMID:19634143
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1313702	E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in increased expression of COL6A2 mRNA	PMID:18499699
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of COL6A2 mRNA	PMID:17440010
1313701	COL6A2	collagen type VI alpha 2 chain	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of COL6A2 mRNA	PMID:38568856
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of FAM241B mRNA	PMID:38218311
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313705	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FAM241B mRNA	PMID:33045310
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of FAM241B mRNA	PMID:36331819
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of FAM241B mRNA	PMID:26079696
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313705	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FAM241B mRNA	PMID:30319688
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FAM241B mRNA	PMID:37992649
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FAM241B mRNA	PMID:37992649
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305587	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FAM241B mRNA	PMID:33387578
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FAM241B mRNA	PMID:28818685
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FAM241B mRNA	PMID:36331819
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FAM241B mRNA	PMID:31738976
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of FAM241B mRNA	PMID:19549813
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FAM241B gene	PMID:27153756
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FAM241B exon	PMID:30157460
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305587	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FAM241B mRNA	PMID:31150632
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C040641	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA	PMID:27424125
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313705	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of FAM241B mRNA	PMID:35897073
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305587	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FAM241B mRNA	PMID:31881176
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of FAM241B mRNA	PMID:23557933
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D019833	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA	PMID:27424125
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305587	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FAM241B mRNA	PMID:34747641
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305587	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FAM241B mRNA	PMID:32109520|PMID:34747641
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:28197	daidzein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C004742	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA	PMID:27424125
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of FAM241B mRNA	PMID:28001369
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FAM241B mRNA	PMID:33212167
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305587	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of FAM241B mRNA	PMID:28959563
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FAM241B mRNA	PMID:37992649
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of FAM241B mRNA	PMID:20044591
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FAM241B mRNA	PMID:38568856
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of FAM241B mRNA	PMID:29453283
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FAM241B promoter	PMID:27901495
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FAM241B mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305587	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of FAM241B mRNA	PMID:24136188
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305587	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FAM241B mRNA	PMID:34492290
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305587	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FAM241B mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313705	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM241B mRNA	PMID:35598803
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305587	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of FAM241B mRNA	PMID:41034487
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313705	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of FAM241B mRNA	PMID:32156529
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313705	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of FAM241B exon	PMID:33297965
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:34778	glycitein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C086566	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA	PMID:27424125
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of FAM241B mRNA	PMID:36117858
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of FAM241B mRNA	PMID:29024780
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FAM241B mRNA	PMID:38174414|PMID:38568856
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FAM241B mRNA	PMID:31738976
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of FAM241B mRNA	PMID:24449571
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FAM241B mRNA	PMID:31533062
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of FAM241B mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of FAM241B mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of FAM241B mRNA	PMID:36331819
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FAM241B mRNA	PMID:25979313
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FAM241B gene	PMID:29154799
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of FAM241B mRNA	PMID:17183730
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305587	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of FAM241B mRNA	PMID:41580965
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FAM241B mRNA	PMID:25562108
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C013908	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA	PMID:27424125
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313705	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FAM241B mRNA	PMID:28973697
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FAM241B mRNA	PMID:37992649
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FAM241B mRNA	PMID:38832940
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of FAM241B mRNA	PMID:22077320
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305587	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of FAM241B mRNA	PMID:29391264
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305587	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of FAM241B mRNA	PMID:24136188
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313705	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of FAM241B mRNA	PMID:36117858
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of FAM241B mRNA	PMID:20977926
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of FAM241B mRNA	PMID:17183730
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:6078	ivermectin	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of FAM241B protein	PMID:32959892
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of FAM241B mRNA	PMID:31758290
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:80373	glycitin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C433283	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] affects the expression of FAM241B mRNA	PMID:27424125
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1305587	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of FAM241B mRNA	PMID:32109520
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1305587	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of FAM241B mRNA	PMID:24136188
1313704	FAM241B	family with sequence similarity 241 member B	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305587	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of FAM241B mRNA	PMID:23034163
1313706	RAG2	recombination activating 2	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C007262	deoxynivalenol results in increased expression of RAG2 mRNA	PMID:38549690
1313706	RAG2	recombination activating 2	gene	CHEBI:132446	perfluorobutanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C539348	perfluorobutanesulfonic acid results in decreased expression of RAG2 mRNA	PMID:38549690
1313706	RAG2	recombination activating 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of RAG2 mRNA	PMID:36326898|PMID:38549690
1313706	RAG2	recombination activating 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313707	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RAG2 mRNA	PMID:12057914
1313706	RAG2	recombination activating 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RAG2 gene	PMID:27153756
1313706	RAG2	recombination activating 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313707	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of RAG2 mRNA	PMID:40618947
1313706	RAG2	recombination activating 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313707	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAG2 mRNA	PMID:26377647
1313706	RAG2	recombination activating 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305588	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of RAG2 mRNA	PMID:26033743
1313706	RAG2	recombination activating 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305588	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of RAG2 mRNA	PMID:26033743
1313706	RAG2	recombination activating 2	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1305588	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of RAG2 mRNA	PMID:16483693
1313706	RAG2	recombination activating 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313707	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of RAG2 mRNA	PMID:20542052
1313706	RAG2	recombination activating 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313707	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RAG2 promoter	PMID:27312807
1313706	RAG2	recombination activating 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in increased expression of RAG2 mRNA	PMID:30616060
1313706	RAG2	recombination activating 2	gene	CHEBI:34591	bromodichloromethane	multiple interactions	ISO	RGD:1313707	E	RGD:6480464	20140812	CTD	MESH:C025191	[PRF1 protein co-treated with RAG2 protein] affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of CASP3 protein modified form]; [PRF1 protein co-treated with RAG2 protein] affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IL2 mRNA]; [PRF1 protein co-treated with RAG2 protein] affects the susceptibility to [bromodichloromethane co-treated with Dietary Fats]	PMID:24211274
1313706	RAG2	recombination activating 2	gene	CHEBI:35546	perfluorodecanoic acid	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C036567	perfluorodecanoic acid results in decreased expression of RAG2 mRNA	PMID:38549690
1313706	RAG2	recombination activating 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RAG2 mRNA	PMID:36326898|PMID:38549690
1313706	RAG2	recombination activating 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RAG2 mRNA	PMID:24449571
1313706	RAG2	recombination activating 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RAG2 mRNA	PMID:36326898|PMID:38549690
1313706	RAG2	recombination activating 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RAG2 mRNA	PMID:36326898|PMID:38549690
1313706	RAG2	recombination activating 2	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1313707	E	RGD:6480464	20130416	CTD	MESH:C017160	cypermethrin results in increased expression of RAG2 mRNA	PMID:21142847
1313706	RAG2	recombination activating 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305588	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RAG2 mRNA	PMID:33387578
1313706	RAG2	recombination activating 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1313707	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of RAG2 mRNA	PMID:19812364
1313706	RAG2	recombination activating 2	gene	CHEBI:83492	perfluorohexanoic acid	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C479228	perfluorohexanoic acid results in decreased expression of RAG2 mRNA	PMID:38549690
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of FGD5 mRNA	PMID:26272509|PMID:27188386
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313709	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FGD5 mRNA	PMID:33045310
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313709	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FGD5 mRNA	PMID:26251327
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FGD5 mRNA	PMID:35811015
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FGD5 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of FGD5 mRNA	PMID:35811015
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of FGD5 mRNA	PMID:20404318
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313709	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FGD5 mRNA	PMID:37992649
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1305589	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of FGD5 mRNA	PMID:22967744
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313709	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FGD5 mRNA	PMID:37992649
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of FGD5 exon	PMID:30157460
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FGD5 mRNA	PMID:32234424
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FGD5 exon	PMID:30157460
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313709	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FGD5 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FGD5 mRNA	PMID:27106289|PMID:34911549
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of FGD5 mRNA	PMID:19774075
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313709	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of FGD5 protein	PMID:37208198
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of FGD5 mRNA	PMID:23557933
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of FGD5 mRNA	PMID:23300844
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1305589	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of FGD5 mRNA	PMID:17898221
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of FGD5 mRNA	PMID:25583101
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313709	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FGD5 mRNA	PMID:21570461
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305589	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FGD5 mRNA	PMID:32109520
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305589	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FGD5 mRNA	PMID:34747641
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313709	E	RGD:6480464	20140408	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FGD5 mRNA	PMID:23994337
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313709	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FGD5 mRNA	PMID:37992649
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FGD5 intron; Benzo(a)pyrene affects the methylation of FGD5 promoter	PMID:27901495|PMID:30157460
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FGD5 mRNA	PMID:32234424
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313709	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FGD5 mRNA	PMID:27195522
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313709	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FGD5 mRNA	PMID:22228805|PMID:32417428
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of FGD5 gene	PMID:25435355
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of FGD5 mRNA	PMID:37690743
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313709	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of FGD5 mRNA	PMID:23557971
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313709	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FGD5 promoter	PMID:35295148
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313709	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of FGD5 mRNA	PMID:18648102
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305589	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FGD5 mRNA	PMID:25181051
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305589	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FGD5 mRNA	PMID:30816183|PMID:32145629
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313709	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of FGD5 mRNA	PMID:26063408
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313709	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of FGD5 mRNA	PMID:30951980
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313709	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of FGD5 mRNA	PMID:26682919
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1313709	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of FGD5 mRNA	PMID:23994337
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of FGD5 gene	PMID:31601247
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313709	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of FGD5 exon	PMID:33297965
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313709	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FGD5 mRNA	PMID:30951980|PMID:33297965
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313709	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of FGD5 mRNA	PMID:26377693
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of FGD5 exon; benzo(e)pyrene results in increased methylation of FGD5 intron	PMID:30157460
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313709	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of FGD5 mRNA	PMID:30951980
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313709	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FGD5 mRNA	PMID:37019170
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FGD5 mRNA	PMID:19320972
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313709	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FGD5 mRNA	PMID:40194260
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FGD5 mRNA	PMID:25979313
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of FGD5 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FGD5 gene	PMID:29154799
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of FGD5 mRNA	PMID:27989131
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313709	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FGD5 mRNA	PMID:28973697
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313709	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FGD5 mRNA	PMID:37992649
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FGD5 mRNA	PMID:38832940
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of FGD5 mRNA	PMID:24935251|PMID:26272509
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of FGD5 mRNA	PMID:35811015
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FGD5 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of FGD5 mRNA	PMID:35811015
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of FGD5 mRNA	PMID:32234424
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of FGD5 mRNA	PMID:23300844
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313709	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of FGD5 protein	PMID:36851058
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of FGD5 exon; Methapyrilene results in increased methylation of FGD5 intron	PMID:30157460
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305589	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FGD5 gene	PMID:35440735
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313709	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FGD5 mRNA	PMID:22206623
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313709	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of FGD5 mRNA	PMID:23994337
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1305589	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of FGD5 mRNA	PMID:23665939
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FGD5 gene]	PMID:28238834
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of FGD5 mRNA	PMID:32234424
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of FGD5 mRNA	PMID:26272509
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FGD5 mRNA	PMID:27188386
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305589	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of FGD5 mRNA	PMID:19281266
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313709	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of FGD5 mRNA	PMID:28973697
1313708	FGD5	FYVE, RhoGEF and PH domain containing 5	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305589	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of FGD5 mRNA	PMID:19015723
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SAR1B mRNA	PMID:38218311
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305590	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of SAR1B mRNA	PMID:21551480
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SAR1B mRNA	PMID:21934132
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SAR1B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SAR1B mRNA	PMID:32699268
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SAR1B mRNA	PMID:36331819
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313711	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of SAR1B mRNA	PMID:40945087
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313711	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SAR1B mRNA	PMID:30319688
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SAR1B mRNA	PMID:29432896
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313711	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SAR1B mRNA	PMID:39241906
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SAR1B mRNA	PMID:39298647
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SAR1B mRNA	PMID:19448997
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313711	E	RGD:6480464	20180116	CTD	MESH:D014241	Trichloroethylene results in increased expression of SAR1B mRNA	PMID:28973375
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SAR1B mRNA	PMID:37042841
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SAR1B mRNA	PMID:21179406
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SAR1B mRNA	PMID:33848595
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1313711	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SAR1B mRNA	PMID:17997037
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SAR1B mRNA	PMID:36331819
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1313711	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SAR1B mRNA	PMID:17997037
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1313711	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of SAR1B mRNA	PMID:27462272
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SAR1B mRNA	PMID:35301059
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SAR1B mRNA	PMID:37325564
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SAR1B mRNA	PMID:23649840
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SAR1B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SAR1B mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of SAR1B mRNA	PMID:32699268
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SAR1B mRNA	PMID:22206623
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D012643	Selenium results in decreased expression of SAR1B mRNA	PMID:19244175
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SAR1B mRNA	PMID:26272509
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA	PMID:27188386
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305590	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SAR1B mRNA	PMID:31881176
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SAR1B mRNA	PMID:23557933
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of SAR1B gene	PMID:31636367
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313711	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SAR1B mRNA	PMID:21570461
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305590	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SAR1B mRNA	PMID:34747641
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of SAR1B protein	PMID:39603559
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SAR1B mRNA	PMID:28001369
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SAR1B mRNA	PMID:30851411
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SAR1B mRNA	PMID:24690739
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of SAR1B mRNA	PMID:25523186
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305590	E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in decreased expression of SAR1B protein	PMID:38266420
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SAR1B mRNA	PMID:38568856
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of SAR1B mRNA	PMID:22378314
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SAR1B mRNA	PMID:32234424
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of SAR1B mRNA	PMID:25523186
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SAR1B mRNA	PMID:24690739
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1305590	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of SAR1B mRNA	PMID:24136188
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305590	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SAR1B mRNA	PMID:34492290
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313711	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of SAR1B mRNA	PMID:17426115|PMID:18301758
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SAR1B mRNA	PMID:19710929
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305590	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SAR1B mRNA	PMID:30903817
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305590	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SAR1B mRNA	PMID:25181051
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SAR1B mRNA	PMID:39298647
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SAR1B protein	PMID:34186270
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SAR1B mRNA	PMID:28628672
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305590	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SAR1B mRNA	PMID:17602206
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SAR1B mRNA	PMID:28628672
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313711	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of SAR1B mRNA	PMID:34813904
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305590	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SAR1B mRNA	PMID:17602206
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305590	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SAR1B mRNA	PMID:35163327
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SAR1B mRNA	PMID:38568856
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SAR1B mRNA	PMID:35301059
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SAR1B mRNA	PMID:37325564
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1313711	E	RGD:6480464	20121113	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of SAR1B mRNA	PMID:18281256
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305590	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SAR1B mRNA	PMID:35163327
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305590	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SAR1B mRNA	PMID:24386269
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SAR1B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SAR1B mRNA	PMID:32699268
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D012643	Selenium results in decreased expression of SAR1B mRNA	PMID:19244175
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of SAR1B mRNA	PMID:17585979
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SAR1B mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SAR1B mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SAR1B mRNA	PMID:36331819
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SAR1B mRNA	PMID:25979313
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SAR1B mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386|PMID:29154799
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of SAR1B gene	PMID:29501571
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA	PMID:27188386
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SAR1B mRNA	PMID:19770486
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of SAR1B mRNA	PMID:27989131
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SAR1B mRNA	PMID:28628672
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305590	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of SAR1B mRNA	PMID:24136188
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SAR1B mRNA	PMID:27188386
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of SAR1B mRNA	PMID:24935251|PMID:26272509
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA	PMID:27188386
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of SAR1B mRNA	PMID:24690739
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:46666	crocidolite asbestos	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite inhibits the reaction [SPARC gene mutant form results in increased expression of SAR1B mRNA]	PMID:19446018
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313711	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of SAR1B mRNA	PMID:22334560
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of SAR1B mRNA	PMID:26272509
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA	PMID:27188386
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SAR1B mRNA	PMID:28628672
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of SAR1B mRNA	PMID:40234311
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of SAR1B mRNA	PMID:26705709
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D015474	Isotretinoin results in decreased expression of SAR1B mRNA	PMID:20436886
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SAR1B protein	PMID:32959892
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305590	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of SAR1B mRNA	PMID:24136188
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of SAR1B mRNA	PMID:15336504
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305590	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SAR1B gene	PMID:35440735
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SAR1B protein	PMID:34186270
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SAR1B mRNA	PMID:22206623
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313711	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SAR1B mRNA	PMID:22206623
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305590	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of SAR1B mRNA	PMID:24136188
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SAR1B mRNA	PMID:30851411
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA	PMID:27188386
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305590	E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SAR1B mRNA	PMID:31826744
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1313711	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of SAR1B mRNA	PMID:22334560
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313711	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in increased expression of SAR1B mRNA	PMID:21278054|PMID:22334560
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313711	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of SAR1B mRNA	PMID:40826991
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of SAR1B protein	PMID:26903627
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SAR1B mRNA	PMID:27188386
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313711	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of SAR1B protein	PMID:24648495
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1305590	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of SAR1B protein	PMID:35544339
1313710	SAR1B	secretion associated Ras related GTPase 1B	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of SAR1B mRNA	PMID:27188386
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1313713	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in increased expression of SLC37A2 protein	PMID:36252740
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:10110	zidovudine	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D015215	Zidovudine results in increased expression of SLC37A2 mRNA	PMID:24292225
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313713	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SLC37A2 mRNA	PMID:33045310
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313713	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC37A2 mRNA	PMID:20938992
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SLC37A2 mRNA	PMID:26079696
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SLC37A2 mRNA	PMID:20044591
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of SLC37A2 mRNA	PMID:21632981
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313713	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SLC37A2 mRNA	PMID:39241906
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1564160	E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of SLC37A2 mRNA	PMID:35192832
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313713	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SLC37A2 mRNA	PMID:39298647
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1564160	E	RGD:6480464	20210406	CTD	MESH:D004958	[Testosterone co-treated with Estradiol] results in decreased expression of SLC37A2 mRNA	PMID:32741896
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1564160	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC37A2 mRNA	PMID:33387578
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313713	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC37A2 mRNA	PMID:20938992
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of SLC37A2 mRNA	PMID:21540246
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313713	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC37A2 mRNA	PMID:37992649
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1564160	E	RGD:6480464	20210406	CTD	MESH:D013739	[Testosterone co-treated with Estradiol] results in decreased expression of SLC37A2 mRNA	PMID:32741896
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313713	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC37A2 mRNA	PMID:37992649
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SLC37A2 mRNA	PMID:23825647
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1564160	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SLC37A2 mRNA	PMID:33387578
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SLC37A2 mRNA	PMID:28818685
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SLC37A2 mRNA	PMID:23825647
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC37A2 mRNA	PMID:35301059
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:23414	copper(II) sulfate	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of SLC37A2 mRNA	PMID:19549813
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLC37A2 mRNA	PMID:32234424
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1313713	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of SLC37A2 mRNA	PMID:31939706
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1564160	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC37A2 mRNA	PMID:31150632
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1564160	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SLC37A2 mRNA	PMID:33387578
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313713	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC37A2 mRNA	PMID:20938992
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SLC37A2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SLC37A2 mRNA	PMID:32525701|PMID:40512198
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313713	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC37A2 mRNA	PMID:40504410
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1564160	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC37A2 mRNA	PMID:33854195
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313713	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SLC37A2 mRNA	PMID:28960355
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1564160	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLC37A2 mRNA	PMID:31881176
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of SLC37A2 mRNA	PMID:23195993
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313713	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC37A2 mRNA	PMID:33956508
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC37A2 mRNA	PMID:20106945|PMID:21632981|PMID:26159488
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC37A2 mRNA	PMID:33212167
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC37A2 mRNA	PMID:30851411
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313713	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in decreased expression of SLC37A2 mRNA	PMID:35032568
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1313713	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in increased expression of SLC37A2 mRNA	PMID:17205981
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313713	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC37A2 mRNA	PMID:37992649
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC37A2 mRNA	PMID:38568856
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SLC37A2 mRNA	PMID:40512198
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313713	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC37A2 mRNA	PMID:40504410
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC37A2 intron; Benzo(a)pyrene affects the methylation of SLC37A2 promoter	PMID:27901495|PMID:30157460
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC37A2 mRNA	PMID:20106945|PMID:32234424
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313713	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC37A2 mRNA	PMID:19770486
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLC37A2 3' UTR	PMID:27901495
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313713	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to SLC37A2 promoter]	PMID:19654925
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1313713	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in increased expression of SLC37A2 mRNA	PMID:17205981
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313713	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SLC37A2 mRNA	PMID:29341224
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of SLC37A2 mRNA	PMID:38568856
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1564160	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of SLC37A2 mRNA	PMID:25729387
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1564160	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SLC37A2 mRNA	PMID:25729387
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1564160	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SLC37A2 mRNA	PMID:30047161
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1564160	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of SLC37A2 mRNA	PMID:30012374
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313713	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of SLC37A2 mRNA	PMID:18648102
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313713	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC37A2 mRNA	PMID:18489776
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313713	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC37A2 mRNA	PMID:32156529
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1564160	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC37A2 mRNA	PMID:35192832
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in increased expression of SLC37A2 mRNA	PMID:27685785
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313713	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SLC37A2 mRNA	PMID:39298647
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313713	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of SLC37A2 intron	PMID:28392331
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313713	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SLC37A2 mRNA	PMID:32715474|PMID:37019170
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1564160	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC37A2 mRNA	PMID:33854195
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1564160	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SLC37A2 mRNA	PMID:21266533
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1564160	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of SLC37A2 mRNA	PMID:32680482
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLC37A2 mRNA	PMID:38174414
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC37A2 mRNA	PMID:35301059
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLC37A2 mRNA	PMID:32588087
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313713	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of SLC37A2 mRNA	PMID:39529242
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SLC37A2 mRNA	PMID:36864359|PMID:40419075
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLC37A2 mRNA	PMID:25979313
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1564160	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SLC37A2 mRNA	PMID:30047161
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1564160	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC37A2 mRNA	PMID:33854195
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313713	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC37A2 mRNA	PMID:37992649
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1564160	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC37A2 mRNA	PMID:33854195
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1564160	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC37A2 mRNA	PMID:33387578
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SLC37A2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SLC37A2 mRNA	PMID:32525701|PMID:40512198
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313713	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC37A2 mRNA	PMID:40504410
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1564160	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SLC37A2 mRNA	PMID:29391264
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of SLC37A2 mRNA	PMID:32234424
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of SLC37A2 mRNA	PMID:38825487
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313713	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SLC37A2 mRNA; Nanotubes, Carbon results in increased expression of SLC37A2 mRNA	PMID:25554681
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1564160	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SLC37A2 mRNA	PMID:30047161
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313713	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SLC37A2 mRNA	PMID:38701926
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1564160	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC37A2 mRNA	PMID:33854195
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1564160	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of SLC37A2 mRNA	PMID:25729387
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1564160	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SLC37A2 mRNA	PMID:25729387
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1564160	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SLC37A2 gene	PMID:35440735
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313713	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC37A2 mRNA	PMID:22206623
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases expression	ISO	RGD:1564160	E	RGD:6480464	20210406	CTD	MESH:C074283	estradiol 3-benzoate results in decreased expression of SLC37A2 mRNA	PMID:32741896
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC37A2 mRNA	PMID:30851411
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:78492	diallyl trisulfide	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in increased expression of SLC37A2 mRNA	PMID:34995734
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC37A2 gene]	PMID:28238834
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital affects the expression of SLC37A2 mRNA	PMID:19084549
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of SLC37A2 mRNA	PMID:26079696
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SLC37A2 mRNA	PMID:32525701
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1564160	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SLC37A2 mRNA	PMID:30047161
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SLC37A2 mRNA	PMID:38568856
1313712	SLC37A2	solute carrier family 37 member 2	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313713	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of SLC37A2 mRNA	PMID:35537566
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ADGRE5 mRNA	PMID:27188386
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of ADGRE5 mRNA	PMID:31016361
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313718	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ADGRE5 mRNA	PMID:20188158
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ADGRE5 mRNA	PMID:23724009
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ADGRE5 mRNA	PMID:33167477
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of ADGRE5 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of ADGRE5 mRNA	PMID:30951980
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:15368	acrolein	increases expression	ISO	RGD:1313718	E	RGD:6480464	20121113	CTD	MESH:D000171	Acrolein results in increased expression of ADGRE5 mRNA	PMID:18515264
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:15414	S-adenosyl-L-methionine	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D012436	S-Adenosylmethionine results in decreased expression of ADGRE5 mRNA	PMID:18098314
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ADGRE5 mRNA	PMID:20044591
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:D011794	Quercetin results in decreased expression of ADGRE5 mRNA	PMID:21738342
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313718	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ADGRE5 mRNA	PMID:25890327
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ADGRE5 mRNA	PMID:39298647
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of ADGRE5 mRNA	PMID:23019147
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ADGRE5 mRNA	PMID:30165855
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ADGRE5 mRNA	PMID:21179406
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRE5 mRNA	PMID:37992649
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1305595	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of ADGRE5 mRNA	PMID:22967744
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRE5 mRNA	PMID:37992649
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:17650	cortisol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006854	Hydrocortisone results in decreased expression of ADGRE5 mRNA	PMID:21267416
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305595	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ADGRE5 mRNA	PMID:26577399
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ADGRE5 mRNA	PMID:16002434
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305595	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ADGRE5 mRNA	PMID:33387578
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305595	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ADGRE5 mRNA	PMID:22061828
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADGRE5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ADGRE5 mRNA	PMID:39836092
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADGRE5 mRNA	PMID:35301059
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADGRE5 mRNA	PMID:37236586
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRE5 mRNA	PMID:29950665
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ADGRE5 mRNA	PMID:19549813
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ADGRE5 protein	PMID:20106945
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1305595	E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in decreased expression of ADGRE5 mRNA	PMID:28623178
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ADGRE5 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ADGRE5 mRNA	PMID:34911549
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305595	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of ADGRE5 mRNA	PMID:30779732
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313718	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ADGRE5 mRNA	PMID:27339419
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADGRE5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADGRE5 mRNA	PMID:39836092
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADGRE5 mRNA	PMID:40504410
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305595	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ADGRE5 mRNA	PMID:31881176
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in decreased expression of ADGRE5 mRNA	PMID:21738342
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1305595	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ADGRE5 mRNA	PMID:25905778
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of ADGRE5 mRNA	PMID:18930951
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:D019833	Genistein results in decreased expression of ADGRE5 mRNA	PMID:21738342
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in decreased expression of ADGRE5 mRNA	PMID:12540486
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D009532	Nickel results in increased expression of ADGRE5 mRNA	PMID:24768652|PMID:25583101
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313718	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADGRE5 mRNA	PMID:21570461|PMID:24680724
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305595	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ADGRE5 mRNA	PMID:28959563
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of ADGRE5 mRNA	PMID:24690739
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADGRE5 mRNA	PMID:15467011
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRE5 mRNA	PMID:37992649
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADGRE5 mRNA	PMID:38568856
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313718	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of ADGRE5 mRNA	PMID:36209798
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADGRE5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADGRE5 mRNA	PMID:39836092
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADGRE5 mRNA	PMID:40504410
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADGRE5 promoter	PMID:27901495
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADGRE5 mRNA	PMID:20064835|PMID:30453624
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADGRE5 mRNA	PMID:32234424
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313718	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADGRE5 mRNA	PMID:22228805
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADGRE5 3' UTR	PMID:27901495
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of ADGRE5 mRNA	PMID:24690739
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADGRE5 mRNA	PMID:15467011
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1305595	E	RGD:6480464	20120412	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ADGRE5 mRNA	PMID:21602193
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ADGRE5 mRNA	PMID:19128835
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1313718	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ADGRE5 mRNA	PMID:39716349
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRE5 mRNA	PMID:29950665
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305595	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ADGRE5 mRNA	PMID:34492290
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ADGRE5 mRNA	PMID:18648102
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ADGRE5 mRNA	PMID:19710929
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305595	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ADGRE5 mRNA	PMID:19167457
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRE5 mRNA	PMID:29275510
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305595	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRE5 mRNA	PMID:33296240|PMID:41034487
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305595	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ADGRE5 mRNA	PMID:25181051
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313718	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ADGRE5 mRNA	PMID:30951980
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of ADGRE5 mRNA	PMID:30951980
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:33418	graphite	affects expression	ISO	RGD:1305595	E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of ADGRE5 mRNA	PMID:29933104
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ADGRE5 mRNA	PMID:39298647
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313718	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ADGRE5 mRNA	PMID:30951980
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313718	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ADGRE5 mRNA	PMID:30951980
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of ADGRE5 mRNA	PMID:30951980
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313718	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ADGRE5 mRNA	PMID:28392331
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313718	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ADGRE5 mRNA	PMID:37019170
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRE5 mRNA	PMID:29950665
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:1313718	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of ADGRE5 mRNA	PMID:25270620
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADGRE5 mRNA	PMID:37042841
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305595	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of ADGRE5 mRNA	PMID:35163327
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305595	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADGRE5 mRNA	PMID:35163327
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADGRE5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ADGRE5 mRNA	PMID:39836092
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADGRE5 mRNA	PMID:35301059
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADGRE5 mRNA	PMID:37236586
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305595	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADGRE5 mRNA	PMID:35163327
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ADGRE5 mRNA	PMID:24449571
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D014635	Valproic Acid affects the expression of ADGRE5 mRNA	PMID:25979313
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ADGRE5 mRNA	PMID:29154799
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305595	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ADGRE5 mRNA	PMID:41580965
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRE5 mRNA	PMID:37992649
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of ADGRE5 mRNA	PMID:23649840
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of ADGRE5 mRNA	PMID:18502557
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ADGRE5 mRNA; Okadaic Acid results in increased expression of ADGRE5 protein	PMID:38832940
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ADGRE5 mRNA	PMID:17562736
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of ADGRE5 mRNA	PMID:24690739
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ADGRE5 mRNA	PMID:29279043
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADGRE5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADGRE5 mRNA	PMID:39836092
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADGRE5 mRNA	PMID:40504410
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of ADGRE5 mRNA	PMID:31838189
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:48607	lithium chloride	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in increased expression of ADGRE5 mRNA	PMID:23527032
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ADGRE5 mRNA	PMID:12072388
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ADGRE5 mRNA	PMID:19128835
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1313718	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ADGRE5 mRNA	PMID:39716349
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ADGRE5 mRNA; Nanotubes, Carbon results in decreased expression of ADGRE5 mRNA	PMID:25554681
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313718	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of ADGRE5 mRNA	PMID:40234311
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of ADGRE5 mRNA	PMID:20436886
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADGRE5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ADGRE5 mRNA	PMID:39836092
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ADGRE5 mRNA	PMID:23650126
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:67040	S-adenosyl-L-methioninate	decreases expression	ISO	RGD:1313718	E	RGD:6480464	20140805	CTD	MESH:D012436	S-Adenosylmethionine results in decreased expression of ADGRE5 mRNA	PMID:18098314
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ADGRE5 protein	PMID:31285264
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of ADGRE5 mRNA	PMID:32858204
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ADGRE5 mRNA	PMID:19482888
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313718	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ADGRE5 mRNA]	PMID:19482888
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1313718	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of ADGRE5 mRNA	PMID:27029645
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of ADGRE5 mRNA	PMID:31734321
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305595	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ADGRE5 mRNA	PMID:21346803
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of ADGRE5 protein	PMID:15785241
1313717	ADGRE5	adhesion G protein-coupled receptor E5	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305595	E	RGD:6480464	20151215	CTD	MESH:C025643	vinclozolin results in increased expression of ADGRE5 mRNA	PMID:22570695|PMID:23034163
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of GBA2 mRNA	PMID:38218311
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313722	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of GBA2 mRNA]	PMID:19467301
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GBA2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GBA2 mRNA	PMID:32699268
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of GBA2 mRNA	PMID:39298647
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305598	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of GBA2 gene	PMID:27618143
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of GBA2 mRNA	PMID:21179406
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of GBA2 mRNA	PMID:28818685
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313722	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GBA2 mRNA	PMID:36331819
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313722	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GBA2 mRNA	PMID:37236586
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GBA2 gene	PMID:27153756
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GBA2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GBA2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of GBA2 mRNA	PMID:32699268
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of GBA2 mRNA	PMID:31919559
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1313722	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in increased expression of GBA2 mRNA	PMID:16917069
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of GBA2 mRNA	PMID:23195993
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313722	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GBA2 mRNA	PMID:21570461
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GBA2 mRNA	PMID:19684285
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305598	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GBA2 mRNA	PMID:21215274|PMID:33387578
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GBA2 mRNA	PMID:19684285
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GBA2 mRNA	PMID:30851411
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of GBA2 mRNA	PMID:32763439
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:30145	lithium atom	increases expression	ISO	RGD:1313722	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in increased expression of GBA2 protein	PMID:40770094
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:30146	lithium hydride	increases expression	ISO	RGD:1313722	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in increased expression of GBA2 protein	PMID:40770094
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313722	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GBA2 promoter	PMID:35295148
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of GBA2 mRNA	PMID:18648102
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of GBA2 mRNA	PMID:23811191
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305598	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GBA2 mRNA	PMID:25181051
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305598	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GBA2 mRNA	PMID:36041667
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GBA2 mRNA	PMID:39298647
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305598	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GBA2 mRNA	PMID:36041667
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GBA2 mRNA	PMID:28628672
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305598	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GBA2 mRNA	PMID:36041667
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of GBA2 gene	PMID:22964155
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GBA2 mRNA	PMID:28628672
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305598	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GBA2 mRNA	PMID:18164116
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GBA2 mRNA	PMID:37042841
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313722	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GBA2 mRNA	PMID:37236586
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of GBA2 mRNA	PMID:19320972
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of GBA2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of GBA2 mRNA	PMID:32699268
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of GBA2 mRNA	PMID:23811191
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313722	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GBA2 mRNA	PMID:36331819
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313722	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of GBA2 mRNA	PMID:17292431
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GBA2 mRNA	PMID:28628672
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313722	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GBA2 mRNA	PMID:17562736
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GBA2 mRNA	PMID:28628672
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GBA2 mRNA; Nanotubes, Carbon results in decreased expression of GBA2 mRNA	PMID:25620056
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of GBA2 protein	PMID:36851058
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:68508	diethyl maleate	decreases expression	ISO	RGD:1313722	E	RGD:6480464	20150127	CTD	MESH:C014476	diethyl maleate results in decreased expression of GBA2 mRNA	PMID:25270620
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1305598	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GBA2 mRNA	PMID:18164116
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GBA2 mRNA	PMID:30851411
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GBA2 gene]	PMID:28238834
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313722	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of GBA2 mRNA	PMID:19270015
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305598	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of GBA2 mRNA	PMID:21346803
1313721	GBA2	glucosylceramidase beta 2	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305598	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of GBA2 mRNA	PMID:23034163
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550260	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RSPH14 mRNA	PMID:30529165
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RSPH14 mRNA	PMID:26079696
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305601	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of RSPH14 gene	PMID:35440735
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305601	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RSPH14 mRNA	PMID:33387578
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305601	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of RSPH14 mRNA	PMID:26577399
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RSPH14 gene	PMID:27153756
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305601	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RSPH14 mRNA	PMID:32109520
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305601	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of RSPH14 mRNA	PMID:28959563
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1550260	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of RSPH14 protein	PMID:28918527
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of RSPH14 gene	PMID:28589171
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1550260	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RSPH14 intron	PMID:27901495
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RSPH14 promoter	PMID:27901495
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RSPH14 mRNA	PMID:25895662
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550260	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of RSPH14 mRNA	PMID:23557971
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305601	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RSPH14 mRNA	PMID:25181051|PMID:41034487
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305601	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RSPH14 gene	PMID:28505145
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RSPH14 intron	PMID:30157460
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of RSPH14 mRNA	PMID:18175754
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550260	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RSPH14 mRNA; Nanotubes, Carbon results in decreased expression of RSPH14 mRNA	PMID:25554681
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RSPH14 intron	PMID:30157460
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305601	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of RSPH14 mRNA	PMID:27291303
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305601	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RSPH14 mRNA	PMID:24780913
1313725	RSPH14	radial spoke head 14 homolog	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305601	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of RSPH14 gene	PMID:31682807
1313727	EPHB3	EPH receptor B3	gene	CHEBI:10106	zearalenone	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D015025	Zearalenone results in decreased expression of EPHB3 mRNA	PMID:36828454
1313727	EPHB3	EPH receptor B3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of EPHB3 mRNA	PMID:38218311
1313727	EPHB3	EPH receptor B3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of EPHB3 mRNA	PMID:33045310
1313727	EPHB3	EPH receptor B3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313728	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of EPHB3 mRNA	PMID:20188158
1313727	EPHB3	EPH receptor B3	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	EXP		E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of EPHB3 mRNA	PMID:23792671
1313727	EPHB3	EPH receptor B3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of EPHB3 mRNA	PMID:23724009
1313727	EPHB3	EPH receptor B3	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of EPHB3 mRNA	PMID:26079696
1313727	EPHB3	EPH receptor B3	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305602	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of EPHB3 gene	PMID:35440735
1313727	EPHB3	EPH receptor B3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of EPHB3 mRNA	PMID:22378314
1313727	EPHB3	EPH receptor B3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313728	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of EPHB3 mRNA	PMID:30319688
1313727	EPHB3	EPH receptor B3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of EPHB3 mRNA	PMID:35811015
1313727	EPHB3	EPH receptor B3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EPHB3 mRNA	PMID:35811015
1313727	EPHB3	EPH receptor B3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D004958	Estradiol results in decreased expression of EPHB3 mRNA	PMID:36828454
1313727	EPHB3	EPH receptor B3	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of EPHB3 mRNA	PMID:38568856
1313727	EPHB3	EPH receptor B3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of EPHB3 mRNA	PMID:15363585
1313727	EPHB3	EPH receptor B3	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of EPHB3 mRNA	PMID:26079696
1313727	EPHB3	EPH receptor B3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHB3 mRNA	PMID:37992649
1313727	EPHB3	EPH receptor B3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHB3 mRNA	PMID:37992649
1313727	EPHB3	EPH receptor B3	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of EPHB3 mRNA	PMID:18247414
1313727	EPHB3	EPH receptor B3	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of EPHB3 protein	PMID:34122009
1313727	EPHB3	EPH receptor B3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305602	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of EPHB3 mRNA	PMID:33387578
1313727	EPHB3	EPH receptor B3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of EPHB3 mRNA	PMID:28818685
1313727	EPHB3	EPH receptor B3	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of EPHB3 mRNA	PMID:18247414
1313727	EPHB3	EPH receptor B3	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in decreased expression of EPHB3 mRNA	PMID:12634122
1313727	EPHB3	EPH receptor B3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EPHB3 mRNA	PMID:37325564
1313727	EPHB3	EPH receptor B3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305602	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EPHB3 mRNA	PMID:23630614
1313727	EPHB3	EPH receptor B3	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313728	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of EPHB3 mRNA	PMID:25629700
1313727	EPHB3	EPH receptor B3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EPHB3 mRNA	PMID:22206623
1313727	EPHB3	EPH receptor B3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EPHB3 gene	PMID:25304211
1313727	EPHB3	EPH receptor B3	gene	CHEBI:27878	2-naphthylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015081	2-Naphthylamine results in increased expression of EPHB3 mRNA	PMID:18247414
1313727	EPHB3	EPH receptor B3	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of EPHB3 mRNA	PMID:27392435
1313727	EPHB3	EPH receptor B3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of EPHB3 mRNA	PMID:27392435
1313727	EPHB3	EPH receptor B3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of EPHB3 mRNA	PMID:23625948
1313727	EPHB3	EPH receptor B3	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305602	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of EPHB3 mRNA	PMID:15691709
1313727	EPHB3	EPH receptor B3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305602	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPHB3 mRNA	PMID:32109520
1313727	EPHB3	EPH receptor B3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPHB3 mRNA	PMID:19933214
1313727	EPHB3	EPH receptor B3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EPHB3 mRNA	PMID:29803840
1313727	EPHB3	EPH receptor B3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of EPHB3 mRNA	PMID:39631538
1313727	EPHB3	EPH receptor B3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHB3 mRNA	PMID:37992649
1313727	EPHB3	EPH receptor B3	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of EPHB3 gene	PMID:28589171
1313727	EPHB3	EPH receptor B3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EPHB3 mRNA	PMID:18247414
1313727	EPHB3	EPH receptor B3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EPHB3 promoter	PMID:27901495
1313727	EPHB3	EPH receptor B3	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of EPHB3 protein	PMID:34122009
1313727	EPHB3	EPH receptor B3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of EPHB3 mRNA	PMID:25895662
1313727	EPHB3	EPH receptor B3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of EPHB3 gene	PMID:31601247
1313727	EPHB3	EPH receptor B3	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1305602	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of EPHB3 mRNA	PMID:11578147
1313727	EPHB3	EPH receptor B3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313728	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EPHB3 promoter	PMID:35295148
1313727	EPHB3	EPH receptor B3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313728	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of EPHB3 gene	PMID:35295148
1313727	EPHB3	EPH receptor B3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305602	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EPHB3 mRNA	PMID:34492290
1313727	EPHB3	EPH receptor B3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313728	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of EPHB3 mRNA	PMID:28472532
1313727	EPHB3	EPH receptor B3	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305602	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of EPHB3 mRNA	PMID:19167457
1313727	EPHB3	EPH receptor B3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of EPHB3 mRNA	PMID:27685785|PMID:36828454
1313727	EPHB3	EPH receptor B3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305602	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EPHB3 mRNA	PMID:25181051|PMID:33296240|PMID:34947998
1313727	EPHB3	EPH receptor B3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305602	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of EPHB3 mRNA	PMID:41034487
1313727	EPHB3	EPH receptor B3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313728	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of EPHB3 mRNA	PMID:32156529
1313727	EPHB3	EPH receptor B3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of EPHB3 gene	PMID:31601247
1313727	EPHB3	EPH receptor B3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of EPHB3 mRNA	PMID:25172293
1313727	EPHB3	EPH receptor B3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313728	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of EPHB3 gene	PMID:31683443
1313727	EPHB3	EPH receptor B3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313728	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of EPHB3 promoter	PMID:33297965
1313727	EPHB3	EPH receptor B3	gene	CHEBI:34687	dibutyl phthalate	affects expression	ISO	RGD:1305602	E	RGD:6480464	20190910	CTD	MESH:D003993	Dibutyl Phthalate affects the expression of EPHB3 mRNA	PMID:30934153
1313727	EPHB3	EPH receptor B3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305602	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of EPHB3 mRNA	PMID:35163327
1313727	EPHB3	EPH receptor B3	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305602	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of EPHB3 mRNA	PMID:30723492
1313727	EPHB3	EPH receptor B3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of EPHB3 mRNA	PMID:38568856
1313727	EPHB3	EPH receptor B3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EPHB3 mRNA	PMID:38174414
1313727	EPHB3	EPH receptor B3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EPHB3 mRNA	PMID:37325564
1313727	EPHB3	EPH receptor B3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305602	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of EPHB3 mRNA	PMID:35163327
1313727	EPHB3	EPH receptor B3	gene	CHEBI:35559	furan	decreases methylation	ISO	RGD:1305602	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of EPHB3 gene	PMID:27387713
1313727	EPHB3	EPH receptor B3	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305602	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of EPHB3 mRNA	PMID:27387713
1313727	EPHB3	EPH receptor B3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of EPHB3 mRNA	PMID:24449571
1313727	EPHB3	EPH receptor B3	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of EPHB3 protein	PMID:34122009
1313727	EPHB3	EPH receptor B3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of EPHB3 mRNA	PMID:40194260
1313727	EPHB3	EPH receptor B3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of EPHB3 mRNA	PMID:31533062
1313727	EPHB3	EPH receptor B3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313728	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of EPHB3 mRNA	PMID:17292431
1313727	EPHB3	EPH receptor B3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of EPHB3 mRNA	PMID:24383497|PMID:26272509
1313727	EPHB3	EPH receptor B3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHB3 mRNA	PMID:27188386
1313727	EPHB3	EPH receptor B3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHB3 mRNA	PMID:37992649
1313727	EPHB3	EPH receptor B3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of EPHB3 mRNA	PMID:38832940
1313727	EPHB3	EPH receptor B3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313728	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EPHB3 mRNA	PMID:17562736
1313727	EPHB3	EPH receptor B3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305602	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EPHB3 mRNA	PMID:33387578
1313727	EPHB3	EPH receptor B3	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of EPHB3 mRNA	PMID:24714768
1313727	EPHB3	EPH receptor B3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EPHB3 mRNA	PMID:35811015
1313727	EPHB3	EPH receptor B3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EPHB3 gene	PMID:25304211
1313727	EPHB3	EPH receptor B3	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of EPHB3 mRNA	PMID:38568856
1313727	EPHB3	EPH receptor B3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313728	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of EPHB3 mRNA; Nanotubes, Carbon results in decreased expression of EPHB3 mRNA	PMID:25554681
1313727	EPHB3	EPH receptor B3	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1313728	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of EPHB3 mRNA	PMID:17982090
1313727	EPHB3	EPH receptor B3	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313728	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of EPHB3 mRNA	PMID:23608068
1313727	EPHB3	EPH receptor B3	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of EPHB3 mRNA	PMID:31629900
1313727	EPHB3	EPH receptor B3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305602	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of EPHB3 gene	PMID:35440735
1313727	EPHB3	EPH receptor B3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313728	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EPHB3 mRNA	PMID:22206623
1313727	EPHB3	EPH receptor B3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHB3 mRNA	PMID:27188386
1313727	EPHB3	EPH receptor B3	gene	CHEBI:78543	ponatinib	decreases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C545373	ponatinib results in decreased activity of EPHB3 protein	PMID:19878872
1313727	EPHB3	EPH receptor B3	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1313728	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of EPHB3 mRNA	PMID:18958704
1313727	EPHB3	EPH receptor B3	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305602	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of EPHB3 mRNA	PMID:24780913
1313727	EPHB3	EPH receptor B3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305602	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of EPHB3 mRNA	PMID:24780913
1313727	EPHB3	EPH receptor B3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHB3 mRNA	PMID:27188386
1313727	EPHB3	EPH receptor B3	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305602	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of EPHB3 mRNA	PMID:19281266
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of PFDN1 mRNA	PMID:35967413
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305603	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of PFDN1 mRNA	PMID:21551480
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PFDN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PFDN1 mRNA	PMID:32699268
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313730	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of PFDN1 mRNA	PMID:40945087
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1313730	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of PFDN1 mRNA	PMID:20362636
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313730	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PFDN1 mRNA	PMID:30319688
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313730	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PFDN1 mRNA	PMID:39241906
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305603	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of PFDN1 mRNA	PMID:26496021
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1305603	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of PFDN1 mRNA	PMID:22967744
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of PFDN1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PFDN1 mRNA]	PMID:20230807
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313730	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PFDN1 mRNA	PMID:33754040
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305603	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PFDN1 mRNA	PMID:22061828
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1313730	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PFDN1 mRNA	PMID:20230807
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of PFDN1 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of PFDN1 mRNA; Caffeine promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PFDN1 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PFDN1 mRNA]	PMID:20230807
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PFDN1 mRNA	PMID:36331819
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PFDN1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of PFDN1 mRNA	PMID:39836092
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of PFDN1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PFDN1 mRNA]	PMID:20230807
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PFDN1 mRNA	PMID:37236586|PMID:37325564
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PFDN1 gene	PMID:27153756
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PFDN1 intron	PMID:30157460
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PFDN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PFDN1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PFDN1 mRNA	PMID:32699268
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PFDN1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PFDN1 mRNA	PMID:34911549
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313730	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PFDN1 mRNA	PMID:31919559
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PFDN1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PFDN1 mRNA	PMID:39836092
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PFDN1 mRNA	PMID:40504410
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of PFDN1 mRNA; Caffeine promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PFDN1 mRNA]	PMID:20230807
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313730	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of PFDN1 mRNA	PMID:30912803
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305603	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PFDN1 mRNA	PMID:34747641
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313730	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PFDN1 mRNA	PMID:21570461
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305603	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PFDN1 mRNA	PMID:33387578
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PFDN1 mRNA	PMID:17942748
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PFDN1 mRNA	PMID:33212167
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PFDN1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PFDN1 mRNA	PMID:39836092
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PFDN1 mRNA	PMID:40504410
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313730	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PFDN1 mRNA	PMID:18648102
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305603	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of PFDN1 mRNA	PMID:33296240
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of PFDN1 protein	PMID:37567409
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305603	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PFDN1 mRNA	PMID:25181051
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305603	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PFDN1 gene	PMID:28505145
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305603	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of PFDN1 mRNA	PMID:26496021
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313730	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PFDN1 mRNA	PMID:17361019
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313730	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of PFDN1 mRNA	PMID:34813904
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305603	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of PFDN1 gene	PMID:33148267
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PFDN1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of PFDN1 mRNA	PMID:39836092
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PFDN1 mRNA	PMID:38568856
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305603	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PFDN1 protein	PMID:21699967
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PFDN1 mRNA	PMID:37236586|PMID:37325564
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PFDN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PFDN1 mRNA	PMID:32699268
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PFDN1 mRNA	PMID:31533062
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PFDN1 mRNA	PMID:36331819
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:46195	paracetamol	affects response to substance	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	PFDN1 gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313730	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PFDN1 mRNA	PMID:29279043
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PFDN1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PFDN1 mRNA	PMID:39836092
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PFDN1 mRNA	PMID:40504410
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313730	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of PFDN1 mRNA	PMID:35436446
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313730	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PFDN1 mRNA	PMID:17942748
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313730	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PFDN1 mRNA	PMID:17942748
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305603	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PFDN1 mRNA	PMID:24136188
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305603	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PFDN1 mRNA	PMID:24136188
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PFDN1 protein	PMID:32959892
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PFDN1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of PFDN1 mRNA	PMID:39836092
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:1305603	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of PFDN1 mRNA	PMID:24136188
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1313730	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of PFDN1 mRNA	PMID:27462272
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305603	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of PFDN1 gene	PMID:33148267
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313730	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PFDN1 mRNA	PMID:22206623
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PFDN1 protein	PMID:37664457
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PFDN1 gene]	PMID:28238834
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313730	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PFDN1 mRNA	PMID:30294300
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1305603	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of PFDN1 protein	PMID:28903499
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313730	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PFDN1 mRNA	PMID:40826991
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of PFDN1 mRNA	PMID:24921660
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PFDN1 protein	PMID:37664457
1313729	PFDN1	prefoldin subunit 1	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305603	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of PFDN1 gene	PMID:31682807
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of NOP14 protein	PMID:39638853
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305605	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOP14 mRNA]	PMID:31150632
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NOP14 mRNA	PMID:33167477
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOP14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOP14 mRNA	PMID:32699268
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NOP14 mRNA	PMID:30529165
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313733	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NOP14 mRNA	PMID:39241906
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP14 mRNA]	PMID:39241906
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of NOP14 mRNA	PMID:31614463
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313733	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of NOP14 mRNA	PMID:39298647
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of NOP14 mRNA	PMID:38568856
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313733	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NOP14 mRNA	PMID:33754040
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Haloperidol] results in increased expression of NOP14 protein	PMID:34122009
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NOP14 protein	PMID:37730182
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305605	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NOP14 mRNA	PMID:33387578
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of NOP14 intron	PMID:30157460
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NOP14 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NOP14 mRNA	PMID:37236586|PMID:37325564
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NOP14 gene	PMID:27153756
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of NOP14 protein	PMID:39638853
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOP14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOP14 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of NOP14 mRNA	PMID:32699268
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305605	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NOP14 mRNA	PMID:31150632
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313733	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NOP14 mRNA	PMID:31919559
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305605	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NOP14 mRNA]	PMID:31150632
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP14 mRNA	PMID:40504410
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NOP14 mRNA	PMID:23557933
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313733	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NOP14 mRNA	PMID:21570461
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305605	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NOP14 mRNA	PMID:33387578
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NOP14 mRNA	PMID:33212167
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NOP14 mRNA	PMID:15467011
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NOP14 mRNA	PMID:29803840
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NOP14 mRNA	PMID:38568856
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP14 mRNA	PMID:40504410
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313733	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NOP14 mRNA	PMID:22228805
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of NOP14 gene	PMID:25435355
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of NOP14 mRNA	PMID:15467011
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305605	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of NOP14 mRNA	PMID:23411599|PMID:34492290
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313733	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NOP14 mRNA	PMID:33221593
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305605	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NOP14 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313733	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NOP14 mRNA	PMID:39298647
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313733	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of NOP14 intron	PMID:28392331
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313733	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of NOP14 mRNA	PMID:34813904
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1305605	E	RGD:6480464	20120814	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of NOP14 mRNA	PMID:19041683
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305605	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of NOP14 mRNA	PMID:32680482
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP14 mRNA]	PMID:39241906
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NOP14 mRNA	PMID:37042841
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NOP14 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NOP14 mRNA	PMID:37236586|PMID:37325564
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of NOP14 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of NOP14 mRNA	PMID:32699268
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of NOP14 mRNA	PMID:28302478
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of NOP14 mRNA	PMID:31533062
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NOP14 mRNA	PMID:25979313
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313733	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NOP14 mRNA	PMID:17292431
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of NOP14 mRNA	PMID:23179753
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313733	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NOP14 mRNA	PMID:17562736
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NOP14 mRNA	PMID:40504410
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313733	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NOP14 mRNA; Nanotubes, Carbon results in increased expression of NOP14 mRNA	PMID:25554681
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NOP14 mRNA	PMID:35964746
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313733	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NOP14 mRNA	PMID:19042947
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:5613	haloperidol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in increased expression of NOP14 protein	PMID:34122009
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NOP14 protein	PMID:32959892
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313733	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NOP14 mRNA	PMID:22206623
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NOP14 mRNA	PMID:37199045
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of NOP14 protein	PMID:39638853
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313733	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of NOP14 mRNA	PMID:30294300
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313733	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NOP14 mRNA]	PMID:39241906
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of NOP14 mRNA	PMID:34581912
1313732	NOP14	NOP14 nucleolar protein	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NOP14 mRNA	PMID:38568856
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ADAMTSL5 mRNA	PMID:38218311
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305607	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of ADAMTSL5 mRNA	PMID:25152437
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313736	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ADAMTSL5 mRNA	PMID:37995155
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADAMTSL5 gene	PMID:20938992
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313736	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ADAMTSL5 mRNA	PMID:30319688
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ADAMTSL5 mRNA	PMID:39241906
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ADAMTSL5 mRNA	PMID:31614463
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol promotes the reaction [ESR2 protein affects the expression of ADAMTSL5 mRNA]	PMID:20404318
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADAMTSL5 gene	PMID:20938992
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADAMTSL5 mRNA	PMID:37042841
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL5 mRNA	PMID:37992649
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ADAMTSL5 mRNA	PMID:33359661
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL5 mRNA	PMID:37992649
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313736	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ADAMTSL5 mRNA	PMID:34319233
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305607	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ADAMTSL5 mRNA	PMID:33387578
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADAMTSL5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ADAMTSL5 mRNA	PMID:39836092
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of ADAMTSL5 mRNA	PMID:33914522
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADAMTSL5 mRNA	PMID:28111341
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ADAMTSL5 mRNA	PMID:34911549
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305607	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADAMTSL5 mRNA	PMID:33387578
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADAMTSL5 gene	PMID:20938992
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADAMTSL5 gene	PMID:25304211
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADAMTSL5 mRNA	PMID:39836092
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1305607	E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of ADAMTSL5 mRNA	PMID:38314887
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305607	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ADAMTSL5 mRNA	PMID:31881176
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313736	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADAMTSL5 mRNA	PMID:21570461
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305607	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADAMTSL5 mRNA	PMID:32109520
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1305607	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of ADAMTSL5 mRNA	PMID:28959563
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADAMTSL5 mRNA	PMID:29803840
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL5 mRNA	PMID:37992649
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAMTSL5 mRNA	PMID:37682722
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ADAMTSL5 mRNA	PMID:38568856
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADAMTSL5 mRNA	PMID:39836092
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ADAMTSL5 5' UTR	PMID:27901495
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ADAMTSL5 mRNA]	PMID:22228805
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313736	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ADAMTSL5 mRNA	PMID:29203145
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ADAMTSL5 mRNA	PMID:35295148
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313736	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADAMTSL5 gene; titanium dioxide results in decreased methylation of ADAMTSL5 promoter alternative form	PMID:35295148
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313736	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of ADAMTSL5 mRNA	PMID:27760801|PMID:29264374
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1313736	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of ADAMTSL5 mRNA	PMID:33914522
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAMTSL5 mRNA	PMID:23146750
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305607	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAMTSL5 mRNA	PMID:34947998
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305607	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ADAMTSL5 mRNA	PMID:25181051
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313736	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ADAMTSL5 mRNA	PMID:26063408|PMID:32156529
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of ADAMTSL5 mRNA	PMID:23146750
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ADAMTSL5 mRNA	PMID:23146750
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313736	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ADAMTSL5 gene	PMID:31683443
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313736	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ADAMTSL5 mRNA	PMID:40203079
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ADAMTSL5 mRNA	PMID:38685157
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305607	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ADAMTSL5 mRNA	PMID:32680482
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305607	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADAMTSL5 mRNA	PMID:35163327
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADAMTSL5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ADAMTSL5 mRNA	PMID:39836092
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADAMTSL5 mRNA	PMID:28111341
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ADAMTSL5 mRNA	PMID:23146750
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305607	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADAMTSL5 mRNA	PMID:35163327
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:3764	clotrimazole	decreases expression	ISO	RGD:1305607	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of ADAMTSL5 mRNA	PMID:30047161
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313736	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADAMTSL5 mRNA	PMID:40194260
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ADAMTSL5 mRNA	PMID:31533062
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305607	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ADAMTSL5 mRNA	PMID:30047161
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ADAMTSL5 mRNA	PMID:28973697
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313736	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL5 mRNA	PMID:37992649
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADAMTSL5 gene	PMID:25304211
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADAMTSL5 mRNA	PMID:39836092
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1305607	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of ADAMTSL5 mRNA	PMID:29391264
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313736	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ADAMTSL5 mRNA	PMID:17942748
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ADAMTSL5 mRNA	PMID:25554681
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305607	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ADAMTSL5 mRNA	PMID:30047161
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ADAMTSL5 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ADAMTSL5 mRNA	PMID:39836092
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of ADAMTSL5 mRNA	PMID:36907384
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313736	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ADAMTSL5 mRNA	PMID:26307267
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313736	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADAMTSL5 mRNA	PMID:22206623
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ADAMTSL5 gene]	PMID:28238834
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ADAMTSL5 mRNA	PMID:23146750
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313736	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ADAMTSL5 mRNA	PMID:39847705
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305607	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ADAMTSL5 mRNA	PMID:30047161
1313735	ADAMTSL5	ADAMTS like 5	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ADAMTSL5 mRNA	PMID:38568856
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313738	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ADGRB1 mRNA	PMID:37995155
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313738	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ADGRB1 mRNA	PMID:20188158
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ADGRB1 gene	PMID:20938992
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C018475	butyraldehyde results in increased expression of ADGRB1 mRNA	PMID:26079696
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313738	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ADGRB1 mRNA	PMID:30319688
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313738	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ADGRB1 mRNA	PMID:30319688
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D011794	Quercetin metabolite results in increased expression of ADGRB1 mRNA; Quercetin results in increased expression of ADGRB1 mRNA	PMID:36982678
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:D011794	[bisphenol A co-treated with Quercetin metabolite] results in increased expression of ADGRB1 mRNA	PMID:36982678
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ADGRB1 mRNA	PMID:35811015
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ADGRB1 mRNA	PMID:30510588
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ADGRB1 gene	PMID:20938992
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:16836	4-nitrophenol	increases expression	ISO	RGD:1313738	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in increased expression of ADGRB1 mRNA	PMID:34673133
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C005556	propionaldehyde results in increased expression of ADGRB1 mRNA	PMID:26079696
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA	PMID:37567420
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:17558	quercitrin	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:C012526	quercitrin results in decreased expression of ADGRB1 mRNA	PMID:25193878
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA	PMID:37567420
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305608	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of ADGRB1 mRNA	PMID:22061828
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:17846	(S)-naringenin	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C005273	naringenin metabolite results in increased expression of ADGRB1 mRNA	PMID:36235125
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:17846	(S)-naringenin	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C005273	[naringenin co-treated with bisphenol A] results in increased expression of ADGRB1 mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of ADGRB1 mRNA	PMID:36235125
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ADGRB1 mRNA	PMID:39836092
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADGRB1 mRNA	PMID:29950665
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305608	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ADGRB1 mRNA	PMID:21396975
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ADGRB1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ADGRB1 gene	PMID:20938992|PMID:22206623
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADGRB1 gene	PMID:25304211
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ADGRB1 mRNA	PMID:19244175
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ADGRB1 mRNA	PMID:28903495
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ADGRB1 mRNA	PMID:33212167
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ADGRB1 mRNA	PMID:32763439
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA	PMID:37567420
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ADGRB1 mRNA	PMID:38568856
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313738	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of ADGRB1 mRNA	PMID:37682722
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADGRB1 5' UTR; Benzo(a)pyrene affects the methylation of ADGRB1 intron	PMID:27901495|PMID:30157460
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ADGRB1 3' UTR; Benzo(a)pyrene results in decreased methylation of ADGRB1 promoter	PMID:27901495
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADGRB1 exon	PMID:27901495
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ADGRB1 mRNA	PMID:37690743
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313738	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADGRB1 gene; titanium dioxide results in decreased methylation of ADGRB1 promoter	PMID:35295148
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313738	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ADGRB1 gene	PMID:35295148
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADGRB1 mRNA	PMID:29950665
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305608	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRB1 mRNA	PMID:30816183
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313738	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRB1 mRNA	PMID:32156529
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	[bisphenol A co-treated with Quercetin metabolite] results in increased expression of ADGRB1 mRNA; [naringenin co-treated with bisphenol A] results in increased expression of ADGRB1 mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of ADGRB1 mRNA	PMID:36235125|PMID:36982678
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of ADGRB1 mRNA	PMID:19244175
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313738	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ADGRB1 gene	PMID:31683443
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313738	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ADGRB1 exon	PMID:33297965
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ADGRB1 intron	PMID:30157460
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADGRB1 mRNA	PMID:29950665
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313738	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ADGRB1 mRNA	PMID:21266533
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20130416	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of ADGRB1 mRNA	PMID:23017109
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ADGRB1 mRNA	PMID:39836092
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ADGRB1 mRNA	PMID:19244175
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313738	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ADGRB1 mRNA	PMID:40194260
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313738	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ADGRB1 mRNA	PMID:17292431
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ADGRB1 gene	PMID:29154799
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA	PMID:37567420
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ADGRB1 mRNA	PMID:35811015
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADGRB1 gene	PMID:25304211
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:50594	carbon nanotube	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	[Nanotubes, Carbon co-treated with calfactant] results in decreased expression of ADGRB1 protein	PMID:23026733
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20130416	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of ADGRB1 mRNA	PMID:23017109
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of ADGRB1 mRNA	PMID:39836092
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ADGRB1 intron	PMID:30157460
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313738	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADGRB1 mRNA	PMID:22206623
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ADGRB1 mRNA	PMID:22206623
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:749466	calfactant	multiple interactions	EXP		E	RGD:6480464	20260721	CTD	MESH:C117342	[Nanotubes, Carbon co-treated with calfactant] results in decreased expression of ADGRB1 protein	PMID:23026733
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313738	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA	PMID:37567420
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305608	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ADGRB1 mRNA	PMID:27291303
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305608	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ADGRB1 mRNA	PMID:23640034
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C046012	pentanal results in increased expression of ADGRB1 mRNA	PMID:26079696
1313737	ADGRB1	adhesion G protein-coupled receptor B1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305608	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ADGRB1 mRNA	PMID:24780913
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313740	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SHCBP1L mRNA	PMID:33045310
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313740	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SHCBP1L mRNA	PMID:37995155
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SHCBP1L mRNA	PMID:31614463
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHCBP1L mRNA	PMID:37567420
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHCBP1L mRNA	PMID:37567420
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:2208	purine-6-thiol	increases expression	ISO	RGD:1305609	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of SHCBP1L mRNA	PMID:23358152
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SHCBP1L mRNA	PMID:37236586
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHCBP1L mRNA	PMID:37567420
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313740	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SHCBP1L mRNA	PMID:37682722
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SHCBP1L promoter	PMID:27901495
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305609	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SHCBP1L mRNA	PMID:25181051|PMID:41034487
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313740	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SHCBP1L exon	PMID:33297965
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SHCBP1L mRNA	PMID:37236586
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305609	E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of SHCBP1L mRNA	PMID:35594946
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHCBP1L mRNA	PMID:37567420
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of SHCBP1L mRNA	PMID:24449571
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:50667	mercaptopurine	increases expression	ISO	RGD:1305609	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of SHCBP1L mRNA	PMID:23358152
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1313740	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SHCBP1L mRNA	PMID:37567420
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	ISO	RGD:1305609	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of SHCBP1L mRNA	PMID:23358152
1313739	SHCBP1L	SHC binding and spindle associated 1 like	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313740	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SHCBP1L mRNA	PMID:35537566
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305610	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of SH3TC1 mRNA	PMID:21551480
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SH3TC1 mRNA	PMID:33045310
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of SH3TC1 mRNA	PMID:25596134
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SH3TC1 mRNA	PMID:35811015
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SH3TC1 mRNA	PMID:39241906
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SH3TC1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SH3TC1 mRNA	PMID:35811015
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of SH3TC1 mRNA	PMID:27664576
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of SH3TC1 mRNA	PMID:26079696
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313742	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3TC1 mRNA	PMID:37992649
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of SH3TC1 mRNA	PMID:21592394
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SH3TC1 mRNA	PMID:21592394
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of SH3TC1 mRNA	PMID:31256213
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313742	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3TC1 mRNA	PMID:37992649
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SH3TC1 mRNA	PMID:16002434|PMID:21592394
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SH3TC1 mRNA	PMID:21592394
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305610	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SH3TC1 mRNA	PMID:33387578
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SH3TC1 mRNA	PMID:28818685
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of SH3TC1 mRNA	PMID:37748715
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313742	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SH3TC1 mRNA	PMID:37325564
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SH3TC1 mRNA	PMID:19549813
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SH3TC1 mRNA	PMID:18593933
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305610	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SH3TC1 mRNA	PMID:31881176
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of SH3TC1 mRNA	PMID:25596134
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SH3TC1 mRNA	PMID:27594783
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SH3TC1 mRNA	PMID:24768652|PMID:25583101
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313742	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SH3TC1 mRNA	PMID:21570461
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SH3TC1 mRNA	PMID:31961203
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313742	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3TC1 mRNA	PMID:37992649
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SH3TC1 mRNA	PMID:29432896
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of SH3TC1 mRNA	PMID:34032870|PMID:38568856
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SH3TC1 5' UTR; Benzo(a)pyrene affects the methylation of SH3TC1 intron	PMID:27901495|PMID:30157460
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SH3TC1 mRNA	PMID:21569818
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SH3TC1 exon; Benzo(a)pyrene results in decreased methylation of SH3TC1 promoter	PMID:27901495
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SH3TC1 mRNA	PMID:18593933
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:31175	adefovir pivoxil	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in decreased expression of SH3TC1 mRNA	PMID:25596134
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313742	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SH3TC1 mRNA	PMID:23557971
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305610	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SH3TC1 mRNA	PMID:34492290
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313742	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SH3TC1 mRNA	PMID:23811191
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SH3TC1 mRNA	PMID:30903817
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305610	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SH3TC1 mRNA	PMID:25181051
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305610	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SH3TC1 mRNA	PMID:34947998
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SH3TC1 gene	PMID:31601247
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313742	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SH3TC1 mRNA	PMID:33221593
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313742	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SH3TC1 exon	PMID:33297965
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313742	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SH3TC1 mRNA	PMID:30951980
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SH3TC1 intron	PMID:30157460
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313742	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SH3TC1 mRNA	PMID:37019170
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SH3TC1 mRNA	PMID:25596134
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305610	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of SH3TC1 promoter	PMID:22457795
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313742	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SH3TC1 mRNA	PMID:37325564
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305610	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SH3TC1 mRNA	PMID:24386269
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SH3TC1 mRNA	PMID:24449571
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of SH3TC1 mRNA	PMID:25596134
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SH3TC1 mRNA	PMID:31533062
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C480342	clothianidin results in increased expression of SH3TC1 mRNA	PMID:29044138
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SH3TC1 mRNA	PMID:28001369
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SH3TC1 gene	PMID:29154799
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SH3TC1 mRNA	PMID:25596134
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SH3TC1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313742	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3TC1 mRNA	PMID:37992649
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SH3TC1 mRNA	PMID:38832940
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313742	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SH3TC1 mRNA	PMID:17562736
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305610	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SH3TC1 mRNA	PMID:33387578
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SH3TC1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SH3TC1 mRNA	PMID:35811015
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SH3TC1 mRNA	PMID:38568856
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of SH3TC1 mRNA	PMID:25596134
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of SH3TC1 mRNA	PMID:25554681
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:5855	ibuprofen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of SH3TC1 mRNA	PMID:25596134
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:5864	ifosfamide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of SH3TC1 mRNA	PMID:25596134
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SH3TC1 mRNA	PMID:28988120
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SH3TC1 intron	PMID:30157460
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313742	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SH3TC1 mRNA	PMID:22206623
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:80799	Bufotalin	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of SH3TC1 mRNA	PMID:39904859
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:82036	prothioconazole	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in increased expression of SH3TC1 mRNA	PMID:35048155
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305610	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SH3TC1 mRNA	PMID:24780913
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305610	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SH3TC1 mRNA	PMID:21346803
1313741	SH3TC1	SH3 domain and tetratricopeptide repeats 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SH3TC1 mRNA	PMID:38568856
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of SMARCE1 protein	PMID:39638853
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SMARCE1 mRNA	PMID:38218311
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1304726	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of SMARCE1 mRNA	PMID:21551480
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SMARCE1 mRNA	PMID:33167477
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SMARCE1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SMARCE1 mRNA	PMID:32699268
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SMARCE1 mRNA	PMID:20044591
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1304726	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SMARCE1 gene	PMID:27618143
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SMARCE1 mRNA	PMID:37042841
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SMARCE1 mRNA	PMID:23649840
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SMARCE1 mRNA	PMID:37236586
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SMARCE1 mRNA	PMID:19549813
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SMARCE1 mRNA	PMID:23649840
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SMARCE1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SMARCE1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of SMARCE1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of SMARCE1 mRNA	PMID:32699268|PMID:35430440
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SMARCE1 mRNA	PMID:22171008
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SMARCE1 mRNA	PMID:31919559
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SMARCE1 protein	PMID:35688186
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of SMARCE1 protein	PMID:25505154
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SMARCE1 mRNA	PMID:23557933
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SMARCE1 mRNA	PMID:28903495
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313744	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMARCE1 mRNA	PMID:21570461
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SMARCE1 mRNA	PMID:17942748
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of SMARCE1 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCE1 mRNA	PMID:17942748|PMID:19465110
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SMARCE1 mRNA	PMID:28001369
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SMARCE1 mRNA	PMID:27188386
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SMARCE1 protein	PMID:33212167
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of SMARCE1 mRNA	PMID:26272509
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMARCE1 mRNA	PMID:27188386
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313744	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SMARCE1 mRNA	PMID:27862939
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SMARCE1 mRNA	PMID:29803840
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:29365	phosgene	affects expression	ISO	RGD:1313744	E	RGD:6480464	20120515	CTD	MESH:D010705	Phosgene affects the expression of SMARCE1 mRNA	PMID:16300373
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SMARCE1 mRNA	PMID:34032870|PMID:39719251
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313744	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of SMARCE1 mRNA	PMID:36209798
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMARCE1 mRNA	PMID:21632981|PMID:26238291
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SMARCE1 3' UTR; Benzo(a)pyrene results in decreased methylation of SMARCE1 promoter	PMID:27901495
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1304726	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SMARCE1 mRNA	PMID:21839799
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of SMARCE1 mRNA	PMID:22171008
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SMARCE1 mRNA	PMID:20382639
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of SMARCE1 mRNA	PMID:34408198
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313744	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SMARCE1 gene	PMID:35295148
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SMARCE1 mRNA	PMID:18648102
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1304726	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SMARCE1 mRNA	PMID:25181051
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SMARCE1 mRNA	PMID:33221593
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313744	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SMARCE1 mRNA	PMID:26063408
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to SMARCE1 promoter]	PMID:20348232
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313744	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SMARCE1 mRNA	PMID:39298647
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SMARCE1 mRNA	PMID:37019170
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313744	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of SMARCE1 protein	PMID:35362542
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SMARCE1 protein]	PMID:35362542
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SMARCE1 gene	PMID:22964155
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SMARCE1 mRNA	PMID:17361019|PMID:21266533
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SMARCE1 mRNA	PMID:37042841
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:351346	phenethyl isothiocyanate	affects binding	EXP		E	RGD:6480464	20120717	CTD	MESH:C058305	SMARCE1 protein binds to phenethyl isothiocyanate	PMID:21838287
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SMARCE1 mRNA	PMID:38568856
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1304726	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SMARCE1 mRNA	PMID:33453195
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SMARCE1 mRNA	PMID:37236586
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of SMARCE1 mRNA	PMID:19429403
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SMARCE1 mRNA	PMID:24449571
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SMARCE1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SMARCE1 mRNA	PMID:32699268
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of SMARCE1 mRNA	PMID:19429403
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SMARCE1 mRNA	PMID:25979313
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMARCE1 mRNA	PMID:23179753
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in decreased expression of SMARCE1 mRNA	PMID:20546886|PMID:21427059
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1304726	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of SMARCE1 mRNA	PMID:41580965
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SMARCE1 mRNA	PMID:25562108|PMID:27989131
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1304726	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of SMARCE1 mRNA	PMID:24136188
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SMARCE1 mRNA	PMID:27188386
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SMARCE1 mRNA	PMID:24935251|PMID:26272509
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMARCE1 mRNA	PMID:27188386
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMARCE1 mRNA	PMID:21420995
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1304726	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMARCE1 mRNA	PMID:33387578
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SMARCE1 mRNA	PMID:17942748
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCE1 mRNA	PMID:17942748
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SMARCE1 protein]	PMID:35362542
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1304726	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of SMARCE1 mRNA	PMID:24136188
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1304726	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of SMARCE1 mRNA	PMID:34044035
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313744	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SMARCE1 mRNA	PMID:35964746
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1304726	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of SMARCE1 mRNA	PMID:24793618
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SMARCE1 protein	PMID:32959892
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SMARCE1 mRNA	PMID:23650126
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1313744	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SMARCE1 protein	PMID:26558463
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313744	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of SMARCE1 protein	PMID:36851058
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:73390	promegestone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011397	Promegestone promotes the reaction [SMARCE1 protein binds to PGR protein]	PMID:19609353
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313744	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SMARCE1 mRNA	PMID:22206623
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SMARCE1 protein	PMID:37664457
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of SMARCE1 protein	PMID:31285264
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of SMARCE1 mRNA	PMID:12517777
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMARCE1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMARCE1 mRNA	PMID:27188386
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SMARCE1 gene]	PMID:28238834
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of SMARCE1 mRNA	PMID:21858171
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1304726	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SMARCE1 mRNA	PMID:24780913
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SMARCE1 protein; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMARCE1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SMARCE1 mRNA	PMID:27188386|PMID:37664457
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1304726	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of SMARCE1 mRNA	PMID:19281266
1313743	SMARCE1	SWI/SNF related BAF chromatin remodeling complex subunit E1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1304726	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of SMARCE1 protein	PMID:35544339
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SPAG6 mRNA	PMID:27188386
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1620435	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SPAG6 mRNA	PMID:33045310
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:15365	acetylsalicylic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of SPAG6 mRNA	PMID:11906190
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305616	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of SPAG6 gene	PMID:35440735
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1620435	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SPAG6 mRNA	PMID:30319688
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305616	E	RGD:6480464	20211221	CTD	MESH:D014241	Trichloroethylene results in increased expression of SPAG6 mRNA	PMID:33387578
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SPAG6 mRNA	PMID:31163220
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1620435	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SPAG6 mRNA	PMID:34319233
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305616	E	RGD:6480464	20211221	CTD	MESH:D003471	Cuprizone results in increased expression of SPAG6 mRNA	PMID:26577399
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPAG6 mRNA	PMID:35301059
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SPAG6 gene	PMID:27153756
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305616	E	RGD:6480464	20211221	CTD	MESH:D000661	Amphetamine results in increased expression of SPAG6 mRNA	PMID:30779732
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1620435	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SPAG6 mRNA	PMID:25629700
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:27496	simazine	decreases expression	ISO	RGD:1620435	E	RGD:6480464	20151222	CTD	MESH:D012839	Simazine results in decreased expression of SPAG6 mRNA	PMID:22984576
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SPAG6 mRNA	PMID:26272509
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA	PMID:27188386
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1305616	E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of SPAG6 mRNA	PMID:38314887
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305616	E	RGD:6480464	20211221	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPAG6 mRNA	PMID:33387578
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SPAG6 mRNA	PMID:28001369
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1620435	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SPAG6 protein	PMID:28918527
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SPAG6 mRNA	PMID:22316170
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPAG6 mRNA	PMID:17879257
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305616	E	RGD:6480464	20211221	CTD	MESH:C004312	glycidol results in decreased expression of SPAG6 mRNA	PMID:24915197
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPAG6 gene	PMID:31601247
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1620435	E	RGD:6480464	20151222	CTD	MESH:C009495	titanium dioxide results in decreased expression of SPAG6 mRNA	PMID:23557971
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620435	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SPAG6 gene	PMID:35295148
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1620435	E	RGD:6480464	20151222	CTD	MESH:C006253	pirinixic acid results in increased expression of SPAG6 mRNA	PMID:20813756
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305616	E	RGD:6480464	20211221	CTD	MESH:C006780	bisphenol A affects the expression of SPAG6 mRNA	PMID:25181051
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1620435	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SPAG6 mRNA	PMID:30951980
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPAG6 gene	PMID:31601247
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1620435	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SPAG6 exon	PMID:33297965
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1620435	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of SPAG6 intron	PMID:28392331
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPAG6 mRNA	PMID:35301059
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305616	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SPAG6 mRNA	PMID:30047161
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1620435	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of SPAG6 mRNA	PMID:39529242
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1620435	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of SPAG6 mRNA	PMID:29038090
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPAG6 mRNA	PMID:25979313
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SPAG6 gene	PMID:29154799
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SPAG6 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:27188386|PMID:28001369
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305616	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SPAG6 mRNA	PMID:30047161
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1620435	E	RGD:6480464	20151222	CTD	MESH:D013629	Tamoxifen affects the expression of SPAG6 mRNA	PMID:17555576
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SPAG6 mRNA	PMID:27188386
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1620435	E	RGD:6480464	20151222	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SPAG6 mRNA	PMID:17555576
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of SPAG6 mRNA	PMID:26272509
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA	PMID:27188386
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620435	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SPAG6 mRNA; Nanotubes, Carbon results in decreased expression of SPAG6 mRNA	PMID:25554681
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA	PMID:27188386
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:84491	poly(I:C)	decreases expression	ISO	RGD:1305616	E	RGD:6480464	20211221	CTD	MESH:D011070	Poly I-C results in decreased expression of SPAG6 mRNA	PMID:26923065
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1305616	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of SPAG6 mRNA	PMID:30047161
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305616	E	RGD:6480464	20211221	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SPAG6 mRNA	PMID:25825206|PMID:30047161
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPAG6 mRNA	PMID:27188386
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1305616	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of SPAG6 mRNA	PMID:30047161
1313749	SPAG6	sperm associated antigen 6	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305616	E	RGD:6480464	20211221	CTD	MESH:C025643	vinclozolin results in increased expression of SPAG6 mRNA	PMID:22615374
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1313753	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in increased expression of TBK1 mRNA	PMID:33227293
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313753	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of TBK1 mRNA	PMID:26251327
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1313753	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of TBK1 promoter	PMID:26251327
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TBK1 mRNA	PMID:33167477
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBK1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TBK1 mRNA	PMID:32699268
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D010100	Oxygen deficiency results in increased expression of TBK1 mRNA	PMID:23452621
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D010100	3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of TBK1 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of TBK1 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of TBK1 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of TBK1 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of TBK1 mRNA]	PMID:23452621
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	ISO	RGD:1313753	E	RGD:6480464	20210406	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of TBK1 protein	PMID:32905826
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20210406	CTD	MESH:D019308	amlexanox inhibits the reaction [Palmitic Acid results in increased phosphorylation of TBK1 protein]	PMID:32905826
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:15864	luteolin	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D047311	Luteolin results in decreased activity of TBK1 protein	PMID:19426678
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20240402	CTD	MESH:C015329	Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased phosphorylation of TBK1 protein]	PMID:36583613
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:16243	quercetin	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased activity of TBK1 protein	PMID:19426678
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:16412	lipopolysaccharide	increases phosphorylation	ISO	RGD:1313753	E	RGD:6480464	20200331	CTD	MESH:D008070	Lipopolysaccharides results in increased phosphorylation of TBK1 protein	PMID:25780039
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:16412	lipopolysaccharide	increases response to substance	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	TBK1 protein results in increased susceptibility to Lipopolysaccharides	PMID:21904615
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20200331	CTD	MESH:D008070	APPL1 protein promotes the reaction [Lipopolysaccharides results in increased phosphorylation of TBK1 protein]; bafilomycin A1 promotes the reaction [Lipopolysaccharides results in increased phosphorylation of TBK1 protein]; DNM2 protein promotes the reaction [Lipopolysaccharides results in increased phosphorylation of TBK1 protein]; Lipopolysaccharides promotes the reaction [APPL1 protein binds to TBK1 protein modified form]; Lipopolysaccharides promotes the reaction [APPL1 protein binds to TBK1 protein]; Lipopolysaccharides promotes the reaction [Lipopolysaccharides results in increased phosphorylation of TBK1 protein]; N'-(3,4-dihydroxybenzylidene)-3-hydroxy-2-naphthahydrazide inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of TBK1 protein]	PMID:25780039
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313753	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TBK1 mRNA	PMID:39298647
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of TBK1 mRNA	PMID:20655997
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313753	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of TBK1 mRNA	PMID:23892564
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases phosphorylation	ISO	RGD:1313753	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased phosphorylation of TBK1 protein	PMID:36583613
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20240402	CTD	MESH:D004051	Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased phosphorylation of TBK1 protein]	PMID:36583613
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1588588	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TBK1 mRNA	PMID:22061828
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBK1 mRNA	PMID:39836092
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:188131	Phytolaccoside E	increases phosphorylation	EXP		E	RGD:6480464	20230502	CTD	MESH:C076297	esculentoside A results in increased phosphorylation of TBK1 protein	PMID:36460195
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:22689	bafilomycin A1	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20200331	CTD	MESH:C040929	bafilomycin A1 promotes the reaction [Lipopolysaccharides results in increased phosphorylation of TBK1 protein]; bafilomycin A1 promotes the reaction [Poly I-C results in increased phosphorylation of TBK1 protein]	PMID:25780039
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TBK1 mRNA	PMID:37236586
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:233321	Mitoquinone	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20251104	CTD	MESH:C429014	mitoquinone inhibits the reaction [Cadmium Chloride results in increased phosphorylation of TBK1 protein]	PMID:39587603
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:233645	4-Octyl itaconate	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20260804	CTD	MESH:C000708109	4-octyl itaconate inhibits the reaction [cyclic guanosine monophosphate-adenosine monophosphate results in increased phosphorylation of TBK1 protein]; 4-octyl itaconate inhibits the reaction [STING1 protein mutant form results in increased phosphorylation of TBK1 protein]; 4-octyl itaconate inhibits the reaction [vadimezan results in increased phosphorylation of TBK1 protein]	PMID:36862550|PMID:37624697
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TBK1 mRNA	PMID:19549813
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TBK1 mRNA	PMID:23649840
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313753	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TBK1 mRNA	PMID:19770486
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TBK1 mRNA	PMID:23649840
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBK1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TBK1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TBK1 mRNA	PMID:32699268
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TBK1 mRNA]	PMID:22206623
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBK1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TBK1 mRNA	PMID:39836092
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of TBK1 protein	PMID:35688186
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of TBK1 mRNA	PMID:31295307
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:C059514	resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of TBK1 mRNA]	PMID:23452621
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol inhibits the reaction [TBK1 protein results in increased activity of IRF3 protein]; resveratrol inhibits the reaction [TBK1 protein results in increased phosphorylation of IRF3 protein]	PMID:16116226|PMID:16678799
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313753	E	RGD:6480464	20160210	CTD	MESH:D002945	Cisplatin results in increased expression of TBK1 mRNA	PMID:26546572
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20160210	CTD	MESH:D002945	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [Cisplatin results in increased expression of TBK1 mRNA]	PMID:26546572
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:28088	genistein	increases methylation	ISO	RGD:1588588	E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of TBK1 gene	PMID:28505145
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D019833	Genistein inhibits the reaction [Oxygen deficiency results in increased expression of TBK1 mRNA]	PMID:23452621
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313753	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TBK1 mRNA	PMID:21570461|PMID:24680724
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1588588	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TBK1 mRNA	PMID:33387578
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313753	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBK1 mRNA	PMID:17942748
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1588588	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBK1 mRNA	PMID:32109520
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TBK1 mRNA	PMID:17942748
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TBK1 mRNA	PMID:33212167
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:28412	eriodictyol	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C007619	eriodictyol results in decreased activity of TBK1 protein	PMID:19426678
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TBK1 mRNA	PMID:32763439
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:2922	auranofin	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20120412	CTD	MESH:D001310	Auranofin inhibits the reaction [TBK1 protein results in increased activity of IRF3 protein]	PMID:17034761
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TBK1 mRNA	PMID:38568856|PMID:39719251
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313753	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of TBK1 mRNA	PMID:19822182
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBK1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TBK1 mRNA	PMID:39836092
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of TBK1 mRNA	PMID:29453283
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313753	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of TBK1 mRNA	PMID:17127020
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313753	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TBK1 mRNA	PMID:22228805
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TBK1 mRNA	PMID:19150397
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:30621	diarsenic trioxide	increases phosphorylation	ISO	RGD:1313753	E	RGD:6480464	20251007	CTD	MESH:C006632	Arsenic Trioxide results in increased phosphorylation of TBK1 protein	PMID:38684648
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:31205	amlexanox	decreases activity	EXP		E	RGD:6480464	20200519	CTD	MESH:C045742	amlexanox results in decreased activity of TBK1 protein	PMID:25321315
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:31205	amlexanox	decreases phosphorylation	ISO	RGD:1313753	E	RGD:6480464	20200519	CTD	MESH:C045742	amlexanox results in decreased phosphorylation of TBK1 protein	PMID:31697998
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:31205	amlexanox	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20200519	CTD	MESH:C045742	amlexanox inhibits the reaction [Acetaminophen results in increased phosphorylation of TBK1 protein]; amlexanox inhibits the reaction [Palmitic Acid results in increased phosphorylation of TBK1 protein]; amlexanox inhibits the reaction [Paraquat results in increased phosphorylation of TBK1 protein]	PMID:31697998|PMID:32763286|PMID:32905826
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313753	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TBK1 promoter	PMID:35295148
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1588588	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TBK1 mRNA	PMID:34492290
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313753	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of TBK1 mRNA	PMID:28472532
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1588588	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TBK1 mRNA	PMID:25181051
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313753	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TBK1 mRNA	PMID:33221593
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1588588	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of TBK1 mRNA	PMID:30816183|PMID:32528016
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C005290	oxybenzone results in increased expression of TBK1 mRNA	PMID:36581016
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313753	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TBK1 mRNA	PMID:39298647
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1313753	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of TBK1 gene	PMID:38995845
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313753	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TBK1 mRNA	PMID:34813904
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:34905	paraquat	increases phosphorylation	ISO	RGD:1313753	E	RGD:6480464	20210504	CTD	MESH:D010269	Paraquat results in increased phosphorylation of TBK1 protein	PMID:32763286
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20210504	CTD	MESH:D010269	amlexanox inhibits the reaction [Paraquat results in increased phosphorylation of TBK1 protein]	PMID:32763286
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBK1 mRNA	PMID:39836092
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TBK1 mRNA	PMID:38568856
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313753	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TBK1 mRNA	PMID:39587603
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:35456	cadmium dichloride	increases phosphorylation	ISO	RGD:1313753	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased phosphorylation of TBK1 protein	PMID:39587603
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TBK1 mRNA; mitoquinone inhibits the reaction [Cadmium Chloride results in increased phosphorylation of TBK1 protein]; RU.521 inhibits the reaction [Cadmium Chloride results in increased expression of TBK1 mRNA]; RU.521 inhibits the reaction [Cadmium Chloride results in increased phosphorylation of TBK1 protein]	PMID:37236586|PMID:39587603
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TBK1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TBK1 mRNA	PMID:32699268
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313753	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of TBK1 mRNA	PMID:17585979
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TBK1 mRNA	PMID:28302478
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TBK1 mRNA	PMID:27153767
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D003474	Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of TBK1 mRNA]	PMID:23452621
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TBK1 mRNA	PMID:25562108
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313753	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TBK1 mRNA	PMID:17555576
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313753	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TBK1 mRNA	PMID:17562736
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of TBK1 mRNA	PMID:27761495
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:46195	paracetamol	increases phosphorylation	ISO	RGD:1313753	E	RGD:6480464	20200519	CTD	MESH:D000082	Acetaminophen results in increased phosphorylation of TBK1 protein	PMID:31697998
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20200519	CTD	MESH:D000082	[vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of TBK1 protein; amlexanox inhibits the reaction [Acetaminophen results in increased phosphorylation of TBK1 protein]	PMID:31697998|PMID:37046119
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBK1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TBK1 mRNA	PMID:39836092
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:48843	disodium selenite	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite inhibits the reaction [TBK1 protein results in increased activity of IRF3 protein]	PMID:18279804
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313753	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TBK1 mRNA	PMID:17555576
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313753	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TBK1 mRNA	PMID:17942748
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TBK1 mRNA	PMID:17942748
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:49900	arsenous acid	increases phosphorylation	ISO	RGD:1313753	E	RGD:6480464	20251007	CTD	MESH:C032793	Arsenic Trioxide results in increased phosphorylation of TBK1 protein	PMID:38684648
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1588588	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of TBK1 mRNA	PMID:19162173
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TBK1 mRNA	PMID:35964746
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1588588	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TBK1 mRNA	PMID:24136188
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:53473	beryllium sulfate	increases phosphorylation	EXP		E	RGD:6480464	20250603	CTD	MESH:C020711	beryllium sulfate results in increased phosphorylation of TBK1 protein	PMID:38778435
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:53473	beryllium sulfate	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:C020711	STING1 protein promotes the reaction [beryllium sulfate results in increased phosphorylation of TBK1 protein]	PMID:38778435
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TBK1 protein	PMID:32959892
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TBK1 mRNA	PMID:39836092
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313753	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of TBK1 mRNA	PMID:20003209
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1588588	E	RGD:6480464	20211109	CTD	MESH:D007545	[Isoproterenol co-treated with POSTN protein] results in decreased expression of TBK1 mRNA	PMID:30303030
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:6682	mangiferin	decreases expression	ISO	RGD:1313753	E	RGD:6480464	20120412	CTD	MESH:C013592	mangiferin results in decreased expression of TBK1 mRNA	PMID:15135318
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313753	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TBK1 mRNA	PMID:22206623
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TBK1 mRNA]	PMID:22206623
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1588588	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TBK1 mRNA	PMID:24136188
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:75095	chrysin	decreases activity	EXP		E	RGD:6480464	20130903	CTD	MESH:C043561	chrysin results in decreased activity of TBK1 protein	PMID:19426678
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:75934	vadimezan	increases phosphorylation	ISO	RGD:1313753	E	RGD:6480464	20260804	CTD	MESH:C066668	vadimezan results in increased phosphorylation of TBK1 protein	PMID:36862550|PMID:37624697
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:75934	vadimezan	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C066668	[vadimezan co-treated with STING1 protein] results in increased phosphorylation of TBK1 protein; ACOD1 protein inhibits the reaction [[vadimezan co-treated with STING1 protein] results in increased phosphorylation of TBK1 protein]; ACOD1 protein mutant form inhibits the reaction [[vadimezan co-treated with STING1 protein] results in increased phosphorylation of TBK1 protein]	PMID:36862550
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:75934	vadimezan	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20230801	CTD	MESH:C066668	4-octyl itaconate inhibits the reaction [vadimezan results in increased phosphorylation of TBK1 protein]; [vadimezan affects the reaction [P2RX1 protein affects the susceptibility to Acetaminophen]] which affects the phosphorylation of TBK1 protein; dimethyl itaconate inhibits the reaction [vadimezan results in increased phosphorylation of TBK1 protein]; STING1 protein affects the reaction [vadimezan results in increased phosphorylation of TBK1 protein]; TBK1 protein affects the reaction [vadimezan results in increased expression of ACOD1 protein]; TBK1 protein affects the reaction [vadimezan results in increased phosphorylation of STING1 protein]	PMID:36862550|PMID:37046119|PMID:37624697
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313753	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of TBK1 mRNA	PMID:31388691
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:82288	o-anisidine	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C003898	2-anisidine results in decreased expression of TBK1 mRNA	PMID:28089782
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:84491	poly(I:C)	increases phosphorylation	ISO	RGD:1313753	E	RGD:6480464	20200331	CTD	MESH:D011070	Poly I-C results in increased phosphorylation of TBK1 protein	PMID:25780039
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1313753	E	RGD:6480464	20200331	CTD	MESH:D011070	APPL1 protein promotes the reaction [Poly I-C results in increased phosphorylation of TBK1 protein]; bafilomycin A1 promotes the reaction [Poly I-C results in increased phosphorylation of TBK1 protein]	PMID:25780039
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313753	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of TBK1 mRNA	PMID:21278054
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1588588	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TBK1 mRNA	PMID:24780913
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in increased expression of TBK1 mRNA	PMID:11093808
1313752	TBK1	TANK binding kinase 1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313753	E	RGD:6480464	20230502	CTD	MESH:C001899	triptolide results in increased expression of TBK1 mRNA; triptolide results in increased expression of TBK1 protein	PMID:36520315
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:10110	zidovudine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	Zidovudine results in increased expression of NDUFAB1 mRNA	PMID:16894629
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFAB1 mRNA	PMID:18313992
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NDUFAB1 mRNA	PMID:22629407
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of NDUFAB1 mRNA]	PMID:22629407
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NDUFAB1 mRNA	PMID:22378314
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:16136	hydrogen sulfide	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20181113	CTD	MESH:D006862	Hydrogen Sulfide results in decreased expression of NDUFAB1 protein	PMID:29932956
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1305619	E	RGD:6480464	20141007	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of NDUFAB1 mRNA	PMID:17347304
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313755	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NDUFAB1 mRNA	PMID:39241906
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFAB1 mRNA	PMID:31059760
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NDUFAB1 mRNA]	PMID:39241906
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of NDUFAB1 mRNA	PMID:39298647
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NDUFAB1 mRNA	PMID:37042841
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:17303	morphine	affects expression	ISO	RGD:1313755	E	RGD:6480464	20120412	CTD	MESH:D009020	Morphine affects the expression of NDUFAB1 mRNA	PMID:20144693
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:17578	toluene	affects expression	ISO	RGD:1305619	E	RGD:6480464	20141007	CTD	MESH:D014050	Toluene affects the expression of NDUFAB1 mRNA	PMID:21827849
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NDUFAB1 mRNA	PMID:35550907
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305619	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of NDUFAB1 mRNA	PMID:22061828
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:17833	gentamycin	multiple interactions	ISO	RGD:1305619	E	RGD:6480464	20191112	CTD	MESH:D005839	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein	PMID:30545405
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NDUFAB1 mRNA	PMID:36331819
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NDUFAB1 mRNA	PMID:39836092
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NDUFAB1 mRNA	PMID:19549813
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1305619	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of NDUFAB1 protein	PMID:33236894
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313755	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NDUFAB1 mRNA	PMID:19770486
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NDUFAB1 mRNA	PMID:31919559
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NDUFAB1 mRNA	PMID:22206623
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NDUFAB1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of NDUFAB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NDUFAB1 mRNA	PMID:39836092|PMID:40512198
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313755	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of NDUFAB1 mRNA	PMID:30912803
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28001	vancomycin	multiple interactions	ISO	RGD:1305619	E	RGD:6480464	20191112	CTD	MESH:D014640	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein	PMID:30545405
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313755	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NDUFAB1 mRNA	PMID:21570461
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFAB1 mRNA	PMID:20106945|PMID:21632981
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305619	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFAB1 mRNA	PMID:27913140|PMID:32109520
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305619	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NDUFAB1 mRNA	PMID:33387578
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of NDUFAB1 mRNA	PMID:17702527
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1313755	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of NDUFAB1 mRNA	PMID:17702527
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NDUFAB1 mRNA	PMID:30851411
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of NDUFAB1 mRNA	PMID:27862939
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of NDUFAB1 mRNA	PMID:26873546
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of NDUFAB1 mRNA	PMID:29803840
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:28971	ampicillin	multiple interactions	ISO	RGD:1305619	E	RGD:6480464	20191112	CTD	MESH:D000667	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein	PMID:30545405
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of NDUFAB1 mRNA	PMID:34032870
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NDUFAB1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of NDUFAB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NDUFAB1 mRNA	PMID:39836092|PMID:40512198
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NDUFAB1 mRNA	PMID:22378314
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NDUFAB1 mRNA	PMID:17879257
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313755	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NDUFAB1 mRNA	PMID:19770486|PMID:22228805
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of NDUFAB1 mRNA	PMID:33053406
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to NDUFAB1 mRNA]	PMID:32406909
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of NDUFAB1 mRNA	PMID:19073995
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of NDUFAB1 mRNA	PMID:19422848
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of NDUFAB1 mRNA	PMID:22521957|PMID:29633893
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of NDUFAB1 mRNA	PMID:21829687
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305619	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of NDUFAB1 mRNA	PMID:30047161
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1305619	E	RGD:6480464	20141007	CTD	MESH:C006253	pirinixic acid results in increased expression of NDUFAB1 mRNA	PMID:19162173
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313755	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NDUFAB1 mRNA	PMID:11798191|PMID:15375163|PMID:18301758|PMID:20813756|PMID:23811191
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NDUFAB1 mRNA	PMID:30903817
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305619	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NDUFAB1 mRNA	PMID:25181051
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFAB1 mRNA; bisphenol A results in decreased expression of NDUFAB1 protein	PMID:29275510|PMID:37664457
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFAB1 mRNA; bisphenol A results in decreased expression of NDUFAB1 protein	PMID:37992956
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFAB1 protein	PMID:37567409
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305619	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFAB1 mRNA	PMID:34947998
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305619	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NDUFAB1 mRNA	PMID:36041667
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34283	oxybenzone	increases expression	ISO	RGD:1305619	E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of NDUFAB1 mRNA	PMID:30316929
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of NDUFAB1 gene	PMID:31601247
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313755	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NDUFAB1 mRNA	PMID:39298647
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305619	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NDUFAB1 mRNA	PMID:36041667
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305619	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of NDUFAB1 mRNA	PMID:36041667
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313755	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NDUFAB1 mRNA	PMID:37019170
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NDUFAB1 mRNA	PMID:17361019|PMID:21266533
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NDUFAB1 mRNA]	PMID:39241906
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NDUFAB1 mRNA	PMID:39836092
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of NDUFAB1 protein	PMID:26879310
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of NDUFAB1 mRNA	PMID:17585979
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of NDUFAB1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NDUFAB1 mRNA]	PMID:17585979
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of NDUFAB1 mRNA	PMID:26352163
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313755	E	RGD:6480464	20130416	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NDUFAB1 mRNA	PMID:20936131
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20130416	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NDUFAB1 mRNA; PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of NDUFAB1 mRNA]	PMID:20936131|PMID:36331819
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:39501	2,2,2-tetramine	multiple interactions	ISO	RGD:1305619	E	RGD:6480464	20141007	CTD	MESH:D014266	Trientine inhibits the reaction [Streptozocin results in increased expression of NDUFAB1 protein]	PMID:19634143
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NDUFAB1 mRNA	PMID:25979313
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305619	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of NDUFAB1 mRNA	PMID:30047161
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305619	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NDUFAB1 mRNA	PMID:30047161
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of NDUFAB1 mRNA	PMID:27989131
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide affects the expression of NDUFAB1 mRNA	PMID:16570282
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of NDUFAB1 mRNA	PMID:28973697
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305619	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of NDUFAB1 mRNA	PMID:24136188
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313755	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NDUFAB1 mRNA	PMID:17562736
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of NDUFAB1 mRNA	PMID:31059760
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFAB1 mRNA	PMID:31059760
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of NDUFAB1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NDUFAB1 mRNA]	PMID:17585979
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:46345	5-fluorouracil	affects expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D005472	Fluorouracil affects the expression of NDUFAB1 mRNA	PMID:34151400
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NDUFAB1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of NDUFAB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NDUFAB1 mRNA	PMID:39836092|PMID:40512198
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1313755	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of NDUFAB1 mRNA	PMID:30529165
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of NDUFAB1 mRNA	PMID:18175754
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305619	E	RGD:6480464	20141007	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NDUFAB1 mRNA	PMID:17108234
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:4917	eugenol	decreases expression	ISO	RGD:1305619	E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in decreased expression of NDUFAB1 protein	PMID:39793947
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of NDUFAB1 mRNA	PMID:19422848
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of NDUFAB1 mRNA	PMID:22521957|PMID:29633893
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1313755	E	RGD:6480464	20120412	CTD	MESH:D011345	Fenofibrate results in increased expression of NDUFAB1 mRNA	PMID:11798191
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of NDUFAB1 mRNA	PMID:25620056
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313755	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NDUFAB1 mRNA; Nanotubes, Carbon results in increased expression of NDUFAB1 mRNA	PMID:25554681
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305619	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of NDUFAB1 mRNA	PMID:24136188
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305619	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of NDUFAB1 mRNA	PMID:30047161
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305619	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NDUFAB1 mRNA	PMID:30047161
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	ISO	RGD:1305619	E	RGD:6480464	20141007	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of NDUFAB1 mRNA	PMID:19162173
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20120412	CTD	MESH:D005485	Flutamide analog results in decreased expression of NDUFAB1 mRNA; Flutamide results in decreased expression of NDUFAB1 mRNA	PMID:17702527
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305619	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NDUFAB1 mRNA	PMID:24136188
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1313755	E	RGD:6480464	20120412	CTD	MESH:D005485	Flutamide analog results in increased expression of NDUFAB1 mRNA; Flutamide results in increased expression of NDUFAB1 mRNA	PMID:17702527
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313755	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NDUFAB1 mRNA	PMID:19042947
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:6030	isoniazide	affects expression	ISO	RGD:1313755	E	RGD:6480464	20141014	CTD	MESH:D007538	Isoniazid affects the expression of NDUFAB1 mRNA	PMID:24848797
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:6030	isoniazide	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of NDUFAB1 protein	PMID:40015660
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NDUFAB1 protein	PMID:32959892
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NDUFAB1 mRNA	PMID:39836092
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFAB1 mRNA	PMID:18313992
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDUFAB1 mRNA	PMID:21641980
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of NDUFAB1 mRNA	PMID:37939859
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:6909	metronidazole	multiple interactions	ISO	RGD:1305619	E	RGD:6480464	20191112	CTD	MESH:D008795	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein	PMID:30545405
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of NDUFAB1 protein	PMID:34186270
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NDUFAB1 mRNA	PMID:22206623
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NDUFAB1 protein	PMID:37664457
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305619	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of NDUFAB1 mRNA	PMID:24136188
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:7507	neomycin	multiple interactions	ISO	RGD:1305619	E	RGD:6480464	20191112	CTD	MESH:D009355	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein	PMID:30545405
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NDUFAB1 mRNA	PMID:30851411
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NDUFAB1 gene]	PMID:28238834
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1313755	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in increased expression of NDUFAB1 mRNA	PMID:22538082
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313755	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of NDUFAB1 mRNA	PMID:30294300
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313755	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of NDUFAB1 mRNA	PMID:21795629
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305619	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NDUFAB1 mRNA	PMID:30047161
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305619	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of NDUFAB1 mRNA	PMID:30047161
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313755	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of NDUFAB1 mRNA]	PMID:39241906
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of NDUFAB1 protein	PMID:37664457
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1305619	E	RGD:6480464	20141007	CTD	MESH:D013311	Streptozocin results in increased expression of NDUFAB1 protein	PMID:19634143
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1305619	E	RGD:6480464	20141007	CTD	MESH:D013311	Trientine inhibits the reaction [Streptozocin results in increased expression of NDUFAB1 protein]	PMID:19634143
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of NDUFAB1 mRNA	PMID:22378314
1313754	NDUFAB1	NADH:ubiquinone oxidoreductase subunit AB1	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1305619	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of NDUFAB1 mRNA	PMID:30047161
1313756	MYL6	myosin light chain 6	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of MYL6 mRNA	PMID:35967413
1313756	MYL6	myosin light chain 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313757	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MYL6 mRNA	PMID:33045310
1313756	MYL6	myosin light chain 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313757	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of MYL6 mRNA	PMID:26251327
1313756	MYL6	myosin light chain 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1313757	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of MYL6 promoter	PMID:26251327
1313756	MYL6	myosin light chain 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of MYL6 mRNA	PMID:17218384|PMID:23724009|PMID:33167477
1313756	MYL6	myosin light chain 6	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MYL6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MYL6 mRNA	PMID:32699268
1313756	MYL6	myosin light chain 6	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313757	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of MYL6 mRNA	PMID:40945087
1313756	MYL6	myosin light chain 6	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313757	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MYL6 mRNA	PMID:39241906
1313756	MYL6	myosin light chain 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of MYL6 mRNA	PMID:23019147
1313756	MYL6	myosin light chain 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313757	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MYL6 mRNA; Estradiol results in decreased expression of MYL6 protein; Estradiol results in decreased expression of MYL6 protein alternative form	PMID:26903627|PMID:39298647
1313756	MYL6	myosin light chain 6	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of MYL6 mRNA	PMID:11179685
1313756	MYL6	myosin light chain 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of MYL6 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of MYL6 mRNA]	PMID:11179685
1313756	MYL6	myosin light chain 6	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of MYL6 mRNA	PMID:16949557
1313756	MYL6	myosin light chain 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313757	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MYL6 mRNA	PMID:33754040
1313756	MYL6	myosin light chain 6	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MYL6 protein	PMID:37730182
1313756	MYL6	myosin light chain 6	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of MYL6 mRNA	PMID:16949557
1313756	MYL6	myosin light chain 6	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MYL6 protein	PMID:23301498
1313756	MYL6	myosin light chain 6	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1589019	E	RGD:6480464	20211109	CTD	MESH:C016517	indole-3-carbinol affects the expression of MYL6 mRNA	PMID:21396975
1313756	MYL6	myosin light chain 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1589019	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MYL6 mRNA	PMID:33354967
1313756	MYL6	myosin light chain 6	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MYL6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MYL6 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of MYL6 mRNA	PMID:32699268
1313756	MYL6	myosin light chain 6	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of MYL6 protein	PMID:38598786
1313756	MYL6	myosin light chain 6	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1589019	E	RGD:6480464	20211109	CTD	MESH:D000661	Amphetamine results in increased expression of MYL6 mRNA	PMID:30779732
1313756	MYL6	myosin light chain 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313757	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MYL6 mRNA	PMID:22206623
1313756	MYL6	myosin light chain 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MYL6 mRNA	PMID:40512198
1313756	MYL6	myosin light chain 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313757	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MYL6 mRNA	PMID:40504410
1313756	MYL6	myosin light chain 6	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of MYL6 mRNA	PMID:19244175
1313756	MYL6	myosin light chain 6	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of MYL6 mRNA	PMID:19244175
1313756	MYL6	myosin light chain 6	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MYL6 mRNA	PMID:28903495
1313756	MYL6	myosin light chain 6	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of MYL6 mRNA	PMID:28903495
1313756	MYL6	myosin light chain 6	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of MYL6 mRNA	PMID:27594783
1313756	MYL6	myosin light chain 6	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1589019	E	RGD:6480464	20211109	CTD	MESH:D002945	Cisplatin results in increased expression of MYL6 protein	PMID:22023808
1313756	MYL6	myosin light chain 6	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of MYL6 mRNA	PMID:27392435
1313756	MYL6	myosin light chain 6	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in increased expression of MYL6 protein	PMID:20884965
1313756	MYL6	myosin light chain 6	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	ESR1 promotes the reaction [Genistein results in increased expression of MYL6 protein]	PMID:20884965
1313756	MYL6	myosin light chain 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313757	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MYL6 mRNA	PMID:21570461|PMID:24680724
1313756	MYL6	myosin light chain 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1589019	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MYL6 mRNA	PMID:34747641
1313756	MYL6	myosin light chain 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of MYL6 mRNA]	PMID:11179685
1313756	MYL6	myosin light chain 6	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1589019	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of MYL6 mRNA	PMID:28959563
1313756	MYL6	myosin light chain 6	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1589019	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of MYL6 mRNA	PMID:30556269
1313756	MYL6	myosin light chain 6	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313757	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of MYL6 protein	PMID:28918527
1313756	MYL6	myosin light chain 6	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of MYL6 protein	PMID:29385562
1313756	MYL6	myosin light chain 6	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of MYL6 mRNA	PMID:29803840
1313756	MYL6	myosin light chain 6	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of MYL6 mRNA	PMID:20044591
1313756	MYL6	myosin light chain 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of MYL6 mRNA	PMID:39719251
1313756	MYL6	myosin light chain 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MYL6 mRNA	PMID:38568856
1313756	MYL6	myosin light chain 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1589019	E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in increased expression of MYL6 protein	PMID:38266420
1313756	MYL6	myosin light chain 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MYL6 mRNA	PMID:40512198
1313756	MYL6	myosin light chain 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313757	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MYL6 mRNA	PMID:40504410
1313756	MYL6	myosin light chain 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313757	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MYL6 mRNA	PMID:23735875
1313756	MYL6	myosin light chain 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MYL6 protein	PMID:18495319
1313756	MYL6	myosin light chain 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313757	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MYL6 mRNA	PMID:22228805
1313756	MYL6	myosin light chain 6	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313757	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to MYL6 promoter]	PMID:19654925
1313756	MYL6	myosin light chain 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MYL6 protein]	PMID:32406909
1313756	MYL6	myosin light chain 6	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1589019	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of MYL6 mRNA	PMID:30556269
1313756	MYL6	myosin light chain 6	gene	CHEBI:30145	lithium atom	decreases expression	ISO	RGD:1589019	E	RGD:6480464	20150303	CTD	MESH:D008094	Lithium results in decreased expression of MYL6 protein	PMID:18296634
1313756	MYL6	myosin light chain 6	gene	CHEBI:30146	lithium hydride	decreases expression	ISO	RGD:1589019	E	RGD:6480464	20150303	CTD	MESH:D008094	Lithium results in decreased expression of MYL6 protein	PMID:18296634
1313756	MYL6	myosin light chain 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MYL6 protein	PMID:20416286
1313756	MYL6	myosin light chain 6	gene	CHEBI:3139	bleomycin A2	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:D001761	Bleomycin results in decreased expression of MYL6 mRNA	PMID:40645554
1313756	MYL6	myosin light chain 6	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1589019	E	RGD:6480464	20211109	CTD	MESH:D001761	Bleomycin results in increased expression of MYL6 protein	PMID:25933445
1313756	MYL6	myosin light chain 6	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MYL6 gene	PMID:31601247
1313756	MYL6	myosin light chain 6	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1589019	E	RGD:6480464	20211109	CTD	MESH:D005897	Glafenine results in increased expression of MYL6 mRNA	PMID:24136188
1313756	MYL6	myosin light chain 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313757	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MYL6 mRNA	PMID:18648102
1313756	MYL6	myosin light chain 6	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MYL6 mRNA	PMID:30903817
1313756	MYL6	myosin light chain 6	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MYL6 mRNA	PMID:29275510
1313756	MYL6	myosin light chain 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313757	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MYL6 mRNA; bisphenol A results in decreased expression of MYL6 protein	PMID:33221593|PMID:35598803|PMID:35999755
1313756	MYL6	myosin light chain 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MYL6 protein	PMID:32981897|PMID:34186270|PMID:37567409
1313756	MYL6	myosin light chain 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313757	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MYL6 mRNA	PMID:32156529
1313756	MYL6	myosin light chain 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1589019	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MYL6 mRNA	PMID:25181051
1313756	MYL6	myosin light chain 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313757	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MYL6 promoter	PMID:27312807
1313756	MYL6	myosin light chain 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of MYL6 gene	PMID:31601247
1313756	MYL6	myosin light chain 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313757	E	RGD:6480464	20230207	CTD	MESH:C006780	[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of MYL6 protein	PMID:35999755
1313756	MYL6	myosin light chain 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1589019	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MYL6 mRNA	PMID:36041667
1313756	MYL6	myosin light chain 6	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of MYL6 mRNA	PMID:19244175
1313756	MYL6	myosin light chain 6	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of MYL6 mRNA	PMID:19244175
1313756	MYL6	myosin light chain 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313757	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MYL6 mRNA	PMID:39298647
1313756	MYL6	myosin light chain 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1589019	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MYL6 mRNA	PMID:36041667
1313756	MYL6	myosin light chain 6	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of MYL6 protein	PMID:34186270
1313756	MYL6	myosin light chain 6	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1589019	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MYL6 mRNA	PMID:36041667
1313756	MYL6	myosin light chain 6	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of MYL6 protein	PMID:34186270
1313756	MYL6	myosin light chain 6	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313757	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of MYL6 protein	PMID:35999755
1313756	MYL6	myosin light chain 6	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313757	E	RGD:6480464	20230207	CTD	MESH:D016264	[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of MYL6 protein	PMID:35999755
1313756	MYL6	myosin light chain 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313757	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MYL6 mRNA	PMID:17361019|PMID:21266533
1313756	MYL6	myosin light chain 6	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of MYL6 protein	PMID:38598786
1313756	MYL6	myosin light chain 6	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1313757	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in decreased expression of MYL6 mRNA	PMID:16797015
1313756	MYL6	myosin light chain 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MYL6 mRNA	PMID:37042841
1313756	MYL6	myosin light chain 6	gene	CHEBI:351346	phenethyl isothiocyanate	affects binding	EXP		E	RGD:6480464	20120717	CTD	MESH:C058305	MYL6 protein binds to phenethyl isothiocyanate	PMID:21838287
1313756	MYL6	myosin light chain 6	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1589019	E	RGD:6480464	20211109	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MYL6 mRNA	PMID:30723492
1313756	MYL6	myosin light chain 6	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MYL6 mRNA	PMID:18560533|PMID:38568856
1313756	MYL6	myosin light chain 6	gene	CHEBI:35861	dibenzo[a,l]pyrene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C041517	dibenzo(a,l)pyrene results in increased expression of MYL6 protein	PMID:18495319
1313756	MYL6	myosin light chain 6	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MYL6 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MYL6 mRNA	PMID:32699268
1313756	MYL6	myosin light chain 6	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of MYL6 mRNA	PMID:19244175
1313756	MYL6	myosin light chain 6	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of MYL6 mRNA	PMID:19244175
1313756	MYL6	myosin light chain 6	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MYL6 mRNA	PMID:28302478
1313756	MYL6	myosin light chain 6	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MYL6 mRNA	PMID:31533062
1313756	MYL6	myosin light chain 6	gene	CHEBI:39178	clothianidin	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in decreased expression of MYL6 mRNA	PMID:31626844
1313756	MYL6	myosin light chain 6	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of MYL6 mRNA	PMID:26352163
1313756	MYL6	myosin light chain 6	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313757	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MYL6 mRNA	PMID:17963808
1313756	MYL6	myosin light chain 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MYL6 mRNA	PMID:25562108
1313756	MYL6	myosin light chain 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313757	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MYL6 mRNA	PMID:17562736
1313756	MYL6	myosin light chain 6	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MYL6 mRNA	PMID:29432896
1313756	MYL6	myosin light chain 6	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of MYL6 protein	PMID:29553831
1313756	MYL6	myosin light chain 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MYL6 mRNA	PMID:40512198
1313756	MYL6	myosin light chain 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313757	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MYL6 mRNA	PMID:40504410
1313756	MYL6	myosin light chain 6	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313757	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of MYL6 mRNA	PMID:35436446
1313756	MYL6	myosin light chain 6	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1589019	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of MYL6 mRNA	PMID:29097150
1313756	MYL6	myosin light chain 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313757	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MYL6 mRNA	PMID:14976129
1313756	MYL6	myosin light chain 6	gene	CHEBI:50182	3,3'-diindolylmethane	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C016392	3,3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of MYL6 mRNA]	PMID:11179685
1313756	MYL6	myosin light chain 6	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1589019	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of MYL6 mRNA	PMID:23962444
1313756	MYL6	myosin light chain 6	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1313757	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of MYL6 mRNA	PMID:26377693
1313756	MYL6	myosin light chain 6	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MYL6 protein	PMID:32959892
1313756	MYL6	myosin light chain 6	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MYL6 protein	PMID:34186270
1313756	MYL6	myosin light chain 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313757	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MYL6 mRNA	PMID:22206623
1313756	MYL6	myosin light chain 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313757	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MYL6 mRNA	PMID:22206623
1313756	MYL6	myosin light chain 6	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MYL6 protein	PMID:37664457
1313756	MYL6	myosin light chain 6	gene	CHEBI:753233	coal tar	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of MYL6 protein	PMID:18495319
1313756	MYL6	myosin light chain 6	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MYL6 protein	PMID:31285264
1313756	MYL6	myosin light chain 6	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1589019	E	RGD:6480464	20150303	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MYL6 mRNA	PMID:15215175
1313756	MYL6	myosin light chain 6	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MYL6 mRNA	PMID:19159669
1313756	MYL6	myosin light chain 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of MYL6 mRNA	PMID:19095052
1313756	MYL6	myosin light chain 6	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313757	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of MYL6 mRNA	PMID:40826991
1313756	MYL6	myosin light chain 6	gene	CHEBI:88212	lead(II) chloride	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C029891	lead chloride results in increased expression of MYL6 protein	PMID:24419708
1313756	MYL6	myosin light chain 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MYL6 protein	PMID:37664457
1313756	MYL6	myosin light chain 6	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of MYL6 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of MYL6 protein	PMID:38598786
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313759	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of USP20 mRNA	PMID:33045310
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of USP20 mRNA	PMID:26251327
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313759	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of USP20 mRNA	PMID:20188158
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of USP20 mRNA	PMID:23724009
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of USP20 mRNA	PMID:30319688
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of USP20 mRNA	PMID:39241906
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305621	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of USP20 mRNA	PMID:33387578
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of USP20 mRNA	PMID:37042841
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313759	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of USP20 mRNA	PMID:21318169
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305621	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of USP20 mRNA	PMID:33387578
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of USP20 mRNA	PMID:28818685
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of USP20 mRNA	PMID:36331819
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of USP20 mRNA	PMID:33914522
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20150127	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of USP20 mRNA	PMID:25270620
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of USP20 mRNA	PMID:22206623
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of USP20 gene	PMID:25304211
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP20 mRNA	PMID:40504410
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of USP20 mRNA	PMID:16705744
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313759	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of USP20 mRNA	PMID:21570461
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305621	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of USP20 mRNA	PMID:33387578
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of USP20 mRNA	PMID:33212167
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of USP20 mRNA	PMID:30851411
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of USP20 protein	PMID:35688186
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of USP20 mRNA	PMID:38568856
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP20 mRNA	PMID:40504410
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of USP20 intron	PMID:30157460
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313759	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of USP20 mRNA	PMID:22228805
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of USP20 mRNA	PMID:25895662
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313759	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of USP20 gene	PMID:35295148
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313759	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of USP20 mRNA	PMID:18301758|PMID:21318169|PMID:23811191
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of USP20 mRNA]	PMID:21318169
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of USP20 mRNA	PMID:33914522
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305621	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of USP20 mRNA	PMID:25181051
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of USP20 intron	PMID:30157460
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of USP20 mRNA	PMID:34813904
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of USP20 mRNA	PMID:34813904
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of USP20 mRNA	PMID:38568856
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of USP20 mRNA	PMID:40419075
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of USP20 mRNA	PMID:36331819
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305621	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of USP20 mRNA	PMID:33387578
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of USP20 gene	PMID:25304211
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of USP20 mRNA	PMID:40504410
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of USP20 mRNA	PMID:25554681
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305621	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of USP20 mRNA	PMID:24136188
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of USP20 mRNA	PMID:28988120
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313759	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of USP20 mRNA	PMID:26307267
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of USP20 intron	PMID:30157460
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of USP20 mRNA	PMID:22206623
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of USP20 mRNA	PMID:22714537
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of USP20 mRNA	PMID:30851411
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to USP20 gene]	PMID:28238834
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313759	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of USP20 mRNA	PMID:19482888
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313759	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of USP20 mRNA]	PMID:19482888
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1313759	E	RGD:6480464	20230801	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of USP20 mRNA	PMID:33269387
1313758	USP20	ubiquitin specific peptidase 20	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305621	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of USP20 mRNA	PMID:21346803
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of MRPS34 mRNA	PMID:37995155
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPS34 mRNA	PMID:33167477
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1305623	E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in decreased expression of MRPS34 protein	PMID:40631627
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPS34 mRNA	PMID:31059760
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313762	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MRPS34 mRNA	PMID:39298647
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MRPS34 mRNA	PMID:37042841
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of MRPS34 mRNA	PMID:23649840
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1305623	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of MRPS34 protein	PMID:40631627
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of MRPS34 mRNA	PMID:28973375
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1305623	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of MRPS34 protein	PMID:40631627
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305623	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MRPS34 mRNA	PMID:22061828
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPS34 mRNA	PMID:36331819
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPS34 mRNA	PMID:28111341
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MRPS34 mRNA	PMID:19549813
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MRPS34 mRNA	PMID:23649840
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MRPS34 mRNA	PMID:23649840
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS34 mRNA	PMID:22206623
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS34 mRNA	PMID:40504410
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313762	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of MRPS34 mRNA	PMID:30912803
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313762	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPS34 mRNA	PMID:21570461
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305623	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPS34 mRNA	PMID:32109520
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313762	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPS34 mRNA	PMID:18796159
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of MRPS34 mRNA	PMID:29803840
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPS34 mRNA	PMID:38568856
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of MRPS34 mRNA	PMID:34032870|PMID:39719251
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [MRPS34 protein binds to CAPRIN1 protein]	PMID:33939924
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS34 mRNA	PMID:40504410
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MRPS34 mRNA	PMID:27195522
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305623	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of MRPS34 mRNA	PMID:24136188
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305623	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MRPS34 mRNA	PMID:30047161
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPS34 mRNA	PMID:33221593
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305623	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPS34 mRNA	PMID:25181051|PMID:30816183|PMID:32145629
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305623	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MRPS34 gene	PMID:28505145
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313762	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPS34 mRNA	PMID:39298647
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313762	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MRPS34 mRNA	PMID:37019170
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305623	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MRPS34 mRNA	PMID:17602206
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of MRPS34 gene	PMID:22964155
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MRPS34 mRNA	PMID:17361019|PMID:21266533
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MRPS34 mRNA	PMID:34813904
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of MRPS34 mRNA	PMID:34813904
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305623	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MRPS34 mRNA	PMID:17602206
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305623	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MRPS34 mRNA	PMID:32680482
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305623	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of MRPS34 promoter	PMID:22457795
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPS34 mRNA	PMID:28111341
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305623	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of MRPS34 gene	PMID:22079235
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of MRPS34 mRNA	PMID:17585979
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPS34 mRNA	PMID:36331819
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRPS34 mRNA	PMID:25979313
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in decreased expression of MRPS34 mRNA	PMID:29501571
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MRPS34 mRNA	PMID:23179753
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MRPS34 gene	PMID:29154799
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305623	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MRPS34 mRNA	PMID:30047161
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MRPS34 mRNA	PMID:25562108
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1305623	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of MRPS34 protein	PMID:40631627
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305623	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of MRPS34 mRNA	PMID:24136188
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPS34 mRNA	PMID:22230336|PMID:25704631|PMID:31059760
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305623	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MRPS34 mRNA	PMID:33387578
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPS34 mRNA	PMID:31059760
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS34 mRNA	PMID:40504410
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of MRPS34 mRNA	PMID:18175754
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1305623	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of MRPS34 mRNA	PMID:23962444
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305623	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MRPS34 mRNA	PMID:30047161
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305623	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MRPS34 mRNA	PMID:24136188
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MRPS34 protein	PMID:32959892
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305623	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of MRPS34 mRNA	PMID:24136188
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of MRPS34 mRNA	PMID:37939859
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MRPS34 mRNA	PMID:22206623
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313762	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS34 mRNA	PMID:22206623
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305623	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MRPS34 mRNA	PMID:24136188
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MRPS34 protein	PMID:31285264
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1305623	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased expression of MRPS34 mRNA	PMID:37162024
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:7719	ochratoxin A	increases methylation	ISO	RGD:1305623	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased methylation of MRPS34 gene	PMID:37162024
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1313762	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of MRPS34 mRNA	PMID:31558096
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305623	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of MRPS34 mRNA	PMID:30047161
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313762	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of MRPS34 mRNA	PMID:40826991
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305623	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MRPS34 mRNA	PMID:21346803
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MRPS34 mRNA	PMID:38568856
1313761	MRPS34	mitochondrial ribosomal protein S34	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305623	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MRPS34 mRNA	PMID:21346803
1313763	PALMD	palmdelphin	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of PALMD protein	PMID:36641056
1313763	PALMD	palmdelphin	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PALMD mRNA	PMID:30529165
1313763	PALMD	palmdelphin	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PALMD mRNA	PMID:21632981
1313763	PALMD	palmdelphin	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313764	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PALMD mRNA	PMID:39241906
1313763	PALMD	palmdelphin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of PALMD mRNA]	PMID:39241906
1313763	PALMD	palmdelphin	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of PALMD mRNA	PMID:31614463
1313763	PALMD	palmdelphin	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PALMD mRNA	PMID:39298647
1313763	PALMD	palmdelphin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305624	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of PALMD mRNA	PMID:32145629
1313763	PALMD	palmdelphin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of PALMD mRNA	PMID:20660070
1313763	PALMD	palmdelphin	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D002635	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PALMD mRNA	PMID:34589561
1313763	PALMD	palmdelphin	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of PALMD mRNA	PMID:20660070
1313763	PALMD	palmdelphin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of PALMD mRNA	PMID:22017230
1313763	PALMD	palmdelphin	gene	CHEBI:174733	Licochalcone B	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of PALMD mRNA	PMID:33647349
1313763	PALMD	palmdelphin	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of PALMD mRNA	PMID:31256213
1313763	PALMD	palmdelphin	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D006000	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PALMD mRNA	PMID:34589561
1313763	PALMD	palmdelphin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PALMD mRNA	PMID:31163220
1313763	PALMD	palmdelphin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PALMD mRNA	PMID:32235866|PMID:34319233
1313763	PALMD	palmdelphin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA	PMID:39150890
1313763	PALMD	palmdelphin	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PALMD mRNA	PMID:28818685
1313763	PALMD	palmdelphin	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PALMD mRNA	PMID:36331819
1313763	PALMD	palmdelphin	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of PALMD mRNA	PMID:24376830
1313763	PALMD	palmdelphin	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PALMD mRNA	PMID:19549813
1313763	PALMD	palmdelphin	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PALMD mRNA	PMID:22100608|PMID:27153756
1313763	PALMD	palmdelphin	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PALMD gene	PMID:27153756
1313763	PALMD	palmdelphin	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305624	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of PALMD mRNA	PMID:30779732
1313763	PALMD	palmdelphin	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PALMD mRNA	PMID:25629700
1313763	PALMD	palmdelphin	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D006002	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PALMD mRNA	PMID:34589561
1313763	PALMD	palmdelphin	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PALMD mRNA	PMID:32525701
1313763	PALMD	palmdelphin	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of PALMD mRNA	PMID:38460933
1313763	PALMD	palmdelphin	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of PALMD mRNA	PMID:38460933
1313763	PALMD	palmdelphin	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PALMD protein	PMID:35688186
1313763	PALMD	palmdelphin	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PALMD mRNA	PMID:27392435
1313763	PALMD	palmdelphin	gene	CHEBI:28088	genistein	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein affects the expression of PALMD mRNA	PMID:26865667
1313763	PALMD	palmdelphin	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PALMD mRNA	PMID:24768652|PMID:25583101
1313763	PALMD	palmdelphin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313764	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PALMD mRNA	PMID:21570461
1313763	PALMD	palmdelphin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305624	E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PALMD mRNA	PMID:21215274|PMID:21724226
1313763	PALMD	palmdelphin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PALMD mRNA	PMID:19770486|PMID:21889950
1313763	PALMD	palmdelphin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305624	E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PALMD mRNA	PMID:26232522
1313763	PALMD	palmdelphin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PALMD mRNA	PMID:25975270
1313763	PALMD	palmdelphin	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of PALMD mRNA	PMID:39709020
1313763	PALMD	palmdelphin	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PALMD mRNA	PMID:30851411
1313763	PALMD	palmdelphin	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PALMD mRNA	PMID:32763439
1313763	PALMD	palmdelphin	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PALMD mRNA	PMID:20971185
1313763	PALMD	palmdelphin	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PALMD mRNA	PMID:29803840
1313763	PALMD	palmdelphin	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of PALMD protein	PMID:35688186
1313763	PALMD	palmdelphin	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D003840	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PALMD mRNA	PMID:34589561
1313763	PALMD	palmdelphin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PALMD mRNA	PMID:23876855|PMID:39719251
1313763	PALMD	palmdelphin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PALMD mRNA	PMID:22178795
1313763	PALMD	palmdelphin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PALMD mRNA	PMID:19770486
1313763	PALMD	palmdelphin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313764	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PALMD mRNA	PMID:21569818|PMID:22610609
1313763	PALMD	palmdelphin	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PALMD mRNA	PMID:27858113
1313763	PALMD	palmdelphin	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PALMD mRNA	PMID:20971185
1313763	PALMD	palmdelphin	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PALMD mRNA; Silicon Dioxide results in decreased expression of PALMD mRNA	PMID:25351596|PMID:25895662
1313763	PALMD	palmdelphin	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of PALMD mRNA	PMID:35984750
1313763	PALMD	palmdelphin	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305624	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of PALMD mRNA	PMID:24915197
1313763	PALMD	palmdelphin	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305624	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PALMD mRNA	PMID:24136188
1313763	PALMD	palmdelphin	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305624	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of PALMD mRNA	PMID:25729387
1313763	PALMD	palmdelphin	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305624	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of PALMD mRNA	PMID:24136188
1313763	PALMD	palmdelphin	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1313764	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of PALMD mRNA	PMID:17656681
1313763	PALMD	palmdelphin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1305624	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PALMD mRNA	PMID:25380136
1313763	PALMD	palmdelphin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PALMD mRNA	PMID:18648102
1313763	PALMD	palmdelphin	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313764	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PALMD mRNA	PMID:18301758|PMID:23811191
1313763	PALMD	palmdelphin	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PALMD mRNA	PMID:19710929
1313763	PALMD	palmdelphin	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PALMD mRNA; bisphenol A affects the expression of PALMD protein	PMID:30903817|PMID:34186270
1313763	PALMD	palmdelphin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305624	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PALMD mRNA	PMID:25181051
1313763	PALMD	palmdelphin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PALMD mRNA	PMID:33221593
1313763	PALMD	palmdelphin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305624	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of PALMD mRNA	PMID:32145629
1313763	PALMD	palmdelphin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313764	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of PALMD mRNA	PMID:32156529
1313763	PALMD	palmdelphin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PALMD mRNA	PMID:39298647
1313763	PALMD	palmdelphin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of PALMD protein	PMID:34186270
1313763	PALMD	palmdelphin	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313764	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PALMD mRNA	PMID:26377693
1313763	PALMD	palmdelphin	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PALMD mRNA	PMID:27858113
1313763	PALMD	palmdelphin	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PALMD protein	PMID:34186270
1313763	PALMD	palmdelphin	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PALMD protein	PMID:34186270
1313763	PALMD	palmdelphin	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1305624	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of PALMD mRNA	PMID:21241498
1313763	PALMD	palmdelphin	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA	PMID:39150890
1313763	PALMD	palmdelphin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PALMD mRNA	PMID:21266533
1313763	PALMD	palmdelphin	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA	PMID:39150890
1313763	PALMD	palmdelphin	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA	PMID:39150890
1313763	PALMD	palmdelphin	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PALMD mRNA	PMID:28628672
1313763	PALMD	palmdelphin	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PALMD mRNA	PMID:12771043|PMID:17942915
1313763	PALMD	palmdelphin	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of PALMD mRNA]	PMID:17942915
1313763	PALMD	palmdelphin	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of PALMD mRNA]	PMID:39241906
1313763	PALMD	palmdelphin	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305624	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of PALMD mRNA	PMID:30589522
1313763	PALMD	palmdelphin	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305624	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PALMD mRNA	PMID:35163327
1313763	PALMD	palmdelphin	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313764	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of PALMD mRNA	PMID:26377693
1313763	PALMD	palmdelphin	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA	PMID:39150890
1313763	PALMD	palmdelphin	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305624	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PALMD mRNA	PMID:35163327
1313763	PALMD	palmdelphin	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PALMD mRNA	PMID:19320972
1313763	PALMD	palmdelphin	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305624	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PALMD mRNA	PMID:24386269
1313763	PALMD	palmdelphin	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	ISO	RGD:1305624	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of PALMD mRNA	PMID:25380136
1313763	PALMD	palmdelphin	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D005999	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of PALMD mRNA	PMID:34589561
1313763	PALMD	palmdelphin	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313764	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of PALMD mRNA	PMID:28962523
1313763	PALMD	palmdelphin	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313764	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of PALMD mRNA	PMID:18353800
1313763	PALMD	palmdelphin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313764	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PALMD mRNA	PMID:40194260
1313763	PALMD	palmdelphin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PALMD mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PALMD mRNA	PMID:36331819
1313763	PALMD	palmdelphin	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of PALMD mRNA	PMID:29154799
1313763	PALMD	palmdelphin	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PALMD gene	PMID:29154799
1313763	PALMD	palmdelphin	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305624	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in increased expression of PALMD mRNA	PMID:38685447|PMID:41580965
1313763	PALMD	palmdelphin	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PALMD mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1313763	PALMD	palmdelphin	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of PALMD mRNA	PMID:19770486
1313763	PALMD	palmdelphin	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PALMD mRNA	PMID:28628672
1313763	PALMD	palmdelphin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PALMD mRNA	PMID:28973697
1313763	PALMD	palmdelphin	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305624	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of PALMD mRNA	PMID:24136188
1313763	PALMD	palmdelphin	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PALMD mRNA	PMID:38832940
1313763	PALMD	palmdelphin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PALMD mRNA	PMID:17562736
1313763	PALMD	palmdelphin	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PALMD mRNA	PMID:21420995
1313763	PALMD	palmdelphin	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of PALMD mRNA	PMID:38460933
1313763	PALMD	palmdelphin	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PALMD mRNA	PMID:32525701
1313763	PALMD	palmdelphin	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of PALMD mRNA	PMID:31838189
1313763	PALMD	palmdelphin	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PALMD mRNA	PMID:26865667
1313763	PALMD	palmdelphin	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of PALMD mRNA	PMID:18936297
1313763	PALMD	palmdelphin	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PALMD mRNA	PMID:28628672
1313763	PALMD	palmdelphin	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305624	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PALMD mRNA	PMID:30307764
1313763	PALMD	palmdelphin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PALMD mRNA; Nanotubes, Carbon results in decreased expression of PALMD mRNA	PMID:25554681|PMID:25620056
1313763	PALMD	palmdelphin	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305624	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of PALMD mRNA	PMID:22504374
1313763	PALMD	palmdelphin	gene	CHEBI:50867	ciprofibrate	increases expression	ISO	RGD:1313764	E	RGD:6480464	20120412	CTD	MESH:C019304	ciprofibrate results in increased expression of PALMD mRNA	PMID:12771043
1313763	PALMD	palmdelphin	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305624	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of PALMD mRNA	PMID:24136188
1313763	PALMD	palmdelphin	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1313764	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of PALMD mRNA	PMID:26377693
1313763	PALMD	palmdelphin	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PALMD mRNA	PMID:27858113
1313763	PALMD	palmdelphin	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PALMD mRNA	PMID:27858113
1313763	PALMD	palmdelphin	gene	CHEBI:63598	levofloxacin	decreases expression	ISO	RGD:1305624	E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of PALMD mRNA	PMID:24136188
1313763	PALMD	palmdelphin	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305624	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of PALMD mRNA	PMID:25729387
1313763	PALMD	palmdelphin	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PALMD mRNA	PMID:23650126
1313763	PALMD	palmdelphin	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PALMD mRNA	PMID:20147733
1313763	PALMD	palmdelphin	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PALMD mRNA	PMID:36907384
1313763	PALMD	palmdelphin	gene	CHEBI:6651	malathion	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in decreased expression of PALMD mRNA	PMID:37047231
1313763	PALMD	palmdelphin	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PALMD mRNA	PMID:31758290
1313763	PALMD	palmdelphin	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PALMD protein	PMID:34186270
1313763	PALMD	palmdelphin	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305624	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PALMD mRNA	PMID:24136188
1313763	PALMD	palmdelphin	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PALMD protein	PMID:31285264
1313763	PALMD	palmdelphin	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PALMD mRNA	PMID:30851411
1313763	PALMD	palmdelphin	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PALMD mRNA	PMID:39150890
1313763	PALMD	palmdelphin	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PALMD gene]	PMID:28238834
1313763	PALMD	palmdelphin	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D010634	Phenobarbital results in decreased expression of PALMD protein	PMID:35881160
1313763	PALMD	palmdelphin	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313764	E	RGD:6480464	20230502	CTD	MESH:D010634	Phenobarbital results in decreased expression of PALMD protein	PMID:35881160
1313763	PALMD	palmdelphin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313764	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PALMD mRNA	PMID:38648751
1313763	PALMD	palmdelphin	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PALMD mRNA	PMID:32525701
1313763	PALMD	palmdelphin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305624	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PALMD mRNA	PMID:22504374|PMID:24780913
1313763	PALMD	palmdelphin	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313764	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of PALMD mRNA]	PMID:39241906
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TAF11 mRNA	PMID:20044591
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of TAF11 mRNA	PMID:20655997
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TAF11 mRNA	PMID:19549813
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313767	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TAF11 mRNA	PMID:22206623
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313767	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF11 mRNA	PMID:40504410
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TAF11 mRNA	PMID:23557933
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313767	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TAF11 mRNA	PMID:21570461
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TAF11 mRNA	PMID:30851411
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TAF11 mRNA	PMID:32763439
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313767	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF11 mRNA	PMID:40504410
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313767	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF11 mRNA	PMID:22228805
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:3016	Benoxacor	increases expression	ISO	RGD:1313767	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in increased expression of TAF11 mRNA	PMID:34850242
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313767	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TAF11 mRNA	PMID:29264374
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313767	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TAF11 mRNA	PMID:19710929
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF11 mRNA	PMID:29275510
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313767	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF11 mRNA	PMID:29161229
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305626	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TAF11 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF11 mRNA	PMID:28628672
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313767	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TAF11 mRNA	PMID:37019170
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF11 mRNA	PMID:28628672
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of TAF11 mRNA	PMID:17312168
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313767	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TAF11 mRNA	PMID:17292431
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TAF11 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TAF11 mRNA	PMID:25562108
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF11 mRNA	PMID:28628672
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TAF11 mRNA	PMID:21420995
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313767	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF11 mRNA	PMID:40504410
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of TAF11 mRNA	PMID:28628672
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313767	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TAF11 mRNA	PMID:22206623
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313767	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TAF11 mRNA	PMID:22206623
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TAF11 mRNA	PMID:30851411
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TAF11 gene]	PMID:28238834
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:9130	sevoflurane	decreases methylation	ISO	RGD:1313767	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in decreased methylation of TAF11 mRNA	PMID:35249202
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305626	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of TAF11 mRNA	PMID:19281266
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305626	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TAF11 mRNA	PMID:19281266
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305626	E	RGD:6480464	20140805	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TAF11 mRNA	PMID:21346803
1313766	TAF11	TATA-box binding protein associated factor 11	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305626	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TAF11 mRNA	PMID:23034163
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CTDSP1 mRNA	PMID:33045310
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305629	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CTDSP1 mRNA]	PMID:31150632
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTDSP1 protein]	PMID:38195004
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CTDSP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CTDSP1 mRNA	PMID:32699268
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CTDSP1 mRNA	PMID:30529165
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CTDSP1 mRNA	PMID:26079696
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313771	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CTDSP1 mRNA	PMID:30319688
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CTDSP1 mRNA	PMID:37042841
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CTDSP1 mRNA	PMID:26079696
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CTDSP1 mRNA	PMID:34319233
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305629	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CTDSP1 mRNA	PMID:26577399
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305629	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CTDSP1 mRNA	PMID:33387578
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305629	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CTDSP1 mRNA	PMID:22061828
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CTDSP1 mRNA	PMID:36331819
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSP1 mRNA	PMID:39836092
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTDSP1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTDSP1 protein	PMID:38195004
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CTDSP1 mRNA	PMID:19549813
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CTDSP1 mRNA	PMID:23649840
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of CTDSP1 mRNA	PMID:19376150
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CTDSP1 mRNA	PMID:27153756
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CTDSP1 mRNA	PMID:23649840
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in decreased expression of CTDSP1 mRNA	PMID:28652203
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CTDSP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CTDSP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of CTDSP1 mRNA	PMID:32699268
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305629	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CTDSP1 mRNA	PMID:31150632
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CTDSP1 mRNA	PMID:31919559
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305629	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CTDSP1 mRNA]	PMID:31150632
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CTDSP1 mRNA	PMID:22206623
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTDSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CTDSP1 mRNA	PMID:39836092|PMID:40512198
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CTDSP1 mRNA	PMID:26272509
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA	PMID:27188386
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in decreased expression of CTDSP1 mRNA	PMID:37386098
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	CTDSP1 protein results in decreased susceptibility to Cisplatin	PMID:16734730
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313771	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CTDSP1 mRNA	PMID:21570461
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305629	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CTDSP1 mRNA	PMID:21215274
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CTDSP1 mRNA	PMID:28001369
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CTDSP1 mRNA	PMID:33212167
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of CTDSP1 mRNA	PMID:26272509
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA	PMID:27188386
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CTDSP1 mRNA	PMID:32763439
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305629	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CTDSP1 mRNA	PMID:28959563
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CTDSP1 mRNA	PMID:21281968|PMID:38568856
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CTDSP1 mRNA	PMID:39719251
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTDSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CTDSP1 mRNA	PMID:39836092|PMID:40512198
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CTDSP1 promoter	PMID:27901495
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of CTDSP1 protein	PMID:37955338
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of CTDSP1 mRNA	PMID:26014281
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CTDSP1 mRNA	PMID:26705709
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of CTDSP1 mRNA	PMID:35984750
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305629	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CTDSP1 mRNA	PMID:34492290
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305629	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CTDSP1 mRNA	PMID:25181051
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305629	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CTDSP1 mRNA	PMID:34947998
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313771	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CTDSP1 mRNA	PMID:32156529|PMID:33221593
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313771	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CTDSP1 gene	PMID:31683443
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CTDSP1 mRNA	PMID:39298647
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313771	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CTDSP1 mRNA	PMID:37019170
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:1305629	E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of CTDSP1 mRNA	PMID:17602206
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of CTDSP1 gene	PMID:22964155
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313771	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of CTDSP1 mRNA	PMID:34813904
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1313771	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of CTDSP1 mRNA	PMID:34813904
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CTDSP1 mRNA	PMID:37042841
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSP1 mRNA	PMID:39836092
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CTDSP1 mRNA	PMID:38174414
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305629	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of CTDSP1 promoter	PMID:22457795
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTDSP1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CTDSP1 protein	PMID:38195004
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CTDSP1 mRNA	PMID:19376846
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CTDSP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CTDSP1 mRNA	PMID:32699268
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CTDSP1 mRNA	PMID:31533062
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CTDSP1 mRNA	PMID:36331819
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CTDSP1 mRNA	PMID:29154799
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CTDSP1 gene	PMID:29154799
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CTDSP1 mRNA	PMID:25562108
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of CTDSP1 mRNA]	PMID:21233418
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CTDSP1 mRNA	PMID:38832940
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of CTDSP1 mRNA	PMID:22083351
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CTDSP1 mRNA	PMID:28542535
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313771	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CTDSP1 mRNA	PMID:17562736
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CTDSP1 mRNA	PMID:21420995
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305629	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CTDSP1 mRNA	PMID:33387578
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTDSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CTDSP1 mRNA	PMID:39836092|PMID:40512198
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CTDSP1 mRNA	PMID:30529165
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313771	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CTDSP1 mRNA	PMID:35436446
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of CTDSP1 mRNA	PMID:26272509
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA	PMID:27188386
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CTDSP1 mRNA	PMID:26705709
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CTDSP1 mRNA	PMID:35964746
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305629	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of CTDSP1 mRNA	PMID:24136188
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CTDSP1 mRNA	PMID:39836092
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313771	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CTDSP1 mRNA	PMID:22206623
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA	PMID:27188386
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1305629	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of CTDSP1 mRNA	PMID:19162173
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of CTDSP1 mRNA	PMID:39904859
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTDSP1 mRNA	PMID:27188386
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of CTDSP1 mRNA	PMID:26014281
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CTDSP1 mRNA	PMID:38568856
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CTDSP1 mRNA	PMID:28973697
1313770	CTDSP1	CTD small phosphatase 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313771	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CTDSP1 mRNA	PMID:35537566
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ELOVL4 mRNA	PMID:26079696
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ELOVL4 mRNA	PMID:30510588
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313773	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of ELOVL4 mRNA	PMID:19484750
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305630	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ELOVL4 mRNA	PMID:33387578
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ELOVL4 mRNA	PMID:26079696
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of ELOVL4 mRNA	PMID:31256213
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ELOVL4 mRNA	PMID:28818685
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:23414	copper(II) sulfate	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of ELOVL4 mRNA	PMID:19549813
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ELOVL4 mRNA	PMID:25629700
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ELOVL4 mRNA	PMID:32525701
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313773	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELOVL4 mRNA	PMID:40504410
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313773	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of ELOVL4 mRNA	PMID:23625948
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ELOVL4 mRNA	PMID:23152189
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305630	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ELOVL4 mRNA	PMID:33387578
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of ELOVL4 mRNA	PMID:35954277
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of ELOVL4 mRNA	PMID:36209798
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ELOVL4 mRNA	PMID:22714537|PMID:38568856
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313773	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELOVL4 mRNA	PMID:40504410
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ELOVL4 promoter	PMID:27901495
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ELOVL4 mRNA	PMID:27131904
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ELOVL4 mRNA; Silicon Dioxide results in increased expression of ELOVL4 mRNA	PMID:23806026|PMID:25351596|PMID:25895662
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313773	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ELOVL4 gene	PMID:35295148
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313773	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ELOVL4 gene	PMID:35295148
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305630	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ELOVL4 mRNA	PMID:25181051|PMID:41034487
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ELOVL4 mRNA	PMID:32156529|PMID:34585602
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ELOVL4 gene	PMID:31601247
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305630	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ELOVL4 mRNA	PMID:34947998
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ELOVL4 mRNA	PMID:26377693
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313773	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ELOVL4 mRNA	PMID:37019170
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of ELOVL4 mRNA	PMID:37047231
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305630	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ELOVL4 mRNA	PMID:35163327
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ELOVL4 mRNA	PMID:38382870
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ELOVL4 mRNA	PMID:37738295
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305630	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ELOVL4 mRNA	PMID:35163327
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ELOVL4 mRNA	PMID:40194260
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ELOVL4 mRNA	PMID:31533062
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ELOVL4 mRNA	PMID:25979313
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ELOVL4 mRNA	PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of ELOVL4 mRNA	PMID:24935251|PMID:26272509
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ELOVL4 mRNA	PMID:27188386
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305630	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ELOVL4 mRNA	PMID:33387578
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ELOVL4 mRNA	PMID:32525701
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313773	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELOVL4 mRNA	PMID:40504410
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305630	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ELOVL4 mRNA	PMID:30307764
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of ELOVL4 mRNA	PMID:31629900
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of ELOVL4 mRNA	PMID:20436886
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ELOVL4 mRNA	PMID:31758290
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ELOVL4 mRNA	PMID:22714537
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ELOVL4 mRNA	PMID:27188386
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ELOVL4 gene]	PMID:28238834
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:81980	triticonazole	increases expression	ISO	RGD:1305630	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in increased expression of ELOVL4 mRNA	PMID:36084822
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:8228	pioglitazone	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C060836	Pioglitazone results in increased expression of ELOVL4 mRNA	PMID:30031879
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ELOVL4 mRNA	PMID:26079696
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ELOVL4 mRNA	PMID:32525701
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ELOVL4 mRNA	PMID:27188386
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313773	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ELOVL4 mRNA	PMID:27131904
1313772	ELOVL4	ELOVL fatty acid elongase 4	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ELOVL4 mRNA	PMID:38568856
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305632	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of ASH2L mRNA	PMID:21551480
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313776	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ASH2L mRNA	PMID:33045310
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ASH2L gene	PMID:20938992
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ASH2L mRNA	PMID:36331819
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of ASH2L mRNA; Ethanol results in increased expression of ASH2L protein	PMID:28986285|PMID:35149083
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305632	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ASH2L gene	PMID:27618143
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ASH2L gene	PMID:20938992
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ASH2L mRNA	PMID:37042841
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ASH2L protein	PMID:37730182
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305632	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ASH2L mRNA	PMID:22061828
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ASH2L mRNA	PMID:19549813
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ASH2L protein	PMID:23301498
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ASH2L mRNA	PMID:23649840
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ASH2L mRNA	PMID:21867686
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ASH2L gene	PMID:20938992
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASH2L mRNA	PMID:39836092
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ASH2L mRNA	PMID:27594783
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1305632	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of ASH2L gene	PMID:28505145
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313776	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASH2L mRNA	PMID:21570461
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305632	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ASH2L mRNA	PMID:33387578
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASH2L mRNA	PMID:17942748
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ASH2L protein	PMID:39603559
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ASH2L mRNA	PMID:28001369
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ASH2L mRNA	PMID:29803840
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:29323	methylazoxymethanol	decreases expression	ISO	RGD:1305632	E	RGD:6480464	20141223	CTD	MESH:C030667	methylazoxymethanol results in decreased expression of ASH2L protein	PMID:23932495
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ASH2L mRNA	PMID:38568856
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASH2L mRNA	PMID:39836092
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ASH2L intron	PMID:30157460
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313776	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ASH2L mRNA	PMID:23557971
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305632	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ASH2L mRNA	PMID:23411599
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313776	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ASH2L promoter	PMID:27334623
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of ASH2L protein	PMID:31675489
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305632	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ASH2L mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305632	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ASH2L mRNA	PMID:25181051
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305632	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ASH2L gene	PMID:28505145
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305632	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of ASH2L gene	PMID:28505145
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of ASH2L protein	PMID:31675489
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of ASH2L mRNA	PMID:24752500
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313776	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ASH2L mRNA	PMID:39298647
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313776	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ASH2L mRNA	PMID:37019170
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305632	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ASH2L promoter	PMID:22457795
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:38518	benzophenanthridine	decreases expression	EXP		E	RGD:6480464	20170117	CTD	MESH:D053119	Benzophenanthridines analog results in decreased expression of ASH2L mRNA	PMID:23117580
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313776	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ASH2L protein	PMID:26178269
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ASH2L mRNA	PMID:36331819
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ASH2L mRNA	PMID:25979313
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ASH2L mRNA	PMID:25562108
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:4356	desferrioxamine B	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D003676	Deferoxamine affects the expression of ASH2L mRNA	PMID:23483119
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:4356	desferrioxamine B	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D003676	Deferoxamine results in increased expression of ASH2L mRNA	PMID:23483119
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313776	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ASH2L mRNA	PMID:17562736
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305632	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ASH2L mRNA	PMID:33387578
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASH2L mRNA	PMID:39836092
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of ASH2L mRNA	PMID:24752500
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of ASH2L mRNA	PMID:31675489
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ASH2L mRNA	PMID:22079256
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313776	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASH2L mRNA	PMID:17942748
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305632	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ASH2L mRNA	PMID:24136188
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305632	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ASH2L mRNA	PMID:24136188
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313776	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ASH2L mRNA	PMID:19042947
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305632	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ASH2L mRNA	PMID:30467583
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313776	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ASH2L mRNA	PMID:22206623
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ASH2L mRNA	PMID:22079256
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ASH2L mRNA	PMID:22079256
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305632	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ASH2L mRNA	PMID:21346803
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ASH2L protein	PMID:31675489
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ASH2L protein	PMID:31675489
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305632	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ASH2L mRNA	PMID:21346803
1313775	ASH2L	ASH2 like, histone lysine methyltransferase complex subunit	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305632	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ASH2L mRNA	PMID:21346803
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of RRP1B protein	PMID:39638853
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305633	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of RRP1B mRNA	PMID:25152437
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of RRP1B mRNA	PMID:23724009|PMID:33167477
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of RRP1B protein	PMID:28073184
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of RRP1B mRNA	PMID:19484750
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of RRP1B mRNA	PMID:23019147|PMID:31614463
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313778	E	RGD:6480464	20150609	CTD	MESH:D004958	Estradiol results in increased expression of RRP1B mRNA	PMID:25575267
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of RRP1B mRNA	PMID:38568856
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RRP1B mRNA	PMID:37042841
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313778	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RRP1B mRNA	PMID:23892564
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305633	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of RRP1B mRNA	PMID:26577399
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RRP1B protein	PMID:37730182
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305633	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RRP1B mRNA	PMID:33387578
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313778	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RRP1B mRNA	PMID:28111341
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RRP1B mRNA	PMID:19549813
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RRP1B protein	PMID:23301498
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RRP1B gene	PMID:27153756
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313778	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RRP1B mRNA	PMID:19770486
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of RRP1B mRNA	PMID:23649840
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313778	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RRP1B mRNA	PMID:34911549
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305633	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of RRP1B mRNA	PMID:30779732
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RRP1B mRNA	PMID:25629700
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of RRP1B mRNA	PMID:33512557
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of RRP1B protein	PMID:35688186
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of RRP1B protein	PMID:25505154
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RRP1B mRNA	PMID:23557933
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:27974	estriol	increases expression	ISO	RGD:1313778	E	RGD:6480464	20150609	CTD	MESH:D004964	Estriol results in increased expression of RRP1B mRNA	PMID:25575267
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313778	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RRP1B mRNA	PMID:21570461
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RRP1B mRNA	PMID:21889950
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313778	E	RGD:6480464	20140408	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RRP1B mRNA	PMID:16611356|PMID:23994337
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of RRP1B mRNA	PMID:33512557
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305633	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of RRP1B mRNA	PMID:28959563
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RRP1B mRNA	PMID:29803840
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of RRP1B protein	PMID:35688186
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:29014	cordycepin	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in decreased expression of RRP1B mRNA	PMID:32042022
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RRP1B mRNA	PMID:38568856
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of RRP1B mRNA	PMID:34032870
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [RRP1B protein binds to CAPRIN1 protein]	PMID:33939924
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RRP1B mRNA	PMID:22316170|PMID:26238291
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RRP1B promoter	PMID:27901495
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RRP1B mRNA	PMID:19150397
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305633	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RRP1B mRNA	PMID:30047161
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313778	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RRP1B gene	PMID:35295148
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305633	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RRP1B mRNA	PMID:23411599|PMID:34492290
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of RRP1B mRNA	PMID:23811191
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313778	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RRP1B mRNA	PMID:19710929
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313778	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of RRP1B mRNA	PMID:28472532
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305633	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RRP1B mRNA	PMID:25181051|PMID:30816183
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of RRP1B mRNA	PMID:25912373
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305633	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RRP1B mRNA	PMID:34947998
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313778	E	RGD:6480464	20150609	CTD	MESH:C006780	bisphenol A results in increased expression of RRP1B mRNA	PMID:25575267
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	increases expression	ISO	RGD:1313778	E	RGD:6480464	20150609	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of RRP1B mRNA	PMID:25575267
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1313778	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of RRP1B mRNA	PMID:23994337
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RRP1B intron	PMID:30157460
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RRP1B mRNA	PMID:38685157
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313778	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of RRP1B enhancer	PMID:28392331
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313778	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RRP1B mRNA	PMID:37019170
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313778	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of RRP1B mRNA	PMID:34813904
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313778	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of RRP1B mRNA	PMID:34813904
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305633	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of RRP1B mRNA	PMID:30589522
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313778	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RRP1B mRNA	PMID:28111341
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313778	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of RRP1B mRNA	PMID:28903501
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RRP1B mRNA	PMID:19320972
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of RRP1B mRNA	PMID:28302478
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313778	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of RRP1B mRNA	PMID:19136453
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RRP1B gene	PMID:29154799
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RRP1B mRNA	PMID:23179753
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305633	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RRP1B mRNA	PMID:30047161
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313778	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RRP1B mRNA	PMID:17555576
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313778	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of RRP1B mRNA	PMID:22733784
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313778	E	RGD:6480464	20150609	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RRP1B mRNA	PMID:25575267
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of RRP1B mRNA	PMID:33512557
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313778	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RRP1B mRNA	PMID:17562736
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1313778	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of RRP1B mRNA	PMID:35436446
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313778	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RRP1B mRNA	PMID:17555576
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305633	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RRP1B mRNA	PMID:30047161
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305633	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of RRP1B mRNA	PMID:24793618
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305633	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RRP1B mRNA	PMID:24136188
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313778	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of RRP1B mRNA	PMID:19042947
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RRP1B protein	PMID:32959892
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1305633	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of RRP1B mRNA	PMID:20080153
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of RRP1B intron	PMID:30157460
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305633	E	RGD:6480464	20121113	CTD	MESH:D008701	Methapyrilene results in increased expression of RRP1B mRNA	PMID:22484513
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313778	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of RRP1B mRNA	PMID:22206623
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RRP1B protein	PMID:37664457
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313778	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of RRP1B mRNA	PMID:23994337
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305633	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of RRP1B mRNA	PMID:23914054
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305633	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RRP1B mRNA	PMID:30047161
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RRP1B protein	PMID:37664457
1313777	RRP1B	ribosomal RNA processing 1B	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of RRP1B mRNA	PMID:33512557
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of DDX27 protein	PMID:39638853
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305634	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX27 mRNA]	PMID:31150632
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX27 mRNA	PMID:30529165
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of DDX27 mRNA	PMID:22378314
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313780	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of DDX27 mRNA	PMID:30319688
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313780	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DDX27 mRNA	PMID:30319688
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313780	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DDX27 mRNA	PMID:39241906
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of DDX27 mRNA]	PMID:39241906
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DDX27 mRNA	PMID:19698761
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of DDX27 mRNA	PMID:20823114
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DDX27 mRNA	PMID:37042841
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of DDX27 protein	PMID:39638853
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of DDX27 mRNA	PMID:27106289
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305634	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DDX27 mRNA	PMID:31150632
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313780	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DDX27 mRNA	PMID:27339419|PMID:31919559
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305634	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX27 mRNA]	PMID:31150632
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DDX27 gene	PMID:25304211
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX27 mRNA	PMID:40504410
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of DDX27 protein	PMID:25505154
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DDX27 mRNA	PMID:23557933
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of DDX27 mRNA	PMID:30912803
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313780	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DDX27 mRNA	PMID:21570461
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305634	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of DDX27 mRNA	PMID:19013527
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DDX27 mRNA	PMID:29803840
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313780	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of DDX27 mRNA	PMID:39631538
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of DDX27 protein	PMID:29044176
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX27 mRNA	PMID:40504410
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DDX27 protein	PMID:33278487
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305634	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DDX27 mRNA	PMID:23411599|PMID:34492290
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313780	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of DDX27 mRNA	PMID:28472532
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of DDX27 mRNA	PMID:30903817
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305634	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DDX27 mRNA	PMID:25181051
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of DDX27 protein	PMID:37567409
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DDX27 mRNA	PMID:33221593
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305634	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DDX27 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313780	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DDX27 mRNA	PMID:39298647
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DDX27 mRNA	PMID:37019170
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DDX27 mRNA	PMID:21266533
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305634	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of DDX27 mRNA	PMID:32680482
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of DDX27 mRNA]	PMID:39241906
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in decreased expression of DDX27 mRNA]	PMID:19030233
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313780	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of DDX27 mRNA	PMID:28903501
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of DDX27 mRNA	PMID:36331819
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305634	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of DDX27 mRNA	PMID:25993096
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of DDX27 mRNA	PMID:17183730
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DDX27 mRNA	PMID:20106945|PMID:25562108
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313780	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of DDX27 mRNA	PMID:18502557
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:44616	afimoxifene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of DDX27 mRNA	PMID:19698761
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313780	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DDX27 mRNA	PMID:17562736
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of DDX27 gene	PMID:25304211
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DDX27 mRNA	PMID:40504410
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305634	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of DDX27 mRNA	PMID:29097150
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313780	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DDX27 mRNA	PMID:17942748
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of DDX27 mRNA	PMID:20823114
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DDX27 mRNA	PMID:35964746
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305634	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DDX27 mRNA	PMID:24136188
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:5613	haloperidol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in increased expression of DDX27 protein	PMID:34122009
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of DDX27 mRNA	PMID:17183730
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DDX27 protein	PMID:32959892
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DDX27 mRNA	PMID:23650126
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of DDX27 mRNA	PMID:20823114
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of DDX27 mRNA	PMID:28444820
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DDX27 protein	PMID:37664457
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:7599	Nivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of DDX27 protein	PMID:39638853
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of DDX27 protein	PMID:39638853
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313780	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of DDX27 mRNA]	PMID:39241906
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313780	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of DDX27 mRNA	PMID:40826991
1313779	DDX27	DEAD-box helicase 27	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DDX27 protein	PMID:37664457
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1313782	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of IL1F10 mRNA	PMID:22968694
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Triclosan inhibits the reaction [Lipopolysaccharides results in increased expression of IL1F10 mRNA]	PMID:20507366
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:164200	triclosan	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014260	Triclosan inhibits the reaction [Lipopolysaccharides results in increased expression of IL1F10 mRNA]	PMID:20507366
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305635	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of IL1F10 mRNA	PMID:33387578
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of IL1F10 gene	PMID:33872906
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of IL1F10 mRNA	PMID:31256213
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of IL1F10 gene	PMID:33872906
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:193350	ferulic acid	multiple interactions	ISO	RGD:1313782	E	RGD:6480464	20241119	CTD	MESH:C004999	ferulic acid inhibits the reaction [Imiquimod results in decreased expression of IL1F10 mRNA]	PMID:31054998
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of IL1F10 gene	PMID:27153756
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D001151	Arsenic affects the expression of IL1F10 protein	PMID:24675094
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of IL1F10 mRNA	PMID:30851411
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1305635	E	RGD:6480464	20170110	CTD	MESH:D004317	Doxorubicin results in increased expression of IL1F10 mRNA	PMID:27181935
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1305635	E	RGD:6480464	20170110	CTD	MESH:D004317	Doxorubicin inhibits the reaction [Fungal Polysaccharides results in increased expression of IL1F10 mRNA]; Fungal Polysaccharides inhibits the reaction [Doxorubicin results in increased expression of IL1F10 mRNA]	PMID:27181935
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of IL1F10 5' UTR	PMID:27901495
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IL1F10 promoter	PMID:27901495
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:3020	benzalkonium chloride	multiple interactions	ISO	RGD:1313782	E	RGD:6480464	20190219	CTD	MESH:D001548	[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of IL1F10 mRNA	PMID:30171875
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of IL1F10 mRNA	PMID:25895662
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IL1F10 protein]	PMID:26598702
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of IL1F10 gene	PMID:31601247
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313782	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of IL1F10 mRNA	PMID:29264374
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313782	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of IL1F10 mRNA	PMID:35295148
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313782	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of IL1F10 mRNA	PMID:18648102
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305635	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IL1F10 mRNA	PMID:25181051
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313782	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of IL1F10 mRNA	PMID:32156529
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of IL1F10 gene	PMID:31601247
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305635	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of IL1F10 promoter	PMID:22457795
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:36704	imiquimod	decreases expression	ISO	RGD:1313782	E	RGD:6480464	20190910	CTD	MESH:C056493	Imiquimod results in decreased expression of IL1F10 mRNA	PMID:31054998
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:36704	imiquimod	multiple interactions	ISO	RGD:1313782	E	RGD:6480464	20190910	CTD	MESH:C056493	ferulic acid inhibits the reaction [Imiquimod results in decreased expression of IL1F10 mRNA]	PMID:31054998
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of IL1F10 protein	PMID:24675094
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to IL1F10 protein]	PMID:26598702
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:6078	ivermectin	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of IL1F10 protein	PMID:32959892
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of IL1F10 mRNA	PMID:30851411
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IL1F10 gene]	PMID:28238834
1313781	IL1F10	interleukin 1 family member 10	gene	CHEBI:81980	triticonazole	increases expression	ISO	RGD:1305635	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in increased expression of IL1F10 mRNA	PMID:36084822
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ZNF410 mRNA	PMID:38218311
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552255	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ZFP410 mRNA	PMID:20188158
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZNF410 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZNF410 mRNA	PMID:32699268
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF410 mRNA	PMID:37042841
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ZNF410 mRNA	PMID:21179406
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:17447	geraniol	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of ZNF410 mRNA	PMID:27683099
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZNF410 protein	PMID:37730182
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZNF410 mRNA	PMID:28818685
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552255	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP410 mRNA	PMID:36331819
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZNF410 mRNA	PMID:35301059
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZNF410 mRNA	PMID:23649840
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZNF410 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZNF410 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ZNF410 mRNA	PMID:32699268
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ZNF410 mRNA	PMID:18593933
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552255	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ZFP410 mRNA	PMID:31919559
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552255	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZFP410 mRNA	PMID:25629700
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552255	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZFP410 mRNA	PMID:22206623
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ZNF410 mRNA	PMID:23557933
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ZNF410 mRNA	PMID:27594783
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552255	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP410 mRNA	PMID:21570461
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305636	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP410 mRNA	PMID:33387578
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552255	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZFP410 mRNA	PMID:17942748
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of ZNF410 mRNA	PMID:39709020
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZNF410 mRNA	PMID:32763439
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF410 mRNA	PMID:28595984
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF410 mRNA	PMID:39719251
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552255	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZFP410 mRNA	PMID:22228805
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ZNF410 mRNA	PMID:18593933
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZNF410 mRNA	PMID:19150397
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1552255	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ZFP410 mRNA	PMID:35676786
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552255	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP410 gene	PMID:35295148
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305636	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ZFP410 mRNA	PMID:34492290
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305636	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP410 mRNA; bisphenol A results in increased expression of ZNF410 mRNA	PMID:25181051|PMID:34947998
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552255	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP410 mRNA	PMID:33221593
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305636	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZFP410 gene	PMID:28505145
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ZNF410 mRNA	PMID:25979313
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1552255	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ZFP410 mRNA	PMID:38685157
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF410 mRNA	PMID:28628672
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552255	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ZFP410 mRNA	PMID:21266533
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF410 mRNA	PMID:28628672
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305636	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZFP410 mRNA	PMID:33453195
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZNF410 mRNA	PMID:35301059
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZNF410 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZNF410 mRNA	PMID:32699268
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ZNF410 mRNA	PMID:31533062
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552255	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP410 mRNA	PMID:36331819
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF410 mRNA	PMID:20106945|PMID:25562108
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF410 mRNA	PMID:28628672
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of ZNF410 mRNA	PMID:24449571
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552255	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ZFP410 mRNA	PMID:35436446
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305636	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of ZFP410 mRNA; Ethinyl Estradiol results in decreased expression of ZNF410 mRNA	PMID:15953391|PMID:17108234
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552255	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZFP410 mRNA	PMID:17942748
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF410 mRNA	PMID:28628672
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1552255	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ZFP410 mRNA	PMID:35676786
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1552255	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of ZFP410 mRNA	PMID:40234311
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552255	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFP410 mRNA	PMID:22206623
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552255	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZFP410 mRNA	PMID:22206623
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF410 protein	PMID:31285264
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ZNF410 mRNA	PMID:19159669
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1552255	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of ZFP410 mRNA	PMID:21195148
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1552255	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of ZFP410 mRNA	PMID:21195148
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305636	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZFP410 mRNA	PMID:24780913
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1552255	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of ZFP410 mRNA	PMID:21195148
1313783	ZNF410	zinc finger protein 410	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305636	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of ZFP410 gene	PMID:31079544
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of STN1 mRNA	PMID:23724009
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of STN1 mRNA	PMID:26079696
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of STN1 mRNA	PMID:22378314
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of STN1 mRNA	PMID:21632981
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of STN1 mRNA	PMID:22574217
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of STN1 mRNA	PMID:21179406
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of STN1 mRNA	PMID:36139627
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305637	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of STN1 mRNA	PMID:33387578
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305637	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of STN1 protein	PMID:34915118
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of STN1 gene	PMID:27153756
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of STN1 mRNA	PMID:23649840
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550272	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of STN1 mRNA	PMID:34911549
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305637	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of STN1 mRNA	PMID:30779732
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305637	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of STN1 mRNA	PMID:31150632
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D001151	Arsenic results in decreased expression of STN1 mRNA	PMID:25460668
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1550272	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of STN1 mRNA	PMID:28960355
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of STN1 mRNA	PMID:23557933
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of STN1 mRNA	PMID:19921347
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D002945	Cisplatin results in increased expression of STN1 mRNA	PMID:27392435
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20171114	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of STN1 mRNA	PMID:27392435
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550272	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STN1 mRNA	PMID:21570461
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of STN1 mRNA	PMID:28001369
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of STN1 mRNA	PMID:33212167
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of STN1 mRNA	PMID:32763439
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of STN1 mRNA	PMID:29803840
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of STN1 mRNA	PMID:38568856
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of STN1 promoter	PMID:27901495
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550272	E	RGD:6480464	20170516	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of STN1 mRNA]	PMID:22228805
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305637	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of STN1 mRNA	PMID:34492290
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of STN1 mRNA	PMID:19710929
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305637	E	RGD:6480464	20170516	CTD	MESH:C006780	bisphenol A affects the expression of STN1 mRNA	PMID:25181051
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1550272	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of STN1 promoter	PMID:27334623
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305637	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of STN1 mRNA	PMID:30816183|PMID:34947998
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550272	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of STN1 mRNA	PMID:39298647
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of STN1 gene	PMID:31601247
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STN1 mRNA	PMID:28628672
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550272	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of STN1 mRNA	PMID:37019170
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550272	E	RGD:6480464	20170516	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of STN1 mRNA	PMID:21266533
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STN1 mRNA	PMID:28628672
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of STN1 mRNA	PMID:38568856
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of STN1 mRNA	PMID:19320972|PMID:19376846
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:37825	p-toluidine	increases expression	ISO	RGD:1305637	E	RGD:6480464	20171114	CTD	MESH:C029370	4-toluidine results in increased expression of STN1 mRNA	PMID:27638505
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STN1 mRNA	PMID:25979313
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of STN1 mRNA	PMID:26272509
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of STN1 gene	PMID:29154799
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STN1 mRNA	PMID:27188386
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of STN1 mRNA	PMID:25562108
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STN1 mRNA	PMID:28628672
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of STN1 mRNA	PMID:24935251
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D001151	Arsenic results in decreased expression of STN1 mRNA	PMID:25460668
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305637	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of STN1 mRNA	PMID:29391264
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of STN1 mRNA	PMID:28628672
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305637	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of STN1 mRNA	PMID:30307764
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of STN1 mRNA	PMID:24810058
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of STN1 mRNA	PMID:31758290
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550272	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of STN1 mRNA	PMID:22206623
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of STN1 mRNA	PMID:22714537
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of STN1 mRNA	PMID:36139627
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STN1 mRNA	PMID:27188386
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to STN1 gene]	PMID:28238834
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of STN1 mRNA	PMID:39904859
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305637	E	RGD:6480464	20170516	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of STN1 mRNA	PMID:23914054
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1550272	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of STN1 mRNA	PMID:40826991
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STN1 mRNA	PMID:27188386
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of STN1 mRNA	PMID:38568856
1313785	STN1	STN1 subunit of CST complex	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of STN1 mRNA	PMID:29301935
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552256	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ADPRHL1 mRNA	PMID:33045310
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ADPRHL1 mRNA	PMID:30510588
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ADPRHL1 mRNA	PMID:31614463
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305641	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ADPRHL1 mRNA	PMID:33387578
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased expression of ADPRHL1 mRNA	PMID:26717081
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:17578	toluene	increases methylation	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased methylation of ADPRHL1 gene	PMID:26717081
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ADPRHL1 gene	PMID:27153756
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ADPRHL1 mRNA	PMID:35430440
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552256	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ADPRHL1 mRNA]	PMID:22206623
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ADPRHL1 mRNA	PMID:27392435
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552256	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ADPRHL1 mRNA	PMID:17942748
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ADPRHL1 mRNA	PMID:33212167
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ADPRHL1 mRNA	PMID:32763439
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADPRHL1 mRNA	PMID:29803840
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADPRHL1 promoter	PMID:27901495
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552256	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADPRHL1 mRNA	PMID:22228805
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ADPRHL1 mRNA]	PMID:32406909
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552256	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ADPRHL1 mRNA	PMID:23557971
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552256	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ADPRHL1 mRNA	PMID:20813756|PMID:23811191
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1552256	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of ADPRHL1 mRNA	PMID:20813756
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ADPRHL1 mRNA	PMID:38479592
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305641	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADPRHL1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of ADPRHL1 protein	PMID:37567409
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305641	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of ADPRHL1 mRNA	PMID:41034487
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305641	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ADPRHL1 gene	PMID:28505145
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:34283	oxybenzone	affects expression	ISO	RGD:1305641	E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone affects the expression of ADPRHL1 mRNA	PMID:30316929
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of ADPRHL1 gene	PMID:31601247
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552256	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ADPRHL1 exon	PMID:28392331
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305641	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ADPRHL1 mRNA	PMID:32680482
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADPRHL1 mRNA	PMID:37042841
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305641	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADPRHL1 mRNA	PMID:35163327
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305641	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ADPRHL1 promoter	PMID:22457795
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305641	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADPRHL1 mRNA	PMID:35163327
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ADPRHL1 mRNA	PMID:31533062
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ADPRHL1 gene	PMID:29154799
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552256	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ADPRHL1 mRNA	PMID:17555576
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ADPRHL1 mRNA	PMID:38832940
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552256	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ADPRHL1 mRNA	PMID:17562736
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:4798	entacapone	affects binding	ISO	RGD:1305641	E	RGD:6480464	20170303	CTD	MESH:C071192	entacapone binds to ADPRHL1 protein	PMID:19783845
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552256	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ADPRHL1 mRNA	PMID:35436446
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552256	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ADPRHL1 mRNA	PMID:17555576
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552256	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ADPRHL1 mRNA	PMID:17942748
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:63630	tolcapone	affects binding	ISO	RGD:1305641	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to ADPRHL1 protein	PMID:19783845
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ADPRHL1 mRNA	PMID:31758290
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552256	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADPRHL1 mRNA	PMID:22206623
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552256	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ADPRHL1 mRNA]	PMID:22206623
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305641	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ADPRHL1 mRNA	PMID:21346803
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:8093	phenylephrine	increases expression	ISO	RGD:1305641	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in increased expression of ADPRHL1 mRNA	PMID:18158353
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305641	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ADPRHL1 mRNA	PMID:24780913
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:9466	Testosterone propionate	decreases expression	ISO	RGD:1552256	E	RGD:6480464	20141111	CTD	MESH:D043343	Testosterone Propionate results in decreased expression of ADPRHL1 mRNA	PMID:15601916
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ADPRHL1 mRNA	PMID:38568856
1313790	ADPRHL1	ADP-ribosylhydrolase like 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305641	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ADPRHL1 mRNA	PMID:21346803
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ORMDL2 mRNA	PMID:35967413
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313792	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ORMDL2 mRNA	PMID:33045310
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313792	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ORMDL2 mRNA	PMID:37995155
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ORMDL2 mRNA	PMID:33167477
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ORMDL2 mRNA	PMID:21632981
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313792	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ORMDL2 mRNA	PMID:39241906
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313792	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ORMDL2 mRNA	PMID:39298647
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ORMDL2 mRNA	PMID:37042841
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ORMDL2 mRNA	PMID:28818685
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313792	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ORMDL2 mRNA	PMID:36331819
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1313792	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in increased expression of ORMDL2 mRNA	PMID:29279043
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of ORMDL2 mRNA	PMID:24376830
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:23414	copper(II) sulfate	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of ORMDL2 mRNA	PMID:19549813
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ORMDL2 protein	PMID:20106945
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ORMDL2 mRNA	PMID:21632981
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ORMDL2 mRNA	PMID:35430440
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313792	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ORMDL2 mRNA	PMID:25629700
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313792	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ORMDL2 mRNA	PMID:22206623
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ORMDL2 mRNA	PMID:39836092
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ORMDL2 mRNA	PMID:26272509
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ORMDL2 mRNA	PMID:27188386
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1313792	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ORMDL2 protein	PMID:25505154
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ORMDL2 mRNA	PMID:27392435
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ORMDL2 mRNA	PMID:23195993
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ORMDL2 mRNA	PMID:20106945|PMID:21632981
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of ORMDL2 mRNA	PMID:33512557
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ORMDL2 mRNA	PMID:33212167
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ORMDL2 mRNA	PMID:30851411
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305642	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ORMDL2 mRNA	PMID:28959563
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ORMDL2 mRNA	PMID:29803840
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ORMDL2 mRNA	PMID:20044591
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ORMDL2 mRNA	PMID:38568856
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ORMDL2 mRNA	PMID:39836092
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ORMDL2 mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313792	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ORMDL2 mRNA	PMID:21715664
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305642	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ORMDL2 mRNA	PMID:34492290
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313792	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ORMDL2 mRNA	PMID:18445702
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313792	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of ORMDL2 mRNA	PMID:28329830
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ORMDL2 protein	PMID:33376534
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305642	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ORMDL2 mRNA	PMID:25181051
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313792	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ORMDL2 mRNA	PMID:33221593
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305642	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ORMDL2 gene	PMID:28505145
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305642	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ORMDL2 mRNA	PMID:36041667
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305642	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ORMDL2 mRNA	PMID:36041667
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305642	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ORMDL2 mRNA	PMID:36041667
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305642	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ORMDL2 mRNA	PMID:17602206
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305642	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ORMDL2 mRNA	PMID:17602206
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305642	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ORMDL2 promoter	PMID:22457795
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1305642	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ORMDL2 mRNA	PMID:19162173
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ORMDL2 mRNA	PMID:19376846
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ORMDL2 mRNA	PMID:24449571
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313792	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ORMDL2 mRNA	PMID:40194260
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313792	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ORMDL2 mRNA	PMID:36331819
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in decreased expression of ORMDL2 mRNA	PMID:17685462
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ORMDL2 mRNA	PMID:25979313
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ORMDL2 gene	PMID:29154799
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ORMDL2 mRNA	PMID:23179753|PMID:27188386
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ORMDL2 mRNA	PMID:25562108
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ORMDL2 mRNA	PMID:38832940
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ORMDL2 mRNA	PMID:27188386
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ORMDL2 mRNA	PMID:28542535
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313792	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ORMDL2 mRNA	PMID:17562736
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ORMDL2 mRNA	PMID:39836092
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ORMDL2 mRNA	PMID:22079256
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of ORMDL2 mRNA	PMID:18175754
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313792	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ORMDL2 mRNA; Nanotubes, Carbon results in decreased expression of ORMDL2 mRNA	PMID:25620056
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of ORMDL2 mRNA	PMID:20436886
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:6078	ivermectin	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of ORMDL2 protein	PMID:32959892
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313792	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ORMDL2 mRNA	PMID:22206623
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ORMDL2 mRNA	PMID:22079256
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ORMDL2 mRNA	PMID:22079256
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of ORMDL2 mRNA	PMID:19287073
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ORMDL2 mRNA	PMID:30851411
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ORMDL2 mRNA	PMID:27188386
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of ORMDL2 mRNA	PMID:33512557
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ORMDL2 mRNA	PMID:27188386
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ORMDL2 mRNA	PMID:29301935
1313791	ORMDL2	ORMDL sphingolipid biosynthesis regulator 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305642	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ORMDL2 mRNA	PMID:21346803
1313793	CTNND1	catenin delta 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CTNND1 mRNA	PMID:38218311
1313793	CTNND1	catenin delta 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1552257	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of CTNND1 mRNA	PMID:33045310
1313793	CTNND1	catenin delta 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552257	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CTNND1 mRNA	PMID:20188158
1313793	CTNND1	catenin delta 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1552257	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of CTNND1 mRNA	PMID:16236135
1313793	CTNND1	catenin delta 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of CTNND1 protein	PMID:39571964
1313793	CTNND1	catenin delta 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of CTNND1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of CTNND1 mRNA	PMID:32699268
1313793	CTNND1	catenin delta 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CTNND1 mRNA	PMID:26079696
1313793	CTNND1	catenin delta 1	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of CTNND1 protein	PMID:28073184
1313793	CTNND1	catenin delta 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CTNND1 protein	PMID:21179406
1313793	CTNND1	catenin delta 1	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of CTNND1 protein	PMID:18603805
1313793	CTNND1	catenin delta 1	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of CTNND1 protein	PMID:35688186
1313793	CTNND1	catenin delta 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CTNND1 protein	PMID:20172018
1313793	CTNND1	catenin delta 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CTNND1 mRNA	PMID:39241906
1313793	CTNND1	catenin delta 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	CTNND1 protein affects the reaction [Lipopolysaccharides affects the localization of RELA protein]; CTNND1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 mRNA]; CTNND1 protein inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL8 protein]	PMID:20172018
1313793	CTNND1	catenin delta 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305643	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of CTNND1 protein	PMID:32145629
1313793	CTNND1	catenin delta 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552257	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of CTNND1 mRNA	PMID:14648872
1313793	CTNND1	catenin delta 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CTNND1 mRNA	PMID:25510870
1313793	CTNND1	catenin delta 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305643	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CTNND1 mRNA	PMID:33387578
1313793	CTNND1	catenin delta 1	gene	CHEBI:16796	melatonin	decreases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D008550	Melatonin results in decreased expression of CTNND1 protein	PMID:37755321
1313793	CTNND1	catenin delta 1	gene	CHEBI:16796	melatonin	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:D008550	MIR532 promotes the reaction [Melatonin results in decreased expression of CTNND1 protein]	PMID:37755321
1313793	CTNND1	catenin delta 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CTNND1 mRNA	PMID:23649840
1313793	CTNND1	catenin delta 1	gene	CHEBI:17287	N-phosphocreatine	multiple interactions	ISO	RGD:1305643	E	RGD:6480464	20240430	CTD	MESH:D010725	Phosphocreatine promotes the reaction [Doxorubicin results in decreased expression of CTNND1 mRNA]	PMID:37597758
1313793	CTNND1	catenin delta 1	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in increased expression of CTNND1 protein	PMID:34122009
1313793	CTNND1	catenin delta 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CTNND1 protein	PMID:37730182
1313793	CTNND1	catenin delta 1	gene	CHEBI:17847	p-cresol	multiple interactions	ISO	RGD:1305643	E	RGD:6480464	20140114	CTD	MESH:C032538	4-cresol affects the localization of and results in decreased phosphorylation of CTNND1 protein; 4-cresol inhibits the reaction [CTNND1 protein binds to CDH2 protein]; Go 6976 inhibits the reaction [4-cresol affects the localization of and results in decreased phosphorylation of CTNND1 protein]; Go 6976 inhibits the reaction [4-cresol inhibits the reaction [CTNND1 protein binds to CDH2 protein]]; PRKCA mutant form inhibits the reaction [4-cresol affects the localization of and results in decreased phosphorylation of CTNND1 protein]	PMID:23466501
1313793	CTNND1	catenin delta 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CTNND1 mRNA	PMID:25510870
1313793	CTNND1	catenin delta 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CTNND1 mRNA	PMID:25510870
1313793	CTNND1	catenin delta 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CTNND1 mRNA	PMID:19549813
1313793	CTNND1	catenin delta 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CTNND1 protein	PMID:23301498
1313793	CTNND1	catenin delta 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CTNND1 mRNA	PMID:23649840
1313793	CTNND1	catenin delta 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CTNND1 mRNA	PMID:23649840
1313793	CTNND1	catenin delta 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of CTNND1 protein	PMID:19845377
1313793	CTNND1	catenin delta 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of CTNND1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of CTNND1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of CTNND1 mRNA	PMID:32699268
1313793	CTNND1	catenin delta 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CTNND1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of CTNND1 protein	PMID:38598786
1313793	CTNND1	catenin delta 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CTNND1 mRNA	PMID:22206623
1313793	CTNND1	catenin delta 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTNND1 mRNA	PMID:39836092
1313793	CTNND1	catenin delta 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CTNND1 protein	PMID:35688186
1313793	CTNND1	catenin delta 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1552257	E	RGD:6480464	20141111	CTD	MESH:C059514	resveratrol results in increased expression of CTNND1 protein	PMID:24330398
1313793	CTNND1	catenin delta 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in decreased expression of CTNND1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of CTNND1 mRNA	PMID:19167446|PMID:23557933
1313793	CTNND1	catenin delta 1	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of CTNND1 mRNA	PMID:28903495
1313793	CTNND1	catenin delta 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305643	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CTNND1 mRNA	PMID:33387578|PMID:34747641
1313793	CTNND1	catenin delta 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CTNND1 protein	PMID:28918527
1313793	CTNND1	catenin delta 1	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20230404	CTD	MESH:D012969	DKK1 protein inhibits the reaction [Sodium Fluoride results in increased expression of CTNND1 protein]	PMID:36063856
1313793	CTNND1	catenin delta 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1305643	E	RGD:6480464	20240430	CTD	MESH:D004317	Doxorubicin results in decreased expression of CTNND1 mRNA	PMID:37597758
1313793	CTNND1	catenin delta 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1305643	E	RGD:6480464	20240430	CTD	MESH:D004317	Phosphocreatine promotes the reaction [Doxorubicin results in decreased expression of CTNND1 mRNA]	PMID:37597758
1313793	CTNND1	catenin delta 1	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of CTNND1 protein	PMID:35688186
1313793	CTNND1	catenin delta 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of CTNND1 mRNA	PMID:20044591
1313793	CTNND1	catenin delta 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CTNND1 mRNA	PMID:24431212
1313793	CTNND1	catenin delta 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in decreased expression of CTNND1 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTNND1 mRNA	PMID:39571964|PMID:39836092
1313793	CTNND1	catenin delta 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CTNND1 5' UTR; Benzo(a)pyrene affects the methylation of CTNND1 promoter	PMID:27901495
1313793	CTNND1	catenin delta 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CTNND1 mRNA	PMID:19770486
1313793	CTNND1	catenin delta 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1552257	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CTNND1 exon; Benzo(a)pyrene results in increased methylation of CTNND1 intron	PMID:27901495
1313793	CTNND1	catenin delta 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1552257	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CTNND1 mRNA	PMID:27131904
1313793	CTNND1	catenin delta 1	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	CTNND1 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1313793	CTNND1	catenin delta 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1552257	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CTNND1 mRNA	PMID:35676786
1313793	CTNND1	catenin delta 1	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of CTNND1 mRNA	PMID:34408198
1313793	CTNND1	catenin delta 1	gene	CHEBI:31206	ammonium chloride	increases expression	ISO	RGD:1305643	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride results in increased expression of CTNND1 protein	PMID:16483693
1313793	CTNND1	catenin delta 1	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of CTNND1 gene	PMID:31601247
1313793	CTNND1	catenin delta 1	gene	CHEBI:31991	phenol red	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D010637	[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of CTNND1 protein	PMID:31629898
1313793	CTNND1	catenin delta 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305643	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of CTNND1 mRNA	PMID:30047161
1313793	CTNND1	catenin delta 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CTNND1 mRNA	PMID:30903817
1313793	CTNND1	catenin delta 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305643	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CTNND1 mRNA	PMID:30816183|PMID:34947998
1313793	CTNND1	catenin delta 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of CTNND1 protein	PMID:34186270|PMID:37567409
1313793	CTNND1	catenin delta 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305643	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CTNND1 mRNA; bisphenol A results in increased expression of CTNND1 protein	PMID:25181051|PMID:32145629
1313793	CTNND1	catenin delta 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of CTNND1 protein	PMID:31629898
1313793	CTNND1	catenin delta 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CTNND1 protein	PMID:31675489
1313793	CTNND1	catenin delta 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CTNND1 mRNA	PMID:25510870
1313793	CTNND1	catenin delta 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of CTNND1 mRNA	PMID:25510870
1313793	CTNND1	catenin delta 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CTNND1 mRNA	PMID:23146750
1313793	CTNND1	catenin delta 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CTNND1 mRNA	PMID:39298647
1313793	CTNND1	catenin delta 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CTNND1 protein	PMID:34186270
1313793	CTNND1	catenin delta 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552257	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CTNND1 mRNA	PMID:38685157
1313793	CTNND1	catenin delta 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CTNND1 protein	PMID:34186270
1313793	CTNND1	catenin delta 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of CTNND1 mRNA	PMID:28392331
1313793	CTNND1	catenin delta 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1552257	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of CTNND1 intron	PMID:28392331
1313793	CTNND1	catenin delta 1	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1552257	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of CTNND1 mRNA	PMID:31558096
1313793	CTNND1	catenin delta 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552257	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CTNND1 mRNA	PMID:37019170
1313793	CTNND1	catenin delta 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552257	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CTNND1 mRNA	PMID:17361019|PMID:21266533
1313793	CTNND1	catenin delta 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CTNND1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CTNND1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of CTNND1 protein	PMID:38598786
1313793	CTNND1	catenin delta 1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D010269	Paraquat results in decreased expression of CTNND1 mRNA alternative form	PMID:24912632
1313793	CTNND1	catenin delta 1	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20150714	CTD	MESH:D010269	mangiferin inhibits the reaction [Paraquat results in decreased expression of and affects the localization of CTNND1 protein]; mangiferin inhibits the reaction [Paraquat results in decreased expression of CTNND1 mRNA alternative form]; Paraquat results in decreased expression of and affects the localization of CTNND1 protein	PMID:24912632
1313793	CTNND1	catenin delta 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CTNND1 mRNA	PMID:38568856
1313793	CTNND1	catenin delta 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CTNND1 mRNA	PMID:25882684|PMID:26472689
1313793	CTNND1	catenin delta 1	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1552257	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of CTNND1 mRNA	PMID:19429403
1313793	CTNND1	catenin delta 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CTNND1 mRNA	PMID:23146750
1313793	CTNND1	catenin delta 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CTNND1 mRNA	PMID:19320972
1313793	CTNND1	catenin delta 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of CTNND1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of CTNND1 mRNA	PMID:32699268
1313793	CTNND1	catenin delta 1	gene	CHEBI:38604	pyrimidifen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of CTNND1 mRNA	PMID:33512557
1313793	CTNND1	catenin delta 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CTNND1 mRNA	PMID:31533062
1313793	CTNND1	catenin delta 1	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of CTNND1 mRNA	PMID:19167446
1313793	CTNND1	catenin delta 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in decreased expression of CTNND1 mRNA	PMID:19167446
1313793	CTNND1	catenin delta 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1552257	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of CTNND1 mRNA	PMID:19429403
1313793	CTNND1	catenin delta 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1552257	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of CTNND1 mRNA	PMID:31558096
1313793	CTNND1	catenin delta 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CTNND1 mRNA	PMID:25979313
1313793	CTNND1	catenin delta 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of CTNND1 mRNA	PMID:23179753
1313793	CTNND1	catenin delta 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of CTNND1 mRNA	PMID:17183730
1313793	CTNND1	catenin delta 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CTNND1 mRNA	PMID:20106945
1313793	CTNND1	catenin delta 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1552257	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CTNND1 mRNA	PMID:14648872
1313793	CTNND1	catenin delta 1	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of CTNND1 mRNA	PMID:33512557
1313793	CTNND1	catenin delta 1	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of CTNND1 mRNA	PMID:24449571
1313793	CTNND1	catenin delta 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of CTNND1 mRNA	PMID:21678067
1313793	CTNND1	catenin delta 1	gene	CHEBI:44658	okadaic acid	increases phosphorylation	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased phosphorylation of CTNND1 protein	PMID:38832940
1313793	CTNND1	catenin delta 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CTNND1 mRNA	PMID:21420995
1313793	CTNND1	catenin delta 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305643	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CTNND1 mRNA	PMID:33387578
1313793	CTNND1	catenin delta 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CTNND1 mRNA	PMID:29279043
1313793	CTNND1	catenin delta 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CTNND1 mRNA	PMID:39836092
1313793	CTNND1	catenin delta 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of CTNND1 mRNA	PMID:31675489
1313793	CTNND1	catenin delta 1	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of CTNND1 mRNA	PMID:26833863
1313793	CTNND1	catenin delta 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305643	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CTNND1 mRNA	PMID:29391264
1313793	CTNND1	catenin delta 1	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	CTNND1 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1313793	CTNND1	catenin delta 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1552257	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CTNND1 mRNA	PMID:35676786
1313793	CTNND1	catenin delta 1	gene	CHEBI:5011	fenpyroximate	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of CTNND1 mRNA	PMID:33512557
1313793	CTNND1	catenin delta 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1552257	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of CTNND1 mRNA	PMID:27915011
1313793	CTNND1	catenin delta 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CTNND1 mRNA; Nanotubes, Carbon results in decreased expression of CTNND1 mRNA	PMID:25554681
1313793	CTNND1	catenin delta 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305643	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of CTNND1 mRNA	PMID:30047161
1313793	CTNND1	catenin delta 1	gene	CHEBI:51913	Goe 6976	multiple interactions	ISO	RGD:1305643	E	RGD:6480464	20140114	CTD	MESH:C081021	Go 6976 inhibits the reaction [4-cresol affects the localization of and results in decreased phosphorylation of CTNND1 protein]; Go 6976 inhibits the reaction [4-cresol inhibits the reaction [CTNND1 protein binds to CDH2 protein]]	PMID:23466501
1313793	CTNND1	catenin delta 1	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of CTNND1 mRNA	PMID:17183730
1313793	CTNND1	catenin delta 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1305643	E	RGD:6480464	20180116	CTD	MESH:C082359	imidacloprid results in increased expression of CTNND1 mRNA	PMID:27792329
1313793	CTNND1	catenin delta 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305643	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of CTNND1 mRNA	PMID:28801915
1313793	CTNND1	catenin delta 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1552257	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CTNND1 protein	PMID:26558463
1313793	CTNND1	catenin delta 1	gene	CHEBI:6682	mangiferin	multiple interactions	EXP		E	RGD:6480464	20150714	CTD	MESH:C013592	mangiferin inhibits the reaction [Paraquat results in decreased expression of and affects the localization of CTNND1 protein]; mangiferin inhibits the reaction [Paraquat results in decreased expression of CTNND1 mRNA alternative form]	PMID:24912632
1313793	CTNND1	catenin delta 1	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in increased expression of CTNND1 protein	PMID:34122009
1313793	CTNND1	catenin delta 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CTNND1 protein	PMID:34186270
1313793	CTNND1	catenin delta 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552257	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CTNND1 mRNA	PMID:22206623
1313793	CTNND1	catenin delta 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CTNND1 mRNA	PMID:22206623
1313793	CTNND1	catenin delta 1	gene	CHEBI:7719	ochratoxin A	decreases acetylation	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased acetylation of CTNND1 promoter	PMID:29098329
1313793	CTNND1	catenin delta 1	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased expression of CTNND1 mRNA	PMID:29098329
1313793	CTNND1	catenin delta 1	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	[ochratoxin A results in decreased acetylation of CTNND1 promoter] which results in decreased expression of CTNND1 mRNA	PMID:29098329
1313793	CTNND1	catenin delta 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CTNND1 mRNA	PMID:23146750
1313793	CTNND1	catenin delta 1	gene	CHEBI:81794	thifluzamide	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of CTNND1 mRNA	PMID:33512557
1313793	CTNND1	catenin delta 1	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1305643	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of CTNND1 protein	PMID:28903499
1313793	CTNND1	catenin delta 1	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1552257	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of CTNND1 mRNA	PMID:31558096
1313793	CTNND1	catenin delta 1	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of CTNND1 mRNA	PMID:33512557
1313793	CTNND1	catenin delta 1	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of CTNND1 protein	PMID:38348393
1313793	CTNND1	catenin delta 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305643	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CTNND1 mRNA	PMID:30047161
1313793	CTNND1	catenin delta 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305643	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CTNND1 mRNA	PMID:24780913
1313793	CTNND1	catenin delta 1	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1552257	E	RGD:6480464	20240430	CTD	MESH:C028577	monobutyl phthalate results in increased expression of CTNND1 protein	PMID:35278568
1313793	CTNND1	catenin delta 1	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1552257	E	RGD:6480464	20240430	CTD	MESH:C028577	alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [monobutyl phthalate results in increased expression of CTNND1 protein]	PMID:35278568
1313793	CTNND1	catenin delta 1	gene	CHEBI:91108	SB 431542	increases expression	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of CTNND1 protein	PMID:25670856
1313793	CTNND1	catenin delta 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1552257	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CTNND1 mRNA	PMID:27131904
1313793	CTNND1	catenin delta 1	gene	CHEBI:9422	tebufenpyrad	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of CTNND1 mRNA	PMID:33512557
1313793	CTNND1	catenin delta 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of CTNND1 mRNA	PMID:29301935
1313793	CTNND1	catenin delta 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CTNND1 protein	PMID:38598786
1313793	CTNND1	catenin delta 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552257	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CTNND1 mRNA	PMID:28973697
1313797	CHIT1	chitinase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313798	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CHIT1 mRNA	PMID:33045310
1313797	CHIT1	chitinase 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305646	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CHIT1 gene	PMID:28931070|PMID:35440735
1313797	CHIT1	chitinase 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CHIT1 mRNA	PMID:22378314
1313797	CHIT1	chitinase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313798	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CHIT1 mRNA	PMID:19484750
1313797	CHIT1	chitinase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CHIT1 mRNA	PMID:37042841
1313797	CHIT1	chitinase 1	gene	CHEBI:17029	chitin	affects binding	ISO	RGD:1313798	E	RGD:6480464	20130611	CTD	MESH:D002686	CHIT1 protein binds to Chitin	PMID:16005164
1313797	CHIT1	chitinase 1	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CHIT1 mRNA	PMID:26079696
1313797	CHIT1	chitinase 1	gene	CHEBI:2038	5-azacytidine	increases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of CHIT1 mRNA	PMID:20823114
1313797	CHIT1	chitinase 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313798	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of CHIT1 mRNA	PMID:19376150
1313797	CHIT1	chitinase 1	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of CHIT1 mRNA	PMID:23033980
1313797	CHIT1	chitinase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313798	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of CHIT1 mRNA	PMID:40618947
1313797	CHIT1	chitinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305646	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CHIT1 mRNA	PMID:34747641
1313797	CHIT1	chitinase 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305646	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CHIT1 mRNA	PMID:28959563
1313797	CHIT1	chitinase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHIT1 promoter	PMID:27901495
1313797	CHIT1	chitinase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CHIT1 mRNA	PMID:19128835
1313797	CHIT1	chitinase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CHIT1 gene	PMID:31601247
1313797	CHIT1	chitinase 1	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305646	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of CHIT1 mRNA	PMID:25729387
1313797	CHIT1	chitinase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313798	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CHIT1 mRNA	PMID:23557971|PMID:35295148
1313797	CHIT1	chitinase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CHIT1 mRNA	PMID:19710929
1313797	CHIT1	chitinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305646	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CHIT1 mRNA	PMID:25181051|PMID:34947998
1313797	CHIT1	chitinase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CHIT1 gene	PMID:31601247
1313797	CHIT1	chitinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in decreased expression of CHIT1 mRNA	PMID:30616060
1313797	CHIT1	chitinase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CHIT1 mRNA	PMID:37042841
1313797	CHIT1	chitinase 1	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305646	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of CHIT1 gene	PMID:22079235
1313797	CHIT1	chitinase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313798	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CHIT1 mRNA	PMID:40194260
1313797	CHIT1	chitinase 1	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1313798	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of CHIT1 mRNA	PMID:29038090
1313797	CHIT1	chitinase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CHIT1 mRNA	PMID:23179753|PMID:26272509
1313797	CHIT1	chitinase 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHIT1 mRNA	PMID:27188386
1313797	CHIT1	chitinase 1	gene	CHEBI:40808	ALLOSAMIDIN	decreases activity	ISO	RGD:1313798	E	RGD:6480464	20141111	CTD	MESH:C054851	allosamidin results in decreased activity of CHIT1 protein	PMID:16005164
1313797	CHIT1	chitinase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313798	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CHIT1 mRNA	PMID:17562736
1313797	CHIT1	chitinase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of CHIT1 mRNA	PMID:26690555
1313797	CHIT1	chitinase 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CHIT1 mRNA	PMID:19128835
1313797	CHIT1	chitinase 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313798	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CHIT1 mRNA	PMID:21641980
1313797	CHIT1	chitinase 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305646	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of CHIT1 mRNA	PMID:25729387
1313797	CHIT1	chitinase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHIT1 mRNA	PMID:27188386
1313797	CHIT1	chitinase 1	gene	CHEBI:8228	pioglitazone	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:C060836	Pioglitazone results in decreased expression of CHIT1 mRNA	PMID:30031879
1313797	CHIT1	chitinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305646	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CHIT1 mRNA	PMID:24780913
1313797	CHIT1	chitinase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHIT1 mRNA	PMID:27188386
1313797	CHIT1	chitinase 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CHIT1 mRNA	PMID:38568856
1313797	CHIT1	chitinase 1	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305646	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of CHIT1 gene	PMID:31079544
1313800	FBXO7	F-box protein 7	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313801	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of FBXO7 mRNA	PMID:22629407
1313800	FBXO7	F-box protein 7	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313801	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of FBXO7 mRNA]	PMID:22629407
1313800	FBXO7	F-box protein 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FBXO7 mRNA	PMID:37042841
1313800	FBXO7	F-box protein 7	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305648	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of FBXO7 mRNA	PMID:33387578
1313800	FBXO7	F-box protein 7	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1313801	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of FBXO7 mRNA	PMID:18930951
1313800	FBXO7	F-box protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313801	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXO7 mRNA	PMID:21570461
1313800	FBXO7	F-box protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313801	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBXO7 mRNA	PMID:19465110|PMID:21354282
1313800	FBXO7	F-box protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305648	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBXO7 mRNA	PMID:33387578
1313800	FBXO7	F-box protein 7	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of FBXO7 protein	PMID:39603559
1313800	FBXO7	F-box protein 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FBXO7 mRNA	PMID:28001369
1313800	FBXO7	F-box protein 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313801	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FBXO7 mRNA	PMID:21715664|PMID:22228805
1313800	FBXO7	F-box protein 7	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of FBXO7 gene	PMID:31601247
1313800	FBXO7	F-box protein 7	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305648	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of FBXO7 mRNA	PMID:24136188
1313800	FBXO7	F-box protein 7	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of FBXO7 mRNA	PMID:31745603
1313800	FBXO7	F-box protein 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313801	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXO7 gene	PMID:35295148
1313800	FBXO7	F-box protein 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313801	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FBXO7 promoter alternative form	PMID:35295148
1313800	FBXO7	F-box protein 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXO7 protein	PMID:31675489
1313800	FBXO7	F-box protein 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305648	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXO7 mRNA	PMID:41034487
1313800	FBXO7	F-box protein 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305648	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FBXO7 mRNA	PMID:25181051
1313800	FBXO7	F-box protein 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305648	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of FBXO7 mRNA	PMID:36041667
1313800	FBXO7	F-box protein 7	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of FBXO7 protein	PMID:31675489
1313800	FBXO7	F-box protein 7	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313801	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of FBXO7 mRNA	PMID:26682919
1313800	FBXO7	F-box protein 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305648	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of FBXO7 mRNA	PMID:36041667
1313800	FBXO7	F-box protein 7	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of FBXO7 gene	PMID:31601247
1313800	FBXO7	F-box protein 7	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305648	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of FBXO7 mRNA	PMID:36041667
1313800	FBXO7	F-box protein 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313801	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FBXO7 mRNA	PMID:37019170
1313800	FBXO7	F-box protein 7	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305648	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of FBXO7 gene	PMID:22079235
1313800	FBXO7	F-box protein 7	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FBXO7 mRNA	PMID:25979313
1313800	FBXO7	F-box protein 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313801	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of FBXO7 mRNA	PMID:17292431
1313800	FBXO7	F-box protein 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXO7 mRNA	PMID:23179753|PMID:28001369
1313800	FBXO7	F-box protein 7	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305648	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of FBXO7 mRNA	PMID:41580965
1313800	FBXO7	F-box protein 7	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of FBXO7 mRNA	PMID:33512557
1313800	FBXO7	F-box protein 7	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of FBXO7 mRNA	PMID:27188386
1313800	FBXO7	F-box protein 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313801	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FBXO7 mRNA	PMID:17562736
1313800	FBXO7	F-box protein 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of FBXO7 mRNA	PMID:21420995
1313800	FBXO7	F-box protein 7	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of FBXO7 mRNA	PMID:31675489
1313800	FBXO7	F-box protein 7	gene	CHEBI:5011	fenpyroximate	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of FBXO7 mRNA	PMID:33512557
1313800	FBXO7	F-box protein 7	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313801	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of FBXO7 mRNA	PMID:19042947
1313800	FBXO7	F-box protein 7	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FBXO7 protein	PMID:32959892
1313800	FBXO7	F-box protein 7	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of FBXO7 mRNA; 1-Methyl-4-phenylpyridinium results in increased expression of FBXO7 protein	PMID:41640382
1313800	FBXO7	F-box protein 7	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305648	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of FBXO7 mRNA	PMID:24136188
1313800	FBXO7	F-box protein 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FBXO7 gene]	PMID:28238834
1313800	FBXO7	F-box protein 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FBXO7 protein	PMID:31675489
1313800	FBXO7	F-box protein 7	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of FBXO7 protein	PMID:31675489
1313800	FBXO7	F-box protein 7	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of FBXO7 mRNA	PMID:33512557
1313800	FBXO7	F-box protein 7	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of FBXO7 mRNA	PMID:29301935
1313800	FBXO7	F-box protein 7	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of FBXO7 mRNA	PMID:27188386
1313800	FBXO7	F-box protein 7	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1305648	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of FBXO7 protein	PMID:32519852
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313804	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MGAT4A mRNA	PMID:33045310
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of MGAT4A mRNA	PMID:23724009|PMID:33167477
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313804	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of MGAT4A mRNA	PMID:40945087
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313804	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MGAT4A mRNA	PMID:39241906
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of MGAT4A mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of MGAT4A mRNA	PMID:26667767|PMID:35811015
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of MGAT4A mRNA	PMID:21185374
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of MGAT4A mRNA	PMID:30165855
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of MGAT4A mRNA	PMID:26079696
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGAT4A mRNA	PMID:37992649
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGAT4A mRNA	PMID:37992649
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MGAT4A protein	PMID:37730182
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MGAT4A mRNA	PMID:28111341|PMID:37236586
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MGAT4A mRNA	PMID:22100608
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MGAT4A intron	PMID:30157460
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MGAT4A mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MGAT4A mRNA	PMID:35430440|PMID:41430723
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of MGAT4A mRNA	PMID:19774075
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305650	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MGAT4A mRNA	PMID:30779732
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1313804	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of MGAT4A mRNA	PMID:31939706
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MGAT4A gene] which results in increased expression of MGAT4A mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MGAT4A gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MGAT4A mRNA	PMID:40504410
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of MGAT4A mRNA	PMID:26272509
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT4A mRNA	PMID:27188386
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313804	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of MGAT4A mRNA	PMID:28960355
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[Lipopolysaccharides co-treated with resveratrol] results in decreased expression of MGAT4A mRNA	PMID:26667767
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MGAT4A mRNA	PMID:28903495
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MGAT4A mRNA	PMID:24768652|PMID:25583101
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305650	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MGAT4A mRNA	PMID:22298810
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313804	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MGAT4A mRNA	PMID:26377647
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305650	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MGAT4A mRNA	PMID:34747641
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313804	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MGAT4A mRNA	PMID:26290441
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MGAT4A mRNA	PMID:28001369
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of MGAT4A mRNA	PMID:23649840
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MGAT4A mRNA	PMID:29803840
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGAT4A mRNA	PMID:37992649
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of MGAT4A mRNA	PMID:34032870
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305650	E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of MGAT4A mRNA	PMID:35314868
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MGAT4A mRNA	PMID:17879257
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313804	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of MGAT4A mRNA	PMID:37682722
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MGAT4A gene] which results in increased expression of MGAT4A mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MGAT4A gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MGAT4A mRNA	PMID:40504410
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MGAT4A promoter	PMID:27901495
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305650	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MGAT4A mRNA	PMID:34492290
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305650	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MGAT4A mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305650	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MGAT4A gene	PMID:28505145
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of MGAT4A mRNA	PMID:25979313
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MGAT4A intron	PMID:30157460
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313804	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of MGAT4A intron	PMID:28392331
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313804	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MGAT4A mRNA	PMID:20524982
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305650	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of MGAT4A mRNA	PMID:32680482
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MGAT4A mRNA	PMID:37042841
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305650	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MGAT4A mRNA	PMID:33453195
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MGAT4A mRNA	PMID:28111341|PMID:37236586
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305650	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of MGAT4A mRNA	PMID:27387713
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MGAT4A mRNA	PMID:19320972
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C018021	cobaltous chloride results in increased expression of MGAT4A mRNA	PMID:20105288
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MGAT4A mRNA	PMID:24449571
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MGAT4A mRNA	PMID:28302478
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MGAT4A mRNA	PMID:31533062
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MGAT4A mRNA	PMID:25979313
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of MGAT4A mRNA	PMID:24935251
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MGAT4A gene	PMID:29154799
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MGAT4A mRNA	PMID:25562108
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of MGAT4A promoter	PMID:27989131
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313804	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MGAT4A mRNA	PMID:28973697
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGAT4A mRNA	PMID:37992649
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of MGAT4A mRNA	PMID:24935251|PMID:26272509
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of MGAT4A mRNA	PMID:24935251
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT4A mRNA	PMID:27188386
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D000082	Acetaminophen results in increased expression of MGAT4A mRNA	PMID:26497421
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305650	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MGAT4A mRNA	PMID:33387578
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of MGAT4A mRNA	PMID:35811015
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313804	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MGAT4A mRNA	PMID:29279043
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MGAT4A gene] which results in increased expression of MGAT4A mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MGAT4A gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MGAT4A mRNA	PMID:40504410
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313804	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of MGAT4A mRNA	PMID:35436446
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305650	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MGAT4A mRNA	PMID:29097150
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313804	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MGAT4A mRNA; Nanotubes, Carbon results in increased expression of MGAT4A mRNA	PMID:25554681
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305650	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of MGAT4A mRNA	PMID:24793618
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313804	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MGAT4A mRNA	PMID:38701926
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MGAT4A mRNA	PMID:26378955
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313804	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MGAT4A mRNA	PMID:26378955
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MGAT4A intron	PMID:30157460
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305650	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MGAT4A gene	PMID:35440735
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313804	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MGAT4A mRNA	PMID:22206623
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of MGAT4A mRNA	PMID:22714537
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT4A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT4A mRNA	PMID:27188386
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313804	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MGAT4A mRNA	PMID:31388691
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT4A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MGAT4A mRNA	PMID:27188386
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MGAT4A mRNA	PMID:29301935
1313803	MGAT4A	alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305650	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MGAT4A mRNA	PMID:23034163
1313806	MKX	mohawk homeobox	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of MKX mRNA	PMID:34925699
1313806	MKX	mohawk homeobox	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MKX gene	PMID:20938992
1313806	MKX	mohawk homeobox	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of MKX mRNA	PMID:23019147
1313806	MKX	mohawk homeobox	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of MKX mRNA	PMID:30165855
1313806	MKX	mohawk homeobox	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305652	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of MKX mRNA	PMID:26496021
1313806	MKX	mohawk homeobox	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MKX gene	PMID:20938992
1313806	MKX	mohawk homeobox	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305652	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of MKX mRNA	PMID:26577399
1313806	MKX	mohawk homeobox	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305652	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MKX mRNA	PMID:33387578
1313806	MKX	mohawk homeobox	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKX mRNA	PMID:39836092
1313806	MKX	mohawk homeobox	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MKX gene	PMID:27153756
1313806	MKX	mohawk homeobox	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305652	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MKX mRNA	PMID:33387578
1313806	MKX	mohawk homeobox	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of MKX gene	PMID:20938992
1313806	MKX	mohawk homeobox	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKX mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MKX mRNA	PMID:39836092
1313806	MKX	mohawk homeobox	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313807	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of MKX mRNA	PMID:32186404
1313806	MKX	mohawk homeobox	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MKX mRNA	PMID:25583101
1313806	MKX	mohawk homeobox	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313807	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MKX mRNA	PMID:21570461|PMID:24058054|PMID:28922406
1313806	MKX	mohawk homeobox	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313807	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MKX mRNA	PMID:19933214
1313806	MKX	mohawk homeobox	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305652	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MKX mRNA	PMID:32109520
1313806	MKX	mohawk homeobox	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to MKX promoter]	PMID:19654925
1313806	MKX	mohawk homeobox	gene	CHEBI:28842	octadecanoic acid	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C031183	stearic acid results in increased expression of MKX mRNA	PMID:32347412
1313806	MKX	mohawk homeobox	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313807	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of MKX mRNA	PMID:36209798|PMID:37682722
1313806	MKX	mohawk homeobox	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKX mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MKX mRNA; sodium arsenite results in decreased expression of and affects the splicing of MKX mRNA	PMID:25879800|PMID:39836092
1313806	MKX	mohawk homeobox	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MKX mRNA	PMID:34876320
1313806	MKX	mohawk homeobox	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MKX mRNA	PMID:34876320
1313806	MKX	mohawk homeobox	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MKX intron	PMID:30157460
1313806	MKX	mohawk homeobox	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MKX 5' UTR; Benzo(a)pyrene results in increased methylation of MKX promoter	PMID:27901495
1313806	MKX	mohawk homeobox	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of MKX promoter	PMID:23974009
1313806	MKX	mohawk homeobox	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313807	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MKX mRNA	PMID:27131904
1313806	MKX	mohawk homeobox	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313807	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MKX gene	PMID:35295148
1313806	MKX	mohawk homeobox	gene	CHEBI:33007	chromium(6+)	affects expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MKX mRNA	PMID:30690063
1313806	MKX	mohawk homeobox	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of MKX mRNA	PMID:27685785
1313806	MKX	mohawk homeobox	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305652	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MKX mRNA	PMID:30816183
1313806	MKX	mohawk homeobox	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305652	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of MKX mRNA	PMID:26496021
1313806	MKX	mohawk homeobox	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313807	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of MKX mRNA	PMID:39298647
1313806	MKX	mohawk homeobox	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S affects the methylation of MKX gene	PMID:31601247
1313806	MKX	mohawk homeobox	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313807	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of MKX mRNA	PMID:30951980
1313806	MKX	mohawk homeobox	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305652	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of MKX gene	PMID:33148267
1313806	MKX	mohawk homeobox	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKX mRNA	PMID:39836092
1313806	MKX	mohawk homeobox	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305652	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MKX mRNA	PMID:33453195
1313806	MKX	mohawk homeobox	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MKX mRNA	PMID:32588087
1313806	MKX	mohawk homeobox	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MKX gene	PMID:29154799
1313806	MKX	mohawk homeobox	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of MKX mRNA	PMID:24935251
1313806	MKX	mohawk homeobox	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MKX mRNA	PMID:20106945|PMID:27989131
1313806	MKX	mohawk homeobox	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of MKX mRNA	PMID:38832940
1313806	MKX	mohawk homeobox	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of MKX mRNA	PMID:24935251
1313806	MKX	mohawk homeobox	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305652	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MKX mRNA	PMID:33387578
1313806	MKX	mohawk homeobox	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of MKX mRNA	PMID:16510598
1313806	MKX	mohawk homeobox	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKX mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MKX mRNA	PMID:39836092
1313806	MKX	mohawk homeobox	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MKX mRNA	PMID:22079256
1313806	MKX	mohawk homeobox	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MKX mRNA	PMID:34876320
1313806	MKX	mohawk homeobox	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of MKX mRNA	PMID:22714537
1313806	MKX	mohawk homeobox	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MKX mRNA	PMID:39836092
1313806	MKX	mohawk homeobox	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305652	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of MKX gene	PMID:33148267
1313806	MKX	mohawk homeobox	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313807	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MKX mRNA	PMID:22206623
1313806	MKX	mohawk homeobox	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MKX mRNA	PMID:22079256
1313806	MKX	mohawk homeobox	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of MKX mRNA	PMID:22714537
1313806	MKX	mohawk homeobox	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MKX mRNA	PMID:22079256
1313806	MKX	mohawk homeobox	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MKX protein	PMID:31285264
1313806	MKX	mohawk homeobox	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of MKX mRNA	PMID:18927307
1313806	MKX	mohawk homeobox	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1313807	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of MKX mRNA	PMID:34876320
1313806	MKX	mohawk homeobox	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313807	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MKX mRNA	PMID:27131904
1313806	MKX	mohawk homeobox	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MKX mRNA	PMID:29301935
1313810	ACTL7B	actin like 7B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313811	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ACTL7B mRNA	PMID:33045310
1313810	ACTL7B	actin like 7B	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305655	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ACTL7B mRNA	PMID:33387578
1313810	ACTL7B	actin like 7B	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305655	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ACTL7B gene	PMID:27618143
1313810	ACTL7B	actin like 7B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACTL7B mRNA	PMID:35301059
1313810	ACTL7B	actin like 7B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313811	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ACTL7B mRNA	PMID:27106289
1313810	ACTL7B	actin like 7B	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305655	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ACTL7B mRNA	PMID:31881176
1313810	ACTL7B	actin like 7B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313811	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACTL7B mRNA	PMID:21570461
1313810	ACTL7B	actin like 7B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305655	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACTL7B mRNA	PMID:33387578
1313810	ACTL7B	actin like 7B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313811	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACTL7B mRNA	PMID:31961203
1313810	ACTL7B	actin like 7B	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ACTL7B mRNA	PMID:33212167
1313810	ACTL7B	actin like 7B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ACTL7B promoter	PMID:27901495
1313810	ACTL7B	actin like 7B	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1305655	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of ACTL7B mRNA	PMID:32479839
1313810	ACTL7B	actin like 7B	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313811	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACTL7B mRNA	PMID:35295148
1313810	ACTL7B	actin like 7B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313811	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACTL7B mRNA	PMID:19710929
1313810	ACTL7B	actin like 7B	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305655	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ACTL7B mRNA	PMID:19167457
1313810	ACTL7B	actin like 7B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of ACTL7B mRNA	PMID:23146750
1313810	ACTL7B	actin like 7B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305655	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ACTL7B mRNA	PMID:25181051
1313810	ACTL7B	actin like 7B	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of ACTL7B mRNA	PMID:23146750
1313810	ACTL7B	actin like 7B	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ACTL7B mRNA	PMID:23146750
1313810	ACTL7B	actin like 7B	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of ACTL7B mRNA	PMID:37047231
1313810	ACTL7B	actin like 7B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACTL7B mRNA	PMID:35301059
1313810	ACTL7B	actin like 7B	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ACTL7B mRNA	PMID:23146750
1313810	ACTL7B	actin like 7B	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305655	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of ACTL7B mRNA	PMID:25539665
1313810	ACTL7B	actin like 7B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313811	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ACTL7B mRNA	PMID:40194260
1313810	ACTL7B	actin like 7B	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ACTL7B mRNA	PMID:25979313
1313810	ACTL7B	actin like 7B	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ACTL7B gene	PMID:29154799
1313810	ACTL7B	actin like 7B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313811	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ACTL7B mRNA	PMID:28973697
1313810	ACTL7B	actin like 7B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ACTL7B mRNA	PMID:23146750
1313810	ACTL7B	actin like 7B	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305655	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ACTL7B mRNA	PMID:23914054
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of IGFBPL1 mRNA	PMID:26272509
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBPL1 mRNA	PMID:27188386
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of IGFBPL1 mRNA	PMID:21934132
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of IGFBPL1 mRNA	PMID:24763279
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of IGFBPL1 mRNA	PMID:26079696
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in increased expression of IGFBPL1 mRNA	PMID:28986285
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D004958	Estradiol results in decreased expression of IGFBPL1 mRNA	PMID:28591870|PMID:28711546
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGFBPL1 mRNA	PMID:25510870
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305656	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of IGFBPL1 gene	PMID:27618143
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305656	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of IGFBPL1 mRNA	PMID:26577399
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGFBPL1 mRNA	PMID:25510870
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGFBPL1 mRNA	PMID:25510870
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of IGFBPL1 mRNA	PMID:23557933
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of IGFBPL1 mRNA	PMID:28903495
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305656	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of IGFBPL1 mRNA	PMID:28959563
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of IGFBPL1 mRNA	PMID:25879800
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IGFBPL1 3' UTR; Benzo(a)pyrene results in increased methylation of IGFBPL1 5' UTR	PMID:27901495
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:31767	lead diacetate	affects expression	ISO	RGD:1305656	E	RGD:6480464	20120918	CTD	MESH:C008261	lead acetate affects the expression of IGFBPL1 mRNA	PMID:21864555
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305656	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IGFBPL1 mRNA	PMID:25181051
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313813	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of IGFBPL1 mRNA	PMID:32156529|PMID:32365465
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305656	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of IGFBPL1 mRNA	PMID:30816183|PMID:34947998
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGFBPL1 mRNA	PMID:25510870
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IGFBPL1 mRNA	PMID:25510870
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to IGFBPL1 promoter]	PMID:20348232
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313813	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of IGFBPL1 gene	PMID:31683443
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313813	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of IGFBPL1 mRNA	PMID:30951980
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313813	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of IGFBPL1 exon	PMID:33297965
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313813	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of IGFBPL1 mRNA	PMID:30951980
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313813	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of IGFBPL1 exon; butylbenzyl phthalate results in increased methylation of IGFBPL1 intron	PMID:28392331
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305656	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of IGFBPL1 mRNA	PMID:22110744
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305656	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of IGFBPL1 mRNA	PMID:32680482
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305656	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of IGFBPL1 promoter	PMID:22457795
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305656	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of IGFBPL1 mRNA	PMID:24386269
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of IGFBPL1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of IGFBPL1 mRNA]	PMID:17585979
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of IGFBPL1 mRNA	PMID:31533062
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1305656	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of IGFBPL1 mRNA	PMID:22110744
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of IGFBPL1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBPL1 mRNA	PMID:27188386
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1313813	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of IGFBPL1 mRNA	PMID:25123088
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IGFBPL1 mRNA	PMID:38832940
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of IGFBPL1 mRNA	PMID:24935251
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313813	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IGFBPL1 mRNA	PMID:17562736
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313813	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of IGFBPL1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of IGFBPL1 mRNA]	PMID:17585979
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305656	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of IGFBPL1 mRNA	PMID:30307764
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305656	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of IGFBPL1 mRNA	PMID:20080153
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313813	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of IGFBPL1 mRNA	PMID:22206623
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBPL1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBPL1 mRNA	PMID:27188386
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IGFBPL1 gene]	PMID:28238834
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305656	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of IGFBPL1 mRNA	PMID:21394737
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:81922	flusilazole	decreases expression	ISO	RGD:1305656	E	RGD:6480464	20170725	CTD	MESH:C061365	flusilazole results in decreased expression of IGFBPL1 mRNA	PMID:28263823
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1313813	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of IGFBPL1 mRNA	PMID:27029645
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305656	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of IGFBPL1 mRNA	PMID:24780913
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBPL1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBPL1 mRNA	PMID:27188386
1313812	IGFBPL1	insulin like growth factor binding protein like 1	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1305656	E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in increased expression of IGFBPL1 mRNA	PMID:26141394
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313815	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PPP2R5E mRNA	PMID:33045310
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of PPP2R5E mRNA]	PMID:19467301
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP2R5E mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPP2R5E gene	PMID:20938992
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPP2R5E mRNA	PMID:36331819
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:15891	taurine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013654	Taurine results in decreased expression of PPP2R5E mRNA	PMID:16579726
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PPP2R5E mRNA	PMID:22378314
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PPP2R5E mRNA	PMID:39298647
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305657	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of PPP2R5E gene	PMID:27618143
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP2R5E mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPP2R5E gene	PMID:20938992
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PPP2R5E mRNA	PMID:23649840
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:17578	toluene	affects expression	ISO	RGD:1305657	E	RGD:6480464	20121113	CTD	MESH:D014050	Toluene affects the expression of PPP2R5E mRNA	PMID:21827849
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:17642	pentachlorophenol	affects expression	ISO	RGD:1313815	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol affects the expression of PPP2R5E mRNA	PMID:23892564
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PPP2R5E protein	PMID:37730182
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PPP2R5E intron	PMID:30157460
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP2R5E mRNA	PMID:36331819
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	decreases response to substance	EXP		E	RGD:6480464	20150609	CTD	MESH:D008769	PPP2R5E protein results in decreased susceptibility to Methylnitronitrosoguanidine	PMID:25772433
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPP2R5E mRNA	PMID:37236586
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PPP2R5E mRNA	PMID:19549813
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of PPP2R5E mRNA	PMID:23487506
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PPP2R5E mRNA	PMID:35430440
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP2R5E mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PPP2R5E gene	PMID:20938992
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:27504	mitomycin C	decreases response to substance	EXP		E	RGD:6480464	20150609	CTD	MESH:D016685	PPP2R5E protein results in decreased susceptibility to Mitomycin	PMID:25772433
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPP2R5E mRNA	PMID:40512198
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PPP2R5E mRNA	PMID:19244175
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:27656	camptothecin	decreases response to substance	EXP		E	RGD:6480464	20150609	CTD	MESH:D002166	PPP2R5E protein results in decreased susceptibility to Camptothecin	PMID:25772433
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:27656	camptothecin	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:D002166	Camptothecin affects the localization of [PPP2R5E protein binds to PPP2CA protein]; PPP2R5E protein inhibits the reaction [Camptothecin results in increased expression of H2AX protein modified form]	PMID:25772433
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PPP2R5E mRNA	PMID:26272509
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA	PMID:27188386
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PPP2R5E protein	PMID:35688186
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313815	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPP2R5E mRNA	PMID:21570461|PMID:24680724
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305657	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPP2R5E mRNA	PMID:21215274
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20140408	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPP2R5E mRNA	PMID:23994337
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP2R5E mRNA	PMID:17942748
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PPP2R5E mRNA	PMID:33212167
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PPP2R5E mRNA	PMID:29803840
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of PPP2R5E protein	PMID:35688186
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:29287	gold atom	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in decreased expression of PPP2R5E mRNA	PMID:19695318
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PPP2R5E mRNA	PMID:38568856
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPP2R5E mRNA	PMID:40512198
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of PPP2R5E mRNA	PMID:17127020
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PPP2R5E intron	PMID:30157460
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PPP2R5E mRNA	PMID:19770486
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313815	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PPP2R5E mRNA	PMID:22228805
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to PPP2R5E mRNA]	PMID:32406909
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:30050	gold(0)	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in decreased expression of PPP2R5E mRNA	PMID:19695318
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PPP2R5E mRNA	PMID:19150397|PMID:20018196
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PPP2R5E mRNA	PMID:39716349
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305657	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PPP2R5E mRNA	PMID:24136188
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305657	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPP2R5E mRNA	PMID:25729387
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313815	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PPP2R5E gene; titanium dioxide results in decreased methylation of PPP2R5E promoter	PMID:35295148
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313815	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PPP2R5E promoter	PMID:35295148
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of PPP2R5E mRNA	PMID:23811191
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305657	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PPP2R5E mRNA	PMID:25181051
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of PPP2R5E protein	PMID:31675489
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PPP2R5E gene	PMID:31601247
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305657	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PPP2R5E gene	PMID:28505145
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of PPP2R5E protein	PMID:31675489
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PPP2R5E mRNA	PMID:23994337
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313815	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PPP2R5E mRNA	PMID:39298647
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PPP2R5E intron	PMID:30157460
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PPP2R5E mRNA	PMID:34813904
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of PPP2R5E mRNA	PMID:34813904
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPP2R5E mRNA	PMID:37042841
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPP2R5E mRNA	PMID:37236586
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PPP2R5E mRNA	PMID:24449571
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313815	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of PPP2R5E mRNA	PMID:18353800
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of PPP2R5E mRNA	PMID:19244175
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of PPP2R5E mRNA	PMID:19167446
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PPP2R5E mRNA	PMID:40419075
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP2R5E mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PPP2R5E mRNA	PMID:36331819
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PPP2R5E mRNA	PMID:17292431
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PPP2R5E mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA	PMID:27188386
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of PPP2R5E mRNA	PMID:19770486
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PPP2R5E mRNA	PMID:17555576
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PPP2R5E mRNA	PMID:21420995
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPP2R5E mRNA	PMID:40512198
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:4744	Echimidine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C000615871	[CYP3A4 protein results in increased metabolism of echimidine] which results in increased expression of PPP2R5E mRNA	PMID:33884520
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of PPP2R5E mRNA	PMID:18175754
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PPP2R5E mRNA	PMID:17555576
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of PPP2R5E mRNA	PMID:17942748
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PPP2R5E mRNA	PMID:17942748
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313815	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP2R5E mRNA	PMID:17942748
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PPP2R5E mRNA	PMID:39716349
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313815	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PPP2R5E mRNA	PMID:25620056
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PPP2R5E protein	PMID:32959892
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305657	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of PPP2R5E mRNA	PMID:25729387
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305657	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPP2R5E mRNA	PMID:25729387
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1305657	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of PPP2R5E mRNA	PMID:24136188
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305657	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of PPP2R5E mRNA	PMID:30467583
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PPP2R5E intron	PMID:30157460
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305657	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PPP2R5E gene	PMID:35440735
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:6980	monocrotaline	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in increased expression of PPP2R5E mRNA	PMID:33884520
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PPP2R5E mRNA	PMID:22206623
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305657	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PPP2R5E mRNA	PMID:24136188
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1313815	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of PPP2R5E mRNA	PMID:23994337
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA	PMID:27188386
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313815	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of PPP2R5E mRNA	PMID:23091169
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PPP2R5E protein	PMID:31675489
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305657	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PPP2R5E mRNA	PMID:27291303
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305657	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of PPP2R5E mRNA	PMID:23640034
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP2R5E mRNA	PMID:27188386
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305657	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PPP2R5E mRNA	PMID:21346803
1313814	PPP2R5E	protein phosphatase 2 regulatory subunit B'epsilon	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305657	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of PPP2R5E mRNA	PMID:19015723
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TAF1C mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TAF1C gene	PMID:20938992
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TAF1C mRNA	PMID:22378314
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305658	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of TAF1C mRNA	PMID:32145629
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TAF1C mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TAF1C gene	PMID:20938992
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313817	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TAF1C mRNA	PMID:34319233
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TAF1C protein	PMID:37730182
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305658	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TAF1C mRNA	PMID:33387578
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF1C mRNA	PMID:39836092
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305658	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TAF1C mRNA	PMID:23630614
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313817	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TAF1C mRNA	PMID:19770486
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305658	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TAF1C mRNA	PMID:31150632
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313817	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TAF1C mRNA	PMID:25629700
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TAF1C mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TAF1C gene	PMID:20938992
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF1C mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TAF1C mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1C mRNA	PMID:39836092|PMID:40512198
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1C mRNA	PMID:40504410
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TAF1C protein	PMID:35688186
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of TAF1C mRNA	PMID:27594783
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1313817	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of TAF1C protein	PMID:22006019
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313817	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TAF1C mRNA	PMID:21570461
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305658	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TAF1C mRNA	PMID:33387578
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TAF1C mRNA	PMID:17942748
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TAF1C mRNA	PMID:33212167
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TAF1C mRNA	PMID:29803840
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of TAF1C protein	PMID:35688186
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of TAF1C mRNA	PMID:39719251
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF1C mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TAF1C mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1C mRNA	PMID:39836092|PMID:40512198
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1C mRNA	PMID:40504410
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TAF1C 5' UTR	PMID:27901495
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305658	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TAF1C mRNA	PMID:21839799
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF1C mRNA	PMID:17879257
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313817	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF1C mRNA	PMID:19770486
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313817	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TAF1C mRNA	PMID:27131904
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313817	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TAF1C gene	PMID:35295148
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305658	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TAF1C mRNA	PMID:23411599|PMID:34492290
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313817	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of TAF1C mRNA	PMID:18648102
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF1C mRNA	PMID:25047013
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305658	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF1C mRNA	PMID:32145629|PMID:33296240
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305658	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TAF1C mRNA	PMID:25181051|PMID:34947998
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313817	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TAF1C mRNA	PMID:33221593
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of TAF1C mRNA	PMID:36804509
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313817	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TAF1C mRNA	PMID:38685157
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313817	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TAF1C mRNA	PMID:37019170
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF1C mRNA	PMID:39836092
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305658	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TAF1C mRNA	PMID:33453195
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TAF1C mRNA	PMID:31533062
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TAF1C gene	PMID:29154799
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305658	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TAF1C mRNA	PMID:33387578
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF1C mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of TAF1C mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1C mRNA	PMID:39836092|PMID:40512198
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1C mRNA	PMID:40504410
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:4775	ellagic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004610	Ellagic Acid results in decreased expression of TAF1C mRNA	PMID:12002526
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305658	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TAF1C mRNA	PMID:29391264
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313817	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TAF1C mRNA	PMID:17942748
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TAF1C protein	PMID:32959892
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF1C mRNA	PMID:39836092
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:6809	methamphetamine	affects methylation	ISO	RGD:1313817	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine affects the methylation of TAF1C promoter	PMID:26307267
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313817	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of TAF1C mRNA	PMID:26307267
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313817	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TAF1C mRNA	PMID:22206623
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313817	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TAF1C mRNA	PMID:30294300
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313817	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TAF1C mRNA	PMID:27131904
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305658	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TAF1C mRNA	PMID:21346803
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313817	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of TAF1C mRNA	PMID:32835833
1313816	TAF1C	TATA-box binding protein associated factor, RNA polymerase I subunit C	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313817	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of TAF1C mRNA	PMID:35537566
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313819	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PIKFYVE mRNA	PMID:33045310
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313819	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PIKFYVE mRNA	PMID:20188158
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of PIKFYVE mRNA	PMID:15498508
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PIKFYVE mRNA	PMID:23724009
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of PIKFYVE protein	PMID:28073184
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:16170	mercury(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of PIKFYVE mRNA	PMID:19937285
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313819	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PIKFYVE mRNA	PMID:30319688
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PIKFYVE mRNA	PMID:37042841
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1592067	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PIKFYVE mRNA	PMID:27523638
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PIKFYVE protein	PMID:37730182
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1592067	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PIKFYVE mRNA	PMID:33387578
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PIKFYVE mRNA	PMID:28818685
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:230506	apilimod	affects binding	EXP		E	RGD:6480464	20240507	CTD	MESH:C504227	apilimod binds to PIKFYVE protein	PMID:28104689
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:230506	apilimod	decreases activity	EXP		E	RGD:6480464	20240507	CTD	MESH:C504227	apilimod results in decreased activity of PIKFYVE protein	PMID:27438886|PMID:28403145|PMID:30240452|PMID:32707573|PMID:32764148
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:230506	apilimod	decreases activity	ISO	RGD:1592067	E	RGD:6480464	20240507	CTD	MESH:C504227	apilimod results in decreased activity of PIKFYVE protein	PMID:24600036
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:230506	apilimod	decreases response to substance	EXP		E	RGD:6480464	20240507	CTD	MESH:C504227	PIKFYVE protein mutant form results in decreased susceptibility to apilimod	PMID:28104689
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:230506	apilimod	multiple interactions	EXP		E	RGD:6480464	20240507	CTD	MESH:C504227	[[apilimod results in decreased activity of PIKFYVE protein] which results in increased expression of ATF3 protein] inhibits the reaction [IRF7 protein results in increased expression of IFNB1 mRNA]; apilimod binds to and results in decreased activity of PIKFYVE protein	PMID:23890009|PMID:24600036
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313819	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PIKFYVE mRNA	PMID:19770486
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:25195	mercury atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of PIKFYVE mRNA	PMID:19937285
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1592067	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PIKFYVE mRNA	PMID:30779732
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PIKFYVE protein	PMID:35688186
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PIKFYVE mRNA	PMID:23557933
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1592067	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PIKFYVE mRNA	PMID:22298810
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1592067	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PIKFYVE mRNA	PMID:33387578
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of PIKFYVE mRNA	PMID:24834073
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of PIKFYVE mRNA	PMID:29301061|PMID:38568856
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PIKFYVE mRNA	PMID:22316170
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313819	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PIKFYVE mRNA	PMID:15034205
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PIKFYVE mRNA	PMID:21871943
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313819	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of PIKFYVE mRNA]	PMID:15034205
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PIKFYVE mRNA]	PMID:32406909
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313819	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PIKFYVE mRNA	PMID:27131904
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PIKFYVE mRNA	PMID:19150397
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of PIKFYVE gene	PMID:31601247
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of PIKFYVE mRNA	PMID:15498508
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1592067	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PIKFYVE mRNA	PMID:34492290
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:33128	C60 fullerene	affects expression	ISO	RGD:1592067	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 affects the expression of PIKFYVE mRNA	PMID:19167457
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1592067	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PIKFYVE mRNA	PMID:25181051|PMID:30816183
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PIKFYVE gene	PMID:31601247
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of PIKFYVE gene	PMID:31601247
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of PIKFYVE gene	PMID:31601247
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1592067	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of PIKFYVE gene	PMID:33148267
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PIKFYVE mRNA	PMID:37042841
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1592067	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PIKFYVE mRNA	PMID:24386269
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PIKFYVE mRNA	PMID:31533062
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PIKFYVE mRNA	PMID:27153767
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PIKFYVE mRNA	PMID:25979313
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1592067	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PIKFYVE mRNA	PMID:29427782
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of PIKFYVE mRNA	PMID:23179753
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313819	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PIKFYVE mRNA	PMID:28973697
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of PIKFYVE mRNA	PMID:26690555
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1592067	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PIKFYVE mRNA	PMID:33387578
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313819	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PIKFYVE mRNA	PMID:29279043
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of PIKFYVE mRNA	PMID:40706910
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313819	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of PIKFYVE mRNA	PMID:23608068
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1592067	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of PIKFYVE gene	PMID:33148267
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1592067	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PIKFYVE mRNA	PMID:24780913
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313819	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of PIKFYVE mRNA	PMID:27131904
1313818	PIKFYVE	phosphoinositide kinase, FYVE-type zinc finger containing	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PIKFYVE mRNA	PMID:38568856
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313823	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FBXW5 mRNA	PMID:20188158
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313823	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of FBXW5 mRNA	PMID:30319688
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FBXW5 mRNA	PMID:39241906
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313823	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FBXW5 mRNA	PMID:39298647
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of FBXW5 mRNA	PMID:20823114
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305661	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FBXW5 mRNA	PMID:33387578
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FBXW5 mRNA	PMID:37042841
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of FBXW5 mRNA	PMID:18045764
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of FBXW5 mRNA	PMID:17997037
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FBXW5 protein	PMID:37730182
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:18248	iron atom	multiple interactions	ISO	RGD:1305661	E	RGD:6480464	20150512	CTD	MESH:D007501	[Tungsten co-treated with Nickel co-treated with Iron] results in decreased expression of FBXW5 mRNA	PMID:24619124
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXW5 mRNA	PMID:39836092
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of FBXW5 mRNA	PMID:17997037
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of FBXW5 mRNA	PMID:19376150
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FBXW5 mRNA	PMID:23649840
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of FBXW5 mRNA	PMID:35430440
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of FBXW5 mRNA	PMID:22206623
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXW5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXW5 mRNA	PMID:39836092
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXW5 mRNA	PMID:40504410
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:27638	cobalt atom	multiple interactions	ISO	RGD:1305661	E	RGD:6480464	20150512	CTD	MESH:D003035	[Tungsten co-treated with Nickel co-treated with Cobalt] results in decreased expression of FBXW5 mRNA	PMID:24619124
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:27998	tungsten	multiple interactions	ISO	RGD:1305661	E	RGD:6480464	20150512	CTD	MESH:D014414	[Tungsten co-treated with Nickel co-treated with Cobalt] results in decreased expression of FBXW5 mRNA; [Tungsten co-treated with Nickel co-treated with Iron] results in decreased expression of FBXW5 mRNA	PMID:24619124
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1305661	E	RGD:6480464	20150512	CTD	MESH:D009532	[Tungsten co-treated with Nickel co-treated with Cobalt] results in decreased expression of FBXW5 mRNA; [Tungsten co-treated with Nickel co-treated with Iron] results in decreased expression of FBXW5 mRNA	PMID:24619124
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305661	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBXW5 mRNA	PMID:33387578
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FBXW5 mRNA	PMID:17942748
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313823	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of FBXW5 mRNA	PMID:30807115
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FBXW5 mRNA	PMID:38568856
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXW5 mRNA	PMID:39719251
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXW5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXW5 mRNA	PMID:39836092
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXW5 mRNA	PMID:40504410
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of FBXW5 mRNA	PMID:35676786
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:31746	kainic acid	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20120412	CTD	MESH:D007608	Kainic Acid results in decreased expression of FBXW5 mRNA	PMID:17997037
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305661	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FBXW5 mRNA	PMID:34492290
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313823	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of FBXW5 mRNA	PMID:18301758
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305661	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of FBXW5 mRNA	PMID:19167457
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305661	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FBXW5 mRNA	PMID:25181051
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXW5 mRNA	PMID:28628672
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305661	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXW5 mRNA	PMID:36041667
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313823	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of FBXW5 mRNA	PMID:39298647
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305661	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXW5 mRNA	PMID:36041667
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBXW5 mRNA	PMID:28628672
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305661	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBXW5 mRNA	PMID:36041667
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313823	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FBXW5 mRNA	PMID:37019170
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of FBXW5 gene	PMID:22964155
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305661	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of FBXW5 mRNA	PMID:21266533
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of FBXW5 mRNA	PMID:34813904
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXW5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBXW5 mRNA	PMID:28628672
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of FBXW5 mRNA	PMID:34813904
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXW5 mRNA	PMID:39836092
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305661	E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FBXW5 mRNA	PMID:24619124
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FBXW5 mRNA	PMID:31533062
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305661	E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXW5 mRNA	PMID:21318169
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FBXW5 gene	PMID:29154799
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXW5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBXW5 mRNA	PMID:28628672
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305661	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXW5 mRNA	PMID:33387578
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FBXW5 mRNA	PMID:29432896
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXW5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXW5 mRNA	PMID:39836092
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXW5 mRNA	PMID:40504410
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of FBXW5 mRNA	PMID:35436446
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313823	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FBXW5 mRNA	PMID:17942748
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FBXW5 mRNA	PMID:17942748
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXW5 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBXW5 mRNA	PMID:28628672
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313823	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of FBXW5 mRNA	PMID:35676786
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of FBXW5 mRNA	PMID:20823114
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1305661	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of FBXW5 mRNA	PMID:23962444
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FBXW5 mRNA	PMID:35964746
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXW5 mRNA	PMID:39836092
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:63940	sodium tungstate	decreases expression	ISO	RGD:1305661	E	RGD:6480464	20150512	CTD	MESH:C025399	sodium tungstate(VI) results in decreased expression of FBXW5 mRNA	PMID:24619124
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of FBXW5 mRNA	PMID:20823114
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313823	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FBXW5 mRNA	PMID:22206623
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313823	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of FBXW5 mRNA	PMID:22206623
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:80630	irinotecan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in increased expression of FBXW5 mRNA	PMID:20185912
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313823	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of FBXW5 mRNA	PMID:30294300
1313822	FBXW5	F-box and WD repeat domain containing 5	gene	CHEBI:82664	iron(0)	multiple interactions	ISO	RGD:1305661	E	RGD:6480464	20150512	CTD	MESH:D007501	[Tungsten co-treated with Nickel co-treated with Iron] results in decreased expression of FBXW5 mRNA	PMID:24619124
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ZNF143 mRNA	PMID:33167477
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ZNF143 mRNA	PMID:26079696
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:15756	hexadecanoic acid	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of ZNF143 mRNA	PMID:39506029
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ZNF143 mRNA	PMID:22378314
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313825	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFP143 mRNA	PMID:39241906
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305662	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ZFP143 mRNA	PMID:33387578
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZNF143 mRNA	PMID:28818685
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ZNF143 intron	PMID:30157460
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ZNF143 mRNA	PMID:19549813
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313825	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ZFP143 mRNA	PMID:19770486
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZNF143 gene	PMID:27153756
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ZNF143 mRNA	PMID:41430723
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:26523	reactive oxygen species	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D017382	[IGF1 protein results in increased abundance of Reactive Oxygen Species] which results in increased expression of ZNF143 protein; monodansylcadaverine inhibits the reaction [[IGF1 protein results in increased abundance of Reactive Oxygen Species] which results in increased expression of ZNF143 protein]	PMID:20733350
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF143 gene	PMID:25304211
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ZNF143 mRNA	PMID:23557933
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ZNF143 mRNA	PMID:27392435
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZNF143 mRNA	PMID:22298810
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313825	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP143 mRNA	PMID:21570461
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313825	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP143 mRNA	PMID:25975270
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305662	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of ZFP143 mRNA	PMID:28374803
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZNF143 mRNA	PMID:32763439
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of ZNF143 mRNA	PMID:24690739
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF143 mRNA	PMID:29803840
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF143 mRNA	PMID:38568856
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZNF143 3' UTR; Benzo(a)pyrene affects the methylation of ZNF143 intron	PMID:27901495|PMID:30157460
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313825	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZFP143 mRNA	PMID:22228805
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of ZNF143 mRNA	PMID:24690739
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ZNF143 mRNA; Silicon Dioxide results in increased expression of ZNF143 mRNA	PMID:23806026|PMID:25351596
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313825	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP143 gene; titanium dioxide results in decreased methylation of ZFP143 promoter	PMID:35295148
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305662	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ZFP143 mRNA	PMID:34492290
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of ZNF143 mRNA	PMID:38479592
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ZNF143 mRNA	PMID:29275510
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305662	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZNF143 mRNA	PMID:34947998
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313825	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP143 mRNA	PMID:33221593
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305662	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZNF143 mRNA	PMID:25181051
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305662	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZFP143 gene	PMID:28505145
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ZNF143 intron	PMID:30157460
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF143 mRNA	PMID:37042841
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZNF143 mRNA	PMID:38174414|PMID:38568856
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305662	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ZFP143 mRNA	PMID:30047161
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ZNF143 mRNA	PMID:28302478
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ZNF143 mRNA	PMID:40419075
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF143 mRNA	PMID:23179753
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305662	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ZFP143 mRNA	PMID:30047161
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF143 mRNA	PMID:20106945|PMID:25562108
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313825	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZFP143 mRNA	PMID:17562736
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305662	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZFP143 mRNA	PMID:33387578
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ZNF143 mRNA	PMID:29067470
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of ZNF143 mRNA	PMID:24690739
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1313825	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ZFP143 mRNA	PMID:19446018
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF143 gene	PMID:25304211
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of ZNF143 mRNA	PMID:22077320
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313825	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ZFP143 mRNA	PMID:35436446
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305662	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ZFP143 mRNA	PMID:30047161
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313825	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ZFP143 mRNA	PMID:35964746
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:52007	monodansylcadaverine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C008542	monodansylcadaverine inhibits the reaction [[IGF1 protein results in increased abundance of Reactive Oxygen Species] which results in increased expression of ZNF143 protein]	PMID:20733350
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:52289	wortmannin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin inhibits the reaction [IGF1 protein results in increased expression of ZNF143 protein]	PMID:20733350
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ZNF143 intron	PMID:30157460
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313825	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFP143 mRNA	PMID:22206623
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:77986	dibenziodolium	multiple interactions	EXP		E	RGD:6480464	20140415	CTD	MESH:C007517	diphenyleneiodonium inhibits the reaction [IGF1 protein results in increased expression of ZNF143 protein]	PMID:20733350
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305662	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ZFP143 mRNA	PMID:32109520
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305662	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZFP143 mRNA	PMID:30047161
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ZNF143 mRNA	PMID:38568856
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1313825	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of ZFP143 mRNA	PMID:32835833
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313825	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ZNF143 mRNA	PMID:28973697
1313824	ZNF143	zinc finger protein 143	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305662	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of ZFP143 gene	PMID:31682807
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305663	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RAB40B mRNA]	PMID:31150632
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RAB40B mRNA	PMID:26079696
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313827	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RAB40B mRNA	PMID:30319688
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RAB40B mRNA	PMID:21632981
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313827	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of RAB40B mRNA	PMID:19484750
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of RAB40B mRNA	PMID:33448797
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of RAB40B mRNA]	PMID:33448797
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of RAB40B mRNA	PMID:33448797
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of RAB40B mRNA]	PMID:33448797
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RAB40B mRNA	PMID:33387578
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of RAB40B mRNA	PMID:24376830
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RAB40B mRNA	PMID:19549813
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RAB40B intron	PMID:30157460
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RAB40B mRNA	PMID:30723492|PMID:31150632
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305663	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of RAB40B mRNA]	PMID:31150632
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of RAB40B mRNA	PMID:40512198
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of RAB40B protein	PMID:35688186
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RAB40B mRNA	PMID:31881176
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	RAB40B protein affects the susceptibility to Cisplatin	PMID:16217747
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of RAB40B mRNA	PMID:24768652
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305663	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAB40B mRNA	PMID:32109520
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RAB40B mRNA	PMID:28001369
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of RAB40B mRNA	PMID:26272509
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB40B mRNA	PMID:27188386
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RAB40B mRNA	PMID:29803840
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RAB40B mRNA	PMID:38568856
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of RAB40B mRNA	PMID:40512198
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RAB40B intron	PMID:30157460
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RAB40B mRNA	PMID:26238291
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1305663	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RAB40B mRNA	PMID:21839799
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RAB40B mRNA	PMID:25895662
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RAB40B mRNA	PMID:29341224
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:31348	capecitabine	increases response to substance	EXP		E	RGD:6480464	20170228	CTD	MESH:C110904	RAB40B protein results in increased susceptibility to Capecitabine	PMID:16734730
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:31521	doxifluridine	increases response to substance	EXP		E	RGD:6480464	20130806	CTD	MESH:C025034	RAB40B protein results in increased susceptibility to doxifluridine	PMID:16734730
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RAB40B mRNA	PMID:30047161
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of RAB40B mRNA	PMID:29264374
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313827	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RAB40B gene	PMID:35295148
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RAB40B mRNA	PMID:34492290
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RAB40B mRNA	PMID:25380136
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RAB40B mRNA	PMID:34947998
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in decreased methylation of RAB40B intron	PMID:29721103
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305663	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RAB40B mRNA	PMID:25181051|PMID:41034487
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313827	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in increased expression of RAB40B mRNA	PMID:29161229|PMID:32156529
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305663	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RAB40B gene	PMID:28505145
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RAB40B mRNA	PMID:28628672
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of RAB40B mRNA	PMID:26682919
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RAB40B intron	PMID:30157460
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RAB40B mRNA	PMID:28628672
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305663	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of RAB40B mRNA	PMID:22110744
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313827	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of RAB40B mRNA	PMID:36117858
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305663	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of RAB40B mRNA	PMID:30589522
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305663	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RAB40B mRNA	PMID:35163327
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of RAB40B mRNA	PMID:25380136
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305663	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RAB40B mRNA	PMID:35163327
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of RAB40B mRNA	PMID:19376846
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305663	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of RAB40B mRNA	PMID:24386269
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of RAB40B mRNA	PMID:25380136
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RAB40B mRNA	PMID:24449571
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RAB40B mRNA	PMID:28302478
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of RAB40B mRNA	PMID:19167446
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB40B mRNA	PMID:19167446
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RAB40B mRNA	PMID:25979313
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of RAB40B mRNA	PMID:29154799
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RAB40B mRNA	PMID:22083351|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RAB40B gene	PMID:29154799
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB40B mRNA	PMID:27188386
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RAB40B mRNA	PMID:30047161
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RAB40B mRNA	PMID:25562108
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1313827	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in increased expression of RAB40B mRNA	PMID:40633821
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RAB40B mRNA	PMID:28628672
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of RAB40B mRNA	PMID:33448797
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:D005947	fucoxanthin inhibits the reaction [Glucose results in decreased expression of RAB40B mRNA]	PMID:33448797
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RAB40B mRNA	PMID:38832940
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of RAB40B mRNA	PMID:22083351
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RAB40B mRNA	PMID:24935251
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305663	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RAB40B mRNA	PMID:33387578
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of RAB40B mRNA	PMID:40512198
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RAB40B mRNA	PMID:28628672
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RAB40B mRNA	PMID:30047161
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1313827	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in decreased expression of RAB40B mRNA]	PMID:33448797
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313827	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of RAB40B mRNA	PMID:36117858
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313827	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of RAB40B mRNA	PMID:38701926
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of RAB40B mRNA	PMID:24136188
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of RAB40B mRNA	PMID:28988120
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RAB40B intron	PMID:30157460
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RAB40B mRNA	PMID:31758290
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB40B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB40B mRNA	PMID:27188386
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1313827	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of RAB40B mRNA	PMID:25270620
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAB40B mRNA	PMID:19167446
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313827	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of RAB40B mRNA	PMID:38648751
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of RAB40B mRNA	PMID:23640034
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RAB40B mRNA	PMID:30047161
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAB40B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB40B mRNA	PMID:27188386
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305663	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RAB40B mRNA	PMID:19281266
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305663	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RAB40B mRNA	PMID:21346803
1313826	RAB40B	RAB40B, member RAS oncogene family	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305663	E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of RAB40B mRNA	PMID:22615374
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of UNC45B mRNA	PMID:30510588
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305666	E	RGD:6480464	20160607	CTD	MESH:D004958	Estradiol results in decreased expression of UNC45B mRNA	PMID:26945725
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UNC45B mRNA	PMID:25510870
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305666	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of UNC45B mRNA	PMID:33387578
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1305666	E	RGD:6480464	20180116	CTD	MESH:D009538	Nicotine results in decreased expression of UNC45B mRNA	PMID:27782041
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313831	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of UNC45B mRNA	PMID:32235866
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of UNC45B protein	PMID:34122009
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of UNC45B intron	PMID:30157460
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1305666	E	RGD:6480464	20180116	CTD	MESH:D009538	Nicotine results in decreased expression of UNC45B mRNA	PMID:27782041
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UNC45B mRNA	PMID:25510870
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UNC45B mRNA	PMID:25510870
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305666	E	RGD:6480464	20150609	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UNC45B mRNA	PMID:22129741
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of UNC45B mRNA	PMID:21641981
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of UNC45B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of UNC45B mRNA	PMID:34911549
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305666	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UNC45B mRNA	PMID:32109520
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UNC45B mRNA	PMID:19933214
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of UNC45B mRNA	PMID:29803840
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of UNC45B promoter	PMID:27901495
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UNC45B mRNA	PMID:22228805
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of UNC45B 5' UTR	PMID:27901495
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:C015001	arsenite results in decreased expression of UNC45B mRNA	PMID:18929588
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of UNC45B protein	PMID:34122009
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313831	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UNC45B gene	PMID:35295148
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305666	E	RGD:6480464	20150609	CTD	MESH:C069837	fullerene C60 results in increased expression of UNC45B mRNA	PMID:19167457
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305666	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of UNC45B mRNA	PMID:41034487
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of UNC45B protein	PMID:37567409
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313831	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of UNC45B mRNA	PMID:32156529
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313831	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of UNC45B mRNA	PMID:26682919
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UNC45B mRNA	PMID:25510870
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of UNC45B mRNA	PMID:25510870
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313831	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of UNC45B gene	PMID:31683443
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313831	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of UNC45B mRNA	PMID:39298647
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313831	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of UNC45B mRNA	PMID:30951980
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313831	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of UNC45B mRNA	PMID:30951980
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305666	E	RGD:6480464	20150609	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of UNC45B mRNA	PMID:22129741
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UNC45B mRNA	PMID:37042841
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1305666	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of UNC45B mRNA	PMID:35163327
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305666	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of UNC45B mRNA	PMID:35163327
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305666	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of UNC45B mRNA	PMID:35163327
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305666	E	RGD:6480464	20150609	CTD	MESH:C039281	furan results in increased methylation of UNC45B gene	PMID:22079235
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of UNC45B protein	PMID:34122009
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1305666	E	RGD:6480464	20180116	CTD	MESH:C464485	acetamiprid results in decreased expression of UNC45B mRNA	PMID:27782041
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of UNC45B promoter	PMID:27989131
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:D000082	Acetaminophen affects the expression of UNC45B mRNA	PMID:17562736
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of UNC45B mRNA	PMID:26690555
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:46680	serpentine asbestos	decreases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of UNC45B 3' UTR; Asbestos, Serpentine results in decreased methylation of UNC45B 5' UTR	PMID:29523930
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305666	E	RGD:6480464	20150609	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of UNC45B mRNA	PMID:15576828
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1313831	E	RGD:6480464	20150609	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of UNC45B mRNA	PMID:19042947
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1305666	E	RGD:6480464	20180116	CTD	MESH:C082359	imidacloprid results in decreased expression of UNC45B mRNA	PMID:27782041
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313831	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of UNC45B mRNA	PMID:36907384
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of UNC45B mRNA	PMID:29522793
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to UNC45B gene]	PMID:28238834
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305666	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of UNC45B mRNA	PMID:32109520
1313830	UNC45B	unc-45 myosin chaperone B	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313831	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of UNC45B mRNA	PMID:27935865
1313832	VSX1	visual system homeobox 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313833	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of VSX1 mRNA	PMID:33045310
1313832	VSX1	visual system homeobox 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of VSX1 protein	PMID:18951874
1313832	VSX1	visual system homeobox 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in increased expression of VSX1 mRNA	PMID:27905399
1313832	VSX1	visual system homeobox 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305667	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of VSX1 mRNA	PMID:33387578
1313832	VSX1	visual system homeobox 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of VSX1 mRNA	PMID:19549813
1313832	VSX1	visual system homeobox 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305667	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of VSX1 mRNA	PMID:23630614
1313832	VSX1	visual system homeobox 1	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305667	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of VSX1 mRNA	PMID:31129395
1313832	VSX1	visual system homeobox 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VSX1 mRNA	PMID:27188386
1313832	VSX1	visual system homeobox 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of VSX1 mRNA	PMID:23557933
1313832	VSX1	visual system homeobox 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of VSX1 mRNA	PMID:27392435
1313832	VSX1	visual system homeobox 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313833	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VSX1 mRNA	PMID:24058054
1313832	VSX1	visual system homeobox 1	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of VSX1 protein	PMID:18951874
1313832	VSX1	visual system homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of VSX1 3' UTR; Benzo(a)pyrene affects the methylation of VSX1 promoter	PMID:27901495
1313832	VSX1	visual system homeobox 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of VSX1 exon	PMID:27901495
1313832	VSX1	visual system homeobox 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of VSX1 promoter	PMID:23974009
1313832	VSX1	visual system homeobox 1	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305667	E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in decreased expression of VSX1 mRNA	PMID:33150645
1313832	VSX1	visual system homeobox 1	gene	CHEBI:30966	glycidol	increases methylation	ISO	RGD:1305667	E	RGD:6480464	20231003	CTD	MESH:C004312	glycidol results in increased methylation of VSX1 promoter	PMID:33150595
1313832	VSX1	visual system homeobox 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313833	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VSX1 gene	PMID:35295148
1313832	VSX1	visual system homeobox 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313833	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of VSX1 promoter	PMID:27334623
1313832	VSX1	visual system homeobox 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305667	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of VSX1 mRNA	PMID:25181051
1313832	VSX1	visual system homeobox 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305667	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of VSX1 gene	PMID:28505145
1313832	VSX1	visual system homeobox 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1313833	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of VSX1 promoter	PMID:27312807
1313832	VSX1	visual system homeobox 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305667	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of VSX1 mRNA	PMID:31129395
1313832	VSX1	visual system homeobox 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of VSX1 mRNA	PMID:28298639
1313832	VSX1	visual system homeobox 1	gene	CHEBI:35004	Tetrachlorobisphenol A	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C041181	tetrachlorodian results in increased expression of VSX1 mRNA	PMID:31326446
1313832	VSX1	visual system homeobox 1	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305667	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of VSX1 mRNA	PMID:35163327
1313832	VSX1	visual system homeobox 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305667	E	RGD:6480464	20231003	CTD	MESH:D014635	Valproic Acid results in decreased expression of VSX1 mRNA	PMID:33150595
1313832	VSX1	visual system homeobox 1	gene	CHEBI:39867	valproic acid	increases methylation	ISO	RGD:1305667	E	RGD:6480464	20231003	CTD	MESH:D014635	Valproic Acid results in increased methylation of VSX1 promoter	PMID:33150595
1313832	VSX1	visual system homeobox 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of VSX1 mRNA	PMID:22230336
1313832	VSX1	visual system homeobox 1	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of VSX1 promoter	PMID:29626692
1313832	VSX1	visual system homeobox 1	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of VSX1 promoter	PMID:29626692
1313832	VSX1	visual system homeobox 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305667	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of VSX1 mRNA	PMID:29391264
1313832	VSX1	visual system homeobox 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VSX1 mRNA	PMID:27188386
1313832	VSX1	visual system homeobox 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305667	E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in decreased expression of VSX1 mRNA	PMID:33150595
1313832	VSX1	visual system homeobox 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases methylation	ISO	RGD:1305667	E	RGD:6480464	20231003	CTD	MESH:D011441	Propylthiouracil results in increased methylation of VSX1 promoter	PMID:33150595
1313832	VSX1	visual system homeobox 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VSX1 mRNA	PMID:27188386
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:10607	n-propyl gallate	affects expression	ISO	RGD:1305668	E	RGD:6480464	20141111	CTD	MESH:D011435	Propyl Gallate affects the expression of PAIP1 mRNA	PMID:18539377
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PAIP1 mRNA	PMID:23724009
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PAIP1 mRNA	PMID:22378314
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313835	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of PAIP1 mRNA	PMID:40945087
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of PAIP1 mRNA	PMID:12419474
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:17833	gentamycin	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of PAIP1 mRNA	PMID:20849824
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313835	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PAIP1 mRNA	PMID:37236586
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PAIP1 mRNA	PMID:19549813
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PAIP1 protein	PMID:23301498
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1305668	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of PAIP1 protein	PMID:33236894
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:2682	amphotericin B	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D000666	Amphotericin B results in decreased expression of PAIP1 mRNA	PMID:20849824
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PAIP1 protein	PMID:35688186
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D002945	Cisplatin results in decreased expression of PAIP1 mRNA	PMID:20849824
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313835	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PAIP1 mRNA	PMID:21570461
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PAIP1 mRNA	PMID:28001369
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PAIP1 mRNA	PMID:33212167
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of PAIP1 mRNA	PMID:23649840
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305668	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PAIP1 mRNA	PMID:28959563
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PAIP1 mRNA	PMID:20971185
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PAIP1 mRNA	PMID:29803840
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313835	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of PAIP1 mRNA	PMID:22342234
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PAIP1 promoter	PMID:27901495
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PAIP1 mRNA	PMID:20971185
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PAIP1 mRNA	PMID:25351596
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PAIP1 mRNA	PMID:19150397
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305668	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PAIP1 mRNA	PMID:30047161
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313835	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PAIP1 mRNA	PMID:18648102
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313835	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PAIP1 mRNA	PMID:18445702
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of PAIP1 mRNA	PMID:12419474
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305668	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PAIP1 mRNA	PMID:19167457
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305668	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PAIP1 mRNA	PMID:25181051
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PAIP1 mRNA	PMID:29275510|PMID:33670352
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313835	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PAIP1 mRNA	PMID:26063408
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PAIP1 mRNA	PMID:28628672
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313835	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PAIP1 mRNA	PMID:39298647
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313835	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PAIP1 mRNA	PMID:21266533
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PAIP1 mRNA	PMID:28628672
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305668	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PAIP1 mRNA	PMID:33453195
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313835	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PAIP1 mRNA	PMID:37236586
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PAIP1 mRNA	PMID:19376846
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PAIP1 mRNA	PMID:28302478
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of PAIP1 mRNA	PMID:19167446
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PAIP1 mRNA	PMID:23179753|PMID:27188386
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305668	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of PAIP1 mRNA	PMID:38685447|PMID:41580965
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:4027	cyclophosphamide	decreases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of PAIP1 mRNA	PMID:20849824
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PAIP1 mRNA	PMID:28628672
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313835	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PAIP1 mRNA	PMID:28973697
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of PAIP1 mRNA	PMID:33512557
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of PAIP1 mRNA	PMID:23649840
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PAIP1 mRNA	PMID:24935251|PMID:26272509
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAIP1 mRNA	PMID:27188386
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D000082	Acetaminophen results in decreased expression of PAIP1 mRNA	PMID:21420995|PMID:26497421
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of PAIP1 mRNA]	PMID:15016801
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313835	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of PAIP1 mRNA	PMID:35436446
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PAIP1 mRNA	PMID:28628672
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:49976	zinc dichloride	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C016837	zinc chloride results in decreased expression of PAIP1 mRNA	PMID:18947441
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305668	E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of PAIP1 mRNA	PMID:38685447|PMID:41580965
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305668	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of PAIP1 mRNA	PMID:19162173
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PAIP1 protein	PMID:32959892
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1305668	E	RGD:6480464	20170725	CTD	MESH:D008694	Methamphetamine results in increased expression of PAIP1 mRNA	PMID:28341135
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305668	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of PAIP1 mRNA	PMID:30467583
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1313835	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of PAIP1 mRNA	PMID:28444820
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313835	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PAIP1 mRNA	PMID:22206623
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PAIP1 protein	PMID:37664457
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAIP1 mRNA	PMID:27188386
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313835	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of PAIP1 mRNA	PMID:31388691
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313835	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PAIP1 mRNA	PMID:30294300
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305668	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PAIP1 mRNA	PMID:30047161
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PAIP1 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAIP1 mRNA	PMID:27188386|PMID:37664457
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PAIP1 mRNA	PMID:29301935
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1313835	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of PAIP1 protein	PMID:24648495
1313834	PAIP1	poly(A) binding protein interacting protein 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305668	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of PAIP1 mRNA	PMID:19015723
1313837	LMO4	LIM domain only 4	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:D004237	Diuron results in decreased expression of STIMATE mRNA	PMID:21551480
1313837	LMO4	LIM domain only 4	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305670	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of LMO4 mRNA	PMID:21551480
1313837	LMO4	LIM domain only 4	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of LMO4 mRNA	PMID:26272509
1313837	LMO4	LIM domain only 4	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO4 mRNA	PMID:27188386
1313837	LMO4	LIM domain only 4	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313838	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of LMO4 mRNA	PMID:33045310
1313837	LMO4	LIM domain only 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of LMO4 mRNA	PMID:23724009
1313837	LMO4	LIM domain only 4	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313838	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of LMO4 mRNA	PMID:30319688
1313837	LMO4	LIM domain only 4	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of LMO4 mRNA	PMID:29432896
1313837	LMO4	LIM domain only 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313838	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of LMO4 mRNA	PMID:39298647
1313837	LMO4	LIM domain only 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305670	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LMO4 mRNA	PMID:33387578
1313837	LMO4	LIM domain only 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LMO4 mRNA	PMID:37042841
1313837	LMO4	LIM domain only 4	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D002635	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of LMO4 mRNA	PMID:34589561
1313837	LMO4	LIM domain only 4	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of LMO4 mRNA	PMID:18037150
1313837	LMO4	LIM domain only 4	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of STIMATE mRNA	PMID:26496021
1313837	LMO4	LIM domain only 4	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D006000	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of LMO4 mRNA	PMID:34589561
1313837	LMO4	LIM domain only 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LMO4 mRNA	PMID:19850644
1313837	LMO4	LIM domain only 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of LMO4 mRNA]	PMID:19850644
1313837	LMO4	LIM domain only 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:D005839	Gentamicins results in decreased expression of STIMATE mRNA	PMID:33387578
1313837	LMO4	LIM domain only 4	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305670	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of LMO4 mRNA	PMID:22061828
1313837	LMO4	LIM domain only 4	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of LMO4 mRNA	PMID:28818685
1313837	LMO4	LIM domain only 4	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LMO4 mRNA	PMID:39836092
1313837	LMO4	LIM domain only 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LMO4 mRNA	PMID:37236586
1313837	LMO4	LIM domain only 4	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LMO4 mRNA	PMID:19549813
1313837	LMO4	LIM domain only 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LMO4 gene	PMID:27153756
1313837	LMO4	LIM domain only 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of LMO4 mRNA	PMID:27106289
1313837	LMO4	LIM domain only 4	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1313838	E	RGD:6480464	20200519	CTD	MESH:D015032	Zinc deficiency results in increased expression of LMO4 mRNA	PMID:31505237
1313837	LMO4	LIM domain only 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LMO4 mRNA	PMID:22206623
1313837	LMO4	LIM domain only 4	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D006002	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of LMO4 mRNA	PMID:34589561
1313837	LMO4	LIM domain only 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LMO4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO4 mRNA	PMID:39836092
1313837	LMO4	LIM domain only 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO4 mRNA	PMID:40504410
1313837	LMO4	LIM domain only 4	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of LMO4 mRNA	PMID:26272509
1313837	LMO4	LIM domain only 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO4 mRNA	PMID:27188386
1313837	LMO4	LIM domain only 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LMO4 mRNA	PMID:28960355
1313837	LMO4	LIM domain only 4	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of LMO4 mRNA	PMID:24768652
1313837	LMO4	LIM domain only 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313838	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LMO4 mRNA	PMID:21570461
1313837	LMO4	LIM domain only 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LMO4 mRNA	PMID:20106945|PMID:21632981
1313837	LMO4	LIM domain only 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305670	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LMO4 mRNA	PMID:33387578|PMID:34747641
1313837	LMO4	LIM domain only 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LMO4 mRNA	PMID:17942748
1313837	LMO4	LIM domain only 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LMO4 mRNA	PMID:28001369
1313837	LMO4	LIM domain only 4	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of LMO4 mRNA	PMID:28001369
1313837	LMO4	LIM domain only 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of LMO4 mRNA	PMID:16243910
1313837	LMO4	LIM domain only 4	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D003840	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of LMO4 mRNA	PMID:34589561
1313837	LMO4	LIM domain only 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LMO4 mRNA	PMID:38568856
1313837	LMO4	LIM domain only 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LMO4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO4 mRNA	PMID:39836092
1313837	LMO4	LIM domain only 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO4 mRNA	PMID:40504410
1313837	LMO4	LIM domain only 4	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of LMO4 mRNA	PMID:22378314
1313837	LMO4	LIM domain only 4	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313838	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of LMO4 mRNA	PMID:22342234
1313837	LMO4	LIM domain only 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LMO4 promoter	PMID:27901495
1313837	LMO4	LIM domain only 4	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of LMO4 promoter	PMID:23974009
1313837	LMO4	LIM domain only 4	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1313838	E	RGD:6480464	20200519	CTD	MESH:D015032	Zinc deficiency results in increased expression of LMO4 mRNA	PMID:31505237
1313837	LMO4	LIM domain only 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LMO4 mRNA	PMID:20382639
1313837	LMO4	LIM domain only 4	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:D005897	Glafenine results in increased expression of STIMATE mRNA	PMID:24136188
1313837	LMO4	LIM domain only 4	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of LMO4 mRNA	PMID:38568856
1313837	LMO4	LIM domain only 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305670	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of LMO4 mRNA	PMID:25729387
1313837	LMO4	LIM domain only 4	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of STIMATE mRNA	PMID:30047161
1313837	LMO4	LIM domain only 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313838	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LMO4 gene	PMID:35295148
1313837	LMO4	LIM domain only 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313838	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LMO4 promoter	PMID:35295148
1313837	LMO4	LIM domain only 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305670	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LMO4 mRNA	PMID:34492290
1313837	LMO4	LIM domain only 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LMO4 mRNA	PMID:18445702
1313837	LMO4	LIM domain only 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LMO4 mRNA	PMID:19710929
1313837	LMO4	LIM domain only 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LMO4 mRNA	PMID:19710929
1313837	LMO4	LIM domain only 4	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of LMO4 mRNA	PMID:38479592
1313837	LMO4	LIM domain only 4	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of LMO4 mRNA	PMID:28329830
1313837	LMO4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305670	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of LMO4 mRNA; bisphenol A affects the expression of STIMATE mRNA	PMID:25181051
1313837	LMO4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313838	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of LMO4 promoter	PMID:27334623
1313837	LMO4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of LMO4 mRNA	PMID:29275510
1313837	LMO4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305670	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of LMO4 mRNA	PMID:32145629
1313837	LMO4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in increased expression of STIMATE mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313837	LMO4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in increased methylation of STIMATE gene	PMID:28505145
1313837	LMO4	LIM domain only 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of STIMATE mRNA; [bisphenol A co-treated with Testosterone] results in increased expression of STIMATE mRNA	PMID:26496021|PMID:36041667
1313837	LMO4	LIM domain only 4	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of LMO4 mRNA	PMID:25979313
1313837	LMO4	LIM domain only 4	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of LMO4 mRNA	PMID:26682919
1313837	LMO4	LIM domain only 4	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305670	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of LMO4 mRNA	PMID:23196670
1313837	LMO4	LIM domain only 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of STIMATE mRNA	PMID:36041667
1313837	LMO4	LIM domain only 4	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of STIMATE mRNA	PMID:36041667
1313837	LMO4	LIM domain only 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305670	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LMO4 mRNA	PMID:21266533
1313837	LMO4	LIM domain only 4	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313838	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of LMO4 mRNA	PMID:34813904
1313837	LMO4	LIM domain only 4	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313838	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of LMO4 mRNA	PMID:34813904
1313837	LMO4	LIM domain only 4	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LMO4 mRNA	PMID:39836092
1313837	LMO4	LIM domain only 4	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of STIMATE promoter	PMID:22457795
1313837	LMO4	LIM domain only 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LMO4 mRNA	PMID:37236586
1313837	LMO4	LIM domain only 4	gene	CHEBI:35572	phorone	affects expression	ISO	RGD:1305670	E	RGD:6480464	20120501	CTD	MESH:C018637	phorone affects the expression of LMO4 mRNA	PMID:18198479
1313837	LMO4	LIM domain only 4	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of STIMATE mRNA	PMID:30047161
1313837	LMO4	LIM domain only 4	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D005999	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of LMO4 mRNA	PMID:34589561
1313837	LMO4	LIM domain only 4	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313838	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of LMO4 mRNA	PMID:18353800
1313837	LMO4	LIM domain only 4	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of LMO4 mRNA	PMID:26352163
1313837	LMO4	LIM domain only 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of LMO4 mRNA	PMID:40419075
1313837	LMO4	LIM domain only 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LMO4 mRNA	PMID:25979313
1313837	LMO4	LIM domain only 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313838	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid affects the expression of LMO4 mRNA	PMID:17292431|PMID:17963808
1313837	LMO4	LIM domain only 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of LMO4 mRNA	PMID:28001369
1313837	LMO4	LIM domain only 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of LMO4 mRNA	PMID:19136453
1313837	LMO4	LIM domain only 4	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LMO4 gene	PMID:29154799
1313837	LMO4	LIM domain only 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of LMO4 mRNA	PMID:26272509
1313837	LMO4	LIM domain only 4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO4 mRNA	PMID:27188386
1313837	LMO4	LIM domain only 4	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:D000640	Amitrole results in increased expression of STIMATE mRNA	PMID:30047161
1313837	LMO4	LIM domain only 4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in increased expression of LMO4 mRNA	PMID:20106945|PMID:22147139
1313837	LMO4	LIM domain only 4	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of LMO4 mRNA	PMID:15171707
1313837	LMO4	LIM domain only 4	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of LMO4 mRNA	PMID:24449571
1313837	LMO4	LIM domain only 4	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of LMO4 mRNA	PMID:24935251
1313837	LMO4	LIM domain only 4	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of LMO4 mRNA	PMID:24935251|PMID:26272509
1313837	LMO4	LIM domain only 4	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO4 mRNA	PMID:27188386
1313837	LMO4	LIM domain only 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LMO4 mRNA	PMID:17562736
1313837	LMO4	LIM domain only 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of LMO4 mRNA	PMID:21420995|PMID:29067470
1313837	LMO4	LIM domain only 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305670	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LMO4 mRNA; Acetaminophen results in increased expression of STIMATE mRNA	PMID:33387578
1313837	LMO4	LIM domain only 4	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D000082	[Acetaminophen co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of LMO4 mRNA	PMID:34589561
1313837	LMO4	LIM domain only 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LMO4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO4 mRNA	PMID:39836092
1313837	LMO4	LIM domain only 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LMO4 mRNA	PMID:40504410
1313837	LMO4	LIM domain only 4	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of LMO4 mRNA	PMID:35537566
1313837	LMO4	LIM domain only 4	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of LMO4 mRNA	PMID:31838189
1313837	LMO4	LIM domain only 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LMO4 mRNA	PMID:17942748
1313837	LMO4	LIM domain only 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313838	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LMO4 mRNA; Nanotubes, Carbon results in increased expression of LMO4 mRNA	PMID:25554681|PMID:25620056
1313837	LMO4	LIM domain only 4	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305670	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of LMO4 mRNA	PMID:41580965
1313837	LMO4	LIM domain only 4	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:D008713	Methimazole results in increased expression of STIMATE mRNA	PMID:30047161
1313837	LMO4	LIM domain only 4	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D011192	Potassium Dichromate results in increased expression of LMO4 mRNA	PMID:11678601
1313837	LMO4	LIM domain only 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LMO4 mRNA	PMID:39836092
1313837	LMO4	LIM domain only 4	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305670	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of LMO4 mRNA	PMID:25729387
1313837	LMO4	LIM domain only 4	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of LMO4 mRNA	PMID:28988120
1313837	LMO4	LIM domain only 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305670	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of LMO4 mRNA	PMID:28801915
1313837	LMO4	LIM domain only 4	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305670	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of LMO4 mRNA	PMID:30467583
1313837	LMO4	LIM domain only 4	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:D008731	Methoxychlor affects the methylation of STIMATE gene	PMID:35440735
1313837	LMO4	LIM domain only 4	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20190910	CTD	MESH:C581157	XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of LMO4 mRNA]	PMID:29891994
1313837	LMO4	LIM domain only 4	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of LMO4 mRNA	PMID:31758290
1313837	LMO4	LIM domain only 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LMO4 mRNA	PMID:22206623
1313837	LMO4	LIM domain only 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LMO4 mRNA	PMID:22206623
1313837	LMO4	LIM domain only 4	gene	CHEBI:76290	PhIP	decreases expression	ISO	RGD:1305670	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of LMO4 mRNA	PMID:15215175
1313837	LMO4	LIM domain only 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO4 mRNA	PMID:27188386
1313837	LMO4	LIM domain only 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LMO4 gene]	PMID:28238834
1313837	LMO4	LIM domain only 4	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20120613	CTD	MESH:D010634	Phenobarbital results in decreased expression of LMO4 mRNA	PMID:19363144|PMID:19482888
1313837	LMO4	LIM domain only 4	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313838	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of LMO4 mRNA]	PMID:19482888
1313837	LMO4	LIM domain only 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305670	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of LMO4 mRNA; Propylthiouracil results in increased expression of STIMATE mRNA	PMID:24780913|PMID:30047161
1313837	LMO4	LIM domain only 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LMO4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LMO4 mRNA	PMID:27188386
1313837	LMO4	LIM domain only 4	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LMO4 mRNA	PMID:38568856
1313837	LMO4	LIM domain only 4	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of LMO4 mRNA	PMID:22378314
1313837	LMO4	LIM domain only 4	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C032910	triadimefon results in increased expression of LMO4 mRNA	PMID:26705709
1313837	LMO4	LIM domain only 4	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313838	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of LMO4 mRNA	PMID:35537566
1313837	LMO4	LIM domain only 4	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305670	E	RGD:6480464	20260811	CTD	MESH:C025643	vinclozolin results in increased expression of STIMATE mRNA	PMID:22570695
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SPOCK3 mRNA	PMID:21934132
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313841	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SPOCK3 mRNA	PMID:24205000
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313841	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SPOCK3 mRNA	PMID:30319688
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of SPOCK3 mRNA	PMID:19429434
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313841	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPOCK3 mRNA	PMID:25510870
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313841	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of SPOCK3 mRNA	PMID:33711761
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305672	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SPOCK3 mRNA	PMID:33387578
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305672	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SPOCK3 promoter	PMID:23359474
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:181932	3-Nitrobenzanthrone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C117220	3-nitrobenzanthrone results in decreased expression of SPOCK3 mRNA	PMID:34036453
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313841	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPOCK3 mRNA	PMID:25510870
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313841	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPOCK3 mRNA	PMID:25510870
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SPOCK3 mRNA	PMID:19549813
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:2422	acetohydrazide	decreases expression	ISO	RGD:1313841	E	RGD:6480464	20120412	CTD	MESH:C014949	acetylhydrazine results in decreased expression of SPOCK3 mRNA	PMID:15282401
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SPOCK3 mRNA	PMID:22100608|PMID:32234424|PMID:35690182
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313841	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SPOCK3 mRNA	PMID:25629700
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:27470	folic acid	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of SPOCK3 mRNA	PMID:21867686
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SPOCK3 mRNA	PMID:26272509
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPOCK3 mRNA	PMID:27188386
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313841	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SPOCK3 mRNA	PMID:28960355
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313841	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPOCK3 mRNA	PMID:21570461|PMID:24680724
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305672	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPOCK3 mRNA	PMID:32109520
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPOCK3 mRNA	PMID:21296121
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SPOCK3 mRNA	PMID:33212167
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of SPOCK3 gene	PMID:28589171
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SPOCK3 mRNA	PMID:32234424|PMID:35690182
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SPOCK3 promoter	PMID:27901495
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313841	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to SPOCK3 promoter]	PMID:19654925
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of SPOCK3 mRNA	PMID:37690743
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of SPOCK3 gene	PMID:31601247
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313841	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SPOCK3 mRNA	PMID:29264374
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305672	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPOCK3 mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305672	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SPOCK3 promoter	PMID:23359474
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313841	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPOCK3 mRNA	PMID:25510870
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313841	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of SPOCK3 mRNA	PMID:25510870
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313841	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SPOCK3 intron	PMID:28392331
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305672	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SPOCK3 promoter	PMID:23359474
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305672	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SPOCK3 mRNA	PMID:32680482
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305672	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of SPOCK3 promoter	PMID:22457795
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SPOCK3 mRNA	PMID:24449571
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPOCK3 mRNA	PMID:25979313
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313841	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of SPOCK3 mRNA	PMID:24896083
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SPOCK3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPOCK3 mRNA	PMID:27188386
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SPOCK3 mRNA	PMID:38832940
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in increased expression of SPOCK3 mRNA	PMID:24935251|PMID:27188386
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305672	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SPOCK3 mRNA	PMID:33387578
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of SPOCK3 mRNA	PMID:32234424|PMID:35690182
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:6382	Lasiocarpine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005136	lasiocarpine results in decreased expression of SPOCK3 mRNA	PMID:32234424|PMID:35690182
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SPOCK3 mRNA	PMID:24810058
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPOCK3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPOCK3 mRNA	PMID:27188386
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SPOCK3 gene]	PMID:28238834
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305672	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SPOCK3 mRNA	PMID:32109520
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313841	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SPOCK3 mRNA	PMID:38648751
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of SPOCK3 mRNA	PMID:32234424|PMID:35690182
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:83258	fenamidone	decreases expression	ISO	RGD:1313841	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in decreased expression of SPOCK3 mRNA	PMID:27029645
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313841	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SPOCK3 mRNA	PMID:21795629
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305672	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SPOCK3 mRNA	PMID:24780913
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:8772	raloxifene	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of SPOCK3 mRNA	PMID:19429434
1313840	SPOCK3	SPARC (osteonectin), cwcv and kazal like domains proteoglycan 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPOCK3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPOCK3 mRNA	PMID:27188386
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ADGRG3 mRNA	PMID:33167477
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20190409	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADGRG3 mRNA	PMID:30529165
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADGRG3 mRNA	PMID:25510870
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADGRG3 mRNA	PMID:37042841
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1550278	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in decreased expression of ADGRG3 mRNA	PMID:15120971|PMID:15122651
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRG3 mRNA	PMID:37992649
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:174733	Licochalcone B	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of ADGRG3 mRNA	PMID:33647349
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRG3 mRNA	PMID:37992649
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D014520	Urethane results in decreased expression of ADGRG3 mRNA	PMID:28818685
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ADGRG3 mRNA	PMID:36331819
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADGRG3 mRNA	PMID:25510870
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADGRG3 mRNA	PMID:25510870
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ADGRG3 mRNA	PMID:41430723
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ADGRG3 mRNA	PMID:22206623
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550278	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADGRG3 mRNA	PMID:26377647
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305674	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADGRG3 mRNA	PMID:32109520
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550278	E	RGD:6480464	20160822	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADGRG3 mRNA	PMID:21889950|PMID:25975270|PMID:26290441|PMID:28922406
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of ADGRG3 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADGRG3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ADGRG3 mRNA	PMID:16214954|PMID:17942748|PMID:25975270
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1550278	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of ADGRG3 mRNA	PMID:39631538
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRG3 mRNA	PMID:37992649
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADGRG3 promoter	PMID:27901495
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ADGRG3 3' UTR	PMID:27901495
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550278	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADGRG3 mRNA	PMID:32417428
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ADGRG3 mRNA	PMID:37690743
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1305674	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of ADGRG3 mRNA	PMID:32479839
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305674	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ADGRG3 mRNA	PMID:34492290
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1550278	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ADGRG3 mRNA	PMID:18648102
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305674	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRG3 mRNA	PMID:25181051
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550278	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ADGRG3 mRNA	PMID:32156529|PMID:33221593
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADGRG3 mRNA	PMID:25510870
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ADGRG3 mRNA	PMID:25510870
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C543008	bisphenol S results in decreased expression of ADGRG3 mRNA	PMID:33476716
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550278	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ADGRG3 mRNA	PMID:39298647
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1550278	E	RGD:6480464	20160822	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of ADGRG3 mRNA	PMID:26377693
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1550278	E	RGD:6480464	20160822	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of ADGRG3 mRNA	PMID:26377693
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550278	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ADGRG3 mRNA	PMID:38685157
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADGRG3 mRNA	PMID:37042841
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of ADGRG3 mRNA	PMID:29024780
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305674	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADGRG3 mRNA	PMID:35163327
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ADGRG3 mRNA	PMID:25812627
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305674	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADGRG3 mRNA	PMID:35163327
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ADGRG3 mRNA	PMID:25812627
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550278	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADGRG3 mRNA	PMID:40194260
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C000944	dicrotophos results in increased expression of ADGRG3 mRNA	PMID:28302478
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ADGRG3 mRNA	PMID:25812627
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ADGRG3 mRNA	PMID:36331819
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D016572	Cyclosporine results in increased expression of ADGRG3 mRNA	PMID:25562108
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550278	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ADGRG3 mRNA	PMID:20937368
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550278	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ADGRG3 mRNA	PMID:28973697
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADGRG3 mRNA	PMID:37992649
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ADGRG3 mRNA	PMID:38832940
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADGRG3 mRNA	PMID:22230336
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C016766	sulforaphane results in increased expression of ADGRG3 mRNA	PMID:26833863
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADGRG3 mRNA	PMID:17942748
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of ADGRG3 mRNA	PMID:38568856
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550278	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ADGRG3 mRNA	PMID:25620056
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550278	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ADGRG3 mRNA; Nanotubes, Carbon results in increased expression of ADGRG3 mRNA	PMID:25554681
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ADGRG3 mRNA	PMID:28988120
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ADGRG3 mRNA	PMID:27935865
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550278	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADGRG3 mRNA	PMID:22206623
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550278	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ADGRG3 mRNA	PMID:22206623
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550278	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ADGRG3 mRNA	PMID:22206623
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ADGRG3 gene]	PMID:28238834
1313843	ADGRG3	adhesion G protein-coupled receptor G3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ADGRG3 mRNA	PMID:29301935
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of LRCH1 mRNA	PMID:27188386
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of LRCH1 mRNA	PMID:23724009
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of LRCH1 mRNA	PMID:21934132
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of LRCH1 mRNA	PMID:21632981
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of LRCH1 mRNA	PMID:29581250
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1558043	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LRCH1 mRNA	PMID:39241906
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1558043	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of LRCH1 mRNA	PMID:39298647
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LRCH1 mRNA	PMID:31163220
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of LRCH1 protein	PMID:37730182
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1558043	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of LRCH1 mRNA]	PMID:22206623
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of LRCH1 mRNA	PMID:26272509
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRCH1 mRNA	PMID:27188386
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of LRCH1 protein	PMID:35688186
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1558043	E	RGD:6480464	20231003	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in increased methylation of LRCH1 intron	PMID:33445541
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of LRCH1 mRNA	PMID:27392435
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1558043	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRCH1 mRNA	PMID:21570461
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1595678	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRCH1 mRNA	PMID:32109520
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1595678	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRCH1 mRNA	PMID:33387578
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LRCH1 mRNA	PMID:33212167
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LRCH1 mRNA	PMID:30851411
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LRCH1 mRNA	PMID:29803840
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1558043	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of LRCH1 mRNA	PMID:39631538
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of LRCH1 protein	PMID:35688186
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LRCH1 promoter	PMID:27901495
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1558043	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRCH1 mRNA	PMID:19770486
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1558043	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LRCH1 exon; Benzo(a)pyrene results in increased methylation of LRCH1 intron	PMID:27901495
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to LRCH1 mRNA]	PMID:32406909
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of LRCH1 mRNA	PMID:25895662
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LRCH1 mRNA	PMID:20382639
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LRCH1 gene	PMID:31601247
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1558043	E	RGD:6480464	20231003	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in increased methylation of LRCH1 intron	PMID:33445541
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1595678	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of LRCH1 mRNA	PMID:25729387
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1595678	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of LRCH1 mRNA	PMID:30047161
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1558043	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRCH1 gene	PMID:35295148
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1595678	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of LRCH1 mRNA	PMID:23411599
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LRCH1 mRNA	PMID:19710929
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1595678	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LRCH1 mRNA	PMID:34947998
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1595678	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LRCH1 mRNA	PMID:25181051
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1595678	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LRCH1 gene	PMID:28505145
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LRCH1 gene	PMID:31601247
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of LRCH1 mRNA	PMID:25979313
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1558043	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LRCH1 mRNA	PMID:21266533
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1595678	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LRCH1 mRNA	PMID:21266533
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LRCH1 mRNA	PMID:37042841
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1595678	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LRCH1 mRNA	PMID:35163327
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1595678	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of LRCH1 mRNA	PMID:35163327
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1595678	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of LRCH1 gene	PMID:22079235
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LRCH1 gene	PMID:29154799
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of LRCH1 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRCH1 mRNA	PMID:27188386
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of LRCH1 mRNA	PMID:25562108
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of LRCH1 mRNA	PMID:24935251|PMID:26272509
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRCH1 mRNA	PMID:27188386
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1595678	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of LRCH1 mRNA	PMID:29391264
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LRCH1 mRNA	PMID:22079256
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1558043	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LRCH1 mRNA; Nanotubes, Carbon results in decreased expression of LRCH1 mRNA	PMID:25554681
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1595678	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of LRCH1 mRNA	PMID:30047161
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1558043	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of LRCH1 mRNA	PMID:23608068
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1595678	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of LRCH1 mRNA	PMID:25729387
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1595678	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of LRCH1 mRNA	PMID:25729387
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of LRCH1 mRNA	PMID:28988120
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1558043	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LRCH1 mRNA	PMID:22206623
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1558043	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of LRCH1 mRNA]	PMID:22206623
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of LRCH1 mRNA	PMID:22079256
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LRCH1 mRNA	PMID:22079256
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LRCH1 mRNA	PMID:30851411
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRCH1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRCH1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRCH1 mRNA	PMID:27188386
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of LRCH1 mRNA	PMID:26079696
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1595678	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of LRCH1 mRNA	PMID:30047161
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRCH1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRCH1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRCH1 mRNA	PMID:27188386
1313845	LRCH1	leucine rich repeats and calponin homology domain containing 1	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1595678	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of LRCH1 gene	PMID:31079544
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of CADM2 mRNA	PMID:21934132
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313848	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CADM2 mRNA	PMID:24205000
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20150127	CTD	MESH:D008628	Mercury analog results in decreased expression of CADM2 mRNA	PMID:25056781
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313848	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CADM2 mRNA	PMID:30319688
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of CADM2 mRNA	PMID:29980752
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305678	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CADM2 mRNA	PMID:33387578
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CADM2 mRNA	PMID:26079696
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CADM2 intron	PMID:30157460
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CADM2 protein	PMID:20106945
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CADM2 gene	PMID:27153756
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CADM2 intron	PMID:30157460
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20150127	CTD	MESH:D008628	Mercury analog results in decreased expression of CADM2 mRNA	PMID:25056781
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313848	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CADM2 mRNA	PMID:27106289
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CADM2 mRNA	PMID:25629700
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of CADM2 mRNA	PMID:26272509
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA	PMID:27188386
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CADM2 mRNA	PMID:28903495
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CADM2 mRNA	PMID:24768652|PMID:25583101
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305678	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CADM2 mRNA	PMID:32109520
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CADM2 mRNA	PMID:28001369
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CADM2 mRNA	PMID:23179753
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1305678	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CADM2 mRNA	PMID:27257137
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CADM2 mRNA	PMID:25879800
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CADM2 5' UTR; Benzo(a)pyrene results in increased methylation of CADM2 exon; Benzo(a)pyrene results in increased methylation of CADM2 promoter	PMID:27901495
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CADM2 mRNA	PMID:29341224
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CADM2 gene	PMID:31601247
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313848	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CADM2 gene	PMID:35295148
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305678	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CADM2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CADM2 mRNA	PMID:32156529|PMID:39742910
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305678	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of CADM2 mRNA	PMID:29097150
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CADM2 gene	PMID:31601247
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CADM2 gene	PMID:31601247
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CADM2 intron	PMID:30157460
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CADM2 mRNA	PMID:25979313
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305678	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of CADM2 mRNA	PMID:29427782
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CADM2 mRNA	PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA	PMID:27188386
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CADM2 mRNA	PMID:20106945
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313848	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CADM2 mRNA	PMID:28973697
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CADM2 mRNA	PMID:38832940
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of CADM2 mRNA	PMID:27188386
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA	PMID:27188386
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in increased expression of CADM2 mRNA	PMID:27188386
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305678	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CADM2 mRNA	PMID:33387578
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305678	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CADM2 mRNA	PMID:29097150
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CADM2 mRNA	PMID:32234424
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of CADM2 mRNA	PMID:26272509
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA	PMID:27188386
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CADM2 mRNA	PMID:22079614
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CADM2 intron	PMID:30157460
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1305678	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of CADM2 mRNA	PMID:27840820
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA	PMID:27188386
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305678	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CADM2 mRNA	PMID:32109520
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313848	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of CADM2 mRNA	PMID:27935865
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305678	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CADM2 mRNA	PMID:24780913
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CADM2 mRNA	PMID:27188386
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CADM2 mRNA	PMID:38568856
1313847	CADM2	cell adhesion molecule 2	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of CADM2 mRNA	PMID:27188386
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313850	E	RGD:6480464	20171010	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ADTRP mRNA	PMID:28558994
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305679	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADTRP mRNA]	PMID:31150632
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of ADTRP mRNA	PMID:34925699
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:136638	9-hydroxyoctadecanoic acid	affects chemical synthesis	ISO	RGD:1313850	E	RGD:6480464	20200609	CTD	MESH:C070375	ADTRP protein affects the chemical synthesis of 9-hydroxystearic acid	PMID:32152231
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ADTRP mRNA	PMID:26079696
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305679	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of ADTRP gene	PMID:28931070
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ADTRP mRNA	PMID:39241906
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of ADTRP mRNA	PMID:35811015
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313850	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ADTRP mRNA	PMID:39298647
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313850	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ADTRP mRNA	PMID:33711761
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305679	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ADTRP mRNA	PMID:33387578
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ADTRP mRNA	PMID:37042841
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of ADTRP mRNA	PMID:27664576
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ADTRP mRNA	PMID:26079696
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of ADTRP mRNA	PMID:31256213
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of ADTRP mRNA	PMID:23825647
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ADTRP mRNA	PMID:28085963
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305679	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ADTRP mRNA	PMID:27523638
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:17833	gentamycin	affects expression	ISO	RGD:1305679	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins affects the expression of ADTRP mRNA	PMID:33387578
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of ADTRP mRNA	PMID:23825647
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:188851	Muraglitazar	increases expression	ISO	RGD:1305679	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of ADTRP mRNA	PMID:21515302
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:2663	amiodarone	affects expression	ISO	RGD:1305679	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of ADTRP mRNA	PMID:19483382
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305679	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADTRP mRNA	PMID:31150632
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADTRP mRNA	PMID:31919559
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305679	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADTRP mRNA]	PMID:31150632
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305679	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ADTRP mRNA	PMID:31881176
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:28088	genistein	increases methylation	ISO	RGD:1305679	E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of ADTRP gene	PMID:28505145
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305679	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADTRP mRNA	PMID:21215274
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305679	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADTRP mRNA	PMID:33387578
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ADTRP mRNA	PMID:20971185
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313850	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ADTRP mRNA	PMID:27862939
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313850	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ADTRP gene	PMID:39894169
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ADTRP mRNA	PMID:38568856|PMID:39719251
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADTRP mRNA	PMID:22316170
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADTRP 3' UTR	PMID:27901495
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of ADTRP mRNA	PMID:20971185
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:3023	benzbromarone	affects expression	ISO	RGD:1305679	E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of ADTRP mRNA	PMID:19483382
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ADTRP mRNA	PMID:23806026
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ADTRP gene	PMID:31601247
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305679	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of ADTRP mRNA	PMID:24136188
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313850	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of ADTRP mRNA	PMID:22609695
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1305679	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of ADTRP mRNA	PMID:16507785
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:32195	Tesaglitazar	increases expression	ISO	RGD:1305679	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of ADTRP mRNA	PMID:21515302
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1305679	E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of ADTRP mRNA	PMID:19483382
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305679	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ADTRP mRNA	PMID:34492290
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1305679	E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ADTRP mRNA	PMID:28943392
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1305679	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of ADTRP mRNA	PMID:19483382
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305679	E	RGD:6480464	20160210	CTD	MESH:C006780	bisphenol A affects the expression of ADTRP mRNA	PMID:25181051
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305679	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ADTRP mRNA	PMID:30816183|PMID:32528016
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305679	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of ADTRP mRNA	PMID:41034487
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313850	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ADTRP mRNA	PMID:32156529|PMID:37894381
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ADTRP gene	PMID:31601247
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	ISO	RGD:1305679	E	RGD:6480464	20210112	CTD	MESH:C023035	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased expression of ADTRP mRNA	PMID:30744511
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ADTRP mRNA	PMID:39298647
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ADTRP mRNA	PMID:26377693
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ADTRP mRNA	PMID:38685157
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313850	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ADTRP intron	PMID:28392331
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305679	E	RGD:6480464	20150127	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ADTRP mRNA	PMID:24893172
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305679	E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ADTRP mRNA	PMID:28943392
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ADTRP mRNA	PMID:38174414|PMID:38568856
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305679	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ADTRP mRNA	PMID:28511854
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313850	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ADTRP mRNA	PMID:28558994
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305679	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ADTRP gene	PMID:22079235
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ADTRP mRNA	PMID:19320972
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305679	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ADTRP mRNA	PMID:24386269
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:3750	clofibrate	affects expression	ISO	RGD:1305679	E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of ADTRP mRNA	PMID:19483382
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313850	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of ADTRP mRNA	PMID:23811191
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:1305679	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of ADTRP mRNA	PMID:27638505
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313850	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADTRP mRNA	PMID:28558994
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313850	E	RGD:6480464	20171010	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ADTRP mRNA	PMID:28558994
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313850	E	RGD:6480464	20171010	CTD	MESH:C076994	PPARA protein affects the reaction [perfluorooctane sulfonic acid results in increased expression of ADTRP mRNA]	PMID:28558994
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ADTRP mRNA	PMID:29154799
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ADTRP gene	PMID:29154799
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ADTRP mRNA	PMID:23179753
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of ADTRP mRNA	PMID:27989131
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313850	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ADTRP mRNA	PMID:28973697
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ADTRP mRNA	PMID:38832940
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:4488	diallyl disulfide	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C028009	diallyl disulfide inhibits the reaction [tobacco tar analog results in increased expression of ADTRP mRNA]	PMID:36758788
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305679	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ADTRP mRNA	PMID:33387578
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of ADTRP mRNA	PMID:35811015
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305679	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ADTRP mRNA	PMID:29391264
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:4886	L-ethionine	affects expression	ISO	RGD:1305679	E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of ADTRP mRNA	PMID:19483382
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313850	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ADTRP mRNA	PMID:25620056
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305679	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ADTRP mRNA	PMID:24136188|PMID:24793618
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313850	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ADTRP mRNA	PMID:38701926
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of ADTRP mRNA	PMID:20436886
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1305679	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of ADTRP mRNA	PMID:33484710
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	ISO	RGD:1305679	E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of ADTRP mRNA	PMID:19483382
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:7772	omeprazole	affects expression	ISO	RGD:1305679	E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of ADTRP mRNA	PMID:19483382
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1313850	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of ADTRP mRNA	PMID:26655953
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:81517	3,4,5,3',4',5'-Hexachlorobiphenyl	multiple interactions	ISO	RGD:1305679	E	RGD:6480464	20210112	CTD	MESH:C027309	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 3,4,5,3',4',5'-hexachlorobiphenyl co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased expression of ADTRP mRNA	PMID:30744511
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313850	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ADTRP mRNA	PMID:38648751
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of ADTRP mRNA	PMID:26705709
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305679	E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of ADTRP mRNA	PMID:19483382
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305679	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ADTRP mRNA	PMID:24780913
1313849	ADTRP	androgen dependent TFPI regulating protein	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1305679	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of ADTRP mRNA	PMID:21515302
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of BICRAL mRNA	PMID:26079696
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D001280	Atrazine results in decreased expression of BICRAL mRNA	PMID:22378314
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of BICRAL mRNA	PMID:39241906
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305680	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of GLTSCR1L mRNA	PMID:32145629
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BICRAL mRNA	PMID:37042841
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of BICRAL mRNA	PMID:23892564
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of BICRAL protein	PMID:37730182
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305680	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of BICRAL mRNA	PMID:33387578
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of BICRAL intron	PMID:30157460
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of BICRAL promoter	PMID:21291286
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BICRAL mRNA	PMID:39836092
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of BICRAL mRNA	PMID:26272509
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICRAL mRNA	PMID:27188386
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of BICRAL protein	PMID:35688186
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313852	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of GLTSCR1L mRNA	PMID:28960355
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305680	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of BICRAL mRNA	PMID:31881176
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of BICRAL mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of BICRAL mRNA	PMID:23557933
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D002945	Cisplatin results in decreased expression of BICRAL mRNA	PMID:27594783
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of GLTSCR1L mRNA	PMID:30912803
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305680	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BICRAL mRNA	PMID:33387578
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of BICRAL mRNA	PMID:33212167
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BICRAL mRNA	PMID:39836092
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BICRAL intron	PMID:30157460
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of BICRAL mRNA	PMID:21632981|PMID:26238291
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of BICRAL gene	PMID:25435355
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to BICRAL mRNA]	PMID:32406909
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of BICRAL mRNA	PMID:25351596
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of BICRAL mRNA	PMID:35984750
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1305680	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of BICRAL mRNA	PMID:24395379
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of BICRAL gene	PMID:31601247
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305680	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of BICRAL mRNA	PMID:34492290
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305680	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of BICRAL mRNA; bisphenol A results in decreased expression of GLTSCR1L mRNA	PMID:25181051|PMID:32145629
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313852	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of BICRAL mRNA	PMID:26063408
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of BICRAL gene	PMID:31601247
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of BICRAL mRNA	PMID:25979313
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of BICRAL mRNA	PMID:39298647
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of BICRAL intron	PMID:30157460
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BICRAL mRNA	PMID:28628672
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of BICRAL mRNA	PMID:34813904
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BICRAL mRNA	PMID:28628672
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313852	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of BICRAL mRNA	PMID:36117858
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C000944	dicrotophos results in increased expression of BICRAL mRNA	PMID:28302478
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of BICRAL mRNA	PMID:31533062
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of BICRAL mRNA	PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICRAL mRNA	PMID:27188386
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305680	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of BICRAL mRNA	PMID:38685447|PMID:41580965
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BICRAL mRNA	PMID:28628672
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of BICRAL mRNA	PMID:22230336
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305680	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of BICRAL mRNA	PMID:33387578
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of BICRAL promoter	PMID:21291286
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BICRAL mRNA	PMID:39836092
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of BICRAL mRNA	PMID:28628672
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of BICRAL mRNA; Nanotubes, Carbon results in decreased expression of BICRAL mRNA	PMID:25554681
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313852	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of BICRAL mRNA	PMID:36117858
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of BICRAL mRNA	PMID:28988120
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of BICRAL intron	PMID:30157460
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICRAL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICRAL mRNA	PMID:27188386
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313852	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of BICRAL mRNA	PMID:23091169
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313852	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of BICRAL mRNA	PMID:39847705
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICRAL mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BICRAL mRNA	PMID:27188386
1313851	BICRAL	BICRA like chromatin remodeling complex associated protein	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313852	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of BICRAL mRNA	PMID:28973697
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBR2 gene	PMID:20938992
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of UBR2 mRNA	PMID:33167477
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1593237	E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in decreased expression of UBR2 protein	PMID:40631627
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of UBR2 mRNA	PMID:22378314
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614185	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of UBR2 mRNA	PMID:39241906
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of UBR2 mRNA	PMID:39298647
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of UBR2 mRNA	PMID:22217510
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBR2 gene	PMID:20938992
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of UBR2 mRNA	PMID:37042841
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1593237	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of UBR2 protein	PMID:40631627
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:17241	1H-pyrazole	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:C031280	pyrazole results in decreased expression of UBR2 mRNA	PMID:17945193
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1593237	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of UBR2 protein	PMID:40631627
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of UBR2 mRNA	PMID:21318169|PMID:33754040
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1614185	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UBR2 mRNA	PMID:36331819
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of UBR2 mRNA	PMID:39836092
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of UBR2 mRNA	PMID:19549813
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of UBR2 mRNA	PMID:23649840
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1593237	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of UBR2 mRNA	PMID:33354967
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of UBR2 intron	PMID:30157460
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of UBR2 mRNA	PMID:23649840
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of UBR2 mRNA	PMID:41430723
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of UBR2 mRNA	PMID:18593933
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of UBR2 mRNA	PMID:25629700
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UBR2 gene	PMID:20938992
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of UBR2 gene	PMID:25304211
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBR2 mRNA	PMID:39836092
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of UBR2 protein	PMID:35688186
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of UBR2 mRNA	PMID:23557933
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of UBR2 mRNA	PMID:30912803
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBR2 mRNA	PMID:19684285
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1593237	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBR2 mRNA	PMID:33387578
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBR2 mRNA	PMID:19684285
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of UBR2 mRNA	PMID:19684285
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of UBR2 mRNA	PMID:23649840
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of UBR2 mRNA	PMID:32763439
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1614185	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of UBR2 mRNA	PMID:39631538
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of UBR2 protein	PMID:35688186
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UBR2 mRNA	PMID:38568856
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBR2 mRNA; sodium arsenite promotes the reaction [UBR2 protein binds to CAPRIN1 protein]	PMID:33939924|PMID:39836092
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBR2 mRNA	PMID:19770486
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to UBR2 mRNA]	PMID:32406909
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of UBR2 mRNA	PMID:18593933
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in increased expression of UBR2 mRNA	PMID:26551752
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of UBR2 mRNA	PMID:19150397
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1593237	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of UBR2 mRNA	PMID:24136188
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1593237	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of UBR2 mRNA	PMID:25729387
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1593237	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of UBR2 mRNA	PMID:30047161
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614185	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBR2 gene; titanium dioxide results in decreased methylation of UBR2 promoter	PMID:35295148
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1614185	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of UBR2 mRNA	PMID:23557971
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1593237	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of UBR2 mRNA	PMID:34492290
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of UBR2 mRNA	PMID:21318169|PMID:23811191
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of UBR2 mRNA]	PMID:21318169
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1593237	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of UBR2 mRNA	PMID:30816183|PMID:32528016
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of UBR2 mRNA	PMID:26063408
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1593237	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UBR2 mRNA	PMID:25181051|PMID:29097150|PMID:32145629
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1614185	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of UBR2 mRNA	PMID:33221593
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1614185	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of UBR2 gene	PMID:31683443
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of UBR2 mRNA	PMID:39298647
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1614185	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of UBR2 mRNA	PMID:36464114
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of UBR2 mRNA	PMID:37019170
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBR2 mRNA	PMID:37042841
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of UBR2 mRNA	PMID:39836092
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1593237	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of UBR2 mRNA	PMID:30723492
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of UBR2 mRNA	PMID:38568856
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of UBR2 mRNA	PMID:19320972|PMID:19376846
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1593237	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of UBR2 mRNA	PMID:24386269
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of UBR2 mRNA	PMID:23811191
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1614185	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of UBR2 mRNA	PMID:36331819
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1593237	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of UBR2 mRNA	PMID:30047161
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1593237	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in decreased expression of UBR2 protein	PMID:40631627
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of UBR2 mRNA	PMID:23649840
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of UBR2 mRNA	PMID:17562736
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of UBR2 mRNA	PMID:21420995
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of UBR2 gene	PMID:25304211
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBR2 mRNA	PMID:39836092
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in increased expression of UBR2 mRNA	PMID:26615145
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of UBR2 mRNA	PMID:22079256
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of UBR2 mRNA	PMID:35436446
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:D011345	Fenofibrate results in increased expression of UBR2 mRNA	PMID:21318169
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:D011345	[PPARA protein affects the susceptibility to Fenofibrate] which affects the expression of UBR2 mRNA	PMID:21318169
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1593237	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of UBR2 mRNA	PMID:30047161
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:52774	pentane-2,3-dione	increases expression	ISO	RGD:1593237	E	RGD:6480464	20150512	CTD	MESH:C013186	2,3-pentanedione results in increased expression of UBR2 mRNA	PMID:25710175
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of UBR2 mRNA	PMID:39836092
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1593237	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of UBR2 mRNA	PMID:25729387
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:D007545	Isoproterenol results in increased expression of UBR2 mRNA	PMID:20003209
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1614185	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in increased expression of UBR2 mRNA	PMID:36914120
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1614185	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of UBR2 mRNA	PMID:36464114
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of UBR2 mRNA	PMID:22206623
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of UBR2 mRNA	PMID:22079256
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of UBR2 mRNA	PMID:22079256
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:D010695	Phlorhizin results in increased expression of UBR2 mRNA	PMID:22538082
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1593237	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of UBR2 mRNA	PMID:32109520
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1614185	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of UBR2 mRNA	PMID:31388691
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1593237	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of UBR2 mRNA	PMID:23640034
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1614185	E	RGD:6480464	20130618	CTD	MESH:C045950	propiconazole results in decreased expression of UBR2 mRNA	PMID:21278054
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1593237	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of UBR2 mRNA	PMID:30047161
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in increased expression of UBR2 mRNA	PMID:26551752
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1614185	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of UBR2 protein	PMID:24648495
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1593237	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of UBR2 mRNA	PMID:23034163
1313853	UBR2	ubiquitin protein ligase E3 component n-recognin 2	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1593237	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of UBR2 gene	PMID:31682807
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CMTM7 mRNA	PMID:38218311
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1591926	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of CMTM7 mRNA	PMID:25152437
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of CMTM7 mRNA	PMID:31016361
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CMTM7 mRNA	PMID:20938992
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of CMTM7 mRNA	PMID:23724009
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of CMTM7 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of CMTM7 mRNA	PMID:30951980
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CMTM7 mRNA	PMID:22378314
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CMTM7 mRNA	PMID:21632981
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313856	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CMTM7 mRNA	PMID:39241906
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of CMTM7 mRNA	PMID:22574217
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of CMTM7 mRNA	PMID:23019147
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CMTM7 mRNA	PMID:38568856
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CMTM7 mRNA	PMID:20938992
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CMTM7 mRNA	PMID:37992649
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of CMTM7 mRNA	PMID:22017230
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CMTM7 mRNA	PMID:37992649
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313856	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CMTM7 mRNA	PMID:33754040
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1591926	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CMTM7 mRNA	PMID:27523638
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CMTM7 mRNA	PMID:36331819
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CMTM7 mRNA	PMID:39836092
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:188855	Octicizer	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C018535	2-ethylhexyldiphenylphosphate results in decreased expression of CMTM7 mRNA	PMID:33969458
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CMTM7 mRNA	PMID:23649840
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of CMTM7 mRNA	PMID:19774075
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313856	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CMTM7 mRNA	PMID:31919559
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CMTM7 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CMTM7 mRNA	PMID:20938992|PMID:22206623
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CMTM7 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CMTM7 mRNA	PMID:32525701|PMID:39836092
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1591926	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CMTM7 mRNA	PMID:31881176
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of CMTM7 gene	PMID:31636367
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CMTM7 mRNA	PMID:27392435
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CMTM7 mRNA	PMID:27392435
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of CMTM7 mRNA	PMID:23019147
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CMTM7 mRNA	PMID:24768652|PMID:25583101
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313856	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CMTM7 mRNA	PMID:21570461
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1591926	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CMTM7 mRNA	PMID:34747641
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1591926	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CMTM7 mRNA	PMID:32109520
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313856	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CMTM7 mRNA	PMID:20819909
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1591926	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CMTM7 mRNA	PMID:21215274|PMID:33387578
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CMTM7 gene]	PMID:20819909
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CMTM7 mRNA	PMID:20971185
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CMTM7 mRNA	PMID:29803840
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CMTM7 mRNA	PMID:37992649
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CMTM7 mRNA	PMID:38568856
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313856	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CMTM7 mRNA	PMID:37682722
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CMTM7 mRNA	PMID:39836092
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of CMTM7 mRNA	PMID:22378314
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CMTM7 mRNA	PMID:20064835
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CMTM7 mRNA]	PMID:22228805
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CMTM7 mRNA	PMID:20971185
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of CMTM7 gene	PMID:31601247
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313856	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CMTM7 enhancer; titanium dioxide results in decreased methylation of CMTM7 gene	PMID:35295148
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1591926	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CMTM7 mRNA	PMID:23411599|PMID:34492290
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CMTM7 mRNA	PMID:19710929
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1591926	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CMTM7 mRNA	PMID:34947998
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1591926	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CMTM7 mRNA	PMID:25181051
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of CMTM7 mRNA	PMID:30951980
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CMTM7 mRNA	PMID:33969458
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313856	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CMTM7 gene	PMID:31683443
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of CMTM7 mRNA	PMID:30951980
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313856	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CMTM7 mRNA	PMID:37019170
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CMTM7 mRNA	PMID:37042841
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CMTM7 mRNA	PMID:39836092
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CMTM7 mRNA	PMID:19320972
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CMTM7 mRNA	PMID:24449571
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CMTM7 mRNA	PMID:40419075
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CMTM7 mRNA	PMID:36331819
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CMTM7 mRNA	PMID:25979313
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of CMTM7 mRNA	PMID:24935251|PMID:26272509
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CMTM7 mRNA	PMID:27188386
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:41607	crotonaldehyde	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in decreased expression of CMTM7 mRNA	PMID:20471460
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CMTM7 mRNA	PMID:37992649
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CMTM7 mRNA	PMID:38832940
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of CMTM7 mRNA	PMID:24935251|PMID:26272509
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CMTM7 mRNA	PMID:27188386
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313856	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CMTM7 mRNA	PMID:17562736
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CMTM7 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CMTM7 mRNA	PMID:32525701|PMID:39836092
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of CMTM7 mRNA	PMID:36621641
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1591926	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CMTM7 mRNA	PMID:29391264
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CMTM7 mRNA	PMID:35964746
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313856	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CMTM7 mRNA	PMID:38701926
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CMTM7 mRNA	PMID:39836092
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1313856	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of CMTM7 mRNA	PMID:19812364
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CMTM7 mRNA	PMID:31758290
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313856	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CMTM7 mRNA	PMID:22206623
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313856	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CMTM7 mRNA	PMID:22206623
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CMTM7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CMTM7 mRNA	PMID:27188386
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of CMTM7 mRNA	PMID:33969458
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CMTM7 mRNA	PMID:33969458
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313856	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of CMTM7 mRNA	PMID:30953684
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CMTM7 mRNA	PMID:32525701
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CMTM7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CMTM7 mRNA	PMID:27188386
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1591926	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of CMTM7 mRNA	PMID:19281266
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CMTM7 mRNA	PMID:38568856
1313855	CMTM7	CKLF like MARVEL transmembrane domain containing 7	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1591926	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of CMTM7 gene	PMID:31682807
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of SYNCRIP protein	PMID:36252740
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1557624	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of SYNCRIP mRNA	PMID:33045310
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SYNCRIP protein]	PMID:38195004
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SYNCRIP; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SYNCRIP gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SYNCRIP mRNA	PMID:20938992
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SYNCRIP mRNA	PMID:23724009
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SYNCRIP mRNA	PMID:36331819
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:15738	staurosporine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019311	Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of SYNCRIP protein]	PMID:19331829
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SYNCRIP mRNA	PMID:22378314
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1557624	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SYNCRIP mRNA	PMID:30319688
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in decreased expression of SYNCRIP mRNA	PMID:28986285
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SYNCRIP mRNA	PMID:20044591
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1557624	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SYNCRIP mRNA	PMID:39241906
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SYNCRIP mRNA]	PMID:39241906
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1557624	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of SYNCRIP mRNA	PMID:15598610
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1557624	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SYNCRIP mRNA	PMID:39298647
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:16526	carbon dioxide	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:D002245	[[Vehicle Emissions results in increased abundance of Air Pollutants] which results in increased abundance of Carbon Dioxide] which affects the expression of SYNCRIP mRNA	PMID:29980036
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SYNCRIP mRNA	PMID:38568856
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305683	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SYNCRIP mRNA	PMID:33387578
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305683	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SYNCRIP gene	PMID:27618143
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SYNCRIP; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SYNCRIP gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SYNCRIP mRNA	PMID:20938992
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of SYNCRIP protein	PMID:32044396
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SYNCRIP mRNA	PMID:23649840
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SYNCRIP mRNA	PMID:21179406
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:175901	gemcitabine	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in decreased expression of SYNCRIP mRNA	PMID:17039268
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SYNCRIP mRNA	PMID:33754040
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305683	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SYNCRIP mRNA	PMID:22061828
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SYNCRIP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SYNCRIP protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SYNCRIP protein	PMID:33040242|PMID:38195004
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SYNCRIP mRNA	PMID:37236586
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SYNCRIP mRNA	PMID:19549813
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SYNCRIP protein	PMID:23301498
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of SYNCRIP mRNA	PMID:23649840
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SYNCRIP mRNA	PMID:23649840
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SYNCRIP protein	PMID:38598786
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1557624	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SYNCRIP mRNA	PMID:27339419|PMID:31919559
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SYNCRIP mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SYNCRIP; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SYNCRIP gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SYNCRIP mRNA	PMID:20938992|PMID:22206623
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SYNCRIP mRNA	PMID:19244175
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SYNCRIP mRNA	PMID:26272509
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA	PMID:27188386
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SYNCRIP protein	PMID:35688186
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1557624	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of SYNCRIP mRNA	PMID:28960355
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of SYNCRIP mRNA	PMID:23300844
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1557624	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of SYNCRIP mRNA	PMID:34813904
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SYNCRIP mRNA	PMID:24768652|PMID:25583101
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557624	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SYNCRIP mRNA	PMID:21570461
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305683	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SYNCRIP mRNA	PMID:33387578
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1557624	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SYNCRIP mRNA	PMID:19465110
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305683	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of SYNCRIP mRNA	PMID:19013527
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SYNCRIP mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNCRIP mRNA	PMID:27188386
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SYNCRIP mRNA	PMID:33212167
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA	PMID:27188386
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of SYNCRIP mRNA	PMID:23649840
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1557624	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of SYNCRIP protein	PMID:21146535
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of SYNCRIP mRNA	PMID:20971185
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SYNCRIP mRNA	PMID:29803840
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SYNCRIP mRNA	PMID:38568856
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of SYNCRIP mRNA	PMID:22378314
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SYNCRIP mRNA	PMID:20106945|PMID:21632981
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SYNCRIP mRNA	PMID:19770486
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:29866	arsenite(3-)	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite affects the localization of SYNCRIP protein	PMID:19331829
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1557624	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of SYNCRIP protein	PMID:21146535
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of SYNCRIP mRNA	PMID:20971185
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:3048	benzatropine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in decreased expression of SYNCRIP protein	PMID:34122009
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SYNCRIP mRNA	PMID:19150397|PMID:20018196|PMID:26238291
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SYNCRIP mRNA	PMID:20458559
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of SYNCRIP mRNA	PMID:31745603
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305683	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SYNCRIP mRNA	PMID:25729387
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SYNCRIP mRNA	PMID:23557971
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557624	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SYNCRIP gene	PMID:35295148
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1557624	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SYNCRIP promoter	PMID:35295148
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557624	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SYNCRIP mRNA	PMID:18445702
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1557624	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SYNCRIP mRNA	PMID:28472532
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SYNCRIP protein	PMID:33376534|PMID:34186270|PMID:37567409
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SYNCRIP mRNA	PMID:33221593
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased methylation of SYNCRIP gene	PMID:22576693
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased expression of SYNCRIP mRNA	PMID:22576693
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305683	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SYNCRIP mRNA	PMID:25181051|PMID:30816183
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1557624	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in increased expression of SYNCRIP mRNA	PMID:21932408
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SYNCRIP mRNA	PMID:19244175
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SYNCRIP protein	PMID:34186270
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1557624	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SYNCRIP mRNA	PMID:39298647
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of SYNCRIP protein	PMID:34186270
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SYNCRIP protein	PMID:34186270
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SYNCRIP mRNA]	PMID:39241906
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SYNCRIP mRNA	PMID:37042841
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SYNCRIP mRNA	PMID:38568856
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SYNCRIP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SYNCRIP protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SYNCRIP protein	PMID:33040242|PMID:38195004
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SYNCRIP mRNA	PMID:37236586
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SYNCRIP mRNA	PMID:19320972|PMID:19376846
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305683	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SYNCRIP mRNA	PMID:24386269
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:35842	antirheumatic drug	affects expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents affects the expression of SYNCRIP mRNA	PMID:24449571
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SYNCRIP mRNA	PMID:19244175
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate affects the localization of SYNCRIP protein	PMID:19331829
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of SYNCRIP protein]	PMID:19331829
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:3766	clozapine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of SYNCRIP protein	PMID:34122009
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SYNCRIP mRNA	PMID:19167446
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of SYNCRIP mRNA	PMID:26352163
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SYNCRIP mRNA	PMID:36331819
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid affects the expression of SYNCRIP mRNA	PMID:23179753|PMID:25979313|PMID:26272509
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1557624	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SYNCRIP mRNA	PMID:17292431
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SYNCRIP mRNA	PMID:24935251|PMID:25192806|PMID:27188386|PMID:28001369|PMID:29154799
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20120717	CTD	MESH:D014635	Valproic Acid results in decreased expression of SYNCRIP mRNA	PMID:19136453|PMID:21427059
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of SYNCRIP mRNA	PMID:27188386
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305683	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of SYNCRIP mRNA	PMID:41580965
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of SYNCRIP mRNA	PMID:22147139
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:43572	kojic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of SYNCRIP mRNA	PMID:16595896
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of SYNCRIP mRNA	PMID:23649840
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SYNCRIP mRNA	PMID:22083351|PMID:27188386
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A affects the expression of SYNCRIP mRNA	PMID:26272509
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of SYNCRIP mRNA	PMID:24935251
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SYNCRIP mRNA	PMID:24935251
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNCRIP mRNA	PMID:27188386
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557624	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SYNCRIP mRNA	PMID:17562736
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SYNCRIP mRNA	PMID:21420995
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305683	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SYNCRIP mRNA	PMID:33387578
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of SYNCRIP mRNA	PMID:17039268
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SYNCRIP mRNA	PMID:29279043
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SYNCRIP mRNA	PMID:20458559
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SYNCRIP mRNA	PMID:23300844
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557624	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SYNCRIP mRNA; Nanotubes, Carbon results in increased expression of SYNCRIP mRNA	PMID:25554681|PMID:25620056
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305683	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SYNCRIP mRNA	PMID:24136188
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1557624	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SYNCRIP mRNA	PMID:19042947
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SYNCRIP protein	PMID:32959892
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SYNCRIP mRNA	PMID:21641980
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305683	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SYNCRIP mRNA	PMID:25729387
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305683	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SYNCRIP mRNA	PMID:25729387
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SYNCRIP mRNA	PMID:23650126
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SYNCRIP mRNA	PMID:24810058
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of SYNCRIP mRNA	PMID:28444820
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SYNCRIP mRNA	PMID:22206623
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SYNCRIP mRNA	PMID:22206623
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305683	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of SYNCRIP mRNA	PMID:24136188
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:75175	3',5'-cyclic UMP	affects binding	EXP		E	RGD:6480464	20220405	CTD	MESH:C045338	SYNCRIP protein binds to cyclic 3',5'-uridine monophosphate	PMID:30528433
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of SYNCRIP protein	PMID:31285264
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNCRIP mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNCRIP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of SYNCRIP mRNA	PMID:27188386
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of SYNCRIP mRNA	PMID:30928695
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SYNCRIP gene]	PMID:28238834
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1557624	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SYNCRIP mRNA	PMID:30294300
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:8249	piroxicam	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of SYNCRIP mRNA	PMID:21858171
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1557624	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of SYNCRIP mRNA	PMID:30953684
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA	PMID:27188386
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SYNCRIP mRNA]	PMID:39241906
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1557624	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of SYNCRIP mRNA	PMID:40826991
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNCRIP mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNCRIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SYNCRIP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of SYNCRIP mRNA	PMID:27188386
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305683	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SYNCRIP mRNA	PMID:21346803
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of SYNCRIP mRNA	PMID:17440010
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:9516	thapsigargin	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:D019284	Thapsigargin affects the localization of SYNCRIP protein	PMID:19331829
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1305683	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of SYNCRIP protein	PMID:35544339
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SYNCRIP mRNA	PMID:27188386
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SYNCRIP protein	PMID:38598786
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305683	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SYNCRIP mRNA	PMID:21346803
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1557624	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SYNCRIP mRNA	PMID:28973697
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1557624	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SYNCRIP mRNA	PMID:18930950
1313857	SYNCRIP	synaptotagmin binding cytoplasmic RNA interacting protein	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305683	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of SYNCRIP mRNA	PMID:22570695
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PCMTD2 mRNA	PMID:38218311
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PCMTD2 mRNA	PMID:33045310
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305684	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PCMTD2 mRNA]	PMID:31150632
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PCMTD2 mRNA	PMID:33167477
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313859	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PCMTD2 mRNA	PMID:30529165
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PCMTD2 mRNA	PMID:26079696
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313859	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PCMTD2 mRNA	PMID:30319688
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in decreased expression of PCMTD2 mRNA	PMID:19167417
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of PCMTD2 mRNA	PMID:18951874
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PCMTD2 mRNA	PMID:39241906
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of PCMTD2 mRNA	PMID:31614463
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PCMTD2 mRNA	PMID:32145629
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PCMTD2 mRNA	PMID:39298647
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PCMTD2 mRNA	PMID:37042841
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PCMTD2 mRNA	PMID:33387578
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305684	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PCMTD2 mRNA	PMID:22061828
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313859	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PCMTD2 mRNA	PMID:36331819
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PCMTD2 mRNA	PMID:39836092
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of PCMTD2 mRNA	PMID:17103032
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of PCMTD2 mRNA	PMID:41580963
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305684	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of PCMTD2 mRNA	PMID:31129395
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PCMTD2 mRNA	PMID:31150632
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PCMTD2 mRNA	PMID:27339419|PMID:31919559
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305684	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PCMTD2 mRNA]	PMID:31150632
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PCMTD2 mRNA	PMID:25629700
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PCMTD2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCMTD2 mRNA	PMID:39836092
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PCMTD2 mRNA	PMID:31881176
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PCMTD2 mRNA	PMID:23557933
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PCMTD2 mRNA	PMID:27392435
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PCMTD2 mRNA	PMID:27392435
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PCMTD2 mRNA	PMID:22574217
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCMTD2 mRNA	PMID:33387578
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PCMTD2 mRNA	PMID:30851411
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PCMTD2 mRNA	PMID:28959563
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313859	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of PCMTD2 mRNA	PMID:39631538
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of PCMTD2 mRNA	PMID:28595984|PMID:38568856
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PCMTD2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCMTD2 mRNA	PMID:39836092
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313859	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PCMTD2 mRNA	PMID:22228805
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PCMTD2 mRNA; Silicon Dioxide results in decreased expression of PCMTD2 mRNA	PMID:23806026|PMID:25351596
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PCMTD2 mRNA	PMID:24136188
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313859	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PCMTD2 gene	PMID:35295148
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PCMTD2 mRNA	PMID:30723492
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PCMTD2 mRNA	PMID:19162173
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PCMTD2 mRNA	PMID:18445702
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of PCMTD2 mRNA	PMID:32145629
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of PCMTD2 mRNA	PMID:29275510
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305684	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PCMTD2 mRNA	PMID:25181051|PMID:33296240
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305684	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of PCMTD2 mRNA	PMID:31129395
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PCMTD2 mRNA	PMID:39298647
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PCMTD2 mRNA	PMID:39836092
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PCMTD2 mRNA	PMID:19162173
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PCMTD2 mRNA	PMID:19320972
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PCMTD2 mRNA	PMID:31533062
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313859	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PCMTD2 mRNA	PMID:36331819
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PCMTD2 mRNA	PMID:25979313
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313859	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PCMTD2 mRNA	PMID:17292431
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCMTD2 mRNA	PMID:23179753
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PCMTD2 gene	PMID:29154799
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305684	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of PCMTD2 mRNA	PMID:41580965
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PCMTD2 mRNA	PMID:20106945|PMID:25562108
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PCMTD2 mRNA	PMID:38832940
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PCMTD2 mRNA	PMID:27188386
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313859	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PCMTD2 mRNA	PMID:17562736
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PCMTD2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCMTD2 mRNA	PMID:39836092
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PCMTD2 mRNA; Nanotubes, Carbon results in decreased expression of PCMTD2 mRNA	PMID:25554681|PMID:25620056
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of PCMTD2 mRNA	PMID:19162173
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of PCMTD2 mRNA	PMID:24136188
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PCMTD2 mRNA	PMID:39836092
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of PCMTD2 mRNA	PMID:15336504
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313859	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of PCMTD2 mRNA	PMID:20003209
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PCMTD2 mRNA	PMID:22206623
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of PCMTD2 mRNA	PMID:28960945
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PCMTD2 mRNA	PMID:30851411
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCMTD2 gene]	PMID:28238834
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313859	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of PCMTD2 mRNA	PMID:23091169
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1305684	E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PCMTD2 mRNA	PMID:31826744
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313859	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PCMTD2 mRNA	PMID:39847705
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of PCMTD2 mRNA	PMID:21278054
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PCMTD2 mRNA	PMID:38568856
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313859	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PCMTD2 mRNA	PMID:28973697
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305684	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of PCMTD2 mRNA	PMID:19015723
1313858	PCMTD2	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305684	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PCMTD2 mRNA	PMID:23034163
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of RHPN1 mRNA	PMID:35877022
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of RHPN1 mRNA	PMID:30165855
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of RHPN1 mRNA	PMID:38568856
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305688	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RHPN1 mRNA	PMID:33387578
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of RHPN1 mRNA	PMID:26079696
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313864	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RHPN1 mRNA	PMID:39922521
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313864	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RHPN1 mRNA	PMID:39922521
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313864	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RHPN1 mRNA	PMID:34319233
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305688	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RHPN1 mRNA	PMID:33387578
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1305688	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RHPN1 mRNA	PMID:33354967
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305688	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RHPN1 mRNA	PMID:31881176
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of RHPN1 mRNA	PMID:27392435
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313864	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of RHPN1 mRNA	PMID:23625948
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305688	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RHPN1 mRNA	PMID:33387578
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of RHPN1 mRNA	PMID:29955902
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of RHPN1 mRNA	PMID:32763439
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RHPN1 mRNA	PMID:38568856
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313864	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to RHPN1 promoter]	PMID:19654925
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313864	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RHPN1 gene	PMID:35295148
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313864	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RHPN1 mRNA	PMID:18648102
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313864	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of RHPN1 mRNA	PMID:25172293
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305688	E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of RHPN1 mRNA	PMID:32119087
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313864	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of RHPN1 exon	PMID:33297965
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313864	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RHPN1 mRNA	PMID:32715474
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313864	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RHPN1 mRNA	PMID:21266533
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RHPN1 mRNA	PMID:37042841
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305688	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RHPN1 mRNA	PMID:35163327
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305688	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RHPN1 mRNA	PMID:35163327
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305688	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RHPN1 mRNA	PMID:24386269
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RHPN1 mRNA	PMID:24449571
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313864	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RHPN1 mRNA	PMID:40194260
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RHPN1 mRNA	PMID:31533062
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RHPN1 mRNA	PMID:25979313
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RHPN1 gene	PMID:29154799
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of RHPN1 promoter	PMID:27989131
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313864	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of RHPN1 mRNA	PMID:39922521
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RHPN1 mRNA	PMID:38832940
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305688	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RHPN1 mRNA	PMID:33387578
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of RHPN1 mRNA	PMID:31838189
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of RHPN1 mRNA	PMID:32234424
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313864	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of RHPN1 mRNA	PMID:38701926
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RHPN1 mRNA	PMID:24810058
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of RHPN1 mRNA	PMID:39904859
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305688	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RHPN1 mRNA	PMID:24780913|PMID:36843608
1313863	RHPN1	rhophilin Rho GTPase binding protein 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RHPN1 mRNA	PMID:38568856
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C084079	triptonide results in increased expression of TMEM254 mRNA	PMID:33045310
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of TMEM254 mRNA; [bisphenol A co-treated with Tretinoin] results in increased expression of TMEM254 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of TMEM254 mRNA; [bisphenol F co-treated with Tretinoin] results in increased expression of TMEM254 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of TMEM254 mRNA; [bisphenol S co-treated with Tretinoin] results in increased expression of TMEM254 mRNA	PMID:30951980
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20150714	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of TMEM254 mRNA	PMID:24763279
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TMEM254 mRNA	PMID:26079696
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305689	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of TMEM254 mRNA	PMID:32145629
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313866	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of TMEM254 mRNA	PMID:39298647
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TMEM254 mRNA	PMID:37042841
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TMEM254 mRNA	PMID:19850644
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of TMEM254 mRNA]	PMID:19850644
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TMEM254 mRNA	PMID:28818685
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TMEM254 mRNA	PMID:19549813
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TMEM254 mRNA	PMID:19770486
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of TMEM254 mRNA	PMID:23195993|PMID:24768652
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305689	E	RGD:6480464	20181016	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM254 mRNA	PMID:21215274|PMID:33387578
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of TMEM254 mRNA	PMID:16214954
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TMEM254 mRNA	PMID:28001369
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM254 mRNA	PMID:30851411
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of TMEM254 mRNA	PMID:39631538
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of TMEM254 mRNA	PMID:29453283
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TMEM254 promoter	PMID:27901495
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMEM254 3' UTR	PMID:27901495
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TMEM254 mRNA	PMID:39716349
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C008261	lead acetate results in decreased expression of TMEM254 mRNA	PMID:25270620
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313866	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMEM254 gene; titanium dioxide results in decreased methylation of TMEM254 promoter	PMID:35295148
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C006253	pirinixic acid results in increased expression of TMEM254 mRNA	PMID:18301758|PMID:23811191
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:33083	fluoranthene	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C007738	fluoranthene results in decreased expression of TMEM254 mRNA	PMID:28329830
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of TMEM254 mRNA	PMID:28329830
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305689	E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A affects the expression of TMEM254 mRNA	PMID:25181051|PMID:32145629
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305689	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM254 mRNA	PMID:30816183|PMID:32528016
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM254 mRNA	PMID:30951980|PMID:35598803
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM254 mRNA	PMID:30951980|PMID:33221593
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C006780	[bisphenol A co-treated with LIF protein] results in increased expression of TMEM254 mRNA; [bisphenol A co-treated with Tretinoin] results in decreased expression of TMEM254 mRNA; [bisphenol A co-treated with Tretinoin] results in increased expression of TMEM254 mRNA	PMID:30951980
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305689	E	RGD:6480464	20181016	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TMEM254 mRNA	PMID:23196670
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C543008	bisphenol S affects the expression of TMEM254 mRNA	PMID:30951980
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TMEM254 mRNA	PMID:39298647
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C543008	[bisphenol S co-treated with LIF protein] affects the expression of TMEM254 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of TMEM254 mRNA; [bisphenol S co-treated with Tretinoin] results in increased expression of TMEM254 mRNA	PMID:30951980
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C008745	bisphenol F results in decreased expression of TMEM254 mRNA	PMID:30951980
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C008745	bisphenol F results in increased expression of TMEM254 mRNA	PMID:30951980
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM254 mRNA	PMID:28628672
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C008745	[bisphenol F co-treated with LIF protein] results in decreased expression of TMEM254 mRNA; [bisphenol F co-treated with LIF protein] results in increased expression of TMEM254 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of TMEM254 mRNA; [bisphenol F co-treated with Tretinoin] results in increased expression of TMEM254 mRNA	PMID:30951980
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:34786	Heptachlor epoxide	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D006534	Heptachlor Epoxide results in decreased expression of TMEM254 mRNA	PMID:25270620
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM254 mRNA	PMID:28628672
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305689	E	RGD:6480464	20181016	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of TMEM254 promoter	PMID:22457795
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TMEM254 mRNA	PMID:31533062
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of TMEM254 mRNA	PMID:40419075
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM254 mRNA	PMID:25979313
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM254 mRNA	PMID:17292431|PMID:17963808
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM254 mRNA	PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D014635	Valproic Acid results in decreased expression of TMEM254 mRNA	PMID:21427059
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of TMEM254 mRNA	PMID:19101580
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM254 mRNA	PMID:27188386
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TMEM254 mRNA	PMID:20106945|PMID:25562108
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM254 mRNA	PMID:28628672
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D017313	Fenretinide results in decreased expression of TMEM254 mRNA	PMID:28973697
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D000082	Acetaminophen affects the expression of TMEM254 mRNA	PMID:17562736
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305689	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TMEM254 mRNA	PMID:33387578
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in decreased expression of TMEM254 mRNA	PMID:29246445
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313866	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form promotes the reaction [Acetaminophen results in decreased expression of TMEM254 mRNA]	PMID:29246445
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1305689	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of TMEM254 mRNA	PMID:29391264
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TMEM254 mRNA	PMID:28628672
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TMEM254 mRNA	PMID:39716349
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of TMEM254 mRNA	PMID:20977926
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of TMEM254 mRNA	PMID:20436886
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TMEM254 mRNA	PMID:25270620
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305689	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TMEM254 mRNA	PMID:37269647
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TMEM254 mRNA	PMID:31758290
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM254 mRNA	PMID:30851411
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM254 mRNA	PMID:27188386
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1313866	E	RGD:6480464	20211012	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of TMEM254 mRNA	PMID:25270620
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305689	E	RGD:6480464	20181016	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of TMEM254 mRNA	PMID:23914054
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of TMEM254 mRNA	PMID:26079696
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TMEM254 mRNA	PMID:27188386
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305689	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TMEM254 mRNA	PMID:23034163
1313865	TMEM254	transmembrane protein 254	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305689	E	RGD:6480464	20181016	CTD	MESH:C025643	vinclozolin results in increased expression of TMEM254 mRNA	PMID:22570695
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313871	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ABHD8 mRNA	PMID:20188158
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ABHD8 mRNA	PMID:36331819
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313871	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ABHD8 mRNA	PMID:30319688
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305693	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ABHD8 mRNA	PMID:32145629
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ABHD8 mRNA	PMID:37042841
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ABHD8 mRNA	PMID:21179406
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ABHD8 mRNA	PMID:26079696
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased expression of ABHD8 mRNA	PMID:26717081
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:17578	toluene	increases methylation	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased methylation of ABHD8 gene	PMID:26717081
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313871	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ABHD8 mRNA	PMID:34319233
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305693	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ABHD8 mRNA	PMID:33387578
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ABHD8 mRNA	PMID:28818685
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1305693	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of ABHD8 mRNA	PMID:28522335
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305693	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABHD8 mRNA	PMID:22129741
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of ABHD8 mRNA	PMID:25102026
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ABHD8 mRNA	PMID:34911549
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305693	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ABHD8 mRNA	PMID:31881176
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ABHD8 mRNA	PMID:28903495
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313871	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABHD8 mRNA	PMID:21570461
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ABHD8 mRNA	PMID:33212167
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD8 mRNA	PMID:30851411
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305693	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ABHD8 mRNA	PMID:28959563
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313871	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ABHD8 mRNA	PMID:39631538
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABHD8 mRNA	PMID:34032870
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ABHD8 mRNA	PMID:38568856
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ABHD8 promoter	PMID:27901495
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313871	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ABHD8 mRNA	PMID:27195522
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ABHD8 5' UTR	PMID:27901495
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to ABHD8 promoter]	PMID:19654925
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313871	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ABHD8 mRNA	PMID:23221170
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313871	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ABHD8 gene	PMID:35295148
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1305693	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of ABHD8 mRNA	PMID:34492290
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313871	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ABHD8 mRNA	PMID:23811191
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ABHD8 mRNA	PMID:19710929
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305693	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ABHD8 mRNA	PMID:19167457
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305693	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of ABHD8 mRNA	PMID:32145629
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ABHD8 gene	PMID:31601247
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305693	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ABHD8 mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313871	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ABHD8 mRNA	PMID:32156529|PMID:33221593
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313871	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ABHD8 mRNA	PMID:37019170
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305693	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ABHD8 mRNA	PMID:21266533
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313871	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ABHD8 mRNA	PMID:21266533
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313871	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ABHD8 mRNA	PMID:34813904
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313871	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ABHD8 mRNA	PMID:34813904
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305693	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABHD8 mRNA	PMID:22129741
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of ABHD8 mRNA	PMID:36117858
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ABHD8 mRNA	PMID:37042841
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ABHD8 mRNA	PMID:38568856
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313871	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ABHD8 mRNA	PMID:17585979
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ABHD8 mRNA	PMID:36331819
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ABHD8 gene	PMID:29154799
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313871	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ABHD8 mRNA	PMID:28973697
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of ABHD8 mRNA	PMID:38825487
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305693	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ABHD8 mRNA	PMID:30307764
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ABHD8 mRNA	PMID:35964746
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313871	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of ABHD8 mRNA	PMID:36117858
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313871	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ABHD8 mRNA	PMID:22206623
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD8 mRNA	PMID:30851411
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:8772	raloxifene	affects response to substance	EXP		E	RGD:6480464	20230801	CTD	MESH:D020849	ABHD8 affects the susceptibility to Raloxifene Hydrochloride	PMID:32934756
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ABHD8 mRNA	PMID:29301935
1313870	ABHD8	abhydrolase domain containing 8	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305693	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ABHD8 mRNA	PMID:19015723
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of MRPL54 mRNA	PMID:35967413
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:137392	chlormequat chloride	increases expression	ISO	RGD:1305694	E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of MRPL54 protein	PMID:34958886
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MRPL54 mRNA	PMID:30529165
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL54 mRNA	PMID:36331819
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313873	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPL54 mRNA	PMID:39241906
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL54 mRNA	PMID:31059760
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MRPL54 mRNA	PMID:21179406
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1313873	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of MRPL54 mRNA	PMID:17456735
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MRPL54 mRNA	PMID:28412506
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MRPL54 mRNA	PMID:35550907
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313873	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MRPL54 mRNA	PMID:19850644|PMID:33754040
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of MRPL54 mRNA]	PMID:19850644
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305694	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MRPL54 mRNA	PMID:33387578
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL54 mRNA	PMID:36331819
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1313873	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of MRPL54 mRNA	PMID:17456735
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MRPL54 mRNA	PMID:23649840
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MRPL54 gene	PMID:27153756
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313873	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MRPL54 mRNA	PMID:19770486
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1313873	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of MRPL54 mRNA	PMID:12763052
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MRPL54 mRNA	PMID:34911549
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL54 mRNA	PMID:22206623
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPL54 mRNA	PMID:40504410
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:27585	selenomethionine	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012645	Selenomethionine affects the expression of MRPL54 mRNA	PMID:17222674
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313873	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of MRPL54 mRNA	PMID:30912803
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313873	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPL54 mRNA	PMID:21570461
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305694	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPL54 mRNA	PMID:32109520
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305694	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPL54 mRNA	PMID:33387578
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of MRPL54 protein	PMID:39603559
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MRPL54 mRNA	PMID:30851411
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPL54 mRNA	PMID:36209798
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPL54 mRNA	PMID:40504410
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MRPL54 mRNA	PMID:20106945
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313873	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MRPL54 mRNA	PMID:22228805
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305694	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of MRPL54 mRNA	PMID:24136188
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305694	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MRPL54 mRNA	PMID:30047161
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of MRPL54 mRNA	PMID:18648102
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313873	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MRPL54 mRNA	PMID:18301758|PMID:23811191
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL54 mRNA	PMID:38568856
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL54 mRNA	PMID:33221593|PMID:35598803
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305694	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL54 mRNA	PMID:25181051|PMID:32145629
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313873	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL54 mRNA	PMID:32156529
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C543008	bisphenol S results in decreased expression of MRPL54 mRNA	PMID:38568856
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313873	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPL54 mRNA	PMID:39298647
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MRPL54 mRNA	PMID:38685157
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313873	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MRPL54 mRNA	PMID:37019170
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313873	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MRPL54 mRNA	PMID:34813904
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313873	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of MRPL54 mRNA	PMID:34813904
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MRPL54 mRNA	PMID:37042841
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of MRPL54 mRNA	PMID:17585979
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MRPL54 mRNA	PMID:39529242
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MRPL54 mRNA	PMID:27153767
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL54 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL54 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MRPL54 mRNA	PMID:36331819
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of MRPL54 mRNA	PMID:29154799
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MRPL54 gene	PMID:29154799
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305694	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MRPL54 mRNA	PMID:30047161
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of MRPL54 promoter	PMID:27989131
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MRPL54 mRNA	PMID:25562108
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL54 mRNA	PMID:25704631|PMID:31059760
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL54 mRNA	PMID:31059760
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPL54 mRNA	PMID:40504410
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:47381	diclofenac	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20240702	CTD	MESH:D004008	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL54 mRNA	PMID:37844793
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313873	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of MRPL54 mRNA	PMID:22334560
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305694	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of MRPL54 mRNA	PMID:29097150
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313873	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MRPL54 mRNA	PMID:17942748
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20240702	CTD	MESH:D004997	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL54 mRNA	PMID:37844793
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313873	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MRPL54 mRNA	PMID:25554681
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305694	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MRPL54 mRNA	PMID:24136188
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305694	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MRPL54 mRNA	PMID:30047161
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305694	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MRPL54 mRNA	PMID:24136188
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:5855	ibuprofen	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20240702	CTD	MESH:D007052	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL54 mRNA	PMID:37844793
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of MRPL54 mRNA	PMID:27714895
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313873	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL54 mRNA	PMID:22206623
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1305694	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased expression of MRPL54 mRNA	PMID:37162024
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:7719	ochratoxin A	increases methylation	ISO	RGD:1305694	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased methylation of MRPL54 gene	PMID:37162024
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MRPL54 mRNA	PMID:30851411
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1313873	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of MRPL54 mRNA	PMID:22334560
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313873	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in increased expression of MRPL54 mRNA	PMID:22334560
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305694	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of MRPL54 mRNA	PMID:30047161
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313873	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of MRPL54 mRNA	PMID:40826991
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1305694	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of MRPL54 mRNA	PMID:24136188
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:9466	Testosterone propionate	increases expression	ISO	RGD:1313873	E	RGD:6480464	20141111	CTD	MESH:D043343	Testosterone Propionate results in increased expression of MRPL54 mRNA	PMID:15601916
1313872	MRPL54	mitochondrial ribosomal protein L54	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305694	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MRPL54 mRNA	PMID:23034163|PMID:23555832
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of LSM14A mRNA	PMID:38218311
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313875	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of LSM14A mRNA	PMID:33045310
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of LSM14A mRNA	PMID:15498508
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313875	E	RGD:6480464	20181113	CTD	MESH:D004958	Estradiol affects the expression of LSM14A mRNA	PMID:30077407
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313875	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LSM14A mRNA	PMID:39298647
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20181113	CTD	MESH:D004958	[Polyphenols co-treated with Estradiol] results in increased expression of LSM14A mRNA	PMID:30077407
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of LSM14A protein	PMID:37730182
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305695	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LSM14A mRNA	PMID:33387578
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LSM14A intron	PMID:30157460
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LSM14A mRNA	PMID:37236586
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of LSM14A protein	PMID:23301498
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LSM14A intron	PMID:30157460
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of LSM14A mRNA	PMID:23649840
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM14A mRNA	PMID:22206623
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LSM14A mRNA	PMID:40504410
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of LSM14A protein	PMID:35688186
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of LSM14A mRNA	PMID:23557933
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of LSM14A mRNA	PMID:19921347
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313875	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LSM14A mRNA	PMID:21570461
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305695	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LSM14A mRNA	PMID:34747641
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LSM14A mRNA	PMID:33212167
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305695	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of LSM14A mRNA	PMID:28959563
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LSM14A mRNA	PMID:29803840
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of LSM14A protein	PMID:35688186
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of LSM14A mRNA	PMID:20044591
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LSM14A mRNA	PMID:40504410
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LSM14A intron	PMID:30157460
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to LSM14A mRNA]	PMID:32406909
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LSM14A mRNA	PMID:19150397
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of LSM14A mRNA	PMID:15498508
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305695	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LSM14A mRNA	PMID:34492290
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of LSM14A protein	PMID:37567409
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305695	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LSM14A mRNA	PMID:34947998
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305695	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LSM14A mRNA	PMID:25181051|PMID:30816183
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of LSM14A mRNA	PMID:25979313
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LSM14A mRNA	PMID:28628672
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LSM14A intron	PMID:30157460
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1305695	E	RGD:6480464	20260303	CTD	MESH:C008745	bisphenol F results in decreased expression of LSM14A protein	PMID:40188933
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LSM14A mRNA	PMID:28628672
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LSM14A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LSM14A mRNA	PMID:28628672
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LSM14A mRNA	PMID:37236586
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LSM14A mRNA	PMID:19320972
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of LSM14A mRNA	PMID:24449571
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LSM14A mRNA	PMID:31533062
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LSM14A mRNA	PMID:25979313
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of LSM14A mRNA	PMID:23179753|PMID:28001369|PMID:29154799
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of LSM14A mRNA	PMID:25562108
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LSM14A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LSM14A mRNA	PMID:28628672
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of LSM14A mRNA	PMID:21420995
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of LSM14A mRNA	PMID:40504410
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of LSM14A mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of LSM14A mRNA	PMID:28628672
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LSM14A protein	PMID:32959892
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313875	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of LSM14A mRNA	PMID:23650126
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313875	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of LSM14A mRNA	PMID:20003209
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LSM14A intron	PMID:30157460
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LSM14A protein	PMID:34186270
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313875	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM14A mRNA	PMID:22206623
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LSM14A gene]	PMID:28238834
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305695	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LSM14A mRNA	PMID:21346803
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of LSM14A mRNA	PMID:29301935
1313874	LSM14A	LSM14A mRNA processing body assembly factor	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305695	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LSM14A mRNA	PMID:21346803
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313877	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of HSH2D mRNA	PMID:33045310
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of HSH2D mRNA	PMID:33167477
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:2321939	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of HSH2D mRNA	PMID:33729688
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313877	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of HSH2D mRNA	PMID:36331819
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of HSH2D mRNA	PMID:31614463
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of HSH2D mRNA	PMID:30165855
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:2321939	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HSH2D mRNA	PMID:32741896
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of HSH2D mRNA	PMID:23649840
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of HSH2D mRNA	PMID:21592394
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of HSH2D mRNA	PMID:21592394
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:2321939	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HSH2D mRNA	PMID:32741896
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313877	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of HSH2D mRNA	PMID:34319233
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of HSH2D mRNA	PMID:21592394
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of HSH2D mRNA	PMID:21592394
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:2321939	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of HSH2D mRNA	PMID:33387578
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of HSH2D mRNA	PMID:24376830
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of HSH2D mRNA	PMID:22100608
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of HSH2D mRNA	PMID:23649840
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:2321939	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of HSH2D mRNA	PMID:31881176
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313877	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of HSH2D mRNA	PMID:21151649
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of HSH2D mRNA	PMID:24768652|PMID:25583101
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:2321939	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HSH2D mRNA	PMID:34747641
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HSH2D mRNA	PMID:33212167
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313877	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of HSH2D mRNA	PMID:37682722
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HSH2D 5' UTR; Benzo(a)pyrene affects the methylation of HSH2D intron	PMID:27901495|PMID:30157460
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of HSH2D mRNA	PMID:37690743
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313877	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of HSH2D mRNA	PMID:35295148
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:2321939	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of HSH2D mRNA	PMID:34492290
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2321939	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of HSH2D mRNA	PMID:34947998
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of HSH2D polyA tail	PMID:30157460
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313877	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HSH2D mRNA	PMID:37019170
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313877	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of HSH2D mRNA	PMID:32715474
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HSH2D mRNA	PMID:37042841
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HSH2D mRNA	PMID:38382870
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of HSH2D mRNA	PMID:37738295
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313877	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of HSH2D mRNA	PMID:40194260
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313877	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of HSH2D mRNA	PMID:36331819
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313877	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of HSH2D mRNA	PMID:29038090
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of HSH2D mRNA	PMID:17400583
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of HSH2D mRNA	PMID:26690555
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313877	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of HSH2D mRNA	PMID:25554681
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313877	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of HSH2D mRNA	PMID:35964746
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313877	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of HSH2D mRNA	PMID:38701926
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of HSH2D polyA tail	PMID:30157460
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313877	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of HSH2D mRNA	PMID:22206623
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:2321939	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of HSH2D mRNA	PMID:32741896
1313876	HSH2D	hematopoietic SH2 domain containing	gene	CHEBI:80491	pinostrobin	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C411294	pinostrobin results in increased expression of HSH2D mRNA	PMID:37777166
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305698	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TAF1A mRNA]	PMID:31150632
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of TAF1A mRNA	PMID:21934132
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TAF1A mRNA	PMID:21632981
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of TAF1A mRNA	PMID:22574217
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D014241	Trichloroethylene results in increased expression of TAF1A protein	PMID:22771849
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TAF1A mRNA	PMID:23649840
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TAF1A mRNA	PMID:21179406
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in decreased expression of TAF1A protein	PMID:34122009
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TAF1A protein	PMID:37730182
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TAF1A mRNA	PMID:28818685
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TAF1A mRNA	PMID:37236586
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TAF1A mRNA	PMID:19549813
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of TAF1A protein	PMID:20106945
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TAF1A mRNA	PMID:22100608|PMID:27153756
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313880	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TAF1A mRNA	PMID:19770486
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1305698	E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in increased expression of TAF1A mRNA	PMID:31129395
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305698	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of TAF1A mRNA	PMID:31129395
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305698	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TAF1A mRNA	PMID:31150632
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313880	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TAF1A mRNA	PMID:31919559
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305698	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TAF1A mRNA]	PMID:31150632
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1A mRNA	PMID:39836092
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1A mRNA	PMID:40504410
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of TAF1A mRNA	PMID:27392435
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TAF1A mRNA	PMID:25583101
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TAF1A mRNA	PMID:20106945|PMID:21632981
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:28177	theophylline	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in increased expression of TAF1A mRNA	PMID:18951874
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305698	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TAF1A mRNA	PMID:28959563
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1A mRNA	PMID:39836092
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1A mRNA	PMID:40504410
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TAF1A mRNA	PMID:22316170
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF1A mRNA	PMID:17879257|PMID:20106945
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to TAF1A mRNA]	PMID:32406909
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TAF1A mRNA	PMID:20018196|PMID:20382639
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of TAF1A mRNA	PMID:28329830
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305698	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF1A mRNA	PMID:25181051
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305698	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TAF1A mRNA	PMID:31129395
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305698	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of TAF1A mRNA	PMID:31129395
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313880	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TAF1A mRNA	PMID:38685157
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TAF1A mRNA	PMID:37042841
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TAF1A mRNA	PMID:38568856
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TAF1A mRNA	PMID:37236586
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TAF1A mRNA	PMID:25979313
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of TAF1A mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of TAF1A mRNA	PMID:29154799
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TAF1A mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TAF1A mRNA	PMID:38832940
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313880	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TAF1A mRNA	PMID:17562736
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1A mRNA	PMID:39836092
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TAF1A mRNA	PMID:40504410
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313880	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TAF1A mRNA	PMID:35436446
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1313880	E	RGD:6480464	20200317	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of TAF1A mRNA	PMID:22078008
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305698	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TAF1A gene	PMID:35440735
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of TAF1A protein	PMID:34122009
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313880	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TAF1A mRNA	PMID:22206623
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1313880	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of TAF1A mRNA	PMID:25566086
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TAF1A mRNA	PMID:37199045
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TAF1A gene]	PMID:28238834
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:94287	erastin	decreases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:C477224	erastin results in decreased expression of TAF1A mRNA alternative form	PMID:35234341
1313879	TAF1A	TATA-box binding protein associated factor, RNA polymerase I subunit A	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313880	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of TAF1A mRNA	PMID:35537566
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313882	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of P3H3 mRNA	PMID:33045310
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of P3H3 mRNA	PMID:20938992
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313882	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of P3H3 mRNA	PMID:30319688
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of P3H3 mRNA	PMID:39241906
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P3H3 mRNA]	PMID:39241906
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313882	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of P3H3 mRNA	PMID:19484750
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of P3H3 mRNA	PMID:30165855
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305699	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of P3H3 gene	PMID:27618143
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of P3H3 mRNA	PMID:20938992
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H3 mRNA	PMID:37992649
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H3 mRNA	PMID:37992649
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of P3H3 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of P3H3 mRNA]	PMID:20230807
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305699	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of P3H3 mRNA	PMID:33387578
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1313882	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of P3H3 mRNA	PMID:20230807
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of P3H3 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of P3H3 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of P3H3 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of P3H3 mRNA]	PMID:20230807
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of P3H3 mRNA	PMID:39836092
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of P3H3 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of P3H3 mRNA]	PMID:20230807
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of P3H3 mRNA	PMID:29950665
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of P3H3 mRNA	PMID:19549813
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of P3H3 mRNA	PMID:19376150
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of P3H3 intron	PMID:30157460
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of P3H3 mRNA	PMID:35430440
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305699	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of P3H3 mRNA	PMID:30779732
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of P3H3 mRNA	PMID:20938992
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of P3H3 mRNA	PMID:39836092
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of P3H3 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of P3H3 mRNA]	PMID:20230807
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of P3H3 mRNA	PMID:27392435
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1305699	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of P3H3 mRNA	PMID:17341692
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305699	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of P3H3 mRNA	PMID:34747641
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to P3H3 promoter]	PMID:19654925
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of P3H3 mRNA	PMID:33212167
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of P3H3 mRNA	PMID:24690739
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of P3H3 mRNA	PMID:29803840
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H3 mRNA	PMID:37992649
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of P3H3 mRNA	PMID:38568856
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of P3H3 mRNA	PMID:39836092
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of P3H3 intron	PMID:30157460
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of P3H3 exon; Benzo(a)pyrene results in increased methylation of P3H3 promoter	PMID:27901495
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of P3H3 mRNA	PMID:24690739
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305699	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of P3H3 mRNA	PMID:25729387
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313882	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of P3H3 gene	PMID:35295148
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of P3H3 mRNA	PMID:29950665
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305699	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of P3H3 mRNA	PMID:19167457
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305699	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of P3H3 mRNA	PMID:25181051
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of P3H3 protein	PMID:34186270
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305699	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of P3H3 mRNA	PMID:41034487
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313882	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of P3H3 promoter	PMID:27312807
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313882	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of P3H3 mRNA	PMID:30951980|PMID:33221593
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	P3H3 mRNA affects the susceptibility to Carmustine	PMID:16365179
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313882	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of P3H3 gene	PMID:31683443
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313882	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of P3H3 mRNA	PMID:30951980
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313882	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of P3H3 promoter	PMID:33297965
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of P3H3 intron	PMID:30157460
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313882	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of P3H3 mRNA	PMID:30951980
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of P3H3 protein	PMID:34186270
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of P3H3 mRNA	PMID:31558096
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of P3H3 mRNA	PMID:29950665
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P3H3 mRNA]	PMID:39241906
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of P3H3 mRNA	PMID:39836092
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of P3H3 protein	PMID:26879310
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305699	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of P3H3 mRNA	PMID:27387713
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of P3H3 mRNA	PMID:19320972
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313882	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of P3H3 mRNA	PMID:40194260
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of P3H3 mRNA	PMID:31533062
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of P3H3 mRNA	PMID:40419075
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of P3H3 mRNA	PMID:23179753|PMID:28001369
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of P3H3 gene	PMID:29154799
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of P3H3 mRNA	PMID:37992649
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313882	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of P3H3 mRNA	PMID:17562736
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of P3H3 mRNA	PMID:24690739
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of P3H3 mRNA	PMID:39836092
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305699	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of P3H3 mRNA	PMID:29391264
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305699	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of P3H3 mRNA	PMID:17557909
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305699	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of P3H3 mRNA	PMID:22504374
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of P3H3 protein	PMID:32959892
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of P3H3 mRNA	PMID:39836092
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305699	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of P3H3 mRNA	PMID:25729387
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of P3H3 protein	PMID:36851058
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of P3H3 intron	PMID:30157460
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	P3H3 mRNA affects the susceptibility to temozolomide	PMID:16365179
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313882	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of P3H3 mRNA	PMID:22206623
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of P3H3 mRNA	PMID:37199045
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of P3H3 mRNA	PMID:31558096
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305699	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of P3H3 mRNA	PMID:22504374
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313882	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of P3H3 mRNA]	PMID:39241906
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of P3H3 mRNA	PMID:40826991
1313881	P3H3	prolyl 3-hydroxylase 3	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313882	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of P3H3 mRNA	PMID:35537566
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CATSPER3 mRNA	PMID:36331819
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of CATSPER3 mRNA	PMID:21632981
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CATSPER3 mRNA	PMID:37992649
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CATSPER3 mRNA	PMID:37992649
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1305700	E	RGD:6480464	20250506	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CATSPER3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CATSPER3 protein	PMID:38798119
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313884	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of CATSPER3 mRNA	PMID:28960355
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CATSPER3 mRNA	PMID:37992649
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CATSPER3 mRNA	PMID:38568856
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1305700	E	RGD:6480464	20250506	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CATSPER3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CATSPER3 protein	PMID:38798119
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313884	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CATSPER3 mRNA	PMID:20813756
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305700	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CATSPER3 mRNA	PMID:25181051
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313884	E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in decreased expression of CATSPER3 mRNA; bisphenol A results in decreased expression of CATSPER3 protein	PMID:34953956
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313884	E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of CATSPER3 mRNA	PMID:38922122
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20250114	CTD	MESH:C006780	TET1 protein inhibits the reaction [bisphenol A results in decreased expression of CATSPER3 protein]	PMID:34953956
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313884	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CATSPER3 mRNA	PMID:40194260
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CATSPER3 mRNA	PMID:31533062
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of CATSPER3 mRNA	PMID:36331819
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313884	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CATSPER3 mRNA	PMID:37992649
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1305700	E	RGD:6480464	20250506	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CATSPER3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CATSPER3 protein	PMID:38798119
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CATSPER3 mRNA	PMID:32234424
1313883	CATSPER3	cation channel sperm associated 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CATSPER3 gene]	PMID:28238834
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MBD4 mRNA	PMID:38218311
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313886	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MBD4 mRNA	PMID:33045310
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:136185	VX nerve agent	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C009680	VX-agent results in increased expression of MBD4 mRNA	PMID:38555327
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:147675	5-iodo-2'-deoxyuridine	affects response to substance	ISO	RGD:1313886	E	RGD:6480464	20191114	CTD	MESH:D007065	MBD4 protein affects the susceptibility to Idoxuridine	PMID:16885370
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MBD4 mRNA	PMID:33167477
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MBD4 mRNA	PMID:21179406
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of MBD4 mRNA	PMID:27655674
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MBD4 mRNA	PMID:21632981
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:16243	quercetin	decreases expression	ISO	RGD:1585874	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of MBD4 mRNA	PMID:17103110
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313886	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MBD4 mRNA	PMID:39241906
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of MBD4 mRNA; Estradiol results in decreased expression of MBD4 protein	PMID:22952798
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D004958	Estradiol results in increased expression of MBD4 mRNA	PMID:30684530
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:16469	17beta-estradiol	increases methylation	EXP		E	RGD:6480464	20240402	CTD	MESH:D004958	Estradiol results in increased methylation of MBD4 promoter	PMID:35747940
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	[Estradiol co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased methylation of MBD4 promoter; Estradiol promotes the reaction [sodium arsenite results in decreased expression of MBD4 protein]; sodium arsenite promotes the reaction [Estradiol results in decreased expression of MBD4 mRNA]; sodium arsenite promotes the reaction [Estradiol results in decreased expression of MBD4 protein]	PMID:22952798|PMID:35747940
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MBD4 mRNA	PMID:37042841
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313886	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MBD4 mRNA	PMID:37992649
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:17303	morphine	affects expression	ISO	RGD:1313886	E	RGD:6480464	20220111	CTD	MESH:D009020	Morphine affects the expression of MBD4 mRNA	PMID:33891991
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313886	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MBD4 mRNA	PMID:37992649
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MBD4 protein	PMID:37730182
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1585874	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MBD4 mRNA	PMID:33387578
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MBD4 mRNA	PMID:31390735
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313886	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MBD4 mRNA	PMID:37236586
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MBD4 mRNA	PMID:19549813
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MBD4 gene	PMID:27153756
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of MBD4 mRNA	PMID:41430723
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1585874	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MBD4 mRNA	PMID:31150632
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313886	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MBD4 mRNA	PMID:25629700|PMID:39617304
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313886	E	RGD:6480464	20250902	CTD	MESH:D005492	Folic Acid results in increased expression of MBD4 protein	PMID:39617304
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313886	E	RGD:6480464	20250902	CTD	MESH:D005492	Decitabine promotes the reaction [Folic Acid results in increased expression of MBD4 protein]; trichostatin A inhibits the reaction [Folic Acid results in increased expression of MBD4 protein]	PMID:39617304
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[Estradiol co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased methylation of MBD4 promoter; [sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of MBD4 promoter	PMID:35747940
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of MBD4 mRNA	PMID:19244175
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MBD4 protein	PMID:35688186
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of MBD4 mRNA	PMID:31295307
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1585874	E	RGD:6480464	20210608	CTD	MESH:C059514	Resveratrol results in decreased expression of MBD4 mRNA	PMID:33775663
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of MBD4 mRNA	PMID:19561079
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313886	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MBD4 mRNA	PMID:21570461
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313886	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MBD4 mRNA	PMID:37172768
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MBD4 mRNA	PMID:28001369
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MBD4 mRNA	PMID:30851411
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of MBD4 mRNA	PMID:23649840
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MBD4 mRNA	PMID:29803840|PMID:36634904
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313886	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MBD4 mRNA	PMID:37992649
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of MBD4 protein	PMID:35688186
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:29147	3,N(4)-ethenocytosine	affects glycosylation	EXP		E	RGD:6480464	20170303	CTD	MESH:C018289	MBD4 protein affects the glycosylation of 3,N(4)-ethenocytosine	PMID:11056019
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the expression of MBD4 mRNA	PMID:22952798
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of MBD4 gene	PMID:28589171
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of MBD4 protein	PMID:22952798
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of MBD4 mRNA	PMID:30191986|PMID:38146662
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[Estradiol co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased methylation of MBD4 promoter; [sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of MBD4 promoter; Estradiol promotes the reaction [sodium arsenite results in decreased expression of MBD4 protein]; sodium arsenite promotes the reaction [Estradiol results in decreased expression of MBD4 mRNA]; sodium arsenite promotes the reaction [Estradiol results in decreased expression of MBD4 protein]	PMID:22952798|PMID:35747940
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MBD4 mRNA	PMID:20018196
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MBD4 mRNA	PMID:26238291
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of MBD4 mRNA	PMID:20458559
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of MBD4 mRNA	PMID:38568856
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:31823	mercury dichloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D008627	[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD4 mRNA	PMID:27188386
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1585874	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of MBD4 mRNA	PMID:30047161
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1585874	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MBD4 mRNA	PMID:34492290
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MBD4 mRNA	PMID:19710929
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1585874	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MBD4 mRNA	PMID:30816183
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of MBD4 mRNA	PMID:19244175
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313886	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MBD4 mRNA	PMID:40203079
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1313886	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of MBD4 promoter	PMID:33297965
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313886	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MBD4 mRNA	PMID:21266533
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MBD4 mRNA	PMID:37042841
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MBD4 mRNA	PMID:38568856
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MBD4 mRNA	PMID:31390735
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313886	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MBD4 mRNA	PMID:37236586
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of MBD4 mRNA	PMID:19244175
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MBD4 mRNA	PMID:28302478
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313886	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of MBD4 mRNA	PMID:39529242
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of MBD4 mRNA	PMID:23179753
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MBD4 gene	PMID:29154799
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of MBD4 mRNA	PMID:29154799
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1585874	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of MBD4 mRNA	PMID:30047161
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1313886	E	RGD:6480464	20130416	CTD	MESH:C017160	cypermethrin results in increased expression of MBD4 mRNA	PMID:21142847
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313886	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MBD4 mRNA	PMID:28973697
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313886	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MBD4 mRNA	PMID:37992649
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of MBD4 mRNA	PMID:23649840
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MBD4 mRNA	PMID:38832940
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1313886	E	RGD:6480464	20250902	CTD	MESH:C012589	trichostatin A inhibits the reaction [Folic Acid results in increased expression of MBD4 protein]	PMID:39617304
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MBD4 mRNA	PMID:21420995
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MBD4 mRNA	PMID:22230336
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:46345	5-fluorouracil	increases metabolic processing	ISO	RGD:1313886	E	RGD:6480464	20120412	CTD	MESH:D005472	MBD4 protein results in increased metabolism of Fluorouracil	PMID:16885370
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MBD4 mRNA	PMID:29523930
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[Estradiol co-treated with [sodium arsenite results in increased abundance of Arsenic]] results in increased methylation of MBD4 promoter; [sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of MBD4 promoter	PMID:35747940
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1313886	E	RGD:6480464	20130514	CTD	MESH:D018038	Sodium Selenite results in decreased expression of MBD4 mRNA	PMID:23274088
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of MBD4 mRNA	PMID:20458559
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1313886	E	RGD:6480464	20250902	CTD	MESH:C014347	Decitabine promotes the reaction [Folic Acid results in increased expression of MBD4 protein]	PMID:39617304
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313886	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of MBD4 mRNA	PMID:25554681|PMID:31978390
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1585874	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of MBD4 mRNA	PMID:30047161
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of MBD4 mRNA	PMID:20977926
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313886	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MBD4 mRNA	PMID:19042947
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:53700	quinoline yellow	increases expression	EXP		E	RGD:6480464	20250506	CTD	MESH:C019303	quinoline yellow results in increased expression of MBD4 mRNA	PMID:28893156
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	MBD4 protein affects the susceptibility to Topotecan	PMID:16217747
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of MBD4 mRNA	PMID:28988120
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1313886	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in increased expression of MBD4 mRNA	PMID:22078008
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of MBD4 mRNA	PMID:31758290
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MBD4 protein	PMID:31285264
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MBD4 mRNA	PMID:30851411
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD4 mRNA	PMID:27188386
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1585874	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of MBD4 mRNA	PMID:32109520
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1585874	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MBD4 mRNA	PMID:23914054
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313886	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MBD4 mRNA	PMID:39847705
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1585874	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MBD4 mRNA	PMID:30047161
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MBD4 mRNA	PMID:27188386
1313885	MBD4	methyl-CpG binding domain 4, DNA glycosylase	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of MBD4 mRNA	PMID:17440010
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305702	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of TBX5 gene	PMID:35440735
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313888	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in decreased expression of TBX5 mRNA	PMID:17676605
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of TBX5 mRNA	PMID:27905399
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TBX5 mRNA	PMID:31163220
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313888	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TBX5 mRNA	PMID:34319233
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313888	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased methylation of and results in increased expression of TBX5 mRNA	PMID:34120004
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1313888	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of TBX5 mRNA	PMID:33914522
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in decreased expression of TBX5 mRNA	PMID:29993192
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1313888	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in increased expression of TBX5 mRNA	PMID:18579281
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TBX5 gene	PMID:27153756
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TBX5 intron	PMID:30157460
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313888	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TBX5 mRNA	PMID:34911549
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of TBX5 mRNA	PMID:23557933
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of TBX5 promoter	PMID:22847954
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313888	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TBX5 mRNA	PMID:24058054
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313888	E	RGD:6480464	20151110	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TBX5 mRNA	PMID:26139165
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313888	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TBX5 mRNA	PMID:27862939
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TBX5 mRNA	PMID:29803840
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of TBX5 gene	PMID:28589171
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TBX5 5' UTR; Benzo(a)pyrene affects the methylation of TBX5 exon; Benzo(a)pyrene affects the methylation of TBX5 promoter	PMID:27901495
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313888	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TBX5 mRNA	PMID:22228805
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of TBX5 promoter	PMID:23974009
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1313888	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TBX5 mRNA	PMID:27131904
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TBX5 gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of TBX5 gene	PMID:31601247
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313888	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TBX5 gene	PMID:35295148
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1313888	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of TBX5 mRNA	PMID:33914522
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313888	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TBX5 promoter	PMID:27334623
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305702	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TBX5 mRNA	PMID:25181051
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TBX5 gene	PMID:31601247
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of TBX5 mRNA	PMID:29275510
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305702	E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of TBX5 mRNA	PMID:36779543
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313888	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TBX5 mRNA	PMID:30951980
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TBX5 gene	PMID:31601247
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:33418	graphite	affects expression	ISO	RGD:1305702	E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of TBX5 mRNA	PMID:29933104
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of TBX5 gene	PMID:31601247
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313888	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TBX5 mRNA	PMID:30951980
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1305702	E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBX5 protein	PMID:34896426
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313888	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TBX5 mRNA	PMID:30951980
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of TBX5 gene	PMID:31601247
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313888	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TBX5 mRNA	PMID:37019170
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305702	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TBX5 mRNA	PMID:21266533
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of TBX5 promoter	PMID:22847954
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TBX5 mRNA	PMID:31533062
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of TBX5 promoter	PMID:22847954
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1305702	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of TBX5 protein	PMID:34896426
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313888	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of TBX5 mRNA	PMID:20219112
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1305702	E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBX5 protein	PMID:34896426
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1305702	E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBX5 protein	PMID:34896426
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TBX5 mRNA	PMID:38832940
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of TBX5 mRNA	PMID:17331233
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313888	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TBX5 mRNA	PMID:29279043
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1305702	E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBX5 protein	PMID:34896426
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305702	E	RGD:6480464	20171010	CTD	MESH:C007350	nitrofen results in decreased expression of TBX5 mRNA; nitrofen results in decreased expression of TBX5 protein	PMID:27833996
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TBX5 gene]	PMID:28238834
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1313888	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TBX5 mRNA	PMID:27131904
1313887	TBX5	T-box transcription factor 5	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305702	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of TBX5 gene	PMID:31682807
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of OTX2 mRNA	PMID:34925699
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:15343	acetaldehyde	affects expression	ISO	RGD:1313893	E	RGD:6480464	20121009	CTD	MESH:D000079	Acetaldehyde affects the expression of OTX2 mRNA	PMID:22634333
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of OTX2 gene	PMID:20938992
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin affects the expression of OTX2 mRNA	PMID:31600526
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1313893	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin affects the expression of OTX2 mRNA	PMID:16211290
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of OTX2 mRNA	PMID:21934132|PMID:34742744|PMID:40359302
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1305705	E	RGD:6480464	20150623	CTD	MESH:D014212	Tretinoin results in decreased expression of OTX2 mRNA	PMID:20488242
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of OTX2 mRNA	PMID:16788091|PMID:21427059|PMID:36189433
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D014212	4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; 4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [Tretinoin results in decreased expression of OTX2 mRNA]; 4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; 4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid inhibits the reaction [Tretinoin results in decreased expression of OTX2 mRNA]; 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline promotes the reaction [Tretinoin results in decreased expression of OTX2 mRNA]; [bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA; Fulvestrant promotes the reaction [Tretinoin results in decreased expression of OTX2 mRNA]; LE 135 affects the reaction [Tretinoin results in decreased expression of OTX2 mRNA]; LE 135 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; LY2955303 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; LY2955303 inhibits the reaction [Tretinoin results in decreased expression of OTX2 mRNA]	PMID:40359302
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of OTX2 mRNA	PMID:36189433
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D000431	Ethanol results in decreased expression of OTX2 mRNA	PMID:25566775
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:D000431	[Folic Acid co-treated with Ethanol] results in decreased expression of OTX2 mRNA	PMID:25566775
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of OTX2 mRNA	PMID:30510588
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:16494	lipoic acid	multiple interactions	ISO	RGD:1305705	E	RGD:6480464	20190910	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]	PMID:31068541
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305705	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of OTX2 mRNA	PMID:33387578
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of OTX2 gene	PMID:20938992
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:167162	L-ascorbic acid 2-phosphate	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C011669	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA	PMID:34480604
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:167657	CHIR-98014	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C473710	Chir 98014 results in decreased expression of OTX2 mRNA	PMID:22723015
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of OTX2 mRNA	PMID:36189433
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of OTX2 mRNA	PMID:36189433
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:D004051	Diethylhexyl Phthalate promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305705	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of OTX2 mRNA	PMID:26577399
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of OTX2 gene; Aflatoxin B1 results in decreased methylation of OTX2 promoter	PMID:27153756|PMID:30157460
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1305705	E	RGD:6480464	20150623	CTD	MESH:C011559	tributyltin results in increased expression of OTX2 mRNA	PMID:21683754
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of OTX2 mRNA	PMID:25629700
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:D005492	[Folic Acid co-treated with Ethanol] results in decreased expression of OTX2 mRNA	PMID:25566775
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of OTX2 gene	PMID:20938992
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of OTX2 mRNA	PMID:26272509
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA	PMID:27188386
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1313893	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of OTX2 mRNA	PMID:28960355
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of OTX2 mRNA	PMID:23557933
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20231205	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of OTX2 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of OTX2 mRNA	PMID:28050121|PMID:39150886
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of OTX2 mRNA	PMID:24058054|PMID:33956508
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:D012402	Rotenone affects the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of OTX2 mRNA	PMID:28001369
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:28299	quercetin 3-O-beta-D-glucofuranoside	multiple interactions	ISO	RGD:1305705	E	RGD:6480464	20190910	CTD	MESH:C016527	isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]	PMID:31068541
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in decreased expression of OTX2 mRNA	PMID:35032568
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305705	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OTX2 mRNA	PMID:26033743
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1305705	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of OTX2 mRNA	PMID:26033743
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:D001205	[[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA	PMID:34480604
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of OTX2 gene	PMID:28589171
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of OTX2 5' UTR; Benzo(a)pyrene affects the methylation of OTX2 promoter	PMID:27901495
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305705	E	RGD:6480464	20150623	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of OTX2 mRNA	PMID:21839799
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313893	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of OTX2 mRNA	PMID:27195522
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of OTX2 promoter	PMID:23974009
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305705	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OTX2 mRNA	PMID:26033743
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1305705	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of OTX2 mRNA	PMID:26033743
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:30314	(R)-lipoic acid	multiple interactions	ISO	RGD:1305705	E	RGD:6480464	20190910	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]	PMID:31068541
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of OTX2 mRNA	PMID:26551752
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1305705	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of OTX2 mRNA	PMID:24395379
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1305705	E	RGD:6480464	20150623	CTD	MESH:D000643	Ammonium Chloride affects the expression of OTX2 mRNA	PMID:16483693
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:31638	fulvestrant	increases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C070081	Fulvestrant results in increased expression of OTX2 mRNA	PMID:40359302
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C070081	Fulvestrant promotes the reaction [Tretinoin results in decreased expression of OTX2 mRNA]	PMID:40359302
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:31746	kainic acid	decreases expression	ISO	RGD:1305705	E	RGD:6480464	20150623	CTD	MESH:D007608	Kainic Acid results in decreased expression of OTX2 mRNA	PMID:19700661
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:31767	lead diacetate	affects expression	ISO	RGD:1305705	E	RGD:6480464	20150623	CTD	MESH:C008261	lead acetate affects the expression of OTX2 mRNA	PMID:21864555
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1305705	E	RGD:6480464	20150623	CTD	MESH:C008261	lead acetate results in decreased expression of OTX2 mRNA	PMID:22641619
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1313893	E	RGD:6480464	20231205	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of OTX2 protein; [lead acetate results in increased abundance of Lead] which results in increased expression of OTX2 mRNA	PMID:28050121|PMID:39150886
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305705	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of OTX2 mRNA	PMID:30047161
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313893	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of OTX2 gene; titanium dioxide results in decreased methylation of OTX2 promoter alternative form	PMID:35295148
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:32888	gamma-hexachlorocyclohexane	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:D001556	Hexachlorocyclohexane inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C006780	bisphenol A results in decreased expression of OTX2 mRNA	PMID:33476716
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C006780	bisphenol A results in increased expression of OTX2 mRNA	PMID:40359302
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305705	E	RGD:6480464	20150623	CTD	MESH:C006780	bisphenol A results in increased expression of OTX2 mRNA	PMID:25181051
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C006780	4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; 4-(5,6-dihydro-5,5-dimethyl-8-(quinolin-3-yl)naphthalen-2-carboxamido)benzoic acid inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; [bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA; LE 135 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]; LY2955303 inhibits the reaction [[bisphenol A co-treated with Tretinoin] results in decreased expression of OTX2 mRNA]	PMID:40359302
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of OTX2 mRNA	PMID:25979313
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:3390	carbaryl	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:D012721	Carbaryl inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:34575	bisphenol F	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C008745	bisphenol F results in decreased expression of OTX2 mRNA	PMID:33476716
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:34608	captan	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:D002215	Captan promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:34682	diazinon	decreases expression	ISO	RGD:1305705	E	RGD:6480464	20180410	CTD	MESH:D003976	Diazinon results in decreased expression of OTX2 mRNA	PMID:29108742
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:34696	dieldrin	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:D004026	Dieldrin inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1313893	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride affects the expression of OTX2 mRNA	PMID:18974090
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of OTX2 mRNA	PMID:25979313
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of OTX2 mRNA	PMID:22723015|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:34742744
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of OTX2 mRNA	PMID:19136453|PMID:20546886|PMID:21427059|PMID:24896083
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; Valproic Acid inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:27188386|PMID:32949729
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305705	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of OTX2 mRNA	PMID:30047161
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of OTX2 mRNA	PMID:22723015|PMID:24935251|PMID:26272509
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA	PMID:27188386
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D005472	Fluorouracil results in decreased expression of OTX2 mRNA	PMID:30518710
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313893	E	RGD:6480464	20200714	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of OTX2 mRNA	PMID:31978390
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305705	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of OTX2 mRNA	PMID:30047161
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:5118	fluoxetine	affects expression	ISO	RGD:1313893	E	RGD:6480464	20181113	CTD	MESH:D005473	Fluoxetine affects the expression of OTX2 mRNA	PMID:29893963
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:5693	hexachlorophene	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:D006582	Hexachlorophene inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:62878	XAV939	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C544261	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA	PMID:34480604
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases response to substance	ISO	RGD:1313893	E	RGD:6480464	20130514	CTD	MESH:D015655	OTX2 protein results in decreased susceptibility to 1-Methyl-4-phenylpyridinium	PMID:20573704
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:68352	quercetin 3-O-beta-D-glucopyranoside	multiple interactions	ISO	RGD:1305705	E	RGD:6480464	20190910	CTD	MESH:C016527	isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]	PMID:31068541
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA; Captan promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Carbaryl inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; decamethrin affects the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Dieldrin inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Diethylhexyl Phthalate promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Hexachlorocyclohexane inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Hexachlorophene inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Rotenone affects the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Valproic Acid inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:32949729
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA	PMID:27188386
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1313893	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of OTX2 mRNA	PMID:22634333
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305705	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of OTX2 mRNA	PMID:30047161
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305705	E	RGD:6480464	20190910	CTD	MESH:D011441	Propylthiouracil results in increased expression of OTX2 mRNA	PMID:31068541
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1305705	E	RGD:6480464	20190910	CTD	MESH:D011441	isoquercitrin analog inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]; Thioctic Acid inhibits the reaction [Propylthiouracil results in increased expression of OTX2 mRNA]	PMID:31068541
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA	PMID:27188386
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:91091	CHIR 99021	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C473711	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of OTX2 mRNA	PMID:34480604
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OTX2 mRNA; Captan promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Carbaryl inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; decamethrin affects the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Dieldrin inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Diethylhexyl Phthalate promotes the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Hexachlorocyclohexane inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Hexachlorophene inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Rotenone affects the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]; Valproic Acid inhibits the reaction [[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with LDN 193189] results in increased expression of OTX2 mRNA]	PMID:27188386|PMID:32949729
1313892	OTX2	orthodenticle homeobox 2	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of OTX2 mRNA	PMID:26551752
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313895	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of H1F1 mRNA	PMID:33045310
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of H1-1 mRNA	PMID:26516004
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:164200	triclosan	increases methylation	EXP		E	RGD:6480464	20220607	CTD	MESH:D014260	Triclosan results in increased methylation of H1-1 gene	PMID:34523531
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of H1-1 mRNA	PMID:38568856
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313895	E	RGD:6480464	20180116	CTD	MESH:D014241	Trichloroethylene results in decreased expression of H1F1 mRNA	PMID:28973375
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1313895	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate affects the expression of H1F1 mRNA	PMID:33754040
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305706	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of H1F1 mRNA	PMID:33387578
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of H1-1 mRNA	PMID:17103032
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of H1-1 mRNA	PMID:35301059
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313895	E	RGD:6480464	20181016	CTD	MESH:D002251	[PANX1 protein co-treated with Carbon Tetrachloride] affects the expression of H1F1 mRNA	PMID:29987408
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:27563	arsenic atom	decreases methylation	EXP		E	RGD:6480464	20200310	CTD	MESH:D001151	Arsenic results in decreased methylation of H1-1 promoter	PMID:31135185
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305706	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of H1F1 mRNA	PMID:31881176
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in increased expression of H1-1 mRNA	PMID:41028656
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of H1-1 mRNA	PMID:41028656
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of H1-1 mRNA	PMID:38568856
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of H1-1 mRNA	PMID:25266719
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313895	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of H1F1 mRNA	PMID:37682722
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of H1-1 5' UTR; Benzo(a)pyrene results in decreased methylation of H1-1 exon; Benzo(a)pyrene results in decreased methylation of H1-1 promoter	PMID:27901495
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313895	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of H1F1 mRNA	PMID:20504355
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of H1-1 mRNA	PMID:41028656
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of H1-1 mRNA	PMID:34973136
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313895	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of H1F1 promoter alternative form	PMID:35295148
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1305706	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of H1F1 mRNA	PMID:30012374
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313895	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of H1F1 mRNA	PMID:23557971
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of H1-1 mRNA; bisphenol A results in decreased expression of H1-1 protein	PMID:29275510|PMID:33376534
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305706	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of H1F1 mRNA	PMID:25181051
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:34568	Benzo[ghi]perylene	decreases expression	ISO	RGD:1313895	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in decreased expression of H1F1 mRNA	PMID:26377693
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1313895	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of H1F1 protein	PMID:35362542
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313895	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of H1F1 protein]	PMID:35362542
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1305706	E	RGD:6480464	20191112	CTD	MESH:D002509	Cephaloridine results in increased expression of H1F1 mRNA	PMID:18500788
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of H1-1 mRNA	PMID:35301059
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305706	E	RGD:6480464	20191112	CTD	MESH:C039281	furan results in increased methylation of H1F1 gene	PMID:22079235
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of H1-1 mRNA	PMID:19320972
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1313895	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of H1F1 mRNA	PMID:28962523
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313895	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of H1F1 mRNA	PMID:39529242
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313895	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of H1F1 mRNA	PMID:24896083
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:43572	kojic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of H1-1 mRNA	PMID:16595896
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of H1-1 mRNA	PMID:26690555
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305706	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of H1F1 mRNA	PMID:33387578
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:47217	arsane	decreases methylation	EXP		E	RGD:6480464	20200310	CTD	MESH:D001151	Arsenic results in decreased methylation of H1-1 promoter	PMID:31135185
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305706	E	RGD:6480464	20191112	CTD	MESH:D004726	Endosulfan results in increased expression of H1F1 mRNA	PMID:29391264
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of H1-1 mRNA	PMID:22079256
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1313895	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of H1F1 protein]	PMID:35362542
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313895	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of H1F1 mRNA; Nanotubes, Carbon results in increased expression of H1F1 mRNA	PMID:25554681
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1313895	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of H1F1 mRNA	PMID:26377693
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313895	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of H1F1 mRNA	PMID:19042947
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of H1-1 mRNA	PMID:31629900
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313895	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of H1F1 mRNA	PMID:38701926
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1305706	E	RGD:6480464	20191112	CTD	MESH:C025340	manganese chloride results in decreased expression of H1F1 mRNA	PMID:28801915
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305706	E	RGD:6480464	20191112	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of H1F1 mRNA	PMID:28801915
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:72676	versicolorin A	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C029826	versicolorin A results in increased expression of H1-1 mRNA	PMID:32106047
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313895	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of H1F1 mRNA	PMID:22206623
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of H1-1 mRNA	PMID:22079256
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of H1-1 mRNA	PMID:22079256
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to H1-1 gene]	PMID:28238834
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313895	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of H1F1 mRNA	PMID:38648751
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305706	E	RGD:6480464	20191112	CTD	MESH:D011441	Propylthiouracil affects the expression of H1F1 mRNA	PMID:24780913
1313894	H1-1	H1.1 linker histone, cluster member	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1305706	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of H1F1 protein	PMID:35544339
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305707	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of CAPRIN1 mRNA	PMID:25152437
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305707	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of CAPRIN1 mRNA	PMID:21551480
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CAPRIN1 mRNA	PMID:33045310
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CAPRIN1 protein]	PMID:38195004
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of CAPRIN1 mRNA	PMID:15498508
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of CAPRIN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA	PMID:32699268|PMID:32845096
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CAPRIN1 mRNA	PMID:36331819
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CAPRIN1 mRNA	PMID:26079696
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CAPRIN1 mRNA	PMID:22378314
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313897	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CAPRIN1 mRNA	PMID:30319688
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D000431	Ethanol results in increased expression of CAPRIN1 mRNA	PMID:27010169
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313897	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CAPRIN1 mRNA	PMID:39241906
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of CAPRIN1 mRNA	PMID:22574217
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313897	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CAPRIN1 mRNA	PMID:39298647
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1305707	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CAPRIN1 mRNA	PMID:23829299
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CAPRIN1 mRNA	PMID:19448997
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CAPRIN1 mRNA	PMID:21179406
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CAPRIN1 mRNA	PMID:33754040
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of CAPRIN1 protein	PMID:34122009
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:17924	D-glucitol	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:D013012	Sorbitol promotes the reaction [SNRNP200 protein binds to CAPRIN1 protein]	PMID:33939924
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CAPRIN1 mRNA	PMID:36331819
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CAPRIN1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CAPRIN1 protein	PMID:38195004
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CAPRIN1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CAPRIN1 mRNA	PMID:28111341|PMID:37236586
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CAPRIN1 protein	PMID:23301498
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CAPRIN1 gene	PMID:28458013
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of CAPRIN1 mRNA	PMID:15674844
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of CAPRIN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of CAPRIN1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CAPRIN1 mRNA	PMID:34911549
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:2663	amiodarone	affects expression	ISO	RGD:1305707	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of CAPRIN1 mRNA	PMID:19483382
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CAPRIN1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CAPRIN1 protein	PMID:38598786
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CAPRIN1 mRNA	PMID:22206623
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CAPRIN1 protein	PMID:35688186
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of CAPRIN1 protein	PMID:25505154
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CAPRIN1 mRNA	PMID:23557933
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of CAPRIN1 mRNA	PMID:34813904
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in increased expression of CAPRIN1 mRNA	PMID:18922574
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313897	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CAPRIN1 mRNA	PMID:21570461
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CAPRIN1 mRNA	PMID:19465110
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:28177	theophylline	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in increased expression of CAPRIN1 mRNA	PMID:18951874
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305707	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of CAPRIN1 protein	PMID:35544339
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CAPRIN1 mRNA	PMID:28001369
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CAPRIN1 mRNA	PMID:33212167
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CAPRIN1 mRNA	PMID:29803840
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:29678	sodium arsenite	affects localization	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the localization of CAPRIN1 protein	PMID:19073175|PMID:33939924
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of CAPRIN1 mRNA; sodium arsenite results in decreased expression of CAPRIN1 protein	PMID:30528433|PMID:38568856
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	Emetine inhibits the reaction [sodium arsenite affects the localization of CAPRIN1 protein]; sodium arsenite promotes the reaction [ABCC1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ACTG1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ADAMTS12 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [AFMID protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [AHNAK2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [AHSA1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ANKRD17 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ANXA6 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [AP3D1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ARF1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ARFGAP2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ARPC5 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ASF1B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ATRX protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [BIN3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [BOLA2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [BUD23 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [C11ORF68 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [C17ORF100 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CAMSAP2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CAVIN1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CCDC71 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CCNL2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CCT7 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CDC16 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CDC27 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CDIPT protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CDK5 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CENPE protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CEP131 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CHCHD3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CHD1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CHTOP protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CKM protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CLINT1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CMPK1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CNOT4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [COG5 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CPA4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CSNK2A2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [CTPS1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DDX46 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DHCR24 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DMD protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DNAJB4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DOCK9 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DTYMK protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DYNC1LI1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [DYNLL2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ECH1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [EIF2A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [EIF2D protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [EIF4A2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ELMO2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ELOB protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ELOVL1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [EMC1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ERP29 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [EXOC6B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [EXOSC5 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [FGF3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [FKBP2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [FMNL1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [FMR1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [FNDC3A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [FRY protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GALNT2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GART protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GCC2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GNE protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GOSR1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GPR107 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GPR156 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GSPT1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [GSTM2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [H2AC18 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [H3C15 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HADH protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HAUS5 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HBA1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HCK protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HLA-C protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HMGB1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HNF1A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HNRNPA3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HSD17B11 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [HUWE1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [IGDCC3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [IQCN protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ISYNA1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ITGB4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [KIF5A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [KLF3-AS1 mRNA binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [KNDC1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [KRT8 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [LARS2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [LATS1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [LMAN2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [LMF2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MAP1S protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MAP7D3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MED4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MRPL11 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MRPL44 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MRPL46 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MRPS34 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MSI2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MTAP protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MTHFD2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MTREX protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MVB12A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MYH2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MYH7 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [MZT2B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NCBP2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NDUFS3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NFATC4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NHEJ1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NHSL2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NIFK protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NNMT protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NUP85 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [NUP98 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ORMDL3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PABPC4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PAFAH1B3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PBK protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PCDH11X protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PCYT1B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PDIA3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PDXDC1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PFN2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PIGS protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PIK3R4 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PLEC protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [POLR2E protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PPIE protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PPP2CB protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PRKAR2A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PRKCA protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PRRG1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PSMB7 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PSMC2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PSMC6 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PSME1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PTGES3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PTP4A1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PTPN23 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PUM1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [PYGB protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RANGAP1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RBM10 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RELCH protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RNF40 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [ROCK1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RPL36A protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RPS21 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RRBP1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RRP1B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [RTCB protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SART3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SCGN protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SCO2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SEC24C protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SEH1L protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SGTA protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SHLD3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SLC25A10 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SLC25A13 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SLC35F6 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SNAP29 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SNX1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SNX12 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SRFBP1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [STT3B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [SULT1A3 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TBC1D15 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TBC1D5 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TGM2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TIMM29 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TIMMDC1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TIPRL protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TJP1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TMEM11 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TRAM1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TRIM47 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TRIM56 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TTI1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TTLL12 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TTN protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [TYMS protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [UBAP2L protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [UBE2M protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [UBR2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [UNC13B protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [UNC13D protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [VPS53 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [WASF2 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [WDR6 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [WWP1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [XPC protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [YARS1 protein binds to CAPRIN1 protein]; sodium arsenite promotes the reaction [YBX1 protein binds to CAPRIN1 protein]	PMID:19073175|PMID:33939924
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CAPRIN1 mRNA	PMID:19770486|PMID:22228805
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CAPRIN1 protein]	PMID:32406909
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:3023	benzbromarone	affects expression	ISO	RGD:1305707	E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of CAPRIN1 mRNA	PMID:19483382
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of CAPRIN1 protein	PMID:34122009
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CAPRIN1 mRNA	PMID:19150397
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305707	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of CAPRIN1 mRNA	PMID:24136188
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305707	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CAPRIN1 mRNA	PMID:25729387
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of CAPRIN1 mRNA	PMID:15498508
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CAPRIN1 mRNA	PMID:29264374
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313897	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CAPRIN1 gene	PMID:35295148
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1305707	E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of CAPRIN1 mRNA	PMID:19483382
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305707	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CAPRIN1 mRNA	PMID:23411599|PMID:34492290
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1305707	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of CAPRIN1 mRNA	PMID:19483382
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CAPRIN1 mRNA	PMID:18445702
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1305707	E	RGD:6480464	20121113	CTD	MESH:C006253	pirinixic acid results in increased expression of CAPRIN1 mRNA	PMID:22484513
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CAPRIN1 mRNA	PMID:18301758
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C006780	bisphenol A affects the expression of CAPRIN1 mRNA	PMID:27010169
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of CAPRIN1 protein	PMID:37567409
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305707	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CAPRIN1 mRNA	PMID:30816183|PMID:34947998
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of CAPRIN1 protein	PMID:34186270
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305707	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CAPRIN1 mRNA	PMID:25181051
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of CAPRIN1 mRNA	PMID:19925653
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313897	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CAPRIN1 mRNA	PMID:39298647
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CAPRIN1 protein	PMID:34186270
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313897	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CAPRIN1 mRNA	PMID:38685157
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CAPRIN1 protein	PMID:34186270
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of CAPRIN1 protein	PMID:38598786
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CAPRIN1 mRNA	PMID:37042841
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of CAPRIN1 mRNA	PMID:26377693
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CAPRIN1 mRNA	PMID:38568856
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CAPRIN1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CAPRIN1 protein	PMID:38195004
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of CAPRIN1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CAPRIN1 mRNA	PMID:28111341|PMID:37236586
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CAPRIN1 protein	PMID:26879310
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CAPRIN1 mRNA	PMID:19320972
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313897	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CAPRIN1 mRNA	PMID:18353800
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of CAPRIN1 mRNA	PMID:32699268
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:3750	clofibrate	affects expression	ISO	RGD:1305707	E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of CAPRIN1 mRNA	PMID:19483382
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CAPRIN1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CAPRIN1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CAPRIN1 mRNA	PMID:36331819
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CAPRIN1 mRNA	PMID:25979313
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CAPRIN1 mRNA	PMID:17963808
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CAPRIN1 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAPRIN1 mRNA	PMID:27188386
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CAPRIN1 mRNA	PMID:17555576
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of CAPRIN1 mRNA	PMID:36621641
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of CAPRIN1 mRNA	PMID:27188386
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:45863	paclitaxel	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of CAPRIN1 mRNA	PMID:18058816
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CAPRIN1 mRNA	PMID:28542535
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CAPRIN1 mRNA	PMID:17562736
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CAPRIN1 mRNA	PMID:21420995
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of CAPRIN1 mRNA	PMID:20977926
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1305707	E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of CAPRIN1 mRNA	PMID:21061450
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:4781	emetine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004640	Emetine inhibits the reaction [sodium arsenite affects the localization of CAPRIN1 protein]	PMID:19073175
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313897	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CAPRIN1 mRNA	PMID:35436446
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of CAPRIN1 mRNA	PMID:18175754
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:4886	L-ethionine	affects expression	ISO	RGD:1305707	E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of CAPRIN1 mRNA	PMID:19483382
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313897	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CAPRIN1 mRNA	PMID:17555576
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305707	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of CAPRIN1 mRNA	PMID:30307764
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305707	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CAPRIN1 mRNA	PMID:24136188
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CAPRIN1 mRNA	PMID:35964746
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305707	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CAPRIN1 mRNA	PMID:24136188
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313897	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CAPRIN1 mRNA	PMID:19042947
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313897	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of CAPRIN1 mRNA	PMID:23608068
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CAPRIN1 protein	PMID:32959892
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of CAPRIN1 mRNA	PMID:27188386
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305707	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CAPRIN1 mRNA	PMID:25729387
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305707	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CAPRIN1 mRNA	PMID:30467583
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in increased expression of CAPRIN1 mRNA	PMID:22101062
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CAPRIN1 mRNA	PMID:31758290
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CAPRIN1 protein	PMID:34186270
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313897	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CAPRIN1 mRNA	PMID:22206623
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CAPRIN1 mRNA	PMID:22206623
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CAPRIN1 protein	PMID:37664457
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305707	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CAPRIN1 mRNA	PMID:24136188
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:7599	Nivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of CAPRIN1 protein	PMID:39638853
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1305707	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CAPRIN1 mRNA	PMID:15215175
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	ISO	RGD:1305707	E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of CAPRIN1 mRNA	PMID:19483382
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:7772	omeprazole	affects expression	ISO	RGD:1305707	E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of CAPRIN1 mRNA	PMID:19483382
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAPRIN1 mRNA	PMID:27188386
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 promotes the reaction [NR1H4 protein binds to CAPRIN1 gene]	PMID:20091679
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313897	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CAPRIN1 mRNA	PMID:31388691
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1305707	E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of CAPRIN1 protein	PMID:19954255
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of CAPRIN1 mRNA	PMID:26079696
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305707	E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of CAPRIN1 mRNA	PMID:19483382
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CAPRIN1 protein; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CAPRIN1 mRNA	PMID:27188386|PMID:37664457
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305707	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CAPRIN1 mRNA	PMID:21346803
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of CAPRIN1 protein	PMID:38598786
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305707	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CAPRIN1 mRNA	PMID:21346803
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1313897	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CAPRIN1 mRNA	PMID:18930950
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305707	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CAPRIN1 mRNA	PMID:19015723
1313896	CAPRIN1	cell cycle associated protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305707	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of CAPRIN1 mRNA	PMID:20566332
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of C10ORF90 mRNA	PMID:33167477
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313899	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of D7ERTD443E mRNA	PMID:39241906
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313899	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of D7ERTD443E mRNA	PMID:33711761
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of C10ORF90 mRNA	PMID:26079696
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of C10ORF90 intron	PMID:30157460
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of C10ORF90 intron	PMID:30157460
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1313899	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of D7ERTD443E mRNA	PMID:39984025
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of C10ORF90 intron	PMID:30157460
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313899	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of D7ERTD443E mRNA	PMID:31626304
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313899	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of D7ERTD443E mRNA	PMID:32186404
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of C10ORF90 mRNA	PMID:29301061
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of C10ORF90 promoter	PMID:27901495
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of C10ORF90 exon	PMID:27901495
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313899	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of D7ERTD443E mRNA	PMID:20813756
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of C10ORF90 mRNA	PMID:36804509
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C008745	bisphenol F results in increased expression of C10ORF90 mRNA	PMID:33476716
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of C10ORF90 mRNA	PMID:38382870
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of C10ORF90 mRNA	PMID:38832940
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313899	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of D7ERTD443E mRNA	PMID:38701926
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:6078	ivermectin	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of C10ORF90 protein	PMID:32959892
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1313899	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of D7ERTD443E mRNA	PMID:36907384
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of C10ORF90 mRNA	PMID:31758290
1313898	C10orf90	chromosome 10 open reading frame 90	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313899	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of D7ERTD443E mRNA	PMID:22206623
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:9299787	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of ARMH3 gene	PMID:35440735
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of ARMH3 mRNA	PMID:18951874
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARMH3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ARMH3 mRNA	PMID:39836092
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ARMH3 mRNA	PMID:23649840
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:9299787	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of ARMH3 mRNA	PMID:41580963
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of ARMH3 mRNA	PMID:18414638
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARMH3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARMH3 mRNA	PMID:39836092
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ARMH3 mRNA	PMID:23557933
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:9299787	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARMH3 mRNA	PMID:32109520
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ARMH3 protein	PMID:39603559
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARMH3 mRNA	PMID:33212167
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ARMH3 mRNA	PMID:30851411
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARMH3 mRNA	PMID:29803840
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARMH3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARMH3 mRNA	PMID:39836092
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARMH3 promoter	PMID:27901495
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:9299787	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ARMH3 mRNA	PMID:34492290
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARMH3 gene	PMID:31601247
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313901	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ARMH3 mRNA	PMID:38685157
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313901	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ARMH3 intron	PMID:28392331
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313901	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ARMH3 mRNA	PMID:34813904
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARMH3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ARMH3 mRNA	PMID:39836092
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARMH3 mRNA	PMID:29154799
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ARMH3 mRNA	PMID:23179753
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ARMH3 mRNA	PMID:24935251
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:9299787	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARMH3 mRNA	PMID:33387578
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of ARMH3 mRNA	PMID:18414638
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARMH3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ARMH3 mRNA	PMID:39836092
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313901	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ARMH3 mRNA	PMID:35964746
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ARMH3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ARMH3 mRNA	PMID:39836092
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ARMH3 mRNA	PMID:30851411
1313900	ARMH3	armadillo like helical domain containing 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313901	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of ARMH3 mRNA	PMID:39847705
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of AP1G2 mRNA	PMID:38218311
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313903	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of AP1G2 mRNA	PMID:33045310
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:132606	mono(2-ethyl-5-oxohexyl) phthalate	affects expression	EXP		E	RGD:6480464	20220906	CTD	MESH:C080276	mono(2-ethyl-5-oxohexyl)phthalate affects the expression of AP1G2 mRNA	PMID:34478338
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:132844	glycidyl methacrylate	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of AP1G2 protein	PMID:36641056
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of AP1G2 mRNA	PMID:33167477
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AP1G2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AP1G2 mRNA	PMID:32699268
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313903	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of AP1G2 mRNA	PMID:39241906
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of AP1G2 mRNA	PMID:30510588
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313903	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of AP1G2 mRNA	PMID:39298647
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:2324507	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of AP1G2 protein	PMID:34915118
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1313903	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of AP1G2 mRNA	PMID:19376150
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AP1G2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AP1G2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of AP1G2 mRNA	PMID:32699268
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AP1G2 mRNA	PMID:40512198
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313903	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AP1G2 mRNA	PMID:40504410
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of AP1G2 mRNA	PMID:27392435
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313903	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AP1G2 mRNA	PMID:21570461
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:2324507	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AP1G2 mRNA	PMID:34747641
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AP1G2 mRNA	PMID:20106945
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of AP1G2 mRNA	PMID:29955902
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of AP1G2 mRNA	PMID:28001369
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313903	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in increased expression of AP1G2 mRNA	PMID:35032568
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of AP1G2 mRNA	PMID:39719251
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AP1G2 mRNA	PMID:40512198
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313903	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AP1G2 mRNA	PMID:40504410
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:2324507	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of AP1G2 mRNA	PMID:34492290
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313903	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of AP1G2 mRNA	PMID:19710929
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of AP1G2 protein	PMID:31675489
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of AP1G2 protein	PMID:31675489
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313903	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of AP1G2 promoter	PMID:33297965
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313903	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of AP1G2 mRNA	PMID:38685157
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:34631	chlorpyrifos	affects expression	ISO	RGD:2324507	E	RGD:6480464	20120522	CTD	MESH:D004390	Chlorpyrifos affects the expression of AP1G2 mRNA	PMID:17452286
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313903	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of AP1G2 mRNA	PMID:34813904
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AP1G2 mRNA	PMID:37042841
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of AP1G2 mRNA	PMID:38568856
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of AP1G2 mRNA	PMID:25812627
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AP1G2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AP1G2 mRNA	PMID:32699268
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of AP1G2 mRNA	PMID:25812627
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of AP1G2 mRNA	PMID:31533062
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of AP1G2 mRNA	PMID:25812627
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AP1G2 mRNA	PMID:25979313
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of AP1G2 mRNA	PMID:29154799
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of AP1G2 gene	PMID:29154799
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of AP1G2 mRNA	PMID:12782123
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of AP1G2 mRNA	PMID:22230336
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AP1G2 mRNA	PMID:40512198
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313903	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AP1G2 mRNA	PMID:40504410
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of AP1G2 mRNA	PMID:31675489
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:2324507	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of AP1G2 mRNA	PMID:29391264
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313903	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of AP1G2 mRNA	PMID:35436446
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:2324507	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of AP1G2 mRNA	PMID:34044035
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AP1G2 protein	PMID:32959892
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of AP1G2 mRNA	PMID:31758290
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:749301	potassium perchlorate	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of AP1G2 mRNA	PMID:29673971
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AP1G2 gene]	PMID:28238834
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of AP1G2 protein	PMID:31675489
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of AP1G2 protein	PMID:31675489
1313902	AP1G2	adaptor related protein complex 1 subunit gamma 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313903	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of AP1G2 mRNA	PMID:35537566
1313904	FOXN3	forkhead box N3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of FOXN3 mRNA	PMID:38218311
1313904	FOXN3	forkhead box N3	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of FOXN3 mRNA	PMID:21551480
1313904	FOXN3	forkhead box N3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of FOXN3 mRNA	PMID:33045310
1313904	FOXN3	forkhead box N3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305711	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FOXN3 mRNA]	PMID:31150632
1313904	FOXN3	forkhead box N3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313905	E	RGD:6480464	20250401	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CHES1 mRNA	PMID:20938992
1313904	FOXN3	forkhead box N3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of FOXN3 mRNA	PMID:23724009
1313904	FOXN3	forkhead box N3	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D010100	Oxygen deficiency results in increased expression of FOXN3 mRNA	PMID:24403227
1313904	FOXN3	forkhead box N3	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:D010100	1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of FOXN3 mRNA]	PMID:24403227
1313904	FOXN3	forkhead box N3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of FOXN3 mRNA	PMID:22378314
1313904	FOXN3	forkhead box N3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313905	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FOXN3 mRNA	PMID:30319688
1313904	FOXN3	forkhead box N3	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CHES1 mRNA	PMID:20044591
1313904	FOXN3	forkhead box N3	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of CHES1 mRNA	PMID:18951874
1313904	FOXN3	forkhead box N3	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of FOXN3 mRNA	PMID:21632981
1313904	FOXN3	forkhead box N3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FOXN3 mRNA	PMID:39241906
1313904	FOXN3	forkhead box N3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of FOXN3 mRNA	PMID:31614463
1313904	FOXN3	forkhead box N3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of FOXN3 mRNA	PMID:32145629
1313904	FOXN3	forkhead box N3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313905	E	RGD:6480464	20250401	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CHES1 mRNA	PMID:20938992
1313904	FOXN3	forkhead box N3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FOXN3 mRNA	PMID:37042841
1313904	FOXN3	forkhead box N3	gene	CHEBI:16716	benzene	affects expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene affects the expression of FOXN3 mRNA	PMID:16188086
1313904	FOXN3	forkhead box N3	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of FOXN3 mRNA	PMID:27523638
1313904	FOXN3	forkhead box N3	gene	CHEBI:17833	gentamycin	affects expression	ISO	RGD:1305711	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins affects the expression of FOXN3 mRNA	PMID:33387578
1313904	FOXN3	forkhead box N3	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of FOXN3 intron	PMID:30157460
1313904	FOXN3	forkhead box N3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FOXN3 mRNA	PMID:35301059
1313904	FOXN3	forkhead box N3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313905	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FOXN3 mRNA	PMID:37325564
1313904	FOXN3	forkhead box N3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FOXN3 mRNA	PMID:19549813
1313904	FOXN3	forkhead box N3	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of FOXN3 intron	PMID:30157460
1313904	FOXN3	forkhead box N3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FOXN3 gene	PMID:27153756
1313904	FOXN3	forkhead box N3	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313905	E	RGD:6480464	20120501	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of FOXN3 mRNA	PMID:21785161
1313904	FOXN3	forkhead box N3	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of FOXN3 mRNA	PMID:30779732
1313904	FOXN3	forkhead box N3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FOXN3 mRNA	PMID:31150632
1313904	FOXN3	forkhead box N3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FOXN3 mRNA	PMID:31919559
1313904	FOXN3	forkhead box N3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305711	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FOXN3 mRNA]	PMID:31150632
1313904	FOXN3	forkhead box N3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313905	E	RGD:6480464	20250401	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of CHES1 mRNA	PMID:20938992
1313904	FOXN3	forkhead box N3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FOXN3 gene	PMID:25304211
1313904	FOXN3	forkhead box N3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FOXN3 mRNA	PMID:39836092
1313904	FOXN3	forkhead box N3	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1313905	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of FOXN3 mRNA	PMID:35897073
1313904	FOXN3	forkhead box N3	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FOXN3 mRNA	PMID:31881176
1313904	FOXN3	forkhead box N3	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of FOXN3 mRNA	PMID:12569576
1313904	FOXN3	forkhead box N3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305711	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FOXN3 mRNA	PMID:32109520
1313904	FOXN3	forkhead box N3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313905	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FOXN3 mRNA	PMID:24058054
1313904	FOXN3	forkhead box N3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FOXN3 mRNA	PMID:20106945|PMID:21632981
1313904	FOXN3	forkhead box N3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FOXN3 mRNA	PMID:21215274|PMID:33387578
1313904	FOXN3	forkhead box N3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20250401	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHES1 mRNA	PMID:19770486
1313904	FOXN3	forkhead box N3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305711	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FOXN3 mRNA	PMID:34747641
1313904	FOXN3	forkhead box N3	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305711	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of FOXN3 mRNA	PMID:28374803
1313904	FOXN3	forkhead box N3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FOXN3 mRNA	PMID:33212167
1313904	FOXN3	forkhead box N3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FOXN3 mRNA	PMID:29803840
1313904	FOXN3	forkhead box N3	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of FOXN3 protein	PMID:35688186
1313904	FOXN3	forkhead box N3	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D024483	Vitamin K 3 affects the expression of CHES1 mRNA	PMID:20044591
1313904	FOXN3	forkhead box N3	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of FOXN3 gene	PMID:28589171
1313904	FOXN3	forkhead box N3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FOXN3 mRNA	PMID:39836092
1313904	FOXN3	forkhead box N3	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of CHES1 mRNA	PMID:22316170
1313904	FOXN3	forkhead box N3	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1313905	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of FOXN3 mRNA	PMID:22342234
1313904	FOXN3	forkhead box N3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FOXN3 5' UTR; Benzo(a)pyrene affects the methylation of FOXN3 intron; Benzo(a)pyrene affects the methylation of FOXN3 promoter	PMID:27901495|PMID:30157460
1313904	FOXN3	forkhead box N3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FOXN3 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:26238291
1313904	FOXN3	forkhead box N3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of FOXN3 mRNA	PMID:27131904
1313904	FOXN3	forkhead box N3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of FOXN3 mRNA	PMID:25351596
1313904	FOXN3	forkhead box N3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of FOXN3 mRNA	PMID:23221170
1313904	FOXN3	forkhead box N3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FOXN3 mRNA	PMID:19150397|PMID:20018196
1313904	FOXN3	forkhead box N3	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of FOXN3 mRNA	PMID:24136188
1313904	FOXN3	forkhead box N3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305711	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of FOXN3 mRNA	PMID:25729387
1313904	FOXN3	forkhead box N3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of FOXN3 mRNA	PMID:30047161
1313904	FOXN3	forkhead box N3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313905	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FOXN3 gene	PMID:35295148
1313904	FOXN3	forkhead box N3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305711	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FOXN3 mRNA	PMID:25181051|PMID:32145629
1313904	FOXN3	forkhead box N3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of FOXN3 mRNA	PMID:36232920
1313904	FOXN3	forkhead box N3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of FOXN3 mRNA	PMID:37894381|PMID:38074096
1313904	FOXN3	forkhead box N3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FOXN3 gene	PMID:31601247
1313904	FOXN3	forkhead box N3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313905	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of FOXN3 promoter	PMID:27312807
1313904	FOXN3	forkhead box N3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of FOXN3 mRNA	PMID:20678512|PMID:36232920
1313904	FOXN3	forkhead box N3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305711	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of FOXN3 mRNA	PMID:30816183
1313904	FOXN3	forkhead box N3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305711	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FOXN3 gene	PMID:28505145
1313904	FOXN3	forkhead box N3	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of FOXN3 mRNA	PMID:26682919
1313904	FOXN3	forkhead box N3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305711	E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of FOXN3 mRNA	PMID:32119087
1313904	FOXN3	forkhead box N3	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1305711	E	RGD:6480464	20180515	CTD	MESH:D008748	Methylcholanthrene results in increased expression of FOXN3 mRNA	PMID:29094188
1313904	FOXN3	forkhead box N3	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1305711	E	RGD:6480464	20180515	CTD	MESH:D008748	alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of FOXN3 mRNA]	PMID:29094188
1313904	FOXN3	forkhead box N3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of FOXN3 mRNA	PMID:39298647
1313904	FOXN3	forkhead box N3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313905	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of FOXN3 mRNA	PMID:40203079
1313904	FOXN3	forkhead box N3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of FOXN3 intron	PMID:30157460
1313904	FOXN3	forkhead box N3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313905	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of FOXN3 mRNA	PMID:38685157
1313904	FOXN3	forkhead box N3	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1313905	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of FOXN3 intron	PMID:28392331
1313904	FOXN3	forkhead box N3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of FOXN3 mRNA	PMID:18668222
1313904	FOXN3	forkhead box N3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313905	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FOXN3 mRNA	PMID:37019170
1313904	FOXN3	forkhead box N3	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305711	E	RGD:6480464	20250401	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHES1 mRNA	PMID:17602206
1313904	FOXN3	forkhead box N3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of FOXN3 mRNA	PMID:21266533
1313904	FOXN3	forkhead box N3	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305711	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of FOXN3 mRNA	PMID:22546817
1313904	FOXN3	forkhead box N3	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313905	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of FOXN3 mRNA	PMID:34813904
1313904	FOXN3	forkhead box N3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305711	E	RGD:6480464	20250401	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CHES1 mRNA	PMID:17602206
1313904	FOXN3	forkhead box N3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305711	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of FOXN3 gene	PMID:33148267
1313904	FOXN3	forkhead box N3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FOXN3 mRNA	PMID:37042841
1313904	FOXN3	forkhead box N3	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of FOXN3 mRNA	PMID:30589522
1313904	FOXN3	forkhead box N3	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of FOXN3 mRNA	PMID:30723492
1313904	FOXN3	forkhead box N3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FOXN3 mRNA	PMID:35301059
1313904	FOXN3	forkhead box N3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313905	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FOXN3 mRNA	PMID:37325564
1313904	FOXN3	forkhead box N3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FOXN3 mRNA	PMID:24449571
1313904	FOXN3	forkhead box N3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FOXN3 mRNA	PMID:31533062
1313904	FOXN3	forkhead box N3	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D003375	Coumestrol results in decreased expression of CHES1 mRNA	PMID:19167446
1313904	FOXN3	forkhead box N3	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHES1 mRNA	PMID:19167446
1313904	FOXN3	forkhead box N3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of FOXN3 mRNA	PMID:23179753
1313904	FOXN3	forkhead box N3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FOXN3 gene	PMID:29154799
1313904	FOXN3	forkhead box N3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of FOXN3 mRNA	PMID:30047161
1313904	FOXN3	forkhead box N3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FOXN3 mRNA	PMID:25562108
1313904	FOXN3	forkhead box N3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313905	E	RGD:6480464	20250401	CTD	MESH:D013629	Tamoxifen affects the expression of CHES1 mRNA	PMID:17555576
1313904	FOXN3	forkhead box N3	gene	CHEBI:41774	tamoxifen	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of FOXN3 mRNA	PMID:15849065
1313904	FOXN3	forkhead box N3	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	FOXN3 protein affects the susceptibility to Methotrexate	PMID:16217747
1313904	FOXN3	forkhead box N3	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of FOXN3 mRNA	PMID:24136188
1313904	FOXN3	forkhead box N3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313905	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FOXN3 mRNA	PMID:17562736
1313904	FOXN3	forkhead box N3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of FOXN3 mRNA	PMID:33387578
1313904	FOXN3	forkhead box N3	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	FOXN3 protein affects the susceptibility to Fluorouracil	PMID:15352031
1313904	FOXN3	forkhead box N3	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of FOXN3 protein	PMID:15352031
1313904	FOXN3	forkhead box N3	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of FOXN3 promoter	PMID:29626692
1313904	FOXN3	forkhead box N3	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of FOXN3 promoter	PMID:29626692
1313904	FOXN3	forkhead box N3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FOXN3 gene	PMID:25304211
1313904	FOXN3	forkhead box N3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FOXN3 mRNA	PMID:39836092
1313904	FOXN3	forkhead box N3	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of FOXN3 mRNA	PMID:22077320
1313904	FOXN3	forkhead box N3	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D018038	Sodium Selenite results in increased expression of CHES1 mRNA	PMID:18175754
1313904	FOXN3	forkhead box N3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313905	E	RGD:6480464	20250401	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CHES1 mRNA	PMID:17555576
1313904	FOXN3	forkhead box N3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FOXN3 mRNA; Nanotubes, Carbon results in decreased expression of FOXN3 mRNA	PMID:25554681
1313904	FOXN3	forkhead box N3	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of FOXN3 mRNA	PMID:30047161
1313904	FOXN3	forkhead box N3	gene	CHEBI:50692	mifepristone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of FOXN3 mRNA	PMID:17584828
1313904	FOXN3	forkhead box N3	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of FOXN3 mRNA	PMID:24136188
1313904	FOXN3	forkhead box N3	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D011192	Potassium Dichromate results in increased expression of FOXN3 mRNA	PMID:11678601
1313904	FOXN3	forkhead box N3	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1313905	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of FOXN3 mRNA	PMID:20829426
1313904	FOXN3	forkhead box N3	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of FOXN3 mRNA	PMID:25729387
1313904	FOXN3	forkhead box N3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305711	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of FOXN3 mRNA	PMID:25729387
1313904	FOXN3	forkhead box N3	gene	CHEBI:63933	Aroclor 1254	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of FOXN3 mRNA	PMID:16934159
1313904	FOXN3	forkhead box N3	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of FOXN3 mRNA	PMID:28988120
1313904	FOXN3	forkhead box N3	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of FOXN3 intron	PMID:30157460
1313904	FOXN3	forkhead box N3	gene	CHEBI:6842	methoxychlor	affects expression	ISO	RGD:1313905	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor affects the expression of FOXN3 mRNA	PMID:20829426
1313904	FOXN3	forkhead box N3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305711	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of FOXN3 gene	PMID:33148267
1313904	FOXN3	forkhead box N3	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of FOXN3 mRNA	PMID:31758290
1313904	FOXN3	forkhead box N3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FOXN3 mRNA	PMID:22206623
1313904	FOXN3	forkhead box N3	gene	CHEBI:749301	potassium perchlorate	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of FOXN3 mRNA	PMID:29673971
1313904	FOXN3	forkhead box N3	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of FOXN3 mRNA	PMID:24136188
1313904	FOXN3	forkhead box N3	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of FOXN3 mRNA	PMID:26720608
1313904	FOXN3	forkhead box N3	gene	CHEBI:76995	alpha-naphthoflavone	multiple interactions	ISO	RGD:1305711	E	RGD:6480464	20180515	CTD	MESH:C011512	alpha-naphthoflavone inhibits the reaction [Methylcholanthrene results in increased expression of FOXN3 mRNA]	PMID:29094188
1313904	FOXN3	forkhead box N3	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305711	E	RGD:6480464	20250401	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of CHES1 mRNA	PMID:21346803
1313904	FOXN3	forkhead box N3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FOXN3 gene]	PMID:28238834
1313904	FOXN3	forkhead box N3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313905	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of FOXN3 mRNA	PMID:23091169
1313904	FOXN3	forkhead box N3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of FOXN3 mRNA	PMID:32109520
1313904	FOXN3	forkhead box N3	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of FOXN3 mRNA	PMID:31388691
1313904	FOXN3	forkhead box N3	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CHES1 mRNA	PMID:19167446
1313904	FOXN3	forkhead box N3	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CHES1 mRNA; propiconazole results in decreased expression of FOXN3 mRNA	PMID:21278054
1313904	FOXN3	forkhead box N3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305711	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FOXN3 mRNA	PMID:24780913|PMID:30047161
1313904	FOXN3	forkhead box N3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of FOXN3 mRNA	PMID:27131904
1313904	FOXN3	forkhead box N3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305711	E	RGD:6480464	20250401	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CHES1 mRNA	PMID:21346803
1313904	FOXN3	forkhead box N3	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of FOXN3 mRNA	PMID:29301935
1313904	FOXN3	forkhead box N3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313905	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of FOXN3 mRNA	PMID:28973697
1313904	FOXN3	forkhead box N3	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305711	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of FOXN3 gene	PMID:31682807
1313904	FOXN3	forkhead box N3	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305711	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of FOXN3 mRNA	PMID:23034163
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313907	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ETF1 gene	PMID:20938992
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313907	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ETF1 mRNA; [sulforaphane affects the susceptibility to Oxygen] which affects the expression of ETF1 mRNA	PMID:30529165
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313907	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ETF1 mRNA	PMID:39241906
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313907	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of ETF1 mRNA	PMID:15598610
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ETF1 mRNA	PMID:31614463
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313907	E	RGD:6480464	20150609	CTD	MESH:D004958	Estradiol results in increased expression of ETF1 mRNA	PMID:25575267|PMID:39298647
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313907	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of ETF1 mRNA	PMID:19448997
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313907	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ETF1 gene	PMID:20938992
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ETF1 mRNA	PMID:37042841
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of ETF1 mRNA	PMID:19162166
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ETF1 mRNA	PMID:33754040
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305712	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ETF1 mRNA	PMID:22061828|PMID:33387578
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ETF1 mRNA	PMID:39836092
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ETF1 mRNA	PMID:19549813
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ETF1 mRNA	PMID:23649840
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ETF1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ETF1 mRNA	PMID:35430440|PMID:41430723
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ETF1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ETF1 protein	PMID:38598786
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ETF1 mRNA	PMID:18593933
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313907	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ETF1 mRNA	PMID:27339419|PMID:31919559
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ETF1 mRNA	PMID:25629700
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313907	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ETF1 gene	PMID:20938992
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ETF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ETF1 mRNA	PMID:39836092
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ETF1 protein	PMID:38460933
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of ETF1 protein	PMID:37208198
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305712	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of ETF1 mRNA	PMID:20187946
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:27974	estriol	increases expression	ISO	RGD:1313907	E	RGD:6480464	20150609	CTD	MESH:D004964	Estriol results in increased expression of ETF1 mRNA	PMID:25575267
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313907	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ETF1 mRNA	PMID:21570461
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ETF1 mRNA	PMID:19770486
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ETF1 mRNA	PMID:32763439
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	increases expression	ISO	RGD:1313907	E	RGD:6480464	20120814	CTD	MESH:D019328	Buthionine Sulfoximine results in increased expression of ETF1 mRNA	PMID:15707499
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of ETF1 mRNA	PMID:39719251
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ETF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ETF1 mRNA	PMID:39836092
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313907	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ETF1 mRNA	PMID:19770486
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:3016	Benoxacor	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in decreased expression of ETF1 mRNA	PMID:34850242
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ETF1 mRNA	PMID:18593933
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ETF1 mRNA	PMID:26238291
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:31206	ammonium chloride	increases expression	ISO	RGD:1305712	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride results in increased expression of ETF1 mRNA	PMID:12420312
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1313907	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of ETF1 mRNA	PMID:22609695
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305712	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ETF1 mRNA	PMID:30047161
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313907	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ETF1 gene; titanium dioxide results in decreased methylation of ETF1 promoter	PMID:35295148
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305712	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ETF1 mRNA	PMID:34492290
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313907	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ETF1 mRNA	PMID:28472532
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ETF1 mRNA	PMID:30903817
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of ETF1 protein	PMID:37567409
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ETF1 mRNA	PMID:26063408
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305712	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ETF1 mRNA	PMID:25181051
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313907	E	RGD:6480464	20150609	CTD	MESH:C006780	bisphenol A results in increased expression of ETF1 mRNA	PMID:25575267
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	increases expression	ISO	RGD:1313907	E	RGD:6480464	20150609	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of ETF1 mRNA	PMID:25575267
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313907	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ETF1 gene	PMID:31683443
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313907	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ETF1 mRNA	PMID:39298647
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ETF1 protein	PMID:34186270
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313907	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ETF1 mRNA	PMID:38685157
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ETF1 protein	PMID:34186270
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305712	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ETF1 mRNA	PMID:21266533
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of ETF1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ETF1 protein	PMID:38598786
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313907	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ETF1 mRNA	PMID:34813904
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305712	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ETF1 mRNA	PMID:32680482
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ETF1 mRNA	PMID:37042841
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of ETF1 mRNA	PMID:29024780
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ETF1 mRNA	PMID:39836092
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305712	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ETF1 mRNA	PMID:30047161
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:3750	clofibrate	affects expression	ISO	RGD:1313907	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate affects the expression of ETF1 mRNA	PMID:17585979
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ETF1 mRNA	PMID:28302478
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ETF1 mRNA	PMID:31533062
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305712	E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in increased expression of ETF1 mRNA	PMID:12325037
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ETF1 mRNA	PMID:25979313
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313907	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ETF1 mRNA	PMID:17292431
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ETF1 mRNA	PMID:23179753|PMID:29154799
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305712	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ETF1 mRNA	PMID:30047161
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ETF1 mRNA	PMID:20106945
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313907	E	RGD:6480464	20150609	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ETF1 mRNA	PMID:25575267
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of ETF1 mRNA	PMID:33512557
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313907	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ETF1 mRNA	PMID:17562736
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of ETF1 mRNA]	PMID:15016801
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ETF1 protein	PMID:38460933
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1305712	E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of ETF1 mRNA	PMID:21061450
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ETF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ETF1 mRNA	PMID:39836092
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1313907	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ETF1 mRNA	PMID:30529165
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313907	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ETF1 mRNA; Nanotubes, Carbon results in increased expression of ETF1 mRNA	PMID:25554681|PMID:25620056
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305712	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ETF1 mRNA	PMID:30047161
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305712	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ETF1 mRNA	PMID:24136188
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313907	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ETF1 mRNA	PMID:19042947
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ETF1 protein	PMID:32959892
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ETF1 mRNA	PMID:39836092
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313907	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ETF1 mRNA	PMID:23650126
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of ETF1 mRNA	PMID:15336504
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313907	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of ETF1 mRNA	PMID:20003209
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ETF1 protein	PMID:34186270
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ETF1 protein	PMID:37664457
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305712	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ETF1 mRNA	PMID:24136188
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of ETF1 protein	PMID:39638853
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of ETF1 protein	PMID:39638853
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313907	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ETF1 mRNA	PMID:30294300
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305712	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ETF1 mRNA	PMID:30047161
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ETF1 protein	PMID:37664457
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305712	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ETF1 mRNA	PMID:19281266
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1305712	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of ETF1 protein	PMID:35544339
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of ETF1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ETF1 protein	PMID:38598786
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305712	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ETF1 mRNA	PMID:21346803
1313906	ETF1	eukaryotic translation termination factor 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305712	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ETF1 mRNA	PMID:19015723
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ZSWIM1 mRNA	PMID:37995155
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZSWIM1 mRNA	PMID:26079696
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of ZSWIM1 mRNA	PMID:19484750
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313911	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ZSWIM1 mRNA	PMID:39298647
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZSWIM1 mRNA	PMID:37042841
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305715	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ZSWIM1 mRNA	PMID:33387578
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZSWIM1 mRNA	PMID:28818685
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZSWIM1 mRNA	PMID:35301059
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZSWIM1 mRNA	PMID:25629700
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313911	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZSWIM1 mRNA	PMID:21570461
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305715	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZSWIM1 mRNA	PMID:33387578
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313911	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZSWIM1 mRNA	PMID:25975270
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZSWIM1 mRNA	PMID:33212167
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZSWIM1 mRNA	PMID:29803840
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ZSWIM1 3' UTR	PMID:27901495
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313911	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZSWIM1 mRNA	PMID:22228805
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ZSWIM1 mRNA	PMID:29264374
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305715	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZSWIM1 mRNA	PMID:34492290
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313911	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZSWIM1 promoter	PMID:27312807
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ZSWIM1 mRNA	PMID:21266533
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ZSWIM1 mRNA	PMID:34813904
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZSWIM1 mRNA	PMID:35301059
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ZSWIM1 mRNA	PMID:24449571
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ZSWIM1 mRNA	PMID:28302478
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ZSWIM1 mRNA	PMID:22230336
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305715	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZSWIM1 mRNA	PMID:33387578
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ZSWIM1 mRNA	PMID:29432896
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313911	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ZSWIM1 mRNA	PMID:40826991
1313910	ZSWIM1	zinc finger SWIM-type containing 1	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305715	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ZSWIM1 mRNA	PMID:19281266
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D015025	Zearalenone results in increased expression of HAT1 mRNA	PMID:32119988
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of HAT1 mRNA	PMID:16054129|PMID:33167477
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:16118	berberine	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D001599	Berberine results in increased expression of HAT1 mRNA	PMID:27311644
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313913	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of HAT1 mRNA	PMID:30319688
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of HAT1 mRNA	PMID:27655674
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:16243	quercetin	increases activity	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in increased activity of HAT1 protein	PMID:21165570
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in increased activity of HAT1 protein]; pyrazolanthrone inhibits the reaction [Quercetin results in increased activity of HAT1 protein]	PMID:21165570
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313913	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HAT1 mRNA	PMID:39241906
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of HAT1 mRNA	PMID:22952798
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305716	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of HAT1 mRNA	PMID:32145629
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol inhibits the reaction [sodium arsenite results in increased expression of HAT1 mRNA]; sodium arsenite inhibits the reaction [Estradiol results in increased expression of HAT1 mRNA]	PMID:22952798
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of HAT1 mRNA	PMID:38568856
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:16643	L-methionine	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20221206	CTD	MESH:D008715	Methionine results in decreased expression of HAT1 mRNA	PMID:35314295
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of HAT1 mRNA	PMID:21179406
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of HAT1 mRNA	PMID:38685446
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of HAT1 protein; [Cuprizone co-treated with Cannabidiol] results in decreased expression of HAT1 protein; [Cuprizone co-treated with Clozapine] results in decreased expression of HAT1 protein	PMID:34122009
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of HAT1 protein	PMID:37730182
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HAT1 mRNA	PMID:36331819
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HAT1 mRNA	PMID:37236586
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HAT1 protein	PMID:23301498
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305716	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HAT1 mRNA	PMID:33354967
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313913	E	RGD:6480464	20160119	CTD	MESH:D009151	Mustard Gas results in increased expression of HAT1 mRNA	PMID:26392148
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of HAT1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of HAT1 mRNA	PMID:34911549
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:27086	tributylstannane	increases activity	ISO	RGD:1305716	E	RGD:6480464	20120412	CTD	MESH:C011559	tributyltin results in increased activity of HAT1 protein	PMID:15603928
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313913	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of HAT1 mRNA	PMID:27339419|PMID:31919559
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of HAT1 mRNA	PMID:25629700
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of HAT1 promoter	PMID:21291286
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HAT1 mRNA	PMID:40512198
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:27618	chalcone	decreases activity	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D002599	Chalcone analog results in decreased activity of HAT1 protein	PMID:22155221
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:C010974	Glyphosate results in increased expression of HAT1 mRNA	PMID:40578477
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of HAT1 mRNA	PMID:27392435|PMID:35279909
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20220705	CTD	MESH:D002945	Cisplatin results in decreased expression of HAT1 mRNA; Cisplatin results in decreased expression of HAT1 protein	PMID:35279909
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of HAT1 mRNA	PMID:27594783
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20220705	CTD	MESH:D002945	MIR486 mRNA affects the reaction [Cisplatin results in decreased expression of HAT1 protein]	PMID:35279909
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1313913	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of HAT1 mRNA	PMID:30912803
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313913	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HAT1 mRNA	PMID:21570461
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305716	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HAT1 mRNA	PMID:34747641
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HAT1 mRNA	PMID:17942748
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305716	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of HAT1 protein	PMID:35544339
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of HAT1 mRNA	PMID:33512557
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HAT1 mRNA	PMID:33212167
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of HAT1 mRNA	PMID:32763439
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:28812	(aminomethyl)phosphonic acid	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:C036423	1-aminomethylphosphonic acid results in increased expression of HAT1 mRNA	PMID:40578477
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of HAT1 mRNA	PMID:25523186
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of HAT1 mRNA	PMID:39719251
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HAT1 mRNA; sodium arsenite results in increased expression of HAT1 protein	PMID:22952798|PMID:28595984|PMID:34032870|PMID:38146662|PMID:38228842|PMID:38568856
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313913	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of HAT1 mRNA	PMID:19822182
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HAT1 mRNA; epigallocatechin gallate inhibits the reaction [sodium arsenite results in increased expression of HAT1 mRNA]; Estradiol inhibits the reaction [sodium arsenite results in increased expression of HAT1 mRNA]; sodium arsenite inhibits the reaction [Estradiol results in increased expression of HAT1 mRNA]	PMID:22952798|PMID:38146662|PMID:40512198
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of HAT1 mRNA]	PMID:22228805
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to HAT1 mRNA]	PMID:32406909
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of HAT1 mRNA	PMID:25523186
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of HAT1 protein	PMID:34122009
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HAT1 protein	PMID:25419056
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:31206	ammonium chloride	increases expression	ISO	RGD:1305716	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride results in increased expression of HAT1 protein	PMID:16483693
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305716	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of HAT1 mRNA	PMID:25729387
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305716	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HAT1 mRNA	PMID:25729387
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305716	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of HAT1 mRNA	PMID:30047161
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305716	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of HAT1 mRNA	PMID:24136188
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313913	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HAT1 gene	PMID:35295148
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305716	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of HAT1 mRNA	PMID:34492290
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313913	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of HAT1 mRNA	PMID:17950772|PMID:18301758|PMID:23811191
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of HAT1 mRNA]	PMID:17950772
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of HAT1 mRNA	PMID:30903817
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305716	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of HAT1 mRNA	PMID:32145629
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of HAT1 mRNA; bisphenol A results in decreased expression of HAT1 protein	PMID:29275510|PMID:31675489|PMID:37567409
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305716	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of HAT1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of HAT1 gene	PMID:31601247
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of HAT1 mRNA	PMID:28765096
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305716	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of HAT1 mRNA	PMID:25181051
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313913	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of HAT1 mRNA	PMID:26063408
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of HAT1 protein	PMID:31675489
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of HAT1 mRNA	PMID:24752500
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1313913	E	RGD:6480464	20240206	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of HAT1 mRNA	PMID:37080397
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of HAT1 mRNA	PMID:28628672
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HAT1 mRNA	PMID:28628672
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1305716	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of HAT1 mRNA	PMID:21241498
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1313913	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of HAT1 mRNA	PMID:31558096
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HAT1 mRNA	PMID:37019170
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of HAT1 mRNA	PMID:17361019
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of HAT1 mRNA	PMID:34813904
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HAT1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of HAT1 mRNA	PMID:28628672
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of HAT1 mRNA	PMID:17854601
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of HAT1 mRNA]	PMID:17854601
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HAT1 mRNA	PMID:37042841
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:35036	fentin chloride	increases activity	ISO	RGD:1305716	E	RGD:6480464	20141104	CTD	MESH:C012594	triphenyltin chloride results in increased activity of HAT1 protein	PMID:15603928
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HAT1 mRNA	PMID:37236586
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of HAT1 mRNA	PMID:19376846
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:3766	clozapine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	[Cuprizone co-treated with Clozapine] results in decreased expression of HAT1 protein	PMID:34122009
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of HAT1 mRNA	PMID:28302478
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of HAT1 mRNA	PMID:19167446
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of HAT1 mRNA	PMID:39529242
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of HAT1 mRNA	PMID:27153767
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313913	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of HAT1 protein	PMID:26178269
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HAT1 mRNA	PMID:36331819
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HAT1 mRNA	PMID:25979313
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of HAT1 mRNA	PMID:23179753|PMID:29154799
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305716	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of HAT1 mRNA	PMID:41580965
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305716	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of HAT1 mRNA	PMID:30047161
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of HAT1 mRNA	PMID:25562108
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of HAT1 mRNA	PMID:17555576
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HAT1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of HAT1 mRNA	PMID:28628672
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313913	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of HAT1 mRNA	PMID:28973697
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of HAT1 mRNA	PMID:27188386
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HAT1 mRNA	PMID:17562736
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of HAT1 mRNA	PMID:22230336
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of HAT1 promoter	PMID:21291286
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of HAT1 mRNA	PMID:40512198
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of HAT1 mRNA	PMID:24752500
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of HAT1 mRNA	PMID:31675489
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C045651	epigallocatechin gallate inhibits the reaction [sodium arsenite results in increased expression of HAT1 mRNA]	PMID:38146662
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1313913	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of HAT1 mRNA	PMID:35436446
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:48965	trans-chalcone	decreases activity	ISO	RGD:1313913	E	RGD:6480464	20140805	CTD	MESH:D002599	Chalcone analog results in decreased activity of HAT1 protein	PMID:22155221
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of HAT1 mRNA	PMID:17555576
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of HAT1 mRNA	PMID:17942748
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313913	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HAT1 mRNA	PMID:17942748
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HAT1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of HAT1 mRNA	PMID:28628672
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HAT1 protein	PMID:25419056
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313913	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of HAT1 mRNA; Nanotubes, Carbon results in increased expression of HAT1 mRNA	PMID:25554681
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305716	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of HAT1 mRNA	PMID:24136188
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305716	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of HAT1 mRNA	PMID:23962444
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305716	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of HAT1 mRNA	PMID:30047161
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305716	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of HAT1 mRNA	PMID:24136188
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313913	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of HAT1 mRNA	PMID:19042947
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HAT1 protein	PMID:32959892
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C025340	manganese chloride results in decreased expression of HAT1 protein	PMID:29155171
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1305716	E	RGD:6480464	20180703	CTD	MESH:C025340	manganese chloride results in decreased expression of HAT1 protein	PMID:29155171
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305716	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HAT1 mRNA	PMID:25729387
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313913	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of HAT1 mRNA	PMID:23650126
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of HAT1 protein	PMID:34122009
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:749016	gossypol acetic acid	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of HAT1 protein	PMID:29938581
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:753820	batroxobin	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:D012103	Batroxobin analog results in increased expression of HAT1 mRNA	PMID:31271808
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of HAT1 protein	PMID:39638853
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of HAT1 mRNA	PMID:30928695
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HAT1 gene]	PMID:28238834
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of HAT1 mRNA	PMID:19159669
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313913	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of HAT1 mRNA	PMID:23091169
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HAT1 protein	PMID:31675489
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of HAT1 protein	PMID:31675489
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of HAT1 mRNA	PMID:21858171
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of HAT1 mRNA	PMID:33512557
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305716	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of HAT1 mRNA	PMID:30047161
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [Quercetin results in increased activity of HAT1 protein]	PMID:21165570
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of HAT1 mRNA	PMID:27188386
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305716	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of HAT1 mRNA	PMID:21346803
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1305716	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of HAT1 mRNA	PMID:30047161
1313912	HAT1	histone acetyltransferase 1	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of HAT1 mRNA	PMID:19140230
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305721	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of L3HYPDH mRNA]	PMID:31150632
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of L3HYPDH mRNA	PMID:33167477
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of L3HYPDH mRNA	PMID:36331819
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1305721	E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of L3HYPDH mRNA	PMID:17347304
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313919	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of L3HYPDH mRNA	PMID:39241906
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of L3HYPDH mRNA	PMID:31614463
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of L3HYPDH mRNA	PMID:38568856
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of L3HYPDH mRNA	PMID:16002434
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of L3HYPDH mRNA	PMID:28818685
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of L3HYPDH mRNA	PMID:36331819
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305721	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of L3HYPDH mRNA	PMID:28522335
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of L3HYPDH mRNA	PMID:37236586
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of L3HYPDH gene	PMID:27153756
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of L3HYPDH mRNA	PMID:27153756
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of L3HYPDH mRNA	PMID:31150632
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313919	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of L3HYPDH mRNA	PMID:27339419|PMID:31919559
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305721	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of L3HYPDH mRNA]	PMID:31150632
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of L3HYPDH mRNA	PMID:40504410
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of L3HYPDH mRNA	PMID:25583101
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305721	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of L3HYPDH mRNA	PMID:22298810
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of L3HYPDH mRNA	PMID:21215274|PMID:32109520
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305721	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of L3HYPDH mRNA	PMID:33387578
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1313919	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of L3HYPDH protein	PMID:28918527
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of L3HYPDH mRNA	PMID:38568856
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313919	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of L3HYPDH protein	PMID:29044176
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of L3HYPDH mRNA	PMID:40504410
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of L3HYPDH mRNA	PMID:26238291
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of L3HYPDH mRNA	PMID:35984750
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of L3HYPDH mRNA	PMID:16507785
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of L3HYPDH mRNA	PMID:30047161
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of L3HYPDH mRNA	PMID:23411599|PMID:34492290
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of L3HYPDH mRNA	PMID:25380136
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20200609	CTD	MESH:C074702	[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of L3HYPDH mRNA; SHH protein affects the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of L3HYPDH mRNA]	PMID:31756458
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in decreased expression of L3HYPDH mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of L3HYPDH protein	PMID:34186270
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1305721	E	RGD:6480464	20120412	CTD	MESH:C014024	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of L3HYPDH mRNA	PMID:16984957
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	ISO	RGD:1305721	E	RGD:6480464	20120412	CTD	MESH:C023035	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of L3HYPDH mRNA	PMID:16984957
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of L3HYPDH protein	PMID:34186270
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of L3HYPDH mRNA	PMID:21266533
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of L3HYPDH mRNA	PMID:37042841
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305721	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of L3HYPDH mRNA	PMID:30589522
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of L3HYPDH mRNA	PMID:25380136|PMID:30723492
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of L3HYPDH mRNA	PMID:25993096
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of L3HYPDH mRNA	PMID:37236586
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of L3HYPDH mRNA	PMID:25380136
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of L3HYPDH mRNA	PMID:31533062
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of L3HYPDH mRNA	PMID:40419075
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of L3HYPDH mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of L3HYPDH mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of L3HYPDH mRNA	PMID:36331819
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of L3HYPDH mRNA	PMID:25979313
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of L3HYPDH mRNA	PMID:30047161
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of L3HYPDH mRNA	PMID:25562108
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of L3HYPDH mRNA	PMID:21420995
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305721	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of L3HYPDH mRNA	PMID:33387578
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of L3HYPDH mRNA	PMID:40504410
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of L3HYPDH mRNA	PMID:31838189
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of L3HYPDH mRNA	PMID:29391264
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of L3HYPDH mRNA	PMID:36868495
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of L3HYPDH mRNA	PMID:30047161
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:53444	potassium dichromate	multiple interactions	ISO	RGD:1313919	E	RGD:6480464	20200609	CTD	MESH:D011192	[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of L3HYPDH mRNA; SHH protein affects the reaction [[Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in increased expression of L3HYPDH mRNA]	PMID:31756458
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of L3HYPDH mRNA	PMID:24136188
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1305721	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of L3HYPDH mRNA	PMID:24136188
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of L3HYPDH protein	PMID:34186270
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of L3HYPDH mRNA	PMID:22714537
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of L3HYPDH mRNA	PMID:38568856
1313918	L3HYPDH	trans-L-3-hydroxyproline dehydratase	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313919	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of L3HYPDH mRNA	PMID:35537566
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:621692	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TMEM14C mRNA]	PMID:31150632
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313921	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMEM14C mRNA	PMID:36331819
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313921	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TMEM14C mRNA	PMID:39241906
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of TMEM14C mRNA	PMID:23019147
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313921	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TMEM14C mRNA	PMID:39298647
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:621692	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of TMEM14C mRNA	PMID:32145629
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313921	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TMEM14C mRNA	PMID:34319233
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:188851	Muraglitazar	increases expression	ISO	RGD:621692	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of TMEM14C mRNA	PMID:21515302
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM14C mRNA	PMID:35301059
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:234430	gardiquimod	decreases expression	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in decreased expression of TMEM14C mRNA	PMID:28003376
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:234430	gardiquimod	multiple interactions	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of TMEM14C mRNA]	PMID:28003376
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TMEM14C mRNA	PMID:23649840
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:621692	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TMEM14C mRNA	PMID:33354967
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TMEM14C mRNA	PMID:23649840
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313921	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TMEM14C mRNA	PMID:34911549
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313921	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TMEM14C mRNA	PMID:31919559
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:621692	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TMEM14C mRNA	PMID:31150632
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:621692	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TMEM14C mRNA]	PMID:31150632
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313921	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM14C mRNA	PMID:22206623
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of TMEM14C mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMEM14C mRNA	PMID:40512198
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313921	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TMEM14C mRNA	PMID:40504410
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:621692	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TMEM14C mRNA	PMID:31881176
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313921	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of TMEM14C mRNA	PMID:40618947
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of TMEM14C mRNA	PMID:27594783
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:621692	E	RGD:6480464	20160412	CTD	MESH:D003042	Cocaine results in increased expression of TMEM14C protein	PMID:25100957
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313921	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM14C mRNA	PMID:21570461
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313921	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TMEM14C mRNA	PMID:21354282|PMID:28213091
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313921	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM14C mRNA	PMID:17942748
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313921	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TMEM14C mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TMEM14C gene]	PMID:17942748|PMID:28213091
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of TMEM14C mRNA	PMID:33512557
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM14C mRNA	PMID:30851411
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of TMEM14C mRNA	PMID:29803840
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:29021	hexane	decreases methylation	ISO	RGD:621692	E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of TMEM14C promoter	PMID:23740543
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of TMEM14C mRNA	PMID:39719251
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of TMEM14C mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMEM14C mRNA	PMID:40512198
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313921	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TMEM14C mRNA	PMID:40504410
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TMEM14C promoter	PMID:27901495
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to TMEM14C mRNA]	PMID:32406909
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:621692	E	RGD:6480464	20131220	CTD	MESH:D000643	Ammonium Chloride affects the expression of TMEM14C mRNA	PMID:16483693
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:621692	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TMEM14C mRNA	PMID:25729387
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:32195	Tesaglitazar	increases expression	ISO	RGD:621692	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of TMEM14C mRNA	PMID:21515302
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:621692	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of TMEM14C mRNA	PMID:24136188
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313921	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMEM14C gene; titanium dioxide results in decreased methylation of TMEM14C promoter	PMID:35295148
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:621692	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TMEM14C mRNA	PMID:34492290
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313921	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of TMEM14C mRNA	PMID:18648102
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:621692	E	RGD:6480464	20131220	CTD	MESH:C006253	pirinixic acid results in increased expression of TMEM14C mRNA	PMID:22484513
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313921	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM14C mRNA	PMID:33221593
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:621692	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM14C mRNA	PMID:34947998
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:621692	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM14C mRNA	PMID:25181051|PMID:32145629
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:621692	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TMEM14C gene	PMID:28505145
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of TMEM14C protein	PMID:33376534
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:621692	E	RGD:6480464	20131220	CTD	MESH:D002995	Clofibric Acid affects the expression of TMEM14C mRNA	PMID:17602206
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:621692	E	RGD:6480464	20131220	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TMEM14C mRNA	PMID:21266533
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMEM14C mRNA	PMID:37042841
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM14C mRNA	PMID:35301059
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of TMEM14C mRNA	PMID:25812627
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:621692	E	RGD:6480464	20131220	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of TMEM14C mRNA	PMID:16221955
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1313921	E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in increased expression of TMEM14C mRNA	PMID:21139344
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:621692	E	RGD:6480464	20131220	CTD	MESH:D002994	Clofibrate results in increased expression of TMEM14C mRNA	PMID:12851107
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of TMEM14C mRNA]	PMID:28003376
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TMEM14C mRNA	PMID:25812627
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TMEM14C mRNA	PMID:28302478
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of TMEM14C mRNA	PMID:26352163
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313921	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TMEM14C mRNA	PMID:36331819
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM14C mRNA	PMID:25979313
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:621692	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of TMEM14C mRNA	PMID:41580965
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:621692	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TMEM14C mRNA	PMID:24136188
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313921	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TMEM14C mRNA	PMID:17562736
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:621692	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM14C mRNA	PMID:33387578
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of TMEM14C mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TMEM14C mRNA	PMID:40512198
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313921	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of TMEM14C mRNA	PMID:40504410
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of TMEM14C mRNA	PMID:18175754
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313921	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TMEM14C mRNA	PMID:17942748
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313921	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TMEM14C mRNA	PMID:17942748
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313921	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TMEM14C mRNA	PMID:25620056
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313921	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TMEM14C mRNA; Nanotubes, Carbon results in increased expression of TMEM14C mRNA	PMID:25554681
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:621692	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of TMEM14C mRNA	PMID:24136188
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313921	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TMEM14C mRNA	PMID:35964746
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:621692	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TMEM14C mRNA	PMID:24136188
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TMEM14C protein	PMID:32959892
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:621692	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of TMEM14C mRNA	PMID:25729387
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:621692	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TMEM14C mRNA	PMID:25729387
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:621692	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of TMEM14C mRNA	PMID:24136188
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313921	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TMEM14C mRNA	PMID:22206623
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313921	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM14C mRNA	PMID:22206623
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:621692	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TMEM14C mRNA	PMID:24136188
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TMEM14C mRNA	PMID:30851411
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313921	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of TMEM14C mRNA	PMID:31388691
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of TMEM14C mRNA	PMID:33512557
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D020123	Sirolimus inhibits the reaction [TP73 protein results in increased expression of TMEM14C mRNA]	PMID:21245298
1313920	TMEM14C	transmembrane protein 14C	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:621692	E	RGD:6480464	20131220	CTD	MESH:C057693	troglitazone results in increased expression of TMEM14C mRNA	PMID:21515302
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313924	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FBXL4 mRNA	PMID:33045310
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of FBXL4 mRNA	PMID:25812627
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313924	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of FBXL4 mRNA]	PMID:19467301
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FBXL4 mRNA	PMID:33167477
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FBXL4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of FBXL4 mRNA	PMID:32699268
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313924	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FBXL4 mRNA	PMID:30319688
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of FBXL4 mRNA	PMID:20044591
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313924	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FBXL4 mRNA	PMID:39241906
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305724	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FBXL4 mRNA	PMID:33387578
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of FBXL4 mRNA	PMID:23649840
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305724	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FBXL4 mRNA	PMID:33387578
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of FBXL4 intron	PMID:30157460
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of FBXL4 exon	PMID:30157460
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXL4 mRNA	PMID:39836092
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FBXL4 mRNA	PMID:19549813
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of FBXL4 mRNA	PMID:23649840
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FBXL4 intron	PMID:30157460
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of FBXL4 mRNA	PMID:23649840
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FBXL4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of FBXL4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of FBXL4 mRNA	PMID:32699268
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305724	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of FBXL4 mRNA	PMID:31129395
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313924	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FBXL4 mRNA	PMID:25629700
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXL4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXL4 mRNA	PMID:39836092
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313924	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of FBXL4 mRNA	PMID:28960355
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in decreased expression of FBXL4 mRNA	PMID:37386098
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313924	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXL4 mRNA	PMID:21570461
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FBXL4 mRNA	PMID:33212167
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of FBXL4 mRNA	PMID:39709020
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of FBXL4 mRNA	PMID:23649840
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of FBXL4 mRNA	PMID:28595984|PMID:34032870|PMID:38568856
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXL4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXL4 mRNA	PMID:39836092
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBXL4 promoter	PMID:27901495
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313924	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FBXL4 mRNA	PMID:22228805
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FBXL4 5' UTR	PMID:27901495
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of FBXL4 gene	PMID:25435355
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of FBXL4 mRNA	PMID:23806026
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of FBXL4 mRNA	PMID:20458559
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305724	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of FBXL4 mRNA	PMID:30047161
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313924	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXL4 gene	PMID:35295148
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305724	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FBXL4 mRNA	PMID:34492290
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FBXL4 mRNA	PMID:19710929
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305724	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FBXL4 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:41034487
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305724	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of FBXL4 mRNA	PMID:31129395
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313924	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of FBXL4 mRNA	PMID:26377693
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313924	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of FBXL4 mRNA	PMID:28392331
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FBXL4 mRNA	PMID:37042841
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXL4 mRNA	PMID:39836092
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXL4 mRNA	PMID:38568856
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of FBXL4 mRNA	PMID:25812627
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of FBXL4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of FBXL4 mRNA	PMID:32699268
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313924	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FBXL4 mRNA	PMID:40194260
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of FBXL4 mRNA	PMID:28302478
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FBXL4 mRNA	PMID:31533062
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of FBXL4 mRNA	PMID:25812627|PMID:40419075
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXL4 mRNA	PMID:24935251
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305724	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of FBXL4 mRNA	PMID:30047161
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of FBXL4 mRNA	PMID:23649840
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FBXL4 mRNA	PMID:38832940
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of FBXL4 mRNA	PMID:24935251
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313924	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FBXL4 mRNA	PMID:17562736
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305724	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXL4 mRNA	PMID:33387578
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXL4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXL4 mRNA	PMID:39836092
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of FBXL4 mRNA	PMID:22077320
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FBXL4 mRNA	PMID:22079256
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of FBXL4 mRNA	PMID:23228038
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of FBXL4 mRNA	PMID:20458559
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305724	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of FBXL4 mRNA	PMID:24136188
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305724	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of FBXL4 mRNA	PMID:23962444
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305724	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of FBXL4 mRNA	PMID:30047161
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305724	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of FBXL4 mRNA	PMID:28801915
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBXL4 mRNA	PMID:39836092
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305724	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of FBXL4 mRNA	PMID:28801915
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1305724	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of FBXL4 mRNA	PMID:19564919
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313924	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FBXL4 mRNA	PMID:22206623
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of FBXL4 mRNA	PMID:22079256
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FBXL4 mRNA	PMID:22079256
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:755208	eprenetapopt	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of FBXL4 mRNA	PMID:19946333
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of FBXL4 mRNA]	PMID:19946333
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1305724	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FBXL4 mRNA	PMID:27291303
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305724	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FBXL4 mRNA	PMID:30047161
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305724	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of FBXL4 mRNA	PMID:19281266
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1305724	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of FBXL4 mRNA	PMID:24136188
1313923	FBXL4	F-box and leucine rich repeat protein 4	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1305724	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of FBXL4 protein	PMID:32519852
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313926	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of VSTM2L mRNA	PMID:20188158
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of VSTM2L mRNA	PMID:36189433
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of VSTM2L mRNA	PMID:35811015
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of VSTM2L mRNA	PMID:30510588
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of VSTM2L mRNA	PMID:31614463
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of VSTM2L mRNA	PMID:30165855
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305725	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of VSTM2L mRNA	PMID:32741896
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VSTM2L mRNA	PMID:25510870
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of VSTM2L mRNA	PMID:38568856
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305725	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of VSTM2L mRNA	PMID:33387578
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of VSTM2L gene	PMID:30521419
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of VSTM2L mRNA	PMID:36189433
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of VSTM2L mRNA	PMID:21592394
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of VSTM2L mRNA	PMID:21592394
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305725	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of VSTM2L mRNA	PMID:32741896
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of VSTM2L mRNA	PMID:31163220
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of VSTM2L mRNA	PMID:21592394
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of VSTM2L mRNA	PMID:21592394
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305725	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of VSTM2L mRNA	PMID:33387578
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D002104	Cadmium results in increased expression of VSTM2L mRNA	PMID:31082426
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VSTM2L mRNA	PMID:25510870
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VSTM2L mRNA	PMID:25510870
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of VSTM2L mRNA	PMID:32234424
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of VSTM2L mRNA	PMID:28903495
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305725	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VSTM2L mRNA	PMID:32109520
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of VSTM2L mRNA	PMID:28001369
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of VSTM2L mRNA	PMID:29803840
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of VSTM2L mRNA	PMID:29803840
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of VSTM2L mRNA	PMID:35954277
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of VSTM2L mRNA	PMID:22378314
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of VSTM2L promoter	PMID:27901495
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of VSTM2L mRNA	PMID:20064835|PMID:32234424
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of VSTM2L mRNA	PMID:25895662
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of VSTM2L mRNA	PMID:38568856
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313926	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VSTM2L gene	PMID:35295148
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313926	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of VSTM2L mRNA	PMID:18648102
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of VSTM2L mRNA	PMID:19710929
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313926	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of VSTM2L mRNA	PMID:28472532
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305725	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of VSTM2L mRNA	PMID:25181051
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of VSTM2L gene	PMID:31601247
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313926	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of VSTM2L mRNA	PMID:34585602
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VSTM2L mRNA	PMID:25510870
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313926	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of VSTM2L mRNA	PMID:25510870
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313926	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of VSTM2L exon; bisphenol S affects the methylation of VSTM2L gene	PMID:31683443|PMID:33297965
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313926	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of VSTM2L intron	PMID:28392331
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313926	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of VSTM2L mRNA	PMID:18353800
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of VSTM2L mRNA	PMID:31533062
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of VSTM2L mRNA	PMID:25979313
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of VSTM2L mRNA	PMID:29154799
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of VSTM2L mRNA	PMID:23179753|PMID:27188386
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of VSTM2L gene	PMID:29154799
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of VSTM2L mRNA	PMID:20106945
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of VSTM2L mRNA	PMID:38832940
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305725	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of VSTM2L mRNA	PMID:33387578
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of VSTM2L mRNA	PMID:35811015
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of VSTM2L mRNA	PMID:38568856
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313926	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of VSTM2L mRNA	PMID:22206623
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305725	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of VSTM2L mRNA	PMID:32741896
1313925	VSTM2L	V-set and transmembrane domain containing 2 like	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of VSTM2L mRNA	PMID:26079696
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of TUBGCP3 mRNA	PMID:31016361
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313928	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TUBGCP3 gene	PMID:20938992
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313928	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TUBGCP3 mRNA	PMID:30319688
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TUBGCP3 mRNA	PMID:21632981
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313928	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TUBGCP3 gene	PMID:20938992
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of TUBGCP3 gene	PMID:33872906
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of TUBGCP3 gene	PMID:33872906
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TUBGCP3 mRNA	PMID:28818685
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TUBGCP3 polyA tail	PMID:30157460
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:23808	dimethylarsinous acid	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in increased expression of TUBGCP3 mRNA	PMID:23487506
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TUBGCP3 polyA tail	PMID:30157460
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1305726	E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in decreased expression of TUBGCP3 mRNA	PMID:31129395
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313928	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TUBGCP3 mRNA	PMID:25629700
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313928	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TUBGCP3 gene	PMID:20938992
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TUBGCP3 gene	PMID:25304211
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TUBGCP3 mRNA]	PMID:11007951
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of TUBGCP3 mRNA	PMID:26272509
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA	PMID:27188386
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TUBGCP3 mRNA	PMID:23557933
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of TUBGCP3 mRNA	PMID:19921347
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:28009	N-acetyl-beta-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in decreased expression of TUBGCP3 mRNA	PMID:18047607
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TUBGCP3 mRNA	PMID:22574217
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TUBGCP3 mRNA	PMID:11007951
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313928	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TUBGCP3 mRNA	PMID:19465110
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TUBGCP3 mRNA]	PMID:11007951
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1313928	E	RGD:6480464	20120613	CTD	MESH:D012402	Rotenone affects the expression of TUBGCP3 mRNA	PMID:21893155
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1313928	E	RGD:6480464	20120613	CTD	MESH:D012402	TRP53 affects the reaction [Rotenone affects the expression of TUBGCP3 mRNA]	PMID:21893155
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TUBGCP3 mRNA	PMID:28001369
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TUBGCP3 mRNA	PMID:33212167
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TUBGCP3 mRNA	PMID:38568856
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TUBGCP3 polyA tail	PMID:30157460
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TUBGCP3 mRNA	PMID:20064835
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TUBGCP3 mRNA]	PMID:32406909
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TUBGCP3 mRNA	PMID:19150397|PMID:20382639
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305726	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TUBGCP3 mRNA	PMID:25729387
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313928	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TUBGCP3 promoter	PMID:35295148
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313928	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of TUBGCP3 mRNA	PMID:29264374
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313928	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TUBGCP3 mRNA	PMID:33221593
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305726	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TUBGCP3 mRNA	PMID:25181051|PMID:30816183
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of TUBGCP3 protein	PMID:33376534
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313928	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of TUBGCP3 mRNA	PMID:33297965
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of TUBGCP3 polyA tail	PMID:30157460
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313928	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TUBGCP3 mRNA	PMID:38685157
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313928	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TUBGCP3 mRNA	PMID:37019170
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TUBGCP3 mRNA	PMID:37042841
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TUBGCP3 mRNA	PMID:38568856
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305726	E	RGD:6480464	20130806	CTD	MESH:C039281	furan results in increased methylation of TUBGCP3 gene	PMID:22079235
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TUBGCP3 mRNA	PMID:31533062
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of TUBGCP3 mRNA	PMID:31626844
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TUBGCP3 mRNA	PMID:26272509
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA	PMID:27188386
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of TUBGCP3 mRNA	PMID:27989131
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1313928	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of TUBGCP3 mRNA	PMID:19770486
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TUBGCP3 mRNA	PMID:28542535
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TUBGCP3 mRNA	PMID:21420995
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TUBGCP3 gene	PMID:25304211
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of TUBGCP3 mRNA	PMID:16984733
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:506227	N-acetyl-D-glucosamine	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D000117	Acetylglucosamine results in decreased expression of TUBGCP3 mRNA	PMID:18047607
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305726	E	RGD:6480464	20130806	CTD	MESH:D005485	Flutamide results in increased expression of TUBGCP3 mRNA	PMID:20566332
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1313928	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of TUBGCP3 mRNA	PMID:26377693
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TUBGCP3 protein	PMID:32959892
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	TUBGCP3 protein affects the susceptibility to Topotecan	PMID:16217747
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305726	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TUBGCP3 mRNA	PMID:25729387
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of TUBGCP3 mRNA	PMID:15336504
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of TUBGCP3 polyA tail	PMID:30157460
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305726	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TUBGCP3 gene	PMID:35440735
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313928	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TUBGCP3 mRNA	PMID:22206623
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TUBGCP3 mRNA	PMID:37199045
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of TUBGCP3 protein	PMID:31285264
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA	PMID:27188386
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TUBGCP3 gene]	PMID:28238834
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TUBGCP3 mRNA	PMID:27188386
1313927	TUBGCP3	tubulin gamma complex component 3	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of TUBGCP3 mRNA	PMID:27188386
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:10022	deoxynivalenol	affects phosphorylation	ISO	RGD:1313931	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol affects the phosphorylation of MKNK2 protein	PMID:23811945
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in decreased expression of MKNK2 mRNA	PMID:31863870
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of MKNK2 mRNA	PMID:38218311
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313931	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MKNK2 mRNA	PMID:33045310
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305728	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MKNK2 mRNA]	PMID:31150632
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MKNK2 mRNA	PMID:20188158
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010100	Oxygen deficiency results in increased expression of MKNK2 mRNA	PMID:20042640
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MKNK2 mRNA	PMID:30529165
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305728	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of MKNK2 gene	PMID:35440735
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MKNK2 mRNA	PMID:22378314
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in decreased expression of MKNK2 mRNA	PMID:15513904
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MKNK2 mRNA	PMID:21632981
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D011794	Quercetin results in increased expression of MKNK2 mRNA	PMID:30152185
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MKNK2 mRNA	PMID:39241906
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of MKNK2 mRNA	PMID:31614463
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MKNK2 mRNA	PMID:39298647
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of MKNK2 mRNA	PMID:23019147
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of MKNK2 mRNA	PMID:15289156
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of MKNK2 mRNA	PMID:30165855
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of MKNK2 mRNA	PMID:33711761
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MKNK2 gene	PMID:30521419
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of MKNK2 mRNA	PMID:18037150
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MKNK2 protein	PMID:37730182
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MKNK2 mRNA	PMID:28818685
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MKNK2 mRNA	PMID:36331819
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MKNK2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of MKNK2 mRNA	PMID:39836092
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MKNK2 mRNA	PMID:37236586
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MKNK2 mRNA	PMID:19549813
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MKNK2 mRNA	PMID:35430440
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305728	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MKNK2 mRNA	PMID:31150632
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313931	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MKNK2 mRNA	PMID:31919559
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305728	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MKNK2 mRNA]	PMID:31150632
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MKNK2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:32525701|PMID:39836092
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:40504410
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of MKNK2 mRNA	PMID:38460933
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of MKNK2 mRNA	PMID:31295307
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of MKNK2 mRNA	PMID:28189721|PMID:28960355
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of MKNK2 mRNA	PMID:23557933
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of MKNK2 mRNA	PMID:23300844
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1305728	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of MKNK2 mRNA	PMID:21993003
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1305728	E	RGD:6480464	20120412	CTD	MESH:D002945	Oxytocin inhibits the reaction [Cisplatin results in increased expression of MKNK2 mRNA]	PMID:21993003
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1313931	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of MKNK2 mRNA	PMID:34813904
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in increased expression of MKNK2 mRNA	PMID:22228119
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of MKNK2 mRNA	PMID:15289156
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313931	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MKNK2 mRNA	PMID:21570461
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305728	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MKNK2 mRNA	PMID:21215274
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305728	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of MKNK2 mRNA	PMID:28374803
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MKNK2 mRNA	PMID:30851411
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of MKNK2 mRNA	PMID:23649840
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MKNK2 mRNA	PMID:30911355
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313931	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of MKNK2 mRNA	PMID:39631538
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of MKNK2 mRNA	PMID:29319823|PMID:34032870
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of MKNK2 mRNA	PMID:28595984
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MKNK2 mRNA	PMID:38568856|PMID:39719251
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MKNK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:39836092
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:40504410
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to MKNK2 promoter]	PMID:19654925
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MKNK2 mRNA	PMID:30911355
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	MKNK2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:18299328
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK2 protein; MAPK14 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK2 protein]; MKNK2 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EIF4E protein]	PMID:18299328
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20150127	CTD	MESH:C008261	lead acetate results in decreased expression of MKNK2 mRNA	PMID:25270620
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1305728	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of MKNK2 mRNA	PMID:32479839
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313931	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MKNK2 promoter	PMID:35295148
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305728	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MKNK2 mRNA	PMID:34492290
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305728	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MKNK2 mRNA	PMID:25181051
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305728	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of MKNK2 mRNA	PMID:32145629
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of MKNK2 mRNA	PMID:25047013|PMID:29275510
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305728	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MKNK2 mRNA	PMID:34947998
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313931	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MKNK2 mRNA	PMID:32156529
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of MKNK2 mRNA	PMID:24752500
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313931	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of MKNK2 mRNA	PMID:39298647
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of MKNK2 mRNA	PMID:33297965
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MKNK2 3' UTR	PMID:30157460
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313931	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MKNK2 mRNA	PMID:37019170
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305728	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of MKNK2 mRNA	PMID:18164116
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MKNK2 mRNA	PMID:37042841
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1305728	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of MKNK2 mRNA	PMID:30589522
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MKNK2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of MKNK2 mRNA	PMID:39836092
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313931	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MKNK2 mRNA	PMID:26377693
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305728	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MKNK2 mRNA	PMID:30723492
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305728	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of MKNK2 promoter	PMID:22457795
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MKNK2 mRNA	PMID:37236586
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305728	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of MKNK2 mRNA	PMID:26194646
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of MKNK2 mRNA	PMID:19376846
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313931	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of MKNK2 mRNA	PMID:18353800
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of MKNK2 mRNA	PMID:17585979
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:37825	p-toluidine	increases expression	ISO	RGD:1305728	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of MKNK2 mRNA	PMID:27638505
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MKNK2 mRNA	PMID:32588087
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MKNK2 mRNA	PMID:31533062
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of MKNK2 mRNA	PMID:19167446
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MKNK2 mRNA	PMID:19167446
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MKNK2 mRNA	PMID:40419075
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MKNK2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MKNK2 mRNA	PMID:36331819
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MKNK2 mRNA	PMID:25979313
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MKNK2 gene	PMID:29154799
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305728	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of MKNK2 mRNA	PMID:38685447|PMID:41580965
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MKNK2 mRNA	PMID:25562108|PMID:27989131
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of MKNK2 mRNA	PMID:25047013
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1313931	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of MKNK2 mRNA	PMID:22733784
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MKNK2 mRNA	PMID:15289156
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of MKNK2 mRNA	PMID:23649840
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MKNK2 mRNA	PMID:38832940
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MKNK2 mRNA	PMID:27188386
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of MKNK2 mRNA	PMID:28542535
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MKNK2 mRNA	PMID:15606129|PMID:17562736
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of MKNK2 mRNA	PMID:21420995|PMID:29067470
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305728	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MKNK2 mRNA	PMID:33387578
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of MKNK2 promoter	PMID:29626692
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of MKNK2 promoter	PMID:29626692
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:46680	serpentine asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of MKNK2 promoter	PMID:29626692
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MKNK2 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:32525701|PMID:39836092
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:40504410
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of MKNK2 mRNA	PMID:24752500
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of MKNK2 mRNA	PMID:35436446
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of MKNK2 mRNA	PMID:24383545
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MKNK2 mRNA	PMID:17942748
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	MKNK2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:18299328
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK2 protein; MAPK14 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of MKNK2 protein]; MKNK2 protein promotes the reaction [Arsenic Trioxide results in increased phosphorylation of and results in increased activity of EIF4E protein]	PMID:18299328
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of MKNK2 mRNA	PMID:23300844
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313931	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MKNK2 mRNA; Nanotubes, Carbon results in decreased expression of MKNK2 mRNA	PMID:25554681|PMID:25620056
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305728	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of MKNK2 mRNA	PMID:41580965
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MKNK2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of MKNK2 mRNA	PMID:39836092
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	MKNK2 protein affects the susceptibility to Topotecan	PMID:16217747
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1305728	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of MKNK2 mRNA	PMID:24136188
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MKNK2 mRNA	PMID:15336504
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of MKNK2 mRNA	PMID:15003993
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1313931	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of MKNK2 mRNA	PMID:36851058
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of MKNK2 mRNA	PMID:20003209
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MKNK2 3' UTR	PMID:30157460
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:68508	diethyl maleate	decreases expression	ISO	RGD:1305728	E	RGD:6480464	20121009	CTD	MESH:C014476	diethyl maleate results in decreased expression of MKNK2 mRNA	PMID:21161181
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:72754	bisphenol AF	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in decreased expression of MKNK2 mRNA	PMID:25912373
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305728	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of MKNK2 mRNA	PMID:24136188
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of MKNK2 mRNA	PMID:36318118
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1305728	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of MKNK2 mRNA	PMID:15215175
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1305728	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of MKNK2 mRNA	PMID:18164116
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1305728	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of MKNK2 mRNA	PMID:23665939
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MKNK2 mRNA	PMID:30851411
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:7872	oxytocin	multiple interactions	ISO	RGD:1305728	E	RGD:6480464	20120412	CTD	MESH:D010121	Oxytocin inhibits the reaction [Cisplatin results in increased expression of MKNK2 mRNA]	PMID:21993003
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:8064	phenformin	decreases expression	ISO	RGD:1305728	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of MKNK2 mRNA	PMID:31324951
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of MKNK2 mRNA	PMID:19270015|PMID:19482888
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313931	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MKNK2 mRNA]	PMID:19482888
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MKNK2 mRNA	PMID:19167446
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of MKNK2 mRNA	PMID:32525701
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1305728	E	RGD:6480464	20160822	CTD	MESH:D013311	Streptozocin results in increased expression of MKNK2 mRNA	PMID:25905778
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of MKNK2 mRNA	PMID:31863870
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MKNK2 mRNA	PMID:38568856
1313930	MKNK2	MAPK interacting serine/threonine kinase 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305728	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MKNK2 mRNA	PMID:23034163
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of LRP8 mRNA	PMID:33045310
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305729	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LRP8 mRNA]	PMID:31150632
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313933	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of LRP8 mRNA	PMID:20188158
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:149906	Tanshinone I	decreases expression	EXP		E	RGD:6480464	20200602	CTD	MESH:C021751	tanshinone results in decreased expression of LRP8 mRNA	PMID:15849732
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of LRP8 mRNA	PMID:21934132|PMID:33167477
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of LRP8 mRNA	PMID:26516004
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305729	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LRP8 mRNA	PMID:33729688
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313933	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of LRP8 mRNA	PMID:30319688
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313933	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of LRP8 mRNA	PMID:30319688
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of LRP8 mRNA	PMID:23019147|PMID:31614463
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of LRP8 mRNA	PMID:20660070
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305729	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LRP8 mRNA	PMID:33387578
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LRP8 mRNA	PMID:37042841
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of LRP8 mRNA	PMID:23649840
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of LRP8 mRNA	PMID:20660070
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313933	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LRP8 mRNA	PMID:39922521
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313933	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRP8 mRNA	PMID:37992649
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313933	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LRP8 mRNA	PMID:39922521
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313933	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRP8 mRNA	PMID:37992649
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305729	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LRP8 mRNA	PMID:33387578
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of LRP8 mRNA	PMID:28818685
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP8 mRNA	PMID:39836092
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRP8 mRNA	PMID:35301059
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LRP8 mRNA	PMID:19549813
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of LRP8 mRNA	PMID:23649840
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313933	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of LRP8 mRNA	PMID:27776689
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of LRP8 protein	PMID:20106945
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of LRP8 mRNA	PMID:21632981|PMID:21641981
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LRP8 mRNA	PMID:22100608
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of LRP8 mRNA	PMID:23649840
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of LRP8 mRNA	PMID:25102026
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313933	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LRP8 mRNA	PMID:34911549
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of LRP8 mRNA	PMID:17484886
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305729	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LRP8 mRNA	PMID:31150632
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305729	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LRP8 mRNA]	PMID:31150632
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LRP8 mRNA	PMID:25629700
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LRP8 gene	PMID:25304211
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP8 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LRP8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRP8 mRNA	PMID:32525701|PMID:39836092
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:27568	selenium atom	affects abundance	ISO	RGD:1313933	E	RGD:6480464	20120918	CTD	MESH:D012643	LRP8 protein affects the abundance of Selenium	PMID:17314095|PMID:17553992
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:27568	selenium atom	affects response to substance	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D012643	LRP8 protein affects the susceptibility to Selenium	PMID:18172410
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:27568	selenium atom	increases uptake	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D012643	LRP8 protein results in increased uptake of Selenium	PMID:19007311
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA	PMID:27188386
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of LRP8 mRNA	PMID:19167446
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313933	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of LRP8 mRNA	PMID:40618947
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of LRP8 mRNA	PMID:27392435
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of LRP8 mRNA	PMID:23019147
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of LRP8 mRNA	PMID:24768652|PMID:25583101
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRP8 mRNA	PMID:22298810
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRP8 mRNA	PMID:20106945
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305729	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRP8 mRNA	PMID:33387578
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRP8 mRNA	PMID:19770486
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of LRP8 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRP8 mRNA	PMID:27188386
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LRP8 mRNA	PMID:33212167
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LRP8 mRNA	PMID:30851411
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of LRP8 mRNA	PMID:23649840
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of LRP8 mRNA	PMID:32763439
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of LRP8 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of LRP8 mRNA	PMID:20971185|PMID:24690739
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LRP8 mRNA	PMID:29803840
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313933	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of LRP8 mRNA	PMID:36227756
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313933	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRP8 mRNA	PMID:37992649
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of LRP8 mRNA	PMID:34032870
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LRP8 mRNA	PMID:38568856
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of LRP8 mRNA	PMID:25493608
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRP8 mRNA	PMID:39836092
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of LRP8 mRNA	PMID:22378314|PMID:29453283
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of LRP8 mRNA	PMID:22316170
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LRP8 promoter	PMID:27901495
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRP8 mRNA	PMID:20106945|PMID:21632981
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LRP8 mRNA	PMID:26238291|PMID:32234424
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LRP8 mRNA	PMID:19770486
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of LRP8 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of LRP8 mRNA	PMID:20971185|PMID:24690739
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LRP8 mRNA	PMID:19150397|PMID:20018196
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of LRP8 mRNA	PMID:38568856
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1305729	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of LRP8 mRNA	PMID:16507785
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of LRP8 mRNA	PMID:31745603
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313933	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRP8 gene	PMID:35295148
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305729	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LRP8 mRNA	PMID:34492290
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:C006253	pirinixic acid results in increased expression of LRP8 mRNA	PMID:20813756
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305729	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of LRP8 mRNA	PMID:30816183|PMID:34947998
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305729	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LRP8 mRNA	PMID:25181051
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LRP8 gene	PMID:31601247
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1313933	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of LRP8 promoter	PMID:27312807
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C006780	bisphenol A results in increased expression of LRP8 mRNA	PMID:38568856
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LRP8 mRNA	PMID:28628672
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313933	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of LRP8 gene	PMID:31683443
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LRP8 intron	PMID:30157460
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of LRP8 mRNA	PMID:28392331
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313933	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LRP8 intron	PMID:28392331
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313933	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of LRP8 mRNA	PMID:37019170
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:34693	Dicyclohexyl phthalate	decreases expression	ISO	RGD:1305729	E	RGD:6480464	20260303	CTD	MESH:C036042	dicyclohexyl phthalate results in decreased expression of LRP8 mRNA	PMID:40690386
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1313933	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of LRP8 gene	PMID:38995845
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:34709	Diisodecyl phthalate	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20150127	CTD	MESH:C042080	diisodecyl phthalate results in decreased expression of LRP8 mRNA	PMID:25270620
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LRP8 mRNA	PMID:28628672
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305729	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of LRP8 mRNA	PMID:32680482
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LRP8 mRNA	PMID:37042841
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP8 mRNA	PMID:39836092
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305729	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LRP8 mRNA	PMID:33453195
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRP8 mRNA	PMID:35301059
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LRP8 mRNA	PMID:19376846
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C018021	cobaltous chloride results in increased expression of LRP8 mRNA	PMID:20105288
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LRP8 mRNA	PMID:24449571
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:36904	elemental selenium	affects abundance	ISO	RGD:1313933	E	RGD:6480464	20120918	CTD	MESH:D012643	LRP8 protein affects the abundance of Selenium	PMID:17314095|PMID:17553992
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:36904	elemental selenium	affects response to substance	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D012643	LRP8 protein affects the susceptibility to Selenium	PMID:18172410
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:36904	elemental selenium	increases uptake	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:D012643	LRP8 protein results in increased uptake of Selenium	PMID:19007311
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LRP8 mRNA	PMID:40194260
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of LRP8 mRNA	PMID:28302478
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of LRP8 mRNA	PMID:19167446
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of LRP8 mRNA	PMID:19167446
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LRP8 mRNA	PMID:25979313
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRP8 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA	PMID:27188386
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of LRP8 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:41607	crotonaldehyde	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in decreased expression of LRP8 mRNA	PMID:20471460
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LRP8 mRNA	PMID:28628672
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313933	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of LRP8 mRNA	PMID:39922521
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313933	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LRP8 mRNA	PMID:37992649
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LRP8 mRNA	PMID:38832940
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of LRP8 mRNA	PMID:27188386
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of LRP8 mRNA	PMID:28542535
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in decreased expression of LRP8 mRNA	PMID:27188386
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of LRP8 mRNA	PMID:29067470
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305729	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LRP8 mRNA	PMID:33387578
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of LRP8 mRNA	PMID:16101138
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of LRP8 mRNA	PMID:24690739
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LRP8 gene	PMID:25304211
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP8 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LRP8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRP8 mRNA	PMID:32525701|PMID:39836092
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1313933	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in increased expression of LRP8 mRNA	PMID:35537566
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of LRP8 mRNA	PMID:31838189
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305729	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of LRP8 mRNA	PMID:29391264
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of LRP8 mRNA	PMID:32234424
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of LRP8 mRNA	PMID:38568856
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LRP8 mRNA	PMID:28628672
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313933	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of LRP8 mRNA	PMID:25554681
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1305729	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of LRP8 mRNA	PMID:23962444
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of LRP8 mRNA	PMID:23608068
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313933	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of LRP8 mRNA	PMID:38701926
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1313933	E	RGD:6480464	20120918	CTD	MESH:C025340	manganese chloride results in increased expression of LRP8 mRNA	PMID:22407947
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRP8 mRNA	PMID:39836092
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1313933	E	RGD:6480464	20120515	CTD	MESH:C017096	n-butoxyethanol results in increased expression of LRP8 mRNA	PMID:19812364
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of LRP8 mRNA	PMID:28988120
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LRP8 intron	PMID:30157460
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305729	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LRP8 gene	PMID:35440735
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of LRP8 mRNA	PMID:37199045
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:75701	sarin	increases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of LRP8 mRNA	PMID:19522546
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LRP8 mRNA	PMID:30851411
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRP8 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA	PMID:27188386
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313933	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of LRP8 mRNA	PMID:38648751
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:81766	hexaconazole	affects expression	ISO	RGD:1313933	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole affects the expression of LRP8 mRNA	PMID:21195148
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1313933	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of LRP8 mRNA	PMID:21195148
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:82284	2-Amino-9H-pyrido[2,3-b]indole	increases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C017822	2-amino-9H-pyrido(2,3-b)indole results in increased expression of LRP8 mRNA	PMID:40713012
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of LRP8 mRNA	PMID:32525701
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA	PMID:27188386
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LRP8 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRP8 mRNA	PMID:27188386
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of LRP8 mRNA	PMID:22378314
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:9665	triadimefon	affects expression	ISO	RGD:1313933	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon affects the expression of LRP8 mRNA	PMID:21195148
1313932	LRP8	LDL receptor related protein 8	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313933	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of LRP8 mRNA	PMID:35537566
1313935	PHF12	PHD finger protein 12	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313936	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of PHF12 mRNA	PMID:33045310
1313935	PHF12	PHD finger protein 12	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PHF12 mRNA	PMID:26079696
1313935	PHF12	PHD finger protein 12	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313936	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PHF12 mRNA	PMID:30319688
1313935	PHF12	PHD finger protein 12	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313936	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PHF12 mRNA	PMID:30319688
1313935	PHF12	PHD finger protein 12	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of PHF12 mRNA	PMID:23019147
1313935	PHF12	PHD finger protein 12	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PHF12 mRNA	PMID:37042841
1313935	PHF12	PHD finger protein 12	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PHF12 mRNA	PMID:20655997
1313935	PHF12	PHD finger protein 12	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PHF12 protein	PMID:37730182
1313935	PHF12	PHD finger protein 12	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305731	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PHF12 mRNA	PMID:33387578
1313935	PHF12	PHD finger protein 12	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313936	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PHF12 mRNA	PMID:36331819
1313935	PHF12	PHD finger protein 12	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PHF12 mRNA	PMID:35301059
1313935	PHF12	PHD finger protein 12	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313936	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PHF12 mRNA	PMID:19770486
1313935	PHF12	PHD finger protein 12	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PHF12 mRNA	PMID:35430440
1313935	PHF12	PHD finger protein 12	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PHF12 mRNA	PMID:25629700
1313935	PHF12	PHD finger protein 12	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PHF12 mRNA	PMID:40512198
1313935	PHF12	PHD finger protein 12	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313936	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PHF12 mRNA	PMID:40504410
1313935	PHF12	PHD finger protein 12	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PHF12 mRNA	PMID:30912803
1313935	PHF12	PHD finger protein 12	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1305731	E	RGD:6480464	20200519	CTD	MESH:D009532	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of PHF12 mRNA	PMID:31734292
1313935	PHF12	PHD finger protein 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313936	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PHF12 mRNA	PMID:21570461
1313935	PHF12	PHD finger protein 12	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PHF12 mRNA	PMID:29803840
1313935	PHF12	PHD finger protein 12	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of PHF12 protein	PMID:35688186
1313935	PHF12	PHD finger protein 12	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PHF12 mRNA	PMID:38568856
1313935	PHF12	PHD finger protein 12	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313936	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of PHF12 gene	PMID:39894169
1313935	PHF12	PHD finger protein 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PHF12 mRNA	PMID:40512198
1313935	PHF12	PHD finger protein 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313936	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PHF12 mRNA	PMID:40504410
1313935	PHF12	PHD finger protein 12	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PHF12 intron	PMID:30157460
1313935	PHF12	PHD finger protein 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313936	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PHF12 mRNA	PMID:22228805
1313935	PHF12	PHD finger protein 12	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PHF12 mRNA	PMID:20382639
1313935	PHF12	PHD finger protein 12	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PHF12 mRNA	PMID:21461292
1313935	PHF12	PHD finger protein 12	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of PHF12 gene	PMID:31601247
1313935	PHF12	PHD finger protein 12	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305731	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PHF12 mRNA	PMID:25729387
1313935	PHF12	PHD finger protein 12	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313936	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PHF12 gene	PMID:35295148
1313935	PHF12	PHD finger protein 12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PHF12 mRNA	PMID:33221593
1313935	PHF12	PHD finger protein 12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305731	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PHF12 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1313935	PHF12	PHD finger protein 12	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PHF12 mRNA	PMID:38685157
1313935	PHF12	PHD finger protein 12	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PHF12 mRNA	PMID:37042841
1313935	PHF12	PHD finger protein 12	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PHF12 mRNA	PMID:35301059
1313935	PHF12	PHD finger protein 12	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1313936	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of PHF12 mRNA	PMID:17585979
1313935	PHF12	PHD finger protein 12	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PHF12 mRNA	PMID:28302478
1313935	PHF12	PHD finger protein 12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313936	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PHF12 mRNA	PMID:36331819
1313935	PHF12	PHD finger protein 12	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of PHF12 mRNA	PMID:28001369
1313935	PHF12	PHD finger protein 12	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PHF12 gene	PMID:29154799
1313935	PHF12	PHD finger protein 12	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305731	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PHF12 mRNA	PMID:30047161
1313935	PHF12	PHD finger protein 12	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1313936	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of PHF12 mRNA	PMID:18502557
1313935	PHF12	PHD finger protein 12	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in decreased expression of PHF12 mRNA	PMID:17585979
1313935	PHF12	PHD finger protein 12	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of PHF12 mRNA	PMID:40512198
1313935	PHF12	PHD finger protein 12	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313936	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of PHF12 mRNA	PMID:40504410
1313935	PHF12	PHD finger protein 12	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PHF12 mRNA	PMID:21461292
1313935	PHF12	PHD finger protein 12	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305731	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PHF12 mRNA	PMID:30047161
1313935	PHF12	PHD finger protein 12	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313936	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PHF12 mRNA	PMID:35964746
1313935	PHF12	PHD finger protein 12	gene	CHEBI:53001	nickel sulfate	multiple interactions	ISO	RGD:1305731	E	RGD:6480464	20200519	CTD	MESH:C029938	[nickel sulfate results in increased abundance of Nickel] which results in decreased expression of PHF12 mRNA	PMID:31734292
1313935	PHF12	PHD finger protein 12	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305731	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PHF12 mRNA	PMID:25729387
1313935	PHF12	PHD finger protein 12	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313936	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of PHF12 mRNA	PMID:31388691
1313935	PHF12	PHD finger protein 12	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of PHF12 mRNA	PMID:39847705
1313935	PHF12	PHD finger protein 12	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305731	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PHF12 mRNA	PMID:30047161
1313935	PHF12	PHD finger protein 12	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305731	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PHF12 mRNA	PMID:19281266
1313935	PHF12	PHD finger protein 12	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305731	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PHF12 mRNA	PMID:21346803
1313935	PHF12	PHD finger protein 12	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305731	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PHF12 mRNA	PMID:21346803
1313935	PHF12	PHD finger protein 12	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313936	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PHF12 mRNA	PMID:28973697
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of LIMS1 mRNA	PMID:38218311
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313938	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of LIMS1 mRNA	PMID:26251327
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of LIMS1 mRNA	PMID:21934132|PMID:33167477
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1313938	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of LIMS1 mRNA	PMID:40945087
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313938	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LIMS1 mRNA	PMID:30517762
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313938	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LIMS1 mRNA	PMID:39241906
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313938	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of LIMS1 mRNA]	PMID:39241906
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1560732	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of LIMS1 protein	PMID:32145629
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LIMS1 mRNA	PMID:37042841
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of LIMS1 mRNA	PMID:21592394
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of LIMS1 mRNA	PMID:21592394
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LIMS1 mRNA	PMID:31163220
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of LIMS1 mRNA	PMID:21592394
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of LIMS1 mRNA	PMID:21592394
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1560732	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LIMS1 mRNA	PMID:33387578
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LIMS1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LIMS1 mRNA	PMID:39836092
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1313938	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of LIMS1 mRNA	PMID:33914522
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:2038	5-azacytidine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001374	Azacitidine results in increased expression of LIMS1 mRNA	PMID:19194470
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LIMS1 mRNA	PMID:19549813
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1560732	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of LIMS1 protein	PMID:33236894
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LIMS1 gene	PMID:27153756
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313938	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LIMS1 mRNA	PMID:19770486
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of LIMS1 mRNA	PMID:41430723
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313938	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LIMS1 mRNA	PMID:31919559
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1313938	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of LIMS1 mRNA	PMID:30517762
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313938	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LIMS1 mRNA	PMID:25629700
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313938	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of LIMS1 mRNA]	PMID:22206623
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LIMS1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LIMS1 mRNA	PMID:39836092
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1560732	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of LIMS1 mRNA	PMID:31881176
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of LIMS1 mRNA	PMID:27392435
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of LIMS1 mRNA	PMID:27392435
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313938	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LIMS1 mRNA	PMID:26377647
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1560732	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LIMS1 mRNA	PMID:33387578|PMID:34747641
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313938	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LIMS1 mRNA	PMID:19770486
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LIMS1 mRNA	PMID:33212167
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of LIMS1 mRNA	PMID:23649840
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LIMS1 mRNA	PMID:38568856
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LIMS1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LIMS1 mRNA	PMID:39836092
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LIMS1 5' UTR	PMID:27901495
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to LIMS1 mRNA]	PMID:32406909
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:30512	silver atom	multiple interactions	ISO	RGD:1560732	E	RGD:6480464	20150310	CTD	MESH:D012834	[Silver analog co-treated with Povidone] results in increased expression of LIMS1 mRNA	PMID:25194297
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of LIMS1 mRNA	PMID:38568856
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1560732	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of LIMS1 mRNA	PMID:30047161
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313938	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LIMS1 promoter	PMID:35295148
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313938	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LIMS1 gene	PMID:35295148
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1560732	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LIMS1 mRNA	PMID:34492290
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1313938	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of LIMS1 mRNA	PMID:33914522
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of LIMS1 protein	PMID:31675489
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313938	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of LIMS1 protein	PMID:35999755
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1560732	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LIMS1 mRNA	PMID:34947998
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LIMS1 gene	PMID:31601247
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313938	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in increased expression of LIMS1 mRNA	PMID:21932408|PMID:33221593
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1560732	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of LIMS1 protein	PMID:32145629
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LIMS1 mRNA	PMID:28628672
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of LIMS1 protein	PMID:31675489
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1313938	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of LIMS1 protein	PMID:35999755
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1560732	E	RGD:6480464	20150127	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of LIMS1 mRNA	PMID:24893172
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313938	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LIMS1 mRNA	PMID:17361019|PMID:21266533
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LIMS1 mRNA	PMID:28628672
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1313938	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of LIMS1 mRNA]	PMID:39241906
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LIMS1 mRNA	PMID:37042841
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LIMS1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LIMS1 mRNA	PMID:39836092
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of LIMS1 mRNA	PMID:19376846
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1560732	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of LIMS1 mRNA	PMID:24386269
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in decreased expression of LIMS1 mRNA	PMID:17685462
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LIMS1 gene	PMID:29154799
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1560732	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of LIMS1 mRNA	PMID:30047161
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of LIMS1 mRNA	PMID:20106945|PMID:25562108
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LIMS1 mRNA	PMID:28628672
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313938	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of LIMS1 mRNA	PMID:28973697
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LIMS1 mRNA	PMID:38832940
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313938	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LIMS1 mRNA	PMID:17562736
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of LIMS1 mRNA	PMID:25757056
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LIMS1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LIMS1 mRNA	PMID:39836092
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of LIMS1 mRNA	PMID:31675489
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of LIMS1 mRNA	PMID:28628672
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of LIMS1 mRNA	PMID:19194470
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1560732	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of LIMS1 mRNA	PMID:30047161
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313938	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LIMS1 mRNA	PMID:35964746
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of LIMS1 mRNA	PMID:20977926
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:53248	poly(vinylpyrrolidone)	multiple interactions	ISO	RGD:1560732	E	RGD:6480464	20150310	CTD	MESH:D011205	[Silver analog co-treated with Povidone] results in increased expression of LIMS1 mRNA	PMID:25194297
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1313938	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of LIMS1 mRNA	PMID:20829426
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LIMS1 protein	PMID:32959892
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LIMS1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of LIMS1 mRNA	PMID:39836092
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1313938	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LIMS1 mRNA	PMID:26378955
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:63933	Aroclor 1254	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of LIMS1 mRNA	PMID:16934159
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of LIMS1 mRNA	PMID:15336504
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of LIMS1 mRNA	PMID:31758290
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LIMS1 protein	PMID:34186270
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313938	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LIMS1 mRNA	PMID:22206623
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313938	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of LIMS1 mRNA]	PMID:22206623
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of LIMS1 mRNA	PMID:19159669
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313938	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of LIMS1 mRNA	PMID:23091169
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:8093	phenylephrine	affects localization	ISO	RGD:1560732	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine affects the localization of LIMS1 protein	PMID:16170337
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313938	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of LIMS1 mRNA	PMID:31388691
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of LIMS1 protein	PMID:31675489
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of LIMS1 protein	PMID:31675489
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313938	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of LIMS1 mRNA	PMID:21795629
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1560732	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of LIMS1 mRNA	PMID:24780913|PMID:30047161
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1313938	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of LIMS1 mRNA]	PMID:39241906
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313938	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of LIMS1 mRNA	PMID:40826991
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:9141	silver(0)	multiple interactions	ISO	RGD:1560732	E	RGD:6480464	20150310	CTD	MESH:D012834	[Silver analog co-treated with Povidone] results in increased expression of LIMS1 mRNA	PMID:25194297
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of LIMS1 mRNA	PMID:17440010
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LIMS1 mRNA	PMID:38568856
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of LIMS1 mRNA	PMID:27188386
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1560732	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LIMS1 mRNA	PMID:21346803
1313937	LIMS1	LIM zinc finger domain containing 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1560732	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of LIMS1 mRNA	PMID:23555832
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ILF2 mRNA	PMID:33167477
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313941	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ILF2 mRNA	PMID:30319688
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313941	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ILF2 mRNA	PMID:39241906
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of ILF2 mRNA	PMID:16474171
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305734	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ILF2 gene	PMID:27618143
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of ILF2 mRNA	PMID:27683099
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313941	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ILF2 mRNA	PMID:34319233
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in decreased expression of ILF2 protein	PMID:34122009
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ILF2 protein	PMID:37730182
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ILF2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ILF2 mRNA	PMID:39836092
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:183083	indirubin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C027185	indirubin results in decreased expression of ILF2 mRNA	PMID:15056799
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1313941	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of ILF2 mRNA	PMID:27462272
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ILF2 protein	PMID:23301498
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313941	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ILF2 mRNA	PMID:19770486
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of ILF2 mRNA	PMID:23033980
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of ILF2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of ILF2 protein	PMID:38598786
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ILF2 mRNA]	PMID:22206623
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ILF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ILF2 mRNA	PMID:39836092
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ILF2 mRNA	PMID:40504410
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313941	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ILF2 mRNA	PMID:28960355
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:27827	paraoxon	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D010261	Paraoxon results in increased expression of ILF2 protein	PMID:20931991
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1313941	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of ILF2 protein	PMID:25505154
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of ILF2 mRNA	PMID:16474171
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313941	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ILF2 mRNA	PMID:21570461
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ILF2 mRNA	PMID:17942748
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ILF2 mRNA	PMID:30851411
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305734	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ILF2 mRNA	PMID:28959563
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ILF2 mRNA	PMID:20044591
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ILF2 gene	PMID:28589171
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ILF2 mRNA	PMID:38568856
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ILF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ILF2 mRNA	PMID:39836092
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ILF2 mRNA	PMID:40504410
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILF2 mRNA	PMID:27858113
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ILF2 mRNA]	PMID:32406909
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1313941	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of ILF2 gene	PMID:35295148
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ILF2 mRNA; bisphenol A results in decreased expression of ILF2 protein	PMID:29275510|PMID:37567409
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305734	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ILF2 mRNA	PMID:25181051
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of ILF2 mRNA; bisphenol A results in increased expression of ILF2 protein	PMID:16474171|PMID:34186270
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305734	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ILF2 mRNA	PMID:36041667
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305734	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ILF2 mRNA	PMID:36041667
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILF2 mRNA	PMID:27858113
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305734	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ILF2 mRNA	PMID:36041667
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of ILF2 protein	PMID:38598786
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ILF2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ILF2 mRNA	PMID:39836092
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ILF2 mRNA	PMID:19320972|PMID:19376846
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ILF2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ILF2 mRNA]	PMID:17585979
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ILF2 mRNA	PMID:19167446
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILF2 mRNA	PMID:19167446
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313941	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ILF2 mRNA	PMID:39529242
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of ILF2 mRNA	PMID:26352163
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ILF2 mRNA	PMID:20106945
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:40909	azoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of ILF2 mRNA	PMID:33512557
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ILF2 mRNA	PMID:38832940
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ILF2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ILF2 mRNA]	PMID:17585979
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ILF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ILF2 mRNA	PMID:39836092
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ILF2 mRNA	PMID:40504410
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of ILF2 protein	PMID:31195006
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313941	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ILF2 mRNA	PMID:17942748
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ILF2 mRNA	PMID:17942748
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILF2 mRNA	PMID:27858113
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of ILF2 mRNA	PMID:27858113
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1313941	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ILF2 mRNA	PMID:23608068
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ILF2 protein	PMID:32959892
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ILF2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ILF2 mRNA	PMID:39836092
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of ILF2 protein	PMID:34122009
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ILF2 protein	PMID:34186270
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313941	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ILF2 mRNA	PMID:22206623
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313941	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ILF2 mRNA]	PMID:22206623
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ILF2 protein	PMID:31285264
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:75701	sarin	decreases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of ILF2 mRNA	PMID:19522546
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:75701	sarin	increases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of ILF2 mRNA	PMID:19522546
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305734	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ILF2 mRNA	PMID:21346803
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ILF2 mRNA	PMID:30851411
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ILF2 gene]	PMID:28238834
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ILF2 mRNA	PMID:19167446
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305734	E	RGD:6480464	20120522	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ILF2 mRNA	PMID:21346803
1313940	ILF2	interleukin enhancer binding factor 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of ILF2 protein	PMID:38598786
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305735	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GRHL1 mRNA]	PMID:31150632
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRHL1 mRNA	PMID:20938992
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of GRHL1 mRNA	PMID:21934132
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of GRHL1 mRNA	PMID:26516004
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GRHL1 mRNA	PMID:36331819
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of GRHL1 mRNA	PMID:26079696
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1618199	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of GRHL1 mRNA	PMID:30319688
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1618199	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of GRHL1 mRNA	PMID:39241906
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of GRHL1 mRNA	PMID:30510588
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of GRHL1 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of GRHL1 mRNA	PMID:20660070|PMID:30165855
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRHL1 mRNA	PMID:20938992
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of GRHL1 mRNA	PMID:20660070
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of GRHL1 mRNA	PMID:26079696
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of GRHL1 mRNA	PMID:31256213
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of GRHL1 mRNA	PMID:16002434|PMID:26485663
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of GRHL1 mRNA	PMID:28818685
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D002104	Cadmium results in increased expression of GRHL1 mRNA	PMID:30125854
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GRHL1 mRNA	PMID:23649840
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of GRHL1 mRNA	PMID:35430440
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GRHL1 mRNA	PMID:18593933
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305735	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GRHL1 mRNA	PMID:31150632
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1618199	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GRHL1 mRNA	PMID:31919559
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305735	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GRHL1 mRNA]	PMID:31150632
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GRHL1 mRNA	PMID:20938992
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of GRHL1 mRNA	PMID:40504410
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D000966	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of GRHL1 mRNA	PMID:32076005
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of GRHL1 protein	PMID:35688186
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1618199	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of GRHL1 mRNA	PMID:28960355
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of GRHL1 mRNA	PMID:27392435
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305735	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GRHL1 mRNA	PMID:32109520
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618199	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GRHL1 mRNA	PMID:24058054|PMID:26377647
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GRHL1 mRNA	PMID:23152189
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of GRHL1 mRNA	PMID:28001369
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of GRHL1 mRNA	PMID:39709020
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of GRHL1 mRNA	PMID:32763439
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of GRHL1 mRNA	PMID:20971185
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1618199	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of GRHL1 mRNA	PMID:27862939
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GRHL1 mRNA	PMID:38568856
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C017947	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of GRHL1 mRNA	PMID:32076005
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of GRHL1 mRNA	PMID:40504410
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GRHL1 promoter	PMID:27901495
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C015001	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of GRHL1 mRNA; arsenite inhibits the reaction [G3BP1 protein binds to GRHL1 mRNA]	PMID:32076005|PMID:32406909
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of GRHL1 mRNA	PMID:20971185
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of GRHL1 mRNA	PMID:18593933
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:30297	antimonite	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C061374	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of GRHL1 mRNA	PMID:32076005
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of GRHL1 mRNA	PMID:26014281
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305735	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of GRHL1 mRNA	PMID:30047161
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1618199	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of GRHL1 mRNA	PMID:29264374
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1618199	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GRHL1 promoter	PMID:35295148
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:32234	titanium dioxide	increases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in increased methylation of GRHL1 promoter	PMID:34973136
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305735	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of GRHL1 mRNA	PMID:23411599
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1618199	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of GRHL1 mRNA	PMID:18301758|PMID:23811191
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GRHL1 mRNA	PMID:19710929
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of GRHL1 mRNA	PMID:27685785
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of GRHL1 gene	PMID:31601247
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1618199	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of GRHL1 mRNA	PMID:26377693
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1618199	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of GRHL1 mRNA	PMID:30951980
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1618199	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of GRHL1 intron	PMID:28392331
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1618199	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of GRHL1 mRNA	PMID:24535843
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GRHL1 mRNA	PMID:37042841
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1305735	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of GRHL1 mRNA	PMID:22110744
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305735	E	RGD:6480464	20191008	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GRHL1 mRNA	PMID:31077537
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GRHL1 mRNA	PMID:38174414|PMID:38568856
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305735	E	RGD:6480464	20191008	CTD	MESH:D019256	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of GRHL1 mRNA	PMID:31077537
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1618199	E	RGD:6480464	20190312	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of GRHL1 mRNA	PMID:30711707
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1618199	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of GRHL1 mRNA	PMID:24183702
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of GRHL1 mRNA	PMID:24449571
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1618199	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of GRHL1 mRNA	PMID:18353800
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1618199	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of GRHL1 mRNA	PMID:23811191
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GRHL1 mRNA	PMID:32588087
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of GRHL1 mRNA	PMID:36864359
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of GRHL1 mRNA	PMID:40419075
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GRHL1 mRNA	PMID:36331819
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1618199	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of GRHL1 mRNA	PMID:29038090
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1618199	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of GRHL1 mRNA	PMID:23125180
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GRHL1 mRNA	PMID:25979313
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1618199	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of GRHL1 mRNA	PMID:17963808
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of GRHL1 mRNA	PMID:19101580|PMID:24383497|PMID:24935251|PMID:25192806|PMID:27188386
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of GRHL1 gene	PMID:29501571
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305735	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of GRHL1 mRNA	PMID:30047161
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of GRHL1 mRNA	PMID:25562108
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of GRHL1 mRNA	PMID:20106945
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1618199	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of GRHL1 mRNA	PMID:28973697
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GRHL1 mRNA	PMID:38832940
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:4488	diallyl disulfide	multiple interactions	ISO	RGD:1305735	E	RGD:6480464	20191008	CTD	MESH:C028009	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of GRHL1 mRNA	PMID:31077537
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of GRHL1 mRNA	PMID:28542535
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of GRHL1 mRNA	PMID:24935251
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1618199	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GRHL1 mRNA	PMID:17562736
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of GRHL1 mRNA	PMID:21420995|PMID:29067470
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1618199	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of GRHL1 mRNA	PMID:40504410
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of GRHL1 mRNA	PMID:18175754
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA	PMID:27188386
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305735	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of GRHL1 mRNA	PMID:30307764
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1618199	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GRHL1 mRNA; Nanotubes, Carbon results in decreased expression of GRHL1 mRNA	PMID:25554681
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1618199	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GRHL1 mRNA; Nanotubes, Carbon results in increased expression of GRHL1 mRNA	PMID:25620056
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305735	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of GRHL1 mRNA	PMID:30047161
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of GRHL1 mRNA	PMID:31629900
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA	PMID:27188386
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GRHL1 gene]	PMID:28238834
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1618199	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of GRHL1 mRNA	PMID:23091169
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1305735	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of GRHL1 mRNA	PMID:32109520
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1618199	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of GRHL1 mRNA	PMID:31388691
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of GRHL1 mRNA	PMID:26079696
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305735	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of GRHL1 mRNA	PMID:30047161
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA	PMID:27188386
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of GRHL1 mRNA	PMID:19429434
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of GRHL1 mRNA	PMID:31734321
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GRHL1 mRNA	PMID:27188386
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of GRHL1 mRNA	PMID:26014281
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of GRHL1 mRNA	PMID:38568856
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1618199	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of GRHL1 mRNA	PMID:32835833
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1618199	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of GRHL1 mRNA	PMID:35537566
1313942	GRHL1	grainyhead like transcription factor 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305735	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of GRHL1 mRNA	PMID:19015723
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of AAED1 mRNA	PMID:33167477
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313945	E	RGD:6480464	20190409	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PRXL2C mRNA	PMID:30529165
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313945	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of AAED1 mRNA	PMID:30319688
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PRXL2C mRNA	PMID:21632981
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313945	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PRXL2C mRNA	PMID:39241906
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of PRXL2C mRNA	PMID:20106945
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313945	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PRXL2C mRNA	PMID:39298647
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1589650	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of PRXL2C mRNA	PMID:26496021
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1589650	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PRXL2C mRNA	PMID:33387578
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PRXL2C mRNA	PMID:37042841
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1589650	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PRXL2C mRNA	PMID:26577399
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PRXL2C protein	PMID:37730182
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1589650	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PRXL2C mRNA	PMID:33387578
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PRXL2C mRNA	PMID:27153756
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313945	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRXL2C mRNA	PMID:22206623
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1589650	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PRXL2C mRNA	PMID:31881176
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PRXL2C mRNA	PMID:23195993|PMID:24768652|PMID:25583101
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRXL2C mRNA	PMID:20106945|PMID:21632981
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1589650	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRXL2C mRNA	PMID:32109520
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of PRXL2C mRNA	PMID:39709020
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of PRXL2C protein	PMID:35688186
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1589650	E	RGD:6480464	20150714	CTD	MESH:C006780	bisphenol A results in decreased expression of PRXL2C mRNA	PMID:25181051|PMID:41034487
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of AAED1 mRNA	PMID:36232920
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1589650	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of AAED1 mRNA	PMID:32145629
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1589650	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of PRXL2C mRNA	PMID:26496021
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313945	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of AAED1 mRNA	PMID:30951980
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313945	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of AAED1 mRNA	PMID:36331819
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PRXL2C mRNA	PMID:25979313
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of PRXL2C mRNA	PMID:29154799
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PRXL2C mRNA	PMID:24935251|PMID:26272509
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRXL2C mRNA	PMID:27188386
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PRXL2C mRNA	PMID:20106945|PMID:25562108
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of PRXL2C mRNA	PMID:25047013
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1589650	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PRXL2C mRNA	PMID:33387578
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1589650	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PRXL2C mRNA	PMID:29391264
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PRXL2C mRNA	PMID:22079256
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of PRXL2C mRNA	PMID:18175754
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313945	E	RGD:6480464	20190409	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PRXL2C mRNA; Nanotubes, Carbon results in decreased expression of PRXL2C mRNA	PMID:25554681
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1589650	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PRXL2C mRNA	PMID:24136188
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1589650	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of PRXL2C mRNA	PMID:24793618
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1589650	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PRXL2C mRNA	PMID:24136188
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1589650	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of PRXL2C mRNA	PMID:24136188
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313945	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PRXL2C mRNA	PMID:22206623
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PRXL2C mRNA	PMID:22079256
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PRXL2C mRNA	PMID:22079256
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRXL2C mRNA	PMID:27188386
1313944	PRXL2C	peroxiredoxin like 2C	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRXL2C mRNA	PMID:27188386
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313947	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of UPF1 mRNA	PMID:33045310
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313947	E	RGD:6480464	20160119	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of UPF1 mRNA	PMID:20188158
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UPF1 gene	PMID:20938992
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313947	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of UPF1 mRNA	PMID:40945087
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313947	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of UPF1 mRNA	PMID:30319688
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313947	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of UPF1 mRNA	PMID:39241906
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313947	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of UPF1 mRNA	PMID:39298647
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of UPF1 mRNA	PMID:20404318
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of UPF1 mRNA	PMID:38568856
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UPF1 gene	PMID:20938992
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of UPF1 mRNA	PMID:21179406
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of UPF1 mRNA	PMID:38160208
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313947	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of UPF1 mRNA	PMID:22401849
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of UPF1 protein	PMID:37730182
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of UPF1 mRNA	PMID:28818685
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UPF1 mRNA	PMID:35301059
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UPF1 mRNA	PMID:28111341
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1313947	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of UPF1 intron	PMID:27776689
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313947	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of UPF1 mRNA	PMID:19770486
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of UPF1 mRNA	PMID:23649840
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of UPF1 mRNA	PMID:35430440
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of UPF1 mRNA	PMID:34911549
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of UPF1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of UPF1 protein	PMID:38598786
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of UPF1 mRNA	PMID:18593933
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313947	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UPF1 mRNA	PMID:31919559
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UPF1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of UPF1 gene	PMID:20938992|PMID:22206623
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of UPF1 gene	PMID:25304211
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UPF1 mRNA	PMID:40504410
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:27656	camptothecin	decreases response to substance	EXP		E	RGD:6480464	20160315	CTD	MESH:D002166	UPF1 mRNA results in decreased susceptibility to Camptothecin	PMID:25269479
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of UPF1 protein	PMID:35688186
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313947	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of UPF1 mRNA	PMID:30912803
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313947	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UPF1 mRNA	PMID:21570461
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20160119	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPF1 mRNA	PMID:17942748
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of UPF1 mRNA	PMID:29955902
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of UPF1 mRNA	PMID:33212167
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1589127	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of UPF1 mRNA	PMID:28959563
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1313947	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of UPF1 mRNA	PMID:27862939
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of UPF1 protein	PMID:35688186
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of UPF1 mRNA	PMID:29319823
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of UPF1 protein	PMID:30528433|PMID:38228842
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of UPF1 mRNA	PMID:34032870
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite inhibits the reaction [UPF1 protein binds to Ribonucleotides]	PMID:30528433
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UPF1 mRNA	PMID:40504410
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313947	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UPF1 mRNA	PMID:19770486|PMID:22228805
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of UPF1 3' UTR	PMID:27901495
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20120515	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of UPF1 mRNA]; Benzo(a)pyrene promotes the reaction [AHR protein binds to UPF1 promoter]	PMID:19654925|PMID:22228805
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of UPF1 mRNA	PMID:18593933
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:31205	amlexanox	affects localization	EXP		E	RGD:6480464	20190219	CTD	MESH:C045742	amlexanox affects the localization of UPF1 protein	PMID:28743738
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313947	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of UPF1 gene	PMID:35295148
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1589127	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of UPF1 mRNA	PMID:34492290
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1313947	E	RGD:6480464	20160119	CTD	MESH:C006253	pirinixic acid results in decreased expression of UPF1 mRNA	PMID:18445702
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the methylation of UPF1 promoter	PMID:36572933
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of UPF1 protein	PMID:31675489
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of UPF1 protein	PMID:34186270
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313947	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of UPF1 mRNA	PMID:33221593
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1589127	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UPF1 mRNA	PMID:25181051
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of UPF1 protein	PMID:31675489
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:3423	carmustine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of UPF1 mRNA	PMID:15980968
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313947	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of UPF1 gene	PMID:31683443
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of UPF1 gene	PMID:31601247
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of UPF1 protein	PMID:34186270
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1313947	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of UPF1 mRNA	PMID:36464114
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313947	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of UPF1 mRNA	PMID:37019170
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of UPF1 gene	PMID:22964155
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of UPF1 protein	PMID:38598786
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UPF1 mRNA	PMID:37042841
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UPF1 mRNA	PMID:35301059
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UPF1 mRNA	PMID:28111341
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of UPF1 protein	PMID:26879310
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone promotes the reaction [NDRG1 protein binds to UPF1 protein]	PMID:17220478
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of UPF1 mRNA	PMID:28302478
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UPF1 mRNA	PMID:25979313
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of UPF1 gene	PMID:29154799
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1313947	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of UPF1 mRNA	PMID:19770486
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of UPF1 mRNA	PMID:14699072
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in decreased expression of UPF1 mRNA	PMID:19059307
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:42768	geneticin	affects localization	EXP		E	RGD:6480464	20190219	CTD	MESH:C010680	antibiotic G 418 affects the localization of UPF1 protein	PMID:28743738
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:44616	afimoxifene	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C016601	afimoxifene results in increased expression of UPF1 mRNA	PMID:16849584
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of UPF1 gene	PMID:25304211
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UPF1 mRNA	PMID:40504410
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of UPF1 mRNA	PMID:31675489
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313947	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of UPF1 mRNA	PMID:17555576
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20160119	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UPF1 mRNA	PMID:17942748
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of UPF1 mRNA	PMID:23228038
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of UPF1 mRNA	PMID:35964746
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:529996	cytochalasin D	affects localization	EXP		E	RGD:6480464	20190219	CTD	MESH:D015638	Cytochalasin D affects the localization of UPF1 protein	PMID:28743738
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:529996	cytochalasin D	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D015638	Cytochalasin D inhibits the reaction [UPF1 protein binds to ACTG1 protein]	PMID:28743738
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UPF1 protein	PMID:32959892
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:66104	jaspamide	affects localization	EXP		E	RGD:6480464	20190219	CTD	MESH:C057531	jasplakinolide affects the localization of UPF1 protein	PMID:28743738
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:66104	jaspamide	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C057531	jasplakinolide inhibits the reaction [UPF1 protein binds to ACTG1 protein]	PMID:28743738
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1313947	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of UPF1 mRNA	PMID:36464114
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313947	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UPF1 mRNA	PMID:22206623
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313947	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of UPF1 mRNA	PMID:31388691
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of UPF1 protein	PMID:31675489
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of UPF1 mRNA	PMID:14699072
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of UPF1 mRNA	PMID:19059307
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of UPF1 mRNA	PMID:27188386
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of UPF1 protein	PMID:38598786
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313947	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of UPF1 mRNA	PMID:28973697
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1313947	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of UPF1 mRNA	PMID:35537566
1313946	UPF1	UPF1 RNA helicase and ATPase	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1589127	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of UPF1 mRNA	PMID:23034163
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1305739	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ADAM23 mRNA	PMID:30071829
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313950	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ADAM23 mRNA	PMID:20188158
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:142921	3-phenylprop-2-enal	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased expression of ADAM23 mRNA	PMID:19524605
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ADAM23 mRNA	PMID:21934132|PMID:23724009
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of ADAM23 mRNA	PMID:16604517
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313950	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAM23 mRNA	PMID:36331819
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ADAM23 mRNA	PMID:22378314
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of ADAM23 mRNA	PMID:29018328
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ADAM23 mRNA	PMID:30510588
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305739	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ADAM23 mRNA	PMID:32145629
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ADAM23 mRNA	PMID:30165855
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1313950	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ADAM23 mRNA	PMID:33711761
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305739	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ADAM23 gene	PMID:27618143
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ADAM23 mRNA	PMID:22401849
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ADAM23 mRNA	PMID:31163220
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305739	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ADAM23 mRNA	PMID:28522335
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of ADAM23 mRNA	PMID:39984025
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ADAM23 gene; Aflatoxin B1 results in decreased methylation of ADAM23 intron	PMID:27153756|PMID:30157460
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ADAM23 mRNA	PMID:17484886
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1305739	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of ADAM23 gene	PMID:35440735
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ADAM23 mRNA	PMID:28960355
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305739	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ADAM23 mRNA	PMID:31881176
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:27889	lead(0)	increases methylation	ISO	RGD:1313950	E	RGD:6480464	20250311	CTD	MESH:D007854	Lead results in increased methylation of ADAM23 gene	PMID:38833407
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ADAM23 mRNA	PMID:27392435
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ADAM23 mRNA	PMID:27392435
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of ADAM23 promoter	PMID:22847954
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313950	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADAM23 mRNA	PMID:26377647
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADAM23 mRNA	PMID:19933214
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305739	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADAM23 mRNA	PMID:32109520
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305739	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ADAM23 mRNA	PMID:28959563
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAM23 mRNA	PMID:34032870
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of ADAM23 mRNA	PMID:17127020
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADAM23 mRNA	PMID:22316170
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ADAM23 mRNA	PMID:20713471|PMID:32417428
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADAM23 promoter	PMID:27901495
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313950	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADAM23 gene	PMID:35295148
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305739	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ADAM23 mRNA	PMID:34492290
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of ADAM23 mRNA	PMID:18648102
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ADAM23 mRNA	PMID:18648102
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305739	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ADAM23 mRNA	PMID:25181051|PMID:32145629
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305739	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAM23 mRNA	PMID:30816183
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAM23 mRNA	PMID:32156529
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305739	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of ADAM23 mRNA	PMID:29097150
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313950	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of ADAM23 mRNA	PMID:38701888
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ADAM23 gene	PMID:31601247
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ADAM23 mRNA	PMID:40203079
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ADAM23 intron	PMID:30157460
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1305739	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ADAM23 protein	PMID:34058248
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313950	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ADAM23 mRNA	PMID:37019170
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313950	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ADAM23 mRNA	PMID:24535843
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305739	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ADAM23 gene	PMID:22079235
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ADAM23 mRNA	PMID:19320972
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of ADAM23 promoter	PMID:22847954
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of ADAM23 promoter	PMID:22847954
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313950	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ADAM23 mRNA	PMID:39529242
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313950	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAM23 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ADAM23 mRNA	PMID:36331819
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ADAM23 mRNA	PMID:24383497
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ADAM23 mRNA	PMID:28973697
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313950	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ADAM23 mRNA	PMID:17562736
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305739	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ADAM23 mRNA	PMID:33387578
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313950	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ADAM23 mRNA	PMID:35436446
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305739	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ADAM23 mRNA	PMID:29097150
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305739	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ADAM23 mRNA	PMID:30307764
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313950	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ADAM23 mRNA; Nanotubes, Carbon results in increased expression of ADAM23 mRNA	PMID:25620056
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ADAM23 intron	PMID:30157460
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305739	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ADAM23 gene	PMID:35440735
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ADAM23 mRNA	PMID:31758290
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1305739	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ADAM23 mRNA	PMID:27567155
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313950	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ADAM23 mRNA	PMID:22206623
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ADAM23 mRNA	PMID:30928695
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313950	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ADAM23 mRNA	PMID:23091169
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313950	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of ADAM23 mRNA	PMID:24535843
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1313950	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ADAM23 mRNA	PMID:31388691
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1313950	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ADAM23 mRNA	PMID:27935865
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in increased expression of ADAM23 mRNA	PMID:25572481
1313949	ADAM23	ADAM metallopeptidase domain 23	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305739	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of ADAM23 gene	PMID:31682807
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CYBRD1 mRNA	PMID:27188386
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313952	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CYBRD1 mRNA	PMID:33045310
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:15379	dioxygen	affects methylation	ISO	RGD:1313952	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency affects the methylation of CYBRD1 promoter	PMID:24205000
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1313952	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CYBRD1 mRNA	PMID:24205000
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CYBRD1 mRNA	PMID:30529165
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305740	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of CYBRD1 gene	PMID:35440735
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CYBRD1 mRNA	PMID:22378314
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1313952	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CYBRD1 mRNA	PMID:30319688
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313952	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CYBRD1 mRNA	PMID:30319688
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CYBRD1 mRNA	PMID:29432896
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305740	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CYBRD1 mRNA	PMID:27523638
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305740	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CYBRD1 mRNA	PMID:26577399
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305740	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CYBRD1 mRNA	PMID:33387578
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CYBRD1 intron	PMID:30157460
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:18248	iron atom	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D007501	Iron results in decreased expression of CYBRD1 protein	PMID:18815723
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D007501	Iron results in increased expression of CYBRD1 protein	PMID:18815723
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:1305740	E	RGD:6480464	20150512	CTD	MESH:D007501	Iron deficiency results in increased expression of CYBRD1 mRNA	PMID:16629162|PMID:19821111|PMID:21540277|PMID:23814049
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:1313952	E	RGD:6480464	20150609	CTD	MESH:D007501	Iron deficiency results in increased expression of CYBRD1 mRNA	PMID:23776592
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20260113	CTD	MESH:D002104	Cadmium results in decreased expression of CYBRD1 mRNA	PMID:37505606
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1305740	E	RGD:6480464	20250114	CTD	MESH:D002104	Cadmium results in increased expression of CYBRD1 mRNA	PMID:39025289
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYBRD1 mRNA	PMID:32645461
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20200915	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYBRD1 mRNA	PMID:32645461
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CYBRD1 intron	PMID:30157460
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CYBRD1 mRNA	PMID:34911549
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C040641	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA	PMID:27424125
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of CYBRD1 mRNA	PMID:26272509
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYBRD1 mRNA	PMID:27188386
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CYBRD1 mRNA	PMID:27594783
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CYBRD1 mRNA	PMID:27392435
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1313952	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of CYBRD1 mRNA	PMID:32186404
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D019833	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA	PMID:27424125
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CYBRD1 mRNA	PMID:23195993|PMID:24768652|PMID:25583101
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CYBRD1 mRNA	PMID:22298810
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CYBRD1 mRNA	PMID:17101203
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305740	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CYBRD1 mRNA	PMID:33387578
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CYBRD1 mRNA	PMID:28213091
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:28197	daidzein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C004742	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA	PMID:27424125
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305740	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper deficiency results in increased expression of CYBRD1 mRNA	PMID:19821111
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1313952	E	RGD:6480464	20151110	CTD	MESH:D003300	Copper deficiency results in increased expression of CYBRD1 mRNA; Copper deficiency results in increased expression of CYBRD1 protein	PMID:23555700
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20151110	CTD	MESH:D003300	EPAS1 gene mutant form inhibits the reaction [Copper deficiency results in increased expression of CYBRD1 mRNA]	PMID:23555700
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of CYBRD1 mRNA	PMID:29803840
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CYBRD1 mRNA	PMID:29432896
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:29073	L-ascorbic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D001205	Ascorbic Acid results in decreased expression of CYBRD1 protein	PMID:18815723
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:29073	L-ascorbic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D001205	Ascorbic Acid results in increased expression of CYBRD1 protein	PMID:18815723
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CYBRD1 mRNA	PMID:34032870|PMID:38568856|PMID:39719251
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of CYBRD1 mRNA	PMID:39232337
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20250805	CTD	MESH:C017947	Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in decreased expression of CYBRD1 mRNA]	PMID:39232337
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305740	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper deficiency results in increased expression of CYBRD1 mRNA	PMID:19821111
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1313952	E	RGD:6480464	20151110	CTD	MESH:D003300	Copper deficiency results in increased expression of CYBRD1 mRNA; Copper deficiency results in increased expression of CYBRD1 protein	PMID:23555700
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20151110	CTD	MESH:D003300	EPAS1 gene mutant form inhibits the reaction [Copper deficiency results in increased expression of CYBRD1 mRNA]	PMID:23555700
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CYBRD1 mRNA	PMID:39716349
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CYBRD1 mRNA	PMID:15761015
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:31856	mithramycin	decreases expression	ISO	RGD:1305740	E	RGD:6480464	20150512	CTD	MESH:D008926	Plicamycin results in decreased expression of CYBRD1 mRNA	PMID:23814049
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:31856	mithramycin	multiple interactions	ISO	RGD:1305740	E	RGD:6480464	20150512	CTD	MESH:D008926	Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of CYBRD1 mRNA]	PMID:23814049
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of CYBRD1 mRNA	PMID:27760801
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313952	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CYBRD1 gene	PMID:35295148
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1305740	E	RGD:6480464	20140812	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of CYBRD1 mRNA	PMID:24418189
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:33007	chromium(6+)	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20140812	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of CYBRD1 mRNA	PMID:24418189
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305740	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CYBRD1 mRNA	PMID:34947998
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CYBRD1 gene	PMID:31601247
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of CYBRD1 mRNA; bisphenol A results in increased expression of CYBRD1 protein	PMID:29275510|PMID:34186270
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305740	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CYBRD1 mRNA	PMID:25181051
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313952	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of CYBRD1 mRNA	PMID:32156529
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313952	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of CYBRD1 mRNA	PMID:26682919
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:34283	oxybenzone	increases expression	ISO	RGD:1305740	E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of CYBRD1 mRNA	PMID:30316929
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1305740	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CYBRD1 mRNA	PMID:23196670
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313952	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CYBRD1 exon	PMID:33297965
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CYBRD1 protein	PMID:34186270
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CYBRD1 protein	PMID:34186270
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313952	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CYBRD1 3' UTR	PMID:28392331
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313952	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CYBRD1 mRNA	PMID:21266533
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:34778	glycitein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C086566	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA	PMID:27424125
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305740	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of CYBRD1 mRNA	PMID:32680482
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CYBRD1 mRNA	PMID:37042841
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYBRD1 mRNA	PMID:32645461
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20200915	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYBRD1 mRNA	PMID:32645461
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305740	E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in increased expression of CYBRD1 mRNA	PMID:23814049
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1305740	E	RGD:6480464	20150512	CTD	MESH:C018021	Plicamycin inhibits the reaction [cobaltous chloride results in increased expression of CYBRD1 mRNA]	PMID:23814049
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313952	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CYBRD1 mRNA	PMID:40194260
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CYBRD1 mRNA	PMID:31533062
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1313952	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of CYBRD1 mRNA	PMID:39529242
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1305740	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of CYBRD1 mRNA	PMID:22561333
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1313952	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of CYBRD1 mRNA	PMID:22155349
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CYBRD1 mRNA	PMID:25979313
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of CYBRD1 mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CYBRD1 mRNA	PMID:23179753|PMID:26272509|PMID:27188386
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313952	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of CYBRD1 mRNA	PMID:24896083
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYBRD1 mRNA	PMID:27188386
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C013908	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA	PMID:27424125
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CYBRD1 mRNA	PMID:38832940
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of CYBRD1 mRNA	PMID:24935251
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305740	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CYBRD1 mRNA	PMID:33387578
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1305740	E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of CYBRD1 mRNA	PMID:37567419
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of CYBRD1 mRNA	PMID:38568856
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CYBRD1 mRNA	PMID:39716349
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CYBRD1 mRNA	PMID:15761015
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CYBRD1 mRNA; Nanotubes, Carbon results in decreased expression of CYBRD1 mRNA	PMID:25554681
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313952	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of CYBRD1 mRNA	PMID:40234311
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CYBRD1 mRNA	PMID:31758290
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CYBRD1 protein	PMID:34186270
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313952	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CYBRD1 mRNA	PMID:22206623
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:78492	diallyl trisulfide	increases expression	ISO	RGD:1305740	E	RGD:6480464	20240604	CTD	MESH:C042577	diallyl trisulfide results in increased expression of CYBRD1 mRNA	PMID:34014027
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYBRD1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYBRD1 mRNA	PMID:27188386
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CYBRD1 gene]	PMID:28238834
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:80373	glycitin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C433283	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CYBRD1 mRNA	PMID:27424125
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:82664	iron(0)	decreases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron results in decreased expression of CYBRD1 protein	PMID:18815723
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron results in increased expression of CYBRD1 protein	PMID:18815723
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:1305740	E	RGD:6480464	20150512	CTD	MESH:D007501	Iron deficiency results in increased expression of CYBRD1 mRNA	PMID:16629162|PMID:19821111|PMID:21540277|PMID:23814049
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:1313952	E	RGD:6480464	20150609	CTD	MESH:D007501	Iron deficiency results in increased expression of CYBRD1 mRNA	PMID:23776592
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305740	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CYBRD1 mRNA	PMID:24780913
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYBRD1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYBRD1 mRNA	PMID:27188386
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:9410	taurodeoxycholic acid	multiple interactions	ISO	RGD:1313952	E	RGD:6480464	20250805	CTD	MESH:D013657	Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in decreased expression of CYBRD1 mRNA]	PMID:39232337
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CYBRD1 mRNA	PMID:38568856
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305740	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CYBRD1 mRNA	PMID:19015723
1313951	CYBRD1	cytochrome b reductase 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305740	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of CYBRD1 mRNA	PMID:23034163
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TIA1 mRNA	PMID:38218311
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305742	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of TIA1 mRNA	PMID:21551480
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TIA1 mRNA	PMID:33045310
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of TIA1 mRNA	PMID:16166294
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TIA1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TIA1 mRNA	PMID:32699268
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of TIA1 mRNA	PMID:29432896
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TIA1 mRNA	PMID:21179406
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TIA1 mRNA	PMID:21632981
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TIA1 mRNA	PMID:39241906
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of TIA1 mRNA	PMID:31614463
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313956	E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in increased expression of TIA1 mRNA	PMID:22467019
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TIA1 mRNA	PMID:25510870
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TIA1 mRNA	PMID:38568856
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:16610	spermidine	multiple interactions	ISO	RGD:1305742	E	RGD:6480464	20130122	CTD	MESH:D013095	Spermidine inhibits the reaction [Pentanoic Acids affects the localization of TIA1 protein]	PMID:22555848
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TIA1 mRNA	PMID:37042841
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TIA1 mRNA	PMID:23649840
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TIA1 mRNA	PMID:21179406
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:17148	putrescine	multiple interactions	ISO	RGD:1305742	E	RGD:6480464	20130122	CTD	MESH:D011700	[ODC1 protein results in increased abundance of Putrescine] which affects the localization of TIA1 protein; Pentanoic Acids inhibits the reaction [[ODC1 protein results in increased abundance of Putrescine] which affects the localization of TIA1 protein]; Putrescine inhibits the reaction [Pentanoic Acids affects the localization of TIA1 protein]	PMID:22555848
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1313956	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TIA1 mRNA	PMID:33754040|PMID:34319233
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305742	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TIA1 mRNA	PMID:33387578
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TIA1 mRNA	PMID:28818685
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:18170	selenic acid	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D064586	Selenic Acid promotes the reaction [TUBA4A protein binds to TIA1 protein]	PMID:31585128
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIA1 mRNA	PMID:39836092
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of TIA1 mRNA	PMID:27462272
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIA1 mRNA	PMID:35301059
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIA1 mRNA	PMID:37236586
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TIA1 mRNA	PMID:25510870
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TIA1 mRNA	PMID:25510870
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:23643	depsipeptide	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D047630	[decitabine co-treated with Depsipeptides] results in decreased expression of TIA1 mRNA	PMID:17064661
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TIA1 gene	PMID:27153756
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313956	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TIA1 mRNA	PMID:19770486
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TIA1 mRNA	PMID:23649840
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TIA1 mRNA	PMID:23649840
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TIA1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TIA1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TIA1 mRNA	PMID:32699268
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:27363	zinc atom	affects binding	ISO	RGD:1313956	E	RGD:6480464	20220510	CTD	MESH:D015032	Zinc binds to TIA1 protein	PMID:29298433
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TIA1 mRNA	PMID:25629700
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIA1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TIA1 mRNA	PMID:39836092
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TIA1 mRNA	PMID:19244175
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of TIA1 mRNA	PMID:19244175
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:27585	selenomethionine	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D012645	Selenomethionine promotes the reaction [TUBA4A protein binds to TIA1 protein]	PMID:31585128
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1305742	E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [sodium arsenite affects the localization of TIA1 protein]; TIA1 mutant form inhibits the reaction [Pentanoic Acids results in decreased susceptibility to [TNF protein co-treated with Cycloheximide]]; TIA1 mutant form inhibits the reaction [sodium arsenite results in decreased susceptibility to [TNF protein co-treated with Cycloheximide]]	PMID:19171178|PMID:22555848
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:27690	acetazolamide	increases expression	ISO	RGD:1313956	E	RGD:6480464	20120717	CTD	MESH:D000086	Acetazolamide results in increased expression of TIA1 mRNA	PMID:19274763
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of TIA1 mRNA	PMID:28903495
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of TIA1 mRNA	PMID:15256057
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313956	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TIA1 mRNA	PMID:21570461
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305742	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TIA1 mRNA	PMID:33387578
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of TIA1 protein	PMID:39603559
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TIA1 mRNA	PMID:28001369
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TIA1 mRNA	PMID:33212167
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305742	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TIA1 mRNA	PMID:30556269
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TIA1 mRNA	PMID:20971185
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of TIA1 mRNA	PMID:16404146|PMID:29803840
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of TIA1 mRNA	PMID:25523186
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	affects localization	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the localization of TIA1 protein	PMID:16951406
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	affects localization	ISO	RGD:1305742	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the localization of TIA1 protein	PMID:19171178
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of TIA1 mRNA	PMID:28595984|PMID:34032870|PMID:38568856
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1313956	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of TIA1 gene	PMID:39894169
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIA1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TIA1 mRNA; EIF2A protein mutant form inhibits the reaction [sodium arsenite affects the localization of TIA1 protein]; sodium arsenite promotes the reaction [AGO2 protein binds to TIA1 protein]	PMID:16951406|PMID:30404558|PMID:39836092
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1305742	E	RGD:6480464	20161228	CTD	MESH:C017947	Cycloheximide inhibits the reaction [sodium arsenite affects the localization of TIA1 protein]; sodium arsenite promotes the reaction [TIA1 protein binds to ELAV1 protein binds to DYNLL2 protein]; TIA1 mutant form inhibits the reaction [sodium arsenite results in decreased susceptibility to [TNF protein co-treated with Cycloheximide]]	PMID:19171178|PMID:22555848
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite promotes the reaction [ELAVL1 protein binds to TIA1 protein]; sodium arsenite promotes the reaction [TARDBP protein binds to TIA1 protein]; sodium arsenite promotes the reaction [TIA1 protein binds to and affects the localization of GRIA2 mRNA]; sodium arsenite promotes the reaction [TIA1 protein binds to and affects the localization of YBX1 protein]	PMID:19765185|PMID:24231679
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TIA1 mRNA	PMID:26238291
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313956	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TIA1 mRNA	PMID:19770486
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to TIA1 protein]	PMID:32406909
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of TIA1 mRNA	PMID:25523186
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305742	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TIA1 mRNA	PMID:30556269
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TIA1 mRNA	PMID:20971185
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:30185	zinc(0)	affects binding	ISO	RGD:1313956	E	RGD:6480464	20220510	CTD	MESH:D015032	Zinc binds to TIA1 protein	PMID:29298433
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TIA1 mRNA	PMID:19073995
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TIA1 mRNA	PMID:20018196|PMID:26238291
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305742	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TIA1 mRNA	PMID:30047161
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TIA1 mRNA	PMID:30903817
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TIA1 mRNA; bisphenol A results in decreased expression of TIA1 protein	PMID:29275510|PMID:33376534
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TIA1 mRNA	PMID:32156529
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305742	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TIA1 mRNA	PMID:25181051|PMID:27571134
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of TIA1 mRNA	PMID:19244175
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of TIA1 mRNA	PMID:19244175
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TIA1 mRNA	PMID:25510870
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TIA1 mRNA	PMID:25510870
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TIA1 mRNA	PMID:40203079
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TIA1 mRNA	PMID:28628672
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TIA1 mRNA	PMID:38685157
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TIA1 mRNA	PMID:17361019|PMID:21266533
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TIA1 mRNA	PMID:28628672
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305742	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of TIA1 mRNA	PMID:22546817
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of TIA1 mRNA	PMID:17312168
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:34905	paraquat	affects splicing	ISO	RGD:1313956	E	RGD:6480464	20171114	CTD	MESH:D010269	Paraquat affects the splicing of TIA1 exon	PMID:27111068
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20171114	CTD	MESH:D010269	Paraquat results in decreased expression of TIA1 protein	PMID:27111068
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TIA1 mRNA	PMID:37042841
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIA1 mRNA	PMID:39836092
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TIA1 mRNA	PMID:38174414
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIA1 mRNA	PMID:35301059
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIA1 mRNA	PMID:37236586
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TIA1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TIA1 mRNA	PMID:32699268
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TIA1 mRNA	PMID:19244175
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of TIA1 mRNA	PMID:19244175
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TIA1 mRNA	PMID:28302478
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TIA1 mRNA	PMID:31533062
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TIA1 mRNA	PMID:25979313
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305742	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of TIA1 mRNA	PMID:29427782
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of TIA1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of TIA1 mRNA	PMID:21427059
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIA1 mRNA	PMID:27188386
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305742	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TIA1 mRNA	PMID:30047161
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TIA1 mRNA	PMID:25562108|PMID:27989131
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TIA1 mRNA	PMID:28628672
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1313956	E	RGD:6480464	20121009	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of TIA1 mRNA	PMID:22467019
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:45863	paclitaxel	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	TIA1 protein affects the susceptibility to Paclitaxel	PMID:16217747
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of TIA1 mRNA	PMID:26272509
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIA1 mRNA	PMID:27188386
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313956	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TIA1 mRNA	PMID:17562736
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TIA1 mRNA	PMID:21420995
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305742	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TIA1 mRNA	PMID:33387578
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIA1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TIA1 mRNA	PMID:39836092
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:4781	emetine	multiple interactions	ISO	RGD:1313956	E	RGD:6480464	20120412	CTD	MESH:D004640	Emetine affects the reaction [TARDBP protein binds to TIA1 protein]	PMID:19765185
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TIA1 mRNA	PMID:22079256
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TIA1 mRNA	PMID:35436446
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:48843	disodium selenite	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D018038	Sodium Selenite promotes the reaction [TUBA4A protein binds to TIA1 protein]	PMID:31585128
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TIA1 mRNA	PMID:28628672
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with Depsipeptides] results in decreased expression of TIA1 mRNA	PMID:17064661
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305742	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of TIA1 mRNA	PMID:30307764
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305742	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TIA1 mRNA	PMID:30047161
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:50729	mitoxantrone	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	TIA1 protein affects the susceptibility to Mitoxantrone	PMID:16217747
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of TIA1 mRNA	PMID:31629900
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TIA1 protein	PMID:32959892
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305742	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of TIA1 mRNA	PMID:20080153
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIA1 mRNA	PMID:39836092
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	TIA1 protein affects the susceptibility to Topotecan	PMID:16217747
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of TIA1 mRNA	PMID:19812364
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:63933	Aroclor 1254	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TIA1 mRNA	PMID:16934159
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TIA1 mRNA	PMID:23650126
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of TIA1 mRNA	PMID:15336504
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1313956	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of TIA1 mRNA	PMID:27462272
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TIA1 mRNA	PMID:31758290
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313956	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TIA1 mRNA	PMID:22206623
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of TIA1 protein	PMID:37664457
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:75175	3',5'-cyclic UMP	affects binding	EXP		E	RGD:6480464	20220405	CTD	MESH:C045338	TIA1 protein binds to cyclic 3',5'-uridine monophosphate	PMID:30528433
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TIA1 mRNA	PMID:22079256
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TIA1 mRNA	PMID:22079256
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIA1 mRNA	PMID:27188386
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313956	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TIA1 mRNA	PMID:23091169
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1305742	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of TIA1 mRNA	PMID:32109520
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of TIA1 protein	PMID:38348393
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313956	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of TIA1 mRNA	PMID:21795629
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305742	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TIA1 mRNA	PMID:30047161
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1313956	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of TIA1 mRNA	PMID:40826991
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of TIA1 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIA1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIA1 mRNA	PMID:27188386|PMID:37664457
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305742	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of TIA1 mRNA	PMID:19281266
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:94646	N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C034161	flupirtine results in decreased expression of TIA1 protein	PMID:9804146
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TIA1 mRNA	PMID:38568856
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305742	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of TIA1 mRNA	PMID:19015723
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305742	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of TIA1 mRNA	PMID:22570695
1313955	TIA1	TIA1 cytotoxic granule associated RNA binding protein	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305742	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of TIA1 mRNA	PMID:20566332
1313957	RCOR1	REST corepressor 1	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of RCOR1 mRNA	PMID:31863870
1313957	RCOR1	REST corepressor 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:7505493	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of RCOR1 mRNA	PMID:25152437
1313957	RCOR1	REST corepressor 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:7505493	E	RGD:6480464	20140729	CTD	MESH:D004237	Diuron results in increased expression of RCOR1 mRNA	PMID:21551480
1313957	RCOR1	REST corepressor 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of RCOR1 protein	PMID:39571964
1313957	RCOR1	REST corepressor 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D010100	[KDM1A protein binds to RCOR1 protein] promotes the reaction [Oxygen deficiency results in decreased expression of MLH1 mRNA]; [KDM1A protein binds to RCOR1 protein] promotes the reaction [Oxygen deficiency results in decreased expression of MLH1 protein]; [KDM1A protein binds to RCOR1 protein] promotes the reaction [Oxygen deficiency results in increased methylation of MLH1 promoter]; RCOR1 protein promotes the reaction [Oxygen deficiency results in increased methylation of MLH1 promoter]	PMID:25043185
1313957	RCOR1	REST corepressor 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:7505493	E	RGD:6480464	20140729	CTD	MESH:D004958	Estradiol results in decreased expression of RCOR1 mRNA	PMID:20068009|PMID:32145629
1313957	RCOR1	REST corepressor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550294	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RCOR1 mRNA	PMID:39298647
1313957	RCOR1	REST corepressor 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D004958	Estradiol inhibits the reaction [TNF protein inhibits the reaction [RCOR1 protein binds to IL6 promoter]]; RCOR1 mutant form inhibits the reaction [Estradiol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]	PMID:24771768
1313957	RCOR1	REST corepressor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RCOR1 mRNA	PMID:37042841
1313957	RCOR1	REST corepressor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550294	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RCOR1 mRNA	PMID:33754040
1313957	RCOR1	REST corepressor 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RCOR1 protein	PMID:37730182
1313957	RCOR1	REST corepressor 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:7505493	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RCOR1 mRNA	PMID:33387578
1313957	RCOR1	REST corepressor 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:7505493	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of RCOR1 mRNA	PMID:22061828
1313957	RCOR1	REST corepressor 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RCOR1 mRNA	PMID:28818685
1313957	RCOR1	REST corepressor 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:7505493	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of RCOR1 protein	PMID:34915118
1313957	RCOR1	REST corepressor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550294	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RCOR1 mRNA	PMID:37236586
1313957	RCOR1	REST corepressor 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RCOR1 mRNA	PMID:41430723
1313957	RCOR1	REST corepressor 1	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RCOR1 mRNA	PMID:21867686
1313957	RCOR1	REST corepressor 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550294	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RCOR1 mRNA	PMID:25629700
1313957	RCOR1	REST corepressor 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RCOR1 protein	PMID:35688186
1313957	RCOR1	REST corepressor 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:C059514	[TNF protein co-treated with resveratrol] promotes the reaction [RCOR1 protein binds to IL6 promoter]; fulvestrant inhibits the reaction [[TNF protein co-treated with resveratrol] promotes the reaction [RCOR1 protein binds to IL6 promoter]]; RCOR1 mutant form inhibits the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; resveratrol inhibits the reaction [TNF protein inhibits the reaction [RCOR1 protein binds to IL6 promoter]]	PMID:24771768
1313957	RCOR1	REST corepressor 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of RCOR1 mRNA	PMID:27594783
1313957	RCOR1	REST corepressor 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550294	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RCOR1 mRNA	PMID:30912803
1313957	RCOR1	REST corepressor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550294	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RCOR1 mRNA	PMID:16611356|PMID:20702594|PMID:21570461|PMID:24680724
1313957	RCOR1	REST corepressor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:7505493	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RCOR1 mRNA	PMID:33387578
1313957	RCOR1	REST corepressor 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RCOR1 mRNA	PMID:33212167
1313957	RCOR1	REST corepressor 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1550294	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of RCOR1 protein	PMID:28918527
1313957	RCOR1	REST corepressor 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RCOR1 mRNA	PMID:29803840
1313957	RCOR1	REST corepressor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of RCOR1 protein	PMID:38228842
1313957	RCOR1	REST corepressor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in decreased expression of RCOR1 protein	PMID:39571964
1313957	RCOR1	REST corepressor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1550294	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RCOR1 intron	PMID:27901495
1313957	RCOR1	REST corepressor 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RCOR1 mRNA]	PMID:32406909
1313957	RCOR1	REST corepressor 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RCOR1 mRNA	PMID:19150397|PMID:20382639
1313957	RCOR1	REST corepressor 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RCOR1 gene; Fulvestrant inhibits the reaction [[TNF protein co-treated with Resveratrol] promotes the reaction [RCOR1 protein binds to IL6 promoter]]	PMID:24771768|PMID:31601247
1313957	RCOR1	REST corepressor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550294	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RCOR1 gene; titanium dioxide results in decreased methylation of RCOR1 promoter	PMID:35295148
1313957	RCOR1	REST corepressor 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550294	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RCOR1 gene	PMID:35295148
1313957	RCOR1	REST corepressor 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:7505493	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RCOR1 mRNA	PMID:34492290
1313957	RCOR1	REST corepressor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:7505493	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of RCOR1 mRNA	PMID:32145629
1313957	RCOR1	REST corepressor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:7505493	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RCOR1 mRNA	PMID:25181051
1313957	RCOR1	REST corepressor 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:7505493	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RCOR1 gene	PMID:28505145
1313957	RCOR1	REST corepressor 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RCOR1 gene	PMID:31601247
1313957	RCOR1	REST corepressor 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of RCOR1 protein	PMID:31675489
1313957	RCOR1	REST corepressor 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550294	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RCOR1 mRNA	PMID:38685157
1313957	RCOR1	REST corepressor 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RCOR1 mRNA	PMID:37042841
1313957	RCOR1	REST corepressor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550294	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RCOR1 mRNA	PMID:37236586
1313957	RCOR1	REST corepressor 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RCOR1 protein	PMID:26879310
1313957	RCOR1	REST corepressor 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RCOR1 mRNA	PMID:24449571
1313957	RCOR1	REST corepressor 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550294	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of RCOR1 mRNA	PMID:23811191
1313957	RCOR1	REST corepressor 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of RCOR1 mRNA	PMID:28302478
1313957	RCOR1	REST corepressor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RCOR1 mRNA	PMID:40419075
1313957	RCOR1	REST corepressor 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in increased expression of RCOR1 mRNA	PMID:23527032
1313957	RCOR1	REST corepressor 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RCOR1 gene	PMID:29154799
1313957	RCOR1	REST corepressor 1	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RCOR1 mRNA	PMID:14699072
1313957	RCOR1	REST corepressor 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RCOR1 mRNA	PMID:38832940
1313957	RCOR1	REST corepressor 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550294	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RCOR1 mRNA	PMID:17562736
1313957	RCOR1	REST corepressor 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:7505493	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RCOR1 mRNA	PMID:33387578
1313957	RCOR1	REST corepressor 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RCOR1 mRNA	PMID:22230336|PMID:29067470
1313957	RCOR1	REST corepressor 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of RCOR1 mRNA	PMID:31675489
1313957	RCOR1	REST corepressor 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:7505493	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of RCOR1 mRNA	PMID:24793618
1313957	RCOR1	REST corepressor 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RCOR1 protein	PMID:32959892
1313957	RCOR1	REST corepressor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550294	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RCOR1 mRNA	PMID:22206623
1313957	RCOR1	REST corepressor 1	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of RCOR1 protein	PMID:31285264
1313957	RCOR1	REST corepressor 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:7505493	E	RGD:6480464	20140729	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of RCOR1 mRNA	PMID:21346803
1313957	RCOR1	REST corepressor 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550294	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of RCOR1 mRNA	PMID:23091169
1313957	RCOR1	REST corepressor 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1550294	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of RCOR1 mRNA	PMID:19270015
1313957	RCOR1	REST corepressor 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1550294	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of RCOR1 mRNA	PMID:20702594
1313957	RCOR1	REST corepressor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RCOR1 protein	PMID:31675489
1313957	RCOR1	REST corepressor 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550294	E	RGD:6480464	20171114	CTD	MESH:C009277	sodium arsenate results in increased expression of RCOR1 mRNA	PMID:27751817|PMID:30953684
1313957	RCOR1	REST corepressor 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:7505493	E	RGD:6480464	20140729	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RCOR1 mRNA	PMID:21346803
1313957	RCOR1	REST corepressor 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RCOR1 mRNA	PMID:38568856
1313957	RCOR1	REST corepressor 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550294	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of RCOR1 mRNA	PMID:28973697
1313957	RCOR1	REST corepressor 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:7505493	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of RCOR1 mRNA	PMID:18042343
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of STAC mRNA	PMID:26079696
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305745	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of STAC gene	PMID:28931070
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305745	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of STAC mRNA	PMID:33387578
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of STAC mRNA	PMID:21179406
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305745	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of STAC mRNA	PMID:26496021
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1313961	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of STAC mRNA	PMID:36706583
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of STAC mRNA	PMID:23825647
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313961	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of STAC mRNA	PMID:27405655
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of STAC mRNA	PMID:26485663
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of STAC intron	PMID:30157460
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of STAC mRNA	PMID:23825647
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:232796	cadmium acetate	increases expression	EXP		E	RGD:6480464	20250107	CTD	MESH:C028031	cadmium acetate results in increased expression of STAC mRNA	PMID:18155341
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of STAC gene; Aflatoxin B1 results in decreased methylation of STAC intron	PMID:27153756|PMID:30157460
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313961	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of STAC mRNA	PMID:25629700
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of STAC mRNA	PMID:40512198
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of STAC mRNA	PMID:41028656
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of STAC mRNA	PMID:27392435
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of STAC mRNA	PMID:27392435
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305745	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of STAC mRNA	PMID:26033743
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of STAC mRNA	PMID:41028656
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1305745	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of STAC mRNA	PMID:26033743
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:28876	melphalan	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of STAC mRNA	PMID:22363485
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of STAC mRNA	PMID:29301061|PMID:39719251
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of STAC mRNA	PMID:40512198
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STAC intron	PMID:30157460
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STAC mRNA	PMID:32234424
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313961	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STAC mRNA	PMID:22228805
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of STAC exon; Benzo(a)pyrene results in increased methylation of STAC promoter	PMID:27901495
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313961	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to STAC promoter]	PMID:19654925
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305745	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of STAC mRNA	PMID:26033743
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of STAC mRNA	PMID:41028656
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1305745	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of STAC mRNA	PMID:26033743
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313961	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of STAC mRNA	PMID:27131904
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of STAC mRNA	PMID:38568856
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305745	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of STAC mRNA	PMID:30047161
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305745	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of STAC mRNA	PMID:30816183
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305745	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STAC mRNA	PMID:25181051
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of STAC gene	PMID:31601247
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305745	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of STAC mRNA	PMID:26496021
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of STAC mRNA	PMID:25979313
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313961	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of STAC mRNA	PMID:18353800
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:3764	clotrimazole	increases expression	ISO	RGD:1305745	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of STAC mRNA	PMID:30047161
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of STAC mRNA	PMID:32588087
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STAC mRNA	PMID:25979313
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of STAC gene	PMID:29154799
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305745	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of STAC mRNA	PMID:30047161
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of STAC mRNA	PMID:20106945
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of STAC mRNA	PMID:27188386
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in increased expression of STAC mRNA	PMID:27188386
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of STAC mRNA	PMID:29067470
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of STAC mRNA	PMID:40512198
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305745	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of STAC mRNA	PMID:29391264
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of STAC mRNA	PMID:38825487
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of STAC mRNA	PMID:22714537
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of STAC mRNA	PMID:31758290
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305745	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of STAC mRNA	PMID:33484710
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to STAC gene]	PMID:28238834
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305745	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of STAC mRNA	PMID:30047161
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305745	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of STAC mRNA	PMID:24780913
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305745	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of STAC mRNA	PMID:30047161
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1313961	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in increased expression of STAC mRNA	PMID:36706583
1313960	STAC	SH3 and cysteine rich domain	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313961	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of STAC mRNA	PMID:27131904
1313962	DPEP2	dipeptidase 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of DPEP2 mRNA	PMID:35967413
1313962	DPEP2	dipeptidase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313963	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DPEP2 mRNA	PMID:33045310
1313962	DPEP2	dipeptidase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313963	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of DPEP2 mRNA	PMID:26251327
1313962	DPEP2	dipeptidase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DPEP2 mRNA	PMID:19619570
1313962	DPEP2	dipeptidase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DPEP2 mRNA	PMID:19619570
1313962	DPEP2	dipeptidase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305746	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DPEP2 mRNA	PMID:32741896
1313962	DPEP2	dipeptidase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DPEP2 mRNA	PMID:37042841
1313962	DPEP2	dipeptidase 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313963	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in increased expression of DPEP2 mRNA	PMID:31525975
1313962	DPEP2	dipeptidase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313963	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of DPEP2 mRNA	PMID:22401849
1313962	DPEP2	dipeptidase 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305746	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DPEP2 mRNA	PMID:32741896
1313962	DPEP2	dipeptidase 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313963	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in increased expression of DPEP2 mRNA	PMID:31525975
1313962	DPEP2	dipeptidase 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305746	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of DPEP2 mRNA	PMID:22061828|PMID:33387578
1313962	DPEP2	dipeptidase 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DPEP2 mRNA	PMID:28818685
1313962	DPEP2	dipeptidase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313963	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DPEP2 mRNA	PMID:37325564
1313962	DPEP2	dipeptidase 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1313963	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DPEP2 mRNA	PMID:29950665
1313962	DPEP2	dipeptidase 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DPEP2 mRNA	PMID:35430440
1313962	DPEP2	dipeptidase 2	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305746	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of DPEP2 mRNA	PMID:30779732
1313962	DPEP2	dipeptidase 2	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305746	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of DPEP2 mRNA	PMID:31129395
1313962	DPEP2	dipeptidase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1313963	E	RGD:6480464	20260303	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DPEP2 mRNA	PMID:40389097
1313962	DPEP2	dipeptidase 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305746	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DPEP2 mRNA	PMID:31881176
1313962	DPEP2	dipeptidase 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313963	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of DPEP2 mRNA	PMID:40618947
1313962	DPEP2	dipeptidase 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of DPEP2 mRNA	PMID:25583101
1313962	DPEP2	dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313963	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DPEP2 mRNA	PMID:26377647
1313962	DPEP2	dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DPEP2 mRNA	PMID:19619570
1313962	DPEP2	dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DPEP2 mRNA	PMID:19619570
1313962	DPEP2	dipeptidase 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305746	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of DPEP2 mRNA	PMID:28959563
1313962	DPEP2	dipeptidase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313963	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of DPEP2 mRNA	PMID:37682722
1313962	DPEP2	dipeptidase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DPEP2 mRNA	PMID:38568856
1313962	DPEP2	dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DPEP2 promoter	PMID:27901495
1313962	DPEP2	dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1305746	E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DPEP2 mRNA	PMID:30085273
1313962	DPEP2	dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313963	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DPEP2 mRNA	PMID:22228805
1313962	DPEP2	dipeptidase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of DPEP2 gene	PMID:31601247
1313962	DPEP2	dipeptidase 2	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305746	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of DPEP2 mRNA	PMID:25729387
1313962	DPEP2	dipeptidase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305746	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DPEP2 mRNA	PMID:25729387
1313962	DPEP2	dipeptidase 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1313963	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DPEP2 mRNA	PMID:29950665
1313962	DPEP2	dipeptidase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305746	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DPEP2 mRNA	PMID:25181051|PMID:34947998
1313962	DPEP2	dipeptidase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305746	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DPEP2 mRNA	PMID:30816183|PMID:32528016
1313962	DPEP2	dipeptidase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305746	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of DPEP2 mRNA	PMID:31129395
1313962	DPEP2	dipeptidase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1313963	E	RGD:6480464	20230207	CTD	MESH:C006780	[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of DPEP2 protein	PMID:35999755
1313962	DPEP2	dipeptidase 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1305746	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of DPEP2 mRNA	PMID:23196670
1313962	DPEP2	dipeptidase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of DPEP2 gene	PMID:31601247
1313962	DPEP2	dipeptidase 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313963	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of DPEP2 mRNA	PMID:26377693
1313962	DPEP2	dipeptidase 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1313963	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of DPEP2 intron	PMID:28392331
1313962	DPEP2	dipeptidase 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1313963	E	RGD:6480464	20190702	CTD	MESH:D016264	[Dextran Sulfate co-treated with bisphenol A] results in decreased expression of DPEP2 protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DPEP2 mRNA	PMID:29950665|PMID:35999755
1313962	DPEP2	dipeptidase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DPEP2 mRNA	PMID:37042841
1313962	DPEP2	dipeptidase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313963	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DPEP2 mRNA	PMID:37325564
1313962	DPEP2	dipeptidase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313963	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DPEP2 mRNA	PMID:40194260
1313962	DPEP2	dipeptidase 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313963	E	RGD:6480464	20191210	CTD	MESH:D005947	Glucose results in increased expression of DPEP2 mRNA	PMID:31525975
1313962	DPEP2	dipeptidase 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305746	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DPEP2 mRNA	PMID:33387578
1313962	DPEP2	dipeptidase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313963	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DPEP2 mRNA; Nanotubes, Carbon results in increased expression of DPEP2 mRNA	PMID:25554681
1313962	DPEP2	dipeptidase 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313963	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of DPEP2 mRNA	PMID:40234311
1313962	DPEP2	dipeptidase 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313963	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of DPEP2 mRNA	PMID:38701926
1313962	DPEP2	dipeptidase 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305746	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of DPEP2 mRNA	PMID:28801915
1313962	DPEP2	dipeptidase 2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305746	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of DPEP2 mRNA	PMID:25729387
1313962	DPEP2	dipeptidase 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305746	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DPEP2 mRNA	PMID:25729387
1313962	DPEP2	dipeptidase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305746	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of DPEP2 mRNA	PMID:28801915
1313962	DPEP2	dipeptidase 2	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305746	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of DPEP2 mRNA	PMID:35283115
1313962	DPEP2	dipeptidase 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305746	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DPEP2 mRNA	PMID:32741896
1313962	DPEP2	dipeptidase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DPEP2 gene]	PMID:28238834
1313962	DPEP2	dipeptidase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313963	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DPEP2 mRNA	PMID:38648751
1313962	DPEP2	dipeptidase 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DPEP2 mRNA	PMID:38568856
1313962	DPEP2	dipeptidase 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of DPEP2 mRNA	PMID:29301935
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:10022	deoxynivalenol	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20180116	CTD	MESH:C007262	[deoxynivalenol results in increased susceptibility to Antigens] which results in increased expression of STAT4 mRNA	PMID:28935500
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of STAT4 mRNA	PMID:20938992
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20250401	CTD	MESH:D011794	[Quercetin co-treated with Lipopolysaccharides] results in decreased expression of STAT4 mRNA; Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT4 protein]	PMID:38823456
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of STAT4 mRNA	PMID:35811015
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:16412	lipopolysaccharide	increases phosphorylation	ISO	RGD:1313965	E	RGD:6480464	20250401	CTD	MESH:D008070	Lipopolysaccharides results in increased phosphorylation of STAT4 protein	PMID:38823456
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STAT4 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of STAT4 mRNA	PMID:35811015
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20161228	CTD	MESH:D008070	[Quercetin co-treated with Lipopolysaccharides] results in decreased expression of STAT4 mRNA; chlorophyllin inhibits the reaction [Lipopolysaccharides results in increased activity of STAT4 protein]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT4 protein]	PMID:16275627|PMID:38823456
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of STAT4 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of STAT4 mRNA	PMID:20404318|PMID:30165855
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of STAT4 mRNA	PMID:20938992
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of STAT4 mRNA	PMID:16188087|PMID:19162166|PMID:20036648
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20140408	CTD	MESH:D008550	Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA]	PMID:23963992
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of STAT4 mRNA	PMID:26079696
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1313965	E	RGD:6480464	20120613	CTD	MESH:D014050	Toluene results in increased expression of STAT4 mRNA	PMID:21601613
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305747	E	RGD:6480464	20220816	CTD	MESH:D005839	Gentamicins results in increased expression of STAT4 mRNA	PMID:22061828
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:232141	chlorophyllin	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20241119	CTD	MESH:C007020	chlorophyllin inhibits the reaction [Lipopolysaccharides results in increased activity of STAT4 protein]	PMID:16275627
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1305747	E	RGD:6480464	20220816	CTD	MESH:D000157	Aconitine results in increased expression of STAT4 protein	PMID:33236894
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1305747	E	RGD:6480464	20220816	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of STAT4 mRNA	PMID:19480007
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of STAT4 mRNA	PMID:41430723
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of STAT4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of STAT4 mRNA	PMID:34911549
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:27363	zinc atom	increases activity	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased activity of STAT4 protein	PMID:18356318
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of STAT4 mRNA	PMID:20938992
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of STAT4 promoter	PMID:21291286
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of STAT4 mRNA	PMID:40512198
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STAT4 mRNA	PMID:40504410
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:2762	antimycin A	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of STAT4 mRNA	PMID:33512557
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305747	E	RGD:6480464	20220816	CTD	MESH:C030686	acetamide results in increased expression of STAT4 mRNA	PMID:31881176
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of STAT4 mRNA	PMID:41028656
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of STAT4 mRNA	PMID:27392435
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of STAT4 mRNA	PMID:27392435
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1313965	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of STAT4 mRNA	PMID:32186404
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of STAT4 mRNA	PMID:25583101
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313965	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STAT4 mRNA	PMID:24058054
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of STAT4 mRNA	PMID:18684927|PMID:37172768
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases phosphorylation	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased phosphorylation of STAT4 protein	PMID:18684927
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STAT4 mRNA	PMID:17942748
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of STAT4 mRNA	PMID:33512557
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of STAT4 mRNA	PMID:33212167
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305747	E	RGD:6480464	20220816	CTD	MESH:D020106	Acrylamide results in increased expression of STAT4 mRNA	PMID:28959563
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of STAT4 mRNA	PMID:41028656
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of STAT4 mRNA	PMID:29803840
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313965	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of STAT4 mRNA	PMID:36227756
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of STAT4 mRNA	PMID:29301061|PMID:39900124
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of STAT4 mRNA	PMID:40512198
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STAT4 mRNA	PMID:40504410
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STAT4 3' UTR	PMID:27901495
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:29865	benzo[a]pyrene	affects response to substance	EXP		E	RGD:6480464	20200317	CTD	MESH:D001564	STAT4 gene SNP affects the susceptibility to Benzo(a)pyrene	PMID:28807506
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of STAT4 promoter	PMID:27901495
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STAT4 mRNA	PMID:32234424
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313965	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STAT4 mRNA	PMID:22228805
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of STAT4 mRNA	PMID:41028656
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:30185	zinc(0)	increases activity	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased activity of STAT4 protein	PMID:18356318
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of STAT4 mRNA	PMID:25895662
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313965	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of STAT4 mRNA	PMID:29341224
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to STAT4 protein]	PMID:26598702
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1305747	E	RGD:6480464	20220816	CTD	MESH:D000643	Ammonium Chloride affects the expression of STAT4 mRNA	PMID:16483693
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313965	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of STAT4 mRNA	PMID:29264374|PMID:32333507
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305747	E	RGD:6480464	20220816	CTD	MESH:D013853	Thioacetamide results in increased expression of STAT4 mRNA	PMID:34492290
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1313965	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of STAT4 promoter	PMID:27334623
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305747	E	RGD:6480464	20220816	CTD	MESH:C006780	bisphenol A results in decreased expression of STAT4 mRNA	PMID:25181051|PMID:27178563
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305747	E	RGD:6480464	20220816	CTD	MESH:C006780	bisphenol A results in increased expression of STAT4 mRNA	PMID:34947998|PMID:41034487
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1305747	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of STAT4 mRNA	PMID:21241498
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of STAT4 mRNA	PMID:17374397
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20140408	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA]; Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA]	PMID:23963992
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of STAT4 mRNA	PMID:37042841
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of STAT4 mRNA	PMID:38568856
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:35549	perfluorooctanoic acid	increases activity	EXP		E	RGD:6480464	20170207	CTD	MESH:C023036	perfluorooctanoic acid results in increased activity of STAT4 protein	PMID:27589886
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of STAT4 mRNA	PMID:36326898
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1313965	E	RGD:6480464	20230207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of STAT4 protein	PMID:36214631|PMID:37422089
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313965	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of STAT4 mRNA	PMID:40194260
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of STAT4 mRNA	PMID:31533062
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1313965	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of STAT4 mRNA	PMID:29038090
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin promotes the reaction [IFNB1 protein results in increased phosphorylation of STAT4 protein]	PMID:17979888
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STAT4 mRNA	PMID:25979313
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of STAT4 mRNA	PMID:26272509
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of STAT4 mRNA	PMID:24935251
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STAT4 mRNA	PMID:27188386
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of STAT4 mRNA	PMID:27989131
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D016572	Cyclosporine results in increased expression of STAT4 mRNA	PMID:33631201
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1305747	E	RGD:6480464	20220816	CTD	MESH:C017160	cypermethrin results in decreased expression of STAT4 mRNA	PMID:22528246
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1313965	E	RGD:6480464	20211012	CTD	MESH:C017160	cypermethrin results in decreased expression of STAT4 mRNA	PMID:31659573
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20211012	CTD	MESH:C017160	Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of STAT4 mRNA]	PMID:31659573
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of STAT4 mRNA	PMID:33512557
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of STAT4 mRNA	PMID:33512557
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of STAT4 mRNA	PMID:17400583
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of STAT4 mRNA	PMID:38832940
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:4469	(S)-amphetamine	decreases expression	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D003913	Dextroamphetamine results in decreased expression of STAT4 mRNA	PMID:12205029
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:4469	(S)-amphetamine	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D003913	SOD1 inhibits the reaction [Dextroamphetamine results in decreased expression of STAT4 mRNA]	PMID:12205029
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of STAT4 mRNA	PMID:24935251
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of STAT4 mRNA	PMID:26690555
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STAT4 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of STAT4 mRNA	PMID:35811015
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of STAT4 mRNA	PMID:18687144
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of STAT4 mRNA	PMID:24160326
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of STAT4 promoter	PMID:21291286
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of STAT4 mRNA	PMID:40512198
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STAT4 mRNA	PMID:40504410
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:47381	diclofenac	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D004008	Diclofenac results in decreased expression of STAT4 mRNA	PMID:19192274
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of STAT4 mRNA	PMID:18175754
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:48843	disodium selenite	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20211012	CTD	MESH:D018038	Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of STAT4 mRNA]	PMID:31659573
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of STAT4 mRNA	PMID:17555576
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STAT4 mRNA	PMID:17942748
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:4917	eugenol	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D005054	Eugenol results in increased expression of STAT4 mRNA	PMID:17374397
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to STAT4 protein]	PMID:26598702
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases response to substance	ISO	RGD:1313965	E	RGD:6480464	20120412	CTD	MESH:D008770	STAT4 gene mutant form results in increased susceptibility to Methylnitrosourea	PMID:11418001
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313965	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of STAT4 mRNA	PMID:25554681
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20140408	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA; Melatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA]; Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of STAT4 mRNA]	PMID:23963992
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:52646	leptomycin B	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:C038753	leptomycin B affects the localization of STAT4 protein	PMID:15004198
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C029938	nickel sulfate results in increased expression of STAT4 mRNA	PMID:16780908|PMID:17374397
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313965	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of STAT4 mRNA	PMID:19042947
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313965	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of STAT4 mRNA	PMID:38701926
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:59132	antigen	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20180116	CTD	MESH:D000941	[deoxynivalenol results in increased susceptibility to Antigens] which results in increased expression of STAT4 mRNA; [ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of STAT4 mRNA	PMID:28935500
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:6888	6alpha-methylprednisolone	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008775	Methylprednisolone results in decreased expression of STAT4 mRNA	PMID:19192274
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313965	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of STAT4 mRNA	PMID:22206623
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1313965	E	RGD:6480464	20180116	CTD	MESH:C025589	[ochratoxin A results in increased susceptibility to Antigens] which results in increased expression of STAT4 mRNA	PMID:28935500
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STAT4 mRNA	PMID:27188386
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:8107	phenytoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010672	Phenytoin results in decreased expression of STAT4 mRNA	PMID:14741686
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D010894	Piroxicam results in decreased expression of STAT4 mRNA	PMID:19192274
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of STAT4 mRNA	PMID:33512557
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:8378	prednisolone	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D011239	Prednisolone results in decreased expression of STAT4 mRNA	PMID:19192274
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STAT4 mRNA	PMID:27188386
1313964	STAT4	signal transducer and activator of transcription 4	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305747	E	RGD:6480464	20220816	CTD	MESH:C025643	vinclozolin results in increased methylation of STAT4 gene	PMID:31682807
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1587375	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of EXT1 mRNA	PMID:25152437
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of EXT1 mRNA	PMID:33167477
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of EXT1 mRNA	PMID:22378314
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1313967	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of EXT1 mRNA	PMID:30319688
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EXT1 mRNA	PMID:35811015
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of EXT1 mRNA	PMID:19167446
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313967	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EXT1 mRNA	PMID:39298647
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of EXT1 mRNA	PMID:38568856
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EXT1 mRNA	PMID:37042841
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of EXT1 mRNA	PMID:20655997
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313967	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of EXT1 mRNA	PMID:33754040
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1587375	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of EXT1 mRNA	PMID:26577399
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1587375	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of EXT1 mRNA	PMID:22061828|PMID:33387578
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of EXT1 mRNA	PMID:28818685
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EXT1 mRNA	PMID:35301059
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:232105	dicyclanil	increases expression	ISO	RGD:1313967	E	RGD:6480464	20241119	CTD	MESH:C121718	dicyclanil results in increased expression of EXT1 mRNA	PMID:15664270
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of EXT1 mRNA	PMID:19549813
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:234430	gardiquimod	increases expression	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in increased expression of EXT1 mRNA	PMID:28003376
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:234430	gardiquimod	multiple interactions	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of EXT1 mRNA]	PMID:28003376
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EXT1 gene	PMID:27153756
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20240109	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the methylation of EXT1 gene	PMID:35835166
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of EXT1 mRNA	PMID:18593933
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EXT1 gene	PMID:25304211
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of EXT1 mRNA	PMID:19244175
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of EXT1 mRNA	PMID:19561079
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of EXT1 mRNA	PMID:27392435
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313967	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EXT1 mRNA	PMID:21570461|PMID:24680724
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313967	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EXT1 mRNA	PMID:17942748
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EXT1 mRNA	PMID:33212167
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of EXT1 mRNA	PMID:23649840
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D004317	Doxorubicin results in decreased expression of EXT1 mRNA	PMID:38447685
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313967	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of EXT1 mRNA	PMID:19073829
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EXT1 mRNA	PMID:29432896
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1313967	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite affects the methylation of EXT1 gene	PMID:39894169
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of EXT1 mRNA	PMID:12634122
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EXT1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313967	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EXT1 mRNA	PMID:19770486
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1313967	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EXT1 intron	PMID:27901495
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EXT1 promoter	PMID:27901495
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of EXT1 mRNA	PMID:18593933
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of EXT1 mRNA	PMID:20382639
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of EXT1 mRNA	PMID:19150397
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1587375	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of EXT1 mRNA	PMID:25729387
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313967	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EXT1 gene; titanium dioxide results in decreased methylation of EXT1 promoter	PMID:35295148
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1587375	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of EXT1 mRNA	PMID:34947998|PMID:41034487
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of EXT1 gene	PMID:31601247
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of EXT1 mRNA	PMID:29275510
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313967	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in increased expression of EXT1 mRNA	PMID:21932408
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1587375	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EXT1 mRNA	PMID:25181051|PMID:30816183
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of EXT1 mRNA	PMID:19244175
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of EXT1 mRNA	PMID:19244175
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313967	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of EXT1 mRNA	PMID:21266533
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1587375	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of EXT1 mRNA	PMID:21266533
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313967	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of EXT1 mRNA	PMID:34813904
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1313967	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of EXT1 mRNA	PMID:34813904
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313967	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of EXT1 mRNA	PMID:36117858
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EXT1 mRNA	PMID:35301059
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EXT1 mRNA	PMID:19320972
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of EXT1 mRNA	PMID:19244175
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of EXT1 mRNA]	PMID:28003376
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of EXT1 mRNA	PMID:31533062
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of EXT1 mRNA	PMID:19167446
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXT1 mRNA	PMID:19167446
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of EXT1 mRNA	PMID:40419075
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of EXT1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of EXT1 gene	PMID:29154799
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EXT1 mRNA	PMID:23179753|PMID:28001369
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXT1 mRNA	PMID:27188386
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1587375	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of EXT1 mRNA	PMID:30047161
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of EXT1 mRNA	PMID:27989131
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313967	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of EXT1 mRNA	PMID:28973697
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1587375	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of EXT1 mRNA	PMID:24136188
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of EXT1 mRNA	PMID:38832940
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of EXT1 mRNA	PMID:24935251|PMID:26272509
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXT1 mRNA	PMID:27188386
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313967	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EXT1 mRNA	PMID:17562736
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of EXT1 mRNA	PMID:21420995
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of EXT1 mRNA	PMID:29067470
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1587375	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EXT1 mRNA	PMID:33387578
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EXT1 mRNA	PMID:35811015
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EXT1 gene	PMID:25304211
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1587375	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of EXT1 mRNA	PMID:29391264
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313967	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EXT1 mRNA	PMID:17942748
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313967	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of EXT1 mRNA; Nanotubes, Carbon results in increased expression of EXT1 mRNA	PMID:25554681
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1587375	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of EXT1 mRNA	PMID:30047161
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313967	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of EXT1 mRNA	PMID:36117858
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1587375	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of EXT1 mRNA	PMID:25729387
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1587375	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of EXT1 mRNA	PMID:25729387
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of EXT1 mRNA	PMID:28988120
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:68641	(-)-cotinine	affects methylation	EXP		E	RGD:6480464	20160822	CTD	MESH:D003367	Cotinine affects the methylation of EXT1 gene	PMID:22851337
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:69355	casticin	increases expression	ISO	RGD:1313967	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in increased expression of EXT1 mRNA	PMID:28444820
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of EXT1 mRNA	PMID:31758290
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313967	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of EXT1 mRNA	PMID:22206623
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:77012	methylseleninic acid	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of EXT1 mRNA	PMID:18548127
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXT1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXT1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXT1 mRNA	PMID:27188386
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EXT1 gene]	PMID:28238834
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:80025	Salinomycin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of EXT1 mRNA	PMID:19682730
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:81555	Enterolactone	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of EXT1 mRNA	PMID:19167446
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EXT1 mRNA	PMID:19167446
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1313967	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of EXT1 mRNA	PMID:31558096
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of EXT1 mRNA	PMID:33512557
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of EXT1 mRNA	PMID:35688559
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1587375	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of EXT1 mRNA	PMID:30047161
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1587375	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of EXT1 mRNA	PMID:30047161
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of EXT1 mRNA	PMID:26272509
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXT1 mRNA	PMID:27188386
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1313967	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of EXT1 protein	PMID:35357534
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXT1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXT1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EXT1 mRNA	PMID:27188386
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1587375	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of EXT1 mRNA	PMID:19281266
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of EXT1 mRNA	PMID:38568856
1313966	EXT1	exostosin glycosyltransferase 1	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1587375	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of EXT1 gene	PMID:31682807
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of ZDHHC21 mRNA	PMID:26272509|PMID:27188386
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZDHHC21 mRNA	PMID:27188386
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1313970	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ZDHHC21 mRNA	PMID:33045310
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of ZDHHC21 mRNA	PMID:31016361
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313970	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ZDHHC21 mRNA	PMID:20188158
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:142921	3-phenylprop-2-enal	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased expression of ZDHHC21 mRNA	PMID:19524605
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313970	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZDHHC21 gene	PMID:20938992
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of ZDHHC21 mRNA	PMID:23724009
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ZDHHC21 mRNA	PMID:21632981
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313970	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZDHHC21 mRNA	PMID:39241906
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ZDHHC21 mRNA	PMID:30165855
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313970	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZDHHC21 gene	PMID:20938992
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1313970	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of ZDHHC21 mRNA	PMID:23892564
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305750	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZDHHC21 mRNA	PMID:33387578
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ZDHHC21 mRNA	PMID:39836092
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZDHHC21 mRNA	PMID:35301059
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZDHHC21 gene	PMID:27153756
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ZDHHC21 mRNA	PMID:23649840
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305750	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZDHHC21 mRNA	PMID:30779732
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313970	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZDHHC21 gene	PMID:20938992
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313970	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZDHHC21 mRNA	PMID:21570461
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305750	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZDHHC21 mRNA	PMID:33387578
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ZDHHC21 mRNA	PMID:28001369
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZDHHC21 mRNA	PMID:33212167
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ZDHHC21 mRNA	PMID:30851411
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ZDHHC21 mRNA	PMID:32763439
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZDHHC21 mRNA	PMID:29803840
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of ZDHHC21 mRNA	PMID:34032870|PMID:38568856
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZDHHC21 promoter	PMID:27901495
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:30563	silicon dioxide	increases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased methylation of ZDHHC21 promoter	PMID:34973136
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313970	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZDHHC21 gene	PMID:35295148
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313970	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZDHHC21 promoter	PMID:35295148
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313970	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ZDHHC21 mRNA	PMID:28472532
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:33146	vanadyl sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C034028	vanadyl sulfate results in decreased expression of ZDHHC21 mRNA	PMID:16330358
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of ZDHHC21 mRNA	PMID:31715268
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305750	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZDHHC21 mRNA	PMID:25181051
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305750	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of ZDHHC21 mRNA	PMID:29097150|PMID:30816183
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ZDHHC21 mRNA	PMID:28628672
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305750	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:36041667
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:28628672
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305750	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:36041667
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313970	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ZDHHC21 mRNA	PMID:38685157
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305750	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:36041667
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1305750	E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZDHHC21 mRNA	PMID:18668222
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ZDHHC21 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:28628672
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZDHHC21 mRNA	PMID:37042841
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ZDHHC21 mRNA	PMID:39836092
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZDHHC21 mRNA	PMID:35301059
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305750	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ZDHHC21 mRNA	PMID:25539665
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ZDHHC21 mRNA	PMID:19320972
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ZDHHC21 mRNA	PMID:24449571
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1305750	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ZDHHC21 mRNA	PMID:23125180
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZDHHC21 mRNA	PMID:23179753|PMID:25979313
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305750	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of ZDHHC21 mRNA	PMID:29427782
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305750	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZDHHC21 mRNA	PMID:29427782
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZDHHC21 gene	PMID:29154799
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ZDHHC21 mRNA	PMID:24383497
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZDHHC21 mRNA	PMID:25562108
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ZDHHC21 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:28628672
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ZDHHC21 mRNA	PMID:27188386
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313970	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZDHHC21 mRNA	PMID:17562736
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305750	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZDHHC21 mRNA	PMID:33387578
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305750	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ZDHHC21 mRNA	PMID:29097150
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ZDHHC21 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ZDHHC21 mRNA	PMID:28628672
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313970	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ZDHHC21 mRNA	PMID:25554681
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of ZDHHC21 mRNA	PMID:22714537
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ZDHHC21 mRNA	PMID:39836092
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZDHHC21 mRNA	PMID:26378955
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313970	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZDHHC21 mRNA	PMID:22206623
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ZDHHC21 mRNA	PMID:30851411
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZDHHC21 mRNA	PMID:27188386
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of ZDHHC21 mRNA	PMID:18927307
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313970	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ZDHHC21 mRNA	PMID:21795629
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1305750	E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of ZDHHC21 mRNA	PMID:26923065
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZDHHC21 mRNA	PMID:27188386
1313969	ZDHHC21	zDHHC palmitoyltransferase 21	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305750	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of ZDHHC21 mRNA	PMID:23034163
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1313973	E	RGD:6480464	20230404	CTD	MESH:D015025	Zearalenone results in decreased expression of PSMD2 protein	PMID:36252740
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PSMD2 mRNA	PMID:38218311
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:149906	Tanshinone I	increases expression	EXP		E	RGD:6480464	20200602	CTD	MESH:C021751	tanshinone results in increased expression of PSMD2 mRNA	PMID:15849732
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of PSMD2 mRNA	PMID:32845096
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1313973	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of PSMD2 mRNA	PMID:40945087
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313973	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PSMD2 mRNA	PMID:30319688
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PSMD2 mRNA	PMID:21632981
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313973	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PSMD2 mRNA	PMID:39241906
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313973	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PSMD2 mRNA	PMID:39298647
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PSMD2 mRNA	PMID:30165855
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:16602	trichloroethene	affects expression	ISO	RGD:1313973	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene affects the expression of PSMD2 mRNA	PMID:21135412
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1313973	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of PSMD2 mRNA	PMID:17945193
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:17303	morphine	decreases expression	ISO	RGD:1305752	E	RGD:6480464	20130416	CTD	MESH:D009020	Morphine results in decreased expression of PSMD2 protein	PMID:23056601
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:17303	morphine	multiple interactions	ISO	RGD:1305752	E	RGD:6480464	20130416	CTD	MESH:D009020	Morphine deficiency inhibits the reaction [Morphine results in decreased expression of PSMD2 protein]	PMID:23056601
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1313973	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PSMD2 mRNA	PMID:33754040
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1305752	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PSMD2 mRNA	PMID:21318169
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PSMD2 protein	PMID:37730182
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD2 mRNA	PMID:35301059
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PSMD2 mRNA	PMID:19549813
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PSMD2 protein	PMID:23301498
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PSMD2 mRNA	PMID:22100608
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of PSMD2 mRNA	PMID:32845096
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of PSMD2 protein	PMID:38598786
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD2 mRNA	PMID:35809665
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313973	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD2 mRNA	PMID:40504410
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PSMD2 protein	PMID:35688186
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313973	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of PSMD2 protein	PMID:37208198
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PSMD2 mRNA	PMID:28903495
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of PSMD2 mRNA	PMID:19921347
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSMD2 mRNA	PMID:22574217
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313973	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSMD2 mRNA	PMID:21570461
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313973	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMD2 mRNA	PMID:17942748
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of PSMD2 mRNA	PMID:33512557
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305752	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of PSMD2 protein	PMID:35544339
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PSMD2 mRNA	PMID:33212167
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PSMD2 mRNA	PMID:30851411
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305752	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of PSMD2 protein	PMID:29459688
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of PSMD2 mRNA	PMID:34032870|PMID:38568856
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313973	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD2 mRNA	PMID:40504410
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PSMD2 exon	PMID:30157460
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PSMD2 3' UTR; Benzo(a)pyrene results in increased methylation of PSMD2 promoter	PMID:27901495
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:3016	Benoxacor	decreases expression	ISO	RGD:1313973	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in decreased expression of PSMD2 mRNA	PMID:34850242
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305752	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of PSMD2 mRNA	PMID:30047161
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313973	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PSMD2 mRNA	PMID:23811191
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:32687	piperonyl butoxide	increases expression	ISO	RGD:1305752	E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of PSMD2 mRNA	PMID:22484513
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305752	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PSMD2 mRNA	PMID:25181051
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305752	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PSMD2 gene	PMID:28505145
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305752	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PSMD2 mRNA	PMID:36041667
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of PSMD2 mRNA	PMID:19244175
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	affects expression	ISO	RGD:1305752	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT affects the expression of PSMD2 mRNA	PMID:17984292
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1305752	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of PSMD2 mRNA	PMID:24096037
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1313973	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of PSMD2 mRNA	PMID:24096037
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of PSMD2 protein	PMID:34186270
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313973	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PSMD2 mRNA	PMID:39298647
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PSMD2 mRNA	PMID:28628672
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305752	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PSMD2 mRNA	PMID:36041667
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1305752	E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PSMD2 protein	PMID:34896426
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313973	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of PSMD2 mRNA	PMID:38685157
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305752	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PSMD2 mRNA	PMID:36041667
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD2 protein	PMID:38598786
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PSMD2 mRNA	PMID:28628672
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PSMD2 mRNA	PMID:37042841
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1313973	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PSMD2 mRNA	PMID:18974090
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD2 mRNA	PMID:35301059
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1313973	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of PSMD2 mRNA	PMID:19429403
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PSMD2 protein	PMID:22609092
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305752	E	RGD:6480464	20120613	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of PSMD2 mRNA	PMID:19162173|PMID:21318169|PMID:30047161
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PSMD2 mRNA	PMID:19320972|PMID:19376846
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of PSMD2 protein	PMID:17152098
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone promotes the reaction [NDRG1 protein binds to PSMD2 protein]	PMID:17220478
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1305752	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of PSMD2 protein	PMID:34896426
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1313973	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of PSMD2 mRNA	PMID:19429403
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1313973	E	RGD:6480464	20130416	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PSMD2 mRNA	PMID:20936131
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1313973	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of PSMD2 mRNA	PMID:31558096
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PSMD2 mRNA	PMID:23179753
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1305752	E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in increased expression of PSMD2 mRNA	PMID:21318169
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305752	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of PSMD2 mRNA	PMID:30047161
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PSMD2 mRNA	PMID:20106945|PMID:25562108
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1305752	E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PSMD2 protein	PMID:34896426
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1305752	E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PSMD2 protein	PMID:34896426
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of PSMD2 mRNA	PMID:33512557
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PSMD2 mRNA	PMID:28628672
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305752	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of PSMD2 mRNA	PMID:24136188
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PSMD2 mRNA	PMID:38832940
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD2 mRNA	PMID:35809665
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313973	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD2 mRNA	PMID:40504410
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1313973	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of PSMD2 mRNA	PMID:26934552
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305752	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PSMD2 mRNA	PMID:24096037
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313973	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PSMD2 mRNA	PMID:24096037
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313973	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMD2 mRNA	PMID:17942748
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of PSMD2 mRNA	PMID:17211630
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of PSMD2 mRNA	PMID:28628672
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1305752	E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PSMD2 protein	PMID:34896426
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305752	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PSMD2 mRNA	PMID:24136188
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305752	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of PSMD2 mRNA	PMID:30047161
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305752	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PSMD2 mRNA	PMID:24136188
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313973	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PSMD2 mRNA	PMID:19042947
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PSMD2 protein	PMID:32959892
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305752	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of PSMD2 mRNA	PMID:24136188
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:63952	arsenic trichloride	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD2 mRNA	PMID:35809665
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305752	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of PSMD2 mRNA	PMID:24136188
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1305752	E	RGD:6480464	20211109	CTD	MESH:D007545	[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD2 mRNA	PMID:30303030
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PSMD2 protein	PMID:34186270
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313973	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PSMD2 mRNA	PMID:22206623
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:74926	patulin	increases expression	ISO	RGD:1313973	E	RGD:6480464	20221101	CTD	MESH:D010365	Patulin results in increased expression of PSMD2 mRNA	PMID:35367319
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:74926	patulin	multiple interactions	ISO	RGD:1313973	E	RGD:6480464	20221101	CTD	MESH:D010365	NFE2L1 protein affects the reaction [Patulin results in increased expression of PSMD2 mRNA]	PMID:35367319
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305752	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PSMD2 mRNA	PMID:24136188
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PSMD2 mRNA	PMID:31806706
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PSMD2 protein	PMID:31285264
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of PSMD2 protein	PMID:39638853
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of PSMD2 protein	PMID:39638853
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PSMD2 mRNA	PMID:30851411
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:79369	elesclomol	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C512195	elesclomol results in increased expression of PSMD2 mRNA	PMID:18723479
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313973	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PSMD2 mRNA	PMID:30294300
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of PSMD2 mRNA	PMID:33512557
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:8493	Propiverine	affects binding	ISO	RGD:1305752	E	RGD:6480464	20180410	CTD	MESH:C015586	propiverine binds to PSMD2 protein	PMID:29273565
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305752	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of PSMD2 mRNA	PMID:30047161
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PSMD2 mRNA	PMID:38568856
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of PSMD2 protein	PMID:38598786
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305752	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PSMD2 mRNA	PMID:21346803
1313972	PSMD2	proteasome 26S subunit ubiquitin receptor, non-ATPase 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305752	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PSMD2 mRNA	PMID:23034163
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZKSCAN3 mRNA	PMID:35811015
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZKSCAN3 mRNA	PMID:39241906
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ZKSCAN3 mRNA	PMID:35811015
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:16551	alpha,alpha-trehalose	increases expression	ISO	RGD:1614314	E	RGD:6480464	20210608	CTD	MESH:D014199	Trehalose results in increased expression of ZKSCAN3 mRNA	PMID:30335591
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZKSCAN3 mRNA	PMID:37042841
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of ZKSCAN3 mRNA	PMID:27462272
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1614314	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZKSCAN3 mRNA	PMID:37325564
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZKSCAN3 mRNA	PMID:19549813
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZKSCAN3 gene	PMID:27153756
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:27452	styrene	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20180116	CTD	MESH:D020058	Styrene results in decreased expression of ZKSCAN3 mRNA	PMID:28951217
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1305753	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of ZKSCAN3 mRNA	PMID:25905778
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:28053	melibiose	increases expression	ISO	RGD:1614314	E	RGD:6480464	20210608	CTD	MESH:D008553	Melibiose results in increased expression of ZKSCAN3 mRNA	PMID:30335591
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ZKSCAN3 mRNA	PMID:24768652
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614314	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZKSCAN3 mRNA	PMID:21570461|PMID:24058054
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZKSCAN3 mRNA	PMID:32763439
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614314	E	RGD:6480464	20131220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZKSCAN3 mRNA	PMID:22228805
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of ZKSCAN3 gene	PMID:31601247
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305753	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ZKSCAN3 mRNA	PMID:30047161
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614314	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZKSCAN3 gene; titanium dioxide results in decreased methylation of ZKSCAN3 promoter	PMID:35295148
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1614314	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of ZKSCAN3 mRNA	PMID:29264374
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:33146	vanadyl sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C034028	vanadyl sulfate results in increased expression of ZKSCAN3 mRNA	PMID:16330358
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ZKSCAN3 mRNA	PMID:32156529
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZKSCAN3 gene	PMID:31601247
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305753	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZKSCAN3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1614314	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZKSCAN3 mRNA	PMID:33221593|PMID:38074096
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of ZKSCAN3 gene	PMID:31601247
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ZKSCAN3 mRNA	PMID:38685157
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZKSCAN3 mRNA	PMID:37042841
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZKSCAN3 mRNA	PMID:38568856
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1614314	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZKSCAN3 mRNA	PMID:37325564
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ZKSCAN3 mRNA	PMID:40419075
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZKSCAN3 mRNA	PMID:25979313
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZKSCAN3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZKSCAN3 mRNA	PMID:27188386
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305753	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ZKSCAN3 mRNA	PMID:30047161
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZKSCAN3 mRNA	PMID:25562108
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1614314	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ZKSCAN3 mRNA	PMID:28973697
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of ZKSCAN3 mRNA	PMID:24449571
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305753	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of ZKSCAN3 mRNA	PMID:24136188
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ZKSCAN3 mRNA	PMID:24935251
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614314	E	RGD:6480464	20131220	CTD	MESH:D000082	Acetaminophen affects the expression of ZKSCAN3 mRNA	PMID:17562736
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:46345	5-fluorouracil	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	ZKSCAN3 protein results in decreased susceptibility to Fluorouracil	PMID:18519692
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ZKSCAN3 mRNA	PMID:35811015
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ZKSCAN3 mRNA	PMID:29279043
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ZKSCAN3 mRNA	PMID:35436446
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ZKSCAN3 mRNA	PMID:25554681
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1614314	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ZKSCAN3 mRNA	PMID:25620056
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305753	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ZKSCAN3 mRNA	PMID:30047161
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1614314	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of ZKSCAN3 mRNA	PMID:26377693
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:6359	lactulose	increases expression	ISO	RGD:1614314	E	RGD:6480464	20210608	CTD	MESH:D007792	Lactulose results in increased expression of ZKSCAN3 mRNA	PMID:30335591
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ZKSCAN3 mRNA	PMID:31758290
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305753	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ZKSCAN3 mRNA	PMID:24136188
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZKSCAN3 mRNA	PMID:27188386
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1614314	E	RGD:6480464	20131220	CTD	MESH:D010634	Phenobarbital affects the expression of ZKSCAN3 mRNA	PMID:23091169
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1614314	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ZKSCAN3 mRNA	PMID:21795629
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1305753	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of ZKSCAN3 mRNA	PMID:30047161
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305753	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZKSCAN3 mRNA	PMID:30047161
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZKSCAN3 mRNA	PMID:27188386
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305753	E	RGD:6480464	20131220	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ZKSCAN3 mRNA	PMID:21346803
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZKSCAN3 mRNA	PMID:29301935
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305753	E	RGD:6480464	20131220	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ZKSCAN3 mRNA	PMID:21346803
1313974	ZKSCAN3	zinc finger with KRAB and SCAN domains 3	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305753	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of ZKSCAN3 mRNA	PMID:18042343
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305754	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TTPAL mRNA]	PMID:31150632
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1313977	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TTPAL mRNA	PMID:20188158
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TTPAL mRNA	PMID:36331819
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of TTPAL mRNA	PMID:24763279
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TTPAL mRNA	PMID:22378314
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313977	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TTPAL mRNA	PMID:30319688
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313977	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TTPAL mRNA	PMID:39241906
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313977	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TTPAL mRNA	PMID:39298647
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of TTPAL mRNA	PMID:30165855
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305754	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of TTPAL mRNA	PMID:26496021
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TTPAL mRNA	PMID:37042841
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1313977	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of TTPAL mRNA	PMID:33848595
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of TTPAL mRNA]	PMID:33848595
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1313977	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of TTPAL gene	PMID:34319233
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305754	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of TTPAL mRNA	PMID:26577399
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305754	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TTPAL mRNA	PMID:22061828|PMID:33387578
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TTPAL mRNA	PMID:28818685
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TTPAL mRNA	PMID:36331819
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTPAL mRNA	PMID:28111341|PMID:37325564
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1313977	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TTPAL mRNA	PMID:19770486
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305754	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TTPAL mRNA	PMID:30779732
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305754	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TTPAL mRNA	PMID:31150632
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305754	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TTPAL mRNA]	PMID:31150632
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TTPAL gene	PMID:25304211
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTPAL mRNA	PMID:40504410
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313977	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TTPAL mRNA	PMID:28960355
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TTPAL mRNA	PMID:23557933
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313977	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTPAL mRNA	PMID:21570461
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TTPAL mRNA	PMID:25975270
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TTPAL mRNA	PMID:30851411
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305754	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TTPAL mRNA	PMID:28959563
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTPAL mRNA	PMID:38568856
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTPAL mRNA	PMID:40504410
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313977	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TTPAL mRNA	PMID:22228805
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TTPAL 5' UTR; Benzo(a)pyrene results in increased methylation of TTPAL promoter	PMID:27901495
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TTPAL mRNA	PMID:25351596
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TTPAL mRNA	PMID:19150397
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of TTPAL mRNA	PMID:34408198
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TTPAL mRNA	PMID:35984750
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1313977	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TTPAL mRNA	PMID:29264374
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313977	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TTPAL gene	PMID:35295148
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305754	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TTPAL mRNA	PMID:23411599|PMID:34492290
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TTPAL mRNA	PMID:19710929
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305754	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TTPAL mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313977	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TTPAL mRNA	PMID:26063408
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305754	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of TTPAL mRNA	PMID:26496021
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313977	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TTPAL mRNA	PMID:39298647
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTPAL mRNA	PMID:28628672
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of TTPAL gene	PMID:22964155
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTPAL mRNA	PMID:28628672
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TTPAL mRNA	PMID:37042841
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305754	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of TTPAL mRNA	PMID:30589522
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305754	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of TTPAL mRNA	PMID:35163327
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTPAL mRNA	PMID:28111341|PMID:37325564
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313977	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TTPAL mRNA	PMID:28903501
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TTPAL mRNA	PMID:24449571
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of TTPAL mRNA	PMID:28302478
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TTPAL mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TTPAL mRNA	PMID:36331819
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TTPAL mRNA	PMID:23179753
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TTPAL mRNA	PMID:25562108|PMID:27989131
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:41607	crotonaldehyde	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in decreased expression of TTPAL mRNA	PMID:20471460
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTPAL mRNA	PMID:28628672
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1313977	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TTPAL mRNA	PMID:28973697
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313977	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TTPAL mRNA	PMID:17562736
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TTPAL mRNA	PMID:22230336
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305754	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TTPAL mRNA	PMID:33387578
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TTPAL gene	PMID:25304211
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TTPAL mRNA	PMID:40504410
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of TTPAL mRNA	PMID:28628672
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313977	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TTPAL mRNA; Nanotubes, Carbon results in increased expression of TTPAL mRNA	PMID:25554681|PMID:25620056
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:50819	ferric oxide	decreases expression	ISO	RGD:1313977	E	RGD:6480464	20141223	CTD	MESH:C000499	ferric oxide analog results in decreased expression of TTPAL mRNA	PMID:25086211
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313977	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TTPAL mRNA	PMID:35964746
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of TTPAL mRNA	PMID:20977926
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of TTPAL mRNA	PMID:28988120
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:6809	methamphetamine	decreases methylation	ISO	RGD:1313977	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased methylation of TTPAL promoter	PMID:26307267
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1305754	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of TTPAL mRNA	PMID:23665939
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TTPAL mRNA	PMID:30851411
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TTPAL mRNA	PMID:38568856
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TTPAL mRNA	PMID:29301935
1313976	TTPAL	alpha tocopherol transfer protein like	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305754	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TTPAL mRNA	PMID:23034163
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:10101	zalcitabine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016047	Zalcitabine results in increased expression of TYMP protein	PMID:16457948
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:10110	zidovudine	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	Zidovudine results in increased activity of TYMP protein	PMID:16457948
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:10110	zidovudine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	Zidovudine results in increased expression of TYMP mRNA; Zidovudine results in increased expression of TYMP protein	PMID:16457948
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:10110	zidovudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	[5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] results in decreased susceptibility to [Zidovudine co-treated with doxifluridine]; [Zidovudine results in increased activity of TYMP protein] which results in increased susceptibility to doxifluridine	PMID:16457948
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:11563	2-deoxy-alpha-D-ribose 1-phosphate	increases abundance	EXP		E	RGD:6480464	20140805	CTD	MESH:C031302	TYMP protein results in increased abundance of 2-deoxyribose 1-phosphate	PMID:11103787
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of TYMP mRNA	PMID:15456535
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:15365	acetylsalicylic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TYMP mRNA]	PMID:14573775
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010100	[Thymidine co-treated with TYMP co-treated with Oxygen deficiency] results in increased expression of HIF1A protein	PMID:15841086
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of TYMP mRNA	PMID:15282401
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:15640	5-formyltetrahydrofolic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002955	TYMP mRNA affects the susceptibility to [irinotecan co-treated with Fluorouracil co-treated with Leucovorin]	PMID:17454858
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of TYMP mRNA	PMID:39506029
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TYMP mRNA	PMID:35811015
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TYMP mRNA]	PMID:35811015
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of TYMP mRNA	PMID:30510588
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305756	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of SCO2 mRNA; Estradiol affects the expression of TYMP mRNA	PMID:32145629
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313980	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TYMP mRNA	PMID:39298647
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of TYMP mRNA	PMID:38568856
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305756	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TYMP mRNA	PMID:33387578
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TYMP mRNA	PMID:18045764|PMID:23649840
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TYMP mRNA	PMID:37992649
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of TYMP mRNA	PMID:33359661
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of TYMP mRNA	PMID:21592394
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of TYMP mRNA	PMID:21592394
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:17579	beta-carotene	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20140909	CTD	MESH:D019207	[BCO1 protein affects the susceptibility to beta Carotene] which affects the expression of TYMP mRNA	PMID:24657404
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:175901	gemcitabine	affects response to substance	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	TYMP protein affects the susceptibility to Gemcitabine	PMID:18728667
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:175901	gemcitabine	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	[TYMP protein co-treated with DPYD protein] affects the susceptibility to Gemcitabine; TYMP protein affects the susceptibility to [Gemcitabine co-treated with Mitomycin]	PMID:18728667
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TYMP mRNA	PMID:37992649
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:17748	thymidine	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D013936	TYMP protein results in increased phosphorylation of Thymidine	PMID:11103787
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:17748	thymidine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013936	[Thymidine co-treated with TYMP co-treated with Oxygen deficiency] results in increased expression of HIF1A protein; [Thymidine co-treated with TYMP protein] results in increased expression of HMOX1 protein; [Thymidine co-treated with TYMP protein] results in increased expression of MMP1 protein; [Thymidine co-treated with TYMP protein] results in increased secretion of CXCL8 protein; [TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein; Acetylcysteine inhibits the reaction [[TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein]; Thymine inhibits the reaction [[Thymidine co-treated with TYMP protein] results in increased expression of MMP1 protein]; Thymine inhibits the reaction [[Thymidine co-treated with TYMP protein] results in increased secretion of CXCL8 protein]; Thymine inhibits the reaction [[TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein]	PMID:11103787|PMID:15841086
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305756	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TYMP mRNA	PMID:26577399
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:17821	thymine	increases abundance	EXP		E	RGD:6480464	20120412	CTD	MESH:D013941	TYMP protein results in increased abundance of Thymine	PMID:11103787
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:17821	thymine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013941	Thymine inhibits the reaction [[Thymidine co-treated with TYMP protein] results in increased expression of MMP1 protein]; Thymine inhibits the reaction [[Thymidine co-treated with TYMP protein] results in increased secretion of CXCL8 protein]; Thymine inhibits the reaction [[TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein]	PMID:11103787
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of TYMP mRNA	PMID:21592394
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of TYMP mRNA	PMID:21592394
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TYMP mRNA	PMID:36331819
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:19452	2-amino-4,6-dinitrotoluene	affects expression	ISO	RGD:1305756	E	RGD:6480464	20140304	CTD	MESH:C035208	2-amino-4,6-dinitrotoluene affects the expression of TYMP mRNA	PMID:21346803
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:2423	acetylleucyl-leucyl-norleucinal	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C063261	acetylleucyl-leucyl-norleucinal inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; acetylleucyl-leucyl-norleucinal inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]	PMID:21444628|PMID:30796972
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of TYMP mRNA	PMID:12763052
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of TYMP mRNA	PMID:35430440
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of TYMP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of TYMP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of TYMP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of TYMP protein	PMID:38598786
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TYMP mRNA	PMID:22206623
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:27504	mitomycin C	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	Mitomycin results in decreased expression of TYMP mRNA	PMID:16568373
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:27504	mitomycin C	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	TYMP protein affects the susceptibility to [Gemcitabine co-treated with Mitomycin]	PMID:18728667
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TYMP mRNA	PMID:19244175
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:27641	cycloheximide	decreases expression	EXP		E	RGD:6480464	20190702	CTD	MESH:D003513	Cycloheximide results in decreased expression of TYMP protein	PMID:30796972
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:D003513	salinomycin inhibits the reaction [Cycloheximide results in decreased expression of TYMP protein]; tanespimycin inhibits the reaction [salinomycin inhibits the reaction [Cycloheximide results in decreased expression of TYMP protein]]	PMID:30796972
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin inhibits the reaction [IFNA1 protein results in increased expression of TYMP mRNA]; Dactinomycin inhibits the reaction [IFNB1 protein results in increased expression of TYMP mRNA]; Dactinomycin inhibits the reaction [IFNG protein results in increased expression of TYMP mRNA]; Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]; tanespimycin inhibits the reaction [Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]]	PMID:15937643|PMID:30796972
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1305756	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of TYMP gene	PMID:31011160
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305756	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TYMP mRNA	PMID:31881176
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:27899	cisplatin	decreases degradation	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased degradation of TYMP protein	PMID:21444628
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of TYMP mRNA	PMID:16568373|PMID:27392435
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	TYMP protein results in decreased susceptibility to Cisplatin	PMID:21444628
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Curcumin results in decreased expression of TYMP protein] which results in increased susceptibility to Cisplatin; [Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein; [TYMP protein co-treated with DPYD protein] affects the susceptibility to Cisplatin; acetylleucyl-leucyl-norleucinal inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; TYMP inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; TYMP inhibits the reaction [Cisplatin results in increased activity of CASP9 protein]; TYMP protein inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; TYMP protein inhibits the reaction [Cisplatin results in increased activity of CASP9 protein]; U 0126 inhibits the reaction [Cisplatin results in decreased degradation of TYMP protein]	PMID:12565868|PMID:14727531|PMID:18728667|PMID:21444628|PMID:21493726
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TYMP mRNA	PMID:25583101
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305756	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TYMP mRNA	PMID:32109520
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TYMP mRNA	PMID:28922406
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305756	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TYMP mRNA	PMID:28374803
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:28445	vincristine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	TYMP inhibits the reaction [Vincristine results in increased phosphorylation of BCL2 protein]	PMID:15907805
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:28542	2-deoxy-D-ribofuranose 1-phosphate	increases abundance	EXP		E	RGD:6480464	20140805	CTD	MESH:C031302	TYMP protein results in increased abundance of 2-deoxyribose 1-phosphate	PMID:11103787
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:28584	gossypol	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D006072	Gossypol inhibits the reaction [zoledronic acid results in increased expression of TYMP mRNA]	PMID:19825521
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	[Doxorubicin co-treated with Cyclophosphamide] results in increased expression of TYMP protein	PMID:15150550
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TYMP mRNA	PMID:37992649
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[TYMP protein co-treated with Thymidine] results in increased expression of HMOX1 protein]	PMID:11103787
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:2930	aurothioglucose	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D006051	[Dexamethasone co-treated with Aurothioglucose] inhibits the reaction [IL1B protein results in increased expression of TYMP mRNA]	PMID:15990992
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TYMP mRNA	PMID:38568856|PMID:39719251
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TYMP protein	PMID:33278487
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TYMP 5' UTR; Benzo(a)pyrene results in increased methylation of TYMP exon; Benzo(a)pyrene results in increased methylation of TYMP promoter	PMID:27901495
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of TYMP mRNA	PMID:26014281
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TYMP mRNA	PMID:25351596
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to TYMP protein]	PMID:26598702
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TYMP mRNA	PMID:35984750
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1313980	E	RGD:6480464	20211207	CTD	MESH:D001761	Bleomycin results in increased expression of TYMP protein	PMID:30825431
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20211207	CTD	MESH:D001761	Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of TYMP protein]	PMID:30825431
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:31521	doxifluridine	affects expression	EXP		E	RGD:6480464	20130806	CTD	MESH:C025034	doxifluridine affects the expression of TYMP mRNA	PMID:18630517
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:31521	doxifluridine	increases metabolic processing	EXP		E	RGD:6480464	20130806	CTD	MESH:C025034	TYMP protein results in increased metabolism of doxifluridine	PMID:21804305
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:31521	doxifluridine	increases metabolic processing	ISO	RGD:1305756	E	RGD:6480464	20130806	CTD	MESH:C025034	TYMP protein results in increased metabolism of doxifluridine	PMID:21804305
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:31521	doxifluridine	increases metabolic processing	ISO	RGD:1313980	E	RGD:6480464	20130806	CTD	MESH:C025034	TYMP protein results in increased metabolism of doxifluridine	PMID:21804305
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:31521	doxifluridine	increases response to substance	EXP		E	RGD:6480464	20130806	CTD	MESH:C025034	TYMP protein results in increased susceptibility to doxifluridine	PMID:15864645
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:31521	doxifluridine	multiple interactions	EXP		E	RGD:6480464	20130806	CTD	MESH:C025034	[5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] results in decreased susceptibility to [Zidovudine co-treated with doxifluridine]; [5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride results in decreased activity of TYMP protein] which results in decreased susceptibility to doxifluridine; [IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to doxifluridine; [Paclitaxel co-treated with doxifluridine] affects the expression of TYMP mRNA; [TYMP protein results in increased expression of IFNA1 mRNA] which results in increased susceptibility to doxifluridine; [Zidovudine results in increased activity of TYMP protein] which results in increased susceptibility to doxifluridine; doxifluridine promotes the reaction [TNF protein results in increased expression of TYMP mRNA]	PMID:15301717|PMID:16457948|PMID:17988526|PMID:18630517
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:31941	oxaliplatin	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	TYMP protein affects the susceptibility to oxaliplatin	PMID:18728667
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[TYMP protein co-treated with DPYD protein] affects the susceptibility to oxaliplatin	PMID:18728667
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313980	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TYMP mRNA	PMID:23557971|PMID:29264374
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305756	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of TYMP mRNA	PMID:23411599|PMID:34492290
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1305756	E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of TYMP mRNA	PMID:28943392
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313980	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TYMP mRNA	PMID:17426115|PMID:18445702|PMID:23811191
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313980	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of TYMP mRNA	PMID:28472532
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:33007	chromium(6+)	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of TYMP protein	PMID:28596144
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TYMP mRNA	PMID:30903817
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of TYMP mRNA	PMID:20678512
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TYMP mRNA	PMID:33221593
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of TYMP protein	PMID:34186270
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305756	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TYMP mRNA	PMID:25181051
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305756	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TYMP gene	PMID:28505145
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of TYMP mRNA	PMID:19244175
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1313980	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of TYMP mRNA	PMID:39298647
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of TYMP protein	PMID:34186270
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313980	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TYMP mRNA	PMID:37019170
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1313980	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of TYMP mRNA	PMID:34813904
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of TYMP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of TYMP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of TYMP protein	PMID:38598786
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of TYMP mRNA	PMID:34813904
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305756	E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of TYMP mRNA	PMID:28943392
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:34892	nocodazole	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015739	[TYMP co-treated with Nocodazole] results in decreased expression of FASLG mRNA; [TYMP co-treated with Nocodazole] results in decreased expression of FASLG protein; TYMP affects the reaction [Nocodazole results in increased phosphorylation of and results in increased activity of MAPK1 protein]; TYMP affects the reaction [Nocodazole results in increased phosphorylation of and results in increased activity of MAPK3 protein]; TYMP inhibits the reaction [Nocodazole results in increased cleavage of PARP1 protein]; TYMP inhibits the reaction [Nocodazole results in increased phosphorylation of BCL2 protein]	PMID:15907805
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TYMP mRNA	PMID:37042841
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of TYMP mRNA	PMID:26377693
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305756	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of TYMP mRNA	PMID:30723492
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TYMP mRNA	PMID:38174414|PMID:38568856
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305756	E	RGD:6480464	20130618	CTD	MESH:C039281	furan results in increased methylation of TYMP gene	PMID:22079235
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TYMP mRNA	PMID:24449571
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TYMP mRNA	PMID:19244175
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased activity of TYMP protein	PMID:14573775
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of TYMP mRNA	PMID:14573775
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	Aspirin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TYMP mRNA]; TNF affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of TYMP mRNA]	PMID:14573775
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:38221	fumonisin B1	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 results in decreased expression of TYMP mRNA	PMID:16221962
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TYMP mRNA	PMID:36331819
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of TYMP mRNA; Curcumin results in decreased expression of TYMP protein	PMID:21493726
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	[Curcumin results in decreased expression of TYMP protein] which results in increased susceptibility to Cisplatin	PMID:21493726
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TYMP gene	PMID:29154799
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:4027	cyclophosphamide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	[Doxorubicin co-treated with Cyclophosphamide] results in increased expression of TYMP protein; [Epirubicin co-treated with Cyclophosphamide] results in increased expression of TYMP protein	PMID:15150550
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of TYMP mRNA	PMID:20106945
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	[Dexamethasone co-treated with Aurothioglucose] inhibits the reaction [IL1B protein results in increased expression of TYMP mRNA]	PMID:15990992
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TYMP mRNA	PMID:37992649
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:43602	obeticholic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of TYMP mRNA	PMID:27939613
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TYMP mRNA	PMID:38832940
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of TYMP mRNA; Paclitaxel results in increased expression of TYMP protein	PMID:15492279|PMID:18630517
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	[Paclitaxel co-treated with doxifluridine] affects the expression of TYMP mRNA; [TYMP mutant form co-treated with Paclitaxel] results in increased cleavage of CASP8 protein; TYMP inhibits the reaction [Paclitaxel results in increased cleavage of PARP1 protein]; TYMP inhibits the reaction [Paclitaxel results in increased expression of FASLG mRNA]; TYMP inhibits the reaction [Paclitaxel results in increased expression of FASLG protein]; TYMP inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]; TYMP mutant form promotes the reaction [Paclitaxel results in increased cleavage of CASP3 protein]; TYMP mutant form promotes the reaction [Paclitaxel results in increased cleavage of PARP1 protein]	PMID:15492279|PMID:15907805|PMID:18630517
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313980	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TYMP mRNA	PMID:17562736
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TYMP mRNA	PMID:21420995
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305756	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TYMP mRNA	PMID:33387578
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120918	CTD	MESH:D005472	TYMP protein affects the susceptibility to Fluorouracil	PMID:15041737|PMID:15538739|PMID:15655543|PMID:16160472
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of TYMP mRNA	PMID:16568373
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:46345	5-fluorouracil	decreases response to substance	ISO	RGD:1313980	E	RGD:6480464	20120412	CTD	MESH:D005472	TYMP mRNA results in decreased susceptibility to Fluorouracil	PMID:16525674
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein; [IFNG protein results in increased expression of TYMP protein] which results in increased susceptibility to Fluorouracil; acetylleucyl-leucyl-norleucinal inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; TYMP mRNA affects the susceptibility to [Irinotecan co-treated with Fluorouracil co-treated with Leucovorin]	PMID:15301717|PMID:17454858|PMID:21444628
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of TYMP mRNA	PMID:19825521
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:46557	zoledronic acid	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	Gossypol inhibits the reaction [zoledronic acid results in increased expression of TYMP mRNA]	PMID:19825521
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TYMP mRNA]	PMID:35811015
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:47898	4'-epidoxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015251	[Epirubicin co-treated with Cyclophosphamide] results in increased expression of TYMP protein	PMID:15150550
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305756	E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of TYMP mRNA	PMID:15953391
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to TYMP protein]	PMID:26598702
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1305756	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of TYMP mRNA	PMID:23962444
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C029938	nickel sulfate results in decreased expression of TYMP mRNA	PMID:18832182
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:53001	nickel sulfate	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:C029938	[macrophage stimulatory lipopeptide 2 co-treated with nickel sulfate] results in decreased expression of TYMP mRNA	PMID:18832182
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of TYMP mRNA	PMID:38701926
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TYMP protein	PMID:32959892
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:63581	stavudine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018119	Stavudine results in increased expression of TYMP protein	PMID:16457948
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:63616	pemetrexed	increases response to substance	EXP		E	RGD:6480464	20170303	CTD	MESH:C085586	TYMP protein results in increased susceptibility to Pemetrexed	PMID:17575230
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:6382	Lasiocarpine	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C005136	lasiocarpine metabolite results in increased expression of TYMP mRNA	PMID:30465738
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1313980	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of TYMP mRNA	PMID:14729362
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:64153	tanespimycin	decreases expression	EXP		E	RGD:6480464	20190702	CTD	MESH:C112765	tanespimycin results in decreased expression of TYMP mRNA; tanespimycin results in decreased expression of TYMP protein	PMID:30796972
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:64153	tanespimycin	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:C112765	[salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP mRNA]; [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP protein]; [tanespimycin co-treated with salinomycin] results in decreased expression of TYMP mRNA; acetylleucyl-leucyl-norleucinal inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]; SB 203580 promotes the reaction [[tanespimycin co-treated with salinomycin] results in decreased expression of TYMP mRNA]; tanespimycin inhibits the reaction [Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]]; tanespimycin inhibits the reaction [salinomycin inhibits the reaction [Cycloheximide results in decreased expression of TYMP protein]]; tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP mRNA]; tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]	PMID:30796972
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol analog promotes the reaction [Bleomycin results in increased expression of TYMP protein]	PMID:30825431
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TYMP mRNA	PMID:31758290
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TYMP mRNA	PMID:22206623
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Fluorouracil co-treated with Cisplatin] results in decreased stability of TYMP protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]	PMID:21444628|PMID:30796972
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:755540	docetaxel	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	[FEC protocol co-treated with Docetaxel] results in increased expression of TYMP protein	PMID:15150550
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1305756	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in increased expression of TYMP mRNA	PMID:26720608
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	ISO	RGD:1305756	E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of TYMP promoter	PMID:27415467
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305756	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of TYMP mRNA	PMID:21346803
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:80025	Salinomycin	decreases response to substance	EXP		E	RGD:6480464	20190702	CTD	MESH:C010327	TYMP protein results in decreased susceptibility to salinomycin	PMID:30796972
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:80025	Salinomycin	increases expression	EXP		E	RGD:6480464	20190702	CTD	MESH:C010327	salinomycin results in increased expression of TYMP mRNA; salinomycin results in increased expression of TYMP protein	PMID:30796972
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:80025	Salinomycin	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:C010327	[salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP mRNA]; [salinomycin co-treated with tanespimycin] inhibits the reaction [MAP2K6 protein results in increased expression of TYMP protein]; [tanespimycin co-treated with salinomycin] results in decreased expression of TYMP mRNA; acetylleucyl-leucyl-norleucinal inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]]; Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]; salinomycin inhibits the reaction [Cycloheximide results in decreased expression of TYMP protein]; SB 203580 inhibits the reaction [salinomycin results in increased expression of TYMP mRNA]; SB 203580 promotes the reaction [[tanespimycin co-treated with salinomycin] results in decreased expression of TYMP mRNA]; tanespimycin inhibits the reaction [Dactinomycin promotes the reaction [salinomycin results in increased expression of TYMP mRNA]]; tanespimycin inhibits the reaction [salinomycin inhibits the reaction [Cycloheximide results in decreased expression of TYMP protein]]; tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP mRNA]; tanespimycin inhibits the reaction [salinomycin results in increased expression of TYMP protein]	PMID:30796972
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:80630	irinotecan	multiple interactions	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	TYMP mRNA affects the susceptibility to [Irinotecan co-treated with Fluorouracil co-treated with Leucovorin]	PMID:17454858
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of TYMP mRNA	PMID:19482888
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313980	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of TYMP mRNA]	PMID:19482888
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:8093	phenylephrine	decreases expression	ISO	RGD:1305756	E	RGD:6480464	20260811	CTD	MESH:D010656	Phenylephrine results in decreased expression of SCO2 protein	PMID:25107896
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:8093	phenylephrine	multiple interactions	ISO	RGD:1305756	E	RGD:6480464	20260811	CTD	MESH:D010656	VEGFA protein inhibits the reaction [Phenylephrine results in decreased expression of SCO2 protein]	PMID:25107896
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1313980	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of TYMP mRNA	PMID:21278054
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of TYMP mRNA	PMID:31734321
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:90705	SB 203580	decreases expression	EXP		E	RGD:6480464	20190702	CTD	MESH:C093642	SB 203580 results in decreased expression of TYMP mRNA	PMID:30796972
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:90705	SB 203580	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:C093642	SB 203580 inhibits the reaction [salinomycin results in increased expression of TYMP mRNA]; SB 203580 promotes the reaction [[tanespimycin co-treated with salinomycin] results in decreased expression of TYMP mRNA]	PMID:30796972
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of TYMP mRNA	PMID:26014281
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305756	E	RGD:6480464	20130618	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TYMP mRNA	PMID:21346803
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:9334	sulfasalazine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012460	Sulfasalazine results in decreased expression of TYMP mRNA	PMID:15269287
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:9334	sulfasalazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012460	Sulfasalazine inhibits the reaction [IFNG protein results in increased activity of TYMP protein]; Sulfasalazine inhibits the reaction [TNF protein results in increased activity of TYMP protein]; Sulfasalazine results in decreased expression of and results in decreased activity of TYMP protein	PMID:15269287
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TYMP mRNA	PMID:29301935
1313979	TYMP	thymidine phosphorylase	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of TYMP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of TYMP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of TYMP protein	PMID:38598786
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of ZNF112 mRNA	PMID:31016361
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of ZNF112 mRNA	PMID:23724009
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ZNF112 mRNA	PMID:22378314
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ZNF112 mRNA	PMID:21632981
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of ZNF112 mRNA	PMID:20655997
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305757	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP112 mRNA	PMID:33387578
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:17967	urethane	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane affects the expression of ZNF112 mRNA	PMID:28818685
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ZNF112 mRNA	PMID:19549813
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305757	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZFP112 mRNA	PMID:30779732
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305757	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP112 mRNA	PMID:22298810
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305757	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP112 mRNA	PMID:33387578
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ZNF112 mRNA	PMID:28001369
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ZNF112 protein	PMID:35688186
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF112 mRNA	PMID:34032870
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313982	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZFP112 mRNA	PMID:37682722
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZFP112 exon	PMID:27901495
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZFP112 promoter	PMID:27901495
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ZFP112 mRNA	PMID:25351596
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313982	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ZFP112 mRNA	PMID:18648102
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305757	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP112 mRNA	PMID:25181051
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	ZNF112 mRNA affects the susceptibility to Carmustine	PMID:16365179
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313982	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZFP112 mRNA	PMID:37019170
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ZNF112 mRNA	PMID:40419075
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZNF112 mRNA	PMID:25979313
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF112 mRNA	PMID:28001369
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZNF112 gene	PMID:29154799
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ZFP112 mRNA	PMID:23179753
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ZNF112 mRNA	PMID:38832940
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ZNF112 mRNA	PMID:27188386
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305757	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZFP112 mRNA	PMID:33387578
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ZNF112 mRNA	PMID:28988120
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	ZNF112 mRNA affects the susceptibility to temozolomide	PMID:16365179
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF112 protein	PMID:31285264
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF112 gene]	PMID:28238834
1313981	ZNF112	zinc finger protein 112	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305757	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ZFP112 mRNA	PMID:19281266
1313984	PXN	paxillin	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PXN mRNA	PMID:38218311
1313984	PXN	paxillin	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of PXN mRNA	PMID:15928584
1313984	PXN	paxillin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of PXN; Tretinoin results in increased expression of PXN mRNA	PMID:24819975|PMID:33167477|PMID:9081214
1313984	PXN	paxillin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	[LCP2 protein co-treated with CSF1R protein] promotes the reaction [Tretinoin results in increased expression of PXN protein]; SUMO1 mutant form inhibits the reaction [Tretinoin results in increased expression of PXN mRNA]	PMID:16439309|PMID:24819975
1313984	PXN	paxillin	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PXN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PXN mRNA	PMID:32699268
1313984	PXN	paxillin	gene	CHEBI:16170	mercury(0)	affects localization	EXP		E	RGD:6480464	20231031	CTD	MESH:D008628	Mercury affects the localization of PXN protein	PMID:26600472
1313984	PXN	paxillin	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1313985	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PXN mRNA	PMID:30319688
1313984	PXN	paxillin	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of PXN protein	PMID:31494107
1313984	PXN	paxillin	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of PXN protein	PMID:35688186
1313984	PXN	paxillin	gene	CHEBI:16325	lithocholic acid	multiple interactions	EXP		E	RGD:6480464	20131210	CTD	MESH:D008095	Lithocholic Acid results in decreased phosphorylation of and results in decreased activity of PXN protein	PMID:21224350
1313984	PXN	paxillin	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PXN mRNA	PMID:39241906
1313984	PXN	paxillin	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of PXN mRNA	PMID:22574217
1313984	PXN	paxillin	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of PXN mRNA	PMID:24758408
1313984	PXN	paxillin	gene	CHEBI:16469	17beta-estradiol	increases phosphorylation	EXP		E	RGD:6480464	20160607	CTD	MESH:D004958	Estradiol results in increased phosphorylation of PXN protein	PMID:27026707
1313984	PXN	paxillin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PXN mRNA; EGF protein inhibits the reaction [Estradiol results in decreased expression of PXN mRNA]	PMID:24758408|PMID:30165855
1313984	PXN	paxillin	gene	CHEBI:16684	atropine	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D001285	Atropine inhibits the reaction [[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]]	PMID:10537051
1313984	PXN	paxillin	gene	CHEBI:16842	formaldehyde	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased phosphorylation of and results in decreased expression of PXN protein; Formaldehyde results in increased phosphorylation of and results in increased activity of PXN protein	PMID:16352387|PMID:26400731
1313984	PXN	paxillin	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in decreased expression of PXN protein	PMID:31483951
1313984	PXN	paxillin	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in increased expression of PXN protein modified form	PMID:31483951
1313984	PXN	paxillin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of PXN protein modified form]; RHOA protein inhibits the reaction [Glucose results in decreased expression of PXN protein]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]	PMID:31483951
1313984	PXN	paxillin	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in increased expression of PXN protein	PMID:20463053
1313984	PXN	paxillin	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in decreased expression of PXN protein	PMID:31483951
1313984	PXN	paxillin	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in increased expression of PXN protein modified form	PMID:31483951
1313984	PXN	paxillin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of PXN protein modified form]; RHOA protein inhibits the reaction [Glucose results in decreased expression of PXN protein]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]	PMID:31483951
1313984	PXN	paxillin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PXN mRNA	PMID:31163220
1313984	PXN	paxillin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305759	E	RGD:6480464	20260303	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate] results in increased expression of PXN protein	PMID:40914504
1313984	PXN	paxillin	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PXN protein	PMID:37730182
1313984	PXN	paxillin	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in increased expression of PXN mRNA	PMID:22562489
1313984	PXN	paxillin	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PXN mRNA	PMID:35301059
1313984	PXN	paxillin	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PXN protein	PMID:23301498
1313984	PXN	paxillin	gene	CHEBI:25195	mercury atom	affects localization	EXP		E	RGD:6480464	20231031	CTD	MESH:D008628	Mercury affects the localization of PXN protein	PMID:26600472
1313984	PXN	paxillin	gene	CHEBI:25351	mevalonic acid	multiple interactions	ISO	RGD:1305759	E	RGD:6480464	20230502	CTD	MESH:D008798	Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [AGT protein results in increased phosphorylation of PXN protein]]	PMID:22306966
1313984	PXN	paxillin	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PXN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PXN mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of PXN mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PXN mRNA	PMID:32699268|PMID:35430440
1313984	PXN	paxillin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PXN mRNA	PMID:27106289
1313984	PXN	paxillin	gene	CHEBI:26523	reactive oxygen species	increases phosphorylation	EXP		E	RGD:6480464	20170303	CTD	MESH:D017382	Reactive Oxygen Species results in increased phosphorylation of PXN protein	PMID:11213483
1313984	PXN	paxillin	gene	CHEBI:26523	reactive oxygen species	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D017382	Anethole Trithione inhibits the reaction [Reactive Oxygen Species results in increased phosphorylation of PXN protein]	PMID:11213483
1313984	PXN	paxillin	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of PXN protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PXN protein	PMID:38598786
1313984	PXN	paxillin	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PXN mRNA	PMID:40512198
1313984	PXN	paxillin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PXN mRNA	PMID:40504410
1313984	PXN	paxillin	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PXN mRNA	PMID:26272509
1313984	PXN	paxillin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PXN mRNA	PMID:27188386
1313984	PXN	paxillin	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PXN protein	PMID:35688186
1313984	PXN	paxillin	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1305759	E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol inhibits the reaction [dinitrophenyl-human serum albumin conjugate results in increased phosphorylation of PXN protein]	PMID:26621445
1313984	PXN	paxillin	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20161025	CTD	MESH:C059514	resveratrol inhibits the reaction [dinitrophenyl-human serum albumin conjugate results in increased phosphorylation of PXN protein]	PMID:26621445
1313984	PXN	paxillin	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1313985	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of PXN mRNA	PMID:21151649
1313984	PXN	paxillin	gene	CHEBI:27961	1,8-cineole	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D000077591	Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of PXN protein modified form]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in increased expression of PXN protein modified form]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]	PMID:31483951
1313984	PXN	paxillin	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PXN mRNA	PMID:30912803
1313984	PXN	paxillin	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in decreased expression of PXN mRNA	PMID:22228119
1313984	PXN	paxillin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313985	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PXN mRNA	PMID:21570461
1313984	PXN	paxillin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305759	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PXN mRNA	PMID:34747641
1313984	PXN	paxillin	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PXN mRNA	PMID:33212167
1313984	PXN	paxillin	gene	CHEBI:28304	heparin	decreases phosphorylation	ISO	RGD:1313985	E	RGD:6480464	20120412	CTD	MESH:D006493	Heparin results in decreased phosphorylation of PXN protein	PMID:18674534
1313984	PXN	paxillin	gene	CHEBI:28584	gossypol	decreases phosphorylation	EXP		E	RGD:6480464	20250506	CTD	MESH:D006072	Gossypol results in decreased phosphorylation of PXN protein	PMID:39263880
1313984	PXN	paxillin	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of PXN protein	PMID:35688186
1313984	PXN	paxillin	gene	CHEBI:28940	calciol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in increased expression of PXN	PMID:9081214
1313984	PXN	paxillin	gene	CHEBI:29014	cordycepin	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:C058120	Ammonium Chloride inhibits the reaction [cordycepin results in decreased expression of PXN protein]; cordycepin results in decreased expression of and results in decreased phosphorylation of PXN protein	PMID:28068557
1313984	PXN	paxillin	gene	CHEBI:2965	BQ 123	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C072247	[BQ 788 co-treated with cyclo(Trp-Asp-Pro-Val-Leu)] inhibits the reaction [EDN1 protein results in increased phosphorylation of PXN protein]	PMID:12875994
1313984	PXN	paxillin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305759	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PXN protein	PMID:19072884
1313984	PXN	paxillin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20220809	CTD	MESH:C017947	sodium arsenite results in decreased expression of PXN mRNA	PMID:26674514
1313984	PXN	paxillin	gene	CHEBI:29678	sodium arsenite	decreases phosphorylation	ISO	RGD:1305759	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased phosphorylation of PXN protein	PMID:15537746
1313984	PXN	paxillin	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PXN mRNA	PMID:40512198
1313984	PXN	paxillin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PXN mRNA	PMID:40504410
1313984	PXN	paxillin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PXN 5' UTR	PMID:27901495
1313984	PXN	paxillin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PXN mRNA; Benzo(a)pyrene results in decreased expression of PXN protein	PMID:31255691|PMID:32717239
1313984	PXN	paxillin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PXN mRNA	PMID:32234424
1313984	PXN	paxillin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PXN promoter	PMID:27901495
1313984	PXN	paxillin	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of PXN mRNA	PMID:33053406
1313984	PXN	paxillin	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PXN mRNA	PMID:23806026
1313984	PXN	paxillin	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PXN mRNA	PMID:25895662
1313984	PXN	paxillin	gene	CHEBI:30778	gallic acid	decreases phosphorylation	EXP		E	RGD:6480464	20240903	CTD	MESH:D005707	Gallic Acid results in decreased phosphorylation of PXN protein	PMID:38100242
1313984	PXN	paxillin	gene	CHEBI:31206	ammonium chloride	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:D000643	Ammonium Chloride inhibits the reaction [cordycepin results in decreased expression of PXN protein]	PMID:28068557
1313984	PXN	paxillin	gene	CHEBI:31221	Anetholtrithion	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:D000781	Anethole Trithione inhibits the reaction [Reactive Oxygen Species results in increased phosphorylation of PXN protein]	PMID:11213483
1313984	PXN	paxillin	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PXN gene	PMID:31601247
1313984	PXN	paxillin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of PXN mRNA	PMID:18648102
1313984	PXN	paxillin	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305759	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PXN mRNA	PMID:25181051
1313984	PXN	paxillin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of PXN protein	PMID:34186270
1313984	PXN	paxillin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of PXN protein	PMID:37567409
1313984	PXN	paxillin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313985	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of PXN mRNA	PMID:32156529
1313984	PXN	paxillin	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PXN gene	PMID:31601247
1313984	PXN	paxillin	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PXN mRNA	PMID:25979313
1313984	PXN	paxillin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PXN mRNA	PMID:39298647
1313984	PXN	paxillin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1313985	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PXN exon	PMID:33297965
1313984	PXN	paxillin	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PXN protein	PMID:34186270
1313984	PXN	paxillin	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313985	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PXN intron	PMID:28392331
1313984	PXN	paxillin	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1305759	E	RGD:6480464	20260303	CTD	MESH:C027561	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate] results in increased expression of PXN protein	PMID:40914504
1313984	PXN	paxillin	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1305759	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PXN mRNA	PMID:20691718
1313984	PXN	paxillin	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1313985	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PXN mRNA	PMID:32715474|PMID:37019170
1313984	PXN	paxillin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1313985	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PXN mRNA	PMID:21266533
1313984	PXN	paxillin	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305759	E	RGD:6480464	20260303	CTD	MESH:D003993	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate] results in increased expression of PXN protein	PMID:40914504
1313984	PXN	paxillin	gene	CHEBI:34696	dieldrin	increases response to substance	EXP		E	RGD:6480464	20201006	CTD	MESH:D004026	PXN gene mutant form results in increased susceptibility to Dieldrin	PMID:32421776
1313984	PXN	paxillin	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of PXN protein	PMID:38598786
1313984	PXN	paxillin	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PXN mRNA	PMID:37042841
1313984	PXN	paxillin	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PXN protein	PMID:28527916
1313984	PXN	paxillin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PXN mRNA	PMID:35301059
1313984	PXN	paxillin	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1305759	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PXN mRNA	PMID:19162173
1313984	PXN	paxillin	gene	CHEBI:35549	perfluorooctanoic acid	increases phosphorylation	EXP		E	RGD:6480464	20170516	CTD	MESH:C023036	perfluorooctanoic acid results in increased phosphorylation of PXN protein	PMID:27572461
1313984	PXN	paxillin	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PXN mRNA	PMID:19320972
1313984	PXN	paxillin	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PXN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PXN mRNA	PMID:32699268
1313984	PXN	paxillin	gene	CHEBI:38322	oxotremorine M	increases phosphorylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C042743	oxotremorine M results in increased phosphorylation of PXN protein	PMID:10537051
1313984	PXN	paxillin	gene	CHEBI:38322	oxotremorine M	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C042743	[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]; Atropine inhibits the reaction [[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]]; wortmannin inhibits the reaction [oxotremorine M results in increased phosphorylation of PXN protein]	PMID:10537051
1313984	PXN	paxillin	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PXN mRNA	PMID:28302478
1313984	PXN	paxillin	gene	CHEBI:38757	isoflavones	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones affects the expression of PXN mRNA	PMID:16365062
1313984	PXN	paxillin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases phosphorylation	EXP		E	RGD:6480464	20170516	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased phosphorylation of PXN protein	PMID:27572461
1313984	PXN	paxillin	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PXN mRNA	PMID:25979313
1313984	PXN	paxillin	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in decreased expression of PXN mRNA	PMID:23527032
1313984	PXN	paxillin	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PXN mRNA	PMID:23179753
1313984	PXN	paxillin	gene	CHEBI:40070	4-hydroxycoumarin	affects localization	ISO	RGD:1313985	E	RGD:6480464	20120904	CTD	MESH:C068805	4-hydroxycoumarin affects the localization of PXN protein	PMID:18492274
1313984	PXN	paxillin	gene	CHEBI:40070	4-hydroxycoumarin	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20120904	CTD	MESH:C068805	4-hydroxycoumarin results in decreased expression of PXN mRNA alternative form; 4-hydroxycoumarin results in decreased expression of PXN protein alternative form	PMID:18492274
1313984	PXN	paxillin	gene	CHEBI:40070	4-hydroxycoumarin	decreases phosphorylation	ISO	RGD:1313985	E	RGD:6480464	20120904	CTD	MESH:C068805	4-hydroxycoumarin results in decreased phosphorylation of PXN protein	PMID:18492274
1313984	PXN	paxillin	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PXN mRNA	PMID:25562108
1313984	PXN	paxillin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313985	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PXN mRNA	PMID:28973697
1313984	PXN	paxillin	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in decreased expression of PXN protein	PMID:31483951
1313984	PXN	paxillin	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in increased expression of PXN protein modified form	PMID:31483951
1313984	PXN	paxillin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20201103	CTD	MESH:D005947	Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]; Eucalyptol inhibits the reaction [Glucose results in increased expression of PXN protein modified form]; RHOA protein inhibits the reaction [Glucose results in decreased expression of PXN protein]; RHOA protein promotes the reaction [Eucalyptol inhibits the reaction [Glucose results in decreased expression of PXN protein]]	PMID:31483951
1313984	PXN	paxillin	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of PXN mRNA	PMID:17400583|PMID:21678067
1313984	PXN	paxillin	gene	CHEBI:4512	Dictamnine	decreases phosphorylation	EXP		E	RGD:6480464	20230905	CTD	MESH:C026398	dictamnine results in decreased phosphorylation of PXN protein	PMID:34861243
1313984	PXN	paxillin	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PXN mRNA; vorinostat results in increased expression of PXN protein	PMID:19911379
1313984	PXN	paxillin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313985	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PXN mRNA	PMID:17562736
1313984	PXN	paxillin	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PXN mRNA	PMID:22230336|PMID:26690555
1313984	PXN	paxillin	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PXN mRNA	PMID:40512198
1313984	PXN	paxillin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313985	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PXN mRNA	PMID:40504410
1313984	PXN	paxillin	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D004726	Endosulfan results in decreased expression of PXN mRNA	PMID:28108160|PMID:30090376|PMID:40706910
1313984	PXN	paxillin	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305759	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PXN mRNA	PMID:29391264
1313984	PXN	paxillin	gene	CHEBI:48607	lithium chloride	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in increased expression of PXN mRNA	PMID:23527032
1313984	PXN	paxillin	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of PXN mRNA	PMID:18175754
1313984	PXN	paxillin	gene	CHEBI:52289	wortmannin	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C009687	[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]; Atropine inhibits the reaction [[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]]; wortmannin inhibits the reaction [oxotremorine M results in increased phosphorylation of PXN protein]	PMID:10537051
1313984	PXN	paxillin	gene	CHEBI:5855	ibuprofen	decreases expression	ISO	RGD:1305759	E	RGD:6480464	20120412	CTD	MESH:D007052	Ibuprofen results in decreased expression of PXN mRNA; Ibuprofen results in decreased expression of PXN protein	PMID:16463375
1313984	PXN	paxillin	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1313985	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of PXN mRNA	PMID:20829426
1313984	PXN	paxillin	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PXN protein	PMID:32959892
1313984	PXN	paxillin	gene	CHEBI:66331	xanthohumol	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C104536	xanthohumol results in decreased expression of PXN protein	PMID:23503627
1313984	PXN	paxillin	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1313985	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of PXN mRNA	PMID:26307267
1313984	PXN	paxillin	gene	CHEBI:6842	methoxychlor	affects expression	ISO	RGD:1313985	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor affects the expression of PXN mRNA	PMID:20829426
1313984	PXN	paxillin	gene	CHEBI:68508	diethyl maleate	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C014476	diethyl maleate results in increased expression of PXN mRNA	PMID:33545341
1313984	PXN	paxillin	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1305759	E	RGD:6480464	20230801	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of PXN mRNA	PMID:36657700
1313984	PXN	paxillin	gene	CHEBI:6925	microcystin-LR	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C057862	cyanoginosin LR results in increased expression of PXN mRNA	PMID:27796937
1313984	PXN	paxillin	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PXN protein	PMID:34186270
1313984	PXN	paxillin	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1313985	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of PXN mRNA	PMID:22206623
1313984	PXN	paxillin	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PXN protein	PMID:37664457
1313984	PXN	paxillin	gene	CHEBI:750004	bq 788	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C086539	[BQ 788 co-treated with cyclo(Trp-Asp-Pro-Val-Leu)] inhibits the reaction [EDN1 protein results in increased phosphorylation of PXN protein]	PMID:12875994
1313984	PXN	paxillin	gene	CHEBI:75253	phenylarsine oxide	affects localization	EXP		E	RGD:6480464	20130903	CTD	MESH:C029341	oxophenylarsine affects the localization of PXN protein	PMID:9546377
1313984	PXN	paxillin	gene	CHEBI:75253	phenylarsine oxide	increases phosphorylation	EXP		E	RGD:6480464	20130903	CTD	MESH:C029341	oxophenylarsine results in increased phosphorylation of PXN protein	PMID:10537051
1313984	PXN	paxillin	gene	CHEBI:75253	phenylarsine oxide	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C029341	[oxotremorine M co-treated with Wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]; Atropine inhibits the reaction [[oxotremorine M co-treated with Wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]]	PMID:10537051
1313984	PXN	paxillin	gene	CHEBI:77850	toxaphene	increases degradation	EXP		E	RGD:6480464	20140415	CTD	MESH:D014112	Toxaphene results in increased degradation of PXN protein	PMID:12139946
1313984	PXN	paxillin	gene	CHEBI:77850	toxaphene	multiple interactions	EXP		E	RGD:6480464	20140415	CTD	MESH:D014112	CAT protein inhibits the reaction [Toxaphene results in increased degradation of PXN protein]	PMID:12139946
1313984	PXN	paxillin	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PXN mRNA	PMID:27188386
1313984	PXN	paxillin	gene	CHEBI:78734	tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:D001285	Atropine inhibits the reaction [[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]]	PMID:10537051
1313984	PXN	paxillin	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of PXN mRNA	PMID:26079696
1313984	PXN	paxillin	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PXN mRNA	PMID:40826991
1313984	PXN	paxillin	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PXN protein; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PXN mRNA	PMID:27188386|PMID:37664457
1313984	PXN	paxillin	gene	CHEBI:9150	simvastatin	affects localization	ISO	RGD:1305759	E	RGD:6480464	20121009	CTD	MESH:D019821	Simvastatin affects the localization of PXN protein	PMID:22306966
1313984	PXN	paxillin	gene	CHEBI:9150	simvastatin	decreases phosphorylation	ISO	RGD:1305759	E	RGD:6480464	20121009	CTD	MESH:D019821	Simvastatin results in decreased phosphorylation of PXN protein	PMID:22306966
1313984	PXN	paxillin	gene	CHEBI:9150	simvastatin	multiple interactions	ISO	RGD:1305759	E	RGD:6480464	20121009	CTD	MESH:D019821	Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [AGT protein results in increased phosphorylation of PXN protein]]; Simvastatin inhibits the reaction [AGT protein results in increased phosphorylation of and affects the localization of PXN protein]	PMID:22306966
1313984	PXN	paxillin	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305759	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PXN mRNA	PMID:19281266
1313984	PXN	paxillin	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305759	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PXN mRNA	PMID:21346803
1313984	PXN	paxillin	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of PXN mRNA	PMID:34581912
1313984	PXN	paxillin	gene	CHEBI:9448	terbinafine	decreases phosphorylation	EXP		E	RGD:6480464	20161213	CTD	MESH:C041359	terbinafine results in decreased phosphorylation of PXN protein	PMID:17172416
1313984	PXN	paxillin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PXN protein	PMID:38598786
1313984	PXN	paxillin	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305759	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PXN mRNA	PMID:21346803
1313984	PXN	paxillin	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1313985	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PXN mRNA	PMID:28973697
1313984	PXN	paxillin	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305759	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin affects the expression of PXN mRNA	PMID:23034163
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:10110	zidovudine	decreases response to substance	EXP		E	RGD:6480464	20120918	CTD	MESH:D015215	XPC protein results in decreased susceptibility to Zidovudine	PMID:21192964
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:10110	zidovudine	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D015215	Zidovudine results in increased expression of XPC mRNA; Zidovudine results in increased expression of XPC protein	PMID:21192964|PMID:23675285
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XPC mRNA	PMID:32699268
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of XPC mRNA	PMID:25596134
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of XPC mRNA	PMID:21751221
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16243	quercetin	affects response to substance	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	XPC protein affects the susceptibility to Quercetin	PMID:22280988
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of XPC mRNA	PMID:21632981
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1305760	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of XPC mRNA	PMID:17103110
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D004958	Estradiol results in decreased expression of XPC mRNA	PMID:22082530
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of XPC mRNA	PMID:32145629
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D004958	decitabine inhibits the reaction [Estradiol results in decreased expression of XPC mRNA]	PMID:22082530
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of XPC mRNA	PMID:37042841
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16708	adenine	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D000225	Adenine results in decreased expression of XPC mRNA	PMID:24211769
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16716	benzene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in decreased expression of XPC mRNA	PMID:18724895
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of XPC mRNA	PMID:19162166
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in increased expression of XPC mRNA	PMID:15342939
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of XPC mRNA	PMID:23649840
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:17356	2-acetamidofluorene	decreases response to substance	ISO	RGD:1313987	E	RGD:6480464	20130514	CTD	MESH:D015073	XPC protein results in decreased susceptibility to 2-Acetylaminofluorene	PMID:23153559
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:17488	scopoletin	affects response to substance	EXP		E	RGD:6480464	20121009	CTD	MESH:D012603	XPC protein affects the susceptibility to Scopoletin	PMID:22280988
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects response to substance	ISO	RGD:1313987	E	RGD:6480464	20170725	CTD	MESH:D004051	XPC protein affects the susceptibility to Diethylhexyl Phthalate	PMID:24084170
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of XPC protein	PMID:37730182
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of XPC mRNA	PMID:33387578
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305760	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of XPC mRNA	PMID:22061828
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:18227	sterigmatocystin	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D013241	Sterigmatocystin results in increased expression of XPC mRNA	PMID:23296099
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of XPC mRNA	PMID:37236586
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:229924	pifithrin-alpha hydrobromide	multiple interactions	EXP		E	RGD:6480464	20240409	CTD	MESH:C121565	pifithrin inhibits the reaction [benzo(a)pyrene diolepoxide I results in increased expression of XPC mRNA]	PMID:27694624
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of XPC mRNA	PMID:23649840
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of XPC protein	PMID:20106945
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of XPC mRNA	PMID:21641981|PMID:27153756|PMID:29445054
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in increased expression of XPC protein	PMID:39638853
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of XPC mRNA	PMID:23649840
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1313987	E	RGD:6480464	20240206	CTD	MESH:D009151	Mustard Gas results in increased expression of XPC mRNA	PMID:19778212
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D010126	Ozone results in increased expression of XPC mRNA	PMID:27206323
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XPC mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of XPC mRNA	PMID:32699268
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1305760	E	RGD:6480464	20250114	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Particulate Matter co-treated with Ozone]] which results in decreased expression of XPC mRNA	PMID:36423397
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305760	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of XPC mRNA	PMID:30779732
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of XPC mRNA	PMID:17484886
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of XPC mRNA	PMID:31150632
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of XPC mRNA	PMID:25629700
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of XPC mRNA]	PMID:30020114
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of XPC mRNA]; Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of XPC mRNA]	PMID:22206623|PMID:30020114
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of XPC	PMID:21235219
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27563	arsenic atom	affects response to substance	EXP		E	RGD:6480464	20160705	CTD	MESH:D001151	XPC gene SNP affects the susceptibility to Arsenic	PMID:25759212
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA; NFE2L1 protein alternative form inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA]	PMID:32188015|PMID:39836092
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of XPC mRNA	PMID:40504410
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of XPC protein	PMID:35688186
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of XPC mRNA	PMID:25596134
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20210608	CTD	MESH:C059514	Resveratrol results in decreased expression of XPC mRNA	PMID:33775663
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of XPC mRNA	PMID:23557933
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27882	(S)-colchicine	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D003078	Colchicine results in decreased expression of XPC mRNA	PMID:24211769
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20120918	CTD	MESH:D002945	XPC protein affects the susceptibility to Cisplatin	PMID:22331493
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin results in decreased expression of XPC mRNA	PMID:24211769
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	XPC protein results in decreased susceptibility to Cisplatin	PMID:21327329
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002945	Cisplatin results in increased expression of XPC mRNA; Cisplatin results in increased expression of XPC protein	PMID:21532991|PMID:21696631|PMID:21742020|PMID:22331493|PMID:25596134
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27899	cisplatin	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	XPC protein results in increased susceptibility to Cisplatin	PMID:21324906
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[sodium arsenite results in decreased expression of XPC protein] which results in increased susceptibility to Cisplatin; Cisplatin inhibits the reaction [Piroxicam results in decreased expression of XPC mRNA]; RAD23B mutant form inhibits the reaction [Cisplatin results in increased expression of XPC protein]; sodium arsenite inhibits the reaction [Cisplatin results in increased expression of XPC protein]; TP53 protein affects the reaction [Cisplatin results in increased expression of XPC protein]	PMID:21696631|PMID:21742020|PMID:21858171|PMID:22331493
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of XPC mRNA	PMID:30912803
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313987	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of XPC mRNA	PMID:21570461
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of XPC mRNA	PMID:33387578
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of XPC mRNA	PMID:19428948
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of XPC mRNA	PMID:17942748
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of XPC mRNA	PMID:28374803
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of XPC mRNA	PMID:39709020
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of XPC mRNA	PMID:30851411
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28509	chloroethene	affects response to substance	EXP		E	RGD:6480464	20121113	CTD	MESH:D014752	XPC gene polymorphism affects the susceptibility to Vinyl Chloride	PMID:21216194
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:2866	ascaridole	affects response to substance	EXP		E	RGD:6480464	20121009	CTD	MESH:C043372	XPC protein affects the susceptibility to ascaridole	PMID:22280988
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of XPC mRNA	PMID:15467011
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of XPC mRNA	PMID:29803840
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20230704	CTD	MESH:D004317	XPC protein affects the susceptibility to Doxorubicin	PMID:36634904
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004317	Doxorubicin results in increased expression of XPC mRNA	PMID:36634904|PMID:40854400
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D004317	FOXO3 protein affects the reaction [Doxorubicin results in increased expression of XPC mRNA]	PMID:40854400
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of XPC protein	PMID:35688186
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of XPC mRNA	PMID:36057382
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of XPC mRNA; sodium arsenite results in decreased expression of XPC protein	PMID:12377979|PMID:12760830|PMID:19382146|PMID:28237621|PMID:34032870|PMID:37762697
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of XPC mRNA; sodium arsenite results in decreased expression of XPC protein	PMID:17558810|PMID:28237621
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of XPC mRNA	PMID:38568856
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313987	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of XPC mRNA	PMID:25787150
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite results in decreased expression of XPC protein] which results in increased susceptibility to Cisplatin; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sodium arsenite results in decreased expression of XPC protein]; NFE2L1 protein alternative form inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA]; sodium arsenite inhibits the reaction [Cisplatin results in increased expression of XPC protein]; sodium arsenite promotes the reaction [XPC protein binds to CAPRIN1 protein]	PMID:21696631|PMID:22331493|PMID:28237621|PMID:32188015|PMID:33939924|PMID:39836092
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of XPC mRNA	PMID:40504410
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	XPC polyA tail polymorphism affects the susceptibility to Benzo(a)pyrene	PMID:15471894
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	affects response to substance	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D001564	XPC protein affects the susceptibility to Benzo(a)pyrene	PMID:16094661
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of XPC mRNA; Benzo(a)pyrene results in decreased expression of XPC protein	PMID:19748547|PMID:30020114
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of XPC mRNA	PMID:20504355|PMID:30020114
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20140211	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of XPC mRNA; Benzo(a)pyrene results in increased expression of XPC protein	PMID:23894430|PMID:27694624|PMID:32234424
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of XPC mRNA	PMID:19428948
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	[3,4,5,3',4'-pentachlorobiphenyl co-treated with Benzo(a)pyrene] results in decreased expression of XPC protein; Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of XPC mRNA]	PMID:19553035|PMID:30020114
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to XPC promoter]; Folic Acid inhibits the reaction [Benzo(a)pyrene results in decreased expression of XPC mRNA]	PMID:19654925|PMID:30020114
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of XPC mRNA	PMID:36057382
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of XPC mRNA	PMID:15467011
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of XPC mRNA; 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of XPC protein	PMID:18085531|PMID:28593498
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:30621	diarsenic trioxide	affects response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	XPC protein affects the susceptibility to Arsenic Trioxide	PMID:20403967|PMID:22280988
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:31355	carboplatin	decreases response to substance	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D016190	XPC results in decreased susceptibility to Carboplatin	PMID:19372135
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of XPC mRNA	PMID:24136188
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of XPC mRNA	PMID:24136188
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:32509	pirinixic acid	affects response to substance	ISO	RGD:1313987	E	RGD:6480464	20130514	CTD	MESH:C006253	XPC protein affects the susceptibility to pirinixic acid	PMID:23153559
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of XPC mRNA	PMID:19710929
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of XPC mRNA	PMID:12419474
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305760	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of XPC mRNA	PMID:25181051
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of XPC protein	PMID:31675489
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of XPC mRNA	PMID:32145629
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in decreased methylation of XPC promoter	PMID:30352284
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305760	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of XPC mRNA	PMID:34947998
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of XPC protein	PMID:31675489
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C023035	[3,4,5,3',4'-pentachlorobiphenyl co-treated with Benzo(a)pyrene] results in decreased expression of XPC protein	PMID:19553035
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of XPC mRNA	PMID:39298647
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313987	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of XPC mRNA	PMID:38685157
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1313987	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of XPC mRNA	PMID:36464114
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of XPC mRNA	PMID:21266533
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20200714	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of XPC mRNA	PMID:31318015
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:34905	paraquat	affects response to substance	ISO	RGD:1313987	E	RGD:6480464	20170725	CTD	MESH:D010269	XPC protein affects the susceptibility to Paraquat	PMID:24084170
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of XPC mRNA	PMID:25596134|PMID:38568856
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of XPC mRNA	PMID:37236586
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20121009	CTD	MESH:C039281	furan results in decreased expression of XPC mRNA	PMID:22507866
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:3647	chlorpromazine	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20150825	CTD	MESH:D002746	Chlorpromazine results in decreased expression of XPC mRNA	PMID:25596134
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:36704	imiquimod	increases expression	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:C056493	imiquimod results in increased expression of XPC mRNA	PMID:21878529
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of XPC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of XPC mRNA	PMID:32699268
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:3696	cidofovir anhydrous	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in increased expression of XPC mRNA	PMID:25596134
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:39478	buta-1,3-diene	increases response to substance	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:C031763	XPC gene mutant form results in increased susceptibility to 1,3-butadiene	PMID:16730686
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1313987	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of XPC mRNA	PMID:31558096
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of XPC mRNA	PMID:25979313
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of XPC mRNA	PMID:21507255
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid promotes the reaction [CREB1 protein binds to XPC promoter]; Valproic Acid promotes the reaction [SP1 protein binds to XPC promoter]	PMID:21507255
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:4027	cyclophosphamide	affects expression	ISO	RGD:1305760	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide affects the expression of XPC mRNA	PMID:11056294
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D003520	Cyclophosphamide results in increased expression of XPC mRNA	PMID:29445054
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of XPC mRNA	PMID:25596134
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of XPC mRNA	PMID:25596134
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:4031	cyclosporin A	decreases response to substance	ISO	RGD:1313987	E	RGD:6480464	20130514	CTD	MESH:D016572	XPC protein results in decreased susceptibility to Cyclosporine	PMID:23153559
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:41922	diethylstilbestrol	decreases response to substance	ISO	RGD:1313987	E	RGD:6480464	20130514	CTD	MESH:D004054	XPC protein results in decreased susceptibility to Diethylstilbestrol	PMID:23153559
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:42068	idarubicin	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20180116	CTD	MESH:D015255	[Dexrazoxane co-treated with Idarubicin] results in increased expression of XPC mRNA	PMID:28973540
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:44423	hydroxyurea	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of XPC mRNA	PMID:18647660
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of XPC mRNA	PMID:24136188
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of XPC mRNA	PMID:38832940
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of XPC mRNA	PMID:22230336
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305760	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of XPC mRNA	PMID:33387578
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:46661	asbestos	affects response to substance	EXP		E	RGD:6480464	20201006	CTD	MESH:D001194	XPC alternative form affects the susceptibility to Asbestos	PMID:28687356
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of XPC	PMID:21235219
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:47217	arsane	affects response to substance	EXP		E	RGD:6480464	20160705	CTD	MESH:D001151	XPC gene SNP affects the susceptibility to Arsenic	PMID:25759212
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA; NFE2L1 protein alternative form inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPC mRNA]	PMID:32188015|PMID:39836092
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of XPC mRNA	PMID:40504410
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of XPC mRNA	PMID:31675489
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:48513	carbazoles	affects response to substance	EXP		E	RGD:6480464	20170303	CTD	MESH:D002227	XPC protein affects the susceptibility to Carbazoles	PMID:22280988
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of XPC mRNA	PMID:17942748
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:49900	arsenous acid	affects response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	XPC protein affects the susceptibility to Arsenic Trioxide	PMID:20403967|PMID:22280988
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of XPC mRNA	PMID:25596134
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of XPC mRNA	PMID:22082530
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Estradiol results in decreased expression of XPC mRNA]	PMID:22082530
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:50223	(+)-dexrazoxane	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20180116	CTD	MESH:D064730	[Dexrazoxane co-treated with Idarubicin] results in increased expression of XPC mRNA	PMID:28973540
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313987	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of XPC mRNA; Nanotubes, Carbon results in decreased expression of XPC mRNA	PMID:25554681
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:5864	ifosfamide	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in increased expression of XPC mRNA	PMID:25596134
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of XPC mRNA	PMID:24136188
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of XPC mRNA	PMID:25596134
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1305760	E	RGD:6480464	20200114	CTD	MESH:D008687	Metformin results in increased expression of XPC mRNA	PMID:31324951
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1313987	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of XPC mRNA	PMID:36464114
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313987	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of XPC mRNA	PMID:22206623
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of XPC mRNA]	PMID:22206623
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of XPC mRNA	PMID:24136188
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	EXP		E	RGD:6480464	20171114	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [sodium arsenite results in decreased expression of XPC protein]	PMID:28237621
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:75270	nimustine	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:D015376	Nimustine results in increased expression of XPC mRNA	PMID:18089819
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:75270	nimustine	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:D015376	TP53 affects the reaction [Nimustine results in increased expression of XPC mRNA]	PMID:18089819
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:75393	Y-27632	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C108830	Y 27632 results in increased expression of XPC mRNA	PMID:20878077
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of XPC protein	PMID:31285264
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of XPC protein	PMID:39638853
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in increased expression of XPC protein	PMID:39638853
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of XPC mRNA	PMID:30851411
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:78708	Nonidet P-40	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C010615	Nonidet P-40 results in decreased expression of XPC mRNA	PMID:26552463
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to XPC gene]	PMID:28238834
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of XPC protein	PMID:31675489
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1313987	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of XPC mRNA	PMID:38995820
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of XPC mRNA	PMID:21858171
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of XPC mRNA]	PMID:21858171
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:82527	Ptaquiloside	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C043680	ptaquiloside results in increased expression of XPC mRNA	PMID:22143989
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of XPC mRNA	PMID:33512557
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of XPC mRNA	PMID:23726867
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of XPC mRNA	PMID:33645215
1313986	XPC	XPC complex subunit, DNA damage recognition and repair factor	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1305760	E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of XPC mRNA	PMID:25596134
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of MYLIP mRNA	PMID:26272509
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1313989	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MYLIP mRNA	PMID:33045310
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MYLIP mRNA	PMID:26251327
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1305761	E	RGD:6480464	20130806	CTD	MESH:D014212	Tretinoin results in decreased expression of MYLIP mRNA	PMID:20488242
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of MYLIP mRNA	PMID:21934132
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MYLIP mRNA	PMID:22378314
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of MYLIP mRNA	PMID:21632981
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MYLIP mRNA	PMID:39241906
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of MYLIP mRNA	PMID:30510588
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of MYLIP mRNA	PMID:19167446
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313989	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MYLIP mRNA; Estradiol results in increased expression of MYLIP protein	PMID:39298647
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of MYLIP mRNA	PMID:38568856
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305761	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MYLIP mRNA	PMID:33387578
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305761	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of MYLIP gene	PMID:27618143
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MYLIP mRNA	PMID:37042841
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of MYLIP mRNA	PMID:20655997|PMID:23649840
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of MYLIP mRNA	PMID:21795739
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of MYLIP mRNA	PMID:18037150
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MYLIP mRNA	PMID:21179406
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYLIP mRNA	PMID:37992649
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of MYLIP mRNA	PMID:22017230
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1313989	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of MYLIP mRNA	PMID:33848595
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of MYLIP mRNA	PMID:33647349
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of MYLIP mRNA	PMID:31256213
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYLIP mRNA	PMID:37992649
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MYLIP mRNA	PMID:37536456
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305761	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of MYLIP mRNA	PMID:26577399
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MYLIP mRNA	PMID:16002434
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305761	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MYLIP mRNA	PMID:22061828
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MYLIP mRNA	PMID:28818685
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:188736	Archazolid B	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C519728	archazolid B results in decreased expression of MYLIP mRNA	PMID:25218289
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of MYLIP mRNA	PMID:21120746
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MYLIP mRNA	PMID:37236586
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MYLIP mRNA	PMID:19549813
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MYLIP mRNA	PMID:23649840
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MYLIP gene	PMID:27153756
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MYLIP mRNA	PMID:23649840
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MYLIP mRNA	PMID:34911549
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of MYLIP mRNA	PMID:18593933
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MYLIP mRNA	PMID:25629700
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MYLIP mRNA	PMID:22206623
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:27504	mitomycin C	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	MYLIP protein affects the susceptibility to Mitomycin	PMID:16217747
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:27563	arsenic atom	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	MYLIP mRNA results in decreased susceptibility to Arsenic	PMID:17976673
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MYLIP mRNA	PMID:40512198
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MYLIP gene] which results in decreased expression of MYLIP mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MYLIP gene; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MYLIP mRNA	PMID:40504410
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of MYLIP mRNA	PMID:35897073
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305761	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MYLIP mRNA	PMID:31881176
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D007854	Lead affects the expression of MYLIP mRNA	PMID:22313790|PMID:28903495
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of MYLIP mRNA	PMID:18847459
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305761	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MYLIP mRNA	PMID:22298810|PMID:34747641
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305761	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MYLIP mRNA	PMID:33387578
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MYLIP mRNA	PMID:21802500
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305761	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MYLIP mRNA	PMID:32109520
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MYLIP mRNA	PMID:25975270
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MYLIP mRNA	PMID:28001369
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MYLIP mRNA	PMID:33212167
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MYLIP mRNA	PMID:30851411
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of MYLIP mRNA	PMID:26272509
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28428	beta-hexachlorocyclohexane	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in decreased expression of MYLIP mRNA	PMID:25270620
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305761	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MYLIP mRNA	PMID:28959563
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of MYLIP mRNA	PMID:32763439
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of MYLIP mRNA	PMID:21198554
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MYLIP mRNA; [NSC 689534 binds to Copper] which results in increased expression of MYLIP mRNA	PMID:20971185|PMID:24690739
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of MYLIP mRNA	PMID:29803840
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313989	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of MYLIP mRNA	PMID:25896364|PMID:39631538
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYLIP mRNA	PMID:37992649
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of MYLIP mRNA	PMID:39719251
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite results in decreased expression of MYLIP mRNA	PMID:35202923
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MYLIP mRNA	PMID:38568856
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MYLIP mRNA	PMID:40512198
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20240430	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MYLIP gene] which results in decreased expression of MYLIP mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MYLIP gene; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MYLIP mRNA; salvin inhibits the reaction [sodium arsenite results in decreased expression of MYLIP mRNA]	PMID:35202923|PMID:40504410
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MYLIP mRNA	PMID:22378314
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MYLIP mRNA	PMID:20064835|PMID:21802500|PMID:22316170
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313989	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MYLIP mRNA	PMID:22228805
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MYLIP promoter	PMID:27901495
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MYLIP mRNA; [NSC 689534 binds to Copper] which results in increased expression of MYLIP mRNA	PMID:20971185|PMID:24690739
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of MYLIP mRNA	PMID:18593933
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MYLIP mRNA	PMID:20018196
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of MYLIP mRNA	PMID:20382639
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305761	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of MYLIP mRNA	PMID:30047161
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313989	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MYLIP promoter	PMID:35295148
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1313989	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MYLIP gene	PMID:35295148
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305761	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MYLIP mRNA	PMID:34492290
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:33007	chromium(6+)	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of MYLIP mRNA	PMID:30690063
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of MYLIP mRNA	PMID:38479592
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305761	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MYLIP mRNA	PMID:25181051
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305761	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MYLIP mRNA	PMID:30816183|PMID:32528016
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1313989	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of MYLIP mRNA	PMID:30951980|PMID:34585602
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305761	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MYLIP gene	PMID:28505145
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MYLIP mRNA	PMID:25172293
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1313989	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MYLIP gene	PMID:31683443
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313989	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of MYLIP mRNA	PMID:30951980
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1305761	E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein	PMID:34896426
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1313989	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of MYLIP mRNA	PMID:30951980
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1313989	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of MYLIP mRNA	PMID:28392331
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:34786	Heptachlor epoxide	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in decreased expression of MYLIP mRNA	PMID:25270620
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of MYLIP mRNA	PMID:36117858
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MYLIP mRNA	PMID:37042841
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MYLIP mRNA	PMID:38568856
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MYLIP mRNA	PMID:37236586
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305761	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of MYLIP mRNA	PMID:27387713
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1313989	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of MYLIP mRNA	PMID:18353800
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MYLIP mRNA	PMID:31533062
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of MYLIP mRNA	PMID:19167446
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYLIP mRNA	PMID:19167446
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1305761	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of MYLIP protein	PMID:34896426
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of MYLIP mRNA	PMID:26352163
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:39483	sodium dichromate	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in increased expression of MYLIP mRNA	PMID:17685462
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MYLIP mRNA	PMID:25979313
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1313989	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MYLIP mRNA	PMID:17292431
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MYLIP mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1313989	E	RGD:6480464	20120515	CTD	MESH:D014635	Valproic Acid results in increased expression of MYLIP mRNA	PMID:19136453|PMID:21427059
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MYLIP mRNA	PMID:25562108
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1305761	E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein	PMID:34896426
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of MYLIP mRNA	PMID:40633821
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1305761	E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein	PMID:34896426
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYLIP mRNA	PMID:37992649
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:44616	afimoxifene	decreases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C016601	afimoxifene results in decreased expression of MYLIP mRNA	PMID:16849584
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MYLIP mRNA	PMID:38832940
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of MYLIP mRNA	PMID:24935251|PMID:26272509
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of MYLIP mRNA	PMID:21420995|PMID:29067470
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305761	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MYLIP mRNA	PMID:33387578
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:46345	5-fluorouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil affects the expression of MYLIP mRNA	PMID:16584549
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of MYLIP mRNA	PMID:24690739
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:47217	arsane	decreases response to substance	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	MYLIP mRNA results in decreased susceptibility to Arsenic	PMID:17976673
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MYLIP mRNA	PMID:40512198
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MYLIP gene] which results in decreased expression of MYLIP mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of MYLIP gene; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MYLIP mRNA	PMID:40504410
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305761	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MYLIP mRNA	PMID:29391264
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MYLIP mRNA	PMID:22079256
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1305761	E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein	PMID:34896426
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313989	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of MYLIP mRNA	PMID:25554681
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MYLIP mRNA	PMID:25554681
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313989	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MYLIP mRNA; Nanotubes, Carbon results in increased expression of MYLIP mRNA	PMID:25620056
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305761	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of MYLIP mRNA	PMID:30047161
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1313989	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of MYLIP mRNA	PMID:40234311
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:50692	mifepristone	decreases expression	ISO	RGD:1305761	E	RGD:6480464	20150825	CTD	MESH:D015735	Mifepristone results in decreased expression of MYLIP mRNA	PMID:25972201
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of MYLIP mRNA	PMID:36117858
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of MYLIP mRNA	PMID:22714537
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of MYLIP mRNA	PMID:31629900
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of MYLIP mRNA	PMID:26272509
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of MYLIP mRNA	PMID:25270620
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MYLIP mRNA	PMID:22079614
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1313989	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of MYLIP mRNA	PMID:20003209
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:65585	carnosic acid	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20240430	CTD	MESH:C018381	salvin inhibits the reaction [sodium arsenite results in decreased expression of MYLIP mRNA]	PMID:35202923
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MYLIP mRNA	PMID:31758290
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MYLIP mRNA	PMID:22206623
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MYLIP mRNA	PMID:22206623
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of MYLIP mRNA	PMID:22079256|PMID:22714537
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MYLIP mRNA	PMID:22079256
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of MYLIP mRNA	PMID:29522793
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:757488	omega-3 fatty acids	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20260714	CTD	MESH:D015525	Fatty Acids, Omega-3 results in decreased expression of MYLIP mRNA	PMID:23333450
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MYLIP mRNA	PMID:30851411
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MYLIP gene]	PMID:28238834
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:79995	GW 3965	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C473027	GW 3965 results in increased expression of MYLIP mRNA	PMID:27598782
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:79997	GW 4064	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C412815	GW 4064 results in decreased expression of MYLIP mRNA	PMID:31437187
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1313989	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MYLIP mRNA	PMID:23091169
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1313989	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of MYLIP mRNA	PMID:19482888
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313989	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of MYLIP mRNA]	PMID:19482888
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYLIP mRNA	PMID:19167446
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313989	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MYLIP mRNA	PMID:39847705
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305761	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MYLIP mRNA	PMID:30047161
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of MYLIP mRNA	PMID:26272509
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYLIP mRNA	PMID:27188386
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305761	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of MYLIP mRNA	PMID:19281266
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MYLIP mRNA	PMID:38568856
1313988	MYLIP	myosin regulatory light chain interacting protein	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MYLIP mRNA	PMID:29301935
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of EBNA1BP2 protein	PMID:39638853
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1313991	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of EBNA1BP2 mRNA	PMID:33045310
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1313991	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of EBNA1BP2 mRNA	PMID:37995155
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305762	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EBNA1BP2 mRNA]	PMID:31150632
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of EBNA1BP2 mRNA	PMID:16054129|PMID:23724009
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EBNA1BP2 mRNA	PMID:30529165
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of EBNA1BP2 mRNA	PMID:22378314
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:16130	DDT	increases expression	ISO	RGD:1305762	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased expression of EBNA1BP2 mRNA	PMID:30207508
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of EBNA1BP2 mRNA	PMID:20044591
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313991	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EBNA1BP2 mRNA	PMID:39241906
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1313991	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of EBNA1BP2 mRNA	PMID:15598610
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of EBNA1BP2 mRNA	PMID:38568856
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EBNA1BP2 mRNA	PMID:37042841
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of EBNA1BP2 protein	PMID:32044396
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of EBNA1BP2 protein	PMID:34122009
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305762	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of EBNA1BP2 mRNA	PMID:22061828
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EBNA1BP2 mRNA	PMID:36331819
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EBNA1BP2 mRNA	PMID:37236586
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of EBNA1BP2 mRNA	PMID:23649840
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EBNA1BP2 gene	PMID:27153756
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of EBNA1BP2 protein	PMID:39638853
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of EBNA1BP2 mRNA	PMID:23649840
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1305762	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of EBNA1BP2 mRNA	PMID:41580963
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305762	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of EBNA1BP2 mRNA	PMID:33387578
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305762	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EBNA1BP2 mRNA	PMID:31150632
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313991	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EBNA1BP2 mRNA	PMID:27339419|PMID:31919559
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305762	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EBNA1BP2 mRNA]	PMID:31150632
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1313991	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of EBNA1BP2 mRNA	PMID:25629700
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EBNA1BP2 mRNA	PMID:22206623
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EBNA1BP2 mRNA	PMID:40504410
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:2762	antimycin A	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of EBNA1BP2 mRNA	PMID:33512557
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of EBNA1BP2 mRNA	PMID:23557933
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of EBNA1BP2 mRNA	PMID:27594783
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of EBNA1BP2 mRNA	PMID:25583101
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313991	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EBNA1BP2 mRNA	PMID:21570461
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EBNA1BP2 mRNA	PMID:21215274
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EBNA1BP2 mRNA	PMID:30851411
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1313991	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of EBNA1BP2 mRNA	PMID:30807115
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EBNA1BP2 mRNA	PMID:29803840
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of EBNA1BP2 mRNA	PMID:20044591
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of EBNA1BP2 mRNA	PMID:38568856
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EBNA1BP2 mRNA	PMID:40504410
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313991	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EBNA1BP2 mRNA	PMID:22228805
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of EBNA1BP2 protein	PMID:34122009
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of EBNA1BP2 mRNA	PMID:25895662
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1313991	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of EBNA1BP2 mRNA	PMID:35676786
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:D005897	Glafenine results in increased expression of EBNA1BP2 mRNA	PMID:24136188
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305762	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of EBNA1BP2 mRNA	PMID:25729387
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313991	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EBNA1BP2 promoter alternative form	PMID:35295148
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:D013853	Thioacetamide results in increased expression of EBNA1BP2 mRNA	PMID:23411599|PMID:34492290
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313991	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of EBNA1BP2 mRNA	PMID:18648102
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of EBNA1BP2 mRNA; bisphenol A results in decreased expression of EBNA1BP2 protein	PMID:29275510|PMID:37567409
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305762	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of EBNA1BP2 mRNA	PMID:33296240
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:C006780	bisphenol A results in increased expression of EBNA1BP2 mRNA	PMID:25181051|PMID:36779543
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313991	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EBNA1BP2 mRNA	PMID:39298647
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1313991	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of EBNA1BP2 intron	PMID:28392331
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EBNA1BP2 mRNA	PMID:17602206
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of EBNA1BP2 mRNA	PMID:17602206
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305762	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of EBNA1BP2 mRNA	PMID:32680482
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EBNA1BP2 mRNA	PMID:37236586
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313991	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of EBNA1BP2 mRNA	PMID:28903501
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EBNA1BP2 mRNA	PMID:19320972|PMID:19376846
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of EBNA1BP2 mRNA	PMID:24449571
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1313991	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of EBNA1BP2 mRNA	PMID:25908611
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313991	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of EBNA1BP2 mRNA	PMID:17585979
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of EBNA1BP2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of EBNA1BP2 mRNA]	PMID:17585979
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of EBNA1BP2 mRNA	PMID:26352163
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EBNA1BP2 mRNA	PMID:36331819
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:C016104	sodium bichromate results in increased expression of EBNA1BP2 mRNA	PMID:25993096
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EBNA1BP2 mRNA	PMID:25979313
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of EBNA1BP2 mRNA	PMID:23179753|PMID:25192806|PMID:26272509|PMID:28001369
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBNA1BP2 mRNA	PMID:27188386
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of EBNA1BP2 mRNA	PMID:22147139
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of EBNA1BP2 mRNA	PMID:20106945
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of EBNA1BP2 promoter	PMID:27989131
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of EBNA1BP2 mRNA	PMID:33512557
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:C012655	nimesulide results in increased expression of EBNA1BP2 mRNA	PMID:24136188
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of EBNA1BP2 mRNA	PMID:38832940
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1313991	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EBNA1BP2 mRNA	PMID:17562736
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of EBNA1BP2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of EBNA1BP2 mRNA]	PMID:17585979
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EBNA1BP2 mRNA	PMID:40504410
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305762	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of EBNA1BP2 mRNA	PMID:29391264
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1313991	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of EBNA1BP2 mRNA	PMID:35676786
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313991	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of EBNA1BP2 mRNA; Nanotubes, Carbon results in increased expression of EBNA1BP2 mRNA	PMID:25554681|PMID:25620056
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1305762	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of EBNA1BP2 mRNA	PMID:34044035
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:D005485	Flutamide results in increased expression of EBNA1BP2 mRNA	PMID:24136188
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313991	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of EBNA1BP2 mRNA	PMID:19042947
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EBNA1BP2 protein	PMID:32959892
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of EBNA1BP2 mRNA	PMID:25729387
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305762	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of EBNA1BP2 mRNA	PMID:24136188
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313991	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of EBNA1BP2 mRNA	PMID:23650126
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of EBNA1BP2 protein	PMID:34186270
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1313991	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EBNA1BP2 mRNA	PMID:22206623
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EBNA1BP2 protein	PMID:37664457
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:C051752	nefazodone results in increased expression of EBNA1BP2 mRNA	PMID:24136188
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of EBNA1BP2 protein	PMID:31285264
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of EBNA1BP2 protein	PMID:39638853
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of EBNA1BP2 mRNA	PMID:21346803
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EBNA1BP2 mRNA	PMID:30851411
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBNA1BP2 mRNA	PMID:27188386
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EBNA1BP2 gene]	PMID:28238834
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of EBNA1BP2 mRNA	PMID:21858171
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1313991	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of EBNA1BP2 mRNA	PMID:39847705
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1313991	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of EBNA1BP2 mRNA	PMID:21278054
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EBNA1BP2 protein; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EBNA1BP2 mRNA	PMID:27188386|PMID:37664457
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of EBNA1BP2 mRNA	PMID:21346803
1313990	EBNA1BP2	EBNA1 binding protein 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305762	E	RGD:6480464	20160906	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EBNA1BP2 mRNA	PMID:21346803
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:132446	perfluorobutanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C539348	perfluorobutanesulfonic acid results in decreased expression of KCNJ6 mRNA	PMID:40334771
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:132446	perfluorobutanesulfonic acid	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C539348	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of KCNJ6 mRNA	PMID:40334771
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of KCNJ6 mRNA	PMID:34925699
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of KCNJ6 mRNA	PMID:24763279
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of KCNJ6 mRNA	PMID:26079696
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:16236	ethanol	increases activity	ISO	RGD:731945	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in increased activity of KCNJ6 protein	PMID:16626657
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:2959	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol promotes the reaction [[KCNJ3 protein binds to KCNJ6 protein] which results in increased transport of Potassium]; Ethosuximide inhibits the reaction [Ethanol promotes the reaction [[KCNJ3 protein binds to KCNJ6 protein] which results in increased transport of Potassium]]	PMID:18977371
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:731945	E	RGD:6480464	20120412	CTD	MESH:D000431	Ethanol results in increased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]; Sertraline inhibits the reaction [Ethanol results in increased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]]	PMID:22164246
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:17578	toluene	decreases activity	ISO	RGD:731945	E	RGD:6480464	20120412	CTD	MESH:D014050	Toluene results in decreased activity of KCNJ6 protein	PMID:16626657
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:2959	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of KCNJ6 mRNA	PMID:26577399
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	affects response to substance	ISO	RGD:731945	E	RGD:6480464	20120613	CTD	MESH:D015632	KCNJ6 affects the susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	PMID:8172626
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:18160	ubiquinone-9	decreases abundance	ISO	RGD:731945	E	RGD:6480464	20120412	CTD	MESH:C030571	KCNJ6 gene mutant form results in decreased abundance of ubiquinone 9	PMID:15256069
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:18243	dopamine	decreases abundance	ISO	RGD:731945	E	RGD:6480464	20120412	CTD	MESH:D004298	KCNJ6 gene mutant form results in decreased abundance of Dopamine	PMID:15256069
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KCNJ6 gene	PMID:27153756
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:26216	potassium atom	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D011188	KCNJ6 protein results in increased transport of Potassium	PMID:11707631
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:26216	potassium atom	increases transport	ISO	RGD:731945	E	RGD:6480464	20120918	CTD	MESH:D011188	KCNJ6 protein results in increased transport of Potassium	PMID:12684268
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:26216	potassium atom	multiple interactions	ISO	RGD:2959	E	RGD:6480464	20120412	CTD	MESH:D011188	[KCNJ6 protein binds to KCNJ3 protein] which results in increased transport of Potassium; Ethanol promotes the reaction [[KCNJ3 protein binds to KCNJ6 protein] which results in increased transport of Potassium]; Ethosuximide inhibits the reaction [Ethanol promotes the reaction [[KCNJ3 protein binds to KCNJ6 protein] which results in increased transport of Potassium]]	PMID:18977371
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:26216	potassium atom	multiple interactions	ISO	RGD:731945	E	RGD:6480464	20120412	CTD	MESH:D011188	[KCNJ3 protein binds to KCNJ6 protein] which results in increased transport of Potassium; [KCNJ3 protein co-treated with KCNJ6 protein] results in increased transport of Potassium; Ethosuximide inhibits the reaction [[KCNJ3 protein binds to KCNJ6 protein] which results in increased transport of Potassium]; Fluoxetine inhibits the reaction [[KCNJ3 protein co-treated with KCNJ6 protein] results in increased transport of Potassium]; Fluoxetine inhibits the reaction [KCNJ6 protein results in increased transport of Potassium]	PMID:12684268|PMID:18977371
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:2675	amoxapine	multiple interactions	ISO	RGD:731945	E	RGD:6480464	20120412	CTD	MESH:D000657	Amoxapine results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]	PMID:22164246
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of KCNJ6 mRNA	PMID:41028656
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of KCNJ6 mRNA	PMID:19921347
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of KCNJ6 mRNA	PMID:27392435
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of KCNJ6 mRNA	PMID:27392435
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:2959	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of KCNJ6 mRNA	PMID:20187946
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of KCNJ6 mRNA	PMID:12629581
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:2959	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of KCNJ6 mRNA	PMID:17898221
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:2959	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KCNJ6 mRNA	PMID:32109520
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KCNJ6 mRNA	PMID:11489354
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KCNJ6 mRNA	PMID:23203475
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of KCNJ6 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of KCNJ6 mRNA	PMID:20971185|PMID:41028656
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:2972	baclofen	increases response to substance	ISO	RGD:731945	E	RGD:6480464	20120412	CTD	MESH:D001418	KCNJ6 results in increased susceptibility to Baclofen	PMID:12836919
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KCNJ6 5' UTR; Benzo(a)pyrene affects the methylation of KCNJ6 intron	PMID:27901495|PMID:30157460
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:731945	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KCNJ6 intron	PMID:27901495
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KCNJ6 mRNA	PMID:38036013
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:2959	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KCNJ6 mRNA	PMID:21839799
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KCNJ6 exon; Benzo(a)pyrene results in increased methylation of KCNJ6 promoter	PMID:27901495
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of KCNJ6 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of KCNJ6 mRNA	PMID:20971185|PMID:41028656
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:30440	thallium atom	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D013793	[GRM8 protein results in increased activity of [KCNJ3 protein binds to KCNJ6 protein]] which results in increased transport of Thallium	PMID:22275899
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:31526	(S)-duloxetine hydrochloride	multiple interactions	ISO	RGD:731945	E	RGD:6480464	20160119	CTD	MESH:D000068736	Duloxetine Hydrochloride results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]	PMID:22164246
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of KCNJ6 gene	PMID:31601247
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of KCNJ6 gene	PMID:31601247
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:731945	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of KCNJ6 mRNA	PMID:35295148
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:731945	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KCNJ6 gene	PMID:35295148
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2959	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KCNJ6 mRNA	PMID:25181051|PMID:41034487
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of KCNJ6 gene	PMID:31601247
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of KCNJ6 gene	PMID:31601247
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:731945	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of KCNJ6 gene	PMID:31683443
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of KCNJ6 gene	PMID:31601247
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:731945	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of KCNJ6 exon	PMID:33297965
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:731945	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of KCNJ6 intron	PMID:28392331
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:731945	E	RGD:6480464	20190219	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of KCNJ6 mRNA	PMID:29156651|PMID:32715474
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:731945	E	RGD:6480464	20121113	CTD	MESH:D010269	Paraquat results in increased expression of KCNJ6 mRNA	PMID:22563483
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C023036	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of KCNJ6 mRNA	PMID:40334771
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:2959	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of KCNJ6 mRNA	PMID:27638505
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:731945	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of KCNJ6 mRNA	PMID:40194260
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of KCNJ6 mRNA	PMID:40419075
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of KCNJ6 mRNA	PMID:40334771
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KCNJ6 mRNA	PMID:25979313
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:2959	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of KCNJ6 mRNA	PMID:29427782
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:46245	coenzyme Q10	decreases abundance	ISO	RGD:731945	E	RGD:6480464	20161213	CTD	MESH:C024989	KCNJ6 gene mutant form results in decreased abundance of coenzyme Q10	PMID:15256069
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:46678	amosite asbestos	increases expression	ISO	RGD:731945	E	RGD:6480464	20161213	CTD	MESH:D017639	Asbestos, Amosite results in increased expression of KCNJ6 mRNA	PMID:23917077
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:4887	ethosuximide	multiple interactions	ISO	RGD:2959	E	RGD:6480464	20120412	CTD	MESH:D005013	Ethosuximide inhibits the reaction [Ethanol promotes the reaction [[KCNJ3 protein binds to KCNJ6 protein] which results in increased transport of Potassium]]	PMID:18977371
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:4887	ethosuximide	multiple interactions	ISO	RGD:731945	E	RGD:6480464	20120412	CTD	MESH:D005013	Ethosuximide inhibits the reaction [[KCNJ3 protein binds to KCNJ6 protein] which results in increased transport of Potassium]	PMID:18977371
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:51137	mianserin	multiple interactions	ISO	RGD:731945	E	RGD:6480464	20120412	CTD	MESH:D008803	Mianserin affects the activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]	PMID:22164246
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:5118	fluoxetine	multiple interactions	ISO	RGD:731945	E	RGD:6480464	20120918	CTD	MESH:D005473	Fluoxetine inhibits the reaction [[KCNJ3 protein co-treated with KCNJ6 protein] results in increased transport of Potassium]; Fluoxetine inhibits the reaction [KCNJ6 protein results in increased transport of Potassium]	PMID:12684268
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:5299	Geniposide	increases expression	ISO	RGD:731945	E	RGD:6480464	20240305	CTD	MESH:C007835	geniposide results in increased expression of KCNJ6 mRNA	PMID:37311497
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:6015	isoflurane	increases methylation	ISO	RGD:731945	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in increased methylation of KCNJ6 mRNA	PMID:35249202
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D015655	KCNJ6 protein promotes the reaction [SNCA protein results in increased susceptibility to 1-Methyl-4-phenylpyridinium]	PMID:15888489
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:731945	E	RGD:6480464	20120613	CTD	MESH:D008694	Methamphetamine results in decreased expression of KCNJ6 mRNA	PMID:21886566
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:6950	mirtazapine	multiple interactions	ISO	RGD:731945	E	RGD:6480464	20161213	CTD	MESH:C035133	mirtazapine affects the activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]	PMID:22164246
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:7494	nefazodone	multiple interactions	ISO	RGD:731945	E	RGD:6480464	20120412	CTD	MESH:C051752	nefazodone affects the activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]	PMID:22164246
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:7936	paroxetine	multiple interactions	ISO	RGD:731945	E	RGD:6480464	20120412	CTD	MESH:D017374	Paroxetine results in decreased activity of [KCNJ3 protein binds to KCNJ6 protein]; Paroxetine results in decreased activity of [KCNJ6 protein binds to KCNJ5 protein]; Paroxetine results in decreased activity of [KCNJ6 protein binds to KCNJ6 protein]	PMID:17072103
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:2959	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of KCNJ6 mRNA	PMID:32109520
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:2959	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KCNJ6 mRNA	PMID:24780913
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:2959	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of KCNJ6 mRNA	PMID:24780913
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:9123	sertraline	multiple interactions	ISO	RGD:731945	E	RGD:6480464	20120412	CTD	MESH:D020280	Sertraline inhibits the reaction [Ethanol results in increased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]]; Sertraline results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]	PMID:22164246
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:9130	sevoflurane	increases methylation	ISO	RGD:731945	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased methylation of KCNJ6 mRNA	PMID:35249202
1313992	KCNJ6	potassium inwardly rectifying channel subfamily J member 6	gene	CHEBI:9944	venlafaxine hydrochloride	multiple interactions	ISO	RGD:731945	E	RGD:6480464	20170303	CTD	MESH:D000069470	Venlafaxine Hydrochloride affects the activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]	PMID:22164246
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of NUSAP1 mRNA	PMID:31863870
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in decreased expression of NUSAP1 mRNA	PMID:24172598
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NUSAP1 mRNA	PMID:39752319
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of NUSAP1 mRNA	PMID:34925699
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NUSAP1 mRNA	PMID:20938992
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D014212	Tretinoin results in decreased expression of NUSAP1 mRNA	PMID:16249480|PMID:21934132|PMID:33167477
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of NUSAP1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of NUSAP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of NUSAP1 mRNA	PMID:32699268|PMID:32845096
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of NUSAP1 mRNA	PMID:21632981
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:16412	lipopolysaccharide	affects expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D008070	Lipopolysaccharides affects the expression of NUSAP1 mRNA	PMID:28070326
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D008070	Plant Extracts affects the reaction [Lipopolysaccharides affects the expression of NUSAP1 mRNA]	PMID:28070326
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305764	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of NUSAP1 mRNA	PMID:32145629
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of NUSAP1 mRNA	PMID:23019147
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of NUSAP1 mRNA	PMID:39298647
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:D004958	Estradiol results in increased expression of NUSAP1 mRNA	PMID:18310284|PMID:19167446
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313994	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of NUSAP1 mRNA	PMID:25210133
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in increased expression of NUSAP1 mRNA]	PMID:25210133
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUSAP1 mRNA	PMID:25510870
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NUSAP1 mRNA	PMID:33387578
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of NUSAP1 mRNA	PMID:25549359
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NUSAP1 mRNA	PMID:20938992
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:16767	3,4-dichloroaniline	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in decreased expression of NUSAP1 mRNA	PMID:24172598
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of NUSAP1 mRNA	PMID:21795739
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of NUSAP1 mRNA	PMID:18070364
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of NUSAP1 mRNA	PMID:26079696
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NUSAP1 mRNA	PMID:39752319
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:17300	tetrachloroethene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of NUSAP1 mRNA	PMID:19031421
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of NUSAP1 mRNA	PMID:21592394
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of NUSAP1 mRNA	PMID:21592394
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1305764	E	RGD:6480464	20130312	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of NUSAP1 mRNA	PMID:22584684
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of NUSAP1 mRNA	PMID:27683099
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:177387	brequinar	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C046943	brequinar results in decreased expression of NUSAP1 mRNA	PMID:39900124
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305764	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of NUSAP1 mRNA	PMID:26577399
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NUSAP1 protein	PMID:37730182
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of NUSAP1 mRNA	PMID:21592394
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of NUSAP1 mRNA	PMID:21592394
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NUSAP1 mRNA	PMID:28818685
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NUSAP1 mRNA	PMID:36331819
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:2038	5-azacytidine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001374	[Azacitidine co-treated with Thalidomide] affects the expression of NUSAP1 mRNA	PMID:18720364
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of NUSAP1 mRNA	PMID:21120746|PMID:24376830
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUSAP1 mRNA	PMID:28111341
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUSAP1 mRNA	PMID:25510870
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUSAP1 mRNA	PMID:25510870
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NUSAP1 mRNA	PMID:19549813
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of NUSAP1 mRNA	PMID:23649840
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of NUSAP1 protein	PMID:20106945
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of NUSAP1 mRNA	PMID:27153756
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305764	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NUSAP1 mRNA	PMID:23630614|PMID:25378103
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of NUSAP1 mRNA	PMID:23649840
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of NUSAP1 mRNA	PMID:25102026
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of NUSAP1 mRNA	PMID:32553695
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of NUSAP1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of NUSAP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of NUSAP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of NUSAP1 mRNA	PMID:32699268|PMID:32845096
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NUSAP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of NUSAP1 mRNA; TTPA protein affects the reaction [Ozone results in increased expression of NUSAP1 mRNA]	PMID:19555225|PMID:27106289|PMID:34911549
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of NUSAP1 mRNA	PMID:22171008
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D014747	NUSAP1 protein affects the susceptibility to Vinblastine	PMID:16217747
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of NUSAP1 mRNA	PMID:17484886
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1313994	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NUSAP1 mRNA	PMID:27339419|PMID:29987408|PMID:31919559
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NUSAP1 mRNA	PMID:25629700
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D005492	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of NUSAP1 mRNA	PMID:24657277
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NUSAP1 mRNA	PMID:20938992
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27504	mitomycin C	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in decreased expression of NUSAP1 mRNA	PMID:25270620
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NUSAP1 mRNA	PMID:39836092
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUSAP1 mRNA	PMID:40504410
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of NUSAP1 mRNA	PMID:26272509
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUSAP1 mRNA	PMID:27188386
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of NUSAP1 protein	PMID:35688186
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of NUSAP1 mRNA	PMID:28960355
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305764	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of NUSAP1 mRNA	PMID:31881176
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of NUSAP1 mRNA	PMID:19167446
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in decreased expression of NUSAP1 mRNA	PMID:25270620|PMID:40618947
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in increased expression of NUSAP1 mRNA	PMID:19031421
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUSAP1 mRNA	PMID:22298810
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305764	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUSAP1 mRNA	PMID:22298810
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313994	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUSAP1 mRNA	PMID:21570461
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NUSAP1 mRNA	PMID:21802500
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NUSAP1 mRNA	PMID:32109520|PMID:33387578
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305764	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NUSAP1 mRNA	PMID:34747641
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NUSAP1 mRNA	PMID:17942748
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of NUSAP1 mRNA	PMID:33512557
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of NUSAP1 mRNA	PMID:28374803
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NUSAP1 mRNA	PMID:33212167
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305764	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of NUSAP1 mRNA	PMID:28959563
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305764	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of NUSAP1 mRNA	PMID:30556269
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NUSAP1 mRNA	PMID:20971185
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	NUSAP1 protein affects the susceptibility to Doxorubicin	PMID:16217747
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NUSAP1 mRNA	PMID:29803840|PMID:30031762
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of NUSAP1 mRNA	PMID:39631538
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1313994	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of NUSAP1 mRNA	PMID:36227756
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:29014	cordycepin	increases expression	ISO	RGD:1313994	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in increased expression of NUSAP1 mRNA	PMID:32042022
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of NUSAP1 mRNA	PMID:22623647
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NUSAP1 mRNA	PMID:38568856
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of NUSAP1 mRNA	PMID:17998272
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of NUSAP1 mRNA	PMID:29301061
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1313994	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of NUSAP1 mRNA	PMID:39095385
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NUSAP1 mRNA	PMID:39836092
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUSAP1 mRNA	PMID:40504410
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NUSAP1 mRNA	PMID:22378314
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NUSAP1 mRNA	PMID:21632981|PMID:21802500|PMID:26238291
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NUSAP1 mRNA	PMID:21569818
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of NUSAP1 mRNA; Benzo(a)pyrene results in increased expression of NUSAP1 mRNA	PMID:32417428|PMID:32553695
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305764	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of NUSAP1 mRNA	PMID:30556269
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NUSAP1 mRNA	PMID:20971185
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of NUSAP1 mRNA	PMID:22171008
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of NUSAP1 mRNA	PMID:27131904
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NUSAP1 mRNA	PMID:25351596
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1313994	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NUSAP1 mRNA	PMID:29341224
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUSAP1 mRNA	PMID:20018196|PMID:20382639
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of NUSAP1 mRNA	PMID:20458559
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:3090	bicalutamide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in decreased expression of NUSAP1 mRNA	PMID:15638997
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of NUSAP1 mRNA	PMID:25729387
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305764	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NUSAP1 mRNA	PMID:25729387
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305764	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of NUSAP1 mRNA	PMID:30047161
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1305764	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of NUSAP1 mRNA	PMID:30012374
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1313994	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of NUSAP1 mRNA	PMID:23557971
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305764	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of NUSAP1 mRNA	PMID:23411599|PMID:34492290
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of NUSAP1 mRNA	PMID:18648102
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of NUSAP1 mRNA	PMID:17950772
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NUSAP1 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of NUSAP1 mRNA]	PMID:17950772|PMID:19710929
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of NUSAP1 mRNA	PMID:19191707
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1313994	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of NUSAP1 mRNA	PMID:28472532
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of NUSAP1 mRNA	PMID:38479592
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NUSAP1 mRNA	PMID:30903817
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305764	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of NUSAP1 mRNA	PMID:32145629
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of NUSAP1 mRNA	PMID:29275510
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NUSAP1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305764	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NUSAP1 mRNA	PMID:36041667
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of NUSAP1 mRNA	PMID:26682919
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUSAP1 mRNA	PMID:25510870
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of NUSAP1 mRNA	PMID:25510870
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of NUSAP1 mRNA	PMID:20713471
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of NUSAP1 mRNA	PMID:39298647|PMID:40203079
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305764	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NUSAP1 mRNA	PMID:36041667
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of NUSAP1 mRNA	PMID:26377693
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305764	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NUSAP1 mRNA	PMID:36041667
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NUSAP1 mRNA	PMID:24535843
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1313994	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of NUSAP1 mRNA	PMID:26377693
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305764	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of NUSAP1 mRNA	PMID:30723492
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NUSAP1 mRNA	PMID:25993096
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NUSAP1 mRNA	PMID:28111341
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305764	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of NUSAP1 mRNA	PMID:25539665
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305764	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of NUSAP1 mRNA	PMID:30047161
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1313994	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of NUSAP1 mRNA	PMID:22698814
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NUSAP1 mRNA	PMID:19376846
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NUSAP1 mRNA	PMID:24386269
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of NUSAP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of NUSAP1 mRNA	PMID:32699268
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of NUSAP1 mRNA	PMID:19031421
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of NUSAP1 mRNA	PMID:32588087
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of NUSAP1 mRNA	PMID:40194260
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1313994	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NUSAP1 mRNA	PMID:40194260
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of NUSAP1 mRNA	PMID:28302478
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NUSAP1 mRNA	PMID:31533062
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of NUSAP1 mRNA	PMID:19167446
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUSAP1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of NUSAP1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of NUSAP1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of NUSAP1 mRNA]	PMID:18310284|PMID:19167446
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of NUSAP1 mRNA	PMID:39529242
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NUSAP1 mRNA	PMID:40419075
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NUSAP1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NUSAP1 mRNA	PMID:36331819
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NUSAP1 mRNA	PMID:25979313
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of NUSAP1 mRNA	PMID:28001369
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of NUSAP1 mRNA	PMID:41580965
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305764	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NUSAP1 mRNA	PMID:30047161
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NUSAP1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of NUSAP1 mRNA	PMID:33512557
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:41308	benzophenone	increases expression	ISO	RGD:1305764	E	RGD:6480464	20130312	CTD	MESH:C047723	benzophenone results in increased expression of NUSAP1 mRNA	PMID:22584684
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of NUSAP1 mRNA	PMID:17555576
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1313994	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of NUSAP1 mRNA	PMID:28973697
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of NUSAP1 mRNA	PMID:23649840
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of NUSAP1 mRNA	PMID:24657277
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:44185	methotrexate	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	[Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of NUSAP1 mRNA	PMID:24657277
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NUSAP1 mRNA	PMID:38832940
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:45863	paclitaxel	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	NUSAP1 protein affects the susceptibility to Paclitaxel	PMID:16217747
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NUSAP1 mRNA	PMID:33387578
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NUSAP1 mRNA	PMID:22230336
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NUSAP1 mRNA	PMID:39836092
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NUSAP1 mRNA	PMID:40504410
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305764	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of NUSAP1 mRNA	PMID:29391264
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:4846	erythromycin estolate	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20140812	CTD	MESH:D004918	Erythromycin Estolate results in decreased expression of NUSAP1 mRNA	PMID:24412560
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:4846	erythromycin estolate	increases expression	ISO	RGD:1305764	E	RGD:6480464	20140812	CTD	MESH:D004918	Erythromycin Estolate results in increased expression of NUSAP1 mRNA	PMID:24412560
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NUSAP1 mRNA	PMID:17555576
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NUSAP1 mRNA	PMID:17942748
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NUSAP1 mRNA	PMID:17942748
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of NUSAP1 mRNA	PMID:20458559
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1313994	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of NUSAP1 mRNA	PMID:25270620
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1313994	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of NUSAP1 mRNA	PMID:25554681
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1313994	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NUSAP1 mRNA	PMID:25554681
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305764	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NUSAP1 mRNA	PMID:30047161
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of NUSAP1 mRNA	PMID:21148553
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305764	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of NUSAP1 mRNA	PMID:24793618
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1313994	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NUSAP1 mRNA	PMID:19042947
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of NUSAP1 protein	PMID:23718831
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1313994	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of NUSAP1 mRNA	PMID:38701926
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of NUSAP1 mRNA	PMID:20080153
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of NUSAP1 mRNA	PMID:25729387
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305764	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NUSAP1 mRNA	PMID:25729387
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of NUSAP1 mRNA	PMID:24136188
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of NUSAP1 mRNA	PMID:23650126
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of NUSAP1 mRNA	PMID:28988120
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of NUSAP1 mRNA	PMID:24136188
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of NUSAP1 mRNA	PMID:15336504
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NUSAP1 mRNA	PMID:24810058
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NUSAP1 mRNA	PMID:37269647
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of NUSAP1 mRNA	PMID:19031421
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305764	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of NUSAP1 mRNA	PMID:35283115
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305764	E	RGD:6480464	20130312	CTD	MESH:D008701	Methapyrilene results in increased expression of NUSAP1 mRNA	PMID:22584684
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:70778	GW 7647	increases expression	ISO	RGD:1313994	E	RGD:6480464	20250805	CTD	MESH:C453899	GW 7647 results in increased expression of NUSAP1 mRNA	PMID:40216583
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:70778	GW 7647	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250805	CTD	MESH:C453899	PPARA gene mutant form inhibits the reaction [GW 7647 results in increased expression of NUSAP1 mRNA]	PMID:40216583
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NUSAP1 mRNA	PMID:39752319
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of NUSAP1 mRNA	PMID:27225895
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of NUSAP1 mRNA	PMID:27225895
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of NUSAP1 mRNA	PMID:29522793
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of NUSAP1 mRNA	PMID:27858113
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NUSAP1 mRNA	PMID:37199045
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1305764	E	RGD:6480464	20190219	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of NUSAP1 mRNA	PMID:29877212
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:76989	phytoestrogen	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:D048789	Phytoestrogens results in increased expression of NUSAP1 mRNA	PMID:18310284
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of NUSAP1 mRNA	PMID:34995734
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUSAP1 mRNA	PMID:27188386
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of NUSAP1 mRNA	PMID:18927307
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in decreased expression of NUSAP1 mRNA	PMID:20097248
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:8064	phenformin	decreases expression	ISO	RGD:1305764	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of NUSAP1 mRNA	PMID:31324951
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1313994	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of NUSAP1 mRNA	PMID:19482888|PMID:23091169
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of NUSAP1 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NUSAP1 mRNA]	PMID:19482888|PMID:24535843
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of NUSAP1 mRNA	PMID:19167446
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1313994	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of NUSAP1 mRNA	PMID:38648751
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of NUSAP1 mRNA	PMID:26705709
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of NUSAP1 mRNA	PMID:32234424
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305764	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of NUSAP1 mRNA	PMID:24780913|PMID:30047161
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:85993	palbociclib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of NUSAP1 mRNA	PMID:22869556
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1313994	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of NUSAP1 mRNA	PMID:39752319
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1305764	E	RGD:6480464	20200915	CTD	MESH:C009237	senecionine results in increased expression of NUSAP1 mRNA	PMID:32419051
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUSAP1 mRNA	PMID:27188386
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:9111	Senkirkine	increases expression	ISO	RGD:1305764	E	RGD:6480464	20200915	CTD	MESH:C009238	senkirkine results in increased expression of NUSAP1 mRNA	PMID:32419051
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of NUSAP1 mRNA	PMID:27131904
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:9513	thalidomide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013792	[Azacitidine co-treated with Thalidomide] affects the expression of NUSAP1 mRNA	PMID:18720364
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of NUSAP1 mRNA	PMID:22378314
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of NUSAP1 mRNA	PMID:19140230
1313993	NUSAP1	nucleolar and spindle associated protein 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1313994	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of NUSAP1 mRNA	PMID:35537566
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of HBQ1 mRNA	PMID:26079696
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of HBQ1 mRNA	PMID:26079696
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of HBQ1 mRNA	PMID:28412506
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of HBQ1 mRNA	PMID:28818685
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of HBQ1 mRNA	PMID:23557933
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1623541	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of HBQ1B mRNA	PMID:40618947
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of HBQ1 mRNA	PMID:27392435
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of HBQ1 mRNA	PMID:27392435
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:2320907	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of HBQ1 mRNA	PMID:28374803
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of HBQ1 mRNA	PMID:29955902
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of HBQ1 mRNA	PMID:22378314
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HBQ1 3' UTR; Benzo(a)pyrene results in increased methylation of HBQ1 exon; Benzo(a)pyrene results in increased methylation of HBQ1 promoter	PMID:27901495
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1623541	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of HBQ1B mRNA	PMID:29264374
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2320907	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of HBQ1 mRNA	PMID:32145629
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1623541	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of HBQ1B mRNA	PMID:28392331
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1623541	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of HBQ1B mRNA	PMID:32715474
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:2320907	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of HBQ1B mRNA	PMID:30723492
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of HBQ1 mRNA	PMID:36251517
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:39426	perfluorobutyric acid	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C033094	perfluorobutyric acid results in increased expression of HBQ1 mRNA	PMID:36251517
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HBQ1 mRNA	PMID:25979313
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of HBQ1 mRNA	PMID:28001369
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of HBQ1 gene	PMID:29154799
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623541	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of HBQ1 mRNA	PMID:17562736
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of HBQ1 mRNA	PMID:22230336
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of HBQ1 mRNA	PMID:18175754
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1623541	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of HBQ1B mRNA	PMID:23608068
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of HBQ1 mRNA	PMID:24810058
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:78492	diallyl trisulfide	increases expression	ISO	RGD:2320907	E	RGD:6480464	20240604	CTD	MESH:C042577	diallyl trisulfide results in increased expression of HBQ1B mRNA	PMID:34014027
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of HBQ1 mRNA	PMID:30458266
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of HBQ1 mRNA	PMID:26079696
1313995	HBQ1	hemoglobin subunit theta 1	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of HBQ1 mRNA	PMID:22378314
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of NUDT21 mRNA	PMID:15498508|PMID:33167477
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552286	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of NUDT21 mRNA	PMID:30319688
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of NUDT21 mRNA	PMID:35877022
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of NUDT21 mRNA	PMID:38568856
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NUDT21 mRNA	PMID:37042841
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552286	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NUDT21 mRNA	PMID:33754040
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305766	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of NUDT21 mRNA	PMID:22061828
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NUDT21 mRNA	PMID:35301059
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552286	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUDT21 mRNA	PMID:22206623
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:27563	arsenic atom	increases ubiquitination	EXP		E	RGD:6480464	20230704	CTD	MESH:D001151	Arsenic results in increased ubiquitination of NUDT21 protein	PMID:35994080
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NUDT21 mRNA	PMID:23557933
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of NUDT21 mRNA	PMID:27594783
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1552286	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of NUDT21 mRNA	PMID:30912803
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1552286	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of NUDT21 mRNA	PMID:18930951
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUDT21 mRNA	PMID:22574217
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552286	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NUDT21 mRNA	PMID:21570461
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305766	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NUDT21 mRNA	PMID:33387578
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552286	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NUDT21 mRNA	PMID:26290441
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552286	E	RGD:6480464	20161115	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NUDT21 mRNA	PMID:17942748
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of NUDT21 mRNA	PMID:33512557
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of NUDT21 mRNA	PMID:28001369
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NUDT21 mRNA	PMID:33212167
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NUDT21 mRNA	PMID:30851411
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NUDT21 mRNA	PMID:20971185
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:29678	sodium arsenite	increases activity	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in increased activity of NUDT21 protein	PMID:30528433
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NUDT21 mRNA	PMID:21632981
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552286	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NUDT21 mRNA	PMID:22228805
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to NUDT21 protein]; arsenite promotes the reaction [G3BP1 protein binds to NUDT21 mRNA]	PMID:32406909
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NUDT21 mRNA	PMID:20971185
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NUDT21 mRNA	PMID:26238291
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305766	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NUDT21 mRNA	PMID:25729387
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:32181	tamibarotene	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of NUDT21 mRNA	PMID:15498508
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552286	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NUDT21 gene	PMID:35295148
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552286	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NUDT21 mRNA	PMID:23811191
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of NUDT21 mRNA	PMID:30903817
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of NUDT21 protein	PMID:34186270
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305766	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of NUDT21 mRNA	PMID:30816183
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305766	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NUDT21 mRNA	PMID:25181051
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of NUDT21 protein	PMID:31675489
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1552286	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of NUDT21 mRNA	PMID:20713471
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of NUDT21 protein	PMID:34186270
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of NUDT21 protein	PMID:34186270
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1552286	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of NUDT21 mRNA	PMID:34813904
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NUDT21 mRNA	PMID:37042841
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NUDT21 mRNA	PMID:38174414
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NUDT21 mRNA	PMID:35301059
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of NUDT21 mRNA	PMID:19167446
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552286	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NUDT21 mRNA	PMID:36331819
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NUDT21 mRNA	PMID:25979313
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of NUDT21 mRNA	PMID:23179753
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of NUDT21 gene	PMID:29154799
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased expression of NUDT21 mRNA; Valproic Acid results in increased expression of NUDT21 protein	PMID:29501571
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of NUDT21 gene	PMID:29501571
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NUDT21 mRNA	PMID:25562108
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1552286	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of NUDT21 mRNA	PMID:19770486
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552286	E	RGD:6480464	20161115	CTD	MESH:D013629	Tamoxifen affects the expression of NUDT21 mRNA	PMID:17555576
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1552286	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of NUDT21 mRNA	PMID:17998272
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1552286	E	RGD:6480464	20161115	CTD	MESH:D008727	Methotrexate affects the expression of NUDT21 mRNA	PMID:18502557
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUDT21 mRNA	PMID:27188386
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552286	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NUDT21 mRNA	PMID:17562736
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D000082	Acetaminophen results in decreased expression of NUDT21 mRNA	PMID:21420995|PMID:26497421
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:47217	arsane	increases ubiquitination	EXP		E	RGD:6480464	20230704	CTD	MESH:D001151	Arsenic results in increased ubiquitination of NUDT21 protein	PMID:35994080
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of NUDT21 mRNA	PMID:31675489
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552286	E	RGD:6480464	20161115	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NUDT21 mRNA	PMID:17555576
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552286	E	RGD:6480464	20161115	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NUDT21 mRNA	PMID:17942748
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552286	E	RGD:6480464	20161115	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NUDT21 mRNA	PMID:17942748
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552286	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of NUDT21 mRNA	PMID:25554681
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552286	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NUDT21 mRNA	PMID:19042947
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D015474	Isotretinoin results in decreased expression of NUDT21 mRNA	PMID:20436886
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NUDT21 protein	PMID:32959892
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305766	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NUDT21 mRNA	PMID:25729387
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of NUDT21 mRNA	PMID:15336504
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of NUDT21 mRNA	PMID:15336504
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NUDT21 protein	PMID:24806433
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of NUDT21 protein	PMID:34186270
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552286	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NUDT21 mRNA	PMID:22206623
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305766	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of NUDT21 mRNA	PMID:22124623
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NUDT21 mRNA	PMID:30851411
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUDT21 mRNA	PMID:27188386
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552286	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of NUDT21 mRNA	PMID:30294300
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1305766	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of NUDT21 protein	PMID:28903499
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of NUDT21 protein	PMID:31675489
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of NUDT21 mRNA	PMID:21858171
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUDT21 mRNA	PMID:27188386
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1552286	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of NUDT21 protein	PMID:24648495
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of NUDT21 mRNA	PMID:19140230
1313996	NUDT21	nudix hydrolase 21	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552286	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of NUDT21 mRNA	PMID:28973697
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CPSF3 mRNA	PMID:26251327
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1313999	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of CPSF3 promoter	PMID:26251327
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CPSF3 mRNA	PMID:33167477
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of CPSF3 protein	PMID:39571964
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CPSF3 mRNA	PMID:22378314
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1313999	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CPSF3 mRNA	PMID:30319688
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1313999	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CPSF3 mRNA	PMID:39241906
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1313999	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CPSF3 mRNA	PMID:39298647
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CPSF3 mRNA	PMID:37042841
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of CPSF3 protein	PMID:34122009
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CPSF3 protein	PMID:37730182
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305767	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CPSF3 mRNA	PMID:22061828
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CPSF3 mRNA	PMID:35301059
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CPSF3 mRNA	PMID:19549813
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CPSF3 protein	PMID:23301498
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CPSF3 intron	PMID:30157460
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CPSF3 gene	PMID:27153756
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CPSF3 mRNA	PMID:35430440
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CPSF3 protein	PMID:35688186
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1305767	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CPSF3 mRNA	PMID:26302742
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of CPSF3 mRNA	PMID:23195993
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1313999	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CPSF3 mRNA	PMID:21570461
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of CPSF3 protein	PMID:39603559
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CPSF3 mRNA	PMID:33212167
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305767	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CPSF3 mRNA	PMID:28959563
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CPSF3 mRNA	PMID:20971185
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CPSF3 mRNA	PMID:38568856
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in decreased expression of CPSF3 protein	PMID:39571964
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CPSF3 intron	PMID:30157460
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of CPSF3 protein	PMID:37955338
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CPSF3 mRNA]	PMID:32406909
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CPSF3 mRNA	PMID:20971185
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of CPSF3 protein	PMID:34122009
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of CPSF3 mRNA	PMID:20542052
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1313999	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CPSF3 gene	PMID:35295148
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of CPSF3 protein	PMID:37567409
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305767	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CPSF3 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CPSF3 mRNA	PMID:33670352
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305767	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CPSF3 gene	PMID:28505145
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CPSF3 protein	PMID:31675489
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1313999	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CPSF3 mRNA	PMID:39298647
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CPSF3 mRNA	PMID:37019170
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305767	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CPSF3 mRNA	PMID:17602206
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CPSF3 mRNA	PMID:17361019|PMID:21266533
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305767	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CPSF3 mRNA	PMID:17602206
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CPSF3 mRNA	PMID:37042841
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CPSF3 mRNA	PMID:38568856
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305767	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of CPSF3 promoter	PMID:22457795
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CPSF3 mRNA	PMID:35301059
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of CPSF3 mRNA	PMID:17585979
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of CPSF3 mRNA	PMID:19167446
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CPSF3 mRNA	PMID:21420995
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1313999	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CPSF3 mRNA	PMID:29279043
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of CPSF3 mRNA	PMID:31675489
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CPSF3 mRNA	PMID:22079256
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305767	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CPSF3 mRNA	PMID:24136188
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1313999	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CPSF3 mRNA	PMID:35964746
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305767	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CPSF3 mRNA	PMID:24136188
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CPSF3 protein	PMID:32959892
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1313999	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CPSF3 mRNA	PMID:22206623
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305767	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CPSF3 mRNA	PMID:24136188
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CPSF3 mRNA	PMID:22079256
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CPSF3 mRNA	PMID:22079256
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1313999	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CPSF3 mRNA	PMID:30294300
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CPSF3 protein	PMID:31675489
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305767	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CPSF3 mRNA	PMID:21346803
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1305767	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of CPSF3 mRNA	PMID:24136188
1313998	CPSF3	cleavage and polyadenylation specific factor 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CPSF3 mRNA	PMID:38568856
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PINK1 mRNA]	PMID:31150632
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:134606	toyocamycin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240305	CTD	MESH:D014127	Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]	PMID:37692514
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PINK1 mRNA	PMID:30071829
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15343	acetaldehyde	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D000079	Acetaldehyde results in decreased expression of PINK1 mRNA; Acetaldehyde results in decreased expression of PINK1 protein	PMID:35595033
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15343	acetaldehyde	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D000079	PINK1 protein inhibits the reaction [Acetaldehyde results in decreased expression of FTH1 protein]; Silybin inhibits the reaction [Acetaldehyde results in decreased expression of PINK1 mRNA]; Silybin inhibits the reaction [Acetaldehyde results in decreased expression of PINK1 protein]	PMID:35595033
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15355	acetylcholine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20211207	CTD	MESH:D000109	Acetylcholine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein]	PMID:34547296
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20260602	CTD	MESH:D010100	Oxygen deficiency results in increased expression of PINK1 protein	PMID:39829390
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:D010100	3-methyladenine inhibits the reaction [Oxygen deficiency results in increased expression of PINK1 protein]; BNIP3 protein affects the reaction [Oxygen deficiency results in increased expression of PINK1 protein]; HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of PINK1 protein]; YTHDF2 protein affects the reaction [Oxygen deficiency results in increased expression of PINK1 protein]	PMID:39829390
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20151013	CTD	MESH:D010100	[Antagomirs results in decreased expression of MIR205 mRNA] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]; [Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]]; [Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein; [Oxygen deficiency co-treated with Oxygen] results in increased expression of PINK1 protein; dorsomorphin inhibits the reaction [sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of PINK1 protein]]; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein]; Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]; sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of PINK1 protein]	PMID:21159781|PMID:34078833|PMID:34358556
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20171010	CTD	MESH:D010100	[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of PINK1 protein; genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of PINK1 protein]	PMID:28477916
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of PINK1 mRNA	PMID:39506029
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15756	hexadecanoic acid	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of PINK1 protein	PMID:40023272
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D019308	3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of PINK1 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of PINK1 mRNA; Palmitic Acid inhibits the reaction [Cyclosporine results in decreased expression of PINK1 protein]	PMID:32369900|PMID:40023272
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15891	taurine	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20190507	CTD	MESH:D013654	Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PINK1 protein]; Taurine inhibits the reaction [sodium arsenite results in decreased expression of PINK1 protein]	PMID:30551535
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1305769	E	RGD:6480464	20201103	CTD	MESH:D001280	Atrazine results in increased expression of PINK1 mRNA; Atrazine results in increased expression of PINK1 protein	PMID:30084861
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of PINK1 mRNA; Atrazine results in increased expression of PINK1 protein	PMID:40209350
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15930	atrazine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D001280	[Curcumin co-treated with Atrazine] results in increased expression of PINK1 mRNA; [Curcumin co-treated with Atrazine] results in increased expression of PINK1 protein; Curcumin inhibits the reaction [Atrazine results in increased expression of PINK1 protein]; Curcumin promotes the reaction [Atrazine results in increased expression of PINK1 mRNA]	PMID:40209350
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240402	CTD	MESH:C015329	Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PINK1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PINK1 protein]	PMID:33908429|PMID:36583613
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16112	chlorogenic acid	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:D002726	Chlorogenic Acid inhibits the reaction [amyloid beta-protein (1-42) results in increased expression of PINK1 mRNA]	PMID:40695427
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16196	oleic acid	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D019301	Oleic Acid results in decreased expression of PINK1 protein	PMID:36592823
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16196	oleic acid	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D019301	3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of PINK1 mRNA]; [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of PINK1 mRNA; Metformin inhibits the reaction [Oleic Acid results in decreased expression of PINK1 protein]; qidan inhibits the reaction [Oleic Acid results in decreased expression of PINK1 protein]	PMID:32369900|PMID:36592823
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D000431	Ethanol results in decreased expression of PINK1 mRNA; Ethanol results in decreased expression of PINK1 protein	PMID:35595033
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D000431	PINK1 protein inhibits the reaction [Ethanol results in decreased expression of FTH1 protein]; Silybin inhibits the reaction [Ethanol results in decreased expression of PINK1 mRNA]; Silybin inhibits the reaction [Ethanol results in decreased expression of PINK1 protein]	PMID:35595033
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16240	hydrogen peroxide	affects response to substance	EXP		E	RGD:6480464	20130416	CTD	MESH:D006861	PINK1 protein affects the susceptibility to Hydrogen Peroxide	PMID:21366594
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of PINK1 mRNA	PMID:30316844
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1305769	E	RGD:6480464	20151013	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of PINK1 protein	PMID:21159781
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20130416	CTD	MESH:D006861	BMAL1 protein affects the reaction [Polyphenols inhibits the reaction [Hydrogen Peroxide results in decreased expression of PINK1 mRNA]]; HMOX1 protein affects the reaction [PINK1 protein affects the susceptibility to Hydrogen Peroxide]; PINK1 protein affects the reaction [Hydrogen Peroxide results in increased expression of HMOX1 protein]; PINK1 protein affects the reaction [Hydrogen Peroxide results in increased expression of TRAP1 protein]; Polyphenols inhibits the reaction [Hydrogen Peroxide results in decreased expression of PINK1 mRNA]	PMID:21366594|PMID:30316844
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D006861	PINK1 protein affects the reaction [Hydrogen Peroxide results in increased chemical synthesis of Reactive Oxygen Species]	PMID:21421046
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PINK1 mRNA	PMID:39241906
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PINK1 mRNA]	PMID:39241906
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PINK1 mRNA	PMID:32145629
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305769	E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in increased expression of PINK1 mRNA	PMID:35192832
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PINK1 mRNA	PMID:30165855
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16494	lipoic acid	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240109	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Sodium Fluoride results in increased expression of PINK1 mRNA]	PMID:37739047
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16509	1,4-benzoquinone	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:C004532	quinone results in increased expression of PINK1 mRNA; quinone results in increased expression of PINK1 protein	PMID:29567065
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16509	1,4-benzoquinone	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:C004532	Acetylcysteine inhibits the reaction [quinone results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [quinone results in increased expression of PINK1 mRNA]; Cyclosporine inhibits the reaction [quinone results in increased expression of PINK1 protein]	PMID:29567065
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PINK1 mRNA	PMID:38568856
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305769	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PINK1 mRNA	PMID:33387578
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PINK1 mRNA	PMID:37042841
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16796	melatonin	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D008550	Melatonin results in increased expression of PINK1 protein	PMID:37028639
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16796	melatonin	increases expression	ISO	RGD:1314002	E	RGD:6480464	20230704	CTD	MESH:D008550	Melatonin results in increased expression of PINK1 protein	PMID:37028639
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16796	melatonin	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D008550	[PINK1 protein co-treated with BNIP3 protein] affects the reaction [Melatonin promotes the reaction [Paraquat results in increased expression of BNIP3 protein]]; [PINK1 protein co-treated with BNIP3 protein] affects the reaction [Melatonin promotes the reaction [Paraquat results in increased expression of PINK1 protein]]; [PINK1 protein co-treated with BNIP3 protein] affects the reaction [Melatonin results in increased expression of BNIP3 protein]; [PINK1 protein co-treated with BNIP3 protein] affects the reaction [Melatonin results in increased expression of PINK1 protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA]; Melatonin promotes the reaction [Paraquat results in increased expression of PINK1 protein]	PMID:33962019|PMID:37028639
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20180313	CTD	MESH:D008550	Melatonin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PINK1 protein]; Melatonin inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]	PMID:26882442|PMID:29966675
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20230704	CTD	MESH:D008550	[BNIP3 protein co-treated with PINK1 protein] affects the reaction [Melatonin inhibits the reaction [Paraquat results in increased secretion of IL1B protein]]; [BNIP3 protein co-treated with PINK1 protein] affects the reaction [Melatonin inhibits the reaction [Paraquat results in increased secretion of TNF protein]]; Melatonin promotes the reaction [Paraquat results in increased expression of PINK1 protein]	PMID:37028639
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:16836	4-nitrophenol	increases expression	ISO	RGD:1314002	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in increased expression of PINK1 mRNA	PMID:34673133
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:168442	Urolithin A	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20250603	CTD	MESH:C026423	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]; 3-methyladenine inhibits the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]; AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]; bardoxolone methyl affects the reaction [AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]]; LONP1 protein affects the reaction [AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]]; PINK1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PRKN protein]]; PINK1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in increased expression of SQSTM1 protein]]	PMID:39725191
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:168442	Urolithin A	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20250603	CTD	MESH:C026423	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]	PMID:39725191
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20220705	CTD	MESH:D005947	Glucose results in decreased expression of PINK1 protein	PMID:35243728
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D005947	Glucose results in increased expression of PINK1 mRNA	PMID:33962019
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1314002	E	RGD:6480464	20250902	CTD	MESH:D005947	Glucose results in increased expression of PINK1 protein	PMID:38334676
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D005947	[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA]	PMID:33962019
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20220705	CTD	MESH:D005947	Inositol inhibits the reaction [Glucose results in decreased expression of PINK1 protein]	PMID:35243728
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20250902	CTD	MESH:D005947	imeglimin inhibits the reaction [Glucose results in increased expression of PINK1 protein]	PMID:38334676
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314002	E	RGD:6480464	20240305	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein	PMID:37692514
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased expression of PINK1 protein; Acetylcysteine inhibits the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased expression of PINK1 protein]; mono-(2-ethylhexyl)phthalate affects the cleavage of and affects the expression of PINK1 protein alternative form; PINK1 protein promotes the reaction [[[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] affects the localization of and results in increased activity of and results in increased ubiquitination of PRKN protein] which results in increased degradation of PRKN protein]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of COX4I1 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of MFN1 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of MFN2 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of TIMM23 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of TOMM20 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of VDAC1 protein]]	PMID:33161305|PMID:42054602
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240305	CTD	MESH:C016599	4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]; Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]	PMID:37692514
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:173086	ferrostatin-1	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C573944	ferrostatin-1 inhibits the reaction [osthol results in increased expression of PINK1 protein]	PMID:40446951
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20220705	CTD	MESH:D005947	Glucose results in decreased expression of PINK1 protein	PMID:35243728
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D005947	Glucose results in increased expression of PINK1 mRNA	PMID:33962019
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1314002	E	RGD:6480464	20250902	CTD	MESH:D005947	Glucose results in increased expression of PINK1 protein	PMID:38334676
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D005947	[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA]	PMID:33962019
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20220705	CTD	MESH:D005947	Inositol inhibits the reaction [Glucose results in decreased expression of PINK1 protein]	PMID:35243728
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20250902	CTD	MESH:D005947	imeglimin inhibits the reaction [Glucose results in increased expression of PINK1 protein]	PMID:38334676
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:177406	Bardoxolone methyl	increases expression	ISO	RGD:1305769	E	RGD:6480464	20250603	CTD	MESH:C445068	bardoxolone methyl results in increased expression of PINK1 protein	PMID:39725191
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:177406	Bardoxolone methyl	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20250603	CTD	MESH:C445068	bardoxolone methyl affects the reaction [AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]]	PMID:39725191
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PINK1 mRNA; Diethylhexyl Phthalate results in increased expression of PINK1 protein	PMID:34822940
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1305769	E	RGD:6480464	20240305	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PINK1 protein	PMID:37692514
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314002	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PINK1 mRNA; Diethylhexyl Phthalate results in increased expression of PINK1 protein	PMID:33908429|PMID:36583613
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240402	CTD	MESH:D004051	Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PINK1 mRNA]; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PINK1 protein]	PMID:33908429|PMID:36583613
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17750	glycine betaine	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20240903	CTD	MESH:D001622	Betaine inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]	PMID:38651543
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of PINK1 mRNA	PMID:16002434
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D005839	Gentamicins results in decreased expression of PINK1 protein	PMID:42173392
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17833	gentamycin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D005839	Formoterol Fumarate inhibits the reaction [Gentamicins results in decreased expression of PINK1 protein]	PMID:42173392
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	affects response to substance	ISO	RGD:1314002	E	RGD:6480464	20190219	CTD	MESH:D015632	PINK1 protein affects the susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine	PMID:22511790
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20201215	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of PINK1 mRNA; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of PINK1 protein	PMID:28978077
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20190219	CTD	MESH:D015632	AM 1241 inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of PINK1 mRNA]; AM 1241 inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of PINK1 protein]; PARK7 protein inhibits the reaction [PINK1 protein affects the susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine]; PRKN protein inhibits the reaction [PINK1 protein affects the susceptibility to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine]	PMID:22511790|PMID:28978077
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PINK1 mRNA	PMID:28818685
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:18243	dopamine	affects abundance	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D004298	PINK1 protein affects the abundance of Dopamine	PMID:22043175
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:18243	dopamine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D004298	[PINK1 mutant form results in increased susceptibility to Paraquat] which results in decreased abundance of Dopamine; Paraquat affects the reaction [PINK1 protein affects the abundance of Dopamine]	PMID:22043175
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:18421	superoxide	affects abundance	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D013481	PINK1 protein affects the abundance of Superoxides	PMID:21421046
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20240903	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of PINK1 protein	PMID:38373586
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20240903	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of PINK1 protein	PMID:38373586
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20240903	CTD	MESH:D000517	Cyclosporine inhibits the reaction [ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]]; ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]; TFEB protein promotes the reaction [ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]]	PMID:38373586
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240903	CTD	MESH:D000517	ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]	PMID:38373586
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:18917	1,3-dichloropropan-2-ol	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20230905	CTD	MESH:C033489	1,3-dichloro-2-propanol results in decreased expression of PINK1 protein	PMID:36000575
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:194147	aristolochic acids	increases expression	ISO	RGD:1305769	E	RGD:6480464	20230103	CTD	MESH:D034341	Aristolochic Acids results in increased expression of PINK1 mRNA	PMID:19717638
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:22689	bafilomycin A1	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20240430	CTD	MESH:C040929	bafilomycin A1 inhibits the reaction [Lidocaine results in increased expression of PINK1 protein]	PMID:37914286
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20260407	CTD	MESH:D002104	Cadmium results in decreased expression of PINK1 protein	PMID:40345518
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1305769	E	RGD:6480464	20230905	CTD	MESH:D002104	Cadmium results in increased expression of PINK1 mRNA	PMID:34816377
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1314002	E	RGD:6480464	20160210	CTD	MESH:D002104	Cadmium results in increased expression of PINK1; Cadmium results in increased expression of PINK1 protein	PMID:25464205|PMID:37270049
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20230905	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PINK1 mRNA]; Cyclosporine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]	PMID:34816377|PMID:39208572
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20160210	CTD	MESH:D002104	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein; Acetylcarnitine inhibits the reaction [Cadmium results in increased expression of PINK1]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PINK1]; Cyclosporine inhibits the reaction [Cadmium results in increased expression of PINK1]; PINK1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKN protein]; PINK1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SQSTM1 protein]; PINK1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased lipidation of MAP1LC3B protein]	PMID:25464205|PMID:34952138|PMID:37022104
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:232424	MitoTEMPO	multiple interactions	EXP		E	RGD:6480464	20241203	CTD	MESH:C555916	MitoTEMPO inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]; MitoTEMPO inhibits the reaction [trifloxystrobin results in increased expression of PINK1 protein]	PMID:27853101|PMID:29729358
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:233256	A-967079	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20250408	CTD	MESH:C560402	A 967079 inhibits the reaction [Ozone results in decreased expression of PINK1 protein]	PMID:35928613
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:233321	Mitoquinone	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20251007	CTD	MESH:C429014	mitoquinone promotes the reaction [sodium arsenite results in increased expression of PINK1 protein]	PMID:38653026
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1305769	E	RGD:6480464	20120412	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of PINK1 gene	PMID:16495775
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:24848	inositol	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20220705	CTD	MESH:D007294	Inositol inhibits the reaction [Glucose results in decreased expression of PINK1 protein]	PMID:35243728
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PINK1 mRNA	PMID:33354967
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314002	E	RGD:6480464	20221004	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PINK1 mRNA; Aflatoxin B1 results in increased expression of PINK1 protein	PMID:35304092|PMID:35810998
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:2504	aflatoxin B1	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20221004	CTD	MESH:D016604	PRKN protein affects the reaction [Aflatoxin B1 results in increased expression of PINK1 mRNA]; PRKN protein affects the reaction [Aflatoxin B1 results in increased expression of PINK1 protein]	PMID:35304092
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20231031	CTD	MESH:D010126	Ozone results in decreased expression of PINK1 protein	PMID:35928613
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1314002	E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of PINK1 protein	PMID:35866636
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PINK1 mRNA	PMID:35430440
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20220809	CTD	MESH:D010126	3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide inhibits the reaction [Ozone results in decreased expression of PINK1 protein]; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PINK1 mRNA; A 967079 inhibits the reaction [Ozone results in decreased expression of PINK1 protein]	PMID:34911549|PMID:35928613
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:26523	reactive oxygen species	decreases chemical synthesis	ISO	RGD:1314002	E	RGD:6480464	20170303	CTD	MESH:D017382	PINK1 protein results in decreased chemical synthesis of Reactive Oxygen Species	PMID:21421046
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:26523	reactive oxygen species	increases chemical synthesis	EXP		E	RGD:6480464	20170303	CTD	MESH:D017382	PINK1 gene mutant form results in increased chemical synthesis of Reactive Oxygen Species	PMID:20547144
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20170303	CTD	MESH:D017382	PINK1 protein affects the reaction [Hydrogen Peroxide results in increased chemical synthesis of Reactive Oxygen Species]	PMID:21421046
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20180313	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of PINK1 mRNA; Carbon Tetrachloride results in decreased expression of PINK1 protein	PMID:26882442|PMID:31150632
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314002	E	RGD:6480464	20221101	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PINK1 protein	PMID:35405287
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20180313	CTD	MESH:D002251	Melatonin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PINK1 protein]; schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PINK1 mRNA]	PMID:26882442|PMID:31150632
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20221101	CTD	MESH:D002251	Sirolimus inhibits the reaction [Carbon Tetrachloride results in increased expression of PINK1 protein]	PMID:35405287
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260113	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PINK1 protein	PMID:40081728
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:2762	antimycin A	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of PINK1 mRNA	PMID:33512557
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:2762	antimycin A	multiple interactions	EXP		E	RGD:6480464	20191105	CTD	MESH:D000968	[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of PRKN protein]; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] results in increased expression of SQSTM1 mRNA]; PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]]	PMID:28366621
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PINK1 mRNA	PMID:31881176
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1305769	E	RGD:6480464	20200915	CTD	MESH:C059514	Resveratrol results in increased expression of PINK1 protein	PMID:32619457
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314002	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of PINK1 mRNA	PMID:22610192
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PINK1 mRNA	PMID:23557933
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20200915	CTD	MESH:C059514	[Resveratrol co-treated with Benzo(a)pyrene] results in increased expression of PINK1 protein	PMID:32619457
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PINK1 mRNA	PMID:28903495
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20260407	CTD	MESH:D007854	Lead results in decreased expression of PINK1 protein	PMID:40345518
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27889	lead(0)	increases expression	ISO	RGD:1305769	E	RGD:6480464	20230905	CTD	MESH:D007854	Lead results in increased expression of PINK1 mRNA	PMID:34816377
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27889	lead(0)	multiple interactions	EXP		E	RGD:6480464	20230606	CTD	MESH:D007854	[[amyloid beta-protein (25-35) co-treated with amyloid beta-protein (1-40)] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [amyloid beta-protein (1-40) co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]; [amyloid beta-protein (25-35) co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein; amyloid beta-protein (1-40) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]; amyloid beta-protein (25-35) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]	PMID:35300571
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20230905	CTD	MESH:D007854	Acetylcysteine inhibits the reaction [Lead results in increased expression of PINK1 mRNA]	PMID:34816377
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of PINK1 mRNA	PMID:23300844
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20250311	CTD	MESH:D002945	Cisplatin results in decreased expression of PINK1	PMID:39102946
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1305769	E	RGD:6480464	20180313	CTD	MESH:D002945	Cisplatin results in increased expression of PINK1 protein	PMID:28698153
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in increased expression of PINK1 mRNA	PMID:21858171
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20180313	CTD	MESH:D002945	Curcumin inhibits the reaction [Cisplatin results in increased expression of PINK1 protein]; Linagliptin inhibits the reaction [Cisplatin results in decreased expression of PINK1]	PMID:28698153|PMID:39102946
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of PINK1 mRNA	PMID:18930951
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20230801	CTD	MESH:D009532	[nickel chloride results in increased abundance of Nickel] which affects the expression of and affects the localization of PINK1 protein	PMID:36794572
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PINK1 mRNA	PMID:21215274
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PINK1 mRNA	PMID:20106945|PMID:21632981
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305769	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PINK1 mRNA	PMID:32109520|PMID:34747641
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of PINK1 mRNA	PMID:17942748
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28135	ponasterone A	increases expression	ISO	RGD:1305769	E	RGD:6480464	20230606	CTD	MESH:C008999	[ponasterone A results in increased expression of PINK1 protein] which results in increased expression of MFN2 protein; ponasterone A results in increased expression of PINK1 protein	PMID:20164189
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28135	ponasterone A	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20230606	CTD	MESH:C008999	[ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of DNM1L protein; [ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of FIS1 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of FIS1 protein]	PMID:20164189
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	affects localization	EXP		E	RGD:6480464	20200714	CTD	MESH:D012402	Rotenone affects the localization of PINK1 protein	PMID:32001317
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	affects response to substance	EXP		E	RGD:6480464	20130416	CTD	MESH:D012402	PINK1 protein affects the susceptibility to Rotenone	PMID:16226715|PMID:20940149
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	affects response to substance	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D012402	PINK1 protein affects the susceptibility to Rotenone	PMID:21421046|PMID:26916954
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of PINK1 mRNA	PMID:33512557
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20201006	CTD	MESH:D012402	Rotenone results in decreased expression of PINK1 mRNA; Rotenone results in decreased expression of PINK1 protein	PMID:32392329|PMID:36538285|PMID:37956489
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	PINK1 protein results in decreased susceptibility to Rotenone	PMID:19492085
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D012402	Rotenone results in increased expression of PINK1 protein	PMID:37156403
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305769	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of PINK1 mRNA	PMID:28374803
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of PINK1 protein	PMID:20464527
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:D012402	4,5,6,7-tetrabromobenzotriazole inhibits the reaction [Rotenone results in increased expression of PINK1 protein]; CSNK2A1 protein affects the reaction [Rotenone results in increased expression of PINK1 protein]; DNM1L protein affects the reaction [Rotenone affects the localization of PINK1 protein]; PGAM5 protein affects the reaction [Rotenone results in increased expression of PINK1 protein]; PINK1 protein affects the reaction [Rotenone results in increased cleavage of CASP3 protein]; Rotenone promotes the reaction [PRKN protein binds to PINK1 protein]	PMID:32001317|PMID:37156403
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20211012	CTD	MESH:D012402	[Particulate Matter co-treated with Rotenone] results in decreased expression of PINK1 protein; Formoterol Fumarate inhibits the reaction [Rotenone results in decreased expression of PINK1 protein]; repaglinide inhibits the reaction [Rotenone results in decreased expression of PINK1 mRNA]; Sirolimus inhibits the reaction [[Particulate Matter co-treated with Rotenone] results in decreased expression of PINK1 protein]	PMID:33823232|PMID:36538285|PMID:37956489
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20211012	CTD	MESH:D012402	[Particulate Matter co-treated with Rotenone] results in decreased expression of PINK1 protein; Sirolimus inhibits the reaction [[Particulate Matter co-treated with Rotenone] results in decreased expression of PINK1 protein]	PMID:33823232
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PINK1 mRNA	PMID:28001369
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PINK1 mRNA	PMID:33212167
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of PINK1 mRNA	PMID:39709020
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28285	oligomycin A	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:C031004	[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of PRKN protein]; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]; PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] results in increased expression of SQSTM1 mRNA]; PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]]	PMID:28366621
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PINK1 mRNA	PMID:30851411
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PINK1 mRNA	PMID:28959563
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of PINK1 mRNA	PMID:22465980
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314002	E	RGD:6480464	20240109	CTD	MESH:D012969	Sodium Fluoride results in increased expression of PINK1 mRNA	PMID:37739047
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240109	CTD	MESH:D012969	Thioctic Acid inhibits the reaction [Sodium Fluoride results in increased expression of PINK1 mRNA]	PMID:37739047
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20250603	CTD	MESH:D004317	Doxorubicin results in decreased expression of PINK1 protein	PMID:39725191
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20250603	CTD	MESH:D004317	Doxorubicin results in decreased expression of PINK1 protein	PMID:39725191
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D004317	Doxorubicin results in increased expression of PINK1 protein	PMID:29729358
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1305769	E	RGD:6480464	20171010	CTD	MESH:D004317	Doxorubicin results in increased expression of PINK1 protein	PMID:26678157|PMID:29966675|PMID:38651543
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D004317	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]; MitoTEMPO inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]	PMID:29729358
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20181113	CTD	MESH:D004317	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]; 3-methyladenine inhibits the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]; AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]; bardoxolone methyl affects the reaction [AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]]; Betaine inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]; LONP1 protein affects the reaction [AMBRA1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]]; Melatonin inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]; PINK1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PRKN protein]]; PINK1 protein affects the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in increased expression of SQSTM1 protein]]	PMID:29966675|PMID:38651543|PMID:39725191
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20250603	CTD	MESH:D004317	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]	PMID:39725191
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20230704	CTD	MESH:D005632	[Tribulus extract co-treated with Fructose] results in decreased expression of PINK1 protein	PMID:36214339
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [quinone results in increased expression of PINK1 protein]	PMID:29567065|PMID:33161305
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20230905	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [Lead results in increased expression of PINK1 mRNA]	PMID:34816377|PMID:39208572
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20160210	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [Cadmium results in increased expression of PINK1]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [tricalcium phosphate results in increased expression of PINK1 protein]	PMID:25464205|PMID:34547296|PMID:37678662|PMID:37692514
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:28984	aluminium atom	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20211207	CTD	MESH:D000535	[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA; [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein; Acetylcholine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA]	PMID:34547296
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	affects expression	ISO	RGD:1314002	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite affects the expression of PINK1 protein	PMID:36557995
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PINK1 gene	PMID:28589171
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of PINK1 protein	PMID:30551535
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PINK1 mRNA	PMID:38568856
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314002	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PINK1 mRNA; sodium arsenite results in increased expression of PINK1 protein	PMID:20883709|PMID:36557995|PMID:38653026
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20190507	CTD	MESH:C017947	Rosiglitazone inhibits the reaction [sodium arsenite results in decreased expression of PINK1 protein]; Taurine inhibits the reaction [sodium arsenite results in decreased expression of PINK1 protein]	PMID:30551535
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240402	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PINK1 protein; Cyclosporine affects the reaction [sodium arsenite affects the expression of PINK1 protein]; Cyclosporine inhibits the reaction [sodium arsenite results in increased expression of PINK1 protein]; mitoquinone promotes the reaction [sodium arsenite results in increased expression of PINK1 protein]	PMID:36557995|PMID:38653026|PMID:40081728
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of PINK1 mRNA	PMID:17127020
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of PINK1 mRNA	PMID:22378314
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PINK1 mRNA	PMID:20127859
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PINK1 promoter	PMID:27901495
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1305769	E	RGD:6480464	20200915	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PINK1 protein	PMID:32619457|PMID:36736873
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20200915	CTD	MESH:D001564	[Resveratrol co-treated with Benzo(a)pyrene] results in increased expression of PINK1 protein	PMID:32619457
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of PINK1 mRNA	PMID:22465980
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:30314	(R)-lipoic acid	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240109	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Sodium Fluoride results in increased expression of PINK1 mRNA]	PMID:37739047
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PINK1 mRNA; Silicon Dioxide results in decreased expression of PINK1 mRNA; Silicon Dioxide results in decreased expression of PINK1 protein	PMID:25895662|PMID:36309172
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20231205	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PINK1 mRNA; Silicon Dioxide results in decreased expression of PINK1 protein	PMID:36309172
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20231205	CTD	MESH:D012822	PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of ACTA2 protein]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of COL1A1 mRNA]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of COL1A2 protein]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of FN1 mRNA]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of IL1B mRNA]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of IL1B protein]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of NLRP3 mRNA]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of NLRP3 protein]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of TGFB1 mRNA]; PINK1 protein inhibits the reaction [Silicon Dioxide results in increased expression of TGFB1 protein]	PMID:36309172
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PINK1 protein	PMID:30551535
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PINK1 protein	PMID:27318970
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein]	PMID:27318970
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20191114	CTD	MESH:C006632	Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PINK1 protein]	PMID:30551535
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:31429	colforsin daropate hydrochloride	multiple interactions	EXP		E	RGD:6480464	20170725	CTD	MESH:D005576	PINK1 protein affects the reaction [Colforsin results in decreased expression of DNM1L protein]	PMID:24792327
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:31633	formoterol fumarate	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20260804	CTD	MESH:D000068759	Formoterol Fumarate inhibits the reaction [Rotenone results in decreased expression of PINK1 protein]	PMID:37956489
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:31633	formoterol fumarate	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D000068759	Formoterol Fumarate inhibits the reaction [Gentamicins results in decreased expression of PINK1 protein]	PMID:42173392
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PINK1 mRNA	PMID:24136188
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:31705	iodixanol	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20190312	CTD	MESH:C044834	[Drinking Water deficiency co-treated with Furosemide co-treated with iodixanol] results in increased expression of PINK1 protein	PMID:29860548
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20181113	CTD	MESH:C008261	[[amyloid beta-protein (25-35) co-treated with amyloid beta-protein (1-40)] co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [amyloid beta-protein (1-40) co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [amyloid beta-protein (1-40) co-treated with amyloid beta-protein (25-35)] promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]; [amyloid beta-protein (25-35) co-treated with [lead acetate results in increased abundance of Lead]] results in decreased expression of PINK1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein; amyloid beta-protein (1-40) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]; amyloid beta-protein (25-35) promotes the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of PINK1 protein]; lead acetate promotes the reaction [PINK1 protein binds to ATM protein]; lead acetate results in increased expression of and results in increased phosphorylation of PINK1 protein	PMID:29660402|PMID:35300571
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:32130	silver(1+) nitrate	increases expression	ISO	RGD:1314002	E	RGD:6480464	20221206	CTD	MESH:D012835	Silver Nitrate results in increased expression of PINK1 protein	PMID:35697184
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3215	bupivacaine	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20220607	CTD	MESH:D002045	Bupivacaine results in decreased expression of PINK1 protein	PMID:34793778
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3215	bupivacaine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20220607	CTD	MESH:D002045	HSPA12A protein inhibits the reaction [Bupivacaine results in decreased expression of PINK1 protein]	PMID:34793778
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PINK1 mRNA	PMID:30047161
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1305769	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of PINK1 mRNA	PMID:24136188
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of PINK1 mRNA	PMID:23557971
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314002	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PINK1 gene	PMID:35295148
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C009495	titanium dioxide results in increased expression of PINK1 mRNA	PMID:30273564
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PINK1 mRNA	PMID:34492290
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PINK1 mRNA	PMID:19710929
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3259	CCCP	affects localization	ISO	RGD:1305769	E	RGD:6480464	20180313	CTD	MESH:D002258	Carbonyl Cyanide m-Chlorophenyl Hydrazone affects the localization of PINK1 protein	PMID:24879156
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3259	CCCP	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D002258	Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of PINK1 protein	PMID:27318970|PMID:29371327|PMID:37060996
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3259	CCCP	increases stability	EXP		E	RGD:6480464	20150825	CTD	MESH:D002258	Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased stability of PINK1 protein	PMID:26070385
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3259	CCCP	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D002258	[Carbonyl Cyanide m-Chlorophenyl Hydrazone co-treated with PRKN protein] results in increased expression of PINK1 protein; [Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of and affects the localization of PINK1 protein] promotes the reaction [FKBP5 protein binds to PINK1 protein]; [mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased expression of PINK1 protein; Acetylcysteine inhibits the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased expression of PINK1 protein]; Carbonyl Cyanide m-Chlorophenyl Hydrazone promotes the reaction [PINK1 protein binds to ATM protein]; Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of and affects the localization of PINK1 protein; Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of and results in increased phosphorylation of PINK1 protein; MIR593 inhibits the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone results in increased expression of PINK1 protein]; PINK1 protein promotes the reaction [[[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] affects the localization of and results in increased activity of and results in increased ubiquitination of PRKN protein] which results in increased degradation of PRKN protein]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of COX4I1 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of MFN1 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of MFN2 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of TIMM23 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of TOMM20 protein]]; PINK1 protein promotes the reaction [PRKN protein promotes the reaction [[mono-(2-ethylhexyl)phthalate co-treated with Carbonyl Cyanide m-Chlorophenyl Hydrazone] results in increased degradation of VDAC1 protein]]	PMID:28673964|PMID:29660402|PMID:30734931|PMID:33161305|PMID:37060996
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3259	CCCP	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20180313	CTD	MESH:D002258	BECN1 protein affects the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone affects the localization of PINK1 protein]; PINK1 protein affects the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone affects the localization of PRKN protein]	PMID:24879156
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3259	CCCP	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20141014	CTD	MESH:D002258	PINK1 gene mutant form inhibits the reaction [Carbonyl Cyanide m-Chlorophenyl Hydrazone affects the localization of PRKN protein]	PMID:22872702
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:33007	chromium(6+)	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of PINK1 protein	PMID:30715550|PMID:32866567
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:33007	chromium(6+)	increases expression	ISO	RGD:1314002	E	RGD:6480464	20210706	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of PINK1 protein	PMID:32866567
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C074702	HMGA2 protein promotes the reaction [chromium hexavalent ion results in increased expression of PINK1 protein]	PMID:32866567
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of PINK1 mRNA	PMID:32145629
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305769	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of PINK1 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314002	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PINK1 mRNA	PMID:26063408
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of PINK1 mRNA	PMID:19244175
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:33629	aluminium(0)	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20211207	CTD	MESH:D000535	[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA; [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein; Acetylcholine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA]	PMID:34547296
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3374	capsaicin	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D002211	Capsaicin results in increased expression of PINK1 mRNA	PMID:36044967
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of PINK1 mRNA	PMID:26682919
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314002	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PINK1 mRNA	PMID:39298647|PMID:40203079
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20190219	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PINK1 mRNA	PMID:29156651
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34631	chlorpyrifos	increases stability	EXP		E	RGD:6480464	20150825	CTD	MESH:D004390	Chlorpyrifos results in increased stability of PINK1 protein	PMID:26070385
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:1305769	E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of PINK1 mRNA	PMID:17602206
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34679	Di-n-octyl phthalate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010715	di-n-octyl phthalate results in increased expression of PINK1 mRNA; di-n-octyl phthalate results in increased expression of PINK1 protein	PMID:34822940
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34682	diazinon	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20130416	CTD	MESH:D003976	Diazinon results in decreased expression of PINK1 mRNA	PMID:21968025
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34887	nickel dichloride	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20230801	CTD	MESH:C022838	[nickel chloride results in increased abundance of Nickel] which affects the expression of and affects the localization of PINK1 protein	PMID:36794572
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	affects response to substance	EXP		E	RGD:6480464	20210810	CTD	MESH:D010269	PINK1 protein affects the susceptibility to Paraquat	PMID:33383311
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20121113	CTD	MESH:D010269	Paraquat results in decreased expression of PINK1 mRNA	PMID:22563483|PMID:36108500
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D010269	Paraquat results in increased expression of PINK1 protein	PMID:30144575|PMID:37028639
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314002	E	RGD:6480464	20230704	CTD	MESH:D010269	Paraquat results in increased expression of PINK1 protein	PMID:37028639
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	increases response to substance	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D010269	PINK1 mutant form results in increased susceptibility to Paraquat	PMID:22043175
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D010269	[BNIP3 protein co-treated with PINK1 protein] affects the reaction [Paraquat results in increased expression of COX2 protein]; [BNIP3 protein co-treated with PINK1 protein] affects the reaction [Paraquat results in increased expression of TLR9 protein]; [PINK1 protein co-treated with BNIP3 protein] affects the reaction [Melatonin promotes the reaction [Paraquat results in increased expression of BNIP3 protein]]; [PINK1 protein co-treated with BNIP3 protein] affects the reaction [Melatonin promotes the reaction [Paraquat results in increased expression of PINK1 protein]]; Melatonin promotes the reaction [Paraquat results in increased expression of PINK1 protein]; oren gedoku to inhibits the reaction [Paraquat results in increased expression of and affects the localization of PINK1 protein]; Paraquat results in increased expression of and affects the localization of PINK1 protein; PRKN protein affects the reaction [Paraquat results in increased expression of PINK1 protein]	PMID:30144575|PMID:33383311|PMID:37028639
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20130416	CTD	MESH:D010269	[BNIP3 protein co-treated with PINK1 protein] affects the reaction [Melatonin inhibits the reaction [Paraquat results in increased secretion of IL1B protein]]; [BNIP3 protein co-treated with PINK1 protein] affects the reaction [Melatonin inhibits the reaction [Paraquat results in increased secretion of TNF protein]]; [PINK1 mutant form results in increased susceptibility to Paraquat] which results in decreased abundance of Dopamine; Melatonin promotes the reaction [Paraquat results in increased expression of PINK1 protein]; Paraquat affects the reaction [PINK1 protein affects the abundance of Dopamine]	PMID:22043175|PMID:37028639
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PINK1 mRNA]	PMID:39241906
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PINK1 mRNA	PMID:37042841
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of PINK1 mRNA	PMID:30723492
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PINK1 mRNA	PMID:33453195
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PINK1 mRNA	PMID:38174414
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305769	E	RGD:6480464	20231003	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PINK1 protein	PMID:37451666
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PINK1 mRNA	PMID:20883709
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20231003	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 mRNA]; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; SIRT1 protein inhibits the reaction [Cadmium Chloride results in increased expression of PINK1 protein]	PMID:37451666|PMID:39208572
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20220510	CTD	MESH:D019256	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein; PINK1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PRKN protein]; PINK1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SQSTM1 protein]; PINK1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased lipidation of MAP1LC3B protein]	PMID:34952138|PMID:37022104
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of PINK1 mRNA	PMID:30047161
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20210504	CTD	MESH:D002738	Chloroquine inhibits the reaction [Acetaminophen results in increased expression of PINK1 protein]; Chloroquine inhibits the reaction [coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of PINK1 protein]]	PMID:33271250
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3764	clotrimazole	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of PINK1 mRNA	PMID:30047161
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:37659	oleanolic acid	increases expression	EXP		E	RGD:6480464	20220906	CTD	MESH:D009828	Oleanolic Acid results in increased expression of PINK1 protein	PMID:35690101
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1314002	E	RGD:6480464	20240903	CTD	MESH:C056933	fumonisin B1 results in increased expression of PINK1 protein	PMID:38705344
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:38604	pyrimidifen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of PINK1 mRNA	PMID:33512557
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:38635	3-methyladenine	multiple interactions	EXP		E	RGD:6480464	20260602	CTD	MESH:C025946	3-methyladenine inhibits the reaction [Oxygen deficiency results in increased expression of PINK1 protein]	PMID:39829390
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:38635	3-methyladenine	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20250603	CTD	MESH:C025946	3-methyladenine inhibits the reaction [3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one inhibits the reaction [Doxorubicin results in decreased expression of PINK1 protein]]	PMID:39725191
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of PINK1 mRNA	PMID:19167446
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1305769	E	RGD:6480464	20250902	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PINK1 protein	PMID:39894534
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of PINK1 mRNA	PMID:25993096
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3962	curcumin	increases expression	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D003474	Curcumin results in increased expression of PINK1 protein	PMID:40209350
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20180313	CTD	MESH:D003474	Curcumin inhibits the reaction [Cisplatin results in increased expression of PINK1 protein]	PMID:28698153
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260804	CTD	MESH:D003474	[Curcumin co-treated with Atrazine] results in increased expression of PINK1 mRNA; [Curcumin co-treated with Atrazine] results in increased expression of PINK1 protein; Curcumin inhibits the reaction [Atrazine results in increased expression of PINK1 protein]; Curcumin promotes the reaction [Atrazine results in increased expression of PINK1 mRNA]	PMID:40209350
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PINK1 mRNA	PMID:17292431
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of PINK1 mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PINK1 mRNA	PMID:30047161
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D016572	Cyclosporine results in decreased expression of PINK1 protein	PMID:27318970|PMID:40023272
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314002	E	RGD:6480464	20240402	CTD	MESH:D016572	Cyclosporine results in increased expression of PINK1 protein	PMID:36557995
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20171114	CTD	MESH:D016572	Cyclosporine inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [quinone results in increased expression of PINK1 mRNA]; Cyclosporine inhibits the reaction [quinone results in increased expression of PINK1 protein]; Palmitic Acid inhibits the reaction [Cyclosporine results in decreased expression of PINK1 protein]	PMID:27318970|PMID:29567065|PMID:40023272
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20240903	CTD	MESH:D016572	Cyclosporine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]]	PMID:38373586|PMID:39208572
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20160210	CTD	MESH:D016572	Cyclosporine affects the reaction [sodium arsenite affects the expression of PINK1 protein]; Cyclosporine inhibits the reaction [Cadmium results in increased expression of PINK1]; Cyclosporine inhibits the reaction [sodium arsenite results in increased expression of PINK1 protein]	PMID:25464205|PMID:36557995|PMID:38653026
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of PINK1 mRNA	PMID:33512557
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240305	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]	PMID:37692514
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PINK1 mRNA	PMID:17555576
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:42160	dithionite(2-)	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20220111	CTD	MESH:D004227	[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein]	PMID:34078833
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:42567	fisetin	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C017875	fisetin inhibits the reaction [amyloid beta-protein (1-42) results in increased expression of PINK1 mRNA]	PMID:40695427
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20220705	CTD	MESH:D005947	Glucose results in decreased expression of PINK1 protein	PMID:35243728
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D005947	Glucose results in increased expression of PINK1 mRNA	PMID:33962019
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1314002	E	RGD:6480464	20250902	CTD	MESH:D005947	Glucose results in increased expression of PINK1 protein	PMID:38334676
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D005947	[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA]	PMID:33962019
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20220705	CTD	MESH:D005947	Inositol inhibits the reaction [Glucose results in decreased expression of PINK1 protein]	PMID:35243728
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20250902	CTD	MESH:D005947	imeglimin inhibits the reaction [Glucose results in increased expression of PINK1 protein]	PMID:38334676
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:4356	desferrioxamine B	multiple interactions	EXP		E	RGD:6480464	20220111	CTD	MESH:D003676	[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of PINK1 mRNA]	PMID:33962019
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of PINK1 mRNA	PMID:33512557
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:45951	trifluoperazine	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D014268	[PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of ATP6V1H mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of LAMP1 mRNA; [PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]] which affects the expression of TFEB mRNA; PINK1 protein affects the susceptibility to [Trifluoperazine co-treated with Antimycin A co-treated with oligomycin A]; Trifluoperazine affects the reaction [PINK1 protein affects the reaction [[oligomycin A co-treated with Antimycin A] affects the localization of TFEB protein]]	PMID:28366621
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PINK1 mRNA	PMID:28542535
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PINK1 mRNA	PMID:17562736
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PINK1 mRNA	PMID:33387578
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20231031	CTD	MESH:D000082	Acetaminophen results in decreased expression of PINK1 mRNA	PMID:37179516
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of PINK1 mRNA	PMID:22230336|PMID:25704631
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314002	E	RGD:6480464	20210504	CTD	MESH:D000082	Acetaminophen results in increased expression of PINK1 protein	PMID:33271250
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20210504	CTD	MESH:D000082	Chloroquine inhibits the reaction [Acetaminophen results in increased expression of PINK1 protein]; Chloroquine inhibits the reaction [coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of PINK1 protein]]; coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of PINK1 protein]	PMID:33271250
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:46245	coenzyme Q10	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20210504	CTD	MESH:C024989	Chloroquine inhibits the reaction [coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of PINK1 protein]]; coenzyme Q10 promotes the reaction [Acetaminophen results in increased expression of PINK1 protein]	PMID:33271250
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:46961	phytosphingosine	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C012491	phytosphingosine results in decreased expression of PINK1 protein	PMID:36334778
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:46979	N-acetylsphingosine	decreases response to substance	EXP		E	RGD:6480464	20170725	CTD	MESH:C064769	PINK1 protein results in decreased susceptibility to N-acetylsphingosine	PMID:24792327
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:46979	N-acetylsphingosine	decreases response to substance	ISO	RGD:1314002	E	RGD:6480464	20170725	CTD	MESH:C064769	PINK1 protein results in decreased susceptibility to N-acetylsphingosine	PMID:24792327
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260113	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PINK1 protein	PMID:40081728
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:47426	furosemide	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20190312	CTD	MESH:D005665	[Drinking Water deficiency co-treated with Furosemide co-treated with iodixanol] results in increased expression of PINK1 protein	PMID:29860548
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:47495	N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20181113	CTD	MESH:C063509	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased expression of PINK1 protein	PMID:29870751
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:47495	N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20181113	CTD	MESH:C063509	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [T-2 Toxin results in increased expression of PINK1 protein]	PMID:29870751
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:47697	4,5,6,7-TETRABROMOBENZOTRIAZOLE	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:C405354	4,5,6,7-tetrabromobenzotriazole inhibits the reaction [Rotenone results in increased expression of PINK1 protein]	PMID:37156403
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of PINK1 mRNA	PMID:31838189
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of PINK1 mRNA	PMID:26833863
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PINK1 mRNA	PMID:17555576
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of PINK1 mRNA	PMID:17942748
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of PINK1 mRNA	PMID:17942748
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PINK1 protein	PMID:30551535
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PINK1 protein	PMID:27318970
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein]; Cyclosporine inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein]	PMID:27318970
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20191114	CTD	MESH:C032793	Taurine inhibits the reaction [Arsenic Trioxide results in decreased expression of PINK1 protein]	PMID:30551535
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:5011	fenpyroximate	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of PINK1 mRNA	PMID:33512557
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of PINK1 mRNA	PMID:23300844
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305769	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PINK1 mRNA	PMID:31734597
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PINK1 mRNA; Nanotubes, Carbon results in decreased expression of PINK1 mRNA	PMID:25554681
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PINK1 mRNA	PMID:30047161
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:50924	sorafenib	affects response to substance	ISO	RGD:1314002	E	RGD:6480464	20180313	CTD	MESH:C471405	PINK1 protein affects the susceptibility to sorafenib	PMID:28673964
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:50924	sorafenib	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:C471405	sorafenib results in increased expression of PINK1 protein	PMID:28673964
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:50924	sorafenib	increases expression	ISO	RGD:1314002	E	RGD:6480464	20180313	CTD	MESH:C471405	sorafenib results in increased expression of PINK1 protein	PMID:28673964
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:50924	sorafenib	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:C471405	[sorafenib co-treated with PRKN protein] results in increased expression of PINK1 protein; PINK1 protein affects the reaction [sorafenib affects the localization of PRKN protein]	PMID:28673964
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:5199	Fusaric acid	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D005669	Fusaric Acid results in increased expression of PINK1 protein	PMID:30582969
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:5298	Genipin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20171010	CTD	MESH:C007834	genipin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of PINK1 protein]	PMID:28477916
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:53248	poly(vinylpyrrolidone)	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20221206	CTD	MESH:D011205	[Silver Compounds co-treated with Povidone] results in increased expression of PINK1 protein	PMID:35697184
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:57589	O-acetyl-L-carnitine	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20170103	CTD	MESH:D000108	Acetylcarnitine inhibits the reaction [Cadmium results in increased expression of PINK1]	PMID:25464205
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:5759	Honokiol	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20220510	CTD	MESH:C005499	honokiol inhibits the reaction [amyloid beta-protein (1-42) results in decreased expression of PINK1 protein]; SIRT3 protein affects the reaction [honokiol inhibits the reaction [amyloid beta-protein (1-42) results in decreased expression of PINK1 protein]]	PMID:34752757
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:61057	tacrolimus hydrate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016559	PINK1 protein affects the reaction [Tacrolimus results in increased phosphorylation of DNM1L protein]	PMID:19492085
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C025340	manganese chloride results in decreased expression of PINK1 mRNA	PMID:27913844
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:63041	manganese(II) chloride	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:C025340	manganese chloride results in increased methylation of PINK1 gene	PMID:27913844
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PINK1 mRNA	PMID:26378955
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D015655	PINK1 protein affects the susceptibility to 1-Methyl-4-phenylpyridinium	PMID:16226715
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20150825	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PINK1 protein	PMID:24475098
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PINK1 protein	PMID:36078115
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases response to substance	EXP		E	RGD:6480464	20130514	CTD	MESH:D015655	PINK1 gene mutant form results in increased susceptibility to 1-Methyl-4-phenylpyridinium	PMID:20547144
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	EXP		E	RGD:6480464	20130416	CTD	MESH:D015655	PINK1 protein affects the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HMOX1 mRNA]; PINK1 protein affects the reaction [1-Methyl-4-phenylpyridinium results in increased expression of HMOX1 protein]	PMID:21366594
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305769	E	RGD:6480464	20240430	CTD	MESH:D008012	Lidocaine results in increased expression of PINK1 protein	PMID:37914286
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:6456	lidocaine	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20240430	CTD	MESH:D008012	bafilomycin A1 inhibits the reaction [Lidocaine results in increased expression of PINK1 protein]; dorsomorphin inhibits the reaction [Lidocaine results in increased expression of PINK1 protein]; MK-8722 promotes the reaction [Lidocaine results in increased expression of PINK1 protein]	PMID:37914286
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:65585	carnosic acid	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C018381	PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of PRKN protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of VDAC1 protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in increased cleavage of CASP3 protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in increased cleavage of PARP1 protein]]; salvin inhibits the reaction [Oxidopamine results in decreased expression of PINK1 protein]	PMID:30707903
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:67989	ginsenoside Rb1	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20240903	CTD	MESH:C442759	Cyclosporine inhibits the reaction [ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]]; ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]; TFEB protein promotes the reaction [ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]]	PMID:38373586
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:67989	ginsenoside Rb1	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240903	CTD	MESH:C442759	ginsenoside Rb1 inhibits the reaction [alpha-Chlorohydrin results in decreased expression of PINK1 protein]	PMID:38373586
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:D008687	Metformin inhibits the reaction [Oleic Acid results in decreased expression of PINK1 protein]	PMID:36592823
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240604	CTD	MESH:D008687	Metformin inhibits the reaction [Dietary Fats results in decreased expression of PINK1 protein]	PMID:36592823
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:68610	linagliptin	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20250311	CTD	MESH:D000069476	Linagliptin inhibits the reaction [Cisplatin results in decreased expression of PINK1]	PMID:39102946
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:69478	cannabidiol	affects expression	ISO	RGD:1305769	E	RGD:6480464	20241203	CTD	MESH:D002185	Cannabidiol affects the expression of PINK1 mRNA	PMID:38182033
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:69832	osthole	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:C046627	osthol results in increased expression of PINK1 protein	PMID:40446951
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:69832	osthole	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C046627	erastin promotes the reaction [osthol results in increased expression of PINK1 protein]; ferrostatin-1 inhibits the reaction [osthol results in increased expression of PINK1 protein]; TFRC protein promotes the reaction [osthol results in increased expression of PINK1 protein]	PMID:40446951
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PINK1 mRNA	PMID:31758290
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone results in decreased expression of PINK1 protein	PMID:29729358
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	increases expression	ISO	RGD:1314002	E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone results in increased expression of PINK1 protein	PMID:34952138
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in increased expression of PINK1 protein]; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Doxorubicin results in increased expression of PINK1 protein]; 3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [ophiopogonin D results in increased expression of PINK1 protein]	PMID:27318970|PMID:29729358|PMID:35905946
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PINK1 protein]	PMID:34952138
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:749016	gossypol acetic acid	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of PINK1 protein	PMID:41134649
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305769	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PINK1 mRNA	PMID:24136188
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases cleavage	EXP		E	RGD:6480464	20260707	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of PINK1 protein	PMID:37060996
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PINK1 protein	PMID:39442788
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C072553	BAG2 protein inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PINK1 protein]; MIR593 inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased cleavage of PINK1 protein]	PMID:37060996|PMID:39442788
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20230606	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[ponasterone A results in increased expression of PINK1 protein] which results in decreased expression of FIS1 protein]	PMID:20164189
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:75458	carbonyl cyanide p-trifluoromethoxyphenylhydrazone	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20180313	CTD	MESH:D002259	PINK1 protein affects the reaction [Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone affects the localization of PRKN protein]	PMID:24879156
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of PINK1 mRNA	PMID:28960945
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:755912	aluminum chloride	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260714	CTD	MESH:D000077410	[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA; [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein; Acetylcholine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of PINK1 mRNA]	PMID:34547296
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:756996	imeglimin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260714	CTD	MESH:C575881	imeglimin inhibits the reaction [Glucose results in increased expression of PINK1 protein]	PMID:38334676
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305769	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of PINK1 mRNA	PMID:19717638
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PINK1 mRNA	PMID:30851411
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20220308	CTD	MESH:C516138	dorsomorphin inhibits the reaction [Lidocaine results in increased expression of PINK1 protein]; dorsomorphin inhibits the reaction [sappanone A inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of PINK1 protein]]	PMID:34358556|PMID:37914286
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:78741	oxidopamine	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016627	Oxidopamine results in decreased expression of PINK1 protein	PMID:30707903
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:78741	oxidopamine	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D016627	PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of PRKN protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in decreased expression of VDAC1 protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in increased cleavage of CASP3 protein]]; PINK1 protein affects the reaction [salvin inhibits the reaction [Oxidopamine results in increased cleavage of PARP1 protein]]; salvin inhibits the reaction [Oxidopamine results in decreased expression of PINK1 protein]	PMID:30707903
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:80883	Ophiopogonin D	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C046996	ophiopogonin D results in increased expression of PINK1 protein	PMID:35905946
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:80883	Ophiopogonin D	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:C046996	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [ophiopogonin D results in increased expression of PINK1 protein]	PMID:35905946
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1314002	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in increased expression of PINK1 mRNA	PMID:22538082
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:81794	thifluzamide	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of PINK1 mRNA	PMID:33512557
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:81833	trifloxystrobin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C467051	trifloxystrobin results in increased expression of PINK1 protein	PMID:27853101
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:81833	trifloxystrobin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C467051	MitoTEMPO inhibits the reaction [trifloxystrobin results in increased expression of PINK1 protein]	PMID:27853101
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1314002	E	RGD:6480464	20200310	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of PINK1 mRNA	PMID:29699156
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in increased expression of PINK1 mRNA	PMID:21858171
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of PINK1 mRNA	PMID:33512557
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314002	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of PINK1 mRNA	PMID:39847705
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305769	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PINK1 mRNA	PMID:30047161
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PINK1 mRNA]	PMID:39241906
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:8802	remifentanil	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20220111	CTD	MESH:C071741	[Antagomirs results in decreased expression of MIR205 mRNA] promotes the reaction [Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]]; Remifentanil inhibits the reaction [[Oxygen co-treated with Dithionite] results in decreased expression of PINK1 protein]; Remifentanil inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PINK1 protein]	PMID:34078833
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:8805	Repaglinide	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20230704	CTD	MESH:C072379	repaglinide inhibits the reaction [Rotenone results in decreased expression of PINK1 mRNA]	PMID:36538285
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:9144	silibinin	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C440975	Silybin inhibits the reaction [Acetaldehyde results in decreased expression of PINK1 mRNA]; Silybin inhibits the reaction [Acetaldehyde results in decreased expression of PINK1 protein]; Silybin inhibits the reaction [Ethanol results in decreased expression of PINK1 mRNA]; Silybin inhibits the reaction [Ethanol results in decreased expression of PINK1 protein]	PMID:35595033
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20211012	CTD	MESH:D020123	Sirolimus inhibits the reaction [[Particulate Matter co-treated with Rotenone] results in decreased expression of PINK1 protein]	PMID:33823232
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20211012	CTD	MESH:D020123	Sirolimus inhibits the reaction [[Particulate Matter co-treated with Rotenone] results in decreased expression of PINK1 protein]; Sirolimus inhibits the reaction [Carbon Tetrachloride results in increased expression of PINK1 protein]	PMID:33823232|PMID:35405287
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305769	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PINK1 mRNA	PMID:21346803
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20211109	CTD	MESH:D013311	[Dietary Fats co-treated with Streptozocin] results in increased expression of PINK1 mRNA	PMID:33812996
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1305769	E	RGD:6480464	20181113	CTD	MESH:D013605	T-2 Toxin results in increased expression of PINK1 mRNA; T-2 Toxin results in increased expression of PINK1 protein	PMID:29870751
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:9381	T-2 toxin	multiple interactions	ISO	RGD:1305769	E	RGD:6480464	20181113	CTD	MESH:D013605	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [T-2 Toxin results in increased expression of PINK1 protein]; NFE2L2 protein affects the reaction [T-2 Toxin results in increased expression of PINK1 protein]; PINK1 promotes the reaction [T-2 Toxin results in increased expression of DNM1L mRNA]; PINK1 promotes the reaction [T-2 Toxin results in increased expression of FIS1 mRNA]; PINK1 promotes the reaction [T-2 Toxin results in increased expression of MFN1 mRNA]; PINK1 promotes the reaction [T-2 Toxin results in increased expression of OPA1 mRNA]	PMID:29870751|PMID:36863559
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:9422	tebufenpyrad	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of PINK1 mRNA	PMID:33512557
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:94287	erastin	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C477224	erastin promotes the reaction [osthol results in increased expression of PINK1 protein]	PMID:40446951
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of PINK1 mRNA	PMID:22378314
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305769	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PINK1 mRNA	PMID:21346803
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:9679	tricalcium bis(phosphate)	multiple interactions	ISO	RGD:1314002	E	RGD:6480464	20240305	CTD	MESH:C018392	Acetylcysteine inhibits the reaction [tricalcium phosphate results in increased expression of PINK1 protein]; tricalcium phosphate results in increased expression of and results in increased localization of PINK1 protein	PMID:37678662
1314001	PINK1	PTEN induced kinase 1	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1305769	E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in increased expression of PINK1 mRNA	PMID:24136188
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RBM22 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RBM22 mRNA	PMID:32699268
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1314004	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of RBM22 mRNA	PMID:25056781
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314004	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RBM22 mRNA	PMID:30319688
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RBM22 mRNA	PMID:37042841
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RBM22 mRNA	PMID:28818685
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RBM22 mRNA	PMID:19549813
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RBM22 mRNA	PMID:23649840
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1314004	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of RBM22 mRNA	PMID:27776689
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1314004	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of RBM22 mRNA	PMID:25056781
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RBM22 mRNA	PMID:23649840
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RBM22 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RBM22 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RBM22 mRNA	PMID:32699268
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RBM22 mRNA	PMID:18593933
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314004	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RBM22 mRNA	PMID:25629700
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1314004	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of RBM22 protein	PMID:25505154
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RBM22 mRNA	PMID:27392435
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1305770	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of RBM22 gene	PMID:28505145
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305770	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RBM22 mRNA	PMID:33387578
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of RBM22 protein	PMID:38228842
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RBM22 mRNA	PMID:38568856
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RBM22 promoter	PMID:27901495
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RBM22 mRNA	PMID:18593933
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of RBM22 mRNA	PMID:31745603
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314004	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RBM22 gene	PMID:35295148
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305770	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RBM22 mRNA	PMID:34492290
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314004	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RBM22 mRNA	PMID:33221593
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305770	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RBM22 mRNA	PMID:25181051
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314004	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of RBM22 mRNA	PMID:39742910
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305770	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of RBM22 gene	PMID:28505145
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314004	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RBM22 mRNA	PMID:39298647
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RBM22 mRNA	PMID:37042841
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RBM22 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RBM22 mRNA	PMID:32699268
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RBM22 mRNA	PMID:25979313
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of RBM22 mRNA	PMID:23179753|PMID:27188386
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RBM22 mRNA	PMID:17183730
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	Vorinostat results in decreased expression of RBM22 mRNA	PMID:22083351|PMID:27188386|PMID:33770205
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RBM22 mRNA	PMID:28542535
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314004	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RBM22 mRNA	PMID:17562736
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of RBM22 mRNA	PMID:21148743
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305770	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of RBM22 mRNA	PMID:24793618
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RBM22 mRNA	PMID:17183730
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RBM22 protein	PMID:32959892
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RBM22 protein	PMID:37664457
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:75175	3',5'-cyclic UMP	affects binding	EXP		E	RGD:6480464	20220405	CTD	MESH:C045338	RBM22 protein binds to cyclic 3',5'-uridine monophosphate	PMID:30528433
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of RBM22 protein	PMID:31285264
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314004	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of RBM22 mRNA	PMID:30294300
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305770	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RBM22 mRNA	PMID:24780913
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C496932	Panobinostat results in decreased expression of RBM22 mRNA	PMID:33770205
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RBM22 protein	PMID:37664457
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305770	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RBM22 mRNA	PMID:21346803
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of RBM22 mRNA	PMID:29301935
1314003	RBM22	RNA binding motif protein 22	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of RBM22 mRNA	PMID:27188386
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CASP8AP2 mRNA	PMID:33045310
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1305771	E	RGD:6480464	20161213	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CASP8AP2 mRNA	PMID:26476374
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305771	E	RGD:6480464	20161213	CTD	MESH:D010100	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CASP8AP2 mRNA]	PMID:26476374
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CASP8AP2 mRNA	PMID:22378314
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:155663665|PMID:28367268	20221202	RGD	MESH:D006861	hydrogen peroxide decreases expression of CASP8AP2 protein in umbilical vein endothelial cells	
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1305771	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CASP8AP2 mRNA]	PMID:26476374
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314006	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CASP8AP2 mRNA	PMID:39241906
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CASP8AP2 mRNA	PMID:38568856
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:16598	DDE	increases expression	ISO	RGD:1305771	E	RGD:6480464	20140909	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CASP8AP2 mRNA	PMID:24576310
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of CASP8AP2 mRNA	PMID:20655997
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314006	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of CASP8AP2 mRNA	PMID:20463053
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CASP8AP2 mRNA	PMID:33754040
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of CASP8AP2 protein	PMID:34122009
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CASP8AP2 protein	PMID:37730182
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305771	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CASP8AP2 mRNA	PMID:33387578
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305771	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CASP8AP2 mRNA	PMID:22061828
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CASP8AP2 mRNA	PMID:19549813
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314006	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CASP8AP2 mRNA	PMID:19770486
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CASP8AP2 intron	PMID:30157460
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of CASP8AP2 mRNA	PMID:26760959
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CASP8AP2 mRNA	PMID:23649840
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1314006	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of CASP8AP2 mRNA	PMID:15674844
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314006	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CASP8AP2 mRNA	PMID:31919559
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CASP8AP2 mRNA	PMID:25629700
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:27514	genistein 7-O-beta-D-glucoside	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C040641	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA	PMID:27424125
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CASP8AP2 protein	PMID:35688186
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1305771	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of CASP8AP2 mRNA	PMID:25905778
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of CASP8AP2 mRNA	PMID:19167446
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CASP8AP2 mRNA	PMID:27594783
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CASP8AP2 mRNA	PMID:30912803
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of CASP8AP2 mRNA	PMID:15256057
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D019833	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA	PMID:27424125
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314006	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CASP8AP2 mRNA	PMID:24680724
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305771	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CASP8AP2 mRNA	PMID:32109520|PMID:33387578
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CASP8AP2 mRNA	PMID:18691609
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305771	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CASP8AP2 mRNA	PMID:19520675|PMID:34747641
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314006	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CASP8AP2 mRNA	PMID:19465110
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:28197	daidzein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C004742	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA	PMID:27424125
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CASP8AP2 mRNA	PMID:33212167
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314006	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of CASP8AP2 mRNA	PMID:27862939
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CASP8AP2 mRNA	PMID:29803840
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of CASP8AP2 protein	PMID:35688186
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CASP8AP2 mRNA	PMID:38568856
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CASP8AP2 mRNA	PMID:16014739
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of CASP8AP2 mRNA	PMID:17879257
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CASP8AP2 intron	PMID:30157460
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CASP8AP2 mRNA	PMID:40419235
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of CASP8AP2 protein	PMID:34122009
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CASP8AP2 mRNA	PMID:19073995
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CASP8AP2 mRNA	PMID:20382639
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1305771	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CASP8AP2 mRNA	PMID:19730151
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased localization of [CASP8AP2 protein co-treated with PML protein]; Arsenic Trioxide results in increased localization of and results in increased degradation of CASP8AP2 protein	PMID:23673342
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305771	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of CASP8AP2 mRNA	PMID:25729387
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305771	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of CASP8AP2 mRNA	PMID:25729387
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:32063	propylparaben	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C006068	propylparaben results in increased expression of CASP8AP2 mRNA	PMID:24481588
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314006	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CASP8AP2 gene; titanium dioxide results in decreased methylation of CASP8AP2 promoter	PMID:35295148
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305771	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CASP8AP2 mRNA	PMID:34492290
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CASP8AP2 mRNA	PMID:38479592
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305771	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of CASP8AP2 mRNA	PMID:19167457
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305771	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CASP8AP2 mRNA	PMID:25181051|PMID:32145629
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	ISO	RGD:1305771	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of CASP8AP2 mRNA; o,p'-DDT results in decreased expression of CASP8AP2 mRNA	PMID:22937105
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1305771	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in increased expression of CASP8AP2 mRNA	PMID:22937105
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20140909	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of CASP8AP2 mRNA	PMID:24680724
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314006	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of CASP8AP2 mRNA	PMID:33297965
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305771	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of CASP8AP2 mRNA	PMID:22546817
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305771	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CASP8AP2 mRNA	PMID:22546817
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to CASP8AP2 protein	PMID:32991956
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:34778	glycitein	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C086566	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA	PMID:27424125
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1314006	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CASP8AP2 mRNA	PMID:17854601
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314006	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CASP8AP2 mRNA]	PMID:17854601
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CASP8AP2 mRNA	PMID:37042841
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CASP8AP2 mRNA	PMID:24982889
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305771	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased expression of CASP8AP2 mRNA	PMID:22079235
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:38319	usnic acid	increases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in increased expression of CASP8AP2 mRNA	PMID:32508146
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of CASP8AP2 mRNA	PMID:19167446
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CASP8AP2 mRNA	PMID:27153767|PMID:40419075
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1305771	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of CASP8AP2 mRNA	PMID:23125180
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1305771	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of CASP8AP2 mRNA	PMID:22110744
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of CASP8AP2 mRNA	PMID:28001369
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of CASP8AP2 mRNA	PMID:21041162
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:41922	diethylstilbestrol	affects expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol affects the expression of CASP8AP2 mRNA	PMID:36621641
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:42202	daidzein 7-O-beta-D-glucoside	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C013908	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA	PMID:27424125
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:44185	methotrexate	increases response to substance	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	CASP8AP2 mRNA results in increased susceptibility to Methotrexate	PMID:22753658
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314006	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CASP8AP2 mRNA	PMID:17562736
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CASP8AP2 mRNA	PMID:22230336
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:47519	ketoconazole	affects expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole affects the expression of CASP8AP2 mRNA	PMID:36621641
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1305771	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CASP8AP2 mRNA	PMID:19730151
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased localization of [CASP8AP2 protein co-treated with PML protein]; Arsenic Trioxide results in increased localization of and results in increased degradation of CASP8AP2 protein	PMID:23673342
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314006	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CASP8AP2 mRNA	PMID:19042947
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:53154	8'-apo-beta,psi-caroten-8'-al	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004984	apocarotenal results in increased expression of CASP8AP2 mRNA	PMID:17034753
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314006	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CASP8AP2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CASP8AP2 mRNA	PMID:21641980|PMID:26378955
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305771	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of CASP8AP2 mRNA	PMID:25729387
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in decreased expression of CASP8AP2 mRNA	PMID:33244087
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:6954	Mitotane	increases expression	ISO	RGD:1305771	E	RGD:6480464	20191114	CTD	MESH:D008939	Mitotane analog results in increased expression of CASP8AP2 mRNA; Mitotane results in increased expression of CASP8AP2 mRNA	PMID:23485034
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314006	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CASP8AP2 mRNA	PMID:22206623
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of CASP8AP2 protein	PMID:31285264
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of CASP8AP2 mRNA	PMID:30928695
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:80373	glycitin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C433283	[daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA	PMID:27424125
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CASP8AP2 mRNA	PMID:27589474
1314005	CASP8AP2	caspase 8 associated protein 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305771	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CASP8AP2 mRNA	PMID:21346803
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:15343	acetaldehyde	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D000079	Acetaldehyde results in increased expression of YAF2 mRNA	PMID:23416264
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of YAF2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of YAF2 mRNA	PMID:32699268
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314011	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of YAF2 mRNA	PMID:36331819
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314011	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of YAF2 mRNA	PMID:30319688
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314011	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of YAF2 mRNA	PMID:30319688
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314011	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of YAF2 mRNA	PMID:39241906
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of YAF2 mRNA	PMID:37042841
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314011	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of YAF2 mRNA	PMID:19850644
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314011	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of YAF2 mRNA]	PMID:19850644
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of YAF2 protein	PMID:37730182
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314011	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of YAF2 mRNA	PMID:36331819
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of YAF2 mRNA	PMID:39836092
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of YAF2 mRNA	PMID:19549813
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of YAF2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of YAF2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of YAF2 mRNA	PMID:32699268
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314011	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of YAF2 mRNA]	PMID:22206623
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of YAF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of YAF2 mRNA	PMID:39836092
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of YAF2 protein	PMID:35688186
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314011	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of YAF2 mRNA	PMID:28189721|PMID:28960355
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of YAF2 mRNA	PMID:23557933
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of YAF2 mRNA	PMID:27392435
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of YAF2 mRNA	PMID:27392435
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314011	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of YAF2 mRNA	PMID:19770486
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of YAF2 mRNA	PMID:29803840
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of YAF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of YAF2 mRNA	PMID:39836092
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of YAF2 mRNA	PMID:17879257
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of YAF2 promoter	PMID:27901495
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of YAF2 gene	PMID:31601247
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1582851	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of YAF2 mRNA	PMID:25729387
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1582851	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of YAF2 mRNA	PMID:30047161
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314011	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of YAF2 gene; titanium dioxide results in decreased methylation of YAF2 promoter	PMID:35295148
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314011	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of YAF2 mRNA	PMID:17426115|PMID:18301758
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1582851	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of YAF2 mRNA	PMID:25181051
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1582851	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of YAF2 mRNA	PMID:41034487
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of YAF2 gene	PMID:31601247
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of YAF2 gene	PMID:31601247
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of YAF2 mRNA	PMID:25979313
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of YAF2 gene	PMID:31601247
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314011	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of YAF2 mRNA	PMID:21266533
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1582851	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of YAF2 mRNA	PMID:21266533
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of YAF2 mRNA	PMID:39836092
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of YAF2 mRNA	PMID:38568856
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of YAF2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of YAF2 mRNA	PMID:32699268
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of YAF2 mRNA	PMID:31533062
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314011	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of YAF2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of YAF2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of YAF2 mRNA	PMID:36331819
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1582851	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of YAF2 mRNA	PMID:30047161
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of YAF2 mRNA	PMID:25562108
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of YAF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of YAF2 mRNA	PMID:39836092
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1582851	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of YAF2 mRNA	PMID:30047161
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314011	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of YAF2 mRNA	PMID:35964746
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of YAF2 mRNA	PMID:39836092
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1582851	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of YAF2 mRNA	PMID:25729387
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1314011	E	RGD:6480464	20200317	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of YAF2 mRNA	PMID:22078008
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314011	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of YAF2 mRNA	PMID:22206623
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314011	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of YAF2 mRNA]	PMID:22206623
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to YAF2 gene]	PMID:28238834
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of YAF2 mRNA	PMID:18927307
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of YAF2 mRNA	PMID:19159669
1314010	YAF2	YY1 associated factor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1582851	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of YAF2 mRNA	PMID:30047161
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of INPP5F mRNA	PMID:33167477
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of INPP5F mRNA	PMID:24763279
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305777	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of INPP5F gene	PMID:35440735
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of INPP5F mRNA	PMID:18951874
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1314014	E	RGD:6480464	20200211	CTD	MESH:D006861	N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of INPP5F protein]	PMID:31494107
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314014	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of INPP5F mRNA	PMID:39241906
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of INPP5F mRNA	PMID:31614463
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of INPP5F mRNA	PMID:38685446
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305777	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of INPP5F mRNA	PMID:26496021
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of INPP5F protein	PMID:37730182
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of INPP5F gene	PMID:27153756
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314014	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of INPP5F mRNA	PMID:19770486
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of INPP5F gene	PMID:28458013
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of INPP5F mRNA	PMID:25629700
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:2762	antimycin A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D000968	Antimycin A results in decreased expression of INPP5F mRNA	PMID:33770205
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of INPP5F protein	PMID:35688186
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1305777	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA	PMID:33854195
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of INPP5F mRNA	PMID:28903495
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27889	lead(0)	decreases methylation	ISO	RGD:1314014	E	RGD:6480464	20250311	CTD	MESH:D007854	Lead results in decreased methylation of INPP5F gene	PMID:38833407
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of INPP5F mRNA	PMID:27392435
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1314014	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in increased expression of INPP5F mRNA	PMID:16917069
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305777	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of INPP5F mRNA	PMID:22298810
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314014	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of INPP5F mRNA	PMID:21570461
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305777	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of INPP5F mRNA	PMID:21215274
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of INPP5F mRNA	PMID:19465110
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1305777	E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of INPP5F mRNA]	PMID:21215274
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of INPP5F mRNA	PMID:33212167
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of INPP5F mRNA	PMID:29803840
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D014415	Tunicamycin results in decreased expression of INPP5F mRNA	PMID:33770205
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of INPP5F mRNA	PMID:22228805
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314014	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of INPP5F mRNA	PMID:19770486|PMID:22228805
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of INPP5F promoter	PMID:27901495
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of INPP5F protein	PMID:37955338
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314014	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of INPP5F gene; titanium dioxide results in decreased methylation of INPP5F promoter	PMID:35295148
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305777	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of INPP5F mRNA	PMID:34492290
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of INPP5F mRNA	PMID:23811191
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314014	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of INPP5F mRNA	PMID:19710929
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of INPP5F protein	PMID:33376534
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of INPP5F gene	PMID:31601247
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305777	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of INPP5F mRNA	PMID:25181051
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305777	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of INPP5F mRNA	PMID:26496021
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314014	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of INPP5F mRNA	PMID:39298647
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34568	Benzo[ghi]perylene	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in decreased expression of INPP5F mRNA	PMID:26377693
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of INPP5F mRNA	PMID:26377693
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1314014	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of INPP5F mRNA	PMID:28392331
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1305777	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA	PMID:33854195
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1314014	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of INPP5F gene	PMID:38995845
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314014	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of INPP5F mRNA	PMID:34813904
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of INPP5F mRNA	PMID:37042841
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of INPP5F mRNA	PMID:24449571
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of INPP5F mRNA	PMID:40419075
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of INPP5F mRNA	PMID:25979313
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of INPP5F mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369|PMID:29154799
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of INPP5F gene	PMID:29154799
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5F mRNA	PMID:27188386
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of INPP5F mRNA	PMID:25562108
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1305777	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA	PMID:33854195
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of INPP5F mRNA	PMID:38832940
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C111237	Vorinostat results in increased expression of INPP5F mRNA	PMID:33770205
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1305777	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA	PMID:33854195
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of INPP5F mRNA	PMID:28542535
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314014	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of INPP5F mRNA	PMID:17562736
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305777	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of INPP5F mRNA	PMID:33387578
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305777	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of INPP5F mRNA	PMID:29391264
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314014	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of INPP5F mRNA	PMID:40234311
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314014	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of INPP5F mRNA	PMID:23608068
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1305777	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA	PMID:33854195
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305777	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of INPP5F mRNA	PMID:20080153
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in increased expression of INPP5F mRNA	PMID:16982809
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305777	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of INPP5F gene	PMID:35440735
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5F mRNA	PMID:27188386
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1305777	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of INPP5F mRNA	PMID:20345932
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314014	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of INPP5F mRNA	PMID:31388691
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305777	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of INPP5F mRNA	PMID:24780913
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C496932	Panobinostat results in increased expression of INPP5F mRNA	PMID:33770205
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP5F mRNA	PMID:27188386
1314013	INPP5F	inositol polyphosphate-5-phosphatase F	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of INPP5F mRNA	PMID:33770205
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1622774	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TIGD4 mRNA	PMID:33045310
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TIGD4 mRNA	PMID:35811015
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of TIGD4 mRNA]	PMID:35811015
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TIGD4 mRNA	PMID:31163220
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:27470	folic acid	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of TIGD4 mRNA	PMID:21867686
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TIGD4 mRNA	PMID:27392435
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of TIGD4 mRNA	PMID:27392435
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TIGD4 mRNA	PMID:28001369
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305780	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TIGD4 mRNA	PMID:25181051
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1622774	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in decreased expression of TIGD4 mRNA	PMID:38701888
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of TIGD4 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TIGD4 gene	PMID:29154799
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIGD4 mRNA	PMID:27188386
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of TIGD4 mRNA	PMID:24935251
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of TIGD4 mRNA]	PMID:35811015
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1622774	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TIGD4 mRNA	PMID:22206623
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of TIGD4 mRNA	PMID:29522793
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIGD4 mRNA	PMID:27188386
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of TIGD4 mRNA	PMID:26079696
1314017	TIGD4	tigger transposable element derived 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIGD4 mRNA	PMID:27188386
1314019	SNX10	sorting nexin 10	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SNX10 mRNA	PMID:27188386
1314019	SNX10	sorting nexin 10	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314020	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of SNX10 mRNA	PMID:33045310
1314019	SNX10	sorting nexin 10	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305782	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SNX10 mRNA]	PMID:31150632
1314019	SNX10	sorting nexin 10	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SNX10 mRNA	PMID:23724009
1314019	SNX10	sorting nexin 10	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SNX10 mRNA	PMID:33167477
1314019	SNX10	sorting nexin 10	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX10 mRNA	PMID:36331819
1314019	SNX10	sorting nexin 10	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314020	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SNX10 mRNA	PMID:30319688
1314019	SNX10	sorting nexin 10	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314020	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SNX10 mRNA	PMID:30319688
1314019	SNX10	sorting nexin 10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SNX10 mRNA	PMID:35811015
1314019	SNX10	sorting nexin 10	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of SNX10 mRNA	PMID:30510588
1314019	SNX10	sorting nexin 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314020	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SNX10 mRNA	PMID:39298647
1314019	SNX10	sorting nexin 10	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305782	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of SNX10 mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SNX10 mRNA	PMID:26496021|PMID:32741896
1314019	SNX10	sorting nexin 10	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNX10 mRNA	PMID:37042841
1314019	SNX10	sorting nexin 10	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of SNX10 mRNA	PMID:21540246
1314019	SNX10	sorting nexin 10	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305782	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SNX10 mRNA	PMID:32741896
1314019	SNX10	sorting nexin 10	gene	CHEBI:17750	glycine betaine	decreases expression	ISO	RGD:1305782	E	RGD:6480464	20151215	CTD	MESH:D001622	Betaine results in decreased expression of SNX10 mRNA	PMID:26391144
1314019	SNX10	sorting nexin 10	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305782	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of SNX10 mRNA	PMID:26577399
1314019	SNX10	sorting nexin 10	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNX10 mRNA	PMID:36331819
1314019	SNX10	sorting nexin 10	gene	CHEBI:188851	Muraglitazar	increases expression	ISO	RGD:1305782	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of SNX10 mRNA	PMID:21515302
1314019	SNX10	sorting nexin 10	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of SNX10 mRNA	PMID:23369406
1314019	SNX10	sorting nexin 10	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of SNX10 mRNA	PMID:37236586
1314019	SNX10	sorting nexin 10	gene	CHEBI:230506	apilimod	affects response to substance	EXP		E	RGD:6480464	20240507	CTD	MESH:C504227	SNX10 protein affects the susceptibility to apilimod	PMID:28104689|PMID:28350209
1314019	SNX10	sorting nexin 10	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305782	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of SNX10 mRNA	PMID:21396975
1314019	SNX10	sorting nexin 10	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305782	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SNX10 mRNA	PMID:22129741
1314019	SNX10	sorting nexin 10	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305782	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SNX10 mRNA	PMID:23630614|PMID:25378103
1314019	SNX10	sorting nexin 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SNX10 intron	PMID:30157460
1314019	SNX10	sorting nexin 10	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D014747	SNX10 protein affects the susceptibility to Vinblastine	PMID:16217747
1314019	SNX10	sorting nexin 10	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305782	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SNX10 mRNA	PMID:31150632
1314019	SNX10	sorting nexin 10	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314020	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SNX10 mRNA	PMID:31919559
1314019	SNX10	sorting nexin 10	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305782	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SNX10 mRNA]	PMID:31150632
1314019	SNX10	sorting nexin 10	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX10 mRNA	PMID:39836092
1314019	SNX10	sorting nexin 10	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305782	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SNX10 mRNA	PMID:31881176
1314019	SNX10	sorting nexin 10	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314020	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of SNX10 protein	PMID:25505154
1314019	SNX10	sorting nexin 10	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of SNX10 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of SNX10 mRNA	PMID:19167446|PMID:23557933
1314019	SNX10	sorting nexin 10	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SNX10 mRNA	PMID:28903495
1314019	SNX10	sorting nexin 10	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SNX10 mRNA	PMID:27594783
1314019	SNX10	sorting nexin 10	gene	CHEBI:27997	elaidic acid	increases expression	ISO	RGD:1314020	E	RGD:6480464	20260804	CTD	MESH:C011459	elaidic acid results in increased expression of SNX10 mRNA; elaidic acid results in increased expression of SNX10 protein	PMID:42191079
1314019	SNX10	sorting nexin 10	gene	CHEBI:27997	elaidic acid	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20260804	CTD	MESH:C011459	GAS5 protein affects the reaction [elaidic acid results in increased expression of SNX10 protein]; MIR27B inhibits the reaction [elaidic acid results in increased expression of SNX10 mRNA]; MIR27B inhibits the reaction [elaidic acid results in increased expression of SNX10 protein]; SNX10 protein affects the reaction [elaidic acid results in decreased expression of LAMP2 protein]; SNX10 protein affects the reaction [elaidic acid results in increased expression of CTSA protein]	PMID:42191079
1314019	SNX10	sorting nexin 10	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SNX10 mRNA	PMID:25583101
1314019	SNX10	sorting nexin 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305782	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX10 mRNA	PMID:22298810
1314019	SNX10	sorting nexin 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314020	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX10 mRNA	PMID:21570461
1314019	SNX10	sorting nexin 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305782	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SNX10 mRNA	PMID:34747641
1314019	SNX10	sorting nexin 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SNX10 mRNA	PMID:25975270
1314019	SNX10	sorting nexin 10	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SNX10 mRNA	PMID:33212167
1314019	SNX10	sorting nexin 10	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1305782	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of SNX10 mRNA	PMID:28959563
1314019	SNX10	sorting nexin 10	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	SNX10 protein affects the susceptibility to Doxorubicin	PMID:16217747
1314019	SNX10	sorting nexin 10	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SNX10 mRNA	PMID:29803840
1314019	SNX10	sorting nexin 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314020	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNX10 mRNA	PMID:37682722
1314019	SNX10	sorting nexin 10	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SNX10 mRNA	PMID:38568856
1314019	SNX10	sorting nexin 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX10 mRNA	PMID:39836092
1314019	SNX10	sorting nexin 10	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of SNX10 mRNA	PMID:22378314
1314019	SNX10	sorting nexin 10	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314020	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SNX10 mRNA	PMID:23221170
1314019	SNX10	sorting nexin 10	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SNX10 gene	PMID:31601247
1314019	SNX10	sorting nexin 10	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1305782	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of SNX10 mRNA	PMID:22641619
1314019	SNX10	sorting nexin 10	gene	CHEBI:32195	Tesaglitazar	increases expression	ISO	RGD:1305782	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of SNX10 mRNA	PMID:21515302
1314019	SNX10	sorting nexin 10	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1314020	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of SNX10 enhancer	PMID:35295148
1314019	SNX10	sorting nexin 10	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305782	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SNX10 mRNA	PMID:23411599|PMID:34492290
1314019	SNX10	sorting nexin 10	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314020	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SNX10 mRNA	PMID:18648102
1314019	SNX10	sorting nexin 10	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314020	E	RGD:6480464	20120515	CTD	MESH:C006253	pirinixic acid results in increased expression of SNX10 mRNA	PMID:18301758|PMID:18445702
1314019	SNX10	sorting nexin 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305782	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SNX10 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314019	SNX10	sorting nexin 10	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SNX10 gene	PMID:31601247
1314019	SNX10	sorting nexin 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305782	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNX10 mRNA	PMID:25181051
1314019	SNX10	sorting nexin 10	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SNX10 gene	PMID:31601247
1314019	SNX10	sorting nexin 10	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305782	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of SNX10 mRNA	PMID:26496021
1314019	SNX10	sorting nexin 10	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314020	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SNX10 mRNA	PMID:26682919
1314019	SNX10	sorting nexin 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314020	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of SNX10 mRNA	PMID:39298647
1314019	SNX10	sorting nexin 10	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314020	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SNX10 mRNA	PMID:32715474|PMID:37019170
1314019	SNX10	sorting nexin 10	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1305782	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of SNX10 mRNA	PMID:19638242
1314019	SNX10	sorting nexin 10	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305782	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SNX10 mRNA	PMID:22129741
1314019	SNX10	sorting nexin 10	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305782	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of SNX10 gene	PMID:33148267
1314019	SNX10	sorting nexin 10	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SNX10 mRNA	PMID:37042841
1314019	SNX10	sorting nexin 10	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305782	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SNX10 mRNA	PMID:30589522
1314019	SNX10	sorting nexin 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of SNX10 mRNA	PMID:37236586
1314019	SNX10	sorting nexin 10	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305782	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of SNX10 mRNA	PMID:25539665
1314019	SNX10	sorting nexin 10	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314020	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SNX10 mRNA	PMID:28903501
1314019	SNX10	sorting nexin 10	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SNX10 mRNA	PMID:19376846
1314019	SNX10	sorting nexin 10	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305782	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SNX10 mRNA	PMID:24386269
1314019	SNX10	sorting nexin 10	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SNX10 mRNA	PMID:24449571
1314019	SNX10	sorting nexin 10	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314020	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of SNX10 mRNA	PMID:18353800
1314019	SNX10	sorting nexin 10	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SNX10 mRNA	PMID:28302478
1314019	SNX10	sorting nexin 10	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX10 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of SNX10 mRNA	PMID:19167446
1314019	SNX10	sorting nexin 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SNX10 mRNA	PMID:27153767
1314019	SNX10	sorting nexin 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNX10 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX10 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SNX10 mRNA	PMID:36331819
1314019	SNX10	sorting nexin 10	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SNX10 mRNA	PMID:25979313
1314019	SNX10	sorting nexin 10	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SNX10 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1314019	SNX10	sorting nexin 10	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314020	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in decreased expression of SNX10 mRNA	PMID:20546886
1314019	SNX10	sorting nexin 10	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of SNX10 mRNA	PMID:24935251
1314019	SNX10	sorting nexin 10	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1314020	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of SNX10 mRNA	PMID:15331540
1314019	SNX10	sorting nexin 10	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SNX10 mRNA	PMID:25562108|PMID:27989131
1314019	SNX10	sorting nexin 10	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314020	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SNX10 mRNA	PMID:28973697
1314019	SNX10	sorting nexin 10	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314020	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SNX10 mRNA	PMID:28973697
1314019	SNX10	sorting nexin 10	gene	CHEBI:43572	kojic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of SNX10 mRNA	PMID:16595896
1314019	SNX10	sorting nexin 10	gene	CHEBI:45863	paclitaxel	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	SNX10 protein affects the susceptibility to Paclitaxel	PMID:16217747
1314019	SNX10	sorting nexin 10	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SNX10 mRNA	PMID:24935251
1314019	SNX10	sorting nexin 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314020	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNX10 mRNA	PMID:17562736
1314019	SNX10	sorting nexin 10	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SNX10 mRNA	PMID:21420995
1314019	SNX10	sorting nexin 10	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305782	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SNX10 mRNA	PMID:33387578
1314019	SNX10	sorting nexin 10	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SNX10 mRNA	PMID:35811015
1314019	SNX10	sorting nexin 10	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX10 mRNA	PMID:39836092
1314019	SNX10	sorting nexin 10	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1314020	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of SNX10 mRNA	PMID:26934552
1314019	SNX10	sorting nexin 10	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of SNX10 mRNA	PMID:19194470
1314019	SNX10	sorting nexin 10	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314020	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SNX10 mRNA; Nanotubes, Carbon results in increased expression of SNX10 mRNA	PMID:25554681|PMID:25620056
1314019	SNX10	sorting nexin 10	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305782	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of SNX10 mRNA	PMID:34044035
1314019	SNX10	sorting nexin 10	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305782	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of SNX10 mRNA	PMID:24793618
1314019	SNX10	sorting nexin 10	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305782	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SNX10 mRNA	PMID:24136188
1314019	SNX10	sorting nexin 10	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of SNX10 mRNA	PMID:22714537
1314019	SNX10	sorting nexin 10	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314020	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SNX10 mRNA	PMID:38701926
1314019	SNX10	sorting nexin 10	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of SNX10 mRNA	PMID:27188386
1314019	SNX10	sorting nexin 10	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305782	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of SNX10 gene	PMID:33148267
1314019	SNX10	sorting nexin 10	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SNX10 mRNA	PMID:31758290
1314019	SNX10	sorting nexin 10	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of SNX10 mRNA	PMID:22714537
1314019	SNX10	sorting nexin 10	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SNX10 mRNA	PMID:37199045
1314019	SNX10	sorting nexin 10	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305782	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SNX10 mRNA	PMID:32741896
1314019	SNX10	sorting nexin 10	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1305782	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of SNX10 mRNA	PMID:23665939
1314019	SNX10	sorting nexin 10	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314020	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SNX10 mRNA	PMID:23091169
1314019	SNX10	sorting nexin 10	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314020	E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in increased expression of SNX10 mRNA	PMID:19270015|PMID:19482888
1314019	SNX10	sorting nexin 10	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314020	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SNX10 mRNA]	PMID:19482888
1314019	SNX10	sorting nexin 10	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305782	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SNX10 mRNA	PMID:32109520
1314019	SNX10	sorting nexin 10	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SNX10 mRNA	PMID:19167446
1314019	SNX10	sorting nexin 10	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314020	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SNX10 mRNA	PMID:21795629
1314019	SNX10	sorting nexin 10	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314020	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SNX10 mRNA	PMID:21278054
1314019	SNX10	sorting nexin 10	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of SNX10 mRNA	PMID:22378314
1314019	SNX10	sorting nexin 10	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1305782	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of SNX10 mRNA	PMID:21515302
1314019	SNX10	sorting nexin 10	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305782	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of SNX10 mRNA	PMID:19015723
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305783	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of HMGXB4 mRNA	PMID:25152437
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of HMGXB4 mRNA	PMID:33167477
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of HMGXB4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of HMGXB4 mRNA	PMID:32699268
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of HMGXB4 mRNA	PMID:38568856
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HMGXB4 mRNA	PMID:37042841
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of HMGXB4 mRNA	PMID:20655997
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of HMGXB4 mRNA	PMID:27683099
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of HMGXB4 protein	PMID:37730182
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305783	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of HMGXB4 mRNA	PMID:33387578
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314022	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HMGXB4 mRNA	PMID:36331819
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of HMGXB4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of HMGXB4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of HMGXB4 mRNA	PMID:32699268
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of HMGXB4 mRNA	PMID:19774075
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of HMGXB4 mRNA	PMID:19244175
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of HMGXB4 mRNA	PMID:19244175
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of HMGXB4 protein	PMID:35688186
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314022	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in increased expression of HMGXB4 mRNA	PMID:28189721|PMID:28960355
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314022	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of HMGXB4 mRNA	PMID:30912803
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314022	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HMGXB4 mRNA	PMID:21570461
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314022	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HMGXB4 mRNA	PMID:17942748
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HMGXB4 mRNA	PMID:33212167
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of HMGXB4 mRNA	PMID:32763439
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305783	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of HMGXB4 mRNA	PMID:28959563
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314022	E	RGD:6480464	20250401	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of HMGB2L1 mRNA	PMID:27862939
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HMGXB4 mRNA	PMID:29803840
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of HMGXB4 protein	PMID:35688186
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314022	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased expression of HMGXB4 mRNA	PMID:32068019
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HMGXB4 promoter	PMID:27901495
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314022	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HMGXB4 mRNA	PMID:22228805
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HMGXB4 mRNA	PMID:20382639
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of HMGXB4 mRNA	PMID:26238291
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314022	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of HMGXB4 gene	PMID:35295148
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314022	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HMGXB4 mRNA	PMID:19710929
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305783	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HMGXB4 mRNA	PMID:25181051
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305783	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HMGXB4 gene	PMID:28505145
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of HMGXB4 mRNA	PMID:19244175
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of HMGXB4 mRNA	PMID:19244175
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314022	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HMGXB4 mRNA	PMID:37019170
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HMGXB4 mRNA	PMID:38174414
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of HMGXB4 mRNA	PMID:26472689
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of HMGXB4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of HMGXB4 mRNA	PMID:32699268
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of HMGXB4 mRNA	PMID:19244175
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of HMGXB4 mRNA	PMID:19244175
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314022	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of HMGXB4 mRNA	PMID:36331819
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HMGXB4 mRNA	PMID:25979313
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in decreased expression of HMGXB4 mRNA	PMID:23179753|PMID:25192806
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314022	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of HMGXB4 mRNA	PMID:21427059
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HMGXB4 gene	PMID:29154799
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of HMGXB4 mRNA	PMID:17183730
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of HMGXB4 mRNA	PMID:25562108
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314022	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HMGXB4 mRNA	PMID:17562736
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314022	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HMGXB4 mRNA	PMID:17942748
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305783	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of HMGXB4 mRNA	PMID:30307764
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of HMGXB4 mRNA	PMID:17183730
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of HMGXB4 mRNA	PMID:28988120
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314022	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of HMGXB4 mRNA	PMID:22206623
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of HMGXB4 protein	PMID:31285264
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HMGXB4 gene]	PMID:28238834
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314022	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of HMGXB4 mRNA	PMID:23091169
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305783	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of HMGXB4 mRNA	PMID:23640034
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305783	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of HMGXB4 mRNA	PMID:19281266
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of HMGXB4 mRNA	PMID:38568856
1314021	HMGXB4	HMG-box containing 4	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of HMGXB4 mRNA	PMID:29301935
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314024	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ELMO2 mRNA	PMID:33045310
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314024	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ELMO2 mRNA	PMID:20188158
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ELMO2 mRNA	PMID:36331819
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of ELMO2 mRNA	PMID:30319688
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of ELMO2 mRNA]	PMID:19442820
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314024	E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in decreased expression of ELMO2 mRNA	PMID:22467019
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314024	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ELMO2 mRNA	PMID:39298647
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305784	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ELMO2 mRNA	PMID:26496021
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ELMO2 mRNA	PMID:38568856
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ELMO2 mRNA	PMID:37042841
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of ELMO2 mRNA	PMID:21592394
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of ELMO2 mRNA	PMID:21592394
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of ELMO2 mRNA]	PMID:19442820
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305784	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ELMO2 mRNA	PMID:26577399
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ELMO2 mRNA	PMID:21592394
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of ELMO2 mRNA	PMID:21592394
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ELMO2 mRNA	PMID:28818685
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ELMO2 mRNA	PMID:39836092
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:194147	aristolochic acids	increases expression	ISO	RGD:1305784	E	RGD:6480464	20230103	CTD	MESH:D034341	Aristolochic Acids results in increased expression of ELMO2 mRNA	PMID:19717638
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ELMO2 mRNA	PMID:29950665
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ELMO2 exon	PMID:30157460
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314024	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ELMO2 mRNA	PMID:17484886
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305784	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ELMO2 mRNA	PMID:31881176
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of ELMO2 mRNA; Cisplatin results in increased expression of ELMO2 protein	PMID:16803524|PMID:27392435
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ELMO2 mRNA	PMID:27392435
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:27928	parathion	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in decreased methylation of ELMO2 promoter	PMID:22847954
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314024	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ELMO2 mRNA	PMID:21570461
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ELMO2 promoter]	PMID:19654925
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ELMO2 protein	PMID:39603559
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [ELMO2 protein binds to CAPRIN1 protein]	PMID:33939924
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1305784	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ELMO2 mRNA	PMID:21839799
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314024	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ELMO2 mRNA	PMID:22228805
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314024	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ELMO2 mRNA	PMID:27131904
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:30563	silicon dioxide	decreases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased methylation of ELMO2 promoter	PMID:34973136
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ELMO2 mRNA	PMID:34973136
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ELMO2 mRNA	PMID:19150397
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ELMO2 gene	PMID:31601247
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314024	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ELMO2 promoter	PMID:35295148
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ELMO2 mRNA	PMID:29950665
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305784	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ELMO2 mRNA	PMID:34492290
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314024	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ELMO2 mRNA	PMID:28472532
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305784	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ELMO2 mRNA	PMID:25181051
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ELMO2 mRNA; bisphenol A results in decreased expression of ELMO2 protein	PMID:33376534|PMID:36232920
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ELMO2 gene	PMID:31601247
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305784	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of ELMO2 mRNA	PMID:26496021
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ELMO2 mRNA	PMID:28628672
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ELMO2 protein	PMID:34186270
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELMO2 mRNA	PMID:28628672
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ELMO2 protein	PMID:34186270
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314024	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ELMO2 mRNA	PMID:37019170
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ELMO2 mRNA	PMID:29950665
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELMO2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ELMO2 mRNA	PMID:28628672
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ELMO2 mRNA	PMID:37042841
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ELMO2 mRNA	PMID:39836092
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ELMO2 protein	PMID:26879310
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of ELMO2 mRNA	PMID:19320972
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:38689	fonofos	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in decreased methylation of ELMO2 promoter	PMID:22847954
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:38960	terbufos	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in decreased methylation of ELMO2 promoter	PMID:22847954
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of ELMO2 mRNA	PMID:19167446
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314024	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ELMO2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ELMO2 mRNA	PMID:36331819
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ELMO2 mRNA	PMID:25979313
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ELMO2 gene	PMID:29154799
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELMO2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ELMO2 mRNA	PMID:28628672
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ELMO2 mRNA	PMID:22230336
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of ELMO2 protein	PMID:16803524
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ELMO2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ELMO2 mRNA	PMID:28628672
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1305784	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of ELMO2 mRNA	PMID:30307764
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ELMO2 protein	PMID:32959892
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of ELMO2 mRNA	PMID:39836092
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314024	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ELMO2 mRNA	PMID:22206623
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305784	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of ELMO2 mRNA	PMID:19717638
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ELMO2 gene]	PMID:28238834
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ELMO2 protein	PMID:31675489
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305784	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ELMO2 mRNA	PMID:24780913
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314024	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ELMO2 mRNA	PMID:27131904
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:9516	thapsigargin	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019284	4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in decreased expression of ELMO2 mRNA]; caffeic acid promotes the reaction [Thapsigargin results in decreased expression of ELMO2 mRNA]; Drugs, Chinese Herbal promotes the reaction [Thapsigargin results in decreased expression of ELMO2 mRNA]	PMID:19442820
1314023	ELMO2	engulfment and cell motility 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305784	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ELMO2 mRNA	PMID:21346803
1314025	MANBA	mannosidase beta	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MANBA mRNA	PMID:33045310
1314025	MANBA	mannosidase beta	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305785	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MANBA mRNA]	PMID:31150632
1314025	MANBA	mannosidase beta	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MANBA mRNA	PMID:33167477
1314025	MANBA	mannosidase beta	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305785	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MANBA gene	PMID:28931070
1314025	MANBA	mannosidase beta	gene	CHEBI:16130	DDT	increases methylation	ISO	RGD:1305785	E	RGD:6480464	20211012	CTD	MESH:D003634	DDT results in increased methylation of MANBA gene	PMID:31682807
1314025	MANBA	mannosidase beta	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of MANBA mRNA	PMID:33711761
1314025	MANBA	mannosidase beta	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MANBA mRNA	PMID:37042841
1314025	MANBA	mannosidase beta	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MANBA mRNA	PMID:28818685
1314025	MANBA	mannosidase beta	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MANBA mRNA	PMID:19549813
1314025	MANBA	mannosidase beta	gene	CHEBI:234430	gardiquimod	decreases expression	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in decreased expression of MANBA mRNA	PMID:28003376
1314025	MANBA	mannosidase beta	gene	CHEBI:234430	gardiquimod	multiple interactions	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of MANBA mRNA]	PMID:28003376
1314025	MANBA	mannosidase beta	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MANBA intron	PMID:30157460
1314025	MANBA	mannosidase beta	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MANBA mRNA	PMID:23649840
1314025	MANBA	mannosidase beta	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of MANBA mRNA	PMID:41430723
1314025	MANBA	mannosidase beta	gene	CHEBI:2663	amiodarone	affects expression	ISO	RGD:1305785	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of MANBA mRNA	PMID:18355885
1314025	MANBA	mannosidase beta	gene	CHEBI:2666	amitriptyline	affects expression	ISO	RGD:1305785	E	RGD:6480464	20120412	CTD	MESH:D000639	Amitriptyline affects the expression of MANBA mRNA	PMID:18355885
1314025	MANBA	mannosidase beta	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314026	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MANBA mRNA	PMID:17484886
1314025	MANBA	mannosidase beta	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MANBA mRNA	PMID:31919559
1314025	MANBA	mannosidase beta	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305785	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MANBA mRNA	PMID:31150632
1314025	MANBA	mannosidase beta	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305785	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MANBA mRNA]	PMID:31150632
1314025	MANBA	mannosidase beta	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1305785	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of MANBA gene	PMID:31011160
1314025	MANBA	mannosidase beta	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MANBA mRNA	PMID:28903495
1314025	MANBA	mannosidase beta	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of MANBA mRNA	PMID:23300844
1314025	MANBA	mannosidase beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314026	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MANBA mRNA	PMID:25975270
1314025	MANBA	mannosidase beta	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305785	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of MANBA mRNA	PMID:28374803
1314025	MANBA	mannosidase beta	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of MANBA mRNA	PMID:29955902
1314025	MANBA	mannosidase beta	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305785	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of MANBA protein	PMID:35544339
1314025	MANBA	mannosidase beta	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of MANBA mRNA	PMID:39709020
1314025	MANBA	mannosidase beta	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MANBA mRNA	PMID:30851411
1314025	MANBA	mannosidase beta	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314026	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of MANBA protein	PMID:28918527
1314025	MANBA	mannosidase beta	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MANBA intron	PMID:30157460
1314025	MANBA	mannosidase beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MANBA mRNA	PMID:19770486
1314025	MANBA	mannosidase beta	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314026	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MANBA gene	PMID:35295148
1314025	MANBA	mannosidase beta	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305785	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MANBA mRNA	PMID:23411599
1314025	MANBA	mannosidase beta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305785	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of MANBA mRNA	PMID:30723492
1314025	MANBA	mannosidase beta	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of MANBA mRNA	PMID:18445702
1314025	MANBA	mannosidase beta	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314026	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MANBA mRNA	PMID:18301758|PMID:23811191
1314025	MANBA	mannosidase beta	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305785	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MANBA mRNA	PMID:25181051
1314025	MANBA	mannosidase beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305785	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MANBA mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314025	MANBA	mannosidase beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20150127	CTD	MESH:C006780	bisphenol A results in decreased expression of MANBA mRNA	PMID:25270620
1314025	MANBA	mannosidase beta	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of MANBA mRNA	PMID:29275510
1314025	MANBA	mannosidase beta	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MANBA mRNA	PMID:28628672
1314025	MANBA	mannosidase beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of MANBA mRNA	PMID:39298647
1314025	MANBA	mannosidase beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MANBA mRNA	PMID:28628672
1314025	MANBA	mannosidase beta	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of MANBA intron	PMID:30157460
1314025	MANBA	mannosidase beta	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MANBA mRNA	PMID:28628672
1314025	MANBA	mannosidase beta	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314026	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of MANBA intron	PMID:28392331
1314025	MANBA	mannosidase beta	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MANBA mRNA	PMID:34813904
1314025	MANBA	mannosidase beta	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MANBA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MANBA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MANBA mRNA	PMID:28628672
1314025	MANBA	mannosidase beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MANBA mRNA	PMID:37042841
1314025	MANBA	mannosidase beta	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305785	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of MANBA mRNA	PMID:30589522
1314025	MANBA	mannosidase beta	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305785	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MANBA mRNA	PMID:30723492
1314025	MANBA	mannosidase beta	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MANBA mRNA	PMID:24449571
1314025	MANBA	mannosidase beta	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in decreased expression of MANBA mRNA]	PMID:28003376
1314025	MANBA	mannosidase beta	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MANBA mRNA	PMID:25979313
1314025	MANBA	mannosidase beta	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of MANBA mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1314025	MANBA	mannosidase beta	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MANBA mRNA	PMID:20106945
1314025	MANBA	mannosidase beta	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314026	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MANBA mRNA	PMID:20937368
1314025	MANBA	mannosidase beta	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MANBA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MANBA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MANBA mRNA	PMID:28628672
1314025	MANBA	mannosidase beta	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314026	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MANBA mRNA	PMID:28973697
1314025	MANBA	mannosidase beta	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D000082	Acetaminophen affects the expression of MANBA mRNA	PMID:25458485
1314025	MANBA	mannosidase beta	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MANBA mRNA	PMID:22230336
1314025	MANBA	mannosidase beta	gene	CHEBI:47499	imipramine	affects expression	ISO	RGD:1305785	E	RGD:6480464	20120412	CTD	MESH:D007099	Imipramine affects the expression of MANBA mRNA	PMID:18355885
1314025	MANBA	mannosidase beta	gene	CHEBI:47519	ketoconazole	affects expression	ISO	RGD:1305785	E	RGD:6480464	20120412	CTD	MESH:D007654	Ketoconazole affects the expression of MANBA mRNA	PMID:18355885
1314025	MANBA	mannosidase beta	gene	CHEBI:47780	clomipramine	affects expression	ISO	RGD:1305785	E	RGD:6480464	20120412	CTD	MESH:D002997	Clomipramine affects the expression of MANBA mRNA	PMID:18355885
1314025	MANBA	mannosidase beta	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of MANBA mRNA	PMID:35436446
1314025	MANBA	mannosidase beta	gene	CHEBI:4811	epoxiconazole	multiple interactions	ISO	RGD:1305785	E	RGD:6480464	20180515	CTD	MESH:C109476	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MANBA mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MANBA mRNA	PMID:29038839
1314025	MANBA	mannosidase beta	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of MANBA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MANBA mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of MANBA mRNA	PMID:28628672
1314025	MANBA	mannosidase beta	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of MANBA mRNA	PMID:23300844
1314025	MANBA	mannosidase beta	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305785	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of MANBA mRNA	PMID:23962444
1314025	MANBA	mannosidase beta	gene	CHEBI:6078	ivermectin	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of MANBA protein	PMID:32959892
1314025	MANBA	mannosidase beta	gene	CHEBI:63598	levofloxacin	decreases expression	ISO	RGD:1305785	E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of MANBA mRNA	PMID:24136188
1314025	MANBA	mannosidase beta	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305785	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of MANBA mRNA	PMID:24136188
1314025	MANBA	mannosidase beta	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of MANBA intron	PMID:30157460
1314025	MANBA	mannosidase beta	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MANBA protein	PMID:34186270
1314025	MANBA	mannosidase beta	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314026	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MANBA mRNA	PMID:22206623
1314025	MANBA	mannosidase beta	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MANBA mRNA	PMID:30851411
1314025	MANBA	mannosidase beta	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314026	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MANBA mRNA	PMID:31388691
1314025	MANBA	mannosidase beta	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305785	E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MANBA mRNA	PMID:31826744
1314025	MANBA	mannosidase beta	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1305785	E	RGD:6480464	20180515	CTD	MESH:C093628	cyproconazole results in increased expression of MANBA mRNA	PMID:29038839
1314025	MANBA	mannosidase beta	gene	CHEBI:81758	cyproconazole	multiple interactions	ISO	RGD:1305785	E	RGD:6480464	20180515	CTD	MESH:C093628	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MANBA mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of MANBA mRNA	PMID:29038839
1314025	MANBA	mannosidase beta	gene	CHEBI:8434	prochloraz	multiple interactions	ISO	RGD:1305785	E	RGD:6480464	20180515	CTD	MESH:C045362	[cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of MANBA mRNA	PMID:29038839
1314025	MANBA	mannosidase beta	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305785	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MANBA mRNA	PMID:24780913
1314025	MANBA	mannosidase beta	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305785	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MANBA mRNA	PMID:21346803
1314025	MANBA	mannosidase beta	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MANBA mRNA	PMID:29301935
1314025	MANBA	mannosidase beta	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305785	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MANBA mRNA	PMID:21346803
1314025	MANBA	mannosidase beta	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305785	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MANBA mRNA	PMID:23034163
1314025	MANBA	mannosidase beta	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305785	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MANBA mRNA	PMID:20566332
1314027	PLEK2	pleckstrin 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305786	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PLEK2 mRNA]	PMID:31150632
1314027	PLEK2	pleckstrin 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314028	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLEK2 mRNA	PMID:20938992
1314027	PLEK2	pleckstrin 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PLEK2 mRNA	PMID:26079696
1314027	PLEK2	pleckstrin 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314028	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in increased expression of PLEK2 mRNA	PMID:19167417
1314027	PLEK2	pleckstrin 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PLEK2 mRNA	PMID:20044591
1314027	PLEK2	pleckstrin 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PLEK2 mRNA	PMID:35811015
1314027	PLEK2	pleckstrin 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLEK2 mRNA	PMID:35811015
1314027	PLEK2	pleckstrin 2	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of PLEK2 mRNA	PMID:30510588
1314027	PLEK2	pleckstrin 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PLEK2 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of PLEK2 mRNA	PMID:17404688|PMID:30165855
1314027	PLEK2	pleckstrin 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PLEK2 mRNA	PMID:38568856
1314027	PLEK2	pleckstrin 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305786	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PLEK2 mRNA	PMID:33387578
1314027	PLEK2	pleckstrin 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314028	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLEK2 mRNA	PMID:20938992
1314027	PLEK2	pleckstrin 2	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of PLEK2 mRNA	PMID:17404688
1314027	PLEK2	pleckstrin 2	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of PLEK2 mRNA	PMID:17404688
1314027	PLEK2	pleckstrin 2	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of PLEK2 mRNA	PMID:26079696
1314027	PLEK2	pleckstrin 2	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLEK2 mRNA	PMID:36139627
1314027	PLEK2	pleckstrin 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305786	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEK2 mRNA	PMID:39012411
1314027	PLEK2	pleckstrin 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PLEK2 mRNA	PMID:22100608
1314027	PLEK2	pleckstrin 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PLEK2 intron	PMID:30157460
1314027	PLEK2	pleckstrin 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314028	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PLEK2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PLEK2 mRNA	PMID:34911549
1314027	PLEK2	pleckstrin 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305786	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PLEK2 mRNA	PMID:31150632
1314027	PLEK2	pleckstrin 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305786	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PLEK2 mRNA]	PMID:31150632
1314027	PLEK2	pleckstrin 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314028	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLEK2 mRNA	PMID:20938992
1314027	PLEK2	pleckstrin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLEK2 mRNA	PMID:39836092
1314027	PLEK2	pleckstrin 2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314028	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of PLEK2 mRNA	PMID:40618947
1314027	PLEK2	pleckstrin 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PLEK2 mRNA	PMID:27392435
1314027	PLEK2	pleckstrin 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PLEK2 mRNA	PMID:25583101
1314027	PLEK2	pleckstrin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314028	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLEK2 mRNA	PMID:21570461|PMID:26377647
1314027	PLEK2	pleckstrin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PLEK2 mRNA	PMID:15328365
1314027	PLEK2	pleckstrin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLEK2 mRNA	PMID:17942748
1314027	PLEK2	pleckstrin 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314028	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of PLEK2 mRNA	PMID:32937126
1314027	PLEK2	pleckstrin 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305786	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PLEK2 mRNA	PMID:28959563
1314027	PLEK2	pleckstrin 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of PLEK2 mRNA	PMID:29301061|PMID:39719251
1314027	PLEK2	pleckstrin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLEK2 mRNA	PMID:39836092
1314027	PLEK2	pleckstrin 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLEK2 exon	PMID:30157460
1314027	PLEK2	pleckstrin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PLEK2 promoter	PMID:27901495
1314027	PLEK2	pleckstrin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLEK2 mRNA	PMID:32234424
1314027	PLEK2	pleckstrin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1305786	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLEK2 mRNA	PMID:21839799
1314027	PLEK2	pleckstrin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314028	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PLEK2 mRNA	PMID:19770486
1314027	PLEK2	pleckstrin 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of PLEK2 promoter	PMID:23974009
1314027	PLEK2	pleckstrin 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PLEK2 mRNA	PMID:25895662
1314027	PLEK2	pleckstrin 2	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	PLEK2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1314027	PLEK2	pleckstrin 2	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305786	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of PLEK2 mRNA	PMID:24915197
1314027	PLEK2	pleckstrin 2	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of PLEK2 mRNA	PMID:37690743
1314027	PLEK2	pleckstrin 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PLEK2 gene; [bisphenol S co-treated with Fulvestrant] results in increased methylation of PLEK2 gene	PMID:31601247
1314027	PLEK2	pleckstrin 2	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305786	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of PLEK2 mRNA	PMID:25729387
1314027	PLEK2	pleckstrin 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305786	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PLEK2 mRNA	PMID:25729387
1314027	PLEK2	pleckstrin 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305786	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of PLEK2 mRNA	PMID:30047161
1314027	PLEK2	pleckstrin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314028	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PLEK2 gene; titanium dioxide results in decreased methylation of PLEK2 promoter	PMID:35295148
1314027	PLEK2	pleckstrin 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314028	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PLEK2 promoter	PMID:35295148
1314027	PLEK2	pleckstrin 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314028	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of PLEK2 mRNA	PMID:17426115|PMID:20813756
1314027	PLEK2	pleckstrin 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314028	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PLEK2 mRNA	PMID:28472532
1314027	PLEK2	pleckstrin 2	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of PLEK2 mRNA	PMID:30690063
1314027	PLEK2	pleckstrin 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305786	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PLEK2 mRNA	PMID:25181051
1314027	PLEK2	pleckstrin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305786	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PLEK2 mRNA	PMID:32145629|PMID:34947998
1314027	PLEK2	pleckstrin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PLEK2 gene	PMID:31601247
1314027	PLEK2	pleckstrin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314028	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of PLEK2 mRNA	PMID:40203079
1314027	PLEK2	pleckstrin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of PLEK2 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PLEK2 mRNA	PMID:28628672|PMID:31601247
1314027	PLEK2	pleckstrin 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314028	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PLEK2 mRNA	PMID:28392331
1314027	PLEK2	pleckstrin 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314028	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PLEK2 mRNA	PMID:37019170
1314027	PLEK2	pleckstrin 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314028	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PLEK2 mRNA	PMID:32715474
1314027	PLEK2	pleckstrin 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PLEK2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of PLEK2 mRNA	PMID:28628672
1314027	PLEK2	pleckstrin 2	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1314028	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PLEK2 mRNA	PMID:24535843
1314027	PLEK2	pleckstrin 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305786	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PLEK2 mRNA	PMID:35163327
1314027	PLEK2	pleckstrin 2	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1305786	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of PLEK2 mRNA	PMID:18500788
1314027	PLEK2	pleckstrin 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PLEK2 mRNA	PMID:38568856
1314027	PLEK2	pleckstrin 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305786	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLEK2 mRNA	PMID:39012411
1314027	PLEK2	pleckstrin 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305786	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PLEK2 mRNA	PMID:35163327
1314027	PLEK2	pleckstrin 2	gene	CHEBI:35559	furan	decreases methylation	ISO	RGD:1305786	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of PLEK2 gene	PMID:27387713
1314027	PLEK2	pleckstrin 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305786	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of PLEK2 mRNA	PMID:25539665|PMID:26194646|PMID:27387713
1314027	PLEK2	pleckstrin 2	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305786	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PLEK2 gene	PMID:22079235
1314027	PLEK2	pleckstrin 2	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C100187	chloropicrin results in decreased expression of PLEK2 mRNA	PMID:28476498
1314027	PLEK2	pleckstrin 2	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305786	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of PLEK2 mRNA	PMID:25993096
1314027	PLEK2	pleckstrin 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PLEK2 gene	PMID:29154799
1314027	PLEK2	pleckstrin 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of PLEK2 mRNA	PMID:29154799
1314027	PLEK2	pleckstrin 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305786	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of PLEK2 mRNA	PMID:30047161
1314027	PLEK2	pleckstrin 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PLEK2 mRNA	PMID:17555576
1314027	PLEK2	pleckstrin 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PLEK2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of PLEK2 mRNA	PMID:28628672
1314027	PLEK2	pleckstrin 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PLEK2 mRNA	PMID:38832940
1314027	PLEK2	pleckstrin 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLEK2 mRNA	PMID:22230336
1314027	PLEK2	pleckstrin 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PLEK2 mRNA	PMID:35811015
1314027	PLEK2	pleckstrin 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PLEK2 mRNA	PMID:39836092
1314027	PLEK2	pleckstrin 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305786	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLEK2 mRNA	PMID:29391264
1314027	PLEK2	pleckstrin 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLEK2 mRNA	PMID:22079256
1314027	PLEK2	pleckstrin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PLEK2 mRNA	PMID:17555576
1314027	PLEK2	pleckstrin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PLEK2 mRNA	PMID:17942748
1314027	PLEK2	pleckstrin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLEK2 mRNA	PMID:17942748
1314027	PLEK2	pleckstrin 2	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of PLEK2 mRNA	PMID:38568856
1314027	PLEK2	pleckstrin 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of PLEK2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of PLEK2 mRNA	PMID:28628672
1314027	PLEK2	pleckstrin 2	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	PLEK2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1314027	PLEK2	pleckstrin 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305786	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of PLEK2 mRNA	PMID:28801915
1314027	PLEK2	pleckstrin 2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305786	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of PLEK2 mRNA	PMID:25729387
1314027	PLEK2	pleckstrin 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305786	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PLEK2 mRNA	PMID:25729387
1314027	PLEK2	pleckstrin 2	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314028	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of PLEK2 mRNA	PMID:19812364
1314027	PLEK2	pleckstrin 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PLEK2 mRNA	PMID:15336504
1314027	PLEK2	pleckstrin 2	gene	CHEBI:6456	lidocaine	decreases expression	ISO	RGD:1305786	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in decreased expression of PLEK2 mRNA	PMID:35283115
1314027	PLEK2	pleckstrin 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of PLEK2 mRNA	PMID:31758290
1314027	PLEK2	pleckstrin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314028	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PLEK2 mRNA	PMID:22206623
1314027	PLEK2	pleckstrin 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PLEK2 mRNA	PMID:22079256|PMID:22714537
1314027	PLEK2	pleckstrin 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLEK2 mRNA	PMID:22079256
1314027	PLEK2	pleckstrin 2	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1305786	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of PLEK2 mRNA	PMID:33484710
1314027	PLEK2	pleckstrin 2	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLEK2 mRNA	PMID:36139627
1314027	PLEK2	pleckstrin 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305786	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of PLEK2 mRNA	PMID:21346803
1314027	PLEK2	pleckstrin 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1305786	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of PLEK2 mRNA	PMID:32109520
1314027	PLEK2	pleckstrin 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of PLEK2 mRNA	PMID:26079696
1314027	PLEK2	pleckstrin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305786	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PLEK2 mRNA	PMID:24780913
1314027	PLEK2	pleckstrin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305786	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of PLEK2 mRNA	PMID:30047161
1314027	PLEK2	pleckstrin 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305786	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PLEK2 mRNA	PMID:21346803
1314027	PLEK2	pleckstrin 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PLEK2 mRNA	PMID:38568856
1314027	PLEK2	pleckstrin 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305786	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PLEK2 mRNA	PMID:21346803
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:10110	zidovudine	increases expression	ISO	RGD:1305787	E	RGD:6480464	20171010	CTD	MESH:D015215	Zidovudine results in increased expression of AGPAT3 mRNA	PMID:28619387
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1305787	E	RGD:6480464	20171010	CTD	MESH:D015215	[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA; silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA]	PMID:28619387
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305787	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of AGPAT3 mRNA	PMID:21551480
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of AGPAT3 mRNA	PMID:21934132
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AGPAT3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of AGPAT3 mRNA	PMID:32699268
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:15571	hydrazine	increases expression	ISO	RGD:1314030	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in increased expression of AGPAT3 mRNA	PMID:15282401
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1305787	E	RGD:6480464	20140715	CTD	MESH:D002392	Catechin inhibits the reaction [Dietary Fats results in increased expression of AGPAT3 mRNA]	PMID:23365609
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of AGPAT3 mRNA	PMID:22378314
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314030	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of AGPAT3 mRNA	PMID:30319688
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314030	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of AGPAT3 mRNA	PMID:19693291|PMID:39298647
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of AGPAT3 mRNA	PMID:23649840|PMID:27905399
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314030	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in increased expression of AGPAT3 mRNA	PMID:19693291
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of AGPAT3 protein	PMID:37730182
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305787	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of AGPAT3 mRNA	PMID:22061828
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of AGPAT3 intron	PMID:30157460
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of AGPAT3 mRNA	PMID:17103032
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of AGPAT3 mRNA	PMID:19549813
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of AGPAT3 mRNA	PMID:23649840
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1305787	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of AGPAT3 protein	PMID:33236894
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of AGPAT3 mRNA	PMID:19770486
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of AGPAT3 gene	PMID:27153756
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of AGPAT3 gene	PMID:28458013
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of AGPAT3 mRNA	PMID:23649840
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AGPAT3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of AGPAT3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of AGPAT3 mRNA	PMID:32699268
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1305787	E	RGD:6480464	20260407	CTD	MESH:D000638	Amiodarone results in increased expression of AGPAT3 mRNA	PMID:40216313
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305787	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of AGPAT3 mRNA	PMID:30779732
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1314030	E	RGD:6480464	20140715	CTD	MESH:C011559	tributyltin results in increased expression of AGPAT3 mRNA	PMID:23428407
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305787	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AGPAT3 mRNA	PMID:31150632
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AGPAT3 gene	PMID:25304211
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of AGPAT3 mRNA	PMID:26272509
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	PMID:27188386
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of AGPAT3 mRNA	PMID:23557933
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of AGPAT3 mRNA	PMID:25583101
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314030	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AGPAT3 mRNA	PMID:21570461
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AGPAT3 mRNA	PMID:23152189
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AGPAT3 mRNA	PMID:20106945|PMID:21632981
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305787	E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AGPAT3 mRNA	PMID:21215274|PMID:26232522
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1305787	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone affects the expression of AGPAT3 mRNA	PMID:28374803
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of AGPAT3 mRNA	PMID:33212167
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of AGPAT3 mRNA	PMID:30851411
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of AGPAT3 mRNA	PMID:29803840
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of AGPAT3 mRNA	PMID:20044591
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of AGPAT3 mRNA	PMID:38568856
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AGPAT3 mRNA	PMID:26238291|PMID:32234424
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AGPAT3 mRNA	PMID:21715664
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314030	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AGPAT3 mRNA	PMID:22228805
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AGPAT3 5' UTR; Benzo(a)pyrene results in increased methylation of AGPAT3 promoter	PMID:27901495
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314030	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to AGPAT3 promoter]	PMID:19654925
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of AGPAT3 mRNA	PMID:20018196
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of AGPAT3 gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of AGPAT3 gene	PMID:31601247
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314030	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of AGPAT3 mRNA	PMID:17950772|PMID:18301758|PMID:23811191
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314030	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of AGPAT3 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of AGPAT3 mRNA]	PMID:17950772|PMID:19710929
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314030	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of AGPAT3 mRNA	PMID:28472532
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305787	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of AGPAT3 mRNA	PMID:25181051
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305787	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of AGPAT3 mRNA	PMID:30816183
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of AGPAT3 gene	PMID:31601247
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314030	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of AGPAT3 mRNA	PMID:34585602|PMID:35479511
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305787	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of AGPAT3 gene	PMID:28505145
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of AGPAT3 gene	PMID:31601247
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of AGPAT3 mRNA	PMID:26682919
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314030	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of AGPAT3 mRNA	PMID:39298647
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of AGPAT3 gene	PMID:31601247
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of AGPAT3 mRNA	PMID:34813904
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314030	E	RGD:6480464	20140715	CTD	MESH:D015056	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of AGPAT3 mRNA	PMID:23428407
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of AGPAT3 mRNA	PMID:34813904
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AGPAT3 mRNA	PMID:37042841
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of AGPAT3 mRNA	PMID:38568856
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305787	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of AGPAT3 promoter	PMID:22457795
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305787	E	RGD:6480464	20120613	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of AGPAT3 mRNA	PMID:21723365
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of AGPAT3 mRNA	PMID:17553155
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of AGPAT3 mRNA	PMID:24449571
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AGPAT3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of AGPAT3 mRNA	PMID:32699268
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of AGPAT3 mRNA	PMID:19167446
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314030	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of AGPAT3 mRNA	PMID:17963808
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of AGPAT3 mRNA	PMID:23179753|PMID:27188386
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of AGPAT3 gene	PMID:29154799
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305787	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of AGPAT3 mRNA	PMID:38685447
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of AGPAT3 mRNA	PMID:20106945|PMID:25562108
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of AGPAT3 promoter	PMID:27989131
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1314030	E	RGD:6480464	20190910	CTD	MESH:D003907	Dexamethasone results in increased expression of AGPAT3 mRNA	PMID:31053639
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314030	E	RGD:6480464	20140715	CTD	MESH:D003907	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of AGPAT3 mRNA; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of AGPAT3 mRNA]	PMID:23428407|PMID:31053639
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of AGPAT3 mRNA	PMID:17400583
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of AGPAT3 mRNA	PMID:38832940
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of AGPAT3 mRNA	PMID:24935251|PMID:26272509
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	PMID:27188386
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of AGPAT3 mRNA	PMID:21420995
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305787	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of AGPAT3 mRNA	PMID:33387578
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AGPAT3 gene	PMID:25304211
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305787	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of AGPAT3 mRNA	PMID:29391264
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of AGPAT3 mRNA	PMID:35436446
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of AGPAT3 mRNA	PMID:23228038
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1305787	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of AGPAT3 mRNA	PMID:36868495
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305787	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of AGPAT3 mRNA	PMID:30307764
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314030	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of AGPAT3 mRNA; Nanotubes, Carbon results in increased expression of AGPAT3 mRNA	PMID:25554681|PMID:25620056
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305787	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of AGPAT3 mRNA	PMID:24136188
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305787	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of AGPAT3 mRNA	PMID:41580965
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314030	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of AGPAT3 mRNA	PMID:35964746
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305787	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of AGPAT3 mRNA	PMID:24136188
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:6030	isoniazide	increases expression	ISO	RGD:1305787	E	RGD:6480464	20171010	CTD	MESH:D007538	Isoniazid results in increased expression of AGPAT3 mRNA	PMID:28619387
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:6030	isoniazide	multiple interactions	ISO	RGD:1305787	E	RGD:6480464	20171010	CTD	MESH:D007538	[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA; silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA]	PMID:28619387
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of AGPAT3 mRNA	PMID:20436886
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305787	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of AGPAT3 mRNA	PMID:24136188
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305787	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of AGPAT3 mRNA	PMID:30467583
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305787	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of AGPAT3 gene	PMID:35440735
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of AGPAT3 mRNA	PMID:22206623
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:77850	toxaphene	increases expression	ISO	RGD:1305787	E	RGD:6480464	20141014	CTD	MESH:D014112	Toxaphene results in increased expression of AGPAT3 mRNA	PMID:23153324
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of AGPAT3 mRNA	PMID:30851411
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	PMID:27188386
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1305787	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of AGPAT3 mRNA	PMID:27291303
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305787	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of AGPAT3 mRNA	PMID:23640034
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AGPAT3 mRNA	PMID:27188386
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:9144	silibinin	multiple interactions	ISO	RGD:1305787	E	RGD:6480464	20191114	CTD	MESH:C440975	Silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA]	PMID:28619387
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305787	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of AGPAT3 mRNA	PMID:19281266
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of AGPAT3 mRNA	PMID:38568856
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305787	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of AGPAT3 mRNA	PMID:21346803
1314029	AGPAT3	1-acylglycerol-3-phosphate O-acyltransferase 3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314030	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of AGPAT3 mRNA	PMID:28973697
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305788	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of SCMH1 mRNA	PMID:21551480
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314032	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SCMH1 mRNA	PMID:33045310
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314032	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SCMH1 mRNA	PMID:20188158
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SCMH1 mRNA	PMID:21934132
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SCMH1 mRNA	PMID:26079696
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SCMH1 mRNA	PMID:21632981
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314032	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SCMH1 mRNA	PMID:39241906
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SCMH1 mRNA	PMID:23649840
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SCMH1 protein	PMID:37730182
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305788	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of SCMH1 mRNA	PMID:22061828
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SCMH1 mRNA	PMID:28818685
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SCMH1 mRNA	PMID:19549813
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1314032	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of SCMH1 mRNA	PMID:32553695
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305788	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SCMH1 mRNA	PMID:30779732
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314032	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SCMH1 mRNA]	PMID:22206623
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SCMH1 mRNA	PMID:40512198
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305788	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SCMH1 mRNA	PMID:31881176
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314032	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SCMH1 mRNA	PMID:30912803
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314032	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of SCMH1 mRNA	PMID:32186404
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314032	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SCMH1 mRNA	PMID:21570461
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SCMH1 mRNA	PMID:20106945|PMID:21632981
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314032	E	RGD:6480464	20201006	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SCMH1 mRNA	PMID:32553695
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SCMH1 mRNA	PMID:33212167
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SCMH1 mRNA	PMID:32763439
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SCMH1 mRNA	PMID:38568856
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SCMH1 mRNA	PMID:40512198
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SCMH1 5' UTR	PMID:27901495
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SCMH1 mRNA	PMID:20106945|PMID:21632981
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314032	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of SCMH1 mRNA	PMID:32553695
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314032	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SCMH1 mRNA	PMID:27131904
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314032	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SCMH1 gene	PMID:35295148
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305788	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SCMH1 mRNA	PMID:19167457
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305788	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SCMH1 mRNA	PMID:25181051
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314032	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SCMH1 promoter	PMID:27334623
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SCMH1 mRNA	PMID:29275510
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305788	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SCMH1 gene	PMID:28505145
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SCMH1 mRNA	PMID:19244175
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SCMH1 promoter	PMID:30157460
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SCMH1 mRNA	PMID:28628672
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314032	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SCMH1 mRNA	PMID:28392331
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SCMH1 mRNA	PMID:28628672
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SCMH1 mRNA	PMID:38568856
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305788	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SCMH1 mRNA	PMID:24386269
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SCMH1 mRNA	PMID:32588087
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SCMH1 gene	PMID:29154799
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SCMH1 mRNA	PMID:25562108
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SCMH1 mRNA	PMID:20106945
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SCMH1 mRNA	PMID:28628672
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SCMH1 mRNA	PMID:38832940
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305788	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SCMH1 mRNA	PMID:33387578
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of SCMH1 mRNA	PMID:40512198
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1314032	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of SCMH1 mRNA	PMID:35436446
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SCMH1 mRNA	PMID:28628672
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314032	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of SCMH1 mRNA	PMID:23608068
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SCMH1 promoter	PMID:30157460
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314032	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SCMH1 mRNA	PMID:22206623
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314032	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SCMH1 mRNA]	PMID:22206623
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:75175	3',5'-cyclic UMP	affects binding	EXP		E	RGD:6480464	20220405	CTD	MESH:C045338	SCMH1 protein binds to cyclic 3',5'-uridine monophosphate	PMID:30528433
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314032	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of SCMH1 mRNA	PMID:19482888
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314032	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SCMH1 mRNA]	PMID:19482888
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314032	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SCMH1 mRNA	PMID:21795629
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314032	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SCMH1 mRNA	PMID:27131904
1314031	SCMH1	Scm polycomb group protein homolog 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305788	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of SCMH1 mRNA	PMID:23034163
1314033	WDR1	WD repeat domain 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305789	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of WDR1 mRNA	PMID:21551480
1314033	WDR1	WD repeat domain 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314034	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of WDR1 mRNA	PMID:20188158
1314033	WDR1	WD repeat domain 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of WDR1 mRNA	PMID:33167477
1314033	WDR1	WD repeat domain 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of WDR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of WDR1 mRNA	PMID:32699268
1314033	WDR1	WD repeat domain 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314034	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of WDR1 mRNA	PMID:30319688
1314033	WDR1	WD repeat domain 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	ISO	RGD:1305789	E	RGD:6480464	20130514	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of WDR1 protein	PMID:23178681
1314033	WDR1	WD repeat domain 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1305789	E	RGD:6480464	20130514	CTD	MESH:D006861	Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of WDR1 protein]	PMID:23178681
1314033	WDR1	WD repeat domain 1	gene	CHEBI:16325	lithocholic acid	decreases expression	EXP		E	RGD:6480464	20131210	CTD	MESH:D008095	Lithocholic Acid results in decreased expression of WDR1 protein	PMID:21224350
1314033	WDR1	WD repeat domain 1	gene	CHEBI:16336	hyaluronic acid	multiple interactions	ISO	RGD:1305789	E	RGD:6480464	20130514	CTD	MESH:D006820	Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of WDR1 protein]	PMID:23178681
1314033	WDR1	WD repeat domain 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314034	E	RGD:6480464	20181113	CTD	MESH:D004958	Estradiol results in increased expression of WDR1 mRNA	PMID:30077407
1314033	WDR1	WD repeat domain 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20181113	CTD	MESH:D004958	[Polyphenols co-treated with Estradiol] results in increased expression of WDR1 mRNA	PMID:30077407
1314033	WDR1	WD repeat domain 1	gene	CHEBI:16482	naphthalene	decreases expression	ISO	RGD:1314034	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in decreased expression of WDR1 protein	PMID:19438287
1314033	WDR1	WD repeat domain 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305789	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of WDR1 mRNA	PMID:33387578
1314033	WDR1	WD repeat domain 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of WDR1 mRNA	PMID:20655997|PMID:23649840
1314033	WDR1	WD repeat domain 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of WDR1 mRNA	PMID:21179406
1314033	WDR1	WD repeat domain 1	gene	CHEBI:17362	quinoline	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C037219	quinoline analog results in increased expression of WDR1 protein	PMID:18645022
1314033	WDR1	WD repeat domain 1	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D014050	Toluene results in decreased expression of WDR1 mRNA	PMID:28245982
1314033	WDR1	WD repeat domain 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WDR1 mRNA	PMID:27153756
1314033	WDR1	WD repeat domain 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305789	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WDR1 mRNA	PMID:33354967
1314033	WDR1	WD repeat domain 1	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1305789	E	RGD:6480464	20120918	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of WDR1 protein	PMID:22248470
1314033	WDR1	WD repeat domain 1	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1305789	E	RGD:6480464	20120918	CTD	MESH:D015127	[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of WDR1 protein	PMID:22248470
1314033	WDR1	WD repeat domain 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of WDR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of WDR1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of WDR1 mRNA	PMID:32699268
1314033	WDR1	WD repeat domain 1	gene	CHEBI:2654	aminoglutethimide	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in increased expression of WDR1 protein	PMID:26102013
1314033	WDR1	WD repeat domain 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of WDR1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of WDR1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of WDR1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of WDR1 protein	PMID:38598786
1314033	WDR1	WD repeat domain 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314034	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of WDR1 mRNA	PMID:27339419|PMID:31919559
1314033	WDR1	WD repeat domain 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of WDR1 mRNA	PMID:22206623
1314033	WDR1	WD repeat domain 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WDR1 mRNA	PMID:40504410
1314033	WDR1	WD repeat domain 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of WDR1 mRNA	PMID:19244175
1314033	WDR1	WD repeat domain 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of WDR1 mRNA	PMID:26272509
1314033	WDR1	WD repeat domain 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WDR1 mRNA	PMID:27188386
1314033	WDR1	WD repeat domain 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of WDR1 mRNA	PMID:24768652|PMID:25583101
1314033	WDR1	WD repeat domain 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314034	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WDR1 mRNA	PMID:21570461
1314033	WDR1	WD repeat domain 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305789	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WDR1 mRNA	PMID:34747641
1314033	WDR1	WD repeat domain 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WDR1 mRNA	PMID:17942748
1314033	WDR1	WD repeat domain 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of WDR1 mRNA	PMID:23179753
1314033	WDR1	WD repeat domain 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1314034	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of WDR1 mRNA	PMID:30807115
1314033	WDR1	WD repeat domain 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of WDR1 mRNA	PMID:31162603
1314033	WDR1	WD repeat domain 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of WDR1 mRNA	PMID:29432896
1314033	WDR1	WD repeat domain 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of WDR1 mRNA	PMID:38568856
1314033	WDR1	WD repeat domain 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WDR1 mRNA	PMID:40504410
1314033	WDR1	WD repeat domain 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of WDR1 intron	PMID:30157460
1314033	WDR1	WD repeat domain 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314034	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of WDR1 mRNA	PMID:19770486
1314033	WDR1	WD repeat domain 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314034	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WDR1 mRNA	PMID:22228805
1314033	WDR1	WD repeat domain 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of WDR1 mRNA	PMID:31162603
1314033	WDR1	WD repeat domain 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of WDR1 mRNA	PMID:19150397|PMID:20018196
1314033	WDR1	WD repeat domain 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305789	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of WDR1 mRNA	PMID:30047161
1314033	WDR1	WD repeat domain 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314034	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of WDR1 gene	PMID:35295148
1314033	WDR1	WD repeat domain 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305789	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of WDR1 mRNA	PMID:34492290
1314033	WDR1	WD repeat domain 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of WDR1 mRNA	PMID:18648102
1314033	WDR1	WD repeat domain 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314034	E	RGD:6480464	20150127	CTD	MESH:C006253	pirinixic acid results in decreased expression of WDR1 mRNA	PMID:25270620
1314033	WDR1	WD repeat domain 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of WDR1 mRNA	PMID:19710929
1314033	WDR1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of WDR1 mRNA	PMID:30903817
1314033	WDR1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305789	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of WDR1 mRNA	PMID:25181051
1314033	WDR1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR1 protein	PMID:34186270
1314033	WDR1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305789	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314033	WDR1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314034	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR1 protein	PMID:35999755
1314033	WDR1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of WDR1 gene	PMID:31601247
1314033	WDR1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of WDR1 protein	PMID:37567409
1314033	WDR1	WD repeat domain 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305789	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of WDR1 protein	PMID:32145629
1314033	WDR1	WD repeat domain 1	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of WDR1 mRNA	PMID:19244175
1314033	WDR1	WD repeat domain 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of WDR1 protein	PMID:34186270
1314033	WDR1	WD repeat domain 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314034	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of WDR1 mRNA	PMID:30951980|PMID:39298647
1314033	WDR1	WD repeat domain 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of WDR1 protein	PMID:34186270
1314033	WDR1	WD repeat domain 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314034	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of WDR1 intron	PMID:28392331
1314033	WDR1	WD repeat domain 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314034	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of WDR1 mRNA	PMID:37019170
1314033	WDR1	WD repeat domain 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314034	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of WDR1 protein	PMID:35999755
1314033	WDR1	WD repeat domain 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305789	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of WDR1 mRNA	PMID:21266533
1314033	WDR1	WD repeat domain 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314034	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of WDR1 mRNA	PMID:17361019|PMID:21266533
1314033	WDR1	WD repeat domain 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of WDR1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of WDR1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of WDR1 protein	PMID:38598786
1314033	WDR1	WD repeat domain 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1305789	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of WDR1 mRNA	PMID:19638242
1314033	WDR1	WD repeat domain 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in increased expression of WDR1 protein	PMID:34064677
1314033	WDR1	WD repeat domain 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of WDR1 mRNA	PMID:19320972
1314033	WDR1	WD repeat domain 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of WDR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of WDR1 mRNA	PMID:32699268
1314033	WDR1	WD repeat domain 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of WDR1 mRNA	PMID:19244175
1314033	WDR1	WD repeat domain 1	gene	CHEBI:38757	isoflavones	multiple interactions	ISO	RGD:1305789	E	RGD:6480464	20170303	CTD	MESH:D007529	[9,10-Dimethyl-1,2-benzanthracene co-treated with Isoflavones] results in increased expression of WDR1 protein	PMID:22248470
1314033	WDR1	WD repeat domain 1	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of WDR1 mRNA	PMID:26352163
1314033	WDR1	WD repeat domain 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of WDR1 mRNA	PMID:40419075
1314033	WDR1	WD repeat domain 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of WDR1 mRNA	PMID:25979313
1314033	WDR1	WD repeat domain 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of WDR1 mRNA	PMID:23179753
1314033	WDR1	WD repeat domain 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305789	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of WDR1 mRNA	PMID:38685447
1314033	WDR1	WD repeat domain 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305789	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of WDR1 mRNA	PMID:30047161
1314033	WDR1	WD repeat domain 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of WDR1 mRNA	PMID:25562108
1314033	WDR1	WD repeat domain 1	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of WDR1 mRNA	PMID:14699072
1314033	WDR1	WD repeat domain 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of WDR1 mRNA	PMID:17555576
1314033	WDR1	WD repeat domain 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of WDR1 mRNA	PMID:18502557
1314033	WDR1	WD repeat domain 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of WDR1 mRNA	PMID:38832940
1314033	WDR1	WD repeat domain 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of WDR1 mRNA	PMID:17562736
1314033	WDR1	WD repeat domain 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305789	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of WDR1 mRNA	PMID:33387578
1314033	WDR1	WD repeat domain 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314034	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in increased expression of WDR1 mRNA	PMID:29246445
1314033	WDR1	WD repeat domain 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of WDR1 mRNA]	PMID:29246445
1314033	WDR1	WD repeat domain 1	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of WDR1 mRNA	PMID:20977926
1314033	WDR1	WD repeat domain 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WDR1 mRNA	PMID:40504410
1314033	WDR1	WD repeat domain 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314034	E	RGD:6480464	20120918	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of WDR1 mRNA	PMID:14976129|PMID:17555576|PMID:17942748
1314033	WDR1	WD repeat domain 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WDR1 mRNA	PMID:17942748
1314033	WDR1	WD repeat domain 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314034	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of WDR1 mRNA; Nanotubes, Carbon results in increased expression of WDR1 mRNA	PMID:25554681
1314033	WDR1	WD repeat domain 1	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305789	E	RGD:6480464	20200519	CTD	MESH:C082360	fipronil results in increased expression of WDR1 mRNA	PMID:31881178
1314033	WDR1	WD repeat domain 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305789	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of WDR1 mRNA	PMID:41580965
1314033	WDR1	WD repeat domain 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305789	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of WDR1 mRNA	PMID:30047161
1314033	WDR1	WD repeat domain 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of WDR1 mRNA	PMID:35964746
1314033	WDR1	WD repeat domain 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305789	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of WDR1 mRNA	PMID:24793618
1314033	WDR1	WD repeat domain 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of WDR1 protein	PMID:32959892
1314033	WDR1	WD repeat domain 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of WDR1 mRNA	PMID:15336504
1314033	WDR1	WD repeat domain 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of WDR1 mRNA	PMID:31758290
1314033	WDR1	WD repeat domain 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of WDR1 protein	PMID:34186270
1314033	WDR1	WD repeat domain 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of WDR1 mRNA	PMID:22206623
1314033	WDR1	WD repeat domain 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of WDR1 mRNA	PMID:37199045
1314033	WDR1	WD repeat domain 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of WDR1 protein	PMID:39638853
1314033	WDR1	WD repeat domain 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WDR1 mRNA	PMID:27188386
1314033	WDR1	WD repeat domain 1	gene	CHEBI:79516	Nonylphenol	increases expression	ISO	RGD:1305789	E	RGD:6480464	20141111	CTD	MESH:C025256	nonylphenol results in increased expression of WDR1 protein	PMID:19260726
1314033	WDR1	WD repeat domain 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to WDR1 gene]	PMID:28238834
1314033	WDR1	WD repeat domain 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1314034	E	RGD:6480464	20150127	CTD	MESH:D010634	Phenobarbital results in decreased expression of WDR1 mRNA	PMID:25270620
1314033	WDR1	WD repeat domain 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of WDR1 mRNA	PMID:19482888
1314033	WDR1	WD repeat domain 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314034	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of WDR1 mRNA]	PMID:19482888
1314033	WDR1	WD repeat domain 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314034	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of WDR1 mRNA	PMID:31388691
1314033	WDR1	WD repeat domain 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1305789	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of WDR1 mRNA	PMID:30047161
1314033	WDR1	WD repeat domain 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305789	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of WDR1 mRNA	PMID:30047161
1314033	WDR1	WD repeat domain 1	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of WDR1 mRNA	PMID:14699072
1314033	WDR1	WD repeat domain 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WDR1 mRNA	PMID:27188386
1314033	WDR1	WD repeat domain 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of WDR1 mRNA	PMID:38568856
1314033	WDR1	WD repeat domain 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1305789	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of WDR1 protein	PMID:35544339
1314033	WDR1	WD repeat domain 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of WDR1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of WDR1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of WDR1 protein	PMID:38598786
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314036	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PHYHIP mRNA	PMID:33045310
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of PHYHIP mRNA	PMID:15498508|PMID:23724009
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of PHYHIP mRNA	PMID:24763279
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314036	E	RGD:6480464	20161025	CTD	MESH:D001280	Atrazine results in decreased expression of PHYHIP mRNA	PMID:27655631
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314036	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PHYHIP mRNA	PMID:30319688
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PHYHIP mRNA	PMID:25510870
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305790	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PHYHIP mRNA	PMID:33387578
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of PHYHIP mRNA	PMID:36695872
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of PHYHIP mRNA	PMID:33359661
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314036	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PHYHIP mRNA	PMID:35716406
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305790	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PHYHIP mRNA	PMID:26577399
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PHYHIP mRNA	PMID:36139627
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PHYHIP mRNA	PMID:25510870
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PHYHIP mRNA	PMID:25510870
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PHYHIP mRNA	PMID:19549813
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PHYHIP gene	PMID:27153756
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHYHIP mRNA	PMID:40504410
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHYHIP mRNA	PMID:27188386
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PHYHIP mRNA	PMID:28903495
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PHYHIP mRNA	PMID:25583101
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314036	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PHYHIP mRNA	PMID:21570461|PMID:24680724
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305790	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHYHIP mRNA	PMID:33387578
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHYHIP mRNA	PMID:17942748
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1314036	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of PHYHIP mRNA	PMID:30807115
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314036	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PHYHIP mRNA	PMID:39631538
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHYHIP mRNA	PMID:40504410
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PHYHIP 5' UTR	PMID:27901495
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PHYHIP mRNA	PMID:32234424
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PHYHIP promoter	PMID:27901495
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PHYHIP mRNA	PMID:25351596
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of PHYHIP mRNA	PMID:37690743
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of PHYHIP mRNA	PMID:15498508
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314036	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PHYHIP mRNA	PMID:29264374
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305790	E	RGD:6480464	20150630	CTD	MESH:C006780	bisphenol A affects the expression of PHYHIP mRNA	PMID:25181051
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305790	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PHYHIP mRNA	PMID:30816183|PMID:34947998
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PHYHIP mRNA	PMID:25510870
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PHYHIP mRNA	PMID:25510870
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314036	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PHYHIP 3' UTR	PMID:28392331
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314036	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PHYHIP mRNA	PMID:32715474
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1314036	E	RGD:6480464	20180828	CTD	MESH:D019256	Cadmium Chloride affects the expression of PHYHIP mRNA	PMID:29408670
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314036	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PHYHIP mRNA	PMID:40194260
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314036	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PHYHIP mRNA	PMID:39529242
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305790	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PHYHIP mRNA	PMID:30047161
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PHYHIP mRNA	PMID:38832940
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHYHIP mRNA	PMID:40504410
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of PHYHIP mRNA	PMID:31838189
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314036	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of PHYHIP mRNA	PMID:35436446
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314036	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PHYHIP mRNA	PMID:17942748
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in decreased expression of PHYHIP mRNA	PMID:17211630
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305790	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PHYHIP mRNA	PMID:30047161
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1314036	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of PHYHIP mRNA	PMID:26377693
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1305790	E	RGD:6480464	20150630	CTD	MESH:D007649	Ketamine results in increased expression of PHYHIP mRNA	PMID:20080153
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314036	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of PHYHIP mRNA	PMID:19812364
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PHYHIP mRNA	PMID:24810058
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1314036	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PHYHIP mRNA	PMID:36907384
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of PHYHIP mRNA	PMID:36318118
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PHYHIP mRNA	PMID:36139627
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHYHIP mRNA	PMID:27188386
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1305790	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of PHYHIP mRNA	PMID:30047161
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305790	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PHYHIP mRNA	PMID:30047161
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHYHIP mRNA	PMID:27188386
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305790	E	RGD:6480464	20150630	CTD	MESH:D012999	Soman results in decreased expression of PHYHIP mRNA	PMID:19281266
1314035	PHYHIP	phytanoyl-CoA 2-hydroxylase interacting protein	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1314036	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of PHYHIP mRNA	PMID:32835833
1314037	SNX8	sorting nexin 8	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314038	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SNX8 mRNA	PMID:33045310
1314037	SNX8	sorting nexin 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SNX8; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNX8 gene	PMID:20938992
1314037	SNX8	sorting nexin 8	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNX8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNX8 mRNA	PMID:32699268
1314037	SNX8	sorting nexin 8	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SNX8 mRNA	PMID:26079696
1314037	SNX8	sorting nexin 8	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305791	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of SNX8 gene	PMID:28931070
1314037	SNX8	sorting nexin 8	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of SNX8 mRNA	PMID:21632981
1314037	SNX8	sorting nexin 8	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314038	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SNX8 mRNA	PMID:39241906
1314037	SNX8	sorting nexin 8	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SNX8 mRNA	PMID:38568856
1314037	SNX8	sorting nexin 8	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305791	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SNX8 mRNA	PMID:33387578
1314037	SNX8	sorting nexin 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SNX8; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNX8 gene	PMID:20938992
1314037	SNX8	sorting nexin 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNX8 mRNA	PMID:37042841
1314037	SNX8	sorting nexin 8	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SNX8 protein	PMID:37730182
1314037	SNX8	sorting nexin 8	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305791	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SNX8 mRNA	PMID:33387578
1314037	SNX8	sorting nexin 8	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of SNX8 intron	PMID:30157460
1314037	SNX8	sorting nexin 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNX8 mRNA	PMID:37236586
1314037	SNX8	sorting nexin 8	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SNX8 mRNA	PMID:19549813
1314037	SNX8	sorting nexin 8	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SNX8 protein	PMID:23301498
1314037	SNX8	sorting nexin 8	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SNX8 intron	PMID:30157460
1314037	SNX8	sorting nexin 8	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SNX8 mRNA	PMID:23649840
1314037	SNX8	sorting nexin 8	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNX8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNX8 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of SNX8 mRNA	PMID:32699268
1314037	SNX8	sorting nexin 8	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305791	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SNX8 mRNA	PMID:30779732
1314037	SNX8	sorting nexin 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNX8 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of SNX8; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SNX8 gene	PMID:20938992|PMID:22206623
1314037	SNX8	sorting nexin 8	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SNX8 gene	PMID:25304211
1314037	SNX8	sorting nexin 8	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SNX8 protein	PMID:35688186
1314037	SNX8	sorting nexin 8	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SNX8 mRNA	PMID:24768652|PMID:25583101
1314037	SNX8	sorting nexin 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314038	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX8 mRNA	PMID:21570461
1314037	SNX8	sorting nexin 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305791	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNX8 mRNA	PMID:33387578
1314037	SNX8	sorting nexin 8	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SNX8 mRNA	PMID:33212167
1314037	SNX8	sorting nexin 8	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SNX8 mRNA	PMID:29803840
1314037	SNX8	sorting nexin 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314038	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNX8 mRNA	PMID:37682722
1314037	SNX8	sorting nexin 8	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SNX8 mRNA	PMID:38568856
1314037	SNX8	sorting nexin 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SNX8 mRNA	PMID:20106945
1314037	SNX8	sorting nexin 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314038	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNX8 mRNA	PMID:22228805
1314037	SNX8	sorting nexin 8	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SNX8 mRNA	PMID:25895662
1314037	SNX8	sorting nexin 8	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of SNX8 gene	PMID:31601247
1314037	SNX8	sorting nexin 8	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314038	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SNX8 promoter	PMID:35295148
1314037	SNX8	sorting nexin 8	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305791	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SNX8 mRNA	PMID:23411599|PMID:34492290
1314037	SNX8	sorting nexin 8	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SNX8 mRNA	PMID:19710929
1314037	SNX8	sorting nexin 8	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314038	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SNX8 mRNA	PMID:28472532
1314037	SNX8	sorting nexin 8	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305791	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of SNX8 mRNA	PMID:19167457
1314037	SNX8	sorting nexin 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of SNX8 protein	PMID:31675489
1314037	SNX8	sorting nexin 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305791	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SNX8 mRNA	PMID:34947998
1314037	SNX8	sorting nexin 8	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SNX8 gene	PMID:31601247
1314037	SNX8	sorting nexin 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305791	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNX8 mRNA	PMID:25181051
1314037	SNX8	sorting nexin 8	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305791	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SNX8 gene	PMID:28505145
1314037	SNX8	sorting nexin 8	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305791	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SNX8 mRNA	PMID:36041667
1314037	SNX8	sorting nexin 8	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of SNX8 protein	PMID:31675489
1314037	SNX8	sorting nexin 8	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of SNX8 mRNA	PMID:36804509
1314037	SNX8	sorting nexin 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305791	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SNX8 mRNA	PMID:36041667
1314037	SNX8	sorting nexin 8	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305791	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SNX8 mRNA	PMID:36041667
1314037	SNX8	sorting nexin 8	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314038	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of SNX8 mRNA	PMID:34813904
1314037	SNX8	sorting nexin 8	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314038	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SNX8 mRNA	PMID:34813904
1314037	SNX8	sorting nexin 8	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SNX8 mRNA	PMID:38568856
1314037	SNX8	sorting nexin 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNX8 mRNA	PMID:37236586
1314037	SNX8	sorting nexin 8	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305791	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of SNX8 mRNA	PMID:25539665
1314037	SNX8	sorting nexin 8	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305791	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SNX8 gene	PMID:22079235
1314037	SNX8	sorting nexin 8	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SNX8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SNX8 mRNA	PMID:32699268
1314037	SNX8	sorting nexin 8	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SNX8 mRNA	PMID:28302478
1314037	SNX8	sorting nexin 8	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SNX8 mRNA	PMID:25979313
1314037	SNX8	sorting nexin 8	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SNX8 mRNA	PMID:28001369
1314037	SNX8	sorting nexin 8	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SNX8 gene	PMID:29154799
1314037	SNX8	sorting nexin 8	gene	CHEBI:40036	amitrole	affects expression	ISO	RGD:1305791	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole affects the expression of SNX8 mRNA	PMID:41580965
1314037	SNX8	sorting nexin 8	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305791	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of SNX8 mRNA	PMID:38685447
1314037	SNX8	sorting nexin 8	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SNX8 mRNA	PMID:20106945|PMID:25562108
1314037	SNX8	sorting nexin 8	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SNX8 mRNA	PMID:38832940
1314037	SNX8	sorting nexin 8	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305791	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SNX8 mRNA	PMID:33387578
1314037	SNX8	sorting nexin 8	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SNX8 mRNA	PMID:29432896
1314037	SNX8	sorting nexin 8	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SNX8 gene	PMID:25304211
1314037	SNX8	sorting nexin 8	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of SNX8 mRNA	PMID:22077320
1314037	SNX8	sorting nexin 8	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of SNX8 mRNA	PMID:31675489
1314037	SNX8	sorting nexin 8	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305791	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SNX8 mRNA	PMID:29391264
1314037	SNX8	sorting nexin 8	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SNX8 mRNA	PMID:22079256
1314037	SNX8	sorting nexin 8	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305791	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of SNX8 mRNA	PMID:23962444|PMID:34044035
1314037	SNX8	sorting nexin 8	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305791	E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of SNX8 mRNA	PMID:38685447|PMID:41580965
1314037	SNX8	sorting nexin 8	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SNX8 mRNA	PMID:35964746
1314037	SNX8	sorting nexin 8	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314038	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SNX8 mRNA	PMID:19042947
1314037	SNX8	sorting nexin 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314038	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SNX8 mRNA	PMID:22206623
1314037	SNX8	sorting nexin 8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314038	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNX8 mRNA	PMID:22206623
1314037	SNX8	sorting nexin 8	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SNX8 mRNA	PMID:22079256
1314037	SNX8	sorting nexin 8	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SNX8 mRNA	PMID:22079256
1314037	SNX8	sorting nexin 8	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314038	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SNX8 mRNA	PMID:31388691
1314037	SNX8	sorting nexin 8	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SNX8 protein	PMID:31675489
1314037	SNX8	sorting nexin 8	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SNX8 protein	PMID:31675489
1314037	SNX8	sorting nexin 8	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305791	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SNX8 mRNA	PMID:23034163
1314037	SNX8	sorting nexin 8	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305791	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of SNX8 gene	PMID:31079544
1314039	KRT36	keratin 36	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305792	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRT36 mRNA	PMID:32741896
1314039	KRT36	keratin 36	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305792	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KRT36 mRNA	PMID:33387578
1314039	KRT36	keratin 36	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305792	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRT36 mRNA	PMID:32741896
1314039	KRT36	keratin 36	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1314040	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in increased expression of KRT36 mRNA	PMID:31626304
1314039	KRT36	keratin 36	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KRT36 mRNA	PMID:21867686
1314039	KRT36	keratin 36	gene	CHEBI:27563	arsenic atom	decreases methylation	EXP		E	RGD:6480464	20200310	CTD	MESH:D001151	Arsenic results in decreased methylation of KRT36 gene	PMID:31135185
1314039	KRT36	keratin 36	gene	CHEBI:27732	caffeine	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D002110	Caffeine results in decreased expression of KRT36 protein	PMID:31195006
1314039	KRT36	keratin 36	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of KRT36 mRNA	PMID:23557933
1314039	KRT36	keratin 36	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314040	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KRT36 mRNA	PMID:21570461
1314039	KRT36	keratin 36	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314040	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of KRT36 mRNA	PMID:35295148
1314039	KRT36	keratin 36	gene	CHEBI:33146	vanadyl sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C034028	vanadyl sulfate results in increased expression of KRT36 mRNA	PMID:16330358
1314039	KRT36	keratin 36	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305792	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT36 mRNA	PMID:25181051
1314039	KRT36	keratin 36	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305792	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT36 mRNA	PMID:35163327
1314039	KRT36	keratin 36	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305792	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of KRT36 promoter	PMID:22457795
1314039	KRT36	keratin 36	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305792	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT36 mRNA	PMID:35163327
1314039	KRT36	keratin 36	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305792	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of KRT36 mRNA	PMID:24386269
1314039	KRT36	keratin 36	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1314040	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of KRT36 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of KRT36 mRNA]	PMID:17585979
1314039	KRT36	keratin 36	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KRT36 gene	PMID:29154799
1314039	KRT36	keratin 36	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314040	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of KRT36 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of KRT36 mRNA]	PMID:17585979
1314039	KRT36	keratin 36	gene	CHEBI:47217	arsane	decreases methylation	EXP		E	RGD:6480464	20200310	CTD	MESH:D001151	Arsenic results in decreased methylation of KRT36 gene	PMID:31135185
1314039	KRT36	keratin 36	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314040	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KRT36 mRNA	PMID:22206623
1314039	KRT36	keratin 36	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305792	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of KRT36 mRNA	PMID:32741896
1314039	KRT36	keratin 36	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305792	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of KRT36 mRNA	PMID:23914054
1314039	KRT36	keratin 36	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1314040	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of KRT36 mRNA	PMID:28973697
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of WBP1L mRNA	PMID:37995155
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305793	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of WBP1L mRNA]	PMID:31150632
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of WBP1L mRNA	PMID:26251327
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314042	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of WBP1L mRNA	PMID:20188158
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1314042	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of WBP1L promoter	PMID:26251327
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of WBP1L mRNA	PMID:33167477
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of WBP1L mRNA	PMID:21632981
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305793	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of WBP1L mRNA	PMID:32145629
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of WBP1L mRNA	PMID:39298647
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of WBP1L mRNA	PMID:37042841
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of WBP1L mRNA	PMID:21592394
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of WBP1L mRNA	PMID:21592394
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of WBP1L protein	PMID:37730182
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of WBP1L mRNA	PMID:21592394
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of WBP1L mRNA	PMID:21592394
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305793	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of WBP1L mRNA	PMID:33387578
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314042	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of WBP1L mRNA	PMID:36331819
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WBP1L mRNA	PMID:39836092
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314042	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WBP1L mRNA	PMID:37236586
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305793	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of WBP1L mRNA	PMID:31150632
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305793	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of WBP1L mRNA]	PMID:31150632
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WBP1L mRNA	PMID:39836092
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of WBP1L protein	PMID:35688186
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of WBP1L mRNA	PMID:28960355
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305793	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of WBP1L mRNA	PMID:31881176
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of WBP1L mRNA	PMID:28903495
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305793	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WBP1L mRNA	PMID:22298810|PMID:34747641
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305793	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WBP1L mRNA	PMID:21215274|PMID:33387578
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WBP1L mRNA	PMID:19770486
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WBP1L mRNA	PMID:20106945|PMID:21632981
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of WBP1L mRNA	PMID:30851411
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:28509	chloroethene	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in decreased expression of WBP1L mRNA	PMID:18579281
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WBP1L mRNA; [sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of WBP1L promoter	PMID:18448484|PMID:39836092
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of WBP1L mRNA	PMID:19770486
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WBP1L mRNA	PMID:20106945
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WBP1L 5' UTR	PMID:27901495
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of WBP1L mRNA	PMID:19150397
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of WBP1L gene	PMID:31601247
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1305793	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of WBP1L mRNA	PMID:24136188
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314042	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of WBP1L gene	PMID:35295148
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305793	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of WBP1L mRNA	PMID:23411599|PMID:34492290
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314042	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of WBP1L mRNA	PMID:18301758|PMID:23811191
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305793	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of WBP1L mRNA	PMID:32145629
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305793	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of WBP1L mRNA	PMID:25181051
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of WBP1L gene	PMID:31601247
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to WBP1L promoter]	PMID:20348232
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of WBP1L mRNA	PMID:39298647
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314042	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of WBP1L promoter	PMID:33297965
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314042	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of WBP1L intron	PMID:28392331
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WBP1L mRNA	PMID:39836092
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of WBP1L mRNA	PMID:38568856
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314042	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WBP1L mRNA	PMID:37236586
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305793	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of WBP1L mRNA	PMID:26194646
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314042	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of WBP1L mRNA	PMID:28903501
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of WBP1L mRNA	PMID:24449571
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314042	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of WBP1L mRNA	PMID:23811191
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:3766	clozapine	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20120412	CTD	MESH:D003024	Clozapine results in decreased expression of WBP1L mRNA	PMID:14647396
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of WBP1L mRNA	PMID:40194260
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of WBP1L mRNA	PMID:40419075
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314042	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of WBP1L mRNA	PMID:36331819
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of WBP1L mRNA	PMID:23179753
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305793	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of WBP1L mRNA	PMID:41580965
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of WBP1L mRNA	PMID:20106945
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314042	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of WBP1L mRNA	PMID:17562736
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of WBP1L mRNA	PMID:21420995
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305793	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of WBP1L mRNA	PMID:33387578
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WBP1L mRNA	PMID:39836092
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305793	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of WBP1L mRNA	PMID:24136188
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:5613	haloperidol	decreases expression	ISO	RGD:1314042	E	RGD:6480464	20120412	CTD	MESH:D006220	Haloperidol results in decreased expression of WBP1L mRNA	PMID:14647396
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WBP1L mRNA	PMID:39836092
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305793	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of WBP1L gene	PMID:35440735
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314042	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of WBP1L mRNA	PMID:22206623
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of WBP1L mRNA	PMID:30851411
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1305793	E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in increased expression of WBP1L mRNA	PMID:24136188
1314041	WBP1L	WW domain binding protein 1 like	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305793	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of WBP1L mRNA	PMID:20566332
1314043	DSP	desmoplakin	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1620673	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DSP mRNA	PMID:33045310
1314043	DSP	desmoplakin	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DSP protein]	PMID:38195004
1314043	DSP	desmoplakin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of DSP mRNA	PMID:21934132
1314043	DSP	desmoplakin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of DSP mRNA	PMID:16604517
1314043	DSP	desmoplakin	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1620673	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of DSP mRNA	PMID:20880076
1314043	DSP	desmoplakin	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DSP mRNA	PMID:26079696
1314043	DSP	desmoplakin	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of DSP mRNA	PMID:29432896
1314043	DSP	desmoplakin	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1305794	E	RGD:6480464	20121113	CTD	MESH:D000431	Ethanol inhibits the reaction [Dietary Fats results in increased expression of DSP mRNA]	PMID:21051528
1314043	DSP	desmoplakin	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DSP mRNA	PMID:35811015
1314043	DSP	desmoplakin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of DSP mRNA]	PMID:35811015
1314043	DSP	desmoplakin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1620673	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DSP mRNA	PMID:39298647
1314043	DSP	desmoplakin	gene	CHEBI:16583	butane-2,3-dione	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D003931	Diacetyl results in decreased expression of DSP protein	PMID:34031698
1314043	DSP	desmoplakin	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of DSP mRNA	PMID:38568856
1314043	DSP	desmoplakin	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305794	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DSP mRNA	PMID:33387578
1314043	DSP	desmoplakin	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of DSP mRNA	PMID:17556502|PMID:22238285
1314043	DSP	desmoplakin	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:D011374	NCOA2 protein affects the reaction [Progesterone results in decreased expression of DSP mRNA]	PMID:17556502
1314043	DSP	desmoplakin	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1620673	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of DSP mRNA	PMID:23892564
1314043	DSP	desmoplakin	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1620673	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DSP mRNA	PMID:34319233
1314043	DSP	desmoplakin	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DSP protein	PMID:37730182
1314043	DSP	desmoplakin	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of DSP mRNA	PMID:26485663
1314043	DSP	desmoplakin	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DSP mRNA	PMID:28818685
1314043	DSP	desmoplakin	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305794	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of DSP protein	PMID:34915118
1314043	DSP	desmoplakin	gene	CHEBI:207229	dihydroartemisinin	affects binding	EXP		E	RGD:6480464	20170303	CTD	MESH:C039060	artenimol analog binds to DSP protein	PMID:26340163
1314043	DSP	desmoplakin	gene	CHEBI:22977	cadmium atom	affects binding	EXP		E	RGD:6480464	20150512	CTD	MESH:D002104	DSP protein binds to Cadmium	PMID:23896426
1314043	DSP	desmoplakin	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DSP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DSP protein	PMID:38195004
1314043	DSP	desmoplakin	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DSP mRNA	PMID:19549813
1314043	DSP	desmoplakin	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DSP protein	PMID:23301498
1314043	DSP	desmoplakin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1620673	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DSP mRNA	PMID:19770486
1314043	DSP	desmoplakin	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DSP gene	PMID:27153756
1314043	DSP	desmoplakin	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of DSP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DSP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DSP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of DSP protein	PMID:38598786
1314043	DSP	desmoplakin	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305794	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of DSP mRNA	PMID:30779732
1314043	DSP	desmoplakin	gene	CHEBI:27363	zinc atom	affects binding	EXP		E	RGD:6480464	20150512	CTD	MESH:D015032	DSP protein binds to Zinc	PMID:23896426
1314043	DSP	desmoplakin	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1620673	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of DSP mRNA	PMID:31919559
1314043	DSP	desmoplakin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620673	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DSP mRNA	PMID:22206623
1314043	DSP	desmoplakin	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of DSP mRNA	PMID:26272509
1314043	DSP	desmoplakin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA	PMID:27188386
1314043	DSP	desmoplakin	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of DSP protein	PMID:35688186
1314043	DSP	desmoplakin	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of DSP mRNA	PMID:41028656
1314043	DSP	desmoplakin	gene	CHEBI:27889	lead(0)	affects binding	EXP		E	RGD:6480464	20150512	CTD	MESH:D007854	DSP protein binds to Lead	PMID:23896426
1314043	DSP	desmoplakin	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of DSP protein	PMID:17075605
1314043	DSP	desmoplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620673	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DSP mRNA	PMID:21570461
1314043	DSP	desmoplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305794	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DSP mRNA	PMID:33387578
1314043	DSP	desmoplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DSP mRNA; Tetrachlorodibenzodioxin results in increased expression of DSP protein	PMID:21632981|PMID:37788135
1314043	DSP	desmoplakin	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of DSP protein	PMID:39603559
1314043	DSP	desmoplakin	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305794	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of DSP mRNA	PMID:28374803
1314043	DSP	desmoplakin	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DSP mRNA	PMID:23179753|PMID:27188386
1314043	DSP	desmoplakin	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305794	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of DSP mRNA	PMID:28959563
1314043	DSP	desmoplakin	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of DSP mRNA	PMID:41028656
1314043	DSP	desmoplakin	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of DSP protein	PMID:28918527
1314043	DSP	desmoplakin	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	DSP protein affects the susceptibility to Doxorubicin	PMID:16217747
1314043	DSP	desmoplakin	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of DSP mRNA	PMID:29803840
1314043	DSP	desmoplakin	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of DSP protein	PMID:35688186
1314043	DSP	desmoplakin	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1305794	E	RGD:6480464	20121113	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Dietary Fats results in increased expression of DSP mRNA]	PMID:21051528
1314043	DSP	desmoplakin	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of DSP gene	PMID:28589171
1314043	DSP	desmoplakin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DSP mRNA	PMID:12634122|PMID:38568856
1314043	DSP	desmoplakin	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305794	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of DSP protein	PMID:29459688
1314043	DSP	desmoplakin	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite inhibits the reaction [H3-3A protein binds to DSP protein]	PMID:37734572
1314043	DSP	desmoplakin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DSP promoter	PMID:27901495
1314043	DSP	desmoplakin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DSP mRNA; Benzo(a)pyrene results in decreased expression of DSP protein	PMID:31255691|PMID:32717239
1314043	DSP	desmoplakin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DSP mRNA	PMID:22316170
1314043	DSP	desmoplakin	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1620673	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DSP mRNA	PMID:22228805|PMID:27195522
1314043	DSP	desmoplakin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DSP 3' UTR	PMID:27901495
1314043	DSP	desmoplakin	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of DSP mRNA	PMID:41028656
1314043	DSP	desmoplakin	gene	CHEBI:30185	zinc(0)	affects binding	EXP		E	RGD:6480464	20150512	CTD	MESH:D015032	DSP protein binds to Zinc	PMID:23896426
1314043	DSP	desmoplakin	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of DSP mRNA	PMID:25895662
1314043	DSP	desmoplakin	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DSP protein	PMID:25419056
1314043	DSP	desmoplakin	gene	CHEBI:30772	butyric acid	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D020148	Butyric Acid results in increased expression of DSP mRNA	PMID:34581912
1314043	DSP	desmoplakin	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305794	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of DSP mRNA	PMID:24136188
1314043	DSP	desmoplakin	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of DSP mRNA	PMID:38568856
1314043	DSP	desmoplakin	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1305794	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of DSP mRNA	PMID:22641619
1314043	DSP	desmoplakin	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620673	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DSP gene	PMID:35295148
1314043	DSP	desmoplakin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1620673	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of DSP mRNA	PMID:35295148
1314043	DSP	desmoplakin	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305794	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DSP mRNA	PMID:23411599
1314043	DSP	desmoplakin	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of DSP mRNA	PMID:18445702
1314043	DSP	desmoplakin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of DSP protein	PMID:31675489
1314043	DSP	desmoplakin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305794	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DSP mRNA	PMID:25181051|PMID:32145629
1314043	DSP	desmoplakin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of DSP mRNA	PMID:26063408|PMID:33221593
1314043	DSP	desmoplakin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of DSP mRNA; bisphenol A results in increased expression of DSP protein	PMID:36232920|PMID:37567409
1314043	DSP	desmoplakin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1620673	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of DSP mRNA	PMID:35598803
1314043	DSP	desmoplakin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DSP mRNA	PMID:39298647
1314043	DSP	desmoplakin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C543008	bisphenol S results in increased expression of DSP mRNA	PMID:25912373
1314043	DSP	desmoplakin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1620673	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of DSP exon	PMID:33297965
1314043	DSP	desmoplakin	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20230704	CTD	MESH:C008745	bisphenol F results in decreased expression of DSP mRNA	PMID:36706583
1314043	DSP	desmoplakin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1620673	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DSP mRNA	PMID:38685157
1314043	DSP	desmoplakin	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DSP mRNA	PMID:37019170
1314043	DSP	desmoplakin	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305794	E	RGD:6480464	20150127	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DSP mRNA	PMID:24893172
1314043	DSP	desmoplakin	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305794	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DSP mRNA	PMID:21266533
1314043	DSP	desmoplakin	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of DSP protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of DSP protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of DSP protein	PMID:38598786
1314043	DSP	desmoplakin	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of DSP mRNA	PMID:28628672
1314043	DSP	desmoplakin	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1620673	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of DSP mRNA	PMID:34813904
1314043	DSP	desmoplakin	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of DSP mRNA	PMID:37047231
1314043	DSP	desmoplakin	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305794	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of DSP mRNA	PMID:35163327
1314043	DSP	desmoplakin	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1620673	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of DSP mRNA	PMID:26377693
1314043	DSP	desmoplakin	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DSP mRNA	PMID:38568856
1314043	DSP	desmoplakin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DSP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of DSP protein	PMID:38195004
1314043	DSP	desmoplakin	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of DSP mRNA	PMID:19429403
1314043	DSP	desmoplakin	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305794	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of DSP mRNA	PMID:35163327
1314043	DSP	desmoplakin	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of DSP mRNA	PMID:28903501
1314043	DSP	desmoplakin	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of DSP mRNA	PMID:31255691
1314043	DSP	desmoplakin	gene	CHEBI:35861	dibenzo[a,l]pyrene	increases expression	ISO	RGD:1620673	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in increased expression of DSP mRNA	PMID:25908611
1314043	DSP	desmoplakin	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of DSP mRNA	PMID:40194260
1314043	DSP	desmoplakin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620673	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DSP mRNA	PMID:40194260
1314043	DSP	desmoplakin	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of DSP mRNA	PMID:28302478
1314043	DSP	desmoplakin	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of DSP mRNA	PMID:31533062
1314043	DSP	desmoplakin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of DSP mRNA	PMID:19429403
1314043	DSP	desmoplakin	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of DSP mRNA	PMID:29154799
1314043	DSP	desmoplakin	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D014635	Valproic Acid results in increased expression of DSP mRNA	PMID:23527032|PMID:24383497|PMID:24935251|PMID:26272509|PMID:26705709
1314043	DSP	desmoplakin	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA	PMID:27188386
1314043	DSP	desmoplakin	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of DSP mRNA	PMID:28628672
1314043	DSP	desmoplakin	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1620673	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DSP mRNA	PMID:28973697
1314043	DSP	desmoplakin	gene	CHEBI:44658	okadaic acid	increases expression	ISO	RGD:1620673	E	RGD:6480464	20150127	CTD	MESH:D019319	Okadaic Acid results in increased expression of DSP mRNA	PMID:25270620
1314043	DSP	desmoplakin	gene	CHEBI:45863	paclitaxel	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	DSP protein affects the susceptibility to Paclitaxel	PMID:16217747
1314043	DSP	desmoplakin	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C012589	trichostatin A results in increased expression of DSP mRNA	PMID:24935251|PMID:26272509|PMID:26705709
1314043	DSP	desmoplakin	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA	PMID:27188386
1314043	DSP	desmoplakin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DSP mRNA	PMID:17562736
1314043	DSP	desmoplakin	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305794	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DSP mRNA	PMID:33387578
1314043	DSP	desmoplakin	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of DSP mRNA]	PMID:35811015
1314043	DSP	desmoplakin	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1620673	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of DSP mRNA	PMID:30529165
1314043	DSP	desmoplakin	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305794	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of DSP mRNA	PMID:29391264
1314043	DSP	desmoplakin	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305794	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DSP mRNA	PMID:17557909
1314043	DSP	desmoplakin	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of DSP mRNA	PMID:38568856
1314043	DSP	desmoplakin	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of DSP mRNA	PMID:26272509
1314043	DSP	desmoplakin	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA	PMID:27188386
1314043	DSP	desmoplakin	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of DSP mRNA	PMID:28628672
1314043	DSP	desmoplakin	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DSP protein	PMID:25419056
1314043	DSP	desmoplakin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of DSP mRNA]	PMID:21095227
1314043	DSP	desmoplakin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DSP mRNA; Nanotubes, Carbon results in decreased expression of DSP mRNA	PMID:25554681|PMID:25620056
1314043	DSP	desmoplakin	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305794	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of DSP mRNA	PMID:34044035
1314043	DSP	desmoplakin	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	DSP protein affects the susceptibility to Topotecan	PMID:16217747
1314043	DSP	desmoplakin	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DSP mRNA	PMID:23650126
1314043	DSP	desmoplakin	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of DSP mRNA	PMID:28988120
1314043	DSP	desmoplakin	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of DSP mRNA	PMID:36907384
1314043	DSP	desmoplakin	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of DSP protein	PMID:37788135
1314043	DSP	desmoplakin	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1620673	E	RGD:6480464	20200331	CTD	MESH:D012970	Sodium Glutamate results in increased expression of DSP mRNA	PMID:19001666
1314043	DSP	desmoplakin	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1620673	E	RGD:6480464	20200331	CTD	MESH:D012970	[Sodium Glutamate co-treated with Trans Fatty Acids] results in decreased expression of DSP mRNA	PMID:19001666
1314043	DSP	desmoplakin	gene	CHEBI:6651	malathion	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in increased expression of DSP mRNA	PMID:37047231
1314043	DSP	desmoplakin	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1620673	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of DSP mRNA	PMID:26307267
1314043	DSP	desmoplakin	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1305794	E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of DSP mRNA	PMID:39938710
1314043	DSP	desmoplakin	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1620673	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of DSP mRNA	PMID:22206623
1314043	DSP	desmoplakin	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1620673	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DSP mRNA	PMID:22206623
1314043	DSP	desmoplakin	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DSP mRNA	PMID:22714537
1314043	DSP	desmoplakin	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of DSP mRNA	PMID:37199045
1314043	DSP	desmoplakin	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1305794	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of DSP mRNA	PMID:33484710
1314043	DSP	desmoplakin	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA	PMID:27188386
1314043	DSP	desmoplakin	gene	CHEBI:79516	Nonylphenol	increases expression	ISO	RGD:1305794	E	RGD:6480464	20141111	CTD	MESH:C025256	nonylphenol results in increased expression of DSP protein	PMID:19260726
1314043	DSP	desmoplakin	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DSP gene]	PMID:28238834
1314043	DSP	desmoplakin	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1620673	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DSP mRNA	PMID:23091169
1314043	DSP	desmoplakin	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of DSP mRNA	PMID:19363144
1314043	DSP	desmoplakin	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1620673	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DSP mRNA	PMID:38648751
1314043	DSP	desmoplakin	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1620673	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of DSP mRNA	PMID:21278054
1314043	DSP	desmoplakin	gene	CHEBI:91108	SB 431542	increases expression	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of DSP protein	PMID:25670856
1314043	DSP	desmoplakin	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DSP mRNA	PMID:27188386
1314043	DSP	desmoplakin	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305794	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DSP mRNA	PMID:21346803
1314043	DSP	desmoplakin	gene	CHEBI:92181	lasalocid	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D007832	Lasalocid results in increased expression of DSP protein	PMID:37788135
1314043	DSP	desmoplakin	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of DSP mRNA	PMID:29301935
1314043	DSP	desmoplakin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of DSP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of DSP protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of DSP protein	PMID:38598786
1314043	DSP	desmoplakin	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305794	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DSP mRNA	PMID:21346803
1314043	DSP	desmoplakin	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C032910	triadimefon results in decreased expression of DSP mRNA	PMID:26705709
1314043	DSP	desmoplakin	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305794	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of DSP mRNA	PMID:19015723
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1557923	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of ATR mRNA	PMID:33045310
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20170228	CTD	MESH:C015499	[schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased expression of BSCL2 mRNA]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of CHEK1 protein]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRP53 protein]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Cisplatin results in increased expression of BSCL2 mRNA]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Cisplatin results in increased phosphorylation of CHEK1 protein]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Cisplatin results in increased phosphorylation of TRP53 protein]	PMID:22003191
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D001241	Aspirin results in decreased expression of ATR mRNA	PMID:20514442
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:15368	acrolein	increases phosphorylation	EXP		E	RGD:6480464	20220510	CTD	MESH:D000171	Acrolein results in increased phosphorylation of ATR protein	PMID:34958888
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1557923	E	RGD:6480464	20160705	CTD	MESH:D001280	Atrazine results in increased expression of ATR protein	PMID:26518232
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of ATR mRNA	PMID:29018328
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ATR mRNA	PMID:21632981
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1557923	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATR mRNA	PMID:39241906
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D004958	Estradiol results in increased expression of ATR mRNA	PMID:24481588|PMID:31614463|PMID:36581016
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1557923	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ATR mRNA	PMID:39298647
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATR mRNA	PMID:25510870
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of ATR mRNA	PMID:38568856
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of ATR mRNA	PMID:34673133
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [aflatoxin G1 results in increased expression of ATR protein modified form]	PMID:23907605
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1557923	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ATR mRNA	PMID:34319233
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	increases phosphorylation	ISO	RGD:1557923	E	RGD:6480464	20140408	CTD	MESH:D014527	Uric Acid results in increased phosphorylation of ATR protein	PMID:23619996
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20140408	CTD	MESH:D014527	NLRP3 gene mutant form inhibits the reaction [Uric Acid results in increased phosphorylation of ATR protein]	PMID:23619996
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305796	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ATR mRNA	PMID:26577399
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ATR protein	PMID:37730182
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:17846	(S)-naringenin	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C005273	[naringenin co-treated with bisphenol A] results in increased expression of ATR mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of ATR mRNA	PMID:36235125
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ATR mRNA	PMID:28818685
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:18152	myricetin	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C040015	myricetin affects the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine affects the expression of ATR mRNA]	PMID:32342131
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:18227	sterigmatocystin	increases phosphorylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D013241	Sterigmatocystin results in increased phosphorylation of ATR protein	PMID:26914363
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:18227	sterigmatocystin	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D013241	ATR protein promotes the reaction [Sterigmatocystin results in increased phosphorylation of CHEK1 protein]	PMID:26914363
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:18358	methoxsalen	multiple interactions	EXP		E	RGD:6480464	20140311	CTD	MESH:D008730	Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of ATR protein modified form]	PMID:23907605
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine inhibits the reaction [aflatoxin G1 results in increased expression of ATR protein modified form]	PMID:23907605
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:191092	Decamethylcyclopentasiloxane	decreases expression	EXP		E	RGD:6480464	20220614	CTD	MESH:C114768	decamethylcyclopentasiloxane results in decreased expression of ATR mRNA	PMID:27601420
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D008769	ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F1 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of E2F3 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 mRNA]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2 protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TP53 protein]	PMID:26921499
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:229764	selinexor	multiple interactions	EXP		E	RGD:6480464	20240409	CTD	MESH:C585161	[selinexor co-treated with INCB057643] results in decreased phosphorylation of ATR protein	PMID:37899423
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:22977	cadmium atom	increases phosphorylation	EXP		E	RGD:6480464	20260303	CTD	MESH:D002104	Cadmium results in increased phosphorylation of ATR protein	PMID:40505819
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of ATR protein	PMID:40288561
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATR mRNA	PMID:25510870
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATR mRNA	PMID:25510870
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:233415	Pf-06840003	multiple interactions	EXP		E	RGD:6480464	20250408	CTD	MESH:C000625742	PF-06840003 inhibits the reaction [APP protein mutant form results in decreased expression of ATR mRNA]	PMID:39172838
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ATR mRNA	PMID:19549813
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ATR mRNA	PMID:27153756
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ATR gene	PMID:27153756
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:25640	octamethylcyclotetrasiloxane	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:C024064	octamethylcyclotetrasiloxane results in decreased expression of ATR mRNA	PMID:27601420
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ATR mRNA	PMID:27106289
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305796	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ATR mRNA	PMID:30779732
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ATR mRNA	PMID:25629700
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATR gene	PMID:25304211
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27656	camptothecin	decreases response to substance	EXP		E	RGD:6480464	20160315	CTD	MESH:D002166	ATR mRNA results in decreased susceptibility to Camptothecin; ATR protein results in decreased susceptibility to Camptothecin	PMID:25269479
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27656	camptothecin	increases phosphorylation	EXP		E	RGD:6480464	20160315	CTD	MESH:D002166	Camptothecin results in increased phosphorylation of ATR protein	PMID:25269479|PMID:30555576
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27656	camptothecin	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D002166	3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide inhibits the reaction [Camptothecin results in increased phosphorylation of ATR protein]	PMID:25269479
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:2766	aphidicolin	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20120918	CTD	MESH:D016590	[schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased expression of BSCL2 mRNA]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of CHEK1 protein]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Aphidicolin results in increased phosphorylation of TRP53 protein]	PMID:22003191
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27732	caffeine	affects activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine affects the activity of ATR protein	PMID:11507241
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ATR protein	PMID:35688186
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27732	caffeine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	[[Caffeine results in decreased activity of ATR protein] co-treated with [Caffeine results in decreased activity of ATM protein]] results in decreased susceptibility to Acrylamide; Caffeine inhibits the reaction [[resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]]; Caffeine inhibits the reaction [Hydroxyurea promotes the reaction [ATR protein results in increased phosphorylation of and results in increased activity of CHEK1 protein]]; Caffeine inhibits the reaction [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]]	PMID:15975956|PMID:18158334|PMID:20734998
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1557923	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of ATR mRNA	PMID:28960355
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ATR mRNA; [Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]; [Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] which results in increased phosphorylation of H2AX protein; Caffeine inhibits the reaction [[Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] results in increased activity of [CHEK1 protein co-treated with CHEK2 protein]]; Caffeine inhibits the reaction [Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]]; Resveratrol results in increased activity of [ATM protein co-treated with ATR protein]	PMID:15975956|PMID:23557933
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ATR mRNA	PMID:27594783
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20140812	CTD	MESH:D002945	Cisplatin results in decreased expression of ATR mRNA	PMID:24865317
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	ATR results in decreased susceptibility to Cisplatin	PMID:21652733
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased activity of ATR protein	PMID:21324906
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1305796	E	RGD:6480464	20160607	CTD	MESH:D002945	Cisplatin results in increased expression of ATR protein modified form	PMID:26739623
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	increases phosphorylation	EXP		E	RGD:6480464	20240109	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of ATR protein	PMID:37802411
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1557923	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of ATR protein	PMID:22006019
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide inhibits the reaction [Cisplatin results in increased phosphorylation of ATR protein]; [4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to Cisplatin; [ATR co-treated with TP53] results in decreased susceptibility to Cisplatin; Cisplatin promotes the reaction [MSH2 protein binds to and affects the localization of ATR protein]; ERCC6 protein inhibits the reaction [Cisplatin results in increased activity of ATR protein]; PTEN protein affects the reaction [Cisplatin results in increased phosphorylation of ATR protein]	PMID:21258400|PMID:21285353|PMID:21324906|PMID:21730979|PMID:37802411
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1305796	E	RGD:6480464	20160607	CTD	MESH:D002945	Lovastatin inhibits the reaction [Cisplatin results in increased expression of ATR protein modified form]	PMID:26739623
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20120918	CTD	MESH:D002945	[Cisplatin co-treated with Lutein] results in decreased expression of ATR mRNA; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Cisplatin results in increased expression of BSCL2 mRNA]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Cisplatin results in increased phosphorylation of CHEK1 protein]; [schizandrin B results in decreased activity of ATR protein] inhibits the reaction [Cisplatin results in increased phosphorylation of TRP53 protein]	PMID:22003191|PMID:24865317
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of ATR mRNA	PMID:18191903
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:28619	acrylamide	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D020106	[[Caffeine results in decreased activity of ATR protein] co-treated with [Caffeine results in decreased activity of ATM protein]] results in decreased susceptibility to Acrylamide	PMID:20734998
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ATR mRNA	PMID:30911355
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20180828	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATR mRNA	PMID:29653124
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:28748	doxorubicin	increases phosphorylation	ISO	RGD:1557923	E	RGD:6480464	20121113	CTD	MESH:D004317	Doxorubicin results in increased phosphorylation of ATR protein	PMID:22242153
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:D004317	[3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide affects the susceptibility to Doxorubicin] which results in decreased phosphorylation of ATR protein; [prexasertib affects the susceptibility to Doxorubicin] which results in decreased phosphorylation of ATR protein; [TP53 protein affects the susceptibility to Doxorubicin] which affects the expression of ATR mRNA	PMID:34519926|PMID:36634904
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:28838	lutein	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20140812	CTD	MESH:D014975	Lutein results in decreased expression of ATR mRNA	PMID:24865317
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:28838	lutein	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20140812	CTD	MESH:D014975	[Cisplatin co-treated with Lutein] results in decreased expression of ATR mRNA	PMID:24865317
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:28863	flavanones	decreases phosphorylation	EXP		E	RGD:6480464	20170303	CTD	MESH:D044950	Flavanones results in decreased phosphorylation of ATR protein	PMID:21616090
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20160210	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ATR protein]	PMID:26451628
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:28984	aluminium atom	increases expression	ISO	RGD:1557923	E	RGD:6480464	20260113	CTD	MESH:D000535	Aluminum results in increased expression of ATR mRNA	PMID:40915522
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:29014	cordycepin	increases phosphorylation	EXP		E	RGD:6480464	20240604	CTD	MESH:C058120	cordycepin results in increased phosphorylation of ATR protein	PMID:32451092
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of ATR mRNA	PMID:36057382
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ATR gene	PMID:28589171
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATR mRNA; sodium arsenite results in decreased expression of ATR protein	PMID:23618899|PMID:37762697|PMID:38568856|PMID:39719251
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of ATR mRNA	PMID:36057382
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ATR mRNA	PMID:30911355
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1557923	E	RGD:6480464	20121009	CTD	MESH:D012834	Silver affects the expression of ATR mRNA	PMID:19429238
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ATR mRNA	PMID:19150397
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:30621	diarsenic trioxide	increases activity	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased activity of ATR protein	PMID:16891316
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:30621	diarsenic trioxide	increases activity	ISO	RGD:1557923	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased activity of ATR protein	PMID:16891316
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATR mRNA	PMID:29274334
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Erlotinib Hydrochloride promotes the reaction [Arsenic Trioxide results in increased expression of ATR mRNA]	PMID:29274334
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D005707	Gallic Acid results in decreased expression of ATR mRNA	PMID:21887735
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C015358	methylparaben results in increased expression of ATR mRNA	PMID:24481588
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:32063	propylparaben	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C006068	propylparaben results in increased expression of ATR mRNA	PMID:24481588
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:32130	silver(1+) nitrate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in increased expression of ATR mRNA	PMID:22831968
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ATR mRNA	PMID:35295148
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1305796	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of ATR mRNA	PMID:34492290
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305796	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ATR mRNA	PMID:23411599
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557923	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ATR mRNA	PMID:17950772|PMID:18301758|PMID:23811191
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of ATR mRNA]	PMID:17950772
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of ATR mRNA	PMID:12419474
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1557923	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of ATR mRNA	PMID:19191707
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1557923	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ATR mRNA	PMID:28472532
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:33007	chromium(6+)	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C074702	chromium hexavalent ion results in increased activity of ATR protein	PMID:16876463
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C074702	ATR protein affects the reaction [chromium hexavalent ion results in increased phosphorylation of H2AX protein]; ATR protein affects the reaction [chromium hexavalent ion results in increased ubiquitination of H2AX protein]; chromium hexavalent ion promotes the reaction [ATR protein results in increased phosphorylation of SMC1A protein]; RAD17 protein affects the reaction [chromium hexavalent ion promotes the reaction [ATR protein results in increased phosphorylation of SMC1A protein]]	PMID:16876463|PMID:25288669
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:33007	chromium(6+)	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20150127	CTD	MESH:C074702	ATR protein affects the reaction [chromium hexavalent ion results in increased phosphorylation of H2AX protein]; ATR protein affects the reaction [chromium hexavalent ion results in increased ubiquitination of H2AX protein]	PMID:25288669
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305796	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ATR mRNA	PMID:25181051
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ATR mRNA	PMID:36235125|PMID:36982678
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305796	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ATR mRNA	PMID:30816183
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ATR gene	PMID:31601247
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305796	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of ATR mRNA	PMID:32145629
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	[naringenin co-treated with bisphenol A] results in increased expression of ATR mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of ATR mRNA	PMID:36235125
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:33629	aluminium(0)	increases expression	ISO	RGD:1557923	E	RGD:6480464	20260113	CTD	MESH:D000535	Aluminum results in increased expression of ATR mRNA	PMID:40915522
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATR mRNA	PMID:25510870
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ATR mRNA	PMID:25510870
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:3423	carmustine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	ATR protein affects the reaction [Carmustine results in increased phosphorylation of and results in increased activity of CHEK1 protein]	PMID:19261750
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C005290	oxybenzone results in increased expression of ATR mRNA	PMID:36581016
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1557923	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ATR mRNA	PMID:39298647
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1557923	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of ATR mRNA	PMID:36464114
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ATR mRNA	PMID:37019170
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1557923	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ATR mRNA; Diethylnitrosamine results in increased expression of ATR protein	PMID:19919837
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20120412	CTD	MESH:D004052	ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of ATR mRNA]; ATM protein inhibits the reaction [Diethylnitrosamine results in increased expression of ATR protein]	PMID:19919837
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATR mRNA	PMID:37042841
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATR mRNA	PMID:26472689
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:35456	cadmium dichloride	increases phosphorylation	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased phosphorylation of ATR protein	PMID:39778856
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased phosphorylation of ATR protein	PMID:40288561
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ATR mRNA	PMID:24449571
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of ATR mRNA	PMID:19318562
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases phosphorylation	EXP		E	RGD:6480464	20130312	CTD	MESH:D015741	Metribolone results in increased phosphorylation of ATR protein	PMID:23272087
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	ATR mutant form inhibits the reaction [Metribolone results in increased expression of H2AX protein]; Metribolone promotes the reaction [AR protein binds to ATR promoter]; Metribolone promotes the reaction [UXT protein binds to ATR promoter]	PMID:19318562|PMID:23272087
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1557923	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ATR mRNA	PMID:40194260
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ATR mRNA	PMID:28302478
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:39171	nitenpyram	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:C464843	nitenpyram results in decreased expression of ATR mRNA	PMID:35568224
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ATR mRNA	PMID:23179753
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:40303	lovastatin	multiple interactions	ISO	RGD:1305796	E	RGD:6480464	20160607	CTD	MESH:D008148	Lovastatin inhibits the reaction [Cisplatin results in increased expression of ATR protein modified form]	PMID:26739623
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:4042	cypermethrin	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C017160	cypermethrin results in decreased expression of ATR protein	PMID:36063984
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C107676	deguelin results in decreased expression of ATR mRNA	PMID:22227970
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:44423	hydroxyurea	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006918	[4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to Hydroxyurea; Caffeine inhibits the reaction [Hydroxyurea promotes the reaction [ATR protein results in increased phosphorylation of and results in increased activity of CHEK1 protein]]	PMID:18158334|PMID:21730979
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:44442	6-(cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine	decreases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C475622	4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR	PMID:21730979
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:44442	6-(cyclohexylmethoxy)-5-nitrosopyrimidine-2,4-diamine	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C475622	4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of ATR protein]; 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin results in increased phosphorylation of ATR protein]; [4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to Cisplatin; [4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to Hydroxyurea; [4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to temozolomide	PMID:21730979|PMID:25748550
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:44616	afimoxifene	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	ATR results in decreased susceptibility to afimoxifene	PMID:21233418
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D017239	[Paclitaxel co-treated with Metformin] results in decreased expression of ATR mRNA	PMID:29309887
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557923	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ATR mRNA	PMID:17562736
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATR mRNA	PMID:21420995
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ATR mRNA	PMID:26690555
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATR gene	PMID:25304211
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:472805	ouabain	decreases phosphorylation	EXP		E	RGD:6480464	20200609	CTD	MESH:D010042	Ouabain results in decreased phosphorylation of ATR protein	PMID:31436044
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of ATR mRNA	PMID:22077320
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATR mRNA	PMID:22079256
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:4911	etoposide	increases phosphorylation	ISO	RGD:1557923	E	RGD:6480464	20121113	CTD	MESH:D005047	Etoposide results in increased phosphorylation of ATR protein	PMID:22242153
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:4918	O-methyleugenol	increases phosphorylation	EXP		E	RGD:6480464	20180515	CTD	MESH:C005223	methyleugenol results in increased phosphorylation of ATR protein	PMID:28818686
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:49900	arsenous acid	increases activity	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased activity of ATR protein	PMID:16891316
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:49900	arsenous acid	increases activity	ISO	RGD:1557923	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased activity of ATR protein	PMID:16891316
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATR mRNA	PMID:29274334
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Erlotinib Hydrochloride promotes the reaction [Arsenic Trioxide results in increased expression of ATR mRNA]	PMID:29274334
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:50102	N-methyl-N-nitrosourea	affects localization	ISO	RGD:1557923	E	RGD:6480464	20120412	CTD	MESH:D008770	Methylnitrosourea affects the localization of ATR protein	PMID:21285353
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:50102	N-methyl-N-nitrosourea	multiple interactions	ISO	RGD:1557923	E	RGD:6480464	20120412	CTD	MESH:D008770	MSH2 protein promotes the reaction [Methylnitrosourea affects the localization of ATR protein]	PMID:21285353
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects localization	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the localization of ATR protein modified form	PMID:17991895
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of ATR mRNA	PMID:27915011
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases activity	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased activity of ATR protein	PMID:17977830
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	ATR protein affects the reaction [Decitabine results in increased expression of TP53 protein]; Decitabine promotes the reaction [ATR protein results in increased phosphorylation of TP53 protein]; RPA1 protein affects the reaction [Decitabine results in increased activity of ATR protein]	PMID:17977830
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:50161	motexafin gadolinium	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in decreased expression of ATR mRNA	PMID:16357179
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of ATR mRNA	PMID:16357179
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557923	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ATR mRNA; Nanotubes, Carbon results in increased expression of ATR mRNA	PMID:25620056
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305796	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of ATR mRNA	PMID:23962444
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:53212	isocyanates	increases expression	EXP		E	RGD:6480464	20170131	CTD	MESH:D017953	Isocyanates results in increased expression of ATR protein	PMID:19283680
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:53509	erlotinib hydrochloride	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:D000069347	Erlotinib Hydrochloride results in increased expression of ATR mRNA	PMID:29274334
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:53509	erlotinib hydrochloride	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D000069347	Erlotinib Hydrochloride promotes the reaction [Arsenic Trioxide results in increased expression of ATR mRNA]	PMID:29274334
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:53700	quinoline yellow	increases expression	EXP		E	RGD:6480464	20250506	CTD	MESH:C019303	quinoline yellow results in increased expression of ATR mRNA	PMID:28893156
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:60761	floxuridine	decreases response to substance	EXP		E	RGD:6480464	20120501	CTD	MESH:D005467	ATR protein results in decreased susceptibility to Floxuridine	PMID:21613406|PMID:22194930
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:62984	zinc acetate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in decreased expression of ATR mRNA	PMID:16357179
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:62984	zinc acetate	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of ATR mRNA	PMID:16357179
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:63020	yttrium chloride	affects expression	ISO	RGD:1305796	E	RGD:6480464	20220705	CTD	MESH:C064782	yttrium chloride affects the expression of ATR protein	PMID:35088107
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ATR mRNA	PMID:12419474
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D008687	[Paclitaxel co-treated with Metformin] results in decreased expression of ATR mRNA	PMID:29309887
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of ATR mRNA	PMID:27462272
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:69355	casticin	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C054133	casticin results in decreased expression of ATR protein	PMID:29098808
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:72564	temozolomide	multiple interactions	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	[4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine results in decreased activity of ATR] which results in increased susceptibility to temozolomide	PMID:21730979
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1557923	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of ATR mRNA	PMID:36464114
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1557923	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ATR mRNA	PMID:22206623
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:747627	Prexasertib	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C000608121	[prexasertib affects the susceptibility to Doxorubicin] which results in decreased phosphorylation of ATR protein	PMID:34519926
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C051752	nefazodone results in decreased expression of ATR mRNA	PMID:27288927
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ATR mRNA	PMID:22079256
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATR mRNA	PMID:22079256
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ATR mRNA	PMID:37199045
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:756940	abbv-744	increases phosphorylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000706695	ABBV-744 results in increased phosphorylation of ATR protein	PMID:37769529
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:76290	PhIP	affects expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine affects the expression of ATR mRNA	PMID:32342131
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:76290	PhIP	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C049584	myricetin affects the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine affects the expression of ATR mRNA]	PMID:32342131
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:78708	Nonidet P-40	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C010615	Nonidet P-40 results in decreased expression of ATR mRNA	PMID:26552463
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATR gene]	PMID:28238834
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1557923	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ATR mRNA	PMID:23091169
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:80706	Aflatoxin G1	increases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:C027955	aflatoxin G1 results in increased activity of ATR protein	PMID:23907605
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:80706	Aflatoxin G1	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C027955	aflatoxin G1 results in increased expression of ATR protein modified form	PMID:23907605
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:80706	Aflatoxin G1	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C027955	Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of ATR protein modified form]; Nicotine inhibits the reaction [aflatoxin G1 results in increased expression of ATR protein modified form]	PMID:23907605
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1557923	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of ATR mRNA	PMID:21278054
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1557923	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of ATR mRNA	PMID:40826991
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:88542	Butylparaben	increases expression	EXP		E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in increased expression of ATR mRNA	PMID:24481588
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1557923	E	RGD:6480464	20121009	CTD	MESH:D012834	Silver affects the expression of ATR mRNA	PMID:19429238
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ATR mRNA	PMID:38568856
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1557923	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ATR mRNA	PMID:35537566
1314047	ATR	ATR checkpoint kinase	gene	CHEBI:9763	trovafloxacin	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C080163	4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [[trovafloxacin co-treated with TNF protein] results in increased phosphorylation of ATR protein]; 4-cyclohexylmethoxy-5-nitrosopyrimidine-2,6-diamine inhibits the reaction [trovafloxacin results in increased phosphorylation of ATR protein]; [trovafloxacin co-treated with TNF protein] results in increased phosphorylation of and results in increased activity of ATR protein; trovafloxacin results in increased phosphorylation of and results in increased activity of ATR protein; U 0126 inhibits the reaction [trovafloxacin results in increased activity of ATR protein]	PMID:25748550
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TTC39B mRNA	PMID:26272509
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39B mRNA	PMID:27188386
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TTC39B mRNA	PMID:39752319
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of TTC39B mRNA]	PMID:19467301
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TTC39B mRNA	PMID:30529165
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TTC39B mRNA	PMID:36331819
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of TTC39B mRNA	PMID:40945087
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1314049	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of TTC39B mRNA	PMID:18978301
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305797	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TTC39B mRNA	PMID:33387578
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1314049	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of TTC39B mRNA	PMID:17251523
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TTC39B mRNA	PMID:37992649
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TTC39B mRNA	PMID:39752319
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:174733	Licochalcone B	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of TTC39B mRNA	PMID:33647349
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TTC39B mRNA	PMID:37992649
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305797	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TTC39B mRNA	PMID:33387578
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of TTC39B mRNA	PMID:39836092
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:22718	benzoates	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in increased expression of TTC39B mRNA	PMID:29472718
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTC39B mRNA	PMID:35301059
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTC39B mRNA	PMID:37236586
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TTC39B mRNA	PMID:19549813
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1305797	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of TTC39B protein	PMID:33236894
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305797	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of TTC39B mRNA	PMID:21396975
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TTC39B mRNA	PMID:27153756
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TTC39B gene	PMID:27153756
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314049	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TTC39B mRNA	PMID:19770486
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of TTC39B mRNA	PMID:32525701
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305797	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TTC39B mRNA	PMID:31881176
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:28088	genistein	increases methylation	ISO	RGD:1305797	E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of TTC39B gene	PMID:28505145
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTC39B mRNA	PMID:22574217
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TTC39B mRNA	PMID:20106945|PMID:21632981
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305797	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TTC39B mRNA	PMID:33387578
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TTC39B mRNA	PMID:33212167
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TTC39B mRNA	PMID:30851411
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:28428	beta-hexachlorocyclohexane	increases expression	ISO	RGD:1314049	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in increased expression of TTC39B mRNA	PMID:25270620
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TTC39B mRNA	PMID:29803840
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TTC39B mRNA	PMID:37992649
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TTC39B mRNA	PMID:37682722
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of TTC39B mRNA	PMID:34032870|PMID:38568856
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TTC39B mRNA	PMID:20064835
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314049	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TTC39B intron	PMID:27901495
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314049	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TTC39B mRNA	PMID:19770486
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TTC39B promoter	PMID:27901495
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TTC39B mRNA	PMID:25895662
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TTC39B mRNA	PMID:29264374
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314049	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TTC39B gene	PMID:35295148
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of TTC39B mRNA	PMID:23811191
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314049	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TTC39B mRNA	PMID:17426115
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305797	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TTC39B mRNA	PMID:25181051
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314049	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of TTC39B mRNA	PMID:26063408
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TTC39B mRNA	PMID:39298647
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314049	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TTC39B intron	PMID:28392331
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of TTC39B mRNA	PMID:34813904
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:1314049	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of TTC39B mRNA	PMID:25270620
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of TTC39B mRNA	PMID:34813904
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TTC39B mRNA	PMID:37042841
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of TTC39B mRNA	PMID:39836092
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TTC39B mRNA	PMID:38174414
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTC39B mRNA	PMID:35301059
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TTC39B mRNA	PMID:37236586
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305797	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of TTC39B mRNA	PMID:24386269
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TTC39B mRNA	PMID:24449571
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TTC39B mRNA	PMID:32588087
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TTC39B mRNA	PMID:28302478
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TTC39B mRNA	PMID:31533062
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of TTC39B mRNA	PMID:19167446
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TTC39B mRNA	PMID:19167446
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TTC39B mRNA	PMID:36331819
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TTC39B mRNA	PMID:23179753|PMID:28001369
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TTC39B mRNA	PMID:24935251|PMID:27188386
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TTC39B mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of TTC39B mRNA	PMID:37992649
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TTC39B mRNA	PMID:24935251
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314049	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TTC39B mRNA	PMID:17562736
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of TTC39B mRNA	PMID:29067470
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305797	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TTC39B mRNA	PMID:33387578
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of TTC39B mRNA	PMID:32525701
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	ISO	RGD:1314049	E	RGD:401827839|PMID:29593532	20230929	RGD	MESH:C045651	(-)-epigallocatechin 3-gallate decreases expression of Ttc39b mRNA and protein in liver	
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of TTC39B mRNA	PMID:18175754
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305797	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of TTC39B mRNA	PMID:30307764
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314049	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TTC39B mRNA; Nanotubes, Carbon results in increased expression of TTC39B mRNA	PMID:25554681|PMID:25620056
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314049	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of TTC39B mRNA	PMID:40234311
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305797	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TTC39B mRNA	PMID:24136188
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314049	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TTC39B mRNA	PMID:19042947
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314049	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TTC39B mRNA	PMID:38701926
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of TTC39B mRNA	PMID:39836092
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1314049	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of TTC39B mRNA	PMID:25270620
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1305797	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of TTC39B mRNA	PMID:19564919
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TTC39B mRNA	PMID:39752319
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of TTC39B mRNA	PMID:31758290
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TTC39B mRNA	PMID:22206623
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TTC39B mRNA	PMID:30851411
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39B mRNA	PMID:27188386
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314049	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TTC39B mRNA	PMID:23091169
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of TTC39B mRNA	PMID:19167446
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of TTC39B mRNA	PMID:26705709
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of TTC39B mRNA	PMID:32525701
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314049	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of TTC39B mRNA	PMID:21278054
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1314049	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of TTC39B mRNA	PMID:39752319
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC39B mRNA	PMID:27188386
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305797	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TTC39B mRNA	PMID:19281266
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TTC39B mRNA	PMID:38568856
1314048	TTC39B	tetratricopeptide repeat domain 39B	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314049	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TTC39B mRNA	PMID:35537566
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314051	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MBOAT2 mRNA	PMID:26251327
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MBOAT2 mRNA	PMID:20938992
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MBOAT2 mRNA	PMID:33167477
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of MBOAT2 mRNA	PMID:20880076
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MBOAT2 mRNA	PMID:30529165
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314051	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MBOAT2 mRNA	PMID:30319688
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of MBOAT2 mRNA	PMID:29581250
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MBOAT2 mRNA	PMID:30165855
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305798	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of MBOAT2 mRNA; [Testosterone co-treated with Estradiol] results in increased expression of MBOAT2 mRNA	PMID:26496021|PMID:32741896
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MBOAT2 mRNA	PMID:20938992
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MBOAT2 mRNA	PMID:37042841
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of MBOAT2 mRNA	PMID:22017230
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305798	E	RGD:6480464	20210406	CTD	MESH:D013739	[Testosterone co-treated with Estradiol] results in increased expression of MBOAT2 mRNA	PMID:32741896
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of MBOAT2 mRNA	PMID:31256213
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314051	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MBOAT2 mRNA	PMID:33754040
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MBOAT2 protein	PMID:37730182
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1314051	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MBOAT2 mRNA	PMID:18579281
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MBOAT2 gene	PMID:27153756
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MBOAT2 intron	PMID:30157460
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305798	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of MBOAT2 mRNA	PMID:30779732
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MBOAT2 mRNA	PMID:20938992
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of MBOAT2 mRNA	PMID:24768652
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314051	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MBOAT2 mRNA	PMID:21570461
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MBOAT2 mRNA	PMID:17942748
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MBOAT2 mRNA	PMID:33212167
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305798	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MBOAT2 mRNA	PMID:28959563
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MBOAT2 mRNA	PMID:29803840
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MBOAT2 mRNA	PMID:38568856
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MBOAT2 promoter	PMID:27901495
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MBOAT2 mRNA	PMID:22610609
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MBOAT2 mRNA	PMID:27858113
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314051	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MBOAT2 mRNA	PMID:27131904
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of MBOAT2 gene	PMID:31601247
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of MBOAT2 mRNA	PMID:31745603
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305798	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of MBOAT2 mRNA	PMID:30047161
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1314051	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of MBOAT2 promoter	PMID:35295148
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314051	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MBOAT2 gene	PMID:35295148
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305798	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MBOAT2 mRNA	PMID:30816183|PMID:34947998
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305798	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MBOAT2 gene	PMID:28505145
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of MBOAT2 gene	PMID:31601247
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305798	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of MBOAT2 mRNA	PMID:26496021
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314051	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MBOAT2 mRNA	PMID:26377693
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MBOAT2 mRNA	PMID:27858113
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1314051	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of MBOAT2 intron	PMID:28392331
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MBOAT2 mRNA	PMID:17361019|PMID:21266533
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D010269	Paraquat results in increased expression of MBOAT2 mRNA	PMID:22563483
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D010269	[Paraquat co-treated with Maneb] affects the expression of MBOAT2 mRNA	PMID:22563483
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MBOAT2 mRNA	PMID:37042841
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305798	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MBOAT2 mRNA	PMID:35163327
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1314051	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MBOAT2 mRNA	PMID:26377693
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305798	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MBOAT2 mRNA	PMID:35163327
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305798	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of MBOAT2 mRNA	PMID:30047161
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314051	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MBOAT2 mRNA	PMID:40194260
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:38626	pyridaben	increases expression	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:C428725	pyridaben results in increased expression of MBOAT2 mRNA	PMID:22563483
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MBOAT2 mRNA	PMID:31533062
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MBOAT2 mRNA	PMID:40419075
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of MBOAT2 mRNA	PMID:23179753
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of MBOAT2 mRNA	PMID:29154799
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305798	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of MBOAT2 mRNA	PMID:30047161
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314051	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MBOAT2 mRNA	PMID:17555576
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MBOAT2 mRNA	PMID:36621641
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314051	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MBOAT2 mRNA	PMID:28973697
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of MBOAT2 mRNA]	PMID:21233418
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314051	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MBOAT2 mRNA	PMID:17555576
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314051	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MBOAT2 mRNA	PMID:17942748
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MBOAT2 mRNA	PMID:17942748
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305798	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of MBOAT2 mRNA	PMID:30047161
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1314051	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of MBOAT2 mRNA	PMID:26377693
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MBOAT2 mRNA	PMID:27858113
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MBOAT2 mRNA	PMID:27858113
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314051	E	RGD:6480464	20121113	CTD	MESH:D008344	[Paraquat co-treated with Maneb] affects the expression of MBOAT2 mRNA	PMID:22563483
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314051	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of MBOAT2 mRNA	PMID:23608068
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of MBOAT2 mRNA	PMID:20436886
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305798	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MBOAT2 gene	PMID:35440735
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314051	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MBOAT2 mRNA	PMID:22206623
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305798	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MBOAT2 mRNA	PMID:30047161
1314050	MBOAT2	membrane bound glycerophospholipid O-acyltransferase 2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314051	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MBOAT2 mRNA	PMID:27131904
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:10101	zalcitabine	multiple interactions	ISO	RGD:1305799	E	RGD:6480464	20120412	CTD	MESH:D016047	[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of DEPDC1B mRNA	PMID:18606552
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DEPDC1B mRNA	PMID:33167477
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305799	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of DEPDC1B gene	PMID:28931070
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DEPDC1B mRNA	PMID:29432896
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of DEPDC1B mRNA	PMID:21632981
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of DEPDC1B protein	PMID:35688186
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DEPDC1B mRNA	PMID:39298647
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DEPDC1B mRNA	PMID:16474171
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305799	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DEPDC1B mRNA	PMID:32741896
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of DEPDC1B mRNA	PMID:38568856
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of DEPDC1B mRNA	PMID:23649840
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of DEPDC1B mRNA	PMID:21540246
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of DEPDC1B mRNA	PMID:26079696
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of DEPDC1B mRNA	PMID:28973375
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of DEPDC1B mRNA	PMID:21592394
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of DEPDC1B mRNA	PMID:21592394
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305799	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DEPDC1B mRNA	PMID:32741896
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of DEPDC1B protein	PMID:37730182
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of DEPDC1B mRNA	PMID:21592394
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of DEPDC1B mRNA	PMID:21592394
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of DEPDC1B mRNA	PMID:24376830
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DEPDC1B mRNA	PMID:19549813
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of DEPDC1B mRNA	PMID:23649840
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1550310	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of DEPDC1B intron	PMID:27776689
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of DEPDC1B protein	PMID:20106945
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305799	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DEPDC1B mRNA	PMID:23630614
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DEPDC1B mRNA	PMID:23649840
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of DEPDC1B mRNA	PMID:25102026
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20140408	CTD	MESH:D010126	Ozone results in decreased expression of DEPDC1B mRNA	PMID:24336422
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550310	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of DEPDC1B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of DEPDC1B mRNA	PMID:27106289|PMID:34911549
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of DEPDC1B mRNA	PMID:32525701
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of DEPDC1B mRNA	PMID:33512557
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305799	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DEPDC1B mRNA	PMID:31881176
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of DEPDC1B mRNA	PMID:28903495
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of DEPDC1B mRNA	PMID:23300844
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of DEPDC1B mRNA	PMID:16474171
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of DEPDC1B mRNA	PMID:25583101
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550310	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DEPDC1B mRNA	PMID:21570461|PMID:26377647
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DEPDC1B mRNA	PMID:21632981|PMID:21802500
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305799	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DEPDC1B mRNA	PMID:33387578
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of DEPDC1B mRNA	PMID:33512557
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DEPDC1B mRNA	PMID:33212167
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of DEPDC1B mRNA	PMID:32763439
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of DEPDC1B mRNA	PMID:22623647
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DEPDC1B mRNA	PMID:22714537|PMID:38568856
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of DEPDC1B mRNA	PMID:17998272
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of DEPDC1B mRNA	PMID:29301061
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of DEPDC1B mRNA	PMID:22378314
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1550310	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DEPDC1B exon; Benzo(a)pyrene results in decreased methylation of DEPDC1B intron	PMID:27901495
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1550310	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DEPDC1B mRNA	PMID:29341224
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DEPDC1B mRNA	PMID:19150397|PMID:20382639
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of DEPDC1B mRNA	PMID:31745603
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305799	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DEPDC1B mRNA	PMID:25729387
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550310	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DEPDC1B promoter	PMID:35295148
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550310	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of DEPDC1B mRNA	PMID:23557971
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305799	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of DEPDC1B mRNA	PMID:34492290
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of DEPDC1B mRNA	PMID:38479592
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of DEPDC1B mRNA	PMID:30903817
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of DEPDC1B mRNA	PMID:29275510
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305799	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DEPDC1B mRNA	PMID:25181051|PMID:32145629
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of DEPDC1B mRNA	PMID:16474171
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305799	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DEPDC1B gene	PMID:28505145
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1550310	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of DEPDC1B mRNA	PMID:20713471
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1550310	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of DEPDC1B mRNA	PMID:20713471
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550310	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of DEPDC1B gene	PMID:31683443
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of DEPDC1B mRNA	PMID:40203079
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1550310	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of DEPDC1B mRNA	PMID:26377693
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1550310	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DEPDC1B intron	PMID:28392331
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DEPDC1B mRNA	PMID:37042841
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305799	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of DEPDC1B mRNA	PMID:30723492
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DEPDC1B mRNA	PMID:38568856
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of DEPDC1B mRNA	PMID:36326898
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305799	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of DEPDC1B mRNA	PMID:25539665
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of DEPDC1B mRNA	PMID:25908611
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of DEPDC1B mRNA	PMID:32588087
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550310	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DEPDC1B mRNA	PMID:40194260
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of DEPDC1B mRNA	PMID:33512557
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DEPDC1B mRNA	PMID:28302478
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of DEPDC1B mRNA	PMID:31533062
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of DEPDC1B mRNA]	PMID:18310284
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of DEPDC1B mRNA	PMID:39529242
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DEPDC1B mRNA	PMID:40419075
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of DEPDC1B mRNA	PMID:27188386|PMID:28001369
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of DEPDC1B mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:40909	azoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of DEPDC1B mRNA	PMID:33512557
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550310	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of DEPDC1B mRNA	PMID:28973697
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of DEPDC1B mRNA	PMID:33512557
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DEPDC1B mRNA	PMID:38832940
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550310	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DEPDC1B mRNA	PMID:17562736
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305799	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DEPDC1B mRNA	PMID:33387578
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1550310	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DEPDC1B mRNA	PMID:29279043
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of DEPDC1B mRNA	PMID:32525701
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550310	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of DEPDC1B mRNA	PMID:35436446
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:5011	fenpyroximate	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of DEPDC1B mRNA	PMID:33512557
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of DEPDC1B mRNA	PMID:23300844
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1550310	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of DEPDC1B mRNA	PMID:25554681
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550310	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DEPDC1B mRNA	PMID:25554681
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of DEPDC1B mRNA	PMID:21148553
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1305799	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of DEPDC1B mRNA	PMID:21983209
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550310	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DEPDC1B mRNA	PMID:19042947
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1550310	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of DEPDC1B mRNA	PMID:38701926
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:63618	pravastatin	affects expression	ISO	RGD:1550310	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin affects the expression of DEPDC1B mRNA	PMID:27225895
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:63618	pravastatin	decreases expression	ISO	RGD:1305799	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of DEPDC1B mRNA	PMID:27225895
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305799	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of DEPDC1B mRNA	PMID:25729387
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305799	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DEPDC1B mRNA	PMID:25729387
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DEPDC1B mRNA	PMID:24810058
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305799	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DEPDC1B mRNA	PMID:37269647
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1550310	E	RGD:6480464	20200317	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of DEPDC1B mRNA	PMID:22078008
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1305799	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of DEPDC1B mRNA	PMID:27225895
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of DEPDC1B mRNA	PMID:27225895
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305799	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of DEPDC1B mRNA	PMID:32741896
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of DEPDC1B mRNA	PMID:32858204
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of DEPDC1B mRNA	PMID:34995734
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of DEPDC1B mRNA	PMID:18927307
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550310	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DEPDC1B mRNA	PMID:23091169
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of DEPDC1B mRNA	PMID:33512557
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of DEPDC1B mRNA	PMID:32234424
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of DEPDC1B mRNA	PMID:33512557
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of DEPDC1B mRNA	PMID:32525701
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305799	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of DEPDC1B mRNA	PMID:24780913
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of DEPDC1B mRNA	PMID:26272509
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:85993	palbociclib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of DEPDC1B mRNA	PMID:22869556
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of DEPDC1B mRNA	PMID:22378314
1314052	DEPDC1B	DEP domain containing 1B	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550310	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of DEPDC1B mRNA	PMID:35537566
1314056	HOXC9	homeobox C9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of HOXC9 mRNA	PMID:23830798
1314056	HOXC9	homeobox C9	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1595784	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of HOXC9 gene	PMID:28931070
1314056	HOXC9	homeobox C9	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of HOXC9 mRNA	PMID:30510588
1314056	HOXC9	homeobox C9	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1595784	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HOXC9 mRNA	PMID:33387578
1314056	HOXC9	homeobox C9	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314057	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of HOXC9 mRNA	PMID:34319233
1314056	HOXC9	homeobox C9	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of HOXC9 protein	PMID:37730182
1314056	HOXC9	homeobox C9	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of HOXC9 mRNA	PMID:24376830
1314056	HOXC9	homeobox C9	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HOXC9 mRNA	PMID:35301059
1314056	HOXC9	homeobox C9	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HOXC9 mRNA	PMID:19549813
1314056	HOXC9	homeobox C9	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HOXC9 gene	PMID:27153756
1314056	HOXC9	homeobox C9	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1314057	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of HOXC9 mRNA	PMID:15674843
1314056	HOXC9	homeobox C9	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1595784	E	RGD:6480464	20210112	CTD	MESH:D010126	Ozone results in decreased expression of HOXC9 mRNA	PMID:23968387
1314056	HOXC9	homeobox C9	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1595784	E	RGD:6480464	20210112	CTD	MESH:D010126	[Ozone co-treated with Fructose] results in decreased expression of HOXC9 mRNA; [Particulate Matter co-treated with Ozone co-treated with Fructose] results in decreased expression of HOXC9 mRNA; [Particulate Matter co-treated with Ozone] results in decreased expression of HOXC9 mRNA	PMID:23968387
1314056	HOXC9	homeobox C9	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of HOXC9 mRNA	PMID:27392435
1314056	HOXC9	homeobox C9	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314057	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of HOXC9 mRNA	PMID:32186404
1314056	HOXC9	homeobox C9	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of HOXC9 mRNA	PMID:25583101
1314056	HOXC9	homeobox C9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314057	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HOXC9 mRNA	PMID:21570461|PMID:24058054
1314056	HOXC9	homeobox C9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1595784	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HOXC9 mRNA	PMID:33387578
1314056	HOXC9	homeobox C9	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HOXC9 mRNA	PMID:33212167
1314056	HOXC9	homeobox C9	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1595784	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of HOXC9 mRNA	PMID:28959563
1314056	HOXC9	homeobox C9	gene	CHEBI:28757	fructose	decreases expression	ISO	RGD:1595784	E	RGD:6480464	20210112	CTD	MESH:D005632	Fructose results in decreased expression of HOXC9 mRNA	PMID:23968387
1314056	HOXC9	homeobox C9	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1595784	E	RGD:6480464	20210112	CTD	MESH:D005632	[Ozone co-treated with Fructose] results in decreased expression of HOXC9 mRNA; [Particulate Matter co-treated with Ozone co-treated with Fructose] results in decreased expression of HOXC9 mRNA; Fructose affects the reaction [Particulate Matter results in decreased expression of HOXC9 mRNA]	PMID:23968387
1314056	HOXC9	homeobox C9	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of HOXC9 mRNA	PMID:29453283
1314056	HOXC9	homeobox C9	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1314057	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of HOXC9 mRNA	PMID:22342234
1314056	HOXC9	homeobox C9	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HOXC9 5' UTR; Benzo(a)pyrene results in decreased methylation of HOXC9 exon; Benzo(a)pyrene results in decreased methylation of HOXC9 promoter	PMID:27901495
1314056	HOXC9	homeobox C9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HOXC9 mRNA	PMID:26238291
1314056	HOXC9	homeobox C9	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:D001564	[AHR gene mutant form affects the susceptibility to Benzo(a)pyrene] which results in decreased expression of HOXC9 mRNA	PMID:38036013
1314056	HOXC9	homeobox C9	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of HOXC9 promoter	PMID:23974009
1314056	HOXC9	homeobox C9	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HOXC9 protein	PMID:35467087
1314056	HOXC9	homeobox C9	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HOXC9 gene	PMID:31601247
1314056	HOXC9	homeobox C9	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1595784	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of HOXC9 mRNA	PMID:25729387
1314056	HOXC9	homeobox C9	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314057	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of HOXC9 mRNA	PMID:23557971
1314056	HOXC9	homeobox C9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314057	E	RGD:6480464	20140513	CTD	MESH:C006780	bisphenol A results in increased expression of HOXC9 mRNA	PMID:24465770
1314056	HOXC9	homeobox C9	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HOXC9 gene	PMID:31601247
1314056	HOXC9	homeobox C9	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HOXC9 mRNA	PMID:28628672
1314056	HOXC9	homeobox C9	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HOXC9 mRNA	PMID:28628672
1314056	HOXC9	homeobox C9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HOXC9 mRNA	PMID:35301059
1314056	HOXC9	homeobox C9	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of HOXC9 mRNA	PMID:24449571
1314056	HOXC9	homeobox C9	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HOXC9 mRNA	PMID:28628672
1314056	HOXC9	homeobox C9	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1595784	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of HOXC9 mRNA	PMID:33387578
1314056	HOXC9	homeobox C9	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of HOXC9 mRNA	PMID:28628672
1314056	HOXC9	homeobox C9	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HOXC9 protein	PMID:35467087
1314056	HOXC9	homeobox C9	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of HOXC9 mRNA	PMID:22714537
1314056	HOXC9	homeobox C9	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1595784	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of HOXC9 mRNA	PMID:25729387
1314056	HOXC9	homeobox C9	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of HOXC9 mRNA	PMID:31758290
1314056	HOXC9	homeobox C9	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of HOXC9 mRNA	PMID:22714537
1314056	HOXC9	homeobox C9	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in decreased expression of HOXC9 mRNA	PMID:29453283
1314058	SNX15	sorting nexin 15	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX15 mRNA	PMID:36331819
1314058	SNX15	sorting nexin 15	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNX15 mRNA	PMID:37042841
1314058	SNX15	sorting nexin 15	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314059	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SNX15 mRNA	PMID:33754040
1314058	SNX15	sorting nexin 15	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305803	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SNX15 mRNA	PMID:33387578
1314058	SNX15	sorting nexin 15	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SNX15 mRNA	PMID:28818685
1314058	SNX15	sorting nexin 15	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of SNX15 mRNA	PMID:39836092
1314058	SNX15	sorting nexin 15	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNX15 mRNA	PMID:37236586
1314058	SNX15	sorting nexin 15	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1305803	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SNX15 mRNA	PMID:33354967
1314058	SNX15	sorting nexin 15	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SNX15 intron	PMID:30157460
1314058	SNX15	sorting nexin 15	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314059	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SNX15 mRNA	PMID:25629700
1314058	SNX15	sorting nexin 15	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX15 mRNA	PMID:22206623
1314058	SNX15	sorting nexin 15	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SNX15 gene	PMID:25304211
1314058	SNX15	sorting nexin 15	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX15 mRNA	PMID:39836092
1314058	SNX15	sorting nexin 15	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX15 mRNA	PMID:40504410
1314058	SNX15	sorting nexin 15	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SNX15 protein	PMID:35688186
1314058	SNX15	sorting nexin 15	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SNX15 mRNA	PMID:23557933
1314058	SNX15	sorting nexin 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314059	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX15 mRNA	PMID:21570461
1314058	SNX15	sorting nexin 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305803	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNX15 mRNA	PMID:33387578
1314058	SNX15	sorting nexin 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314059	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNX15 mRNA	PMID:19770486
1314058	SNX15	sorting nexin 15	gene	CHEBI:28262	dimethyl sulfoxide	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004121	Dimethyl Sulfoxide affects the expression of SNX15 mRNA	PMID:24834073
1314058	SNX15	sorting nexin 15	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314059	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SNX15 mRNA	PMID:27862939
1314058	SNX15	sorting nexin 15	gene	CHEBI:28869	menadione	decreases expression	ISO	RGD:1314059	E	RGD:6480464	20150127	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of SNX15 mRNA	PMID:25270620
1314058	SNX15	sorting nexin 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX15 mRNA	PMID:39836092
1314058	SNX15	sorting nexin 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX15 mRNA	PMID:40504410
1314058	SNX15	sorting nexin 15	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SNX15 promoter	PMID:27901495
1314058	SNX15	sorting nexin 15	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305803	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SNX15 mRNA	PMID:34492290
1314058	SNX15	sorting nexin 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305803	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SNX15 mRNA	PMID:25181051
1314058	SNX15	sorting nexin 15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305803	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SNX15 mRNA	PMID:30816183|PMID:32528016
1314058	SNX15	sorting nexin 15	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1305803	E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of SNX15 mRNA	PMID:23829299
1314058	SNX15	sorting nexin 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314059	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SNX15 gene	PMID:31683443
1314058	SNX15	sorting nexin 15	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNX15 mRNA	PMID:28628672
1314058	SNX15	sorting nexin 15	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases methylation	ISO	RGD:1314059	E	RGD:6480464	20140610	CTD	MESH:D004137	Dinitrochlorobenzene results in increased methylation of SNX15 promoter	PMID:24675093
1314058	SNX15	sorting nexin 15	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNX15 mRNA	PMID:28628672
1314058	SNX15	sorting nexin 15	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of SNX15 mRNA	PMID:39836092
1314058	SNX15	sorting nexin 15	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNX15 mRNA	PMID:37236586
1314058	SNX15	sorting nexin 15	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SNX15 mRNA	PMID:19320972
1314058	SNX15	sorting nexin 15	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305803	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SNX15 mRNA	PMID:24386269
1314058	SNX15	sorting nexin 15	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX15 mRNA	PMID:36331819
1314058	SNX15	sorting nexin 15	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SNX15 mRNA	PMID:25979313
1314058	SNX15	sorting nexin 15	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SNX15 gene	PMID:29154799
1314058	SNX15	sorting nexin 15	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNX15 mRNA	PMID:28628672
1314058	SNX15	sorting nexin 15	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305803	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SNX15 mRNA	PMID:33387578
1314058	SNX15	sorting nexin 15	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SNX15 gene	PMID:25304211
1314058	SNX15	sorting nexin 15	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX15 mRNA	PMID:39836092
1314058	SNX15	sorting nexin 15	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX15 mRNA	PMID:40504410
1314058	SNX15	sorting nexin 15	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305803	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SNX15 mRNA	PMID:29391264
1314058	SNX15	sorting nexin 15	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNX15 mRNA	PMID:28628672
1314058	SNX15	sorting nexin 15	gene	CHEBI:50091	S-nitrosoglutathione	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione affects the expression of SNX15 mRNA	PMID:38825487
1314058	SNX15	sorting nexin 15	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1305803	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of SNX15 mRNA	PMID:34044035
1314058	SNX15	sorting nexin 15	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305803	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SNX15 mRNA	PMID:24136188
1314058	SNX15	sorting nexin 15	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SNX15 protein	PMID:32959892
1314058	SNX15	sorting nexin 15	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of SNX15 mRNA	PMID:39836092
1314058	SNX15	sorting nexin 15	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314059	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SNX15 mRNA	PMID:22206623
1314058	SNX15	sorting nexin 15	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314059	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX15 mRNA	PMID:22206623
1314058	SNX15	sorting nexin 15	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of SNX15 mRNA	PMID:24834073
1314058	SNX15	sorting nexin 15	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305803	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SNX15 mRNA	PMID:21346803
1314058	SNX15	sorting nexin 15	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305803	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SNX15 mRNA	PMID:21346803
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D015025	Zearalenone results in increased expression of DUSP2 mRNA	PMID:36828454
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DUSP2 mRNA	PMID:38218311
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314061	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DUSP2 mRNA	PMID:33045310
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of DUSP2 mRNA	PMID:37995155
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DUSP2 mRNA	PMID:20938992
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of DUSP2 mRNA	PMID:23724009
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1305804	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of DUSP2 mRNA	PMID:20488242
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DUSP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DUSP2 mRNA	PMID:32699268
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DUSP2 mRNA	PMID:20044591
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DUSP2 mRNA	PMID:35811015
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314061	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DUSP2 mRNA	PMID:25890327
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of DUSP2 mRNA]	PMID:35811015
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of DUSP2 mRNA	PMID:23019147|PMID:36828454
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of DUSP2 mRNA	PMID:38568856
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305804	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DUSP2 mRNA	PMID:33387578
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DUSP2 mRNA	PMID:20938992
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DUSP2 mRNA	PMID:37042841
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in decreased expression of DUSP2 mRNA	PMID:15120971|PMID:15122651
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of DUSP2 mRNA	PMID:17938736|PMID:28937961
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1314061	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of DUSP2 mRNA	PMID:17178593|PMID:39922521
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DUSP2 mRNA	PMID:37992649
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of DUSP2 mRNA	PMID:33647349
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:17627	ferroheme b	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20120814	CTD	MESH:D006418	Heme metabolite results in decreased expression of DUSP2 mRNA	PMID:19191707
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1314061	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of DUSP2 mRNA	PMID:17178593|PMID:39922521
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DUSP2 mRNA	PMID:37992649
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DUSP2 mRNA	PMID:28085963|PMID:34319233
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305804	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DUSP2 mRNA	PMID:33387578
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:17883	hydrogen chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006851	Hydrochloric Acid results in decreased expression of DUSP2 mRNA	PMID:15046208
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014284	Triiodothyronine results in decreased expression of DUSP2 mRNA	PMID:14761676
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014284	[Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DUSP2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in decreased expression of DUSP2 mRNA]	PMID:14761676
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in increased expression of DUSP2 mRNA	PMID:29993192
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DUSP2 mRNA	PMID:19549813
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DUSP2 mRNA	PMID:22100608|PMID:32234424
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305804	E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DUSP2 mRNA	PMID:25378103
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DUSP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DUSP2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of DUSP2 mRNA	PMID:32699268
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of DUSP2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of DUSP2 mRNA	PMID:34911549
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:26355	heme b	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20140805	CTD	MESH:D006418	Heme metabolite results in decreased expression of DUSP2 mRNA	PMID:19191707
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DUSP2 mRNA	PMID:18593933
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of DUSP2 mRNA	PMID:20938992
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	multiple interactions	EXP		E	RGD:6480464	20180410	CTD	MESH:D000966	Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP2 mRNA]	PMID:28713220
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of DUSP2 mRNA	PMID:31295307
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of DUSP2 mRNA	PMID:31295307
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314061	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of DUSP2 mRNA	PMID:28960355
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305804	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DUSP2 mRNA	PMID:31881176
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of DUSP2 mRNA	PMID:23019147
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305804	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DUSP2 mRNA	PMID:34747641
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305804	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DUSP2 mRNA	PMID:32109520
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in decreased expression of DUSP2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in decreased expression of DUSP2 mRNA]	PMID:14761676
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314061	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of DUSP2 mRNA	PMID:32937126
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DUSP2 mRNA	PMID:33212167
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of DUSP2 mRNA	PMID:23649840
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305804	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of DUSP2 mRNA	PMID:28959563
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305804	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of DUSP2 mRNA	PMID:26033743
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of DUSP2 mRNA	PMID:24690739
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DUSP2 mRNA	PMID:37992649
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of DUSP2 mRNA	PMID:20044591
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:28876	melphalan	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in increased expression of DUSP2 mRNA	PMID:22363485
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of DUSP2 mRNA	PMID:35954277|PMID:39719251
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of DUSP2 mRNA	PMID:34032870|PMID:38568856
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite inhibits the reaction [BMP6 protein results in increased expression of DUSP2 mRNA]	PMID:23566955|PMID:28713220
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DUSP2 mRNA	PMID:34876320
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DUSP2 mRNA	PMID:34876320
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DUSP2 promoter	PMID:27901495
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DUSP2 mRNA	PMID:20064835
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DUSP2 mRNA	PMID:21569818
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DUSP2 3' UTR	PMID:27901495
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DUSP2 mRNA	PMID:32234424
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DUSP2 exon	PMID:27901495
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to DUSP2 promoter]	PMID:19654925
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305804	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of DUSP2 mRNA	PMID:26033743
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of DUSP2 mRNA	PMID:24690739
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DUSP2 mRNA	PMID:18593933
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of DUSP2 mRNA	PMID:27131904
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of DUSP2 mRNA	PMID:26014281
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of DUSP2 mRNA	PMID:25895662
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314061	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DUSP2 mRNA	PMID:19073995|PMID:29341224|PMID:33720480|PMID:38811393
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DUSP2 mRNA	PMID:20458559
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305804	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of DUSP2 mRNA	PMID:25729387
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305804	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of DUSP2 mRNA	PMID:30047161
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314061	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DUSP2 gene	PMID:35295148
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1305804	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of DUSP2 mRNA	PMID:30012374
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314061	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of DUSP2 mRNA	PMID:23557971
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305804	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of DUSP2 mRNA	PMID:34492290
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314061	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of DUSP2 mRNA	PMID:23811191
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305804	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DUSP2 mRNA	PMID:25181051
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314061	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of DUSP2 mRNA	PMID:32156529
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1314061	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of DUSP2 mRNA	PMID:25172293
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314061	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of DUSP2 mRNA	PMID:30951980
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314061	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of DUSP2 mRNA	PMID:30951980
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1305804	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of DUSP2 mRNA	PMID:21241498
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:34696	dieldrin	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D004026	Dieldrin results in increased expression of DUSP2 mRNA	PMID:31068361
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DUSP2 mRNA	PMID:37042841
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305804	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of DUSP2 mRNA	PMID:35163327
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DUSP2 mRNA	PMID:38174414|PMID:38568856
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305804	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DUSP2 mRNA	PMID:36928142
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:36009	omega-6 fatty acid	increases expression	EXP		E	RGD:6480464	20170117	CTD	MESH:D043371	Fatty Acids, Omega-6 results in increased expression of DUSP2 mRNA	PMID:16823509
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of DUSP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of DUSP2 mRNA	PMID:32699268
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:37415	alpha-amanitin	affects expression	ISO	RGD:1314061	E	RGD:6480464	20240903	CTD	MESH:D053959	Alpha-Amanitin affects the expression of DUSP2 mRNA	PMID:38531469
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of DUSP2 mRNA	PMID:31068361
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:38211	potassium bromate	affects expression	ISO	RGD:1314061	E	RGD:6480464	20160607	CTD	MESH:C019536	potassium bromate affects the expression of DUSP2 mRNA	PMID:27082013
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:38211	potassium bromate	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20160607	CTD	MESH:C019536	[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [potassium bromate affects the expression of DUSP2 mRNA]	PMID:27082013
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of DUSP2 mRNA	PMID:29038090
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:D014635	Valproic Acid results in increased methylation of DUSP2 gene	PMID:28853863|PMID:29154799|PMID:29201983
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305804	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of DUSP2 mRNA	PMID:30047161
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20120515	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of DUSP2 mRNA	PMID:21041162
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in increased expression of DUSP2 mRNA	PMID:19059307
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of DUSP2 mRNA	PMID:21041162
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1314061	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of DUSP2 mRNA	PMID:22733784
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1314061	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in increased expression of DUSP2 mRNA	PMID:17178593|PMID:39922521
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DUSP2 mRNA	PMID:37992649
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of DUSP2 mRNA	PMID:23649840
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of DUSP2 mRNA	PMID:17400583
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DUSP2 mRNA	PMID:38832940
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20120613	CTD	MESH:C012589	[[decitabine co-treated with trichostatin A] affects the methylation of DUSP2 promoter] which affects the expression of DUSP2 mRNA	PMID:18836996
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305804	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DUSP2 mRNA	PMID:33387578
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of DUSP2 mRNA	PMID:24690739
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of DUSP2 mRNA]	PMID:35811015
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of DUSP2 mRNA	PMID:17331233
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305804	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of DUSP2 mRNA	PMID:29391264
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DUSP2 mRNA	PMID:34876320
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:4911	etoposide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	DUSP2 protein affects the susceptibility to Etoposide	PMID:16217747
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP2 mRNA	PMID:27188386
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DUSP2 mRNA	PMID:20458559
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20191114	CTD	MESH:C014347	[[Decitabine co-treated with trichostatin A] affects the methylation of DUSP2 promoter] which affects the expression of DUSP2 mRNA	PMID:18836996
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1314061	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of DUSP2 mRNA	PMID:25554681
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314061	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DUSP2 mRNA	PMID:25554681
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305804	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of DUSP2 mRNA	PMID:30047161
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1314061	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of DUSP2 mRNA	PMID:26377693
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of DUSP2 mRNA	PMID:31629900
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314061	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of DUSP2 mRNA	PMID:38701926
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305804	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of DUSP2 mRNA	PMID:28801915
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305804	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of DUSP2 mRNA	PMID:25729387
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305804	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of DUSP2 mRNA	PMID:25729387
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of DUSP2 mRNA	PMID:19812364
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305804	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of DUSP2 mRNA	PMID:28801915
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314061	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DUSP2 mRNA	PMID:22206623
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of DUSP2 mRNA	PMID:22714537
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:757488	omega-3 fatty acids	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:D015525	Fatty Acids, Omega-3 results in increased expression of DUSP2 mRNA	PMID:16823509
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP2 mRNA	PMID:27188386
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:80630	irinotecan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in increased expression of DUSP2 mRNA; Irinotecan results in increased expression of DUSP2 mRNA	PMID:15956246
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314061	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DUSP2 mRNA	PMID:38648751
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of DUSP2 mRNA	PMID:30458266
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of DUSP2 mRNA	PMID:32234424
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1314061	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of DUSP2 mRNA	PMID:34876320
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305804	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of DUSP2 mRNA	PMID:25825206|PMID:30047161
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of DUSP2 mRNA	PMID:16497877
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of DUSP2 mRNA	PMID:19059307
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of DUSP2 mRNA	PMID:31734321
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP2 mRNA	PMID:27188386
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314061	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of DUSP2 mRNA	PMID:27131904
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of DUSP2 mRNA	PMID:26014281
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DUSP2 mRNA	PMID:38568856
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of DUSP2 mRNA	PMID:29301935
1314060	DUSP2	dual specificity phosphatase 2	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314061	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of DUSP2 mRNA	PMID:35537566
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of CARD6 mRNA	PMID:23830798|PMID:33167477
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CARD6 mRNA	PMID:39241906
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of CARD6 mRNA	PMID:22574217
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of CARD6 mRNA	PMID:20106945
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305805	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of CARD6 mRNA	PMID:32145629
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CARD6 mRNA	PMID:39298647
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D004958	Estradiol results in increased expression of CARD6 mRNA	PMID:23373633
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:16598	DDE	affects expression	ISO	RGD:1305805	E	RGD:6480464	20140909	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene affects the expression of CARD6 mRNA	PMID:24576310
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CARD6 mRNA	PMID:38568856
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:17183	sanguinarine	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C005705	[sanguinarine co-treated with arsenic trioxide] results in increased expression of CARD6 mRNA	PMID:24345465
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of CARD6 mRNA	PMID:21592394
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of CARD6 mRNA	PMID:21592394
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314063	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CARD6 mRNA	PMID:34319233
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CARD6 mRNA	PMID:21592394
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of CARD6 mRNA	PMID:21592394
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305805	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CARD6 mRNA	PMID:33387578
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CARD6 mRNA	PMID:28818685
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CARD6 mRNA	PMID:36331819
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CARD6 mRNA	PMID:37236586
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CARD6 mRNA	PMID:19549813
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CARD6 protein	PMID:20106945
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CARD6 mRNA	PMID:21641981
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314063	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CARD6 mRNA	PMID:19770486
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of CARD6 mRNA	PMID:26760959
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CARD6 mRNA	PMID:34911549
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CARD6 mRNA	PMID:40504410
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARD6 mRNA	PMID:27188386
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CARD6 mRNA	PMID:30912803
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of CARD6 mRNA	PMID:23195993
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305805	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CARD6 mRNA	PMID:33387578
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305805	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CARD6 mRNA	PMID:19520675|PMID:34747641
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CARD6 mRNA	PMID:28001369
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CARD6 mRNA	PMID:33212167
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of CARD6 mRNA	PMID:20971185
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CARD6 mRNA	PMID:29803840
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:28757	fructose	decreases expression	ISO	RGD:1305805	E	RGD:6480464	20250401	CTD	MESH:D005632	Fructose results in decreased expression of CARD6 protein	PMID:37186242
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1305805	E	RGD:6480464	20250401	CTD	MESH:D005632	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Fructose results in decreased expression of CARD6 protein]; nuciferine inhibits the reaction [Fructose results in decreased expression of CARD6 protein]	PMID:37186242
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CARD6 mRNA	PMID:38568856|PMID:39719251
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CARD6 mRNA	PMID:40504410
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CARD6 mRNA	PMID:20106945
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314063	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CARD6 mRNA	PMID:22610609
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of CARD6 mRNA	PMID:20971185
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of CARD6 mRNA	PMID:25075043
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CARD6 mRNA	PMID:25895662
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of CARD6 mRNA	PMID:24345465
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CARD6 mRNA	PMID:38479592
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305805	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of CARD6 mRNA	PMID:32145629
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305805	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CARD6 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CARD6 mRNA	PMID:28628672
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	ISO	RGD:1305805	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT analog results in decreased expression of CARD6 mRNA	PMID:22937105
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CARD6 mRNA	PMID:39298647
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CARD6 mRNA	PMID:28628672
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CARD6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CARD6 mRNA	PMID:28628672
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D010269	Paraquat results in decreased expression of CARD6 mRNA	PMID:18836921
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CARD6 mRNA	PMID:38174414|PMID:38382870
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CARD6 mRNA	PMID:37236586
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of CARD6 mRNA	PMID:32588087
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CARD6 mRNA	PMID:36331819
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of CARD6 mRNA	PMID:29038090
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CARD6 mRNA	PMID:29154799
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CARD6 gene	PMID:29154799
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CARD6 mRNA	PMID:20106945
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CARD6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CARD6 mRNA	PMID:28628672
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:44616	afimoxifene	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C016601	afimoxifene results in increased expression of CARD6 mRNA	PMID:23373633
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CARD6 mRNA	PMID:21420995|PMID:29067470
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305805	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CARD6 mRNA	PMID:33387578
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CARD6 mRNA	PMID:40504410
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of CARD6 mRNA	PMID:22077320
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CARD6 mRNA	PMID:35436446
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CARD6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CARD6 mRNA	PMID:28628672
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[sanguinarine co-treated with Arsenic Trioxide] results in increased expression of CARD6 mRNA	PMID:24345465
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:50035	alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of CARD6 mRNA	PMID:25075043
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CARD6 mRNA	PMID:25554681
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314063	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CARD6 mRNA	PMID:35964746
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1305805	E	RGD:6480464	20250401	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Fructose results in decreased expression of CARD6 protein]	PMID:37186242
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARD6 mRNA	PMID:27188386
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CARD6 mRNA	PMID:19159669
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:80770	Brevetoxin B	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C043466	brevetoxin 2 results in increased expression of CARD6 mRNA	PMID:20498034
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of CARD6 mRNA	PMID:19095052
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of CARD6 mRNA	PMID:24921660
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARD6 mRNA	PMID:27188386
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:93751	PF-3758309	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C550923	PF 3758309 results in decreased expression of CARD6 mRNA	PMID:29048629
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of CARD6 mRNA	PMID:29301935
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314063	E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of CARD6 mRNA	PMID:17569031|PMID:28973697
1314062	CARD6	caspase recruitment domain family member 6	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305805	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of CARD6 mRNA	PMID:23555832
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of COL14A1 mRNA	PMID:25152437
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305806	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of COL14A1 mRNA	PMID:21551480
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of COL14A1 mRNA	PMID:26272509
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA	PMID:27188386
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552297	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of COL14A1 mRNA	PMID:33045310
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:132448	perfluorohexanesulfonic acid	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230307	CTD	MESH:C471071	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of COL14A1 mRNA	PMID:36270329
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of COL14A1 mRNA	PMID:21934132
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1552297	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of COL14A1 mRNA	PMID:20880076
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305806	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of COL14A1 mRNA	PMID:33729688
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of COL14A1 mRNA	PMID:36331819
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305806	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of COL14A1 gene	PMID:28931070
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in decreased expression of COL14A1 mRNA	PMID:19167417
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D000431	Ethanol results in increased expression of COL14A1 mRNA	PMID:31059573
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of COL14A1 mRNA	PMID:30510588
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D014260	Triclosan results in increased expression of COL14A1 mRNA	PMID:34681664
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of COL14A1 mRNA	PMID:39298647
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305806	E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in increased expression of COL14A1 mRNA	PMID:32145629|PMID:35192832
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552297	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of COL14A1 mRNA	PMID:19484750
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in decreased expression of COL14A1 mRNA	PMID:20226447
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of COL14A1 mRNA	PMID:20226447
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL14A1 mRNA	PMID:37992649
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL14A1 mRNA	PMID:37992649
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305806	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of COL14A1 mRNA	PMID:27523638
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in increased expression of COL14A1 protein	PMID:34122009
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305806	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of COL14A1 mRNA	PMID:33387578
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COL14A1 mRNA	PMID:36331819
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:2038	5-azacytidine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001374	Azacitidine results in increased expression of COL14A1 mRNA	PMID:19194470
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COL14A1 mRNA	PMID:31738976
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL14A1 mRNA	PMID:29950665
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in increased expression of COL14A1 protein]	PMID:32272095
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305806	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of COL14A1 mRNA	PMID:21396975
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of COL14A1 mRNA	PMID:32234424
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305806	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of COL14A1 mRNA	PMID:23630614
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of COL14A1 mRNA	PMID:34911549
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of COL14A1 mRNA	PMID:17484886
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552297	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of COL14A1 mRNA	PMID:27339419|PMID:29987408
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of COL14A1 mRNA	PMID:21867686
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COL14A1 mRNA	PMID:40504410
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of COL14A1 mRNA	PMID:19244175
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1552297	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of COL14A1 protein	PMID:37208198
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of COL14A1 mRNA	PMID:28189721|PMID:28960355
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305806	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of COL14A1 mRNA	PMID:31881176
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of COL14A1 mRNA	PMID:40618947
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of COL14A1 promoter	PMID:22847954
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1552297	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of COL14A1 mRNA	PMID:32186404
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of COL14A1 mRNA	PMID:24768652|PMID:25583101
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305806	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COL14A1 mRNA	PMID:32109520
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552297	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COL14A1 mRNA	PMID:16962184|PMID:26377647
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COL14A1 mRNA	PMID:34747641
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COL14A1 mRNA	PMID:19770486|PMID:33956508
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1305806	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone affects the expression of COL14A1 mRNA	PMID:28374803
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of COL14A1 protein	PMID:39603559
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of COL14A1 mRNA	PMID:28001369
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of COL14A1 mRNA	PMID:33212167
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of COL14A1 mRNA	PMID:30556269
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of COL14A1 protein	PMID:28918527
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of COL14A1 mRNA	PMID:39631538
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL14A1 mRNA	PMID:37992649
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of COL14A1 protein	PMID:29459688
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20191008	CTD	MESH:C017947	sodium arsenite results in decreased expression of COL14A1 mRNA	PMID:31170414
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COL14A1 mRNA	PMID:40504410
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of COL14A1 5' UTR; Benzo(a)pyrene affects the methylation of COL14A1 exon	PMID:27901495|PMID:30157460
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of COL14A1 promoter	PMID:27901495
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of COL14A1 mRNA	PMID:30556269
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in increased expression of COL14A1 protein	PMID:34122009
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of COL14A1 mRNA	PMID:22431001
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of COL14A1 mRNA	PMID:29203145
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of COL14A1 mRNA	PMID:20458559
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1552297	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of COL14A1 mRNA	PMID:36087614
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305806	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of COL14A1 mRNA	PMID:25729387
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of COL14A1 mRNA	PMID:24136188
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of COL14A1 mRNA	PMID:23557971|PMID:27760801
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552297	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of COL14A1 mRNA	PMID:35295148
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL14A1 mRNA	PMID:29950665
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of COL14A1 mRNA	PMID:25181051|PMID:34947998
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of COL14A1 mRNA	PMID:27685785
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305806	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of COL14A1 mRNA	PMID:32145629|PMID:36779543
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552297	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of COL14A1 mRNA	PMID:30951980|PMID:32156529|PMID:38701888
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of COL14A1 mRNA	PMID:39298647
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552297	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of COL14A1 mRNA	PMID:30951980|PMID:40203079
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:34440	4-nonylphenol	multiple interactions	EXP		E	RGD:6480464	20140311	CTD	MESH:C041594	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of COL14A1 mRNA	PMID:23626723
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C105260	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of COL14A1 mRNA	PMID:23626723
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1552297	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of COL14A1 mRNA	PMID:26377693
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:34569	Benzo[k]fluoranthene	affects expression	ISO	RGD:1552297	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene affects the expression of COL14A1 mRNA	PMID:26377693
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552297	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of COL14A1 mRNA	PMID:30951980|PMID:38685157
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1552297	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of COL14A1 intron	PMID:28392331
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1552297	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in increased expression of COL14A1 protein	PMID:32272095
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL14A1 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of COL14A1 protein]	PMID:29950665|PMID:32272095
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D010269	Paraquat results in decreased expression of COL14A1 mRNA	PMID:34681664
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of COL14A1 mRNA	PMID:36117858
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of COL14A1 mRNA	PMID:30589522
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305806	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of COL14A1 mRNA	PMID:35163327
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C019566	[4-tert-octylphenol co-treated with 4-nonylphenol] results in increased expression of COL14A1 mRNA	PMID:23626723
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COL14A1 mRNA	PMID:31738976
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305806	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of COL14A1 mRNA	PMID:35163327
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230307	CTD	MESH:C023036	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of COL14A1 mRNA	PMID:36270329
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305806	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of COL14A1 mRNA	PMID:27387713
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of COL14A1 mRNA	PMID:19244175
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:38397	perfluorononanoic acid	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230307	CTD	MESH:C101816	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of COL14A1 mRNA	PMID:36270329
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of COL14A1 promoter	PMID:22847954
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of COL14A1 mRNA	PMID:31533062
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of COL14A1 promoter	PMID:22847954
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1552297	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of COL14A1 mRNA	PMID:39529242
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230307	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COL14A1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of COL14A1 mRNA; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] results in decreased expression of COL14A1 mRNA	PMID:36270329|PMID:36331819
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COL14A1 mRNA	PMID:25979313
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552297	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of COL14A1 mRNA	PMID:17963808
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of COL14A1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA	PMID:27188386
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D016572	Cyclosporine results in decreased expression of COL14A1 mRNA	PMID:34681664
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of COL14A1 mRNA	PMID:25047013
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of COL14A1 mRNA	PMID:28973697
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of COL14A1 mRNA	PMID:37992649
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of COL14A1 mRNA	PMID:24136188
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of COL14A1 mRNA	PMID:38832940
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of COL14A1 mRNA	PMID:24935251
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COL14A1 mRNA	PMID:33387578
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COL14A1 mRNA	PMID:40504410
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of COL14A1 mRNA	PMID:29391264
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of COL14A1 mRNA	PMID:37567419
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of COL14A1 mRNA	PMID:20458559
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of COL14A1 mRNA	PMID:19194470
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of COL14A1 mRNA; Nanotubes, Carbon results in decreased expression of COL14A1 mRNA	PMID:25554681|PMID:25620056
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of COL14A1 mRNA	PMID:24136188
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of COL14A1 mRNA	PMID:36117858
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:52774	pentane-2,3-dione	increases expression	ISO	RGD:1305806	E	RGD:6480464	20150512	CTD	MESH:C013186	2,3-pentanedione results in increased expression of COL14A1 mRNA	PMID:25710175
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of COL14A1 protein	PMID:23718831
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of COL14A1 mRNA	PMID:20436886
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1552297	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of COL14A1 mRNA	PMID:21641980
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305806	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of COL14A1 mRNA	PMID:25729387
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305806	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of COL14A1 mRNA	PMID:25729387
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of COL14A1 mRNA	PMID:19812364
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of COL14A1 mRNA	PMID:36851058
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305806	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of COL14A1 gene	PMID:35440735
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of COL14A1 mRNA	PMID:24136188
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of COL14A1 mRNA	PMID:29522793
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA	PMID:27188386
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to COL14A1 gene]	PMID:28238834
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1305806	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of COL14A1 mRNA	PMID:32109520
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1552297	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of COL14A1 mRNA	PMID:38648751
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of COL14A1 mRNA	PMID:26705709
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552297	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of COL14A1 mRNA	PMID:39847705
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305806	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of COL14A1 mRNA	PMID:24780913
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of COL14A1 mRNA	PMID:26272509
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA	PMID:27188386
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:8887	rofecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C116926	rofecoxib results in decreased expression of COL14A1 mRNA	PMID:17070997
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL14A1 mRNA	PMID:27188386
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of COL14A1 mRNA	PMID:17440010
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of COL14A1 mRNA	PMID:28973697
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552297	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of COL14A1 mRNA	PMID:35537566
1314064	COL14A1	collagen type XIV alpha 1 chain	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305806	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of COL14A1 mRNA	PMID:23034163
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305809	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of NKAIN4 mRNA	PMID:21551480|PMID:25152437
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NKAIN4 gene	PMID:20938992
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NKAIN4 mRNA	PMID:24236059
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NKAIN4 mRNA	PMID:30529165
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of NKAIN4 mRNA	PMID:26079696
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314068	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of NKAIN4 mRNA	PMID:30319688
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314068	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NKAIN4 mRNA	PMID:39241906
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NKAIN4 gene	PMID:20938992
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1305809	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of NKAIN4 mRNA	PMID:22967744
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20250401	CTD	MESH:D004051	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of NKAIN4 mRNA	PMID:31606821
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of NKAIN4 intron	PMID:30157460
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NKAIN4 intron	PMID:30157460
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NKAIN4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of NKAIN4 mRNA	PMID:34911549
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NKAIN4 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of NKAIN4 mRNA]	PMID:20938992|PMID:22206623
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314068	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of NKAIN4 mRNA	PMID:32186404
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305809	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NKAIN4 mRNA	PMID:33387578
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NKAIN4 mRNA	PMID:28001369
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of NKAIN4 mRNA	PMID:32763439
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of NKAIN4 mRNA	PMID:29301061
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NKAIN4 3' UTR	PMID:27901495
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NKAIN4 exon; Benzo(a)pyrene results in increased methylation of NKAIN4 promoter	PMID:27901495
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to NKAIN4 promoter]	PMID:19654925
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314068	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of NKAIN4 mRNA	PMID:27131904
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1314068	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of NKAIN4 mRNA	PMID:23557971
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314068	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of NKAIN4 mRNA	PMID:27760801
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314068	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NKAIN4 gene	PMID:35295148
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305809	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NKAIN4 mRNA	PMID:25181051
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314068	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of NKAIN4 mRNA	PMID:26063408|PMID:35598803
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314068	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of NKAIN4 mRNA	PMID:32156529
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305809	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NKAIN4 gene	PMID:28505145
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314068	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S affects the expression of NKAIN4 mRNA	PMID:30951980
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of NKAIN4 intron	PMID:30157460
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314068	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of NKAIN4 mRNA	PMID:30951980
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314068	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of NKAIN4 intron	PMID:28392331
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305809	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NKAIN4 mRNA	PMID:21266533
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NKAIN4 mRNA	PMID:38382870
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314068	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NKAIN4 mRNA	PMID:24982889
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NKAIN4 mRNA	PMID:25979313
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314068	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NKAIN4 mRNA	PMID:17963808
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of NKAIN4 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA	PMID:27188386
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314068	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of NKAIN4 mRNA	PMID:28973697
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of NKAIN4 mRNA	PMID:24449571
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of NKAIN4 mRNA	PMID:26272509
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA	PMID:27188386
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of NKAIN4 mRNA	PMID:24935251|PMID:26272509
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA	PMID:27188386
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305809	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NKAIN4 mRNA	PMID:33387578
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:46742	Nutlin-3	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of NKAIN4 mRNA	PMID:38460933
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314068	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of NKAIN4 mRNA; Nanotubes, Carbon results in decreased expression of NKAIN4 mRNA	PMID:25554681
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314068	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of NKAIN4 mRNA	PMID:23608068
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of NKAIN4 intron	PMID:30157460
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305809	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of NKAIN4 gene	PMID:35440735
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314068	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NKAIN4 mRNA	PMID:22206623
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of NKAIN4 mRNA]	PMID:22206623
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA	PMID:27188386
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314068	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of NKAIN4 mRNA	PMID:38648751
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NKAIN4 mRNA	PMID:27188386
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314068	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of NKAIN4 mRNA	PMID:27131904
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1314068	E	RGD:6480464	20250401	CTD	MESH:D013311	Streptozocin results in increased expression of NKAIN4 mRNA	PMID:31606821
1314067	NKAIN4	sodium/potassium transporting ATPase interacting 4	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1314068	E	RGD:6480464	20250401	CTD	MESH:D013311	[Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of NKAIN4 mRNA	PMID:31606821
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of TSPAN4 mRNA	PMID:35967413
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20150630	CTD	MESH:D004237	Diuron results in decreased expression of TSPAN4 mRNA	PMID:21551480|PMID:25152437
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TSPAN4 mRNA	PMID:27188386
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1552299	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TSPAN4 mRNA	PMID:37995155
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN4 protein]	PMID:38195004
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of TSPAN4 mRNA]	PMID:19467301
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552299	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TSPAN4 mRNA	PMID:20188158|PMID:26251327
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of TSPAN4 mRNA	PMID:23830798
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of TSPAN4 mRNA	PMID:21934132|PMID:23724009
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TSPAN4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TSPAN4 mRNA	PMID:32699268
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TSPAN4 mRNA	PMID:30529165
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TSPAN4 mRNA	PMID:36331819
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TSPAN4 mRNA	PMID:21632981
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TSPAN4 mRNA	PMID:39298647
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305810	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TSPAN4 mRNA	PMID:27523638
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TSPAN4 3' UTR	PMID:30157460
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TSPAN4 mRNA	PMID:39836092
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of TSPAN4 mRNA	PMID:28522335
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN4 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN4 protein	PMID:38195004
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TSPAN4 mRNA	PMID:37236586
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TSPAN4 mRNA	PMID:33354967
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1552299	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in increased expression of TSPAN4 mRNA	PMID:17095637
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TSPAN4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TSPAN4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TSPAN4 mRNA	PMID:32699268
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TSPAN4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TSPAN4 mRNA	PMID:34911549
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305810	E	RGD:6480464	20150630	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TSPAN4 mRNA	PMID:16239168
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552299	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TSPAN4 mRNA	PMID:31919559
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TSPAN4 mRNA	PMID:39836092|PMID:40512198
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of TSPAN4 gene] which results in increased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of TSPAN4 gene	PMID:40504410
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of TSPAN4 mRNA	PMID:26272509
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TSPAN4 mRNA	PMID:27188386
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of TSPAN4 mRNA	PMID:18930951
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552299	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TSPAN4 mRNA	PMID:21570461
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20150630	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TSPAN4 mRNA	PMID:21215274|PMID:32109520
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TSPAN4 mRNA	PMID:17942748
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TSPAN4 mRNA	PMID:28374803
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TSPAN4 mRNA	PMID:33212167
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of TSPAN4 mRNA	PMID:21198554
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TSPAN4 mRNA	PMID:29803840
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TSPAN4 mRNA	PMID:38568856
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of TSPAN4 mRNA	PMID:39719251
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TSPAN4 mRNA	PMID:39836092|PMID:40512198
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of TSPAN4 gene] which results in increased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of TSPAN4 gene	PMID:40504410
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TSPAN4 5' UTR	PMID:27901495
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552299	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TSPAN4 mRNA	PMID:22610609
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TSPAN4 promoter	PMID:27901495
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSPAN4 mRNA	PMID:27858113
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1305810	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of TSPAN4 mRNA	PMID:38458666
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TSPAN4 mRNA	PMID:20458559
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TSPAN4 gene	PMID:31601247
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305810	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of TSPAN4 mRNA	PMID:24136188
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305810	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of TSPAN4 mRNA	PMID:25729387
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TSPAN4 mRNA	PMID:30047161
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552299	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TSPAN4 gene	PMID:35295148
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552299	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of TSPAN4 mRNA	PMID:27760801
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TSPAN4 mRNA	PMID:34492290
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of TSPAN4 mRNA	PMID:23811191
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552299	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TSPAN4 mRNA	PMID:18445702
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TSPAN4 mRNA	PMID:19710929
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305810	E	RGD:6480464	20150630	CTD	MESH:C069837	fullerene C60 results in increased expression of TSPAN4 mRNA	PMID:19167457
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TSPAN4 mRNA	PMID:34947998
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of TSPAN4 mRNA	PMID:29161229
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TSPAN4 gene	PMID:31601247
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1552299	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of TSPAN4 promoter	PMID:27312807
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305810	E	RGD:6480464	20150630	CTD	MESH:C006780	bisphenol A results in increased expression of TSPAN4 mRNA	PMID:25181051
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552299	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TSPAN4 mRNA	PMID:32156529|PMID:33221593
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TSPAN4 gene	PMID:31601247
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:3423	carmustine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of TSPAN4 mRNA	PMID:15980968
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TSPAN4 mRNA	PMID:39298647
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552299	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TSPAN4 mRNA	PMID:30951980
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1552299	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of TSPAN4 mRNA	PMID:26377693
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSPAN4 mRNA	PMID:27858113
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TSPAN4 3' UTR	PMID:30157460
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1552299	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of TSPAN4 mRNA	PMID:26377693
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552299	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TSPAN4 mRNA	PMID:30951980
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552299	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TSPAN4 mRNA	PMID:21266533
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TSPAN4 mRNA	PMID:37042841
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1305810	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of TSPAN4 mRNA	PMID:38458666
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305810	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TSPAN4 mRNA	PMID:35163327
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TSPAN4 mRNA	PMID:39836092
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1552299	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of TSPAN4 mRNA	PMID:26377693
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN4 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of TSPAN4 protein	PMID:38195004
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TSPAN4 mRNA	PMID:37236586
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305810	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TSPAN4 mRNA	PMID:35163327
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TSPAN4 mRNA	PMID:19376846
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TSPAN4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TSPAN4 mRNA	PMID:32699268
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of TSPAN4 mRNA	PMID:17585979
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TSPAN4 mRNA	PMID:36331819
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TSPAN4 mRNA	PMID:25979313
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TSPAN4 mRNA	PMID:19101580|PMID:23179753|PMID:27188386|PMID:28001369
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TSPAN4 gene	PMID:29154799
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TSPAN4 mRNA	PMID:30047161
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305810	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of TSPAN4 mRNA	PMID:41580965
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TSPAN4 mRNA	PMID:25562108
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1552299	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of TSPAN4 mRNA	PMID:18502557
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	TSPAN4 protein affects the susceptibility to Methotrexate	PMID:16217747
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552299	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TSPAN4 mRNA	PMID:17562736
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TSPAN4 mRNA	PMID:21420995
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TSPAN4 mRNA	PMID:33387578
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1305810	E	RGD:6480464	20150630	CTD	MESH:C005219	methyl cellosolve results in increased expression of TSPAN4 mRNA	PMID:21061450
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TSPAN4 mRNA	PMID:39836092|PMID:40512198
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of TSPAN4 gene] which results in increased expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the expression of TSPAN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of TSPAN4 gene	PMID:40504410
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1552299	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of TSPAN4 mRNA	PMID:26934552
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TSPAN4 mRNA	PMID:35436446
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TSPAN4 mRNA	PMID:17942748
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TSPAN4 mRNA	PMID:20458559
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TSPAN4 mRNA	PMID:25554681
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552299	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TSPAN4 mRNA; Nanotubes, Carbon results in increased expression of TSPAN4 mRNA	PMID:25554681|PMID:25620056
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20150630	CTD	MESH:C082360	fipronil results in decreased expression of TSPAN4 mRNA	PMID:23962444
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TSPAN4 mRNA	PMID:30047161
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1552299	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of TSPAN4 mRNA	PMID:26377693
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSPAN4 mRNA	PMID:27858113
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1552299	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of TSPAN4 mRNA	PMID:27858113
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552299	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TSPAN4 mRNA	PMID:38701926
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TSPAN4 mRNA	PMID:39836092
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305810	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of TSPAN4 mRNA	PMID:25729387
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305810	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of TSPAN4 mRNA	PMID:25729387
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1552299	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of TSPAN4 mRNA	PMID:23650126
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1552299	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in decreased expression of TSPAN4 mRNA	PMID:36914120
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TSPAN4 3' UTR	PMID:30157460
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1552299	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of TSPAN4 mRNA	PMID:27858113
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TSPAN4 mRNA	PMID:27188386
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:80630	irinotecan	increases expression	ISO	RGD:1305810	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan results in increased expression of TSPAN4 mRNA	PMID:20097248
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:8064	phenformin	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of TSPAN4 mRNA	PMID:31324951
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of TSPAN4 mRNA	PMID:19159669
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552299	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TSPAN4 mRNA	PMID:39847705
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TSPAN4 mRNA	PMID:30047161
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TSPAN4 mRNA	PMID:27188386
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TSPAN4 mRNA	PMID:38568856
1314069	TSPAN4	tetraspanin 4	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305810	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of TSPAN4 mRNA	PMID:23034163
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PCDHB7 mRNA	PMID:26272509
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA	PMID:27188386
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314072	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB7 mRNA	PMID:20938992
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:11368541	E	RGD:6480464	20230131	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PCDHB7 mRNA	PMID:33387578
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314072	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB7 mRNA	PMID:20938992
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:11368541	E	RGD:6480464	20230131	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of PCDHB7 mRNA	PMID:26496021
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDHB7 gene	PMID:27153756
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314072	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PCDHB7 mRNA	PMID:25629700
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314072	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PCDHB7 mRNA	PMID:20938992
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314072	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PCDHB7 mRNA	PMID:28960355
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDHB7 mRNA	PMID:20106945
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDHB7 mRNA	PMID:27188386
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDHB7 exon; Benzo(a)pyrene affects the methylation of PCDHB7 promoter	PMID:27901495
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of PCDHB7 promoter	PMID:23974009
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of PCDHB7 mRNA	PMID:37690743
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PCDHB7 gene	PMID:31601247
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:11368541	E	RGD:6480464	20230131	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDHB7 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of PCDHB7 gene	PMID:31601247
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of PCDHB7 gene	PMID:31601247
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:11368541	E	RGD:6480464	20230131	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of PCDHB7 mRNA	PMID:26496021
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:11368541	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PCDHB7 mRNA	PMID:35163327
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1314072	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of PCDHB7 mRNA	PMID:26377693
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:11368541	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PCDHB7 mRNA	PMID:35163327
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PCDHB7 mRNA	PMID:31533062
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PCDHB7 mRNA	PMID:25979313
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCDHB7 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PCDHB7 gene	PMID:29154799
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA	PMID:27188386
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PCDHB7 mRNA	PMID:20106945
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PCDHB7 mRNA	PMID:26272509
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA	PMID:27188386
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1314072	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of PCDHB7 mRNA	PMID:30529165
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:11368541	E	RGD:6480464	20230131	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of PCDHB7 mRNA	PMID:27840820
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of PCDHB7 mRNA	PMID:29522793
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDHB7 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA	PMID:27188386
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:82527	Ptaquiloside	decreases expression	ISO	RGD:1314072	E	RGD:6480464	20141111	CTD	MESH:C043680	ptaquiloside results in decreased expression of PCDHB7 mRNA	PMID:23274088
1314071	PCDHB7	protocadherin beta 7	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDHB7 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDHB7 mRNA	PMID:27188386
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1305813	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FBXL7 mRNA	PMID:30071829
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of FBXL7 mRNA	PMID:20880076
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FBXL7 mRNA	PMID:36331819
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of FBXL7 mRNA	PMID:31614463
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of FBXL7 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of FBXL7 mRNA	PMID:20660070|PMID:30165855
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of FBXL7 mRNA	PMID:25549359
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305813	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FBXL7 mRNA	PMID:33387578
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of FBXL7 mRNA	PMID:20660070
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA	PMID:37992649
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA	PMID:37992649
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA	PMID:39150890
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FBXL7 protein	PMID:37730182
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of FBXL7 intron	PMID:30157460
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBXL7 mRNA	PMID:35301059
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FBXL7 intron	PMID:30157460
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FBXL7 mRNA	PMID:34911549
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305813	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FBXL7 mRNA	PMID:31150632
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1620364	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FBXL7 mRNA	PMID:17484886
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FBXL7 gene	PMID:25304211
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXL7 mRNA	PMID:39836092
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA]	PMID:37992649
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1620364	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of FBXL7 mRNA	PMID:28960355
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of FBXL7 mRNA	PMID:23557933
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBXL7 mRNA	PMID:19933214
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305813	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBXL7 mRNA	PMID:33387578
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FBXL7 mRNA	PMID:33212167
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305813	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of FBXL7 mRNA	PMID:26033743
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1305813	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA	PMID:26033743
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA	PMID:37992649
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA]	PMID:37992649
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FBXL7 mRNA	PMID:38568856
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXL7 mRNA	PMID:39836092
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBXL7 intron	PMID:30157460
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FBXL7 mRNA	PMID:21569818
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FBXL7 3' UTR	PMID:27901495
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FBXL7 5' UTR; Benzo(a)pyrene results in increased methylation of FBXL7 promoter	PMID:27901495
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305813	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of FBXL7 mRNA	PMID:26033743
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1305813	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA	PMID:26033743
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of FBXL7 mRNA	PMID:27131904
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FBXL7 mRNA	PMID:20382639
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of FBXL7 mRNA	PMID:15725085
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXL7 gene	PMID:31601247
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620364	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXL7 gene	PMID:35295148
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:33007	chromium(6+)	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of FBXL7 mRNA	PMID:27793765
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305813	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXL7 mRNA	PMID:34947998
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FBXL7 gene	PMID:31601247
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXL7 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL7 mRNA	PMID:28628672|PMID:31601247
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of FBXL7 mRNA	PMID:19244175
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of FBXL7 intron	PMID:30157460
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA	PMID:39150890
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA	PMID:39150890
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA	PMID:39150890
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL7 mRNA	PMID:28628672
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305813	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of FBXL7 mRNA	PMID:30723492
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FBXL7 mRNA	PMID:38382870
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBXL7 mRNA	PMID:35301059
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA	PMID:39150890
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FBXL7 mRNA	PMID:24449571
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FBXL7 mRNA	PMID:36331819
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of FBXL7 mRNA	PMID:29038090
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXL7 mRNA	PMID:23179753
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1620364	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXL7 mRNA	PMID:24896083
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FBXL7 gene	PMID:29154799
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of FBXL7 mRNA	PMID:27989131
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of FBXL7 promoter	PMID:27989131
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL7 mRNA	PMID:28628672
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1620364	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FBXL7 mRNA	PMID:28973697
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of FBXL7 mRNA	PMID:37992649
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of FBXL7 mRNA	PMID:38832940
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXL7 mRNA	PMID:29067470
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305813	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXL7 mRNA	PMID:33387578
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1305813	E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of FBXL7 mRNA	PMID:21061450
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FBXL7 gene	PMID:25304211
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXL7 mRNA	PMID:39836092
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FBXL7 mRNA	PMID:22079256
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:1305813	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of FBXL7 gene	PMID:37958445
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXL7 mRNA	PMID:28628672
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of FBXL7 mRNA	PMID:15725085
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FBXL7 mRNA	PMID:25554681
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of FBXL7 mRNA	PMID:19042947
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of FBXL7 mRNA	PMID:20436886
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of FBXL7 intron	PMID:30157460
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305813	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FBXL7 gene	PMID:35440735
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of FBXL7 mRNA	PMID:31758290
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1620364	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FBXL7 mRNA	PMID:22206623
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of FBXL7 mRNA	PMID:22079256
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FBXL7 mRNA	PMID:22079256
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1620364	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of FBXL7 mRNA	PMID:39150890
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FBXL7 gene]	PMID:28238834
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305813	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of FBXL7 mRNA	PMID:23640034
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1620364	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of FBXL7 mRNA	PMID:21795629
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of FBXL7 mRNA	PMID:27131904
1314074	FBXL7	F-box and leucine rich repeat protein 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1620364	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of FBXL7 mRNA	PMID:28973697
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of TFDP2 mRNA	PMID:26272509|PMID:27188386
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA	PMID:27188386
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1552301	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of TFDP2 mRNA	PMID:33045310
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:135741	testosterone undecanoate	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C010792	testosterone undecanoate results in decreased expression of TFDP2 mRNA	PMID:19074003
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TFDP2 mRNA	PMID:20938992
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of TFDP2 mRNA	PMID:15498508|PMID:16129123|PMID:33167477
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of TFDP2 mRNA	PMID:32845096
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1552301	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of TFDP2 mRNA	PMID:22629407
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of TFDP2 mRNA]	PMID:22629407
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TFDP2 mRNA	PMID:21632981
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TFDP2 mRNA	PMID:39241906
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552301	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TFDP2 mRNA	PMID:39298647
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305814	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TFDP2 gene	PMID:27618143
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TFDP2 mRNA	PMID:20938992
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TFDP2 mRNA	PMID:37042841
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TFDP2 mRNA	PMID:23649840
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:17660	N(6)-dimethylallyladenine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C001478	N(6)-(delta(2)-isopentenyl)adenine results in decreased expression of TFDP2 mRNA	PMID:16129123
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TFDP2 protein	PMID:37730182
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of TFDP2 mRNA	PMID:16129123
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TFDP2 mRNA	PMID:33387578
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TFDP2 mRNA	PMID:28818685
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TFDP2 intron	PMID:30157460
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TFDP2 mRNA	PMID:36331819
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TFDP2 mRNA	PMID:28111341|PMID:37236586
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TFDP2 mRNA	PMID:23649840
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TFDP2 mRNA	PMID:33354967
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TFDP2 intron	PMID:30157460
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of TFDP2 mRNA	PMID:26760959
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of TFDP2 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of TFDP2 mRNA	PMID:32845096|PMID:35430440
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:2682	amphotericin B	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of TFDP2 mRNA; Amphotericin B results in decreased expression of TFDP2 mRNA	PMID:28534445
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1552301	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of TFDP2 mRNA	PMID:17484886
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TFDP2 mRNA	PMID:31150632
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TFDP2 mRNA	PMID:25629700
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TFDP2 mRNA	PMID:20938992
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27563	arsenic atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased expression of TFDP2 mRNA	PMID:11134558
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TFDP2 mRNA	PMID:40504410
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of TFDP2 mRNA	PMID:26272509
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA	PMID:27188386
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TFDP2 mRNA	PMID:28960355
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TFDP2 mRNA	PMID:31881176
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TFDP2 mRNA	PMID:28903495
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of TFDP2 mRNA	PMID:27594783
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of TFDP2 mRNA	PMID:22023808
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1305814	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of TFDP2 mRNA	PMID:17898221
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TFDP2 mRNA	PMID:24768652|PMID:25583101
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552301	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TFDP2 mRNA	PMID:21570461|PMID:24058054
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TFDP2 mRNA	PMID:12377990
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TFDP2 mRNA	PMID:28001369
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of TFDP2 mRNA	PMID:26272509
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA	PMID:27188386
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552301	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of TFDP2 mRNA	PMID:25896364|PMID:39631538
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:29014	cordycepin	increases expression	ISO	RGD:1552301	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in increased expression of TFDP2 mRNA	PMID:32042022
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TFDP2 mRNA	PMID:40504410
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TFDP2 intron	PMID:30157460
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TFDP2 mRNA	PMID:20106945|PMID:21632981
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TFDP2 mRNA	PMID:21715664
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305814	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TFDP2 mRNA	PMID:25729387
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:32130	silver(1+) nitrate	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D012835	Silver Nitrate analog results in increased expression of TFDP2 mRNA	PMID:22831968
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TFDP2 mRNA	PMID:30047161
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of TFDP2 mRNA	PMID:15498508
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552301	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TFDP2 promoter	PMID:35295148
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TFDP2 mRNA	PMID:34492290
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of TFDP2 mRNA	PMID:12419474
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305814	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TFDP2 mRNA	PMID:25181051
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1552301	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TFDP2 promoter	PMID:27334623
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TFDP2 mRNA	PMID:30816183
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TFDP2 mRNA	PMID:26063408
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305814	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of TFDP2 mRNA	PMID:32145629
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552301	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of TFDP2 mRNA	PMID:35598803
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of TFDP2 mRNA	PMID:25172293
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TFDP2 mRNA	PMID:39298647
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of TFDP2 intron	PMID:30157460
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552301	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TFDP2 mRNA	PMID:32715474|PMID:37019170
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305814	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of TFDP2 mRNA	PMID:22546817
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552301	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TFDP2 mRNA	PMID:17361019|PMID:21266533
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305814	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of TFDP2 mRNA	PMID:22546817
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TFDP2 mRNA	PMID:37042841
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20191008	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TFDP2 mRNA	PMID:31077537
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TFDP2 mRNA	PMID:12160620|PMID:26472689
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305814	E	RGD:6480464	20191008	CTD	MESH:D019256	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of TFDP2 mRNA	PMID:31077537
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TFDP2 mRNA	PMID:28111341|PMID:37236586
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TFDP2 mRNA	PMID:22941251
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of TFDP2 mRNA	PMID:19320972
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of TFDP2 mRNA	PMID:40434365
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of TFDP2 mRNA	PMID:39529242
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TFDP2 mRNA	PMID:36331819
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TFDP2 mRNA	PMID:25979313
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TFDP2 mRNA	PMID:23179753|PMID:28001369
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TFDP2 mRNA	PMID:30047161
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:41774	tamoxifen	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of TFDP2 mRNA	PMID:15590111
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of TFDP2 mRNA	PMID:36621641
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of TFDP2 mRNA	PMID:21658437
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TFDP2 mRNA	PMID:38832940
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:4488	diallyl disulfide	multiple interactions	ISO	RGD:1305814	E	RGD:6480464	20191008	CTD	MESH:C028009	[Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of TFDP2 mRNA	PMID:31077537
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of TFDP2 mRNA	PMID:26272509
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA	PMID:27188386
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TFDP2 mRNA	PMID:29279043
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of TFDP2 mRNA	PMID:29279043
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:47217	arsane	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased expression of TFDP2 mRNA	PMID:11134558
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TFDP2 mRNA	PMID:40504410
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of TFDP2 mRNA	PMID:36621641
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TFDP2 mRNA	PMID:29391264
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TFDP2 mRNA	PMID:22079256
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of TFDP2 mRNA	PMID:18936297
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:49553	copper(II) chloride	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride affects the expression of TFDP2 mRNA	PMID:17211630
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1552301	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of TFDP2 mRNA; Nanotubes, Carbon analog affects the expression of TFDP2 mRNA	PMID:25554681
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552301	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TFDP2 mRNA	PMID:25620056
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TFDP2 mRNA	PMID:30047161
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:53444	potassium dichromate	affects expression	ISO	RGD:1552301	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate affects the expression of TFDP2 mRNA	PMID:23608068
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of TFDP2 mRNA	PMID:20436886
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TFDP2 mRNA	PMID:21641980
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of TFDP2 mRNA	PMID:25729387
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305814	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TFDP2 mRNA	PMID:25729387
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1552301	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of TFDP2 mRNA	PMID:19812364
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1552301	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of TFDP2 mRNA	PMID:20003209
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of TFDP2 intron	PMID:30157460
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TFDP2 mRNA	PMID:22079256
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TFDP2 mRNA	PMID:22079256
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of TFDP2 protein	PMID:31285264
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of TFDP2 mRNA	PMID:32858204
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:7719	ochratoxin A	decreases acetylation	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased acetylation of TFDP2 promoter	PMID:29098329
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased expression of TFDP2 mRNA	PMID:29098329
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	[ochratoxin A results in decreased acetylation of TFDP2 promoter] which results in decreased expression of TFDP2 mRNA	PMID:29098329
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA	PMID:27188386
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TFDP2 gene]	PMID:28238834
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of TFDP2 mRNA	PMID:19482888
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1552301	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of TFDP2 mRNA]	PMID:19482888
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552301	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of TFDP2 mRNA	PMID:39847705
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305814	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TFDP2 mRNA	PMID:30047161
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TFDP2 mRNA	PMID:27188386
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305814	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TFDP2 mRNA	PMID:19281266
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1305814	E	RGD:6480464	20141111	CTD	MESH:C001899	triptolide results in increased expression of TFDP2 mRNA	PMID:23639586
1314075	TFDP2	transcription factor Dp-2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552301	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TFDP2 mRNA	PMID:35537566
1314078	KERA	keratocan	gene	CHEBI:16602	trichloroethene	decreases methylation	ISO	RGD:1305816	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of KERA gene	PMID:27618143
1314078	KERA	keratocan	gene	CHEBI:18291	manganese atom	increases expression	ISO	RGD:1305816	E	RGD:6480464	20161115	CTD	MESH:D008345	Manganese results in increased expression of KERA mRNA	PMID:26745496
1314078	KERA	keratocan	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KERA gene	PMID:27153756
1314078	KERA	keratocan	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1314079	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in increased expression of KERA mRNA	PMID:16917069
1314078	KERA	keratocan	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314079	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KERA mRNA	PMID:21570461
1314078	KERA	keratocan	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305816	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of KERA mRNA	PMID:28959563
1314078	KERA	keratocan	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KERA promoter	PMID:27901495
1314078	KERA	keratocan	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KERA 3' UTR	PMID:27901495
1314078	KERA	keratocan	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305816	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KERA mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314078	KERA	keratocan	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305816	E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in increased expression of KERA mRNA	PMID:36779543
1314078	KERA	keratocan	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314079	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KERA mRNA	PMID:21266533
1314078	KERA	keratocan	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305816	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KERA mRNA	PMID:35163327
1314078	KERA	keratocan	gene	CHEBI:35154	manganese(0)	increases expression	ISO	RGD:1305816	E	RGD:6480464	20161115	CTD	MESH:D008345	Manganese results in increased expression of KERA mRNA	PMID:26745496
1314078	KERA	keratocan	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305816	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KERA mRNA	PMID:35163327
1314078	KERA	keratocan	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of KERA mRNA	PMID:24449571
1314078	KERA	keratocan	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KERA mRNA	PMID:25979313
1314078	KERA	keratocan	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of KERA mRNA	PMID:27188386
1314078	KERA	keratocan	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305816	E	RGD:6480464	20161115	CTD	MESH:C025340	manganese chloride results in increased expression of KERA mRNA	PMID:26745496
1314078	KERA	keratocan	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1305816	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of KERA mRNA	PMID:27840820
1314078	KERA	keratocan	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of KERA mRNA	PMID:37199045
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of EIPR1 mRNA	PMID:38218311
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EIPR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EIPR1 mRNA	PMID:32699268
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550318	E	RGD:6480464	20190702	CTD	MESH:D000431	Ethanol affects the splicing of EIPR1 mRNA	PMID:30319688
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550318	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EIPR1 mRNA	PMID:39241906
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of EIPR1 protein	PMID:37730182
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305817	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of EIPR1 mRNA	PMID:33387578
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of EIPR1 intron	PMID:30157460
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of EIPR1 protein	PMID:20106945
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of EIPR1 intron	PMID:30157460
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EIPR1 intron	PMID:30157460
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EIPR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EIPR1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of EIPR1 mRNA	PMID:32699268
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305817	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of EIPR1 mRNA	PMID:33387578
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305817	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EIPR1 mRNA	PMID:31150632
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EIPR1 gene	PMID:25304211
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EIPR1 mRNA	PMID:39836092
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550318	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIPR1 mRNA	PMID:40504410
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of EIPR1 protein	PMID:35688186
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of EIPR1 mRNA	PMID:19561079
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EIPR1 mRNA	PMID:21570461
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EIPR1 mRNA	PMID:39836092
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550318	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIPR1 mRNA	PMID:40504410
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EIPR1 intron	PMID:30157460
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EIPR1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EIPR1 mRNA	PMID:21715664
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EIPR1 mRNA	PMID:22228805
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to EIPR1 mRNA]	PMID:32406909
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of EIPR1 mRNA	PMID:26238291
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of EIPR1 mRNA	PMID:34408198
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305817	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of EIPR1 mRNA	PMID:24136188
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550318	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TSSC1 gene	PMID:35295148
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of EIPR1 mRNA	PMID:38479592
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of EIPR1 protein	PMID:31675489
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305817	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EIPR1 mRNA	PMID:25181051|PMID:30816183
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of EIPR1 gene	PMID:31601247
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305817	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of EIPR1 mRNA; bisphenol A results in increased expression of TSSC1 mRNA	PMID:32145629|PMID:34947998
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305817	E	RGD:6480464	20181016	CTD	MESH:C006780	bisphenol A results in increased methylation of EIPR1 gene	PMID:28505145
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of EIPR1 protein	PMID:31675489
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550318	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EIPR1 mRNA	PMID:39298647
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190702	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of EIPR1 intron	PMID:30157460
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EIPR1 mRNA	PMID:38568856
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EIPR1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EIPR1 mRNA	PMID:32699268
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D014635	Valproic Acid affects the expression of EIPR1 mRNA	PMID:17292431
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1305817	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of EIPR1 mRNA	PMID:21346803
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305817	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EIPR1 mRNA	PMID:33387578
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of EIPR1 mRNA]	PMID:15016801
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of EIPR1 gene	PMID:25304211
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EIPR1 mRNA	PMID:39836092
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550318	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIPR1 mRNA	PMID:40504410
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EIPR1 mRNA	PMID:22079256
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of EIPR1 mRNA	PMID:25620056
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of EIPR1 mRNA; Nanotubes, Carbon results in increased expression of EIPR1 mRNA	PMID:25554681
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550318	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EIPR1 mRNA	PMID:35964746
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EIPR1 protein	PMID:32959892
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1550318	E	RGD:6480464	20180116	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of EIPR1 mRNA	PMID:23650126
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D008701	Methapyrilene results in increased methylation of EIPR1 intron	PMID:30157460
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550318	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TSSC1 mRNA	PMID:22206623
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of EIPR1 mRNA	PMID:22079256
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EIPR1 mRNA	PMID:22079256
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305817	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of EIPR1 mRNA	PMID:21346803
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of EIPR1 mRNA	PMID:38568856
1314080	EIPR1	EARP complex and GARP complex interacting protein 1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1305817	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of EIPR1 protein	PMID:32519852
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552575	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PLPP7 mRNA	PMID:33045310
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLPP7 protein]	PMID:38195004
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PLPP7 mRNA	PMID:26079696
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1305821	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of PLPP7 mRNA	PMID:36841081
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552575	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PLPP7 mRNA	PMID:39241906
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of PLPP7 mRNA	PMID:30510588
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1552575	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of PLPP7 mRNA	PMID:33711761
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305821	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PLPP7 mRNA	PMID:33387578
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PLPP7 mRNA	PMID:21179406
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of PLPP7 mRNA	PMID:26079696
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLPP7 mRNA	PMID:37992649
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLPP7 mRNA	PMID:37992649
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PLPP7 mRNA	PMID:31163220
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP7 mRNA	PMID:39150890
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PLPP7 protein	PMID:37730182
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305821	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PLPP7 mRNA	PMID:33387578
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PLPP7 intron	PMID:30157460
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLPP7 mRNA	PMID:36331819
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in decreased expression of PLPP7 mRNA	PMID:29993192
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLPP7 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLPP7 protein	PMID:38195004
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PLPP7 protein	PMID:35688186
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305821	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PLPP7 mRNA	PMID:31881176
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552575	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PLPP7 mRNA	PMID:21570461
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PLPP7 mRNA	PMID:33212167
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1552575	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PLPP7 mRNA	PMID:39631538
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLPP7 mRNA	PMID:37992649
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PLPP7 promoter	PMID:27901495
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PLPP7 mRNA	PMID:25895662
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552575	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of PLPP7 mRNA	PMID:29264374
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305821	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PLPP7 mRNA	PMID:25181051
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552575	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PLPP7 gene	PMID:31683443
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP7 mRNA	PMID:39150890
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552575	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PLPP7 mRNA	PMID:37019170
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305821	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PLPP7 mRNA	PMID:21266533
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP7 mRNA	PMID:39150890
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP7 mRNA	PMID:39150890
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1305821	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of PLPP7 mRNA	PMID:35163327
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305821	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PLPP7 mRNA	PMID:35163327
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLPP7 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PLPP7 protein	PMID:38195004
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP7 mRNA	PMID:39150890
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305821	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PLPP7 mRNA	PMID:35163327
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PLPP7 mRNA	PMID:31533062
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLPP7 mRNA	PMID:36331819
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLPP7 mRNA	PMID:25979313
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLPP7 mRNA	PMID:26272509|PMID:28001369
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PLPP7 gene	PMID:29154799
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161115	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP7 mRNA	PMID:27188386
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLPP7 mRNA	PMID:37992649
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552575	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PLPP7 mRNA	PMID:17562736
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305821	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLPP7 mRNA	PMID:33387578
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of PLPP7 mRNA	PMID:40706910
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305821	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PLPP7 mRNA	PMID:29391264
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552575	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PLPP7 mRNA	PMID:35436446
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PLPP7 mRNA	PMID:24810058
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1552575	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PLPP7 mRNA	PMID:36907384
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP7 mRNA	PMID:27188386
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1552575	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLPP7 mRNA	PMID:39150890
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLPP7 mRNA	PMID:27188386
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305821	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PLPP7 mRNA	PMID:19281266
1314085	PLPP7	phospholipid phosphatase 7 (inactive)	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305821	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PLPP7 mRNA	PMID:23034163
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305825	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of TPTE2 gene	PMID:28931070
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305825	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TPTE2 mRNA	PMID:33387578
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1305825	E	RGD:6480464	20130910	CTD	MESH:D011374	Progesterone results in increased expression of TPTE2 mRNA	PMID:21770760
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TPTE2 mRNA	PMID:22100608
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305825	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TPTE2 mRNA	PMID:33354967
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1305825	E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of TPTE2 mRNA	PMID:35737395
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305825	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TPTE2 mRNA	PMID:32109520
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305825	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TPTE2 mRNA	PMID:28959563
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TPTE2 mRNA	PMID:25895662
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of TPTE2 gene	PMID:31601247
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305825	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TPTE2 gene	PMID:28505145
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:34911	permethrin	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in decreased expression of TPTE2 mRNA	PMID:37047231
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of TPTE2 mRNA	PMID:17183730
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of TPTE2 mRNA	PMID:24449571
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:50594	carbon nanotube	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TPTE2 mRNA	PMID:28673683
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of TPTE2 mRNA	PMID:22714537
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of TPTE2 mRNA	PMID:17183730
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:64153	tanespimycin	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:C112765	tanespimycin analog results in increased expression of TPTE2 protein	PMID:31370342
1314090	TPTE2	transmembrane phosphoinositide 3-phosphatase and tensin homolog 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1305825	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of TPTE2 mRNA	PMID:27840820
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DNAJB4 mRNA	PMID:38218311
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314093	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of DNAJB4 mRNA	PMID:33045310
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314093	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of DNAJB4 mRNA	PMID:37995155
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305826	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DNAJB4 mRNA]	PMID:31150632
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:142921	3-phenylprop-2-enal	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C012843	cinnamaldehyde results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:15368	acrolein	increases expression	ISO	RGD:1305826	E	RGD:6480464	20241001	CTD	MESH:D000171	Acrolein results in increased expression of DNAJB4 mRNA	PMID:38090360
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJB4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJB4 mRNA	PMID:32699268
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16016	dihydroxyacetone	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D004098	Dihydroxyacetone results in increased expression of DNAJB4 mRNA	PMID:32506039
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of DNAJB4 mRNA	PMID:21632981
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314093	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DNAJB4 mRNA	PMID:15919760
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DNAJB4 mRNA	PMID:20106945
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1305826	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DNAJB4 mRNA	PMID:23829299
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of DNAJB4 mRNA	PMID:38568856
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DNAJB4 mRNA	PMID:37042841
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D001554	Benzene results in increased expression of DNAJB4 mRNA	PMID:21843810
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of DNAJB4 mRNA	PMID:20655997|PMID:23649840
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:16980	geranial	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C007076	citral results in increased expression of DNAJB4 mRNA	PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:17177	cinnamyl alcohol	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C020722	cinnamyl alcohol results in increased expression of DNAJB4 mRNA	PMID:23999411
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:175304	Dodecyl gallate	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C008259	lauryl gallate results in increased expression of DNAJB4 mRNA	PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:17642	pentachlorophenol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010416	Pentachlorophenol results in increased expression of DNAJB4 mRNA	PMID:18486366
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DNAJB4 mRNA	PMID:21318169
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DNAJB4 protein	PMID:37730182
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305826	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DNAJB4 mRNA	PMID:33387578
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DNAJB4 mRNA	PMID:28818685
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:18224	isoeugenol	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C036643	isoeugenol results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB4 mRNA	PMID:39836092
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305826	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of DNAJB4 protein	PMID:34915118
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:188648	3,3',4',5-tetrachlorosalicylanilide	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C003390	3,3',4',5-tetrachlorosalicylanilide results in increased expression of DNAJB4 mRNA	PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of DNAJB4 mRNA	PMID:21120746
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB4 mRNA	PMID:35301059
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:23316	citral	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C007076	citral results in increased expression of DNAJB4 mRNA	PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:23414	copper(II) sulfate	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of DNAJB4 mRNA	PMID:19549813
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of DNAJB4 mRNA	PMID:23649840
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1305826	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of DNAJB4 protein	PMID:33236894
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of DNAJB4 protein	PMID:20106945
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DNAJB4 mRNA	PMID:23649840
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	ISO	RGD:1305826	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of DNAJB4 mRNA	PMID:15651846
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:25712	organoselenium compound	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:D016566	[Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB4 mRNA	PMID:25167922
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1305826	E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of DNAJB4 mRNA	PMID:35737395
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120515	CTD	MESH:D010126	Ozone results in increased expression of DNAJB4 mRNA	PMID:21543283
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJB4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJB4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DNAJB4 mRNA	PMID:32699268
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DNAJB4 mRNA	PMID:18593933
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305826	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DNAJB4 mRNA	PMID:31150632
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314093	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DNAJB4 mRNA	PMID:31919559
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305826	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DNAJB4 mRNA]	PMID:31150632
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJB4 mRNA	PMID:39836092
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DNAJB4 mRNA	PMID:19244175
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D000966	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of DNAJB4 mRNA	PMID:32076005
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27638	cobalt atom	multiple interactions	EXP		E	RGD:6480464	20130514	CTD	MESH:D003035	[tungsten carbide co-treated with Cobalt] results in increased expression of DNAJB4 mRNA	PMID:23052192
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27810	resorcinol	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C031389	resorcinol results in increased expression of DNAJB4 mRNA	PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20200211	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DNAJB4 mRNA]	PMID:31298478
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in increased expression of DNAJB4 mRNA	PMID:37386098
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of DNAJB4 mRNA	PMID:19561079
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of DNAJB4 mRNA	PMID:32186404
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305826	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DNAJB4 mRNA	PMID:32109520|PMID:33387578
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNAJB4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DNAJB4 mRNA	PMID:17942748|PMID:25975270
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of DNAJB4 mRNA	PMID:33512557
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DNAJB4 mRNA	PMID:28001369
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of DNAJB4 mRNA	PMID:30851411
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28600	farnesol	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D005204	Farnesol results in increased expression of DNAJB4 mRNA	PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of DNAJB4 mRNA	PMID:32763439
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of DNAJB4 mRNA; [Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB4 mRNA	PMID:20971185|PMID:25167922
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28878	dodecan-1-ol	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D007851	Dodecanol analog results in increased expression of DNAJB4 mRNA	PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [elesclomol results in increased expression of DNAJB4 mRNA]	PMID:18723479
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:28987	abietic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C023710	abietic acid results in increased expression of DNAJB4 mRNA	PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DNAJB4 mRNA	PMID:12634122|PMID:24516582|PMID:38568856
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJB4 mRNA; [sodium arsenite results in increased abundance of arsenite] which results in increased expression of DNAJB4 mRNA; sodium arsenite promotes the reaction [DNAJB4 protein binds to CAPRIN1 protein]	PMID:32076005|PMID:33939924|PMID:39836092
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29693	thiostrepton	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D013883	Thiostrepton results in increased expression of DNAJB4 mRNA	PMID:22321511
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of DNAJB4 mRNA	PMID:21714911
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of DNAJB4 mRNA; Benzo(a)pyrene results in increased expression of DNAJB4 mRNA; Benzo(a)pyrene results in increased expression of DNAJB4 protein	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:24356939|PMID:26238291|PMID:33278487
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNAJB4 mRNA	PMID:21569818|PMID:22228805
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJB4 mRNA	PMID:27858113
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C015001	[sodium arsenite results in increased abundance of arsenite] which results in increased expression of DNAJB4 mRNA	PMID:32076005
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of DNAJB4 mRNA; [Organoselenium Compounds binds to Copper] which results in increased expression of DNAJB4 mRNA	PMID:20971185|PMID:25167922
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DNAJB4 mRNA	PMID:18593933
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:30297	antimonite	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C061374	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of DNAJB4 mRNA	PMID:32076005
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of DNAJB4 mRNA	PMID:26014281|PMID:28959546
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DNAJB4 mRNA	PMID:25351596
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DNAJB4 mRNA	PMID:15761015|PMID:19417148|PMID:24356939|PMID:25258189
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DNAJB4 gene	PMID:31601247
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of DNAJB4 mRNA	PMID:38568856
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1305826	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of DNAJB4 mRNA	PMID:16507785
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32076	zinc pyrithione	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C010423	pyrithione zinc results in increased expression of DNAJB4 mRNA	PMID:21424779
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314093	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DNAJB4 promoter alternative form	PMID:35295148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314093	E	RGD:6480464	20200211	CTD	MESH:C009495	titanium dioxide results in increased expression of DNAJB4 mRNA	PMID:31298478
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20200211	CTD	MESH:C009495	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of DNAJB4 mRNA]	PMID:31298478
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DNAJB4 mRNA	PMID:18648102
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of DNAJB4 mRNA	PMID:21318169
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of DNAJB4 mRNA]	PMID:21318169
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of DNAJB4 mRNA	PMID:19191707
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:32888	gamma-hexachlorocyclohexane	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D001556	Hexachlorocyclohexane results in increased expression of DNAJB4 mRNA	PMID:24356939
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of DNAJB4 mRNA	PMID:30903817
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJB4 mRNA	PMID:29275510
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305826	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJB4 mRNA	PMID:34947998
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJB4 protein	PMID:35999755
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DNAJB4 gene	PMID:31601247
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305826	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DNAJB4 mRNA	PMID:25181051
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314093	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of DNAJB4 mRNA	PMID:39742910
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1314093	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DNAJB4 promoter	PMID:27312807
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DNAJB4 gene	PMID:31601247
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33227	(E)-cinnamyl alcohol	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C020722	cinnamyl alcohol results in increased expression of DNAJB4 mRNA	PMID:23999411
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of DNAJB4 mRNA	PMID:19244175
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of DNAJB4 mRNA	PMID:24752500
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:3390	carbaryl	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D012721	Carbaryl results in increased expression of DNAJB4 mRNA	PMID:27829164
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34288	2-hydroxyethyl methacrylate	increases expression	EXP		E	RGD:6480464	20200310	CTD	MESH:C005044	hydroxyethyl methacrylate results in increased expression of DNAJB4 mRNA	PMID:30497689
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34292	1,3-benzothiazole-2-thiol	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C005563	captax results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314093	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DNAJB4 mRNA	PMID:39298647|PMID:40203079
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34544	Aurin	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:C017037	aurin results in increased expression of DNAJB4 mRNA	PMID:25477506
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJB4 mRNA	PMID:27858113
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34578	Bisphenol A diglycidyl ether	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C019273	bisphenol A diglycidyl ether results in increased expression of DNAJB4 mRNA	PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of DNAJB4 protein	PMID:34186270
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314093	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DNAJB4 intron	PMID:28392331
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of DNAJB4 protein	PMID:35362542
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of DNAJB4 protein]	PMID:35362542
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34682	diazinon	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D003976	Diazinon results in increased expression of DNAJB4 mRNA	PMID:24356939
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DNAJB4 mRNA	PMID:21266533
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D004137	NFE2L2 protein affects the reaction [Dinitrochlorobenzene results in increased expression of DNAJB4 mRNA]	PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34779	glyoxal	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D006037	Glyoxal results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of DNAJB4 mRNA	PMID:17312168
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in increased expression of DNAJB4 protein	PMID:34064677
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DNAJB4 mRNA	PMID:37042841
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB4 mRNA	PMID:39836092
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305826	E	RGD:6480464	20121009	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of DNAJB4 mRNA	PMID:20551477
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNAJB4 mRNA	PMID:38174414|PMID:38568856
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJB4 mRNA	PMID:35301059
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1314093	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of DNAJB4 mRNA	PMID:24183702
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of DNAJB4 mRNA	PMID:19320972|PMID:19376846|PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJB4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJB4 mRNA	PMID:32699268
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DNAJB4 mRNA	PMID:19244175
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of DNAJB4 mRNA	PMID:17585979
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:3764	clotrimazole	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D003022	Clotrimazole results in increased expression of DNAJB4 mRNA	PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314093	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DNAJB4 mRNA	PMID:40194260
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DNAJB4 mRNA	PMID:28302478
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of DNAJB4 mRNA	PMID:26352163
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DNAJB4 mRNA	PMID:40419075
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of DNAJB4 mRNA	PMID:23179753
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DNAJB4 gene	PMID:29154799
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in increased expression of DNAJB4 mRNA	PMID:19136453|PMID:20546886
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D003520	Cyclophosphamide metabolite results in increased expression of DNAJB4 mRNA	PMID:24356939
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of DNAJB4 mRNA	PMID:27989131
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of DNAJB4 mRNA	PMID:19770486
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in increased expression of DNAJB4 mRNA	PMID:20106945|PMID:21632981
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of DNAJB4 mRNA	PMID:33512557
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:41607	crotonaldehyde	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in increased expression of DNAJB4 mRNA	PMID:20471460
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of DNAJB4 mRNA	PMID:17555576
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of DNAJB4 mRNA	PMID:27188386
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DNAJB4 mRNA	PMID:17562736
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of DNAJB4 mRNA	PMID:21420995|PMID:22230336
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D000082	MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of DNAJB4 mRNA]	PMID:18700144
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:46202	undecanal	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C479548	undecanal analog results in increased expression of DNAJB4 mRNA	PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DNAJB4 mRNA	PMID:39836092
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of DNAJB4 mRNA	PMID:24752500
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of DNAJB4 mRNA	PMID:31838189
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DNAJB4 mRNA	PMID:22079256
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DNAJB4 mRNA	PMID:17555576
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DNAJB4 mRNA	PMID:17942748
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNAJB4 mRNA	PMID:17942748
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4917	eugenol	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D005054	Eugenol results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of DNAJB4 protein]	PMID:35362542
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DNAJB4 mRNA	PMID:15761015|PMID:19417148|PMID:24356939|PMID:25258189
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in decreased expression of DNAJB4 mRNA	PMID:21318169
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20120613	CTD	MESH:D011345	PPARA protein affects the reaction [Fenofibrate results in decreased expression of DNAJB4 mRNA]	PMID:21318169
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:50161	motexafin gadolinium	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of DNAJB4 mRNA	PMID:16357179
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of DNAJB4 mRNA	PMID:16357179
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:50545	trans-isoeugenol	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C036643	isoeugenol results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:50594	carbon nanotube	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DNAJB4 mRNA	PMID:17450800
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of DNAJB4 mRNA	PMID:40234311
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJB4 mRNA	PMID:27858113
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:51403	1,4-phenylenediamine	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C029728	4-phenylenediamine results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of DNAJB4 mRNA	PMID:27858113
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:53049	1-fluoro-2,4-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004139	Dinitrofluorobenzene results in increased expression of DNAJB4 mRNA	PMID:23999411
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D010081	Oxazolone results in increased expression of DNAJB4 mRNA	PMID:23999411
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of DNAJB4 mRNA	PMID:31629900
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DNAJB4 protein	PMID:32959892
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:62822	4-nitrobenzyl bromide	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C027563	4-nitrobenzyl bromide results in increased expression of DNAJB4 mRNA	PMID:23999411
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:62823	2-bromo-2-(bromomethyl)pentanedinitrile	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C039411	1,2-dibromo-2,4-dicyanobutane results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:62984	zinc acetate	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in increased expression of DNAJB4 mRNA	PMID:16357179
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:62984	zinc acetate	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of DNAJB4 mRNA	PMID:16357179
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DNAJB4 mRNA	PMID:39836092
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of DNAJB4 mRNA	PMID:19812364
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DNAJB4 mRNA	PMID:23650126
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:63959	celastrol	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C050414	celastrol results in decreased expression of DNAJB4 mRNA	PMID:39181414
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:63959	celastrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C050414	celastrol results in increased expression of DNAJB4 mRNA	PMID:17010675
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of DNAJB4 mRNA	PMID:15336504
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:65954	gedunin	increases expression	EXP		E	RGD:6480464	20130305	CTD	MESH:C106014	gedunin results in increased expression of DNAJB4 mRNA	PMID:17010675
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1305826	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of DNAJB4 mRNA	PMID:19564919
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1305826	E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of DNAJB4 mRNA	PMID:19564919
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:68508	diethyl maleate	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C014476	diethyl maleate results in increased expression of DNAJB4 mRNA	PMID:33545341
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D002185	Cannabidiol results in increased expression of DNAJB4 mRNA	PMID:26504004
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D002185	[Dronabinol co-treated with Cannabidiol] results in increased expression of DNAJB4 mRNA	PMID:26504004
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DNAJB4 protein	PMID:34186270
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:73297	SCH 23390	multiple interactions	ISO	RGD:1305826	E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of DNAJB4 mRNA	PMID:19564919
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DNAJB4 mRNA	PMID:22206623
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DNAJB4 mRNA	PMID:22079256
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DNAJB4 mRNA	PMID:22079256
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C025589	ochratoxin A metabolite results in increased expression of DNAJB4 mRNA; ochratoxin A results in increased expression of DNAJB4 mRNA	PMID:24356939
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of DNAJB4 mRNA	PMID:30851411
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:79369	elesclomol	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C512195	elesclomol results in increased expression of DNAJB4 mRNA	PMID:18723479
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:79369	elesclomol	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:C512195	Acetylcysteine inhibits the reaction [elesclomol results in increased expression of DNAJB4 mRNA]	PMID:18723479
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of DNAJB4 mRNA	PMID:19270015
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1314093	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of DNAJB4 mRNA	PMID:22538082
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1314093	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of DNAJB4 mRNA	PMID:38995820
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:82283	Tungsten carbide	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C002802	[tungsten carbide co-treated with Cobalt] results in increased expression of DNAJB4 mRNA	PMID:23052192
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:82465	2-Ethylhexyl acrylate	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C036758	2-ethylhexyl acrylate results in increased expression of DNAJB4 mRNA	PMID:27965148
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314093	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of DNAJB4 mRNA	PMID:19363144|PMID:21278054
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:85014	2,5-hexanedione	increases expression	ISO	RGD:1305826	E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione results in increased expression of DNAJB4 mRNA	PMID:22952946
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:87368	diethyl malate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C058705	diethyl malate results in increased expression of DNAJB4 mRNA	PMID:38498338
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:8772	raloxifene	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of DNAJB4 mRNA	PMID:16497877
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of DNAJB4 mRNA	PMID:23999411
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of DNAJB4 mRNA	PMID:26014281|PMID:28959546
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305826	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DNAJB4 mRNA	PMID:21346803
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D013893	Thiram results in increased expression of DNAJB4 mRNA	PMID:23999411|PMID:27965148|PMID:38568856
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9513	thalidomide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013792	Thalidomide analog results in increased expression of DNAJB4 mRNA	PMID:20525221
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013849	Thimerosal results in increased expression of DNAJB4 mRNA	PMID:16870260
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305826	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DNAJB4 mRNA	PMID:21346803
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1314093	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon results in increased expression of DNAJB4 mRNA	PMID:19363144
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of DNAJB4 mRNA	PMID:19631733
1314092	DNAJB4	DnaJ heat shock protein family (Hsp40) member B4	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of DNAJB4 mRNA	PMID:19631733
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CNDP2 mRNA	PMID:38218311
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CNDP2 mRNA	PMID:38218311
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305827	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of CNDP2 mRNA	PMID:21551480
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305827	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of CNDP2 gene	PMID:35440735
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CNDP2 mRNA	PMID:22378314
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314095	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CNDP2 mRNA	PMID:30319688
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314095	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CNDP2 mRNA	PMID:39298647
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314095	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CNDP2 mRNA	PMID:15289156|PMID:19484750
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of CNDP2 mRNA	PMID:26496021
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CNDP2 mRNA	PMID:37042841
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of CNDP2 mRNA	PMID:21540246
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314095	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of CNDP2 mRNA	PMID:20463053
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:17362	quinoline	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C037219	quinoline analog results in increased expression of CNDP2 protein	PMID:18645022
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA	PMID:30698749
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305827	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CNDP2 mRNA	PMID:33387578
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:17833	gentamycin	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20191112	CTD	MESH:D005839	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein	PMID:30545405
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CNDP2 mRNA	PMID:28818685
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CNDP2 mRNA	PMID:19770486
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:D015127	[Dietary Fats co-treated with Dietary Sucrose co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of CNDP2 protein	PMID:39910959
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CNDP2 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of CNDP2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CNDP2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CNDP2 protein	PMID:38598786
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305827	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CNDP2 mRNA	PMID:30779732
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314095	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CNDP2 mRNA	PMID:31919559
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314095	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CNDP2 mRNA	PMID:25629700
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CNDP2 protein	PMID:35688186
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA	PMID:33854195
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CNDP2 mRNA	PMID:23557933
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of CNDP2 mRNA	PMID:19921347
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:28001	vancomycin	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20191112	CTD	MESH:D014640	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein	PMID:30545405
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of CNDP2 mRNA	PMID:15289156
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305827	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CNDP2 mRNA	PMID:34747641
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314095	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CNDP2 mRNA	PMID:21570461|PMID:24680724
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305827	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CNDP2 mRNA	PMID:21215274|PMID:32109520
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CNDP2 mRNA	PMID:18691609
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of CNDP2 mRNA	PMID:39709020
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:28971	ampicillin	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20191112	CTD	MESH:D000667	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein	PMID:30545405
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CNDP2 mRNA	PMID:38568856
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CNDP2 5' UTR; Benzo(a)pyrene affects the methylation of CNDP2 exon; Benzo(a)pyrene affects the methylation of CNDP2 promoter	PMID:27901495
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of CNDP2 mRNA	PMID:21829687
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305827	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CNDP2 mRNA	PMID:30047161
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314095	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CNDP2 promoter	PMID:35295148
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305827	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of CNDP2 mRNA	PMID:34492290
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A affects the expression of CNDP2 protein	PMID:34186270
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305827	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CNDP2 mRNA	PMID:25181051
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305827	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CNDP2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of CNDP2 mRNA	PMID:26496021
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CNDP2 protein	PMID:34186270
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CNDP2 mRNA	PMID:28628672
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:C041594	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA	PMID:30698749
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:C105260	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA	PMID:30698749
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CNDP2 protein	PMID:34186270
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CNDP2 mRNA	PMID:28628672
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CNDP2 protein	PMID:34186270
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:C027561	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA	PMID:30698749
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1314095	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of CNDP2 mRNA	PMID:31558096
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA	PMID:33854195
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of CNDP2 gene	PMID:22964155
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:D003993	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA	PMID:30698749
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CNDP2 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of CNDP2 protein	PMID:38598786
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CNDP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CNDP2 mRNA	PMID:28628672
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CNDP2 mRNA	PMID:37042841
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305827	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of CNDP2 mRNA	PMID:30589522
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CNDP2 mRNA	PMID:35163327
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20250401	CTD	MESH:C019566	[Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with 4-nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of CNDP2 mRNA	PMID:30698749
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CNDP2 mRNA	PMID:35163327
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CNDP2 mRNA	PMID:17553155|PMID:19376846
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CNDP2 mRNA	PMID:24449571
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314095	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CNDP2 mRNA	PMID:18353800
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of CNDP2 protein	PMID:17152098
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone promotes the reaction [NDRG1 protein binds to CNDP2 protein]	PMID:17220478
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CNDP2 mRNA	PMID:28302478
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of CNDP2 mRNA	PMID:26352163
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CNDP2 mRNA	PMID:25979313
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CNDP2 gene	PMID:29154799
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of CNDP2 mRNA	PMID:23179753|PMID:24383497
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in increased expression of CNDP2 mRNA	PMID:19136453
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305827	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CNDP2 mRNA	PMID:30047161
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CNDP2 mRNA	PMID:21163907
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA	PMID:33854195
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CNDP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CNDP2 mRNA	PMID:28628672
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CNDP2 mRNA	PMID:15289156
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314095	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CNDP2 mRNA	PMID:28973697
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305827	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CNDP2 mRNA	PMID:24136188
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA	PMID:33854195
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1305827	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of CNDP2 mRNA	PMID:21346803
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314095	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CNDP2 mRNA	PMID:17562736
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CNDP2 mRNA	PMID:21420995
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of CNDP2 mRNA	PMID:31675489
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305827	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CNDP2 mRNA	PMID:17557909
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1305827	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of CNDP2 mRNA	PMID:36868495
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CNDP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CNDP2 mRNA	PMID:28628672
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314095	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CNDP2 mRNA; Nanotubes, Carbon results in increased expression of CNDP2 mRNA	PMID:25554681
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305827	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of CNDP2 mRNA	PMID:24136188
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305827	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CNDP2 mRNA	PMID:30047161
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA	PMID:33854195
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of CNDP2 mRNA	PMID:20436886
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CNDP2 protein	PMID:32959892
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1305827	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CNDP2 mRNA	PMID:24136188
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314095	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of CNDP2 mRNA	PMID:15003993
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314095	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of CNDP2 mRNA	PMID:36851058
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305827	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of CNDP2 mRNA	PMID:30467583
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:6909	metronidazole	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20191112	CTD	MESH:D008795	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein	PMID:30545405
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CNDP2 mRNA	PMID:31758290
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CNDP2 protein	PMID:34186270
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314095	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CNDP2 mRNA	PMID:22206623
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:7507	neomycin	multiple interactions	ISO	RGD:1305827	E	RGD:6480464	20191112	CTD	MESH:D009355	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein	PMID:30545405
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CNDP2 protein	PMID:39638853
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CNDP2 gene]	PMID:28238834
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1314095	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of CNDP2 mRNA	PMID:38995820
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1305827	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of CNDP2 protein	PMID:28903499
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1314095	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of CNDP2 mRNA	PMID:31558096
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CNDP2 protein	PMID:31675489
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305827	E	RGD:6480464	20200915	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CNDP2 mRNA	PMID:32679240
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of CNDP2 protein	PMID:38348393
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CNDP2 mRNA	PMID:38568856
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1305827	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of CNDP2 protein	PMID:35544339
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CNDP2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of CNDP2 protein	PMID:38598786
1314094	CNDP2	carnosine dipeptidase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305827	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CNDP2 mRNA	PMID:21346803
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314098	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LCMT2 mRNA	PMID:33045310
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314098	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of LCMT2 mRNA	PMID:37995155
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of LCMT2 mRNA	PMID:31016361
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314098	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of LCMT2 mRNA	PMID:20188158
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of LCMT2 mRNA	PMID:24236059
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of LCMT2 mRNA	PMID:22378314
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of LCMT2 mRNA	PMID:20044591
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305829	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LCMT2 mRNA	PMID:33387578
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LCMT2 mRNA	PMID:37042841
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of LCMT2 mRNA	PMID:20655997
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305829	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of LCMT2 mRNA	PMID:33387578
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of LCMT2 mRNA	PMID:28818685
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314098	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LCMT2 mRNA	PMID:37236586
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of LCMT2 mRNA	PMID:19549813
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of LCMT2 mRNA	PMID:35430440
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314098	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of LCMT2 mRNA	PMID:28960355
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of LCMT2 mRNA	PMID:23557933
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of LCMT2 mRNA	PMID:23300844
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LCMT2 mRNA	PMID:22574217
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305829	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LCMT2 mRNA	PMID:33387578
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LCMT2 mRNA	PMID:29803840
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LCMT2 mRNA	PMID:38568856
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of LCMT2 mRNA	PMID:28595984|PMID:34032870
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of LCMT2 mRNA	PMID:22378314
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of LCMT2 mRNA	PMID:25351596
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of LCMT2 mRNA	PMID:35984750
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:32687	piperonyl butoxide	decreases expression	ISO	RGD:1305829	E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in decreased expression of LCMT2 mRNA	PMID:22484513
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305829	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of LCMT2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of LCMT2 mRNA; Vitamin E results in increased expression of LCMT2 protein	PMID:9359698
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of LCMT2 gene	PMID:22964155
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LCMT2 mRNA	PMID:37042841
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314098	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LCMT2 mRNA	PMID:37236586
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of LCMT2 mRNA	PMID:23978341
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of LCMT2 mRNA	PMID:19167446
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LCMT2 mRNA	PMID:19167446
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LCMT2 mRNA	PMID:25979313
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314098	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of LCMT2 mRNA	PMID:17963808
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of LCMT2 mRNA	PMID:29154799
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of LCMT2 mRNA	PMID:23179753
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of LCMT2 mRNA	PMID:25562108
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:46345	5-fluorouracil	increases response to substance	ISO	RGD:1314098	E	RGD:6480464	20120412	CTD	MESH:D005472	LCMT2 results in increased susceptibility to Fluorouracil	PMID:9359698
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:46345	5-fluorouracil	multiple interactions	ISO	RGD:1314098	E	RGD:6480464	20120412	CTD	MESH:D005472	LCMT2 results in increased susceptibility to [pyrrolidine dithiocarbamic acid co-treated with Fluorouracil]	PMID:9359698
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of LCMT2 mRNA	PMID:18175754
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of LCMT2 mRNA	PMID:23300844
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of LCMT2 mRNA	PMID:31758290
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of LCMT2 mRNA	PMID:36318118
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:78782	pyrrolidine dithiocarbamate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:C020972	pyrrolidine dithiocarbamic acid results in increased expression of LCMT2 mRNA; pyrrolidine dithiocarbamic acid results in increased expression of LCMT2 protein	PMID:9359698
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:78782	pyrrolidine dithiocarbamate	increases response to substance	ISO	RGD:1314098	E	RGD:6480464	20140708	CTD	MESH:C020972	LCMT2 results in increased susceptibility to pyrrolidine dithiocarbamic acid	PMID:9359698
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	EXP		E	RGD:6480464	20140708	CTD	MESH:C020972	pyrrolidine dithiocarbamic acid promotes the reaction [CEBPB protein binds to LCMT2 promoter]	PMID:9359698
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	ISO	RGD:1314098	E	RGD:6480464	20140708	CTD	MESH:C020972	LCMT2 results in increased susceptibility to [pyrrolidine dithiocarbamic acid co-treated with Fluorouracil]	PMID:9359698
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LCMT2 gene]	PMID:28238834
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314098	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of LCMT2 mRNA	PMID:19270015
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of LCMT2 mRNA	PMID:19167446
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305829	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LCMT2 mRNA	PMID:21346803
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of LCMT2 mRNA	PMID:38568856
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of LCMT2 mRNA	PMID:29301935
1314097	LCMT2	leucine carboxyl methyltransferase 2	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of LCMT2 mRNA	PMID:22378314
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314100	E	RGD:6480464	20180828	CTD	MESH:D004958	Estradiol results in decreased expression of CALHM4 mRNA	PMID:19484750
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314100	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of CALHM4 mRNA	PMID:36209798
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FAM26D 5' UTR; Benzo(a)pyrene affects the methylation of FAM26D promoter	PMID:27901495
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FAM26D 3' UTR	PMID:27901495
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CALHM4 gene	PMID:31601247
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CALHM4 gene	PMID:31601247
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1595701	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CALHM4 mRNA	PMID:25181051
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CALHM4 gene	PMID:31601247
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1595701	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CALHM4 mRNA	PMID:35163327
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1595701	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of CALHM4 mRNA	PMID:35163327
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314100	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CALHM4 mRNA	PMID:40194260
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CALHM4 gene	PMID:29154799
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1595701	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CALHM4 mRNA	PMID:33387578
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1595701	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CALHM4 mRNA	PMID:29391264
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314100	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CALHM4 mRNA	PMID:35436446
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C082360	fipronil results in increased expression of CALHM4 mRNA	PMID:27091632
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C082360	[fipronil co-treated with DEET] results in increased expression of CALHM4 mRNA	PMID:27091632
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314100	E	RGD:6480464	20180828	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CALHM4 mRNA	PMID:23608068
1314099	CALHM4	calcium homeostasis modulator family member 4	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D003671	[fipronil co-treated with DEET] results in increased expression of CALHM4 mRNA	PMID:27091632
1314101	POMP	proteasome maturation protein	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of POMP mRNA	PMID:38218311
1314101	POMP	proteasome maturation protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314102	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POMP mRNA	PMID:39241906
1314101	POMP	proteasome maturation protein	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1314102	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of POMP mRNA	PMID:17945193
1314101	POMP	proteasome maturation protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314102	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of POMP mRNA	PMID:19850644|PMID:33754040
1314101	POMP	proteasome maturation protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of POMP mRNA]	PMID:19850644
1314101	POMP	proteasome maturation protein	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POMP mRNA	PMID:39836092
1314101	POMP	proteasome maturation protein	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POMP mRNA	PMID:35301059
1314101	POMP	proteasome maturation protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POMP mRNA	PMID:37236586
1314101	POMP	proteasome maturation protein	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of POMP mRNA	PMID:19549813
1314101	POMP	proteasome maturation protein	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of POMP intron	PMID:30157460
1314101	POMP	proteasome maturation protein	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305831	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of POMP mRNA	PMID:30779732
1314101	POMP	proteasome maturation protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305831	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of POMP mRNA	PMID:33387578
1314101	POMP	proteasome maturation protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POMP mRNA	PMID:22206623
1314101	POMP	proteasome maturation protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POMP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POMP mRNA	PMID:39836092
1314101	POMP	proteasome maturation protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POMP mRNA	PMID:40504410
1314101	POMP	proteasome maturation protein	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314102	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of POMP protein	PMID:25505154
1314101	POMP	proteasome maturation protein	gene	CHEBI:28088	genistein	decreases methylation	ISO	RGD:1305831	E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in decreased methylation of POMP gene	PMID:28505145
1314101	POMP	proteasome maturation protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314102	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POMP mRNA	PMID:21570461
1314101	POMP	proteasome maturation protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305831	E	RGD:6480464	20150623	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POMP mRNA	PMID:18796159
1314101	POMP	proteasome maturation protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314102	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POMP mRNA	PMID:16214954|PMID:18796159
1314101	POMP	proteasome maturation protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20120412	CTD	MESH:D013749	AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of POMP mRNA]	PMID:16214954
1314101	POMP	proteasome maturation protein	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POMP mRNA	PMID:30851411
1314101	POMP	proteasome maturation protein	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of POMP mRNA	PMID:32763439
1314101	POMP	proteasome maturation protein	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of POMP mRNA	PMID:29803840
1314101	POMP	proteasome maturation protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of POMP mRNA	PMID:39719251
1314101	POMP	proteasome maturation protein	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of POMP mRNA	PMID:28595984|PMID:34032870|PMID:38568856
1314101	POMP	proteasome maturation protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POMP mRNA; [sodium arsenite co-treated with lead acetate] results in decreased expression of POMP protein; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POMP mRNA	PMID:38072110|PMID:39836092
1314101	POMP	proteasome maturation protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POMP mRNA	PMID:40504410
1314101	POMP	proteasome maturation protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314102	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POMP mRNA	PMID:22228805
1314101	POMP	proteasome maturation protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of POMP promoter	PMID:27901495
1314101	POMP	proteasome maturation protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to POMP mRNA]	PMID:32406909
1314101	POMP	proteasome maturation protein	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in decreased expression of POMP protein	PMID:38072110
1314101	POMP	proteasome maturation protein	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305831	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of POMP mRNA	PMID:30047161
1314101	POMP	proteasome maturation protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314102	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of POMP gene	PMID:35295148
1314101	POMP	proteasome maturation protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314102	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of POMP mRNA	PMID:23557971
1314101	POMP	proteasome maturation protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305831	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of POMP mRNA	PMID:34492290
1314101	POMP	proteasome maturation protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of POMP mRNA	PMID:29275510
1314101	POMP	proteasome maturation protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314102	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of POMP mRNA	PMID:33221593
1314101	POMP	proteasome maturation protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305831	E	RGD:6480464	20150623	CTD	MESH:C006780	bisphenol A results in increased expression of POMP mRNA	PMID:25181051
1314101	POMP	proteasome maturation protein	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	ISO	RGD:1305831	E	RGD:6480464	20150623	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of POMP mRNA	PMID:12082028
1314101	POMP	proteasome maturation protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314102	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of POMP mRNA	PMID:39298647
1314101	POMP	proteasome maturation protein	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314102	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of POMP mRNA	PMID:37019170
1314101	POMP	proteasome maturation protein	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314102	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of POMP mRNA	PMID:34813904
1314101	POMP	proteasome maturation protein	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314102	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of POMP mRNA	PMID:34813904
1314101	POMP	proteasome maturation protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of POMP mRNA	PMID:37042841
1314101	POMP	proteasome maturation protein	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POMP mRNA	PMID:39836092
1314101	POMP	proteasome maturation protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of POMP mRNA	PMID:38568856
1314101	POMP	proteasome maturation protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POMP mRNA	PMID:35301059
1314101	POMP	proteasome maturation protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of POMP mRNA	PMID:37236586
1314101	POMP	proteasome maturation protein	gene	CHEBI:35546	perfluorodecanoic acid	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C036567	perfluorodecanoic acid results in increased expression of POMP mRNA	PMID:38568856
1314101	POMP	proteasome maturation protein	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1305831	E	RGD:6480464	20150623	CTD	MESH:D002994	Clofibrate results in increased expression of POMP mRNA	PMID:12851107
1314101	POMP	proteasome maturation protein	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of POMP mRNA	PMID:28302478
1314101	POMP	proteasome maturation protein	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of POMP mRNA	PMID:26352163
1314101	POMP	proteasome maturation protein	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of POMP mRNA	PMID:25979313
1314101	POMP	proteasome maturation protein	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of POMP mRNA	PMID:23179753
1314101	POMP	proteasome maturation protein	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305831	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of POMP mRNA	PMID:30047161
1314101	POMP	proteasome maturation protein	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of POMP mRNA	PMID:20106945
1314101	POMP	proteasome maturation protein	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1305831	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of POMP mRNA	PMID:24136188
1314101	POMP	proteasome maturation protein	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of POMP mRNA	PMID:38832940
1314101	POMP	proteasome maturation protein	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of POMP mRNA	PMID:27188386
1314101	POMP	proteasome maturation protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POMP mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POMP mRNA	PMID:39836092
1314101	POMP	proteasome maturation protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POMP mRNA	PMID:40504410
1314101	POMP	proteasome maturation protein	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305831	E	RGD:6480464	20150623	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of POMP mRNA	PMID:12082028
1314101	POMP	proteasome maturation protein	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of POMP mRNA	PMID:17211630
1314101	POMP	proteasome maturation protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314102	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of POMP mRNA; Nanotubes, Carbon results in increased expression of POMP mRNA	PMID:25554681
1314101	POMP	proteasome maturation protein	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1305831	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of POMP mRNA	PMID:24136188
1314101	POMP	proteasome maturation protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of POMP mRNA	PMID:35964746
1314101	POMP	proteasome maturation protein	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305831	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of POMP mRNA	PMID:24136188
1314101	POMP	proteasome maturation protein	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1314102	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of POMP mRNA	PMID:26377693
1314101	POMP	proteasome maturation protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POMP mRNA	PMID:39836092
1314101	POMP	proteasome maturation protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314102	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POMP mRNA	PMID:22206623
1314101	POMP	proteasome maturation protein	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305831	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of POMP mRNA	PMID:24136188
1314101	POMP	proteasome maturation protein	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POMP mRNA	PMID:30851411
1314101	POMP	proteasome maturation protein	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305831	E	RGD:6480464	20150623	CTD	MESH:D010634	Phenobarbital results in increased expression of POMP mRNA	PMID:12082028
1314101	POMP	proteasome maturation protein	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1305831	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of POMP mRNA	PMID:30047161
1314101	POMP	proteasome maturation protein	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305831	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of POMP mRNA	PMID:30047161
1314101	POMP	proteasome maturation protein	gene	CHEBI:9352	sulindac	decreases expression	ISO	RGD:1305831	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of POMP mRNA	PMID:24136188
1314101	POMP	proteasome maturation protein	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of POMP mRNA	PMID:38568856
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552306	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PRPF31 mRNA	PMID:26251327
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1552306	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of PRPF31 promoter	PMID:26251327
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1552306	E	RGD:6480464	20150127	CTD	MESH:D008628	Mercury analog results in decreased expression of PRPF31 mRNA	PMID:25056781
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552306	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PRPF31 mRNA	PMID:39241906
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRPF31 mRNA	PMID:25510870
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:166595	Yessotoxin	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in decreased expression of PRPF31 mRNA	PMID:30679557
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552306	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of PRPF31 mRNA	PMID:20463053
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PRPF31 protein	PMID:37730182
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of PRPF31 mRNA	PMID:28111341
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRPF31 mRNA	PMID:25510870
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRPF31 mRNA	PMID:25510870
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PRPF31 mRNA	PMID:23649840
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1305832	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of PRPF31 protein	PMID:33236894
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1552306	E	RGD:6480464	20150127	CTD	MESH:D008628	Mercury analog results in decreased expression of PRPF31 mRNA	PMID:25056781
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PRPF31 mRNA	PMID:23649840
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552306	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PRPF31 mRNA	PMID:31919559
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PRPF31 gene	PMID:25304211
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PRPF31 protein	PMID:35688186
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552306	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PRPF31 mRNA	PMID:21570461
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PRPF31 mRNA	PMID:17942748
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRPF31 mRNA	PMID:17942748
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PRPF31 mRNA	PMID:33212167
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of PRPF31 protein	PMID:35688186
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PRPF31 mRNA	PMID:38568856
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of PRPF31 mRNA	PMID:34032870
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PRPF31 protein	PMID:20097212
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552306	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PRPF31 gene	PMID:35295148
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PRPF31 mRNA	PMID:18301758
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305832	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PRPF31 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305832	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRPF31 mRNA	PMID:36041667
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRPF31 mRNA	PMID:25510870
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PRPF31 mRNA	PMID:25510870
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552306	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PRPF31 mRNA	PMID:39298647
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305832	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRPF31 mRNA	PMID:36041667
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305832	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PRPF31 mRNA	PMID:36041667
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PRPF31 mRNA	PMID:21266533
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of PRPF31 mRNA	PMID:28111341
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PRPF31 gene	PMID:29154799
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of PRPF31 promoter	PMID:27989131
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PRPF31 mRNA	PMID:17555576
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PRPF31 gene	PMID:25304211
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PRPF31 mRNA	PMID:17555576
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PRPF31 mRNA	PMID:17942748
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552306	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PRPF31 mRNA	PMID:17942748
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552306	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PRPF31 mRNA	PMID:19042947
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PRPF31 protein	PMID:32959892
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PRPF31 protein	PMID:34186270
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552306	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PRPF31 mRNA	PMID:22206623
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PRPF31 protein	PMID:37664457
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PRPF31 protein	PMID:31285264
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PRPF31 gene]	PMID:28238834
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552306	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PRPF31 mRNA	PMID:30294300
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PRPF31 protein	PMID:31675489
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:81980	triticonazole	decreases expression	ISO	RGD:1305832	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of PRPF31 mRNA	PMID:36084822
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PRPF31 protein	PMID:37664457
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305832	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PRPF31 mRNA	PMID:21346803
1314103	PRPF31	pre-mRNA processing factor 31	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305832	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PRPF31 mRNA	PMID:23034163
1314106	TECTB	tectorin beta	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314107	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TECTB mRNA	PMID:33045310
1314106	TECTB	tectorin beta	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305835	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TECTB mRNA	PMID:33387578
1314106	TECTB	tectorin beta	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TECTB gene	PMID:27153756
1314106	TECTB	tectorin beta	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314107	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TECTB mRNA	PMID:28960355
1314106	TECTB	tectorin beta	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of TECTB mRNA	PMID:41028656
1314106	TECTB	tectorin beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314107	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TECTB mRNA	PMID:21570461
1314106	TECTB	tectorin beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305835	E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TECTB mRNA	PMID:21724226|PMID:33387578
1314106	TECTB	tectorin beta	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of TECTB mRNA	PMID:29955902
1314106	TECTB	tectorin beta	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305835	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TECTB mRNA	PMID:26033743
1314106	TECTB	tectorin beta	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TECTB mRNA	PMID:41028656
1314106	TECTB	tectorin beta	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1305835	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of TECTB mRNA	PMID:26033743
1314106	TECTB	tectorin beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TECTB mRNA	PMID:32234424
1314106	TECTB	tectorin beta	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TECTB exon; Benzo(a)pyrene results in increased methylation of TECTB promoter	PMID:27901495
1314106	TECTB	tectorin beta	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305835	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TECTB mRNA	PMID:26033743
1314106	TECTB	tectorin beta	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TECTB mRNA	PMID:41028656
1314106	TECTB	tectorin beta	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1305835	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of TECTB mRNA	PMID:26033743
1314106	TECTB	tectorin beta	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314107	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of TECTB mRNA	PMID:18648102
1314106	TECTB	tectorin beta	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314107	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TECTB mRNA	PMID:19710929
1314106	TECTB	tectorin beta	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305835	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TECTB mRNA	PMID:25181051
1314106	TECTB	tectorin beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305835	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TECTB mRNA	PMID:34947998
1314106	TECTB	tectorin beta	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305835	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of TECTB mRNA	PMID:32680482
1314106	TECTB	tectorin beta	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305835	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TECTB mRNA	PMID:35163327
1314106	TECTB	tectorin beta	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305835	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TECTB mRNA	PMID:35163327
1314106	TECTB	tectorin beta	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314107	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of TECTB mRNA	PMID:28962523
1314106	TECTB	tectorin beta	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314107	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TECTB mRNA	PMID:40194260
1314106	TECTB	tectorin beta	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TECTB gene	PMID:29154799
1314106	TECTB	tectorin beta	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305835	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TECTB mRNA	PMID:33387578
1314106	TECTB	tectorin beta	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305835	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TECTB mRNA	PMID:29391264
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RASGEF1A mRNA	PMID:26272509|PMID:27188386
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGEF1A mRNA	PMID:27188386
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314109	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RASGEF1A mRNA	PMID:30529165
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of RASGEF1A mRNA	PMID:26079696
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314109	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of RASGEF1A mRNA	PMID:30319688
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of RASGEF1A mRNA	PMID:31614463
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305836	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RASGEF1A mRNA	PMID:33387578
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RASGEF1A mRNA	PMID:37042841
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of RASGEF1A mRNA	PMID:26079696
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305836	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RASGEF1A mRNA	PMID:26577399
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of RASGEF1A intron	PMID:30157460
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RASGEF1A intron	PMID:30157460
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314109	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of RASGEF1A mRNA	PMID:34911549
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of RASGEF1A mRNA	PMID:26272509
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASGEF1A mRNA	PMID:27188386
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RASGEF1A mRNA	PMID:28903495
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RASGEF1A mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314109	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of RASGEF1A mRNA	PMID:27862939
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of RASGEF1A gene	PMID:28589171
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314109	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of RASGEF1A mRNA	PMID:36209798
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RASGEF1A 5' UTR; Benzo(a)pyrene affects the methylation of RASGEF1A intron	PMID:27901495|PMID:30157460
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RASGEF1A promoter	PMID:27901495
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RASGEF1A gene	PMID:31601247
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314109	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of RASGEF1A mRNA	PMID:23557971|PMID:27760801
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of RASGEF1A gene	PMID:31601247
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305836	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RASGEF1A mRNA	PMID:25181051
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314109	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of RASGEF1A mRNA	PMID:32156529
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305836	E	RGD:6480464	20180220	CTD	MESH:C006780	bisphenol A results in increased expression of RASGEF1A mRNA	PMID:27178563
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RASGEF1A gene	PMID:31601247
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of RASGEF1A gene	PMID:31601247
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RASGEF1A intron	PMID:30157460
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314109	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RASGEF1A mRNA	PMID:37019170
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314109	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of RASGEF1A mRNA	PMID:36117858
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RASGEF1A mRNA	PMID:37042841
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RASGEF1A mRNA	PMID:24449571
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RASGEF1A mRNA	PMID:25979313
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314109	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RASGEF1A mRNA	PMID:17963808
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of RASGEF1A mRNA	PMID:23179753|PMID:26272509|PMID:27188386|PMID:29154799
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGEF1A mRNA	PMID:27188386
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of RASGEF1A mRNA	PMID:27188386
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RASGEF1A mRNA	PMID:24935251
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314109	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RASGEF1A mRNA; Nanotubes, Carbon results in decreased expression of RASGEF1A mRNA	PMID:25554681
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314109	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of RASGEF1A mRNA	PMID:36117858
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RASGEF1A intron	PMID:30157460
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314109	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RASGEF1A mRNA	PMID:22206623
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGEF1A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASGEF1A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGEF1A mRNA	PMID:27188386
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of RASGEF1A mRNA	PMID:26079696
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305836	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RASGEF1A mRNA	PMID:24780913
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGEF1A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RASGEF1A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASGEF1A mRNA	PMID:27188386
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305836	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RASGEF1A mRNA	PMID:19281266
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of RASGEF1A mRNA	PMID:27188386
1314108	RASGEF1A	RasGEF domain family member 1A	gene	CHEBI:9546	thimerosal	increases expression	ISO	RGD:1314109	E	RGD:6480464	20140715	CTD	MESH:D013849	Thimerosal results in increased expression of RASGEF1A mRNA	PMID:24675092
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305837	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SPIRE2 mRNA]	PMID:31150632
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1305837	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SPIRE2 mRNA	PMID:30071829
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPIRE2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPIRE2 gene	PMID:20938992
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1305837	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of SPIRE2 mRNA	PMID:20488242
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SPIRE2 mRNA	PMID:36331819
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of SPIRE2 protein	PMID:35688186
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of SPIRE2 mRNA	PMID:31614463
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of SPIRE2 mRNA	PMID:20404318
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305837	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SPIRE2 mRNA	PMID:33387578
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPIRE2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPIRE2 gene	PMID:20938992
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of SPIRE2 gene	PMID:30521419
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA	PMID:37992649
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA	PMID:37992649
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SPIRE2 protein	PMID:37730182
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of SPIRE2 intron	PMID:30157460
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPIRE2 mRNA	PMID:36331819
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SPIRE2 gene; Aflatoxin B1 results in increased methylation of SPIRE2 intron	PMID:27153756|PMID:30157460
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305837	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SPIRE2 mRNA	PMID:31150632
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305837	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SPIRE2 mRNA]	PMID:31150632
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314111	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SPIRE2 mRNA	PMID:25629700
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPIRE2 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SPIRE2 gene	PMID:20938992
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SPIRE2 gene	PMID:25304211
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SPIRE2 protein	PMID:35688186
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305837	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SPIRE2 mRNA	PMID:31881176
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SPIRE2 mRNA	PMID:23557933
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305837	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPIRE2 mRNA	PMID:22298810
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314111	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPIRE2 mRNA	PMID:21570461|PMID:26377647
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314111	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SPIRE2 mRNA	PMID:19933214
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305837	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPIRE2 mRNA	PMID:33387578
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SPIRE2 mRNA	PMID:33212167
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305837	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SPIRE2 mRNA	PMID:26033743
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1305837	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA	PMID:26033743
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA	PMID:37992649
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SPIRE2 mRNA	PMID:39719251
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SPIRE2 intron; Benzo(a)pyrene affects the methylation of SPIRE2 promoter	PMID:27901495|PMID:30157460
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305837	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SPIRE2 mRNA	PMID:26033743
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1305837	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA	PMID:26033743
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314111	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SPIRE2 mRNA	PMID:29203145
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314111	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SPIRE2 gene	PMID:35295148
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314111	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of SPIRE2 mRNA	PMID:29264374
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305837	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SPIRE2 mRNA	PMID:23411599|PMID:34492290
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314111	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SPIRE2 mRNA	PMID:18648102
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305837	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPIRE2 mRNA	PMID:25181051
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314111	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of SPIRE2 mRNA	PMID:32156529
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SPIRE2 intron	PMID:30157460
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314111	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SPIRE2 mRNA	PMID:37019170
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305837	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SPIRE2 mRNA	PMID:36928142
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314111	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SPIRE2 mRNA	PMID:40194260
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SPIRE2 mRNA	PMID:31533062
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of SPIRE2 mRNA	PMID:19167446
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:39178	clothianidin	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C480342	clothianidin results in decreased expression of SPIRE2 mRNA	PMID:29044138
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPIRE2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SPIRE2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SPIRE2 mRNA	PMID:36331819
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314111	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of SPIRE2 mRNA	PMID:21427059
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SPIRE2 gene	PMID:29154799
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SPIRE2 mRNA	PMID:25562108
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of SPIRE2 promoter	PMID:27989131
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314111	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPIRE2 mRNA	PMID:37992649
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314111	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SPIRE2 mRNA	PMID:17562736
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of SPIRE2 mRNA	PMID:29067470
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305837	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SPIRE2 mRNA	PMID:33387578
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1314111	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SPIRE2 mRNA	PMID:29279043
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SPIRE2 gene	PMID:25304211
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305837	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SPIRE2 mRNA	PMID:29391264
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SPIRE2 intron	PMID:30157460
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314111	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SPIRE2 mRNA	PMID:22206623
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305837	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of SPIRE2 mRNA	PMID:26720608
1314110	SPIRE2	spire type actin nucleation factor 2	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314111	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of SPIRE2 mRNA	PMID:40826991
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ARIH2 mRNA	PMID:37995155
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314114	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of ARIH2 mRNA]	PMID:19467301
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of ARIH2 protein	PMID:39571964
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ARIH2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ARIH2 mRNA	PMID:32699268
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314114	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ARIH2 mRNA	PMID:30319688
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314114	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ARIH2 mRNA	PMID:39298647
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1305839	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ARIH2 mRNA	PMID:23829299
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARIH2 mRNA	PMID:37042841
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ARIH2 mRNA	PMID:21318169
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1305839	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ARIH2 mRNA	PMID:21318169
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305839	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ARIH2 mRNA	PMID:33387578
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of ARIH2 mRNA	PMID:37748715
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314114	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARIH2 mRNA	PMID:36331819
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARIH2 mRNA	PMID:19770486
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ARIH2 mRNA	PMID:23649840
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ARIH2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ARIH2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of ARIH2 mRNA	PMID:32699268
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ARIH2 mRNA	PMID:21867686
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of ARIH2 mRNA	PMID:18414638
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ARIH2 mRNA	PMID:23557933
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ARIH2 mRNA	PMID:27392435
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314114	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARIH2 mRNA	PMID:21570461
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARIH2 mRNA	PMID:19770486
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ARIH2 protein	PMID:39603559
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ARIH2 mRNA	PMID:20061341
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305839	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ARIH2 mRNA	PMID:28959563
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of ARIH2 protein	PMID:38228842
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in decreased expression of ARIH2 protein	PMID:39571964
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of ARIH2 mRNA	PMID:29453283
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARIH2 5' UTR	PMID:27901495
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARIH2 mRNA	PMID:26238291
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ARIH2 mRNA	PMID:25351596
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ARIH2 mRNA	PMID:23806026
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of ARIH2 gene	PMID:31601247
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305839	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ARIH2 mRNA	PMID:25729387
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305839	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ARIH2 mRNA	PMID:30047161
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305839	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ARIH2 mRNA	PMID:34492290
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ARIH2 mRNA	PMID:18648102
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ARIH2 mRNA	PMID:15375163
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ARIH2 mRNA	PMID:30903817
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305839	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARIH2 mRNA	PMID:25181051
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ARIH2 mRNA	PMID:33221593|PMID:38074096
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARIH2 gene	PMID:31601247
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305839	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ARIH2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARIH2 mRNA	PMID:28628672
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305839	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:36041667
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ARIH2 mRNA	PMID:25979313
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314114	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ARIH2 mRNA	PMID:39298647
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:28628672
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305839	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:36041667
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34445	4-tert-Octylphenol	increases expression	ISO	RGD:1305839	E	RGD:6480464	20141111	CTD	MESH:C105260	4-tert-octylphenol results in increased expression of ARIH2 mRNA	PMID:17011747
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of ARIH2 gene	PMID:31601247
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305839	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:36041667
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314114	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ARIH2 intron	PMID:28392331
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ARIH2 mRNA	PMID:20350560
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305839	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARIH2 mRNA	PMID:21266533
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARIH2 mRNA	PMID:21266533
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34696	dieldrin	decreases response to substance	EXP		E	RGD:6480464	20201006	CTD	MESH:D004026	ARIH2 gene mutant form results in decreased susceptibility to Dieldrin	PMID:32421776
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARIH2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:28628672
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARIH2 mRNA	PMID:37042841
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:35096	p-tert-Amylphenol	increases expression	ISO	RGD:1305839	E	RGD:6480464	20191114	CTD	MESH:C019566	4-tert-octylphenol results in increased expression of ARIH2 mRNA	PMID:17011747
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ARIH2 mRNA	PMID:38568856
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305839	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARIH2 mRNA	PMID:33453195
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314114	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARIH2 mRNA	PMID:20061341
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ARIH2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ARIH2 mRNA	PMID:32699268
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ARIH2 mRNA	PMID:17585979
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ARIH2 mRNA	PMID:32588087
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314114	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARIH2 mRNA	PMID:36331819
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARIH2 mRNA	PMID:25979313
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in increased expression of ARIH2 mRNA	PMID:23179753|PMID:25192806|PMID:29154799
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ARIH2 mRNA	PMID:17183730
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305839	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ARIH2 mRNA	PMID:30047161
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ARIH2 mRNA	PMID:20106945
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARIH2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:28628672
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1305839	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ARIH2 mRNA	PMID:17011747
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314114	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ARIH2 mRNA	PMID:28973697
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of ARIH2 mRNA	PMID:33512557
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314114	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARIH2 mRNA	PMID:17562736
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ARIH2 mRNA	PMID:29067470
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314114	E	RGD:6480464	20150414	CTD	MESH:D000082	[CTH gene mutant form results in increased susceptibility to Acetaminophen] which affects the expression of ARIH2 protein	PMID:25499718
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of ARIH2 mRNA	PMID:18414638
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of ARIH2 mRNA	PMID:18175754
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ARIH2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ARIH2 mRNA	PMID:28628672
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305839	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ARIH2 mRNA	PMID:30047161
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305839	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ARIH2 mRNA	PMID:24136188
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1314114	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of ARIH2 mRNA	PMID:26377693
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ARIH2 mRNA	PMID:17183730
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305839	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ARIH2 mRNA	PMID:25729387
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:6887	methylphenidate	decreases expression	ISO	RGD:1314114	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in decreased expression of ARIH2 mRNA	PMID:22470460
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of ARIH2 mRNA	PMID:22101062
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314114	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ARIH2 mRNA	PMID:22206623
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305839	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARIH2 mRNA	PMID:30047161
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305839	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ARIH2 mRNA	PMID:19281266
1314113	ARIH2	ariadne RBR E3 ubiquitin protein ligase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305839	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ARIH2 mRNA	PMID:21346803
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314116	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ABCG4 mRNA	PMID:33045310
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314116	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ABCG4 mRNA	PMID:20188158
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ABCG4 mRNA	PMID:26079696
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ABCG4 mRNA	PMID:30165855
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305840	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ABCG4 mRNA	PMID:26496021
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ABCG4 mRNA	PMID:26079696
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1314116	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ABCG4 mRNA	PMID:39922521
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ABCG4 mRNA	PMID:33359661
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305840	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of ABCG4 mRNA	PMID:26496021
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1314116	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ABCG4 mRNA	PMID:39922521
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305840	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ABCG4 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA]	PMID:22129741
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ABCG4 mRNA	PMID:22100608
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314116	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ABCG4 mRNA	PMID:25629700
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314116	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ABCG4 mRNA]	PMID:22206623
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABCG4 mRNA	PMID:32525701
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of ABCG4 mRNA	PMID:38460933
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ABCG4 mRNA	PMID:38460933
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314116	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ABCG4 mRNA	PMID:28960355
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305840	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ABCG4 mRNA	PMID:31881176
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ABCG4 mRNA	PMID:28903495
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ABCG4 mRNA	PMID:27392435
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ABCG4 mRNA	PMID:27392435
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305840	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABCG4 mRNA	PMID:22298810
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314116	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABCG4 mRNA	PMID:21570461
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:28445	vincristine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	[Vincristine results in decreased susceptibility to Vincristine] which results in decreased expression of ABCG4 mRNA	PMID:19944135
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1305840	E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ABCG4 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA]	PMID:22129741
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ABCG4 promoter	PMID:27901495
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABCG4 mRNA	PMID:32234424
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314116	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ABCG4 mRNA	PMID:22228805
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ABCG4 3' UTR	PMID:27901495
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ABCG4 mRNA	PMID:37690743
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305840	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ABCG4 mRNA	PMID:25729387
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305840	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ABCG4 mRNA	PMID:25729387
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305840	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ABCG4 mRNA	PMID:30047161
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314116	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ABCG4 promoter	PMID:35295148
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305840	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCG4 mRNA	PMID:30816183
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314116	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCG4 mRNA	PMID:32156529
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305840	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of ABCG4 mRNA; [bisphenol A co-treated with Testosterone] results in decreased expression of ABCG4 mRNA	PMID:26496021
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1314116	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of ABCG4 mRNA	PMID:26377693
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:34631	chlorpyrifos	affects expression	ISO	RGD:1314116	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos affects the expression of ABCG4 mRNA	PMID:37019170
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314116	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ABCG4 mRNA	PMID:21266533
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305840	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ABCG4 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of ABCG4 mRNA]	PMID:22129741
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ABCG4 mRNA	PMID:31533062
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1314116	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ABCG4 mRNA	PMID:39529242
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305840	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ABCG4 mRNA	PMID:30047161
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314116	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ABCG4 mRNA	PMID:28973697
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1314116	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ABCG4 mRNA	PMID:39922521
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1314116	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of ABCG4 mRNA	PMID:18502557
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ABCG4 mRNA	PMID:38832940
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305840	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ABCG4 mRNA	PMID:33387578
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ABCG4 mRNA	PMID:38460933
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABCG4 mRNA	PMID:32525701
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305840	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ABCG4 mRNA	PMID:29391264
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:4953	exemestane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C056516	exemestane results in increased expression of ABCG4 mRNA	PMID:17254854
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305840	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ABCG4 mRNA	PMID:30307764
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305840	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ABCG4 mRNA	PMID:30047161
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314116	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of ABCG4 mRNA	PMID:23608068
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305840	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of ABCG4 mRNA	PMID:25729387
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305840	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ABCG4 mRNA	PMID:25729387
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314116	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ABCG4 mRNA	PMID:22206623
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314116	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ABCG4 mRNA]	PMID:22206623
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of ABCG4 mRNA	PMID:36318118
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305840	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of ABCG4 mRNA	PMID:33484710
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:7719	ochratoxin A	decreases methylation	ISO	RGD:1305840	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased methylation of ABCG4 gene	PMID:37162024
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305840	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased expression of ABCG4 mRNA	PMID:37162024
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314116	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ABCG4 mRNA	PMID:38648751
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ABCG4 mRNA	PMID:26079696
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ABCG4 mRNA	PMID:32525701
1314115	ABCG4	ATP binding cassette subfamily G member 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305840	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ABCG4 mRNA	PMID:30047161
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305841	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of GPR158 gene	PMID:28931070
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of GPR158 mRNA	PMID:29581250
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of GPR158 protein	PMID:37730182
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of GPR158 intron	PMID:30157460
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPR158 mRNA	PMID:35301059
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GPR158 gene; Aflatoxin B1 results in decreased methylation of GPR158 intron	PMID:27153756|PMID:30157460
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305841	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of GPR158 mRNA	PMID:31129395
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GPR158 mRNA	PMID:21867686
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552307	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GPR158 mRNA	PMID:25629700
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1305841	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of GPR158 gene	PMID:35440735
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305841	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPR158 mRNA	PMID:32109520
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552307	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPR158 mRNA	PMID:21570461
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305841	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of GPR158 mRNA	PMID:28374803
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1552307	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of GPR158 mRNA	PMID:36209798
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552307	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of GPR158 mRNA	PMID:37682722
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GPR158 3' UTR	PMID:27901495
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of GPR158 promoter	PMID:23974009
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of GPR158 gene	PMID:31601247
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552307	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GPR158 gene	PMID:35295148
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of GPR158 mRNA	PMID:27685785
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305841	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GPR158 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552307	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of GPR158 mRNA	PMID:32156529
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305841	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of GPR158 mRNA	PMID:31129395
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552307	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of GPR158 gene	PMID:31683443
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of GPR158 gene	PMID:31601247
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552307	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of GPR158 intron	PMID:28392331
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305841	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of GPR158 mRNA	PMID:32680482
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GPR158 mRNA	PMID:35301059
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GPR158 mRNA	PMID:31533062
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GPR158 mRNA	PMID:25979313
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GPR158 gene	PMID:29154799
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of GPR158 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR158 mRNA	PMID:27188386
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of GPR158 mRNA	PMID:20106945
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of GPR158 mRNA	PMID:24935251
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552307	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GPR158 mRNA	PMID:17562736
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305841	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of GPR158 gene	PMID:35440735
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552307	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GPR158 mRNA	PMID:22206623
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR158 mRNA	PMID:27188386
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of GPR158 mRNA	PMID:19095052
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305841	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GPR158 mRNA	PMID:24780913|PMID:25825206
1314117	GPR158	G protein-coupled receptor 158	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPR158 mRNA	PMID:27188386
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1623709	E	RGD:6480464	20190910	CTD	MESH:D002794	[Dietary Fats co-treated with Choline deficiency] results in increased expression of SLC17A4 mRNA; PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in increased expression of SLC17A4 mRNA]	PMID:29246445
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D000431	Ethanol results in decreased expression of SLC17A4 mRNA	PMID:31059573
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1623709	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of SLC17A4 mRNA	PMID:39298647
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of SLC17A4 mRNA	PMID:20106945
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1584758	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SLC17A4 mRNA	PMID:32145629
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1584758	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC17A4 mRNA	PMID:33387578
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1623709	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC17A4 mRNA	PMID:37992649
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1623709	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC17A4 mRNA	PMID:37992649
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1584758	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of SLC17A4 mRNA	PMID:28522335
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[APOE protein alternative form results in increased susceptibility to Cadmium] which results in decreased expression of SLC17A4 mRNA	PMID:35878927
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SLC17A4 protein	PMID:20106945
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SLC17A4 mRNA	PMID:22100608|PMID:27153756
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLC17A4 gene	PMID:27153756
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1584758	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC17A4 mRNA	PMID:31150632
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1623709	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC17A4 mRNA	PMID:40504410
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1623709	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SLC17A4 mRNA	PMID:28189721|PMID:28960355
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC17A4 mRNA	PMID:20106945
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1584758	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC17A4 mRNA	PMID:32109520
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1623709	E	RGD:6480464	20150825	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC17A4 mRNA	PMID:25975270
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013749	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC17A4 mRNA	PMID:26159488
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1623709	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of SLC17A4 mRNA	PMID:30807115
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1623709	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC17A4 mRNA	PMID:37992649
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC17A4 mRNA	PMID:29301061
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1623709	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC17A4 mRNA	PMID:40504410
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC17A4 3' UTR; Benzo(a)pyrene affects the methylation of SLC17A4 5' UTR; Benzo(a)pyrene affects the methylation of SLC17A4 promoter	PMID:27901495
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of SLC17A4 gene	PMID:25435355
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SLC17A4 mRNA	PMID:34973136
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC17A4 gene	PMID:31601247
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1584758	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of SLC17A4 mRNA	PMID:24136188
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1584758	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC17A4 mRNA	PMID:23411599
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1623709	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of SLC17A4 mRNA	PMID:23811191
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1623709	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SLC17A4 mRNA	PMID:28472532
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1584758	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC17A4 mRNA	PMID:25181051
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1584758	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SLC17A4 mRNA	PMID:32145629|PMID:34947998
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC17A4 gene	PMID:31601247
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S affects the methylation of SLC17A4 gene	PMID:31601247
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623709	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SLC17A4 mRNA	PMID:39298647|PMID:40203079
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1623709	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of SLC17A4 mRNA	PMID:26377693
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1623709	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of SLC17A4 mRNA	PMID:34813904
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1584758	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of SLC17A4 mRNA	PMID:30589522
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1623709	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SLC17A4 mRNA	PMID:28903501
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1584758	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SLC17A4 mRNA	PMID:24386269
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SLC17A4 mRNA	PMID:27153767
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1584758	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of SLC17A4 mRNA	PMID:25993096
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1623709	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SLC17A4 mRNA	PMID:17292431
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of SLC17A4 mRNA	PMID:29154799
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SLC17A4 gene	PMID:29154799
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC17A4 mRNA	PMID:20106945|PMID:27989131
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1623709	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC17A4 mRNA	PMID:37992649
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SLC17A4 mRNA	PMID:38832940
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623709	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLC17A4 mRNA	PMID:17562736
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC17A4 mRNA	PMID:26690555|PMID:29067470
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1623709	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLC17A4 mRNA	PMID:40504410
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:4791	endosulfan	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D004726	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC17A4 mRNA	PMID:26159488
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1623709	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SLC17A4 mRNA	PMID:35436446
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1623709	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of SLC17A4 mRNA	PMID:25620056
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1623709	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SLC17A4 mRNA	PMID:25620056
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1584758	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of SLC17A4 mRNA	PMID:24793618
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1623709	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of SLC17A4 mRNA	PMID:36851058
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC17A4 gene]	PMID:28238834
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1623709	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of SLC17A4 mRNA	PMID:26655953
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1584758	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SLC17A4 mRNA	PMID:32109520
1314119	SLC17A4	solute carrier family 17 member 4	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of SLC17A4 mRNA	PMID:25572481
1314120	CALN1	calneuron 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CALN1 mRNA	PMID:27188386
1314120	CALN1	calneuron 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CALN1 gene	PMID:20938992
1314120	CALN1	calneuron 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314121	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of CALN1 mRNA	PMID:36189433
1314120	CALN1	calneuron 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CALN1 mRNA	PMID:36189433
1314120	CALN1	calneuron 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of CALN1 mRNA	PMID:24763279
1314120	CALN1	calneuron 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305843	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CALN1 gene	PMID:28931070
1314120	CALN1	calneuron 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314121	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CALN1 mRNA	PMID:30319688
1314120	CALN1	calneuron 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314121	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CALN1 mRNA	PMID:39298647
1314120	CALN1	calneuron 1	gene	CHEBI:16548	chlordecone	affects response to substance	EXP		E	RGD:6480464	20150609	CTD	MESH:D007631	CALN1 gene SNP affects the susceptibility to Chlordecone	PMID:25622337
1314120	CALN1	calneuron 1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305843	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of CALN1 gene	PMID:27618143
1314120	CALN1	calneuron 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CALN1 gene	PMID:20938992
1314120	CALN1	calneuron 1	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1314121	E	RGD:6480464	20250114	CTD	MESH:D001554	Benzene results in decreased expression of CALN1 mRNA	PMID:37084897
1314120	CALN1	calneuron 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CALN1 mRNA	PMID:23649840
1314120	CALN1	calneuron 1	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1314121	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of CALN1 mRNA	PMID:22238285
1314120	CALN1	calneuron 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CALN1 mRNA	PMID:37992649
1314120	CALN1	calneuron 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CALN1 mRNA	PMID:36189433
1314120	CALN1	calneuron 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314121	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of CALN1 mRNA	PMID:33848595
1314120	CALN1	calneuron 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CALN1 mRNA	PMID:37992649
1314120	CALN1	calneuron 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CALN1 mRNA	PMID:31163220
1314120	CALN1	calneuron 1	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of CALN1 intron	PMID:30157460
1314120	CALN1	calneuron 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1305843	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of CALN1 mRNA	PMID:28522335
1314120	CALN1	calneuron 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CALN1 mRNA	PMID:23649840
1314120	CALN1	calneuron 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CALN1 protein	PMID:20106945
1314120	CALN1	calneuron 1	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of CALN1 intron	PMID:30157460
1314120	CALN1	calneuron 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CALN1 mRNA	PMID:23649840
1314120	CALN1	calneuron 1	gene	CHEBI:25710	organophosphorus compound	multiple interactions	ISO	RGD:1305843	E	RGD:6480464	20250401	CTD	MESH:D009943	[Dust results in increased abundance of Organophosphorus Compounds] which results in increased expression of CALN1 mRNA	PMID:39658253
1314120	CALN1	calneuron 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CALN1 gene	PMID:20938992
1314120	CALN1	calneuron 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of CALN1 mRNA	PMID:26272509
1314120	CALN1	calneuron 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CALN1 mRNA	PMID:27188386
1314120	CALN1	calneuron 1	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1305843	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of CALN1 gene	PMID:31011160
1314120	CALN1	calneuron 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of CALN1 mRNA	PMID:41028656
1314120	CALN1	calneuron 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CALN1 mRNA	PMID:28903495
1314120	CALN1	calneuron 1	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of CALN1 promoter	PMID:22847954
1314120	CALN1	calneuron 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CALN1 mRNA	PMID:19684285
1314120	CALN1	calneuron 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314121	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CALN1 mRNA	PMID:19684285
1314120	CALN1	calneuron 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CALN1 mRNA	PMID:17942748
1314120	CALN1	calneuron 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of CALN1 mRNA	PMID:26272509
1314120	CALN1	calneuron 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CALN1 mRNA	PMID:27188386
1314120	CALN1	calneuron 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CALN1 mRNA	PMID:41028656
1314120	CALN1	calneuron 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1305843	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in decreased expression of CALN1 mRNA	PMID:26033743
1314120	CALN1	calneuron 1	gene	CHEBI:28748	doxorubicin	affects methylation	ISO	RGD:1305843	E	RGD:6480464	20180116	CTD	MESH:D004317	Doxorubicin affects the methylation of CALN1 gene	PMID:28962528
1314120	CALN1	calneuron 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CALN1 mRNA	PMID:30031762
1314120	CALN1	calneuron 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CALN1 mRNA	PMID:37992649
1314120	CALN1	calneuron 1	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of CALN1 gene	PMID:28589171
1314120	CALN1	calneuron 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CALN1 mRNA	PMID:21457566
1314120	CALN1	calneuron 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CALN1 5' UTR	PMID:27901495
1314120	CALN1	calneuron 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CALN1 mRNA	PMID:20106945
1314120	CALN1	calneuron 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CALN1 mRNA	PMID:22316170
1314120	CALN1	calneuron 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CALN1 promoter	PMID:27901495
1314120	CALN1	calneuron 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of CALN1 promoter	PMID:23974009
1314120	CALN1	calneuron 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CALN1 mRNA	PMID:41028656
1314120	CALN1	calneuron 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1305843	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in decreased expression of CALN1 mRNA	PMID:26033743
1314120	CALN1	calneuron 1	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CALN1 gene	PMID:31601247
1314120	CALN1	calneuron 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CALN1 gene	PMID:31601247
1314120	CALN1	calneuron 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314121	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CALN1 mRNA	PMID:29264374
1314120	CALN1	calneuron 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314121	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CALN1 gene	PMID:35295148
1314120	CALN1	calneuron 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314121	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CALN1 mRNA	PMID:18301758|PMID:23811191
1314120	CALN1	calneuron 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305843	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CALN1 mRNA	PMID:25181051|PMID:30816183
1314120	CALN1	calneuron 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314121	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CALN1 mRNA	PMID:32156529
1314120	CALN1	calneuron 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305843	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of CALN1 mRNA	PMID:29097150
1314120	CALN1	calneuron 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305843	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CALN1 gene	PMID:28505145
1314120	CALN1	calneuron 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CALN1 gene	PMID:31601247
1314120	CALN1	calneuron 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CALN1 mRNA	PMID:25979313
1314120	CALN1	calneuron 1	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of CALN1 intron	PMID:30157460
1314120	CALN1	calneuron 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314121	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CALN1 mRNA	PMID:38685157
1314120	CALN1	calneuron 1	gene	CHEBI:34575	bisphenol F	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	bisphenol F results in increased methylation of CALN1 gene	PMID:31601247
1314120	CALN1	calneuron 1	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1314121	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of CALN1 intron	PMID:28392331
1314120	CALN1	calneuron 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of CALN1 mRNA	PMID:36117858
1314120	CALN1	calneuron 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305843	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of CALN1 gene	PMID:33148267
1314120	CALN1	calneuron 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CALN1 mRNA	PMID:38568856
1314120	CALN1	calneuron 1	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305843	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of CALN1 mRNA	PMID:25539665
1314120	CALN1	calneuron 1	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of CALN1 promoter	PMID:22847954
1314120	CALN1	calneuron 1	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of CALN1 promoter	PMID:22847954
1314120	CALN1	calneuron 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CALN1 mRNA	PMID:25979313
1314120	CALN1	calneuron 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314121	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CALN1 mRNA	PMID:17963808
1314120	CALN1	calneuron 1	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of CALN1 promoter	PMID:27989131
1314120	CALN1	calneuron 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CALN1 mRNA	PMID:37992649
1314120	CALN1	calneuron 1	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1314121	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of CALN1 mRNA	PMID:18502557
1314120	CALN1	calneuron 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of CALN1 mRNA	PMID:24449571
1314120	CALN1	calneuron 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of CALN1 mRNA	PMID:29067470
1314120	CALN1	calneuron 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1314121	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CALN1 mRNA	PMID:29279043
1314120	CALN1	calneuron 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CALN1 mRNA	PMID:17942748
1314120	CALN1	calneuron 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CALN1 mRNA	PMID:32234424
1314120	CALN1	calneuron 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314121	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CALN1 mRNA	PMID:25620056
1314120	CALN1	calneuron 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314121	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of CALN1 mRNA	PMID:36117858
1314120	CALN1	calneuron 1	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CALN1 mRNA	PMID:22079614
1314120	CALN1	calneuron 1	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of CALN1 intron	PMID:30157460
1314120	CALN1	calneuron 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305843	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of CALN1 gene	PMID:33148267
1314120	CALN1	calneuron 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CALN1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CALN1 mRNA	PMID:27188386
1314120	CALN1	calneuron 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314121	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CALN1 mRNA	PMID:31388691
1314120	CALN1	calneuron 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314121	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CALN1 mRNA	PMID:38648751
1314120	CALN1	calneuron 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of CALN1 mRNA	PMID:26705709
1314120	CALN1	calneuron 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305843	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CALN1 mRNA	PMID:24780913
1314120	CALN1	calneuron 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CALN1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CALN1 mRNA	PMID:27188386
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ARPC2 mRNA	PMID:35967413
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305848	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of ARPC2 mRNA	PMID:21551480
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ARPC2 mRNA	PMID:33167477
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ARPC2 mRNA	PMID:36331819
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314127	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ARPC2 mRNA	PMID:30319688
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1305848	E	RGD:6480464	20171010	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ARPC2 protein	PMID:24152438
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1305848	E	RGD:6480464	20171010	CTD	MESH:D006861	NOX1 protein affects the reaction [Hydrogen Peroxide results in increased expression of ARPC2 protein]; SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of ARPC2 protein]	PMID:24152438
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314127	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ARPC2 mRNA	PMID:39241906
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1305848	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ARPC2 protein	PMID:21673325
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305848	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ARPC2 protein	PMID:22061828
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARPC2 mRNA	PMID:36331819
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1305848	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of ARPC2 protein	PMID:33236894
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ARPC2 gene	PMID:27153756
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ARPC2 protein	PMID:38598786
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314127	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ARPC2 mRNA	PMID:31919559
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ARPC2 mRNA	PMID:22206623
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of ARPC2 promoter	PMID:21291286
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in increased expression of ARPC2 mRNA	PMID:37386098
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ARPC2 mRNA	PMID:27392435
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:27928	parathion	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in decreased methylation of ARPC2 promoter	PMID:22847954
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D019833	Genistein results in decreased expression of ARPC2 mRNA	PMID:22228119
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305848	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARPC2 mRNA	PMID:34747641
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314127	E	RGD:6480464	20181113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARPC2 protein	PMID:29935226
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARPC2 mRNA	PMID:17942748
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305848	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of ARPC2 mRNA	PMID:19013527
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314127	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ARPC2 protein	PMID:28918527
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARPC2 mRNA	PMID:29803840
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305848	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARPC2 protein	PMID:29459688
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARPC2 mRNA	PMID:32234424
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1305848	E	RGD:6480464	20171010	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ARPC2 mRNA	PMID:18685790
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of ARPC2 mRNA	PMID:31745603
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305848	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ARPC2 mRNA	PMID:30047161
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314127	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARPC2 gene	PMID:35295148
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305848	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ARPC2 mRNA	PMID:19167457
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ARPC2 mRNA; bisphenol A results in decreased expression of ARPC2 protein	PMID:29275510|PMID:31675489|PMID:34186270
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314127	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ARPC2 mRNA; bisphenol A results in decreased expression of ARPC2 protein	PMID:33221593|PMID:35999755
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1305848	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ARPC2 gene	PMID:28505145
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of ARPC2 protein	PMID:37567409
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305848	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ARPC2 mRNA	PMID:25181051
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:3423	carmustine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of ARPC2 mRNA	PMID:15980968
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of ARPC2 protein	PMID:34186270
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314127	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ARPC2 mRNA	PMID:39298647
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ARPC2 protein	PMID:34186270
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314127	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ARPC2 intron	PMID:28392331
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314127	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of ARPC2 protein	PMID:35999755
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305848	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARPC2 mRNA	PMID:21266533
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314127	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARPC2 mRNA	PMID:17361019|PMID:21266533
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to ARPC2 protein	PMID:32991956
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ARPC2 protein	PMID:38598786
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305848	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of ARPC2 gene	PMID:33148267
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARPC2 mRNA	PMID:37042841
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARPC2 protein	PMID:24527689
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ARPC2 mRNA	PMID:19320972
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ARPC2 mRNA	PMID:24449571
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314127	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of ARPC2 mRNA	PMID:17585979
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:D013755	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ARPC2 mRNA; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ARPC2 mRNA]	PMID:15477007
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1305848	E	RGD:6480464	20171010	CTD	MESH:D013755	Ro 32-0432 inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [CORO1B protein binds to ARPC2 protein]]; Tetradecanoylphorbol Acetate inhibits the reaction [CORO1B protein binds to ARPC2 protein]	PMID:16027158
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:38689	fonofos	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in decreased methylation of ARPC2 promoter	PMID:22847954
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:38960	terbufos	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in decreased methylation of ARPC2 promoter	PMID:22847954
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of ARPC2 mRNA	PMID:26352163
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ARPC2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ARPC2 mRNA	PMID:36331819
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ARPC2 mRNA	PMID:23179753
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ARPC2 gene	PMID:29154799
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305848	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ARPC2 mRNA	PMID:30047161
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ARPC2 mRNA	PMID:20106945|PMID:25562108
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ARPC2 mRNA	PMID:38832940
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314127	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARPC2 mRNA	PMID:17562736
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of ARPC2 promoter	PMID:21291286
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of ARPC2 mRNA	PMID:18175754
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314127	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARPC2 mRNA	PMID:17942748
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARPC2 mRNA	PMID:17942748
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305848	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ARPC2 mRNA	PMID:30047161
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ARPC2 mRNA	PMID:35964746
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of ARPC2 mRNA	PMID:16780908
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ARPC2 protein	PMID:32959892
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARPC2 mRNA	PMID:21641980
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314127	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ARPC2 mRNA	PMID:23650126
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:63954	ionomycin	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:D015759	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ARPC2 mRNA; pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ARPC2 mRNA]	PMID:15477007
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1314127	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ARPC2 protein	PMID:26558463
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305848	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of ARPC2 gene	PMID:33148267
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ARPC2 protein	PMID:34186270
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314127	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ARPC2 mRNA	PMID:22206623
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314127	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ARPC2 mRNA	PMID:22206623
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	EXP		E	RGD:6480464	20140708	CTD	MESH:C020972	pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ARPC2 mRNA]	PMID:15477007
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:79516	Nonylphenol	decreases expression	ISO	RGD:1305848	E	RGD:6480464	20141111	CTD	MESH:C025256	nonylphenol results in decreased expression of ARPC2 protein	PMID:19260726
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305848	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of ARPC2 mRNA	PMID:30047161
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314127	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ARPC2 mRNA	PMID:21795629
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305848	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ARPC2 mRNA	PMID:30047161
1314126	ARPC2	actin related protein 2/3 complex subunit 2	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:1305848	E	RGD:6480464	20171010	CTD	MESH:C093642	SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of ARPC2 protein]	PMID:24152438
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RIN3 gene	PMID:20938992
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RIN3 mRNA	PMID:33167477
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305849	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of RIN3 gene	PMID:35440735
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RIN3 mRNA	PMID:39241906
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of RIN3 mRNA	PMID:23019147
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RIN3 gene	PMID:20938992
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1305849	E	RGD:6480464	20120412	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of RIN3 mRNA	PMID:16809437
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of RIN3 mRNA	PMID:21592394
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of RIN3 mRNA	PMID:21592394
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RIN3 mRNA	PMID:31163220
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of RIN3 mRNA	PMID:21592394
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of RIN3 mRNA	PMID:21592394
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305849	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of RIN3 mRNA	PMID:22061828
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RIN3 mRNA	PMID:28818685
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RIN3 mRNA	PMID:36331819
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305849	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of RIN3 protein	PMID:34915118
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RIN3 mRNA	PMID:35301059
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RIN3 mRNA	PMID:37236586|PMID:37325564
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RIN3 mRNA	PMID:19549813
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RIN3 mRNA	PMID:21641981
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RIN3 exon; Aflatoxin B1 results in decreased methylation of RIN3 intron	PMID:30157460
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RIN3 promoter	PMID:30157460
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of RIN3 mRNA	PMID:19774075
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RIN3 gene	PMID:20938992
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RIN3 mRNA	PMID:40512198
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of RIN3 gene] which results in decreased expression of RIN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the expression of RIN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of RIN3 gene	PMID:40504410
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RIN3 protein	PMID:35688186
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:1305849	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of RIN3 gene	PMID:31011160
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RIN3 mRNA	PMID:23557933
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of RIN3 mRNA	PMID:30912803
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305849	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RIN3 mRNA	PMID:22298810|PMID:34747641
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314129	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RIN3 mRNA	PMID:21570461
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314129	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of RIN3 mRNA	PMID:39631538
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RIN3 mRNA	PMID:38568856
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of RIN3 mRNA	PMID:39719251
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RIN3 mRNA	PMID:40512198
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of RIN3 gene] which results in decreased expression of RIN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the expression of RIN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of RIN3 gene	PMID:40504410
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RIN3 intron	PMID:30157460
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RIN3 mRNA	PMID:26238291
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314129	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RIN3 mRNA	PMID:21569818|PMID:22228805
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314129	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RIN3 intron	PMID:27901495
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of RIN3 gene	PMID:25435355
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305849	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RIN3 mRNA	PMID:25729387
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of RIN3 mRNA	PMID:23557971
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314129	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RIN3 promoter	PMID:35295148
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305849	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RIN3 mRNA	PMID:34492290
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of RIN3 gene	PMID:23968726
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305849	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RIN3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of RIN3 mRNA	PMID:36232920
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314129	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of RIN3 mRNA	PMID:30951980|PMID:32156529|PMID:34585602
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305849	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RIN3 gene	PMID:28505145
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1314129	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RIN3 promoter	PMID:27312807
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20180515	CTD	MESH:D008748	[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of RIN3 mRNA	PMID:25926378
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RIN3 mRNA	PMID:39298647
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314129	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of RIN3 mRNA	PMID:30951980
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314129	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RIN3 mRNA	PMID:30951980
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314129	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RIN3 intron	PMID:28392331
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of RIN3 mRNA	PMID:34813904
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of RIN3 mRNA	PMID:34813904
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of RIN3 gene	PMID:23968726
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RIN3 mRNA	PMID:37042841
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RIN3 mRNA	PMID:35301059
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RIN3 mRNA	PMID:37236586|PMID:37325564
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RIN3 mRNA	PMID:23146750
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305849	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of RIN3 mRNA	PMID:35163327
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RIN3 mRNA	PMID:24449571
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of RIN3 mRNA	PMID:28302478
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RIN3 mRNA	PMID:36331819
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1314129	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of RIN3 mRNA	PMID:23125180
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RIN3 gene	PMID:29154799
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of RIN3 mRNA	PMID:17183730
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RIN3 mRNA	PMID:25562108
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of RIN3 mRNA	PMID:24449571
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314129	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RIN3 mRNA	PMID:17562736
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305849	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RIN3 mRNA	PMID:33387578
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RIN3 mRNA	PMID:40512198
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of RIN3 gene] which results in decreased expression of RIN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the expression of RIN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of RIN3 gene	PMID:40504410
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314129	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of RIN3 mRNA	PMID:25554681
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20180515	CTD	MESH:D037742	[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of RIN3 mRNA	PMID:25926378
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314129	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RIN3 mRNA	PMID:35964746
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of RIN3 mRNA	PMID:17183730
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314129	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RIN3 mRNA	PMID:38701926
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305849	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RIN3 mRNA	PMID:25729387
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RIN3 mRNA	PMID:22079614
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314129	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RIN3 mRNA	PMID:22206623
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305849	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of RIN3 mRNA	PMID:33484710
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RIN3 gene]	PMID:28238834
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RIN3 mRNA	PMID:23146750
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of RIN3 mRNA	PMID:39847705
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305849	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RIN3 mRNA	PMID:24780913
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314129	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RIN3 mRNA	PMID:40826991
1314128	RIN3	Ras and Rab interactor 3	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305849	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RIN3 mRNA	PMID:19281266
1314130	ASTN2	astrotactin 2	gene	CHEBI:110423	clodronic acid	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in increased expression of ASTN2 mRNA	PMID:25596134
1314130	ASTN2	astrotactin 2	gene	CHEBI:15365	acetylsalicylic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of ASTN2 mRNA	PMID:11906190
1314130	ASTN2	astrotactin 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ASTN2 mRNA	PMID:23724009
1314130	ASTN2	astrotactin 2	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ASTN2 mRNA	PMID:25596134
1314130	ASTN2	astrotactin 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314131	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ASTN2 mRNA	PMID:36331819
1314130	ASTN2	astrotactin 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:2320342	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of ASTN2 gene	PMID:28931070|PMID:35440735
1314130	ASTN2	astrotactin 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314131	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ASTN2 mRNA	PMID:30319688
1314130	ASTN2	astrotactin 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ASTN2 mRNA	PMID:20044591
1314130	ASTN2	astrotactin 2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of ASTN2 mRNA	PMID:22574217
1314130	ASTN2	astrotactin 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ASTN2 mRNA	PMID:23649840
1314130	ASTN2	astrotactin 2	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ASTN2 mRNA	PMID:26079696
1314130	ASTN2	astrotactin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:2320342	E	RGD:6480464	20191112	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN2 mRNA	PMID:31199487
1314130	ASTN2	astrotactin 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:2320342	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ASTN2 mRNA	PMID:26577399
1314130	ASTN2	astrotactin 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314131	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASTN2 mRNA	PMID:37236586
1314130	ASTN2	astrotactin 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ASTN2 mRNA	PMID:19549813
1314130	ASTN2	astrotactin 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ASTN2 mRNA	PMID:23649840
1314130	ASTN2	astrotactin 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ASTN2 protein	PMID:20106945
1314130	ASTN2	astrotactin 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ASTN2 gene	PMID:27153756
1314130	ASTN2	astrotactin 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ASTN2 mRNA	PMID:21632981
1314130	ASTN2	astrotactin 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ASTN2 intron	PMID:30157460
1314130	ASTN2	astrotactin 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ASTN2 mRNA	PMID:23649840
1314130	ASTN2	astrotactin 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314131	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ASTN2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ASTN2 mRNA	PMID:34911549
1314130	ASTN2	astrotactin 2	gene	CHEBI:27871	chloroacetaldehyde	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in increased expression of ASTN2 mRNA	PMID:25596134
1314130	ASTN2	astrotactin 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ASTN2 mRNA	PMID:23557933
1314130	ASTN2	astrotactin 2	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of ASTN2 mRNA	PMID:23300844
1314130	ASTN2	astrotactin 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ASTN2 mRNA	PMID:27594783
1314130	ASTN2	astrotactin 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in increased expression of ASTN2 mRNA	PMID:25596134
1314130	ASTN2	astrotactin 2	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of ASTN2 promoter	PMID:22847954
1314130	ASTN2	astrotactin 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ASTN2 mRNA	PMID:24768652|PMID:25583101
1314130	ASTN2	astrotactin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:2320342	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ASTN2 mRNA	PMID:32109520
1314130	ASTN2	astrotactin 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ASTN2 mRNA	PMID:33212167
1314130	ASTN2	astrotactin 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ASTN2 mRNA	PMID:32763439
1314130	ASTN2	astrotactin 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ASTN2 mRNA	PMID:20971185
1314130	ASTN2	astrotactin 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ASTN2 mRNA	PMID:29803840
1314130	ASTN2	astrotactin 2	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ASTN2 gene	PMID:28589171
1314130	ASTN2	astrotactin 2	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of ASTN2 mRNA	PMID:20106945|PMID:22316170
1314130	ASTN2	astrotactin 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ASTN2 intron; Benzo(a)pyrene affects the methylation of ASTN2 promoter	PMID:27901495|PMID:30157460
1314130	ASTN2	astrotactin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ASTN2 mRNA	PMID:21632981
1314130	ASTN2	astrotactin 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ASTN2 mRNA	PMID:20971185
1314130	ASTN2	astrotactin 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ASTN2 gene	PMID:31601247
1314130	ASTN2	astrotactin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314131	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ASTN2 gene	PMID:35295148
1314130	ASTN2	astrotactin 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314131	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of ASTN2 mRNA	PMID:29264374
1314130	ASTN2	astrotactin 2	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of ASTN2 gene	PMID:31601247
1314130	ASTN2	astrotactin 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of ASTN2 mRNA	PMID:20678512
1314130	ASTN2	astrotactin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314131	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of ASTN2 mRNA	PMID:25594700
1314130	ASTN2	astrotactin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ASTN2 gene	PMID:31601247
1314130	ASTN2	astrotactin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ASTN2 gene	PMID:31601247
1314130	ASTN2	astrotactin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314131	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ASTN2 mRNA	PMID:30951980
1314130	ASTN2	astrotactin 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ASTN2 intron	PMID:30157460
1314130	ASTN2	astrotactin 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314131	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ASTN2 mRNA	PMID:30951980
1314130	ASTN2	astrotactin 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314131	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ASTN2 intron	PMID:28392331
1314130	ASTN2	astrotactin 2	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:2320342	E	RGD:6480464	20191112	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN2 mRNA	PMID:31199487
1314130	ASTN2	astrotactin 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:2320342	E	RGD:6480464	20191112	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN2 mRNA	PMID:31199487
1314130	ASTN2	astrotactin 2	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:2320342	E	RGD:6480464	20191112	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN2 mRNA	PMID:31199487
1314130	ASTN2	astrotactin 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:2320342	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of ASTN2 mRNA	PMID:30723492
1314130	ASTN2	astrotactin 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ASTN2 mRNA	PMID:38382870
1314130	ASTN2	astrotactin 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ASTN2 mRNA	PMID:21457566
1314130	ASTN2	astrotactin 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314131	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASTN2 mRNA	PMID:37236586
1314130	ASTN2	astrotactin 2	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:2320342	E	RGD:6480464	20191112	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN2 mRNA	PMID:31199487
1314130	ASTN2	astrotactin 2	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of ASTN2 promoter	PMID:22847954
1314130	ASTN2	astrotactin 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ASTN2 mRNA	PMID:31533062
1314130	ASTN2	astrotactin 2	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of ASTN2 promoter	PMID:22847954
1314130	ASTN2	astrotactin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ASTN2 mRNA	PMID:40419075
1314130	ASTN2	astrotactin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314131	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ASTN2 mRNA	PMID:36331819
1314130	ASTN2	astrotactin 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ASTN2 mRNA	PMID:25979313
1314130	ASTN2	astrotactin 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ASTN2 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386
1314130	ASTN2	astrotactin 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ASTN2 gene	PMID:29154799
1314130	ASTN2	astrotactin 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASTN2 mRNA	PMID:27188386
1314130	ASTN2	astrotactin 2	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of ASTN2 mRNA	PMID:25596134
1314130	ASTN2	astrotactin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ASTN2 mRNA	PMID:25562108
1314130	ASTN2	astrotactin 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ASTN2 mRNA	PMID:24935251
1314130	ASTN2	astrotactin 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ASTN2 mRNA	PMID:29067470
1314130	ASTN2	astrotactin 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314131	E	RGD:6480464	20120412	CTD	MESH:D000082	MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ASTN2 mRNA]	PMID:18700144
1314130	ASTN2	astrotactin 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ASTN2 mRNA	PMID:23300844
1314130	ASTN2	astrotactin 2	gene	CHEBI:6809	methamphetamine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008694	ASTN2 gene SNP affects the susceptibility to Methamphetamine	PMID:18316681
1314130	ASTN2	astrotactin 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ASTN2 intron	PMID:30157460
1314130	ASTN2	astrotactin 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASTN2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASTN2 mRNA	PMID:27188386
1314130	ASTN2	astrotactin 2	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:2320342	E	RGD:6480464	20191112	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of ASTN2 mRNA	PMID:31199487
1314130	ASTN2	astrotactin 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ASTN2 gene]	PMID:28238834
1314130	ASTN2	astrotactin 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:2320342	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ASTN2 mRNA	PMID:32109520
1314130	ASTN2	astrotactin 2	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of ASTN2 mRNA	PMID:26272509
1314130	ASTN2	astrotactin 2	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASTN2 mRNA	PMID:27188386
1314130	ASTN2	astrotactin 2	gene	CHEBI:8922	Rutecarpine	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C028632	rutecarpine results in decreased expression of ASTN2 mRNA	PMID:34955744
1314130	ASTN2	astrotactin 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASTN2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASTN2 mRNA	PMID:27188386
1314130	ASTN2	astrotactin 2	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ASTN2 mRNA	PMID:17440010
1314130	ASTN2	astrotactin 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ASTN2 mRNA	PMID:38568856
1314130	ASTN2	astrotactin 2	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:2320342	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of ASTN2 gene	PMID:31682807
1314133	FKRP	fukutin related protein	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FKRP protein]	PMID:38195004
1314133	FKRP	fukutin related protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of FKRP mRNA	PMID:23724009
1314133	FKRP	fukutin related protein	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FKRP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FKRP mRNA	PMID:32699268
1314133	FKRP	fukutin related protein	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of FKRP mRNA	PMID:22378314
1314133	FKRP	fukutin related protein	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314134	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FKRP mRNA	PMID:30319688
1314133	FKRP	fukutin related protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of FKRP mRNA	PMID:21179406
1314133	FKRP	fukutin related protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314134	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FKRP mRNA	PMID:39298647
1314133	FKRP	fukutin related protein	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305852	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of FKRP gene	PMID:27618143
1314133	FKRP	fukutin related protein	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of FKRP mRNA	PMID:21179406
1314133	FKRP	fukutin related protein	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305852	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FKRP mRNA	PMID:33387578
1314133	FKRP	fukutin related protein	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FKRP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FKRP protein	PMID:38195004
1314133	FKRP	fukutin related protein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FKRP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FKRP mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of FKRP mRNA	PMID:32699268
1314133	FKRP	fukutin related protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314134	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FKRP mRNA	PMID:22206623
1314133	FKRP	fukutin related protein	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of FKRP mRNA	PMID:25583101
1314133	FKRP	fukutin related protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305852	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FKRP mRNA	PMID:33387578
1314133	FKRP	fukutin related protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314134	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FKRP mRNA	PMID:31961203
1314133	FKRP	fukutin related protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314134	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FKRP mRNA	PMID:17942748
1314133	FKRP	fukutin related protein	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FKRP mRNA	PMID:29803840
1314133	FKRP	fukutin related protein	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FKRP mRNA	PMID:38568856
1314133	FKRP	fukutin related protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FKRP mRNA	PMID:20106945
1314133	FKRP	fukutin related protein	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FKRP promoter	PMID:27901495
1314133	FKRP	fukutin related protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FKRP 5' UTR	PMID:27901495
1314133	FKRP	fukutin related protein	gene	CHEBI:30778	gallic acid	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of FKRP mRNA	PMID:34408198
1314133	FKRP	fukutin related protein	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of FKRP mRNA	PMID:35984750
1314133	FKRP	fukutin related protein	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FKRP gene	PMID:31601247
1314133	FKRP	fukutin related protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305852	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FKRP mRNA	PMID:25181051|PMID:34947998
1314133	FKRP	fukutin related protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314134	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of FKRP mRNA	PMID:32156529
1314133	FKRP	fukutin related protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FKRP gene	PMID:31601247
1314133	FKRP	fukutin related protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of FKRP gene	PMID:31601247
1314133	FKRP	fukutin related protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FKRP mRNA	PMID:37042841
1314133	FKRP	fukutin related protein	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305852	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of FKRP promoter	PMID:22457795
1314133	FKRP	fukutin related protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FKRP protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of FKRP protein	PMID:38195004
1314133	FKRP	fukutin related protein	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FKRP mRNA	PMID:24449571
1314133	FKRP	fukutin related protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of FKRP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of FKRP mRNA	PMID:32699268
1314133	FKRP	fukutin related protein	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FKRP mRNA	PMID:31533062
1314133	FKRP	fukutin related protein	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FKRP mRNA	PMID:25979313
1314133	FKRP	fukutin related protein	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FKRP gene	PMID:29154799
1314133	FKRP	fukutin related protein	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FKRP mRNA	PMID:25562108
1314133	FKRP	fukutin related protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314134	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FKRP mRNA	PMID:17562736
1314133	FKRP	fukutin related protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of FKRP mRNA	PMID:22230336|PMID:29067470
1314133	FKRP	fukutin related protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305852	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FKRP mRNA	PMID:33387578
1314133	FKRP	fukutin related protein	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314134	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FKRP mRNA	PMID:17942748
1314133	FKRP	fukutin related protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314134	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of FKRP mRNA	PMID:35964746
1314133	FKRP	fukutin related protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314134	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FKRP mRNA	PMID:22206623
1314133	FKRP	fukutin related protein	gene	CHEBI:75249	potassium chromate	increases expression	ISO	RGD:1314134	E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of FKRP protein	PMID:23618972
1314133	FKRP	fukutin related protein	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FKRP gene]	PMID:28238834
1314133	FKRP	fukutin related protein	gene	CHEBI:86204	chromium trinitrate	increases expression	ISO	RGD:1314134	E	RGD:6480464	20170228	CTD	MESH:C041167	chromium nitrate results in increased expression of FKRP protein	PMID:23618972
1314133	FKRP	fukutin related protein	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314134	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of FKRP mRNA	PMID:40826991
1314133	FKRP	fukutin related protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305852	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FKRP mRNA	PMID:21346803
1314133	FKRP	fukutin related protein	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305852	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of FKRP mRNA	PMID:21346803
1314133	FKRP	fukutin related protein	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305852	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of FKRP mRNA	PMID:23034163
1314133	FKRP	fukutin related protein	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305852	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of FKRP mRNA	PMID:23869203
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1591931	E	RGD:6480464	20140729	CTD	MESH:D004237	Diuron results in decreased expression of SH3BGRL2 mRNA	PMID:21551480
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552309	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SH3BGRL2 mRNA	PMID:36331819
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552309	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SH3BGRL2 mRNA	PMID:30319688
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SH3BGRL2 mRNA	PMID:21632981
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552309	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SH3BGRL2 mRNA	PMID:39298647
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1591931	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of SH3BGRL2 mRNA	PMID:26496021
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:16716	benzene	decreases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in decreased expression of SH3BGRL2 mRNA	PMID:19162166
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SH3BGRL2 mRNA	PMID:21179406
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1552309	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SH3BGRL2 mRNA	PMID:19850644
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552309	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of SH3BGRL2 mRNA]	PMID:19850644
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552309	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SH3BGRL2 mRNA	PMID:36331819
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:22718	benzoates	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in increased expression of SH3BGRL2 mRNA	PMID:29472718
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SH3BGRL2 mRNA	PMID:35301059
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SH3BGRL2 mRNA	PMID:19549813
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1591931	E	RGD:6480464	20140729	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SH3BGRL2 mRNA	PMID:22129741
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1552309	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SH3BGRL2 mRNA	PMID:19770486
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SH3BGRL2 gene	PMID:27153756
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SH3BGRL2 intron	PMID:30157460
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552309	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SH3BGRL2 mRNA	PMID:28960355
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of SH3BGRL2 mRNA	PMID:24768652|PMID:25583101
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of SH3BGRL2 mRNA	PMID:23195993
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552309	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SH3BGRL2 mRNA	PMID:21570461
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552309	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SH3BGRL2 mRNA	PMID:19684285
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SH3BGRL2 mRNA	PMID:19684285
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SH3BGRL2 mRNA	PMID:30851411
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SH3BGRL2 mRNA	PMID:34032870|PMID:39719251
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of SH3BGRL2 mRNA	PMID:22714537
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SH3BGRL2 mRNA	PMID:32234424
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1591931	E	RGD:6480464	20140729	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SH3BGRL2 mRNA	PMID:21839799
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552309	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SH3BGRL2 mRNA	PMID:19770486
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SH3BGRL2 3' UTR	PMID:27901495
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SH3BGRL2 mRNA	PMID:25895662
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1591931	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SH3BGRL2 mRNA	PMID:25729387
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552309	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of SH3BGRL2 mRNA	PMID:23557971
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552309	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SH3BGRL2 gene	PMID:35295148
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552309	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of SH3BGRL2 mRNA	PMID:35295148
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552309	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SH3BGRL2 mRNA	PMID:18445702
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552309	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SH3BGRL2 mRNA	PMID:18301758|PMID:23811191
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552309	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SH3BGRL2 mRNA	PMID:28472532
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1591931	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SH3BGRL2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1591931	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of SH3BGRL2 mRNA	PMID:32145629
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1591931	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SH3BGRL2 gene	PMID:28505145
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1591931	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of SH3BGRL2 mRNA	PMID:26496021
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1552309	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SH3BGRL2 mRNA	PMID:26682919
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552309	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SH3BGRL2 mRNA	PMID:30951980|PMID:39298647
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1552309	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of SH3BGRL2 mRNA	PMID:26377693
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552309	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SH3BGRL2 mRNA	PMID:38685157
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552309	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SH3BGRL2 mRNA	PMID:37019170
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1591931	E	RGD:6480464	20140729	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of SH3BGRL2 mRNA	PMID:22129741
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SH3BGRL2 mRNA	PMID:37042841
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SH3BGRL2 mRNA	PMID:38568856
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SH3BGRL2 mRNA	PMID:35301059
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SH3BGRL2 mRNA	PMID:32588087|PMID:36326898
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SH3BGRL2 mRNA	PMID:32588087
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of SH3BGRL2 mRNA	PMID:36864359
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552309	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SH3BGRL2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SH3BGRL2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SH3BGRL2 mRNA	PMID:36331819
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SH3BGRL2 mRNA	PMID:25979313
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SH3BGRL2 gene	PMID:29154799
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SH3BGRL2 mRNA	PMID:23179753|PMID:29154799
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of SH3BGRL2 mRNA	PMID:20106945
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SH3BGRL2 mRNA	PMID:25562108
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SH3BGRL2 mRNA	PMID:36621641
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1552309	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SH3BGRL2 mRNA	PMID:28973697
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SH3BGRL2 mRNA	PMID:29067470
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of SH3BGRL2 mRNA	PMID:25572481
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552309	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SH3BGRL2 mRNA	PMID:35964746
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1552309	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of SH3BGRL2 mRNA	PMID:19042947
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1552309	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of SH3BGRL2 mRNA	PMID:38701926
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1591931	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of SH3BGRL2 mRNA	PMID:28801915
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1591931	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SH3BGRL2 mRNA	PMID:25729387
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SH3BGRL2 mRNA	PMID:28988120
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1591931	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SH3BGRL2 gene	PMID:35440735
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552309	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SH3BGRL2 mRNA	PMID:22206623
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SH3BGRL2 mRNA	PMID:37199045
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SH3BGRL2 mRNA	PMID:30851411
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SH3BGRL2 gene]	PMID:28238834
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SH3BGRL2 protein	PMID:37385330
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552309	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SH3BGRL2 mRNA	PMID:39847705
1314135	SH3BGRL2	SH3 domain binding glutamate rich protein like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1591931	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SH3BGRL2 mRNA	PMID:24780913
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	affects expression	EXP		E	RGD:6480464	20130416	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl affects the expression of DNAH3 mRNA	PMID:20638727
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:16583	butane-2,3-dione	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D003931	Diacetyl results in decreased expression of DNAH3 mRNA	PMID:30710127
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:17303	morphine	decreases expression	ISO	RGD:1615518	E	RGD:6480464	20120412	CTD	MESH:D009020	Morphine results in decreased expression of DNAH3 mRNA	PMID:21178816
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of DNAH3 mRNA	PMID:33647349
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305855	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of DNAH3 mRNA	PMID:26577399
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DNAH3 mRNA	PMID:28818685
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1615518	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DNAH3 mRNA	PMID:36331819
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305855	E	RGD:6480464	20140729	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA]	PMID:22129741
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of DNAH3 intron	PMID:30157460
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:2682	amphotericin B	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in increased expression of DNAH3 mRNA	PMID:28534445
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1305855	E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of DNAH3 mRNA	PMID:38314887
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:27928	parathion	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in decreased methylation of DNAH3 promoter	PMID:22847954
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1615518	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNAH3 mRNA	PMID:21354282|PMID:39270811|PMID:39401686
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1305855	E	RGD:6480464	20140729	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA]	PMID:22129741
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DNAH3 mRNA	PMID:38568856
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DNAH3 intron	PMID:30157460
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of DNAH3 mRNA	PMID:19150397
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of DNAH3 gene	PMID:31601247
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1615518	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of DNAH3 mRNA	PMID:23557971
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305855	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAH3 mRNA	PMID:25181051
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1615518	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAH3 mRNA	PMID:32156529
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DNAH3 gene	PMID:31601247
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of DNAH3 gene	PMID:31601247
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305855	E	RGD:6480464	20140729	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of DNAH3 mRNA]	PMID:22129741
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DNAH3 mRNA	PMID:38568856
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1615518	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DNAH3 mRNA	PMID:40194260
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:38689	fonofos	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in decreased methylation of DNAH3 promoter	PMID:22847954
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:38960	terbufos	decreases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in decreased methylation of DNAH3 promoter	PMID:22847954
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1615518	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DNAH3 mRNA	PMID:36331819
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DNAH3 mRNA	PMID:38832940
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615518	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DNAH3 mRNA	PMID:25554681
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:52774	pentane-2,3-dione	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C013186	2,3-pentanedione results in decreased expression of DNAH3 mRNA	PMID:30710127
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:5613	haloperidol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in increased expression of DNAH3 protein	PMID:34122009
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1615518	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of DNAH3 mRNA	PMID:38701926
1314138	DNAH3	dynein axonemal heavy chain 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DNAH3 gene]	PMID:28238834
1314139	TPSD1	tryptase delta 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TPSD1 promoter	PMID:27901495
1314139	TPSD1	tryptase delta 1	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of TPSD1 mRNA	PMID:37690743
1314139	TPSD1	tryptase delta 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TPSD1 gene	PMID:31601247
1314139	TPSD1	tryptase delta 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TPSD1 gene	PMID:29154799
1314139	TPSD1	tryptase delta 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of TPSD1 mRNA	PMID:26690555
1314139	TPSD1	tryptase delta 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TPSD1 gene]	PMID:28238834
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in decreased expression of CDC42EP3 mRNA	PMID:15894607|PMID:21934132|PMID:33167477
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of CDC42EP3 mRNA	PMID:23724009
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in decreased expression of CDC42EP3 mRNA	PMID:15894607
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314142	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDC42EP3 mRNA	PMID:30529165
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CDC42EP3 mRNA	PMID:22378314
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1305858	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of CDC42EP3 mRNA	PMID:36841081
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of CDC42EP3 mRNA	PMID:29581250
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314142	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CDC42EP3 mRNA	PMID:39241906
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CDC42EP3 mRNA	PMID:38568856
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305858	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CDC42EP3 mRNA	PMID:33387578
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CDC42EP3 mRNA	PMID:23649840
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of CDC42EP3 mRNA	PMID:17404688|PMID:21795739
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1314142	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of CDC42EP3 mRNA	PMID:22238285
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CDC42EP3 mRNA	PMID:21179406
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of CDC42EP3 mRNA	PMID:21592394
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of CDC42EP3 mRNA	PMID:21592394
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305858	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of CDC42EP3 mRNA	PMID:26496021
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314142	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CDC42EP3 mRNA	PMID:34319233
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CDC42EP3 protein	PMID:37730182
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CDC42EP3 mRNA	PMID:21592394
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of CDC42EP3 mRNA	PMID:21592394
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305858	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CDC42EP3 mRNA	PMID:33387578
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CDC42EP3 mRNA	PMID:28818685
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDC42EP3 mRNA	PMID:39836092
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of CDC42EP3 mRNA	PMID:23649840
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CDC42EP3 protein	PMID:20106945
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CDC42EP3 mRNA	PMID:27153756
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CDC42EP3 mRNA	PMID:41430723
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CDC42EP3 mRNA	PMID:18593933
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305858	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CDC42EP3 mRNA	PMID:31150632
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314142	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CDC42EP3 mRNA	PMID:17484886
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CDC42EP3 mRNA	PMID:25629700
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDC42EP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC42EP3 mRNA	PMID:39836092
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDC42EP3 mRNA	PMID:27188386
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CDC42EP3 mRNA	PMID:35897073
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305858	E	RGD:6480464	20120522	CTD	MESH:D002945	Cisplatin results in decreased expression of CDC42EP3 mRNA	PMID:22023808
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CDC42EP3 mRNA	PMID:27594783
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314142	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of CDC42EP3 mRNA	PMID:21151649
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:28088	genistein	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein affects the expression of CDC42EP3 mRNA	PMID:26865667
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314142	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDC42EP3 mRNA	PMID:21570461
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305858	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC42EP3 mRNA	PMID:34747641
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CDC42EP3 mRNA	PMID:19465110
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of CDC42EP3 mRNA	PMID:29955902
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CDC42EP3 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CDC42EP3 mRNA	PMID:30851411
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of CDC42EP3 mRNA	PMID:23649840
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CDC42EP3 mRNA	PMID:32763439
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CDC42EP3 mRNA	PMID:29803840
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of CDC42EP3 protein	PMID:35688186
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:28876	melphalan	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of CDC42EP3 mRNA	PMID:22363485
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of CDC42EP3 mRNA	PMID:34032870
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDC42EP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC42EP3 mRNA	PMID:39836092
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CDC42EP3 5' UTR; Benzo(a)pyrene results in decreased methylation of CDC42EP3 promoter	PMID:27901495
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314142	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CDC42EP3 mRNA	PMID:22228805
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CDC42EP3 mRNA]	PMID:32406909
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CDC42EP3 mRNA	PMID:18593933
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of CDC42EP3 mRNA	PMID:20382639
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CDC42EP3 mRNA	PMID:15894607
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CDC42EP3 gene	PMID:31601247
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314142	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CDC42EP3 promoter	PMID:35295148
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314142	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CDC42EP3 gene; titanium dioxide results in increased methylation of CDC42EP3 promoter	PMID:35295148
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314142	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CDC42EP3 mRNA	PMID:19710929
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314142	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of CDC42EP3 mRNA	PMID:28329830
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20131210	CTD	MESH:C006780	bisphenol A results in decreased expression of CDC42EP3 mRNA	PMID:23798566
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CDC42EP3 gene	PMID:31601247
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305858	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CDC42EP3 mRNA	PMID:30816183|PMID:32528016|PMID:33296240
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314142	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of CDC42EP3 mRNA	PMID:30951980|PMID:32156529
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305858	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CDC42EP3 gene	PMID:28505145
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of CDC42EP3 gene	PMID:31601247
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305858	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of CDC42EP3 mRNA	PMID:26496021
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CDC42EP3 mRNA	PMID:25979313
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314142	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CDC42EP3 mRNA	PMID:30951980|PMID:40203079
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314142	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CDC42EP3 mRNA	PMID:30951980
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314142	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CDC42EP3 mRNA	PMID:21266533
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CDC42EP3 mRNA	PMID:37042841
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305858	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CDC42EP3 mRNA	PMID:30589522
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDC42EP3 mRNA	PMID:39836092
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CDC42EP3 mRNA	PMID:38568856
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305858	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CDC42EP3 mRNA	PMID:36928142
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CDC42EP3 mRNA	PMID:19320972
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314142	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CDC42EP3 mRNA	PMID:40194260
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CDC42EP3 mRNA	PMID:31533062
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CDC42EP3 mRNA	PMID:25979313
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314142	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CDC42EP3 mRNA	PMID:17292431
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of CDC42EP3 mRNA	PMID:28001369
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of CDC42EP3 mRNA	PMID:27989131
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314142	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CDC42EP3 mRNA	PMID:28973697
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CDC42EP3 mRNA	PMID:38832940
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CDC42EP3 mRNA	PMID:24935251|PMID:26272509
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC42EP3 mRNA	PMID:27188386
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314142	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CDC42EP3 mRNA	PMID:17562736
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of CDC42EP3 mRNA	PMID:21420995
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of CDC42EP3 mRNA	PMID:33725128
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDC42EP3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CDC42EP3 mRNA	PMID:39836092
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1305858	E	RGD:6480464	20170725	CTD	MESH:D007654	Ketoconazole results in increased expression of CDC42EP3 mRNA	PMID:28263823
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDC42EP3 mRNA	PMID:22079256
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CDC42EP3 mRNA	PMID:26865667
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1305858	E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CDC42EP3 mRNA	PMID:26865667
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in decreased expression of CDC42EP3 mRNA	PMID:15894607
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CDC42EP3 mRNA; Nanotubes, Carbon results in decreased expression of CDC42EP3 mRNA	PMID:25554681
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1305858	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of CDC42EP3 mRNA	PMID:21983209
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305858	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of CDC42EP3 mRNA	PMID:20080153
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305858	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of CDC42EP3 mRNA	PMID:28801915
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CDC42EP3 mRNA	PMID:39836092
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of CDC42EP3 mRNA	PMID:15336504
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305858	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CDC42EP3 mRNA	PMID:37269647
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of CDC42EP3 mRNA	PMID:36907384
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of CDC42EP3 mRNA	PMID:20003209
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of CDC42EP3 mRNA	PMID:37939859
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1305858	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of CDC42EP3 mRNA	PMID:19564919
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314142	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CDC42EP3 mRNA	PMID:22206623
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of CDC42EP3 mRNA	PMID:22079256
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDC42EP3 mRNA	PMID:22079256
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:77012	methylseleninic acid	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of CDC42EP3 mRNA	PMID:18548127
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CDC42EP3 mRNA	PMID:30851411
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC42EP3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDC42EP3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC42EP3 mRNA	PMID:27188386
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CDC42EP3 mRNA	PMID:19159669
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:81760	difenoconazole	increases expression	ISO	RGD:1305858	E	RGD:6480464	20170725	CTD	MESH:C115058	difenoconazole results in increased expression of CDC42EP3 mRNA	PMID:28263823
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:81922	flusilazole	increases expression	ISO	RGD:1305858	E	RGD:6480464	20170725	CTD	MESH:C061365	flusilazole results in increased expression of CDC42EP3 mRNA	PMID:28263823
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of CDC42EP3 mRNA	PMID:35688559
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1305858	E	RGD:6480464	20171114	CTD	MESH:C045950	propiconazole results in increased expression of CDC42EP3 mRNA	PMID:28970091
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305858	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CDC42EP3 mRNA	PMID:24780913
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of CDC42EP3 mRNA	PMID:26272509
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC42EP3 mRNA	PMID:27188386
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of CDC42EP3 mRNA	PMID:24921660
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC42EP3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDC42EP3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CDC42EP3 mRNA	PMID:27188386
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1305858	E	RGD:6480464	20170725	CTD	MESH:C032910	triadimefon results in increased expression of CDC42EP3 mRNA	PMID:28263823
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305858	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CDC42EP3 mRNA	PMID:19015723
1314141	CDC42EP3	CDC42 effector protein 3	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305858	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of CDC42EP3 mRNA	PMID:23555832
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305859	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of ELF5 mRNA	PMID:21551480
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305859	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of ELF5 mRNA	PMID:25152437
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ELF5 mRNA	PMID:30529165
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of ELF5 mRNA	PMID:30517762
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of ELF5 mRNA	PMID:24758408
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of ELF5 mRNA	PMID:19619570
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314144	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of ELF5 mRNA	PMID:19484750
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ELF5 mRNA; EGF protein promotes the reaction [Estradiol results in decreased expression of ELF5 mRNA]	PMID:19619570|PMID:24758408
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305859	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of ELF5 mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ELF5 mRNA	PMID:26496021|PMID:32741896
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314144	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ELF5 mRNA	PMID:33711761
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305859	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ELF5 mRNA	PMID:33387578
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ELF5 mRNA	PMID:37992649
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305859	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ELF5 mRNA	PMID:32741896
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of ELF5 mRNA	PMID:31256213
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ELF5 mRNA	PMID:37992649
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ELF5 mRNA	PMID:28085963
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ELF5 mRNA	PMID:36139627
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:2208	purine-6-thiol	decreases expression	ISO	RGD:1305859	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of ELF5 mRNA	PMID:23358152
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1314144	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of ELF5 mRNA	PMID:39984025
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ELF5 intron	PMID:30157460
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in decreased expression of ELF5 mRNA	PMID:30517762
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ELF5 mRNA	PMID:21867686
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ELF5 mRNA	PMID:26272509
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:27188386
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1305859	E	RGD:6480464	20130514	CTD	MESH:D019833	Genistein results in increased expression of ELF5 mRNA	PMID:23160963
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D019833	[Dexamethasone co-treated with Genistein] results in decreased expression of ELF5 mRNA	PMID:25136773
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1305859	E	RGD:6480464	20130514	CTD	MESH:D019833	[Genistein co-treated with vinclozolin] results in increased expression of ELF5 mRNA	PMID:23160963
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ELF5 mRNA	PMID:24768652|PMID:25583101
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ELF5 mRNA	PMID:19619570
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314144	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ELF5 mRNA	PMID:17035482|PMID:24058054|PMID:37172768
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of ELF5 mRNA	PMID:19619570
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ELF5 mRNA	PMID:37992649
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ELF5 mRNA	PMID:37682722
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ELF5 5' UTR	PMID:27901495
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ELF5 promoter	PMID:27901495
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in decreased expression of ELF5 mRNA	PMID:22609695
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305859	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ELF5 mRNA	PMID:30047161
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314144	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ELF5 mRNA	PMID:23557971|PMID:35295148
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314144	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ELF5 promoter	PMID:27334623
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305859	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ELF5 mRNA	PMID:25181051
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314144	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ELF5 mRNA	PMID:32156529
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305859	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ELF5 gene	PMID:28505145
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1314144	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ELF5 promoter	PMID:27312807
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305859	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of ELF5 mRNA	PMID:26496021
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ELF5 mRNA	PMID:26682919
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1314144	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ELF5 promoter	PMID:33297965
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ELF5 intron	PMID:30157460
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of ELF5 mRNA	PMID:26377693
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ELF5 mRNA	PMID:37019170
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of ELF5 mRNA	PMID:29024780
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305859	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ELF5 mRNA	PMID:24386269
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ELF5 mRNA	PMID:19167446
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ELF5 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:27188386
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305859	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ELF5 mRNA	PMID:30047161
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D003907	Dexamethasone results in decreased expression of ELF5 mRNA	PMID:25136773
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D003907	[Dexamethasone co-treated with Genistein] results in decreased expression of ELF5 mRNA	PMID:25136773
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1314144	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ELF5 mRNA	PMID:15171707
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314144	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ELF5 mRNA	PMID:37992649
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ELF5 mRNA	PMID:24935251|PMID:26272509
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:27188386
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ELF5 mRNA	PMID:25351596
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of ELF5 mRNA	PMID:26272509
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:27188386
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ELF5 mRNA; Nanotubes, Carbon results in decreased expression of ELF5 mRNA	PMID:25554681
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:50667	mercaptopurine	decreases expression	ISO	RGD:1305859	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in decreased expression of ELF5 mRNA	PMID:23358152
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305859	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ELF5 mRNA	PMID:30047161
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:50692	mifepristone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D015735	Mifepristone inhibits the reaction [16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione results in increased expression of ELF5 protein]	PMID:20519331
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ELF5 mRNA	PMID:38701926
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314144	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of ELF5 mRNA	PMID:15003993
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:64213	cantharidin	increases expression	ISO	RGD:1314144	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in increased expression of ELF5 mRNA	PMID:36907384
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:64227	ciglitazone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C039671	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ELF5 mRNA; [ciglitazone binds to PPARG protein] which results in increased expression of ELF5 mRNA	PMID:16197558
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ELF5 intron	PMID:30157460
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:73390	promegestone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011397	Promegestone results in increased expression of ELF5 protein	PMID:20519331
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1305859	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of ELF5 mRNA	PMID:27840820
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ELF5 mRNA	PMID:36139627
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305859	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of ELF5 mRNA	PMID:32741896
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:27188386
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ELF5 gene]	PMID:28238834
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:79997	GW 4064	decreases expression	ISO	RGD:1314144	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in decreased expression of ELF5 mRNA	PMID:26655953
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305859	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ELF5 mRNA	PMID:32109520
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ELF5 mRNA	PMID:19167446
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305859	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ELF5 mRNA	PMID:23640034
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305859	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ELF5 mRNA	PMID:30047161
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of ELF5 mRNA	PMID:26272509
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:27188386
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:91108	SB 431542	affects expression	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide affects the expression of ELF5 mRNA	PMID:25670856
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:91108	SB 431542	decreases methylation	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased methylation of ELF5 promoter	PMID:25670856
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with BMP4 protein] results in decreased methylation of ELF5 promoter; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ELF5 mRNA	PMID:25670856|PMID:27188386
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:94796	3,7-dihydropurine-6-thione	decreases expression	ISO	RGD:1305859	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in decreased expression of ELF5 mRNA	PMID:23358152
1314143	ELF5	E74 like ETS transcription factor 5	gene	CHEBI:9986	vinclozolin	multiple interactions	ISO	RGD:1305859	E	RGD:6480464	20141111	CTD	MESH:C025643	[Genistein co-treated with vinclozolin] results in increased expression of ELF5 mRNA	PMID:23160963
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552901	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TMEM63B mRNA	PMID:33045310
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305862	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TMEM63B mRNA]	PMID:31150632
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20130423	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of TMEM63B mRNA]	PMID:19467301
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552901	E	RGD:6480464	20130423	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TMEM63B mRNA	PMID:20188158
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TMEM63B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TMEM63B mRNA	PMID:32699268
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552901	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TMEM63B mRNA	PMID:30319688
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552901	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TMEM63B mRNA	PMID:39298647
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of TMEM63B mRNA	PMID:38568856
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305862	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TMEM63B mRNA	PMID:33387578
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TMEM63B protein	PMID:37730182
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TMEM63B mRNA	PMID:36331819
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TMEM63B mRNA	PMID:35301059
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM63B mRNA	PMID:37236586
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TMEM63B gene	PMID:27153756
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TMEM63B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TMEM63B mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TMEM63B mRNA	PMID:32699268
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305862	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TMEM63B mRNA	PMID:31150632
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305862	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TMEM63B mRNA]	PMID:31150632
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1552901	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of TMEM63B mRNA	PMID:25629700
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM63B mRNA	PMID:22206623
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TMEM63B gene	PMID:25304211
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of TMEM63B mRNA	PMID:38460933
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of TMEM63B mRNA	PMID:38460933
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of TMEM63B mRNA	PMID:27392435
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of TMEM63B mRNA	PMID:27392435
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552901	E	RGD:6480464	20130423	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TMEM63B mRNA	PMID:21570461
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305862	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TMEM63B mRNA	PMID:33387578
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TMEM63B mRNA	PMID:33212167
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TMEM63B mRNA	PMID:32763439
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of TMEM63B mRNA	PMID:29803840
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20130423	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TMEM63B mRNA	PMID:22228805
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TMEM63B 5' UTR	PMID:27901495
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TMEM63B mRNA	PMID:29264374
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552901	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TMEM63B gene	PMID:35295148
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305862	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TMEM63B mRNA	PMID:34492290
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305862	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TMEM63B mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TMEM63B mRNA	PMID:26063408
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TMEM63B gene	PMID:31601247
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552901	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in increased expression of TMEM63B mRNA	PMID:35479511
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TMEM63B mRNA	PMID:39298647
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1552901	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of TMEM63B exon	PMID:33297965
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552901	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TMEM63B mRNA	PMID:38685157
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1552901	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of TMEM63B mRNA	PMID:34813904
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1552901	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of TMEM63B mRNA	PMID:34813904
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TMEM63B mRNA	PMID:37042841
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TMEM63B mRNA	PMID:35301059
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TMEM63B mRNA	PMID:37236586
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of TMEM63B mRNA	PMID:28903501
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TMEM63B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TMEM63B mRNA	PMID:32699268
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TMEM63B mRNA	PMID:36331819
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552901	E	RGD:6480464	20130423	CTD	MESH:D014635	Valproic Acid affects the expression of TMEM63B mRNA	PMID:17292431
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TMEM63B gene	PMID:29154799
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM63B mRNA	PMID:22230336
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305862	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TMEM63B mRNA	PMID:33387578
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:46742	Nutlin-3	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	nutlin 3 results in increased expression of TMEM63B mRNA	PMID:38460933
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of TMEM63B mRNA	PMID:38460933
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TMEM63B gene	PMID:25304211
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305862	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TMEM63B mRNA	PMID:29391264
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TMEM63B mRNA	PMID:35436446
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552901	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TMEM63B mRNA; Nanotubes, Carbon results in decreased expression of TMEM63B mRNA	PMID:25554681|PMID:25620056
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552901	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TMEM63B mRNA	PMID:22206623
1314147	TMEM63B	transmembrane protein 63B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1305862	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TMEM63B mRNA	PMID:21394737
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of STK32C mRNA	PMID:38218311
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314151	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of STK32C mRNA	PMID:33045310
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of STK32C mRNA	PMID:31016361
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314151	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of STK32C mRNA	PMID:36189433
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314151	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of STK32C mRNA	PMID:36189433
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of STK32C mRNA	PMID:26079696
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314151	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of STK32C mRNA	PMID:30319688
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of STK32C mRNA	PMID:31614463
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305864	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of STK32C mRNA	PMID:20068009
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of STK32C mRNA	PMID:37042841
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314151	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of STK32C mRNA	PMID:36189433
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314151	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of STK32C mRNA	PMID:36189433
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of STK32C mRNA	PMID:31163220
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314151	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of STK32C mRNA	PMID:34319233
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305864	E	RGD:6480464	20191112	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA	PMID:31199487
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305864	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of STK32C mRNA	PMID:33387578
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of STK32C mRNA	PMID:28818685
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of STK32C intron	PMID:30157460
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of STK32C polyA tail	PMID:30157460
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of STK32C intron; Aflatoxin B1 results in increased methylation of STK32C polyA tail	PMID:30157460
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of STK32C protein	PMID:35688186
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305864	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of STK32C mRNA	PMID:31881176
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314151	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STK32C mRNA	PMID:24680724
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314151	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of STK32C mRNA	PMID:17942748
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305864	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of STK32C mRNA	PMID:28959563
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1314151	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of STK32C mRNA	PMID:30807115
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of STK32C mRNA	PMID:32763439
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of STK32C mRNA	PMID:38568856
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314151	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of STK32C mRNA	PMID:37682722
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STK32C intron; Benzo(a)pyrene affects the methylation of STK32C polyA tail	PMID:30157460
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STK32C protein	PMID:32717239
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of STK32C promoter	PMID:27901495
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314151	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of STK32C 5' UTR; Benzo(a)pyrene results in increased methylation of STK32C exon; Benzo(a)pyrene results in increased methylation of STK32C intron	PMID:27901495
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1305864	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of STK32C mRNA	PMID:38458666
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314151	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of STK32C mRNA	PMID:29341224
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of STK32C gene	PMID:31601247
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:31767	lead diacetate	affects expression	ISO	RGD:1305864	E	RGD:6480464	20230404	CTD	MESH:C008261	lead acetate affects the expression of STK32C protein	PMID:36539177
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314151	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STK32C gene; titanium dioxide results in decreased methylation of STK32C promoter	PMID:35295148
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314151	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of STK32C gene	PMID:35295148
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314151	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of STK32C mRNA	PMID:18648102
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314151	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of STK32C mRNA	PMID:19710929
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305864	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STK32C mRNA	PMID:25181051
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of STK32C gene	PMID:31601247
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305864	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of STK32C gene	PMID:28505145
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of STK32C gene	PMID:31601247
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305864	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STK32C mRNA	PMID:36041667
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314151	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of STK32C mRNA	PMID:30951980
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of STK32C gene	PMID:31601247
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305864	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STK32C mRNA	PMID:36041667
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of STK32C intron	PMID:30157460
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of STK32C polyA tail	PMID:30157460
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305864	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STK32C mRNA	PMID:36041667
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1305864	E	RGD:6480464	20191112	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA	PMID:31199487
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305864	E	RGD:6480464	20191112	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA	PMID:31199487
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1305864	E	RGD:6480464	20191112	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA	PMID:31199487
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1305864	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of STK32C mRNA	PMID:38458666
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of STK32C mRNA	PMID:38382870
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1305864	E	RGD:6480464	20191112	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA	PMID:31199487
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STK32C mRNA	PMID:25979313
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of STK32C gene	PMID:29154799
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314151	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of STK32C mRNA	PMID:17555576
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of STK32C mRNA	PMID:38832940
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of STK32C mRNA	PMID:28542535
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STK32C mRNA	PMID:27188386
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305864	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of STK32C mRNA	PMID:33387578
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:46666	crocidolite asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased methylation of STK32C gene	PMID:29523930
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:46680	serpentine asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of STK32C gene	PMID:29523930
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305864	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of STK32C mRNA	PMID:29391264
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314151	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of STK32C mRNA	PMID:35436446
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314151	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of STK32C mRNA	PMID:17555576
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314151	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of STK32C mRNA	PMID:17942748
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305864	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of STK32C mRNA	PMID:30307764
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of STK32C intron	PMID:30157460
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of STK32C polyA tail	PMID:30157460
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of STK32C mRNA	PMID:37199045
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STK32C mRNA	PMID:27188386
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1305864	E	RGD:6480464	20191112	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of STK32C mRNA	PMID:31199487
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to STK32C gene]	PMID:28238834
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305864	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of STK32C mRNA	PMID:36843608
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of STK32C mRNA	PMID:27188386
1314150	STK32C	serine/threonine kinase 32C	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305864	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of STK32C gene	PMID:31079544
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314153	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZFP451 mRNA	PMID:33045310
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ZNF451 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ZNF451 mRNA	PMID:32699268
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZNF451 mRNA	PMID:26079696
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:15767	dichloromethane	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20171010	CTD	MESH:D008752	Methylene Chloride results in decreased expression of ZFP451 mRNA	PMID:28392392
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305865	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ZFP451 gene	PMID:27618143
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ZNF451 mRNA	PMID:23649840
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ZFP451 mRNA	PMID:33754040
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZNF451 protein	PMID:37730182
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of ZNF451 intron	PMID:30157460
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314153	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZFP451 mRNA	PMID:28111341
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ZNF451 mRNA	PMID:23649840
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZNF451 gene	PMID:27153756
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314153	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ZFP451 mRNA	PMID:19770486
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZNF451 mRNA	PMID:23649840
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ZNF451 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ZNF451 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of ZNF451 mRNA	PMID:32699268
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF451 mRNA	PMID:39836092
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ZNF451 mRNA	PMID:23557933
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:28077	rifampicin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in decreased expression of ZNF451 mRNA	PMID:24552687
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314153	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP451 mRNA	PMID:21570461
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ZNF451 mRNA	PMID:28001369
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1314153	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ZFP451 gene	PMID:39894169
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF451 mRNA	PMID:38568856
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF451 mRNA	PMID:39836092
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZNF451 intron	PMID:30157460
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314153	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZFP451 mRNA	PMID:22228805
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZNF451 mRNA	PMID:20018196
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314153	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ZFP451 mRNA	PMID:35676786
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314153	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP451 promoter	PMID:35295148
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305865	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ZFP451 mRNA	PMID:34492290
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305865	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF451 mRNA	PMID:25181051
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ZFP451 mRNA	PMID:38685157
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ZFP451 mRNA	PMID:28392331
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZFP451 mRNA	PMID:37019170
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314153	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ZFP451 mRNA	PMID:21266533
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ZFP451 mRNA	PMID:34813904
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF451 mRNA	PMID:37042841
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314153	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZFP451 mRNA	PMID:28111341
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ZNF451 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ZNF451 mRNA	PMID:32699268
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ZNF451 mRNA	PMID:28302478
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1305865	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ZFP451 mRNA	PMID:23125180
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZNF451 mRNA	PMID:25979313
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF451 mRNA	PMID:23179753|PMID:24383497|PMID:25192806|PMID:28001369
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZNF451 gene	PMID:29154799
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ZNF451 mRNA	PMID:25562108
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314153	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ZNF451 mRNA	PMID:28973697
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of ZNF451 mRNA	PMID:33512557
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of ZNF451 mRNA	PMID:23649840
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ZNF451 mRNA	PMID:24935251
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314153	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZFP451 mRNA	PMID:17562736
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ZNF451 mRNA	PMID:29523930
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF451 mRNA	PMID:39836092
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1314153	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of ZFP451 mRNA	PMID:31099283
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in decreased expression of ZNF451 protein	PMID:26722802
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305865	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ZFP451 mRNA	PMID:29097150
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314153	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ZFP451 mRNA	PMID:35676786
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305865	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ZFP451 mRNA	PMID:24793618
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305865	E	RGD:6480464	20120814	CTD	MESH:D005485	Flutamide results in increased expression of ZFP451 mRNA	PMID:20566332
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ZFP451 mRNA	PMID:23608068
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:6076	itraconazole	increases expression	ISO	RGD:1314153	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of ZFP451 mRNA	PMID:31099283
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ZNF451 mRNA	PMID:28988120
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1314153	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of ZFP451 mRNA	PMID:20003209
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ZNF451 mRNA	PMID:31758290
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314153	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFP451 mRNA	PMID:22206623
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:756894	tak-243	affects sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 affects the sumoylation of ZNF451 protein	PMID:31285264
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF451 gene]	PMID:28238834
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of ZNF451 mRNA	PMID:19095052
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:94366	2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one	increases expression	ISO	RGD:1314153	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of ZFP451 mRNA	PMID:31099283
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ZNF451 mRNA	PMID:38568856
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305865	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of ZFP451 gene	PMID:31079544
1314152	ZNF451	zinc finger protein 451	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305865	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of ZFP451 mRNA	PMID:23034163
1314155	SNPH	syntaphilin	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314156	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SNPH mRNA	PMID:37995155
1314155	SNPH	syntaphilin	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314156	E	RGD:6480464	20130618	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SNPH mRNA	PMID:20188158
1314155	SNPH	syntaphilin	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314156	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SNPH mRNA	PMID:30319688
1314155	SNPH	syntaphilin	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314156	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of SNPH mRNA	PMID:30319688
1314155	SNPH	syntaphilin	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314156	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SNPH mRNA	PMID:39241906
1314155	SNPH	syntaphilin	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SNPH mRNA	PMID:38568856
1314155	SNPH	syntaphilin	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305867	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SNPH mRNA	PMID:33387578
1314155	SNPH	syntaphilin	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305867	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SNPH gene	PMID:27618143
1314155	SNPH	syntaphilin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNPH mRNA	PMID:37042841
1314155	SNPH	syntaphilin	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of SNPH 3' UTR	PMID:30157460
1314155	SNPH	syntaphilin	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of SNPH intron	PMID:30157460
1314155	SNPH	syntaphilin	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1314156	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of SNPH mRNA	PMID:39984025
1314155	SNPH	syntaphilin	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SNPH gene	PMID:27153756
1314155	SNPH	syntaphilin	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SNPH exon	PMID:30157460
1314155	SNPH	syntaphilin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314156	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNPH mRNA	PMID:22206623
1314155	SNPH	syntaphilin	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305867	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SNPH mRNA	PMID:31881176
1314155	SNPH	syntaphilin	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305867	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of SNPH mRNA	PMID:20187946
1314155	SNPH	syntaphilin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305867	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNPH mRNA	PMID:33387578
1314155	SNPH	syntaphilin	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SNPH mRNA	PMID:33212167
1314155	SNPH	syntaphilin	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SNPH mRNA	PMID:29803840
1314155	SNPH	syntaphilin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SNPH 3' UTR; Benzo(a)pyrene affects the methylation of SNPH exon	PMID:30157460
1314155	SNPH	syntaphilin	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SNPH promoter	PMID:27901495
1314155	SNPH	syntaphilin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SNPH 3' UTR; Benzo(a)pyrene results in increased methylation of SNPH 5' UTR	PMID:27901495
1314155	SNPH	syntaphilin	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314156	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNPH gene	PMID:35295148
1314155	SNPH	syntaphilin	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314156	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SNPH gene	PMID:35295148
1314155	SNPH	syntaphilin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314156	E	RGD:6480464	20130618	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SNPH mRNA	PMID:18648102
1314155	SNPH	syntaphilin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305867	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SNPH mRNA	PMID:25181051
1314155	SNPH	syntaphilin	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SNPH intron	PMID:30157460
1314155	SNPH	syntaphilin	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SNPH mRNA	PMID:37042841
1314155	SNPH	syntaphilin	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SNPH mRNA	PMID:24449571
1314155	SNPH	syntaphilin	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SNPH mRNA	PMID:38568856
1314155	SNPH	syntaphilin	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SNPH mRNA	PMID:31533062
1314155	SNPH	syntaphilin	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of SNPH mRNA	PMID:28001369
1314155	SNPH	syntaphilin	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SNPH mRNA	PMID:38832940
1314155	SNPH	syntaphilin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314156	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of SNPH mRNA	PMID:17562736
1314155	SNPH	syntaphilin	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of SNPH mRNA	PMID:29067470
1314155	SNPH	syntaphilin	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305867	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SNPH mRNA	PMID:33387578
1314155	SNPH	syntaphilin	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of SNPH mRNA	PMID:24714768
1314155	SNPH	syntaphilin	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SNPH intron	PMID:30157460
1314155	SNPH	syntaphilin	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305867	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SNPH gene	PMID:35440735
1314155	SNPH	syntaphilin	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1314156	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SNPH mRNA	PMID:27935865
1314155	SNPH	syntaphilin	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314156	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of SNPH mRNA	PMID:22206623
1314155	SNPH	syntaphilin	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1305867	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of SNPH protein	PMID:28903499
1314155	SNPH	syntaphilin	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SNPH mRNA	PMID:29301935
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1550327	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of ADGRF3 mRNA	PMID:36189433
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550327	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADGRF3 mRNA	PMID:36189433
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305868	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ADGRF3 mRNA	PMID:33387578
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550327	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ADGRF3 mRNA	PMID:36189433
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ADGRF3 mRNA	PMID:28818685
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305868	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ADGRF3 mRNA	PMID:23630614
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ADGRF3 gene	PMID:27153756
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305868	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ADGRF3 mRNA	PMID:31881176
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ADGRF3 mRNA	PMID:23557933
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ADGRF3 mRNA	PMID:33212167
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20161115	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ADGRF3 gene	PMID:25435355
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1305868	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of ADGRF3 mRNA	PMID:32479839
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550327	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ADGRF3 mRNA	PMID:29264374
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305868	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADGRF3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ADGRF3 gene	PMID:31601247
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550327	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ADGRF3 mRNA	PMID:40203079
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ADGRF3 mRNA	PMID:37042841
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1550327	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of ADGRF3 mRNA	PMID:28962523
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550327	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADGRF3 mRNA	PMID:40194260
1314157	ADGRF3	adhesion G protein-coupled receptor F3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305868	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ADGRF3 gene	PMID:35440735
1314160	PCDH18	protocadherin 18	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PCDH18 mRNA	PMID:27188386
1314160	PCDH18	protocadherin 18	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PCDH18 mRNA	PMID:33045310
1314160	PCDH18	protocadherin 18	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PCDH18 mRNA	PMID:20188158
1314160	PCDH18	protocadherin 18	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of PCDH18 mRNA	PMID:21934132
1314160	PCDH18	protocadherin 18	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PCDH18 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PCDH18 mRNA	PMID:32699268
1314160	PCDH18	protocadherin 18	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PCDH18 mRNA	PMID:35811015
1314160	PCDH18	protocadherin 18	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PCDH18 mRNA	PMID:35811015
1314160	PCDH18	protocadherin 18	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDH18 mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of PCDH18 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of PCDH18 mRNA	PMID:20660070|PMID:20823114|PMID:30165855
1314160	PCDH18	protocadherin 18	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PCDH18 mRNA	PMID:25549359
1314160	PCDH18	protocadherin 18	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of PCDH18 mRNA	PMID:20660070
1314160	PCDH18	protocadherin 18	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PCDH18 mRNA	PMID:21179406
1314160	PCDH18	protocadherin 18	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH18 mRNA	PMID:37992649
1314160	PCDH18	protocadherin 18	gene	CHEBI:17578	toluene	increases expression	ISO	RGD:1305870	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in increased expression of PCDH18 mRNA	PMID:22967744
1314160	PCDH18	protocadherin 18	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH18 mRNA	PMID:37992649
1314160	PCDH18	protocadherin 18	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314161	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PCDH18 mRNA	PMID:28085963
1314160	PCDH18	protocadherin 18	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305870	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PCDH18 mRNA	PMID:26577399
1314160	PCDH18	protocadherin 18	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305870	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PCDH18 mRNA	PMID:33387578
1314160	PCDH18	protocadherin 18	gene	CHEBI:2038	5-azacytidine	decreases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in decreased expression of PCDH18 mRNA	PMID:20823114
1314160	PCDH18	protocadherin 18	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PCDH18 mRNA	PMID:40288432
1314160	PCDH18	protocadherin 18	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDH18 gene	PMID:27153756
1314160	PCDH18	protocadherin 18	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of PCDH18 mRNA	PMID:32553695
1314160	PCDH18	protocadherin 18	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of PCDH18 mRNA	PMID:19555225
1314160	PCDH18	protocadherin 18	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PCDH18 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PCDH18 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of PCDH18 mRNA	PMID:32699268
1314160	PCDH18	protocadherin 18	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PCDH18 mRNA	PMID:34911549
1314160	PCDH18	protocadherin 18	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCDH18 mRNA	PMID:39836092
1314160	PCDH18	protocadherin 18	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PCDH18 mRNA	PMID:26272509
1314160	PCDH18	protocadherin 18	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA	PMID:27188386
1314160	PCDH18	protocadherin 18	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305870	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of PCDH18 mRNA	PMID:31881176
1314160	PCDH18	protocadherin 18	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1314161	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in increased expression of PCDH18 mRNA	PMID:16917069
1314160	PCDH18	protocadherin 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305870	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDH18 mRNA	PMID:21215274|PMID:33387578|PMID:34747641
1314160	PCDH18	protocadherin 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDH18 mRNA	PMID:19933214|PMID:32553695
1314160	PCDH18	protocadherin 18	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of PCDH18 mRNA	PMID:29955902
1314160	PCDH18	protocadherin 18	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314161	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of PCDH18 mRNA	PMID:32937126
1314160	PCDH18	protocadherin 18	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PCDH18 mRNA	PMID:28001369
1314160	PCDH18	protocadherin 18	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of PCDH18 mRNA	PMID:26272509
1314160	PCDH18	protocadherin 18	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA	PMID:27188386
1314160	PCDH18	protocadherin 18	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PCDH18 mRNA	PMID:32763439
1314160	PCDH18	protocadherin 18	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305870	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PCDH18 mRNA	PMID:28959563
1314160	PCDH18	protocadherin 18	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PCDH18 mRNA	PMID:20971185
1314160	PCDH18	protocadherin 18	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PCDH18 mRNA	PMID:29803840
1314160	PCDH18	protocadherin 18	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of PCDH18 mRNA	PMID:39631538
1314160	PCDH18	protocadherin 18	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH18 mRNA	PMID:37992649
1314160	PCDH18	protocadherin 18	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of PCDH18 mRNA	PMID:29301061|PMID:34032870
1314160	PCDH18	protocadherin 18	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCDH18 mRNA	PMID:39836092
1314160	PCDH18	protocadherin 18	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of PCDH18 mRNA	PMID:22378314
1314160	PCDH18	protocadherin 18	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20120717	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in decreased expression of PCDH18 mRNA; Benzo(a)pyrene results in decreased expression of PCDH18 mRNA	PMID:20713471|PMID:21569818|PMID:32553695
1314160	PCDH18	protocadherin 18	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PCDH18 3' UTR	PMID:27901495
1314160	PCDH18	protocadherin 18	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PCDH18 mRNA	PMID:20971185
1314160	PCDH18	protocadherin 18	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of PCDH18 gene	PMID:31601247
1314160	PCDH18	protocadherin 18	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305870	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of PCDH18 mRNA	PMID:24136188
1314160	PCDH18	protocadherin 18	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in decreased expression of PCDH18 mRNA	PMID:22613225
1314160	PCDH18	protocadherin 18	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305870	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PCDH18 mRNA	PMID:34492290
1314160	PCDH18	protocadherin 18	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305870	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDH18 mRNA	PMID:34947998
1314160	PCDH18	protocadherin 18	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PCDH18 gene	PMID:31601247
1314160	PCDH18	protocadherin 18	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of PCDH18 mRNA	PMID:29275510
1314160	PCDH18	protocadherin 18	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305870	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PCDH18 mRNA	PMID:25181051|PMID:30816183
1314160	PCDH18	protocadherin 18	gene	CHEBI:34237	2,4-diaminotoluene	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in decreased expression of PCDH18 mRNA	PMID:20713471
1314160	PCDH18	protocadherin 18	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of PCDH18 mRNA	PMID:20713471
1314160	PCDH18	protocadherin 18	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314161	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PCDH18 mRNA	PMID:30951980
1314160	PCDH18	protocadherin 18	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314161	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PCDH18 mRNA	PMID:30951980
1314160	PCDH18	protocadherin 18	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of PCDH18 gene	PMID:31601247
1314160	PCDH18	protocadherin 18	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PCDH18 mRNA	PMID:20350560
1314160	PCDH18	protocadherin 18	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of PCDH18 mRNA	PMID:36117858
1314160	PCDH18	protocadherin 18	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1305870	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of PCDH18 mRNA	PMID:30589522
1314160	PCDH18	protocadherin 18	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PCDH18 mRNA	PMID:38382870
1314160	PCDH18	protocadherin 18	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305870	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PCDH18 mRNA	PMID:25993096
1314160	PCDH18	protocadherin 18	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305870	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of PCDH18 mRNA	PMID:26194646
1314160	PCDH18	protocadherin 18	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PCDH18 mRNA	PMID:24449571
1314160	PCDH18	protocadherin 18	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PCDH18 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PCDH18 mRNA	PMID:32699268
1314160	PCDH18	protocadherin 18	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PCDH18 mRNA	PMID:40194260
1314160	PCDH18	protocadherin 18	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PCDH18 mRNA	PMID:40419075
1314160	PCDH18	protocadherin 18	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of PCDH18 mRNA	PMID:23125180
1314160	PCDH18	protocadherin 18	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCDH18 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:27188386
1314160	PCDH18	protocadherin 18	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305870	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of PCDH18 mRNA	PMID:30047161
1314160	PCDH18	protocadherin 18	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of PCDH18 mRNA	PMID:40633821
1314160	PCDH18	protocadherin 18	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PCDH18 mRNA	PMID:28973697
1314160	PCDH18	protocadherin 18	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDH18 mRNA	PMID:37992649
1314160	PCDH18	protocadherin 18	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PCDH18 mRNA	PMID:38832940
1314160	PCDH18	protocadherin 18	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PCDH18 mRNA	PMID:24935251|PMID:26272509
1314160	PCDH18	protocadherin 18	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA	PMID:27188386
1314160	PCDH18	protocadherin 18	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305870	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PCDH18 mRNA	PMID:33387578
1314160	PCDH18	protocadherin 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of PCDH18 mRNA	PMID:33725128
1314160	PCDH18	protocadherin 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PCDH18 mRNA	PMID:35811015
1314160	PCDH18	protocadherin 18	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PCDH18 mRNA	PMID:29279043
1314160	PCDH18	protocadherin 18	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PCDH18 mRNA	PMID:39836092
1314160	PCDH18	protocadherin 18	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of PCDH18 mRNA	PMID:22079256
1314160	PCDH18	protocadherin 18	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PCDH18 mRNA	PMID:22079256
1314160	PCDH18	protocadherin 18	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of PCDH18 mRNA	PMID:26272509
1314160	PCDH18	protocadherin 18	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA	PMID:27188386
1314160	PCDH18	protocadherin 18	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDH18 mRNA	PMID:20823114
1314160	PCDH18	protocadherin 18	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1305870	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of PCDH18 mRNA	PMID:23962444
1314160	PCDH18	protocadherin 18	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305870	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of PCDH18 mRNA	PMID:30047161
1314160	PCDH18	protocadherin 18	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of PCDH18 mRNA	PMID:36117858
1314160	PCDH18	protocadherin 18	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of PCDH18 mRNA	PMID:31629900
1314160	PCDH18	protocadherin 18	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of PCDH18 mRNA	PMID:36851058
1314160	PCDH18	protocadherin 18	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1314161	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PCDH18 mRNA	PMID:36907384
1314160	PCDH18	protocadherin 18	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of PCDH18 mRNA	PMID:20823114
1314160	PCDH18	protocadherin 18	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PCDH18 mRNA	PMID:22079256
1314160	PCDH18	protocadherin 18	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PCDH18 mRNA	PMID:22079256
1314160	PCDH18	protocadherin 18	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of PCDH18 mRNA	PMID:29522793
1314160	PCDH18	protocadherin 18	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of PCDH18 mRNA	PMID:34995734
1314160	PCDH18	protocadherin 18	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA	PMID:27188386
1314160	PCDH18	protocadherin 18	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDH18 gene]	PMID:28238834
1314160	PCDH18	protocadherin 18	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of PCDH18 mRNA	PMID:19095052
1314160	PCDH18	protocadherin 18	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of PCDH18 mRNA	PMID:38995820
1314160	PCDH18	protocadherin 18	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1314161	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PCDH18 mRNA	PMID:27935865
1314160	PCDH18	protocadherin 18	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305870	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PCDH18 mRNA	PMID:24780913
1314160	PCDH18	protocadherin 18	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PCDH18 mRNA	PMID:27188386
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of TNFSF13 mRNA	PMID:25152437
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TNFSF13 mRNA	PMID:20938992
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TNFSF13 mRNA	PMID:26079696
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFSF13 mRNA	PMID:31059760
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314163	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFSF13 mRNA	PMID:21131560
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of TNFSF13 mRNA	PMID:31059760
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20161228	CTD	MESH:D008070	Tetrachlorodibenzodioxin promotes the reaction [Lipopolysaccharides results in increased expression of TNFSF13 mRNA]	PMID:21131560
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of TNFSF13 mRNA	PMID:35192832
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TNFSF13 mRNA	PMID:20938992
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of TNFSF13 mRNA	PMID:33448797
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of TNFSF13 mRNA]	PMID:33448797|PMID:37992649
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of TNFSF13 mRNA	PMID:21592394
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of TNFSF13 mRNA	PMID:21592394
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of TNFSF13 mRNA	PMID:33448797
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of TNFSF13 mRNA]	PMID:33448797|PMID:37992649
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of TNFSF13 mRNA	PMID:27523638
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of TNFSF13 mRNA	PMID:21592394
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of TNFSF13 mRNA	PMID:21592394
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TNFSF13 mRNA	PMID:33387578
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of TNFSF13 mRNA	PMID:28522335
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of TNFSF13 mRNA	PMID:21120746
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:232141	chlorophyllin	multiple interactions	EXP		E	RGD:6480464	20241119	CTD	MESH:C007020	chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of TNFSF13 mRNA]	PMID:19152381
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of TNFSF13 mRNA	PMID:26760959
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D009151	Mustard Gas results in increased expression of TNFSF13 mRNA	PMID:33491125
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TNFSF13 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TNFSF13 mRNA	PMID:34911549
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314163	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of TNFSF13 mRNA	PMID:17484886
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TNFSF13 mRNA	PMID:20938992
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]	PMID:37992649
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of TNFSF13 mRNA	PMID:19921347
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of TNFSF13 mRNA	PMID:18423122
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TNFSF13 mRNA	PMID:21215274|PMID:34747641
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TNFSF13 mRNA	PMID:21131560
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314163	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFSF13 mRNA	PMID:21131560
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [Lipopolysaccharides results in increased expression of TNFSF13 mRNA]	PMID:21131560
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of TNFSF13 mRNA	PMID:28374803
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TNFSF13 mRNA	PMID:33212167
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1305871	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of TNFSF13 mRNA	PMID:28959563
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20260707	CTD	MESH:D005632	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA	PMID:37992649
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20260707	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]	PMID:37992649
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TNFSF13 5' UTR	PMID:27901495
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TNFSF13 mRNA	PMID:19770486
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TNFSF13 promoter	PMID:27901495
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TNFSF13 mRNA	PMID:19152381
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of TNFSF13 mRNA]	PMID:19152381
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TNFSF13 mRNA; Silicon Dioxide results in decreased expression of TNFSF13 mRNA	PMID:25351596|PMID:25895662
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1305871	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TNFSF13 mRNA	PMID:22431001
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314163	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TNFSF13 mRNA	PMID:29203145
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TNFSF13 mRNA	PMID:15761015
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of TNFSF13 mRNA	PMID:24915197
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305871	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TNFSF13 mRNA	PMID:25729387
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305871	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TNFSF13 mRNA	PMID:34492290
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TNFSF13 mRNA	PMID:25181051|PMID:34947998
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314163	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of TNFSF13 mRNA	PMID:26682919
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TNFSF13 mRNA	PMID:23196670
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TNFSF13 mRNA	PMID:38685157
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20180703	CTD	MESH:D004137	Dinitrochlorobenzene results in decreased expression of TNFSF13 mRNA	PMID:21404309
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TNFSF13 mRNA	PMID:37042841
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of TNFSF13 mRNA	PMID:26194646
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TNFSF13 mRNA	PMID:19376846
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TNFSF13 mRNA	PMID:24449571
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:38319	usnic acid	increases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C073339	usnic acid results in increased expression of TNFSF13 mRNA	PMID:32508146
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314163	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TNFSF13 mRNA	PMID:40194260
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:D005947	Glucose results in decreased expression of TNFSF13 mRNA	PMID:33448797
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFSF13 mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of TNFSF13 mRNA]	PMID:33448797|PMID:37992649
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TNFSF13 mRNA	PMID:38832940
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of TNFSF13 mRNA	PMID:18058816
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314163	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TNFSF13 mRNA	PMID:17562736
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of TNFSF13 mRNA	PMID:31059760
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TNFSF13 mRNA	PMID:33387578
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of TNFSF13 mRNA; [Dietary Carbohydrates co-treated with Acetaminophen] results in increased expression of TNFSF13 mRNA	PMID:17093179|PMID:31059760
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of TNFSF13 mRNA	PMID:18423122|PMID:20003335
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:47426	furosemide	affects expression	ISO	RGD:1305871	E	RGD:6480464	20120412	CTD	MESH:D005665	Furosemide affects the expression of TNFSF13 mRNA	PMID:17497460
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TNFSF13 mRNA	PMID:29391264
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TNFSF13 mRNA	PMID:15761015
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of TNFSF13 mRNA	PMID:17145863
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314163	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of TNFSF13 mRNA	PMID:40234311
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of TNFSF13 mRNA	PMID:19162173
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1314163	E	RGD:6480464	20210504	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Glucose results in decreased expression of TNFSF13 mRNA]	PMID:33448797
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20180703	CTD	MESH:D010081	Oxazolone results in decreased expression of TNFSF13 mRNA	PMID:21404309
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:53556	toluene 2,4-diisocyanate	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20180703	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in decreased expression of TNFSF13 mRNA	PMID:21404309
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:59224	cetrorelix	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C062876	cetrorelix results in decreased expression of TNFSF13 mRNA	PMID:21062912
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:6015	isoflurane	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20120412	CTD	MESH:D007530	Isoflurane results in decreased expression of TNFSF13 mRNA	PMID:16978161
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305871	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TNFSF13 mRNA	PMID:25729387
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of TNFSF13 mRNA	PMID:19751817
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of TNFSF13 mRNA	PMID:30467583
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:7983	pentobarbital	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20120412	CTD	MESH:D010424	Pentobarbital results in decreased expression of TNFSF13 mRNA	PMID:16978161
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TNFSF13 gene]	PMID:28238834
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:8064	phenformin	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of TNFSF13 mRNA	PMID:31324951
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1314163	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of TNFSF13 mRNA	PMID:18958704
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:8207	(+)-pilocarpine	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in decreased expression of TNFSF13 mRNA	PMID:17971868
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of TNFSF13 mRNA	PMID:23640034
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314163	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of TNFSF13 mRNA	PMID:39847705
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305871	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TNFSF13 mRNA	PMID:24780913|PMID:25825206
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305871	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TNFSF13 mRNA	PMID:19281266
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TNFSF13 mRNA	PMID:38568856
1314162	TNFSF13	TNF superfamily member 13	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314163	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of TNFSF13 mRNA	PMID:35537566
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of NAALAD2 mRNA	PMID:26272509
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA	PMID:27188386
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:132612	monobenzyl phthalate	decreases methylation	EXP		E	RGD:6480464	20260303	CTD	MESH:C103325	mono-benzyl phthalate results in decreased methylation of NAALAD2 gene	PMID:35032864
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of NAALAD2 mRNA	PMID:21632981
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of NAALAD2 mRNA	PMID:39241906
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of NAALAD2 mRNA]	PMID:39241906
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305872	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NAALAD2 mRNA	PMID:33387578
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:16602	trichloroethene	decreases methylation	ISO	RGD:1305872	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of NAALAD2 gene	PMID:27618143
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:16899	D-mannitol	increases expression	ISO	RGD:1314165	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in increased expression of NAALAD2 mRNA	PMID:25270620
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAALAD2 mRNA	PMID:37992649
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAALAD2 mRNA	PMID:37992649
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NAALAD2 mRNA	PMID:31163220
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of NAALAD2 mRNA	PMID:28818685
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:18357	(R)-noradrenaline	decreases expression	ISO	RGD:1305872	E	RGD:6480464	20241105	CTD	MESH:D009638	Norepinephrine results in decreased expression of NAALAD2 mRNA	PMID:14618266
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NAALAD2 mRNA	PMID:19549813
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NAALAD2 gene	PMID:27153756
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NAALAD2 mRNA	PMID:34911549
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314165	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of NAALAD2 mRNA	PMID:17484886
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NAALAD2 mRNA	PMID:21867686
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314165	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of NAALAD2 mRNA	PMID:28960355
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of NAALAD2 mRNA	PMID:25583101
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305872	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NAALAD2 mRNA	PMID:33387578
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314165	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NAALAD2 mRNA	PMID:28213091
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NAALAD2 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NAALAD2 mRNA	PMID:33212167
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of NAALAD2 mRNA	PMID:32763439
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314165	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of NAALAD2 mRNA	PMID:39631538
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAALAD2 mRNA	PMID:37992649
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314165	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of NAALAD2 mRNA	PMID:37682722
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NAALAD2 promoter	PMID:27901495
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NAALAD2 mRNA	PMID:20106945
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NAALAD2 5' UTR; Benzo(a)pyrene results in increased methylation of NAALAD2 exon	PMID:27901495
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1314165	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of NAALAD2 protein	PMID:37955338
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NAALAD2 mRNA	PMID:25351596
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of NAALAD2 gene	PMID:31601247
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:31823	mercury dichloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D008627	[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAALAD2 mRNA	PMID:27188386
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305872	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of NAALAD2 mRNA	PMID:41034487
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305872	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NAALAD2 gene	PMID:28505145
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of NAALAD2 gene	PMID:31601247
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:34440	4-nonylphenol	multiple interactions	EXP		E	RGD:6480464	20140311	CTD	MESH:C041594	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of NAALAD2 mRNA	PMID:23626723
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:34445	4-tert-Octylphenol	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C105260	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of NAALAD2 mRNA	PMID:23626723
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305872	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of NAALAD2 gene	PMID:33148267
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of NAALAD2 mRNA]	PMID:39241906
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NAALAD2 mRNA	PMID:37042841
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:35096	p-tert-Amylphenol	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C019566	[4-tert-octylphenol co-treated with 4-nonylphenol] results in decreased expression of NAALAD2 mRNA	PMID:23626723
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of NAALAD2 protein	PMID:26879310
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314165	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of NAALAD2 mRNA	PMID:17585979
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of NAALAD2 mRNA	PMID:28302478
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of NAALAD2 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of NAALAD2 mRNA	PMID:23179753|PMID:24935251|PMID:27188386
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA	PMID:27188386
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NAALAD2 mRNA	PMID:20106945|PMID:25562108
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314165	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of NAALAD2 mRNA	PMID:17555576
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAALAD2 mRNA	PMID:37992649
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NAALAD2 mRNA	PMID:38832940
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of NAALAD2 mRNA	PMID:24935251|PMID:26272509
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of NAALAD2 mRNA	PMID:24935251
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA	PMID:27188386
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of NAALAD2 mRNA	PMID:29067470
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305872	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of NAALAD2 mRNA	PMID:29391264
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314165	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NAALAD2 mRNA	PMID:17555576
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314165	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NAALAD2 mRNA	PMID:17942748
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305872	E	RGD:6480464	20210706	CTD	MESH:C017690	fenvalerate results in increased expression of NAALAD2 protein	PMID:33656234
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305872	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of NAALAD2 gene	PMID:33148267
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of NAALAD2 mRNA	PMID:32858204
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAALAD2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA	PMID:27188386
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of NAALAD2 mRNA	PMID:30928695
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NAALAD2 gene]	PMID:28238834
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of NAALAD2 mRNA	PMID:27935865
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314165	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of NAALAD2 mRNA]	PMID:39241906
1314164	NAALAD2	N-acetylated alpha-linked acidic dipeptidase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA; [NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAALAD2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NAALAD2 mRNA	PMID:27188386
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of RIN2 mRNA	PMID:21551480
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of RIN2 mRNA	PMID:26272509
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RIN2 mRNA	PMID:27188386
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of RIN2 mRNA	PMID:33045310
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314167	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RIN2 gene	PMID:20938992
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of RIN2 mRNA	PMID:21934132|PMID:33167477
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1305873	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of RIN2 mRNA	PMID:20488242
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314167	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RIN2 mRNA	PMID:30319688
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314167	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RIN2 mRNA	PMID:30319688
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of RIN2 mRNA	PMID:39709020
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:16243	quercetin	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin affects the expression of RIN2 mRNA	PMID:21632981
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RIN2 mRNA	PMID:25890327
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RIN2 mRNA	PMID:35811015
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of RIN2 mRNA	PMID:31614463
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314167	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of RIN2 mRNA	PMID:29980752
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of RIN2 mRNA	PMID:38568856
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305873	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RIN2 gene	PMID:27618143
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314167	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RIN2 gene	PMID:20938992
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of RIN2 mRNA	PMID:23649840
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of RIN2 mRNA	PMID:21592394
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314167	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of RIN2 mRNA	PMID:33848595
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of RIN2 mRNA	PMID:21592394
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1314167	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of RIN2 mRNA]	PMID:33848595
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of RIN2 mRNA	PMID:21592394
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of RIN2 mRNA	PMID:21592394
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RIN2 mRNA	PMID:33387578
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RIN2 mRNA	PMID:28818685
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of RIN2 intron	PMID:30157460
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RIN2 mRNA	PMID:39836092
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1314167	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in increased expression of RIN2 mRNA	PMID:18579281
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RIN2 mRNA	PMID:23649840
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RIN2 exon	PMID:30157460
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RIN2 intron	PMID:30157460
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RIN2 mRNA	PMID:23649840
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of RIN2 mRNA	PMID:41580963
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RIN2 mRNA	PMID:31150632
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RIN2 mRNA	PMID:31919559
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RIN2 mRNA	PMID:21867686
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314167	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RIN2 gene	PMID:20938992
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RIN2 mRNA	PMID:39836092
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of RIN2 mRNA	PMID:21603599
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314167	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RIN2 mRNA	PMID:21570461
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RIN2 mRNA	PMID:34747641
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RIN2 mRNA	PMID:20106945|PMID:21632981
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RIN2 mRNA	PMID:28001369
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RIN2 mRNA	PMID:19465457
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RIN2 mRNA	PMID:29803840
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:2948	azathioprine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of RIN2 mRNA	PMID:22623647
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RIN2 mRNA	PMID:38568856
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1314167	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of RIN2 gene	PMID:39894169
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RIN2 mRNA	PMID:39836092
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of RIN2 mRNA	PMID:20106945
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RIN2 3' UTR; Benzo(a)pyrene affects the methylation of RIN2 intron	PMID:27901495|PMID:30157460
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RIN2 mRNA	PMID:20064835
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RIN2 mRNA	PMID:21632981|PMID:22316170
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314167	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RIN2 mRNA	PMID:22228805
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RIN2 exon; Benzo(a)pyrene results in increased methylation of RIN2 promoter	PMID:27901495
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314167	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RIN2 intron	PMID:27901495
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RIN2 mRNA	PMID:19073995|PMID:33720480
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RIN2 mRNA	PMID:19150397
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of RIN2 mRNA	PMID:24136188
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305873	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RIN2 mRNA	PMID:25729387
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RIN2 mRNA	PMID:30047161
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314167	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RIN2 mRNA	PMID:18301758
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314167	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RIN2 mRNA	PMID:19710929
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RIN2 mRNA	PMID:30816183|PMID:32528016
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RIN2 gene	PMID:31601247
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305873	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RIN2 mRNA	PMID:25181051
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305873	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RIN2 gene	PMID:28505145
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314167	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of RIN2 gene	PMID:31683443
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RIN2 mRNA	PMID:39298647
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314167	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of RIN2 exon	PMID:33297965
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of RIN2 mRNA	PMID:26377693
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RIN2 intron	PMID:30157460
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305873	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RIN2 mRNA	PMID:21266533
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314167	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RIN2 mRNA	PMID:21266533
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of RIN2 mRNA	PMID:29024780
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RIN2 mRNA	PMID:39836092
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RIN2 mRNA	PMID:38568856
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C018021	cobaltous chloride results in increased expression of RIN2 mRNA	PMID:23052192
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314167	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RIN2 mRNA	PMID:40194260
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:38561	fluvastatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C065180	[zoledronic acid co-treated with fluvastatin] results in increased expression of RIN2 mRNA	PMID:16996129
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in decreased expression of RIN2 mRNA	PMID:17685462
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314167	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RIN2 mRNA	PMID:17292431
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of RIN2 mRNA	PMID:29154799
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RIN2 gene	PMID:29154799
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RIN2 mRNA	PMID:26272509
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RIN2 mRNA	PMID:30047161
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine affects the expression of RIN2 mRNA	PMID:20106945
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RIN2 mRNA	PMID:21632981|PMID:25562108
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314167	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RIN2 mRNA	PMID:28973697
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of RIN2 mRNA	PMID:24136188
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RIN2 mRNA	PMID:38832940
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RIN2 mRNA	PMID:24935251
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of RIN2 mRNA	PMID:21420995|PMID:29067470
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RIN2 mRNA	PMID:33387578
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:46557	zoledronic acid	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	[zoledronic acid co-treated with fluvastatin] results in increased expression of RIN2 mRNA	PMID:16996129
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RIN2 mRNA	PMID:35811015
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RIN2 mRNA	PMID:39836092
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RIN2 mRNA	PMID:29391264
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RIN2 mRNA	PMID:25554681
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RIN2 mRNA	PMID:30047161
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of RIN2 mRNA	PMID:24136188
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of RIN2 mRNA	PMID:26377693
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of RIN2 mRNA	PMID:19042947
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305873	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of RIN2 mRNA	PMID:28801915
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RIN2 mRNA	PMID:39836092
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305873	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RIN2 mRNA	PMID:25729387
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of RIN2 intron	PMID:30157460
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1314167	E	RGD:6480464	20141111	CTD	MESH:D002185	Cannabidiol results in decreased expression of RIN2 mRNA	PMID:21542829
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of RIN2 protein	PMID:31285264
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305873	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of RIN2 mRNA	PMID:21346803
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RIN2 mRNA	PMID:27188386
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:80025	Salinomycin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of RIN2 mRNA	PMID:19682730
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314167	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of RIN2 mRNA	PMID:21795629
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305873	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RIN2 mRNA	PMID:30047161
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RIN2 mRNA	PMID:27188386
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RIN2 mRNA	PMID:38568856
1314166	RIN2	Ras and Rab interactor 2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305873	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RIN2 mRNA	PMID:19015723
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of HDAC10 mRNA	PMID:38218311
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of HDAC10 mRNA	PMID:38218311
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1620648	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of HDAC10 mRNA	PMID:15282401
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of HDAC10 mRNA	PMID:26079696
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1620648	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HDAC10 mRNA	PMID:39241906
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of HDAC10 mRNA	PMID:30510588
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HDAC10 mRNA	PMID:37042841
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1620648	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of HDAC10 mRNA	PMID:19376150
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of HDAC10 mRNA	PMID:35430440
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of HDAC10 mRNA	PMID:30779732
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1620648	E	RGD:6480464	20170516	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of HDAC10 mRNA	PMID:27396813
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HDAC10 mRNA	PMID:40512198
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of HDAC10 mRNA	PMID:19921347
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305874	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of HDAC10 mRNA	PMID:20187946
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620648	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HDAC10 mRNA	PMID:20702594|PMID:21570461
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HDAC10 mRNA	PMID:32109520
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305874	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HDAC10 mRNA	PMID:33387578
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of HDAC10 mRNA	PMID:29955902
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased expression of HDAC10 mRNA	PMID:32844245
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HDAC10 mRNA	PMID:40512198
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1620648	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HDAC10 mRNA	PMID:22228805
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HDAC10 promoter	PMID:27901495
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1620648	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HDAC10 mRNA	PMID:35676786
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of HDAC10 mRNA	PMID:30047161
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C009495	titanium dioxide results in increased expression of HDAC10 mRNA	PMID:33064449
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of HDAC10 mRNA	PMID:34492290
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1620648	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of HDAC10 mRNA	PMID:18648102
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HDAC10 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305874	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HDAC10 gene	PMID:28505145
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HDAC10 mRNA	PMID:28628672
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1620648	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of HDAC10 gene	PMID:31683443
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of HDAC10 gene	PMID:31601247
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1620648	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of HDAC10 mRNA	PMID:39298647
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HDAC10 mRNA	PMID:28628672
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1305874	E	RGD:6480464	20210406	CTD	MESH:D000487	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC10 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC10 mRNA	PMID:33051911|PMID:33396045|PMID:34896426
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1620648	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of HDAC10 mRNA	PMID:30951980|PMID:38685157
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1620648	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of HDAC10 mRNA	PMID:37019170
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305874	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of HDAC10 mRNA	PMID:17602206
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HDAC10 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HDAC10 mRNA	PMID:28628672
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305874	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of HDAC10 mRNA	PMID:17602206
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HDAC10 mRNA	PMID:37042841
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of HDAC10 mRNA	PMID:24386269
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620648	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of HDAC10 mRNA	PMID:40194260
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of HDAC10 mRNA	PMID:31533062
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of HDAC10 mRNA	PMID:34896426
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of HDAC10 mRNA	PMID:30047161
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1305874	E	RGD:6480464	20210406	CTD	MESH:C037304	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC10 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC10 mRNA	PMID:33051911|PMID:33396045|PMID:34896426
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1305874	E	RGD:6480464	20210406	CTD	MESH:C017160	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC10 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC10 mRNA	PMID:33051911|PMID:33396045|PMID:34896426
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HDAC10 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HDAC10 mRNA	PMID:28628672
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of HDAC10 mRNA	PMID:32088792
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of HDAC10 mRNA	PMID:24449571
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of HDAC10 mRNA	PMID:38832940
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1620648	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HDAC10 mRNA	PMID:17562736
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HDAC10 mRNA	PMID:40512198
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HDAC10 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of HDAC10 mRNA	PMID:28628672
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1620648	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HDAC10 mRNA	PMID:35676786
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of HDAC10 mRNA	PMID:30307764
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1305874	E	RGD:6480464	20210406	CTD	MESH:C017690	[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC10 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC10 mRNA	PMID:33051911|PMID:33396045|PMID:34896426
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:50182	3,3'-diindolylmethane	multiple interactions	ISO	RGD:1620648	E	RGD:6480464	20140812	CTD	MESH:C016392	3,3'-diindolylmethane promotes the reaction [enterotoxin B, staphylococcal results in decreased expression of HDAC10 mRNA]	PMID:24200994
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of HDAC10 mRNA	PMID:30047161
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305874	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of HDAC10 mRNA	PMID:22504374
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1620648	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of HDAC10 mRNA	PMID:35964746
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1620648	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of HDAC10 mRNA	PMID:26377693
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of HDAC10 mRNA	PMID:20977926
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:52774	pentane-2,3-dione	increases expression	ISO	RGD:1305874	E	RGD:6480464	20150512	CTD	MESH:C013186	2,3-pentanedione results in increased expression of HDAC10 mRNA	PMID:25710175
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:6437	levetiracetam	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20181113	CTD	MESH:D000077287	Levetiracetam results in decreased expression of HDAC10 mRNA	PMID:20345932
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in decreased expression of HDAC10 mRNA	PMID:25452209
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:749301	potassium perchlorate	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of HDAC10 mRNA	PMID:29673971
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305874	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of HDAC10 mRNA	PMID:21346803
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HDAC10 gene]	PMID:28238834
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of HDAC10 mRNA	PMID:30047161
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1620648	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of HDAC10 mRNA	PMID:20702594
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of HDAC10 mRNA	PMID:23914054
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305874	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HDAC10 mRNA	PMID:30047161
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305874	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of HDAC10 mRNA	PMID:22504374|PMID:24780913
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305874	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of HDAC10 mRNA	PMID:21346803
1314168	HDAC10	histone deacetylase 10	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305874	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of HDAC10 mRNA	PMID:21346803
1314170	SIRT7	sirtuin 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314171	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SIRT7 mRNA	PMID:33045310
1314170	SIRT7	sirtuin 7	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SIRT7 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SIRT7 mRNA	PMID:32699268
1314170	SIRT7	sirtuin 7	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314171	E	RGD:6480464	20180515	CTD	MESH:D010100	[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT7 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT7 protein; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein modified form]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein]	PMID:28675767
1314170	SIRT7	sirtuin 7	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SIRT7 mRNA	PMID:22378314
1314170	SIRT7	sirtuin 7	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of SIRT7 mRNA	PMID:21632981
1314170	SIRT7	sirtuin 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314171	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SIRT7 mRNA	PMID:39241906
1314170	SIRT7	sirtuin 7	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314171	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of SIRT7 mRNA	PMID:33711761
1314170	SIRT7	sirtuin 7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314171	E	RGD:6480464	20180515	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT7 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT7 protein; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein modified form]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein]	PMID:28675767
1314170	SIRT7	sirtuin 7	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314171	E	RGD:6480464	20190910	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT7 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT7 protein	PMID:31016965
1314170	SIRT7	sirtuin 7	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of SIRT7 mRNA	PMID:33647349
1314170	SIRT7	sirtuin 7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314171	E	RGD:6480464	20180515	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT7 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT7 protein; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein modified form]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein]	PMID:28675767
1314170	SIRT7	sirtuin 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314171	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SIRT7 mRNA	PMID:33908429
1314170	SIRT7	sirtuin 7	gene	CHEBI:197221	NORCANTHARIDIN	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C069741	norcantharidin results in decreased expression of SIRT7 mRNA; norcantharidin results in decreased expression of SIRT7 protein	PMID:34272796
1314170	SIRT7	sirtuin 7	gene	CHEBI:197221	NORCANTHARIDIN	multiple interactions	EXP		E	RGD:6480464	20231003	CTD	MESH:C069741	[norcantharidin co-treated with Paclitaxel] results in decreased expression of and affects the localization of SIRT7 protein; [norcantharidin co-treated with Paclitaxel] results in decreased expression of SIRT7 mRNA; Paclitaxel promotes the reaction [norcantharidin results in decreased expression of SIRT7 mRNA]; Paclitaxel promotes the reaction [norcantharidin results in decreased expression of SIRT7 protein]; SIRT7 protein inhibits the reaction [[norcantharidin co-treated with Paclitaxel] results in increased cleavage of PARP1 protein]; SIRT7 protein inhibits the reaction [[norcantharidin co-treated with Paclitaxel] results in increased expression of ATF4 protein]; SIRT7 protein inhibits the reaction [[norcantharidin co-treated with Paclitaxel] results in increased expression of DDIT3 protein]; SIRT7 protein inhibits the reaction [[norcantharidin co-treated with Paclitaxel] results in increased phosphorylation of EIF2S1 protein]	PMID:34272796
1314170	SIRT7	sirtuin 7	gene	CHEBI:22977	cadmium atom	affects methylation	ISO	RGD:1305876	E	RGD:6480464	20200317	CTD	MESH:D002104	Cadmium affects the methylation of SIRT7 gene	PMID:29381301
1314170	SIRT7	sirtuin 7	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SIRT7 mRNA	PMID:19549813
1314170	SIRT7	sirtuin 7	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SIRT7 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SIRT7 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of SIRT7 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of SIRT7 mRNA	PMID:32699268|PMID:35430440
1314170	SIRT7	sirtuin 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314171	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SIRT7 mRNA	PMID:31919559
1314170	SIRT7	sirtuin 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314171	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SIRT7 mRNA	PMID:22206623
1314170	SIRT7	sirtuin 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314171	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIRT7 mRNA	PMID:40504410
1314170	SIRT7	sirtuin 7	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314171	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of SIRT7 mRNA	PMID:21151649
1314170	SIRT7	sirtuin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314171	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SIRT7 mRNA	PMID:21570461
1314170	SIRT7	sirtuin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305876	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SIRT7 mRNA	PMID:34747641
1314170	SIRT7	sirtuin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SIRT7 mRNA	PMID:20106945|PMID:21632981
1314170	SIRT7	sirtuin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305876	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SIRT7 mRNA	PMID:33387578
1314170	SIRT7	sirtuin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314171	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SIRT7 promoter]	PMID:19654925
1314170	SIRT7	sirtuin 7	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SIRT7 mRNA	PMID:33212167
1314170	SIRT7	sirtuin 7	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SIRT7 mRNA	PMID:32763439
1314170	SIRT7	sirtuin 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SIRT7 mRNA	PMID:38568856|PMID:39719251
1314170	SIRT7	sirtuin 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314171	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIRT7 mRNA	PMID:40504410
1314170	SIRT7	sirtuin 7	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014415	Tunicamycin results in increased expression of SIRT7 mRNA; Tunicamycin results in increased expression of SIRT7 protein	PMID:24210820
1314170	SIRT7	sirtuin 7	gene	CHEBI:29699	tunicamycin	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D014415	SIRT7 protein inhibits the reaction [Tunicamycin results in increased expression of DDIT3 mRNA]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased expression of HSPA5 mRNA]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased phosphorylation of EIF2S1 protein]; SIRT7 protein inhibits the reaction [Tunicamycin results in increased splicing of XBP1 mRNA]	PMID:24210820
1314170	SIRT7	sirtuin 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314171	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SIRT7 mRNA	PMID:21569818|PMID:22228805
1314170	SIRT7	sirtuin 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314171	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SIRT7 gene	PMID:35295148
1314170	SIRT7	sirtuin 7	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305876	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SIRT7 mRNA	PMID:23411599
1314170	SIRT7	sirtuin 7	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314171	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of SIRT7 mRNA	PMID:18445702|PMID:23811191
1314170	SIRT7	sirtuin 7	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305876	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of SIRT7 mRNA	PMID:30816183
1314170	SIRT7	sirtuin 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305876	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SIRT7 mRNA	PMID:25181051|PMID:32528016|PMID:34947998
1314170	SIRT7	sirtuin 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314171	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of SIRT7 mRNA	PMID:35598803
1314170	SIRT7	sirtuin 7	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314171	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SIRT7 promoter	PMID:27312807
1314170	SIRT7	sirtuin 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased expression of SIRT7 mRNA	PMID:32030086
1314170	SIRT7	sirtuin 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314171	E	RGD:6480464	20190910	CTD	MESH:C006780	bisphenol A results in increased expression of SIRT7 mRNA	PMID:31016965
1314170	SIRT7	sirtuin 7	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305876	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SIRT7 gene	PMID:28505145
1314170	SIRT7	sirtuin 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314171	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SIRT7 mRNA	PMID:39298647
1314170	SIRT7	sirtuin 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314171	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of SIRT7 mRNA	PMID:40203079
1314170	SIRT7	sirtuin 7	gene	CHEBI:34595	Butylbenzyl phthalate	affects expression	ISO	RGD:1314171	E	RGD:6480464	20190910	CTD	MESH:C027561	butylbenzyl phthalate affects the expression of SIRT7 mRNA	PMID:31016965
1314170	SIRT7	sirtuin 7	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314171	E	RGD:6480464	20170516	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SIRT7 mRNA	PMID:27923775
1314170	SIRT7	sirtuin 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SIRT7 mRNA	PMID:37042841
1314170	SIRT7	sirtuin 7	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SIRT7 mRNA	PMID:38174414
1314170	SIRT7	sirtuin 7	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1314171	E	RGD:6480464	20190910	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of SIRT7 mRNA	PMID:31016965
1314170	SIRT7	sirtuin 7	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of SIRT7 mRNA	PMID:19376846
1314170	SIRT7	sirtuin 7	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SIRT7 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SIRT7 mRNA	PMID:32699268
1314170	SIRT7	sirtuin 7	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314171	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of SIRT7 mRNA	PMID:23811191
1314170	SIRT7	sirtuin 7	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SIRT7 mRNA	PMID:31533062
1314170	SIRT7	sirtuin 7	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D003474	Curcumin results in decreased expression of SIRT7	PMID:25644192
1314170	SIRT7	sirtuin 7	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SIRT7 mRNA	PMID:25979313
1314170	SIRT7	sirtuin 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314171	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in increased expression of SIRT7 mRNA	PMID:19136453|PMID:21427059
1314170	SIRT7	sirtuin 7	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SIRT7 gene	PMID:29154799
1314170	SIRT7	sirtuin 7	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SIRT7 mRNA	PMID:25562108
1314170	SIRT7	sirtuin 7	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1314171	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of SIRT7 mRNA	PMID:17555576
1314170	SIRT7	sirtuin 7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314171	E	RGD:6480464	20180515	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT7 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of SIRT7 protein; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein modified form]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of TRP53 protein]	PMID:28675767
1314170	SIRT7	sirtuin 7	gene	CHEBI:45863	paclitaxel	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D017239	Paclitaxel results in decreased expression of SIRT7 mRNA; Paclitaxel results in decreased expression of SIRT7 protein	PMID:34272796
1314170	SIRT7	sirtuin 7	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:D017239	[norcantharidin co-treated with Paclitaxel] results in decreased expression of and affects the localization of SIRT7 protein; [norcantharidin co-treated with Paclitaxel] results in decreased expression of SIRT7 mRNA; Paclitaxel promotes the reaction [norcantharidin results in decreased expression of SIRT7 mRNA]; Paclitaxel promotes the reaction [norcantharidin results in decreased expression of SIRT7 protein]; SIRT7 protein inhibits the reaction [[norcantharidin co-treated with Paclitaxel] results in increased cleavage of PARP1 protein]; SIRT7 protein inhibits the reaction [[norcantharidin co-treated with Paclitaxel] results in increased expression of ATF4 protein]; SIRT7 protein inhibits the reaction [[norcantharidin co-treated with Paclitaxel] results in increased expression of DDIT3 protein]; SIRT7 protein inhibits the reaction [[norcantharidin co-treated with Paclitaxel] results in increased phosphorylation of EIF2S1 protein]	PMID:34272796
1314170	SIRT7	sirtuin 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314171	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SIRT7 mRNA	PMID:17562736
1314170	SIRT7	sirtuin 7	gene	CHEBI:46195	paracetamol	affects methylation	ISO	RGD:1305876	E	RGD:6480464	20200317	CTD	MESH:D000082	Acetaminophen affects the methylation of SIRT7 gene	PMID:29381301
1314170	SIRT7	sirtuin 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of SIRT7 mRNA	PMID:25704631
1314170	SIRT7	sirtuin 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314171	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SIRT7 mRNA	PMID:40504410
1314170	SIRT7	sirtuin 7	gene	CHEBI:47776	very-low-density lipoprotein triglyceride	decreases secretion	ISO	RGD:1314171	E	RGD:6480464	20170303	CTD	MESH:C030106	SIRT7 gene mutant form results in decreased secretion of very low density lipoprotein triglyceride	PMID:24210820
1314170	SIRT7	sirtuin 7	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	affects methylation	ISO	RGD:1305876	E	RGD:6480464	20200317	CTD	MESH:C045651	epigallocatechin gallate affects the methylation of SIRT7 gene	PMID:29381301
1314170	SIRT7	sirtuin 7	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of SIRT7 mRNA	PMID:17211630
1314170	SIRT7	sirtuin 7	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1314171	E	RGD:6480464	20160412	CTD	MESH:D008687	Metformin results in decreased expression of SIRT7 mRNA	PMID:24687991
1314170	SIRT7	sirtuin 7	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1314171	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of SIRT7 mRNA	PMID:26307267
1314170	SIRT7	sirtuin 7	gene	CHEBI:6809	methamphetamine	increases methylation	ISO	RGD:1314171	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased methylation of SIRT7 promoter	PMID:26307267
1314170	SIRT7	sirtuin 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314171	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SIRT7 mRNA	PMID:22206623
1314170	SIRT7	sirtuin 7	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of SIRT7 protein	PMID:31285264
1314170	SIRT7	sirtuin 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SIRT7 gene]	PMID:28238834
1314170	SIRT7	sirtuin 7	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1314171	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of SIRT7 mRNA	PMID:21278054
1314170	SIRT7	sirtuin 7	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SIRT7 mRNA	PMID:38568856
1314170	SIRT7	sirtuin 7	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1314171	E	RGD:6480464	20140513	CTD	MESH:D019284	Thapsigargin results in increased expression of SIRT7 mRNA; Thapsigargin results in increased expression of SIRT7 protein	PMID:24210820
1314170	SIRT7	sirtuin 7	gene	CHEBI:9516	thapsigargin	multiple interactions	ISO	RGD:1314171	E	RGD:6480464	20140513	CTD	MESH:D019284	XBP1 gene mutant form inhibits the reaction [Thapsigargin results in increased expression of SIRT7 mRNA]; XBP1 gene mutant form inhibits the reaction [Thapsigargin results in increased expression of SIRT7 protein]	PMID:24210820
1314170	SIRT7	sirtuin 7	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305876	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of SIRT7 mRNA	PMID:22570695
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of GNS mRNA	PMID:16054129|PMID:33167477
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of GNS mRNA	PMID:26079696
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1305877	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of GNS mRNA	PMID:36841081
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314173	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GNS mRNA	PMID:39241906
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314173	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of GNS mRNA	PMID:39298647
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:166595	Yessotoxin	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in increased expression of GNS mRNA	PMID:30679557
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of GNS mRNA	PMID:23649840
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of GNS mRNA	PMID:21179406
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305877	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of GNS mRNA	PMID:22061828|PMID:33387578
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314173	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GNS mRNA	PMID:36331819
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305877	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of GNS mRNA	PMID:28522335
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in increased expression of GNS mRNA	PMID:23369406
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GNS protein	PMID:23301498
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of GNS mRNA	PMID:23649840
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GNS mRNA	PMID:23649840
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1305877	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of GNS mRNA	PMID:41580963
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:2654	aminoglutethimide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in decreased expression of GNS protein	PMID:26102013
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305877	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of GNS mRNA	PMID:31150632
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314173	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNS mRNA	PMID:40504410
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of GNS mRNA	PMID:19244175
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of GNS mRNA	PMID:23557933
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314173	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of GNS mRNA	PMID:30912803
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of GNS mRNA	PMID:23195993
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314173	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GNS mRNA	PMID:21570461
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305877	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GNS mRNA	PMID:32109520|PMID:34747641
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314173	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to GNS promoter]	PMID:19654925
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:28304	heparin	affects degradation	EXP		E	RGD:6480464	20120501	CTD	MESH:D006493	GNS affects the degradation of Heparin	PMID:3391615
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:28815	heparan sulfate	affects degradation	EXP		E	RGD:6480464	20120501	CTD	MESH:D006497	GNS affects the degradation of Heparan Sulfate	PMID:3391615
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the expression of GNS mRNA	PMID:20816728
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GNS mRNA	PMID:38568856
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314173	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNS mRNA	PMID:40504410
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of GNS mRNA	PMID:22378314
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GNS promoter	PMID:27901495
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GNS mRNA	PMID:22316170
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314173	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to GNS promoter]	PMID:19654925
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305877	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of GNS mRNA	PMID:24136188
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314173	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GNS gene	PMID:35295148
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314173	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of GNS mRNA	PMID:23557971
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305877	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of GNS mRNA	PMID:25181051
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of GNS protein	PMID:34186270
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305877	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GNS mRNA	PMID:34947998
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of GNS mRNA; bisphenol A results in increased expression of GNS protein	PMID:29275510|PMID:37567409
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314173	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GNS mRNA	PMID:34585602|PMID:35479511
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305877	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GNS mRNA	PMID:36041667
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:33418	graphite	affects expression	ISO	RGD:1305877	E	RGD:6480464	20181113	CTD	MESH:D006108	Graphite affects the expression of GNS mRNA	PMID:29933104
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of GNS mRNA	PMID:25979313
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314173	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GNS mRNA	PMID:39298647
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of GNS protein	PMID:34186270
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314173	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of GNS mRNA	PMID:40203079
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305877	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GNS mRNA	PMID:36041667
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of GNS protein	PMID:34186270
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305877	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of GNS mRNA	PMID:36041667
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of GNS protein	PMID:34186270
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1305877	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of GNS mRNA	PMID:35163327
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305877	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of GNS mRNA	PMID:35163327
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GNS protein	PMID:26220685
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305877	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of GNS mRNA	PMID:35163327
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of GNS mRNA	PMID:24449571
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of GNS mRNA	PMID:19244175
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GNS mRNA	PMID:31533062
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of GNS mRNA	PMID:19167446
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314173	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GNS mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of GNS mRNA	PMID:36331819
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GNS mRNA	PMID:25979313
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of GNS mRNA	PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of GNS mRNA	PMID:20106945
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305877	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of GNS mRNA	PMID:24136188
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of GNS mRNA	PMID:22230336
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314173	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GNS mRNA	PMID:40504410
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305877	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of GNS mRNA	PMID:29391264
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:4917	eugenol	decreases expression	ISO	RGD:1305877	E	RGD:6480464	20250902	CTD	MESH:D005054	Eugenol results in decreased expression of GNS protein	PMID:39793947
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305877	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of GNS mRNA	PMID:30307764
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:60924	keratan sulfate	affects degradation	EXP		E	RGD:6480464	20170303	CTD	MESH:D007632	GNS affects the degradation of Keratan Sulfate	PMID:3391615
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1305877	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of GNS mRNA	PMID:24136188
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of GNS mRNA	PMID:15336504
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1314173	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of GNS mRNA	PMID:20003209
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of GNS protein	PMID:34186270
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of GNS protein	PMID:37664457
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305877	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of GNS mRNA	PMID:24136188
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1314173	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of GNS mRNA	PMID:23091169
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1314173	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of GNS mRNA	PMID:38995820
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of GNS mRNA	PMID:33512557
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of GNS mRNA	PMID:35688559
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1314173	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of GNS mRNA	PMID:21278054
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of GNS protein	PMID:37664457
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305877	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of GNS mRNA	PMID:19281266
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of GNS mRNA	PMID:38568856
1314172	GNS	glucosamine (N-acetyl)-6-sulfatase	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314173	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of GNS mRNA	PMID:28973697
1314174	CLDN12	claudin 12	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CLDN12 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CLDN12 mRNA	PMID:32699268
1314174	CLDN12	claudin 12	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314175	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CLDN12 mRNA	PMID:30319688
1314174	CLDN12	claudin 12	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1561053	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CLDN12 mRNA	PMID:33387578
1314174	CLDN12	claudin 12	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CLDN12 mRNA	PMID:37042841
1314174	CLDN12	claudin 12	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CLDN12 mRNA	PMID:23649840
1314174	CLDN12	claudin 12	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CLDN12 mRNA	PMID:21179406
1314174	CLDN12	claudin 12	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of CLDN12 mRNA	PMID:21592394
1314174	CLDN12	claudin 12	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of CLDN12 mRNA	PMID:21592394
1314174	CLDN12	claudin 12	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CLDN12 mRNA	PMID:21592394
1314174	CLDN12	claudin 12	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of CLDN12 mRNA	PMID:21592394
1314174	CLDN12	claudin 12	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1561053	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CLDN12 mRNA	PMID:33387578
1314174	CLDN12	claudin 12	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314175	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CLDN12 mRNA	PMID:36331819
1314174	CLDN12	claudin 12	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CLDN12 mRNA	PMID:39836092
1314174	CLDN12	claudin 12	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314175	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CLDN12 mRNA	PMID:28111341|PMID:40850461
1314174	CLDN12	claudin 12	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CLDN12 mRNA	PMID:19549813
1314174	CLDN12	claudin 12	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CLDN12 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CLDN12 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of CLDN12 mRNA	PMID:32699268
1314174	CLDN12	claudin 12	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314175	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CLDN12 mRNA	PMID:31919559
1314174	CLDN12	claudin 12	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CLDN12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CLDN12 mRNA	PMID:39836092
1314174	CLDN12	claudin 12	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CLDN12 protein	PMID:35688186
1314174	CLDN12	claudin 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314175	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLDN12 mRNA	PMID:21570461
1314174	CLDN12	claudin 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1561053	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLDN12 mRNA	PMID:33387578
1314174	CLDN12	claudin 12	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CLDN12 mRNA	PMID:30851411
1314174	CLDN12	claudin 12	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of CLDN12 mRNA	PMID:20971185
1314174	CLDN12	claudin 12	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CLDN12 mRNA	PMID:29803840
1314174	CLDN12	claudin 12	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of CLDN12 mRNA	PMID:25523186
1314174	CLDN12	claudin 12	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CLDN12 mRNA	PMID:38568856
1314174	CLDN12	claudin 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CLDN12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CLDN12 mRNA	PMID:39836092
1314174	CLDN12	claudin 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314175	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CLDN12 mRNA	PMID:22228805
1314174	CLDN12	claudin 12	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of CLDN12 mRNA	PMID:25523186
1314174	CLDN12	claudin 12	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of CLDN12 mRNA	PMID:20971185
1314174	CLDN12	claudin 12	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CLDN12 mRNA	PMID:25895662
1314174	CLDN12	claudin 12	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314175	E	RGD:6480464	20200804	CTD	MESH:C009495	titanium dioxide results in increased expression of CLDN12 mRNA	PMID:32333507
1314174	CLDN12	claudin 12	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1561053	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of CLDN12 mRNA	PMID:19167457
1314174	CLDN12	claudin 12	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1561053	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CLDN12 mRNA	PMID:25181051
1314174	CLDN12	claudin 12	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CLDN12 mRNA	PMID:29275510
1314174	CLDN12	claudin 12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1561053	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CLDN12 mRNA	PMID:34947998
1314174	CLDN12	claudin 12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314175	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CLDN12 mRNA	PMID:33221593
1314174	CLDN12	claudin 12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1561053	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CLDN12 mRNA	PMID:30816183
1314174	CLDN12	claudin 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314175	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CLDN12 mRNA	PMID:39298647
1314174	CLDN12	claudin 12	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314175	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CLDN12 mRNA	PMID:38685157
1314174	CLDN12	claudin 12	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314175	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CLDN12 mRNA	PMID:21266533
1314174	CLDN12	claudin 12	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314175	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of CLDN12 mRNA	PMID:34813904
1314174	CLDN12	claudin 12	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314175	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of CLDN12 mRNA	PMID:36117858
1314174	CLDN12	claudin 12	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of CLDN12 mRNA	PMID:29024780
1314174	CLDN12	claudin 12	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CLDN12 mRNA	PMID:39836092
1314174	CLDN12	claudin 12	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CLDN12 mRNA	PMID:25851441|PMID:38174414
1314174	CLDN12	claudin 12	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314175	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CLDN12 mRNA	PMID:28111341|PMID:40850461
1314174	CLDN12	claudin 12	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CLDN12 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CLDN12 mRNA	PMID:32699268
1314174	CLDN12	claudin 12	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CLDN12 mRNA	PMID:28302478
1314174	CLDN12	claudin 12	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CLDN12 mRNA	PMID:31533062
1314174	CLDN12	claudin 12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CLDN12 mRNA	PMID:40419075
1314174	CLDN12	claudin 12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314175	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CLDN12 mRNA	PMID:36331819
1314174	CLDN12	claudin 12	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CLDN12 gene	PMID:29154799
1314174	CLDN12	claudin 12	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in decreased expression of CLDN12 protein	PMID:24907557
1314174	CLDN12	claudin 12	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of CLDN12 mRNA	PMID:27989131
1314174	CLDN12	claudin 12	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314175	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CLDN12 mRNA	PMID:17562736
1314174	CLDN12	claudin 12	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CLDN12 mRNA	PMID:22230336
1314174	CLDN12	claudin 12	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1561053	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CLDN12 mRNA	PMID:33387578
1314174	CLDN12	claudin 12	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CLDN12 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CLDN12 mRNA	PMID:39836092
1314174	CLDN12	claudin 12	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314175	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CLDN12 mRNA	PMID:35436446
1314174	CLDN12	claudin 12	gene	CHEBI:48607	lithium chloride	decreases expression	ISO	RGD:1314175	E	RGD:6480464	20211012	CTD	MESH:D018021	Lithium Chloride results in decreased expression of CLDN12 mRNA	PMID:33901603
1314174	CLDN12	claudin 12	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314175	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of CLDN12 mRNA	PMID:36117858
1314174	CLDN12	claudin 12	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1314175	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of CLDN12 mRNA	PMID:19042947
1314174	CLDN12	claudin 12	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of CLDN12 mRNA	PMID:31629900
1314174	CLDN12	claudin 12	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CLDN12 mRNA	PMID:39836092
1314174	CLDN12	claudin 12	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314175	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLDN12 mRNA	PMID:21641980
1314174	CLDN12	claudin 12	gene	CHEBI:6651	malathion	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in increased expression of CLDN12 mRNA	PMID:37047231
1314174	CLDN12	claudin 12	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CLDN12 mRNA	PMID:31758290
1314174	CLDN12	claudin 12	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314175	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CLDN12 mRNA	PMID:22206623
1314174	CLDN12	claudin 12	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CLDN12 mRNA	PMID:37199045
1314174	CLDN12	claudin 12	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of CLDN12 mRNA	PMID:30851411
1314174	CLDN12	claudin 12	gene	CHEBI:78492	diallyl trisulfide	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in increased expression of CLDN12 mRNA	PMID:34995734
1314174	CLDN12	claudin 12	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CLDN12 gene]	PMID:28238834
1314174	CLDN12	claudin 12	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CLDN12 mRNA	PMID:19159669
1314174	CLDN12	claudin 12	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1314175	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CLDN12 mRNA	PMID:21278054
1314174	CLDN12	claudin 12	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1561053	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CLDN12 mRNA	PMID:24780913
1314174	CLDN12	claudin 12	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1561053	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of CLDN12 mRNA	PMID:19281266
1314174	CLDN12	claudin 12	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of CLDN12 mRNA	PMID:19140230
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314177	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CARM1 mRNA	PMID:33045310
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314177	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CARM1 mRNA	PMID:37995155
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:136004	linsidomine	increases oxidation	ISO	RGD:1305879	E	RGD:6480464	20180220	CTD	MESH:C002385	linsidomine results in increased oxidation of CARM1 protein	PMID:28086193
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CARM1 mRNA	PMID:33167477
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CARM1 mRNA	PMID:22378314
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314177	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CARM1 mRNA	PMID:39241906
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of CARM1 mRNA	PMID:19167446|PMID:31646340
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol inhibits the reaction [Fulvestrant results in increased expression of CARM1 mRNA]; Estradiol promotes the reaction [CARM1 protein binds to TFF1 promoter]	PMID:20360387|PMID:31646340
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:16643	L-methionine	increases expression	ISO	RGD:1314177	E	RGD:6480464	20221206	CTD	MESH:D008715	Methionine deficiency results in increased expression of CARM1 mRNA	PMID:35314295
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:16680	S-adenosyl-L-homocysteine	decreases activity	EXP		E	RGD:6480464	20220111	CTD	MESH:D012435	S-Adenosylhomocysteine results in decreased activity of CARM1 protein	PMID:33577917
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:17489	3',5'-cyclic AMP	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D000242	Cyclic AMP results in increased phosphorylation of CARM1 protein	PMID:20360387
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:17489	3',5'-cyclic AMP	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000242	[Cyclic AMP results in increased phosphorylation of CARM1 protein] promotes the reaction [CARM1 protein binds to ESR1 protein]; CARM1 protein promotes the reaction [Cyclic AMP results in increased activity of ESR1 protein]; CARM1 protein promotes the reaction [Cyclic AMP results in increased expression of TFF1 mRNA]; Cyclic AMP promotes the reaction [CARM1 protein binds to ESR1 protein]; Cyclic AMP promotes the reaction [CARM1 protein binds to TFF1 promoter]	PMID:20360387
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314177	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of CARM1 mRNA	PMID:23892564
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305879	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CARM1 protein	PMID:34915118
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D002104	Cadmium results in decreased expression of CARM1 mRNA	PMID:31646340
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D002104	Cadmium inhibits the reaction [Fulvestrant results in increased expression of CARM1 mRNA]	PMID:31646340
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314177	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CARM1 mRNA	PMID:37236586
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CARM1 protein	PMID:23301498
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of CARM1 mRNA	PMID:23649840
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CARM1 mRNA	PMID:23649840
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314177	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CARM1 mRNA	PMID:40504410
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CARM1 mRNA	PMID:28903495
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314177	E	RGD:6480464	20190910	CTD	MESH:D002945	Cisplatin results in increased expression of CARM1 protein	PMID:31256211
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1314177	E	RGD:6480464	20190910	CTD	MESH:D002945	CARM1 protein affects the reaction [Cisplatin results in increased cleavage of CASP3 protein]; CARM1 protein affects the reaction [Cisplatin results in increased cleavage of CASP9 protein]; CARM1 protein affects the reaction [Cisplatin results in increased cleavage of PARP1 protein]; CARM1 protein affects the reaction [Cisplatin results in increased expression of DDIT3 protein]; CARM1 protein affects the reaction [Cisplatin results in increased phosphorylation of TRP53 protein]	PMID:31256211
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305879	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of CARM1 mRNA	PMID:20187946
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314177	E	RGD:6480464	20160412	CTD	MESH:D019833	Genistein results in increased expression of CARM1 mRNA	PMID:24967385
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314177	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CARM1 mRNA	PMID:21570461|PMID:26377647
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305879	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CARM1 mRNA	PMID:33387578
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of CARM1 protein	PMID:39603559
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CARM1 mRNA	PMID:26272509
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARM1 mRNA	PMID:27188386
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305879	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CARM1 mRNA	PMID:28959563
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CARM1 mRNA	PMID:29803840
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin promotes the reaction [CARM1 protein binds to ESR1 promoter]; Doxorubicin promotes the reaction [TP53 protein binds to CARM1 protein]	PMID:19351845
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:29678	sodium arsenite	affects localization	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the localization of CARM1 protein	PMID:23699174
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased expression of CARM1 mRNA	PMID:32844245
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:29678	sodium arsenite	decreases response to substance	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	CARM1 protein results in decreased susceptibility to sodium arsenite	PMID:23699174
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CARM1 mRNA	PMID:39719251
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314177	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in increased expression of CARM1 mRNA	PMID:39095385
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[CARM1 mutant form co-treated with sodium arsenite] results in increased expression of ALOX12 mRNA; [CARM1 mutant form co-treated with sodium arsenite] results in increased expression of BNIP3 mRNA; [CARM1 mutant form co-treated with sodium arsenite] results in increased expression of MB mRNA; [CARM1 mutant form co-treated with sodium arsenite] results in increased expression of PRDX3 mRNA; [CARM1 mutant form co-treated with sodium arsenite] results in increased expression of TRAPPC6A mRNA; CARM1 mutant form inhibits the reaction [sodium arsenite results in decreased expression of EPHX2 mRNA]; CARM1 mutant form inhibits the reaction [sodium arsenite results in decreased expression of KRT1 mRNA]; CARM1 mutant form inhibits the reaction [sodium arsenite results in increased expression of FTH1 mRNA]; CARM1 mutant form inhibits the reaction [sodium arsenite results in increased expression of FTH1 protein]; CARM1 mutant form promotes the reaction [sodium arsenite results in increased expression of FTH1 mRNA]; CARM1 mutant form promotes the reaction [sodium arsenite results in increased expression of GCLC mRNA]; CARM1 mutant form promotes the reaction [sodium arsenite results in increased expression of HSP90AA1 mRNA]; CARM1 mutant form promotes the reaction [sodium arsenite results in increased expression of SPINK1 mRNA]	PMID:23699174
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314177	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CARM1 mRNA	PMID:40504410
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314177	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CARM1 mRNA	PMID:22228805
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CARM1 mRNA	PMID:40419235
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314177	E	RGD:6480464	20130618	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CARM1 mRNA]	PMID:22228805
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:C015001	arsenite results in decreased expression of CARM1 mRNA	PMID:31646340
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C015001	arsenite inhibits the reaction [Fulvestrant results in increased expression of CARM1 mRNA]	PMID:31646340
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CARM1 protein	PMID:25419056
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:31638	fulvestrant	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:C070081	Fulvestrant results in increased expression of CARM1 mRNA	PMID:31646340
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C070081	arsenite inhibits the reaction [Fulvestrant results in increased expression of CARM1 mRNA]; Cadmium inhibits the reaction [Fulvestrant results in increased expression of CARM1 mRNA]; Estradiol inhibits the reaction [Fulvestrant results in increased expression of CARM1 mRNA]	PMID:31646340
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305879	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CARM1 mRNA	PMID:23411599
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305879	E	RGD:6480464	20161025	CTD	MESH:C069837	fullerene C60 results in decreased expression of CARM1 mRNA	PMID:19167457
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of CARM1 protein	PMID:37567409
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305879	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CARM1 mRNA	PMID:25181051|PMID:34947998
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CARM1 intron	PMID:30157460
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314177	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CARM1 mRNA	PMID:38685157
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314177	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CARM1 mRNA	PMID:37019170
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1314177	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of CARM1 mRNA	PMID:34813904
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314177	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CARM1 mRNA	PMID:37236586
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CARM1 mRNA	PMID:19320972
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305879	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of CARM1 mRNA	PMID:29427782
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CARM1 gene	PMID:29154799
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[CARM1 protein binds to ESR1 protein] which affects the susceptibility to Tamoxifen; CARM1 protein promotes the reaction [Tamoxifen results in increased activity of ESR1 protein]	PMID:20360387
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of CARM1 mRNA	PMID:22230336
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305879	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CARM1 mRNA	PMID:33387578
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314177	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CARM1 mRNA	PMID:40504410
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314177	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CARM1 mRNA	PMID:35436446
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CARM1 protein	PMID:25419056
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314177	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CARM1 mRNA; Nanotubes, Carbon results in increased expression of CARM1 mRNA	PMID:25554681
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305879	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CARM1 mRNA	PMID:24136188
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CARM1 protein	PMID:32959892
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:63580	ribavirin	decreases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D012254	Ribavirin results in decreased expression of CARM1 protein	PMID:34919946
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:63580	ribavirin	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:D012254	Ribavirin inhibits the reaction [CARM1 protein binds to EIF4E promoter]; Ribavirin inhibits the reaction [CARM1 protein binds to VEGFA promoter]	PMID:34919946
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314177	E	RGD:6480464	20130618	CTD	MESH:C017096	n-butoxyethanol results in increased expression of CARM1 mRNA	PMID:19812364
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CARM1 intron	PMID:30157460
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314177	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CARM1 mRNA	PMID:22206623
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of CARM1 protein	PMID:37664457
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CARM1 protein	PMID:39638853
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of CARM1 protein	PMID:39638853
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305879	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of CARM1 mRNA	PMID:21346803
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARM1 mRNA	PMID:27188386
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CARM1 gene]	PMID:28238834
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of CARM1 protein; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARM1 mRNA	PMID:27188386|PMID:37664457
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305879	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CARM1 mRNA	PMID:21346803
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CARM1 mRNA	PMID:38568856
1314176	CARM1	coactivator associated arginine methyltransferase 1	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of CARM1 mRNA	PMID:27188386
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of GPR107 mRNA	PMID:38218311
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of GPR107 mRNA	PMID:38218311
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314181	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of GPR107 mRNA	PMID:37995155
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of GPR107 mRNA	PMID:33167477
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314181	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GPR107 mRNA	PMID:36331819
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314181	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of GPR107 mRNA	PMID:39298647
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of GPR107 mRNA	PMID:24376830
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of GPR107 mRNA	PMID:19549813
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GPR107 polyA tail	PMID:30157460
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GPR107 mRNA	PMID:23649840
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314181	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GPR107 mRNA	PMID:22206623
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of GPR107 mRNA	PMID:19244175
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314181	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPR107 mRNA	PMID:21570461
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GPR107 mRNA	PMID:21296121
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GPR107 mRNA	PMID:38568856
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite promotes the reaction [GPR107 protein binds to CAPRIN1 protein]	PMID:33939924
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GPR107 mRNA	PMID:26238291
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:3016	Benoxacor	increases expression	ISO	RGD:1314181	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in increased expression of GPR107 mRNA	PMID:34850242
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314181	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GPR107 gene	PMID:35295148
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305882	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GPR107 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of GPR107 mRNA	PMID:19244175
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314181	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GPR107 mRNA	PMID:39298647
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314181	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GPR107 mRNA	PMID:37019170
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314181	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of GPR107 mRNA	PMID:21266533
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1305882	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of GPR107 mRNA	PMID:22110744
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305882	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of GPR107 mRNA	PMID:24386269
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of GPR107 mRNA	PMID:19244175
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314181	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GPR107 mRNA	PMID:36331819
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GPR107 mRNA	PMID:23179753|PMID:25979313
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of GPR107 mRNA	PMID:20106945
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of GPR107 protein	PMID:31195006
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305882	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of GPR107 mRNA	PMID:24793618
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of GPR107 mRNA	PMID:15336504
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305882	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of GPR107 mRNA	PMID:30467583
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305882	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of GPR107 gene	PMID:35440735
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1314181	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of GPR107 mRNA	PMID:22206623
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314181	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GPR107 mRNA	PMID:22206623
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:755208	eprenetapopt	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of GPR107 mRNA	PMID:19946333
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of GPR107 mRNA	PMID:19095052
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of GPR107 mRNA	PMID:38568856
1314180	GPR107	G protein-coupled receptor 107	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305882	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of GPR107 mRNA	PMID:23034163
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1618275	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MED13L mRNA	PMID:33045310
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1618275	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MED13L mRNA	PMID:20188158|PMID:26251327
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MED13L mRNA	PMID:26079696
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1618275	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MED13L mRNA	PMID:30319688
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MED13L mRNA	PMID:20044591
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of MED13L protein	PMID:18951874
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1618275	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MED13L mRNA	PMID:39241906
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305884	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of MED13L mRNA	PMID:32145629
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of MED13L mRNA	PMID:31614463
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MED13L mRNA	PMID:37042841
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of MED13L mRNA	PMID:20655997
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MED13L protein	PMID:37730182
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305884	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MED13L mRNA	PMID:22061828|PMID:33387578
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MED13L mRNA	PMID:28818685
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1618275	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MED13L mRNA	PMID:36331819
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MED13L mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MED13L mRNA	PMID:39836092
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MED13L mRNA	PMID:35301059
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MED13L mRNA	PMID:19549813
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MED13L gene	PMID:27153756
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MED13L mRNA	PMID:23649840
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of MED13L mRNA	PMID:41430723
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in decreased expression of MED13L mRNA	PMID:18593933
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MED13L mRNA; [Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of MED13L gene; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MED13L mRNA	PMID:39164771|PMID:39836092
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of MED13L mRNA	PMID:19244175
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MED13L mRNA	PMID:26272509
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MED13L mRNA	PMID:27188386
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MED13L protein	PMID:35688186
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1305884	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of MED13L gene	PMID:31011160
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1618275	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MED13L mRNA	PMID:30912803
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618275	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MED13L mRNA	PMID:21570461|PMID:24680724
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1618275	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MED13L mRNA	PMID:17337447
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305884	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MED13L mRNA	PMID:34747641
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of MED13L mRNA	PMID:29704546
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of MED13L protein	PMID:18951874
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MED13L mRNA	PMID:28001369
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MED13L mRNA; aristolochic acid I results in decreased expression of MED13L protein	PMID:33212167
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	MED13L mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide]	PMID:16896004
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of MED13L protein	PMID:35688186
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MED13L mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MED13L mRNA	PMID:39836092
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MED13L mRNA	PMID:20064835
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1618275	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MED13L intron	PMID:27901495
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to MED13L mRNA]	PMID:32406909
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in decreased expression of MED13L mRNA	PMID:18593933
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1618275	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MED13L mRNA	PMID:27131904
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MED13L mRNA	PMID:19150397
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1618275	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of MED13L mRNA	PMID:20542052
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305884	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MED13L mRNA	PMID:25729387
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1618275	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MED13L promoter	PMID:35295148
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1618275	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of MED13L mRNA	PMID:28329830
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305884	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MED13L mRNA	PMID:25181051|PMID:32145629
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1618275	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of MED13L mRNA	PMID:38074096
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1618275	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of MED13L promoter	PMID:27312807
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305884	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of MED13L mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305884	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MED13L mRNA	PMID:36041667
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of MED13L mRNA	PMID:24752500
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1305884	E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of MED13L mRNA	PMID:23829299
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to MED13L promoter]	PMID:20348232
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1618275	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of MED13L mRNA	PMID:39298647
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of MED13L gene	PMID:31601247
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1618275	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of MED13L mRNA	PMID:40203079
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305884	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MED13L mRNA	PMID:36041667
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MED13L intron	PMID:30157460
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305884	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of MED13L mRNA	PMID:36041667
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1618275	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of MED13L intron	PMID:28392331
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1618275	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MED13L mRNA	PMID:37019170
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305884	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of MED13L gene	PMID:33148267
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MED13L mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MED13L mRNA	PMID:39836092
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MED13L mRNA	PMID:35301059
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of MED13L mRNA	PMID:19244175
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of MED13L mRNA	PMID:28302478
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MED13L mRNA	PMID:31533062
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1618275	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MED13L mRNA	PMID:36331819
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MED13L mRNA	PMID:25979313
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of MED13L mRNA	PMID:23179753
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MED13L gene	PMID:29154799
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MED13L mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MED13L mRNA	PMID:27188386
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:4027	cyclophosphamide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	MED13L mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide]	PMID:16896004
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of MED13L mRNA	PMID:25562108
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of MED13L mRNA	PMID:23649840
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of MED13L mRNA	PMID:24449571
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of MED13L mRNA	PMID:27188386
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	MED13L mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide]	PMID:16896004
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of MED13L mRNA	PMID:24935251|PMID:26272509
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MED13L mRNA	PMID:27188386
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	MED13L mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide]	PMID:16896004
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of MED13L mRNA	PMID:20977926
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MED13L mRNA	PMID:29523930
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MED13L mRNA; [Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of MED13L gene; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MED13L mRNA	PMID:39164771|PMID:39836092
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of MED13L mRNA	PMID:24752500
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MED13L mRNA	PMID:22079256
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1305884	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of MED13L mRNA	PMID:19162173
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of MED13L mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MED13L mRNA	PMID:39836092
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305884	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MED13L mRNA	PMID:25729387
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305884	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MED13L mRNA	PMID:25729387
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of MED13L mRNA	PMID:28988120
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305884	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of MED13L mRNA	PMID:30467583
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MED13L intron	PMID:30157460
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305884	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of MED13L gene	PMID:35440735
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305884	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of MED13L gene	PMID:33148267
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MED13L mRNA	PMID:31758290
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1618275	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MED13L mRNA	PMID:22206623
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MED13L mRNA	PMID:22079256
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MED13L mRNA	PMID:22079256
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MED13L mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MED13L mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MED13L mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MED13L mRNA	PMID:27188386
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MED13L mRNA	PMID:19159669
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of MED13L mRNA	PMID:26272509
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MED13L mRNA	PMID:27188386
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MED13L mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MED13L mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MED13L mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MED13L mRNA	PMID:27188386
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1618275	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of MED13L mRNA	PMID:27131904
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MED13L mRNA	PMID:38568856
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of MED13L mRNA	PMID:29301935
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of MED13L mRNA	PMID:27188386
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1618275	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of MED13L mRNA	PMID:28973697
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1618275	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of MED13L mRNA	PMID:28973697
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305884	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of MED13L mRNA	PMID:19015723
1314183	MED13L	mediator complex subunit 13L	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305884	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MED13L mRNA	PMID:23034163
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SULT1C2 mRNA	PMID:38218311
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SULT1C2 mRNA	PMID:26272509
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA	PMID:27188386
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SULT1C2A mRNA]	PMID:31150632
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SULT1C2 mRNA	PMID:21934132
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SULT1C2 mRNA	PMID:36331819
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SULT1C2 mRNA	PMID:26079696
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of SULT1C2 mRNA	PMID:39506029
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305885	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of SULT1C2 gene	PMID:28931070
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of SULT1C2 mRNA	PMID:17347304
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SULT1C2 mRNA	PMID:21632981
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:16433	trans-caffeic acid	increases sulfation	EXP		E	RGD:6480464	20140805	CTD	MESH:C040048	SULT1C2 protein results in increased sulfation of caffeic acid	PMID:17433394
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of SULT1C2 mRNA	PMID:23019147
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SULT1C2 mRNA	PMID:39298647
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305885	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SULT1C2A mRNA	PMID:32145629
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:165219	PCB138	increases expression	ISO	RGD:1305885	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of SULT1C2 mRNA	PMID:23829299
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:16580	N-hydroxy-4-aminobiphenyl	increases sulfation	EXP		E	RGD:6480464	20120412	CTD	MESH:C014593	SULT1C2 protein results in increased sulfation of N-hydroxy-4-aminobiphenyl	PMID:17433394
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:16755	chenodeoxycholic acid	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002635	Chenodeoxycholic Acid results in increased expression of SULT1C2 mRNA	PMID:27174168
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:16836	4-nitrophenol	increases sulfation	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C024836	SULT1C2 protein results in increased sulfation of 4-nitrophenol; SULT1C2A protein results in increased sulfation of 4-nitrophenol	PMID:10872834
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:16856	glutathione	increases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D005978	Glutathione deficiency results in increased expression of SULT1C2 mRNA	PMID:15345336
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SULT1C2 mRNA	PMID:37992649
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:17356	2-acetamidofluorene	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20121113	CTD	MESH:D015073	2-Acetylaminofluorene results in decreased expression of SULT1C2 mRNA	PMID:21607683
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:17395	cis-caffeic acid	increases sulfation	EXP		E	RGD:6480464	20120412	CTD	MESH:C040048	SULT1C2 protein results in increased sulfation of caffeic acid	PMID:17433394
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SULT1C2 mRNA	PMID:37992649
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D002117	Calcitriol results in increased expression of SULT1C2 mRNA	PMID:27107558
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SULT1C2 mRNA	PMID:28818685
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:18135	catechol	increases sulfation	EXP		E	RGD:6480464	20120412	CTD	MESH:C034221	SULT1C2 protein results in increased sulfation of catechol	PMID:17433394
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SULT1C2 mRNA	PMID:36331819
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of SULT1C2 protein; alpha-Chlorohydrin results in decreased expression of SULT1C2A protein	PMID:34915118
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:2038	5-azacytidine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001374	Azacitidine results in increased expression of SULT1C2 mRNA	PMID:19194470
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SULT1C2 mRNA	PMID:39012411
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SULT1C2 mRNA	PMID:29950665
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SULT1C2 mRNA	PMID:19549813
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SULT1C2 protein	PMID:20106945
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SULT1C2 gene	PMID:27153756
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SULT1C2 mRNA	PMID:27106289
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1623189	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of SULT1C2 mRNA	PMID:31939706
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SULT1C2 mRNA; Carbon Tetrachloride results in decreased expression of SULT1C2 protein; Carbon Tetrachloride results in decreased expression of SULT1C2A mRNA	PMID:12629582|PMID:30723492|PMID:31150632
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SULT1C2 mRNA	PMID:27339419|PMID:31919559
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SULT1C2A mRNA]	PMID:31150632
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SULT1C2 mRNA	PMID:22206623
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SULT1C2 mRNA	PMID:40504410
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SULT1C2 mRNA	PMID:26272509
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA	PMID:27188386
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SULT1C2A mRNA	PMID:31881176
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:27878	2-naphthylamine	increases sulfation	EXP		E	RGD:6480464	20120412	CTD	MESH:D015081	SULT1C2 protein results in increased sulfation of 2-Naphthylamine	PMID:17433394
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of SULT1C2 protein	PMID:22096581
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in decreased expression of SULT1C2 mRNA	PMID:25905778
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1623189	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of SULT1C2 mRNA	PMID:34813904
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of SULT1C2A gene; [bisphenol A co-treated with Genistein] results in increased methylation of SULT1C2A gene	PMID:28505145
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SULT1C2A mRNA	PMID:22298810
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623189	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SULT1C2 mRNA	PMID:21570461|PMID:26377647
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SULT1C2 mRNA	PMID:20106945
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SULT1C2 mRNA	PMID:21215274
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SULT1C2 mRNA	PMID:28922406
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1305885	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone affects the expression of SULT1C2 mRNA	PMID:28374803
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305885	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of SULT1C2A mRNA	PMID:28374803
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SULT1C2 mRNA	PMID:33212167
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D020106	Acrylamide results in increased expression of SULT1C2A mRNA	PMID:15749267
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D003300	Copper results in decreased expression of SULT1C2 mRNA	PMID:22465980
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SULT1C2 mRNA	PMID:37992649
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in decreased expression of SULT1C2 protein	PMID:38266420
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SULT1C2 mRNA	PMID:40504410
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SULT1C2 5' UTR; Benzo(a)pyrene affects the methylation of SULT1C2 promoter	PMID:27901495
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SULT1C2 mRNA	PMID:20106945|PMID:26238291|PMID:32234424
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SULT1C2 3' UTR	PMID:27901495
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D003300	Copper results in decreased expression of SULT1C2 mRNA	PMID:22465980
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SULT1C2 mRNA	PMID:25895662
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SULT1C2 mRNA	PMID:26705709
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D000643	Ammonium Chloride affects the expression of SULT1C2 mRNA; Ammonium Chloride affects the expression of SULT1C2A mRNA	PMID:16483693
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D005897	Glafenine results in decreased expression of SULT1C2A mRNA	PMID:24136188
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in decreased expression of SULT1C2 mRNA	PMID:22609695
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:32090	Rebamipide	increases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C052785	rebamipide results in increased expression of SULT1C2 mRNA	PMID:18299717
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1623189	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SULT1C2 mRNA	PMID:23557971
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SULT1C2 mRNA	PMID:29950665
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SULT1C2 mRNA; Thioacetamide results in decreased expression of SULT1C2A mRNA	PMID:34492290
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of SULT1C2A mRNA	PMID:28943392
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SULT1C2 mRNA	PMID:30723492
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of SULT1C2 mRNA	PMID:23811191
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C006780	bisphenol A affects the expression of SULT1C2 mRNA	PMID:25181051
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of SULT1C2A mRNA	PMID:35192832
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305885	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SULT1C2 mRNA; bisphenol A results in increased expression of SULT1C2A mRNA	PMID:30816183|PMID:32145629
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C006780	bisphenol A results in increased methylation of SULT1C2A gene	PMID:28505145
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of SULT1C2A gene; [bisphenol A co-treated with Genistein] results in increased methylation of SULT1C2A gene	PMID:28505145
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SULT1C2 mRNA	PMID:39298647|PMID:40203079
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in decreased expression of SULT1C2 mRNA]	PMID:40203079
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SULT1C2 mRNA	PMID:38685157
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SULT1C2 mRNA	PMID:29950665
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of SULT1C2 mRNA; Diethylnitrosamine results in decreased expression of SULT1C2A mRNA	PMID:19638242
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20121113	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of SULT1C2 mRNA	PMID:21607683
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SULT1C2 mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1C2 mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of SULT1C2A mRNA; [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of SULT1C2 mRNA	PMID:18164116|PMID:18253720|PMID:18544905|PMID:28943392
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:34911	permethrin	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in decreased expression of SULT1C2 mRNA	PMID:37047231
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1305885	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of SULT1C2A mRNA	PMID:30589522
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of SULT1C2 mRNA	PMID:29024780
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D002509	Cephaloridine results in decreased expression of SULT1C2 mRNA; Cephaloridine results in decreased expression of SULT1C2A mRNA	PMID:18500788
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of SULT1C2 mRNA; 1-Naphthylisothiocyanate results in decreased expression of SULT1C2A mRNA	PMID:30723492
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SULT1C2 mRNA	PMID:25993096
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SULT1C2 mRNA	PMID:39012411
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20220705	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SULT1C2A protein	PMID:34958885
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C039281	furan results in decreased expression of SULT1C2 mRNA; furan results in decreased expression of SULT1C2A mRNA	PMID:15120968|PMID:25539665|PMID:26194646
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in decreased expression of SULT1C2 mRNA	PMID:24183702|PMID:37517673
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SULT1C2 mRNA	PMID:19162173
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1623189	E	RGD:6480464	20161025	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SULT1C2 mRNA	PMID:27413110
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of SULT1C2 mRNA	PMID:28962523
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SULT1C2 mRNA	PMID:32588087
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SULT1C2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SULT1C2 mRNA	PMID:36331819
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C016104	sodium bichromate affects the expression of SULT1C2 mRNA	PMID:25993096
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C016104	sodium bichromate results in increased expression of SULT1C2 mRNA	PMID:22561333
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SULT1C2 mRNA	PMID:25979313
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of SULT1C2 mRNA	PMID:29154799
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SULT1C2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA	PMID:27188386
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SULT1C2 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:41879	dexamethasone	affects expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D003907	Dexamethasone affects the expression of SULT1C2 mRNA	PMID:15102944
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1623189	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SULT1C2 mRNA	PMID:28973697
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SULT1C2 mRNA	PMID:37992649
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:43572	kojic acid	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C011890	[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1C2 mRNA	PMID:18544905
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of SULT1C2 mRNA	PMID:24449571
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C012655	nimesulide results in decreased expression of SULT1C2A mRNA	PMID:24136188
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SULT1C2 mRNA	PMID:38832940
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:45285	pyrazinecarboxamide	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180703	CTD	MESH:D011718	Pyrazinamide results in decreased expression of SULT1C2A mRNA	PMID:22431067
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SULT1C2 mRNA	PMID:26272509|PMID:27188386
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA	PMID:27188386
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in increased expression of SULT1C2 mRNA	PMID:24935251|PMID:26272509|PMID:27188386
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA	PMID:27188386
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1623189	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SULT1C2 mRNA	PMID:17562736
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SULT1C2 mRNA	PMID:29067470
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:47032	1,4-dioxane	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20211109	CTD	MESH:C025223	1,4-dioxane results in decreased expression of SULT1C2 mRNA	PMID:33693819
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SULT1C2 mRNA	PMID:40504410
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SULT1C2A mRNA	PMID:17108234
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SULT1C2 mRNA	PMID:26705709
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D011345	[Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of SULT1C2 mRNA	PMID:18253720
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SULT1C2 mRNA; Nanotubes, Carbon results in decreased expression of SULT1C2 mRNA	PMID:25620056
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:5063	fipronil	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C082360	fipronil results in increased expression of SULT1C2 mRNA	PMID:27091632
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1623189	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of SULT1C2 mRNA	PMID:23962444
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C082360	[fipronil co-treated with DEET] results in increased expression of SULT1C2 mRNA	PMID:27091632
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D005485	Flutamide results in decreased expression of SULT1C2 mRNA; Flutamide results in decreased expression of SULT1C2A mRNA	PMID:24136188
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of SULT1C2 mRNA	PMID:38701926
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of SULT1C2 mRNA	PMID:27188386
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of SULT1C2 mRNA	PMID:26272509
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA	PMID:27188386
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:63618	pravastatin	affects expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D017035	Pravastatin affects the expression of SULT1C2 mRNA	PMID:27225895
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:63618	pravastatin	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of SULT1C2 mRNA	PMID:27225895
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305885	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SULT1C2A gene	PMID:35440735
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D003671	[fipronil co-treated with DEET] results in increased expression of SULT1C2 mRNA	PMID:27091632
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1623189	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SULT1C2 mRNA	PMID:22206623
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SULT1C2 mRNA	PMID:22206623
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:749301	potassium perchlorate	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in increased expression of SULT1C2 mRNA	PMID:29673971
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C051752	nefazodone results in decreased expression of SULT1C2A mRNA	PMID:24136188
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:75170	zaragozic acid A	affects expression	ISO	RGD:1623189	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 affects the expression of SULT1C2 mRNA	PMID:27225895
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:75170	zaragozic acid A	increases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C075117	squalestatin 1 results in increased expression of SULT1C2 mRNA	PMID:27225895
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of SULT1C2A protein	PMID:19716841
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SULT1C2 mRNA	PMID:18164116
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C025589	ochratoxin A results in decreased expression of SULT1C2A mRNA	PMID:12700408
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA	PMID:27188386
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1623189	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of SULT1C2 mRNA	PMID:19270015|PMID:19482888|PMID:21335049|PMID:23091169
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SULT1C2 mRNA]	PMID:19482888
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1623189	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SULT1C2 mRNA	PMID:38648751
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:81927	enilconazole	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C017435	enilconazole results in increased expression of SULT1C2 mRNA	PMID:32201337
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1623189	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SULT1C2 mRNA	PMID:27935865
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:82337	2-Amino-3-methyl-9H-pyrido[2,3-b]indole	increases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:C017821	SULT1C2 protein results in increased activity of 2-amino-3-methyl-9H-pyrido(2,3-b)indole	PMID:14729582
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of SULT1C2 mRNA	PMID:26079696
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:8493	Propiverine	affects binding	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C015586	propiverine binds to SULT1C2A protein	PMID:29273565
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of SULT1C2 mRNA	PMID:26272509
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA	PMID:27188386
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SULT1C2 mRNA	PMID:27188386
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SULT1C2 mRNA; 2,4-dinitrotoluene affects the expression of SULT1C2A mRNA	PMID:21346803
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in decreased expression of SULT1C2 mRNA	PMID:25905778
1314184	SULT1C2	sulfotransferase family 1C member 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305885	E	RGD:6480464	20180417	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SULT1C2 mRNA; 2,6-dinitrotoluene affects the expression of SULT1C2A mRNA	PMID:21346803
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305886	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SH3GLB2 mRNA]	PMID:31150632
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314187	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SH3GLB2 mRNA	PMID:36331819
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:16170	mercury(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of SH3GLB2 mRNA	PMID:16823088
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314187	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SH3GLB2 mRNA	PMID:30319688
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314187	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of SH3GLB2 mRNA	PMID:33711761
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305886	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SH3GLB2 gene	PMID:27618143
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of SH3GLB2 mRNA	PMID:27905399
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1314187	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of SH3GLB2 mRNA	PMID:23892564
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305886	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SH3GLB2 mRNA	PMID:33387578
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1314187	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of SH3GLB2 mRNA	PMID:33914522
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314187	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SH3GLB2 mRNA	PMID:37236586
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314187	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SH3GLB2 mRNA	PMID:19770486
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:25195	mercury atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of SH3GLB2 mRNA	PMID:16823088
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SH3GLB2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SH3GLB2 protein	PMID:38598786
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305886	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SH3GLB2 mRNA	PMID:31150632
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305886	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SH3GLB2 mRNA]	PMID:31150632
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1314187	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of SH3GLB2 mRNA	PMID:25629700
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SH3GLB2 mRNA	PMID:40512198
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SH3GLB2 protein	PMID:35688186
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of SH3GLB2 mRNA	PMID:27392435
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SH3GLB2 mRNA	PMID:27392435
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314187	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SH3GLB2 mRNA	PMID:21570461
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305886	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SH3GLB2 mRNA	PMID:32109520|PMID:34747641
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314187	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SH3GLB2 mRNA	PMID:17942748
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314187	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SH3GLB2 mRNA	PMID:17942748
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of SH3GLB2 protein	PMID:39603559
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SH3GLB2 mRNA; aristolochic acid I results in decreased expression of SH3GLB2 protein	PMID:33212167
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SH3GLB2 mRNA	PMID:32763439
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314187	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SH3GLB2 protein	PMID:28918527
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314187	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of SH3GLB2 mRNA	PMID:39631538
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SH3GLB2 mRNA	PMID:39719251
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SH3GLB2 mRNA	PMID:40512198
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305886	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SH3GLB2 mRNA	PMID:34492290
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314187	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SH3GLB2 mRNA	PMID:18648102
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1314187	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of SH3GLB2 mRNA	PMID:33914522
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of SH3GLB2 protein	PMID:31675489
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305886	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SH3GLB2 mRNA	PMID:25181051
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305886	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SH3GLB2 mRNA	PMID:36041667
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of SH3GLB2 protein	PMID:31675489
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305886	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SH3GLB2 mRNA	PMID:36041667
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305886	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SH3GLB2 mRNA	PMID:36041667
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314187	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SH3GLB2 mRNA	PMID:32715474
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314187	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SH3GLB2 mRNA	PMID:37019170
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314187	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SH3GLB2 mRNA	PMID:17361019
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of SH3GLB2 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SH3GLB2 protein	PMID:38598786
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305886	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SH3GLB2 mRNA	PMID:32680482
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SH3GLB2 mRNA	PMID:37042841
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314187	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SH3GLB2 mRNA	PMID:37236586
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305886	E	RGD:6480464	20130806	CTD	MESH:C039281	furan results in increased methylation of SH3GLB2 gene	PMID:22079235
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SH3GLB2 mRNA	PMID:19376846
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305886	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SH3GLB2 mRNA	PMID:24386269
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of SH3GLB2 mRNA	PMID:17010196
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of SH3GLB2 mRNA	PMID:40434365
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SH3GLB2 mRNA	PMID:31533062
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314187	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SH3GLB2 mRNA	PMID:36331819
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314187	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SH3GLB2 mRNA	PMID:17292431
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305886	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of SH3GLB2 mRNA	PMID:29427782
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SH3GLB2 mRNA	PMID:26272509
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3GLB2 mRNA	PMID:27188386
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314187	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of SH3GLB2 mRNA	PMID:19770486
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314187	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SH3GLB2 mRNA	PMID:17555576
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	SH3GLB2 protein affects the susceptibility to Methotrexate	PMID:16217747
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314187	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SH3GLB2 mRNA	PMID:17562736
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SH3GLB2 mRNA	PMID:22230336
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SH3GLB2 mRNA	PMID:40512198
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314187	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SH3GLB2 mRNA	PMID:17555576
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314187	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SH3GLB2 mRNA	PMID:17942748
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314187	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SH3GLB2 mRNA	PMID:17942748
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314187	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SH3GLB2 mRNA	PMID:35964746
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	ISO	RGD:1305886	E	RGD:6480464	20130806	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of SH3GLB2 mRNA	PMID:21983209
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of SH3GLB2 mRNA	PMID:20977926
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of SH3GLB2 protein	PMID:23718831
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SH3GLB2 protein	PMID:32959892
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3GLB2 mRNA	PMID:27188386
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314187	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SH3GLB2 mRNA	PMID:39847705
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3GLB2 mRNA	PMID:27188386
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SH3GLB2 mRNA	PMID:29301935
1314186	SH3GLB2	SH3 domain containing GRB2 like, endophilin B2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of SH3GLB2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SH3GLB2 protein	PMID:38598786
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of HS6ST3 mRNA	PMID:27188386
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314190	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HS6ST3 gene	PMID:20938992
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of HS6ST3 mRNA	PMID:21934132
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:15379	dioxygen	affects methylation	ISO	RGD:1314190	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency affects the methylation of HS6ST3 promoter	PMID:24205000
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1314190	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of HS6ST3 mRNA	PMID:24205000
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of HS6ST3 mRNA	PMID:24763279
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305888	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of HS6ST3 gene	PMID:35440735
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314190	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of HS6ST3 mRNA	PMID:30319688
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305888	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of HS6ST3 mRNA	PMID:33387578
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314190	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HS6ST3 gene	PMID:20938992
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305888	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of HS6ST3 mRNA	PMID:26577399
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of HS6ST3 intron	PMID:30157460
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of HS6ST3 mRNA	PMID:32234424|PMID:35690182
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HS6ST3 gene	PMID:27153756
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of HS6ST3 intron	PMID:30157460
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314190	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HS6ST3 gene	PMID:20938992
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1314190	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of HS6ST3 mRNA	PMID:35489704
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1305888	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of HS6ST3 gene	PMID:31011160
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314190	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of HS6ST3 mRNA	PMID:28960355
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of HS6ST3 mRNA	PMID:41028656
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of HS6ST3 mRNA	PMID:21603599
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of HS6ST3 mRNA	PMID:25583101
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314190	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HS6ST3 mRNA	PMID:21570461
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305888	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of HS6ST3 mRNA	PMID:28959563
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305888	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of HS6ST3 mRNA	PMID:26033743
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of HS6ST3 mRNA	PMID:41028656
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of HS6ST3 mRNA	PMID:21714911
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HS6ST3 3' UTR; Benzo(a)pyrene affects the methylation of HS6ST3 intron	PMID:27901495|PMID:30157460
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HS6ST3 mRNA	PMID:32234424|PMID:35690182
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314190	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HS6ST3 intron	PMID:27901495
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HS6ST3 5' UTR; Benzo(a)pyrene results in increased methylation of HS6ST3 exon; Benzo(a)pyrene results in increased methylation of HS6ST3 promoter	PMID:27901495
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305888	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of HS6ST3 mRNA	PMID:26033743
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of HS6ST3 mRNA	PMID:41028656
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314190	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HS6ST3 gene; titanium dioxide results in decreased methylation of HS6ST3 promoter	PMID:35295148
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314190	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of HS6ST3 mRNA	PMID:35295148
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314190	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of HS6ST3 mRNA	PMID:18648102
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305888	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HS6ST3 mRNA	PMID:25181051|PMID:34947998
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305888	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of HS6ST3 mRNA	PMID:30816183|PMID:32528016|PMID:41034487
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305888	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HS6ST3 gene	PMID:28505145
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314190	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HS6ST3 mRNA	PMID:37019170
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:34911	permethrin	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in decreased expression of HS6ST3 mRNA	PMID:37047231
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305888	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] affects the methylation of HS6ST3 gene	PMID:33148267
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of HS6ST3 mRNA	PMID:24449571
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of HS6ST3 mRNA	PMID:31533062
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HS6ST3 mRNA	PMID:25979313
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HS6ST3 gene	PMID:29154799
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of HS6ST3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS6ST3 mRNA	PMID:27188386
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of HS6ST3 mRNA	PMID:24449571
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305888	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HS6ST3 mRNA	PMID:33387578
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305888	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of HS6ST3 mRNA	PMID:29097150
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of HS6ST3 mRNA	PMID:32234424|PMID:35690182
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:6382	Lasiocarpine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005136	lasiocarpine results in decreased expression of HS6ST3 mRNA	PMID:32234424|PMID:35690182
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305888	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] affects the methylation of HS6ST3 gene	PMID:33148267
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314190	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of HS6ST3 mRNA	PMID:22206623
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS6ST3 mRNA	PMID:27188386
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of HS6ST3 mRNA	PMID:32234424|PMID:35690182
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305888	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HS6ST3 mRNA	PMID:24780913
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS6ST3 mRNA	PMID:27188386
1314189	HS6ST3	heparan sulfate 6-O-sulfotransferase 3	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305888	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased methylation of HS6ST3 gene	PMID:31682807
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of POLR3H mRNA	PMID:25812627
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314192	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of POLR3H mRNA	PMID:20188158
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of POLR3H mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of POLR3H mRNA	PMID:32699268
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of POLR3H protein	PMID:18951874
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314192	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POLR3H mRNA	PMID:39241906
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of POLR3H mRNA	PMID:31614463
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of POLR3H mRNA	PMID:21179406
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of POLR3H 3' UTR	PMID:33872906
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of POLR3H 3' UTR	PMID:33872906
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305889	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of POLR3H mRNA	PMID:33387578
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1314192	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of POLR3H mRNA	PMID:27462272
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of POLR3H mRNA	PMID:23649840
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of POLR3H mRNA	PMID:23649840
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of POLR3H mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of POLR3H mRNA; [Volatile Organic Compounds co-treated with Ozone] affects the expression of POLR3H mRNA	PMID:32699268
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314192	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of POLR3H mRNA	PMID:25629700
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314192	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of POLR3H mRNA	PMID:28960355
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314192	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLR3H mRNA	PMID:21570461
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305889	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POLR3H mRNA	PMID:33387578
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of POLR3H protein	PMID:18951874
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POLR3H mRNA	PMID:30851411
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of POLR3H mRNA	PMID:32763439
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of POLR3H mRNA	PMID:29803840
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of POLR3H mRNA	PMID:38568856
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314192	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of POLR3H mRNA	PMID:37682722
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of POLR3H mRNA	PMID:22378314
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314192	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POLR3H mRNA	PMID:22228805
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of POLR3H mRNA	PMID:26551752
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of POLR3H mRNA	PMID:25895662
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of POLR3H mRNA	PMID:35984750
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305889	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of POLR3H mRNA	PMID:24136188
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314192	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of POLR3H gene; titanium dioxide results in decreased methylation of POLR3H promoter	PMID:35295148
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305889	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of POLR3H mRNA	PMID:34492290
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314192	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of POLR3H mRNA	PMID:18301758
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305889	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of POLR3H mRNA	PMID:25181051
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305889	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of POLR3H mRNA	PMID:36041667
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of POLR3H mRNA	PMID:25979313
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314192	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of POLR3H mRNA	PMID:39298647
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of POLR3H mRNA	PMID:28628672
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305889	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of POLR3H mRNA	PMID:36041667
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314192	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of POLR3H mRNA	PMID:38685157
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305889	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of POLR3H mRNA	PMID:36041667
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of POLR3H mRNA	PMID:28628672
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305889	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of POLR3H mRNA	PMID:21297351
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of POLR3H mRNA	PMID:25812627|PMID:36326898
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305889	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of POLR3H gene	PMID:22079235
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of POLR3H mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of POLR3H mRNA	PMID:32699268
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of POLR3H mRNA	PMID:25812627
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of POLR3H mRNA	PMID:25812627
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of POLR3H mRNA	PMID:25979313
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314192	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of POLR3H mRNA	PMID:17963808
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of POLR3H mRNA	PMID:23179753|PMID:24935251
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of POLR3H mRNA	PMID:28628672
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of POLR3H mRNA	PMID:38832940
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of POLR3H mRNA	PMID:22079256
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of POLR3H mRNA	PMID:28628672
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314192	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of POLR3H mRNA	PMID:25554681
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of POLR3H mRNA	PMID:20977926
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305889	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of POLR3H mRNA	PMID:20080153
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of POLR3H mRNA	PMID:22079256
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of POLR3H mRNA	PMID:22079256
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POLR3H mRNA	PMID:30851411
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314192	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of POLR3H mRNA	PMID:30294300
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314192	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of POLR3H mRNA	PMID:39847705
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of POLR3H mRNA	PMID:26551752
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305889	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of POLR3H mRNA	PMID:21346803
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of POLR3H mRNA	PMID:38568856
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of POLR3H mRNA	PMID:29301935
1314191	POLR3H	RNA polymerase III subunit H	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of POLR3H mRNA	PMID:22378314
1314197	TCF7	transcription factor 7	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TCF7 mRNA	PMID:38218311
1314197	TCF7	transcription factor 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314198	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TCF7 mRNA	PMID:37995155
1314197	TCF7	transcription factor 7	gene	CHEBI:15343	acetaldehyde	affects expression	ISO	RGD:1314198	E	RGD:6480464	20121009	CTD	MESH:D000079	Acetaldehyde affects the expression of TCF7 mRNA	PMID:22634333
1314197	TCF7	transcription factor 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314198	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TCF7 gene	PMID:20938992
1314197	TCF7	transcription factor 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314198	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TCF7 mRNA	PMID:36331819
1314197	TCF7	transcription factor 7	gene	CHEBI:15600	(+)-catechin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002392	Catechin results in increased expression of TCF7 mRNA	PMID:15465739
1314197	TCF7	transcription factor 7	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TCF7 mRNA	PMID:26079696
1314197	TCF7	transcription factor 7	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20170110	CTD	MESH:D011794	Quercetin inhibits the reaction [PLAUR protein results in increased expression of TCF7 protein]	PMID:22511755
1314197	TCF7	transcription factor 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TCF7 mRNA	PMID:21540303
1314197	TCF7	transcription factor 7	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TCF7 mRNA	PMID:35811015
1314197	TCF7	transcription factor 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TCF7 mRNA]	PMID:35811015
1314197	TCF7	transcription factor 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of TCF7 mRNA	PMID:30165855
1314197	TCF7	transcription factor 7	gene	CHEBI:16482	naphthalene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C031721	naphthalene results in increased expression of TCF7 mRNA	PMID:14595851
1314197	TCF7	transcription factor 7	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TCF7 mRNA	PMID:38568856
1314197	TCF7	transcription factor 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314198	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TCF7 gene	PMID:20938992
1314197	TCF7	transcription factor 7	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TCF7 mRNA	PMID:26079696
1314197	TCF7	transcription factor 7	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of TCF7 mRNA	PMID:33359661
1314197	TCF7	transcription factor 7	gene	CHEBI:17558	quercitrin	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin affects the expression of TCF7 mRNA	PMID:25193878
1314197	TCF7	transcription factor 7	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of TCF7 protein	PMID:37730182
1314197	TCF7	transcription factor 7	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305894	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TCF7 mRNA	PMID:33387578
1314197	TCF7	transcription factor 7	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305894	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TCF7 mRNA	PMID:22061828
1314197	TCF7	transcription factor 7	gene	CHEBI:17965	isoorientin	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C057912	homoorientin results in decreased expression of TCF7 protein	PMID:34019859
1314197	TCF7	transcription factor 7	gene	CHEBI:18170	selenic acid	increases expression	ISO	RGD:1314198	E	RGD:6480464	20170103	CTD	MESH:D064586	Selenic Acid results in increased expression of TCF7 mRNA	PMID:16444006
1314197	TCF7	transcription factor 7	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TCF7 intron	PMID:30157460
1314197	TCF7	transcription factor 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314198	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TCF7 mRNA	PMID:36331819
1314197	TCF7	transcription factor 7	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TCF7 protein; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TCF7 protein]	PMID:32522577
1314197	TCF7	transcription factor 7	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1314198	E	RGD:6480464	20241203	CTD	MESH:D001397	[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of TCF7 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of TCF7 mRNA]	PMID:31715269
1314197	TCF7	transcription factor 7	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TCF7 mRNA	PMID:19549813
1314197	TCF7	transcription factor 7	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of TCF7 intron	PMID:30157460
1314197	TCF7	transcription factor 7	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1314198	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of TCF7 mRNA	PMID:33026818
1314197	TCF7	transcription factor 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314198	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TCF7 mRNA	PMID:34911549
1314197	TCF7	transcription factor 7	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of TCF7 mRNA	PMID:19774075
1314197	TCF7	transcription factor 7	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305894	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TCF7 mRNA	PMID:30779732
1314197	TCF7	transcription factor 7	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314198	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of TCF7 mRNA	PMID:17484886
1314197	TCF7	transcription factor 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314198	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TCF7 gene	PMID:20938992
1314197	TCF7	transcription factor 7	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314198	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TCF7 mRNA	PMID:28960355
1314197	TCF7	transcription factor 7	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in decreased expression of TCF7 mRNA	PMID:19167446|PMID:21188121
1314197	TCF7	transcription factor 7	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of TCF7 mRNA	PMID:23557933
1314197	TCF7	transcription factor 7	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305894	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of TCF7 mRNA	PMID:22023808
1314197	TCF7	transcription factor 7	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TCF7 mRNA	PMID:24768652|PMID:25583101
1314197	TCF7	transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314198	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TCF7 mRNA	PMID:21570461
1314197	TCF7	transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305894	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TCF7 mRNA	PMID:33387578
1314197	TCF7	transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314198	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TCF7 mRNA	PMID:21041162|PMID:24058054
1314197	TCF7	transcription factor 7	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of TCF7 protein	PMID:39603559
1314197	TCF7	transcription factor 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TCF7 mRNA	PMID:33212167
1314197	TCF7	transcription factor 7	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of TCF7 mRNA	PMID:30911355
1314197	TCF7	transcription factor 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314198	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TCF7 mRNA	PMID:16014739
1314197	TCF7	transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TCF7 intron	PMID:30157460
1314197	TCF7	transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TCF7 mRNA	PMID:20498004
1314197	TCF7	transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TCF7 promoter	PMID:27901495
1314197	TCF7	transcription factor 7	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of TCF7 mRNA	PMID:30911355
1314197	TCF7	transcription factor 7	gene	CHEBI:30145	lithium atom	increases expression	ISO	RGD:1314198	E	RGD:6480464	20250204	CTD	MESH:D008094	Lithium results in increased expression of TCF7 protein	PMID:17329570
1314197	TCF7	transcription factor 7	gene	CHEBI:30146	lithium hydride	increases expression	ISO	RGD:1314198	E	RGD:6480464	20250204	CTD	MESH:D008094	Lithium results in increased expression of TCF7 protein	PMID:17329570
1314197	TCF7	transcription factor 7	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TCF7 mRNA	PMID:27829220
1314197	TCF7	transcription factor 7	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of TCF7 mRNA	PMID:35984750
1314197	TCF7	transcription factor 7	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C008261	lead acetate results in increased expression of TCF7 mRNA	PMID:37939567
1314197	TCF7	transcription factor 7	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305894	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of TCF7 mRNA	PMID:25729387
1314197	TCF7	transcription factor 7	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305894	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of TCF7 mRNA	PMID:25729387
1314197	TCF7	transcription factor 7	gene	CHEBI:32223	tibolone	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C027385	tibolone results in decreased expression of TCF7 mRNA	PMID:22217510
1314197	TCF7	transcription factor 7	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314198	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of TCF7 mRNA	PMID:35295148
1314197	TCF7	transcription factor 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314198	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TCF7 promoter	PMID:35295148
1314197	TCF7	transcription factor 7	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305894	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TCF7 mRNA	PMID:34492290
1314197	TCF7	transcription factor 7	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314198	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of TCF7 mRNA	PMID:18648102
1314197	TCF7	transcription factor 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TCF7 mRNA	PMID:33670352
1314197	TCF7	transcription factor 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314198	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TCF7 mRNA	PMID:33221593
1314197	TCF7	transcription factor 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314198	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of TCF7 mRNA	PMID:38701888
1314197	TCF7	transcription factor 7	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TCF7 mRNA	PMID:25979313
1314197	TCF7	transcription factor 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314198	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TCF7 mRNA	PMID:39298647|PMID:40203079
1314197	TCF7	transcription factor 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1314198	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of TCF7 promoter	PMID:33297965
1314197	TCF7	transcription factor 7	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of TCF7 intron	PMID:30157460
1314197	TCF7	transcription factor 7	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314198	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of TCF7 intron	PMID:28392331
1314197	TCF7	transcription factor 7	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314198	E	RGD:6480464	20200519	CTD	MESH:D016264	[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of TCF7 mRNA; celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of TCF7 mRNA]	PMID:31715269
1314197	TCF7	transcription factor 7	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305894	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of TCF7 mRNA	PMID:22546817
1314197	TCF7	transcription factor 7	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of TCF7 gene	PMID:22964155
1314197	TCF7	transcription factor 7	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305894	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of TCF7 mRNA	PMID:22546817
1314197	TCF7	transcription factor 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of TCF7 mRNA	PMID:28628672
1314197	TCF7	transcription factor 7	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305894	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of TCF7 mRNA	PMID:22546817
1314197	TCF7	transcription factor 7	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1314198	E	RGD:6480464	20190219	CTD	MESH:D010269	Paraquat results in decreased expression of TCF7 mRNA	PMID:27788593
1314197	TCF7	transcription factor 7	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D010269	Paraquat results in increased expression of TCF7 mRNA	PMID:28619522
1314197	TCF7	transcription factor 7	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1305894	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of TCF7 mRNA	PMID:35163327
1314197	TCF7	transcription factor 7	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305894	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TCF7 mRNA	PMID:35163327
1314197	TCF7	transcription factor 7	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305894	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TCF7 mRNA	PMID:33453195
1314197	TCF7	transcription factor 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TCF7 protein; ARL6 protein inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TCF7 protein]	PMID:32522577
1314197	TCF7	transcription factor 7	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305894	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TCF7 mRNA	PMID:35163327
1314197	TCF7	transcription factor 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314198	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TCF7 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TCF7 mRNA	PMID:36331819
1314197	TCF7	transcription factor 7	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314198	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of TCF7 mRNA	PMID:29038090
1314197	TCF7	transcription factor 7	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TCF7 mRNA	PMID:25979313
1314197	TCF7	transcription factor 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314198	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TCF7 mRNA	PMID:17292431
1314197	TCF7	transcription factor 7	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1314198	E	RGD:6480464	20120515	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of TCF7 mRNA	PMID:21041162
1314197	TCF7	transcription factor 7	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1314198	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of TCF7 mRNA	PMID:21041162
1314197	TCF7	transcription factor 7	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of TCF7 mRNA	PMID:28628672
1314197	TCF7	transcription factor 7	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1314198	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of TCF7 mRNA	PMID:21041162
1314197	TCF7	transcription factor 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314198	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TCF7 mRNA	PMID:28973697
1314197	TCF7	transcription factor 7	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TCF7 mRNA	PMID:38832940
1314197	TCF7	transcription factor 7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305894	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TCF7 mRNA	PMID:33387578
1314197	TCF7	transcription factor 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TCF7 mRNA	PMID:22230336
1314197	TCF7	transcription factor 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of TCF7 mRNA]	PMID:35811015
1314197	TCF7	transcription factor 7	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305894	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TCF7 mRNA	PMID:29391264
1314197	TCF7	transcription factor 7	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of TCF7 mRNA	PMID:18175754
1314197	TCF7	transcription factor 7	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of TCF7 mRNA	PMID:28628672
1314197	TCF7	transcription factor 7	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TCF7 mRNA	PMID:27829220
1314197	TCF7	transcription factor 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of TCF7 mRNA	PMID:19387464
1314197	TCF7	transcription factor 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1314198	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of TCF7 mRNA	PMID:27915011
1314197	TCF7	transcription factor 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314198	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TCF7 mRNA; Nanotubes, Carbon results in decreased expression of TCF7 mRNA	PMID:25554681
1314197	TCF7	transcription factor 7	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of TCF7 mRNA	PMID:20977926
1314197	TCF7	transcription factor 7	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314198	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TCF7 mRNA	PMID:38701926
1314197	TCF7	transcription factor 7	gene	CHEBI:59016	neohesperidin	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C546526	neohesperidin results in increased expression of TCF7 mRNA	PMID:34020675
1314197	TCF7	transcription factor 7	gene	CHEBI:59016	neohesperidin	increases expression	ISO	RGD:1314198	E	RGD:6480464	20250902	CTD	MESH:C546526	neohesperidin results in increased expression of TCF7 mRNA; neohesperidin results in increased expression of TCF7 protein	PMID:34919014
1314197	TCF7	transcription factor 7	gene	CHEBI:59016	neohesperidin	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C546526	DKK1 protein inhibits the reaction [neohesperidin results in increased expression of TCF7 mRNA]	PMID:34020675
1314197	TCF7	transcription factor 7	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305894	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of TCF7 mRNA	PMID:25729387
1314197	TCF7	transcription factor 7	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305894	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of TCF7 mRNA	PMID:25729387
1314197	TCF7	transcription factor 7	gene	CHEBI:63959	celastrol	multiple interactions	ISO	RGD:1314198	E	RGD:6480464	20210608	CTD	MESH:C050414	celastrol inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of TCF7 mRNA]	PMID:31715269
1314197	TCF7	transcription factor 7	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of TCF7 intron	PMID:30157460
1314197	TCF7	transcription factor 7	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305894	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TCF7 gene	PMID:35440735
1314197	TCF7	transcription factor 7	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1314198	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of TCF7 mRNA	PMID:28444820
1314197	TCF7	transcription factor 7	gene	CHEBI:72544	flavonoids	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in decreased expression of TCF7 mRNA	PMID:15465739
1314197	TCF7	transcription factor 7	gene	CHEBI:72544	flavonoids	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in increased expression of TCF7 mRNA	PMID:15465739
1314197	TCF7	transcription factor 7	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314198	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TCF7 mRNA	PMID:22206623
1314197	TCF7	transcription factor 7	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of TCF7 mRNA	PMID:36318118
1314197	TCF7	transcription factor 7	gene	CHEBI:7553	niclosamide	multiple interactions	ISO	RGD:1314198	E	RGD:6480464	20210810	CTD	MESH:D009534	Niclosamide affects the reaction [FAS protein mutant form affects the expression of TCF7 protein]	PMID:33632240
1314197	TCF7	transcription factor 7	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305894	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of TCF7 mRNA	PMID:33484710
1314197	TCF7	transcription factor 7	gene	CHEBI:76995	alpha-naphthoflavone	increases expression	EXP		E	RGD:6480464	20140204	CTD	MESH:C011512	alpha-naphthoflavone results in increased expression of TCF7 mRNA	PMID:18762178
1314197	TCF7	transcription factor 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TCF7 gene]	PMID:28238834
1314197	TCF7	transcription factor 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314198	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of TCF7 mRNA	PMID:23091169
1314197	TCF7	transcription factor 7	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314198	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TCF7 mRNA	PMID:19482888
1314197	TCF7	transcription factor 7	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314198	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of TCF7 mRNA]	PMID:19482888
1314197	TCF7	transcription factor 7	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314198	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TCF7 mRNA	PMID:38648751
1314197	TCF7	transcription factor 7	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1314198	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of TCF7 mRNA	PMID:22634333
1314197	TCF7	transcription factor 7	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of TCF7 mRNA	PMID:26079696
1314197	TCF7	transcription factor 7	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of TCF7 mRNA	PMID:35688559
1314197	TCF7	transcription factor 7	gene	CHEBI:86290	6-bromoindirubin-3'-oxime	increases expression	ISO	RGD:1314198	E	RGD:6480464	20250204	CTD	MESH:C483321	6-bromoindirubin-3'-oxime results in increased expression of TCF7 protein	PMID:17329570
1314197	TCF7	transcription factor 7	gene	CHEBI:90388	AH23848	multiple interactions	EXP		E	RGD:6480464	20151208	CTD	MESH:C046926	[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in decreased expression of TCF7 protein	PMID:19407222
1314197	TCF7	transcription factor 7	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of TCF7 mRNA	PMID:29301935
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of MRRF mRNA	PMID:23724009|PMID:33167477
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MRRF mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MRRF mRNA	PMID:32699268
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRRF mRNA	PMID:22378314
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of MRRF mRNA]	PMID:19442820
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of MRRF mRNA	PMID:23649840
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of MRRF mRNA]	PMID:19442820
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of MRRF mRNA	PMID:39836092
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MRRF gene	PMID:27153756
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MRRF mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MRRF mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of MRRF mRNA	PMID:32699268
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314202	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MRRF mRNA	PMID:25629700
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of MRRF mRNA	PMID:40512198
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314202	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRRF mRNA	PMID:40504410
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314202	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRRF mRNA	PMID:24058054
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305897	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRRF mRNA	PMID:33387578
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305897	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MRRF mRNA	PMID:28959563
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRRF mRNA	PMID:28595984|PMID:38568856
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of MRRF mRNA	PMID:40512198
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314202	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRRF mRNA	PMID:40504410
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of MRRF mRNA	PMID:22378314
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314202	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MRRF mRNA	PMID:22228805
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1314202	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of MRRF protein	PMID:37955338
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MRRF mRNA]	PMID:32406909
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314202	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of MRRF mRNA	PMID:35295148
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314202	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MRRF gene	PMID:35295148
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314202	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MRRF mRNA	PMID:23811191
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of MRRF protein	PMID:34186270
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305897	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MRRF mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of MRRF protein	PMID:34186270
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of MRRF mRNA	PMID:39836092
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MRRF mRNA	PMID:38568856
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of MRRF mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of MRRF mRNA	PMID:32699268
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:1305897	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of MRRF mRNA	PMID:27638505
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314202	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MRRF mRNA	PMID:17963808
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MRRF gene	PMID:29154799
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MRRF mRNA	PMID:26272509
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of MRRF mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRRF mRNA	PMID:17183730|PMID:27188386
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of MRRF mRNA	PMID:27188386
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1305897	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of MRRF mRNA	PMID:21346803
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of MRRF mRNA	PMID:40512198
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314202	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRRF mRNA	PMID:40504410
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of MRRF mRNA	PMID:17183730
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of MRRF mRNA	PMID:39836092
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of MRRF mRNA	PMID:37939859
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1314202	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of MRRF mRNA	PMID:22206623
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRRF mRNA	PMID:27188386
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MRRF gene]	PMID:28238834
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314202	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of MRRF mRNA	PMID:21278054
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MRRF mRNA	PMID:27188386
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305897	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of MRRF mRNA	PMID:19281266
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of MRRF mRNA	PMID:22378314
1314201	MRRF	mitochondrial ribosome recycling factor	gene	CHEBI:9516	thapsigargin	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019284	4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in decreased expression of MRRF mRNA]; caffeic acid promotes the reaction [Thapsigargin results in decreased expression of MRRF mRNA]; Drugs, Chinese Herbal promotes the reaction [Thapsigargin results in decreased expression of MRRF mRNA]	PMID:19442820
1314203	BEND7	BEN domain containing 7	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of BEND7 mRNA	PMID:31863870
1314203	BEND7	BEN domain containing 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314204	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of BEND7 mRNA	PMID:20188158|PMID:26251327
1314203	BEND7	BEN domain containing 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1314204	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of BEND7 promoter	PMID:26251327
1314203	BEND7	BEN domain containing 7	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of BEND7 mRNA	PMID:23724009
1314203	BEND7	BEN domain containing 7	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of BEND7 mRNA	PMID:26079696
1314203	BEND7	BEN domain containing 7	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314204	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BEND7 mRNA	PMID:25510870
1314203	BEND7	BEN domain containing 7	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of BEND7 mRNA	PMID:38568856
1314203	BEND7	BEN domain containing 7	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305898	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of BEND7 mRNA	PMID:33387578
1314203	BEND7	BEN domain containing 7	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305898	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of BEND7 mRNA	PMID:26577399
1314203	BEND7	BEN domain containing 7	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of BEND7 protein	PMID:37730182
1314203	BEND7	BEN domain containing 7	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314204	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BEND7 mRNA	PMID:25510870
1314203	BEND7	BEN domain containing 7	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314204	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BEND7 mRNA	PMID:25510870
1314203	BEND7	BEN domain containing 7	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of BEND7 mRNA	PMID:19549813
1314203	BEND7	BEN domain containing 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305898	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BEND7 mRNA	PMID:31150632
1314203	BEND7	BEN domain containing 7	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1314204	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of BEND7 mRNA	PMID:28960355
1314203	BEND7	BEN domain containing 7	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305898	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of BEND7 mRNA	PMID:31881176
1314203	BEND7	BEN domain containing 7	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of BEND7 promoter	PMID:22847954
1314203	BEND7	BEN domain containing 7	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of BEND7 mRNA	PMID:24768652|PMID:25583101
1314203	BEND7	BEN domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305898	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BEND7 mRNA	PMID:22298810
1314203	BEND7	BEN domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314204	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BEND7 mRNA	PMID:21570461
1314203	BEND7	BEN domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BEND7 mRNA	PMID:27913140
1314203	BEND7	BEN domain containing 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of BEND7 mRNA	PMID:33212167
1314203	BEND7	BEN domain containing 7	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305898	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of BEND7 mRNA	PMID:28959563
1314203	BEND7	BEN domain containing 7	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of BEND7 mRNA	PMID:29803840
1314203	BEND7	BEN domain containing 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of BEND7 mRNA	PMID:34032870|PMID:39719251
1314203	BEND7	BEN domain containing 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of BEND7 mRNA	PMID:38568856
1314203	BEND7	BEN domain containing 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BEND7 promoter	PMID:27901495
1314203	BEND7	BEN domain containing 7	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314204	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of BEND7 mRNA	PMID:27131904
1314203	BEND7	BEN domain containing 7	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of BEND7 mRNA	PMID:26014281
1314203	BEND7	BEN domain containing 7	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of BEND7 mRNA	PMID:34973136
1314203	BEND7	BEN domain containing 7	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305898	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of BEND7 mRNA	PMID:34492290
1314203	BEND7	BEN domain containing 7	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314204	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of BEND7 mRNA	PMID:18648102
1314203	BEND7	BEN domain containing 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305898	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of BEND7 mRNA	PMID:25181051
1314203	BEND7	BEN domain containing 7	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of BEND7 gene	PMID:31601247
1314203	BEND7	BEN domain containing 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305898	E	RGD:6480464	20180220	CTD	MESH:C006780	bisphenol A results in increased expression of BEND7 mRNA	PMID:27178563
1314203	BEND7	BEN domain containing 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314204	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of BEND7 mRNA	PMID:34585602
1314203	BEND7	BEN domain containing 7	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314204	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BEND7 mRNA	PMID:25510870
1314203	BEND7	BEN domain containing 7	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314204	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BEND7 mRNA	PMID:25510870
1314203	BEND7	BEN domain containing 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314204	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of BEND7 mRNA	PMID:37019170
1314203	BEND7	BEN domain containing 7	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314204	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of BEND7 mRNA	PMID:36117858
1314203	BEND7	BEN domain containing 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BEND7 mRNA	PMID:37042841
1314203	BEND7	BEN domain containing 7	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305898	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of BEND7 mRNA	PMID:25539665
1314203	BEND7	BEN domain containing 7	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of BEND7 promoter	PMID:22847954
1314203	BEND7	BEN domain containing 7	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of BEND7 promoter	PMID:22847954
1314203	BEND7	BEN domain containing 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314204	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of BEND7 mRNA	PMID:17292431
1314203	BEND7	BEN domain containing 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of BEND7 mRNA	PMID:26272509
1314203	BEND7	BEN domain containing 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of BEND7 mRNA	PMID:24935251
1314203	BEND7	BEN domain containing 7	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of BEND7 gene	PMID:29154799
1314203	BEND7	BEN domain containing 7	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BEND7 mRNA	PMID:27188386
1314203	BEND7	BEN domain containing 7	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of BEND7 mRNA	PMID:20106945
1314203	BEND7	BEN domain containing 7	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of BEND7 mRNA	PMID:24935251|PMID:26272509
1314203	BEND7	BEN domain containing 7	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of BEND7 mRNA	PMID:24935251
1314203	BEND7	BEN domain containing 7	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BEND7 mRNA	PMID:27188386
1314203	BEND7	BEN domain containing 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of BEND7 mRNA	PMID:29067470
1314203	BEND7	BEN domain containing 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305898	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of BEND7 mRNA	PMID:33387578
1314203	BEND7	BEN domain containing 7	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314204	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of BEND7 mRNA	PMID:29279043
1314203	BEND7	BEN domain containing 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314204	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of BEND7 mRNA; Nanotubes, Carbon results in decreased expression of BEND7 mRNA	PMID:25554681
1314203	BEND7	BEN domain containing 7	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314204	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of BEND7 mRNA	PMID:36117858
1314203	BEND7	BEN domain containing 7	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of BEND7 mRNA	PMID:28988120
1314203	BEND7	BEN domain containing 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BEND7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BEND7 mRNA	PMID:27188386
1314203	BEND7	BEN domain containing 7	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BEND7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BEND7 mRNA	PMID:27188386
1314203	BEND7	BEN domain containing 7	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314204	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of BEND7 mRNA	PMID:27131904
1314203	BEND7	BEN domain containing 7	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of BEND7 mRNA	PMID:26014281
1314203	BEND7	BEN domain containing 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314204	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of BEND7 mRNA	PMID:28973697
1314203	BEND7	BEN domain containing 7	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305898	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of BEND7 mRNA	PMID:19015723
1314206	SPART	spartin	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:C084079	triptonide results in decreased expression of SPART mRNA	PMID:33045310
1314206	SPART	spartin	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314207	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SPG20 mRNA	PMID:37995155
1314206	SPART	spartin	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SPART mRNA	PMID:26251327
1314206	SPART	spartin	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SPART mRNA	PMID:20188158
1314206	SPART	spartin	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SPART mRNA	PMID:26079696
1314206	SPART	spartin	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D000431	Ethanol affects the splicing of SPART mRNA	PMID:30319688
1314206	SPART	spartin	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of SPART protein	PMID:31494107
1314206	SPART	spartin	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314207	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SPART mRNA	PMID:39241906
1314206	SPART	spartin	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of SPART mRNA	PMID:19167446
1314206	SPART	spartin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of SPART mRNA	PMID:26496021
1314206	SPART	spartin	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D001554	Benzene results in increased expression of SPART mRNA	PMID:20018183
1314206	SPART	spartin	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SPART mRNA	PMID:23649840
1314206	SPART	spartin	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of SPART mRNA	PMID:26496021
1314206	SPART	spartin	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SPART mRNA	PMID:23892564
1314206	SPART	spartin	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:D005839	Gentamicins results in increased expression of SPART mRNA	PMID:22061828
1314206	SPART	spartin	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314207	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPART mRNA	PMID:37236586
1314206	SPART	spartin	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SPART mRNA	PMID:19549813
1314206	SPART	spartin	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SPART protein	PMID:23301498
1314206	SPART	spartin	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of SPART mRNA	PMID:23649840
1314206	SPART	spartin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SPART mRNA	PMID:19770486
1314206	SPART	spartin	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SPART gene; Aflatoxin B1 results in increased methylation of SPART intron	PMID:27153756|PMID:30157460
1314206	SPART	spartin	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SPART mRNA	PMID:23649840
1314206	SPART	spartin	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SPART mRNA	PMID:34911549
1314206	SPART	spartin	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SPART protein	PMID:35688186
1314206	SPART	spartin	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D014414	Tungsten results in decreased expression of SPART mRNA	PMID:30912803
1314206	SPART	spartin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPART mRNA	PMID:19770486|PMID:21570461
1314206	SPART	spartin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SPART mRNA	PMID:17942748
1314206	SPART	spartin	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of SPART protein	PMID:39603559
1314206	SPART	spartin	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SPART mRNA	PMID:33212167
1314206	SPART	spartin	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SPART mRNA	PMID:39709020
1314206	SPART	spartin	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SPART mRNA	PMID:30851411
1314206	SPART	spartin	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of SPART mRNA	PMID:23649840
1314206	SPART	spartin	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:D020106	Acrylamide results in decreased expression of SPART mRNA	PMID:28959563
1314206	SPART	spartin	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SPART mRNA	PMID:32763439
1314206	SPART	spartin	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPART mRNA	PMID:15467011
1314206	SPART	spartin	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SPART mRNA	PMID:29803840
1314206	SPART	spartin	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1314207	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of SPG20 gene	PMID:39894169
1314206	SPART	spartin	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SPART mRNA	PMID:38568856
1314206	SPART	spartin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20230404	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SPART promoter	PMID:27901495
1314206	SPART	spartin	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of SPART mRNA	PMID:15467011
1314206	SPART	spartin	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305900	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SPG20 mRNA	PMID:30047161
1314206	SPART	spartin	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:D002065	Buspirone results in decreased expression of SPART mRNA	PMID:24136188
1314206	SPART	spartin	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305900	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SPART mRNA	PMID:34492290
1314206	SPART	spartin	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SPART mRNA	PMID:18648102
1314206	SPART	spartin	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A affects the expression of SPART mRNA	PMID:25181051
1314206	SPART	spartin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305900	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of SPG20 mRNA	PMID:32145629
1314206	SPART	spartin	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A results in increased methylation of SPART gene	PMID:28505145
1314206	SPART	spartin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of SPART mRNA; [bisphenol A co-treated with Testosterone] results in increased expression of SPART mRNA	PMID:26496021
1314206	SPART	spartin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314207	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of SPART mRNA	PMID:39298647
1314206	SPART	spartin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314207	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SPART mRNA	PMID:38685157
1314206	SPART	spartin	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SPART protein	PMID:34186270
1314206	SPART	spartin	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SPART mRNA	PMID:17602206
1314206	SPART	spartin	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SPART mRNA	PMID:21266533
1314206	SPART	spartin	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SPART mRNA	PMID:17602206
1314206	SPART	spartin	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:C005445	triphenyl phosphate results in increased expression of SPART mRNA	PMID:30589522
1314206	SPART	spartin	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314207	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPART mRNA	PMID:37236586
1314206	SPART	spartin	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SPART mRNA	PMID:28903501
1314206	SPART	spartin	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SPART mRNA	PMID:24386269
1314206	SPART	spartin	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of SPART mRNA	PMID:19376846
1314206	SPART	spartin	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C000944	dicrotophos results in decreased expression of SPART mRNA	PMID:28302478
1314206	SPART	spartin	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of SPART mRNA	PMID:19167446
1314206	SPART	spartin	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPART mRNA	PMID:25979313
1314206	SPART	spartin	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:D014635	Valproic Acid results in increased expression of SPART mRNA	PMID:29154799
1314206	SPART	spartin	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305900	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SPG20 mRNA	PMID:30047161
1314206	SPART	spartin	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SPART mRNA	PMID:25562108
1314206	SPART	spartin	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SPART mRNA	PMID:20106945
1314206	SPART	spartin	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D016572	Cyclosporine results in increased expression of SPART mRNA	PMID:19770486
1314206	SPART	spartin	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D013629	Tamoxifen affects the expression of SPART mRNA	PMID:17555576
1314206	SPART	spartin	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	SPART protein affects the susceptibility to Methotrexate	PMID:16217747
1314206	SPART	spartin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D000082	Acetaminophen affects the expression of SPART mRNA	PMID:17562736
1314206	SPART	spartin	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C088658	Zoledronic Acid results in decreased expression of SPART protein	PMID:28871336
1314206	SPART	spartin	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:C109476	epoxiconazole results in decreased expression of SPART mRNA	PMID:35436446
1314206	SPART	spartin	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SPART mRNA	PMID:17555576
1314206	SPART	spartin	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of SPART mRNA	PMID:17942748
1314206	SPART	spartin	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SPART mRNA	PMID:17942748
1314206	SPART	spartin	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SPART mRNA; Nanotubes, Carbon results in increased expression of SPART mRNA	PMID:25554681|PMID:25620056
1314206	SPART	spartin	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305900	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SPG20 mRNA	PMID:30047161
1314206	SPART	spartin	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:D005485	Flutamide results in increased expression of SPART mRNA	PMID:24136188
1314206	SPART	spartin	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SPART protein	PMID:32959892
1314206	SPART	spartin	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SPART mRNA	PMID:23650126
1314206	SPART	spartin	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of SPART mRNA	PMID:37939859
1314206	SPART	spartin	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:D008701	Methapyrilene results in decreased expression of SPART mRNA	PMID:30467583
1314206	SPART	spartin	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SPART protein	PMID:34186270
1314206	SPART	spartin	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314207	E	RGD:6480464	20230404	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SPART mRNA	PMID:22206623
1314206	SPART	spartin	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SPART protein	PMID:37664457
1314206	SPART	spartin	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C025589	ochratoxin A results in increased expression of SPART mRNA	PMID:30559759
1314206	SPART	spartin	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of SPART mRNA	PMID:30851411
1314206	SPART	spartin	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305900	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SPART mRNA	PMID:36843608
1314206	SPART	spartin	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305900	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SPG20 mRNA	PMID:30047161
1314206	SPART	spartin	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SPART protein	PMID:37664457
1314206	SPART	spartin	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:D012999	Soman results in decreased expression of SPART mRNA	PMID:19281266
1314206	SPART	spartin	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SPART mRNA	PMID:29301935
1314206	SPART	spartin	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:C080163	trovafloxacin results in decreased expression of SPART mRNA	PMID:24136188
1314206	SPART	spartin	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305900	E	RGD:6480464	20230404	CTD	MESH:C025643	vinclozolin affects the expression of SPART mRNA	PMID:19015723
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552322	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CSTF3 gene	PMID:20938992
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CSTF3 mRNA	PMID:33167477
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CSTF3 mRNA	PMID:22378314
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CSTF3 mRNA	PMID:29432896
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CSTF3 mRNA	PMID:20044591
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552322	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CSTF3 mRNA	PMID:39241906
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CSTF3 mRNA	PMID:38568856
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552322	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CSTF3 gene	PMID:20938992
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CSTF3 mRNA	PMID:21179406
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305901	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CSTF3 promoter	PMID:23359474
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of CSTF3 protein	PMID:37730182
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305901	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CSTF3 mRNA	PMID:33387578
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of CSTF3 mRNA	PMID:28818685
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552322	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CSTF3 mRNA	PMID:37236586
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CSTF3 mRNA	PMID:19549813
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305901	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of CSTF3 mRNA	PMID:21396975
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305901	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CSTF3 mRNA	PMID:33387578
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552322	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CSTF3 mRNA	PMID:31919559
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552322	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSTF3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CSTF3 gene	PMID:20938992|PMID:22206623
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CSTF3 protein	PMID:35688186
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1552322	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form co-treated with TNF protein] results in increased expression of CSTF3 mRNA	PMID:23625948
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552322	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CSTF3 mRNA	PMID:21570461
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305901	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CSTF3 mRNA	PMID:32109520
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552322	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CSTF3 mRNA	PMID:21354282
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552322	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSTF3 mRNA	PMID:17942748
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CSTF3 mRNA	PMID:30851411
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CSTF3 mRNA	PMID:32763439
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CSTF3 mRNA	PMID:20971185
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CSTF3 mRNA	PMID:38568856
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CSTF3 promoter	PMID:27901495
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CSTF3 mRNA	PMID:32234424
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552322	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CSTF3 mRNA	PMID:22228805
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of CSTF3 mRNA	PMID:20971185
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in decreased expression of CSTF3 mRNA	PMID:28959546
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CSTF3 mRNA	PMID:25895662
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CSTF3 mRNA	PMID:26238291
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of CSTF3 mRNA	PMID:17762391
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552322	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CSTF3 gene; titanium dioxide results in decreased methylation of CSTF3 promoter	PMID:35295148
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305901	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CSTF3 mRNA	PMID:23411599|PMID:34492290
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552322	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CSTF3 mRNA	PMID:17426115
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CSTF3 protein	PMID:33376534
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305901	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CSTF3 mRNA	PMID:25181051|PMID:34947998
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305901	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CSTF3 promoter	PMID:23359474
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of CSTF3 mRNA	PMID:24752500|PMID:25979313
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of CSTF3 gene	PMID:31601247
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552322	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CSTF3 mRNA	PMID:39298647
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CSTF3 mRNA	PMID:28628672
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1552322	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of CSTF3 mRNA	PMID:28392331
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552322	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CSTF3 mRNA	PMID:37019170
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552322	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CSTF3 mRNA	PMID:21266533
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305901	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CSTF3 promoter	PMID:23359474
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CSTF3 mRNA	PMID:28628672
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CSTF3 mRNA	PMID:37042841
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CSTF3 mRNA	PMID:38568856
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552322	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CSTF3 mRNA	PMID:37236586
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305901	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of CSTF3 mRNA	PMID:25539665
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1552322	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of CSTF3 mRNA	PMID:24183702
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1552322	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CSTF3 mRNA	PMID:18353800
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CSTF3 mRNA	PMID:28302478
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305901	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of CSTF3 mRNA	PMID:25993096
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CSTF3 mRNA	PMID:25979313
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552322	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CSTF3 mRNA	PMID:17963808
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CSTF3 mRNA	PMID:23179753|PMID:27188386
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CSTF3 mRNA	PMID:25562108
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552322	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CSTF3 mRNA	PMID:17555576
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CSTF3 mRNA	PMID:28628672
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CSTF3 mRNA	PMID:38832940
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CSTF3 mRNA	PMID:24935251
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1305901	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of CSTF3 mRNA	PMID:21346803
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552322	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CSTF3 mRNA	PMID:17562736
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	CSTF3 protein affects the susceptibility to Fluorouracil	PMID:15331170
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of CSTF3 mRNA	PMID:15331170
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of CSTF3 mRNA	PMID:24752500
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552322	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CSTF3 mRNA	PMID:17555576
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552322	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSTF3 mRNA	PMID:17942748
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CSTF3 mRNA	PMID:28628672
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:50292	cadmium sulfate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C037123	cadmium sulfate results in increased expression of CSTF3 mRNA	PMID:21783983
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552322	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CSTF3 mRNA	PMID:25620056
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552322	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CSTF3 mRNA	PMID:25554681
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305901	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of CSTF3 mRNA	PMID:24793618
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1552322	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of CSTF3 mRNA	PMID:26377693
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CSTF3 protein	PMID:32959892
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1552322	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CSTF3 mRNA	PMID:21641980
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1552322	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CSTF3 mRNA	PMID:23650126
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552322	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CSTF3 mRNA	PMID:22206623
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552322	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CSTF3 mRNA	PMID:22206623
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1305901	E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in increased expression of CSTF3 mRNA	PMID:18417182
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305901	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of CSTF3 mRNA	PMID:21346803
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CSTF3 mRNA	PMID:30851411
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CSTF3 mRNA	PMID:19159669
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552322	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CSTF3 mRNA	PMID:23091169
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552322	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CSTF3 mRNA	PMID:30294300
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in decreased expression of CSTF3 mRNA	PMID:28959546
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305901	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CSTF3 mRNA	PMID:21346803
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CSTF3 mRNA	PMID:38568856
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305901	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CSTF3 mRNA	PMID:21346803
1314208	CSTF3	cleavage stimulation factor subunit 3	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of CSTF3 mRNA	PMID:19140230
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:C007262	deoxynivalenol results in increased expression of KAT2B protein	PMID:30286430
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:10022	deoxynivalenol	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:C007262	KAT2B protein affects the reaction [deoxynivalenol results in increased expression of ATF3 protein alternative form]	PMID:30286430
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D015025	Zearalenone results in increased expression of KAT2B mRNA	PMID:32119988
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of KAT2B mRNA	PMID:26272509
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA	PMID:27188386
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314210	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of KAT2B mRNA	PMID:33045310
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KAT2B mRNA	PMID:39752319
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:15346	coenzyme A	affects binding	ISO	RGD:1314210	E	RGD:6480464	20170613	CTD	MESH:D003065	Coenzyme A binds to KAT2B protein	PMID:28077572
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:15351	acetyl-CoA	affects binding	ISO	RGD:1314210	E	RGD:6480464	20170613	CTD	MESH:D000105	Acetyl Coenzyme A binds to KAT2B protein	PMID:28077572
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D014212	Tretinoin results in increased expression of KAT2B mRNA; Tretinoin results in increased expression of KAT2B protein	PMID:28053092
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20140812	CTD	MESH:D014212	KAT2B protein promotes the reaction [Tretinoin results in increased expression of CCL2 mRNA]; KAT2B protein promotes the reaction [Tretinoin results in increased expression of FGR mRNA]; KAT2B protein promotes the reaction [Tretinoin results in increased expression of ITGAM mRNA]; KAT2B protein promotes the reaction [Tretinoin results in increased expression of ITGAM protein]; Tretinoin inhibits the reaction [[KAT2B protein binds to MAPK3 promoter] which affects the expression of MAPK3 mRNA]	PMID:16050810|PMID:28053092
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20140812	CTD	MESH:D014212	Tretinoin affects the reaction [KAT2B protein binds to NR2C1 promoter]	PMID:17389641
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:15479	isobutyryl-CoA	affects binding	ISO	RGD:1314210	E	RGD:6480464	20170613	CTD	MESH:C050106	isobutyryl-coenzyme A binds to KAT2B protein	PMID:28077572
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:15517	butyryl-CoA	affects binding	ISO	RGD:1314210	E	RGD:6480464	20170613	CTD	MESH:C024343	butyryl-coenzyme A binds to KAT2B protein	PMID:28077572
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:15551	prostaglandin E2	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:D015232	KAT2B protein affects the reaction [Dinoprostone promotes the reaction [EP300 protein binds to CYP19A1 promoter]]; KAT2B protein affects the reaction [Dinoprostone promotes the reaction [HIF1A protein binds to EP300 protein]]; KAT2B protein affects the reaction [Dinoprostone results in increased expression of and results in increased acetylation of HIF1A protein]; KAT2B protein affects the reaction [Dinoprostone results in increased expression of CYP19A1 protein]	PMID:30409902
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of KAT2B mRNA	PMID:26079696
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of KAT2B mRNA	PMID:22378314
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of KAT2B mRNA	PMID:21632981
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of KAT2B mRNA	PMID:25210133
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D004958	Estradiol results in increased expression of KAT2B mRNA	PMID:19619570
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of KAT2B mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of KAT2B mRNA; Estradiol affects the reaction [TNF protein promotes the reaction [KAT2B protein binds to IL6 promoter]]	PMID:19619570|PMID:24771768|PMID:30165855
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KAT2B mRNA	PMID:37042841
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of KAT2B mRNA	PMID:23649840
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KAT2B mRNA	PMID:39752319
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:174627	2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid	decreases activity	ISO	RGD:1314210	E	RGD:6480464	20210706	CTD	MESH:C088115	anacardic acid results in decreased activity of KAT2B protein	PMID:31927229
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:17580	linalool	multiple interactions	EXP		E	RGD:6480464	20130416	CTD	MESH:C018584	linalool inhibits the reaction [KAT2B protein binds to HMGCR promoter]	PMID:21944868
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305902	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of KAT2B mRNA	PMID:27523638
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of KAT2B protein	PMID:37730182
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305902	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of KAT2B mRNA	PMID:22061828
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:17846	(S)-naringenin	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C005273	naringenin metabolite results in increased expression of KAT2B mRNA	PMID:36235125
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:17846	(S)-naringenin	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C005273	[naringenin co-treated with bisphenol A] results in increased expression of KAT2B mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of KAT2B mRNA	PMID:36235125
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KAT2B mRNA	PMID:28818685
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of KAT2B intron	PMID:30157460
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of KAT2B mRNA	PMID:36331819
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of KAT2B mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of KAT2B mRNA	PMID:39836092
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:18421	superoxide	decreases abundance	EXP		E	RGD:6480464	20160315	CTD	MESH:D013481	KAT2B protein results in decreased abundance of Superoxides	PMID:25440059
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of KAT2B mRNA	PMID:24376830
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of KAT2B mRNA	PMID:23649840
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KAT2B intron	PMID:30157460
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of KAT2B mRNA	PMID:23649840
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20160119	CTD	MESH:D009151	Mustard Gas results in decreased expression of KAT2B mRNA	PMID:26392148
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of KAT2B mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of KAT2B mRNA	PMID:35430440|PMID:41430723
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of KAT2B mRNA	PMID:27106289
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of KAT2B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KAT2B mRNA	PMID:39836092
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of KAT2B mRNA	PMID:40504410
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of KAT2B mRNA	PMID:26272509
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA	PMID:27188386
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of KAT2B mRNA	PMID:28189721|PMID:28960355
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:C059514	resveratrol results in increased expression of KAT2B mRNA	PMID:15767336
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of KAT2B mRNA; resveratrol affects the reaction [TNF protein promotes the reaction [KAT2B protein binds to IL6 promoter]]	PMID:19167446|PMID:24771768
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314210	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of KAT2B mRNA	PMID:21151649
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of KAT2B mRNA	PMID:27392435
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in decreased expression of KAT2B mRNA	PMID:26865667
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314210	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KAT2B mRNA	PMID:21570461
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KAT2B mRNA	PMID:33956508
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KAT2B mRNA	PMID:19619570|PMID:20106945|PMID:21632981
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20140812	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of KAT2B mRNA	PMID:19619570
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KAT2B mRNA	PMID:28001369
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of KAT2B mRNA	PMID:16001973
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305902	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of KAT2B mRNA	PMID:28959563
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:28741	sodium fluoride	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20210504	CTD	MESH:D012969	Sodium Fluoride promotes the reaction [TRP53 protein binds to KAT2B protein]	PMID:31927229
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KAT2B mRNA	PMID:29803840
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D004317	Doxorubicin results in increased expression of KAT2B mRNA	PMID:16001973
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased expression of KAT2B mRNA	PMID:32844245
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of KAT2B mRNA	PMID:19822182
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of KAT2B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KAT2B mRNA	PMID:39836092
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of KAT2B mRNA	PMID:40504410
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of KAT2B mRNA	PMID:29453283
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1314210	E	RGD:6480464	20140812	CTD	MESH:D014415	Tunicamycin results in increased expression of KAT2B mRNA	PMID:17127020
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KAT2B mRNA	PMID:21714911|PMID:32234424
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KAT2B mRNA	PMID:22228805
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KAT2B mRNA	PMID:30453624
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to KAT2B mRNA]	PMID:32406909
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of KAT2B mRNA	PMID:20458559
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:31206	ammonium chloride	increases expression	ISO	RGD:1305902	E	RGD:6480464	20140812	CTD	MESH:D000643	Ammonium Chloride results in increased expression of KAT2B protein	PMID:16483693
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1305902	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of KAT2B mRNA	PMID:24136188
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of KAT2B mRNA	PMID:31745603
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314210	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KAT2B gene	PMID:35295148
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305902	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of KAT2B mRNA	PMID:34492290
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of KAT2B mRNA	PMID:30690063
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20140812	CTD	MESH:C006780	bisphenol A affects the expression of KAT2B mRNA	PMID:20170705
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305902	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KAT2B mRNA	PMID:25181051
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314210	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of KAT2B mRNA	PMID:30303745
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	[naringenin co-treated with bisphenol A] results in increased expression of KAT2B mRNA; [naringenin metabolite co-treated with bisphenol A] results in increased expression of KAT2B mRNA	PMID:36235125
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20160607	CTD	MESH:C006780	[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA]	PMID:27082013
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of KAT2B mRNA	PMID:39298647
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of KAT2B intron	PMID:30157460
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of KAT2B mRNA	PMID:26377693
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314210	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of KAT2B mRNA	PMID:38685157
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314210	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of KAT2B mRNA	PMID:21266533
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1314210	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of KAT2B mRNA	PMID:34813904
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1305902	E	RGD:6480464	20140812	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of KAT2B mRNA	PMID:19638242
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305902	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of KAT2B mRNA	PMID:22546817
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of KAT2B mRNA	PMID:29024780
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of KAT2B mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of KAT2B mRNA	PMID:39836092
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015741	[Metribolone binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to KAT2B protein modified form]	PMID:28751236
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:38211	potassium bromate	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20160607	CTD	MESH:C019536	[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA; [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [[potassium bromate co-treated with bisphenol A] affects the expression of KAT2B mRNA]	PMID:27082013
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:38561	fluvastatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C065180	[zoledronic acid co-treated with fluvastatin] results in increased expression of KAT2B mRNA	PMID:16996129
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D003375	Coumestrol results in decreased expression of KAT2B mRNA	PMID:19167446
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20140812	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in decreased expression of KAT2B mRNA	PMID:19167446
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of KAT2B mRNA	PMID:27153767|PMID:40419075
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of KAT2B mRNA	PMID:36331819
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1314210	E	RGD:6480464	20141223	CTD	MESH:C031763	1,3-butadiene results in increased expression of KAT2B mRNA	PMID:25237060
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of KAT2B mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:28001369
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of KAT2B gene	PMID:29154799
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA	PMID:27188386
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of KAT2B mRNA	PMID:20106945|PMID:25562108
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of KAT2B promoter	PMID:27989131
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D003907	Dexamethasone results in increased expression of KAT2B mRNA	PMID:19022236
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of KAT2B mRNA	PMID:28973697
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of KAT2B mRNA	PMID:21678067
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:44185	methotrexate	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate promotes the reaction [E2F1 protein binds to KAT2B protein]	PMID:22484375
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:44423	hydroxyurea	increases expression	ISO	RGD:1314210	E	RGD:6480464	20161025	CTD	MESH:D006918	Hydroxyurea results in increased expression of KAT2B mRNA	PMID:27208086
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of KAT2B mRNA	PMID:38832940
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:46024	trichostatin A	affects localization	EXP		E	RGD:6480464	20140812	CTD	MESH:C012589	trichostatin A affects the localization of KAT2B protein	PMID:15647279
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of KAT2B mRNA	PMID:22723015|PMID:24935251|PMID:26272509
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of KAT2B mRNA	PMID:24935251
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20140812	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA; trichostatin A promotes the reaction [KAT2B protein binds to TGFBR2 promoter]	PMID:15647279|PMID:27188386
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314210	E	RGD:6480464	20140812	CTD	MESH:D000082	Acetaminophen affects the expression of KAT2B mRNA	PMID:17562736
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of KAT2B mRNA	PMID:22230336
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:46557	zoledronic acid	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	[zoledronic acid co-treated with fluvastatin] results in increased expression of KAT2B mRNA	PMID:16996129
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of KAT2B mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KAT2B mRNA	PMID:39836092
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of KAT2B mRNA	PMID:40504410
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of KAT2B mRNA	PMID:26833863
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20140812	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KAT2B mRNA	PMID:22079256
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D018038	Sodium Selenite results in decreased expression of KAT2B mRNA	PMID:18175754
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of KAT2B mRNA	PMID:20170705|PMID:26865667
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1305902	E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of KAT2B mRNA	PMID:20170705|PMID:26865667
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20140812	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of KAT2B mRNA	PMID:18936297
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of KAT2B mRNA	PMID:20458559
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine promotes the reaction [KAT2B protein binds to TP53 protein]	PMID:17977830
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314210	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of KAT2B mRNA	PMID:25554681
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of KAT2B mRNA	PMID:20471514
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of KAT2B mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of KAT2B mRNA	PMID:39836092
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305902	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of KAT2B mRNA	PMID:30467583
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of KAT2B intron	PMID:30157460
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:68534	enzalutamide	affects expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C540278	enzalutamide affects the expression of KAT2B mRNA	PMID:30940724
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KAT2B mRNA	PMID:39752319
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of KAT2B mRNA	PMID:31758290
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KAT2B mRNA	PMID:22206623
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of KAT2B mRNA	PMID:22079256|PMID:22714537
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20140812	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KAT2B mRNA	PMID:22079256
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA	PMID:27188386
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of KAT2B mRNA	PMID:30928695
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KAT2B gene]	PMID:28238834
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:80630	irinotecan	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in increased expression of KAT2B mRNA	PMID:18927307
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314210	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of KAT2B mRNA	PMID:23091169
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20140812	CTD	MESH:D010634	Phenobarbital results in decreased expression of KAT2B mRNA	PMID:19363144
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:83605	3,5-diethoxycarbonyl-1,4-dihydrocollidine	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20141202	CTD	MESH:D003997	Dicarbethoxydihydrocollidine results in decreased expression of KAT2B mRNA	PMID:18098314
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of KAT2B protein	PMID:26193056
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20140812	CTD	MESH:C045950	propiconazole results in decreased expression of KAT2B mRNA	PMID:19363144|PMID:21278054
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of KAT2B mRNA	PMID:26272509
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA	PMID:27188386
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1314210	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KAT2B mRNA	PMID:39752319
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KAT2B mRNA	PMID:27188386
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305902	E	RGD:6480464	20140812	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of KAT2B mRNA	PMID:21346803
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of KAT2B mRNA	PMID:27188386
1314209	KAT2B	lysine acetyltransferase 2B	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1314210	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon results in decreased expression of KAT2B mRNA	PMID:19363144
1314212	EPYC	epiphycan	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of EPYC mRNA	PMID:27188386
1314212	EPYC	epiphycan	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314213	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of EPYC mRNA	PMID:36189433
1314212	EPYC	epiphycan	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305904	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of EPYC gene	PMID:35440735
1314212	EPYC	epiphycan	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of EPYC mRNA	PMID:22378314
1314212	EPYC	epiphycan	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314213	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of EPYC mRNA	PMID:30319688
1314212	EPYC	epiphycan	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305904	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of EPYC mRNA	PMID:33387578
1314212	EPYC	epiphycan	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314213	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EPYC mRNA	PMID:34319233
1314212	EPYC	epiphycan	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EPYC gene	PMID:27153756
1314212	EPYC	epiphycan	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of EPYC mRNA]	PMID:11007951
1314212	EPYC	epiphycan	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314213	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of EPYC mRNA	PMID:28960355
1314212	EPYC	epiphycan	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPYC mRNA	PMID:11007951
1314212	EPYC	epiphycan	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305904	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPYC mRNA	PMID:32109520
1314212	EPYC	epiphycan	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314213	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPYC mRNA	PMID:15328365|PMID:16611356|PMID:19933214
1314212	EPYC	epiphycan	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of EPYC mRNA]	PMID:11007951
1314212	EPYC	epiphycan	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305904	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of EPYC mRNA	PMID:28959563
1314212	EPYC	epiphycan	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin affects the expression of EPYC mRNA	PMID:15205334
1314212	EPYC	epiphycan	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of EPYC mRNA	PMID:39719251
1314212	EPYC	epiphycan	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314213	E	RGD:6480464	20170725	CTD	MESH:C017947	sodium arsenite results in decreased expression of EPYC mRNA	PMID:28206643
1314212	EPYC	epiphycan	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EPYC mRNA	PMID:22316170
1314212	EPYC	epiphycan	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of EPYC mRNA	PMID:26705709
1314212	EPYC	epiphycan	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314213	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of EPYC mRNA	PMID:18648102
1314212	EPYC	epiphycan	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305904	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of EPYC mRNA	PMID:25181051
1314212	EPYC	epiphycan	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of EPYC mRNA	PMID:38832940
1314212	EPYC	epiphycan	gene	CHEBI:46345	5-fluorouracil	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil affects the expression of EPYC mRNA	PMID:15205334
1314212	EPYC	epiphycan	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of EPYC mRNA	PMID:26705709
1314212	EPYC	epiphycan	gene	CHEBI:50292	cadmium sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate results in decreased expression of EPYC mRNA	PMID:12064557
1314212	EPYC	epiphycan	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1314213	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of EPYC mRNA	PMID:19042947
1314212	EPYC	epiphycan	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1314213	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPYC mRNA	PMID:27935865
1314212	EPYC	epiphycan	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1305904	E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of EPYC mRNA	PMID:39938710
1314212	EPYC	epiphycan	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314213	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EPYC mRNA	PMID:22206623
1314212	EPYC	epiphycan	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of EPYC mRNA	PMID:29522793
1314212	EPYC	epiphycan	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EPYC gene]	PMID:28238834
1314212	EPYC	epiphycan	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314213	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of EPYC mRNA	PMID:38648751
1314212	EPYC	epiphycan	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1314213	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of EPYC mRNA	PMID:27935865
1314212	EPYC	epiphycan	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of EPYC mRNA	PMID:31863870
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314215	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC7A4 mRNA	PMID:36331819
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of SLC7A4 mRNA	PMID:30510588
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of SLC7A4 protein	PMID:18191855
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305905	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SLC7A4 mRNA	PMID:32145629
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314215	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of SLC7A4 mRNA	PMID:19484750
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC7A4 mRNA	PMID:30165855
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305905	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC7A4 mRNA	PMID:33387578
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of SLC7A4 mRNA	PMID:21540246
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1314215	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SLC7A4 mRNA	PMID:33848595
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314215	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SLC7A4 mRNA	PMID:35550907
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SLC7A4 protein	PMID:37730182
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305905	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SLC7A4 mRNA	PMID:33387578
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1314215	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of SLC7A4 mRNA	PMID:39984025
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLC7A4 promoter	PMID:30157460
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314215	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC7A4 mRNA	PMID:22206623
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305905	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLC7A4 mRNA	PMID:31881176
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC7A4 mRNA	PMID:23557933
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SLC7A4 mRNA	PMID:28903495
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305905	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC7A4 mRNA	PMID:32109520
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314215	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC7A4 mRNA	PMID:19770486|PMID:19933214
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC7A4 mRNA	PMID:33212167
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC7A4 mRNA	PMID:30851411
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314215	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC7A4 mRNA	PMID:22228805
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SLC7A4 promoter	PMID:27901495
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1314215	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of SLC7A4 promoter	PMID:35295148
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305905	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SLC7A4 mRNA	PMID:34492290
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305905	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC7A4 mRNA	PMID:25181051|PMID:32145629
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of SLC7A4 mRNA	PMID:21703328
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314215	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of SLC7A4 mRNA	PMID:40203079
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314215	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SLC7A4 mRNA	PMID:17361019|PMID:21266533
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305905	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SLC7A4 mRNA	PMID:32680482
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305905	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SLC7A4 mRNA	PMID:33453195
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLC7A4 mRNA	PMID:12160620
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305905	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of SLC7A4 mRNA	PMID:25539665
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314215	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLC7A4 mRNA	PMID:40194260
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314215	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC7A4 mRNA	PMID:36331819
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SLC7A4 gene	PMID:29154799
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305905	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of SLC7A4 mRNA	PMID:41580965
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314215	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SLC7A4 mRNA	PMID:28973697
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305905	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC7A4 mRNA	PMID:33387578
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1314215	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of SLC7A4 mRNA	PMID:26934552
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305905	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SLC7A4 mRNA	PMID:29391264
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314215	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SLC7A4 mRNA; Nanotubes, Carbon results in decreased expression of SLC7A4 mRNA	PMID:25554681|PMID:25620056
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:50692	mifepristone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in decreased expression of SLC7A4 mRNA	PMID:17584828
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1314215	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of SLC7A4 mRNA	PMID:38701926
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314215	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC7A4 mRNA	PMID:22206623
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1305905	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of SLC7A4 mRNA	PMID:23665939
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC7A4 mRNA	PMID:30851411
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305905	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SLC7A4 mRNA	PMID:23640034
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1314215	E	RGD:6480464	20200310	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SLC7A4 mRNA	PMID:29699156
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:8772	raloxifene	affects expression	ISO	RGD:1305905	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of SLC7A4 mRNA	PMID:16079270
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1305905	E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of SLC7A4 mRNA	PMID:29162477
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305905	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of SLC7A4 mRNA	PMID:19281266
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1314215	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of SLC7A4 mRNA	PMID:32835833
1314214	SLC7A4	solute carrier family 7 member 4	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305905	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of SLC7A4 mRNA	PMID:22570695|PMID:23034163
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305906	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of LATS2 mRNA	PMID:25152437
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314217	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of LATS2 mRNA	PMID:33045310
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:132446	perfluorobutanesulfonic acid	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20241203	CTD	MESH:C539348	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate co-treated with perfluorobutanesulfonic acid] results in increased expression of LATS2 mRNA	PMID:39141488
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LATS2 gene	PMID:20938992
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20210309	CTD	MESH:D001280	Atrazine results in decreased expression of LATS2 mRNA	PMID:33463082
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of LATS2 mRNA	PMID:20044591
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LATS2 mRNA	PMID:39241906
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of LATS2 mRNA	PMID:24758408
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LATS2 mRNA	PMID:39298647
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LATS2 gene	PMID:20938992
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LATS2 mRNA	PMID:37042841
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of LATS2 mRNA	PMID:23649840
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LATS2 mRNA	PMID:39150890
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of LATS2 mRNA	PMID:28818685
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LATS2 intron	PMID:30157460
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of LATS2 mRNA	PMID:33914522
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LATS2 mRNA	PMID:19549813
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of LATS2 mRNA	PMID:23649840
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LATS2 intron	PMID:30157460
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314217	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LATS2 mRNA	PMID:19770486
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of LATS2 mRNA	PMID:23649840
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of LATS2 mRNA	PMID:34911549
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:27363	zinc atom	affects binding	EXP		E	RGD:6480464	20231003	CTD	MESH:D015032	Zinc binds to LATS2 protein	PMID:35027733
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of LATS2 mRNA; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc binds to LATS2 protein]	PMID:18593933|PMID:35027733
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314217	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of LATS2 mRNA	PMID:17484886
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of LATS2 mRNA	PMID:25629700
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LATS2 gene	PMID:20938992
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of LATS2 mRNA	PMID:40512198
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of LATS2 protein	PMID:35688186
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of LATS2 mRNA	PMID:27392435
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of LATS2 mRNA	PMID:27392435
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of LATS2 mRNA	PMID:30912803
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314217	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LATS2 mRNA	PMID:21570461
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of LATS2 mRNA	PMID:28001369
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of LATS2 mRNA	PMID:32763439
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:28694	copper atom	affects binding	EXP		E	RGD:6480464	20231003	CTD	MESH:D003300	Copper binds to LATS2 protein	PMID:35027733
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in decreased expression of LATS2 protein	PMID:16246896
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of LATS2 mRNA	PMID:20971185
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of LATS2 mRNA	PMID:29803840
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of LATS2 protein	PMID:35688186
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of LATS2 mRNA	PMID:20044591
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LATS2 mRNA	PMID:38568856
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of LATS2 mRNA	PMID:40512198
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LATS2 intron	PMID:30157460
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to LATS2 promoter]	PMID:19654925
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to LATS2 mRNA]	PMID:32406909
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:30052	copper(0)	affects binding	EXP		E	RGD:6480464	20231003	CTD	MESH:D003300	Copper binds to LATS2 protein	PMID:35027733
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in decreased expression of LATS2 protein	PMID:16246896
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of LATS2 mRNA	PMID:20971185
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:30185	zinc(0)	affects binding	EXP		E	RGD:6480464	20231003	CTD	MESH:D015032	Zinc binds to LATS2 protein	PMID:35027733
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of LATS2 mRNA; N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc binds to LATS2 protein]	PMID:18593933|PMID:35027733
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of LATS2 mRNA	PMID:26014281
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of LATS2 mRNA	PMID:19150397|PMID:20018196
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of LATS2 mRNA	PMID:20458559
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of LATS2 mRNA	PMID:35984750
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305906	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of LATS2 mRNA	PMID:25729387
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305906	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of LATS2 mRNA	PMID:25729387
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of LATS2 mRNA	PMID:23557971
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314217	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LATS2 gene	PMID:35295148
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314217	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LATS2 gene	PMID:35295148
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:32588	potassium chloride	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D011189	[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of LATS2 mRNA	PMID:29691375
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305906	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of LATS2 mRNA	PMID:19167457
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of LATS2 mRNA	PMID:33914522
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of LATS2 mRNA	PMID:20170705
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305906	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of LATS2 mRNA	PMID:25181051
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305906	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of LATS2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314217	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LATS2 mRNA	PMID:32156529
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305906	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of LATS2 gene	PMID:28505145
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of LATS2 mRNA	PMID:25979313
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314217	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of LATS2 mRNA	PMID:39298647
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314217	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of LATS2 gene	PMID:31683443
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314217	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of LATS2 mRNA	PMID:30951980
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LATS2 mRNA	PMID:39150890
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305906	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of LATS2 mRNA	PMID:22546817
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314217	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of LATS2 mRNA	PMID:17361019|PMID:21266533
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LATS2 mRNA	PMID:39150890
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LATS2 mRNA	PMID:39150890
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LATS2 mRNA	PMID:38174414|PMID:38568856
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LATS2 mRNA	PMID:39150890
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20241203	CTD	MESH:C023036	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate co-treated with perfluorobutanesulfonic acid] results in increased expression of LATS2 mRNA	PMID:39141488
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of LATS2 mRNA	PMID:24449571
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LATS2 mRNA	PMID:38568856
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20241203	CTD	MESH:C076994	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate co-treated with perfluorobutanesulfonic acid] results in increased expression of LATS2 mRNA	PMID:39141488
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LATS2 mRNA	PMID:25979313
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of LATS2 mRNA	PMID:23179753
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of LATS2 mRNA	PMID:25562108
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of LATS2 mRNA	PMID:19770486
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:42567	fisetin	increases phosphorylation	EXP		E	RGD:6480464	20200211	CTD	MESH:C017875	fisetin results in increased phosphorylation of LATS2 protein	PMID:31044527
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of LATS2 mRNA	PMID:28973697
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of LATS2 mRNA	PMID:26272509
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LATS2 mRNA	PMID:27188386
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314217	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LATS2 mRNA	PMID:17562736
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of LATS2 mRNA	PMID:29279043
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of LATS2 mRNA	PMID:18687144
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1305906	E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of LATS2 mRNA	PMID:21061450
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of LATS2 mRNA	PMID:40512198
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of LATS2 mRNA	PMID:22077320
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of LATS2 mRNA	PMID:22079256
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of LATS2 mRNA	PMID:35436446
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of LATS2 mRNA	PMID:20458559
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the methylation of LATS2 promoter	PMID:17049657
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine affects the methylation of LATS2 promoter] which affects the expression of LATS2 mRNA	PMID:17049657
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LATS2 mRNA	PMID:25554681
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LATS2 mRNA	PMID:35964746
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305906	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of LATS2 mRNA	PMID:25729387
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305906	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of LATS2 mRNA	PMID:25729387
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:67991	(20S)-ginsenoside Rg3	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C097367	ginsenoside Rg3 results in increased expression of LATS2 mRNA	PMID:31916386
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305906	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LATS2 gene	PMID:35440735
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LATS2 mRNA	PMID:22206623
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of LATS2 mRNA	PMID:22079256
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of LATS2 mRNA	PMID:22079256
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LATS2 mRNA	PMID:27188386
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1314217	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of LATS2 mRNA	PMID:39150890
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314217	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of LATS2 mRNA	PMID:23091169
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314217	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of LATS2 mRNA	PMID:31388691
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of LATS2 mRNA	PMID:19095052
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1314217	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of LATS2 mRNA	PMID:27029645
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305906	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of LATS2 mRNA	PMID:24780913
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1314217	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of LATS2 mRNA	PMID:40826991
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of LATS2 mRNA	PMID:18778698
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc binds to LATS2 protein]; TP53 mutant form inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of LATS2 mRNA]	PMID:18778698|PMID:35027733
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LATS2 mRNA	PMID:27188386
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of LATS2 mRNA	PMID:26014281
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LATS2 mRNA	PMID:38568856
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:9513	thalidomide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013792	Thalidomide analog results in increased expression of LATS2 mRNA	PMID:20525221
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1314217	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of LATS2 mRNA	PMID:28973697
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1314217	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in decreased expression of LATS2 mRNA	PMID:34182078
1314216	LATS2	large tumor suppressor kinase 2	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1314217	E	RGD:6480464	20230606	CTD	MESH:C025643	vinclozolin results in increased expression of LATS2 mRNA	PMID:36642194
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of TAF10 mRNA	PMID:15498508|PMID:23724009|PMID:33167477
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of TAF10 mRNA	PMID:22378314
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314219	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TAF10 mRNA	PMID:30319688
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314219	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TAF10 mRNA	PMID:39241906
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1314219	E	RGD:6480464	20130618	CTD	MESH:D004958	Estradiol affects the expression of TAF10 mRNA	PMID:15598610
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1314219	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of TAF10 mRNA	PMID:28973375
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314219	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TAF10 mRNA	PMID:33754040
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TAF10 protein	PMID:37730182
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF10 mRNA	PMID:39836092
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1314219	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in increased expression of TAF10 mRNA	PMID:29279043
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:232796	cadmium acetate	increases expression	EXP		E	RGD:6480464	20250107	CTD	MESH:C028031	cadmium acetate results in increased expression of TAF10 mRNA	PMID:12965115
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TAF10 protein	PMID:23301498
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314219	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TAF10 mRNA	PMID:34911549
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314219	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TAF10 mRNA	PMID:22206623
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF10 mRNA	PMID:39836092
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TAF10 mRNA	PMID:19244175
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314219	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of TAF10 mRNA	PMID:30912803
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314219	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TAF10 mRNA	PMID:20702594|PMID:21570461
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305907	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TAF10 mRNA	PMID:32109520|PMID:34747641
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305907	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TAF10 mRNA	PMID:33387578
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TAF10 mRNA	PMID:33212167
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF10 mRNA	PMID:39836092
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF10 mRNA	PMID:20106945|PMID:21632981
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TAF10 gene	PMID:31601247
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1305907	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of TAF10 mRNA	PMID:24136188
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of TAF10 mRNA	PMID:15498508
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305907	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TAF10 mRNA	PMID:25181051
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314219	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TAF10 promoter	PMID:27334623
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305907	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF10 mRNA	PMID:34947998
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TAF10 gene	PMID:31601247
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314219	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TAF10 mRNA	PMID:39298647
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314219	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TAF10 mRNA	PMID:38685157
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314219	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TAF10 mRNA	PMID:37019170
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TAF10 mRNA	PMID:37042841
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF10 mRNA	PMID:39836092
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TAF10 mRNA	PMID:19320972
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305907	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TAF10 mRNA	PMID:24386269
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TAF10 mRNA	PMID:19244175
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1314219	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of TAF10 protein	PMID:26178269
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314219	E	RGD:6480464	20130618	CTD	MESH:D014635	Valproic Acid affects the expression of TAF10 mRNA	PMID:17963808
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314219	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of TAF10 mRNA	PMID:17562736
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305907	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TAF10 mRNA	PMID:33387578
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF10 mRNA	PMID:39836092
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314219	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TAF10 mRNA	PMID:25554681
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TAF10 mRNA	PMID:39836092
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314219	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TAF10 mRNA	PMID:22206623
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314219	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TAF10 mRNA	PMID:22206623
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1305907	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of TAF10 mRNA	PMID:15215175
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TAF10 gene]	PMID:28238834
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:80491	pinostrobin	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C411294	pinostrobin results in increased expression of TAF10 mRNA	PMID:37777166
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1314219	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of TAF10 mRNA	PMID:20702594
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314219	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of TAF10 mRNA	PMID:30294300
1314218	TAF10	TATA-box binding protein associated factor 10	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TAF10 mRNA	PMID:38568856
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:110423	clodronic acid	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in increased expression of TNFAIP8 mRNA	PMID:25596134
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1305908	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of TNFAIP8 mRNA	PMID:21551480
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314221	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of TNFAIP8; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TNFAIP8 gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TNFAIP8 mRNA	PMID:20938992
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of TNFAIP8 mRNA	PMID:21934132
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TNFAIP8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TNFAIP8 mRNA	PMID:32699268
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of TNFAIP8 mRNA	PMID:25596134
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1314221	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of TNFAIP8 mRNA	PMID:24205000
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314221	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TNFAIP8 mRNA	PMID:36331819
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TNFAIP8 mRNA	PMID:26079696
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1305908	E	RGD:6480464	20121009	CTD	MESH:D008628	Mercury results in decreased expression of TNFAIP8 mRNA	PMID:22688007
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16170	mercury(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of TNFAIP8 mRNA	PMID:17547211
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314221	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TNFAIP8 mRNA	PMID:30319688
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of TNFAIP8 protein	PMID:18951874
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TNFAIP8 mRNA	PMID:21632981
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of TNFAIP8 mRNA	PMID:29581250
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFAIP8 mRNA	PMID:35811015
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314221	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TNFAIP8 mRNA	PMID:39241906
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TNFAIP8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TNFAIP8 mRNA	PMID:35811015
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of TNFAIP8 mRNA	PMID:23019147
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314221	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TNFAIP8 mRNA	PMID:39298647
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of TNFAIP8 mRNA	PMID:20660070
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305908	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TNFAIP8 gene	PMID:27618143
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314221	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of TNFAIP8; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TNFAIP8 gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TNFAIP8 mRNA	PMID:20938992
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TNFAIP8 mRNA	PMID:37042841
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of TNFAIP8 mRNA	PMID:20660070
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314221	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFAIP8 mRNA	PMID:37992649
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314221	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFAIP8 mRNA	PMID:37992649
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TNFAIP8 protein	PMID:31163220
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TNFAIP8 mRNA	PMID:31163220
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305908	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of TNFAIP8 promoter	PMID:23359474
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of TNFAIP8 mRNA	PMID:16002434
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305908	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TNFAIP8 mRNA	PMID:33387578
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305908	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TNFAIP8 mRNA	PMID:22061828
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TNFAIP8 mRNA	PMID:28818685
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in decreased expression of TNFAIP8 mRNA	PMID:29993192
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in increased expression of TNFAIP8 mRNA	PMID:23369406
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of TNFAIP8 mRNA	PMID:36602393
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305908	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of TNFAIP8 mRNA	PMID:21396975
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of TNFAIP8 protein	PMID:20106945
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TNFAIP8 gene	PMID:27153756
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TNFAIP8 mRNA	PMID:27153756
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of TNFAIP8 mRNA	PMID:26760959
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1305908	E	RGD:6480464	20121009	CTD	MESH:D008628	Mercury results in decreased expression of TNFAIP8 mRNA	PMID:22688007
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:25195	mercury atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of TNFAIP8 mRNA	PMID:17547211
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TNFAIP8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TNFAIP8 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TNFAIP8 mRNA	PMID:32699268
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314221	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TNFAIP8 mRNA	PMID:27339419
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314221	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TNFAIP8 mRNA	PMID:25629700
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314221	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TNFAIP8 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of TNFAIP8; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TNFAIP8 gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TNFAIP8 mRNA	PMID:20938992|PMID:22206623
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TNFAIP8 gene	PMID:25304211
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305908	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TNFAIP8 mRNA	PMID:31881176
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	TNFAIP8 results in decreased susceptibility to Cisplatin	PMID:21969086
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in increased expression of TNFAIP8 mRNA	PMID:25596134|PMID:27392435
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314221	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of TNFAIP8 mRNA	PMID:21151649
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1314221	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of TNFAIP8 mRNA	PMID:18930951
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of TNFAIP8 mRNA	PMID:15378649
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314221	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TNFAIP8 mRNA	PMID:21570461
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305908	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TNFAIP8 mRNA	PMID:33387578
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305908	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNFAIP8 mRNA	PMID:34747641
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of TNFAIP8 protein	PMID:18951874
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TNFAIP8 mRNA	PMID:33212167
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314221	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in decreased expression of TNFAIP8 mRNA	PMID:25896364|PMID:39631538
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314221	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFAIP8 mRNA	PMID:37992649
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TNFAIP8 mRNA	PMID:38568856
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314221	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TNFAIP8 mRNA	PMID:37682722|PMID:39095385
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TNFAIP8 promoter	PMID:27901495
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TNFAIP8 mRNA	PMID:20106945|PMID:21632981|PMID:32234424
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314221	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TNFAIP8 mRNA	PMID:22228805
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314221	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TNFAIP8 mRNA	PMID:19073995|PMID:33720480
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314221	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TNFAIP8 mRNA	PMID:23221170
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TNFAIP8 mRNA	PMID:19150397
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TNFAIP8 mRNA	PMID:17547211
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TNFAIP8 gene	PMID:31601247
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305908	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TNFAIP8 mRNA	PMID:25729387
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314221	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TNFAIP8 mRNA	PMID:19710929
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1314221	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of TNFAIP8 mRNA	PMID:19191707
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1314221	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of TNFAIP8 mRNA	PMID:19191707
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of TNFAIP8 mRNA	PMID:30690063
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305908	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TNFAIP8 mRNA	PMID:25181051
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305908	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TNFAIP8 mRNA	PMID:30816183|PMID:34947998
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TNFAIP8 gene	PMID:31601247
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of TNFAIP8 protein	PMID:34186270
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314221	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of TNFAIP8 mRNA	PMID:38701888
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TNFAIP8 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TNFAIP8 mRNA	PMID:28628672|PMID:31601247
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305908	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of TNFAIP8 promoter	PMID:23359474
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1314221	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of TNFAIP8 mRNA	PMID:26682919
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of TNFAIP8 protein	PMID:34186270
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TNFAIP8 mRNA	PMID:28628672
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1314221	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of TNFAIP8 intron	PMID:28392331
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305908	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of TNFAIP8 promoter	PMID:23359474
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1305908	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of TNFAIP8 mRNA	PMID:22546817
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TNFAIP8 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TNFAIP8 mRNA	PMID:28628672
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C022838	nickel chloride results in increased expression of TNFAIP8 mRNA	PMID:17312168|PMID:17547211
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305908	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of TNFAIP8 gene	PMID:33148267
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TNFAIP8 mRNA	PMID:37042841
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of TNFAIP8 mRNA	PMID:29024780
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TNFAIP8 mRNA	PMID:38568856
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of TNFAIP8 mRNA	PMID:36602393
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of TNFAIP8 mRNA	PMID:17547211
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1305908	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of TNFAIP8 mRNA	PMID:25380136
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TNFAIP8 mRNA	PMID:24449571
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314221	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of TNFAIP8 mRNA	PMID:18353800
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:3647	chlorpromazine	increases expression	ISO	RGD:1305908	E	RGD:6480464	20150825	CTD	MESH:D002746	Chlorpromazine results in increased expression of TNFAIP8 mRNA	PMID:25596134
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TNFAIP8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TNFAIP8 mRNA	PMID:32699268
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TNFAIP8 mRNA	PMID:28302478
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TNFAIP8 mRNA	PMID:31533062
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314221	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TNFAIP8 mRNA	PMID:36331819
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TNFAIP8 mRNA	PMID:25979313
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TNFAIP8 mRNA	PMID:23179753
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of TNFAIP8 mRNA	PMID:19101580
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of TNFAIP8 mRNA	PMID:17183730
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of TNFAIP8 mRNA	PMID:20106945|PMID:27989131
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TNFAIP8 mRNA	PMID:25562108
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of TNFAIP8 mRNA	PMID:25047013
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TNFAIP8 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TNFAIP8 mRNA	PMID:28628672
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314221	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TNFAIP8 mRNA	PMID:37992649
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of TNFAIP8 mRNA	PMID:17400583
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TNFAIP8 mRNA	PMID:28542535
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314221	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TNFAIP8 mRNA	PMID:17562736
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305908	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TNFAIP8 mRNA	PMID:33387578
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of TNFAIP8 mRNA	PMID:24714768|PMID:25596134
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TNFAIP8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of TNFAIP8 mRNA	PMID:35811015
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of TNFAIP8 mRNA	PMID:24160326
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of TNFAIP8 mRNA	PMID:25757056
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:46680	serpentine asbestos	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine affects the expression of TNFAIP8 mRNA	PMID:24160326
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:46680	serpentine asbestos	decreases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of TNFAIP8 gene	PMID:29523930
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of TNFAIP8 gene	PMID:25304211
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TNFAIP8 mRNA	PMID:22079256
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314221	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TNFAIP8 mRNA	PMID:35436446
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305908	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of TNFAIP8 mRNA	PMID:17351261
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TNFAIP8 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of TNFAIP8 mRNA	PMID:28628672
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TNFAIP8 mRNA	PMID:17547211
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:50161	motexafin gadolinium	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in decreased expression of TNFAIP8 mRNA	PMID:16357179
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TNFAIP8 mRNA	PMID:16357179
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314221	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TNFAIP8 mRNA	PMID:25554681
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305908	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of TNFAIP8 mRNA	PMID:23962444
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314221	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TNFAIP8 mRNA	PMID:35964746
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of TNFAIP8 mRNA	PMID:17183730
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:5855	ibuprofen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in decreased expression of TNFAIP8 mRNA	PMID:25596134
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:5864	ifosfamide	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in increased expression of TNFAIP8 mRNA	PMID:25596134
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314221	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TNFAIP8 mRNA	PMID:38701926
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TNFAIP8 protein	PMID:32959892
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:62984	zinc acetate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in decreased expression of TNFAIP8 mRNA	PMID:16357179
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:62984	zinc acetate	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of TNFAIP8 mRNA	PMID:16357179
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314221	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFAIP8 mRNA	PMID:26378955
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:63630	tolcapone	affects binding	ISO	RGD:1305908	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to TNFAIP8 protein	PMID:19783845
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	TNFAIP8 protein affects the susceptibility to Topotecan	PMID:16217747
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305908	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TNFAIP8 mRNA	PMID:25729387
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of TNFAIP8 mRNA	PMID:17547211
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1305908	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of TNFAIP8 mRNA	PMID:25596134
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305908	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TNFAIP8 gene	PMID:35440735
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305908	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of TNFAIP8 gene	PMID:33148267
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314221	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TNFAIP8 mRNA	PMID:22206623
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TNFAIP8 mRNA	PMID:22079256|PMID:22714537
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TNFAIP8 mRNA	PMID:22079256
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TNFAIP8 gene]	PMID:28238834
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305908	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of TNFAIP8 mRNA	PMID:24780913
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305908	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of TNFAIP8 mRNA	PMID:25825206
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of TNFAIP8 mRNA	PMID:12756304
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305908	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of TNFAIP8 mRNA	PMID:19281266
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305908	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TNFAIP8 mRNA	PMID:21346803
1314220	TNFAIP8	TNF alpha induced protein 8	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305908	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of TNFAIP8 gene	PMID:31079544
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:10110	zidovudine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	Zidovudine results in increased expression of NDUFB5 mRNA	PMID:16894629
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1314223	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in decreased expression of NDUFB5 mRNA	PMID:18313992
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NDUFB5 mRNA	PMID:22378314
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NDUFB5 mRNA	PMID:29432896
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314223	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NDUFB5 mRNA	PMID:39241906
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFB5 mRNA	PMID:31059760
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of NDUFB5 mRNA	PMID:23019147
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305909	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of NDUFB5 mRNA	PMID:32145629
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of NDUFB5 protein	PMID:20109541
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NDUFB5 mRNA	PMID:37042841
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:17578	toluene	affects expression	ISO	RGD:1305909	E	RGD:6480464	20121113	CTD	MESH:D014050	Toluene affects the expression of NDUFB5 mRNA	PMID:21827849
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1314223	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of NDUFB5 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NDUFB5 mRNA]	PMID:20230807
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314223	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NDUFB5 mRNA	PMID:33754040
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305909	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of NDUFB5 mRNA	PMID:22061828
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1314223	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NDUFB5 mRNA	PMID:20230807
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1314223	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of NDUFB5 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of NDUFB5 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NDUFB5 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NDUFB5 mRNA]	PMID:20230807
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of NDUFB5 mRNA	PMID:28818685
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1314223	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of NDUFB5 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NDUFB5 mRNA]	PMID:20230807
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1314223	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of NDUFB5 mRNA	PMID:27462272
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1314223	E	RGD:6480464	20151110	CTD	MESH:D002104	Cadmium results in increased expression of NDUFB5 mRNA	PMID:26187450
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NDUFB5 mRNA	PMID:19549813
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of NDUFB5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NDUFB5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NDUFB5 mRNA	PMID:39836092|PMID:40512198
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314223	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NDUFB5 mRNA	PMID:40504410
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1314223	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of NDUFB5 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of NDUFB5 mRNA]	PMID:20230807
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305909	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of NDUFB5 mRNA	PMID:31881176
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314223	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of NDUFB5 mRNA	PMID:22610192
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314223	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of NDUFB5 mRNA	PMID:30912803
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFB5 mRNA	PMID:23152189
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305909	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFB5 mRNA	PMID:32109520
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305909	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NDUFB5 mRNA	PMID:33387578
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314223	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NDUFB5 mRNA	PMID:17942748
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of NDUFB5 mRNA	PMID:18191903
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of NDUFB5 mRNA	PMID:32763439
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NDUFB5 mRNA	PMID:29803840
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314223	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of NDUFB5 mRNA	PMID:26873546
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NDUFB5 mRNA	PMID:29432896
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of NDUFB5 mRNA	PMID:39719251
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314223	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of NDUFB5 protein	PMID:29044176
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of NDUFB5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NDUFB5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NDUFB5 mRNA	PMID:39836092|PMID:40512198
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314223	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NDUFB5 mRNA	PMID:40504410
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to NDUFB5 mRNA]	PMID:32406909
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NDUFB5 mRNA	PMID:19150397
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314223	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of NDUFB5 mRNA	PMID:18648102
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305909	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NDUFB5 mRNA	PMID:25181051
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFB5 mRNA	PMID:29718440
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305909	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFB5 mRNA	PMID:32145629
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314223	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFB5 mRNA	PMID:34585602
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFB5 protein	PMID:34186270
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314223	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NDUFB5 mRNA	PMID:39298647
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of NDUFB5 protein	PMID:34186270
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305909	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NDUFB5 mRNA	PMID:21266533
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305909	E	RGD:6480464	20171010	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFB5 mRNA	PMID:28659758
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:3764	clotrimazole	increases expression	ISO	RGD:1305909	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of NDUFB5 mRNA	PMID:30047161
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of NDUFB5 mRNA	PMID:28302478
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of NDUFB5 mRNA	PMID:26352163
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314223	E	RGD:6480464	20130416	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NDUFB5 mRNA	PMID:20936131
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314223	E	RGD:6480464	20130416	CTD	MESH:C076994	PPARA protein inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of NDUFB5 mRNA]	PMID:20936131
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NDUFB5 mRNA	PMID:25979313
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305909	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NDUFB5 mRNA	PMID:30047161
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NDUFB5 mRNA	PMID:38832940
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1305909	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of NDUFB5 mRNA	PMID:21346803
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314223	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NDUFB5 mRNA	PMID:17562736
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of NDUFB5 mRNA	PMID:29067470|PMID:31059760
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of NDUFB5 mRNA	PMID:25704631
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of NDUFB5 mRNA	PMID:31059760
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of NDUFB5 mRNA	PMID:29432896
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of NDUFB5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NDUFB5 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NDUFB5 mRNA	PMID:39836092|PMID:40512198
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314223	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of NDUFB5 mRNA	PMID:40504410
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314223	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NDUFB5 mRNA	PMID:17942748
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314223	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NDUFB5 mRNA	PMID:17942748
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305909	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NDUFB5 mRNA	PMID:30047161
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1314223	E	RGD:6480464	20120814	CTD	MESH:D005485	Flutamide results in decreased expression of NDUFB5 mRNA	PMID:19442681
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:6030	isoniazide	affects expression	ISO	RGD:1314223	E	RGD:6480464	20141014	CTD	MESH:D007538	Isoniazid affects the expression of NDUFB5 mRNA	PMID:24848797
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1314223	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in decreased expression of NDUFB5 mRNA	PMID:18313992
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1305909	E	RGD:6480464	20211109	CTD	MESH:D007545	[Isoproterenol co-treated with POSTN protein] results in decreased expression of NDUFB5 mRNA	PMID:30303030
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of NDUFB5 mRNA	PMID:37939859
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305909	E	RGD:6480464	20171010	CTD	MESH:D003671	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFB5 mRNA	PMID:28659758
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of NDUFB5 protein	PMID:34186270
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314223	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NDUFB5 mRNA	PMID:22206623
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of NDUFB5 mRNA	PMID:39904859
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1314223	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of NDUFB5 mRNA	PMID:31558096
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305909	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of NDUFB5 mRNA	PMID:30047161
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1305909	E	RGD:6480464	20171010	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFB5 mRNA	PMID:28659758
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:90943	osimertinib	increases expression	ISO	RGD:1305909	E	RGD:6480464	20250506	CTD	MESH:C000603933	osimertinib results in increased expression of NDUFB5 protein	PMID:38734218
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:9381	T-2 toxin	multiple interactions	ISO	RGD:1305909	E	RGD:6480464	20230801	CTD	MESH:D013605	T-2 Toxin promotes the reaction [GABPA protein binds to NDUFB5]	PMID:36863559
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NDUFB5 mRNA	PMID:38568856
1314222	NDUFB5	NADH:ubiquinone oxidoreductase subunit B5	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305909	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of NDUFB5 mRNA	PMID:23555832
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of SORCS1 mRNA	PMID:26272509
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS1 mRNA	PMID:27188386
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of SORCS1 mRNA	PMID:23724009
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314225	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SORCS1 mRNA	PMID:30319688
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of SORCS1 mRNA	PMID:30510588
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1305910	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SORCS1 mRNA	PMID:23829299
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305910	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SORCS1 mRNA	PMID:33387578
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SORCS1 mRNA	PMID:21179406
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314225	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SORCS1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SORCS1 mRNA	PMID:37567420
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1314225	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of SORCS1 mRNA	PMID:28973375
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314225	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SORCS1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SORCS1 mRNA	PMID:37567420
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SORCS1 mRNA	PMID:31163220
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305910	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SORCS1 mRNA	PMID:26577399
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SORCS1 mRNA	PMID:35301059
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:24527	herbicide	multiple interactions	ISO	RGD:1314225	E	RGD:6480464	20231031	CTD	MESH:D006540	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SORCS1 mRNA	PMID:37567420
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314225	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SORCS1 mRNA	PMID:25629700
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SORCS1 mRNA	PMID:26272509
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS1 mRNA	PMID:27188386
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314225	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SORCS1 mRNA	PMID:28960355
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SORCS1 mRNA	PMID:28903495
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314225	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of SORCS1 mRNA	PMID:40618947
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314225	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SORCS1 mRNA	PMID:15034205
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314225	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SORCS1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SORCS1 mRNA	PMID:37567420
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314225	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SORCS1 mRNA	PMID:37682722
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SORCS1 mRNA	PMID:38568856
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SORCS1 mRNA	PMID:22316170
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314225	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SORCS1 mRNA	PMID:15034205
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314225	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SORCS1 intron	PMID:27901495
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SORCS1 promoter	PMID:27901495
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1305910	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SORCS1 mRNA	PMID:38458666
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SORCS1 mRNA	PMID:26705709
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SORCS1 gene	PMID:31601247
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314225	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SORCS1 gene	PMID:35295148
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314225	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SORCS1 gene	PMID:35295148
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314225	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SORCS1 mRNA	PMID:18648102
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305910	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SORCS1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:41034487
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of SORCS1 gene	PMID:31601247
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SORCS1 gene	PMID:31601247
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SORCS1 mRNA	PMID:25979313
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S affects the methylation of SORCS1 gene	PMID:31601247
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314225	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SORCS1 intron	PMID:28392331
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314225	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SORCS1 mRNA	PMID:37019170
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1305910	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of SORCS1 mRNA	PMID:38458666
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SORCS1 mRNA	PMID:35301059
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SORCS1 mRNA	PMID:25979313
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305910	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of SORCS1 mRNA	PMID:29427782
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of SORCS1 mRNA	PMID:24935251
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of SORCS1 mRNA	PMID:23179753|PMID:24935251|PMID:28001369
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314225	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SORCS1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SORCS1 mRNA	PMID:37567420
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of SORCS1 mRNA	PMID:24935251
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of SORCS1 mRNA	PMID:24935251|PMID:26272509
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SORCS1 mRNA	PMID:27188386
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305910	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SORCS1 mRNA	PMID:33387578
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305910	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SORCS1 mRNA	PMID:29391264
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of SORCS1 mRNA	PMID:18175754
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of SORCS1 mRNA	PMID:26272509
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS1 mRNA	PMID:27188386
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SORCS1 mRNA	PMID:26705709
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1305910	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of SORCS1 mRNA	PMID:20080153
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1314225	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SORCS1 mRNA	PMID:27935865
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1314225	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of SORCS1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SORCS1 mRNA	PMID:37567420
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305910	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of SORCS1 mRNA	PMID:33484710
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SORCS1 mRNA	PMID:27188386
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305910	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SORCS1 mRNA	PMID:32109520
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1305910	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SORCS1 mRNA	PMID:21394737
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1314225	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of SORCS1 mRNA	PMID:27935865
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305910	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SORCS1 mRNA	PMID:24780913
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SORCS1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SORCS1 mRNA	PMID:27188386
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:9665	triadimefon	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C032910	triadimefon results in increased expression of SORCS1 mRNA	PMID:26705709
1314224	SORCS1	sortilin related VPS10 domain containing receptor 1	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1305910	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of SORCS1 gene	PMID:31079544
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:135357	zimeldine	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:D015031	Zimeldine results in decreased expression of AP1S1 mRNA	PMID:17175557
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314227	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of AP1S1 mRNA	PMID:20188158
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AP1S1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AP1S1 mRNA	PMID:32699268
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of AP1S1 mRNA	PMID:26079696
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1314227	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of AP1S1 mRNA	PMID:40945087
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314227	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of AP1S1 mRNA	PMID:30319688
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of AP1S1 mRNA	PMID:29432896
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of AP1S1 mRNA	PMID:21179406
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of AP1S1 mRNA	PMID:21632981
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314227	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of AP1S1 mRNA	PMID:39241906
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of AP1S1 mRNA	PMID:19167446
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of AP1S1 mRNA	PMID:37042841
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:166595	Yessotoxin	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in increased expression of AP1S1 mRNA	PMID:30679557
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of AP1S1 mRNA	PMID:26079696
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314227	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AP1S1 mRNA	PMID:36331819
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of AP1S1 mRNA	PMID:17103032
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AP1S1 mRNA	PMID:35301059
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1314227	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of AP1S1 protein]	PMID:32272095
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in decreased expression of AP1S1 mRNA	PMID:23033980
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AP1S1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AP1S1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of AP1S1 mRNA	PMID:32699268
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314227	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of AP1S1 mRNA	PMID:34911549
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:2663	amiodarone	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D000638	Amiodarone results in decreased expression of AP1S1 mRNA	PMID:17175557|PMID:17567588
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000638	Amiodarone results in increased expression of AP1S1 mRNA	PMID:29248575
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:2666	amitriptyline	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D000639	Amitriptyline results in decreased expression of AP1S1 mRNA	PMID:17175557|PMID:17567588
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314227	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of AP1S1 mRNA	PMID:31919559
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314227	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of AP1S1 mRNA	PMID:25629700
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314227	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AP1S1 mRNA	PMID:40504410
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of AP1S1 mRNA	PMID:26272509
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AP1S1 mRNA	PMID:27188386
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of AP1S1 mRNA	PMID:27392435
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of AP1S1 mRNA	PMID:27392435
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:27902	tetracycline	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013752	Tetracycline results in decreased expression of AP1S1 mRNA	PMID:17175557
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314227	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of AP1S1 mRNA	PMID:30912803
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314227	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AP1S1 mRNA	PMID:18343893|PMID:20702594|PMID:21570461|PMID:24680724
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314227	E	RGD:6480464	20140408	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AP1S1 mRNA	PMID:15328365|PMID:19770486|PMID:23994337
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314227	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AP1S1 mRNA	PMID:17942748
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:28694	copper atom	affects metabolic processing	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	AP1S1 gene mutant form affects the metabolism of Copper	PMID:23423674
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[AP1S1 gene mutant form affects the metabolism of Copper] which results in decreased expression of ABCD3 protein; [AP1S1 gene mutant form affects the metabolism of Copper] which results in decreased expression of COX2 protein; [AP1S1 gene mutant form affects the metabolism of Copper] which results in decreased expression of COX4I1 protein; [AP1S1 gene mutant form affects the metabolism of Copper] which results in decreased expression of SOD1 protein; AP1S1 gene mutant form inhibits the reaction [Copper affects the localization of ATP7A protein]	PMID:23423674
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of AP1S1 mRNA	PMID:28595984|PMID:34032870
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314227	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AP1S1 mRNA	PMID:40504410
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of AP1S1 promoter	PMID:27901495
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314227	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AP1S1 mRNA	PMID:22228805
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:30052	copper(0)	affects metabolic processing	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	AP1S1 gene mutant form affects the metabolism of Copper	PMID:23423674
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[AP1S1 gene mutant form affects the metabolism of Copper] which results in decreased expression of ABCD3 protein; [AP1S1 gene mutant form affects the metabolism of Copper] which results in decreased expression of COX2 protein; [AP1S1 gene mutant form affects the metabolism of Copper] which results in decreased expression of COX4I1 protein; [AP1S1 gene mutant form affects the metabolism of Copper] which results in decreased expression of SOD1 protein; AP1S1 gene mutant form inhibits the reaction [Copper affects the localization of ATP7A protein]	PMID:23423674
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of AP1S1 mRNA	PMID:19150397
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of AP1S1 mRNA	PMID:17258074
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305911	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of AP1S1 mRNA	PMID:34492290
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314227	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of AP1S1 mRNA	PMID:28329830
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305911	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of AP1S1 mRNA	PMID:19167457
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of AP1S1 mRNA	PMID:30903817
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305911	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of AP1S1 mRNA	PMID:25181051
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305911	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AP1S1 mRNA	PMID:36041667
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1314227	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of AP1S1 mRNA	PMID:23994337
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314227	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of AP1S1 mRNA	PMID:39298647
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305911	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AP1S1 mRNA	PMID:36041667
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305911	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AP1S1 mRNA	PMID:36041667
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314227	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of AP1S1 mRNA	PMID:37019170
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314227	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of AP1S1 protein	PMID:32272095
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314227	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of AP1S1 protein]	PMID:32272095
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1314227	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of AP1S1 mRNA	PMID:34813904
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AP1S1 mRNA	PMID:35301059
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:35553	perhexiline	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D010480	Perhexiline results in decreased expression of AP1S1 mRNA	PMID:17175557
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of AP1S1 mRNA	PMID:19376846
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:3647	chlorpromazine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D002746	Chlorpromazine results in decreased expression of AP1S1 mRNA	PMID:17175557
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AP1S1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AP1S1 mRNA	PMID:32699268
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:3766	clozapine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003024	Clozapine results in decreased expression of AP1S1 mRNA	PMID:17175557
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of AP1S1 mRNA	PMID:31533062
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314227	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AP1S1 mRNA	PMID:36331819
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AP1S1 mRNA	PMID:25979313
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314227	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of AP1S1 mRNA	PMID:17292431
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of AP1S1 mRNA	PMID:28001369
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305911	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of AP1S1 mRNA	PMID:30047161
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of AP1S1 mRNA	PMID:20106945|PMID:25562108
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314227	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of AP1S1 mRNA	PMID:17555576
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:41774	tamoxifen	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013629	Tamoxifen results in decreased expression of AP1S1 mRNA	PMID:17175557|PMID:17567588
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:43572	kojic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of AP1S1 mRNA	PMID:16595896
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314227	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of AP1S1 mRNA	PMID:17562736
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of AP1S1 mRNA	PMID:29067470
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305911	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of AP1S1 mRNA	PMID:33387578
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of AP1S1 mRNA	PMID:22230336
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314227	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AP1S1 mRNA	PMID:40504410
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D007654	Ketoconazole results in decreased expression of AP1S1 mRNA	PMID:17175557
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:47780	clomipramine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D002997	Clomipramine results in decreased expression of AP1S1 mRNA	PMID:15342952|PMID:17175557
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314227	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of AP1S1 mRNA	PMID:35436446
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314227	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of AP1S1 mRNA	PMID:17555576
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314227	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of AP1S1 mRNA	PMID:17942748
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314227	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AP1S1 mRNA	PMID:17942748
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of AP1S1 mRNA	PMID:17258074
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of AP1S1 mRNA	PMID:17908484
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305911	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of AP1S1 mRNA	PMID:30047161
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:5118	fluoxetine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005473	Fluoxetine results in decreased expression of AP1S1 mRNA	PMID:15342952
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305911	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of AP1S1 mRNA	PMID:24136188
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1314227	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of AP1S1 mRNA	PMID:26377693
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of AP1S1 mRNA	PMID:20977926
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1314227	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of AP1S1 mRNA	PMID:20829426
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AP1S1 protein	PMID:32959892
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:63598	levofloxacin	decreases expression	ISO	RGD:1305911	E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of AP1S1 mRNA	PMID:24136188
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:6538	loratadine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D017336	Loratadine results in decreased expression of AP1S1 mRNA	PMID:17567588
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:6842	methoxychlor	affects expression	ISO	RGD:1314227	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor affects the expression of AP1S1 mRNA	PMID:20829426
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of AP1S1 mRNA	PMID:31758290
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of AP1S1 mRNA	PMID:37199045
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:75984	flecainide	decreases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D005424	Flecainide results in decreased expression of AP1S1 mRNA	PMID:17175557
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1314227	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of AP1S1 mRNA	PMID:23994337
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AP1S1 mRNA	PMID:27188386
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1314227	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of AP1S1 mRNA	PMID:18343893|PMID:20702594
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of AP1S1 protein	PMID:31675489
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of AP1S1 mRNA	PMID:26079696
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305911	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of AP1S1 mRNA	PMID:30047161
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AP1S1 mRNA	PMID:27188386
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of AP1S1 mRNA	PMID:38568856
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:9566	thioridazine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013881	Thioridazine results in decreased expression of AP1S1 mRNA	PMID:15342952|PMID:17175557
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1305911	E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of AP1S1 mRNA	PMID:24136188
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305911	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of AP1S1 mRNA	PMID:19015723
1314226	AP1S1	adaptor related protein complex 1 subunit sigma 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305911	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of AP1S1 mRNA	PMID:23034163
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RACGAP1 mRNA	PMID:38218311
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RACGAP1 mRNA	PMID:33167477
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RACGAP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RACGAP1 mRNA	PMID:32699268
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305912	E	RGD:6480464	20220510	CTD	MESH:D010100	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of RACGAP1 mRNA]; [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of RACGAP1 mRNA	PMID:33729688
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of RACGAP1 protein	PMID:28073184
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:16170	mercury(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of RACGAP1 mRNA	PMID:17547211
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314229	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RACGAP1 mRNA	PMID:39241906
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of RACGAP1 mRNA	PMID:16474171|PMID:16514628|PMID:19167446
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RACGAP1 mRNA	PMID:25510870
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305912	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RACGAP1 mRNA	PMID:33387578
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1314229	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of RACGAP1 mRNA	PMID:25549359
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RACGAP1 mRNA	PMID:37042841
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of RACGAP1 mRNA	PMID:21795739
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RACGAP1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RACGAP1 mRNA	PMID:37992649
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:17315	D-glucosamine	decreases expression	ISO	RGD:1305912	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of RACGAP1 mRNA	PMID:17109745
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of RACGAP1 mRNA	PMID:21592394
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of RACGAP1 mRNA	PMID:21592394
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of RACGAP1 mRNA	PMID:27683099
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RACGAP1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RACGAP1 mRNA	PMID:37992649
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1305912	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RACGAP1 mRNA	PMID:33789034
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305912	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of RACGAP1 mRNA	PMID:26577399
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RACGAP1 protein	PMID:37730182
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of RACGAP1 mRNA	PMID:21592394
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of RACGAP1 mRNA	PMID:21592394
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RACGAP1 mRNA	PMID:28818685
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RACGAP1 mRNA	PMID:36331819
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RACGAP1 mRNA	PMID:39836092
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:2038	5-azacytidine	increases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of RACGAP1 mRNA	PMID:20823114
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	ISO	RGD:1305912	E	RGD:6480464	20141111	CTD	MESH:D005944	Glucosamine results in decreased expression of RACGAP1 mRNA	PMID:17109745
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20120717	CTD	MESH:D008769	[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RACGAP1 mRNA	PMID:19840844
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of RACGAP1 mRNA	PMID:21120746|PMID:24376830
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RACGAP1 mRNA	PMID:25510870
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RACGAP1 mRNA	PMID:25510870
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RACGAP1 mRNA	PMID:19549813
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of RACGAP1 protein	PMID:20106945
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305912	E	RGD:6480464	20141111	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RACGAP1 mRNA	PMID:23630614|PMID:25378103
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:25195	mercury atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of RACGAP1 mRNA	PMID:17547211
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of RACGAP1 mRNA	PMID:25102026
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1314229	E	RGD:6480464	20150609	CTD	MESH:D010126	Ozone results in increased expression of RACGAP1 mRNA	PMID:19555225|PMID:25658374
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RACGAP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RACGAP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RACGAP1 mRNA	PMID:32699268
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RACGAP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of RACGAP1 mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of RACGAP1 mRNA	PMID:25658374|PMID:27106289|PMID:34911549
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D014747	RACGAP1 protein affects the susceptibility to Vinblastine	PMID:16217747
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314229	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of RACGAP1 mRNA	PMID:17484886
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314229	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RACGAP1 mRNA	PMID:27339419|PMID:31919559
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314229	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RACGAP1 mRNA	PMID:25629700
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RACGAP1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of RACGAP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RACGAP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RACGAP1 mRNA	PMID:39836092|PMID:40512198
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RACGAP1 protein	PMID:35688186
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RACGAP1 mRNA]	PMID:37992649
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305912	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RACGAP1 mRNA	PMID:31881176
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol results in increased expression of RACGAP1 mRNA	PMID:19167446
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of RACGAP1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of RACGAP1 mRNA	PMID:19167446|PMID:23557933
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1305912	E	RGD:6480464	20141111	CTD	MESH:D002945	Cisplatin results in decreased expression of RACGAP1 mRNA	PMID:22023808
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin inhibits the reaction [Piroxicam results in increased expression of RACGAP1 mRNA]	PMID:21858171
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of RACGAP1 mRNA	PMID:16474171
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305912	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RACGAP1 mRNA	PMID:34747641
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314229	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RACGAP1 mRNA	PMID:15034205
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RACGAP1 mRNA; AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of RACGAP1 mRNA]	PMID:15034205|PMID:17942748
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305912	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of RACGAP1 mRNA	PMID:28374803
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305912	E	RGD:6480464	20141111	CTD	MESH:D012402	Rotenone results in increased expression of RACGAP1 mRNA	PMID:19013527
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RACGAP1 protein	PMID:33212167
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	ISO	RGD:1305912	E	RGD:6480464	20141111	CTD	MESH:D005944	Glucosamine results in decreased expression of RACGAP1 mRNA	PMID:17109745
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305912	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of RACGAP1 mRNA	PMID:28959563
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305912	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RACGAP1 mRNA	PMID:30556269
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of RACGAP1 mRNA	PMID:20971185
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	RACGAP1 protein affects the susceptibility to Doxorubicin	PMID:16217747
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RACGAP1 mRNA	PMID:29803840|PMID:30031762
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RACGAP1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RACGAP1 mRNA	PMID:37992649
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of RACGAP1 protein	PMID:35688186
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RACGAP1 mRNA]	PMID:37992649
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of RACGAP1 mRNA	PMID:22623647
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RACGAP1 mRNA	PMID:38568856
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of RACGAP1 mRNA	PMID:29301061
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RACGAP1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of RACGAP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RACGAP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RACGAP1 mRNA	PMID:39836092|PMID:40512198
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RACGAP1 promoter	PMID:27901495
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RACGAP1 mRNA	PMID:20064835
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314229	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RACGAP1 mRNA	PMID:15034205
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314229	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RACGAP1 mRNA	PMID:20713471|PMID:32417428
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20120515	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of RACGAP1 mRNA]; Benzo(a)pyrene promotes the reaction [AHR protein binds to RACGAP1 promoter]	PMID:15034205|PMID:19654925
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1314229	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of RACGAP1 mRNA	PMID:18929588
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RACGAP1 mRNA]	PMID:32406909
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305912	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of RACGAP1 mRNA	PMID:30556269
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of RACGAP1 mRNA	PMID:20971185
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:30145	lithium atom	increases expression	ISO	RGD:1305912	E	RGD:6480464	20141111	CTD	MESH:D008094	Lithium results in increased expression of RACGAP1 mRNA	PMID:21711903
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:30146	lithium hydride	increases expression	ISO	RGD:1305912	E	RGD:6480464	20141111	CTD	MESH:D008094	Lithium results in increased expression of RACGAP1 mRNA	PMID:21711903
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314229	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RACGAP1 mRNA	PMID:29341224
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RACGAP1 mRNA	PMID:20382639
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of RACGAP1 mRNA	PMID:17547211
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of RACGAP1 mRNA	PMID:34408198
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:3090	bicalutamide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in decreased expression of RACGAP1 mRNA	PMID:15638997
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:31638	fulvestrant	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of RACGAP1 mRNA	PMID:16514628
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1305912	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of RACGAP1 mRNA	PMID:25729387
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305912	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RACGAP1 mRNA	PMID:25729387
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305912	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RACGAP1 mRNA	PMID:30047161
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1314229	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of RACGAP1 mRNA	PMID:17656681
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1305912	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of RACGAP1 mRNA	PMID:30012374
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314229	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of RACGAP1 mRNA	PMID:23557971|PMID:29264374
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305912	E	RGD:6480464	20141111	CTD	MESH:D013853	Thioacetamide results in increased expression of RACGAP1 mRNA	PMID:23411599|PMID:34492290
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314229	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RACGAP1 mRNA	PMID:17950772|PMID:18301758
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of RACGAP1 mRNA]	PMID:17950772
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:32687	piperonyl butoxide	increases expression	ISO	RGD:1305912	E	RGD:6480464	20141111	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of RACGAP1 mRNA	PMID:22484513
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of RACGAP1 mRNA	PMID:38479592
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RACGAP1 mRNA	PMID:29275510
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305912	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of RACGAP1 mRNA	PMID:25181051|PMID:26982218|PMID:30816183|PMID:32528016
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of RACGAP1 mRNA	PMID:16474171
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314229	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of RACGAP1 mRNA	PMID:26682919
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RACGAP1 mRNA	PMID:25510870
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of RACGAP1 mRNA	PMID:25510870
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1314229	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of RACGAP1 mRNA	PMID:20713471
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314229	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RACGAP1 mRNA	PMID:39298647|PMID:40203079
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RACGAP1 mRNA	PMID:28628672
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314229	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of RACGAP1 mRNA	PMID:26377693
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305912	E	RGD:6480464	20141111	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RACGAP1 mRNA	PMID:21266533
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RACGAP1 mRNA	PMID:28628672
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1305912	E	RGD:6480464	20141111	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of RACGAP1 mRNA	PMID:19041683
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RACGAP1 mRNA	PMID:24535843
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C022838	nickel chloride results in increased expression of RACGAP1 mRNA	PMID:17547211
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RACGAP1 mRNA	PMID:39836092
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1314229	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of RACGAP1 mRNA	PMID:26377693
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305912	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of RACGAP1 mRNA	PMID:30723492
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RACGAP1 mRNA	PMID:38568856
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305912	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RACGAP1 mRNA	PMID:25993096
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305912	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of RACGAP1 mRNA	PMID:25539665
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305912	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of RACGAP1 mRNA	PMID:30047161
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314229	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of RACGAP1 mRNA	PMID:28962523
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RACGAP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RACGAP1 mRNA	PMID:32699268
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314229	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RACGAP1 mRNA	PMID:40194260
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314229	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RACGAP1 mRNA	PMID:40194260
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:38757	isoflavones	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones results in decreased expression of RACGAP1 mRNA	PMID:17374662
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RACGAP1 mRNA	PMID:31533062
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of RACGAP1 mRNA	PMID:19167446
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RACGAP1 mRNA; [Coumestrol co-treated with ESR1 protein] results in increased expression of RACGAP1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of RACGAP1 mRNA; ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of RACGAP1 mRNA]	PMID:18310284|PMID:19167446
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314229	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of RACGAP1 mRNA	PMID:39529242
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RACGAP1 mRNA	PMID:40419075
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RACGAP1 mRNA	PMID:36331819
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RACGAP1 mRNA	PMID:25979313
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of RACGAP1 mRNA	PMID:29154799
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305912	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RACGAP1 mRNA	PMID:30047161
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RACGAP1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314229	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RACGAP1 mRNA	PMID:17555576
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RACGAP1 mRNA	PMID:28628672
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314229	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RACGAP1 mRNA	PMID:28973697
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RACGAP1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of RACGAP1 mRNA	PMID:37992649
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:44616	afimoxifene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of RACGAP1 mRNA	PMID:16514628
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RACGAP1 mRNA	PMID:38832940
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:44658	okadaic acid	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20120717	CTD	MESH:D019319	[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RACGAP1 mRNA	PMID:19840844
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RACGAP1 mRNA	PMID:22230336
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RACGAP1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of RACGAP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RACGAP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RACGAP1 mRNA	PMID:39836092|PMID:40512198
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of RACGAP1 mRNA	PMID:22077320
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	ISO	RGD:1305912	E	RGD:6480464	20141111	CTD	MESH:D005944	Glucosamine results in decreased expression of RACGAP1 mRNA	PMID:17109745
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314229	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RACGAP1 mRNA	PMID:17555576
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314229	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RACGAP1 mRNA	PMID:17942748
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RACGAP1 mRNA	PMID:17942748
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RACGAP1 mRNA	PMID:28628672
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of RACGAP1 mRNA	PMID:17547211
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1314229	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of RACGAP1 mRNA	PMID:25554681
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314229	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RACGAP1 mRNA	PMID:25554681
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305912	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RACGAP1 mRNA	PMID:30047161
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of RACGAP1 mRNA	PMID:21148553
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314229	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of RACGAP1 mRNA	PMID:19042947
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314229	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RACGAP1 mRNA	PMID:38701926
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RACGAP1 protein	PMID:32959892
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RACGAP1 mRNA	PMID:39836092
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305912	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of RACGAP1 mRNA	PMID:25729387
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305912	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RACGAP1 mRNA	PMID:25729387
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314229	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RACGAP1 mRNA	PMID:23650126
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of RACGAP1 mRNA	PMID:28988120
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of RACGAP1 mRNA	PMID:17547211
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305912	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of RACGAP1 mRNA	PMID:35283115
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:6887	methylphenidate	decreases expression	ISO	RGD:1314229	E	RGD:6480464	20121113	CTD	MESH:D008774	Methylphenidate results in decreased expression of RACGAP1 mRNA	PMID:22470460
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:72754	bisphenol AF	affects expression	ISO	RGD:1314229	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the expression of RACGAP1 mRNA	PMID:36625514
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314229	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RACGAP1 mRNA	PMID:22206623
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1305912	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of RACGAP1 mRNA	PMID:27225895
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1314229	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of RACGAP1 mRNA	PMID:27225895
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of RACGAP1 mRNA; incobotulinumtoxinA results in decreased expression of RACGAP1 protein	PMID:29522793
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1314229	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of RACGAP1 mRNA	PMID:27858113
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RACGAP1 mRNA	PMID:37199045
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:754951	siponimod	increases expression	ISO	RGD:1305912	E	RGD:6480464	20260714	CTD	MESH:C578989	siponimod results in increased expression of RACGAP1 mRNA	PMID:29556671
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of RACGAP1 protein	PMID:31285264
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1305912	E	RGD:6480464	20190219	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of RACGAP1 mRNA	PMID:29877212
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of RACGAP1 mRNA	PMID:34995734
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RACGAP1 gene]	PMID:28238834
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314229	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of RACGAP1 mRNA	PMID:19482888|PMID:23091169
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314229	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RACGAP1 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RACGAP1 mRNA]	PMID:19482888|PMID:24535843
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:81555	Enterolactone	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	2,3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RACGAP1 mRNA	PMID:19167446
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RACGAP1 mRNA	PMID:19167446
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314229	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of RACGAP1 mRNA	PMID:38648751
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of RACGAP1 mRNA	PMID:32234424
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:8249	piroxicam	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of RACGAP1 mRNA	PMID:21858171
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in increased expression of RACGAP1 mRNA]	PMID:21858171
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314229	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RACGAP1 mRNA	PMID:39847705
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305912	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RACGAP1 mRNA	PMID:24780913|PMID:30047161
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:85993	palbociclib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C500026	palbociclib results in decreased expression of RACGAP1 mRNA	PMID:22869556
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of RACGAP1 mRNA	PMID:16514628
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:90724	AM-251	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C103505	AM 251 results in decreased expression of RACGAP1 mRNA	PMID:16500647
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:9150	simvastatin	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in decreased expression of RACGAP1 mRNA	PMID:17428261
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305912	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RACGAP1 mRNA	PMID:19281266
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RACGAP1 mRNA	PMID:38568856
1314228	RACGAP1	Rac GTPase activating protein 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314229	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of RACGAP1 mRNA	PMID:35537566
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of RPL10L mRNA	PMID:25812627
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:177802	Cuprizon	affects expression	ISO	RGD:1305913	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of RPL10L mRNA	PMID:27523638
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RPL10L mRNA	PMID:41430723
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1621305	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of RPL10L protein	PMID:29044176
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1621305	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of RPL10L mRNA	PMID:37682722
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RPL10L exon	PMID:27901495
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1305913	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RPL10L mRNA	PMID:21839799
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1305913	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of RPL10L mRNA	PMID:16483693
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1305913	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of RPL10L mRNA	PMID:22641619
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305913	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RPL10L mRNA	PMID:25181051
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305913	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL10L mRNA	PMID:35192832
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305913	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of RPL10L mRNA	PMID:32145629
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RPL10L mRNA	PMID:25812627
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RPL10L mRNA	PMID:25812627
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RPL10L mRNA	PMID:25812627
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of RPL10L mRNA	PMID:23179753|PMID:27188386
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RPL10L gene	PMID:29154799
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of RPL10L mRNA	PMID:20106945
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305913	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RPL10L mRNA	PMID:33387578
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of RPL10L mRNA	PMID:18175754
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305913	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of RPL10L mRNA	PMID:24793618
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1305913	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of RPL10L mRNA	PMID:27840820
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of RPL10L protein	PMID:31285264
1314230	RPL10L	ribosomal protein L10 like	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1305913	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of RPL10L mRNA	PMID:32109520
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of HES7 mRNA	PMID:38218311
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314232	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of HES7 mRNA	PMID:37995155
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin inhibits the reaction [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide promotes the reaction [Chir 99021 results in increased expression of HES7 mRNA]]	PMID:31711903
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of HES7 mRNA	PMID:26079696
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of HES7 mRNA	PMID:38568856
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305914	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of HES7 mRNA	PMID:33387578
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of HES7 mRNA	PMID:26079696
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314232	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HES7 mRNA	PMID:37992649
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of HES7 mRNA	PMID:33647349
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314232	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HES7 mRNA	PMID:37992649
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of HES7 mRNA	PMID:24376830
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HES7 gene	PMID:27153756
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of HES7 mRNA	PMID:27392435
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305914	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HES7 mRNA	PMID:33387578
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of HES7 mRNA	PMID:27188386
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314232	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HES7 mRNA	PMID:37992649
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of HES7 mRNA	PMID:38568856
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314232	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of HES7 mRNA	PMID:37682722
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in increased expression of HES7 mRNA	PMID:35954277
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HES7 promoter	PMID:27901495
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of HES7 promoter	PMID:23974009
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314232	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of HES7 mRNA	PMID:27131904
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314232	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HES7 mRNA	PMID:39716349
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305914	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of HES7 mRNA	PMID:30047161
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314232	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of HES7 gene	PMID:35295148
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305914	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of HES7 mRNA	PMID:25181051
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of HES7 mRNA	PMID:29275510
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305914	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of HES7 mRNA	PMID:17379624
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1305914	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of HES7 mRNA	PMID:26194646
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D014635	Valproic Acid results in increased expression of HES7 mRNA	PMID:34742744
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314232	E	RGD:6480464	20170207	CTD	MESH:D014635	Valproic Acid results in increased expression of HES7 mRNA	PMID:27693483
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314232	E	RGD:6480464	20170207	CTD	MESH:D014635	4-(2-(5,6-dihydro-5,5-dimethyl-8-(2-phenylethynyl)naphthalen-2-yl)ethen-1-yl)benzoic acid inhibits the reaction [Valproic Acid results in increased expression of HES7 mRNA]	PMID:27693483
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305914	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of HES7 mRNA	PMID:30047161
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314232	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of HES7 mRNA	PMID:37992649
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HES7 mRNA	PMID:38832940
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of HES7 mRNA	PMID:29067470
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:48607	lithium chloride	increases expression	ISO	RGD:1314232	E	RGD:6480464	20130611	CTD	MESH:D018021	Lithium Chloride results in increased expression of HES7 mRNA	PMID:23326414
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314232	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HES7 mRNA	PMID:39716349
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305914	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of HES7 mRNA	PMID:30047161
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:5118	fluoxetine	affects expression	ISO	RGD:1314232	E	RGD:6480464	20181113	CTD	MESH:D005473	Fluoxetine affects the expression of HES7 mRNA	PMID:29893963
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314232	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of HES7 mRNA	PMID:23608068
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of HES7 mRNA	PMID:24810058
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HES7 gene]	PMID:28238834
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305914	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of HES7 mRNA	PMID:32109520
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305914	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of HES7 mRNA	PMID:30047161
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1305914	E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of HES7 mRNA	PMID:29162477
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:91091	CHIR 99021	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C473711	Chir 99021 results in increased expression of HES7 mRNA	PMID:31711903
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:91091	CHIR 99021	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C473711	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide promotes the reaction [Chir 99021 results in increased expression of HES7 mRNA]; Tretinoin inhibits the reaction [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide promotes the reaction [Chir 99021 results in increased expression of HES7 mRNA]]	PMID:31711903
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide promotes the reaction [Chir 99021 results in increased expression of HES7 mRNA]; Tretinoin inhibits the reaction [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide promotes the reaction [Chir 99021 results in increased expression of HES7 mRNA]]	PMID:31711903
1314231	HES7	hes family bHLH transcription factor 7	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314232	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of HES7 mRNA	PMID:27131904
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1622979	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of NPBWR1 mRNA	PMID:36189433
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1622979	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NPBWR1 mRNA	PMID:36189433
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of NPBWR1 mRNA	PMID:22378314
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NPBWR1 mRNA	PMID:35811015
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305917	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of NPBWR1 mRNA	PMID:33387578
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1622979	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NPBWR1 mRNA	PMID:36189433
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:17558	quercitrin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of NPBWR1 mRNA	PMID:25193878
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305917	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NPBWR1 mRNA	PMID:33387578
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305917	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NPBWR1 mRNA	PMID:39012411
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NPBWR1 exon	PMID:27901495
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of NPBWR1 promoter	PMID:23974009
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of NPBWR1 mRNA	PMID:35984750
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of NPBWR1 gene	PMID:31601247
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622979	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NPBWR1 gene	PMID:35295148
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305917	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of NPBWR1 mRNA	PMID:19167457
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305917	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of NPBWR1 mRNA	PMID:41034487
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305917	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of NPBWR1 mRNA	PMID:34947998
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of NPBWR1 gene	PMID:31601247
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1622979	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of NPBWR1 gene	PMID:31683443
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305917	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NPBWR1 mRNA	PMID:39012411
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NPBWR1 gene	PMID:29154799
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of NPBWR1 mRNA	PMID:35811015
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NPBWR1 mRNA	PMID:35811015
1314235	NPBWR1	neuropeptides B and W receptor 1	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:1305917	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of NPBWR1 gene	PMID:37958445
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305919	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZFP213 mRNA]	PMID:31150632
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1615452	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP213 gene	PMID:20938992
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1615452	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ZFP213 mRNA	PMID:39298647
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1615452	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP213 gene	PMID:20938992
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF213 mRNA	PMID:37042841
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1615452	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ZFP213 mRNA	PMID:34319233
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305919	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ZFP213 mRNA	PMID:26577399
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305919	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP213 mRNA	PMID:33387578
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZNF213 mRNA	PMID:28818685
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305919	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZFP213 mRNA	PMID:30779732
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305919	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ZFP213 mRNA	PMID:31150632
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305919	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZFP213 mRNA]	PMID:31150632
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1615452	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP213 gene	PMID:20938992
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1615452	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP213 mRNA	PMID:21570461
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305919	E	RGD:6480464	20131220	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP213 mRNA	PMID:21215274
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1615452	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP213 mRNA	PMID:19465110
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305919	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP213 mRNA	PMID:33387578
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZNF213 mRNA	PMID:33212167
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305919	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ZFP213 mRNA	PMID:28959563
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF213 mRNA	PMID:38568856|PMID:39719251
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZNF213 promoter	PMID:27901495
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ZNF213 protein]	PMID:26598702
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ZNF213 mRNA	PMID:35984750
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1615452	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP213 enhancer; titanium dioxide results in decreased methylation of ZFP213 promoter	PMID:35295148
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1615452	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZFP213 gene	PMID:35295148
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305919	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZFP213 mRNA	PMID:34492290
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1615452	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ZFP213 promoter	PMID:27334623
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1615452	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZFP213 mRNA	PMID:37019170
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305919	E	RGD:6480464	20131220	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ZFP213 mRNA	PMID:21266533
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ZNF213 mRNA	PMID:28302478
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ZNF213 mRNA	PMID:31533062
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ZNF213 mRNA	PMID:29067470
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305919	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZFP213 mRNA	PMID:33387578
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to ZNF213 protein]	PMID:26598702
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1615452	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ZFP213 mRNA	PMID:25620056
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ZNF213 mRNA	PMID:31758290
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ZNF213 mRNA	PMID:37199045
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:7719	ochratoxin A	increases methylation	ISO	RGD:1305919	E	RGD:6480464	20160210	CTD	MESH:C025589	ochratoxin A results in increased methylation of ZFP213 gene	PMID:26431795
1314237	ZNF213	zinc finger protein 213	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZNF213 mRNA	PMID:29301935
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305920	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of TTC7B mRNA	PMID:25152437
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of TTC7B mRNA	PMID:31016361
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TTC7B mRNA	PMID:33167477
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TTC7B mRNA	PMID:20044591
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of TTC7B mRNA	PMID:21632981
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1618253	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TTC7B mRNA	PMID:39298647
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TTC7B mRNA	PMID:37042841
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of TTC7B mRNA	PMID:23649840
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1618253	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of TTC7B mRNA	PMID:33848595
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1618253	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of TTC7B mRNA]	PMID:33848595
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1618253	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TTC7B mRNA	PMID:34319233
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TTC7B protein	PMID:37730182
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305920	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TTC7B mRNA	PMID:33387578
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of TTC7B intron	PMID:30157460
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1618253	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TTC7B mRNA	PMID:36331819
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:2394	acetochlor	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:C043377	[Herbicides results in increased abundance of acetochlor] which affects the methylation of TTC7B gene	PMID:34516295
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:24527	herbicide	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:D006540	[Herbicides results in increased abundance of acetochlor] which affects the methylation of TTC7B gene	PMID:34516295
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305920	E	RGD:6480464	20130806	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TTC7B mRNA	PMID:22129741
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of TTC7B protein	PMID:20106945
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of TTC7B intron	PMID:30157460
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TTC7B mRNA	PMID:21641981|PMID:27153756
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1618253	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TTC7B mRNA	PMID:19770486
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1618253	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TTC7B mRNA	PMID:28189721|PMID:28960355
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of TTC7B gene	PMID:31636367
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TTC7B mRNA	PMID:27392435
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of TTC7B mRNA	PMID:27392435
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1305920	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of TTC7B mRNA	PMID:17898221
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305920	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TTC7B mRNA	PMID:21215274
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1618253	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TTC7B mRNA	PMID:19933214|PMID:26290441
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of TTC7B mRNA; Rotenone results in increased expression of TTC7B protein	PMID:29955902|PMID:39603559
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305920	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of TTC7B mRNA	PMID:28374803
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TTC7B mRNA	PMID:23179753|PMID:26272509
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC7B mRNA	PMID:27188386
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TTC7B mRNA	PMID:33212167
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305920	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TTC7B mRNA	PMID:28959563
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305920	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TTC7B mRNA	PMID:28959563
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1305920	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TTC7B mRNA	PMID:30556269
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1305920	E	RGD:6480464	20130806	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TTC7B mRNA	PMID:22129741
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TTC7B mRNA	PMID:38568856
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TTC7B promoter	PMID:27901495
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TTC7B mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1618253	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TTC7B mRNA	PMID:19770486
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1305920	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TTC7B mRNA	PMID:30556269
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TTC7B mRNA	PMID:26238291
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TTC7B mRNA	PMID:20458559
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1618253	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TTC7B mRNA	PMID:35676786
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TTC7B gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of TTC7B gene	PMID:31601247
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305920	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TTC7B mRNA	PMID:30047161
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TTC7B mRNA	PMID:19710929
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of TTC7B mRNA	PMID:38479592
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305920	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TTC7B mRNA	PMID:25181051
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of TTC7B mRNA; bisphenol A results in decreased expression of TTC7B protein	PMID:22576693|PMID:31675489
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1618253	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TTC7B mRNA	PMID:26063408
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TTC7B gene	PMID:31601247
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of TTC7B mRNA	PMID:31715268
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1618253	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TTC7B mRNA	PMID:33221593
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of TTC7B gene	PMID:22576693
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TTC7B gene	PMID:31601247
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305920	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TTC7B mRNA	PMID:36041667
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1618253	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of TTC7B mRNA	PMID:40203079
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305920	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TTC7B mRNA	PMID:36041667
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of TTC7B gene	PMID:31601247
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305920	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of TTC7B mRNA	PMID:36041667
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1618253	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of TTC7B intron	PMID:28392331
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1618253	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TTC7B mRNA	PMID:37019170
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305920	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TTC7B mRNA	PMID:21266533
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1618253	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of TTC7B mRNA	PMID:34813904
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1618253	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of TTC7B mRNA	PMID:24535843
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305920	E	RGD:6480464	20130806	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of TTC7B mRNA	PMID:22129741
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1305920	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of TTC7B gene	PMID:33148267
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TTC7B mRNA	PMID:37042841
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of TTC7B mRNA	PMID:29024780
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305920	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TTC7B mRNA	PMID:35163327
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305920	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TTC7B mRNA	PMID:35163327
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TTC7B mRNA	PMID:24449571
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TTC7B mRNA	PMID:31533062
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1618253	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TTC7B mRNA	PMID:36331819
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TTC7B mRNA	PMID:25979313
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of TTC7B mRNA	PMID:29154799
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305920	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TTC7B mRNA	PMID:30047161
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TTC7B mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1618253	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TTC7B mRNA	PMID:28973697
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1618253	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TTC7B mRNA	PMID:17562736
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305920	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TTC7B mRNA	PMID:33387578
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of TTC7B mRNA	PMID:29067470
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of TTC7B mRNA	PMID:31675489
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305920	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TTC7B mRNA	PMID:29391264
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1618253	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of TTC7B mRNA	PMID:35436446
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of TTC7B mRNA	PMID:32234424
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TTC7B mRNA	PMID:20458559
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1618253	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TTC7B mRNA	PMID:35676786
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305920	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of TTC7B mRNA	PMID:30307764
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305920	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TTC7B mRNA	PMID:30047161
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305920	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TTC7B gene	PMID:35440735
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:68641	(-)-cotinine	affects methylation	EXP		E	RGD:6480464	20130312	CTD	MESH:D003367	Cotinine affects the methylation of TTC7B gene	PMID:22851337
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1305920	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of TTC7B gene	PMID:33148267
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TTC7B mRNA	PMID:37199045
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305920	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of TTC7B mRNA	PMID:33484710
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC7B mRNA	PMID:27188386
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of TTC7B mRNA	PMID:19159669
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1618253	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of TTC7B mRNA	PMID:38995820
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of TTC7B mRNA	PMID:32234424
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1618253	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of TTC7B mRNA	PMID:21278054
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305920	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TTC7B mRNA	PMID:30047161
1314238	TTC7B	tetratricopeptide repeat domain 7B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TTC7B mRNA	PMID:27188386
1314240	PKN3	protein kinase N3	gene	CHEBI:16547	coniferyl aldehyde	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:C075384	PKN3 mutant form inhibits the reaction [coniferaldehyde affects the localization of and results in increased phosphorylation of NFE2L2 protein]; PKN3 mutant form inhibits the reaction [coniferaldehyde results in increased expression of HMOX1 protein]	PMID:26275128
1314240	PKN3	protein kinase N3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PKN3 mRNA	PMID:37042841
1314240	PKN3	protein kinase N3	gene	CHEBI:187088	Muconic dialdehyde	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C034476	muconaldehyde results in decreased expression of PKN3 mRNA	PMID:40300100
1314240	PKN3	protein kinase N3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314241	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PKN3 mRNA	PMID:34911549
1314240	PKN3	protein kinase N3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314241	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PKN3 mRNA	PMID:40504410
1314240	PKN3	protein kinase N3	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PKN3 protein	PMID:35688186
1314240	PKN3	protein kinase N3	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305921	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PKN3 mRNA	PMID:31881176
1314240	PKN3	protein kinase N3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PKN3 mRNA	PMID:27392435
1314240	PKN3	protein kinase N3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314241	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PKN3 mRNA	PMID:21570461
1314240	PKN3	protein kinase N3	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of PKN3 mRNA	PMID:29955902
1314240	PKN3	protein kinase N3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305921	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PKN3 mRNA	PMID:28959563
1314240	PKN3	protein kinase N3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of PKN3 mRNA	PMID:30911355
1314240	PKN3	protein kinase N3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314241	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PKN3 mRNA	PMID:40504410
1314240	PKN3	protein kinase N3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PKN3 intron	PMID:30157460
1314240	PKN3	protein kinase N3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314241	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PKN3 mRNA	PMID:27195522
1314240	PKN3	protein kinase N3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314241	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PKN3 mRNA	PMID:21569818|PMID:22228805|PMID:22610609
1314240	PKN3	protein kinase N3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PKN3 exon; Benzo(a)pyrene results in increased methylation of PKN3 promoter	PMID:27901495
1314240	PKN3	protein kinase N3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314241	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PKN3 mRNA	PMID:27858113
1314240	PKN3	protein kinase N3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of PKN3 mRNA	PMID:30911355
1314240	PKN3	protein kinase N3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305921	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PKN3 mRNA	PMID:34492290
1314240	PKN3	protein kinase N3	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305921	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of PKN3 mRNA	PMID:19167457
1314240	PKN3	protein kinase N3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305921	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PKN3 mRNA	PMID:25181051
1314240	PKN3	protein kinase N3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305921	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of PKN3 mRNA	PMID:30816183
1314240	PKN3	protein kinase N3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314241	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of PKN3 mRNA	PMID:40203079
1314240	PKN3	protein kinase N3	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314241	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PKN3 mRNA	PMID:26377693
1314240	PKN3	protein kinase N3	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314241	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PKN3 mRNA	PMID:27858113
1314240	PKN3	protein kinase N3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314241	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PKN3 mRNA	PMID:38685157
1314240	PKN3	protein kinase N3	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1314241	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of PKN3 mRNA	PMID:26377693
1314240	PKN3	protein kinase N3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PKN3 mRNA	PMID:26472689
1314240	PKN3	protein kinase N3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PKN3 mRNA	PMID:38568856
1314240	PKN3	protein kinase N3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PKN3 mRNA	PMID:19320972
1314240	PKN3	protein kinase N3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314241	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PKN3 mRNA	PMID:40194260
1314240	PKN3	protein kinase N3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314241	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PKN3 mRNA	PMID:40194260
1314240	PKN3	protein kinase N3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PKN3 mRNA	PMID:31533062
1314240	PKN3	protein kinase N3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314241	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PKN3 mRNA	PMID:39529242
1314240	PKN3	protein kinase N3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of PKN3 mRNA	PMID:29154799
1314240	PKN3	protein kinase N3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PKN3 gene	PMID:29154799
1314240	PKN3	protein kinase N3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PKN3 mRNA	PMID:20106945
1314240	PKN3	protein kinase N3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314241	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PKN3 mRNA	PMID:17555576
1314240	PKN3	protein kinase N3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of PKN3 mRNA	PMID:29067470
1314240	PKN3	protein kinase N3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314241	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PKN3 mRNA	PMID:40504410
1314240	PKN3	protein kinase N3	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305921	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PKN3 mRNA	PMID:29391264
1314240	PKN3	protein kinase N3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314241	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PKN3 mRNA	PMID:35436446
1314240	PKN3	protein kinase N3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314241	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PKN3 mRNA	PMID:17555576
1314240	PKN3	protein kinase N3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314241	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PKN3 mRNA	PMID:25554681
1314240	PKN3	protein kinase N3	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1314241	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of PKN3 mRNA	PMID:26377693
1314240	PKN3	protein kinase N3	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314241	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PKN3 mRNA	PMID:27858113
1314240	PKN3	protein kinase N3	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314241	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PKN3 mRNA	PMID:27858113
1314240	PKN3	protein kinase N3	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of PKN3 mRNA	PMID:28988120
1314240	PKN3	protein kinase N3	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1314241	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of PKN3 mRNA	PMID:26307267
1314240	PKN3	protein kinase N3	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PKN3 mRNA	PMID:31758290
1314240	PKN3	protein kinase N3	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1314241	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of PKN3 mRNA	PMID:27858113
1314240	PKN3	protein kinase N3	gene	CHEBI:78160	bleomycin A5	decreases expression	EXP		E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in decreased expression of PKN3 mRNA	PMID:21040473
1314240	PKN3	protein kinase N3	gene	CHEBI:80799	Bufotalin	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of PKN3 mRNA	PMID:39904859
1314240	PKN3	protein kinase N3	gene	CHEBI:81922	flusilazole	decreases expression	ISO	RGD:1305921	E	RGD:6480464	20170725	CTD	MESH:C061365	flusilazole results in decreased expression of PKN3 mRNA	PMID:28263823
1314240	PKN3	protein kinase N3	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314241	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of PKN3 mRNA	PMID:40826991
1314240	PKN3	protein kinase N3	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1305921	E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of PKN3 mRNA	PMID:29162477
1314240	PKN3	protein kinase N3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PKN3 mRNA	PMID:29301935
1314240	PKN3	protein kinase N3	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of PKN3 mRNA	PMID:27188386
1314240	PKN3	protein kinase N3	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of PKN3 mRNA	PMID:19140230
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:132238	iron(III) nitrilotriacetate	decreases expression	ISO	RGD:1305922	E	RGD:6480464	20160705	CTD	MESH:C020326	ferric nitrilotriacetate results in decreased expression of PTPRB mRNA	PMID:10854235
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PTPRB mRNA	PMID:20188158
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PTPRB mRNA	PMID:23724009
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of PTPRB mRNA	PMID:24236059|PMID:26516004
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305922	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of PTPRB gene	PMID:28931070|PMID:35440735
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	[Ethanol co-treated with Folic Acid] results in increased expression of PTPRB mRNA	PMID:23378141
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305922	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PTPRB mRNA	PMID:32145629
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PTPRB mRNA	PMID:30165855
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552328	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PTPRB mRNA	PMID:36331819
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:188855	Octicizer	multiple interactions	ISO	RGD:1552328	E	RGD:6480464	20220104	CTD	MESH:C018535	[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of PTPRB mRNA	PMID:33367866
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PTPRB gene	PMID:27153756
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1552328	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PTPRB mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PTPRB mRNA	PMID:27106289|PMID:34911549
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PTPRB mRNA	PMID:25629700
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D005492	[Ethanol co-treated with Folic Acid] results in increased expression of PTPRB mRNA	PMID:23378141
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PTPRB mRNA	PMID:27392435
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PTPRB mRNA	PMID:27392435
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of PTPRB mRNA	PMID:18000554
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1552328	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of PTPRB mRNA	PMID:32186404
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PTPRB mRNA	PMID:25583101
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305922	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PTPRB mRNA	PMID:22298810|PMID:34747641
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552328	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PTPRB mRNA	PMID:21570461
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552328	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PTPRB mRNA	PMID:19465110|PMID:19933214
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of PTPRB mRNA	PMID:20971185
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PTPRB mRNA	PMID:30031762
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PTPRB mRNA	PMID:22714537
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PTPRB mRNA	PMID:21569818
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552328	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PTPRB mRNA	PMID:22228805
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552328	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PTPRB mRNA	PMID:27858113
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of PTPRB mRNA	PMID:20971185
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PTPRB mRNA	PMID:25895662
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PTPRB mRNA	PMID:23221170
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of PTPRB gene	PMID:31601247
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of PTPRB mRNA	PMID:23557971
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552328	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PTPRB promoter	PMID:35295148
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305922	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of PTPRB mRNA	PMID:30816183|PMID:32145629
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552328	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of PTPRB mRNA	PMID:32156529
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of PTPRB gene	PMID:31601247
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of PTPRB gene	PMID:31601247
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of PTPRB mRNA	PMID:26682919
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of PTPRB mRNA	PMID:19041380
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of PTPRB mRNA	PMID:39298647|PMID:40203079
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1552328	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PTPRB promoter	PMID:33297965
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552328	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PTPRB mRNA	PMID:30951980|PMID:40203079
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1552328	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of PTPRB exon	PMID:33297965
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of PTPRB mRNA	PMID:26377693
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1552328	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PTPRB mRNA	PMID:27858113
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552328	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PTPRB mRNA	PMID:30951980|PMID:38685157
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552328	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PTPRB mRNA	PMID:37019170
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of PTPRB mRNA	PMID:17312168|PMID:21455298
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:35019	tributyl phosphate	multiple interactions	ISO	RGD:1552328	E	RGD:6480464	20210406	CTD	MESH:C009524	[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of PTPRB mRNA	PMID:33367866
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PTPRB mRNA	PMID:37042841
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:35033	triphenyl phosphate	multiple interactions	ISO	RGD:1552328	E	RGD:6480464	20210406	CTD	MESH:C005445	[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of PTPRB mRNA	PMID:33367866
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	multiple interactions	ISO	RGD:1552328	E	RGD:6480464	20210406	CTD	MESH:C031324	[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of PTPRB mRNA	PMID:33367866
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	multiple interactions	ISO	RGD:1552328	E	RGD:6480464	20210406	CTD	MESH:C013320	[tris(2-butoxyethyl) phosphate co-treated with IMOL S-140 co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate co-treated with tributyl phosphate] results in decreased expression of PTPRB mRNA	PMID:33367866
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305922	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PTPRB mRNA	PMID:35163327
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1305922	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of PTPRB mRNA	PMID:18500788
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305922	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PTPRB mRNA	PMID:33453195
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305922	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PTPRB mRNA	PMID:35163327
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PTPRB mRNA	PMID:24449571
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of PTPRB mRNA	PMID:17585979
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552328	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PTPRB mRNA	PMID:40194260
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PTPRB mRNA	PMID:39529242
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:39178	clothianidin	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in decreased expression of PTPRB mRNA	PMID:31626844
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552328	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PTPRB mRNA	PMID:36331819
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305922	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PTPRB mRNA	PMID:29427782
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1305922	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of PTPRB mRNA	PMID:29427782
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305922	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of PTPRB mRNA	PMID:41580965
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305922	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of PTPRB mRNA	PMID:24136188
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PTPRB mRNA	PMID:38832940
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PTPRB mRNA	PMID:24935251
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of PTPRB mRNA	PMID:29279043
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PTPRB mRNA; Nanotubes, Carbon results in decreased expression of PTPRB mRNA	PMID:25554681
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1552328	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PTPRB mRNA	PMID:27858113
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1552328	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of PTPRB mRNA	PMID:27858113
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of PTPRB mRNA	PMID:22714537
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of PTPRB mRNA	PMID:20436886
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of PTPRB mRNA	PMID:28988120
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1305922	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of PTPRB mRNA	PMID:24136188
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PTPRB gene]	PMID:28238834
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of PTPRB mRNA	PMID:19482888|PMID:23091169
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1552328	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of PTPRB mRNA]	PMID:19482888
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1552328	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PTPRB mRNA	PMID:30294300
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of PTPRB mRNA	PMID:21795629
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552328	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of PTPRB mRNA	PMID:21795629
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PTPRB mRNA	PMID:29301935
1314242	PTPRB	protein tyrosine phosphatase receptor type B	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552328	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of PTPRB mRNA	PMID:28973697
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ZFPM1 mRNA	PMID:37995155
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:142290	anagrelide	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C021139	anagrelide inhibits the reaction [THPO protein results in increased expression of ZFPM1 mRNA]	PMID:20586925
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:D014212	Tretinoin results in increased expression of ZFPM1 mRNA	PMID:16604517
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZFPM1 mRNA	PMID:36331819
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ZFPM1 mRNA	PMID:22378314
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314246	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ZFPM1 mRNA	PMID:30319688
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314246	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZFPM1 mRNA	PMID:12057914
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ZFPM1 mRNA	PMID:30510588
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:D004958	Estradiol affects the expression of ZFPM1 mRNA	PMID:15598610
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314246	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ZFPM1 mRNA	PMID:39298647
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:D014241	Trichloroethylene results in increased expression of ZFPM1 mRNA	PMID:19448997
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ZFPM1 mRNA	PMID:37992649
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ZFPM1 mRNA	PMID:37992649
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ZFPM1 mRNA	PMID:33754040
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZFPM1 protein	PMID:37730182
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1582810	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFPM1 mRNA	PMID:33387578
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFPM1 mRNA	PMID:36331819
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:2038	5-azacytidine	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20250805	CTD	MESH:D001374	Azacitidine inhibits the reaction [butylbenzyl phthalate results in decreased expression of ZFPM1 mRNA]	PMID:28392331
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of ZFPM1 mRNA	PMID:19376150
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZFPM1 intron	PMID:30157460
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZFPM1 mRNA	PMID:23649840
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZFPM1 gene	PMID:25304211
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D001151	Arsenic inhibits the reaction [GATA1 protein binds to ZFPM1 protein]	PMID:33149232
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20210907	CTD	MESH:D001151	Arsenic inhibits the reaction [GATA1 protein binds to ZFPM1 protein]	PMID:33149232
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ZFPM1 protein	PMID:35688186
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ZFPM1 mRNA	PMID:23557933
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:D003042	Cocaine results in increased expression of ZFPM1 mRNA	PMID:18355967
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:D003042	FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of ZFPM1 mRNA]	PMID:18355967
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ZFPM1 mRNA	PMID:30912803
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314246	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFPM1 mRNA	PMID:26377647
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFPM1 mRNA	PMID:26290441|PMID:37172768
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1582810	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFPM1 mRNA	PMID:21215274|PMID:34747641
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of ZFPM1 mRNA	PMID:16214954
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZFPM1 mRNA	PMID:29803840
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZFPM1 mRNA	PMID:16243910|PMID:39631538
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ZFPM1 mRNA	PMID:37992649
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZFPM1 mRNA	PMID:34032870|PMID:38568856
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZFPM1 intron	PMID:30157460
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZFPM1 mRNA	PMID:21569818|PMID:22228805
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZFPM1 3' UTR	PMID:27901495
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1582810	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of ZFPM1 mRNA	PMID:24915197
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ZFPM1 mRNA	PMID:23557971
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314246	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFPM1 gene; titanium dioxide results in decreased methylation of ZFPM1 promoter	PMID:35295148
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1582810	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZFPM1 mRNA	PMID:34492290
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ZFPM1 mRNA	PMID:18648102
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ZFPM1 mRNA	PMID:19710929
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1582810	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ZFPM1 mRNA	PMID:19167457
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1582810	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ZFPM1 mRNA	PMID:32145629
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1582810	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFPM1 mRNA	PMID:30816183|PMID:34947998
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZFPM1 gene	PMID:31601247
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314246	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZFPM1 promoter	PMID:27312807
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314246	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFPM1 mRNA	PMID:32156529|PMID:34585602
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1582810	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZFPM1 mRNA	PMID:25181051
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314246	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ZFPM1 gene	PMID:31683443
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314246	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ZFPM1 exon	PMID:33297965
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314246	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ZFPM1 mRNA	PMID:39298647|PMID:40203079
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ZFPM1 mRNA	PMID:28392331
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314246	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ZFPM1 intron	PMID:28392331
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20250805	CTD	MESH:C027561	Azacitidine inhibits the reaction [butylbenzyl phthalate results in decreased expression of ZFPM1 mRNA]	PMID:28392331
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of ZFPM1 gene	PMID:22964155
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ZFPM1 mRNA	PMID:28903501
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:D002994	Clofibrate results in decreased expression of ZFPM1 mRNA	PMID:17585979
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ZFPM1 mRNA	PMID:40194260
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ZFPM1 mRNA	PMID:28302478
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of ZFPM1 mRNA	PMID:19167446
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFPM1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZFPM1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ZFPM1 mRNA	PMID:36331819
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZFPM1 gene	PMID:29154799
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:D013629	Tamoxifen affects the expression of ZFPM1 mRNA	PMID:17555576
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of ZFPM1 mRNA	PMID:25123088
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314246	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ZFPM1 mRNA	PMID:28973697
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ZFPM1 mRNA	PMID:37992649
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ZFPM1 mRNA	PMID:38832940
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of ZFPM1 mRNA	PMID:17562736
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1582810	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZFPM1 mRNA	PMID:32479839|PMID:33387578
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ZFPM1 mRNA	PMID:22230336|PMID:29067470
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1582810	E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of ZFPM1 mRNA	PMID:21061450
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZFPM1 gene	PMID:25304211
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D001151	Arsenic inhibits the reaction [GATA1 protein binds to ZFPM1 protein]	PMID:33149232
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20210907	CTD	MESH:D001151	Arsenic inhibits the reaction [GATA1 protein binds to ZFPM1 protein]	PMID:33149232
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1582810	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ZFPM1 mRNA	PMID:29391264
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of ZFPM1 mRNA	PMID:18175754
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314246	E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ZFPM1 mRNA	PMID:17555576
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1582810	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ZFPM1 mRNA	PMID:30307764
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314246	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ZFPM1 mRNA	PMID:25554681
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1582810	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of ZFPM1 mRNA	PMID:23962444
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of ZFPM1 mRNA	PMID:20977926
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1314246	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of ZFPM1 mRNA	PMID:20829426
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314246	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ZFPM1 mRNA	PMID:39847705
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314246	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ZFPM1 mRNA	PMID:40826991
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	multiple interactions	ISO	RGD:1314246	E	RGD:6480464	20210907	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [GATA1 protein binds to ZFPM1 protein]	PMID:33149232
1314245	ZFPM1	zinc finger protein, FOG family member 1	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of ZFPM1 mRNA	PMID:22378314
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:10110	zidovudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with IFNA1 protein] results in increased expression of SLC24A4 mRNA	PMID:20370541
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1620579	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SLC24A4 mRNA	PMID:33045310
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SLC24A4 mRNA	PMID:33167477
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of SLC24A4 mRNA	PMID:22378314
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1620579	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of SLC24A4 mRNA	PMID:30319688
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1620579	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SLC24A4 mRNA	PMID:30319688
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1620579	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SLC24A4 mRNA	PMID:30319688
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305926	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SLC24A4 mRNA	PMID:33387578
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLC24A4 mRNA	PMID:37042841
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305926	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of SLC24A4 mRNA	PMID:27523638
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLC24A4 intron	PMID:30157460
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLC24A4 mRNA	PMID:41430723
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLC24A4 gene	PMID:25304211
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1305926	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of SLC24A4 gene	PMID:35440735
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of SLC24A4 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of SLC24A4 mRNA	PMID:23557933|PMID:41028656
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1305926	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of SLC24A4 mRNA	PMID:17898221
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305926	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC24A4 mRNA	PMID:32109520
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of SLC24A4 mRNA	PMID:29955902
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1305926	E	RGD:6480464	20120918	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SLC24A4 mRNA	PMID:22193206
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SLC24A4 mRNA	PMID:41028656
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1305926	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of SLC24A4 mRNA	PMID:27257137
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC24A4 promoter	PMID:27901495
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of SLC24A4 gene	PMID:25435355
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:29866	arsenite(3-)	decreases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased methylation of SLC24A4 promoter	PMID:23974009
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of SLC24A4 mRNA	PMID:41028656
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1620579	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SLC24A4 mRNA	PMID:27131904
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SLC24A4 mRNA	PMID:25895662
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305926	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of SLC24A4 mRNA	PMID:24915197
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of SLC24A4 mRNA	PMID:37690743
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620579	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC24A4 promoter	PMID:35295148
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305926	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of SLC24A4 mRNA	PMID:19167457
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC24A4 mRNA	PMID:31715268
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305926	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC24A4 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305926	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SLC24A4 gene	PMID:28505145
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1620579	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SLC24A4 intron	PMID:28392331
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1305926	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SLC24A4 mRNA	PMID:32680482
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305926	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of SLC24A4 mRNA	PMID:30723492
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305926	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of SLC24A4 mRNA	PMID:25539665
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1620579	E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SLC24A4 mRNA	PMID:21139344
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620579	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLC24A4 mRNA	PMID:40194260
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLC24A4 gene	PMID:25304211
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of SLC24A4 mRNA	PMID:40706910
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305926	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SLC24A4 mRNA	PMID:29391264
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305926	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SLC24A4 mRNA	PMID:30307764
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1620579	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SLC24A4 mRNA	PMID:25554681
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1620579	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of SLC24A4 mRNA	PMID:23608068
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SLC24A4 mRNA	PMID:24810058
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:64227	ciglitazone	decreases expression	ISO	RGD:1305926	E	RGD:6480464	20120918	CTD	MESH:C039671	ciglitazone results in decreased expression of SLC24A4 mRNA	PMID:22193206
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC24A4 gene]	PMID:28238834
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of SLC24A4 mRNA	PMID:26079696
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305926	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of SLC24A4 mRNA	PMID:24780913
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305926	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SLC24A4 mRNA	PMID:25825206
1314247	SLC24A4	solute carrier family 24 member 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1620579	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SLC24A4 mRNA	PMID:27131904
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of BAZ1B protein	PMID:39638853
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314249	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of BAZ1B mRNA	PMID:26251327
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1314249	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of BAZ1B promoter	PMID:26251327
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314249	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BAZ1B gene	PMID:20938992
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of BAZ1B mRNA	PMID:15928584
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of BAZ1B mRNA	PMID:22378314
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314249	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of BAZ1B mRNA	PMID:39241906
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314249	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of BAZ1B mRNA	PMID:39298647
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1597089	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of BAZ1B mRNA	PMID:33387578
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1314249	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of BAZ1B mRNA	PMID:19448997
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314249	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BAZ1B gene	PMID:20938992
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BAZ1B mRNA	PMID:37042841
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:16716	benzene	increases expression	ISO	RGD:1314249	E	RGD:6480464	20120501	CTD	MESH:D001554	Benzene results in increased expression of BAZ1B mRNA	PMID:20018183
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of BAZ1B mRNA	PMID:27683099
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314249	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of BAZ1B mRNA	PMID:33754040
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314249	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of BAZ1B mRNA	PMID:34319233
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	affects abundance	EXP		E	RGD:6480464	20130312	CTD	MESH:D014527	BAZ1B gene SNP affects the abundance of Uric Acid	PMID:23263486
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of BAZ1B protein; [Cuprizone co-treated with Cannabidiol] results in decreased expression of BAZ1B protein; [Cuprizone co-treated with Clozapine] results in decreased expression of BAZ1B protein	PMID:34122009
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of BAZ1B protein	PMID:37730182
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314249	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BAZ1B mRNA	PMID:37236586
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1597089	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BAZ1B mRNA	PMID:39012411
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of BAZ1B protein	PMID:23301498
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BAZ1B protein	PMID:39638853
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314249	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BAZ1B mRNA	PMID:19770486
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1597089	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of BAZ1B mRNA	PMID:31150632
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314249	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BAZ1B gene	PMID:20938992
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BAZ1B mRNA	PMID:19244175
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of BAZ1B protein	PMID:35688186
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314249	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of BAZ1B mRNA	PMID:28960355
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1314249	E	RGD:6480464	20180313	CTD	MESH:D003042	Cocaine results in increased expression of BAZ1B mRNA	PMID:27053203
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1314249	E	RGD:6480464	20180313	CTD	MESH:D003042	[SMARCA5 protein co-treated with BAZ1B protein] results in increased susceptibility to Cocaine; Cocaine promotes the reaction [BAZ1B protein binds to SPHKAP gene]; Cocaine results in increased expression of and affects the activity of BAZ1B protein	PMID:27053203
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314249	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of BAZ1B mRNA	PMID:30912803
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314249	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BAZ1B mRNA	PMID:24680724
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1597089	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BAZ1B mRNA	PMID:33387578
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1597089	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BAZ1B mRNA	PMID:34747641
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1597089	E	RGD:6480464	20170516	CTD	MESH:D012402	Rotenone results in increased expression of BAZ1B mRNA	PMID:27979718
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of BAZ1B mRNA	PMID:33212167
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1597089	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of BAZ1B mRNA	PMID:30556269
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of BAZ1B protein	PMID:35688186
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of BAZ1B protein	PMID:38228842
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314249	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of BAZ1B mRNA	PMID:16014739
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1597089	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of BAZ1B mRNA	PMID:30556269
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of BAZ1B protein	PMID:34122009
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BAZ1B mRNA	PMID:19150397
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314249	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BAZ1B gene; titanium dioxide results in decreased methylation of BAZ1B promoter	PMID:35295148
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314249	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of BAZ1B gene	PMID:35295148
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1597089	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of BAZ1B mRNA	PMID:34492290
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314249	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of BAZ1B mRNA	PMID:18301758
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1597089	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of BAZ1B mRNA	PMID:25181051
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of BAZ1B protein	PMID:31675489
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1597089	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of BAZ1B mRNA	PMID:30816183
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of BAZ1B gene	PMID:31601247
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of BAZ1B protein	PMID:31675489
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of BAZ1B mRNA	PMID:19244175
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314249	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of BAZ1B mRNA	PMID:39298647
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314249	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of BAZ1B mRNA	PMID:28392331
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1597089	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of BAZ1B mRNA	PMID:21266533
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BAZ1B mRNA	PMID:37042841
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1597089	E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of BAZ1B mRNA	PMID:17616710
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:35176	zinc sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in increased expression of BAZ1B mRNA	PMID:16330358
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1314249	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride affects the expression of BAZ1B mRNA	PMID:18974090
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of BAZ1B mRNA	PMID:26472689
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314249	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BAZ1B mRNA	PMID:37236586
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1597089	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BAZ1B mRNA	PMID:39012411
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BAZ1B mRNA	PMID:19244175
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314249	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of BAZ1B mRNA	PMID:17585979
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:3766	clozapine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	[Cuprizone co-treated with Clozapine] results in decreased expression of BAZ1B protein	PMID:34122009
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of BAZ1B mRNA	PMID:31533062
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of BAZ1B mRNA	PMID:40419075
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314249	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of BAZ1B mRNA	PMID:21427059
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of BAZ1B gene	PMID:29154799
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1597089	E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of BAZ1B mRNA	PMID:36653537
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of BAZ1B mRNA	PMID:31675489
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314249	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of BAZ1B mRNA	PMID:35436446
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1597089	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of BAZ1B mRNA	PMID:30307764
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314249	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of BAZ1B mRNA	PMID:35964746
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314249	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of BAZ1B mRNA	PMID:19042947
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1314249	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of BAZ1B mRNA	PMID:20829426
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of BAZ1B protein	PMID:32959892
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of BAZ1B mRNA	PMID:15336504
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1314249	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of BAZ1B protein	PMID:26558463
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1314249	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of BAZ1B mRNA	PMID:26307267
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:6842	methoxychlor	affects expression	ISO	RGD:1314249	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor affects the expression of BAZ1B mRNA	PMID:20829426
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of BAZ1B protein	PMID:34122009
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314249	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of BAZ1B mRNA	PMID:22206623
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of BAZ1B protein	PMID:31285264
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1597089	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of BAZ1B mRNA	PMID:21346803
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of BAZ1B protein	PMID:31675489
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1597089	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of BAZ1B mRNA	PMID:23914054
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of BAZ1B protein	PMID:38348393
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1597089	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of BAZ1B mRNA	PMID:24780913
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1597089	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of BAZ1B mRNA	PMID:19281266
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1597089	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of BAZ1B mRNA	PMID:21346803
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:9288	streptozocin	affects expression	ISO	RGD:1314249	E	RGD:6480464	20150825	CTD	MESH:D013311	Streptozocin affects the expression of BAZ1B mRNA	PMID:26073000
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1314249	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of BAZ1B protein	PMID:24648495
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1597089	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of BAZ1B mRNA	PMID:21346803
1314248	BAZ1B	bromodomain adjacent to zinc finger domain 1B	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1597089	E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of BAZ1B mRNA	PMID:22615374
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of KRIT1 mRNA	PMID:38218311
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KRIT1 mRNA	PMID:38218311
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1614252	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of KRIT1 mRNA	PMID:33045310
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of KRIT1 mRNA	PMID:33167477
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of KRIT1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of KRIT1 mRNA	PMID:32699268
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:15571	hydrazine	increases expression	ISO	RGD:1614252	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in increased expression of KRIT1 mRNA	PMID:15282401
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:15891	taurine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013654	Taurine results in increased expression of KRIT1 mRNA	PMID:16579726
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of KRIT1 mRNA	PMID:22378314
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1614252	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of KRIT1 mRNA	PMID:30319688
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of KRIT1 mRNA	PMID:20044591
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:16240	hydrogen peroxide	increases secretion	ISO	RGD:1614252	E	RGD:6480464	20121218	CTD	MESH:D006861	Hydrogen Peroxide results in increased secretion of KRIT1 mRNA	PMID:21179422
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of KRIT1 mRNA	PMID:21632981
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KRIT1 mRNA	PMID:37042841
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of KRIT1 mRNA	PMID:21179406
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1614252	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of KRIT1 mRNA	PMID:23892564
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KRIT1 mRNA	PMID:31163220
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KRIT1 protein	PMID:37730182
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1614252	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of KRIT1 mRNA	PMID:28111341
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:2422	acetohydrazide	increases expression	ISO	RGD:1614252	E	RGD:6480464	20120412	CTD	MESH:C014949	acetylhydrazine results in increased expression of KRIT1 mRNA	PMID:15282401
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of KRIT1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of KRIT1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of KRIT1 mRNA	PMID:32699268
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KRIT1 mRNA	PMID:21867686
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1614252	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of KRIT1 mRNA	PMID:28960355
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of KRIT1 mRNA	PMID:23557933
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of KRIT1 mRNA	PMID:18000554
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614252	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KRIT1 mRNA	PMID:21570461|PMID:24680724
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305929	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KRIT1 mRNA	PMID:33387578
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KRIT1 mRNA	PMID:28001369
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of KRIT1 mRNA	PMID:33212167
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of KRIT1 protein	PMID:30528433
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1614252	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased expression of KRIT1 mRNA	PMID:32068019
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614252	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KRIT1 mRNA	PMID:22228805
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1614252	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of KRIT1 mRNA]	PMID:22228805
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KRIT1 mRNA	PMID:19150397|PMID:20018196
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1614252	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of KRIT1 gene	PMID:35295148
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305929	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of KRIT1 mRNA	PMID:34492290
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1614252	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of KRIT1 mRNA	PMID:23811191
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of KRIT1 mRNA	PMID:36232920
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305929	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KRIT1 mRNA	PMID:25181051|PMID:34947998
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:D010269	KRIT1 protein promotes the reaction [Paraquat results in increased expression of COL27A1 mRNA]; KRIT1 protein promotes the reaction [Paraquat results in increased expression of COL28A1 mRNA]	PMID:33495402
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KRIT1 mRNA	PMID:37042841
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1614252	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of KRIT1 mRNA	PMID:28111341
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of KRIT1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of KRIT1 mRNA	PMID:32699268
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of KRIT1 mRNA	PMID:27153767
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1614252	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of KRIT1 mRNA	PMID:36331819
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1305929	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of KRIT1 mRNA	PMID:23125180
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of KRIT1 mRNA	PMID:25562108
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1614252	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of KRIT1 mRNA	PMID:28973697
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1614252	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of KRIT1 mRNA	PMID:18502557
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of KRIT1 mRNA	PMID:21420995
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305929	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KRIT1 mRNA	PMID:33387578
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1614252	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of KRIT1 mRNA	PMID:29279043
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KRIT1 mRNA	PMID:22079256
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of KRIT1 mRNA	PMID:20977926
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1614252	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of KRIT1 mRNA	PMID:23650126
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1305929	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of KRIT1 mRNA	PMID:30467583
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1614252	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KRIT1 mRNA	PMID:22206623
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of KRIT1 mRNA	PMID:22079256
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KRIT1 mRNA	PMID:22079256
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KRIT1 gene]	PMID:28238834
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of KRIT1 mRNA	PMID:18927307
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1305929	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of KRIT1 mRNA	PMID:20345932
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of KRIT1 mRNA	PMID:26079696
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1614252	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of KRIT1 mRNA	PMID:21795629
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1614252	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of KRIT1 mRNA	PMID:21795629|PMID:30953684
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305929	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of KRIT1 mRNA	PMID:21346803
1314251	KRIT1	KRIT1 ankyrin repeat containing	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of KRIT1 mRNA	PMID:38568856
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SDCCAG3 mRNA	PMID:33167477
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ENTR1 mRNA	PMID:21179406
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:16243	quercetin	affects expression	ISO	RGD:1305930	E	RGD:6480464	20181113	CTD	MESH:D011794	Quercetin affects the expression of ENTR1 mRNA	PMID:18178720
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1620028	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ENTR1 mRNA	PMID:39241906
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ENTR1 mRNA	PMID:31614463
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ENTR1 mRNA	PMID:37042841
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1620028	E	RGD:6480464	20181113	CTD	MESH:D013739	Testosterone results in decreased expression of ENTR1 mRNA	PMID:20600201|PMID:21669218
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of ENTR1 protein	PMID:37730182
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305930	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ENTR1 mRNA	PMID:33387578
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ENTR1 mRNA	PMID:19549813
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ENTR1 protein	PMID:23301498
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305930	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ENTR1 mRNA	PMID:31150632
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1620028	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ENTR1 mRNA	PMID:40504410
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1620028	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SDCCAG3 mRNA	PMID:28960355
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ENTR1 mRNA	PMID:25583101
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620028	E	RGD:6480464	20181113	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ENTR1 mRNA	PMID:21570461
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ENTR1 mRNA	PMID:33212167
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305930	E	RGD:6480464	20181113	CTD	MESH:D020106	Acrylamide results in increased expression of ENTR1 mRNA	PMID:28959563
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1620028	E	RGD:6480464	20181113	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ENTR1 mRNA	PMID:27862939
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ENTR1 mRNA	PMID:29803840
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ENTR1 protein	PMID:35688186
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ENTR1 mRNA	PMID:38568856
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1620028	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ENTR1 mRNA	PMID:40504410
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ENTR1 mRNA	PMID:25895662
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1620028	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of ENTR1 mRNA	PMID:35295148
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1620028	E	RGD:6480464	20181113	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ENTR1 mRNA	PMID:18648102
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305930	E	RGD:6480464	20181113	CTD	MESH:C069837	fullerene C60 results in decreased expression of ENTR1 mRNA	PMID:19167457
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305930	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A affects the expression of ENTR1 mRNA	PMID:25181051
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305930	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in increased methylation of ENTR1 gene	PMID:28505145
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1305930	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of ENTR1 mRNA	PMID:30589522
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ENTR1 mRNA	PMID:38568856
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ENTR1 mRNA	PMID:26472689
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ENTR1 mRNA	PMID:19320972|PMID:19376846
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:36015	1,1,1-trichloroethane	increases expression	ISO	RGD:1620028	E	RGD:6480464	20181113	CTD	MESH:C024566	1,1,1-trichloroethane results in increased expression of ENTR1 mRNA	PMID:25270620
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of ENTR1 mRNA	PMID:17010196
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ENTR1 mRNA	PMID:31533062
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ENTR1 mRNA	PMID:23179753
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ENTR1 gene	PMID:29154799
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1620028	E	RGD:6480464	20181113	CTD	MESH:D013629	Tamoxifen affects the expression of ENTR1 mRNA	PMID:17555576
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:46195	paracetamol	affects response to substance	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	ENTR1 gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ENTR1 mRNA	PMID:29067470
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1620028	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ENTR1 mRNA	PMID:40504410
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of ENTR1 mRNA	PMID:18175754
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1620028	E	RGD:6480464	20181113	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ENTR1 mRNA	PMID:17555576
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305930	E	RGD:6480464	20181113	CTD	MESH:D005485	Flutamide results in increased expression of ENTR1 mRNA	PMID:24136188
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305930	E	RGD:6480464	20181113	CTD	MESH:C045463	Leflunomide results in increased expression of ENTR1 mRNA	PMID:24136188
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ENTR1 mRNA	PMID:31758290
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1305930	E	RGD:6480464	20181113	CTD	MESH:C051752	nefazodone results in increased expression of ENTR1 mRNA	PMID:24136188
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SDCCAG3 gene]	PMID:28238834
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of ENTR1 mRNA	PMID:39904859
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305930	E	RGD:6480464	20181113	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ENTR1 mRNA	PMID:21346803
1314253	ENTR1	endosome associated trafficking regulator 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ENTR1 mRNA	PMID:38568856
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314255	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ABCA9 mRNA	PMID:30319688
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314255	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ABCA9 mRNA	PMID:30319688
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:16359	cholic acid	multiple interactions	ISO	RGD:1314255	E	RGD:6480464	20190910	CTD	MESH:D019826	[NR1H4 protein mutant form inhibits the reaction [Cholic Acid results in increased phosphorylation of NR1H4 protein]] which results in decreased expression of ABCA9 mRNA	PMID:30996006
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314255	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ABCA9 mRNA	PMID:39241906
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314255	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ABCA9 mRNA	PMID:39298647
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ABCA9 mRNA	PMID:22017230
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314255	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ABCA9 mRNA	PMID:34319233
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:18291	manganese atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of ABCA9 mRNA	PMID:17175027
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of ABCA9 mRNA	PMID:24376830
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314255	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABCA9 mRNA	PMID:37236586
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314255	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ABCA9 mRNA	PMID:34911549
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1314255	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of ABCA9 mRNA	PMID:20857495
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ABCA9 mRNA	PMID:24768652|PMID:25583101
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ABCA9 mRNA	PMID:29803840
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314255	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABCA9 mRNA	PMID:39515575
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314255	E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in increased expression of ABCA9 mRNA	PMID:33145626
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ABCA9 promoter	PMID:27901495
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314255	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ABCA9 mRNA	PMID:20713471
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1314255	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of ABCA9 protein	PMID:37955338
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1314255	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of ABCA9 mRNA	PMID:20857495
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ABCA9 mRNA	PMID:20458559
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of ABCA9 mRNA	PMID:38568856
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314255	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ABCA9 mRNA	PMID:29264374
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305931	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ABCA9 mRNA	PMID:32145629
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305931	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ABCA9 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314255	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ABCA9 mRNA	PMID:30951980
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ABCA9 gene	PMID:31601247
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314255	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ABCA9 mRNA	PMID:30951980
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314255	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ABCA9 mRNA	PMID:30951980
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:35154	manganese(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of ABCA9 mRNA	PMID:17175027
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314255	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABCA9 mRNA	PMID:37236586
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314255	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ABCA9 mRNA	PMID:40194260
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314255	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ABCA9 mRNA	PMID:39529242
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314255	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ABCA9 mRNA	PMID:28973697
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ABCA9 mRNA	PMID:38832940
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ABCA9 mRNA	PMID:21420995
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ABCA9 mRNA	PMID:20458559
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314255	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ABCA9 mRNA	PMID:25554681
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314255	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of ABCA9 mRNA	PMID:40234311
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in increased expression of ABCA9 mRNA	PMID:17175027
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of ABCA9 mRNA	PMID:29522793
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:755540	docetaxel	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	[Docetaxel results in decreased susceptibility to Docetaxel] which results in increased expression of ABCA9 mRNA	PMID:19944135
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ABCA9 gene]	PMID:28238834
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305931	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ABCA9 mRNA	PMID:32109520
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314255	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ABCA9 mRNA	PMID:30294300
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314255	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ABCA9 mRNA	PMID:39847705
1314254	ABCA9	ATP binding cassette subfamily A member 9	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1314255	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of ABCA9 mRNA	PMID:28973697
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314268	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PLCL2 mRNA	PMID:33045310
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PLCL2 mRNA	PMID:36331819
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of PLCL2 mRNA	PMID:24763279
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PLCL2 mRNA	PMID:22378314
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314268	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PLCL2 mRNA	PMID:30319688
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314268	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PLCL2 mRNA	PMID:30319688
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314268	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PLCL2 mRNA	PMID:39241906
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PLCL2 mRNA]	PMID:39241906
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of PLCL2 mRNA	PMID:30510588
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305941	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLCL2 mRNA	PMID:32741896
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PLCL2 mRNA	PMID:37042841
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D005557	Formaldehyde results in decreased expression of PLCL2 mRNA	PMID:23416264
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PLCL2 mRNA	PMID:23649840
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:16899	D-mannitol	decreases expression	ISO	RGD:1314268	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in decreased expression of PLCL2 mRNA	PMID:25270620
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305941	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLCL2 mRNA	PMID:32741896
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLCL2 mRNA	PMID:39150890
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PLCL2 protein	PMID:37730182
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305941	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of PLCL2 mRNA	PMID:22061828
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLCL2 mRNA	PMID:36331819
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PLCL2 protein	PMID:20106945
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314268	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PLCL2 mRNA	PMID:19770486
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PLCL2 mRNA	PMID:23649840
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PLCL2 mRNA	PMID:35430440
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PLCL2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PLCL2 mRNA	PMID:34911549
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLCL2 mRNA	PMID:22206623
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PLCL2 mRNA	PMID:26272509
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLCL2 mRNA	PMID:27188386
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PLCL2 mRNA	PMID:27392435
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PLCL2 mRNA	PMID:27392435
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of PLCL2 mRNA	PMID:24768652
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305941	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLCL2 mRNA	PMID:32109520|PMID:33387578
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PLCL2 mRNA	PMID:28001369
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305941	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PLCL2 mRNA	PMID:28959563
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1305941	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper deficiency results in decreased expression of PLCL2 mRNA	PMID:19821111
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PLCL2 mRNA	PMID:20971185
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of PLCL2 protein	PMID:35688186
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:28876	melphalan	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of PLCL2 mRNA	PMID:22363485
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:29191	hydroxyl	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PLCL2-AS1 mRNA] which results in increased expression of PLCL2 mRNA	PMID:33656867
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PLCL2 mRNA	PMID:20106945
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PLCL2 exon	PMID:27901495
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PLCL2 promoter	PMID:27901495
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PLCL2 mRNA]	PMID:22228805
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1305941	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper deficiency results in decreased expression of PLCL2 mRNA	PMID:19821111
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PLCL2 mRNA	PMID:20971185
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PLCL2 mRNA	PMID:19150397
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305941	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PLCL2 mRNA	PMID:25729387
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305941	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PLCL2 mRNA	PMID:30047161
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314268	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of PLCL2 mRNA	PMID:23557971
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305941	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of PLCL2 mRNA	PMID:34492290
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1314268	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of PLCL2 mRNA	PMID:18648102
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314268	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PLCL2 mRNA	PMID:17950772
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLCL2 mRNA	PMID:19710929
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of PLCL2 mRNA]	PMID:17950772
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of PLCL2 mRNA	PMID:28329830
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305941	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PLCL2 mRNA	PMID:25181051
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PLCL2 mRNA	PMID:25979313
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314268	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PLCL2 intron	PMID:28392331
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLCL2 mRNA	PMID:39150890
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314268	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PLCL2 mRNA	PMID:21266533
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLCL2 mRNA	PMID:39150890
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLCL2 mRNA	PMID:39150890
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PLCL2 mRNA]	PMID:39241906
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLCL2 mRNA	PMID:39150890
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1305941	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of PLCL2 mRNA	PMID:30047161
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314268	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of PLCL2 mRNA	PMID:18353800
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314268	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PLCL2 mRNA	PMID:40194260
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PLCL2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PLCL2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of PLCL2 mRNA	PMID:36331819
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314268	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of PLCL2 mRNA	PMID:29038090
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PLCL2 mRNA	PMID:25979313
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLCL2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:27188386|PMID:28001369|PMID:29154799
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PLCL2 gene	PMID:29154799
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305941	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PLCL2 mRNA	PMID:30047161
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PLCL2 mRNA	PMID:20106945
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PLCL2 mRNA	PMID:38832940
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of PLCL2 mRNA	PMID:24935251
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of PLCL2-AS1 mRNA] which results in increased expression of PLCL2 mRNA	PMID:33656867
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLCL2 mRNA	PMID:21420995
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of PLCL2 mRNA	PMID:24714768
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314268	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PLCL2 mRNA	PMID:25554681
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305941	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PLCL2 mRNA	PMID:30047161
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314268	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of PLCL2 mRNA	PMID:38701926
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of PLCL2 mRNA	PMID:20436886
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1305941	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of PLCL2 mRNA	PMID:25729387
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305941	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PLCL2 mRNA	PMID:25729387
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314268	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PLCL2 mRNA	PMID:22206623
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PLCL2 mRNA	PMID:22206623
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of PLCL2 mRNA	PMID:22714537
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305941	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLCL2 mRNA	PMID:32741896
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLCL2 mRNA	PMID:27188386
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PLCL2 mRNA	PMID:39150890
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PLCL2 gene]	PMID:28238834
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1314268	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of PLCL2 mRNA	PMID:19482888
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of PLCL2 mRNA]	PMID:19482888
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305941	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PLCL2 mRNA	PMID:30047161
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314268	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PLCL2 mRNA]	PMID:39241906
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLCL2 mRNA	PMID:27188386
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305941	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PLCL2 mRNA	PMID:21346803
1314267	PLCL2	phospholipase C like 2	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PLCL2 mRNA	PMID:29301935
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314270	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RAI14 mRNA	PMID:33045310
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305942	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RAI14 mRNA]	PMID:31150632
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314270	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RAI14 mRNA	PMID:20188158
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of RAI14 mRNA	PMID:23724009
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of RAI14 mRNA	PMID:23830798
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305942	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of RAI14 mRNA	PMID:33729688
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1314270	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of RAI14 protein	PMID:31494107
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RAI14 mRNA	PMID:21632981
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of RAI14 protein	PMID:35688186
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314270	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RAI14 mRNA	PMID:39241906
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314270	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of RAI14 mRNA]	PMID:39241906
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of RAI14 mRNA	PMID:14699072
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of RAI14 mRNA	PMID:19619570|PMID:24758408|PMID:31614463
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314270	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RAI14 mRNA	PMID:39298647
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of RAI14 mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of RAI14 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of RAI14 mRNA; EGF protein promotes the reaction [Estradiol results in increased expression of RAI14 mRNA]	PMID:19619570|PMID:20660070|PMID:24758408|PMID:30165855
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of RAI14 mRNA	PMID:20660070
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of RAI14 mRNA	PMID:21592394
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of RAI14 mRNA	PMID:21592394
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305942	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of RAI14 mRNA	PMID:26577399
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RAI14 protein	PMID:37730182
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of RAI14 mRNA	PMID:21592394
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of RAI14 mRNA	PMID:21592394
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305942	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RAI14 mRNA	PMID:33387578
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RAI14 mRNA	PMID:28818685
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAI14 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RAI14 mRNA	PMID:39836092
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:188851	Muraglitazar	decreases expression	ISO	RGD:1305942	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of RAI14 mRNA	PMID:21515302
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RAI14 mRNA	PMID:19549813
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RAI14 mRNA	PMID:22100608
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RAI14 intron	PMID:30157460
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	ISO	RGD:1305942	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of RAI14 mRNA	PMID:15651846
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305942	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RAI14 mRNA	PMID:31150632
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305942	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RAI14 mRNA]	PMID:31150632
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314270	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RAI14 mRNA	PMID:25629700
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314270	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RAI14 mRNA	PMID:22206623
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1314270	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of RAI14 mRNA	PMID:19654921
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAI14 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RAI14 mRNA	PMID:32525701|PMID:39836092
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of RAI14 protein	PMID:35688186
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RAI14 mRNA	PMID:28903495
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of RAI14 mRNA	PMID:19561079
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RAI14 mRNA	PMID:27392435
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1305942	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of RAI14 mRNA	PMID:17898221
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314270	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of RAI14 mRNA	PMID:32186404
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305942	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAI14 mRNA	PMID:34747641
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314270	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAI14 mRNA	PMID:21570461
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314270	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RAI14 mRNA	PMID:27913140
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAI14 mRNA	PMID:19619570
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305942	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAI14 mRNA	PMID:33387578
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314270	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAI14 mRNA	PMID:19465110
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of RAI14 mRNA	PMID:19619570
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314270	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RAI14 mRNA	PMID:17942748
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RAI14 mRNA	PMID:33212167
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305942	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of RAI14 mRNA	PMID:28959563
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RAI14 mRNA	PMID:29803840
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314270	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of RAI14 mRNA	PMID:39631538
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of RAI14 protein	PMID:35688186
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:29287	gold atom	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D006046	Gold results in increased expression of RAI14 mRNA	PMID:29705079
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RAI14 mRNA; sodium arsenite results in increased expression of RAI14 protein	PMID:38568856|PMID:39571964
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAI14 mRNA	PMID:39836092
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RAI14 intron; Benzo(a)pyrene affects the methylation of RAI14 promoter	PMID:27901495|PMID:30157460
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RAI14 mRNA	PMID:20064835
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314270	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RAI14 exon; Benzo(a)pyrene results in increased methylation of RAI14 intron	PMID:27901495
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314270	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to RAI14 promoter]	PMID:19654925
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1314270	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of RAI14 protein	PMID:37955338
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of RAI14 promoter	PMID:23974009
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:30050	gold(0)	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D006046	Gold results in increased expression of RAI14 mRNA	PMID:29705079
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of RAI14 mRNA	PMID:25895662
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RAI14 gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of RAI14 gene	PMID:31601247
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of RAI14 mRNA	PMID:38568856
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305942	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of RAI14 mRNA	PMID:25729387
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305942	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RAI14 mRNA	PMID:25729387
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:32195	Tesaglitazar	decreases expression	ISO	RGD:1305942	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of RAI14 mRNA	PMID:21515302
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1314270	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of RAI14 promoter	PMID:35295148
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305942	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RAI14 mRNA	PMID:34492290
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314270	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RAI14 mRNA	PMID:18301758
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of RAI14 mRNA	PMID:25047013
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of RAI14 gene	PMID:31601247
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of RAI14 protein	PMID:34186270
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305942	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RAI14 mRNA	PMID:25181051|PMID:32145629|PMID:34947998
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314270	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RAI14 mRNA	PMID:26063408
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305942	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RAI14 gene	PMID:28505145
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of RAI14 gene	PMID:31601247
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of RAI14 protein	PMID:31675489
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of RAI14 mRNA	PMID:19244175
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RAI14 protein	PMID:34186270
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of RAI14 gene	PMID:31601247
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RAI14 protein	PMID:34186270
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314270	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of RAI14 mRNA	PMID:28392331
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305942	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RAI14 mRNA	PMID:21266533
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314270	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RAI14 mRNA	PMID:21266533
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314270	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of RAI14 mRNA	PMID:34813904
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314270	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of RAI14 mRNA]	PMID:39241906
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of RAI14 mRNA	PMID:29024780
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAI14 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RAI14 mRNA	PMID:39836092
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RAI14 mRNA	PMID:19320972
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305942	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of RAI14 mRNA	PMID:24386269
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RAI14 mRNA	PMID:31533062
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of RAI14 mRNA	PMID:26352163
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RAI14 mRNA	PMID:40419075
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RAI14 mRNA	PMID:25979313
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of RAI14 mRNA	PMID:22147139
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RAI14 mRNA	PMID:25562108
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of RAI14 mRNA	PMID:25047013
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RAI14 mRNA	PMID:38832940
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen affects the expression of RAI14 mRNA	PMID:25704631
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314270	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RAI14 mRNA	PMID:17562736
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305942	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RAI14 mRNA	PMID:33387578
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RAI14 mRNA	PMID:22230336
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of RAI14 mRNA	PMID:24714768
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314270	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of RAI14 mRNA	PMID:29279043
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1314270	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of RAI14 mRNA	PMID:19654921
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAI14 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RAI14 mRNA	PMID:32525701|PMID:39836092
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of RAI14 mRNA	PMID:31675489
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314270	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RAI14 mRNA	PMID:35436446
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314270	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RAI14 mRNA	PMID:17942748
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305942	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of RAI14 mRNA	PMID:22504374
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305942	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of RAI14 mRNA	PMID:24793618
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314270	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of RAI14 mRNA	PMID:23608068
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAI14 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of RAI14 mRNA	PMID:39836092
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	RAI14 protein affects the susceptibility to Topotecan	PMID:16217747
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305942	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of RAI14 mRNA	PMID:25729387
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305942	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RAI14 mRNA	PMID:25729387
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1314270	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of RAI14 mRNA	PMID:22078008
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RAI14 protein	PMID:34186270
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314270	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RAI14 mRNA	PMID:22206623
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:75253	phenylarsine oxide	increases expression	ISO	RGD:1314270	E	RGD:6480464	20251007	CTD	MESH:C029341	oxophenylarsine results in increased expression of RAI14 mRNA	PMID:37699712
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of RAI14 mRNA	PMID:32858204
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RAI14 gene]	PMID:28238834
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of RAI14 mRNA	PMID:19159669
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314270	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of RAI14 mRNA	PMID:23091169
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:8093	phenylephrine	increases expression	ISO	RGD:1305942	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in increased expression of RAI14 mRNA	PMID:18158353
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1305942	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of RAI14 mRNA	PMID:27291303
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of RAI14 protein	PMID:31675489
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of RAI14 protein	PMID:31675489
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305942	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of RAI14 mRNA	PMID:23914054
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:84070	sodium arsenate	affects expression	ISO	RGD:1314270	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate affects the expression of RAI14 mRNA	PMID:39847705
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314270	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of RAI14 mRNA	PMID:21795629
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of RAI14 mRNA	PMID:32525701
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305942	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RAI14 mRNA	PMID:22504374|PMID:24780913|PMID:25825206
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314270	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of RAI14 mRNA]	PMID:39241906
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RAI14 mRNA	PMID:38568856
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314270	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of RAI14 mRNA	PMID:28973697
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305942	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RAI14 mRNA	PMID:19015723
1314269	RAI14	retinoic acid induced 14	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305942	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of RAI14 mRNA	PMID:23034163
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of NCF4 mRNA	PMID:35967413
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of NCF4 mRNA	PMID:34925699
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NCF4 mRNA	PMID:20938992
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of NCF4 mRNA	PMID:33167477
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1593157	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of NCF4 mRNA	PMID:33729688
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20230117	CTD	MESH:D011794	Quercetin inhibits the reaction [o,p'-DDT results in increased expression of NCF4 mRNA]	PMID:35122929
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1593157	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NCF4 mRNA	PMID:32741896
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20150714	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of NCF4 mRNA	PMID:25386960
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NCF4 mRNA	PMID:20938992
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NCF4 mRNA	PMID:37042841
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NCF4 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of NCF4 mRNA	PMID:37567420|PMID:37992649
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1593157	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NCF4 mRNA	PMID:32741896
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NCF4 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of NCF4 mRNA	PMID:37567420|PMID:37992649
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1593157	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of NCF4 mRNA	PMID:27523638
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:18406	AICA ribonucleotide	multiple interactions	ISO	RGD:1593157	E	RGD:6480464	20120717	CTD	MESH:C031143	AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of NCF4 protein]	PMID:21195169
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1314272	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of NCF4 mRNA	PMID:39984025
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NCF4 mRNA	PMID:35301059
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of NCF4 mRNA	PMID:23649840
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of NCF4 mRNA	PMID:23033980
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of NCF4 mRNA	PMID:35430440
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NCF4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of NCF4 mRNA	PMID:34911549
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1593157	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of NCF4 mRNA	PMID:30779732
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NCF4 mRNA	PMID:20938992
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NCF4 mRNA	PMID:40504410
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1593157	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of NCF4 mRNA	PMID:31881176
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1314272	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of NCF4 protein	PMID:18952886
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of NCF4 mRNA	PMID:24768652|PMID:25583101
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314272	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NCF4 mRNA	PMID:21570461|PMID:26377647
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1593157	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NCF4 mRNA	PMID:34747641
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314272	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NCF4 mRNA	PMID:16120747|PMID:26290441
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1593157	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NCF4 mRNA	PMID:32109520
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NCF4 mRNA	PMID:17942748
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1593157	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of NCF4 mRNA	PMID:30556269
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314272	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of NCF4 mRNA	PMID:39631538
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NCF4 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of NCF4 mRNA	PMID:37567420|PMID:37992649
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:28939	N-acetyl-L-cysteine	decreases expression	ISO	RGD:1593157	E	RGD:6480464	20120717	CTD	MESH:D000111	Acetylcysteine results in decreased expression of NCF4 protein	PMID:21195169
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1593157	E	RGD:6480464	20120717	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of NCF4 protein]	PMID:21195169
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NCF4 mRNA	PMID:40504410
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NCF4 promoter	PMID:27901495
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NCF4 mRNA	PMID:22316170
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314272	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NCF4 mRNA	PMID:22228805|PMID:32417428|PMID:35567930
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1593157	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of NCF4 mRNA	PMID:30556269
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314272	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NCF4 mRNA	PMID:23221170
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1593157	E	RGD:6480464	20210706	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NCF4 mRNA	PMID:32721576
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NCF4 gene	PMID:31601247
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1593157	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of NCF4 mRNA	PMID:30047161
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314272	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of NCF4 mRNA	PMID:23557971
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1593157	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of NCF4 mRNA	PMID:34492290
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314272	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of NCF4 mRNA	PMID:18648102
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314272	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of NCF4 mRNA	PMID:17426115
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:33007	chromium(6+)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of NCF4 protein	PMID:21742780
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1593157	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NCF4 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314272	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of NCF4 mRNA	PMID:32156529
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1593157	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of NCF4 mRNA	PMID:32145629
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NCF4 gene	PMID:31601247
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C016340	o,p'-DDT results in increased expression of NCF4 mRNA	PMID:35122929
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	multiple interactions	EXP		E	RGD:6480464	20230117	CTD	MESH:C016340	Quercetin inhibits the reaction [o,p'-DDT results in increased expression of NCF4 mRNA]	PMID:35122929
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314272	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of NCF4 mRNA	PMID:26682919
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of NCF4 mRNA	PMID:30821169
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1314272	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of NCF4 mRNA	PMID:20713471
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NCF4 mRNA	PMID:30821169
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of NCF4 intron	PMID:30157460
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1314272	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of NCF4 mRNA	PMID:26377693
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314272	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NCF4 mRNA	PMID:32715474
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D010269	Paraquat results in increased expression of NCF4 mRNA	PMID:34097952
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314272	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of NCF4 protein	PMID:39748354
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NCF4 mRNA	PMID:37042841
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NCF4 protein	PMID:21195169
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1593157	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NCF4 protein	PMID:21195169
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NCF4 mRNA	PMID:35301059
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1593157	E	RGD:6480464	20120717	CTD	MESH:D019256	Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of NCF4 protein]; AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of NCF4 protein]; PTEN inhibits the reaction [Cadmium Chloride results in increased expression of NCF4 protein]; Sirolimus inhibits the reaction [Cadmium Chloride results in increased expression of NCF4 protein]	PMID:21195169
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1593157	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of NCF4 mRNA	PMID:30047161
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of NCF4 mRNA	PMID:24449571
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314272	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of NCF4 mRNA	PMID:29038090
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1314272	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of NCF4 mRNA	PMID:23125180
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in decreased expression of NCF4 mRNA	PMID:17685462
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NCF4 gene	PMID:29154799
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1593157	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NCF4 mRNA	PMID:30047161
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314272	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of NCF4 mRNA	PMID:17555576
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NCF4 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of NCF4 mRNA	PMID:37567420|PMID:37992649
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of NCF4 mRNA	PMID:17400583
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of NCF4 mRNA	PMID:21678067
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314272	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NCF4 mRNA	PMID:17562736
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314272	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of NCF4 mRNA	PMID:29279043
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NCF4 mRNA	PMID:40504410
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1314272	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of NCF4 mRNA	PMID:26934552
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314272	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NCF4 mRNA	PMID:17555576
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314272	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NCF4 mRNA	PMID:17942748
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1593157	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NCF4 mRNA	PMID:17557909
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NCF4 mRNA	PMID:17942748
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1593157	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in increased expression of NCF4 mRNA	PMID:36868495
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate affects the reaction [MTF1 affects the expression of NCF4 mRNA]	PMID:16221973
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314272	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NCF4 mRNA; Nanotubes, Carbon results in increased expression of NCF4 mRNA	PMID:25554681
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1593157	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NCF4 mRNA	PMID:30047161
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314272	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of NCF4 mRNA	PMID:40234311
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NCF4 mRNA	PMID:35964746
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of NCF4 mRNA	PMID:20977926
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:53490	N-formyl-L-methionyl-L-leucyl-L-phenylalanine	affects localization	ISO	RGD:1593157	E	RGD:6480464	20240806	CTD	MESH:D009240	N-Formylmethionine Leucyl-Phenylalanine affects the localization of NCF4 protein	PMID:19445920
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:53490	N-formyl-L-methionyl-L-leucyl-L-phenylalanine	multiple interactions	ISO	RGD:1593157	E	RGD:6480464	20240806	CTD	MESH:D009240	2-benzyl-3-(4-hydroxymethylphenyl)indazole inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine affects the localization of NCF4 protein]	PMID:19445920
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314272	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of NCF4 mRNA	PMID:38701926
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1593157	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of NCF4 mRNA	PMID:28801915
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314272	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of NCF4 mRNA	PMID:14729362
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of NCF4 intron	PMID:30157460
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1314272	E	RGD:6480464	20231031	CTD	MESH:C057862	cyanoginosin LR results in increased expression of NCF4 mRNA	PMID:37342990
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314272	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NCF4 mRNA	PMID:22206623
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1314272	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of NCF4 mRNA	PMID:37567420
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1593157	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NCF4 mRNA	PMID:32741896
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NCF4 gene]	PMID:28238834
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of NCF4 mRNA	PMID:30821169|PMID:31251971
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:C070055	AHR protein affects the reaction [2,3',4,4',5-pentachlorobiphenyl results in increased expression of NCF4 mRNA]	PMID:31251971
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1593157	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of NCF4 mRNA	PMID:24780913
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1593157	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of NCF4 mRNA	PMID:30047161
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1314272	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of NCF4 protein	PMID:35357534
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1593157	E	RGD:6480464	20120717	CTD	MESH:D020123	Sirolimus inhibits the reaction [Cadmium Chloride results in increased expression of NCF4 protein]	PMID:21195169
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1593157	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of NCF4 mRNA	PMID:19281266
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1593157	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of NCF4 gene	PMID:31079544
1314271	NCF4	neutrophil cytosolic factor 4	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1593157	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of NCF4 mRNA	PMID:23034163
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MRM2 mRNA	PMID:38218311
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550350	E	RGD:6480464	20160822	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MRM2 gene	PMID:20938992
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550350	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRM2 mRNA	PMID:36331819
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRM2 mRNA	PMID:22378314
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550350	E	RGD:6480464	20160822	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MRM2 gene	PMID:20938992
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MRM2 mRNA	PMID:37042841
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:16708	adenine	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D000225	Adenine results in decreased expression of MRM2 mRNA	PMID:24211769
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of MRM2 mRNA	PMID:20655997
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305944	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MRM2 mRNA	PMID:33387578
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MRM2 mRNA	PMID:19549813
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MRM2 mRNA	PMID:24211769
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MRM2 mRNA	PMID:22100608
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1550350	E	RGD:6480464	20160822	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MRM2 mRNA	PMID:19770486
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MRM2 mRNA	PMID:24211769
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550350	E	RGD:6480464	20160822	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MRM2 gene	PMID:20938992
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:27504	mitomycin C	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D016685	Mitomycin results in decreased expression of MRM2 mRNA	PMID:24211769
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:27882	(S)-colchicine	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D003078	Colchicine results in decreased expression of MRM2 mRNA	PMID:24211769
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of MRM2 mRNA	PMID:19921347
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin results in decreased expression of MRM2 mRNA	PMID:24211769
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1550350	E	RGD:6480464	20160822	CTD	MESH:D003042	Cocaine results in increased expression of MRM2 mRNA	PMID:20056891
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305944	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRM2 mRNA	PMID:33387578
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1550350	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of MRM2 mRNA	PMID:32937126
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MRM2 mRNA]	PMID:32406909
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of MRM2 mRNA	PMID:35984750
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305944	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MRM2 mRNA	PMID:34492290
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550350	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRM2 mRNA	PMID:39298647
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305944	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MRM2 mRNA	PMID:35163327
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305944	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MRM2 mRNA	PMID:35163327
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MRM2 mRNA	PMID:19376846
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of MRM2 mRNA	PMID:19167446
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRM2 mRNA	PMID:19167446
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550350	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRM2 mRNA	PMID:36331819
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRM2 mRNA	PMID:25979313
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MRM2 gene	PMID:29154799
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MRM2 mRNA	PMID:25562108
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:44423	hydroxyurea	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D006918	Hydroxyurea results in decreased expression of MRM2 mRNA	PMID:24211769
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550350	E	RGD:6480464	20160822	CTD	MESH:D000082	Acetaminophen affects the expression of MRM2 mRNA	PMID:17562736
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:4911	etoposide	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D005047	Etoposide results in decreased expression of MRM2 mRNA	PMID:24211769
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1550350	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of MRM2 mRNA	PMID:40234311
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305944	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MRM2 mRNA	PMID:24136188
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of MRM2 mRNA	PMID:28988120|PMID:29427785
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MRM2 mRNA	PMID:31758290
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of MRM2 mRNA	PMID:36318118
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MRM2 gene]	PMID:28238834
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MRM2 mRNA	PMID:19167446
1314273	MRM2	mitochondrial rRNA methyltransferase 2	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of MRM2 mRNA	PMID:24921660
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SLAMF9 mRNA	PMID:38218311
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:125472	N-(6-acetamidohexyl)acetamide	decreases expression	ISO	RGD:1314276	E	RGD:6480464	20170228	CTD	MESH:C014026	hexamethylene bisacetamide results in decreased expression of SLAMF9 mRNA	PMID:26941288
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314276	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SLAMF9 mRNA	PMID:33045310
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314276	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLAMF9 mRNA	PMID:20938992
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314276	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of SLAMF9 mRNA	PMID:30517762
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SLAMF9 mRNA	PMID:30165855
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305945	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLAMF9 mRNA	PMID:32741896
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305945	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLAMF9 mRNA	PMID:33387578
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314276	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLAMF9 mRNA	PMID:20938992
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314276	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLAMF9 mRNA	PMID:37992649
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305945	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLAMF9 mRNA	PMID:32741896
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314276	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLAMF9 mRNA	PMID:37992649
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305945	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLAMF9 mRNA	PMID:39012411
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314276	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLAMF9 mRNA	PMID:19770486
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of SLAMF9 mRNA	PMID:25102026
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305945	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of SLAMF9 mRNA	PMID:30779732
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314276	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SLAMF9 mRNA	PMID:31919559
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1314276	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of SLAMF9 mRNA	PMID:30517762
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314276	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLAMF9 mRNA	PMID:20938992
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314276	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLAMF9 mRNA	PMID:40504410
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314276	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SLAMF9 mRNA	PMID:28960355
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305945	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLAMF9 mRNA	PMID:31881176
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SLAMF9 mRNA	PMID:23557933
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314276	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of SLAMF9 mRNA	PMID:40618947
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314276	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLAMF9 mRNA	PMID:21570461|PMID:23238561|PMID:26377647
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305945	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLAMF9 mRNA	PMID:23238561|PMID:34747641
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1305945	E	RGD:6480464	20200211	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SLAMF9 mRNA	PMID:31378766
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1305945	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SLAMF9 mRNA	PMID:30556269
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314276	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLAMF9 mRNA	PMID:39631538
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314276	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLAMF9 mRNA	PMID:37992649
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314276	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLAMF9 mRNA	PMID:40504410
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314276	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLAMF9 mRNA	PMID:21569818
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314276	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLAMF9 mRNA	PMID:23735875
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLAMF9 3' UTR; Benzo(a)pyrene results in increased methylation of SLAMF9 promoter	PMID:27901495
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1305945	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SLAMF9 mRNA	PMID:30556269
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1305945	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of SLAMF9 mRNA	PMID:25729387
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305945	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SLAMF9 mRNA	PMID:25729387
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1305945	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of SLAMF9 mRNA	PMID:30012374
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314276	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SLAMF9 mRNA	PMID:23557971
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305945	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SLAMF9 mRNA	PMID:34492290
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305945	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SLAMF9 mRNA	PMID:25380136
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305945	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLAMF9 mRNA	PMID:25181051|PMID:32145629
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305945	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SLAMF9 mRNA	PMID:30816183|PMID:32528016
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314276	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with LIF protein] results in decreased expression of SLAMF9 mRNA	PMID:30951980
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLAMF9 mRNA	PMID:38174414
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305945	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLAMF9 mRNA	PMID:39012411
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305945	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of SLAMF9 mRNA	PMID:26194646|PMID:27387713
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1305945	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of SLAMF9 mRNA	PMID:25380136
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314276	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLAMF9 mRNA	PMID:37992649
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1314276	E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SLAMF9 mRNA	PMID:26941288
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1305945	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of SLAMF9 mRNA	PMID:21346803
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314276	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLAMF9 mRNA	PMID:17562736
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314276	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SLAMF9 mRNA	PMID:40504410
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305945	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SLAMF9 mRNA	PMID:17557909
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1314276	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of SLAMF9 mRNA; Nanotubes, Carbon analog affects the expression of SLAMF9 mRNA	PMID:25554681
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314276	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SLAMF9 mRNA	PMID:38701926
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:63613	nevirapine	decreases expression	ISO	RGD:1305945	E	RGD:6480464	20140114	CTD	MESH:D019829	Nevirapine results in decreased expression of SLAMF9 mRNA	PMID:23947594
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1305945	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of SLAMF9 mRNA	PMID:25729387
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305945	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SLAMF9 mRNA	PMID:25729387
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1314276	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of SLAMF9 mRNA	PMID:23650126
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314276	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of SLAMF9 mRNA	PMID:36851058
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305945	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of SLAMF9 mRNA	PMID:35283115
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314276	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SLAMF9 mRNA	PMID:22206623
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305945	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLAMF9 mRNA	PMID:32741896
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLAMF9 gene]	PMID:28238834
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314276	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SLAMF9 mRNA	PMID:38648751
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of SLAMF9 mRNA	PMID:32234424
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314276	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SLAMF9 mRNA	PMID:39847705
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305945	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SLAMF9 mRNA	PMID:19281266
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314276	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SLAMF9 mRNA	PMID:35537566
1314275	SLAMF9	SLAM family member 9	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305945	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SLAMF9 mRNA	PMID:22615374|PMID:23034163
1314277	EFNA2	ephrin A2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314278	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of EFNA2 mRNA	PMID:33045310
1314277	EFNA2	ephrin A2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314278	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EFNA2 gene	PMID:20938992
1314277	EFNA2	ephrin A2	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1314278	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of EFNA2 mRNA	PMID:15282401
1314277	EFNA2	ephrin A2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EFNA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of EFNA2 mRNA	PMID:35811015
1314277	EFNA2	ephrin A2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of EFNA2 mRNA	PMID:31614463
1314277	EFNA2	ephrin A2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:620389	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of EFNA2 mRNA	PMID:33387578
1314277	EFNA2	ephrin A2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314278	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EFNA2 gene	PMID:20938992
1314277	EFNA2	ephrin A2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314278	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EFNA2 mRNA	PMID:37992649
1314277	EFNA2	ephrin A2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314278	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EFNA2 mRNA	PMID:37992649
1314277	EFNA2	ephrin A2	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of EFNA2 mRNA	PMID:23825647
1314277	EFNA2	ephrin A2	gene	CHEBI:17833	gentamycin	affects expression	ISO	RGD:620389	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins affects the expression of EFNA2 mRNA	PMID:33387578
1314277	EFNA2	ephrin A2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EFNA2 mRNA	PMID:28818685
1314277	EFNA2	ephrin A2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314278	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EFNA2 mRNA	PMID:36331819
1314277	EFNA2	ephrin A2	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of EFNA2 mRNA	PMID:23825647
1314277	EFNA2	ephrin A2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314278	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EFNA2 gene	PMID:20938992
1314277	EFNA2	ephrin A2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of EFNA2 mRNA	PMID:26272509
1314277	EFNA2	ephrin A2	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:620389	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of EFNA2 gene	PMID:31011160
1314277	EFNA2	ephrin A2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:620389	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of EFNA2 mRNA	PMID:31881176
1314277	EFNA2	ephrin A2	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20140513	CTD	MESH:D007854	Lead affects the methylation of EFNA2 gene	PMID:24519525
1314277	EFNA2	ephrin A2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of EFNA2 mRNA	PMID:27392435
1314277	EFNA2	ephrin A2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of EFNA2 mRNA	PMID:27392435
1314277	EFNA2	ephrin A2	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:620389	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of EFNA2 mRNA	PMID:15691709
1314277	EFNA2	ephrin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314278	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EFNA2 mRNA	PMID:21570461
1314277	EFNA2	ephrin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314278	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EFNA2 mRNA	PMID:19933214
1314277	EFNA2	ephrin A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:620389	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EFNA2 mRNA	PMID:32109520
1314277	EFNA2	ephrin A2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:620389	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of EFNA2 mRNA	PMID:26033743
1314277	EFNA2	ephrin A2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314278	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EFNA2 mRNA	PMID:37992649
1314277	EFNA2	ephrin A2	gene	CHEBI:28876	melphalan	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in increased expression of EFNA2 mRNA	PMID:22363485
1314277	EFNA2	ephrin A2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EFNA2 mRNA	PMID:38568856
1314277	EFNA2	ephrin A2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EFNA2 promoter	PMID:27901495
1314277	EFNA2	ephrin A2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EFNA2 exon	PMID:27901495
1314277	EFNA2	ephrin A2	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1314278	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of EFNA2 mRNA	PMID:18929588
1314277	EFNA2	ephrin A2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1314278	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in decreased expression of EFNA2 mRNA]	PMID:18929588
1314277	EFNA2	ephrin A2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:620389	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of EFNA2 mRNA	PMID:26033743
1314277	EFNA2	ephrin A2	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:620389	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of EFNA2 mRNA	PMID:16483693
1314277	EFNA2	ephrin A2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of EFNA2 gene	PMID:31601247
1314277	EFNA2	ephrin A2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314278	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EFNA2 gene	PMID:35295148
1314277	EFNA2	ephrin A2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:620389	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EFNA2 mRNA	PMID:34492290
1314277	EFNA2	ephrin A2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314278	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of EFNA2 mRNA	PMID:28329830
1314277	EFNA2	ephrin A2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:620389	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EFNA2 mRNA	PMID:25181051
1314277	EFNA2	ephrin A2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314278	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of EFNA2 mRNA	PMID:32156529
1314277	EFNA2	ephrin A2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:620389	E	RGD:6480464	20241203	CTD	MESH:C006780	bisphenol A results in increased expression of EFNA2 mRNA	PMID:37105472
1314277	EFNA2	ephrin A2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:620389	E	RGD:6480464	20241203	CTD	MESH:C006780	cyanidin-3-O-beta-glucopyranoside inhibits the reaction [bisphenol A results in increased expression of EFNA2 mRNA]; protocatechuic acid inhibits the reaction [bisphenol A results in increased expression of EFNA2 mRNA]	PMID:37105472
1314277	EFNA2	ephrin A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314278	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of EFNA2 mRNA	PMID:39298647
1314277	EFNA2	ephrin A2	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of EFNA2 intron	PMID:30157460
1314277	EFNA2	ephrin A2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of EFNA2 gene	PMID:31601247
1314277	EFNA2	ephrin A2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of EFNA2 gene	PMID:22964155
1314277	EFNA2	ephrin A2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314278	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EFNA2 mRNA	PMID:17361019|PMID:21266533
1314277	EFNA2	ephrin A2	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1314278	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of EFNA2 gene	PMID:38995845
1314277	EFNA2	ephrin A2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of EFNA2 mRNA	PMID:29024780
1314277	EFNA2	ephrin A2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:620389	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of EFNA2 mRNA	PMID:27387713
1314277	EFNA2	ephrin A2	gene	CHEBI:36062	3,4-dihydroxybenzoic acid	multiple interactions	ISO	RGD:620389	E	RGD:6480464	20241203	CTD	MESH:C009091	protocatechuic acid inhibits the reaction [bisphenol A results in increased expression of EFNA2 mRNA]	PMID:37105472
1314277	EFNA2	ephrin A2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314278	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of EFNA2 mRNA	PMID:28962523
1314277	EFNA2	ephrin A2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314278	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of EFNA2 mRNA	PMID:40194260
1314277	EFNA2	ephrin A2	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of EFNA2 mRNA	PMID:28302478
1314277	EFNA2	ephrin A2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of EFNA2 mRNA	PMID:31533062
1314277	EFNA2	ephrin A2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314278	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EFNA2 mRNA	PMID:36331819
1314277	EFNA2	ephrin A2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of EFNA2 mRNA	PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799
1314277	EFNA2	ephrin A2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of EFNA2 gene	PMID:29154799
1314277	EFNA2	ephrin A2	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of EFNA2 promoter	PMID:27989131
1314277	EFNA2	ephrin A2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314278	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EFNA2 mRNA	PMID:37992649
1314277	EFNA2	ephrin A2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of EFNA2 mRNA	PMID:22230336
1314277	EFNA2	ephrin A2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:620389	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EFNA2 mRNA	PMID:33387578
1314277	EFNA2	ephrin A2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of EFNA2 mRNA	PMID:33725128|PMID:35811015
1314277	EFNA2	ephrin A2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EFNA2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of EFNA2 mRNA	PMID:35811015
1314277	EFNA2	ephrin A2	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of EFNA2 mRNA	PMID:26272509
1314277	EFNA2	ephrin A2	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:620389	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of EFNA2 mRNA	PMID:20080153
1314277	EFNA2	ephrin A2	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of EFNA2 intron	PMID:30157460
1314277	EFNA2	ephrin A2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of EFNA2 mRNA	PMID:37199045
1314277	EFNA2	ephrin A2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:620389	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of EFNA2 mRNA	PMID:32109520
1314277	EFNA2	ephrin A2	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of EFNA2 mRNA	PMID:24834073
1314277	EFNA2	ephrin A2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:620389	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of EFNA2 mRNA	PMID:24780913
1314277	EFNA2	ephrin A2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of EFNA2 mRNA	PMID:38568856
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of IFT57 mRNA	PMID:26272509
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA	PMID:27188386
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314280	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IFT57 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of IFT57 gene	PMID:20938992
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of IFT57 mRNA	PMID:21934132|PMID:33167477
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of IFT57 mRNA	PMID:26079696
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of IFT57 protein	PMID:18951874
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of IFT57 mRNA	PMID:29581250
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314280	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IFT57 mRNA	PMID:39241906
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314280	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IFT57 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of IFT57 gene	PMID:20938992
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314280	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFT57 mRNA	PMID:37992649
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314280	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFT57 mRNA	PMID:37992649
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of IFT57 mRNA	PMID:31163220
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305947	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of IFT57 mRNA	PMID:22061828
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IFT57 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of IFT57 mRNA	PMID:39836092
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of IFT57 mRNA	PMID:19549813
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305947	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of IFT57 mRNA	PMID:30779732
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305947	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of IFT57 mRNA	PMID:31150632
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314280	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of IFT57 mRNA	PMID:31919559
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314280	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IFT57 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of IFT57 gene	PMID:20938992
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IFT57 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IFT57 mRNA	PMID:39836092
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of IFT57 mRNA	PMID:26272509
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA	PMID:27188386
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314280	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of IFT57 mRNA	PMID:28960355
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of IFT57 mRNA	PMID:23557933
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin promotes the reaction [jinfukang results in decreased expression of IFT57 mRNA]; jinfukang promotes the reaction [Cisplatin results in decreased expression of IFT57 mRNA]	PMID:27392435
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314280	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of IFT57 mRNA	PMID:30912803
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of IFT57 protein	PMID:18951874
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of IFT57 mRNA	PMID:28001369
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of IFT57 mRNA	PMID:20971185
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IFT57 mRNA	PMID:29803840
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314280	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFT57 mRNA	PMID:37992649
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of IFT57 mRNA	PMID:38568856
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IFT57 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IFT57 mRNA	PMID:39836092
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:29866	arsenite(3-)	affects expression	EXP		E	RGD:6480464	20130416	CTD	MESH:C015001	arsenite affects the expression of IFT57 mRNA	PMID:22959463
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of IFT57 mRNA	PMID:20971185
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314280	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IFT57 promoter	PMID:35295148
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305947	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of IFT57 mRNA	PMID:34492290
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305947	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of IFT57 mRNA	PMID:32145629
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305947	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of IFT57 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of IFT57 mRNA	PMID:25979313
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314280	E	RGD:6480464	20200915	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl affects the reaction [NR1I2 protein affects the expression of IFT57 mRNA]	PMID:32352317
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of IFT57 gene	PMID:31601247
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1305947	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of IFT57 mRNA	PMID:22546817
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IFT57 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of IFT57 mRNA	PMID:39836092
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:35176	zinc sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in increased expression of IFT57 mRNA	PMID:16330358
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305947	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of IFT57 gene	PMID:22079235
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of IFT57 mRNA	PMID:28302478
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of IFT57 mRNA	PMID:31533062
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IFT57 mRNA	PMID:25979313
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314280	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of IFT57 mRNA	PMID:17292431
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of IFT57 mRNA	PMID:26272509
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of IFT57 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of IFT57 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA	PMID:17183730|PMID:27188386
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305947	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of IFT57 mRNA	PMID:41580965
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of IFT57 promoter	PMID:27989131
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314280	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFT57 mRNA	PMID:37992649
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of IFT57 mRNA	PMID:27188386
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of IFT57 mRNA	PMID:28542535
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of IFT57 mRNA	PMID:24935251
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314280	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IFT57 mRNA	PMID:17562736
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IFT57 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IFT57 mRNA	PMID:39836092
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1305947	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of IFT57 mRNA	PMID:17557909
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of IFT57 mRNA	PMID:26272509
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA	PMID:27188386
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of IFT57 mRNA	PMID:17183730
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of IFT57 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of IFT57 mRNA	PMID:39836092
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314280	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IFT57 mRNA	PMID:26378955
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of IFT57 mRNA	PMID:31758290
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314280	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IFT57 mRNA	PMID:22206623
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA	PMID:27188386
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IFT57 gene]	PMID:28238834
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314280	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of IFT57 mRNA	PMID:19482888
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314280	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of IFT57 mRNA]	PMID:19482888
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of IFT57 mRNA	PMID:26079696
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IFT57 mRNA	PMID:27188386
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of IFT57 mRNA	PMID:38568856
1314279	IFT57	intraflagellar transport 57	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305947	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of IFT57 mRNA	PMID:23555832
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314282	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of SEC61A2 mRNA	PMID:37995155
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1305948	E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in increased expression of SEC61A2 protein	PMID:40631627
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SEC61A2 mRNA	PMID:37042841
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1305948	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of SEC61A2 protein	PMID:40631627
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of SEC61A2 mRNA	PMID:33359661
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1305948	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of SEC61A2 protein	PMID:40631627
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314282	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SEC61A2 mRNA	PMID:33754040
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305948	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SEC61A2 mRNA	PMID:33387578
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SEC61A2 mRNA	PMID:35301059
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314282	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SEC61A2 mRNA	PMID:19770486
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SEC61A2 mRNA	PMID:23649840
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314282	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SEC61A2 mRNA	PMID:40504410
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314282	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SEC61A2 mRNA	PMID:28960355
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314282	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEC61A2 mRNA	PMID:21570461
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314282	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SEC61A2 mRNA	PMID:19933214|PMID:26290441
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SEC61A2 mRNA	PMID:28001369
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1314282	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of SEC61A2 mRNA	PMID:30807115
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SEC61A2 mRNA	PMID:29803840
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SEC61A2 mRNA	PMID:38568856
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314282	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SEC61A2 mRNA	PMID:40504410
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314282	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SEC61A2 gene	PMID:35295148
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314282	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SEC61A2 mRNA	PMID:18301758
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305948	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SEC61A2 mRNA	PMID:25181051
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305948	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SEC61A2 mRNA	PMID:30816183|PMID:34947998
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314282	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SEC61A2 mRNA	PMID:26063408|PMID:32156529
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SEC61A2 gene	PMID:31601247
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SEC61A2 mRNA	PMID:25979313
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314282	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SEC61A2 mRNA	PMID:38685157
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314282	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SEC61A2 mRNA	PMID:28392331
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SEC61A2 mRNA	PMID:37042841
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SEC61A2 mRNA	PMID:35301059
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314282	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of SEC61A2 mRNA	PMID:17585979
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SEC61A2 mRNA	PMID:25979313
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of SEC61A2 mRNA	PMID:26272509
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314282	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of SEC61A2 mRNA	PMID:21427059
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SEC61A2 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEC61A2 mRNA	PMID:27188386
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:41791	calyculin A	increases expression	ISO	RGD:1314282	E	RGD:6480464	20150127	CTD	MESH:C059041	calyculin A results in increased expression of SEC61A2 mRNA	PMID:25270620
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314282	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SEC61A2 mRNA	PMID:28973697
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1305948	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of SEC61A2 protein	PMID:40631627
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SEC61A2 mRNA	PMID:38832940
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of SEC61A2 mRNA	PMID:28542535
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SEC61A2 mRNA	PMID:21420995|PMID:22230336
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314282	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SEC61A2 mRNA	PMID:40504410
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of SEC61A2 mRNA	PMID:22077320
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305948	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of SEC61A2 mRNA	PMID:34044035
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314282	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of SEC61A2 protein	PMID:36851058
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEC61A2 mRNA	PMID:27188386
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314282	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SEC61A2 mRNA	PMID:30294300
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:81760	difenoconazole	increases expression	ISO	RGD:1305948	E	RGD:6480464	20170725	CTD	MESH:C115058	difenoconazole results in increased expression of SEC61A2 mRNA	PMID:28263823
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314282	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of SEC61A2 mRNA	PMID:39847705
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1305948	E	RGD:6480464	20171114	CTD	MESH:C045950	propiconazole results in decreased expression of SEC61A2 mRNA	PMID:28970091
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1314282	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of SEC61A2 mRNA	PMID:40826991
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SEC61A2 mRNA	PMID:27188386
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305948	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SEC61A2 mRNA	PMID:21346803
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305948	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of SEC61A2 mRNA	PMID:19015723
1314281	SEC61A2	SEC61 translocon subunit alpha 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305948	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of SEC61A2 mRNA	PMID:23555832
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ZBED4 mRNA	PMID:33167477
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ZBED4 mRNA	PMID:22378314
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1622984	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZBED4 mRNA	PMID:39241906
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ZBED4 mRNA	PMID:21179406
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of ZBED4 protein	PMID:37730182
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305949	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZBED4 mRNA	PMID:33387578
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZBED4 mRNA	PMID:28818685
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305949	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ZBED4 mRNA	PMID:28522335
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ZBED4 mRNA	PMID:22100608
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZBED4 exon	PMID:30157460
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1622984	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZBED4 mRNA	PMID:22206623
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ZBED4 protein	PMID:35688186
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ZBED4 mRNA	PMID:28903495
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ZBED4 mRNA	PMID:27594783
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZBED4 mRNA	PMID:22574217
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622984	E	RGD:6480464	20140722	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZBED4 mRNA	PMID:21570461
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305949	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZBED4 mRNA	PMID:33387578
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1622984	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of ZBED4 mRNA	PMID:32937126
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZBED4 mRNA	PMID:29803840
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZBED4 mRNA	PMID:38568856
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ZBED4 mRNA	PMID:29301061
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZBED4 5' UTR; Benzo(a)pyrene affects the methylation of ZBED4 exon; Benzo(a)pyrene affects the methylation of ZBED4 intron	PMID:27901495|PMID:30157460
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1622984	E	RGD:6480464	20140722	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZBED4 mRNA	PMID:22228805
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of ZBED4 gene	PMID:25435355
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1305949	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of ZBED4 mRNA	PMID:38458666
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZBED4 mRNA	PMID:20382639
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305949	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ZBED4 mRNA	PMID:25729387
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305949	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ZBED4 mRNA	PMID:30047161
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622984	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZBED4 promoter	PMID:35295148
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305949	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ZBED4 mRNA	PMID:34492290
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1622984	E	RGD:6480464	20140722	CTD	MESH:C006253	pirinixic acid results in decreased expression of ZBED4 mRNA	PMID:23811191
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305949	E	RGD:6480464	20150616	CTD	MESH:C006780	bisphenol A affects the expression of ZBED4 mRNA	PMID:25181051
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305949	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ZBED4 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305949	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ZBED4 mRNA	PMID:36041667
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1305949	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ZBED4 mRNA	PMID:36041667
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ZBED4 exon	PMID:30157460
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1305949	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ZBED4 mRNA	PMID:36041667
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1622984	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ZBED4 mRNA	PMID:28392331
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1622984	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ZBED4 intron	PMID:28392331
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZBED4 mRNA	PMID:37042841
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1305949	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of ZBED4 mRNA	PMID:38458666
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZBED4 mRNA	PMID:38568856
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ZBED4 mRNA	PMID:24449571
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:1305949	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of ZBED4 mRNA	PMID:27638505
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ZBED4 mRNA	PMID:28302478
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZBED4 mRNA	PMID:25979313
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZBED4 gene	PMID:29154799
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305949	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ZBED4 mRNA	PMID:30047161
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ZBED4 mRNA	PMID:20106945
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622984	E	RGD:6480464	20140722	CTD	MESH:D000082	Acetaminophen affects the expression of ZBED4 mRNA	PMID:17562736
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305949	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZBED4 mRNA	PMID:33387578
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1622984	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ZBED4 mRNA	PMID:35436446
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305949	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ZBED4 mRNA	PMID:30047161
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1622984	E	RGD:6480464	20140722	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ZBED4 mRNA	PMID:19042947
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305949	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ZBED4 mRNA	PMID:25729387
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ZBED4 exon	PMID:30157460
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1622984	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZBED4 mRNA	PMID:22206623
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1622984	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZBED4 mRNA	PMID:22206623
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ZBED4 protein	PMID:31285264
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305949	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZBED4 mRNA	PMID:30047161
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305949	E	RGD:6480464	20150616	CTD	MESH:D011441	Propylthiouracil results in increased expression of ZBED4 mRNA	PMID:24780913
1314283	ZBED4	zinc finger BED-type containing 4	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305949	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ZBED4 mRNA	PMID:23034163
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314285	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MYBPC3 mRNA	PMID:33045310
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:136004	linsidomine	increases oxidation	ISO	RGD:1305950	E	RGD:6480464	20180220	CTD	MESH:C002385	linsidomine results in increased oxidation of MYBPC3 protein	PMID:28086193
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of MYBPC3 mRNA	PMID:30510588
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MYBPC3 mRNA	PMID:37042841
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYBPC3 mRNA	PMID:37992649
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MYBPC3 mRNA	PMID:36706583
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYBPC3 mRNA	PMID:37992649
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305950	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MYBPC3 mRNA	PMID:33387578|PMID:38056816
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:17833	gentamycin	multiple interactions	ISO	RGD:1305950	E	RGD:6480464	20241001	CTD	MESH:D005839	Curcumin inhibits the reaction [Gentamicins results in increased expression of MYBPC3 mRNA]	PMID:38056816
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1305950	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MYBPC3 mRNA	PMID:39012411
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:22984	calcium atom	increases response to substance	ISO	RGD:1314285	E	RGD:6480464	20180220	CTD	MESH:D002118	MYBPC3 gene mutant form results in increased susceptibility to Calcium	PMID:27994558
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:22984	calcium atom	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20180220	CTD	MESH:D002118	epigallocatechin gallate inhibits the reaction [MYBPC3 gene mutant form results in increased susceptibility to Calcium]	PMID:27994558
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MYBPC3 mRNA	PMID:29950665
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MYBPC3 mRNA	PMID:35430440
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of MYBPC3 mRNA	PMID:34911549
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305950	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of MYBPC3 mRNA	PMID:30779732
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:27470	folic acid	affects expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D005492	Folic Acid affects the expression of MYBPC3 mRNA	PMID:34742744
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1314285	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of MYBPC3 mRNA	PMID:25629700
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305950	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MYBPC3 mRNA	PMID:31881176
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314285	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of MYBPC3 mRNA	PMID:32186404
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314285	E	RGD:6480464	20151013	CTD	MESH:D004317	Doxorubicin results in increased expression of MYBPC3 protein	PMID:21251210
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYBPC3 mRNA	PMID:37992649
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:29320	calcium(0)	increases response to substance	ISO	RGD:1314285	E	RGD:6480464	20180220	CTD	MESH:D002118	MYBPC3 gene mutant form results in increased susceptibility to Calcium	PMID:27994558
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:29320	calcium(0)	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20180220	CTD	MESH:D002118	epigallocatechin gallate inhibits the reaction [MYBPC3 gene mutant form results in increased susceptibility to Calcium]	PMID:27994558
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314285	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of MYBPC3 protein	PMID:39888327
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314285	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MYBPC3 mRNA	PMID:22228805
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MYBPC3 3' UTR	PMID:27901495
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1305950	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of MYBPC3 mRNA	PMID:24915197
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of MYBPC3 mRNA	PMID:37690743
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314285	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of MYBPC3 mRNA	PMID:23557971
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MYBPC3 mRNA	PMID:29950665
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305950	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MYBPC3 mRNA	PMID:34492290
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of MYBPC3 gene	PMID:23968726
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1305950	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of MYBPC3 mRNA	PMID:19167457
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305950	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MYBPC3 mRNA	PMID:25181051
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of MYBPC3 protein	PMID:37567409
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314285	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of MYBPC3 mRNA	PMID:30951980|PMID:34585602
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:33216	bisphenol A	increases phosphorylation	ISO	RGD:1314285	E	RGD:6480464	20240305	CTD	MESH:C006780	bisphenol A results in increased phosphorylation of MYBPC3 protein	PMID:31685870
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314285	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MYBPC3 gene	PMID:31683443
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314285	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of MYBPC3 mRNA	PMID:30951980
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314285	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of MYBPC3 mRNA	PMID:30951980
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314285	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MYBPC3 mRNA	PMID:32715474|PMID:37019170
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of MYBPC3 mRNA	PMID:29950665
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305950	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MYBPC3 mRNA	PMID:21266533
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314285	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MYBPC3 mRNA	PMID:17361019|PMID:21266533
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of MYBPC3 gene	PMID:23968726
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305950	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MYBPC3 mRNA	PMID:32680482
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MYBPC3 mRNA	PMID:37042841
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1305950	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MYBPC3 mRNA	PMID:39012411
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305950	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MYBPC3 mRNA	PMID:28511854
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314285	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MYBPC3 mRNA	PMID:40194260
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MYBPC3 mRNA	PMID:31533062
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1305950	E	RGD:6480464	20241001	CTD	MESH:D003474	Curcumin inhibits the reaction [Gentamicins results in increased expression of MYBPC3 mRNA]	PMID:38056816
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYBPC3 mRNA	PMID:37992649
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1314285	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of MYBPC3 mRNA	PMID:29279043
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:4744	Echimidine	decreases expression	ISO	RGD:1305950	E	RGD:6480464	20211109	CTD	MESH:C000615871	echimidine results in decreased expression of MYBPC3 mRNA	PMID:34185104
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1314285	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of MYBPC3 mRNA	PMID:30529165
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305950	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MYBPC3 mRNA	PMID:29391264
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20180220	CTD	MESH:C045651	epigallocatechin gallate inhibits the reaction [MYBPC3 gene mutant form results in increased susceptibility to Calcium]	PMID:27994558
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of MYBPC3 mRNA	PMID:18175754
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:5643	Heliotrine	decreases expression	ISO	RGD:1305950	E	RGD:6480464	20211109	CTD	MESH:C010178	heliotrine results in decreased expression of MYBPC3 mRNA	PMID:34185104
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314285	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MYBPC3 mRNA	PMID:38701926
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1314285	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of MYBPC3 mRNA	PMID:36907384
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:64317	isoprenaline	affects response to substance	ISO	RGD:1314285	E	RGD:6480464	20140610	CTD	MESH:D007545	MYBPC3 protein affects the susceptibility to Isoproterenol	PMID:23896226
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:64317	isoprenaline	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D007545	MYBPC3 mutant form results in increased susceptibility to [Isoproterenol co-treated with Phenylephrine]	PMID:22076249
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20140513	CTD	MESH:D007545	MYBPC3 gene mutant form results in increased susceptibility to [Isoproterenol co-treated with Phenylephrine]	PMID:22076249
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1314285	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of MYBPC3 mRNA	PMID:26307267
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	affects response to substance	ISO	RGD:1314285	E	RGD:6480464	20160315	CTD	MESH:C072553	MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde	PMID:25566086
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1314285	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of MYBPC3 mRNA	PMID:25566086
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20160315	CTD	MESH:C072553	[MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of BOK mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of CAV1 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of CCNB1 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of CDH3 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of CDK1 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of CKB mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of EGFL7 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of FAHD1 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of G0S2 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of GPR146 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of H2AC10 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of H2AC12 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of H2AC13 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of H2AC15 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of H2AC22 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of H2AC7 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of HAGHL mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of HOPX mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of KBTBD11 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of KY mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of LGALS1 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of LRRC10 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of LRRC75A mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of MCM5 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of MMP23 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of MYL12B mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of MYLK mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of NRM mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of PBK mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of PDLIM4 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of PLEKHG2 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of PLK1 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of PPARGC1B mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of PPP1R3G mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of ROBO4 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of RRM2 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of SYNPO mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of TK1 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of TMEM176A mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of TMEM176B mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of TRIB2 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of ZFYVE21 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of ATG12 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of EIF2AK2 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of FAM13B mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of GADD45G mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of HSPA8 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of LUC7L mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of NRIP3 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of SF1 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of SWT1 mRNA; [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of UFD1 mRNA; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ACAA2 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ACTC1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ADSS1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of APH1A mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ARG1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ART3 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of C1QB mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CA14 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CAVIN1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CENPA mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CHRM2 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CKMT2 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CLIP4 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CMYA5 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CORIN mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of EGLN1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of EGLN3 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ENO3 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of FBXO10 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of GSG1L mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of GUCY1A1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of GYG1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of H2-AB1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of HES1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of HIGD1B mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of HR mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of HSPB2 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of KLHL6 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of LDB3 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of LMO7 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of LRRC10 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of LXN mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of MB mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of MYBPC3 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of MYBPHL mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of MYL1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of MYL7 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of MYO5B mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of MYZAP mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of NACAD mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of NIPSNAP2 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of NMRK2 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PCDH7 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PDK1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PDLIM5 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PERM1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PFKP mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PIP5K1B mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PLAC8 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PPP1R14C mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of PRC1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of RARRES2 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of SH3KBP1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of SNRK mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of SPON2 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of SPSB4 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of SSPN mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of TFRC mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of THY1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of TMEM204 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of TMOD1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of TNNI2 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of TRIL mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of TSC22D4 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of UNC13C mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ZBTB8B mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of CD14 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of CLDN4 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of DNMT3L mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of DYNC1H1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GDF15 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of INSL6 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of KIF1A mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MAP1B mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MLKL mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MOCS1 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MT3 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of NGF mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PDPN mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SLC6A9 mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SPRR2G mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SYBU mRNA]; MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of TENM4 mRNA]	PMID:25566086
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1305950	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of MYBPC3 mRNA	PMID:33484710
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:77733	2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile	affects response to substance	ISO	RGD:1314285	E	RGD:6480464	20140805	CTD	MESH:D014700	MYBPC3 protein affects the susceptibility to Verapamil	PMID:23896226
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MYBPC3 gene]	PMID:28238834
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:8093	phenylephrine	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D010656	MYBPC3 mutant form results in increased susceptibility to [Isoproterenol co-treated with Phenylephrine]	PMID:22076249
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:8093	phenylephrine	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20140513	CTD	MESH:D010656	MYBPC3 gene mutant form results in increased susceptibility to [Isoproterenol co-treated with Phenylephrine]	PMID:22076249
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1314285	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of MYBPC3 mRNA	PMID:26377693
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305950	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of MYBPC3 mRNA	PMID:23914054
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1314285	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of MYBPC3 mRNA	PMID:36706583
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1305950	E	RGD:6480464	20211109	CTD	MESH:C009237	senecionine results in decreased expression of MYBPC3 mRNA	PMID:34185104
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1314285	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of MYBPC3 mRNA	PMID:26006729|PMID:26217789
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314285	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of MYBPC3 mRNA	PMID:35537566
1314284	MYBPC3	myosin binding protein C3	gene	CHEBI:9948	verapamil	affects response to substance	ISO	RGD:1314285	E	RGD:6480464	20140610	CTD	MESH:D014700	MYBPC3 protein affects the susceptibility to Verapamil	PMID:23896226
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1620397	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of IQGAP3 mRNA	PMID:26251327
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IQGAP3 mRNA	PMID:20938992
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305951	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of IQGAP3 gene	PMID:35440735
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of IQGAP3 mRNA	PMID:30510588
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1305951	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of IQGAP3 mRNA	PMID:32145629
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of IQGAP3 mRNA	PMID:19167446
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IQGAP3 mRNA	PMID:25510870
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of IQGAP3 protein	PMID:20109541
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of IQGAP3 mRNA	PMID:38568856
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IQGAP3 mRNA	PMID:20938992
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of IQGAP3 mRNA	PMID:21795739
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:17151	xylitol	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D014993	Xylitol results in increased expression of IQGAP3 mRNA	PMID:32275922
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of IQGAP3 mRNA	PMID:26079696
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IQGAP3 mRNA	PMID:37992649
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of IQGAP3 mRNA	PMID:21592394
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of IQGAP3 mRNA	PMID:21592394
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IQGAP3 mRNA	PMID:37992649
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1620397	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of IQGAP3 mRNA	PMID:34319233
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of IQGAP3 protein	PMID:37730182
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of IQGAP3 mRNA	PMID:21592394
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of IQGAP3 mRNA	PMID:21592394
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IQGAP3 mRNA	PMID:36331819
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of IQGAP3 mRNA	PMID:39836092
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1620397	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of IQGAP3 mRNA	PMID:39984025
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IQGAP3 mRNA	PMID:37325564
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IQGAP3 mRNA	PMID:25510870
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IQGAP3 mRNA	PMID:25510870
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of IQGAP3 mRNA	PMID:23649840
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1620397	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of IQGAP3 mRNA	PMID:19770486
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305951	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IQGAP3 mRNA	PMID:23630614|PMID:25378103
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of IQGAP3 mRNA	PMID:23649840
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of IQGAP3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of IQGAP3 mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of IQGAP3 mRNA	PMID:25658374|PMID:27106289|PMID:34911549
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1620397	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of IQGAP3 mRNA	PMID:17484886
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1620397	E	RGD:6480464	20250114	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of IQGAP3 mRNA	PMID:38992766
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20250114	CTD	MESH:D002251	[Verteporfin co-treated with calcipotriene] inhibits the reaction [Carbon Tetrachloride results in increased expression of IQGAP3 mRNA]; calcipotriene inhibits the reaction [Carbon Tetrachloride results in increased expression of IQGAP3 mRNA]; Verteporfin inhibits the reaction [Carbon Tetrachloride results in increased expression of IQGAP3 mRNA]	PMID:38992766
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IQGAP3 mRNA	PMID:20938992
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IQGAP3 mRNA	PMID:40512198
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of IQGAP3 protein	PMID:35688186
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305951	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of IQGAP3 mRNA	PMID:31881176
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of IQGAP3 mRNA	PMID:23557933
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of IQGAP3 mRNA	PMID:27594783
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620397	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IQGAP3 mRNA	PMID:21570461
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305951	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IQGAP3 mRNA	PMID:32109520
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305951	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IQGAP3 mRNA	PMID:34747641
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of IQGAP3 mRNA	PMID:33212167
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of IQGAP3 mRNA	PMID:32763439
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of IQGAP3 mRNA	PMID:29803840
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IQGAP3 mRNA	PMID:30031762
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IQGAP3 mRNA	PMID:37992649
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of IQGAP3 mRNA	PMID:22714537
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of IQGAP3 mRNA	PMID:29301061|PMID:39719251
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IQGAP3 mRNA	PMID:40512198
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1620397	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IQGAP3 mRNA	PMID:22228805
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1620397	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IQGAP3 mRNA	PMID:32417428
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IQGAP3 promoter	PMID:27901495
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to IQGAP3 mRNA]	PMID:32406909
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of IQGAP3 mRNA	PMID:20382639
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1305951	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of IQGAP3 mRNA	PMID:32479839
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305951	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of IQGAP3 mRNA	PMID:25729387
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620397	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IQGAP3 gene	PMID:35295148
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:32293	verteporfin	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20250114	CTD	MESH:C098350	[Verteporfin co-treated with calcipotriene] inhibits the reaction [Carbon Tetrachloride results in increased expression of IQGAP3 mRNA]; Verteporfin inhibits the reaction [Carbon Tetrachloride results in increased expression of IQGAP3 mRNA]	PMID:38992766
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305951	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of IQGAP3 mRNA	PMID:34492290
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1620397	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of IQGAP3 mRNA	PMID:28472532
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of IQGAP3 mRNA	PMID:38479592
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305951	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of IQGAP3 mRNA	PMID:19167457
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of IQGAP3 mRNA; bisphenol A results in decreased expression of IQGAP3 protein	PMID:29275510|PMID:33376534
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305951	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IQGAP3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305951	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of IQGAP3 mRNA	PMID:32145629
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	[ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of IQGAP3 protein]	PMID:33376534
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1620397	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of IQGAP3 mRNA	PMID:26682919
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IQGAP3 mRNA	PMID:25510870
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of IQGAP3 mRNA	PMID:25510870
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1620397	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of IQGAP3 mRNA	PMID:20713471
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1620397	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of IQGAP3 mRNA	PMID:20713471
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1620397	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of IQGAP3 mRNA	PMID:39298647|PMID:40203079
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1620397	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of IQGAP3 mRNA	PMID:26377693
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of IQGAP3 intron	PMID:30157460
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1620397	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of IQGAP3 mRNA	PMID:37019170
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1620397	E	RGD:6480464	20160119	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of IQGAP3 mRNA	PMID:26464624
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of IQGAP3 mRNA	PMID:26678675
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of IQGAP3 mRNA	PMID:39836092
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1620397	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of IQGAP3 mRNA	PMID:26377693
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305951	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of IQGAP3 mRNA	PMID:30723492
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of IQGAP3 mRNA	PMID:26472689
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IQGAP3 mRNA	PMID:37325564
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305951	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of IQGAP3 mRNA	PMID:24386269
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IQGAP3 mRNA	PMID:24449571
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1620397	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of IQGAP3 mRNA	PMID:28962523
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1620397	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of IQGAP3 mRNA	PMID:17585979
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1620397	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of IQGAP3 mRNA	PMID:40194260
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620397	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IQGAP3 mRNA	PMID:40194260
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of IQGAP3 mRNA	PMID:28302478
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of IQGAP3 mRNA	PMID:31533062
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of IQGAP3 mRNA	PMID:19167446
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IQGAP3 mRNA	PMID:19167446
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1620397	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of IQGAP3 mRNA	PMID:39529242
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IQGAP3 mRNA	PMID:36331819
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1620397	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of IQGAP3 mRNA	PMID:29038090
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of IQGAP3 mRNA	PMID:28001369
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IQGAP3 mRNA	PMID:37992649
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of IQGAP3 mRNA	PMID:38832940
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of IQGAP3 mRNA	PMID:29067470
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of IQGAP3 mRNA	PMID:22230336
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305951	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of IQGAP3 mRNA	PMID:33387578
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of IQGAP3 mRNA	PMID:17331233
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IQGAP3 mRNA	PMID:40512198
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305951	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of IQGAP3 mRNA	PMID:29391264
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1305951	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of IQGAP3 mRNA	PMID:17351261
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1620397	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of IQGAP3 mRNA	PMID:25554681
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1620397	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IQGAP3 mRNA	PMID:25554681
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:50749	calcipotriol	multiple interactions	ISO	RGD:1620397	E	RGD:6480464	20250114	CTD	MESH:C055085	[Verteporfin co-treated with calcipotriene] inhibits the reaction [Carbon Tetrachloride results in increased expression of IQGAP3 mRNA]; calcipotriene inhibits the reaction [Carbon Tetrachloride results in increased expression of IQGAP3 mRNA]	PMID:38992766
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of IQGAP3 mRNA	PMID:21148553
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:51876	auramine O	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D001576	Benzophenoneidum results in increased expression of IQGAP3 protein	PMID:28722353
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1620397	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of IQGAP3 mRNA	PMID:19042947
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1620397	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IQGAP3 mRNA	PMID:38701926
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of IQGAP3 protein	PMID:32959892
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of IQGAP3 mRNA	PMID:39836092
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305951	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of IQGAP3 mRNA	PMID:25729387
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of IQGAP3 mRNA	PMID:28988120
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1305951	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of IQGAP3 mRNA	PMID:37269647
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305951	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of IQGAP3 mRNA	PMID:35283115
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of IQGAP3 intron	PMID:30157460
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1305951	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of IQGAP3 mRNA	PMID:27225895
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1620397	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of IQGAP3 mRNA	PMID:27225895
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of IQGAP3 mRNA	PMID:22714537
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of IQGAP3 mRNA	PMID:29522793
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:753233	coal tar	increases expression	ISO	RGD:1620397	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of IQGAP3 mRNA	PMID:27858113
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1620397	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of IQGAP3 mRNA	PMID:23091169
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of IQGAP3 mRNA	PMID:19167446
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1620397	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of IQGAP3 mRNA	PMID:38648751
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of IQGAP3 mRNA	PMID:32234424
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305951	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of IQGAP3 mRNA	PMID:24780913
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of IQGAP3 mRNA	PMID:19140230
1314286	IQGAP3	IQ motif containing GTPase activating protein 3	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1620397	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of IQGAP3 mRNA	PMID:35537566
1314288	RNF26	ring finger protein 26	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314289	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RNF26 mRNA	PMID:26251327
1314288	RNF26	ring finger protein 26	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1314289	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of RNF26 promoter	PMID:26251327
1314288	RNF26	ring finger protein 26	gene	CHEBI:15365	acetylsalicylic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of RNF26 mRNA	PMID:11906190
1314288	RNF26	ring finger protein 26	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of RNF26 mRNA	PMID:22378314
1314288	RNF26	ring finger protein 26	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314289	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RNF26 mRNA	PMID:30319688
1314288	RNF26	ring finger protein 26	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of RNF26 mRNA	PMID:20044591
1314288	RNF26	ring finger protein 26	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305953	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RNF26 mRNA	PMID:33387578
1314288	RNF26	ring finger protein 26	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RNF26 mRNA	PMID:19549813
1314288	RNF26	ring finger protein 26	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1314289	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of RNF26 mRNA	PMID:19376150
1314288	RNF26	ring finger protein 26	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314289	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RNF26 mRNA	PMID:19770486
1314288	RNF26	ring finger protein 26	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of RNF26 mRNA	PMID:23649840
1314288	RNF26	ring finger protein 26	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314289	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RNF26 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of RNF26 mRNA	PMID:34911549
1314288	RNF26	ring finger protein 26	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1305953	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of RNF26 mRNA	PMID:30779732
1314288	RNF26	ring finger protein 26	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of RNF26 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of RNF26 mRNA	PMID:19167446|PMID:23557933
1314288	RNF26	ring finger protein 26	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of RNF26 mRNA	PMID:27594783
1314288	RNF26	ring finger protein 26	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314289	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF26 mRNA	PMID:21570461
1314288	RNF26	ring finger protein 26	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305953	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNF26 mRNA	PMID:33387578
1314288	RNF26	ring finger protein 26	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RNF26 mRNA	PMID:33212167
1314288	RNF26	ring finger protein 26	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of RNF26 mRNA	PMID:32763439
1314288	RNF26	ring finger protein 26	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RNF26 mRNA	PMID:38568856
1314288	RNF26	ring finger protein 26	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of RNF26 mRNA	PMID:39719251
1314288	RNF26	ring finger protein 26	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RNF26 promoter	PMID:27901495
1314288	RNF26	ring finger protein 26	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RNF26 mRNA	PMID:20382639
1314288	RNF26	ring finger protein 26	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305953	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of RNF26 mRNA	PMID:24136188
1314288	RNF26	ring finger protein 26	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1305953	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RNF26 mRNA	PMID:34492290
1314288	RNF26	ring finger protein 26	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314289	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RNF26 mRNA	PMID:18648102
1314288	RNF26	ring finger protein 26	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314289	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of RNF26 mRNA	PMID:17426115
1314288	RNF26	ring finger protein 26	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of RNF26 mRNA	PMID:38479592
1314288	RNF26	ring finger protein 26	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314289	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF26 mRNA	PMID:35598803
1314288	RNF26	ring finger protein 26	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305953	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RNF26 mRNA	PMID:25181051|PMID:34947998
1314288	RNF26	ring finger protein 26	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305953	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF26 gene	PMID:28505145
1314288	RNF26	ring finger protein 26	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RNF26 mRNA	PMID:28628672
1314288	RNF26	ring finger protein 26	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314289	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RNF26 mRNA	PMID:38685157
1314288	RNF26	ring finger protein 26	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RNF26 mRNA	PMID:28628672
1314288	RNF26	ring finger protein 26	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314289	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of RNF26 mRNA	PMID:28392331
1314288	RNF26	ring finger protein 26	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RNF26 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RNF26 mRNA	PMID:28628672
1314288	RNF26	ring finger protein 26	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RNF26 mRNA	PMID:38568856
1314288	RNF26	ring finger protein 26	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305953	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RNF26 mRNA	PMID:33453195
1314288	RNF26	ring finger protein 26	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1305953	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RNF26 mRNA	PMID:24386269
1314288	RNF26	ring finger protein 26	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of RNF26 mRNA	PMID:28302478
1314288	RNF26	ring finger protein 26	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of RNF26 mRNA	PMID:19167446
1314288	RNF26	ring finger protein 26	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF26 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of RNF26 mRNA	PMID:19167446
1314288	RNF26	ring finger protein 26	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RNF26 mRNA	PMID:25562108
1314288	RNF26	ring finger protein 26	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RNF26 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RNF26 mRNA	PMID:28628672
1314288	RNF26	ring finger protein 26	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305953	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of RNF26 mRNA	PMID:24136188
1314288	RNF26	ring finger protein 26	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305953	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RNF26 mRNA	PMID:33387578
1314288	RNF26	ring finger protein 26	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RNF26 mRNA	PMID:22230336
1314288	RNF26	ring finger protein 26	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RNF26 mRNA	PMID:22079256
1314288	RNF26	ring finger protein 26	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314289	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of RNF26 mRNA	PMID:35436446
1314288	RNF26	ring finger protein 26	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of RNF26 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RNF26 mRNA	PMID:28628672
1314288	RNF26	ring finger protein 26	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314289	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RNF26 mRNA; Nanotubes, Carbon results in increased expression of RNF26 mRNA	PMID:25554681
1314288	RNF26	ring finger protein 26	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314289	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of RNF26 mRNA	PMID:19042947
1314288	RNF26	ring finger protein 26	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of RNF26 mRNA	PMID:28988120
1314288	RNF26	ring finger protein 26	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RNF26 mRNA	PMID:22079256
1314288	RNF26	ring finger protein 26	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RNF26 mRNA	PMID:22079256
1314288	RNF26	ring finger protein 26	gene	CHEBI:755208	eprenetapopt	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of RNF26 mRNA	PMID:19946333
1314288	RNF26	ring finger protein 26	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of RNF26 mRNA]	PMID:19946333
1314288	RNF26	ring finger protein 26	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1305953	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of RNF26 mRNA	PMID:26720608
1314288	RNF26	ring finger protein 26	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RNF26 gene]	PMID:28238834
1314288	RNF26	ring finger protein 26	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RNF26 mRNA	PMID:19167446
1314288	RNF26	ring finger protein 26	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314289	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RNF26 mRNA	PMID:39847705
1314288	RNF26	ring finger protein 26	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in decreased expression of RNF26 mRNA	PMID:11906190
1314288	RNF26	ring finger protein 26	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RNF26 mRNA	PMID:38568856
1314288	RNF26	ring finger protein 26	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of RNF26 mRNA	PMID:29301935
1314288	RNF26	ring finger protein 26	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314289	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of RNF26 mRNA	PMID:28973697
1314288	RNF26	ring finger protein 26	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1305953	E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of RNF26 mRNA	PMID:24136188
1314288	RNF26	ring finger protein 26	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305953	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of RNF26 mRNA	PMID:23034163
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1314292	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of POP4 mRNA	PMID:29980752
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of POP4 mRNA	PMID:37042841
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314292	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of POP4 mRNA	PMID:32235866
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POP4 mRNA	PMID:39836092
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305955	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of POP4 mRNA	PMID:21396975
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POP4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POP4 mRNA	PMID:39836092
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	POP4 protein affects the susceptibility to Cisplatin	PMID:16217747
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of POP4 mRNA	PMID:27392435
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314292	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POP4 mRNA	PMID:21570461
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314292	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POP4 mRNA	PMID:17942748
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POP4 mRNA	PMID:30851411
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305955	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of POP4 mRNA	PMID:28959563
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of POP4 mRNA	PMID:24690739
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of POP4 mRNA	PMID:28595984|PMID:34032870|PMID:38568856
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POP4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POP4 mRNA	PMID:39836092
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314292	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of POP4 mRNA	PMID:22228805
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314292	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of POP4 mRNA]	PMID:22228805
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of POP4 mRNA	PMID:24690739
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305955	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of POP4 mRNA	PMID:25729387
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of POP4 mRNA	PMID:29275510
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314292	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of POP4 mRNA	PMID:33221593
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305955	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of POP4 mRNA	PMID:25181051
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314292	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of POP4 mRNA	PMID:39298647
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1314292	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of POP4 mRNA	PMID:28392331
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POP4 mRNA	PMID:39836092
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314292	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of POP4 mRNA	PMID:36331819
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314292	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of POP4 mRNA	PMID:17555576
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305955	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of POP4 mRNA	PMID:33387578
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of POP4 mRNA	PMID:24690739
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POP4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POP4 mRNA	PMID:39836092
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of POP4 mRNA	PMID:18175754
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314292	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of POP4 mRNA	PMID:17555576
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314292	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of POP4 mRNA	PMID:17942748
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314292	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POP4 mRNA	PMID:17942748
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314292	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of POP4 mRNA; Nanotubes, Carbon results in increased expression of POP4 mRNA	PMID:25554681
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305955	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of POP4 mRNA	PMID:24136188
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POP4 mRNA	PMID:39836092
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305955	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of POP4 mRNA	PMID:25729387
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314292	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of POP4 protein	PMID:36851058
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314292	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of POP4 mRNA	PMID:22206623
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of POP4 protein	PMID:31285264
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of POP4 mRNA	PMID:30851411
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314292	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of POP4 mRNA	PMID:30294300
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305955	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of POP4 mRNA	PMID:21346803
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of POP4 mRNA	PMID:34581912
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of POP4 mRNA	PMID:29301935
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305955	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of POP4 mRNA	PMID:21346803
1314291	POP4	POP4 ribonuclease P/MRP subunit	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305955	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of POP4 mRNA	PMID:23034163
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of TDRD6 mRNA	PMID:21934132
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314294	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TDRD6 mRNA	PMID:25510870
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314294	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TDRD6 mRNA	PMID:34319233
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TDRD6 mRNA	PMID:35301059
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314294	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TDRD6 mRNA	PMID:28111341
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314294	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TDRD6 mRNA	PMID:25510870
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314294	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TDRD6 mRNA	PMID:25510870
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of TDRD6 protein	PMID:20106945
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TDRD6 mRNA	PMID:24768652|PMID:25583101
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TDRD6 mRNA	PMID:20106945
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314294	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TDRD6 gene	PMID:35295148
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305956	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TDRD6 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TDRD6 gene	PMID:31601247
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305956	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TDRD6 gene	PMID:28505145
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314294	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TDRD6 mRNA	PMID:25510870
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314294	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of TDRD6 mRNA	PMID:25510870
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1314294	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of TDRD6 exon	PMID:33297965
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314294	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TDRD6 mRNA	PMID:37019170
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:34911	permethrin	decreases methylation	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in decreased methylation of TDRD6 promoter	PMID:37047231
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of TDRD6 mRNA	PMID:37047231
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TDRD6 mRNA	PMID:35301059
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314294	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TDRD6 mRNA	PMID:28111341
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314294	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TDRD6 mRNA	PMID:40194260
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TDRD6 mRNA	PMID:26272509
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TDRD6 gene	PMID:29154799
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TDRD6 mRNA	PMID:27188386
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of TDRD6 mRNA	PMID:20106945
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TDRD6 mRNA	PMID:24935251
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:1305956	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of TDRD6 gene	PMID:37958445
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:6651	malathion	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in increased expression of TDRD6 mRNA	PMID:37047231
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TDRD6 mRNA	PMID:27188386
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TDRD6 gene]	PMID:28238834
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TDRD6 mRNA	PMID:27188386
1314293	TDRD6	tudor domain containing 6	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of TDRD6 mRNA	PMID:27188386
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in increased expression of PLXDC2 mRNA	PMID:19371625
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314301	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PLXDC2 mRNA	PMID:37995155
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1305962	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PLXDC2 mRNA	PMID:30071829
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLXDC2 mRNA	PMID:20938992
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLXDC2 mRNA	PMID:30529165
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305962	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of PLXDC2 gene	PMID:28931070|PMID:35440735
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314301	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of PLXDC2 mRNA	PMID:40945087
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:16130	DDT	decreases expression	ISO	RGD:1305962	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of PLXDC2 mRNA	PMID:30207508
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1314301	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of PLXDC2 mRNA	PMID:20362636
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314301	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PLXDC2 mRNA	PMID:30319688
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314301	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PLXDC2 mRNA	PMID:39241906
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PLXDC2 mRNA	PMID:35811015
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of PLXDC2 mRNA	PMID:21185374
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314301	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of PLXDC2 mRNA	PMID:19484750
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305962	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLXDC2 mRNA	PMID:32741896
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314301	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of PLXDC2 mRNA	PMID:33711761
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PLXDC2 mRNA	PMID:38568856
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLXDC2 mRNA	PMID:20938992
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PLXDC2 mRNA	PMID:37042841
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLXDC2 mRNA	PMID:37992649
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of PLXDC2 mRNA	PMID:22017230
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305962	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLXDC2 mRNA	PMID:32741896
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLXDC2 mRNA	PMID:37992649
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314301	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PLXDC2 mRNA	PMID:34319233
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of PLXDC2 mRNA	PMID:26485663
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305962	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PLXDC2 mRNA	PMID:33387578
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of PLXDC2 intron	PMID:30157460
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305962	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of PLXDC2 mRNA; alpha-Chlorohydrin results in increased expression of PLXDC2 protein	PMID:28522335|PMID:34915118
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLXDC2 mRNA	PMID:35301059
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20200714	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLXDC2 mRNA; [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of PLXDC2 mRNA	PMID:31904401|PMID:37236586
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305962	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of PLXDC2 mRNA	PMID:21396975
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PLXDC2 gene	PMID:27153756
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PLXDC2 mRNA	PMID:41430723
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PLXDC2 mRNA	PMID:34911549
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305962	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of PLXDC2 mRNA	PMID:31129395
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314301	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PLXDC2 mRNA	PMID:17484886
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PLXDC2 mRNA	PMID:20938992
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PLXDC2 mRNA	PMID:32525701
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLXDC2 mRNA	PMID:40504410
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of PLXDC2 mRNA	PMID:19371625
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:27881	resveratrol	increases phosphorylation	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased phosphorylation of PLXDC2 protein	PMID:25311616
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PLXDC2 mRNA	PMID:28903495
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of PLXDC2 promoter	PMID:22847954
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305962	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLXDC2 mRNA	PMID:32109520
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314301	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PLXDC2 mRNA	PMID:19933214
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLXDC2 mRNA	PMID:17942748
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of PLXDC2 mRNA	PMID:33512557
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314301	E	RGD:6480464	20180703	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PLXDC2 mRNA	PMID:29261810
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PLXDC2 mRNA	PMID:33212167
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PLXDC2 mRNA	PMID:30851411
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1314301	E	RGD:6480464	20180703	CTD	MESH:D020106	Acrylamide results in decreased expression of PLXDC2 mRNA	PMID:29261810
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PLXDC2 mRNA	PMID:29803840
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLXDC2 mRNA	PMID:37992649
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1314301	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite affects the methylation of PLXDC2 gene	PMID:39894169
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of PLXDC2 mRNA	PMID:39719251
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314301	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PLXDC2 mRNA	PMID:37682722
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLXDC2 mRNA	PMID:40504410
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PLXDC2 mRNA	PMID:20064835
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased expression of PLXDC2 mRNA	PMID:23974009
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PLXDC2 mRNA	PMID:23806026
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305962	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PLXDC2 mRNA	PMID:25729387
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314301	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of PLXDC2 mRNA	PMID:27760801
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of PLXDC2 mRNA	PMID:38479592
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of PLXDC2 gene	PMID:31601247
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305962	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PLXDC2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of PLXDC2 mRNA	PMID:19371625
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305962	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of PLXDC2 mRNA	PMID:41034487
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314301	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of PLXDC2 mRNA	PMID:30951980
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305962	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PLXDC2 gene	PMID:28505145
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305962	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of PLXDC2 mRNA	PMID:31129395
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1314301	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of PLXDC2 mRNA	PMID:25172293
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314301	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PLXDC2 mRNA	PMID:30951980
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314301	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of PLXDC2 mRNA	PMID:30951980
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314301	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PLXDC2 mRNA	PMID:28392331
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PLXDC2 mRNA	PMID:38568856
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PLXDC2 mRNA	PMID:35301059
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20200714	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PLXDC2 mRNA; [Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of PLXDC2 mRNA	PMID:31904401|PMID:37236586
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305962	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of PLXDC2 mRNA	PMID:27387713
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20200714	CTD	MESH:D013755	[Tetradecanoylphorbol Acetate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the expression of PLXDC2 mRNA	PMID:31904401
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of PLXDC2 promoter	PMID:22847954
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of PLXDC2 promoter	PMID:22847954
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1305962	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PLXDC2 mRNA	PMID:29427782
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PLXDC2 mRNA	PMID:26272509|PMID:28001369|PMID:29154799
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PLXDC2 gene	PMID:29154799
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLXDC2 mRNA	PMID:27188386
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305962	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of PLXDC2 mRNA	PMID:41580965
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PLXDC2 mRNA	PMID:20106945|PMID:27989131
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of PLXDC2 mRNA	PMID:33512557
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of PLXDC2 mRNA	PMID:25047013
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of PLXDC2 mRNA	PMID:19371625
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PLXDC2 mRNA	PMID:37992649
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PLXDC2 mRNA	PMID:38832940
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of PLXDC2 mRNA	PMID:24935251|PMID:26272509
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLXDC2 mRNA	PMID:27188386
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305962	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PLXDC2 mRNA	PMID:33387578
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of PLXDC2 mRNA	PMID:26690555
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PLXDC2 mRNA	PMID:35811015
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PLXDC2 mRNA	PMID:32525701
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PLXDC2 mRNA	PMID:40504410
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of PLXDC2 mRNA	PMID:26833863
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305962	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PLXDC2 mRNA	PMID:29391264
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314301	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLXDC2 mRNA	PMID:17942748
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314301	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PLXDC2 mRNA; Nanotubes, Carbon results in decreased expression of PLXDC2 mRNA	PMID:25554681|PMID:25620056
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314301	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of PLXDC2 mRNA	PMID:40234311
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:50692	mifepristone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of PLXDC2 mRNA	PMID:17584828
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305962	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PLXDC2 mRNA	PMID:25729387
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:6842	methoxychlor	increases methylation	ISO	RGD:1305962	E	RGD:6480464	20130514	CTD	MESH:D008731	Methoxychlor results in increased methylation of PLXDC2 gene	PMID:19589859
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of PLXDC2 mRNA	PMID:29522793
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305962	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLXDC2 mRNA	PMID:32741896
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PLXDC2 mRNA	PMID:30851411
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLXDC2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLXDC2 mRNA	PMID:27188386
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of PLXDC2 mRNA	PMID:19159669
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1305962	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of PLXDC2 mRNA	PMID:32109520
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314301	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PLXDC2 mRNA	PMID:38648751
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of PLXDC2 mRNA	PMID:33512557
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:84070	sodium arsenate	affects expression	ISO	RGD:1314301	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate affects the expression of PLXDC2 mRNA	PMID:39847705
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of PLXDC2 mRNA	PMID:32525701
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305962	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PLXDC2 mRNA	PMID:24780913
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLXDC2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PLXDC2 mRNA	PMID:27188386
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1305962	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PLXDC2 mRNA	PMID:19281266
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PLXDC2 mRNA	PMID:29301935
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305962	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of PLXDC2 mRNA	PMID:19015723
1314300	PLXDC2	plexin domain containing 2	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305962	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of PLXDC2 mRNA	PMID:23034163|PMID:23555832
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ZBTB7B mRNA	PMID:38218311
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1557107	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZBTB7B mRNA	PMID:33045310
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1557107	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of ZBTB7B mRNA	PMID:16604517
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ZBTB7B mRNA	PMID:33167477
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1557107	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZBTB7B mRNA	PMID:36331819
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1557107	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ZBTB7B mRNA	PMID:30319688
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1557107	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ZBTB7B mRNA	PMID:39298647
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ZBTB7B mRNA	PMID:30165855
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1557107	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZBTB7B mRNA	PMID:25510870
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ZBTB7B mRNA	PMID:38568856
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:16856	glutathione	decreases expression	ISO	RGD:1305963	E	RGD:6480464	20120918	CTD	MESH:D005978	Glutathione deficiency results in decreased expression of ZBTB7B mRNA	PMID:20621112
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ZBTB7B mRNA	PMID:36314267
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1557107	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of ZBTB7B mRNA	PMID:20403060
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZBTB7B mRNA	PMID:28818685
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1557107	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZBTB7B mRNA	PMID:36331819
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of ZBTB7B mRNA	PMID:17103032
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZBTB7B mRNA	PMID:35301059
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1557107	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZBTB7B mRNA	PMID:25510870
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1557107	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZBTB7B mRNA	PMID:25510870
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ZBTB7B mRNA	PMID:35430440
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1305963	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of ZBTB7B mRNA	PMID:31129395
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305963	E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ZBTB7B mRNA	PMID:30690589
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:27385	tetrachloromethane	increases methylation	ISO	RGD:1305963	E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in increased methylation of ZBTB7B promoter	PMID:30690589
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1557107	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZBTB7B mRNA	PMID:25629700
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1557107	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZBTB7B mRNA	PMID:22206623
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305963	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ZBTB7B mRNA	PMID:31881176
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ZBTB7B mRNA	PMID:27594783
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305963	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZBTB7B mRNA	PMID:33387578
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1557107	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZBTB7B mRNA	PMID:24058054
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1557107	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZBTB7B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZBTB7B mRNA	PMID:17942748|PMID:25975270
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZBTB7B mRNA	PMID:32763439
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZBTB7B mRNA	PMID:29803840
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1557107	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZBTB7B mRNA	PMID:39515575
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZBTB7B mRNA	PMID:38568856|PMID:39719251
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZBTB7B 5' UTR	PMID:27901495
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZBTB7B mRNA	PMID:26238291
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZBTB7B 3' UTR	PMID:27901495
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ZBTB7B mRNA	PMID:25895662
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557107	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZBTB7B gene; titanium dioxide results in decreased methylation of ZBTB7B promoter	PMID:35295148
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1557107	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZBTB7B gene; titanium dioxide results in increased methylation of ZBTB7B promoter	PMID:35295148
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1305963	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ZBTB7B mRNA	PMID:30723492
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1557107	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ZBTB7B mRNA	PMID:18648102
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1557107	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ZBTB7B promoter	PMID:27334623
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZBTB7B protein	PMID:33376534
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1557107	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZBTB7B mRNA	PMID:33221593
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305963	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZBTB7B mRNA	PMID:25181051
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305963	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of ZBTB7B mRNA	PMID:31129395
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1557107	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZBTB7B mRNA	PMID:25510870
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1557107	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZBTB7B mRNA	PMID:25510870
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1557107	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ZBTB7B exon	PMID:33297965
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1557107	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ZBTB7B mRNA	PMID:37019170
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZBTB7B mRNA	PMID:37042841
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZBTB7B mRNA	PMID:38568856
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZBTB7B mRNA	PMID:35301059
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:35546	perfluorodecanoic acid	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C036567	perfluorodecanoic acid results in decreased expression of ZBTB7B mRNA	PMID:38568856
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1557107	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ZBTB7B mRNA	PMID:28903501
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305963	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of ZBTB7B mRNA	PMID:24386269
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:35861	dibenzo[a,l]pyrene	increases expression	ISO	RGD:1557107	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in increased expression of ZBTB7B mRNA	PMID:25908611
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ZBTB7B mRNA	PMID:38568856
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1557107	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ZBTB7B mRNA	PMID:40194260
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1557107	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZBTB7B mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ZBTB7B mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ZBTB7B mRNA	PMID:36331819
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1557107	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ZBTB7B mRNA	PMID:17963808
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557107	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZBTB7B mRNA	PMID:17562736
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZBTB7B mRNA	PMID:29067470
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305963	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZBTB7B mRNA	PMID:33387578
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305963	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ZBTB7B mRNA	PMID:29391264
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1557107	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ZBTB7B mRNA	PMID:17942748
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1557107	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZBTB7B mRNA	PMID:17942748
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557107	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ZBTB7B mRNA; Nanotubes, Carbon results in increased expression of ZBTB7B mRNA	PMID:25554681|PMID:31978390
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in decreased expression of ZBTB7B mRNA	PMID:16982809
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1557107	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZBTB7B mRNA	PMID:22206623
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of ZBTB7B mRNA	PMID:36318118
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1557107	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of ZBTB7B mRNA	PMID:27029645
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305963	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZBTB7B mRNA	PMID:24780913
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1557107	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ZBTB7B mRNA	PMID:40826991
1314302	ZBTB7B	zinc finger and BTB domain containing 7B	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305963	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ZBTB7B mRNA	PMID:21346803
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314305	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ATAD3A mRNA	PMID:33045310
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314305	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ATAD3A mRNA	PMID:37995155
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314305	E	RGD:6480464	20171010	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ATAD3A mRNA	PMID:28558994
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:132448	perfluorohexanesulfonic acid	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20171010	CTD	MESH:C471071	PPARA protein affects the reaction [perfluorohexanesulfonic acid results in increased expression of ATAD3A mRNA]	PMID:28558994
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305964	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ATAD3A mRNA]	PMID:31150632
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of ATAD3A protein	PMID:36641056
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATAD3A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATAD3A mRNA	PMID:32699268
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of ATAD3A mRNA	PMID:26516004
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ATAD3A mRNA	PMID:30529165
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ATAD3A mRNA	PMID:36331819
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314305	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ATAD3A mRNA	PMID:30319688
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ATAD3A mRNA	PMID:20044591
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314305	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATAD3A mRNA	PMID:39241906
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of ATAD3A mRNA]	PMID:39241906
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305964	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ATAD3A mRNA	PMID:32145629
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ATAD3A mRNA	PMID:31614463
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314305	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ATAD3A mRNA	PMID:39298647
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:16563	tetrahydropalmatine	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in increased expression of ATAD3A protein	PMID:20109541
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1305964	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ATAD3A mRNA	PMID:33387578
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATAD3A mRNA	PMID:37042841
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314305	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of ATAD3A mRNA	PMID:23892564
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ATAD3A protein	PMID:37730182
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ATAD3A mRNA	PMID:28818685
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATAD3A mRNA	PMID:36331819
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305964	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ATAD3A protein	PMID:34915118
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ATAD3A protein	PMID:23301498
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314305	E	RGD:6480464	20131220	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ATAD3A mRNA	PMID:19770486
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATAD3A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATAD3A mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of ATAD3A mRNA	PMID:32699268
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305964	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ATAD3A mRNA	PMID:31150632
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305964	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ATAD3A mRNA]	PMID:31150632
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ATAD3A mRNA]	PMID:22206623
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATAD3A mRNA	PMID:40504410
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ATAD3A protein	PMID:35688186
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ATAD3A mRNA	PMID:27392435
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1305964	E	RGD:6480464	20150825	CTD	MESH:D019833	Genistein results in decreased expression of ATAD3A protein	PMID:24552547
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314305	E	RGD:6480464	20131220	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATAD3A mRNA	PMID:21570461
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20131220	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATAD3A mRNA	PMID:17942748
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ATAD3A mRNA	PMID:20971185
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of ATAD3A mRNA	PMID:28595984|PMID:34032870|PMID:38568856
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1305964	E	RGD:6480464	20250401	CTD	MESH:C017947	sodium arsenite results in increased expression of ATAD3 protein	PMID:29459688
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATAD3A mRNA	PMID:40504410
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of ATAD3A mRNA	PMID:29453283
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314305	E	RGD:6480464	20131220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATAD3A mRNA	PMID:19770486
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATAD3A 5' UTR	PMID:27901495
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ATAD3A mRNA	PMID:20971185
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ATAD3A protein	PMID:25419056
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305964	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ATAD3A mRNA	PMID:34492290
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314305	E	RGD:6480464	20131220	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ATAD3A mRNA	PMID:18648102
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314305	E	RGD:6480464	20131220	CTD	MESH:C006253	pirinixic acid results in increased expression of ATAD3A mRNA	PMID:18301758
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314305	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ATAD3A mRNA	PMID:28472532
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ATAD3A mRNA	PMID:38479592
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ATAD3A mRNA; bisphenol A results in decreased expression of ATAD3A protein	PMID:29275510|PMID:34186270
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305964	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ATAD3A mRNA; bisphenol A results in increased expression of ATAD3A protein	PMID:24552547|PMID:25181051|PMID:34947998
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:33375	gadolinium atom	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20260203	CTD	MESH:D005682	[gadolinium chloride results in increased abundance of Gadolinium] which results in decreased expression of ATAD3A protein; [gadolinium oxide results in increased abundance of Gadolinium] which results in decreased expression of ATAD3A protein	PMID:40796065
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1305964	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of ATAD3A mRNA	PMID:24096037
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1314305	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of ATAD3A mRNA	PMID:24096037
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of ATAD3A protein	PMID:34186270
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314305	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ATAD3A mRNA	PMID:39298647
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ATAD3A protein	PMID:34186270
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1314305	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of ATAD3A mRNA	PMID:31558096
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in increased expression of ATAD3A protein	PMID:34064677
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305964	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ATAD3A mRNA	PMID:32680482
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of ATAD3A mRNA]	PMID:39241906
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1314305	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ATAD3A mRNA	PMID:28558994
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314305	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ATAD3A mRNA	PMID:28903501
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ATAD3A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ATAD3A mRNA	PMID:32699268
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:37288	gadolinium trichloride	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20260203	CTD	MESH:C038958	[gadolinium chloride results in increased abundance of Gadolinium] which results in decreased expression of ATAD3A protein	PMID:40796065
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20131220	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ATAD3A mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATAD3A mRNA]	PMID:17585979
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:3766	clozapine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of ATAD3A protein	PMID:34122009
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314305	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ATAD3A mRNA	PMID:28558994
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1314305	E	RGD:6480464	20171010	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ATAD3A mRNA	PMID:28558994
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATAD3A mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ATAD3A mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ATAD3A mRNA	PMID:36331819
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATAD3A mRNA	PMID:25979313
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ATAD3A mRNA	PMID:23179753
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ATAD3A gene	PMID:29154799
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of ATAD3A mRNA	PMID:36621641
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ATAD3A mRNA	PMID:38832940
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20131220	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ATAD3A mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ATAD3A mRNA]	PMID:17585979
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ATAD3A mRNA	PMID:29523930
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATAD3A mRNA	PMID:40504410
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314305	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ATAD3A mRNA	PMID:35436446
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of ATAD3A mRNA	PMID:18936297
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305964	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ATAD3A mRNA	PMID:24096037
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314305	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ATAD3A mRNA	PMID:17942748|PMID:24096037
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20131220	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATAD3A mRNA	PMID:17942748
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of ATAD3A mRNA	PMID:38568856
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ATAD3A protein	PMID:25419056
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314305	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ATAD3A mRNA	PMID:25620056
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314305	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ATAD3A mRNA; Nanotubes, Carbon results in increased expression of ATAD3A mRNA	PMID:25554681
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305964	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ATAD3A mRNA	PMID:24136188
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314305	E	RGD:6480464	20131220	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ATAD3A mRNA	PMID:19042947
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ATAD3A protein	PMID:32959892
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:63630	tolcapone	affects binding	ISO	RGD:1305964	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to ATAD3A protein	PMID:19783845
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ATAD3A protein	PMID:34186270
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314305	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ATAD3A mRNA	PMID:22206623
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ATAD3A mRNA]	PMID:22206623
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ATAD3A protein	PMID:37664457
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:754906	afuresertib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of ATAD3A mRNA	PMID:28960945
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1305964	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ATAD3A mRNA	PMID:21346803
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314305	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of ATAD3A mRNA]	PMID:39241906
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ATAD3A protein	PMID:37664457
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305964	E	RGD:6480464	20131220	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ATAD3A mRNA	PMID:21346803
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305964	E	RGD:6480464	20131220	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ATAD3A mRNA	PMID:21346803
1314304	ATAD3A	ATPase family AAA domain containing 3A	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305964	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ATAD3A mRNA	PMID:23034163
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314307	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of NCK2 mRNA	PMID:33045310
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305965	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NCK2 mRNA]	PMID:31150632
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1305965	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NCK2 mRNA	PMID:30071829
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of NCK2 mRNA	PMID:33167477
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1314307	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of NCK2 mRNA	PMID:15282401
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305965	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of NCK2 gene	PMID:35440735
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of NCK2 protein	PMID:18951874
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of NCK2 mRNA	PMID:30165855
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of NCK2 mRNA	PMID:17572062
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314307	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NCK2 mRNA	PMID:37992649
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314307	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NCK2 mRNA	PMID:37992649
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305965	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of NCK2 mRNA	PMID:26577399
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of NCK2 protein	PMID:37730182
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305965	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NCK2 mRNA	PMID:33387578
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of NCK2 mRNA	PMID:28818685
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NCK2 mRNA	PMID:35301059
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305965	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NCK2 mRNA	PMID:23630614|PMID:25378103
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NCK2 gene	PMID:27153756
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305965	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NCK2 mRNA	PMID:31150632
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305965	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NCK2 mRNA]	PMID:31150632
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:27656	camptothecin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002166	Camptothecin results in decreased expression of NCK2 mRNA	PMID:17374387
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of NCK2 mRNA	PMID:27392435
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:27924	phenylhydrazine	decreases expression	ISO	RGD:1305965	E	RGD:6480464	20120412	CTD	MESH:C030299	phenylhydrazine results in decreased expression of NCK2 mRNA	PMID:17082564
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305965	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NCK2 mRNA	PMID:22298810
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of NCK2 protein	PMID:18951874
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314307	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of NCK2 mRNA	PMID:32937126
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:2825	aristolochic acid A	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:C000228	aristolochic acid I inhibits the reaction [SLIT2 protein results in increased expression of NCK2 mRNA]; aristolochic acid I inhibits the reaction [SLIT2 protein results in increased expression of NCK2 protein]; NCK1 protein inhibits the reaction [aristolochic acid I inhibits the reaction [SLIT2 protein results in increased expression of NCK2 mRNA]]; NCK1 protein inhibits the reaction [aristolochic acid I inhibits the reaction [SLIT2 protein results in increased expression of NCK2 protein]]	PMID:30381256
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NCK2 mRNA	PMID:29803840
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314307	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NCK2 mRNA	PMID:37992649
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of NCK2 gene	PMID:28589171
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NCK2 mRNA	PMID:38568856
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NCK2 5' UTR	PMID:27901495
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NCK2 promoter	PMID:27901495
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NCK2 gene	PMID:31601247
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305965	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of NCK2 mRNA	PMID:25729387
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305965	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of NCK2 mRNA	PMID:30047161
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314307	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NCK2 gene	PMID:35295148
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314307	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NCK2 gene	PMID:35295148
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305965	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of NCK2 mRNA	PMID:23411599
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314307	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of NCK2 mRNA	PMID:18648102
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314307	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NCK2 mRNA	PMID:18301758|PMID:23811191
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314307	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NCK2 mRNA	PMID:19710929
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305965	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NCK2 mRNA	PMID:25181051
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of NCK2 gene	PMID:31601247
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305965	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of NCK2 mRNA	PMID:30816183|PMID:34947998|PMID:38750585
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314307	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of NCK2 mRNA	PMID:32156529
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NCK2 gene	PMID:31601247
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1314307	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of NCK2 mRNA	PMID:20713471
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of NCK2 intron	PMID:30157460
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314307	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of NCK2 intron	PMID:28392331
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314307	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NCK2 mRNA	PMID:37019170
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NCK2 mRNA	PMID:37042841
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NCK2 mRNA	PMID:38568856
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1305965	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of NCK2 promoter	PMID:22457795
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NCK2 mRNA	PMID:35301059
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305965	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of NCK2 gene	PMID:22079235
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:1305965	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of NCK2 mRNA	PMID:27638505
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NCK2 mRNA	PMID:32588087
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NCK2 mRNA	PMID:25979313
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314307	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of NCK2 mRNA	PMID:17963808
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305965	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of NCK2 mRNA	PMID:38685447|PMID:41580965
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305965	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NCK2 mRNA	PMID:30047161
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of NCK2 mRNA	PMID:27989131
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of NCK2 mRNA	PMID:20106945
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:41977	daunorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003630	Daunorubicin results in decreased expression of NCK2 mRNA	PMID:17374387
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314307	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of NCK2 mRNA	PMID:28973697
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314307	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NCK2 mRNA	PMID:37992649
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314307	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NCK2 mRNA	PMID:17562736
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of NCK2 mRNA	PMID:29067470
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:4911	etoposide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in decreased expression of NCK2 mRNA	PMID:17374387
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305965	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of NCK2 mRNA	PMID:41580965
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305965	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NCK2 mRNA	PMID:30047161
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314307	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NCK2 mRNA	PMID:35964746
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305965	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of NCK2 mRNA	PMID:25729387
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314307	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of NCK2 mRNA	PMID:23650126
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314307	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of NCK2 protein	PMID:36851058
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of NCK2 intron	PMID:30157460
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of NCK2 mRNA	PMID:31758290
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314307	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NCK2 mRNA	PMID:22206623
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NCK2 gene]	PMID:28238834
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:8050	phenacetin	decreases expression	ISO	RGD:1305965	E	RGD:6480464	20120412	CTD	MESH:D010615	Phenacetin results in decreased expression of NCK2 mRNA	PMID:17082564
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1305965	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of NCK2 mRNA	PMID:30047161
1314306	NCK2	NCK adaptor protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305965	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of NCK2 mRNA	PMID:30047161
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314309	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of KLF16 mRNA	PMID:37995155
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of KLF16 mRNA	PMID:31016361
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314309	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of KLF16 mRNA	PMID:20188158
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KLF16 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KLF16 mRNA	PMID:32699268
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of KLF16 mRNA	PMID:23019147|PMID:31614463
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305966	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of KLF16 mRNA	PMID:32145629
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KLF16 protein	PMID:37730182
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305966	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of KLF16 mRNA	PMID:33387578
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLF16 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of KLF16 mRNA	PMID:39836092
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1305966	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of KLF16 mRNA	PMID:41580963
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KLF16 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KLF16 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of KLF16 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of KLF16 mRNA	PMID:32699268|PMID:35430440
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of KLF16 mRNA	PMID:19774075
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314309	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KLF16 mRNA	PMID:31919559
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314309	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KLF16 mRNA	PMID:22206623
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of KLF16 promoter	PMID:21291286
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLF16 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLF16 mRNA	PMID:39836092
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314309	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLF16 mRNA	PMID:40504410
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of KLF16 protein	PMID:35688186
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314309	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of KLF16 mRNA	PMID:28960355
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of KLF16 mRNA	PMID:23557933
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of KLF16 mRNA	PMID:27594783
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314309	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KLF16 mRNA	PMID:21570461|PMID:24058054
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305966	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KLF16 mRNA	PMID:33387578
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314309	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KLF16 mRNA	PMID:19933214
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of KLF16 mRNA	PMID:33212167
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of KLF16 mRNA	PMID:32763439
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KLF16 mRNA	PMID:38568856|PMID:39719251
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLF16 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLF16 mRNA	PMID:39836092
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314309	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLF16 mRNA	PMID:40504410
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KLF16 protein	PMID:32717239
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314309	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KLF16 mRNA	PMID:22228805
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of KLF16 mRNA	PMID:38568856
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C015358	methylparaben results in increased expression of KLF16 mRNA	PMID:38568856
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305966	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of KLF16 mRNA	PMID:30047161
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314309	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KLF16 gene; titanium dioxide results in decreased methylation of KLF16 promoter	PMID:35295148
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314309	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of KLF16 promoter	PMID:27334623
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305966	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KLF16 mRNA	PMID:25181051|PMID:32145629
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314309	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of KLF16 mRNA	PMID:32156529
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of KLF16 intron	PMID:30157460
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314309	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of KLF16 intron	PMID:28392331
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314309	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KLF16 mRNA	PMID:37019170
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of KLF16 gene	PMID:22964155
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KLF16 mRNA	PMID:37042841
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305966	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of KLF16 mRNA	PMID:30589522
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLF16 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of KLF16 mRNA	PMID:39836092
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KLF16 mRNA	PMID:38174414
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:35546	perfluorodecanoic acid	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C036567	perfluorodecanoic acid results in decreased expression of KLF16 mRNA	PMID:38568856
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of KLF16 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of KLF16 mRNA	PMID:32699268
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of KLF16 mRNA	PMID:38568856
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of KLF16 mRNA	PMID:28302478
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of KLF16 mRNA	PMID:31533062
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314309	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of KLF16 mRNA	PMID:36331819
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in increased expression of KLF16 mRNA	PMID:37505509
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KLF16 gene	PMID:29154799
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305966	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of KLF16 mRNA	PMID:30047161
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KLF16 mRNA	PMID:25562108
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KLF16 mRNA	PMID:38832940
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314309	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KLF16 mRNA	PMID:17562736
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of KLF16 mRNA	PMID:29067470
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305966	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KLF16 mRNA	PMID:33387578
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of KLF16 promoter	PMID:21291286
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLF16 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLF16 mRNA	PMID:39836092
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314309	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLF16 mRNA	PMID:40504410
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of KLF16 mRNA	PMID:38568856
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305966	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of KLF16 mRNA	PMID:30047161
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314309	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of KLF16 mRNA	PMID:35964746
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of KLF16 protein	PMID:32959892
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KLF16 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of KLF16 mRNA	PMID:39836092
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of KLF16 mRNA	PMID:24810058
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of KLF16 intron	PMID:30157460
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314309	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KLF16 mRNA	PMID:22206623
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1305966	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of KLF16 mRNA	PMID:23640034
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314309	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of KLF16 mRNA	PMID:39847705
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305966	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of KLF16 mRNA	PMID:24780913|PMID:30047161
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:9150	simvastatin	increases expression	ISO	RGD:1314309	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of KLF16 mRNA	PMID:19262002
1314308	KLF16	KLF transcription factor 16	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of KLF16 mRNA	PMID:29301935
1314310	CUX2	cut like homeobox 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314311	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CUX2 mRNA	PMID:33045310
1314310	CUX2	cut like homeobox 2	gene	CHEBI:15767	dichloromethane	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20171010	CTD	MESH:D008752	Methylene Chloride results in decreased expression of CUX2 mRNA	PMID:28392392
1314310	CUX2	cut like homeobox 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305967	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of CUX2 gene	PMID:35440735
1314310	CUX2	cut like homeobox 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CUX2 mRNA	PMID:22378314
1314310	CUX2	cut like homeobox 2	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1305967	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in increased expression of CUX2 mRNA	PMID:21565894
1314310	CUX2	cut like homeobox 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in decreased expression of CUX2 mRNA	PMID:17023530
1314310	CUX2	cut like homeobox 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CUX2 mRNA	PMID:35811015
1314310	CUX2	cut like homeobox 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CUX2 mRNA	PMID:39241906
1314310	CUX2	cut like homeobox 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314311	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CUX2 mRNA	PMID:12057914
1314310	CUX2	cut like homeobox 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CUX2 mRNA	PMID:35811015
1314310	CUX2	cut like homeobox 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CUX2 mRNA	PMID:39298647
1314310	CUX2	cut like homeobox 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305967	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of CUX2 mRNA	PMID:32145629
1314310	CUX2	cut like homeobox 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of CUX2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of CUX2 mRNA	PMID:17404688|PMID:30165855
1314310	CUX2	cut like homeobox 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305967	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CUX2 mRNA	PMID:33387578
1314310	CUX2	cut like homeobox 2	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of CUX2 mRNA	PMID:18070364
1314310	CUX2	cut like homeobox 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of CUX2 mRNA	PMID:17404688
1314310	CUX2	cut like homeobox 2	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in increased expression of CUX2 mRNA	PMID:17404688
1314310	CUX2	cut like homeobox 2	gene	CHEBI:17303	morphine	increases expression	ISO	RGD:1314311	E	RGD:6480464	20120412	CTD	MESH:D009020	Morphine results in increased expression of CUX2 mRNA	PMID:21178816
1314310	CUX2	cut like homeobox 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314311	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of CUX2 mRNA	PMID:23892564
1314310	CUX2	cut like homeobox 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CUX2 mRNA	PMID:31163220
1314310	CUX2	cut like homeobox 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CUX2 mRNA	PMID:34319233
1314310	CUX2	cut like homeobox 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305967	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of CUX2 mRNA	PMID:22061828
1314310	CUX2	cut like homeobox 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CUX2 intron	PMID:30157460
1314310	CUX2	cut like homeobox 2	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of CUX2 mRNA	PMID:27462272
1314310	CUX2	cut like homeobox 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314311	E	RGD:6480464	20260203	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CUX2 mRNA	PMID:40850461
1314310	CUX2	cut like homeobox 2	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1314311	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of CUX2 intron	PMID:27776689
1314310	CUX2	cut like homeobox 2	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305967	E	RGD:6480464	20130806	CTD	MESH:C016517	indole-3-carbinol affects the expression of CUX2 mRNA	PMID:21396975
1314310	CUX2	cut like homeobox 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305967	E	RGD:6480464	20130806	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA]	PMID:22129741
1314310	CUX2	cut like homeobox 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of CUX2 protein	PMID:20106945
1314310	CUX2	cut like homeobox 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CUX2 gene	PMID:27153756
1314310	CUX2	cut like homeobox 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CUX2 intron	PMID:30157460
1314310	CUX2	cut like homeobox 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1314311	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of CUX2 mRNA	PMID:15674843
1314310	CUX2	cut like homeobox 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305967	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CUX2 mRNA	PMID:31150632
1314310	CUX2	cut like homeobox 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CUX2 mRNA	PMID:25629700
1314310	CUX2	cut like homeobox 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CUX2 gene	PMID:25304211
1314310	CUX2	cut like homeobox 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CUX2 mRNA	PMID:32525701
1314310	CUX2	cut like homeobox 2	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1305967	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of CUX2 gene	PMID:35440735
1314310	CUX2	cut like homeobox 2	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1305967	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA	PMID:33854195
1314310	CUX2	cut like homeobox 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of CUX2 mRNA	PMID:41028656
1314310	CUX2	cut like homeobox 2	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314311	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of CUX2 mRNA	PMID:40618947
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1305967	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of CUX2 gene	PMID:28505145
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CUX2 mRNA	PMID:22298810
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314311	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CUX2 mRNA	PMID:28922406
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CUX2 mRNA	PMID:19692669|PMID:20106945
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305967	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CUX2 mRNA	PMID:21215274
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CUX2 mRNA	PMID:26290441|PMID:37172768
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314311	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CUX2 mRNA	PMID:21889950|PMID:24058054
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314311	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CUX2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CUX2 promoter]	PMID:17942748|PMID:19654925
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of CUX2 mRNA	PMID:29955902
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305967	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of CUX2 mRNA	PMID:28374803
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CUX2 mRNA	PMID:28001369
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CUX2 mRNA	PMID:32763439
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CUX2 mRNA	PMID:41028656
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CUX2 mRNA	PMID:29803840
1314310	CUX2	cut like homeobox 2	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1305967	E	RGD:6480464	20130806	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA]	PMID:22129741
1314310	CUX2	cut like homeobox 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of CUX2 mRNA	PMID:29301061
1314310	CUX2	cut like homeobox 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314311	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of CUX2 mRNA	PMID:37682722
1314310	CUX2	cut like homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CUX2 intron	PMID:30157460
1314310	CUX2	cut like homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CUX2 mRNA	PMID:20106945|PMID:32234424
1314310	CUX2	cut like homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314311	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CUX2 intron	PMID:27901495
1314310	CUX2	cut like homeobox 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CUX2 promoter	PMID:27901495
1314310	CUX2	cut like homeobox 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of CUX2 mRNA	PMID:41028656
1314310	CUX2	cut like homeobox 2	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of CUX2 mRNA	PMID:35984750
1314310	CUX2	cut like homeobox 2	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of CUX2 gene	PMID:31601247
1314310	CUX2	cut like homeobox 2	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1305967	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of CUX2 mRNA	PMID:32479839
1314310	CUX2	cut like homeobox 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305967	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CUX2 mRNA	PMID:30047161
1314310	CUX2	cut like homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1305967	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of CUX2 mRNA	PMID:30012374
1314310	CUX2	cut like homeobox 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314311	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CUX2 gene	PMID:35295148
1314310	CUX2	cut like homeobox 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314311	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CUX2 promoter	PMID:35295148
1314310	CUX2	cut like homeobox 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305967	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CUX2 mRNA	PMID:34492290
1314310	CUX2	cut like homeobox 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of CUX2 mRNA	PMID:20813756|PMID:23811191
1314310	CUX2	cut like homeobox 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CUX2 mRNA	PMID:19710929
1314310	CUX2	cut like homeobox 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314311	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of CUX2 promoter	PMID:27334623
1314310	CUX2	cut like homeobox 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305967	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of CUX2 mRNA	PMID:32145629|PMID:35192832
1314310	CUX2	cut like homeobox 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CUX2 gene	PMID:31601247
1314310	CUX2	cut like homeobox 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305967	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CUX2 mRNA	PMID:30816183
1314310	CUX2	cut like homeobox 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305967	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CUX2 gene	PMID:28505145
1314310	CUX2	cut like homeobox 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305967	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of CUX2 gene	PMID:28505145
1314310	CUX2	cut like homeobox 2	gene	CHEBI:3423	carmustine	affects expression	ISO	RGD:1305967	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine affects the expression of CUX2 mRNA	PMID:19174181
1314310	CUX2	cut like homeobox 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CUX2 mRNA	PMID:19692669
1314310	CUX2	cut like homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CUX2 mRNA	PMID:39298647
1314310	CUX2	cut like homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of CUX2 gene	PMID:31601247
1314310	CUX2	cut like homeobox 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314311	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CUX2 exon	PMID:33297965
1314310	CUX2	cut like homeobox 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CUX2 intron	PMID:30157460
1314310	CUX2	cut like homeobox 2	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1314311	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of CUX2 intron	PMID:28392331
1314310	CUX2	cut like homeobox 2	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1305967	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA	PMID:33854195
1314310	CUX2	cut like homeobox 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of CUX2 gene	PMID:22964155
1314310	CUX2	cut like homeobox 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314311	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CUX2 mRNA	PMID:21266533
1314310	CUX2	cut like homeobox 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305967	E	RGD:6480464	20130806	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA; Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA]	PMID:22129741
1314310	CUX2	cut like homeobox 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305967	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of CUX2 mRNA	PMID:30589522
1314310	CUX2	cut like homeobox 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314311	E	RGD:6480464	20260203	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CUX2 mRNA	PMID:40850461
1314310	CUX2	cut like homeobox 2	gene	CHEBI:37187	lead nitrate	multiple interactions	ISO	RGD:1314311	E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate affects the reaction [CUX2 affects the expression of MT1 mRNA]; lead nitrate affects the reaction [CUX2 affects the expression of MT2 mRNA]	PMID:11891201
1314310	CUX2	cut like homeobox 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CUX2 mRNA	PMID:25979313
1314310	CUX2	cut like homeobox 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314311	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CUX2 mRNA	PMID:17963808
1314310	CUX2	cut like homeobox 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of CUX2 mRNA	PMID:23179753|PMID:23527032|PMID:26272509|PMID:28001369|PMID:29154799
1314310	CUX2	cut like homeobox 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CUX2 mRNA	PMID:23179753|PMID:24935251|PMID:27188386
1314310	CUX2	cut like homeobox 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUX2 mRNA	PMID:27188386
1314310	CUX2	cut like homeobox 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305967	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CUX2 mRNA	PMID:30047161
1314310	CUX2	cut like homeobox 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CUX2 mRNA	PMID:20106945|PMID:27989131
1314310	CUX2	cut like homeobox 2	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1305967	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA	PMID:33854195
1314310	CUX2	cut like homeobox 2	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of CUX2 mRNA	PMID:25123088
1314310	CUX2	cut like homeobox 2	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1314311	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of CUX2 mRNA	PMID:17555576
1314310	CUX2	cut like homeobox 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CUX2 mRNA	PMID:38832940
1314310	CUX2	cut like homeobox 2	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1305967	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA	PMID:33854195
1314310	CUX2	cut like homeobox 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of CUX2 mRNA	PMID:24935251|PMID:26272509
1314310	CUX2	cut like homeobox 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of CUX2 mRNA	PMID:24935251
1314310	CUX2	cut like homeobox 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUX2 mRNA	PMID:27188386
1314310	CUX2	cut like homeobox 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of CUX2 mRNA	PMID:29067470
1314310	CUX2	cut like homeobox 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CUX2 mRNA	PMID:35811015
1314310	CUX2	cut like homeobox 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CUX2 mRNA	PMID:19446018
1314310	CUX2	cut like homeobox 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CUX2 gene	PMID:25304211
1314310	CUX2	cut like homeobox 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CUX2 mRNA	PMID:32525701
1314310	CUX2	cut like homeobox 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305967	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CUX2 mRNA	PMID:29391264
1314310	CUX2	cut like homeobox 2	gene	CHEBI:4811	epoxiconazole	affects expression	ISO	RGD:1314311	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole affects the expression of CUX2 mRNA	PMID:35436446
1314310	CUX2	cut like homeobox 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314311	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CUX2 mRNA	PMID:17942748
1314310	CUX2	cut like homeobox 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314311	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CUX2 mRNA	PMID:17942748
1314310	CUX2	cut like homeobox 2	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CUX2 mRNA	PMID:32234424
1314310	CUX2	cut like homeobox 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CUX2 mRNA	PMID:25620056
1314310	CUX2	cut like homeobox 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305967	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CUX2 mRNA	PMID:30047161
1314310	CUX2	cut like homeobox 2	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1305967	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA	PMID:33854195
1314310	CUX2	cut like homeobox 2	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of CUX2 mRNA	PMID:20436886
1314310	CUX2	cut like homeobox 2	gene	CHEBI:63613	nevirapine	decreases expression	ISO	RGD:1305967	E	RGD:6480464	20140114	CTD	MESH:D019829	Nevirapine metabolite results in decreased expression of CUX2 mRNA	PMID:23947594
1314310	CUX2	cut like homeobox 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of CUX2 mRNA	PMID:24810058
1314310	CUX2	cut like homeobox 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305967	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CUX2 mRNA	PMID:28801915
1314310	CUX2	cut like homeobox 2	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CUX2 mRNA	PMID:22079614
1314310	CUX2	cut like homeobox 2	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1314311	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of CUX2 mRNA	PMID:20003209
1314310	CUX2	cut like homeobox 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CUX2 intron	PMID:30157460
1314310	CUX2	cut like homeobox 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305967	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CUX2 gene	PMID:35440735
1314310	CUX2	cut like homeobox 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUX2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUX2 mRNA	PMID:27188386
1314310	CUX2	cut like homeobox 2	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CUX2 mRNA	PMID:19159669
1314310	CUX2	cut like homeobox 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CUX2 mRNA	PMID:32525701
1314310	CUX2	cut like homeobox 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305967	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CUX2 mRNA	PMID:30047161
1314310	CUX2	cut like homeobox 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUX2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUX2 mRNA	PMID:27188386
1314310	CUX2	cut like homeobox 2	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314311	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of CUX2 mRNA	PMID:35537566
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of CHMP5 mRNA	PMID:35967413
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of CHMP5 mRNA	PMID:33167477
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550717	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CHMP5 mRNA	PMID:30319688
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of CHMP5 mRNA	PMID:23019147
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550717	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CHMP5 mRNA	PMID:39298647
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CHMP5 mRNA	PMID:23649840
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550717	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CHMP5 mRNA	PMID:34319233
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CHMP5 mRNA	PMID:19549813
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CHMP5 protein	PMID:23301498
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of CHMP5 mRNA	PMID:25102026
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305968	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of CHMP5 mRNA	PMID:30779732
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550717	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHMP5 mRNA	PMID:22206623
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHMP5 mRNA	PMID:39836092
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550717	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CHMP5 mRNA	PMID:40504410
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of CHMP5 protein	PMID:35688186
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CHMP5 mRNA	PMID:23557933
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1305968	E	RGD:6480464	20250311	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in increased expression of CHMP5 mRNA	PMID:39276841
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550717	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHMP5 mRNA	PMID:21570461
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CHMP5 mRNA	PMID:33212167
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1305968	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of CHMP5 mRNA	PMID:28959563
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of CHMP5 mRNA	PMID:39719251
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CHMP5 mRNA; sodium arsenite results in increased expression of CHMP5 protein	PMID:38228842|PMID:38568856
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHMP5 mRNA	PMID:39836092
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550717	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CHMP5 mRNA	PMID:40504410
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1305968	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CHMP5 mRNA	PMID:21839799
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550717	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CHMP5 mRNA	PMID:22228805
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1550717	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CHMP5 3' UTR; Benzo(a)pyrene results in increased methylation of CHMP5 exon; Benzo(a)pyrene results in increased methylation of CHMP5 intron	PMID:27901495
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CHMP5 mRNA]	PMID:32406909
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1305968	E	RGD:6480464	20250311	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in increased expression of CHMP5 mRNA	PMID:39276841
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550717	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CHMP5 gene	PMID:35295148
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550717	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CHMP5 mRNA	PMID:18445702
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CHMP5 mRNA	PMID:38479592
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305968	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of CHMP5 mRNA	PMID:41034487
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of CHMP5 mRNA; bisphenol A results in increased expression of CHMP5 protein	PMID:25047013|PMID:37567409
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305968	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CHMP5 mRNA	PMID:25181051|PMID:41034487
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CHMP5 protein	PMID:34186270
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CHMP5 protein	PMID:34186270
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550717	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CHMP5 mRNA	PMID:38685157
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CHMP5 mRNA	PMID:37042841
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305968	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of CHMP5 gene	PMID:22079235
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CHMP5 mRNA	PMID:28302478
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CHMP5 mRNA	PMID:31533062
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of CHMP5 mRNA	PMID:26352163
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of CHMP5 mRNA	PMID:29154799
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of CHMP5 mRNA	PMID:17183730
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CHMP5 mRNA	PMID:20106945|PMID:25562108
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:45979	thiabendazole	affects expression	ISO	RGD:1305968	E	RGD:6480464	20120412	CTD	MESH:D013827	Thiabendazole affects the expression of CHMP5 mRNA	PMID:18539377
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CHMP5 mRNA	PMID:39836092
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550717	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CHMP5 mRNA	PMID:40504410
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550717	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CHMP5 mRNA	PMID:35436446
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of CHMP5 mRNA	PMID:17183730
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CHMP5 protein	PMID:32959892
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:64227	ciglitazone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C039671	[ciglitazone binds to PPARG protein] which results in increased expression of CHMP5 mRNA	PMID:16197558
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1550717	E	RGD:6480464	20200317	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of CHMP5 mRNA	PMID:22078008
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550717	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CHMP5 mRNA	PMID:22206623
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550717	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CHMP5 mRNA	PMID:22206623
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550717	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CHMP5 mRNA	PMID:31388691
1314312	CHMP5	charged multivesicular body protein 5	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of CHMP5 mRNA	PMID:27188386
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1314315	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in decreased expression of VPS4B mRNA	PMID:16931933
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314315	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of VPS4B mRNA	PMID:33045310
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of VPS4B mRNA	PMID:22378314
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of VPS4B mRNA	PMID:23649840
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of VPS4B protein	PMID:37730182
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305969	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of VPS4B mRNA	PMID:22061828
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of VPS4B mRNA	PMID:28818685
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305969	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of VPS4B protein	PMID:34915118
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314315	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VPS4B mRNA	PMID:37325564
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of VPS4B mRNA	PMID:19549813
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of VPS4B mRNA	PMID:23649840
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314315	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of VPS4B mRNA	PMID:31919559
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314315	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of VPS4B mRNA	PMID:25629700
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314315	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VPS4B mRNA	PMID:22206623
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314315	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of VPS4B mRNA	PMID:32186404
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305969	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of VPS4B mRNA	PMID:33387578
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305969	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VPS4B mRNA	PMID:32109520
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314315	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VPS4B mRNA	PMID:19770486
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of VPS4B protein	PMID:39603559
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of VPS4B mRNA	PMID:32763439
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314315	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of VPS4B protein	PMID:28918527
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of VPS4B mRNA	PMID:29803840
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of VPS4B protein	PMID:35688186
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of VPS4B mRNA	PMID:38568856
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314315	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of VPS4B mRNA	PMID:22228805
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of VPS4B mRNA	PMID:19150397
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of VPS4B mRNA	PMID:26238291
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314315	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of VPS4B mRNA	PMID:18648102
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of VPS4B protein	PMID:31675489
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305969	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of VPS4B mRNA	PMID:34947998
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of VPS4B protein	PMID:34186270
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305969	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of VPS4B mRNA	PMID:25181051
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314315	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of VPS4B mRNA	PMID:40036665
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VPS4B mRNA	PMID:28628672
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of VPS4B protein	PMID:31675489
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314315	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of VPS4B mRNA	PMID:39298647
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of VPS4B protein	PMID:38598786
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VPS4B mRNA	PMID:28628672
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314315	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of VPS4B mRNA	PMID:37325564
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of VPS4B mRNA	PMID:19376846
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of VPS4B mRNA	PMID:28302478
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314315	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of VPS4B mRNA	PMID:19770486
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VPS4B mRNA	PMID:28628672
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314315	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of VPS4B mRNA	PMID:17562736
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305969	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of VPS4B mRNA	PMID:33387578
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1314315	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of VPS4B	PMID:19105532
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VPS4B mRNA	PMID:28628672
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305969	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of VPS4B mRNA	PMID:24136188|PMID:24793618
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of VPS4B protein	PMID:32959892
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1314315	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in decreased expression of VPS4B mRNA	PMID:16931933
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314315	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of VPS4B mRNA	PMID:23650126
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of VPS4B mRNA	PMID:28988120
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1314315	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of VPS4B protein	PMID:26558463
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of VPS4B protein	PMID:34186270
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314315	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of VPS4B mRNA	PMID:22206623
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314315	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VPS4B mRNA	PMID:22206623
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to VPS4B gene]	PMID:28238834
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of VPS4B protein	PMID:31675489
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of VPS4B protein	PMID:31675489
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305969	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of VPS4B mRNA	PMID:19281266
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of VPS4B protein	PMID:38598786
1314314	VPS4B	vacuolar protein sorting 4 homolog B	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1305969	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of VPS4B mRNA	PMID:21346803
1314316	CD68	CD68 molecule	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1314317	E	RGD:6480464	20150414	CTD	MESH:C007262	deoxynivalenol results in increased expression of CD68 mRNA	PMID:25549547
1314316	CD68	CD68 molecule	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CD68 mRNA	PMID:38218311
1314316	CD68	CD68 molecule	gene	CHEBI:110423	clodronic acid	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20160510	CTD	MESH:D004002	Clodronic Acid inhibits the reaction [PTEN gene mutant form results in increased expression of CD68 mRNA]	PMID:27022031
1314316	CD68	CD68 molecule	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CD68 mRNA	PMID:33045310
1314316	CD68	CD68 molecule	gene	CHEBI:132606	mono(2-ethyl-5-oxohexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:C080276	mono(2-ethyl-5-oxohexyl)phthalate results in decreased expression of CD68 mRNA	PMID:32015430
1314316	CD68	CD68 molecule	gene	CHEBI:132612	monobenzyl phthalate	increases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:C103325	mono-benzyl phthalate results in increased expression of CD68 mRNA	PMID:32015430
1314316	CD68	CD68 molecule	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CD68 protein]	PMID:38195004
1314316	CD68	CD68 molecule	gene	CHEBI:135136	nifuroxazide	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20180410	CTD	MESH:C013150	nifuroxazide inhibits the reaction [Streptozocin results in increased expression of CD68 protein]	PMID:29291386
1314316	CD68	CD68 molecule	gene	CHEBI:146244	HU-308	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20200407	CTD	MESH:C402416	HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CD68 protein]	PMID:29560022
1314316	CD68	CD68 molecule	gene	CHEBI:149906	Tanshinone I	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20200602	CTD	MESH:C021751	tanshinone results in decreased expression of CD68 protein	PMID:20854809
1314316	CD68	CD68 molecule	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20121113	CTD	MESH:D002794	[Dietary Fats co-treated with Choline deficiency] results in increased expression of CD68 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] results in increased expression of CD68 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CD68 mRNA; [Methionine deficiency co-treated with Choline deficiency] results in increased expression of CD68 mRNA; PANX1 gene mutant form inhibits the reaction [[Dietary Fats co-treated with Choline deficiency] results in increased expression of CD68 mRNA]; Smoke affects the reaction [[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] results in increased expression of CD68 mRNA]	PMID:20697377|PMID:20938992|PMID:29246445|PMID:31678261
1314316	CD68	CD68 molecule	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1314317	E	RGD:40925931|PMID:25004394	20210122	RGD	MESH:D014212	all-trans-retinoic acid decreases expression of CD68 protein in colonic lamina propria of DSS-induced colitis mice	
1314316	CD68	CD68 molecule	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of CD68 mRNA	PMID:33167477
1314316	CD68	CD68 molecule	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20220809	CTD	MESH:D014212	[Chir 99021 co-treated with BMP4 protein co-treated with FGF10 protein co-treated with FGF7 protein co-treated with Tretinoin] results in increased expression of CD68 mRNA	PMID:35267148
1314316	CD68	CD68 molecule	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20190910	CTD	MESH:D010100	HU 308 inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CD68 protein]; iodopravadoline inhibits the reaction [peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CD68 protein]]; peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CD68 protein]	PMID:29560022
1314316	CD68	CD68 molecule	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CD68 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of CD68 mRNA	PMID:19640911|PMID:30529165
1314316	CD68	CD68 molecule	gene	CHEBI:15551	prostaglandin E2	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20150310	CTD	MESH:D015232	Dinoprostone inhibits the reaction [Carbon Tetrachloride results in increased expression of CD68 protein]	PMID:25432964
1314316	CD68	CD68 molecule	gene	CHEBI:15600	(+)-catechin	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20130122	CTD	MESH:D002392	[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CD68 mRNA	PMID:16806235
1314316	CD68	CD68 molecule	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of CD68 mRNA	PMID:26079696
1314316	CD68	CD68 molecule	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1314317	E	RGD:6480464	20210406	CTD	MESH:D019308	Palmitic Acid results in increased expression of CD68 mRNA	PMID:32905826
1314316	CD68	CD68 molecule	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20210406	CTD	MESH:D019308	amlexanox inhibits the reaction [Palmitic Acid results in increased expression of CD68 mRNA]	PMID:32905826
1314316	CD68	CD68 molecule	gene	CHEBI:15939	glycyrrhizinic acid	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20241001	CTD	MESH:D019695	Glycyrrhizic Acid inhibits the reaction [Sodium Nitrite results in increased expression of CD68 protein]	PMID:33030083
1314316	CD68	CD68 molecule	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1305970	E	RGD:407424596|PMID:23277536	20240730	RGD	MESH:D000431	ethanol increases expression of CD68 protein in liver	
1314316	CD68	CD68 molecule	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1305970	E	RGD:407424599|PMID:29399060	20240731	RGD	MESH:D000431	ethanol increases expression of Cd68 mRNA and protein in liver	
1314316	CD68	CD68 molecule	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314317	E	RGD:6480464	20180313	CTD	MESH:D000431	Ethanol results in increased expression of CD68 mRNA	PMID:26858005
1314316	CD68	CD68 molecule	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1305970	E	RGD:407424596|PMID:23277536	20240730	RGD	MESH:D000431	puerarin inhibits the reaction [ethanol increases expression of CD68 protein in liver]	
1314316	CD68	CD68 molecule	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20180313	CTD	MESH:D000431	[Fructose co-treated with Ethanol] results in increased expression of CD68 mRNA	PMID:26858005
1314316	CD68	CD68 molecule	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CD68 mRNA	PMID:21179406
1314316	CD68	CD68 molecule	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1314317	E	RGD:6480464	20120501	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of CD68 mRNA	PMID:14729362|PMID:15003993
1314316	CD68	CD68 molecule	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin inhibits the reaction [Dietary Fats results in increased expression of CD68 mRNA]; Quercetin inhibits the reaction [Dietary Fats results in increased expression of CD68 protein]	PMID:25614714
1314316	CD68	CD68 molecule	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1305970	E	RGD:6480464	20171114	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CD68 mRNA; Lipopolysaccharides results in increased expression of CD68 protein	PMID:28693884|PMID:29425760|PMID:33766721
1314316	CD68	CD68 molecule	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314317	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CD68 mRNA	PMID:27339419
1314316	CD68	CD68 molecule	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[Lipopolysaccharides co-treated with IFNG protein co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CD68 protein; Lipopolysaccharides inhibits the reaction [Propofol results in increased expression of CD68 mRNA]; Lipopolysaccharides inhibits the reaction [Sevoflurane results in increased expression of CD68 mRNA]	PMID:35953652|PMID:40783014
1314316	CD68	CD68 molecule	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20140805	CTD	MESH:C040048	[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CD68 mRNA	PMID:16806235
1314316	CD68	CD68 molecule	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol affects the expression of CD68 mRNA	PMID:25321415
1314316	CD68	CD68 molecule	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of CD68 mRNA	PMID:15598610
1314316	CD68	CD68 molecule	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CD68 mRNA	PMID:39298647
1314316	CD68	CD68 molecule	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305970	E	RGD:6480464	20181016	CTD	MESH:D004958	Estradiol results in increased expression of CD68 protein	PMID:29425760
1314316	CD68	CD68 molecule	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314317	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of CD68 mRNA	PMID:15289156|PMID:19484750
1314316	CD68	CD68 molecule	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20130813	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD68 mRNA; [Estradiol co-treated with Progesterone] results in decreased expression of CD68 mRNA	PMID:21277368|PMID:32741896
1314316	CD68	CD68 molecule	gene	CHEBI:16598	DDE	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D003633	[Lipopolysaccharides co-treated with IFNG protein co-treated with Dichlorodiphenyl Dichloroethylene] affects the expression of CD68 protein	PMID:40783014
1314316	CD68	CD68 molecule	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305970	E	RGD:6480464	20260804	CTD	MESH:D014241	Trichloroethylene results in increased expression of CD68 protein	PMID:38705492
1314316	CD68	CD68 molecule	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20260804	CTD	MESH:D014241	2,6-dimethyl-4-(6-(5-(1-methylcyclopropoxy)-1H-indazol-3-yl)pyrimidin-4-yl)morpholine inhibits the reaction [Trichloroethylene results in increased expression of CD68 protein]	PMID:38705492
1314316	CD68	CD68 molecule	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] results in increased expression of CD68 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CD68 mRNA; [Methionine deficiency co-treated with Choline deficiency] results in increased expression of CD68 mRNA; Smoke affects the reaction [[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] results in increased expression of CD68 mRNA]	PMID:20697377|PMID:20938992|PMID:31678261
1314316	CD68	CD68 molecule	gene	CHEBI:16708	adenine	increases expression	ISO	RGD:1314317	E	RGD:6480464	20220111	CTD	MESH:D000225	Adenine results in increased expression of CD68 mRNA; Adenine results in increased expression of CD68 protein	PMID:34619300
1314316	CD68	CD68 molecule	gene	CHEBI:16827	corticosterone	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20180828	CTD	MESH:D003345	[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA]	PMID:29751049
1314316	CD68	CD68 molecule	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of CD68 mRNA	PMID:39245080
1314316	CD68	CD68 molecule	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20130813	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of CD68 mRNA	PMID:21277368
1314316	CD68	CD68 molecule	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CD68 mRNA	PMID:26079696
1314316	CD68	CD68 molecule	gene	CHEBI:17226	rosmarinic acid	decreases expression	ISO	RGD:1305970	E	RGD:6480464	20240206	CTD	MESH:C041376	Rosmarinic Acid results in decreased expression of CD68 protein	PMID:28789951
1314316	CD68	CD68 molecule	gene	CHEBI:172336	2,2'-Methylenebis(4-methyl-6-tert-butylphenol)	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C008437	[CYP3A4 protein affects the susceptibility to 2,2'-methylenebis(4-methyl-6-tert-butylphenol)] which affects the expression of CD68 mRNA	PMID:38160208
1314316	CD68	CD68 molecule	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased cleavage of CD68 protein; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CD68 mRNA	PMID:37992649
1314316	CD68	CD68 molecule	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of CD68 mRNA	PMID:21592394
1314316	CD68	CD68 molecule	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of CD68 mRNA	PMID:21592394
1314316	CD68	CD68 molecule	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD68 mRNA	PMID:32741896
1314316	CD68	CD68 molecule	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20130122	CTD	MESH:C040048	[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CD68 mRNA	PMID:16806235
1314316	CD68	CD68 molecule	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased cleavage of CD68 protein; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CD68 mRNA	PMID:37992649
1314316	CD68	CD68 molecule	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20180828	CTD	MESH:D009538	[Nicotine results in increased abundance of Cotinine] which results in increased expression of CD68 mRNA	PMID:29617909
1314316	CD68	CD68 molecule	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1305970	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CD68 mRNA; Diethylhexyl Phthalate results in increased expression of CD68 protein	PMID:30550969|PMID:32533902
1314316	CD68	CD68 molecule	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate promotes the reaction [Dietary Fats results in increased expression of CD68 mRNA]	PMID:34303773
1314316	CD68	CD68 molecule	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305970	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CD68 mRNA; Cuprizone results in increased expression of CD68 protein	PMID:26577399|PMID:27523638
1314316	CD68	CD68 molecule	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1314317	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CD68 mRNA	PMID:30468814
1314316	CD68	CD68 molecule	gene	CHEBI:177802	Cuprizon	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20210907	CTD	MESH:D003471	Genistein inhibits the reaction [Cuprizone results in increased expression of CD68 mRNA]	PMID:30468814
1314316	CD68	CD68 molecule	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CD68 mRNA	PMID:21592394
1314316	CD68	CD68 molecule	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of CD68 mRNA	PMID:21592394
1314316	CD68	CD68 molecule	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305970	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CD68 mRNA	PMID:22061828|PMID:33387578
1314316	CD68	CD68 molecule	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1314317	E	RGD:6480464	20140715	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CD68 mRNA	PMID:22746536|PMID:27277809
1314316	CD68	CD68 molecule	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20140715	CTD	MESH:D015632	(2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid) trifluoroethylamide inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CD68 mRNA]; 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CD68 mRNA]; Dimethyl Fumarate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CD68 mRNA]	PMID:22746536|PMID:27277809
1314316	CD68	CD68 molecule	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CD68 mRNA	PMID:28818685
1314316	CD68	CD68 molecule	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of CD68 mRNA	PMID:37748715
1314316	CD68	CD68 molecule	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CD68 mRNA	PMID:36331819
1314316	CD68	CD68 molecule	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CD68 mRNA	PMID:39836092
1314316	CD68	CD68 molecule	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1305970	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CD68 mRNA	PMID:28522335
1314316	CD68	CD68 molecule	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20180828	CTD	MESH:D009538	[Nicotine results in increased abundance of Cotinine] which results in increased expression of CD68 mRNA	PMID:29617909
1314316	CD68	CD68 molecule	gene	CHEBI:2208	purine-6-thiol	increases expression	ISO	RGD:1305970	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of CD68 mRNA	PMID:23358152
1314316	CD68	CD68 molecule	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CD68 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CD68 protein	PMID:38195004
1314316	CD68	CD68 molecule	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20210608	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CD68 mRNA; [NFE2L2 protein affects the susceptibility to [Cadmium Chloride results in increased abundance of Cadmium]] which results in increased expression of CD68 mRNA	PMID:33398418|PMID:37236586
1314316	CD68	CD68 molecule	gene	CHEBI:231613	AM6545	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20240702	CTD	MESH:C551825	AM6545 inhibits the reaction [Streptozocin results in increased expression of CD68 mRNA]; AM6545 promotes the reaction [Perindopril inhibits the reaction [Streptozocin results in increased expression of CD68 mRNA]]; Perindopril promotes the reaction [AM6545 inhibits the reaction [Streptozocin results in increased expression of CD68 mRNA]]	PMID:30184259
1314316	CD68	CD68 molecule	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CD68 mRNA	PMID:19549813
1314316	CD68	CD68 molecule	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1305970	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CD68 mRNA	PMID:33354967
1314316	CD68	CD68 molecule	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of CD68 mRNA	PMID:25102026
1314316	CD68	CD68 molecule	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CD68 mRNA	PMID:35430440
1314316	CD68	CD68 molecule	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CD68 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CD68 mRNA	PMID:34911549
1314316	CD68	CD68 molecule	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20180313	CTD	MESH:D012965	[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CD68 mRNA; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CD68 mRNA]	PMID:27678262
1314316	CD68	CD68 molecule	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1305970	E	RGD:6480464	20150825	CTD	MESH:C011559	tributyltin results in increased expression of CD68 protein	PMID:25819109
1314316	CD68	CD68 molecule	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CD68 mRNA	PMID:17484886
1314316	CD68	CD68 molecule	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314317	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CD68 mRNA; Carbon Tetrachloride results in increased expression of CD68 protein	PMID:25432964|PMID:27339419|PMID:29987408|PMID:31919559
1314316	CD68	CD68 molecule	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20150310	CTD	MESH:D002251	Dinoprostone inhibits the reaction [Carbon Tetrachloride results in increased expression of CD68 protein]	PMID:25432964
1314316	CD68	CD68 molecule	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1314317	E	RGD:6480464	20220111	CTD	MESH:D005492	Folic Acid results in increased expression of CD68 mRNA; Folic Acid results in increased expression of CD68 protein	PMID:34619300
1314316	CD68	CD68 molecule	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CD68 mRNA	PMID:20938992
1314316	CD68	CD68 molecule	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CD68 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CD68 mRNA	PMID:32525701|PMID:39836092
1314316	CD68	CD68 molecule	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20221206	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 protein; Minocycline affects the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 protein]; Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 mRNA]	PMID:35351628|PMID:35777461|PMID:40504410
1314316	CD68	CD68 molecule	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1314317	E	RGD:6480464	20191105	CTD	MESH:D000968	Antimycin A results in increased expression of CD68 mRNA	PMID:19304788
1314316	CD68	CD68 molecule	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305970	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CD68 mRNA	PMID:31881176
1314316	CD68	CD68 molecule	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of CD68 mRNA	PMID:25905778
1314316	CD68	CD68 molecule	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20130122	CTD	MESH:C059514	[resveratrol co-treated with Catechin co-treated with caffeic acid] results in decreased expression of CD68 mRNA; resveratrol inhibits the reaction [Calcium Chloride results in increased expression of CD68 mRNA]	PMID:16806235|PMID:21530968
1314316	CD68	CD68 molecule	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CD68 mRNA	PMID:27392435
1314316	CD68	CD68 molecule	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of CD68 mRNA	PMID:20702592
1314316	CD68	CD68 molecule	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CD68 mRNA	PMID:27392435
1314316	CD68	CD68 molecule	gene	CHEBI:28073	chromium atom	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20130611	CTD	MESH:D002857	Chromium inhibits the reaction [Dietary Fats results in increased expression of CD68 protein]	PMID:20513351
1314316	CD68	CD68 molecule	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1305970	E	RGD:6480464	20250311	CTD	MESH:D019833	Genistein results in increased expression of CD68 mRNA	PMID:32533902
1314316	CD68	CD68 molecule	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of CD68 mRNA	PMID:15289156
1314316	CD68	CD68 molecule	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20190219	CTD	MESH:D019833	Genistein inhibits the reaction [Cuprizone results in increased expression of CD68 mRNA]	PMID:30468814
1314316	CD68	CD68 molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305970	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CD68 mRNA	PMID:34747641
1314316	CD68	CD68 molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314317	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CD68 mRNA	PMID:21570461|PMID:28922406
1314316	CD68	CD68 molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305970	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CD68 mRNA	PMID:21215274
1314316	CD68	CD68 molecule	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314317	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CD68 mRNA	PMID:27713108
1314316	CD68	CD68 molecule	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1305970	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of CD68 mRNA; Rotenone results in increased expression of CD68 protein	PMID:17356569|PMID:28374803|PMID:29649621
1314316	CD68	CD68 molecule	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314317	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in increased expression of CD68 mRNA	PMID:19304788|PMID:23186747
1314316	CD68	CD68 molecule	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20201103	CTD	MESH:D012402	PARK7 protein inhibits the reaction [Rotenone results in increased expression of CD68 protein]	PMID:29649621
1314316	CD68	CD68 molecule	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20120412	CTD	MESH:D012402	N-(1-methylethyl)-1,1,2-trimethylpropylamine inhibits the reaction [Rotenone results in increased expression of CD68 protein]	PMID:17356569
1314316	CD68	CD68 molecule	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1305970	E	RGD:6480464	20200211	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CD68 mRNA	PMID:31378766
1314316	CD68	CD68 molecule	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CD68 mRNA	PMID:33212167
1314316	CD68	CD68 molecule	gene	CHEBI:2825	aristolochic acid A	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20160510	CTD	MESH:C000228	[aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CD68 mRNA	PMID:23912714
1314316	CD68	CD68 molecule	gene	CHEBI:28527	rutin	decreases expression	ISO	RGD:1305970	E	RGD:6480464	20171114	CTD	MESH:D012431	Rutin results in decreased expression of CD68 protein	PMID:28693884
1314316	CD68	CD68 molecule	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20151013	CTD	MESH:D003300	[gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of CD68 mRNA; [gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of CD68 protein	PMID:25813056
1314316	CD68	CD68 molecule	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20180515	CTD	MESH:D019328	[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CD68 mRNA; gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CD68 mRNA]	PMID:26177832
1314316	CD68	CD68 molecule	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of CD68 mRNA	PMID:39631538
1314316	CD68	CD68 molecule	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CD68 mRNA	PMID:29803840
1314316	CD68	CD68 molecule	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314317	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of CD68 mRNA	PMID:25896364
1314316	CD68	CD68 molecule	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20120412	CTD	MESH:D005632	[Dietary Fats co-treated with Fructose] results in increased expression of CD68 mRNA; [gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of CD68 mRNA; [gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of CD68 protein	PMID:19632207|PMID:25813056
1314316	CD68	CD68 molecule	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20180313	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased cleavage of CD68 protein; [FGF21 gene mutant form results in increased susceptibility to Fructose] which results in increased expression of CD68 mRNA; [Fructose co-treated with Ethanol] results in increased expression of CD68 mRNA; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CD68 mRNA	PMID:26858005|PMID:28123933|PMID:37992649
1314316	CD68	CD68 molecule	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased cleavage of CD68 protein	PMID:37992649
1314316	CD68	CD68 molecule	gene	CHEBI:28925	mechlorethamine	increases expression	ISO	RGD:1305970	E	RGD:6480464	20180313	CTD	MESH:D008466	Mechlorethamine results in increased expression of CD68 protein	PMID:26273949
1314316	CD68	CD68 molecule	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of CD68 mRNA	PMID:22714537|PMID:38568856
1314316	CD68	CD68 molecule	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CD68 mRNA	PMID:39836092
1314316	CD68	CD68 molecule	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20221206	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 protein; Minocycline affects the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 protein]; Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 mRNA]	PMID:35351628|PMID:35777461|PMID:40504410
1314316	CD68	CD68 molecule	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314317	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CD68 mRNA	PMID:22228805
1314316	CD68	CD68 molecule	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CD68 exon; Benzo(a)pyrene results in increased methylation of CD68 promoter	PMID:27901495
1314316	CD68	CD68 molecule	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20151013	CTD	MESH:D003300	[gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of CD68 mRNA; [gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of CD68 protein	PMID:25813056
1314316	CD68	CD68 molecule	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314317	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CD68 mRNA	PMID:27131904
1314316	CD68	CD68 molecule	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CD68 mRNA	PMID:25895662
1314316	CD68	CD68 molecule	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1305970	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CD68 mRNA	PMID:22431001
1314316	CD68	CD68 molecule	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314317	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CD68 mRNA	PMID:29341224|PMID:38811393
1314316	CD68	CD68 molecule	gene	CHEBI:30768	propionic acid	increases expression	ISO	RGD:1305970	E	RGD:6480464	20120412	CTD	MESH:C029658	propionic acid results in increased expression of CD68 protein	PMID:16950524
1314316	CD68	CD68 molecule	gene	CHEBI:30772	butyric acid	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20180828	CTD	MESH:D020148	Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA]	PMID:29751049
1314316	CD68	CD68 molecule	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of CD68 mRNA	PMID:35984750
1314316	CD68	CD68 molecule	gene	CHEBI:31205	amlexanox	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20210406	CTD	MESH:C045742	amlexanox inhibits the reaction [Palmitic Acid results in increased expression of CD68 mRNA]	PMID:32905826
1314316	CD68	CD68 molecule	gene	CHEBI:31746	kainic acid	increases expression	ISO	RGD:1305970	E	RGD:6480464	20121009	CTD	MESH:D007608	Kainic Acid results in increased expression of CD68 mRNA	PMID:19700661
1314316	CD68	CD68 molecule	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1314317	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of CD68 mRNA	PMID:21829687
1314316	CD68	CD68 molecule	gene	CHEBI:32026	Poloxamer	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20200915	CTD	MESH:D020442	Poloxamer inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CD68 mRNA]	PMID:32169474
1314316	CD68	CD68 molecule	gene	CHEBI:32181	tamibarotene	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of CD68 mRNA	PMID:20861477
1314316	CD68	CD68 molecule	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1305970	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of CD68 mRNA	PMID:24136188
1314316	CD68	CD68 molecule	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314317	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of CD68 mRNA	PMID:23557971|PMID:27760801
1314316	CD68	CD68 molecule	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305970	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CD68 mRNA	PMID:34492290
1314316	CD68	CD68 molecule	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CD68 mRNA	PMID:28943392
1314316	CD68	CD68 molecule	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305970	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CD68 mRNA	PMID:25380136
1314316	CD68	CD68 molecule	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CD68 mRNA	PMID:19710929
1314316	CD68	CD68 molecule	gene	CHEBI:32798	9-cis,11-trans-octadecadienoic acid	affects expression	ISO	RGD:1314317	E	RGD:6480464	20170110	CTD	MESH:C503589	cis-9, trans-11-conjugated linoleic acid affects the expression of CD68 mRNA	PMID:17327424
1314316	CD68	CD68 molecule	gene	CHEBI:3312	calcium dichloride	increases expression	ISO	RGD:1314317	E	RGD:6480464	20130122	CTD	MESH:D002122	Calcium Chloride results in increased expression of CD68 mRNA	PMID:21530968
1314316	CD68	CD68 molecule	gene	CHEBI:3312	calcium dichloride	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20130122	CTD	MESH:D002122	resveratrol inhibits the reaction [Calcium Chloride results in increased expression of CD68 mRNA]	PMID:21530968
1314316	CD68	CD68 molecule	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CD68 mRNA	PMID:30903817
1314316	CD68	CD68 molecule	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305970	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CD68 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314316	CD68	CD68 molecule	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305970	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CD68 mRNA; bisphenol A results in increased expression of CD68 protein	PMID:25181051|PMID:34165232
1314316	CD68	CD68 molecule	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314317	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of CD68 mRNA	PMID:25047101|PMID:34585602
1314316	CD68	CD68 molecule	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20211109	CTD	MESH:C006780	lithospermate B inhibits the reaction [bisphenol A results in increased expression of CD68 protein]	PMID:34165232
1314316	CD68	CD68 molecule	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1305970	E	RGD:6480464	20170613	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CD68 mRNA	PMID:28300664
1314316	CD68	CD68 molecule	gene	CHEBI:3374	capsaicin	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin results in decreased expression of CD68 mRNA	PMID:19798065
1314316	CD68	CD68 molecule	gene	CHEBI:3380	captopril	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20260804	CTD	MESH:D002216	Captopril inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of CD68 mRNA]	PMID:41596164
1314316	CD68	CD68 molecule	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314317	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of CD68 mRNA	PMID:26682919
1314316	CD68	CD68 molecule	gene	CHEBI:3423	carmustine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of CD68 mRNA	PMID:15980968
1314316	CD68	CD68 molecule	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CD68 mRNA	PMID:39298647
1314316	CD68	CD68 molecule	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314317	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of CD68 mRNA	PMID:40203079
1314316	CD68	CD68 molecule	gene	CHEBI:34591	bromodichloromethane	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20140211	CTD	MESH:C025191	[Dietary Fats co-treated with bromodichloromethane] results in increased expression of CD68 mRNA; gadolinium chloride inhibits the reaction [[Dietary Fats co-treated with bromodichloromethane] results in increased expression of CD68 mRNA]	PMID:23438451
1314316	CD68	CD68 molecule	gene	CHEBI:34671	Deoxycorticosterone acetate	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20180313	CTD	MESH:D064791	[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CD68 mRNA; CXCR2 gene mutant form inhibits the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] results in increased expression of CD68 mRNA]	PMID:27678262
1314316	CD68	CD68 molecule	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of CD68 protein	PMID:35362542
1314316	CD68	CD68 molecule	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1314317	E	RGD:40925931|PMID:25004394	20210122	RGD	MESH:D016264	dextran sulfate increases expression of CD68 protein in colonic lamina propria of mice	
1314316	CD68	CD68 molecule	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of CD68 protein]	PMID:35362542
1314316	CD68	CD68 molecule	gene	CHEBI:34757	fenitrothion	increases expression	ISO	RGD:1305970	E	RGD:6480464	20190409	CTD	MESH:D005278	Fenitrothion results in increased expression of CD68 protein	PMID:30578656
1314316	CD68	CD68 molecule	gene	CHEBI:34757	fenitrothion	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20190409	CTD	MESH:D005278	[Fenitrothion co-treated with Potassium Dichromate] results in increased expression of CD68 protein; Plant Extracts inhibits the reaction [[Fenitrothion co-treated with Potassium Dichromate] results in increased expression of CD68 protein]; Plant Extracts inhibits the reaction [Fenitrothion results in increased expression of CD68 protein]	PMID:30578656
1314316	CD68	CD68 molecule	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1305970	E	RGD:6480464	20260113	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of CD68 protein	PMID:40882885
1314316	CD68	CD68 molecule	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of CD68 mRNA; Mirtazapine promotes the reaction [Diethylnitrosamine results in increased expression of CD68 protein]	PMID:28943392|PMID:40882885
1314316	CD68	CD68 molecule	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in decreased expression of CD68 mRNA	PMID:21371552
1314316	CD68	CD68 molecule	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20190611	CTD	MESH:D010269	[MTHFR gene polymorphism affects the susceptibility to Paraquat] which results in increased expression of CD68 protein; [Paraquat co-treated with Maneb] results in increased expression of CD68 mRNA; Poloxamer inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CD68 mRNA]	PMID:30726997|PMID:32169474
1314316	CD68	CD68 molecule	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20180828	CTD	MESH:D026023	[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA]	PMID:29751049
1314316	CD68	CD68 molecule	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of CD68 mRNA	PMID:29024780
1314316	CD68	CD68 molecule	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CD68 mRNA	PMID:39836092
1314316	CD68	CD68 molecule	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305970	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of CD68 mRNA	PMID:25380136
1314316	CD68	CD68 molecule	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305970	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CD68 mRNA	PMID:25993096|PMID:33453195
1314316	CD68	CD68 molecule	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CD68 mRNA	PMID:38174414
1314316	CD68	CD68 molecule	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CD68 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of CD68 protein	PMID:38195004
1314316	CD68	CD68 molecule	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20210608	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CD68 mRNA; [NFE2L2 protein affects the susceptibility to [Cadmium Chloride results in increased abundance of Cadmium]] which results in increased expression of CD68 mRNA	PMID:33398418|PMID:37236586
1314316	CD68	CD68 molecule	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1305970	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CD68 mRNA	PMID:30047161
1314316	CD68	CD68 molecule	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305970	E	RGD:6480464	20190507	CTD	MESH:C018021	cobaltous chloride results in increased expression of CD68 protein	PMID:30551423
1314316	CD68	CD68 molecule	gene	CHEBI:35696	cobalt dichloride	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20190507	CTD	MESH:C018021	Plant Extracts inhibits the reaction [cobaltous chloride results in increased expression of CD68 protein]	PMID:30551423
1314316	CD68	CD68 molecule	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1305970	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of CD68 mRNA; Dimethylnitrosamine results in increased expression of CD68 protein	PMID:18371158|PMID:25380136
1314316	CD68	CD68 molecule	gene	CHEBI:35807	N-nitrosodimethylamine	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20120412	CTD	MESH:D004128	Drugs, Chinese Herbal inhibits the reaction [Dimethylnitrosamine results in increased expression of CD68 protein]	PMID:18371158
1314316	CD68	CD68 molecule	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CD68 mRNA	PMID:24449571
1314316	CD68	CD68 molecule	gene	CHEBI:37288	gadolinium trichloride	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20151013	CTD	MESH:C038958	[gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of CD68 mRNA; [gadolinium chloride co-treated with Fructose co-treated with Copper deficiency] results in decreased expression of CD68 protein; gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CD68 mRNA]	PMID:25813056|PMID:26177832
1314316	CD68	CD68 molecule	gene	CHEBI:37288	gadolinium trichloride	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20140211	CTD	MESH:C038958	gadolinium chloride inhibits the reaction [[Dietary Fats co-treated with bromodichloromethane] results in increased expression of CD68 mRNA]	PMID:23438451
1314316	CD68	CD68 molecule	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of CD68 mRNA; Tetradecanoylphorbol Acetate results in increased expression of CD68 protein	PMID:25128825|PMID:28720485|PMID:31011801
1314316	CD68	CD68 molecule	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314317	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CD68 mRNA	PMID:40194260
1314316	CD68	CD68 molecule	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CD68 mRNA	PMID:31533062
1314316	CD68	CD68 molecule	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1305970	E	RGD:6480464	20250805	CTD	MESH:C464485	acetamiprid results in increased expression of CD68 protein	PMID:39719252
1314316	CD68	CD68 molecule	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CD68 mRNA	PMID:40419075
1314316	CD68	CD68 molecule	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1305970	E	RGD:6480464	20250902	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CD68 protein	PMID:39894534
1314316	CD68	CD68 molecule	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CD68 mRNA	PMID:36331819
1314316	CD68	CD68 molecule	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305970	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CD68 mRNA	PMID:30047161
1314316	CD68	CD68 molecule	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CD68 mRNA	PMID:20106945
1314316	CD68	CD68 molecule	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CD68 mRNA	PMID:25562108|PMID:27989131
1314316	CD68	CD68 molecule	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1305970	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of CD68 mRNA	PMID:21865292
1314316	CD68	CD68 molecule	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314317	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of CD68 mRNA	PMID:19770486
1314316	CD68	CD68 molecule	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1314317	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in increased expression of CD68 mRNA	PMID:40633821
1314316	CD68	CD68 molecule	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CD68 mRNA	PMID:17555576
1314316	CD68	CD68 molecule	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20121113	CTD	MESH:D013629	[bexarotene co-treated with Tamoxifen] results in decreased expression of CD68 mRNA	PMID:17630414
1314316	CD68	CD68 molecule	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of CD68 protein	PMID:10614771
1314316	CD68	CD68 molecule	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1314317	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in increased expression of CD68 mRNA	PMID:21041162
1314316	CD68	CD68 molecule	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CD68 mRNA	PMID:15289156
1314316	CD68	CD68 molecule	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased cleavage of CD68 protein; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CD68 mRNA	PMID:37992649
1314316	CD68	CD68 molecule	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in decreased expression of CD68 mRNA; Methotrexate results in decreased expression of CD68 protein	PMID:15476228|PMID:19732956
1314316	CD68	CD68 molecule	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1305970	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of CD68 mRNA	PMID:24136188
1314316	CD68	CD68 molecule	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CD68 mRNA	PMID:38832940
1314316	CD68	CD68 molecule	gene	CHEBI:44915	propofol	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D015742	Propofol results in increased expression of CD68 mRNA	PMID:35953652
1314316	CD68	CD68 molecule	gene	CHEBI:44915	propofol	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D015742	Lipopolysaccharides inhibits the reaction [Propofol results in increased expression of CD68 mRNA]	PMID:35953652
1314316	CD68	CD68 molecule	gene	CHEBI:45863	paclitaxel	increases expression	ISO	RGD:1305970	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of CD68 protein	PMID:16854522
1314316	CD68	CD68 molecule	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CD68 mRNA	PMID:17562736
1314316	CD68	CD68 molecule	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305970	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CD68 mRNA	PMID:33387578
1314316	CD68	CD68 molecule	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of CD68 mRNA; Acetaminophen results in increased expression of CD68 protein	PMID:11981759|PMID:19420014|PMID:29246445
1314316	CD68	CD68 molecule	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of CD68 mRNA]	PMID:29246445
1314316	CD68	CD68 molecule	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of CD68 mRNA	PMID:24714768
1314316	CD68	CD68 molecule	gene	CHEBI:46661	asbestos	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001194	Asbestos results in increased expression of CD68 mRNA	PMID:22398240
1314316	CD68	CD68 molecule	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1314317	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CD68 mRNA	PMID:19446018
1314316	CD68	CD68 molecule	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of CD68 mRNA	PMID:29523930
1314316	CD68	CD68 molecule	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CD68 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CD68 mRNA	PMID:32525701|PMID:39836092
1314316	CD68	CD68 molecule	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20221206	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 protein; Minocycline affects the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 protein]; Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 mRNA]	PMID:35351628|PMID:35777461|PMID:40504410
1314316	CD68	CD68 molecule	gene	CHEBI:47495	N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20201215	CTD	MESH:C063509	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [F2 protein results in increased expression of CD68 mRNA]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [1,1-dimethylbutyl-1-deoxy-Delta(9)-THC inhibits the reaction [F2 protein results in increased expression of CD68 protein]]	PMID:27261088
1314316	CD68	CD68 molecule	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of CD68 mRNA	PMID:26833863
1314316	CD68	CD68 molecule	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305970	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CD68 mRNA	PMID:29391264
1314316	CD68	CD68 molecule	gene	CHEBI:48131	nonanedioic acid	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20161213	CTD	MESH:C010038	azelaic acid results in decreased expression of CD68 mRNA	PMID:19880116
1314316	CD68	CD68 molecule	gene	CHEBI:48318	fragrance	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:D010476	Perfume results in increased expression of CD68 mRNA	PMID:24768652
1314316	CD68	CD68 molecule	gene	CHEBI:48720	argatroban	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20210309	CTD	MESH:C031942	argatroban inhibits the reaction [Dietary Fats results in increased expression of CD68 mRNA]	PMID:22841818
1314316	CD68	CD68 molecule	gene	CHEBI:48765	dimethylarsinic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in increased expression of CD68 mRNA	PMID:17720352
1314316	CD68	CD68 molecule	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CD68 mRNA	PMID:17555576
1314316	CD68	CD68 molecule	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1305970	E	RGD:6480464	20120613	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CD68 mRNA	PMID:17351261|PMID:17557909
1314316	CD68	CD68 molecule	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CD68 mRNA	PMID:12072388
1314316	CD68	CD68 molecule	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of CD68 protein]	PMID:35362542
1314316	CD68	CD68 molecule	gene	CHEBI:50594	carbon nanotube	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CD68 protein	PMID:31047983
1314316	CD68	CD68 molecule	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314317	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CD68 mRNA; Nanotubes, Carbon results in increased expression of CD68 mRNA	PMID:25554681
1314316	CD68	CD68 molecule	gene	CHEBI:50667	mercaptopurine	increases expression	ISO	RGD:1305970	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of CD68 mRNA	PMID:23358152
1314316	CD68	CD68 molecule	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305970	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CD68 mRNA	PMID:30047161
1314316	CD68	CD68 molecule	gene	CHEBI:50673	methimazole	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20180515	CTD	MESH:D008713	[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CD68 mRNA; gadolinium chloride inhibits the reaction [[Buthionine Sulfoximine results in increased susceptibility to Methimazole] which results in increased expression of CD68 mRNA]	PMID:26177832
1314316	CD68	CD68 molecule	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314317	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of CD68 mRNA	PMID:40234311
1314316	CD68	CD68 molecule	gene	CHEBI:50694	minocycline	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20240430	CTD	MESH:D008911	Minocycline affects the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 protein]; Minocycline inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CD68 mRNA]	PMID:35351628
1314316	CD68	CD68 molecule	gene	CHEBI:50859	bexarotene	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20170303	CTD	MESH:C095105	[bexarotene co-treated with Tamoxifen] results in decreased expression of CD68 mRNA	PMID:17630414
1314316	CD68	CD68 molecule	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1305970	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of CD68 mRNA	PMID:24136188
1314316	CD68	CD68 molecule	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305970	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of CD68 mRNA	PMID:24793618
1314316	CD68	CD68 molecule	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20200915	CTD	MESH:D008344	[Paraquat co-treated with Maneb] results in increased expression of CD68 mRNA; Poloxamer inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CD68 mRNA]	PMID:32169474
1314316	CD68	CD68 molecule	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of CD68 mRNA	PMID:22714537
1314316	CD68	CD68 molecule	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1305970	E	RGD:6480464	20190409	CTD	MESH:D011192	Potassium Dichromate results in increased expression of CD68 protein	PMID:30578656
1314316	CD68	CD68 molecule	gene	CHEBI:53444	potassium dichromate	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20190409	CTD	MESH:D011192	[Fenitrothion co-treated with Potassium Dichromate] results in increased expression of CD68 protein; Plant Extracts inhibits the reaction [[Fenitrothion co-treated with Potassium Dichromate] results in increased expression of CD68 protein]; Plant Extracts inhibits the reaction [Potassium Dichromate results in increased expression of CD68 protein]	PMID:30578656
1314316	CD68	CD68 molecule	gene	CHEBI:53515	pluronic P-123	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20200915	CTD	MESH:D020442	Poloxamer inhibits the reaction [[Paraquat co-treated with Maneb] results in increased expression of CD68 mRNA]	PMID:32169474
1314316	CD68	CD68 molecule	gene	CHEBI:5352	Gingerenone A	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20240305	CTD	MESH:C000604237	gingerenone A inhibits the reaction [Dietary Fats results in increased expression of CD68 mRNA]	PMID:28556482
1314316	CD68	CD68 molecule	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314317	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CD68 mRNA	PMID:38701926
1314316	CD68	CD68 molecule	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1305970	E	RGD:6480464	20120501	CTD	MESH:D016559	Tacrolimus results in increased expression of CD68 mRNA	PMID:21865292
1314316	CD68	CD68 molecule	gene	CHEBI:61159	conjugated linoleic acid	increases expression	ISO	RGD:1314317	E	RGD:6480464	20170228	CTD	MESH:D044243	Linoleic Acids, Conjugated results in increased expression of CD68 mRNA	PMID:17322064
1314316	CD68	CD68 molecule	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CD68 mRNA	PMID:39836092
1314316	CD68	CD68 molecule	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of CD68 mRNA	PMID:19812364
1314316	CD68	CD68 molecule	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases response to substance	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:D020122	CD68 protein results in decreased susceptibility to tert-Butylhydroperoxide	PMID:15003993
1314316	CD68	CD68 molecule	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of CD68 mRNA	PMID:15336504
1314316	CD68	CD68 molecule	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314317	E	RGD:6480464	20120613	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of CD68 mRNA	PMID:14729362|PMID:15003993|PMID:15336504
1314316	CD68	CD68 molecule	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305970	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of CD68 mRNA	PMID:35283115
1314316	CD68	CD68 molecule	gene	CHEBI:64983	alternariol	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C005197	alternariol results in increased expression of CD68 protein	PMID:26341179
1314316	CD68	CD68 molecule	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305970	E	RGD:6480464	20180116	CTD	MESH:D008701	Methapyrilene results in increased expression of CD68 mRNA	PMID:28935588
1314316	CD68	CD68 molecule	gene	CHEBI:68641	(-)-cotinine	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20180828	CTD	MESH:D003367	[Nicotine results in increased abundance of Cotinine] which results in increased expression of CD68 mRNA	PMID:29617909
1314316	CD68	CD68 molecule	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1314317	E	RGD:6480464	20210706	CTD	MESH:C057862	cyanoginosin LR results in increased expression of CD68 protein	PMID:33474710
1314316	CD68	CD68 molecule	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased expression of CD68 mRNA	PMID:27932991
1314316	CD68	CD68 molecule	gene	CHEBI:6950	mirtazapine	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20260113	CTD	MESH:C035133	Mirtazapine promotes the reaction [Diethylnitrosamine results in increased expression of CD68 protein]	PMID:40882885
1314316	CD68	CD68 molecule	gene	CHEBI:6980	monocrotaline	increases expression	ISO	RGD:1305970	E	RGD:736802361|PMID:24790141	20260728	RGD	MESH:D016686	Monocrotaline increases expression of protein in pulmonary arterioles and alveoli	
1314316	CD68	CD68 molecule	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CD68 mRNA	PMID:31758290
1314316	CD68	CD68 molecule	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314317	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CD68 mRNA	PMID:22206623
1314316	CD68	CD68 molecule	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of CD68 mRNA	PMID:22714537
1314316	CD68	CD68 molecule	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of CD68 mRNA	PMID:36318118
1314316	CD68	CD68 molecule	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1305970	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of CD68 mRNA	PMID:33484710
1314316	CD68	CD68 molecule	gene	CHEBI:76004	dimethyl fumarate	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20180220	CTD	MESH:C056020	Dimethyl Fumarate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CD68 mRNA]	PMID:27277809
1314316	CD68	CD68 molecule	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20210406	CTD	MESH:C074283	[Dietary Fats co-treated with estradiol 3-benzoate] results in increased expression of CD68 mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CD68 mRNA	PMID:32741896|PMID:39368565
1314316	CD68	CD68 molecule	gene	CHEBI:77890	1-O-palmitoyl-2-O-(5-oxovaleryl)-sn-glycero-3-phosphocholine	increases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:C400184	1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of CD68 mRNA	PMID:16386258
1314316	CD68	CD68 molecule	gene	CHEBI:78870	sodium nitrite	increases expression	ISO	RGD:1305970	E	RGD:6480464	20241001	CTD	MESH:D012977	Sodium Nitrite results in increased expression of CD68 protein	PMID:33030083
1314316	CD68	CD68 molecule	gene	CHEBI:78870	sodium nitrite	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20241001	CTD	MESH:D012977	Glycyrrhizic Acid inhibits the reaction [Sodium Nitrite results in increased expression of CD68 protein]	PMID:33030083
1314316	CD68	CD68 molecule	gene	CHEBI:7889	paeoniflorin	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20190910	CTD	MESH:C015423	iodopravadoline inhibits the reaction [peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CD68 protein]]; peoniflorin inhibits the reaction [[Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CD68 protein]	PMID:29560022
1314316	CD68	CD68 molecule	gene	CHEBI:79997	GW 4064	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in decreased expression of CD68 mRNA	PMID:23371517
1314316	CD68	CD68 molecule	gene	CHEBI:8024	perindopril	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20201215	CTD	MESH:D020913	AM6545 promotes the reaction [Perindopril inhibits the reaction [Streptozocin results in increased expression of CD68 mRNA]]; Perindopril inhibits the reaction [Streptozocin results in increased expression of CD68 mRNA]; Perindopril promotes the reaction [AM6545 inhibits the reaction [Streptozocin results in increased expression of CD68 mRNA]]	PMID:30184259
1314316	CD68	CD68 molecule	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of CD68 mRNA	PMID:19482888
1314316	CD68	CD68 molecule	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CD68 mRNA]	PMID:19482888
1314316	CD68	CD68 molecule	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314317	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CD68 mRNA	PMID:38648751
1314316	CD68	CD68 molecule	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1314317	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of CD68 mRNA	PMID:27029645
1314316	CD68	CD68 molecule	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of CD68 mRNA	PMID:32525701
1314316	CD68	CD68 molecule	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305970	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CD68 mRNA	PMID:24780913|PMID:30047161
1314316	CD68	CD68 molecule	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20180828	CTD	MESH:D011729	[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA]	PMID:29751049
1314316	CD68	CD68 molecule	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20230801	CTD	MESH:D020849	Raloxifene Hydrochloride affects the reaction [[APOE protein affects the susceptibility to Dietary Fats] which affects the expression of CD68 protein]	PMID:32828944
1314316	CD68	CD68 molecule	gene	CHEBI:88522	Monobutylphthalate	increases expression	EXP		E	RGD:6480464	20221206	CTD	MESH:C028577	monobutyl phthalate results in increased expression of CD68 mRNA	PMID:32015430
1314316	CD68	CD68 molecule	gene	CHEBI:9017	Salvianolic acid A	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20241203	CTD	MESH:C066201	salvianolic acid A affects the reaction [[Streptozocin co-treated with [APOE protein affects the susceptibility to Dietary Fats]] affects the expression of CD68 mRNA]	PMID:39047806
1314316	CD68	CD68 molecule	gene	CHEBI:90714	retinoic acid receptor antagonist	increases expression	ISO	RGD:1314317	E	RGD:40925931|PMID:25004394	20210122	RGD		retinoic acid receptor antagonist LE135 increases expression of CD68 protein in colonic lamina propria of DSS-induced colitis mice	
1314316	CD68	CD68 molecule	gene	CHEBI:91091	CHIR 99021	multiple interactions	EXP		E	RGD:6480464	20220809	CTD	MESH:C473711	[Chir 99021 co-treated with BMP4 protein co-treated with FGF10 protein co-treated with FGF7 protein co-treated with Tretinoin] results in increased expression of CD68 mRNA	PMID:35267148
1314316	CD68	CD68 molecule	gene	CHEBI:9130	sevoflurane	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C009250	Sevoflurane results in increased expression of CD68 mRNA	PMID:35953652
1314316	CD68	CD68 molecule	gene	CHEBI:9130	sevoflurane	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:C009250	Lipopolysaccharides inhibits the reaction [Sevoflurane results in increased expression of CD68 mRNA]	PMID:35953652
1314316	CD68	CD68 molecule	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314317	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CD68 mRNA	PMID:27131904
1314316	CD68	CD68 molecule	gene	CHEBI:9168	sirolimus	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in decreased expression of CD68 mRNA	PMID:17016853
1314316	CD68	CD68 molecule	gene	CHEBI:9168	sirolimus	decreases expression	ISO	RGD:1305970	E	RGD:6480464	20120501	CTD	MESH:D020123	Sirolimus results in decreased expression of CD68 mRNA	PMID:21865292
1314316	CD68	CD68 molecule	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1305970	E	RGD:6480464	20180410	CTD	MESH:D013311	Streptozocin results in increased expression of CD68 protein	PMID:29291386
1314316	CD68	CD68 molecule	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1314317	E	RGD:6480464	20201215	CTD	MESH:D013311	Streptozocin results in increased expression of CD68 mRNA	PMID:30184259
1314316	CD68	CD68 molecule	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1305970	E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of CD68 mRNA; nifuroxazide inhibits the reaction [Streptozocin results in increased expression of CD68 protein]	PMID:25905778|PMID:29291386
1314316	CD68	CD68 molecule	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20201215	CTD	MESH:D013311	[Streptozocin co-treated with [APOE protein affects the susceptibility to Dietary Fats]] affects the expression of CD68 mRNA; AM6545 inhibits the reaction [Streptozocin results in increased expression of CD68 mRNA]; AM6545 promotes the reaction [Perindopril inhibits the reaction [Streptozocin results in increased expression of CD68 mRNA]]; Perindopril inhibits the reaction [Streptozocin results in increased expression of CD68 mRNA]; Perindopril promotes the reaction [AM6545 inhibits the reaction [Streptozocin results in increased expression of CD68 mRNA]]; salvianolic acid A affects the reaction [[Streptozocin co-treated with [APOE protein affects the susceptibility to Dietary Fats]] affects the expression of CD68 mRNA]	PMID:30184259|PMID:39047806
1314316	CD68	CD68 molecule	gene	CHEBI:94385	(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic acid	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20170307	CTD	MESH:C031942	argatroban inhibits the reaction [Dietary Fats results in increased expression of CD68 mRNA]	PMID:22841818
1314316	CD68	CD68 molecule	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	ISO	RGD:1305970	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of CD68 mRNA	PMID:23358152
1314316	CD68	CD68 molecule	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1314317	E	RGD:6480464	20230502	CTD	MESH:C001899	triptolide results in decreased expression of CD68 mRNA	PMID:36520315
1314316	CD68	CD68 molecule	gene	CHEBI:9747	Triptolide	multiple interactions	ISO	RGD:1314317	E	RGD:6480464	20230502	CTD	MESH:C001899	STING1 protein affects the reaction [triptolide results in decreased expression of CD68 mRNA]	PMID:36520315
1314316	CD68	CD68 molecule	gene	CHEBI:9927	valsartan	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C081489	Valsartan results in decreased expression of CD68 mRNA	PMID:22768174
1314316	CD68	CD68 molecule	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305970	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of CD68 mRNA	PMID:23034163
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of LSM3 protein	PMID:39638853
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314319	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of LSM3 mRNA	PMID:30319688
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314319	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LSM3 mRNA	PMID:39241906
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305971	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of LSM3 mRNA	PMID:32145629
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:166595	Yessotoxin	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in decreased expression of LSM3 mRNA	PMID:30679557
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1305971	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of LSM3 mRNA	PMID:22967744
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305971	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LSM3 mRNA	PMID:33387578
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of LSM3 mRNA	PMID:19549813
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1314319	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of LSM3 3' UTR; Ethylnitrosourea results in increased mutagenesis of LSM3 gene	PMID:27776689
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305971	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of LSM3 mRNA	PMID:21396975
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314319	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LSM3 mRNA	PMID:31919559
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314319	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM3 mRNA	PMID:22206623
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LSM3 mRNA	PMID:39836092
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305971	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of LSM3 mRNA	PMID:31881176
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1314319	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of LSM3 protein	PMID:25505154
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314319	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of LSM3 mRNA	PMID:30912803
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305971	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LSM3 mRNA	PMID:34747641
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314319	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LSM3 mRNA	PMID:21570461
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305971	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LSM3 mRNA	PMID:33387578
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LSM3 mRNA	PMID:28001369
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LSM3 mRNA	PMID:30851411
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of LSM3 mRNA	PMID:32763439
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314319	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of LSM3 mRNA	PMID:39631538
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314319	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LSM3 protein	PMID:29044176
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of LSM3 mRNA	PMID:28595984|PMID:34032870
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LSM3 mRNA	PMID:39836092
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LSM3 promoter	PMID:27901495
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to LSM3 mRNA]	PMID:32406909
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1305971	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of LSM3 mRNA	PMID:30047161
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314319	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LSM3 gene	PMID:35295148
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305971	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of LSM3 mRNA	PMID:23411599|PMID:34492290
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314319	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LSM3 mRNA	PMID:18301758|PMID:20813756
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of LSM3 mRNA	PMID:30903817
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of LSM3 mRNA	PMID:29275510
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314319	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LSM3 mRNA	PMID:33221593
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305971	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LSM3 mRNA	PMID:25181051|PMID:32145629
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314319	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of LSM3 mRNA	PMID:38685157
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314319	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of LSM3 protein	PMID:35362542
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314319	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of LSM3 protein]	PMID:35362542
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1314319	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of LSM3 mRNA	PMID:34813904
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1314319	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of LSM3 mRNA	PMID:34813904
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LSM3 mRNA	PMID:37042841
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LSM3 mRNA	PMID:19376846
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314319	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of LSM3 mRNA	PMID:39529242
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314319	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of LSM3 mRNA	PMID:36331819
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305971	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of LSM3 mRNA	PMID:41580965
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305971	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of LSM3 mRNA	PMID:30047161
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of LSM3 mRNA	PMID:25562108
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314319	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LSM3 mRNA	PMID:17562736
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LSM3 mRNA	PMID:39836092
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314319	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of LSM3 mRNA	PMID:35436446
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1314319	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of LSM3 protein]	PMID:35362542
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305971	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of LSM3 mRNA	PMID:30047161
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314319	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LSM3 mRNA	PMID:35964746
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314319	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of LSM3 mRNA	PMID:19042947
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LSM3 protein	PMID:32959892
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:1305971	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of LSM3 mRNA	PMID:24136188
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1314319	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of LSM3 mRNA	PMID:20003209
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305971	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of LSM3 mRNA	PMID:30467583
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314319	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of LSM3 mRNA	PMID:22206623
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of LSM3 mRNA	PMID:30851411
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to LSM3 gene]	PMID:28238834
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of LSM3 mRNA	PMID:19159669
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314319	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of LSM3 mRNA	PMID:23091169
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314319	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of LSM3 mRNA	PMID:30294300
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305971	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of LSM3 mRNA	PMID:30047161
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305971	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of LSM3 mRNA	PMID:21346803
1314318	LSM3	LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1305971	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of LSM3 mRNA	PMID:30047161
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:110423	clodronic acid	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in increased expression of SECTM1 mRNA	PMID:25596134
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SECTM1 mRNA	PMID:27188386
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314322	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SECTM1A mRNA	PMID:33045310
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of SECTM1 mRNA	PMID:25596134
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SECTM1A mRNA	PMID:36331819
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314322	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SECTM1A mRNA	PMID:39298647
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:D004958	Estradiol results in increased expression of SECTM1A mRNA	PMID:32145629
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of SECTM1 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of SECTM1 mRNA	PMID:17404688|PMID:30165855
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of SECTM1A mRNA	PMID:26496021
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:D014241	Trichloroethylene results in increased expression of SECTM1A mRNA	PMID:33387578
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SECTM1 mRNA	PMID:37042841
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of SECTM1 mRNA	PMID:17404688
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in increased expression of SECTM1 mRNA	PMID:17404688
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SECTM1A mRNA	PMID:37992649
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of SECTM1 mRNA	PMID:21592394
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SECTM1 mRNA	PMID:21592394
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SECTM1A mRNA	PMID:37992649
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:17750	glycine betaine	increases expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:D001622	Betaine results in increased expression of SECTM1A mRNA	PMID:26391144
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:D003471	Cuprizone results in increased expression of SECTM1 mRNA	PMID:26577399|PMID:27523638
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SECTM1 mRNA	PMID:21592394
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SECTM1 mRNA	PMID:21592394
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SECTM1 mRNA	PMID:28818685
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of SECTM1 intron	PMID:30157460
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314322	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SECTM1A mRNA	PMID:19770486
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:D015032	Zinc deficiency results in increased expression of SECTM1 mRNA	PMID:19111725
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SECTM1A mRNA	PMID:40504410
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:27871	chloroacetaldehyde	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in increased expression of SECTM1 mRNA	PMID:25596134
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1314322	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of SECTM1 mRNA	PMID:18930951
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314322	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of SECTM1 mRNA; Genistein results in decreased expression of SECTM1A mRNA	PMID:32186404
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of SECTM1 mRNA	PMID:23195993
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SECTM1 mRNA	PMID:25583101
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314322	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SECTM1A mRNA	PMID:21570461|PMID:26377647
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SECTM1 mRNA	PMID:21632981|PMID:21998131|PMID:22903824
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SECTM1 mRNA	PMID:29803840
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SECTM1A mRNA	PMID:37992649
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of SECTM1 mRNA	PMID:22714537|PMID:38568856
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314322	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SECTM1A mRNA	PMID:37682722
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of SECTM1 mRNA	PMID:34032870|PMID:39719251
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SECTM1A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SECTM1A mRNA	PMID:34876320|PMID:40504410
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SECTM1A mRNA	PMID:34876320
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SECTM1 5' UTR; Benzo(a)pyrene affects the methylation of SECTM1 promoter	PMID:27901495
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SECTM1 mRNA	PMID:20064835|PMID:20106945
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314322	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SECTM1A mRNA	PMID:19770486
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SECTM1 3' UTR	PMID:27901495
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:D015032	Zinc deficiency results in increased expression of SECTM1 mRNA	PMID:19111725
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314322	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SECTM1A mRNA	PMID:29341224
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SECTM1 mRNA	PMID:22521957
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SECTM1 mRNA	PMID:19128835
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of SECTM1 mRNA	PMID:35984750
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:D013853	Thioacetamide results in increased expression of SECTM1A mRNA	PMID:34492290
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314322	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SECTM1A mRNA	PMID:28472532
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:C006780	bisphenol A results in decreased expression of SECTM1 mRNA	PMID:25181051
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314322	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SECTM1A promoter	PMID:27312807
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:C006780	bisphenol A results in increased expression of SECTM1A mRNA	PMID:32145629
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of SECTM1A mRNA	PMID:26496021
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:34107	1-nitropyrene	decreases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in decreased expression of SECTM1 mRNA	PMID:19041380
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of SECTM1 mRNA	PMID:36804509
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SECTM1A mRNA	PMID:21241498
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:34698	diethyl phthalate	decreases expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:C007379	diethyl phthalate results in decreased expression of SECTM1 mRNA	PMID:32341500
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1314322	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of SECTM1A mRNA	PMID:24535843
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SECTM1A mRNA	PMID:24535843
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SECTM1 mRNA	PMID:37042841
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of SECTM1 mRNA	PMID:29024780
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SECTM1A mRNA	PMID:35163327
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:D002509	Cephaloridine results in increased expression of SECTM1A mRNA	PMID:18500788
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SECTM1 mRNA	PMID:25596134
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SECTM1 mRNA	PMID:37738295
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SECTM1A mRNA	PMID:35163327
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SECTM1 mRNA	PMID:24449571
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314322	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of SECTM1A mRNA	PMID:28962523
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SECTM1 mRNA	PMID:28302478
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SECTM1A mRNA	PMID:36331819
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of SECTM1 mRNA	PMID:29154799
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SECTM1 gene	PMID:29154799
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SECTM1A mRNA	PMID:37992649
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:43572	kojic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of SECTM1 mRNA	PMID:16595896
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SECTM1 mRNA	PMID:38832940
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SECTM1A mRNA	PMID:40504410
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:D004726	Endosulfan results in decreased expression of SECTM1A mRNA	PMID:29391264
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314322	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SECTM1A mRNA	PMID:35436446
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SECTM1A mRNA	PMID:34876320
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SECTM1 mRNA	PMID:22521957
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SECTM1 mRNA	PMID:19128835
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of SECTM1 mRNA	PMID:38825487
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:51052	lucanthone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in increased expression of SECTM1 mRNA	PMID:21148553
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of SECTM1 mRNA	PMID:22714537
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314322	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of SECTM1A mRNA	PMID:23608068
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of SECTM1 mRNA	PMID:31629900
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314322	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SECTM1A mRNA	PMID:38701926
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SECTM1 mRNA	PMID:15336504
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314322	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SECTM1A mRNA	PMID:22206623
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of SECTM1 mRNA	PMID:27840820
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of SECTM1 mRNA	PMID:35486664
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:79089	ceric oxide	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:C030583	ceric oxide analog results in decreased expression of SECTM1 mRNA	PMID:24821434
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314322	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of SECTM1A mRNA	PMID:19482888
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SECTM1A mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SECTM1A mRNA]	PMID:19482888|PMID:24535843
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of SECTM1 mRNA	PMID:26705709
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1314322	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SECTM1A mRNA	PMID:34876320
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305973	E	RGD:6480464	20260120	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SECTM1A mRNA	PMID:21346803
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SECTM1 mRNA	PMID:38568856
1314321	SECTM1	secreted and transmembrane 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SECTM1 mRNA	PMID:29301935
1314323	CERS1	ceramide synthase 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1622181	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of CERS1 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of CERS1 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of CERS1 mRNA	PMID:30951980
1314323	CERS1	ceramide synthase 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C018475	butyraldehyde results in increased expression of CERS1 mRNA	PMID:26079696
1314323	CERS1	ceramide synthase 1	gene	CHEBI:16325	lithocholic acid	increases expression	ISO	RGD:1622181	E	RGD:6480464	20131210	CTD	MESH:D008095	Lithocholic Acid results in increased expression of CERS1 mRNA	PMID:21480330
1314323	CERS1	ceramide synthase 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C005556	propionaldehyde results in increased expression of CERS1 mRNA	PMID:26079696
1314323	CERS1	ceramide synthase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1622181	E	RGD:6480464	20260707	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CERS1 mRNA	PMID:37776818
1314323	CERS1	ceramide synthase 1	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of CERS1 mRNA	PMID:20401667
1314323	CERS1	ceramide synthase 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1622181	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of CERS1 mRNA	PMID:40618947
1314323	CERS1	ceramide synthase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CERS1 mRNA	PMID:27392435
1314323	CERS1	ceramide synthase 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CERS1 mRNA	PMID:28001369
1314323	CERS1	ceramide synthase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CERS1 protein	PMID:33212167
1314323	CERS1	ceramide synthase 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305974	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CERS1 mRNA	PMID:28959563
1314323	CERS1	ceramide synthase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CERS1 promoter	PMID:27901495
1314323	CERS1	ceramide synthase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CERS1 gene; [bisphenol F co-treated with Fulvestrant] results in increased methylation of CERS1 gene	PMID:31601247
1314323	CERS1	ceramide synthase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305974	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CERS1 mRNA	PMID:25181051
1314323	CERS1	ceramide synthase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1622181	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CERS1 mRNA	PMID:30951980
1314323	CERS1	ceramide synthase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CERS1 gene	PMID:31601247
1314323	CERS1	ceramide synthase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1622181	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of CERS1 mRNA	PMID:30951980
1314323	CERS1	ceramide synthase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1622181	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S affects the expression of CERS1 mRNA	PMID:30951980
1314323	CERS1	ceramide synthase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of CERS1 gene	PMID:31601247
1314323	CERS1	ceramide synthase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1622181	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with LIF protein] results in increased expression of CERS1 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of CERS1 mRNA	PMID:30951980
1314323	CERS1	ceramide synthase 1	gene	CHEBI:34575	bisphenol F	affects expression	ISO	RGD:1622181	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F affects the expression of CERS1 mRNA	PMID:30951980
1314323	CERS1	ceramide synthase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of CERS1 gene	PMID:31601247
1314323	CERS1	ceramide synthase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1622181	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with LIF protein] results in increased expression of CERS1 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of CERS1 mRNA	PMID:30951980
1314323	CERS1	ceramide synthase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CERS1 mRNA	PMID:38382870
1314323	CERS1	ceramide synthase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CERS1 mRNA	PMID:38568856
1314323	CERS1	ceramide synthase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1622181	E	RGD:6480464	20260707	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CERS1 mRNA	PMID:37776818
1314323	CERS1	ceramide synthase 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1305974	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CERS1 mRNA	PMID:35163327
1314323	CERS1	ceramide synthase 1	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305974	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of CERS1 gene	PMID:22079235
1314323	CERS1	ceramide synthase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1622181	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CERS1 mRNA	PMID:40194260
1314323	CERS1	ceramide synthase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CERS1 mRNA	PMID:25979313
1314323	CERS1	ceramide synthase 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CERS1 gene	PMID:29154799
1314323	CERS1	ceramide synthase 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CERS1 mRNA	PMID:38832940
1314323	CERS1	ceramide synthase 1	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1305974	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of CERS1 mRNA	PMID:28801915
1314323	CERS1	ceramide synthase 1	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of CERS1 protein	PMID:31285264
1314323	CERS1	ceramide synthase 1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C046012	pentanal results in increased expression of CERS1 mRNA	PMID:26079696
1314326	THBS3	thrombospondin 3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of THBS3 mRNA	PMID:38218311
1314326	THBS3	thrombospondin 3	gene	CHEBI:134926	drometrizole	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C033674	benazol P affects the expression of THBS3 mRNA	PMID:36586167
1314326	THBS3	thrombospondin 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314327	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of THBS3 mRNA	PMID:20188158
1314326	THBS3	thrombospondin 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of THBS3 mRNA	PMID:20938992
1314326	THBS3	thrombospondin 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of THBS3 mRNA	PMID:30529165
1314326	THBS3	thrombospondin 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of THBS3 mRNA	PMID:21179406
1314326	THBS3	thrombospondin 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of THBS3 mRNA	PMID:31614463
1314326	THBS3	thrombospondin 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of THBS3 mRNA	PMID:20938992
1314326	THBS3	thrombospondin 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of THBS3 mRNA	PMID:37042841
1314326	THBS3	thrombospondin 3	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1314327	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of THBS3 mRNA	PMID:22238285
1314326	THBS3	thrombospondin 3	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of THBS3 mRNA	PMID:21179406
1314326	THBS3	thrombospondin 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of THBS3 mRNA	PMID:37992649
1314326	THBS3	thrombospondin 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of THBS3 mRNA	PMID:37992649
1314326	THBS3	thrombospondin 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of THBS3 mRNA	PMID:39150890
1314326	THBS3	thrombospondin 3	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1596780	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of THBS3 mRNA	PMID:27523638
1314326	THBS3	thrombospondin 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of THBS3 mRNA	PMID:39836092
1314326	THBS3	thrombospondin 3	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20150609	CTD	MESH:D010126	Ozone results in decreased expression of THBS3 mRNA	PMID:25658374
1314326	THBS3	thrombospondin 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of THBS3 mRNA	PMID:35430440
1314326	THBS3	thrombospondin 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of THBS3 mRNA; [NOTCH4 gene mutant form affects the susceptibility to Ozone] which affects the expression of THBS3 mRNA	PMID:25658374|PMID:27106289|PMID:34911549
1314326	THBS3	thrombospondin 3	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314327	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of THBS3 mRNA	PMID:17484886
1314326	THBS3	thrombospondin 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of THBS3 mRNA	PMID:20938992
1314326	THBS3	thrombospondin 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of THBS3 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of THBS3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of THBS3 mRNA	PMID:39836092|PMID:40512198
1314326	THBS3	thrombospondin 3	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of THBS3 mRNA	PMID:31295307
1314326	THBS3	thrombospondin 3	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of THBS3 mRNA	PMID:28903495
1314326	THBS3	thrombospondin 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of THBS3 mRNA	PMID:27392435
1314326	THBS3	thrombospondin 3	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in decreased expression of THBS3 mRNA	PMID:12540486
1314326	THBS3	thrombospondin 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314327	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of THBS3 mRNA	PMID:21570461
1314326	THBS3	thrombospondin 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of THBS3 mRNA	PMID:12167310
1314326	THBS3	thrombospondin 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of THBS3 mRNA	PMID:32763439
1314326	THBS3	thrombospondin 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of THBS3 mRNA	PMID:30911355
1314326	THBS3	thrombospondin 3	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of THBS3 mRNA	PMID:27862939
1314326	THBS3	thrombospondin 3	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004317	Doxorubicin results in increased expression of THBS3 mRNA	PMID:37062353
1314326	THBS3	thrombospondin 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of THBS3 mRNA	PMID:37992649
1314326	THBS3	thrombospondin 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of THBS3 mRNA	PMID:34032870
1314326	THBS3	thrombospondin 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1596780	E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of THBS3 mRNA	PMID:35314868
1314326	THBS3	thrombospondin 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of THBS3 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of THBS3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of THBS3 mRNA	PMID:39836092|PMID:40512198
1314326	THBS3	thrombospondin 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of THBS3 mRNA	PMID:21569818
1314326	THBS3	thrombospondin 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of THBS3 mRNA	PMID:30911355
1314326	THBS3	thrombospondin 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of THBS3 mRNA; Silicon Dioxide results in decreased expression of THBS3 mRNA	PMID:25351596|PMID:25895662
1314326	THBS3	thrombospondin 3	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of THBS3 mRNA	PMID:27760801
1314326	THBS3	thrombospondin 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of THBS3 mRNA	PMID:34585602
1314326	THBS3	thrombospondin 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1596780	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of THBS3 mRNA	PMID:30816183|PMID:32528016
1314326	THBS3	thrombospondin 3	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of THBS3 mRNA	PMID:25979313
1314326	THBS3	thrombospondin 3	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of THBS3 mRNA	PMID:26377693
1314326	THBS3	thrombospondin 3	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of THBS3 mRNA	PMID:26377693
1314326	THBS3	thrombospondin 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of THBS3 mRNA	PMID:38685157
1314326	THBS3	thrombospondin 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of THBS3 mRNA	PMID:28628672
1314326	THBS3	thrombospondin 3	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of THBS3 mRNA	PMID:39150890
1314326	THBS3	thrombospondin 3	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of THBS3 mRNA	PMID:39150890
1314326	THBS3	thrombospondin 3	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of THBS3 mRNA	PMID:39150890
1314326	THBS3	thrombospondin 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of THBS3 mRNA	PMID:28628672
1314326	THBS3	thrombospondin 3	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314327	E	RGD:6480464	20210209	CTD	MESH:D010269	Paraquat results in increased expression of THBS3 mRNA	PMID:21463325
1314326	THBS3	thrombospondin 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of THBS3 mRNA	PMID:37042841
1314326	THBS3	thrombospondin 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1596780	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of THBS3 mRNA	PMID:35163327
1314326	THBS3	thrombospondin 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of THBS3 mRNA	PMID:39836092
1314326	THBS3	thrombospondin 3	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of THBS3 mRNA	PMID:26377693
1314326	THBS3	thrombospondin 3	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1596780	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of THBS3 mRNA	PMID:30723492
1314326	THBS3	thrombospondin 3	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of THBS3 mRNA	PMID:39150890
1314326	THBS3	thrombospondin 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1596780	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of THBS3 mRNA	PMID:35163327
1314326	THBS3	thrombospondin 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1596780	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of THBS3 mRNA	PMID:24386269
1314326	THBS3	thrombospondin 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314327	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of THBS3 mRNA	PMID:40194260
1314326	THBS3	thrombospondin 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of THBS3 mRNA	PMID:31533062
1314326	THBS3	thrombospondin 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of THBS3 mRNA	PMID:39529242
1314326	THBS3	thrombospondin 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of THBS3 mRNA	PMID:25979313
1314326	THBS3	thrombospondin 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of THBS3 mRNA	PMID:28001369|PMID:29154799
1314326	THBS3	thrombospondin 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of THBS3 gene	PMID:29154799
1314326	THBS3	thrombospondin 3	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of THBS3 mRNA	PMID:25047013
1314326	THBS3	thrombospondin 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of THBS3 mRNA	PMID:28628672
1314326	THBS3	thrombospondin 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of THBS3 mRNA	PMID:28973697
1314326	THBS3	thrombospondin 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of THBS3 mRNA	PMID:37992649
1314326	THBS3	thrombospondin 3	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of THBS3 mRNA	PMID:38832940
1314326	THBS3	thrombospondin 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of THBS3 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of THBS3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of THBS3 mRNA	PMID:39836092|PMID:40512198
1314326	THBS3	thrombospondin 3	gene	CHEBI:47426	furosemide	affects expression	ISO	RGD:1596780	E	RGD:6480464	20130806	CTD	MESH:D005665	Furosemide affects the expression of THBS3 mRNA	PMID:16526316
1314326	THBS3	thrombospondin 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of THBS3 mRNA	PMID:28628672
1314326	THBS3	thrombospondin 3	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1314327	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of THBS3 mRNA	PMID:27915011
1314326	THBS3	thrombospondin 3	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1596780	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of THBS3 mRNA	PMID:30307764
1314326	THBS3	thrombospondin 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314327	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of THBS3 mRNA; Nanotubes, Carbon results in decreased expression of THBS3 mRNA	PMID:25554681
1314326	THBS3	thrombospondin 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of THBS3 mRNA	PMID:39836092
1314326	THBS3	thrombospondin 3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314327	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of THBS3 mRNA	PMID:14729362
1314326	THBS3	thrombospondin 3	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in increased expression of THBS3 mRNA	PMID:16982809
1314326	THBS3	thrombospondin 3	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1596780	E	RGD:6480464	20230307	CTD	MESH:D008694	Methamphetamine results in increased expression of THBS3 mRNA	PMID:35863504
1314326	THBS3	thrombospondin 3	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of THBS3 mRNA	PMID:31758290
1314326	THBS3	thrombospondin 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314327	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of THBS3 mRNA	PMID:22206623
1314326	THBS3	thrombospondin 3	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of THBS3 mRNA	PMID:28960945
1314326	THBS3	thrombospondin 3	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1314327	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of THBS3 mRNA	PMID:39150890
1314326	THBS3	thrombospondin 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to THBS3 gene]	PMID:28238834
1314326	THBS3	thrombospondin 3	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of THBS3 mRNA	PMID:31863870
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1305978	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of GLIPR1 mRNA	PMID:21551480
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of GLIPR1 mRNA	PMID:27188386
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314329	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GLIPR1 mRNA	PMID:33045310
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314329	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of GLIPR1 mRNA	PMID:37995155
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLIPR1 mRNA	PMID:20938992
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of GLIPR1 mRNA	PMID:33167477
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1305978	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of GLIPR1 mRNA	PMID:20488242
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305978	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GLIPR1 mRNA	PMID:33729688
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GLIPR1 mRNA	PMID:36331819
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of GLIPR1 mRNA	PMID:26079696
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GLIPR1 mRNA	PMID:29432896
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of GLIPR1 mRNA	PMID:21632981
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314329	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GLIPR1 mRNA	PMID:39241906
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of GLIPR1 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of GLIPR1 mRNA	PMID:20660070|PMID:30165855
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1305978	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GLIPR1 mRNA	PMID:32741896
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1305978	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of GLIPR1 gene	PMID:27618143
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLIPR1 mRNA	PMID:20938992
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of GLIPR1 mRNA	PMID:23649840
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of GLIPR1 mRNA	PMID:21540246
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of GLIPR1 mRNA	PMID:20660070
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of GLIPR1 mRNA	PMID:26079696
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GLIPR1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GLIPR1 mRNA	PMID:37567420|PMID:37992649
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1305978	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GLIPR1 mRNA	PMID:32741896
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:17558	quercitrin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in decreased expression of GLIPR1 mRNA	PMID:25193878
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GLIPR1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GLIPR1 mRNA	PMID:37567420|PMID:37992649
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of GLIPR1 mRNA	PMID:16949557
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1305978	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of GLIPR1 mRNA	PMID:27523638
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305978	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of GLIPR1 mRNA	PMID:22061828
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of GLIPR1 mRNA	PMID:28818685
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GLIPR1 mRNA	PMID:39836092
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of GLIPR1 mRNA	PMID:16949557
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of GLIPR1 mRNA	PMID:19549813
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of GLIPR1 protein	PMID:20106945
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of GLIPR1 mRNA	PMID:22100608
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of GLIPR1 mRNA	PMID:27153756
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of GLIPR1 gene	PMID:27153756
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of GLIPR1 mRNA	PMID:25102026
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1305978	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of GLIPR1 mRNA	PMID:30779732
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314329	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of GLIPR1 mRNA	PMID:17484886
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314329	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GLIPR1 mRNA	PMID:31919559
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLIPR1 mRNA	PMID:20938992
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GLIPR1 gene	PMID:25304211
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GLIPR1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GLIPR1 mRNA	PMID:39836092
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GLIPR1 mRNA	PMID:40504410
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of GLIPR1 mRNA	PMID:26272509
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLIPR1 mRNA	PMID:27188386
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C010974	Glyphosate results in decreased expression of GLIPR1 mRNA	PMID:40865780
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GLIPR1 mRNA	PMID:37567420
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305978	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of GLIPR1 mRNA	PMID:31881176
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of GLIPR1 mRNA	PMID:23557933
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of GLIPR1 mRNA	PMID:27392435
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314329	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of GLIPR1 mRNA	PMID:21151649
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of GLIPR1 mRNA	PMID:27392435
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of GLIPR1 mRNA	PMID:25583101
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305978	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GLIPR1 mRNA	PMID:34747641
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GLIPR1 mRNA	PMID:17101203
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305978	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GLIPR1 mRNA	PMID:20059583
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314329	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GLIPR1 mRNA	PMID:20819909
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to GLIPR1 gene]	PMID:20819909
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of GLIPR1 mRNA	PMID:28001369
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1305978	E	RGD:6480464	20200211	CTD	MESH:C004925	methylmercuric chloride results in increased expression of GLIPR1 mRNA	PMID:31378766
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GLIPR1 mRNA	PMID:33212167
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of GLIPR1 mRNA	PMID:23649840
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1305978	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of GLIPR1 mRNA	PMID:30556269
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of GLIPR1 mRNA	PMID:20971185
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GLIPR1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GLIPR1 mRNA	PMID:37567420|PMID:37992649
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of GLIPR1 mRNA	PMID:29432896
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of GLIPR1 mRNA	PMID:34032870
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GLIPR1 mRNA	PMID:38568856
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GLIPR1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GLIPR1 mRNA	PMID:39836092
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GLIPR1 mRNA	PMID:40504410
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GLIPR1 mRNA	PMID:20106945|PMID:21871943|PMID:22316170|PMID:26238291|PMID:32234424
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1305978	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of GLIPR1 mRNA	PMID:30556269
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of GLIPR1 mRNA	PMID:20971185
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314329	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of GLIPR1 mRNA	PMID:27131904
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of GLIPR1 mRNA	PMID:25351596
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314329	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of GLIPR1 mRNA	PMID:29341224
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of GLIPR1 mRNA	PMID:19128835
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of GLIPR1 mRNA	PMID:35984750
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1305978	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of GLIPR1 mRNA	PMID:24395379
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GLIPR1 gene	PMID:31601247
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of GLIPR1 mRNA	PMID:38568856
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314329	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of GLIPR1 mRNA	PMID:35295148
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314329	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of GLIPR1 mRNA	PMID:27760801
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305978	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of GLIPR1 mRNA	PMID:34492290
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305978	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of GLIPR1 mRNA	PMID:25380136
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314329	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of GLIPR1 mRNA	PMID:23811191
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GLIPR1 mRNA	PMID:19710929
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of GLIPR1 mRNA	PMID:29275510
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305978	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GLIPR1 mRNA	PMID:25181051
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of GLIPR1 gene	PMID:31601247
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305978	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of GLIPR1 mRNA	PMID:41034487
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of GLIPR1 gene	PMID:31601247
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of GLIPR1 mRNA	PMID:19041380
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1305978	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of GLIPR1 mRNA	PMID:23196670
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314329	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GLIPR1 mRNA	PMID:32715474
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305978	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of GLIPR1 mRNA	PMID:21266533
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1314329	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of GLIPR1 mRNA	PMID:24535843
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GLIPR1 mRNA	PMID:37042841
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of GLIPR1 mRNA	PMID:29024780
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GLIPR1 mRNA	PMID:39836092
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1305978	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of GLIPR1 mRNA	PMID:25380136
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1305978	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of GLIPR1 mRNA	PMID:22110744
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GLIPR1 mRNA	PMID:38382870|PMID:38568856
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305978	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GLIPR1 mRNA	PMID:25993096
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of GLIPR1 mRNA	PMID:19320972
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1305978	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of GLIPR1 mRNA	PMID:25380136
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of GLIPR1 mRNA	PMID:24449571
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314329	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GLIPR1 mRNA	PMID:40194260
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of GLIPR1 mRNA	PMID:40434365
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of GLIPR1 mRNA	PMID:40419075
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GLIPR1 mRNA	PMID:36331819
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GLIPR1 mRNA	PMID:25979313
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GLIPR1 gene	PMID:29154799
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of GLIPR1 mRNA	PMID:23179753|PMID:26272509|PMID:27188386|PMID:28001369
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLIPR1 mRNA	PMID:27188386
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of GLIPR1 mRNA	PMID:22147139
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GLIPR1 mRNA	PMID:20106945|PMID:25562108
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of GLIPR1 mRNA	PMID:36621641
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GLIPR1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GLIPR1 mRNA	PMID:37567420|PMID:37992649
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of GLIPR1 mRNA	PMID:23649840
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GLIPR1 mRNA	PMID:38832940
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of GLIPR1 mRNA	PMID:27188386
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314329	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GLIPR1 mRNA	PMID:17562736
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of GLIPR1 mRNA	PMID:21420995
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305978	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GLIPR1 mRNA	PMID:33387578
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D005472	Fluorouracil results in increased expression of GLIPR1 mRNA	PMID:24737281
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of GLIPR1 mRNA	PMID:20977926
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GLIPR1 gene	PMID:25304211
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GLIPR1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GLIPR1 mRNA	PMID:39836092
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GLIPR1 mRNA	PMID:40504410
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:48318	fragrance	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:D010476	Perfume results in increased expression of GLIPR1 mRNA	PMID:24768652
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of GLIPR1 mRNA	PMID:32234424
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of GLIPR1 mRNA	PMID:23228038
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLIPR1 mRNA	PMID:27188386
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of GLIPR1 mRNA	PMID:19128835
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the methylation of GLIPR1 promoter	PMID:18030365
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314329	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of GLIPR1 mRNA; Nanotubes, Carbon results in increased expression of GLIPR1 mRNA	PMID:25554681
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of GLIPR1 mRNA	PMID:22714537
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GLIPR1 mRNA	PMID:39836092
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLIPR1 mRNA	PMID:26378955
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of GLIPR1 mRNA	PMID:28988120
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of GLIPR1 mRNA	PMID:15336504
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1305978	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GLIPR1 mRNA	PMID:28801915
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GLIPR1 mRNA	PMID:20147733
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1305978	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of GLIPR1 mRNA	PMID:35283115
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of GLIPR1 mRNA	PMID:31758290
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314329	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GLIPR1 mRNA	PMID:22206623
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of GLIPR1 mRNA	PMID:22714537
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1314329	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GLIPR1 mRNA	PMID:37567420
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1305978	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GLIPR1 mRNA	PMID:32741896
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLIPR1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLIPR1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLIPR1 mRNA	PMID:27188386
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GLIPR1 gene]	PMID:28238834
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314329	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of GLIPR1 mRNA	PMID:38648751
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of GLIPR1 mRNA	PMID:21858171
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314329	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of GLIPR1 mRNA	PMID:39847705
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLIPR1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLIPR1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GLIPR1 mRNA	PMID:27188386
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314329	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of GLIPR1 mRNA	PMID:27131904
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of GLIPR1 mRNA	PMID:38568856
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C032910	triadimefon results in decreased expression of GLIPR1 mRNA	PMID:26705709
1314328	GLIPR1	GLI pathogenesis related 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1305978	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of GLIPR1 mRNA	PMID:19015723
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of BMP5 mRNA	PMID:38218311
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of BMP5 mRNA	PMID:26272509|PMID:27188386
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA	PMID:27188386
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1305979	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of BMP5 gene	PMID:35440735
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of BMP5 mRNA	PMID:35811015
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of BMP5 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of BMP5 mRNA	PMID:35811015
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of BMP5 mRNA	PMID:14699072
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305979	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of BMP5 mRNA	PMID:32145629
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314331	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of BMP5 mRNA	PMID:29980752
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:167162	L-ascorbic acid 2-phosphate	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C011669	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of BMP5 mRNA	PMID:34480604
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of BMP5 mRNA	PMID:17556502
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1314331	E	RGD:6480464	20120412	CTD	MESH:D011374	NCOA2 protein affects the reaction [Progesterone results in decreased expression of BMP5 mRNA]; PGR protein affects the reaction [Progesterone results in decreased expression of BMP5 mRNA]	PMID:17556502
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of BMP5 mRNA	PMID:36695872
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1314331	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of BMP5 mRNA	PMID:28973375
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:17650	cortisol	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:D006854	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of BMP5 mRNA	PMID:34480604
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1314331	E	RGD:6480464	20120501	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of BMP5 gene	PMID:10517996|PMID:9475716|PMID:9825669
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1305979	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of BMP5 mRNA	PMID:21396975
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1305979	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA	PMID:22129741
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of BMP5 gene	PMID:27153756
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of BMP5 mRNA	PMID:17484886
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of BMP5 mRNA	PMID:19654921
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of BMP5 mRNA	PMID:26272509
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA	PMID:27188386
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1305979	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of BMP5 gene	PMID:35440735
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of BMP5 mRNA	PMID:31295307
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305979	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of BMP5 mRNA	PMID:31881176
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of BMP5 mRNA	PMID:19167446
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of BMP5 mRNA	PMID:32186404
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BMP5 mRNA	PMID:24035824|PMID:26290441
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of BMP5 mRNA	PMID:29955902
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of BMP5 mRNA	PMID:28001369
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of BMP5 mRNA	PMID:26272509
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA	PMID:27188386
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305979	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of BMP5 mRNA	PMID:28959563
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of BMP5 mRNA	PMID:21198554
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of BMP5 mRNA	PMID:29803840
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:28830	chlorambucil	increases mutagenesis	ISO	RGD:1314331	E	RGD:6480464	20120412	CTD	MESH:D002699	Chlorambucil results in increased mutagenesis of BMP5 gene	PMID:10517996
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1305979	E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA	PMID:22129741
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:D001205	[[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of BMP5 mRNA	PMID:34480604
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of BMP5 mRNA	PMID:19615344
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of BMP5 mRNA	PMID:35202923|PMID:37682722
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314331	E	RGD:6480464	20240430	CTD	MESH:C017947	salvin inhibits the reaction [sodium arsenite results in decreased expression of BMP5 mRNA]	PMID:35202923
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BMP5 exon	PMID:27901495
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314331	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BMP5 intron	PMID:27901495
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of BMP5 mRNA	PMID:33053406
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305979	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of BMP5 mRNA	PMID:25729387
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305979	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of BMP5 mRNA	PMID:30047161
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of BMP5 mRNA	PMID:35295148
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314331	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of BMP5 mRNA	PMID:19710929
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305979	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of BMP5 mRNA	PMID:25181051|PMID:34947998|PMID:35192832
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of BMP5 mRNA	PMID:33221593
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305979	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of BMP5 mRNA	PMID:32145629
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314331	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of BMP5 mRNA	PMID:30951980
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305979	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of BMP5 gene	PMID:28505145
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	BMP5 mRNA affects the susceptibility to Carmustine	PMID:16365179
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314331	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of BMP5 gene	PMID:31683443
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314331	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of BMP5 mRNA	PMID:30951980
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314331	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of BMP5 mRNA	PMID:30951980|PMID:38685157
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:34693	Dicyclohexyl phthalate	increases expression	ISO	RGD:1305979	E	RGD:6480464	20260303	CTD	MESH:C036042	dicyclohexyl phthalate results in increased expression of BMP5 mRNA	PMID:40690386
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of BMP5 mRNA	PMID:24535843
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1305979	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA	PMID:22129741
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314331	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BMP5 mRNA	PMID:24535843
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305979	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of BMP5 mRNA	PMID:35163327
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D019256	Cadmium Chloride results in increased expression of BMP5 mRNA	PMID:27375191
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305979	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of BMP5 mRNA	PMID:35163327
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314331	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of BMP5 mRNA	PMID:40194260
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of BMP5 mRNA	PMID:31533062
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of BMP5 mRNA	PMID:19167446
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of BMP5 mRNA	PMID:23125180
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of BMP5 gene	PMID:29154799
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of BMP5 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314331	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of BMP5 mRNA	PMID:24896083
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA	PMID:27188386
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305979	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of BMP5 mRNA	PMID:30047161
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of BMP5 mRNA	PMID:14699072
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:43572	kojic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of BMP5 mRNA	PMID:16595896
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of BMP5 mRNA	PMID:26272509|PMID:27188386
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA	PMID:27188386
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of BMP5 mRNA	PMID:24935251|PMID:26272509
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA	PMID:27188386
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of BMP5 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of BMP5 mRNA	PMID:35811015
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of BMP5 mRNA	PMID:19654921
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1305979	E	RGD:6480464	20231031	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of BMP5 mRNA	PMID:37567419
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of BMP5 mRNA	PMID:26272509
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA	PMID:27188386
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1314331	E	RGD:6480464	20120412	CTD	MESH:D008770	Methylnitrosourea results in increased mutagenesis of BMP5 gene	PMID:10517996|PMID:17174358
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of BMP5 mRNA	PMID:27915011
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314331	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of BMP5 mRNA	PMID:25554681
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305979	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of BMP5 mRNA	PMID:30047161
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314331	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of BMP5 mRNA	PMID:40234311
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314331	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of BMP5 mRNA	PMID:23608068
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of BMP5 mRNA	PMID:26272509
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA	PMID:27188386
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:62878	XAV939	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C544261	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of BMP5 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of BMP5 mRNA	PMID:34480604
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305979	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of BMP5 mRNA	PMID:25729387
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of BMP5 mRNA	PMID:24810058
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:65585	carnosic acid	multiple interactions	ISO	RGD:1314331	E	RGD:6480464	20240430	CTD	MESH:C018381	salvin inhibits the reaction [sodium arsenite results in decreased expression of BMP5 mRNA]	PMID:35202923
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305979	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of BMP5 gene	PMID:35440735
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:6925	microcystin-LR	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C057862	cyanoginosin LR results in increased expression of BMP5 mRNA	PMID:29518473
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	BMP5 mRNA affects the susceptibility to temozolomide	PMID:16365179
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of BMP5 mRNA	PMID:34480604
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:75261	arotinoid acid	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C038864	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of BMP5 mRNA	PMID:34480604
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA	PMID:27188386
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314331	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of BMP5 mRNA	PMID:23091169
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314331	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BMP5 mRNA	PMID:24535843
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314331	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of BMP5 mRNA	PMID:31388691
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314331	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of BMP5 mRNA	PMID:38648751
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314331	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of BMP5 mRNA	PMID:21795629
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305979	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of BMP5 mRNA	PMID:30047161
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of BMP5 mRNA	PMID:26272509
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA	PMID:27188386
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:91091	CHIR 99021	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C473711	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of BMP5 mRNA; [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of BMP5 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of BMP5 mRNA	PMID:34480604
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of BMP5 mRNA; [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA	PMID:27188386|PMID:34480604
1314330	BMP5	bone morphogenetic protein 5	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305979	E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of BMP5 mRNA	PMID:22615374
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MBD1 mRNA	PMID:20938992
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of MBD1 protein	PMID:39571964
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of MBD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of MBD1 mRNA	PMID:32699268
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of MBD1 mRNA	PMID:20880076
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MBD1 mRNA	PMID:30529165
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MBD1 mRNA	PMID:26079696
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of MBD1 mRNA	PMID:22952798
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314333	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of MBD1 mRNA	PMID:39298647
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol inhibits the reaction [sodium arsenite results in increased expression of MBD1 mRNA]	PMID:22952798
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314333	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of MBD1 mRNA	PMID:33711761
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of MBD1 mRNA	PMID:38568856
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MBD1 mRNA	PMID:20938992
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MBD1 mRNA	PMID:37042841
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:17303	morphine	affects expression	ISO	RGD:1314333	E	RGD:6480464	20220111	CTD	MESH:D009020	Morphine affects the expression of MBD1 mRNA	PMID:33891991
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314333	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MBD1 mRNA	PMID:23892564
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MBD1 protein	PMID:37730182
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305980	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MBD1 mRNA	PMID:33387578
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of MBD1 mRNA	PMID:28818685
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of MBD1 3' UTR	PMID:30157460
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MBD1 mRNA	PMID:37236586
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MBD1 mRNA	PMID:18579281
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MBD1 mRNA	PMID:19549813
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MBD1 protein	PMID:23301498
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases expression	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:D005038	Ethylnitrosourea results in increased expression of MBD1; Ethylnitrosourea results in increased expression of MBD1 mRNA	PMID:19100860|PMID:21154115
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MBD1 gene; Aflatoxin B1 results in decreased methylation of MBD1 polyA tail	PMID:27153756|PMID:30157460
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314333	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MBD1 mRNA	PMID:19770486
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MBD1 exon	PMID:30157460
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MBD1 mRNA	PMID:23649840
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of MBD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of MBD1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of MBD1 mRNA	PMID:32699268
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:D010126	TTPA protein affects the reaction [Ozone results in increased expression of MBD1 mRNA]	PMID:19555225
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MBD1 mRNA	PMID:17484886
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305980	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MBD1 mRNA	PMID:31150632
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314333	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MBD1 mRNA	PMID:31919559
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MBD1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MBD1 mRNA	PMID:20938992|PMID:22206623
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of MBD1 mRNA	PMID:19654921
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MBD1 mRNA	PMID:40512198
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of MBD1 mRNA	PMID:19244175
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MBD1 protein	PMID:35688186
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of MBD1 mRNA	PMID:28189721|PMID:28960355
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of MBD1 protein	PMID:25505154
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1305980	E	RGD:6480464	20120918	CTD	MESH:D003042	Cocaine results in increased expression of MBD1 protein	PMID:16670375
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314333	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MBD1 mRNA	PMID:21570461
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MBD1 mRNA	PMID:19770486
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MBD1 mRNA	PMID:17942748
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MBD1 mRNA	PMID:17942748
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MBD1 protein	PMID:33212167
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of MBD1 mRNA	PMID:20971185
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MBD1 mRNA	PMID:15467011
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314333	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of MBD1 mRNA	PMID:27862939
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314333	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of MBD1 mRNA	PMID:39631538
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of MBD1 protein	PMID:35688186
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:29365	phosgene	affects expression	ISO	RGD:1314333	E	RGD:6480464	20120515	CTD	MESH:D010705	Phosgene affects the expression of MBD1 mRNA	PMID:16300373
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in decreased expression of MBD1 protein	PMID:39571964
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MBD1 mRNA	PMID:22952798|PMID:38568856|PMID:39719251
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314333	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MBD1 mRNA	PMID:19822182
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in decreased expression of MBD1 protein; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MBD1 mRNA; Estradiol inhibits the reaction [sodium arsenite results in increased expression of MBD1 mRNA]	PMID:22952798|PMID:39571964|PMID:40512198
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314333	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MBD1 mRNA	PMID:21569818
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of MBD1 mRNA	PMID:20971185
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MBD1 mRNA	PMID:15467011
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of MBD1 mRNA	PMID:34408198
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305980	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of MBD1 mRNA	PMID:30047161
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20120717	CTD	MESH:C009495	titanium dioxide results in decreased expression of MBD1 mRNA	PMID:19464567
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314333	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MBD1 mRNA	PMID:23557971|PMID:27760801
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305980	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MBD1 mRNA	PMID:23411599|PMID:34492290
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of MBD1 mRNA	PMID:23811191
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MBD1 mRNA	PMID:18445702
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305980	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MBD1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314333	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of MBD1 mRNA	PMID:25594700
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of MBD1 mRNA	PMID:19244175
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314333	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of MBD1 mRNA	PMID:39298647
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1314333	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MBD1 mRNA	PMID:34813904
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of MBD1 mRNA	PMID:19100860
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:D010269	Paraquat results in increased expression of MBD1 mRNA	PMID:12595580
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MBD1 mRNA	PMID:38568856
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MBD1 mRNA	PMID:37236586
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314333	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of MBD1 mRNA	PMID:18353800
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of MBD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of MBD1 mRNA	PMID:32699268
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of MBD1 mRNA	PMID:19244175
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1305980	E	RGD:6480464	20171010	CTD	MESH:D002994	Clofibrate results in decreased expression of MBD1 mRNA	PMID:28495587
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of MBD1 mRNA	PMID:40194260
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of MBD1 mRNA	PMID:36331819
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1314333	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of MBD1 mRNA	PMID:23125180
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MBD1 mRNA	PMID:17963808
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of MBD1 mRNA	PMID:28001369
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MBD1 gene	PMID:29154799
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305980	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of MBD1 mRNA	PMID:30047161
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of MBD1 mRNA	PMID:19770486
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MBD1 mRNA	PMID:20106945
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MBD1 mRNA	PMID:20937368
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314333	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MBD1 mRNA	PMID:28973697
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of MBD1 mRNA	PMID:24449571
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MBD1 mRNA	PMID:17562736
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MBD1 mRNA	PMID:29279043
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of MBD1 mRNA	PMID:19654921
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MBD1 mRNA	PMID:40512198
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of MBD1 mRNA	PMID:35436446
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MBD1 mRNA	PMID:17942748
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of MBD1 mRNA	PMID:19329758
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314333	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MBD1 mRNA; Nanotubes, Carbon results in increased expression of MBD1 mRNA	PMID:25554681
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305980	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of MBD1 mRNA	PMID:30047161
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MBD1 mRNA	PMID:35964746
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:5118	fluoxetine	increases expression	ISO	RGD:1305980	E	RGD:6480464	20120918	CTD	MESH:D005473	Fluoxetine results in increased expression of MBD1 mRNA; Fluoxetine results in increased expression of MBD1 protein	PMID:16670375
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1305980	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MBD1 mRNA	PMID:24136188
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of MBD1 mRNA	PMID:20977926
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:6076	itraconazole	increases expression	ISO	RGD:1314333	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of MBD1 mRNA	PMID:31099283
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of MBD1 mRNA	PMID:16934159
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1314333	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of MBD1 mRNA	PMID:20003209
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MBD1 mRNA	PMID:22206623
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314333	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MBD1 mRNA	PMID:22206623
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of MBD1 protein	PMID:31285264
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1305980	E	RGD:6480464	20171010	CTD	MESH:D010634	Phenobarbital results in decreased expression of MBD1 mRNA	PMID:28495587
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1314333	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of MBD1 mRNA	PMID:19270015
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314333	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of MBD1 mRNA	PMID:38648751
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1305980	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of MBD1 mRNA	PMID:30047161
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305980	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MBD1 mRNA	PMID:30047161
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1305980	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MBD1 mRNA	PMID:21346803
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:94366	2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one	increases expression	ISO	RGD:1314333	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in increased expression of MBD1 mRNA	PMID:31099283
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MBD1 mRNA	PMID:38568856
1314332	MBD1	methyl-CpG binding domain protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305980	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of MBD1 mRNA	PMID:23034163
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D014212	Tretinoin results in increased expression of CIAO3 mRNA	PMID:33167477
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CIAO3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CIAO3 mRNA	PMID:32699268
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of CIAO3 mRNA	PMID:22378314
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CIAO3 mRNA	PMID:37042841
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305982	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CIAO3 mRNA	PMID:33387578
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314336	E	RGD:6480464	20260707	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CIAO3 mRNA	PMID:36331819
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314336	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CIAO3 mRNA	PMID:37236586
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CIAO3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CIAO3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of CIAO3 mRNA	PMID:32699268
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314336	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CIAO3 mRNA	PMID:22206623
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CIAO3 gene	PMID:25304211
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314336	E	RGD:6480464	20260707	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CIAO3 mRNA	PMID:28960355
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314336	E	RGD:6480464	20190611	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CIAO3 mRNA	PMID:21570461|PMID:24680724
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314336	E	RGD:6480464	20190611	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CIAO3 mRNA	PMID:28213091
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305982	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CIAO3 mRNA	PMID:33387578
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314336	E	RGD:6480464	20190611	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CIAO3 mRNA	PMID:17942748
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of CIAO3 protein	PMID:39603559
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CIAO3 mRNA	PMID:32763439
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of CIAO3 mRNA	PMID:29319823
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CIAO3 mRNA	PMID:38568856
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of CIAO3 gene	PMID:31601247
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314336	E	RGD:6480464	20190611	CTD	MESH:C006253	pirinixic acid results in increased expression of CIAO3 mRNA	PMID:18301758|PMID:23811191
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305982	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CIAO3 mRNA	PMID:30816183|PMID:32528016
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305982	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CIAO3 mRNA	PMID:25181051|PMID:34947998
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314336	E	RGD:6480464	20260707	CTD	MESH:C543008	bisphenol S affects the methylation of CIAO3 gene	PMID:31683443
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of CIAO3 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIAO3 mRNA	PMID:28628672|PMID:31601247
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIAO3 mRNA	PMID:28628672
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314336	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CIAO3 mRNA	PMID:37236586
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1305982	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of CIAO3 gene	PMID:22079235
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CIAO3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CIAO3 mRNA	PMID:32699268
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:38604	pyrimidifen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of CIAO3 mRNA	PMID:33512557
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314336	E	RGD:6480464	20260707	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CIAO3 mRNA	PMID:36331819
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1314336	E	RGD:6480464	20260707	CTD	MESH:C016104	sodium bichromate results in decreased expression of CIAO3 mRNA	PMID:31558096
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314336	E	RGD:6480464	20190611	CTD	MESH:D014635	Valproic Acid affects the expression of CIAO3 mRNA	PMID:17292431
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CIAO3 gene	PMID:29154799
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of CIAO3 promoter	PMID:27989131
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIAO3 mRNA	PMID:28628672
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314336	E	RGD:6480464	20190611	CTD	MESH:D000082	Acetaminophen affects the expression of CIAO3 mRNA	PMID:17562736
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CIAO3 gene	PMID:25304211
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314336	E	RGD:6480464	20190611	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CIAO3 mRNA	PMID:17942748
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CIAO3 mRNA	PMID:28628672
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1305982	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of CIAO3 mRNA	PMID:20080153
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314336	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CIAO3 mRNA	PMID:22206623
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CIAO3 mRNA	PMID:37199045
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CIAO3 mRNA	PMID:38568856
1314335	CIAO3	cytosolic iron-sulfur assembly component 3	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1305982	E	RGD:6480464	20260707	CTD	MESH:C001899	triptolide results in increased expression of CIAO3 protein	PMID:32519852
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1305983	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in decreased expression of PTTG1IP mRNA	PMID:20488242
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PTTG1IP mRNA	PMID:26079696
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314338	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PTTG1IP mRNA	PMID:39241906
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of PTTG1IP mRNA	PMID:35877022
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314338	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PTTG1IP mRNA]	PMID:39241906
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314338	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PTTG1IP mRNA	PMID:39298647
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1314338	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of PTTG1IP mRNA	PMID:33914522
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1314338	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of PTTG1IP mRNA	PMID:27462272
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314338	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PTTG1IP mRNA	PMID:19770486
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PTTG1IP mRNA	PMID:35430440
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:2663	amiodarone	affects expression	ISO	RGD:1305983	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of PTTG1IP mRNA	PMID:19483382
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314338	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PTTG1IP mRNA	PMID:22206623
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of PTTG1IP protein	PMID:35688186
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PTTG1IP mRNA	PMID:23557933
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314338	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PTTG1IP mRNA	PMID:21570461
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305983	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PTTG1IP mRNA	PMID:21215274
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305983	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PTTG1IP mRNA	PMID:32109520|PMID:34747641
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1305983	E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of PTTG1IP mRNA]	PMID:21215274
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of PTTG1IP protein	PMID:39603559
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314338	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PTTG1IP mRNA	PMID:19465457
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1305983	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PTTG1IP mRNA	PMID:28959563
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PTTG1IP mRNA	PMID:38568856|PMID:39719251
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PTTG1IP promoter	PMID:27901495
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:3023	benzbromarone	affects expression	ISO	RGD:1305983	E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of PTTG1IP mRNA	PMID:19483382
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PTTG1IP mRNA	PMID:25895662
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1305983	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PTTG1IP mRNA	PMID:30047161
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1305983	E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of PTTG1IP mRNA	PMID:19483382
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1305983	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of PTTG1IP mRNA	PMID:19483382
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1314338	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of PTTG1IP mRNA	PMID:33914522
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PTTG1IP mRNA	PMID:30903817
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of PTTG1IP protein	PMID:34186270
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305983	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PTTG1IP mRNA	PMID:25181051
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of PTTG1IP protein	PMID:34186270
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314338	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of PTTG1IP mRNA	PMID:38685157
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PTTG1IP protein	PMID:34186270
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:1305983	E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of PTTG1IP mRNA	PMID:17602206
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314338	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of PTTG1IP mRNA	PMID:34813904
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1314338	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of PTTG1IP mRNA	PMID:34813904
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314338	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PTTG1IP mRNA]	PMID:39241906
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PTTG1IP mRNA	PMID:37042841
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1305983	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PTTG1IP mRNA	PMID:33453195
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1305983	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PTTG1IP promoter	PMID:22457795
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of PTTG1IP mRNA	PMID:19376846
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PTTG1IP mRNA	PMID:24449571
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314338	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of PTTG1IP mRNA	PMID:18353800
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:3750	clofibrate	affects expression	ISO	RGD:1305983	E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of PTTG1IP mRNA	PMID:19483382
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305983	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PTTG1IP mRNA	PMID:30047161
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305983	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of PTTG1IP mRNA	PMID:41580965
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1314338	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of PTTG1IP mRNA	PMID:22733784
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PTTG1IP mRNA	PMID:28542535
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314338	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of PTTG1IP mRNA	PMID:35436446
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of PTTG1IP mRNA	PMID:18175754
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:4886	L-ethionine	affects expression	ISO	RGD:1305983	E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of PTTG1IP mRNA	PMID:19483382
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314338	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PTTG1IP mRNA	PMID:25554681
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1305983	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PTTG1IP mRNA	PMID:30047161
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314338	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PTTG1IP mRNA	PMID:35964746
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:64213	cantharidin	increases expression	ISO	RGD:1314338	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in increased expression of PTTG1IP mRNA	PMID:36907384
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305983	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PTTG1IP gene	PMID:35440735
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PTTG1IP protein	PMID:34186270
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314338	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PTTG1IP mRNA	PMID:22206623
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314338	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PTTG1IP mRNA	PMID:22206623
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	ISO	RGD:1305983	E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of PTTG1IP mRNA	PMID:19483382
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:7772	omeprazole	affects expression	ISO	RGD:1305983	E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of PTTG1IP mRNA	PMID:19483382
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PTTG1IP gene]	PMID:28238834
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1314338	E	RGD:6480464	20150127	CTD	MESH:D010634	Phenobarbital results in decreased expression of PTTG1IP mRNA	PMID:23091169|PMID:25270620
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314338	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of PTTG1IP mRNA	PMID:21795629
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314338	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of PTTG1IP mRNA	PMID:21795629
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1305983	E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of PTTG1IP mRNA	PMID:19483382
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1305983	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PTTG1IP mRNA	PMID:30047161
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314338	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of PTTG1IP mRNA]	PMID:39241906
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305983	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PTTG1IP mRNA	PMID:19281266
1314337	PTTG1IP	PTTG1 interacting protein	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PTTG1IP mRNA	PMID:38568856
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305987	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of UQCRH mRNA]	PMID:31150632
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of UQCRH mRNA	PMID:22378314
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550364	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of UQCRH mRNA	PMID:30319688
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of UQCRH mRNA	PMID:21179406
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550364	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of UQCRH mRNA	PMID:39241906
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of UQCRH mRNA	PMID:35877022
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1305987	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of UQCRH mRNA	PMID:32145629
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550364	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UQCRH mRNA	PMID:25510870
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:16990	bilirubin IXalpha	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin results in decreased expression of UQCRH mRNA	PMID:20196124
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of UQCRH mRNA	PMID:21179406
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1550364	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of UQCRH mRNA	PMID:17178593
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550364	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of UQCRH mRNA	PMID:28085963
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550364	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of UQCRH mRNA	PMID:33754040
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:17833	gentamycin	multiple interactions	ISO	RGD:1305987	E	RGD:6480464	20191112	CTD	MESH:D005839	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRH protein	PMID:30545405
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1550364	E	RGD:6480464	20120522	CTD	MESH:D005944	Glucosamine results in increased expression of UQCRH mRNA	PMID:17178593
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UQCRH mRNA	PMID:35301059
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550364	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UQCRH mRNA	PMID:25510870
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550364	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UQCRH mRNA	PMID:25510870
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305987	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of UQCRH mRNA	PMID:31150632
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305987	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of UQCRH mRNA]	PMID:31150632
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550364	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of UQCRH mRNA	PMID:25629700
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550364	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UQCRH mRNA	PMID:22206623
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of UQCRH mRNA; [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in decreased expression of UQCRH mRNA	PMID:35809665
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550364	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of UQCRH mRNA	PMID:40504410
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of UQCRH mRNA	PMID:19244175
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1305987	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of UQCRH mRNA	PMID:31881176
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1550364	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of UQCRH mRNA	PMID:22610192
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of UQCRH mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of UQCRH mRNA	PMID:23557933
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1305987	E	RGD:6480464	20120522	CTD	MESH:D003042	Cocaine affects the expression of UQCRH mRNA	PMID:20187946
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1550364	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of UQCRH mRNA	PMID:30912803
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:28001	vancomycin	multiple interactions	ISO	RGD:1305987	E	RGD:6480464	20191112	CTD	MESH:D014640	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRH protein	PMID:30545405
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305987	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UQCRH mRNA	PMID:34747641
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550364	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UQCRH mRNA	PMID:21570461
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550364	E	RGD:6480464	20120522	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UQCRH mRNA	PMID:17942748
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UQCRH mRNA	PMID:30851411
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1550364	E	RGD:6480464	20120522	CTD	MESH:D005944	Glucosamine results in increased expression of UQCRH mRNA	PMID:17178593
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in decreased expression of UQCRH mRNA; [Disulfiram binds to Copper] which results in decreased expression of UQCRH mRNA	PMID:24690739|PMID:35809665
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1550364	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of UQCRH protein	PMID:27548804
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of UQCRH mRNA	PMID:18510171
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of UQCRH mRNA	PMID:29803840
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1550364	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in increased expression of UQCRH mRNA	PMID:26873546
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:28971	ampicillin	multiple interactions	ISO	RGD:1305987	E	RGD:6480464	20191112	CTD	MESH:D000667	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRH protein	PMID:30545405
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of UQCRH mRNA	PMID:39719251
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1305987	E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in increased expression of UQCRH protein	PMID:38266420
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550364	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of UQCRH mRNA	PMID:40504410
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of UQCRH mRNA	PMID:22378314
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to UQCRH mRNA]	PMID:32406909
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in decreased expression of UQCRH mRNA; [Disulfiram binds to Copper] which results in decreased expression of UQCRH mRNA	PMID:24690739|PMID:35809665
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of UQCRH mRNA	PMID:25258189
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550364	E	RGD:6480464	20120522	CTD	MESH:C006253	pirinixic acid results in decreased expression of UQCRH mRNA	PMID:17950772
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of UQCRH mRNA	PMID:38479592
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of UQCRH mRNA	PMID:30903817
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305987	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of UQCRH mRNA	PMID:32145629
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550364	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of UQCRH mRNA	PMID:35598803
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550364	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of UQCRH mRNA	PMID:38074096
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550364	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UQCRH mRNA	PMID:25510870
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550364	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of UQCRH mRNA	PMID:25510870
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550364	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of UQCRH mRNA	PMID:39298647
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:1305987	E	RGD:6480464	20120522	CTD	MESH:D002995	Clofibric Acid affects the expression of UQCRH mRNA	PMID:17602206
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:34696	dieldrin	decreases expression	ISO	RGD:1305987	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin results in decreased expression of UQCRH mRNA	PMID:23153324
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1550364	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of UQCRH mRNA	PMID:34813904
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:34785	heptachlor	decreases expression	ISO	RGD:1305987	E	RGD:6480464	20141014	CTD	MESH:D006533	Heptachlor results in decreased expression of UQCRH mRNA	PMID:23153324
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1550364	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of UQCRH mRNA	PMID:34813904
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of UQCRH mRNA	PMID:35301059
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1550364	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of UQCRH mRNA	PMID:28903501
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of UQCRH mRNA	PMID:19244175
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of UQCRH mRNA	PMID:28302478
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of UQCRH mRNA	PMID:26352163
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide affects the expression of UQCRH mRNA	PMID:16570282
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in increased expression of UQCRH mRNA	PMID:31059760
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1550364	E	RGD:6480464	20120717	CTD	MESH:D000082	Acetaminophen results in increased expression of UQCRH protein	PMID:21329376
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:46345	5-fluorouracil	affects expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D005472	Fluorouracil affects the expression of UQCRH mRNA	PMID:34151400
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C088658	zoledronic acid results in decreased expression of UQCRH protein	PMID:28871336
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of UQCRH mRNA	PMID:24690739
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of UQCRH mRNA; [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in decreased expression of UQCRH mRNA	PMID:35809665
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550364	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of UQCRH mRNA	PMID:40504410
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1550364	E	RGD:6480464	20120522	CTD	MESH:D005944	Glucosamine results in increased expression of UQCRH mRNA	PMID:17178593
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1550364	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of UQCRH mRNA	PMID:35436446
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550364	E	RGD:6480464	20120522	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of UQCRH mRNA	PMID:17555576
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550364	E	RGD:6480464	20120522	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of UQCRH mRNA	PMID:17942748
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:49553	copper(II) chloride	decreases expression	ISO	RGD:1550364	E	RGD:6480464	20181016	CTD	MESH:C029892	cupric chloride results in decreased expression of UQCRH protein	PMID:29617964
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of UQCRH mRNA	PMID:25258189
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:50223	(+)-dexrazoxane	increases expression	ISO	RGD:1550364	E	RGD:6480464	20170303	CTD	MESH:D064730	Dexrazoxane results in increased expression of UQCRH mRNA	PMID:26873546
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1550364	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of UQCRH mRNA	PMID:40234311
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:50729	mitoxantrone	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	UQCRH protein affects the susceptibility to Mitoxantrone	PMID:16217747
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1550364	E	RGD:6480464	20120814	CTD	MESH:D005485	Flutamide results in decreased expression of UQCRH mRNA	PMID:19442681
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:6030	isoniazide	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of UQCRH protein	PMID:40015660
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UQCRH protein	PMID:32959892
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:63952	arsenic trichloride	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of UQCRH mRNA; [Copper co-treated with [arsenic trichloride results in increased abundance of Arsenic]] results in decreased expression of UQCRH mRNA	PMID:35809665
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305987	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of UQCRH mRNA	PMID:30467583
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:6909	metronidazole	multiple interactions	ISO	RGD:1305987	E	RGD:6480464	20191112	CTD	MESH:D008795	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRH protein	PMID:30545405
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of UQCRH protein	PMID:34186270
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550364	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of UQCRH mRNA	PMID:22206623
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550364	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of UQCRH mRNA	PMID:22206623
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:7507	neomycin	multiple interactions	ISO	RGD:1305987	E	RGD:6480464	20191112	CTD	MESH:D009355	[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRH protein	PMID:30545405
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in increased expression of UQCRH mRNA	PMID:17316727
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of UQCRH mRNA	PMID:30851411
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1550364	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of UQCRH mRNA	PMID:31388691
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1550364	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in increased expression of UQCRH protein	PMID:26903627
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:90633	perfluorododecanoic acid	decreases expression	ISO	RGD:1305987	E	RGD:6480464	20170303	CTD	MESH:C522391	perfluorododecanoic acid results in decreased expression of UQCRH protein	PMID:19854247
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:90633	perfluorododecanoic acid	increases expression	ISO	RGD:1305987	E	RGD:6480464	20170303	CTD	MESH:C522391	perfluorododecanoic acid results in increased expression of UQCRH mRNA	PMID:19854247
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:94688	5-methyl-4-oxido-2-pyrazin-4-iumcarboxylic acid	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C027696	acipimox results in increased expression of UQCRH mRNA	PMID:25352640
1314343	UQCRH	ubiquinol-cytochrome c reductase hinge protein	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of UQCRH mRNA	PMID:22378314
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314348	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DUSP15 mRNA	PMID:33045310
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of DUSP15 mRNA	PMID:35811015
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305990	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DUSP15 mRNA	PMID:33387578
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1305990	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DUSP15 promoter	PMID:23359474
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305990	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of DUSP15 mRNA	PMID:26577399|PMID:27523638
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DUSP15 mRNA	PMID:28818685
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of DUSP15 exon	PMID:30157460
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1305990	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DUSP15 mRNA	PMID:31150632
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of DUSP15 mRNA	PMID:38460933
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of DUSP15 mRNA	PMID:38460933
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:27810	resorcinol	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in decreased expression of DUSP15 mRNA	PMID:22623647
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of DUSP15 mRNA	PMID:23557933
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of DUSP15 mRNA	PMID:27392435
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DUSP15 mRNA	PMID:27913140
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305990	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DUSP15 mRNA	PMID:33387578
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DUSP15 mRNA	PMID:33212167
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1305990	E	RGD:6480464	20200714	CTD	MESH:D004317	Doxorubicin results in decreased expression of DUSP15 mRNA	PMID:32289291
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314348	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of DUSP15 mRNA	PMID:36209798
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314348	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DUSP15 mRNA	PMID:22228805
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314348	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of DUSP15 mRNA	PMID:29264374
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314348	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DUSP15 gene	PMID:35295148
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314348	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DUSP15 mRNA	PMID:18648102
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1305990	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of DUSP15 mRNA	PMID:19167457
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1305990	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A affects the expression of DUSP15 mRNA	PMID:35192832
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305990	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DUSP15 mRNA	PMID:25181051
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1305990	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DUSP15 promoter	PMID:23359474
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314348	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of DUSP15 gene	PMID:31683443
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305990	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DUSP15 mRNA	PMID:21266533
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1305990	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DUSP15 promoter	PMID:23359474
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DUSP15 mRNA	PMID:28302478
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C480342	clothianidin results in increased expression of DUSP15 mRNA	PMID:29044138
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1305990	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of DUSP15 mRNA	PMID:38685447
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of DUSP15 mRNA	PMID:35811015
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of DUSP15 mRNA	PMID:35811015
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of DUSP15 mRNA	PMID:38460933
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314348	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of DUSP15 mRNA	PMID:35436446
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of DUSP15 mRNA	PMID:32234424
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of DUSP15 mRNA	PMID:20977926
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of DUSP15 mRNA	PMID:28988120
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314348	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DUSP15 mRNA	PMID:22206623
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DUSP15 gene]	PMID:28238834
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of DUSP15 mRNA	PMID:32234424
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:9168	sirolimus	decreases expression	ISO	RGD:1305990	E	RGD:6480464	20120501	CTD	MESH:D020123	Sirolimus results in decreased expression of DUSP15 mRNA	PMID:21865292
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1305990	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of DUSP15 mRNA	PMID:20566332
1314347	DUSP15	dual specificity phosphatase 15	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1305990	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of DUSP15 gene	PMID:31079544
1314349	PROCR	protein C receptor	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PROCR mRNA	PMID:26272509|PMID:27188386
1314349	PROCR	protein C receptor	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROCR mRNA	PMID:27188386
1314349	PROCR	protein C receptor	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314350	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PROCR mRNA	PMID:37995155
1314349	PROCR	protein C receptor	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1305991	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PROCR mRNA]	PMID:31150632
1314349	PROCR	protein C receptor	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PROCR mRNA	PMID:20938992
1314349	PROCR	protein C receptor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1305991	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in decreased expression of PROCR mRNA	PMID:20488242
1314349	PROCR	protein C receptor	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PROCR mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PROCR mRNA	PMID:32699268
1314349	PROCR	protein C receptor	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1305991	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PROCR mRNA	PMID:33729688
1314349	PROCR	protein C receptor	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PROCR mRNA	PMID:26079696
1314349	PROCR	protein C receptor	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1314350	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of PROCR mRNA	PMID:40945087
1314349	PROCR	protein C receptor	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PROCR mRNA	PMID:21632981
1314349	PROCR	protein C receptor	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314350	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PROCR mRNA	PMID:39241906
1314349	PROCR	protein C receptor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314350	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PROCR mRNA	PMID:27339419
1314349	PROCR	protein C receptor	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1314350	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of PROCR mRNA	PMID:15598610
1314349	PROCR	protein C receptor	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of PROCR mRNA	PMID:19619570
1314349	PROCR	protein C receptor	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PROCR mRNA	PMID:19619570
1314349	PROCR	protein C receptor	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PROCR mRNA	PMID:20938992
1314349	PROCR	protein C receptor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PROCR mRNA	PMID:37042841
1314349	PROCR	protein C receptor	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PROCR mRNA	PMID:23649840
1314349	PROCR	protein C receptor	gene	CHEBI:16856	glutathione	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005978	Glutathione inhibits the reaction [Doxorubicin results in decreased expression of PROCR protein]	PMID:17172434
1314349	PROCR	protein C receptor	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of PROCR mRNA	PMID:26079696
1314349	PROCR	protein C receptor	gene	CHEBI:17226	rosmarinic acid	affects localization	ISO	RGD:1314350	E	RGD:6480464	20240206	CTD	MESH:C041376	Rosmarinic Acid affects the localization of PROCR protein	PMID:23774263
1314349	PROCR	protein C receptor	gene	CHEBI:17226	rosmarinic acid	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C041376	[Rosmarinic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ADAM17 protein]] which affects the localization of PROCR protein; [Rosmarinic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ADAM17 protein]] which results in decreased cleavage of and results in decreased secretion of PROCR protein; [Rosmarinic Acid results in decreased expression of ADAM17 protein] inhibits the reaction [IL1B protein affects the localization of PROCR protein]; [Rosmarinic Acid results in decreased expression of ADAM17 protein] inhibits the reaction [IL1B protein results in increased cleavage of and results in increased secretion of PROCR protein]; [Rosmarinic Acid results in decreased expression of ADAM17 protein] inhibits the reaction [TNF protein affects the localization of PROCR protein]; [Rosmarinic Acid results in decreased expression of ADAM17 protein] inhibits the reaction [TNF protein results in increased cleavage of and results in increased secretion of PROCR protein]; Rosmarinic Acid inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PROCR protein]; Rosmarinic Acid results in decreased cleavage of and results in decreased secretion of PROCR protein	PMID:23774263
1314349	PROCR	protein C receptor	gene	CHEBI:17226	rosmarinic acid	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20240206	CTD	MESH:C041376	Rosmarinic Acid results in decreased cleavage of and results in decreased secretion of PROCR protein	PMID:23774263
1314349	PROCR	protein C receptor	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PROCR mRNA	PMID:37992649
1314349	PROCR	protein C receptor	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PROCR mRNA	PMID:37992649
1314349	PROCR	protein C receptor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PROCR mRNA	PMID:39150890
1314349	PROCR	protein C receptor	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1305991	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PROCR mRNA	PMID:33387578
1314349	PROCR	protein C receptor	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PROCR mRNA	PMID:39836092
1314349	PROCR	protein C receptor	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PROCR mRNA	PMID:19549813
1314349	PROCR	protein C receptor	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1314350	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of PROCR mRNA	PMID:19376150
1314349	PROCR	protein C receptor	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of PROCR protein	PMID:20106945
1314349	PROCR	protein C receptor	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PROCR mRNA; Aflatoxin B1 results in increased expression of PROCR protein	PMID:21527772|PMID:21632981|PMID:21641981|PMID:27153756
1314349	PROCR	protein C receptor	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PROCR mRNA	PMID:21527772|PMID:23649840
1314349	PROCR	protein C receptor	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of PROCR mRNA	PMID:21527772
1314349	PROCR	protein C receptor	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PROCR mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PROCR mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PROCR mRNA	PMID:32699268
1314349	PROCR	protein C receptor	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314350	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PROCR mRNA	PMID:17484886
1314349	PROCR	protein C receptor	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1305991	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PROCR mRNA	PMID:31150632
1314349	PROCR	protein C receptor	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314350	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PROCR mRNA	PMID:27339419|PMID:31919559
1314349	PROCR	protein C receptor	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1305991	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PROCR mRNA]	PMID:31150632
1314349	PROCR	protein C receptor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PROCR mRNA	PMID:20938992
1314349	PROCR	protein C receptor	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PROCR gene	PMID:25304211
1314349	PROCR	protein C receptor	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PROCR mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PROCR mRNA	PMID:39836092
1314349	PROCR	protein C receptor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PROCR mRNA	PMID:40504410
1314349	PROCR	protein C receptor	gene	CHEBI:27666	actinomycin D	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin results in increased expression of PROCR mRNA	PMID:21527772
1314349	PROCR	protein C receptor	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314350	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of PROCR mRNA	PMID:28960355
1314349	PROCR	protein C receptor	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1305991	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PROCR mRNA	PMID:31881176
1314349	PROCR	protein C receptor	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of PROCR mRNA	PMID:23300844
1314349	PROCR	protein C receptor	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PROCR mRNA	PMID:27392435
1314349	PROCR	protein C receptor	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PROCR mRNA	PMID:27392435
1314349	PROCR	protein C receptor	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PROCR mRNA	PMID:24768652|PMID:25583101
1314349	PROCR	protein C receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314350	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PROCR mRNA	PMID:21570461
1314349	PROCR	protein C receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PROCR mRNA	PMID:19619570
1314349	PROCR	protein C receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PROCR mRNA	PMID:20106945|PMID:21632981
1314349	PROCR	protein C receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305991	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PROCR mRNA	PMID:34747641
1314349	PROCR	protein C receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of PROCR mRNA	PMID:19619570
1314349	PROCR	protein C receptor	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1305991	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of PROCR mRNA	PMID:28374803
1314349	PROCR	protein C receptor	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314350	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of PROCR protein	PMID:28918527
1314349	PROCR	protein C receptor	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314350	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of PROCR mRNA	PMID:27862939
1314349	PROCR	protein C receptor	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of PROCR mRNA; Doxorubicin results in decreased expression of PROCR protein	PMID:17172434
1314349	PROCR	protein C receptor	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased metabolism of and results in increased secretion of PROCR protein; Glutathione inhibits the reaction [Doxorubicin results in decreased expression of PROCR protein]	PMID:17172434
1314349	PROCR	protein C receptor	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PROCR mRNA	PMID:37992649
1314349	PROCR	protein C receptor	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PROCR mRNA	PMID:38568856
1314349	PROCR	protein C receptor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314350	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of PROCR mRNA	PMID:37682722
1314349	PROCR	protein C receptor	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PROCR mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PROCR mRNA	PMID:39836092
1314349	PROCR	protein C receptor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PROCR mRNA	PMID:40504410
1314349	PROCR	protein C receptor	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of PROCR mRNA	PMID:29453283
1314349	PROCR	protein C receptor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PROCR promoter	PMID:27901495
1314349	PROCR	protein C receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PROCR mRNA	PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170|PMID:26238291|PMID:32234424
1314349	PROCR	protein C receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314350	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PROCR mRNA	PMID:19770486
1314349	PROCR	protein C receptor	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to PROCR mRNA]	PMID:32406909
1314349	PROCR	protein C receptor	gene	CHEBI:30563	silicon dioxide	affects secretion	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog affects the secretion of PROCR protein	PMID:25895662
1314349	PROCR	protein C receptor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314350	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PROCR mRNA	PMID:19073995|PMID:23221170|PMID:33720480|PMID:38811393
1314349	PROCR	protein C receptor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PROCR mRNA	PMID:20382639|PMID:26238291
1314349	PROCR	protein C receptor	gene	CHEBI:30772	butyric acid	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D020148	Butyric Acid results in increased expression of PROCR mRNA	PMID:34581912
1314349	PROCR	protein C receptor	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1314350	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of PROCR mRNA	PMID:20542052
1314349	PROCR	protein C receptor	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305991	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of PROCR mRNA	PMID:25729387
1314349	PROCR	protein C receptor	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1305991	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of PROCR mRNA	PMID:30012374
1314349	PROCR	protein C receptor	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305991	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PROCR mRNA	PMID:23411599|PMID:34492290
1314349	PROCR	protein C receptor	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1305991	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PROCR mRNA	PMID:25380136
1314349	PROCR	protein C receptor	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PROCR mRNA	PMID:19710929
1314349	PROCR	protein C receptor	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1314350	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of PROCR mRNA	PMID:19191707
1314349	PROCR	protein C receptor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305991	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PROCR mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314349	PROCR	protein C receptor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314350	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of PROCR mRNA	PMID:27623287|PMID:32156529
1314349	PROCR	protein C receptor	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PROCR mRNA	PMID:28628672
1314349	PROCR	protein C receptor	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1305991	E	RGD:6480464	20170613	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of PROCR mRNA	PMID:28300664
1314349	PROCR	protein C receptor	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1314350	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of PROCR mRNA	PMID:25172293
1314349	PROCR	protein C receptor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314350	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PROCR mRNA	PMID:30951980
1314349	PROCR	protein C receptor	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314350	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PROCR mRNA	PMID:26377693
1314349	PROCR	protein C receptor	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1314350	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of PROCR mRNA	PMID:26377693
1314349	PROCR	protein C receptor	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PROCR mRNA	PMID:28628672
1314349	PROCR	protein C receptor	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PROCR mRNA	PMID:39150890
1314349	PROCR	protein C receptor	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1305991	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PROCR mRNA	PMID:21266533
1314349	PROCR	protein C receptor	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PROCR mRNA	PMID:39150890
1314349	PROCR	protein C receptor	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PROCR mRNA	PMID:39150890
1314349	PROCR	protein C receptor	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PROCR mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PROCR mRNA	PMID:28628672
1314349	PROCR	protein C receptor	gene	CHEBI:34840	methyl methacrylate	increases expression	ISO	RGD:1314350	E	RGD:6480464	20120412	CTD	MESH:D020366	Methylmethacrylate results in increased expression of PROCR mRNA	PMID:16916219
1314349	PROCR	protein C receptor	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of PROCR mRNA	PMID:21527772
1314349	PROCR	protein C receptor	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1305991	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in increased expression of PROCR mRNA	PMID:20095324|PMID:32680482
1314349	PROCR	protein C receptor	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314350	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of PROCR protein	PMID:39748354
1314349	PROCR	protein C receptor	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1305991	E	RGD:6480464	20130416	CTD	MESH:D010269	Unithiol inhibits the reaction [Paraquat results in increased expression of PROCR mRNA]	PMID:20095324
1314349	PROCR	protein C receptor	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PROCR mRNA	PMID:39836092
1314349	PROCR	protein C receptor	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1314350	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of PROCR mRNA	PMID:26377693
1314349	PROCR	protein C receptor	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1305991	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of PROCR mRNA	PMID:22110744
1314349	PROCR	protein C receptor	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PROCR mRNA	PMID:26472689
1314349	PROCR	protein C receptor	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PROCR mRNA	PMID:39150890
1314349	PROCR	protein C receptor	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305991	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of PROCR mRNA	PMID:27387713
1314349	PROCR	protein C receptor	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1305991	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of PROCR mRNA	PMID:25380136
1314349	PROCR	protein C receptor	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PROCR mRNA	PMID:24449571
1314349	PROCR	protein C receptor	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PROCR mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PROCR mRNA	PMID:32699268
1314349	PROCR	protein C receptor	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	affects localization	EXP		E	RGD:6480464	20140211	CTD	MESH:D013755	Tetradecanoylphorbol Acetate affects the localization of PROCR protein	PMID:23774263
1314349	PROCR	protein C receptor	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	decreases cleavage	ISO	RGD:1314350	E	RGD:6480464	20140812	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in decreased cleavage of PROCR protein	PMID:24632454
1314349	PROCR	protein C receptor	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of PROCR protein modified form	PMID:26298005
1314349	PROCR	protein C receptor	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20140211	CTD	MESH:D013755	[Rosmarinic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ADAM17 protein]] which affects the localization of PROCR protein; [Rosmarinic Acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of ADAM17 protein]] which results in decreased cleavage of and results in decreased secretion of PROCR protein; Methylthiouracil inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PROCR protein modified form]; Rosmarinic Acid inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PROCR protein]; Tetradecanoylphorbol Acetate promotes the reaction [ADAM17 protein results in increased cleavage of PROCR protein]; Tetradecanoylphorbol Acetate results in increased cleavage of and results in increased secretion of PROCR protein; withaferin A inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [ADAM17 protein results in increased cleavage of PROCR protein]]	PMID:23774263|PMID:24632454|PMID:26298005
1314349	PROCR	protein C receptor	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20140812	CTD	MESH:D013755	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased cleavage of PROCR protein]; pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased cleavage of PROCR protein]; SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased cleavage of PROCR protein]	PMID:24632454
1314349	PROCR	protein C receptor	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314350	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PROCR mRNA	PMID:40194260
1314349	PROCR	protein C receptor	gene	CHEBI:38561	fluvastatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C065180	fluvastatin results in increased expression of PROCR protein	PMID:16142594
1314349	PROCR	protein C receptor	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PROCR mRNA	PMID:28302478
1314349	PROCR	protein C receptor	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1305991	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of PROCR mRNA	PMID:25993096
1314349	PROCR	protein C receptor	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PROCR mRNA	PMID:25979313
1314349	PROCR	protein C receptor	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PROCR mRNA	PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799
1314349	PROCR	protein C receptor	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROCR mRNA	PMID:27188386
1314349	PROCR	protein C receptor	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305991	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of PROCR mRNA	PMID:41580965
1314349	PROCR	protein C receptor	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in increased expression of PROCR mRNA	PMID:21527772
1314349	PROCR	protein C receptor	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in increased expression of PROCR mRNA	PMID:20106945|PMID:21632981
1314349	PROCR	protein C receptor	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of PROCR mRNA	PMID:25047013
1314349	PROCR	protein C receptor	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PROCR mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PROCR mRNA	PMID:28628672
1314349	PROCR	protein C receptor	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PROCR mRNA	PMID:37992649
1314349	PROCR	protein C receptor	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of PROCR mRNA	PMID:17379860
1314349	PROCR	protein C receptor	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PROCR mRNA	PMID:38832940
1314349	PROCR	protein C receptor	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PROCR mRNA	PMID:18769122
1314349	PROCR	protein C receptor	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PROCR mRNA	PMID:26272509
1314349	PROCR	protein C receptor	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROCR mRNA	PMID:27188386
1314349	PROCR	protein C receptor	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314350	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PROCR mRNA	PMID:17562736
1314349	PROCR	protein C receptor	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305991	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PROCR mRNA	PMID:33387578
1314349	PROCR	protein C receptor	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314350	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of PROCR mRNA	PMID:11264010
1314349	PROCR	protein C receptor	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in increased expression of PROCR mRNA]	PMID:15016801
1314349	PROCR	protein C receptor	gene	CHEBI:46677	amphibole asbestos	increases expression	ISO	RGD:1305991	E	RGD:6480464	20170303	CTD	MESH:D017636	Asbestos, Amphibole results in increased expression of PROCR mRNA	PMID:22352330
1314349	PROCR	protein C receptor	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PROCR gene	PMID:25304211
1314349	PROCR	protein C receptor	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PROCR mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PROCR mRNA	PMID:39836092
1314349	PROCR	protein C receptor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PROCR mRNA	PMID:40504410
1314349	PROCR	protein C receptor	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1314350	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of PROCR mRNA	PMID:26934552
1314349	PROCR	protein C receptor	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305991	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PROCR mRNA	PMID:29391264
1314349	PROCR	protein C receptor	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1314350	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of PROCR mRNA	PMID:17555576
1314349	PROCR	protein C receptor	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in increased expression of PROCR mRNA	PMID:21527772
1314349	PROCR	protein C receptor	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of PROCR mRNA	PMID:32234424
1314349	PROCR	protein C receptor	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PROCR mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PROCR mRNA	PMID:28628672
1314349	PROCR	protein C receptor	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of PROCR mRNA	PMID:23300844
1314349	PROCR	protein C receptor	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314350	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PROCR mRNA; Nanotubes, Carbon results in increased expression of PROCR mRNA	PMID:25554681
1314349	PROCR	protein C receptor	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314350	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of PROCR mRNA	PMID:40234311
1314349	PROCR	protein C receptor	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PROCR protein	PMID:32959892
1314349	PROCR	protein C receptor	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PROCR mRNA	PMID:39836092
1314349	PROCR	protein C receptor	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of PROCR mRNA	PMID:21641980
1314349	PROCR	protein C receptor	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305991	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of PROCR mRNA	PMID:25729387
1314349	PROCR	protein C receptor	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1305991	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PROCR gene	PMID:35440735
1314349	PROCR	protein C receptor	gene	CHEBI:69120	withaferin A	multiple interactions	EXP		E	RGD:6480464	20140812	CTD	MESH:C009684	withaferin A inhibits the reaction [IL1B protein promotes the reaction [ADAM17 protein results in increased cleavage of PROCR protein]]; withaferin A inhibits the reaction [Tetradecanoylphorbol Acetate promotes the reaction [ADAM17 protein results in increased cleavage of PROCR protein]]; withaferin A inhibits the reaction [TNF protein promotes the reaction [ADAM17 protein results in increased cleavage of PROCR protein]]	PMID:24632454
1314349	PROCR	protein C receptor	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314350	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PROCR mRNA	PMID:22206623
1314349	PROCR	protein C receptor	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PROCR mRNA	PMID:37199045
1314349	PROCR	protein C receptor	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROCR mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROCR mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROCR mRNA	PMID:27188386
1314349	PROCR	protein C receptor	gene	CHEBI:78886	2-tert-butylhydroquinone	increases expression	ISO	RGD:1314350	E	RGD:6480464	20140708	CTD	MESH:C018855	2-tert-butylhydroquinone results in increased expression of PROCR mRNA	PMID:16014739
1314349	PROCR	protein C receptor	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PROCR mRNA	PMID:39150890
1314349	PROCR	protein C receptor	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PROCR gene]	PMID:28238834
1314349	PROCR	protein C receptor	gene	CHEBI:8093	phenylephrine	increases expression	ISO	RGD:1305991	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in increased expression of PROCR mRNA	PMID:18158353
1314349	PROCR	protein C receptor	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314350	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PROCR mRNA	PMID:38648751
1314349	PROCR	protein C receptor	gene	CHEBI:82346	Methylthiouracil	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D008779	Methylthiouracil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PROCR protein modified form]; Methylthiouracil inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PROCR protein modified form]; Methylthiouracil inhibits the reaction [TNF protein results in increased expression of PROCR protein modified form]	PMID:26298005
1314349	PROCR	protein C receptor	gene	CHEBI:82346	Methylthiouracil	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20151215	CTD	MESH:D008779	Methylthiouracil inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PROCR protein modified form]	PMID:26298005
1314349	PROCR	protein C receptor	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased cleavage of PROCR protein]	PMID:24632454
1314349	PROCR	protein C receptor	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:1314350	E	RGD:6480464	20170303	CTD	MESH:C093642	SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased cleavage of PROCR protein]	PMID:24632454
1314349	PROCR	protein C receptor	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROCR mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROCR mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PROCR mRNA	PMID:27188386
1314349	PROCR	protein C receptor	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305991	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PROCR mRNA	PMID:19281266
1314349	PROCR	protein C receptor	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1314350	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of PROCR mRNA	PMID:28973697
1314349	PROCR	protein C receptor	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314350	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of PROCR mRNA	PMID:35537566
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314353	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TRIM46 mRNA	PMID:33045310
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of TRIM46 mRNA	PMID:22378314
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRIM46 mRNA	PMID:37042841
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TRIM46 mRNA	PMID:21179406
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TRIM46 mRNA	PMID:26079696
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314353	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TRIM46 mRNA	PMID:37992649
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314353	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TRIM46 mRNA	PMID:37992649
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:17775	7,9-dihydro-1H-purine-2,6,8(3H)-trione	affects abundance	EXP		E	RGD:6480464	20130312	CTD	MESH:D014527	TRIM46 gene SNP affects the abundance of Uric Acid	PMID:23263486
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014284	Triiodothyronine results in increased expression of TRIM46 mRNA	PMID:23397585
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314353	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TRIM46 mRNA	PMID:34911549
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314353	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRIM46 mRNA	PMID:21570461
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TRIM46 mRNA	PMID:33212167
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314353	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TRIM46 mRNA	PMID:37992649
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TRIM46 promoter	PMID:27901495
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314353	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TRIM46 mRNA	PMID:27131904
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314353	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TRIM46 mRNA	PMID:32156529
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305993	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TRIM46 mRNA	PMID:25181051
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305993	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TRIM46 gene	PMID:28505145
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314353	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TRIM46 mRNA	PMID:40203079
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1314353	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of TRIM46 exon	PMID:33297965
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314353	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TRIM46 mRNA	PMID:38685157
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314353	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TRIM46 intron	PMID:28392331
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314353	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TRIM46 mRNA	PMID:37019170
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1305993	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TRIM46 mRNA	PMID:35163327
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRIM46 mRNA	PMID:26472689
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1305993	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of TRIM46 mRNA	PMID:35163327
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1305993	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TRIM46 mRNA	PMID:27387713
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TRIM46 mRNA	PMID:24449571
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314353	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TRIM46 mRNA	PMID:40194260
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of TRIM46 mRNA	PMID:17183730
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314353	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of TRIM46 mRNA	PMID:19770486
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314353	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of TRIM46 mRNA	PMID:37992649
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TRIM46 mRNA	PMID:38832940
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of TRIM46 mRNA	PMID:26690555
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1314353	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of TRIM46 mRNA	PMID:35537566
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TRIM46 mRNA	PMID:22079256
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of TRIM46 mRNA	PMID:17183730
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314353	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TRIM46 mRNA	PMID:22206623
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of TRIM46 mRNA	PMID:22079256
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TRIM46 mRNA	PMID:22079256
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:754906	afuresertib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of TRIM46 mRNA	PMID:28960945
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314353	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of TRIM46 mRNA	PMID:27131904
1314352	TRIM46	tripartite motif containing 46	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314353	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TRIM46 mRNA	PMID:35537566
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:15343	acetaldehyde	affects expression	ISO	RGD:1314355	E	RGD:6480464	20121009	CTD	MESH:D000079	Acetaldehyde affects the expression of NODAL mRNA	PMID:22634333
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314355	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NODAL gene	PMID:20938992
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:15366	acetic acid	affects expression	ISO	RGD:1314355	E	RGD:6480464	20120717	CTD	MESH:D019342	Acetic Acid affects the expression of NODAL protein	PMID:21296659
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin affects the expression of NODAL mRNA	PMID:31600526
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D014212	[4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] inhibits the reaction [Chir 99021 results in increased expression of NODAL mRNA]	PMID:31711903
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of NODAL mRNA	PMID:22378314
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in increased expression of NODAL mRNA	PMID:23378141
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314355	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of NODAL mRNA	PMID:30319688
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1305994	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of NODAL mRNA	PMID:33387578
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314355	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NODAL gene	PMID:20938992
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NODAL mRNA	PMID:37042841
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1305994	E	RGD:6480464	20130910	CTD	MESH:D011374	Progesterone results in decreased expression of NODAL mRNA	PMID:21770760
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314355	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of NODAL mRNA	PMID:36189433
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1314355	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of NODAL mRNA	PMID:22138414
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314355	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NODAL gene	PMID:20938992
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of NODAL mRNA	PMID:38460933
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of NODAL mRNA	PMID:23557933
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of NODAL mRNA	PMID:21224400
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:27899	cisplatin	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	NODAL results in increased susceptibility to Cisplatin	PMID:21224400
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314355	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NODAL mRNA	PMID:21354282
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305994	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NODAL mRNA	PMID:33387578
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:C004925	methylmercuric chloride results in increased expression of NODAL mRNA	PMID:22555245|PMID:23903816
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1314355	E	RGD:6480464	20121009	CTD	MESH:C004925	methylmercuric chloride results in increased expression of NODAL mRNA	PMID:22555245
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of NODAL mRNA	PMID:19615344
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314355	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of NODAL mRNA	PMID:39232337
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite co-treated with monoisoamyl-2,3-dimercaptosuccinate] results in decreased expression of NODAL mRNA	PMID:19615344
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NODAL promoter	PMID:27901495
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NODAL exon	PMID:27901495
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314355	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to NODAL promoter]	PMID:19654925
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:31355	carboplatin	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D016190	NODAL results in increased susceptibility to Carboplatin	PMID:21224400
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314355	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NODAL gene	PMID:35295148
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314355	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of NODAL mRNA	PMID:23557971
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305994	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of NODAL mRNA	PMID:34492290
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1314355	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of NODAL mRNA	PMID:18648102
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305994	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NODAL mRNA	PMID:25181051
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of NODAL mRNA	PMID:18007998
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305994	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in increased expression of NODAL mRNA	PMID:29323181
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314355	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of NODAL enhancer	PMID:28392331
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314355	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NODAL mRNA	PMID:37019170
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314355	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NODAL mRNA	PMID:32715474
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NODAL mRNA	PMID:37042841
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NODAL mRNA	PMID:25979313|PMID:26072468
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314355	E	RGD:6480464	20150825	CTD	MESH:D014635	Valproic Acid affects the expression of NODAL mRNA	PMID:26072468
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314355	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NODAL mRNA	PMID:17562736
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1305994	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NODAL mRNA	PMID:33387578
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1314355	E	RGD:6480464	20120717	CTD	MESH:D005472	Fluorouracil results in decreased expression of NODAL protein	PMID:21296659
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of NODAL mRNA	PMID:28056339
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of NODAL mRNA	PMID:38460933
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1314355	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of NODAL mRNA	PMID:27915011
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314355	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of NODAL mRNA	PMID:25620056
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:5118	fluoxetine	affects expression	ISO	RGD:1314355	E	RGD:6480464	20181113	CTD	MESH:D005473	Fluoxetine affects the expression of NODAL mRNA	PMID:29893963
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314355	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of NODAL mRNA	PMID:23608068
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:64206	bromochloroacetic acid	affects expression	ISO	RGD:1314355	E	RGD:6480464	20120717	CTD	MESH:C099813	bromochloroacetic acid affects the expression of NODAL protein	PMID:21296659
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:8093	phenylephrine	affects expression	ISO	RGD:1305994	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine affects the expression of NODAL mRNA; Phenylephrine affects the expression of NODAL protein	PMID:11029149
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:81351	Activin A	increases expression	EXP		E	RGD:153350163|PMID:25659497	20220913	RGD		Activin A increases expression of NODAL mRNA in trophoblast cells	
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1314355	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of NODAL mRNA	PMID:22634333
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:91091	CHIR 99021	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C473711	Chir 99021 results in increased expression of NODAL mRNA	PMID:31711903
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:91091	CHIR 99021	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C473711	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Chir 99021 results in increased expression of NODAL mRNA]; [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] inhibits the reaction [Chir 99021 results in increased expression of NODAL mRNA]	PMID:31711903
1314354	NODAL	nodal growth differentiation factor	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Chir 99021 results in increased expression of NODAL mRNA]; [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] inhibits the reaction [Chir 99021 results in increased expression of NODAL mRNA]	PMID:31711903
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1305996	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of WDFY1 mRNA	PMID:30071829
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1620804	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of WDFY1 mRNA	PMID:20188158
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1620804	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of WDFY1 mRNA	PMID:20938992
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of WDFY1 mRNA	PMID:32845096
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1620804	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of WDFY1 mRNA	PMID:40945087
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1620804	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of WDFY1 mRNA	PMID:30319688
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of WDFY1 mRNA	PMID:21632981
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1620804	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of WDFY1 mRNA	PMID:39241906
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1620804	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of WDFY1 mRNA	PMID:39298647
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1620804	E	RGD:6480464	20181113	CTD	MESH:D004958	Estradiol results in increased expression of WDFY1 mRNA	PMID:30077407
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1620804	E	RGD:6480464	20181113	CTD	MESH:D004958	[Polyphenols co-treated with Estradiol] results in increased expression of WDFY1 mRNA	PMID:30077407
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1620804	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of WDFY1 mRNA	PMID:20938992
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of WDFY1 mRNA	PMID:37042841
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of WDFY1 mRNA	PMID:23649840
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1620804	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of WDFY1 mRNA	PMID:33754040
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of WDFY1 protein	PMID:37730182
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305996	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of WDFY1 mRNA	PMID:33387578
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of WDFY1 exon	PMID:30157460
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of WDFY1 mRNA	PMID:35301059
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:234430	gardiquimod	increases expression	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in increased expression of WDFY1 mRNA	PMID:28003376
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:234430	gardiquimod	multiple interactions	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of WDFY1 mRNA]	PMID:28003376
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of WDFY1 mRNA	PMID:23649840
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1620804	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WDFY1 mRNA	PMID:19770486
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of WDFY1 exon; Aflatoxin B1 results in increased methylation of WDFY1 intron	PMID:30157460
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of WDFY1 mRNA	PMID:23649840
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1620804	E	RGD:6480464	20120515	CTD	MESH:D010126	Ozone results in increased expression of WDFY1 mRNA	PMID:20826374
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of WDFY1 mRNA	PMID:32845096
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1620804	E	RGD:6480464	20120515	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of WDFY1 mRNA; IL10 gene mutant form promotes the reaction [Ozone results in increased expression of WDFY1 mRNA]	PMID:20826374|PMID:34911549
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620804	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of WDFY1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of WDFY1 mRNA	PMID:20938992|PMID:22206623
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1620804	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WDFY1 mRNA	PMID:40504410
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of WDFY1 mRNA	PMID:26272509
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDFY1 mRNA	PMID:27188386
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of WDFY1 protein	PMID:35688186
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1620804	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of WDFY1 mRNA	PMID:28189721|PMID:28960355
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of WDFY1 mRNA	PMID:23557933
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1305996	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WDFY1 mRNA	PMID:34747641
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620804	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WDFY1 mRNA	PMID:21570461
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of WDFY1 mRNA	PMID:28001369
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1620804	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in decreased expression of WDFY1 mRNA	PMID:35032568
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of WDFY1 mRNA	PMID:29803840
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of WDFY1 mRNA	PMID:25879800
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1620804	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WDFY1 mRNA	PMID:40504410
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WDFY1 promoter	PMID:27901495
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to WDFY1 mRNA]	PMID:32406909
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:30512	silver atom	multiple interactions	ISO	RGD:1305996	E	RGD:6480464	20150310	CTD	MESH:D012834	[Silver analog co-treated with Povidone] results in increased expression of WDFY1 mRNA	PMID:25194297
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1620804	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of WDFY1 mRNA	PMID:35295148
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620804	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of WDFY1 gene	PMID:35295148
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1620804	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of WDFY1 mRNA	PMID:18648102
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of WDFY1 protein	PMID:31675489
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of WDFY1 mRNA	PMID:29275510
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305996	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of WDFY1 mRNA	PMID:25181051
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of WDFY1 protein	PMID:31675489
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1620804	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of WDFY1 mRNA	PMID:39298647
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of WDFY1 exon	PMID:30157460
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1620804	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of WDFY1 mRNA	PMID:38685157
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of WDFY1 protein	PMID:34186270
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of WDFY1 mRNA	PMID:35301059
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of WDFY1 mRNA]	PMID:28003376
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of WDFY1 mRNA	PMID:31533062
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1305996	E	RGD:6480464	20130806	CTD	MESH:D002737	Chloroprene results in increased expression of WDFY1 mRNA	PMID:23125180
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of WDFY1 mRNA	PMID:25979313
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of WDFY1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of WDFY1 mRNA	PMID:19101580
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDFY1 mRNA	PMID:27188386
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1305996	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of WDFY1 mRNA	PMID:41580965
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of WDFY1 mRNA	PMID:25562108
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of WDFY1 mRNA	PMID:26272509|PMID:27188386
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDFY1 mRNA	PMID:27188386
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of WDFY1 mRNA	PMID:24935251|PMID:26272509
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDFY1 mRNA	PMID:27188386
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1620804	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of WDFY1 mRNA	PMID:17562736
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1620804	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WDFY1 mRNA	PMID:40504410
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of WDFY1 mRNA	PMID:40706910
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of WDFY1 mRNA	PMID:18175754
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620804	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of WDFY1 mRNA; Nanotubes, Carbon results in decreased expression of WDFY1 mRNA	PMID:25554681|PMID:25620056
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1305996	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of WDFY1 mRNA	PMID:34044035
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:53248	poly(vinylpyrrolidone)	multiple interactions	ISO	RGD:1305996	E	RGD:6480464	20150310	CTD	MESH:D011205	[Silver analog co-treated with Povidone] results in increased expression of WDFY1 mRNA	PMID:25194297
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of WDFY1 protein	PMID:32959892
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of WDFY1 exon	PMID:30157460
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1620804	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of WDFY1 mRNA	PMID:22206623
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1620804	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of WDFY1 mRNA	PMID:22206623
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDFY1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDFY1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDFY1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDFY1 mRNA	PMID:27188386
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:80630	irinotecan	affects expression	ISO	RGD:1305996	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan affects the expression of WDFY1 mRNA	PMID:20097248
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1620804	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of WDFY1 mRNA	PMID:23091169
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of WDFY1 protein	PMID:31675489
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of WDFY1 protein	PMID:31675489
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDFY1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDFY1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDFY1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDFY1 mRNA	PMID:27188386
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:9141	silver(0)	multiple interactions	ISO	RGD:1305996	E	RGD:6480464	20150310	CTD	MESH:D012834	[Silver analog co-treated with Povidone] results in increased expression of WDFY1 mRNA	PMID:25194297
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of WDFY1 mRNA	PMID:29301935
1314357	WDFY1	WD repeat and FYVE domain containing 1	gene	CHEBI:9944	venlafaxine hydrochloride	increases expression	ISO	RGD:1305996	E	RGD:6480464	20180313	CTD	MESH:D000069470	Venlafaxine Hydrochloride results in increased expression of WDFY1 mRNA	PMID:25423262
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLIG3 mRNA	PMID:27188386
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314359	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of OLIG3 mRNA	PMID:37995155
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314359	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of OLIG3 gene	PMID:20938992
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D014212	Tretinoin results in increased expression of OLIG3 mRNA	PMID:31711903
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D014212	[Chir 99021 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] results in increased expression of OLIG3 mRNA	PMID:31711903
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000431	Ethanol results in decreased expression of OLIG3 mRNA	PMID:28986285
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in increased expression of OLIG3 mRNA	PMID:23378141
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	[Ethanol co-treated with Folic Acid] results in increased expression of OLIG3 mRNA	PMID:23378141
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of OLIG3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of OLIG3 mRNA	PMID:35811015
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314359	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OLIG3 mRNA	PMID:25510870
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314359	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of OLIG3 gene	PMID:20938992
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of OLIG3 mRNA	PMID:31163220
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:180654	N(4)-hydroxycytidine	increases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:C010737	N(4)-hydroxycytidine results in increased expression of OLIG3 mRNA	PMID:40692086
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OLIG3 mRNA	PMID:35301059
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314359	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OLIG3 mRNA	PMID:25510870
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314359	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OLIG3 mRNA	PMID:25510870
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of OLIG3 gene	PMID:27153756
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D005492	[Ethanol co-treated with Folic Acid] results in increased expression of OLIG3 mRNA	PMID:23378141
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314359	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of OLIG3 gene	PMID:20938992
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:27732	caffeine	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D002110	Caffeine results in increased expression of OLIG3 mRNA	PMID:31711903
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1305997	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of OLIG3 gene	PMID:31011160
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of OLIG3 mRNA	PMID:23557933
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of OLIG3 promoter	PMID:22847954
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of OLIG3 promoter	PMID:27901495
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of OLIG3 mRNA	PMID:22316170
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of OLIG3 exon	PMID:27901495
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of OLIG3 mRNA	PMID:30453624
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of OLIG3 promoter	PMID:23974009
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of OLIG3 mRNA	PMID:23806026
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:30742	ethylene glycol	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D019855	Ethylene Glycol results in increased expression of OLIG3 mRNA	PMID:31711903
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314359	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of OLIG3 gene	PMID:35295148
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C006780	bisphenol A results in decreased expression of OLIG3 mRNA	PMID:33476716
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305997	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of OLIG3 mRNA	PMID:25181051
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1305997	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of OLIG3 gene	PMID:28505145
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of OLIG3 mRNA	PMID:33476716
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314359	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OLIG3 mRNA	PMID:25510870
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314359	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of OLIG3 mRNA	PMID:25510870
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314359	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of OLIG3 mRNA	PMID:18974090
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OLIG3 mRNA	PMID:35301059
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of OLIG3 protein	PMID:22609092
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of OLIG3 promoter	PMID:22847954
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of OLIG3 promoter	PMID:22847954
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of OLIG3 mRNA	PMID:25979313
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D014635	Valproic Acid results in decreased expression of OLIG3 mRNA	PMID:34742744
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of OLIG3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:31711903
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLIG3 mRNA	PMID:27188386
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:421707	abacavir	increases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:C106538	Abacavir results in increased expression of OLIG3 mRNA	PMID:31711903
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of OLIG3 mRNA	PMID:24935251
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D005472	Fluorouracil results in decreased expression of OLIG3 mRNA	PMID:31711903
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of OLIG3 mRNA	PMID:35811015
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of OLIG3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of OLIG3 mRNA	PMID:35811015
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:52172	nilotinib	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C498826	nilotinib results in increased expression of OLIG3 mRNA	PMID:31711903
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1314359	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of OLIG3 mRNA	PMID:38701926
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D015474	Isotretinoin results in increased expression of OLIG3 mRNA	PMID:31711903
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:70752	dabigatran	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D000069604	Dabigatran results in increased expression of OLIG3 mRNA	PMID:31711903
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314359	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of OLIG3 mRNA	PMID:22206623
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLIG3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLIG3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLIG3 mRNA	PMID:27188386
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D010672	Phenytoin results in increased expression of OLIG3 mRNA	PMID:31711903
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLIG3 mRNA	PMID:27188386
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:91091	CHIR 99021	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C473711	[Chir 99021 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] results in increased expression of OLIG3 mRNA	PMID:31711903
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:91108	SB 431542	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased expression of OLIG3 mRNA	PMID:25670856
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[Chir 99021 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] results in increased expression of OLIG3 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLIG3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLIG3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OLIG3 mRNA	PMID:27188386|PMID:31711903
1314358	OLIG3	oligodendrocyte transcription factor 3	gene	CHEBI:9513	thalidomide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D013792	Thalidomide results in increased expression of OLIG3 mRNA	PMID:31711903
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of KLK8 mRNA	PMID:26272509|PMID:27188386
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLK8 mRNA	PMID:27188386
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314361	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of KLK8 mRNA	PMID:37995155
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:136004	linsidomine	increases oxidation	ISO	RGD:1305998	E	RGD:6480464	20180220	CTD	MESH:C002385	linsidomine results in increased oxidation of KLK8 protein	PMID:28086193
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of KLK8 mRNA	PMID:26079696
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314361	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KLK8 mRNA	PMID:39241906
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314361	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of KLK8 mRNA]	PMID:39241906
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of KLK8 mRNA	PMID:30510588
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of KLK8 mRNA	PMID:26079696
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305998	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of KLK8 mRNA	PMID:26577399
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of KLK8 mRNA	PMID:26485663
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1314361	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of KLK8 mRNA	PMID:39984025
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of KLK8 mRNA	PMID:21120746
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314361	E	RGD:6480464	20260203	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KLK8 mRNA	PMID:40850461
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:22984	calcium atom	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium results in increased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1314361	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of KLK8 mRNA	PMID:27776689
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:25107	magnesium atom	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D008274	Magnesium results in increased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314361	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of KLK8 mRNA	PMID:12763052|PMID:33026818
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of KLK8 mRNA	PMID:41430723
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:26216	potassium atom	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D011188	Potassium results in increased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:27363	zinc atom	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314361	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KLK8 mRNA	PMID:25629700
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KLK8 mRNA	PMID:32525701
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of KLK8 mRNA	PMID:26272509
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLK8 mRNA	PMID:27188386
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	KLK8 protein affects the susceptibility to Cisplatin	PMID:16217747
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with panobinostat] affects the expression of KLK8 mRNA	PMID:21791302
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314361	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KLK8 mRNA	PMID:21570461
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314361	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KLK8 mRNA	PMID:17035482
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314361	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of KLK8 mRNA	PMID:17942748
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KLK8 mRNA	PMID:28001369
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KLK8 mRNA	PMID:30851411
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1305998	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of KLK8 mRNA	PMID:28959563
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:29320	calcium(0)	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium results in increased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of KLK8 gene	PMID:28589171
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314361	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of KLK8 mRNA	PMID:37682722
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KLK8 5' UTR; Benzo(a)pyrene affects the methylation of KLK8 promoter	PMID:27901495
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KLK8 exon	PMID:27901495
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1305998	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KLK8 mRNA	PMID:21839799
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:30185	zinc(0)	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in decreased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:3020	benzalkonium chloride	increases expression	ISO	RGD:1314361	E	RGD:6480464	20190219	CTD	MESH:D001548	Benzalkonium Compounds results in increased expression of KLK8 mRNA	PMID:30171875
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1305998	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of KLK8 mRNA	PMID:16483693
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314361	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of KLK8 mRNA	PMID:23557971|PMID:29264374
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314361	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KLK8 promoter	PMID:35295148
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:32588	potassium chloride	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D011189	Potassium Chloride results in increased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:32599	magnesium sulfate	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D008278	Magnesium Sulfate results in increased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:3312	calcium dichloride	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D002122	Calcium Chloride results in increased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1305998	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KLK8 mRNA	PMID:25181051
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314361	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of KLK8 mRNA	PMID:32156529
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314361	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of KLK8 mRNA	PMID:30951980
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1314361	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of KLK8 mRNA	PMID:28392331
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of KLK8 gene	PMID:22964155
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of KLK8 mRNA	PMID:37047231
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314361	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of KLK8 mRNA]	PMID:39241906
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:35176	zinc sulfate	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1314361	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of KLK8 mRNA	PMID:26377693
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1305998	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KLK8 mRNA	PMID:33453195
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314361	E	RGD:6480464	20260203	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KLK8 mRNA	PMID:40850461
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314361	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of KLK8 mRNA	PMID:40194260
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KLK8 mRNA	PMID:25979313
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of KLK8 mRNA	PMID:28001369
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of KLK8 gene	PMID:29154799
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:41470	chymostatin	decreases activity	EXP		E	RGD:6480464	20141111	CTD	MESH:C002101	chymostatin results in decreased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314361	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of KLK8 mRNA	PMID:17555576
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1314361	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of KLK8 mRNA	PMID:15171707
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of KLK8 mRNA	PMID:24935251
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KLK8 mRNA	PMID:32525701
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314361	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of KLK8 mRNA	PMID:17555576
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1314361	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of KLK8 mRNA	PMID:17942748
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314361	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of KLK8 mRNA	PMID:17942748
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of KLK8 mRNA	PMID:26272509
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLK8 mRNA	PMID:27188386
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of KLK8 mRNA	PMID:38825487
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1305998	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of KLK8 mRNA	PMID:30307764
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314361	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of KLK8 mRNA	PMID:25554681
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:53001	nickel sulfate	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in decreased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:6426	leupeptin	decreases activity	EXP		E	RGD:6480464	20161213	CTD	MESH:C032854	leupeptin results in decreased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:6636	magnesium dichloride	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D015636	Magnesium Chloride results in increased activity of KLK8 protein	PMID:16800733
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KLK8 mRNA	PMID:30851411
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLK8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLK8 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLK8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLK8 mRNA	PMID:27188386
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1305998	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of KLK8 mRNA	PMID:23640034
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of KLK8 mRNA	PMID:26079696
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KLK8 mRNA	PMID:32525701
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of KLK8 mRNA	PMID:26272509
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[Cisplatin co-treated with Panobinostat] affects the expression of KLK8 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLK8 mRNA	PMID:21791302|PMID:27188386
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314361	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of KLK8 mRNA]	PMID:39241906
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1314361	E	RGD:6480464	20240430	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of KLK8 mRNA	PMID:35278568
1314360	KLK8	kallikrein related peptidase 8	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLK8 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLK8 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KLK8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLK8 mRNA	PMID:27188386
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CSRNP1 mRNA	PMID:38218311
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CSRNP1 mRNA	PMID:37995155
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:15343	acetaldehyde	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D000079	Acetaldehyde results in increased expression of CSRNP1 mRNA	PMID:23416264
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20131220	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AXUD1 mRNA	PMID:20938992
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of CSRNP1 mRNA	PMID:33167477
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of CSRNP1 mRNA	PMID:30951980
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CSRNP1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of CSRNP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of CSRNP1 mRNA	PMID:32699268|PMID:32845096
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CSRNP1 mRNA	PMID:30529165
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of CSRNP1 mRNA	PMID:26079696
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CSRNP1 mRNA	PMID:22378314
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CSRNP1 mRNA	PMID:39241906
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of CSRNP1 mRNA	PMID:30510588
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20131220	CTD	MESH:D004958	Estradiol results in decreased expression of AXUD1 mRNA	PMID:19167446
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1305999	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of CSRNP1 mRNA	PMID:32145629
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314363	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of CSRNP1 mRNA	PMID:25210133|PMID:39298647
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of CSRNP1 mRNA	PMID:30165855
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of CSRNP1 mRNA	PMID:38568856
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20131220	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AXUD1 mRNA	PMID:20938992
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CSRNP1 mRNA	PMID:37042841
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CSRNP1 mRNA	PMID:23649840
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1314363	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of CSRNP1 mRNA	PMID:17178593
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1314363	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of CSRNP1 mRNA	PMID:28973375
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of CSRNP1 mRNA	PMID:21592394
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of CSRNP1 mRNA	PMID:21592394
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of CSRNP1 mRNA	PMID:33647349
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:174748	C.I. Natural Red 20	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20210706	CTD	MESH:C016101	shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of AXUD1 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of AXUD1 mRNA]	PMID:25451590
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1314363	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of CSRNP1 mRNA	PMID:17178593
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CSRNP1 mRNA	PMID:34319233
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CSRNP1 mRNA	PMID:39150890
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1305999	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CSRNP1 mRNA	PMID:26577399
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CSRNP1 mRNA	PMID:21592394
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of CSRNP1 mRNA	PMID:21592394
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1305999	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CSRNP1 mRNA	PMID:33387578
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CSRNP1 mRNA	PMID:28818685
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CSRNP1 mRNA	PMID:36331819
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CSRNP1 mRNA	PMID:37236586
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CSRNP1 mRNA	PMID:19549813
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1305999	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CSRNP1 mRNA	PMID:33354967
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	ISO	RGD:1305999	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of CSRNP1 mRNA	PMID:15651846
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CSRNP1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of CSRNP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of CSRNP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of CSRNP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of CSRNP1 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CSRNP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CSRNP1 mRNA	PMID:34911549
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CSRNP1 mRNA	PMID:18593933
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314363	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CSRNP1 mRNA	PMID:31919559
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CSRNP1 mRNA	PMID:25629700
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20131220	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of AXUD1 mRNA	PMID:20938992
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CSRNP1 mRNA	PMID:40504410
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of CSRNP1 mRNA	PMID:33512557
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSRNP1 mRNA	PMID:27188386
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1305999	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSRNP1 mRNA	PMID:33854195
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of CSRNP1 mRNA	PMID:27392435
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CSRNP1 mRNA	PMID:27594783
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of CSRNP1 mRNA	PMID:27392435
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314363	E	RGD:6480464	20131220	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AXUD1 mRNA	PMID:21570461
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1305999	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CSRNP1 mRNA	PMID:32109520
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CSRNP1 mRNA	PMID:19933214
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1305999	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CSRNP1 mRNA	PMID:33387578
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314363	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CSRNP1 mRNA	PMID:24058054
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSRNP1 mRNA	PMID:17942748
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CSRNP1 mRNA	PMID:33212167
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CSRNP1 mRNA	PMID:30851411
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of CSRNP1 mRNA	PMID:32763439
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1314363	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of CSRNP1 mRNA	PMID:30807115
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20131220	CTD	MESH:D003561	Cytarabine results in decreased expression of AXUD1 mRNA	PMID:21198554
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of AXUD1 mRNA; [NSC 689534 binds to Copper] which results in increased expression of CSRNP1 mRNA	PMID:20971185|PMID:24690739
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CSRNP1 mRNA	PMID:29803840
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314363	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of CSRNP1 mRNA	PMID:16243910|PMID:25896364|PMID:39631538
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of CSRNP1 mRNA	PMID:39719251
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CSRNP1 mRNA	PMID:38568856
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314363	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of CSRNP1 mRNA	PMID:36209798|PMID:39232337
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20250805	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CSRNP1 mRNA; Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in increased expression of CSRNP1 mRNA]	PMID:39232337|PMID:40504410
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1314363	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of CSRNP1 mRNA	PMID:17127020
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CSRNP1 5' UTR; Benzo(a)pyrene affects the methylation of CSRNP1 promoter	PMID:27901495
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CSRNP1 mRNA	PMID:20064835|PMID:32234424
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314363	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CSRNP1 mRNA	PMID:21569818
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of AXUD1 mRNA; [NSC 689534 binds to Copper] which results in increased expression of CSRNP1 mRNA	PMID:20971185|PMID:24690739
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of CSRNP1 mRNA	PMID:18593933
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314363	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CSRNP1 mRNA	PMID:27131904
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1305999	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of CSRNP1 mRNA	PMID:38458666
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CSRNP1 mRNA	PMID:23806026
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314363	E	RGD:6480464	20250401	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CSRNP1 mRNA	PMID:38811393
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CSRNP1 mRNA	PMID:19150397
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:30768	propionic acid	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C029658	propionic acid results in increased expression of CSRNP1 mRNA	PMID:31526819
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of CSRNP1 mRNA	PMID:35984750
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1305999	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of CSRNP1 mRNA	PMID:16507785
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1305999	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of CSRNP1 mRNA	PMID:25729387
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:32146	sodium hypochlorite	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D012973	Sodium Hypochlorite results in increased expression of CSRNP1 mRNA	PMID:37149095
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314363	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CSRNP1 gene	PMID:35295148
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314363	E	RGD:6480464	20130611	CTD	MESH:C009495	titanium dioxide results in increased expression of AXUD1 mRNA	PMID:27760801
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314363	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CSRNP1 gene	PMID:35295148
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1305999	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CSRNP1 mRNA	PMID:34492290
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20131220	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of AXUD1 mRNA	PMID:18648102
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of CSRNP1 mRNA	PMID:23811191
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20131220	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of AXUD1 mRNA	PMID:19191707
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:3305	Calcimycin	increases expression	ISO	RGD:1314363	E	RGD:6480464	20150414	CTD	MESH:D000001	Calcimycin results in increased expression of AXUD1 mRNA	PMID:25451590
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:3305	Calcimycin	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20150414	CTD	MESH:D000001	shikonin inhibits the reaction [Calcimycin results in increased expression of AXUD1 mRNA]	PMID:25451590
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of CSRNP1 mRNA	PMID:28329830
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CSRNP1 mRNA	PMID:29275510
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of CSRNP1 mRNA	PMID:25594700
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1305999	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CSRNP1 mRNA	PMID:25181051
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314363	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of CSRNP1 mRNA	PMID:30951980|PMID:32156529
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CSRNP1 mRNA	PMID:39298647
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314363	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CSRNP1 exon	PMID:33297965
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314363	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CSRNP1 mRNA	PMID:30951980|PMID:40203079
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in increased expression of CSRNP1 mRNA]	PMID:40203079
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314363	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of CSRNP1 mRNA	PMID:26377693
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314363	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CSRNP1 mRNA	PMID:30951980
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of CSRNP1 mRNA	PMID:30951980
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CSRNP1 mRNA	PMID:39150890
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314363	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CSRNP1 mRNA	PMID:37019170
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1305999	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSRNP1 mRNA	PMID:33854195
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1305999	E	RGD:6480464	20131220	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of AXUD1 mRNA	PMID:21266533
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CSRNP1 mRNA	PMID:39150890
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34696	dieldrin	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D004026	Dieldrin results in increased expression of CSRNP1 mRNA	PMID:31068361
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CSRNP1 mRNA	PMID:39150890
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of CSRNP1 mRNA	PMID:34813904
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1305999	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CSRNP1 mRNA	PMID:22546817
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D010269	Paraquat results in increased expression of CSRNP1 mRNA	PMID:35182771
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of CSRNP1 mRNA	PMID:39241906
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CSRNP1 mRNA	PMID:37042841
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1305999	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of CSRNP1 mRNA	PMID:30589522
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1305999	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of CSRNP1 mRNA	PMID:38458666
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1305999	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of CSRNP1 mRNA	PMID:22110744
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CSRNP1 mRNA	PMID:38174414
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CSRNP1 mRNA	PMID:37236586
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CSRNP1 mRNA	PMID:39150890
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314363	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of CSRNP1 mRNA	PMID:28903501
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20131220	CTD	MESH:C018021	cobaltous chloride results in increased expression of AXUD1 mRNA	PMID:19320972
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1305999	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of CSRNP1 mRNA	PMID:24386269
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CSRNP1 mRNA	PMID:24449571
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of CSRNP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of CSRNP1 mRNA	PMID:32699268
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CSRNP1 mRNA	PMID:31533062
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20131220	CTD	MESH:D003375	Coumestrol results in decreased expression of AXUD1 mRNA	PMID:19167446
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20131220	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AXUD1 mRNA	PMID:19167446
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CSRNP1 mRNA	PMID:40419075
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CSRNP1 mRNA	PMID:36331819
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CSRNP1 gene	PMID:29154799
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of CSRNP1 mRNA	PMID:28001369|PMID:29154799
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CSRNP1 mRNA	PMID:20106945|PMID:25562108
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1305999	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSRNP1 mRNA	PMID:33854195
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314363	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CSRNP1 mRNA	PMID:28973697
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1314363	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in increased expression of CSRNP1 mRNA	PMID:17178593
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of CSRNP1 mRNA	PMID:33512557
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20131220	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of AXUD1 mRNA]	PMID:21233418
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CSRNP1 mRNA	PMID:38832940
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1305999	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSRNP1 mRNA	PMID:33854195
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314363	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CSRNP1 mRNA	PMID:17562736
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of CSRNP1 mRNA	PMID:21420995|PMID:29067470
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1305999	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CSRNP1 mRNA	PMID:33387578
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of AXUD1 mRNA	PMID:24690739
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of CSRNP1 mRNA	PMID:25757056
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CSRNP1 mRNA	PMID:18687144
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of CSRNP1 mRNA	PMID:40504410
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1305999	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of CSRNP1 mRNA	PMID:29391264
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20131220	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of AXUD1 mRNA	PMID:22079256
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CSRNP1 mRNA	PMID:35436446
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314363	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CSRNP1 mRNA	PMID:17942748
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSRNP1 mRNA	PMID:17942748
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of CSRNP1 mRNA	PMID:23228038
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of CSRNP1 mRNA	PMID:38568856
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1314363	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of CSRNP1 mRNA	PMID:25554681
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CSRNP1 mRNA	PMID:25554681|PMID:25620056
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314363	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CSRNP1 mRNA	PMID:25620056
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1305999	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CSRNP1 mRNA	PMID:30047161
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of CSRNP1 mRNA	PMID:31629900
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1305999	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSRNP1 mRNA	PMID:33854195
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1305999	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of CSRNP1 mRNA	PMID:25729387
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CSRNP1 mRNA	PMID:28988120
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1305999	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of CSRNP1 mRNA	PMID:24136188
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1305999	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of CSRNP1 mRNA	PMID:30467583
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20201215	CTD	MESH:D002185	Cannabidiol inhibits the reaction [MOG protein modified form results in increased expression of CSRNP1 mRNA]	PMID:27256343
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1314363	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of CSRNP1 mRNA	PMID:22206623
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20131220	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of AXUD1 mRNA	PMID:22079256
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20131220	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of AXUD1 mRNA	PMID:22079256
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in increased expression of CSRNP1 mRNA	PMID:28284560
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of CSRNP1 protein	PMID:31285264
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1305999	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of CSRNP1 mRNA	PMID:23665939
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CSRNP1 mRNA	PMID:30851411
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSRNP1 mRNA	PMID:27188386
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of CSRNP1 mRNA	PMID:39150890
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AXUD1 gene]	PMID:28238834
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of CSRNP1 mRNA	PMID:19270015
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1305999	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of CSRNP1 mRNA	PMID:30047161
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:81068	Shikonin	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20210907	CTD	MESH:C016101	shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of AXUD1 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of AXUD1 mRNA]	PMID:25451590
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of AXUD1 mRNA	PMID:19167446
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of CSRNP1 mRNA	PMID:26079696
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of CSRNP1 mRNA	PMID:30953684
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1305999	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CSRNP1 mRNA	PMID:30047161
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of CSRNP1 mRNA	PMID:39241906
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of CSRNP1 mRNA	PMID:40826991
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:87368	diethyl malate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C058705	diethyl malate results in increased expression of CSRNP1 mRNA	PMID:38498338
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of CSRNP1 mRNA	PMID:31734321
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSRNP1 mRNA	PMID:27188386
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314363	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CSRNP1 mRNA	PMID:27131904
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1305999	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of CSRNP1 mRNA	PMID:19281266
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of CSRNP1 mRNA	PMID:34581912
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:9410	taurodeoxycholic acid	multiple interactions	ISO	RGD:1314363	E	RGD:6480464	20250805	CTD	MESH:D013657	Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in increased expression of CSRNP1 mRNA]	PMID:39232337
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CSRNP1 mRNA	PMID:38568856
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of CSRNP1 mRNA	PMID:29301935
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in increased expression of CSRNP1 mRNA	PMID:29453283
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314363	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CSRNP1 mRNA	PMID:28973697
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314363	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of CSRNP1 mRNA	PMID:35537566
1314362	CSRNP1	cysteine and serine rich nuclear protein 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1305999	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CSRNP1 mRNA	PMID:23034163
1314366	TNN	tenascin N	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of TNN mRNA	PMID:26272509
1314366	TNN	tenascin N	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNN mRNA	PMID:27188386
1314366	TNN	tenascin N	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306002	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TNN mRNA]	PMID:31150632
1314366	TNN	tenascin N	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314367	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TNN mRNA	PMID:30529165
1314366	TNN	tenascin N	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306002	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of TNN gene	PMID:35440735
1314366	TNN	tenascin N	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1306002	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of TNN mRNA	PMID:36841081
1314366	TNN	tenascin N	gene	CHEBI:16130	DDT	decreases methylation	ISO	RGD:1306002	E	RGD:6480464	20211012	CTD	MESH:D003634	DDT results in decreased methylation of TNN gene	PMID:31682807
1314366	TNN	tenascin N	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306002	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TNN mRNA	PMID:33387578
1314366	TNN	tenascin N	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of TNN mRNA	PMID:23649840
1314366	TNN	tenascin N	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314367	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TNN mRNA	PMID:34319233
1314366	TNN	tenascin N	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of TNN mRNA	PMID:16002434
1314366	TNN	tenascin N	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306002	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TNN mRNA	PMID:33387578
1314366	TNN	tenascin N	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of TNN exon	PMID:30157460
1314366	TNN	tenascin N	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1314367	E	RGD:6480464	20210810	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TNN mRNA	PMID:33187795
1314366	TNN	tenascin N	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of TNN mRNA	PMID:23649840
1314366	TNN	tenascin N	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TNN gene	PMID:27153756
1314366	TNN	tenascin N	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TNN mRNA	PMID:23649840
1314366	TNN	tenascin N	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314367	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TNN mRNA	PMID:34911549
1314366	TNN	tenascin N	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306002	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TNN mRNA	PMID:30779732
1314366	TNN	tenascin N	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306002	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TNN mRNA	PMID:31150632
1314366	TNN	tenascin N	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306002	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TNN mRNA]	PMID:31150632
1314366	TNN	tenascin N	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TNN mRNA	PMID:24768652|PMID:25583101
1314366	TNN	tenascin N	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306002	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TNN mRNA	PMID:34747641
1314366	TNN	tenascin N	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1306002	E	RGD:6480464	20170516	CTD	MESH:D012402	Rotenone results in decreased expression of TNN mRNA	PMID:27979718
1314366	TNN	tenascin N	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306002	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TNN mRNA	PMID:26033743
1314366	TNN	tenascin N	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1306002	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TNN mRNA	PMID:27257137
1314366	TNN	tenascin N	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TNN mRNA	PMID:38568856
1314366	TNN	tenascin N	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TNN 5' UTR; Benzo(a)pyrene affects the methylation of TNN promoter	PMID:27901495
1314366	TNN	tenascin N	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314367	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TNN exon; Benzo(a)pyrene results in decreased methylation of TNN intron	PMID:27901495
1314366	TNN	tenascin N	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TNN 3' UTR	PMID:27901495
1314366	TNN	tenascin N	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of TNN gene	PMID:25435355
1314366	TNN	tenascin N	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306002	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TNN mRNA	PMID:26033743
1314366	TNN	tenascin N	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of TNN mRNA	PMID:37690743
1314366	TNN	tenascin N	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314367	E	RGD:6480464	20120717	CTD	MESH:C009495	titanium dioxide results in decreased expression of TNN mRNA	PMID:19464567
1314366	TNN	tenascin N	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1306002	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of TNN mRNA	PMID:30012374
1314366	TNN	tenascin N	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314367	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of TNN mRNA	PMID:35295148
1314366	TNN	tenascin N	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306002	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TNN mRNA	PMID:34492290
1314366	TNN	tenascin N	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306002	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TNN mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314366	TNN	tenascin N	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314367	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of TNN exon	PMID:33297965
1314366	TNN	tenascin N	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TNN exon	PMID:30157460
1314366	TNN	tenascin N	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1314367	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of TNN mRNA	PMID:26377693
1314366	TNN	tenascin N	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306002	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TNN mRNA	PMID:21266533
1314366	TNN	tenascin N	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314367	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TNN mRNA	PMID:21266533
1314366	TNN	tenascin N	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1306002	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of TNN mRNA	PMID:35163327
1314366	TNN	tenascin N	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TNN mRNA	PMID:38568856
1314366	TNN	tenascin N	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306002	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TNN mRNA	PMID:27387713
1314366	TNN	tenascin N	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314367	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TNN mRNA	PMID:40194260
1314366	TNN	tenascin N	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of TNN mRNA	PMID:24383497|PMID:24935251
1314366	TNN	tenascin N	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of TNN mRNA	PMID:26272509
1314366	TNN	tenascin N	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNN mRNA	PMID:27188386
1314366	TNN	tenascin N	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of TNN mRNA	PMID:24935251
1314366	TNN	tenascin N	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306002	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TNN mRNA	PMID:29391264
1314366	TNN	tenascin N	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314367	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TNN mRNA; Nanotubes, Carbon results in decreased expression of TNN mRNA	PMID:25554681
1314366	TNN	tenascin N	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1306002	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of TNN mRNA	PMID:34044035
1314366	TNN	tenascin N	gene	CHEBI:52774	pentane-2,3-dione	increases expression	ISO	RGD:1306002	E	RGD:6480464	20150512	CTD	MESH:C013186	2,3-pentanedione results in increased expression of TNN mRNA	PMID:25710175
1314366	TNN	tenascin N	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314367	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TNN mRNA	PMID:19042947
1314366	TNN	tenascin N	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of TNN mRNA	PMID:20436886
1314366	TNN	tenascin N	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNN mRNA	PMID:27188386
1314366	TNN	tenascin N	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1306002	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of TNN mRNA	PMID:28801915
1314366	TNN	tenascin N	gene	CHEBI:63041	manganese(II) chloride	increases methylation	ISO	RGD:1306002	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased methylation of TNN gene	PMID:28801915
1314366	TNN	tenascin N	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1306002	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of TNN mRNA	PMID:28801915
1314366	TNN	tenascin N	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1306002	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TNN mRNA	PMID:37269647
1314366	TNN	tenascin N	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314367	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of TNN mRNA	PMID:36851058
1314366	TNN	tenascin N	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TNN exon	PMID:30157460
1314366	TNN	tenascin N	gene	CHEBI:6980	monocrotaline	increases expression	ISO	RGD:1306002	E	RGD:6480464	20160315	CTD	MESH:D016686	Monocrotaline results in increased expression of TNN protein	PMID:24947524
1314366	TNN	tenascin N	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNN mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNN mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNN mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNN mRNA	PMID:27188386
1314366	TNN	tenascin N	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of TNN mRNA	PMID:26705709
1314366	TNN	tenascin N	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306002	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of TNN mRNA	PMID:24780913|PMID:25825206
1314366	TNN	tenascin N	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of TNN mRNA	PMID:26272509
1314366	TNN	tenascin N	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNN mRNA	PMID:27188386
1314366	TNN	tenascin N	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNN mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNN mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNN mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TNN mRNA	PMID:27188386
1314366	TNN	tenascin N	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TNN mRNA	PMID:38568856
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of GIGYF2 mRNA	PMID:38218311
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1614934	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of GIGYF2 mRNA	PMID:33045310
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1614934	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of GIGYF2 mRNA	PMID:26251327
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of GIGYF2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of GIGYF2 mRNA	PMID:32699268
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1614934	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GIGYF2 mRNA	PMID:36331819
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of GIGYF2 mRNA	PMID:40865780
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1614934	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of GIGYF2 mRNA	PMID:30319688
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:2318130	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of GIGYF2 mRNA	PMID:32145629
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GIGYF2 mRNA	PMID:37042841
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of GIGYF2 mRNA	PMID:23649840
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:2318130	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of GIGYF2 mRNA	PMID:27523638
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of GIGYF2 protein	PMID:37730182
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of GIGYF2 mRNA	PMID:19549813
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GIGYF2 protein	PMID:23301498
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GIGYF2 gene	PMID:27153756
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of GIGYF2 intron	PMID:30157460
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of GIGYF2 mRNA	PMID:23649840
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	EXP		E	RGD:6480464	20151013	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of GIGYF2 protein	PMID:19845377
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of GIGYF2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of GIGYF2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of GIGYF2 mRNA	PMID:32699268
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of GIGYF2 protein	PMID:35688186
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C010974	Glyphosate results in decreased expression of GIGYF2 mRNA	PMID:40865780
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of GIGYF2 mRNA	PMID:23557933
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614934	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GIGYF2 mRNA	PMID:21570461|PMID:26377647
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1614934	E	RGD:6480464	20151013	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GIGYF2 mRNA	PMID:17942748
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D024483	Vitamin K 3 affects the expression of GIGYF2 mRNA	PMID:20044591
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of GIGYF2 protein	PMID:30528433
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GIGYF2 promoter	PMID:27901495
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1614934	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of GIGYF2 protein	PMID:37955338
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GIGYF2 mRNA	PMID:19150397
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of GIGYF2 mRNA	PMID:26238291
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of GIGYF2 mRNA	PMID:20458559
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of GIGYF2 mRNA	PMID:34408198
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:2318130	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of GIGYF2 mRNA	PMID:25729387
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1614934	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of GIGYF2 mRNA	PMID:23557971
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614934	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GIGYF2 gene	PMID:35295148
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1614934	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of GIGYF2 gene	PMID:35295148
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:2318130	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of GIGYF2 mRNA	PMID:32145629
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of GIGYF2 protein	PMID:37567409
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of GIGYF2 mRNA; bisphenol A results in increased expression of GIGYF2 protein	PMID:29275510|PMID:34186270
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of GIGYF2 mRNA	PMID:19244175
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1614934	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of GIGYF2 mRNA	PMID:26682919
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of GIGYF2 protein	PMID:34186270
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GIGYF2 mRNA	PMID:37042841
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of GIGYF2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of GIGYF2 mRNA	PMID:32699268
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1614934	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GIGYF2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of GIGYF2 mRNA	PMID:36331819
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GIGYF2 mRNA	PMID:25979313
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GIGYF2 gene	PMID:29154799
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of GIGYF2 mRNA	PMID:23649840
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614934	E	RGD:6480464	20151013	CTD	MESH:D000082	Acetaminophen affects the expression of GIGYF2 mRNA	PMID:17562736
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of GIGYF2 mRNA	PMID:26690555
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of GIGYF2 mRNA	PMID:21420995
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of GIGYF2 mRNA	PMID:18687144
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GIGYF2 mRNA	PMID:22079256
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1614934	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of GIGYF2 mRNA	PMID:35436446
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1614934	E	RGD:6480464	20151013	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of GIGYF2 mRNA	PMID:17555576
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1614934	E	RGD:6480464	20151013	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of GIGYF2 mRNA	PMID:17942748
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1614934	E	RGD:6480464	20151013	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GIGYF2 mRNA	PMID:17942748
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of GIGYF2 mRNA	PMID:20458559
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of GIGYF2 protein	PMID:32959892
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GIGYF2 mRNA	PMID:26378955
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:2318130	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of GIGYF2 mRNA	PMID:25729387
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:2318130	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of GIGYF2 mRNA	PMID:25729387
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1614934	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of GIGYF2 mRNA	PMID:20003209
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1614934	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of GIGYF2 mRNA	PMID:26307267
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1614934	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of GIGYF2 mRNA	PMID:22206623
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of GIGYF2 mRNA	PMID:22079256
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GIGYF2 mRNA	PMID:22079256
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1614934	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of GIGYF2 mRNA	PMID:23091169
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1614934	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of GIGYF2 mRNA	PMID:31388691
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1614934	E	RGD:6480464	20151013	CTD	MESH:C045950	propiconazole results in increased expression of GIGYF2 mRNA	PMID:21278054
1314368	GIGYF2	GRB10 interacting GYF protein 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1614934	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of GIGYF2 mRNA	PMID:28973697
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314370	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ALG3 mRNA	PMID:30529165
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:16170	mercury(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of ALG3 mRNA	PMID:16823088
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314370	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ALG3 mRNA	PMID:39241906
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of ALG3 mRNA	PMID:23019147
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306004	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ALG3 mRNA	PMID:33387578
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ALG3 mRNA	PMID:37042841
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1314370	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of ALG3 mRNA	PMID:28973375
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1314370	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of ALG3 mRNA	PMID:33848595
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ALG3 protein	PMID:37730182
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306004	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ALG3 mRNA	PMID:33387578
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314370	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ALG3 mRNA	PMID:36331819
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ALG3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ALG3 mRNA	PMID:39836092
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ALG3 mRNA	PMID:35301059
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:25195	mercury atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of ALG3 mRNA	PMID:16823088
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20250204	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ALG3 mRNA	PMID:35091019
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ALG3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALG3 mRNA	PMID:39836092|PMID:40512198
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314370	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ALG3 mRNA	PMID:40504410
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ALG3 mRNA	PMID:19244175
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ALG3 mRNA	PMID:23557933
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ALG3 mRNA	PMID:27594783
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314370	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ALG3 mRNA	PMID:21570461
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306004	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALG3 mRNA	PMID:33387578
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314370	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ALG3 mRNA	PMID:17942748
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306004	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of ALG3 mRNA	PMID:28374803
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ALG3 mRNA	PMID:38568856
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ALG3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALG3 mRNA	PMID:39836092|PMID:40512198
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314370	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ALG3 mRNA	PMID:40504410
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1314370	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of ALG3 protein	PMID:37955338
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306004	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of ALG3 mRNA	PMID:24136188
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ALG3 mRNA	PMID:19710929
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ALG3 mRNA	PMID:25047013
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314370	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ALG3 mRNA	PMID:26512966|PMID:32156529
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306004	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ALG3 mRNA	PMID:25181051
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306004	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ALG3 gene	PMID:28505145
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of ALG3 mRNA	PMID:19244175
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1306004	E	RGD:6480464	20260303	CTD	MESH:C008745	bisphenol F results in decreased expression of ALG3 protein	PMID:40188933
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ALG3 mRNA	PMID:28628672
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314370	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ALG3 mRNA	PMID:37019170
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ALG3 mRNA	PMID:28628672
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ALG3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ALG3 mRNA	PMID:39836092
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ALG3 mRNA	PMID:35301059
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:36009	omega-6 fatty acid	decreases expression	EXP		E	RGD:6480464	20170117	CTD	MESH:D043371	Fatty Acids, Omega-6 results in decreased expression of ALG3 mRNA	PMID:16823509
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ALG3 mRNA	PMID:19244175
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ALG3 mRNA	PMID:40419075
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314370	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ALG3 mRNA	PMID:36331819
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314370	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ALG3 mRNA	PMID:17292431
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ALG3 mRNA	PMID:28628672
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314370	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ALG3 mRNA	PMID:17562736
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of ALG3 mRNA	PMID:26690555
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of ALG3 mRNA]	PMID:15016801
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ALG3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ALG3 mRNA	PMID:39836092|PMID:40512198
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314370	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ALG3 mRNA	PMID:40504410
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314370	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ALG3 mRNA	PMID:35436446
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314370	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ALG3 mRNA	PMID:17942748
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314370	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ALG3 mRNA	PMID:17942748
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ALG3 mRNA	PMID:28628672
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314370	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ALG3 mRNA; Nanotubes, Carbon results in increased expression of ALG3 mRNA	PMID:25554681
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306004	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ALG3 mRNA	PMID:24136188
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306004	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ALG3 mRNA	PMID:24136188
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ALG3 protein	PMID:32959892
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:61057	tacrolimus hydrate	decreases expression	ISO	RGD:1314370	E	RGD:6480464	20150127	CTD	MESH:D016559	Tacrolimus results in decreased expression of ALG3 mRNA	PMID:25270620
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ALG3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ALG3 mRNA	PMID:39836092
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:67895	corosolic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of ALG3 mRNA	PMID:37939859
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306004	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ALG3 mRNA	PMID:24136188
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:757488	omega-3 fatty acids	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:D015525	Fatty Acids, Omega-3 results in decreased expression of ALG3 mRNA	PMID:16823509
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of ALG3 mRNA	PMID:18548127
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1306004	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ALG3 mRNA	PMID:21346803
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1306004	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ALG3 mRNA	PMID:12082028
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314370	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ALG3 mRNA	PMID:30294300
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314370	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of ALG3 mRNA	PMID:30953684
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ALG3 mRNA	PMID:38568856
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306004	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ALG3 mRNA	PMID:21346803
1314369	ALG3	ALG3 alpha-1,3- mannosyltransferase	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306004	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ALG3 mRNA	PMID:23034163
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314373	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of BRMS1L mRNA	PMID:30319688
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314373	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of BRMS1L mRNA	PMID:39241906
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BRMS1L mRNA	PMID:37042841
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of BRMS1L mRNA	PMID:23649840
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314373	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of BRMS1L mRNA	PMID:23892564
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314373	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of BRMS1L mRNA	PMID:34319233
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of BRMS1L protein	PMID:37730182
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306006	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of BRMS1L mRNA	PMID:33387578
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of BRMS1L mRNA	PMID:28818685
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1314373	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of BRMS1L mRNA	PMID:37748715
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BRMS1L mRNA	PMID:35301059
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of BRMS1L mRNA	PMID:23649840
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BRMS1L mRNA	PMID:21641981
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of BRMS1L mRNA	PMID:23649840
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314373	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of BRMS1L mRNA	PMID:22206623
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of BRMS1L mRNA	PMID:27392435
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of BRMS1L mRNA	PMID:27392435
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306006	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BRMS1L mRNA	PMID:33387578
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of BRMS1L mRNA	PMID:33512557
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of BRMS1L mRNA	PMID:39709020
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of BRMS1L mRNA	PMID:38568856
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314373	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of BRMS1L mRNA	PMID:22700541
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BRMS1L mRNA	PMID:22316170|PMID:26238291
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1306006	E	RGD:6480464	20171219	CTD	MESH:D012822	Silicon Dioxide results in increased expression of BRMS1L mRNA	PMID:22431001
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BRMS1L mRNA	PMID:19150397
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of BRMS1L mRNA	PMID:26238291
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306006	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of BRMS1L mRNA	PMID:30047161
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314373	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BRMS1L gene; titanium dioxide results in decreased methylation of BRMS1L promoter	PMID:35295148
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1306006	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of BRMS1L mRNA	PMID:30012374
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306006	E	RGD:6480464	20171219	CTD	MESH:C006780	bisphenol A affects the expression of BRMS1L mRNA	PMID:25181051
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306006	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of BRMS1L mRNA	PMID:41034487
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314373	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of BRMS1L mRNA	PMID:21266533
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306006	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of BRMS1L mRNA	PMID:32680482
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BRMS1L mRNA	PMID:35301059
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of BRMS1L mRNA	PMID:24449571
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of BRMS1L mRNA	PMID:28302478
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BRMS1L mRNA	PMID:25979313
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of BRMS1L mRNA	PMID:23179753
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306006	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of BRMS1L mRNA	PMID:30047161
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of BRMS1L mRNA	PMID:33512557
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of BRMS1L mRNA	PMID:33512557
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of BRMS1L mRNA	PMID:23649840
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of BRMS1L mRNA	PMID:27188386
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of BRMS1L mRNA	PMID:22230336
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306006	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of BRMS1L mRNA	PMID:30047161
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of BRMS1L mRNA	PMID:28988120
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314373	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of BRMS1L mRNA	PMID:22206623
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of BRMS1L protein	PMID:31285264
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of BRMS1L mRNA	PMID:30928695
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of BRMS1L mRNA	PMID:23146750
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1306006	E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of BRMS1L mRNA	PMID:26923065
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306006	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of BRMS1L mRNA	PMID:30047161
1314372	BRMS1L	BRMS1 like transcriptional repressor	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306006	E	RGD:6480464	20171219	CTD	MESH:D012999	Soman results in decreased expression of BRMS1L mRNA	PMID:19281266
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550368	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ZBTB6 mRNA	PMID:20188158
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZBTB6 mRNA	PMID:37042841
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of ZBTB6 mRNA	PMID:20655997
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZBTB6 mRNA	PMID:28818685
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZBTB6 mRNA	PMID:35301059
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1306007	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of ZBTB6 mRNA	PMID:41580963
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ZBTB6 mRNA	PMID:35430440
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZBTB6 mRNA	PMID:39836092
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ZBTB6 mRNA	PMID:26272509
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB6 mRNA	PMID:27188386
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ZBTB6 protein	PMID:35688186
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550368	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZBTB6 mRNA	PMID:24680724
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306007	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZBTB6 mRNA	PMID:33387578
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ZBTB6 mRNA	PMID:28001369
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZBTB6 mRNA	PMID:33212167
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ZBTB6 mRNA	PMID:30851411
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZBTB6 mRNA	PMID:32763439
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306007	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ZBTB6 mRNA	PMID:28959563
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZBTB6 mRNA	PMID:29803840
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZBTB6 mRNA	PMID:39719251
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZBTB6 mRNA	PMID:39836092
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ZBTB6 mRNA	PMID:23806026
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306007	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ZBTB6 mRNA	PMID:34492290
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306007	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZBTB6 mRNA	PMID:25181051
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550368	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ZBTB6 mRNA	PMID:33221593
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306007	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of ZBTB6 mRNA	PMID:33296240
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550368	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ZBTB6 mRNA	PMID:37019170
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZBTB6 mRNA	PMID:37042841
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZBTB6 mRNA	PMID:35301059
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ZBTB6 mRNA	PMID:28302478
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZBTB6 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZBTB6 mRNA	PMID:25562108
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ZBTB6 mRNA	PMID:24935251
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZBTB6 mRNA	PMID:39836092
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of ZBTB6 mRNA	PMID:40706910
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1550368	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of ZBTB6 mRNA	PMID:40234311
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ZBTB6 mRNA	PMID:28988120
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550368	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZBTB6 mRNA	PMID:22206623
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZBTB6 protein	PMID:31285264
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ZBTB6 mRNA	PMID:30851411
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB6 mRNA	PMID:27188386
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ZBTB6 mRNA	PMID:30928695
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZBTB6 gene]	PMID:28238834
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1306007	E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of ZBTB6 mRNA	PMID:26923065
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306007	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ZBTB6 mRNA	PMID:24780913
1314374	ZBTB6	zinc finger and BTB domain containing 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZBTB6 mRNA	PMID:27188386
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314377	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ARMC12 mRNA	PMID:33045310
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of ARMC12 mRNA	PMID:29581250
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314377	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ARMC12 mRNA	PMID:39298647
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306008	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ARMC12 mRNA	PMID:33387578
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1314377	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of ARMC12 mRNA	PMID:28973375
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ARMC12 mRNA	PMID:31163220
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:177802	Cuprizon	affects expression	ISO	RGD:1306008	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of ARMC12 mRNA	PMID:27523638
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314377	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ARMC12 mRNA	PMID:28960355
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306008	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ARMC12 mRNA	PMID:26033743
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314377	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ARMC12 protein	PMID:28918527
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ARMC12 mRNA	PMID:32234424
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306008	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ARMC12 mRNA	PMID:26033743
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ARMC12 mRNA	PMID:25895662
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ARMC12 mRNA	PMID:37690743
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of ARMC12 gene	PMID:31601247
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306008	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ARMC12 mRNA	PMID:25181051
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to ARMC12 promoter]	PMID:20348232
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314377	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ARMC12 mRNA	PMID:39298647
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of ARMC12 gene	PMID:31601247
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1306008	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ARMC12 promoter	PMID:22457795
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARMC12 mRNA	PMID:26690555
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314377	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ARMC12 mRNA	PMID:38701926
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1314377	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of ARMC12 mRNA	PMID:36851058
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306008	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ARMC12 gene	PMID:35440735
1314376	ARMC12	armadillo repeat containing 12	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306008	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARMC12 mRNA	PMID:24780913
1314380	CUL7	cullin 7	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1622331	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in decreased expression of CUL7 mRNA	PMID:18313992
1314380	CUL7	cullin 7	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1622331	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CUL7 mRNA	PMID:33045310
1314380	CUL7	cullin 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1622331	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CUL7 mRNA	PMID:37995155
1314380	CUL7	cullin 7	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1622331	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CUL7 mRNA	PMID:20188158
1314380	CUL7	cullin 7	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CUL7 mRNA	PMID:26079696
1314380	CUL7	cullin 7	gene	CHEBI:15866	2-deoxy-D-glucose	multiple interactions	ISO	RGD:1622331	E	RGD:6480464	20160412	CTD	MESH:D003847	[INS1 protein co-treated with CUL7 mutant form] results in increased uptake of Deoxyglucose	PMID:24219910
1314380	CUL7	cullin 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1622331	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CUL7 mRNA	PMID:39241906
1314380	CUL7	cullin 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1622331	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CUL7 mRNA	PMID:39298647
1314380	CUL7	cullin 7	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1587048	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CUL7 mRNA	PMID:33387578
1314380	CUL7	cullin 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1622331	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CUL7 mRNA	PMID:36331819
1314380	CUL7	cullin 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1622331	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CUL7 mRNA	PMID:37236586
1314380	CUL7	cullin 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CUL7 mRNA	PMID:19549813
1314380	CUL7	cullin 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1622331	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CUL7 mRNA	PMID:22206623
1314380	CUL7	cullin 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1622331	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CUL7 mRNA	PMID:40504410
1314380	CUL7	cullin 7	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CUL7 mRNA	PMID:19244175
1314380	CUL7	cullin 7	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CUL7 mRNA	PMID:27392435
1314380	CUL7	cullin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1587048	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CUL7 mRNA	PMID:33387578
1314380	CUL7	cullin 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1622331	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CUL7 mRNA	PMID:26290441
1314380	CUL7	cullin 7	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of CUL7 mRNA	PMID:39709020
1314380	CUL7	cullin 7	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CUL7 mRNA	PMID:32763439
1314380	CUL7	cullin 7	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of CUL7 mRNA	PMID:29803840
1314380	CUL7	cullin 7	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of CUL7 protein	PMID:35688186
1314380	CUL7	cullin 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CUL7 mRNA	PMID:38568856
1314380	CUL7	cullin 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1622331	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CUL7 mRNA	PMID:40504410
1314380	CUL7	cullin 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CUL7 promoter	PMID:27901495
1314380	CUL7	cullin 7	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1622331	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of CUL7 mRNA	PMID:17656681
1314380	CUL7	cullin 7	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1622331	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CUL7 gene	PMID:35295148
1314380	CUL7	cullin 7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1622331	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CUL7 mRNA	PMID:17950772|PMID:23811191
1314380	CUL7	cullin 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1622331	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of CUL7 mRNA]	PMID:17950772
1314380	CUL7	cullin 7	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1622331	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CUL7 mRNA	PMID:28472532
1314380	CUL7	cullin 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1587048	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CUL7 mRNA	PMID:34947998
1314380	CUL7	cullin 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of CUL7 mRNA	PMID:29275510
1314380	CUL7	cullin 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1587048	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CUL7 mRNA	PMID:25181051
1314380	CUL7	cullin 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1622331	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CUL7 gene	PMID:31683443
1314380	CUL7	cullin 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1622331	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CUL7 promoter	PMID:33297965
1314380	CUL7	cullin 7	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1622331	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CUL7 mRNA	PMID:37019170
1314380	CUL7	cullin 7	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1622331	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of CUL7 gene	PMID:38995845
1314380	CUL7	cullin 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CUL7 mRNA	PMID:38568856
1314380	CUL7	cullin 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1622331	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CUL7 mRNA	PMID:37236586
1314380	CUL7	cullin 7	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CUL7 mRNA	PMID:19244175
1314380	CUL7	cullin 7	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1622331	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of CUL7 mRNA	PMID:23811191
1314380	CUL7	cullin 7	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CUL7 mRNA	PMID:31533062
1314380	CUL7	cullin 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1622331	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CUL7 protein	PMID:26178269
1314380	CUL7	cullin 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CUL7 mRNA	PMID:40419075
1314380	CUL7	cullin 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1622331	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CUL7 mRNA	PMID:36331819
1314380	CUL7	cullin 7	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CUL7 mRNA	PMID:25979313
1314380	CUL7	cullin 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of CUL7 mRNA	PMID:29154799
1314380	CUL7	cullin 7	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1622331	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of CUL7 mRNA	PMID:21427059
1314380	CUL7	cullin 7	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1622331	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of CUL7 mRNA	PMID:21427059
1314380	CUL7	cullin 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1622331	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CUL7 mRNA	PMID:28973697
1314380	CUL7	cullin 7	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CUL7 mRNA	PMID:38832940
1314380	CUL7	cullin 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622331	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CUL7 mRNA	PMID:17562736
1314380	CUL7	cullin 7	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1587048	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CUL7 mRNA	PMID:33387578
1314380	CUL7	cullin 7	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1622331	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CUL7 mRNA	PMID:29279043
1314380	CUL7	cullin 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1622331	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CUL7 mRNA	PMID:40504410
1314380	CUL7	cullin 7	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1622331	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in decreased expression of CUL7 mRNA	PMID:26934552
1314380	CUL7	cullin 7	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1622331	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CUL7 mRNA	PMID:35436446
1314380	CUL7	cullin 7	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1587048	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of CUL7 mRNA	PMID:17557909
1314380	CUL7	cullin 7	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1622331	E	RGD:6480464	20120814	CTD	MESH:D005485	Flutamide results in decreased expression of CUL7 mRNA	PMID:19442681
1314380	CUL7	cullin 7	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of CUL7 protein	PMID:23718831
1314380	CUL7	cullin 7	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CUL7 protein	PMID:32959892
1314380	CUL7	cullin 7	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1622331	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in decreased expression of CUL7 mRNA	PMID:18313992
1314380	CUL7	cullin 7	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1622331	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CUL7 mRNA	PMID:22206623
1314380	CUL7	cullin 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1622331	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CUL7 mRNA	PMID:22206623
1314380	CUL7	cullin 7	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of CUL7 mRNA	PMID:28960945
1314380	CUL7	cullin 7	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of CUL7 mRNA	PMID:19287073
1314380	CUL7	cullin 7	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of CUL7 mRNA	PMID:31734321
1314381	RNF126	ring finger protein 126	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RNF126 mRNA	PMID:33167477
1314381	RNF126	ring finger protein 126	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of RNF126 mRNA	PMID:22378314
1314381	RNF126	ring finger protein 126	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1314382	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of RNF126 mRNA	PMID:40945087
1314381	RNF126	ring finger protein 126	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RNF126 mRNA	PMID:29432896
1314381	RNF126	ring finger protein 126	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314382	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RNF126 mRNA	PMID:39241906
1314381	RNF126	ring finger protein 126	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of RNF126 mRNA	PMID:31614463
1314381	RNF126	ring finger protein 126	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314382	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RNF126 mRNA	PMID:39298647
1314381	RNF126	ring finger protein 126	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306011	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RNF126 gene	PMID:27618143
1314381	RNF126	ring finger protein 126	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314382	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of RNF126 mRNA	PMID:20403060
1314381	RNF126	ring finger protein 126	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306011	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of RNF126 mRNA	PMID:26577399
1314381	RNF126	ring finger protein 126	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306011	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of RNF126 mRNA	PMID:22061828|PMID:33387578
1314381	RNF126	ring finger protein 126	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314382	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RNF126 mRNA	PMID:36331819
1314381	RNF126	ring finger protein 126	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RNF126 mRNA	PMID:35301059
1314381	RNF126	ring finger protein 126	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314382	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RNF126 mRNA	PMID:37236586
1314381	RNF126	ring finger protein 126	gene	CHEBI:2394	acetochlor	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:C043377	[Herbicides results in increased abundance of acetochlor] which affects the methylation of RNF126 gene	PMID:34516295
1314381	RNF126	ring finger protein 126	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of RNF126 mRNA	PMID:23649840
1314381	RNF126	ring finger protein 126	gene	CHEBI:24527	herbicide	multiple interactions	EXP		E	RGD:6480464	20220906	CTD	MESH:D006540	[Herbicides results in increased abundance of acetochlor] which affects the methylation of RNF126 gene	PMID:34516295
1314381	RNF126	ring finger protein 126	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314382	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RNF126 mRNA	PMID:40504410
1314381	RNF126	ring finger protein 126	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306011	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RNF126 mRNA	PMID:33387578
1314381	RNF126	ring finger protein 126	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314382	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RNF126 mRNA	PMID:17942748
1314381	RNF126	ring finger protein 126	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314382	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RNF126 mRNA	PMID:17942748
1314381	RNF126	ring finger protein 126	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314382	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of RNF126 mRNA	PMID:15467011
1314381	RNF126	ring finger protein 126	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RNF126 mRNA	PMID:29432896
1314381	RNF126	ring finger protein 126	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RNF126 mRNA	PMID:38568856
1314381	RNF126	ring finger protein 126	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of RNF126 mRNA	PMID:39719251
1314381	RNF126	ring finger protein 126	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314382	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RNF126 mRNA	PMID:40504410
1314381	RNF126	ring finger protein 126	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314382	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RNF126 mRNA	PMID:22228805
1314381	RNF126	ring finger protein 126	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RNF126 promoter	PMID:27901495
1314381	RNF126	ring finger protein 126	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314382	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of RNF126 mRNA	PMID:15467011
1314381	RNF126	ring finger protein 126	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306011	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of RNF126 mRNA	PMID:24136188
1314381	RNF126	ring finger protein 126	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306011	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RNF126 mRNA	PMID:30047161
1314381	RNF126	ring finger protein 126	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314382	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RNF126 gene; titanium dioxide results in decreased methylation of RNF126 promoter; titanium dioxide results in decreased methylation of RNF126 promoter alternative form	PMID:35295148
1314381	RNF126	ring finger protein 126	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314382	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RNF126 gene	PMID:35295148
1314381	RNF126	ring finger protein 126	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314382	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of RNF126 mRNA	PMID:18301758|PMID:23811191
1314381	RNF126	ring finger protein 126	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306011	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF126 mRNA	PMID:25181051|PMID:33296240
1314381	RNF126	ring finger protein 126	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306011	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RNF126 mRNA	PMID:34947998
1314381	RNF126	ring finger protein 126	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306011	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RNF126 mRNA	PMID:36041667
1314381	RNF126	ring finger protein 126	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306011	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RNF126 mRNA	PMID:36041667
1314381	RNF126	ring finger protein 126	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314382	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RNF126 mRNA	PMID:38685157
1314381	RNF126	ring finger protein 126	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306011	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RNF126 mRNA	PMID:36041667
1314381	RNF126	ring finger protein 126	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314382	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RNF126 mRNA	PMID:37019170
1314381	RNF126	ring finger protein 126	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314382	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RNF126 mRNA	PMID:21266533
1314381	RNF126	ring finger protein 126	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RNF126 mRNA	PMID:38174414
1314381	RNF126	ring finger protein 126	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1306011	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of RNF126 promoter	PMID:22457795
1314381	RNF126	ring finger protein 126	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RNF126 mRNA	PMID:35301059
1314381	RNF126	ring finger protein 126	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314382	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RNF126 mRNA	PMID:37236586
1314381	RNF126	ring finger protein 126	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of RNF126 mRNA	PMID:19376846
1314381	RNF126	ring finger protein 126	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1306011	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of RNF126 mRNA	PMID:24386269
1314381	RNF126	ring finger protein 126	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RNF126 mRNA	PMID:31533062
1314381	RNF126	ring finger protein 126	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314382	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RNF126 mRNA	PMID:36331819
1314381	RNF126	ring finger protein 126	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314382	E	RGD:6480464	20120515	CTD	MESH:D014635	Valproic Acid affects the expression of RNF126 mRNA	PMID:17292431|PMID:17963808
1314381	RNF126	ring finger protein 126	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RNF126 mRNA	PMID:23179753
1314381	RNF126	ring finger protein 126	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RNF126 gene	PMID:29154799
1314381	RNF126	ring finger protein 126	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306011	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RNF126 mRNA	PMID:30047161
1314381	RNF126	ring finger protein 126	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of RNF126 mRNA	PMID:20106945
1314381	RNF126	ring finger protein 126	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314382	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RNF126 mRNA	PMID:17555576
1314381	RNF126	ring finger protein 126	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314382	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RNF126 mRNA	PMID:17562736
1314381	RNF126	ring finger protein 126	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306011	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RNF126 mRNA	PMID:33387578
1314381	RNF126	ring finger protein 126	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of RNF126 mRNA	PMID:29432896
1314381	RNF126	ring finger protein 126	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314382	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RNF126 mRNA	PMID:40504410
1314381	RNF126	ring finger protein 126	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306011	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RNF126 mRNA	PMID:29391264
1314381	RNF126	ring finger protein 126	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314382	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RNF126 mRNA	PMID:17555576
1314381	RNF126	ring finger protein 126	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314382	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RNF126 mRNA	PMID:17942748
1314381	RNF126	ring finger protein 126	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314382	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RNF126 mRNA	PMID:17942748
1314381	RNF126	ring finger protein 126	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306011	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RNF126 mRNA	PMID:30047161
1314381	RNF126	ring finger protein 126	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314382	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RNF126 mRNA	PMID:35964746
1314381	RNF126	ring finger protein 126	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306011	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RNF126 mRNA	PMID:24136188
1314381	RNF126	ring finger protein 126	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RNF126 protein	PMID:32959892
1314381	RNF126	ring finger protein 126	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314382	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of RNF126 protein	PMID:36851058
1314381	RNF126	ring finger protein 126	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314382	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RNF126 mRNA	PMID:22206623
1314381	RNF126	ring finger protein 126	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314382	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RNF126 mRNA	PMID:40826991
1314381	RNF126	ring finger protein 126	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306011	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RNF126 mRNA	PMID:21346803
1314383	TSGA13	testis specific 13	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314384	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TSGA13 mRNA	PMID:25510870
1314383	TSGA13	testis specific 13	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1584118	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TSGA13 mRNA	PMID:33387578
1314383	TSGA13	testis specific 13	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314384	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TSGA13 mRNA	PMID:25510870
1314383	TSGA13	testis specific 13	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314384	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TSGA13 mRNA	PMID:25510870
1314383	TSGA13	testis specific 13	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of TSGA13 mRNA	PMID:41028656
1314383	TSGA13	testis specific 13	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1584118	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TSGA13 mRNA	PMID:26033743
1314383	TSGA13	testis specific 13	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TSGA13 mRNA	PMID:41028656
1314383	TSGA13	testis specific 13	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314384	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of TSGA13 mRNA	PMID:37682722
1314383	TSGA13	testis specific 13	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TSGA13 promoter	PMID:27901495
1314383	TSGA13	testis specific 13	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1584118	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of TSGA13 mRNA	PMID:26033743
1314383	TSGA13	testis specific 13	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of TSGA13 mRNA	PMID:41028656
1314383	TSGA13	testis specific 13	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TSGA13 gene	PMID:31601247
1314383	TSGA13	testis specific 13	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1584118	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TSGA13 mRNA	PMID:25181051
1314383	TSGA13	testis specific 13	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of TSGA13 gene	PMID:31601247
1314383	TSGA13	testis specific 13	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314384	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TSGA13 mRNA	PMID:25510870
1314383	TSGA13	testis specific 13	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314384	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TSGA13 mRNA	PMID:25510870
1314383	TSGA13	testis specific 13	gene	CHEBI:42223	emodin	increases expression	ISO	RGD:1314384	E	RGD:6480464	20180703	CTD	MESH:D004642	Emodin results in increased expression of TSGA13 mRNA	PMID:21319176
1314383	TSGA13	testis specific 13	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1314384	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of TSGA13 mRNA	PMID:18502557
1314383	TSGA13	testis specific 13	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314384	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TSGA13 mRNA	PMID:38701926
1314383	TSGA13	testis specific 13	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TSGA13 gene]	PMID:28238834
1314383	TSGA13	testis specific 13	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1584118	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TSGA13 mRNA	PMID:19281266
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SCARF2 mRNA	PMID:38218311
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314386	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SCARF2 mRNA	PMID:26251327
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314386	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol A co-treated with Tretinoin] results in decreased expression of SCARF2 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of SCARF2 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of SCARF2 mRNA	PMID:30951980
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SCARF2 mRNA	PMID:26079696
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314386	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SCARF2 mRNA	PMID:39298647
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SCARF2 mRNA	PMID:30165855
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306013	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SCARF2 mRNA	PMID:33387578
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SCARF2 mRNA	PMID:21179406
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314386	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SCARF2 mRNA	PMID:35716406
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306013	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SCARF2 mRNA	PMID:26577399
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SCARF2 protein	PMID:37730182
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of SCARF2 mRNA	PMID:26485663
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306013	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SCARF2 mRNA	PMID:33387578
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SCARF2 mRNA	PMID:28818685
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SCARF2 mRNA	PMID:39836092
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SCARF2 mRNA	PMID:32234424
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SCARF2 gene	PMID:25304211
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SCARF2 mRNA	PMID:39836092
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306013	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SCARF2 mRNA	PMID:31881176
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306013	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SCARF2 mRNA	PMID:22298810|PMID:34747641
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306013	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SCARF2 mRNA	PMID:33387578
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SCARF2 mRNA	PMID:33212167
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of SCARF2 mRNA	PMID:27188386
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of SCARF2 mRNA	PMID:32763439
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of SCARF2 mRNA	PMID:24690739
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SCARF2 mRNA	PMID:39836092
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SCARF2 mRNA	PMID:32234424
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314386	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SCARF2 mRNA	PMID:27195522
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SCARF2 5' UTR; Benzo(a)pyrene results in increased methylation of SCARF2 promoter	PMID:27901495
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in increased expression of SCARF2 mRNA	PMID:24690739
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SCARF2 mRNA	PMID:20458559
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C008261	lead acetate results in decreased expression of SCARF2 mRNA	PMID:37939567
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314386	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SCARF2 enhancer; titanium dioxide results in decreased methylation of SCARF2 gene	PMID:35295148
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:33146	vanadyl sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C034028	vanadyl sulfate results in decreased expression of SCARF2 mRNA	PMID:16330358
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306013	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SCARF2 mRNA	PMID:25181051|PMID:34947998
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314386	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SCARF2 mRNA	PMID:34585602
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314386	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with Tretinoin] results in decreased expression of SCARF2 mRNA	PMID:30951980
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314386	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SCARF2 gene	PMID:31683443
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1314386	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of SCARF2 exon	PMID:33297965
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314386	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of SCARF2 mRNA	PMID:30951980
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314386	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SCARF2 mRNA	PMID:38685157
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1314386	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of SCARF2 mRNA	PMID:30951980
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314386	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SCARF2 mRNA	PMID:21266533
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306013	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SCARF2 mRNA	PMID:32680482
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SCARF2 mRNA	PMID:37042841
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of SCARF2 mRNA	PMID:29024780
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SCARF2 mRNA	PMID:39836092
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:35559	furan	decreases methylation	ISO	RGD:1306013	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of SCARF2 gene	PMID:27387713
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306013	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of SCARF2 mRNA	PMID:27387713
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314386	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SCARF2 mRNA	PMID:40194260
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SCARF2 mRNA	PMID:31533062
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SCARF2 mRNA	PMID:40419075
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SCARF2 gene	PMID:29154799
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1314386	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of SCARF2 mRNA	PMID:18502557
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SCARF2 mRNA	PMID:38832940
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306013	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SCARF2 mRNA	PMID:33387578
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of SCARF2 mRNA	PMID:24690739
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SCARF2 gene	PMID:25304211
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SCARF2 mRNA	PMID:39836092
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SCARF2 mRNA	PMID:20458559
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314386	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SCARF2 mRNA; Nanotubes, Carbon results in decreased expression of SCARF2 mRNA	PMID:25554681|PMID:25620056
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306013	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of SCARF2 mRNA	PMID:22504374
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314386	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of SCARF2 mRNA	PMID:40234311
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1306013	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of SCARF2 mRNA	PMID:20080153
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SCARF2 mRNA	PMID:39836092
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1306013	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of SCARF2 mRNA	PMID:19564919
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:749301	potassium perchlorate	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of SCARF2 mRNA	PMID:29673971
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1314386	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of SCARF2 mRNA	PMID:27029645
1314385	SCARF2	scavenger receptor class F member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306013	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of SCARF2 mRNA	PMID:22504374
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314388	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MRPS24 mRNA	PMID:33045310
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306014	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MRPS24 mRNA]	PMID:31150632
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MRPS24 gene	PMID:20938992
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of MRPS24 mRNA	PMID:30951980
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MRPS24 mRNA	PMID:22378314
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1314388	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of MRPS24 mRNA	PMID:40945087
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MRPS24 mRNA	PMID:31059760
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPS24 mRNA	PMID:35811015
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314388	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPS24 mRNA	PMID:39241906
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPS24 mRNA; [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MRPS24 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MRPS24 mRNA	PMID:31059760|PMID:35811015
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone promotes the reaction [Biomarkers metabolite binds to MRPS24 gene]	PMID:31084621
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of MRPS24 mRNA	PMID:38568856
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MRPS24 gene	PMID:20938992
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of MRPS24 mRNA	PMID:33647349
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314388	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MRPS24 mRNA	PMID:33754040
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306014	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MRPS24 mRNA	PMID:31150632
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306014	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MRPS24 mRNA]	PMID:31150632
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS24 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MRPS24 gene	PMID:20938992|PMID:22206623
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPS24 mRNA	PMID:40504410
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306014	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MRPS24 mRNA	PMID:31881176
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306014	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPS24 mRNA	PMID:32109520
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314388	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPS24 mRNA	PMID:18343893
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314388	E	RGD:6480464	20140408	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPS24 mRNA	PMID:23994337
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306014	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPS24 mRNA	PMID:33387578
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314388	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPS24 mRNA	PMID:28922406
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPS24 mRNA	PMID:17942748
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MRPS24 mRNA	PMID:34089799
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MRPS24 mRNA	PMID:33212167
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of MRPS24 mRNA	PMID:29803840
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS24 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS24 mRNA	PMID:23783067
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of MRPS24 protein	PMID:35688186
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPS24 mRNA	PMID:40504410
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314388	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MRPS24 gene	PMID:35295148
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306014	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPS24 mRNA	PMID:34947998
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314388	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPS24 mRNA	PMID:35598803
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306014	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPS24 mRNA	PMID:25181051
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314388	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MRPS24 mRNA	PMID:32156529|PMID:33221593|PMID:38074096
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of MRPS24 gene	PMID:31601247
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1314388	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of MRPS24 mRNA	PMID:23994337
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314388	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPS24 mRNA	PMID:39298647
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of MRPS24 gene	PMID:31601247
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of MRPS24 mRNA	PMID:30951980
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314388	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MRPS24 mRNA	PMID:37019170
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314388	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MRPS24 mRNA	PMID:21266533
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRPS24 mRNA	PMID:25979313
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314388	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MRPS24 mRNA	PMID:17963808
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of MRPS24 mRNA	PMID:23179753
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in increased expression of MRPS24 mRNA	PMID:37505509
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of MRPS24 mRNA	PMID:17183730
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPS24 mRNA	PMID:31059760
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306014	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MRPS24 mRNA	PMID:33387578
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPS24 mRNA	PMID:31059760
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MRPS24 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MRPS24 mRNA	PMID:35811015
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPS24 mRNA	PMID:40504410
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of MRPS24 mRNA	PMID:31838189
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of MRPS24 mRNA	PMID:18175754
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPS24 mRNA	PMID:17942748
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306014	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MRPS24 mRNA	PMID:24136188
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of MRPS24 mRNA	PMID:17183730
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:1306014	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of MRPS24 mRNA	PMID:24136188
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1314388	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of MRPS24 mRNA	PMID:23650126
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS24 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPS24 mRNA	PMID:23783067
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314388	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS24 mRNA	PMID:22206623
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1314388	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of MRPS24 mRNA	PMID:23994337
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MRPS24 gene]	PMID:28238834
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1314388	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of MRPS24 mRNA	PMID:18343893
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1306014	E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MRPS24 mRNA	PMID:31826744
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306014	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of MRPS24 mRNA	PMID:19281266
1314387	MRPS24	mitochondrial ribosomal protein S24	gene	CHEBI:9352	sulindac	decreases expression	ISO	RGD:1306014	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of MRPS24 mRNA	PMID:24136188
1314390	MYO1G	myosin IG	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of MYO1G mRNA	PMID:35967413
1314390	MYO1G	myosin IG	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314391	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MYO1G mRNA	PMID:33045310
1314390	MYO1G	myosin IG	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of MYO1G mRNA	PMID:33167477
1314390	MYO1G	myosin IG	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1306016	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of MYO1G mRNA	PMID:33729688
1314390	MYO1G	myosin IG	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314391	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MYO1G mRNA	PMID:39241906
1314390	MYO1G	myosin IG	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MYO1G mRNA	PMID:37042841
1314390	MYO1G	myosin IG	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYO1G mRNA	PMID:37992649
1314390	MYO1G	myosin IG	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYO1G mRNA	PMID:37992649
1314390	MYO1G	myosin IG	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306016	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MYO1G mRNA	PMID:27523638
1314390	MYO1G	myosin IG	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306016	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MYO1G mRNA	PMID:22061828
1314390	MYO1G	myosin IG	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MYO1G mRNA	PMID:28818685
1314390	MYO1G	myosin IG	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of MYO1G exon	PMID:30157460
1314390	MYO1G	myosin IG	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1314391	E	RGD:6480464	20130514	CTD	MESH:D002104	Cadmium results in decreased expression of MYO1G mRNA	PMID:23358151
1314390	MYO1G	myosin IG	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306016	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MYO1G mRNA	PMID:39012411
1314390	MYO1G	myosin IG	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MYO1G exon; Aflatoxin B1 results in increased methylation of MYO1G gene	PMID:28458013|PMID:30157460
1314390	MYO1G	myosin IG	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306016	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MYO1G mRNA	PMID:30779732
1314390	MYO1G	myosin IG	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MYO1G mRNA	PMID:40504410
1314390	MYO1G	myosin IG	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306016	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MYO1G mRNA	PMID:31881176
1314390	MYO1G	myosin IG	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MYO1G mRNA	PMID:25583101
1314390	MYO1G	myosin IG	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306016	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MYO1G mRNA	PMID:34747641
1314390	MYO1G	myosin IG	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314391	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MYO1G mRNA	PMID:26377647
1314390	MYO1G	myosin IG	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1306016	E	RGD:6480464	20200211	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MYO1G mRNA	PMID:31378766
1314390	MYO1G	myosin IG	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MYO1G mRNA	PMID:33212167
1314390	MYO1G	myosin IG	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	ISO	RGD:1306016	E	RGD:6480464	20120918	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of MYO1G mRNA	PMID:22193206
1314390	MYO1G	myosin IG	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYO1G mRNA	PMID:37992649
1314390	MYO1G	myosin IG	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of MYO1G mRNA	PMID:39719251
1314390	MYO1G	myosin IG	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314391	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of MYO1G mRNA	PMID:36209798
1314390	MYO1G	myosin IG	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYO1G mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MYO1G mRNA	PMID:34876320|PMID:40504410
1314390	MYO1G	myosin IG	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYO1G mRNA	PMID:34876320
1314390	MYO1G	myosin IG	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MYO1G exon; Benzo(a)pyrene affects the methylation of MYO1G promoter	PMID:27901495|PMID:30157460
1314390	MYO1G	myosin IG	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314391	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MYO1G mRNA	PMID:21569818
1314390	MYO1G	myosin IG	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MYO1G 3' UTR	PMID:27901495
1314390	MYO1G	myosin IG	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MYO1G mRNA	PMID:20064835|PMID:30453624
1314390	MYO1G	myosin IG	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314391	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MYO1G mRNA	PMID:22228805
1314390	MYO1G	myosin IG	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MYO1G mRNA	PMID:27858113
1314390	MYO1G	myosin IG	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314391	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MYO1G mRNA	PMID:29341224
1314390	MYO1G	myosin IG	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306016	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of MYO1G mRNA	PMID:24136188
1314390	MYO1G	myosin IG	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314391	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of MYO1G mRNA	PMID:27760801|PMID:29264374
1314390	MYO1G	myosin IG	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314391	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MYO1G promoter	PMID:35295148
1314390	MYO1G	myosin IG	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314391	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MYO1G mRNA	PMID:23557971
1314390	MYO1G	myosin IG	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1306016	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of MYO1G mRNA	PMID:19162173
1314390	MYO1G	myosin IG	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MYO1G protein	PMID:33376534
1314390	MYO1G	myosin IG	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306016	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MYO1G mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314390	MYO1G	myosin IG	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306016	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of MYO1G mRNA	PMID:41034487
1314390	MYO1G	myosin IG	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314391	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MYO1G mRNA	PMID:32156529|PMID:38701888
1314390	MYO1G	myosin IG	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306016	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MYO1G gene	PMID:28505145
1314390	MYO1G	myosin IG	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314391	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of MYO1G mRNA	PMID:26377693
1314390	MYO1G	myosin IG	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MYO1G mRNA	PMID:27858113
1314390	MYO1G	myosin IG	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of MYO1G exon	PMID:30157460
1314390	MYO1G	myosin IG	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1306016	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of MYO1G mRNA	PMID:35163327
1314390	MYO1G	myosin IG	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1306016	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of MYO1G mRNA	PMID:22110744
1314390	MYO1G	myosin IG	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306016	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MYO1G mRNA	PMID:39012411
1314390	MYO1G	myosin IG	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1306016	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MYO1G mRNA	PMID:19162173
1314390	MYO1G	myosin IG	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1306016	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of MYO1G mRNA	PMID:19162173
1314390	MYO1G	myosin IG	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MYO1G mRNA	PMID:24449571
1314390	MYO1G	myosin IG	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314391	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MYO1G mRNA	PMID:40194260
1314390	MYO1G	myosin IG	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314391	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of MYO1G mRNA	PMID:29038090
1314390	MYO1G	myosin IG	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1314391	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of MYO1G mRNA	PMID:23125180
1314390	MYO1G	myosin IG	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1306016	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of MYO1G mRNA	PMID:22110744
1314390	MYO1G	myosin IG	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MYO1G gene	PMID:29154799
1314390	MYO1G	myosin IG	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314391	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of MYO1G mRNA	PMID:28973697
1314390	MYO1G	myosin IG	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MYO1G mRNA	PMID:37992649
1314390	MYO1G	myosin IG	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1306016	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of MYO1G mRNA	PMID:24136188
1314390	MYO1G	myosin IG	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MYO1G mRNA	PMID:38832940
1314390	MYO1G	myosin IG	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314391	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MYO1G mRNA	PMID:17562736
1314390	MYO1G	myosin IG	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MYO1G mRNA	PMID:40504410
1314390	MYO1G	myosin IG	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of MYO1G mRNA	PMID:31838189
1314390	MYO1G	myosin IG	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYO1G mRNA	PMID:34876320
1314390	MYO1G	myosin IG	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1314391	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of MYO1G mRNA	PMID:25554681
1314390	MYO1G	myosin IG	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314391	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of MYO1G mRNA	PMID:25554681
1314390	MYO1G	myosin IG	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314391	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of MYO1G mRNA	PMID:40234311
1314390	MYO1G	myosin IG	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306016	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MYO1G mRNA	PMID:24136188
1314390	MYO1G	myosin IG	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1314391	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of MYO1G mRNA	PMID:26377693
1314390	MYO1G	myosin IG	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MYO1G mRNA	PMID:27858113
1314390	MYO1G	myosin IG	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MYO1G mRNA	PMID:27858113
1314390	MYO1G	myosin IG	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314391	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of MYO1G mRNA	PMID:38701926
1314390	MYO1G	myosin IG	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1314391	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of MYO1G mRNA	PMID:19812364
1314390	MYO1G	myosin IG	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314391	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of MYO1G mRNA	PMID:36851058
1314390	MYO1G	myosin IG	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of MYO1G exon	PMID:30157460
1314390	MYO1G	myosin IG	gene	CHEBI:68641	(-)-cotinine	affects methylation	EXP		E	RGD:6480464	20130312	CTD	MESH:D003367	Cotinine affects the methylation of MYO1G gene	PMID:22851337
1314390	MYO1G	myosin IG	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314391	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MYO1G mRNA	PMID:22206623
1314390	MYO1G	myosin IG	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306016	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MYO1G mRNA	PMID:24136188
1314390	MYO1G	myosin IG	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1306016	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of MYO1G mRNA	PMID:19162173
1314390	MYO1G	myosin IG	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1314391	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of MYO1G mRNA	PMID:34876320
1314390	MYO1G	myosin IG	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of MYO1G mRNA	PMID:29301935
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552350	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ANKMY2 mRNA	PMID:20188158
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ANKMY2 mRNA	PMID:33167477
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of ANKMY2 protein	PMID:39571964
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ANKMY2 mRNA	PMID:21632981
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552350	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ANKMY2 mRNA	PMID:39241906
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of ANKMY2 mRNA	PMID:22574217
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ANKMY2 mRNA	PMID:31614463
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ANKMY2 mRNA	PMID:37042841
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ANKMY2 mRNA	PMID:16002434
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ANKMY2 mRNA	PMID:39836092
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306017	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ANKMY2 protein	PMID:34915118
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ANKMY2 mRNA	PMID:19549813
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ANKMY2 gene	PMID:27153756
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ANKMY2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ANKMY2 mRNA	PMID:39836092
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ANKMY2 mRNA	PMID:23557933
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of ANKMY2 mRNA	PMID:23300844
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ANKMY2 mRNA	PMID:27594783
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552350	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ANKMY2 mRNA	PMID:21570461|PMID:24680724
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ANKMY2 mRNA	PMID:33212167
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ANKMY2 mRNA	PMID:34032870
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ANKMY2 mRNA	PMID:38568856
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ANKMY2 mRNA; [sodium arsenite co-treated with Tretinoin] results in increased expression of ANKMY2 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ANKMY2 mRNA	PMID:39571964|PMID:39836092
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ANKMY2 protein	PMID:32717239
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ANKMY2 mRNA	PMID:19150397
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306017	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ANKMY2 mRNA	PMID:25729387
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306017	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ANKMY2 mRNA	PMID:30047161
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552350	E	RGD:6480464	20150310	CTD	MESH:C009495	titanium dioxide analog results in increased expression of ANKMY2 mRNA	PMID:25111187
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1552350	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ANKMY2 mRNA	PMID:18648102
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552350	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ANKMY2 mRNA	PMID:33221593
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306017	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ANKMY2 mRNA	PMID:25181051
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANKMY2 mRNA	PMID:28628672
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552350	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ANKMY2 mRNA	PMID:37019170
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANKMY2 mRNA	PMID:28628672
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ANKMY2 mRNA	PMID:37042841
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ANKMY2 mRNA	PMID:39836092
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1306017	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ANKMY2 promoter	PMID:22457795
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ANKMY2 mRNA	PMID:24449571
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ANKMY2 mRNA	PMID:28302478
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ANKMY2 mRNA	PMID:25979313
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ANKMY2 gene	PMID:29154799
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in increased expression of ANKMY2 mRNA	PMID:19101580|PMID:22083351|PMID:28001369|PMID:29154799
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306017	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ANKMY2 mRNA	PMID:30047161
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ANKMY2 mRNA	PMID:20106945
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANKMY2 mRNA	PMID:28628672
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ANKMY2 mRNA	PMID:22083351
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of ANKMY2 mRNA	PMID:26272509
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKMY2 mRNA	PMID:27188386
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552350	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ANKMY2 mRNA	PMID:17562736
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of ANKMY2 mRNA	PMID:21420995
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ANKMY2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ANKMY2 mRNA	PMID:39836092
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ANKMY2 mRNA	PMID:22079256
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552350	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ANKMY2 mRNA	PMID:35436446
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ANKMY2 mRNA	PMID:28628672
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ANKMY2 mRNA	PMID:23300844
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552350	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ANKMY2 mRNA	PMID:35964746
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306017	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ANKMY2 mRNA	PMID:24793618
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ANKMY2 protein	PMID:32959892
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ANKMY2 mRNA	PMID:39836092
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306017	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ANKMY2 mRNA	PMID:25729387
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ANKMY2 mRNA	PMID:15336504
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ANKMY2 mRNA	PMID:22079256
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ANKMY2 mRNA	PMID:22079256
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of ANKMY2 mRNA	PMID:36318118
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKMY2 mRNA	PMID:27188386
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ANKMY2 gene]	PMID:28238834
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1306017	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of ANKMY2 mRNA	PMID:30047161
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1306017	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ANKMY2 mRNA	PMID:27291303
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306017	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ANKMY2 mRNA	PMID:30047161
1314392	ANKMY2	ankyrin repeat and MYND domain containing 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKMY2 mRNA	PMID:27188386
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:C084079	triptonide results in increased expression of AKP3 mRNA	PMID:33045310
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of ALPP protein	PMID:36641056
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of ALPP mRNA; Tretinoin results in decreased expression of ALPP protein	PMID:23830798|PMID:30093655
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ALPP mRNA	PMID:22378314
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:16130	DDT	decreases methylation	ISO	RGD:2325055	E	RGD:6480464	20260811	CTD	MESH:D003634	DDT results in decreased methylation of AKP3 gene	PMID:31682807
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ALPP mRNA	PMID:21179406
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ALPP mRNA	PMID:12057914
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of ALPP mRNA; Estradiol results in increased expression of ALPP protein	PMID:16053526|PMID:23019147
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ALPP mRNA; [Progesterone co-treated with Estradiol] results in increased expression of ALPP mRNA	PMID:17404688|PMID:30165855
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ALPP mRNA	PMID:38568856
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D002635	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ALPP mRNA	PMID:33819548
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in increased expression of ALPP mRNA	PMID:28937961
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of ALPP mRNA	PMID:17404688
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in increased expression of ALPP mRNA	PMID:17404688
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ALPP mRNA	PMID:36695872
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:17263	estrone	increases chemical synthesis	EXP		E	RGD:6480464	20120412	CTD	MESH:D004970	ALPP protein results in increased chemical synthesis of Estrone	PMID:1495895
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:17347	testosterone	increases chemical synthesis	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	ALPP protein results in increased chemical synthesis of Testosterone	PMID:1495895
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:17440	4-nitrophenyl phosphate	increases chemical synthesis	EXP		E	RGD:6480464	20120412	CTD	MESH:C008644	ALPP protein results in increased chemical synthesis of nitrophenylphosphate	PMID:1495895
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:17489	3',5'-cyclic AMP	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000242	[Colforsin results in increased abundance of Cyclic AMP] which results in increased expression of ALPP mRNA	PMID:16036225
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D006000	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ALPP mRNA	PMID:33819548
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:17703	26-hydroxycholesterol	decreases activity	EXP		E	RGD:6480464	20250401	CTD	MESH:C076996	27-hydroxycholesterol results in decreased activity of ALPP protein	PMID:38180513
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:180876	Norfluoxetine	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C036139	norfluoxetine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]	PMID:16036225
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:22984	calcium atom	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium binds to ALPP protein	PMID:16815919
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ALPP mRNA	PMID:32234424
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:2679	amphetamine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine promotes the reaction [Isoproterenol results in increased expression of ALPP mRNA]	PMID:16036225
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D006002	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ALPP mRNA	PMID:33819548
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:27563	arsenic atom	affects expression	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:D001151	Arsenic affects the expression of AKP3 mRNA	PMID:36720308
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:27632	acetophenone	increases chemical synthesis	EXP		E	RGD:6480464	20120412	CTD	MESH:C038699	ALPP protein results in increased chemical synthesis of acetophenone	PMID:1495895
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ALPP mRNA	PMID:38460933
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ALPP mRNA	PMID:23557933
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein results in increased expression of ALPP mRNA	PMID:23019147|PMID:26865667
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AKP3 mRNA	PMID:21570461
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:2325055	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ALPP mRNA	PMID:32109520
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013749	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of ALPP mRNA	PMID:26159488
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:2325055	E	RGD:6480464	20260811	CTD	MESH:D003300	Copper deficiency results in increased expression of AKP3 mRNA	PMID:26033743
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ALPP protein	PMID:35688186
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D003840	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ALPP mRNA	PMID:33819548
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:29320	calcium(0)	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium binds to ALPP protein	PMID:16815919
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ALPP mRNA	PMID:39719251
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:C017947	sodium arsenite results in increased expression of AKP3 mRNA	PMID:37668303
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKP3 mRNA	PMID:34876320
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKP3 mRNA	PMID:34876320
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ALPP mRNA	PMID:35870112
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ALPP exon; Benzo(a)pyrene results in decreased methylation of ALPP promoter	PMID:27901495
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:2325055	E	RGD:6480464	20260811	CTD	MESH:D003300	Copper deficiency results in increased expression of AKP3 mRNA	PMID:26033743
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of ALPP mRNA	PMID:28959546
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ALPP mRNA	PMID:20018196
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ALPP protein	PMID:30093655
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:2325055	E	RGD:6480464	20260811	CTD	MESH:D000643	Ammonium Chloride affects the expression of AKP3 mRNA	PMID:16483693
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D000069446	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ALPP mRNA	PMID:33819548
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:31429	colforsin daropate hydrochloride	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D005576	Colforsin results in increased expression of ALPP mRNA	PMID:16036225
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:31429	colforsin daropate hydrochloride	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D005576	[Colforsin results in increased abundance of Cyclic AMP] which results in increased expression of ALPP mRNA; Chlorpromazine inhibits the reaction [Colforsin results in increased expression of ALPP mRNA]; Clozapine inhibits the reaction [Colforsin results in increased expression of ALPP mRNA]; Desipramine inhibits the reaction [Colforsin results in increased expression of ALPP mRNA]	PMID:16036225
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:C009495	titanium dioxide results in decreased expression of AKP3 mRNA	PMID:29264374
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of AKP3 mRNA	PMID:18648102
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:C006253	pirinixic acid results in decreased expression of AKP3 mRNA	PMID:17426115
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2325055	E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in decreased expression of AKP3 mRNA	PMID:25181051
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A results in increased expression of ALPP mRNA	PMID:23019147
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:33418	graphite	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D006108	Graphite results in increased expression of ALPP protein	PMID:22157353
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:34873	N-nitrosodiethylamine	increases activity	ISO	RGD:2325055	E	RGD:6480464	20170829	CTD	MESH:D004052	Diethylnitrosamine results in increased activity of ALPP protein	PMID:15563447
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:2325055	E	RGD:6480464	20170829	CTD	MESH:D004052	Plant Extracts inhibits the reaction [Diethylnitrosamine results in increased activity of ALPP protein]	PMID:15563447
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ALPP mRNA	PMID:23978341
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:2325055	E	RGD:6480464	20260811	CTD	MESH:C039281	furan results in increased methylation of AKP3 gene	PMID:22079235
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D005999	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ALPP mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ALPP mRNA	PMID:33819548
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:36383	strontium dichloride	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:C025700	strontium chloride binds to ALPP protein	PMID:16815919
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:3647	chlorpromazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002746	Chlorpromazine inhibits the reaction [Colforsin results in increased expression of ALPP mRNA]; Chlorpromazine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]	PMID:16036225
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:37659	oleanolic acid	increases expression	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:D009828	Oleanolic Acid results in increased expression of AKP3 protein	PMID:39030772
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:37659	oleanolic acid	multiple interactions	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:D009828	GW 4064 inhibits the reaction [Oleanolic Acid results in increased expression of AKP3 protein]; sulfanitran inhibits the reaction [Oleanolic Acid results in increased expression of AKP3 protein]; verlukast promotes the reaction [Oleanolic Acid results in increased expression of AKP3 protein]	PMID:39030772
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:3766	clozapine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003024	Clozapine inhibits the reaction [Colforsin results in increased expression of ALPP mRNA]; Clozapine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]	PMID:16036225
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ALPP mRNA	PMID:32588087
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of ALPP mRNA	PMID:26352163|PMID:28476498
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ALPP mRNA	PMID:32588087
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:D014635	Valproic Acid affects the expression of AKP3 mRNA	PMID:17963808
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ALPP gene	PMID:29154799
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D016572	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ALPP mRNA	PMID:33819548
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:42534	epitestosterone	increases chemical synthesis	EXP		E	RGD:6480464	20140304	CTD	MESH:D004845	ALPP protein results in increased chemical synthesis of Epitestosterone	PMID:1495895
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	ALPP protein affects the susceptibility to Methotrexate	PMID:16217747
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ALPP mRNA	PMID:38832940
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:4488	diallyl disulfide	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C028009	diallyl disulfide inhibits the reaction [tobacco tar analog results in decreased expression of ALPP mRNA]	PMID:36758788
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D000082	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ALPP mRNA	PMID:33819548
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ALPP mRNA	PMID:29523930
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ALPP mRNA	PMID:38460933
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:47217	arsane	affects expression	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:D001151	Arsenic affects the expression of AKP3 mRNA	PMID:36720308
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:47781	desipramine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003891	Desipramine inhibits the reaction [Colforsin results in increased expression of ALPP mRNA]; Desipramine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]	PMID:16036225
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of ALPP mRNA	PMID:31838189
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of ALPP mRNA	PMID:26833863
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:4791	endosulfan	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D004726	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of ALPP mRNA	PMID:26159488
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:48607	lithium chloride	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D018021	Lithium Chloride results in increased activity of ALPP protein	PMID:16053526
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKP3 mRNA	PMID:34876320
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ALPP mRNA	PMID:18936297
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:4911	etoposide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	ALPP protein affects the susceptibility to Etoposide	PMID:16217747
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ALPP protein	PMID:30093655
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of ALPP mRNA	PMID:38825487
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the methylation of ALPP gene	PMID:17630775
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of ALPP mRNA]	PMID:21095227
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of AKP3 protein	PMID:21135415
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:50594	carbon nanotube	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ALPP mRNA; Nanotubes, Carbon results in increased expression of ALPP protein	PMID:15585362|PMID:22157353
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:64317	isoprenaline	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of ALPP mRNA	PMID:16036225
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:64317	isoprenaline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D007545	Amphetamine promotes the reaction [Isoproterenol results in increased expression of ALPP mRNA]; Chlorpromazine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]; Clozapine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]; Desipramine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]; ICI 118551 inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]; norfluoxetine inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]	PMID:16036225
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:64983	alternariol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005197	alternariol results in increased expression of ALPP mRNA	PMID:32328700
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:6619	MK 571	multiple interactions	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:C059141	verlukast promotes the reaction [Oleanolic Acid results in increased expression of AKP3 protein]	PMID:39030772
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:73289	ICI 118551	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C026777	ICI 118551 inhibits the reaction [Isoproterenol results in increased expression of ALPP mRNA]	PMID:16036225
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:7494	nefazodone	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:C051752	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ALPP mRNA	PMID:33819548
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ALPP mRNA	PMID:22714537
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:76591	(25R)-cholest-5-ene-3beta,26-diol	decreases activity	EXP		E	RGD:6480464	20250401	CTD	MESH:C076996	27-hydroxycholesterol results in decreased activity of ALPP protein	PMID:38180513
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:78420	icariin	increases secretion	EXP		E	RGD:6480464	20260303	CTD	MESH:C056599	icariin results in increased secretion of ALPP protein	PMID:30066868
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:C412815	GW 4064 inhibits the reaction [Oleanolic Acid results in increased expression of AKP3 protein]	PMID:39030772
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ALPP mRNA	PMID:19159669
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:82538	Sunset Yellow FCF	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:C005842	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ALPP mRNA	PMID:33819548
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:10148	E	RGD:6480464	20260811	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of AKP3 mRNA	PMID:34876320
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of ALPP mRNA	PMID:28959546
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ALPP mRNA	PMID:38568856
1314395	ALPP	alkaline phosphatase, placental	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in increased expression of ALPP mRNA	PMID:29453283
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D014212	Tretinoin affects the expression of ZFPM2 mRNA	PMID:34742744
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of ZFPM2 mRNA	PMID:21934132
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:16130	DDT	increases methylation	EXP		E	RGD:6480464	20190910	CTD	MESH:D003634	DDT results in increased methylation of ZFPM2 gene	PMID:30822522
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550372	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of ZFPM2 mRNA	PMID:25210133
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of ZFPM2 mRNA	PMID:20655997
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ZFPM2 mRNA	PMID:33359661
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550372	E	RGD:6480464	20161025	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ZFPM2 mRNA	PMID:27060630
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1550372	E	RGD:6480464	20120412	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of ZFPM2 gene	PMID:16724327
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ZFPM2 gene	PMID:27153756
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZFPM2 intron	PMID:30157460
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1550372	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of ZFPM2 mRNA	PMID:17484886
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550372	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZFPM2 mRNA	PMID:25629700
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ZFPM2 mRNA	PMID:26272509
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZFPM2 mRNA	PMID:27188386
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306021	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ZFPM2 mRNA	PMID:31881176
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1306021	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of ZFPM2 mRNA	PMID:17898221
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of ZFPM2 mRNA	PMID:15256057
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ZFPM2 mRNA	PMID:25583101
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550372	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFPM2 mRNA	PMID:18691609|PMID:19933214
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550372	E	RGD:6480464	20210209	CTD	MESH:D013749	[Tetrachlorodibenzodioxin affects the methylation of ZFPM2 promoter] which results in increased expression of ZFPM2 mRNA	PMID:33017471
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ZFPM2 mRNA	PMID:28001369
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ZFPM2 mRNA	PMID:33212167
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of ZFPM2 mRNA	PMID:26272509
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFPM2 mRNA	PMID:27188386
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306021	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ZFPM2 mRNA	PMID:28959563
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of ZFPM2 mRNA	PMID:21198554
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZFPM2 mRNA	PMID:29803840
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ZFPM2 gene	PMID:28589171
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZFPM2 mRNA	PMID:38568856
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZFPM2 5' UTR	PMID:27901495
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZFPM2 promoter	PMID:27901495
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1550372	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ZFPM2 mRNA	PMID:27131904
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ZFPM2 mRNA	PMID:25351596
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of ZFPM2 mRNA	PMID:20382639
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ZFPM2 mRNA	PMID:22521957
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ZFPM2 gene	PMID:31601247
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550372	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFPM2 gene; titanium dioxide results in decreased methylation of ZFPM2 promoter	PMID:35295148
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550372	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZFPM2 gene	PMID:35295148
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1550372	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ZFPM2 mRNA	PMID:18648102
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFPM2 mRNA	PMID:29275510
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306021	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFPM2 mRNA	PMID:25181051
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306021	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFPM2 mRNA	PMID:34947998
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306021	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZFPM2 gene	PMID:28505145
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases methylation	EXP		E	RGD:6480464	20190910	CTD	MESH:C016340	o,p'-DDT results in increased methylation of ZFPM2 gene	PMID:30822522
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550372	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ZFPM2 mRNA	PMID:30951980
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of ZFPM2 gene	PMID:31601247
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550372	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ZFPM2 mRNA	PMID:30951980
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of ZFPM2 mRNA	PMID:17312168
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306021	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ZFPM2 mRNA	PMID:35163327
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306021	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ZFPM2 mRNA	PMID:35163327
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ZFPM2 mRNA	PMID:24449571
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1550372	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZFPM2 mRNA	PMID:24896083
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ZFPM2 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZFPM2 mRNA	PMID:27188386
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ZFPM2 mRNA	PMID:20106945
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ZFPM2 mRNA	PMID:24935251
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ZFPM2 mRNA	PMID:24935251
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550372	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZFPM2 mRNA	PMID:17562736
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZFPM2 mRNA	PMID:22230336
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:1306021	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of ZFPM2 gene	PMID:37958445
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ZFPM2 mRNA	PMID:22521957
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306021	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ZFPM2 mRNA	PMID:30307764
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:52136	glufosinate	decreases expression	ISO	RGD:1550372	E	RGD:6480464	20230905	CTD	MESH:C003121	phosphinothricin results in decreased expression of ZFPM2 mRNA	PMID:34597628
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:6651	malathion	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in increased expression of ZFPM2 mRNA	PMID:37047231
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550372	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFPM2 mRNA	PMID:22206623
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ZFPM2 mRNA	PMID:37199045
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFPM2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZFPM2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZFPM2 mRNA	PMID:27188386
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZFPM2 gene]	PMID:28238834
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:8093	phenylephrine	decreases response to substance	ISO	RGD:1550372	E	RGD:6480464	20120412	CTD	MESH:D010656	ZFPM2 protein results in decreased susceptibility to Phenylephrine	PMID:15220332
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:8093	phenylephrine	multiple interactions	ISO	RGD:1306021	E	RGD:6480464	20120412	CTD	MESH:D010656	ZFPM2 protein inhibits the reaction [Phenylephrine promotes the reaction [GATA4 protein binds to EP300 protein]]; ZFPM2 protein inhibits the reaction [Phenylephrine results in increased activity of GATA4 protein]; ZFPM2 protein inhibits the reaction [Phenylephrine results in increased expression of EDN1 mRNA]; ZFPM2 protein inhibits the reaction [Phenylephrine results in increased expression of MYH7 mRNA]; ZFPM2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]	PMID:15220332
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1550372	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of ZFPM2 mRNA	PMID:31388691
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306021	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ZFPM2 mRNA	PMID:24780913
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFPM2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZFPM2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZFPM2 mRNA	PMID:27188386
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1550372	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ZFPM2 mRNA	PMID:27131904
1314398	ZFPM2	zinc finger protein, FOG family member 2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306021	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ZFPM2 mRNA	PMID:19281266
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314402	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of DNAJC8 mRNA	PMID:33045310
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314402	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of DNAJC8 mRNA	PMID:20188158
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314402	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DNAJC8 mRNA	PMID:30319688
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1306024	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of DNAJC8 mRNA	PMID:23829299
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DNAJC8 mRNA	PMID:37042841
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1314402	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of DNAJC8 mRNA	PMID:17251523
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1314402	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of DNAJC8 mRNA	PMID:23892564
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314402	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DNAJC8 mRNA	PMID:33754040
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314402	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DNAJC8 mRNA	PMID:36331819
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306024	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of DNAJC8 protein	PMID:34915118
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314402	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJC8 mRNA	PMID:37236586
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1314402	E	RGD:6480464	20250401	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNAJC8 protein	PMID:39910959
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of DNAJC8 mRNA	PMID:35430440
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314402	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DNAJC8 mRNA	PMID:22206623
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of DNAJC8 mRNA	PMID:23557933
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of DNAJC8 mRNA	PMID:27392435
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314402	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DNAJC8 mRNA	PMID:21570461
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1314402	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of DNAJC8 gene	PMID:39894169
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314402	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DNAJC8 mRNA	PMID:22228805
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314402	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DNAJC8 mRNA	PMID:27858113
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306024	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of DNAJC8 mRNA	PMID:30047161
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314402	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DNAJC8 promoter alternative form	PMID:35295148
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DNAJC8 mRNA	PMID:19710929
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306024	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DNAJC8 mRNA	PMID:25181051
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306024	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJC8 mRNA	PMID:41034487
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314402	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJC8 mRNA	PMID:33221593
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306024	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of DNAJC8 mRNA	PMID:41034487
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of DNAJC8 mRNA	PMID:24752500
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314402	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DNAJC8 mRNA	PMID:39298647
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314402	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DNAJC8 mRNA	PMID:27858113
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:34679	Di-n-octyl phthalate	increases expression	ISO	RGD:1314402	E	RGD:6480464	20240305	CTD	MESH:C010715	di-n-octyl phthalate results in increased expression of DNAJC8 mRNA	PMID:37810885
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314402	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DNAJC8 mRNA	PMID:21266533
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314402	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DNAJC8 mRNA	PMID:37236586
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of DNAJC8 mRNA	PMID:24449571
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of DNAJC8 mRNA	PMID:26352163
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314402	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DNAJC8 mRNA	PMID:36331819
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314402	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DNAJC8 mRNA	PMID:17963808
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of DNAJC8 mRNA	PMID:23179753
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of DNAJC8 mRNA	PMID:17183730
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306024	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of DNAJC8 mRNA	PMID:30047161
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1306024	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of DNAJC8 mRNA	PMID:21865292
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of DNAJC8 mRNA	PMID:36621641
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314402	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DNAJC8 mRNA	PMID:17562736
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314402	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of DNAJC8 mRNA	PMID:29279043
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of DNAJC8 mRNA	PMID:24752500
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1306024	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of DNAJC8 mRNA	PMID:29097150
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306024	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of DNAJC8 mRNA	PMID:30047161
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306024	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of DNAJC8 mRNA	PMID:24136188
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314402	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DNAJC8 mRNA	PMID:27858113
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314402	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DNAJC8 mRNA	PMID:27858113
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of DNAJC8 mRNA	PMID:17183730
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DNAJC8 protein	PMID:32959892
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314402	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DNAJC8 mRNA	PMID:23650126
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DNAJC8 protein	PMID:34186270
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314402	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DNAJC8 mRNA	PMID:22206623
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314402	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DNAJC8 mRNA	PMID:22206623
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of DNAJC8 protein	PMID:31285264
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1306024	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of DNAJC8 mRNA	PMID:30047161
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306024	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of DNAJC8 mRNA	PMID:30047161
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306024	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of DNAJC8 mRNA	PMID:19281266
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306024	E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in increased expression of DNAJC8 mRNA	PMID:22615374
1314401	DNAJC8	DnaJ heat shock protein family (Hsp40) member C8	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1306024	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of DNAJC8 gene	PMID:31079544
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306025	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NAGA mRNA]	PMID:31150632
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of NAGA mRNA	PMID:33167477
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of NAGA mRNA	PMID:24763279
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of NAGA mRNA	PMID:26079696
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314404	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of NAGA mRNA	PMID:39241906
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of NAGA mRNA	PMID:38568856
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of NAGA mRNA	PMID:23649840
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306025	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of NAGA mRNA	PMID:26577399
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314404	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NAGA mRNA	PMID:37236586
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NAGA mRNA	PMID:19549813
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1306025	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of NAGA protein	PMID:33236894
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NAGA intron	PMID:30157460
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of NAGA mRNA	PMID:23649840
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306025	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NAGA mRNA	PMID:31150632
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306025	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NAGA mRNA]	PMID:31150632
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NAGA mRNA	PMID:39836092
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of NAGA mRNA	PMID:27594783
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of NAGA mRNA	PMID:27392435
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314404	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of NAGA mRNA	PMID:30912803
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of NAGA mRNA	PMID:23195993
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of NAGA mRNA	PMID:25583101
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314404	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NAGA mRNA	PMID:21570461
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314404	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NAGA mRNA	PMID:33956508
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306025	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of NAGA protein	PMID:35544339
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NAGA mRNA	PMID:33212167
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of NAGA mRNA	PMID:32763439
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314404	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of NAGA protein	PMID:28918527
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of NAGA gene	PMID:28589171
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NAGA mRNA	PMID:39836092
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NAGA exon	PMID:27901495
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1306025	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of NAGA mRNA	PMID:24136188
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1314404	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of NAGA mRNA	PMID:21829687
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314404	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NAGA promoter alternative form	PMID:35295148
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306025	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of NAGA mRNA	PMID:23411599|PMID:34492290
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1306025	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of NAGA mRNA	PMID:19162173
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NAGA mRNA	PMID:19710929
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314404	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of NAGA mRNA	PMID:28472532
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:3305	Calcimycin	affects activity	ISO	RGD:1306025	E	RGD:6480464	20141111	CTD	MESH:D000001	Calcimycin affects the activity of NAGA protein	PMID:18475545
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1314404	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A affects the expression of NAGA mRNA	PMID:35341816
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of NAGA protein	PMID:31675489
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306025	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of NAGA mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of NAGA protein	PMID:34186270|PMID:37567409
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306025	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NAGA mRNA	PMID:25181051
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306025	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NAGA mRNA	PMID:36041667
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of NAGA protein	PMID:31675489
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306025	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NAGA mRNA	PMID:36041667
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306025	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NAGA mRNA	PMID:36041667
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of NAGA protein	PMID:34186270
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1314404	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of NAGA mRNA	PMID:28392331
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314404	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NAGA mRNA	PMID:37019170
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306025	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NAGA mRNA	PMID:21266533
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314404	E	RGD:6480464	20220607	CTD	MESH:D003993	[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in decreased expression of NAGA protein	PMID:34864091
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314404	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NAGA mRNA	PMID:37236586
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NAGA mRNA	PMID:19320972
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of NAGA mRNA	PMID:24449571
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1314404	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of NAGA mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NAGA mRNA]	PMID:17585979
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NAGA mRNA	PMID:31533062
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in decreased expression of NAGA mRNA	PMID:17685462
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NAGA mRNA	PMID:25979313
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NAGA mRNA	PMID:20106945|PMID:25562108
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of NAGA mRNA	PMID:22230336
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306025	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NAGA mRNA	PMID:33387578
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314404	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of NAGA mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NAGA mRNA]	PMID:17585979
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1314404	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of NAGA mRNA	PMID:29279043
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NAGA mRNA	PMID:39836092
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314404	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NAGA mRNA	PMID:17942748
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1314404	E	RGD:6480464	20220607	CTD	MESH:D037742	[Dibutyl Phthalate co-treated with Nanotubes, Carbon] results in decreased expression of NAGA protein	PMID:34864091
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306025	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of NAGA mRNA	PMID:24136188
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of NAGA protein	PMID:34186270
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1306025	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of NAGA mRNA	PMID:24136188
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of NAGA mRNA	PMID:19287073
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NAGA gene]	PMID:28238834
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NAGA protein	PMID:31675489
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of NAGA protein	PMID:31675489
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306025	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of NAGA mRNA	PMID:19281266
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of NAGA mRNA	PMID:29301935
1314403	NAGA	alpha-N-acetylgalactosaminidase	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306025	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of NAGA mRNA	PMID:23034163
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of EPC1 mRNA	PMID:27188386
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of EPC1 mRNA	PMID:22378314
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of EPC1 mRNA	PMID:20044591
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314408	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of EPC1 mRNA	PMID:39241906
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:2324280	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of EPC1 mRNA	PMID:33387578
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EPC1 mRNA	PMID:37042841
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of EPC1 mRNA	PMID:20655997|PMID:23649840
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of EPC1 protein	PMID:37730182
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:2324280	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of EPC1 mRNA	PMID:22061828|PMID:33387578
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of EPC1 mRNA	PMID:19549813
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of EPC1 mRNA	PMID:23649840
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314408	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EPC1 mRNA	PMID:19770486
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of EPC1 mRNA	PMID:23649840
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314408	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of EPC1 mRNA	PMID:34911549
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of EPC1 mRNA	PMID:19774075
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314408	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of EPC1 mRNA	PMID:17484886
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314408	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of EPC1 mRNA	PMID:25629700
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314408	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EPC1 mRNA	PMID:22206623
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of EPC1 protein	PMID:35688186
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of EPC1 mRNA	PMID:23557933
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314408	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EPC1 mRNA	PMID:16611356
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314408	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPC1 mRNA	PMID:19770486
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:2324280	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPC1 mRNA	PMID:33387578
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of EPC1 mRNA	PMID:32763439
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314408	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of EPC1 mRNA]; MT2 affects the reaction [Copper results in increased expression of EPC1 mRNA]	PMID:16629173
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EPC1 mRNA	PMID:38568856
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20170613	CTD	MESH:C017947	[sodium arsenite co-treated with sodium arsenite deficiency] results in decreased methylation of EPC1 gene; sodium arsenite deficiency inhibits the reaction [sodium arsenite results in decreased expression of EPC1 mRNA]	PMID:28336213
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314408	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EPC1 mRNA	PMID:22228805
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314408	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EPC1 exon; Benzo(a)pyrene results in increased methylation of EPC1 intron	PMID:27901495
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314408	E	RGD:6480464	20130910	CTD	MESH:D003300	MT1 affects the reaction [Copper results in increased expression of EPC1 mRNA]; MT2 affects the reaction [Copper results in increased expression of EPC1 mRNA]	PMID:16629173
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of EPC1 gene	PMID:31601247
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314408	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EPC1 gene; titanium dioxide results in decreased methylation of EPC1 promoter	PMID:35295148
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314408	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of EPC1 mRNA	PMID:23557971
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:2324280	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EPC1 mRNA	PMID:34492290
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314408	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of EPC1 mRNA	PMID:28329830
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314408	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of EPC1 mRNA	PMID:33221593
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314408	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of EPC1 mRNA	PMID:40036665
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2324280	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EPC1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EPC1 mRNA	PMID:28628672
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EPC1 mRNA	PMID:28628672
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of EPC1 mRNA	PMID:24449571
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of EPC1 mRNA	PMID:28302478
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EPC1 mRNA	PMID:25979313
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of EPC1 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386|PMID:29154799
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314408	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of EPC1 mRNA	PMID:21427059
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of EPC1 mRNA	PMID:17183730
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EPC1 mRNA	PMID:28628672
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of EPC1 mRNA	PMID:24935251
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314408	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EPC1 mRNA	PMID:17562736
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of EPC1 mRNA	PMID:26690555
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:2324280	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EPC1 mRNA	PMID:33387578
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of EPC1 mRNA	PMID:18687144
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314408	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of EPC1 mRNA	PMID:17555576
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EPC1 mRNA	PMID:28628672
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314408	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of EPC1 mRNA; Nanotubes, Carbon results in decreased expression of EPC1 mRNA	PMID:25554681|PMID:31978390
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:53049	1-fluoro-2,4-dinitrobenzene	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004139	Dinitrofluorobenzene results in increased expression of EPC1 mRNA	PMID:23999411
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of EPC1 mRNA	PMID:17183730
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of EPC1 mRNA	PMID:28988120
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314408	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of EPC1 mRNA	PMID:22206623
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314408	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EPC1 mRNA	PMID:22206623
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of EPC1 protein	PMID:31285264
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:2324280	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of EPC1 mRNA	PMID:33484710
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EPC1 gene]	PMID:28238834
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:2324280	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of EPC1 mRNA	PMID:24780913
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of EPC1 mRNA	PMID:38568856
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of EPC1 mRNA	PMID:27188386
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314408	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of EPC1 mRNA	PMID:28973697
1314407	EPC1	enhancer of polycomb 1	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of EPC1 mRNA	PMID:19140230
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of KLF7 mRNA	PMID:33167477
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of KLF7 mRNA	PMID:24236059
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314411	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KLF7 mRNA	PMID:39241906
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314411	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of KLF7 mRNA	PMID:26582142
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314411	E	RGD:6480464	20161228	CTD	MESH:D008070	(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of KLF7 mRNA]	PMID:26582142
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of KLF7 mRNA	PMID:30165855
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of KLF7 mRNA	PMID:26496021
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of KLF7 mRNA	PMID:38568856
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KLF7 mRNA	PMID:37042841
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of KLF7 mRNA	PMID:20655997
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of KLF7 mRNA	PMID:27664576
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:17303	morphine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D009020	Morphine results in increased expression of KLF7 mRNA; Morphine results in increased expression of KLF7 protein	PMID:14644156
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:17303	morphine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D009020	Naloxone inhibits the reaction [Morphine results in increased expression of KLF7 mRNA]	PMID:14644156
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314411	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of KLF7 mRNA	PMID:33848595
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:17447	geraniol	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of KLF7 mRNA	PMID:27683099
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of KLF7 mRNA	PMID:31256213
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240305	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KLF7 mRNA; Diethylhexyl Phthalate results in decreased expression of KLF7 protein	PMID:37734194
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20240305	CTD	MESH:D004051	KLF7 protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of TP53 mRNA]; KLF7 protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of TP53 protein]; KLF7 protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CCR2 mRNA]; KLF7 protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CTNNB1 mRNA]; KLF7 protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of CTNNB1 protein]; KLF7 protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of MYD88 mRNA]	PMID:37734194
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:177802	Cuprizon	affects expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:D003471	Cuprizone affects the expression of KLF7 mRNA	PMID:27523638
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of KLF7 mRNA	PMID:36139627
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of KLF7 mRNA	PMID:28818685
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of KLF7 mRNA; Methylnitronitrosoguanidine results in increased expression of KLF7 protein	PMID:38184286
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	ISO	RGD:1314411	E	RGD:6480464	20241105	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of KLF7 mRNA; Methylnitronitrosoguanidine results in increased expression of KLF7 protein	PMID:38184286
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:D008769	KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 mRNA]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 protein]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDH2 mRNA]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDH2 protein]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 protein]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RELA protein]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of SNAI1 protein]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of TWIST1 protein]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of VIM mRNA]]; KLF7 protein inhibits the reaction [MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of VIM protein]]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of KLF7 mRNA]; MIR520F inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of KLF7 protein]	PMID:38184286
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1314411	E	RGD:6480464	20241105	CTD	MESH:D008769	KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDH1 mRNA]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of CDH2 mRNA]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of NFKB1 protein]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of SNAI1 protein]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of TWIST1 protein]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of VIM mRNA]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased phosphorylation of RELA protein]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased secretion of IL1B protein]; KLF7 protein promotes the reaction [Methylnitronitrosoguanidine results in increased secretion of IL6 protein]	PMID:38184286
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLF7 mRNA	PMID:35301059
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KLF7 mRNA	PMID:19549813
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KLF7 gene	PMID:27153756
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314411	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KLF7 mRNA	PMID:19770486
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314411	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of KLF7 mRNA	PMID:12763052
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of KLF7 mRNA	PMID:41430723
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314411	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of KLF7 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of KLF7 mRNA	PMID:34911549
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of KLF7 mRNA	PMID:33387578
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:27452	styrene	decreases expression	ISO	RGD:1314411	E	RGD:6480464	20180116	CTD	MESH:D020058	Styrene results in decreased expression of KLF7 mRNA	PMID:28951217
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KLF7 mRNA	PMID:40512198
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314411	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLF7 mRNA	PMID:40504410
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:C030686	acetamide results in increased expression of KLF7 mRNA	PMID:31881176
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of KLF7 mRNA	PMID:27392435
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:D002945	Cisplatin results in decreased expression of KLF7 mRNA	PMID:22023808
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of KLF7 mRNA	PMID:27392435
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1314411	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form] results in increased expression of KLF7 mRNA	PMID:23625948
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KLF7 mRNA	PMID:22574217
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314411	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KLF7 mRNA	PMID:21570461|PMID:24058054
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314411	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KLF7 mRNA	PMID:19465110|PMID:19770486|PMID:26290441
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314411	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KLF7 mRNA	PMID:17942748|PMID:37172768
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314411	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KLF7 mRNA	PMID:17942748
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of KLF7 mRNA	PMID:28001369
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of KLF7 mRNA	PMID:33212167
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of KLF7 mRNA	PMID:30851411
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:D020106	Acrylamide results in decreased expression of KLF7 mRNA	PMID:28959563
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of KLF7 mRNA	PMID:20971185
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KLF7 mRNA	PMID:40512198
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314411	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLF7 mRNA	PMID:40504410
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KLF7 intron	PMID:30157460
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314411	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KLF7 mRNA	PMID:22228805
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:30045	divanadium pentaoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C066075	vanadium pentoxide results in increased expression of KLF7 mRNA	PMID:17459161
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of KLF7 mRNA	PMID:20971185
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of KLF7 mRNA	PMID:26014281
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314411	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of KLF7 mRNA	PMID:19073995
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314411	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of KLF7 mRNA	PMID:23557971
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314411	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KLF7 promoter	PMID:35295148
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306029	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of KLF7 mRNA	PMID:34492290
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1314411	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of KLF7 mRNA	PMID:19191707
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:C069837	fullerene C60 results in decreased expression of KLF7 mRNA	PMID:19167457
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314411	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of KLF7 mRNA	PMID:38074096
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of KLF7 mRNA	PMID:25181051|PMID:41034487
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of KLF7 mRNA	PMID:26496021
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314411	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of KLF7 mRNA	PMID:26682919
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314411	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of KLF7 mRNA	PMID:33297965
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314411	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of KLF7 mRNA	PMID:17361019|PMID:21266533
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1314411	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of KLF7 mRNA	PMID:34813904
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1314411	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of KLF7 mRNA	PMID:34813904
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KLF7 mRNA	PMID:37042841
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306029	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of KLF7 mRNA	PMID:35163327
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:D002509	Cephaloridine results in decreased expression of KLF7 mRNA	PMID:18500788
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLF7 mRNA	PMID:35301059
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306029	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of KLF7 mRNA	PMID:35163327
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:C039281	furan results in decreased expression of KLF7 mRNA	PMID:26194646
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:C018021	cobaltous chloride results in decreased expression of KLF7 mRNA	PMID:24386269
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of KLF7 mRNA	PMID:24449571
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of KLF7 mRNA	PMID:31533062
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1314411	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of KLF7 mRNA	PMID:39529242
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of KLF7 mRNA	PMID:23179753
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of KLF7 mRNA	PMID:28001369
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314411	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of KLF7 mRNA	PMID:17555576
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in increased expression of KLF7 mRNA	PMID:15958647
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314411	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of KLF7 mRNA	PMID:28973697
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of KLF7 mRNA	PMID:38832940
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314411	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KLF7 mRNA	PMID:17562736
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of KLF7 mRNA	PMID:20977926
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314411	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of KLF7 mRNA	PMID:29279043
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KLF7 mRNA	PMID:40512198
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314411	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KLF7 mRNA	PMID:40504410
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of KLF7 mRNA	PMID:22077320
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of KLF7 mRNA	PMID:31838189
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KLF7 mRNA	PMID:22079256
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of KLF7 mRNA	PMID:18175754
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314411	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of KLF7 mRNA	PMID:17555576
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of KLF7 mRNA	PMID:15953391
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314411	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KLF7 mRNA	PMID:17942748
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of KLF7 mRNA	PMID:23228038
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314411	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of KLF7 mRNA	PMID:25554681
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:D005485	Flutamide results in decreased expression of KLF7 mRNA	PMID:24793618
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314411	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KLF7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of KLF7 mRNA	PMID:21641980|PMID:26378955
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314411	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of KLF7 mRNA	PMID:19812364
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of KLF7 mRNA	PMID:28988120
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1314411	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of KLF7 mRNA	PMID:26307267
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314411	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KLF7 mRNA	PMID:22206623
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:7459	naloxone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D009270	Naloxone inhibits the reaction [Morphine results in increased expression of KLF7 mRNA]	PMID:14644156
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of KLF7 mRNA	PMID:22079256
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KLF7 mRNA	PMID:22079256
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of KLF7 protein	PMID:31285264
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of KLF7 mRNA	PMID:36139627
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of KLF7 mRNA	PMID:30851411
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KLF7 gene]	PMID:28238834
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314411	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of KLF7 mRNA	PMID:23091169
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314411	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of KLF7 mRNA	PMID:21795629
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314411	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of KLF7 mRNA	PMID:21795629
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of KLF7 mRNA	PMID:26014281
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:D012999	Soman results in increased expression of KLF7 mRNA	PMID:19281266
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314411	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of KLF7 mRNA	PMID:28973697
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:C025643	vinclozolin results in decreased expression of KLF7 mRNA	PMID:23034163
1314410	KLF7	KLF transcription factor 7	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1306029	E	RGD:6480464	20220208	CTD	MESH:C025643	vinclozolin results in increased methylation of KLF7 gene	PMID:31682807
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552354	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ATF7IP mRNA	PMID:33045310
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552354	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ATF7IP mRNA	PMID:26251327
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552354	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ATF7IP gene	PMID:20938992
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATF7IP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATF7IP mRNA	PMID:32699268
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552354	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ATF7IP mRNA	PMID:36331819
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of ATF7IP protein	PMID:28073184
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ATF7IP mRNA	PMID:22378314
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ATF7IP mRNA	PMID:21632981
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552354	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ATF7IP mRNA	PMID:39241906
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ATF7IP mRNA	PMID:31614463
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of ATF7IP mRNA	PMID:19429434
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306030	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ATF7IP mRNA	PMID:33387578
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552354	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ATF7IP gene	PMID:20938992
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATF7IP mRNA	PMID:37042841
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:17315	D-glucosamine	increases expression	ISO	RGD:1552354	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in increased expression of ATF7IP mRNA	PMID:17178593
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ATF7IP mRNA	PMID:33359661
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ATF7IP protein	PMID:37730182
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306030	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ATF7IP mRNA	PMID:22061828
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ATF7IP mRNA	PMID:28818685
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:20993	aldehydo-D-glucosamine	increases expression	ISO	RGD:1552354	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ATF7IP mRNA	PMID:17178593
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1552354	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of ATF7IP mRNA	PMID:27776689
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATF7IP gene	PMID:27153756
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATF7IP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATF7IP mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ATF7IP mRNA	PMID:32699268
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ATF7IP mRNA	PMID:18593933
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552354	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ATF7IP gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ATF7IP mRNA]	PMID:20938992|PMID:22206623
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATF7IP gene	PMID:25304211
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF7IP mRNA	PMID:39836092
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552354	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ATF7IP mRNA	PMID:40504410
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ATF7IP protein	PMID:35688186
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:27810	resorcinol	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in decreased expression of ATF7IP mRNA	PMID:22623647
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1552354	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ATF7IP mRNA	PMID:30912803
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552354	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATF7IP mRNA	PMID:21570461
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306030	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATF7IP mRNA	PMID:33387578
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306030	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATF7IP mRNA	PMID:34747641
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ATF7IP mRNA	PMID:26272509
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATF7IP mRNA	PMID:27188386
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ATF7IP mRNA	PMID:33212167
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:28393	beta-D-glucosamine	increases expression	ISO	RGD:1552354	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ATF7IP mRNA	PMID:17178593
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATF7IP mRNA	PMID:29803840
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552354	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of ATF7IP mRNA	PMID:39631538
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of ATF7IP protein	PMID:35688186
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ATF7IP mRNA	PMID:38568856
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552354	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ATF7IP mRNA	PMID:19822182
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF7IP mRNA	PMID:39836092
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552354	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ATF7IP mRNA	PMID:40504410
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATF7IP 5' UTR	PMID:27901495
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ATF7IP mRNA]	PMID:32406909
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ATF7IP mRNA	PMID:18593933
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1552354	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ATF7IP mRNA	PMID:27131904
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ATF7IP mRNA	PMID:20018196
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:31746	kainic acid	decreases expression	ISO	RGD:1306030	E	RGD:6480464	20130806	CTD	MESH:D007608	Kainic Acid results in decreased expression of ATF7IP mRNA	PMID:19700661
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306030	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ATF7IP mRNA	PMID:25729387
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306030	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ATF7IP mRNA	PMID:30047161
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552354	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of ATF7IP mRNA	PMID:27760801
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552354	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ATF7IP gene	PMID:35295148
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306030	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ATF7IP mRNA	PMID:34492290
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306030	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ATF7IP mRNA	PMID:25181051
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552354	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ATF7IP mRNA	PMID:33221593
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ATF7IP gene	PMID:31601247
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306030	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ATF7IP mRNA	PMID:30816183
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552354	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ATF7IP mRNA	PMID:26063408
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552354	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ATF7IP mRNA	PMID:38685157
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552354	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ATF7IP intron	PMID:28392331
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552354	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ATF7IP mRNA	PMID:37019170
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATF7IP mRNA	PMID:38174414
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306030	E	RGD:6480464	20130806	CTD	MESH:C039281	furan results in increased methylation of ATF7IP gene	PMID:22079235
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATF7IP mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATF7IP mRNA	PMID:32699268
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ATF7IP mRNA	PMID:31533062
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552354	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ATF7IP mRNA	PMID:36331819
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ATF7IP mRNA	PMID:23179753
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306030	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ATF7IP mRNA	PMID:30047161|PMID:38685447
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1552354	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of ATF7IP mRNA	PMID:40633821
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:41774	tamoxifen	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of ATF7IP mRNA	PMID:19429434
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1552354	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of ATF7IP mRNA	PMID:18502557
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ATF7IP mRNA	PMID:24935251|PMID:26272509
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATF7IP mRNA	PMID:27188386
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552354	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ATF7IP mRNA	PMID:17562736
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306030	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ATF7IP mRNA	PMID:33387578
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of ATF7IP mRNA	PMID:21420995
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of ATF7IP mRNA	PMID:17331233
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATF7IP gene	PMID:25304211
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATF7IP mRNA	PMID:39836092
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552354	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ATF7IP mRNA	PMID:40504410
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:1552354	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in increased expression of ATF7IP mRNA	PMID:17178593
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552354	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ATF7IP mRNA; Nanotubes, Carbon results in decreased expression of ATF7IP mRNA	PMID:25554681
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306030	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ATF7IP mRNA	PMID:30047161|PMID:41580965
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306030	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ATF7IP mRNA	PMID:24136188
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306030	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of ATF7IP mRNA	PMID:25729387
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306030	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ATF7IP mRNA	PMID:25729387
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ATF7IP mRNA	PMID:28988120
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552354	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ATF7IP mRNA]	PMID:22206623
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ATF7IP protein	PMID:31285264
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of ATF7IP mRNA	PMID:20816883
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATF7IP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATF7IP mRNA	PMID:27188386
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATF7IP gene]	PMID:28238834
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306030	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ATF7IP mRNA	PMID:30047161
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:8772	raloxifene	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of ATF7IP mRNA	PMID:19429434
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ATF7IP mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATF7IP mRNA	PMID:27188386
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1552354	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ATF7IP mRNA	PMID:27131904
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306030	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ATF7IP mRNA	PMID:21346803
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ATF7IP mRNA	PMID:38568856
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ATF7IP mRNA	PMID:29301935
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of ATF7IP mRNA	PMID:27188386
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552354	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ATF7IP mRNA	PMID:28973697
1314412	ATF7IP	activating transcription factor 7 interacting protein	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306030	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of ATF7IP mRNA	PMID:18042343
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:10106	zearalenone	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D015025	Zearalenone results in decreased expression of MFAP2 mRNA	PMID:36828454
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MFAP2 mRNA	PMID:38218311
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306031	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of MFAP2 mRNA	PMID:25152437
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314414	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MFAP2 mRNA	PMID:37995155
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MFAP2 mRNA	PMID:20938992
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin metabolite results in decreased expression of MFAP2 mRNA; Tretinoin results in decreased expression of MFAP2 mRNA	PMID:15982314
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D004958	Estradiol results in decreased expression of MFAP2 mRNA	PMID:36828454
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306031	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of MFAP2 mRNA	PMID:32145629
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314414	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of MFAP2 mRNA	PMID:19484750
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of MFAP2 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of MFAP2 mRNA	PMID:17404688|PMID:30165855
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306031	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MFAP2 mRNA	PMID:32741896
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20180116	CTD	MESH:D004958	[bisphenol A results in increased susceptibility to Estradiol] which results in decreased expression of MFAP2 mRNA	PMID:27312807
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306031	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MFAP2 mRNA	PMID:33387578
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MFAP2 mRNA	PMID:20938992
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of MFAP2 mRNA	PMID:17404688
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MFAP2 mRNA	PMID:37992649
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of MFAP2 mRNA	PMID:33359661
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306031	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MFAP2 mRNA	PMID:32741896
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MFAP2 mRNA	PMID:37992649
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314414	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MFAP2 mRNA	PMID:33754040|PMID:34319233
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306031	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of MFAP2 mRNA	PMID:26577399
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of MFAP2 mRNA	PMID:26485663
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MFAP2 mRNA	PMID:36331819
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:2038	5-azacytidine	decreases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in decreased expression of MFAP2 mRNA	PMID:20823114
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1306031	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of MFAP2 protein	PMID:33236894
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MFAP2 mRNA	PMID:34911549
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MFAP2 mRNA	PMID:20938992
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:27563	arsenic atom	decreases methylation	EXP		E	RGD:6480464	20200310	CTD	MESH:D001151	Arsenic results in decreased methylation of MFAP2 5' UTR	PMID:31135185
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of MFAP2 mRNA	PMID:19244175
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:27698	vanadium atom	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of MFAP2 mRNA	PMID:19000753
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of MFAP2 mRNA	PMID:23557933
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306031	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MFAP2 mRNA	PMID:34747641
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314414	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MFAP2 mRNA	PMID:19465110
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MFAP2 mRNA	PMID:17942748
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1306031	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of MFAP2 mRNA	PMID:28959563
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of MFAP2 mRNA	PMID:32763439
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of MFAP2 mRNA	PMID:20971185
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MFAP2 mRNA	PMID:29803840
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MFAP2 mRNA	PMID:37992649
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:29021	hexane	decreases methylation	ISO	RGD:1306031	E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of MFAP2 promoter	PMID:23740543
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MFAP2 mRNA	PMID:38568856
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MFAP2 promoter	PMID:27901495
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314414	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MFAP2 mRNA	PMID:21569818|PMID:22228805|PMID:22610609
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MFAP2 5' UTR	PMID:27901495
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MFAP2 mRNA	PMID:27858113
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:29866	arsenite(3-)	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased expression of MFAP2 mRNA	PMID:23974009
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of MFAP2 promoter	PMID:23974009
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of MFAP2 mRNA	PMID:20971185
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of MFAP2 mRNA	PMID:25895662
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306031	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of MFAP2 mRNA	PMID:30047161
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314414	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of MFAP2 mRNA	PMID:23557971
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314414	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MFAP2 gene	PMID:35295148
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:C009495	[Vitallium analog binds to titanium dioxide] which results in increased expression of MFAP2 mRNA	PMID:23825117
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306031	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of MFAP2 mRNA	PMID:19167457
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of MFAP2 mRNA	PMID:36828454
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306031	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MFAP2 mRNA	PMID:25181051|PMID:34947998
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of MFAP2 gene	PMID:31601247
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314414	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of MFAP2 promoter	PMID:27312807
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of MFAP2 mRNA	PMID:27685785
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314414	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of MFAP2 mRNA	PMID:30951980
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A results in increased susceptibility to Estradiol] which results in decreased expression of MFAP2 mRNA	PMID:27312807
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of MFAP2 mRNA	PMID:19244175
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314414	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of MFAP2 mRNA	PMID:30951980
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1314414	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of MFAP2 mRNA	PMID:26377693
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MFAP2 mRNA	PMID:27858113
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of MFAP2 intron	PMID:30157460
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of MFAP2 protein	PMID:34186270
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314414	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of MFAP2 mRNA	PMID:30951980
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of MFAP2 protein	PMID:34186270
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314414	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MFAP2 mRNA	PMID:37019170
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306031	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MFAP2 mRNA	PMID:21266533
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306031	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MFAP2 mRNA	PMID:35163327
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:35170	vanadium(0)	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of MFAP2 mRNA	PMID:19000753
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306031	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MFAP2 mRNA	PMID:35163327
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306031	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of MFAP2 mRNA	PMID:27387713
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MFAP2 mRNA	PMID:24449571
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314414	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of MFAP2 mRNA	PMID:18353800
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of MFAP2 mRNA	PMID:19244175
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:3764	clotrimazole	decreases expression	ISO	RGD:1306031	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of MFAP2 mRNA	PMID:30047161
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MFAP2 mRNA	PMID:31533062
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MFAP2 mRNA	PMID:40419075
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MFAP2 mRNA	PMID:36331819
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MFAP2 mRNA	PMID:25979313
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of MFAP2 mRNA	PMID:23179753|PMID:27188386
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MFAP2 gene	PMID:29154799
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306031	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of MFAP2 mRNA	PMID:30047161
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314414	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MFAP2 mRNA	PMID:17555576
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of MFAP2 mRNA	PMID:25047013
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314414	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MFAP2 mRNA	PMID:28973697
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MFAP2 mRNA	PMID:37992649
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of MFAP2 mRNA	PMID:22230336
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:47217	arsane	decreases methylation	EXP		E	RGD:6480464	20200310	CTD	MESH:D001151	Arsenic results in decreased methylation of MFAP2 5' UTR	PMID:31135185
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of MFAP2 mRNA	PMID:31838189
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306031	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MFAP2 mRNA	PMID:29391264
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1306031	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of MFAP2 mRNA	PMID:37958445
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1314414	E	RGD:6480464	20200804	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of MFAP2 mRNA	PMID:32052077
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:1306031	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of MFAP2 gene	PMID:37958445
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314414	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MFAP2 mRNA	PMID:17555576
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MFAP2 mRNA	PMID:17942748
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of MFAP2 mRNA	PMID:17145863
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:50648	9-cis-retinoic acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in decreased expression of MFAP2 mRNA	PMID:15982314
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306031	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of MFAP2 mRNA	PMID:30047161
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MFAP2 mRNA	PMID:27858113
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314414	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MFAP2 mRNA	PMID:27858113
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of MFAP2 mRNA	PMID:15982314
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of MFAP2 mRNA	PMID:20436886
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1306031	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of MFAP2 mRNA	PMID:28801915
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:63041	manganese(II) chloride	decreases methylation	ISO	RGD:1306031	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased methylation of MFAP2 gene	PMID:28801915
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases methylation	ISO	RGD:1306031	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased methylation of MFAP2 gene	PMID:28801915
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of MFAP2 mRNA	PMID:24810058
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of MFAP2 intron	PMID:30157460
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of MFAP2 mRNA	PMID:31758290
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MFAP2 protein	PMID:34186270
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314414	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MFAP2 mRNA	PMID:22206623
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of MFAP2 protein	PMID:37664457
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1314414	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of MFAP2 mRNA	PMID:27858113
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1306031	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MFAP2 mRNA	PMID:32741896
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:80656	all-trans-4-oxoretinoic acid	decreases expression	EXP		E	RGD:6480464	20150120	CTD	MESH:C002202	4-oxoretinoic acid results in decreased expression of MFAP2 mRNA	PMID:15982314
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1306031	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of MFAP2 mRNA	PMID:32109520
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314414	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MFAP2 mRNA	PMID:31388691
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1314414	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of MFAP2 mRNA	PMID:26377693
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306031	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of MFAP2 mRNA	PMID:24780913
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of MFAP2 protein	PMID:37664457
1314413	MFAP2	microfibril associated protein 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MFAP2 mRNA	PMID:38568856
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1552356	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of FBXW8 mRNA	PMID:37995155
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552356	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of FBXW8 mRNA	PMID:26251327
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FBXW8 mRNA	PMID:33167477
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of FBXW8 mRNA	PMID:26079696
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552356	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FBXW8 mRNA	PMID:39241906
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of FBXW8 mRNA	PMID:33359661
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of FBXW8 mRNA	PMID:28818685
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552356	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXW8 mRNA	PMID:28111341
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FBXW8 intron	PMID:30157460
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FBXW8 gene	PMID:25304211
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552356	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXW8 mRNA	PMID:40504410
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1306032	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of FBXW8 gene	PMID:35440735
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552356	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXW8 mRNA	PMID:21570461
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552356	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXW8 mRNA	PMID:40504410
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBXW8 intron	PMID:30157460
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FBXW8 promoter	PMID:27901495
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to FBXW8 mRNA]	PMID:32406909
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXW8 gene	PMID:34973136
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306032	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of FBXW8 mRNA	PMID:23411599
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306032	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXW8 mRNA	PMID:25181051
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306032	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of FBXW8 mRNA	PMID:41034487
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552356	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of FBXW8 mRNA	PMID:33221593
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of FBXW8 intron	PMID:30157460
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552356	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXW8 mRNA	PMID:28111341
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FBXW8 mRNA	PMID:19320972
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FBXW8 mRNA	PMID:31533062
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of FBXW8 mRNA	PMID:40419075
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FBXW8 mRNA	PMID:38832940
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FBXW8 gene	PMID:25304211
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552356	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXW8 mRNA	PMID:40504410
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1306032	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in decreased expression of FBXW8 mRNA	PMID:30307764
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of FBXW8 intron	PMID:30157460
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306032	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FBXW8 gene	PMID:35440735
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552356	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of FBXW8 mRNA	PMID:23091169
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:81543	Tributyltin oxide	increases phosphorylation	ISO	RGD:1552356	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased phosphorylation of FBXW8 protein	PMID:22174045
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1306032	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of FBXW8 mRNA	PMID:27291303
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306032	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FBXW8 mRNA	PMID:24780913
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of FBXW8 mRNA	PMID:29301935
1314415	FBXW8	F-box and WD repeat domain containing 8	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306032	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of FBXW8 mRNA	PMID:21346803
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314420	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of EPB41L4A mRNA	PMID:37995155
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	affects expression	ISO	RGD:1306034	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine affects the expression of EPB41L4A mRNA	PMID:30071829
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314420	E	RGD:6480464	20151110	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of EPB41L4A; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPB41L4A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EPB41L4A gene	PMID:20938992
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of EPB41L4A mRNA	PMID:21934132
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1306034	E	RGD:6480464	20151110	CTD	MESH:D014212	Tretinoin results in increased expression of EPB41L4A mRNA	PMID:20488242
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of EPB41L4A mRNA	PMID:26079696
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of EPB41L4A mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of EPB41L4A mRNA	PMID:17404688|PMID:20823114
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of EPB41L4A mRNA	PMID:38568856
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306034	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of EPB41L4A gene	PMID:27618143
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314420	E	RGD:6480464	20151110	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of EPB41L4A; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPB41L4A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EPB41L4A gene	PMID:20938992
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of EPB41L4A mRNA	PMID:17404688
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306034	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of EPB41L4A mRNA	PMID:26577399
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306034	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EPB41L4A mRNA	PMID:33387578
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EPB41L4A mRNA	PMID:28818685
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EPB41L4A gene	PMID:27153756
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306034	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EPB41L4A mRNA	PMID:23630614
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EPB41L4A intron	PMID:30157460
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314420	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of EPB41L4A mRNA	PMID:25629700
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314420	E	RGD:6480464	20151110	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of EPB41L4A; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EPB41L4A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EPB41L4A gene	PMID:20938992
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314420	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EPB41L4A mRNA	PMID:40504410
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314420	E	RGD:6480464	20151110	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EPB41L4A mRNA	PMID:21570461
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314420	E	RGD:6480464	20151110	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPB41L4A mRNA	PMID:19933214
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314420	E	RGD:6480464	20210209	CTD	MESH:D013749	[Tetrachlorodibenzodioxin affects the methylation of EPB41L4A intron] which results in decreased expression of EPB41L4A mRNA	PMID:33017471
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of EPB41L4A mRNA	PMID:28001369
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314420	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of EPB41L4A mRNA	PMID:39631538
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:28854	2,4-D	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of EPB41L4A mRNA	PMID:40294809
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of EPB41L4A mRNA	PMID:39719251
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314420	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EPB41L4A mRNA	PMID:40504410
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EPB41L4A intron	PMID:30157460
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EPB41L4A promoter	PMID:27901495
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314420	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EPB41L4A intron	PMID:27901495
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EPB41L4A mRNA	PMID:22316170
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of EPB41L4A mRNA; Silicon Dioxide results in decreased expression of EPB41L4A mRNA	PMID:25351596|PMID:25895662
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of EPB41L4A mRNA	PMID:20382639
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of EPB41L4A mRNA	PMID:35984750
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306034	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of EPB41L4A mRNA	PMID:30047161
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314420	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EPB41L4A gene; titanium dioxide results in decreased methylation of EPB41L4A promoter	PMID:35295148
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314420	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of EPB41L4A gene	PMID:35295148
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306034	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of EPB41L4A mRNA	PMID:23411599
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314420	E	RGD:6480464	20151110	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of EPB41L4A mRNA	PMID:18648102
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314420	E	RGD:6480464	20151110	CTD	MESH:C006253	pirinixic acid results in increased expression of EPB41L4A mRNA	PMID:20813756
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314420	E	RGD:6480464	20151110	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of EPB41L4A mRNA	PMID:20813756
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A affects the expression of EPB41L4A mRNA	PMID:22574217
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306034	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of EPB41L4A mRNA	PMID:25181051
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314420	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of EPB41L4A promoter	PMID:27334623
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of EPB41L4A mRNA	PMID:27685785
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306034	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of EPB41L4A mRNA	PMID:32145629
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314420	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of EPB41L4A mRNA	PMID:26063408
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306034	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of EPB41L4A mRNA	PMID:41034487
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314420	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of EPB41L4A mRNA	PMID:32156529
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314420	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of EPB41L4A mRNA	PMID:40203079
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314420	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of EPB41L4A mRNA	PMID:38685157
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314420	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of EPB41L4A intron	PMID:28392331
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314420	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of EPB41L4A mRNA	PMID:37019170
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306034	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of EPB41L4A gene	PMID:33148267
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EPB41L4A mRNA	PMID:37042841
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EPB41L4A mRNA	PMID:38382870
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1314420	E	RGD:6480464	20190312	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of EPB41L4A mRNA	PMID:30711707
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306034	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of EPB41L4A mRNA	PMID:25539665|PMID:26194646|PMID:27387713
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306034	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EPB41L4A mRNA	PMID:24386269
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of EPB41L4A mRNA	PMID:31533062
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EPB41L4A mRNA	PMID:25979313
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of EPB41L4A gene	PMID:29154799
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of EPB41L4A mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:27188386
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306034	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of EPB41L4A mRNA	PMID:30047161
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314420	E	RGD:6480464	20151110	CTD	MESH:D013629	Tamoxifen affects the expression of EPB41L4A mRNA	PMID:17555576
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314420	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of EPB41L4A mRNA	PMID:28973697
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of EPB41L4A mRNA]	PMID:21233418
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of EPB41L4A mRNA	PMID:24935251
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306034	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EPB41L4A mRNA	PMID:33387578
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of EPB41L4A mRNA	PMID:25351596
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314420	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of EPB41L4A mRNA	PMID:29279043
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314420	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EPB41L4A mRNA	PMID:40504410
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of EPB41L4A mRNA	PMID:31838189
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306034	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of EPB41L4A mRNA	PMID:29391264
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314420	E	RGD:6480464	20151110	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of EPB41L4A mRNA	PMID:17555576
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of EPB41L4A mRNA	PMID:38568856
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of EPB41L4A mRNA	PMID:20823114
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306034	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of EPB41L4A mRNA	PMID:30047161
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314420	E	RGD:6480464	20151110	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of EPB41L4A mRNA	PMID:23608068
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of EPB41L4A mRNA	PMID:20823114
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306034	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of EPB41L4A gene	PMID:33148267
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of EPB41L4A mRNA	PMID:29522793
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EPB41L4A gene]	PMID:28238834
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306034	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EPB41L4A mRNA	PMID:30047161
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of EPB41L4A mRNA	PMID:27188386
1314419	EPB41L4A	erythrocyte membrane protein band 4.1 like 4A	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306034	E	RGD:6480464	20151110	CTD	MESH:C025643	vinclozolin affects the expression of EPB41L4A mRNA	PMID:19015723
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:10022	deoxynivalenol	decreases phosphorylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C007262	deoxynivalenol results in decreased phosphorylation of YAP1 protein	PMID:33890134
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:10106	zearalenone	increases expression	ISO	RGD:1550378	E	RGD:6480464	20190219	CTD	MESH:D015025	Zearalenone results in increased expression of YAP1 mRNA	PMID:30138655
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:10106	zearalenone	increases phosphorylation	ISO	RGD:1550378	E	RGD:6480464	20190219	CTD	MESH:D015025	Zearalenone results in increased phosphorylation of YAP1 protein	PMID:30138655
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:10136	gingerol	affects localization	EXP		E	RGD:6480464	20210406	CTD	MESH:C007845	gingerol affects the localization of YAP1 protein	PMID:32926756
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:10136	gingerol	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C007845	[gingerol co-treated with YAP1 protein] results in increased phosphorylation of YAP1 protein; gingerol inhibits the reaction [YAP1 protein results in increased expression of MMP2 protein]; gingerol inhibits the reaction [YAP1 protein results in increased expression of SNAI2 protein]; gingerol inhibits the reaction [YAP1 protein results in increased expression of VIM protein]; gingerol results in decreased expression of and results in increased phosphorylation of YAP1 protein	PMID:32926756
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550378	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of YAP1 mRNA	PMID:33045310
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:132446	perfluorobutanesulfonic acid	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20241203	CTD	MESH:C539348	[perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate co-treated with perfluorobutanesulfonic acid] results in increased expression of YAP1 mRNA; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate co-treated with perfluorobutanesulfonic acid] results in increased expression of YAP1 protein	PMID:39141488
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306035	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of YAP1 mRNA]	PMID:31150632
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of YAP1 gene	PMID:20938992
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of YAP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of YAP1 mRNA	PMID:32699268
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20221101	CTD	MESH:D010100	[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of YAP1 mRNA; [Oxygen deficiency co-treated with Oxygen] results in decreased expression of YAP1 mRNA; Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of YAP1 mRNA]; SNHG12 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of YAP1 protein]; SNHG12 mRNA promotes the reaction [Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of YAP1 mRNA]]; YAP1 promotes the reaction [SNHG12 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BECN1 protein]]; YAP1 promotes the reaction [SNHG12 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased cleavage of CASP3 protein]]; YAP1 promotes the reaction [SNHG12 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in increased expression of SQSTM1 protein]]; YAP1 promotes the reaction [SNHG12 mRNA promotes the reaction [Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of MAP1LC3B protein]]]	PMID:35307376
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:15756	hexadecanoic acid	affects localization	EXP		E	RGD:6480464	20231031	CTD	MESH:D019308	Palmitic Acid affects the localization of YAP1 protein	PMID:37117602
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:16196	oleic acid	affects localization	EXP		E	RGD:6480464	20231031	CTD	MESH:D019301	Oleic Acid affects the localization of YAP1 protein	PMID:37117602
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:16226	limonin	affects localization	EXP		E	RGD:6480464	20200519	CTD	MESH:C001546	limonin affects the localization of YAP1 protein	PMID:30738134
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550378	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of YAP1 mRNA	PMID:30319688
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of YAP1 mRNA	PMID:21632981
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550378	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of YAP1 mRNA	PMID:39241906
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of YAP1 mRNA	PMID:22574217
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550378	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of YAP1 mRNA	PMID:39298647
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1550378	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of YAP1 mRNA	PMID:19448997
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of YAP1 gene	PMID:20938992
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1306035	E	RGD:6480464	20220607	CTD	MESH:D008550	Melatonin inhibits the reaction [Cyclophosphamide results in decreased expression of and results in increased phosphorylation of YAP1 protein]; Melatonin inhibits the reaction [Doxorubicin results in increased phosphorylation of YAP1 protein]; Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased phosphorylation of YAP1 protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in decreased expression of and results in increased cleavage of CASP9 protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in decreased expression of OPA1 protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased expression of ACSL4 protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased expression of BAX protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased expression of FUNDC1 protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased expression of NPPB protein]]	PMID:35093381|PMID:36154502
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of YAP1 mRNA	PMID:23649840
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 mRNA	PMID:31351048
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:C016599	IRF1 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 mRNA]; IRF1 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 protein]; LATS1 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased stability of YAP1 protein]; mono-(2-ethylhexyl)phthalate results in increased expression of and results in decreased phosphorylation of and results in increased activity of and affects the localization of and results in increased stability of YAP1 protein	PMID:31351048
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:174541	Licochalcone A	decreases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:C070840	licochalcone A results in decreased expression of YAP1 mRNA; licochalcone A results in decreased expression of YAP1 protein	PMID:34845814
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:174541	Licochalcone A	multiple interactions	EXP		E	RGD:6480464	20220809	CTD	MESH:C070840	XMU-MP-1 inhibits the reaction [licochalcone A results in increased expression of YAP1 protein modified form]	PMID:34845814
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:175901	gemcitabine	affects response to substance	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	YAP1 protein affects the susceptibility to Gemcitabine	PMID:26894857
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:175901	gemcitabine	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine promotes the reaction [nuciferine results in decreased expression of and results in increased phosphorylation of YAP1 protein]; SFN protein affects the reaction [YAP1 protein promotes the reaction [SFN protein results in decreased susceptibility to Gemcitabine]]; YAP1 protein affects the reaction [Gemcitabine results in increased activity of and results in increased cleavage of CASP8 protein]; YAP1 protein affects the reaction [Gemcitabine results in increased cleavage of PARP1 protein]; YAP1 protein promotes the reaction [SFN protein results in decreased susceptibility to Gemcitabine]	PMID:26894857|PMID:31627466
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1550378	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of YAP1 mRNA	PMID:23892564
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:177802	Cuprizon	affects expression	ISO	RGD:1306035	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of YAP1 mRNA	PMID:27523638
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of YAP1 protein	PMID:37730182
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of YAP1 mRNA	PMID:36331819
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:211238	Torularhodin	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20250506	CTD	MESH:C078923	torularhodin inhibits the reaction [Dietary Fats results in decreased expression of YAP1 protein]	PMID:36234935
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:231615	XMU-MP-1	decreases phosphorylation	EXP		E	RGD:6480464	20240702	CTD	MESH:C000625617	XMU-MP-1 results in decreased phosphorylation of YAP1 protein	PMID:35027733
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:231615	XMU-MP-1	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C000625617	XMU-MP-1 inhibits the reaction [evodiamine results in decreased expression of YAP1 mRNA]; XMU-MP-1 inhibits the reaction [evodiamine results in decreased expression of YAP1 protein]; XMU-MP-1 inhibits the reaction [evodiamine results in increased phosphorylation of YAP1 protein]; XMU-MP-1 inhibits the reaction [licochalcone A results in increased expression of YAP1 protein modified form]; XMU-MP-1 inhibits the reaction [MAP3K20 protein results in increased phosphorylation of YAP1 protein]	PMID:31044527|PMID:32057900|PMID:34845814
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of YAP1 mRNA	PMID:19549813
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of YAP1 mRNA	PMID:23649840
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1306035	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of YAP1 protein	PMID:33236894
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of YAP1 mRNA	PMID:22100608
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of YAP1 protein	PMID:39638853
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of YAP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of YAP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of YAP1 mRNA	PMID:32699268
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of YAP1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of YAP1 protein	PMID:38598786
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of YAP1 mRNA	PMID:18593933
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306035	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of YAP1 mRNA	PMID:31150632
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550378	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of YAP1 mRNA; Carbon Tetrachloride results in increased expression of YAP1 protein	PMID:31919559|PMID:32996673|PMID:38992766
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306035	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of YAP1 mRNA]	PMID:31150632
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20210309	CTD	MESH:D002251	GANT 61 inhibits the reaction [Carbon Tetrachloride results in increased expression of YAP1 mRNA]; GANT 61 inhibits the reaction [Carbon Tetrachloride results in increased expression of YAP1 protein]	PMID:32996673
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of YAP1 gene	PMID:20938992
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27563	arsenic atom	affects localization	EXP		E	RGD:6480464	20230502	CTD	MESH:D001151	Arsenic affects the localization of YAP1 protein	PMID:28524356
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27563	arsenic atom	affects localization	ISO	RGD:1550378	E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic affects the localization of YAP1 protein	PMID:23942117
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in increased expression of and results in decreased phosphorylation of YAP1 protein	PMID:23942117
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of YAP1 mRNA	PMID:19684285
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of YAP1 mRNA	PMID:26272509
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA	PMID:27188386
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of YAP1 protein	PMID:35688186
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1306035	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of YAP1 gene	PMID:31011160
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27827	paraoxon	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D010261	Paraoxon results in decreased expression of YAP1 mRNA	PMID:24413757
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306035	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of YAP1 mRNA	PMID:31881176
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20120717	CTD	MESH:D002945	YAP1 results in decreased susceptibility to Cisplatin	PMID:20947521
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of YAP1 protein modified form	PMID:21214929
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1550378	E	RGD:6480464	20220510	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of YAP1 protein	PMID:35219798
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27899	cisplatin	increases response to substance	EXP		E	RGD:6480464	20120717	CTD	MESH:D002945	YAP1 protein results in increased susceptibility to Cisplatin	PMID:20729916
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in decreased phosphorylation of and affects the localization of YAP1 protein; [Cisplatin results in increased expression of MIR630] which results in decreased expression of YAP1 mRNA; [YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein; [YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of BAX protein; [YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of FAS protein; [YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of PMAIP1 protein; [YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of TNFRSF10B protein; wortmannin promotes the reaction [Cisplatin results in increased expression of YAP1 protein modified form]; YAP1 protein inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; YAP1 protein inhibits the reaction [Cisplatin results in increased cleavage of CASP8 protein]; YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]	PMID:20947521|PMID:21214929|PMID:21274007
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20220510	CTD	MESH:D002945	Imatinib Mesylate inhibits the reaction [Cisplatin results in increased phosphorylation of YAP1 protein]	PMID:35219798
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of YAP1 promoter	PMID:22847954
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550378	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of YAP1 mRNA	PMID:21570461|PMID:36222588
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects response to substance	EXP		E	RGD:6480464	20200211	CTD	MESH:D013749	YAP1 affects the susceptibility to Tetrachlorodibenzodioxin	PMID:31536130
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306035	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of YAP1 mRNA	PMID:33387578
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550378	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of YAP1 mRNA	PMID:33956508
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of YAP1 mRNA	PMID:19684285
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of YAP1 mRNA; YAP1 affects the reaction [Tetrachlorodibenzodioxin results in increased expression of BMF mRNA]; YAP1 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]	PMID:19684285|PMID:31536130|PMID:34403729
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28177	theophylline	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in decreased expression of YAP1 mRNA	PMID:18951874
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of YAP1 mRNA	PMID:28001369
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28694	copper atom	decreases phosphorylation	EXP		E	RGD:6480464	20231003	CTD	MESH:D003300	Copper results in decreased phosphorylation of YAP1 protein	PMID:35027733
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of YAP1 mRNA	PMID:29803840
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1306035	E	RGD:6480464	20201006	CTD	MESH:D004317	Doxorubicin results in decreased expression of YAP1 mRNA; Doxorubicin results in decreased expression of YAP1 protein	PMID:32434049
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28748	doxorubicin	decreases response to substance	ISO	RGD:1306035	E	RGD:6480464	20201006	CTD	MESH:D004317	YAP1 protein results in decreased susceptibility to Doxorubicin	PMID:32434049
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of YAP1 protein modified form	PMID:21214929
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28748	doxorubicin	increases phosphorylation	ISO	RGD:1306035	E	RGD:6480464	20220607	CTD	MESH:D004317	Doxorubicin results in increased phosphorylation of YAP1 protein	PMID:35093381
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in decreased phosphorylation of and affects the localization of YAP1 protein; [YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein; [YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of BAX protein; [YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of FAS protein; [YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of PMAIP1 protein; [YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in increased expression of TNFRSF10B protein; wortmannin promotes the reaction [Doxorubicin results in increased expression of YAP1 protein modified form]; YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]	PMID:21214929
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1306035	E	RGD:6480464	20201006	CTD	MESH:D004317	Doxorubicin inhibits the reaction [YAP1 protein binds to PRKN promoter]; Melatonin inhibits the reaction [Doxorubicin results in increased phosphorylation of YAP1 protein]; Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased phosphorylation of YAP1 protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in decreased expression of and results in increased cleavage of CASP9 protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in decreased expression of OPA1 protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased expression of ACSL4 protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased expression of BAX protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased expression of FUNDC1 protein]]; YAP1 protein affects the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased expression of NPPB protein]]	PMID:32434049|PMID:35093381
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of YAP1 protein	PMID:35688186
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of YAP1 mRNA	PMID:28595984|PMID:38568856
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of YAP1 mRNA	PMID:20106945
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to YAP1 mRNA]	PMID:32406909
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:30052	copper(0)	decreases phosphorylation	EXP		E	RGD:6480464	20231003	CTD	MESH:D003300	Copper results in decreased phosphorylation of YAP1 protein	PMID:35027733
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of YAP1 mRNA	PMID:18593933
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of YAP1 mRNA	PMID:19150397
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of YAP1 gene	PMID:31601247
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:31767	lead diacetate	affects expression	ISO	RGD:1306035	E	RGD:6480464	20130806	CTD	MESH:C008261	lead acetate affects the expression of YAP1 mRNA	PMID:21864555
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1550378	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of YAP1 mRNA	PMID:17656681
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550378	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of YAP1 gene	PMID:35295148
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550378	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of YAP1 promoter	PMID:35295148
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:32293	verteporfin	decreases activity	EXP		E	RGD:6480464	20220405	CTD	MESH:C098350	Verteporfin results in decreased activity of YAP1 protein	PMID:34351699|PMID:34480788|PMID:34826200
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:32293	verteporfin	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C098350	Verteporfin results in decreased expression of YAP1 protein	PMID:31494105
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:32293	verteporfin	decreases expression	ISO	RGD:1306035	E	RGD:6480464	20220607	CTD	MESH:C098350	Verteporfin results in decreased expression of YAP1 protein	PMID:35093381
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:32293	verteporfin	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:C098350	Verteporfin inhibits the reaction [AMOTL1 protein results in increased activity of YAP1 protein]; Verteporfin inhibits the reaction [RASAL2 protein results in increased activity of YAP1 protein]; Verteporfin inhibits the reaction [YAP1 protein results in increased expression of ANKRD1 mRNA]; Verteporfin inhibits the reaction [YAP1 protein results in increased expression of CCN1 mRNA]; Verteporfin inhibits the reaction [YAP1 protein results in increased expression of CCN2 mRNA]	PMID:29725256|PMID:34480788|PMID:34826200
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:32293	verteporfin	multiple interactions	ISO	RGD:1306035	E	RGD:6480464	20220607	CTD	MESH:C098350	Verteporfin inhibits the reaction [Melatonin inhibits the reaction [Doxorubicin results in increased phosphorylation of YAP1 protein]]	PMID:35093381
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:32293	verteporfin	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20181113	CTD	MESH:C098350	Verteporfin inhibits the reaction [YAP1 protein binds to TEAD1 protein]	PMID:29893953
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306035	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of YAP1 mRNA	PMID:34492290
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20250506	CTD	MESH:C006253	pirinixic acid deficiency inhibits the reaction [pirinixic acid results in increased expression of and affects the localization of YAP1 protein]; pirinixic acid results in increased expression of and affects the localization of YAP1 protein	PMID:38734220
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in decreased expression of YAP1 protein	PMID:38326183
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306035	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of YAP1 mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550378	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in decreased expression of YAP1 protein	PMID:38103660|PMID:38326183
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of YAP1 protein	PMID:37567409
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550378	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of YAP1 mRNA	PMID:26063408
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306035	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of YAP1 gene	PMID:28505145
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:33216	bisphenol A	increases phosphorylation	ISO	RGD:1550378	E	RGD:6480464	20220510	CTD	MESH:C006780	bisphenol A results in increased phosphorylation of YAP1 protein	PMID:35219798
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20241105	CTD	MESH:C006780	YAP1 protein affects the reaction [bisphenol A results in decreased expression of GPX4 protein]; YAP1 protein affects the reaction [bisphenol A results in increased expression of PTGS2 protein]; YAP1 protein affects the reaction [bisphenol A results in increased lipidation of MAP1LC3B protein]; YAP1 protein inhibits the reaction [bisphenol A results in decreased expression of GPX4 protein]; YAP1 protein inhibits the reaction [bisphenol A results in increased expression of PTGS2 protein]; YAP1 protein inhibits the reaction [bisphenol A results in increased expression of WWTR1 protein]; YAP1 protein inhibits the reaction [bisphenol A results in increased lipidation of and results in increased localization of MAP1LC3B protein]	PMID:38103660|PMID:38326183
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20220510	CTD	MESH:C006780	Imatinib Mesylate inhibits the reaction [bisphenol A results in increased phosphorylation of YAP1 protein]	PMID:35219798
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of YAP1 mRNA	PMID:25979313
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of YAP1 protein	PMID:34186270
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550378	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of YAP1 mRNA	PMID:39298647
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YAP1 mRNA	PMID:28628672
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1550378	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of YAP1 mRNA	PMID:31558096
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20140114	CTD	MESH:D016264	[RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased phosphorylation of and affects the localization of YAP1 protein	PMID:24146755
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550378	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of YAP1 mRNA	PMID:17361019
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of YAP1 protein	PMID:38598786
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YAP1 mRNA	PMID:28628672
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20121113	CTD	MESH:D004052	[1,4-bis(2-(3,5-dichloropyridyloxy))benzene co-treated with Diethylnitrosamine] results in increased expression of and affects the localization of YAP1 protein	PMID:21391223
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of YAP1 mRNA	PMID:38568856
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:35456	cadmium dichloride	increases localization	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in increased localization of YAP1 protein	PMID:28450285
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20231003	CTD	MESH:D019256	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium Chloride promotes the reaction [YAP1 protein binds to SMAD2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium Chloride promotes the reaction [YAP1 protein binds to SMAD3 protein]]; [Cadmium Chloride results in decreased activity of LATS1 protein] which results in decreased phosphorylation of YAP1 protein; Cadmium Chloride promotes the reaction [YAP1 protein binds to SMAD2 protein]; Cadmium Chloride promotes the reaction [YAP1 protein binds to SMAD3 protein]; Cadmium Chloride results in decreased phosphorylation of and affects the localization of YAP1 protein; Roscovitine inhibits the reaction [Cadmium Chloride promotes the reaction [YAP1 protein binds to SMAD2 protein]]; Roscovitine inhibits the reaction [Cadmium Chloride promotes the reaction [YAP1 protein binds to SMAD3 protein]]	PMID:28450285|PMID:35027733
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20231003	CTD	MESH:D019256	Cadmium Chloride results in increased expression of and affects the localization of YAP1 protein	PMID:35027733
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1550378	E	RGD:6480464	20230307	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of YAP1 mRNA	PMID:36152675
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of and results in decreased phosphorylation of YAP1 protein	PMID:35346789
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20241203	CTD	MESH:C023036	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid] results in decreased expression of and results in increased phosphorylation of YAP1 protein; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate co-treated with perfluorobutanesulfonic acid] results in increased expression of YAP1 mRNA; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate co-treated with perfluorobutanesulfonic acid] results in increased expression of YAP1 protein	PMID:39141488|PMID:39746460
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306035	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of YAP1 protein	PMID:27371368
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20250506	CTD	MESH:D011285	Pregnenolone Carbonitrile deficiency inhibits the reaction [Pregnenolone Carbonitrile results in increased expression of and affects the localization of YAP1 protein]; Pregnenolone Carbonitrile results in increased expression of and affects the localization of YAP1 protein	PMID:38734220
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of YAP1 mRNA	PMID:24449571
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:36386	dichloroacetic acid	affects localization	EXP		E	RGD:6480464	20211109	CTD	MESH:D003999	Dichloroacetic Acid affects the localization of YAP1 protein	PMID:33405312
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:36386	dichloroacetic acid	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D003999	YAP1 protein mutant form inhibits the reaction [Dichloroacetic Acid results in decreased expression of EPCAM mRNA]; YAP1 protein mutant form inhibits the reaction [Dichloroacetic Acid results in decreased expression of EPCAM protein]; YAP1 protein mutant form inhibits the reaction [Dichloroacetic Acid results in decreased expression of KLF4 mRNA]; YAP1 protein mutant form inhibits the reaction [Dichloroacetic Acid results in decreased expression of KLF4 protein]; YAP1 protein mutant form inhibits the reaction [Dichloroacetic Acid results in decreased expression of PROM1 mRNA]; YAP1 protein mutant form inhibits the reaction [Dichloroacetic Acid results in decreased expression of PROM1 protein]	PMID:33405312
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:3647	chlorpromazine	multiple interactions	EXP		E	RGD:6480464	20190312	CTD	MESH:D002746	Chlorpromazine results in decreased expression of and results in increased phosphorylation of and affects the localization of YAP1 protein	PMID:30703373
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of YAP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of YAP1 mRNA	PMID:32699268
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of YAP1 promoter	PMID:22847954
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of YAP1 mRNA	PMID:31533062
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of YAP1 promoter	PMID:22847954
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of YAP1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of YAP1 mRNA; [perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid] results in decreased expression of and results in increased phosphorylation of YAP1 protein; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate co-treated with perfluorobutanesulfonic acid] results in increased expression of YAP1 mRNA; [perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate co-treated with perfluorobutanesulfonic acid] results in increased expression of YAP1 protein	PMID:36331819|PMID:39141488|PMID:39746460
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of YAP1 mRNA	PMID:25979313
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of YAP1 mRNA	PMID:29154799
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1550378	E	RGD:6480464	20120918	CTD	MESH:D014635	Valproic Acid results in decreased expression of YAP1 mRNA	PMID:20546886|PMID:21427059
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of YAP1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA	PMID:27188386
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:4027	cyclophosphamide	multiple interactions	ISO	RGD:1306035	E	RGD:6480464	20240806	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of and results in increased phosphorylation of YAP1 protein; Melatonin inhibits the reaction [Cyclophosphamide results in decreased expression of and results in increased phosphorylation of YAP1 protein]	PMID:36154502
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YAP1 mRNA	PMID:28628672
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:42567	fisetin	multiple interactions	EXP		E	RGD:6480464	20200211	CTD	MESH:C017875	fisetin results in increased phosphorylation of and affects the localization of YAP1 protein	PMID:31044527
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of YAP1 mRNA	PMID:24935251|PMID:26272509
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA	PMID:27188386
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of YAP1 mRNA	PMID:21420995
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306035	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of YAP1 mRNA	PMID:33387578
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:46195	paracetamol	decreases response to substance	ISO	RGD:1550378	E	RGD:6480464	20220111	CTD	MESH:D000082	YAP1 gene mutant form results in decreased susceptibility to Acetaminophen	PMID:34546377
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20220111	CTD	MESH:D000082	Acetaminophen results in increased expression of and affects the localization of YAP1 protein; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased activity of CTNNB1 protein]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of AXIN2 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of CCND1 protein]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of CDK4 protein]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of CYP1A2 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of CYP7B1 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of DDIT3 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of ELOVL3 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of ERBB3 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of HSD17B2 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of HSD3B5 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of LECT2 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of NR5A2 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of NUDT7 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of OAT mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of RGN mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of SAA1 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased expression of SAA2 mRNA]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased phosphorylation of RB1 protein]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased secretion of SAA1 protein]; YAP1 gene mutant form promotes the reaction [Acetaminophen results in increased secretion of SAA2 protein]	PMID:34546377
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of YAP1 mRNA	PMID:18687144
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:46727	quartz	affects expression	ISO	RGD:1550378	E	RGD:6480464	20230117	CTD	MESH:D011791	Quartz affects the expression of YAP1 protein	PMID:36053221
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:46727	quartz	affects localization	ISO	RGD:1550378	E	RGD:6480464	20230117	CTD	MESH:D011791	Quartz affects the localization of YAP1 protein	PMID:36053221
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:46727	quartz	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20230117	CTD	MESH:D011791	CAV1 protein modified form inhibits the reaction [Quartz affects the localization of YAP1 protein]; CAV1 protein modified form inhibits the reaction [Quartz results in increased expression of YAP1 protein]	PMID:36053221
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:47217	arsane	affects localization	EXP		E	RGD:6480464	20230502	CTD	MESH:D001151	Arsenic affects the localization of YAP1 protein	PMID:28524356
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:47217	arsane	affects localization	ISO	RGD:1550378	E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic affects the localization of YAP1 protein	PMID:23942117
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in increased expression of and results in decreased phosphorylation of YAP1 protein	PMID:23942117
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:4948	Evodiamine	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine results in decreased expression of YAP1 mRNA; evodiamine results in decreased expression of YAP1 protein	PMID:32057900
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:4948	Evodiamine	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine results in increased phosphorylation of and affects the localization of YAP1 protein; XMU-MP-1 inhibits the reaction [evodiamine results in decreased expression of YAP1 mRNA]; XMU-MP-1 inhibits the reaction [evodiamine results in decreased expression of YAP1 protein]; XMU-MP-1 inhibits the reaction [evodiamine results in increased phosphorylation of YAP1 protein]	PMID:32057900
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YAP1 mRNA	PMID:28628672
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:49976	zinc dichloride	multiple interactions	EXP		E	RGD:6480464	20231003	CTD	MESH:C016837	zinc chloride results in decreased phosphorylation of and affects the localization of YAP1 protein	PMID:35027733
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:5001	fenofibrate	affects localization	ISO	RGD:1550378	E	RGD:6480464	20241203	CTD	MESH:D011345	Fenofibrate affects the localization of YAP1 protein	PMID:39442682
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20241203	CTD	MESH:D011345	Fenofibrate results in increased expression of and results in decreased phosphorylation of YAP1 protein	PMID:39442682
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306035	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of YAP1 mRNA	PMID:34044035
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:50924	sorafenib	decreases response to substance	EXP		E	RGD:6480464	20180828	CTD	MESH:C471405	YAP1 protein results in decreased susceptibility to sorafenib	PMID:29698666
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1550378	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of YAP1 mRNA	PMID:26377693
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:52289	wortmannin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin promotes the reaction [Cisplatin results in increased expression of YAP1 protein modified form]; wortmannin promotes the reaction [Doxorubicin results in increased expression of YAP1 protein modified form]	PMID:21214929
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:5855	ibuprofen	decreases expression	ISO	RGD:1550378	E	RGD:6480464	20231205	CTD	MESH:D007052	Ibuprofen results in decreased expression of YAP1 mRNA	PMID:37453669
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:5855	ibuprofen	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20231205	CTD	MESH:D007052	Ibuprofen results in decreased expression of and results in increased phosphorylation of YAP1 protein	PMID:37453669
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of YAP1 protein	PMID:32959892
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of and results in decreased phosphorylation of YAP1 protein	PMID:23671600
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:63637	vemurafenib	affects localization	EXP		E	RGD:6480464	20171010	CTD	MESH:C551177	vemurafenib affects the localization of YAP1 protein	PMID:26668268
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:63637	vemurafenib	decreases response to substance	EXP		E	RGD:6480464	20171010	CTD	MESH:C551177	YAP1 protein mutant form results in decreased susceptibility to vemurafenib	PMID:26668268
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:63637	vemurafenib	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:C551177	[YAP1 protein mutant form results in decreased susceptibility to vemurafenib] inhibits the reaction [vemurafenib results in decreased expression of MYC protein]; [YAP1 protein mutant form results in decreased susceptibility to vemurafenib] inhibits the reaction [vemurafenib results in decreased phosphorylation of MAPK1 protein]; [YAP1 protein mutant form results in decreased susceptibility to vemurafenib] inhibits the reaction [vemurafenib results in decreased phosphorylation of MAPK3 protein]	PMID:26668268
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium Chloride promotes the reaction [YAP1 protein binds to SMAD2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium Chloride promotes the reaction [YAP1 protein binds to SMAD3 protein]]	PMID:28450285
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:66104	jaspamide	multiple interactions	EXP		E	RGD:6480464	20170725	CTD	MESH:C057531	jasplakinolide results in decreased phosphorylation of and affects the localization of YAP1 protein; YAP1 protein affects the reaction [jasplakinolide results in increased expression of CCN1 protein]; YAP1 protein affects the reaction [jasplakinolide results in increased expression of CCN2 protein]	PMID:24040060
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:67991	(20S)-ginsenoside Rg3	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C097367	ginsenoside Rg3 results in decreased expression of YAP1 mRNA	PMID:31916386
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of YAP1 mRNA	PMID:25912373
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550378	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of YAP1 mRNA	PMID:22206623
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:748285	napabucasin	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621033	napabucasin results in decreased expression of YAP1 mRNA	PMID:25605917
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [tcdA protein, Clostridium difficile results in decreased expression of YAP1 protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [toxB protein, Clostridium difficile results in decreased expression of YAP1 protein]	PMID:33251692
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:754906	afuresertib	decreases phosphorylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased phosphorylation of YAP1 protein	PMID:28960945
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:758254	ovatodiolide	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C432447	ovatodiolide results in decreased expression of YAP1 protein	PMID:29698666
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:76604	MeIQx	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in decreased expression of YAP1 mRNA	PMID:20816883
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in decreased expression of YAP1 protein	PMID:39638853
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1306035	E	RGD:6480464	20200609	CTD	MESH:C025589	ochratoxin A results in increased expression of YAP1 protein	PMID:31369848
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:7726	octreotide	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20221101	CTD	MESH:D015282	Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of YAP1 mRNA]; SNHG12 mRNA promotes the reaction [Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of YAP1 mRNA]]; YAP1 promotes the reaction [SNHG12 mRNA promotes the reaction [Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of MAP1LC3B protein]]]; YAP1 promotes the reaction [SNHG12 mRNA results in increased susceptibility to Octreotide]	PMID:35307376
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA	PMID:27188386
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:80799	Bufotalin	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of YAP1 mRNA	PMID:39904859
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:80923	Caulerpin	decreases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:C000392	caulerpin results in decreased expression of YAP1 mRNA; caulerpin results in decreased expression of YAP1 protein	PMID:40902831
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:80923	Caulerpin	increases phosphorylation	EXP		E	RGD:6480464	20260303	CTD	MESH:C000392	caulerpin results in increased phosphorylation of YAP1 protein	PMID:40902831
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306035	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of YAP1 mRNA	PMID:32109520
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1306035	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of YAP1 protein	PMID:28903499
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of YAP1 mRNA	PMID:26272509
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA	PMID:27188386
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of YAP1 mRNA	PMID:27188386
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:9130	sevoflurane	decreases phosphorylation	ISO	RGD:1550378	E	RGD:6480464	20250506	CTD	MESH:C009250	Sevoflurane results in decreased phosphorylation of YAP1 protein	PMID:39182851
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:9130	sevoflurane	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20250506	CTD	MESH:C009250	PLIN4 protein promotes the reaction [Sevoflurane results in decreased phosphorylation of YAP1 protein]	PMID:39182851
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:94807	acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester	decreases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C041747	nitazoxanide results in decreased expression of YAP1 protein	PMID:39084502
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of YAP1 protein	PMID:38598786
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1550378	E	RGD:6480464	20201103	CTD	MESH:C025643	vinclozolin results in decreased expression of YAP1 mRNA	PMID:31601345|PMID:34182078|PMID:36642194
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1306035	E	RGD:6480464	20191112	CTD	MESH:C025643	vinclozolin results in decreased methylation of YAP1 gene	PMID:30207508
1314421	YAP1	Yes1 associated transcriptional regulator	gene	CHEBI:9986	vinclozolin	multiple interactions	ISO	RGD:1550378	E	RGD:6480464	20201103	CTD	MESH:C025643	vinclozolin results in decreased expression of and results in increased phosphorylation of YAP1 protein	PMID:31601345|PMID:34182078|PMID:36642194
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SLC10A5 mRNA	PMID:38218311
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623755	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SLC10A5 mRNA	PMID:33045310
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306036	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC10A5 mRNA]	PMID:31150632
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1623755	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SLC10A5 mRNA	PMID:39298647
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306036	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SLC10A5 mRNA	PMID:33387578
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1623755	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SLC10A5 mRNA	PMID:37992649
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1623755	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SLC10A5 mRNA	PMID:37992649
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC10A5 mRNA	PMID:36139627
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306036	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SLC10A5 mRNA	PMID:33387578
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1623755	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC10A5 mRNA	PMID:36331819
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLC10A5 gene	PMID:27153756
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306036	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC10A5 mRNA	PMID:31150632
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306036	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC10A5 mRNA]	PMID:31150632
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of SLC10A5 promoter	PMID:21291286
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SLC10A5 mRNA	PMID:27392435
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SLC10A5 mRNA	PMID:27392435
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306036	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC10A5 mRNA	PMID:33387578
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1623755	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC10A5 mRNA	PMID:26290441
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013749	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC10A5 mRNA	PMID:26159488
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1306036	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of SLC10A5 mRNA	PMID:28374803
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC10A5 mRNA	PMID:33212167
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1623755	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SLC10A5 mRNA	PMID:37992649
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC10A5 mRNA	PMID:34032870
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC10A5 mRNA	PMID:32234424
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SLC10A5 promoter	PMID:27901495
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1623755	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of SLC10A5 mRNA	PMID:35295148
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306036	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC10A5 mRNA	PMID:25181051|PMID:30816183
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306036	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of SLC10A5 mRNA	PMID:41034487
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306036	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SLC10A5 gene	PMID:28505145
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623755	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SLC10A5 mRNA	PMID:39298647
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1623755	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SLC10A5 mRNA	PMID:38685157
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1623755	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SLC10A5 mRNA	PMID:37019170
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of SLC10A5 mRNA	PMID:29024780
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1306036	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of SLC10A5 mRNA	PMID:25539665
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SLC10A5 mRNA	PMID:32588087
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1623755	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SLC10A5 mRNA	PMID:40194260
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SLC10A5 mRNA	PMID:31533062
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623755	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC10A5 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLC10A5 mRNA	PMID:36331819
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1306036	E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in decreased expression of SLC10A5 mRNA	PMID:35594946
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1623755	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SLC10A5 mRNA	PMID:37992649
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SLC10A5 mRNA	PMID:38832940
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1623755	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC10A5 mRNA	PMID:29246445
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1623755	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form promotes the reaction [Acetaminophen results in decreased expression of SLC10A5 mRNA]	PMID:29246445
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of SLC10A5 promoter	PMID:21291286
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306036	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SLC10A5 mRNA	PMID:29391264
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:4791	endosulfan	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D004726	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of SLC10A5 mRNA	PMID:26159488
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of SLC10A5 mRNA	PMID:32234424
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SLC10A5 mRNA	PMID:37199045
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC10A5 mRNA	PMID:36139627
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:80491	pinostrobin	increases phosphorylation	EXP		E	RGD:6480464	20240206	CTD	MESH:C411294	pinostrobin results in increased phosphorylation of SLC10A5 protein	PMID:37164308
1314423	SLC10A5	solute carrier family 10 member 5	gene	CHEBI:8064	phenformin	decreases expression	ISO	RGD:1306036	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of SLC10A5 mRNA	PMID:31324951
1314425	CORO1C	coronin 1C	gene	CHEBI:10106	zearalenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in increased expression of CORO1C mRNA	PMID:19371625
1314425	CORO1C	coronin 1C	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CORO1C mRNA	PMID:38218311
1314425	CORO1C	coronin 1C	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314426	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of CORO1C mRNA	PMID:33045310
1314425	CORO1C	coronin 1C	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314426	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CORO1C mRNA	PMID:20188158
1314425	CORO1C	coronin 1C	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CORO1C mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CORO1C mRNA	PMID:32699268
1314425	CORO1C	coronin 1C	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314426	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CORO1C mRNA	PMID:36331819
1314425	CORO1C	coronin 1C	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314426	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CORO1C mRNA	PMID:30319688
1314425	CORO1C	coronin 1C	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314426	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CORO1C mRNA	PMID:39241906
1314425	CORO1C	coronin 1C	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of CORO1C mRNA	PMID:31614463
1314425	CORO1C	coronin 1C	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314426	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CORO1C mRNA	PMID:39298647
1314425	CORO1C	coronin 1C	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1564490	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CORO1C mRNA	PMID:33387578
1314425	CORO1C	coronin 1C	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1564490	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CORO1C mRNA	PMID:22061828
1314425	CORO1C	coronin 1C	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314426	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CORO1C mRNA	PMID:28111341
1314425	CORO1C	coronin 1C	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CORO1C protein	PMID:23301498
1314425	CORO1C	coronin 1C	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CORO1C mRNA	PMID:27153756
1314425	CORO1C	coronin 1C	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CORO1C mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CORO1C mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of CORO1C mRNA	PMID:32699268
1314425	CORO1C	coronin 1C	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CORO1C protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CORO1C protein	PMID:38598786
1314425	CORO1C	coronin 1C	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314426	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CORO1C mRNA	PMID:27339419|PMID:31919559
1314425	CORO1C	coronin 1C	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CORO1C gene	PMID:25304211
1314425	CORO1C	coronin 1C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314426	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CORO1C mRNA	PMID:40504410
1314425	CORO1C	coronin 1C	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in increased expression of CORO1C mRNA	PMID:19371625
1314425	CORO1C	coronin 1C	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	CORO1C protein affects the susceptibility to Cisplatin	PMID:16217747
1314425	CORO1C	coronin 1C	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CORO1C mRNA	PMID:27594783
1314425	CORO1C	coronin 1C	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of CORO1C mRNA	PMID:27392435
1314425	CORO1C	coronin 1C	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1314426	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of CORO1C mRNA	PMID:18930951
1314425	CORO1C	coronin 1C	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of CORO1C mRNA	PMID:19371625
1314425	CORO1C	coronin 1C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314426	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CORO1C mRNA	PMID:21570461
1314425	CORO1C	coronin 1C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1564490	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CORO1C mRNA	PMID:22298810
1314425	CORO1C	coronin 1C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1564490	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CORO1C mRNA	PMID:21215274
1314425	CORO1C	coronin 1C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1564490	E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of CORO1C mRNA]	PMID:21215274
1314425	CORO1C	coronin 1C	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CORO1C mRNA	PMID:29432896
1314425	CORO1C	coronin 1C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314426	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CORO1C mRNA	PMID:40504410
1314425	CORO1C	coronin 1C	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CORO1C 5' UTR	PMID:27901495
1314425	CORO1C	coronin 1C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CORO1C mRNA	PMID:20064835
1314425	CORO1C	coronin 1C	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314426	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CORO1C mRNA	PMID:19770486
1314425	CORO1C	coronin 1C	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314426	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CORO1C mRNA	PMID:22228805
1314425	CORO1C	coronin 1C	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20140812	CTD	MESH:D001564	[Soot co-treated with Benzo(a)pyrene] results in increased expression of CORO1C protein	PMID:24464499
1314425	CORO1C	coronin 1C	gene	CHEBI:3000	beauvericin	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C004456	[beauvericin co-treated with enniatins] results in increased expression of CORO1C protein	PMID:32407736
1314425	CORO1C	coronin 1C	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CORO1C mRNA	PMID:25895662
1314425	CORO1C	coronin 1C	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CORO1C mRNA	PMID:19150397
1314425	CORO1C	coronin 1C	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CORO1C gene	PMID:31601247
1314425	CORO1C	coronin 1C	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1564490	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CORO1C mRNA	PMID:30047161
1314425	CORO1C	coronin 1C	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1564490	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of CORO1C mRNA	PMID:24136188
1314425	CORO1C	coronin 1C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314426	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CORO1C gene	PMID:35295148
1314425	CORO1C	coronin 1C	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314426	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of CORO1C mRNA	PMID:29264374
1314425	CORO1C	coronin 1C	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314426	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CORO1C promoter	PMID:35295148
1314425	CORO1C	coronin 1C	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1564490	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CORO1C mRNA	PMID:34492290
1314425	CORO1C	coronin 1C	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CORO1C mRNA	PMID:19710929
1314425	CORO1C	coronin 1C	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1564490	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CORO1C mRNA	PMID:25181051
1314425	CORO1C	coronin 1C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of CORO1C protein	PMID:34186270
1314425	CORO1C	coronin 1C	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314426	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CORO1C mRNA; bisphenol A results in decreased expression of CORO1C protein	PMID:33221593|PMID:35999755
1314425	CORO1C	coronin 1C	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CORO1C gene	PMID:31601247
1314425	CORO1C	coronin 1C	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of CORO1C mRNA; bisphenol A results in increased expression of CORO1C protein	PMID:19371625|PMID:37567409
1314425	CORO1C	coronin 1C	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of CORO1C gene	PMID:31601247
1314425	CORO1C	coronin 1C	gene	CHEBI:34107	1-nitropyrene	increases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in increased expression of CORO1C mRNA	PMID:19041380
1314425	CORO1C	coronin 1C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of CORO1C gene	PMID:31601247
1314425	CORO1C	coronin 1C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CORO1C protein	PMID:34186270
1314425	CORO1C	coronin 1C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314426	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CORO1C mRNA	PMID:39298647
1314425	CORO1C	coronin 1C	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314426	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CORO1C mRNA	PMID:38685157
1314425	CORO1C	coronin 1C	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CORO1C mRNA	PMID:28628672
1314425	CORO1C	coronin 1C	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314426	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of CORO1C protein	PMID:35999755
1314425	CORO1C	coronin 1C	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1564490	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CORO1C mRNA	PMID:21266533
1314425	CORO1C	coronin 1C	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314426	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of CORO1C mRNA	PMID:34813904
1314425	CORO1C	coronin 1C	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of CORO1C protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CORO1C protein	PMID:38598786
1314425	CORO1C	coronin 1C	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CORO1C mRNA	PMID:28628672
1314425	CORO1C	coronin 1C	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CORO1C mRNA	PMID:37042841
1314425	CORO1C	coronin 1C	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1564490	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of CORO1C mRNA	PMID:30589522
1314425	CORO1C	coronin 1C	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314426	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CORO1C mRNA	PMID:28111341
1314425	CORO1C	coronin 1C	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CORO1C mRNA	PMID:19320972
1314425	CORO1C	coronin 1C	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CORO1C mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CORO1C mRNA	PMID:32699268
1314425	CORO1C	coronin 1C	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CORO1C mRNA	PMID:31533062
1314425	CORO1C	coronin 1C	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of CORO1C mRNA	PMID:19167446
1314425	CORO1C	coronin 1C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of CORO1C mRNA	PMID:40419075
1314425	CORO1C	coronin 1C	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314426	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CORO1C mRNA	PMID:36331819
1314425	CORO1C	coronin 1C	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in decreased expression of CORO1C mRNA	PMID:17685462
1314425	CORO1C	coronin 1C	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CORO1C mRNA	PMID:25979313
1314425	CORO1C	coronin 1C	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314426	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CORO1C mRNA	PMID:17292431
1314425	CORO1C	coronin 1C	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of CORO1C mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509
1314425	CORO1C	coronin 1C	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CORO1C mRNA	PMID:27188386
1314425	CORO1C	coronin 1C	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1564490	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CORO1C mRNA	PMID:30047161
1314425	CORO1C	coronin 1C	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of CORO1C mRNA	PMID:22147139
1314425	CORO1C	coronin 1C	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CORO1C mRNA	PMID:28628672
1314425	CORO1C	coronin 1C	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314426	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CORO1C mRNA	PMID:28973697
1314425	CORO1C	coronin 1C	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1564490	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of CORO1C mRNA	PMID:24136188
1314425	CORO1C	coronin 1C	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CORO1C mRNA; Okadaic Acid results in increased expression of CORO1C protein	PMID:38832940
1314425	CORO1C	coronin 1C	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of CORO1C mRNA	PMID:29067470
1314425	CORO1C	coronin 1C	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CORO1C gene	PMID:25304211
1314425	CORO1C	coronin 1C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314426	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CORO1C mRNA	PMID:40504410
1314425	CORO1C	coronin 1C	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314426	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CORO1C mRNA	PMID:17942748
1314425	CORO1C	coronin 1C	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CORO1C mRNA	PMID:28628672
1314425	CORO1C	coronin 1C	gene	CHEBI:49668	gefitinib	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:C419708	CORO1C protein affects the susceptibility to gefitinib	PMID:15496427
1314425	CORO1C	coronin 1C	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1564490	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CORO1C mRNA	PMID:30047161
1314425	CORO1C	coronin 1C	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CORO1C protein	PMID:32959892
1314425	CORO1C	coronin 1C	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1564490	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of CORO1C mRNA	PMID:24136188
1314425	CORO1C	coronin 1C	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1314426	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CORO1C protein	PMID:26558463
1314425	CORO1C	coronin 1C	gene	CHEBI:64648	enniatin	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C100264	[beauvericin co-treated with enniatins] results in increased expression of CORO1C protein	PMID:32407736
1314425	CORO1C	coronin 1C	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1314426	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in increased expression of CORO1C mRNA	PMID:17654400
1314425	CORO1C	coronin 1C	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CORO1C mRNA	PMID:31758290
1314425	CORO1C	coronin 1C	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CORO1C protein	PMID:34186270
1314425	CORO1C	coronin 1C	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1564490	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of CORO1C mRNA	PMID:24136188
1314425	CORO1C	coronin 1C	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CORO1C mRNA	PMID:27188386
1314425	CORO1C	coronin 1C	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CORO1C gene]	PMID:28238834
1314425	CORO1C	coronin 1C	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1564490	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of CORO1C mRNA	PMID:32109520
1314425	CORO1C	coronin 1C	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of CORO1C protein	PMID:31675489
1314425	CORO1C	coronin 1C	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314426	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of CORO1C mRNA	PMID:21795629
1314425	CORO1C	coronin 1C	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1564490	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of CORO1C mRNA	PMID:30047161
1314425	CORO1C	coronin 1C	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1564490	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CORO1C mRNA	PMID:30047161
1314425	CORO1C	coronin 1C	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CORO1C mRNA	PMID:27188386
1314425	CORO1C	coronin 1C	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in increased expression of CORO1C mRNA	PMID:31863870
1314425	CORO1C	coronin 1C	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of CORO1C protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CORO1C protein	PMID:38598786
1314425	CORO1C	coronin 1C	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314426	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CORO1C mRNA	PMID:28973697
1314425	CORO1C	coronin 1C	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1564490	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of CORO1C mRNA	PMID:19015723
1314427	C1QL1	complement C1q like 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of C1QL1 mRNA	PMID:23724009
1314427	C1QL1	complement C1q like 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of C1QL1 mRNA	PMID:22378314
1314427	C1QL1	complement C1q like 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of C1QL1 mRNA	PMID:30165855
1314427	C1QL1	complement C1q like 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306039	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of C1QL1 mRNA	PMID:33387578
1314427	C1QL1	complement C1q like 1	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1314428	E	RGD:6480464	20250114	CTD	MESH:D001554	Benzene results in decreased expression of C1QL1 mRNA	PMID:37084897
1314427	C1QL1	complement C1q like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C1QL1 mRNA	PMID:39836092
1314427	C1QL1	complement C1q like 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in increased expression of C1QL1 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of C1QL1 mRNA	PMID:23557933|PMID:41028656
1314427	C1QL1	complement C1q like 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of C1QL1 mRNA	PMID:28903495
1314427	C1QL1	complement C1q like 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of C1QL1 mRNA	PMID:27392435
1314427	C1QL1	complement C1q like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314428	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to C1QL1 promoter]	PMID:19654925
1314427	C1QL1	complement C1q like 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of C1QL1 mRNA; aristolochic acid I results in decreased expression of C1QL1 protein	PMID:33212167
1314427	C1QL1	complement C1q like 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306039	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of C1QL1 mRNA	PMID:28959563
1314427	C1QL1	complement C1q like 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of C1QL1 mRNA; [Copper co-treated with Resveratrol] results in increased expression of C1QL1 mRNA	PMID:31162603|PMID:41028656
1314427	C1QL1	complement C1q like 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of C1QL1 mRNA	PMID:34032870
1314427	C1QL1	complement C1q like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C1QL1 mRNA	PMID:39836092
1314427	C1QL1	complement C1q like 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of C1QL1 promoter	PMID:27901495
1314427	C1QL1	complement C1q like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1306039	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of C1QL1 mRNA	PMID:21839799
1314427	C1QL1	complement C1q like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of C1QL1 3' UTR	PMID:27901495
1314427	C1QL1	complement C1q like 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of C1QL1 mRNA	PMID:17879257|PMID:32234424
1314427	C1QL1	complement C1q like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of C1QL1 exon	PMID:27901495
1314427	C1QL1	complement C1q like 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of C1QL1 promoter	PMID:23974009
1314427	C1QL1	complement C1q like 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of C1QL1 mRNA; [Copper co-treated with Resveratrol] results in increased expression of C1QL1 mRNA	PMID:31162603|PMID:41028656
1314427	C1QL1	complement C1q like 1	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of C1QL1 mRNA	PMID:37690743
1314427	C1QL1	complement C1q like 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314428	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of C1QL1 gene	PMID:35295148
1314427	C1QL1	complement C1q like 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314428	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of C1QL1 promoter	PMID:35295148
1314427	C1QL1	complement C1q like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306039	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of C1QL1 mRNA	PMID:25181051
1314427	C1QL1	complement C1q like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314428	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of C1QL1 mRNA	PMID:35598803
1314427	C1QL1	complement C1q like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306039	E	RGD:6480464	20180220	CTD	MESH:C006780	bisphenol A results in increased expression of C1QL1 mRNA	PMID:27178563
1314427	C1QL1	complement C1q like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314428	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of C1QL1 mRNA	PMID:30951980
1314427	C1QL1	complement C1q like 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1314428	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of C1QL1 promoter	PMID:27312807
1314427	C1QL1	complement C1q like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306039	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of C1QL1 mRNA	PMID:36041667
1314427	C1QL1	complement C1q like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306039	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of C1QL1 mRNA	PMID:36041667
1314427	C1QL1	complement C1q like 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306039	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of C1QL1 mRNA	PMID:36041667
1314427	C1QL1	complement C1q like 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314428	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of C1QL1 3' UTR	PMID:28392331
1314427	C1QL1	complement C1q like 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of C1QL1 mRNA	PMID:38382870
1314427	C1QL1	complement C1q like 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of C1QL1 mRNA	PMID:31533062
1314427	C1QL1	complement C1q like 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of C1QL1 mRNA	PMID:25979313
1314427	C1QL1	complement C1q like 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of C1QL1 mRNA	PMID:23179753|PMID:28001369
1314427	C1QL1	complement C1q like 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of C1QL1 gene	PMID:29154799
1314427	C1QL1	complement C1q like 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of C1QL1 mRNA	PMID:20106945
1314427	C1QL1	complement C1q like 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of C1QL1 mRNA	PMID:38832940
1314427	C1QL1	complement C1q like 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of C1QL1 mRNA	PMID:29067470
1314427	C1QL1	complement C1q like 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306039	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of C1QL1 mRNA	PMID:33387578
1314427	C1QL1	complement C1q like 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of C1QL1 mRNA	PMID:39836092
1314427	C1QL1	complement C1q like 1	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of C1QL1 mRNA	PMID:31838189
1314427	C1QL1	complement C1q like 1	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1306039	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of C1QL1 mRNA	PMID:19564919
1314427	C1QL1	complement C1q like 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306039	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of C1QL1 mRNA	PMID:32109520
1314427	C1QL1	complement C1q like 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of C1QL1 mRNA	PMID:19095052
1314427	C1QL1	complement C1q like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306039	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of C1QL1 mRNA	PMID:24780913
1314427	C1QL1	complement C1q like 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306039	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of C1QL1 mRNA	PMID:19281266
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CREB3L2 mRNA	PMID:38218311
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1550380	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CREB3L2 mRNA	PMID:20188158
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of CREB3L2 mRNA	PMID:33167477
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550380	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of CREB3L2 mRNA	PMID:30951980
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:15767	dichloromethane	decreases expression	ISO	RGD:1550380	E	RGD:6480464	20171010	CTD	MESH:D008752	Methylene Chloride results in decreased expression of CREB3L2 mRNA	PMID:28392392
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CREB3L2 mRNA	PMID:22378314
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1550380	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CREB3L2 mRNA	PMID:30319688
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550380	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of CREB3L2 mRNA	PMID:30319688
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CREB3L2 mRNA	PMID:21632981
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of CREB3L2 mRNA	PMID:29581250
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550380	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CREB3L2 mRNA	PMID:39298647
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306040	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of CREB3L2 mRNA	PMID:26496021
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of CREB3L2 mRNA	PMID:38685446
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:17447	geraniol	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of CREB3L2 mRNA	PMID:27683099
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CREB3L2 protein	PMID:37730182
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306040	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CREB3L2 mRNA	PMID:33387578
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CREB3L2 mRNA	PMID:35301059
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CREB3L2 mRNA	PMID:23649840
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550380	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CREB3L2 mRNA	PMID:31919559
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550380	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CREB3L2 mRNA	PMID:25629700
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CREB3L2 protein	PMID:35688186
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of CREB3L2 mRNA	PMID:31295307
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306040	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of CREB3L2 mRNA	PMID:31881176
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1550380	E	RGD:6480464	20200211	CTD	MESH:C059514	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CREB3L2 mRNA]	PMID:31298478
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1306040	E	RGD:6480464	20231031	CTD	MESH:D007854	Lead results in decreased expression of and results in increased methylation of CREB3L2 mRNA	PMID:37269892
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550380	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CREB3L2 mRNA	PMID:30912803
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:28017	starch	multiple interactions	ISO	RGD:1306040	E	RGD:6480464	20170516	CTD	MESH:D013213	Starch analog inhibits the reaction [Rapeseed Oil metabolite results in decreased expression of CREB3L2 mRNA]	PMID:27363782
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550380	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CREB3L2 mRNA	PMID:21570461
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306040	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CREB3L2 mRNA	PMID:32109520
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550380	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CREB3L2 mRNA	PMID:26290441|PMID:33956508
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306040	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CREB3L2 mRNA	PMID:33387578
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550380	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CREB3L2 mRNA	PMID:24058054
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550380	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CREB3L2 mRNA	PMID:25975270
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CREB3L2 mRNA	PMID:33212167
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of CREB3L2 mRNA; [Chelating Agents binds to Copper] which results in increased expression of CREB3L2 mRNA	PMID:30911355
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:28812	(aminomethyl)phosphonic acid	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:C036423	1-aminomethylphosphonic acid results in increased expression of CREB3L2 mRNA	PMID:31295307
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CREB3L2 mRNA	PMID:38568856|PMID:39719251
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of CREB3L2 mRNA	PMID:22378314|PMID:29453283
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1550380	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of CREB3L2 mRNA	PMID:17127020
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CREB3L2 mRNA	PMID:20106945|PMID:21632981
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550380	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CREB3L2 mRNA	PMID:19770486
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CREB3L2 3' UTR	PMID:27901495
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to CREB3L2 mRNA]	PMID:32406909
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of CREB3L2 mRNA; [Chelating Agents binds to Copper] which results in increased expression of CREB3L2 mRNA	PMID:30911355
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1550380	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CREB3L2 mRNA	PMID:27131904
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1550380	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CREB3L2 mRNA	PMID:23221170
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CREB3L2 mRNA	PMID:20018196
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1550380	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of CREB3L2 mRNA	PMID:29095437
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1550380	E	RGD:6480464	20191114	CTD	MESH:C006632	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CREB3L2 mRNA]	PMID:29095437
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of CREB3L2 mRNA	PMID:38568856
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306040	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CREB3L2 mRNA	PMID:30047161
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550380	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CREB3L2 gene	PMID:35295148
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550380	E	RGD:6480464	20200211	CTD	MESH:C009495	titanium dioxide results in increased expression of CREB3L2 mRNA	PMID:31298478
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550380	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CREB3L2 promoter	PMID:35295148
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1550380	E	RGD:6480464	20200211	CTD	MESH:C009495	Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CREB3L2 mRNA]	PMID:31298478
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550380	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of CREB3L2 mRNA	PMID:17426115|PMID:23811191
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1550380	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CREB3L2 mRNA	PMID:19710929
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306040	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of CREB3L2 mRNA	PMID:32145629
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1550380	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of CREB3L2 promoter	PMID:27334623
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306040	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CREB3L2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306040	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CREB3L2 mRNA	PMID:25181051|PMID:33296240
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550380	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of CREB3L2 mRNA	PMID:30951980
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306040	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of CREB3L2 mRNA	PMID:26496021
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1306040	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CREB3L2 mRNA	PMID:23196670|PMID:32119087
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550380	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CREB3L2 mRNA	PMID:30951980|PMID:39298647
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550380	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of CREB3L2 mRNA	PMID:30951980|PMID:38685157
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:34575	bisphenol F	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	bisphenol F results in increased methylation of CREB3L2 gene	PMID:31601247
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1550380	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of CREB3L2 mRNA	PMID:30951980
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550380	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CREB3L2 mRNA	PMID:21266533
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306040	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of CREB3L2 mRNA	PMID:32680482
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1550380	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of CREB3L2 mRNA]	PMID:19030233
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CREB3L2 mRNA	PMID:37042841
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CREB3L2 mRNA	PMID:38568856
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CREB3L2 mRNA	PMID:35301059
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CREB3L2 mRNA	PMID:19320972
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1550380	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CREB3L2 mRNA	PMID:18353800
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550380	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of CREB3L2 mRNA	PMID:23811191
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:3764	clotrimazole	increases expression	ISO	RGD:1306040	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of CREB3L2 mRNA	PMID:30047161
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550380	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CREB3L2 mRNA	PMID:40194260
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CREB3L2 mRNA	PMID:28302478
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CREB3L2 mRNA	PMID:25979313
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CREB3L2 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CREB3L2 mRNA	PMID:27188386
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306040	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CREB3L2 mRNA	PMID:30047161
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CREB3L2 mRNA	PMID:25562108
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CREB3L2 mRNA	PMID:20106945
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1550380	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CREB3L2 mRNA	PMID:17555576
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550380	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of CREB3L2 mRNA	PMID:28973697
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of CREB3L2 mRNA	PMID:24449571
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of CREB3L2 mRNA	PMID:24935251|PMID:26272509
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CREB3L2 mRNA	PMID:27188386
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550380	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CREB3L2 mRNA	PMID:17562736
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306040	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CREB3L2 mRNA	PMID:33387578
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CREB3L2 mRNA	PMID:29432896
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1550380	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of CREB3L2 mRNA	PMID:26934552
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550380	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CREB3L2 mRNA	PMID:17555576
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1550380	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of CREB3L2 mRNA	PMID:29095437
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1550380	E	RGD:6480464	20191114	CTD	MESH:C032793	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CREB3L2 mRNA]	PMID:29095437
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550380	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CREB3L2 mRNA	PMID:25620056
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306040	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CREB3L2 mRNA	PMID:30047161
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1550380	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of CREB3L2 mRNA	PMID:19812364
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1306040	E	RGD:6480464	20200114	CTD	MESH:D008687	Metformin results in increased expression of CREB3L2 mRNA	PMID:31324951
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1550380	E	RGD:6480464	20190219	CTD	MESH:D008687	Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CREB3L2 mRNA]	PMID:29095437
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306040	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CREB3L2 gene	PMID:35440735
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CREB3L2 mRNA	PMID:31758290
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:72754	bisphenol AF	decreases expression	ISO	RGD:1306040	E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in decreased expression of CREB3L2 mRNA	PMID:39938710
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550380	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CREB3L2 mRNA	PMID:22206623
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of CREB3L2 protein	PMID:31285264
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of CREB3L2 mRNA	PMID:34995734
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CREB3L2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CREB3L2 mRNA	PMID:27188386
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1550380	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CREB3L2 mRNA	PMID:30294300
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1550380	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of CREB3L2 mRNA	PMID:21278054
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306040	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CREB3L2 mRNA	PMID:30047161
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CREB3L2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CREB3L2 mRNA	PMID:27188386
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1550380	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CREB3L2 mRNA	PMID:27131904
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CREB3L2 mRNA	PMID:38568856
1314429	CREB3L2	cAMP responsive element binding protein 3 like 2	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of CREB3L2 mRNA	PMID:22378314|PMID:29453283
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SUGP2 mRNA	PMID:38218311
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314433	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of SUGP2 mRNA	PMID:33045310
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314433	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SUGP2 mRNA	PMID:33045310
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SUGP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SUGP2 mRNA	PMID:32699268
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SUGP2 mRNA	PMID:26079696
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314433	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SUGP2 mRNA	PMID:30319688
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SUGP2 mRNA	PMID:37042841
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SUGP2 mRNA	PMID:21179406
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SUGP2 protein	PMID:37730182
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SUGP2 mRNA	PMID:19549813
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SUGP2 protein	PMID:23301498
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314433	E	RGD:6480464	20120821	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SUGP2 mRNA	PMID:19770486
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SUGP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SUGP2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of SUGP2 mRNA	PMID:32699268
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314433	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SUGP2 mRNA	PMID:40504410
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SUGP2 protein	PMID:35688186
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SUGP2 mRNA	PMID:23557933
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of SUGP2 mRNA	PMID:23300844
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SUGP2 mRNA	PMID:28001369
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SUGP2 mRNA	PMID:29803840
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SUGP2 mRNA	PMID:38568856
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314433	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SUGP2 mRNA	PMID:40504410
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SUGP2 mRNA	PMID:20064835
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314433	E	RGD:6480464	20120925	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SUGP2 mRNA	PMID:22228805
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314433	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SUGP2 mRNA	PMID:39716349
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314433	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SUGP2 gene	PMID:35295148
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314433	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SUGP2 promoter	PMID:35295148
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306042	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SUGP2 mRNA	PMID:23411599
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314433	E	RGD:6480464	20120821	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SUGP2 mRNA	PMID:18648102
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314433	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of SUGP2 mRNA	PMID:32156529
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306042	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of SUGP2 mRNA	PMID:41034487
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUGP2 mRNA	PMID:28628672
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306042	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SUGP2 mRNA	PMID:36041667
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SUGP2 mRNA	PMID:28628672
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306042	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SUGP2 mRNA	PMID:36041667
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SUGP2 mRNA	PMID:28628672
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306042	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SUGP2 mRNA	PMID:36041667
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314433	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of SUGP2 mRNA	PMID:34813904
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUGP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SUGP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SUGP2 mRNA	PMID:28628672
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SUGP2 mRNA	PMID:19376846
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SUGP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SUGP2 mRNA	PMID:32699268
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1306042	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of SUGP2 mRNA	PMID:29427782
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of SUGP2 mRNA	PMID:26272509|PMID:28001369
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SUGP2 gene	PMID:29154799
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SUGP2 mRNA	PMID:23179753
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUGP2 mRNA	PMID:27188386
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314433	E	RGD:6480464	20120821	CTD	MESH:D013629	Tamoxifen affects the expression of SUGP2 mRNA	PMID:17555576
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUGP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SUGP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SUGP2 mRNA	PMID:28628672
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of SUGP2 mRNA	PMID:17400583
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SUGP2 mRNA	PMID:26272509
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUGP2 mRNA	PMID:27188386
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306042	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SUGP2 mRNA	PMID:33387578
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of SUGP2 mRNA	PMID:29523930
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1314433	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SUGP2 mRNA	PMID:29279043
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314433	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SUGP2 mRNA	PMID:40504410
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314433	E	RGD:6480464	20120821	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SUGP2 mRNA	PMID:17555576
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SUGP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SUGP2 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SUGP2 mRNA	PMID:28628672
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314433	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SUGP2 mRNA	PMID:39716349
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SUGP2 mRNA	PMID:23300844
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SUGP2 protein	PMID:32959892
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:63959	celastrol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C050414	celastrol results in increased expression of SUGP2 mRNA	PMID:39181414
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of SUGP2 mRNA	PMID:28988120
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SUGP2 mRNA	PMID:15336504
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SUGP2 mRNA	PMID:31758290
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314433	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SUGP2 mRNA	PMID:22206623
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SUGP2 protein	PMID:37664457
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of SUGP2 protein	PMID:39638853
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUGP2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUGP2 mRNA	PMID:27188386
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1306042	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of SUGP2 protein	PMID:28903499
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:90724	AM-251	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C103505	AM 251 results in decreased expression of SUGP2 mRNA	PMID:16500647
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of SUGP2 protein; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUGP2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SUGP2 mRNA	PMID:27188386|PMID:37664457
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306042	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SUGP2 mRNA	PMID:21346803
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of SUGP2 mRNA	PMID:17440010
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SUGP2 mRNA	PMID:38568856
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306042	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SUGP2 mRNA	PMID:21346803
1314432	SUGP2	SURP and G-patch domain containing 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314433	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SUGP2 mRNA	PMID:28973697
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of DMRT3 mRNA	PMID:26272509
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMRT3 mRNA	PMID:27188386
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314435	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of DMRT3 mRNA	PMID:37995155
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DMRT3 mRNA	PMID:31163220
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306043	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of DMRT3 mRNA	PMID:26577399
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DMRT3 gene	PMID:27153756
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DMRT3 gene	PMID:28458013
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of DMRT3 mRNA	PMID:26272509
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMRT3 mRNA	PMID:27188386
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1306043	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DMRT3 gene	PMID:33854195
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314435	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DMRT3 mRNA	PMID:24058054
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306043	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DMRT3 mRNA	PMID:32109520
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DMRT3 mRNA	PMID:28001369
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314435	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of DMRT3 mRNA	PMID:37682722
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DMRT3 promoter	PMID:27901495
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314435	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DMRT3 mRNA	PMID:27195522
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DMRT3 exon	PMID:27901495
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of DMRT3 promoter	PMID:23974009
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314435	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DMRT3 promoter	PMID:35295148
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314435	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of DMRT3 promoter	PMID:27334623
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306043	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DMRT3 mRNA	PMID:25181051|PMID:34947998
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DMRT3 gene	PMID:31601247
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314435	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of DMRT3 mRNA	PMID:34585602
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314435	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of DMRT3 gene	PMID:31683443
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1306043	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DMRT3 gene	PMID:33854195
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306043	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DMRT3 mRNA	PMID:35163327
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306043	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DMRT3 mRNA	PMID:35163327
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of DMRT3 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DMRT3 gene	PMID:29154799
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMRT3 mRNA	PMID:27188386
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1306043	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DMRT3 gene	PMID:33854195
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1306043	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DMRT3 gene	PMID:33854195
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of DMRT3 mRNA	PMID:24935251|PMID:26272509
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMRT3 mRNA	PMID:27188386
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306043	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DMRT3 mRNA	PMID:33387578
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1306043	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DMRT3 gene	PMID:33854195
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314435	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DMRT3 mRNA	PMID:22206623
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMRT3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMRT3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMRT3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMRT3 mRNA	PMID:27188386
1314434	DMRT3	doublesex and mab-3 related transcription factor 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMRT3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMRT3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMRT3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DMRT3 mRNA	PMID:27188386
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306044	E	RGD:6480464	20160712	CTD	MESH:D004237	Diuron results in decreased expression of USP13 mRNA	PMID:25152437
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306044	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of USP13 mRNA]	PMID:31150632
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of USP13 mRNA	PMID:15498508|PMID:33167477
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of USP13 mRNA	PMID:26079696
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1552359	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of USP13 mRNA	PMID:40945087
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of USP13 mRNA	PMID:21632981
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of USP13 mRNA	PMID:38568856
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306044	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of USP13 gene	PMID:27618143
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of USP13 mRNA	PMID:23649840
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of USP13 protein	PMID:37730182
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306044	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of USP13 mRNA	PMID:33387578
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of USP13 mRNA	PMID:35301059
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306044	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of USP13 mRNA	PMID:39012411
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of USP13 mRNA	PMID:19549813
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1306044	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of USP13 protein	PMID:33236894
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of USP13 mRNA	PMID:22100608
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of USP13 intron	PMID:30157460
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306044	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of USP13 mRNA	PMID:31150632
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306044	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of USP13 mRNA]	PMID:31150632
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of USP13 mRNA	PMID:16835338
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of USP13 mRNA	PMID:26272509
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP13 mRNA	PMID:27188386
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1552359	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of USP13 mRNA	PMID:35489704
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of USP13 mRNA	PMID:25583101
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of USP13 protein	PMID:39603559
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of USP13 mRNA	PMID:33212167
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306044	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of USP13 mRNA	PMID:28959563
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of USP13 mRNA	PMID:20971185
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:28783	zinc protoporphyrin	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:C017803	[lead acetate co-treated with zinc protoporphyrin] results in increased expression of USP13 mRNA	PMID:22839698
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of USP13 mRNA	PMID:38568856
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of USP13 mRNA	PMID:20064835
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552359	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of USP13 mRNA	PMID:22228805
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of USP13 mRNA	PMID:22316170
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552359	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of USP13 mRNA]	PMID:22228805
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of USP13 mRNA	PMID:20971185
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:C008261	[lead acetate co-treated with zinc protoporphyrin] results in increased expression of USP13 mRNA	PMID:22839698
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of USP13 mRNA	PMID:15498508
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552359	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of USP13 gene	PMID:35295148
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306044	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of USP13 mRNA	PMID:34492290
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of USP13 mRNA	PMID:19710929
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306044	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of USP13 mRNA	PMID:34947998
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of USP13 mRNA	PMID:25979313
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of USP13 gene	PMID:31601247
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of USP13 intron	PMID:30157460
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of USP13 mRNA	PMID:28628672
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552359	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of USP13 intron	PMID:28392331
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of USP13 mRNA	PMID:28628672
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1552359	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of USP13 mRNA	PMID:36117858
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of USP13 mRNA	PMID:37042841
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of USP13 mRNA	PMID:29024780
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1306044	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of USP13 mRNA	PMID:35163327
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306044	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of USP13 mRNA	PMID:35163327
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of USP13 mRNA	PMID:35301059
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306044	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of USP13 mRNA	PMID:39012411
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306044	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of USP13 mRNA	PMID:35163327
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of USP13 mRNA	PMID:19320972
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of USP13 mRNA	PMID:25979313
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of USP13 mRNA	PMID:23179753|PMID:28001369
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of USP13 mRNA	PMID:28628672
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of USP13 mRNA	PMID:28542535
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of USP13 mRNA	PMID:24714768
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of USP13 mRNA	PMID:29432896
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of USP13 mRNA	PMID:16835338
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306044	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of USP13 mRNA	PMID:29391264
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of USP13 mRNA	PMID:22079256
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:1306044	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of USP13 gene	PMID:37958445
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of USP13 mRNA	PMID:28628672
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1552359	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of USP13 mRNA	PMID:36117858
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in decreased expression of USP13 mRNA	PMID:16780908
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:67895	corosolic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of USP13 mRNA	PMID:37939859
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of USP13 intron	PMID:30157460
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306044	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of USP13 gene	PMID:35440735
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552359	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of USP13 mRNA	PMID:22206623
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of USP13 mRNA	PMID:22079256
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of USP13 mRNA	PMID:22079256
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of USP13 protein	PMID:31285264
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP13 mRNA	PMID:27188386
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to USP13 gene]	PMID:28238834
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1552359	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of USP13 mRNA	PMID:27935865
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1306044	E	RGD:6480464	20160712	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of USP13 mRNA	PMID:23914054
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:8772	raloxifene	decreases expression	ISO	RGD:1552359	E	RGD:6480464	20230801	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of USP13 mRNA	PMID:33269387
1314436	USP13	ubiquitin specific peptidase 13	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of USP13 mRNA	PMID:27188386
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of RRM2B mRNA	PMID:31863870
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:10110	zidovudine	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D015215	Zidovudine results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of RRM2B mRNA	PMID:25596134
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1557502	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RRM2B mRNA	PMID:26251327
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of RRM2B mRNA	PMID:25596134
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1557502	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RRM2B mRNA	PMID:36331819
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RRM2B mRNA	PMID:21632981
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1557502	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RRM2B mRNA	PMID:39241906
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004958	Estradiol results in increased expression of RRM2B mRNA	PMID:36581016
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1557502	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of RRM2B mRNA	PMID:29980752
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of RRM2B mRNA	PMID:23649840
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of RRM2B mRNA	PMID:26079696
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:17303	morphine	increases expression	ISO	RGD:1557502	E	RGD:6480464	20120412	CTD	MESH:D009020	Morphine results in increased expression of RRM2B mRNA	PMID:21178816
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of RRM2B mRNA	PMID:33359661
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:17356	2-acetamidofluorene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:17698	chloramphenicol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D002701	Chloramphenicol results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of RRM2B protein	PMID:37730182
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1557502	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RRM2B mRNA	PMID:36331819
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:2038	5-azacytidine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001374	Azacitidine results in increased expression of RRM2B mRNA	PMID:19010910
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	affects expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D008769	Methylnitronitrosoguanidine affects the expression of RRM2B mRNA	PMID:26921499
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D008769	ATR protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; CHEK2 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]; E2F1 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]; E2F3 protein promotes the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B mRNA]; Methylnitronitrosoguanidine results in increased expression of and affects the localization of RRM2B protein; TP53 protein mutant form inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of RRM2B protein]	PMID:26921499
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RRM2B mRNA	PMID:35301059
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306045	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RRM2B mRNA	PMID:39012411
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:231347	triapine	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:C078157	[Cisplatin co-treated with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone] results in increased expression of RRM2B protein	PMID:20954859
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:23808	dimethylarsinous acid	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C472511	dimethylarsinous acid results in increased expression of RRM2B mRNA	PMID:20886546
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RRM2B mRNA	PMID:23649840
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D005038	Ethylnitrosourea results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of RRM2B protein	PMID:20106945
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RRM2B mRNA	PMID:21632981|PMID:21641981|PMID:21704725|PMID:22100608|PMID:27153756
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306045	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RRM2B mRNA	PMID:23630614
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1557502	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RRM2B mRNA	PMID:19770486
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RRM2B mRNA	PMID:21704725|PMID:23649840
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of RRM2B mRNA	PMID:25102026
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of RRM2B mRNA	PMID:35430440
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1557502	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RRM2B mRNA	PMID:25629700
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1557502	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of RRM2B mRNA	PMID:19654921
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1557502	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RRM2B mRNA	PMID:40504410
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of RRM2B mRNA	PMID:33512557
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of RRM2B mRNA	PMID:38460933
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of RRM2B protein; [Dactinomycin co-treated with nutlin 3] results in increased expression of RRM2B mRNA	PMID:38460933
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of RRM2B mRNA	PMID:26272509
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRM2B mRNA	PMID:27188386
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306045	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RRM2B mRNA	PMID:31881176
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27871	chloroacetaldehyde	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde affects the expression of RRM2B mRNA	PMID:25596134
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C059514	resveratrol results in increased expression of RRM2B mRNA	PMID:15767336|PMID:26341291
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RRM2B mRNA	PMID:23557933
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RRM2B mRNA	PMID:28903495
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of RRM2B mRNA	PMID:25596134
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of RRM2B mRNA; Cisplatin results in increased expression of RRM2B protein	PMID:21704725|PMID:21875941|PMID:25450742|PMID:27392435|PMID:27594783
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1557502	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of RRM2B mRNA	PMID:21151649
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone] results in increased expression of RRM2B protein; TP53 affects the reaction [Cisplatin results in increased expression of RRM2B protein]	PMID:20954859|PMID:21875941
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of RRM2B mRNA	PMID:18847459
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306045	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RRM2B mRNA	PMID:22298810
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557502	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RRM2B mRNA	PMID:21570461
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:28123	diethanolamine	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C020283	diethanolamine results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RRM2B mRNA	PMID:28001369
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RRM2B mRNA	PMID:30851411
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of RRM2B mRNA	PMID:30911355
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D004317	Doxorubicin affects the expression of RRM2B mRNA	PMID:25529476
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004317	Doxorubicin results in increased expression of RRM2B mRNA; Doxorubicin results in increased expression of RRM2B protein	PMID:21704725|PMID:26025680|PMID:30031762|PMID:38447685
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20200310	CTD	MESH:D004317	Doxorubicin inhibits the reaction [KDM8 protein binds to RRM2B promoter]; Doxorubicin promotes the reaction [TP53 protein binds to RRM2B promoter]; KDM8 protein affects the reaction [Doxorubicin results in increased expression of RRM2B protein]	PMID:26025680
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of RRM2B mRNA	PMID:29319823
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of RRM2B mRNA; sodium arsenite results in decreased expression of RRM2B protein	PMID:37762697|PMID:38228842
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of RRM2B mRNA	PMID:21704725|PMID:38568856|PMID:39900124
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1557502	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RRM2B mRNA	PMID:40504410
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of RRM2B mRNA	PMID:22378314|PMID:39900124
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of RRM2B mRNA	PMID:21873647
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of RRM2B mRNA; Benzo(a)pyrene results in increased expression of RRM2B mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:21704725|PMID:22316170|PMID:30453624|PMID:32234424|PMID:40280401
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RRM2B mRNA	PMID:40280401
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RRM2B mRNA]	PMID:32406909
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of RRM2B mRNA	PMID:30911355
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of RRM2B mRNA	PMID:20382639|PMID:28593498
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:31175	adefovir pivoxil	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of RRM2B mRNA	PMID:25596134
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:31429	colforsin daropate hydrochloride	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D005576	Colforsin inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of RRM2B mRNA]	PMID:40834992
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557502	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RRM2B gene; titanium dioxide results in decreased methylation of RRM2B promoter	PMID:35295148
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557502	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of RRM2B mRNA	PMID:23811191
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of RRM2B mRNA	PMID:38479592
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of RRM2B protein	PMID:37567409
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306045	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RRM2B mRNA	PMID:30816183|PMID:34947998
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of RRM2B protein	PMID:33376534
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of RRM2B mRNA	PMID:25979313
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of RRM2B mRNA	PMID:40834992
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C014024	Colforsin inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of RRM2B mRNA]	PMID:40834992
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	EXP		E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:34283	oxybenzone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C005290	oxybenzone results in increased expression of RRM2B mRNA	PMID:36581016
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of RRM2B gene	PMID:31601247
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RRM2B mRNA	PMID:40280401
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RRM2B protein	PMID:34186270
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1557502	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RRM2B mRNA	PMID:28392331
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1557502	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RRM2B mRNA	PMID:37019170
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RRM2B mRNA	PMID:37042841
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RRM2B mRNA	PMID:38382870
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RRM2B mRNA	PMID:25596134
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RRM2B mRNA	PMID:35301059
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306045	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RRM2B mRNA	PMID:39012411
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004128	Dimethylnitrosamine metabolite results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of RRM2B mRNA	PMID:25596134
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1557502	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of RRM2B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RRM2B mRNA]	PMID:17585979
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:38211	potassium bromate	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C019536	potassium bromate results in increased expression of RRM2B mRNA	PMID:30559759
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1557502	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RRM2B mRNA	PMID:40194260
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RRM2B mRNA	PMID:28302478
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RRM2B mRNA	PMID:31533062
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1557502	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RRM2B mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RRM2B mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of RRM2B mRNA	PMID:36331819
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RRM2B mRNA	PMID:25979313
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of RRM2B mRNA	PMID:19101580
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:4027	cyclophosphamide	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003520	Cyclophosphamide metabolite results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RRM2B mRNA	PMID:20106945|PMID:25596134
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:42725	3-methyl-3H-imidazo[4,5-f]quinolin-2-amine	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C029216	2-amino-3-methylimidazo(4,5-f)quinoline results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of RRM2B mRNA	PMID:23649840
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of RRM2B mRNA	PMID:21678067
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:44423	hydroxyurea	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006918	Hydroxyurea results in increased expression of RRM2B mRNA	PMID:18647660
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of RRM2B mRNA	PMID:27188386
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RRM2B mRNA	PMID:22230336
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306045	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RRM2B mRNA	PMID:33387578
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1557502	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of RRM2B mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RRM2B mRNA]	PMID:17585979
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:46345	5-fluorouracil	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	RRM2B protein results in decreased susceptibility to Fluorouracil	PMID:15890238
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D005472	Fluorouracil results in increased expression of RRM2B mRNA	PMID:16557594|PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in increased expression of RRM2B mRNA]	PMID:15016801
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of RRM2B protein; [Dactinomycin co-treated with nutlin 3] results in increased expression of RRM2B mRNA	PMID:38460933
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:46938	zebularine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C009131	pyrimidin-2-one beta-ribofuranoside results in increased expression of RRM2B mRNA	PMID:19010910
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1557502	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of RRM2B mRNA	PMID:19654921
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1557502	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RRM2B mRNA	PMID:40504410
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of RRM2B mRNA	PMID:40706910
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306045	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of RRM2B mRNA	PMID:29391264
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of RRM2B mRNA	PMID:24383545
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:48943	isobutyraldehyde	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C017439	isobutyraldehyde results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:4911	etoposide	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D005047	Etoposide results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:4917	eugenol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D005054	Eugenol results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of RRM2B mRNA; Decitabine results in increased expression of RRM2B protein	PMID:19010910
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	TP53 protein affects the reaction [Decitabine results in increased expression of RRM2B mRNA]	PMID:19010910
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:51348	tetraphene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RRM2B mRNA	PMID:40280401
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:51687	chrysene	multiple interactions	EXP		E	RGD:6480464	20260407	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of RRM2B mRNA	PMID:40280401
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of RRM2B mRNA	PMID:20977926
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of RRM2B protein	PMID:23718831
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:53556	toluene 2,4-diisocyanate	decreases expression	ISO	RGD:1557502	E	RGD:6480464	20180703	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in decreased expression of RRM2B mRNA	PMID:21404309
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:5864	ifosfamide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of RRM2B mRNA	PMID:25596134
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:6030	isoniazide	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of RRM2B protein	PMID:40015660
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RRM2B mRNA	PMID:26378955
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1557502	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of RRM2B mRNA	PMID:19812364
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:64648	enniatin	decreases expression	ISO	RGD:1306045	E	RGD:6480464	20170228	CTD	MESH:C100264	enniatins results in decreased expression of RRM2B mRNA	PMID:27163883
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1306045	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of RRM2B mRNA	PMID:25596134
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RRM2B protein	PMID:34186270
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of RRM2B mRNA	PMID:21704725
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	ISO	RGD:1306045	E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of RRM2B protein	PMID:14587038
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:C025589	ochratoxin A results in increased expression of RRM2B mRNA	PMID:30559759
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of RRM2B mRNA	PMID:30851411
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRM2B mRNA	PMID:27188386
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1557502	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of RRM2B mRNA	PMID:21795629
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	increases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of RRM2B mRNA	PMID:33645215
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRM2B mRNA	PMID:27188386
1314438	RRM2B	ribonucleotide reductase regulatory TP53 inducible subunit M2B	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306045	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of RRM2B mRNA	PMID:23034163
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of FHOD3 mRNA	PMID:38218311
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of FHOD3 mRNA	PMID:21934132
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1621343	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FHOD3 mRNA	PMID:36189433
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1621343	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of FHOD3 mRNA	PMID:20880076
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:2322319	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FHOD3 mRNA	PMID:33729688
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:2322319	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of FHOD3 mRNA	PMID:36841081
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1621343	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FHOD3 mRNA	PMID:30319688
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FHOD3 mRNA	PMID:35811015
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of FHOD3 mRNA	PMID:30510588
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of FHOD3 mRNA	PMID:30165855
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:2322319	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of FHOD3 mRNA	PMID:33387578
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of FHOD3 mRNA	PMID:20864642
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of FHOD3 mRNA	PMID:26079696
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1621343	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FHOD3 mRNA	PMID:36189433
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of FHOD3 mRNA	PMID:16002434
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of FHOD3 intron	PMID:30157460
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of FHOD3 mRNA	PMID:23487506
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:2322319	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of FHOD3 protein	PMID:33236894
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of FHOD3 intron	PMID:30157460
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FHOD3 mRNA	PMID:22100608|PMID:32234424
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1621343	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FHOD3 mRNA	PMID:19770486
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FHOD3 promoter	PMID:30157460
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of FHOD3 mRNA	PMID:23649840
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1621343	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in decreased expression of FHOD3 mRNA	PMID:32553695
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of FHOD3 mRNA	PMID:19244175
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of FHOD3 mRNA	PMID:26272509
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA	PMID:27188386
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:2322319	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of FHOD3 gene	PMID:35440735
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of FHOD3 mRNA	PMID:28903495
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of FHOD3 mRNA	PMID:19561079
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of FHOD3 mRNA	PMID:27392435
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of FHOD3 mRNA	PMID:24768652|PMID:25583101
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621343	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FHOD3 mRNA	PMID:21570461
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1621343	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FHOD3 mRNA	PMID:19770486
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FHOD3 mRNA	PMID:20106945
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1621343	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FHOD3 mRNA	PMID:19465110
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FHOD3 mRNA	PMID:28001369
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FHOD3 mRNA	PMID:33212167
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of FHOD3 mRNA	PMID:26272509
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA	PMID:27188386
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:2322319	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of FHOD3 mRNA	PMID:28959563
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FHOD3 mRNA	PMID:29803840
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1621343	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of FHOD3 mRNA	PMID:37682722
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FHOD3 intron	PMID:30157460
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FHOD3 mRNA	PMID:32234424
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1621343	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FHOD3 mRNA	PMID:19770486|PMID:20713471
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1621343	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FHOD3 intron	PMID:27901495
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1621343	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of FHOD3 mRNA	PMID:27131904
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of FHOD3 mRNA	PMID:25351596
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of FHOD3 mRNA	PMID:20382639
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of FHOD3 gene	PMID:31601247
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] affects the methylation of FHOD3 gene; [bisphenol S co-treated with Fulvestrant] results in increased methylation of FHOD3 gene	PMID:31601247
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1621343	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FHOD3 gene	PMID:35295148
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1621343	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of FHOD3 gene	PMID:35295148
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of FHOD3 gene	PMID:31601247
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of FHOD3 mRNA	PMID:29275510
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1621343	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of FHOD3 mRNA	PMID:26063408
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2322319	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FHOD3 mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:2322319	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FHOD3 gene	PMID:28505145
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] affects the methylation of FHOD3 gene	PMID:31601247
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S affects the methylation of FHOD3 gene	PMID:31601247
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1621343	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of FHOD3 exon	PMID:33297965
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of FHOD3 gene	PMID:31601247
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1621343	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of FHOD3 mRNA	PMID:26377693
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of FHOD3 intron	PMID:30157460
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1621343	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of FHOD3 mRNA	PMID:38685157
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1621343	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of FHOD3 intron	PMID:28392331
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1621343	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of FHOD3 mRNA	PMID:37019170
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1621343	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of FHOD3 mRNA	PMID:21266533
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1621343	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of FHOD3 gene	PMID:38995845
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:2322319	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FHOD3 mRNA	PMID:35163327
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:2322319	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FHOD3 mRNA	PMID:35163327
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FHOD3 mRNA	PMID:24449571
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of FHOD3 mRNA	PMID:19244175
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of FHOD3 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of FHOD3 mRNA	PMID:23179753
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of FHOD3 gene	PMID:29154799
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA	PMID:27188386
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1621343	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of FHOD3 mRNA	PMID:28973697
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of FHOD3 mRNA	PMID:26272509
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA	PMID:27188386
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of FHOD3 mRNA	PMID:24935251|PMID:26272509
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA	PMID:27188386
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of FHOD3 mRNA	PMID:22230336
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of FHOD3 mRNA	PMID:33725128
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FHOD3 mRNA	PMID:35811015
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1621343	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of FHOD3 mRNA	PMID:30529165
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:2322319	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of FHOD3 mRNA	PMID:29391264
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of FHOD3 mRNA	PMID:32234424
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of FHOD3 mRNA	PMID:26272509
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA	PMID:27188386
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1621343	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of FHOD3 mRNA	PMID:25620056
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of FHOD3 mRNA	PMID:28988120
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of FHOD3 mRNA	PMID:15336504
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:2322319	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of FHOD3 mRNA	PMID:37269647
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of FHOD3 intron	PMID:30157460
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1621343	E	RGD:6480464	20190910	CTD	MESH:C581157	XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of FHOD3 mRNA]	PMID:29891994
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of FHOD3 mRNA	PMID:22714537
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:2322319	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of FHOD3 mRNA	PMID:33484710
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA	PMID:27188386
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FHOD3 gene]	PMID:28238834
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:2322319	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of FHOD3 mRNA	PMID:32109520
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:2322319	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FHOD3 mRNA	PMID:36843608
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of FHOD3 mRNA	PMID:26272509
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA	PMID:27188386
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHOD3 mRNA	PMID:27188386
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1621343	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of FHOD3 mRNA	PMID:27131904
1314439	FHOD3	formin homology 2 domain containing 3	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:2322319	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of FHOD3 gene	PMID:31079544
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of REEP5 protein]	PMID:38195004
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1306047	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of REEP5 mRNA	PMID:30071829
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314441	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of REEP5 mRNA	PMID:20938992
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314441	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of REEP5 mRNA	PMID:36331819
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of REEP5 mRNA	PMID:20044591
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306047	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of REEP5 mRNA	PMID:32145629
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314441	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of REEP5 mRNA	PMID:15289156|PMID:39298647
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of REEP5 protein	PMID:20109541
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314441	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of REEP5 mRNA	PMID:20938992
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D002635	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of REEP5 mRNA	PMID:33819548
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314441	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of REEP5 mRNA	PMID:37992649
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314441	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of REEP5 mRNA	PMID:37992649
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D006000	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of REEP5 mRNA	PMID:33819548
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of REEP5 protein	PMID:31163220
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314441	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of REEP5 mRNA	PMID:33754040
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314441	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of REEP5 mRNA	PMID:36331819
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:183415	delta8-THC	affects binding	ISO	RGD:1314441	E	RGD:6480464	20211207	CTD	MESH:C035731	delta-8-tetrahydrocannabinol binds to REEP5 protein	PMID:29992186
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1314441	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of REEP5 mRNA	PMID:27462272
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of REEP5 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of REEP5 protein	PMID:38195004
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306047	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of REEP5 mRNA	PMID:21396975
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1306047	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of REEP5 mRNA	PMID:22129741
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of REEP5 mRNA	PMID:23649840
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of REEP5 mRNA	PMID:35430440
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of REEP5 protein	PMID:38598786
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306047	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of REEP5 mRNA	PMID:31150632
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314441	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of REEP5 mRNA	PMID:27339419|PMID:31919559
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314441	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of REEP5 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of REEP5 mRNA	PMID:20938992|PMID:22206623
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D006002	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of REEP5 mRNA	PMID:33819548
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of REEP5 mRNA	PMID:26272509
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP5 mRNA	PMID:27188386
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306047	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of REEP5 mRNA	PMID:31881176
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of REEP5 mRNA	PMID:28903495
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of REEP5 mRNA]	PMID:21858171
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of REEP5 protein	PMID:20884965
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in increased expression of REEP5 protein	PMID:20884965
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314441	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of REEP5 mRNA	PMID:15289156
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	ESR2 promotes the reaction [Genistein results in decreased expression of REEP5 protein]; ESR2 promotes the reaction [Genistein results in increased expression of REEP5 protein]	PMID:20884965
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314441	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of REEP5 mRNA	PMID:21570461|PMID:26377647
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306047	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of REEP5 mRNA	PMID:34747641
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306047	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of REEP5 mRNA	PMID:21215274
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314441	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of REEP5 mRNA	PMID:26290441
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of REEP5 mRNA	PMID:33212167
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314441	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of REEP5 mRNA	PMID:37992649
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D003840	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of REEP5 mRNA	PMID:33819548
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D000069446	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of REEP5 mRNA	PMID:33819548
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306047	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of REEP5 mRNA	PMID:24136188
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of REEP5 mRNA	PMID:31745603
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314441	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of REEP5 mRNA	PMID:29264374
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314441	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of REEP5 promoter	PMID:35295148
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306047	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of REEP5 mRNA	PMID:23411599
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1306047	E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of REEP5 mRNA	PMID:28943392
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1306047	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of REEP5 mRNA	PMID:25380136
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314441	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of REEP5 mRNA	PMID:17426115
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314441	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of REEP5 mRNA	PMID:18301758
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306047	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of REEP5 mRNA	PMID:30816183
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of REEP5 mRNA	PMID:20678512
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306047	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of REEP5 mRNA	PMID:32145629
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of REEP5 mRNA	PMID:28628672
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314441	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of REEP5 mRNA	PMID:39298647
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of REEP5 protein	PMID:34186270
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1306047	E	RGD:6480464	20121009	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of REEP5 mRNA	PMID:18668222
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314441	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of REEP5 mRNA	PMID:37019170
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of REEP5 gene	PMID:22964155
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of REEP5 protein	PMID:38598786
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of REEP5 mRNA	PMID:28628672
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306047	E	RGD:6480464	20121009	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of REEP5 mRNA; [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of REEP5 mRNA	PMID:22129741|PMID:28943392
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of REEP5 mRNA	PMID:37042841
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1306047	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of REEP5 mRNA	PMID:30589522
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1306047	E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of REEP5 mRNA	PMID:17616710
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306047	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of REEP5 mRNA	PMID:25380136
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of REEP5 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of REEP5 protein	PMID:38195004
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of REEP5 mRNA	PMID:24449571
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D005999	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of REEP5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of REEP5 mRNA	PMID:33819548
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:37825	p-toluidine	increases expression	ISO	RGD:1306047	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of REEP5 mRNA	PMID:27638505
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of REEP5 mRNA	PMID:28302478
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of REEP5 mRNA	PMID:19167446
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of REEP5 mRNA	PMID:19167446
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314441	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of REEP5 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of REEP5 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of REEP5 mRNA	PMID:36331819
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of REEP5 mRNA	PMID:25979313
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of REEP5 mRNA	PMID:29154799
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of REEP5 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314441	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of REEP5 mRNA	PMID:21427059
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP5 mRNA	PMID:27188386
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306047	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of REEP5 mRNA	PMID:41580965
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of REEP5 mRNA	PMID:25562108
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D016572	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of REEP5 mRNA	PMID:33819548
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of REEP5 mRNA	PMID:28628672
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1314441	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of REEP5 mRNA	PMID:15289156
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314441	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of REEP5 mRNA	PMID:28973697
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314441	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of REEP5 mRNA	PMID:37992649
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of REEP5 mRNA	PMID:24935251|PMID:26272509
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP5 mRNA	PMID:27188386
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D000082	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of REEP5 mRNA	PMID:33819548
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of REEP5 mRNA	PMID:28628672
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306047	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of REEP5 mRNA	PMID:24136188
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314441	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of REEP5 mRNA	PMID:35964746
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306047	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of REEP5 mRNA	PMID:24136188
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of REEP5 protein	PMID:32959892
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1306047	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of REEP5 mRNA	PMID:20080153
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314441	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of REEP5 mRNA	PMID:23650126
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of REEP5 mRNA	PMID:15336504
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of REEP5 mRNA	PMID:15336504
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1314441	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of REEP5 protein	PMID:36851058
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of REEP5 protein	PMID:34186270
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314441	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of REEP5 mRNA	PMID:22206623
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306047	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of REEP5 mRNA	PMID:24136188
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:7494	nefazodone	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:C051752	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of REEP5 mRNA	PMID:33819548
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP5 mRNA	PMID:27188386
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to REEP5 gene]	PMID:28238834
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1306047	E	RGD:6480464	20190219	CTD	MESH:D010634	Phenobarbital results in increased expression of REEP5 mRNA	PMID:28520973
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of REEP5 mRNA	PMID:19167446
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1306047	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of REEP5 mRNA	PMID:21394737
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of REEP5 mRNA	PMID:21858171
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Cisplatin inhibits the reaction [Piroxicam results in decreased expression of REEP5 mRNA]	PMID:21858171
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP5 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of REEP5 mRNA	PMID:27188386
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306047	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of REEP5 mRNA	PMID:21346803
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of REEP5 mRNA	PMID:38568856
1314440	REEP5	receptor accessory protein 5	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1314441	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of REEP5 mRNA	PMID:28973697
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1550384	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TUBE1 mRNA	PMID:33045310
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TUBE1 mRNA	PMID:33167477
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TUBE1 mRNA	PMID:20044591
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of TUBE1 mRNA	PMID:34581912
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550384	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TUBE1 mRNA	PMID:39241906
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TUBE1 mRNA	PMID:31614463
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306048	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TUBE1 gene	PMID:27618143
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:175901	gemcitabine	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in increased expression of TUBE1 mRNA	PMID:17039268
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1550384	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of TUBE1 mRNA	PMID:23892564
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306048	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of TUBE1 mRNA	PMID:21396975
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of TUBE1 protein	PMID:20106945
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of TUBE1 mRNA	PMID:21632981
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TUBE1 gene	PMID:27153756
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550384	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TUBE1 mRNA	PMID:34911549
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306048	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of TUBE1 mRNA	PMID:30779732
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306048	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TUBE1 mRNA	PMID:31881176
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1550384	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of TUBE1 mRNA	PMID:30912803
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TUBE1 mRNA	PMID:20106945|PMID:21632981
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306048	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TUBE1 mRNA	PMID:33387578
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306048	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of TUBE1 mRNA	PMID:19013527
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TUBE1 mRNA	PMID:33212167
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TUBE1 mRNA	PMID:39709020
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TUBE1 mRNA	PMID:29803840
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:28971	ampicillin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000667	Ampicillin results in decreased expression of TUBE1 mRNA	PMID:21632981
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TUBE1 mRNA	PMID:34032870
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TUBE1 mRNA	PMID:38568856
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550384	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of TUBE1 mRNA	PMID:37682722
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TUBE1 mRNA	PMID:20106945|PMID:21632981
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of TUBE1 mRNA	PMID:31745603
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306048	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TUBE1 mRNA	PMID:25729387
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306048	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TUBE1 mRNA	PMID:23411599
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TUBE1 mRNA	PMID:19710929
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TUBE1 mRNA	PMID:30903817
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1306048	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TUBE1 promoter	PMID:27415467
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306048	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TUBE1 mRNA	PMID:25181051|PMID:34947998
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1550384	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TUBE1 mRNA	PMID:37019170
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1306048	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of TUBE1 mRNA	PMID:22546817
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550384	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TUBE1 mRNA	PMID:17361019|PMID:21266533
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1306048	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of TUBE1 mRNA	PMID:22546817
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1306048	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of TUBE1 mRNA	PMID:22546817
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TUBE1 mRNA	PMID:37042841
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TUBE1 mRNA	PMID:38382870
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TUBE1 mRNA	PMID:32588087
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550384	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of TUBE1 mRNA	PMID:40194260
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TUBE1 mRNA	PMID:28302478
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TUBE1 mRNA	PMID:31533062
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1550384	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of TUBE1 mRNA	PMID:39529242
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of TUBE1 mRNA	PMID:40419075
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of TUBE1 mRNA	PMID:29154799
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TUBE1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of TUBE1 mRNA	PMID:29067470
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306048	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TUBE1 mRNA	PMID:33387578
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of TUBE1 mRNA	PMID:33725128
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D018038	Sodium Selenite results in increased expression of TUBE1 mRNA	PMID:24383545
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:48981	quinolin-8-ol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in decreased expression of TUBE1 mRNA	PMID:21632981
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of TUBE1 mRNA	PMID:17401462
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306048	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of TUBE1 mRNA	PMID:30307764
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550384	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TUBE1 mRNA	PMID:25554681
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306048	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TUBE1 mRNA	PMID:25729387
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases methylation	ISO	RGD:1306048	E	RGD:6480464	20180116	CTD	MESH:C074283	estradiol 3-benzoate results in increased methylation of TUBE1 promoter	PMID:27415467
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TUBE1 gene]	PMID:28238834
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of TUBE1 mRNA	PMID:19159669
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of TUBE1 mRNA	PMID:19095052
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:82036	prothioconazole	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C550005	prothioconazole results in increased expression of TUBE1 mRNA	PMID:35048155
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306048	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TUBE1 mRNA	PMID:21346803
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in decreased expression of TUBE1 mRNA	PMID:34581912
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TUBE1 mRNA	PMID:38568856
1314442	TUBE1	tubulin epsilon 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550384	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TUBE1 mRNA	PMID:35537566
1314443	SMOX	spermine oxidase	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C007262	deoxynivalenol results in increased expression of SMOX mRNA	PMID:26763390
1314443	SMOX	spermine oxidase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306049	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SMOX mRNA]	PMID:31150632
1314443	SMOX	spermine oxidase	gene	CHEBI:15343	acetaldehyde	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D000079	Acetaldehyde results in increased expression of SMOX mRNA	PMID:23707493
1314443	SMOX	spermine oxidase	gene	CHEBI:15343	acetaldehyde	increases response to substance	EXP		E	RGD:6480464	20140114	CTD	MESH:D000079	SMOX results in increased susceptibility to Acetaldehyde	PMID:23707493
1314443	SMOX	spermine oxidase	gene	CHEBI:15343	acetaldehyde	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:D000079	[SMOX results in increased susceptibility to Acetaldehyde] which results in increased abundance of Acrolein	PMID:23707493
1314443	SMOX	spermine oxidase	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SMOX mRNA	PMID:20938992
1314443	SMOX	spermine oxidase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D014212	Tretinoin results in increased expression of SMOX mRNA	PMID:15498508|PMID:16054129
1314443	SMOX	spermine oxidase	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:D000171	[SMOX results in increased susceptibility to Acetaldehyde] which results in increased abundance of Acrolein	PMID:23707493
1314443	SMOX	spermine oxidase	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1306049	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of SMOX mRNA	PMID:33729688
1314443	SMOX	spermine oxidase	gene	CHEBI:15746	spermine	increases oxidation	EXP		E	RGD:6480464	20140114	CTD	MESH:D013096	SMOX protein results in increased oxidation of Spermine	PMID:23707493
1314443	SMOX	spermine oxidase	gene	CHEBI:15746	spermine	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:D013096	[SMOX protein results in increased oxidation of Spermine] which results in increased abundance of Spermidine	PMID:23707493
1314443	SMOX	spermine oxidase	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of SMOX mRNA	PMID:22378314
1314443	SMOX	spermine oxidase	gene	CHEBI:16130	DDT	decreases methylation	ISO	RGD:1306049	E	RGD:6480464	20211012	CTD	MESH:D003634	DDT results in decreased methylation of SMOX gene	PMID:31682807
1314443	SMOX	spermine oxidase	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314444	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SMOX mRNA	PMID:30319688
1314443	SMOX	spermine oxidase	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of SMOX mRNA	PMID:21632981
1314443	SMOX	spermine oxidase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314444	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SMOX mRNA	PMID:39241906
1314443	SMOX	spermine oxidase	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of SMOX mRNA	PMID:14699072
1314443	SMOX	spermine oxidase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	Estradiol results in increased expression of SMOX mRNA	PMID:23019147|PMID:26865669|PMID:31614463
1314443	SMOX	spermine oxidase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306049	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SMOX mRNA	PMID:32145629
1314443	SMOX	spermine oxidase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SMOX mRNA; ESR2 protein affects the reaction [Estradiol results in increased expression of SMOX mRNA]	PMID:14699072|PMID:30165855
1314443	SMOX	spermine oxidase	gene	CHEBI:16610	spermidine	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:D013095	[SMOX protein results in increased oxidation of Spermine] which results in increased abundance of Spermidine	PMID:23707493
1314443	SMOX	spermine oxidase	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SMOX mRNA	PMID:20938992
1314443	SMOX	spermine oxidase	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1314444	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of SMOX mRNA	PMID:17178593
1314443	SMOX	spermine oxidase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SMOX mRNA	PMID:37992649
1314443	SMOX	spermine oxidase	gene	CHEBI:17263	estrone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004970	Estrone results in increased expression of SMOX mRNA	PMID:26865669
1314443	SMOX	spermine oxidase	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of SMOX mRNA	PMID:21592394
1314443	SMOX	spermine oxidase	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314444	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of SMOX mRNA	PMID:20403060
1314443	SMOX	spermine oxidase	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SMOX mRNA	PMID:21592394
1314443	SMOX	spermine oxidase	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1314444	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of SMOX mRNA	PMID:17178593
1314443	SMOX	spermine oxidase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SMOX mRNA	PMID:37992649
1314443	SMOX	spermine oxidase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314444	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SMOX mRNA	PMID:34319233
1314443	SMOX	spermine oxidase	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SMOX mRNA	PMID:21592394
1314443	SMOX	spermine oxidase	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SMOX mRNA	PMID:21592394
1314443	SMOX	spermine oxidase	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306049	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of SMOX mRNA	PMID:22061828
1314443	SMOX	spermine oxidase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306049	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SMOX mRNA	PMID:33387578
1314443	SMOX	spermine oxidase	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SMOX mRNA	PMID:28818685
1314443	SMOX	spermine oxidase	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of SMOX intron	PMID:30157460
1314443	SMOX	spermine oxidase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SMOX mRNA	PMID:36331819
1314443	SMOX	spermine oxidase	gene	CHEBI:193591	Didecyldimethylammonium	increases expression	EXP		E	RGD:6480464	20221018	CTD	MESH:C027118	didecyldimethylammonium results in increased expression of SMOX mRNA	PMID:32763356
1314443	SMOX	spermine oxidase	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SMOX mRNA	PMID:29950665
1314443	SMOX	spermine oxidase	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SMOX mRNA	PMID:19549813
1314443	SMOX	spermine oxidase	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SMOX mRNA	PMID:21641981|PMID:22100608
1314443	SMOX	spermine oxidase	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1306049	E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in increased expression of SMOX mRNA	PMID:35737395
1314443	SMOX	spermine oxidase	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of SMOX mRNA	PMID:19774075
1314443	SMOX	spermine oxidase	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SMOX mRNA	PMID:18593933
1314443	SMOX	spermine oxidase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306049	E	RGD:6480464	20190507	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SMOX mRNA	PMID:30723492|PMID:31150632
1314443	SMOX	spermine oxidase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314444	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SMOX mRNA	PMID:27339419|PMID:31919559
1314443	SMOX	spermine oxidase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306049	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SMOX mRNA]	PMID:31150632
1314443	SMOX	spermine oxidase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SMOX mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SMOX mRNA]	PMID:20938992|PMID:22206623
1314443	SMOX	spermine oxidase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SMOX mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMOX mRNA	PMID:40512198
1314443	SMOX	spermine oxidase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMOX mRNA	PMID:40504410
1314443	SMOX	spermine oxidase	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of SMOX mRNA	PMID:19244175
1314443	SMOX	spermine oxidase	gene	CHEBI:27732	caffeine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in increased expression of SMOX mRNA	PMID:11793227
1314443	SMOX	spermine oxidase	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306049	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SMOX mRNA	PMID:31881176
1314443	SMOX	spermine oxidase	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SMOX mRNA	PMID:28903495
1314443	SMOX	spermine oxidase	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in increased expression of SMOX mRNA	PMID:24280081|PMID:27594783
1314443	SMOX	spermine oxidase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314444	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in increased expression of SMOX mRNA	PMID:15464296|PMID:15471895|PMID:24280081
1314443	SMOX	spermine oxidase	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D019833	Genistein results in increased expression of SMOX mRNA	PMID:23019147|PMID:26865669
1314443	SMOX	spermine oxidase	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of SMOX mRNA	PMID:23195993
1314443	SMOX	spermine oxidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314444	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMOX mRNA	PMID:21570461
1314443	SMOX	spermine oxidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306049	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SMOX mRNA	PMID:32109520|PMID:34747641
1314443	SMOX	spermine oxidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SMOX mRNA	PMID:12377990
1314443	SMOX	spermine oxidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306049	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SMOX mRNA	PMID:33387578
1314443	SMOX	spermine oxidase	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SMOX mRNA	PMID:33212167
1314443	SMOX	spermine oxidase	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SMOX mRNA	PMID:30851411
1314443	SMOX	spermine oxidase	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SMOX mRNA	PMID:24690739
1314443	SMOX	spermine oxidase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SMOX mRNA	PMID:29803840
1314443	SMOX	spermine oxidase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SMOX mRNA	PMID:37992649
1314443	SMOX	spermine oxidase	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of SMOX mRNA	PMID:20044591
1314443	SMOX	spermine oxidase	gene	CHEBI:2948	azathioprine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of SMOX mRNA	PMID:22623647
1314443	SMOX	spermine oxidase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SMOX mRNA	PMID:38568856
1314443	SMOX	spermine oxidase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SMOX mRNA	PMID:39719251
1314443	SMOX	spermine oxidase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SMOX mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMOX mRNA	PMID:40512198
1314443	SMOX	spermine oxidase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMOX mRNA	PMID:40504410
1314443	SMOX	spermine oxidase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314444	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SMOX mRNA	PMID:22228805
1314443	SMOX	spermine oxidase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SMOX 3' UTR	PMID:27901495
1314443	SMOX	spermine oxidase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SMOX mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1314443	SMOX	spermine oxidase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314444	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SMOX mRNA	PMID:19770486
1314443	SMOX	spermine oxidase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SMOX 5' UTR	PMID:27901495
1314443	SMOX	spermine oxidase	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SMOX mRNA]	PMID:22228805
1314443	SMOX	spermine oxidase	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SMOX mRNA	PMID:24690739
1314443	SMOX	spermine oxidase	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of SMOX mRNA	PMID:25075043
1314443	SMOX	spermine oxidase	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SMOX mRNA	PMID:18593933
1314443	SMOX	spermine oxidase	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SMOX mRNA	PMID:26014281
1314443	SMOX	spermine oxidase	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314444	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SMOX mRNA	PMID:27131904
1314443	SMOX	spermine oxidase	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SMOX mRNA	PMID:25895662
1314443	SMOX	spermine oxidase	gene	CHEBI:31638	fulvestrant	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C070081	fulvestrant results in decreased expression of SMOX mRNA	PMID:26865669
1314443	SMOX	spermine oxidase	gene	CHEBI:31669	hexestrol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D006589	Hexestrol results in increased expression of SMOX mRNA	PMID:26865669
1314443	SMOX	spermine oxidase	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of SMOX mRNA	PMID:38568856
1314443	SMOX	spermine oxidase	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1306049	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of SMOX mRNA	PMID:32479839
1314443	SMOX	spermine oxidase	gene	CHEBI:31941	oxaliplatin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Fluorouracil] results in increased expression of and results in increased activity of SMOX protein; [oxaliplatin co-treated with Fluorouracil] results in increased expression of SMOX mRNA	PMID:17987291
1314443	SMOX	spermine oxidase	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of SMOX mRNA	PMID:15498508
1314443	SMOX	spermine oxidase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314444	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SMOX gene	PMID:35295148
1314443	SMOX	spermine oxidase	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314444	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SMOX gene	PMID:35295148
1314443	SMOX	spermine oxidase	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SMOX mRNA	PMID:29950665
1314443	SMOX	spermine oxidase	gene	CHEBI:32497	thioacetamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide results in increased expression of SMOX mRNA	PMID:11793227
1314443	SMOX	spermine oxidase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306049	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SMOX mRNA	PMID:34492290
1314443	SMOX	spermine oxidase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314444	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SMOX mRNA	PMID:18648102
1314443	SMOX	spermine oxidase	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SMOX mRNA	PMID:19710929
1314443	SMOX	spermine oxidase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SMOX mRNA	PMID:30903817
1314443	SMOX	spermine oxidase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306049	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SMOX mRNA	PMID:25181051
1314443	SMOX	spermine oxidase	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314444	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SMOX promoter	PMID:27312807
1314443	SMOX	spermine oxidase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SMOX mRNA	PMID:29275510
1314443	SMOX	spermine oxidase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306049	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SMOX mRNA	PMID:30816183|PMID:32145629
1314443	SMOX	spermine oxidase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306049	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SMOX mRNA	PMID:36041667
1314443	SMOX	spermine oxidase	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of SMOX mRNA	PMID:19244175
1314443	SMOX	spermine oxidase	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314444	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SMOX mRNA	PMID:26682919
1314443	SMOX	spermine oxidase	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of SMOX mRNA	PMID:36804509
1314443	SMOX	spermine oxidase	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	ISO	RGD:1306049	E	RGD:6480464	20140805	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of SMOX mRNA	PMID:23829299
1314443	SMOX	spermine oxidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306049	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SMOX mRNA	PMID:36041667
1314443	SMOX	spermine oxidase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306049	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of SMOX mRNA	PMID:36041667
1314443	SMOX	spermine oxidase	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314444	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SMOX mRNA	PMID:28392331
1314443	SMOX	spermine oxidase	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314444	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SMOX intron	PMID:28392331
1314443	SMOX	spermine oxidase	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SMOX mRNA	PMID:29950665
1314443	SMOX	spermine oxidase	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1314444	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of SMOX mRNA	PMID:17942915|PMID:24535843
1314443	SMOX	spermine oxidase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of SMOX mRNA]	PMID:17942915
1314443	SMOX	spermine oxidase	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1314444	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in decreased expression of SMOX mRNA	PMID:21371552
1314443	SMOX	spermine oxidase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SMOX mRNA	PMID:37042841
1314443	SMOX	spermine oxidase	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306049	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SMOX mRNA	PMID:35163327
1314443	SMOX	spermine oxidase	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SMOX mRNA	PMID:38174414
1314443	SMOX	spermine oxidase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1306049	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SMOX mRNA	PMID:28511854
1314443	SMOX	spermine oxidase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306049	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SMOX mRNA	PMID:35163327
1314443	SMOX	spermine oxidase	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SMOX mRNA	PMID:24449571
1314443	SMOX	spermine oxidase	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314444	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of SMOX mRNA	PMID:28962523
1314443	SMOX	spermine oxidase	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of SMOX mRNA	PMID:19244175
1314443	SMOX	spermine oxidase	gene	CHEBI:3752	clomiphene	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D002996	Clomiphene results in decreased expression of SMOX mRNA	PMID:26865669
1314443	SMOX	spermine oxidase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SMOX mRNA	PMID:32588087
1314443	SMOX	spermine oxidase	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SMOX mRNA	PMID:31533062
1314443	SMOX	spermine oxidase	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1314444	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of SMOX mRNA	PMID:39529242
1314443	SMOX	spermine oxidase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SMOX mRNA	PMID:40419075
1314443	SMOX	spermine oxidase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SMOX mRNA	PMID:36331819
1314443	SMOX	spermine oxidase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314444	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SMOX mRNA	PMID:17292431
1314443	SMOX	spermine oxidase	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SMOX gene	PMID:29154799
1314443	SMOX	spermine oxidase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SMOX mRNA	PMID:20106945|PMID:25562108
1314443	SMOX	spermine oxidase	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of SMOX mRNA	PMID:25047013
1314443	SMOX	spermine oxidase	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SMOX mRNA	PMID:26865669
1314443	SMOX	spermine oxidase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314444	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SMOX mRNA	PMID:28973697
1314443	SMOX	spermine oxidase	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1314444	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in increased expression of SMOX mRNA	PMID:17178593
1314443	SMOX	spermine oxidase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SMOX mRNA	PMID:37992649
1314443	SMOX	spermine oxidase	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SMOX mRNA	PMID:38832940
1314443	SMOX	spermine oxidase	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in increased expression of SMOX mRNA	PMID:28542535
1314443	SMOX	spermine oxidase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314444	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SMOX mRNA	PMID:17562736
1314443	SMOX	spermine oxidase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SMOX mRNA	PMID:11793227|PMID:22230336
1314443	SMOX	spermine oxidase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306049	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SMOX mRNA	PMID:33387578
1314443	SMOX	spermine oxidase	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	[oxaliplatin co-treated with Fluorouracil] results in increased expression of and results in increased activity of SMOX protein; [oxaliplatin co-treated with Fluorouracil] results in increased expression of SMOX mRNA	PMID:17987291
1314443	SMOX	spermine oxidase	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of SMOX mRNA	PMID:24714768
1314443	SMOX	spermine oxidase	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of SMOX mRNA	PMID:24690739
1314443	SMOX	spermine oxidase	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of SMOX mRNA	PMID:24160326
1314443	SMOX	spermine oxidase	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SMOX mRNA	PMID:18687144
1314443	SMOX	spermine oxidase	gene	CHEBI:46680	serpentine asbestos	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine affects the expression of SMOX mRNA	PMID:24160326
1314443	SMOX	spermine oxidase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of SMOX mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMOX mRNA	PMID:40512198
1314443	SMOX	spermine oxidase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SMOX mRNA	PMID:40504410
1314443	SMOX	spermine oxidase	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of SMOX mRNA	PMID:31838189
1314443	SMOX	spermine oxidase	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306049	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SMOX mRNA	PMID:29391264
1314443	SMOX	spermine oxidase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SMOX mRNA	PMID:22079256
1314443	SMOX	spermine oxidase	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of SMOX mRNA	PMID:18175754
1314443	SMOX	spermine oxidase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306049	E	RGD:6480464	20140805	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SMOX mRNA	PMID:17557909
1314443	SMOX	spermine oxidase	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of SMOX mRNA	PMID:38568856
1314443	SMOX	spermine oxidase	gene	CHEBI:50035	alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of SMOX mRNA	PMID:25075043
1314443	SMOX	spermine oxidase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314444	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SMOX mRNA; Nanotubes, Carbon results in increased expression of SMOX mRNA	PMID:25554681
1314443	SMOX	spermine oxidase	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of SMOX mRNA	PMID:31629900
1314443	SMOX	spermine oxidase	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1306049	E	RGD:6480464	20140805	CTD	MESH:D007649	Ketamine results in increased expression of SMOX mRNA	PMID:20080153
1314443	SMOX	spermine oxidase	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314444	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of SMOX mRNA	PMID:19812364
1314443	SMOX	spermine oxidase	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of SMOX mRNA	PMID:15336504
1314443	SMOX	spermine oxidase	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SMOX mRNA	PMID:20147733
1314443	SMOX	spermine oxidase	gene	CHEBI:6716	medroxyprogesterone acetate	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in decreased expression of SMOX mRNA	PMID:20843944
1314443	SMOX	spermine oxidase	gene	CHEBI:6784	mestranol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D008656	Mestranol results in increased expression of SMOX mRNA	PMID:26865669
1314443	SMOX	spermine oxidase	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1314444	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of SMOX mRNA	PMID:26307267
1314443	SMOX	spermine oxidase	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SMOX mRNA	PMID:31758290
1314443	SMOX	spermine oxidase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314444	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SMOX mRNA	PMID:22206623
1314443	SMOX	spermine oxidase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314444	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SMOX mRNA]	PMID:22206623
1314443	SMOX	spermine oxidase	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of SMOX mRNA	PMID:22079256
1314443	SMOX	spermine oxidase	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SMOX mRNA	PMID:22079256
1314443	SMOX	spermine oxidase	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SMOX mRNA	PMID:37199045
1314443	SMOX	spermine oxidase	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of SMOX mRNA	PMID:36318118
1314443	SMOX	spermine oxidase	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1306049	E	RGD:6480464	20211012	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of SMOX mRNA	PMID:33945839
1314443	SMOX	spermine oxidase	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SMOX mRNA	PMID:30851411
1314443	SMOX	spermine oxidase	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SMOX mRNA	PMID:19159669
1314443	SMOX	spermine oxidase	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SMOX mRNA	PMID:26014281
1314443	SMOX	spermine oxidase	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314444	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SMOX mRNA	PMID:27131904
1314443	SMOX	spermine oxidase	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SMOX mRNA	PMID:38568856
1314443	SMOX	spermine oxidase	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SMOX mRNA	PMID:27188386
1314443	SMOX	spermine oxidase	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1314444	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of SMOX mRNA	PMID:32835833
1314443	SMOX	spermine oxidase	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1306049	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of SMOX gene	PMID:31079544
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of GDAP2 mRNA	PMID:38218311
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010100	Oxygen deficiency results in increased expression of GDAP2 mRNA	PMID:17175027
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314446	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GDAP2 mRNA	PMID:36331819
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314446	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of GDAP2 mRNA	PMID:30319688
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1314446	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of GDAP2 mRNA	PMID:19448997
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GDAP2 mRNA	PMID:37042841
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of GDAP2 mRNA	PMID:28818685
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:18291	manganese atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of GDAP2 mRNA	PMID:17175027
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GDAP2 gene	PMID:27153756
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306050	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GDAP2 mRNA	PMID:31150632
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314446	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GDAP2 mRNA	PMID:31919559
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314446	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GDAP2 mRNA	PMID:40504410
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of GDAP2 mRNA	PMID:23557933
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of GDAP2 mRNA	PMID:28001369
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GDAP2 mRNA	PMID:33212167
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GDAP2 mRNA	PMID:30851411
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of GDAP2 mRNA	PMID:20971185
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GDAP2 mRNA	PMID:29803840
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GDAP2 mRNA	PMID:38568856
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314446	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GDAP2 mRNA	PMID:40504410
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GDAP2 5' UTR	PMID:27901495
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GDAP2 protein	PMID:32717239
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of GDAP2 mRNA	PMID:20971185
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GDAP2 mRNA	PMID:20018196
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of GDAP2 gene	PMID:31601247
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1314446	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of GDAP2 mRNA	PMID:21829687
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314446	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GDAP2 gene	PMID:35295148
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314446	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of GDAP2 mRNA	PMID:18648102
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306050	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of GDAP2 mRNA	PMID:34947998
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314446	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of GDAP2 mRNA	PMID:26063408
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306050	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of GDAP2 mRNA	PMID:30816183|PMID:32528016
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306050	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GDAP2 gene	PMID:28505145
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314446	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of GDAP2 mRNA	PMID:26682919
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314446	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of GDAP2 mRNA	PMID:39298647
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of GDAP2 gene	PMID:31601247
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of GDAP2 gene	PMID:31601247
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GDAP2 mRNA	PMID:37042841
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:35154	manganese(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of GDAP2 mRNA	PMID:17175027
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306050	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of GDAP2 gene	PMID:22079235
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GDAP2 mRNA	PMID:31533062
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314446	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GDAP2 mRNA	PMID:36331819
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of GDAP2 mRNA	PMID:23179753
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GDAP2 gene	PMID:29154799
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of GDAP2 mRNA	PMID:29154799
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GDAP2 mRNA	PMID:20106945|PMID:25562108
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314446	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GDAP2 mRNA	PMID:17562736
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306050	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GDAP2 mRNA	PMID:33387578
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314446	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GDAP2 mRNA	PMID:40504410
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314446	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of GDAP2 mRNA	PMID:25554681|PMID:25620056
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306050	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of GDAP2 mRNA	PMID:24136188
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in increased expression of GDAP2 mRNA	PMID:17175027
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306050	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of GDAP2 gene	PMID:35440735
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GDAP2 mRNA	PMID:30851411
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GDAP2 gene]	PMID:28238834
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314446	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of GDAP2 mRNA	PMID:31388691
1314445	GDAP2	ganglioside induced differentiation associated protein 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of GDAP2 mRNA	PMID:38568856
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314449	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ADAM30 mRNA	PMID:33045310
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of ADAM30 mRNA	PMID:34925699
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ADAM30 mRNA	PMID:22378314
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1594713	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of ADAM30 mRNA	PMID:26496021
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:18145	(R,R,R)-alpha-tocopherol	multiple interactions	ISO	RGD:1594713	E	RGD:6480464	20250902	CTD	MESH:D024502	[Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [sodium arsenite results in increased expression of ADAM30 mRNA]	PMID:37704839
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ADAM30 exon	PMID:30157460
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314449	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ADAM30 mRNA	PMID:27106289
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1314449	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of ADAM30 mRNA	PMID:25629700
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314449	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADAM30 mRNA	PMID:21570461
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1594713	E	RGD:6480464	20250902	CTD	MESH:D001205	[Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [sodium arsenite results in increased expression of ADAM30 mRNA]	PMID:37704839
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314449	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ADAM30 mRNA	PMID:16014739
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1594713	E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite results in increased expression of ADAM30 mRNA	PMID:37704839
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1594713	E	RGD:6480464	20250902	CTD	MESH:C017947	[Ascorbic Acid co-treated with alpha-Tocopherol] inhibits the reaction [sodium arsenite results in increased expression of ADAM30 mRNA]	PMID:37704839
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADAM30 exon	PMID:27901495
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADAM30 promoter	PMID:27901495
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314449	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ADAM30 mRNA	PMID:29264374
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1594713	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAM30 mRNA	PMID:25181051
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1594713	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ADAM30 mRNA	PMID:34947998|PMID:41034487
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1594713	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of ADAM30 mRNA	PMID:26496021
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:34911	permethrin	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in decreased expression of ADAM30 mRNA	PMID:37047231
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314449	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of ADAM30 mRNA	PMID:28962523
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ADAM30 mRNA	PMID:26690555
1314448	ADAM30	ADAM metallopeptidase domain 30	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314449	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ADAM30 mRNA	PMID:35436446
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:10022	deoxynivalenol	affects phosphorylation	ISO	RGD:1314453	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol affects the phosphorylation of PEA15A protein	PMID:23811945
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PEA15 mRNA	PMID:38218311
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306055	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of PEA15A mRNA	PMID:21551480
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314453	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PEA15A mRNA	PMID:33045310
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314453	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PEA15 mRNA	PMID:20188158
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PEA15 mRNA	PMID:20938992
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PEA15 mRNA	PMID:33167477
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1306055	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in decreased expression of PEA15 mRNA	PMID:20488242
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PEA15 mRNA	PMID:23724009
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PEA15 mRNA	PMID:26079696
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1306055	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of PEA15 mRNA	PMID:36841081
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PEA15 mRNA	PMID:22378314
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314453	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PEA15A mRNA	PMID:30319688
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of PEA15 mRNA	PMID:21632981
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of PEA15 mRNA	PMID:29581250
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	ISO	RGD:1314453	E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of PEA15 mRNA	PMID:17023530
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314453	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of PEA15A mRNA	PMID:39298647
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306055	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of PEA15 mRNA	PMID:32145629
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PEA15 mRNA	PMID:30165855
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306055	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of PEA15A gene	PMID:27618143
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PEA15 mRNA	PMID:20938992
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PEA15 mRNA	PMID:23649840
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PEA15A mRNA	PMID:37992649
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of PEA15 mRNA	PMID:33647349
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PEA15A mRNA	PMID:37992649
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PEA15 protein	PMID:37730182
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306055	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PEA15 mRNA	PMID:33387578
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of PEA15 mRNA	PMID:28818685
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PEA15 mRNA	PMID:39836092
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1314453	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of PEA15A mRNA	PMID:33914522
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:188851	Muraglitazar	decreases expression	ISO	RGD:1306055	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of PEA15 mRNA	PMID:21515302
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:196991	4-hydroperoxycyclophosphamide	decreases expression	ISO	RGD:1314453	E	RGD:6480464	20120814	CTD	MESH:C011272	perfosfamide results in decreased expression of PEA15 mRNA	PMID:19429390
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of PEA15 mRNA	PMID:12634122
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of PEA15 protein	PMID:28860664
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PEA15 mRNA	PMID:19549813
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PEA15 mRNA	PMID:23649840
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:2422	acetohydrazide	decreases expression	ISO	RGD:1314453	E	RGD:6480464	20120412	CTD	MESH:C014949	acetylhydrazine results in decreased expression of PEA15 mRNA	PMID:15282401
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PEA15 gene	PMID:27153756
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PEA15 mRNA	PMID:22100608
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314453	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PEA15 mRNA	PMID:19770486
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PEA15 mRNA	PMID:23649840
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PEA15 mRNA	PMID:35430440
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PEA15 mRNA	PMID:18593933
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314453	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PEA15A mRNA	PMID:31919559
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PEA15A mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PEA15 mRNA	PMID:20938992|PMID:22206623
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PEA15 gene	PMID:25304211
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PEA15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PEA15 mRNA	PMID:39836092
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PEA15A mRNA	PMID:40504410
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of PEA15 mRNA	PMID:19244175
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PEA15 mRNA	PMID:26272509
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PEA15 mRNA	PMID:27188386
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of PEA15 protein	PMID:35688186
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PEA15 mRNA	PMID:28903495
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of PEA15 mRNA	PMID:27594783
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin promotes the reaction [jinfukang results in decreased expression of PEA15 mRNA]; jinfukang promotes the reaction [Cisplatin results in decreased expression of PEA15 mRNA]	PMID:27392435
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1314453	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of PEA15 mRNA	PMID:18930951
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306055	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PEA15A mRNA	PMID:22298810
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314453	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PEA15 mRNA	PMID:21570461
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306055	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PEA15 mRNA	PMID:34747641
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:28177	theophylline	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in decreased expression of PEA15 mRNA	PMID:16083514
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of PEA15 mRNA	PMID:23649840
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PEA15A mRNA	PMID:15467011
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of PEA15 protein	PMID:29385562
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314453	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in decreased expression of PEA15A mRNA	PMID:25896364|PMID:39631538
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PEA15A mRNA	PMID:37992649
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PEA15 mRNA; sodium arsenite results in increased expression of PEA15 protein	PMID:38228842|PMID:38568856
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314453	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PEA15 mRNA	PMID:16014739
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PEA15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PEA15 mRNA	PMID:39836092
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PEA15A mRNA	PMID:40504410
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of PEA15 mRNA	PMID:22378314
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PEA15 mRNA	PMID:20106945|PMID:21632981|PMID:26238291|PMID:32234424
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of PEA15A mRNA	PMID:15467011
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PEA15 mRNA	PMID:18593933
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PEA15 mRNA	PMID:25895662
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PEA15 mRNA	PMID:19150397
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of PEA15 mRNA	PMID:38568856
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1306055	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of PEA15A mRNA	PMID:25729387
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306055	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of PEA15A mRNA	PMID:25729387
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:32095	retinyl acetate	increases expression	ISO	RGD:1314453	E	RGD:6480464	20120412	CTD	MESH:C009166	retinol acetate results in increased expression of PEA15A mRNA	PMID:16772331
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306055	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of PEA15 mRNA	PMID:30047161
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306055	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PEA15 mRNA	PMID:34492290
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1306055	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PEA15A mRNA	PMID:25380136
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314453	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of PEA15 mRNA	PMID:18648102
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1314453	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of PEA15A mRNA	PMID:33914522
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PEA15 mRNA	PMID:30903817
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of PEA15 protein	PMID:37567409
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306055	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PEA15 mRNA	PMID:25181051|PMID:32145629
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306055	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PEA15 gene	PMID:28505145
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306055	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PEA15 mRNA	PMID:36041667
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of PEA15 mRNA	PMID:19244175
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PEA15 mRNA	PMID:25979313
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314453	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of PEA15A mRNA	PMID:26682919
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306055	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PEA15 mRNA	PMID:36041667
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PEA15 protein	PMID:34186270
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PEA15 mRNA	PMID:28628672
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306055	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PEA15 mRNA	PMID:36041667
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PEA15 protein	PMID:34186270
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1306055	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of PEA15 mRNA	PMID:21241498
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314453	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of PEA15A protein	PMID:35362542
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PEA15A protein]	PMID:35362542
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1306055	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of PEA15 mRNA	PMID:22546817
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306055	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PEA15A mRNA	PMID:21266533
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306055	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PEA15A mRNA	PMID:21266533
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1314453	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of PEA15A mRNA	PMID:34813904
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of PEA15 protein	PMID:38598786
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PEA15 mRNA	PMID:28628672
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1306055	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of PEA15 mRNA	PMID:22546817
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PEA15 mRNA	PMID:39836092
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306055	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of PEA15A mRNA	PMID:25380136
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PEA15 mRNA	PMID:38568856
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:35559	furan	decreases methylation	ISO	RGD:1306055	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of PEA15A gene	PMID:27387713
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306055	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of PEA15A mRNA	PMID:27387713
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1306055	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of PEA15A mRNA	PMID:25380136
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of PEA15 mRNA	PMID:19244175
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PEA15 mRNA	PMID:31533062
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of PEA15 mRNA	PMID:26352163
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PEA15 mRNA	PMID:25979313
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314453	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PEA15 mRNA	PMID:17292431
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PEA15 gene	PMID:29154799
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of PEA15 mRNA	PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306055	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of PEA15 mRNA	PMID:30047161
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of PEA15 promoter	PMID:27989131
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PEA15 mRNA	PMID:20106945|PMID:25562108
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:41791	calyculin A	increases expression	ISO	RGD:1314453	E	RGD:6480464	20150127	CTD	MESH:C059041	calyculin A results in increased expression of PEA15A mRNA	PMID:25270620
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1314453	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of PEA15A mRNA	PMID:22733784
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PEA15 mRNA	PMID:28628672
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PEA15A mRNA	PMID:37992649
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:44915	propofol	decreases expression	ISO	RGD:1306055	E	RGD:6480464	20240430	CTD	MESH:D015742	Propofol results in decreased expression of PEA15 mRNA; Propofol results in decreased expression of PEA15 protein	PMID:31257496
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:44915	propofol	multiple interactions	ISO	RGD:1306055	E	RGD:6480464	20240430	CTD	MESH:D015742	PEA15 protein inhibits the reaction [Propofol results in decreased expression of BCL2 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased expression of CASP3 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased expression of RPS6KA3 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of CREB1 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of MAPK1 protein]; PEA15 protein inhibits the reaction [Propofol results in decreased phosphorylation of MAPK3 protein]; PEA15 protein inhibits the reaction [Propofol results in increased cleavage of CASP3 protein]; PEA15 protein inhibits the reaction [Propofol results in increased expression of BAX protein]	PMID:31257496
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PEA15 mRNA	PMID:21420995|PMID:22230336|PMID:29067470
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306055	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PEA15 mRNA	PMID:33387578
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of PEA15 mRNA	PMID:24714768
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of PEA15 mRNA	PMID:21148743
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PEA15 gene	PMID:25304211
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PEA15 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PEA15 mRNA	PMID:39836092
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PEA15A mRNA	PMID:40504410
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1306055	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of PEA15 mRNA	PMID:37077353
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:48607	lithium chloride	multiple interactions	ISO	RGD:1306055	E	RGD:6480464	20200211	CTD	MESH:D018021	[Pilocarpine co-treated with Lithium Chloride co-treated with 3-chloroacetylindole] results in decreased phosphorylation of PEA15 protein; [Pilocarpine co-treated with Lithium Chloride] results in decreased phosphorylation of PEA15 protein	PMID:31396050
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of PEA15A protein]	PMID:35362542
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PEA15 mRNA	PMID:28628672
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306055	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of PEA15 mRNA	PMID:30047161
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PEA15A mRNA	PMID:35964746
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	ISO	RGD:1306055	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of PEA15A mRNA	PMID:21983209
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PEA15 protein	PMID:32959892
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PEA15 mRNA	PMID:39836092
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1306055	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of PEA15 mRNA	PMID:25729387
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306055	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of PEA15A mRNA	PMID:25729387
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1314453	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of PEA15A mRNA	PMID:27462272
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PEA15 protein	PMID:34186270
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314453	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PEA15A mRNA	PMID:22206623
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314453	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PEA15A mRNA	PMID:22206623
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PEA15 protein	PMID:37664457
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:755208	eprenetapopt	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt results in increased expression of PEA15 mRNA	PMID:19946333
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt results in increased expression of PEA15 mRNA]	PMID:19946333
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PEA15 mRNA	PMID:27188386
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:8093	phenylephrine	increases expression	ISO	RGD:1306055	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in increased expression of PEA15 mRNA	PMID:18158353
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:8207	(+)-pilocarpine	multiple interactions	ISO	RGD:1306055	E	RGD:6480464	20200211	CTD	MESH:D010862	[Pilocarpine co-treated with Lithium Chloride co-treated with 3-chloroacetylindole] results in decreased phosphorylation of PEA15 protein; [Pilocarpine co-treated with Lithium Chloride] results in decreased phosphorylation of PEA15 protein	PMID:31396050
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:83537	1-benzylpiperazine	increases expression	ISO	RGD:1306055	E	RGD:6480464	20170221	CTD	MESH:C006737	N-benzylpiperazine results in increased expression of PEA15 mRNA	PMID:26821219
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314453	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of PEA15A mRNA	PMID:30953684|PMID:39847705
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306055	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of PEA15 mRNA	PMID:30047161
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:90724	AM-251	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C103505	AM 251 results in increased expression of PEA15 mRNA	PMID:16500647
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PEA15 protein; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PEA15 mRNA	PMID:27188386|PMID:37664457
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306055	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PEA15 mRNA	PMID:19281266
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of PEA15 mRNA	PMID:34581912
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PEA15 mRNA	PMID:38568856
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of PEA15 protein	PMID:38598786
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1306055	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in decreased expression of PEA15 mRNA	PMID:21515302
1314452	PEA15	proliferation and apoptosis adaptor protein 15	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306055	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PEA15 mRNA	PMID:23034163
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CARD19 mRNA	PMID:38218311
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CARD19 mRNA	PMID:26272509
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARD19 mRNA	PMID:27188386
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1332175	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of CARD19 mRNA	PMID:37995155
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1332175	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of CARD19 mRNA	PMID:30951980
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of CARD19 mRNA	PMID:22378314
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1332175	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CARD19 mRNA	PMID:39241906
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306058	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CARD19 mRNA	PMID:33387578
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1332175	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CARD19 mRNA	PMID:33754040
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CARD19 mRNA	PMID:28818685
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306058	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CARD19 protein	PMID:34915118
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CARD19 mRNA	PMID:19549813
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1306058	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of CARD19 protein	PMID:33236894
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CARD19 mRNA	PMID:35430440
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1332175	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CARD19 mRNA	PMID:31919559
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CARD19 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CARD19 mRNA	PMID:40512198
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CARD19 mRNA	PMID:27594783
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306058	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CARD19 mRNA	PMID:34747641
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306058	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CARD19 mRNA	PMID:33387578
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of CARD19 mRNA	PMID:28001369
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CARD19 mRNA	PMID:33212167
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306058	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CARD19 mRNA	PMID:28959563
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CARD19 mRNA	PMID:38568856
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1332175	E	RGD:6480464	20251104	CTD	MESH:C017947	sodium arsenite results in decreased expression of CARD19 mRNA	PMID:39095385
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CARD19 mRNA	PMID:39719251
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CARD19 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CARD19 mRNA	PMID:40512198
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CARD19 promoter	PMID:27901495
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CARD19 mRNA	PMID:21632981
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1306058	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of CARD19 mRNA	PMID:32479839
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306058	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CARD19 mRNA	PMID:34947998
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1332175	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CARD19 mRNA	PMID:34585602
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1332175	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of CARD19 mRNA	PMID:30951980
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1332175	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of CARD19 mRNA	PMID:26377693
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1332175	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of CARD19 mRNA	PMID:28392331
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CARD19 mRNA	PMID:37042841
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CARD19 mRNA	PMID:38568856
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of CARD19 mRNA	PMID:31533062
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CARD19 mRNA	PMID:25979313
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of CARD19 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CARD19 gene	PMID:29154799
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARD19 mRNA	PMID:27188386
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CARD19 mRNA	PMID:25562108
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CARD19 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CARD19 mRNA	PMID:40512198
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of CARD19 mRNA	PMID:31838189
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1332175	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CARD19 mRNA	PMID:35964746
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1332175	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CARD19 mRNA	PMID:38701926
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CARD19 protein	PMID:32959892
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of CARD19 mRNA	PMID:31758290
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CARD19 mRNA	PMID:37199045
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1306058	E	RGD:6480464	20160119	CTD	MESH:D009966	Orphenadrine affects the expression of CARD19 mRNA	PMID:23665939
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARD19 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARD19 mRNA	PMID:27188386
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306058	E	RGD:6480464	20160119	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CARD19 mRNA	PMID:24780913
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1332175	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of CARD19 mRNA	PMID:40826991
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARD19 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CARD19 mRNA	PMID:27188386
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306058	E	RGD:6480464	20160119	CTD	MESH:C025643	vinclozolin results in decreased expression of CARD19 mRNA	PMID:23034163
1314456	CARD19	caspase recruitment domain family member 19	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1306058	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of CARD19 gene	PMID:31079544
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306061	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of PGM2 mRNA	PMID:21551480
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PGM2 mRNA	PMID:22378314
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314460	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PGM2 mRNA	PMID:30319688
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of PGM2 mRNA	PMID:18951874
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PGM2 mRNA	PMID:21632981
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of PGM2 mRNA	PMID:29581250
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:16412	lipopolysaccharide	decreases methylation	ISO	RGD:1314460	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased methylation of PGM2 gene	PMID:21212295
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314460	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PGM2 mRNA	PMID:39241906
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314460	E	RGD:6480464	20161228	CTD	MESH:D008070	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of PGM2 gene	PMID:21212295
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of PGM2 mRNA	PMID:30165855
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of PGM2 mRNA	PMID:38568856
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306061	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PGM2 mRNA	PMID:33387578
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PGM2 protein	PMID:37730182
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PGM2 mRNA	PMID:39836092
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of PGM2 mRNA	PMID:17103032
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PGM2 mRNA	PMID:27153756
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1314460	E	RGD:6480464	20250401	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in decreased expression of PGM2 protein	PMID:39910959
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PGM2 mRNA	PMID:41430723
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PGM2 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of PGM2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of PGM2 protein	PMID:38598786
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314460	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PGM2 mRNA	PMID:31919559
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PGM2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PGM2 mRNA	PMID:39836092
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PGM2 mRNA	PMID:26272509
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM2 mRNA	PMID:27188386
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of PGM2 protein	PMID:35688186
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306061	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PGM2 mRNA	PMID:31881176
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PGM2 mRNA	PMID:23557933
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of PGM2 mRNA	PMID:23195993
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PGM2 mRNA	PMID:25583101
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314460	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PGM2 mRNA	PMID:21570461
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PGM2 mRNA	PMID:17101203
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314460	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PGM2 mRNA	PMID:19770486
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases methylation	ISO	RGD:1314460	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased methylation of PGM2 gene	PMID:21212295
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306061	E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PGM2 mRNA	PMID:26232522|PMID:34747641
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314460	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of PGM2 gene	PMID:21212295
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PGM2 mRNA	PMID:33212167
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PGM2 mRNA	PMID:32763439
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PGM2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PGM2 mRNA	PMID:39836092
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314460	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PGM2 mRNA	PMID:22228805
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PGM2 promoter	PMID:27901495
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of PGM2 gene	PMID:25435355
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PGM2 mRNA	PMID:26238291
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1314460	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PGM2 mRNA	PMID:29095437
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PGM2 protein	PMID:25419056
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1314460	E	RGD:6480464	20191114	CTD	MESH:C006632	Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of PGM2 mRNA]	PMID:29095437
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PGM2 gene	PMID:31601247
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314460	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PGM2 gene	PMID:35295148
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306061	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PGM2 mRNA	PMID:34492290
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314460	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of PGM2 mRNA	PMID:17426115|PMID:18301758
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PGM2 mRNA	PMID:19710929
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314460	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of PGM2 mRNA	PMID:28329830
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of PGM2 protein	PMID:31675489|PMID:34186270
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306061	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PGM2 mRNA	PMID:34947998
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314460	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of PGM2 protein	PMID:35999755
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PGM2 gene	PMID:31601247
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306061	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PGM2 mRNA	PMID:25181051
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of PGM2 gene	PMID:31601247
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of PGM2 protein	PMID:31675489
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	PGM2 mRNA affects the susceptibility to Carmustine	PMID:16365179
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PGM2 protein	PMID:34186270
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PGM2 protein	PMID:34186270
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314460	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PGM2 intron	PMID:28392331
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1314460	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of PGM2 mRNA	PMID:31558096
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314460	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of PGM2 protein	PMID:35999755
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306061	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PGM2 mRNA	PMID:21266533
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of PGM2 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PGM2 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of PGM2 protein	PMID:38598786
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314460	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of PGM2 mRNA	PMID:36117858
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PGM2 mRNA	PMID:37042841
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PGM2 mRNA	PMID:39836092
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1314460	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of PGM2 mRNA	PMID:19429403
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1314460	E	RGD:6480464	20140311	CTD	MESH:C023036	Dietary Fats, Unsaturated inhibits the reaction [perfluorooctanoic acid results in increased expression of PGM2 mRNA]	PMID:23626681
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306061	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of PGM2 mRNA	PMID:27387713
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PGM2 mRNA	PMID:19320972
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of PGM2 mRNA	PMID:24449571
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1314460	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of PGM2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PGM2 mRNA]	PMID:17585979
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of PGM2 protein	PMID:17152098
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PGM2 mRNA	PMID:28302478
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PGM2 mRNA	PMID:31533062
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1314460	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of PGM2 mRNA	PMID:19429403
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314460	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PGM2 protein	PMID:26178269
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PGM2 mRNA	PMID:25979313
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of PGM2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:27188386
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PGM2 mRNA	PMID:20106945
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PGM2 mRNA	PMID:25562108
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:43572	kojic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of PGM2 mRNA	PMID:16595896
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306061	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PGM2 mRNA	PMID:33387578
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of PGM2 mRNA	PMID:21420995
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314460	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of PGM2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PGM2 mRNA]	PMID:17585979
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PGM2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PGM2 mRNA	PMID:39836092
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of PGM2 mRNA	PMID:31675489
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of PGM2 mRNA	PMID:18175754
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1314460	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PGM2 mRNA	PMID:29095437
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PGM2 protein	PMID:25419056
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1314460	E	RGD:6480464	20191114	CTD	MESH:C032793	Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of PGM2 mRNA]	PMID:29095437
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314460	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PGM2 mRNA	PMID:25554681
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306061	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of PGM2 mRNA	PMID:23962444
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314460	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of PGM2 mRNA	PMID:36117858
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PGM2 protein	PMID:32959892
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PGM2 mRNA	PMID:39836092
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314460	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of PGM2 mRNA	PMID:15003993
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:6801	metformin	multiple interactions	ISO	RGD:1314460	E	RGD:6480464	20190219	CTD	MESH:D008687	Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of PGM2 mRNA]	PMID:29095437
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	PGM2 mRNA affects the susceptibility to temozolomide	PMID:16365179
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PGM2 mRNA	PMID:31758290
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PGM2 protein	PMID:34186270
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314460	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PGM2 mRNA	PMID:22206623
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PGM2 protein	PMID:37664457
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM2 mRNA	PMID:27188386
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PGM2 gene]	PMID:28238834
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PGM2 protein	PMID:31675489
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1314460	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of PGM2 mRNA	PMID:31558096
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of PGM2 protein	PMID:31675489
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of PGM2 protein; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PGM2 mRNA	PMID:27188386|PMID:37664457
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PGM2 mRNA	PMID:38568856
1314459	PGM2	phosphoglucomutase 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of PGM2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of PGM2 protein	PMID:38598786
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SKIC3 protein]	PMID:38195004
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SKIC3 mRNA	PMID:19074003
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306062	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of SKIC3 gene	PMID:35440735
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314462	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SKIC3 mRNA	PMID:39241906
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of SKIC3 protein	PMID:20109541
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306062	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SKIC3 mRNA	PMID:33387578
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SKIC3 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SKIC3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SKIC3 protein	PMID:35301059|PMID:38195004
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314462	E	RGD:6480464	20230207	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SKIC3 mRNA	PMID:19770486
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314462	E	RGD:6480464	20230207	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SKIC3 mRNA	PMID:34911549
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1314462	E	RGD:6480464	20230207	CTD	MESH:D005492	Folic Acid results in increased expression of SKIC3 mRNA	PMID:25629700
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SKIC3 gene	PMID:25304211
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SKIC3 mRNA	PMID:19244175
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SKIC3 mRNA	PMID:23557933
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SKIC3 mRNA	PMID:28903495
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:28177	theophylline	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in decreased expression of SKIC3 mRNA	PMID:18951874
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SKIC3 mRNA	PMID:28001369
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SKIC3 mRNA	PMID:33212167
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306062	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SKIC3 mRNA	PMID:28959563
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314462	E	RGD:6480464	20230207	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SKIC3 mRNA	PMID:22228805
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to SKIC3 mRNA]	PMID:32406909
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SKIC3 mRNA	PMID:25351596
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306062	E	RGD:6480464	20161213	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in decreased expression of SKIC3 mRNA	PMID:25729387
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306062	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SKIC3 mRNA	PMID:25181051|PMID:30816183
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SKIC3 mRNA	PMID:25047013
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306062	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of TTC37 mRNA	PMID:32145629
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SKIC3 mRNA	PMID:19244175
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314462	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SKIC3 mRNA	PMID:38685157
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1314462	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of SKIC3 protein	PMID:35362542
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314462	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SKIC3 protein]	PMID:35362542
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TTC37 mRNA	PMID:37042841
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306062	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SKIC3 mRNA	PMID:33453195
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SKIC3 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SKIC3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SKIC3 protein	PMID:35301059|PMID:38195004
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SKIC3 mRNA	PMID:24449571
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SKIC3 mRNA	PMID:19244175
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SKIC3 mRNA	PMID:28302478
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SKIC3 mRNA	PMID:31533062
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SKIC3 mRNA	PMID:27153767
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SKIC3 mRNA	PMID:36621641
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SKIC3 mRNA	PMID:26272509
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SKIC3 gene	PMID:25304211
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314462	E	RGD:6480464	20230207	CTD	MESH:C109476	epoxiconazole results in decreased expression of SKIC3 mRNA	PMID:35436446
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1314462	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of SKIC3 protein]	PMID:35362542
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306062	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SKIC3 mRNA	PMID:24136188
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of SKIC3 mRNA	PMID:26705709
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306062	E	RGD:6480464	20160315	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in decreased expression of SKIC3 mRNA	PMID:25729387
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:6443	levonorgestrel	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SKIC3 mRNA	PMID:19074003
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SKIC3 mRNA	PMID:22714537
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:76290	PhIP	increases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of SKIC3 mRNA	PMID:20816883
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SKIC3 protein	PMID:31675489
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SKIC3 mRNA	PMID:29301935
1314461	SKIC3	SKI3 subunit of superkiller complex	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of SKIC3 mRNA	PMID:27188386
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SNRPC mRNA	PMID:38218311
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SNRPC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SNRPC mRNA	PMID:32699268
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306065	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SNRPC mRNA	PMID:32145629
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:166595	Yessotoxin	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in decreased expression of SNRPC mRNA	PMID:30679557
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314466	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SNRPC mRNA	PMID:33754040
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SNRPC protein	PMID:37730182
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306065	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SNRPC mRNA	PMID:22061828
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SNRPC protein	PMID:23301498
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306065	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of SNRPC mRNA	PMID:21396975
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SNRPC mRNA	PMID:27153756
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1314466	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of SNRPC mRNA	PMID:15674844
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SNRPC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SNRPC mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of SNRPC mRNA	PMID:32699268
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314466	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SNRPC mRNA	PMID:34911549
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314466	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SNRPC mRNA	PMID:25629700
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314466	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNRPC mRNA	PMID:22206623
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SNRPC protein	PMID:35688186
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1314466	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of SNRPC mRNA	PMID:28960355
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SNRPC mRNA	PMID:28903495
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of SNRPC mRNA	PMID:27392435
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314466	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SNRPC mRNA	PMID:30912803
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314466	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SNRPC mRNA	PMID:19465110|PMID:21354282
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314466	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNRPC mRNA	PMID:17942748
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1314466	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of SNRPC protein	PMID:21146535
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNRPC protein	PMID:38228842
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of SNRPC mRNA	PMID:34032870
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to SNRPC mRNA]	PMID:32406909
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1314466	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of SNRPC protein	PMID:21146535
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314466	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of SNRPC mRNA	PMID:35295148
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314466	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNRPC promoter	PMID:35295148
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314466	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SNRPC gene	PMID:35295148
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306065	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SNRPC mRNA	PMID:23411599
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SNRPC mRNA	PMID:30903817
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of SNRPC mRNA; bisphenol A results in decreased expression of SNRPC protein	PMID:29275510|PMID:33376534
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306065	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNRPC mRNA	PMID:25181051
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306065	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SNRPC mRNA	PMID:36041667
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314466	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SNRPC mRNA	PMID:39298647
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306065	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SNRPC mRNA	PMID:36041667
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306065	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SNRPC mRNA	PMID:36041667
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314466	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SNRPC mRNA	PMID:37019170
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314466	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SNRPC mRNA	PMID:21266533
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SNRPC protein	PMID:24527689
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SNRPC protein	PMID:26879310
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SNRPC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SNRPC mRNA	PMID:32699268
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314466	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of SNRPC mRNA	PMID:17585979
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1306065	E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in increased expression of SNRPC mRNA	PMID:35594946
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314466	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNRPC mRNA	PMID:17562736
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314466	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SNRPC mRNA	PMID:17942748
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314466	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNRPC mRNA	PMID:17942748
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:50102	N-methyl-N-nitrosourea	decreases expression	ISO	RGD:1314466	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in decreased expression of SNRPC mRNA	PMID:25270620
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1306065	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of SNRPC mRNA	PMID:34044035
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306065	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SNRPC mRNA	PMID:24136188
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SNRPC protein	PMID:32959892
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SNRPC mRNA	PMID:31758290
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314466	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNRPC mRNA	PMID:22206623
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306065	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of SNRPC mRNA	PMID:24136188
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of SNRPC mRNA	PMID:37199045
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1306065	E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in increased expression of SNRPC mRNA	PMID:18417182
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SNRPC gene]	PMID:28238834
1314465	SNRPC	small nuclear ribonucleoprotein polypeptide C	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314466	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SNRPC mRNA	PMID:30294300
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1557306	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ADAMTS10 mRNA	PMID:33045310
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1598320	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADAMTS10 mRNA]	PMID:31150632
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ADAMTS10 mRNA	PMID:26079696
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1557306	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ADAMTS10 mRNA	PMID:30517762
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of ADAMTS10 mRNA	PMID:18951874
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1557306	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ADAMTS10 mRNA	PMID:39241906
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ADAMTS10 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ADAMTS10 mRNA	PMID:35811015
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ADAMTS10 mRNA	PMID:30165855
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1598320	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ADAMTS10 mRNA	PMID:33387578
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of ADAMTS10 mRNA	PMID:26079696
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADAMTS10 mRNA	PMID:35301059
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1557306	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ADAMTS10 mRNA	PMID:37325564
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ADAMTS10 exon	PMID:30157460
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1557306	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ADAMTS10 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ADAMTS10 mRNA	PMID:34911549
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1598320	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ADAMTS10 mRNA	PMID:30779732
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1598320	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADAMTS10 mRNA	PMID:31150632
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1557306	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ADAMTS10 mRNA	PMID:30517762
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1598320	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADAMTS10 mRNA]	PMID:31150632
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1557306	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADAMTS10 mRNA	PMID:40504410
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1557306	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ADAMTS10 mRNA	PMID:28960355
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ADAMTS10 mRNA	PMID:27392435
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1557306	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADAMTS10 mRNA	PMID:33956508
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1598320	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADAMTS10 mRNA	PMID:33387578|PMID:34747641
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of ADAMTS10 mRNA	PMID:29955902
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADAMTS10 mRNA	PMID:29803840
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in increased expression of ADAMTS10 mRNA	PMID:35954277
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1557306	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADAMTS10 mRNA	PMID:40504410
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADAMTS10 5' UTR	PMID:27901495
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ADAMTS10 promoter	PMID:27901495
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1598320	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ADAMTS10 mRNA	PMID:30047161
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557306	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ADAMTS10 gene	PMID:35295148
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1598320	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAMTS10 mRNA	PMID:25181051
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1557306	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ADAMTS10 mRNA	PMID:33221593
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1557306	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ADAMTS10 mRNA	PMID:40203079
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ADAMTS10 gene	PMID:31601247
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ADAMTS10 intron	PMID:30157460
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1557306	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ADAMTS10 mRNA	PMID:38685157
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADAMTS10 mRNA	PMID:35301059
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557306	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ADAMTS10 mRNA	PMID:37325564
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1598320	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ADAMTS10 mRNA	PMID:30047161
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ADAMTS10 mRNA	PMID:31533062
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ADAMTS10 gene	PMID:29154799
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ADAMTS10 mRNA	PMID:17183730
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1598320	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ADAMTS10 mRNA	PMID:30047161
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1557306	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ADAMTS10 mRNA	PMID:28973697
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ADAMTS10 mRNA	PMID:38832940
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADAMTS10 mRNA	PMID:22230336|PMID:29067470
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of ADAMTS10 mRNA	PMID:35811015
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ADAMTS10 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ADAMTS10 mRNA	PMID:35811015
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1557306	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ADAMTS10 mRNA	PMID:40504410
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1557306	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ADAMTS10 mRNA; Nanotubes, Carbon results in decreased expression of ADAMTS10 mRNA	PMID:25554681
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1598320	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ADAMTS10 mRNA	PMID:30047161
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1557306	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of ADAMTS10 mRNA	PMID:40234311
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ADAMTS10 mRNA	PMID:17183730
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1557306	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ADAMTS10 mRNA	PMID:26378955
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ADAMTS10 intron	PMID:30157460
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ADAMTS10 mRNA	PMID:37199045
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of ADAMTS10 mRNA	PMID:28960945
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:755208	eprenetapopt	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of ADAMTS10 mRNA	PMID:19946333
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of ADAMTS10 mRNA]	PMID:19946333
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of ADAMTS10 mRNA	PMID:39904859
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ADAMTS10 mRNA	PMID:26079696
1314467	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1598320	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of ADAMTS10 mRNA	PMID:30047161
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of ESF1 protein	PMID:39638853
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314469	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ESF1 mRNA	PMID:33045310
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ESF1 mRNA	PMID:33167477
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of ESF1 protein	PMID:28073184
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of ESF1 mRNA	PMID:40865780
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314469	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ESF1 mRNA	PMID:39241906
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ESF1 mRNA	PMID:31614463
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306067	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ESF1 mRNA	PMID:33387578
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of ESF1 mRNA	PMID:20655997
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ESF1 protein	PMID:37730182
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ESF1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ESF1 mRNA	PMID:39836092
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314469	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ESF1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ESF1 mRNA	PMID:37236586|PMID:37325564
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ESF1 mRNA	PMID:23649840
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314469	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ESF1 mRNA	PMID:27339419|PMID:31919559
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314469	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ESF1 mRNA	PMID:22206623
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ESF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ESF1 mRNA	PMID:39836092
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ESF1 protein	PMID:35688186
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C010974	Glyphosate results in decreased expression of ESF1 mRNA	PMID:40865780
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ESF1 mRNA	PMID:23557933
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306067	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ESF1 mRNA	PMID:33387578
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ESF1 mRNA	PMID:20106945
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306067	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ESF1 mRNA	PMID:32109520
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ESF1 mRNA	PMID:33212167
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ESF1 protein	PMID:35688186
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ESF1 mRNA	PMID:22714537|PMID:38568856
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314469	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased expression of ESF1 mRNA	PMID:32068019
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ESF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ESF1 mRNA	PMID:39836092
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ESF1 mRNA	PMID:22316170
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306067	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ESF1 mRNA	PMID:34492290
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314469	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ESF1 mRNA	PMID:28472532
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306067	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ESF1 mRNA	PMID:25181051
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314469	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ESF1 mRNA	PMID:33221593
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314469	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of ESF1 mRNA	PMID:40036665
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314469	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of ESF1 mRNA	PMID:32742594|PMID:39298647
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314469	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ESF1 mRNA	PMID:37019170
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ESF1 mRNA	PMID:37042841
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1306067	E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of ESF1 mRNA	PMID:17616710
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ESF1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ESF1 mRNA	PMID:39836092
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ESF1 mRNA	PMID:38174414
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314469	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ESF1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ESF1 mRNA	PMID:37236586|PMID:37325564
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1314469	E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in increased expression of ESF1 mRNA	PMID:21139344
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ESF1 mRNA	PMID:28302478
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ESF1 mRNA	PMID:31533062
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ESF1 mRNA	PMID:27153767
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1306067	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ESF1 mRNA	PMID:23125180
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1306067	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of ESF1 mRNA	PMID:25993096
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ESF1 mRNA	PMID:23179753
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314469	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of ESF1 mRNA	PMID:19770486
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ESF1 mRNA	PMID:20106945
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ESF1 mRNA	PMID:27188386
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314469	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ESF1 mRNA	PMID:17562736
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306067	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ESF1 mRNA	PMID:33387578
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ESF1 mRNA	PMID:18687144
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ESF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ESF1 mRNA	PMID:39836092
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306067	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ESF1 mRNA	PMID:24136188
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of ESF1 mRNA	PMID:20977926
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of ESF1 mRNA	PMID:22714537
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ESF1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ESF1 mRNA	PMID:39836092
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ESF1 mRNA	PMID:28988120
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1314469	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of ESF1 mRNA	PMID:27462272
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1314469	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of ESF1 mRNA	PMID:28444820
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314469	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ESF1 mRNA	PMID:22206623
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314469	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ESF1 mRNA	PMID:22206623
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ESF1 protein	PMID:31285264
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ESF1 mRNA	PMID:30928695
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1314469	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of ESF1 mRNA	PMID:23091169
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1306067	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of ESF1 mRNA	PMID:32109520
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1314469	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of ESF1 mRNA	PMID:21278054
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ESF1 mRNA	PMID:17440010
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1314469	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of ESF1 protein	PMID:24648495
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of ESF1 mRNA	PMID:27188386
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314469	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ESF1 mRNA	PMID:28973697
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306067	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ESF1 mRNA	PMID:19015723
1314468	ESF1	ESF1 nucleolar pre-rRNA processing protein	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306067	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of ESF1 mRNA	PMID:20566332
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314471	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ARHGAP1 mRNA	PMID:33045310
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314471	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ARHGAP1 mRNA	PMID:20188158
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ARHGAP1 mRNA	PMID:26079696
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314471	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ARHGAP1 mRNA	PMID:30319688
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:16563	tetrahydropalmatine	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in decreased expression of ARHGAP1 protein	PMID:20109541
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306068	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ARHGAP1 gene	PMID:27618143
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARHGAP1 mRNA	PMID:37042841
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:168138	2-amino-14,16-dimethyloctadecan-3-ol	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C507616	2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of ARHGAP1 protein	PMID:32044396
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:16899	D-mannitol	increases expression	ISO	RGD:1314471	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in increased expression of ARHGAP1 mRNA	PMID:25270620
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ARHGAP1 mRNA	PMID:21179406
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1306068	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of ARHGAP1 mRNA	PMID:22967744
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ARHGAP1 protein	PMID:31163220
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ARHGAP1 mRNA	PMID:31163220
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ARHGAP1 protein	PMID:37730182
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ARHGAP1 intron	PMID:30157460
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:187088	Muconic dialdehyde	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C034476	muconaldehyde results in decreased expression of ARHGAP1 mRNA	PMID:40300100
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGAP1 mRNA	PMID:35301059
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314471	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGAP1 mRNA	PMID:37236586
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ARHGAP1 mRNA	PMID:19549813
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1306068	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of ARHGAP1 protein	PMID:33236894
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ARHGAP1 intron	PMID:30157460
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of ARHGAP1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of ARHGAP1 protein	PMID:38598786
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314471	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ARHGAP1 mRNA	PMID:17484886
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP1 mRNA	PMID:39836092
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314471	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP1 mRNA	PMID:40504410
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ARHGAP1 protein	PMID:35688186
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of ARHGAP1 mRNA	PMID:28903495
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of ARHGAP1 mRNA	PMID:27594783
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1306068	E	RGD:6480464	20160412	CTD	MESH:D003042	Cocaine results in increased expression of ARHGAP1 protein	PMID:25100957
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of ARHGAP1 mRNA	PMID:23195993
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314471	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARHGAP1 mRNA	PMID:21570461
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314471	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGAP1 mRNA	PMID:17942748
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306068	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of ARHGAP1 mRNA	PMID:28374803
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ARHGAP1 mRNA	PMID:33212167
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARHGAP1 mRNA	PMID:29803840
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ARHGAP1 protein	PMID:35688186
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of ARHGAP1 protein	PMID:30528433
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ARHGAP1 mRNA; sodium arsenite results in increased expression of ARHGAP1 protein	PMID:21925251|PMID:39719251
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP1 mRNA	PMID:39836092
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314471	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP1 mRNA	PMID:40504410
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ARHGAP1 exon	PMID:30157460
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314471	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARHGAP1 mRNA	PMID:22228805
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ARHGAP1 protein	PMID:25419056
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306068	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of ARHGAP1 mRNA	PMID:24136188
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306068	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ARHGAP1 mRNA	PMID:30047161
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314471	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARHGAP1 promoter	PMID:35295148
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314471	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ARHGAP1 mRNA	PMID:18648102
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306068	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARHGAP1 mRNA	PMID:25181051
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314471	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ARHGAP1 mRNA; bisphenol A results in decreased expression of ARHGAP1 protein	PMID:35999755|PMID:37894381
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of ARHGAP1 protein	PMID:37567409
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314471	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ARHGAP1 gene	PMID:31683443
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of ARHGAP1 protein	PMID:34186270
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ARHGAP1 protein	PMID:34186270
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ARHGAP1 protein	PMID:34186270
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314471	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ARHGAP1 mRNA	PMID:37019170
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314471	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of ARHGAP1 protein	PMID:35999755
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314471	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARHGAP1 mRNA	PMID:21266533
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of ARHGAP1 protein	PMID:38598786
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARHGAP1 mRNA	PMID:37042841
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ARHGAP1 mRNA	PMID:38568856
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306068	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ARHGAP1 mRNA	PMID:33453195
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGAP1 mRNA	PMID:35301059
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314471	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGAP1 mRNA	PMID:37236586
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1306068	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ARHGAP1 mRNA	PMID:30047161
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ARHGAP1 mRNA	PMID:19376846
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of ARHGAP1 protein	PMID:17152098
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ARHGAP1 mRNA	PMID:28302478
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ARHGAP1 mRNA	PMID:25979313
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306068	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ARHGAP1 mRNA	PMID:30047161
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ARHGAP1 mRNA	PMID:36621641
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of ARHGAP1 mRNA	PMID:24449571
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314471	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARHGAP1 mRNA	PMID:17562736
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ARHGAP1 mRNA	PMID:21420995
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314471	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ARHGAP1 mRNA	PMID:29279043
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP1 mRNA	PMID:39836092
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314471	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARHGAP1 mRNA	PMID:40504410
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314471	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ARHGAP1 mRNA	PMID:35436446
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314471	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARHGAP1 mRNA	PMID:17942748
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314471	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARHGAP1 mRNA	PMID:17942748
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ARHGAP1 protein	PMID:25419056
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306068	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ARHGAP1 mRNA	PMID:30047161
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306068	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of ARHGAP1 mRNA	PMID:22504374
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314471	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of ARHGAP1 mRNA	PMID:40234311
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of ARHGAP1 mRNA	PMID:20977926
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ARHGAP1 protein	PMID:32959892
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1306068	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ARHGAP1 mRNA	PMID:30467583
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:68233	(Z)-3-butylidenephthalide	increases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C026105	butylidenephthalide results in increased expression of ARHGAP1 protein	PMID:23770345
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ARHGAP1 protein	PMID:34186270
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314471	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ARHGAP1 mRNA	PMID:22206623
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ARHGAP1 protein	PMID:37664457
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of ARHGAP1 protein	PMID:39638853
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1306068	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ARHGAP1 mRNA	PMID:27291303
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306068	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARHGAP1 mRNA	PMID:30047161
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306068	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of ARHGAP1 mRNA	PMID:22504374
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ARHGAP1 protein	PMID:37664457
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306068	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ARHGAP1 mRNA	PMID:21346803
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of ARHGAP1 protein	PMID:38598786
1314470	ARHGAP1	Rho GTPase activating protein 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306068	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ARHGAP1 mRNA	PMID:19015723
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of VRK1 mRNA	PMID:38218311
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	[Tretinoin co-treated with Ascorbic Acid] results in decreased expression of VRK1 mRNA	PMID:16443354
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of VRK1 mRNA	PMID:22378314
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of VRK1 mRNA	PMID:21632981
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306069	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of VRK1 mRNA	PMID:32145629
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of VRK1 mRNA	PMID:19167446
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of VRK1 mRNA	PMID:38568856
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of VRK1 mRNA	PMID:21592394
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of VRK1 mRNA	PMID:21592394
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of VRK1 protein	PMID:37730182
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of VRK1 mRNA	PMID:21592394
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of VRK1 mRNA	PMID:21592394
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of VRK1 mRNA	PMID:28818685
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of VRK1 protein	PMID:23301498
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of VRK1 protein	PMID:20106945
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of VRK1 mRNA	PMID:25102026
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314473	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of VRK1 mRNA	PMID:34911549
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314473	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of VRK1 mRNA	PMID:40504410
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306069	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of VRK1 mRNA	PMID:31881176
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of VRK1 mRNA	PMID:19167446
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1314473	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of VRK1 mRNA	PMID:18930951
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VRK1 mRNA	PMID:22574217
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314473	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VRK1 mRNA	PMID:21570461
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of VRK1 mRNA	PMID:21802500
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306069	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of VRK1 mRNA	PMID:32109520
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306069	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VRK1 mRNA	PMID:33387578
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of VRK1 mRNA	PMID:30851411
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20250204	CTD	MESH:D004317	[VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of ALKBH5 protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of ATRX protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of BOD1L1 protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of DHX36 protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of H1-5 protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of HNRNPD protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of HP1BP3 protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of LMNA protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of MCM3 protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of MLH1 protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of MORC2 protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of MYBBP1A protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of NBN protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of NUCKS1 protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of PRKRA protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of RBBP6 protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of RIF1 protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of TP53BP1 protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of TRRAP protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of WDR33 protein; [VRK1 protein affects the susceptibility to Doxorubicin] which affects the phosphorylation of ZNF830 protein; VRK1 protein affects the reaction [Doxorubicin results in increased phosphorylation of NUCKS1 protein]; VRK1 protein affects the reaction [Doxorubicin results in increased phosphorylation of RNF169 protein]; VRK1 protein affects the reaction [Doxorubicin results in increased phosphorylation of SETX protein]; VRK1 protein affects the reaction [Doxorubicin results in increased phosphorylation of SP1 protein]; VRK1 protein affects the reaction [Doxorubicin results in increased phosphorylation of TP53BP1 protein]; VRK1 protein affects the reaction [Doxorubicin results in increased phosphorylation of TPR protein]; VRK1 protein affects the reaction [Doxorubicin results in increased phosphorylation of XRCC1 protein]	PMID:38367682
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001205	[Tretinoin co-treated with Ascorbic Acid] results in decreased expression of VRK1 mRNA	PMID:16443354
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of VRK1 mRNA	PMID:22623647
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of VRK1 mRNA	PMID:38568856
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of VRK1 mRNA	PMID:34032870
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314473	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of VRK1 mRNA	PMID:40504410
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of VRK1 mRNA	PMID:20106945|PMID:21632981|PMID:21802500
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314473	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of VRK1 mRNA	PMID:19770486
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314473	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of VRK1 mRNA	PMID:22228805
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1314473	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of VRK1 mRNA	PMID:18929588
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of VRK1 mRNA	PMID:20382639
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1306069	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of VRK1 mRNA	PMID:25729387
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306069	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of VRK1 mRNA	PMID:25729387
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314473	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VRK1 promoter	PMID:35295148
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314473	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of VRK1 mRNA	PMID:28472532
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of VRK1 mRNA; bisphenol A results in decreased expression of VRK1 protein	PMID:29275510|PMID:31675489|PMID:37567409
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306069	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of VRK1 mRNA	PMID:34947998|PMID:41034487
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314473	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of VRK1 mRNA	PMID:35598803
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of VRK1 protein	PMID:31675489
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of VRK1 mRNA	PMID:25979313
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1306069	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of VRK1 mRNA	PMID:23196670
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314473	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of VRK1 mRNA	PMID:40203079
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314473	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of VRK1 intron	PMID:28392331
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1306069	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of VRK1 mRNA	PMID:30589522
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of VRK1 protein	PMID:26879310
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of VRK1 mRNA	PMID:28302478
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of VRK1 mRNA	PMID:31533062
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of VRK1 mRNA	PMID:19167446
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VRK1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of VRK1 mRNA	PMID:19167446
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314473	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of VRK1 mRNA	PMID:39529242
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of VRK1 mRNA	PMID:25979313
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of VRK1 mRNA	PMID:29154799
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of VRK1 mRNA	PMID:20106945|PMID:21632981
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of VRK1 mRNA	PMID:38832940
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of VRK1 mRNA	PMID:22230336
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306069	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of VRK1 mRNA	PMID:33387578
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314473	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of VRK1 mRNA	PMID:40504410
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of VRK1 mRNA	PMID:31675489
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of VRK1 mRNA	PMID:22079256
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:50102	N-methyl-N-nitrosourea	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D008770	Methylnitrosourea results in decreased expression of VRK1 protein	PMID:27233451
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:50102	N-methyl-N-nitrosourea	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D008770	TP53 protein promotes the reaction [Methylnitrosourea results in decreased expression of VRK1 protein]	PMID:27233451
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314473	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of VRK1 mRNA	PMID:25554681
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1306069	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of VRK1 mRNA	PMID:34044035
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306069	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of VRK1 mRNA	PMID:25729387
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cannabidiol co-treated with moringin] results in increased expression of VRK1 mRNA	PMID:30096889
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314473	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of VRK1 mRNA	PMID:22206623
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of VRK1 mRNA	PMID:22079256
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of VRK1 mRNA	PMID:22079256
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of VRK1 mRNA	PMID:29522793
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:754906	afuresertib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of VRK1 mRNA	PMID:28960945
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of VRK1 protein	PMID:31285264
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of VRK1 mRNA	PMID:30851411
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to VRK1 gene]	PMID:28238834
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of VRK1 mRNA	PMID:19167446
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of VRK1 protein	PMID:31675489
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of VRK1 protein	PMID:31675489
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of VRK1 mRNA	PMID:21858171
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of VRK1 mRNA	PMID:33512557
1314472	VRK1	VRK serine/threonine kinase 1	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of VRK1 mRNA	PMID:19140230
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ROM1 mRNA	PMID:22378314
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of ROM1 mRNA	PMID:17962382
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314475	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ROM1 mRNA	PMID:33711761
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of ROM1 mRNA	PMID:21592394
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of ROM1 mRNA	PMID:21592394
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306070	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ROM1 mRNA	PMID:26577399
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ROM1 mRNA	PMID:21592394
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of ROM1 mRNA	PMID:21592394
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306070	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ROM1 mRNA	PMID:33387578
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of ROM1 mRNA	PMID:38460933
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of ROM1 mRNA	PMID:38460933
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of ROM1 mRNA	PMID:27392435
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ROM1 mRNA	PMID:27392435
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314475	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ROM1 mRNA	PMID:21570461
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306070	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ROM1 mRNA	PMID:28959563
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ROM1 mRNA	PMID:20044591
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:3090	bicalutamide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of ROM1 mRNA	PMID:15790403
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306070	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ROM1 mRNA	PMID:34492290
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314475	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ROM1 mRNA	PMID:18648102
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1306070	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ROM1 mRNA	PMID:19162173
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306070	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ROM1 mRNA	PMID:25181051|PMID:34947998
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of ROM1 mRNA	PMID:27685785
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314475	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ROM1 mRNA	PMID:32156529
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314475	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ROM1 gene	PMID:31683443
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ROM1 mRNA	PMID:28628672
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ROM1 mRNA	PMID:28628672
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1306070	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ROM1 mRNA	PMID:19162173
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ROM1 mRNA	PMID:31533062
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ROM1 mRNA	PMID:26272509
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ROM1 mRNA	PMID:27188386
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306070	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of ROM1 mRNA	PMID:38685447
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ROM1 mRNA	PMID:28628672
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314475	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ROM1 mRNA	PMID:17562736
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of ROM1 mRNA	PMID:38460933
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ROM1 mRNA	PMID:28628672
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ROM1 mRNA	PMID:27188386
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ROM1 gene]	PMID:28238834
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ROM1 mRNA	PMID:19159669
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:8772	raloxifene	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of ROM1 mRNA	PMID:17962382
1314474	ROM1	retinal outer segment membrane protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ROM1 mRNA	PMID:27188386
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of INPP1 mRNA	PMID:38218311
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of INPP1 mRNA	PMID:21934132|PMID:33167477
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of INPP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of INPP1 mRNA	PMID:32699268
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of INPP1 mRNA	PMID:31614463
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of INPP1 mRNA	PMID:37042841
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of INPP1 mRNA	PMID:19162166
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of INPP1 mRNA	PMID:23649840
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of INPP1 mRNA	PMID:33359661
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314477	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of INPP1 mRNA	PMID:34319233
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306071	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of INPP1 mRNA	PMID:33387578
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:188938	Allylamine	increases expression	ISO	RGD:1306071	E	RGD:6480464	20220208	CTD	MESH:D000499	Allylamine results in increased expression of INPP1 mRNA	PMID:15910882
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:23414	copper(II) sulfate	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of INPP1 mRNA	PMID:19549813
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of INPP1 mRNA	PMID:23649840
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of INPP1 protein	PMID:20106945
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of INPP1 gene	PMID:27153756
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of INPP1 mRNA	PMID:21632981|PMID:21641981|PMID:27153756
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of INPP1 mRNA	PMID:23649840
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of INPP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of INPP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of INPP1 mRNA	PMID:32699268
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of INPP1 mRNA	PMID:18593933
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1314477	E	RGD:6480464	20251007	CTD	MESH:D001151	Arsenic results in decreased expression of INPP1 protein	PMID:37888683
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314477	E	RGD:6480464	20251007	CTD	MESH:D001151	GW 4064 affects the reaction [Arsenic results in decreased expression of INPP1 protein]	PMID:37888683
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of INPP1 mRNA	PMID:33512557
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of INPP1 mRNA	PMID:38460933
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of INPP1 protein; [Dactinomycin co-treated with nutlin 3] results in increased expression of INPP1 mRNA	PMID:38460933
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of INPP1 mRNA	PMID:26272509
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP1 mRNA	PMID:27188386
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of INPP1 mRNA	PMID:17984146
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306071	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of INPP1 mRNA	PMID:31881176
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of INPP1 mRNA	PMID:23300844
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of INPP1 mRNA	PMID:27392435|PMID:27594783
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314477	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of INPP1 mRNA	PMID:21151649
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314477	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of INPP1 mRNA	PMID:32186404
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314477	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of INPP1 mRNA	PMID:21570461
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306071	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of INPP1 mRNA	PMID:34747641
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of INPP1 mRNA	PMID:33512557
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of INPP1 mRNA; aristolochic acid I results in increased expression of INPP1 protein	PMID:33212167
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of INPP1 mRNA	PMID:23649840
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of INPP1 mRNA	PMID:22378314
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of INPP1 exon	PMID:27901495
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of INPP1 mRNA; Benzo(a)pyrene results in increased expression of INPP1 protein	PMID:20106945|PMID:21632981|PMID:26238291|PMID:32234424|PMID:33278487
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of INPP1 gene	PMID:25435355
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1314477	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of INPP1 protein	PMID:37955338
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to INPP1 mRNA]	PMID:32406909
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of INPP1 mRNA	PMID:18593933
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314477	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of INPP1 mRNA	PMID:27131904
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of INPP1 mRNA	PMID:25895662
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	INPP1 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1314477	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of INPP1 mRNA	PMID:21829687
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314477	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of INPP1 gene	PMID:35295148
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314477	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of INPP1 mRNA	PMID:18301758
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314477	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of INPP1 mRNA	PMID:19710929
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of INPP1 mRNA	PMID:30903817
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306071	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of INPP1 mRNA	PMID:25181051
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of INPP1 mRNA	PMID:25979313
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1314477	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of INPP1 mRNA	PMID:24535843
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of INPP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of INPP1 mRNA	PMID:32699268
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314477	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of INPP1 mRNA	PMID:17585979
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of INPP1 mRNA	PMID:31533062
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of INPP1 mRNA	PMID:40419075
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314477	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of INPP1 mRNA	PMID:17292431
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of INPP1 mRNA	PMID:28001369|PMID:29154799
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of INPP1 mRNA	PMID:20106945|PMID:25562108
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased expression of INPP1 mRNA	PMID:12782123
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of INPP1 mRNA	PMID:23649840
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of INPP1 mRNA	PMID:24935251
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of INPP1 mRNA	PMID:21420995
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306071	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of INPP1 mRNA	PMID:33387578
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of INPP1 protein; [Dactinomycin co-treated with nutlin 3] results in increased expression of INPP1 mRNA	PMID:38460933
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1314477	E	RGD:6480464	20251007	CTD	MESH:D001151	Arsenic results in decreased expression of INPP1 protein	PMID:37888683
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314477	E	RGD:6480464	20251007	CTD	MESH:D001151	GW 4064 affects the reaction [Arsenic results in decreased expression of INPP1 protein]	PMID:37888683
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of INPP1 mRNA	PMID:26833863
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1306071	E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan affects the expression of INPP1 mRNA	PMID:31464424
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306071	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of INPP1 mRNA	PMID:29391264
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	INPP1 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of INPP1 mRNA	PMID:23300844
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306071	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of INPP1 mRNA	PMID:24136188
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of INPP1 protein	PMID:32959892
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of INPP1 mRNA	PMID:27188386
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of INPP1 mRNA	PMID:28988120
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:7438	N-methylformamide	decreases expression	ISO	RGD:1314477	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide analog results in decreased expression of INPP1 mRNA; methylformamide results in decreased expression of INPP1 mRNA	PMID:17040096
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP1 mRNA	PMID:27188386
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to INPP1 gene]	PMID:28238834
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1314477	E	RGD:6480464	20251007	CTD	MESH:C412815	GW 4064 affects the reaction [Arsenic results in decreased expression of INPP1 protein]	PMID:37888683
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314477	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of INPP1 mRNA	PMID:23091169
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314477	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of INPP1 mRNA	PMID:39847705
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP1 mRNA	PMID:27188386
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314477	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of INPP1 mRNA	PMID:27131904
1314476	INPP1	inositol polyphosphate-1-phosphatase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306071	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of INPP1 mRNA	PMID:21346803
1314481	SRP72	signal recognition particle 72	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of SRP72 mRNA	PMID:38218311
1314481	SRP72	signal recognition particle 72	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314482	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SRP72 mRNA	PMID:33045310
1314481	SRP72	signal recognition particle 72	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314482	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SRP72 mRNA	PMID:26251327
1314481	SRP72	signal recognition particle 72	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1314482	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of SRP72 promoter	PMID:26251327
1314481	SRP72	signal recognition particle 72	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SRP72 mRNA	PMID:33167477
1314481	SRP72	signal recognition particle 72	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SRP72 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SRP72 mRNA	PMID:32699268
1314481	SRP72	signal recognition particle 72	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314482	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SRP72 mRNA	PMID:36331819
1314481	SRP72	signal recognition particle 72	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314482	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SRP72 mRNA	PMID:30319688
1314481	SRP72	signal recognition particle 72	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SRP72 mRNA	PMID:20044591
1314481	SRP72	signal recognition particle 72	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314482	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SRP72 mRNA	PMID:39241906
1314481	SRP72	signal recognition particle 72	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of SRP72 mRNA	PMID:19167446
1314481	SRP72	signal recognition particle 72	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314482	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SRP72 mRNA	PMID:39298647
1314481	SRP72	signal recognition particle 72	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D002635	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of SRP72 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of SRP72 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of SRP72 mRNA	PMID:33819548
1314481	SRP72	signal recognition particle 72	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SRP72 mRNA	PMID:23649840
1314481	SRP72	signal recognition particle 72	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D006000	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of SRP72 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of SRP72 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of SRP72 mRNA	PMID:33819548
1314481	SRP72	signal recognition particle 72	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SRP72 protein	PMID:37730182
1314481	SRP72	signal recognition particle 72	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1564787	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of SRP72 protein	PMID:34915118
1314481	SRP72	signal recognition particle 72	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of SRP72 mRNA	PMID:26760959
1314481	SRP72	signal recognition particle 72	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SRP72 mRNA	PMID:23649840
1314481	SRP72	signal recognition particle 72	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SRP72 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SRP72 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of SRP72 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of SRP72 mRNA	PMID:32699268|PMID:35430440
1314481	SRP72	signal recognition particle 72	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of SRP72 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SRP72 protein	PMID:38598786
1314481	SRP72	signal recognition particle 72	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314482	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SRP72 mRNA	PMID:31919559
1314481	SRP72	signal recognition particle 72	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314482	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SRP72 mRNA	PMID:22206623
1314481	SRP72	signal recognition particle 72	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D006002	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of SRP72 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of SRP72 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of SRP72 mRNA	PMID:33819548
1314481	SRP72	signal recognition particle 72	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SRP72 protein	PMID:35688186
1314481	SRP72	signal recognition particle 72	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1314482	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of SRP72 protein	PMID:36173347
1314481	SRP72	signal recognition particle 72	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314482	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of SRP72 protein	PMID:25505154
1314481	SRP72	signal recognition particle 72	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314482	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SRP72 mRNA	PMID:30912803
1314481	SRP72	signal recognition particle 72	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314482	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SRP72 mRNA	PMID:21570461
1314481	SRP72	signal recognition particle 72	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SRP72 mRNA	PMID:33212167
1314481	SRP72	signal recognition particle 72	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of SRP72 protein	PMID:35688186
1314481	SRP72	signal recognition particle 72	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D003840	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of SRP72 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of SRP72 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of SRP72 mRNA	PMID:33819548
1314481	SRP72	signal recognition particle 72	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of SRP72 protein	PMID:30528433
1314481	SRP72	signal recognition particle 72	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314482	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SRP72 mRNA	PMID:20504355
1314481	SRP72	signal recognition particle 72	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314482	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SRP72 mRNA	PMID:22228805
1314481	SRP72	signal recognition particle 72	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SRP72 mRNA	PMID:26238291
1314481	SRP72	signal recognition particle 72	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D000069446	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of SRP72 mRNA	PMID:33819548
1314481	SRP72	signal recognition particle 72	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1564787	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SRP72 mRNA	PMID:24136188
1314481	SRP72	signal recognition particle 72	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of SRP72 mRNA	PMID:17762391
1314481	SRP72	signal recognition particle 72	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1564787	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of SRP72 mRNA	PMID:24136188
1314481	SRP72	signal recognition particle 72	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314482	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SRP72 gene	PMID:35295148
1314481	SRP72	signal recognition particle 72	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314482	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SRP72 gene	PMID:35295148
1314481	SRP72	signal recognition particle 72	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1564787	E	RGD:6480464	20150303	CTD	MESH:D013853	Thioacetamide results in decreased expression of SRP72 mRNA	PMID:23411599
1314481	SRP72	signal recognition particle 72	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of SRP72 mRNA	PMID:30903817
1314481	SRP72	signal recognition particle 72	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of SRP72 protein	PMID:34186270
1314481	SRP72	signal recognition particle 72	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1564787	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SRP72 mRNA	PMID:25181051|PMID:30816183
1314481	SRP72	signal recognition particle 72	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1564787	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SRP72 gene	PMID:28505145
1314481	SRP72	signal recognition particle 72	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314482	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SRP72 mRNA	PMID:39298647
1314481	SRP72	signal recognition particle 72	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SRP72 mRNA	PMID:28628672
1314481	SRP72	signal recognition particle 72	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SRP72 protein	PMID:34186270
1314481	SRP72	signal recognition particle 72	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314482	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SRP72 mRNA	PMID:37019170
1314481	SRP72	signal recognition particle 72	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1564787	E	RGD:6480464	20150303	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SRP72 mRNA	PMID:24893172
1314481	SRP72	signal recognition particle 72	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to SRP72 protein	PMID:32991956
1314481	SRP72	signal recognition particle 72	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene results in decreased expression of SRP72 mRNA	PMID:17374397
1314481	SRP72	signal recognition particle 72	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of SRP72 protein	PMID:38598786
1314481	SRP72	signal recognition particle 72	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SRP72 mRNA	PMID:28628672
1314481	SRP72	signal recognition particle 72	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1314482	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of SRP72 mRNA]	PMID:19030233
1314481	SRP72	signal recognition particle 72	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SRP72 mRNA	PMID:37042841
1314481	SRP72	signal recognition particle 72	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SRP72 protein	PMID:26879310
1314481	SRP72	signal recognition particle 72	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1314482	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of SRP72 mRNA	PMID:25908611
1314481	SRP72	signal recognition particle 72	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D005999	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of SRP72 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of SRP72 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of SRP72 mRNA	PMID:33819548
1314481	SRP72	signal recognition particle 72	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SRP72 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SRP72 mRNA	PMID:32699268
1314481	SRP72	signal recognition particle 72	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SRP72 mRNA	PMID:28302478
1314481	SRP72	signal recognition particle 72	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SRP72 mRNA	PMID:31533062
1314481	SRP72	signal recognition particle 72	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314482	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SRP72 mRNA	PMID:36331819
1314481	SRP72	signal recognition particle 72	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SRP72 mRNA	PMID:25979313
1314481	SRP72	signal recognition particle 72	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SRP72 mRNA	PMID:19101580|PMID:23179753|PMID:27188386
1314481	SRP72	signal recognition particle 72	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of SRP72 mRNA	PMID:17183730
1314481	SRP72	signal recognition particle 72	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SRP72 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1314481	SRP72	signal recognition particle 72	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D016572	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of SRP72 mRNA	PMID:33819548
1314481	SRP72	signal recognition particle 72	gene	CHEBI:40909	azoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of SRP72 mRNA	PMID:33512557
1314481	SRP72	signal recognition particle 72	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SRP72 mRNA	PMID:28628672
1314481	SRP72	signal recognition particle 72	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of SRP72 mRNA	PMID:33512557
1314481	SRP72	signal recognition particle 72	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in increased expression of SRP72 mRNA	PMID:16584549
1314481	SRP72	signal recognition particle 72	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of SRP72 mRNA	PMID:18175754
1314481	SRP72	signal recognition particle 72	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SRP72 mRNA	PMID:28628672
1314481	SRP72	signal recognition particle 72	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314482	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SRP72 mRNA; Nanotubes, Carbon results in increased expression of SRP72 mRNA	PMID:25554681
1314481	SRP72	signal recognition particle 72	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in decreased expression of SRP72 mRNA	PMID:17374397|PMID:18651567
1314481	SRP72	signal recognition particle 72	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010081	Oxazolone results in decreased expression of SRP72 mRNA	PMID:17374397
1314481	SRP72	signal recognition particle 72	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of SRP72 mRNA	PMID:17183730
1314481	SRP72	signal recognition particle 72	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SRP72 protein	PMID:32959892
1314481	SRP72	signal recognition particle 72	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314482	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SRP72 mRNA	PMID:23650126
1314481	SRP72	signal recognition particle 72	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1564787	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of SRP72 mRNA	PMID:30467583
1314481	SRP72	signal recognition particle 72	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SRP72 protein	PMID:34186270
1314481	SRP72	signal recognition particle 72	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1314482	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SRP72 mRNA	PMID:22206623
1314481	SRP72	signal recognition particle 72	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314482	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SRP72 mRNA	PMID:22206623
1314481	SRP72	signal recognition particle 72	gene	CHEBI:7494	nefazodone	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:C051752	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of SRP72 mRNA	PMID:33819548
1314481	SRP72	signal recognition particle 72	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314482	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SRP72 mRNA	PMID:23091169
1314481	SRP72	signal recognition particle 72	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314482	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SRP72 mRNA	PMID:30294300
1314481	SRP72	signal recognition particle 72	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of SRP72 mRNA	PMID:33512557
1314481	SRP72	signal recognition particle 72	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of SRP72 protein	PMID:38598786
1314481	SRP72	signal recognition particle 72	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1564787	E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of SRP72 mRNA	PMID:24136188
1314481	SRP72	signal recognition particle 72	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1564787	E	RGD:6480464	20150303	CTD	MESH:C025643	vinclozolin affects the expression of SRP72 mRNA	PMID:19015723
1314481	SRP72	signal recognition particle 72	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1564787	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SRP72 mRNA	PMID:23034163
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of NTSR1 mRNA	PMID:38218311
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552366	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of NTSR1 mRNA	PMID:20188158
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1552366	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of NTSR1 mRNA	PMID:36189433
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1552366	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NTSR1 mRNA	PMID:36189433
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of NTSR1 mRNA	PMID:26079696
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:15756	hexadecanoic acid	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D019308	Palmitic Acid results in increased expression of NTSR1 mRNA	PMID:32347412
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1552366	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of NTSR1 mRNA	PMID:30319688
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of NTSR1 mRNA	PMID:35811015
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NTSR1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of NTSR1 mRNA	PMID:35811015
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552366	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NTSR1 mRNA	PMID:25510870
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of NTSR1 mRNA	PMID:38568856
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1552366	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of NTSR1 mRNA	PMID:36189433
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:17303	morphine	affects response to substance	ISO	RGD:1552366	E	RGD:6480464	20120412	CTD	MESH:D009020	NTSR1 protein affects the susceptibility to Morphine	PMID:20727387
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1552366	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in decreased expression of NTSR1 mRNA	PMID:19693291
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:174733	Licochalcone B	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of NTSR1 mRNA	PMID:33647349
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of NTSR1 mRNA	PMID:23825647
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NTSR1 mRNA	PMID:36139627
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of NTSR1 intron	PMID:30157460
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of NTSR1 mRNA	PMID:23825647
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NTSR1 mRNA	PMID:35301059
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552366	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NTSR1 mRNA	PMID:37325564|PMID:40850461
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552366	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NTSR1 mRNA	PMID:25510870
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552366	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NTSR1 mRNA	PMID:25510870
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1306076	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NTSR1 mRNA	PMID:22129741
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1306076	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of NTSR1 mRNA	PMID:23630614
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NTSR1 intron	PMID:30157460
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NTSR1 exon	PMID:30157460
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1306076	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of NTSR1 mRNA	PMID:41580963
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of NTSR1 mRNA	PMID:38460933
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of NTSR1 promoter	PMID:22847954
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306076	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NTSR1 mRNA	PMID:33387578
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1552366	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NTSR1 mRNA	PMID:21385734
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1552366	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of NTSR1 mRNA	PMID:30807115
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306076	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of NTSR1 mRNA	PMID:26033743
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NTSR1 intron; Benzo(a)pyrene affects the methylation of NTSR1 polyA tail	PMID:30157460
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NTSR1 5' UTR; Benzo(a)pyrene results in increased methylation of NTSR1 promoter	PMID:27901495
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306076	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of NTSR1 mRNA	PMID:26033743
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of NTSR1 mRNA	PMID:25895662
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of NTSR1 mRNA	PMID:25258189
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1306076	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of NTSR1 mRNA	PMID:24395379
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306076	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of NTSR1 mRNA	PMID:34492290
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1552366	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of NTSR1 mRNA	PMID:18648102
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306076	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NTSR1 mRNA	PMID:25181051
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552366	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of NTSR1 mRNA	PMID:32156529
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306076	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of NTSR1 mRNA	PMID:30816183
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552366	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NTSR1 mRNA	PMID:25510870
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552366	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of NTSR1 mRNA	PMID:25510870
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of NTSR1 intron	PMID:30157460
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1552366	E	RGD:6480464	20230704	CTD	MESH:C008745	bisphenol F results in decreased expression of NTSR1 mRNA	PMID:36706583
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of NTSR1 gene	PMID:22964155
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306076	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of NTSR1 mRNA	PMID:22129741
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of NTSR1 mRNA	PMID:29024780
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NTSR1 mRNA	PMID:35301059
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552366	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NTSR1 mRNA	PMID:37325564|PMID:40850461
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of NTSR1 promoter	PMID:22847954
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:38757	isoflavones	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones affects the expression of NTSR1 mRNA	PMID:16365062
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of NTSR1 promoter	PMID:22847954
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1306076	E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in increased expression of NTSR1 mRNA	PMID:35594946
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NTSR1 gene	PMID:29154799
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306076	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NTSR1 mRNA	PMID:33387578
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	NTSR1 protein affects the susceptibility to Fluorouracil	PMID:15352031
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of NTSR1 protein	PMID:15352031
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NTSR1 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of NTSR1 mRNA	PMID:35811015
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of NTSR1 mRNA	PMID:38460933
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of NTSR1 mRNA	PMID:25258189
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306076	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of NTSR1 mRNA	PMID:30307764
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases response to substance	ISO	RGD:1552366	E	RGD:6480464	20150512	CTD	MESH:D014302	NTSR1 protein results in increased susceptibility to Trinitrobenzenesulfonic Acid	PMID:25307345
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1552366	E	RGD:6480464	20150512	CTD	MESH:D014302	NTSR1 protein affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of VEGFA mRNA]	PMID:25307345
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of NTSR1 mRNA	PMID:24810058
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of NTSR1 intron	PMID:30157460
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552366	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NTSR1 mRNA	PMID:22206623
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:7542	neurotensin	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D009496	Neurotensin binds to NTSR1 protein	PMID:19874804
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NTSR1 mRNA	PMID:36139627
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NTSR1 gene]	PMID:28238834
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:79997	GW 4064	decreases expression	ISO	RGD:1552366	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in decreased expression of NTSR1 mRNA	PMID:26655953
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:80491	pinostrobin	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C411294	pinostrobin results in increased expression of NTSR1 mRNA	PMID:37777166
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:8058	phencyclidine	multiple interactions	ISO	RGD:1552366	E	RGD:6480464	20121218	CTD	MESH:D010622	NTSR1 gene affects the reaction [Phencyclidine results in decreased expression of DRD1 protein]	PMID:20659557
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306076	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of NTSR1 mRNA	PMID:24780913
1314483	NTSR1	neurotensin receptor 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306076	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of NTSR1 mRNA	PMID:19281266
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:131825	8,5'-cyclo-2'-deoxyadenosine	affects metabolic processing	ISO	RGD:1314486	E	RGD:6480464	20160503	CTD	MESH:C056752	NEIL1 protein affects the metabolism of 8,5'-cyclo-2'-deoxyadenosine	PMID:20067321
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306077	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NEIL1 mRNA]	PMID:31150632
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:15379	dioxygen	affects metabolic processing	ISO	RGD:1314486	E	RGD:6480464	20121113	CTD	MESH:D010100	NEIL1 affects the metabolism of Oxygen	PMID:21285402
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:16240	hydrogen peroxide	decreases activity	EXP		E	RGD:6480464	20120717	CTD	MESH:D006861	Hydrogen Peroxide results in decreased activity of NEIL1 protein	PMID:20622253
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D006861	tris(2-carboxyethyl)phosphine inhibits the reaction [Hydrogen Peroxide results in decreased activity of NEIL1 protein]	PMID:20622253
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314486	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of NEIL1 mRNA	PMID:39241906
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:16526	carbon dioxide	affects abundance	ISO	RGD:1314486	E	RGD:6480464	20121113	CTD	MESH:D002245	NEIL1 affects the abundance of Carbon Dioxide	PMID:21285402
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NEIL1 mRNA	PMID:37042841
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:17296	aniline	increases expression	ISO	RGD:1306077	E	RGD:6480464	20120918	CTD	MESH:C023650	aniline results in increased expression of NEIL1; aniline results in increased expression of NEIL1 mRNA; aniline results in increased expression of NEIL1 protein	PMID:21145906|PMID:23352893
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306077	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NEIL1 mRNA	PMID:33387578
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:18248	iron atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D007501	Curcumin inhibits the reaction [Iron binds to and results in decreased activity of NEIL1 protein]; Edetic Acid inhibits the reaction [Iron binds to and results in decreased activity of NEIL1 protein]; Iron binds to and affects the folding of and results in decreased activity of NEIL1 protein; Iron binds to and inhibits the reaction [NEIL1 protein binds to FEN1 protein]; Iron binds to and inhibits the reaction [NEIL1 protein binds to POLB protein]	PMID:20622253
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NEIL1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NEIL1 protein	PMID:31390735
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1314486	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of NEIL1 intron	PMID:27776689
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:26523	reactive oxygen species	decreases response to substance	EXP		E	RGD:6480464	20170303	CTD	MESH:D017382	NEIL1 protein results in decreased susceptibility to Reactive Oxygen Species	PMID:26134572
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306077	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of NEIL1 mRNA	PMID:30779732
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306077	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NEIL1 mRNA	PMID:31150632
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306077	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NEIL1 mRNA]	PMID:31150632
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314486	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of NEIL1 mRNA]	PMID:22206623
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NEIL1 gene	PMID:25304211
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of NEIL1 mRNA	PMID:27392435
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:27983	4,6-diamino-5-formamidopyrimidine	affects metabolic processing	EXP		E	RGD:6480464	20150203	CTD	MESH:C039544	NEIL1 protein affects the metabolism of 4,6-diamino-5-N-formamidopyrimidine	PMID:17389588
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of NEIL1 mRNA	PMID:25583101
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314486	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NEIL1 mRNA	PMID:21570461
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NEIL1 mRNA	PMID:33212167
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[tris(2-carboxyethyl)phosphine co-treated with Edetic Acid] inhibits the reaction [Copper results in decreased activity of NEIL1 protein]; Copper binds to and affects the folding of and results in decreased activity of NEIL1 protein; Curcumin inhibits the reaction [Copper binds to and results in decreased activity of NEIL1 protein]	PMID:20622253
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314486	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of NEIL1 mRNA	PMID:27862939
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of NEIL1 mRNA	PMID:29803840
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:29145	2,6-diamino-5-formamido-4-hydroxypyrimidine	affects metabolic processing	EXP		E	RGD:6480464	20120412	CTD	MESH:C071023	NEIL1 protein affects the metabolism of 2,6-diamino-4-hydroxy-5-formamidopyrimidine	PMID:17389588
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:29145	2,6-diamino-5-formamido-4-hydroxypyrimidine	affects metabolic processing	ISO	RGD:1314486	E	RGD:6480464	20120412	CTD	MESH:C071023	NEIL1 protein affects the metabolism of 2,6-diamino-4-hydroxy-5-formamidopyrimidine	PMID:20067321
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of NEIL1 gene	PMID:28589171
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NEIL1 promoter	PMID:27901495
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NEIL1 exon	PMID:27901495
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NEIL1 mRNA	PMID:27694624
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[tris(2-carboxyethyl)phosphine co-treated with Edetic Acid] inhibits the reaction [Copper results in decreased activity of NEIL1 protein]; Copper binds to and affects the folding of and results in decreased activity of NEIL1 protein; Curcumin inhibits the reaction [Copper binds to and results in decreased activity of NEIL1 protein]	PMID:20622253
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of NEIL1 mRNA	PMID:34408198
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306077	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of NEIL1 mRNA	PMID:25729387
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306077	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of NEIL1 mRNA	PMID:34492290
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314486	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of NEIL1 mRNA	PMID:18648102
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306077	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NEIL1 mRNA	PMID:25181051
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314486	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of NEIL1 mRNA	PMID:39298647
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314486	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of NEIL1 mRNA	PMID:38685157
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1314486	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of NEIL1 mRNA	PMID:36464114
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306077	E	RGD:6480464	20190312	CTD	MESH:D010269	Paraquat results in decreased expression of NEIL1 mRNA	PMID:27993944
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of NEIL1 mRNA	PMID:29024780
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NEIL1 mRNA	PMID:38568856
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NEIL1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NEIL1 protein	PMID:31390735
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306077	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NEIL1 mRNA	PMID:24386269
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314486	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NEIL1 mRNA	PMID:40194260
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003474	Curcumin inhibits the reaction [Copper binds to and results in decreased activity of NEIL1 protein]; Curcumin inhibits the reaction [Iron binds to and results in decreased activity of NEIL1 protein]	PMID:20622253
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of NEIL1 mRNA	PMID:29154799
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NEIL1 gene	PMID:29154799
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NEIL1 mRNA	PMID:38832940
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of NEIL1 mRNA	PMID:26272509
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEIL1 mRNA	PMID:27188386
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306077	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NEIL1 mRNA	PMID:33387578
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of NEIL1 gene	PMID:25304211
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:4735	ethylenediaminetetraacetic acid	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:D004492	[tris(2-carboxyethyl)phosphine co-treated with Edetic Acid] inhibits the reaction [Copper results in decreased activity of NEIL1 protein]; Edetic Acid inhibits the reaction [Iron binds to and results in decreased activity of NEIL1 protein]	PMID:20622253
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of NEIL1 mRNA	PMID:31838189
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314486	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of NEIL1 mRNA	PMID:19042947
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:63213	TCEP	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C080938	[tris(2-carboxyethyl)phosphine co-treated with Edetic Acid] inhibits the reaction [Copper results in decreased activity of NEIL1 protein]; tris(2-carboxyethyl)phosphine inhibits the reaction [Hydrogen Peroxide results in decreased activity of NEIL1 protein]	PMID:20622253
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1306077	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of NEIL1 mRNA	PMID:25729387
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306077	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of NEIL1 mRNA	PMID:25729387
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1314486	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of NEIL1 mRNA	PMID:36464114
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314486	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NEIL1 mRNA	PMID:22206623
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314486	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of NEIL1 mRNA]	PMID:22206623
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NEIL1 mRNA	PMID:37199045
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEIL1 mRNA	PMID:27188386
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NEIL1 gene]	PMID:28238834
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:82664	iron(0)	multiple interactions	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Curcumin inhibits the reaction [Iron binds to and results in decreased activity of NEIL1 protein]; Edetic Acid inhibits the reaction [Iron binds to and results in decreased activity of NEIL1 protein]; Iron binds to and affects the folding of and results in decreased activity of NEIL1 protein; Iron binds to and inhibits the reaction [NEIL1 protein binds to FEN1 protein]; Iron binds to and inhibits the reaction [NEIL1 protein binds to POLB protein]	PMID:20622253
1314485	NEIL1	nei like DNA glycosylase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEIL1 mRNA	PMID:27188386
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of CYP2S1 mRNA	PMID:26272509
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYP2S1 mRNA	PMID:27188386
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:132098	methoxyacetic acid	affects expression	ISO	RGD:1314488	E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid affects the expression of CYP2S1 mRNA	PMID:20421339
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of CYP2S1 mRNA	PMID:37995155
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	ISO	RGD:1314488	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin affects the expression of CYP2S1 mRNA	PMID:20421339
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:15367	all-trans-retinoic acid	affects metabolic processing	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	CYP2S1 protein affects the metabolism of Tretinoin	PMID:16054184
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of CYP2S1 mRNA	PMID:12711469|PMID:16985168
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:15367	all-trans-retinoic acid	increases metabolic processing	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	CYP2S1 protein results in increased metabolism of Tretinoin	PMID:12711469
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Tretinoin; [CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Tretinoin	PMID:19713358
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen affects the reaction [CYP2S1 protein results in increased reduction of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole metabolite]	PMID:23682735
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:15429	hydroxylamine	increases reduction	EXP		E	RGD:6480464	20130312	CTD	MESH:D019811	CYP2S1 protein results in increased reduction of Hydroxylamine	PMID:22734839
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:15429	hydroxylamine	multiple interactions	EXP		E	RGD:6480464	20130312	CTD	MESH:D019811	[CYP2S1 protein results in increased reduction of Hydroxylamine] which results in increased chemical synthesis of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole	PMID:22734839
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CYP2S1 mRNA	PMID:26079696
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1306078	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of CYP2S1 mRNA	PMID:36841081
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	[[CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol] which results in increased abundance of benzo(a)pyrene-7,8,9,10-tetrol; [[CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-1,6-quinone; [[CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-3,6-quinone; [[CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-6,12-quinone; [CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Aflatoxin B1; [CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Benzo(a)pyrene; [CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Tretinoin	PMID:19713358
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of CYP2S1 mRNA	PMID:21632981
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in increased expression of CYP2S1 mRNA	PMID:21632981
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CYP2S1 mRNA	PMID:30165855
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:16482	naphthalene	affects metabolic processing	EXP		E	RGD:6480464	20120412	CTD	MESH:C031721	CYP2S1 protein affects the metabolism of naphthalene	PMID:16054184
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of CYP2S1 mRNA	PMID:21592394
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of CYP2S1 mRNA	PMID:21592394
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:17650	cortisol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D006854	Hydrocortisone results in decreased expression of CYP2S1 mRNA	PMID:22155357
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306078	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CYP2S1 mRNA	PMID:26577399
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of CYP2S1 mRNA	PMID:16002434
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CYP2S1 mRNA	PMID:21592394|PMID:27107558
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of CYP2S1 mRNA	PMID:21592394
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:1784	biphenyl-4-amine	increases reduction	EXP		E	RGD:6480464	20140114	CTD	MESH:C006757	CYP2S1 protein results in increased reduction of 4-biphenylamine analog	PMID:23682735
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CYP2S1 mRNA	PMID:39836092
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1314488	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2S1 mRNA	PMID:29950665
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:233415	Pf-06840003	multiple interactions	EXP		E	RGD:6480464	20250408	CTD	MESH:C000625742	PF-06840003 inhibits the reaction [APAF1 protein mutant form results in increased expression of CYP2S1 mRNA]; PF-06840003 inhibits the reaction [MAPT protein mutant form results in increased expression of CYP2S1 mRNA]	PMID:39172838
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:233415	Pf-06840003	multiple interactions	ISO	RGD:1314488	E	RGD:6480464	20250408	CTD	MESH:C000625742	PF-06840003 inhibits the reaction [[amyloid beta-protein (1-42) binds to MAPT protein] which results in increased expression of CYP2S1 mRNA]	PMID:39172838
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CYP2S1 mRNA	PMID:22100608
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Aflatoxin B1; [CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Aflatoxin B1	PMID:19713358
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of CYP2S1 mRNA	PMID:25102026
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015127	[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of 9,10-Dimethyl-1,2-benzanthracene	PMID:19713358
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of CYP2S1 mRNA	PMID:12763052
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314488	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CYP2S1 mRNA	PMID:34911549
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1314488	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of CYP2S1 mRNA	PMID:31939706
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CYP2S1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CYP2S1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYP2S1 mRNA	PMID:39836092|PMID:40512198
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of CYP2S1 protein	PMID:38460933
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1314488	E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP2S1 mRNA]	PMID:17277313
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1306078	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of CYP2S1 gene	PMID:35440735
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:27878	2-naphthylamine	increases reduction	EXP		E	RGD:6480464	20140114	CTD	MESH:D015081	CYP2S1 protein results in increased reduction of 2-Naphthylamine analog	PMID:23682735
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of CYP2S1 mRNA	PMID:27392435
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of CYP2S1 mRNA	PMID:27392435
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:28077	rifampicin	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D012293	[Rifampin co-treated with NR1I2 protein] results in increased expression of CYP2S1 mRNA	PMID:21127053
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314488	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of CYP2S1 mRNA	PMID:32186404
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314488	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CYP2S1 mRNA	PMID:21570461
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CYP2S1 mRNA	PMID:19770486
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYP2S1 mRNA	PMID:22344700
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306078	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYP2S1 mRNA	PMID:19883719
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314488	E	RGD:6480464	20140408	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYP2S1 mRNA	PMID:17277313|PMID:17942748|PMID:19933214|PMID:21995607|PMID:23994337|PMID:28213091
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314488	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CYP2S1 mRNA; AHR affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP2S1 mRNA]; Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP2S1 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [[AHR protein binds to ARNT protein] which binds to CYP2S1 promoter]; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP2S1 gene]	PMID:17277313|PMID:17942748|PMID:21995607|PMID:28213091
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CYP2S1 mRNA	PMID:33212167
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:28358	rac-lactic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of CYP2S1 mRNA	PMID:30851411
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:2948	azathioprine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of CYP2S1 mRNA	PMID:22623647
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CYP2S1 mRNA	PMID:37682722
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of CYP2S1 mRNA	PMID:29301061|PMID:39719251
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CYP2S1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CYP2S1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYP2S1 mRNA	PMID:39836092|PMID:40512198
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CYP2S1 mRNA	PMID:19770486
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CYP2S1 mRNA	PMID:21632981|PMID:22316170|PMID:32234424
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314488	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CYP2S1 mRNA	PMID:21995607
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	[[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-1,6-quinone; [[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-3,6-quinone; [[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-6,12-quinone; [[CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-1,6-quinone; [[CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-3,6-quinone; [[CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-6,12-quinone; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene; [CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of Benzo(a)pyrene	PMID:19713358
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314488	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR affects the reaction [Benzo(a)pyrene results in increased expression of CYP2S1 mRNA]; AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CYP2S1 mRNA]; Benzo(a)pyrene promotes the reaction [AHR protein binds to CYP2S1 promoter]	PMID:21995607|PMID:22228805
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:3001	beclomethasone	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001507	Beclomethasone results in decreased expression of CYP2S1 mRNA	PMID:22155357
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314488	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CYP2S1 mRNA	PMID:27131904
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CYP2S1 mRNA	PMID:25895662
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CYP2S1 mRNA	PMID:20382639
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1314488	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of CYP2S1 mRNA	PMID:23557971
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314488	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2S1 mRNA	PMID:29950665
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CYP2S1 mRNA	PMID:17426115
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314488	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CYP2S1 mRNA	PMID:19710929
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20240305	CTD	MESH:C006780	bisphenol A affects the expression of CYP2S1 mRNA	PMID:36466761
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of CYP2S1 mRNA; bisphenol A results in decreased expression of CYP2S1 protein	PMID:31715268|PMID:37567409
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306078	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CYP2S1 mRNA	PMID:25181051
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306078	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CYP2S1 mRNA	PMID:34947998
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314488	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CYP2S1 mRNA	PMID:32156529|PMID:34585602
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1314488	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP2S1 mRNA	PMID:23994337
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1306078	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of CYP2S1 mRNA	PMID:19883719
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of CYP2S1 mRNA	PMID:40203079
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314488	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of CYP2S1 mRNA	PMID:30951980
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:34562	Benzo[a]pyrene-7,8-diol	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C017228	[[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol] which results in increased abundance of benzo(a)pyrene-7,8,9,10-tetrol; [[CYP2S1 protein co-treated with Hydrogen Peroxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol] which results in increased abundance of benzo(a)pyrene-7,8,9,10-tetrol; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol	PMID:19713358
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1314488	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of CYP2S1 mRNA	PMID:28392331
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314488	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CYP2S1 exon	PMID:28392331
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314488	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2S1 mRNA	PMID:29950665
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of CYP2S1 gene	PMID:22964155
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of CYP2S1 mRNA	PMID:29024780
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CYP2S1 mRNA	PMID:39836092
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of CYP2S1 mRNA	PMID:26377693
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306078	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CYP2S1 mRNA	PMID:33453195
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CYP2S1 protein	PMID:26879310
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CYP2S1 mRNA	PMID:24449571
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314488	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CYP2S1 mRNA	PMID:40194260
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CYP2S1 mRNA	PMID:40419075
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314488	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CYP2S1 mRNA	PMID:20421339
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014635	Valproic Acid results in increased expression of CYP2S1 mRNA	PMID:23527032
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314488	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of CYP2S1 mRNA	PMID:21427059
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of CYP2S1 mRNA	PMID:19770486
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CYP2S1 mRNA	PMID:25562108
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314488	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CYP2S1 mRNA	PMID:17555576
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D003907	Dexamethasone results in decreased expression of CYP2S1 mRNA; Dexamethasone results in decreased expression of CYP2S1 protein	PMID:22155357
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D003907	NR3C1 protein promotes the reaction [Dexamethasone results in decreased expression of CYP2S1 mRNA]; NR3C1 protein promotes the reaction [Dexamethasone results in decreased expression of CYP2S1 protein]; trichostatin A inhibits the reaction [Dexamethasone results in decreased expression of CYP2S1 mRNA]	PMID:22155357
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of CYP2S1 mRNA	PMID:28973697
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:43602	obeticholic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of CYP2S1 mRNA	PMID:27939613
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CYP2S1 mRNA	PMID:38832940
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C012589	trichostatin A inhibits the reaction [Dexamethasone results in decreased expression of CYP2S1 mRNA]	PMID:22155357
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in decreased expression of CYP2S1 mRNA	PMID:17585979
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306078	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CYP2S1 mRNA	PMID:33387578
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:46345	5-fluorouracil	affects expression	ISO	RGD:1314488	E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil affects the expression of CYP2S1 mRNA	PMID:20421339
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of CYP2S1 protein	PMID:38460933
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CYP2S1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CYP2S1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYP2S1 mRNA	PMID:39836092|PMID:40512198
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of CYP2S1 mRNA	PMID:18175754
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314488	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CYP2S1 mRNA	PMID:17555576
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314488	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CYP2S1 mRNA	PMID:17942748
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314488	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CYP2S1 mRNA	PMID:17942748
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:4911	etoposide	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20150127	CTD	MESH:D005047	Etoposide results in decreased expression of CYP2S1 mRNA	PMID:25270620
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CYP2S1 mRNA; Nanotubes, Carbon results in decreased expression of CYP2S1 mRNA	PMID:25554681
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314488	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of CYP2S1 mRNA	PMID:40234311
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:5106	flunisolide	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C007734	flunisolide results in decreased expression of CYP2S1 mRNA	PMID:22155357
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of CYP2S1 mRNA	PMID:38701926
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CYP2S1 protein	PMID:32959892
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CYP2S1 mRNA	PMID:39836092
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314488	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP2S1 mRNA	PMID:26378955
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:71418	triamcinolone acetonide	decreases expression	EXP		E	RGD:6480464	20130115	CTD	MESH:D014222	Triamcinolone Acetonide results in decreased expression of CYP2S1 mRNA	PMID:22155357
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314488	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CYP2S1 mRNA	PMID:22206623
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CYP2S1 protein	PMID:37664457
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:753233	coal tar	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of CYP2S1 mRNA	PMID:12711469|PMID:16054184
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1314488	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CYP2S1 mRNA	PMID:23994337
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of CYP2S1 mRNA	PMID:30851411
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYP2S1 mRNA	PMID:27188386
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:78673	cumene hydroperoxide	multiple interactions	EXP		E	RGD:6480464	20140708	CTD	MESH:C007164	[[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol] which results in increased abundance of benzo(a)pyrene-7,8,9,10-tetrol; [[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-1,6-quinone; [[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-3,6-quinone; [[CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene] which results in increased abundance of benzo(a)pyrene-6,12-quinone; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of 9,10-dihydrobenzo(a)pyrene; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of 9,10-Dimethyl-1,2-benzanthracene; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Aflatoxin B1; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Benzo(a)pyrene; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of benzo(a)pyrene 7,8-dihydrodiol; [CYP2S1 protein co-treated with cumene hydroperoxide] results in increased oxidation of Tretinoin	PMID:19713358
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314488	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of CYP2S1 mRNA	PMID:38648751
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:8378	prednisolone	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011239	Prednisolone results in decreased expression of CYP2S1 mRNA	PMID:22155357
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:88522	Monobutylphthalate	affects expression	ISO	RGD:1314488	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate affects the expression of CYP2S1 mRNA	PMID:20421339
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of CYP2S1 protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYP2S1 mRNA	PMID:27188386|PMID:37664457
1314487	CYP2S1	cytochrome P450 family 2 subfamily S member 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314488	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of CYP2S1 mRNA	PMID:27131904
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of BLVRB mRNA	PMID:26272509|PMID:27188386
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BLVRB mRNA	PMID:27188386
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314491	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of BLVRB mRNA	PMID:33045310
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314491	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of BLVRB mRNA	PMID:37995155
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of BLVRB mRNA	PMID:16249480
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of BLVRB mRNA	PMID:36331819
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314491	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of BLVRB mRNA	PMID:30319688
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:16236	ethanol	decreases activity	ISO	RGD:1306080	E	RGD:6480464	20141007	CTD	MESH:D000431	Ethanol results in decreased activity of BLVRB protein	PMID:11173977
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:16243	quercetin	affects expression	ISO	RGD:1306080	E	RGD:6480464	20141007	CTD	MESH:D011794	Quercetin affects the expression of BLVRB mRNA	PMID:18178720
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314491	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of BLVRB mRNA	PMID:21356202
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of BLVRB mRNA	PMID:30510588
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1314491	E	RGD:6480464	20180116	CTD	MESH:D014241	Trichloroethylene results in increased expression of BLVRB mRNA	PMID:28973375
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of BLVRB mRNA	PMID:23649840
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BLVRB mRNA	PMID:37992649
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of BLVRB mRNA	PMID:33647349
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BLVRB mRNA	PMID:37992649
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314491	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of BLVRB mRNA	PMID:23892564
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314491	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of BLVRB mRNA	PMID:34319233
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314491	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of BLVRB mRNA	PMID:19850644
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of BLVRB mRNA]	PMID:19850644
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:17793	calycosin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C121707	7,3'-dihydroxy-4'-methoxyisoflavone results in increased expression of BLVRB protein	PMID:24455688
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:18227	sterigmatocystin	increases expression	ISO	RGD:1314491	E	RGD:6480464	20120501	CTD	MESH:D013241	Sterigmatocystin results in increased expression of BLVRB mRNA	PMID:21356202
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BLVRB mRNA	PMID:36331819
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:211551	TMC-120A	increases expression	ISO	RGD:1314491	E	RGD:6480464	20231219	CTD	MESH:C402696	TMC 120A results in increased expression of BLVRB mRNA	PMID:21356202
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20120717	CTD	MESH:D008769	[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of BLVRB mRNA	PMID:19840844
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BLVRB protein	PMID:33040242
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BLVRB mRNA	PMID:37236586
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of BLVRB mRNA	PMID:19549813
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of BLVRB mRNA	PMID:23649840
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1314491	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of BLVRB mRNA	PMID:19376150
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of BLVRB mRNA	PMID:23649840
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:25442	mycotoxin	increases expression	ISO	RGD:1314491	E	RGD:6480464	20170228	CTD	MESH:D009183	Mycotoxins results in increased expression of BLVRB mRNA	PMID:21356202
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of BLVRB mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of BLVRB mRNA	PMID:34911549
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of BLVRB protein	PMID:38598786
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314491	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of BLVRB mRNA	PMID:17484886
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BLVRB mRNA	PMID:39836092
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BLVRB mRNA	PMID:19244175
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of BLVRB protein	PMID:38460933
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of BLVRB mRNA	PMID:28903495
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of BLVRB mRNA	PMID:23300844
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314491	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of BLVRB mRNA	PMID:40618947
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of BLVRB mRNA	PMID:27594783
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314491	E	RGD:6480464	20220111	CTD	MESH:D002945	Cisplatin results in increased expression of BLVRB mRNA	PMID:34626751
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306080	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BLVRB mRNA	PMID:34747641
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314491	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BLVRB mRNA	PMID:21570461
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306080	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BLVRB mRNA	PMID:32109520
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BLVRB mRNA	PMID:20106945|PMID:21632981
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314491	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BLVRB mRNA	PMID:28213091
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of BLVRB mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to BLVRB promoter]	PMID:16214954|PMID:19654925
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of BLVRB mRNA	PMID:29955902
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306080	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of BLVRB mRNA	PMID:28374803
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of BLVRB mRNA	PMID:28001369
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of BLVRB mRNA	PMID:33212167
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of BLVRB mRNA	PMID:30851411
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of BLVRB mRNA	PMID:26272509
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BLVRB mRNA	PMID:27188386
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1306080	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of BLVRB mRNA	PMID:28959563
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of BLVRB mRNA	PMID:20971185
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of BLVRB mRNA	PMID:29803840
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BLVRB mRNA	PMID:37992649
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:28869	menadione	increases expression	ISO	RGD:1314491	E	RGD:6480464	20150127	CTD	MESH:D024483	Vitamin K 3 results in increased expression of BLVRB mRNA	PMID:25270620
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:29365	phosgene	affects expression	ISO	RGD:1314491	E	RGD:6480464	20120515	CTD	MESH:D010705	Phosgene affects the expression of BLVRB mRNA	PMID:16300373
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C017947	sodium arsenite results in increased expression of BLVRB mRNA	PMID:36586010|PMID:38568856|PMID:39719251
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1306080	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of BLVRB protein	PMID:29459688
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314491	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of BLVRB mRNA	PMID:16014739|PMID:25270620
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BLVRB mRNA	PMID:39836092
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BLVRB mRNA	PMID:20106945|PMID:21632981
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314491	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BLVRB mRNA	PMID:19770486|PMID:21569818|PMID:21715664
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of BLVRB mRNA	PMID:20971185
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314491	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of BLVRB mRNA	PMID:27131904
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of BLVRB mRNA	PMID:15725085|PMID:27829220|PMID:29633893
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1306080	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of BLVRB mRNA	PMID:24136188
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of BLVRB mRNA	PMID:38568856
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1314491	E	RGD:6480464	20150127	CTD	MESH:C008261	lead acetate results in increased expression of BLVRB mRNA	PMID:25270620
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1306080	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of BLVRB mRNA	PMID:25729387
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306080	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of BLVRB mRNA	PMID:25729387
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1306080	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of BLVRB mRNA	PMID:24136188
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314491	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of BLVRB gene	PMID:35295148
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306080	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of BLVRB mRNA	PMID:34492290
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314491	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of BLVRB mRNA	PMID:18301758|PMID:23811191
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1314491	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of BLVRB mRNA	PMID:19191707
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of BLVRB mRNA	PMID:30903817
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306080	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of BLVRB mRNA	PMID:25181051
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314491	E	RGD:6480464	20121009	CTD	MESH:C006780	bisphenol A results in increased expression of BLVRB mRNA	PMID:22687993
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20140715	CTD	MESH:C014024	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of BLVRB protein; [NR1I2 protein affects the susceptibility to 2,4,5,2',4',5'-hexachlorobiphenyl] which affects the expression of BLVRB mRNA	PMID:23457121|PMID:32352317
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20140715	CTD	MESH:C023035	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of BLVRB protein	PMID:23457121
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of BLVRB protein	PMID:34186270
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314491	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of BLVRB mRNA	PMID:39298647|PMID:40203079
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of BLVRB protein	PMID:34186270
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of BLVRB protein	PMID:34186270
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314491	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of BLVRB mRNA	PMID:37019170
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314491	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of BLVRB mRNA	PMID:17361019
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314491	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of BLVRB mRNA	PMID:21266533
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of BLVRB protein	PMID:38598786
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20160412	CTD	MESH:D004052	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylnitrosamine] results in increased expression of BLVRB protein; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of BLVRB mRNA	PMID:23457121|PMID:24535843
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in decreased expression of BLVRB protein	PMID:34064677
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BLVRB mRNA	PMID:37042841
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of BLVRB mRNA	PMID:29024780
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306080	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of BLVRB mRNA	PMID:35163327
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:351346	phenethyl isothiocyanate	increases expression	ISO	RGD:1306080	E	RGD:6480464	20141007	CTD	MESH:C058305	phenethyl isothiocyanate results in increased expression of BLVRB mRNA	PMID:17616710
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1306080	E	RGD:6480464	20141007	CTD	MESH:D002509	Cephaloridine results in increased expression of BLVRB mRNA	PMID:18500788
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306080	E	RGD:6480464	20141007	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of BLVRB protein	PMID:22081424
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BLVRB protein	PMID:33040242
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BLVRB mRNA	PMID:37236586
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1314491	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of BLVRB mRNA	PMID:20118188
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306080	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of BLVRB mRNA	PMID:35163327
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20120412	CTD	MESH:C023036	PPARA promotes the reaction [perfluorooctanoic acid results in decreased expression of BLVRB mRNA]	PMID:20118188
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1306080	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of BLVRB mRNA	PMID:26194646
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1306080	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of BLVRB mRNA	PMID:24386269
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of BLVRB mRNA	PMID:17547211
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BLVRB mRNA	PMID:19244175
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1306080	E	RGD:6480464	20141007	CTD	MESH:D002994	Clofibrate results in increased expression of BLVRB protein	PMID:16470657
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314491	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of BLVRB mRNA	PMID:40194260
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of BLVRB mRNA	PMID:31533062
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of BLVRB mRNA	PMID:19167446
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of BLVRB mRNA	PMID:27153767
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BLVRB mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of BLVRB mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of BLVRB mRNA	PMID:36331819
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1314491	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of BLVRB mRNA	PMID:29038090
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1314491	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of BLVRB mRNA	PMID:23125180
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BLVRB mRNA	PMID:25979313
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314491	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of BLVRB mRNA	PMID:17292431
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of BLVRB mRNA	PMID:19101580|PMID:23179753|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314491	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in increased expression of BLVRB mRNA	PMID:20546886|PMID:21427059
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BLVRB mRNA	PMID:27188386
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1306080	E	RGD:6480464	20141007	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of BLVRB protein	PMID:9006340
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314491	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in decreased expression of BLVRB mRNA	PMID:25270620
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of BLVRB mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of BLVRB mRNA	PMID:37992649
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1306080	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of BLVRB mRNA	PMID:24136188
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of BLVRB mRNA]	PMID:21233418
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:44658	okadaic acid	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20120717	CTD	MESH:D019319	[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of BLVRB mRNA	PMID:19840844
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of BLVRB mRNA; vorinostat results in increased expression of BLVRB protein	PMID:17593366|PMID:27188386
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	BLVRB protein affects the susceptibility to Fluorouracil	PMID:16217747
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of BLVRB protein	PMID:38460933
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BLVRB mRNA	PMID:39836092
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306080	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of BLVRB mRNA	PMID:29391264
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314491	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of BLVRB mRNA	PMID:35436446
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of BLVRB mRNA	PMID:17211630
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of BLVRB mRNA	PMID:15725085|PMID:27829220|PMID:29633893
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of BLVRB mRNA	PMID:23300844
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306080	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of BLVRB mRNA	PMID:24136188
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306080	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of BLVRB mRNA	PMID:24136188
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of BLVRB mRNA	PMID:20977926
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of BLVRB mRNA	PMID:20436886
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of BLVRB protein	PMID:32959892
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of BLVRB mRNA	PMID:21641980
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306080	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of BLVRB mRNA	PMID:25729387
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306080	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of BLVRB mRNA	PMID:25729387
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1306080	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of BLVRB mRNA	PMID:24136188
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314491	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of BLVRB mRNA	PMID:19812364
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1306080	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of BLVRB mRNA	PMID:24136188
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of BLVRB mRNA	PMID:24810058
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1314491	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of BLVRB mRNA	PMID:36851058
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:64227	ciglitazone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C039671	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of BLVRB mRNA	PMID:16197558
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:6456	lidocaine	decreases expression	ISO	RGD:1306080	E	RGD:6480464	20160607	CTD	MESH:D008012	Lidocaine results in decreased expression of BLVRB protein	PMID:27018092
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:65408	andrographolide	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20121218	CTD	MESH:C030419	[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of BLVRB mRNA	PMID:19737545
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:68508	diethyl maleate	increases expression	ISO	RGD:1314491	E	RGD:6480464	20150127	CTD	MESH:C014476	diethyl maleate results in increased expression of BLVRB mRNA	PMID:25270620|PMID:34626751
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:68792	asperentin	increases expression	ISO	RGD:1314491	E	RGD:6480464	20131008	CTD	MESH:C000488	cladosporin results in increased expression of BLVRB mRNA	PMID:21356202
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:68794	neoechinulin A	increases expression	ISO	RGD:1314491	E	RGD:6480464	20170228	CTD	MESH:C490266	neoechinulin A results in increased expression of BLVRB mRNA	PMID:21356202
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1314491	E	RGD:6480464	20120412	CTD	MESH:C057862	cyanoginosin LR results in increased expression of BLVRB mRNA	PMID:17654400
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of BLVRB mRNA	PMID:31518892
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of BLVRB mRNA	PMID:31758290
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of BLVRB protein	PMID:34186270
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306080	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of BLVRB mRNA	PMID:24136188
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1314491	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of BLVRB mRNA	PMID:25566086
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:76326	N-nitrosomorpholine	increases expression	ISO	RGD:1306080	E	RGD:6480464	20141007	CTD	MESH:C002741	N-nitrosomorpholine results in increased expression of BLVRB protein	PMID:19716841
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20140204	CTD	MESH:D019324	[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of BLVRB mRNA	PMID:19737545
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C025589	ochratoxin A results in decreased expression of BLVRB mRNA	PMID:32905824
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of BLVRB mRNA	PMID:30851411
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BLVRB mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BLVRB mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BLVRB mRNA	PMID:27188386
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:78886	2-tert-butylhydroquinone	increases expression	ISO	RGD:1314491	E	RGD:6480464	20140708	CTD	MESH:C018855	2-tert-butylhydroquinone results in increased expression of BLVRB mRNA	PMID:16014739
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:79516	Nonylphenol	increases expression	ISO	RGD:1306080	E	RGD:6480464	20141111	CTD	MESH:C025256	nonylphenol results in increased expression of BLVRB protein	PMID:19260726
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BLVRB gene]	PMID:28238834
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314491	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of BLVRB mRNA	PMID:19482888
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314491	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of BLVRB mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of BLVRB mRNA]	PMID:19482888|PMID:24535843
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306080	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of BLVRB mRNA	PMID:32109520
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314491	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of BLVRB mRNA	PMID:38648751
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314491	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of BLVRB mRNA	PMID:40826991
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of BLVRB mRNA	PMID:31734321
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BLVRB mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BLVRB mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BLVRB mRNA	PMID:27188386
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314491	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of BLVRB mRNA	PMID:27131904
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of BLVRB mRNA	PMID:38568856
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306080	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of BLVRB mRNA	PMID:20566332
1314490	BLVRB	biliverdin reductase B	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306080	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of BLVRB mRNA	PMID:23034163
1314493	CABP4	calcium binding protein 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314494	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CABP4 mRNA	PMID:33045310
1314493	CABP4	calcium binding protein 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314494	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CABP4 mRNA	PMID:39241906
1314493	CABP4	calcium binding protein 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306083	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CABP4 mRNA	PMID:32741896
1314493	CABP4	calcium binding protein 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314494	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CABP4 mRNA	PMID:37567420
1314493	CABP4	calcium binding protein 4	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306083	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CABP4 mRNA	PMID:32741896
1314493	CABP4	calcium binding protein 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314494	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CABP4 mRNA	PMID:37567420
1314493	CABP4	calcium binding protein 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CABP4 mRNA	PMID:31163220
1314493	CABP4	calcium binding protein 4	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1314494	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CABP4 mRNA	PMID:37567420
1314493	CABP4	calcium binding protein 4	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314494	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of CABP4 mRNA	PMID:32186404
1314493	CABP4	calcium binding protein 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314494	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CABP4 mRNA	PMID:37567420
1314493	CABP4	calcium binding protein 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CABP4 mRNA	PMID:38568856
1314493	CABP4	calcium binding protein 4	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314494	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of CABP4 mRNA	PMID:35295148
1314493	CABP4	calcium binding protein 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of CABP4 mRNA	PMID:20170705
1314493	CABP4	calcium binding protein 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306083	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CABP4 mRNA	PMID:25181051
1314493	CABP4	calcium binding protein 4	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CABP4 mRNA	PMID:28628672
1314493	CABP4	calcium binding protein 4	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CABP4 mRNA	PMID:28628672
1314493	CABP4	calcium binding protein 4	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1306083	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of CABP4 mRNA	PMID:35163327
1314493	CABP4	calcium binding protein 4	gene	CHEBI:35176	zinc sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in increased expression of CABP4 mRNA	PMID:16330358
1314493	CABP4	calcium binding protein 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306083	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CABP4 mRNA	PMID:33453195
1314493	CABP4	calcium binding protein 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314494	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CABP4 mRNA	PMID:40194260
1314493	CABP4	calcium binding protein 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CABP4 gene	PMID:29154799
1314493	CABP4	calcium binding protein 4	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CABP4 mRNA	PMID:28628672
1314493	CABP4	calcium binding protein 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314494	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CABP4 mRNA	PMID:37567420
1314493	CABP4	calcium binding protein 4	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CABP4 mRNA	PMID:28628672
1314493	CABP4	calcium binding protein 4	gene	CHEBI:5063	fipronil	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C082360	fipronil results in decreased expression of CABP4 mRNA	PMID:27091632
1314493	CABP4	calcium binding protein 4	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of CABP4 mRNA	PMID:27091632
1314493	CABP4	calcium binding protein 4	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1306083	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of CABP4 mRNA	PMID:21983209
1314493	CABP4	calcium binding protein 4	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of CABP4 mRNA	PMID:27091632
1314493	CABP4	calcium binding protein 4	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1314494	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CABP4 mRNA	PMID:37567420
1314493	CABP4	calcium binding protein 4	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1306083	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CABP4 mRNA	PMID:32741896
1314493	CABP4	calcium binding protein 4	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1314494	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of CABP4 mRNA	PMID:26655953
1314493	CABP4	calcium binding protein 4	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1306083	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of CABP4 mRNA	PMID:23640034
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1619987	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CYB5R1 mRNA	PMID:33045310
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1619987	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYB5R1 mRNA	PMID:20938992
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of CYB5R1 mRNA	PMID:23724009
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1619987	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CYB5R1 mRNA	PMID:39241906
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1619987	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYB5R1 mRNA	PMID:20938992
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CYB5R1 mRNA	PMID:37042841
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of CYB5R1 mRNA	PMID:23649840
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of CYB5R1 mRNA	PMID:26079696
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1619987	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CYB5R1 mRNA	PMID:34319233
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CYB5R1 mRNA	PMID:31163220
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Haloperidol] results in increased expression of CYB5R1 protein	PMID:34122009
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1619987	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYB5R1 mRNA	PMID:36331819
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CYB5R1 mRNA	PMID:39836092
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306084	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CYB5R1 protein	PMID:34915118
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYB5R1 mRNA	PMID:35301059
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1619987	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CYB5R1 mRNA	PMID:19770486
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of CYB5R1 mRNA	PMID:23649840
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of CYB5R1 mRNA	PMID:25102026
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CYB5R1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of CYB5R1 protein	PMID:38598786
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1619987	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CYB5R1 mRNA	PMID:27339419|PMID:31919559
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1619987	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CYB5R1 mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CYB5R1 mRNA]	PMID:20938992|PMID:22206623
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CYB5R1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CYB5R1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYB5R1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYB5R1 mRNA	PMID:39836092|PMID:40512198
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of CYB5R1 mRNA	PMID:26272509
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYB5R1 mRNA	PMID:27188386
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306084	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CYB5R1 mRNA	PMID:31881176
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1619987	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of CYB5R1 protein	PMID:25505154
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of CYB5R1 mRNA	PMID:19167446
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of CYB5R1 gene	PMID:31636367
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of CYB5R1 mRNA	PMID:27594783
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1619987	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CYB5R1 mRNA	PMID:21570461|PMID:24680724
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306084	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CYB5R1 mRNA	PMID:32109520
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1619987	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of CYB5R1 mRNA	PMID:17702527
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306084	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CYB5R1 mRNA	PMID:28959563
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1619987	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of CYB5R1 mRNA	PMID:30807115
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1619987	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of CYB5R1 protein	PMID:28918527
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of CYB5R1 mRNA	PMID:20044591
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CYB5R1 mRNA	PMID:38568856|PMID:39719251
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CYB5R1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CYB5R1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYB5R1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYB5R1 mRNA	PMID:39836092|PMID:40512198
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1619987	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CYB5R1 mRNA	PMID:19770486|PMID:21715664
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CYB5R1 mRNA	PMID:21632981
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1619987	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CYB5R1 mRNA	PMID:22228805
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CYB5R1 promoter	PMID:27901495
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1619987	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of CYB5R1 protein	PMID:37955338
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CYB5R1 mRNA	PMID:20382639
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1619987	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of CYB5R1 mRNA	PMID:35295148
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1619987	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of CYB5R1 mRNA	PMID:19136022
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1619987	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of CYB5R1 mRNA	PMID:23811191
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306084	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CYB5R1 mRNA	PMID:25181051
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of CYB5R1 protein	PMID:31675489
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1619987	E	RGD:6480464	20240206	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of CYB5R1 mRNA	PMID:37080397
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1619987	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CYB5R1 mRNA	PMID:39298647
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CYB5R1 protein	PMID:34186270
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1619987	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of CYB5R1 mRNA	PMID:40203079
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1619987	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in increased expression of CYB5R1 mRNA]	PMID:40203079
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:34421	4-Hydroxybenzophenone	increases expression	ISO	RGD:1619987	E	RGD:6480464	20221101	CTD	MESH:C024292	4-hydroxybenzophenone results in increased expression of CYB5R1 mRNA	PMID:35476924
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CYB5R1 protein	PMID:34186270
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CYB5R1 mRNA	PMID:28628672
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1619987	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CYB5R1 mRNA	PMID:34289071
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of CYB5R1 protein	PMID:38598786
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CYB5R1 mRNA	PMID:28628672
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CYB5R1 mRNA	PMID:39836092
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CYB5R1 mRNA	PMID:35301059
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of CYB5R1 mRNA	PMID:19320972|PMID:19376846
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of CYB5R1 protein	PMID:34122009
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1619987	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CYB5R1 mRNA	PMID:40194260
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of CYB5R1 mRNA	PMID:31533062
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYB5R1 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of CYB5R1 mRNA	PMID:19167446
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1619987	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of CYB5R1 mRNA	PMID:39529242
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of CYB5R1 mRNA	PMID:40419075
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1619987	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYB5R1 mRNA	PMID:36331819
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CYB5R1 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CYB5R1 gene	PMID:29154799
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of CYB5R1 mRNA	PMID:17183730
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of CYB5R1 mRNA	PMID:20106945|PMID:27989131
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1619987	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of CYB5R1 mRNA	PMID:17555576
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CYB5R1 mRNA	PMID:28628672
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in increased expression of CYB5R1 mRNA	PMID:28542535
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1619987	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CYB5R1 mRNA	PMID:17562736
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:46195	paracetamol	affects response to substance	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	CYB5R1 gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CYB5R1 mRNA	PMID:22230336
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306084	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of CYB5R1 mRNA	PMID:33387578
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1619987	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CYB5R1 mRNA	PMID:29279043
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CYB5R1 mRNA; [[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CYB5R1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CYB5R1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CYB5R1 mRNA	PMID:39836092|PMID:40512198
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of CYB5R1 mRNA	PMID:31675489
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CYB5R1 mRNA	PMID:28628672
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:50161	motexafin gadolinium	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in increased expression of CYB5R1 mRNA	PMID:16357179
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CYB5R1 mRNA	PMID:16357179
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1619987	E	RGD:6480464	20120412	CTD	MESH:D005485	Flutamide analog results in increased expression of CYB5R1 mRNA; Flutamide results in increased expression of CYB5R1 mRNA	PMID:17702527
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of CYB5R1 mRNA	PMID:20977926
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:5613	haloperidol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in increased expression of CYB5R1 protein	PMID:34122009
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of CYB5R1 mRNA	PMID:17183730
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:62984	zinc acetate	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in increased expression of CYB5R1 mRNA	PMID:16357179
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:62984	zinc acetate	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CYB5R1 mRNA	PMID:16357179
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CYB5R1 mRNA	PMID:39836092
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1619987	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of CYB5R1 mRNA	PMID:22776087
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:69355	casticin	decreases expression	ISO	RGD:1619987	E	RGD:6480464	20171114	CTD	MESH:C054133	casticin results in decreased expression of CYB5R1 mRNA	PMID:28444820
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CYB5R1 protein	PMID:34186270
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1306084	E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of CYB5R1 mRNA	PMID:39938710
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1619987	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CYB5R1 mRNA	PMID:22206623
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1619987	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CYB5R1 mRNA]	PMID:22206623
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYB5R1 mRNA	PMID:27188386
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CYB5R1 gene]	PMID:28238834
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1619987	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of CYB5R1 mRNA	PMID:19136022
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CYB5R1 mRNA	PMID:19167446
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1306084	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of CYB5R1 protein	PMID:28903499
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1619987	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of CYB5R1 mRNA	PMID:21278054
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYB5R1 mRNA	PMID:27188386
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306084	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CYB5R1 mRNA	PMID:21346803
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:9381	T-2 toxin	decreases expression	ISO	RGD:1306084	E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin results in decreased expression of CYB5R1 mRNA	PMID:26141394
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of CYB5R1 mRNA	PMID:29301935
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1306084	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of CYB5R1 protein	PMID:35544339
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in increased expression of CYB5R1 mRNA	PMID:29453283
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of CYB5R1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CYB5R1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of CYB5R1 protein	PMID:38598786
1314495	CYB5R1	cytochrome b5 reductase 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306084	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CYB5R1 mRNA	PMID:23034163
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of H4C8 mRNA	PMID:33167477
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20180417	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of H4C12 mRNA; Oxygen deficiency results in decreased expression of H4C8 mRNA	PMID:24205000
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1318740	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of H4C8 mRNA	PMID:36331819
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of H4C8 mRNA	PMID:24763279
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of H4C8 mRNA	PMID:40865780
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:16118	berberine	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D001599	Berberine results in decreased expression of H4C8 mRNA	PMID:27311644
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in decreased expression of H4C8 mRNA	PMID:23378141
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of H4C8 mRNA	PMID:39241906
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of H4C8 mRNA	PMID:22217510
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1318740	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone promotes the reaction [Biomarkers metabolite binds to H4C8 gene]	PMID:31084621
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of H4C8 mRNA	PMID:38568856
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of H4C8 mRNA	PMID:26079696
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of H4C8 mRNA	PMID:21592394
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of H4C8 mRNA	PMID:21592394
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C031927	hydroquinone results in decreased expression of H4C8 mRNA	PMID:23416264
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1318740	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of H4C8 mRNA	PMID:36706583
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of H4C8 mRNA	PMID:36139627
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of H4C8 mRNA	PMID:21592394
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of H4C8 mRNA	PMID:21592394
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1318740	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of H4C8 mRNA	PMID:36331819
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of H4C8 mRNA	PMID:35301059
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1318740	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of H4C8 mRNA	PMID:37236586
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of H4C8 mRNA	PMID:19549813
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of H4C8 mRNA	PMID:27153756
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of H4C8 gene	PMID:27153756
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of H4C8 mRNA	PMID:23649840
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:2654	aminoglutethimide	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in increased expression of H4C8 protein	PMID:26102013
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of H4C8 mRNA	PMID:19774075
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of H4C8 mRNA	PMID:18593933
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1318740	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of H4C8 mRNA	PMID:40504410
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of H4C12 mRNA	PMID:35897073
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of H4C8 mRNA	PMID:27392435|PMID:27594783
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of H4C8 mRNA	PMID:27392435
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:27928	parathion	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in decreased expression of H4C8 mRNA	PMID:34813904
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1318740	E	RGD:6480464	20191008	CTD	MESH:D014640	Vancomycin results in increased expression of H4C8 mRNA	PMID:18930951
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1318740	E	RGD:6480464	20180417	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of H4C12 mRNA; Tetrachlorodibenzodioxin affects the expression of H4C8 mRNA	PMID:21570461|PMID:24680724|PMID:26377647
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of H4C8 mRNA	PMID:20106945|PMID:21632981
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of H4C8 mRNA	PMID:33212167
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of H4C8 mRNA	PMID:30851411
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20200825	CTD	MESH:D020106	Acrylamide results in decreased expression of H4C12 mRNA	PMID:30807115
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of H4C8 mRNA	PMID:20971185
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D004317	Doxorubicin affects the expression of H4C8 mRNA	PMID:25529476
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of H4C8 mRNA	PMID:29803840
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of H4C8 mRNA	PMID:20044591
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of H4C8 mRNA	PMID:34032870|PMID:39719251
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of H4C12 mRNA; sodium arsenite results in decreased expression of H4C8 mRNA	PMID:37682722
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of H4C8 mRNA	PMID:38568856
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1318740	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of H4C8 mRNA	PMID:40504410
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of H4C8 mRNA	PMID:29453283
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of H4C8 mRNA	PMID:22316170
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20180417	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of H4C12 mRNA; Benzo(a)pyrene results in decreased expression of H4C8 mRNA	PMID:20127859
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of H4C8 mRNA	PMID:20106945|PMID:21632981
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20250902	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of H4C8 promoter	PMID:27901495
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of H4C8 mRNA	PMID:20971185
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:30145	lithium atom	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of H4C8 protein	PMID:40770094
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:30146	lithium hydride	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in decreased expression of H4C8 protein	PMID:40770094
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of H4C8 mRNA	PMID:18593933
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of H4C8 mRNA	PMID:25895662
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of H4C8 mRNA; Silicon Dioxide results in increased expression of H4C8 mRNA	PMID:23806026|PMID:25351596
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of H4C8 mRNA	PMID:22521957
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:30772	butyric acid	decreases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D020148	Butyric Acid results in decreased expression of H4C8 protein	PMID:34581912
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1318740	E	RGD:6480464	20200825	CTD	MESH:C009495	titanium dioxide results in increased expression of H4C12 mRNA	PMID:29264374
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1318740	E	RGD:6480464	20191008	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of H4C8 mRNA	PMID:19710929
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:33090	picene	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C056699	picene results in increased expression of H4C8 mRNA	PMID:32251684
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1318740	E	RGD:6480464	20240305	CTD	MESH:C006780	bisphenol A affects the expression of H4C12 mRNA	PMID:36347119
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of H4C8 mRNA	PMID:29275510
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20240305	CTD	MESH:C006780	bisphenol A results in decreased expression of H4C8 mRNA	PMID:36347119
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1318740	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of H4C12 mRNA; bisphenol A results in increased expression of H4C8 mRNA	PMID:33221593
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:34237	2,4-diaminotoluene	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20191008	CTD	MESH:C010914	2,4-diaminotoluene results in decreased expression of H4C8 mRNA	PMID:20713471
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of H4C8 mRNA	PMID:28628672
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20200825	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of H4C12 mRNA	PMID:26377693
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of H4C8 mRNA	PMID:28628672
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of H4C8 mRNA	PMID:28392331
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of H4C8 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of H4C8 mRNA	PMID:28628672
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of H4C8 mRNA	PMID:35301059
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1318740	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of H4C8 mRNA	PMID:37236586
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of H4C8 mRNA	PMID:36326898
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1318740	E	RGD:6480464	20200825	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of H4C12 mRNA	PMID:28962523
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of H4C8 mRNA	PMID:19167446
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H4C8 mRNA	PMID:19167446
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of H4C8 mRNA	PMID:40419075
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1318740	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of H4C8 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of H4C8 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of H4C8 mRNA	PMID:36331819
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of H4C8 mRNA	PMID:22147139|PMID:27989131
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of H4C8 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of H4C8 mRNA	PMID:28628672
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1318740	E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen affects the expression of H4C8 mRNA	PMID:17562736
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of H4C8 mRNA	PMID:29067470
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	Zoledronic Acid results in increased expression of H4C8 mRNA	PMID:24714768
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of H4C8 mRNA	PMID:18687144
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1318740	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of H4C8 mRNA	PMID:40504410
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of H4C8 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of H4C8 mRNA	PMID:28628672
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of H4C8 mRNA	PMID:22521957
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:6078	ivermectin	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of H4C8 protein	PMID:32959892
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1318740	E	RGD:6480464	20191008	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of H4C8 mRNA	PMID:23650126
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of H4C8 mRNA	PMID:24810058
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:72676	versicolorin A	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C029826	versicolorin A results in decreased expression of H4C8 mRNA	PMID:32106047
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of H4C8 mRNA	PMID:29522793
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of H4C8 mRNA	PMID:36139627
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of H4C8 mRNA	PMID:30851411
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of H4C8 mRNA	PMID:30928695
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to H4C8 gene]	PMID:28238834
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	affects expression	ISO	RGD:1318740	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl affects the expression of H4C8 mRNA	PMID:31388691
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of H4C8 mRNA	PMID:19167446
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of H4C8 mRNA	PMID:32234424
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1318740	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of H4C8 mRNA	PMID:39847705
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1318740	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of H4C8 mRNA	PMID:36706583
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of H4C8 mRNA	PMID:24921660
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of H4C8 mRNA	PMID:31734321
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of H4C8 mRNA	PMID:34581912
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of H4C8 mRNA	PMID:27188386
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1318740	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of H4C8 mRNA	PMID:32835833
1314497	H4C8	H4 clustered histone 8	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1318740	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of H4C12 mRNA; trovafloxacin results in decreased expression of H4C8 mRNA	PMID:35537566
1314499	RIOK1	RIO kinase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RIOK1 mRNA	PMID:33167477
1314499	RIOK1	RIO kinase 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RIOK1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RIOK1 mRNA	PMID:32699268
1314499	RIOK1	RIO kinase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of RIOK1 mRNA	PMID:31614463
1314499	RIOK1	RIO kinase 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of RIOK1 mRNA	PMID:20655997
1314499	RIOK1	RIO kinase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314500	E	RGD:6480464	20250902	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of RIOK1 mRNA	PMID:20463053
1314499	RIOK1	RIO kinase 1	gene	CHEBI:17558	quercitrin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of RIOK1 mRNA	PMID:25193878
1314499	RIOK1	RIO kinase 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RIOK1 protein	PMID:37730182
1314499	RIOK1	RIO kinase 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RIOK1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of RIOK1 mRNA	PMID:39836092
1314499	RIOK1	RIO kinase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RIOK1 mRNA	PMID:22100608
1314499	RIOK1	RIO kinase 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RIOK1 gene	PMID:28458013
1314499	RIOK1	RIO kinase 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RIOK1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RIOK1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of RIOK1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RIOK1 mRNA	PMID:32699268|PMID:35430440
1314499	RIOK1	RIO kinase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306086	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RIOK1 mRNA	PMID:31150632
1314499	RIOK1	RIO kinase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314500	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RIOK1 mRNA	PMID:31919559
1314499	RIOK1	RIO kinase 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314500	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RIOK1 mRNA	PMID:25629700
1314499	RIOK1	RIO kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RIOK1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RIOK1 mRNA	PMID:39836092
1314499	RIOK1	RIO kinase 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RIOK1 protein	PMID:35688186
1314499	RIOK1	RIO kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314500	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RIOK1 mRNA	PMID:21570461
1314499	RIOK1	RIO kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RIOK1 mRNA	PMID:20106945|PMID:21632981
1314499	RIOK1	RIO kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306086	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RIOK1 mRNA	PMID:33387578
1314499	RIOK1	RIO kinase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RIOK1 mRNA	PMID:33212167
1314499	RIOK1	RIO kinase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of RIOK1 mRNA	PMID:20371982|PMID:38568856
1314499	RIOK1	RIO kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RIOK1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RIOK1 mRNA	PMID:39836092
1314499	RIOK1	RIO kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314500	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RIOK1 mRNA	PMID:22228805
1314499	RIOK1	RIO kinase 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314500	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of RIOK1 mRNA]	PMID:22228805
1314499	RIOK1	RIO kinase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RIOK1 mRNA	PMID:19150397
1314499	RIOK1	RIO kinase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314500	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RIOK1 gene	PMID:35295148
1314499	RIOK1	RIO kinase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306086	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RIOK1 mRNA	PMID:34492290
1314499	RIOK1	RIO kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314500	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RIOK1 mRNA	PMID:33221593
1314499	RIOK1	RIO kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306086	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RIOK1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314499	RIOK1	RIO kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314500	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RIOK1 mRNA	PMID:26063408
1314499	RIOK1	RIO kinase 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306086	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RIOK1 gene	PMID:28505145
1314499	RIOK1	RIO kinase 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	affects expression	ISO	RGD:1314500	E	RGD:6480464	20140909	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl affects the expression of RIOK1 mRNA	PMID:24680724
1314499	RIOK1	RIO kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C543008	bisphenol S results in increased expression of RIOK1 mRNA	PMID:25912373
1314499	RIOK1	RIO kinase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314500	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RIOK1 mRNA	PMID:37019170
1314499	RIOK1	RIO kinase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306086	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RIOK1 mRNA	PMID:21266533
1314499	RIOK1	RIO kinase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RIOK1 mRNA	PMID:37042841
1314499	RIOK1	RIO kinase 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RIOK1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of RIOK1 mRNA	PMID:39836092
1314499	RIOK1	RIO kinase 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RIOK1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RIOK1 mRNA	PMID:32699268
1314499	RIOK1	RIO kinase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RIOK1 mRNA	PMID:32588087
1314499	RIOK1	RIO kinase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RIOK1 mRNA	PMID:23179753|PMID:29154799
1314499	RIOK1	RIO kinase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RIOK1 mRNA	PMID:20106945|PMID:25562108
1314499	RIOK1	RIO kinase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314500	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RIOK1 mRNA	PMID:28973697
1314499	RIOK1	RIO kinase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RIOK1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RIOK1 mRNA	PMID:39836092
1314499	RIOK1	RIO kinase 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RIOK1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of RIOK1 mRNA	PMID:39836092
1314499	RIOK1	RIO kinase 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314500	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RIOK1 mRNA	PMID:23650126
1314499	RIOK1	RIO kinase 1	gene	CHEBI:67895	corosolic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of RIOK1 mRNA	PMID:37939859
1314499	RIOK1	RIO kinase 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RIOK1 mRNA	PMID:31758290
1314499	RIOK1	RIO kinase 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RIOK1 mRNA	PMID:25912373
1314499	RIOK1	RIO kinase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314500	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RIOK1 mRNA	PMID:22206623
1314499	RIOK1	RIO kinase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RIOK1 gene]	PMID:28238834
1314499	RIOK1	RIO kinase 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314500	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of RIOK1 mRNA	PMID:21795629
1314499	RIOK1	RIO kinase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306086	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RIOK1 mRNA	PMID:21346803
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of AUH mRNA	PMID:38218311
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1306087	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of AUH mRNA	PMID:21551480
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314502	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of AUH mRNA	PMID:37995155
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306087	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AUH mRNA]	PMID:31150632
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of AUH mRNA	PMID:36331819
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of AUH mRNA	PMID:26079696
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of AUH mRNA	PMID:22378314
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314502	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of AUH mRNA	PMID:30319688
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of AUH mRNA	PMID:21632981
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1306087	E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in increased expression of AUH mRNA	PMID:21565894
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314502	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of AUH mRNA	PMID:39241906
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1314502	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of AUH mRNA	PMID:15598610
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of AUH mRNA	PMID:31614463
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314502	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of AUH mRNA	PMID:39298647
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AUH mRNA	PMID:25510870
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306087	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of AUH mRNA	PMID:33387578
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of AUH mRNA	PMID:37042841
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of AUH mRNA	PMID:23649840
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306087	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of AUH mRNA	PMID:33387578
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AUH mRNA	PMID:36331819
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of AUH mRNA	PMID:23369406
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AUH mRNA	PMID:25510870
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AUH mRNA	PMID:25510870
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of AUH mRNA	PMID:19549813
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of AUH mRNA	PMID:23649840
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of AUH mRNA	PMID:22100608
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of AUH mRNA	PMID:23649840
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of AUH mRNA	PMID:35430440
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306087	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AUH mRNA	PMID:31150632
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306087	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AUH mRNA]	PMID:31150632
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AUH mRNA	PMID:22206623
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of AUH mRNA	PMID:40504410
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1314502	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of AUH protein	PMID:36173347
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:27789	1,2-dichloroethane	affects expression	ISO	RGD:1314502	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride affects the expression of AUH mRNA	PMID:28960355
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306087	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of AUH mRNA	PMID:31881176
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314502	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of AUH mRNA	PMID:22610192
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1314502	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in increased expression of AUH mRNA	PMID:16917069
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1314502	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of AUH mRNA	PMID:18930951
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1306087	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of AUH gene	PMID:28505145
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306087	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AUH mRNA	PMID:22298810
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314502	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AUH mRNA	PMID:24680724
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306087	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AUH mRNA	PMID:21215274
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314502	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AUH mRNA	PMID:20819909
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306087	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AUH mRNA	PMID:33387578
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to AUH gene]	PMID:20819909
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of AUH mRNA	PMID:33212167
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314502	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of AUH mRNA	PMID:26873546
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of AUH mRNA	PMID:20044591
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of AUH mRNA	PMID:38568856
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1306087	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of AUH protein	PMID:29459688
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of AUH mRNA	PMID:40504410
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of AUH mRNA	PMID:22378314
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AUH mRNA	PMID:32234424
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of AUH mRNA; Silicon Dioxide results in decreased expression of AUH protein	PMID:25895662|PMID:27917503
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of AUH mRNA	PMID:38568856
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314502	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of AUH mRNA	PMID:35295148
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314502	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of AUH gene	PMID:35295148
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306087	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of AUH mRNA	PMID:34492290
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314502	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of AUH mRNA	PMID:23811191
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314502	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of AUH mRNA	PMID:33221593
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306087	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of AUH gene	PMID:28505145
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1314502	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of AUH mRNA	PMID:26682919
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AUH mRNA	PMID:25510870
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of AUH mRNA	PMID:25510870
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1314502	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of AUH intron	PMID:28392331
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306087	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of AUH gene	PMID:33148267
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of AUH protein	PMID:26879310
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306087	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of AUH gene	PMID:22079235
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of AUH mRNA	PMID:28302478
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of AUH mRNA	PMID:31533062
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of AUH mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of AUH mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of AUH mRNA	PMID:36331819
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of AUH mRNA	PMID:20106945|PMID:25562108
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314502	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of AUH mRNA	PMID:28973697
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of AUH mRNA	PMID:17400583
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of AUH mRNA	PMID:38832940
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314502	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of AUH mRNA	PMID:17562736
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of AUH mRNA	PMID:25704631|PMID:29067470
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:46727	quartz	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D011791	Quartz results in increased expression of AUH protein	PMID:27917503
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of AUH mRNA	PMID:40504410
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:4798	entacapone	affects binding	ISO	RGD:1306087	E	RGD:6480464	20170303	CTD	MESH:C071192	entacapone binds to AUH protein	PMID:19783845
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1306087	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of AUH mRNA	PMID:36868495
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1314502	E	RGD:6480464	20200714	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of AUH mRNA	PMID:31978390
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314502	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of AUH mRNA; Nanotubes, Carbon results in increased expression of AUH mRNA	PMID:25620056
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306087	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of AUH mRNA	PMID:23962444
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306087	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of AUH mRNA	PMID:24136188
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314502	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of AUH mRNA	PMID:19042947
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:63630	tolcapone	affects binding	ISO	RGD:1306087	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to AUH protein	PMID:19783845
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306087	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of AUH gene	PMID:33148267
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314502	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of AUH mRNA	PMID:22206623
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314502	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of AUH mRNA	PMID:22206623
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306087	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of AUH mRNA	PMID:24136188
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:76290	PhIP	decreases expression	ISO	RGD:1306087	E	RGD:6480464	20211012	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of AUH mRNA	PMID:33945839
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of AUH mRNA	PMID:19159669
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1314502	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of AUH mRNA	PMID:22538082
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306087	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of AUH mRNA	PMID:19281266
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:9352	sulindac	multiple interactions	ISO	RGD:1306087	E	RGD:6480464	20120717	CTD	MESH:D013467	[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of AUH mRNA	PMID:20371263
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of AUH mRNA	PMID:38568856
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of AUH mRNA	PMID:29301935
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of AUH mRNA	PMID:22378314
1314501	AUH	AU RNA binding methylglutaconyl-CoA hydratase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306087	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of AUH mRNA	PMID:21346803
1314503	SFXN4	sideroflexin 4	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1314504	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in increased expression of SFXN4 mRNA	PMID:18313992
1314503	SFXN4	sideroflexin 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314504	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SFXN4 mRNA	PMID:33045310
1314503	SFXN4	sideroflexin 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314504	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SFXN4 mRNA	PMID:20938992
1314503	SFXN4	sideroflexin 4	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SFXN4 mRNA	PMID:22378314
1314503	SFXN4	sideroflexin 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314504	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SFXN4 mRNA	PMID:30319688
1314503	SFXN4	sideroflexin 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SFXN4 mRNA	PMID:21179406
1314503	SFXN4	sideroflexin 4	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of SFXN4 mRNA	PMID:18951874
1314503	SFXN4	sideroflexin 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314504	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SFXN4 mRNA	PMID:39241906
1314503	SFXN4	sideroflexin 4	gene	CHEBI:16433	trans-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of SFXN4 mRNA]	PMID:19442820
1314503	SFXN4	sideroflexin 4	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SFXN4 mRNA	PMID:38568856
1314503	SFXN4	sideroflexin 4	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306088	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SFXN4 mRNA	PMID:33387578
1314503	SFXN4	sideroflexin 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314504	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SFXN4 mRNA	PMID:20938992
1314503	SFXN4	sideroflexin 4	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SFXN4 mRNA	PMID:23649840
1314503	SFXN4	sideroflexin 4	gene	CHEBI:17395	cis-caffeic acid	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:C040048	caffeic acid promotes the reaction [Thapsigargin results in decreased expression of SFXN4 mRNA]	PMID:19442820
1314503	SFXN4	sideroflexin 4	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SFXN4 mRNA	PMID:28818685
1314503	SFXN4	sideroflexin 4	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SFXN4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SFXN4 mRNA	PMID:39836092
1314503	SFXN4	sideroflexin 4	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SFXN4 mRNA	PMID:35301059
1314503	SFXN4	sideroflexin 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SFXN4 mRNA	PMID:19549813
1314503	SFXN4	sideroflexin 4	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of SFXN4 mRNA	PMID:23649840
1314503	SFXN4	sideroflexin 4	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SFXN4 mRNA	PMID:23649840
1314503	SFXN4	sideroflexin 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314504	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SFXN4 mRNA	PMID:20938992
1314503	SFXN4	sideroflexin 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SFXN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFXN4 mRNA	PMID:39836092
1314503	SFXN4	sideroflexin 4	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of SFXN4 protein	PMID:35688186
1314503	SFXN4	sideroflexin 4	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306088	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SFXN4 mRNA	PMID:31881176
1314503	SFXN4	sideroflexin 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SFXN4 mRNA	PMID:23557933
1314503	SFXN4	sideroflexin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306088	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SFXN4 mRNA	PMID:33387578
1314503	SFXN4	sideroflexin 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314504	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SFXN4 mRNA	PMID:21354282
1314503	SFXN4	sideroflexin 4	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of SFXN4 mRNA	PMID:29955902
1314503	SFXN4	sideroflexin 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SFXN4 mRNA	PMID:27188386
1314503	SFXN4	sideroflexin 4	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SFXN4 mRNA	PMID:33212167
1314503	SFXN4	sideroflexin 4	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of SFXN4 mRNA	PMID:20971185
1314503	SFXN4	sideroflexin 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SFXN4 mRNA	PMID:29803840
1314503	SFXN4	sideroflexin 4	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314504	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of SFXN4 mRNA	PMID:39631538
1314503	SFXN4	sideroflexin 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SFXN4 mRNA	PMID:38568856
1314503	SFXN4	sideroflexin 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SFXN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFXN4 mRNA	PMID:39836092
1314503	SFXN4	sideroflexin 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SFXN4 promoter	PMID:27901495
1314503	SFXN4	sideroflexin 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314504	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SFXN4 mRNA	PMID:22228805
1314503	SFXN4	sideroflexin 4	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1314504	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of SFXN4 mRNA	PMID:18929588
1314503	SFXN4	sideroflexin 4	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1314504	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in increased expression of SFXN4 mRNA]	PMID:18929588
1314503	SFXN4	sideroflexin 4	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of SFXN4 mRNA	PMID:20971185
1314503	SFXN4	sideroflexin 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306088	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SFXN4 mRNA	PMID:34492290
1314503	SFXN4	sideroflexin 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306088	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SFXN4 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314503	SFXN4	sideroflexin 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306088	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SFXN4 mRNA	PMID:25181051
1314503	SFXN4	sideroflexin 4	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SFXN4 mRNA	PMID:25979313
1314503	SFXN4	sideroflexin 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of SFXN4 protein	PMID:31945527
1314503	SFXN4	sideroflexin 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306088	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SFXN4 mRNA	PMID:21266533
1314503	SFXN4	sideroflexin 4	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SFXN4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SFXN4 mRNA	PMID:39836092
1314503	SFXN4	sideroflexin 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SFXN4 mRNA	PMID:38568856
1314503	SFXN4	sideroflexin 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SFXN4 mRNA	PMID:35301059
1314503	SFXN4	sideroflexin 4	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306088	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of SFXN4 mRNA	PMID:25539665|PMID:26194646
1314503	SFXN4	sideroflexin 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SFXN4 mRNA	PMID:19320972
1314503	SFXN4	sideroflexin 4	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of SFXN4 mRNA	PMID:17010196
1314503	SFXN4	sideroflexin 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SFXN4 mRNA	PMID:32588087
1314503	SFXN4	sideroflexin 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314504	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SFXN4 mRNA	PMID:40194260
1314503	SFXN4	sideroflexin 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SFXN4 mRNA	PMID:25979313
1314503	SFXN4	sideroflexin 4	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of SFXN4 mRNA	PMID:23179753|PMID:27188386|PMID:29501571
1314503	SFXN4	sideroflexin 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SFXN4 mRNA	PMID:23179753
1314503	SFXN4	sideroflexin 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314504	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of SFXN4 mRNA	PMID:21427059
1314503	SFXN4	sideroflexin 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of SFXN4 gene	PMID:29501571
1314503	SFXN4	sideroflexin 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314504	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SFXN4 mRNA	PMID:28973697
1314503	SFXN4	sideroflexin 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of SFXN4 mRNA	PMID:21420995|PMID:22230336|PMID:25704631|PMID:29067470
1314503	SFXN4	sideroflexin 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306088	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SFXN4 mRNA	PMID:33387578
1314503	SFXN4	sideroflexin 4	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SFXN4 mRNA	PMID:29432896
1314503	SFXN4	sideroflexin 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SFXN4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SFXN4 mRNA	PMID:39836092
1314503	SFXN4	sideroflexin 4	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306088	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SFXN4 mRNA	PMID:29391264
1314503	SFXN4	sideroflexin 4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314504	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SFXN4 mRNA	PMID:17555576
1314503	SFXN4	sideroflexin 4	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1314504	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of SFXN4 mRNA	PMID:40234311
1314503	SFXN4	sideroflexin 4	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314504	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of SFXN4 mRNA	PMID:23608068
1314503	SFXN4	sideroflexin 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of SFXN4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of SFXN4 mRNA	PMID:39836092
1314503	SFXN4	sideroflexin 4	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1314504	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in increased expression of SFXN4 mRNA	PMID:18313992
1314503	SFXN4	sideroflexin 4	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1314504	E	RGD:6480464	20141111	CTD	MESH:D002185	Cannabidiol results in increased expression of SFXN4 mRNA	PMID:21542829
1314503	SFXN4	sideroflexin 4	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of SFXN4 mRNA	PMID:22101062
1314503	SFXN4	sideroflexin 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314504	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SFXN4 mRNA	PMID:22206623
1314503	SFXN4	sideroflexin 4	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1306088	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of SFXN4 mRNA	PMID:21346803
1314503	SFXN4	sideroflexin 4	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314504	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of SFXN4 mRNA	PMID:31388691
1314503	SFXN4	sideroflexin 4	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306088	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of SFXN4 mRNA	PMID:19281266
1314503	SFXN4	sideroflexin 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306088	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SFXN4 mRNA	PMID:21346803
1314503	SFXN4	sideroflexin 4	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SFXN4 mRNA	PMID:38568856
1314503	SFXN4	sideroflexin 4	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019284	Thapsigargin results in decreased expression of SFXN4 mRNA	PMID:19442820
1314503	SFXN4	sideroflexin 4	gene	CHEBI:9516	thapsigargin	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019284	4-methoxycinnamate methyl ester promotes the reaction [Thapsigargin results in decreased expression of SFXN4 mRNA]; caffeic acid promotes the reaction [Thapsigargin results in decreased expression of SFXN4 mRNA]; Drugs, Chinese Herbal promotes the reaction [Thapsigargin results in decreased expression of SFXN4 mRNA]	PMID:19442820
1314503	SFXN4	sideroflexin 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306088	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SFXN4 mRNA	PMID:21346803
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:10110	zidovudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with IFNA1 protein] results in increased expression of MNDA mRNA	PMID:20370541
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of MNDA mRNA	PMID:17218384|PMID:33167477
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PYHIN1 mRNA	PMID:30529165
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314506	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IFI211 mRNA	PMID:39241906
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MNDA mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of MNDA mRNA	PMID:35811015
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFI211 mRNA]	PMID:39241906
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314506	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of IFI211 mRNA	PMID:39298647
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306089	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MNDA mRNA	PMID:32741896
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone promotes the reaction [Biomarkers metabolite binds to MNDA gene]	PMID:31084621
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306089	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of MNDA mRNA	PMID:33387578
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MNDA mRNA	PMID:37042841
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFI211 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFI211 mRNA	PMID:37992649
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306089	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MNDA mRNA	PMID:32741896
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFI211 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFI211 mRNA	PMID:37992649
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PYHIN1 mRNA	PMID:23892564
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306089	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MNDA mRNA	PMID:22061828|PMID:33387578
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MNDA mRNA	PMID:35301059
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306089	E	RGD:6480464	20131220	CTD	MESH:C016517	indole-3-carbinol affects the expression of IFI204 mRNA	PMID:21396975
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314506	E	RGD:6480464	20140826	CTD	MESH:D010126	Ozone results in decreased expression of MNDA mRNA; Ozone results in decreased expression of PYHIN1 mRNA	PMID:16183385|PMID:33026818
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MNDA mRNA	PMID:35430440
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306089	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of IFI204 mRNA	PMID:30779732
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PYHIN1 mRNA	PMID:27339419
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of MNDA protein	PMID:35688186
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFI211 mRNA]	PMID:37992649
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PYHIN1 mRNA	PMID:28960355
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306089	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MNDA mRNA	PMID:31881176
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of MNDA mRNA	PMID:23195993
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of MNDA mRNA	PMID:24768652|PMID:25583101
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PYHIN1 mRNA	PMID:26377647
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306089	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MNDA mRNA	PMID:34747641
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306089	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MNDA mRNA	PMID:33387578
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314506	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MNDA mRNA	PMID:26290441
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1306089	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of IFI204 mRNA	PMID:30556269
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFI211 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFI211 mRNA	PMID:37992649
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFI211 mRNA]	PMID:37992649
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314506	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of IFI211 mRNA	PMID:37682722
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MNDA mRNA	PMID:20064835
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PYHIN1 mRNA	PMID:21569818
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1306089	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of IFI204 mRNA	PMID:30556269
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:D012834	Silver affects the expression of PYHIN1 mRNA	PMID:27131904
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314506	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MNDA mRNA	PMID:29341224
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:30703	tetrathiomolybdate(2-)	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C020809	tetrathiomolybdate results in increased expression of MNDA mRNA	PMID:37290678
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1306089	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of MNDA mRNA	PMID:25729387
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306089	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MNDA mRNA	PMID:25729387
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314506	E	RGD:6480464	20170905	CTD	MESH:C009495	titanium dioxide results in increased expression of IFI211 mRNA; titanium dioxide results in increased expression of PYHIN1 mRNA	PMID:23557971|PMID:27760801
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306089	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MNDA mRNA	PMID:34492290
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1306089	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of IFI204 mRNA	PMID:25380136
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of MNDA mRNA	PMID:12419474
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of MNDA mRNA	PMID:28329830
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306089	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MNDA mRNA	PMID:25181051
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PYHIN1 mRNA	PMID:26377693
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1306089	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of MNDA mRNA	PMID:21241498
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:D016264	Dextran Sulfate results in increased expression of PYHIN1 mRNA	PMID:23894361
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1306089	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MNDA mRNA	PMID:32680482
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFI211 mRNA]	PMID:39241906
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MNDA mRNA	PMID:37042841
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306089	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of IFI204 mRNA	PMID:25380136
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MNDA mRNA	PMID:35301059
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1314506	E	RGD:6480464	20190312	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of IFI211 mRNA	PMID:30711707
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306089	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of IFI204 mRNA	PMID:27387713
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1306089	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of IFI204 mRNA	PMID:25380136
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MNDA mRNA	PMID:24449571
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20140826	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of MNDA mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MNDA mRNA]	PMID:17585979
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:C031763	1,3-butadiene results in decreased expression of PYHIN1 mRNA	PMID:29038090
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:D002737	Chloroprene results in decreased expression of PYHIN1 mRNA	PMID:23125180
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:D013629	Tamoxifen affects the expression of PYHIN1 mRNA	PMID:20937368
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFI211 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IFI211 mRNA	PMID:37992649
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306089	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MNDA mRNA	PMID:33387578
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20140826	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of MNDA mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MNDA mRNA]	PMID:17585979
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of MNDA mRNA	PMID:35811015
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MNDA mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of MNDA mRNA	PMID:35811015
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1314506	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of IFI211 mRNA	PMID:29279043
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:46680	serpentine asbestos	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in decreased expression of MNDA mRNA	PMID:21148743
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1314506	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of MNDA mRNA	PMID:26934552
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of MNDA mRNA	PMID:26833863
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306089	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MNDA mRNA	PMID:29391264
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314506	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of IFI211 mRNA	PMID:35436446
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of PYHIN1 mRNA	PMID:25554681
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314506	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MNDA mRNA	PMID:25620056
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314506	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MNDA mRNA; Nanotubes, Carbon results in increased expression of MNDA mRNA; Nanotubes, Carbon results in increased expression of PYHIN1 mRNA	PMID:25554681
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1306089	E	RGD:6480464	20240806	CTD	MESH:C000499	ferric oxide analog results in increased expression of MNDA mRNA	PMID:38615722
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1314506	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of MNDA mRNA	PMID:26377693
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1314506	E	RGD:6480464	20140826	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of MNDA mRNA	PMID:17982090
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314506	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IFI211 mRNA	PMID:38701926
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:63041	manganese(II) chloride	decreases expression	ISO	RGD:1306089	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in decreased expression of IFI204 mRNA	PMID:28801915
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20140826	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of MNDA mRNA	PMID:21641980
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306089	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MNDA mRNA	PMID:25729387
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1314506	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of IFI211 mRNA	PMID:36907384
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1306089	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of MNDA mRNA	PMID:33484710
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases expression	ISO	RGD:1306089	E	RGD:6480464	20210406	CTD	MESH:C074283	estradiol 3-benzoate results in increased expression of MNDA mRNA	PMID:32741896
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1306089	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MNDA mRNA	PMID:32741896
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314506	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of IFI211 mRNA	PMID:38648751
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1314506	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of MNDA mRNA	PMID:26377693
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:84070	sodium arsenate	affects expression	ISO	RGD:1314506	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate affects the expression of IFI211 mRNA	PMID:39847705
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314506	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of IFI211 mRNA]	PMID:39241906
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1314506	E	RGD:6480464	20240924	CTD	MESH:D012834	Silver affects the expression of PYHIN1 mRNA	PMID:27131904
1314505	MNDA	myeloid cell nuclear differentiation antigen	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314506	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of MNDA mRNA; trovafloxacin results in increased expression of PYHIN1 mRNA	PMID:35537566
1314509	RNF6	ring finger protein 6	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of RNF6 mRNA	PMID:31016361
1314509	RNF6	ring finger protein 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550389	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RNF6 gene	PMID:20938992
1314509	RNF6	ring finger protein 6	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RNF6 mRNA	PMID:26079696
1314509	RNF6	ring finger protein 6	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550389	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RNF6 mRNA	PMID:30319688
1314509	RNF6	ring finger protein 6	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306092	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of RNF6 gene	PMID:27618143
1314509	RNF6	ring finger protein 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550389	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RNF6 gene	PMID:20938992
1314509	RNF6	ring finger protein 6	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of RNF6 intron	PMID:30157460
1314509	RNF6	ring finger protein 6	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RNF6 mRNA	PMID:39836092
1314509	RNF6	ring finger protein 6	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RNF6 mRNA	PMID:27153756
1314509	RNF6	ring finger protein 6	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of RNF6 mRNA	PMID:19774075
1314509	RNF6	ring finger protein 6	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RNF6 mRNA	PMID:21867686
1314509	RNF6	ring finger protein 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550389	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RNF6 gene	PMID:20938992
1314509	RNF6	ring finger protein 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RNF6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RNF6 mRNA	PMID:39836092
1314509	RNF6	ring finger protein 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550389	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RNF6 mRNA	PMID:40504410
1314509	RNF6	ring finger protein 6	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1550389	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of RNF6 protein	PMID:25505154
1314509	RNF6	ring finger protein 6	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RNF6 mRNA	PMID:23557933
1314509	RNF6	ring finger protein 6	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RNF6 mRNA	PMID:28903495
1314509	RNF6	ring finger protein 6	gene	CHEBI:28077	rifampicin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in decreased expression of RNF6 mRNA	PMID:24552687
1314509	RNF6	ring finger protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550389	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF6 mRNA	PMID:21570461
1314509	RNF6	ring finger protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306092	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNF6 mRNA	PMID:33387578
1314509	RNF6	ring finger protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550389	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RNF6 mRNA	PMID:17942748
1314509	RNF6	ring finger protein 6	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RNF6 mRNA	PMID:28001369
1314509	RNF6	ring finger protein 6	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of RNF6 mRNA	PMID:39709020
1314509	RNF6	ring finger protein 6	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RNF6 mRNA	PMID:29803840
1314509	RNF6	ring finger protein 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNF6 mRNA	PMID:38568856
1314509	RNF6	ring finger protein 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550389	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of RNF6 mRNA	PMID:36209798
1314509	RNF6	ring finger protein 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RNF6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RNF6 mRNA	PMID:39836092
1314509	RNF6	ring finger protein 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550389	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RNF6 mRNA	PMID:40504410
1314509	RNF6	ring finger protein 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550389	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RNF6 mRNA	PMID:22228805
1314509	RNF6	ring finger protein 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RNF6 promoter	PMID:27901495
1314509	RNF6	ring finger protein 6	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of RNF6 mRNA; Silicon Dioxide results in increased expression of RNF6 mRNA	PMID:23806026|PMID:25351596
1314509	RNF6	ring finger protein 6	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of RNF6 mRNA	PMID:15761015
1314509	RNF6	ring finger protein 6	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RNF6 gene	PMID:31601247
1314509	RNF6	ring finger protein 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550389	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of RNF6 mRNA	PMID:23557971
1314509	RNF6	ring finger protein 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306092	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RNF6 mRNA	PMID:34492290
1314509	RNF6	ring finger protein 6	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550389	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RNF6 mRNA	PMID:18445702
1314509	RNF6	ring finger protein 6	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1550389	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of RNF6 mRNA	PMID:37894381
1314509	RNF6	ring finger protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306092	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RNF6 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314509	RNF6	ring finger protein 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1550389	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RNF6 promoter	PMID:27312807
1314509	RNF6	ring finger protein 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RNF6 gene	PMID:31601247
1314509	RNF6	ring finger protein 6	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RNF6 intron	PMID:30157460
1314509	RNF6	ring finger protein 6	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1550389	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RNF6 mRNA	PMID:28392331
1314509	RNF6	ring finger protein 6	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306092	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RNF6 mRNA	PMID:21266533
1314509	RNF6	ring finger protein 6	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1550389	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of RNF6 mRNA	PMID:34813904
1314509	RNF6	ring finger protein 6	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1550389	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in decreased expression of RNF6 mRNA	PMID:21371552
1314509	RNF6	ring finger protein 6	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1550389	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of RNF6 mRNA]	PMID:19030233
1314509	RNF6	ring finger protein 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RNF6 mRNA	PMID:37042841
1314509	RNF6	ring finger protein 6	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RNF6 mRNA	PMID:39836092
1314509	RNF6	ring finger protein 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1550389	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RNF6 mRNA	PMID:24982889
1314509	RNF6	ring finger protein 6	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1550389	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RNF6 mRNA	PMID:24982889
1314509	RNF6	ring finger protein 6	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of RNF6 mRNA	PMID:19376846
1314509	RNF6	ring finger protein 6	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RNF6 mRNA	PMID:28302478
1314509	RNF6	ring finger protein 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RNF6 mRNA	PMID:25979313
1314509	RNF6	ring finger protein 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of RNF6 mRNA	PMID:29154799
1314509	RNF6	ring finger protein 6	gene	CHEBI:40036	amitrole	affects expression	ISO	RGD:1306092	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole affects the expression of RNF6 mRNA	PMID:41580965
1314509	RNF6	ring finger protein 6	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306092	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of RNF6 mRNA	PMID:38685447
1314509	RNF6	ring finger protein 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RNF6 mRNA	PMID:20106945|PMID:25562108
1314509	RNF6	ring finger protein 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550389	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RNF6 mRNA	PMID:17562736
1314509	RNF6	ring finger protein 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RNF6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RNF6 mRNA	PMID:39836092
1314509	RNF6	ring finger protein 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550389	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RNF6 mRNA	PMID:40504410
1314509	RNF6	ring finger protein 6	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RNF6 mRNA	PMID:22079256
1314509	RNF6	ring finger protein 6	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1550389	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RNF6 mRNA	PMID:17555576
1314509	RNF6	ring finger protein 6	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550389	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RNF6 mRNA	PMID:17942748
1314509	RNF6	ring finger protein 6	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550389	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RNF6 mRNA	PMID:17942748
1314509	RNF6	ring finger protein 6	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of RNF6 mRNA	PMID:15761015
1314509	RNF6	ring finger protein 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550389	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RNF6 mRNA	PMID:25554681
1314509	RNF6	ring finger protein 6	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306092	E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of RNF6 mRNA	PMID:38685447|PMID:41580965
1314509	RNF6	ring finger protein 6	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1306092	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of RNF6 mRNA	PMID:21983209
1314509	RNF6	ring finger protein 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of RNF6 mRNA	PMID:39836092
1314509	RNF6	ring finger protein 6	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1550389	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RNF6 mRNA	PMID:26378955
1314509	RNF6	ring finger protein 6	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1550389	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RNF6 mRNA	PMID:23650126
1314509	RNF6	ring finger protein 6	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1306092	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of RNF6 mRNA	PMID:30467583
1314509	RNF6	ring finger protein 6	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RNF6 intron	PMID:30157460
1314509	RNF6	ring finger protein 6	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550389	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RNF6 mRNA	PMID:22206623
1314509	RNF6	ring finger protein 6	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1306092	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of RNF6 mRNA	PMID:27840820
1314509	RNF6	ring finger protein 6	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RNF6 mRNA	PMID:22079256
1314509	RNF6	ring finger protein 6	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RNF6 mRNA	PMID:22079256
1314509	RNF6	ring finger protein 6	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550389	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of RNF6 mRNA	PMID:23091169
1314509	RNF6	ring finger protein 6	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of RNF6 mRNA	PMID:26079696
1314509	RNF6	ring finger protein 6	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1550389	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of RNF6 mRNA	PMID:21278054
1314509	RNF6	ring finger protein 6	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306092	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RNF6 mRNA	PMID:19281266
1314509	RNF6	ring finger protein 6	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RNF6 mRNA	PMID:38568856
1314509	RNF6	ring finger protein 6	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550389	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of RNF6 mRNA	PMID:28973697
1314509	RNF6	ring finger protein 6	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1550389	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of RNF6 mRNA	PMID:18930950
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ZNF397 mRNA	PMID:33167477
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1621521	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ZFP397 mRNA	PMID:39298647
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ZNF397 mRNA	PMID:30165855
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1621521	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP397 mRNA	PMID:25510870
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:6504280	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP397 mRNA	PMID:33387578
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1621521	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP397 mRNA	PMID:25510870
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1621521	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP397 mRNA	PMID:25510870
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZNF397 mRNA	PMID:19549813
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1621521	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZFP397 mRNA	PMID:25629700
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ZNF397 mRNA	PMID:26272509
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF397 mRNA	PMID:27188386
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ZNF397 mRNA	PMID:23557933
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621521	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP397 mRNA	PMID:21570461
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ZNF397 mRNA	PMID:28001369
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF397 mRNA	PMID:29803840
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF397 mRNA	PMID:38568856
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZNF397 mRNA	PMID:20064835
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1621521	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of ZFP397 mRNA	PMID:27131904
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:C015358	methylparaben results in increased expression of ZNF397 mRNA	PMID:17121429
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:32588	potassium chloride	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D011189	[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of ZNF397 mRNA	PMID:29691375
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:6504280	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP397 mRNA	PMID:30816183
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:6504280	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP397 mRNA	PMID:41034487
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF397 mRNA	PMID:28628672
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1621521	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP397 mRNA	PMID:25510870
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1621521	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP397 mRNA	PMID:25510870
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZNF397 mRNA	PMID:28628672
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF397 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZNF397 mRNA	PMID:28628672
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF397 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF397 mRNA	PMID:27188386
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF397 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZNF397 mRNA	PMID:28628672
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of ZNF397 mRNA	PMID:24935251|PMID:26272509
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ZNF397 mRNA	PMID:24935251
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF397 mRNA	PMID:27188386
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF397 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of ZNF397 mRNA	PMID:28628672
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of ZNF397 mRNA	PMID:27188386
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1621521	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of ZFP397 mRNA	PMID:27462272
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF397 protein	PMID:31285264
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF397 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF397 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF397 mRNA	PMID:27188386
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF397 gene]	PMID:28238834
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:88542	Butylparaben	increases expression	EXP		E	RGD:6480464	20200407	CTD	MESH:C038091	butylparaben results in increased expression of ZNF397 mRNA	PMID:17121429
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF397 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF397 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF397 mRNA	PMID:27188386
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1621521	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of ZFP397 mRNA	PMID:27131904
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ZNF397 mRNA	PMID:38568856
1314512	ZNF397	zinc finger protein 397	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1621521	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ZNF397 mRNA	PMID:28973697
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:15379	dioxygen	affects methylation	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:D010100	Oxygen deficiency affects the methylation of DOP1B promoter	PMID:24205000
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of DOP1B mRNA	PMID:24205000
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314516	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DOP1B mRNA	PMID:30529165
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:D000431	Ethanol results in increased expression of DOP1B mRNA	PMID:19167417
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DOP1B mRNA	PMID:21179406
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of DOP1B mRNA	PMID:19167446
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306097	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of DOPEY2 mRNA	PMID:32145629
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314516	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DOP1B mRNA	PMID:39298647
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of DOP1B mRNA	PMID:30165855
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314516	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DOP1B mRNA	PMID:37992649
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314516	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DOP1B mRNA	PMID:37992649
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DOPEY2 mRNA	PMID:31163220
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of DOP1B protein	PMID:37730182
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of DOP1B mRNA	PMID:28818685
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of DOP1B intron	PMID:30157460
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314516	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DOPEY2 mRNA	PMID:36331819
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DOP1B mRNA	PMID:39836092
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314516	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DOP1B mRNA	PMID:37236586
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DOP1B mRNA	PMID:19549813
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of DOP1B intron	PMID:30157460
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DOP1B mRNA	PMID:23649840
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314516	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of DOPEY2 mRNA	PMID:27106289
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DOP1B mRNA	PMID:39836092
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of DOP1B protein	PMID:35688186
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314516	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of DOPEY2 mRNA	PMID:28960355
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of DOP1B mRNA	PMID:27392435|PMID:27594783
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306097	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DOP1B mRNA	PMID:34747641
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DOP1B mRNA	PMID:19770486
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DOPEY2 mRNA	PMID:30851411
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314516	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DOP1B mRNA	PMID:37992649
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314516	E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite results in decreased expression of DOP1B mRNA	PMID:35202923
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314516	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of DOP1B mRNA	PMID:36209798
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DOP1B mRNA	PMID:39836092
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314516	E	RGD:6480464	20240430	CTD	MESH:C017947	salvin inhibits the reaction [sodium arsenite results in decreased expression of DOP1B mRNA]	PMID:35202923
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DOP1B mRNA	PMID:20064835
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DOP1B mRNA	PMID:19770486
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DOPEY2 5' UTR	PMID:27901495
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of DOP1B gene	PMID:25435355
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:29866	arsenite(3-)	decreases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased methylation of DOP1B promoter	PMID:23974009
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to DOP1B mRNA]	PMID:32406909
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DOP1B mRNA	PMID:20382639
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:C006253	pirinixic acid results in increased expression of DOP1B mRNA	PMID:18301758
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DOP1B mRNA	PMID:19710929
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:C074702	chromium hexavalent ion affects the expression of DOP1B mRNA	PMID:28472532
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of DOP1B protein	PMID:31675489
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306097	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of DOP1B mRNA; bisphenol A results in decreased expression of DOPEY2 mRNA	PMID:30816183|PMID:32145629
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306097	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DOP1B mRNA	PMID:25181051
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306097	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DOP1B gene	PMID:28505145
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DOP1B protein	PMID:31675489
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314516	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of DOP1B mRNA; bisphenol S results in decreased expression of DOPEY2 mRNA	PMID:33297965|PMID:39298647
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314516	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of DOP1B mRNA	PMID:40203079
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of DOP1B intron	PMID:30157460
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314516	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DOP1B intron	PMID:28392331
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306097	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DOP1B mRNA	PMID:21266533
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DOP1B mRNA	PMID:37042841
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of DOP1B mRNA	PMID:29024780
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DOP1B mRNA	PMID:39836092
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DOP1B mRNA	PMID:38174414
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314516	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DOP1B mRNA	PMID:37236586
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of DOP1B mRNA	PMID:28903501
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of DOP1B mRNA	PMID:19167446
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1314516	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of DOP1B mRNA	PMID:39529242
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DOP1B mRNA	PMID:40419075
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314516	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DOPEY2 mRNA	PMID:36331819
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DOP1B mRNA	PMID:25979313
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:D014635	Valproic Acid affects the expression of DOP1B mRNA	PMID:17963808
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DOP1B mRNA	PMID:25562108
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314516	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DOP1B mRNA	PMID:37992649
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DOP1B mRNA	PMID:38832940
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of DOP1B mRNA	PMID:22230336|PMID:29067470
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314516	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of DOP1B mRNA	PMID:29279043
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DOP1B mRNA	PMID:39836092
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DOP1B mRNA	PMID:22079256
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314516	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of DOP1B mRNA	PMID:35436446
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DOP1B mRNA; Nanotubes, Carbon results in decreased expression of DOP1B mRNA	PMID:25554681
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DOP1B mRNA	PMID:25620056
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of DOP1B mRNA	PMID:23608068
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of DOP1B mRNA	PMID:20436886
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of DOP1B mRNA	PMID:39836092
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of DOP1B mRNA	PMID:23650126
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:65585	carnosic acid	multiple interactions	ISO	RGD:1314516	E	RGD:6480464	20240430	CTD	MESH:C018381	salvin inhibits the reaction [sodium arsenite results in decreased expression of DOP1B mRNA]	PMID:35202923
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of DOP1B intron	PMID:30157460
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of DOP1B mRNA	PMID:31758290
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314516	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DOPEY2 mRNA	PMID:22206623
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DOP1B mRNA	PMID:22079256
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DOP1B mRNA	PMID:22079256
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DOPEY2 mRNA	PMID:30851411
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DOPEY2 gene]	PMID:28238834
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DOP1B protein	PMID:31675489
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1306097	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DOP1B mRNA	PMID:27291303
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of DOP1B protein	PMID:31675489
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314516	E	RGD:6480464	20181113	CTD	MESH:C045950	propiconazole results in increased expression of DOP1B mRNA	PMID:21278054
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306097	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DOP1B mRNA	PMID:21346803
1314515	DOP1B	DOP1 leucine zipper like protein B	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306097	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of DOP1B mRNA	PMID:23034163
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314519	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ITIH1 mRNA	PMID:33045310
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314519	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ITIH1 mRNA	PMID:37995155
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:134926	drometrizole	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C033674	benazol P affects the expression of ITIH1 mRNA	PMID:36586167
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ITIH1 mRNA	PMID:20188158
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314519	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ITIH1 mRNA	PMID:36331819
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:16170	mercury(0)	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D008628	Mercury affects the expression of ITIH1 protein	PMID:22030286
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ITIH1 mRNA	PMID:21632981
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:16336	hyaluronic acid	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D006820	TNFAIP6 protein promotes the reaction [ITIH1 protein binds to Hyaluronic Acid]	PMID:25561734
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314519	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ITIH1 mRNA	PMID:39298647
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306099	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ITIH1 mRNA	PMID:33387578
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314519	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ITIH1 mRNA	PMID:37992649
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of ITIH1 mRNA	PMID:22401849
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314519	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ITIH1 mRNA	PMID:37992649
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ITIH1 mRNA	PMID:28818685
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ITIH1 intron	PMID:30157460
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314519	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ITIH1 mRNA	PMID:36331819
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese promotes the reaction [ITIH1 protein binds to TNFAIP6 protein]	PMID:16768462
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:22977	cadmium atom	affects binding	EXP		E	RGD:6480464	20150512	CTD	MESH:D002104	ITIH1 protein binds to Cadmium	PMID:23896426
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:22984	calcium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium promotes the reaction [ITIH1 protein binds to TNFAIP6 protein]	PMID:16768462
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1314519	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ITIH1 protein]	PMID:32272095
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ITIH1 mRNA	PMID:19549813
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ITIH1 protein	PMID:20106945
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ITIH1 mRNA	PMID:27153756|PMID:30157460
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ITIH1 mRNA	PMID:19770486
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ITIH1 gene; Aflatoxin B1 results in decreased methylation of ITIH1 intron	PMID:27153756|PMID:30157460
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:25107	magnesium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008274	Magnesium promotes the reaction [ITIH1 protein binds to TNFAIP6 protein]	PMID:16768462
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:25195	mercury atom	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D008628	Mercury affects the expression of ITIH1 protein	PMID:22030286
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306099	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ITIH1 mRNA	PMID:30779732
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:27363	zinc atom	affects binding	EXP		E	RGD:6480464	20150512	CTD	MESH:D015032	ITIH1 protein binds to Zinc	PMID:23896426
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306099	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ITIH1 mRNA	PMID:31150632
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306099	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ITIH1 mRNA	PMID:31881176
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:28112	nickel atom	affects binding	EXP		E	RGD:6480464	20150512	CTD	MESH:D009532	ITIH1 protein binds to Nickel	PMID:23896426
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ITIH1 mRNA	PMID:21632981|PMID:26238291
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306099	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ITIH1 mRNA	PMID:28959563
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:28694	copper atom	affects binding	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	ITIH1 protein binds to Copper	PMID:23896426
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314519	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ITIH1 protein	PMID:28918527
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314519	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ITIH1 mRNA	PMID:37992649
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:29320	calcium(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium promotes the reaction [ITIH1 protein binds to TNFAIP6 protein]	PMID:16768462
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of ITIH1 mRNA	PMID:29301061
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ITIH1 mRNA	PMID:37682722
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ITIH1 promoter	PMID:27901495
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ITIH1 mRNA	PMID:26238291|PMID:32234424
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ITIH1 mRNA	PMID:19770486
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ITIH1 exon	PMID:27901495
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:30052	copper(0)	affects binding	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	ITIH1 protein binds to Copper	PMID:23896426
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:30185	zinc(0)	affects binding	EXP		E	RGD:6480464	20150512	CTD	MESH:D015032	ITIH1 protein binds to Zinc	PMID:23896426
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1306099	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ITIH1 mRNA	PMID:22431001
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314519	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ITIH1 mRNA	PMID:29341224
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ITIH1 mRNA	PMID:20458559
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ITIH1 gene	PMID:31601247
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ITIH1 gene	PMID:31601247
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1306099	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of ITIH1 mRNA	PMID:30012374
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306099	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ITIH1 mRNA	PMID:34492290
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1306099	E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ITIH1 mRNA	PMID:28943392
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of ITIH1 mRNA	PMID:16221962|PMID:20813756|PMID:23811191
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314519	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in decreased expression of ITIH1 mRNA	PMID:20813756
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:3312	calcium dichloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002122	Calcium Chloride promotes the reaction [ITIH1 protein binds to TNFAIP6 protein]	PMID:16768462
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306099	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ITIH1 mRNA	PMID:25181051|PMID:30903817
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ITIH1 gene	PMID:31601247
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314519	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in increased expression of ITIH1 mRNA	PMID:30245210
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:3423	carmustine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of ITIH1 mRNA	PMID:15980968
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ITIH1 mRNA	PMID:39298647
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of ITIH1 gene	PMID:31601247
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1314519	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ITIH1 protein	PMID:32272095
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314519	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ITIH1 protein]	PMID:32272095
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314519	E	RGD:6480464	20220607	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ITIH1 protein	PMID:34864091
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ITIH1 mRNA	PMID:34813904
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ITIH1 mRNA	PMID:28628672
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306099	E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ITIH1 mRNA	PMID:28943392
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:35033	triphenyl phosphate	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C005445	triphenyl phosphate results in increased expression of ITIH1 mRNA	PMID:28934090
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese promotes the reaction [ITIH1 protein binds to TNFAIP6 protein]	PMID:16768462
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:35260	1-benzofuran	affects expression	ISO	RGD:1314519	E	RGD:6480464	20121113	CTD	MESH:C105430	benzofuran affects the expression of ITIH1 mRNA	PMID:17114358
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ITIH1 mRNA	PMID:38382870
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1306099	E	RGD:6480464	20130806	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ITIH1 promoter	PMID:22457795
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1306099	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of ITIH1 mRNA	PMID:25539665
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306099	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ITIH1 mRNA	PMID:24386269
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of ITIH1 mRNA	PMID:28962523
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:37397	chondroitin sulfate	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D002809	TNFAIP6 protein promotes the reaction [ITIH1 protein binds to Chondroitin Sulfates]	PMID:25561734
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ITIH1 mRNA	PMID:17585979
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1314519	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ITIH1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ITIH1 mRNA]	PMID:17585979
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:1306099	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of ITIH1 mRNA	PMID:27638505
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:38221	fumonisin B1	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 results in decreased expression of ITIH1 mRNA	PMID:16221962
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314519	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ITIH1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ITIH1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ITIH1 mRNA	PMID:36331819
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1306099	E	RGD:6480464	20130806	CTD	MESH:C016104	sodium bichromate affects the expression of ITIH1 mRNA	PMID:22110744
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ITIH1 mRNA	PMID:25979313
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ITIH1 mRNA	PMID:29154799
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1306099	E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in increased expression of ITIH1 mRNA	PMID:35594946
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ITIH1 mRNA	PMID:20106945|PMID:25562108
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ITIH1 mRNA	PMID:28628672
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314519	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of ITIH1 mRNA	PMID:37992649
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1306099	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of ITIH1 mRNA	PMID:24136188
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ITIH1 mRNA	PMID:38832940
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ITIH1 mRNA	PMID:29067470
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314519	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ITIH1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ITIH1 mRNA]	PMID:17585979
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:46727	quartz	increases expression	ISO	RGD:1306099	E	RGD:6480464	20130806	CTD	MESH:D011791	Quartz results in increased expression of ITIH1 mRNA	PMID:19836432
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306099	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ITIH1 mRNA	PMID:29391264
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in decreased expression of ITIH1 mRNA	PMID:22334560
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ITIH1 mRNA	PMID:32234424
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ITIH1 mRNA	PMID:28628672
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ITIH1 mRNA	PMID:20458559
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1306099	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ITIH1 mRNA	PMID:19836432
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314519	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ITIH1 mRNA	PMID:25554681
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:50594	carbon nanotube	increases secretion	ISO	RGD:1314519	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased secretion of ITIH1 protein	PMID:25598225
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306099	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ITIH1 mRNA	PMID:24136188
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:53003	naphthalene-1,5-diamine	affects expression	ISO	RGD:1314519	E	RGD:6480464	20121113	CTD	MESH:C034086	1,5-naphthalenediamine affects the expression of ITIH1 mRNA	PMID:17114358
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride promotes the reaction [ITIH1 protein binds to TNFAIP6 protein]	PMID:16768462
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:6636	magnesium dichloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015636	Magnesium Chloride promotes the reaction [ITIH1 protein binds to TNFAIP6 protein]	PMID:16768462
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1306099	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ITIH1 mRNA	PMID:24136188
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of ITIH1 mRNA	PMID:35486664
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1306099	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of ITIH1 mRNA	PMID:33484710
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ITIH1 gene]	PMID:28238834
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1306099	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of ITIH1 mRNA	PMID:32109520
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314519	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of ITIH1 mRNA	PMID:38648751
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in decreased expression of ITIH1 mRNA	PMID:22334560
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of ITIH1 mRNA	PMID:32234424
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1306099	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ITIH1 mRNA	PMID:23914054
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1314519	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in decreased expression of ITIH1 mRNA	PMID:21278054|PMID:22334560
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306099	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ITIH1 mRNA	PMID:21346803
1314518	ITIH1	inter-alpha-trypsin inhibitor heavy chain 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306099	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ITIH1 mRNA	PMID:21346803
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of COMMD4 mRNA	PMID:38218311
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314526	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of COMMD4 mRNA	PMID:37995155
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of COMMD4 mRNA	PMID:24763279
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of COMMD4 mRNA	PMID:38568856
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COMMD4 mRNA	PMID:37042841
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of COMMD4 protein	PMID:31163220
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314526	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of COMMD4 mRNA	PMID:33754040
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of COMMD4 mRNA	PMID:28818685
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314526	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COMMD4 mRNA	PMID:37236586
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COMMD4 mRNA	PMID:19549813
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1314526	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of COMMD4 gene	PMID:27776689
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314526	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COMMD4 mRNA	PMID:22206623
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COMMD4 mRNA	PMID:40512198
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of COMMD4 mRNA	PMID:19244175
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of COMMD4 mRNA	PMID:27594783
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314526	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COMMD4 mRNA	PMID:21570461
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306104	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COMMD4 mRNA	PMID:21215274
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1306104	E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of COMMD4 mRNA]	PMID:21215274
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of COMMD4 mRNA	PMID:28001369
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of COMMD4 mRNA	PMID:30851411
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of COMMD4 mRNA	PMID:34032870
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COMMD4 mRNA	PMID:40512198
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1314526	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of COMMD4 protein	PMID:37955338
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to COMMD4 mRNA]	PMID:32406909
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of COMMD4 mRNA	PMID:38479592
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of COMMD4 mRNA	PMID:30903817
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306104	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of COMMD4 mRNA	PMID:25181051
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306104	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of COMMD4 mRNA	PMID:32145629
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306104	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of COMMD4 mRNA	PMID:34947998
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314526	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of COMMD4 mRNA	PMID:33221593
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of COMMD4 protein	PMID:31675489
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1306104	E	RGD:6480464	20180116	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of COMMD4 mRNA	PMID:28970181
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314526	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of COMMD4 mRNA	PMID:26377693
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1314526	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of COMMD4 mRNA	PMID:28392331
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314526	E	RGD:6480464	20190312	CTD	MESH:D004390	Chlorpyrifos results in increased expression of COMMD4 mRNA	PMID:27737797|PMID:37019170
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314526	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COMMD4 mRNA	PMID:37236586
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of COMMD4 mRNA	PMID:19320972|PMID:19376846
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of COMMD4 mRNA	PMID:19244175
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314526	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of COMMD4 mRNA	PMID:17585979
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of COMMD4 mRNA	PMID:31533062
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of COMMD4 mRNA	PMID:19167446
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314526	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of COMMD4 mRNA	PMID:17963808
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of COMMD4 mRNA	PMID:25562108
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:4042	cypermethrin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C017160	cypermethrin results in increased expression of COMMD4 mRNA	PMID:27704156
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of COMMD4 mRNA	PMID:27188386
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306104	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COMMD4 mRNA	PMID:33387578
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of COMMD4 mRNA	PMID:40512198
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of COMMD4 mRNA	PMID:31675489
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314526	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of COMMD4 mRNA	PMID:35436446
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in decreased expression of COMMD4 mRNA	PMID:17211630
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314526	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of COMMD4 mRNA	PMID:35964746
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of COMMD4 protein	PMID:32959892
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:6382	Lasiocarpine	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in increased expression of COMMD4 mRNA	PMID:40054833
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314526	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COMMD4 mRNA	PMID:22206623
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of COMMD4 protein	PMID:31285264
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of COMMD4 mRNA	PMID:30851411
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of COMMD4 protein	PMID:31675489
1314525	COMMD4	COMM domain containing 4	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of COMMD4 protein	PMID:31675489
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C014638	beta-lapachone results in decreased expression of ENTREP3 mRNA	PMID:38218311
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314530	E	RGD:6480464	20221004	CTD	MESH:C084079	triptonide results in decreased expression of ENTREP3 mRNA	PMID:33045310
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314530	E	RGD:6480464	20260707	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ENTREP3 mRNA	PMID:37995155
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases methylation	ISO	RGD:1314530	E	RGD:6480464	20221004	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased methylation of ENTREP3 promoter	PMID:26251327
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314530	E	RGD:6480464	20221004	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ENTREP3 mRNA	PMID:26251327
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ENTREP3 mRNA	PMID:33167477
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314530	E	RGD:6480464	20221004	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ENTREP3 mRNA	PMID:30529165
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314530	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ENTREP3 mRNA	PMID:39241906
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306107	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ENTREP3 mRNA	PMID:33387578
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ENTREP3 mRNA	PMID:37042841
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314530	E	RGD:6480464	20260707	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ENTREP3 mRNA	PMID:34319233
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ENTREP3 protein	PMID:37730182
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306107	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ENTREP3 mRNA	PMID:33387578
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306107	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of ENTREP3 mRNA	PMID:21396975
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ENTREP3 mRNA	PMID:23649840
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306107	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ENTREP3 mRNA	PMID:30779732
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314530	E	RGD:6480464	20221004	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ENTREP3 mRNA	PMID:22206623
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314530	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ENTREP3 mRNA	PMID:40504410
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ENTREP3 mRNA	PMID:23557933
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of ENTREP3 mRNA	PMID:19921347
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ENTREP3 mRNA	PMID:27392435
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of ENTREP3 promoter	PMID:22847954
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306107	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ENTREP3 mRNA	PMID:32109520
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ENTREP3 mRNA	PMID:32763439
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ENTREP3 mRNA	PMID:20971185
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C017947	sodium arsenite results in decreased expression of ENTREP3 mRNA	PMID:38568856
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314530	E	RGD:6480464	20260707	CTD	MESH:C017947	sodium arsenite results in decreased expression of ENTREP3 mRNA	PMID:37682722
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314530	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ENTREP3 mRNA	PMID:40504410
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314530	E	RGD:6480464	20221004	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ENTREP3 mRNA	PMID:22228805
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ENTREP3 promoter	PMID:27901495
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ENTREP3 mRNA	PMID:20971185
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306107	E	RGD:6480464	20161213	CTD	MESH:C030110	[Oxaliplatin co-treated with Topotecan] results in increased expression of ENTREP3 mRNA	PMID:25729387
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314530	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ENTREP3 gene	PMID:35295148
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306107	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ENTREP3 mRNA	PMID:34492290
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314530	E	RGD:6480464	20221004	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of ENTREP3 mRNA	PMID:28329830
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306107	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ENTREP3 mRNA	PMID:25181051
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306107	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ENTREP3 mRNA	PMID:30816183|PMID:34947998
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ENTREP3 gene	PMID:31601247
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314530	E	RGD:6480464	20221004	CTD	MESH:C543008	bisphenol S results in decreased methylation of ENTREP3 exon	PMID:33297965
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314530	E	RGD:6480464	20221004	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of ENTREP3 mRNA	PMID:26377693
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314530	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ENTREP3 mRNA	PMID:38685157
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314530	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ENTREP3 enhancer; butylbenzyl phthalate results in decreased methylation of ENTREP3 intron	PMID:28392331
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of ENTREP3 gene	PMID:22964155
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306107	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ENTREP3 mRNA	PMID:21266533
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ENTREP3 mRNA	PMID:38174414|PMID:38568856
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306107	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ENTREP3 mRNA	PMID:21297351
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1306107	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of ENTREP3 promoter	PMID:22457795
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ENTREP3 mRNA	PMID:19320972
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306107	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ENTREP3 mRNA	PMID:24386269
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ENTREP3 mRNA	PMID:28302478
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of ENTREP3 promoter	PMID:22847954
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of ENTREP3 promoter	PMID:22847954
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314530	E	RGD:6480464	20221004	CTD	MESH:C031763	1,3-butadiene results in decreased expression of ENTREP3 mRNA	PMID:29038090
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ENTREP3 mRNA	PMID:21420995|PMID:26690555
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306107	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ENTREP3 mRNA	PMID:33387578
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	ENTREP3 protein affects the susceptibility to Fluorouracil	PMID:16217747
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314530	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ENTREP3 mRNA	PMID:40504410
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of ENTREP3 mRNA	PMID:40706910
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314530	E	RGD:6480464	20221004	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ENTREP3 mRNA	PMID:25554681
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1306107	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of ENTREP3 mRNA	PMID:23962444
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306107	E	RGD:6480464	20160315	CTD	MESH:D019772	[Oxaliplatin co-treated with Topotecan] results in increased expression of ENTREP3 mRNA	PMID:25729387
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314530	E	RGD:6480464	20221004	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ENTREP3 mRNA	PMID:22206623
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1306107	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of ENTREP3 mRNA	PMID:26720608
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D013893	Thiram results in decreased expression of ENTREP3 mRNA	PMID:38568856
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314530	E	RGD:6480464	20260707	CTD	MESH:C080163	trovafloxacin results in increased expression of ENTREP3 mRNA	PMID:35537566
1314529	ENTREP3	endosomal transmembrane epsin interactor 3	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306107	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ENTREP3 mRNA	PMID:23034163
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:10101	zalcitabine	multiple interactions	ISO	RGD:1306109	E	RGD:6480464	20120412	CTD	MESH:D016047	[gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in decreased expression of SLC35G2 mRNA	PMID:18606552
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SLC35G2 mRNA	PMID:38218311
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306109	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of SLC35G2 mRNA	PMID:21551480
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SLC35G2 mRNA	PMID:26272509
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA	PMID:27188386
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1618936	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SLC35G2 mRNA	PMID:33045310
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1618936	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of SLC35G2 mRNA	PMID:37995155
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SLC35G2 mRNA	PMID:33167477
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SLC35G2 mRNA	PMID:20044591
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of SLC35G2 mRNA	PMID:21632981
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1618936	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SLC35G2 mRNA	PMID:39298647
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306109	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC35G2 mRNA	PMID:33387578
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SLC35G2 mRNA	PMID:37042841
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SLC35G2 mRNA	PMID:21179406
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of SLC35G2 protein	PMID:37730182
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SLC35G2 mRNA	PMID:19549813
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SLC35G2 mRNA	PMID:21641981|PMID:27153756
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306109	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of SLC35G2 mRNA	PMID:30779732
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SLC35G2 mRNA	PMID:26272509
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA	PMID:27188386
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SLC35G2 protein	PMID:35688186
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC35G2 mRNA	PMID:23557933
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SLC35G2 mRNA	PMID:28903495
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC35G2 mRNA	PMID:26238291
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306109	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC35G2 mRNA	PMID:32109520
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SLC35G2 mRNA	PMID:28001369
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC35G2 mRNA	PMID:33212167
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of SLC35G2 mRNA	PMID:26272509
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA	PMID:27188386
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of SLC35G2 mRNA	PMID:20971185
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of SLC35G2 protein	PMID:35688186
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC35G2 mRNA	PMID:21281968|PMID:38568856
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC35G2 promoter	PMID:27901495
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SLC35G2 5' UTR	PMID:27901495
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC35G2 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1618936	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC35G2 mRNA	PMID:27858113
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of SLC35G2 mRNA	PMID:20971185
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SLC35G2 mRNA	PMID:25895662
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SLC35G2 mRNA	PMID:19150397
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1618936	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC35G2 gene	PMID:35295148
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306109	E	RGD:6480464	20160210	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC35G2 mRNA	PMID:25181051
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SLC35G2 mRNA	PMID:25979313
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1618936	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC35G2 mRNA	PMID:27858113
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1618936	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SLC35G2 intron	PMID:28392331
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306109	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLC35G2 mRNA	PMID:33453195
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SLC35G2 mRNA	PMID:40419075
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLC35G2 mRNA	PMID:25979313
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC35G2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA	PMID:27188386
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D016572	Cyclosporine results in increased expression of SLC35G2 mRNA	PMID:20106945|PMID:25562108
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C012589	trichostatin A results in increased expression of SLC35G2 mRNA	PMID:24935251
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of SLC35G2 mRNA	PMID:31838189
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SLC35G2 mRNA	PMID:38568856
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of SLC35G2 mRNA	PMID:26272509
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA	PMID:27188386
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1618936	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC35G2 mRNA	PMID:27858113
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1618936	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC35G2 mRNA	PMID:27858113
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	SLC35G2 protein affects the susceptibility to Topotecan	PMID:16217747
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SLC35G2 mRNA	PMID:28988120
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of SLC35G2 mRNA	PMID:15336504
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA	PMID:27188386
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA	PMID:27188386
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C089595	cylindrospermopsin results in increased expression of SLC35G2 mRNA	PMID:24921660
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35G2 mRNA	PMID:27188386
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306109	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of SLC35G2 mRNA	PMID:19281266
1314532	SLC35G2	solute carrier family 35 member G2	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D019284	Thapsigargin results in increased expression of SLC35G2 mRNA	PMID:29453283
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of COX7A2L mRNA	PMID:25812627
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of COX7A2L mRNA	PMID:31059760
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX7A2L mRNA	PMID:31059760
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of COX7A2L mRNA	PMID:17266178
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of COX7A2L mRNA	PMID:33359661
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:17578	toluene	affects expression	ISO	RGD:1306111	E	RGD:6480464	20130115	CTD	MESH:D014050	Toluene affects the expression of COX7A2L mRNA	PMID:21827849
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1557452	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of COX7A2L mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of COX7A2L mRNA]	PMID:20230807
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1557452	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of COX7A2L mRNA	PMID:33754040
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1557452	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of COX7A2L mRNA	PMID:20230807
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1557452	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of COX7A2L mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of COX7A2L mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of COX7A2L mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of COX7A2L mRNA]	PMID:20230807
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1557452	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of COX7A2L mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of COX7A2L mRNA]	PMID:20230807
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1557452	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COX7A2L mRNA	PMID:37325564
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COX7A2L mRNA	PMID:19549813
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1306111	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of COX7A2L mRNA	PMID:31129395
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of COX7A2L mRNA	PMID:22171008
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1557452	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of COX7A2L mRNA	PMID:40504410
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1557452	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of COX7A2L mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of COX7A2L mRNA]	PMID:20230807
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of COX7A2L protein	PMID:20884965
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of COX7A2L mRNA	PMID:17266178
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	ESR2 promotes the reaction [Genistein results in decreased expression of COX7A2L protein]	PMID:20884965
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557452	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COX7A2L mRNA	PMID:21570461
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of COX7A2L mRNA	PMID:23152189
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306111	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of COX7A2L mRNA	PMID:33387578
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1557452	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of COX7A2L mRNA	PMID:17942748
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:28197	daidzein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004742	daidzein results in increased expression of COX7A2L mRNA	PMID:17266178
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of COX7A2L protein	PMID:39603559
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1557452	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of COX7A2L mRNA	PMID:17702527
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1557452	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of COX7A2L protein	PMID:28918527
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of COX7A2L mRNA	PMID:29803840
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of COX7A2L mRNA	PMID:38568856
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1557452	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of COX7A2L mRNA	PMID:40504410
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to COX7A2L mRNA]	PMID:32406909
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of COX7A2L mRNA	PMID:22171008
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1557452	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of COX7A2L mRNA	PMID:39716349
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1306111	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of COX7A2L mRNA	PMID:24136188
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1557452	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of COX7A2L mRNA	PMID:23557971
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557452	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of COX7A2L mRNA	PMID:16221962
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306111	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of COX7A2L mRNA	PMID:34947998
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1557452	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of COX7A2L mRNA	PMID:33221593
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of COX7A2L protein	PMID:37567409
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306111	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of COX7A2L mRNA	PMID:25181051
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1557452	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of COX7A2L mRNA	PMID:32156529
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306111	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of COX7A2L mRNA; [bisphenol A co-treated with tributyltin] results in increased expression of COX7A2L mRNA	PMID:31129395|PMID:36041667
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1557452	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of COX7A2L mRNA	PMID:39298647|PMID:40203079
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306111	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of COX7A2L mRNA	PMID:36041667
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1557452	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of COX7A2L mRNA	PMID:38685157
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306111	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of COX7A2L mRNA	PMID:36041667
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1557452	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of COX7A2L mRNA	PMID:28392331
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1557452	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of COX7A2L mRNA	PMID:37019170
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1557452	E	RGD:6480464	20130514	CTD	MESH:D010269	[Paraquat co-treated with Maneb] results in decreased expression of COX7A2L mRNA	PMID:18386188
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306111	E	RGD:6480464	20171010	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of COX7A2L mRNA	PMID:28659758
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1557452	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of COX7A2L mRNA	PMID:37325564
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1557452	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of COX7A2L mRNA	PMID:40194260
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of COX7A2L mRNA	PMID:28302478
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of COX7A2L mRNA	PMID:26352163
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of COX7A2L mRNA	PMID:25812627
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1557452	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in increased expression of COX7A2L mRNA	PMID:19136453
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of COX7A2L mRNA	PMID:25562108
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1557452	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of COX7A2L mRNA	PMID:17555576
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of COX7A2L mRNA	PMID:25704631
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of COX7A2L mRNA	PMID:31059760
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of COX7A2L mRNA	PMID:29523930
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1557452	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of COX7A2L mRNA	PMID:40504410
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1557452	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of COX7A2L mRNA	PMID:17555576
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1557452	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of COX7A2L mRNA	PMID:17942748
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1557452	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of COX7A2L mRNA	PMID:17942748
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1557452	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of COX7A2L mRNA	PMID:39716349
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1557452	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of COX7A2L mRNA; Nanotubes, Carbon results in decreased expression of COX7A2L mRNA	PMID:25554681
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557452	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of COX7A2L mRNA; Nanotubes, Carbon results in increased expression of COX7A2L mRNA	PMID:25620056
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1557452	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of COX7A2L mRNA	PMID:40234311
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1557452	E	RGD:6480464	20120412	CTD	MESH:D005485	Flutamide results in increased expression of COX7A2L mRNA	PMID:17702527
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1557452	E	RGD:6480464	20130514	CTD	MESH:D008344	[Paraquat co-treated with Maneb] results in decreased expression of COX7A2L mRNA	PMID:18386188
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:6078	ivermectin	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of COX7A2L protein	PMID:32959892
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:64243	monosodium L-glutamate	increases expression	ISO	RGD:1557452	E	RGD:6480464	20200331	CTD	MESH:D012970	Sodium Glutamate results in increased expression of COX7A2L mRNA	PMID:20111022
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306111	E	RGD:6480464	20171010	CTD	MESH:D003671	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of COX7A2L mRNA	PMID:28659758
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1557452	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of COX7A2L mRNA	PMID:22206623
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in increased expression of COX7A2L mRNA	PMID:17316727
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1557452	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of COX7A2L mRNA	PMID:31388691
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1557452	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of COX7A2L mRNA	PMID:39847705
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306111	E	RGD:6480464	20130514	CTD	MESH:D011441	Propylthiouracil results in decreased expression of COX7A2L mRNA	PMID:18077114
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1306111	E	RGD:6480464	20171010	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of COX7A2L mRNA	PMID:28659758
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of COX7A2L mRNA	PMID:38568856
1314534	COX7A2L	cytochrome c oxidase subunit 7A2 like	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1306111	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of COX7A2L gene	PMID:31079544
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of EIF3F protein	PMID:39638853
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314536	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EIF3F gene	PMID:20938992
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of EIF3F mRNA	PMID:33167477
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1314536	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of EIF3F mRNA	PMID:40945087
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:16170	mercury(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of EIF3F mRNA	PMID:16823088
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of EIF3F mRNA	PMID:22489041
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:16243	quercetin	affects binding	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin analog binds to EIF3F protein	PMID:21798748
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314536	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EIF3F mRNA	PMID:39241906
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of EIF3F mRNA	PMID:22574217
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314536	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EIF3F gene	PMID:20938992
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314536	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EIF3F mRNA	PMID:33754040
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of EIF3F protein	PMID:37730182
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306112	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of EIF3F mRNA	PMID:22061828
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314536	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EIF3F mRNA	PMID:36331819
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF3F mRNA	PMID:35301059
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of EIF3F mRNA	PMID:19549813
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EIF3F gene	PMID:27153756
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:25195	mercury atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of EIF3F mRNA	PMID:16823088
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EIF3F protein	PMID:38598786
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314536	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EIF3F mRNA	PMID:31919559
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314536	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EIF3F mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EIF3F gene	PMID:20938992|PMID:22206623
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of EIF3F protein	PMID:38460933
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of EIF3F protein	PMID:35688186
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1314536	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of EIF3F protein	PMID:37208198
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314536	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of EIF3F mRNA	PMID:40618947
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314536	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EIF3F mRNA	PMID:21570461
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306112	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EIF3F mRNA	PMID:34747641
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306112	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EIF3F mRNA	PMID:33387578
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314536	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF3F mRNA	PMID:17942748
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of EIF3F mRNA	PMID:28001369
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314536	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of EIF3F protein	PMID:28918527
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of EIF3F protein	PMID:30528433
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C017947	sodium arsenite results in increased expression of EIF3F protein	PMID:28713220
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C017947	sodium arsenite promotes the reaction [H3-3A protein binds to EIF3F protein]	PMID:37734572
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314536	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EIF3F mRNA	PMID:22228805
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EIF3F promoter	PMID:27901495
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to EIF3F mRNA]	PMID:32406909
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of EIF3F mRNA	PMID:19150397
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of EIF3F mRNA	PMID:20458559
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of EIF3F gene	PMID:31601247
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314536	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of EIF3F mRNA	PMID:23557971
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314536	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EIF3F enhancer	PMID:35295148
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314536	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of EIF3F mRNA	PMID:28472532
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306112	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of EIF3F mRNA	PMID:25181051
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314536	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of EIF3F mRNA	PMID:32156529|PMID:33221593
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of EIF3F gene	PMID:31601247
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1314536	E	RGD:6480464	20240206	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of EIF3F mRNA	PMID:37080397
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314536	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of EIF3F mRNA	PMID:39298647|PMID:40203079
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314536	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of EIF3F mRNA	PMID:37019170
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:1306112	E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of EIF3F mRNA	PMID:17602206
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314536	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of EIF3F mRNA	PMID:34813904
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of EIF3F protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EIF3F protein	PMID:38598786
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:35456	cadmium dichloride	affects localization	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the localization of EIF3F protein	PMID:18261755
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EIF3F mRNA	PMID:26472689
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF3F mRNA	PMID:35301059
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of EIF3F mRNA	PMID:19376846
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of EIF3F mRNA	PMID:24449571
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:39178	clothianidin	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in decreased expression of EIF3F mRNA	PMID:31626844
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of EIF3F mRNA	PMID:26352163
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C100187	chloropicrin results in decreased expression of EIF3F mRNA	PMID:28476498
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314536	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EIF3F mRNA	PMID:36331819
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of EIF3F mRNA	PMID:26272509
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314536	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of EIF3F mRNA	PMID:17555576
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of EIF3F mRNA	PMID:38832940
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of EIF3F protein	PMID:22230336
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of EIF3F protein	PMID:38460933
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of EIF3F protein	PMID:25470785
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of EIF3F protein	PMID:31195006
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314536	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of EIF3F mRNA	PMID:17555576
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314536	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EIF3F mRNA	PMID:17942748
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314536	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF3F mRNA	PMID:17942748
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of EIF3F mRNA	PMID:20458559
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306112	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of EIF3F mRNA	PMID:34044035
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314536	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EIF3F mRNA	PMID:35964746
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EIF3F protein	PMID:32959892
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of EIF3F protein	PMID:34186270
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314536	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EIF3F mRNA	PMID:22206623
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EIF3F protein	PMID:37664457
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of EIF3F mRNA	PMID:22714537
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of EIF3F protein	PMID:39638853
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EIF3F gene]	PMID:28238834
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314536	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of EIF3F mRNA	PMID:30294300
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of EIF3F protein	PMID:38348393
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EIF3F protein	PMID:37664457
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of EIF3F mRNA	PMID:29301935
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of EIF3F mRNA	PMID:27188386
1314535	EIF3F	eukaryotic translation initiation factor 3 subunit F	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of EIF3F protein	PMID:38598786
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of FJX1 mRNA	PMID:26272509
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA	PMID:27188386
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314538	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of FJX1 mRNA	PMID:37995155
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306113	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FJX1 mRNA]	PMID:31150632
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314538	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FJX1 mRNA	PMID:20188158
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	EXP		E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of FJX1 mRNA	PMID:23792671
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of FJX1 mRNA	PMID:21934132|PMID:23830798
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1306113	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FJX1 mRNA	PMID:33729688
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of FJX1 mRNA	PMID:22378314
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314538	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FJX1 mRNA	PMID:30319688
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314538	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FJX1 mRNA	PMID:30319688
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of FJX1 mRNA	PMID:20044591
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FJX1 mRNA	PMID:35811015
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of FJX1 mRNA]	PMID:35811015
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of FJX1 mRNA	PMID:30510588
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of FJX1 mRNA	PMID:31614463
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of FJX1 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of FJX1 mRNA	PMID:17404688|PMID:20660070
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of FJX1 mRNA	PMID:38568856
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of FJX1 mRNA	PMID:20655997
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of FJX1 mRNA	PMID:17404688|PMID:20864642
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of FJX1 mRNA; [Progesterone co-treated with Estradiol] results in decreased expression of FJX1 mRNA	PMID:17404688|PMID:20660070
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314538	E	RGD:6480464	20170516	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of FJX1 mRNA	PMID:28085963
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306113	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FJX1 mRNA	PMID:33387578
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of FJX1 mRNA	PMID:28818685
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FJX1 mRNA	PMID:39836092
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:188736	Archazolid B	decreases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C519728	archazolid B results in decreased expression of FJX1 mRNA	PMID:25218289
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of FJX1 mRNA	PMID:19549813
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of FJX1 mRNA	PMID:23649840
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FJX1 gene	PMID:27153756
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FJX1 mRNA	PMID:21641981|PMID:22100608|PMID:27153756
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of FJX1 mRNA	PMID:23649840
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of FJX1 mRNA	PMID:25102026
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306113	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FJX1 mRNA	PMID:31150632
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306113	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FJX1 mRNA]	PMID:31150632
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FJX1 mRNA	PMID:39836092
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of FJX1 mRNA	PMID:26272509
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA	PMID:27188386
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of FJX1 mRNA	PMID:27392435
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of FJX1 mRNA	PMID:27392435
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314538	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of FJX1 mRNA	PMID:32186404
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of FJX1 mRNA	PMID:25583101
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306113	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ANKHD1-EIF4EBP3 mRNA; Tetrachlorodibenzodioxin results in decreased expression of FJX1 mRNA	PMID:21215274|PMID:33387578
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314538	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FJX1 mRNA	PMID:19770486
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314538	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FJX1 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to FJX1 promoter]	PMID:17942748|PMID:19654925
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of FJX1 mRNA	PMID:26272509
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA	PMID:27188386
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of FJX1 mRNA	PMID:32763439
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306113	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of FJX1 mRNA	PMID:28959563
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:29021	hexane	decreases methylation	ISO	RGD:1306113	E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of FJX1 promoter	PMID:23740543
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FJX1 mRNA	PMID:38568856
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FJX1 mRNA	PMID:39836092
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of FJX1 mRNA	PMID:22378314|PMID:29453283
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FJX1 promoter	PMID:27901495
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314538	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FJX1 mRNA	PMID:19770486
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314538	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FJX1 mRNA	PMID:22228805
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of FJX1 mRNA	PMID:25895662
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of FJX1 mRNA	PMID:20382639
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of FJX1 mRNA	PMID:35984750
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1306113	E	RGD:6480464	20260811	CTD	MESH:D002065	Buspirone results in increased expression of ANKHD1-EIF4EBP3 mRNA	PMID:24136188
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314538	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FJX1 gene	PMID:35295148
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306113	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FJX1 mRNA	PMID:34492290
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314538	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of FJX1 mRNA	PMID:20813756
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314538	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FJX1 mRNA	PMID:19710929
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:32687	piperonyl butoxide	decreases expression	ISO	RGD:1306113	E	RGD:6480464	20260811	CTD	MESH:D010882	Piperonyl Butoxide results in decreased expression of ANKHD1-EIF4EBP3 mRNA	PMID:22484513
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306113	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FJX1 mRNA	PMID:25181051
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of FJX1 mRNA	PMID:29275510
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314538	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of FJX1 promoter	PMID:27312807
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306113	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of FJX1 mRNA	PMID:30816183
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314538	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of FJX1 mRNA	PMID:32156529
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306113	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FJX1 gene	PMID:28505145
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FJX1 mRNA	PMID:28628672
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314538	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of FJX1 gene	PMID:31683443
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314538	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of FJX1 mRNA	PMID:40203079
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FJX1 mRNA	PMID:28628672
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314538	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of FJX1 mRNA	PMID:26377693
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FJX1 mRNA	PMID:28628672
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314538	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FJX1 mRNA	PMID:37019170
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306113	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of FJX1 mRNA	PMID:21266533
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FJX1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FJX1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FJX1 mRNA	PMID:28628672
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1306113	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of FJX1 mRNA	PMID:32680482
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306113	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of FJX1 mRNA	PMID:35163327
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FJX1 mRNA	PMID:39836092
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FJX1 mRNA	PMID:38174414|PMID:38568856
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306113	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FJX1 mRNA	PMID:36928142
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306113	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of FJX1 mRNA	PMID:35163327
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FJX1 mRNA	PMID:19320972
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306113	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FJX1 mRNA	PMID:24386269
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314538	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of FJX1 mRNA	PMID:28962523
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of FJX1 mRNA	PMID:40434365
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FJX1 mRNA	PMID:31533062
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of FJX1 mRNA	PMID:26352163|PMID:28476498
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1314538	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of FJX1 mRNA	PMID:29038090
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FJX1 mRNA	PMID:25979313
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of FJX1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FJX1 gene	PMID:29154799
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of FJX1 mRNA	PMID:23179753|PMID:27188386
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA	PMID:27188386
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of FJX1 mRNA	PMID:27989131
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of FJX1 mRNA	PMID:20106945
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FJX1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FJX1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FJX1 mRNA	PMID:28628672
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of FJX1 mRNA	PMID:24935251|PMID:26272509
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA	PMID:27188386
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of FJX1 mRNA	PMID:21420995
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306113	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of FJX1 mRNA	PMID:33387578
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of FJX1 mRNA	PMID:24714768
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of FJX1 mRNA]	PMID:35811015
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of FJX1 mRNA	PMID:18687144|PMID:29523930
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FJX1 mRNA	PMID:39836092
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1306113	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of FJX1 mRNA	PMID:29391264
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314538	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FJX1 mRNA	PMID:17942748
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:4948	Evodiamine	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine results in decreased expression of FJX1 mRNA	PMID:32057900
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of FJX1 mRNA	PMID:26272509
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of FJX1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of FJX1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FJX1 mRNA	PMID:28628672
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314538	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of FJX1 mRNA; Nanotubes, Carbon results in increased expression of FJX1 mRNA	PMID:25554681
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306113	E	RGD:6480464	20260811	CTD	MESH:D005485	Flutamide results in decreased expression of ANKHD1-EIF4EBP3 mRNA	PMID:24136188
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314538	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of FJX1 mRNA	PMID:19042947
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314538	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of FJX1 mRNA	PMID:38701926
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FJX1 mRNA	PMID:39836092
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	FJX1 protein affects the susceptibility to Topotecan	PMID:16217747
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1306113	E	RGD:6480464	20260811	CTD	MESH:C406224	valdecoxib results in decreased expression of ANKHD1-EIF4EBP3 mRNA	PMID:24136188
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of FJX1 mRNA	PMID:28988120
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of FJX1 mRNA	PMID:20847119
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:64090	tert-butyl hydroperoxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of FJX1 mRNA]	PMID:20847119
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of FJX1 mRNA	PMID:24810058
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1306113	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of FJX1 mRNA	PMID:19564919
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA	PMID:27188386
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:8228	pioglitazone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C060836	[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA	PMID:20847119
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of FJX1 mRNA	PMID:26272509
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FJX1 mRNA	PMID:27188386
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of FJX1 mRNA	PMID:38568856
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of FJX1 mRNA	PMID:22378314
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1306113	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of FJX1 protein	PMID:32519852
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:9753	troglitazone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C057693	[Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of FJX1 mRNA]	PMID:20847119
1314537	FJX1	four-jointed box kinase 1	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1306113	E	RGD:6480464	20260811	CTD	MESH:C080163	trovafloxacin results in increased expression of ANKHD1-EIF4EBP3 mRNA	PMID:24136188
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1552372	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of HACE1 mRNA	PMID:33045310
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of HACE1 mRNA	PMID:22378314
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552372	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HACE1 mRNA	PMID:39241906
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306114	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of HACE1 mRNA	PMID:33387578
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552372	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of HACE1 mRNA	PMID:22401849
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HACE1 mRNA	PMID:19549813
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of HACE1 mRNA	PMID:23649840
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of HACE1 mRNA	PMID:23649840
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552372	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of HACE1 mRNA	PMID:22206623
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of HACE1 protein	PMID:35688186
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of HACE1 mRNA	PMID:23557933
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552372	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HACE1 mRNA	PMID:21570461
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HACE1 mRNA	PMID:33212167
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552372	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased expression of HACE1 mRNA	PMID:32068019
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552372	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HACE1 mRNA	PMID:22228805
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HACE1 promoter	PMID:27901495
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to HACE1 mRNA]	PMID:32406909
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HACE1 gene	PMID:31601247
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306114	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HACE1 mRNA	PMID:25729387
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552372	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HACE1 gene	PMID:35295148
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552372	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of HACE1 promoter	PMID:35295148
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1552372	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of HACE1 mRNA	PMID:28472532
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306114	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HACE1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of HACE1 mRNA	PMID:27685785
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306114	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of HACE1 gene	PMID:28505145
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of HACE1 gene	PMID:31601247
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of HACE1 protein	PMID:31675489
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HACE1 mRNA	PMID:37042841
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306114	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of HACE1 mRNA	PMID:33453195
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HACE1 mRNA	PMID:25979313
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of HACE1 mRNA	PMID:23179753|PMID:29154799
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of HACE1 mRNA	PMID:25562108
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306114	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HACE1 mRNA	PMID:33387578
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of HACE1 mRNA	PMID:31675489
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of HACE1 mRNA	PMID:16984733
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552372	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of HACE1 mRNA; Nanotubes, Carbon results in decreased expression of HACE1 mRNA	PMID:25554681
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306114	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of HACE1 mRNA	PMID:24136188
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1306114	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of HACE1 mRNA	PMID:21983209
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1552372	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of HACE1 mRNA	PMID:23608068
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306114	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HACE1 mRNA	PMID:25729387
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1306114	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of HACE1 mRNA	PMID:30467583
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306114	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of HACE1 gene	PMID:35440735
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552372	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of HACE1 mRNA	PMID:22206623
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HACE1 gene]	PMID:28238834
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HACE1 protein	PMID:31675489
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of HACE1 protein	PMID:31675489
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306114	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of HACE1 mRNA	PMID:21346803
1314539	HACE1	HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1306114	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of HACE1 gene	PMID:31079544
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	affects expression	ISO	RGD:1306116	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine affects the expression of FHIP2A mRNA	PMID:30071829
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FHIP2A gene	PMID:20938992
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of FHIP2A mRNA	PMID:23724009
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314543	E	RGD:6480464	20241105	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FHIP2A mRNA	PMID:36331819
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of FHIP2A mRNA	PMID:26079696
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314543	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FHIP2A mRNA	PMID:39241906
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306116	E	RGD:6480464	20241105	CTD	MESH:D004958	Estradiol results in decreased expression of FHIP2A mRNA	PMID:32145629
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314543	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FHIP2A mRNA	PMID:39298647
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of FHIP2A mRNA	PMID:22217510
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FHIP2A gene	PMID:20938992
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20241105	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FHIP2A mRNA	PMID:37042841
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of FHIP2A mRNA	PMID:20655997
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314543	E	RGD:6480464	20250805	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FHIP2A mRNA	PMID:34319233
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306116	E	RGD:6480464	20241105	CTD	MESH:D005839	Gentamicins results in decreased expression of FHIP2A mRNA	PMID:33387578
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FHIP2A mRNA	PMID:28818685
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314543	E	RGD:6480464	20241105	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FHIP2A mRNA	PMID:36331819
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FHIP2A mRNA	PMID:19770486
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FHIP2A mRNA	PMID:31919559
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FHIP2A gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of FHIP2A mRNA]	PMID:20938992|PMID:22206623
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306116	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FHIP2A mRNA	PMID:21215274
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306116	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FHIP2A mRNA	PMID:32109520
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of FHIP2A protein	PMID:39603559
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FHIP2A mRNA	PMID:33212167
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:D004317	Doxorubicin results in decreased expression of FHIP2A mRNA	PMID:19277126
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20241105	CTD	MESH:C017947	sodium arsenite results in increased expression of FHIP2A mRNA	PMID:38568856
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FHIP2A promoter	PMID:27901495
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306116	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FHIP2A mRNA	PMID:34492290
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:C006253	pirinixic acid results in increased expression of FHIP2A mRNA	PMID:17426115
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FHIP2A mRNA	PMID:19710929
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:C074702	chromium hexavalent ion affects the expression of FHIP2A mRNA	PMID:28472532
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306116	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in decreased expression of FHIP2A mRNA	PMID:32145629
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314543	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FHIP2A mRNA	PMID:33221593
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of FHIP2A gene	PMID:31601247
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of FHIP2A protein	PMID:34186270
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306116	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FHIP2A mRNA	PMID:25181051|PMID:29097150|PMID:30816183
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:C006780	bisphenol A results in increased expression of FHIP2A mRNA	PMID:26063408
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306116	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FHIP2A mRNA	PMID:36041667
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of FHIP2A protein	PMID:34186270
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1314543	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of FHIP2A exon	PMID:33297965
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306116	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FHIP2A mRNA	PMID:36041667
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306116	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FHIP2A mRNA	PMID:36041667
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20241105	CTD	MESH:C005445	triphenyl phosphate affects the expression of FHIP2A mRNA	PMID:37042841
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FHIP2A mRNA	PMID:24449571
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314543	E	RGD:6480464	20241105	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FHIP2A mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FHIP2A mRNA	PMID:36331819
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FHIP2A mRNA	PMID:25979313
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:D014635	Valproic Acid affects the expression of FHIP2A mRNA	PMID:17963808
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of FHIP2A mRNA	PMID:23179753|PMID:25192806|PMID:26272509|PMID:28001369
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHIP2A mRNA	PMID:27188386
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306116	E	RGD:6480464	20241105	CTD	MESH:D000082	Acetaminophen results in decreased expression of FHIP2A mRNA	PMID:33387578
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306116	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FHIP2A mRNA	PMID:29097150
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FHIP2A mRNA; Nanotubes, Carbon results in decreased expression of FHIP2A mRNA	PMID:25554681
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FHIP2A protein	PMID:32959892
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FHIP2A mRNA	PMID:22206623
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of FHIP2A mRNA]	PMID:22206623
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHIP2A mRNA	PMID:27188386
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:80025	Salinomycin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of FHIP2A mRNA	PMID:19682730
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314543	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of FHIP2A mRNA	PMID:39847705
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:C045950	propiconazole results in decreased expression of FHIP2A mRNA	PMID:21278054
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FHIP2A mRNA	PMID:27188386
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of FHIP2A mRNA	PMID:29301935
1314542	FHIP2A	FHF complex subunit HOOK interacting protein 2A	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314543	E	RGD:6480464	20210907	CTD	MESH:C057693	Troglitazone results in decreased expression of FHIP2A mRNA	PMID:28973697
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306117	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of STXBP6 mRNA	PMID:25152437
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1314545	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of STXBP6 mRNA	PMID:39752319
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314545	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STXBP6 mRNA	PMID:30529165
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of STXBP6 mRNA	PMID:24763279
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of STXBP6 mRNA	PMID:26079696
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:16130	DDT	decreases expression	ISO	RGD:1306117	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of STXBP6 mRNA	PMID:30207508
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STXBP6 mRNA	PMID:35811015
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of STXBP6 mRNA	PMID:30510588
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of STXBP6 mRNA	PMID:23019147
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of STXBP6 mRNA	PMID:39298647
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of STXBP6 mRNA	PMID:20660070
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of STXBP6 mRNA	PMID:33711761
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in decreased expression of STXBP6 mRNA	PMID:27664576
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of STXBP6 mRNA	PMID:20660070
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of STXBP6 mRNA	PMID:26079696
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1306117	E	RGD:6480464	20120412	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of STXBP6 mRNA	PMID:16809437
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314545	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of STXBP6 mRNA	PMID:39752319
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of STXBP6 mRNA	PMID:31256213
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of STXBP6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of STXBP6 mRNA	PMID:39836092
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314545	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STXBP6 mRNA	PMID:37236586
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of STXBP6 mRNA	PMID:19549813
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of STXBP6 mRNA	PMID:19770486
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of STXBP6 gene	PMID:27153756
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of STXBP6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STXBP6 mRNA	PMID:39836092
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of STXBP6 mRNA	PMID:26272509
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STXBP6 mRNA	PMID:27188386
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:27808	heroin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003932	Heroin results in decreased expression of STXBP6 mRNA	PMID:16710320
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306117	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of STXBP6 mRNA	PMID:31881176
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of STXBP6 mRNA	PMID:27392435
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:28088	genistein	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein affects the expression of STXBP6 mRNA	PMID:26865667
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of STXBP6 mRNA	PMID:24768652|PMID:25583101
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306117	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STXBP6 mRNA	PMID:32109520
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314545	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STXBP6 mRNA	PMID:21570461
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of STXBP6 mRNA	PMID:19933214
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1306117	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone affects the expression of STXBP6 mRNA	PMID:28374803
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of STXBP6 mRNA	PMID:33212167
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of STXBP6 mRNA	PMID:30851411
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of STXBP6 mRNA	PMID:32763439
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306117	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of STXBP6 mRNA	PMID:30556269
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of STXBP6 mRNA	PMID:29803840
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of STXBP6 mRNA	PMID:37682722
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of STXBP6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STXBP6 mRNA	PMID:39836092
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STXBP6 5' UTR	PMID:27901495
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STXBP6 mRNA	PMID:20106945|PMID:21632981
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STXBP6 mRNA	PMID:19770486
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1306117	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STXBP6 mRNA	PMID:21839799
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of STXBP6 promoter	PMID:27901495
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306117	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of STXBP6 mRNA	PMID:30556269
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of STXBP6 mRNA	PMID:28959546
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of STXBP6 mRNA	PMID:19150397
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of STXBP6 mRNA	PMID:26705709
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of STXBP6 mRNA	PMID:22521957
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314545	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STXBP6 gene	PMID:35295148
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306117	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of STXBP6 mRNA	PMID:34492290
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of STXBP6 mRNA	PMID:23811191
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314545	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of STXBP6 mRNA	PMID:17426115
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:33007	chromium(6+)	affects expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of STXBP6 mRNA	PMID:30690063
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306117	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of STXBP6 mRNA	PMID:25181051
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306117	E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in decreased expression of STXBP6 mRNA	PMID:38750585|PMID:41034487
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of STXBP6 mRNA	PMID:33221593
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of STXBP6 gene	PMID:31601247
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306117	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of STXBP6 gene	PMID:28505145
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of STXBP6 mRNA	PMID:25172293
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	STXBP6 mRNA affects the susceptibility to Carmustine	PMID:16365179
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of STXBP6 mRNA	PMID:39298647
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1314545	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of STXBP6 mRNA	PMID:34813904
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1306117	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of STXBP6 mRNA	PMID:30589522
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of STXBP6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of STXBP6 mRNA	PMID:39836092
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314545	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STXBP6 mRNA	PMID:37236586
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of STXBP6 mRNA	PMID:24449571
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of STXBP6 mRNA	PMID:28302478
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of STXBP6 mRNA	PMID:31533062
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of STXBP6 mRNA	PMID:40419075
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STXBP6 mRNA	PMID:25979313
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of STXBP6 mRNA	PMID:23179753
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of STXBP6 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369|PMID:29154799
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STXBP6 mRNA	PMID:27188386
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306117	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of STXBP6 mRNA	PMID:30047161
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of STXBP6 mRNA	PMID:19770486
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of STXBP6 mRNA	PMID:28973697
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of STXBP6 mRNA	PMID:24935251
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314545	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of STXBP6 mRNA	PMID:17562736
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STXBP6 mRNA	PMID:35811015
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of STXBP6 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STXBP6 mRNA	PMID:39836092
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STXBP6 mRNA	PMID:22079256
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:48765	dimethylarsinic acid	decreases expression	ISO	RGD:1306117	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in decreased expression of STXBP6 mRNA	PMID:37958445
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:1306117	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of STXBP6 gene	PMID:37958445
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of STXBP6 mRNA	PMID:26865667
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of STXBP6 mRNA	PMID:26705709
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of STXBP6 mRNA	PMID:22521957
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of STXBP6 mRNA]	PMID:21095227
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of STXBP6 mRNA; Nanotubes, Carbon results in decreased expression of STXBP6 mRNA	PMID:25554681|PMID:25620056
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306117	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of STXBP6 mRNA	PMID:30047161
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of STXBP6 mRNA	PMID:22714537
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of STXBP6 protein	PMID:23718831
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of STXBP6 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of STXBP6 mRNA	PMID:39836092
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314545	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of STXBP6 protein	PMID:36851058
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1314545	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of STXBP6 mRNA	PMID:39752319
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	STXBP6 mRNA affects the susceptibility to temozolomide	PMID:16365179
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of STXBP6 mRNA	PMID:31758290
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of STXBP6 mRNA	PMID:22079256
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of STXBP6 mRNA	PMID:22714537
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of STXBP6 mRNA	PMID:22079256
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of STXBP6 mRNA	PMID:37199045
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1306117	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in increased expression of STXBP6 mRNA	PMID:26720608
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of STXBP6 mRNA	PMID:30851411
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STXBP6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STXBP6 mRNA	PMID:27188386
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:8064	phenformin	increases expression	ISO	RGD:1306117	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in increased expression of STXBP6 mRNA	PMID:31324951
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314545	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of STXBP6 mRNA	PMID:38648751
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of STXBP6 mRNA	PMID:26705709
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of STXBP6 mRNA	PMID:26079696
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:84491	poly(I:C)	multiple interactions	ISO	RGD:1306117	E	RGD:6480464	20201215	CTD	MESH:D011070	[Poly I-C co-treated with HU 211] results in decreased expression of STXBP6 mRNA	PMID:26923065
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1306117	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of STXBP6 mRNA	PMID:24780913
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1314545	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of STXBP6 mRNA	PMID:39752319
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STXBP6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STXBP6 mRNA	PMID:27188386
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D012834	Silver results in increased expression of STXBP6 mRNA	PMID:28959546
1314544	STXBP6	syntaxin binding protein 6	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306117	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of STXBP6 mRNA	PMID:23555832
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314548	E	RGD:6480464	20250204	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MIDEAS mRNA	PMID:36331819
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314548	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MIDEAS mRNA	PMID:39241906
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of MIDEAS mRNA	PMID:23019147
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20250204	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MIDEAS mRNA	PMID:37042841
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of MIDEAS mRNA	PMID:20655997
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MIDEAS protein	PMID:37730182
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314548	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MIDEAS mRNA	PMID:34911549
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MIDEAS mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MIDEAS mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MIDEAS mRNA	PMID:39836092|PMID:40512198
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MIDEAS mRNA	PMID:26272509
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIDEAS mRNA	PMID:27188386
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MIDEAS protein	PMID:35688186
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of MIDEAS mRNA	PMID:28903495
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of MIDEAS mRNA	PMID:27392435
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of MIDEAS mRNA	PMID:27392435
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306119	E	RGD:6480464	20200331	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MIDEAS mRNA	PMID:22298810|PMID:34747641
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306119	E	RGD:6480464	20250204	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MIDEAS mRNA	PMID:33387578
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MIDEAS mRNA	PMID:28001369
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MIDEAS mRNA	PMID:33212167
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MIDEAS mRNA	PMID:29803840
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of MIDEAS protein	PMID:35688186
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MIDEAS mRNA	PMID:38568856
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of MIDEAS mRNA	PMID:39719251
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MIDEAS mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MIDEAS mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MIDEAS mRNA	PMID:39836092|PMID:40512198
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MIDEAS 3' UTR; Benzo(a)pyrene affects the methylation of MIDEAS 5' UTR	PMID:27901495
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314548	E	RGD:6480464	20200331	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MIDEAS mRNA	PMID:27858113
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of MIDEAS mRNA	PMID:26014281
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MIDEAS mRNA	PMID:20382639
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of MIDEAS mRNA	PMID:37690743
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314548	E	RGD:6480464	20200331	CTD	MESH:C009495	titanium dioxide results in increased expression of MIDEAS mRNA	PMID:23557971|PMID:35295148
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306119	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MIDEAS mRNA	PMID:34492290
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314548	E	RGD:6480464	20200331	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of MIDEAS mRNA	PMID:28329830
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306119	E	RGD:6480464	20200331	CTD	MESH:C006780	bisphenol A affects the expression of MIDEAS mRNA	PMID:25181051
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306119	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MIDEAS mRNA	PMID:32145629|PMID:34947998
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to MIDEAS promoter]	PMID:20348232
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314548	E	RGD:6480464	20250204	CTD	MESH:C543008	bisphenol S affects the methylation of MIDEAS gene	PMID:31683443
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314548	E	RGD:6480464	20200331	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MIDEAS mRNA	PMID:27858113
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314548	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of MIDEAS intron	PMID:28392331
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of MIDEAS gene	PMID:22964155
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306119	E	RGD:6480464	20250204	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MIDEAS mRNA	PMID:33453195
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MIDEAS mRNA	PMID:24449571
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of MIDEAS mRNA	PMID:28302478
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314548	E	RGD:6480464	20250204	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MIDEAS mRNA	PMID:36331819
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314548	E	RGD:6480464	20200331	CTD	MESH:C031763	1,3-butadiene results in decreased expression of MIDEAS mRNA	PMID:29038090
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of MIDEAS mRNA	PMID:28001369
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MIDEAS mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:29154799
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MIDEAS gene	PMID:29154799
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIDEAS mRNA	PMID:27188386
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:41607	crotonaldehyde	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C012796	2-butenal results in decreased expression of MIDEAS mRNA	PMID:20471460
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of MIDEAS mRNA	PMID:26272509
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIDEAS mRNA	PMID:27188386
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of MIDEAS mRNA	PMID:29067470
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306119	E	RGD:6480464	20250204	CTD	MESH:D000082	Acetaminophen results in increased expression of MIDEAS mRNA	PMID:33387578
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MIDEAS mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MIDEAS mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MIDEAS mRNA	PMID:39836092|PMID:40512198
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314548	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of MIDEAS mRNA	PMID:35436446
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306119	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of MIDEAS mRNA	PMID:34044035
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1314548	E	RGD:6480464	20200331	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of MIDEAS mRNA	PMID:26377693
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314548	E	RGD:6480464	20200331	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MIDEAS mRNA	PMID:27858113
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1314548	E	RGD:6480464	20200331	CTD	MESH:C031180	chrysene results in decreased expression of MIDEAS mRNA	PMID:26377693
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314548	E	RGD:6480464	20200331	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MIDEAS mRNA	PMID:27858113
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of MIDEAS protein	PMID:23718831
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	Leflunomide results in increased expression of MIDEAS mRNA	PMID:28988120
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MIDEAS protein	PMID:31285264
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIDEAS mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIDEAS mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIDEAS mRNA	PMID:27188386
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIDEAS mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIDEAS mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MIDEAS mRNA	PMID:27188386
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of MIDEAS mRNA	PMID:26014281
1314547	MIDEAS	mitotic deacetylase associated SANT domain protein	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MIDEAS mRNA	PMID:38568856
1314549	TLL1	tolloid like 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1550401	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TLL1 mRNA	PMID:37995155
1314549	TLL1	tolloid like 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1550401	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of TLL1 mRNA	PMID:36189433
1314549	TLL1	tolloid like 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1550401	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of TLL1 mRNA	PMID:16604517
1314549	TLL1	tolloid like 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550401	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TLL1 mRNA	PMID:36189433
1314549	TLL1	tolloid like 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550401	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TLL1 mRNA	PMID:12057914
1314549	TLL1	tolloid like 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of TLL1 mRNA	PMID:30165855
1314549	TLL1	tolloid like 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306120	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of TLL1 mRNA	PMID:26496021
1314549	TLL1	tolloid like 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550401	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TLL1 mRNA	PMID:25510870
1314549	TLL1	tolloid like 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in increased expression of TLL1 mRNA	PMID:27905399
1314549	TLL1	tolloid like 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550401	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of TLL1 mRNA	PMID:36189433
1314549	TLL1	tolloid like 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TLL1 mRNA	PMID:39836092
1314549	TLL1	tolloid like 1	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of TLL1 mRNA	PMID:17103032
1314549	TLL1	tolloid like 1	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1550401	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TLL1 mRNA	PMID:29950665
1314549	TLL1	tolloid like 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550401	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TLL1 mRNA	PMID:25510870
1314549	TLL1	tolloid like 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550401	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TLL1 mRNA	PMID:25510870
1314549	TLL1	tolloid like 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TLL1 gene	PMID:27153756
1314549	TLL1	tolloid like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TLL1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TLL1 mRNA	PMID:39836092
1314549	TLL1	tolloid like 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of TLL1 mRNA	PMID:23557933
1314549	TLL1	tolloid like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306120	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TLL1 mRNA	PMID:34747641
1314549	TLL1	tolloid like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550401	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TLL1 mRNA	PMID:19933214
1314549	TLL1	tolloid like 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TLL1 mRNA	PMID:33212167
1314549	TLL1	tolloid like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TLL1 mRNA	PMID:34032870|PMID:38568856
1314549	TLL1	tolloid like 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550401	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TLL1 mRNA	PMID:37682722
1314549	TLL1	tolloid like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TLL1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TLL1 mRNA	PMID:39836092
1314549	TLL1	tolloid like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TLL1 mRNA	PMID:35870112
1314549	TLL1	tolloid like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TLL1 promoter	PMID:27901495
1314549	TLL1	tolloid like 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1550401	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TLL1 mRNA	PMID:27131904
1314549	TLL1	tolloid like 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TLL1 mRNA	PMID:23806026
1314549	TLL1	tolloid like 1	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of TLL1 gene	PMID:31601247
1314549	TLL1	tolloid like 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550401	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TLL1 gene	PMID:35295148
1314549	TLL1	tolloid like 1	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1550401	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TLL1 mRNA	PMID:29950665
1314549	TLL1	tolloid like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of TLL1 mRNA	PMID:27685785
1314549	TLL1	tolloid like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306120	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TLL1 mRNA	PMID:30816183|PMID:32528016|PMID:38750585
1314549	TLL1	tolloid like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550401	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of TLL1 mRNA	PMID:37105096
1314549	TLL1	tolloid like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306120	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TLL1 mRNA	PMID:25181051
1314549	TLL1	tolloid like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550401	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TLL1 mRNA	PMID:30951980|PMID:32156529
1314549	TLL1	tolloid like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306120	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of TLL1 mRNA	PMID:26496021
1314549	TLL1	tolloid like 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550401	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TLL1 mRNA	PMID:25510870
1314549	TLL1	tolloid like 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550401	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of TLL1 mRNA	PMID:25510870
1314549	TLL1	tolloid like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in decreased expression of TLL1 mRNA	PMID:27685785
1314549	TLL1	tolloid like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550401	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of TLL1 mRNA	PMID:40203079
1314549	TLL1	tolloid like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in increased expression of TLL1 mRNA	PMID:27685785
1314549	TLL1	tolloid like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550401	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TLL1 mRNA	PMID:30951980
1314549	TLL1	tolloid like 1	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1550401	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of TLL1 mRNA	PMID:26377693
1314549	TLL1	tolloid like 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550401	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TLL1 mRNA	PMID:30951980
1314549	TLL1	tolloid like 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1550401	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TLL1 mRNA	PMID:29950665
1314549	TLL1	tolloid like 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TLL1 mRNA	PMID:39836092
1314549	TLL1	tolloid like 1	gene	CHEBI:35176	zinc sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in decreased expression of TLL1 mRNA	PMID:16330358
1314549	TLL1	tolloid like 1	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1306120	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of TLL1 mRNA	PMID:25539665
1314549	TLL1	tolloid like 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TLL1 mRNA	PMID:24449571
1314549	TLL1	tolloid like 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550401	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TLL1 mRNA	PMID:40194260
1314549	TLL1	tolloid like 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TLL1 mRNA	PMID:40419075
1314549	TLL1	tolloid like 1	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1550401	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of TLL1 mRNA	PMID:40633821
1314549	TLL1	tolloid like 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C012589	trichostatin A results in increased expression of TLL1 mRNA	PMID:26705709
1314549	TLL1	tolloid like 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TLL1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TLL1 mRNA	PMID:39836092
1314549	TLL1	tolloid like 1	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of TLL1 mRNA	PMID:31838189
1314549	TLL1	tolloid like 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306120	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TLL1 mRNA	PMID:29391264
1314549	TLL1	tolloid like 1	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of TLL1 mRNA	PMID:26705709
1314549	TLL1	tolloid like 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TLL1 mRNA	PMID:39836092
1314549	TLL1	tolloid like 1	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1550401	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of TLL1 mRNA	PMID:36851058
1314549	TLL1	tolloid like 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TLL1 mRNA	PMID:22714537
1314549	TLL1	tolloid like 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TLL1 mRNA	PMID:37199045
1314549	TLL1	tolloid like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TLL1 gene]	PMID:28238834
1314549	TLL1	tolloid like 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1550401	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of TLL1 mRNA	PMID:27131904
1314549	TLL1	tolloid like 1	gene	CHEBI:9665	triadimefon	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C032910	triadimefon results in decreased expression of TLL1 mRNA	PMID:26705709
1314549	TLL1	tolloid like 1	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1306120	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of TLL1 gene	PMID:31682807
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1619245	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of VPS72 mRNA	PMID:33045310
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in decreased expression of VPS72 protein	PMID:39571964
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:16164	pyrogallol	decreases expression	ISO	RGD:1619245	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in decreased expression of VPS72 mRNA	PMID:20362636
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:16164	pyrogallol	multiple interactions	ISO	RGD:1619245	E	RGD:6480464	20121218	CTD	MESH:D011748	Silymarin inhibits the reaction [Pyrogallol results in decreased expression of VPS72 mRNA]	PMID:20362636
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of VPS72 mRNA	PMID:29432896
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20131220	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TCFL1 mRNA	PMID:20044591
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1619245	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of VPS72 mRNA	PMID:39241906
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1619245	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of VPS72 mRNA	PMID:33711761
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of VPS72 mRNA	PMID:37042841
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of VPS72 protein	PMID:37730182
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306121	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TCFL1 mRNA	PMID:22061828
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of VPS72 mRNA	PMID:19549813
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of VPS72 gene	PMID:25304211
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1619245	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of VPS72 mRNA	PMID:40504410
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20131220	CTD	MESH:D012643	Selenium results in increased expression of TCFL1 mRNA	PMID:19244175
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:2762	antimycin A	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of VPS72 mRNA	PMID:33512557
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of VPS72 mRNA	PMID:23195993
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1619245	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VPS72 mRNA	PMID:21570461|PMID:24058054
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of VPS72 mRNA	PMID:11489354
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306121	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VPS72 mRNA	PMID:33387578
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1619245	E	RGD:6480464	20120515	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of TCFL1 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to VPS72 promoter]	PMID:17942748|PMID:19654925
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of VPS72 mRNA	PMID:33512557
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of VPS72 mRNA	PMID:23649840
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of VPS72 mRNA	PMID:29803840
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1619245	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of VPS72 protein	PMID:29044176
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in decreased expression of VPS72 protein	PMID:39571964
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1619245	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of VPS72 mRNA	PMID:40504410
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of VPS72 promoter	PMID:27901495
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1619245	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of VPS72 mRNA	PMID:29264374
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of VPS72 mRNA	PMID:19710929
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306121	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of VPS72 mRNA	PMID:25181051
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306121	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of VPS72 mRNA	PMID:34947998
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306121	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of VPS72 mRNA	PMID:36041667
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of TCFL1 mRNA	PMID:19244175
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1619245	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of VPS72 gene	PMID:31683443
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1619245	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of VPS72 exon	PMID:33297965
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306121	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of VPS72 mRNA	PMID:36041667
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1619245	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of VPS72 mRNA	PMID:38685157
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306121	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of VPS72 mRNA	PMID:36041667
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1619245	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of VPS72 mRNA	PMID:37019170
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1619245	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of VPS72 mRNA	PMID:17361019|PMID:21266533
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of VPS72 mRNA	PMID:38174414
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in increased expression of VPS72 mRNA	PMID:12160620
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20131220	CTD	MESH:D012643	Selenium results in increased expression of TCFL1 mRNA	PMID:19244175
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1619245	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of VPS72 mRNA	PMID:17585979
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of VPS72 mRNA	PMID:40419075
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of VPS72 mRNA	PMID:25979313
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of VPS72 mRNA	PMID:23179753
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306121	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of VPS72 mRNA	PMID:41580965
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of VPS72 mRNA	PMID:25562108
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1619245	E	RGD:6480464	20131220	CTD	MESH:D013629	Tamoxifen affects the expression of TCFL1 mRNA	PMID:17555576
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of VPS72 mRNA	PMID:23649840
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of VPS72 mRNA	PMID:28542535
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306121	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of VPS72 mRNA	PMID:33387578
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of VPS72 mRNA	PMID:29432896
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of VPS72 gene	PMID:25304211
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1619245	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of VPS72 mRNA	PMID:40504410
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1619245	E	RGD:6480464	20131220	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TCFL1 mRNA	PMID:17555576
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1619245	E	RGD:6480464	20131220	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of TCFL1 mRNA	PMID:17942748
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:5011	fenpyroximate	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of VPS72 mRNA	PMID:33512557
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1306121	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of VPS72 mRNA	PMID:34044035
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1619245	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of VPS72 mRNA	PMID:22206623
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of VPS72 mRNA	PMID:33512557
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1619245	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of VPS72 mRNA	PMID:40826991
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306121	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of VPS72 mRNA	PMID:21346803
1314551	VPS72	vacuolar protein sorting 72 homolog	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306121	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of VPS72 mRNA	PMID:23034163
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314554	E	RGD:6480464	20130618	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLI3 mRNA	PMID:20938992
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314554	E	RGD:6480464	20210309	CTD	MESH:D001280	Atrazine results in decreased expression of GLI3 mRNA	PMID:33463082
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314554	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of GLI3 mRNA	PMID:30319688
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:16236	ethanol	increases cleavage	ISO	RGD:1314554	E	RGD:6480464	20220111	CTD	MESH:D000431	Ethanol results in increased cleavage of GLI3 protein	PMID:34492310
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314554	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of GLI3 mRNA	PMID:30319688
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:620272	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of GLI3 mRNA	PMID:15328011
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of GLI3 mRNA	PMID:19484750
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314554	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of GLI3 mRNA	PMID:19484750
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314554	E	RGD:6480464	20130618	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLI3 mRNA	PMID:20938992
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314554	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GLI3 mRNA	PMID:37992649
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	affects expression	EXP		E	RGD:6480464	20160315	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate affects the expression of GLI3 mRNA	PMID:26710974
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314554	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GLI3 mRNA	PMID:37992649
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:620272	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of GLI3 mRNA	PMID:22061828
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:18248	iron atom	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D007501	[Arsenic co-treated with Iron] results in decreased expression of GLI3 mRNA	PMID:31739468
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GLI3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of GLI3 mRNA	PMID:39836092
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:191178	goralatide	multiple interactions	EXP		E	RGD:6480464	20220614	CTD	MESH:C058504	[goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in decreased expression of GLI3 protein]; goralatide inhibits the reaction [AGT protein results in decreased expression of GLI3 protein]	PMID:31181250
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:191178	goralatide	multiple interactions	ISO	RGD:620272	E	RGD:6480464	20220614	CTD	MESH:C058504	[goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein]; goralatide inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein]	PMID:31181250
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GLI3 mRNA	PMID:35301059
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1314554	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GLI3 mRNA	PMID:29950665
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1314554	E	RGD:6480464	20130618	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of GLI3 gene	PMID:18397875
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GLI3 intron	PMID:30157460
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of GLI3 gene	PMID:27153756
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314554	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GLI3 mRNA	PMID:25629700
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314554	E	RGD:6480464	20130618	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GLI3 mRNA; Folic Acid inhibits the reaction [[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA]	PMID:17688467|PMID:20938992
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001151	Arsenic affects the expression of GLI3 mRNA	PMID:28615018
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GLI3 gene	PMID:25304211
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D001151	Arsenic results in decreased expression of GLI3 mRNA	PMID:31739468
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GLI3 mRNA; [Arsenic co-treated with Iron] results in decreased expression of GLI3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GLI3 mRNA	PMID:31739468|PMID:39836092
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:2762	antimycin A	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of GLI3 mRNA	PMID:33512557
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLI3 mRNA	PMID:27188386
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of GLI3 protein	PMID:35688186
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D002945	Cisplatin results in decreased expression of GLI3 mRNA	PMID:19561079|PMID:21603599
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314554	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GLI3 mRNA	PMID:21570461|PMID:24058054
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:620272	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GLI3 mRNA	PMID:32109520|PMID:33387578
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of GLI3 mRNA	PMID:33512557
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of GLI3 mRNA	PMID:28001369
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GLI3 mRNA	PMID:33212167
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GLI3 mRNA	PMID:30851411
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GLI3 mRNA	PMID:20971185
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314554	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GLI3 mRNA	PMID:37992649
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:28876	melphalan	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in decreased expression of GLI3 mRNA	PMID:22363485
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GLI3 mRNA	PMID:38568856
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314554	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of GLI3 mRNA	PMID:20179202
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GLI3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GLI3 mRNA	PMID:39836092
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of GLI3 mRNA	PMID:21714911
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GLI3 5' UTR	PMID:27901495
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GLI3 promoter	PMID:27901495
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GLI3 mRNA	PMID:32234424
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314554	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GLI3 exon; Benzo(a)pyrene results in increased methylation of GLI3 intron	PMID:27901495
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of GLI3 mRNA	PMID:20971185
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:620272	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of GLI3 protein	PMID:31181250
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:620272	E	RGD:6480464	20191008	CTD	MESH:D012822	[goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein]; AGT protein modified form inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein]; Captopril inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein]; goralatide inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein]	PMID:31181250
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GLI3 mRNA	PMID:19150397|PMID:20382639
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide promotes the reaction [[GLI3 protein binds to KIT promoter] which results in decreased expression of KIT mRNA]; Arsenic Trioxide promotes the reaction [GLI3 protein binds to KIT promoter]	PMID:27793025
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:620272	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of GLI3 mRNA	PMID:32479839
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1314554	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of GLI3 promoter	PMID:35295148
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314554	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GLI3 mRNA	PMID:29950665
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of GLI3 mRNA	PMID:30690063
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C006780	bisphenol A results in decreased expression of GLI3 mRNA	PMID:28238728
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:620272	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GLI3 mRNA	PMID:25181051
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of GLI3 gene	PMID:31601247
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:620272	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GLI3 mRNA	PMID:34858468
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20170725	CTD	MESH:C006780	MIR107 mRNA promotes the reaction [bisphenol A results in decreased expression of GLI3 mRNA]	PMID:28238728
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:3380	captopril	multiple interactions	EXP		E	RGD:6480464	20200609	CTD	MESH:D002216	[goralatide co-treated with Captopril] inhibits the reaction [AGT protein results in decreased expression of GLI3 protein]	PMID:31181250
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:3380	captopril	multiple interactions	ISO	RGD:620272	E	RGD:6480464	20200609	CTD	MESH:D002216	[goralatide co-treated with Captopril] inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein]; Captopril inhibits the reaction [Silicon Dioxide results in decreased expression of GLI3 protein]	PMID:31181250
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314554	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of GLI3 mRNA	PMID:40203079
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1314554	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of GLI3 intron	PMID:28392331
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:620272	E	RGD:6480464	20220208	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GLI3 mRNA	PMID:34858468
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314554	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GLI3 mRNA	PMID:29950665
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:620272	E	RGD:6480464	20161025	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GLI3 mRNA	PMID:25213187|PMID:27079746
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GLI3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of GLI3 mRNA	PMID:39836092
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GLI3 mRNA	PMID:38382870
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:620272	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GLI3 mRNA	PMID:33453195
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GLI3 mRNA	PMID:35301059
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of GLI3 mRNA	PMID:24449571
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:36560	zinc oxide	increases expression	ISO	RGD:1314554	E	RGD:6480464	20220510	CTD	MESH:D015034	Zinc Oxide results in increased expression of GLI3 mRNA	PMID:33236829
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314554	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of GLI3 mRNA	PMID:40194260
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:38604	pyrimidifen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of GLI3 mRNA	PMID:33512557
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of GLI3 mRNA	PMID:31533062
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GLI3 mRNA	PMID:25979313
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GLI3 gene	PMID:29154799
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:39867	valproic acid	decreases response to substance	ISO	RGD:1314554	E	RGD:6480464	20130618	CTD	MESH:D014635	GLI3 protein results in decreased susceptibility to Valproic Acid	PMID:16359493
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of GLI3 mRNA	PMID:24935251|PMID:28001369
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:39867	valproic acid	increases response to substance	ISO	RGD:1314554	E	RGD:6480464	20130618	CTD	MESH:D014635	GLI3 gene mutant form results in increased susceptibility to Valproic Acid	PMID:16359493
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:39867	valproic acid	multiple interactions	ISO	RGD:1314554	E	RGD:6480464	20130618	CTD	MESH:D014635	Valproic Acid promotes the reaction [GLI3 gene mutant form affects the expression of FGF8 mRNA]	PMID:16359493
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D016572	Cyclosporine results in increased expression of GLI3 mRNA	PMID:33631201
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of GLI3 mRNA	PMID:33512557
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314554	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GLI3 mRNA	PMID:37992649
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of GLI3 mRNA	PMID:33512557
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of GLI3 mRNA	PMID:22723015|PMID:24935251
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of GLI3 mRNA	PMID:24935251
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of GLI3 mRNA	PMID:26690555
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001151	Arsenic affects the expression of GLI3 mRNA	PMID:28615018
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GLI3 gene	PMID:25304211
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D001151	Arsenic results in decreased expression of GLI3 mRNA	PMID:31739468
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GLI3 mRNA; [Arsenic co-treated with Iron] results in decreased expression of GLI3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GLI3 mRNA	PMID:31739468|PMID:39836092
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of GLI3 mRNA	PMID:22079256
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GLI3 mRNA	PMID:22079256
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314554	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of GLI3 mRNA	PMID:35436446
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide promotes the reaction [[GLI3 protein binds to KIT promoter] which results in decreased expression of KIT mRNA]; Arsenic Trioxide promotes the reaction [GLI3 protein binds to KIT promoter]	PMID:27793025
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:5011	fenpyroximate	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of GLI3 mRNA	PMID:33512557
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314554	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of GLI3 mRNA	PMID:25554681
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:620272	E	RGD:6480464	20150414	CTD	MESH:D008713	Methimazole results in increased expression of GLI3 mRNA	PMID:25539664
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GLI3 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of GLI3 mRNA	PMID:39836092
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GLI3 mRNA	PMID:26378955
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314554	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLI3 mRNA	PMID:26378955
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:620272	E	RGD:6480464	20220208	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of GLI3 mRNA	PMID:34858468
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:620272	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of GLI3 mRNA	PMID:28801915
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:66903	vismodegib	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:C538724	HhAntag691 inhibits the reaction [AGT protein results in decreased expression of GLI3 protein]	PMID:31181250
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1314554	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of GLI3 mRNA	PMID:27462272
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314554	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of GLI3 mRNA	PMID:22206623
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of GLI3 mRNA	PMID:22079256|PMID:22714537
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GLI3 mRNA	PMID:22079256
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:7719	ochratoxin A	affects response to substance	ISO	RGD:1314554	E	RGD:6480464	20130618	CTD	MESH:C025589	GLI3 gene affects the susceptibility to ochratoxin A	PMID:20201966
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:7719	ochratoxin A	increases response to substance	ISO	RGD:1314554	E	RGD:6480464	20130618	CTD	MESH:C025589	GLI3 gene mutant form results in increased susceptibility to ochratoxin A	PMID:16922921|PMID:17688467
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:7719	ochratoxin A	multiple interactions	ISO	RGD:1314554	E	RGD:6480464	20130618	CTD	MESH:C025589	[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA; Folic Acid inhibits the reaction [[GLI3 gene mutant form co-treated with ochratoxin A] results in increased expression of FGF8 mRNA]; ochratoxin A promotes the reaction [GLI3 gene mutant form results in increased expression of FGF8 protein]	PMID:16922921|PMID:17688467
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of GLI3 mRNA	PMID:30851411
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:78420	icariin	decreases expression	ISO	RGD:1314554	E	RGD:6480464	20260303	CTD	MESH:C056599	icariin results in decreased expression of GLI3 protein	PMID:31617598
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLI3 mRNA	PMID:27188386
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GLI3 gene]	PMID:28238834
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:620272	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of GLI3 mRNA	PMID:32109520
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:82527	Ptaquiloside	decreases expression	ISO	RGD:1314554	E	RGD:6480464	20141111	CTD	MESH:C043680	ptaquiloside results in decreased expression of GLI3 mRNA	PMID:23274088
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:82664	iron(0)	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D007501	[Arsenic co-treated with Iron] results in decreased expression of GLI3 mRNA	PMID:31739468
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of GLI3 mRNA	PMID:33512557
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:620272	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GLI3 mRNA	PMID:36843608
1314553	GLI3	GLI family zinc finger 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GLI3 mRNA	PMID:27188386
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1318952	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PCDHB5 mRNA	PMID:30319688
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of PCDHB5 mRNA	PMID:21185374
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1309895	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of PCDHB5 mRNA; Trichloroethylene results in decreased expression of PCDHB8 mRNA	PMID:33387578
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:16602	trichloroethene	decreases methylation	ISO	RGD:1309895	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of PCDHB5 gene	PMID:27618143
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of PCDHB5 mRNA	PMID:26079696
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1318952	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDHB5 mRNA	PMID:37992649
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1318952	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDHB5 mRNA	PMID:37992649
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1309895	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PCDHB5 mRNA	PMID:33387578
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:193591	Didecyldimethylammonium	decreases expression	EXP		E	RGD:6480464	20221018	CTD	MESH:C027118	didecyldimethylammonium results in decreased expression of PCDHB5 mRNA	PMID:32763356
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDHB5 gene	PMID:27153756
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of PCDHB5 protein	PMID:35688186
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1318952	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PCDHB5 mRNA	PMID:28960355
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of PCDHB5 gene	PMID:31636367
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PCDHB5 mRNA	PMID:27392435
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1309895	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDHB5 mRNA	PMID:33387578
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1309895	E	RGD:6480464	20260811	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PCDHB8 mRNA	PMID:32109520
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PCDHB5 mRNA	PMID:28001369
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1309895	E	RGD:6480464	20260811	CTD	MESH:D020106	Acrylamide results in increased expression of PCDHB8 mRNA	PMID:28959563
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PCDHB5 mRNA	PMID:29803840
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1318952	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDHB5 mRNA	PMID:37992649
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PCDHB5 mRNA	PMID:22714537
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDHB5 exon	PMID:27901495
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PCDHB5 3' UTR; Benzo(a)pyrene results in increased methylation of PCDHB5 promoter	PMID:27901495
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1318952	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of PCDHB5 mRNA	PMID:35295148
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PCDHB5 mRNA	PMID:19710929
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1309895	E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDHB8 mRNA	PMID:25181051|PMID:30816183
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:34107	1-nitropyrene	decreases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in decreased expression of PCDHB5 mRNA	PMID:19041380
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of PCDHB5 gene	PMID:31601247
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1318952	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PCDHB5 mRNA	PMID:39529242
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PCDHB5 mRNA	PMID:40419075
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCDHB5 mRNA	PMID:28001369
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1309895	E	RGD:6480464	20260811	CTD	MESH:D014635	Valproic Acid results in increased expression of PCDHB8 mRNA	PMID:29427782
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PCDHB5 mRNA	PMID:20106945
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1318952	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PCDHB5 mRNA	PMID:37992649
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PCDHB5 mRNA	PMID:38832940
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1309895	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PCDHB5 mRNA	PMID:33387578
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1318952	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PCDHB5 mRNA	PMID:22206623
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of PCDHB5 protein	PMID:31285264
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDHB5 gene]	PMID:28238834
1314555	PCDHB5	protocadherin beta 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1309895	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PCDHB5 mRNA; Propylthiouracil results in increased expression of PCDHB8 mRNA	PMID:24780913
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1622321	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RWDD3 mRNA	PMID:39241906
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of RWDD3 mRNA	PMID:22574217
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of RWDD3 mRNA	PMID:23019147
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1622321	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RWDD3 mRNA	PMID:39298647
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:620472	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RWDD3 mRNA	PMID:33387578
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:620472	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RWDD3 mRNA	PMID:33387578
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1622321	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in increased expression of RWDD3 mRNA	PMID:29279043
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1622321	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RWDD3 mRNA	PMID:37236586
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RWDD3 mRNA	PMID:19549813
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of RWDD3 mRNA	PMID:40512198
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D002166	Camptothecin results in increased expression of RWDD3 mRNA	PMID:33770205
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622321	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RWDD3 mRNA	PMID:21570461
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1622321	E	RGD:6480464	20150825	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RWDD3 mRNA	PMID:25975270
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:620472	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RWDD3 mRNA	PMID:33387578
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1622321	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of RWDD3 mRNA	PMID:27862939
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of RWDD3 mRNA	PMID:40512198
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RWDD3 promoter	PMID:27901495
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1622321	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RWDD3 mRNA	PMID:19770486
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1622321	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RWDD3 mRNA	PMID:19073995
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1622321	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of RWDD3 mRNA	PMID:39716349
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of RWDD3 mRNA	PMID:31745603
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:620472	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of RWDD3 mRNA	PMID:30047161
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1622321	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of RWDD3 mRNA	PMID:23557971
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:620472	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RWDD3 mRNA	PMID:34492290
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:620472	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RWDD3 mRNA	PMID:25181051
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1622321	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RWDD3 mRNA	PMID:39298647
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1622321	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of RWDD3 mRNA	PMID:40203079
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RWDD3 mRNA	PMID:28628672
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1622321	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RWDD3 mRNA	PMID:38685157
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1622321	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RWDD3 mRNA	PMID:28392331
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1622321	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RWDD3 promoter	PMID:28392331
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1622321	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RWDD3 mRNA	PMID:32715474
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RWDD3 mRNA	PMID:28628672
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RWDD3 mRNA	PMID:37042841
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1622321	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RWDD3 mRNA	PMID:37236586
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:620472	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of RWDD3 gene	PMID:22079235
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1622321	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of RWDD3 mRNA	PMID:23811191
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1622321	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RWDD3 mRNA	PMID:40194260
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RWDD3 mRNA	PMID:28302478
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RWDD3 mRNA	PMID:31533062
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RWDD3 mRNA	PMID:23179753
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:620472	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of RWDD3 mRNA	PMID:30047161
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RWDD3 mRNA	PMID:20106945|PMID:25562108
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RWDD3 mRNA	PMID:28628672
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D008727	Methotrexate results in increased expression of RWDD3 mRNA	PMID:33770205
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RWDD3 mRNA	PMID:38832940
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C111237	Vorinostat results in decreased expression of RWDD3 mRNA	PMID:33770205
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RWDD3 mRNA	PMID:28542535
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of RWDD3 mRNA	PMID:40512198
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RWDD3 mRNA	PMID:28628672
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1622321	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of RWDD3 mRNA	PMID:39716349
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1622321	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of RWDD3 mRNA	PMID:25554681
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:620472	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of RWDD3 mRNA	PMID:30047161
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1622321	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of RWDD3 mRNA	PMID:40234311
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1622321	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of RWDD3 mRNA	PMID:26377693
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:620472	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of RWDD3 mRNA	PMID:19564919
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of RWDD3 mRNA	PMID:36318118
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:620472	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of RWDD3 mRNA	PMID:30047161
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of RWDD3 mRNA	PMID:39904859
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:620472	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RWDD3 mRNA	PMID:30047161
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:620472	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RWDD3 mRNA	PMID:19281266
1314557	RWDD3	RWD domain containing 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:620472	E	RGD:6480464	20120522	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RWDD3 mRNA	PMID:21346803
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ANAPC5 mRNA	PMID:38218311
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ANAPC5 mRNA	PMID:38218311
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314559	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ANAPC5 mRNA	PMID:20188158
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314559	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ANAPC5 gene	PMID:20938992
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ANAPC5 mRNA	PMID:33167477
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of ANAPC5 mRNA	PMID:17218384
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1314559	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of ANAPC5 mRNA	PMID:40945087
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314559	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ANAPC5 mRNA	PMID:30319688
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314559	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ANAPC5 mRNA	PMID:39241906
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314559	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ANAPC5 gene	PMID:20938992
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of ANAPC5 mRNA	PMID:34673133
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ANAPC5 mRNA	PMID:23649840
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of ANAPC5 protein	PMID:37730182
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314559	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANAPC5 mRNA	PMID:28111341
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ANAPC5 mRNA	PMID:19549813
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ANAPC5 mRNA	PMID:19770486
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1314559	E	RGD:6480464	20120501	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of ANAPC5 mRNA	PMID:21785161
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ANAPC5 mRNA	PMID:25629700
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314559	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ANAPC5 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ANAPC5 mRNA]	PMID:20938992|PMID:22206623
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314559	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANAPC5 mRNA	PMID:40504410
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ANAPC5 protein	PMID:35688186
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of ANAPC5 mRNA	PMID:31295307
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:1306125	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of ANAPC5 gene	PMID:31011160
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of ANAPC5 mRNA	PMID:19921347
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314559	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ANAPC5 mRNA	PMID:21570461
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ANAPC5 mRNA	PMID:15034205
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306125	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ANAPC5 mRNA	PMID:34747641
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314559	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ANAPC5 mRNA	PMID:18796159
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314559	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of ANAPC5 mRNA; [Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of ANAPC5 mRNA; AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ANAPC5 mRNA]	PMID:15034205|PMID:16214954|PMID:19465110
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of ANAPC5 mRNA	PMID:23649840
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ANAPC5 mRNA	PMID:30911355
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ANAPC5 mRNA	PMID:29432896
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ANAPC5 mRNA	PMID:38568856
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314559	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANAPC5 mRNA	PMID:40504410
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ANAPC5 mRNA	PMID:15034205
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314559	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of ANAPC5 mRNA]	PMID:15034205
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ANAPC5 mRNA	PMID:30911355
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ANAPC5 mRNA	PMID:39716349
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of ANAPC5 mRNA	PMID:27188386
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of ANAPC5 mRNA	PMID:31745603
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1314559	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of ANAPC5 gene	PMID:35295148
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1314559	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of ANAPC5 mRNA	PMID:18648102
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ANAPC5 mRNA	PMID:17426115
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314559	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of ANAPC5 mRNA	PMID:18301758|PMID:21318169
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314559	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of ANAPC5 mRNA]	PMID:21318169
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306125	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of ANAPC5 mRNA	PMID:33296240
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306125	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ANAPC5 mRNA	PMID:25181051
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306125	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ANAPC5 gene	PMID:28505145
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ANAPC5 mRNA	PMID:37019170
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ANAPC5 mRNA	PMID:17361019
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ANAPC5 mRNA	PMID:34813904
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ANAPC5 mRNA	PMID:34813904
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1314559	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ANAPC5 mRNA	PMID:17854601
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314559	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ANAPC5 mRNA]	PMID:17854601
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ANAPC5 mRNA	PMID:37042841
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ANAPC5 mRNA	PMID:38174414
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314559	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANAPC5 mRNA	PMID:28111341
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314559	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ANAPC5 mRNA	PMID:40194260
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ANAPC5 mRNA	PMID:19167446
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ANAPC5 mRNA	PMID:25979313
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ANAPC5 mRNA	PMID:23179753
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314559	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ANAPC5 mRNA	PMID:17555576
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of ANAPC5 mRNA	PMID:23649840
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ANAPC5 mRNA	PMID:21420995
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ANAPC5 mRNA	PMID:29279043
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314559	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ANAPC5 mRNA	PMID:40504410
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314559	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ANAPC5 mRNA	PMID:17555576
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ANAPC5 mRNA	PMID:39716349
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306125	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ANAPC5 mRNA	PMID:24793618
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of ANAPC5 mRNA	PMID:20977926
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of ANAPC5 mRNA	PMID:17895889
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314559	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ANAPC5 mRNA	PMID:19042947
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:63933	Aroclor 1254	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of ANAPC5 mRNA	PMID:16934159
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ANAPC5 mRNA	PMID:15336504
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ANAPC5 mRNA	PMID:24810058
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306125	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ANAPC5 gene	PMID:35440735
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314559	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ANAPC5 mRNA	PMID:22206623
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314559	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ANAPC5 mRNA]	PMID:22206623
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ANAPC5 protein	PMID:31285264
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ANAPC5 gene]	PMID:28238834
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ANAPC5 mRNA	PMID:19159669
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:80799	Bufotalin	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of ANAPC5 mRNA	PMID:39904859
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of ANAPC5 mRNA	PMID:22538082
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ANAPC5 mRNA	PMID:17440010
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ANAPC5 mRNA	PMID:38568856
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306125	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ANAPC5 mRNA	PMID:21346803
1314558	ANAPC5	anaphase promoting complex subunit 5	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314559	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ANAPC5 mRNA	PMID:35537566
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PIP5K1A mRNA	PMID:38218311
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314562	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PIP5K1A mRNA	PMID:33045310
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:132889	graphene oxide	increases expression	ISO	RGD:1314562	E	RGD:6480464	20210406	CTD	MESH:C000628730	graphene oxide results in increased expression of PIP5K1A mRNA	PMID:33227293
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314562	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PIP5K1A mRNA	PMID:26251327
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1314562	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of PIP5K1A promoter	PMID:26251327
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314562	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PIP5K1A mRNA	PMID:36331819
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of PIP5K1A mRNA	PMID:15223131|PMID:19167446
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	ESR1 protein affects the reaction [Estradiol results in increased expression of PIP5K1A mRNA]	PMID:15223131
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1314562	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in decreased expression of PIP5K1A mRNA	PMID:29980752
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1306127	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Genistein] results in increased expression of PIP5K1A mRNA	PMID:32533902
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PIP5K1A protein	PMID:37730182
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306127	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of PIP5K1A mRNA	PMID:22061828
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306127	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PIP5K1A mRNA	PMID:33387578
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PIP5K1A mRNA	PMID:39836092
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:2038	5-azacytidine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001374	Azacitidine results in decreased expression of PIP5K1A mRNA	PMID:19194470
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in increased expression of PIP5K1A protein	PMID:34081812
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D002104	ISA-2011B inhibits the reaction [Cadmium results in increased expression of PIP5K1A protein]	PMID:34081812
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PIP5K1A mRNA	PMID:19549813
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of PIP5K1A mRNA	PMID:19774075
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314562	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PIP5K1A mRNA	PMID:25629700
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PIP5K1A gene	PMID:25304211
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PIP5K1A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PIP5K1A mRNA	PMID:39836092
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PIP5K1A protein	PMID:35688186
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1314562	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in increased expression of PIP5K1A mRNA	PMID:16917069
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1306127	E	RGD:6480464	20250311	CTD	MESH:D019833	[Diethylhexyl Phthalate co-treated with Genistein] results in increased expression of PIP5K1A mRNA	PMID:32533902
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314562	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PIP5K1A mRNA	PMID:21570461
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PIP5K1A mRNA	PMID:30851411
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306127	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PIP5K1A mRNA	PMID:28959563
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PIP5K1A mRNA	PMID:29803840
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:28885	butan-1-ol	multiple interactions	ISO	RGD:1314562	E	RGD:6480464	20120412	CTD	MESH:D020001	1-Butanol inhibits the reaction [lysophosphatidic acid results in increased activity of PIP5K1A protein]	PMID:10913605
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314562	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of PIP5K1A mRNA	PMID:36209798
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PIP5K1A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PIP5K1A mRNA	PMID:39836092
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PIP5K1A promoter	PMID:27901495
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314562	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PIP5K1A mRNA	PMID:27195522
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PIP5K1A 5' UTR	PMID:27901495
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of PIP5K1A mRNA	PMID:26014281
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PIP5K1A mRNA	PMID:23806026
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314562	E	RGD:6480464	20211109	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PIP5K1A mRNA	PMID:33720480
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314562	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PIP5K1A gene; titanium dioxide results in decreased methylation of PIP5K1A promoter alternative form	PMID:35295148
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314562	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of PIP5K1A mRNA	PMID:23557971
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306127	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PIP5K1A mRNA	PMID:34492290
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306127	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of PIP5K1A mRNA	PMID:19167457
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306127	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PIP5K1A mRNA	PMID:25181051
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of PIP5K1A mRNA	PMID:15223131
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306127	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of PIP5K1A mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314562	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PIP5K1A mRNA	PMID:26063408
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	ESR1 protein affects the reaction [bisphenol A results in increased expression of PIP5K1A mRNA]	PMID:15223131
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306127	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PIP5K1A mRNA	PMID:36041667
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306127	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PIP5K1A mRNA	PMID:36041667
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:34568	Benzo[ghi]perylene	decreases expression	ISO	RGD:1314562	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in decreased expression of PIP5K1A mRNA	PMID:26377693
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1306127	E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIP5K1A protein	PMID:34896426
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306127	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of PIP5K1A mRNA	PMID:36041667
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314562	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PIP5K1A mRNA	PMID:37019170
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314562	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PIP5K1A mRNA	PMID:21266533
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1314562	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of PIP5K1A mRNA	PMID:34813904
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PIP5K1A mRNA	PMID:39836092
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PIP5K1A mRNA	PMID:38174414
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314562	E	RGD:6480464	20180828	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PIP5K1A mRNA	PMID:29408670
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314562	E	RGD:6480464	20180828	CTD	MESH:D019256	Cadmium Chloride deficiency affects the reaction [Cadmium Chloride results in increased expression of PIP5K1A mRNA]	PMID:29408670
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of PIP5K1A mRNA	PMID:19320972|PMID:19376846
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of PIP5K1A mRNA	PMID:19167446
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1306127	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of PIP5K1A protein	PMID:34896426
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314562	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PIP5K1A mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PIP5K1A mRNA	PMID:36331819
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PIP5K1A mRNA	PMID:25562108
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1306127	E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIP5K1A protein	PMID:34896426
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1306127	E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIP5K1A protein	PMID:34896426
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of PIP5K1A mRNA	PMID:36621641
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314562	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PIP5K1A mRNA	PMID:17562736
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PIP5K1A gene	PMID:25304211
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PIP5K1A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PIP5K1A mRNA	PMID:39836092
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of PIP5K1A mRNA	PMID:36621641
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1306127	E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIP5K1A protein	PMID:34896426
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314562	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PIP5K1A mRNA; Nanotubes, Carbon results in increased expression of PIP5K1A mRNA	PMID:25554681|PMID:25620056
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:52288	1-octadec-9-enoylglycero-3-phosphate	increases activity	ISO	RGD:1314562	E	RGD:6480464	20120412	CTD	MESH:C032881	lysophosphatidic acid results in increased activity of PIP5K1A protein	PMID:10913605
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:52288	1-octadec-9-enoylglycero-3-phosphate	multiple interactions	ISO	RGD:1314562	E	RGD:6480464	20120412	CTD	MESH:C032881	1-Butanol inhibits the reaction [lysophosphatidic acid results in increased activity of PIP5K1A protein]; DGKA protein promotes the reaction [lysophosphatidic acid results in increased activity of PIP5K1A protein]	PMID:10913605
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of PIP5K1A mRNA	PMID:20977926
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PIP5K1A mRNA	PMID:39836092
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1314562	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of PIP5K1A mRNA	PMID:26307267
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314562	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PIP5K1A mRNA	PMID:22206623
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:748435	pafuramidine	multiple interactions	ISO	RGD:1314562	E	RGD:6480464	20260714	CTD	MESH:C458513	PIP5K1A affects the reaction [pafuramidine results in increased expression of HAVCR1 protein]	PMID:22940726
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of PIP5K1A mRNA	PMID:30851411
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1314562	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of PIP5K1A mRNA	PMID:21278054
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of PIP5K1A mRNA	PMID:26014281
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1314562	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of PIP5K1A mRNA	PMID:18930950
1314561	PIP5K1A	phosphatidylinositol-4-phosphate 5-kinase type 1 alpha	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306127	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of PIP5K1A mRNA	PMID:19015723
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of DAAM2 mRNA	PMID:27188386
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314564	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of DAAM2 mRNA	PMID:20188158
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of DAAM2 mRNA	PMID:33167477
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:15756	hexadecanoic acid	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in increased expression of DAAM2 mRNA	PMID:39506029
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314564	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of DAAM2 mRNA	PMID:30319688
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314564	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DAAM2 mRNA	PMID:39241906
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of DAAM2 mRNA	PMID:30165855
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306128	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of DAAM2 mRNA	PMID:26496021
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306128	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of DAAM2 mRNA	PMID:26496021
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314564	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DAAM2 mRNA	PMID:34319233
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of DAAM2 protein	PMID:37730182
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of DAAM2 intron	PMID:30157460
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1314564	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of DAAM2 mRNA	PMID:27462272
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of DAAM2 promoter	PMID:21291286
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1314564	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of DAAM2 mRNA	PMID:35897073
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314564	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DAAM2 mRNA	PMID:21570461
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DAAM2 mRNA	PMID:20106945|PMID:21632981
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1314564	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of DAAM2 mRNA	PMID:30807115
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of DAAM2 gene	PMID:28589171
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DAAM2 5' UTR; Benzo(a)pyrene affects the methylation of DAAM2 promoter	PMID:27901495
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DAAM2 exon	PMID:27901495
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DAAM2 gene	PMID:31601247
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306128	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DAAM2 mRNA	PMID:25181051
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in decreased expression of DAAM2 mRNA	PMID:31715268
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306128	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of DAAM2 mRNA	PMID:30816183|PMID:41034487
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DAAM2 gene	PMID:31601247
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306128	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of DAAM2 mRNA; [bisphenol A co-treated with Testosterone] results in increased expression of DAAM2 mRNA	PMID:26496021
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1314564	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DAAM2 mRNA	PMID:25172293
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of DAAM2 mRNA	PMID:19244175
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314564	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of DAAM2 mRNA	PMID:40203079
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of DAAM2 gene	PMID:31601247
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1314564	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of DAAM2 exon	PMID:33297965
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of DAAM2 intron	PMID:30157460
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of DAAM2 mRNA	PMID:28628672
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314564	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DAAM2 mRNA	PMID:21266533
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of DAAM2 mRNA	PMID:28628672
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D010269	Paraquat results in decreased expression of DAAM2 mRNA	PMID:28619522
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306128	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of DAAM2 mRNA	PMID:32680482
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306128	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DAAM2 mRNA	PMID:36928142
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314564	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DAAM2 mRNA	PMID:40194260
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of DAAM2 mRNA	PMID:31533062
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DAAM2 mRNA	PMID:40419075
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DAAM2 mRNA	PMID:25979313
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1306128	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of DAAM2 mRNA	PMID:29427782
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of DAAM2 mRNA	PMID:26272509|PMID:28001369
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAAM2 mRNA	PMID:27188386
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of DAAM2 mRNA	PMID:20106945
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of DAAM2 mRNA	PMID:25047013
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of DAAM2 mRNA	PMID:28628672
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of DAAM2 mRNA	PMID:38832940
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of DAAM2 mRNA	PMID:24935251|PMID:26272509
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAAM2 mRNA	PMID:27188386
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of DAAM2 mRNA	PMID:29067470
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of DAAM2 promoter	PMID:21291286
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of DAAM2 mRNA	PMID:40706910
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of DAAM2 mRNA	PMID:28628672
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314564	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DAAM2 mRNA; Nanotubes, Carbon results in decreased expression of DAAM2 mRNA	PMID:25554681
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314564	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of DAAM2 mRNA	PMID:23608068
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of DAAM2 intron	PMID:30157460
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAAM2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAAM2 mRNA	PMID:27188386
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1314564	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of DAAM2 mRNA	PMID:27029645
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAAM2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DAAM2 mRNA	PMID:27188386
1314563	DAAM2	dishevelled associated activator of morphogenesis 2	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1314564	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of DAAM2 mRNA	PMID:26217789
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:10022	deoxynivalenol	increases phosphorylation	ISO	RGD:1314566	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased phosphorylation of THRAP3 protein	PMID:23352502|PMID:23811945
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314566	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of THRAP3 mRNA	PMID:33045310
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314566	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of THRAP3 mRNA	PMID:37995155
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of THRAP3 gene	PMID:20938992
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of THRAP3 mRNA	PMID:21934132
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314566	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of THRAP3 mRNA	PMID:30319688
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:16240	hydrogen peroxide	increases phosphorylation	ISO	RGD:1314566	E	RGD:6480464	20200211	CTD	MESH:D006861	Hydrogen Peroxide results in increased phosphorylation of THRAP3 protein	PMID:31494107
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20200211	CTD	MESH:D006861	N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride promotes the reaction [Hydrogen Peroxide results in increased phosphorylation of THRAP3 protein]	PMID:31494107
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of THRAP3 mRNA	PMID:29581250
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314566	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of THRAP3 mRNA	PMID:39241906
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306129	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of THRAP3 mRNA; Estradiol results in decreased expression of THRAP3 protein	PMID:32145629
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314566	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of THRAP3 mRNA	PMID:39298647
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [THRAP3 protein binds to ESR1 protein]	PMID:27156127
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306129	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of THRAP3 mRNA	PMID:33387578
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of THRAP3 gene	PMID:20938992
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314566	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of THRAP3 mRNA	PMID:33754040
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of THRAP3 protein	PMID:37730182
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of THRAP3 protein	PMID:23301498
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1306129	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of THRAP3 protein	PMID:33236894
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:2504	aflatoxin B1	increases mutagenesis	ISO	RGD:1306129	E	RGD:6480464	20240109	CTD	MESH:D016604	Aflatoxin B1 results in increased mutagenesis of THRAP3 gene	PMID:36908029
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of THRAP3 mRNA	PMID:24381131
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of THRAP3 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of THRAP3 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of THRAP3 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of THRAP3 protein	PMID:38598786
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of THRAP3 gene	PMID:20938992
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of THRAP3 mRNA	PMID:40504410
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of THRAP3 protein	PMID:35688186
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314566	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of THRAP3 mRNA	PMID:28960355
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of THRAP3 mRNA	PMID:23557933
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314566	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of THRAP3 mRNA	PMID:30912803
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314566	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of THRAP3 mRNA	PMID:21570461
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306129	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of THRAP3 mRNA	PMID:34747641
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of THRAP3 mRNA; aristolochic acid I results in decreased expression of THRAP3 protein	PMID:33212167
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of THRAP3 protein	PMID:35688186
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of THRAP3 mRNA	PMID:38568856
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of THRAP3 mRNA	PMID:40504410
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of THRAP3 5' UTR	PMID:27901495
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of THRAP3 promoter	PMID:27901495
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1306129	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of THRAP3 mRNA	PMID:21839799
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of THRAP3 mRNA	PMID:27858113
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of THRAP3 gene	PMID:31601247
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of THRAP3 mRNA	PMID:31745603
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314566	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of THRAP3 gene	PMID:35295148
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314566	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of THRAP3 mRNA	PMID:16985257
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of THRAP3 protein	PMID:34186270
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306129	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of THRAP3 mRNA; bisphenol A results in decreased expression of THRAP3 protein	PMID:32145629|PMID:41034487
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314566	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of THRAP3 mRNA	PMID:33221593
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306129	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of THRAP3 mRNA	PMID:41034487
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314566	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of THRAP3 mRNA	PMID:26063408
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314566	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of THRAP3 gene	PMID:31683443
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of THRAP3 protein	PMID:34186270
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314566	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of THRAP3 mRNA	PMID:39298647
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of THRAP3 mRNA	PMID:27858113
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of THRAP3 gene	PMID:31601247
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of THRAP3 protein	PMID:34186270
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314566	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of THRAP3 mRNA	PMID:37019170
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of THRAP3 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of THRAP3 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of THRAP3 protein	PMID:38598786
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306129	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of THRAP3 mRNA	PMID:21297351
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of THRAP3 mRNA	PMID:24449571
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:35861	dibenzo[a,l]pyrene	increases expression	ISO	RGD:1314566	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in increased expression of THRAP3 mRNA	PMID:25908611
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314566	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of THRAP3 mRNA	PMID:17585979
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:3766	clozapine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of THRAP3 protein	PMID:34122009
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of THRAP3 mRNA	PMID:31533062
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314566	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid analog results in decreased expression of THRAP3 mRNA; Valproic Acid results in decreased expression of THRAP3 mRNA	PMID:21427059
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of THRAP3 mRNA	PMID:17183730
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314566	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of THRAP3 mRNA	PMID:28973697
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of THRAP3 mRNA	PMID:27188386
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306129	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of THRAP3 mRNA	PMID:33387578
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of THRAP3 mRNA	PMID:17331233
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of THRAP3 mRNA	PMID:40504410
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314566	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of THRAP3 mRNA; Nanotubes, Carbon results in decreased expression of THRAP3 mRNA	PMID:25554681
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of THRAP3 mRNA	PMID:35964746
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1314566	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of THRAP3 mRNA	PMID:26377693
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of THRAP3 mRNA	PMID:27858113
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of THRAP3 mRNA	PMID:27858113
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of THRAP3 mRNA	PMID:17183730
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of THRAP3 protein	PMID:32959892
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:6773	Mesaconitine	increases expression	ISO	RGD:1306129	E	RGD:6480464	20231031	CTD	MESH:C019470	mesaconitine results in increased expression of THRAP3 protein	PMID:37182599
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of THRAP3 mRNA	PMID:31758290
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314566	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of THRAP3 mRNA	PMID:22206623
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1314566	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of THRAP3 mRNA	PMID:27858113
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of THRAP3 protein	PMID:31285264
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of THRAP3 mRNA	PMID:18927307
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314566	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of THRAP3 mRNA	PMID:23091169
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314566	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of THRAP3 mRNA	PMID:21795629
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1314566	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of THRAP3 mRNA	PMID:21278054
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306129	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of THRAP3 mRNA	PMID:19281266
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of THRAP3 mRNA	PMID:27188386
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of THRAP3 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of THRAP3 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of THRAP3 protein	PMID:38598786
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314566	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of THRAP3 mRNA	PMID:28973697
1314565	THRAP3	thyroid hormone receptor associated protein 3	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1314566	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of THRAP3 mRNA	PMID:18930950
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314568	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of OVOL2 mRNA	PMID:36189433
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of OVOL2 mRNA	PMID:26079696
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of OVOL2 mRNA	PMID:20044591
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of OVOL2 mRNA	PMID:31614463
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of OVOL2 mRNA	PMID:38568856
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of OVOL2 mRNA	PMID:28818685
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314568	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OVOL2 mRNA	PMID:37325564
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:2682	amphotericin B	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in increased expression of OVOL2 mRNA	PMID:28534445
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314568	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of OVOL2 mRNA	PMID:22206623
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of OVOL2 mRNA	PMID:26272509
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OVOL2 mRNA	PMID:27188386
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of OVOL2 mRNA	PMID:25583101
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314568	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of OVOL2 mRNA	PMID:24058054
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314568	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OVOL2 mRNA	PMID:17942748
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:28216	methylmercury chloride	affects expression	ISO	RGD:1314568	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride affects the expression of OVOL2 mRNA	PMID:21613230
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of OVOL2 mRNA	PMID:28001369
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306130	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OVOL2 mRNA	PMID:26033743
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of OVOL2 promoter	PMID:27901495
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of OVOL2 3' UTR	PMID:27901495
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306130	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of OVOL2 mRNA	PMID:26033743
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of OVOL2 mRNA	PMID:25895662
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to OVOL2 protein]	PMID:26598702
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314568	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of OVOL2 gene; titanium dioxide results in decreased methylation of OVOL2 promoter	PMID:35295148
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of OVOL2 mRNA	PMID:19710929
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314568	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of OVOL2 promoter	PMID:27334623
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306130	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of OVOL2 mRNA	PMID:25181051
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314568	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of OVOL2 mRNA	PMID:26063408
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of OVOL2 mRNA	PMID:25979313
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314568	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of OVOL2 mRNA	PMID:37019170
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314568	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of OVOL2 mRNA	PMID:37325564
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of OVOL2 mRNA	PMID:25979313
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of OVOL2 mRNA	PMID:24383497|PMID:24935251
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of OVOL2 gene	PMID:29154799
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of OVOL2 mRNA	PMID:24935251
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306130	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of OVOL2 mRNA	PMID:33387578
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314568	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of OVOL2 mRNA	PMID:17942748
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314568	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of OVOL2 mRNA	PMID:17942748
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of OVOL2 mRNA	PMID:26272509
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OVOL2 mRNA	PMID:27188386
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to OVOL2 protein]	PMID:26598702
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314568	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of OVOL2 mRNA; Nanotubes, Carbon results in decreased expression of OVOL2 mRNA	PMID:25554681
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314568	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of OVOL2 mRNA	PMID:23608068
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1314568	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of OVOL2 mRNA	PMID:38701926
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314568	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OVOL2 mRNA	PMID:26378955
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314568	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of OVOL2 mRNA	PMID:22206623
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314568	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of OVOL2 mRNA	PMID:22206623
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of OVOL2 mRNA	PMID:37199045
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OVOL2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OVOL2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OVOL2 mRNA	PMID:27188386
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to OVOL2 gene]	PMID:28238834
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314568	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of OVOL2 mRNA	PMID:31388691
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of OVOL2 mRNA	PMID:26079696
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306130	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of OVOL2 mRNA	PMID:24780913
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OVOL2 mRNA	PMID:27188386
1314567	OVOL2	ovo like zinc finger 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OVOL2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OVOL2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of OVOL2 mRNA	PMID:27188386
1314569	SFXN2	sideroflexin 2	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in increased expression of SFXN2 mRNA	PMID:18313992
1314569	SFXN2	sideroflexin 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306131	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SFXN2 mRNA]	PMID:31150632
1314569	SFXN2	sideroflexin 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SFXN2 mRNA	PMID:23724009
1314569	SFXN2	sideroflexin 2	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SFXN2 mRNA	PMID:22378314
1314569	SFXN2	sideroflexin 2	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of SFXN2 mRNA	PMID:18951874
1314569	SFXN2	sideroflexin 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314570	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SFXN2 mRNA	PMID:39241906
1314569	SFXN2	sideroflexin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306131	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of SFXN2 mRNA	PMID:32145629
1314569	SFXN2	sideroflexin 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SFXN2 mRNA	PMID:39298647
1314569	SFXN2	sideroflexin 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of SFXN2 mRNA	PMID:16474171|PMID:19167446|PMID:31614463
1314569	SFXN2	sideroflexin 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of SFXN2 mRNA	PMID:30165855
1314569	SFXN2	sideroflexin 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306131	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of SFXN2 mRNA	PMID:26496021
1314569	SFXN2	sideroflexin 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SFXN2 mRNA	PMID:25510870
1314569	SFXN2	sideroflexin 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SFXN2 mRNA	PMID:33848595
1314569	SFXN2	sideroflexin 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306131	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of SFXN2 mRNA	PMID:26496021
1314569	SFXN2	sideroflexin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SFXN2 mRNA	PMID:34319233
1314569	SFXN2	sideroflexin 2	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SFXN2 mRNA	PMID:36139627
1314569	SFXN2	sideroflexin 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SFXN2 mRNA	PMID:28818685
1314569	SFXN2	sideroflexin 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFXN2 mRNA	PMID:39836092
1314569	SFXN2	sideroflexin 2	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of SFXN2 mRNA	PMID:17103032
1314569	SFXN2	sideroflexin 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306131	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of SFXN2 mRNA	PMID:28522335
1314569	SFXN2	sideroflexin 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SFXN2 mRNA	PMID:25510870
1314569	SFXN2	sideroflexin 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SFXN2 mRNA	PMID:25510870
1314569	SFXN2	sideroflexin 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SFXN2 mRNA	PMID:19549813
1314569	SFXN2	sideroflexin 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of SFXN2 protein	PMID:20106945
1314569	SFXN2	sideroflexin 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SFXN2 mRNA	PMID:19770486
1314569	SFXN2	sideroflexin 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of SFXN2 mRNA	PMID:35430440
1314569	SFXN2	sideroflexin 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306131	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SFXN2 mRNA	PMID:31150632
1314569	SFXN2	sideroflexin 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SFXN2 mRNA	PMID:31919559
1314569	SFXN2	sideroflexin 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306131	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SFXN2 mRNA]	PMID:31150632
1314569	SFXN2	sideroflexin 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SFXN2 mRNA	PMID:25629700
1314569	SFXN2	sideroflexin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFXN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SFXN2 mRNA	PMID:39836092
1314569	SFXN2	sideroflexin 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306131	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SFXN2 mRNA	PMID:31881176
1314569	SFXN2	sideroflexin 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of SFXN2 mRNA	PMID:19167446
1314569	SFXN2	sideroflexin 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of SFXN2 mRNA	PMID:27392435
1314569	SFXN2	sideroflexin 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SFXN2 mRNA	PMID:27392435
1314569	SFXN2	sideroflexin 2	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1314570	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of SFXN2 mRNA	PMID:18930951
1314569	SFXN2	sideroflexin 2	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of SFXN2 mRNA	PMID:16474171
1314569	SFXN2	sideroflexin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SFXN2 mRNA	PMID:19770486|PMID:28213091
1314569	SFXN2	sideroflexin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SFXN2 gene]	PMID:28213091
1314569	SFXN2	sideroflexin 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306131	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of SFXN2 mRNA	PMID:28374803
1314569	SFXN2	sideroflexin 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SFXN2 mRNA	PMID:33212167
1314569	SFXN2	sideroflexin 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306131	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SFXN2 mRNA	PMID:28959563
1314569	SFXN2	sideroflexin 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SFXN2 mRNA	PMID:29803840
1314569	SFXN2	sideroflexin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SFXN2 mRNA	PMID:38568856
1314569	SFXN2	sideroflexin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFXN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SFXN2 mRNA	PMID:39836092
1314569	SFXN2	sideroflexin 2	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of SFXN2 mRNA	PMID:22378314
1314569	SFXN2	sideroflexin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SFXN2 mRNA	PMID:32234424
1314569	SFXN2	sideroflexin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SFXN2 mRNA	PMID:19770486
1314569	SFXN2	sideroflexin 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SFXN2 mRNA	PMID:27858113
1314569	SFXN2	sideroflexin 2	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314570	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SFXN2 mRNA	PMID:27131904
1314569	SFXN2	sideroflexin 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SFXN2 mRNA	PMID:26238291
1314569	SFXN2	sideroflexin 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306131	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of SFXN2 mRNA	PMID:23411599|PMID:34492290
1314569	SFXN2	sideroflexin 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SFXN2 mRNA	PMID:18648102
1314569	SFXN2	sideroflexin 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of SFXN2 mRNA	PMID:38479592
1314569	SFXN2	sideroflexin 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of SFXN2 mRNA; bisphenol A results in decreased expression of SFXN2 protein	PMID:29275510|PMID:33376534
1314569	SFXN2	sideroflexin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306131	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SFXN2 mRNA	PMID:25181051|PMID:32145629
1314569	SFXN2	sideroflexin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of SFXN2 mRNA	PMID:32156529
1314569	SFXN2	sideroflexin 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of SFXN2 mRNA	PMID:16474171
1314569	SFXN2	sideroflexin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306131	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SFXN2 mRNA	PMID:34947998
1314569	SFXN2	sideroflexin 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306131	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of SFXN2 mRNA; [bisphenol A co-treated with Testosterone] results in increased expression of SFXN2 mRNA	PMID:26496021
1314569	SFXN2	sideroflexin 2	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SFXN2 mRNA	PMID:26682919
1314569	SFXN2	sideroflexin 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SFXN2 mRNA	PMID:25510870
1314569	SFXN2	sideroflexin 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SFXN2 mRNA	PMID:25510870
1314569	SFXN2	sideroflexin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20240206	CTD	MESH:C543008	bisphenol S results in decreased expression of SFXN2 mRNA	PMID:37611474|PMID:39298647
1314569	SFXN2	sideroflexin 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SFXN2 mRNA	PMID:27858113
1314569	SFXN2	sideroflexin 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314570	E	RGD:6480464	20240206	CTD	MESH:C008745	bisphenol F results in increased expression of SFXN2 mRNA	PMID:37611474
1314569	SFXN2	sideroflexin 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1314570	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of SFXN2 mRNA	PMID:34813904
1314569	SFXN2	sideroflexin 2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306131	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SFXN2 mRNA	PMID:32680482
1314569	SFXN2	sideroflexin 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of SFXN2 mRNA	PMID:36117858
1314569	SFXN2	sideroflexin 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFXN2 mRNA	PMID:39836092
1314569	SFXN2	sideroflexin 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SFXN2 mRNA	PMID:24449571
1314569	SFXN2	sideroflexin 2	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SFXN2 mRNA	PMID:28302478
1314569	SFXN2	sideroflexin 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SFXN2 mRNA	PMID:31533062
1314569	SFXN2	sideroflexin 2	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SFXN2 mRNA	PMID:19167446
1314569	SFXN2	sideroflexin 2	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFXN2 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of SFXN2 mRNA	PMID:19167446
1314569	SFXN2	sideroflexin 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of SFXN2 mRNA	PMID:39529242
1314569	SFXN2	sideroflexin 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SFXN2 mRNA	PMID:25979313
1314569	SFXN2	sideroflexin 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SFXN2 gene	PMID:29154799
1314569	SFXN2	sideroflexin 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SFXN2 mRNA	PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509
1314569	SFXN2	sideroflexin 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFXN2 mRNA	PMID:27188386
1314569	SFXN2	sideroflexin 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306131	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SFXN2 mRNA	PMID:30047161
1314569	SFXN2	sideroflexin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SFXN2 mRNA	PMID:20106945|PMID:25562108
1314569	SFXN2	sideroflexin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of SFXN2 mRNA	PMID:19770486
1314569	SFXN2	sideroflexin 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of SFXN2 mRNA	PMID:27989131
1314569	SFXN2	sideroflexin 2	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of SFXN2 mRNA]	PMID:21233418
1314569	SFXN2	sideroflexin 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314570	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SFXN2 mRNA	PMID:17562736
1314569	SFXN2	sideroflexin 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of SFXN2 mRNA	PMID:25704631|PMID:26690555
1314569	SFXN2	sideroflexin 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306131	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SFXN2 mRNA	PMID:33387578
1314569	SFXN2	sideroflexin 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFXN2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SFXN2 mRNA	PMID:39836092
1314569	SFXN2	sideroflexin 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SFXN2 mRNA	PMID:35436446
1314569	SFXN2	sideroflexin 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306131	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SFXN2 mRNA	PMID:30047161
1314569	SFXN2	sideroflexin 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SFXN2 mRNA	PMID:27858113
1314569	SFXN2	sideroflexin 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SFXN2 mRNA	PMID:27858113
1314569	SFXN2	sideroflexin 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of SFXN2 mRNA	PMID:36117858
1314569	SFXN2	sideroflexin 2	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of SFXN2 mRNA	PMID:22714537
1314569	SFXN2	sideroflexin 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SFXN2 mRNA	PMID:39836092
1314569	SFXN2	sideroflexin 2	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1314570	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in increased expression of SFXN2 mRNA	PMID:18313992
1314569	SFXN2	sideroflexin 2	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of SFXN2 mRNA	PMID:28988120|PMID:29427785
1314569	SFXN2	sideroflexin 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1306131	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SFXN2 mRNA	PMID:28801915
1314569	SFXN2	sideroflexin 2	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of SFXN2 mRNA	PMID:27462272
1314569	SFXN2	sideroflexin 2	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of SFXN2 mRNA	PMID:22101062
1314569	SFXN2	sideroflexin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314570	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SFXN2 mRNA	PMID:22206623
1314569	SFXN2	sideroflexin 2	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of SFXN2 mRNA	PMID:36318118
1314569	SFXN2	sideroflexin 2	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SFXN2 mRNA	PMID:36139627
1314569	SFXN2	sideroflexin 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFXN2 mRNA	PMID:27188386
1314569	SFXN2	sideroflexin 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314570	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SFXN2 mRNA	PMID:23091169
1314569	SFXN2	sideroflexin 2	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SFXN2 mRNA	PMID:19167446
1314569	SFXN2	sideroflexin 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1306131	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SFXN2 mRNA	PMID:27291303
1314569	SFXN2	sideroflexin 2	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of SFXN2 mRNA	PMID:32234424
1314569	SFXN2	sideroflexin 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1306131	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SFXN2 mRNA	PMID:23640034
1314569	SFXN2	sideroflexin 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1306131	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of SFXN2 mRNA	PMID:23640034
1314569	SFXN2	sideroflexin 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1314570	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of SFXN2 mRNA	PMID:21278054
1314569	SFXN2	sideroflexin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306131	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SFXN2 mRNA	PMID:30047161
1314569	SFXN2	sideroflexin 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SFXN2 mRNA	PMID:27188386
1314569	SFXN2	sideroflexin 2	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314570	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of SFXN2 mRNA	PMID:27131904
1314569	SFXN2	sideroflexin 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SFXN2 mRNA	PMID:38568856
1314569	SFXN2	sideroflexin 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SFXN2 mRNA	PMID:29301935
1314569	SFXN2	sideroflexin 2	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of SFXN2 mRNA	PMID:22378314
1314569	SFXN2	sideroflexin 2	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1306131	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of SFXN2 mRNA	PMID:30047161
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of LY6D mRNA	PMID:37995155
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LY6D mRNA	PMID:20938992
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of LY6D mRNA	PMID:23830798
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1314572	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of LY6D mRNA	PMID:39298647
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of LY6D mRNA	PMID:31614463
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314572	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of LY6D mRNA	PMID:33711761
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306132	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LY6D mRNA	PMID:33387578
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1314572	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of LY6D mRNA	PMID:25549359
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LY6D mRNA	PMID:20938992
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of LY6D mRNA	PMID:26079696
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LY6D mRNA	PMID:37992649
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:17356	2-acetamidofluorene	increases expression	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:D015073	2-Acetylaminofluorene results in increased expression of LY6D mRNA	PMID:17317680
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LY6D mRNA	PMID:37992649
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LY6D mRNA	PMID:28412506
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314572	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LY6D mRNA	PMID:33754040
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of LY6D mRNA	PMID:28818685
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LY6D mRNA	PMID:36331819
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LY6D mRNA	PMID:21641981
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314572	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LY6D mRNA	PMID:19770486
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of LY6D mRNA	PMID:17095637
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of LY6D mRNA	PMID:34911549
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1314572	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of LY6D mRNA	PMID:24489787
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of LY6D protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of LY6D protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of LY6D protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of LY6D protein	PMID:38598786
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306132	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of LY6D mRNA	PMID:30779732
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in decreased expression of LY6D mRNA	PMID:31939706
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314572	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LY6D mRNA	PMID:27339419|PMID:29987408|PMID:31919559
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LY6D mRNA	PMID:20938992
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LY6D gene	PMID:25304211
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LY6D mRNA	PMID:40504410
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:27779	griseofulvin	increases expression	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:D006118	Griseofulvin results in increased expression of LY6D mRNA	PMID:12735108
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of LY6D mRNA	PMID:23557933
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol inhibits the reaction [Dietary Fats affects the expression of LY6D mRNA]	PMID:17086191
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of LY6D gene	PMID:31636367
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of LY6D mRNA	PMID:40618947
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314572	E	RGD:6480464	20140513	CTD	MESH:D019833	Genistein results in increased expression of LY6D mRNA	PMID:22553218|PMID:32186404
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of LY6D mRNA	PMID:25583101
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314572	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LY6D mRNA	PMID:21570461|PMID:26377647
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314572	E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LY6D mRNA	PMID:17035482|PMID:21041162
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306132	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of LY6D mRNA	PMID:28959563
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LY6D mRNA	PMID:37992649
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LY6D mRNA	PMID:38568856
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of LY6D mRNA	PMID:33933676|PMID:37682722
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1314572	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of LY6D gene	PMID:39894169
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of LY6D mRNA	PMID:34032870
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314572	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of LY6D mRNA	PMID:17350061
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LY6D mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LY6D mRNA	PMID:34876320|PMID:40504410
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LY6D mRNA	PMID:34876320
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LY6D promoter	PMID:27901495
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LY6D mRNA	PMID:21569818|PMID:22610609
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LY6D exon	PMID:27901495
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LY6D mRNA	PMID:22316170|PMID:32234424
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314572	E	RGD:6480464	20250401	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LY6D mRNA	PMID:38811393
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of LY6D mRNA	PMID:27760801
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314572	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of LY6D mRNA	PMID:23557971
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of LY6D mRNA	PMID:18648102
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314572	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of LY6D mRNA	PMID:17118139|PMID:17690133|PMID:18301758|PMID:20813756|PMID:23811191
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LY6D mRNA	PMID:19710929
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306132	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LY6D mRNA	PMID:25181051
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of LY6D mRNA	PMID:20739668|PMID:32156529|PMID:38701888
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20250805	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of LY6D protein	PMID:26903627
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LY6D mRNA	PMID:39298647
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314572	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LY6D mRNA	PMID:30951980
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of LY6D mRNA	PMID:38685157
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of LY6D mRNA	PMID:35093514
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of LY6D gene	PMID:22964155
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of LY6D protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of LY6D protein	PMID:38598786
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1314572	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of LY6D mRNA	PMID:12771043|PMID:24535843
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LY6D mRNA	PMID:24535843
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LY6D mRNA	PMID:38382870
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314572	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of LY6D mRNA	PMID:24982889
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1314572	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in increased expression of LY6D mRNA	PMID:24183702
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20121009	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of LY6D mRNA	PMID:22698814
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314572	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of LY6D mRNA	PMID:28962523
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314572	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of LY6D mRNA	PMID:23811191
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of LY6D mRNA	PMID:40194260
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LY6D mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of LY6D mRNA	PMID:36331819
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of LY6D mRNA	PMID:23125180
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of LY6D mRNA	PMID:17292431
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314572	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of LY6D mRNA	PMID:24489787
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LY6D gene	PMID:29154799
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20120515	CTD	MESH:D003907	Dexamethasone results in decreased expression of LY6D mRNA	PMID:21041162
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20120515	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of LY6D mRNA	PMID:21041162
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LY6D mRNA	PMID:37992649
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of LY6D mRNA	PMID:18502557
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LY6D mRNA	PMID:38832940
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LY6D mRNA	PMID:17562736
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of LY6D mRNA	PMID:22230336
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314572	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in increased expression of LY6D mRNA	PMID:29246445
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of LY6D mRNA]	PMID:29246445
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LY6D gene	PMID:25304211
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LY6D mRNA	PMID:40504410
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:47612	bezafibrate	increases expression	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:D001629	Bezafibrate results in increased expression of LY6D mRNA	PMID:17118139
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314572	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of LY6D mRNA	PMID:35436446
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LY6D mRNA	PMID:34876320
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:D011345	Fenofibrate results in increased expression of LY6D mRNA	PMID:17118139
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1314572	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of LY6D mRNA	PMID:25554681
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LY6D mRNA	PMID:25554681
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314572	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of LY6D mRNA; Nanotubes, Carbon results in increased expression of LY6D mRNA	PMID:25620056
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:50867	ciprofibrate	increases expression	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:C019304	ciprofibrate results in increased expression of LY6D mRNA	PMID:12771043
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LY6D mRNA	PMID:35964746
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:53351	chromium(3+) trichloride	decreases expression	ISO	RGD:1314572	E	RGD:6480464	20130611	CTD	MESH:C022990	chromic chloride results in decreased expression of LY6D mRNA	PMID:12128095
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314572	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of LY6D mRNA	PMID:38701926
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:6382	Lasiocarpine	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in increased expression of LY6D mRNA	PMID:40054833
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:64213	cantharidin	increases expression	ISO	RGD:1314572	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in increased expression of LY6D mRNA	PMID:36907384
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of LY6D mRNA	PMID:37939859
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in decreased expression of LY6D mRNA	PMID:33244087
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314572	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LY6D mRNA	PMID:22206623
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of LY6D mRNA	PMID:35486664
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of LY6D mRNA	PMID:19482888
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LY6D mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LY6D mRNA]	PMID:19482888|PMID:24535843
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314572	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of LY6D mRNA	PMID:38648751
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314572	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of LY6D mRNA	PMID:30294300
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:81927	enilconazole	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C017435	enilconazole results in decreased expression of LY6D mRNA	PMID:32201337
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:81981	chlorotoluron	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C007033	chlortoluron results in decreased expression of LY6D mRNA	PMID:39207506
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LY6D mRNA	PMID:34876320
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:8434	prochloraz	increases expression	ISO	RGD:1306132	E	RGD:6480464	20180515	CTD	MESH:C045362	prochloraz results in increased expression of LY6D mRNA	PMID:29038839
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:8489	propiconazole	multiple interactions	ISO	RGD:1314572	E	RGD:6480464	20250902	CTD	MESH:C045950	[propiconazole affects the susceptibility to Dietary Fats] which affects the expression of LY6D mRNA	PMID:39718591
1314571	LY6D	lymphocyte antigen 6 family member D	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of LY6D protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of LY6D protein	PMID:38598786
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:10022	deoxynivalenol	affects phosphorylation	ISO	RGD:1314574	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol affects the phosphorylation of LSP1 protein	PMID:23811945
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in decreased expression of LSP1 mRNA	PMID:31863870
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:10022	deoxynivalenol	increases phosphorylation	ISO	RGD:1314574	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased phosphorylation of LSP1 protein	PMID:23352502
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in decreased expression of LSP1 mRNA	PMID:17557909
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of LSP1 mRNA	PMID:38218311
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of LSP1 mRNA	PMID:25152437
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1306133	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of LSP1 mRNA	PMID:21551480
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of LSP1 mRNA	PMID:33045310
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of LSP1 mRNA	PMID:20188158
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314574	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of LSP1 mRNA	PMID:26251327
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LSP1 mRNA	PMID:20938992
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in increased expression of LSP1 mRNA	PMID:12875902|PMID:15498508|PMID:15894607
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1306133	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of LSP1 mRNA	PMID:20488242
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	[Arsenic Trioxide co-treated with Tretinoin] results in increased expression of LSP1 mRNA; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LSP1 mRNA	PMID:15894607|PMID:38179723
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of LSP1 mRNA	PMID:30951980
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1306133	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of LSP1 mRNA	PMID:33729688
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of LSP1 mRNA	PMID:26079696
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306133	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of LSP1 gene	PMID:28931070
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of LSP1 mRNA	PMID:39241906
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of LSP1 mRNA	PMID:30510588
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of LSP1 mRNA	PMID:15289156
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of LSP1 mRNA	PMID:30165855
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306133	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LSP1 mRNA	PMID:32741896
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314574	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of LSP1 mRNA	PMID:33711761
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of LSP1 mRNA	PMID:38568856
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of LSP1 mRNA	PMID:33387578
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LSP1 mRNA	PMID:20938992
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1306133	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of LSP1 mRNA	PMID:24304932
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LSP1 mRNA	PMID:37992649
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306133	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LSP1 mRNA	PMID:32741896
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LSP1 mRNA	PMID:37992649
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306133	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of LSP1 mRNA	PMID:27523638
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of LSP1 mRNA	PMID:26485663
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of LSP1 mRNA	PMID:12875902
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of LSP1 mRNA	PMID:33387578
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306133	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of LSP1 mRNA	PMID:22061828
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of LSP1 intron	PMID:30157460
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1314574	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of LSP1 mRNA	PMID:39984025
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LSP1 mRNA	PMID:19549813
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306133	E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LSP1 mRNA	PMID:25378103
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of LSP1 3' UTR; Aflatoxin B1 results in increased methylation of LSP1 promoter	PMID:30157460
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of LSP1 mRNA	PMID:35430440
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of LSP1 mRNA	PMID:34911549
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306133	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of LSP1 mRNA	PMID:30779732
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LSP1 mRNA	PMID:20938992
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LSP1 gene	PMID:25304211
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of LSP1 gene] which results in increased expression of LSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of LSP1 gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LSP1 mRNA	PMID:40504410
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of LSP1 mRNA	PMID:19244175
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of LSP1 mRNA	PMID:38460933
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306133	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of LSP1 mRNA	PMID:31881176
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of LSP1 mRNA	PMID:27392435
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20180313	CTD	MESH:D003042	Cocaine results in decreased expression of LSP1 mRNA	PMID:27899881
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of LSP1 mRNA	PMID:15289156
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306133	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LSP1 mRNA	PMID:34747641
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314574	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LSP1 mRNA	PMID:26377647
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LSP1 mRNA	PMID:32109520|PMID:33387578
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314574	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LSP1 mRNA	PMID:26290441
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1306133	E	RGD:6480464	20200211	CTD	MESH:C004925	methylmercuric chloride results in increased expression of LSP1 mRNA	PMID:31378766
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of LSP1 mRNA	PMID:28959563
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in decreased expression of LSP1 mRNA	PMID:25896364|PMID:39631538
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LSP1 mRNA	PMID:37992649
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LSP1 mRNA	PMID:38568856
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of LSP1 gene] which results in increased expression of LSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of LSP1 gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LSP1 mRNA	PMID:40504410
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LSP1 5' UTR; Benzo(a)pyrene affects the methylation of LSP1 intron	PMID:27901495|PMID:30157460
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of LSP1 mRNA	PMID:21871943|PMID:22316170|PMID:32234424
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LSP1 3' UTR	PMID:27901495
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314574	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LSP1 mRNA	PMID:27131904
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of LSP1 mRNA	PMID:25895662
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1306133	E	RGD:6480464	20210706	CTD	MESH:D012822	Silicon Dioxide results in increased expression of LSP1 mRNA	PMID:32721576
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of LSP1 mRNA	PMID:15761015
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Arsenic Trioxide co-treated with Tretinoin] results in increased expression of LSP1 mRNA; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LSP1 mRNA	PMID:15894607|PMID:38179723
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of LSP1 mRNA	PMID:24395379
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1306133	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of LSP1 mRNA	PMID:24915197
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in increased methylation of LSP1 gene	PMID:31601247
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of LSP1 mRNA	PMID:15498508
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306133	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LSP1 mRNA	PMID:34492290
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1306133	E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LSP1 mRNA	PMID:28943392
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314574	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of LSP1 mRNA	PMID:18648102
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of LSP1 mRNA	PMID:17426115
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LSP1 mRNA	PMID:19710929
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of LSP1 gene	PMID:23968726
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306133	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of LSP1 mRNA	PMID:25181051
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of LSP1 mRNA	PMID:25047013
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of LSP1 mRNA	PMID:30816183|PMID:32145629|PMID:32528016
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314574	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of LSP1 mRNA	PMID:30951980|PMID:32156529
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:3423	carmustine	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of LSP1 mRNA	PMID:16005536
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of LSP1 mRNA	PMID:40203079
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314574	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LSP1 mRNA	PMID:30951980
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34445	4-tert-Octylphenol	increases expression	ISO	RGD:1306133	E	RGD:6480464	20141111	CTD	MESH:C105260	4-tert-octylphenol results in increased expression of LSP1 mRNA	PMID:17011747
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LSP1 promoter	PMID:30157460
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1314574	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of LSP1 mRNA	PMID:26377693
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of LSP1 mRNA	PMID:38685157
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314574	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of LSP1 mRNA	PMID:30951980
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in increased methylation of LSP1 gene	PMID:31601247
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of LSP1 mRNA	PMID:30951980
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1306133	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of LSP1 mRNA	PMID:22546817
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of LSP1 gene	PMID:22964155
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1306133	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of LSP1 mRNA	PMID:22546817
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306133	E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LSP1 mRNA	PMID:28943392
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of LSP1 gene	PMID:23968726
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1306133	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of LSP1 mRNA	PMID:22546817
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LSP1 mRNA	PMID:37042841
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of LSP1 mRNA	PMID:29024780
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:35096	p-tert-Amylphenol	increases expression	ISO	RGD:1306133	E	RGD:6480464	20191114	CTD	MESH:C019566	4-tert-octylphenol results in increased expression of LSP1 mRNA	PMID:17011747
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of LSP1 mRNA	PMID:19244175
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of LSP1 mRNA	PMID:17585979
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of LSP1 mRNA	PMID:27153767
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of LSP1 mRNA	PMID:23125180
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314574	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of LSP1 mRNA	PMID:24896083
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LSP1 gene	PMID:29154799
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of LSP1 promoter	PMID:27989131
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of LSP1 mRNA	PMID:25047013
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of LSP1 mRNA	PMID:15289156
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1306133	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of LSP1 mRNA	PMID:17011747|PMID:36653537
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of LSP1 mRNA	PMID:28973697
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LSP1 mRNA	PMID:37992649
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:44185	methotrexate	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in decreased expression of LSP1 mRNA	PMID:16005536
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of LSP1 mRNA	PMID:17400583
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314574	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LSP1 mRNA	PMID:17562736
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of LSP1 mRNA	PMID:33387578
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of LSP1 mRNA	PMID:38460933
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LSP1 gene	PMID:25304211
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of LSP1 gene] which results in increased expression of LSP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of LSP1 gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LSP1 mRNA	PMID:40504410
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of LSP1 mRNA	PMID:26833863
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of LSP1 mRNA	PMID:17557909
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of LSP1 mRNA	PMID:15761015
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Arsenic Trioxide co-treated with Tretinoin] results in increased expression of LSP1 mRNA; [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of LSP1 mRNA	PMID:15894607|PMID:38179723
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306133	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of LSP1 mRNA	PMID:30307764
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LSP1 mRNA; Nanotubes, Carbon results in decreased expression of LSP1 mRNA	PMID:25554681|PMID:25620056
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:50594	carbon nanotube	decreases secretion	ISO	RGD:1314574	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased secretion of LSP1 protein	PMID:25598225
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314574	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of LSP1 mRNA	PMID:40234311
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of LSP1 mRNA	PMID:35964746
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of LSP1 mRNA	PMID:22714537
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314574	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of LSP1 mRNA	PMID:38701926
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314574	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSP1 mRNA	PMID:21641980
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of LSP1 mRNA	PMID:36907384
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:6809	methamphetamine	decreases methylation	ISO	RGD:1314574	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased methylation of LSP1 promoter	PMID:26307267
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LSP1 promoter	PMID:30157460
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314574	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LSP1 mRNA	PMID:22206623
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of LSP1 mRNA	PMID:22714537
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of LSP1 mRNA	PMID:36318118
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:755928	nabiximols	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C587251	nabiximols results in decreased expression of LSP1 mRNA	PMID:29528549
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1306133	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LSP1 mRNA	PMID:32741896
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1306133	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of LSP1 mRNA	PMID:21346803
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314574	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of LSP1 mRNA	PMID:38648751
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of LSP1 mRNA	PMID:23914054
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314574	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of LSP1 mRNA	PMID:39847705
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of LSP1 mRNA	PMID:24780913
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314574	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of LSP1 mRNA	PMID:40826991
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314574	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LSP1 mRNA	PMID:27131904
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:9555	tioguanine	decreases expression	ISO	RGD:1306133	E	RGD:6480464	20130305	CTD	MESH:D013866	Thioguanine results in decreased expression of LSP1 mRNA	PMID:16005536
1314573	LSP1	lymphocyte specific protein 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306133	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin affects the expression of LSP1 mRNA	PMID:23034163
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314576	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SMARCAL1 mRNA	PMID:33045310
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314576	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SMARCAL1 mRNA	PMID:26251327
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of SMARCAL1 mRNA	PMID:24763279
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306134	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of SMARCAL1 gene	PMID:35440735
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SMARCAL1 mRNA	PMID:37042841
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SMARCAL1 mRNA	PMID:21179406
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:17447	geraniol	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of SMARCAL1 mRNA	PMID:27683099
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SMARCAL1 protein	PMID:37730182
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306134	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SMARCAL1 mRNA	PMID:33387578
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SMARCAL1 mRNA	PMID:19549813
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314576	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SMARCAL1 mRNA]	PMID:22206623
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SMARCAL1 protein	PMID:35688186
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SMARCAL1 mRNA	PMID:23557933
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SMARCAL1 mRNA	PMID:28903495
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of SMARCAL1 mRNA	PMID:23300844
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314576	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SMARCAL1 mRNA	PMID:30912803
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314576	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SMARCAL1 mRNA	PMID:21570461
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306134	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SMARCAL1 mRNA	PMID:18796159|PMID:33387578
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314576	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SMARCAL1 mRNA	PMID:19465110
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SMARCAL1 promoter	PMID:27901495
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314576	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SMARCAL1 mRNA	PMID:22228805
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of SMARCAL1 gene	PMID:31601247
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306134	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SMARCAL1 mRNA	PMID:34492290
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314576	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SMARCAL1 mRNA	PMID:18648102
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306134	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SMARCAL1 mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:34947998
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314576	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SMARCAL1 mRNA	PMID:37019170
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306134	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SMARCAL1 mRNA	PMID:21266533
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306134	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of SMARCAL1 gene	PMID:33148267
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SMARCAL1 mRNA	PMID:37042841
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1314576	E	RGD:6480464	20140311	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SMARCAL1 mRNA	PMID:23626681
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1314576	E	RGD:6480464	20140311	CTD	MESH:C023036	[perfluorooctanoic acid co-treated with Dietary Fats, Unsaturated] results in decreased expression of SMARCAL1 mRNA	PMID:23626681
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SMARCAL1 mRNA	PMID:20106945
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314576	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SMARCAL1 mRNA	PMID:17555576
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314576	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SMARCAL1 mRNA	PMID:17562736
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMARCAL1 mRNA	PMID:21420995
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306134	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SMARCAL1 mRNA	PMID:33387578
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMARCAL1 mRNA	PMID:22079256
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314576	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SMARCAL1 mRNA	PMID:17555576
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1314576	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of SMARCAL1 mRNA	PMID:17942748
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SMARCAL1 mRNA	PMID:23300844
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314576	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SMARCAL1 mRNA; Nanotubes, Carbon results in decreased expression of SMARCAL1 mRNA	PMID:25554681|PMID:25620056
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:6078	ivermectin	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of SMARCAL1 protein	PMID:32959892
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306134	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of SMARCAL1 gene	PMID:33148267
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SMARCAL1 mRNA	PMID:31758290
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314576	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SMARCAL1 mRNA	PMID:22206623
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314576	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SMARCAL1 mRNA]	PMID:22206623
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SMARCAL1 mRNA	PMID:22079256
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMARCAL1 mRNA	PMID:22079256
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SMARCAL1 gene]	PMID:28238834
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306134	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SMARCAL1 mRNA	PMID:24780913
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306134	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of SMARCAL1 mRNA	PMID:19281266
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SMARCAL1 mRNA	PMID:38568856
1314575	SMARCAL1	SNF2 related chromatin remodeling annealing helicase 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306134	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SMARCAL1 mRNA	PMID:23034163
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614288	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ATF7IP2 mRNA	PMID:33045310
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1614288	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of ATF7IP2 mRNA	PMID:24205000
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1583744	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ATF7IP2 mRNA	PMID:33387578
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1614288	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ATF7IP2 mRNA	PMID:22401849
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1583744	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ATF7IP2 mRNA	PMID:33387578
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATF7IP2 mRNA	PMID:39836092
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:23414	copper(II) sulfate	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate affects the expression of ATF7IP2 mRNA	PMID:19549813
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1614288	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of ATF7IP2 mRNA	PMID:33026818
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATF7IP2 mRNA	PMID:39836092
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1614288	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ATF7IP2 mRNA	PMID:28960355
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1614288	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of ATF7IP2 mRNA	PMID:32186404
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1583744	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATF7IP2 mRNA	PMID:33387578
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ATF7IP2 mRNA	PMID:32763439
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1614288	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ATF7IP2 mRNA	PMID:27862939
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATF7IP2 mRNA	PMID:29803840
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATF7IP2 mRNA	PMID:34032870
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATF7IP2 mRNA	PMID:39836092
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1614288	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATF7IP2 mRNA	PMID:34876320
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1614288	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATF7IP2 mRNA	PMID:34876320
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATF7IP2 5' UTR	PMID:27901495
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614288	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATF7IP2 gene	PMID:35295148
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ATF7IP2 mRNA	PMID:19710929
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1614288	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ATF7IP2 mRNA	PMID:20739668|PMID:26063408
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1583744	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of ATF7IP2 mRNA	PMID:41034487
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1614288	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ATF7IP2 mRNA	PMID:32715474|PMID:37019170
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATF7IP2 mRNA	PMID:39836092
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATF7IP2 mRNA	PMID:38174414|PMID:38568856
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of ATF7IP2 mRNA	PMID:24935251
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ATF7IP2 mRNA	PMID:25562108
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ATF7IP2 mRNA	PMID:38832940
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ATF7IP2 mRNA	PMID:24935251
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of ATF7IP2 mRNA	PMID:21420995
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATF7IP2 mRNA	PMID:39836092
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1614288	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ATF7IP2 mRNA	PMID:35436446
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1614288	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATF7IP2 mRNA	PMID:34876320
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1614288	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ATF7IP2 mRNA	PMID:23608068
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of ATF7IP2 mRNA	PMID:31629900
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ATF7IP2 mRNA	PMID:39836092
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ATF7IP2 mRNA	PMID:28988120
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:64227	ciglitazone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C039671	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ATF7IP2 mRNA	PMID:16197558
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ATF7IP2 mRNA	PMID:22714537
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATF7IP2 gene]	PMID:28238834
1314578	ATF7IP2	activating transcription factor 7 interacting protein 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1614288	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ATF7IP2 mRNA	PMID:34876320
1314582	RNF11	ring finger protein 11	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:2321596	E	RGD:6480464	20220426	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RNF11 mRNA]	PMID:31150632
1314582	RNF11	ring finger protein 11	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of RNF11 mRNA	PMID:23724009|PMID:33167477
1314582	RNF11	ring finger protein 11	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of RNF11 mRNA	PMID:32845096
1314582	RNF11	ring finger protein 11	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1314583	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RNF11 mRNA	PMID:22629407
1314582	RNF11	ring finger protein 11	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314583	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of RNF11 mRNA]	PMID:22629407
1314582	RNF11	ring finger protein 11	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1314583	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of RNF11 mRNA	PMID:20362636
1314582	RNF11	ring finger protein 11	gene	CHEBI:16164	pyrogallol	multiple interactions	ISO	RGD:1314583	E	RGD:6480464	20121218	CTD	MESH:D011748	Silymarin inhibits the reaction [Pyrogallol results in increased expression of RNF11 mRNA]	PMID:20362636
1314582	RNF11	ring finger protein 11	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314583	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNF11 mRNA	PMID:39241906
1314582	RNF11	ring finger protein 11	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314583	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RNF11 mRNA	PMID:39298647
1314582	RNF11	ring finger protein 11	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:2321596	E	RGD:6480464	20220426	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of RNF11 mRNA	PMID:26496021
1314582	RNF11	ring finger protein 11	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RNF11 mRNA	PMID:28818685
1314582	RNF11	ring finger protein 11	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RNF11 mRNA	PMID:19549813
1314582	RNF11	ring finger protein 11	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RNF11 gene	PMID:27153756
1314582	RNF11	ring finger protein 11	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of RNF11 mRNA	PMID:32845096
1314582	RNF11	ring finger protein 11	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314583	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RNF11 mRNA	PMID:31919559
1314582	RNF11	ring finger protein 11	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:2321596	E	RGD:6480464	20220426	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RNF11 mRNA	PMID:31150632
1314582	RNF11	ring finger protein 11	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:2321596	E	RGD:6480464	20220426	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RNF11 mRNA]	PMID:31150632
1314582	RNF11	ring finger protein 11	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314583	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNF11 mRNA	PMID:22206623
1314582	RNF11	ring finger protein 11	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314583	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RNF11 mRNA	PMID:28960355
1314582	RNF11	ring finger protein 11	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1314583	E	RGD:6480464	20120412	CTD	MESH:D009532	MT1 affects the reaction [Nickel affects the expression of RNF11 mRNA]; MT2 affects the reaction [Nickel affects the expression of RNF11 mRNA]	PMID:16166738
1314582	RNF11	ring finger protein 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314583	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RNF11 mRNA	PMID:21570461
1314582	RNF11	ring finger protein 11	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:2321596	E	RGD:6480464	20220510	CTD	MESH:D012402	Rotenone results in decreased expression of RNF11 mRNA	PMID:28374803
1314582	RNF11	ring finger protein 11	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RNF11 mRNA	PMID:29803840
1314582	RNF11	ring finger protein 11	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of RNF11 mRNA	PMID:25523186
1314582	RNF11	ring finger protein 11	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of RNF11 gene	PMID:28589171
1314582	RNF11	ring finger protein 11	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RNF11 mRNA	PMID:38568856
1314582	RNF11	ring finger protein 11	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RNF11 intron	PMID:30157460
1314582	RNF11	ring finger protein 11	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314583	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RNF11 mRNA	PMID:22228805
1314582	RNF11	ring finger protein 11	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314583	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RNF11 mRNA	PMID:22228805
1314582	RNF11	ring finger protein 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RNF11 promoter	PMID:27901495
1314582	RNF11	ring finger protein 11	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of RNF11 mRNA	PMID:25523186
1314582	RNF11	ring finger protein 11	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:2321596	E	RGD:6480464	20220426	CTD	MESH:C004312	glycidol results in decreased expression of RNF11 mRNA	PMID:24915197
1314582	RNF11	ring finger protein 11	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314583	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RNF11 gene	PMID:35295148
1314582	RNF11	ring finger protein 11	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314583	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of RNF11 mRNA	PMID:16221962|PMID:21318169|PMID:23811191
1314582	RNF11	ring finger protein 11	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314583	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of RNF11 mRNA]	PMID:21318169
1314582	RNF11	ring finger protein 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2321596	E	RGD:6480464	20220426	CTD	MESH:C006780	bisphenol A results in increased expression of RNF11 mRNA	PMID:25181051|PMID:30816183
1314582	RNF11	ring finger protein 11	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:2321596	E	RGD:6480464	20220426	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of RNF11 mRNA	PMID:26496021
1314582	RNF11	ring finger protein 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314583	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RNF11 mRNA	PMID:39298647
1314582	RNF11	ring finger protein 11	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314583	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RNF11 mRNA	PMID:21266533
1314582	RNF11	ring finger protein 11	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RNF11 mRNA	PMID:37042841
1314582	RNF11	ring finger protein 11	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:2321596	E	RGD:6480464	20220510	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RNF11 mRNA	PMID:33453195
1314582	RNF11	ring finger protein 11	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of RNF11 mRNA	PMID:19376846
1314582	RNF11	ring finger protein 11	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RNF11 mRNA	PMID:24449571
1314582	RNF11	ring finger protein 11	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1314583	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of RNF11 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RNF11 mRNA]	PMID:17585979
1314582	RNF11	ring finger protein 11	gene	CHEBI:38221	fumonisin B1	increases expression	ISO	RGD:1314583	E	RGD:6480464	20120412	CTD	MESH:C056933	fumonisin B1 results in increased expression of RNF11 mRNA	PMID:16221962
1314582	RNF11	ring finger protein 11	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RNF11 mRNA	PMID:31533062
1314582	RNF11	ring finger protein 11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of RNF11 mRNA	PMID:40419075
1314582	RNF11	ring finger protein 11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314583	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of RNF11 mRNA	PMID:36331819
1314582	RNF11	ring finger protein 11	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314583	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RNF11 mRNA	PMID:17292431
1314582	RNF11	ring finger protein 11	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RNF11 mRNA	PMID:25562108
1314582	RNF11	ring finger protein 11	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314583	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of RNF11 mRNA	PMID:28973697
1314582	RNF11	ring finger protein 11	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RNF11 mRNA	PMID:28542535
1314582	RNF11	ring finger protein 11	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314583	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RNF11 mRNA	PMID:17562736
1314582	RNF11	ring finger protein 11	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314583	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of RNF11 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of RNF11 mRNA]	PMID:17585979
1314582	RNF11	ring finger protein 11	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of RNF11 mRNA	PMID:22077320
1314582	RNF11	ring finger protein 11	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314583	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of RNF11 mRNA	PMID:25554681
1314582	RNF11	ring finger protein 11	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of RNF11 mRNA	PMID:20977926
1314582	RNF11	ring finger protein 11	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314583	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of RNF11 mRNA	PMID:19812364
1314582	RNF11	ring finger protein 11	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314583	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RNF11 mRNA	PMID:23650126
1314582	RNF11	ring finger protein 11	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314583	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RNF11 mRNA	PMID:22206623
1314582	RNF11	ring finger protein 11	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314583	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RNF11 mRNA	PMID:22206623
1314582	RNF11	ring finger protein 11	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RNF11 mRNA	PMID:38568856
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314585	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of TDRD1 mRNA	PMID:37995155
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TDRD1 mRNA	PMID:21179406
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306140	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TDRD1 mRNA	PMID:33387578
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of TDRD1 mRNA	PMID:26079696
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314585	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TDRD1 mRNA	PMID:33754040
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1314585	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of TDRD1 gene	PMID:34319233
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TDRD1 gene	PMID:27153756
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314585	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TDRD1 mRNA	PMID:25629700
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314585	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TDRD1 mRNA	PMID:15034205
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314585	E	RGD:6480464	20120515	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TDRD1 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TDRD1 promoter]	PMID:15034205|PMID:19654925
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314585	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TDRD1 mRNA	PMID:37682722
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TDRD1 5' UTR	PMID:27901495
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314585	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TDRD1 mRNA	PMID:15034205
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314585	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TDRD1 intron; Benzo(a)pyrene results in decreased methylation of TDRD1 promoter	PMID:27901495
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TDRD1 promoter	PMID:27901495
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314585	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of TDRD1 mRNA]	PMID:15034205
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1306140	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of TDRD1 mRNA	PMID:32479839
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314585	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TDRD1 mRNA	PMID:29264374
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314585	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TDRD1 promoter; titanium dioxide results in decreased methylation of TDRD1 promoter alternative form	PMID:35295148
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306140	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TDRD1 mRNA	PMID:25181051|PMID:34947998
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314585	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TDRD1 mRNA	PMID:26063408
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306140	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of TDRD1 gene	PMID:28505145
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314585	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of TDRD1 mRNA	PMID:30951980
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314585	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of TDRD1 exon	PMID:33297965
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314585	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TDRD1 mRNA	PMID:37019170
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314585	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TDRD1 mRNA	PMID:40194260
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314585	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TDRD1 mRNA	PMID:17292431
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TDRD1 gene	PMID:29154799
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1306140	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of TDRD1 mRNA	PMID:21983209
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314585	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of TDRD1 mRNA	PMID:23608068
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:6651	malathion	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in increased expression of TDRD1 mRNA	PMID:37047231
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TDRD1 mRNA	PMID:31758290
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TDRD1 gene]	PMID:28238834
1314584	TDRD1	tudor domain containing 1	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1314585	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of TDRD1 protein	PMID:35357534
1314586	EVPL	envoplakin	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314587	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EVPL mRNA	PMID:33045310
1314586	EVPL	envoplakin	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of EVPL mRNA	PMID:34925699
1314586	EVPL	envoplakin	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314587	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EVPL mRNA	PMID:20938992
1314586	EVPL	envoplakin	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EVPL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EVPL mRNA	PMID:32699268
1314586	EVPL	envoplakin	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306141	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of EVPL gene	PMID:35440735
1314586	EVPL	envoplakin	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of EVPL mRNA	PMID:35811015
1314586	EVPL	envoplakin	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of EVPL mRNA	PMID:38568856
1314586	EVPL	envoplakin	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314587	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EVPL mRNA	PMID:20938992
1314586	EVPL	envoplakin	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314587	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EVPL mRNA	PMID:37992649
1314586	EVPL	envoplakin	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314587	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EVPL mRNA	PMID:37992649
1314586	EVPL	envoplakin	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of EVPL mRNA	PMID:26485663
1314586	EVPL	envoplakin	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306141	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EVPL mRNA	PMID:33387578
1314586	EVPL	envoplakin	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1314587	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of EVPL mRNA	PMID:27462272
1314586	EVPL	envoplakin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314587	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EVPL mRNA	PMID:19770486
1314586	EVPL	envoplakin	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EVPL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EVPL mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of EVPL mRNA	PMID:32699268
1314586	EVPL	envoplakin	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of EVPL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EVPL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of EVPL protein	PMID:38598786
1314586	EVPL	envoplakin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314587	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EVPL mRNA	PMID:20938992
1314586	EVPL	envoplakin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314587	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EVPL mRNA	PMID:40504410
1314586	EVPL	envoplakin	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of EVPL mRNA	PMID:23557933
1314586	EVPL	envoplakin	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of EVPL mRNA	PMID:19921347
1314586	EVPL	envoplakin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EVPL mRNA	PMID:20106945|PMID:21632981
1314586	EVPL	envoplakin	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of EVPL mRNA	PMID:33212167
1314586	EVPL	envoplakin	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314587	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EVPL mRNA	PMID:37992649
1314586	EVPL	envoplakin	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of EVPL mRNA	PMID:34032870|PMID:39719251
1314586	EVPL	envoplakin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314587	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EVPL mRNA	PMID:40504410
1314586	EVPL	envoplakin	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EVPL promoter	PMID:27901495
1314586	EVPL	envoplakin	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EVPL 3' UTR	PMID:27901495
1314586	EVPL	envoplakin	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of EVPL gene	PMID:25435355
1314586	EVPL	envoplakin	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to EVPL mRNA]	PMID:32406909
1314586	EVPL	envoplakin	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	EVPL protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1314586	EVPL	envoplakin	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of EVPL gene; [bisphenol F co-treated with Fulvestrant] results in decreased methylation of EVPL gene	PMID:31601247
1314586	EVPL	envoplakin	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314587	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EVPL promoter	PMID:35295148
1314586	EVPL	envoplakin	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314587	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of EVPL gene	PMID:35295148
1314586	EVPL	envoplakin	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306141	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EVPL mRNA	PMID:34492290
1314586	EVPL	envoplakin	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314587	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of EVPL mRNA	PMID:23811191
1314586	EVPL	envoplakin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of EVPL mRNA	PMID:18007998
1314586	EVPL	envoplakin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306141	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EVPL mRNA	PMID:25181051|PMID:34947998
1314586	EVPL	envoplakin	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1306141	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of EVPL gene	PMID:28505145
1314586	EVPL	envoplakin	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314587	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of EVPL promoter	PMID:27312807
1314586	EVPL	envoplakin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314587	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of EVPL mRNA	PMID:32156529
1314586	EVPL	envoplakin	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306141	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of EVPL gene	PMID:28505145
1314586	EVPL	envoplakin	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of EVPL gene	PMID:31601247
1314586	EVPL	envoplakin	gene	CHEBI:34247	2,6-di-tert-butyl-4-methylphenol	increases expression	ISO	RGD:1314587	E	RGD:6480464	20120412	CTD	MESH:D002084	Butylated Hydroxytoluene results in increased expression of EVPL mRNA	PMID:19925653
1314586	EVPL	envoplakin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314587	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of EVPL gene	PMID:31683443
1314586	EVPL	envoplakin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314587	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of EVPL mRNA	PMID:30951980
1314586	EVPL	envoplakin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1314587	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of EVPL exon	PMID:33297965
1314586	EVPL	envoplakin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314587	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of EVPL mRNA	PMID:30951980
1314586	EVPL	envoplakin	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of EVPL gene	PMID:31601247
1314586	EVPL	envoplakin	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314587	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of EVPL mRNA	PMID:37019170
1314586	EVPL	envoplakin	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to EVPL protein	PMID:32991956
1314586	EVPL	envoplakin	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of EVPL protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of EVPL protein	PMID:38598786
1314586	EVPL	envoplakin	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314587	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of EVPL mRNA	PMID:28962523
1314586	EVPL	envoplakin	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EVPL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EVPL mRNA	PMID:32699268
1314586	EVPL	envoplakin	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314587	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of EVPL mRNA	PMID:40194260
1314586	EVPL	envoplakin	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of EVPL mRNA	PMID:28302478
1314586	EVPL	envoplakin	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of EVPL gene	PMID:29154799
1314586	EVPL	envoplakin	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306141	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of EVPL mRNA	PMID:30047161
1314586	EVPL	envoplakin	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314587	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EVPL mRNA	PMID:37992649
1314586	EVPL	envoplakin	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306141	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EVPL mRNA	PMID:33387578
1314586	EVPL	envoplakin	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of EVPL mRNA	PMID:35811015
1314586	EVPL	envoplakin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314587	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EVPL mRNA	PMID:40504410
1314586	EVPL	envoplakin	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	EVPL protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1314586	EVPL	envoplakin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314587	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of EVPL mRNA	PMID:25554681
1314586	EVPL	envoplakin	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306141	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of EVPL mRNA	PMID:30047161
1314586	EVPL	envoplakin	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1314587	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of EVPL mRNA	PMID:36851058
1314586	EVPL	envoplakin	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306141	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of EVPL gene	PMID:35440735
1314586	EVPL	envoplakin	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1314587	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of EVPL mRNA	PMID:22206623
1314586	EVPL	envoplakin	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306141	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EVPL mRNA	PMID:24780913
1314586	EVPL	envoplakin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of EVPL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EVPL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of EVPL protein	PMID:38598786
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of DENND2A mRNA	PMID:26272509
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND2A mRNA	PMID:27188386
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1620636	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of DENND2A mRNA	PMID:37995155
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of DENND2A mRNA	PMID:26516004
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of DENND2A mRNA	PMID:22378314
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1620636	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of DENND2A mRNA	PMID:30319688
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1620636	E	RGD:6480464	20150609	CTD	MESH:D004958	Estradiol results in increased expression of DENND2A mRNA	PMID:19484750|PMID:25575267
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in decreased expression of DENND2A mRNA	PMID:17404688
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of DENND2A mRNA	PMID:17404688
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of DENND2A protein	PMID:37730182
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306142	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DENND2A mRNA	PMID:33387578
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1620636	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of DENND2A mRNA	PMID:39984025
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of DENND2A intron	PMID:30157460
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1620636	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of DENND2A mRNA	PMID:34911549
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1620636	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DENND2A mRNA	PMID:17484886
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DENND2A mRNA	PMID:39836092
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:27974	estriol	increases expression	ISO	RGD:1620636	E	RGD:6480464	20150609	CTD	MESH:D004964	Estriol results in increased expression of DENND2A mRNA	PMID:25575267
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306142	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DENND2A mRNA	PMID:22298810
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620636	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DENND2A mRNA	PMID:21570461
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306142	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DENND2A mRNA	PMID:21215274|PMID:32109520
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306142	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DENND2A mRNA	PMID:34747641
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of DENND2A mRNA	PMID:20971185
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	DENND2A protein affects the susceptibility to Doxorubicin	PMID:16217747
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DENND2A mRNA	PMID:29803840
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DENND2A mRNA	PMID:38568856
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DENND2A mRNA	PMID:39836092
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DENND2A promoter	PMID:27901495
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of DENND2A mRNA	PMID:20971185
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of DENND2A gene	PMID:31601247
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620636	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DENND2A promoter	PMID:35295148
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306142	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DENND2A mRNA	PMID:25181051|PMID:32145629
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306142	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of DENND2A mRNA	PMID:30816183|PMID:41034487
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1620636	E	RGD:6480464	20150609	CTD	MESH:C006780	bisphenol A results in increased expression of DENND2A mRNA	PMID:25575267
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DENND2A mRNA	PMID:28628672
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	increases expression	ISO	RGD:1620636	E	RGD:6480464	20150609	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of DENND2A mRNA	PMID:25575267
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1620636	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of DENND2A mRNA	PMID:26682919
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1620636	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of DENND2A gene	PMID:31683443
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1620636	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of DENND2A exon	PMID:33297965
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DENND2A mRNA	PMID:28628672
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1306142	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of DENND2A mRNA	PMID:30589522
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DENND2A mRNA	PMID:38382870
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of DENND2A mRNA	PMID:24449571
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DENND2A mRNA	PMID:40419075
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620636	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of DENND2A mRNA	PMID:36331819
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of DENND2A mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DENND2A gene	PMID:29154799
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND2A mRNA	PMID:27188386
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DENND2A mRNA	PMID:28628672
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1620636	E	RGD:6480464	20150609	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of DENND2A mRNA	PMID:25575267
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1620636	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of DENND2A mRNA	PMID:28973697
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of DENND2A mRNA	PMID:24935251|PMID:26272509
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND2A mRNA	PMID:27188386
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306142	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DENND2A mRNA	PMID:33387578
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of DENND2A mRNA	PMID:26690555
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of DENND2A mRNA	PMID:24714768
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DENND2A mRNA	PMID:39836092
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DENND2A mRNA	PMID:28628672
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620636	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of DENND2A mRNA	PMID:25554681
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:50594	carbon nanotube	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DENND2A mRNA	PMID:24389112
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306142	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of DENND2A mRNA	PMID:23962444
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1306142	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of DENND2A mRNA	PMID:24136188
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of DENND2A mRNA	PMID:31758290
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:72754	bisphenol AF	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in decreased expression of DENND2A mRNA	PMID:25912373
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:72754	bisphenol AF	increases expression	ISO	RGD:1306142	E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in increased expression of DENND2A mRNA	PMID:39938710
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of DENND2A mRNA	PMID:32858204
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND2A mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND2A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND2A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND2A mRNA	PMID:27188386
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1620636	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DENND2A mRNA	PMID:23091169
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of DENND2A mRNA	PMID:26272509
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND2A mRNA	PMID:27188386
1314588	DENND2A	DENN domain containing 2A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND2A mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND2A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND2A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DENND2A mRNA	PMID:27188386
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of EIF4G1 protein	PMID:39638853
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:10022	deoxynivalenol	increases phosphorylation	ISO	RGD:1550408	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased phosphorylation of EIF4G1 protein	PMID:23352502
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of EIF4G1 mRNA	PMID:38218311
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306144	E	RGD:6480464	20150623	CTD	MESH:D004237	Diuron results in decreased expression of EIF4G1 mRNA	PMID:25152437
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1550408	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of EIF4G1 mRNA	PMID:33045310
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550408	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of EIF4G1 mRNA	PMID:20188158
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in increased expression of EIF4G1 mRNA	PMID:15894607
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in increased expression of EIF4G1 mRNA	PMID:15894607
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of EIF4G1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of EIF4G1 mRNA	PMID:32699268
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:15379	dioxygen	affects methylation	ISO	RGD:1550408	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency affects the methylation of EIF4G1 promoter	PMID:24205000
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1550408	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of EIF4G1 mRNA	PMID:24205000
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1550408	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of EIF4G1 mRNA	PMID:36331819
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:15948	lycopene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C015329	lycopene results in increased expression of EIF4G1 mRNA	PMID:16886892
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1550408	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of EIF4G1 mRNA	PMID:20362636
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1550408	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of EIF4G1 mRNA	PMID:25056781
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550408	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of EIF4G1 mRNA	PMID:30319688
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1550408	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of EIF4G1 protein	PMID:31494107
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550408	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EIF4G1 mRNA	PMID:39241906
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of EIF4G1 mRNA	PMID:35877022
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:16469	17beta-estradiol	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased phosphorylation of EIF4G1 protein	PMID:16033851
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	everolimus inhibits the reaction [Estradiol results in increased phosphorylation of EIF4G1 protein]	PMID:16033851
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306144	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of EIF4G1 mRNA	PMID:33387578
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of EIF4G1 mRNA	PMID:21179406
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550408	E	RGD:6480464	20130122	CTD	MESH:D005947	Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]; resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]]	PMID:19765649
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550408	E	RGD:6480464	20130122	CTD	MESH:D005947	Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]; resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]]	PMID:19765649
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1306144	E	RGD:6480464	20150623	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EIF4G1 promoter	PMID:23359474
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of EIF4G1 protein	PMID:37730182
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550408	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EIF4G1 mRNA	PMID:36331819
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EIF4G1 protein	PMID:23301498
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1306144	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of EIF4G1 mRNA	PMID:33354967
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EIF4G1 exon	PMID:30157460
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EIF4G1 gene	PMID:27153756
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1550408	E	RGD:6480464	20150310	CTD	MESH:D008628	Mercury analog results in decreased expression of EIF4G1 mRNA	PMID:25056781
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of EIF4G1 mRNA	PMID:23649840
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases phosphorylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D009151	Mustard Gas results in increased phosphorylation of EIF4G1 protein	PMID:19845377
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of EIF4G1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of EIF4G1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of EIF4G1 mRNA	PMID:32699268
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of EIF4G1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EIF4G1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EIF4G1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of EIF4G1 protein	PMID:38598786
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306144	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of EIF4G1 mRNA	PMID:30779732
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550408	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EIF4G1 mRNA	PMID:22206623
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of EIF4G1 mRNA; [arsenic trichloride results in increased abundance of Arsenic] which affects the expression of EIF4G1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIF4G1 mRNA	PMID:35809665|PMID:40512198
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of EIF4G1 mRNA	PMID:19244175
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of EIF4G1 mRNA	PMID:19244175
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1306144	E	RGD:6480464	20200331	CTD	MESH:D003513	Cycloheximide promotes the reaction [EIF4EBP1 protein binds to EIF4G1 protein]	PMID:22689575
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of EIF4G1 protein	PMID:38460933
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of EIF4G1 protein	PMID:35688186
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1550408	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of EIF4G1 protein	PMID:36173347
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1550408	E	RGD:6480464	20130122	CTD	MESH:C059514	resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]]	PMID:19765649
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of EIF4G1 mRNA	PMID:27594783
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550408	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of EIF4G1 mRNA	PMID:30912803
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	Genistein results in decreased expression of EIF4G1 protein	PMID:20884965
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D019833	ESR2 promotes the reaction [Genistein results in decreased expression of EIF4G1 protein]	PMID:20884965
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550408	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EIF4G1 mRNA	PMID:21570461
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306144	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EIF4G1 mRNA	PMID:32109520|PMID:33387578
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306144	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EIF4G1 mRNA	PMID:34747641
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of EIF4G1 mRNA	PMID:23179753|PMID:26272509
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EIF4G1 mRNA	PMID:29803840
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:28748	doxorubicin	decreases phosphorylation	ISO	RGD:1306144	E	RGD:6480464	20150623	CTD	MESH:D004317	Doxorubicin results in decreased phosphorylation of EIF4G1 protein	PMID:19801490
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1306144	E	RGD:6480464	20150623	CTD	MESH:D004317	NRG1 protein inhibits the reaction [Doxorubicin results in decreased phosphorylation of EIF4G1 protein]	PMID:19801490
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of EIF4G1 protein	PMID:35688186
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1306144	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of EIF4G1 mRNA	PMID:21297353
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of EIF4G1 mRNA	PMID:34032870|PMID:39719251
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of EIF4G1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIF4G1 mRNA; sodium arsenite results in decreased expression of and results in increased activity of EIF4G1 protein	PMID:30528433|PMID:40512198
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EIF4G1 3' UTR	PMID:27901495
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of EIF4G1 gene	PMID:25435355
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:C015001	arsenite promotes the reaction [EIF4E protein binds to EIF4G1 protein]; arsenite promotes the reaction [G3BP1 protein binds to EIF4G1 protein]; MAPK14 protein affects the reaction [arsenite promotes the reaction [EIF4E protein binds to EIF4G1 protein]]	PMID:12781867|PMID:32406909
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of EIF4G1 mRNA	PMID:23911876
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of EIF4G1 mRNA	PMID:15894607
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of EIF4G1 mRNA	PMID:15894607
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of EIF4G1 gene; [bisphenol S co-treated with Fulvestrant] results in decreased methylation of EIF4G1 gene	PMID:31601247
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306144	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of EIF4G1 mRNA	PMID:24136188
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:31739	josamycin	affects response to substance	EXP		E	RGD:6480464	20200609	CTD	MESH:D015570	EIF4G1 protein affects the susceptibility to Josamycin	PMID:31915244
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550408	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EIF4G1 gene	PMID:35295148
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550408	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of EIF4G1 mRNA	PMID:29264374
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306144	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of EIF4G1 mRNA	PMID:30816183|PMID:34947998
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of EIF4G1 mRNA	PMID:29275510
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of EIF4G1 protein	PMID:34186270
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306144	E	RGD:6480464	20150623	CTD	MESH:C006780	bisphenol A results in increased expression of EIF4G1 mRNA	PMID:25181051|PMID:32145629
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of EIF4G1 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF4G1 mRNA	PMID:28628672|PMID:31601247
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306144	E	RGD:6480464	20150623	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EIF4G1 promoter	PMID:23359474
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of EIF4G1 mRNA	PMID:19244175
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of EIF4G1 mRNA	PMID:19244175
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of EIF4G1 mRNA	PMID:19244175
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of EIF4G1 mRNA	PMID:24752500
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1550408	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of EIF4G1 mRNA	PMID:39298647
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of EIF4G1 protein	PMID:34186270
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of EIF4G1 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EIF4G1 mRNA	PMID:28628672|PMID:31601247
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of EIF4G1 protein	PMID:34186270
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550408	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of EIF4G1 mRNA	PMID:38685157
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G1 mRNA	PMID:28628672
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:34595	Butylbenzyl phthalate	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the expression of EIF4G1 protein	PMID:27992464
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1550408	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of EIF4G1 mRNA	PMID:31558096
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1306144	E	RGD:6480464	20150623	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of EIF4G1 promoter	PMID:23359474
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of EIF4G1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of EIF4G1 protein	PMID:38598786
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF4G1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EIF4G1 mRNA	PMID:28628672
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EIF4G1 mRNA	PMID:37042841
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	ISO	RGD:1306144	E	RGD:6480464	20150623	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of EIF4G1 mRNA	PMID:17616710
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EIF4G1 mRNA	PMID:33129824|PMID:38382870
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EIF4G1 mRNA	PMID:19320972
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of EIF4G1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of EIF4G1 mRNA	PMID:32699268
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of EIF4G1 mRNA	PMID:19244175
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of EIF4G1 mRNA	PMID:19244175
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550408	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of EIF4G1 mRNA	PMID:17585979
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D013755	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4G1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4G1 protein]; [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one co-treated with SB 203580] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4G1 protein]; U 0126 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4G1 protein]	PMID:12781867
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of EIF4G1 mRNA	PMID:28302478
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550408	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EIF4G1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of EIF4G1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of EIF4G1 mRNA	PMID:36331819
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1306144	E	RGD:6480464	20150623	CTD	MESH:D002737	Chloroprene results in increased expression of EIF4G1 mRNA	PMID:23125180
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:3962	curcumin	decreases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased phosphorylation of EIF4G1 protein	PMID:18790744
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EIF4G1 mRNA	PMID:25979313
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of EIF4G1 gene	PMID:29154799
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of EIF4G1 mRNA	PMID:23179753
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF4G1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EIF4G1 mRNA	PMID:28628672
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550408	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]; resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]]	PMID:19765649
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1306144	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of EIF4G1 mRNA	PMID:24136188
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of EIF4G1 mRNA	PMID:27188386
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550408	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EIF4G1 mRNA	PMID:17562736
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of EIF4G1 mRNA	PMID:21420995
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306144	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EIF4G1 mRNA	PMID:33387578
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1550408	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in increased expression of EIF4G1 mRNA	PMID:17585979
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of EIF4G1 protein	PMID:38460933
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of EIF4G1 mRNA; [arsenic trichloride results in increased abundance of Arsenic] which affects the expression of EIF4G1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EIF4G1 mRNA	PMID:35809665|PMID:40512198
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of EIF4G1 mRNA	PMID:24752500
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1550408	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of EIF4G1 mRNA	PMID:35436446
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of EIF4G1 mRNA	PMID:18175754
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of EIF4G1 mRNA	PMID:23228038
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF4G1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of EIF4G1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of EIF4G1 mRNA	PMID:28628672
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of EIF4G1 mRNA	PMID:23911876
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of EIF4G1 mRNA	PMID:15894607
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of EIF4G1 mRNA	PMID:15894607
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of EIF4G1 mRNA	PMID:17908484
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:50210	7-methyl-GTP	affects binding	EXP		E	RGD:6480464	20160210	CTD	MESH:C017516	EIF4G1 protein binds to 7-methylguanosine triphosphate	PMID:25940091
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:50210	7-methyl-GTP	multiple interactions	EXP		E	RGD:6480464	20160210	CTD	MESH:C017516	1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [EIF4G1 protein binds to 7-methylguanosine triphosphate]; Sirolimus inhibits the reaction [EIF4G1 protein binds to 7-methylguanosine triphosphate]	PMID:25940091
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306144	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of EIF4G1 mRNA	PMID:24136188
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550408	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EIF4G1 mRNA	PMID:35964746
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306144	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of EIF4G1 mRNA	PMID:24136188
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1550408	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of EIF4G1 mRNA	PMID:26377693
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of EIF4G1 mRNA	PMID:18651567
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550408	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of EIF4G1 mRNA	PMID:19042947
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1550408	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of EIF4G1 mRNA	PMID:20829426
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EIF4G1 protein	PMID:32959892
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1306144	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of EIF4G1 mRNA	PMID:24136188
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:63952	arsenic trichloride	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] which affects the expression of EIF4G1 mRNA	PMID:35809665
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4G1 protein]	PMID:12781867
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:68478	everolimus	multiple interactions	EXP		E	RGD:6480464	20170228	CTD	MESH:C107135	Everolimus inhibits the reaction [Estradiol results in increased phosphorylation of EIF4G1 protein]	PMID:16033851
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of EIF4G1 protein	PMID:34186270
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550408	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of EIF4G1 mRNA	PMID:22206623
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550408	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EIF4G1 mRNA	PMID:22206623
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306144	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of EIF4G1 mRNA	PMID:24136188
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of EIF4G1 mRNA	PMID:37199045
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of EIF4G protein	PMID:30647404
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of EIF4G1 protein	PMID:39638853
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:78160	bleomycin A5	increases expression	EXP		E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in increased expression of EIF4G1 mRNA	PMID:21040473
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1550408	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of EIF4G1 mRNA	PMID:23091169
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1550408	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of EIF4G1 protein	PMID:19552622
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:81543	Tributyltin oxide	decreases phosphorylation	ISO	RGD:1550408	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased phosphorylation of EIF4G1 protein	PMID:22174045
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1550408	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of EIF4G1 mRNA	PMID:31558096
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1306144	E	RGD:6480464	20150623	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of EIF4G1 mRNA	PMID:23640034
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of EIF4G1 protein	PMID:31675489
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:84327	torin 1	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C553294	1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [EIF4G1 protein binds to 7-methylguanosine triphosphate]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [EIF4G1 protein binds to PABPC1 mRNA]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [EIF4G1 protein binds to RPL32 mRNA]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [EIF4G1 protein binds to RPS20 mRNA]; 1-(4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo(h)(1,6)naphthyridin-2(1H)-one inhibits the reaction [EIF4G1 protein binds to RPS6 mRNA]	PMID:25940091
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:90705	SB 203580	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C093642	[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one co-treated with SB 203580] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of EIF4G1 protein]	PMID:12781867
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20160210	CTD	MESH:D020123	Sirolimus inhibits the reaction [EIF4G1 protein binds to 7-methylguanosine triphosphate]; Sirolimus inhibits the reaction [EIF4G1 protein binds to PABPC1 mRNA]; Sirolimus inhibits the reaction [EIF4G1 protein binds to RPL32 mRNA]; Sirolimus inhibits the reaction [EIF4G1 protein binds to RPS20 mRNA]; Sirolimus inhibits the reaction [EIF4G1 protein binds to RPS6 mRNA]	PMID:25940091
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306144	E	RGD:6480464	20150623	CTD	MESH:D012999	Soman results in increased expression of EIF4G1 mRNA	PMID:19281266
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of EIF4G1 mRNA	PMID:33512557
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of EIF4G1 mRNA	PMID:17440010
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of EIF4G1 mRNA	PMID:27188386
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of EIF4G1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of EIF4G1 protein	PMID:38598786
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306144	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of EIF4G1 mRNA	PMID:18042343|PMID:23034163
1314591	EIF4G1	eukaryotic translation initiation factor 4 gamma 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306144	E	RGD:6480464	20150623	CTD	MESH:C025643	vinclozolin results in increased expression of EIF4G1 mRNA	PMID:20566332
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1552375	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LRCH4 mRNA	PMID:33045310
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of LRCH4 mRNA	PMID:22378314
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LRCH4 mRNA	PMID:37042841
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of LRCH4 mRNA	PMID:21179406
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552375	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LRCH4 mRNA	PMID:37567420
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552375	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LRCH4 mRNA	PMID:37567420
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1552375	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of LRCH4 mRNA	PMID:23892564
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306145	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of LRCH4 mRNA	PMID:27523638
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of LRCH4 protein	PMID:37730182
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of LRCH4 mRNA	PMID:28818685
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552375	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRCH4 mRNA	PMID:37236586
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of LRCH4 mRNA	PMID:35430440
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LRCH4 gene	PMID:25304211
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRCH4 mRNA	PMID:40512198
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:27656	camptothecin	decreases response to substance	EXP		E	RGD:6480464	20160315	CTD	MESH:D002166	LRCH4 mRNA results in decreased susceptibility to Camptothecin	PMID:25269479
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of LRCH4 protein	PMID:35688186
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552375	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LRCH4 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to LRCH4 promoter]	PMID:17942748|PMID:19654925
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of LRCH4 mRNA	PMID:33212167
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552375	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LRCH4 mRNA	PMID:37567420
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of LRCH4 protein	PMID:35688186
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1552375	E	RGD:6480464	20231031	CTD	MESH:D015084	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LRCH4 mRNA	PMID:37567420
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of LRCH4 mRNA	PMID:39719251
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRCH4 mRNA	PMID:40512198
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552375	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRCH4 mRNA	PMID:22228805
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552375	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of LRCH4 mRNA]	PMID:22228805
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1552375	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LRCH4 mRNA	PMID:27131904
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552375	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRCH4 gene	PMID:35295148
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306145	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of LRCH4 mRNA	PMID:34492290
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306145	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of LRCH4 mRNA	PMID:25181051|PMID:34947998
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552375	E	RGD:6480464	20131210	CTD	MESH:C006780	bisphenol A results in decreased expression of LRCH4 mRNA	PMID:23798566|PMID:38074096
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1552375	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of LRCH4 promoter	PMID:27312807
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:3423	carmustine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of LRCH4 mRNA	PMID:15980968
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LRCH4 mRNA	PMID:37042841
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552375	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LRCH4 mRNA	PMID:37236586
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of LRCH4 mRNA	PMID:24449571
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:36704	imiquimod	multiple interactions	ISO	RGD:1552375	E	RGD:6480464	20190910	CTD	MESH:C056493	LRCH4 protein promotes the reaction [Imiquimod results in increased expression of TNF protein]	PMID:30523158
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552375	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LRCH4 mRNA	PMID:37567420
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of LRCH4 mRNA	PMID:38832940
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of LRCH4 mRNA	PMID:29067470
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306145	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of LRCH4 mRNA	PMID:33387578
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LRCH4 gene	PMID:25304211
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRCH4 mRNA	PMID:40512198
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552375	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LRCH4 mRNA	PMID:17942748
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of LRCH4 mRNA	PMID:19194470
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552375	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of LRCH4 mRNA	PMID:25554681
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552375	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of LRCH4 mRNA	PMID:38701926
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552375	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LRCH4 mRNA	PMID:22206623
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1552375	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of LRCH4 mRNA	PMID:37567420
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:755208	eprenetapopt	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of LRCH4 mRNA	PMID:19946333
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of LRCH4 mRNA]	PMID:19946333
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:9130	sevoflurane	increases methylation	ISO	RGD:1552375	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased methylation of LRCH4 mRNA	PMID:35249202
1314592	LRCH4	leucine rich repeats and calponin homology domain containing 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1552375	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of LRCH4 mRNA	PMID:27131904
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314595	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PASK mRNA	PMID:20938992
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of PASK mRNA	PMID:26516004
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:16196	oleic acid	increases expression	EXP		E	RGD:6480464	20250506	CTD	MESH:D019301	Oleic Acid results in increased expression of PASK mRNA; Oleic Acid results in increased expression of PASK protein	PMID:26539118
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:16196	oleic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D019301	nuciferine inhibits the reaction [Oleic Acid results in increased expression of PASK mRNA]; nuciferine inhibits the reaction [Oleic Acid results in increased expression of PASK protein]; PASK protein promotes the reaction [Oleic Acid results in decreased secretion of IL10 protein]; PASK protein promotes the reaction [Oleic Acid results in increased expression of ACACA mRNA]; PASK protein promotes the reaction [Oleic Acid results in increased expression of FASN mRNA]; PASK protein promotes the reaction [Oleic Acid results in increased expression of NFKB1 mRNA]; PASK protein promotes the reaction [Oleic Acid results in increased expression of PPARA mRNA]; PASK protein promotes the reaction [Oleic Acid results in increased expression of PPARG mRNA]; PASK protein promotes the reaction [Oleic Acid results in increased expression of SCD mRNA]; PASK protein promotes the reaction [Oleic Acid results in increased expression of SREBF1 mRNA]; PASK protein promotes the reaction [Oleic Acid results in increased expression of SREBF1 protein]; PASK protein promotes the reaction [Oleic Acid results in increased expression of TNF mRNA]; PASK protein promotes the reaction [Oleic Acid results in increased secretion of CXCL8 protein]; PASK protein promotes the reaction [Oleic Acid results in increased secretion of IL6 protein]; PASK protein promotes the reaction [Oleic Acid results in increased secretion of TNF protein]	PMID:26539118
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PASK mRNA	PMID:21632981
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314595	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PASK mRNA	PMID:39241906
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1314595	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of PASK mRNA	PMID:18978301
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314595	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PASK mRNA	PMID:25510870
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314595	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PASK mRNA	PMID:20938992
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PASK mRNA	PMID:37042841
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314595	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PASK mRNA	PMID:34319233
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of PASK protein	PMID:37730182
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:17823	calcitriol	multiple interactions	ISO	RGD:1306146	E	RGD:6480464	20120412	CTD	MESH:D002117	[Calcium co-treated with Calcitriol] affects the expression of PASK mRNA	PMID:15913539
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of PASK mRNA	PMID:39836092
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314595	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PASK mRNA	PMID:37236586
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:22984	calcium atom	multiple interactions	ISO	RGD:1306146	E	RGD:6480464	20120412	CTD	MESH:D002118	[Calcium co-treated with Calcitriol] affects the expression of PASK mRNA	PMID:15913539
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314595	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PASK mRNA	PMID:25510870
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314595	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PASK mRNA	PMID:25510870
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PASK mRNA	PMID:19549813
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PASK mRNA	PMID:22100608
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PASK gene	PMID:27153756
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1314595	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of PASK mRNA	PMID:33026818
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314595	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PASK mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PASK mRNA	PMID:34911549
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314595	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of PASK mRNA	PMID:20938992
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PASK mRNA	PMID:39836092
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of PASK mRNA	PMID:26272509
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PASK mRNA	PMID:27188386
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of PASK protein	PMID:35688186
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306146	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PASK mRNA	PMID:31881176
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PASK mRNA	PMID:25583101
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314595	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PASK mRNA	PMID:21570461|PMID:26377647
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PASK mRNA	PMID:33212167
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PASK mRNA	PMID:32763439
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306146	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PASK mRNA	PMID:28959563
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314595	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of PASK protein	PMID:28918527
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:29320	calcium(0)	multiple interactions	ISO	RGD:1306146	E	RGD:6480464	20120412	CTD	MESH:D002118	[Calcium co-treated with Calcitriol] affects the expression of PASK mRNA	PMID:15913539
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of PASK mRNA	PMID:22623647
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PASK mRNA	PMID:38568856
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of PASK mRNA	PMID:28595984|PMID:34032870
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PASK mRNA	PMID:39836092
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PASK mRNA	PMID:32234424
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306146	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PASK mRNA	PMID:25729387
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314595	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PASK gene; titanium dioxide results in decreased methylation of PASK promoter alternative form	PMID:35295148
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314595	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of PASK mRNA	PMID:23557971
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306146	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PASK mRNA	PMID:34492290
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1314595	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of PASK mRNA	PMID:19136022
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1314595	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of PASK gene	PMID:23968726
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of PASK gene	PMID:31601247
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306146	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PASK mRNA	PMID:25181051
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PASK mRNA	PMID:25979313
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314595	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PASK mRNA	PMID:25510870
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of PASK mRNA	PMID:36804509
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314595	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PASK mRNA	PMID:25510870
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of PASK gene	PMID:31601247
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314595	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PASK mRNA	PMID:26377693
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314595	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PASK mRNA	PMID:37019170
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314595	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of PASK gene	PMID:23968726
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of PASK mRNA	PMID:39836092
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1306146	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of PASK mRNA	PMID:18500788
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306146	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of PASK mRNA	PMID:30723492
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PASK mRNA	PMID:12160620
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314595	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PASK mRNA	PMID:37236586
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306146	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of PASK mRNA	PMID:25539665
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PASK mRNA	PMID:19376846
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314595	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PASK mRNA	PMID:40194260
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PASK mRNA	PMID:31533062
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314595	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PASK mRNA	PMID:39529242
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PASK mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of PASK mRNA	PMID:29067470
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of PASK mRNA	PMID:22230336
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306146	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PASK mRNA	PMID:33387578
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PASK mRNA	PMID:39836092
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306146	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PASK mRNA	PMID:29391264
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314595	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of PASK mRNA	PMID:35436446
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306146	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PASK mRNA	PMID:30307764
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314595	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PASK mRNA; Nanotubes, Carbon results in increased expression of PASK mRNA	PMID:25554681
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306146	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of PASK mRNA	PMID:22504374
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:51397	1,3-dinitrobenzene	decreases expression	ISO	RGD:1306146	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in decreased expression of PASK mRNA	PMID:21983209
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314595	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PASK mRNA	PMID:19042947
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of PASK mRNA	PMID:39836092
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306146	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of PASK mRNA	PMID:25729387
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306146	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PASK mRNA	PMID:25729387
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of PASK mRNA	PMID:15336504
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1306146	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PASK mRNA	PMID:28801915
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:6842	methoxychlor	increases methylation	ISO	RGD:1306146	E	RGD:6480464	20130611	CTD	MESH:D008731	Methoxychlor results in increased methylation of PASK gene	PMID:23303685
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1306146	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of PASK mRNA	PMID:33484710
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PASK mRNA	PMID:27188386
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314595	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of PASK mRNA	PMID:19136022
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306146	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of PASK mRNA	PMID:22504374
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	ISO	RGD:1306146	E	RGD:6480464	20120412	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of PASK mRNA	PMID:12815608
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PASK mRNA	PMID:27188386
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of PASK mRNA	PMID:19140230
1314594	PASK	PAS domain containing serine/threonine kinase	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314595	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of PASK mRNA	PMID:35537566
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of ECPAS mRNA	PMID:26272509
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA	PMID:27188386
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of ECPAS mRNA	PMID:23724009|PMID:33167477
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ECPAS mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ECPAS mRNA	PMID:32699268
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ECPAS mRNA	PMID:26079696
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1306148	E	RGD:6480464	20161025	CTD	MESH:D000431	Ethanol results in decreased expression of ECPAS protein	PMID:19609968
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314599	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ECPAS mRNA	PMID:39241906
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of ECPAS mRNA	PMID:14699072
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314599	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ECPAS mRNA	PMID:39298647
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ECPAS mRNA	PMID:37042841
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ECPAS protein	PMID:37730182
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314599	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ECPAS mRNA	PMID:28111341
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1314599	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ECPAS protein]	PMID:32272095
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ECPAS mRNA	PMID:19549813
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ECPAS protein	PMID:23301498
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ECPAS mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ECPAS mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of ECPAS mRNA	PMID:32699268
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:2663	amiodarone	decreases expression	ISO	RGD:1306148	E	RGD:6480464	20140729	CTD	MESH:D000638	Amiodarone results in decreased expression of ECPAS mRNA	PMID:17991464
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ECPAS protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ECPAS protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of ECPAS protein	PMID:38598786
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306148	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ECPAS mRNA	PMID:31150632
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ECPAS protein	PMID:38460933
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ECPAS mRNA	PMID:26272509
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA	PMID:27188386
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ECPAS mRNA	PMID:23557933
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306148	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ECPAS mRNA	PMID:34747641
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of ECPAS protein	PMID:39603559
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ECPAS mRNA	PMID:28001369
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ECPAS mRNA	PMID:28001369
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ECPAS mRNA	PMID:33212167
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:D020106	Acrylamide results in decreased expression of ECPAS mRNA	PMID:28959563
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ECPAS mRNA	PMID:20044591
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ECPAS mRNA	PMID:21839799
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ECPAS mRNA]	PMID:32406909
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ECPAS mRNA	PMID:20458559
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ECPAS mRNA	PMID:25729387
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C006780	bisphenol A affects the expression of ECPAS mRNA	PMID:30903817
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of ECPAS protein	PMID:37567409
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306148	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ECPAS mRNA	PMID:34947998
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ECPAS protein	PMID:34186270
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306148	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ECPAS mRNA	PMID:25181051
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of ECPAS protein	PMID:34186270
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314599	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ECPAS mRNA	PMID:39298647
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ECPAS protein	PMID:34186270
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314599	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ECPAS mRNA	PMID:28392331
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314599	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ECPAS mRNA	PMID:37019170
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314599	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of ECPAS protein	PMID:32272095
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1314599	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ECPAS protein	PMID:35362542
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314599	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ECPAS protein]; evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ECPAS protein]	PMID:32272095|PMID:35362542
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to ECPAS protein	PMID:32991956
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ECPAS protein	PMID:38598786
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ECPAS mRNA	PMID:37042841
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ECPAS mRNA	PMID:38568856
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314599	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ECPAS mRNA	PMID:28111341
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ECPAS protein	PMID:26879310
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:C018021	cobaltous chloride results in increased expression of ECPAS mRNA	PMID:24386269
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ECPAS mRNA	PMID:24449571
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ECPAS mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ECPAS mRNA	PMID:32699268
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ECPAS mRNA	PMID:31533062
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314599	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ECPAS protein	PMID:26178269
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314599	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ECPAS mRNA	PMID:36331819
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:D002737	Chloroprene results in increased expression of ECPAS mRNA	PMID:23125180
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ECPAS mRNA	PMID:25979313
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of ECPAS mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ECPAS gene	PMID:29154799
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA	PMID:27188386
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ECPAS mRNA	PMID:20106945|PMID:25562108
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ECPAS mRNA	PMID:21658437
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:C012655	nimesulide results in increased expression of ECPAS mRNA	PMID:24136188
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ECPAS mRNA	PMID:28542535
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ECPAS mRNA	PMID:24935251
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ECPAS mRNA	PMID:24935251
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314599	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ECPAS mRNA	PMID:29279043
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ECPAS mRNA	PMID:29523930
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of ECPAS protein	PMID:38460933
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1314599	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ECPAS protein]	PMID:35362542
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ECPAS mRNA	PMID:20458559
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:D018120	Finasteride results in increased expression of ECPAS mRNA	PMID:24136188
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:D005485	Flutamide results in increased expression of ECPAS mRNA	PMID:24136188
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of ECPAS mRNA	PMID:20977926
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ECPAS protein	PMID:32959892
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ECPAS mRNA	PMID:25729387
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:C406224	valdecoxib results in increased expression of ECPAS mRNA	PMID:24136188
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:C045463	leflunomide results in increased expression of ECPAS mRNA	PMID:24136188
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ECPAS protein	PMID:34186270
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ECPAS protein	PMID:37664457
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:C051752	nefazodone results in increased expression of ECPAS mRNA	PMID:24136188
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ECPAS mRNA	PMID:37199045
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA	PMID:27188386
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314599	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ECPAS mRNA	PMID:31388691
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ECPAS mRNA	PMID:26079696
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:85990	panobinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in decreased expression of ECPAS mRNA	PMID:26272509
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA	PMID:27188386
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ECPAS protein; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ECPAS mRNA	PMID:27188386|PMID:37664457
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ECPAS mRNA	PMID:38568856
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ECPAS protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of ECPAS protein	PMID:38598786
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:C025643	vinclozolin results in decreased expression of ECPAS mRNA	PMID:18042343
1314598	ECPAS	Ecm29 proteasome adaptor and scaffold	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306148	E	RGD:6480464	20180515	CTD	MESH:C025643	vinclozolin results in increased expression of ECPAS mRNA	PMID:20566332
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in decreased expression of ATP10A mRNA	PMID:31863870
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306150	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ATP10A mRNA]	PMID:31150632
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314602	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ATP10A gene	PMID:20938992
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306150	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of ATP10A gene	PMID:35440735
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314602	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in increased expression of ATP10A mRNA	PMID:29018328
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of ATP10A mRNA	PMID:29581250
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314602	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATP10A mRNA	PMID:39241906
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ATP10A mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ATP10A mRNA	PMID:35811015
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of ATP10A mRNA	PMID:20660070
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314602	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ATP10A gene	PMID:20938992
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATP10A mRNA	PMID:37042841
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of ATP10A mRNA	PMID:20660070
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314602	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ATP10A mRNA	PMID:37992649
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ATP10A mRNA	PMID:33359661
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314602	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ATP10A mRNA	PMID:37992649
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1314602	E	RGD:6480464	20120515	CTD	MESH:D004051	Diethylhexyl Phthalate affects the expression of ATP10A mRNA	PMID:21636974
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of ATP10A mRNA	PMID:26485663
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1314602	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP10A mRNA	PMID:29950665
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306150	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ATP10A mRNA	PMID:23630614
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ATP10A intron	PMID:30157460
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:25710	organophosphorus compound	multiple interactions	ISO	RGD:1306150	E	RGD:6480464	20250401	CTD	MESH:D009943	[Dust results in increased abundance of Organophosphorus Compounds] which results in decreased expression of ATP10A mRNA	PMID:39658253
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306150	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ATP10A mRNA	PMID:31150632
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306150	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ATP10A mRNA]	PMID:31150632
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314602	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ATP10A gene	PMID:20938992
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306150	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ATP10A mRNA	PMID:31881176
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ATP10A mRNA	PMID:27392435
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1306150	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ATP10A mRNA	PMID:22023808
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ATP10A mRNA	PMID:27392435
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of ATP10A promoter	PMID:22847954
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1306150	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of ATP10A mRNA	PMID:17898221|PMID:27899881
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314602	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATP10A mRNA	PMID:21570461|PMID:26377647
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATP10A mRNA	PMID:27913140
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306150	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ATP10A mRNA	PMID:30556269
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314602	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ATP10A mRNA	PMID:39631538
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314602	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ATP10A mRNA	PMID:37992649
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in increased expression of ATP10A mRNA	PMID:35954277
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ATP10A promoter	PMID:27901495
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ATP10A 3' UTR	PMID:27901495
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314602	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATP10A mRNA	PMID:22228805
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATP10A exon	PMID:27901495
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306150	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ATP10A mRNA	PMID:30556269
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of ATP10A gene	PMID:31601247
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of ATP10A gene	PMID:31601247
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314602	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP10A mRNA	PMID:29950665
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306150	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ATP10A mRNA	PMID:23411599
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ATP10A mRNA	PMID:38479592
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306150	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ATP10A mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314602	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ATP10A mRNA	PMID:30951980
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ATP10A gene	PMID:31601247
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314602	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ATP10A mRNA	PMID:40203079
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ATP10A gene	PMID:31601247
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314602	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ATP10A mRNA	PMID:30951980
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of ATP10A gene	PMID:31601247
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ATP10A intron	PMID:30157460
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1314602	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of ATP10A mRNA	PMID:26377693
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314602	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ATP10A mRNA	PMID:30951980
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314602	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ATP10A 3' UTR	PMID:28392331
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314602	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ATP10A intron	PMID:28392331
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314602	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP10A mRNA	PMID:29950665
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1306150	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ATP10A mRNA	PMID:32680482
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATP10A mRNA	PMID:37042841
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306150	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ATP10A mRNA	PMID:30723492
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1314602	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of ATP10A mRNA	PMID:28962523
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of ATP10A promoter	PMID:22847954
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of ATP10A promoter	PMID:22847954
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATP10A mRNA	PMID:25979313
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314602	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ATP10A mRNA	PMID:28973697
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314602	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ATP10A mRNA	PMID:37992649
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ATP10A mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ATP10A mRNA	PMID:35811015
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314602	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ATP10A mRNA	PMID:35436446
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314602	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ATP10A mRNA	PMID:25554681
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ATP10A intron	PMID:30157460
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314602	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ATP10A mRNA	PMID:22206623
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1306150	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of ATP10A mRNA	PMID:33484710
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314602	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ATP10A mRNA	PMID:19482888
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314602	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ATP10A mRNA]	PMID:19482888
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1306150	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ATP10A mRNA	PMID:23914054
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314602	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of ATP10A mRNA	PMID:39847705
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306150	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ATP10A mRNA	PMID:24780913
1314601	ATP10A	ATPase phospholipid transporting 10A (putative)	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306150	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ATP10A mRNA	PMID:19281266
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ABHD12 mRNA	PMID:38218311
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ABHD12 mRNA	PMID:38218311
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1562570	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of ABHD12 mRNA	PMID:21551480
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314605	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ABHD12 mRNA	PMID:33045310
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1562570	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABHD12 mRNA]	PMID:31150632
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314605	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ABHD12 gene	PMID:20938992
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABHD12 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABHD12 mRNA	PMID:32699268
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ABHD12 mRNA	PMID:22378314
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of ABHD12 mRNA	PMID:20660070
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314605	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ABHD12 gene	PMID:20938992
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ABHD12 mRNA	PMID:23649840
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of ABHD12 mRNA	PMID:20660070
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314605	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ABHD12 mRNA	PMID:33754040
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1314605	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ABHD12 mRNA; Cuprizone results in increased expression of ABHD12 protein	PMID:30075103
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314605	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ABHD12 mRNA	PMID:19770486
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABHD12 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABHD12 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ABHD12 mRNA	PMID:32699268
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1562570	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ABHD12 mRNA	PMID:31150632
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1562570	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABHD12 mRNA]	PMID:31150632
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314605	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ABHD12 gene	PMID:20938992
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ABHD12 mRNA	PMID:26272509
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD12 mRNA	PMID:27188386
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of ABHD12 mRNA	PMID:19921347
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314605	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABHD12 mRNA	PMID:21570461
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1562570	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABHD12 mRNA	PMID:33387578|PMID:34747641
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD12 mRNA	PMID:30851411
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314605	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ABHD12 protein	PMID:28918527
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABHD12 mRNA	PMID:22714537
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314605	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ABHD12 gene	PMID:35295148
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314605	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ABHD12 gene; titanium dioxide results in increased methylation of ABHD12 promoter alternative form	PMID:35295148
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1562570	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ABHD12 mRNA	PMID:34492290
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314605	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ABHD12 mRNA	PMID:17426115
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314605	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ABHD12 mRNA	PMID:28472532
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1562570	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ABHD12 mRNA	PMID:34947998
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1562570	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ABHD12 mRNA	PMID:25181051
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1562570	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ABHD12 gene	PMID:28505145
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1314605	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ABHD12 mRNA	PMID:28392331
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314605	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ABHD12 mRNA	PMID:21266533
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1562570	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ABHD12 mRNA	PMID:21266533
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314605	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ABHD12 mRNA	PMID:24535843
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1562570	E	RGD:6480464	20220705	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ABHD12 protein	PMID:34958885
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ABHD12 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ABHD12 mRNA	PMID:32699268
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314605	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ABHD12 mRNA	PMID:40194260
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABHD12 mRNA	PMID:19167446
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ABHD12 mRNA	PMID:40419075
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ABHD12 mRNA	PMID:25979313
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314605	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ABHD12 mRNA	PMID:17292431
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ABHD12 mRNA	PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509|PMID:27188386
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ABHD12 gene	PMID:29154799
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD12 mRNA	PMID:27188386
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:4021	Cyclopamine	increases expression	ISO	RGD:1314605	E	RGD:6480464	20211109	CTD	MESH:C000541	cyclopamine results in increased expression of ABHD12 mRNA	PMID:33168583
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314605	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ABHD12 mRNA	PMID:17555576
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314605	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ABHD12 mRNA	PMID:28973697
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ABHD12 mRNA	PMID:38832940
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ABHD12 mRNA	PMID:27188386
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ABHD12 mRNA	PMID:22230336
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1562570	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ABHD12 mRNA	PMID:33387578
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314605	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ABHD12 mRNA	PMID:17555576
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314605	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ABHD12 mRNA	PMID:25554681
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314605	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ABHD12 mRNA	PMID:35964746
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:52392	2-arachidonoylglycerol	increases hydrolysis	ISO	RGD:1314605	E	RGD:6480464	20120412	CTD	MESH:C094503	ABHD12 protein results in increased hydrolysis of glyceryl 2-arachidonate	PMID:18096503
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of ABHD12 mRNA	PMID:22714537
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ABHD12 protein	PMID:32959892
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of ABHD12 mRNA	PMID:27918106
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ABHD12 mRNA	PMID:31758290
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314605	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ABHD12 mRNA	PMID:22206623
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ABHD12 mRNA	PMID:30851411
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD12 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD12 mRNA	PMID:27188386
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314605	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of ABHD12 mRNA	PMID:19482888
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314605	E	RGD:6480464	20120412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of ABHD12 mRNA; NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ABHD12 mRNA]	PMID:19482888|PMID:24535843
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314605	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ABHD12 mRNA	PMID:31388691
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ABHD12 mRNA	PMID:19167446
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1562570	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of ABHD12 protein	PMID:28903499
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314605	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ABHD12 mRNA	PMID:39847705
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD12 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABHD12 mRNA	PMID:27188386
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:94686	orlistat	decreases activity	EXP		E	RGD:6480464	20170808	CTD	MESH:C055122	orlistat results in decreased activity of ABHD12 protein	PMID:18657971
1314604	ABHD12	abhydrolase domain containing 12, lysophospholipase	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1314605	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of ABHD12 mRNA	PMID:28973697
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314608	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of COPZ1 mRNA	PMID:20188158
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of COPZ1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of COPZ1 mRNA	PMID:32699268
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:15571	hydrazine	increases expression	ISO	RGD:1314608	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in increased expression of COPZ1 mRNA	PMID:15282401
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of COPZ1 mRNA	PMID:22378314
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314608	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of COPZ1 mRNA	PMID:30319688
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314608	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of COPZ1 mRNA	PMID:39241906
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of COPZ1 mRNA	PMID:37042841
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314608	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of COPZ1 mRNA	PMID:33754040
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of COPZ1 mRNA	PMID:28818685
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of COPZ1 mRNA	PMID:19549813
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of COPZ1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of COPZ1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of COPZ1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of COPZ1 mRNA	PMID:32699268|PMID:35430440
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314608	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COPZ1 mRNA	PMID:22206623
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314608	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of COPZ1 mRNA	PMID:32186404
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314608	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of COPZ1 mRNA	PMID:21570461
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314608	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COPZ1 mRNA	PMID:17942748
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of COPZ1 mRNA; Rotenone results in increased expression of COPZ1 protein	PMID:33512557|PMID:39603559
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306154	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of COPZ1 mRNA	PMID:28959563
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of COPZ1 protein	PMID:30528433
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of COPZ1 mRNA	PMID:26238291
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to COPZ1 mRNA]	PMID:32406909
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306154	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of COPZ1 mRNA	PMID:24136188
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306154	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of COPZ1 mRNA	PMID:34492290
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306154	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of COPZ1 mRNA	PMID:19167457
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of COPZ1 mRNA; bisphenol A results in increased expression of COPZ1 protein	PMID:25047013|PMID:34186270|PMID:37567409
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306154	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of COPZ1 mRNA	PMID:25181051
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306154	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of COPZ1 gene	PMID:28505145
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306154	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of COPZ1 mRNA	PMID:36041667
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of COPZ1 protein	PMID:31675489
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306154	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of COPZ1 mRNA	PMID:36041667
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of COPZ1 protein	PMID:34186270
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COPZ1 mRNA	PMID:28628672
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306154	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of COPZ1 mRNA	PMID:36041667
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314608	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of COPZ1 mRNA	PMID:37019170
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314608	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of COPZ1 protein	PMID:35362542
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314608	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of COPZ1 protein]	PMID:35362542
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306154	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of COPZ1 mRNA	PMID:21266533
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1314608	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of COPZ1 mRNA	PMID:34813904
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COPZ1 mRNA	PMID:28628672
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1314608	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of COPZ1 mRNA	PMID:34813904
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1314608	E	RGD:6480464	20240206	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of COPZ1 protein	PMID:37422089
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of COPZ1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of COPZ1 mRNA	PMID:32699268
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:37825	p-toluidine	increases expression	ISO	RGD:1306154	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of COPZ1 mRNA	PMID:27638505
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of COPZ1 mRNA	PMID:25979313
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of COPZ1 mRNA	PMID:20106945
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COPZ1 mRNA	PMID:28628672
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306154	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of COPZ1 mRNA	PMID:33387578
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314608	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in increased expression of COPZ1 mRNA	PMID:29246445
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314608	E	RGD:6480464	20190910	CTD	MESH:D000082	PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of COPZ1 mRNA]	PMID:29246445
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314608	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of COPZ1 mRNA	PMID:29279043
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of COPZ1 mRNA	PMID:29523930
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of COPZ1 mRNA	PMID:36621641
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of COPZ1 mRNA	PMID:31675489
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of COPZ1 mRNA	PMID:18175754
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314608	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of COPZ1 mRNA	PMID:17942748
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314608	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COPZ1 mRNA	PMID:17942748
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1314608	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of COPZ1 protein]	PMID:35362542
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of COPZ1 mRNA	PMID:28628672
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314608	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of COPZ1 mRNA	PMID:25620056
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of COPZ1 protein	PMID:32959892
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of COPZ1 protein	PMID:34186270
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314608	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of COPZ1 mRNA	PMID:22206623
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of COPZ1 protein	PMID:39638853
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314608	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of COPZ1 mRNA	PMID:31388691
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of COPZ1 protein	PMID:31675489
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306154	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of COPZ1 mRNA	PMID:21346803
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in increased expression of COPZ1 mRNA	PMID:31863870
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306154	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of COPZ1 mRNA	PMID:21346803
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306154	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of COPZ1 mRNA	PMID:19015723
1314607	COPZ1	coat protein complex I subunit zeta 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306154	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of COPZ1 mRNA	PMID:23034163
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314611	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DCLRE1A mRNA	PMID:33045310
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DCLRE1A mRNA	PMID:20044591
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of DCLRE1A mRNA	PMID:39709020
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314611	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DCLRE1A mRNA	PMID:39241906
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314611	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of DCLRE1A mRNA	PMID:39298647
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DCLRE1A mRNA	PMID:37042841
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of DCLRE1A protein	PMID:37730182
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DCLRE1A mRNA	PMID:28818685
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306156	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DCLRE1A mRNA	PMID:39012411
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DCLRE1A mRNA	PMID:19549813
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of DCLRE1A protein	PMID:35688186
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1306156	E	RGD:6480464	20210608	CTD	MESH:C059514	Resveratrol results in decreased expression of DCLRE1A mRNA	PMID:33775663
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of DCLRE1A mRNA	PMID:19167446
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of DCLRE1A mRNA	PMID:27594783
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306156	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DCLRE1A mRNA	PMID:22298810
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314611	E	RGD:6480464	20180116	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DCLRE1A mRNA	PMID:28922406
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306156	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DCLRE1A mRNA	PMID:21215274
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306156	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DCLRE1A mRNA	PMID:33387578
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314611	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DCLRE1A mRNA	PMID:21354282
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314611	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DCLRE1A mRNA	PMID:17942748
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DCLRE1A mRNA	PMID:33212167
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1306156	E	RGD:6480464	20170110	CTD	MESH:D004317	Doxorubicin results in decreased expression of DCLRE1A mRNA	PMID:27181935
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1306156	E	RGD:6480464	20170110	CTD	MESH:D004317	Fungal Polysaccharides inhibits the reaction [Doxorubicin results in decreased expression of DCLRE1A mRNA]	PMID:27181935
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314611	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of DCLRE1A mRNA	PMID:36209798
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306156	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DCLRE1A mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314611	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DCLRE1A mRNA	PMID:33221593
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306156	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DCLRE1A gene	PMID:28505145
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314611	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DCLRE1A mRNA	PMID:39298647
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1314611	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of DCLRE1A mRNA	PMID:36464114
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314611	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DCLRE1A mRNA	PMID:37019170
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DCLRE1A mRNA	PMID:37042841
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1314611	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of DCLRE1A mRNA	PMID:26377693
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DCLRE1A mRNA	PMID:38174414
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306156	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DCLRE1A mRNA	PMID:39012411
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1314611	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of DCLRE1A mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DCLRE1A mRNA]	PMID:17585979
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DCLRE1A mRNA	PMID:28302478
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of DCLRE1A mRNA	PMID:40434365
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of DCLRE1A mRNA	PMID:19167446
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1A mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of DCLRE1A mRNA	PMID:19167446
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DCLRE1A mRNA	PMID:27153767
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DCLRE1A gene	PMID:29154799
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of DCLRE1A mRNA	PMID:25562108
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of DCLRE1A mRNA	PMID:27989131
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314611	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DCLRE1A mRNA	PMID:17562736
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314611	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of DCLRE1A mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DCLRE1A mRNA]	PMID:17585979
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306156	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of DCLRE1A mRNA	PMID:29391264
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DCLRE1A mRNA	PMID:22079256
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314611	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of DCLRE1A mRNA	PMID:35436446
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314611	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DCLRE1A mRNA	PMID:17942748
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1314611	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of DCLRE1A mRNA	PMID:36464114
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of DCLRE1A mRNA	PMID:22079256
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DCLRE1A mRNA	PMID:22079256
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:756894	tak-243	affects sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 affects the sumoylation of DCLRE1A protein	PMID:31285264
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DCLRE1A gene]	PMID:28238834
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of DCLRE1A mRNA; Irinotecan results in decreased expression of DCLRE1A mRNA	PMID:15956246
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314611	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DCLRE1A mRNA	PMID:23091169
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314611	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of DCLRE1A mRNA	PMID:19270015
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DCLRE1A mRNA	PMID:19167446
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:8207	(+)-pilocarpine	increases expression	ISO	RGD:1306156	E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in increased expression of DCLRE1A mRNA	PMID:17971868
1314610	DCLRE1A	DNA cross-link repair 1A	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of DCLRE1A mRNA	PMID:29301935
1314613	HOXB9	homeobox B9	gene	CHEBI:138858	Azaspiracid	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C406592	azaspiracid results in increased expression of HOXB9 mRNA	PMID:28939011
1314613	HOXB9	homeobox B9	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of HOXB9 mRNA	PMID:33167477
1314613	HOXB9	homeobox B9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of HOXB9 mRNA	PMID:17138961|PMID:21934132
1314613	HOXB9	homeobox B9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314614	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of HOXB9 mRNA	PMID:16604517|PMID:16845368
1314613	HOXB9	homeobox B9	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of HOXB9 mRNA	PMID:17175027
1314613	HOXB9	homeobox B9	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of HOXB9 mRNA	PMID:22378314
1314613	HOXB9	homeobox B9	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of HOXB9 mRNA	PMID:20044591
1314613	HOXB9	homeobox B9	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HOXB9 mRNA	PMID:35811015
1314613	HOXB9	homeobox B9	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of HOXB9 mRNA; [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HOXB9 mRNA	PMID:26667767|PMID:35811015
1314613	HOXB9	homeobox B9	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of HOXB9 mRNA	PMID:30510588
1314613	HOXB9	homeobox B9	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol results in increased expression of HOXB9 mRNA	PMID:27182052
1314613	HOXB9	homeobox B9	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306158	E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol results in increased expression of HOXB9 mRNA	PMID:27182052
1314613	HOXB9	homeobox B9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol inhibits the reaction [NCOR1 protein binds to HOXB9 promoter]; Estradiol promotes the reaction [CREBBP protein binds to HOXB9 promoter]; Estradiol promotes the reaction [EP300 protein binds to HOXB9 promoter]; Estradiol promotes the reaction [ESR1 protein binds to HOXB9 promoter]; Estradiol promotes the reaction [KMT2C protein binds to HOXB9 promoter]; Estradiol promotes the reaction [POLR2A protein binds to HOXB9 promoter]	PMID:27182052
1314613	HOXB9	homeobox B9	gene	CHEBI:17076	streptomycin	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D013307	[Penicillins co-treated with Streptomycin] results in increased expression of HOXB9 mRNA	PMID:31711903
1314613	HOXB9	homeobox B9	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of HOXB9 mRNA	PMID:31711903
1314613	HOXB9	homeobox B9	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of HOXB9 mRNA	PMID:23825647
1314613	HOXB9	homeobox B9	gene	CHEBI:17790	methanol	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D000432	Methanol results in increased expression of HOXB9 mRNA	PMID:31711903
1314613	HOXB9	homeobox B9	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HOXB9 mRNA	PMID:36139627
1314613	HOXB9	homeobox B9	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306158	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of HOXB9 mRNA	PMID:33387578
1314613	HOXB9	homeobox B9	gene	CHEBI:18291	manganese atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of HOXB9 mRNA	PMID:17175027
1314613	HOXB9	homeobox B9	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of HOXB9 mRNA	PMID:23825647
1314613	HOXB9	homeobox B9	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1314614	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of HOXB9 mRNA	PMID:15674843
1314613	HOXB9	homeobox B9	gene	CHEBI:26523	reactive oxygen species	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017382	[[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of HOXB9 mRNA	PMID:33656867
1314613	HOXB9	homeobox B9	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of HOXB9 promoter	PMID:21291286
1314613	HOXB9	homeobox B9	gene	CHEBI:2766	aphidicolin	decreases expression	ISO	RGD:1314614	E	RGD:6480464	20181113	CTD	MESH:D016590	Aphidicolin results in decreased expression of HOXB9 mRNA	PMID:29990529
1314613	HOXB9	homeobox B9	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1314614	E	RGD:6480464	20181113	CTD	MESH:C059514	Resveratrol results in decreased expression of HOXB9 mRNA	PMID:29990529
1314613	HOXB9	homeobox B9	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[Lipopolysaccharides co-treated with resveratrol] results in decreased expression of HOXB9 mRNA	PMID:26667767
1314613	HOXB9	homeobox B9	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314614	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of HOXB9 mRNA	PMID:32186404
1314613	HOXB9	homeobox B9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314614	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HOXB9 mRNA	PMID:24058054
1314613	HOXB9	homeobox B9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306158	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HOXB9 mRNA	PMID:33387578
1314613	HOXB9	homeobox B9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314614	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HOXB9 mRNA	PMID:17942748
1314613	HOXB9	homeobox B9	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of HOXB9 mRNA	PMID:33212167
1314613	HOXB9	homeobox B9	gene	CHEBI:29191	hydroxyl	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:D017665	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of HOXB-AS4 mRNA] which results in increased expression of HOXB9 mRNA	PMID:33656867
1314613	HOXB9	homeobox B9	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HOXB9 mRNA	PMID:38568856
1314613	HOXB9	homeobox B9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HOXB9 promoter	PMID:27901495
1314613	HOXB9	homeobox B9	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HOXB9 3' UTR	PMID:27901495
1314613	HOXB9	homeobox B9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HOXB9 mRNA	PMID:32234424
1314613	HOXB9	homeobox B9	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HOXB9 exon	PMID:27901495
1314613	HOXB9	homeobox B9	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of HOXB9 promoter	PMID:23974009
1314613	HOXB9	homeobox B9	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HOXB9 mRNA	PMID:27829220
1314613	HOXB9	homeobox B9	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1314614	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of HOXB9 mRNA	PMID:20542052
1314613	HOXB9	homeobox B9	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314614	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of HOXB9 mRNA	PMID:35295148
1314613	HOXB9	homeobox B9	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314614	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of HOXB9 gene	PMID:35295148
1314613	HOXB9	homeobox B9	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314614	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of HOXB9 promoter	PMID:27334623
1314613	HOXB9	homeobox B9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C006780	bisphenol A results in decreased expression of HOXB9 mRNA	PMID:23146750
1314613	HOXB9	homeobox B9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306158	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HOXB9 mRNA	PMID:25181051
1314613	HOXB9	homeobox B9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314614	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of HOXB9 mRNA	PMID:32156529
1314613	HOXB9	homeobox B9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of HOXB9 mRNA	PMID:27182052
1314613	HOXB9	homeobox B9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306158	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of HOXB9 mRNA	PMID:27182052|PMID:41034487
1314613	HOXB9	homeobox B9	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A inhibits the reaction [NCOR1 protein binds to HOXB9 promoter]; bisphenol A promotes the reaction [CREBBP protein binds to HOXB9 promoter]; bisphenol A promotes the reaction [EP300 protein binds to HOXB9 promoter]; bisphenol A promotes the reaction [ESR1 protein binds to HOXB9 promoter]; bisphenol A promotes the reaction [KMT2C protein binds to HOXB9 promoter]; bisphenol A promotes the reaction [POLR2A protein binds to HOXB9 promoter]	PMID:27182052
1314613	HOXB9	homeobox B9	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of HOXB9 mRNA	PMID:23146750
1314613	HOXB9	homeobox B9	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of HOXB9 mRNA	PMID:23146750
1314613	HOXB9	homeobox B9	gene	CHEBI:35154	manganese(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in decreased expression of HOXB9 mRNA	PMID:17175027
1314613	HOXB9	homeobox B9	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1314614	E	RGD:6480464	20120501	CTD	MESH:D019256	Cadmium Chloride affects the expression of HOXB9 mRNA	PMID:18974090
1314613	HOXB9	homeobox B9	gene	CHEBI:35456	cadmium dichloride	affects methylation	ISO	RGD:1306158	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the methylation of HOXB9 promoter	PMID:22457795
1314613	HOXB9	homeobox B9	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HOXB9 mRNA	PMID:38382870
1314613	HOXB9	homeobox B9	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of HOXB9 mRNA	PMID:23146750
1314613	HOXB9	homeobox B9	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of HOXB9 mRNA	PMID:32588087
1314613	HOXB9	homeobox B9	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of HOXB9 gene	PMID:29154799
1314613	HOXB9	homeobox B9	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D014635	Valproic Acid results in increased expression of HOXB9 mRNA	PMID:31711903
1314613	HOXB9	homeobox B9	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314614	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of HOXB9 mRNA	PMID:24896083
1314613	HOXB9	homeobox B9	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of HOXB9 promoter	PMID:27989131
1314613	HOXB9	homeobox B9	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of HOXB9 mRNA	PMID:20106945
1314613	HOXB9	homeobox B9	gene	CHEBI:421707	abacavir	increases expression	EXP		E	RGD:6480464	20260303	CTD	MESH:C106538	Abacavir results in increased expression of HOXB9 mRNA	PMID:31711903
1314613	HOXB9	homeobox B9	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314614	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of HOXB9 mRNA	PMID:28973697
1314613	HOXB9	homeobox B9	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of HOXB9 mRNA	PMID:24449571
1314613	HOXB9	homeobox B9	gene	CHEBI:44423	hydroxyurea	decreases expression	ISO	RGD:1314614	E	RGD:6480464	20181113	CTD	MESH:D006918	Hydroxyurea results in decreased expression of HOXB9 mRNA	PMID:29990529
1314613	HOXB9	homeobox B9	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HOXB9 mRNA	PMID:38832940
1314613	HOXB9	homeobox B9	gene	CHEBI:4488	diallyl disulfide	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C028009	diallyl disulfide inhibits the reaction [tobacco tar analog results in increased expression of HOXB9 mRNA]	PMID:36758788
1314613	HOXB9	homeobox B9	gene	CHEBI:4489	Diallyl sulfide	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:C038491	allyl sulfide inhibits the reaction [tobacco tar analog results in increased expression of HOXB9 mRNA]	PMID:36758788
1314613	HOXB9	homeobox B9	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HOXB9 mRNA	PMID:27188386
1314613	HOXB9	homeobox B9	gene	CHEBI:4610	dimethylselenide	multiple interactions	EXP		E	RGD:6480464	20211109	CTD	MESH:C013503	[[Hydroxyl Radical results in increased oxidation of dimethylselenide] which results in increased expression of HOXB-AS4 mRNA] which results in increased expression of HOXB9 mRNA; [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in decreased expression of DDIT4-AS1 mRNA] which results in increased expression of HOXB9 mRNA	PMID:33656867
1314613	HOXB9	homeobox B9	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306158	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HOXB9 mRNA	PMID:33387578
1314613	HOXB9	homeobox B9	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HOXB9 mRNA	PMID:35811015
1314613	HOXB9	homeobox B9	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of HOXB9 promoter	PMID:29626692
1314613	HOXB9	homeobox B9	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of HOXB9 promoter	PMID:29626692
1314613	HOXB9	homeobox B9	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of HOXB9 promoter	PMID:21291286
1314613	HOXB9	homeobox B9	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of HOXB9 mRNA	PMID:22079256
1314613	HOXB9	homeobox B9	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314614	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HOXB9 mRNA	PMID:17942748
1314613	HOXB9	homeobox B9	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of HOXB9 mRNA	PMID:32234424
1314613	HOXB9	homeobox B9	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HOXB9 mRNA	PMID:27829220
1314613	HOXB9	homeobox B9	gene	CHEBI:52172	nilotinib	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C498826	nilotinib results in increased expression of HOXB9 mRNA	PMID:31711903
1314613	HOXB9	homeobox B9	gene	CHEBI:63041	manganese(II) chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in decreased expression of HOXB9 mRNA	PMID:17175027
1314613	HOXB9	homeobox B9	gene	CHEBI:63933	Aroclor 1254	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of HOXB9 mRNA	PMID:16934159
1314613	HOXB9	homeobox B9	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HOXB9 mRNA	PMID:22079614
1314613	HOXB9	homeobox B9	gene	CHEBI:69355	casticin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C054133	casticin results in decreased expression of HOXB9 mRNA	PMID:27862857
1314613	HOXB9	homeobox B9	gene	CHEBI:70752	dabigatran	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D000069604	Dabigatran results in increased expression of HOXB9 mRNA	PMID:31711903
1314613	HOXB9	homeobox B9	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of HOXB9 mRNA	PMID:22079256
1314613	HOXB9	homeobox B9	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of HOXB9 mRNA	PMID:22079256
1314613	HOXB9	homeobox B9	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HOXB9 mRNA	PMID:36139627
1314613	HOXB9	homeobox B9	gene	CHEBI:76010	dolutegravir	decreases expression	ISO	RGD:1314614	E	RGD:6480464	20260303	CTD	MESH:C562325	Dolutegravir results in decreased expression of HOXB9 mRNA	PMID:34515794
1314613	HOXB9	homeobox B9	gene	CHEBI:76359	butylated hydroxyanisole	decreases expression	ISO	RGD:1314614	E	RGD:6480464	20180116	CTD	MESH:D002083	Butylated Hydroxyanisole results in decreased expression of HOXB9 mRNA	PMID:28927898
1314613	HOXB9	homeobox B9	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HOXB9 mRNA	PMID:27188386
1314613	HOXB9	homeobox B9	gene	CHEBI:8058	phencyclidine	decreases expression	ISO	RGD:1314614	E	RGD:6480464	20121218	CTD	MESH:D010622	Phencyclidine results in decreased expression of HOXB9 mRNA	PMID:12105081
1314613	HOXB9	homeobox B9	gene	CHEBI:8107	phenytoin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D010672	Phenytoin results in increased expression of HOXB9 mRNA	PMID:31711903
1314613	HOXB9	homeobox B9	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1306158	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of HOXB9 mRNA	PMID:32109520
1314613	HOXB9	homeobox B9	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HOXB9 mRNA	PMID:23146750
1314613	HOXB9	homeobox B9	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of HOXB9 mRNA	PMID:32234424
1314613	HOXB9	homeobox B9	gene	CHEBI:91091	CHIR 99021	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C473711	[Chir 99021 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXB9 mRNA	PMID:31711903
1314613	HOXB9	homeobox B9	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[Chir 99021 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HOXB9 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of HOXB9 mRNA	PMID:27188386|PMID:31711903
1314613	HOXB9	homeobox B9	gene	CHEBI:9513	thalidomide	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D013792	Thalidomide results in increased expression of HOXB9 mRNA	PMID:31711903
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ATP6V0D1 mRNA	PMID:38218311
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of ATP6V0D1 mRNA	PMID:15928584
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in increased expression of ATP6V0D1 mRNA	PMID:15894607|PMID:33167477
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in increased expression of ATP6V0D1 mRNA	PMID:15894607
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP6V0D1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of ATP6V0D1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATP6V0D1 mRNA	PMID:32699268|PMID:32845096
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314616	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ATP6V0D1 mRNA	PMID:30319688
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:166595	Yessotoxin	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in increased expression of ATP6V0D1 mRNA	PMID:30679557
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ATP6V0D1 mRNA	PMID:23649840
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306159	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATP6V0D1 mRNA	PMID:33387578
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ATP6V0D1 mRNA	PMID:28818685
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1314616	E	RGD:6480464	20251202	CTD	MESH:D002104	Cadmium results in increased expression of ATP6V0D1 mRNA	PMID:30324847
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20200114	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V0D1 mRNA; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V0D1 mRNA]; NUPR1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V0D1 mRNA]	PMID:31319114
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314616	E	RGD:6480464	20251202	CTD	MESH:D002104	TFE3 protein affects the reaction [Cadmium results in increased expression of ATP6V0D1 mRNA]	PMID:30324847
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ATP6V0D1 mRNA	PMID:23649840
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1306159	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of ATP6V0D1 protein	PMID:33236894
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ATP6V0D1 intron	PMID:30157460
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:2504	aflatoxin B1	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D016604	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in increased expression of ATP6V0D1 protein	PMID:39638853
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ATP6V0D1 mRNA	PMID:23649840
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP6V0D1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of ATP6V0D1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATP6V0D1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ATP6V0D1 mRNA	PMID:32699268|PMID:32845096
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314616	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP6V0D1 mRNA	PMID:22206623
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATP6V0D1 gene	PMID:25304211
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314616	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATP6V0D1 mRNA	PMID:40504410
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ATP6V0D1 mRNA	PMID:19244175
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1306159	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP6V0D1 mRNA	PMID:33854195
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28077	rifampicin	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D012293	ATP6V0D1 protein affects the reaction [Rifampin inhibits the reaction [Rotenone results in increased lipidation of MAP1LC3B protein]]	PMID:31648047
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306159	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATP6V0D1 mRNA	PMID:34747641
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314616	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATP6V0D1 mRNA	PMID:21570461
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATP6V0D1 mRNA	PMID:20106945|PMID:21632981
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306159	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATP6V0D1 mRNA	PMID:33387578
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314616	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATP6V0D1 mRNA	PMID:19933214
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012402	Rotenone results in increased expression of ATP6V0D1 mRNA; Rotenone results in increased expression of ATP6V0D1 protein	PMID:31648047|PMID:39603559
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D012402	ATP6V0D1 protein affects the reaction [Rifampin inhibits the reaction [Rotenone results in increased lipidation of MAP1LC3B protein]]	PMID:31648047
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ATP6V0D1 mRNA	PMID:33212167
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306159	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ATP6V0D1 mRNA	PMID:28959563
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1306159	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of ATP6V0D1 mRNA	PMID:22465980
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of ATP6V0D1 mRNA	PMID:24690739
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314616	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATP6V0D1 mRNA	PMID:15467011
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ATP6V0D1 mRNA	PMID:29803840
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V0D1 mRNA]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA]	PMID:29307831|PMID:31319114
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ATP6V0D1 mRNA; sodium arsenite results in increased expression of ATP6V0D1 protein	PMID:36989763|PMID:38228842|PMID:38568856|PMID:39719251
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314616	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATP6V0D1 mRNA	PMID:40504410
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ATP6V0D1 promoter	PMID:27901495
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1306159	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of ATP6V0D1 mRNA	PMID:22465980
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of ATP6V0D1 mRNA	PMID:24690739
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314616	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATP6V0D1 mRNA	PMID:15467011
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA	PMID:29307831
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ATP6V0D1 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA]	PMID:15894607|PMID:29307831
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314616	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ATP6V0D1 gene; titanium dioxide results in decreased methylation of ATP6V0D1 promoter	PMID:35295148
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314616	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ATP6V0D1 gene	PMID:35295148
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306159	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ATP6V0D1 mRNA	PMID:34492290
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306159	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ATP6V0D1 mRNA	PMID:19167457
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ATP6V0D1 mRNA; bisphenol A results in increased expression of ATP6V0D1 protein	PMID:29275510|PMID:33376534|PMID:37567409
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306159	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ATP6V0D1 mRNA	PMID:25181051
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314616	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ATP6V0D1 mRNA	PMID:33221593
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of ATP6V0D1 mRNA	PMID:19244175
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ATP6V0D1 mRNA	PMID:25979313
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of ATP6V0D1 protein	PMID:31945527
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314616	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ATP6V0D1 mRNA	PMID:39298647|PMID:40203079
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ATP6V0D1 intron	PMID:30157460
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATP6V0D1 mRNA	PMID:28628672
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ATP6V0D1 protein	PMID:34186270
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1314616	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of ATP6V0D1 mRNA	PMID:31558096
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314616	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ATP6V0D1 mRNA	PMID:37019170
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1306159	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP6V0D1 mRNA	PMID:33854195
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1314616	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ATP6V0D1 protein	PMID:35362542
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314616	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ATP6V0D1 protein]	PMID:35362542
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATP6V0D1 mRNA	PMID:28628672
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ATP6V0D1 mRNA	PMID:37042841
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATP6V0D1 mRNA	PMID:38568856
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314616	E	RGD:6480464	20181113	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATP6V0D1 mRNA	PMID:30030080
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20200114	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V0D1 mRNA; Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V0D1 mRNA]; NUPR1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP6V0D1 mRNA]	PMID:31319114
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:36274	glycochenodeoxycholic acid	decreases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:D005999	Glycochenodeoxycholic Acid results in decreased expression of ATP6V0D1 mRNA	PMID:32439580
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ATP6V0D1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ATP6V0D1 mRNA	PMID:32699268
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ATP6V0D1 mRNA	PMID:19244175
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314616	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ATP6V0D1 mRNA	PMID:17585979
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ATP6V0D1 mRNA	PMID:31533062
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ATP6V0D1 mRNA	PMID:25979313
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of ATP6V0D1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386|PMID:28001369
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0D1 mRNA	PMID:27188386
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306159	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ATP6V0D1 mRNA	PMID:41580965
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1306159	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP6V0D1 mRNA	PMID:33854195
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATP6V0D1 mRNA	PMID:28628672
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1306159	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP6V0D1 mRNA	PMID:33854195
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ATP6V0D1 mRNA	PMID:28542535
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of ATP6V0D1 mRNA	PMID:24690739
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ATP6V0D1 gene	PMID:25304211
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314616	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ATP6V0D1 mRNA	PMID:40504410
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1306159	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of ATP6V0D1 mRNA	PMID:17108234
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1314616	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ATP6V0D1 protein]	PMID:35362542
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1306159	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of ATP6V0D1 mRNA	PMID:36868495
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ATP6V0D1 mRNA	PMID:28628672
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA	PMID:29307831
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ATP6V0D1 mRNA; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATP6V0D1 mRNA]	PMID:15894607|PMID:29307831
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314616	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ATP6V0D1 mRNA	PMID:25554681
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1306159	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP6V0D1 mRNA	PMID:33854195
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:6030	isoniazide	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of ATP6V0D1 protein	PMID:40015660
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ATP6V0D1 protein	PMID:32959892
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ATP6V0D1 intron	PMID:30157460
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of ATP6V0D1 mRNA	PMID:22101062
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ATP6V0D1 mRNA	PMID:31758290
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ATP6V0D1 protein	PMID:34186270
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314616	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP6V0D1 mRNA	PMID:22206623
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of ATP6V0D1 protein	PMID:39638853
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	[Aflatoxin B1 co-treated with beta-Naphthoflavone] results in increased expression of ATP6V0D1 protein	PMID:39638853
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0D1 mRNA	PMID:27188386
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314616	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ATP6V0D1 mRNA	PMID:31388691
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314616	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ATP6V0D1 mRNA	PMID:30294300
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1314616	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of ATP6V0D1 mRNA	PMID:38995820
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1306159	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of ATP6V0D1 protein	PMID:28903499
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:90943	osimertinib	increases expression	ISO	RGD:1306159	E	RGD:6480464	20250506	CTD	MESH:C000603933	osimertinib results in increased expression of ATP6V0D1 protein	PMID:38734218
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP6V0D1 mRNA	PMID:27188386
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306159	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ATP6V0D1 mRNA	PMID:21346803
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ATP6V0D1 mRNA	PMID:38568856
1314615	ATP6V0D1	ATPase H+ transporting V0 subunit d1	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1306159	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of ATP6V0D1 protein	PMID:32519852
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of LRP1B mRNA	PMID:34925699
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306160	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of LRP1B gene	PMID:35440735
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314618	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of LRP1B mRNA	PMID:30319688
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of LRP1B mRNA	PMID:35811015
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRP1B mRNA	PMID:35811015
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306160	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of LRP1B mRNA	PMID:27523638
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of LRP1B intron	PMID:30157460
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of LRP1B mRNA	PMID:22100608|PMID:31555880|PMID:32234424
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20200114	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LRP1B promoter	PMID:31555880
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1306160	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of LRP1B gene	PMID:35440735
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314618	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of LRP1B mRNA	PMID:32186404
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314618	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LRP1B mRNA	PMID:21570461
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314618	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRP1B mRNA	PMID:17942748
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314618	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LRP1B mRNA	PMID:17942748
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of LRP1B mRNA	PMID:33212167
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of LRP1B mRNA	PMID:21198554
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LRP1B promoter	PMID:27901495
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRP1B mRNA	PMID:20106945|PMID:31555880|PMID:32234424
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20200114	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LRP1B promoter	PMID:31555880
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LRP1B 5' UTR	PMID:27901495
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314618	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LRP1B intron	PMID:27901495
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1314618	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of LRP1B protein	PMID:37955338
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314618	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of LRP1B mRNA	PMID:27131904
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314618	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LRP1B mRNA	PMID:18301758
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306160	E	RGD:6480464	20201201	CTD	MESH:C006780	bisphenol A results in decreased expression of LRP1B mRNA	PMID:25181051
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314618	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of LRP1B mRNA	PMID:32156529
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of LRP1B mRNA	PMID:29275510
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314618	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of LRP1B mRNA	PMID:35598803
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of LRP1B mRNA	PMID:25979313
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314618	E	RGD:6480464	20121113	CTD	MESH:D010269	Paraquat results in increased expression of LRP1B mRNA	PMID:22563483
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:39472	1,3,4-thiadiazole	affects expression	ISO	RGD:1306160	E	RGD:6480464	20250204	CTD	MESH:C058949	1,3,4-thiadiazole analog affects the expression of LRP1B mRNA	PMID:30905023
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LRP1B mRNA	PMID:25979313
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1306160	E	RGD:6480464	20201201	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRP1B mRNA	PMID:29427782
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314618	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRP1B mRNA	PMID:24896083
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314618	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of LRP1B mRNA	PMID:17555576
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of LRP1B mRNA	PMID:38832940
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of LRP1B mRNA	PMID:35811015
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of LRP1B mRNA	PMID:31675489
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314618	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of LRP1B mRNA	PMID:17555576
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306160	E	RGD:6480464	20201201	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LRP1B mRNA	PMID:29097150
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314618	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of LRP1B mRNA	PMID:17942748
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314618	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LRP1B mRNA	PMID:17942748
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of LRP1B mRNA	PMID:32234424
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of LRP1B mRNA	PMID:24810058
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306160	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LRP1B gene	PMID:35440735
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of LRP1B protein	PMID:31675489
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of LRP1B protein	PMID:31675489
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306160	E	RGD:6480464	20201201	CTD	MESH:D011441	Propylthiouracil results in increased expression of LRP1B mRNA	PMID:24780913
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314618	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of LRP1B mRNA	PMID:27131904
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306160	E	RGD:6480464	20201201	CTD	MESH:D012999	Soman results in decreased expression of LRP1B mRNA	PMID:19281266
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306160	E	RGD:6480464	20201201	CTD	MESH:C025643	vinclozolin results in decreased expression of LRP1B mRNA	PMID:23869203
1314617	LRP1B	LDL receptor related protein 1B	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1306160	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of LRP1B gene	PMID:31079544
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of FKBP11 mRNA	PMID:38218311
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of FKBP11 mRNA	PMID:38218311
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306161	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of FKBP11 mRNA	PMID:25152437
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of FKBP11 mRNA	PMID:26272509
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FKBP11 mRNA	PMID:27188386
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of FKBP11 mRNA	PMID:26079696
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of FKBP11 mRNA	PMID:29581250
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314620	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FKBP11 mRNA	PMID:39241906
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20171010	CTD	MESH:D004958	Estradiol results in decreased expression of FKBP11 mRNA	PMID:28476547
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314620	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of FKBP11 mRNA	PMID:19484750
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306161	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of FKBP11 mRNA	PMID:26496021
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314620	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of FKBP11 mRNA	PMID:33711761
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1314620	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of FKBP11 mRNA	PMID:17251523
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1314620	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of FKBP11 mRNA	PMID:17945193
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of FKBP11 mRNA	PMID:28973375
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:17315	D-glucosamine	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of FKBP11 mRNA	PMID:17178593
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of FKBP11 mRNA	PMID:33848595
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1314620	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of FKBP11 mRNA]	PMID:33848595
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1306161	E	RGD:6480464	20140408	CTD	MESH:D014050	Toluene results in decreased expression of FKBP11 mRNA	PMID:22967744
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1306161	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FKBP11 mRNA	PMID:21318169
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306161	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of FKBP11 protein	PMID:34915118
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of FKBP11 mRNA	PMID:17178593
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306161	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of FKBP11 mRNA	PMID:21396975
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FKBP11 mRNA	PMID:19770486
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314620	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FKBP11 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FKBP11 mRNA	PMID:34911549
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:2663	amiodarone	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in decreased expression of FKBP11 mRNA	PMID:24535564
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306161	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of FKBP11 mRNA	PMID:30779732
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of FKBP11 mRNA	PMID:22171008
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314620	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of FKBP11 mRNA	PMID:17484886|PMID:27339419|PMID:31919559
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of FKBP11 mRNA	PMID:19167446
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of FKBP11 mRNA	PMID:24768652|PMID:25583101
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314620	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FKBP11 mRNA	PMID:21570461|PMID:26377647
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306161	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FKBP11 mRNA	PMID:18796159|PMID:21215274
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FKBP11 mRNA	PMID:23179753
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FKBP11 mRNA	PMID:33212167
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of FKBP11 mRNA	PMID:17178593
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of FKBP11 mRNA	PMID:32763439
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306161	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of FKBP11 mRNA	PMID:28959563
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1306161	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of FKBP11 mRNA	PMID:30556269
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306161	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of FKBP11 mRNA	PMID:22465980
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:28794	coumarin	increases expression	ISO	RGD:1306161	E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in increased expression of FKBP11 mRNA	PMID:18480146
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314620	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of FKBP11 mRNA	PMID:37682722
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of FKBP11 mRNA	PMID:22378314|PMID:29453283
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FKBP11 promoter	PMID:27901495
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of FKBP11 exon	PMID:27901495
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1306161	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of FKBP11 mRNA	PMID:30556269
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306161	E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in increased expression of FKBP11 mRNA	PMID:22465980
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of FKBP11 mRNA	PMID:22171008
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of FKBP11 mRNA	PMID:20458559
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:3090	bicalutamide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of FKBP11 mRNA	PMID:15638997
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306161	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of FKBP11 mRNA	PMID:24136188
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306161	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of FKBP11 mRNA	PMID:30047161
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of FKBP11 mRNA	PMID:29264374
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314620	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of FKBP11 mRNA	PMID:23557971
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1306161	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in decreased expression of FKBP11 mRNA	PMID:19162173|PMID:21318169
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of FKBP11 mRNA	PMID:20813756|PMID:21318169|PMID:23811191
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314620	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in decreased expression of FKBP11 mRNA; PPARA protein affects the reaction [pirinixic acid results in decreased expression of FKBP11 mRNA]	PMID:20813756|PMID:21318169
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306161	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FKBP11 mRNA	PMID:34947998
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20171010	CTD	MESH:C006780	bisphenol A results in decreased expression of FKBP11 mRNA	PMID:28476547
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306161	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of FKBP11 mRNA	PMID:25181051|PMID:30816183
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306161	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of FKBP11 mRNA	PMID:26496021
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314620	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of FKBP11 mRNA	PMID:26682919
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314620	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FKBP11 mRNA	PMID:30951980|PMID:39298647
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of FKBP11 mRNA	PMID:38685157
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1306161	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of FKBP11 mRNA	PMID:19638242
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1314620	E	RGD:6480464	20160412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of FKBP11 mRNA	PMID:24535843
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1306161	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of FKBP11 mRNA	PMID:22110744
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FKBP11 mRNA	PMID:37042841
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1306161	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of FKBP11 mRNA	PMID:30589522
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306161	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FKBP11 mRNA	PMID:25993096
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1306161	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of FKBP11 promoter	PMID:22457795
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306161	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of FKBP11 mRNA	PMID:25539665
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1306161	E	RGD:6480464	20120918	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of FKBP11 mRNA	PMID:19162173|PMID:21318169
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of FKBP11 mRNA	PMID:19320972|PMID:19376846
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of FKBP11 mRNA	PMID:24449571
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314620	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of FKBP11 mRNA	PMID:18353800
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1314620	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of FKBP11 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FKBP11 mRNA]	PMID:17585979
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314620	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of FKBP11 mRNA	PMID:40194260
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of FKBP11 mRNA	PMID:28302478
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FKBP11 mRNA	PMID:31533062
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of FKBP11 mRNA	PMID:19167446
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP11 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of FKBP11 mRNA	PMID:19167446
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of FKBP11 mRNA	PMID:40419075
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314620	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of FKBP11 mRNA	PMID:17292431
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1306161	E	RGD:6480464	20120613	CTD	MESH:D014635	Valproic Acid results in decreased expression of FKBP11 mRNA	PMID:21318169
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in decreased expression of FKBP11 mRNA	PMID:24535564
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FKBP11 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314620	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in increased expression of FKBP11 mRNA	PMID:19770486|PMID:25270620
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:1314620	E	RGD:6480464	20131210	CTD	MESH:C075773	4-phenylbutyric acid promotes the reaction [LEPR gene mutant form results in increased expression of FKBP11 mRNA]	PMID:23274897
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of FKBP11 mRNA	PMID:28973697
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1306161	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of FKBP11 mRNA	PMID:24136188
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FKBP11 mRNA	PMID:27188386
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of FKBP11 mRNA	PMID:26272509
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FKBP11 mRNA	PMID:27188386
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1306161	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of FKBP11 mRNA	PMID:21346803
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314620	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FKBP11 mRNA	PMID:17562736
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314620	E	RGD:6480464	20190910	CTD	MESH:D000082	Acetaminophen results in increased expression of FKBP11 mRNA	PMID:29246445
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314620	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of FKBP11 mRNA; PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of FKBP11 mRNA]; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of FKBP11 mRNA]	PMID:17585979|PMID:29246445
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	FKBP11 protein affects the susceptibility to Fluorouracil	PMID:16217747
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of FKBP11 mRNA	PMID:17178593
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of FKBP11 mRNA	PMID:20458559
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314620	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of FKBP11 mRNA	PMID:25554681
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306161	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of FKBP11 mRNA	PMID:30047161
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	ISO	RGD:1314620	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of FKBP11 mRNA	PMID:15375163
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306161	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of FKBP11 mRNA	PMID:24793618
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306161	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of FKBP11 mRNA	PMID:24136188
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of FKBP11 mRNA	PMID:23608068
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314620	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of FKBP11 mRNA	PMID:38701926
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of FKBP11 protein	PMID:34186270
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314620	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FKBP11 mRNA	PMID:22206623
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306161	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of FKBP11 mRNA	PMID:24136188
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1306161	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of FKBP11 mRNA	PMID:21346803
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FKBP11 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FKBP11 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FKBP11 mRNA	PMID:27188386
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FKBP11 gene]	PMID:28238834
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of FKBP11 mRNA	PMID:19159669
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1306161	E	RGD:6480464	20120918	CTD	MESH:D010634	Phenobarbital results in increased expression of FKBP11 mRNA	PMID:19162173|PMID:21318169|PMID:30047161
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314620	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of FKBP11 mRNA	PMID:19482888
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314620	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FKBP11 mRNA]	PMID:19482888
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of FKBP11 mRNA	PMID:19167446
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314620	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of FKBP11 mRNA	PMID:38648751
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:C511295	[2,2',4,4'-tetrabromodiphenyl ether affects the methylation of FKBP11 gene] which affects the expression of FKBP11 mRNA	PMID:32653021
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of FKBP11 mRNA	PMID:26079696
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of FKBP11 protein	PMID:38348393
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314620	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of FKBP11 mRNA	PMID:21278054
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306161	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of FKBP11 mRNA	PMID:24780913|PMID:30047161
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1314620	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of FKBP11 mRNA	PMID:40826991
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of FKBP11 mRNA	PMID:31734321
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FKBP11 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FKBP11 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FKBP11 mRNA	PMID:27188386
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306161	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of FKBP11 mRNA	PMID:19281266
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306161	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of FKBP11 mRNA	PMID:19281266
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306161	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of FKBP11 mRNA	PMID:21346803
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of FKBP11 mRNA	PMID:22378314|PMID:29453283
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of FKBP11 mRNA	PMID:32835833
1314619	FKBP11	FKBP prolyl isomerase 11	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314620	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of FKBP11 mRNA	PMID:35537566
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1557232	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TAF9 mRNA	PMID:33045310
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1557232	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of TAF9 mRNA	PMID:16604517
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of TAF9 mRNA	PMID:15309432
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D004958	Estradiol results in increased expression of TAF9 mRNA	PMID:16514628|PMID:18556351
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1557232	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of TAF9 mRNA	PMID:39298647
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1557232	E	RGD:6480464	20130910	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of TAF9 mRNA	PMID:18556351
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:727861	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TAF9 mRNA	PMID:33387578
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:17026	progesterone	multiple interactions	ISO	RGD:1557232	E	RGD:6480464	20130910	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of TAF9 mRNA	PMID:18556351
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TAF9 protein	PMID:37730182
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:727861	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TAF9 mRNA	PMID:22061828
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TAF9 gene	PMID:27153756
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1557232	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TAF9 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TAF9 mRNA	PMID:34911549
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TAF9 mRNA	PMID:18593933
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:727861	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TAF9 mRNA	PMID:31150632
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of TAF9 mRNA	PMID:33512557
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of TAF9 protein	PMID:35688186
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1557232	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TAF9 mRNA	PMID:28960355
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TAF9 mRNA	PMID:23557933
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1557232	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of TAF9 mRNA	PMID:30912803
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1557232	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TAF9 mRNA	PMID:21570461
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:727861	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TAF9 mRNA	PMID:33387578
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1557232	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TAF9 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TAF9 mRNA	PMID:17942748|PMID:25975270
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of TAF9 mRNA	PMID:33512557
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TAF9 mRNA	PMID:28001369
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TAF9 mRNA	PMID:29803840
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of TAF9 mRNA	PMID:17879257
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1557232	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TAF9 mRNA	PMID:22228805
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TAF9 mRNA	PMID:18593933
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1557232	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TAF9 mRNA	PMID:35676786
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:31638	fulvestrant	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of TAF9 mRNA	PMID:16514628
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:31638	fulvestrant	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C070081	fulvestrant results in increased expression of TAF9 mRNA	PMID:12154049
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:727861	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of TAF9 mRNA	PMID:24136188
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:727861	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of TAF9 mRNA	PMID:25729387
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:727861	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of TAF9 mRNA	PMID:30047161
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1557232	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TAF9 gene	PMID:35295148
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:727861	E	RGD:6480464	20141118	CTD	MESH:D013853	Thioacetamide results in increased expression of TAF9 mRNA	PMID:23411599|PMID:34492290
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1557232	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of TAF9 mRNA	PMID:23811191
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1557232	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of TAF9 mRNA	PMID:28472532
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of TAF9 mRNA	PMID:30903817
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1557232	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TAF9 promoter	PMID:27334623
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1557232	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF9 mRNA	PMID:33221593
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:727861	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TAF9 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1557232	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TAF9 mRNA	PMID:39298647
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1557232	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TAF9 mRNA	PMID:32715474
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:727861	E	RGD:6480464	20141118	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TAF9 mRNA	PMID:21266533
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:727861	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of TAF9 mRNA	PMID:32680482
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TAF9 mRNA	PMID:37042841
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of TAF9 mRNA	PMID:19376846
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1557232	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of TAF9 mRNA	PMID:25908611
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1557232	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of TAF9 mRNA	PMID:17585979
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TAF9 mRNA	PMID:28302478
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:727861	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of TAF9 mRNA	PMID:25993096
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TAF9 mRNA	PMID:25979313
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TAF9 gene	PMID:29154799
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:727861	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of TAF9 mRNA	PMID:30047161
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1557232	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TAF9 mRNA	PMID:17555576
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of TAF9 mRNA	PMID:33512557
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:44616	afimoxifene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of TAF9 mRNA	PMID:16514628
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1557232	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TAF9 mRNA	PMID:17562736
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:727861	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TAF9 mRNA	PMID:33387578
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1557232	E	RGD:6480464	20120515	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TAF9 mRNA	PMID:17555576|PMID:17942748
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1557232	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TAF9 mRNA	PMID:17942748
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1557232	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TAF9 mRNA	PMID:35676786
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1557232	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of TAF9 mRNA; Nanotubes, Carbon results in increased expression of TAF9 mRNA	PMID:25554681|PMID:25620056
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:727861	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of TAF9 mRNA	PMID:30047161
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:727861	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TAF9 mRNA	PMID:24136188
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:727861	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of TAF9 mRNA	PMID:24136188
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:727861	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of TAF9 mRNA	PMID:25729387
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:727861	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of TAF9 mRNA	PMID:24136188
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of TAF9 protein	PMID:31285264
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:727861	E	RGD:6480464	20141118	CTD	MESH:C025589	ochratoxin A results in increased expression of TAF9 mRNA	PMID:23358140
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of TAF9 mRNA	PMID:33512557
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of TAF9 mRNA	PMID:33512557
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:727861	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of TAF9 mRNA	PMID:30047161
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of TAF9 mRNA	PMID:16514628
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:8772	raloxifene	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of TAF9 mRNA	PMID:12154049
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:727861	E	RGD:6480464	20141118	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TAF9 mRNA	PMID:21346803
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of TAF9 mRNA	PMID:27188386
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:727861	E	RGD:6480464	20141118	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TAF9 mRNA	PMID:21346803
1314621	TAF9	TATA-box binding protein associated factor 9	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:727861	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of TAF9 mRNA	PMID:23034163
1314623	EPHB6	EPH receptor B6	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of EPHB6 mRNA	PMID:38218311
1314623	EPHB6	EPH receptor B6	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314624	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of EPHB6 mRNA	PMID:37995155
1314623	EPHB6	EPH receptor B6	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306163	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of EPHB6 mRNA]	PMID:31150632
1314623	EPHB6	EPH receptor B6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314624	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of EPHB6 mRNA	PMID:20188158
1314623	EPHB6	EPH receptor B6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of EPHB6 mRNA	PMID:23830798
1314623	EPHB6	EPH receptor B6	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of EPHB6 mRNA	PMID:26079696
1314623	EPHB6	EPH receptor B6	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314624	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of EPHB6 mRNA	PMID:30319688
1314623	EPHB6	EPH receptor B6	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314624	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of EPHB6 mRNA	PMID:39241906
1314623	EPHB6	EPH receptor B6	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of EPHB6 mRNA	PMID:30510588
1314623	EPHB6	EPH receptor B6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314624	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of EPHB6 mRNA	PMID:39298647
1314623	EPHB6	EPH receptor B6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of EPHB6 mRNA	PMID:30165855
1314623	EPHB6	EPH receptor B6	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306163	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of EPHB6 mRNA	PMID:33387578
1314623	EPHB6	EPH receptor B6	gene	CHEBI:17230	homocysteine	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D006710	Homocysteine results in decreased expression of EPHB6 mRNA	PMID:17320366
1314623	EPHB6	EPH receptor B6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314624	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHB6 mRNA	PMID:37992649
1314623	EPHB6	EPH receptor B6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of EPHB6 5' UTR	PMID:33872906
1314623	EPHB6	EPH receptor B6	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of EPHB6 mRNA	PMID:21592394
1314623	EPHB6	EPH receptor B6	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of EPHB6 mRNA	PMID:21592394
1314623	EPHB6	EPH receptor B6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314624	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHB6 mRNA	PMID:37992649
1314623	EPHB6	EPH receptor B6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of EPHB6 5' UTR	PMID:33872906
1314623	EPHB6	EPH receptor B6	gene	CHEBI:17750	glycine betaine	increases expression	ISO	RGD:1306163	E	RGD:6480464	20151215	CTD	MESH:D001622	Betaine results in increased expression of EPHB6 mRNA	PMID:26391144
1314623	EPHB6	EPH receptor B6	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of EPHB6 mRNA	PMID:21592394
1314623	EPHB6	EPH receptor B6	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of EPHB6 mRNA	PMID:21592394
1314623	EPHB6	EPH receptor B6	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of EPHB6 mRNA	PMID:28818685
1314623	EPHB6	EPH receptor B6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306163	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EPHB6 mRNA	PMID:39012411
1314623	EPHB6	EPH receptor B6	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306163	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of EPHB6 mRNA	PMID:21396975
1314623	EPHB6	EPH receptor B6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of EPHB6 gene	PMID:27153756
1314623	EPHB6	EPH receptor B6	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EPHB6 mRNA	PMID:22100608
1314623	EPHB6	EPH receptor B6	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306163	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of EPHB6 mRNA	PMID:30779732
1314623	EPHB6	EPH receptor B6	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306163	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of EPHB6 mRNA	PMID:31150632
1314623	EPHB6	EPH receptor B6	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306163	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of EPHB6 mRNA]	PMID:31150632
1314623	EPHB6	EPH receptor B6	gene	CHEBI:27470	folic acid	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005492	Folic Acid affects the expression of EPHB6 mRNA	PMID:17320366
1314623	EPHB6	EPH receptor B6	gene	CHEBI:27563	arsenic atom	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in increased expression of EPHB6 mRNA	PMID:36861143
1314623	EPHB6	EPH receptor B6	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EPHB6 mRNA	PMID:32525701
1314623	EPHB6	EPH receptor B6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314624	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EPHB6 mRNA	PMID:40504410
1314623	EPHB6	EPH receptor B6	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of EPHB6 mRNA	PMID:19244175
1314623	EPHB6	EPH receptor B6	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1306163	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of EPHB6 gene	PMID:35440735
1314623	EPHB6	EPH receptor B6	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306163	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of EPHB6 mRNA	PMID:31881176
1314623	EPHB6	EPH receptor B6	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of EPHB6 mRNA	PMID:27594783
1314623	EPHB6	EPH receptor B6	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1306163	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of EPHB6 mRNA	PMID:15691709
1314623	EPHB6	EPH receptor B6	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of EPHB6 mRNA	PMID:24768652
1314623	EPHB6	EPH receptor B6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314624	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EPHB6 mRNA	PMID:21570461
1314623	EPHB6	EPH receptor B6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306163	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPHB6 mRNA	PMID:21215274
1314623	EPHB6	EPH receptor B6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306163	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPHB6 mRNA	PMID:33387578
1314623	EPHB6	EPH receptor B6	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of EPHB6 mRNA	PMID:32763439
1314623	EPHB6	EPH receptor B6	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306163	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of EPHB6 mRNA	PMID:28959563
1314623	EPHB6	EPH receptor B6	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of EPHB6 mRNA	PMID:30031762
1314623	EPHB6	EPH receptor B6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314624	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHB6 mRNA	PMID:37992649
1314623	EPHB6	EPH receptor B6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314624	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EPHB6 mRNA	PMID:40504410
1314623	EPHB6	EPH receptor B6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EPHB6 5' UTR	PMID:27901495
1314623	EPHB6	EPH receptor B6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EPHB6 3' UTR	PMID:27901495
1314623	EPHB6	EPH receptor B6	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1314624	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in increased expression of EPHB6 mRNA	PMID:33053406
1314623	EPHB6	EPH receptor B6	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314624	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of EPHB6 mRNA	PMID:27131904
1314623	EPHB6	EPH receptor B6	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of EPHB6 mRNA	PMID:25895662
1314623	EPHB6	EPH receptor B6	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of EPHB6 mRNA	PMID:23806026
1314623	EPHB6	EPH receptor B6	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of EPHB6 mRNA	PMID:35984750
1314623	EPHB6	EPH receptor B6	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of EPHB6 gene	PMID:31601247
1314623	EPHB6	EPH receptor B6	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306163	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of EPHB6 mRNA	PMID:23411599|PMID:34492290
1314623	EPHB6	EPH receptor B6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306163	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of EPHB6 mRNA	PMID:25181051
1314623	EPHB6	EPH receptor B6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306163	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of EPHB6 mRNA	PMID:32145629|PMID:34947998
1314623	EPHB6	EPH receptor B6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314624	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of EPHB6 mRNA	PMID:32156529
1314623	EPHB6	EPH receptor B6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EPHB6 mRNA	PMID:28628672
1314623	EPHB6	EPH receptor B6	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1314624	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of EPHB6 mRNA	PMID:25172293
1314623	EPHB6	EPH receptor B6	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of EPHB6 mRNA	PMID:36804509
1314623	EPHB6	EPH receptor B6	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1314624	E	RGD:6480464	20140715	CTD	MESH:D008748	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of EPHB6 mRNA	PMID:23519560
1314623	EPHB6	EPH receptor B6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314624	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of EPHB6 mRNA	PMID:39298647
1314623	EPHB6	EPH receptor B6	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EPHB6 mRNA	PMID:28628672
1314623	EPHB6	EPH receptor B6	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EPHB6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EPHB6 mRNA	PMID:28628672
1314623	EPHB6	EPH receptor B6	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306163	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of EPHB6 mRNA	PMID:32680482
1314623	EPHB6	EPH receptor B6	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314624	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of EPHB6 mRNA	PMID:36117858
1314623	EPHB6	EPH receptor B6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EPHB6 mRNA	PMID:37042841
1314623	EPHB6	EPH receptor B6	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1314624	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of EPHB6 mRNA	PMID:26377693
1314623	EPHB6	EPH receptor B6	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EPHB6 mRNA	PMID:38382870
1314623	EPHB6	EPH receptor B6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306163	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EPHB6 mRNA	PMID:39012411
1314623	EPHB6	EPH receptor B6	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1306163	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of EPHB6 mRNA	PMID:25539665|PMID:26194646
1314623	EPHB6	EPH receptor B6	gene	CHEBI:35861	dibenzo[a,l]pyrene	affects expression	ISO	RGD:1314624	E	RGD:6480464	20160210	CTD	MESH:C041517	dibenzo(a,l)pyrene affects the expression of EPHB6 mRNA	PMID:26496743
1314623	EPHB6	EPH receptor B6	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of EPHB6 mRNA	PMID:19244175
1314623	EPHB6	EPH receptor B6	gene	CHEBI:37415	alpha-amanitin	affects expression	ISO	RGD:1314624	E	RGD:6480464	20240903	CTD	MESH:D053959	Alpha-Amanitin affects the expression of EPHB6 mRNA	PMID:38531469
1314623	EPHB6	EPH receptor B6	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1314624	E	RGD:6480464	20140715	CTD	MESH:D013755	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of EPHB6 mRNA	PMID:23519560
1314623	EPHB6	EPH receptor B6	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1314624	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of EPHB6 mRNA	PMID:39529242
1314623	EPHB6	EPH receptor B6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314624	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of EPHB6 mRNA	PMID:36331819
1314623	EPHB6	EPH receptor B6	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306163	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of EPHB6 mRNA	PMID:41580965
1314623	EPHB6	EPH receptor B6	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of EPHB6 mRNA	PMID:20106945|PMID:27989131
1314623	EPHB6	EPH receptor B6	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EPHB6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EPHB6 mRNA	PMID:28628672
1314623	EPHB6	EPH receptor B6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314624	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPHB6 mRNA	PMID:37992649
1314623	EPHB6	EPH receptor B6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306163	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EPHB6 mRNA	PMID:33387578
1314623	EPHB6	EPH receptor B6	gene	CHEBI:47217	arsane	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D001151	Arsenic results in increased expression of EPHB6 mRNA	PMID:36861143
1314623	EPHB6	EPH receptor B6	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EPHB6 mRNA	PMID:32525701
1314623	EPHB6	EPH receptor B6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314624	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EPHB6 mRNA	PMID:40504410
1314623	EPHB6	EPH receptor B6	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306163	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of EPHB6 mRNA	PMID:29391264
1314623	EPHB6	EPH receptor B6	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314624	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of EPHB6 mRNA	PMID:35436446
1314623	EPHB6	EPH receptor B6	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EPHB6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of EPHB6 mRNA	PMID:28628672
1314623	EPHB6	EPH receptor B6	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1314624	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of EPHB6 mRNA	PMID:27915011
1314623	EPHB6	EPH receptor B6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314624	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of EPHB6 mRNA; Nanotubes, Carbon results in decreased expression of EPHB6 mRNA	PMID:25554681
1314623	EPHB6	EPH receptor B6	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314624	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of EPHB6 mRNA	PMID:36117858
1314623	EPHB6	EPH receptor B6	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of EPHB6 mRNA	PMID:18651567
1314623	EPHB6	EPH receptor B6	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314624	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of EPHB6 mRNA	PMID:23608068
1314623	EPHB6	EPH receptor B6	gene	CHEBI:5855	ibuprofen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007052	Ibuprofen affects the expression of EPHB6 mRNA	PMID:17070997
1314623	EPHB6	EPH receptor B6	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1314624	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of EPHB6 mRNA	PMID:38701926
1314623	EPHB6	EPH receptor B6	gene	CHEBI:7719	ochratoxin A	increases acetylation	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in increased acetylation of EPHB6 promoter	PMID:29098329
1314623	EPHB6	EPH receptor B6	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in increased expression of EPHB6 mRNA	PMID:29098329
1314623	EPHB6	EPH receptor B6	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	[ochratoxin A results in increased acetylation of EPHB6 promoter] which results in increased expression of EPHB6 mRNA	PMID:29098329
1314623	EPHB6	EPH receptor B6	gene	CHEBI:82335	Indeno[1,2,3-cd]pyrene	decreases expression	ISO	RGD:1314624	E	RGD:6480464	20160119	CTD	MESH:C041508	indeno(1,2,3-cd)pyrene results in decreased expression of EPHB6 mRNA	PMID:26377693
1314623	EPHB6	EPH receptor B6	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of EPHB6 mRNA	PMID:32525701
1314623	EPHB6	EPH receptor B6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306163	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EPHB6 mRNA	PMID:24780913
1314623	EPHB6	EPH receptor B6	gene	CHEBI:87368	diethyl malate	affects expression	ISO	RGD:1314624	E	RGD:6480464	20170303	CTD	MESH:C058705	diethyl malate affects the expression of EPHB6 mRNA	PMID:24814887
1314623	EPHB6	EPH receptor B6	gene	CHEBI:8887	rofecoxib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C116926	rofecoxib results in decreased expression of EPHB6 mRNA	PMID:17070997
1314623	EPHB6	EPH receptor B6	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314624	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of EPHB6 mRNA	PMID:27131904
1314623	EPHB6	EPH receptor B6	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306163	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of EPHB6 mRNA	PMID:21346803
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1306164	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of ZCCHC24 mRNA	PMID:21551480
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1620774	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ZCCHC24 mRNA	PMID:37995155
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306164	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZCCHC24 mRNA]	PMID:31150632
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of ZCCHC24 mRNA	PMID:21934132
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in increased expression of ZCCHC24 mRNA	PMID:15498508
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ZCCHC24 mRNA	PMID:22378314
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1620774	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ZCCHC24 mRNA	PMID:30319688
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZCCHC24 mRNA	PMID:35811015
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1620774	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZCCHC24 mRNA	PMID:39241906
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ZCCHC24 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ZCCHC24 mRNA	PMID:35811015
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1620774	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ZCCHC24 mRNA	PMID:39298647
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of ZCCHC24 mRNA	PMID:27664576
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306164	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZCCHC24 mRNA	PMID:33387578
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZCCHC24 mRNA	PMID:28818685
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ZCCHC24 intron	PMID:30157460
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1620774	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZCCHC24 mRNA	PMID:36331819
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZCCHC24 mRNA	PMID:19549813
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1620774	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ZCCHC24 mRNA	PMID:34911549
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1620774	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of ZCCHC24 mRNA	PMID:17484886
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306164	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ZCCHC24 mRNA	PMID:31150632
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1620774	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ZCCHC24 mRNA	PMID:31919559
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306164	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZCCHC24 mRNA]	PMID:31150632
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ZCCHC24 mRNA	PMID:19244175
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1620774	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of ZCCHC24 mRNA	PMID:35897073
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306164	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ZCCHC24 mRNA	PMID:31881176
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ZCCHC24 mRNA	PMID:23557933
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ZCCHC24 mRNA	PMID:28903495
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1306164	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ZCCHC24 mRNA	PMID:22023808
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306164	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZCCHC24 mRNA	PMID:34747641
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306164	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZCCHC24 mRNA	PMID:33387578
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306164	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ZCCHC24 mRNA	PMID:28959563
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1620774	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ZCCHC24 gene	PMID:39894169
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZCCHC24 mRNA	PMID:38568856
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZCCHC24 intron	PMID:30157460
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZCCHC24 mRNA	PMID:32234424
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ZCCHC24 3' UTR	PMID:27901495
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZCCHC24 promoter	PMID:27901495
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ZCCHC24 mRNA]	PMID:32406909
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ZCCHC24 mRNA	PMID:25895662
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ZCCHC24 mRNA	PMID:25351596
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of ZCCHC24 mRNA	PMID:15498508
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1620774	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of ZCCHC24 mRNA	PMID:29264374
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306164	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZCCHC24 mRNA	PMID:34492290
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1620774	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of ZCCHC24 mRNA	PMID:18648102
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1306164	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ZCCHC24 mRNA	PMID:30723492
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306164	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ZCCHC24 mRNA	PMID:19167457
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306164	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZCCHC24 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ZCCHC24 gene	PMID:31601247
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306164	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ZCCHC24 gene	PMID:28505145
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of ZCCHC24 mRNA	PMID:19244175
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1620774	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ZCCHC24 mRNA	PMID:39298647
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1620774	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ZCCHC24 mRNA	PMID:30951980
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1620774	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of ZCCHC24 intron	PMID:28392331
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306164	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ZCCHC24 mRNA	PMID:21266533
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1620774	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ZCCHC24 mRNA	PMID:34813904
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1620774	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ZCCHC24 mRNA	PMID:34813904
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306164	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of ZCCHC24 gene	PMID:33148267
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZCCHC24 mRNA	PMID:37042841
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1306164	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of ZCCHC24 promoter	PMID:22457795
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306164	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZCCHC24 mRNA	PMID:33453195
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ZCCHC24 mRNA	PMID:24449571
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ZCCHC24 mRNA	PMID:19244175
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1620774	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZCCHC24 mRNA	PMID:36331819
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZCCHC24 gene	PMID:29154799
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of ZCCHC24 mRNA	PMID:19101580|PMID:24935251
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1620774	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in increased expression of ZCCHC24 mRNA	PMID:19136453|PMID:21427059
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZCCHC24 mRNA	PMID:20106945
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in decreased expression of ZCCHC24 mRNA	PMID:19059307
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1620774	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ZCCHC24 mRNA	PMID:28973697
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ZCCHC24 mRNA	PMID:28542535
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ZCCHC24 mRNA	PMID:24935251
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZCCHC24 mRNA	PMID:27188386
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1620774	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZCCHC24 mRNA	PMID:17562736
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZCCHC24 mRNA	PMID:21420995
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306164	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZCCHC24 mRNA	PMID:33387578
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ZCCHC24 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ZCCHC24 mRNA	PMID:35811015
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1620774	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ZCCHC24 mRNA	PMID:29279043
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306164	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ZCCHC24 mRNA	PMID:29391264
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1620774	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of ZCCHC24 mRNA	PMID:35436446
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1306164	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of ZCCHC24 mRNA	PMID:23962444
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306164	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of ZCCHC24 gene	PMID:33148267
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ZCCHC24 mRNA	PMID:31758290
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1620774	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ZCCHC24 mRNA	PMID:22206623
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of ZCCHC24 mRNA	PMID:28960945
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:77012	methylseleninic acid	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of ZCCHC24 mRNA	PMID:18548127
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZCCHC24 mRNA	PMID:27188386
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1620774	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ZCCHC24 mRNA	PMID:23091169
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1306164	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ZCCHC24 mRNA	PMID:23914054
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1620774	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of ZCCHC24 mRNA	PMID:21278054
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of ZCCHC24 mRNA	PMID:14699072
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of ZCCHC24 mRNA	PMID:19059307
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:88046	cylindrospermopsin	decreases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in decreased expression of ZCCHC24 mRNA	PMID:24921660
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZCCHC24 mRNA	PMID:27188386
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ZCCHC24 mRNA	PMID:38568856
1314625	ZCCHC24	zinc finger CCHC-type containing 24	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1620774	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ZCCHC24 mRNA	PMID:35537566
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314628	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZDHHC5 mRNA	PMID:33045310
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ZDHHC5 protein]	PMID:38195004
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314628	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZDHHC5 gene	PMID:20938992
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZDHHC5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZDHHC5 mRNA	PMID:32699268
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ZDHHC5 mRNA	PMID:22378314
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314628	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZDHHC5 mRNA	PMID:39241906
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ZDHHC5 mRNA	PMID:31614463
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314628	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZDHHC5 gene	PMID:20938992
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1314628	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of ZDHHC5 mRNA	PMID:23892564
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ZDHHC5 protein	PMID:37730182
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ZDHHC5 mRNA	PMID:28818685
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1314628	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of ZDHHC5 mRNA	PMID:33914522
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ZDHHC5 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ZDHHC5 protein	PMID:38195004
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZDHHC5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZDHHC5 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of ZDHHC5 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ZDHHC5 mRNA	PMID:32699268|PMID:35430440
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of ZDHHC5 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of ZDHHC5 protein	PMID:38598786
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314628	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZDHHC5 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZDHHC5 gene	PMID:20938992|PMID:22206623
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZDHHC5 gene	PMID:25304211
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ZDHHC5 protein	PMID:35688186
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1589737	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZDHHC5 mRNA	PMID:33387578
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314628	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZDHHC5 mRNA	PMID:17942748
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZDHHC5 mRNA	PMID:29803840
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of ZDHHC5 protein	PMID:35688186
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ZDHHC5 mRNA	PMID:39719251
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ZDHHC5 5' UTR	PMID:27901495
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314628	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to ZDHHC5 promoter]	PMID:19654925
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314628	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ZDHHC5 mRNA	PMID:39716349
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314628	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZDHHC5 promoter	PMID:35295148
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314628	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZDHHC5 gene; titanium dioxide results in increased methylation of ZDHHC5 promoter	PMID:35295148
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314628	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ZDHHC5 mRNA	PMID:19710929
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1314628	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of ZDHHC5 mRNA	PMID:33914522
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1589737	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZDHHC5 mRNA	PMID:25181051
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1589737	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ZDHHC5 mRNA	PMID:21266533
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of ZDHHC5 protein	PMID:38598786
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314628	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of ZDHHC5 mRNA	PMID:36117858
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZDHHC5 mRNA	PMID:37042841
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ZDHHC5 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ZDHHC5 protein	PMID:38195004
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314628	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of ZDHHC5 mRNA	PMID:18353800
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ZDHHC5 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ZDHHC5 mRNA	PMID:32699268
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZDHHC5 mRNA	PMID:25979313
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314628	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ZDHHC5 mRNA	PMID:17963808
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ZDHHC5 mRNA	PMID:23179753
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1589737	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ZDHHC5 mRNA	PMID:30047161
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314628	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ZDHHC5 mRNA	PMID:17555576
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZDHHC5 mRNA	PMID:26690555
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ZDHHC5 mRNA	PMID:22230336
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZDHHC5 gene	PMID:25304211
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314628	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ZDHHC5 mRNA	PMID:17555576
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314628	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ZDHHC5 mRNA	PMID:17942748
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314628	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZDHHC5 mRNA	PMID:17942748
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314628	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ZDHHC5 mRNA	PMID:39716349
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314628	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ZDHHC5 mRNA; Nanotubes, Carbon results in increased expression of ZDHHC5 mRNA	PMID:25554681
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1589737	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ZDHHC5 mRNA	PMID:30047161
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314628	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of ZDHHC5 mRNA	PMID:36117858
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of ZDHHC5 mRNA	PMID:31758290
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314628	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZDHHC5 mRNA	PMID:22206623
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZDHHC5 gene]	PMID:28238834
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1589737	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of ZDHHC5 protein	PMID:28903499
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1589737	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ZDHHC5 mRNA	PMID:23914054
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1589737	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZDHHC5 mRNA	PMID:30047161
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1589737	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of ZDHHC5 mRNA	PMID:19281266
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ZDHHC5 mRNA	PMID:38568856
1314627	ZDHHC5	zDHHC palmitoyltransferase 5	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of ZDHHC5 protein	PMID:38598786
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of STUB1 mRNA	PMID:23724009
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:16170	mercury(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of STUB1 mRNA	PMID:19937285
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol inhibits the reaction [ESR1 protein binds to STUB1 protein]	PMID:16037132
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of STUB1 mRNA	PMID:37042841
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314630	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of STUB1 mRNA	PMID:23892564
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314630	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of STUB1 mRNA	PMID:33754040
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in decreased expression of STUB1 protein	PMID:34122009
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of STUB1 protein	PMID:37730182
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306167	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of STUB1 mRNA	PMID:22061828|PMID:33387578
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of STUB1 mRNA	PMID:39836092
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306167	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of STUB1 protein	PMID:34915118
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1314630	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of STUB1 mRNA	PMID:27462272
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STUB1 mRNA	PMID:37236586
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of STUB1 mRNA	PMID:19549813
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of STUB1 protein	PMID:23301498
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of STUB1 gene	PMID:28458013
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:25195	mercury atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of STUB1 mRNA	PMID:19937285
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:26718	solanesol	multiple interactions	EXP		E	RGD:6480464	20150714	CTD	MESH:C017719	2-phenylacetylenesulfonamide inhibits the reaction [solanesol promotes the reaction [HSF1 protein binds to STUB1 protein]]; geldanamycin inhibits the reaction [solanesol promotes the reaction [HSF1 protein binds to STUB1 protein]]; N2-(1H-indazole-5-yl)-N6-methyl-3-nitropyridine-2,6-diamine inhibits the reaction [solanesol promotes the reaction [HSF1 protein binds to STUB1 protein]]; solanesol promotes the reaction [HSF1 protein binds to STUB1 protein]	PMID:25645596
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314630	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of STUB1 mRNA	PMID:31919559
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STUB1 mRNA	PMID:22206623
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STUB1 mRNA	PMID:40504410
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of STUB1 mRNA	PMID:19244175
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306167	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STUB1 mRNA	PMID:34747641
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306167	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of STUB1 mRNA	PMID:32109520
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314630	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of STUB1 mRNA	PMID:19465110
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306167	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of STUB1 mRNA	PMID:33387578
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STUB1 mRNA	PMID:17942748
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of STUB1 mRNA	PMID:33512557
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of STUB1 mRNA	PMID:33212167
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:28299	quercetin 3-O-beta-D-glucofuranoside	multiple interactions	ISO	RGD:1306167	E	RGD:6480464	20161213	CTD	MESH:C016527	isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of STUB1 mRNA]	PMID:25129099
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of STUB1 mRNA	PMID:32763439
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306167	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of STUB1 mRNA	PMID:28959563
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of STUB1 mRNA	PMID:38568856
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STUB1 mRNA	PMID:40504410
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of STUB1 promoter	PMID:27901495
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in decreased expression of STUB1 protein	PMID:34122009
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to STUB1 protein]	PMID:26598702
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant inhibits the reaction [ESR1 protein binds to STUB1 protein]	PMID:16037132
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306167	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of STUB1 mRNA	PMID:24136188
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314630	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STUB1 gene; titanium dioxide results in decreased methylation of STUB1 promoter	PMID:35295148
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314630	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of STUB1 mRNA	PMID:21318169
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of STUB1 mRNA]	PMID:21318169
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306167	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of STUB1 mRNA	PMID:25181051
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306167	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of STUB1 gene	PMID:28505145
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306167	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of STUB1 mRNA	PMID:36041667
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of STUB1 mRNA	PMID:19244175
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314630	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of STUB1 mRNA	PMID:39298647
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306167	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of STUB1 mRNA	PMID:36041667
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314630	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of STUB1 mRNA	PMID:38685157
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306167	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of STUB1 mRNA	PMID:36041667
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314630	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of STUB1 promoter	PMID:28392331
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1314630	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of STUB1 mRNA	PMID:31558096
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314630	E	RGD:6480464	20190219	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of STUB1 mRNA	PMID:29156651
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of STUB1 gene	PMID:22964155
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314630	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of STUB1 mRNA	PMID:17361019|PMID:21266533
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of STUB1 mRNA	PMID:39836092
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of STUB1 mRNA	PMID:37236586
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of STUB1 mRNA	PMID:19244175
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of STUB1 mRNA	PMID:31533062
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D003474	Curcumin results in decreased expression of STUB1 mRNA	PMID:38229314
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STUB1 mRNA	PMID:25979313
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314630	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of STUB1 mRNA	PMID:17963808
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of STUB1 mRNA	PMID:23179753|PMID:27188386
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of STUB1 gene	PMID:29154799
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [ESR1 protein binds to STUB1 protein]	PMID:16037132
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	STUB1 protein promotes the reaction [vorinostat results in increased degradation of ESR1 protein]	PMID:18342836
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314630	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of STUB1 mRNA	PMID:17562736
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306167	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of STUB1 mRNA	PMID:33387578
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of STUB1 mRNA	PMID:40504410
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1306167	E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan affects the expression of STUB1 mRNA	PMID:31464424
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306167	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of STUB1 mRNA	PMID:29391264
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of STUB1 mRNA	PMID:18175754
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314630	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of STUB1 mRNA	PMID:17942748
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STUB1 mRNA	PMID:17942748
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to STUB1 protein]	PMID:26598702
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306167	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of STUB1 mRNA	PMID:24136188
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:5292	geldanamycin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C001277	geldanamycin inhibits the reaction [solanesol promotes the reaction [HSF1 protein binds to STUB1 protein]]; geldanamycin promotes the reaction [ESR1 protein binds to STUB1 protein]; STUB1 protein promotes the reaction [geldanamycin results in increased degradation of ESR1 protein]	PMID:16037132|PMID:25645596
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of STUB1 protein	PMID:32959892
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of STUB1 mRNA	PMID:39836092
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1306167	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of STUB1 mRNA	PMID:24136188
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases response to substance	EXP		E	RGD:6480464	20210810	CTD	MESH:D015655	STUB1 protein results in decreased susceptibility to 1-Methyl-4-phenylpyridinium	PMID:33472166
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1314630	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of STUB1 mRNA	PMID:26558463
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D015655	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone affects the reaction [STUB1 protein affects the reaction [1-Methyl-4-phenylpyridinium results in increased expression of DNM1L protein]]; STUB1 protein affects the reaction [1-Methyl-4-phenylpyridinium results in increased expression of DNM1L protein]; STUB1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BAX protein]; STUB1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of DNM1L protein]	PMID:33472166
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20210810	CTD	MESH:D015655	STUB1 protein affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of DNM1L protein]	PMID:33472166
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1314630	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of STUB1 protein	PMID:35926579
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:68352	quercetin 3-O-beta-D-glucopyranoside	multiple interactions	ISO	RGD:1306167	E	RGD:6480464	20161213	CTD	MESH:C016527	isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of STUB1 mRNA]	PMID:25129099
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:6842	methoxychlor	increases methylation	ISO	RGD:1306167	E	RGD:6480464	20130611	CTD	MESH:D008731	Methoxychlor results in increased methylation of STUB1 gene	PMID:23303685
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of STUB1 protein	PMID:34186270
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314630	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of STUB1 mRNA	PMID:22206623
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of STUB1 mRNA	PMID:22206623
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:747830	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C549041	3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone affects the reaction [STUB1 protein affects the reaction [1-Methyl-4-phenylpyridinium results in increased expression of DNM1L protein]]	PMID:33472166
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:7549	N(gamma)-nitro-L-arginine methyl ester	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20250902	CTD	MESH:D019331	[NG-Nitroarginine Methyl Ester co-treated with Dietary Fats] results in decreased expression of STUB1 mRNA; imeglimin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with Dietary Fats] results in decreased expression of STUB1 mRNA]	PMID:34375928
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:755912	aluminum chloride	increases expression	ISO	RGD:1314630	E	RGD:6480464	20260714	CTD	MESH:D000077410	Aluminum Chloride results in increased expression of STUB1 protein	PMID:37541565
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:755912	aluminum chloride	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20260714	CTD	MESH:D000077410	STUB1 protein inhibits the reaction [Aluminum Chloride results in increased phosphorylation of MAPT protein]	PMID:37541565
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:756996	imeglimin	multiple interactions	ISO	RGD:1314630	E	RGD:6480464	20260714	CTD	MESH:C575881	imeglimin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with Dietary Fats] results in decreased expression of STUB1 mRNA]	PMID:34375928
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:78741	oxidopamine	increases expression	ISO	RGD:1306167	E	RGD:6480464	20161213	CTD	MESH:D016627	Oxidopamine results in increased expression of STUB1 mRNA	PMID:25129099
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:78741	oxidopamine	multiple interactions	ISO	RGD:1306167	E	RGD:6480464	20161213	CTD	MESH:D016627	isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of STUB1 mRNA]; Levodopa inhibits the reaction [Oxidopamine results in increased expression of STUB1 mRNA]	PMID:25129099
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1314630	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of STUB1 mRNA	PMID:31558096
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314630	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of STUB1 mRNA	PMID:30953684
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306167	E	RGD:6480464	20120522	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of STUB1 mRNA	PMID:21346803
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1306167	E	RGD:6480464	20230307	CTD	MESH:D013311	STUB1 inhibits the reaction [Streptozocin results in decreased expression of AKT1 protein]; STUB1 inhibits the reaction [Streptozocin results in decreased expression of and results in decreased phosphorylation of GSK3B protein]; STUB1 inhibits the reaction [Streptozocin results in decreased expression of and results in decreased phosphorylation of NFE2L2 protein]; STUB1 inhibits the reaction [Streptozocin results in decreased expression of and results in decreased phosphorylation of PRKAA1 protein]; STUB1 inhibits the reaction [Streptozocin results in decreased expression of HMOX1 protein]; STUB1 inhibits the reaction [Streptozocin results in decreased expression of PPARGC1A protein]; STUB1 inhibits the reaction [Streptozocin results in decreased expression of SIRT1 protein]; STUB1 inhibits the reaction [Streptozocin results in decreased expression of SOD2 protein]; STUB1 inhibits the reaction [Streptozocin results in increased phosphorylation of IL1B protein]; STUB1 inhibits the reaction [Streptozocin results in increased phosphorylation of RELA protein]; STUB1 inhibits the reaction [Streptozocin results in increased phosphorylation of TNFA protein]	PMID:35442559
1314629	STUB1	STIP1 homology and U-box containing protein 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of STUB1 mRNA	PMID:38568856
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of INPP5A mRNA	PMID:38218311
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of INPP5A gene	PMID:20938992
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of INPP5A mRNA	PMID:33167477
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306168	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of INPP5A gene	PMID:28931070
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1306168	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of INPP5A mRNA	PMID:36841081
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314632	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of INPP5A mRNA	PMID:30319688
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of INPP5A mRNA	PMID:20404318
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of INPP5A mRNA	PMID:25510870
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:16595	1D-myo-inositol 1,4,5-trisphosphate	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D015544	benzene 1,2,4-trisphosphate inhibits the reaction [INPP5A protein results in increased metabolism of Inositol 1,4,5-Trisphosphate]; Polyphosphates inhibits the reaction [INPP5A protein results in increased metabolism of Inositol 1,4,5-Trisphosphate]	PMID:18574825
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of INPP5A gene	PMID:20938992
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of INPP5A mRNA	PMID:37042841
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of INPP5A gene	PMID:33872906
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of INPP5A gene	PMID:33872906
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306168	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of INPP5A mRNA	PMID:33387578
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of INPP5A mRNA	PMID:28818685
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of INPP5A intron	PMID:30157460
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306168	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INPP5A mRNA	PMID:39012411
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INPP5A mRNA	PMID:37325564
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of INPP5A mRNA	PMID:25510870
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of INPP5A mRNA	PMID:25510870
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of INPP5A mRNA	PMID:19549813
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1306168	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of INPP5A protein	PMID:33236894
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of INPP5A protein	PMID:20106945
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of INPP5A mRNA	PMID:21641981
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of INPP5A gene; Aflatoxin B1 results in increased methylation of INPP5A intron	PMID:27153756|PMID:30157460
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of INPP5A mRNA	PMID:35430440
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of INPP5A mRNA	PMID:34911549
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:26197	polyphosphates	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D011122	Polyphosphates binds to and results in decreased activity of INPP5A protein; Polyphosphates inhibits the reaction [INPP5A protein results in increased metabolism of Inositol 1,4,5-Trisphosphate]	PMID:18574825
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of INPP5A gene	PMID:20938992
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of INPP5A gene	PMID:25304211
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:27563	arsenic atom	affects response to substance	EXP		E	RGD:6480464	20160705	CTD	MESH:D001151	INPP5A gene SNP affects the susceptibility to Arsenic	PMID:25759212
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of INPP5A mRNA	PMID:23557933
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of INPP5A mRNA	PMID:28903495
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of INPP5A mRNA	PMID:19561079
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of INPP5A mRNA	PMID:27392435
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314632	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of INPP5A mRNA	PMID:21570461
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306168	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of INPP5A mRNA	PMID:34747641
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314632	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of INPP5A mRNA	PMID:16467188|PMID:17942748
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of INPP5A mRNA	PMID:17942748
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306168	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of INPP5A mRNA	PMID:19013527
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of INPP5A mRNA	PMID:32763439
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of INPP5A mRNA	PMID:29803840
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of INPP5A intron	PMID:30157460
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of INPP5A mRNA	PMID:20106945|PMID:21632981|PMID:26238291|PMID:32234424
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314632	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of INPP5A mRNA	PMID:19770486
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of INPP5A promoter	PMID:27901495
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of INPP5A 3' UTR	PMID:27901495
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of INPP5A promoter	PMID:23974009
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of INPP5A mRNA	PMID:19150397|PMID:26238291
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of INPP5A gene	PMID:31601247
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314632	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of INPP5A promoter	PMID:35295148
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306168	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of INPP5A mRNA	PMID:25181051
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of INPP5A gene	PMID:31601247
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of INPP5A mRNA	PMID:29275510
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of INPP5A gene	PMID:31601247
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of INPP5A mRNA	PMID:25510870
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of INPP5A mRNA	PMID:25510870
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of INPP5A gene	PMID:31601247
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of INPP5A intron	PMID:30157460
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1314632	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of INPP5A intron	PMID:28392331
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1306168	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of INPP5A mRNA	PMID:17602206
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314632	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of INPP5A mRNA	PMID:17361019|PMID:21266533
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306168	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of INPP5A mRNA	PMID:17602206
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of INPP5A mRNA	PMID:37042841
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306168	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INPP5A mRNA	PMID:39012411
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of INPP5A mRNA	PMID:37325564
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306168	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of INPP5A mRNA	PMID:24386269
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of INPP5A mRNA	PMID:24449571
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of INPP5A mRNA	PMID:31533062
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of INPP5A mRNA	PMID:40419075
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314632	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of INPP5A mRNA	PMID:17963808
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of INPP5A mRNA	PMID:23179753
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of INPP5A gene	PMID:29154799
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of INPP5A mRNA	PMID:20106945
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314632	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of INPP5A mRNA	PMID:17555576
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in decreased expression of INPP5A mRNA	PMID:19059307
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of INPP5A mRNA	PMID:28542535
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314632	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of INPP5A mRNA	PMID:17562736
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of INPP5A mRNA	PMID:21420995
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of INPP5A gene	PMID:25304211
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:47217	arsane	affects response to substance	EXP		E	RGD:6480464	20160705	CTD	MESH:D001151	INPP5A gene SNP affects the susceptibility to Arsenic	PMID:25759212
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of INPP5A mRNA	PMID:22079256
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1306168	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of INPP5A mRNA	PMID:17351261
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314632	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of INPP5A mRNA	PMID:17555576
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314632	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of INPP5A mRNA	PMID:16467188|PMID:17942748
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of INPP5A mRNA	PMID:17942748
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314632	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of INPP5A mRNA; Nanotubes, Carbon results in decreased expression of INPP5A mRNA	PMID:25554681
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314632	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of INPP5A mRNA	PMID:35964746
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:52136	glufosinate	decreases expression	ISO	RGD:1314632	E	RGD:6480464	20230905	CTD	MESH:C003121	phosphinothricin results in decreased expression of INPP5A mRNA	PMID:34597628
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of INPP5A mRNA	PMID:26705709
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1314632	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of INPP5A mRNA	PMID:36851058
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1314632	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of INPP5A mRNA	PMID:36907384
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of INPP5A intron	PMID:30157460
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of INPP5A mRNA	PMID:22079256
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of INPP5A mRNA	PMID:22079256
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314632	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of INPP5A mRNA	PMID:31388691
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1306168	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of INPP5A mRNA	PMID:23640034
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of INPP5A mRNA	PMID:19059307
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306168	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of INPP5A mRNA	PMID:21346803
1314631	INPP5A	inositol polyphosphate-5-phosphatase A	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of INPP5A mRNA	PMID:38568856
1314633	EXOSC8	exosome component 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314634	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EXOSC8 gene	PMID:20938992
1314633	EXOSC8	exosome component 8	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of EXOSC8 mRNA	PMID:33167477
1314633	EXOSC8	exosome component 8	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314634	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of EXOSC8 mRNA	PMID:36331819
1314633	EXOSC8	exosome component 8	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of EXOSC8 mRNA	PMID:21632981
1314633	EXOSC8	exosome component 8	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314634	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EXOSC8 mRNA	PMID:39241906
1314633	EXOSC8	exosome component 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314634	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EXOSC8 gene	PMID:20938992
1314633	EXOSC8	exosome component 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EXOSC8 mRNA	PMID:37042841
1314633	EXOSC8	exosome component 8	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of EXOSC8 mRNA	PMID:21179406
1314633	EXOSC8	exosome component 8	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of EXOSC8 mRNA	PMID:26079696
1314633	EXOSC8	exosome component 8	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of EXOSC8 mRNA	PMID:38685446
1314633	EXOSC8	exosome component 8	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of EXOSC8 mRNA	PMID:21592394
1314633	EXOSC8	exosome component 8	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of EXOSC8 mRNA	PMID:21592394
1314633	EXOSC8	exosome component 8	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of EXOSC8 mRNA	PMID:21592394
1314633	EXOSC8	exosome component 8	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of EXOSC8 mRNA	PMID:21592394
1314633	EXOSC8	exosome component 8	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EXOSC8 mRNA	PMID:28818685
1314633	EXOSC8	exosome component 8	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314634	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EXOSC8 mRNA	PMID:36331819
1314633	EXOSC8	exosome component 8	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314634	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EXOSC8 mRNA	PMID:19770486
1314633	EXOSC8	exosome component 8	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of EXOSC8 mRNA	PMID:35430440
1314633	EXOSC8	exosome component 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314634	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of EXOSC8 mRNA	PMID:17484886
1314633	EXOSC8	exosome component 8	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314634	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of EXOSC8 mRNA	PMID:31919559
1314633	EXOSC8	exosome component 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314634	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EXOSC8 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EXOSC8 gene	PMID:20938992|PMID:22206623
1314633	EXOSC8	exosome component 8	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of EXOSC8 mRNA	PMID:19244175
1314633	EXOSC8	exosome component 8	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of EXOSC8 mRNA	PMID:33512557
1314633	EXOSC8	exosome component 8	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of EXOSC8 protein	PMID:38460933
1314633	EXOSC8	exosome component 8	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in decreased expression of EXOSC8 mRNA	PMID:21858171
1314633	EXOSC8	exosome component 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EXOSC8 mRNA	PMID:22574217
1314633	EXOSC8	exosome component 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314634	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EXOSC8 mRNA	PMID:21570461
1314633	EXOSC8	exosome component 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EXOSC8 mRNA	PMID:21632981
1314633	EXOSC8	exosome component 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306169	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EXOSC8 mRNA	PMID:21215274|PMID:34747641
1314633	EXOSC8	exosome component 8	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of EXOSC8 mRNA	PMID:33512557
1314633	EXOSC8	exosome component 8	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306169	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of EXOSC8 mRNA	PMID:28374803
1314633	EXOSC8	exosome component 8	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of EXOSC8 mRNA	PMID:33212167
1314633	EXOSC8	exosome component 8	gene	CHEBI:28428	beta-hexachlorocyclohexane	increases expression	ISO	RGD:1314634	E	RGD:6480464	20150127	CTD	MESH:C023888	beta-hexachlorocyclohexane results in increased expression of EXOSC8 mRNA	PMID:25270620
1314633	EXOSC8	exosome component 8	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of EXOSC8 mRNA	PMID:32763439
1314633	EXOSC8	exosome component 8	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EXOSC8 mRNA	PMID:29803840
1314633	EXOSC8	exosome component 8	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of EXOSC8 mRNA	PMID:20044591
1314633	EXOSC8	exosome component 8	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of EXOSC8 mRNA	PMID:29432896
1314633	EXOSC8	exosome component 8	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of EXOSC8 mRNA	PMID:36989763
1314633	EXOSC8	exosome component 8	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of EXOSC8 mRNA	PMID:22378314
1314633	EXOSC8	exosome component 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314634	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EXOSC8 mRNA	PMID:21715664
1314633	EXOSC8	exosome component 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314634	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EXOSC8 mRNA	PMID:22228805
1314633	EXOSC8	exosome component 8	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314634	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of EXOSC8 mRNA]	PMID:22228805
1314633	EXOSC8	exosome component 8	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to EXOSC8 mRNA]	PMID:32406909
1314633	EXOSC8	exosome component 8	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of EXOSC8 mRNA	PMID:20382639
1314633	EXOSC8	exosome component 8	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1306169	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of EXOSC8 mRNA	PMID:25729387
1314633	EXOSC8	exosome component 8	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306169	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of EXOSC8 mRNA	PMID:25729387
1314633	EXOSC8	exosome component 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314634	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EXOSC8 gene; titanium dioxide results in decreased methylation of EXOSC8 promoter alternative form	PMID:35295148
1314633	EXOSC8	exosome component 8	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314634	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of EXOSC8 mRNA	PMID:18648102
1314633	EXOSC8	exosome component 8	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314634	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of EXOSC8 mRNA	PMID:18301758
1314633	EXOSC8	exosome component 8	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306169	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of EXOSC8 mRNA	PMID:19167457
1314633	EXOSC8	exosome component 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of EXOSC8 mRNA	PMID:29275510
1314633	EXOSC8	exosome component 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306169	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of EXOSC8 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314633	EXOSC8	exosome component 8	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306169	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EXOSC8 mRNA	PMID:36041667
1314633	EXOSC8	exosome component 8	gene	CHEBI:3374	capsaicin	decreases expression	ISO	RGD:1306169	E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin results in decreased expression of EXOSC8 mRNA	PMID:16278290
1314633	EXOSC8	exosome component 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306169	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EXOSC8 mRNA	PMID:36041667
1314633	EXOSC8	exosome component 8	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314634	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of EXOSC8 mRNA	PMID:38685157
1314633	EXOSC8	exosome component 8	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306169	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of EXOSC8 mRNA	PMID:36041667
1314633	EXOSC8	exosome component 8	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1314634	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of EXOSC8 mRNA	PMID:28392331
1314633	EXOSC8	exosome component 8	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314634	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of EXOSC8 mRNA	PMID:17361019
1314633	EXOSC8	exosome component 8	gene	CHEBI:34786	Heptachlor epoxide	increases expression	ISO	RGD:1314634	E	RGD:6480464	20150127	CTD	MESH:D006534	Heptachlor Epoxide results in increased expression of EXOSC8 mRNA	PMID:25270620
1314633	EXOSC8	exosome component 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EXOSC8 mRNA	PMID:37042841
1314633	EXOSC8	exosome component 8	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EXOSC8 protein	PMID:24527689
1314633	EXOSC8	exosome component 8	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314634	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of EXOSC8 mRNA	PMID:28903501
1314633	EXOSC8	exosome component 8	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of EXOSC8 mRNA	PMID:19320972
1314633	EXOSC8	exosome component 8	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of EXOSC8 mRNA	PMID:19244175
1314633	EXOSC8	exosome component 8	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of EXOSC8 mRNA	PMID:32588087
1314633	EXOSC8	exosome component 8	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of EXOSC8 mRNA	PMID:33512557
1314633	EXOSC8	exosome component 8	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of EXOSC8 mRNA	PMID:28302478
1314633	EXOSC8	exosome component 8	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of EXOSC8 mRNA	PMID:31533062
1314633	EXOSC8	exosome component 8	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of EXOSC8 mRNA	PMID:19167446
1314633	EXOSC8	exosome component 8	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314634	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of EXOSC8 mRNA	PMID:39529242
1314633	EXOSC8	exosome component 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of EXOSC8 mRNA	PMID:36864359
1314633	EXOSC8	exosome component 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314634	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EXOSC8 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of EXOSC8 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of EXOSC8 mRNA	PMID:36331819
1314633	EXOSC8	exosome component 8	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of EXOSC8 mRNA	PMID:29154799
1314633	EXOSC8	exosome component 8	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of EXOSC8 mRNA	PMID:20106945|PMID:27989131
1314633	EXOSC8	exosome component 8	gene	CHEBI:40909	azoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of EXOSC8 mRNA	PMID:33512557
1314633	EXOSC8	exosome component 8	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of EXOSC8 mRNA	PMID:33512557
1314633	EXOSC8	exosome component 8	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of EXOSC8 mRNA	PMID:28542535
1314633	EXOSC8	exosome component 8	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314634	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EXOSC8 mRNA	PMID:17562736
1314633	EXOSC8	exosome component 8	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of EXOSC8 protein	PMID:38460933
1314633	EXOSC8	exosome component 8	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314634	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in increased expression of EXOSC8 mRNA	PMID:22334560
1314633	EXOSC8	exosome component 8	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1306169	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of EXOSC8 mRNA	PMID:17108234
1314633	EXOSC8	exosome component 8	gene	CHEBI:5011	fenpyroximate	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in increased expression of EXOSC8 mRNA	PMID:33512557
1314633	EXOSC8	exosome component 8	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314634	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of EXOSC8 mRNA; Nanotubes, Carbon results in increased expression of EXOSC8 mRNA	PMID:25554681
1314633	EXOSC8	exosome component 8	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of EXOSC8 mRNA	PMID:21148553
1314633	EXOSC8	exosome component 8	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of EXOSC8 mRNA	PMID:22714537
1314633	EXOSC8	exosome component 8	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314634	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of EXOSC8 mRNA	PMID:19042947
1314633	EXOSC8	exosome component 8	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306169	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of EXOSC8 mRNA	PMID:25729387
1314633	EXOSC8	exosome component 8	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1314634	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of EXOSC8 mRNA	PMID:25270620
1314633	EXOSC8	exosome component 8	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1314634	E	RGD:6480464	20200317	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of EXOSC8 mRNA	PMID:22078008
1314633	EXOSC8	exosome component 8	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314634	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EXOSC8 mRNA	PMID:22206623
1314633	EXOSC8	exosome component 8	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of EXOSC8 protein	PMID:37664457
1314633	EXOSC8	exosome component 8	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of EXOSC8 mRNA	PMID:22714537
1314633	EXOSC8	exosome component 8	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314634	E	RGD:6480464	20150127	CTD	MESH:D010634	Phenobarbital results in increased expression of EXOSC8 mRNA	PMID:23091169|PMID:25270620
1314633	EXOSC8	exosome component 8	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314634	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of EXOSC8 mRNA	PMID:30294300
1314633	EXOSC8	exosome component 8	gene	CHEBI:81758	cyproconazole	increases expression	ISO	RGD:1314634	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in increased expression of EXOSC8 mRNA	PMID:22334560
1314633	EXOSC8	exosome component 8	gene	CHEBI:81794	thifluzamide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in increased expression of EXOSC8 mRNA	PMID:33512557
1314633	EXOSC8	exosome component 8	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in decreased expression of EXOSC8 mRNA	PMID:21858171
1314633	EXOSC8	exosome component 8	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of EXOSC8 mRNA	PMID:33512557
1314633	EXOSC8	exosome component 8	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314634	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in increased expression of EXOSC8 mRNA	PMID:21278054|PMID:22334560
1314633	EXOSC8	exosome component 8	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of EXOSC8 protein	PMID:37664457
1314633	EXOSC8	exosome component 8	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306169	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of EXOSC8 mRNA	PMID:21346803
1314633	EXOSC8	exosome component 8	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of EXOSC8 mRNA	PMID:33512557
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	ZNF366 protein promotes the reaction [Tretinoin results in increased activity of [RARA protein binds to RXRA protein]]	PMID:20008677
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	ZNF366 protein inhibits the reaction [Estradiol results in increased activity of ESR1 protein]	PMID:20008677
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1616531	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP366 mRNA	PMID:25510870
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:2322904	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ZFP366 mRNA	PMID:33387578
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	ZNF366 protein inhibits the reaction [Progesterone results in increased activity of PGR protein]	PMID:20008677
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1616531	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFP366 mRNA	PMID:37992649
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1616531	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFP366 mRNA	PMID:37992649
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1616531	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of ZFP366 mRNA	PMID:39984025
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1616531	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP366 mRNA	PMID:25510870
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1616531	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP366 mRNA	PMID:25510870
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ZNF366 mRNA	PMID:41430723
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1616531	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ZFP366 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ZFP366 mRNA	PMID:34911549
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:2322904	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ZFP366 mRNA	PMID:31150632
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF366 gene	PMID:25304211
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1616531	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP366 mRNA	PMID:37172768
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1616531	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFP366 mRNA	PMID:37992649
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1616531	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of ZFP366 mRNA	PMID:37682722
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZNF366 5' UTR	PMID:27901495
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1616531	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZFP366 intron	PMID:27901495
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:2322904	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ZFP366 mRNA	PMID:34492290
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1616531	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP366 mRNA	PMID:32156529
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1616531	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP366 mRNA	PMID:25510870
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1616531	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP366 mRNA	PMID:25510870
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of ZNF366 gene	PMID:31601247
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1616531	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ZFP366 exon	PMID:33297965
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1616531	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ZFP366 mRNA	PMID:38685157
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1616531	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ZFP366 mRNA	PMID:37019170
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:2322904	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of ZFP366 gene	PMID:33148267
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1616531	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ZFP366 mRNA	PMID:36331819
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1616531	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ZFP366 mRNA	PMID:37992649
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1616531	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ZFP366 mRNA	PMID:29279043
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF366 gene	PMID:25304211
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1616531	E	RGD:6480464	20230704	CTD	MESH:D008694	Methamphetamine results in decreased expression of ZFP366 mRNA	PMID:36914120
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:2322904	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of ZFP366 gene	PMID:33148267
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1616531	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ZFP366 mRNA	PMID:27935865
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:73390	promegestone	multiple interactions	EXP		E	RGD:6480464	20130604	CTD	MESH:D011397	ZNF366 protein inhibits the reaction [Promegestone results in increased activity of PGR protein]	PMID:20008677
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:79992	GW 1929	multiple interactions	EXP		E	RGD:6480464	20170103	CTD	MESH:C120099	ZNF366 protein promotes the reaction [GW 1929 results in increased activity of [PPARG protein binds to RXRA protein]]	PMID:20008677
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:2322904	E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of ZFP366 mRNA	PMID:29162477
1314635	ZNF366	zinc finger protein 366	gene	CHEBI:9753	troglitazone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C057693	ZNF366 protein promotes the reaction [troglitazone results in increased activity of [PPARG protein binds to RXRA protein]]	PMID:20008677
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:110423	clodronic acid	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in increased expression of TIPARP mRNA	PMID:25596134
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of TIPARP mRNA	PMID:35967413
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1306171	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of TIPARP mRNA	PMID:21551480|PMID:25152437
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of TIPARP mRNA	PMID:26272509
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314637	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of TIPARP mRNA	PMID:37995155
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306171	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TIPARP mRNA]	PMID:31150632
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TIPARP mRNA	PMID:33167477
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of TIPARP mRNA	PMID:21934132|PMID:23724009
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1306171	E	RGD:6480464	20130806	CTD	MESH:D014212	Tretinoin results in increased expression of TIPARP mRNA	PMID:20488242
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of TIPARP mRNA	PMID:25596134
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TIPARP mRNA	PMID:36331819
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of TIPARP mRNA	PMID:26079696
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TIPARP mRNA	PMID:29432896
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TIPARP mRNA	PMID:20044591
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of TIPARP mRNA	PMID:29581250
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of TIPARP mRNA	PMID:30510588
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of TIPARP mRNA	PMID:14699072
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of TIPARP mRNA	PMID:19619570|PMID:23019147|PMID:25321415|PMID:31614463
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of TIPARP mRNA; [Estradiol co-treated with Progesterone] results in increased expression of TIPARP mRNA; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TIPARP mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of TIPARP mRNA	PMID:19619570|PMID:20404318|PMID:20660070|PMID:30165855
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TIPARP mRNA	PMID:37042841
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of TIPARP mRNA	PMID:20655997
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of TIPARP mRNA	PMID:39245080
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:16990	bilirubin IXalpha	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin results in increased expression of TIPARP mRNA	PMID:20196124
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of TIPARP mRNA	PMID:21795739
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of TIPARP mRNA	PMID:20660070
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of TIPARP mRNA	PMID:26079696
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of TIPARP mRNA	PMID:21592394
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of TIPARP mRNA	PMID:21592394
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306171	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of TIPARP mRNA	PMID:26496021
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:C031927	hydroquinone results in increased expression of TIPARP mRNA	PMID:23416264
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1314637	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of TIPARP mRNA	PMID:17456735
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of TIPARP mRNA	PMID:21592394
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of TIPARP mRNA	PMID:21592394
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306171	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TIPARP mRNA	PMID:22061828|PMID:33387578
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:17939	puromycin	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D011691	Puromycin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]	PMID:12147270
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TIPARP mRNA	PMID:28818685
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIPARP mRNA	PMID:39836092
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1314637	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of TIPARP mRNA	PMID:33914522
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1314637	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of TIPARP mRNA	PMID:17456735
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIPARP mRNA	PMID:35301059
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TIPARP mRNA	PMID:37236586
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:233415	Pf-06840003	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20250408	CTD	MESH:C000625742	PF-06840003 inhibits the reaction [[amyloid beta-protein (1-42) binds to MAPT protein] which results in increased expression of TIPARP mRNA]	PMID:39172838
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TIPARP mRNA	PMID:19549813
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TIPARP gene	PMID:27153756
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TIPARP mRNA	PMID:32234424
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314637	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TIPARP mRNA	PMID:19770486
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1314637	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of TIPARP mRNA	PMID:32553695
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20201006	CTD	MESH:D015127	[9,10-Dimethyl-1,2-benzanthracene results in increased activity of AHR protein] which results in increased expression of TIPARP mRNA	PMID:32553695
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of TIPARP mRNA	PMID:41430723
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TIPARP mRNA	PMID:18593933
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306171	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TIPARP mRNA	PMID:31150632
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314637	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TIPARP mRNA	PMID:31919559
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306171	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TIPARP mRNA]	PMID:31150632
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314637	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TIPARP mRNA	PMID:25629700
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TIPARP mRNA	PMID:22206623
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIPARP mRNA	PMID:39836092
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of TIPARP mRNA	PMID:33512557
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27641	cycloheximide	increases expression	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide results in increased expression of TIPARP mRNA	PMID:12147270
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D003513	AHR protein promotes the reaction [Cycloheximide results in increased expression of TIPARP mRNA]; Cycloheximide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]	PMID:12147270
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27666	actinomycin D	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]	PMID:12147270
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of TIPARP mRNA	PMID:25596134
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C059514	Resveratrol inhibits the reaction [Particulate Matter results in increased expression of TIPARP mRNA]	PMID:21652769
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TIPARP mRNA	PMID:28903495
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27897	tryptophan	increases expression	ISO	RGD:1306171	E	RGD:401793718|PMID:32604820	20230815	RGD		tryptophan in pregnant dams increases expression of mRNA in kidney of male offspring	
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of TIPARP mRNA	PMID:25596134
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of TIPARP mRNA	PMID:27594783
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of TIPARP mRNA	PMID:23195993
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TIPARP mRNA	PMID:22298810
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306171	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TIPARP mRNA	PMID:22298810
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314637	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TIPARP mRNA	PMID:18343893|PMID:21570461|PMID:25703434|PMID:26377647|PMID:36222588
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects response to substance	EXP		E	RGD:6480464	20150825	CTD	MESH:D013749	TIPARP gene SNP affects the susceptibility to Tetrachlorodibenzodioxin	PMID:25975270
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases response to substance	EXP		E	RGD:6480464	20150825	CTD	MESH:D013749	TIPARP protein results in decreased susceptibility to Tetrachlorodibenzodioxin	PMID:25975270
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases response to substance	ISO	RGD:1314637	E	RGD:6480464	20150825	CTD	MESH:D013749	TIPARP protein results in decreased susceptibility to Tetrachlorodibenzodioxin	PMID:25975270
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA	PMID:17968679|PMID:18762178|PMID:19574409|PMID:19619570|PMID:19692669|PMID:20106945|PMID:20702590|PMID:21496263|PMID:21802500|PMID:22903824|PMID:23625689|PMID:24299737|PMID:24806346|PMID:25445724|PMID:26159488|PMID:27913140|PMID:29274782|PMID:29704546|PMID:29738842|PMID:30096437|PMID:30203000
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306171	E	RGD:6480464	20151215	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA	PMID:18796159|PMID:21215274|PMID:21496263|PMID:21724226|PMID:22342509|PMID:24046277|PMID:24355419|PMID:26232522|PMID:27913140|PMID:28433708|PMID:29738842|PMID:32109520
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314637	E	RGD:6480464	20160412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA	PMID:11716501|PMID:12147270|PMID:15328365|PMID:15652763|PMID:16611356|PMID:16962184|PMID:17942748|PMID:18691609|PMID:18796159|PMID:19759094|PMID:19770486|PMID:19933214|PMID:20159946|PMID:20702590|PMID:20702594|PMID:20819909|PMID:21496263|PMID:21889950|PMID:21995607|PMID:23864506|PMID:23994337|PMID:24806346|PMID:25270620|PMID:25958198|PMID:25975270|PMID:26290441|PMID:27913140|PMID:29738842|PMID:29873790|PMID:31511937|PMID:32553695
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases response to substance	ISO	RGD:1314637	E	RGD:6480464	20181113	CTD	MESH:D013749	TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin	PMID:25975270|PMID:29873790|PMID:34129049
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]; [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of TIPARP mRNA; AHR gene SNP affects the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]; AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]; MACROD1 protein inhibits the reaction [[TIPARP protein results in increased ADP-ribosylation of and results in decreased activity of AHR protein] which results in decreased susceptibility to Tetrachlorodibenzodioxin]; MACROD1 protein inhibits the reaction [TIPARP protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]]; Tetrachlorodibenzodioxin inhibits the reaction [TIPARP protein results in increased expression of G6PC1 mRNA]; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TIPARP 3' UTR]; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TIPARP promoter]; Tetrachlorodibenzodioxin promotes the reaction [ARNT protein binds to TIPARP promoter]; Tetrachlorodibenzodioxin promotes the reaction [ESR1 protein binds to TIPARP 3' UTR]; TIPARP gene SNP affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; TIPARP gene SNP affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]; TIPARP inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; TIPARP mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased degradation of AHR protein]; TIPARP mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of AHRR mRNA]; TIPARP mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; TIPARP mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]; TIPARP protein inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; TIPARP-AS1 promotes the reaction [TIPARP inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]]	PMID:19574409|PMID:19619570|PMID:23625689|PMID:24806346|PMID:25445724|PMID:25975270|PMID:29274782|PMID:29738842|PMID:31520823
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1306171	E	RGD:6480464	20180703	CTD	MESH:D013749	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]	PMID:29738842
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of TIPARP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of AASS mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ABLIM3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ACKR1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ACKR5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ACNAT2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ACTA2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ADA mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ADM mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of AGA mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of AKR1B8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ALG2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ALG8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of AMIGO2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of AMIGO3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ANAPC16 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ANKHD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of APOA5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ARFGAP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ARFIP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ARHGAP32 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ARHGAP5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ARL13B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ARPC1B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ARXES1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ASTE1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ATAD2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ATP1B3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ATRIP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of AZIN1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of B4GALNT1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of BAG3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of BCL2L1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of BCL3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of BET1L mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of BHLHE40 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of BMP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of BNIP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of C2CD2L mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CACFD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CALCRL mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CALHM6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CARMIL1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CAVIN2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CBLL1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CBX8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CCDC137 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CCN2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CCND1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CCNE1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CCNE2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CCNT1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CD55 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CDK20 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CFLAR mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CHAC1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CHD7 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CHST12 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CKS1B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CKS2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CLEC4G mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CLN8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CLP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CNTRL mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of COA4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of COG3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of COG6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CPEB3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CPTP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CRCP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CREB3L2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CSRP3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CXCL12 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CYP2B10 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CYP4A14 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of DCBLD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of DCUN1D3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of DDA1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of DDX19B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of DLL4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of DPY19L3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of DUSP7 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ECI2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of EDNRA mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of EEF1E1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of EFHD2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of EHD4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of EIF1AD mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of EIF2AK3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of EIF2B4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ELL mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ELL2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ELOB mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of EOGT mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ERG mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ERO1A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ESAM mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ETNK2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ETS1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of EXOG mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of F8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FAM107A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FBRS mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FCER1G mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FCGR4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FDPS mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FH1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FHL4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FKBP14 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FKBP5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FKBPL mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FLOT2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FOXA2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of FOXA3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GAS6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GCK mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GDA mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GDE1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GFPT1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GFRA1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GGT6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GIMAP9 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GIN1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GMPPB mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GOLGA3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GOLPH3L mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GOLT1B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GORASP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GOT1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GPT2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GRN mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GTF2A2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of GYS1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of H1F3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of H2AC25 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of H2AC4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of H2BC12 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of HDC mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of HECW2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of HEG1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of HGSNAT mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of HHIP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of HIP1R mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of HOPX mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of HS3ST3B1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ICAM1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ID3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IDH3A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IFNGR2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IFRD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IL15RA mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IL17RA mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IL2RG mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of INHBE mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IPPK mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IRAK1BP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IREB2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ISG20 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IVNS1ABP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of JAM2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of JKAMP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of JMJD4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of JUP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of KCTD7 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of KLF10 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of KLHL2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of LASS6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of LCN2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of LENG9 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of LIG4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of LIN52 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of LPIN1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MAD1L1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MAD2L1BP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MAN2A1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MAP3K5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MAP3K6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MAPK14 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MARCO mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MCL1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MCM4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MED18 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MED31 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MFSD2A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MIDN mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MIS12 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MLX mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MMGT1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MMGT2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MRPL22 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MRPL51 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MS4A4B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MYCT1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MYD88 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MYLIP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NAMPT mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NAPB mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NCEH1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NDEL1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NFXL1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NFYB mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NGDN mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NHERF1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NIP7 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NNMT mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NOSTRIN mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NRAS mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NRG4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NUAK2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NUDCD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of OGFRL1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of OR2N1E mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of OR2T6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of OR52R1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of OR5AL5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of OR5W22 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ORAI2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ORC2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of OTOS mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PAFAH1B2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PALMD mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PAQR3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PARP4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PBX3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PCID2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PCSK5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PDCD4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PDCL mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PDE12 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PDE1A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PECAM1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PER1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PFKFB2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PFKFB3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PHLDA2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PHLDB2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PLA1A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PLA2G7 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PLCB4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PLEKHF1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PLIN3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PLK3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PLXNB1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PMS2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PNPLA2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of POFUT2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of POLE4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of POLM mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of POLR1E mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of POLR1H mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of POMGNT1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PPIP5K2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PPME1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PRKCH mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PROX1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PRPF3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PTPN12 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PTPN2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PTPRJ mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PUS7 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RAB27A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RAB2B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RAB3A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RAB3GAP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RABL6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RAD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RAD17 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RAPGEF5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RASL11B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RASSF4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RBSN mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RDH13 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RDH9 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RGP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RHBDD2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RINT1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RNF145 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RNF185 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RNF24 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RRP8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RSPRY1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RUSC1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of S1PR5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SAA1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SCAMP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SCARA5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SDS mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SELP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SEPTIN10 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SERPINA3F mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SERPINA3K mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SERPINA7 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SERTAD3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SH3BP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SIAH2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SIK1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLA mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC10A2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC16A10 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC25A32 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC25A51 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC30A5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC35A4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC37A4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC39A14 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC39A6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC41A1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC43A1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SLC7A5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SNHG5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SNX10 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SP4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SPTY2D1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SRGN mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SRM mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ST3GAL5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of STAB2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of STAP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of STAT2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of STEAP4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SULT1A1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SURF2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TACC1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TACC2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TAF9 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TBC1D8B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TBCCD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TEK mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TGM1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TICAM1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TIFA mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TINF2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TMC7 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TMED3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TMEM167B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TMEM18 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TMEM39A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TMEM41A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TMEM47 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TMEM50B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TMEM87B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TMTC2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TNFRSF11B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TOLLIP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TOMM7 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TPD52 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TRAK2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TRAPPC2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TRIM24 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TRIM3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TRNT1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TTI2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TTLL4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TTPAL mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of TXNDC11 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of UAP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of UBE2G2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of UBIAD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of UBL4A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of UFSP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of UGCG mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of UXT mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of VAMP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of VAMP5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of VASN mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of VCAM1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of VMN1R58 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of VPS37C mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of WDR45B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of XTBD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of YJU2B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of YOD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of YRDC mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZBTB7B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZBTB8A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFAND2A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP119A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP142 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP143 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP27 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP324 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP329 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP40 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP442 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP53 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP595 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP658 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP748 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP788 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP790 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP9 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP933 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP938 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP943 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP947 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFP948 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFPL1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZFYVE21 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZSCAN22 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ZSWIM1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ABCA8B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ABCB4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ABCD2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ABHD4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ABHD5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ACACB mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ACAD8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ACOT3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ACP3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ACTN1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ACTR6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ADAM12 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ADCY9 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ADGRG3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ADGRL2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ADRA1A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of AHI1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of AHRR mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ALDH3B1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ALOX12 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of AMOT mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ANP32A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ANTXR2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of AOX1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of AQP8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ARHGEF10L mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ARL5A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ARL6IP5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ARSG mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ATG2B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ATOH8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ATXN1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of B3GALNT2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of B3GNT2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of BCAR1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of BCL2L11 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of BLTP3B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of BMF mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of BPTF mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of BTRC mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CA2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CASP6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CAV1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CBR3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CCDC93 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CCL28 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CCNG2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CCS mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CDC14B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CDC42BPB mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CDH2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CDKN1B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CHDH mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CHKA mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CLDN1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CNNM3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of COL15A1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CPEB4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CREB3L1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CRTC3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CRYBG3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CSE1L mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CTH mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CTRB1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CXADR mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CXCL2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CXCR5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CXCR7 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CXXC5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CYFIP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CYP1A1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CYP1A2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CYP1B1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CYP2G1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of CYP8B1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DAG1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DAPK2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DCLK3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DCLRE1C mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DCTN6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DDC mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DDIT4L mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DENND2B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DEPTOR mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DHDH mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DHRS9 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DHTKD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DIPK1A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DNA2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DNAJB3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DNAJB4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DNAJB8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DNMT3A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DSC2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of DTX4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ECEL1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of EHBP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of EID3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of EML4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ENDOU mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ENTPD2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ENTPD5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of EPGN mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of EPS8L2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ERBB3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of EREG mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ERMP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ETNPPL mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ETV6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of EVI5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of EXOC3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FABP12 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FABP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FBXO21 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FBXW9 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FDX1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FGD4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FGF21 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FGF23 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FGFR3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FMO1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FMO2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FMO3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FOXO3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FPGS mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FRMD8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FUT4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FZD7 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FZD8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of G6PC1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GADD45B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GADD45G mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GCC1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GCKR mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GCLC mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GCLM mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GFER mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GPR157 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GPR183 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GRAMD1C mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GRAMD2B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GRAMD4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GRPEL2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GTF2I mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of HACL1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of HDAC5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of HES6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of HILPDA mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of HIVEP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of HJV mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of HNF1B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of HPGD mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of HSD17B2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of HSPA2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of HTATIP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of IGFBP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of IGSF3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of IKBKG mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of IL1B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of INSL6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of IRAK2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of JAG1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of JOSD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of KANK1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of KANK2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of KBTBD12 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of KCNK1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of KDM3A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of KLB mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LDB1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LDLR mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LDOC1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LGALS4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LNX2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LPAR6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LPCAT3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LPIN2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LPL mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LRAT mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LRP4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LRRC8D mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LRTM1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MAFF mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MANBA mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MAPK15 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MAPRE3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MEIG1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MEIS2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of METTL27 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MGLL mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MICU2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MINDY1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MREG mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MSRB3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MTNR1A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MYC mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MYO1B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of MYOM1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NAGS mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NDRG1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NDST1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NEK2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NEURL3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NFE2L2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NIBAN2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NME5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NOMO1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NOTCH1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NPC1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NPTX1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NQO1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NR2C1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NR5A2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NRIP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of NUP155 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OCLN mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR10V5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR2A51 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR2Y1G mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR3A1C mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR4A79 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR4K50 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR4K77 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR51A39 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR51AG1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR52A5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR52AE7 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR52D1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR52E18 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR5P4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR5P68 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR5V1B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR8G26 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of OR8K53 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PCP4L1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PDK4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PDPK1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PGAP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PGD mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PHOSPHO1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PIGC mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PIGX mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PIK3R3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PIR mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PJA1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PLA2G12A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PLCG1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PML mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PMM1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PPARD mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PPFIBP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PPNR mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PPP1R3C mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PPP1R9A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PPP2R5A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PREP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PRPF6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PTGES mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PTP4A2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PUM2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of RAB36 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of RHPN2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of RIGI mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of RNF125 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of RXRG mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of RYR3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of S1PR1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of S1PR3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SAMD4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SAP30 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SCARB1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SCPEP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SEC16A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SELENBP1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SELENBP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SELENOI mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SERP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SERPINE1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SETD3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SGK1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SGPL1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SH3PXD2A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SHROOM1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SHROOM3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SIGMAR1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SIPA1L1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC17A8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC18A2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC1A4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC25A28 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC25A42 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC25A45 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC25A46 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC34A2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC35D1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC35F5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC35G1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC46A3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC66A2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC6A6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SMAD3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SMCP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SOCS3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SOX17 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SRPK1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SRSF10 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SRXN1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SSBP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ST8SIA1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ST8SIA3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of STARD13 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of STAT5B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of STAT6 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of STEAP3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of STRBP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SUN3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SYNE1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TAPT1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TAS2R117 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TBC1D1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TBC1D16 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TBC1D31 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TBC1D8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TBCEL mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TCF7L2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TEC mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TERT mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TLE1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TM4SF4 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TMCC3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TNC mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TNFAIP2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TNFAIP8L1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TNFRSF10B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TNFRSF18 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TNFRSF19 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TOR1B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TPPP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TRAF5 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TRIM2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TRIT1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TSHZ1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TSSK1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TTC28 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TUBA8 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TUBB2A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TWSG1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TXNIP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TXNL4A mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of UBE2H mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of UGDH mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of UGT1A10 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of UGT2B35 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of UNC5B mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of USP6NL mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of UVRAG mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of VMN1R49 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of WDR91 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of YPEL2 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ZDHHC25 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ZFHX3 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ZFP28 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ZFP296 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ZFP36L1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ZFP457 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ZFP672 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ZFP78 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of ZMIZ2 mRNA; AHR affects the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]; AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]; ARNT protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]; Cycloheximide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]; Dactinomycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]; lactacystin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]; MACROD1 protein inhibits the reaction [[TIPARP protein results in increased ADP-ribosylation of and results in decreased activity of AHR protein] which results in decreased susceptibility to Tetrachlorodibenzodioxin]; Puromycin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TIPARP gene]; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TIPARP promoter]; TIPARP gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased degradation of AHR protein]; TIPARP gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CD36 mRNA]; TIPARP gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of FASN mRNA]; TIPARP gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of SREBF1 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1B1 gene]]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of CA1 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of EFNA3 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of HSD3B5 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of INMT mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPP1R3G mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of RGS16 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of SERPINA7 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of SULT2A8 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of AHRR mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CD36 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of COL9A2 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 protein]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP2A4 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of ECEL1 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of FGF21 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of FMO3 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of GPNMB mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of IVL mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NFE2L2 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PARM1 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of SERPINE1 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TEKT5 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TGFB1 mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]; TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of ZEB2 mRNA]	PMID:12147270|PMID:16214954|PMID:19759094|PMID:20819909|PMID:21762485|PMID:21889950|PMID:21995607|PMID:24806346|PMID:25975270|PMID:29873790|PMID:34129049
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28145	dibenzofuran	increases expression	ISO	RGD:1306171	E	RGD:6480464	20130806	CTD	MESH:C023614	dibenzofuran analog results in increased expression of TIPARP mRNA	PMID:20566336
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TIPARP mRNA	PMID:28001369
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TIPARP mRNA	PMID:32763439
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of TIPARP mRNA	PMID:20044591
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of TIPARP mRNA	PMID:20829426
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TIPARP mRNA	PMID:29432896
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of TIPARP mRNA	PMID:39719251
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TIPARP mRNA	PMID:38568856
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIPARP mRNA	PMID:39836092
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of TIPARP mRNA	PMID:17127020
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of TIPARP mRNA	PMID:21714911
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TIPARP 5' UTR	PMID:27901495
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TIPARP mRNA	PMID:20064835|PMID:20106945|PMID:21802500|PMID:21887816|PMID:22178795|PMID:24472612|PMID:30453624|PMID:38036013
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314637	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of TIPARP mRNA; Benzo(a)pyrene results in increased expression of TIPARP mRNA	PMID:19770486|PMID:20713471|PMID:21569818|PMID:21715664|PMID:21995607|PMID:32553695
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TIPARP promoter	PMID:27901495
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20121113	CTD	MESH:D001564	[Benzo(a)pyrene results in increased activity of AHR protein] which results in increased expression of TIPARP mRNA; AHR affects the reaction [Benzo(a)pyrene results in increased expression of TIPARP mRNA]; Benzo(a)pyrene promotes the reaction [AHR protein binds to TIPARP promoter]	PMID:21995607|PMID:32553695
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of TIPARP mRNA	PMID:18593933
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:30512	silver atom	multiple interactions	ISO	RGD:1306171	E	RGD:6480464	20150310	CTD	MESH:D012834	[Silver analog co-treated with Povidone] results in increased expression of TIPARP mRNA	PMID:25194297
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TIPARP mRNA	PMID:25895662
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314637	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TIPARP mRNA	PMID:19073995
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TIPARP mRNA	PMID:19150397
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TIPARP mRNA	PMID:20382639
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TIPARP mRNA	PMID:20458559
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of TIPARP mRNA	PMID:35984750
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:31175	adefovir pivoxil	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C106812	adefovir dipivoxil results in increased expression of TIPARP mRNA	PMID:25596134
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of TIPARP mRNA	PMID:38568856
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314637	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TIPARP gene; titanium dioxide results in decreased methylation of TIPARP promoter	PMID:35295148
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306171	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TIPARP mRNA	PMID:34492290
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314637	E	RGD:6480464	20150127	CTD	MESH:C006253	pirinixic acid results in decreased expression of TIPARP mRNA	PMID:25270620
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314637	E	RGD:6480464	20120515	CTD	MESH:C006253	pirinixic acid results in increased expression of TIPARP mRNA	PMID:18301758|PMID:18445702
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1314637	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of TIPARP mRNA	PMID:19191707
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of TIPARP mRNA	PMID:38479592
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:33083	fluoranthene	increases expression	ISO	RGD:1306171	E	RGD:6480464	20150310	CTD	MESH:C007738	fluoranthene results in increased expression of TIPARP mRNA	PMID:25268939
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:33083	fluoranthene	increases expression	ISO	RGD:1314637	E	RGD:6480464	20170725	CTD	MESH:C007738	fluoranthene results in increased expression of TIPARP mRNA	PMID:28329830
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1306171	E	RGD:6480464	20150310	CTD	MESH:C007738	TNF protein inhibits the reaction [fluoranthene results in increased expression of TIPARP mRNA]	PMID:25268939
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of TIPARP mRNA	PMID:28329830
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1314637	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of TIPARP mRNA	PMID:33914522
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of TIPARP mRNA	PMID:27685785|PMID:29275510
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306171	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TIPARP mRNA	PMID:30816183
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306171	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of TIPARP mRNA	PMID:32145629
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306171	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of TIPARP mRNA	PMID:26496021
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34069	1,8-Dinitropyrene	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C033310	1,8-dinitropyrene results in increased expression of TIPARP mRNA	PMID:21887816
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1306171	E	RGD:6480464	20180703	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of TIPARP mRNA	PMID:29738842
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1314637	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of TIPARP mRNA	PMID:20713471
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	affects expression	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl affects the expression of TIPARP mRNA	PMID:18042819
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TIPARP mRNA	PMID:19692669|PMID:23146750|PMID:29738842|PMID:29947894
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1306171	E	RGD:6480464	20180703	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TIPARP mRNA	PMID:29738842|PMID:32119087
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1314637	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of TIPARP mRNA	PMID:20702594|PMID:23994337
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34342	3-methylcholanthrene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene results in increased expression of TIPARP mRNA	PMID:20348232
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of TIPARP mRNA	PMID:20713471
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to TIPARP promoter]	PMID:20348232
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314637	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of TIPARP mRNA	PMID:39298647
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314637	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of TIPARP mRNA	PMID:40203079
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314637	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of TIPARP mRNA	PMID:26377693
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of TIPARP mRNA	PMID:24472612
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1314637	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of TIPARP mRNA	PMID:26377693
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314637	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TIPARP mRNA	PMID:38685157
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306171	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TIPARP mRNA	PMID:21266533
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TIPARP mRNA	PMID:21266533
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1306171	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of TIPARP mRNA	PMID:32680482
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314637	E	RGD:6480464	20210209	CTD	MESH:D010269	Paraquat results in increased expression of TIPARP mRNA	PMID:21463325
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TIPARP mRNA	PMID:37042841
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIPARP mRNA	PMID:39836092
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride affects the expression of TIPARP mRNA	PMID:25596134
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TIPARP mRNA	PMID:35301059
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TIPARP mRNA	PMID:37236586
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20210309	CTD	MESH:C023036	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of TIPARP mRNA	PMID:33325755
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314637	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TIPARP mRNA	PMID:28903501
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of TIPARP mRNA	PMID:19376846
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of TIPARP mRNA	PMID:24449571
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1314637	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of TIPARP mRNA	PMID:25908611
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314637	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of TIPARP mRNA	PMID:18353800
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:3647	chlorpromazine	increases expression	ISO	RGD:1306171	E	RGD:6480464	20150825	CTD	MESH:D002746	Chlorpromazine results in increased expression of TIPARP mRNA	PMID:25596134
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:3696	cidofovir anhydrous	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in increased expression of TIPARP mRNA	PMID:25596134
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of TIPARP mRNA	PMID:26352163
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of TIPARP mRNA	PMID:36331819
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1306171	E	RGD:6480464	20130806	CTD	MESH:D002737	Chloroprene results in increased expression of TIPARP mRNA	PMID:23125180
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TIPARP gene	PMID:29154799
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of TIPARP mRNA	PMID:24935251|PMID:29154799
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine affects the expression of TIPARP mRNA	PMID:25596134
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of TIPARP mRNA	PMID:20106945
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314637	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of TIPARP mRNA	PMID:19770486
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TIPARP mRNA	PMID:17555576
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR1 protein] results in increased expression of TIPARP mRNA	PMID:19059307
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of TIPARP mRNA	PMID:25047013
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TIPARP mRNA	PMID:38832940
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of TIPARP mRNA	PMID:28542535
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TIPARP mRNA	PMID:17562736
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of TIPARP mRNA	PMID:21420995
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of TIPARP mRNA	PMID:24714768|PMID:25596134
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of TIPARP mRNA	PMID:29432896
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of TIPARP mRNA	PMID:18687144
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIPARP mRNA	PMID:39836092
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TIPARP mRNA	PMID:17555576
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TIPARP mRNA	PMID:17942748
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of TIPARP mRNA	PMID:23228038
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of TIPARP mRNA	PMID:38568856
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TIPARP mRNA	PMID:20458559
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1306171	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of TIPARP mRNA	PMID:25596134
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:50594	carbon nanotube	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TIPARP mRNA	PMID:24389112
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:50692	mifepristone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in decreased expression of TIPARP mRNA	PMID:17584828
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:51052	lucanthone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in increased expression of TIPARP mRNA	PMID:21148553
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306171	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of TIPARP mRNA	PMID:24793618
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:52722	lactacystin	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:C067713	lactacystin promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]	PMID:12147270
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of TIPARP mRNA	PMID:18651567
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:53248	poly(vinylpyrrolidone)	multiple interactions	ISO	RGD:1306171	E	RGD:6480464	20150310	CTD	MESH:D011205	[Silver analog co-treated with Povidone] results in increased expression of TIPARP mRNA	PMID:25194297
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:5855	ibuprofen	increases expression	ISO	RGD:1306171	E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in increased expression of TIPARP mRNA	PMID:25596134
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314637	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TIPARP mRNA	PMID:38701926
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1314637	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of TIPARP mRNA	PMID:20829426
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TIPARP mRNA	PMID:39836092
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TIPARP mRNA	PMID:26378955
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of TIPARP mRNA	PMID:19812364
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1314637	E	RGD:6480464	20150127	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of TIPARP mRNA	PMID:25270620
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of TIPARP mRNA	PMID:28988120
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of TIPARP mRNA	PMID:15336504
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TIPARP mRNA	PMID:22079614
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1306171	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of TIPARP mRNA	PMID:25596134
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:6842	methoxychlor	affects expression	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor affects the expression of TIPARP mRNA	PMID:20829426
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314637	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TIPARP mRNA	PMID:22206623
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TIPARP mRNA	PMID:22206623
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1314637	E	RGD:6480464	20130903	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of TIPARP mRNA]	PMID:12147270
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TIPARP mRNA	PMID:37199045
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of TIPARP protein	PMID:31285264
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:76989	phytoestrogen	multiple interactions	EXP		E	RGD:6480464	20210309	CTD	MESH:D048789	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of TIPARP mRNA	PMID:33325755
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:76995	alpha-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20140204	CTD	MESH:C011512	alpha-naphthoflavone results in decreased expression of TIPARP mRNA	PMID:18762178
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:76995	alpha-naphthoflavone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C011512	alpha-naphthoflavone promotes the reaction [Particulate Matter results in increased expression of TIPARP mRNA]	PMID:21652769
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of TIPARP mRNA	PMID:32858204
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:77013	beta-naphthoflavone	increases expression	ISO	RGD:1314637	E	RGD:6480464	20140408	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of TIPARP mRNA	PMID:23994337
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1306171	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of TIPARP mRNA	PMID:21346803
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TIPARP gene]	PMID:28238834
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of TIPARP mRNA	PMID:19159669
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1314637	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of TIPARP mRNA	PMID:23091169
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314637	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TIPARP mRNA	PMID:19270015
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:81501	1,2,3,7,8-Pentachlorodibenzodioxin	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C051452	1,2,3,7,8-pentachlorodibenzo-p-dioxin results in increased expression of TIPARP mRNA	PMID:29738842
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:81501	1,2,3,7,8-Pentachlorodibenzodioxin	increases expression	ISO	RGD:1306171	E	RGD:6480464	20180703	CTD	MESH:C051452	1,2,3,7,8-pentachlorodibenzo-p-dioxin results in increased expression of TIPARP mRNA	PMID:29738842
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1314637	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of TIPARP mRNA	PMID:18343893
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1306171	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of TIPARP mRNA	PMID:24046277
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1314637	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of TIPARP mRNA	PMID:20702594
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:81508	2,3,4,7,8-Pentachlorodibenzofuran	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C038890	2,3,4,7,8-pentachlorodibenzofuran results in increased expression of TIPARP mRNA	PMID:29738842
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:81508	2,3,4,7,8-Pentachlorodibenzofuran	increases expression	ISO	RGD:1306171	E	RGD:6480464	20141111	CTD	MESH:C038890	2,3,4,7,8-pentachlorodibenzofuran results in increased expression of TIPARP mRNA	PMID:21724226|PMID:24046277|PMID:29738842
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1306171	E	RGD:6480464	20180703	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of TIPARP mRNA	PMID:29738842
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:81522	2,3,3',4,4',5-Hexachlorobiphenyl	increases expression	ISO	RGD:1306171	E	RGD:6480464	20180703	CTD	MESH:C087667	2,3,3',4,4',5-hexachlorobiphenyl results in increased expression of TIPARP mRNA	PMID:29738842
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of TIPARP mRNA	PMID:26705709
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of TIPARP mRNA	PMID:19095052
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of TIPARP mRNA	PMID:33512557
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of TIPARP mRNA	PMID:26079696
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of TIPARP mRNA	PMID:19059307
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:9141	silver(0)	multiple interactions	ISO	RGD:1306171	E	RGD:6480464	20150310	CTD	MESH:D012834	[Silver analog co-treated with Povidone] results in increased expression of TIPARP mRNA	PMID:25194297
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306171	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TIPARP mRNA	PMID:19281266
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306171	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of TIPARP mRNA	PMID:19015723
1314636	TIPARP	TCDD inducible poly(ADP-ribose) polymerase	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306171	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of TIPARP mRNA	PMID:20566332
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of STK32B mRNA	PMID:34925699
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of STK32B mRNA	PMID:33167477
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of STK32B mRNA	PMID:22378314
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314641	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of STK32B mRNA	PMID:29980752
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306173	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of STK32B mRNA	PMID:33387578
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of STK32B intron	PMID:30157460
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of STK32B intron	PMID:30157460
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314641	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of STK32B mRNA	PMID:25629700
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of STK32B protein	PMID:35688186
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of STK32B mRNA	PMID:27392435
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314641	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STK32B mRNA	PMID:21570461
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306173	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of STK32B mRNA	PMID:28959563
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of STK32B mRNA	PMID:29319823
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314641	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of STK32B mRNA	PMID:37682722
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of STK32B mRNA	PMID:38568856
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STK32B intron	PMID:30157460
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314641	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of STK32B intron	PMID:27901495
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314641	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of STK32B mRNA	PMID:22228805
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of STK32B exon; Benzo(a)pyrene results in increased methylation of STK32B promoter	PMID:27901495
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to STK32B mRNA]	PMID:32406909
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of STK32B mRNA	PMID:20382639
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314641	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of STK32B mRNA	PMID:18648102
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of STK32B mRNA	PMID:38479592
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306173	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STK32B mRNA	PMID:25181051
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of STK32B gene	PMID:31601247
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1314641	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of STK32B mRNA	PMID:26682919
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of STK32B intron	PMID:30157460
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314641	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of STK32B mRNA	PMID:28392331
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306173	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of STK32B gene	PMID:33148267
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306173	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of STK32B mRNA	PMID:30723492
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of STK32B mRNA	PMID:38568856
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1306173	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of STK32B promoter	PMID:22457795
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1306173	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of STK32B mRNA	PMID:28511854
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of STK32B mRNA	PMID:19320972
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of STK32B mRNA	PMID:40419075
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of STK32B mRNA	PMID:24714768
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of STK32B intron	PMID:30157460
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306173	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of STK32B gene	PMID:35440735
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306173	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of STK32B gene	PMID:33148267
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306173	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of STK32B mRNA	PMID:32109520
1314640	STK32B	serine/threonine kinase 32B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306173	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of STK32B mRNA	PMID:24780913
1314642	LHX6	LIM homeobox 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314643	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LHX6 mRNA	PMID:33045310
1314642	LHX6	LIM homeobox 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314643	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of LHX6 mRNA	PMID:26251327
1314642	LHX6	LIM homeobox 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of LHX6 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of LHX6; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LHX6 gene	PMID:20938992
1314642	LHX6	LIM homeobox 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of LHX6 mRNA	PMID:33167477
1314642	LHX6	LIM homeobox 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1314643	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of LHX6 mRNA	PMID:16000160
1314642	LHX6	LIM homeobox 6	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LHX6 mRNA	PMID:36331819
1314642	LHX6	LIM homeobox 6	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of LHX6 mRNA	PMID:26079696
1314642	LHX6	LIM homeobox 6	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of LHX6 mRNA	PMID:22378314
1314642	LHX6	LIM homeobox 6	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of LHX6 mRNA	PMID:30319688
1314642	LHX6	LIM homeobox 6	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of LHX6 mRNA	PMID:20044591
1314642	LHX6	LIM homeobox 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314643	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of LHX6 mRNA	PMID:39298647
1314642	LHX6	LIM homeobox 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of LHX6 mRNA	PMID:30165855
1314642	LHX6	LIM homeobox 6	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306174	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of LHX6 mRNA	PMID:33387578
1314642	LHX6	LIM homeobox 6	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1314643	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of LHX6 mRNA	PMID:25549359
1314642	LHX6	LIM homeobox 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of LHX6 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of LHX6; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LHX6 gene	PMID:20938992
1314642	LHX6	LIM homeobox 6	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of LHX6 mRNA	PMID:26079696
1314642	LHX6	LIM homeobox 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LHX6 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LHX6 mRNA	PMID:37992649
1314642	LHX6	LIM homeobox 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LHX6 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LHX6 mRNA	PMID:37992649
1314642	LHX6	LIM homeobox 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1306174	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of LHX6 promoter	PMID:23359474
1314642	LHX6	LIM homeobox 6	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306174	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of LHX6 mRNA	PMID:26577399
1314642	LHX6	LIM homeobox 6	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LHX6 mRNA	PMID:36139627
1314642	LHX6	LIM homeobox 6	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of LHX6 intron	PMID:30157460
1314642	LHX6	LIM homeobox 6	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LHX6 mRNA	PMID:36331819
1314642	LHX6	LIM homeobox 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LHX6 mRNA	PMID:37236586
1314642	LHX6	LIM homeobox 6	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of LHX6 mRNA	PMID:19549813
1314642	LHX6	LIM homeobox 6	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314643	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of LHX6 mRNA	PMID:19770486
1314642	LHX6	LIM homeobox 6	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of LHX6 mRNA	PMID:21641981
1314642	LHX6	LIM homeobox 6	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306174	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of LHX6 mRNA	PMID:31150632
1314642	LHX6	LIM homeobox 6	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1314643	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of LHX6 mRNA	PMID:25629700
1314642	LHX6	LIM homeobox 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of LHX6 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of LHX6; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of LHX6 gene	PMID:20938992
1314642	LHX6	LIM homeobox 6	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of LHX6 mRNA	PMID:38460933
1314642	LHX6	LIM homeobox 6	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of LHX6 mRNA	PMID:38460933
1314642	LHX6	LIM homeobox 6	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LHX6 mRNA]	PMID:37992649
1314642	LHX6	LIM homeobox 6	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306174	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of LHX6 mRNA	PMID:31881176
1314642	LHX6	LIM homeobox 6	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of LHX6 mRNA	PMID:23557933
1314642	LHX6	LIM homeobox 6	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of LHX6 mRNA	PMID:27392435
1314642	LHX6	LIM homeobox 6	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314643	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of LHX6 mRNA	PMID:32186404
1314642	LHX6	LIM homeobox 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314643	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LHX6 mRNA	PMID:21570461|PMID:24058054
1314642	LHX6	LIM homeobox 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314643	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LHX6 mRNA	PMID:19770486|PMID:28922406
1314642	LHX6	LIM homeobox 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306174	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LHX6 mRNA	PMID:33387578
1314642	LHX6	LIM homeobox 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LHX6 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LHX6 mRNA	PMID:37992649
1314642	LHX6	LIM homeobox 6	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LHX6 mRNA]	PMID:37992649
1314642	LHX6	LIM homeobox 6	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of LHX6 mRNA	PMID:20044591
1314642	LHX6	LIM homeobox 6	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of LHX6 gene	PMID:28589171
1314642	LHX6	LIM homeobox 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of LHX6 mRNA	PMID:39719251
1314642	LHX6	LIM homeobox 6	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314643	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of LHX6 mRNA	PMID:37682722
1314642	LHX6	LIM homeobox 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LHX6 intron	PMID:30157460
1314642	LHX6	LIM homeobox 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314643	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LHX6 mRNA	PMID:19770486
1314642	LHX6	LIM homeobox 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LHX6 3' UTR	PMID:27901495
1314642	LHX6	LIM homeobox 6	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of LHX6 promoter	PMID:23974009
1314642	LHX6	LIM homeobox 6	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of LHX6 mRNA	PMID:15761015
1314642	LHX6	LIM homeobox 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314643	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LHX6 gene; titanium dioxide results in decreased methylation of LHX6 promoter	PMID:35295148
1314642	LHX6	LIM homeobox 6	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314643	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of LHX6 mRNA	PMID:29264374
1314642	LHX6	LIM homeobox 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314643	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LHX6 gene; titanium dioxide results in increased methylation of LHX6 promoter	PMID:35295148
1314642	LHX6	LIM homeobox 6	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306174	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of LHX6 mRNA	PMID:34492290
1314642	LHX6	LIM homeobox 6	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1314643	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of LHX6 mRNA	PMID:18648102
1314642	LHX6	LIM homeobox 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314643	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of LHX6 mRNA	PMID:23811191
1314642	LHX6	LIM homeobox 6	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306174	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of LHX6 mRNA	PMID:25181051
1314642	LHX6	LIM homeobox 6	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314643	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of LHX6 promoter	PMID:27334623
1314642	LHX6	LIM homeobox 6	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of LHX6 gene	PMID:31601247
1314642	LHX6	LIM homeobox 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314643	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of LHX6 mRNA	PMID:32156529
1314642	LHX6	LIM homeobox 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306174	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of LHX6 promoter	PMID:23359474
1314642	LHX6	LIM homeobox 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314643	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LHX6 mRNA	PMID:39298647
1314642	LHX6	LIM homeobox 6	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of LHX6 intron	PMID:30157460
1314642	LHX6	LIM homeobox 6	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1306174	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of LHX6 promoter	PMID:23359474
1314642	LHX6	LIM homeobox 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LHX6 mRNA	PMID:38382870
1314642	LHX6	LIM homeobox 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LHX6 mRNA	PMID:37236586
1314642	LHX6	LIM homeobox 6	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1306174	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of LHX6 mRNA	PMID:25539665
1314642	LHX6	LIM homeobox 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314643	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LHX6 mRNA	PMID:40194260
1314642	LHX6	LIM homeobox 6	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of LHX6 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LHX6 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of LHX6 mRNA	PMID:36331819
1314642	LHX6	LIM homeobox 6	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of LHX6 gene	PMID:29154799
1314642	LHX6	LIM homeobox 6	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314643	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of LHX6 mRNA	PMID:19770486
1314642	LHX6	LIM homeobox 6	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1314643	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of LHX6 mRNA	PMID:25123088
1314642	LHX6	LIM homeobox 6	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314643	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of LHX6 mRNA	PMID:28973697
1314642	LHX6	LIM homeobox 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LHX6 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LHX6 mRNA	PMID:37992649
1314642	LHX6	LIM homeobox 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314643	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LHX6 mRNA	PMID:17562736
1314642	LHX6	LIM homeobox 6	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of LHX6 promoter	PMID:29626692
1314642	LHX6	LIM homeobox 6	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of LHX6 promoter	PMID:29626692
1314642	LHX6	LIM homeobox 6	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of LHX6 mRNA	PMID:38460933
1314642	LHX6	LIM homeobox 6	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of LHX6 mRNA	PMID:15761015
1314642	LHX6	LIM homeobox 6	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	ISO	RGD:1314643	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of LHX6 mRNA	PMID:27915011
1314642	LHX6	LIM homeobox 6	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314643	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of LHX6 mRNA	PMID:23608068
1314642	LHX6	LIM homeobox 6	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of LHX6 intron	PMID:30157460
1314642	LHX6	LIM homeobox 6	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of LHX6 mRNA	PMID:31758290
1314642	LHX6	LIM homeobox 6	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of LHX6 mRNA	PMID:36318118
1314642	LHX6	LIM homeobox 6	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LHX6 mRNA	PMID:36139627
1314642	LHX6	LIM homeobox 6	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314643	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of LHX6 mRNA	PMID:19482888
1314642	LHX6	LIM homeobox 6	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314643	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LHX6 mRNA]	PMID:19482888
1314642	LHX6	LIM homeobox 6	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314643	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of LHX6 mRNA	PMID:38648751
1314642	LHX6	LIM homeobox 6	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of LHX6 mRNA	PMID:26079696
1314642	LHX6	LIM homeobox 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306174	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of LHX6 mRNA	PMID:24780913|PMID:25825206
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1614085	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of CDK15 mRNA	PMID:36189433
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1614085	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CDK15 mRNA	PMID:36189433
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CDK15 mRNA	PMID:35811015
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CDK15 mRNA	PMID:35811015
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1614085	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CDK15 mRNA	PMID:36189433
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1614085	E	RGD:6480464	20210608	CTD	MESH:D004051	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in increased expression of CDK15 mRNA	PMID:33484791
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CDK15 intron	PMID:30157460
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDK15 mRNA	PMID:35301059
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CDK15 3' UTR; Aflatoxin B1 results in increased methylation of CDK15 exon; Aflatoxin B1 results in increased methylation of CDK15 intron	PMID:30157460
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of CDK15 mRNA	PMID:24768652|PMID:25583101
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614085	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CDK15 mRNA	PMID:26377647
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CDK15 mRNA	PMID:33212167
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of CDK15 mRNA	PMID:27188386
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CDK15 5' UTR; Benzo(a)pyrene affects the methylation of CDK15 intron	PMID:27901495|PMID:30157460
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1614085	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CDK15 mRNA	PMID:29264374
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CDK15 gene	PMID:31601247
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of CDK15 intron	PMID:30157460
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1614085	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CDK15 intron	PMID:28392331
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1614085	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CDK15 mRNA	PMID:37019170
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDK15 mRNA	PMID:35301059
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CDK15 gene	PMID:29154799
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of CDK15 mRNA	PMID:26690555
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CDK15 mRNA	PMID:35811015
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of CDK15 mRNA	PMID:31629900
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:6651	malathion	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in increased expression of CDK15 mRNA	PMID:37047231
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of CDK15 intron	PMID:30157460
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of CDK15 mRNA	PMID:36318118
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CDK15 gene]	PMID:28238834
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1614085	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats co-treated with Diethylhexyl Phthalate] results in increased expression of CDK15 mRNA	PMID:33484791
1314644	CDK15	cyclin dependent kinase 15	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1306205	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in increased methylation of CDK15 gene	PMID:31079544
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ARFGAP2 mRNA	PMID:38218311
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314647	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ARFGAP2 mRNA	PMID:33045310
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314647	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ARFGAP2 mRNA	PMID:20188158
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of ARFGAP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of ARFGAP2 mRNA	PMID:32699268
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ARFGAP2 mRNA	PMID:22378314
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314647	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ARFGAP2 mRNA	PMID:30319688
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314647	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ARFGAP2 mRNA	PMID:39298647
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306177	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ARFGAP2 gene	PMID:27618143
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARFGAP2 mRNA	PMID:37042841
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of ARFGAP2 mRNA	PMID:19162166
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1314647	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of ARFGAP2 mRNA	PMID:17251523
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ARFGAP2 mRNA	PMID:21179406
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of ARFGAP2 protein	PMID:37730182
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306177	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ARFGAP2 mRNA	PMID:22061828|PMID:33387578
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314647	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARFGAP2 mRNA	PMID:36331819
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of ARFGAP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of ARFGAP2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of ARFGAP2 mRNA	PMID:32699268
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARFGAP2 mRNA	PMID:40512198
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ARFGAP2 mRNA	PMID:19244175
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ARFGAP2 protein	PMID:35688186
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ARFGAP2 mRNA	PMID:23557933
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314647	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARFGAP2 mRNA	PMID:21570461
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314647	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARFGAP2 mRNA	PMID:17942748
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ARFGAP2 mRNA	PMID:32763439
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARFGAP2 mRNA; sodium arsenite promotes the reaction [ARFGAP2 protein binds to CAPRIN1 protein]	PMID:33939924|PMID:40512198
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314647	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARFGAP2 mRNA	PMID:15034205
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314647	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of ARFGAP2 mRNA]	PMID:15034205
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1314647	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of ARFGAP2 mRNA	PMID:21829687
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314647	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARFGAP2 gene; titanium dioxide results in decreased methylation of ARFGAP2 promoter	PMID:35295148
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314647	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of ARFGAP2 mRNA	PMID:29264374
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314647	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ARFGAP2 mRNA	PMID:18648102
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314647	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ARFGAP2 mRNA	PMID:18445702
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306177	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARFGAP2 mRNA	PMID:25181051
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of ARFGAP2 protein	PMID:34186270
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306177	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ARFGAP2 mRNA	PMID:30816183|PMID:41034487
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314647	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ARFGAP2 mRNA	PMID:33221593
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:34093	1-Hydroxypyrene	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C033146	1-hydroxypyrene results in decreased expression of ARFGAP2 mRNA	PMID:21854004
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of ARFGAP2 protein	PMID:34186270
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314647	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of ARFGAP2 protein	PMID:35362542
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314647	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ARFGAP2 protein]	PMID:35362542
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of ARFGAP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of ARFGAP2 mRNA	PMID:32699268
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ARFGAP2 mRNA	PMID:19244175
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314647	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARFGAP2 mRNA	PMID:36331819
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARFGAP2 mRNA	PMID:29154799
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314647	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARFGAP2 mRNA	PMID:21427059
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306177	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ARFGAP2 mRNA	PMID:30047161
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314647	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ARFGAP2 mRNA	PMID:28973697
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ARFGAP2 mRNA	PMID:28542535
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314647	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ARFGAP2 mRNA	PMID:29279043
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARFGAP2 mRNA	PMID:40512198
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314647	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARFGAP2 mRNA	PMID:17942748
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314647	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARFGAP2 mRNA	PMID:17942748
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1314647	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of ARFGAP2 protein]	PMID:35362542
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306177	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ARFGAP2 mRNA	PMID:30047161
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ARFGAP2 protein	PMID:32959892
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ARFGAP2 mRNA	PMID:31758290
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ARFGAP2 protein	PMID:34186270
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314647	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ARFGAP2 mRNA	PMID:22206623
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ARFGAP2 protein	PMID:37664457
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1306177	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of ARFGAP2 mRNA	PMID:22124623
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARFGAP2 gene]	PMID:28238834
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1306177	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of ARFGAP2 protein	PMID:28903499
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306177	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARFGAP2 mRNA	PMID:30047161
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of ARFGAP2 mRNA	PMID:31734321
1314646	ARFGAP2	ARF GTPase activating protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ARFGAP2 protein	PMID:37664457
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:10110	zidovudine	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D015215	Zidovudine results in increased expression of SLC26A11 mRNA	PMID:24292225
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1550415	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SLC26A11 mRNA	PMID:20188158
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SLC26A11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SLC26A11 mRNA	PMID:32699268
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550415	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SLC26A11 mRNA	PMID:39241906
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of SLC26A11 mRNA	PMID:19167446
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1306178	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of SLC26A11 mRNA	PMID:23829299
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC26A11 mRNA	PMID:38568856
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SLC26A11 mRNA	PMID:21179406
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SLC26A11 protein	PMID:37730182
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306178	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SLC26A11 mRNA	PMID:33387578
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in increased expression of SLC26A11 mRNA	PMID:20368581
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SLC26A11 mRNA	PMID:19549813
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SLC26A11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SLC26A11 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of SLC26A11 mRNA	PMID:32699268
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:27300	vitamin D	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D014807	Vitamin D affects the expression of SLC26A11 mRNA	PMID:20368581
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLC26A11 gene	PMID:25304211
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of SLC26A11 mRNA	PMID:19167446
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SLC26A11 mRNA	PMID:28903495
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of SLC26A11 mRNA	PMID:27392435
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC26A11 mRNA	PMID:33212167
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLC26A11 mRNA	PMID:29803840
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC26A11 mRNA	PMID:39719251
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SLC26A11 mRNA	PMID:38568856
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC26A11 mRNA	PMID:20106945|PMID:21632981
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLC26A11 5' UTR	PMID:27901495
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SLC26A11 mRNA	PMID:26014281
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550415	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC26A11 gene	PMID:35295148
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550415	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SLC26A11 gene	PMID:35295148
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306178	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of SLC26A11 mRNA	PMID:30816183
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306178	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC26A11 mRNA	PMID:34947998
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550415	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC26A11 mRNA	PMID:32156529
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1550415	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SLC26A11 promoter	PMID:27312807
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SLC26A11 mRNA	PMID:29275510
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306178	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SLC26A11 mRNA	PMID:25181051
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550415	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SLC26A11 mRNA	PMID:33221593
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1550415	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of SLC26A11 mRNA	PMID:25172293
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1550415	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of SLC26A11 mRNA	PMID:26377693
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1550415	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of SLC26A11 mRNA	PMID:28392331
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SLC26A11 mRNA	PMID:36326898
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of SLC26A11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of SLC26A11 mRNA	PMID:32699268
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550415	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLC26A11 mRNA	PMID:40194260
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC26A11 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of SLC26A11 mRNA	PMID:19167446
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLC26A11 mRNA	PMID:25979313
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC26A11 mRNA	PMID:23179753|PMID:27188386
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC26A11 mRNA	PMID:25562108
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SLC26A11 mRNA	PMID:20106945
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550415	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLC26A11 mRNA	PMID:17562736
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306178	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SLC26A11 mRNA	PMID:33387578
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SLC26A11 gene	PMID:25304211
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1550415	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SLC26A11 mRNA	PMID:35436446
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550415	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of SLC26A11 mRNA	PMID:25554681
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1550415	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of SLC26A11 mRNA	PMID:26377693
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of SLC26A11 mRNA	PMID:20977926
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in increased expression of SLC26A11 mRNA	PMID:16982809
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550415	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC26A11 mRNA	PMID:22206623
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC26A11 mRNA	PMID:19167446
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of SLC26A11 mRNA	PMID:20368581
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:89700	3-iodothyronamine	affects uptake	EXP		E	RGD:6480464	20170110	CTD	MESH:C487948	SLC26A11 mRNA affects the uptake of 3-iodothyronamine	PMID:19074582
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SLC26A11 mRNA	PMID:26014281
1314648	SLC26A11	solute carrier family 26 member 11	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SLC26A11 mRNA	PMID:29301935
1314650	CHRDL2	chordin like 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1306179	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of CHRDL2 mRNA	PMID:33729688
1314650	CHRDL2	chordin like 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CHRDL2 mRNA	PMID:26079696
1314650	CHRDL2	chordin like 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306179	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CHRDL2 gene	PMID:28931070
1314650	CHRDL2	chordin like 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1306179	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of CHRDL2 mRNA	PMID:36841081
1314650	CHRDL2	chordin like 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314651	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CHRDL2 mRNA	PMID:39298647
1314650	CHRDL2	chordin like 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306179	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of CHRDL2 mRNA	PMID:33387578
1314650	CHRDL2	chordin like 2	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1314651	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of CHRDL2 mRNA	PMID:22238285
1314650	CHRDL2	chordin like 2	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CHRDL2 mRNA	PMID:26079696
1314650	CHRDL2	chordin like 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314651	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CHRDL2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CHRDL2 mRNA	PMID:37567420
1314650	CHRDL2	chordin like 2	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314651	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in increased expression of CHRDL2 mRNA	PMID:19693291
1314650	CHRDL2	chordin like 2	gene	CHEBI:175901	gemcitabine	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	[Gemcitabine co-treated with Erlotinib Hydrochloride] affects the expression of CHRDL2 protein	PMID:24979617
1314650	CHRDL2	chordin like 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314651	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CHRDL2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CHRDL2 mRNA	PMID:37567420
1314650	CHRDL2	chordin like 2	gene	CHEBI:24527	herbicide	multiple interactions	ISO	RGD:1314651	E	RGD:6480464	20231031	CTD	MESH:D006540	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CHRDL2 mRNA	PMID:37567420
1314650	CHRDL2	chordin like 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CHRDL2 gene	PMID:27153756
1314650	CHRDL2	chordin like 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CHRDL2 intron	PMID:30157460
1314650	CHRDL2	chordin like 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314651	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CHRDL2 mRNA	PMID:27106289
1314650	CHRDL2	chordin like 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CHRDL2 mRNA	PMID:23557933
1314650	CHRDL2	chordin like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314651	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHRDL2 mRNA	PMID:21570461
1314650	CHRDL2	chordin like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306179	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CHRDL2 mRNA	PMID:21215274
1314650	CHRDL2	chordin like 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CHRDL2 mRNA	PMID:29803840
1314650	CHRDL2	chordin like 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314651	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CHRDL2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CHRDL2 mRNA	PMID:37567420
1314650	CHRDL2	chordin like 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHRDL2 5' UTR; Benzo(a)pyrene affects the methylation of CHRDL2 intron	PMID:27901495|PMID:30157460
1314650	CHRDL2	chordin like 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CHRDL2 mRNA	PMID:25895662
1314650	CHRDL2	chordin like 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1306179	E	RGD:6480464	20240806	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CHRDL2 mRNA	PMID:34779285
1314650	CHRDL2	chordin like 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314651	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CHRDL2 promoter	PMID:35295148
1314650	CHRDL2	chordin like 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306179	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CHRDL2 mRNA	PMID:25181051
1314650	CHRDL2	chordin like 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CHRDL2 gene	PMID:31601247
1314650	CHRDL2	chordin like 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of CHRDL2 mRNA	PMID:27685785
1314650	CHRDL2	chordin like 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306179	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CHRDL2 mRNA	PMID:30816183|PMID:32528016
1314650	CHRDL2	chordin like 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306179	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CHRDL2 mRNA	PMID:36041667
1314650	CHRDL2	chordin like 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314651	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of CHRDL2 mRNA	PMID:26682919
1314650	CHRDL2	chordin like 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in increased expression of CHRDL2 mRNA	PMID:36804509
1314650	CHRDL2	chordin like 2	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to CHRDL2 promoter]	PMID:20348232
1314650	CHRDL2	chordin like 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306179	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CHRDL2 mRNA	PMID:36041667
1314650	CHRDL2	chordin like 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306179	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CHRDL2 mRNA	PMID:36041667
1314650	CHRDL2	chordin like 2	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1314651	E	RGD:6480464	20140211	CTD	MESH:D016264	Dextran Sulfate results in increased expression of CHRDL2 mRNA	PMID:23894361
1314650	CHRDL2	chordin like 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306179	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of CHRDL2 mRNA	PMID:30723492
1314650	CHRDL2	chordin like 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306179	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CHRDL2 mRNA	PMID:27387713
1314650	CHRDL2	chordin like 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CHRDL2 gene	PMID:29154799
1314650	CHRDL2	chordin like 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314651	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CHRDL2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CHRDL2 mRNA	PMID:37567420
1314650	CHRDL2	chordin like 2	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1314651	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of CHRDL2 mRNA	PMID:18502557
1314650	CHRDL2	chordin like 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of CHRDL2 mRNA	PMID:29067470
1314650	CHRDL2	chordin like 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314651	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CHRDL2 mRNA; Nanotubes, Carbon results in increased expression of CHRDL2 mRNA	PMID:25554681|PMID:25620056
1314650	CHRDL2	chordin like 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314651	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CHRDL2 mRNA	PMID:23608068
1314650	CHRDL2	chordin like 2	gene	CHEBI:53509	erlotinib hydrochloride	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D000069347	[Gemcitabine co-treated with Erlotinib Hydrochloride] affects the expression of CHRDL2 protein	PMID:24979617
1314650	CHRDL2	chordin like 2	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1314651	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of CHRDL2 mRNA	PMID:36851058
1314650	CHRDL2	chordin like 2	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1314651	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CHRDL2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CHRDL2 mRNA	PMID:37567420
1314650	CHRDL2	chordin like 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CHRDL2 gene]	PMID:28238834
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314653	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LENG8 mRNA	PMID:33045310
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:132606	mono(2-ethyl-5-oxohexyl) phthalate	affects expression	EXP		E	RGD:6480464	20220906	CTD	MESH:C080276	mono(2-ethyl-5-oxohexyl)phthalate affects the expression of LENG8 mRNA	PMID:34478338
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of LENG8 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of LENG8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of LENG8 mRNA	PMID:32699268|PMID:32845096
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314653	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LENG8 mRNA	PMID:36331819
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of LENG8 mRNA	PMID:22378314
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of LENG8 mRNA	PMID:21632981
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306180	E	RGD:6480464	20230207	CTD	MESH:D004958	Estradiol results in decreased expression of LENG8 mRNA	PMID:35192832
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306180	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of LENG8 mRNA	PMID:33387578
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314653	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of LENG8 mRNA	PMID:33754040
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of LENG8 protein	PMID:37730182
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306180	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of LENG8 mRNA	PMID:33387578
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306180	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of LENG8 mRNA	PMID:22061828
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of LENG8 mRNA	PMID:28818685
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LENG8 mRNA	PMID:39836092
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1314653	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of LENG8 mRNA	PMID:27462272
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314653	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LENG8 mRNA	PMID:37325564
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of LENG8 exon	PMID:30157460
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of LENG8 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of LENG8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of LENG8 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of LENG8 mRNA	PMID:32699268|PMID:32845096
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314653	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of LENG8 mRNA	PMID:34911549
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of LENG8 mRNA	PMID:18593933
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LENG8 gene	PMID:25304211
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LENG8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LENG8 mRNA	PMID:39836092
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314653	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of LENG8 mRNA	PMID:28960355
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:27810	resorcinol	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in increased expression of LENG8 mRNA	PMID:22623647
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of LENG8 mRNA	PMID:27594783
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314653	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of LENG8 mRNA	PMID:30912803
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314653	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LENG8 mRNA	PMID:21570461
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306180	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LENG8 mRNA	PMID:33387578
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306180	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LENG8 mRNA	PMID:34747641
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LENG8 mRNA	PMID:30851411
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of LENG8 mRNA	PMID:23649840
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of LENG8 mRNA	PMID:32763439
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306180	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of LENG8 mRNA	PMID:30556269
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of LENG8 mRNA	PMID:29803840
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of LENG8 mRNA	PMID:29301061|PMID:34032870
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of LENG8 mRNA	PMID:39719251
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LENG8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LENG8 mRNA	PMID:39836092
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of LENG8 intron	PMID:30157460
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LENG8 mRNA	PMID:20106945|PMID:21632981
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LENG8 3' UTR	PMID:27901495
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306180	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of LENG8 mRNA	PMID:30556269
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of LENG8 mRNA	PMID:18593933
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of LENG8 mRNA	PMID:20382639
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306180	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of LENG8 mRNA	PMID:30047161
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314653	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LENG8 gene	PMID:35295148
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314653	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of LENG8 mRNA	PMID:28329830
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of LENG8 mRNA	PMID:36232920
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306180	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of LENG8 mRNA	PMID:30816183|PMID:32145629|PMID:35192832
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314653	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of LENG8 mRNA	PMID:32156529|PMID:38074096
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306180	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LENG8 mRNA	PMID:25181051|PMID:27571134
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314653	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in increased expression of LENG8 mRNA	PMID:29165653
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314653	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of LENG8 gene	PMID:31683443
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314653	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of LENG8 mRNA	PMID:39298647
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of LENG8 intron	PMID:30157460
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314653	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of LENG8 mRNA	PMID:30951980|PMID:38685157
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LENG8 mRNA	PMID:39836092
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314653	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LENG8 mRNA	PMID:37325564
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of LENG8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of LENG8 mRNA	PMID:32699268
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of LENG8 mRNA	PMID:28302478
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LENG8 mRNA	PMID:31533062
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314653	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of LENG8 mRNA	PMID:36331819
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1306180	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of LENG8 mRNA	PMID:29427782
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LENG8 gene	PMID:29154799
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306180	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of LENG8 mRNA	PMID:30047161
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of LENG8 mRNA	PMID:20106945
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:43602	obeticholic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in increased expression of LENG8 mRNA	PMID:27939613
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LENG8 gene	PMID:25304211
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LENG8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LENG8 mRNA	PMID:39836092
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of LENG8 mRNA	PMID:22079256
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314653	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of LENG8 mRNA	PMID:35436446
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314653	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of LENG8 mRNA; Nanotubes, Carbon results in decreased expression of LENG8 mRNA	PMID:25554681
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306180	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of LENG8 mRNA	PMID:30047161
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314653	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of LENG8 mRNA	PMID:40234311
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1314653	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of LENG8 mRNA	PMID:26377693
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1306180	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of LENG8 mRNA	PMID:20080153
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LENG8 mRNA	PMID:39836092
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1306180	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of LENG8 mRNA	PMID:24136188
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of LENG8 intron	PMID:30157460
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1314653	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of LENG8 mRNA	PMID:27462272
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314653	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LENG8 mRNA	PMID:22206623
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of LENG8 mRNA	PMID:22079256
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of LENG8 mRNA	PMID:22079256
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of LENG8 mRNA	PMID:30851411
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1306180	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of LENG8 mRNA	PMID:32109520
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306180	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of LENG8 mRNA	PMID:30047161
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LENG8 mRNA	PMID:38568856
1314652	LENG8	leukocyte receptor cluster member 8	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306180	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of LENG8 mRNA	PMID:23034163
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314656	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PHOSPHO1 mRNA	PMID:33045310
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of PHOSPHO1 mRNA	PMID:34925699
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of PHOSPHO1 mRNA	PMID:33167477
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of PHOSPHO1 mRNA	PMID:26079696
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1306182	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of PHOSPHO1 mRNA	PMID:36841081
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PHOSPHO1 mRNA	PMID:35811015
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306182	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of PHOSPHO1 mRNA	PMID:32145629
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314656	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PHOSPHO1 mRNA	PMID:39298647
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306182	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PHOSPHO1 mRNA	PMID:32741896
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306182	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PHOSPHO1 mRNA	PMID:33387578
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PHOSPHO1 mRNA	PMID:37042841
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306182	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PHOSPHO1 mRNA	PMID:32741896
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314656	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PHOSPHO1 mRNA	PMID:23892564
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314656	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PHOSPHO1 mRNA	PMID:19850644
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20120412	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PHOSPHO1 mRNA; PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of PHOSPHO1 mRNA]	PMID:19850644|PMID:39150890
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PHOSPHO1 mRNA	PMID:36139627
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306182	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of PHOSPHO1 mRNA	PMID:33387578
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:18248	iron atom	decreases expression	ISO	RGD:1306182	E	RGD:6480464	20120814	CTD	MESH:D007501	Iron deficiency results in decreased expression of PHOSPHO1 mRNA	PMID:16629162
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	ISO	RGD:1314656	E	RGD:6480464	20141223	CTD	MESH:D014284	Triiodothyronine results in increased expression of PHOSPHO1 mRNA	PMID:25172293
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PHOSPHO1 mRNA	PMID:37236586
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PHOSPHO1 mRNA	PMID:35430440
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PHOSPHO1 mRNA	PMID:21867686
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1314656	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of PHOSPHO1 mRNA	PMID:25629700
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PHOSPHO1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHOSPHO1 mRNA	PMID:32045263|PMID:40504410
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314656	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PHOSPHO1 mRNA	PMID:21570461
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306182	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PHOSPHO1 mRNA	PMID:21215274
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306182	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHOSPHO1 mRNA	PMID:33387578
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314656	E	RGD:6480464	20150825	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PHOSPHO1 mRNA	PMID:25975270|PMID:28922406
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1306182	E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of PHOSPHO1 mRNA]	PMID:21215274
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PHOSPHO1 mRNA	PMID:25975270
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314656	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of PHOSPHO1 protein	PMID:28918527
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PHOSPHO1 gene	PMID:28589171
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314656	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PHOSPHO1 mRNA	PMID:37682722
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20220208	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PHOSPHO1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHOSPHO1 mRNA	PMID:32045263|PMID:40504410
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PHOSPHO1 5' UTR; Benzo(a)pyrene affects the methylation of PHOSPHO1 promoter	PMID:27901495
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PHOSPHO1 mRNA	PMID:22316170
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314656	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PHOSPHO1 mRNA	PMID:22228805
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PHOSPHO1 3' UTR; Benzo(a)pyrene results in increased methylation of PHOSPHO1 exon	PMID:27901495
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of PHOSPHO1 mRNA	PMID:25075043
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:3016	Benoxacor	decreases expression	ISO	RGD:1314656	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in decreased expression of PHOSPHO1 mRNA	PMID:34850242
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314656	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PHOSPHO1 gene; titanium dioxide results in decreased methylation of PHOSPHO1 promoter	PMID:35295148
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314656	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of PHOSPHO1 mRNA	PMID:29264374
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314656	E	RGD:6480464	20120918	CTD	MESH:C006253	pirinixic acid results in increased expression of PHOSPHO1 mRNA	PMID:17426115|PMID:18301758|PMID:20813756
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of PHOSPHO1 mRNA	PMID:20813756
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306182	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PHOSPHO1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306182	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of PHOSPHO1 mRNA	PMID:32145629
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314656	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PHOSPHO1 gene	PMID:31683443
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314656	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of PHOSPHO1 exon	PMID:33297965
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314656	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PHOSPHO1 mRNA	PMID:39298647
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PHOSPHO1 mRNA	PMID:39150890
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314656	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PHOSPHO1 mRNA	PMID:32715474|PMID:37019170
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of PHOSPHO1 gene	PMID:22964155
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314656	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of PHOSPHO1 mRNA	PMID:21266533
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PHOSPHO1 mRNA	PMID:39150890
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PHOSPHO1 mRNA	PMID:39150890
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PHOSPHO1 mRNA	PMID:37042841
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1306182	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of PHOSPHO1 mRNA	PMID:35163327
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306182	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PHOSPHO1 mRNA	PMID:35163327
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306182	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PHOSPHO1 mRNA	PMID:33453195
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PHOSPHO1 mRNA	PMID:37236586
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PHOSPHO1 mRNA	PMID:39150890
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306182	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of PHOSPHO1 mRNA	PMID:35163327
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314656	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of PHOSPHO1 mRNA	PMID:28962523
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314656	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PHOSPHO1 mRNA	PMID:40194260
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PHOSPHO1 mRNA	PMID:31533062
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314656	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PHOSPHO1 mRNA	PMID:17292431|PMID:17963808
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314656	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PHOSPHO1 mRNA	PMID:28973697
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of PHOSPHO1 mRNA	PMID:28542535
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314656	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PHOSPHO1 mRNA	PMID:17562736
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306182	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PHOSPHO1 mRNA	PMID:33387578
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PHOSPHO1 mRNA	PMID:35811015
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PHOSPHO1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PHOSPHO1 mRNA	PMID:32045263|PMID:40504410
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306182	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PHOSPHO1 mRNA	PMID:29391264
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:50035	alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of PHOSPHO1 mRNA	PMID:25075043
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:5014	fenvalerate	decreases expression	ISO	RGD:1306182	E	RGD:6480464	20210706	CTD	MESH:C017690	fenvalerate results in decreased expression of PHOSPHO1 protein	PMID:33656234
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306182	E	RGD:6480464	20260303	CTD	MESH:D005485	Flutamide results in decreased expression of PHOSPHO1 mRNA	PMID:40381864
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314656	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of PHOSPHO1 mRNA	PMID:38701926
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:6375	lansoprazole	decreases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:D064747	Lansoprazole results in decreased activity of PHOSPHO1 protein	PMID:17227223
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:65408	andrographolide	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20121218	CTD	MESH:C030419	[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of PHOSPHO1 mRNA	PMID:19737545
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314656	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PHOSPHO1 mRNA	PMID:22206623
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:756028	mivebresib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in increased expression of PHOSPHO1 mRNA	PMID:35486664
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PHOSPHO1 mRNA	PMID:36139627
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1306182	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of PHOSPHO1 mRNA	PMID:32741896
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20140204	CTD	MESH:D019324	[andrographolide co-treated with beta-Naphthoflavone] results in increased expression of PHOSPHO1 mRNA	PMID:19737545
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:77543	ebselen	decreases activity	EXP		E	RGD:6480464	20140520	CTD	MESH:C042986	ebselen results in decreased activity of PHOSPHO1 protein	PMID:17227223
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1306182	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of PHOSPHO1 mRNA	PMID:23665939
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of PHOSPHO1 mRNA	PMID:39150890
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1314656	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of PHOSPHO1 mRNA	PMID:38995820
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of PHOSPHO1 mRNA	PMID:32234424
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:82664	iron(0)	decreases expression	ISO	RGD:1306182	E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in decreased expression of PHOSPHO1 mRNA	PMID:16629162
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314656	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of PHOSPHO1 mRNA	PMID:21795629
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:85014	2,5-hexanedione	increases expression	ISO	RGD:1306182	E	RGD:6480464	20150303	CTD	MESH:C011269	2,5-hexanedione results in increased expression of PHOSPHO1 mRNA	PMID:22952946
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306182	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PHOSPHO1 mRNA	PMID:24780913|PMID:25825206
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:9130	sevoflurane	increases methylation	ISO	RGD:1314656	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased methylation of PHOSPHO1 mRNA	PMID:35249202
1314655	PHOSPHO1	phosphoethanolamine/phosphocholine phosphatase 1	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of PHOSPHO1 mRNA	PMID:29301935
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of KRR1 protein	PMID:39638853
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306183	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of KRR1 mRNA]	PMID:31150632
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314658	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of KRR1 mRNA	PMID:30529165
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:16412	lipopolysaccharide	decreases methylation	ISO	RGD:1314658	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased methylation of KRR1 gene	PMID:21212295
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:16412	lipopolysaccharide	increases methylation	ISO	RGD:1314658	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased methylation of KRR1 gene	PMID:21212295
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314658	E	RGD:6480464	20161228	CTD	MESH:D008070	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of KRR1 gene	PMID:21212295
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of KRR1 mRNA	PMID:22574217
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KRR1 mRNA	PMID:37042841
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314658	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KRR1 mRNA	PMID:34319233
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of KRR1 protein	PMID:37730182
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306183	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of KRR1 mRNA	PMID:22061828
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306183	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of KRR1 protein	PMID:34915118
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KRR1 mRNA	PMID:19549813
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1314658	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of KRR1 mRNA	PMID:19376150
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306183	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KRR1 mRNA	PMID:31150632
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314658	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KRR1 mRNA	PMID:31919559
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306183	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of KRR1 mRNA]	PMID:31150632
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314658	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KRR1 mRNA	PMID:22206623
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in increased methylation of KRR1 promoter	PMID:21291286
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D012643	Selenium results in decreased expression of KRR1 mRNA	PMID:19244175
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1314658	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of KRR1 protein	PMID:25505154
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314658	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KRR1 mRNA	PMID:21570461|PMID:24680724
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314658	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KRR1 mRNA	PMID:19770486
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases methylation	ISO	RGD:1314658	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased methylation of KRR1 gene	PMID:21212295
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314658	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of KRR1 gene	PMID:21212295
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KRR1 mRNA	PMID:28001369
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of KRR1 mRNA	PMID:25523186
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KRR1 promoter	PMID:27901495
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1314658	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of KRR1 protein	PMID:37955338
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of KRR1 mRNA	PMID:25523186
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KRR1 mRNA	PMID:20018196
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314658	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KRR1 gene	PMID:35295148
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306183	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of KRR1 mRNA	PMID:34492290
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306183	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of KRR1 mRNA	PMID:25181051
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314658	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of KRR1 mRNA	PMID:33221593
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306183	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KRR1 gene	PMID:28505145
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314658	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of KRR1 mRNA	PMID:39298647
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314658	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KRR1 mRNA	PMID:17361019|PMID:21266533
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to KRR1 protein	PMID:32991956
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KRR1 mRNA	PMID:37042841
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120522	CTD	MESH:D012643	Selenium results in decreased expression of KRR1 mRNA	PMID:19244175
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314658	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of KRR1 mRNA	PMID:17585979
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of KRR1 mRNA	PMID:28302478
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1306183	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of KRR1 mRNA	PMID:25993096
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of KRR1 mRNA	PMID:23179753
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	KRR1 protein affects the susceptibility to Methotrexate	PMID:16217747
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of KRR1 mRNA	PMID:27188386
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306183	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KRR1 mRNA	PMID:33387578
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in increased methylation of KRR1 promoter	PMID:21291286
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1314658	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of KRR1 mRNA	PMID:30529165
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314658	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of KRR1 mRNA	PMID:25554681
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:50729	mitoxantrone	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	KRR1 protein affects the susceptibility to Mitoxantrone	PMID:16217747
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306183	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KRR1 mRNA	PMID:24136188
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in decreased expression of KRR1 mRNA	PMID:16780908
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of KRR1 protein	PMID:32959892
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314658	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KRR1 mRNA	PMID:21641980
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314658	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of KRR1 mRNA	PMID:23650126
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1314658	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of KRR1 mRNA	PMID:22206623
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314658	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KRR1 mRNA	PMID:22206623
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of KRR1 protein	PMID:31285264
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:7599	Nivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of KRR1 protein	PMID:39638853
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KRR1 gene]	PMID:28238834
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:8249	piroxicam	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in increased expression of KRR1 mRNA	PMID:21858171
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314658	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of KRR1 mRNA	PMID:39847705
1314657	KRR1	KRR1 small subunit processome component	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of KRR1 mRNA	PMID:27188386
1314662	IVL	involucrin	gene	CHEBI:10782	(S)-(-)-perillyl alcohol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C032208	perillyl alcohol results in decreased expression of IVL protein	PMID:10769631
1314662	IVL	involucrin	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:620141	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of IVL mRNA	PMID:21551480
1314662	IVL	involucrin	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin analog results in decreased expression of IVL mRNA; Tretinoin results in decreased expression of IVL mRNA	PMID:1318502|PMID:17214633
1314662	IVL	involucrin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of IVL mRNA; Tretinoin results in increased expression of IVL protein	PMID:16249480|PMID:17034753|PMID:25240866|PMID:8396608|PMID:9716179
1314662	IVL	involucrin	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin inhibits the reaction [IL1A protein results in increased expression of IVL mRNA]	PMID:17214633
1314662	IVL	involucrin	gene	CHEBI:15420	perillyl alcohol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C032208	perillyl alcohol results in decreased expression of IVL protein	PMID:10769631
1314662	IVL	involucrin	gene	CHEBI:15948	lycopene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C015329	lycopene results in decreased expression of IVL protein	PMID:10769631
1314662	IVL	involucrin	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol results in decreased expression of IVL mRNA	PMID:28701262
1314662	IVL	involucrin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314663	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of IVL mRNA	PMID:19484750
1314662	IVL	involucrin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of IVL mRNA; Fulvestrant inhibits the reaction [Estradiol results in decreased expression of IVL mRNA]	PMID:28701262|PMID:30165855
1314662	IVL	involucrin	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of IVL mRNA	PMID:23649840|PMID:27664576
1314662	IVL	involucrin	gene	CHEBI:17336	all-trans-retinol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014801	Vitamin A results in increased expression of IVL mRNA	PMID:17034753
1314662	IVL	involucrin	gene	CHEBI:17579	beta-carotene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019207	beta Carotene results in increased expression of IVL mRNA	PMID:17034753
1314662	IVL	involucrin	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of IVL mRNA; hydroquinone results in increased expression of IVL protein	PMID:25240866|PMID:31256213
1314662	IVL	involucrin	gene	CHEBI:17594	hydroquinone	increases expression	ISO	RGD:1314663	E	RGD:6480464	20220405	CTD	MESH:C031927	hydroquinone results in increased expression of IVL protein	PMID:25240866
1314662	IVL	involucrin	gene	CHEBI:17650	cortisol	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D006854	Hydrocortisone results in decreased expression of IVL mRNA	PMID:32076005
1314662	IVL	involucrin	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of IVL protein	PMID:16011614
1314662	IVL	involucrin	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of IVL protein	PMID:7508215|PMID:8950452
1314662	IVL	involucrin	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:620141	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of IVL mRNA	PMID:22061828
1314662	IVL	involucrin	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314663	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IVL mRNA	PMID:36331819
1314662	IVL	involucrin	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of IVL protein	PMID:16011614
1314662	IVL	involucrin	gene	CHEBI:22984	calcium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium results in increased expression of IVL mRNA	PMID:10469331
1314662	IVL	involucrin	gene	CHEBI:22984	calcium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	NPS R-467 promotes the reaction [Calcium results in increased expression of IVL mRNA]	PMID:10469331
1314662	IVL	involucrin	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of IVL gene	PMID:27153756
1314662	IVL	involucrin	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314663	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IVL mRNA	PMID:19770486
1314662	IVL	involucrin	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1314663	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in decreased expression of IVL mRNA	PMID:15674843
1314662	IVL	involucrin	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D009151	Mustard Gas results in increased expression of IVL mRNA; Mustard Gas results in increased expression of IVL protein	PMID:21524694
1314662	IVL	involucrin	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of IVL mRNA	PMID:41430723
1314662	IVL	involucrin	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of IVL protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of IVL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of IVL protein	PMID:38598786
1314662	IVL	involucrin	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:620141	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of IVL mRNA	PMID:19111725
1314662	IVL	involucrin	gene	CHEBI:27363	zinc atom	multiple interactions	ISO	RGD:620141	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of IVL mRNA]	PMID:19111725
1314662	IVL	involucrin	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1314663	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of IVL mRNA	PMID:25629700
1314662	IVL	involucrin	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1314663	E	RGD:6480464	20251007	CTD	MESH:D001151	Arsenic results in increased expression of IVL protein	PMID:38299738
1314662	IVL	involucrin	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of IVL mRNA	PMID:32525701
1314662	IVL	involucrin	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D000966	Antimony Potassium Tartrate results in decreased expression of IVL mRNA; Antimony Potassium Tartrate results in decreased expression of IVL protein	PMID:28713220
1314662	IVL	involucrin	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:D000966	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IVL mRNA	PMID:32076005
1314662	IVL	involucrin	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314663	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of IVL mRNA	PMID:28960355
1314662	IVL	involucrin	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IVL mRNA	PMID:25583101
1314662	IVL	involucrin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314663	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IVL mRNA	PMID:21570461
1314662	IVL	involucrin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314663	E	RGD:6480464	20120717	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IVL mRNA	PMID:19770486|PMID:19933214
1314662	IVL	involucrin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IVL protein	PMID:37788135
1314662	IVL	involucrin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314663	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IVL mRNA	PMID:17035482
1314662	IVL	involucrin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314663	E	RGD:6480464	20211109	CTD	MESH:D013749	TIPARP gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of IVL mRNA]	PMID:34129049
1314662	IVL	involucrin	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of IVL mRNA	PMID:23649840
1314662	IVL	involucrin	gene	CHEBI:29320	calcium(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium results in increased expression of IVL mRNA	PMID:10469331
1314662	IVL	involucrin	gene	CHEBI:29320	calcium(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	NPS R-467 promotes the reaction [Calcium results in increased expression of IVL mRNA]	PMID:10469331
1314662	IVL	involucrin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of IVL mRNA; sodium arsenite results in decreased expression of IVL protein	PMID:11485391|PMID:12727804|PMID:20006635|PMID:28713220|PMID:39719251
1314662	IVL	involucrin	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of IVL mRNA; sodium arsenite results in increased expression of IVL protein	PMID:18572023|PMID:19524636|PMID:34032870
1314662	IVL	involucrin	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of IVL mRNA; sodium arsenite affects the reaction [FOS protein binds to IVL promoter]; sodium arsenite affects the reaction [FOSL1 protein binds to IVL promoter]; sodium arsenite affects the reaction [JUNB protein binds to IVL promoter]; sodium arsenite inhibits the reaction [EP300 protein binds to IVL promoter]	PMID:20006635|PMID:32076005
1314662	IVL	involucrin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IVL 5' UTR; Benzo(a)pyrene affects the methylation of IVL promoter	PMID:27901495
1314662	IVL	involucrin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314663	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IVL mRNA	PMID:19770486
1314662	IVL	involucrin	gene	CHEBI:29866	arsenite(3-)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of IVL mRNA; arsenite results in decreased expression of IVL protein	PMID:18633435
1314662	IVL	involucrin	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C015001	[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of IVL mRNA; JAG1 protein inhibits the reaction [arsenite results in decreased expression of IVL mRNA]; RTKI cpd inhibits the reaction [arsenite results in decreased expression of IVL mRNA]	PMID:18633435|PMID:32076005
1314662	IVL	involucrin	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:620141	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of IVL mRNA	PMID:19111725
1314662	IVL	involucrin	gene	CHEBI:30185	zinc(0)	multiple interactions	ISO	RGD:620141	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc inhibits the reaction [Zinc deficiency results in increased expression of IVL mRNA]	PMID:19111725
1314662	IVL	involucrin	gene	CHEBI:30297	antimonite	multiple interactions	EXP		E	RGD:6480464	20210907	CTD	MESH:C061374	[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IVL mRNA	PMID:32076005
1314662	IVL	involucrin	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IVL mRNA	PMID:25351596
1314662	IVL	involucrin	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of IVL protein	PMID:25419056
1314662	IVL	involucrin	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C070081	fulvestrant affects the reaction [bisphenol A affects the expression of IVL mRNA]; fulvestrant inhibits the reaction [Estradiol results in decreased expression of IVL mRNA]	PMID:28701262
1314662	IVL	involucrin	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:C015358	methylparaben results in increased expression of IVL protein	PMID:17186576
1314662	IVL	involucrin	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314663	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of IVL mRNA; pirinixic acid results in increased expression of IVL protein	PMID:10951269
1314662	IVL	involucrin	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the expression of IVL mRNA	PMID:28701262
1314662	IVL	involucrin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:620141	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IVL mRNA	PMID:25181051
1314662	IVL	involucrin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314663	E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased expression of IVL mRNA	PMID:32370801
1314662	IVL	involucrin	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of IVL gene	PMID:31601247
1314662	IVL	involucrin	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	fulvestrant affects the reaction [bisphenol A affects the expression of IVL mRNA]	PMID:28701262
1314662	IVL	involucrin	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to IVL protein	PMID:32991956
1314662	IVL	involucrin	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of IVL protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of IVL protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of IVL protein	PMID:38598786
1314662	IVL	involucrin	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IVL mRNA	PMID:20006635
1314662	IVL	involucrin	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D019256	Cadmium Chloride results in increased expression of IVL protein	PMID:30572105
1314662	IVL	involucrin	gene	CHEBI:36264	molybdate	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C044659	molybdate results in decreased expression of IVL protein	PMID:7848924
1314662	IVL	involucrin	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314663	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of IVL mRNA; Clofibrate results in increased expression of IVL protein	PMID:10951269|PMID:17585979
1314662	IVL	involucrin	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of IVL mRNA	PMID:17148446
1314662	IVL	involucrin	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	increases expression	ISO	RGD:1314663	E	RGD:6480464	20120412	CTD	MESH:D013755	Tetradecanoylphorbol Acetate results in increased expression of IVL mRNA	PMID:10866668
1314662	IVL	involucrin	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IVL mRNA]	PMID:17148446
1314662	IVL	involucrin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314663	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IVL mRNA	PMID:36331819
1314662	IVL	involucrin	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [MAP3K1 protein results in increased expression of IVL mRNA]; Curcumin inhibits the reaction [PRKCD protein results in increased expression of IVL mRNA]; Curcumin inhibits the reaction [PRKCE protein results in increased expression of IVL mRNA]; Curcumin inhibits the reaction [PRKCH protein results in increased expression of IVL mRNA]; Curcumin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IVL mRNA]	PMID:17148446
1314662	IVL	involucrin	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314663	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of IVL mRNA	PMID:17963808
1314662	IVL	involucrin	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of IVL mRNA	PMID:14699072
1314662	IVL	involucrin	gene	CHEBI:41774	tamoxifen	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of IVL mRNA	PMID:15590111
1314662	IVL	involucrin	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in decreased expression of IVL mRNA; ESR2 protein affects the reaction [Tamoxifen results in decreased expression of IVL mRNA]	PMID:14699072|PMID:19059307
1314662	IVL	involucrin	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of IVL mRNA	PMID:23649840
1314662	IVL	involucrin	gene	CHEBI:44597	all-trans-4-oxoretinol	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C041819	4-oxoretinol results in increased expression of IVL mRNA	PMID:17034753
1314662	IVL	involucrin	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314663	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IVL mRNA	PMID:17562736
1314662	IVL	involucrin	gene	CHEBI:46342	undecane	decreases expression	ISO	RGD:620141	E	RGD:6480464	20120918	CTD	MESH:C022884	undecane results in decreased expression of IVL protein	PMID:17337753
1314662	IVL	involucrin	gene	CHEBI:46502	tungstate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C045951	tungstate results in decreased expression of IVL protein	PMID:7848924
1314662	IVL	involucrin	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of IVL mRNA	PMID:25351596
1314662	IVL	involucrin	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1314663	E	RGD:6480464	20251007	CTD	MESH:D001151	Arsenic results in increased expression of IVL protein	PMID:38299738
1314662	IVL	involucrin	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of IVL mRNA	PMID:32525701
1314662	IVL	involucrin	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314663	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of IVL mRNA	PMID:35436446
1314662	IVL	involucrin	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of IVL protein	PMID:25419056
1314662	IVL	involucrin	gene	CHEBI:50385	hemin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006427	Hemin results in decreased expression of IVL mRNA	PMID:20006635
1314662	IVL	involucrin	gene	CHEBI:50648	9-cis-retinoic acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in decreased expression of IVL mRNA	PMID:8853895
1314662	IVL	involucrin	gene	CHEBI:50648	9-cis-retinoic acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in increased expression of IVL mRNA	PMID:17034753
1314662	IVL	involucrin	gene	CHEBI:50749	calcipotriol	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C055085	calcipotriene results in decreased expression of IVL protein	PMID:7508215
1314662	IVL	involucrin	gene	CHEBI:50859	bexarotene	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C095105	bexarotene results in decreased expression of IVL mRNA	PMID:8853895
1314662	IVL	involucrin	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of IVL protein	PMID:10769631
1314662	IVL	involucrin	gene	CHEBI:53154	8'-apo-beta,psi-caroten-8'-al	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004984	apocarotenal results in increased expression of IVL mRNA	PMID:17034753
1314662	IVL	involucrin	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314663	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of IVL mRNA	PMID:23608068
1314662	IVL	involucrin	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of IVL protein	PMID:37788135
1314662	IVL	involucrin	gene	CHEBI:72544	flavonoids	decreases expression	ISO	RGD:620141	E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in decreased expression of IVL mRNA	PMID:18035473
1314662	IVL	involucrin	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	ISO	RGD:1314663	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of IVL mRNA	PMID:25566086
1314662	IVL	involucrin	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of IVL mRNA	PMID:20006635
1314662	IVL	involucrin	gene	CHEBI:75261	arotinoid acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C038864	4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of IVL mRNA	PMID:8853895
1314662	IVL	involucrin	gene	CHEBI:753233	coal tar	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in increased expression of IVL mRNA	PMID:23348739
1314662	IVL	involucrin	gene	CHEBI:753233	coal tar	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar inhibits the reaction [[IL4 protein co-treated with IL13 protein] results in decreased expression of IVL mRNA]	PMID:23348739
1314662	IVL	involucrin	gene	CHEBI:75404	tyrphostin AG 1478	increases expression	EXP		E	RGD:6480464	20160405	CTD	MESH:C101044	RTKI cpd results in increased expression of IVL protein	PMID:18633435
1314662	IVL	involucrin	gene	CHEBI:75404	tyrphostin AG 1478	multiple interactions	EXP		E	RGD:6480464	20160405	CTD	MESH:C101044	RTKI cpd inhibits the reaction [arsenite results in decreased expression of IVL mRNA]	PMID:18633435
1314662	IVL	involucrin	gene	CHEBI:75439	7-O-(beta-D-glucosyl)isovitexin	decreases expression	ISO	RGD:1314663	E	RGD:6480464	20260804	CTD	MESH:C457771	saponarin results in decreased expression of IVL mRNA	PMID:34445132
1314662	IVL	involucrin	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of IVL mRNA	PMID:32151702
1314662	IVL	involucrin	gene	CHEBI:77319	oltipraz	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C026209	oltipraz results in decreased expression of IVL protein	PMID:10769631
1314662	IVL	involucrin	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IVL gene]	PMID:28238834
1314662	IVL	involucrin	gene	CHEBI:80656	all-trans-4-oxoretinoic acid	increases expression	EXP		E	RGD:6480464	20150120	CTD	MESH:C002202	4-oxoretinoic acid results in increased expression of IVL mRNA	PMID:17034753
1314662	IVL	involucrin	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of IVL mRNA; sodium arsenate results in decreased expression of IVL protein	PMID:11485391|PMID:12727804|PMID:20006635|PMID:7848924
1314662	IVL	involucrin	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of IVL mRNA	PMID:32525701
1314662	IVL	involucrin	gene	CHEBI:86193	DAPT	decreases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C419410	N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of IVL mRNA; N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of IVL protein	PMID:18633435
1314662	IVL	involucrin	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314663	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of IVL mRNA	PMID:40826991
1314662	IVL	involucrin	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of IVL mRNA	PMID:14699072
1314662	IVL	involucrin	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of IVL mRNA	PMID:19059307
1314662	IVL	involucrin	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of IVL mRNA; Sodium Dodecyl Sulfate results in increased expression of IVL protein	PMID:25240866
1314662	IVL	involucrin	gene	CHEBI:92181	lasalocid	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D007832	Lasalocid results in increased expression of IVL protein	PMID:37788135
1314662	IVL	involucrin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of IVL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of IVL protein	PMID:38598786
1314662	IVL	involucrin	gene	CHEBI:9907	ursodeoxycholic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014580	Ursodeoxycholic Acid results in decreased expression of IVL protein	PMID:10769631
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KATNBL1 mRNA	PMID:38218311
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of KATNBL1 mRNA	PMID:26079696
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of KATNBL1 mRNA	PMID:21632981
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314665	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of KATNBL1 mRNA	PMID:39241906
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KATNBL1 mRNA	PMID:37042841
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of KATNBL1 mRNA	PMID:26079696
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314665	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of KATNBL1 mRNA	PMID:23892564
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of KATNBL1 protein	PMID:37730182
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KATNBL1 mRNA	PMID:19549813
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314665	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KATNBL1 mRNA	PMID:31919559
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314665	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KATNBL1 mRNA	PMID:40504410
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of KATNBL1 mRNA	PMID:26272509
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KATNBL1 mRNA	PMID:27188386
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of KATNBL1 mRNA	PMID:23557933
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314665	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of KATNBL1 mRNA	PMID:30912803
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1582771	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KATNBL1 mRNA	PMID:33387578
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of KATNBL1 mRNA	PMID:28001369
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of KATNBL1 mRNA	PMID:33212167
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of KATNBL1 mRNA	PMID:26272509
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KATNBL1 mRNA	PMID:27188386
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of KATNBL1 mRNA	PMID:32763439
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1314665	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of KATNBL1 gene	PMID:39894169
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KATNBL1 mRNA	PMID:38568856
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314665	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KATNBL1 mRNA	PMID:40504410
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KATNBL1 promoter	PMID:27901495
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to KATNBL1 mRNA]	PMID:32406909
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KATNBL1 mRNA	PMID:19150397
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of KATNBL1 mRNA	PMID:31745603
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314665	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of KATNBL1 mRNA	PMID:29264374
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1582771	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of KATNBL1 mRNA	PMID:34492290
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314665	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of KATNBL1 mRNA	PMID:28329830
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1582771	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KATNBL1 mRNA	PMID:25181051
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314665	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of KATNBL1 mRNA	PMID:39298647
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314665	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KATNBL1 mRNA	PMID:37019170
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KATNBL1 mRNA	PMID:37042841
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of KATNBL1 mRNA	PMID:38174414|PMID:38568856
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1582771	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of KATNBL1 mRNA	PMID:25539665
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of KATNBL1 mRNA	PMID:28302478
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of KATNBL1 mRNA	PMID:31533062
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of KATNBL1 mRNA	PMID:23179753|PMID:24383497|PMID:24935251
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of KATNBL1 mRNA	PMID:28001369
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KATNBL1 mRNA	PMID:25562108
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of KATNBL1 mRNA	PMID:38832940
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D000082	Acetaminophen affects the expression of KATNBL1 mRNA	PMID:25458485
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of KATNBL1 mRNA	PMID:21420995
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314665	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of KATNBL1 mRNA	PMID:29279043
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314665	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of KATNBL1 mRNA	PMID:40504410
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KATNBL1 mRNA	PMID:22079256
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of KATNBL1 mRNA	PMID:26272509
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KATNBL1 mRNA	PMID:27188386
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1582771	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of KATNBL1 mRNA	PMID:30307764
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of KATNBL1 mRNA	PMID:31758290
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of KATNBL1 mRNA	PMID:22079256
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KATNBL1 mRNA	PMID:22079256
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KATNBL1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KATNBL1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KATNBL1 mRNA	PMID:27188386
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of KATNBL1 mRNA	PMID:26079696
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1314665	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of KATNBL1 mRNA	PMID:40826991
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KATNBL1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KATNBL1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KATNBL1 mRNA	PMID:27188386
1314664	KATNBL1	katanin regulatory subunit B1 like 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KATNBL1 mRNA	PMID:38568856
1314666	WDR37	WD repeat domain 37	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of WDR37 mRNA	PMID:33167477
1314666	WDR37	WD repeat domain 37	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of WDR37 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] affects the expression of WDR37 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of WDR37 mRNA	PMID:32699268|PMID:32845096
1314666	WDR37	WD repeat domain 37	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314667	E	RGD:6480464	20161025	CTD	MESH:D000431	Ethanol affects the expression of WDR37 mRNA	PMID:26730594
1314666	WDR37	WD repeat domain 37	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314667	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of WDR37 mRNA	PMID:30319688
1314666	WDR37	WD repeat domain 37	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314667	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of WDR37 mRNA	PMID:39241906
1314666	WDR37	WD repeat domain 37	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314667	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of WDR37 mRNA	PMID:39298647
1314666	WDR37	WD repeat domain 37	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of WDR37 mRNA	PMID:37042841
1314666	WDR37	WD repeat domain 37	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of WDR37 mRNA	PMID:20655997
1314666	WDR37	WD repeat domain 37	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of WDR37 protein	PMID:37730182
1314666	WDR37	WD repeat domain 37	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306189	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of WDR37 mRNA	PMID:22061828
1314666	WDR37	WD repeat domain 37	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of WDR37 intron	PMID:30157460
1314666	WDR37	WD repeat domain 37	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314667	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of WDR37 mRNA	PMID:36331819
1314666	WDR37	WD repeat domain 37	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1306189	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of WDR37 protein	PMID:33236894
1314666	WDR37	WD repeat domain 37	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of WDR37 intron	PMID:30157460
1314666	WDR37	WD repeat domain 37	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of WDR37 exon; Aflatoxin B1 results in decreased methylation of WDR37 gene	PMID:27153756|PMID:30157460
1314666	WDR37	WD repeat domain 37	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314667	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WDR37 mRNA	PMID:19770486
1314666	WDR37	WD repeat domain 37	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of WDR37 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] affects the expression of WDR37 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of WDR37 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of WDR37 mRNA; [Volatile Organic Compounds co-treated with Ozone] affects the expression of WDR37 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1314666	WDR37	WD repeat domain 37	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314667	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of WDR37 mRNA	PMID:25629700
1314666	WDR37	WD repeat domain 37	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of WDR37 gene	PMID:25304211
1314666	WDR37	WD repeat domain 37	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of WDR37 mRNA	PMID:26272509
1314666	WDR37	WD repeat domain 37	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314667	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of WDR37 mRNA	PMID:28960355
1314666	WDR37	WD repeat domain 37	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of WDR37 mRNA	PMID:23557933
1314666	WDR37	WD repeat domain 37	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of WDR37 mRNA	PMID:19921347
1314666	WDR37	WD repeat domain 37	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WDR37 mRNA	PMID:22574217
1314666	WDR37	WD repeat domain 37	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314667	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WDR37 mRNA	PMID:21570461
1314666	WDR37	WD repeat domain 37	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306189	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WDR37 mRNA	PMID:33387578
1314666	WDR37	WD repeat domain 37	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314667	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WDR37 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to WDR37 promoter]	PMID:17942748|PMID:19654925
1314666	WDR37	WD repeat domain 37	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of WDR37 protein	PMID:39603559
1314666	WDR37	WD repeat domain 37	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306189	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of WDR37 mRNA	PMID:28959563
1314666	WDR37	WD repeat domain 37	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of WDR37 mRNA	PMID:29301061
1314666	WDR37	WD repeat domain 37	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of WDR37 mRNA	PMID:38568856
1314666	WDR37	WD repeat domain 37	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of WDR37 exon	PMID:30157460
1314666	WDR37	WD repeat domain 37	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of WDR37 mRNA alternative form	PMID:40419235
1314666	WDR37	WD repeat domain 37	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314667	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WDR37 mRNA	PMID:22228805
1314666	WDR37	WD repeat domain 37	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WDR37 5' UTR	PMID:27901495
1314666	WDR37	WD repeat domain 37	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of WDR37 mRNA	PMID:19150397
1314666	WDR37	WD repeat domain 37	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of WDR37 gene	PMID:31601247
1314666	WDR37	WD repeat domain 37	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314667	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of WDR37 gene	PMID:35295148
1314666	WDR37	WD repeat domain 37	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306189	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of WDR37 mRNA	PMID:34492290
1314666	WDR37	WD repeat domain 37	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR37 protein	PMID:37664457
1314666	WDR37	WD repeat domain 37	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306189	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of WDR37 mRNA	PMID:25181051
1314666	WDR37	WD repeat domain 37	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of WDR37 gene	PMID:31601247
1314666	WDR37	WD repeat domain 37	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314667	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of WDR37 mRNA	PMID:39298647
1314666	WDR37	WD repeat domain 37	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306189	E	RGD:6480464	20150512	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of WDR37 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of WDR37 promoter	PMID:25374375
1314666	WDR37	WD repeat domain 37	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of WDR37 mRNA	PMID:37042841
1314666	WDR37	WD repeat domain 37	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of WDR37 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of WDR37 mRNA	PMID:32699268
1314666	WDR37	WD repeat domain 37	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314667	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of WDR37 mRNA	PMID:36331819
1314666	WDR37	WD repeat domain 37	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306189	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of WDR37 mRNA	PMID:38685447|PMID:41580965
1314666	WDR37	WD repeat domain 37	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of WDR37 mRNA	PMID:20106945
1314666	WDR37	WD repeat domain 37	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of WDR37 mRNA	PMID:26272509
1314666	WDR37	WD repeat domain 37	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314667	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of WDR37 mRNA	PMID:29279043
1314666	WDR37	WD repeat domain 37	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of WDR37 gene	PMID:25304211
1314666	WDR37	WD repeat domain 37	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314667	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WDR37 mRNA	PMID:17942748
1314666	WDR37	WD repeat domain 37	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306189	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of WDR37 mRNA	PMID:41580965
1314666	WDR37	WD repeat domain 37	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314667	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of WDR37 mRNA	PMID:23608068
1314666	WDR37	WD repeat domain 37	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of WDR37 mRNA	PMID:28988120
1314666	WDR37	WD repeat domain 37	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of WDR37 mRNA	PMID:31758290
1314666	WDR37	WD repeat domain 37	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314667	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of WDR37 mRNA	PMID:22206623
1314666	WDR37	WD repeat domain 37	gene	CHEBI:78492	diallyl trisulfide	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in increased expression of WDR37 mRNA	PMID:34995734
1314666	WDR37	WD repeat domain 37	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1306189	E	RGD:6480464	20150512	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of WDR37 mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of WDR37 promoter	PMID:25374375
1314666	WDR37	WD repeat domain 37	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of WDR37 mRNA	PMID:30458266
1314666	WDR37	WD repeat domain 37	gene	CHEBI:81980	triticonazole	decreases expression	ISO	RGD:1306189	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of WDR37 mRNA	PMID:36084822
1314666	WDR37	WD repeat domain 37	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306189	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of WDR37 mRNA	PMID:19015723
1314668	DDO	D-aspartate oxidase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1595123	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of DDO mRNA]	PMID:31150632
1314668	DDO	D-aspartate oxidase	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1621516	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of DDO mRNA	PMID:30319688
1314668	DDO	D-aspartate oxidase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1621516	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of DDO mRNA	PMID:19484750|PMID:39298647
1314668	DDO	D-aspartate oxidase	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1595123	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DDO mRNA	PMID:33387578
1314668	DDO	D-aspartate oxidase	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of DDO mRNA	PMID:23649840
1314668	DDO	D-aspartate oxidase	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of DDO mRNA	PMID:26079696
1314668	DDO	D-aspartate oxidase	gene	CHEBI:17364	D-aspartic acid	affects abundance	ISO	RGD:1621516	E	RGD:6480464	20211012	CTD	MESH:D026603	DDO protein affects the abundance of D-Aspartic Acid	PMID:16516413|PMID:16525061|PMID:16725213|PMID:18842900|PMID:26961959
1314668	DDO	D-aspartate oxidase	gene	CHEBI:17364	D-aspartic acid	increases degradation	ISO	RGD:1595123	E	RGD:6480464	20211012	CTD	MESH:D026603	DDO protein results in increased degradation of D-Aspartic Acid	PMID:32376478
1314668	DDO	D-aspartate oxidase	gene	CHEBI:17364	D-aspartic acid	increases metabolic processing	ISO	RGD:1621516	E	RGD:6480464	20211012	CTD	MESH:D026603	DDO protein results in increased metabolism of D-Aspartic Acid	PMID:32185508
1314668	DDO	D-aspartate oxidase	gene	CHEBI:190294	calcium silicate	decreases expression	ISO	RGD:1621516	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in decreased expression of DDO mRNA	PMID:29279043
1314668	DDO	D-aspartate oxidase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1621516	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DDO mRNA	PMID:37236586
1314668	DDO	D-aspartate oxidase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DDO mRNA	PMID:19549813
1314668	DDO	D-aspartate oxidase	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of DDO mRNA	PMID:23649840
1314668	DDO	D-aspartate oxidase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DDO mRNA	PMID:23649840
1314668	DDO	D-aspartate oxidase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1595123	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DDO mRNA	PMID:31150632
1314668	DDO	D-aspartate oxidase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1621516	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DDO mRNA	PMID:27339419|PMID:31919559
1314668	DDO	D-aspartate oxidase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1595123	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of DDO mRNA]	PMID:31150632
1314668	DDO	D-aspartate oxidase	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of DDO promoter	PMID:22847954
1314668	DDO	D-aspartate oxidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1621516	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DDO mRNA	PMID:21570461
1314668	DDO	D-aspartate oxidase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1621516	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DDO mRNA	PMID:19770486
1314668	DDO	D-aspartate oxidase	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DDO mRNA	PMID:33212167
1314668	DDO	D-aspartate oxidase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1595123	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of DDO mRNA	PMID:28959563
1314668	DDO	D-aspartate oxidase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1621516	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DDO mRNA	PMID:22228805
1314668	DDO	D-aspartate oxidase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DDO promoter	PMID:27901495
1314668	DDO	D-aspartate oxidase	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1621516	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of DDO mRNA]	PMID:22228805
1314668	DDO	D-aspartate oxidase	gene	CHEBI:31882	N-methyl-D-aspartic acid	affects abundance	ISO	RGD:1621516	E	RGD:6480464	20211012	CTD	MESH:D016202	DDO protein affects the abundance of N-Methylaspartate	PMID:16516413
1314668	DDO	D-aspartate oxidase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1621516	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of DDO mRNA	PMID:23557971
1314668	DDO	D-aspartate oxidase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1595123	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of DDO mRNA	PMID:34492290
1314668	DDO	D-aspartate oxidase	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DDO mRNA	PMID:19710929
1314668	DDO	D-aspartate oxidase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1595123	E	RGD:6480464	20150623	CTD	MESH:C006780	bisphenol A results in decreased expression of DDO mRNA	PMID:25181051
1314668	DDO	D-aspartate oxidase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1621516	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of DDO mRNA	PMID:32156529
1314668	DDO	D-aspartate oxidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1621516	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of DDO mRNA	PMID:39298647|PMID:40203079
1314668	DDO	D-aspartate oxidase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1621516	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of DDO mRNA	PMID:30951980
1314668	DDO	D-aspartate oxidase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1621516	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of DDO mRNA	PMID:30951980
1314668	DDO	D-aspartate oxidase	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1595123	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DDO mRNA	PMID:35163327
1314668	DDO	D-aspartate oxidase	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1621516	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of DDO mRNA	PMID:26377693
1314668	DDO	D-aspartate oxidase	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1595123	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DDO mRNA	PMID:33453195
1314668	DDO	D-aspartate oxidase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1621516	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DDO mRNA	PMID:37236586
1314668	DDO	D-aspartate oxidase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1595123	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of DDO mRNA	PMID:35163327
1314668	DDO	D-aspartate oxidase	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of DDO mRNA	PMID:28302478
1314668	DDO	D-aspartate oxidase	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of DDO promoter	PMID:22847954
1314668	DDO	D-aspartate oxidase	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of DDO promoter	PMID:22847954
1314668	DDO	D-aspartate oxidase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of DDO mRNA	PMID:40419075
1314668	DDO	D-aspartate oxidase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1621516	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of DDO mRNA	PMID:36331819
1314668	DDO	D-aspartate oxidase	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1621516	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of DDO mRNA	PMID:29038090
1314668	DDO	D-aspartate oxidase	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of DDO mRNA	PMID:38832940
1314668	DDO	D-aspartate oxidase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1621516	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DDO mRNA	PMID:17562736
1314668	DDO	D-aspartate oxidase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of DDO mRNA	PMID:29067470
1314668	DDO	D-aspartate oxidase	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1621516	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of DDO mRNA	PMID:35436446
1314668	DDO	D-aspartate oxidase	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of DDO mRNA	PMID:38825487
1314668	DDO	D-aspartate oxidase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1621516	E	RGD:6480464	20211012	CTD	MESH:C014347	Decitabine results in increased expression of DDO mRNA	PMID:26961959
1314668	DDO	D-aspartate oxidase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1621516	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DDO mRNA; Nanotubes, Carbon results in decreased expression of DDO mRNA	PMID:25554681|PMID:25620056
1314668	DDO	D-aspartate oxidase	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of DDO mRNA	PMID:22714537
1314668	DDO	D-aspartate oxidase	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of DDO mRNA	PMID:20436886
1314668	DDO	D-aspartate oxidase	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1595123	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DDO gene	PMID:35440735
1314668	DDO	D-aspartate oxidase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DDO gene]	PMID:28238834
1314668	DDO	D-aspartate oxidase	gene	CHEBI:8058	phencyclidine	affects response to substance	ISO	RGD:1621516	E	RGD:6480464	20211012	CTD	MESH:D010622	DDO protein affects the susceptibility to Phencyclidine	PMID:25979765
1314668	DDO	D-aspartate oxidase	gene	CHEBI:8058	phencyclidine	multiple interactions	ISO	RGD:1621516	E	RGD:6480464	20211012	CTD	MESH:D010622	[DDO protein affects the susceptibility to Phencyclidine] which affects the expression of DLG4 mRNA; [DDO protein affects the susceptibility to Phencyclidine] which affects the expression of HOMER1 mRNA; DDO protein affects the reaction [Phencyclidine results in decreased expression of HOMER1 mRNA]; DDO protein affects the reaction [Phencyclidine results in increased expression of DLG4 mRNA]	PMID:25979765
1314668	DDO	D-aspartate oxidase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1621516	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DDO mRNA	PMID:23091169
1314668	DDO	D-aspartate oxidase	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1621516	E	RGD:6480464	20240430	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of DDO mRNA	PMID:35278568
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1550418	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PARL mRNA	PMID:26251327
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550418	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PARL gene	PMID:20938992
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1550418	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PARL mRNA	PMID:30529165
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1306191	E	RGD:6480464	20201103	CTD	MESH:D001280	Atrazine results in decreased expression of PARL mRNA; Atrazine results in decreased expression of PARL protein	PMID:30084861
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550418	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PARL mRNA	PMID:39241906
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550418	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PARL mRNA	PMID:39298647
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306191	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of PARL gene	PMID:27618143
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550418	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PARL gene	PMID:20938992
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PARL mRNA	PMID:21179406
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306191	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PARL mRNA	PMID:22061828|PMID:33387578
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PARL mRNA	PMID:28818685
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550418	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PARL mRNA	PMID:36331819
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:188855	Octicizer	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C018535	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of PARL protein	PMID:42015365
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1550418	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of PARL mRNA	PMID:27462272
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PARL mRNA	PMID:19549813
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1306191	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of PARL protein	PMID:33236894
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PARL gene	PMID:27153756
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550418	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PARL gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PARL mRNA]	PMID:20938992|PMID:22206623
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PARL gene	PMID:25304211
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550418	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PARL mRNA	PMID:21570461
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306191	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PARL mRNA	PMID:33387578
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550418	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PARL promoter	PMID:35295148
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550418	E	RGD:6480464	20120501	CTD	MESH:C006253	pirinixic acid results in increased expression of PARL mRNA	PMID:17426115|PMID:18301758
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of PARL mRNA	PMID:25047013
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306191	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PARL mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550418	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PARL mRNA	PMID:33221593
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306191	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PARL gene	PMID:28505145
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of PARL mRNA	PMID:19244175
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550418	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PARL mRNA	PMID:39298647
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PARL mRNA	PMID:37042841
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:35033	triphenyl phosphate	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C005445	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of PARL protein	PMID:42015365
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:35037	tris(2-chloroethyl) phosphate	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C031324	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of PARL protein	PMID:42015365
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C013320	[tris(2-butoxyethyl) phosphate co-treated with Tritolyl Phosphates co-treated with tri-(2-chloroisopropyl)phosphate co-treated with tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with santicizer 148 co-treated with tris(chloroethyl)phosphate co-treated with 2-ethylhexyldiphenylphosphate] results in increased expression of PARL protein	PMID:42015365
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306191	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PARL mRNA	PMID:33453195
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PARL protein	PMID:26879310
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550418	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PARL mRNA	PMID:36331819
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of PARL mRNA	PMID:25704631
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306191	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PARL mRNA	PMID:33387578
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PARL gene	PMID:25304211
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550418	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PARL mRNA; Nanotubes, Carbon results in increased expression of PARL mRNA	PMID:25554681|PMID:25620056
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550418	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PARL mRNA	PMID:35964746
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306191	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PARL mRNA	PMID:24136188
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550418	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PARL mRNA	PMID:22206623
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550418	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PARL mRNA]	PMID:22206623
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:75701	sarin	decreases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in decreased expression of PARL mRNA	PMID:19522546
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PARL gene]	PMID:28238834
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1550418	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of PARL mRNA	PMID:31558096
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306191	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PARL mRNA	PMID:21346803
1314669	PARL	presenilin associated rhomboid like	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306191	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PARL mRNA	PMID:21346803
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of EIF5A2 mRNA	PMID:21934132
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314675	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of EIF5A2 mRNA	PMID:39241906
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of EIF5A2 mRNA	PMID:31614463
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1314675	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone inhibits the reaction [Biomarkers metabolite binds to EIF5A2 gene]	PMID:31084621
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of EIF5A2 mRNA	PMID:38568856
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306196	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of EIF5A2 mRNA	PMID:33387578
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of EIF5A2 mRNA	PMID:37042841
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314675	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EIF5A2 mRNA	PMID:37992649
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314675	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EIF5A2 mRNA	PMID:37992649
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306196	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of EIF5A2 mRNA	PMID:26577399|PMID:27523638
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of EIF5A2 mRNA	PMID:16002434
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of EIF5A2 mRNA	PMID:39836092
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314675	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF5A2 mRNA	PMID:37325564
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of EIF5A2 mRNA	PMID:19549813
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306196	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of EIF5A2 mRNA	PMID:21396975
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314675	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of EIF5A2 mRNA	PMID:34911549
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306196	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of EIF5A2 mRNA	PMID:33387578
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314675	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EIF5A2 mRNA	PMID:22206623
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of EIF5A2 mRNA	PMID:32525701
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of EIF5A2 mRNA	PMID:26272509
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EIF5A2 mRNA	PMID:27188386
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of EIF5A2 mRNA	PMID:27392435
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of EIF5A2 mRNA	PMID:27392435
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306196	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EIF5A2 mRNA	PMID:33387578
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of EIF5A2 mRNA	PMID:28001369
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EIF5A2 mRNA	PMID:30851411
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of EIF5A2 mRNA	PMID:32763439
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of EIF5A2 mRNA	PMID:20971185
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of EIF5A2 mRNA	PMID:29803840
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314675	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EIF5A2 mRNA	PMID:37992649
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of EIF5A2 mRNA	PMID:38568856
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EIF5A2 promoter	PMID:27901495
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of EIF5A2 mRNA	PMID:20971185
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of EIF5A2 mRNA	PMID:30983542
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1306196	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of EIF5A2 mRNA	PMID:16483693
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:31429	colforsin daropate hydrochloride	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005576	Colforsin results in decreased expression of EIF5A2 mRNA	PMID:30983542
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of EIF5A2 gene	PMID:31601247
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314675	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of EIF5A2 mRNA	PMID:29264374
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314675	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of EIF5A2 promoter	PMID:35295148
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314675	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of EIF5A2 gene	PMID:35295148
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306196	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of EIF5A2 mRNA	PMID:34492290
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306196	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EIF5A2 mRNA	PMID:25181051
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306196	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of EIF5A2 mRNA	PMID:33296240
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF5A2 mRNA	PMID:28628672
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314675	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of EIF5A2 mRNA	PMID:26682919
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314675	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of EIF5A2 gene	PMID:31683443
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314675	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of EIF5A2 mRNA	PMID:37019170
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF5A2 mRNA	PMID:28628672
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of EIF5A2 mRNA	PMID:37042841
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of EIF5A2 mRNA	PMID:39836092
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314675	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of EIF5A2 mRNA	PMID:37325564
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306196	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of EIF5A2 mRNA	PMID:25539665
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of EIF5A2 mRNA	PMID:24449571
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EIF5A2 mRNA	PMID:25979313
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of EIF5A2 mRNA	PMID:23179753|PMID:24935251|PMID:28001369|PMID:29154799
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of EIF5A2 mRNA	PMID:27989131
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of EIF5A2 mRNA	PMID:25562108
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF5A2 mRNA	PMID:28628672
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314675	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EIF5A2 mRNA	PMID:37992649
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:43572	kojic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of EIF5A2 mRNA	PMID:16595896
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of EIF5A2 mRNA	PMID:28542535
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306196	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of EIF5A2 mRNA	PMID:33387578
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of EIF5A2 mRNA	PMID:32525701
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of EIF5A2 mRNA	PMID:31838189
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of EIF5A2 mRNA	PMID:28628672
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of EIF5A2 mRNA	PMID:30983542
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:50594	carbon nanotube	affects expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of EIF5A2 protein	PMID:22001959
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314675	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of EIF5A2 mRNA	PMID:25554681
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of EIF5A2 mRNA	PMID:39836092
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314675	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of EIF5A2 mRNA	PMID:22206623
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314675	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of EIF5A2 mRNA	PMID:22206623
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EIF5A2 mRNA	PMID:30851411
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EIF5A2 mRNA	PMID:27188386
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of EIF5A2 mRNA	PMID:26705709
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of EIF5A2 mRNA	PMID:32525701
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306196	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EIF5A2 mRNA	PMID:24780913|PMID:25825206
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1314675	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of EIF5A2 mRNA	PMID:40826991
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EIF5A2 mRNA	PMID:27188386
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of EIF5A2 mRNA	PMID:29301935
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of EIF5A2 mRNA	PMID:27188386
1314674	EIF5A2	eukaryotic translation initiation factor 5A2	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306196	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of EIF5A2 mRNA	PMID:23555832
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ZNF319 mRNA	PMID:22378314
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314678	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFP319 mRNA	PMID:39241906
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF319 mRNA	PMID:37042841
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ZNF319 mRNA	PMID:21179406
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306198	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP319 mRNA	PMID:33387578
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZNF319 mRNA	PMID:19549813
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ZNF319 mRNA	PMID:23649840
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1314678	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of ZFP319 mRNA	PMID:27776689
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1306198	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ZFP319 mRNA	PMID:33354967
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZNF319 mRNA	PMID:23649840
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314678	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ZFP319 mRNA	PMID:34911549
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306198	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ZFP319 mRNA	PMID:30779732
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314678	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZFP319 mRNA	PMID:25629700
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in increased expression of ZNF319 mRNA	PMID:19561079
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314678	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ZFP319 mRNA	PMID:30912803
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314678	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP319 mRNA	PMID:21570461
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ZNF319 mRNA	PMID:35984750
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314678	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ZFP319 mRNA	PMID:20813756
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306198	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ZNF319 mRNA	PMID:25181051
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306198	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP319 mRNA	PMID:34947998
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314678	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP319 mRNA	PMID:26063408
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ZNF319 mRNA	PMID:38568856
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ZNF319 mRNA	PMID:31533062
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314678	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of ZFP319 mRNA	PMID:36331819
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZNF319 mRNA	PMID:25979313
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF319 mRNA	PMID:28001369
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1306198	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZFP319 mRNA	PMID:29427782
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZNF319 gene	PMID:29154799
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314678	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ZNF319 mRNA	PMID:28973697
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306198	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZFP319 mRNA	PMID:33387578
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of ZNF319 mRNA	PMID:18175754
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306198	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ZFP319 mRNA	PMID:29097150
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314678	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ZFP319 mRNA	PMID:25554681
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314678	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ZFP319 mRNA	PMID:22206623
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ZNF319 protein	PMID:31285264
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1306198	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of ZFP319 mRNA	PMID:23665939
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF319 gene]	PMID:28238834
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ZNF319 mRNA	PMID:38568856
1314677	ZNF319	zinc finger protein 319	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZNF319 mRNA	PMID:29301935
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1306199	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of BAZ1A mRNA	PMID:21551480
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1620625	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of BAZ1A mRNA	PMID:20188158
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of BAZ1A mRNA	PMID:23724009
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of BAZ1A mRNA	PMID:33167477
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1306199	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of BAZ1A mRNA	PMID:20488242
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of BAZ1A mRNA	PMID:24763279
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of BAZ1A mRNA	PMID:22378314
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of BAZ1A mRNA	PMID:21632981
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1620625	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of BAZ1A mRNA	PMID:39298647
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of BAZ1A mRNA	PMID:23019147|PMID:31614463
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1620625	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BAZ1A mRNA	PMID:25510870
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BAZ1A mRNA	PMID:37042841
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1620625	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of BAZ1A mRNA	PMID:22238285
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of BAZ1A mRNA	PMID:21179406
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1620625	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of BAZ1A mRNA	PMID:22401849
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D014050	Toluene results in increased expression of BAZ1A mRNA	PMID:28245982
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306199	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of BAZ1A mRNA	PMID:26577399
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of BAZ1A protein	PMID:37730182
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306199	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of BAZ1A mRNA	PMID:22061828|PMID:33387578
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BAZ1A mRNA	PMID:35301059
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1620625	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BAZ1A mRNA	PMID:25510870
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1620625	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BAZ1A mRNA	PMID:25510870
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of BAZ1A mRNA	PMID:19549813
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of BAZ1A protein	PMID:20106945
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BAZ1A mRNA	PMID:22100608
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1620625	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BAZ1A mRNA	PMID:19770486
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of BAZ1A mRNA	PMID:41430723
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306199	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of BAZ1A mRNA	PMID:30779732
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1620625	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BAZ1A mRNA	PMID:31919559
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAZ1A mRNA	PMID:39836092
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of BAZ1A mRNA	PMID:26272509
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA	PMID:27188386
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of BAZ1A protein	PMID:35688186
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of BAZ1A mRNA	PMID:28903495
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1620625	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of BAZ1A mRNA	PMID:30912803
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of BAZ1A mRNA	PMID:16963248
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620625	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BAZ1A mRNA	PMID:21570461
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306199	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BAZ1A mRNA	PMID:18465118|PMID:33387578|PMID:34747641
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:28197	daidzein	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C004742	[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of BAZ1A mRNA	PMID:16963248
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of BAZ1A mRNA	PMID:28001369
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1620625	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of BAZ1A protein	PMID:28918527
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of BAZ1A mRNA	PMID:29803840
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAZ1A mRNA	PMID:39836092
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1620625	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of BAZ1A mRNA	PMID:19770486
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BAZ1A mRNA	PMID:22316170|PMID:26238291
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1620625	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of BAZ1A exon; Benzo(a)pyrene results in increased methylation of BAZ1A intron	PMID:27901495
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1620625	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of BAZ1A mRNA	PMID:27131904
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BAZ1A mRNA	PMID:19150397
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of BAZ1A mRNA	PMID:26238291
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of BAZ1A gene	PMID:31601247
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306199	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of BAZ1A mRNA	PMID:25729387
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620625	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BAZ1A gene	PMID:35295148
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306199	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of BAZ1A mRNA	PMID:23411599|PMID:34492290
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1620625	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of BAZ1A mRNA	PMID:19710929
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of BAZ1A mRNA	PMID:29275510
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1620625	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of BAZ1A mRNA	PMID:26063408|PMID:33221593
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306199	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of BAZ1A mRNA	PMID:25181051|PMID:30816183
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306199	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of BAZ1A gene	PMID:28505145
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of BAZ1A mRNA	PMID:19244175
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of BAZ1A mRNA	PMID:25979313
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1620625	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BAZ1A mRNA	PMID:25510870
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1620625	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BAZ1A mRNA	PMID:25510870
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1620625	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of BAZ1A mRNA	PMID:28392331
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306199	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of BAZ1A mRNA	PMID:21266533
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1620625	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of BAZ1A mRNA	PMID:17361019
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:34778	glycitein	multiple interactions	EXP		E	RGD:6480464	20141104	CTD	MESH:C086566	[Genistein co-treated with daidzein co-treated with glycitein] results in increased expression of BAZ1A mRNA	PMID:16963248
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306199	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of BAZ1A gene	PMID:33148267
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BAZ1A mRNA	PMID:37042841
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BAZ1A mRNA	PMID:35301059
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of BAZ1A mRNA	PMID:24449571
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of BAZ1A mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of BAZ1A gene	PMID:29154799
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA	PMID:27188386
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of BAZ1A mRNA	PMID:25562108
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of BAZ1A mRNA	PMID:14699072
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of BAZ1A mRNA	PMID:36621641
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1620625	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of BAZ1A mRNA	PMID:28973697
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of BAZ1A mRNA	PMID:24449571
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of BAZ1A mRNA	PMID:38832940
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of BAZ1A mRNA	PMID:26272509
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA	PMID:27188386
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of BAZ1A mRNA	PMID:24935251|PMID:26272509
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA	PMID:27188386
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1620625	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of BAZ1A mRNA	PMID:17562736
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAZ1A mRNA	PMID:39836092
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in increased expression of BAZ1A protein	PMID:26615145
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BAZ1A mRNA	PMID:22079256
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of BAZ1A mRNA	PMID:18175754
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of BAZ1A mRNA	PMID:16984733
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306199	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of BAZ1A mRNA	PMID:30307764
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1620625	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of BAZ1A mRNA; Nanotubes, Carbon results in increased expression of BAZ1A mRNA	PMID:25554681|PMID:25620056
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1620625	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of BAZ1A mRNA	PMID:19042947
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1620625	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BAZ1A mRNA	PMID:26378955
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306199	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of BAZ1A mRNA	PMID:25729387
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306199	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of BAZ1A mRNA	PMID:25729387
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1306199	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of BAZ1A mRNA	PMID:24136188
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306199	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of BAZ1A gene	PMID:33148267
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1620625	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of BAZ1A mRNA	PMID:22206623
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of BAZ1A mRNA	PMID:22079256
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BAZ1A mRNA	PMID:22079256
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of BAZ1A protein	PMID:31285264
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA	PMID:27188386
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1620625	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of BAZ1A mRNA	PMID:23091169
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of BAZ1A mRNA	PMID:21858171
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1620625	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of BAZ1A mRNA	PMID:21795629
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306199	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of BAZ1A mRNA	PMID:24780913
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of BAZ1A mRNA	PMID:26272509
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA	PMID:27188386
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BAZ1A mRNA	PMID:27188386
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1620625	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of BAZ1A mRNA	PMID:27131904
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306199	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of BAZ1A mRNA	PMID:19281266
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306199	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of BAZ1A mRNA	PMID:21346803
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of BAZ1A mRNA	PMID:17440010
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of BAZ1A mRNA	PMID:38568856
1314679	BAZ1A	bromodomain adjacent to zinc finger domain 1A	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1620625	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of BAZ1A protein	PMID:24648495
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of LRCH3 mRNA	PMID:38218311
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of LRCH3 mRNA	PMID:25812627
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LRCH3 mRNA	PMID:37042841
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of LRCH3 mRNA	PMID:20655997
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314682	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of LRCH3 mRNA	PMID:34319233
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of LRCH3 protein	PMID:37730182
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306200	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LRCH3 mRNA	PMID:33387578
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRCH3 mRNA	PMID:39836092
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LRCH3 gene	PMID:25304211
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRCH3 mRNA	PMID:39836092
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314682	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of LRCH3 mRNA	PMID:30912803
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306200	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRCH3 mRNA	PMID:33387578
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of LRCH3 mRNA	PMID:28001369
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of LRCH3 mRNA	PMID:23649840
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314682	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of LRCH3 protein	PMID:28918527
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of LRCH3 mRNA	PMID:29319823
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of LRCH3 mRNA	PMID:38568856
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRCH3 mRNA	PMID:39836092
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of LRCH3 mRNA	PMID:20106945
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of LRCH3 promoter	PMID:27901495
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to LRCH3 mRNA]	PMID:32406909
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of LRCH3 mRNA	PMID:23806026
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314682	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRCH3 gene	PMID:35295148
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306200	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LRCH3 mRNA	PMID:34492290
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of LRCH3 mRNA	PMID:19710929
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306200	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of LRCH3 mRNA	PMID:30816183
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in decreased expression of LRCH3 mRNA; bisphenol A results in decreased expression of LRCH3 protein	PMID:22576693|PMID:32981897
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306200	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of LRCH3 mRNA	PMID:34947998
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20130122	CTD	MESH:C006780	bisphenol A results in increased methylation of LRCH3 gene	PMID:22576693
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314682	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of LRCH3 mRNA	PMID:39298647
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1306200	E	RGD:6480464	20260303	CTD	MESH:C008745	bisphenol F results in increased expression of LRCH3 protein	PMID:40188933
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LRCH3 mRNA	PMID:37042841
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRCH3 mRNA	PMID:39836092
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of LRCH3 mRNA	PMID:24449571
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of LRCH3 mRNA	PMID:25812627
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of LRCH3 mRNA	PMID:23179753|PMID:24383497|PMID:28001369
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of LRCH3 mRNA	PMID:24935251
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of LRCH3 gene	PMID:29154799
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of LRCH3 mRNA	PMID:23649840
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of LRCH3 mRNA]	PMID:21233418
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of LRCH3 mRNA	PMID:26690555
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LRCH3 gene	PMID:25304211
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRCH3 mRNA	PMID:39836092
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LRCH3 mRNA	PMID:22079256
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LRCH3 protein	PMID:32959892
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LRCH3 mRNA	PMID:39836092
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306200	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LRCH3 gene	PMID:35440735
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of LRCH3 mRNA	PMID:22079256
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of LRCH3 mRNA	PMID:22079256
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of LRCH3 mRNA	PMID:18927307
1314681	LRCH3	leucine rich repeats and calponin homology domain containing 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of LRCH3 mRNA	PMID:38568856
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of IGFBP7 mRNA	PMID:26272509
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA	PMID:27188386
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:132889	graphene oxide	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C000628730	graphene oxide results in increased expression of IGFBP7 protein	PMID:33219560|PMID:33219563
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of IGFBP7 mRNA	PMID:31016361
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:144441	triacsin C	decreases expression	EXP		E	RGD:6480464	20190903	CTD	MESH:C034613	triacsin C results in decreased expression of IGFBP7 mRNA	PMID:16704987
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of IGFBP7 mRNA	PMID:23724009
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of IGFBP7 mRNA	PMID:21934132
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:15756	hexadecanoic acid	increases expression	EXP		E	RGD:401960873|PMID:31397492	20240201	RGD	MESH:D019308	Palmitic acid increases expression of IGFBP7 mRNA and protein in hepatoma cells	
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:15843	arachidonic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D016718	Arachidonic Acid results in decreased expression of IGFBP7 mRNA	PMID:16704987
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1314684	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of IGFBP7 mRNA	PMID:40945087
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of IGFBP7 mRNA	PMID:29432896
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of IGFBP7 mRNA	PMID:32949572
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:16243	quercetin	increases expression	ISO	RGD:1314684	E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of IGFBP7 mRNA	PMID:16455785
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314684	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IGFBP7 mRNA	PMID:39241906
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of IGFBP7 mRNA	PMID:30510588
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306201	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of IGFBP7 mRNA	PMID:32145629
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:167162	L-ascorbic acid 2-phosphate	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C011669	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGFBP7 mRNA	PMID:34480604
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGFBP7 mRNA	PMID:37992649
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of IGFBP7 mRNA	PMID:22017230
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1314684	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of IGFBP7 mRNA	PMID:20403060
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314684	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of IGFBP7 mRNA	PMID:20403060
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGFBP7 mRNA	PMID:37992649
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:17650	cortisol	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:D006854	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IGFBP7 mRNA	PMID:34480604
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of IGFBP7 protein	PMID:31163220
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20120814	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of IGFBP7 mRNA	PMID:19560483
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314684	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of IGFBP7 mRNA	PMID:34319233
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IGFBP7 mRNA	PMID:31163220
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306201	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of IGFBP7 mRNA	PMID:27523638
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of IGFBP7 mRNA	PMID:28818685
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IGFBP7 mRNA	PMID:36331819
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306201	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of IGFBP7 protein	PMID:34915118
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20210209	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IGFBP7 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IGFBP7 mRNA	PMID:33259630|PMID:37236586
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of IGFBP7 protein	PMID:20106945
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IGFBP7 mRNA	PMID:21632981|PMID:21641981
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314684	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of IGFBP7 mRNA	PMID:19770486
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314684	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of IGFBP7 mRNA	PMID:12763052
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:27363	zinc atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of IGFBP7 mRNA	PMID:16979875
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP7 mRNA	PMID:16979875
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306201	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of IGFBP7 mRNA	PMID:16239168
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314684	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of IGFBP7 mRNA	PMID:27339419|PMID:29987408|PMID:31919559
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314684	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of IGFBP7 mRNA	PMID:25629700
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:27470	folic acid	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of IGFBP7 mRNA	PMID:21867686
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of IGFBP7 mRNA	PMID:32525701
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of IGFBP7 mRNA	PMID:40504410
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of IGFBP7 mRNA	PMID:26272509
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA	PMID:27188386
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306201	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of IGFBP7 mRNA	PMID:31881176
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in increased expression of IGFBP7 mRNA	PMID:41028656
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:27899	cisplatin	affects expression	ISO	RGD:1314684	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin affects the expression of IGFBP7 mRNA	PMID:21151649
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306201	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IGFBP7 mRNA	PMID:34747641
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IGFBP7 mRNA	PMID:17101203|PMID:20106945|PMID:21632981
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314684	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IGFBP7 mRNA	PMID:15034205|PMID:33956508
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of IGFBP7 mRNA]	PMID:15034205
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of IGFBP7 mRNA	PMID:28374803
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of IGFBP7 mRNA	PMID:28001369
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004925	methylmercuric chloride results in increased expression of IGFBP7 mRNA	PMID:34089799
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of IGFBP7 mRNA	PMID:28959563
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of IGFBP7 mRNA; [Disulfiram binds to Copper] which results in increased expression of IGFBP7 mRNA; [Disulfiram binds to Copper] which results in increased expression of IGFBP7 protein	PMID:24690739|PMID:41028656
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	IGFBP7 protein affects the susceptibility to Doxorubicin	PMID:16217747
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314684	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of IGFBP7 mRNA	PMID:39631538
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of IGFBP7 mRNA	PMID:29803840
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGFBP7 mRNA	PMID:37992649
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of IGFBP7 mRNA	PMID:29432896
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:D001205	[[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGFBP7 mRNA	PMID:34480604
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:29365	phosgene	affects expression	ISO	RGD:1314684	E	RGD:6480464	20120515	CTD	MESH:D010705	Phosgene affects the expression of IGFBP7 mRNA	PMID:16300373
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1314684	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of IGFBP7 gene	PMID:39894169
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of IGFBP7 mRNA	PMID:38568856
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of IGFBP7 mRNA	PMID:12634122
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of IGFBP7 mRNA	PMID:40504410
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IGFBP7 promoter	PMID:27901495
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314684	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IGFBP7 mRNA	PMID:15034205
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IGFBP7 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:32234424
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314684	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of IGFBP7 mRNA	PMID:22228805
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of IGFBP7 mRNA]	PMID:15034205
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of IGFBP7 mRNA; [Disulfiram binds to Copper] which results in increased expression of IGFBP7 mRNA; [Disulfiram binds to Copper] which results in increased expression of IGFBP7 protein	PMID:24690739|PMID:41028656
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:30185	zinc(0)	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc affects the expression of IGFBP7 mRNA	PMID:16979875
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP7 mRNA	PMID:16979875
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314684	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of IGFBP7 mRNA	PMID:27131904
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of IGFBP7 mRNA	PMID:15725085|PMID:29266867
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [Dasatinib results in increased expression of IGFBP7 mRNA]	PMID:29266867
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:30703	tetrathiomolybdate(2-)	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C020809	tetrathiomolybdate results in increased expression of IGFBP7 mRNA	PMID:37290678
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:3139	bleomycin A2	increases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:D001761	Bleomycin results in increased expression of IGFBP7 mRNA	PMID:40645554
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C008261	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of IGFBP7 mRNA	PMID:12634122
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1306201	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of IGFBP7 mRNA	PMID:25729387
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306201	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of IGFBP7 mRNA	PMID:25729387
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306201	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of IGFBP7 mRNA	PMID:30047161
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of IGFBP7 mRNA	PMID:24136188
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306201	E	RGD:401976485|PMID:25691930	20240227	RGD	MESH:D013853	Thioacetamide increases expression of Igfbp7 protein in the liver	
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306201	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of IGFBP7 mRNA	PMID:30816183
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IGFBP7 mRNA	PMID:25181051
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314684	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in decreased expression of IGFBP7 mRNA	PMID:35479511|PMID:37105096
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306201	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of IGFBP7 mRNA	PMID:32145629
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314684	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of IGFBP7 mRNA	PMID:30951980
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306201	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of IGFBP7 gene	PMID:28505145
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of IGFBP7 mRNA	PMID:25979313
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of IGFBP7 mRNA	PMID:23196670
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314684	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S affects the expression of IGFBP7 mRNA	PMID:30951980
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314684	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of IGFBP7 gene	PMID:31683443
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of IGFBP7 gene	PMID:31601247
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314684	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of IGFBP7 mRNA	PMID:30951980
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20141111	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of IGFBP7 mRNA	PMID:19560483
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314684	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of IGFBP7 intron	PMID:28392331
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314684	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of IGFBP7 mRNA	PMID:37019170
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314684	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of IGFBP7 protein	PMID:35362542
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of IGFBP7 protein]	PMID:35362542
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34680	dipentyl phthalate	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20120814	CTD	MESH:C034171	di-n-pentyl phthalate results in decreased expression of IGFBP7 mRNA	PMID:19560483
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20120814	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of IGFBP7 mRNA	PMID:19560483
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1306201	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of IGFBP7 mRNA	PMID:19638242
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D010269	Paraquat results in decreased expression of IGFBP7 mRNA	PMID:35182771
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in increased expression of IGFBP7 protein	PMID:34064677
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306201	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of IGFBP7 mRNA	PMID:25380136
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of IGFBP7 mRNA	PMID:12634122
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20210209	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IGFBP7 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IGFBP7 mRNA	PMID:33259630|PMID:37236586
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306201	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of IGFBP7 mRNA	PMID:27387713
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1306201	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of IGFBP7 mRNA	PMID:30047161
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of IGFBP7 mRNA	PMID:19320972
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:35696	cobalt dichloride	decreases secretion	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased secretion of IGFBP7 protein	PMID:22079246
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of IGFBP7 mRNA	PMID:16979875
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of IGFBP7 mRNA	PMID:31533062
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of IGFBP7 mRNA	PMID:26352163|PMID:28476498
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of IGFBP7 mRNA	PMID:40419075
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of IGFBP7 mRNA	PMID:36331819
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:3962	curcumin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in increased expression of IGFBP7 mRNA	PMID:21594647
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314684	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of IGFBP7 mRNA	PMID:17963808
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of IGFBP7 mRNA	PMID:29154799
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of IGFBP7 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA	PMID:27188386
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306201	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of IGFBP7 mRNA	PMID:30047161|PMID:41580965
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of IGFBP7 mRNA	PMID:25562108|PMID:27989131
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of IGFBP7 mRNA	PMID:20106945|PMID:21632981|PMID:25562108
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1314684	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of IGFBP7 mRNA	PMID:25123088
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1306201	E	RGD:6480464	20121113	CTD	MESH:D013629	[bexarotene co-treated with Tamoxifen] results in decreased expression of IGFBP7 mRNA	PMID:17630414
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314684	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of IGFBP7 mRNA	PMID:28973697
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of IGFBP7 mRNA	PMID:37992649
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	IGFBP7 protein affects the susceptibility to Methotrexate	PMID:16217747
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of IGFBP7 mRNA	PMID:24136188
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of IGFBP7 mRNA	PMID:24935251|PMID:26272509
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA	PMID:27188386
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314684	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IGFBP7 mRNA	PMID:17562736
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of IGFBP7 mRNA	PMID:29067470|PMID:38614205
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306201	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of IGFBP7 mRNA	PMID:33387578
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:4659	disulfiram	increases expression	EXP		E	RGD:401960877|PMID:24690739	20240201	RGD	MESH:D004221	[Disulfiram cotreated with copper(+2)] increases expression of IGFBP7 mRNA in malignant pleural mesothelioma cells	
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in increased expression of IGFBP7 mRNA; [Disulfiram binds to Copper] which results in increased expression of IGFBP7 protein	PMID:24690739
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of IGFBP7 protein	PMID:29553831
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of IGFBP7 mRNA	PMID:32525701
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of IGFBP7 mRNA	PMID:40504410
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1306201	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in increased expression of IGFBP7 mRNA	PMID:37077353
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of IGFBP7 mRNA	PMID:29391264
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:48242	dichromium trioxide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C023600	[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of IGFBP7 mRNA	PMID:12634122
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of IGFBP7 mRNA	PMID:18175754
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306201	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of IGFBP7 mRNA	PMID:17108234
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:4911	etoposide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	IGFBP7 protein affects the susceptibility to Etoposide	PMID:16217747
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1314684	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of IGFBP7 protein]	PMID:35362542
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of IGFBP7 mRNA	PMID:26272509
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA	PMID:27188386
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of IGFBP7 mRNA	PMID:15725085|PMID:29266867
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [Dasatinib results in increased expression of IGFBP7 mRNA]	PMID:29266867
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the methylation of IGFBP7 exon	PMID:17334979
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of IGFBP7 mRNA; Decitabine results in increased expression of IGFBP7 protein	PMID:16367923|PMID:18981723
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of IGFBP7 mRNA]	PMID:21095227
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306201	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of IGFBP7 mRNA	PMID:30047161
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:50729	mitoxantrone	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	IGFBP7 protein affects the susceptibility to Mitoxantrone	PMID:16217747
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:50859	bexarotene	multiple interactions	ISO	RGD:1306201	E	RGD:6480464	20170303	CTD	MESH:C095105	[bexarotene co-treated with Tamoxifen] results in decreased expression of IGFBP7 mRNA	PMID:17630414
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:53050	trimellitic anhydride	increases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C015559	trimellitic anhydride results in increased expression of IGFBP7 mRNA	PMID:40645554
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of IGFBP7 protein	PMID:32959892
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:62878	XAV939	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C544261	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGFBP7 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGFBP7 mRNA	PMID:34480604
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	IGFBP7 protein affects the susceptibility to Topotecan	PMID:16217747
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1306201	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of IGFBP7 mRNA	PMID:25729387
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306201	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of IGFBP7 mRNA	PMID:25729387
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1314684	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of IGFBP7 protein	PMID:35926579
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of IGFBP7 mRNA	PMID:31758290
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314684	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IGFBP7 mRNA	PMID:22206623
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of IGFBP7 mRNA	PMID:34480604
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of IGFBP7 mRNA	PMID:24136188
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of IGFBP7 mRNA	PMID:22714537
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:75261	arotinoid acid	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C038864	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IGFBP7 mRNA	PMID:34480604
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:755208	eprenetapopt	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt results in increased expression of IGFBP7 mRNA	PMID:19946333
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt results in increased expression of IGFBP7 mRNA]	PMID:19946333
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of IGFBP7 protein	PMID:31285264
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of IGFBP7 mRNA	PMID:32858204
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA	PMID:27188386
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:80025	Salinomycin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of IGFBP7 mRNA	PMID:19682730
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1314684	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of IGFBP7 mRNA	PMID:18958704
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of IGFBP7 mRNA	PMID:24834073
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of IGFBP7 mRNA	PMID:32525701
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of IGFBP7 mRNA	PMID:24780913
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306201	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of IGFBP7 mRNA	PMID:25825206
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of IGFBP7 mRNA	PMID:26272509
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA	PMID:27188386
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:90124	dibromoacetic acid	decreases expression	ISO	RGD:1306201	E	RGD:6480464	20151103	CTD	MESH:C088674	dibromoacetic acid results in decreased expression of IGFBP7 mRNA	PMID:21046364
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:91091	CHIR 99021	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C473711	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of IGFBP7 mRNA; [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGFBP7 mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of IGFBP7 mRNA	PMID:34480604
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of IGFBP7 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IGFBP7 mRNA	PMID:27188386|PMID:34480604
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314684	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of IGFBP7 mRNA	PMID:27131904
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306201	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of IGFBP7 mRNA	PMID:19281266
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1314684	E	RGD:6480464	20190910	CTD	MESH:D013311	Streptozocin results in increased expression of IGFBP7 mRNA	PMID:29673160
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of IGFBP7 mRNA	PMID:38568856
1314683	IGFBP7	insulin like growth factor binding protein 7	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306201	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of IGFBP7 mRNA	PMID:19015723
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1314686	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFAF1 mRNA	PMID:18313992
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314686	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of NDUFAF1 mRNA	PMID:33045310
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NDUFAF1 mRNA	PMID:24236059
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of NDUFAF1 mRNA	PMID:22378314
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of NDUFAF1 mRNA	PMID:20044591
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314686	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NDUFAF1 mRNA	PMID:39241906
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NDUFAF1 mRNA	PMID:37042841
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of NDUFAF1 mRNA	PMID:38685446
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306202	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NDUFAF1 mRNA	PMID:33387578
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306202	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of NDUFAF1 protein	PMID:34915118
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314686	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NDUFAF1 mRNA	PMID:37236586
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NDUFAF1 mRNA	PMID:19549813
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306202	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of NDUFAF1 mRNA	PMID:21396975
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314686	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NDUFAF1 mRNA	PMID:31919559
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314686	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NDUFAF1 mRNA	PMID:22206623
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of NDUFAF1 mRNA	PMID:23195993
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314686	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NDUFAF1 mRNA	PMID:20702594|PMID:21570461
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFAF1 mRNA	PMID:23152189
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306202	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFAF1 mRNA	PMID:33387578
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314686	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFAF1 mRNA	PMID:21354282
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314686	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NDUFAF1 mRNA	PMID:20399798
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1314686	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of NDUFAF1 mRNA	PMID:17702527
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NDUFAF1 mRNA	PMID:30851411
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:28748	doxorubicin	affects expression	ISO	RGD:1314686	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin affects the expression of NDUFAF1 mRNA	PMID:26873546
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1314686	E	RGD:6480464	20160607	CTD	MESH:D004317	[Doxorubicin co-treated with Dexrazoxane] results in decreased expression of NDUFAF1 mRNA	PMID:26873546
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of NDUFAF1 mRNA	PMID:29319823
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314686	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of NDUFAF1 mRNA	PMID:16014739
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NDUFAF1 mRNA	PMID:22378314
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NDUFAF1 promoter	PMID:27901495
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314686	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NDUFAF1 mRNA	PMID:22228805
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of NDUFAF1 mRNA	PMID:22521957
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306202	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of NDUFAF1 mRNA	PMID:30047161
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314686	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of NDUFAF1 mRNA	PMID:18648102
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of NDUFAF1 mRNA	PMID:30690063
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306202	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFAF1 mRNA	PMID:34947998
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314686	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NDUFAF1 mRNA	PMID:39298647
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314686	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NDUFAF1 mRNA	PMID:37019170
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314686	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NDUFAF1 mRNA	PMID:21266533
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314686	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in increased expression of NDUFAF1 mRNA; Paraquat results in increased expression of NDUFAF1 protein	PMID:21371552|PMID:39748354
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NDUFAF1 mRNA	PMID:38568856
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306202	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NDUFAF1 mRNA	PMID:33453195
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314686	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NDUFAF1 mRNA	PMID:37236586
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NDUFAF1 mRNA	PMID:31533062
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306202	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of NDUFAF1 mRNA	PMID:30047161
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of NDUFAF1 mRNA	PMID:21678067
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NDUFAF1 mRNA; Okadaic Acid results in increased expression of NDUFAF1 protein	PMID:38832940
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314686	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NDUFAF1 mRNA	PMID:17562736
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306202	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NDUFAF1 mRNA	PMID:33387578
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of NDUFAF1 mRNA	PMID:25704631
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D005472	Fluorouracil results in increased expression of NDUFAF1 mRNA	PMID:34151400
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NDUFAF1 mRNA	PMID:22079256
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of NDUFAF1 mRNA	PMID:22521957
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:50223	(+)-dexrazoxane	multiple interactions	ISO	RGD:1314686	E	RGD:6480464	20170303	CTD	MESH:D064730	[Doxorubicin co-treated with Dexrazoxane] results in decreased expression of NDUFAF1 mRNA	PMID:26873546
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:50292	cadmium sulfate	decreases expression	ISO	RGD:1314686	E	RGD:6480464	20120717	CTD	MESH:C037123	cadmium sulfate results in decreased expression of NDUFAF1 mRNA	PMID:19274763
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306202	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of NDUFAF1 mRNA	PMID:23962444
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306202	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of NDUFAF1 mRNA	PMID:30047161
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1314686	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of NDUFAF1 mRNA	PMID:40234311
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1314686	E	RGD:6480464	20120814	CTD	MESH:D005485	Flutamide results in decreased expression of NDUFAF1 mRNA	PMID:19442681
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20131220	CTD	MESH:D015474	Isotretinoin results in decreased expression of CIA30 mRNA	PMID:20436886
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1314686	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in increased expression of NDUFAF1 mRNA	PMID:18313992
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314686	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NDUFAF1 mRNA	PMID:22206623
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314686	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NDUFAF1 mRNA	PMID:22206623
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of NDUFAF1 mRNA	PMID:22079256|PMID:22714537
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NDUFAF1 mRNA	PMID:22079256
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NDUFAF1 mRNA	PMID:30851411
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1314686	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of NDUFAF1 mRNA	PMID:22538082
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1314686	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of NDUFAF1 mRNA	PMID:20702594
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1306202	E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of NDUFAF1 mRNA	PMID:31826744
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1306202	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of NDUFAF1 mRNA	PMID:30047161
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306202	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of NDUFAF1 mRNA	PMID:30047161
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1306202	E	RGD:6480464	20181113	CTD	MESH:D013605	T-2 Toxin results in increased expression of NDUFAF1 mRNA	PMID:29870751|PMID:36863559
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:9381	T-2 toxin	multiple interactions	ISO	RGD:1306202	E	RGD:6480464	20230801	CTD	MESH:D013605	GABPA promotes the reaction [T-2 Toxin results in increased expression of NDUFAF1 mRNA]; T-2 Toxin promotes the reaction [GABPA protein binds to NDUFAF1]	PMID:36863559
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of NDUFAF1 mRNA	PMID:29301935
1314685	NDUFAF1	NADH:ubiquinone oxidoreductase complex assembly factor 1	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of NDUFAF1 mRNA	PMID:22378314
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SERPINB1 mRNA	PMID:38218311
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306203	E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in decreased expression of SERPINB1A mRNA	PMID:24172598
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SERPINB1A mRNA	PMID:20188158
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of SERPINB1 mRNA	PMID:14976132
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:15367	all-trans-retinoic acid	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin affects the localization of SERPINB1 protein	PMID:16569592
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of SERPINB1 mRNA	PMID:15498508|PMID:15894607|PMID:16249480|PMID:17218384|PMID:21934132|PMID:23830798|PMID:33167477
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	[Tretinoin co-treated with arsenic trioxide] results in increased expression of SERPINB1 mRNA	PMID:15894607
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SERPINB1A mRNA	PMID:36189433
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SERPINB1A mRNA	PMID:36331819
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1306203	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of SERPINB1A mRNA	PMID:36841081
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:16170	mercury(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of SERPINB1 mRNA	PMID:17547211
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314688	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of SERPINB1A mRNA	PMID:30319688
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314688	E	RGD:6480464	20120515	CTD	MESH:D000431	Ethanol results in increased expression of SERPINB1A mRNA	PMID:21955143
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SERPINB1 mRNA	PMID:20044591
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SERPINB1 mRNA	PMID:21632981
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D011794	Quercetin results in increased expression of SERPINB1 protein	PMID:14750173
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of SERPINB1 mRNA	PMID:23019147|PMID:25321415
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of SERPINB1 mRNA	PMID:22217510
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:16548	chlordecone	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in decreased expression of SERPINB1A mRNA	PMID:33711761
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of SERPINB1 mRNA; Trichloroethylene results in increased expression of SERPINB1 protein	PMID:19109764
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SERPINB1 mRNA	PMID:37042841
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of SERPINB1 mRNA	PMID:27664576
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:16990	bilirubin IXalpha	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin results in decreased expression of SERPINB1A mRNA	PMID:20196124
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1314688	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of SERPINB1A mRNA	PMID:22238285
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1306203	E	RGD:6480464	20240305	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SERPINB1A mRNA	PMID:38113427
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SERPINB1A mRNA	PMID:36189433
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17303	morphine	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20120515	CTD	MESH:D009020	Morphine results in decreased expression of SERPINB1A mRNA	PMID:21955143
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of SERPINB1A mRNA	PMID:20403060|PMID:20844152
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314688	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of SERPINB1A mRNA	PMID:33848595
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306203	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of SERPINB1A mRNA]	PMID:20032058
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of SERPINB1A mRNA]	PMID:33848595
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17362	quinoline	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C037219	quinoline analog results in increased expression of SERPINB1 protein	PMID:18645022
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17650	cortisol	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D006854	Hydrocortisone results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form	PMID:25447644
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17650	cortisol	multiple interactions	ISO	RGD:1306203	E	RGD:6480464	20150310	CTD	MESH:D006854	Hydrocortisone results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1A protein modified form	PMID:25447644
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1314688	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SERPINB1A mRNA	PMID:21955143
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SERPINB1A mRNA	PMID:39150890
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of SERPINB1 mRNA	PMID:15951637|PMID:16002434|PMID:16847355|PMID:26485663
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Ketoconazole promotes the reaction [Calcitriol results in increased expression of SERPINB1 mRNA]	PMID:26485663
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306203	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of SERPINB1A mRNA	PMID:22061828|PMID:33387578
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306203	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SERPINB1A protein	PMID:22061828
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SERPINB1A mRNA	PMID:36331819
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SERPINB1 mRNA	PMID:39836092
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1314688	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SERPINB1A mRNA	PMID:21955143
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in decreased expression of SERPINB1 mRNA	PMID:17547211
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1306203	E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in increased expression of SERPINB1A mRNA	PMID:17327700
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306203	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SERPINB1A mRNA	PMID:39012411
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306203	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of SERPINB1A mRNA	PMID:21396975
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306203	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SERPINB1A mRNA	PMID:23630614|PMID:25378103|PMID:33354967
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:25195	mercury atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of SERPINB1 mRNA	PMID:17547211
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SERPINB1 mRNA	PMID:41430723
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1314688	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of SERPINB1A mRNA	PMID:24535564
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SERPINB1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of SERPINB1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SERPINB1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SERPINB1 protein	PMID:38598786
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1314688	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of SERPINB1A mRNA	PMID:31939706
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SERPINB1A mRNA	PMID:25629700
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SERPINB1A mRNA	PMID:22206623
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SERPINB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SERPINB1 mRNA	PMID:39836092
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20231031	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of SERPINB1A protein	PMID:37527016
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:2761	dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000966	Antimony Potassium Tartrate results in decreased expression of SERPINB1 mRNA	PMID:17547211
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of SERPINB1 protein	PMID:38460933
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of SERPINB1 mRNA	PMID:26272509
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA	PMID:27188386
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SERPINB1 protein	PMID:35688186
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306203	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SERPINB1A mRNA	PMID:31881176
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1306203	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of SERPINB1A mRNA	PMID:25905778
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314688	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of SERPINB1A mRNA	PMID:40618947
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28073	chromium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002857	Chromium results in decreased expression of SERPINB1 mRNA	PMID:17547211
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28077	rifampicin	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D012293	[Rifampin co-treated with NR1I2 protein] results in increased expression of SERPINB1 mRNA	PMID:21127053
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SERPINB1 mRNA	PMID:24768652|PMID:25583101
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314688	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SERPINB1A mRNA	PMID:21570461|PMID:26377647
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306203	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SERPINB1A mRNA	PMID:34747641
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SERPINB1A mRNA	PMID:15034205|PMID:19933214|PMID:26290441
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SERPINB1A mRNA	PMID:17942748
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SERPINB1 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SERPINB1 mRNA; aristolochic acid I results in increased expression of SERPINB1 protein	PMID:33212167
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of SERPINB1 mRNA	PMID:26272509
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA	PMID:27188386
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306203	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SERPINB1A mRNA	PMID:28959563
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1306203	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SERPINB1A mRNA	PMID:30556269
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1306203	E	RGD:6480464	20181113	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of SERPINB1A protein	PMID:29653260
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of SERPINB1 mRNA	PMID:29803840
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of SERPINB1 mRNA	PMID:20044591
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SERPINB1 mRNA	PMID:29432896
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of SERPINB1 mRNA; sodium arsenite results in decreased expression of SERPINB1 protein	PMID:12727804|PMID:29207610
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SERPINB1A mRNA	PMID:37682722|PMID:39095385
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of SERPINB1 mRNA	PMID:39719251
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SERPINB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SERPINB1 mRNA	PMID:39836092
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20231031	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of SERPINB1A protein	PMID:37527016
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SERPINB1 mRNA	PMID:26238291
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SERPINB1A mRNA	PMID:15034205|PMID:22228805
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SERPINB1 mRNA	PMID:22316170
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314688	E	RGD:6480464	20240604	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SERPINB1A mRNA	PMID:38641015
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SERPINB1 promoter	PMID:27901495
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20120918	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINB1A mRNA; AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SERPINB1A mRNA]	PMID:22228805|PMID:27858113
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1306203	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of SERPINB1A mRNA	PMID:30556269
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:30304	antimony(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000965	Antimony results in decreased expression of SERPINB1 mRNA	PMID:17547211
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SERPINB1A mRNA	PMID:27131904
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SERPINB1 mRNA	PMID:25895662
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1306203	E	RGD:6480464	20210706	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SERPINB1A mRNA	PMID:32721576
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SERPINB1 mRNA	PMID:19150397
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SERPINB1 mRNA	PMID:39716349
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SERPINB1 mRNA	PMID:15761015|PMID:20458559|PMID:22521957
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SERPINB1 mRNA	PMID:15894607
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306203	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SERPINB1A mRNA	PMID:25729387
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of SERPINB1 mRNA	PMID:15498508
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306203	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SERPINB1A mRNA	PMID:34492290
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1306203	E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of SERPINB1A mRNA	PMID:28943392
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314688	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SERPINB1A mRNA	PMID:20813756|PMID:23811191
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306203	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SERPINB1 mRNA	PMID:25181051
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306203	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of SERPINB1A mRNA	PMID:32145629
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of SERPINB1A mRNA; bisphenol A results in decreased expression of SERPINB1A protein	PMID:30951980|PMID:34585602|PMID:35999755
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	SERPINB1 mRNA affects the susceptibility to Carmustine	PMID:16365179
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of SERPINB1A mRNA	PMID:30951980|PMID:39298647
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314688	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of SERPINB1A mRNA	PMID:26377693
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINB1A mRNA	PMID:27858113
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of SERPINB1A mRNA	PMID:30951980
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SERPINB1A mRNA	PMID:39150890
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20230207	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of SERPINB1A protein	PMID:35999755
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SERPINB1A mRNA	PMID:21266533
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SERPINB1A mRNA	PMID:39150890
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SERPINB1A mRNA	PMID:39150890
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of SERPINB1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SERPINB1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of SERPINB1 protein	PMID:38598786
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1306203	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of SERPINB1A mRNA	PMID:19638242
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306203	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SERPINB1A mRNA; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of SERPINB1A mRNA	PMID:18164116|PMID:28943392
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C022838	nickel chloride results in decreased expression of SERPINB1 mRNA	PMID:17547211
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20210209	CTD	MESH:D010269	Paraquat results in decreased expression of SERPINB1A mRNA	PMID:21463325
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SERPINB1 mRNA	PMID:37042841
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SERPINB1 mRNA	PMID:39836092
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1314688	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of SERPINB1A mRNA	PMID:26377693
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SERPINB1 mRNA	PMID:17547211
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306203	E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SERPINB1A mRNA	PMID:17327700
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306203	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SERPINB1A mRNA	PMID:39012411
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SERPINB1A mRNA	PMID:39150890
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1306203	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SERPINB1A mRNA	PMID:28511854
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20210309	CTD	MESH:C023036	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of SERPINB1 mRNA	PMID:33325755
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in decreased expression of SERPINB1A mRNA	PMID:24183702
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306203	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of SERPINB1A mRNA	PMID:27387713
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20161025	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SERPINB1A mRNA	PMID:27413110
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of SERPINB1 mRNA	PMID:17547211
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SERPINB1 mRNA	PMID:24449571
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SERPINB1 mRNA	PMID:28302478
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SERPINB1 mRNA	PMID:31533062
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of SERPINB1 mRNA	PMID:19167446
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1314688	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of SERPINB1A mRNA	PMID:39529242
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SERPINB1A mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SERPINB1A mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SERPINB1A mRNA	PMID:36331819
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SERPINB1 mRNA	PMID:25979313
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of SERPINB1 mRNA	PMID:26272509
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of SERPINB1A mRNA	PMID:24896083
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1306203	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in increased expression of SERPINB1A mRNA	PMID:29427782
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314688	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of SERPINB1A mRNA	PMID:24535564
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA	PMID:27188386
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306203	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of SERPINB1A mRNA	PMID:41580965
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SERPINB1 mRNA	PMID:25562108
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314688	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SERPINB1A mRNA	PMID:20937368
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1306203	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in decreased expression of SERPINB1A mRNA	PMID:20032058
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D003907	Dexamethasone results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form	PMID:25447644
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1306203	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1A protein modified form; Testosterone inhibits the reaction [Dexamethasone results in decreased expression of SERPINB1A mRNA]	PMID:20032058|PMID:25447644
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:42491	flavone	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C043562	flavone results in increased expression of SERPINB1 protein	PMID:14750173
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of SERPINB1 mRNA	PMID:21678067
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314688	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SERPINB1A mRNA	PMID:17562736
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306203	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SERPINB1A mRNA	PMID:33387578
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of SERPINB1 mRNA	PMID:29432896
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of SERPINB1 protein	PMID:38460933
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SERPINB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SERPINB1 mRNA	PMID:39836092
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20231031	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased secretion of SERPINB1A protein	PMID:37527016
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:47519	ketoconazole	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D007654	Ketoconazole promotes the reaction [Calcitriol results in increased expression of SERPINB1 mRNA]	PMID:26485663
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SERPINB1 mRNA	PMID:22079256
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314688	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SERPINB1A mRNA	PMID:35436446
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1306203	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of SERPINB1A mRNA	PMID:29097150
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314688	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SERPINB1A mRNA	PMID:17942748
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SERPINB1A mRNA	PMID:17942748
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of SERPINB1 mRNA	PMID:26272509
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA	PMID:27188386
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SERPINB1 mRNA	PMID:39716349
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SERPINB1 mRNA	PMID:15761015|PMID:20458559|PMID:22521957
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Tretinoin co-treated with Arsenic Trioxide] results in increased expression of SERPINB1 mRNA	PMID:15894607
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SERPINB1A mRNA; Nanotubes, Carbon results in decreased expression of SERPINB1A mRNA	PMID:25554681|PMID:25620056
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314688	E	RGD:6480464	20220607	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SERPINB1A protein	PMID:34864091
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:50819	ferric oxide	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20150127	CTD	MESH:C000499	ferric oxide analog results in decreased expression of SERPINB1A mRNA	PMID:24525745
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SERPINB1A mRNA	PMID:35964746
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINB1A mRNA	PMID:27858113
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SERPINB1A mRNA	PMID:27858113
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of SERPINB1 mRNA	PMID:17547211
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of SERPINB1 protein	PMID:23718831
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314688	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SERPINB1A mRNA	PMID:38701926
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SERPINB1 protein	PMID:32959892
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of SERPINB1 mRNA	PMID:27188386
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1306203	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of SERPINB1A mRNA	PMID:20080153
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of SERPINB1 mRNA	PMID:39836092
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:63618	pravastatin	decreases expression	ISO	RGD:1306203	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of SERPINB1A mRNA	PMID:27225895
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:63618	pravastatin	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of SERPINB1A mRNA	PMID:27225895
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	SERPINB1 protein affects the susceptibility to Topotecan	PMID:16217747
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306203	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SERPINB1A mRNA	PMID:25729387
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of SERPINB1 mRNA	PMID:15336504
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of SERPINB1 mRNA	PMID:17547211
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:68637	dexamethasone phosphate	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:C004180	dexamethasone 21-phosphate results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form	PMID:25447644
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:68637	dexamethasone phosphate	multiple interactions	ISO	RGD:1306203	E	RGD:6480464	20150310	CTD	MESH:C004180	dexamethasone 21-phosphate results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1A protein modified form	PMID:25447644
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:71418	triamcinolone acetonide	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D014222	Triamcinolone Acetonide results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form	PMID:25447644
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:71418	triamcinolone acetonide	multiple interactions	ISO	RGD:1306203	E	RGD:6480464	20150310	CTD	MESH:D014222	Triamcinolone Acetonide results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1A protein modified form	PMID:25447644
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	SERPINB1 mRNA affects the susceptibility to temozolomide	PMID:16365179
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SERPINB1A mRNA	PMID:22206623
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SERPINB1A mRNA	PMID:22206623
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SERPINB1 mRNA	PMID:22079256
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SERPINB1 mRNA	PMID:22079256
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1306203	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of SERPINB1A mRNA	PMID:33484710
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:76400	5-(N,N-hexamethylene)amiloride	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:C057360	5-(N,N-hexamethylene)amiloride results in increased cleavage of and results in increased activity of and affects the localization of SERPINB1 protein modified form	PMID:25447644
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:76989	phytoestrogen	multiple interactions	EXP		E	RGD:6480464	20210309	CTD	MESH:D048789	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of SERPINB1 mRNA	PMID:33325755
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1306203	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SERPINB1A mRNA	PMID:18164116
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA	PMID:27188386
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of SERPINB1A mRNA	PMID:39150890
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314688	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of SERPINB1A mRNA	PMID:23091169
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314688	E	RGD:6480464	20120515	CTD	MESH:D010634	Phenobarbital results in increased expression of SERPINB1A mRNA	PMID:19270015|PMID:19482888|PMID:20403969
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314688	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SERPINB1A mRNA	PMID:38648751
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314688	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SERPINB1 mRNA	PMID:30294300
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of SERPINB1A mRNA	PMID:21795629
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314688	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SERPINB1A mRNA	PMID:39847705
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:8489	propiconazole	multiple interactions	ISO	RGD:1314688	E	RGD:6480464	20250902	CTD	MESH:C045950	[propiconazole affects the susceptibility to Dietary Fats] which affects the expression of SERPINB1A mRNA	PMID:39718591
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SERPINB1 mRNA	PMID:27188386
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314688	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SERPINB1A mRNA	PMID:27131904
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306203	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SERPINB1A mRNA	PMID:19281266
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:9352	sulindac	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in increased expression of SERPINB1 mRNA	PMID:11507085
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of SERPINB1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SERPINB1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of SERPINB1 protein	PMID:38598786
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1314688	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of SERPINB1 mRNA	PMID:28973697
1314687	SERPINB1	serpin family B member 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306203	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of SERPINB1A mRNA	PMID:19015723
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314690	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PDE6D mRNA	PMID:30319688
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PDE6D mRNA	PMID:20044591
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of PDE6D mRNA	PMID:23019147
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306204	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PDE6D mRNA	PMID:33387578
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PDE6D mRNA	PMID:21179406
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314690	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PDE6D mRNA	PMID:34319233
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PDE6D mRNA	PMID:19549813
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of PDE6D mRNA	PMID:23649840
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PDE6D intron	PMID:30157460
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of PDE6D mRNA	PMID:23649840
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314690	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PDE6D mRNA	PMID:22206623
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PDE6D gene	PMID:25304211
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PDE6D mRNA	PMID:27392435
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314690	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PDE6D mRNA	PMID:21570461
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306204	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PDE6D mRNA	PMID:21215274
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306204	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PDE6D mRNA	PMID:33387578|PMID:34747641
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1306204	E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of PDE6D mRNA]	PMID:21215274
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314690	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PDE6D mRNA	PMID:17942748
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003561	Cytarabine results in decreased expression of PDE6D mRNA	PMID:19194470
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PDE6D mRNA	PMID:29803840
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of PDE6D mRNA	PMID:29319823
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of PDE6D mRNA	PMID:34032870
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314690	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PDE6D mRNA	PMID:22228805
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PDE6D 3' UTR	PMID:27901495
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314690	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PDE6D promoter alternative form	PMID:35295148
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1306204	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of PDE6D mRNA	PMID:34492290
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314690	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PDE6D mRNA	PMID:20059764
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314690	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PDE6D mRNA	PMID:23811191
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314690	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in decreased expression of PDE6D mRNA]	PMID:20059764
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306204	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PDE6D mRNA	PMID:25181051
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306204	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PDE6D mRNA	PMID:36041667
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of PDE6D mRNA	PMID:25979313
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306204	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PDE6D mRNA	PMID:36041667
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306204	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of PDE6D mRNA	PMID:36041667
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314690	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of PDE6D mRNA	PMID:28392331
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306204	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PDE6D mRNA	PMID:21266533
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PDE6D mRNA	PMID:37042841
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PDE6D mRNA	PMID:19376846
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PDE6D mRNA	PMID:40419075
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PDE6D mRNA	PMID:25979313
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PDE6D gene	PMID:29154799
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in increased expression of PDE6D mRNA	PMID:23179753|PMID:25192806
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PDE6D mRNA	PMID:25562108
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314690	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of PDE6D mRNA	PMID:28973697
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PDE6D mRNA	PMID:38832940
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PDE6D gene	PMID:25304211
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314690	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PDE6D mRNA	PMID:17942748
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314690	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PDE6D mRNA	PMID:17942748
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1306204	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of PDE6D mRNA	PMID:19162173
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PDE6D protein	PMID:32959892
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:63633	triptorelin	decreases expression	ISO	RGD:1306204	E	RGD:6480464	20120412	CTD	MESH:D017329	Triptorelin Pamoate results in decreased expression of PDE6D mRNA	PMID:20463352
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314690	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PDE6D mRNA	PMID:22206623
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PDE6D gene]	PMID:28238834
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306204	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of PDE6D mRNA	PMID:19281266
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:9464	testosterone enanthate	increases expression	ISO	RGD:1306204	E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate results in increased expression of PDE6D mRNA	PMID:20463352
1314689	PDE6D	phosphodiesterase 6D	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306204	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of PDE6D mRNA	PMID:22570695
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of FZD7 mRNA	PMID:26272509
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD7 mRNA	PMID:27188386
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FZD7 gene	PMID:20938992
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of FZD7 mRNA	PMID:21934132|PMID:33167477
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of FZD7 mRNA	PMID:23724009
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314692	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of FZD7 mRNA	PMID:36189433
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FZD7 mRNA	PMID:36189433
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FZD7 mRNA	PMID:30529165
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of FZD7 mRNA	PMID:26079696
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314692	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FZD7 mRNA	PMID:30319688
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of FZD7 mRNA	PMID:20044591
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of FZD7 mRNA	PMID:21632981
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314692	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of FZD7 mRNA	PMID:39241906
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of FZD7 mRNA	PMID:30510588
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of FZD7 mRNA	PMID:14699072
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of FZD7 mRNA	PMID:19167446
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314692	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in decreased expression of FZD7 mRNA	PMID:25210133
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314692	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FZD7 mRNA	PMID:39298647
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of FZD7 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of FZD7 mRNA	PMID:20660070|PMID:30165855
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in decreased expression of FZD7 mRNA]	PMID:25210133
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of FZD7 mRNA	PMID:38568856
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:2321905	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FZD7 mRNA	PMID:33387578
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FZD7 gene	PMID:20938992
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of FZD7 mRNA	PMID:27664576
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of FZD7 mRNA	PMID:20660070
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of FZD7 mRNA	PMID:21179406
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FZD7 mRNA	PMID:36189433
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of FZD7 mRNA	PMID:33647349
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:2321905	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FZD7 mRNA	PMID:33387578
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of FZD7 mRNA	PMID:28818685
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FZD7 mRNA	PMID:36331819
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FZD7 mRNA	PMID:29950665
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of FZD7 protein	PMID:20106945
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20210706	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FZD7 promoter	PMID:32607778
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FZD7 mRNA	PMID:28943387|PMID:32607778
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:25710	organophosphorus compound	multiple interactions	ISO	RGD:2321905	E	RGD:6480464	20250401	CTD	MESH:D009943	[Dust results in increased abundance of Organophosphorus Compounds] which results in increased expression of FZD7 mRNA	PMID:39658253
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:2321905	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of FZD7 mRNA	PMID:30779732
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20121113	CTD	MESH:D005492	[Folic Acid co-treated with sodium arsenite] results in decreased methylation of FZD7 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of FZD7 gene	PMID:20938992|PMID:22959928
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FZD7 mRNA	PMID:39836092
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of FZD7 mRNA	PMID:19244175
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FZD7 mRNA]	PMID:11007951
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:27810	resorcinol	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in increased expression of FZD7 mRNA	PMID:22623647
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of FZD7 mRNA	PMID:23557933
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of FZD7 mRNA	PMID:27392435
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314692	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FZD7 mRNA	PMID:18343893|PMID:21570461
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FZD7 mRNA	PMID:11007951
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314692	E	RGD:6480464	20121002	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FZD7 mRNA	PMID:21354282|PMID:33956508
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:2321905	E	RGD:6480464	20121002	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FZD7 mRNA	PMID:21215274|PMID:33387578
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314692	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FZD7 mRNA	PMID:15328365|PMID:16214954|PMID:21889950|PMID:25975270|PMID:26290441
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FZD7 mRNA]	PMID:11007951
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FZD7 mRNA	PMID:25975270
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of FZD7 mRNA	PMID:29955902
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of FZD7 mRNA	PMID:23179753|PMID:26272509
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD7 mRNA	PMID:27188386
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FZD7 mRNA	PMID:33212167
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FZD7 mRNA	PMID:30851411
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of FZD7 mRNA	PMID:30911355
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28854	2,4-D	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in increased expression of FZD7 mRNA	PMID:40294809
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of FZD7 mRNA	PMID:20044591
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of FZD7 mRNA	PMID:38568856
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314692	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of FZD7 mRNA; sodium arsenite results in increased expression of FZD7 protein	PMID:36209798|PMID:38325618
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FZD7 mRNA	PMID:39836092
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20161228	CTD	MESH:C017947	[Folic Acid co-treated with sodium arsenite] results in decreased methylation of FZD7 mRNA	PMID:22959928
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of FZD7 mRNA	PMID:22378314
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FZD7 mRNA	PMID:20106945|PMID:21632981|PMID:32234424
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1314692	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of FZD7 mRNA	PMID:33053406
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of FZD7 mRNA	PMID:30911355
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of FZD7 mRNA	PMID:25895662
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of FZD7 mRNA	PMID:20382639
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of FZD7 mRNA	PMID:19150397
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:2321905	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of FZD7 mRNA	PMID:32479839
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:2321905	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of FZD7 mRNA	PMID:25729387
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314692	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FZD7 gene; titanium dioxide results in decreased methylation of FZD7 promoter	PMID:35295148
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FZD7 mRNA	PMID:29950665
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:2321905	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of FZD7 mRNA	PMID:34492290
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314692	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of FZD7 mRNA	PMID:18445702|PMID:23811191
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314692	E	RGD:6480464	20121002	CTD	MESH:C006253	pirinixic acid results in increased expression of FZD7 mRNA	PMID:18301758
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FZD7 mRNA	PMID:19710929
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:2321905	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FZD7 mRNA	PMID:25181051
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314692	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FZD7 mRNA	PMID:33221593
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:2321905	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FZD7 mRNA	PMID:34947998
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:2321905	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in increased expression of FZD7 mRNA	PMID:29323181
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FZD7 mRNA	PMID:28628672
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of FZD7 mRNA	PMID:24752500|PMID:25979313
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of FZD7 gene	PMID:31601247
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1314692	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of FZD7 mRNA	PMID:31558096
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314692	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FZD7 mRNA	PMID:37019170
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:2321905	E	RGD:6480464	20121002	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FZD7 mRNA	PMID:18502319
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FZD7 mRNA	PMID:29950665
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:2321905	E	RGD:6480464	20121002	CTD	MESH:D003976	Diazinon affects the expression of FZD7 mRNA	PMID:19130878
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:2321905	E	RGD:6480464	20121002	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of FZD7 mRNA	PMID:21266533
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:2321905	E	RGD:6480464	20121002	CTD	MESH:D004026	Dieldrin affects the expression of FZD7 mRNA	PMID:19130878
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FZD7 mRNA	PMID:28628672
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:2321905	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FZD7 mRNA	PMID:35163327
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:2321905	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of FZD7 mRNA	PMID:30723492
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1314692	E	RGD:6480464	20121002	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FZD7 mRNA; Cadmium Chloride results in increased expression of FZD7 protein	PMID:20478370
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1314692	E	RGD:6480464	20121002	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of FZD7 mRNA	PMID:19429403
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:2321905	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of FZD7 mRNA	PMID:35163327
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of FZD7 mRNA	PMID:19244175
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FZD7 mRNA	PMID:31533062
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1314692	E	RGD:6480464	20121002	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of FZD7 mRNA	PMID:19429403
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FZD7 mRNA	PMID:36331819
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1314692	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in decreased expression of FZD7 mRNA	PMID:31558096
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of FZD7 mRNA	PMID:20106945
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314692	E	RGD:6480464	20121002	CTD	MESH:D013629	Tamoxifen affects the expression of FZD7 mRNA	PMID:17555576
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1314692	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of FZD7 mRNA	PMID:25123088
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FZD7 mRNA	PMID:28628672
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of FZD7 mRNA	PMID:38832940
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of FZD7 mRNA	PMID:24935251
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of FZD7 mRNA	PMID:29067470
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:2321905	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FZD7 mRNA	PMID:33387578
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FZD7 mRNA	PMID:39836092
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of FZD7 mRNA	PMID:24752500
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of FZD7 mRNA	PMID:31838189
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:2321905	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of FZD7 mRNA	PMID:29391264
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314692	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of FZD7 mRNA	PMID:35436446
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314692	E	RGD:6480464	20121002	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FZD7 mRNA	PMID:17555576
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1314692	E	RGD:6480464	20121002	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of FZD7 mRNA	PMID:17942748
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in decreased expression of FZD7 mRNA	PMID:16984733
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FZD7 mRNA	PMID:28628672
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in decreased expression of FZD7 mRNA	PMID:19363521
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1314692	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of FZD7 mRNA	PMID:27915011
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	TP53 protein affects the reaction [Decitabine results in decreased expression of FZD7 mRNA]	PMID:19363521
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314692	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FZD7 mRNA; Nanotubes, Carbon results in decreased expression of FZD7 mRNA	PMID:25554681
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:2321905	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of FZD7 mRNA	PMID:24136188
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314692	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of FZD7 mRNA	PMID:23608068
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of FZD7 mRNA	PMID:26272509
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD7 mRNA	PMID:27188386
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20121002	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FZD7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FZD7 mRNA	PMID:21641980|PMID:26378955
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:2321905	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of FZD7 mRNA	PMID:25729387
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:2321905	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of FZD7 mRNA	PMID:24136188
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:63918	artesunate	increases response to substance	EXP		E	RGD:6480464	20170228	CTD	MESH:C039726	FZD7 mRNA results in increased susceptibility to artesunate	PMID:20144594
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:63959	celastrol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C050414	celastrol results in increased expression of FZD7 mRNA	PMID:39181414
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of FZD7 mRNA	PMID:28988120
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of FZD7 mRNA	PMID:22079614
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in increased expression of FZD7 mRNA	PMID:22101062
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:755208	eprenetapopt	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt results in increased expression of FZD7 mRNA	PMID:19946333
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt results in increased expression of FZD7 mRNA]	PMID:19946333
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of FZD7 mRNA	PMID:30851411
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD7 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD7 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD7 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD7 mRNA	PMID:27188386
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FZD7 gene]	PMID:28238834
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1314692	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of FZD7 mRNA	PMID:18343893
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1314692	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of FZD7 mRNA	PMID:31558096
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1314692	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of FZD7 mRNA	PMID:27029645
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of FZD7 mRNA	PMID:26272509
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD7 mRNA	PMID:27188386
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:87368	diethyl malate	affects expression	ISO	RGD:1314692	E	RGD:6480464	20170303	CTD	MESH:C058705	diethyl malate affects the expression of FZD7 mRNA	PMID:24814887
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of FZD7 mRNA	PMID:31734321
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD7 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD7 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD7 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FZD7 mRNA	PMID:27188386
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of FZD7 mRNA	PMID:22378314
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of FZD7 mRNA	PMID:27188386
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314692	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of FZD7 mRNA	PMID:28973697
1314691	FZD7	frizzled class receptor 7	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1314692	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of FZD7 mRNA	PMID:18930950
1314694	PPHLN1	periphilin 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of PPHLN1 mRNA	PMID:35967413
1314694	PPHLN1	periphilin 1	gene	CHEBI:137392	chlormequat chloride	increases expression	ISO	RGD:1306207	E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of PPHLN1 protein	PMID:34958886
1314694	PPHLN1	periphilin 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1622092	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PPHLN1 mRNA	PMID:20188158
1314694	PPHLN1	periphilin 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PPHLN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PPHLN1 mRNA	PMID:32699268
1314694	PPHLN1	periphilin 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of PPHLN1 mRNA	PMID:24763279
1314694	PPHLN1	periphilin 1	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of PPHLN1 protein	PMID:35688186
1314694	PPHLN1	periphilin 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1622092	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PPHLN1 mRNA	PMID:39241906
1314694	PPHLN1	periphilin 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PPHLN1 mRNA	PMID:37042841
1314694	PPHLN1	periphilin 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PPHLN1 mRNA	PMID:21179406
1314694	PPHLN1	periphilin 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PPHLN1 protein	PMID:37730182
1314694	PPHLN1	periphilin 1	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of PPHLN1 mRNA	PMID:17103032
1314694	PPHLN1	periphilin 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1622092	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPHLN1 mRNA	PMID:37236586
1314694	PPHLN1	periphilin 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PPHLN1 gene; Aflatoxin B1 results in decreased methylation of PPHLN1 polyA tail	PMID:27153756|PMID:30157460
1314694	PPHLN1	periphilin 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PPHLN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PPHLN1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of PPHLN1 mRNA	PMID:32699268
1314694	PPHLN1	periphilin 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PPHLN1 mRNA	PMID:18593933
1314694	PPHLN1	periphilin 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1622092	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PPHLN1 mRNA	PMID:25629700
1314694	PPHLN1	periphilin 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPHLN1 gene	PMID:25304211
1314694	PPHLN1	periphilin 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PPHLN1 protein	PMID:35688186
1314694	PPHLN1	periphilin 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of PPHLN1 mRNA	PMID:23557933
1314694	PPHLN1	periphilin 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PPHLN1 mRNA	PMID:25583101
1314694	PPHLN1	periphilin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622092	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPHLN1 mRNA	PMID:21570461
1314694	PPHLN1	periphilin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPHLN1 mRNA	PMID:23152189
1314694	PPHLN1	periphilin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306207	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PPHLN1 mRNA	PMID:33387578
1314694	PPHLN1	periphilin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1622092	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPHLN1 mRNA	PMID:17942748
1314694	PPHLN1	periphilin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1622092	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPHLN1 mRNA	PMID:17942748
1314694	PPHLN1	periphilin 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PPHLN1 mRNA	PMID:33212167
1314694	PPHLN1	periphilin 1	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of PPHLN1 protein	PMID:35688186
1314694	PPHLN1	periphilin 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PPHLN1 polyA tail	PMID:30157460
1314694	PPHLN1	periphilin 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1622092	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PPHLN1 mRNA	PMID:21569818
1314694	PPHLN1	periphilin 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PPHLN1 3' UTR	PMID:27901495
1314694	PPHLN1	periphilin 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to PPHLN1 mRNA]	PMID:32406909
1314694	PPHLN1	periphilin 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of PPHLN1 mRNA	PMID:18593933
1314694	PPHLN1	periphilin 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PPHLN1 mRNA	PMID:25895662
1314694	PPHLN1	periphilin 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PPHLN1 mRNA	PMID:19150397
1314694	PPHLN1	periphilin 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1622092	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of PPHLN1 mRNA	PMID:18648102
1314694	PPHLN1	periphilin 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1622092	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PPHLN1 mRNA	PMID:23811191
1314694	PPHLN1	periphilin 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PPHLN1 protein	PMID:33376534
1314694	PPHLN1	periphilin 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PPHLN1 gene	PMID:31601247
1314694	PPHLN1	periphilin 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306207	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PPHLN1 mRNA	PMID:25181051|PMID:30816183
1314694	PPHLN1	periphilin 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1622092	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PPHLN1 mRNA	PMID:33221593
1314694	PPHLN1	periphilin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of PPHLN1 gene	PMID:31601247
1314694	PPHLN1	periphilin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1622092	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PPHLN1 mRNA	PMID:39298647
1314694	PPHLN1	periphilin 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of PPHLN1 polyA tail	PMID:30157460
1314694	PPHLN1	periphilin 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1622092	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PPHLN1 mRNA	PMID:37019170
1314694	PPHLN1	periphilin 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPHLN1 mRNA	PMID:37042841
1314694	PPHLN1	periphilin 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1622092	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPHLN1 mRNA	PMID:37236586
1314694	PPHLN1	periphilin 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PPHLN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PPHLN1 mRNA	PMID:32699268
1314694	PPHLN1	periphilin 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of PPHLN1 mRNA	PMID:17010196
1314694	PPHLN1	periphilin 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PPHLN1 mRNA	PMID:28302478
1314694	PPHLN1	periphilin 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1622092	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of PPHLN1 mRNA	PMID:23125180
1314694	PPHLN1	periphilin 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PPHLN1 mRNA	PMID:25979313
1314694	PPHLN1	periphilin 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1622092	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PPHLN1 mRNA	PMID:17292431
1314694	PPHLN1	periphilin 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PPHLN1 mRNA	PMID:23179753
1314694	PPHLN1	periphilin 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306207	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of PPHLN1 mRNA	PMID:38685447|PMID:41580965
1314694	PPHLN1	periphilin 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1622092	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PPHLN1 mRNA	PMID:17555576
1314694	PPHLN1	periphilin 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of PPHLN1 mRNA	PMID:36621641
1314694	PPHLN1	periphilin 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622092	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PPHLN1 mRNA	PMID:17562736
1314694	PPHLN1	periphilin 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPHLN1 gene	PMID:25304211
1314694	PPHLN1	periphilin 1	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of PPHLN1 mRNA	PMID:18175754
1314694	PPHLN1	periphilin 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1622092	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PPHLN1 mRNA	PMID:17555576
1314694	PPHLN1	periphilin 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1622092	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PPHLN1 mRNA	PMID:17942748
1314694	PPHLN1	periphilin 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1622092	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPHLN1 mRNA	PMID:17942748
1314694	PPHLN1	periphilin 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306207	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of PPHLN1 mRNA	PMID:41580965
1314694	PPHLN1	periphilin 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1622092	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PPHLN1 mRNA	PMID:35964746
1314694	PPHLN1	periphilin 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306207	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PPHLN1 mRNA	PMID:24136188
1314694	PPHLN1	periphilin 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PPHLN1 protein	PMID:32959892
1314694	PPHLN1	periphilin 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1622092	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PPHLN1 mRNA	PMID:23650126
1314694	PPHLN1	periphilin 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1306207	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of PPHLN1 mRNA	PMID:30467583
1314694	PPHLN1	periphilin 1	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of PPHLN1 polyA tail	PMID:30157460
1314694	PPHLN1	periphilin 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1622092	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PPHLN1 mRNA	PMID:22206623
1314694	PPHLN1	periphilin 1	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PPHLN1 protein	PMID:31285264
1314694	PPHLN1	periphilin 1	gene	CHEBI:7599	Nivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in increased expression of PPHLN1 protein	PMID:39638853
1314694	PPHLN1	periphilin 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PPHLN1 gene]	PMID:28238834
1314694	PPHLN1	periphilin 1	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of PPHLN1 mRNA	PMID:39904859
1314694	PPHLN1	periphilin 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1622092	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of PPHLN1 mRNA	PMID:21278054
1314694	PPHLN1	periphilin 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306207	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PPHLN1 mRNA	PMID:21346803
1314698	SPIN1	spindlin 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SPIN1 mRNA	PMID:33167477
1314698	SPIN1	spindlin 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SPIN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SPIN1 mRNA	PMID:32699268
1314698	SPIN1	spindlin 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1314699	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of SPIN1 mRNA	PMID:24205000
1314698	SPIN1	spindlin 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SPIN1 mRNA	PMID:36331819
1314698	SPIN1	spindlin 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314699	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SPIN1 mRNA	PMID:30319688
1314698	SPIN1	spindlin 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SPIN1 mRNA	PMID:21179406
1314698	SPIN1	spindlin 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPIN1 mRNA	PMID:25510870
1314698	SPIN1	spindlin 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPIN1 mRNA	PMID:37992649
1314698	SPIN1	spindlin 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPIN1 mRNA	PMID:37992649
1314698	SPIN1	spindlin 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314699	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of SPIN1 mRNA	PMID:23892564
1314698	SPIN1	spindlin 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314699	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SPIN1 mRNA	PMID:34319233
1314698	SPIN1	spindlin 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of SPIN1 intron	PMID:30157460
1314698	SPIN1	spindlin 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SPIN1 mRNA	PMID:36331819
1314698	SPIN1	spindlin 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306210	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of SPIN1 mRNA	PMID:28522335
1314698	SPIN1	spindlin 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPIN1 mRNA	PMID:37236586
1314698	SPIN1	spindlin 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPIN1 mRNA	PMID:25510870
1314698	SPIN1	spindlin 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPIN1 mRNA	PMID:25510870
1314698	SPIN1	spindlin 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SPIN1 mRNA	PMID:19549813
1314698	SPIN1	spindlin 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SPIN1 gene; Aflatoxin B1 results in increased methylation of SPIN1 intron	PMID:27153756|PMID:30157460
1314698	SPIN1	spindlin 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SPIN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SPIN1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of SPIN1 mRNA	PMID:32699268
1314698	SPIN1	spindlin 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314699	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SPIN1 mRNA	PMID:31919559
1314698	SPIN1	spindlin 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314699	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SPIN1 mRNA	PMID:25629700
1314698	SPIN1	spindlin 1	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of SPIN1 mRNA	PMID:16705744
1314698	SPIN1	spindlin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of SPIN1 mRNA	PMID:16214954
1314698	SPIN1	spindlin 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of SPIN1 protein	PMID:39603559
1314698	SPIN1	spindlin 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306210	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of SPIN1 mRNA	PMID:28374803
1314698	SPIN1	spindlin 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SPIN1 mRNA	PMID:33212167
1314698	SPIN1	spindlin 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPIN1 mRNA	PMID:37992649
1314698	SPIN1	spindlin 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SPIN1 intron	PMID:30157460
1314698	SPIN1	spindlin 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SPIN1 3' UTR; Benzo(a)pyrene results in decreased methylation of SPIN1 5' UTR	PMID:27901495
1314698	SPIN1	spindlin 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SPIN1 mRNA	PMID:27858113
1314698	SPIN1	spindlin 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to SPIN1 mRNA]	PMID:32406909
1314698	SPIN1	spindlin 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314699	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SPIN1 mRNA	PMID:27131904
1314698	SPIN1	spindlin 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SPIN1 mRNA	PMID:19150397
1314698	SPIN1	spindlin 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPIN1 gene	PMID:31601247
1314698	SPIN1	spindlin 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306210	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SPIN1 mRNA	PMID:34492290
1314698	SPIN1	spindlin 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306210	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SPIN1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:33296240|PMID:34947998
1314698	SPIN1	spindlin 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SPIN1 gene	PMID:31601247
1314698	SPIN1	spindlin 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPIN1 mRNA	PMID:25510870
1314698	SPIN1	spindlin 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SPIN1 mRNA	PMID:25510870
1314698	SPIN1	spindlin 1	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SPIN1 mRNA	PMID:27858113
1314698	SPIN1	spindlin 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SPIN1 intron	PMID:30157460
1314698	SPIN1	spindlin 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPIN1 mRNA	PMID:28628672
1314698	SPIN1	spindlin 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPIN1 mRNA	PMID:28628672
1314698	SPIN1	spindlin 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1314699	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of SPIN1 mRNA	PMID:34813904
1314698	SPIN1	spindlin 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SPIN1 mRNA	PMID:37042841
1314698	SPIN1	spindlin 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SPIN1 mRNA	PMID:37236586
1314698	SPIN1	spindlin 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SPIN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SPIN1 mRNA	PMID:32699268
1314698	SPIN1	spindlin 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314699	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of SPIN1 mRNA	PMID:17585979
1314698	SPIN1	spindlin 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of SPIN1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SPIN1 mRNA]	PMID:17585979
1314698	SPIN1	spindlin 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of SPIN1 mRNA	PMID:17010196
1314698	SPIN1	spindlin 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SPIN1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SPIN1 mRNA	PMID:36331819
1314698	SPIN1	spindlin 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPIN1 mRNA	PMID:25979313
1314698	SPIN1	spindlin 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314699	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SPIN1 mRNA	PMID:17292431
1314698	SPIN1	spindlin 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314699	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of SPIN1 mRNA	PMID:21427059
1314698	SPIN1	spindlin 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPIN1 mRNA	PMID:28628672
1314698	SPIN1	spindlin 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314699	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SPIN1 mRNA	PMID:28973697
1314698	SPIN1	spindlin 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPIN1 mRNA	PMID:37992649
1314698	SPIN1	spindlin 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SPIN1 mRNA	PMID:27188386
1314698	SPIN1	spindlin 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314699	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SPIN1 mRNA	PMID:17562736
1314698	SPIN1	spindlin 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306210	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SPIN1 mRNA	PMID:33387578
1314698	SPIN1	spindlin 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of SPIN1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SPIN1 mRNA]	PMID:17585979
1314698	SPIN1	spindlin 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of SPIN1 mRNA	PMID:40706910
1314698	SPIN1	spindlin 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306210	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SPIN1 mRNA	PMID:29097150
1314698	SPIN1	spindlin 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SPIN1 mRNA	PMID:28628672
1314698	SPIN1	spindlin 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314699	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SPIN1 mRNA; Nanotubes, Carbon results in increased expression of SPIN1 mRNA	PMID:25554681|PMID:25620056
1314698	SPIN1	spindlin 1	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1314699	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of SPIN1 mRNA	PMID:26377693
1314698	SPIN1	spindlin 1	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SPIN1 mRNA	PMID:27858113
1314698	SPIN1	spindlin 1	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1314699	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of SPIN1 mRNA	PMID:26377693
1314698	SPIN1	spindlin 1	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314699	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SPIN1 mRNA	PMID:27858113
1314698	SPIN1	spindlin 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314699	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SPIN1 mRNA	PMID:23650126
1314698	SPIN1	spindlin 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1306210	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of SPIN1 mRNA	PMID:24136188
1314698	SPIN1	spindlin 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SPIN1 intron	PMID:30157460
1314698	SPIN1	spindlin 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314699	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SPIN1 mRNA	PMID:22206623
1314698	SPIN1	spindlin 1	gene	CHEBI:756894	tak-243	affects sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 affects the sumoylation of SPIN1 protein	PMID:31285264
1314698	SPIN1	spindlin 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of SPIN1 mRNA	PMID:32858204
1314698	SPIN1	spindlin 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314699	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SPIN1 mRNA	PMID:27131904
1314698	SPIN1	spindlin 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SPIN1 mRNA	PMID:38568856
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314701	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TTC7 mRNA	PMID:33045310
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314701	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of TTC7 mRNA]	PMID:19467301
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306211	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of TTC7A gene	PMID:35440735
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TTC7A mRNA	PMID:35811015
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314701	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TTC7 mRNA	PMID:39241906
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TTC7A mRNA	PMID:35811015
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1314701	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of TTC7 mRNA	PMID:23892564
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TTC7A protein	PMID:37730182
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306211	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TTC7A mRNA	PMID:33387578
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of TTC7A intron	PMID:30157460
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TTC7A intron; Aflatoxin B1 results in decreased methylation of TTC7A promoter	PMID:30157460
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TTC7A mRNA	PMID:23649840
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314701	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of TTC7 mRNA	PMID:17484886
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TTC7A mRNA	PMID:21867686
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314701	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TTC7 mRNA	PMID:22206623
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of TTC7A mRNA	PMID:18414638
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of TTC7A mRNA	PMID:19921347
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314701	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TTC7 mRNA	PMID:21570461
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306211	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TTC7 mRNA; Tetrachlorodibenzodioxin results in decreased expression of TTC7A mRNA	PMID:21215274|PMID:33387578
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314701	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TTC7 mRNA	PMID:19933214
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314701	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TTC7 mRNA	PMID:28213091
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314701	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TTC7 gene]	PMID:28213091
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of TTC7A mRNA	PMID:32763439
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TTC7A mRNA	PMID:29803840
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1314701	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite affects the methylation of TTC7 gene	PMID:39894169
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of TTC7A protein	PMID:21925251
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	ISO	RGD:1314701	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TTC7 intron	PMID:27901495
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TTC7A mRNA	PMID:32234424
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314701	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TTC7 exon	PMID:27901495
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314701	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TTC7 mRNA	PMID:27858113
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314701	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TTC7A mRNA	PMID:39716349
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306211	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TTC7A mRNA	PMID:30047161
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314701	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TTC7 mRNA	PMID:29264374
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314701	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TTC7 mRNA	PMID:23557971
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314701	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TTC7 gene	PMID:35295148
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306211	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of TTC7 mRNA; Thioacetamide results in decreased expression of TTC7A mRNA	PMID:23411599|PMID:34492290
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TTC7A mRNA	PMID:19710929
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306211	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TTC7A mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of TTC7A gene	PMID:31601247
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314701	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of TTC7 mRNA	PMID:32156529
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314701	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of TTC7 gene	PMID:31683443
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314701	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TTC7 mRNA	PMID:39298647
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1314701	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of TTC7 mRNA	PMID:26377693
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314701	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TTC7 mRNA	PMID:27858113
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314701	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TTC7 mRNA	PMID:38685157
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314701	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TTC7 intron	PMID:28392331
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314701	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TTC7 mRNA	PMID:37019170
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1306211	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of TTC7A mRNA	PMID:30589522
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1306211	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of TTC7A mRNA	PMID:30047161
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TTC7A mRNA	PMID:31533062
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314701	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TTC7 mRNA	PMID:17963808
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306211	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TTC7A mRNA	PMID:30047161
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:40303	lovastatin	multiple interactions	ISO	RGD:1314701	E	RGD:6480464	20181016	CTD	MESH:D008148	[Dietary Fats co-treated with Lovastatin] affects the expression of FSN mRNA	PMID:29852127
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314701	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TTC7 mRNA	PMID:17562736
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of TTC7A mRNA	PMID:22230336
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306211	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TTC7A mRNA	PMID:33387578
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TTC7A mRNA	PMID:35811015
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of TTC7A mRNA	PMID:18414638
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of TTC7A mRNA	PMID:31838189
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306211	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TTC7A mRNA	PMID:29391264
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314701	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of TTC7 mRNA	PMID:35436446
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314701	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TTC7A mRNA	PMID:39716349
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of TTC7 mRNA]	PMID:21095227
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314701	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of TTC7 mRNA	PMID:25620056
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306211	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of TTC7A mRNA	PMID:34044035
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306211	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TTC7A mRNA	PMID:30047161
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314701	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TTC7 mRNA	PMID:27858113
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314701	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TTC7 mRNA	PMID:27858113
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of TTC7A mRNA	PMID:20977926
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314701	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TTC7 mRNA	PMID:21641980
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306211	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TTC7A gene	PMID:35440735
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314701	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TTC7 mRNA	PMID:22206623
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314701	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of TTC7 mRNA	PMID:22206623
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of TTC7A protein	PMID:31285264
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:80799	Bufotalin	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of TTC7A mRNA	PMID:39904859
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314701	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of TTC7 mRNA	PMID:39847705
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306211	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TTC7A mRNA	PMID:30047161
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of TTC7A mRNA	PMID:34581912
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TTC7A mRNA	PMID:38568856
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1306211	E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of TTC7A mRNA	PMID:24136188
1314700	TTC7A	tetratricopeptide repeat domain 7A	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314701	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of TTC7 mRNA	PMID:35537566
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PAK6 mRNA	PMID:26272509
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA	PMID:27188386
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314704	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PAK6 mRNA	PMID:33045310
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314704	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PAK6 mRNA	PMID:20188158|PMID:26251327
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1314704	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in decreased expression of PAK6 mRNA	PMID:36189433
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D014212	Tretinoin results in increased expression of PAK6 mRNA	PMID:38091671
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314704	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PAK6 mRNA	PMID:36189433
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306213	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of PAK6 gene	PMID:35440735
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of PAK6 mRNA; Estradiol inhibits the reaction [ESR1 protein binds to PAK6 protein]; Estradiol promotes the reaction [ESR1 protein binds to PAK6 protein]	PMID:29389661|PMID:30165855|PMID:32088792
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:165219	PCB138	affects expression	ISO	RGD:1306213	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl affects the expression of PAK6 mRNA	PMID:23829299
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of PAK6 mRNA	PMID:38568856
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PAK6 mRNA	PMID:37042841
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314704	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of PAK6 mRNA	PMID:36189433
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306213	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of PAK6 mRNA	PMID:26496021
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306213	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PAK6 mRNA	PMID:27523638
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306213	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PAK6 mRNA	PMID:26577399
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of PAK6 mRNA	PMID:16002434
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306213	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of PAK6 mRNA	PMID:33387578
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314704	E	RGD:6480464	20260203	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PAK6 mRNA	PMID:40850461
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1306213	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PAK6 mRNA	PMID:22129741
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314704	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PAK6 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of PAK6 mRNA	PMID:34911549
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306213	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PAK6 mRNA	PMID:30779732
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PAK6 mRNA	PMID:26272509
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA	PMID:27188386
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PAK6 mRNA	PMID:23557933
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of PAK6 mRNA	PMID:28903495
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of PAK6 mRNA	PMID:18000554
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314704	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PAK6 mRNA	PMID:21570461
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of PAK6 mRNA	PMID:33212167
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306213	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PAK6 mRNA	PMID:28959563
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306213	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PAK6 mRNA	PMID:26033743
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1306213	E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PAK6 mRNA	PMID:22129741
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PAK6 mRNA	PMID:38568856
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314704	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PAK6 mRNA	PMID:37682722
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PAK6 5' UTR	PMID:27901495
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314704	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PAK6 mRNA	PMID:19770486
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PAK6 exon	PMID:27901495
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PAK6 mRNA	PMID:35870112
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314704	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PAK6 mRNA	PMID:23735875
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1314704	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in increased expression of PAK6 mRNA	PMID:33053406
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306213	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PAK6 mRNA	PMID:26033743
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314704	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PAK6 gene	PMID:35295148
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314704	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PAK6 promoter	PMID:35295148
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306213	E	RGD:6480464	20121009	CTD	MESH:D013853	Thioacetamide results in increased expression of PAK6 mRNA	PMID:22659510
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1314704	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of PAK6 mRNA	PMID:19136022
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314704	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of PAK6 mRNA	PMID:23811191
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:33146	vanadyl sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C034028	vanadyl sulfate results in decreased expression of PAK6 mRNA	PMID:16330358
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306213	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PAK6 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314704	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of PAK6 mRNA	PMID:34585602
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1314704	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PAK6 promoter	PMID:27312807
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to PAK6 protein modified form]	PMID:28751236
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306213	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of PAK6 mRNA	PMID:26496021
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	ISO	RGD:1306213	E	RGD:6480464	20140114	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of PAK6 mRNA	PMID:23829299
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1314704	E	RGD:6480464	20140715	CTD	MESH:D008748	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PAK6 mRNA	PMID:23519560
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314704	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PAK6 gene	PMID:31683443
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:C543008	bisphenol S inhibits the reaction [ESR1 protein binds to PAK6 protein]	PMID:29389661
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PAK6 3' UTR	PMID:30157460
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314704	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PAK6 mRNA	PMID:37019170
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306213	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of PAK6 mRNA	PMID:22129741
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314704	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of PAK6 mRNA	PMID:36117858
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PAK6 mRNA	PMID:37042841
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1314704	E	RGD:6480464	20180828	CTD	MESH:D019256	Cadmium Chloride affects the expression of PAK6 mRNA	PMID:29408670
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PAK6 mRNA	PMID:38568856
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314704	E	RGD:6480464	20260203	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PAK6 mRNA	PMID:40850461
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1314704	E	RGD:6480464	20140715	CTD	MESH:D013755	[Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of PAK6 mRNA	PMID:23519560
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314704	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PAK6 mRNA	PMID:40194260
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PAK6 mRNA	PMID:31533062
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PAK6 mRNA	PMID:25979313
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of PAK6 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PAK6 gene	PMID:29154799
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA	PMID:27188386
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of PAK6 promoter	PMID:27989131
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of PAK6 mRNA	PMID:21678067
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:44616	afimoxifene	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	PAK6 results in decreased susceptibility to afimoxifene	PMID:21233418
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314704	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PAK6 mRNA	PMID:17562736
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306213	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PAK6 mRNA	PMID:33387578
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of PAK6 mRNA	PMID:38568856
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA	PMID:27188386
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314704	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PAK6 mRNA; Nanotubes, Carbon results in increased expression of PAK6 mRNA	PMID:25554681
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:5062	finasteride	decreases expression	ISO	RGD:1306213	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in decreased expression of PAK6 mRNA	PMID:24136188
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314704	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of PAK6 mRNA	PMID:36117858
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314704	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of PAK6 mRNA	PMID:23608068
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1306213	E	RGD:6480464	20230307	CTD	MESH:D008694	Methamphetamine results in decreased expression of PAK6 mRNA	PMID:35863504
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of PAK6 3' UTR	PMID:30157460
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:72754	bisphenol AF	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	[bisphenol AF binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to PAK6 protein modified form]; bisphenol AF inhibits the reaction [ESR1 protein binds to PAK6 protein]	PMID:28751236|PMID:29389661
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of PAK6 mRNA	PMID:29522793
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA	PMID:27188386
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314704	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of PAK6 mRNA	PMID:19136022
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306213	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of PAK6 mRNA	PMID:24780913
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PAK6 mRNA	PMID:27188386
1314703	PAK6	p21 (RAC1) activated kinase 6	gene	CHEBI:9352	sulindac	decreases expression	ISO	RGD:1306213	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of PAK6 mRNA	PMID:24136188
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of TAB1 mRNA	PMID:38218311
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1306216	E	RGD:6480464	20250902	CTD	MESH:D002794	[Methionine co-treated with Betaine co-treated with Choline co-treated with Folic Acid] inhibits the reaction [Carbon Tetrachloride results in increased expression of TAB1 mRNA]	PMID:39736447|PMID:39987517
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314708	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TAB1 mRNA	PMID:39241906
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314708	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TAB1 mRNA	PMID:39298647
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1306216	E	RGD:6480464	20250902	CTD	MESH:D008715	[Methionine co-treated with Betaine co-treated with Choline co-treated with Folic Acid] inhibits the reaction [Carbon Tetrachloride results in increased expression of TAB1 mRNA]	PMID:39736447|PMID:39987517
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TAB1 mRNA	PMID:37042841
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:17688	(S)-nicotine	decreases methylation	ISO	RGD:1306216	E	RGD:6480464	20220705	CTD	MESH:D009538	Nicotine results in decreased methylation of TAB1 gene	PMID:35026373
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:17750	glycine betaine	multiple interactions	ISO	RGD:1306216	E	RGD:6480464	20240430	CTD	MESH:D001622	[Methionine co-treated with Betaine co-treated with Choline co-treated with Folic Acid] inhibits the reaction [Carbon Tetrachloride results in increased expression of TAB1 mRNA]; Betaine inhibits the reaction [Doxorubicin results in increased expression of TAB1 mRNA]	PMID:37840533|PMID:38651543|PMID:39736447|PMID:39987517
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TAB1 mRNA	PMID:28818685
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:18291	manganese atom	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese binds to TAB1 protein	PMID:16879102
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:18723	nicotine	decreases methylation	ISO	RGD:1306216	E	RGD:6480464	20220705	CTD	MESH:D009538	Nicotine results in decreased methylation of TAB1 gene	PMID:35026373
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:22977	cadmium atom	decreases methylation	ISO	RGD:1314708	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in decreased methylation of TAB1 gene	PMID:37023889
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314708	E	RGD:6480464	20130618	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TAB1 mRNA	PMID:19770486
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	Ozone results in decreased expression of TAB1 mRNA	PMID:31476115
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	[Aripiprazole co-treated with Ozone] results in decreased expression of TAB1 mRNA	PMID:31476115
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306216	E	RGD:6480464	20250902	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TAB1 mRNA	PMID:39736447|PMID:39987517
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306216	E	RGD:6480464	20250902	CTD	MESH:D002251	[Methionine co-treated with Betaine co-treated with Choline co-treated with Folic Acid] inhibits the reaction [Carbon Tetrachloride results in increased expression of TAB1 mRNA]	PMID:39736447|PMID:39987517
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1306216	E	RGD:6480464	20250902	CTD	MESH:D005492	[Methionine co-treated with Betaine co-treated with Choline co-treated with Folic Acid] inhibits the reaction [Carbon Tetrachloride results in increased expression of TAB1 mRNA]	PMID:39736447|PMID:39987517
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of TAB1 protein	PMID:35688186
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:27899	cisplatin	decreases phosphorylation	ISO	RGD:1314708	E	RGD:6480464	20130618	CTD	MESH:D002945	Cisplatin results in decreased phosphorylation of TAB1 protein	PMID:22006019
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314708	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TAB1 mRNA	PMID:21570461
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306216	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TAB1 mRNA	PMID:33387578
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314708	E	RGD:6480464	20241203	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TAB1 mRNA	PMID:31961203
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of TAB1 protein	PMID:39603559
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306216	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TAB1 mRNA	PMID:28959563
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of TAB1 mRNA	PMID:30911355
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TAB1 mRNA	PMID:29803840
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1306216	E	RGD:6480464	20240430	CTD	MESH:D004317	Doxorubicin results in increased expression of TAB1 mRNA	PMID:37840533|PMID:38651543
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1306216	E	RGD:6480464	20240430	CTD	MESH:D004317	Betaine inhibits the reaction [Doxorubicin results in increased expression of TAB1 mRNA]	PMID:37840533|PMID:38651543
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TAB1 mRNA	PMID:38568856
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of TAB1 mRNA	PMID:39719251
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TAB1 3' UTR; Benzo(a)pyrene affects the methylation of TAB1 intron	PMID:27901495|PMID:30157460
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TAB1 promoter	PMID:27901495
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of TAB1 mRNA	PMID:30911355
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:31236	aripiprazole	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:C094645	[Aripiprazole co-treated with Ozone] results in decreased expression of TAB1 mRNA	PMID:31476115
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306216	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TAB1 mRNA	PMID:30047161
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1314708	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of TAB1 mRNA	PMID:17656681
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306216	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TAB1 mRNA	PMID:34492290
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314708	E	RGD:6480464	20130618	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of TAB1 mRNA	PMID:18648102
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306216	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TAB1 mRNA	PMID:25181051
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314708	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TAB1 mRNA	PMID:39298647
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314708	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of TAB1 mRNA	PMID:38685157
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314708	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of TAB1 intron	PMID:28392331
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of TAB1 gene	PMID:22964155
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:35154	manganese(0)	affects binding	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese binds to TAB1 protein	PMID:16879102
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TAB1 mRNA	PMID:38568856
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306216	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TAB1 mRNA	PMID:33453195|PMID:36928142
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1306216	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of TAB1 mRNA	PMID:30047161
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306216	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TAB1 mRNA	PMID:30047161
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:43602	obeticholic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of TAB1 mRNA	PMID:27939613
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TAB1 mRNA	PMID:38832940
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314708	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of TAB1 mRNA	PMID:17562736
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306216	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TAB1 mRNA	PMID:33387578
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306216	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TAB1 mRNA	PMID:29391264
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314708	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TAB1 mRNA; Nanotubes, Carbon results in decreased expression of TAB1 mRNA	PMID:25554681
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TAB1 protein	PMID:32959892
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314708	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of TAB1 protein	PMID:36851058
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:6682	mangiferin	decreases expression	ISO	RGD:1314708	E	RGD:6480464	20130618	CTD	MESH:C013592	mangiferin results in decreased expression of TAB1 mRNA	PMID:15135318
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306216	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TAB1 gene	PMID:35440735
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of TAB1 mRNA	PMID:37199045
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TAB1 gene]	PMID:28238834
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:82288	o-anisidine	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C003898	2-anisidine results in decreased expression of TAB1 mRNA	PMID:28089782
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306216	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TAB1 mRNA	PMID:30047161
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of TAB1 mRNA	PMID:24921660
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:9150	simvastatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D019821	Simvastatin results in decreased activity of [MAP3K7 protein co-treated with TAB1 protein]	PMID:17277159
1314707	TAB1	TGF-beta activated kinase 1 (MAP3K7) binding protein 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TAB1 mRNA	PMID:38568856
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of PCP2 mRNA	PMID:31614463
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314710	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCP2 mRNA	PMID:25510870
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PCP2 mRNA	PMID:37042841
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:16899	D-mannitol	increases expression	ISO	RGD:1314710	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in increased expression of PCP2 mRNA	PMID:25270620
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306217	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PCP2 mRNA	PMID:26577399
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:23115	chlorohydrocarbon	increases expression	ISO	RGD:1306217	E	RGD:6480464	20170228	CTD	MESH:D006843	Hydrocarbons, Chlorinated results in increased expression of PCP2 mRNA	PMID:18077114
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314710	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCP2 mRNA	PMID:25510870
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314710	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCP2 mRNA	PMID:25510870
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PCP2 mRNA	PMID:27392435
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314710	E	RGD:6480464	20150127	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PCP2 mRNA	PMID:19933214|PMID:25270620
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCP2 promoter	PMID:27901495
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306217	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PCP2 mRNA	PMID:25181051|PMID:41034487
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314710	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCP2 mRNA	PMID:25510870
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314710	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCP2 mRNA	PMID:25510870
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1314710	E	RGD:6480464	20121113	CTD	MESH:D010269	Paraquat results in decreased expression of PCP2 mRNA	PMID:22563483
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314710	E	RGD:6480464	20121113	CTD	MESH:D010269	[Paraquat co-treated with Maneb] affects the expression of PCP2 mRNA	PMID:22563483
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PCP2 mRNA	PMID:38382870
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1306217	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of PCP2 promoter	PMID:22457795
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PCP2 mRNA	PMID:31533062
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PCP2 mRNA	PMID:25979313
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314710	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PCP2 mRNA	PMID:17562736
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of PCP2 mRNA	PMID:22230336
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1306217	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of PCP2 mRNA	PMID:34044035
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1314710	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of PCP2 mRNA	PMID:26377693
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1314710	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of PCP2 mRNA	PMID:26377693
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314710	E	RGD:6480464	20121113	CTD	MESH:D008344	[Paraquat co-treated with Maneb] affects the expression of PCP2 mRNA	PMID:22563483
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1314710	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of PCP2 mRNA	PMID:19751817
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314710	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PCP2 mRNA	PMID:22206623
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1306217	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of PCP2 protein	PMID:28903499
1314709	PCP2	Purkinje cell protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306217	E	RGD:6480464	20130514	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PCP2 mRNA	PMID:18077114
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1558016	E	RGD:6480464	20260811	CTD	MESH:C084079	triptonide results in increased expression of ANKRD36 mRNA	PMID:33045310
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ANKRD26 mRNA	PMID:33167477
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ANKRD26 mRNA	PMID:26079696
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ANKRD26 mRNA	PMID:22378314
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of ANKRD26 protein	PMID:35688186
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ANKRD26 mRNA	PMID:37042841
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1558016	E	RGD:6480464	20260811	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ANKRD36 mRNA	PMID:34319233
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1310736	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ANKRD26 mRNA	PMID:33387578
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1558016	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ANKRD26 mRNA	PMID:37236586
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ANKRD26 mRNA	PMID:19549813
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ANKRD26 intron	PMID:30157460
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1310736	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ANKRD26 mRNA	PMID:30779732
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1558016	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ANKRD26 mRNA	PMID:25629700
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ANKRD26 protein	PMID:35688186
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ANKRD26 mRNA	PMID:23557933
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1558016	E	RGD:6480464	20260811	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ANKRD36 mRNA	PMID:21570461
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ANKRD26 mRNA	PMID:28001369
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ANKRD26 mRNA	PMID:33212167
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of ANKRD26 mRNA	PMID:26272509
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRD26 mRNA	PMID:27188386
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ANKRD26 mRNA	PMID:29803840
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ANKRD26 protein	PMID:35688186
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ANKRD26 mRNA	PMID:38568856
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ANKRD26 promoter	PMID:27901495
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1558016	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ANKRD26 exon; Benzo(a)pyrene results in increased methylation of ANKRD26 intron	PMID:27901495
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ANKRD26 mRNA	PMID:25895662
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1558016	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of ANKRD26 mRNA	PMID:17656681
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1558016	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ANKRD26 gene; titanium dioxide results in decreased methylation of ANKRD26 promoter	PMID:35295148
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1310736	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ANKRD26 mRNA	PMID:34492290
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:32509	pirinixic acid	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in decreased expression of ANKRD26 mRNA	PMID:17070643
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1558016	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ANKRD26 mRNA	PMID:19710929
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1310736	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of ANKRD26 mRNA	PMID:30816183
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1310736	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ANKRD26 mRNA	PMID:25181051
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1310736	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of ANKRD26 mRNA	PMID:32145629
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ANKRD26 mRNA	PMID:25979313
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ANKRD26 intron	PMID:30157460
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1558016	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ANKRD26 mRNA	PMID:37019170
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1558016	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of ANKRD26 mRNA	PMID:36117858
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ANKRD26 mRNA	PMID:37042841
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1558016	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ANKRD26 mRNA	PMID:37236586
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ANKRD26 mRNA	PMID:24449571
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ANKRD26 mRNA	PMID:28302478
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ANKRD26 mRNA	PMID:31533062
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ANKRD26 mRNA	PMID:27153767
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1310736	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of ANKRD26 mRNA	PMID:22561333
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ANKRD26 mRNA	PMID:25562108
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of ANKRD26 mRNA	PMID:27188386
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1558016	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ANKRD26 mRNA	PMID:17562736
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ANKRD26 mRNA	PMID:22230336
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1310736	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ANKRD26 mRNA	PMID:33387578
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ANKRD26 mRNA	PMID:22079256
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1558016	E	RGD:6480464	20130514	CTD	MESH:D018038	Sodium Selenite results in decreased expression of ANKRD26 mRNA	PMID:23274088
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1558016	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ANKRD26 mRNA	PMID:25554681
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1310736	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ANKRD26 mRNA	PMID:24793618
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:51687	chrysene	decreases expression	ISO	RGD:1558016	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in decreased expression of ANKRD26 mRNA	PMID:26377693
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1558016	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of ANKRD26 mRNA	PMID:36117858
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ANKRD26 protein	PMID:32959892
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1558016	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD26 mRNA	PMID:21641980
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ANKRD26 intron	PMID:30157460
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1310736	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ANKRD26 gene	PMID:35440735
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1558016	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ANKRD26 mRNA	PMID:22206623
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ANKRD26 mRNA	PMID:22079256
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ANKRD26 mRNA	PMID:22079256
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRD26 mRNA	PMID:27188386
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1558016	E	RGD:6480464	20260811	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of ANKRD36 mRNA	PMID:31388691
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ANKRD26 mRNA	PMID:26079696
1314711	ANKRD26	ankyrin repeat domain 26	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ANKRD26 mRNA	PMID:27188386
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of REXO4 protein	PMID:39638853
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of REXO4 mRNA	PMID:38218311
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1622969	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of REXO4 mRNA	PMID:33045310
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1306220	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of REXO4 mRNA	PMID:30071829
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of REXO4 mRNA	PMID:33167477
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of REXO4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of REXO4 mRNA	PMID:32699268
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1622969	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of REXO4 mRNA	PMID:39298647
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of REXO4 mRNA	PMID:37042841
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of REXO4 protein	PMID:37730182
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of REXO4 mRNA	PMID:39836092
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of REXO4 mRNA	PMID:35301059
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1622969	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of REXO4 mRNA	PMID:37236586
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of REXO4 protein	PMID:23301498
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1622969	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of REXO4 mRNA	PMID:19770486
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of REXO4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of REXO4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of REXO4 mRNA	PMID:32699268
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1622969	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of REXO4 mRNA	PMID:27339419|PMID:31919559
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of REXO4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of REXO4 mRNA	PMID:39836092
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of REXO4 protein	PMID:35688186
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in decreased expression of REXO4 mRNA	PMID:21858171
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of REXO4 promoter	PMID:22847954
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306220	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of REXO4 mRNA	PMID:21215274|PMID:33387578
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1622969	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of REXO4 mRNA	PMID:17942748
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1306220	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of REXO4 mRNA	PMID:19013527
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306220	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of REXO4 mRNA	PMID:28374803
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of REXO4 mRNA	PMID:33212167
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of REXO4 mRNA	PMID:21198554
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of REXO4 protein	PMID:35688186
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of REXO4 mRNA	PMID:29432896
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of REXO4 mRNA	PMID:38568856
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of REXO4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of REXO4 mRNA	PMID:39836092
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306220	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of REXO4 mRNA	PMID:25729387
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1622969	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of REXO4 gene	PMID:35295148
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1622969	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of REXO4 mRNA	PMID:18648102
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1622969	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of REXO4 mRNA	PMID:18445702
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1622969	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of REXO4 promoter	PMID:27334623
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306220	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of REXO4 mRNA	PMID:30816183|PMID:34947998
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1622969	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of REXO4 mRNA	PMID:35598803
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306220	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of REXO4 mRNA	PMID:25181051
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1622969	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of REXO4 mRNA	PMID:39298647
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of REXO4 mRNA	PMID:39836092
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of REXO4 mRNA	PMID:26472689
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of REXO4 mRNA	PMID:35301059
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1622969	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of REXO4 mRNA	PMID:37236586
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of REXO4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of REXO4 mRNA	PMID:32699268
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of REXO4 mRNA	PMID:32588087
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of REXO4 promoter	PMID:22847954
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of REXO4 mRNA	PMID:31533062
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of REXO4 promoter	PMID:22847954
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of REXO4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of REXO4 mRNA	PMID:39836092
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1622969	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of REXO4 mRNA	PMID:17942748
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1622969	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of REXO4 mRNA	PMID:35964746
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1622969	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of REXO4 mRNA	PMID:26377693
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of REXO4 mRNA	PMID:39836092
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306220	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of REXO4 mRNA	PMID:25729387
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1622969	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of REXO4 mRNA	PMID:23650126
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1622969	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of REXO4 mRNA	PMID:22206623
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:80799	Bufotalin	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of REXO4 mRNA	PMID:39904859
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in decreased expression of REXO4 mRNA	PMID:21858171
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1622969	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of REXO4 mRNA	PMID:39847705
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1622969	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of REXO4 protein	PMID:35357534
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306220	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of REXO4 mRNA	PMID:19281266
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306220	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of REXO4 mRNA	PMID:21346803
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of REXO4 mRNA	PMID:38568856
1314713	REXO4	RNA exonuclease 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306220	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of REXO4 mRNA	PMID:21346803
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1306221	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of MRPS12 mRNA	PMID:21551480
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPS12 mRNA	PMID:17045167
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552385	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPS12 mRNA	PMID:39241906
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPS12 mRNA	PMID:31059760
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306221	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of MRPS12 mRNA	PMID:32145629
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MRPS12 mRNA	PMID:38568856
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MRPS12 mRNA	PMID:37042841
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of MRPS12 mRNA	PMID:23649840
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of MRPS12 mRNA	PMID:16002434
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1552385	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of MRPS12 mRNA	PMID:37748715
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MRPS12 mRNA	PMID:36331819
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MRPS12 mRNA	PMID:37325564
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MRPS12 mRNA	PMID:19549813
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MRPS12 protein	PMID:23301498
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MRPS12 mRNA	PMID:23649840
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MRPS12 mRNA	PMID:27153756
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MRPS12 mRNA	PMID:23649840
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1552385	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of MRPS12 mRNA	PMID:24489787
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS12 mRNA	PMID:22206623
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS12 mRNA	PMID:40504410
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1552385	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of MRPS12 mRNA	PMID:22610192
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of MRPS12 mRNA	PMID:19921347
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1552385	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in increased expression of MRPS12 mRNA	PMID:16917069
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552385	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPS12 mRNA	PMID:21570461
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306221	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPS12 mRNA	PMID:33387578|PMID:34747641
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPS12 mRNA	PMID:17942748
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MRPS12 mRNA	PMID:33212167
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPS12 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS12 mRNA	PMID:23783067
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of MRPS12 mRNA	PMID:20044591
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPS12 mRNA	PMID:38568856
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of MRPS12 mRNA	PMID:34032870
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS12 mRNA	PMID:40504410
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of MRPS12 mRNA	PMID:22378314
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MRPS12 mRNA	PMID:20106945
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552385	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MRPS12 mRNA	PMID:27195522
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552385	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MRPS12 mRNA	PMID:20504355
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1552385	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of MRPS12 protein	PMID:37955338
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MRPS12 protein	PMID:19364129
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1552385	E	RGD:6480464	20150127	CTD	MESH:C008261	lead acetate results in decreased expression of MRPS12 mRNA	PMID:25270620
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306221	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MRPS12 mRNA	PMID:30047161
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:32497	thioacetamide	increases methylation	ISO	RGD:1306221	E	RGD:6480464	20170516	CTD	MESH:D013853	Thioacetamide results in increased methylation of MRPS12 promoter	PMID:27914986
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306221	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MRPS12 mRNA	PMID:25181051
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552385	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPS12 mRNA	PMID:30245210|PMID:35598803
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306221	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of MRPS12 mRNA	PMID:32145629
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1306221	E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of MRPS12 mRNA	PMID:17316808
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552385	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPS12 mRNA	PMID:39298647
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1552385	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of MRPS12 mRNA	PMID:38685157
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1552385	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of MRPS12 mRNA	PMID:34813904
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1552385	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of MRPS12 mRNA	PMID:34813904
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MRPS12 mRNA	PMID:38568856
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MRPS12 mRNA	PMID:37325564
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1306221	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of MRPS12 mRNA	PMID:30047161
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MRPS12 mRNA	PMID:24449571
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MRPS12 mRNA	PMID:36331819
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MRPS12 mRNA	PMID:23179753|PMID:28001369
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of MRPS12 mRNA	PMID:17183730
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306221	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MRPS12 mRNA	PMID:30047161
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:41791	calyculin A	decreases expression	ISO	RGD:1552385	E	RGD:6480464	20150127	CTD	MESH:C059041	calyculin A results in decreased expression of MRPS12 mRNA	PMID:25270620
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552385	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MRPS12 mRNA	PMID:17562736
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPS12 mRNA	PMID:25704631|PMID:29067470|PMID:31059760
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPS12 mRNA	PMID:31059760
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of MRPS12 mRNA	PMID:29523930
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS12 mRNA	PMID:40504410
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552385	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MRPS12 mRNA	PMID:17942748
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPS12 mRNA	PMID:17942748
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MRPS12 protein	PMID:19364129
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306221	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MRPS12 mRNA	PMID:24136188
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1306221	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of MRPS12 mRNA	PMID:34044035
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306221	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MRPS12 mRNA	PMID:30047161
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MRPS12 mRNA	PMID:35964746
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of MRPS12 mRNA	PMID:20977926
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of MRPS12 mRNA	PMID:17183730
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPS12 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPS12 mRNA	PMID:23783067
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552385	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPS12 mRNA	PMID:22206623
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of MRPS12 mRNA	PMID:37199045
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1552385	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of MRPS12 mRNA	PMID:18958704
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306221	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of MRPS12 mRNA	PMID:30047161
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306221	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MRPS12 mRNA	PMID:21346803
1314714	MRPS12	mitochondrial ribosomal protein S12	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MRPS12 mRNA	PMID:38568856
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314718	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of AQR mRNA	PMID:33045310
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314718	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of AQR mRNA	PMID:39241906
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of AQR mRNA	PMID:37042841
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314718	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of AQR mRNA	PMID:33754040
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of AQR protein	PMID:37730182
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306223	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of AQR mRNA	PMID:22061828
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of AQR protein	PMID:23301498
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314718	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of AQR mRNA	PMID:25629700
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AQR gene	PMID:25304211
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of AQR mRNA	PMID:23557933
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of AQR mRNA	PMID:28903495
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314718	E	RGD:6480464	20140812	CTD	MESH:D002945	Cisplatin results in decreased expression of AQR mRNA	PMID:24865317
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1314718	E	RGD:6480464	20140812	CTD	MESH:D002945	[Cisplatin co-treated with Lutein] results in decreased expression of AQR mRNA	PMID:24865317
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314718	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of AQR mRNA	PMID:21570461
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306223	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AQR mRNA	PMID:34747641
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314718	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AQR mRNA	PMID:19465110
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of AQR mRNA	PMID:33212167
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of AQR mRNA	PMID:30851411
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of AQR mRNA	PMID:29803840
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:28838	lutein	decreases expression	ISO	RGD:1314718	E	RGD:6480464	20140812	CTD	MESH:D014975	Lutein results in decreased expression of AQR mRNA	PMID:24865317
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:28838	lutein	multiple interactions	ISO	RGD:1314718	E	RGD:6480464	20140812	CTD	MESH:D014975	[Cisplatin co-treated with Lutein] results in decreased expression of AQR mRNA	PMID:24865317
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AQR mRNA	PMID:20064835
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314718	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AQR mRNA	PMID:22228805
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to AQR mRNA]	PMID:32406909
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314718	E	RGD:6480464	20121009	CTD	MESH:D012834	Silver results in increased expression of AQR mRNA	PMID:19429238
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314718	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of AQR mRNA	PMID:19073995
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of AQR mRNA	PMID:26238291
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of AQR mRNA	PMID:19150397
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306223	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of AQR mRNA	PMID:25729387
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306223	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of AQR mRNA	PMID:30047161
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314718	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of AQR mRNA	PMID:29264374
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306223	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of AQR mRNA	PMID:34492290
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314718	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of AQR mRNA	PMID:23811191
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of AQR protein	PMID:31675489
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of AQR gene	PMID:31601247
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314718	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of AQR promoter	PMID:27312807
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306223	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of AQR mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of AQR protein	PMID:31675489
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of AQR mRNA	PMID:24752500
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314718	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of AQR mRNA	PMID:38685157
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314718	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of AQR mRNA	PMID:37019170
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to AQR protein	PMID:32991956
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1314718	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in decreased expression of AQR mRNA	PMID:21688324
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314718	E	RGD:6480464	20130416	CTD	MESH:D010269	APOD protein affects the reaction [Paraquat results in decreased expression of AQR mRNA]	PMID:21688324
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AQR mRNA	PMID:37042841
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of AQR mRNA	PMID:38568856
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of AQR mRNA	PMID:24449571
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AQR mRNA	PMID:25979313
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314718	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of AQR mRNA	PMID:17963808
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of AQR mRNA	PMID:23179753|PMID:27188386
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306223	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of AQR mRNA	PMID:30047161
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1314718	E	RGD:6480464	20130416	CTD	MESH:C017160	cypermethrin results in increased expression of AQR mRNA	PMID:21142847
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of AQR mRNA	PMID:22230336
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AQR gene	PMID:25304211
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of AQR mRNA	PMID:24752500
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of AQR mRNA	PMID:31675489
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of AQR mRNA	PMID:22079256
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306223	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of AQR mRNA	PMID:30047161
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AQR protein	PMID:32959892
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306223	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of AQR mRNA	PMID:25729387
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of AQR mRNA	PMID:15336504
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1314718	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of AQR mRNA	PMID:22206623
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of AQR mRNA	PMID:22079256
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of AQR mRNA	PMID:22079256
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of AQR mRNA	PMID:30851411
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of AQR protein	PMID:31675489
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1306223	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of AQR mRNA	PMID:23640034
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1306223	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of AQR mRNA	PMID:30047161
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306223	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of AQR mRNA	PMID:30047161
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314718	E	RGD:6480464	20121009	CTD	MESH:D012834	Silver results in increased expression of AQR mRNA	PMID:19429238
1314717	AQR	aquarius intron-binding spliceosomal factor	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1314718	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of AQR protein	PMID:24648495
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314720	E	RGD:6480464	20200211	CTD	MESH:D010126	Ozone results in decreased expression of GTSF1L mRNA	PMID:31626304|PMID:33026818
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1314720	E	RGD:6480464	20240604	CTD	MESH:C010974	Glyphosate results in decreased expression of GTSF1L mRNA	PMID:33713393
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of GTSF1L promoter	PMID:22847954
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of GTSF1L mRNA	PMID:28001369
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314720	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of GTSF1L mRNA	PMID:37682722
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GTSF1L mRNA	PMID:38568856
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GTSF1L exon	PMID:27901495
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314720	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GTSF1L mRNA	PMID:22228805
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GTSF1L promoter	PMID:27901495
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314720	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of GTSF1L mRNA	PMID:23557971
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306224	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GTSF1L mRNA	PMID:25181051
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314720	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of GTSF1L mRNA	PMID:37019170
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of GTSF1L promoter	PMID:22847954
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of GTSF1L promoter	PMID:22847954
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of GTSF1L mRNA	PMID:31626844
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314720	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of GTSF1L mRNA	PMID:21427059
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306224	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of GTSF1L mRNA	PMID:30307764
1314719	GTSF1L	gametocyte specific factor 1 like	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GTSF1L gene]	PMID:28238834
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:10106	zearalenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in decreased expression of VCPKMT mRNA	PMID:19371625
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of VCPKMT mRNA	PMID:20044591
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1614212	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of VCPKMT mRNA	PMID:39298647
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:7565188	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of VCPKMT mRNA	PMID:32145629
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of VCPKMT mRNA	PMID:37042841
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1614212	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VCPKMT mRNA	PMID:37992649
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1614212	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VCPKMT mRNA	PMID:37992649
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1614212	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of VCPKMT mRNA	PMID:36331819
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of VCPKMT mRNA	PMID:19549813
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:7565188	E	RGD:6480464	20160119	CTD	MESH:C016517	indole-3-carbinol affects the expression of VCPKMT mRNA	PMID:21396975
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of VCPKMT mRNA	PMID:23649840
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of VCPKMT mRNA	PMID:35430440
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1614212	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of VCPKMT mRNA	PMID:31919559
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of VCPKMT mRNA	PMID:19244175
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased expression of VCPKMT mRNA	PMID:19371625
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of VCPKMT mRNA	PMID:23557933
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of VCPKMT mRNA	PMID:27392435
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of VCPKMT mRNA	PMID:27392435
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of VCPKMT mRNA	PMID:19371625
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1614212	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VCPKMT mRNA	PMID:26290441
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of VCPKMT mRNA	PMID:30851411
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1614212	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VCPKMT mRNA	PMID:37992649
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of VCPKMT mRNA	PMID:38568856
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614212	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VCPKMT gene	PMID:35295148
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1614212	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of VCPKMT promoter	PMID:35295148
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of VCPKMT mRNA	PMID:19371625
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1614212	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of VCPKMT mRNA	PMID:32156529
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:7565188	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of VCPKMT mRNA	PMID:30816183|PMID:32145629
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in decreased expression of VCPKMT mRNA	PMID:19371625
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1614212	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of VCPKMT mRNA	PMID:36117858
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of VCPKMT mRNA	PMID:37042841
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of VCPKMT mRNA	PMID:19244175
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1614212	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of VCPKMT mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of VCPKMT mRNA	PMID:36331819
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:41922	diethylstilbestrol	affects expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol affects the expression of VCPKMT mRNA	PMID:36621641
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1614212	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of VCPKMT mRNA	PMID:37992649
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of VCPKMT mRNA	PMID:21420995
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of VCPKMT mRNA	PMID:18687144
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of VCPKMT mRNA	PMID:36621641
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of VCPKMT mRNA	PMID:22079256
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1614212	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of VCPKMT mRNA	PMID:25554681
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:7565188	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of VCPKMT mRNA	PMID:24136188
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1614212	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of VCPKMT mRNA	PMID:36117858
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of VCPKMT mRNA	PMID:22079256
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of VCPKMT mRNA	PMID:22079256
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of VCPKMT mRNA	PMID:30851411
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of VCPKMT mRNA	PMID:24921660
1314724	VCPKMT	valosin containing protein lysine methyltransferase	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of VCPKMT mRNA	PMID:38568856
1314725	SETBP1	SET binding protein 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SETBP1 mRNA	PMID:25812627
1314725	SETBP1	SET binding protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314726	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SETBP1 mRNA	PMID:20188158
1314725	SETBP1	SET binding protein 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SETBP1 mRNA	PMID:26079696
1314725	SETBP1	SET binding protein 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of SETBP1 mRNA	PMID:22378314
1314725	SETBP1	SET binding protein 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314726	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of SETBP1 mRNA	PMID:30319688
1314725	SETBP1	SET binding protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314726	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SETBP1 mRNA	PMID:39241906
1314725	SETBP1	SET binding protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SETBP1 mRNA	PMID:30165855
1314725	SETBP1	SET binding protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306229	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of SETBP1 mRNA	PMID:26496021
1314725	SETBP1	SET binding protein 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314726	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SETBP1 mRNA	PMID:25510870
1314725	SETBP1	SET binding protein 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306229	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SETBP1 mRNA	PMID:33387578
1314725	SETBP1	SET binding protein 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SETBP1 mRNA	PMID:23416264|PMID:23649840
1314725	SETBP1	SET binding protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314726	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SETBP1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SETBP1 mRNA	PMID:37992649
1314725	SETBP1	SET binding protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314726	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SETBP1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SETBP1 mRNA	PMID:37992649
1314725	SETBP1	SET binding protein 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SETBP1 protein	PMID:37730182
1314725	SETBP1	SET binding protein 1	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1314726	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of SETBP1 mRNA	PMID:27462272
1314725	SETBP1	SET binding protein 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314726	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SETBP1 mRNA	PMID:25510870
1314725	SETBP1	SET binding protein 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314726	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SETBP1 mRNA	PMID:25510870
1314725	SETBP1	SET binding protein 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of SETBP1 mRNA	PMID:23649840
1314725	SETBP1	SET binding protein 1	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of SETBP1 exon	PMID:30157460
1314725	SETBP1	SET binding protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SETBP1 mRNA	PMID:22100608|PMID:27153756
1314725	SETBP1	SET binding protein 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SETBP1 mRNA	PMID:23649840
1314725	SETBP1	SET binding protein 1	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SETBP1 mRNA	PMID:19244175
1314725	SETBP1	SET binding protein 1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1314726	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SETBP1 mRNA]	PMID:37992649
1314725	SETBP1	SET binding protein 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314726	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SETBP1 mRNA	PMID:28960355
1314725	SETBP1	SET binding protein 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SETBP1 mRNA	PMID:27392435
1314725	SETBP1	SET binding protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SETBP1 mRNA	PMID:27392435
1314725	SETBP1	SET binding protein 1	gene	CHEBI:28088	genistein	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein affects the expression of SETBP1 mRNA	PMID:26865667
1314725	SETBP1	SET binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314726	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SETBP1 mRNA	PMID:37172768
1314725	SETBP1	SET binding protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SETBP1 mRNA	PMID:28001369
1314725	SETBP1	SET binding protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SETBP1 mRNA	PMID:33212167
1314725	SETBP1	SET binding protein 1	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of SETBP1 mRNA	PMID:23649840
1314725	SETBP1	SET binding protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SETBP1 mRNA	PMID:29803840
1314725	SETBP1	SET binding protein 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314726	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SETBP1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SETBP1 mRNA	PMID:37992649
1314725	SETBP1	SET binding protein 1	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1314726	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SETBP1 mRNA]	PMID:37992649
1314725	SETBP1	SET binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314726	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of SETBP1 mRNA	PMID:37682722
1314725	SETBP1	SET binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SETBP1 5' UTR	PMID:27901495
1314725	SETBP1	SET binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SETBP1 mRNA	PMID:20106945
1314725	SETBP1	SET binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of SETBP1 gene	PMID:25435355
1314725	SETBP1	SET binding protein 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314726	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SETBP1 mRNA	PMID:27131904
1314725	SETBP1	SET binding protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SETBP1 mRNA	PMID:25895662
1314725	SETBP1	SET binding protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SETBP1 mRNA	PMID:19150397
1314725	SETBP1	SET binding protein 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SETBP1 gene; [bisphenol S co-treated with Fulvestrant] results in decreased methylation of SETBP1 gene	PMID:31601247
1314725	SETBP1	SET binding protein 1	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1306229	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of SETBP1 mRNA	PMID:32479839
1314725	SETBP1	SET binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314726	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SETBP1 mRNA	PMID:29264374
1314725	SETBP1	SET binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314726	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SETBP1 gene	PMID:35295148
1314725	SETBP1	SET binding protein 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314726	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SETBP1 promoter	PMID:35295148
1314725	SETBP1	SET binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of SETBP1 mRNA	PMID:20170705
1314725	SETBP1	SET binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SETBP1 mRNA	PMID:25047013
1314725	SETBP1	SET binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306229	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SETBP1 mRNA	PMID:25181051
1314725	SETBP1	SET binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306229	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SETBP1 mRNA	PMID:30816183|PMID:34947998|PMID:38750585
1314725	SETBP1	SET binding protein 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of SETBP1 gene	PMID:31601247
1314725	SETBP1	SET binding protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SETBP1 gene	PMID:31601247
1314725	SETBP1	SET binding protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306229	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of SETBP1 mRNA	PMID:26496021
1314725	SETBP1	SET binding protein 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of SETBP1 mRNA	PMID:19244175
1314725	SETBP1	SET binding protein 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314726	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SETBP1 mRNA	PMID:25510870
1314725	SETBP1	SET binding protein 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314726	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of SETBP1 mRNA	PMID:25510870
1314725	SETBP1	SET binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in decreased methylation of SETBP1 gene	PMID:31601247
1314725	SETBP1	SET binding protein 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of SETBP1 exon	PMID:30157460
1314725	SETBP1	SET binding protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314726	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of SETBP1 intron	PMID:28392331
1314725	SETBP1	SET binding protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SETBP1 mRNA	PMID:37042841
1314725	SETBP1	SET binding protein 1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of SETBP1 mRNA	PMID:29024780
1314725	SETBP1	SET binding protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SETBP1 mRNA	PMID:38382870
1314725	SETBP1	SET binding protein 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SETBP1 mRNA	PMID:25812627
1314725	SETBP1	SET binding protein 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of SETBP1 mRNA	PMID:24449571
1314725	SETBP1	SET binding protein 1	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of SETBP1 mRNA	PMID:19244175
1314725	SETBP1	SET binding protein 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SETBP1 mRNA	PMID:25812627
1314725	SETBP1	SET binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SETBP1 mRNA	PMID:25812627
1314725	SETBP1	SET binding protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of SETBP1 mRNA	PMID:28001369
1314725	SETBP1	SET binding protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1306229	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of SETBP1 mRNA	PMID:29427782
1314725	SETBP1	SET binding protein 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SETBP1 gene	PMID:29154799
1314725	SETBP1	SET binding protein 1	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1314726	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of SETBP1 mRNA	PMID:40633821
1314725	SETBP1	SET binding protein 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1314726	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of SETBP1 mRNA	PMID:17555576
1314725	SETBP1	SET binding protein 1	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of SETBP1 mRNA	PMID:25047013
1314725	SETBP1	SET binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314726	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SETBP1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SETBP1 mRNA	PMID:37992649
1314725	SETBP1	SET binding protein 1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of SETBP1 mRNA	PMID:23649840
1314725	SETBP1	SET binding protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SETBP1 mRNA	PMID:26272509
1314725	SETBP1	SET binding protein 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SETBP1 mRNA	PMID:24935251
1314725	SETBP1	SET binding protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SETBP1 mRNA	PMID:27188386
1314725	SETBP1	SET binding protein 1	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of SETBP1 mRNA	PMID:24714768
1314725	SETBP1	SET binding protein 1	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of SETBP1 mRNA	PMID:22077320
1314725	SETBP1	SET binding protein 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in increased expression of SETBP1 mRNA	PMID:26615145
1314725	SETBP1	SET binding protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SETBP1 mRNA	PMID:20170705|PMID:26865667
1314725	SETBP1	SET binding protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1306229	E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SETBP1 mRNA	PMID:20170705|PMID:26865667
1314725	SETBP1	SET binding protein 1	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of SETBP1 exon	PMID:30157460
1314725	SETBP1	SET binding protein 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SETBP1 mRNA	PMID:22714537
1314725	SETBP1	SET binding protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SETBP1 mRNA	PMID:27188386
1314725	SETBP1	SET binding protein 1	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of SETBP1 mRNA	PMID:26079696
1314725	SETBP1	SET binding protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SETBP1 mRNA	PMID:27188386
1314725	SETBP1	SET binding protein 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314726	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SETBP1 mRNA	PMID:27131904
1314725	SETBP1	SET binding protein 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of SETBP1 mRNA	PMID:29301935
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314729	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RWDD2A mRNA	PMID:33045310
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314729	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RWDD2A mRNA	PMID:20938992
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314729	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RWDD2A mRNA	PMID:30319688
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of RWDD2A mRNA	PMID:20044591
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RWDD2A mRNA	PMID:21632981
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of RWDD2A mRNA	PMID:31614463
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314729	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RWDD2A mRNA	PMID:20938992
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314729	E	RGD:6480464	20210608	CTD	MESH:D004051	Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of RWDD2A mRNA]	PMID:33484791
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314729	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RWDD2A mRNA	PMID:28111341
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RWDD2A mRNA	PMID:19549813
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1314729	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of RWDD2A mRNA	PMID:19376150
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RWDD2A mRNA	PMID:22100608
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314729	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RWDD2A mRNA	PMID:25629700
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314729	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RWDD2A mRNA	PMID:20938992
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of RWDD2A mRNA	PMID:26272509
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RWDD2A mRNA	PMID:27188386
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314729	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RWDD2A mRNA	PMID:28960355
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RWDD2A mRNA	PMID:23557933
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306231	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RWDD2A mRNA	PMID:33387578
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RWDD2A mRNA	PMID:28001369
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of RWDD2A mRNA	PMID:39709020
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RWDD2A mRNA	PMID:30851411
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of RWDD2A mRNA	PMID:34032870
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of RWDD2A mRNA	PMID:22378314
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314729	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RWDD2A mRNA	PMID:27131904
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of RWDD2A mRNA	PMID:35984750
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314729	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of RWDD2A mRNA	PMID:29264374
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314729	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RWDD2A gene; titanium dioxide results in decreased methylation of RWDD2A promoter alternative form	PMID:35295148
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RWDD2A mRNA	PMID:19710929
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306231	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RWDD2A mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314729	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of RWDD2A mRNA	PMID:32156529
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of RWDD2A mRNA	PMID:31715268
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306231	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RWDD2A mRNA	PMID:36041667
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306231	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RWDD2A mRNA	PMID:36041667
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314729	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RWDD2A mRNA	PMID:38685157
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306231	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RWDD2A mRNA	PMID:36041667
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306231	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RWDD2A mRNA	PMID:35163327
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314729	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RWDD2A mRNA	PMID:28111341
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306231	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RWDD2A mRNA	PMID:35163327
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306231	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RWDD2A mRNA	PMID:24386269
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314729	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of RWDD2A mRNA	PMID:28962523
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RWDD2A mRNA	PMID:28302478
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314729	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of RWDD2A mRNA	PMID:39529242
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of RWDD2A mRNA	PMID:40419075
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RWDD2A mRNA	PMID:25979313
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of RWDD2A mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RWDD2A gene	PMID:29154799
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314729	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in increased expression of RWDD2A mRNA	PMID:19136453
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RWDD2A mRNA	PMID:27188386
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RWDD2A mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of RWDD2A mRNA	PMID:24935251|PMID:26272509
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RWDD2A mRNA	PMID:27188386
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306231	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RWDD2A mRNA	PMID:33387578
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RWDD2A mRNA	PMID:22079256
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314729	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of RWDD2A mRNA	PMID:35436446
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1306231	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of RWDD2A mRNA	PMID:20080153
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of RWDD2A mRNA	PMID:28988120
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RWDD2A mRNA	PMID:31758290
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314729	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RWDD2A mRNA	PMID:22206623
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RWDD2A mRNA	PMID:22079256
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RWDD2A mRNA	PMID:22079256
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases expression	ISO	RGD:1306231	E	RGD:6480464	20210406	CTD	MESH:C074283	estradiol 3-benzoate results in decreased expression of RWDD2A mRNA	PMID:32741896
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RWDD2A mRNA	PMID:30851411
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RWDD2A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RWDD2A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RWDD2A mRNA	PMID:27188386
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of RWDD2A mRNA	PMID:19095052
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1306231	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of RWDD2A mRNA	PMID:24780913
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RWDD2A mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RWDD2A mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RWDD2A mRNA	PMID:27188386
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314729	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RWDD2A mRNA	PMID:27131904
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306231	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of RWDD2A mRNA	PMID:19281266
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1314729	E	RGD:6480464	20210608	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in decreased expression of RWDD2A mRNA; Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of RWDD2A mRNA]	PMID:33484791
1314728	RWDD2A	RWD domain containing 2A	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314729	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of RWDD2A mRNA	PMID:35537566
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314734	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of LRRFIP2 mRNA	PMID:33045310
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306234	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LRRFIP2 mRNA]	PMID:31150632
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314734	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of LRRFIP2 mRNA	PMID:30319688
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of LRRFIP2 mRNA	PMID:29581250
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of LRRFIP2 mRNA	PMID:22574217
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of LRRFIP2 mRNA	PMID:31614463
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314734	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of LRRFIP2 mRNA	PMID:29980752
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LRRFIP2 mRNA	PMID:37042841
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of LRRFIP2 protein	PMID:37730182
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306234	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of LRRFIP2 mRNA	PMID:33387578
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRRFIP2 mRNA	PMID:39836092
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306234	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of LRRFIP2 mRNA	PMID:30779732
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306234	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LRRFIP2 mRNA	PMID:31150632
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314734	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of LRRFIP2 mRNA	PMID:27339419|PMID:31919559
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306234	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LRRFIP2 mRNA]	PMID:31150632
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRRFIP2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRRFIP2 mRNA	PMID:39836092
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314734	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRRFIP2 mRNA	PMID:40504410
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of LRRFIP2 protein	PMID:35688186
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of LRRFIP2 mRNA	PMID:23557933
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of LRRFIP2 mRNA	PMID:28903495
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LRRFIP2 mRNA	PMID:22903824
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306234	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LRRFIP2 mRNA	PMID:33387578
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314734	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LRRFIP2 mRNA	PMID:17942748
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of LRRFIP2 mRNA	PMID:38568856|PMID:39719251
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRRFIP2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRRFIP2 mRNA	PMID:39836092
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314734	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRRFIP2 mRNA	PMID:40504410
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1314734	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of LRRFIP2 protein	PMID:37955338
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LRRFIP2 gene; [bisphenol F co-treated with Fulvestrant] results in decreased methylation of LRRFIP2 gene	PMID:31601247
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314734	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LRRFIP2 promoter	PMID:35295148
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314734	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of LRRFIP2 promoter	PMID:35295148
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314734	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of LRRFIP2 mRNA	PMID:18301758|PMID:18445702
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:32585	4-hydroxynon-2-enal	increases expression	ISO	RGD:1314734	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in increased expression of LRRFIP2 mRNA	PMID:19191707
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRFIP2 protein	PMID:33376534
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314734	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LRRFIP2 mRNA	PMID:33221593
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306234	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of LRRFIP2 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LRRFIP2 gene; [ginger extract results in increased abundance of Oils, Volatile] inhibits the reaction [bisphenol A results in decreased expression of LRRFIP2 protein]	PMID:31601247|PMID:33376534
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of LRRFIP2 gene	PMID:31601247
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314734	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of LRRFIP2 exon; butylbenzyl phthalate results in increased methylation of LRRFIP2 intron	PMID:28392331
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of LRRFIP2 mRNA	PMID:37042841
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRRFIP2 mRNA	PMID:39836092
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of LRRFIP2 mRNA	PMID:19376846
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1306234	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of LRRFIP2 mRNA	PMID:24386269
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314734	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of LRRFIP2 mRNA	PMID:17585979
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of LRRFIP2 mRNA	PMID:31533062
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of LRRFIP2 mRNA	PMID:23179753
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of LRRFIP2 mRNA	PMID:20106945|PMID:25562108
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314734	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of LRRFIP2 mRNA	PMID:17555576
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314734	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of LRRFIP2 mRNA	PMID:28973697
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of LRRFIP2 mRNA]	PMID:21233418
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314734	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of LRRFIP2 mRNA	PMID:17562736
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of LRRFIP2 mRNA	PMID:21420995
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRRFIP2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRRFIP2 mRNA	PMID:39836092
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314734	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LRRFIP2 mRNA	PMID:40504410
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of LRRFIP2 mRNA	PMID:36621641
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D004726	Endosulfan results in increased expression of LRRFIP2 protein	PMID:26615145
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306234	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of LRRFIP2 mRNA	PMID:29391264
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314734	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of LRRFIP2 mRNA	PMID:17555576
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314734	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LRRFIP2 mRNA	PMID:17942748
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306234	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of LRRFIP2 mRNA	PMID:24136188
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LRRFIP2 protein	PMID:32959892
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of LRRFIP2 mRNA	PMID:39836092
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314734	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of LRRFIP2 mRNA	PMID:22206623
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of LRRFIP2 mRNA	PMID:38568856
1314733	LRRFIP2	LRR binding FLII interacting protein 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306234	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of LRRFIP2 mRNA	PMID:21346803
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314737	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SCRT1 mRNA	PMID:33045310
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314737	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SCRT1 gene	PMID:20938992
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314737	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SCRT1 mRNA	PMID:30319688
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306236	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SCRT1 mRNA	PMID:33387578
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314737	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SCRT1 gene	PMID:20938992
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in increased expression of SCRT1 mRNA	PMID:27905399
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of SCRT1 mRNA	PMID:33647349
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314737	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SCRT1 gene	PMID:20938992
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306236	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SCRT1 mRNA	PMID:32109520
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314737	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SCRT1 mRNA	PMID:19465110
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306236	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SCRT1 mRNA	PMID:26033743
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1306236	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of SCRT1 mRNA	PMID:26033743
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314737	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SCRT1 mRNA	PMID:27195522
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SCRT1 3' UTR; Benzo(a)pyrene results in increased methylation of SCRT1 promoter	PMID:27901495
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306236	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SCRT1 mRNA	PMID:26033743
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1306236	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of SCRT1 mRNA	PMID:26033743
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314737	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SCRT1 gene; titanium dioxide results in decreased methylation of SCRT1 promoter	PMID:35295148
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314737	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SCRT1 gene	PMID:35295148
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314737	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SCRT1 promoter	PMID:27334623
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306236	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SCRT1 mRNA	PMID:25181051
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314737	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of SCRT1 mRNA	PMID:32156529
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306236	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of SCRT1 mRNA	PMID:41034487
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314737	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SCRT1 mRNA	PMID:26063408
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306236	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SCRT1 mRNA	PMID:36041667
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314737	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of SCRT1 gene	PMID:31683443
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314737	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of SCRT1 mRNA	PMID:30951980
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314737	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of SCRT1 exon	PMID:33297965
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306236	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SCRT1 mRNA	PMID:36041667
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314737	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of SCRT1 mRNA	PMID:30951980
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306236	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SCRT1 mRNA	PMID:36041667
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SCRT1 gene	PMID:29154799
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306236	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SCRT1 mRNA	PMID:30047161
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1306236	E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in increased expression of SCRT1 mRNA	PMID:27281708
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1314737	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of SCRT1 mRNA	PMID:25123088
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SCRT1 mRNA	PMID:38832940
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SCRT1 mRNA	PMID:22079256
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306236	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SCRT1 mRNA	PMID:30047161
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of SCRT1 mRNA	PMID:22079256
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SCRT1 mRNA	PMID:22079256
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of SCRT1 mRNA	PMID:36318118
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306236	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SCRT1 mRNA	PMID:24780913|PMID:30047161
1314736	SCRT1	scratch family transcriptional repressor 1	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of SCRT1 mRNA	PMID:27188386
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of KCTD7 mRNA	PMID:35967413
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of KCTD7 mRNA	PMID:26079696
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314739	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of KCTD7 mRNA	PMID:30319688
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1582914	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KCTD7 mRNA	PMID:33387578
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KCTD7 mRNA	PMID:35301059
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of KCTD7 mRNA	PMID:35430440
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of KCTD7 mRNA	PMID:27392435
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314739	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KCTD7 mRNA	PMID:18343893|PMID:26377647
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314739	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of KCTD7 mRNA	PMID:25975270
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KCTD7 mRNA	PMID:28001369
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KCTD7 mRNA	PMID:29803840
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of KCTD7 mRNA	PMID:29301061
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314739	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of KCTD7 mRNA	PMID:37682722
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1314739	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of KCTD7 mRNA	PMID:17127020
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314739	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of KCTD7 mRNA	PMID:25594700
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1582914	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KCTD7 mRNA	PMID:25181051
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1582914	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KCTD7 gene	PMID:28505145
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KCTD7 mRNA	PMID:37042841
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KCTD7 mRNA	PMID:38568856
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KCTD7 mRNA	PMID:35301059
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of KCTD7 mRNA	PMID:24449571
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314739	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of KCTD7 mRNA	PMID:40194260
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of KCTD7 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of KCTD7 mRNA	PMID:27188386
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in decreased expression of KCTD7 mRNA	PMID:27188386
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of KCTD7 mRNA	PMID:26690555
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1582914	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KCTD7 mRNA	PMID:33387578
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1582914	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of KCTD7 mRNA	PMID:29391264
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1582914	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of KCTD7 mRNA	PMID:29097150
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of KCTD7 mRNA	PMID:28988120
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314739	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KCTD7 mRNA	PMID:22206623
1314738	KCTD7	potassium channel tetramerization domain containing 7	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1314739	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of KCTD7 mRNA	PMID:18343893
1314740	ANGEL1	angel homolog 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ANGEL1 mRNA	PMID:35967413
1314740	ANGEL1	angel homolog 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ANGEL1 mRNA	PMID:22378314
1314740	ANGEL1	angel homolog 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1551421	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ANGEL1 mRNA	PMID:30319688
1314740	ANGEL1	angel homolog 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1551421	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ANGEL1 mRNA	PMID:39241906
1314740	ANGEL1	angel homolog 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of ANGEL1 mRNA	PMID:23019147
1314740	ANGEL1	angel homolog 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306238	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ANGEL1 mRNA	PMID:33387578
1314740	ANGEL1	angel homolog 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306238	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ANGEL1 mRNA	PMID:33387578
1314740	ANGEL1	angel homolog 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ANGEL1 gene	PMID:27153756
1314740	ANGEL1	angel homolog 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ANGEL1 gene	PMID:25304211
1314740	ANGEL1	angel homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1551421	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ANGEL1 mRNA	PMID:21570461
1314740	ANGEL1	angel homolog 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306238	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ANGEL1 mRNA	PMID:21215274
1314740	ANGEL1	angel homolog 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ANGEL1 mRNA	PMID:33212167
1314740	ANGEL1	angel homolog 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ANGEL1 mRNA	PMID:32763439
1314740	ANGEL1	angel homolog 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ANGEL1 mRNA	PMID:29803840
1314740	ANGEL1	angel homolog 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ANGEL1 mRNA	PMID:38568856
1314740	ANGEL1	angel homolog 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of ANGEL1 mRNA	PMID:34032870
1314740	ANGEL1	angel homolog 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ANGEL1 promoter	PMID:27901495
1314740	ANGEL1	angel homolog 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306238	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ANGEL1 mRNA	PMID:30816183|PMID:32528016
1314740	ANGEL1	angel homolog 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306238	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ANGEL1 mRNA	PMID:25181051
1314740	ANGEL1	angel homolog 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1551421	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ANGEL1 mRNA	PMID:39298647
1314740	ANGEL1	angel homolog 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1551421	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ANGEL1 mRNA	PMID:40203079
1314740	ANGEL1	angel homolog 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1551421	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of ANGEL1 promoter	PMID:33297965
1314740	ANGEL1	angel homolog 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1551421	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of ANGEL1 mRNA	PMID:36117858
1314740	ANGEL1	angel homolog 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ANGEL1 mRNA	PMID:37042841
1314740	ANGEL1	angel homolog 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ANGEL1 mRNA	PMID:38174414|PMID:38568856
1314740	ANGEL1	angel homolog 1	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1551421	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ANGEL1 mRNA	PMID:39529242
1314740	ANGEL1	angel homolog 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ANGEL1 mRNA	PMID:25979313
1314740	ANGEL1	angel homolog 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1551421	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of ANGEL1 mRNA	PMID:21427059
1314740	ANGEL1	angel homolog 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ANGEL1 mRNA	PMID:38832940
1314740	ANGEL1	angel homolog 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306238	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ANGEL1 mRNA	PMID:33387578
1314740	ANGEL1	angel homolog 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ANGEL1 gene	PMID:25304211
1314740	ANGEL1	angel homolog 1	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of ANGEL1 mRNA	PMID:18175754
1314740	ANGEL1	angel homolog 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1551421	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of ANGEL1 mRNA	PMID:36117858
1314740	ANGEL1	angel homolog 1	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1306238	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of ANGEL1 mRNA	PMID:19564919
1314740	ANGEL1	angel homolog 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1551421	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ANGEL1 mRNA	PMID:22206623
1314740	ANGEL1	angel homolog 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ANGEL1 gene]	PMID:28238834
1314740	ANGEL1	angel homolog 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ANGEL1 mRNA	PMID:38568856
1314740	ANGEL1	angel homolog 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1551421	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ANGEL1 mRNA	PMID:35537566
1314740	ANGEL1	angel homolog 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306238	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ANGEL1 mRNA	PMID:19015723
1314740	ANGEL1	angel homolog 1	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306238	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of ANGEL1 mRNA	PMID:20566332
1314740	ANGEL1	angel homolog 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306238	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of ANGEL1 mRNA	PMID:20566332
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ZNF76 mRNA	PMID:38218311
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZNF76 mRNA	PMID:26079696
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:16130	DDT	increases methylation	ISO	RGD:1306239	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in increased methylation of ZFP523 gene	PMID:30207508
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314743	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ZFP523 mRNA	PMID:30319688
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314743	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFP523 mRNA	PMID:39241906
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314743	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP523 mRNA	PMID:25510870
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306239	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ZFP523 mRNA	PMID:33387578
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of ZNF76 mRNA	PMID:26079696
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1314743	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of ZFP523 mRNA	PMID:28973375
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of ZNF76 mRNA	PMID:33359661
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:17642	pentachlorophenol	decreases expression	ISO	RGD:1314743	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in decreased expression of ZFP523 mRNA	PMID:23892564
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZNF76 mRNA	PMID:28818685
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314743	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP523 mRNA	PMID:25510870
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314743	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP523 mRNA	PMID:25510870
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ZNF76 gene	PMID:27153756
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306239	E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ZFP523 mRNA	PMID:30690589|PMID:31150632
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:27385	tetrachloromethane	increases methylation	ISO	RGD:1306239	E	RGD:6480464	20190611	CTD	MESH:D002251	Carbon Tetrachloride results in increased methylation of ZFP523 promoter	PMID:30690589
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314743	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ZFP523 mRNA	PMID:25629700
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF76 gene	PMID:25304211
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZNF76 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF76 mRNA	PMID:39836092|PMID:40512198
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ZNF76 mRNA	PMID:28903495
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306239	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP523 mRNA	PMID:33387578
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF76 mRNA	PMID:38568856
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF76 mRNA	PMID:39719251
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZNF76 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF76 mRNA	PMID:39836092|PMID:40512198
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZNF76 5' UTR	PMID:27901495
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314743	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ZFP523 mRNA]	PMID:22228805
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1306239	E	RGD:6480464	20200915	CTD	MESH:D008627	Mercuric Chloride results in increased expression of ZFP523 mRNA	PMID:32599119
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314743	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP523 promoter	PMID:35295148
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314743	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZFP523 gene	PMID:35295148
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306239	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ZFP523 mRNA	PMID:34492290
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306239	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of ZFP523 mRNA	PMID:33296240
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of ZNF76 mRNA	PMID:29275510
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306239	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZNF76 mRNA	PMID:25181051
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314743	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP523 mRNA	PMID:25510870
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314743	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ZFP523 mRNA	PMID:25510870
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314743	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ZFP523 mRNA	PMID:38685157
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314743	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ZFP523 mRNA	PMID:34813904
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306239	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of ZFP523 gene	PMID:33148267
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZNF76 mRNA	PMID:38174414
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314743	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of ZFP523 mRNA	PMID:23811191
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF76 mRNA	PMID:29154799
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZNF76 gene	PMID:29154799
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314743	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ZFP523 mRNA	PMID:17555576
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZNF76 mRNA	PMID:29067470
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306239	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ZFP523 mRNA	PMID:33387578
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNF76 gene	PMID:25304211
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ZNF76 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF76 mRNA	PMID:39836092|PMID:40512198
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314743	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ZFP523 mRNA	PMID:17555576
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314743	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ZFP523 mRNA; Nanotubes, Carbon results in decreased expression of ZFP523 mRNA	PMID:25554681
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1306239	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ZFP523 mRNA	PMID:37269647
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306239	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of ZFP523 gene	PMID:33148267
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF76 protein	PMID:31285264
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ZNF76 mRNA	PMID:26079696
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ZNF76 mRNA	PMID:38568856
1314742	ZNF76	zinc finger protein 76	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306239	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ZFP523 mRNA	PMID:23034163
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306240	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MRPL14 mRNA]	PMID:31150632
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314745	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL14 mRNA	PMID:36331819
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MRPL14 mRNA	PMID:21179406
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314745	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPL14 mRNA	PMID:39241906
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL14 mRNA	PMID:31059760
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MRPL14 mRNA	PMID:37042841
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:17323	trans-pinosylvin	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:C049032	pinosylvin results in decreased expression of MRPL14 mRNA	PMID:23333577
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314745	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MRPL14 mRNA	PMID:33754040
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of MRPL14 mRNA	PMID:39836092
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1314745	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of MRPL14 mRNA	PMID:27462272
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314745	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPL14 mRNA	PMID:37236586
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MRPL14 mRNA	PMID:19549813
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MRPL14 mRNA	PMID:23649840
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MRPL14 gene	PMID:27153756
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314745	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MRPL14 mRNA	PMID:19770486
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MRPL14 mRNA	PMID:23649840
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306240	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MRPL14 mRNA	PMID:31150632
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314745	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MRPL14 mRNA	PMID:31919559
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306240	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MRPL14 mRNA]	PMID:31150632
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314745	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL14 mRNA	PMID:22206623
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314745	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPL14 mRNA	PMID:40504410
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314745	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of MRPL14 mRNA	PMID:30912803
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314745	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPL14 mRNA	PMID:21570461|PMID:24680724
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306240	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPL14 mRNA	PMID:32109520|PMID:34747641
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306240	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPL14 mRNA	PMID:33387578
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of MRPL14 mRNA	PMID:33512557
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MRPL14 mRNA	PMID:30851411
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of MRPL14 mRNA	PMID:34032870
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPL14 mRNA	PMID:38568856
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314745	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPL14 mRNA	PMID:40504410
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314745	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MRPL14 mRNA	PMID:20504355
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MRPL14 mRNA]	PMID:32406909
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314745	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of MRPL14 mRNA	PMID:27131904
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306240	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MRPL14 mRNA	PMID:30047161
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314745	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MRPL14 gene	PMID:35295148
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306240	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MRPL14 mRNA	PMID:34492290
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314745	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of MRPL14 mRNA	PMID:18648102
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314745	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL14 mRNA	PMID:35598803
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of MRPL14 gene	PMID:31601247
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306240	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL14 mRNA	PMID:25181051
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306240	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MRPL14 gene	PMID:28505145
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314745	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MRPL14 gene	PMID:31683443
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314745	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MRPL14 mRNA	PMID:40203079
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314745	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPL14 mRNA	PMID:39298647
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314745	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MRPL14 mRNA	PMID:38685157
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:34631	chlorpyrifos	increases methylation	ISO	RGD:1306240	E	RGD:6480464	20210907	CTD	MESH:D004390	Chlorpyrifos results in increased methylation of MRPL14 gene	PMID:32905263
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in increased expression of MRPL14 mRNA	PMID:39836092
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314745	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPL14 mRNA	PMID:37236586
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1306240	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of MRPL14 mRNA	PMID:26194646
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:36011	pinosylvin	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C049032	pinosylvin results in decreased expression of MRPL14 mRNA	PMID:23333577
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of MRPL14 mRNA	PMID:33512557
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314745	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MRPL14 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MRPL14 mRNA	PMID:36331819
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MRPL14 gene	PMID:29154799
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306240	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MRPL14 mRNA	PMID:30047161
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1314745	E	RGD:6480464	20190219	CTD	MESH:C017160	cypermethrin results in decreased expression of MRPL14 mRNA	PMID:29020013
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1306240	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of MRPL14 mRNA	PMID:24136188
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1306240	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of MRPL14 mRNA	PMID:21346803
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314745	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MRPL14 mRNA	PMID:17562736
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL14 mRNA	PMID:31059760
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306240	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MRPL14 mRNA	PMID:33387578
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL14 mRNA	PMID:31059760
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314745	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPL14 mRNA	PMID:40504410
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314745	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MRPL14 mRNA; Nanotubes, Carbon results in decreased expression of MRPL14 mRNA	PMID:25620056
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306240	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MRPL14 mRNA	PMID:24136188
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306240	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MRPL14 mRNA	PMID:30047161
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314745	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MRPL14 mRNA	PMID:35964746
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in increased expression of MRPL14 mRNA	PMID:39836092
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:1306240	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of MRPL14 mRNA	PMID:24136188
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1306240	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of MRPL14 mRNA	PMID:24136188
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1306240	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of MRPL14 mRNA	PMID:24136188
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314745	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MRPL14 mRNA	PMID:22206623
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314745	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL14 mRNA	PMID:22206623
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:749016	gossypol acetic acid	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in decreased expression of MRPL14 protein	PMID:29938581
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306240	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MRPL14 mRNA	PMID:24136188
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in decreased expression of MRPL14 protein	PMID:39638853
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MRPL14 mRNA	PMID:30851411
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MRPL14 gene]	PMID:28238834
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306240	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of MRPL14 mRNA	PMID:30047161
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314745	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of MRPL14 mRNA	PMID:27131904
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306240	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of MRPL14 mRNA	PMID:19281266
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306240	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MRPL14 mRNA	PMID:21346803
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:9288	streptozocin	affects expression	ISO	RGD:1314745	E	RGD:6480464	20120501	CTD	MESH:D013311	Streptozocin affects the expression of MRPL14 mRNA	PMID:18583417
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of MRPL14 mRNA	PMID:33512557
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MRPL14 mRNA	PMID:38568856
1314744	MRPL14	mitochondrial ribosomal protein L14	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306240	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MRPL14 mRNA	PMID:20566332
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of DCAF4 mRNA	PMID:26272509
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF4 mRNA	PMID:27188386
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DCAF4 mRNA	PMID:33167477
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of DCAF4 mRNA	PMID:20044591
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314747	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DCAF4 mRNA	PMID:39241906
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in decreased expression of DCAF4 mRNA	PMID:21185374
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of DCAF4 mRNA	PMID:38568856
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314747	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DCAF4 mRNA	PMID:37992649
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1314747	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of DCAF4 mRNA	PMID:33848595
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314747	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DCAF4 mRNA	PMID:37992649
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306241	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DCAF4 mRNA	PMID:33387578
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314747	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DCAF4 mRNA	PMID:36331819
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DCAF4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of DCAF4 mRNA	PMID:39836092
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of DCAF4 intron	PMID:30157460
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314747	E	RGD:6480464	20250401	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WDR21 mRNA	PMID:19770486
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314747	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DCAF4 mRNA	PMID:25629700
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:27504	mitomycin C	increases expression	ISO	RGD:1314747	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in increased expression of DCAF4 mRNA	PMID:25270620
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DCAF4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DCAF4 mRNA	PMID:39836092
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:1306241	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of DCAF4 gene	PMID:31011160
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314747	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of DCAF4 mRNA	PMID:28960355
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of DCAF4 mRNA	PMID:19167446
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314747	E	RGD:6480464	20150127	CTD	MESH:D002945	Cisplatin results in increased expression of DCAF4 mRNA	PMID:25270620
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314747	E	RGD:6480464	20250401	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WDR21 mRNA	PMID:21570461
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306241	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DCAF4 mRNA	PMID:21215274
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306241	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DCAF4 mRNA	PMID:33387578
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DCAF4 mRNA	PMID:29803840
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314747	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DCAF4 mRNA	PMID:37992649
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DCAF4 mRNA	PMID:38568856
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DCAF4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DCAF4 mRNA	PMID:39836092
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314747	E	RGD:6480464	20250401	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of WDR21 mRNA	PMID:22228805
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314747	E	RGD:6480464	20250401	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WDR21 mRNA	PMID:19770486
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314747	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DCAF4 mRNA; AHR protein affects the reaction [Benzo(a)pyrene affects the expression of WDR21 mRNA]	PMID:22228805|PMID:27858113
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of DCAF4 mRNA	PMID:34408198
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314747	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DCAF4 promoter	PMID:35295148
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306241	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of DCAF4 mRNA	PMID:34492290
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314747	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of DCAF4 mRNA	PMID:23811191
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306241	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of DCAF4 mRNA	PMID:26982218
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314747	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DCAF4 mRNA	PMID:27858113
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of DCAF4 intron	PMID:30157460
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314747	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of DCAF4 intron	PMID:28392331
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1306241	E	RGD:6480464	20250401	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of WDR21 mRNA	PMID:17602206
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306241	E	RGD:6480464	20250401	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of WDR21 mRNA	PMID:17602206
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DCAF4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of DCAF4 mRNA	PMID:39836092
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1314747	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of DCAF4 mRNA	PMID:26377693
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DCAF4 mRNA	PMID:38174414|PMID:38568856
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:37918	fluorescein 5-isothiocyanate	affects binding	EXP		E	RGD:6480464	20180116	CTD	MESH:D016650	Fluorescein-5-isothiocyanate binds to DCAF4 protein	PMID:27129696
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF4 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of DCAF4 mRNA	PMID:19167446
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314747	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DCAF4 mRNA	PMID:36331819
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DCAF4 mRNA	PMID:25979313
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of DCAF4 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DCAF4 gene	PMID:29154799
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF4 mRNA	PMID:27188386
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306241	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of DCAF4 mRNA	PMID:30047161
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DCAF4 mRNA	PMID:20106945|PMID:25562108
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314747	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DCAF4 mRNA	PMID:37992649
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of DCAF4 mRNA	PMID:24935251|PMID:26272509
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF4 mRNA	PMID:27188386
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306241	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DCAF4 mRNA	PMID:33387578
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DCAF4 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DCAF4 mRNA	PMID:39836092
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:4911	etoposide	increases expression	ISO	RGD:1314747	E	RGD:6480464	20150127	CTD	MESH:D005047	Etoposide results in increased expression of DCAF4 mRNA	PMID:25270620
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1314747	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of DCAF4 mRNA	PMID:25270620
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314747	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of DCAF4 mRNA	PMID:25620056
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306241	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of DCAF4 mRNA	PMID:30047161
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314747	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DCAF4 mRNA	PMID:27858113
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314747	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of DCAF4 mRNA	PMID:27858113
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of DCAF4 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of DCAF4 mRNA	PMID:39836092
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of DCAF4 intron	PMID:30157460
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306241	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DCAF4 gene	PMID:35440735
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of DCAF4 mRNA	PMID:31758290
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of DCAF4 mRNA	PMID:37199045
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1306241	E	RGD:6480464	20250401	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of WDR21 mRNA	PMID:21346803
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF4 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF4 mRNA	PMID:27188386
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF4 mRNA	PMID:19167446
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306241	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DCAF4 mRNA	PMID:30047161
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of DCAF4 mRNA	PMID:26272509
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF4 mRNA	PMID:27188386
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF4 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF4 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF4 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DCAF4 mRNA	PMID:27188386
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306241	E	RGD:6480464	20250401	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of WDR21 mRNA	PMID:21346803
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DCAF4 mRNA	PMID:38568856
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of DCAF4 mRNA	PMID:27188386
1314746	DCAF4	DDB1 and CUL4 associated factor 4	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306241	E	RGD:6480464	20250401	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of WDR21 mRNA	PMID:21346803
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:10110	zidovudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with IFNA1 protein] results in decreased expression of RASSF7 mRNA	PMID:20370541
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RASSF7 mRNA	PMID:38218311
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306244	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of RASSF7 mRNA	PMID:21551480
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1619191	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of RASSF7 mRNA	PMID:33045310
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:15948	lycopene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C015329	lycopene results in increased expression of RASSF7 mRNA	PMID:16886892
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RASSF7 mRNA	PMID:35811015
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:16412	lipopolysaccharide	increases methylation	ISO	RGD:1619191	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased methylation of RASSF7 gene	PMID:21212295
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RASSF7 mRNA	PMID:35811015
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of RASSF7 mRNA	PMID:30510588
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306244	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of RASSF7 mRNA	PMID:32145629
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RASSF7 mRNA	PMID:37042841
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of RASSF7 mRNA	PMID:21179406
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1619191	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of RASSF7 mRNA	PMID:33848595
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1619191	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in increased expression of RASSF7 mRNA]	PMID:33848595
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1619191	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RASSF7 mRNA	PMID:34319233
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RASSF7 mRNA	PMID:28818685
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1619191	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RASSF7 mRNA	PMID:37236586
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306244	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RASSF7 mRNA	PMID:31150632
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1619191	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RASSF7 mRNA	PMID:22206623
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of RASSF7 mRNA	PMID:19244175
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of RASSF7 protein	PMID:35688186
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RASSF7 mRNA	PMID:23557933
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of RASSF7 mRNA	PMID:28903495
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of RASSF7 mRNA	PMID:27594783
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASSF7 mRNA	PMID:22574217
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306244	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASSF7 mRNA	PMID:22298810
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1619191	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASSF7 mRNA	PMID:21570461
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306244	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RASSF7 mRNA	PMID:21215274|PMID:32109520
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306244	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RASSF7 mRNA	PMID:33387578
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of RASSF7 mRNA	PMID:32763439
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of RASSF7 mRNA	PMID:39719251
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RASSF7 mRNA	PMID:25895662
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	RASSF7 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1306244	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of RASSF7 mRNA	PMID:24136188
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1619191	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of RASSF7 promoter alternative form	PMID:35295148
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306244	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of RASSF7 mRNA	PMID:34492290
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1619191	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RASSF7 mRNA	PMID:19710929
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306244	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RASSF7 mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:32528016
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1619191	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of RASSF7 mRNA	PMID:32156529
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of RASSF7 mRNA	PMID:19244175
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1619191	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RASSF7 mRNA	PMID:39298647
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1619191	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of RASSF7 mRNA	PMID:34813904
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1619191	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of RASSF7 mRNA	PMID:34813904
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RASSF7 mRNA	PMID:38568856
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1619191	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RASSF7 mRNA	PMID:37236586
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1619191	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of RASSF7 mRNA	PMID:28903501
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RASSF7 mRNA	PMID:24449571
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1619191	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of RASSF7 mRNA	PMID:18353800
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of RASSF7 mRNA	PMID:19244175
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1619191	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RASSF7 mRNA	PMID:40194260
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1619191	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RASSF7 mRNA	PMID:17292431
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in decreased expression of RASSF7 mRNA	PMID:37505509
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RASSF7 gene	PMID:29154799
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1619191	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RASSF7 mRNA	PMID:17555576
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1619191	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of RASSF7 mRNA	PMID:28973697
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1619191	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RASSF7 mRNA	PMID:28973697
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1619191	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RASSF7 mRNA	PMID:17562736
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of RASSF7 mRNA	PMID:29067470
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306244	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RASSF7 mRNA	PMID:33387578
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C088658	zoledronic acid results in decreased expression of RASSF7 protein	PMID:28871336
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RASSF7 mRNA	PMID:35811015
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1619191	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RASSF7 mRNA	PMID:17555576
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	RASSF7 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1619191	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RASSF7 mRNA; Nanotubes, Carbon results in decreased expression of RASSF7 mRNA	PMID:25554681
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1306244	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in decreased expression of RASSF7 mRNA	PMID:23962444
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1619191	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of RASSF7 mRNA	PMID:23650126
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:64243	monosodium L-glutamate	affects expression	ISO	RGD:1619191	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate affects the expression of RASSF7 mRNA	PMID:22078008
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1619191	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RASSF7 mRNA	PMID:22206623
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1619191	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RASSF7 mRNA	PMID:22206623
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of RASSF7 mRNA	PMID:19159669
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1619191	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RASSF7 mRNA	PMID:40826991
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306244	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RASSF7 mRNA	PMID:21346803
1314751	RASSF7	Ras association domain family member 7	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306244	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RASSF7 mRNA	PMID:19015723
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of ACSS1 protein	PMID:39638853
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306246	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of ACSS1 mRNA	PMID:21551480
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1615097	E	RGD:6480464	20160822	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ACSS1 mRNA	PMID:21705711|PMID:37995155
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20121113	CTD	MESH:D002794	[Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of ACSS1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACSS1 mRNA	PMID:20938992|PMID:29127188
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACSS1 mRNA	PMID:30529165
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of ACSS1 mRNA	PMID:40865780
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1615097	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ACSS1 mRNA	PMID:30319688
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ACSS1 mRNA	PMID:20044591
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ACSS1 mRNA	PMID:35811015
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ACSS1 mRNA	PMID:39241906
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACSS1 mRNA	PMID:35811015
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of ACSS1 mRNA	PMID:31614463
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1615097	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of ACSS1 mRNA	PMID:15289156
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of ACSS1 mRNA	PMID:30165855
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306246	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ACSS1 mRNA	PMID:33387578
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20121113	CTD	MESH:D008715	[Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of ACSS1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACSS1 mRNA	PMID:20938992|PMID:29127188
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D005947	Glucose results in increased expression of ACSS1 mRNA	PMID:36156098
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACSS1 mRNA	PMID:37992649
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of ACSS1 mRNA	PMID:20403060
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1615097	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of ACSS1 mRNA	PMID:33848595
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D005947	Glucose results in increased expression of ACSS1 mRNA	PMID:36156098
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACSS1 mRNA	PMID:37992649
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ACSS1 mRNA	PMID:35550907
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1615097	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ACSS1 mRNA	PMID:35550907
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSS1 mRNA; [Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of ACSS1 mRNA	PMID:31606821|PMID:39150890
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306246	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ACSS1 mRNA	PMID:26577399|PMID:27523638
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306246	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ACSS1 mRNA	PMID:22061828
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ACSS1 mRNA	PMID:28818685
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACSS1 mRNA	PMID:37325564
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS1 mRNA	PMID:29950665
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ACSS1 mRNA	PMID:19549813
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1306246	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSS1 mRNA	PMID:22129741
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ACSS1 mRNA	PMID:32234424
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306246	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of ACSS1 mRNA	PMID:30779732
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1615097	E	RGD:6480464	20200804	CTD	MESH:C011559	tributyltin results in increased expression of ACSS1 mRNA	PMID:31939706
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACSS1 mRNA; [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of ACSS1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ACSS1 mRNA	PMID:20938992|PMID:22206623|PMID:29127188
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS1 mRNA	PMID:32045263
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20260804	CTD	MESH:C010974	Glyphosate results in increased expression of ACSS1 mRNA	PMID:40865780
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306246	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ACSS1 mRNA	PMID:31881176
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of ACSS1 mRNA	PMID:19921347
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of ACSS1 mRNA	PMID:40618947
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1306246	E	RGD:6480464	20180313	CTD	MESH:D003042	Cocaine results in decreased expression of ACSS1 mRNA	PMID:27899881
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1615097	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of ACSS1 mRNA	PMID:18930951
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1615097	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of ACSS1 mRNA	PMID:15289156
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306246	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACSS1 mRNA	PMID:33387578
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of ACSS1 mRNA	PMID:39709020
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ACSS1 mRNA	PMID:32763439
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306246	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of ACSS1 mRNA	PMID:28959563
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306246	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ACSS1 mRNA	PMID:30556269
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ACSS1 mRNA	PMID:20971185
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28748	doxorubicin	decreases acetylation	ISO	RGD:1615097	E	RGD:6480464	20200804	CTD	MESH:D004317	Doxorubicin results in decreased acetylation of ACSS1 protein	PMID:31768571
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of ACSS1 mRNA	PMID:26873546
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1615097	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of ACSS1 mRNA	PMID:39631538
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20160607	CTD	MESH:D004317	[Doxorubicin co-treated with Dexrazoxane] results in increased expression of ACSS1 mRNA; Doxorubicin affects the reaction [SIRT1 protein affects the acetylation of ACSS1 protein]	PMID:26873546|PMID:31768571
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACSS1 mRNA	PMID:37992649
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ACSS1 mRNA	PMID:20044591
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1306246	E	RGD:6480464	20121009	CTD	MESH:D000111	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSS1 mRNA	PMID:22129741
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1615097	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ACSS1 gene	PMID:39894169
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20220208	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS1 mRNA	PMID:32045263
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ACSS1 promoter	PMID:30157460
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACSS1 mRNA; Benzo(a)pyrene results in decreased expression of ACSS1 protein	PMID:32234424|PMID:33278487
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACSS1 mRNA	PMID:22610609
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1615097	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACSS1 mRNA	PMID:22228805
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ACSS1 3' UTR; Benzo(a)pyrene results in increased methylation of ACSS1 exon; Benzo(a)pyrene results in increased methylation of ACSS1 promoter	PMID:27901495
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of ACSS1 promoter	PMID:23974009
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306246	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ACSS1 mRNA	PMID:30556269
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ACSS1 mRNA	PMID:20971185
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of ACSS1 mRNA	PMID:37690743
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ACSS1 gene	PMID:31601247
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1306246	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ACSS1 mRNA	PMID:25729387
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306246	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ACSS1 mRNA	PMID:25729387
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:32138	sodium acetate trihydrate	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D019346	Sodium Acetate results in increased expression of ACSS1 mRNA	PMID:36156098
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACSS1 mRNA	PMID:27760801
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS1 mRNA	PMID:29950665
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1306246	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide affects the expression of ACSS1 mRNA	PMID:34492290
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1615097	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ACSS1 mRNA	PMID:23811191
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306246	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ACSS1 mRNA	PMID:25181051
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:33216	bisphenol A	affects methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A affects the methylation of ACSS1 gene	PMID:31601247
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1615097	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ACSS1 promoter	PMID:27334623
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of ACSS1 protein	PMID:31675489
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of ACSS1 mRNA	PMID:32156529
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1615097	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ACSS1 mRNA	PMID:26063408
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306246	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ACSS1 gene	PMID:28505145
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ACSS1 gene	PMID:31601247
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of ACSS1 protein	PMID:31675489
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ACSS1 mRNA	PMID:26682919
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl results in decreased expression of ACSS1 mRNA	PMID:36804509
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ACSS1 mRNA	PMID:39298647
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSS1 mRNA	PMID:39150890
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS1 mRNA	PMID:29950665
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ACSS1 mRNA	PMID:17361019|PMID:21266533
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSS1 mRNA	PMID:39150890
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSS1 mRNA	PMID:39150890
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306246	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ACSS1 mRNA	PMID:22129741
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306246	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of ACSS1 mRNA	PMID:32680482
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACSS1 mRNA	PMID:37325564
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSS1 mRNA	PMID:39150890
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1615097	E	RGD:6480464	20190507	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ACSS1 mRNA	PMID:30657992
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ACSS1 mRNA	PMID:31533062
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ACSS1 mRNA	PMID:23179753|PMID:26272509
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1615097	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of ACSS1 mRNA	PMID:21427059
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSS1 mRNA	PMID:27188386
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1615097	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of ACSS1 mRNA	PMID:15289156
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:D005947	Glucose results in increased expression of ACSS1 mRNA	PMID:36156098
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ACSS1 mRNA	PMID:37992649
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ACSS1 mRNA	PMID:38832940
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of ACSS1 mRNA	PMID:25704631|PMID:29067470
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACSS1 mRNA	PMID:35811015
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20220208	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACSS1 mRNA	PMID:32045263
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of ACSS1 mRNA	PMID:31675489
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ACSS1 mRNA	PMID:32234424
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:50223	(+)-dexrazoxane	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20170303	CTD	MESH:D064730	Dexrazoxane results in decreased expression of ACSS1 mRNA	PMID:26873546
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:50223	(+)-dexrazoxane	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20170303	CTD	MESH:D064730	[Doxorubicin co-treated with Dexrazoxane] results in increased expression of ACSS1 mRNA	PMID:26873546
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ACSS1 mRNA; Nanotubes, Carbon results in decreased expression of ACSS1 mRNA	PMID:25554681
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:6030	isoniazide	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of ACSS1 protein	PMID:40015660
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306246	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of ACSS1 mRNA	PMID:25729387
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306246	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ACSS1 mRNA	PMID:25729387
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ACSS1 mRNA	PMID:28988120|PMID:29427785
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ACSS1 mRNA	PMID:31758290
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACSS1 mRNA	PMID:22206623
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:76604	MeIQx	decreases expression	EXP		E	RGD:6480464	20140107	CTD	MESH:C036990	2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in decreased expression of ACSS1 mRNA	PMID:20816883
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of ACSS1 protein	PMID:39638853
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1306246	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased expression of ACSS1 mRNA	PMID:37162024
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:7719	ochratoxin A	increases methylation	ISO	RGD:1306246	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased methylation of ACSS1 gene	PMID:37162024
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSS1 mRNA	PMID:27188386
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ACSS1 mRNA	PMID:39150890
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ACSS1 gene]	PMID:28238834
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ACSS1 protein	PMID:31675489
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of ACSS1 mRNA	PMID:30458266
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of ACSS1 mRNA	PMID:32234424
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ACSS1 protein	PMID:31675489
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306246	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ACSS1 mRNA	PMID:24780913
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSS1 mRNA	PMID:27188386
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1615097	E	RGD:6480464	20191008	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased expression of ACSS1 mRNA; [Streptozocin co-treated with Diethylhexyl Phthalate] results in decreased expression of ACSS1 mRNA	PMID:29127188|PMID:31606821
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1615097	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ACSS1 mRNA	PMID:35537566
1314754	ACSS1	acyl-CoA synthetase short chain family member 1	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1306246	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of ACSS1 gene	PMID:31079544
1314756	TLN1	talin 1	gene	CHEBI:10106	zearalenone	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20141223	CTD	MESH:D015025	[Zearalenone co-treated with CGA protein] results in increased expression of TLN1 protein	PMID:25058043
1314756	TLN1	talin 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1550435	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of TLN1 mRNA	PMID:33045310
1314756	TLN1	talin 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TLN1 gene	PMID:20938992
1314756	TLN1	talin 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of TLN1 mRNA	PMID:26079696
1314756	TLN1	talin 1	gene	CHEBI:15940	nicotinic acid	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20161213	CTD	MESH:D009525	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of TLN1 mRNA]	PMID:16940432
1314756	TLN1	talin 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1550435	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of TLN1 mRNA	PMID:30319688
1314756	TLN1	talin 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TLN1 mRNA	PMID:12057914
1314756	TLN1	talin 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550435	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TLN1 mRNA	PMID:39241906
1314756	TLN1	talin 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TLN1 gene	PMID:20938992
1314756	TLN1	talin 1	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in decreased expression of TLN1 protein	PMID:31483951
1314756	TLN1	talin 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20201103	CTD	MESH:D005947	Eucalyptol inhibits the reaction [Glucose results in decreased expression of TLN1 protein]	PMID:31483951
1314756	TLN1	talin 1	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in decreased expression of TLN1 protein	PMID:31483951
1314756	TLN1	talin 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20201103	CTD	MESH:D005947	Eucalyptol inhibits the reaction [Glucose results in decreased expression of TLN1 protein]	PMID:31483951
1314756	TLN1	talin 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TLN1 mRNA	PMID:33754040
1314756	TLN1	talin 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TLN1 mRNA	PMID:31163220
1314756	TLN1	talin 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306247	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of TLN1 mRNA	PMID:26577399
1314756	TLN1	talin 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TLN1 protein	PMID:37730182
1314756	TLN1	talin 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of TLN1 mRNA	PMID:28818685
1314756	TLN1	talin 1	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of TLN1 mRNA	PMID:27462272
1314756	TLN1	talin 1	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TLN1 mRNA	PMID:29950665
1314756	TLN1	talin 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TLN1 protein	PMID:23301498
1314756	TLN1	talin 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TLN1 gene; Aflatoxin B1 results in decreased methylation of TLN1 intron	PMID:27153756|PMID:30157460
1314756	TLN1	talin 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of TLN1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of TLN1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of TLN1 protein	PMID:38598786
1314756	TLN1	talin 1	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TLN1 mRNA	PMID:22171008
1314756	TLN1	talin 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TLN1 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TLN1 mRNA]	PMID:20938992|PMID:22206623
1314756	TLN1	talin 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TLN1 mRNA	PMID:40504410
1314756	TLN1	talin 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TLN1 mRNA	PMID:19244175
1314756	TLN1	talin 1	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of TLN1 protein	PMID:38460933
1314756	TLN1	talin 1	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of TLN1 protein	PMID:35688186
1314756	TLN1	talin 1	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	TLN1 protein affects the susceptibility to Cisplatin	PMID:21720550
1314756	TLN1	talin 1	gene	CHEBI:27899	cisplatin	increases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	TLN1 protein results in increased susceptibility to Cisplatin	PMID:21291860
1314756	TLN1	talin 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	TLN1 protein promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased susceptibility to Cisplatin]; TLN1 protein promotes the reaction [benzyloxycarbonyl-valyl-alanyl-aspartic acid analog results in increased susceptibility to Cisplatin]	PMID:21720550
1314756	TLN1	talin 1	gene	CHEBI:27961	1,8-cineole	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20201103	CTD	MESH:D000077591	Eucalyptol inhibits the reaction [Glucose results in decreased expression of TLN1 protein]; Eucalyptol inhibits the reaction [LEP gene mutant form results in decreased expression of TLN1 protein]	PMID:31483951
1314756	TLN1	talin 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TLN1 mRNA	PMID:30912803
1314756	TLN1	talin 1	gene	CHEBI:28073	chromium atom	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20120412	CTD	MESH:D002857	LEPR gene mutant form promotes the reaction [[Niacin binds to Chromium] which results in increased expression of TLN1 mRNA]	PMID:16940432
1314756	TLN1	talin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306247	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TLN1 mRNA	PMID:34747641
1314756	TLN1	talin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550435	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TLN1 mRNA	PMID:21570461
1314756	TLN1	talin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306247	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TLN1 mRNA	PMID:15644576|PMID:33387578
1314756	TLN1	talin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TLN1 mRNA	PMID:17942748
1314756	TLN1	talin 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1306247	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in decreased expression of TLN1 mRNA	PMID:19013527
1314756	TLN1	talin 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TLN1 mRNA	PMID:28001369|PMID:34089799
1314756	TLN1	talin 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TLN1 mRNA	PMID:33212167
1314756	TLN1	talin 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of TLN1 mRNA	PMID:29803840
1314756	TLN1	talin 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1306247	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of TLN1 protein	PMID:29459688
1314756	TLN1	talin 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TLN1 mRNA	PMID:38568856
1314756	TLN1	talin 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TLN1 mRNA	PMID:40504410
1314756	TLN1	talin 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TLN1 intron	PMID:30157460
1314756	TLN1	talin 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TLN1 mRNA	PMID:19770486
1314756	TLN1	talin 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TLN1 5' UTR	PMID:27901495
1314756	TLN1	talin 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TLN1 mRNA	PMID:26238291
1314756	TLN1	talin 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TLN1 mRNA	PMID:27858113
1314756	TLN1	talin 1	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of TLN1 mRNA	PMID:22171008
1314756	TLN1	talin 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of TLN1 mRNA	PMID:25895662
1314756	TLN1	talin 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TLN1 protein	PMID:25419056
1314756	TLN1	talin 1	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:D005707	Gallic Acid results in decreased expression of TLN1 protein	PMID:38100242
1314756	TLN1	talin 1	gene	CHEBI:31991	phenol red	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D010637	[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of TLN1 protein	PMID:31629898
1314756	TLN1	talin 1	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TLN1 mRNA	PMID:29950665
1314756	TLN1	talin 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306247	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TLN1 mRNA	PMID:25181051
1314756	TLN1	talin 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of TLN1 protein	PMID:34186270
1314756	TLN1	talin 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306247	E	RGD:6480464	20250114	CTD	MESH:C006780	bisphenol A results in decreased expression of TLN1 mRNA	PMID:38750585
1314756	TLN1	talin 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of TLN1 protein	PMID:37567409
1314756	TLN1	talin 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	[Phenolsulfonphthalein deficiency co-treated with bisphenol A deficiency] results in increased expression of TLN1 protein	PMID:31629898
1314756	TLN1	talin 1	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of TLN1 mRNA	PMID:19244175
1314756	TLN1	talin 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of TLN1 mRNA	PMID:26682919
1314756	TLN1	talin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TLN1 mRNA	PMID:39298647
1314756	TLN1	talin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of TLN1 protein	PMID:34186270
1314756	TLN1	talin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550435	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of TLN1 mRNA	PMID:30951980
1314756	TLN1	talin 1	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TLN1 mRNA	PMID:27858113
1314756	TLN1	talin 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of TLN1 protein	PMID:34186270
1314756	TLN1	talin 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550435	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of TLN1 mRNA	PMID:30951980
1314756	TLN1	talin 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TLN1 mRNA	PMID:28628672
1314756	TLN1	talin 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TLN1 protein	PMID:34186270
1314756	TLN1	talin 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of TLN1 mRNA	PMID:29950665
1314756	TLN1	talin 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1550435	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of TLN1 mRNA	PMID:17361019|PMID:21266533
1314756	TLN1	talin 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of TLN1 protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of TLN1 protein	PMID:38598786
1314756	TLN1	talin 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TLN1 mRNA	PMID:28628672
1314756	TLN1	talin 1	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1550435	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of TLN1 mRNA	PMID:17942915
1314756	TLN1	talin 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20120412	CTD	MESH:D004052	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of TLN1 mRNA]	PMID:17942915
1314756	TLN1	talin 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TLN1 mRNA	PMID:37042841
1314756	TLN1	talin 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TLN1 mRNA; Cadmium Chloride results in increased expression of TLN1 protein	PMID:24527689|PMID:38382870|PMID:38568856
1314756	TLN1	talin 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1306247	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of TLN1 promoter	PMID:22457795
1314756	TLN1	talin 1	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1550435	E	RGD:6480464	20240206	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of TLN1 protein	PMID:37422089
1314756	TLN1	talin 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TLN1 mRNA	PMID:19244175
1314756	TLN1	talin 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of TLN1 mRNA	PMID:28302478
1314756	TLN1	talin 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of TLN1 mRNA	PMID:29154799
1314756	TLN1	talin 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TLN1 mRNA	PMID:28628672
1314756	TLN1	talin 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of TLN1 mRNA	PMID:28973697
1314756	TLN1	talin 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550435	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of TLN1 mRNA	PMID:28973697
1314756	TLN1	talin 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20201103	CTD	MESH:D005947	Glucose results in decreased expression of TLN1 protein	PMID:31483951
1314756	TLN1	talin 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20201103	CTD	MESH:D005947	Eucalyptol inhibits the reaction [Glucose results in decreased expression of TLN1 protein]	PMID:31483951
1314756	TLN1	talin 1	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	TLN1 protein affects the susceptibility to Methotrexate	PMID:16217747
1314756	TLN1	talin 1	gene	CHEBI:4469	(S)-amphetamine	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20120412	CTD	MESH:D003913	Dextroamphetamine results in decreased expression of TLN1 mRNA	PMID:12205029
1314756	TLN1	talin 1	gene	CHEBI:4469	(S)-amphetamine	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20120412	CTD	MESH:D003913	SOD1 inhibits the reaction [Dextroamphetamine results in decreased expression of TLN1 mRNA]	PMID:12205029
1314756	TLN1	talin 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550435	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TLN1 mRNA	PMID:17562736
1314756	TLN1	talin 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306247	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TLN1 mRNA	PMID:33387578
1314756	TLN1	talin 1	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of TLN1 protein	PMID:38460933
1314756	TLN1	talin 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TLN1 mRNA	PMID:40504410
1314756	TLN1	talin 1	gene	CHEBI:472805	ouabain	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D010042	Ouabain results in decreased expression of TLN1 mRNA	PMID:28795476
1314756	TLN1	talin 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TLN1 mRNA	PMID:17942748
1314756	TLN1	talin 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of TLN1 mRNA	PMID:28628672
1314756	TLN1	talin 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TLN1 protein	PMID:25419056
1314756	TLN1	talin 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of TLN1 mRNA	PMID:35964746
1314756	TLN1	talin 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306247	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of TLN1 mRNA	PMID:24793618
1314756	TLN1	talin 1	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TLN1 mRNA	PMID:27858113
1314756	TLN1	talin 1	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TLN1 mRNA	PMID:27858113
1314756	TLN1	talin 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550435	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of TLN1 mRNA	PMID:19042947
1314756	TLN1	talin 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TLN1 protein	PMID:32959892
1314756	TLN1	talin 1	gene	CHEBI:63041	manganese(II) chloride	decreases response to substance	ISO	RGD:1550435	E	RGD:6480464	20120717	CTD	MESH:C025340	manganese chloride results in decreased susceptibility to TLN1 protein mutant form	PMID:20971947
1314756	TLN1	talin 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20120717	CTD	MESH:C025340	manganese chloride inhibits the reaction [TLN1 protein mutant form results in decreased activity of [ITGB3 protein binds to ITGA2B protein]]	PMID:20971947
1314756	TLN1	talin 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1550435	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TLN1 protein	PMID:26558463
1314756	TLN1	talin 1	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1306247	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of TLN1 mRNA	PMID:35283115
1314756	TLN1	talin 1	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1550435	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of TLN1 mRNA	PMID:27462272
1314756	TLN1	talin 1	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1306247	E	RGD:6480464	20230801	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of TLN1 mRNA	PMID:36657700
1314756	TLN1	talin 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TLN1 protein	PMID:34186270
1314756	TLN1	talin 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550435	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TLN1 mRNA	PMID:22206623
1314756	TLN1	talin 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550435	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TLN1 mRNA]	PMID:22206623
1314756	TLN1	talin 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TLN1 protein	PMID:37664457
1314756	TLN1	talin 1	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1306247	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of TLN1 mRNA	PMID:33484710
1314756	TLN1	talin 1	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of TLN1 protein	PMID:39638853
1314756	TLN1	talin 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TLN1 gene]	PMID:28238834
1314756	TLN1	talin 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306247	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of TLN1 mRNA	PMID:32109520
1314756	TLN1	talin 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of TLN1 mRNA	PMID:19095052
1314756	TLN1	talin 1	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1550435	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of TLN1 mRNA	PMID:27029645
1314756	TLN1	talin 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of TLN1 mRNA	PMID:21795629
1314756	TLN1	talin 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TLN1 protein	PMID:37664457
1314756	TLN1	talin 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306247	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TLN1 mRNA	PMID:19281266
1314756	TLN1	talin 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TLN1 mRNA	PMID:38568856
1314756	TLN1	talin 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Furaldehyde co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of TLN1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of TLN1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of TLN1 protein	PMID:38598786
1314756	TLN1	talin 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550435	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of TLN1 mRNA	PMID:28973697
1314759	KRT33A	keratin 33A	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306249	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of KRT33A gene	PMID:27618143
1314759	KRT33A	keratin 33A	gene	CHEBI:17303	morphine	increases expression	ISO	RGD:1306249	E	RGD:6480464	20160628	CTD	MESH:D009020	Morphine results in increased expression of KRT33A protein	PMID:23056601
1314759	KRT33A	keratin 33A	gene	CHEBI:17303	morphine	multiple interactions	ISO	RGD:1306249	E	RGD:6480464	20160628	CTD	MESH:D009020	Morphine deficiency inhibits the reaction [Morphine deficiency promotes the reaction [Morphine results in increased expression of KRT33A protein]]; Morphine deficiency promotes the reaction [Morphine results in increased expression of KRT33A protein]	PMID:23056601
1314759	KRT33A	keratin 33A	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306249	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of KRT33A mRNA	PMID:27523638
1314759	KRT33A	keratin 33A	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KRT33A mRNA	PMID:19549813
1314759	KRT33A	keratin 33A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KRT33A gene	PMID:27153756
1314759	KRT33A	keratin 33A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of KRT33A mRNA	PMID:23557933
1314759	KRT33A	keratin 33A	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1306249	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of KRT33A gene; [bisphenol A co-treated with Genistein] results in increased methylation of KRT33B gene	PMID:28505145
1314759	KRT33A	keratin 33A	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of KRT33A mRNA	PMID:29955902
1314759	KRT33A	keratin 33A	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306249	E	RGD:6480464	20230404	CTD	MESH:D020106	Acrylamide results in decreased expression of KRT33B mRNA	PMID:28959563
1314759	KRT33A	keratin 33A	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306249	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of KRT33A mRNA	PMID:28959563
1314759	KRT33A	keratin 33A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314760	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of KRT33A mRNA	PMID:37682722
1314759	KRT33A	keratin 33A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KRT33A mRNA	PMID:22316170
1314759	KRT33A	keratin 33A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KRT33A exon; Benzo(a)pyrene results in increased methylation of KRT33A promoter	PMID:27901495
1314759	KRT33A	keratin 33A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306249	E	RGD:6480464	20160628	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT33A mRNA	PMID:25181051|PMID:34947998
1314759	KRT33A	keratin 33A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306249	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of KRT33B mRNA	PMID:41034487
1314759	KRT33A	keratin 33A	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306249	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KRT33A gene; bisphenol A results in increased methylation of KRT33B gene	PMID:28505145
1314759	KRT33A	keratin 33A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306249	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of KRT33A gene; [bisphenol A co-treated with Genistein] results in increased methylation of KRT33B gene	PMID:28505145
1314759	KRT33A	keratin 33A	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of KRT33A exon	PMID:30157460
1314759	KRT33A	keratin 33A	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1306249	E	RGD:6480464	20160628	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of KRT33A promoter	PMID:22457795
1314759	KRT33A	keratin 33A	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306249	E	RGD:6480464	20160628	CTD	MESH:C039281	furan results in increased expression of KRT33A mRNA	PMID:25539665
1314759	KRT33A	keratin 33A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314760	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of KRT33A mRNA	PMID:17963808
1314759	KRT33A	keratin 33A	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306249	E	RGD:6480464	20160628	CTD	MESH:D005485	Flutamide results in increased expression of KRT33A mRNA	PMID:24793618
1314759	KRT33A	keratin 33A	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of KRT33A exon	PMID:30157460
1314759	KRT33A	keratin 33A	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KRT33A gene]	PMID:28238834
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of L2HGDH mRNA	PMID:22378314
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1550752	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of L2HGDH mRNA	PMID:30319688
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1550752	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of L2HGDH mRNA	PMID:30319688
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1550752	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of L2HGDH mRNA	PMID:39241906
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550752	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of L2HGDH mRNA	PMID:39298647
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of L2HGDH mRNA	PMID:19167446
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1550752	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in decreased expression of L2HGDH mRNA	PMID:22238285
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of L2HGDH mRNA	PMID:21179406
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:17084	2-hydroxyglutaric acid	increases abundance	EXP		E	RGD:6480464	20150609	CTD	MESH:C019417	L2HGDH gene mutant form results in increased abundance of alpha-hydroxyglutarate	PMID:25800467
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306250	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of L2HGDH mRNA	PMID:26577399
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of L2HGDH mRNA	PMID:19549813
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550752	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of L2HGDH mRNA	PMID:34911549
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of L2HGDH mRNA	PMID:18356318
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1550752	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of L2HGDH mRNA	PMID:31919559
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550752	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of L2HGDH mRNA	PMID:28960355
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of L2HGDH mRNA	PMID:19167446
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:28001	vancomycin	increases expression	ISO	RGD:1550752	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in increased expression of L2HGDH mRNA	PMID:18930951
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306250	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of L2HGDH mRNA	PMID:28959563
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1550752	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of L2HGDH protein	PMID:28918527
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of L2HGDH mRNA	PMID:29803840
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of L2HGDH mRNA	PMID:29319823
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of L2HGDH mRNA	PMID:38568856
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550752	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of L2HGDH protein	PMID:29044176
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to L2HGDH protein]	PMID:32406909
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of L2HGDH mRNA	PMID:18356318
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of L2HGDH mRNA	PMID:20018196
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1306250	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of L2HGDH mRNA	PMID:24136188
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:31823	mercury dichloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D008627	[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of L2HGDH mRNA	PMID:27188386
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550752	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of L2HGDH gene	PMID:35295148
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550752	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of L2HGDH mRNA	PMID:18445702
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1550752	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of L2HGDH mRNA	PMID:28472532
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1550752	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of L2HGDH mRNA	PMID:28329830
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306250	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of L2HGDH mRNA	PMID:25181051
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306250	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of L2HGDH mRNA	PMID:34947998
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of L2HGDH gene	PMID:31601247
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1550752	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of L2HGDH mRNA	PMID:26682919
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1550752	E	RGD:6480464	20250805	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of L2HGDH protein	PMID:26903627
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of L2HGDH protein	PMID:31945527
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of L2HGDH protein	PMID:34186270
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of L2HGDH intron	PMID:30157460
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1550752	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of L2HGDH mRNA	PMID:38685157
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1550752	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of L2HGDH mRNA	PMID:34813904
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1550752	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of L2HGDH mRNA	PMID:34813904
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of L2HGDH mRNA	PMID:37047231
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of L2HGDH mRNA	PMID:37042841
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306250	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of L2HGDH mRNA	PMID:25539665
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of L2HGDH mRNA	PMID:19167446
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of L2HGDH mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of L2HGDH mRNA	PMID:19167446
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of L2HGDH mRNA	PMID:25979313
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of L2HGDH mRNA	PMID:29154799
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of L2HGDH mRNA	PMID:20106945
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550752	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of L2HGDH mRNA	PMID:17562736
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1550752	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in decreased expression of L2HGDH mRNA	PMID:19420014
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of L2HGDH mRNA	PMID:25704631
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306250	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of L2HGDH mRNA	PMID:33387578
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of L2HGDH mRNA	PMID:40706910
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1306250	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of L2HGDH mRNA	PMID:36868495
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550752	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of L2HGDH mRNA	PMID:25620056
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of L2HGDH protein	PMID:32959892
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1550752	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of L2HGDH mRNA	PMID:23650126
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of L2HGDH intron	PMID:30157460
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1550752	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in decreased expression of L2HGDH mRNA	PMID:31052254
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550752	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of L2HGDH mRNA	PMID:22206623
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of L2HGDH mRNA	PMID:27188386
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of L2HGDH mRNA	PMID:19167446
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of L2HGDH mRNA	PMID:27188386
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:94688	5-methyl-4-oxido-2-pyrazin-4-iumcarboxylic acid	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C027696	acipimox results in decreased expression of L2HGDH mRNA	PMID:25352640
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of L2HGDH mRNA	PMID:38568856
1314761	L2HGDH	L-2-hydroxyglutarate dehydrogenase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306250	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of L2HGDH mRNA	PMID:21346803
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of ELAVL2 mRNA	PMID:27188386
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314764	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ELAVL2 mRNA	PMID:33045310
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ELAVL2 mRNA	PMID:24236059
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ELAVL2 mRNA	PMID:25510870
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314764	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of ELAVL2 mRNA	PMID:33711761
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:628611	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ELAVL2 mRNA	PMID:33387578
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of ELAVL2 mRNA	PMID:27683099
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:17594	hydroquinone	multiple interactions	EXP		E	RGD:6480464	20230404	CTD	MESH:C031927	[[NOX4 protein results in decreased expression of ELAVL2 protein] which promotes the reaction SIDT2 protein] promotes the reaction [hydroquinone results in decreased degradation of SIRT3 protein]	PMID:35302183
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314764	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ELAVL2 mRNA	PMID:34319233
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ELAVL2 mRNA	PMID:39150890
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:628611	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ELAVL2 mRNA	PMID:26577399
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:628611	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ELAVL2 mRNA	PMID:33387578
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ELAVL2 mRNA	PMID:25510870
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ELAVL2 mRNA	PMID:25510870
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ELAVL2 gene	PMID:27153756
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:628611	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ELAVL2 mRNA	PMID:23630614
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ELAVL2 intron	PMID:30157460
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314764	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ELAVL2 mRNA	PMID:25629700
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] affects the splicing of ELAVL2; [sodium arsenite results in increased abundance of Arsenic] which affects the splicing of ELAVL2	PMID:40512198
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELAVL2 mRNA	PMID:40504410
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:628611	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of ELAVL2 mRNA	PMID:31881176
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of ELAVL2 mRNA	PMID:28903495
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314764	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ELAVL2 mRNA	PMID:21570461
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:628611	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ELAVL2 mRNA	PMID:32109520|PMID:33387578
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of ELAVL2 mRNA	PMID:19465110
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ELAVL2 mRNA	PMID:33212167
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ELAVL2 mRNA	PMID:20971185
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:28869	menadione	affects expression	ISO	RGD:1314764	E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ELAVL2 mRNA	PMID:20829426
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:29014	cordycepin	increases expression	ISO	RGD:1314764	E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin results in increased expression of ELAVL2 mRNA	PMID:32042022
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ELAVL2 mRNA	PMID:38568856|PMID:39719251
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] affects the splicing of ELAVL2; [sodium arsenite results in increased abundance of Arsenic] which affects the splicing of ELAVL2	PMID:40512198
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELAVL2 mRNA	PMID:40504410
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ELAVL2 5' UTR	PMID:27901495
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314764	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ELAVL2 mRNA	PMID:21964900|PMID:27195522
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314764	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ELAVL2 intron	PMID:27901495
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:628611	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ELAVL2 mRNA	PMID:21839799
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ELAVL2 promoter	PMID:27901495
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of ELAVL2 promoter	PMID:23974009
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of ELAVL2 mRNA	PMID:20971185
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:628611	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of ELAVL2 mRNA	PMID:16483693
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:31236	aripiprazole	increases expression	ISO	RGD:628611	E	RGD:6480464	20170228	CTD	MESH:C094645	Aripiprazole results in increased expression of ELAVL2 mRNA	PMID:17868501
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ELAVL2 gene	PMID:31601247
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:628611	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ELAVL2 mRNA	PMID:30047161
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314764	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ELAVL2 promoter	PMID:35295148
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314764	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ELAVL2 gene	PMID:35295148
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314764	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ELAVL2 mRNA	PMID:20813756
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:33007	chromium(6+)	affects expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ELAVL2 mRNA	PMID:30690063
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:628611	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ELAVL2 mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:628611	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of ELAVL2 mRNA	PMID:30816183
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ELAVL2 gene	PMID:31601247
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ELAVL2 mRNA	PMID:25510870
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ELAVL2 mRNA	PMID:25510870
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ELAVL2 intron	PMID:30157460
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314764	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ELAVL2 intron	PMID:28392331
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ELAVL2 mRNA	PMID:39150890
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314764	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ELAVL2 mRNA	PMID:21266533
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ELAVL2 mRNA	PMID:39150890
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ELAVL2 mRNA	PMID:39150890
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ELAVL2 mRNA	PMID:39150890
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314764	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ELAVL2 mRNA	PMID:39529242
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ELAVL2 mRNA	PMID:25979313
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ELAVL2 mRNA	PMID:23179753
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314764	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of ELAVL2 mRNA	PMID:21427059
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ELAVL2 gene	PMID:29154799
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ELAVL2 mRNA	PMID:23179753
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:628611	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ELAVL2 mRNA	PMID:30047161
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of ELAVL2 mRNA	PMID:24935251
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:628611	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ELAVL2 mRNA	PMID:33387578
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] affects the splicing of ELAVL2; [sodium arsenite results in increased abundance of Arsenic] which affects the splicing of ELAVL2	PMID:40512198
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELAVL2 mRNA	PMID:40504410
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ELAVL2 mRNA	PMID:22079256
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:628611	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ELAVL2 mRNA	PMID:29097150
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:628611	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ELAVL2 mRNA	PMID:30307764
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:628611	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ELAVL2 mRNA	PMID:30047161
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1314764	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of ELAVL2 mRNA	PMID:20829426
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ELAVL2 intron	PMID:30157460
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:6842	methoxychlor	affects expression	ISO	RGD:1314764	E	RGD:6480464	20120412	CTD	MESH:D008731	Methoxychlor affects the expression of ELAVL2 mRNA	PMID:20829426
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ELAVL2 mRNA	PMID:22079256
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ELAVL2 mRNA	PMID:22714537
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ELAVL2 mRNA	PMID:22079256
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of ELAVL2 mRNA	PMID:29522793
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:753160	lard	increases expression	ISO	RGD:628611	E	RGD:6480464	20260714	CTD	MESH:C029310	lard results in increased expression of ELAVL2 mRNA	PMID:26115784
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	increases expression	ISO	RGD:628611	E	RGD:6480464	20210406	CTD	MESH:C074283	estradiol 3-benzoate results in increased expression of ELAVL2 mRNA	PMID:32741896
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1314764	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of ELAVL2 mRNA	PMID:39150890
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ELAVL2 gene]	PMID:28238834
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:628611	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of ELAVL2 mRNA	PMID:23914054
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:83258	fenamidone	decreases expression	ISO	RGD:1314764	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in decreased expression of ELAVL2 mRNA	PMID:27029645
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:628611	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ELAVL2 mRNA	PMID:30047161
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:628611	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ELAVL2 mRNA	PMID:24780913
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ELAVL2 mRNA	PMID:38568856
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:628611	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ELAVL2 mRNA	PMID:19015723
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:628611	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of ELAVL2 mRNA	PMID:18042343
1314763	ELAVL2	ELAV like RNA binding protein 2	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:628611	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of ELAVL2 gene	PMID:31682807
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ALOXE3 mRNA	PMID:38218311
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306252	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ALOXE3 mRNA]	PMID:31150632
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ALOXE3 mRNA	PMID:35811015
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ALOXE3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of ALOXE3 mRNA	PMID:35811015
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ALOXE3 mRNA	PMID:31614463
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1314766	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in increased expression of ALOXE3 mRNA	PMID:18978301
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ALOXE3 mRNA	PMID:38568856
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306252	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ALOXE3 mRNA	PMID:33387578
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1314766	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ALOXE3 mRNA	PMID:39922521
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of ALOXE3 mRNA	PMID:33647349
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of ALOXE3 mRNA	PMID:31256213
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1314766	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ALOXE3 mRNA	PMID:39922521
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ALOXE3 mRNA	PMID:36139627
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306252	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ALOXE3 mRNA	PMID:33387578
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ALOXE3 intron	PMID:30157460
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ALOXE3 gene	PMID:27153756
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ALOXE3 exon; Aflatoxin B1 results in increased methylation of ALOXE3 intron	PMID:30157460
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306252	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ALOXE3 mRNA	PMID:31150632
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306252	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ALOXE3 mRNA]	PMID:31150632
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ALOXE3 mRNA	PMID:32525701
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of ALOXE3 mRNA	PMID:38460933
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306252	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ALOXE3 mRNA	PMID:31881176
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314766	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of ALOXE3 mRNA	PMID:40618947
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ALOXE3 mRNA	PMID:27392435
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314766	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ALOXE3 mRNA	PMID:18343893
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALOXE3 mRNA	PMID:23152189
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306252	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ALOXE3 mRNA	PMID:33387578
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ALOXE3 mRNA	PMID:33212167
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ALOXE3 mRNA	PMID:30851411
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1314766	E	RGD:6480464	20231003	CTD	MESH:D012969	Sodium Fluoride results in increased expression of ALOXE3 mRNA	PMID:37245782
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ALOXE3 mRNA	PMID:38568856
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314766	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ALOXE3 mRNA	PMID:27195522
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ALOXE3 mRNA	PMID:32234424
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ALOXE3 3' UTR	PMID:27901495
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ALOXE3 mRNA	PMID:25895662
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	ISO	RGD:1314766	E	RGD:6480464	20250603	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ALOXE3 mRNA	PMID:39826883
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1314766	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in increased expression of ALOXE3 mRNA	PMID:22613225
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306252	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ALOXE3 mRNA	PMID:23411599|PMID:34492290
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314766	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ALOXE3 mRNA	PMID:18648102
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306252	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ALOXE3 mRNA	PMID:25181051
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306252	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ALOXE3 mRNA	PMID:30816183|PMID:32528016
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314766	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ALOXE3 mRNA	PMID:40203079
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of ALOXE3 gene	PMID:31601247
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ALOXE3 intron	PMID:30157460
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314766	E	RGD:6480464	20211109	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ALOXE3 mRNA	PMID:34289071
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of ALOXE3 gene	PMID:22964155
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1306252	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ALOXE3 mRNA	PMID:32680482
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306252	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ALOXE3 mRNA	PMID:35163327
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ALOXE3 mRNA	PMID:21457566|PMID:38568856
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306252	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ALOXE3 mRNA	PMID:35163327
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306252	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ALOXE3 mRNA	PMID:25539665
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:38960	terbufos	affects response to substance	EXP		E	RGD:6480464	20150127	CTD	MESH:C012568	ALOXE3 gene SNP affects the susceptibility to terbufos	PMID:22919386
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ALOXE3 mRNA	PMID:40419075
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of ALOXE3 mRNA	PMID:20106945
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1314766	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of ALOXE3 mRNA	PMID:39922521
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ALOXE3 mRNA	PMID:38832940
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314766	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ALOXE3 mRNA	PMID:17562736
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ALOXE3 mRNA	PMID:29067470
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306252	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ALOXE3 mRNA	PMID:33387578
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ALOXE3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of ALOXE3 mRNA	PMID:35811015
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ALOXE3 mRNA	PMID:32525701
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306252	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ALOXE3 mRNA	PMID:29391264
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1314766	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of ALOXE3 mRNA	PMID:26377693
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of ALOXE3 mRNA	PMID:31629900
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:5855	ibuprofen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007052	Ibuprofen affects the expression of ALOXE3 mRNA	PMID:17070997
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1314766	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of ALOXE3 mRNA	PMID:38701926
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ALOXE3 intron	PMID:30157460
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in increased expression of ALOXE3 mRNA	PMID:33244087
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ALOXE3 mRNA	PMID:36139627
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ALOXE3 mRNA	PMID:30851411
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1314766	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of ALOXE3 mRNA	PMID:18343893
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ALOXE3 mRNA	PMID:32525701
1314765	ALOXE3	arachidonate epidermal lipoxygenase 3	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ALOXE3 mRNA	PMID:38568856
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314768	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of GPR45 mRNA	PMID:33045310
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314768	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of GPR45 mRNA	PMID:37995155
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314768	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of GPR45 mRNA	PMID:30319688
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306253	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of GPR45 gene	PMID:27618143
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1306253	E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in decreased expression of GPR45 mRNA	PMID:31129395
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of GPR45 promoter	PMID:22847954
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314768	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GPR45 mRNA	PMID:21570461
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of GPR45 mRNA	PMID:33212167
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306253	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of GPR45 mRNA	PMID:28959563
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306253	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of GPR45 mRNA	PMID:26033743
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GPR45 3' UTR	PMID:27901495
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of GPR45 mRNA	PMID:22316170
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of GPR45 exon	PMID:27901495
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306253	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of GPR45 mRNA	PMID:26033743
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of GPR45 mRNA	PMID:35984750
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314768	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GPR45 gene	PMID:35295148
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314768	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of GPR45 mRNA	PMID:17950772
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306253	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GPR45 mRNA	PMID:25181051
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of GPR45 gene	PMID:31601247
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314768	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of GPR45 exon	PMID:33297965
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1306253	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of GPR45 promoter	PMID:22457795
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314768	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GPR45 mRNA	PMID:40194260
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of GPR45 promoter	PMID:22847954
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of GPR45 promoter	PMID:22847954
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of GPR45 gene	PMID:29154799
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314768	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GPR45 mRNA	PMID:17562736
1314767	GPR45	G protein-coupled receptor 45	gene	CHEBI:81543	Tributyltin oxide	decreases phosphorylation	ISO	RGD:1314768	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased phosphorylation of GPR45 protein	PMID:22174045
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314770	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of AP2A1 mRNA	PMID:33045310
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AP2A1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AP2A1 mRNA	PMID:32699268
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1314770	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of AP2A1 mRNA	PMID:24205000
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314770	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of AP2A1 mRNA	PMID:30319688
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:16412	lipopolysaccharide	decreases methylation	ISO	RGD:1314770	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased methylation of AP2A1 gene	PMID:21212295
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314770	E	RGD:6480464	20161228	CTD	MESH:D008070	[Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of AP2A1 gene	PMID:21212295
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314770	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of AP2A1 mRNA	PMID:39298647
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314770	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of AP2A1 mRNA	PMID:29980752
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:16563	tetrahydropalmatine	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C014215	tetrahydropalmatine results in increased expression of AP2A1 protein	PMID:20109541
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306254	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of AP2A1 gene	PMID:27618143
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1306254	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of AP2A1 promoter	PMID:23359474
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of AP2A1 protein	PMID:37730182
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of AP2A1 intron	PMID:30157460
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:18248	iron atom	multiple interactions	ISO	RGD:1306254	E	RGD:6480464	20150512	CTD	MESH:D007501	[Tungsten co-treated with Nickel co-treated with Iron] results in decreased expression of AP2A1 mRNA	PMID:24619124
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314770	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AP2A1 mRNA	PMID:28111341
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1314770	E	RGD:6480464	20120412	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of AP2A1 exon	PMID:16300676
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of AP2A1 intron	PMID:30157460
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AP2A1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AP2A1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of AP2A1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of AP2A1 mRNA	PMID:32699268|PMID:35430440
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of AP2A1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of AP2A1 protein	PMID:38598786
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314770	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of AP2A1 mRNA	PMID:22206623
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AP2A1 gene	PMID:25304211
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AP2A1 mRNA	PMID:39836092
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314770	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AP2A1 mRNA	PMID:40504410
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:27638	cobalt atom	multiple interactions	ISO	RGD:1306254	E	RGD:6480464	20150512	CTD	MESH:D003035	[Tungsten co-treated with Nickel co-treated with Cobalt] results in decreased expression of AP2A1 mRNA	PMID:24619124
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1314770	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of AP2A1 protein	PMID:25505154
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of AP2A1 mRNA	PMID:28903495
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314770	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of AP2A1 mRNA	PMID:30912803
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:27998	tungsten	multiple interactions	ISO	RGD:1306254	E	RGD:6480464	20150512	CTD	MESH:D014414	[Tungsten co-treated with Nickel co-treated with Cobalt] results in decreased expression of AP2A1 mRNA; [Tungsten co-treated with Nickel co-treated with Iron] results in decreased expression of AP2A1 mRNA	PMID:24619124
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:28112	nickel atom	multiple interactions	ISO	RGD:1306254	E	RGD:6480464	20150512	CTD	MESH:D009532	[Tungsten co-treated with Nickel co-treated with Cobalt] results in decreased expression of AP2A1 mRNA; [Tungsten co-treated with Nickel co-treated with Iron] results in decreased expression of AP2A1 mRNA	PMID:24619124
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314770	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AP2A1 mRNA	PMID:17942748
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases methylation	ISO	RGD:1314770	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased methylation of AP2A1 gene	PMID:21212295
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306254	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of AP2A1 mRNA	PMID:33387578
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314770	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of AP2A1 mRNA; [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased methylation of AP2A1 gene	PMID:17942748|PMID:21212295
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of AP2A1 mRNA	PMID:33212167
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:28783	zinc protoporphyrin	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:C017803	[lead acetate co-treated with zinc protoporphyrin] results in increased expression of AP2A1 mRNA	PMID:22839698
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AP2A1 mRNA	PMID:39836092
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314770	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AP2A1 mRNA	PMID:40504410
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314770	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of AP2A1 mRNA	PMID:27131904
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of AP2A1 mRNA	PMID:25895662
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of AP2A1 mRNA	PMID:20018196
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20150609	CTD	MESH:C008261	[lead acetate co-treated with zinc protoporphyrin] results in increased expression of AP2A1 mRNA	PMID:22839698
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306254	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of AP2A1 mRNA	PMID:30047161
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314770	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AP2A1 gene; titanium dioxide results in decreased methylation of AP2A1 promoter	PMID:35295148
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314770	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of AP2A1 mRNA	PMID:18648102
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306254	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of AP2A1 mRNA	PMID:19167457
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of AP2A1 protein	PMID:34186270|PMID:37567409
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306254	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of AP2A1 mRNA	PMID:25181051|PMID:34947998
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314770	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of AP2A1 mRNA	PMID:33221593
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306254	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of AP2A1 gene	PMID:28505145
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306254	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of AP2A1 promoter	PMID:23359474
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of AP2A1 intron	PMID:30157460
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AP2A1 mRNA	PMID:28628672
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of AP2A1 protein	PMID:34186270
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1306254	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of AP2A1 promoter	PMID:23359474
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to AP2A1 protein	PMID:32991956
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1314770	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of AP2A1 mRNA	PMID:34813904
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of AP2A1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of AP2A1 protein	PMID:38598786
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AP2A1 mRNA	PMID:28628672
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1314770	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of AP2A1 mRNA	PMID:34813904
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AP2A1 mRNA	PMID:37042841
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of AP2A1 mRNA	PMID:38382870
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314770	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AP2A1 mRNA	PMID:28111341
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1306254	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of AP2A1 mRNA	PMID:30047161
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of AP2A1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of AP2A1 mRNA	PMID:32699268
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306254	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of AP2A1 mRNA	PMID:30047161
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314770	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of AP2A1 mRNA	PMID:17555576
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AP2A1 mRNA	PMID:28628672
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of AP2A1 mRNA	PMID:22230336
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AP2A1 gene	PMID:25304211
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of AP2A1 mRNA	PMID:39836092
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314770	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of AP2A1 mRNA	PMID:40504410
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314770	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of AP2A1 mRNA	PMID:17555576
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1314770	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of AP2A1 mRNA	PMID:17942748
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314770	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of AP2A1 mRNA	PMID:17942748
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AP2A1 mRNA	PMID:28628672
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306254	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of AP2A1 mRNA	PMID:30047161
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of AP2A1 mRNA	PMID:20977926
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AP2A1 protein	PMID:32959892
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of AP2A1 intron	PMID:30157460
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of AP2A1 protein	PMID:34186270
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314770	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of AP2A1 mRNA	PMID:22206623
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314770	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of AP2A1 mRNA	PMID:22206623
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:82664	iron(0)	multiple interactions	ISO	RGD:1306254	E	RGD:6480464	20150512	CTD	MESH:D007501	[Tungsten co-treated with Nickel co-treated with Iron] results in decreased expression of AP2A1 mRNA	PMID:24619124
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1306254	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of AP2A1 mRNA	PMID:30047161
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306254	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of AP2A1 mRNA	PMID:30047161
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:91108	SB 431542	increases expression	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of AP2A1 protein	PMID:25670856
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314770	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of AP2A1 mRNA	PMID:27131904
1314769	AP2A1	adaptor related protein complex 2 subunit alpha 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306254	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of AP2A1 mRNA	PMID:21346803
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:10110	zidovudine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with IFNA1 protein] results in increased expression of ZNF629 mRNA	PMID:20370541
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ZNF629 mRNA	PMID:25812627
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552392	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ZFP629 mRNA	PMID:26251327
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1552392	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of ZFP629 promoter	PMID:26251327
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552392	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ZFP629 mRNA	PMID:30319688
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552392	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ZFP629 mRNA	PMID:39298647
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of ZNF629 protein	PMID:37730182
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306257	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP629 mRNA	PMID:33387578
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZNF629 mRNA	PMID:28818685
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1552392	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of ZFP629 mRNA	PMID:33914522
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZNF629 mRNA	PMID:19549813
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ZNF629 protein	PMID:23301498
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ZNF629 mRNA	PMID:28903495
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552392	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP629 mRNA	PMID:21570461
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306257	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP629 mRNA	PMID:33387578
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ZNF629 mRNA	PMID:32763439
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF629 mRNA	PMID:38568856
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF629 mRNA	PMID:39719251
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552392	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZFP629 mRNA	PMID:22228805
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552392	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to ZFP629 promoter]	PMID:19654925
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ZNF629 mRNA	PMID:35984750
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1552392	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZFP629 gene	PMID:35295148
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552392	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ZFP629 mRNA	PMID:20813756
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306257	E	RGD:6480464	20211012	CTD	MESH:C069837	fullerene C60 results in decreased expression of ZFP629 mRNA	PMID:19167457
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1552392	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of ZFP629 mRNA	PMID:33914522
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1552392	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZFP629 promoter	PMID:27312807
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306257	E	RGD:6480464	20211012	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP629 mRNA; bisphenol A results in increased expression of ZNF629 mRNA	PMID:25181051|PMID:30816183
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1552392	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of ZFP629 gene	PMID:31683443
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552392	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ZFP629 mRNA	PMID:39298647
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ZNF629 promoter	PMID:30157460
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ZNF629 mRNA	PMID:25812627
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1306257	E	RGD:6480464	20211012	CTD	MESH:C018021	cobaltous chloride results in increased expression of ZFP629 mRNA	PMID:24386269
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ZNF629 mRNA	PMID:25812627
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ZNF629 mRNA	PMID:28302478
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ZNF629 mRNA	PMID:25812627
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF629 mRNA	PMID:28001369
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZNF629 gene	PMID:29154799
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZNF629 mRNA	PMID:25562108|PMID:27989131
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ZNF629 mRNA	PMID:38832940
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:46666	crocidolite asbestos	affects expression	ISO	RGD:1552392	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of ZFP629 mRNA	PMID:29279043
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552392	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ZFP629 mRNA; Nanotubes, Carbon results in decreased expression of ZFP629 mRNA	PMID:25554681
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ZNF629 mRNA	PMID:28988120
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ZNF629 promoter	PMID:30157460
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552392	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ZFP629 mRNA	PMID:22206623
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of ZNF629 protein	PMID:31285264
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1552392	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ZFP629 mRNA	PMID:40826991
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZNF629 mRNA	PMID:29301935
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552392	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ZNF629 mRNA	PMID:28973697
1314773	ZNF629	zinc finger protein 629	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1552392	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of ZFP629 mRNA	PMID:35537566
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CLCA1 mRNA	PMID:36189433
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of CLCA1 protein	PMID:31494107
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1314776	E	RGD:6480464	20150310	CTD	MESH:D004958	Estradiol affects the expression of CLCA1 mRNA	PMID:15598610
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306258	E	RGD:6480464	20160607	CTD	MESH:D004958	Estradiol results in increased expression of CLCA1 mRNA	PMID:26945725|PMID:32145629
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306258	E	RGD:6480464	20160607	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of CLCA1 mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA1 mRNA; [Estradiol co-treated with Plant Preparations] results in increased expression of CLCA1 mRNA	PMID:26496021|PMID:26945725|PMID:32741896
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:16482	naphthalene	increases expression	ISO	RGD:1306258	E	RGD:6480464	20150127	CTD	MESH:C031721	naphthalene analog results in increased expression of CLCA1 mRNA	PMID:24976557
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:16842	formaldehyde	decreases expression	ISO	RGD:1306258	E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of CLCA1 mRNA	PMID:24304932
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1314776	E	RGD:6480464	20150310	CTD	MESH:D011374	Progesterone affects the expression of CLCA1 mRNA	PMID:17251523
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:17026	progesterone	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20150310	CTD	MESH:D011374	Progesterone results in decreased expression of CLCA1 mRNA	PMID:22238285
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CLCA1 mRNA	PMID:36189433
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:17245	carbon monoxide	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20200310	CTD	MESH:D002248	[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of CLCA1 mRNA	PMID:29621558
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306258	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA1 mRNA	PMID:32741896
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:17627	ferroheme b	decreases expression	ISO	RGD:1306258	E	RGD:6480464	20150310	CTD	MESH:D006418	Heme results in decreased expression of CLCA1 mRNA	PMID:15539406
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306258	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of CLCA1 mRNA	PMID:26577399
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:18295	histamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006632	Histamine results in increased expression of CLCA1 mRNA	PMID:17622767
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:18388	apigenin	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20121113	CTD	MESH:D047310	Apigenin results in decreased expression of CLCA1 mRNA	PMID:22359648
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:18422	sulfur dioxide	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20200310	CTD	MESH:D013458	[Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of CLCA1 mRNA	PMID:29621558
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1314776	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in increased expression of CLCA1 mRNA	PMID:29279043
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CLCA1 mRNA	PMID:29950665
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314776	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CLCA1 mRNA	PMID:19770486
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:254496	7,12-dimethyltetraphene	decreases expression	ISO	RGD:1306258	E	RGD:6480464	20161025	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CLCA1 mRNA	PMID:19480007
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in decreased expression of CLCA3 mRNA	PMID:33026818
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1314776	E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of CLCA1 mRNA	PMID:28891433
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CLCA1 mRNA	PMID:26203683|PMID:27106289|PMID:34911549
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:26355	heme b	decreases expression	ISO	RGD:1306258	E	RGD:6480464	20150310	CTD	MESH:D006418	Heme results in decreased expression of CLCA1 mRNA	PMID:15539406
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314776	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CLCA1 mRNA	PMID:17484886
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CLCA1 mRNA	PMID:25629700
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of CLCA1 mRNA	PMID:19654921
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1314776	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic results in increased expression of CLCA1 mRNA; Arsenic results in increased expression of CLCA1 protein	PMID:22552367|PMID:23221970
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314776	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of CLCA1 mRNA	PMID:28960355
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:27881	resveratrol	decreases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	Resveratrol results in decreased expression of CLCA1 protein	PMID:26549244
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20230704	CTD	MESH:C059514	Resveratrol inhibits the reaction [OVAL protein results in increased expression of CLCA1 protein]	PMID:26549244
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20120412	CTD	MESH:D014640	Vancomycin results in decreased expression of CLCA1 mRNA	PMID:18930951
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1306258	E	RGD:6480464	20150310	CTD	MESH:D019833	Genistein results in increased expression of CLCA1 mRNA	PMID:17341692
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314776	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CLCA1 mRNA	PMID:18691609
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314776	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CLCA1 mRNA	PMID:19933214
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1306258	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CLCA1 mRNA	PMID:26033743
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of CLCA3 mRNA	PMID:27862939
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314776	E	RGD:6480464	20120918	CTD	MESH:D004317	Doxorubicin results in increased expression of CLCA1 mRNA	PMID:21040762|PMID:39631538
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20120918	CTD	MESH:D004317	[[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of CLCA1 mRNA	PMID:21040762
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of CLCA1 mRNA	PMID:37682722
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314776	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of CLCA1 mRNA	PMID:17350061
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CLCA1 promoter	PMID:27901495
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20150310	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CLCA1 mRNA	PMID:22228805
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1306258	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of CLCA1 mRNA	PMID:26033743
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314776	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CLCA1 mRNA	PMID:29341224
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20150310	CTD	MESH:C009495	titanium dioxide results in decreased expression of CLCA1 mRNA	PMID:23131501|PMID:23557971
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1306258	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of CLCA1 mRNA	PMID:30012374
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314776	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of CLCA1 mRNA	PMID:27760801
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CLCA1 mRNA	PMID:29950665
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314776	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of CLCA1 mRNA	PMID:18445702
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:33007	chromium(6+)	increases expression	ISO	RGD:1314776	E	RGD:6480464	20150310	CTD	MESH:C074702	chromium hexavalent ion results in increased expression of CLCA1 protein	PMID:22552367
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306258	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CLCA1 mRNA	PMID:25181051
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306258	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of CLCA1 mRNA	PMID:26496021
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1314776	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of CLCA1 mRNA	PMID:26377693
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CLCA1 mRNA	PMID:37019170
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CLCA1 mRNA	PMID:29950665
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314776	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CLCA1 mRNA	PMID:21266533
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20140408	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of CLCA1 mRNA; Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of CLCA1 mRNA]	PMID:23963992
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306258	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of CLCA1 mRNA	PMID:27387713
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306258	E	RGD:6480464	20150310	CTD	MESH:C039281	furan results in increased methylation of CLCA1 gene	PMID:22079235
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314776	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CLCA1 mRNA	PMID:18353800
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1314776	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of CLCA1 mRNA	PMID:29038090
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1314776	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of CLCA1 mRNA	PMID:23125180
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314776	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CLCA1 mRNA	PMID:20937368
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1306258	E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CLCA1 mRNA	PMID:21658437
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1314776	E	RGD:6480464	20150310	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of CLCA1 mRNA	PMID:17394237
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1314776	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CLCA1 mRNA	PMID:29279043
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:46676	tremolite asbestos	increases expression	ISO	RGD:1314776	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in increased expression of CLCA1 mRNA	PMID:29279043
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:46680	serpentine asbestos	increases expression	ISO	RGD:1314776	E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of CLCA1 mRNA; Asbestos, Serpentine results in increased expression of CLCA1 protein	PMID:16251409
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of CLCA1 mRNA	PMID:19654921
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1314776	E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic results in increased expression of CLCA1 mRNA; Arsenic results in increased expression of CLCA1 protein	PMID:22552367|PMID:23221970
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306258	E	RGD:6480464	20150310	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CLCA1 mRNA	PMID:17557909
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1314776	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of CLCA1 mRNA; Nanotubes, Carbon affects the expression of CLCA3 mRNA; Nanotubes, Carbon analog affects the expression of CLCA1 mRNA; Nanotubes, Carbon analog affects the expression of CLCA3 mRNA	PMID:25554681
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314776	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CLCA1 mRNA; Nanotubes, Carbon results in increased expression of CLCA3 mRNA	PMID:25620056|PMID:27106021
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20140408	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of CLCA1 mRNA; Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of CLCA1 mRNA]	PMID:23963992
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314776	E	RGD:6480464	20150310	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CLCA1 mRNA	PMID:16141432
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20150310	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in decreased expression of CLCA1 mRNA	PMID:17982090
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20150310	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of CLCA1 mRNA	PMID:23608068
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314776	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of CLCA1 mRNA	PMID:19812364
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CLCA1 mRNA	PMID:23650126
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1314776	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of CLCA1 mRNA	PMID:20003209
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:65585	carnosic acid	increases expression	ISO	RGD:1314776	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in increased expression of CLCA1 protein	PMID:35926579
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:67251	beta-damascenone	increases expression	ISO	RGD:1314776	E	RGD:6480464	20161213	CTD	MESH:C075388	beta-damascenone results in increased expression of CLCA1 mRNA	PMID:22982537
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1306258	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA1 mRNA	PMID:32741896
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:79089	ceric oxide	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C030583	[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLCA1 mRNA	PMID:29792201
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:79089	ceric oxide	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20190910	CTD	MESH:C030583	[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLCA1 mRNA; ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of CLCA1 protein]	PMID:29792201
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1314776	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in decreased expression of CLCA1 mRNA	PMID:19482888
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314776	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of CLCA1 mRNA]	PMID:19482888
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:82272	Erionite	increases expression	ISO	RGD:1314776	E	RGD:6480464	20200915	CTD	MESH:C083174	erionite results in increased expression of CLCA1 mRNA	PMID:29279043
1314775	CLCA1	chloride channel accessory 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306258	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CLCA1 mRNA	PMID:24780913
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1622839	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PKD2L1 mRNA	PMID:33045310
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of PKD2L1 mRNA	PMID:24763279
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306261	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of PKD2L1 gene	PMID:35440735
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in increased expression of PKD2L1 mRNA; [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PKD2L1 mRNA	PMID:20404318|PMID:20823114
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306261	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PKD2L1 mRNA	PMID:33387578
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of PKD2L1 mRNA	PMID:26079696
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:2038	5-azacytidine	increases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of PKD2L1 mRNA	PMID:20823114
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of PKD2L1 mRNA	PMID:23557933
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of PKD2L1 promoter	PMID:22847954
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:28077	rifampicin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in decreased expression of PKD2L1 mRNA	PMID:24552687
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1622839	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PKD2L1 mRNA	PMID:32186404
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PKD2L1 mRNA	PMID:21296121
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306261	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of PKD2L1 mRNA	PMID:28959563
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306261	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PKD2L1 mRNA	PMID:26033743
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:28854	2,4-D	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of PKD2L1 mRNA	PMID:40294809
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of PKD2L1 mRNA	PMID:29301061
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PKD2L1 exon; Benzo(a)pyrene affects the methylation of PKD2L1 intron	PMID:27901495|PMID:30157460
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306261	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of PKD2L1 mRNA	PMID:26033743
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1622839	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of PKD2L1 mRNA	PMID:27131904
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PKD2L1 mRNA	PMID:25895662
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PKD2L1 mRNA	PMID:19128835
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306261	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PKD2L1 mRNA	PMID:25181051
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:34687	dibutyl phthalate	affects expression	ISO	RGD:1306261	E	RGD:6480464	20190910	CTD	MESH:D003993	Dibutyl Phthalate affects the expression of PKD2L1 mRNA	PMID:30934153
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PKD2L1 mRNA	PMID:28628672
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306261	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PKD2L1 mRNA	PMID:35163327
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306261	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PKD2L1 mRNA	PMID:35163327
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of PKD2L1 promoter	PMID:22847954
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of PKD2L1 promoter	PMID:22847954
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PKD2L1 mRNA	PMID:28628672
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PKD2L1 mRNA	PMID:28628672
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PKD2L1 mRNA	PMID:19128835
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:50095	bucladesine	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D003994	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PKD2L1 mRNA	PMID:20823114
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1622839	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of PKD2L1 mRNA	PMID:23608068
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:6716	medroxyprogesterone acetate	multiple interactions	EXP		E	RGD:6480464	20130910	CTD	MESH:D017258	[Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in increased expression of PKD2L1 mRNA	PMID:20823114
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PKD2L1 gene]	PMID:28238834
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1306261	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of PKD2L1 mRNA	PMID:32109520
1314779	PKD2L1	polycystin 2 like 1, transient receptor potential cation channel	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1622839	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of PKD2L1 mRNA	PMID:27131904
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of SLAMF8 mRNA	PMID:35967413
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of SLAMF8 mRNA	PMID:34925699
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SLAMF8 mRNA	PMID:33167477
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314783	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SLAMF8 mRNA	PMID:39241906
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314783	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SLAMF8 mRNA]	PMID:39241906
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314783	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SLAMF8 mRNA	PMID:39298647
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SLAMF8 mRNA	PMID:30165855
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306263	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLAMF8 mRNA	PMID:32741896
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314783	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLAMF8 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of SLAMF8 mRNA	PMID:37567420|PMID:37992649
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306263	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLAMF8 mRNA	PMID:32741896
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314783	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLAMF8 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of SLAMF8 mRNA	PMID:37567420|PMID:37992649
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in decreased expression of SLAMF8 mRNA	PMID:26485663
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306263	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SLAMF8 mRNA	PMID:33387578
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1314783	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of SLAMF8 mRNA	PMID:39984025
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of SLAMF8 mRNA	PMID:24376830
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1314783	E	RGD:6480464	20240206	CTD	MESH:C010974	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of SLAMF8 mRNA	PMID:37567420
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314783	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SLAMF8 mRNA	PMID:28960355
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306263	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SLAMF8 mRNA	PMID:31881176
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SLAMF8 mRNA	PMID:25583101
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306263	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLAMF8 mRNA	PMID:34747641
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314783	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLAMF8 mRNA	PMID:26377647
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306263	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLAMF8 mRNA	PMID:33387578
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306263	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLAMF8 mRNA	PMID:32109520
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306263	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SLAMF8 mRNA	PMID:28959563
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314783	E	RGD:6480464	20231031	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLAMF8 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of SLAMF8 mRNA	PMID:37567420|PMID:37992649
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLAMF8 mRNA	PMID:20064835
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314783	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLAMF8 mRNA	PMID:22228805
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314783	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SLAMF8 mRNA]	PMID:22228805
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314783	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SLAMF8 mRNA	PMID:29341224|PMID:38811393
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1314783	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of SLAMF8 mRNA	PMID:17656681
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1306263	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of SLAMF8 mRNA	PMID:30012374
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306263	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SLAMF8 mRNA	PMID:34492290
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306263	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SLAMF8 mRNA	PMID:30816183|PMID:32528016
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SLAMF8 gene	PMID:31601247
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306263	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SLAMF8 mRNA	PMID:34947998
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314783	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SLAMF8 mRNA	PMID:39298647
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1314783	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of SLAMF8 exon	PMID:33297965
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D004137	Dinitrochlorobenzene results in decreased expression of SLAMF8 mRNA	PMID:17374397
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1306263	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of SLAMF8 mRNA	PMID:32680482
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314783	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SLAMF8 mRNA]	PMID:39241906
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SLAMF8 mRNA	PMID:38382870
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SLAMF8 mRNA	PMID:24449571
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314783	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SLAMF8 mRNA	PMID:40194260
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of SLAMF8 mRNA	PMID:40434365
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:39483	sodium dichromate	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:C016104	sodium bichromate results in decreased expression of SLAMF8 mRNA	PMID:17685462
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314783	E	RGD:6480464	20231031	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLAMF8 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of SLAMF8 mRNA	PMID:37567420|PMID:37992649
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314783	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLAMF8 mRNA	PMID:17562736
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306263	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLAMF8 mRNA	PMID:33387578
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314783	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SLAMF8 mRNA; Nanotubes, Carbon results in increased expression of SLAMF8 mRNA	PMID:25554681
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1314783	E	RGD:6480464	20150127	CTD	MESH:C000499	ferric oxide analog results in increased expression of SLAMF8 mRNA	PMID:24525745
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C029938	nickel sulfate results in decreased expression of SLAMF8 mRNA	PMID:16780908|PMID:17374397
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D010081	Oxazolone results in decreased expression of SLAMF8 mRNA	PMID:17374397
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314783	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SLAMF8 mRNA	PMID:38701926
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1314783	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of SLAMF8 mRNA	PMID:36851058
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1314783	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of SLAMF8 mRNA	PMID:37567420
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1306263	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLAMF8 mRNA	PMID:32741896
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314783	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SLAMF8 mRNA	PMID:38648751
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314783	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of SLAMF8 mRNA	PMID:39847705
1314782	SLAMF8	SLAM family member 8	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314783	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SLAMF8 mRNA]	PMID:39241906
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ZNF124 mRNA	PMID:33167477
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ZNF124 mRNA	PMID:23649840
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZNF124 mRNA	PMID:35301059
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ZNF124 mRNA	PMID:18593933
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ZNF124 mRNA	PMID:23557933
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ZNF124 mRNA	PMID:25523186
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF124 mRNA	PMID:38568856
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of ZNF124 mRNA	PMID:22378314
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZNF124 promoter	PMID:27901495
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of ZNF124 mRNA	PMID:25523186
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ZNF124 mRNA	PMID:18593933
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZNF124 mRNA	PMID:20018196
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of ZNF124 mRNA	PMID:27685785
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF124 mRNA	PMID:28628672
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of ZNF124 gene	PMID:22964155
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF124 mRNA	PMID:28628672
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZNF124 mRNA	PMID:35301059
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ZNF124 mRNA	PMID:24449571
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ZNF124 mRNA	PMID:31533062
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of ZNF124 mRNA	PMID:19167446
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF124 mRNA	PMID:28001369
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZNF124 mRNA	PMID:25562108|PMID:27989131
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF124 mRNA	PMID:28628672
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ZNF124 mRNA	PMID:38832940
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ZNF124 mRNA	PMID:26272509
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF124 mRNA	PMID:27188386
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ZNF124 mRNA	PMID:29067470
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF124 mRNA	PMID:28628672
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF124 protein	PMID:31285264
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF124 mRNA	PMID:27188386
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF124 gene]	PMID:28238834
1314784	ZNF124	zinc finger protein 124	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF124 mRNA	PMID:27188386
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:133296	microcystin RR	decreases expression	EXP		E	RGD:6480464	20161004	CTD	MESH:C063855	microcystin RR results in decreased expression of CAPZA1 protein	PMID:19111056
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:15365	acetylsalicylic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of CAPZA1 mRNA	PMID:15928584
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of CAPZA1 protein	PMID:17051635
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of CAPZA1 mRNA	PMID:33167477
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CAPZA1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CAPZA1 mRNA	PMID:32699268
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of CAPZA1 mRNA	PMID:24763279
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CAPZA1 mRNA	PMID:21179406
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314787	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CAPZA1 mRNA	PMID:39241906
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314787	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CAPZA1 mRNA	PMID:25510870
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1587438	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CAPZA1 mRNA	PMID:33387578
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CAPZA1 protein	PMID:37730182
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1587438	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CAPZA1 mRNA	PMID:22061828
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of CAPZA1 intron	PMID:30157460
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1314787	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of CAPZA1 mRNA	PMID:27462272
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314787	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CAPZA1 mRNA	PMID:25510870
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314787	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CAPZA1 mRNA	PMID:25510870
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CAPZA1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CAPZA1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of CAPZA1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of CAPZA1 mRNA	PMID:32699268|PMID:35430440
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314787	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of CAPZA1 mRNA	PMID:34911549
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CAPZA1 protein	PMID:38598786
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314787	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CAPZA1 mRNA	PMID:22206623
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CAPZA1 mRNA	PMID:28903495
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CAPZA1 mRNA	PMID:22574217
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314787	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CAPZA1 mRNA	PMID:21570461
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1587438	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CAPZA1 mRNA	PMID:34747641
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1587438	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CAPZA1 mRNA	PMID:33387578
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314787	E	RGD:6480464	20120522	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CAPZA1 mRNA	PMID:17942748
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:28177	theophylline	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in decreased expression of CAPZA1 mRNA	PMID:16083514
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of CAPZA1 protein	PMID:39603559
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CAPZA1 mRNA	PMID:33212167
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1587438	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of CAPZA1 mRNA	PMID:28959563
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of CAPZA1 mRNA	PMID:12377979
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314787	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of CAPZA1 protein	PMID:29044176
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CAPZA1 mRNA]; arsenite promotes the reaction [G3BP1 protein binds to CAPZA1 protein]	PMID:32406909
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314787	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CAPZA1 mRNA	PMID:27131904
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1587438	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of CAPZA1 mRNA	PMID:30047161
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314787	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CAPZA1 gene	PMID:35295148
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1587438	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CAPZA1 mRNA	PMID:23411599|PMID:34492290
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1314787	E	RGD:6480464	20120522	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of CAPZA1 mRNA	PMID:18648102
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of CAPZA1 mRNA	PMID:29275510
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1587438	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CAPZA1 mRNA	PMID:30816183|PMID:34947998
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of CAPZA1 protein	PMID:37567409
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1587438	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CAPZA1 mRNA	PMID:25181051
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1587438	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CAPZA1 gene	PMID:28505145
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314787	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CAPZA1 mRNA	PMID:25510870
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314787	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of CAPZA1 mRNA	PMID:25510870
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CAPZA1 protein	PMID:34186270
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314787	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of CAPZA1 mRNA	PMID:38685157
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CAPZA1 protein	PMID:38598786
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:34892	nocodazole	multiple interactions	ISO	RGD:1314787	E	RGD:6480464	20170725	CTD	MESH:D015739	[CAPZA1 protein co-treated with CAPZA2 protein] results in decreased susceptibility to Nocodazole	PMID:22918941
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CAPZA1 mRNA	PMID:37042841
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CAPZA1 mRNA	PMID:18560533
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CAPZA1 protein	PMID:24527689
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CAPZA1 mRNA	PMID:24449571
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CAPZA1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CAPZA1 mRNA	PMID:32699268
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of CAPZA1 protein	PMID:17152098
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CAPZA1 mRNA	PMID:28302478
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CAPZA1 gene	PMID:29154799
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1587438	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of CAPZA1 mRNA	PMID:30047161
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CAPZA1 protein	PMID:38832940
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1587438	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CAPZA1 mRNA	PMID:33387578
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314787	E	RGD:6480464	20120522	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CAPZA1 mRNA	PMID:17942748
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314787	E	RGD:6480464	20120522	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CAPZA1 mRNA	PMID:17942748
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314787	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of CAPZA1 mRNA; Nanotubes, Carbon results in increased expression of CAPZA1 mRNA	PMID:25554681
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1587438	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of CAPZA1 mRNA	PMID:30047161
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314787	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of CAPZA1 mRNA	PMID:38701926
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CAPZA1 protein	PMID:32959892
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:6773	Mesaconitine	decreases expression	ISO	RGD:1587438	E	RGD:6480464	20231031	CTD	MESH:C019470	mesaconitine results in decreased expression of CAPZA1 protein	PMID:37182599
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CAPZA1 protein	PMID:34186270
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314787	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CAPZA1 mRNA	PMID:22206623
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314787	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CAPZA1 mRNA	PMID:22206623
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of CAPZA1 protein	PMID:37664457
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of CAPZA1 protein	PMID:31285264
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of CAPZA1 mRNA	PMID:18548127
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20200114	CTD	MESH:C025589	ochratoxin A results in decreased expression of CAPZA1 protein	PMID:31276768
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of CAPZA1 protein	PMID:16344271
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1314787	E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of CAPZA1 protein	PMID:18550172
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of CAPZA1 protein	PMID:38348393
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314787	E	RGD:6480464	20120522	CTD	MESH:C045950	propiconazole results in increased expression of CAPZA1 mRNA	PMID:21278054
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1587438	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of CAPZA1 mRNA	PMID:30047161
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1587438	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of CAPZA1 mRNA	PMID:30047161
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1314787	E	RGD:6480464	20250805	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of CAPZA1 protein	PMID:26903627
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of CAPZA1 protein	PMID:37664457
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314787	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of CAPZA1 mRNA	PMID:27131904
1314786	CAPZA1	capping actin protein of muscle Z-line subunit alpha 1	gene	CHEBI:9150	simvastatin	decreases expression	ISO	RGD:1587438	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in decreased expression of CAPZA1 protein	PMID:20217863
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ESPL1 mRNA	PMID:20938992
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of ESPL1 mRNA	PMID:26516004
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ESPL1 mRNA	PMID:26079696
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ESPL1 mRNA	PMID:22378314
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1306266	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of ESPL1 mRNA	PMID:32145629
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:D004958	Estradiol results in increased expression of ESPL1 mRNA	PMID:18310284|PMID:19167446
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550440	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of ESPL1 mRNA	PMID:25210133
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20160315	CTD	MESH:D004958	ESR1 protein promotes the reaction [Estradiol results in increased expression of ESPL1 mRNA]	PMID:25210133
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ESPL1 mRNA	PMID:25510870
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ESPL1 mRNA	PMID:20938992
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of ESPL1 mRNA	PMID:26079696
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESPL1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESPL1 mRNA	PMID:37992649
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of ESPL1 mRNA	PMID:21592394
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of ESPL1 mRNA	PMID:21592394
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306266	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of ESPL1 mRNA]	PMID:20032058
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of ESPL1 mRNA	PMID:27683099
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESPL1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESPL1 mRNA	PMID:37992649
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550440	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ESPL1 mRNA	PMID:34319233
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306266	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ESPL1 mRNA	PMID:26577399
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of ESPL1 protein	PMID:37730182
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of ESPL1 mRNA	PMID:21592394
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of ESPL1 mRNA	PMID:21592394
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306266	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ESPL1 mRNA	PMID:22061828
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306266	E	RGD:6480464	20241001	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ESPL1 mRNA	PMID:38301995
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ESPL1 mRNA	PMID:25510870
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ESPL1 mRNA	PMID:25510870
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ESPL1 mRNA	PMID:19549813
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306266	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ESPL1 mRNA	PMID:23630614|PMID:25378103
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ESPL1 mRNA	PMID:27106289
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550440	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ESPL1 mRNA	PMID:31919559
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ESPL1 mRNA	PMID:21867686
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ESPL1 mRNA	PMID:20938992
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ESPL1 protein	PMID:35688186
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of ESPL1 mRNA	PMID:31295307
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESPL1 mRNA]	PMID:37992649
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306266	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ESPL1 mRNA	PMID:31881176
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with Resveratrol] results in increased expression of ESPL1 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of ESPL1 mRNA	PMID:19167446|PMID:23557933
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ESPL1 mRNA	PMID:28903495
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1550440	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of ESPL1 mRNA	PMID:32186404
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ESPL1 mRNA	PMID:25583101
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ESPL1 mRNA	PMID:22574217
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550440	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ESPL1 mRNA	PMID:21570461
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306266	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ESPL1 mRNA	PMID:32109520|PMID:33387578
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ESPL1 mRNA	PMID:21496263
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1550440	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ESPL1 mRNA	PMID:21496263
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ESPL1 mRNA	PMID:17942748
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ESPL1 mRNA	PMID:32763439
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306266	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ESPL1 mRNA	PMID:28959563
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ESPL1 mRNA	PMID:30911355
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1550440	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of ESPL1 mRNA	PMID:36227756
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESPL1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESPL1 mRNA	PMID:37992649
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESPL1 mRNA]	PMID:37992649
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of ESPL1 mRNA	PMID:22623647
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of ESPL1 mRNA	PMID:34032870
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of ESPL1 mRNA; sodium arsenite results in decreased expression of ESPL1 protein	PMID:30528433|PMID:38568856
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ESPL1 mRNA	PMID:29301061|PMID:39719251
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1550440	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ESPL1 protein	PMID:16338954
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of ESPL1 mRNA	PMID:22378314
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1306266	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ESPL1 mRNA	PMID:21839799
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550440	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ESPL1 mRNA	PMID:32417428
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ESPL1 promoter	PMID:27901495
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ESPL1 mRNA]	PMID:32406909
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of ESPL1 mRNA	PMID:30911355
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1550440	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ESPL1 mRNA	PMID:29341224
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ESPL1 mRNA	PMID:19150397|PMID:20382639
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:3139	bleomycin A2	decreases expression	ISO	RGD:1550440	E	RGD:6480464	20211207	CTD	MESH:D001761	Bleomycin results in decreased expression of ESPL1 mRNA	PMID:30825431
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:3139	bleomycin A2	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20211207	CTD	MESH:D001761	Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of ESPL1 mRNA]; lenabasum inhibits the reaction [Bleomycin results in decreased expression of ESPL1 mRNA]	PMID:30825431
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:31638	fulvestrant	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of ESPL1 mRNA	PMID:19016759
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ESPL1 gene; [Fulvestrant co-treated with Sirolimus] results in decreased expression of ESPL1 mRNA	PMID:19016759|PMID:31601247
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1306266	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of ESPL1 mRNA	PMID:25729387
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306266	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ESPL1 mRNA	PMID:25729387
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306266	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of ESPL1 mRNA	PMID:30047161
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1550440	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ESPL1 gene	PMID:35295148
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1306266	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of ESPL1 mRNA	PMID:30012374
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550440	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ESPL1 mRNA	PMID:23557971
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306266	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ESPL1 mRNA	PMID:23411599|PMID:34492290
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ESPL1 mRNA	PMID:19710929
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1550440	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of ESPL1 mRNA	PMID:19191707
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ESPL1 mRNA	PMID:38479592
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306266	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ESPL1 mRNA	PMID:32145629
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306266	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ESPL1 mRNA	PMID:25181051
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1550440	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of ESPL1 mRNA	PMID:29161229
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1550440	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of ESPL1 promoter	PMID:27312807
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of ESPL1 mRNA	PMID:27685785
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306266	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ESPL1 gene	PMID:28505145
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ESPL1 gene	PMID:31601247
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1550440	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of ESPL1 mRNA	PMID:26682919
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ESPL1 mRNA	PMID:25510870
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ESPL1 mRNA	PMID:25510870
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:34237	2,4-diaminotoluene	increases expression	ISO	RGD:1550440	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in increased expression of ESPL1 mRNA	PMID:20713471
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:34342	3-methylcholanthrene	increases expression	ISO	RGD:1550440	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of ESPL1 mRNA	PMID:20713471
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550440	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ESPL1 mRNA	PMID:40203079
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:34578	Bisphenol A diglycidyl ether	affects splicing	ISO	RGD:1550440	E	RGD:6480464	20240305	CTD	MESH:C019273	bisphenol A diglycidyl ether affects the splicing of ESPL1 mRNA	PMID:36464114
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1550440	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ESPL1 mRNA	PMID:28392331
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1306266	E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon affects the expression of ESPL1 mRNA	PMID:22546817
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306266	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ESPL1 mRNA	PMID:21266533
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1306266	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of ESPL1 mRNA	PMID:22546817
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1306266	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of ESPL1 mRNA	PMID:22546817
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:351346	phenethyl isothiocyanate	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C058305	phenethyl isothiocyanate results in decreased expression of ESPL1 mRNA	PMID:26678675
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1306266	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of ESPL1 mRNA	PMID:18500788
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306266	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ESPL1 mRNA	PMID:30723492
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ESPL1 mRNA	PMID:38174414
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ESPL1 mRNA	PMID:36326898
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306266	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of ESPL1 mRNA	PMID:25539665
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1306266	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of ESPL1 mRNA	PMID:30047161
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ESPL1 mRNA	PMID:19376846
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ESPL1 mRNA	PMID:24449571
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:37415	alpha-amanitin	affects expression	ISO	RGD:1550440	E	RGD:6480464	20240903	CTD	MESH:D053959	Alpha-Amanitin affects the expression of ESPL1 mRNA	PMID:38531469
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ESPL1 mRNA	PMID:32588087
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1550440	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ESPL1 mRNA	PMID:40194260
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ESPL1 mRNA	PMID:28302478
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ESPL1 mRNA	PMID:31533062
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of ESPL1 mRNA	PMID:19167446
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ESPL1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ESPL1 mRNA	PMID:19167446
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1550440	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ESPL1 mRNA	PMID:39529242
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ESPL1 mRNA	PMID:40419075
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ESPL1 gene	PMID:29154799
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306266	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of ESPL1 mRNA	PMID:41580965
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306266	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of ESPL1 mRNA	PMID:30047161
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ESPL1 mRNA	PMID:20106945|PMID:25562108
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1306266	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in decreased expression of ESPL1 mRNA	PMID:20032058
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1306266	E	RGD:6480464	20120412	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of ESPL1 mRNA]	PMID:20032058
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESPL1 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ESPL1 mRNA	PMID:37992649
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ESPL1 mRNA	PMID:38832940
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ESPL1 mRNA	PMID:29067470
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306266	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ESPL1 mRNA	PMID:33387578
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ESPL1 mRNA	PMID:22230336
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	ESPL1 protein affects the susceptibility to Fluorouracil	PMID:15548681
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ESPL1 mRNA	PMID:25351596
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:4744	Echimidine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C000615871	[CYP3A4 protein results in increased metabolism of echimidine] which results in decreased expression of ESPL1 mRNA	PMID:33884520
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550440	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ESPL1 mRNA	PMID:17942748
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ESPL1 mRNA	PMID:17942748
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ESPL1 mRNA	PMID:32234424
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1550440	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ESPL1 mRNA; Nanotubes, Carbon results in increased expression of ESPL1 mRNA	PMID:25554681
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306266	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of ESPL1 mRNA	PMID:30047161
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1550440	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of ESPL1 mRNA	PMID:40234311
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of ESPL1 mRNA	PMID:21148553
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1550440	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ESPL1 mRNA	PMID:19042947
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1550440	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ESPL1 mRNA	PMID:38701926
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306266	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of ESPL1 mRNA	PMID:25729387
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306266	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ESPL1 mRNA	PMID:25729387
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:6382	Lasiocarpine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of ESPL1 mRNA	PMID:33884520
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:63924	riddelliine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of ESPL1 mRNA	PMID:33884520
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ESPL1 mRNA	PMID:28988120
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1306266	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of ESPL1 mRNA	PMID:37269647
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1306266	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of ESPL1 mRNA	PMID:35283115
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of ESPL1 mRNA]	PMID:30825431
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:6980	monocrotaline	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of ESPL1 mRNA	PMID:33884520
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:72754	bisphenol AF	affects splicing	ISO	RGD:1550440	E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF affects the splicing of ESPL1 mRNA	PMID:36464114
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550440	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ESPL1 mRNA	PMID:22206623
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:748998	lenabasum	multiple interactions	ISO	RGD:1550440	E	RGD:6480464	20260714	CTD	MESH:C471849	lenabasum inhibits the reaction [Bleomycin results in decreased expression of ESPL1 mRNA]	PMID:30825431
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:76989	phytoestrogen	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:D048789	Phytoestrogens results in increased expression of ESPL1 mRNA	PMID:18310284
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1306266	E	RGD:6480464	20120717	CTD	MESH:C025589	ochratoxin A results in increased expression of ESPL1 mRNA	PMID:19237604|PMID:38301995
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of ESPL1 mRNA	PMID:34995734
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:79997	GW 4064	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C412815	GW 4064 results in increased expression of ESPL1 mRNA	PMID:31437187
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550440	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ESPL1 mRNA	PMID:23091169
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ESPL1 mRNA	PMID:19167446
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of ESPL1 mRNA	PMID:32234424
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550440	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ESPL1 mRNA	PMID:39847705
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306266	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ESPL1 mRNA	PMID:24780913|PMID:30047161
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	[fulvestrant co-treated with Sirolimus] results in decreased expression of ESPL1 mRNA	PMID:19016759
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ESPL1 mRNA	PMID:38568856
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1306266	E	RGD:6480464	20141111	CTD	MESH:C001899	triptolide results in increased expression of ESPL1 mRNA	PMID:23639586
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:9753	troglitazone	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in decreased expression of ESPL1 mRNA	PMID:19140230
1314788	ESPL1	extra spindle pole bodies like 1, separase	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550440	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of ESPL1 mRNA	PMID:35537566
1314790	RASL12	RAS like family 12	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RASL12 mRNA	PMID:26272509|PMID:27188386
1314790	RASL12	RAS like family 12	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL12 mRNA	PMID:27188386
1314790	RASL12	RAS like family 12	gene	CHEBI:16236	ethanol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D000431	Ethanol results in increased expression of RASL12 mRNA	PMID:31059573
1314790	RASL12	RAS like family 12	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of RASL12 mRNA	PMID:30510588
1314790	RASL12	RAS like family 12	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314791	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of RASL12 mRNA	PMID:19484750
1314790	RASL12	RAS like family 12	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Progesterone co-treated with Estradiol] results in decreased expression of RASL12 mRNA	PMID:17404688
1314790	RASL12	RAS like family 12	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	[Progesterone co-treated with Estradiol] results in decreased expression of RASL12 mRNA	PMID:17404688
1314790	RASL12	RAS like family 12	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314791	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RASL12 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RASL12 mRNA	PMID:37567420
1314790	RASL12	RAS like family 12	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314791	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RASL12 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RASL12 mRNA	PMID:37567420
1314790	RASL12	RAS like family 12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RASL12 mRNA	PMID:31163220
1314790	RASL12	RAS like family 12	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306268	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of RASL12 mRNA	PMID:26577399|PMID:27523638
1314790	RASL12	RAS like family 12	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306268	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RASL12 mRNA	PMID:33387578
1314790	RASL12	RAS like family 12	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RASL12 mRNA	PMID:28818685
1314790	RASL12	RAS like family 12	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of RASL12 mRNA	PMID:23300844
1314790	RASL12	RAS like family 12	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1306268	E	RGD:6480464	20161025	CTD	MESH:D002945	Cisplatin results in decreased expression of RASL12 protein	PMID:17321087
1314790	RASL12	RAS like family 12	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of RASL12 mRNA	PMID:25583101
1314790	RASL12	RAS like family 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASL12 mRNA	PMID:22298810
1314790	RASL12	RAS like family 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306268	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASL12 mRNA	PMID:22298810
1314790	RASL12	RAS like family 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306268	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RASL12 mRNA	PMID:32109520|PMID:34747641
1314790	RASL12	RAS like family 12	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RASL12 mRNA	PMID:28001369
1314790	RASL12	RAS like family 12	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RASL12 mRNA	PMID:33212167
1314790	RASL12	RAS like family 12	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of RASL12 mRNA	PMID:29803840
1314790	RASL12	RAS like family 12	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314791	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RASL12 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RASL12 mRNA	PMID:37567420
1314790	RASL12	RAS like family 12	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1314791	E	RGD:6480464	20231031	CTD	MESH:D015084	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RASL12 mRNA	PMID:37567420
1314790	RASL12	RAS like family 12	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RASL12 intron	PMID:30157460
1314790	RASL12	RAS like family 12	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RASL12 mRNA	PMID:32234424
1314790	RASL12	RAS like family 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314791	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RASL12 mRNA	PMID:22228805
1314790	RASL12	RAS like family 12	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RASL12 5' UTR; Benzo(a)pyrene results in increased methylation of RASL12 promoter	PMID:27901495
1314790	RASL12	RAS like family 12	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314791	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of RASL12 mRNA	PMID:35295148
1314790	RASL12	RAS like family 12	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314791	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RASL12 mRNA	PMID:19710929
1314790	RASL12	RAS like family 12	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306268	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RASL12 mRNA	PMID:25181051
1314790	RASL12	RAS like family 12	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of RASL12 mRNA	PMID:25979313
1314790	RASL12	RAS like family 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314791	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of RASL12 mRNA	PMID:40203079
1314790	RASL12	RAS like family 12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314791	E	RGD:6480464	20260113	CTD	MESH:C543008	ATF3 protein affects the reaction [bisphenol S results in decreased expression of RASL12 mRNA]	PMID:40203079
1314790	RASL12	RAS like family 12	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314791	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RASL12 mRNA	PMID:32715474
1314790	RASL12	RAS like family 12	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314791	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RASL12 mRNA	PMID:37019170
1314790	RASL12	RAS like family 12	gene	CHEBI:34682	diazinon	decreases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in decreased methylation of RASL12 gene	PMID:22964155
1314790	RASL12	RAS like family 12	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306268	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RASL12 mRNA	PMID:21266533
1314790	RASL12	RAS like family 12	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314791	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RASL12 mRNA	PMID:21266533
1314790	RASL12	RAS like family 12	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306268	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of RASL12 mRNA	PMID:30723492
1314790	RASL12	RAS like family 12	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306268	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of RASL12 mRNA	PMID:27387713
1314790	RASL12	RAS like family 12	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RASL12 mRNA	PMID:24449571
1314790	RASL12	RAS like family 12	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1306268	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of RASL12 mRNA	PMID:23125180
1314790	RASL12	RAS like family 12	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RASL12 mRNA	PMID:25979313
1314790	RASL12	RAS like family 12	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RASL12 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:29154799
1314790	RASL12	RAS like family 12	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL12 mRNA	PMID:27188386
1314790	RASL12	RAS like family 12	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1314791	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of RASL12 mRNA	PMID:22733784
1314790	RASL12	RAS like family 12	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314791	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RASL12 mRNA	PMID:28973697
1314790	RASL12	RAS like family 12	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314791	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RASL12 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RASL12 mRNA	PMID:37567420
1314790	RASL12	RAS like family 12	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of RASL12 mRNA	PMID:26272509
1314790	RASL12	RAS like family 12	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL12 mRNA	PMID:27188386
1314790	RASL12	RAS like family 12	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of RASL12 mRNA	PMID:24935251|PMID:26272509
1314790	RASL12	RAS like family 12	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL12 mRNA	PMID:27188386
1314790	RASL12	RAS like family 12	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314791	E	RGD:6480464	20150414	CTD	MESH:D000082	[CTH gene mutant form results in increased susceptibility to Acetaminophen] which results in decreased expression of RASL12 protein	PMID:25499718
1314790	RASL12	RAS like family 12	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of RASL12 mRNA	PMID:23300844
1314790	RASL12	RAS like family 12	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314791	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RASL12 mRNA	PMID:25554681
1314790	RASL12	RAS like family 12	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1314791	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of RASL12 mRNA	PMID:36851058
1314790	RASL12	RAS like family 12	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314791	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RASL12 mRNA	PMID:22206623
1314790	RASL12	RAS like family 12	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1314791	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of RASL12 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of RASL12 mRNA	PMID:37567420
1314790	RASL12	RAS like family 12	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL12 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL12 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL12 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL12 mRNA	PMID:27188386
1314790	RASL12	RAS like family 12	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RASL12 gene]	PMID:28238834
1314790	RASL12	RAS like family 12	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1314791	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RASL12 mRNA	PMID:27935865
1314790	RASL12	RAS like family 12	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL12 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL12 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL12 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASL12 mRNA	PMID:27188386
1314790	RASL12	RAS like family 12	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306268	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RASL12 mRNA	PMID:21346803
1314790	RASL12	RAS like family 12	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RASL12 mRNA	PMID:38568856
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of SIPA1L2 mRNA	PMID:25596134
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of SIPA1L2 mRNA	PMID:21934132
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of SIPA1L2 mRNA	PMID:23724009
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of SIPA1L2 mRNA	PMID:25596134
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306269	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of SIPA1L2 gene	PMID:35440735
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314793	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SIPA1L2 mRNA	PMID:30319688
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314793	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SIPA1L2 mRNA	PMID:39241906
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314793	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SIPA1L2 mRNA	PMID:39298647
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of SIPA1L2 mRNA	PMID:21795739
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of SIPA1L2 mRNA; Progesterone inhibits the reaction [Estradiol results in increased expression of SIPA1L2 mRNA]	PMID:21795739|PMID:22217510
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SIPA1L2 mRNA	PMID:38568856
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306269	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SIPA1L2 mRNA	PMID:33387578
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SIPA1L2 mRNA	PMID:37042841
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D005557	Formaldehyde results in decreased expression of SIPA1L2 mRNA	PMID:23416264
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone inhibits the reaction [Estradiol results in increased expression of SIPA1L2 mRNA]	PMID:21795739
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of SIPA1L2 mRNA	PMID:21179406
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of SIPA1L2 mRNA	PMID:21592394
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SIPA1L2 mRNA	PMID:21592394
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SIPA1L2 protein	PMID:37730182
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SIPA1L2 mRNA	PMID:21592394
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SIPA1L2 mRNA	PMID:21592394
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306269	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SIPA1L2 mRNA	PMID:33387578
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SIPA1L2 mRNA	PMID:28818685
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314793	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SIPA1L2 mRNA	PMID:28111341
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SIPA1L2 mRNA	PMID:23649840
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SIPA1L2 gene	PMID:27153756
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SIPA1L2 mRNA	PMID:23649840
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314793	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SIPA1L2 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of SIPA1L2 mRNA	PMID:34911549
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306269	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of SIPA1L2 mRNA	PMID:30779732
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SIPA1L2 mRNA	PMID:26272509
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIPA1L2 mRNA	PMID:27188386
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1314793	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of SIPA1L2 mRNA	PMID:35897073
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of SIPA1L2 mRNA	PMID:25596134
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin affects the expression of SIPA1L2 mRNA	PMID:23300844|PMID:25596134
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314793	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of SIPA1L2 mRNA	PMID:30912803
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:28088	genistein	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D019833	Genistein affects the expression of SIPA1L2 mRNA	PMID:26865667
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306269	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SIPA1L2 mRNA	PMID:34747641
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SIPA1L2 mRNA	PMID:12377990|PMID:22903824|PMID:29704546
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306269	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SIPA1L2 mRNA	PMID:33387578
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of SIPA1L2 mRNA	PMID:29704546
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SIPA1L2 mRNA	PMID:28001369
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SIPA1L2 mRNA	PMID:33212167
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306269	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SIPA1L2 mRNA	PMID:28959563
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of SIPA1L2 mRNA	PMID:21198554
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314793	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of SIPA1L2 mRNA	PMID:39631538
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SIPA1L2 mRNA	PMID:38568856
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of SIPA1L2 mRNA	PMID:34032870
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SIPA1L2 mRNA	PMID:22178795|PMID:32234424
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SIPA1L2 mRNA	PMID:19150397|PMID:20018196
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1306269	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of SIPA1L2 mRNA	PMID:25729387
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306269	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SIPA1L2 mRNA	PMID:25729387
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306269	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SIPA1L2 mRNA	PMID:30047161
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314793	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SIPA1L2 mRNA	PMID:20813756
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SIPA1L2 mRNA	PMID:19710929
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of SIPA1L2 mRNA	PMID:30690063
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of SIPA1L2 mRNA	PMID:20170705
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of SIPA1L2 mRNA; bisphenol A results in decreased expression of SIPA1L2 protein	PMID:31675489|PMID:36232920
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SIPA1L2 gene	PMID:31601247
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306269	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SIPA1L2 mRNA	PMID:25181051
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306269	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SIPA1L2 gene	PMID:28505145
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SIPA1L2 protein	PMID:31675489
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SIPA1L2 mRNA	PMID:25979313
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314793	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of SIPA1L2 mRNA	PMID:26682919
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of SIPA1L2 mRNA	PMID:36804509
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1306269	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SIPA1L2 mRNA	PMID:23196670
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314793	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SIPA1L2 mRNA	PMID:39298647
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1314793	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of SIPA1L2 mRNA	PMID:26377693
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314793	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SIPA1L2 mRNA	PMID:37019170
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314793	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SIPA1L2 mRNA	PMID:21266533
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SIPA1L2 mRNA	PMID:37042841
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306269	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SIPA1L2 mRNA	PMID:33453195
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SIPA1L2 mRNA	PMID:38174414
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314793	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SIPA1L2 mRNA	PMID:28111341
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SIPA1L2 mRNA	PMID:19320972
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314793	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of SIPA1L2 mRNA	PMID:28962523
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of SIPA1L2 mRNA	PMID:25596134
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C480342	clothianidin results in increased expression of SIPA1L2 mRNA	PMID:29044138
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in decreased expression of SIPA1L2 mRNA	PMID:37505509
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of SIPA1L2 mRNA	PMID:24935251|PMID:28001369|PMID:29154799
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306269	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SIPA1L2 mRNA	PMID:30047161
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SIPA1L2 mRNA	PMID:20106945
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of SIPA1L2 mRNA	PMID:25047013
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314793	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SIPA1L2 mRNA	PMID:28973697
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SIPA1L2 mRNA	PMID:38832940
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SIPA1L2 mRNA	PMID:24935251
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of SIPA1L2 mRNA	PMID:29067470
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306269	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SIPA1L2 mRNA	PMID:33387578
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of SIPA1L2 mRNA	PMID:31675489
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306269	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of SIPA1L2 mRNA	PMID:29391264
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SIPA1L2 mRNA	PMID:22079256
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314793	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SIPA1L2 mRNA	PMID:35436446
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SIPA1L2 mRNA	PMID:20170705|PMID:26865667
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of SIPA1L2 mRNA	PMID:26272509
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIPA1L2 mRNA	PMID:27188386
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SIPA1L2 mRNA	PMID:23300844
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306269	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SIPA1L2 mRNA	PMID:30307764
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1314793	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog affects the expression of SIPA1L2 mRNA	PMID:25620056
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314793	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SIPA1L2 mRNA; Nanotubes, Carbon results in decreased expression of SIPA1L2 mRNA	PMID:25554681|PMID:25620056
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306269	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SIPA1L2 mRNA	PMID:30047161
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1314793	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of SIPA1L2 mRNA	PMID:26377693
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:5864	ifosfamide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of SIPA1L2 mRNA	PMID:25596134
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:6015	isoflurane	decreases methylation	ISO	RGD:1314793	E	RGD:6480464	20220809	CTD	MESH:D007530	Isoflurane results in decreased methylation of SIPA1L2 mRNA	PMID:35249202
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1306269	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of SIPA1L2 mRNA	PMID:28801915
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306269	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SIPA1L2 mRNA	PMID:25729387
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306269	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SIPA1L2 mRNA	PMID:25729387
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SIPA1L2 mRNA	PMID:28988120
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1314793	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of SIPA1L2 mRNA	PMID:36907384
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SIPA1L2 mRNA	PMID:22079256|PMID:22714537
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SIPA1L2 mRNA	PMID:22079256
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:756028	mivebresib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in increased expression of SIPA1L2 mRNA	PMID:35486664
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of SIPA1L2 mRNA	PMID:34995734
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIPA1L2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIPA1L2 mRNA	PMID:27188386
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SIPA1L2 gene]	PMID:28238834
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SIPA1L2 protein	PMID:31675489
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SIPA1L2 protein	PMID:31675489
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1306269	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of SIPA1L2 mRNA	PMID:30047161
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306269	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SIPA1L2 mRNA	PMID:30047161
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIPA1L2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SIPA1L2 mRNA	PMID:27188386
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:9130	sevoflurane	decreases methylation	ISO	RGD:1314793	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in decreased methylation of SIPA1L2 mRNA	PMID:35249202
1314792	SIPA1L2	signal induced proliferation associated 1 like 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314793	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SIPA1L2 mRNA	PMID:28973697
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314797	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPIC mRNA	PMID:20938992
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314797	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SPIC mRNA	PMID:36189433
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314797	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SPIC mRNA	PMID:39241906
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314797	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SPIC mRNA	PMID:27339419
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314797	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SPIC mRNA	PMID:39298647
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314797	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPIC mRNA	PMID:20938992
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SPIC mRNA	PMID:23649840
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314797	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPIC mRNA	PMID:37992649
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314797	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of SPIC mRNA	PMID:36189433
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314797	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPIC mRNA	PMID:37992649
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314797	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPIC mRNA	PMID:36331819
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SPIC mRNA	PMID:23649840
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314797	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPIC mRNA	PMID:20938992
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SPIC gene	PMID:25304211
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306272	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SPIC mRNA	PMID:31881176
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314797	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of SPIC mRNA	PMID:40618947
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314797	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPIC mRNA	PMID:24058054
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314797	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SPIC mRNA	PMID:37172768
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of SPIC mRNA	PMID:23649840
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314797	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPIC mRNA	PMID:37992649
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314797	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SPIC mRNA	PMID:23221170
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1306272	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of SPIC mRNA	PMID:25729387
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306272	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SPIC mRNA	PMID:25729387
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314797	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SPIC mRNA	PMID:29264374
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314797	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SPIC mRNA	PMID:20813756
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314797	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of SPIC mRNA	PMID:18445702|PMID:23811191
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314797	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SPIC promoter	PMID:27334623
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306272	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPIC mRNA	PMID:25181051
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314797	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SPIC mRNA	PMID:39298647
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306272	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SPIC mRNA	PMID:32680482
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314797	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPIC mRNA	PMID:36331819
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306272	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of SPIC mRNA	PMID:41580965
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314797	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SPIC mRNA	PMID:37992649
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of SPIC mRNA	PMID:23649840
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314797	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SPIC mRNA	PMID:17562736
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SPIC gene	PMID:25304211
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314797	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SPIC mRNA	PMID:35436446
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314797	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SPIC mRNA; Nanotubes, Carbon results in increased expression of SPIC mRNA	PMID:25554681|PMID:25620056
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314797	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of SPIC mRNA	PMID:23608068
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314797	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SPIC mRNA	PMID:38701926
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1314797	E	RGD:6480464	20180828	CTD	MESH:D016559	Tacrolimus results in increased expression of SPIC mRNA	PMID:29362864
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:63618	pravastatin	decreases expression	ISO	RGD:1306272	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in decreased expression of SPIC mRNA	PMID:27225895
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:63618	pravastatin	increases expression	ISO	RGD:1314797	E	RGD:6480464	20180220	CTD	MESH:D017035	Pravastatin results in increased expression of SPIC mRNA	PMID:27225895
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1306272	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of SPIC mRNA	PMID:25729387
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306272	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SPIC mRNA	PMID:25729387
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1314797	E	RGD:6480464	20141111	CTD	MESH:D002185	Cannabidiol results in increased expression of SPIC mRNA	PMID:21542829
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314797	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SPIC mRNA	PMID:22206623
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SPIC gene]	PMID:28238834
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314797	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of SPIC mRNA	PMID:38648751
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1306272	E	RGD:6480464	20210209	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SPIC mRNA	PMID:31826744
1314796	SPIC	Spi-C transcription factor	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314797	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of SPIC mRNA	PMID:39847705
1314798	FER	FER tyrosine kinase	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of FER mRNA	PMID:38218311
1314798	FER	FER tyrosine kinase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306273	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FER mRNA]	PMID:31150632
1314798	FER	FER tyrosine kinase	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of FER mRNA	PMID:15456535
1314798	FER	FER tyrosine kinase	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306273	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of FER gene	PMID:28931070
1314798	FER	FER tyrosine kinase	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314799	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FER mRNA	PMID:39241906
1314798	FER	FER tyrosine kinase	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306273	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of FER gene	PMID:27618143
1314798	FER	FER tyrosine kinase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1314799	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of FER gene	PMID:34319233
1314798	FER	FER tyrosine kinase	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of FER protein	PMID:37730182
1314798	FER	FER tyrosine kinase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306273	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of FER mRNA	PMID:33387578
1314798	FER	FER tyrosine kinase	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of FER mRNA	PMID:23487506
1314798	FER	FER tyrosine kinase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FER gene	PMID:27153756
1314798	FER	FER tyrosine kinase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314799	E	RGD:6480464	20150310	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FER mRNA	PMID:19770486
1314798	FER	FER tyrosine kinase	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FER intron	PMID:30157460
1314798	FER	FER tyrosine kinase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of FER mRNA	PMID:23649840
1314798	FER	FER tyrosine kinase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306273	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FER mRNA	PMID:31150632
1314798	FER	FER tyrosine kinase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314799	E	RGD:6480464	20150310	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FER mRNA	PMID:17484886
1314798	FER	FER tyrosine kinase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306273	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FER mRNA]	PMID:31150632
1314798	FER	FER tyrosine kinase	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FER gene	PMID:25304211
1314798	FER	FER tyrosine kinase	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of FER mRNA	PMID:26272509
1314798	FER	FER tyrosine kinase	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FER mRNA	PMID:27188386
1314798	FER	FER tyrosine kinase	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of FER protein	PMID:35688186
1314798	FER	FER tyrosine kinase	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1306273	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of FER gene	PMID:35440735
1314798	FER	FER tyrosine kinase	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of FER mRNA	PMID:23557933
1314798	FER	FER tyrosine kinase	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of FER mRNA	PMID:28903495
1314798	FER	FER tyrosine kinase	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of FER mRNA	PMID:27392435
1314798	FER	FER tyrosine kinase	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of FER mRNA	PMID:27392435
1314798	FER	FER tyrosine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314799	E	RGD:6480464	20150310	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FER mRNA	PMID:21570461
1314798	FER	FER tyrosine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306273	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FER mRNA	PMID:32109520
1314798	FER	FER tyrosine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314799	E	RGD:6480464	20150310	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FER mRNA	PMID:17942748
1314798	FER	FER tyrosine kinase	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FER mRNA	PMID:28001369
1314798	FER	FER tyrosine kinase	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FER mRNA	PMID:33212167
1314798	FER	FER tyrosine kinase	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of FER mRNA	PMID:21714911
1314798	FER	FER tyrosine kinase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FER promoter	PMID:27901495
1314798	FER	FER tyrosine kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FER mRNA	PMID:20106945
1314798	FER	FER tyrosine kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314799	E	RGD:6480464	20150310	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FER mRNA	PMID:21715664
1314798	FER	FER tyrosine kinase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FER mRNA	PMID:26238291
1314798	FER	FER tyrosine kinase	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to FER mRNA]	PMID:32406909
1314798	FER	FER tyrosine kinase	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of FER mRNA	PMID:29633893
1314798	FER	FER tyrosine kinase	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1306273	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in decreased expression of FER mRNA	PMID:24395379
1314798	FER	FER tyrosine kinase	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1306273	E	RGD:6480464	20150310	CTD	MESH:D000643	Ammonium Chloride affects the expression of FER mRNA	PMID:16483693
1314798	FER	FER tyrosine kinase	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FER gene	PMID:31601247
1314798	FER	FER tyrosine kinase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306273	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FER mRNA	PMID:34492290
1314798	FER	FER tyrosine kinase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314799	E	RGD:6480464	20150310	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of FER mRNA	PMID:18648102
1314798	FER	FER tyrosine kinase	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of FER mRNA	PMID:19710929
1314798	FER	FER tyrosine kinase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306273	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FER mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314798	FER	FER tyrosine kinase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314799	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FER mRNA	PMID:33221593
1314798	FER	FER tyrosine kinase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of FER mRNA	PMID:33670352
1314798	FER	FER tyrosine kinase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306273	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FER gene	PMID:28505145
1314798	FER	FER tyrosine kinase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FER gene	PMID:31601247
1314798	FER	FER tyrosine kinase	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of FER mRNA	PMID:24752500
1314798	FER	FER tyrosine kinase	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1314799	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of FER mRNA	PMID:26377693
1314798	FER	FER tyrosine kinase	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314799	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of FER intron	PMID:28392331
1314798	FER	FER tyrosine kinase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of FER mRNA	PMID:37042841
1314798	FER	FER tyrosine kinase	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FER mRNA	PMID:21457566
1314798	FER	FER tyrosine kinase	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of FER mRNA	PMID:28302478
1314798	FER	FER tyrosine kinase	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of FER mRNA	PMID:31533062
1314798	FER	FER tyrosine kinase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FER mRNA	PMID:25979313
1314798	FER	FER tyrosine kinase	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FER gene	PMID:29154799
1314798	FER	FER tyrosine kinase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of FER mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1314798	FER	FER tyrosine kinase	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FER mRNA	PMID:27188386
1314798	FER	FER tyrosine kinase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of FER mRNA	PMID:25562108
1314798	FER	FER tyrosine kinase	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	FER protein affects the susceptibility to Methotrexate	PMID:16217747
1314798	FER	FER tyrosine kinase	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of FER mRNA	PMID:38832940
1314798	FER	FER tyrosine kinase	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of FER mRNA	PMID:26272509
1314798	FER	FER tyrosine kinase	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FER mRNA	PMID:27188386
1314798	FER	FER tyrosine kinase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306273	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of FER mRNA	PMID:33387578
1314798	FER	FER tyrosine kinase	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314799	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FER mRNA	PMID:29279043
1314798	FER	FER tyrosine kinase	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FER gene	PMID:25304211
1314798	FER	FER tyrosine kinase	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of FER mRNA	PMID:24752500
1314798	FER	FER tyrosine kinase	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306273	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of FER mRNA	PMID:29391264
1314798	FER	FER tyrosine kinase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FER mRNA	PMID:22079256
1314798	FER	FER tyrosine kinase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314799	E	RGD:6480464	20150310	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FER mRNA	PMID:17942748
1314798	FER	FER tyrosine kinase	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314799	E	RGD:6480464	20150310	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FER mRNA	PMID:17942748
1314798	FER	FER tyrosine kinase	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of FER mRNA	PMID:32234424
1314798	FER	FER tyrosine kinase	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of FER mRNA	PMID:29633893
1314798	FER	FER tyrosine kinase	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314799	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of FER mRNA; Nanotubes, Carbon results in increased expression of FER mRNA	PMID:25554681
1314798	FER	FER tyrosine kinase	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of FER mRNA	PMID:22079256
1314798	FER	FER tyrosine kinase	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FER mRNA	PMID:22079256
1314798	FER	FER tyrosine kinase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FER mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FER mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FER mRNA	PMID:27188386
1314798	FER	FER tyrosine kinase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306273	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of FER mRNA	PMID:32109520
1314798	FER	FER tyrosine kinase	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314799	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of FER mRNA	PMID:39847705
1314798	FER	FER tyrosine kinase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FER mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FER mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FER mRNA	PMID:27188386
1314798	FER	FER tyrosine kinase	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of FER mRNA	PMID:27188386
1314798	FER	FER tyrosine kinase	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314799	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of FER mRNA	PMID:28973697
1314798	FER	FER tyrosine kinase	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306273	E	RGD:6480464	20150310	CTD	MESH:C025643	vinclozolin results in decreased expression of FER mRNA	PMID:22570695
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:10022	deoxynivalenol	increases phosphorylation	ISO	RGD:1314802	E	RGD:6480464	20171212	CTD	MESH:C007262	deoxynivalenol results in increased phosphorylation of SH3BP1 protein	PMID:23352502
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314802	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of SH3BP1 mRNA	PMID:33045310
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314802	E	RGD:6480464	20171212	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of SH3BP1 mRNA	PMID:26251327
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20171212	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SH3BP1 mRNA	PMID:20938992
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1314802	E	RGD:6480464	20171212	CTD	MESH:C029424	hydrazine results in decreased expression of SH3BP1 mRNA	PMID:15282401
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314802	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SH3BP1 mRNA	PMID:39241906
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306275	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SH3BP1 mRNA	PMID:32741896
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SH3BP1 mRNA	PMID:38568856
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20171212	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SH3BP1 mRNA	PMID:20938992
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SH3BP1 mRNA	PMID:37042841
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3BP1 mRNA	PMID:37992649
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306275	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SH3BP1 mRNA	PMID:32741896
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3BP1 mRNA	PMID:37992649
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SH3BP1 protein	PMID:37730182
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306275	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SH3BP1 mRNA	PMID:33387578
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SH3BP1 mRNA	PMID:37236586
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1314802	E	RGD:6480464	20171212	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of SH3BP1 mRNA	PMID:19376150
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SH3BP1 mRNA	PMID:32234424
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20171212	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SH3BP1 mRNA	PMID:20938992
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SH3BP1 mRNA	PMID:40512198
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SH3BP1 mRNA	PMID:40504410
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SH3BP1 protein	PMID:35688186
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314802	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SH3BP1 mRNA	PMID:28960355
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306275	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SH3BP1 mRNA	PMID:33387578
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20171212	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SH3BP1 mRNA	PMID:17942748
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of SH3BP1 protein	PMID:39603559
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SH3BP1 mRNA	PMID:33212167
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SH3BP1 mRNA	PMID:30851411
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3BP1 mRNA	PMID:37992649
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of SH3BP1 mRNA	PMID:22714537
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SH3BP1 mRNA	PMID:40512198
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SH3BP1 mRNA	PMID:40504410
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SH3BP1 intron	PMID:30157460
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SH3BP1 5' UTR; Benzo(a)pyrene results in decreased methylation of SH3BP1 promoter	PMID:27901495
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314802	E	RGD:6480464	20171212	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SH3BP1 mRNA	PMID:21569818
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SH3BP1 3' UTR	PMID:27901495
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SH3BP1 mRNA	PMID:34973136
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306275	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SH3BP1 mRNA	PMID:25181051
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306275	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SH3BP1 mRNA	PMID:30816183|PMID:32528016
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:34283	oxybenzone	decreases expression	ISO	RGD:1314802	E	RGD:6480464	20250311	CTD	MESH:C005290	oxybenzone results in decreased expression of SH3BP1 mRNA	PMID:39343157
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SH3BP1 intron	PMID:30157460
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SH3BP1 gene	PMID:22964155
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SH3BP1 mRNA	PMID:37236586
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314802	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SH3BP1 mRNA	PMID:40194260
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of SH3BP1 mRNA	PMID:28302478
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SH3BP1 mRNA	PMID:31533062
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1314802	E	RGD:6480464	20171212	CTD	MESH:D013629	Tamoxifen results in increased expression of SH3BP1 mRNA	PMID:17555576
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314802	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SH3BP1 mRNA	PMID:28973697
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SH3BP1 mRNA	PMID:37992649
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SH3BP1 mRNA	PMID:38832940
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314802	E	RGD:6480464	20171212	CTD	MESH:D000082	Acetaminophen affects the expression of SH3BP1 mRNA	PMID:17562736
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SH3BP1 mRNA	PMID:40512198
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SH3BP1 mRNA	PMID:40504410
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306275	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SH3BP1 mRNA	PMID:29391264
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314802	E	RGD:6480464	20171212	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SH3BP1 mRNA	PMID:17942748
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1314802	E	RGD:6480464	20171212	CTD	MESH:C031180	chrysene results in increased expression of SH3BP1 mRNA	PMID:26377693
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SH3BP1 protein	PMID:32959892
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SH3BP1 intron	PMID:30157460
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of SH3BP1 mRNA	PMID:31758290
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1306275	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SH3BP1 mRNA	PMID:32741896
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SH3BP1 mRNA	PMID:30851411
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SH3BP1 gene]	PMID:28238834
1314801	SH3BP1	SH3 domain binding protein 1	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SH3BP1 mRNA	PMID:29301935
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of NEDD9 mRNA	PMID:38218311
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in decreased expression of NEDD9 mRNA; Diuron results in decreased expression of NEDD9 mRNA	PMID:24172598|PMID:35967413
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1306276	E	RGD:6480464	20140311	CTD	MESH:D004237	Diuron metabolite results in increased expression of NEDD9 mRNA	PMID:24172598
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of NEDD9 mRNA	PMID:26272509
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of NEDD9 mRNA	PMID:27188386
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEDD9 mRNA	PMID:27188386
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306276	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NEDD9 mRNA]	PMID:31150632
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314804	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of NEDD9 mRNA	PMID:26251327
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NEDD9 mRNA	PMID:20938992
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D014212	Tretinoin metabolite results in increased expression of NEDD9 mRNA; Tretinoin results in increased expression of NEDD9 mRNA	PMID:15982314|PMID:16688769|PMID:21934132|PMID:33167477
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1306276	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of NEDD9 mRNA	PMID:20488242
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Dactinomycin inhibits the reaction [Tretinoin results in increased expression of NEDD9 mRNA]	PMID:16688769
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of NEDD9 mRNA	PMID:26516004
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of NEDD9 mRNA	PMID:26079696
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:15767	dichloromethane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008752	Methylene Chloride results in increased expression of NEDD9 mRNA	PMID:20359517
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16101	ethylbenzene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C004912	ethylbenzene results in increased expression of NEDD9 mRNA	PMID:20359517
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of NEDD9 mRNA	PMID:21632981
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of NEDD9 mRNA	PMID:35811015
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of NEDD9 mRNA	PMID:22574217
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of NEDD9 mRNA	PMID:16474171
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of NEDD9 mRNA	PMID:19619570|PMID:31614463
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306276	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of NEDD9 mRNA	PMID:32145629
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of NEDD9 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of NEDD9 mRNA	PMID:19619570|PMID:30165855
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NEDD9 mRNA	PMID:33387578
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of NEDD9 mRNA	PMID:20359517
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NEDD9 mRNA	PMID:20938992
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NEDD9 mRNA	PMID:37042841
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001554	Benzene results in increased expression of NEDD9 mRNA	PMID:20359517
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16767	3,4-dichloroaniline	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in decreased expression of NEDD9 mRNA	PMID:24172598
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16767	3,4-dichloroaniline	increases expression	ISO	RGD:1306276	E	RGD:6480464	20140311	CTD	MESH:C014464	3,4-dichloroaniline results in increased expression of NEDD9 mRNA	PMID:24172598
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:167830	isorhapontigenin	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C432307	[sodium bichromate co-treated with isorhapontigenin] inhibits the reaction [CTNNB1 protein modified form binds to NEDD9 protein]; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of and results in decreased localization of NEDD9 protein; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of NEDD9 mRNA	PMID:37619952
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of NEDD9 mRNA	PMID:23649840
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NEDD9 mRNA	PMID:37992649
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1314804	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of NEDD9 mRNA	PMID:33848595
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:17578	toluene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014050	Toluene results in increased expression of NEDD9 mRNA	PMID:20359517
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:175901	gemcitabine	increases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C056507	Gemcitabine results in increased expression of NEDD9 mRNA	PMID:17039268
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NEDD9 mRNA	PMID:37992649
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1314804	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of NEDD9 mRNA	PMID:17456735
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of NEDD9 protein	PMID:37730182
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of NEDD9 mRNA	PMID:36139627
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of NEDD9 intron	PMID:30157460
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NEDD9 mRNA	PMID:36331819
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:1306276	E	RGD:6480464	20120814	CTD	MESH:D007501	Iron deficiency results in increased expression of NEDD9 mRNA	PMID:16629162
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1314804	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of NEDD9 mRNA	PMID:17456735
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:19452	2-amino-4,6-dinitrotoluene	affects expression	ISO	RGD:1306276	E	RGD:6480464	20140304	CTD	MESH:C035208	2-amino-4,6-dinitrotoluene affects the expression of NEDD9 mRNA	PMID:21346803
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:22977	cadmium atom	decreases activity	ISO	RGD:1314804	E	RGD:6480464	20210608	CTD	MESH:D002104	Cadmium results in decreased activity of NEDD9 protein	PMID:33642518
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NEDD9 mRNA	PMID:37325564
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NEDD9 mRNA	PMID:19549813
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NEDD9 mRNA	PMID:27153756
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306276	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NEDD9 mRNA	PMID:33354967
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NEDD9 gene	PMID:27153756
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:2682	amphotericin B	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of NEDD9 mRNA	PMID:28534445
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314804	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of NEDD9 mRNA	PMID:17484886
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NEDD9 mRNA	PMID:31150632
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314804	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of NEDD9 mRNA	PMID:31919559
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306276	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NEDD9 mRNA]	PMID:31150632
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314804	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NEDD9 mRNA	PMID:25629700
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NEDD9 mRNA	PMID:20938992
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27504	mitomycin C	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	NEDD9 protein affects the susceptibility to Mitomycin	PMID:16217747
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of NEDD9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NEDD9 mRNA	PMID:40512198
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003609	Dactinomycin inhibits the reaction [Tretinoin results in increased expression of NEDD9 mRNA]	PMID:16688769
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of NEDD9 mRNA	PMID:26272509
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEDD9 mRNA	PMID:27188386
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27698	vanadium atom	increases activity	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased activity of NEDD9 protein	PMID:19000753
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of NEDD9 protein	PMID:35688186
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306276	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of NEDD9 mRNA	PMID:31881176
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of NEDD9 mRNA	PMID:19167446
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	NEDD9 protein affects the susceptibility to Cisplatin	PMID:16217747
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of NEDD9 mRNA	PMID:27594783
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin promotes the reaction [jinfukang results in decreased expression of NEDD9 mRNA]; jinfukang promotes the reaction [Cisplatin results in decreased expression of NEDD9 mRNA]	PMID:27392435
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314804	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of NEDD9 mRNA	PMID:30912803
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28063	o-xylene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C026114	2-xylene results in increased expression of NEDD9 mRNA	PMID:20359517
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of NEDD9 mRNA	PMID:16474171
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314804	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NEDD9 mRNA	PMID:21570461
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NEDD9 mRNA	PMID:29704546
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NEDD9 mRNA	PMID:21215274
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314804	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NEDD9 mRNA	PMID:21354282
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NEDD9 mRNA	PMID:11489354|PMID:16619036|PMID:19619570|PMID:20106945|PMID:21632981|PMID:22903824|PMID:26238291
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306276	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NEDD9 mRNA	PMID:34747641
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314804	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NEDD9 mRNA	PMID:19465110|PMID:19933214
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of NEDD9 mRNA; [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of NEDD9 mRNA	PMID:19619570|PMID:29704546
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of NEDD9 mRNA	PMID:29955902
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306276	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of NEDD9 mRNA	PMID:28374803
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of NEDD9 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEDD9 mRNA	PMID:27188386
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306276	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of NEDD9 mRNA	PMID:30556269
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NEDD9 mRNA	PMID:29803840
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314804	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in increased expression of NEDD9 mRNA	PMID:19277126
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NEDD9 mRNA	PMID:37992649
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:28939	N-acetyl-L-cysteine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine results in decreased expression of NEDD9 mRNA	PMID:16084531
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of NEDD9 mRNA	PMID:34032870|PMID:39719251
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314804	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of NEDD9 mRNA	PMID:16014739|PMID:37682722
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of NEDD9 mRNA	PMID:22714537
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of NEDD9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NEDD9 mRNA	PMID:40512198
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NEDD9 intron	PMID:30157460
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NEDD9 mRNA	PMID:20064835
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314804	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NEDD9 mRNA	PMID:19770486
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NEDD9 mRNA	PMID:17879257|PMID:20106945|PMID:22316170|PMID:26238291
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314804	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NEDD9 mRNA	PMID:21569818
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:30045	divanadium pentaoxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C066075	vanadium pentoxide affects the expression of NEDD9 mRNA	PMID:17459161
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306276	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of NEDD9 mRNA	PMID:30556269
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of NEDD9 mRNA	PMID:25895662
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of NEDD9 mRNA	PMID:25351596
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of NEDD9 mRNA	PMID:20382639
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of NEDD9 mRNA	PMID:24915197
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306276	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NEDD9 mRNA	PMID:25729387
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314804	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NEDD9 promoter	PMID:35295148
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NEDD9 mRNA	PMID:19710929
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of NEDD9 mRNA	PMID:20170705|PMID:30903817
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of NEDD9 mRNA	PMID:16474171|PMID:29275510
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314804	E	RGD:6480464	20180703	CTD	MESH:C006780	bisphenol A results in decreased expression of NEDD9 mRNA	PMID:29161229|PMID:33221593
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of NEDD9 gene	PMID:31601247
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306276	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NEDD9 mRNA	PMID:25181051|PMID:34947998
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314804	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of NEDD9 mRNA	PMID:26063408|PMID:30951980|PMID:34585602
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:34342	3-methylcholanthrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in increased expression of NEDD9 mRNA	PMID:16619036
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314804	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of NEDD9 mRNA	PMID:40203079
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of NEDD9 intron	PMID:30157460
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314804	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of NEDD9 mRNA	PMID:30951980|PMID:38685157
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314804	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of NEDD9 intron	PMID:28392331
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314804	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of NEDD9 mRNA	PMID:21266533
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1314804	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of NEDD9 mRNA	PMID:34813904
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1314804	E	RGD:6480464	20260707	CTD	MESH:D010269	Paraquat results in increased expression of NEDD9 protein	PMID:39748354
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NEDD9 mRNA	PMID:37042841
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1306276	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of NEDD9 mRNA	PMID:30589522
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:35170	vanadium(0)	increases activity	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased activity of NEDD9 protein	PMID:19000753
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride affects the expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1306276	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of NEDD9 mRNA	PMID:22110744
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NEDD9 mRNA	PMID:33770205
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NEDD9 mRNA; Cadmium Chloride results in increased expression of NEDD9 protein	PMID:26220685|PMID:38174414|PMID:38568856
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of NEDD9 mRNA	PMID:37325564
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of NEDD9 mRNA	PMID:25868421
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314804	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of NEDD9 mRNA	PMID:28903501
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NEDD9 mRNA	PMID:19320972|PMID:19376846
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of NEDD9 mRNA	PMID:24386269
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of NEDD9 mRNA	PMID:24449571
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:3647	chlorpromazine	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20150825	CTD	MESH:D002746	Chlorpromazine results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314804	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of NEDD9 mRNA	PMID:40194260
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of NEDD9 mRNA	PMID:31533062
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of NEDD9 mRNA	PMID:19167446
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD9 mRNA; [Coumestrol co-treated with Resveratrol] results in decreased expression of NEDD9 mRNA	PMID:19167446
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314804	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of NEDD9 mRNA	PMID:39529242
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of NEDD9 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of NEDD9 mRNA	PMID:36331819
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1314804	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of NEDD9 mRNA	PMID:23125180
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1306276	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of NEDD9 mRNA	PMID:22110744
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:39483	sodium dichromate	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C016104	[sodium bichromate co-treated with isorhapontigenin] inhibits the reaction [CTNNB1 protein modified form binds to NEDD9 protein]; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of and results in decreased localization of NEDD9 protein; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of NEDD9 mRNA	PMID:37619952
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NEDD9 mRNA	PMID:25979313
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of NEDD9 mRNA	PMID:23179753|PMID:24383497|PMID:28001369
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of NEDD9 mRNA	PMID:38685447|PMID:41580965
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NEDD9 mRNA	PMID:20106945|PMID:25562108|PMID:25596134|PMID:27989131
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of NEDD9 promoter	PMID:27989131
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1314804	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of NEDD9 mRNA	PMID:25123088
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1306276	E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of NEDD9 mRNA	PMID:21658437
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314804	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of NEDD9 mRNA	PMID:28973697
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NEDD9 mRNA	PMID:37992649
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of NEDD9 mRNA	PMID:18769122
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of NEDD9 mRNA	PMID:27188386
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of NEDD9 mRNA	PMID:24935251
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of NEDD9 mRNA	PMID:33387578
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20120412	CTD	MESH:D000082	MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of NEDD9 mRNA]	PMID:18700144
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of NEDD9 mRNA	PMID:35811015
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of NEDD9 mRNA	PMID:25757056
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of NEDD9 mRNA	PMID:25351596
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of NEDD9 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of NEDD9 mRNA	PMID:40512198
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of NEDD9 mRNA	PMID:29391264
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of NEDD9 mRNA	PMID:16084531
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of NEDD9 mRNA	PMID:18175754
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1306276	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of NEDD9 mRNA	PMID:20170705
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:4911	etoposide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	NEDD9 protein affects the susceptibility to Etoposide	PMID:16217747
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of NEDD9 mRNA	PMID:38568856
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:49662	indometacin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007213	Indomethacin results in increased expression of NEDD9 mRNA	PMID:16984733
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:50091	S-nitrosoglutathione	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione affects the expression of NEDD9 mRNA	PMID:38825487
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:50648	9-cis-retinoic acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C103303	Alitretinoin results in increased expression of NEDD9 mRNA	PMID:15982314
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of NEDD9 mRNA	PMID:41580965
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1314804	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of NEDD9 mRNA	PMID:40234311
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1314804	E	RGD:6480464	20150127	CTD	MESH:C000499	ferric oxide analog results in increased expression of NEDD9 mRNA	PMID:24525745
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:51348	tetraphene	multiple interactions	EXP		E	RGD:6480464	20140114	CTD	MESH:C030935	[benz(a)anthracene co-treated with TNF protein] results in increased expression of NEDD9 mRNA	PMID:23396138
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of NEDD9 mRNA	PMID:26705709
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of NEDD9 mRNA	PMID:22714537
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of NEDD9 mRNA	PMID:31629900
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:5855	ibuprofen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:5855	ibuprofen	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20150825	CTD	MESH:D007052	Ibuprofen results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:5864	ifosfamide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of NEDD9 mRNA	PMID:15982314
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:63598	levofloxacin	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in decreased expression of NEDD9 mRNA	PMID:24136188
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of NEDD9 mRNA	PMID:25729387
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306276	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NEDD9 mRNA	PMID:25729387
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1306276	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of NEDD9 mRNA	PMID:24136188
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:63933	Aroclor 1254	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of NEDD9 mRNA	PMID:16934159
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of NEDD9 mRNA	PMID:28988120
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of NEDD9 mRNA	PMID:19031421
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:6801	metformin	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of NEDD9 intron	PMID:30157460
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:69120	withaferin A	decreases expression	ISO	RGD:1314804	E	RGD:6480464	20250708	CTD	MESH:C009684	withaferin A results in decreased expression of NEDD9 protein	PMID:39613173
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:69120	withaferin A	multiple interactions	EXP		E	RGD:6480464	20250708	CTD	MESH:C009684	[withaferin A results in increased phosphorylation of VIM protein] inhibits the reaction [NEDD9 protein binds to VIM protein]; withaferin A inhibits the reaction [NEDD9 protein binds to VIM protein]	PMID:39613173
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:69120	withaferin A	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20250708	CTD	MESH:C009684	[withaferin A results in increased phosphorylation of VIM protein] inhibits the reaction [NEDD9 protein binds to VIM protein]; withaferin A inhibits the reaction [NEDD9 protein binds to VIM protein]	PMID:39613173
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of NEDD9 mRNA	PMID:31758290
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:73726	GW 501516	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C425931	[GW 501516 binds to PPARD protein] which results in increased expression of NEDD9 mRNA	PMID:16197558
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314804	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NEDD9 mRNA	PMID:22206623
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of NEDD9 mRNA	PMID:36139627
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEDD9 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEDD9 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEDD9 mRNA	PMID:27188386
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:80656	all-trans-4-oxoretinoic acid	increases expression	EXP		E	RGD:6480464	20150120	CTD	MESH:C002202	4-oxoretinoic acid results in increased expression of NEDD9 mRNA	PMID:15982314
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314804	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of NEDD9 mRNA	PMID:19482888|PMID:23091169
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NEDD9 mRNA]	PMID:19482888
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of NEDD9 mRNA	PMID:32109520
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NEDD9 mRNA	PMID:19167446
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in decreased expression of NEDD9 mRNA	PMID:38995820
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:81980	triticonazole	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20230704	CTD	MESH:C412303	triticonazole results in decreased expression of NEDD9 mRNA	PMID:36084822
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:1306276	E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of NEDD9 mRNA	PMID:16629162
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314804	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of NEDD9 mRNA	PMID:21278054
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306276	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of NEDD9 mRNA	PMID:24780913
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of NEDD9 mRNA	PMID:24921660
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:90195	tacedinaline	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C081895	tacedinaline results in increased expression of NEDD9 mRNA	PMID:33770205
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NEDD9 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEDD9 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NEDD9 mRNA	PMID:27188386
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306276	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of NEDD9 mRNA	PMID:19281266
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306276	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NEDD9 mRNA	PMID:21346803
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of NEDD9 mRNA	PMID:38568856
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306276	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of NEDD9 mRNA	PMID:21346803
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1306276	E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of NEDD9 mRNA	PMID:25596134
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314804	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of NEDD9 mRNA	PMID:35537566
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1314804	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of NEDD9 mRNA	PMID:18930950
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306276	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of NEDD9 mRNA	PMID:19015723
1314803	NEDD9	neural precursor cell expressed, developmentally down-regulated 9	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306276	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of NEDD9 mRNA	PMID:20566332|PMID:23034163
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ZNF282 mRNA	PMID:33167477
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ZNF282 mRNA	PMID:26079696
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314807	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFP282 mRNA	PMID:39241906
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314807	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZFP282 mRNA	PMID:25510870
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF282 mRNA	PMID:37042841
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ZNF282 mRNA	PMID:21179406
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZNF282 protein	PMID:37730182
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306278	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP282 mRNA	PMID:33387578
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1314807	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of ZFP282 mRNA	PMID:27462272
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of ZNF282 mRNA	PMID:24376830
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314807	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZFP282 mRNA	PMID:25510870
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314807	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZFP282 mRNA	PMID:25510870
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZNF282 mRNA	PMID:23649840
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D002166	Camptothecin results in increased expression of ZNF282 mRNA	PMID:33770205
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ZNF282 protein	PMID:35688186
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314807	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ZFP282 mRNA	PMID:30912803
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314807	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP282 mRNA	PMID:21570461
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314807	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ZFP282 mRNA	PMID:19770486
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZNF282 mRNA	PMID:33212167
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:28680	cytarabine	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D003561	Cytarabine results in increased expression of ZNF282 mRNA	PMID:33770205
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF282 mRNA	PMID:29803840
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF282 mRNA	PMID:39719251
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314807	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZFP282 mRNA	PMID:22228805
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ZNF282 3' UTR	PMID:27901495
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ZNF282 gene	PMID:31601247
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314807	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP282 promoter	PMID:35295148
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314807	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ZFP282 gene	PMID:35295148
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306278	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ZFP282 mRNA	PMID:19167457
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306278	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP282 mRNA; bisphenol A results in increased expression of ZNF282 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ZNF282 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF282 mRNA	PMID:28628672|PMID:31601247
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314807	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZFP282 mRNA	PMID:25510870
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314807	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ZFP282 mRNA	PMID:25510870
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314807	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ZFP282 intron	PMID:28392331
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306278	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ZFP282 mRNA	PMID:21266533
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314807	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ZFP282 mRNA	PMID:34813904
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF282 mRNA	PMID:28628672
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314807	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ZFP282 mRNA	PMID:34813904
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZNF282 mRNA	PMID:38568856
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of ZNF282 mRNA	PMID:19320972|PMID:19376846
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ZNF282 mRNA	PMID:24449571
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZNF282 mRNA	PMID:25979313
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314807	E	RGD:6480464	20120918	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZFP282 mRNA	PMID:19136453|PMID:20546886|PMID:21427059
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314807	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of ZFP282 mRNA	PMID:21427059
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ZNF282 gene	PMID:29154799
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1314807	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of ZFP282 mRNA	PMID:17555576
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF282 mRNA	PMID:28628672
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D008727	Methotrexate results in increased expression of ZNF282 mRNA	PMID:33770205
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ZNF282 mRNA	PMID:28542535
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314807	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZFP282 mRNA	PMID:17562736
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:46345	5-fluorouracil	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D005472	Fluorouracil results in increased expression of ZNF282 mRNA	PMID:33770205
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF282 mRNA	PMID:28628672
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF282 protein	PMID:31285264
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF282 gene]	PMID:28238834
1314806	ZNF282	zinc finger protein 282	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1306278	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ZNF282 mRNA	PMID:23914054
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314809	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ABR mRNA	PMID:33045310
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314809	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of ABR mRNA	PMID:37995155
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314809	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ABR mRNA	PMID:26251327
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1314809	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of ABR promoter	PMID:26251327
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ABR mRNA	PMID:20938992
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306279	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of ABR gene	PMID:35440735
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ABR mRNA	PMID:22378314
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314809	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of ABR mRNA	PMID:30319688
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ABR mRNA	PMID:30517762
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ABR mRNA	PMID:21179406
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314809	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ABR mRNA	PMID:39241906
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ABR mRNA	PMID:25510870
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ABR mRNA	PMID:20938992
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ABR mRNA	PMID:21179406
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ABR mRNA	PMID:37992649
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in increased expression of ABR protein	PMID:20463053
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased expression of ABR mRNA	PMID:26717081
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:17578	toluene	increases methylation	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased methylation of ABR gene	PMID:26717081
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ABR mRNA	PMID:37992649
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ABR mRNA	PMID:28818685
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of ABR intron	PMID:30157460
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ABR promoter	PMID:30157460
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ABR mRNA	PMID:36331819
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:187088	Muconic dialdehyde	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C034476	muconaldehyde results in decreased expression of ABR mRNA	PMID:40300100
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1306279	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of ABR mRNA	PMID:28522335
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ABR mRNA	PMID:25510870
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ABR mRNA	PMID:25510870
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ABR mRNA	PMID:19549813
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of ABR intron	PMID:30157460
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ABR promoter	PMID:30157460
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ABR mRNA	PMID:35430440
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ABR mRNA	PMID:30517762
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABR mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ABR mRNA	PMID:20938992|PMID:22206623
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ABR gene	PMID:25304211
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:27563	arsenic atom	decreases methylation	EXP		E	RGD:6480464	20200310	CTD	MESH:D001151	Arsenic results in decreased methylation of ABR gene	PMID:31135185
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABR mRNA	PMID:39836092
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABR mRNA	PMID:40504410
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ABR mRNA	PMID:19244175
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306279	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ABR mRNA	PMID:31881176
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of ABR gene	PMID:31636367
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	ABR protein affects the susceptibility to Cisplatin	PMID:16217747
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of ABR mRNA	PMID:19561079|PMID:27594783
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314809	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ABR mRNA	PMID:30912803
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314809	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ABR mRNA	PMID:21570461
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306279	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABR mRNA	PMID:32109520
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314809	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ABR mRNA	PMID:20819909
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ABR gene]	PMID:20819909
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:28216	methylmercury chloride	affects expression	ISO	RGD:1306279	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride affects the expression of ABR mRNA	PMID:20864626
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ABR mRNA	PMID:29803840
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ABR mRNA	PMID:37992649
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ABR mRNA	PMID:20044591
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of ABR mRNA	PMID:34032870
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ABR mRNA	PMID:17879257|PMID:29301061|PMID:38568856
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABR mRNA	PMID:39836092
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABR mRNA	PMID:40504410
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ABR 5' UTR; Benzo(a)pyrene affects the methylation of ABR exon; Benzo(a)pyrene affects the methylation of ABR intron	PMID:27901495|PMID:30157460
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ABR mRNA	PMID:20064835|PMID:22316170|PMID:26238291
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314809	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ABR intron	PMID:27901495
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ABR mRNA	PMID:26238291
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ABR gene	PMID:31601247
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314809	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ABR gene	PMID:35295148
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314809	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ABR gene	PMID:35295148
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:32687	piperonyl butoxide	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20140408	CTD	MESH:D010882	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ABR gene	PMID:23968726
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306279	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ABR mRNA	PMID:25181051
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ABR gene	PMID:31601247
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of ABR mRNA	PMID:27685785
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306279	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of ABR mRNA	PMID:29097150|PMID:34947998
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306279	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ABR gene	PMID:28505145
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ABR gene	PMID:31601247
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ABR mRNA	PMID:25510870
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ABR mRNA	PMID:25510870
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of ABR gene	PMID:31601247
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of ABR intron	PMID:30157460
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314809	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ABR mRNA	PMID:21266533
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20140408	CTD	MESH:D004052	[Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ABR gene	PMID:23968726
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ABR mRNA	PMID:37042841
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ABR mRNA	PMID:38568856
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ABR mRNA	PMID:19320972|PMID:19376846
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ABR mRNA	PMID:24449571
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ABR mRNA	PMID:19244175
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ABR mRNA	PMID:31533062
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ABR mRNA	PMID:36331819
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ABR mRNA	PMID:25979313
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ABR mRNA	PMID:23179753
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ABR gene	PMID:29154799
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ABR mRNA	PMID:25562108
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ABR mRNA	PMID:37992649
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:46666	crocidolite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased methylation of ABR promoter	PMID:29626692
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:46678	amosite asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017639	Asbestos, Amosite results in decreased methylation of ABR promoter	PMID:29626692
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:46680	serpentine asbestos	decreases methylation	EXP		E	RGD:6480464	20230207	CTD	MESH:D017632	Asbestos, Serpentine results in decreased methylation of ABR promoter	PMID:29626692
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ABR gene	PMID:25304211
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:47217	arsane	decreases methylation	EXP		E	RGD:6480464	20200310	CTD	MESH:D001151	Arsenic results in decreased methylation of ABR gene	PMID:31135185
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ABR mRNA	PMID:39836092
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ABR mRNA	PMID:40504410
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of ABR mRNA	PMID:40706910
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ABR mRNA	PMID:22079256
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306279	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ABR mRNA	PMID:29097150
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of ABR mRNA	PMID:38568856
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306279	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ABR mRNA	PMID:30307764
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ABR protein	PMID:32959892
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314809	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of ABR mRNA	PMID:15003993
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ABR mRNA	PMID:24810058
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of ABR intron	PMID:30157460
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306279	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ABR gene	PMID:35440735
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314809	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ABR mRNA	PMID:22206623
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ABR mRNA	PMID:22079256
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ABR mRNA	PMID:22079256
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:75253	phenylarsine oxide	increases expression	ISO	RGD:1314809	E	RGD:6480464	20251007	CTD	MESH:C029341	oxophenylarsine results in increased expression of ABR mRNA	PMID:37699712
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ABR mRNA	PMID:37199045
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306279	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ABR mRNA	PMID:24780913
1314808	ABR	ABR activator of RhoGEF and GTPase	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1306279	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of ABR protein	PMID:35544339
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of PPP1R8 mRNA	PMID:22378314
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314811	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of PPP1R8 mRNA	PMID:30319688
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of PPP1R8 mRNA	PMID:12419474
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314811	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PPP1R8 mRNA	PMID:39241906
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PPP1R8 mRNA	PMID:37042841
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306280	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PPP1R8 mRNA	PMID:22061828
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPP1R8 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of PPP1R8 mRNA	PMID:39836092
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPP1R8 mRNA	PMID:35301059
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306280	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPP1R8 mRNA	PMID:39012411
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PPP1R8 mRNA	PMID:19549813
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314811	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PPP1R8 mRNA	PMID:19770486
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1306280	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of PPP1R8 mRNA	PMID:31129395
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314811	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PPP1R8 mRNA	PMID:25629700
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPP1R8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPP1R8 mRNA	PMID:39836092
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPP1R8 mRNA	PMID:22574217
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314811	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPP1R8 mRNA	PMID:21570461
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314811	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPP1R8 mRNA	PMID:19770486
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314811	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP1R8 mRNA	PMID:17942748
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of PPP1R8 protein	PMID:39603559
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1306280	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of PPP1R8 protein	PMID:19072884
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPP1R8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPP1R8 mRNA	PMID:39836092
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PPP1R8 5' UTR	PMID:27901495
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PPP1R8 promoter	PMID:27901495
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to PPP1R8 mRNA]	PMID:32406909
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314811	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PPP1R8 promoter	PMID:35295148
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of PPP1R8 protein	PMID:31675489
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306280	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PPP1R8 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:41034487
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306280	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of PPP1R8 mRNA	PMID:31129395
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314811	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PPP1R8 mRNA	PMID:17361019|PMID:21266533
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPP1R8 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of PPP1R8 mRNA	PMID:39836092
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PPP1R8 mRNA	PMID:38568856
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1306280	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of PPP1R8 promoter	PMID:22457795
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PPP1R8 mRNA	PMID:35301059
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306280	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPP1R8 mRNA	PMID:39012411
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PPP1R8 mRNA	PMID:25979313
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314811	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PPP1R8 mRNA	PMID:17292431
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in decreased expression of PPP1R8 mRNA	PMID:19101580|PMID:22083351|PMID:23179753|PMID:29154799
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314811	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of PPP1R8 mRNA	PMID:21427059
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314811	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PPP1R8 mRNA	PMID:17555576
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of PPP1R8 mRNA	PMID:22083351
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of PPP1R8 mRNA	PMID:22230336
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPP1R8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPP1R8 mRNA	PMID:39836092
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of PPP1R8 mRNA	PMID:31675489
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314811	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PPP1R8 mRNA	PMID:17555576
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314811	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PPP1R8 mRNA	PMID:17942748
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314811	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPP1R8 mRNA	PMID:17942748
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314811	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PPP1R8 mRNA	PMID:35964746
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306280	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PPP1R8 mRNA	PMID:24136188
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314811	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PPP1R8 mRNA	PMID:19042947
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PPP1R8 protein	PMID:32959892
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PPP1R8 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of PPP1R8 mRNA	PMID:39836092
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of PPP1R8 mRNA	PMID:12419474
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1314811	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of PPP1R8 protein	PMID:26558463
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314811	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PPP1R8 mRNA	PMID:22206623
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:7602	nobiletin	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of PPP1R8 protein]	PMID:38348393
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PPP1R8 protein	PMID:31675489
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1306280	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of PPP1R8 protein	PMID:28903499
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of PPP1R8 protein	PMID:31675489
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of PPP1R8 protein	PMID:38348393
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of PPP1R8 protein]	PMID:38348393
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of PPP1R8 mRNA	PMID:24921660
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306280	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of PPP1R8 mRNA	PMID:19281266
1314810	PPP1R8	protein phosphatase 1 regulatory subunit 8	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306280	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PPP1R8 mRNA	PMID:21346803
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306283	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NDUFA8 mRNA]	PMID:31150632
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:D014212	[sodium arsenite co-treated with Tretinoin] results in increased expression of NDUFA8 protein	PMID:39571964
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NDUFA8 mRNA	PMID:22378314
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314816	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of NDUFA8 mRNA	PMID:30319688
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314816	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NDUFA8 mRNA	PMID:39241906
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of NDUFA8 mRNA	PMID:31059760
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306283	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of NDUFA8 protein	PMID:32145629
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NDUFA8 mRNA	PMID:37042841
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:17578	toluene	affects expression	ISO	RGD:1306283	E	RGD:6480464	20121113	CTD	MESH:D014050	Toluene affects the expression of NDUFA8 mRNA	PMID:21827849
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314816	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of NDUFA8 mRNA	PMID:33754040
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1314816	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of NDUFA8 mRNA	PMID:27462272
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NDUFA8 mRNA	PMID:35301059
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NDUFA8 mRNA	PMID:19549813
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306283	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NDUFA8 mRNA	PMID:33354967
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306283	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NDUFA8 mRNA	PMID:31150632
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306283	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NDUFA8 mRNA]	PMID:31150632
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of NDUFA8 mRNA	PMID:23195993
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314816	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NDUFA8 mRNA	PMID:21570461
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFA8 mRNA	PMID:23152189
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306283	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFA8 mRNA	PMID:21215274|PMID:32109520
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314816	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDUFA8 mRNA	PMID:21354282
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314816	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NDUFA8 mRNA	PMID:20399798
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314816	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NDUFA8 mRNA	PMID:17942748
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1314816	E	RGD:6480464	20140408	CTD	MESH:D012402	Rotenone results in decreased expression of NDUFA8 mRNA	PMID:23186747
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NDUFA8 mRNA	PMID:33212167
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NDUFA8 mRNA	PMID:30851411
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314816	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of NDUFA8 mRNA	PMID:26873546
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of NDUFA8 mRNA	PMID:29803840
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1314816	E	RGD:6480464	20160607	CTD	MESH:D004317	[Doxorubicin co-treated with Dexrazoxane] results in increased expression of NDUFA8 mRNA	PMID:26873546
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of NDUFA8 mRNA	PMID:34032870
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of NDUFA8 mRNA	PMID:38568856
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20251104	CTD	MESH:C017947	[sodium arsenite co-treated with Tretinoin] results in increased expression of NDUFA8 protein	PMID:39571964
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314816	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NDUFA8 intron	PMID:27901495
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to NDUFA8 mRNA]	PMID:32406909
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314816	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of NDUFA8 mRNA	PMID:29264374
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306283	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFA8 mRNA	PMID:34947998
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314816	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NDUFA8 mRNA	PMID:33221593|PMID:35598803
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFA8 protein	PMID:37567409
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306283	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFA8 mRNA; bisphenol A results in increased expression of NDUFA8 protein	PMID:25181051|PMID:32145629
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314816	E	RGD:6480464	20230117	CTD	MESH:C006780	bisphenol A results in increased expression of NDUFA8 mRNA	PMID:35479511
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of NDUFA8 protein	PMID:33376534
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314816	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of NDUFA8 mRNA	PMID:39298647
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of NDUFA8 intron	PMID:30157460
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314816	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of NDUFA8 mRNA	PMID:38685157
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:34631	chlorpyrifos	increases methylation	ISO	RGD:1306283	E	RGD:6480464	20210907	CTD	MESH:D004390	Chlorpyrifos results in increased methylation of NDUFA8 gene	PMID:32905263
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314816	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of NDUFA8 mRNA	PMID:34813904
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306283	E	RGD:6480464	20171010	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFA8 mRNA	PMID:28659758
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of NDUFA8 mRNA	PMID:35301059
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of NDUFA8 mRNA	PMID:28302478
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of NDUFA8 mRNA	PMID:31533062
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of NDUFA8 mRNA	PMID:26352163
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314816	E	RGD:6480464	20130416	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NDUFA8 mRNA	PMID:20936131
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314816	E	RGD:6480464	20130416	CTD	MESH:C076994	PPARA protein inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of NDUFA8 mRNA]	PMID:20936131
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NDUFA8 mRNA	PMID:25979313
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of NDUFA8 mRNA	PMID:29154799
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NDUFA8 mRNA	PMID:20106945|PMID:25562108
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:42588	4-hydroxyphenyl retinamide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide affects the expression of NDUFA8 mRNA	PMID:16570282
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen affects the expression of NDUFA8 mRNA	PMID:31059760
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314816	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NDUFA8 mRNA	PMID:17562736
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of NDUFA8 mRNA	PMID:22230336|PMID:25704631
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314816	E	RGD:6480464	20120717	CTD	MESH:D000082	Acetaminophen results in increased expression of NDUFA8 protein	PMID:21329376
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of NDUFA8 mRNA	PMID:31059760
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:48707	(-)-citrinin	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D002953	Citrinin results in decreased expression of NDUFA8 protein	PMID:39638853
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:48707	(-)-citrinin	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:D002953	[Citrinin co-treated with ochratoxin A] results in decreased expression of NDUFA8 protein	PMID:39638853
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314816	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of NDUFA8 mRNA	PMID:17942748
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314816	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NDUFA8 mRNA	PMID:17942748
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:50223	(+)-dexrazoxane	decreases expression	ISO	RGD:1314816	E	RGD:6480464	20170303	CTD	MESH:D064730	Dexrazoxane results in decreased expression of NDUFA8 mRNA	PMID:26873546
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:50223	(+)-dexrazoxane	multiple interactions	ISO	RGD:1314816	E	RGD:6480464	20170303	CTD	MESH:D064730	[Doxorubicin co-treated with Dexrazoxane] results in increased expression of NDUFA8 mRNA	PMID:26873546
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314816	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of NDUFA8 mRNA	PMID:35964746
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306283	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of NDUFA8 mRNA	PMID:24136188
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:6030	isoniazide	affects expression	ISO	RGD:1314816	E	RGD:6480464	20141014	CTD	MESH:D007538	Isoniazid affects the expression of NDUFA8 mRNA	PMID:24848797
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of NDUFA8 protein	PMID:32959892
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of NDUFA8 mRNA	PMID:37939859
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of NDUFA8 intron	PMID:30157460
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306283	E	RGD:6480464	20171010	CTD	MESH:D003671	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFA8 mRNA	PMID:28659758
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314816	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of NDUFA8 mRNA	PMID:22206623
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:D009534	Niclosamide results in decreased expression of NDUFA8 mRNA	PMID:22576131
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of NDUFA8 protein	PMID:39638853
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	[Citrinin co-treated with ochratoxin A] results in decreased expression of NDUFA8 protein	PMID:39638853
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NDUFA8 mRNA	PMID:30851411
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NDUFA8 gene]	PMID:28238834
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314816	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of NDUFA8 mRNA	PMID:30953684
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1306283	E	RGD:6480464	20171010	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFA8 mRNA	PMID:28659758
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306283	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of NDUFA8 mRNA	PMID:19281266
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:9288	streptozocin	affects expression	ISO	RGD:1314816	E	RGD:6480464	20120501	CTD	MESH:D013311	Streptozocin affects the expression of NDUFA8 mRNA	PMID:18583417
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of NDUFA8 mRNA	PMID:38568856
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of NDUFA8 mRNA	PMID:29301935
1314815	NDUFA8	NADH:ubiquinone oxidoreductase subunit A8	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306283	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of NDUFA8 mRNA	PMID:23034163
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306285	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VAV2 mRNA]	PMID:31150632
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314819	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of VAV2 mRNA	PMID:20188158
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314819	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VAV2 gene	PMID:20938992
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of VAV2 protein	PMID:35688186
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D008070	[NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of VAV2 mRNA	PMID:35877022
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of VAV2 mRNA	PMID:30165855
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306285	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of VAV2 mRNA	PMID:33387578
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306285	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of VAV2 gene	PMID:27618143
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314819	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VAV2 gene	PMID:20938992
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of VAV2 protein	PMID:37730182
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306285	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of VAV2 mRNA	PMID:22061828|PMID:33387578
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:18170	selenic acid	decreases expression	ISO	RGD:1314819	E	RGD:6480464	20170103	CTD	MESH:D064586	Selenic Acid results in decreased expression of VAV2 mRNA	PMID:16444006
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of VAV2 intron	PMID:30157460
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:18421	superoxide	increases abundance	ISO	RGD:1314819	E	RGD:6480464	20140610	CTD	MESH:D013481	VAV2 protein results in increased abundance of Superoxides	PMID:23940720
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:18421	superoxide	multiple interactions	ISO	RGD:1314819	E	RGD:6480464	20140610	CTD	MESH:D013481	2-acetylphenothiazine inhibits the reaction [VAV2 protein results in increased abundance of Superoxides]; diphenyleneiodonium inhibits the reaction [VAV2 protein results in increased abundance of Superoxides]	PMID:23940720
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:229202	Tubeimoside II	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C478421	tubeimoside II inhibits the reaction [TGFB1 protein results in increased phosphorylation of VAV2 protein]	PMID:33412154
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:2422	acetohydrazide	decreases expression	ISO	RGD:1314819	E	RGD:6480464	20120412	CTD	MESH:C014949	acetylhydrazine results in decreased expression of VAV2 mRNA	PMID:15282401
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1306285	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of VAV2 mRNA	PMID:22129741
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:2504	aflatoxin B1	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 affects the methylation of VAV2 intron	PMID:30157460
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314819	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of VAV2 mRNA	PMID:19770486
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306285	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of VAV2 mRNA	PMID:30779732
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306285	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of VAV2 mRNA	PMID:31150632
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306285	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VAV2 mRNA]	PMID:31150632
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314819	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VAV2 gene	PMID:20938992
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of VAV2 gene	PMID:25304211
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of VAV2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of VAV2 mRNA	PMID:40512198
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of VAV2 protein	PMID:35688186
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of VAV2 mRNA	PMID:28903495
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314819	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of VAV2 mRNA	PMID:30912803
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306285	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of VAV2 mRNA	PMID:33387578
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of VAV2 mRNA	PMID:33212167
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of VAV2 mRNA	PMID:29803840
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of VAV2 mRNA; sodium arsenite results in decreased expression of VAV2 protein	PMID:38228842|PMID:39719251
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314819	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of VAV2 mRNA	PMID:22700541
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of VAV2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of VAV2 mRNA	PMID:40512198
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of VAV2 intron	PMID:30157460
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of VAV2 mRNA	PMID:20064835
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to VAV2 mRNA]	PMID:32406909
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of VAV2 mRNA	PMID:19150397
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	VAV2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of VAV2 gene	PMID:31601247
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306285	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of VAV2 mRNA	PMID:25729387
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314819	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of VAV2 gene; titanium dioxide results in decreased methylation of VAV2 promoter	PMID:35295148
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314819	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of VAV2 gene	PMID:35295148
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306285	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of VAV2 mRNA	PMID:34492290
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of VAV2 mRNA	PMID:38479592
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306285	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of VAV2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306285	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of VAV2 gene	PMID:28505145
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of VAV2 gene	PMID:31601247
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314819	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of VAV2 mRNA	PMID:39298647
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of VAV2 gene	PMID:31601247
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1314819	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of VAV2 exon	PMID:33297965
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of VAV2 intron	PMID:30157460
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1314819	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of VAV2 intron	PMID:28392331
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314819	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of VAV2 mRNA	PMID:34813904
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314819	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of VAV2 mRNA	PMID:34813904
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306285	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of VAV2 mRNA	PMID:22129741
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306285	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of VAV2 gene	PMID:33148267
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of VAV2 mRNA	PMID:37042841
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1306285	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of VAV2 mRNA	PMID:30589522
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306285	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of VAV2 mRNA	PMID:33453195
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1306285	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of VAV2 promoter	PMID:22457795
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1306285	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of VAV2 mRNA	PMID:19162173
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of VAV2 mRNA	PMID:24449571
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314819	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of VAV2 mRNA	PMID:40194260
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of VAV2 mRNA	PMID:23179753
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1314819	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of VAV2 mRNA	PMID:22733784
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314819	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in decreased expression of VAV2 mRNA	PMID:16467112
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in decreased expression of VAV2 mRNA	PMID:17400583
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1306285	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of VAV2 mRNA	PMID:24136188
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in decreased expression of VAV2 mRNA	PMID:28542535
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314819	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of VAV2 mRNA	PMID:17562736
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of VAV2 mRNA	PMID:26690555
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of VAV2 gene	PMID:25304211
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of VAV2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of VAV2 mRNA	PMID:40512198
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of VAV2 mRNA	PMID:22079256
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	VAV2 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1306285	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of VAV2 mRNA	PMID:34044035
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314819	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of VAV2 mRNA	PMID:35964746
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in decreased expression of VAV2 mRNA	PMID:16780908
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of VAV2 mRNA	PMID:16780908
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of VAV2 protein	PMID:32959892
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306285	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of VAV2 mRNA	PMID:25729387
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306285	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of VAV2 mRNA	PMID:25729387
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1306285	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of VAV2 mRNA	PMID:24136188
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1314819	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of VAV2 mRNA	PMID:19812364
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of VAV2 intron	PMID:30157460
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306285	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of VAV2 gene	PMID:35440735
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306285	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of VAV2 gene	PMID:33148267
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314819	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of VAV2 mRNA	PMID:22206623
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of VAV2 mRNA	PMID:22079256
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of VAV2 mRNA	PMID:22079256
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1306285	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of VAV2 mRNA	PMID:23665939
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:77986	dibenziodolium	multiple interactions	ISO	RGD:1314819	E	RGD:6480464	20140610	CTD	MESH:C007517	diphenyleneiodonium inhibits the reaction [VAV2 protein affects the localization of CD38 protein]; diphenyleneiodonium inhibits the reaction [VAV2 protein results in increased abundance of Superoxides]; diphenyleneiodonium inhibits the reaction [VAV2 protein results in increased expression of and results in increased activity of CD38 protein]	PMID:23940720
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1306285	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of VAV2 mRNA	PMID:19162173
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314819	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of VAV2 mRNA	PMID:31388691
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306285	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of VAV2 mRNA	PMID:21346803
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of VAV2 mRNA	PMID:38568856
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306285	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of VAV2 mRNA	PMID:20566332|PMID:23034163
1314818	VAV2	vav guanine nucleotide exchange factor 2	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1306285	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of VAV2 gene	PMID:31079544
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of IVNS1ABP mRNA	PMID:38218311
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:1367	3,3',4,4'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20121009	CTD	MESH:C028451	3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of IVNS1ABP mRNA]	PMID:19467301
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314825	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of IVNS1ABP mRNA	PMID:20188158
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IVNS1ABP mRNA	PMID:20938992
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D014212	Tretinoin results in increased expression of IVNS1ABP mRNA	PMID:15894607|PMID:33167477
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of IVNS1ABP mRNA	PMID:24763279
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of IVNS1ABP mRNA	PMID:22378314
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:16170	mercury(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of IVNS1ABP mRNA	PMID:16823088
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of IVNS1ABP mRNA	PMID:20044591
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of IVNS1ABP mRNA	PMID:21632981
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of IVNS1ABP mRNA	PMID:29581250
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of IVNS1ABP mRNA	PMID:39241906
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306290	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of IVNS1ABP mRNA	PMID:32145629
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of IVNS1ABP mRNA	PMID:39298647
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314825	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of IVNS1ABP mRNA	PMID:25210133
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of IVNS1ABP mRNA	PMID:30165855
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IVNS1ABP mRNA	PMID:20938992
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of IVNS1ABP mRNA	PMID:37042841
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of IVNS1ABP mRNA	PMID:23649840
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of IVNS1ABP mRNA	PMID:21795739
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314825	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of IVNS1ABP mRNA	PMID:33754040
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of IVNS1ABP protein	PMID:37730182
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306290	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of IVNS1ABP mRNA	PMID:33387578
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of IVNS1ABP mRNA	PMID:28818685
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IVNS1ABP mRNA	PMID:35301059
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IVNS1ABP mRNA	PMID:28111341
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in decreased expression of IVNS1ABP mRNA	PMID:18579281
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of IVNS1ABP gene	PMID:27153756
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:25195	mercury atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of IVNS1ABP mRNA	PMID:16823088
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of IVNS1ABP mRNA	PMID:23649840
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:254496	7,12-dimethyltetraphene	affects expression	ISO	RGD:1314825	E	RGD:6480464	20120501	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene affects the expression of IVNS1ABP mRNA	PMID:21785161
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:2564	aldrin	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20140107	CTD	MESH:D000452	Aldrin results in decreased expression of IVNS1ABP mRNA	PMID:18579281
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D010126	Ozone results in decreased expression of IVNS1ABP mRNA	PMID:12763052
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1306290	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of IVNS1ABP mRNA	PMID:17991464
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306290	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of IVNS1ABP mRNA	PMID:30779732
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of IVNS1ABP mRNA	PMID:17484886
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314825	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of IVNS1ABP mRNA	PMID:31919559
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of IVNS1ABP mRNA	PMID:20938992
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IVNS1ABP gene	PMID:25304211
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of IVNS1ABP mRNA	PMID:39836092
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:27641	cycloheximide	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [Doxorubicin results in decreased expression of IVNS1ABP mRNA]	PMID:17016628
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of IVNS1ABP protein	PMID:35688186
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of IVNS1ABP mRNA	PMID:28960355
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306290	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of IVNS1ABP mRNA	PMID:31881176
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314825	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of IVNS1ABP mRNA	PMID:22610192
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of IVNS1ABP mRNA	PMID:23557933
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306290	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IVNS1ABP mRNA	PMID:22298810
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314825	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IVNS1ABP mRNA	PMID:21570461
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IVNS1ABP mRNA	PMID:20106945|PMID:21632981
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306290	E	RGD:6480464	20161025	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IVNS1ABP mRNA	PMID:18796159|PMID:21215274|PMID:27136898
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IVNS1ABP mRNA	PMID:18796159
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306290	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IVNS1ABP mRNA	PMID:34747641
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of IVNS1ABP mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IVNS1ABP mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IVNS1ABP mRNA	PMID:16214954|PMID:17942748|PMID:25975270
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306290	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of IVNS1ABP mRNA	PMID:19013527|PMID:28374803
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of IVNS1ABP mRNA	PMID:23179753
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of IVNS1ABP mRNA	PMID:33212167
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of IVNS1ABP mRNA	PMID:30851411
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of IVNS1ABP mRNA	PMID:23649840
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in decreased expression of IVNS1ABP mRNA	PMID:17205981
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306290	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of IVNS1ABP mRNA	PMID:30556269
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IVNS1ABP mRNA	PMID:29803840
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of IVNS1ABP mRNA alternative form	PMID:16952015
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28748	doxorubicin	decreases response to substance	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D004317	IVNS1ABP results in decreased susceptibility to Doxorubicin	PMID:16952015
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28748	doxorubicin	increases response to substance	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D004317	IVNS1ABP gene mutant form results in increased susceptibility to Doxorubicin	PMID:15485691
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D004317	Cycloheximide inhibits the reaction [Doxorubicin results in decreased expression of IVNS1ABP mRNA]; Doxorubicin results in decreased stability of and results in decreased expression of IVNS1ABP mRNA	PMID:17016628
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of IVNS1ABP protein	PMID:35688186
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of IVNS1ABP mRNA	PMID:38568856
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of IVNS1ABP mRNA	PMID:39836092
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1314825	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of IVNS1ABP mRNA	PMID:22342234
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of IVNS1ABP mRNA	PMID:20064835|PMID:20106945|PMID:21632981
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of IVNS1ABP 5' UTR; Benzo(a)pyrene results in decreased methylation of IVNS1ABP promoter	PMID:27901495
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20120814	CTD	MESH:D003300	Copper results in decreased expression of IVNS1ABP mRNA	PMID:17205981
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306290	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of IVNS1ABP mRNA	PMID:30556269
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314825	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IVNS1ABP mRNA	PMID:23221170
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of IVNS1ABP mRNA	PMID:19150397
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of IVNS1ABP gene	PMID:31601247
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314825	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IVNS1ABP promoter	PMID:35295148
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	affects expression	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane affects the expression of IVNS1ABP mRNA	PMID:18648102
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of IVNS1ABP mRNA	PMID:20813756
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of IVNS1ABP mRNA	PMID:18445702
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306290	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of IVNS1ABP mRNA	PMID:30903817
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306290	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of IVNS1ABP mRNA	PMID:32145629|PMID:41034487
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306290	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of IVNS1ABP mRNA	PMID:25181051
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of IVNS1ABP gene	PMID:31601247
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of IVNS1ABP mRNA	PMID:25979313
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314825	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of IVNS1ABP mRNA	PMID:39298647
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of IVNS1ABP mRNA	PMID:33297965
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of IVNS1ABP mRNA	PMID:26377693
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306290	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of IVNS1ABP mRNA	PMID:21266533
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of IVNS1ABP mRNA	PMID:36117858
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:34967	rimonabant	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20210202	CTD	MESH:D000077285	Rimonabant inhibits the reaction [Dietary Fats results in increased expression of IVNS1ABP mRNA]	PMID:19030233
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IVNS1ABP mRNA	PMID:37042841
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IVNS1ABP mRNA	PMID:38174414|PMID:38568856
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IVNS1ABP mRNA	PMID:35301059
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IVNS1ABP mRNA	PMID:28111341
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306290	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of IVNS1ABP mRNA	PMID:26194646
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of IVNS1ABP mRNA	PMID:19320972
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IVNS1ABP mRNA	PMID:24449571
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314825	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of IVNS1ABP mRNA	PMID:18353800
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of IVNS1ABP mRNA	PMID:23811191
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314825	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in increased expression of IVNS1ABP mRNA	PMID:17585979
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314825	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IVNS1ABP mRNA	PMID:40194260
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of IVNS1ABP mRNA	PMID:31533062
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of IVNS1ABP mRNA	PMID:19167446
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of IVNS1ABP mRNA	PMID:39529242
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IVNS1ABP mRNA	PMID:25979313
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of IVNS1ABP mRNA	PMID:19101580|PMID:23179753|PMID:28001369
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in increased expression of IVNS1ABP mRNA	PMID:25192806
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of IVNS1ABP mRNA	PMID:20106945|PMID:27989131
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of IVNS1ABP mRNA	PMID:17555576
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1314825	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of IVNS1ABP mRNA	PMID:25123088
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314825	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of IVNS1ABP mRNA	PMID:28973697
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of IVNS1ABP mRNA	PMID:26272509
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IVNS1ABP mRNA	PMID:27188386
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IVNS1ABP mRNA	PMID:17562736
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306290	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of IVNS1ABP mRNA	PMID:33387578
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of IVNS1ABP mRNA	PMID:24714768
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of IVNS1ABP mRNA	PMID:29279043
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of IVNS1ABP gene	PMID:25304211
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of IVNS1ABP mRNA	PMID:39836092
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306290	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of IVNS1ABP mRNA	PMID:29391264
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of IVNS1ABP mRNA	PMID:35436446
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of IVNS1ABP mRNA	PMID:17555576
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of IVNS1ABP mRNA	PMID:17942748
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of IVNS1ABP mRNA	PMID:17942748
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of IVNS1ABP mRNA; Nanotubes, Carbon results in decreased expression of IVNS1ABP mRNA	PMID:25554681
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314825	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IVNS1ABP mRNA	PMID:25620056
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1306290	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of IVNS1ABP mRNA	PMID:19162173
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306290	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of IVNS1ABP mRNA	PMID:24136188
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of IVNS1ABP mRNA	PMID:36117858
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:529996	cytochalasin D	increases response to substance	ISO	RGD:1314825	E	RGD:6480464	20120412	CTD	MESH:D015638	IVNS1ABP gene mutant form results in increased susceptibility to Cytochalasin D	PMID:15485691
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of IVNS1ABP mRNA	PMID:22714537
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of IVNS1ABP protein	PMID:32959892
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1306290	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of IVNS1ABP mRNA	PMID:20080153
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:63598	levofloxacin	increases expression	ISO	RGD:1306290	E	RGD:6480464	20160412	CTD	MESH:D064704	Levofloxacin results in increased expression of IVNS1ABP mRNA	PMID:24136188
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of IVNS1ABP mRNA	PMID:23650126
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of IVNS1ABP protein	PMID:26558463
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:6809	methamphetamine	decreases methylation	ISO	RGD:1314825	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased methylation of IVNS1ABP promoter	PMID:26307267
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1314825	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of IVNS1ABP mRNA	PMID:26307267
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1314825	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of IVNS1ABP mRNA	PMID:22206623
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:753233	coal tar	decreases expression	ISO	RGD:1314825	E	RGD:6480464	20260714	CTD	MESH:D003033	Coal Tar results in decreased expression of IVNS1ABP mRNA	PMID:27858113
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of IVNS1ABP mRNA	PMID:30851411
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IVNS1ABP mRNA	PMID:27188386
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IVNS1ABP gene]	PMID:28238834
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of IVNS1ABP mRNA	PMID:26079696
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IVNS1ABP mRNA	PMID:27188386
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306290	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of IVNS1ABP mRNA	PMID:21346803
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306290	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of IVNS1ABP mRNA	PMID:21346803
1314824	IVNS1ABP	influenza virus NS1A binding protein	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1314825	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IVNS1ABP mRNA	PMID:18930950
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314827	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in increased expression of SLC39A2 mRNA	PMID:19167417|PMID:30319688
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of SLC39A2 mRNA	PMID:30510588
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306291	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of SLC39A2 mRNA; [Testosterone co-treated with Estradiol] results in increased expression of SLC39A2 mRNA	PMID:26496021|PMID:32741896
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:16856	glutathione	multiple interactions	EXP		E	RGD:6480464	20130212	CTD	MESH:D005978	[SLC39A2 protein co-treated with zinc chloride] results in increased abundance of Glutathione	PMID:18385089
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306291	E	RGD:6480464	20210406	CTD	MESH:D013739	[Testosterone co-treated with Estradiol] results in increased expression of SLC39A2 mRNA	PMID:32741896
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D002117	Calcitriol results in decreased expression of SLC39A2 mRNA	PMID:27107558
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SLC39A2 gene	PMID:27153756
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314827	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SLC39A2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLC39A2 mRNA	PMID:34911549
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:27363	zinc atom	increases expression	ISO	RGD:1306291	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in increased expression of SLC39A2 mRNA	PMID:17028381
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:27363	zinc atom	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A2 protein results in increased transport of Zinc	PMID:18326752
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:27363	zinc atom	increases uptake	ISO	RGD:1314827	E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A2 protein results in increased uptake of Zinc	PMID:14525987|PMID:15322118
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314827	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of SLC39A2 mRNA]	PMID:22206623
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:27563	arsenic atom	increases response to substance	EXP		E	RGD:6480464	20180515	CTD	MESH:D001151	SLC39A2 gene SNP results in increased susceptibility to Arsenic	PMID:21947419
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SLC39A2 mRNA	PMID:32525701
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306291	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of SLC39A2 mRNA	PMID:28374803
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC39A2 mRNA	PMID:30851411
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of SLC39A2 mRNA	PMID:21198554
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314827	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC39A2 mRNA	PMID:34876320
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1314827	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC39A2 mRNA	PMID:34876320
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC39A2 exon	PMID:27901495
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SLC39A2 promoter	PMID:27901495
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:30185	zinc(0)	increases expression	ISO	RGD:1306291	E	RGD:6480464	20120412	CTD	MESH:D015032	Zinc results in increased expression of SLC39A2 mRNA	PMID:17028381
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:30185	zinc(0)	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	SLC39A2 protein results in increased transport of Zinc	PMID:18326752
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:30185	zinc(0)	increases uptake	ISO	RGD:1314827	E	RGD:6480464	20130212	CTD	MESH:D015032	SLC39A2 protein results in increased uptake of Zinc	PMID:14525987|PMID:15322118
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SLC39A2 mRNA	PMID:25895662
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314827	E	RGD:6480464	20191008	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SLC39A2 mRNA	PMID:29203145|PMID:29341224
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of SLC39A2 mRNA	PMID:37690743
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1306291	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SLC39A2 promoter	PMID:27415467
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306291	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC39A2 mRNA	PMID:25181051
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314827	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC39A2 mRNA	PMID:32156529|PMID:38074096
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314827	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in increased expression of SLC39A2 mRNA	PMID:29165653
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306291	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of SLC39A2 mRNA	PMID:26496021
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of SLC39A2 mRNA	PMID:19244175
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SLC39A2 mRNA	PMID:25979313
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314827	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SLC39A2 mRNA	PMID:39298647
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314827	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SLC39A2 mRNA	PMID:38685157
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1314827	E	RGD:6480464	20160412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SLC39A2 mRNA	PMID:24535843
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306291	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SLC39A2 gene	PMID:22079235
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SLC39A2 gene	PMID:29154799
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314827	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SLC39A2 mRNA	PMID:17562736
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SLC39A2 mRNA	PMID:25351596
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:47217	arsane	increases response to substance	EXP		E	RGD:6480464	20180515	CTD	MESH:D001151	SLC39A2 gene SNP results in increased susceptibility to Arsenic	PMID:21947419
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SLC39A2 mRNA	PMID:32525701
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:47807	sulforaphane	multiple interactions	EXP		E	RGD:6480464	20130212	CTD	MESH:C016766	sulforaphane promotes the reaction [SLC39A2 protein results in increased activity of NFE2L2 protein]	PMID:18385089
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1314827	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC39A2 mRNA	PMID:34876320
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:49976	zinc dichloride	increases expression	EXP		E	RGD:6480464	20130212	CTD	MESH:C016837	zinc chloride results in increased expression of SLC39A2 mRNA	PMID:18385089
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:49976	zinc dichloride	multiple interactions	EXP		E	RGD:6480464	20130212	CTD	MESH:C016837	[SLC39A2 protein co-treated with zinc chloride] results in increased abundance of Glutathione; zinc chloride promotes the reaction [SLC39A2 protein results in increased activity of NFE2L2 protein]; zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLC mRNA]; zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLM mRNA]	PMID:18385089
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314827	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SLC39A2 mRNA	PMID:22206623
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314827	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of SLC39A2 mRNA]	PMID:22206623
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1306291	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of SLC39A2 mRNA	PMID:33484710
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases expression	ISO	RGD:1306291	E	RGD:6480464	20210406	CTD	MESH:C074283	estradiol 3-benzoate results in decreased expression of SLC39A2 mRNA	PMID:32741896
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC39A2 mRNA	PMID:30851411
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC39A2 gene]	PMID:28238834
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314827	E	RGD:6480464	20160412	CTD	MESH:D010634	[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SLC39A2 mRNA	PMID:24535843
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:84070	sodium arsenate	affects expression	ISO	RGD:1314827	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate affects the expression of SLC39A2 mRNA	PMID:39847705
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of SLC39A2 mRNA	PMID:32525701
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1314827	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SLC39A2 mRNA	PMID:34876320
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of SLC39A2 mRNA	PMID:18385089
1314826	SLC39A2	solute carrier family 39 member 2	gene	CHEBI:88217	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	increases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in increased expression of SLC39A2 mRNA	PMID:12756304
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314831	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SKIL mRNA	PMID:26251327
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:15343	acetaldehyde	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D000079	Acetaldehyde results in increased expression of SKIL mRNA	PMID:23416264
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of SKIL mRNA	PMID:21934132|PMID:23724009|PMID:33167477
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314831	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of SKIL mRNA	PMID:40945087
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314831	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of SKIL mRNA	PMID:30319688
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of SKIL mRNA; Estradiol results in increased expression of SKIL protein	PMID:23019147|PMID:24308608|PMID:26407941
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314831	E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol results in increased expression of SKIL mRNA	PMID:25210133|PMID:39298647
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:621399	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of SKIL mRNA	PMID:32145629
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of SKIL mRNA; Fulvestrant inhibits the reaction [Estradiol results in increased expression of SKIL protein]; Genistein inhibits the reaction [Estradiol results in increased expression of SKIL protein]	PMID:26407941|PMID:30165855
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SKIL mRNA	PMID:38568856
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SKIL mRNA	PMID:37042841
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1314831	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of SKIL mRNA	PMID:17178593
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1314831	E	RGD:6480464	20120501	CTD	MESH:D005947	Glucose results in increased expression of SKIL mRNA	PMID:17178593
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314831	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SKIL mRNA	PMID:34319233
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:621399	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of SKIL mRNA	PMID:26577399
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SKIL protein	PMID:37730182
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:621399	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SKIL mRNA	PMID:33387578
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314831	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SKIL mRNA	PMID:36331819
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314831	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SKIL mRNA	PMID:37236586
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SKIL mRNA	PMID:19549813
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of SKIL mRNA	PMID:23649840
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SKIL intron	PMID:30157460
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SKIL mRNA	PMID:27153756
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314831	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SKIL mRNA	PMID:19770486
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SKIL mRNA	PMID:41430723
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SKIL mRNA	PMID:18593933
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314831	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SKIL mRNA	PMID:31919559
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of SKIL mRNA	PMID:16835338
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SKIL protein	PMID:35688186
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:621399	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of SKIL gene	PMID:35440735
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:27810	resorcinol	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in decreased expression of SKIL mRNA	PMID:22623647
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SKIL mRNA	PMID:23557933
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of SKIL mRNA	PMID:23300844
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of SKIL mRNA	PMID:27392435
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of SKIL mRNA	PMID:27594783
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SKIL mRNA	PMID:27392435
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:D019833	Genistein inhibits the reaction [bisphenol A results in increased expression of SKIL protein]; Genistein inhibits the reaction [Estradiol results in increased expression of SKIL protein]; Genistein inhibits the reaction [nonylphenol results in increased expression of SKIL protein]	PMID:26407941
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314831	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SKIL mRNA	PMID:21570461
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314831	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SKIL mRNA	PMID:19770486
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314831	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SKIL mRNA	PMID:17942748
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:621399	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of SKIL mRNA	PMID:28374803
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SKIL mRNA	PMID:33212167
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of SKIL mRNA	PMID:23649840
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SKIL mRNA; [NSC 689534 binds to Copper] which results in increased expression of SKIL mRNA	PMID:20971185|PMID:24690739
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:28869	menadione	decreases expression	ISO	RGD:1314831	E	RGD:6480464	20150127	CTD	MESH:D024483	Vitamin K 3 results in decreased expression of SKIL mRNA	PMID:25270620
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of SKIL mRNA	PMID:28595984|PMID:34032870|PMID:39719251
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SKIL mRNA	PMID:38568856
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314831	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SKIL mRNA	PMID:19770486
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SKIL mRNA	PMID:20064835
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314831	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SKIL mRNA	PMID:22228805
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SKIL mRNA; [NSC 689534 binds to Copper] which results in increased expression of SKIL mRNA	PMID:20971185|PMID:24690739
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SKIL mRNA	PMID:18593933
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1314831	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SKIL mRNA	PMID:27131904
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SKIL mRNA	PMID:26014281
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SKIL mRNA	PMID:25351596
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314831	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SKIL mRNA	PMID:19073995
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SKIL mRNA	PMID:20382639
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C070081	fulvestrant inhibits the reaction [bisphenol A results in increased expression of SKIL protein]; fulvestrant inhibits the reaction [Estradiol results in increased expression of SKIL protein]; fulvestrant inhibits the reaction [nonylphenol results in increased expression of SKIL protein]	PMID:26407941
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C008261	lead acetate results in increased expression of SKIL mRNA	PMID:37939567
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314831	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SKIL gene; titanium dioxide results in decreased methylation of SKIL promoter	PMID:35295148
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314831	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of SKIL mRNA	PMID:29264374
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:621399	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SKIL mRNA	PMID:23411599|PMID:34492290
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314831	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SKIL mRNA	PMID:17426115
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314831	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of SKIL mRNA	PMID:18445702
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314831	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of SKIL mRNA	PMID:28329830
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:621399	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SKIL mRNA	PMID:25181051
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SKIL protein	PMID:24308608|PMID:26407941
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:621399	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of SKIL mRNA	PMID:29097150|PMID:32145629
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	fulvestrant inhibits the reaction [bisphenol A results in increased expression of SKIL protein]; Genistein inhibits the reaction [bisphenol A results in increased expression of SKIL protein]	PMID:26407941
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314831	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SKIL mRNA	PMID:39298647|PMID:40203079
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:34432	4-octylphenol	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C080417	4-octylphenol results in increased expression of SKIL protein	PMID:24308608
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:34440	4-nonylphenol	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C041594	4-nonylphenol results in increased expression of SKIL protein	PMID:24308608
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314831	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SKIL mRNA	PMID:38685157
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of SKIL gene	PMID:22964155
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1314831	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SKIL mRNA	PMID:17361019|PMID:21266533
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to SKIL protein	PMID:32991956
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:621399	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of SKIL mRNA	PMID:30589522
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SKIL mRNA	PMID:38568856
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314831	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SKIL mRNA	PMID:37236586
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of SKIL mRNA	PMID:36326898
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314831	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of SKIL mRNA	PMID:28903501
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SKIL mRNA	PMID:19320972
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:621399	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of SKIL mRNA	PMID:27638505
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of SKIL mRNA	PMID:19167446
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SKIL mRNA	PMID:27153767
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314831	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SKIL mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SKIL mRNA	PMID:36331819
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SKIL mRNA	PMID:25979313
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:621399	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of SKIL mRNA	PMID:29427782
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of SKIL mRNA	PMID:28001369
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of SKIL promoter	PMID:27989131
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SKIL mRNA	PMID:25562108
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314831	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SKIL mRNA	PMID:28973697
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1314831	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in increased expression of SKIL mRNA	PMID:17178593
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of SKIL mRNA	PMID:23649840
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SKIL mRNA	PMID:38832940
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of SKIL mRNA	PMID:26272509
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SKIL mRNA	PMID:27188386
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314831	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SKIL mRNA	PMID:17562736
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of SKIL mRNA	PMID:29067470
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314831	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of SKIL mRNA	PMID:19420014
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of SKIL mRNA	PMID:24690739
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of SKIL mRNA	PMID:18687144
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of SKIL mRNA	PMID:16835338
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C016766	sulforaphane results in increased expression of SKIL mRNA	PMID:26833863
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:621399	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SKIL mRNA	PMID:29391264
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314831	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SKIL mRNA	PMID:17555576
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314831	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SKIL mRNA	PMID:17942748
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:621399	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SKIL mRNA	PMID:29097150
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314831	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SKIL mRNA	PMID:17942748
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SKIL mRNA	PMID:23300844
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314831	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of SKIL mRNA	PMID:25620056
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1314831	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of SKIL mRNA	PMID:40234311
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:50819	ferric oxide	increases expression	ISO	RGD:1314831	E	RGD:6480464	20150127	CTD	MESH:C000499	ferric oxide analog results in increased expression of SKIL mRNA	PMID:24525745
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314831	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SKIL mRNA	PMID:21641980
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1314831	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of SKIL mRNA	PMID:19812364
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SKIL mRNA	PMID:28988120
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of SKIL protein	PMID:31285264
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:621399	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of SKIL mRNA	PMID:23665939
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SKIL mRNA	PMID:27188386
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:79516	Nonylphenol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C025256	nonylphenol results in increased expression of SKIL protein	PMID:26407941
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:79516	Nonylphenol	multiple interactions	EXP		E	RGD:6480464	20160705	CTD	MESH:C025256	fulvestrant inhibits the reaction [nonylphenol results in increased expression of SKIL protein]; Genistein inhibits the reaction [nonylphenol results in increased expression of SKIL protein]	PMID:26407941
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SKIL gene]	PMID:28238834
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1314831	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of SKIL mRNA	PMID:25270620
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314831	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SKIL mRNA	PMID:21795629
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SKIL mRNA	PMID:27188386
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1314831	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SKIL mRNA	PMID:27131904
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of SKIL mRNA	PMID:26014281
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SKIL mRNA	PMID:38568856
1314830	SKIL	SKI like proto-oncogene	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1314831	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of SKIL mRNA	PMID:18930950
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314833	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MLF2 mRNA	PMID:33045310
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314833	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MLF2 gene	PMID:20938992
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of MLF2 mRNA	PMID:15928584
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314833	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MLF2 gene	PMID:20938992
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MLF2 mRNA	PMID:37042841
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of MLF2 mRNA	PMID:23649840
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314833	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MLF2 mRNA	PMID:33754040
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MLF2 protein	PMID:37730182
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306294	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MLF2 mRNA	PMID:33387578
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314833	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MLF2 mRNA	PMID:36331819
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1314833	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of MLF2 mRNA	PMID:33914522
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314833	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MLF2 mRNA	PMID:28111341
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of MLF2 mRNA	PMID:23649840
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MLF2 mRNA	PMID:23649840
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:254496	7,12-dimethyltetraphene	affects expression	ISO	RGD:1314833	E	RGD:6480464	20120501	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene affects the expression of MLF2 mRNA	PMID:21785161
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MLF2 mRNA	PMID:35430440
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314833	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MLF2 mRNA	PMID:25629700
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314833	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MLF2 gene	PMID:20938992
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MLF2 gene	PMID:25304211
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of MLF2 mRNA	PMID:19244175
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of MLF2 mRNA	PMID:19244175
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of MLF2 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of MLF2 protein	PMID:38460933
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of MLF2 protein	PMID:35688186
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of MLF2 mRNA	PMID:27392435
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of MLF2 mRNA	PMID:27392435
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314833	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MLF2 mRNA	PMID:21570461
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306294	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MLF2 mRNA	PMID:33387578
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of MLF2 mRNA	PMID:29432896
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of MLF2 mRNA	PMID:38568856
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:29865	benzo[a]pyrene	affects expression	ISO	RGD:1314833	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of MLF2 mRNA	PMID:22342234
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314833	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MLF2 mRNA	PMID:22228805
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314833	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MLF2 promoter	PMID:35295148
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314833	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of MLF2 mRNA	PMID:29264374
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306294	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of MLF2 mRNA	PMID:19167457
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1314833	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of MLF2 mRNA	PMID:33914522
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306294	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MLF2 mRNA	PMID:25181051
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314833	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MLF2 mRNA	PMID:32156529
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306294	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MLF2 mRNA	PMID:36041667
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of MLF2 mRNA	PMID:19244175
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of MLF2 mRNA	PMID:19244175
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314833	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MLF2 mRNA	PMID:39298647
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306294	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MLF2 mRNA	PMID:36041667
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314833	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of MLF2 mRNA	PMID:38685157
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MLF2 mRNA	PMID:28628672
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306294	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MLF2 mRNA	PMID:36041667
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314833	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of MLF2 mRNA	PMID:37019170
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of MLF2 gene	PMID:22964155
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314833	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MLF2 mRNA	PMID:17361019
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MLF2 mRNA	PMID:28628672
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MLF2 mRNA	PMID:37042841
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MLF2 protein	PMID:24527689
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314833	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MLF2 mRNA	PMID:28111341
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of MLF2 mRNA	PMID:19244175
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of MLF2 mRNA	PMID:19244175
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314833	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MLF2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of MLF2 mRNA	PMID:36331819
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MLF2 mRNA	PMID:23179753|PMID:28001369
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MLF2 mRNA	PMID:20106945|PMID:25562108
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MLF2 mRNA	PMID:28628672
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314833	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MLF2 mRNA	PMID:17562736
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306294	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of MLF2 mRNA	PMID:33387578
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of MLF2 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of MLF2 protein	PMID:38460933
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of MLF2 gene	PMID:25304211
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of MLF2 mRNA	PMID:40706910
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of MLF2 mRNA	PMID:28628672
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314833	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MLF2 mRNA	PMID:35964746
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:72544	flavonoids	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D005419	Flavonoids results in increased expression of MLF2 mRNA	PMID:15465739
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314833	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MLF2 mRNA	PMID:22206623
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MLF2 protein	PMID:31285264
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314833	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MLF2 mRNA	PMID:23091169
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314833	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MLF2 mRNA	PMID:31388691
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1314833	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of MLF2 mRNA	PMID:26217789
1314832	MLF2	myeloid leukemia factor 2	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MLF2 mRNA	PMID:27188386
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314836	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of RAPSN mRNA	PMID:33045310
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314836	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of RAPSN mRNA	PMID:37995155
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1311592	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of RAPSN mRNA	PMID:36841081
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RAPSN mRNA	PMID:21632981
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314836	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RAPSN mRNA	PMID:39241906
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314836	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RAPSN mRNA]	PMID:39241906
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of RAPSN mRNA	PMID:31614463
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1311592	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of RAPSN mRNA	PMID:22061828
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1311592	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RAPSN mRNA	PMID:33387578
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RAPSN mRNA	PMID:28818685
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of RAPSN mRNA	PMID:35430440
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314836	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of RAPSN mRNA	PMID:17484886
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314836	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RAPSN mRNA	PMID:25629700
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314836	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAPSN mRNA	PMID:21570461
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RAPSN mRNA	PMID:33212167
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RAPSN exon	PMID:27901495
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314836	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RAPSN mRNA	PMID:22228805
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RAPSN promoter	PMID:27901495
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314836	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of RAPSN mRNA	PMID:29264374
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1311592	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RAPSN mRNA	PMID:25181051
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314836	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RAPSN mRNA]	PMID:39241906
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RAPSN mRNA	PMID:37042841
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1311592	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RAPSN mRNA	PMID:21297351
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1311592	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of RAPSN gene	PMID:22079235
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314836	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RAPSN mRNA	PMID:40194260
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RAPSN gene	PMID:29154799
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1311592	E	RGD:6480464	20180220	CTD	MESH:D003520	Cyclophosphamide results in increased expression of RAPSN mRNA	PMID:27281708
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314836	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RAPSN mRNA	PMID:17555576
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RAPSN mRNA	PMID:38832940
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1311592	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of RAPSN mRNA	PMID:29391264
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314836	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RAPSN mRNA	PMID:17555576
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1311592	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of RAPSN mRNA	PMID:30307764
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of RAPSN mRNA	PMID:29522793
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:8093	phenylephrine	decreases expression	ISO	RGD:1311592	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in decreased expression of RAPSN mRNA	PMID:18158353
1314835	RAPSN	receptor associated protein of the synapse	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314836	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of RAPSN mRNA]	PMID:39241906
1314837	PCDH20	protocadherin 20	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PCDH20 mRNA	PMID:38218311
1314837	PCDH20	protocadherin 20	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306297	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of PCDH20 mRNA	PMID:25152437
1314837	PCDH20	protocadherin 20	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PCDH20 mRNA	PMID:26272509
1314837	PCDH20	protocadherin 20	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA	PMID:27188386
1314837	PCDH20	protocadherin 20	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PCDH20 mRNA	PMID:21934132|PMID:23724009
1314837	PCDH20	protocadherin 20	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1306297	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of PCDH20 mRNA	PMID:36841081
1314837	PCDH20	protocadherin 20	gene	CHEBI:16130	DDT	decreases expression	ISO	RGD:1306297	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of PCDH20 mRNA	PMID:30207508
1314837	PCDH20	protocadherin 20	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of PCDH20 mRNA	PMID:30510588
1314837	PCDH20	protocadherin 20	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314838	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PCDH20 mRNA	PMID:37992649
1314837	PCDH20	protocadherin 20	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306297	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of PCDH20 mRNA	PMID:26496021
1314837	PCDH20	protocadherin 20	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314838	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PCDH20 mRNA	PMID:37992649
1314837	PCDH20	protocadherin 20	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314838	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PCDH20 mRNA	PMID:35716406
1314837	PCDH20	protocadherin 20	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306297	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PCDH20 mRNA	PMID:26577399
1314837	PCDH20	protocadherin 20	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1306297	E	RGD:6480464	20200114	CTD	MESH:D010126	Ozone results in increased expression of PCDH20 mRNA	PMID:31397875
1314837	PCDH20	protocadherin 20	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314838	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PCDH20 mRNA	PMID:27106289
1314837	PCDH20	protocadherin 20	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314838	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of PCDH20 mRNA	PMID:25629700
1314837	PCDH20	protocadherin 20	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PCDH20 mRNA	PMID:26272509
1314837	PCDH20	protocadherin 20	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA	PMID:27188386
1314837	PCDH20	protocadherin 20	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PCDH20 mRNA	PMID:25583101
1314837	PCDH20	protocadherin 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306297	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PCDH20 mRNA	PMID:32109520|PMID:33387578
1314837	PCDH20	protocadherin 20	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of PCDH20 mRNA	PMID:29955902
1314837	PCDH20	protocadherin 20	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PCDH20 mRNA	PMID:23179753
1314837	PCDH20	protocadherin 20	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of PCDH20 mRNA	PMID:21198554
1314837	PCDH20	protocadherin 20	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PCDH20 mRNA	PMID:29803840
1314837	PCDH20	protocadherin 20	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314838	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PCDH20 mRNA	PMID:37992649
1314837	PCDH20	protocadherin 20	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PCDH20 5' UTR; Benzo(a)pyrene results in increased methylation of PCDH20 exon; Benzo(a)pyrene results in increased methylation of PCDH20 promoter	PMID:27901495
1314837	PCDH20	protocadherin 20	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PCDH20 mRNA	PMID:26705709
1314837	PCDH20	protocadherin 20	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1306297	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of PCDH20 mRNA	PMID:24915197
1314837	PCDH20	protocadherin 20	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314838	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PCDH20 mRNA	PMID:19710929
1314837	PCDH20	protocadherin 20	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306297	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDH20 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:41034487
1314837	PCDH20	protocadherin 20	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306297	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of PCDH20 mRNA	PMID:31129395|PMID:41034487
1314837	PCDH20	protocadherin 20	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306297	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of PCDH20 mRNA	PMID:26496021
1314837	PCDH20	protocadherin 20	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	ISO	RGD:1314838	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of PCDH20 mRNA	PMID:25172293
1314837	PCDH20	protocadherin 20	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314838	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PCDH20 gene	PMID:31683443
1314837	PCDH20	protocadherin 20	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314838	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of PCDH20 mRNA	PMID:30951980
1314837	PCDH20	protocadherin 20	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306297	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PCDH20 mRNA	PMID:35163327
1314837	PCDH20	protocadherin 20	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306297	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PCDH20 mRNA	PMID:33453195
1314837	PCDH20	protocadherin 20	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306297	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PCDH20 mRNA	PMID:35163327
1314837	PCDH20	protocadherin 20	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of PCDH20 mRNA	PMID:24449571
1314837	PCDH20	protocadherin 20	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314838	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PCDH20 mRNA	PMID:40194260
1314837	PCDH20	protocadherin 20	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1314838	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of PCDH20 mRNA	PMID:29038090
1314837	PCDH20	protocadherin 20	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PCDH20 mRNA	PMID:25979313
1314837	PCDH20	protocadherin 20	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314838	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of PCDH20 mRNA	PMID:17963808
1314837	PCDH20	protocadherin 20	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PCDH20 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:25192806|PMID:26272509|PMID:28001369
1314837	PCDH20	protocadherin 20	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA	PMID:27188386
1314837	PCDH20	protocadherin 20	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PCDH20 mRNA	PMID:20106945
1314837	PCDH20	protocadherin 20	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314838	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of PCDH20 mRNA	PMID:37992649
1314837	PCDH20	protocadherin 20	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PCDH20 mRNA	PMID:38832940
1314837	PCDH20	protocadherin 20	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of PCDH20 mRNA	PMID:24935251
1314837	PCDH20	protocadherin 20	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306297	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PCDH20 mRNA	PMID:33387578
1314837	PCDH20	protocadherin 20	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of PCDH20 mRNA	PMID:24714768
1314837	PCDH20	protocadherin 20	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306297	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of PCDH20 mRNA	PMID:29391264
1314837	PCDH20	protocadherin 20	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of PCDH20 mRNA	PMID:26272509
1314837	PCDH20	protocadherin 20	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA	PMID:27188386
1314837	PCDH20	protocadherin 20	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PCDH20 mRNA	PMID:26705709
1314837	PCDH20	protocadherin 20	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306297	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PCDH20 mRNA	PMID:30307764
1314837	PCDH20	protocadherin 20	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PCDH20 mRNA	PMID:24810058
1314837	PCDH20	protocadherin 20	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PCDH20 mRNA	PMID:22079614
1314837	PCDH20	protocadherin 20	gene	CHEBI:6716	medroxyprogesterone acetate	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in decreased expression of PCDH20 mRNA	PMID:20843944
1314837	PCDH20	protocadherin 20	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PCDH20 mRNA	PMID:31758290
1314837	PCDH20	protocadherin 20	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of PCDH20 mRNA	PMID:36318118
1314837	PCDH20	protocadherin 20	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1306297	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of PCDH20 mRNA	PMID:26720608
1314837	PCDH20	protocadherin 20	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA	PMID:27188386
1314837	PCDH20	protocadherin 20	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDH20 gene]	PMID:28238834
1314837	PCDH20	protocadherin 20	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314838	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of PCDH20 mRNA	PMID:38648751
1314837	PCDH20	protocadherin 20	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of PCDH20 mRNA	PMID:26705709
1314837	PCDH20	protocadherin 20	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306297	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PCDH20 mRNA	PMID:24780913
1314837	PCDH20	protocadherin 20	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of PCDH20 mRNA	PMID:26272509
1314837	PCDH20	protocadherin 20	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA	PMID:27188386
1314837	PCDH20	protocadherin 20	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA	PMID:27188386
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C014638	beta-lapachone results in increased expression of FBH1 mRNA	PMID:38218311
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314840	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of FBH1 mRNA	PMID:33045310
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FBH1 gene	PMID:20938992
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D014212	Tretinoin results in decreased expression of FBH1 mRNA	PMID:33167477
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314840	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of FBH1 mRNA	PMID:39241906
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314840	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of FBH1 mRNA	PMID:39298647
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FBH1 gene	PMID:20938992
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314840	E	RGD:6480464	20260707	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FBH1 mRNA	PMID:36331819
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBH1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of FBH1 mRNA	PMID:39836092
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FBH1 mRNA	PMID:19549813
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of FBH1 mRNA	PMID:22171008
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBH1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FBH1 gene	PMID:20938992|PMID:22206623
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FBH1 gene	PMID:25304211
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBH1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBH1 mRNA	PMID:39836092
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314840	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of FBH1 mRNA	PMID:40504410
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of FBH1 protein	PMID:35688186
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of FBH1 mRNA	PMID:23557933
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of FBH1 mRNA	PMID:27392435
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306298	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBH1 mRNA	PMID:33387578
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBH1 mRNA	PMID:17942748
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FBH1 mRNA	PMID:17942748
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBH1 mRNA	PMID:30851411
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FBH1 mRNA	PMID:29803840
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of FBH1 protein	PMID:35688186
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FBH1 mRNA	PMID:38568856
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBH1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBH1 mRNA	PMID:39836092
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314840	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of FBH1 mRNA	PMID:40504410
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FBH1 mRNA	PMID:20504355|PMID:22228805
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of FBH1 mRNA	PMID:22171008
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314840	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of FBH1 mRNA	PMID:39716349
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314840	E	RGD:6480464	20260707	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBH1 gene; titanium dioxide results in decreased methylation of FBH1 promoter alternative form	PMID:35295148
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:C006253	pirinixic acid results in decreased expression of FBH1 mRNA	PMID:17426115
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C006780	bisphenol A affects the expression of FBH1 mRNA	PMID:22574217
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306298	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FBH1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314840	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of FBH1 mRNA	PMID:39298647
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1314840	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of FBH1 mRNA	PMID:34813904
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBH1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of FBH1 mRNA	PMID:39836092
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBH1 mRNA	PMID:38568856
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:36704	imiquimod	decreases expression	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:C056493	imiquimod results in decreased expression of FBH1 mRNA	PMID:21878529
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:D002994	Clofibrate results in decreased expression of FBH1 mRNA	PMID:23811191
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314840	E	RGD:6480464	20260707	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FBH1 mRNA	PMID:36331819
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20181016	CTD	MESH:D014635	Valproic Acid results in increased methylation of FBH1 gene	PMID:29154799
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:D013629	Tamoxifen affects the expression of FBH1 mRNA	PMID:17555576
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:D000082	Acetaminophen affects the expression of FBH1 mRNA	PMID:17562736
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of FBH1 mRNA	PMID:22230336
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of FBH1 mRNA	PMID:29523930
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of FBH1 gene	PMID:25304211
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBH1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBH1 mRNA	PMID:39836092
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314840	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of FBH1 mRNA	PMID:40504410
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FBH1 mRNA	PMID:22079256
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314840	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of FBH1 mRNA	PMID:35436446
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FBH1 mRNA	PMID:17555576
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FBH1 mRNA	PMID:17942748
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314840	E	RGD:6480464	20181016	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FBH1 mRNA	PMID:17942748
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314840	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of FBH1 mRNA	PMID:39716349
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of FBH1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of FBH1 mRNA	PMID:39836092
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314840	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBH1 mRNA	PMID:22206623
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of FBH1 mRNA	PMID:22079256
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of FBH1 mRNA	PMID:22079256
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D019344	Lactic Acid results in decreased expression of FBH1 mRNA	PMID:30851411
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FBH1 gene]	PMID:28238834
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:80491	pinostrobin	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C411294	pinostrobin results in increased expression of FBH1 mRNA	PMID:37777166
1314839	FBH1	F-box DNA helicase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306298	E	RGD:6480464	20181016	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of FBH1 mRNA	PMID:21346803
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314842	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of IPP mRNA	PMID:37995155
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314842	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of IPP mRNA	PMID:20938992
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of IPP mRNA	PMID:26079696
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of IPP mRNA	PMID:18951874
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306299	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of IPP gene	PMID:27618143
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314842	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of IPP mRNA	PMID:20938992
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of IPP mRNA	PMID:37042841
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306299	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of IPP mRNA	PMID:33387578
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of IPP mRNA	PMID:28818685
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IPP mRNA	PMID:35301059
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314842	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IPP mRNA	PMID:37236586
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of IPP mRNA	PMID:19549813
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of IPP mRNA	PMID:23649840
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of IPP mRNA	PMID:23649840
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314842	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of IPP mRNA	PMID:20938992
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of IPP mRNA	PMID:23557933
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of IPP mRNA	PMID:27392435
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of IPP mRNA	PMID:27392435
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of IPP mRNA	PMID:25583101
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314842	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IPP mRNA	PMID:21570461
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306299	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IPP mRNA	PMID:33387578
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306299	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IPP mRNA	PMID:32109520
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of IPP mRNA	PMID:28001369
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of IPP mRNA	PMID:25351596
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1306299	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of IPP mRNA	PMID:16507785
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1306299	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of IPP mRNA	PMID:25729387
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306299	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of IPP mRNA	PMID:25729387
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306299	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of IPP mRNA	PMID:25181051
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314842	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of IPP mRNA	PMID:26063408
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1314842	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of IPP promoter	PMID:27312807
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of IPP mRNA	PMID:19244175
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314842	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of IPP mRNA	PMID:38685157
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314842	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of IPP mRNA	PMID:37019170
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IPP mRNA	PMID:37042841
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1306299	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of IPP mRNA	PMID:30589522
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of IPP mRNA	PMID:38568856
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IPP mRNA	PMID:35301059
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314842	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IPP mRNA	PMID:37236586
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314842	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IPP mRNA	PMID:40194260
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of IPP mRNA	PMID:25979313
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of IPP mRNA	PMID:23179753|PMID:26272509|PMID:27188386|PMID:28001369|PMID:29154799
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IPP mRNA	PMID:27188386
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of IPP mRNA	PMID:20106945
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of IPP mRNA	PMID:28542535
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of IPP mRNA	PMID:24935251|PMID:26272509
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IPP mRNA	PMID:27188386
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314842	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IPP mRNA	PMID:17562736
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306299	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of IPP mRNA	PMID:33387578
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of IPP mRNA	PMID:22077320
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314842	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of IPP mRNA	PMID:35436446
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306299	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of IPP mRNA	PMID:29097150
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314842	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of IPP mRNA	PMID:19042947
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306299	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of IPP mRNA	PMID:25729387
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306299	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of IPP mRNA	PMID:25729387
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of IPP mRNA	PMID:28988120
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306299	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of IPP gene	PMID:35440735
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of IPP mRNA	PMID:31758290
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1314842	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of IPP mRNA	PMID:22206623
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IPP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IPP mRNA	PMID:27188386
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IPP gene]	PMID:28238834
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1306299	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of IPP mRNA	PMID:20345932
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1314842	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of IPP mRNA	PMID:40826991
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IPP mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IPP mRNA	PMID:27188386
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306299	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of IPP mRNA	PMID:21346803
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of IPP mRNA	PMID:38568856
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of IPP mRNA	PMID:29301935
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1314842	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of IPP mRNA	PMID:26217789
1314841	IPP	intracisternal A particle-promoted polypeptide	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306299	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of IPP mRNA	PMID:21346803
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314847	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ADAM21 mRNA	PMID:33045310
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ADAM21 mRNA	PMID:26079696
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ADAM21 mRNA	PMID:35811015
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ADAM21 mRNA	PMID:26079696
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ADAM21 mRNA	PMID:35301059
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ADAM21 gene	PMID:27153756
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314847	E	RGD:6480464	20180828	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ADAM21 mRNA	PMID:29673856
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAM21 mRNA	PMID:29301061
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314847	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADAM21 mRNA	PMID:37682722
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ADAM21 mRNA	PMID:38568856
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADAM21 mRNA	PMID:22316170
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADAM21 exon; Benzo(a)pyrene results in increased methylation of ADAM21 promoter	PMID:27901495
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ADAM21 gene	PMID:31601247
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of ADAM21 mRNA	PMID:23146750
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314847	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased expression of ADAM21 mRNA	PMID:33297965
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ADAM21 mRNA	PMID:35301059
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ADAM21 mRNA	PMID:24449571
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314847	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ADAM21 mRNA	PMID:40194260
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ADAM21 gene	PMID:29154799
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314847	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ADAM21 mRNA	PMID:17562736
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ADAM21 mRNA	PMID:35811015
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of ADAM21 mRNA	PMID:31838189
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314847	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ADAM21 mRNA	PMID:35436446
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ADAM21 mRNA	PMID:23146750
1314846	ADAM21	ADAM metallopeptidase domain 21	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of ADAM21 mRNA	PMID:17440010
1314849	TJP1	tight junction protein 1	gene	CHEBI:10022	deoxynivalenol	affects localization	EXP		E	RGD:6480464	20160412	CTD	MESH:C007262	deoxynivalenol affects the localization of TJP1 protein	PMID:24568843
1314849	TJP1	tight junction protein 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20211207	CTD	MESH:C007262	deoxynivalenol results in decreased expression of TJP1 mRNA; deoxynivalenol results in decreased expression of TJP1 protein	PMID:34506767|PMID:35381244|PMID:35817260|PMID:41206121
1314849	TJP1	tight junction protein 1	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:C007262	deoxynivalenol results in increased expression of TJP1 mRNA	PMID:24568843
1314849	TJP1	tight junction protein 1	gene	CHEBI:10022	deoxynivalenol	increases expression	ISO	RGD:1314850	E	RGD:6480464	20160412	CTD	MESH:C007262	deoxynivalenol results in increased expression of TJP1 mRNA	PMID:24568843
1314849	TJP1	tight junction protein 1	gene	CHEBI:10022	deoxynivalenol	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20211207	CTD	MESH:C007262	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein]]; Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of and affects the localization of TJP1 protein]; Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]; deoxynivalenol results in decreased expression of and affects the localization of TJP1 protein; lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 protein]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein]	PMID:34506767|PMID:35381244|PMID:35817260
1314849	TJP1	tight junction protein 1	gene	CHEBI:10100	zafirlukast	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:C062735	zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of TJP1 mRNA]; zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of TJP1 protein]	PMID:31816286
1314849	TJP1	tight junction protein 1	gene	CHEBI:10100	zafirlukast	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20200714	CTD	MESH:C062735	zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of TJP1 mRNA]; zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of TJP1 protein]	PMID:31816286
1314849	TJP1	tight junction protein 1	gene	CHEBI:10112	zileuton	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20170303	CTD	MESH:C063449	zileuton inhibits the reaction [dinitrobenzenesulfonic acid affects the localization of TJP1 protein]	PMID:16670640
1314849	TJP1	tight junction protein 1	gene	CHEBI:131923	salubrinal	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20170303	CTD	MESH:C496827	salubrinal inhibits the reaction [Cyclosporine results in decreased expression of TJP1 protein]	PMID:22155090
1314849	TJP1	tight junction protein 1	gene	CHEBI:132106	sodium propionate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20230404	CTD	MESH:C514135	sodium propionate inhibits the reaction [Ethanol results in decreased expression of TJP1 protein]	PMID:35639301
1314849	TJP1	tight junction protein 1	gene	CHEBI:132446	perfluorobutanesulfonic acid	affects expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C539348	perfluorobutanesulfonic acid affects the expression of TJP1 mRNA	PMID:40334771
1314849	TJP1	tight junction protein 1	gene	CHEBI:132446	perfluorobutanesulfonic acid	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C539348	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] affects the expression of TJP1 mRNA	PMID:40334771
1314849	TJP1	tight junction protein 1	gene	CHEBI:15343	acetaldehyde	affects localization	EXP		E	RGD:6480464	20121113	CTD	MESH:D000079	Acetaldehyde affects the localization of TJP1 protein	PMID:17991733|PMID:22563376
1314849	TJP1	tight junction protein 1	gene	CHEBI:15343	acetaldehyde	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000079	chelerythrine inhibits the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]]; EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]; PLCG1 protein affects the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]]; Ro 32-0432 inhibits the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]]	PMID:17991733
1314849	TJP1	tight junction protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20220111	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of TJP1 protein]; NLRP3 protein affects the reaction [[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of TJP1 protein]]	PMID:34416350
1314849	TJP1	tight junction protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of TJP1 mRNA	PMID:16236135
1314849	TJP1	tight junction protein 1	gene	CHEBI:15379	dioxygen	affects localization	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D010100	Oxygen deficiency affects the localization of TJP1 protein	PMID:20164382
1314849	TJP1	tight junction protein 1	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20200114	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of TJP1 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of TJP1 protein; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [PLAT protein promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased degradation of TJP1 protein]]; PLAT protein promotes the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased degradation of TJP1 protein]; zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of TJP1 mRNA]; zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of TJP1 protein]	PMID:23876515|PMID:31816286
1314849	TJP1	tight junction protein 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of TJP1 mRNA; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of TJP1 protein; [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased degradation of TJP1 protein; ML 7 inhibits the reaction [Oxygen deficiency affects the localization of TJP1 protein]; zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of TJP1 mRNA]; zafirlukast inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of TJP1 protein]	PMID:20164382|PMID:23876515|PMID:31816286
1314849	TJP1	tight junction protein 1	gene	CHEBI:15738	staurosporine	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D019311	Staurosporine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]	PMID:16716901
1314849	TJP1	tight junction protein 1	gene	CHEBI:15756	hexadecanoic acid	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20180313	CTD	MESH:D019308	Palmitic Acid results in decreased expression of TJP1 protein	PMID:27689324
1314849	TJP1	tight junction protein 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D019308	[Palmitic Acid co-treated with Arsenic] affects the expression of TJP1 mRNA	PMID:33736254
1314849	TJP1	tight junction protein 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20180313	CTD	MESH:D019308	CA 074 methyl ester inhibits the reaction [Palmitic Acid results in decreased expression of TJP1 protein]; Glycyrrhizic Acid inhibits the reaction [Palmitic Acid results in decreased expression of TJP1 protein]; L 709049 analog inhibits the reaction [Palmitic Acid results in decreased expression of TJP1 protein]	PMID:27689324
1314849	TJP1	tight junction protein 1	gene	CHEBI:15864	luteolin	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:D047311	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 protein]]; Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 mRNA]; Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 protein]; ML 7 inhibits the reaction [Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 protein]]; triptolide inhibits the reaction [Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 protein]]	PMID:33675858
1314849	TJP1	tight junction protein 1	gene	CHEBI:15882	phenol	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:D019800	Phenol affects the localization of TJP1 protein	PMID:19679145
1314849	TJP1	tight junction protein 1	gene	CHEBI:15939	glycyrrhizinic acid	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20250603	CTD	MESH:D019695	Glycyrrhizic Acid inhibits the reaction [TGFB1 protein results in decreased expression of TJP1 protein]	PMID:39800143
1314849	TJP1	tight junction protein 1	gene	CHEBI:15939	glycyrrhizinic acid	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20180220	CTD	MESH:D019695	Glycyrrhizic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Glycyrrhizic Acid inhibits the reaction [Palmitic Acid results in decreased expression of TJP1 protein]; Glycyrrhizic Acid inhibits the reaction [Silicon Dioxide results in decreased expression of TJP1 mRNA]	PMID:27689324|PMID:27783111|PMID:39800143
1314849	TJP1	tight junction protein 1	gene	CHEBI:15948	lycopene	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250708	CTD	MESH:C015329	[Lycopene co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of TJP1 protein; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of TJP1 protein]	PMID:36087924
1314849	TJP1	tight junction protein 1	gene	CHEBI:16112	chlorogenic acid	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20200519	CTD	MESH:D002726	Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 mRNA]; Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 protein]	PMID:31390532
1314849	TJP1	tight junction protein 1	gene	CHEBI:16136	hydrogen sulfide	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20210406	CTD	MESH:D006862	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of TJP1 protein]; [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of TJP1 mRNA; [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of TJP1 protein; Fatty Acids, Omega-3 inhibits the reaction [[Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of TJP1 mRNA]; Fatty Acids, Omega-3 inhibits the reaction [[Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of TJP1 protein]	PMID:33068716
1314849	TJP1	tight junction protein 1	gene	CHEBI:16170	mercury(0)	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20231031	CTD	MESH:D008628	Mercury results in decreased expression of TJP1 mRNA	PMID:37137463
1314849	TJP1	tight junction protein 1	gene	CHEBI:16236	ethanol	affects localization	EXP		E	RGD:6480464	20141223	CTD	MESH:D000431	Ethanol affects the localization of TJP1 protein	PMID:10198341|PMID:22563376|PMID:25226407|PMID:28412402
1314849	TJP1	tight junction protein 1	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:D000431	Ethanol results in decreased expression of TJP1 mRNA; Ethanol results in decreased expression of TJP1 protein	PMID:25226407
1314849	TJP1	tight junction protein 1	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20200519	CTD	MESH:D000431	Ethanol results in decreased expression of TJP1 protein	PMID:31785310|PMID:35639301
1314849	TJP1	tight junction protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1306305	E	RGD:407424596|PMID:23277536	20240730	RGD	MESH:D000431	ethanol increases expression of Tjp1 protein in intestine	
1314849	TJP1	tight junction protein 1	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D000431	Flavonoids inhibits the reaction [Ethanol affects the localization of TJP1 protein]; Plant Extracts inhibits the reaction [Ethanol affects the localization of TJP1 protein]	PMID:28412402
1314849	TJP1	tight junction protein 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1306305	E	RGD:407424596|PMID:23277536	20240730	RGD	MESH:D000431	puerarin inhibits the reaction [ethanol increases expression of Tjp1 protein in intestine]	
1314849	TJP1	tight junction protein 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1306305	E	RGD:598092500|PMID:23582053	20250320	RGD	MESH:D000431	ethanol inhibits the reaction [hypoxia decreases expression of Tjp1 protein in hippocampal slice cultures]	
1314849	TJP1	tight junction protein 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20190507	CTD	MESH:D000431	[ethylene dichloride co-treated with Ethanol] results in decreased expression of TJP1 mRNA; [ethylene dichloride co-treated with Ethanol] results in decreased expression of TJP1 protein; [lipopolysaccharide, E coli O55-B5 co-treated with Ethanol] results in decreased expression of TJP1 protein; Ethanol promotes the reaction [Galactose results in decreased expression of TJP1 protein]; kaempferol inhibits the reaction [Ethanol results in decreased expression of TJP1 protein]; sodium propionate inhibits the reaction [Ethanol results in decreased expression of TJP1 protein]	PMID:30664321|PMID:31785310|PMID:33516661|PMID:35639301
1314849	TJP1	tight junction protein 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TJP1 mRNA	PMID:18661270
1314849	TJP1	tight junction protein 1	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of TJP1 mRNA; Hydrogen Peroxide results in decreased expression of TJP1 protein	PMID:12419474|PMID:20445016
1314849	TJP1	tight junction protein 1	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D006861	Quercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of TJP1 protein]	PMID:20445016
1314849	TJP1	tight junction protein 1	gene	CHEBI:16243	quercetin	affects localization	EXP		E	RGD:6480464	20170516	CTD	MESH:D011794	Quercetin affects the localization of TJP1 protein	PMID:19297429
1314849	TJP1	tight junction protein 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TJP1 mRNA	PMID:21632981
1314849	TJP1	tight junction protein 1	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of TJP1 protein	PMID:35688186
1314849	TJP1	tight junction protein 1	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of TJP1 protein]; Quercetin inhibits the reaction [Indomethacin affects the localization of TJP1 protein]; Quercetin inhibits the reaction [Indomethacin results in decreased expression of TJP1 mRNA]; Quercetin inhibits the reaction [Rotenone affects the localization of TJP1 protein]	PMID:20445016|PMID:23668856
1314849	TJP1	tight junction protein 1	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20210406	CTD	MESH:D011794	Quercetin inhibits the reaction [Indomethacin results in decreased expression of TJP1 mRNA]; Quercetin inhibits the reaction [Indomethacin results in decreased expression of TJP1 protein]	PMID:33276066
1314849	TJP1	tight junction protein 1	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240702	CTD	MESH:D011794	Quercetin inhibits the reaction [Cisplatin results in decreased expression of TJP1 protein]	PMID:38490643
1314849	TJP1	tight junction protein 1	gene	CHEBI:16325	lithocholic acid	multiple interactions	EXP		E	RGD:6480464	20200114	CTD	MESH:D008095	Lithocholic Acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [TNF protein results in decreased expression of and affects the localization of TJP1 protein]]; Lithocholic Acid inhibits the reaction [TNF protein results in decreased expression of and affects the localization of TJP1 protein]; VDR protein affects the reaction [Lithocholic Acid inhibits the reaction [TNF protein results in decreased expression of TJP1 protein]]	PMID:31472180
1314849	TJP1	tight junction protein 1	gene	CHEBI:16347	(R)-carnitine	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20180116	CTD	MESH:D002331	Carnitine inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of TJP1 protein]	PMID:28973641
1314849	TJP1	tight junction protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TJP1 protein	PMID:35774596|PMID:38663798|PMID:38945840
1314849	TJP1	tight junction protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TJP1 mRNA; Lipopolysaccharides results in decreased expression of TJP1 protein	PMID:22344225|PMID:39241906
1314849	TJP1	tight junction protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1306305	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TJP1 protein	PMID:15763998
1314849	TJP1	tight junction protein 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:D008070	[bisphenol F co-treated with Lipopolysaccharides] results in decreased expression of TJP1 mRNA; [bisphenol F co-treated with Lipopolysaccharides] results in decreased expression of TJP1 protein; alisol B 23-acetate inhibits the reaction [Lipopolysaccharides results in decreased expression of TJP1 protein]; DKK3 protein promotes the reaction [Lipopolysaccharides results in decreased expression of TJP1 protein]; nitazoxanide inhibits the reaction [Lipopolysaccharides results in decreased expression of TJP1 protein]; tizoxanide inhibits the reaction [Lipopolysaccharides results in decreased expression of TJP1 protein]	PMID:34774955|PMID:35774596|PMID:38663798|PMID:38945840
1314849	TJP1	tight junction protein 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20230404	CTD	MESH:D008070	[kaempferol inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in decreased expression of TJP1 protein; [Lipopolysaccharides co-treated with TNF protein] results in decreased expression of TJP1 protein; [Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 mRNA; [Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 protein; Lactulose inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 mRNA]; Lactulose inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 protein]; qingdu inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 mRNA]; qingdu inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 protein]	PMID:36049518|PMID:36414212
1314849	TJP1	tight junction protein 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20161025	CTD	MESH:D004958	Estradiol results in decreased expression of TJP1 mRNA	PMID:27174447|PMID:32145629
1314849	TJP1	tight junction protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20161025	CTD	MESH:D004958	[Estradiol co-treated with bisphenol A] results in decreased expression of TJP1 mRNA	PMID:27174447
1314849	TJP1	tight junction protein 1	gene	CHEBI:16480	nitric oxide	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D009569	Nitric Oxide deficiency results in decreased expression of TJP1 protein	PMID:15763998
1314849	TJP1	tight junction protein 1	gene	CHEBI:16480	nitric oxide	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20150714	CTD	MESH:D009569	[NOS2 protein results in increased chemical synthesis of Nitric Oxide] which results in decreased expression of TJP1 mRNA	PMID:25870319
1314849	TJP1	tight junction protein 1	gene	CHEBI:16551	alpha,alpha-trehalose	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20150310	CTD	MESH:D014199	Trehalose inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of TJP1 protein]	PMID:25064079
1314849	TJP1	tight junction protein 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TJP1 mRNA	PMID:33387578
1314849	TJP1	tight junction protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20220111	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of TJP1 protein]; NLRP3 protein affects the reaction [[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of TJP1 protein]]	PMID:34416350
1314849	TJP1	tight junction protein 1	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240109	CTD	MESH:D008550	Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 mRNA]; Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 protein]; Melatonin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 mRNA]	PMID:37598416|PMID:39555739
1314849	TJP1	tight junction protein 1	gene	CHEBI:168396	mycophenolic acid	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D009173	Mycophenolic Acid results in decreased expression of TJP1 protein	PMID:35321622
1314849	TJP1	tight junction protein 1	gene	CHEBI:168396	mycophenolic acid	multiple interactions	EXP		E	RGD:6480464	20230606	CTD	MESH:D009173	schizandrin A inhibits the reaction [Mycophenolic Acid results in decreased expression of TJP1 protein]	PMID:35321622
1314849	TJP1	tight junction protein 1	gene	CHEBI:17158	methylglyoxal	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20250902	CTD	MESH:D011765	Pyruvaldehyde results in decreased expression of TJP1 protein	PMID:39863075
1314849	TJP1	tight junction protein 1	gene	CHEBI:17183	sanguinarine	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005705	sanguinarine results in increased expression of TJP1 mRNA; sanguinarine results in increased expression of TJP1 protein	PMID:37393519
1314849	TJP1	tight junction protein 1	gene	CHEBI:17230	homocysteine	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20170303	CTD	MESH:D006710	Homocysteine results in decreased expression of TJP1 mRNA; Homocysteine results in decreased expression of TJP1 protein	PMID:21647593
1314849	TJP1	tight junction protein 1	gene	CHEBI:17230	homocysteine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20170303	CTD	MESH:D006710	[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of TJP1 mRNA; acetovanillone inhibits the reaction [Homocysteine results in decreased expression of TJP1 protein]; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of TJP1 mRNA]; CYBB mutant form inhibits the reaction [Homocysteine results in decreased expression of TJP1 protein]	PMID:21647593
1314849	TJP1	tight junction protein 1	gene	CHEBI:17234	glucose	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of TJP1 protein	PMID:21617913|PMID:35445903|PMID:39579577
1314849	TJP1	tight junction protein 1	gene	CHEBI:17234	glucose	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of TJP1 protein	PMID:21617913|PMID:27783111|PMID:39922521
1314849	TJP1	tight junction protein 1	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D005947	2-Methoxyestradiol inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; [Acetylcysteine co-treated with ginsenoside Rg3] inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; ML385 inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of TJP1 protein]]	PMID:21617913|PMID:39579577
1314849	TJP1	tight junction protein 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20180220	CTD	MESH:D005947	Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Dichloroacetic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Glycyrrhizic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; NLRP3 protein promotes the reaction [Glucose results in decreased expression of TJP1 protein]; Oxamic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Rotenone promotes the reaction [Glucose results in decreased expression of TJP1 protein]	PMID:27783111|PMID:39922521
1314849	TJP1	tight junction protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250204	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein	PMID:34380243
1314849	TJP1	tight junction protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20121113	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein	PMID:18214902|PMID:29940330
1314849	TJP1	tight junction protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20250603	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein	PMID:36087924|PMID:39360521
1314849	TJP1	tight junction protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1306305	E	RGD:6480464	20250311	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of TJP1 protein	PMID:31726466
1314849	TJP1	tight junction protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20190409	CTD	MESH:C016599	[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein]; mono-(2-ethylhexyl)phthalate results in decreased expression of and results in decreased localization of TJP1 protein; TGFB1 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TJP1 protein]	PMID:29940330|PMID:31726466|PMID:37941498
1314849	TJP1	tight junction protein 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250603	CTD	MESH:C016599	[Lycopene co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of TJP1 protein; selenomethylselenocysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein]	PMID:36087924|PMID:39360521
1314849	TJP1	tight junction protein 1	gene	CHEBI:173086	ferrostatin-1	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250708	CTD	MESH:C573944	ferrostatin-1 inhibits the reaction [butylbenzyl phthalate results in decreased expression of TJP1 protein]	PMID:39921026
1314849	TJP1	tight junction protein 1	gene	CHEBI:17313	7,8-dihydroxycoumarin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240109	CTD	MESH:C039952	daphnetin inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]	PMID:37209277
1314849	TJP1	tight junction protein 1	gene	CHEBI:17394	N(5)-ethyl-L-glutamine	increases expression	ISO	RGD:1314850	E	RGD:6480464	20260407	CTD	MESH:C026166	theanine results in increased expression of TJP1 mRNA	PMID:40311999
1314849	TJP1	tight junction protein 1	gene	CHEBI:17394	N(5)-ethyl-L-glutamine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20260407	CTD	MESH:C026166	theanine inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 mRNA]	PMID:40311999
1314849	TJP1	tight junction protein 1	gene	CHEBI:17574	biochanin A	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240702	CTD	MESH:C004541	biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]	PMID:38648921
1314849	TJP1	tight junction protein 1	gene	CHEBI:17594	hydroquinone	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20170516	CTD	MESH:C031927	hydroquinone results in decreased degradation of and results in increased expression of TJP1 protein	PMID:27587462
1314849	TJP1	tight junction protein 1	gene	CHEBI:17606	diiodine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D007455	[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of TJP1 protein; Iodine results in increased expression of and results in increased localization of TJP1 protein	PMID:16514648
1314849	TJP1	tight junction protein 1	gene	CHEBI:17634	D-glucose	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of TJP1 protein	PMID:21617913|PMID:35445903|PMID:39579577
1314849	TJP1	tight junction protein 1	gene	CHEBI:17634	D-glucose	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of TJP1 protein	PMID:21617913|PMID:27783111|PMID:39922521
1314849	TJP1	tight junction protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D005947	2-Methoxyestradiol inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; [Acetylcysteine co-treated with ginsenoside Rg3] inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; ML385 inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of TJP1 protein]]	PMID:21617913|PMID:39579577
1314849	TJP1	tight junction protein 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20180220	CTD	MESH:D005947	Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Dichloroacetic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Glycyrrhizic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; NLRP3 protein promotes the reaction [Glucose results in decreased expression of TJP1 protein]; Oxamic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Rotenone promotes the reaction [Glucose results in decreased expression of TJP1 protein]	PMID:27783111|PMID:39922521
1314849	TJP1	tight junction protein 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314850	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of TJP1 mRNA	PMID:23892564
1314849	TJP1	tight junction protein 1	gene	CHEBI:17650	cortisol	increases localization	EXP		E	RGD:6480464	20160315	CTD	MESH:D006854	Hydrocortisone results in increased localization of TJP1 protein	PMID:25763180
1314849	TJP1	tight junction protein 1	gene	CHEBI:17650	cortisol	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D006854	GGTI 298 inhibits the reaction [Hydrocortisone results in increased localization of TJP1 protein]	PMID:25763180
1314849	TJP1	tight junction protein 1	gene	CHEBI:176788	dizocilpine maleate	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D016291	Dizocilpine Maleate inhibits the reaction [N-Methylaspartate results in decreased expression of TJP1 mRNA]; Dizocilpine Maleate inhibits the reaction [N-Methylaspartate results in decreased expression of TJP1 protein]	PMID:35257817
1314849	TJP1	tight junction protein 1	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of TJP1 protein	PMID:18844224
1314849	TJP1	tight junction protein 1	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of TJP1 protein	PMID:20722969
1314849	TJP1	tight junction protein 1	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20161213	CTD	MESH:D009538	[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of TJP1 protein; [Saquinavir co-treated with Nicotine] results in decreased expression of TJP1 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of TJP1 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of TJP1 protein]	PMID:20722969
1314849	TJP1	tight junction protein 1	gene	CHEBI:177046	Prothioconazole-desthio	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20230905	CTD	MESH:C000656708	prothioconazole-desthio results in decreased expression of TJP1 mRNA	PMID:36007749
1314849	TJP1	tight junction protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1306305	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate affects the expression of TJP1 protein	PMID:31726466
1314849	TJP1	tight junction protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20190409	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TJP1 protein	PMID:29940330|PMID:30320191
1314849	TJP1	tight junction protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20240206	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of TJP1 mRNA; Diethylhexyl Phthalate results in decreased expression of TJP1 protein	PMID:32235866|PMID:33754040|PMID:36087924|PMID:36174316|PMID:36781136|PMID:37858774|PMID:39360521
1314849	TJP1	tight junction protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1306305	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of TJP1 mRNA; Diethylhexyl Phthalate results in increased expression of TJP1 protein	PMID:26316063|PMID:31726466
1314849	TJP1	tight junction protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20250204	CTD	MESH:D004051	Genistein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TJP1 mRNA]	PMID:26316063
1314849	TJP1	tight junction protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240402	CTD	MESH:D004051	[[Polystyrenes results in increased abundance of Microplastics] which co-treated with Diethylhexyl Phthalate] results in decreased expression of TJP1 protein; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of TJP1 protein; Lycopene inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of TJP1 protein]; selenomethylselenocysteine inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of TJP1 protein]	PMID:36087924|PMID:36174316|PMID:37364641|PMID:39360521
1314849	TJP1	tight junction protein 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of TJP1 protein	PMID:37730182
1314849	TJP1	tight junction protein 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20201215	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TJP1 protein	PMID:31351185
1314849	TJP1	tight junction protein 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20150310	CTD	MESH:D015632	[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of TJP1 protein; Trehalose inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of TJP1 protein]	PMID:25064079
1314849	TJP1	tight junction protein 1	gene	CHEBI:18058	oxamic acid	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:D010072	Oxamic Acid inhibits the reaction [Silicon Dioxide results in decreased expression of TJP1 protein]	PMID:40049282
1314849	TJP1	tight junction protein 1	gene	CHEBI:18058	oxamic acid	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250603	CTD	MESH:D010072	Oxamic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Oxamic Acid inhibits the reaction [Streptozocin results in decreased expression of TJP1 protein]	PMID:39922521
1314849	TJP1	tight junction protein 1	gene	CHEBI:18152	myricetin	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20210406	CTD	MESH:C040015	myricetin inhibits the reaction [Indomethacin results in decreased expression of TJP1 mRNA]; myricetin inhibits the reaction [Indomethacin results in decreased expression of TJP1 protein]	PMID:33276066
1314849	TJP1	tight junction protein 1	gene	CHEBI:18330	isovitexin	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20231003	CTD	MESH:C049772	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [isovitexin inhibits the reaction [TNF protein results in decreased expression of TJP1 protein]]; isovitexin inhibits the reaction [TNF protein results in decreased expression of TJP1 protein]	PMID:37263555
1314849	TJP1	tight junction protein 1	gene	CHEBI:18344	kynurenic acid	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20220607	CTD	MESH:D007736	Kynurenic Acid inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of TJP1 protein]	PMID:35123988
1314849	TJP1	tight junction protein 1	gene	CHEBI:18394	6-O-alpha-D-glucopyranosyl-D-fructofuranose	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250114	CTD	MESH:C008189	isomaltulose inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 mRNA]; isomaltulose inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]	PMID:35894244
1314849	TJP1	tight junction protein 1	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of TJP1 protein	PMID:18844224
1314849	TJP1	tight junction protein 1	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of TJP1 protein	PMID:20722969
1314849	TJP1	tight junction protein 1	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20161213	CTD	MESH:D009538	[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of TJP1 protein; [Saquinavir co-treated with Nicotine] results in decreased expression of TJP1 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of TJP1 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of TJP1 protein]	PMID:20722969
1314849	TJP1	tight junction protein 1	gene	CHEBI:187279	PRIM-O-GLUCOSYLCIMIFUGIN	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C498945	prim-O-glucosylcimifugin results in increased expression of TJP1 protein	PMID:29910215
1314849	TJP1	tight junction protein 1	gene	CHEBI:188855	Octicizer	multiple interactions	EXP		E	RGD:6480464	20260804	CTD	MESH:C018535	[2-ethylhexyldiphenylphosphate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the localization of TJP1 protein	PMID:39137464
1314849	TJP1	tight junction protein 1	gene	CHEBI:191686	Neoisoliquiritin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240903	CTD	MESH:C098467	neoisoliquiritin inhibits the reaction [Cadmium Chloride results in decreased expression of TJP1 protein]	PMID:38401882
1314849	TJP1	tight junction protein 1	gene	CHEBI:193350	ferulic acid	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:C004999	ferulic acid inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein]	PMID:38881217
1314849	TJP1	tight junction protein 1	gene	CHEBI:193350	ferulic acid	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250506	CTD	MESH:C004999	ferulic acid inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein]	PMID:38881217
1314849	TJP1	tight junction protein 1	gene	CHEBI:195250	corn oil	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20250401	CTD	MESH:D003314	[(5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid co-treated with Corn Oil] results in decreased expression of TJP1 mRNA	PMID:39096942
1314849	TJP1	tight junction protein 1	gene	CHEBI:2038	5-azacytidine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001374	Azacitidine results in increased expression of TJP1 mRNA	PMID:18661270
1314849	TJP1	tight junction protein 1	gene	CHEBI:219199	Altertoxin II	multiple interactions	EXP		E	RGD:6480464	20231219	CTD	MESH:C050234	[alternariol co-treated with altertoxin II] affects the reaction [IL1B protein affects the expression of TJP1 mRNA]; [alternariol co-treated with altertoxin II] affects the reaction [IL1B protein affects the expression of TJP1 protein]; [alternariol co-treated with altertoxin II] results in increased expression of TJP1 protein; altertoxin II affects the reaction [IL1B protein affects the expression of and affects the localization of TJP1 protein]; altertoxin II affects the reaction [IL1B protein affects the expression of TJP1 mRNA]; altertoxin II results in increased expression of and affects the localization of TJP1 protein	PMID:35405071
1314849	TJP1	tight junction protein 1	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	Cadmium results in decreased expression of TJP1 mRNA	PMID:32711312
1314849	TJP1	tight junction protein 1	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20251104	CTD	MESH:D002104	Cadmium results in decreased expression of TJP1 mRNA; Cadmium results in decreased expression of TJP1 protein	PMID:32033263|PMID:32711312|PMID:35934034
1314849	TJP1	tight junction protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251202	CTD	MESH:D002104	[2-ethylhexyldiphenylphosphate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the localization of TJP1 protein; Cadmium results in decreased expression of and affects the localization of TJP1 protein	PMID:32711312|PMID:39137464
1314849	TJP1	tight junction protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20200519	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 protein; Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 mRNA]; Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 protein]	PMID:31390532
1314849	TJP1	tight junction protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20251104	CTD	MESH:D002104	6-formylindolo(3,2-b)carbazole inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 mRNA]; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 mRNA; [Cadmium co-treated with Dextran Sulfate] results in decreased expression of TJP1 mRNA; Cadmium promotes the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]; fexaramine inhibits the reaction [Cadmium results in decreased expression of TJP1 mRNA]; Melatonin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 mRNA]	PMID:32711312|PMID:35934034|PMID:38833985|PMID:39555739
1314849	TJP1	tight junction protein 1	gene	CHEBI:22984	calcium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium deficiency inhibits the reaction [TJP1 protein binds to OCLN protein]	PMID:11054866
1314849	TJP1	tight junction protein 1	gene	CHEBI:23115	chlorohydrocarbon	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20260505	CTD	MESH:D006843	[Hydrocarbons, Chlorinated co-treated with Benzothiepins co-treated with 3-xylene analog] results in decreased expression of TJP1 protein	PMID:40619073
1314849	TJP1	tight junction protein 1	gene	CHEBI:232813	KL001	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:C574808	KL001 inhibits the reaction [Antigens, Dermatophagoides results in increased expression of TJP1 mRNA]; KL001 inhibits the reaction [IL13 protein results in increased expression of TJP1 mRNA]; KL001 inhibits the reaction [IL4 protein results in increased expression of TJP1 mRNA]	PMID:37079442
1314849	TJP1	tight junction protein 1	gene	CHEBI:233321	Mitoquinone	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250408	CTD	MESH:C429014	mitoquinone inhibits the reaction [triptolide results in decreased expression of TJP1 mRNA]; mitoquinone inhibits the reaction [triptolide results in decreased expression of TJP1 protein]	PMID:30836114
1314849	TJP1	tight junction protein 1	gene	CHEBI:233358	CU-CPT22	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:C000719992	CU-CPT22 inhibits the reaction [Particulate Matter results in decreased expression of TJP1 protein]	PMID:39189708
1314849	TJP1	tight junction protein 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TJP1 mRNA	PMID:19549813
1314849	TJP1	tight junction protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TJP1 protein	PMID:23301498
1314849	TJP1	tight junction protein 1	gene	CHEBI:25195	mercury atom	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20231031	CTD	MESH:D008628	Mercury results in decreased expression of TJP1 mRNA	PMID:37137463
1314849	TJP1	tight junction protein 1	gene	CHEBI:26710	sodium chloride	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D012965	Sodium Chloride results in decreased expression of TJP1 protein	PMID:37865300
1314849	TJP1	tight junction protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:D012965	[AGT protein co-treated with Sodium Chloride] results in decreased expression of TJP1 mRNA; [AGT protein co-treated with Sodium Chloride] results in decreased expression of TJP1 protein; KLF4 protein affects the reaction [Telmisartan inhibits the reaction [[AGT protein co-treated with Sodium Chloride] results in decreased expression of TJP1 mRNA]]; puerarin inhibits the reaction [Sodium Chloride results in decreased expression of TJP1 protein]; SIRT1 protein promotes the reaction [puerarin inhibits the reaction [Sodium Chloride results in decreased expression of TJP1 protein]]; Telmisartan inhibits the reaction [[AGT protein co-treated with Sodium Chloride] results in decreased expression of TJP1 mRNA]; Telmisartan inhibits the reaction [[AGT protein co-treated with Sodium Chloride] results in decreased expression of TJP1 protein]	PMID:37865300|PMID:40613628
1314849	TJP1	tight junction protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20161213	CTD	MESH:D012965	[Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with TJP1 protein]; CD38 gene mutant form promotes the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with TJP1 protein]]	PMID:21992601
1314849	TJP1	tight junction protein 1	gene	CHEBI:2672	Ammothamnine	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20220809	CTD	MESH:C037573	oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein]	PMID:35290143
1314849	TJP1	tight junction protein 1	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20150825	CTD	MESH:C011559	tributyltin results in decreased expression of TJP1 protein	PMID:26079211
1314849	TJP1	tight junction protein 1	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20150825	CTD	MESH:C011559	Acetylcysteine inhibits the reaction [tributyltin results in decreased expression of TJP1 protein]	PMID:26079211
1314849	TJP1	tight junction protein 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20200519	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of TJP1 protein	PMID:31697926
1314849	TJP1	tight junction protein 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20200519	CTD	MESH:D002251	ginkgolide A inhibits the reaction [Carbon Tetrachloride results in decreased expression of TJP1 protein]	PMID:31697926
1314849	TJP1	tight junction protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20121113	CTD	MESH:D005492	[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of TJP1 mRNA; CYBB mutant form inhibits the reaction [[Folic Acid deficiency results in increased abundance of Homocysteine] which results in decreased expression of TJP1 mRNA]; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of TJP1 mRNA]	PMID:21647593|PMID:22206623
1314849	TJP1	tight junction protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D001151	[Palmitic Acid co-treated with Arsenic] affects the expression of TJP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein; ferulic acid inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein]	PMID:33736254|PMID:38881217
1314849	TJP1	tight junction protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250506	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein; Curcumin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein]; ferulic acid inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein]	PMID:38881217|PMID:39750044
1314849	TJP1	tight junction protein 1	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of TJP1 protein; Selenium results in increased expression of and results in increased localization of TJP1 protein	PMID:16514648
1314849	TJP1	tight junction protein 1	gene	CHEBI:27641	cycloheximide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide results in decreased expression of TJP1 protein	PMID:16087364
1314849	TJP1	tight junction protein 1	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [IFNG protein results in increased expression of TJP1 protein]	PMID:16087364
1314849	TJP1	tight junction protein 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of TJP1 protein	PMID:35688186
1314849	TJP1	tight junction protein 1	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of TJP1 mRNA; Glyphosate results in decreased expression of TJP1 protein	PMID:34906888
1314849	TJP1	tight junction protein 1	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20260113	CTD	MESH:C010974	Glyphosate results in decreased expression of TJP1 protein	PMID:40254291
1314849	TJP1	tight junction protein 1	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20240206	CTD	MESH:C010974	Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of TJP1 protein]; NOX1 protein affects the reaction [Glyphosate results in decreased expression of TJP1 protein]	PMID:34906888
1314849	TJP1	tight junction protein 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20190910	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TJP1 protein	PMID:30081051
1314849	TJP1	tight junction protein 1	gene	CHEBI:27789	1,2-dichloroethane	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20190507	CTD	MESH:C024565	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [ethylene dichloride results in decreased expression of TJP1 protein]; [ethylene dichloride co-treated with Ethanol] results in decreased expression of TJP1 mRNA; [ethylene dichloride co-treated with Ethanol] results in decreased expression of TJP1 protein	PMID:30081051|PMID:30664321
1314849	TJP1	tight junction protein 1	gene	CHEBI:2781	apocynin	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:C056165	acetovanillone inhibits the reaction [2,2',4,6,6'-pentachlorobiphenyl results in decreased expression of TJP1 protein]; acetovanillone inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in decreased expression of TJP1 protein]; acetovanillone inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of TJP1 protein]; acetovanillone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 protein]	PMID:20299304
1314849	TJP1	tight junction protein 1	gene	CHEBI:2781	apocynin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20121113	CTD	MESH:C056165	acetovanillone inhibits the reaction [Homocysteine results in decreased expression of TJP1 protein]	PMID:21647593
1314849	TJP1	tight junction protein 1	gene	CHEBI:27812	Se-methyl-L-selenocysteine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250603	CTD	MESH:C002979	selenomethylselenocysteine inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of TJP1 protein]; selenomethylselenocysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein]	PMID:39360521
1314849	TJP1	tight junction protein 1	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20160822	CTD	MESH:C059514	Resveratrol inhibits the reaction [Aluminum Chloride results in decreased expression of TJP1 mRNA]; Resveratrol inhibits the reaction [Aluminum Chloride results in decreased expression of TJP1 protein]; Resveratrol inhibits the reaction [HMGB1 protein results in decreased expression of TJP1 protein]	PMID:25979658|PMID:34614429|PMID:35156769
1314849	TJP1	tight junction protein 1	gene	CHEBI:27882	(S)-colchicine	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20210706	CTD	MESH:D003078	Colchicine results in decreased expression of TJP1 mRNA	PMID:33002524
1314849	TJP1	tight junction protein 1	gene	CHEBI:27889	lead(0)	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20140513	CTD	MESH:D007854	Lead results in decreased expression of TJP1 protein	PMID:20970449|PMID:24431214
1314849	TJP1	tight junction protein 1	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20121009	CTD	MESH:D007854	[malaoxon co-treated with Lead] results in decreased expression of TJP1 protein; [Malathion co-treated with Lead] results in decreased expression of TJP1 protein	PMID:20970449
1314849	TJP1	tight junction protein 1	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20200804	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of TJP1 protein	PMID:31730887
1314849	TJP1	tight junction protein 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20240702	CTD	MESH:D002945	Cisplatin results in decreased expression of TJP1 protein	PMID:38490643
1314849	TJP1	tight junction protein 1	gene	CHEBI:27899	cisplatin	decreases localization	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased localization of TJP1 protein	PMID:21745194
1314849	TJP1	tight junction protein 1	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:127284886|PMID:32106377	20210615	RGD	MESH:D002945	cisplatin increases expression of TJP1 protein in stomach	
1314849	TJP1	tight junction protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of TJP1 mRNA	PMID:27392435
1314849	TJP1	tight junction protein 1	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D002945	8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate inhibits the reaction [Cisplatin results in decreased localization of TJP1 protein]; Quercetin inhibits the reaction [Cisplatin results in decreased expression of TJP1 protein]; RAPGEF3 mutant form inhibits the reaction [8-(4-chloro-phenylthio)-2'-O-methyladenosine-3'-5'-cyclic monophosphate inhibits the reaction [Cisplatin results in decreased localization of TJP1 protein]]	PMID:21745194|PMID:38490643
1314849	TJP1	tight junction protein 1	gene	CHEBI:28001	vancomycin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20221004	CTD	MESH:D014640	[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 protein]	PMID:35390362
1314849	TJP1	tight junction protein 1	gene	CHEBI:28061	alpha-D-galactose	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20210504	CTD	MESH:D005690	Galactose results in decreased expression of TJP1 protein	PMID:33516661
1314849	TJP1	tight junction protein 1	gene	CHEBI:28061	alpha-D-galactose	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20210504	CTD	MESH:D005690	Ethanol promotes the reaction [Galactose results in decreased expression of TJP1 protein]	PMID:33516661
1314849	TJP1	tight junction protein 1	gene	CHEBI:28077	rifampicin	affects localization	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D012293	Rifampin affects the localization of TJP1 protein	PMID:19577586
1314849	TJP1	tight junction protein 1	gene	CHEBI:28077	rifampicin	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D012293	Rifampin results in decreased expression of TJP1 mRNA	PMID:19577586
1314849	TJP1	tight junction protein 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of TJP1 mRNA	PMID:12075121
1314849	TJP1	tight junction protein 1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20250204	CTD	MESH:D019833	Genistein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TJP1 mRNA]	PMID:26316063
1314849	TJP1	tight junction protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306305	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TJP1 mRNA	PMID:34747641
1314849	TJP1	tight junction protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314850	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TJP1 mRNA	PMID:21570461
1314849	TJP1	tight junction protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TJP1 mRNA; Tetrachlorodibenzodioxin results in decreased expression of TJP1 protein	PMID:26582458|PMID:33387578
1314849	TJP1	tight junction protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TJP1 mRNA	PMID:23152189
1314849	TJP1	tight junction protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20160210	CTD	MESH:D013749	GDNF protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of TJP1 protein]	PMID:26582458
1314849	TJP1	tight junction protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of TJP1 mRNA	PMID:17942748
1314849	TJP1	tight junction protein 1	gene	CHEBI:28201	rotenone	affects localization	EXP		E	RGD:6480464	20150310	CTD	MESH:D012402	Rotenone affects the localization of TJP1 protein	PMID:23668856
1314849	TJP1	tight junction protein 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in decreased expression of TJP1 protein	PMID:35544339
1314849	TJP1	tight junction protein 1	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D012402	Quercetin inhibits the reaction [Rotenone affects the localization of TJP1 protein]; Rotenone inhibits the reaction [Particulate Matter results in decreased expression of TJP1 mRNA]; Rotenone inhibits the reaction [Particulate Matter results in decreased expression of TJP1 protein]	PMID:23668856|PMID:28724416
1314849	TJP1	tight junction protein 1	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250603	CTD	MESH:D012402	Rotenone promotes the reaction [Glucose results in decreased expression of TJP1 protein]	PMID:39922521
1314849	TJP1	tight junction protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20211012	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TJP1 mRNA	PMID:34062221
1314849	TJP1	tight junction protein 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20250603	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TJP1 mRNA; methylmercuric chloride results in decreased expression of TJP1 protein	PMID:39921560
1314849	TJP1	tight junction protein 1	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20211012	CTD	MESH:C004925	Bee Venoms inhibits the reaction [methylmercuric chloride results in decreased expression of TJP1 mRNA]	PMID:34062221
1314849	TJP1	tight junction protein 1	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250603	CTD	MESH:C004925	[methylmercuric chloride co-treated with Dietary Fats] results in decreased expression of TJP1 protein; methylmercuric chloride promotes the reaction [Dietary Fats results in decreased expression of TJP1 mRNA]; methylmercuric chloride promotes the reaction [Dietary Fats results in decreased expression of TJP1 protein]	PMID:39921560
1314849	TJP1	tight junction protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TJP1 mRNA	PMID:33212167
1314849	TJP1	tight junction protein 1	gene	CHEBI:28260	galactose	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20210504	CTD	MESH:D005690	Galactose results in decreased expression of TJP1 protein	PMID:33516661
1314849	TJP1	tight junction protein 1	gene	CHEBI:28260	galactose	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20210504	CTD	MESH:D005690	Ethanol promotes the reaction [Galactose results in decreased expression of TJP1 protein]	PMID:33516661
1314849	TJP1	tight junction protein 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TJP1 mRNA	PMID:18661270
1314849	TJP1	tight junction protein 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TJP1 mRNA	PMID:30851411
1314849	TJP1	tight junction protein 1	gene	CHEBI:28488	m-xylene	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20260505	CTD	MESH:C031285	[Hydrocarbons, Chlorinated co-treated with Benzothiepins co-treated with 3-xylene analog] results in decreased expression of TJP1 protein	PMID:40619073
1314849	TJP1	tight junction protein 1	gene	CHEBI:28498	acadesine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20210706	CTD	MESH:C011651	acadesine inhibits the reaction [SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]]; acadesine promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]	PMID:33400020
1314849	TJP1	tight junction protein 1	gene	CHEBI:28499	kaempferol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C006552	kaempferol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of TJP1 protein]	PMID:38823539
1314849	TJP1	tight junction protein 1	gene	CHEBI:28499	kaempferol	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20230404	CTD	MESH:C006552	[kaempferol inhibits the reaction [Lipopolysaccharides co-treated with TNF protein]] which results in decreased expression of TJP1 protein	PMID:36049518
1314849	TJP1	tight junction protein 1	gene	CHEBI:28499	kaempferol	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20200519	CTD	MESH:C006552	kaempferol inhibits the reaction [Ethanol results in decreased expression of TJP1 protein]; kaempferol inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of TJP1 protein]	PMID:31785310|PMID:38823539
1314849	TJP1	tight junction protein 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20140408	CTD	MESH:D020106	Acrylamide results in decreased expression of TJP1 mRNA; Acrylamide results in decreased expression of TJP1 protein	PMID:22801078
1314849	TJP1	tight junction protein 1	gene	CHEBI:28661	gamma-linolenic acid	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D017965	[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of TJP1 protein	PMID:16514648
1314849	TJP1	tight junction protein 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306305	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TJP1 mRNA	PMID:30556269
1314849	TJP1	tight junction protein 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1314850	E	RGD:6480464	20130910	CTD	MESH:D003300	Copper results in increased expression of TJP1 mRNA	PMID:16629173
1314849	TJP1	tight junction protein 1	gene	CHEBI:28741	sodium fluoride	affects localization	ISO	RGD:1314850	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride affects the localization of TJP1 protein	PMID:27548804
1314849	TJP1	tight junction protein 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20161025	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of TJP1 mRNA	PMID:27237588
1314849	TJP1	tight junction protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TJP1 mRNA	PMID:29803840
1314849	TJP1	tight junction protein 1	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of TJP1 protein	PMID:35688186
1314849	TJP1	tight junction protein 1	gene	CHEBI:28854	2,4-D	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20190219	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid results in decreased expression of TJP1 mRNA; 2,4-Dichlorophenoxyacetic Acid results in decreased expression of TJP1 protein	PMID:28699141
1314849	TJP1	tight junction protein 1	gene	CHEBI:28869	menadione	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D024483	Vitamin K 3 results in increased expression of TJP1 protein	PMID:31238027
1314849	TJP1	tight junction protein 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20200211	CTD	MESH:D000111	[Acetylcysteine co-treated with ginsenoside Rg3] inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Acetylcysteine inhibits the reaction [Particulate Matter results in decreased expression of TJP1 protein]	PMID:29235125|PMID:32687961|PMID:39579577
1314849	TJP1	tight junction protein 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20150825	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of TJP1 protein]; Acetylcysteine inhibits the reaction [tributyltin results in decreased expression of TJP1 protein]	PMID:26079211|PMID:34906888
1314849	TJP1	tight junction protein 1	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20180220	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of TJP1 mRNA]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP1 protein]	PMID:27783111|PMID:33485121|PMID:37598416
1314849	TJP1	tight junction protein 1	gene	CHEBI:28940	calciol	increases expression	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in increased expression of TJP1 mRNA	PMID:16508948
1314849	TJP1	tight junction protein 1	gene	CHEBI:28955	2-methoxy-17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C022830	2-Methoxyestradiol inhibits the reaction [Glucose results in decreased expression of TJP1 protein]	PMID:21617913
1314849	TJP1	tight junction protein 1	gene	CHEBI:28971	ampicillin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20221004	CTD	MESH:D000667	[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 protein]	PMID:35390362
1314849	TJP1	tight junction protein 1	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20190409	CTD	MESH:D001205	[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein]	PMID:29940330
1314849	TJP1	tight junction protein 1	gene	CHEBI:29320	calcium(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002118	Calcium deficiency inhibits the reaction [TJP1 protein binds to OCLN protein]	PMID:11054866
1314849	TJP1	tight junction protein 1	gene	CHEBI:29365	phosgene	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20150714	CTD	MESH:D010705	Phosgene results in decreased expression of TJP1 mRNA	PMID:25870319
1314849	TJP1	tight junction protein 1	gene	CHEBI:29365	phosgene	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20150714	CTD	MESH:D010705	N-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [Phosgene results in decreased expression of TJP1 mRNA]	PMID:25870319
1314849	TJP1	tight junction protein 1	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of TJP1 protein	PMID:34032870
1314849	TJP1	tight junction protein 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of TJP1 mRNA; sodium arsenite results in decreased expression of TJP1 protein	PMID:34032870|PMID:38228842
1314849	TJP1	tight junction protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TJP1 mRNA	PMID:38568856
1314849	TJP1	tight junction protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein; ferulic acid inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein]; sodium arsenite promotes the reaction [TJP1 protein binds to CAPRIN1 protein]	PMID:33939924|PMID:38881217
1314849	TJP1	tight junction protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240430	CTD	MESH:C017947	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide promotes the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein]]; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein; Curcumin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein]; ferulic acid inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]; sodium arsenite promotes the reaction [deoxynivalenol results in decreased expression of TJP1 protein]	PMID:35381244|PMID:38881217|PMID:39750044
1314849	TJP1	tight junction protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TJP1 mRNA; Benzo(a)pyrene results in increased expression of TJP1 protein	PMID:26238291|PMID:26657896
1314849	TJP1	tight junction protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314850	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TJP1 mRNA	PMID:22228805|PMID:33429317
1314849	TJP1	tight junction protein 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of TJP1 mRNA]	PMID:22228805
1314849	TJP1	tight junction protein 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20231205	CTD	MESH:C015001	arsenite results in decreased expression of TJP1 mRNA; arsenite results in decreased expression of TJP1 protein	PMID:37442281
1314849	TJP1	tight junction protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TJP1 mRNA]	PMID:32406909
1314849	TJP1	tight junction protein 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306305	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of TJP1 mRNA	PMID:30556269
1314849	TJP1	tight junction protein 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1314850	E	RGD:6480464	20130910	CTD	MESH:D003300	Copper results in increased expression of TJP1 mRNA	PMID:16629173
1314849	TJP1	tight junction protein 1	gene	CHEBI:30145	lithium atom	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium results in decreased expression of TJP1 protein	PMID:17533168
1314849	TJP1	tight junction protein 1	gene	CHEBI:30146	lithium hydride	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium results in decreased expression of TJP1 protein	PMID:17533168
1314849	TJP1	tight junction protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TJP1 protein	PMID:35288261|PMID:40049282
1314849	TJP1	tight junction protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20250506	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TJP1 protein	PMID:38491797
1314849	TJP1	tight junction protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20250603	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of TJP1 mRNA	PMID:39800143
1314849	TJP1	tight junction protein 1	gene	CHEBI:30563	silicon dioxide	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D012822	A-485 compound inhibits the reaction [Silicon Dioxide results in decreased expression of TJP1 protein]; BMI1 protein inhibits the reaction [Silicon Dioxide results in decreased expression of TJP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Silicon Dioxide results in decreased expression of TJP1 protein]; Oxamic Acid inhibits the reaction [Silicon Dioxide results in decreased expression of TJP1 protein]	PMID:35288261|PMID:40049282
1314849	TJP1	tight junction protein 1	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20250506	CTD	MESH:D012822	MIR204 inhibits the reaction [Silicon Dioxide results in decreased expression of TJP1 protein]; MIR204 promotes the reaction [TGFBR1 protein promotes the reaction [Silicon Dioxide results in decreased expression of TJP1 protein]]; TGFBR1 protein promotes the reaction [Silicon Dioxide results in decreased expression of TJP1 protein]	PMID:38491797
1314849	TJP1	tight junction protein 1	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250603	CTD	MESH:D012822	AGER protein affects the reaction [Silicon Dioxide results in decreased expression of TJP1 mRNA]; Glycyrrhizic Acid inhibits the reaction [Silicon Dioxide results in decreased expression of TJP1 mRNA]	PMID:39800143
1314849	TJP1	tight junction protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TJP1 mRNA	PMID:19150397
1314849	TJP1	tight junction protein 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TJP1 mRNA	PMID:26238291
1314849	TJP1	tight junction protein 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TJP1 mRNA; Arsenic Trioxide results in decreased expression of TJP1 protein	PMID:30032600|PMID:30225639|PMID:32683294
1314849	TJP1	tight junction protein 1	gene	CHEBI:30742	ethylene glycol	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20231003	CTD	MESH:D019855	Ethylene Glycol results in decreased expression of TJP1 mRNA	PMID:37244400
1314849	TJP1	tight junction protein 1	gene	CHEBI:30772	butyric acid	increases expression	ISO	RGD:1306305	E	RGD:6480464	20240806	CTD	MESH:D020148	Butyric Acid results in increased expression of TJP1 mRNA; Butyric Acid results in increased expression of TJP1 protein	PMID:15634758
1314849	TJP1	tight junction protein 1	gene	CHEBI:30805	dodecanoic acid	increases expression	ISO	RGD:1314850	E	RGD:6480464	20211207	CTD	MESH:C030358	lauric acid results in increased expression of TJP1 protein	PMID:34506767
1314849	TJP1	tight junction protein 1	gene	CHEBI:30805	dodecanoic acid	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20211207	CTD	MESH:C030358	lauric acid inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 protein]	PMID:34506767
1314849	TJP1	tight junction protein 1	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in decreased expression of TJP1 protein	PMID:24200059
1314849	TJP1	tight junction protein 1	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:C008261	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of TJP1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of TJP1 protein]	PMID:24200059
1314849	TJP1	tight junction protein 1	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20200804	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of TJP1 protein	PMID:31730887
1314849	TJP1	tight junction protein 1	gene	CHEBI:31882	N-methyl-D-aspartic acid	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:D016202	N-Methylaspartate results in decreased expression of TJP1 mRNA; N-Methylaspartate results in decreased expression of TJP1 protein	PMID:35257817
1314849	TJP1	tight junction protein 1	gene	CHEBI:31882	N-methyl-D-aspartic acid	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:D016202	CAV1 protein affects the reaction [N-Methylaspartate results in decreased expression of TJP1 mRNA]; CAV1 protein affects the reaction [N-Methylaspartate results in decreased expression of TJP1 protein]; Dizocilpine Maleate inhibits the reaction [N-Methylaspartate results in decreased expression of TJP1 mRNA]; Dizocilpine Maleate inhibits the reaction [N-Methylaspartate results in decreased expression of TJP1 protein]; U 0126 inhibits the reaction [N-Methylaspartate results in decreased expression of TJP1 mRNA]; U 0126 inhibits the reaction [N-Methylaspartate results in decreased expression of TJP1 protein]	PMID:35257817
1314849	TJP1	tight junction protein 1	gene	CHEBI:31932	Olmesartan medoxomil	affects localization	EXP		E	RGD:6480464	20220510	CTD	MESH:D000068557	Olmesartan Medoxomil affects the localization of TJP1 protein	PMID:26423313
1314849	TJP1	tight junction protein 1	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1306305	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of TJP1 mRNA	PMID:25729387
1314849	TJP1	tight junction protein 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] affects the expression of TJP1 mRNA	PMID:25729387
1314849	TJP1	tight junction protein 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of TJP1 mRNA	PMID:23557971
1314849	TJP1	tight junction protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314850	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TJP1 gene	PMID:35295148
1314849	TJP1	tight junction protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314850	E	RGD:6480464	20200804	CTD	MESH:C009495	titanium dioxide results in increased expression of TJP1 mRNA	PMID:32333507
1314849	TJP1	tight junction protein 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide results in increased expression of TJP1 mRNA; Thioacetamide results in increased expression of TJP1 protein	PMID:15350541|PMID:23411599
1314849	TJP1	tight junction protein 1	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20240604	CTD	MESH:D013853	[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 mRNA; [Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 protein; Lactulose inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 mRNA]; Lactulose inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 protein]; qingdu inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 mRNA]; qingdu inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 protein]	PMID:36414212
1314849	TJP1	tight junction protein 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of TJP1 mRNA	PMID:18445702
1314849	TJP1	tight junction protein 1	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of TJP1 mRNA	PMID:12419474
1314849	TJP1	tight junction protein 1	gene	CHEBI:32888	gamma-hexachlorocyclohexane	affects localization	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D001556	Hexachlorocyclohexane affects the localization of TJP1 protein	PMID:15194225
1314849	TJP1	tight junction protein 1	gene	CHEBI:32888	gamma-hexachlorocyclohexane	affects localization	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D001556	Hexachlorocyclohexane affects the localization of TJP1 protein	PMID:11532877
1314849	TJP1	tight junction protein 1	gene	CHEBI:32888	gamma-hexachlorocyclohexane	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D001556	Hexachlorocyclohexane results in decreased expression of TJP1 protein	PMID:11532877
1314849	TJP1	tight junction protein 1	gene	CHEBI:32888	gamma-hexachlorocyclohexane	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D001556	Hexachlorocyclohexane promotes the reaction [GJA1 protein binds to TJP1 protein]	PMID:15194225
1314849	TJP1	tight junction protein 1	gene	CHEBI:33130	aluminium hydroxide	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20260303	CTD	MESH:D000536	[Ovalbumin co-treated with Aluminum Hydroxide] results in decreased expression of TJP1 protein; arctigenin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in decreased expression of TJP1 protein]; BIRC3 protein affects the reaction [KLF5 protein inhibits the reaction [arctigenin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in decreased expression of TJP1 protein]]]; Dexamethasone inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in decreased expression of TJP1 protein]; KLF5 protein inhibits the reaction [arctigenin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in decreased expression of TJP1 protein]]	PMID:40803538
1314849	TJP1	tight junction protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306305	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TJP1 mRNA	PMID:25181051
1314849	TJP1	tight junction protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of TJP1 mRNA; bisphenol A results in decreased expression of TJP1 protein	PMID:26363213|PMID:26922907|PMID:31675489
1314849	TJP1	tight junction protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of TJP1 mRNA; bisphenol A results in decreased expression of TJP1 protein	PMID:12075121|PMID:19497385|PMID:32145629|PMID:38750585
1314849	TJP1	tight junction protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of TJP1 mRNA; bisphenol A results in decreased expression of TJP1 protein	PMID:31394344|PMID:32540565|PMID:33221593|PMID:33485121|PMID:34082316|PMID:35278557|PMID:40349747
1314849	TJP1	tight junction protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C006780	bisphenol A results in increased expression of TJP1 protein	PMID:32559890|PMID:37567409
1314849	TJP1	tight junction protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306305	E	RGD:6480464	20120717	CTD	MESH:C006780	bisphenol A results in increased expression of TJP1 protein	PMID:19782717
1314849	TJP1	tight junction protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314850	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of TJP1 mRNA; bisphenol A results in increased expression of TJP1 protein	PMID:26063408|PMID:33802611
1314849	TJP1	tight junction protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of and affects the localization of TJP1 protein	PMID:24532171
1314849	TJP1	tight junction protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20161025	CTD	MESH:C006780	[Estradiol co-treated with bisphenol A] results in decreased expression of TJP1 mRNA	PMID:27174447
1314849	TJP1	tight junction protein 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20220208	CTD	MESH:C006780	4-methyl-N1-(3-phenylpropyl)benzene-1,2-diamine inhibits the reaction [bisphenol A results in decreased expression of TJP1 mRNA]; [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of TJP1 protein; Acetylcysteine inhibits the reaction [bisphenol A results in decreased expression of TJP1 mRNA]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [bisphenol A results in decreased expression of TJP1 mRNA]	PMID:33485121|PMID:37364641
1314849	TJP1	tight junction protein 1	gene	CHEBI:33234	vitamin E	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20161228	CTD	MESH:D024502	[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of TJP1 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of TJP1 protein]	PMID:20722969|PMID:29940330
1314849	TJP1	tight junction protein 1	gene	CHEBI:338412	(-)-anisomycin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20241203	CTD	MESH:D000841	Anisomycin inhibits the reaction [TES protein inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of TJP1 protein]]	PMID:39237074
1314849	TJP1	tight junction protein 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of TJP1 mRNA	PMID:24752500
1314849	TJP1	tight junction protein 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of TJP1 protein	PMID:20299304
1314849	TJP1	tight junction protein 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120515	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of TJP1 protein	PMID:20299304
1314849	TJP1	tight junction protein 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1314850	E	RGD:6480464	20120515	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of TJP1 protein	PMID:20064788
1314849	TJP1	tight junction protein 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:C014024	acetovanillone inhibits the reaction [2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of TJP1 protein]	PMID:20299304
1314849	TJP1	tight junction protein 1	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20120515	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [TJP1 protein binds to OCLN protein]	PMID:20064788
1314849	TJP1	tight junction protein 1	gene	CHEBI:34283	oxybenzone	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20250311	CTD	MESH:C005290	oxybenzone results in decreased expression of TJP1 mRNA; oxybenzone results in decreased expression of TJP1 protein	PMID:39343157
1314849	TJP1	tight junction protein 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 protein	PMID:20299304
1314849	TJP1	tight junction protein 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20240109	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 mRNA; 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 protein	PMID:37598416
1314849	TJP1	tight junction protein 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:C023035	acetovanillone inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 protein]	PMID:20299304
1314849	TJP1	tight junction protein 1	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20120515	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [TJP1 protein binds to OCLN protein]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 mRNA]; Acetylcysteine inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 protein]; Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 mRNA]; Melatonin inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of TJP1 protein]	PMID:20064788|PMID:37598416
1314849	TJP1	tight junction protein 1	gene	CHEBI:3435	carrageenan	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D002351	3-(4-methylphenylsulfonyl)-2-propenenitrile promotes the reaction [Carrageenan results in decreased expression of and affects the localization of TJP1 protein]; Carrageenan results in decreased expression of and affects the localization of TJP1 protein; EGR1 protein inhibits the reaction [Carrageenan results in decreased expression of and affects the localization of TJP1 protein]	PMID:22561171
1314849	TJP1	tight junction protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in decreased expression of TJP1 protein	PMID:34979203
1314849	TJP1	tight junction protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TJP1 mRNA	PMID:39298647
1314849	TJP1	tight junction protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of TJP1 protein	PMID:40086502|PMID:40669749
1314849	TJP1	tight junction protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C543008	SLC4A2 protein affects the reaction [bisphenol S results in increased expression of TJP1 protein]; WNT5A protein affects the reaction [bisphenol S results in increased expression of TJP1 protein]	PMID:40086502|PMID:40669749
1314849	TJP1	tight junction protein 1	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of TJP1 intron	PMID:30157460
1314849	TJP1	tight junction protein 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20230404	CTD	MESH:C008745	bisphenol F results in decreased expression of TJP1 mRNA	PMID:35278557
1314849	TJP1	tight junction protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol F co-treated with Lipopolysaccharides] results in decreased expression of TJP1 mRNA; [bisphenol F co-treated with Lipopolysaccharides] results in decreased expression of TJP1 protein	PMID:34774955
1314849	TJP1	tight junction protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20250708	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of TJP1 mRNA; butylbenzyl phthalate results in decreased expression of TJP1 protein	PMID:28392331|PMID:39921026
1314849	TJP1	tight junction protein 1	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240402	CTD	MESH:C027561	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of TJP1 protein; CP protein inhibits the reaction [butylbenzyl phthalate results in decreased expression of TJP1 protein]; Deferoxamine inhibits the reaction [butylbenzyl phthalate results in decreased expression of TJP1 protein]; ferrostatin-1 inhibits the reaction [butylbenzyl phthalate results in decreased expression of TJP1 protein]	PMID:37364641|PMID:39921026
1314849	TJP1	tight junction protein 1	gene	CHEBI:34631	chlorpyrifos	affects expression	ISO	RGD:1306305	E	RGD:6480464	20141014	CTD	MESH:D004390	Chlorpyrifos affects the expression of TJP1 mRNA	PMID:22611033
1314849	TJP1	tight junction protein 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20160705	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TJP1 mRNA	PMID:25019507
1314849	TJP1	tight junction protein 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of TJP1 mRNA; Chlorpyrifos results in decreased expression of TJP1 protein	PMID:37019170|PMID:40158758
1314849	TJP1	tight junction protein 1	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20240604	CTD	MESH:D004390	[Chlorpyrifos co-treated with Dietary Fats] results in decreased expression of TJP1 mRNA	PMID:34075131
1314849	TJP1	tight junction protein 1	gene	CHEBI:34671	Deoxycorticosterone acetate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20170228	CTD	MESH:D064791	[Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with TJP1 protein]; CD38 gene mutant form promotes the reaction [[Desoxycorticosterone Acetate co-treated with Sodium Chloride] affects the localization of [NPHS2 protein co-treated with TJP1 protein]]	PMID:21992601
1314849	TJP1	tight junction protein 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20201215	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of TJP1 mRNA; Dextran Sulfate results in decreased expression of TJP1 protein	PMID:27995407|PMID:32711312|PMID:35670535|PMID:35894244|PMID:36281492|PMID:36539404|PMID:36577154|PMID:37209277|PMID:37385329|PMID:38648921|PMID:38663798|PMID:39719254|PMID:40311999|PMID:40354872|PMID:40400313
1314849	TJP1	tight junction protein 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20201215	CTD	MESH:D016264	[Cadmium co-treated with Dextran Sulfate] results in decreased expression of TJP1 mRNA; [Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TJP1 protein; biochanin A inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]; Cadmium promotes the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]; daphnetin inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]; fucoxanthin inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]; gamma-sitosterol inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 mRNA]; gamma-sitosterol inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]; HU 211 inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 mRNA]; isomaltulose inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 mRNA]; isomaltulose inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]; Mesalamine inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]; monocyte locomotion inhibitory factor inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 mRNA]; nitazoxanide inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]; nuciferine inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]; obeticholic acid promotes the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TJP1 protein]; theanine inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 mRNA]	PMID:27995407|PMID:32711312|PMID:35439472|PMID:35894244|PMID:36577154|PMID:37209277|PMID:38648921|PMID:38663798|PMID:39719254|PMID:40311999|PMID:40354872|PMID:40400313
1314849	TJP1	tight junction protein 1	gene	CHEBI:34679	Di-n-octyl phthalate	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20240305	CTD	MESH:C010715	di-n-octyl phthalate results in decreased expression of TJP1 mRNA	PMID:37810885
1314849	TJP1	tight junction protein 1	gene	CHEBI:34679	Di-n-octyl phthalate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240402	CTD	MESH:C010715	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of TJP1 protein	PMID:37364641
1314849	TJP1	tight junction protein 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20250311	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TJP1 mRNA; Dibutyl Phthalate results in decreased expression of TJP1 protein	PMID:39461407
1314849	TJP1	tight junction protein 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20250311	CTD	MESH:D003993	necrostatin-1 inhibits the reaction [Dibutyl Phthalate results in decreased expression of TJP1 protein]	PMID:39461407
1314849	TJP1	tight junction protein 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240402	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of TJP1 protein	PMID:37364641
1314849	TJP1	tight junction protein 1	gene	CHEBI:34696	dieldrin	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D004026	Dieldrin results in decreased expression of TJP1 protein	PMID:15082077
1314849	TJP1	tight junction protein 1	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240402	CTD	MESH:C007379	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of TJP1 protein	PMID:37364641
1314849	TJP1	tight junction protein 1	gene	CHEBI:34709	Diisodecyl phthalate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240402	CTD	MESH:C042080	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of TJP1 protein	PMID:37364641
1314849	TJP1	tight junction protein 1	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D010269	Paraquat results in decreased expression of TJP1 protein	PMID:26781174|PMID:30088170|PMID:30698896
1314849	TJP1	tight junction protein 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20170516	CTD	MESH:D010269	Paraquat results in decreased expression of TJP1 protein	PMID:25873302|PMID:26781174|PMID:30088170|PMID:30317802
1314849	TJP1	tight junction protein 1	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D010269	fasudil inhibits the reaction [Paraquat results in decreased expression of TJP1 protein]; HIF1A protein affects the reaction [Paraquat results in decreased expression of TJP1 protein]	PMID:26781174|PMID:30088170
1314849	TJP1	tight junction protein 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20170516	CTD	MESH:D010269	fasudil inhibits the reaction [Paraquat results in decreased expression of TJP1 protein]; HIF1A protein affects the reaction [Paraquat results in decreased expression of TJP1 protein]	PMID:26781174|PMID:30088170
1314849	TJP1	tight junction protein 1	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20230117	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of TJP1 mRNA	PMID:35752650
1314849	TJP1	tight junction protein 1	gene	CHEBI:351346	phenethyl isothiocyanate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240702	CTD	MESH:C058305	phenethyl isothiocyanate inhibits the reaction [Irinotecan results in decreased expression of TJP1 protein]	PMID:38341106
1314849	TJP1	tight junction protein 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20201006	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of TJP1 mRNA; 1-Naphthylisothiocyanate results in decreased expression of TJP1 protein	PMID:32579994|PMID:33400020
1314849	TJP1	tight junction protein 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20201006	CTD	MESH:D015058	acadesine inhibits the reaction [SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]]; acadesine promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]; dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]; dorsomorphin promotes the reaction [SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 mRNA]; SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]	PMID:32579994|PMID:33400020
1314849	TJP1	tight junction protein 1	gene	CHEBI:35456	cadmium dichloride	affects localization	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride affects the localization of TJP1 protein	PMID:24532171
1314849	TJP1	tight junction protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120814	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TJP1 protein	PMID:15618353
1314849	TJP1	tight junction protein 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20240903	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TJP1 protein	PMID:38401882
1314849	TJP1	tight junction protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TJP1 mRNA	PMID:25851441|PMID:25882684
1314849	TJP1	tight junction protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	[2-ethylhexyldiphenylphosphate co-treated with [Cadmium Chloride results in increased abundance of Cadmium]] affects the localization of TJP1 protein; bisindolylmaleimide I inhibits the reaction [Cadmium Chloride affects the localization of TJP1 protein]; Cadmium Chloride affects the localization of and results in decreased expression of TJP1 protein	PMID:25851441|PMID:39137464
1314849	TJP1	tight junction protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20120814	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 protein; Cadmium Chloride results in decreased expression of and affects the localization of TJP1 protein; Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 mRNA]; Chlorogenic Acid inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 protein]; doramapimod inhibits the reaction [Cadmium Chloride results in decreased expression of TJP1 protein]; N(6),N(6)-dimethyladenine promotes the reaction [Cadmium Chloride results in decreased expression of TJP1 protein]	PMID:15618353|PMID:31390532|PMID:36928142
1314849	TJP1	tight junction protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240903	CTD	MESH:D019256	6-formylindolo(3,2-b)carbazole inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 mRNA]; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 mRNA; Melatonin inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TJP1 mRNA]; neoisoliquiritin inhibits the reaction [Cadmium Chloride results in decreased expression of TJP1 protein]	PMID:38401882|PMID:38833985|PMID:39555739
1314849	TJP1	tight junction protein 1	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240402	CTD	MESH:C012125	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of TJP1 protein	PMID:37364641
1314849	TJP1	tight junction protein 1	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of TJP1 mRNA	PMID:40334771
1314849	TJP1	tight junction protein 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of TJP1 mRNA	PMID:19162173
1314849	TJP1	tight junction protein 1	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20230307	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of TJP1 protein	PMID:35066053
1314849	TJP1	tight junction protein 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C023036	[[Polyethylene Terephthalates results in increased abundance of Microplastics] which co-treated with perfluorooctanoic acid] results in decreased expression of TJP1 mRNA; [perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] affects the expression of TJP1 mRNA	PMID:40220582|PMID:40334771
1314849	TJP1	tight junction protein 1	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20200714	CTD	MESH:C039281	furan results in decreased expression of TJP1 protein	PMID:32251705
1314849	TJP1	tight junction protein 1	gene	CHEBI:35559	furan	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20200714	CTD	MESH:C039281	rhodioloside inhibits the reaction [furan results in decreased expression of TJP1 protein]	PMID:32251705
1314849	TJP1	tight junction protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20140513	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TJP1 protein	PMID:21617913
1314849	TJP1	tight junction protein 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of TJP1 mRNA	PMID:24449571
1314849	TJP1	tight junction protein 1	gene	CHEBI:36386	dichloroacetic acid	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250603	CTD	MESH:D003999	Dichloroacetic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Dichloroacetic Acid inhibits the reaction [Streptozocin results in decreased expression of TJP1 protein]	PMID:39922521
1314849	TJP1	tight junction protein 1	gene	CHEBI:3639	chlorothalonil	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C005806	tetrachloroisophthalonitrile results in decreased expression of TJP1 mRNA	PMID:34549778
1314849	TJP1	tight junction protein 1	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[gamma-Linolenic Acid co-treated with Iodine co-treated with Selenium] results in increased expression of and results in increased localization of TJP1 protein; Selenium results in increased expression of and results in increased localization of TJP1 protein	PMID:16514648
1314849	TJP1	tight junction protein 1	gene	CHEBI:37659	oleanolic acid	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20250506	CTD	MESH:D009828	Oleanolic Acid results in decreased expression of TJP1 protein	PMID:39030772
1314849	TJP1	tight junction protein 1	gene	CHEBI:37941	clopidogrel	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C055162	clopidogrel results in decreased expression of TJP1 protein	PMID:23220562
1314849	TJP1	tight junction protein 1	gene	CHEBI:37941	clopidogrel	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C055162	SB 203580 inhibits the reaction [clopidogrel results in decreased expression of TJP1 protein]	PMID:23220562
1314849	TJP1	tight junction protein 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of TJP1 mRNA	PMID:28302478
1314849	TJP1	tight junction protein 1	gene	CHEBI:38697	anthocyanin	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20170110	CTD	MESH:D000872	Anthocyanins inhibits the reaction [Cyclophosphamide results in decreased expression of TJP1 protein]	PMID:25451569
1314849	TJP1	tight junction protein 1	gene	CHEBI:3900	costunolide	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C002602	costunolide results in increased expression of TJP1 protein	PMID:37683593
1314849	TJP1	tight junction protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of TJP1 mRNA	PMID:40334771
1314849	TJP1	tight junction protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TJP1 protein	PMID:36106993
1314849	TJP1	tight junction protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TJP1 mRNA; perfluorooctane sulfonic acid results in decreased expression of TJP1 protein	PMID:19162173|PMID:28439067|PMID:28973641
1314849	TJP1	tight junction protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20131210	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TJP1 protein	PMID:23761298
1314849	TJP1	tight junction protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorobutanesulfonic acid co-treated with ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate] affects the expression of TJP1 mRNA	PMID:40334771
1314849	TJP1	tight junction protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20180116	CTD	MESH:C076994	AKT activator SC79 inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of TJP1 protein]; Carnitine inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of TJP1 protein]	PMID:28439067|PMID:28973641
1314849	TJP1	tight junction protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20131210	CTD	MESH:C076994	SB 203580 inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of TJP1 protein]	PMID:23761298
1314849	TJP1	tight junction protein 1	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20160119	CTD	MESH:D003474	Curcumin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein]; Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of and affects the localization of TJP1 protein]; Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of TJP1 mRNA]; Curcumin inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of TJP1 mRNA]; Curcumin inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of TJP1 protein]	PMID:26191140|PMID:35817260|PMID:39750044
1314849	TJP1	tight junction protein 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TJP1 mRNA	PMID:25979313
1314849	TJP1	tight junction protein 1	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1306305	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of TJP1 mRNA	PMID:29427782
1314849	TJP1	tight junction protein 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20200804	CTD	MESH:D014635	Valproic Acid results in decreased expression of TJP1 protein	PMID:32240654
1314849	TJP1	tight junction protein 1	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20150414	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of TJP1 protein	PMID:25451569
1314849	TJP1	tight junction protein 1	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20200714	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of TJP1 protein	PMID:32151603
1314849	TJP1	tight junction protein 1	gene	CHEBI:4027	cyclophosphamide	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20150414	CTD	MESH:D003520	Anthocyanins inhibits the reaction [Cyclophosphamide results in decreased expression of TJP1 protein]; Plant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of TJP1 protein]	PMID:25451569
1314849	TJP1	tight junction protein 1	gene	CHEBI:4027	cyclophosphamide	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20200714	CTD	MESH:D003520	Fungal Polysaccharides inhibits the reaction [Cyclophosphamide results in decreased expression of TJP1 protein]; Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of TJP1 protein]	PMID:32151603
1314849	TJP1	tight junction protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20120918	CTD	MESH:D016572	Cyclosporine results in decreased expression of TJP1 mRNA; Cyclosporine results in decreased expression of TJP1 protein	PMID:22155090|PMID:22416070
1314849	TJP1	tight junction protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TJP1 mRNA	PMID:20106945|PMID:25562108
1314849	TJP1	tight junction protein 1	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:D016572	Cyclosporine results in increased expression of and affects the localization of TJP1 protein	PMID:40024757
1314849	TJP1	tight junction protein 1	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TJP1 protein]	PMID:15744817
1314849	TJP1	tight junction protein 1	gene	CHEBI:4031	cyclosporin A	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20121009	CTD	MESH:D016572	N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [Cyclosporine results in decreased expression of TJP1 protein]; salubrinal inhibits the reaction [Cyclosporine results in decreased expression of TJP1 protein]	PMID:22155090
1314849	TJP1	tight junction protein 1	gene	CHEBI:4034	cyfluthrin	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C052570	cyfluthrin results in decreased expression of TJP1 mRNA	PMID:36167171
1314849	TJP1	tight junction protein 1	gene	CHEBI:40953	doramapimod	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20251104	CTD	MESH:C452139	doramapimod inhibits the reaction [Cadmium Chloride results in decreased expression of TJP1 protein]	PMID:36928142
1314849	TJP1	tight junction protein 1	gene	CHEBI:41072	3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:C070515	bisindolylmaleimide I inhibits the reaction [Cadmium Chloride affects the localization of TJP1 protein]; bisindolylmaleimide I inhibits the reaction [puag-haad results in increased expression of TJP1 mRNA]; bisindolylmaleimide I inhibits the reaction [puag-haad results in increased expression of TJP1 protein]	PMID:25851441|PMID:28780155
1314849	TJP1	tight junction protein 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of TJP1 mRNA	PMID:17555576
1314849	TJP1	tight junction protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D003907	Dexamethasone affects the reaction [IL1B protein affects the expression of TJP1 mRNA]	PMID:35405071
1314849	TJP1	tight junction protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20260303	CTD	MESH:D003907	Dexamethasone inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in decreased expression of TJP1 protein]	PMID:40803538
1314849	TJP1	tight junction protein 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of TJP1 protein	PMID:21617913|PMID:35445903|PMID:39579577
1314849	TJP1	tight junction protein 1	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20140513	CTD	MESH:D005947	Glucose results in decreased expression of TJP1 protein	PMID:21617913|PMID:27783111|PMID:39922521
1314849	TJP1	tight junction protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D005947	2-Methoxyestradiol inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; [Acetylcysteine co-treated with ginsenoside Rg3] inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; ML385 inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of TJP1 protein]]	PMID:21617913|PMID:39579577
1314849	TJP1	tight junction protein 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20180220	CTD	MESH:D005947	Acetylcysteine inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Dichloroacetic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Glycyrrhizic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; NLRP3 protein promotes the reaction [Glucose results in decreased expression of TJP1 protein]; Oxamic Acid inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; Rotenone promotes the reaction [Glucose results in decreased expression of TJP1 protein]	PMID:27783111|PMID:39922521
1314849	TJP1	tight junction protein 1	gene	CHEBI:42839	3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	affects localization	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D011692	Puromycin Aminonucleoside affects the localization of TJP1 protein	PMID:15798086
1314849	TJP1	tight junction protein 1	gene	CHEBI:42839	3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	increases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D011692	Puromycin Aminonucleoside results in increased expression of TJP1 protein	PMID:15744817
1314849	TJP1	tight junction protein 1	gene	CHEBI:42839	3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D011692	Cyclosporine inhibits the reaction [Puromycin Aminonucleoside results in increased expression of TJP1 protein]	PMID:15744817
1314849	TJP1	tight junction protein 1	gene	CHEBI:43385	5-(2-methylpiperazine-1-sulfonyl)isoquinoline	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D019307	1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]	PMID:16716901
1314849	TJP1	tight junction protein 1	gene	CHEBI:4356	desferrioxamine B	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D003676	Deferoxamine inhibits the reaction [Particulate Matter results in decreased expression of TJP1 protein]	PMID:39189708
1314849	TJP1	tight junction protein 1	gene	CHEBI:4356	desferrioxamine B	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250708	CTD	MESH:D003676	Deferoxamine inhibits the reaction [butylbenzyl phthalate results in decreased expression of TJP1 protein]	PMID:39921026
1314849	TJP1	tight junction protein 1	gene	CHEBI:43602	obeticholic acid	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20220906	CTD	MESH:C464660	obeticholic acid promotes the reaction [[Dietary Fats co-treated with Dextran Sulfate] results in increased expression of TJP1 protein]	PMID:35439472
1314849	TJP1	tight junction protein 1	gene	CHEBI:43871	fasudil	multiple interactions	EXP		E	RGD:6480464	20201103	CTD	MESH:C049347	fasudil inhibits the reaction [Paraquat results in decreased expression of TJP1 protein]	PMID:30088170
1314849	TJP1	tight junction protein 1	gene	CHEBI:43871	fasudil	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20201103	CTD	MESH:C049347	fasudil inhibits the reaction [Paraquat results in decreased expression of TJP1 protein]	PMID:30088170
1314849	TJP1	tight junction protein 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of TJP1 mRNA	PMID:21678067
1314849	TJP1	tight junction protein 1	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019319	Okadaic Acid results in decreased expression of TJP1 protein	PMID:30926360
1314849	TJP1	tight junction protein 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019319	Okadaic Acid results in increased expression of TJP1 mRNA	PMID:30926360
1314849	TJP1	tight junction protein 1	gene	CHEBI:45409	ritonavir	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20170303	CTD	MESH:D019438	Ritonavir results in decreased expression of TJP1 protein	PMID:20722969
1314849	TJP1	tight junction protein 1	gene	CHEBI:45409	ritonavir	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20170303	CTD	MESH:D019438	[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of TJP1 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of TJP1 protein]	PMID:20722969
1314849	TJP1	tight junction protein 1	gene	CHEBI:45716	vorinostat	increases expression	ISO	RGD:1306305	E	RGD:6480464	20240806	CTD	MESH:C111237	Vorinostat results in increased expression of TJP1 protein	PMID:15634758
1314849	TJP1	tight junction protein 1	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TJP1 mRNA	PMID:27188386
1314849	TJP1	tight junction protein 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in increased expression of TJP1 mRNA	PMID:18661270
1314849	TJP1	tight junction protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:C012589	[decitabine co-treated with trichostatin A] results in increased expression of TJP1 mRNA	PMID:17524140
1314849	TJP1	tight junction protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TJP1 mRNA	PMID:17562736
1314849	TJP1	tight junction protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TJP1 mRNA	PMID:33387578
1314849	TJP1	tight junction protein 1	gene	CHEBI:46548	zardaverine	decreases localization	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:C066436	zardaverine results in decreased localization of TJP1 protein	PMID:15082077
1314849	TJP1	tight junction protein 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TJP1 protein	PMID:22573546
1314849	TJP1	tight junction protein 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TJP1 mRNA	PMID:29279043
1314849	TJP1	tight junction protein 1	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of TJP1 mRNA	PMID:21148743
1314849	TJP1	tight junction protein 1	gene	CHEBI:46979	N-acetylsphingosine	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20231031	CTD	MESH:C064769	N-acetylsphingosine results in decreased expression of TJP1 mRNA; N-acetylsphingosine results in decreased expression of TJP1 protein	PMID:28052715
1314849	TJP1	tight junction protein 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20210810	CTD	MESH:D001151	[Palmitic Acid co-treated with Arsenic] affects the expression of TJP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein; ferulic acid inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein]	PMID:33736254|PMID:38881217
1314849	TJP1	tight junction protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250506	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein; Curcumin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein]; ferulic acid inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TJP1 protein]	PMID:38881217|PMID:39750044
1314849	TJP1	tight junction protein 1	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of TJP1 mRNA	PMID:24752500
1314849	TJP1	tight junction protein 1	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20230606	CTD	MESH:D007654	Ketoconazole results in decreased expression of TJP1 mRNA	PMID:37077353
1314849	TJP1	tight junction protein 1	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of TJP1 mRNA	PMID:31675489
1314849	TJP1	tight junction protein 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of TJP1 mRNA	PMID:29391264|PMID:31464424
1314849	TJP1	tight junction protein 1	gene	CHEBI:48347	triclocarban	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20221206	CTD	MESH:C009540	triclocarban results in decreased expression of TJP1 protein	PMID:35413382
1314849	TJP1	tight junction protein 1	gene	CHEBI:48607	lithium chloride	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20211012	CTD	MESH:D018021	Lithium Chloride results in decreased expression of TJP1 mRNA	PMID:33901603
1314849	TJP1	tight junction protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of TJP1 mRNA	PMID:17555576
1314849	TJP1	tight junction protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of TJP1 mRNA	PMID:12075121|PMID:15576828
1314849	TJP1	tight junction protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of TJP1 mRNA	PMID:17942748
1314849	TJP1	tight junction protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of TJP1 mRNA	PMID:17942748
1314849	TJP1	tight junction protein 1	gene	CHEBI:4910	etomidate	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20240702	CTD	MESH:D005045	Etomidate results in decreased expression of TJP1 protein	PMID:38604439
1314849	TJP1	tight junction protein 1	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:C029892	cupric chloride results in decreased expression of TJP1 mRNA	PMID:40913911
1314849	TJP1	tight junction protein 1	gene	CHEBI:49553	copper(II) chloride	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C029892	Matrines promotes the reaction [cupric chloride results in decreased expression of TJP1 mRNA]; osthol promotes the reaction [cupric chloride results in decreased expression of TJP1 mRNA]	PMID:40913911
1314849	TJP1	tight junction protein 1	gene	CHEBI:49662	indometacin	affects localization	EXP		E	RGD:6480464	20150310	CTD	MESH:D007213	Indomethacin affects the localization of TJP1 protein	PMID:23668856
1314849	TJP1	tight junction protein 1	gene	CHEBI:49662	indometacin	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D007213	Indomethacin results in decreased expression of TJP1 mRNA	PMID:23668856
1314849	TJP1	tight junction protein 1	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20210406	CTD	MESH:D007213	Indomethacin results in decreased expression of TJP1 mRNA; Indomethacin results in decreased expression of TJP1 protein	PMID:33276066
1314849	TJP1	tight junction protein 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D007213	Quercetin inhibits the reaction [Indomethacin affects the localization of TJP1 protein]; Quercetin inhibits the reaction [Indomethacin results in decreased expression of TJP1 mRNA]	PMID:23668856
1314849	TJP1	tight junction protein 1	gene	CHEBI:49662	indometacin	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20210406	CTD	MESH:D007213	myricetin inhibits the reaction [Indomethacin results in decreased expression of TJP1 mRNA]; myricetin inhibits the reaction [Indomethacin results in decreased expression of TJP1 protein]; Quercetin inhibits the reaction [Indomethacin results in decreased expression of TJP1 mRNA]; Quercetin inhibits the reaction [Indomethacin results in decreased expression of TJP1 protein]	PMID:33276066
1314849	TJP1	tight junction protein 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TJP1 mRNA; Arsenic Trioxide results in decreased expression of TJP1 protein	PMID:30032600|PMID:30225639|PMID:32683294
1314849	TJP1	tight junction protein 1	gene	CHEBI:50095	bucladesine	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D003994	Bucladesine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]	PMID:16716901
1314849	TJP1	tight junction protein 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1314850	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of TJP1 mRNA	PMID:17524140
1314849	TJP1	tight junction protein 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with trichostatin A] results in increased expression of TJP1 mRNA	PMID:17524140
1314849	TJP1	tight junction protein 1	gene	CHEBI:50692	mifepristone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of TJP1 mRNA	PMID:17584828
1314849	TJP1	tight junction protein 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of TJP1 mRNA	PMID:19162173
1314849	TJP1	tight junction protein 1	gene	CHEBI:50924	sorafenib	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20260203	CTD	MESH:C471405	Sorafenib results in decreased expression of TJP1 mRNA; Sorafenib results in decreased expression of TJP1 protein	PMID:40518001
1314849	TJP1	tight junction protein 1	gene	CHEBI:50924	sorafenib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C471405	sorafenib inhibits the reaction [TGFB1 protein results in decreased expression of TJP1 protein]	PMID:21360571
1314849	TJP1	tight junction protein 1	gene	CHEBI:5186	fucoxanthin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250708	CTD	MESH:C025164	fucoxanthin inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]	PMID:39719254
1314849	TJP1	tight junction protein 1	gene	CHEBI:51913	Goe 6976	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:C081021	Go 6976 inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]	PMID:16716901
1314849	TJP1	tight junction protein 1	gene	CHEBI:52289	wortmannin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin inhibits the reaction [telmisartan affects the localization of TJP1 protein]; wortmannin inhibits the reaction [telmisartan results in decreased expression of TJP1 mRNA]; wortmannin inhibits the reaction [telmisartan results in decreased expression of TJP1 protein]	PMID:19252288
1314849	TJP1	tight junction protein 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	EXP		E	RGD:6480464	20220705	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of TJP1 protein	PMID:34627954
1314849	TJP1	tight junction protein 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of TJP1 mRNA	PMID:19042947
1314849	TJP1	tight junction protein 1	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20220809	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein	PMID:35290143
1314849	TJP1	tight junction protein 1	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20140408	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 mRNA; Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein	PMID:22147983|PMID:22849695|PMID:39237074
1314849	TJP1	tight junction protein 1	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20220809	CTD	MESH:D014302	oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 mRNA]; oxymatrine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein]	PMID:35290143
1314849	TJP1	tight junction protein 1	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20140408	CTD	MESH:D014302	ginsenoside Re inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein]; TES protein inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein]	PMID:22849695|PMID:39237074
1314849	TJP1	tight junction protein 1	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20220809	CTD	MESH:D010081	[Dust co-treated with Oxazolone] results in decreased expression of TJP1 protein	PMID:33911793
1314849	TJP1	tight junction protein 1	gene	CHEBI:53227	poly(ethylene)	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20260113	CTD	MESH:D020959	[Polyethylene results in increased abundance of Microplastics] which results in decreased expression of TJP1 protein	PMID:40701262
1314849	TJP1	tight junction protein 1	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of TJP1 protein	PMID:37146930
1314849	TJP1	tight junction protein 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of TJP1 mRNA	PMID:23608068
1314849	TJP1	tight junction protein 1	gene	CHEBI:53444	potassium dichromate	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D011192	AKT activator SC79 inhibits the reaction [Potassium Dichromate results in decreased expression of TJP1 protein]; benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone inhibits the reaction [Potassium Dichromate results in decreased expression of TJP1 protein]	PMID:37146930
1314849	TJP1	tight junction protein 1	gene	CHEBI:5354	Ginkgoic acid	increases expression	EXP		E	RGD:127284886|PMID:32106377	20210615	RGD	MESH:C112485	Ginkgoic acid increases expression of TJP1 protein in stomach	
1314849	TJP1	tight junction protein 1	gene	CHEBI:5355	Ginkgolide A	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20200519	CTD	MESH:C477042	ginkgolide A inhibits the reaction [Carbon Tetrachloride results in decreased expression of TJP1 protein]	PMID:31697926
1314849	TJP1	tight junction protein 1	gene	CHEBI:5625	Harpagoside	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250902	CTD	MESH:C033249	harpagoside inhibits the reaction [AGT protein alternative form results in decreased expression of TJP1 protein]	PMID:34486189
1314849	TJP1	tight junction protein 1	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20180116	CTD	MESH:C082359	imidacloprid results in decreased expression of TJP1 mRNA	PMID:27792329
1314849	TJP1	tight junction protein 1	gene	CHEBI:60281	N(6),N(6)-dimethyladenine	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20120814	CTD	MESH:C001020	N(6),N(6)-dimethyladenine promotes the reaction [Cadmium Chloride results in decreased expression of TJP1 protein]	PMID:15618353
1314849	TJP1	tight junction protein 1	gene	CHEBI:60312	2-amino-2-deoxy-D-galactopyranose	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20240604	CTD	MESH:D005688	[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 mRNA; [Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 protein; Lactulose inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 mRNA]; Lactulose inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 protein]; qingdu inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 mRNA]; qingdu inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 protein]	PMID:36414212
1314849	TJP1	tight junction protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TJP1 protein	PMID:32959892
1314849	TJP1	tight junction protein 1	gene	CHEBI:61668	oroxylin A	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20201006	CTD	MESH:C080669	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one inhibits the reaction [endotoxin, Escherichia coli results in decreased expression of TJP1 protein]	PMID:32464219
1314849	TJP1	tight junction protein 1	gene	CHEBI:6359	lactulose	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20240604	CTD	MESH:D007792	Lactulose inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 mRNA]; Lactulose inhibits the reaction [[Thioacetamide co-treated with Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of TJP1 protein]	PMID:36414212
1314849	TJP1	tight junction protein 1	gene	CHEBI:63621	saquinavir	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D019258	Saquinavir results in decreased expression of TJP1 protein	PMID:20722969
1314849	TJP1	tight junction protein 1	gene	CHEBI:63621	saquinavir	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D019258	[Saquinavir co-treated with Nicotine co-treated with Ritonavir] results in decreased expression of TJP1 protein; [Saquinavir co-treated with Nicotine] results in decreased expression of TJP1 protein; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of TJP1 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of TJP1 protein]	PMID:20722969
1314849	TJP1	tight junction protein 1	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1306305	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of TJP1 mRNA	PMID:25729387
1314849	TJP1	tight junction protein 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] affects the expression of TJP1 mRNA	PMID:25729387
1314849	TJP1	tight junction protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TJP1 mRNA; Chlorodiphenyl (54% Chlorine) results in decreased expression of TJP1 protein	PMID:23650126
1314849	TJP1	tight junction protein 1	gene	CHEBI:64090	tert-butyl hydroperoxide	affects localization	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide affects the localization of TJP1 protein	PMID:16716901
1314849	TJP1	tight junction protein 1	gene	CHEBI:64090	tert-butyl hydroperoxide	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D020122	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Bucladesine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Go 6976 inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Staurosporine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]	PMID:16716901
1314849	TJP1	tight junction protein 1	gene	CHEBI:6432	levamisole	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20200714	CTD	MESH:D007978	Levamisole inhibits the reaction [Cyclophosphamide results in decreased expression of TJP1 protein]	PMID:32151603
1314849	TJP1	tight junction protein 1	gene	CHEBI:64983	alternariol	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C005197	[alternariol co-treated with altertoxin II] affects the reaction [IL1B protein affects the expression of TJP1 mRNA]; [alternariol co-treated with altertoxin II] affects the reaction [IL1B protein affects the expression of TJP1 protein]; [alternariol co-treated with altertoxin II] results in increased expression of TJP1 protein	PMID:35405071
1314849	TJP1	tight junction protein 1	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lead acetate results in decreased expression of TJP1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TGFB1 protein results in decreased expression of TJP1 protein]	PMID:24200059|PMID:30609689
1314849	TJP1	tight junction protein 1	gene	CHEBI:6541	losartan	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D019808	Losartan results in decreased expression of TJP1 protein	PMID:18400868
1314849	TJP1	tight junction protein 1	gene	CHEBI:6649	malaoxon	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20141111	CTD	MESH:C100082	malaoxon results in decreased expression of TJP1 protein	PMID:20970449
1314849	TJP1	tight junction protein 1	gene	CHEBI:6649	malaoxon	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20141111	CTD	MESH:C100082	[malaoxon co-treated with Lead] results in decreased expression of TJP1 protein	PMID:20970449
1314849	TJP1	tight junction protein 1	gene	CHEBI:6651	malathion	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20121009	CTD	MESH:D008294	Malathion results in decreased expression of TJP1 protein	PMID:20970449
1314849	TJP1	tight junction protein 1	gene	CHEBI:6651	malathion	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20121009	CTD	MESH:D008294	[Malathion co-treated with Lead] results in decreased expression of TJP1 protein	PMID:20970449
1314849	TJP1	tight junction protein 1	gene	CHEBI:67271	MK-2206	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C548887	MK 2206 inhibits the reaction [Particulate Matter results in decreased expression of TJP1 protein]	PMID:32687961
1314849	TJP1	tight junction protein 1	gene	CHEBI:6775	mesalamine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250708	CTD	MESH:D019804	Mesalamine inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]	PMID:39719254
1314849	TJP1	tight junction protein 1	gene	CHEBI:67991	(20S)-ginsenoside Rg3	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:C097367	[Acetylcysteine co-treated with ginsenoside Rg3] inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of TJP1 protein]; ML385 inhibits the reaction [ginsenoside Rg3 inhibits the reaction [Glucose results in decreased expression of TJP1 protein]]	PMID:39579577
1314849	TJP1	tight junction protein 1	gene	CHEBI:67991	(20S)-ginsenoside Rg3	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250506	CTD	MESH:C097367	ginsenoside Rg3 inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of TJP1 protein]	PMID:39579577
1314849	TJP1	tight junction protein 1	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20221004	CTD	MESH:D008694	Methamphetamine results in decreased expression of TJP1 mRNA; Methamphetamine results in decreased expression of TJP1 protein	PMID:35390362
1314849	TJP1	tight junction protein 1	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20221004	CTD	MESH:D008694	[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 protein]; TLR4 gene mutant form inhibits the reaction [Methamphetamine results in decreased expression of TJP1 mRNA]; TLR4 gene mutant form inhibits the reaction [Methamphetamine results in decreased expression of TJP1 protein]	PMID:35390362
1314849	TJP1	tight junction protein 1	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of TJP1 intron	PMID:30157460
1314849	TJP1	tight junction protein 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306305	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TJP1 gene	PMID:35440735
1314849	TJP1	tight junction protein 1	gene	CHEBI:6909	metronidazole	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20221004	CTD	MESH:D008795	[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 protein]	PMID:35390362
1314849	TJP1	tight junction protein 1	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20171114	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of TJP1 protein	PMID:27758031
1314849	TJP1	tight junction protein 1	gene	CHEBI:6925	microcystin-LR	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20150825	CTD	MESH:C057862	cyanoginosin LR results in decreased expression of TJP1 protein	PMID:25986756|PMID:34416350
1314849	TJP1	tight junction protein 1	gene	CHEBI:6925	microcystin-LR	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20220111	CTD	MESH:C057862	[cyanoginosin LR co-treated with LCN2 protein] results in decreased expression of TJP1 protein; [cyanoginosin LR co-treated with N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide] results in increased expression of TJP1 protein; [Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of TJP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [[cyanoginosin LR co-treated with LCN2 protein] results in decreased expression of TJP1 protein]; NLRP3 protein affects the reaction [[Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in decreased expression of TJP1 protein]]	PMID:34416350
1314849	TJP1	tight junction protein 1	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:D002185	Cannabidiol results in increased expression of TJP1 protein	PMID:32656944
1314849	TJP1	tight junction protein 1	gene	CHEBI:69832	osthole	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:C046627	osthol promotes the reaction [cupric chloride results in decreased expression of TJP1 mRNA]	PMID:40913911
1314849	TJP1	tight junction protein 1	gene	CHEBI:72544	flavonoids	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D005419	Flavonoids inhibits the reaction [Ethanol affects the localization of TJP1 protein]	PMID:28412402
1314849	TJP1	tight junction protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TJP1 protein	PMID:34186270
1314849	TJP1	tight junction protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TJP1 mRNA	PMID:22206623
1314849	TJP1	tight junction protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of TJP1 mRNA]	PMID:22206623
1314849	TJP1	tight junction protein 1	gene	CHEBI:747377	LDN-193189	increases expression	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	LDN 193189 results in increased expression of TJP1 protein	PMID:23243027
1314849	TJP1	tight junction protein 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TJP1 protein	PMID:37664457
1314849	TJP1	tight junction protein 1	gene	CHEBI:748837	glyceryl monostearate	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C048159	glyceryl monostearate results in decreased expression of TJP1 mRNA	PMID:38309685
1314849	TJP1	tight junction protein 1	gene	CHEBI:74926	patulin	decreases expression	EXP		E	RGD:6480464	20130806	CTD	MESH:D010365	Patulin results in decreased expression of TJP1 protein	PMID:19013514
1314849	TJP1	tight junction protein 1	gene	CHEBI:7507	neomycin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20221004	CTD	MESH:D009355	[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 protein]	PMID:35390362
1314849	TJP1	tight junction protein 1	gene	CHEBI:755912	aluminum chloride	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20260714	CTD	MESH:D000077410	Aluminum Chloride results in decreased expression of TJP1 mRNA; Aluminum Chloride results in decreased expression of TJP1 protein	PMID:34614429|PMID:35156769
1314849	TJP1	tight junction protein 1	gene	CHEBI:755912	aluminum chloride	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20260714	CTD	MESH:D000077410	Resveratrol inhibits the reaction [Aluminum Chloride results in decreased expression of TJP1 mRNA]; Resveratrol inhibits the reaction [Aluminum Chloride results in decreased expression of TJP1 protein]	PMID:34614429|PMID:35156769
1314849	TJP1	tight junction protein 1	gene	CHEBI:757488	omega-3 fatty acids	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20260714	CTD	MESH:D015525	Fatty Acids, Omega-3 inhibits the reaction [[Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of TJP1 mRNA]; Fatty Acids, Omega-3 inhibits the reaction [[Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of TJP1 protein]	PMID:33068716
1314849	TJP1	tight junction protein 1	gene	CHEBI:76016	vortioxetine	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C557874	Vortioxetine results in decreased expression of TJP1 protein	PMID:38043629
1314849	TJP1	tight junction protein 1	gene	CHEBI:7602	nobiletin	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of TJP1 protein]	PMID:38348393
1314849	TJP1	tight junction protein 1	gene	CHEBI:76208	sodium sulfide (anhydrous)	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20210406	CTD	MESH:C033479	4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of TJP1 protein]; [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of TJP1 mRNA; [Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of TJP1 protein; Fatty Acids, Omega-3 inhibits the reaction [[Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of TJP1 mRNA]; Fatty Acids, Omega-3 inhibits the reaction [[Hydrogen Sulfide results in increased abundance of sodium sulfide] which results in decreased expression of TJP1 protein]	PMID:33068716
1314849	TJP1	tight junction protein 1	gene	CHEBI:77148	ginsenoside Re	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20140408	CTD	MESH:C049864	ginsenoside Re inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein]	PMID:22849695
1314849	TJP1	tight junction protein 1	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C025589	ochratoxin A results in decreased expression of and affects the localization of TJP1 protein	PMID:30763683
1314849	TJP1	tight junction protein 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TJP1 mRNA	PMID:30851411
1314849	TJP1	tight junction protein 1	gene	CHEBI:78373	chelerythrine	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:C016299	chelerythrine inhibits the reaction [EGF protein inhibits the reaction [Acetaldehyde affects the localization of TJP1 protein]]	PMID:17991733
1314849	TJP1	tight junction protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TJP1 mRNA	PMID:27188386
1314849	TJP1	tight junction protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20210706	CTD	MESH:C516138	dorsomorphin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]; dorsomorphin promotes the reaction [SEW2871 inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of TJP1 protein]]	PMID:33400020
1314849	TJP1	tight junction protein 1	gene	CHEBI:78761	ML-7	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070571	ML 7 inhibits the reaction [Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 protein]]	PMID:33675858
1314849	TJP1	tight junction protein 1	gene	CHEBI:78761	ML-7	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20140708	CTD	MESH:C070571	ML 7 inhibits the reaction [Oxygen deficiency affects the localization of TJP1 protein]	PMID:20164382
1314849	TJP1	tight junction protein 1	gene	CHEBI:79	(-)-Arctigenin	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:C071942	arctigenin inhibits the reaction [[IL4 protein co-treated with IL13 protein] results in decreased expression of TJP1 protein]; BIRC3 protein affects the reaction [KLF5 protein inhibits the reaction [arctigenin inhibits the reaction [[IL4 protein co-treated with IL13 protein] results in decreased expression of TJP1 protein]]]; KLF5 protein inhibits the reaction [arctigenin inhibits the reaction [[IL4 protein co-treated with IL13 protein] results in decreased expression of TJP1 protein]]; TNFSF12 protein affects the reaction [BIRC3 protein affects the reaction [KLF5 protein inhibits the reaction [arctigenin inhibits the reaction [[IL4 protein co-treated with IL13 protein] results in decreased expression of TJP1 protein]]]]	PMID:40803538
1314849	TJP1	tight junction protein 1	gene	CHEBI:79	(-)-Arctigenin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20260303	CTD	MESH:C071942	arctigenin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in decreased expression of TJP1 protein]; BIRC3 protein affects the reaction [KLF5 protein inhibits the reaction [arctigenin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in decreased expression of TJP1 protein]]]; KLF5 protein inhibits the reaction [arctigenin inhibits the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in decreased expression of TJP1 protein]]	PMID:40803538
1314849	TJP1	tight junction protein 1	gene	CHEBI:791	17beta-estradiol 17-glucosiduronic acid	affects localization	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:C025483	estradiol-17 beta-glucuronide affects the localization of TJP1 protein	PMID:17463180
1314849	TJP1	tight junction protein 1	gene	CHEBI:7939	parthenolide	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C002669	parthenolide results in increased expression of TJP1 protein	PMID:37683593
1314849	TJP1	tight junction protein 1	gene	CHEBI:79516	Nonylphenol	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20200804	CTD	MESH:C025256	nonylphenol results in decreased expression of TJP1 protein	PMID:32240654
1314849	TJP1	tight junction protein 1	gene	CHEBI:80003	Fexaramine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20251104	CTD	MESH:C474615	fexaramine inhibits the reaction [Cadmium results in decreased expression of TJP1 mRNA]	PMID:35934034
1314849	TJP1	tight junction protein 1	gene	CHEBI:80630	irinotecan	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20240702	CTD	MESH:D000077146	Irinotecan results in decreased expression of TJP1 protein	PMID:38341106
1314849	TJP1	tight junction protein 1	gene	CHEBI:80630	irinotecan	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240702	CTD	MESH:D000077146	GSK484 inhibits the reaction [Irinotecan results in decreased expression of TJP1 protein]; phenethyl isothiocyanate inhibits the reaction [Irinotecan results in decreased expression of TJP1 protein]	PMID:38341106
1314849	TJP1	tight junction protein 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of TJP1 mRNA	PMID:19162173
1314849	TJP1	tight junction protein 1	gene	CHEBI:80818	Deoxyschizandrin	multiple interactions	EXP		E	RGD:6480464	20230606	CTD	MESH:C034734	schizandrin A inhibits the reaction [Mycophenolic Acid results in decreased expression of TJP1 protein]	PMID:35321622
1314849	TJP1	tight junction protein 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of TJP1 protein	PMID:20299304
1314849	TJP1	tight junction protein 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20141111	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of TJP1 protein	PMID:20299304
1314849	TJP1	tight junction protein 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1314850	E	RGD:6480464	20141111	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of TJP1 protein	PMID:20064788
1314849	TJP1	tight junction protein 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C070055	acetovanillone inhibits the reaction [2,3',4,4',5-pentachlorobiphenyl results in decreased expression of TJP1 protein]	PMID:20299304
1314849	TJP1	tight junction protein 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20141111	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl affects the reaction [TJP1 protein binds to OCLN protein]	PMID:20064788
1314849	TJP1	tight junction protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of TJP1 protein	PMID:31622892
1314849	TJP1	tight junction protein 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of TJP1 mRNA	PMID:38648751
1314849	TJP1	tight junction protein 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TJP1 mRNA; 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of TJP1 protein	PMID:25784559|PMID:31622892
1314849	TJP1	tight junction protein 1	gene	CHEBI:81638	Monocyte locomotion inhibitory factor	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20260407	CTD	MESH:C430647	monocyte locomotion inhibitory factor inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 mRNA]	PMID:40354872
1314849	TJP1	tight junction protein 1	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of TJP1 protein	PMID:28903499
1314849	TJP1	tight junction protein 1	gene	CHEBI:81936	octhilinone	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20210608	CTD	MESH:C035331	2-n-octyl-4-isothiazolin-3-one results in decreased expression of TJP1 protein	PMID:33806369
1314849	TJP1	tight junction protein 1	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of TJP1 mRNA	PMID:31558096
1314849	TJP1	tight junction protein 1	gene	CHEBI:8207	(+)-pilocarpine	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20120412	CTD	MESH:D010862	Pilocarpine results in decreased expression of TJP1 protein	PMID:17533168
1314849	TJP1	tight junction protein 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of TJP1 mRNA; decabromobiphenyl ether results in decreased expression of TJP1 protein	PMID:31622892|PMID:33675858
1314849	TJP1	tight junction protein 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of TJP1 protein	PMID:31675489
1314849	TJP1	tight junction protein 1	gene	CHEBI:82436	decabromodiphenyl ether	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 protein]]; Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 mRNA]; Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 protein]; ML 7 inhibits the reaction [Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 protein]]; triptolide inhibits the reaction [Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 protein]]	PMID:33675858
1314849	TJP1	tight junction protein 1	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of TJP1 mRNA	PMID:33512557
1314849	TJP1	tight junction protein 1	gene	CHEBI:83438	1-(5-isoquinolinesulfonyl)-2-methylpiperazine	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20141104	CTD	MESH:D019307	1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]	PMID:16716901
1314849	TJP1	tight junction protein 1	gene	CHEBI:8346	potassium iodide	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20201006	CTD	MESH:D011193	Potassium Iodide results in decreased expression of TJP1 mRNA	PMID:32593569
1314849	TJP1	tight junction protein 1	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of TJP1 protein	PMID:38348393
1314849	TJP1	tight junction protein 1	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of TJP1 protein]	PMID:38348393
1314849	TJP1	tight junction protein 1	gene	CHEBI:8426	probenecid	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20150310	CTD	MESH:D011339	[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of TJP1 protein; Trehalose inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of TJP1 protein]	PMID:25064079
1314849	TJP1	tight junction protein 1	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of TJP1 mRNA	PMID:35688559
1314849	TJP1	tight junction protein 1	gene	CHEBI:8450	procymidone	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20230606	CTD	MESH:C035988	procymidone results in decreased expression of TJP1 mRNA	PMID:36764477
1314849	TJP1	tight junction protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TJP1 mRNA	PMID:24780913
1314849	TJP1	tight junction protein 1	gene	CHEBI:8633	puerarin	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:C033607	puerarin inhibits the reaction [Sodium Chloride results in decreased expression of TJP1 protein]; SIRT1 protein promotes the reaction [puerarin inhibits the reaction [Sodium Chloride results in decreased expression of TJP1 protein]]	PMID:37865300
1314849	TJP1	tight junction protein 1	gene	CHEBI:88522	Monobutylphthalate	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of TJP1 protein	PMID:26922907
1314849	TJP1	tight junction protein 1	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1306305	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of TJP1 protein	PMID:18214902
1314849	TJP1	tight junction protein 1	gene	CHEBI:8899	rottlerin	affects localization	EXP		E	RGD:6480464	20170516	CTD	MESH:C085746	rottlerin affects the localization of TJP1 protein	PMID:19297429
1314849	TJP1	tight junction protein 1	gene	CHEBI:9009	Salidroside	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20200519	CTD	MESH:C009172	rhodioloside inhibits the reaction [furan results in decreased expression of TJP1 protein]; rhodioloside inhibits the reaction [Streptozocin results in decreased expression of TJP1 protein]	PMID:31682803|PMID:32251705
1314849	TJP1	tight junction protein 1	gene	CHEBI:90369	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide	multiple interactions	EXP		E	RGD:6480464	20200114	CTD	MESH:C550547	6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [TNF protein results in decreased expression of and affects the localization of TJP1 protein]; Lithocholic Acid inhibits the reaction [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide promotes the reaction [TNF protein results in decreased expression of and affects the localization of TJP1 protein]]	PMID:31472180
1314849	TJP1	tight junction protein 1	gene	CHEBI:9068	Se-methylselenocysteine	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20250603	CTD	MESH:C002979	selenomethylselenocysteine inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of TJP1 protein]; selenomethylselenocysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein]	PMID:39360521
1314849	TJP1	tight junction protein 1	gene	CHEBI:90705	SB 203580	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C093642	SB 203580 inhibits the reaction [clopidogrel results in decreased expression of TJP1 protein]	PMID:23220562
1314849	TJP1	tight junction protein 1	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20170303	CTD	MESH:C093642	SB 203580 inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of TJP1 protein]	PMID:23761298
1314849	TJP1	tight junction protein 1	gene	CHEBI:91108	SB 431542	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of TJP1 protein	PMID:25670856
1314849	TJP1	tight junction protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [TGFB1 protein results in decreased expression of TJP1 protein]; [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TJP1 protein; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TJP1 mRNA	PMID:27188386|PMID:30609689|PMID:37664457
1314849	TJP1	tight junction protein 1	gene	CHEBI:9288	streptozocin	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20200519	CTD	MESH:D013311	Streptozocin results in decreased expression of TJP1 protein	PMID:31682803|PMID:39922521
1314849	TJP1	tight junction protein 1	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20180220	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in decreased expression of TJP1 protein; Dichloroacetic Acid inhibits the reaction [Streptozocin results in decreased expression of TJP1 protein]; ginsenoside Rg3 inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of TJP1 protein]; NLRP3 protein promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of TJP1 protein]; Oxamic Acid inhibits the reaction [Streptozocin results in decreased expression of TJP1 protein]; rhodioloside inhibits the reaction [Streptozocin results in decreased expression of TJP1 protein]	PMID:27783111|PMID:31682803|PMID:39579577|PMID:39922521
1314849	TJP1	tight junction protein 1	gene	CHEBI:9334	sulfasalazine	multiple interactions	ISO	RGD:1306305	E	RGD:6480464	20220809	CTD	MESH:D012460	Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 mRNA]; Sulfasalazine inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of TJP1 protein]	PMID:35290143
1314849	TJP1	tight junction protein 1	gene	CHEBI:9429	tectorigenin	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20221206	CTD	MESH:C120039	tectorigenin inhibits the reaction [Dietary Fats results in decreased expression of TJP1 mRNA]; tectorigenin inhibits the reaction [Dietary Fats results in decreased expression of TJP1 protein]	PMID:35390440
1314849	TJP1	tight junction protein 1	gene	CHEBI:9434	telmisartan	affects localization	EXP		E	RGD:6480464	20120412	CTD	MESH:C084178	telmisartan affects the localization of TJP1 protein	PMID:19252288
1314849	TJP1	tight junction protein 1	gene	CHEBI:9434	telmisartan	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C084178	Telmisartan results in decreased expression of TJP1 mRNA; Telmisartan results in decreased expression of TJP1 protein	PMID:19252288
1314849	TJP1	tight junction protein 1	gene	CHEBI:9434	telmisartan	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C084178	2-chloro-5-nitrobenzanilide inhibits the reaction [Telmisartan affects the localization of TJP1 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Telmisartan results in decreased expression of TJP1 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Telmisartan results in decreased expression of TJP1 protein]; KLF4 protein affects the reaction [Telmisartan inhibits the reaction [[AGT protein co-treated with Sodium Chloride] results in decreased expression of TJP1 mRNA]]; Telmisartan inhibits the reaction [[AGT protein co-treated with Sodium Chloride] results in decreased expression of TJP1 mRNA]; Telmisartan inhibits the reaction [[AGT protein co-treated with Sodium Chloride] results in decreased expression of TJP1 protein]; Wortmannin inhibits the reaction [Telmisartan affects the localization of TJP1 protein]; Wortmannin inhibits the reaction [Telmisartan results in decreased expression of TJP1 mRNA]; Wortmannin inhibits the reaction [Telmisartan results in decreased expression of TJP1 protein]	PMID:19252288|PMID:40613628
1314849	TJP1	tight junction protein 1	gene	CHEBI:9434	telmisartan	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20260602	CTD	MESH:C084178	Telmisartan inhibits the reaction [[AGT protein co-treated with Sodium Chloride, Dietary] results in decreased expression of TJP1 mRNA]; Telmisartan inhibits the reaction [[AGT protein co-treated with Sodium Chloride, Dietary] results in decreased expression of TJP1 protein]	PMID:40613628
1314849	TJP1	tight junction protein 1	gene	CHEBI:94807	acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:C041747	nitazoxanide inhibits the reaction [IL6 protein results in decreased expression of TJP1 protein]; nitazoxanide inhibits the reaction [Lipopolysaccharides results in decreased expression of TJP1 protein]	PMID:38663798
1314849	TJP1	tight junction protein 1	gene	CHEBI:94807	acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20240604	CTD	MESH:C041747	nitazoxanide inhibits the reaction [Dextran Sulfate results in decreased expression of TJP1 protein]	PMID:38663798
1314849	TJP1	tight junction protein 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TJP1 mRNA	PMID:38568856
1314849	TJP1	tight junction protein 1	gene	CHEBI:9513	thalidomide	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20120412	CTD	MESH:D013792	Thalidomide inhibits the reaction [dinitrobenzenesulfonic acid results in decreased expression of TJP1 protein]	PMID:16680017
1314849	TJP1	tight junction protein 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1314850	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of TJP1 protein	PMID:24648495
1314849	TJP1	tight junction protein 1	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20190702	CTD	MESH:C001899	triptolide results in decreased expression of TJP1 mRNA; triptolide results in decreased expression of TJP1 protein	PMID:30836114
1314849	TJP1	tight junction protein 1	gene	CHEBI:9747	Triptolide	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C001899	triptolide inhibits the reaction [Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 protein]]	PMID:33675858
1314849	TJP1	tight junction protein 1	gene	CHEBI:9747	Triptolide	multiple interactions	ISO	RGD:1314850	E	RGD:6480464	20190702	CTD	MESH:C001899	[triptophenolide co-treated with triptolide] results in decreased expression of TJP1 protein; mitoquinone inhibits the reaction [triptolide results in decreased expression of TJP1 mRNA]; mitoquinone inhibits the reaction [triptolide results in decreased expression of TJP1 protein]	PMID:30836114|PMID:40286878
1314849	TJP1	tight junction protein 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314850	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of TJP1 mRNA	PMID:28973697
1314849	TJP1	tight junction protein 1	gene	CHEBI:9753	troglitazone	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C057693	Troglitazone results in increased expression of and affects the localization of TJP1 protein	PMID:40024757
1314851	ATG12	autophagy related 12	gene	CHEBI:113532	thymoquinone	decreases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:C003466	thymoquinone results in decreased expression of ATG12 protein	PMID:31298468
1314851	ATG12	autophagy related 12	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1558563	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ATG12 mRNA	PMID:33045310
1314851	ATG12	autophagy related 12	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20190409	CTD	MESH:D014212	DAPK2 protein affects the reaction [Tretinoin promotes the reaction [ATG5 protein binds to ATG12 protein]]; Tretinoin promotes the reaction [ATG5 protein binds to ATG12 protein]	PMID:28978663
1314851	ATG12	autophagy related 12	gene	CHEBI:15368	acrolein	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D000171	Acrolein results in increased expression of ATG12 protein	PMID:30205151
1314851	ATG12	autophagy related 12	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20190219	CTD	MESH:D000171	Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG12 protein]	PMID:30205151
1314851	ATG12	autophagy related 12	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ATG12 mRNA	PMID:30529165
1314851	ATG12	autophagy related 12	gene	CHEBI:15738	staurosporine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019311	ATG12 protein affects the susceptibility to Staurosporine	PMID:16497721
1314851	ATG12	autophagy related 12	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ATG12 mRNA	PMID:26079696
1314851	ATG12	autophagy related 12	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of ATG12 mRNA	PMID:22378314
1314851	ATG12	autophagy related 12	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1306306	E	RGD:6480464	20201103	CTD	MESH:D001280	Atrazine results in increased expression of ATG12 mRNA; Atrazine results in increased expression of ATG12 protein	PMID:30084861
1314851	ATG12	autophagy related 12	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1558563	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of ATG12 mRNA	PMID:30319688
1314851	ATG12	autophagy related 12	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1558563	E	RGD:6480464	20160510	CTD	MESH:D000431	Ethanol results in increased expression of ATG12 mRNA	PMID:24492484
1314851	ATG12	autophagy related 12	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20140211	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of ATG12 protein	PMID:23726866
1314851	ATG12	autophagy related 12	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20170516	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with procyanidin B2] results in increased expression of ATG12 mRNA	PMID:27057282
1314851	ATG12	autophagy related 12	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in increased expression of [ATG12 protein binds to ATG5 protein]	PMID:25293876
1314851	ATG12	autophagy related 12	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20210706	CTD	MESH:D011794	Quercetin inhibits the reaction [Ethylnitrosourea results in decreased expression of ATG12 protein]	PMID:32902906
1314851	ATG12	autophagy related 12	gene	CHEBI:16400	gossypetin	multiple interactions	EXP		E	RGD:6480464	20150714	CTD	MESH:C059922	gossypetin promotes the reaction [malondialdehyde-low density lipoprotein, human promotes the reaction [ATG5 protein binds to ATG12 protein]]	PMID:25622137
1314851	ATG12	autophagy related 12	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1558563	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ATG12 mRNA	PMID:39241906
1314851	ATG12	autophagy related 12	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1306306	E	RGD:6480464	20201103	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ATG12 mRNA; Lipopolysaccharides results in increased expression of ATG12 protein	PMID:30084861
1314851	ATG12	autophagy related 12	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1558563	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ATG12 mRNA	PMID:39298647
1314851	ATG12	autophagy related 12	gene	CHEBI:16551	alpha,alpha-trehalose	increases expression	ISO	RGD:1558563	E	RGD:6480464	20210608	CTD	MESH:D014199	Trehalose results in increased expression of ATG12 mRNA	PMID:30335591
1314851	ATG12	autophagy related 12	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ATG12 mRNA	PMID:37042841
1314851	ATG12	autophagy related 12	gene	CHEBI:16796	melatonin	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20240604	CTD	MESH:D008550	Melatonin inhibits the reaction [Glyphosate results in increased expression of ATG12 protein]	PMID:33159990
1314851	ATG12	autophagy related 12	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ATG12 mRNA	PMID:23649840
1314851	ATG12	autophagy related 12	gene	CHEBI:16842	formaldehyde	increases expression	ISO	RGD:1306306	E	RGD:6480464	20260407	CTD	MESH:D005557	Formaldehyde results in increased expression of ATG12 mRNA; Formaldehyde results in increased expression of ATG12 protein	PMID:40578478
1314851	ATG12	autophagy related 12	gene	CHEBI:173719	Curcumol	multiple interactions	ISO	RGD:1306306	E	RGD:6480464	20210706	CTD	MESH:C022801	curcumol inhibits the reaction [VEGFA protein results in increased expression of ATG12 mRNA]	PMID:33549628
1314851	ATG12	autophagy related 12	gene	CHEBI:17447	geraniol	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:C007836	geraniol inhibits the reaction [Rotenone results in decreased expression of ATG12 protein]	PMID:30141137
1314851	ATG12	autophagy related 12	gene	CHEBI:17548	alginic acid	increases expression	ISO	RGD:1558563	E	RGD:6480464	20220510	CTD	MESH:C008970	Alginic Acid results in increased expression of ATG12 protein	PMID:35066102
1314851	ATG12	autophagy related 12	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C031927	hydroquinone results in increased expression of ATG12 protein	PMID:37148176
1314851	ATG12	autophagy related 12	gene	CHEBI:17698	chloramphenicol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002701	Chloramphenicol results in increased expression of ATG12 mRNA	PMID:17457038
1314851	ATG12	autophagy related 12	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306306	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ATG12 mRNA	PMID:33387578
1314851	ATG12	autophagy related 12	gene	CHEBI:1784	biphenyl-4-amine	multiple interactions	EXP		E	RGD:6480464	20260303	CTD	MESH:C006757	4-biphenylamine metabolite affects the reaction [ELAVL1 protein affects the expression of ATG12 protein]	PMID:40378909
1314851	ATG12	autophagy related 12	gene	CHEBI:182159	Cannabidivarin	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20211109	CTD	MESH:C580853	cannabidivarin inhibits the reaction [DMD gene mutant form results in decreased expression of ATG12 mRNA]	PMID:30074247
1314851	ATG12	autophagy related 12	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ATG12 mRNA	PMID:39836092
1314851	ATG12	autophagy related 12	gene	CHEBI:18315	pyrroloquinoline quinone	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D045542	PQQ Cofactor inhibits the reaction [Doxorubicin results in increased expression of ATG12 protein]	PMID:31226464
1314851	ATG12	autophagy related 12	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306306	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ATG12 protein	PMID:34915118
1314851	ATG12	autophagy related 12	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1558563	E	RGD:6480464	20161115	CTD	MESH:D002104	Cadmium results in increased expression of ATG12 mRNA	PMID:27492225
1314851	ATG12	autophagy related 12	gene	CHEBI:231515	lanthanum trichloride	increases expression	ISO	RGD:1306306	E	RGD:6480464	20240702	CTD	MESH:C028521	lanthanum chloride results in increased expression of ATG12 protein	PMID:35090998
1314851	ATG12	autophagy related 12	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ATG12 mRNA	PMID:19549813
1314851	ATG12	autophagy related 12	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of ATG12 mRNA	PMID:23649840
1314851	ATG12	autophagy related 12	gene	CHEBI:23995	N-ethyl-N-nitrosourea	decreases expression	ISO	RGD:1558563	E	RGD:6480464	20210706	CTD	MESH:D005038	Ethylnitrosourea results in decreased expression of ATG12 protein	PMID:32902906
1314851	ATG12	autophagy related 12	gene	CHEBI:23995	N-ethyl-N-nitrosourea	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20210706	CTD	MESH:D005038	Quercetin inhibits the reaction [Ethylnitrosourea results in decreased expression of ATG12 protein]	PMID:32902906
1314851	ATG12	autophagy related 12	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ATG12 gene	PMID:27153756
1314851	ATG12	autophagy related 12	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ATG12 mRNA	PMID:23649840
1314851	ATG12	autophagy related 12	gene	CHEBI:25676	oligopeptide	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D009842	Oligopeptides analog results in decreased expression of ATG12 protein	PMID:24875536
1314851	ATG12	autophagy related 12	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ATG12 mRNA	PMID:18593933
1314851	ATG12	autophagy related 12	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1558563	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ATG12 mRNA	PMID:31919559
1314851	ATG12	autophagy related 12	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATG12 mRNA	PMID:22206623
1314851	ATG12	autophagy related 12	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ATG12 mRNA	PMID:39836092
1314851	ATG12	autophagy related 12	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ATG12 mRNA	PMID:19244175
1314851	ATG12	autophagy related 12	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of ATG12 mRNA	PMID:31874349
1314851	ATG12	autophagy related 12	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1558563	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of ATG12 protein	PMID:31352102|PMID:33159990
1314851	ATG12	autophagy related 12	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20240604	CTD	MESH:C010974	Melatonin inhibits the reaction [Glyphosate results in increased expression of ATG12 protein]	PMID:33159990
1314851	ATG12	autophagy related 12	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1558563	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ATG12 mRNA	PMID:28960355
1314851	ATG12	autophagy related 12	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ATG12 mRNA	PMID:23557933
1314851	ATG12	autophagy related 12	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1558563	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ATG12 mRNA	PMID:21151649
1314851	ATG12	autophagy related 12	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D002945	Cisplatin results in increased expression of ATG12 mRNA	PMID:38498338
1314851	ATG12	autophagy related 12	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	[Nickel co-treated with austenitic steel analog] results in increased expression of ATG12 mRNA	PMID:23638002
1314851	ATG12	autophagy related 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1558563	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ATG12 mRNA	PMID:21570461
1314851	ATG12	autophagy related 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1558563	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ATG12 mRNA	PMID:19770486
1314851	ATG12	autophagy related 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1558563	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ATG12 mRNA	PMID:15328365
1314851	ATG12	autophagy related 12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATG12 mRNA	PMID:17942748
1314851	ATG12	autophagy related 12	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20190702	CTD	MESH:D012402	Rotenone results in decreased expression of ATG12 protein	PMID:30141137
1314851	ATG12	autophagy related 12	gene	CHEBI:28201	rotenone	multiple interactions	EXP		E	RGD:6480464	20190702	CTD	MESH:D012402	geraniol inhibits the reaction [Rotenone results in decreased expression of ATG12 protein]	PMID:30141137
1314851	ATG12	autophagy related 12	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of ATG12 mRNA	PMID:29803840
1314851	ATG12	autophagy related 12	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004317	Doxorubicin results in increased expression of ATG12 protein	PMID:31226464
1314851	ATG12	autophagy related 12	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1558563	E	RGD:6480464	20250603	CTD	MESH:D004317	Doxorubicin results in increased expression of ATG12 mRNA	PMID:38324556
1314851	ATG12	autophagy related 12	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:D004317	PQQ Cofactor inhibits the reaction [Doxorubicin results in increased expression of ATG12 protein]	PMID:31226464
1314851	ATG12	autophagy related 12	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Acrolein results in increased expression of ATG12 protein]; Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG12 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATG12 mRNA]; Acetylcysteine inhibits the reaction [Tobacco Smoke Pollution results in increased expression of ATG12 mRNA]; Acetylcysteine inhibits the reaction [Vorinostat promotes the reaction [ATG5 protein binds to ATG12 protein]]	PMID:20543569|PMID:29307831|PMID:30205151|PMID:33146789|PMID:34439521
1314851	ATG12	autophagy related 12	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20150310	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG12 mRNA]	PMID:24614525
1314851	ATG12	autophagy related 12	gene	CHEBI:29014	cordycepin	affects expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C058120	cordycepin affects the expression of ATG12 mRNA	PMID:36881089
1314851	ATG12	autophagy related 12	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of ATG12 mRNA	PMID:28595984
1314851	ATG12	autophagy related 12	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ATG12 mRNA	PMID:38568856
1314851	ATG12	autophagy related 12	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1558563	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of ATG12 mRNA	PMID:30097599
1314851	ATG12	autophagy related 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ATG12 mRNA	PMID:39836092
1314851	ATG12	autophagy related 12	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20190409	CTD	MESH:C017947	[sodium arsenite co-treated with Dietary Fats] results in increased expression of ATG12 mRNA	PMID:30097599
1314851	ATG12	autophagy related 12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1558563	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ATG12 mRNA	PMID:22228805
1314851	ATG12	autophagy related 12	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1558563	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of ATG12 mRNA	PMID:33053406
1314851	ATG12	autophagy related 12	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ATG12 mRNA]	PMID:32406909
1314851	ATG12	autophagy related 12	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ATG12 mRNA	PMID:18593933
1314851	ATG12	autophagy related 12	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ATG12 mRNA	PMID:20018196
1314851	ATG12	autophagy related 12	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATG12 mRNA	PMID:29307831
1314851	ATG12	autophagy related 12	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1558563	E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of ATG12 mRNA; Arsenic Trioxide results in increased expression of ATG12 protein	PMID:30032600|PMID:30225639|PMID:32112876|PMID:32781346|PMID:33462182|PMID:39716349
1314851	ATG12	autophagy related 12	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG12 mRNA]; Arsenic Trioxide promotes the reaction [ATG5 protein binds to ATG12 protein]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATG12 mRNA]	PMID:28978663|PMID:29307831
1314851	ATG12	autophagy related 12	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20210907	CTD	MESH:C006632	TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATG12 protein]	PMID:33462182
1314851	ATG12	autophagy related 12	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of ATG12 mRNA	PMID:31745603
1314851	ATG12	autophagy related 12	gene	CHEBI:3218	2-(tert-butylimino)-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C083997	buprofezin results in increased expression of ATG12 mRNA	PMID:36287832
1314851	ATG12	autophagy related 12	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1558563	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ATG12 mRNA	PMID:18301758|PMID:20813756|PMID:21318169|PMID:23811191
1314851	ATG12	autophagy related 12	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of ATG12 mRNA]	PMID:21318169
1314851	ATG12	autophagy related 12	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ATG12 mRNA	PMID:34439521
1314851	ATG12	autophagy related 12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306306	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of ATG12 mRNA	PMID:27539358|PMID:30228064|PMID:30816183
1314851	ATG12	autophagy related 12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1558563	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ATG12 mRNA	PMID:26746108
1314851	ATG12	autophagy related 12	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of ATG12 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [bisphenol A results in increased expression of ATG12 mRNA]; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of ATG12 mRNA]; astaxanthine inhibits the reaction [bisphenol A results in increased expression of ATG12 mRNA]	PMID:34439521
1314851	ATG12	autophagy related 12	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of ATG12 mRNA	PMID:19244175
1314851	ATG12	autophagy related 12	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ATG12 mRNA	PMID:25979313
1314851	ATG12	autophagy related 12	gene	CHEBI:34440	4-nonylphenol	increases expression	ISO	RGD:1306306	E	RGD:6480464	20170516	CTD	MESH:C041594	4-nonylphenol results in increased expression of ATG12 mRNA	PMID:28041982|PMID:30228064
1314851	ATG12	autophagy related 12	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20210112	CTD	MESH:D004390	[Paraquat co-treated with Chlorpyrifos] results in increased expression of ATG12 protein	PMID:26884967
1314851	ATG12	autophagy related 12	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1558563	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ATG12 mRNA	PMID:34813904
1314851	ATG12	autophagy related 12	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1558563	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ATG12 mRNA	PMID:34813904
1314851	ATG12	autophagy related 12	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:D010269	Paraquat results in decreased expression of ATG12 protein	PMID:32517337
1314851	ATG12	autophagy related 12	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D010269	Paraquat results in increased expression of ATG12 mRNA	PMID:27220436
1314851	ATG12	autophagy related 12	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1558563	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in increased expression of ATG12 protein	PMID:22292029|PMID:26884967
1314851	ATG12	autophagy related 12	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20170725	CTD	MESH:D010269	3-methyladenine inhibits the reaction [vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG12 protein]]; ATG5 protein affects the reaction [Paraquat results in increased expression of [ATG5 protein binds to ATG12 protein]]; Paraquat results in increased expression of [ATG5 protein binds to ATG12 protein]; vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG12 protein]	PMID:22982048|PMID:32517337
1314851	ATG12	autophagy related 12	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20130416	CTD	MESH:D010269	[Paraquat co-treated with Chlorpyrifos] results in increased expression of ATG12 protein; Maneb promotes the reaction [Paraquat results in increased expression of ATG12 protein]; Paraquat results in increased expression of [ATG5 protein binds to ATG12 protein]	PMID:22292029|PMID:22982048|PMID:26884967
1314851	ATG12	autophagy related 12	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ATG12 mRNA	PMID:39836092
1314851	ATG12	autophagy related 12	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ATG12 mRNA; Cadmium Chloride results in increased expression of ATG12 protein	PMID:33127495|PMID:38174414|PMID:38568856
1314851	ATG12	autophagy related 12	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1558563	E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ATG12 mRNA	PMID:26879310
1314851	ATG12	autophagy related 12	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of ATG12 mRNA	PMID:19376846
1314851	ATG12	autophagy related 12	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:C018021	[cobaltous chloride co-treated with TP53 gene mutant form] results in increased expression of ATG12 protein	PMID:23380477
1314851	ATG12	autophagy related 12	gene	CHEBI:36560	zinc oxide	increases expression	ISO	RGD:1558563	E	RGD:6480464	20150310	CTD	MESH:D015034	Zinc Oxide analog results in increased expression of ATG12 mRNA	PMID:24614525
1314851	ATG12	autophagy related 12	gene	CHEBI:36560	zinc oxide	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20150310	CTD	MESH:D015034	Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased expression of ATG12 mRNA]	PMID:24614525
1314851	ATG12	autophagy related 12	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of ATG12 mRNA	PMID:19244175
1314851	ATG12	autophagy related 12	gene	CHEBI:37943	colistin	increases expression	ISO	RGD:1558563	E	RGD:6480464	20221206	CTD	MESH:D003091	Colistin results in increased expression of ATG12 mRNA	PMID:35378205
1314851	ATG12	autophagy related 12	gene	CHEBI:38635	3-methyladenine	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C025946	3-methyladenine results in decreased expression of ATG12 protein	PMID:32517337
1314851	ATG12	autophagy related 12	gene	CHEBI:38635	3-methyladenine	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C025946	3-methyladenine inhibits the reaction [vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG12 protein]]	PMID:32517337
1314851	ATG12	autophagy related 12	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ATG12 mRNA	PMID:28302478
1314851	ATG12	autophagy related 12	gene	CHEBI:39381	buprofezin	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C083997	buprofezin results in increased expression of ATG12 mRNA	PMID:36287832
1314851	ATG12	autophagy related 12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1306306	E	RGD:6480464	20170516	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ATG12 mRNA	PMID:27825932
1314851	ATG12	autophagy related 12	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1558563	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in increased expression of ATG12 mRNA	PMID:20546886
1314851	ATG12	autophagy related 12	gene	CHEBI:4042	cypermethrin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C017160	cypermethrin results in increased expression of ATG12 mRNA	PMID:27704156
1314851	ATG12	autophagy related 12	gene	CHEBI:40968	astaxanthin	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C005948	astaxanthine inhibits the reaction [bisphenol A results in increased expression of ATG12 mRNA]	PMID:34439521
1314851	ATG12	autophagy related 12	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20230404	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG12 mRNA]; 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG12 protein]	PMID:34175825
1314851	ATG12	autophagy related 12	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in increased expression of ATG12 mRNA	PMID:21678067
1314851	ATG12	autophagy related 12	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	Acetylcysteine inhibits the reaction [vorinostat promotes the reaction [ATG5 protein binds to ATG12 protein]]; vorinostat promotes the reaction [ATG5 protein binds to ATG12 protein]	PMID:20543569
1314851	ATG12	autophagy related 12	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1558563	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ATG12 mRNA	PMID:17562736
1314851	ATG12	autophagy related 12	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of ATG12 mRNA	PMID:21420995
1314851	ATG12	autophagy related 12	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306306	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ATG12 mRNA	PMID:33387578
1314851	ATG12	autophagy related 12	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of ATG12 mRNA	PMID:16510598
1314851	ATG12	autophagy related 12	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ATG12 mRNA	PMID:39836092
1314851	ATG12	autophagy related 12	gene	CHEBI:4778	embelin	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:C010945	embelin results in increased cleavage of [ATG12 protein binds to ATG5 protein]	PMID:28722333
1314851	ATG12	autophagy related 12	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of ATG12 mRNA	PMID:30529165
1314851	ATG12	autophagy related 12	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of ATG12 protein	PMID:39313106
1314851	ATG12	autophagy related 12	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20241203	CTD	MESH:C045651	TFEB protein affects the reaction [epigallocatechin gallate results in increased expression of ATG12 protein]	PMID:39313106
1314851	ATG12	autophagy related 12	gene	CHEBI:49	(+)-Tetrandrine	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C009438	tetrandrine results in increased expression of ATG12 protein	PMID:26822499
1314851	ATG12	autophagy related 12	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATG12 mRNA	PMID:17942748
1314851	ATG12	autophagy related 12	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of ATG12 mRNA	PMID:23228038
1314851	ATG12	autophagy related 12	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATG12 mRNA	PMID:29307831
1314851	ATG12	autophagy related 12	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1558563	E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of ATG12 mRNA; Arsenic Trioxide results in increased expression of ATG12 protein	PMID:30032600|PMID:30225639|PMID:32112876|PMID:32781346|PMID:33462182|PMID:39716349
1314851	ATG12	autophagy related 12	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Acetylcysteine inhibits the reaction [Arsenic Trioxide results in increased expression of ATG12 mRNA]; Arsenic Trioxide promotes the reaction [ATG5 protein binds to ATG12 protein]; TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATG12 mRNA]	PMID:28978663|PMID:29307831
1314851	ATG12	autophagy related 12	gene	CHEBI:49900	arsenous acid	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20210907	CTD	MESH:C032793	TFEB protein affects the reaction [Arsenic Trioxide results in increased expression of ATG12 protein]	PMID:33462182
1314851	ATG12	autophagy related 12	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1558563	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of ATG12 mRNA	PMID:21318169
1314851	ATG12	autophagy related 12	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20120613	CTD	MESH:D011345	PPARA protein affects the reaction [Fenofibrate results in increased expression of ATG12 mRNA]	PMID:21318169
1314851	ATG12	autophagy related 12	gene	CHEBI:50594	carbon nanotube	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of ATG12 mRNA	PMID:30802478
1314851	ATG12	autophagy related 12	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1558563	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of ATG12 mRNA	PMID:40234311
1314851	ATG12	autophagy related 12	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20130416	CTD	MESH:D008344	Maneb promotes the reaction [Paraquat results in increased expression of ATG12 protein]	PMID:22292029
1314851	ATG12	autophagy related 12	gene	CHEBI:5262	galangin	increases expression	EXP		E	RGD:6480464	20141223	CTD	MESH:C037032	galangin results in increased expression of ATG12 mRNA; galangin results in increased expression of ATG12 protein	PMID:25268046
1314851	ATG12	autophagy related 12	gene	CHEBI:5262	galangin	multiple interactions	EXP		E	RGD:6480464	20141223	CTD	MESH:C037032	[ATG12 mutant form co-treated with galangin] results in decreased activity of CASP3 protein; LY2109761 inhibits the reaction [galangin results in increased expression of ATG12 protein]; SMAD4 mutant form inhibits the reaction [galangin results in increased expression of ATG12 protein]	PMID:25268046
1314851	ATG12	autophagy related 12	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1306306	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of ATG12 mRNA	PMID:20080153
1314851	ATG12	autophagy related 12	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ATG12 mRNA	PMID:39836092
1314851	ATG12	autophagy related 12	gene	CHEBI:63112	fingolimod hydrochloride	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:D000068876	Fingolimod Hydrochloride results in increased expression of ATG12 protein	PMID:25939952
1314851	ATG12	autophagy related 12	gene	CHEBI:63918	artesunate	increases expression	EXP		E	RGD:6480464	20200331	CTD	MESH:C039726	Artesunate results in increased expression of ATG12 mRNA	PMID:30551460
1314851	ATG12	autophagy related 12	gene	CHEBI:64163	diquat	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20170516	CTD	MESH:D004178	[Diquat co-treated with procyanidin B2] results in increased expression of ATG12 mRNA	PMID:27057282
1314851	ATG12	autophagy related 12	gene	CHEBI:64648	enniatin	decreases expression	ISO	RGD:1306306	E	RGD:6480464	20170228	CTD	MESH:C100264	enniatins results in decreased expression of ATG12 mRNA	PMID:27163883
1314851	ATG12	autophagy related 12	gene	CHEBI:67992	Ginsenoside Rg5	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C572381	ginsenoside Rg5 results in increased expression of ATG12 protein	PMID:38289222
1314851	ATG12	autophagy related 12	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1558563	E	RGD:6480464	20230404	CTD	MESH:C057862	cyanoginosin LR results in increased expression of ATG12 mRNA; cyanoginosin LR results in increased expression of ATG12 protein	PMID:34175825
1314851	ATG12	autophagy related 12	gene	CHEBI:6925	microcystin-LR	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20230404	CTD	MESH:C057862	4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG12 mRNA]; 4-phenylbutyric acid inhibits the reaction [cyanoginosin LR results in increased expression of ATG12 protein]	PMID:34175825
1314851	ATG12	autophagy related 12	gene	CHEBI:69478	cannabidiol	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20210209	CTD	MESH:D002185	Cannabidiol inhibits the reaction [DMD gene mutant form results in decreased expression of ATG12 mRNA]	PMID:30074247
1314851	ATG12	autophagy related 12	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1558563	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ATG12 mRNA	PMID:22206623
1314851	ATG12	autophagy related 12	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATG12 mRNA	PMID:22206623
1314851	ATG12	autophagy related 12	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20160315	CTD	MESH:C072553	[MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in increased expression of ATG12 mRNA	PMID:25566086
1314851	ATG12	autophagy related 12	gene	CHEBI:75632	procyanidin B2	multiple interactions	ISO	RGD:1558563	E	RGD:6480464	20170516	CTD	MESH:C479580	[Diquat co-treated with procyanidin B2] results in increased expression of ATG12 mRNA; [Hydrogen Peroxide co-treated with procyanidin B2] results in increased expression of ATG12 mRNA	PMID:27057282
1314851	ATG12	autophagy related 12	gene	CHEBI:78708	Nonidet P-40	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C010615	Nonidet P-40 results in increased expression of ATG12 mRNA	PMID:26552463
1314851	ATG12	autophagy related 12	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ATG12 gene]	PMID:28238834
1314851	ATG12	autophagy related 12	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ATG12 mRNA	PMID:19159669
1314851	ATG12	autophagy related 12	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D020849	Raloxifene Hydrochloride promotes the reaction [ATG12 protein binds to ATG5 protein]	PMID:25537862
1314851	ATG12	autophagy related 12	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1558563	E	RGD:6480464	20160822	CTD	MESH:D013311	Streptozocin results in increased expression of ATG12 mRNA	PMID:24889822
1314851	ATG12	autophagy related 12	gene	CHEBI:9381	T-2 toxin	increases expression	ISO	RGD:1558563	E	RGD:6480464	20150825	CTD	MESH:D013605	T-2 Toxin results in increased expression of ATG12 protein	PMID:26138683
1314851	ATG12	autophagy related 12	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1558563	E	RGD:6480464	20170613	CTD	MESH:C001899	triptolide results in increased expression of ATG12 protein	PMID:26990902
1314851	ATG12	autophagy related 12	gene	CHEBI:9763	trovafloxacin	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C080163	trovafloxacin results in increased expression of ATG12 mRNA	PMID:33609687
1314851	ATG12	autophagy related 12	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1558563	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of ATG12 mRNA	PMID:35537566
1314851	ATG12	autophagy related 12	gene	CHEBI:9936	Vasicinone	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C052548	3-methyladenine inhibits the reaction [vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG12 protein]]; vasicinone inhibits the reaction [Paraquat results in decreased expression of ATG12 protein]	PMID:32517337
1314851	ATG12	autophagy related 12	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306306	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ATG12 mRNA	PMID:19015723
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of AGTPBP1 mRNA	PMID:38218311
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of AGTPBP1 mRNA	PMID:38218311
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314854	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of AGTPBP1 mRNA	PMID:37995155
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306307	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of AGTPBP1 mRNA]	PMID:31150632
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314854	E	RGD:6480464	20171212	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of AGTPBP1 mRNA	PMID:26251327
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314854	E	RGD:6480464	20171212	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AGTPBP1 gene	PMID:20938992
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of AGTPBP1 mRNA	PMID:23724009|PMID:33167477
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306307	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of AGTPBP1 gene	PMID:35440735
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1306307	E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of AGTPBP1 mRNA	PMID:17347304
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314854	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of AGTPBP1 mRNA	PMID:30319688
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of AGTPBP1 mRNA	PMID:21632981
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306307	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of AGTPBP1 mRNA	PMID:32145629
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306307	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of AGTPBP1 mRNA	PMID:33387578
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314854	E	RGD:6480464	20171212	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AGTPBP1 gene	PMID:20938992
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of AGTPBP1 mRNA	PMID:37042841
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of AGTPBP1 promoter	PMID:33872906
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of AGTPBP1 promoter	PMID:33872906
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306307	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of AGTPBP1 mRNA	PMID:26577399
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314854	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AGTPBP1 mRNA	PMID:28111341
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of AGTPBP1 mRNA	PMID:19549813
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306307	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of AGTPBP1 mRNA	PMID:23630614|PMID:25378103
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314854	E	RGD:6480464	20171212	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of AGTPBP1 mRNA	PMID:19770486
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306307	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of AGTPBP1 mRNA	PMID:31150632
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306307	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of AGTPBP1 mRNA]	PMID:31150632
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314854	E	RGD:6480464	20171212	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of AGTPBP1 gene	PMID:20938992
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AGTPBP1 gene	PMID:25304211
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of AGTPBP1 mRNA	PMID:40512198
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306307	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of AGTPBP1 mRNA	PMID:31881176
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of AGTPBP1 mRNA	PMID:28903495
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314854	E	RGD:6480464	20171212	CTD	MESH:D019833	Genistein results in decreased expression of AGTPBP1 mRNA	PMID:16169203
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of AGTPBP1 mRNA	PMID:28001369
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of AGTPBP1 mRNA	PMID:33212167
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of AGTPBP1 mRNA	PMID:29803840
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314854	E	RGD:6480464	20171212	CTD	MESH:D004317	Doxorubicin results in increased expression of AGTPBP1 mRNA	PMID:25896364|PMID:39631538
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of AGTPBP1 mRNA	PMID:40512198
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of AGTPBP1 mRNA	PMID:29453283
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314854	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of AGTPBP1 exon; Benzo(a)pyrene results in decreased methylation of AGTPBP1 intron	PMID:27901495
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AGTPBP1 mRNA alternative form	PMID:40419235
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314854	E	RGD:6480464	20171212	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AGTPBP1 mRNA	PMID:19770486
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of AGTPBP1 mRNA	PMID:25351596
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314854	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of AGTPBP1 mRNA	PMID:39716349
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1306307	E	RGD:6480464	20241105	CTD	MESH:C004312	glycidol results in decreased expression of AGTPBP1 mRNA	PMID:37926403
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:31767	lead diacetate	affects expression	ISO	RGD:1306307	E	RGD:6480464	20230404	CTD	MESH:C008261	lead acetate affects the expression of AGTPBP1 protein	PMID:36539177
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314854	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of AGTPBP1 gene	PMID:35295148
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306307	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of AGTPBP1 mRNA	PMID:23411599|PMID:34492290
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1306307	E	RGD:6480464	20180116	CTD	MESH:D013853	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of AGTPBP1 mRNA	PMID:28943392
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314854	E	RGD:6480464	20171212	CTD	MESH:C006253	pirinixic acid results in increased expression of AGTPBP1 mRNA	PMID:23811191
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1306307	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of AGTPBP1 promoter	PMID:27415467
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of AGTPBP1 mRNA	PMID:20678512
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306307	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of AGTPBP1 mRNA	PMID:30816183|PMID:32145629
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306307	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of AGTPBP1 mRNA	PMID:25181051
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of AGTPBP1 mRNA	PMID:19244175
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314854	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of AGTPBP1 mRNA	PMID:32715474
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306307	E	RGD:6480464	20180116	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of AGTPBP1 mRNA	PMID:28943392
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AGTPBP1 mRNA	PMID:37042841
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306307	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of AGTPBP1 mRNA	PMID:35163327
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306307	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of AGTPBP1 mRNA	PMID:30723492
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314854	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AGTPBP1 mRNA	PMID:28111341
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306307	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of AGTPBP1 mRNA	PMID:35163327
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of AGTPBP1 mRNA	PMID:19376846
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of AGTPBP1 mRNA	PMID:28302478
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of AGTPBP1 mRNA	PMID:40434365
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of AGTPBP1 mRNA	PMID:25979313
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of AGTPBP1 mRNA	PMID:29154799
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of AGTPBP1 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314854	E	RGD:6480464	20171212	CTD	MESH:D013629	Tamoxifen affects the expression of AGTPBP1 mRNA	PMID:17555576
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314854	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of AGTPBP1 mRNA	PMID:28973697
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of AGTPBP1 mRNA	PMID:21420995
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1306307	E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of AGTPBP1 mRNA	PMID:21061450
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AGTPBP1 gene	PMID:25304211
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of AGTPBP1 mRNA	PMID:40512198
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314854	E	RGD:6480464	20171212	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of AGTPBP1 mRNA	PMID:17555576
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314854	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of AGTPBP1 mRNA	PMID:39716349
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306307	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of AGTPBP1 mRNA	PMID:30307764
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306307	E	RGD:6480464	20200519	CTD	MESH:C082360	fipronil results in increased expression of AGTPBP1 mRNA	PMID:31881178
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306307	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of AGTPBP1 mRNA	PMID:22504374
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	ISO	RGD:1306307	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of AGTPBP1 mRNA	PMID:19162173
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of AGTPBP1 mRNA	PMID:20977926
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of AGTPBP1 mRNA	PMID:22714537
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:6887	methylphenidate	increases expression	ISO	RGD:1314854	E	RGD:6480464	20171212	CTD	MESH:D008774	Methylphenidate results in increased expression of AGTPBP1 mRNA	PMID:22470460
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of AGTPBP1 mRNA	PMID:30928695
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to AGTPBP1 gene]	PMID:28238834
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314854	E	RGD:6480464	20171212	CTD	MESH:D010634	Phenobarbital affects the expression of AGTPBP1 mRNA	PMID:23091169
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1306307	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of AGTPBP1 mRNA	PMID:23640034
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314854	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of AGTPBP1 mRNA	PMID:39847705
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306307	E	RGD:6480464	20241105	CTD	MESH:D011441	Propylthiouracil results in decreased expression of AGTPBP1 mRNA	PMID:37926403
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306307	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of AGTPBP1 mRNA	PMID:22504374|PMID:36843608
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases methylation	ISO	RGD:1306307	E	RGD:6480464	20241105	CTD	MESH:D011441	Propylthiouracil results in increased methylation of AGTPBP1 gene	PMID:37926403
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314854	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of AGTPBP1 mRNA	PMID:35537566
1314853	AGTPBP1	ATP/GTP binding carboxypeptidase 1	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306307	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of AGTPBP1 mRNA	PMID:19015723
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of MBIP mRNA	PMID:24763279
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of MBIP mRNA	PMID:21632981
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314858	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of MBIP mRNA	PMID:39241906
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of MBIP mRNA	PMID:20655997
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of MBIP protein	PMID:37730182
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MBIP mRNA	PMID:39836092
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314858	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MBIP mRNA	PMID:37236586
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MBIP mRNA	PMID:19549813
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314858	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MBIP mRNA	PMID:25629700
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MBIP mRNA	PMID:39836092
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MBIP protein	PMID:35688186
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314858	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MBIP mRNA	PMID:21570461
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MBIP mRNA	PMID:30851411
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MBIP mRNA	PMID:29803840
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of MBIP protein	PMID:35688186
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MBIP mRNA	PMID:39836092
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314858	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MBIP mRNA	PMID:22228805
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306310	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of MBIP mRNA	PMID:30047161
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306310	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MBIP mRNA	PMID:23411599
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MBIP mRNA	PMID:19710929
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306310	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MBIP mRNA	PMID:25181051|PMID:34947998
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MBIP mRNA	PMID:37042841
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MBIP mRNA	PMID:39836092
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314858	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MBIP mRNA	PMID:37236586
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306310	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MBIP mRNA	PMID:24386269
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MBIP mRNA	PMID:28302478
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MBIP mRNA	PMID:27153767|PMID:40419075
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of MBIP mRNA	PMID:23179753|PMID:28001369
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306310	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of MBIP mRNA	PMID:30047161
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of MBIP mRNA	PMID:26272509
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MBIP mRNA	PMID:27188386
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314858	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MBIP mRNA	PMID:17562736
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306310	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MBIP mRNA	PMID:33387578
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of MBIP mRNA	PMID:24714768
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of MBIP mRNA	PMID:17331233
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MBIP mRNA	PMID:39836092
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1314858	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of MBIP mRNA	PMID:30529165
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1314858	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of MBIP mRNA	PMID:26377693
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MBIP mRNA	PMID:39836092
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314858	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MBIP mRNA	PMID:22206623
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of MBIP protein	PMID:31285264
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MBIP mRNA	PMID:30851411
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MBIP mRNA	PMID:27188386
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306310	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MBIP mRNA	PMID:30047161
1314857	MBIP	MAP3K12 binding inhibitory protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MBIP mRNA	PMID:27188386
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in decreased expression of LAMB1 mRNA	PMID:31863870
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1306311	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of LAMB1 mRNA	PMID:21551480
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LAMB1 protein]	PMID:38195004
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:135947	bazedoxifene	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C447119	bazedoxifene results in increased expression of LAMB1 mRNA	PMID:19914376
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LAMB1 gene	PMID:20938992
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:15366	acetic acid	decreases expression	ISO	RGD:1314860	E	RGD:6480464	20120717	CTD	MESH:D019342	Acetic Acid results in decreased expression of LAMB1 protein	PMID:21296659
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of LAMB1 mRNA	PMID:17138961|PMID:21934132
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314860	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of LAMB1 mRNA	PMID:16236135
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of LAMB1 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of LAMB1 mRNA	PMID:30951980
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of LAMB1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of LAMB1 mRNA	PMID:32699268
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of LAMB1 mRNA	PMID:26079696
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D019308	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of LAMB1 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of LAMB1 mRNA	PMID:30547786
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:15930	atrazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001280	[Atrazine co-treated with Arsenates] results in increased expression of LAMB1 mRNA	PMID:18585445
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:16196	oleic acid	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D019301	[Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of LAMB1 mRNA; [Palmitic Acid co-treated with Oleic Acid] affects the expression of LAMB1 mRNA	PMID:30547786
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of LAMB1 mRNA	PMID:21179406
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LAMB1 mRNA	PMID:35811015
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of LAMB1 mRNA	PMID:30510588
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of LAMB1 mRNA	PMID:30165855
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LAMB1 gene	PMID:20938992
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of LAMB1 mRNA	PMID:37042841
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of LAMB1 gene	PMID:30521419
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:16990	bilirubin IXalpha	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin results in decreased expression of LAMB1 mRNA	PMID:20196124
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20120501	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LAMB1 mRNA; TXNIP promotes the reaction [Glucose results in increased expression of LAMB1 mRNA]	PMID:17178593|PMID:37992649
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:17315	D-glucosamine	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20260203	CTD	MESH:D005944	TXNIP promotes the reaction [Glucosamine results in increased expression of LAMB1 mRNA]	PMID:17178593
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20120501	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LAMB1 mRNA; TXNIP promotes the reaction [Glucose results in increased expression of LAMB1 mRNA]	PMID:17178593|PMID:37992649
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of LAMB1 mRNA	PMID:16949557
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in increased expression of LAMB1 protein	PMID:34122009
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306311	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of LAMB1 mRNA	PMID:33387578
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LAMB1 mRNA	PMID:39836092
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of LAMB1 mRNA	PMID:16949557
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:20993	aldehydo-D-glucosamine	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20120501	CTD	MESH:D005944	TXNIP promotes the reaction [Glucosamine results in increased expression of LAMB1 mRNA]	PMID:17178593
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:22977	cadmium atom	decreases methylation	ISO	RGD:1314860	E	RGD:6480464	20260707	CTD	MESH:D002104	Cadmium results in decreased methylation of LAMB1 gene	PMID:37023889
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LAMB1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LAMB1 protein	PMID:38195004
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20260203	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LAMB1 mRNA	PMID:40850461
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of LAMB1 mRNA	PMID:23649840
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of LAMB1 mRNA	PMID:23649840
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of LAMB1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of LAMB1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of LAMB1 mRNA	PMID:32699268
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of LAMB1 mRNA	PMID:34911549
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LAMB1 mRNA	PMID:16979875
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of LAMB1 gene	PMID:20938992
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LAMB1 gene	PMID:25304211
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1314860	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of LAMB1 mRNA	PMID:19654921
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LAMB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LAMB1 mRNA	PMID:39836092
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LAMB1 mRNA	PMID:40504410
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of LAMB1 mRNA	PMID:26272509
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMB1 mRNA	PMID:27188386
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27732	caffeine	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D002110	Caffeine results in increased expression of LAMB1 protein	PMID:31195006
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1306311	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of LAMB1 gene	PMID:35440735
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27779	griseofulvin	decreases expression	ISO	RGD:1314860	E	RGD:6480464	20131210	CTD	MESH:D006118	Griseofulvin results in decreased expression of LAMB1 protein	PMID:1573853
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of LAMB1 mRNA	PMID:23557933
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of LAMB1 mRNA	PMID:27392435
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:27958	cocaine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of LAMB1 mRNA	PMID:18000554
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314860	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of LAMB1 mRNA	PMID:16169203
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314860	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of LAMB1 mRNA	PMID:21570461|PMID:26377647
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LAMB1 mRNA	PMID:20106945|PMID:21296121|PMID:21632981
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306311	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of LAMB1 mRNA	PMID:33387578
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306311	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of LAMB1 mRNA	PMID:34747641
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314860	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of LAMB1 mRNA	PMID:32937126
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:28393	beta-D-glucosamine	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20120501	CTD	MESH:D005944	TXNIP promotes the reaction [Glucosamine results in increased expression of LAMB1 mRNA]	PMID:17178593
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of LAMB1 mRNA	PMID:30911355
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of LAMB1 mRNA	PMID:29803840
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LAMB1 mRNA	PMID:37992649
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of LAMB1 mRNA	PMID:10910055|PMID:38568856|PMID:39719251
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314860	E	RGD:6480464	20240402	CTD	MESH:C017947	sodium arsenite results in decreased expression of LAMB1 mRNA	PMID:33933676
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LAMB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LAMB1 mRNA	PMID:39836092
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LAMB1 mRNA	PMID:40504410
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in decreased expression of LAMB1 mRNA	PMID:26314263
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1314860	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of LAMB1 intron	PMID:27901495
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of LAMB1 mRNA	PMID:30911355
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LAMB1 mRNA	PMID:16979875
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in increased expression of LAMB1 protein	PMID:34122009
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:30563	silicon dioxide	affects secretion	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog affects the secretion of LAMB1 protein	PMID:25895662
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LAMB1 gene	PMID:31601247
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of LAMB1 mRNA	PMID:38568856
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1306311	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of LAMB1 mRNA	PMID:25729387
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306311	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of LAMB1 mRNA	PMID:25729387
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306311	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of LAMB1 mRNA	PMID:30047161
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314860	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of LAMB1 gene	PMID:35295148
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306311	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of LAMB1 mRNA	PMID:34492290
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314860	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of LAMB1 mRNA	PMID:28472532
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306311	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of LAMB1 mRNA	PMID:30816183
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306311	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of LAMB1 mRNA	PMID:34947998|PMID:38750585
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of LAMB1 mRNA; bisphenol A results in increased expression of LAMB1 protein	PMID:29275510|PMID:34186270|PMID:37567409
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314860	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in increased expression of LAMB1 mRNA	PMID:25594700|PMID:30951980
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of LAMB1 gene	PMID:31601247
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of LAMB1 mRNA	PMID:25979313
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of LAMB1 protein	PMID:31945527
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C543008	bisphenol S results in decreased expression of LAMB1 mRNA	PMID:25912373
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314860	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of LAMB1 mRNA	PMID:40203079
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of LAMB1 protein	PMID:34186270
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314860	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of LAMB1 mRNA	PMID:30951980|PMID:40203079
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of LAMB1 mRNA; ATF3 protein affects the reaction [bisphenol S results in decreased expression of LAMB1 mRNA]	PMID:30951980|PMID:40203079
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314860	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of LAMB1 mRNA	PMID:30951980
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of LAMB1 mRNA	PMID:30951980
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:34696	dieldrin	increases expression	ISO	RGD:1306311	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin results in increased expression of LAMB1 mRNA	PMID:23153324
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20120412	CTD	MESH:D015056	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LAMB1 mRNA	PMID:16054899
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LAMB1 mRNA	PMID:39836092
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of LAMB1 mRNA	PMID:38174414|PMID:38568856
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LAMB1 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of LAMB1 protein	PMID:38195004
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20260203	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LAMB1 mRNA	PMID:40850461
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C018021	cobaltous chloride results in decreased expression of LAMB1 mRNA	PMID:26314263
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:3638	chloroquine	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20200331	CTD	MESH:D002738	Chloroquine inhibits the reaction [LAMB1 protein affects the localization of GJA1 protein]	PMID:22150760
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of LAMB1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of LAMB1 mRNA	PMID:32699268
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013755	[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of LAMB1 mRNA	PMID:16979875
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of LAMB1 mRNA	PMID:31533062
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of LAMB1 mRNA	PMID:26352163
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1314860	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of LAMB1 protein	PMID:26178269
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of LAMB1 mRNA	PMID:25979313
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of LAMB1 mRNA	PMID:29154799
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314860	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of LAMB1 mRNA	PMID:24896083
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306311	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of LAMB1 mRNA	PMID:30047161
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of LAMB1 mRNA	PMID:20106945|PMID:27989131
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20120412	CTD	MESH:D003907	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LAMB1 mRNA	PMID:16054899
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314860	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of LAMB1 mRNA	PMID:28973697
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314860	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of LAMB1 mRNA	PMID:28973697
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20140304	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of LAMB1 mRNA; TXNIP promotes the reaction [Glucose results in increased expression of LAMB1 mRNA]	PMID:17178593|PMID:37992649
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:42839	3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	increases expression	ISO	RGD:1306311	E	RGD:6480464	20120412	CTD	MESH:D011692	Puromycin Aminonucleoside results in increased expression of LAMB1 mRNA	PMID:1762292|PMID:9175058
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:42839	3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine	multiple interactions	ISO	RGD:1306311	E	RGD:6480464	20120412	CTD	MESH:D011692	Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB1 mRNA]; FR 139317 inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB1 mRNA]; Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB1 mRNA]	PMID:1762292|PMID:9175058
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of LAMB1 mRNA	PMID:21420995|PMID:26690555|PMID:29067470
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:46345	5-fluorouracil	decreases expression	ISO	RGD:1314860	E	RGD:6480464	20120717	CTD	MESH:D005472	Fluorouracil results in decreased expression of LAMB1 protein	PMID:21296659
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of LAMB1 mRNA	PMID:24714768
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of LAMB1 mRNA	PMID:35811015
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of LAMB1 gene	PMID:25304211
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1314860	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of LAMB1 mRNA	PMID:19654921
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LAMB1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of LAMB1 mRNA	PMID:39836092
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of LAMB1 mRNA	PMID:40504410
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:4784	enalapril	multiple interactions	ISO	RGD:1306311	E	RGD:6480464	20120412	CTD	MESH:D004656	Enalapril inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB1 mRNA]	PMID:9175058
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20120501	CTD	MESH:D005944	TXNIP promotes the reaction [Glucosamine results in increased expression of LAMB1 mRNA]	PMID:17178593
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:49747	methylmercury(1+)	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C030957	methylmercury II results in decreased expression of LAMB1 mRNA	PMID:26314263
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306311	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of LAMB1 mRNA	PMID:34044035
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306311	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of LAMB1 mRNA	PMID:30047161
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:50729	mitoxantrone	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	LAMB1 protein affects the susceptibility to Mitoxantrone	PMID:16217747
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1314860	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of LAMB1 mRNA	PMID:26377693
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:52722	lactacystin	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20200331	CTD	MESH:C067713	lactacystin inhibits the reaction [LAMB1 protein affects the localization of GJA1 protein]	PMID:22150760
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of LAMB1 protein	PMID:32959892
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1306311	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of LAMB1 mRNA	PMID:20080153
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of LAMB1 mRNA	PMID:39836092
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1306311	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of LAMB1 mRNA	PMID:25729387
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306311	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of LAMB1 mRNA	PMID:25729387
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of LAMB1 mRNA	PMID:15336504
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	affects expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium affects the expression of LAMB1 mRNA	PMID:12710931
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:64206	bromochloroacetic acid	decreases expression	ISO	RGD:1314860	E	RGD:6480464	20120717	CTD	MESH:C099813	bromochloroacetic acid results in decreased expression of LAMB1 protein	PMID:21296659
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1314860	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of LAMB1 mRNA	PMID:20003209
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306311	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of LAMB1 gene	PMID:35440735
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:6887	methylphenidate	increases expression	ISO	RGD:1306311	E	RGD:6480464	20250114	CTD	MESH:D008774	Methylphenidate results in increased expression of LAMB1 mRNA	PMID:17105903
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:6888	6alpha-methylprednisolone	multiple interactions	ISO	RGD:1306311	E	RGD:6480464	20120412	CTD	MESH:D008775	Methylprednisolone inhibits the reaction [Puromycin Aminonucleoside results in increased expression of LAMB1 mRNA]	PMID:1762292
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1314860	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of LAMB1 mRNA	PMID:27462272
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of LAMB1 protein	PMID:34186270
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314860	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of LAMB1 mRNA	PMID:22206623
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of LAMB1 mRNA	PMID:22714537
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1306311	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of LAMB1 mRNA	PMID:33484710
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:77006	17beta-estradiol 3-benzoate	decreases expression	ISO	RGD:1306311	E	RGD:6480464	20210406	CTD	MESH:C074283	estradiol 3-benzoate results in decreased expression of LAMB1 mRNA	PMID:32741896
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of LAMB1 protein	PMID:39638853
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C025589	ochratoxin A metabolite results in decreased expression of LAMB1 mRNA; ochratoxin A results in decreased expression of LAMB1 mRNA	PMID:26314263
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMB1 mRNA	PMID:27188386
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of LAMB1 mRNA	PMID:19159669
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1306311	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of LAMB1 mRNA	PMID:30047161
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:81543	Tributyltin oxide	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of LAMB1 mRNA	PMID:26314263
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:81543	Tributyltin oxide	increases expression	ISO	RGD:1314860	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of LAMB1 mRNA	PMID:18958704
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314860	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of LAMB1 mRNA	PMID:38648751
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1314860	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of LAMB1 mRNA	PMID:27029645
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306311	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of LAMB1 mRNA	PMID:30047161
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1314860	E	RGD:6480464	20230801	CTD	MESH:D020849	[APC protein affects the susceptibility to Raloxifene Hydrochloride] which affects the expression of LAMB1 mRNA	PMID:24431404
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of LAMB1 mRNA	PMID:31734321
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMB1 mRNA	PMID:27188386
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of LAMB1 mRNA	PMID:38568856
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of LAMB1 mRNA	PMID:22378314
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1314860	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of LAMB1 protein	PMID:24648495
1314859	LAMB1	laminin subunit beta 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306311	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of LAMB1 mRNA	PMID:23034163
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of WNT8A mRNA	PMID:26272509
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT8A mRNA	PMID:27188386
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314862	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of WNT8A mRNA	PMID:33045310
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314862	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of WNT8A mRNA	PMID:36189433
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314862	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of WNT8A mRNA	PMID:36189433
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306312	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of WNT8A gene	PMID:28931070
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306312	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of WNT8A mRNA	PMID:33387578
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	affects expression	ISO	RGD:1314862	E	RGD:6480464	20120918	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate affects the expression of WNT8A mRNA	PMID:21195148
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314862	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of WNT8A mRNA	PMID:36189433
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of WNT8A gene	PMID:25304211
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314862	E	RGD:6480464	20251007	CTD	MESH:D001151	[lead acetate results in increased abundance of Lead] inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT8A mRNA]; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT8A mRNA	PMID:38157908
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1314862	E	RGD:6480464	20251007	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT8A mRNA]	PMID:38157908
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1314862	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of WNT8A mRNA	PMID:32186404
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:28112	nickel atom	decreases expression	ISO	RGD:1306312	E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel results in decreased expression of WNT8A mRNA	PMID:19130878
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314862	E	RGD:6480464	20251007	CTD	MESH:C017947	[lead acetate results in increased abundance of Lead] inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT8A mRNA]; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT8A mRNA	PMID:38157908
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1314862	E	RGD:6480464	20251007	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT8A mRNA]	PMID:38157908
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314862	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of WNT8A mRNA	PMID:19710929
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of WNT8A mRNA	PMID:25979313
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:34682	diazinon	decreases expression	ISO	RGD:1306312	E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon results in decreased expression of WNT8A mRNA	PMID:18502319|PMID:19130878
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314862	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of WNT8A mRNA	PMID:17963808
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of WNT8A mRNA	PMID:24935251
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of WNT8A mRNA	PMID:26690555
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D005472	Fluorouracil results in decreased expression of WNT8A mRNA	PMID:24737281
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of WNT8A gene	PMID:25304211
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314862	E	RGD:6480464	20251007	CTD	MESH:D001151	[lead acetate results in increased abundance of Lead] inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT8A mRNA]; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of WNT8A mRNA	PMID:38157908
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	ISO	RGD:1314862	E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of WNT8A mRNA	PMID:27915011
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1314862	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of WNT8A mRNA	PMID:38701926
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT8A mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT8A mRNA	PMID:27188386
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT8A mRNA	PMID:27188386
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:88522	Monobutylphthalate	affects expression	ISO	RGD:1314862	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate affects the expression of WNT8A mRNA	PMID:19162170|PMID:21195148
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT8A mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT8A mRNA	PMID:27188386
1314861	WNT8A	Wnt family member 8A	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1314862	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of WNT8A mRNA	PMID:26217789
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADH6 mRNA]	PMID:31150632
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1615687	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of ADH6B mRNA	PMID:36189433
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of ADH6 mRNA	PMID:26079696
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ADH6 mRNA	PMID:21632981
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1306313	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of ADH6 mRNA	PMID:32145629
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of ADH6 mRNA	PMID:20106945
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1615687	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ADH6B mRNA	PMID:39298647
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:D014241	Trichloroethylene results in decreased expression of ADH6 mRNA	PMID:33387578
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D002635	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ADH6 mRNA	PMID:33819548
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of ADH6 mRNA	PMID:26079696
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D006000	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ADH6 mRNA	PMID:33819548
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1306313	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ADH6 mRNA	PMID:34015638
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ADH6 mRNA	PMID:28818685
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:188851	Muraglitazar	increases expression	ISO	RGD:1306313	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of ADH6 mRNA	PMID:21515302
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002104	Cadmium results in decreased expression of ADH6 mRNA	PMID:17547211
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADH6 mRNA	PMID:35301059
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ADH6 mRNA	PMID:19549813
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ADH6 protein	PMID:20106945
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ADH6 mRNA	PMID:21632981|PMID:21641981|PMID:27153756
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ADH6 mRNA	PMID:33354967
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ADH6 gene	PMID:27153756
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of ADH6 mRNA	PMID:18356318
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ADH6 mRNA	PMID:31150632
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADH6 mRNA]	PMID:31150632
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D006002	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ADH6 mRNA	PMID:33819548
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ADH6 mRNA	PMID:22298810
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ADH6 mRNA	PMID:20106945|PMID:21632981|PMID:26159488|PMID:26238291|PMID:27055685
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013749	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ADH6 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ADH6]; [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ADH6 mRNA; AHR protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of ADH6 mRNA]; ARNT protein affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of ADH6 mRNA]	PMID:26159488|PMID:27055685
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:D012402	Rotenone results in increased expression of ADH6 mRNA	PMID:28374803
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D003840	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ADH6 mRNA	PMID:33819548
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of ADH6 mRNA	PMID:29301061
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ADH6 5' UTR	PMID:27901495
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADH6 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291|PMID:32234424
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ADH6 promoter	PMID:27901495
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of ADH6 mRNA	PMID:18356318
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ADH6 mRNA	PMID:25895662
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1615687	E	RGD:6480464	20181009	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ADH6B mRNA	PMID:23221170
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1615687	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ADH6 mRNA	PMID:39716349
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:31243	atazanavir sulfate	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D000069446	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ADH6 mRNA	PMID:33819548
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:32195	Tesaglitazar	increases expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:C501413	tesaglitazar results in increased expression of ADH6 mRNA	PMID:21515302
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:D013853	Thioacetamide results in increased expression of ADH6 mRNA	PMID:23411599
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of ADH6 mRNA	PMID:30723492
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ADH6 mRNA	PMID:30903817
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:C006780	bisphenol A affects the expression of ADH6 mRNA	PMID:30903817|PMID:32145629
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:C006780	bisphenol A results in decreased expression of ADH6 mRNA	PMID:25181051
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:C006780	bisphenol A results in increased methylation of ADH6 gene	PMID:28505145
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ADH6 mRNA	PMID:27055685
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of ADH6 mRNA	PMID:27055685
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of ADH6 mRNA	PMID:21527772
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306313	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADH6 mRNA	PMID:35163327
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ADH6 mRNA	PMID:17547211
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADH6 mRNA	PMID:35301059
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ADH6 mRNA	PMID:28511854
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306313	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADH6 mRNA	PMID:35163327
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of ADH6 mRNA	PMID:17547211
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D005999	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH6 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of ADH6 mRNA	PMID:33819548
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ADH6 mRNA	PMID:32588087
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ADH6 mRNA	PMID:32588087
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ADH6 mRNA; Valproic Acid results in decreased expression of ADH6 protein	PMID:29154799|PMID:29501571
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ADH6 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D016572	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of ADH6 mRNA	PMID:33819548
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:4035	cyhalothrin	increases expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:C037304	cyhalothrin results in increased expression of ADH6 mRNA	PMID:29727961
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ADH6 mRNA; Okadaic Acid results in decreased expression of ADH6 protein	PMID:38832940
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of ADH6 mRNA	PMID:29067470
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D000082	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of ADH6 mRNA	PMID:33819548
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of ADH6 mRNA	PMID:24714768
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:4791	endosulfan	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D004726	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ADH6 mRNA	PMID:26159488
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of ADH6 mRNA	PMID:32234424
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1615687	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ADH6 mRNA	PMID:39716349
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:6030	isoniazide	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in decreased expression of ADH6 protein	PMID:40015660
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ADH6 mRNA	PMID:28988120
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of ADH6 mRNA	PMID:17547211
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:7494	nefazodone	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:C051752	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of ADH6 mRNA	PMID:33819548
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:C025589	ochratoxin A results in decreased expression of ADH6 mRNA	PMID:30449730
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ADH6 mRNA	PMID:21346803
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:8064	phenformin	increases expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:D010629	Phenformin results in increased expression of ADH6 mRNA	PMID:31324951
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:8069	phenobarbital	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital results in decreased expression of ADH6 mRNA	PMID:19084549
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:82538	Sunset Yellow FCF	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:C005842	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of ADH6 mRNA	PMID:33819548
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of ADH6 mRNA	PMID:26079696
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:88528	hexanal	affects expression	ISO	RGD:1306313	E	RGD:6480464	20211228	CTD	MESH:C010463	n-hexanal affects the expression of ADH6 mRNA	PMID:26880647
1314863	ADH6	alcohol dehydrogenase 6 (class V)	gene	CHEBI:9405	tartrazine	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D013645	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of ADH6 mRNA	PMID:33819548
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314866	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RPL3L mRNA	PMID:33045310
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1314866	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of RPL3L mRNA	PMID:36189433
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314866	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of RPL3L mRNA	PMID:36189433
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306315	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RPL3L mRNA	PMID:33387578
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314866	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of RPL3L mRNA	PMID:36189433
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RPL3L mRNA	PMID:28818685
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of RPL3L mRNA	PMID:19921347
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314866	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RPL3L mRNA	PMID:22228805
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1306315	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of RPL3L mRNA	PMID:25729387
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306315	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RPL3L mRNA	PMID:25729387
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314866	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RPL3L mRNA	PMID:18648102
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306315	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of RPL3L mRNA	PMID:25181051|PMID:32145629
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306315	E	RGD:6480464	20180220	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL3L mRNA	PMID:27178563
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:33418	graphite	increases expression	ISO	RGD:1314866	E	RGD:6480464	20180515	CTD	MESH:D006108	Graphite results in increased expression of RPL3L mRNA	PMID:27440207
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314866	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of RPL3L gene	PMID:31683443
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314866	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of RPL3L exon	PMID:33297965
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314866	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of RPL3L intron	PMID:28392331
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314866	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RPL3L mRNA	PMID:32715474
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate results in decreased expression of RPL3L mRNA	PMID:29024780
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1306315	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of RPL3L mRNA	PMID:35163327
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306315	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RPL3L mRNA	PMID:35163327
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1306315	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of RPL3L mRNA	PMID:35163327
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306315	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of RPL3L mRNA	PMID:35163327
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:38102	triazines	multiple interactions	ISO	RGD:1314866	E	RGD:6480464	20180313	CTD	MESH:D014227	Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of RPL3L mRNA]	PMID:27469509
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1306315	E	RGD:6480464	20221206	CTD	MESH:D014635	Valproic Acid results in increased expression of RPL3L mRNA	PMID:35594946
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RPL3L gene	PMID:29154799
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RPL3L mRNA	PMID:38832940
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:46661	asbestos	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001194	Asbestos results in increased expression of RPL3L mRNA	PMID:22398240
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306315	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RPL3L mRNA	PMID:25729387
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1314866	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of RPL3L mRNA	PMID:36907384
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:79997	GW 4064	decreases expression	ISO	RGD:1314866	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in decreased expression of RPL3L mRNA	PMID:26655953
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1314866	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of RPL3L mRNA	PMID:27935865
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306315	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RPL3L mRNA	PMID:24780913
1314865	RPL3L	ribosomal protein L3 like	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314866	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of RPL3L mRNA	PMID:35537566
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of JRK mRNA	PMID:38218311
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of JRK mRNA	PMID:38218311
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of JRK mRNA	PMID:31016361
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314868	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of JRK mRNA	PMID:20938992
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of JRK mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of JRK mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of JRK mRNA	PMID:32699268|PMID:32845096
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306316	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of JRK gene	PMID:27618143
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314868	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of JRK mRNA	PMID:20938992
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of JRK mRNA	PMID:31256213
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314868	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of JRK mRNA	PMID:34319233
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of JRK protein	PMID:37730182
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306316	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of JRK mRNA	PMID:33387578
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of JRK mRNA	PMID:28818685
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of JRK mRNA	PMID:23649840
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of JRK mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of JRK mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of JRK mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of JRK mRNA	PMID:32699268|PMID:32845096
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306316	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of JRK mRNA	PMID:30779732
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314868	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of JRK mRNA	PMID:20938992
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of JRK protein	PMID:35688186
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of JRK mRNA	PMID:27594783
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of JRK mRNA	PMID:27392435
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306316	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of JRK mRNA	PMID:33387578
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of JRK mRNA	PMID:33212167
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of JRK mRNA	PMID:32763439
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306316	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of JRK mRNA	PMID:28959563
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of JRK mRNA	PMID:29803840
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of JRK mRNA	PMID:38568856
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of JRK mRNA	PMID:20018196
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306316	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of JRK mRNA	PMID:34492290
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306316	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of JRK mRNA	PMID:25181051
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314868	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of JRK mRNA	PMID:17706920
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314868	E	RGD:6480464	20120412	CTD	MESH:C006780	LHB protein affects the reaction [bisphenol A results in increased expression of JRK mRNA]	PMID:17706920
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1314868	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of JRK gene	PMID:31683443
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of JRK mRNA	PMID:37042841
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of JRK mRNA	PMID:38568856
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1306316	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of JRK mRNA	PMID:25539665
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of JRK mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of JRK mRNA	PMID:32699268
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of JRK mRNA	PMID:28302478
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of JRK gene	PMID:29154799
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of JRK mRNA	PMID:38832940
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of JRK mRNA	PMID:28542535
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314868	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of JRK mRNA	PMID:17562736
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306316	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of JRK mRNA	PMID:33387578
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of JRK mRNA	PMID:28988120
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314868	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of JRK mRNA	PMID:22206623
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of JRK protein	PMID:31285264
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:8984	sodium dodecyl sulfate	affects expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate affects the expression of JRK mRNA	PMID:31734321
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306316	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of JRK mRNA	PMID:19281266
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306316	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of JRK mRNA	PMID:19281266
1314867	JRK	Jrk helix-turn-helix protein	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of JRK mRNA	PMID:38568856
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SEC61G mRNA	PMID:38218311
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of SEC61G mRNA	PMID:35967413
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1314870	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61G mRNA	PMID:39752319
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SEC61G mRNA	PMID:26079696
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SEC61G mRNA	PMID:29432896
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314870	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SEC61G mRNA	PMID:39241906
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of SEC61G mRNA	PMID:23019147
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314870	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SEC61G mRNA	PMID:39298647
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314870	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61G mRNA	PMID:39752319
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:17578	toluene	decreases expression	ISO	RGD:1596170	E	RGD:6480464	20140805	CTD	MESH:D014050	Toluene results in decreased expression of SEC61G mRNA	PMID:22967744
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SEC61G mRNA	PMID:16949557
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SEC61G mRNA	PMID:19850644
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SEC61G mRNA	PMID:31163220
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314870	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SEC61G mRNA	PMID:33754040
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:D004051	PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SEC61G mRNA]	PMID:19850644
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1596170	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SEC61G mRNA	PMID:22061828
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SEC61G mRNA	PMID:28818685
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1596170	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of SEC61G mRNA	PMID:28522335
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of SEC61G mRNA	PMID:16949557
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:D008769	[Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SEC61G mRNA	PMID:19840844
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1596170	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SEC61G mRNA	PMID:33387578
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:C059514	resveratrol results in increased expression of SEC61G mRNA	PMID:22610192
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314870	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SEC61G mRNA	PMID:30912803
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SEC61G mRNA	PMID:21570461
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SEC61G mRNA	PMID:15056799
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEC61G mRNA	PMID:17942748
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1596170	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of SEC61G mRNA	PMID:28374803
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of SEC61G protein	PMID:39603559
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SEC61G mRNA	PMID:33212167
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SEC61G mRNA	PMID:30851411
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of SEC61G mRNA	PMID:20044591
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:29073	L-ascorbic acid	decreases expression	ISO	RGD:1596170	E	RGD:6480464	20140805	CTD	MESH:D001205	Ascorbic Acid results in decreased expression of SEC61G mRNA	PMID:15372504
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SEC61G mRNA	PMID:38568856|PMID:39719251
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to SEC61G mRNA]	PMID:32406909
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1596170	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of SEC61G mRNA	PMID:24136188
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of SEC61G mRNA	PMID:38568856
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1596170	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SEC61G mRNA	PMID:30047161
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314870	E	RGD:6480464	20150310	CTD	MESH:C009495	titanium dioxide analog results in decreased expression of SEC61G mRNA	PMID:25111187
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314870	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SEC61G gene	PMID:35295148
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:C009495	titanium dioxide results in increased expression of SEC61G mRNA	PMID:23557971
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SEC61G mRNA	PMID:18648102
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of SEC61G mRNA	PMID:38479592
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of SEC61G mRNA	PMID:29275510
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314870	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SEC61G mRNA	PMID:33221593
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased expression of SEC61G mRNA	PMID:32028606
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314870	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of SEC61G mRNA	PMID:38074096
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1596170	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SEC61G mRNA	PMID:25181051|PMID:30816183
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1596170	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SEC61G mRNA	PMID:36041667
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314870	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SEC61G mRNA	PMID:39298647
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1596170	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SEC61G mRNA	PMID:36041667
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314870	E	RGD:6480464	20230207	CTD	MESH:C008745	bisphenol F results in increased expression of SEC61G mRNA	PMID:35387338
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1596170	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of SEC61G mRNA	PMID:36041667
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314870	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of SEC61G mRNA	PMID:37019170
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1596170	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SEC61G mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SEC61G mRNA	PMID:35163327
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SEC61G mRNA	PMID:38568856
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1596170	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SEC61G mRNA; [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of SEC61G mRNA	PMID:35163327
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:D002922	Ciguatoxins affects the expression of SEC61G mRNA	PMID:18353800
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:D013755	[Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of SEC61G mRNA	PMID:19840844
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SEC61G mRNA	PMID:28302478
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of SEC61G mRNA	PMID:26352163
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1596170	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SEC61G mRNA	PMID:30047161
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SEC61G mRNA	PMID:20106945|PMID:27989131
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1596170	E	RGD:6480464	20230905	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of SEC61G mRNA	PMID:36653537
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:D000082	Acetaminophen affects the expression of SEC61G mRNA	PMID:17562736
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1596170	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SEC61G mRNA	PMID:33387578
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of SEC61G mRNA	PMID:29432896
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of SEC61G mRNA	PMID:18175754
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SEC61G mRNA	PMID:17942748
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SEC61G mRNA	PMID:17942748
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314870	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SEC61G mRNA; Nanotubes, Carbon results in increased expression of SEC61G mRNA	PMID:25554681|PMID:25620056
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1596170	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SEC61G mRNA	PMID:30047161
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1596170	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of SEC61G mRNA	PMID:24793618
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of SEC61G mRNA	PMID:18651567
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:6030	isoniazide	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in decreased expression of SEC61G protein	PMID:40015660
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SEC61G protein	PMID:32959892
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1314870	E	RGD:6480464	20140722	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of SEC61G mRNA	PMID:23650126
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1314870	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61G mRNA	PMID:39752319
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314870	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SEC61G mRNA	PMID:22206623
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:7599	Nivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in decreased expression of SEC61G protein	PMID:39638853
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1596170	E	RGD:6480464	20140805	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of SEC61G mRNA	PMID:15215175
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SEC61G mRNA	PMID:30851411
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of SEC61G mRNA	PMID:19159669
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1596170	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of SEC61G mRNA	PMID:30047161
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314870	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SEC61G mRNA	PMID:30294300
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1596170	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SEC61G mRNA	PMID:30047161
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1314870	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of SEC61G mRNA	PMID:39752319
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:9123	sertraline	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D020280	Sertraline results in decreased expression of SEC61G mRNA	PMID:24865413
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SEC61G mRNA	PMID:38568856
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1596170	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of SEC61G mRNA	PMID:30047161
1314869	SEC61G	SEC61 translocon subunit gamma	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1596170	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of SEC61G mRNA	PMID:23034163
1314871	RPL12	ribosomal protein L12	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of RPL12 protein	PMID:39638853
1314871	RPL12	ribosomal protein L12	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RPL12 mRNA	PMID:38218311
1314871	RPL12	ribosomal protein L12	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314872	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RPL12 mRNA	PMID:36331819
1314871	RPL12	ribosomal protein L12	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D011748	Pyrogallol results in increased expression of RPL12 mRNA	PMID:20362636
1314871	RPL12	ribosomal protein L12	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314872	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of RPL12 mRNA	PMID:30319688
1314871	RPL12	ribosomal protein L12	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314872	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RPL12 mRNA	PMID:39241906
1314871	RPL12	ribosomal protein L12	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314872	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of RPL12 mRNA]	PMID:39241906
1314871	RPL12	ribosomal protein L12	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1565106	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of RPL12 protein	PMID:32145629
1314871	RPL12	ribosomal protein L12	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314872	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RPL12 mRNA	PMID:39298647
1314871	RPL12	ribosomal protein L12	gene	CHEBI:16480	nitric oxide	increases expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D009569	Nitric Oxide deficiency results in increased expression of RPL12 mRNA	PMID:15878706
1314871	RPL12	ribosomal protein L12	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314872	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RPL12 mRNA	PMID:23892564
1314871	RPL12	ribosomal protein L12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RPL12 mRNA	PMID:19850644|PMID:33754040
1314871	RPL12	ribosomal protein L12	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D004051	PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of RPL12 mRNA]	PMID:19850644
1314871	RPL12	ribosomal protein L12	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RPL12 protein	PMID:37730182
1314871	RPL12	ribosomal protein L12	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314872	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL12 mRNA	PMID:36331819
1314871	RPL12	ribosomal protein L12	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1565106	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of RPL12 mRNA	PMID:28522335
1314871	RPL12	ribosomal protein L12	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1314872	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of RPL12 mRNA	PMID:27462272
1314871	RPL12	ribosomal protein L12	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPL12 mRNA	PMID:35301059
1314871	RPL12	ribosomal protein L12	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1565106	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in increased expression of RPL12 mRNA	PMID:41580963
1314871	RPL12	ribosomal protein L12	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1565106	E	RGD:6480464	20120412	CTD	MESH:D010126	[Ozone co-treated with Chlorine] results in decreased expression of RPL12 mRNA	PMID:18636392
1314871	RPL12	ribosomal protein L12	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1565106	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RPL12 mRNA	PMID:31150632|PMID:33387578
1314871	RPL12	ribosomal protein L12	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314872	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL12 mRNA	PMID:22206623
1314871	RPL12	ribosomal protein L12	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of RPL12 mRNA	PMID:27392435
1314871	RPL12	ribosomal protein L12	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314872	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of RPL12 mRNA	PMID:30912803
1314871	RPL12	ribosomal protein L12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPL12 mRNA	PMID:21570461
1314871	RPL12	ribosomal protein L12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1565106	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RPL12 mRNA	PMID:34747641
1314871	RPL12	ribosomal protein L12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RPL12 mRNA	PMID:15328365
1314871	RPL12	ribosomal protein L12	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1565106	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RPL12 mRNA	PMID:33387578
1314871	RPL12	ribosomal protein L12	gene	CHEBI:28714	S-butyl-DL-homocysteine (S,R)-sulfoximine	increases expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D019328	Buthionine Sulfoximine results in increased expression of RPL12 mRNA	PMID:15878706
1314871	RPL12	ribosomal protein L12	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314872	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of RPL12 protein	PMID:28918527
1314871	RPL12	ribosomal protein L12	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of RPL12 protein	PMID:29385562
1314871	RPL12	ribosomal protein L12	gene	CHEBI:29310	dichlorine	multiple interactions	ISO	RGD:1565106	E	RGD:6480464	20120412	CTD	MESH:D002713	[Ozone co-treated with Chlorine] results in decreased expression of RPL12 mRNA	PMID:18636392
1314871	RPL12	ribosomal protein L12	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of RPL12 protein	PMID:30528433
1314871	RPL12	ribosomal protein L12	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RPL12 mRNA	PMID:22228805
1314871	RPL12	ribosomal protein L12	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of RPL12 mRNA]	PMID:22228805
1314871	RPL12	ribosomal protein L12	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RPL12 mRNA]; arsenite promotes the reaction [G3BP1 protein binds to RPL12 protein]	PMID:32406909
1314871	RPL12	ribosomal protein L12	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1565106	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of RPL12 mRNA	PMID:16483693
1314871	RPL12	ribosomal protein L12	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1565106	E	RGD:6480464	20151215	CTD	MESH:D001761	Bleomycin results in increased expression of RPL12 protein	PMID:25933445
1314871	RPL12	ribosomal protein L12	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1565106	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of RPL12 mRNA	PMID:24136188
1314871	RPL12	ribosomal protein L12	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RPL12 mRNA	PMID:18648102
1314871	RPL12	ribosomal protein L12	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of RPL12 mRNA	PMID:30903817
1314871	RPL12	ribosomal protein L12	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1565106	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of RPL12 mRNA	PMID:30903817
1314871	RPL12	ribosomal protein L12	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL12 protein	PMID:34186270|PMID:37567409
1314871	RPL12	ribosomal protein L12	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1565106	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of RPL12 protein	PMID:32145629
1314871	RPL12	ribosomal protein L12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314872	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of RPL12 mRNA	PMID:38074096
1314871	RPL12	ribosomal protein L12	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1565106	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RPL12 mRNA	PMID:25181051|PMID:41034487
1314871	RPL12	ribosomal protein L12	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1565106	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RPL12 mRNA	PMID:36041667
1314871	RPL12	ribosomal protein L12	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1565106	E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of RPL12 mRNA	PMID:17316808
1314871	RPL12	ribosomal protein L12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314872	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RPL12 mRNA	PMID:39298647|PMID:40203079
1314871	RPL12	ribosomal protein L12	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1565106	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RPL12 mRNA	PMID:36041667
1314871	RPL12	ribosomal protein L12	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314872	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of RPL12 mRNA	PMID:38685157
1314871	RPL12	ribosomal protein L12	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RPL12 protein	PMID:34186270
1314871	RPL12	ribosomal protein L12	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1565106	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RPL12 mRNA	PMID:36041667
1314871	RPL12	ribosomal protein L12	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RPL12 protein	PMID:34186270
1314871	RPL12	ribosomal protein L12	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314872	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RPL12 mRNA	PMID:37019170
1314871	RPL12	ribosomal protein L12	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of RPL12 gene	PMID:22964155
1314871	RPL12	ribosomal protein L12	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of RPL12 mRNA	PMID:12771043
1314871	RPL12	ribosomal protein L12	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D010269	[Paraquat co-treated with Maneb] results in decreased expression of RPL12 mRNA	PMID:18386188
1314871	RPL12	ribosomal protein L12	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314872	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of RPL12 mRNA]	PMID:39241906
1314871	RPL12	ribosomal protein L12	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RPL12 mRNA	PMID:37042841
1314871	RPL12	ribosomal protein L12	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RPL12 mRNA	PMID:38568856
1314871	RPL12	ribosomal protein L12	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1565106	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RPL12 mRNA	PMID:33453195
1314871	RPL12	ribosomal protein L12	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPL12 mRNA	PMID:35301059
1314871	RPL12	ribosomal protein L12	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1565106	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of RPL12 mRNA	PMID:26194646
1314871	RPL12	ribosomal protein L12	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314872	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of RPL12 mRNA	PMID:28903501
1314871	RPL12	ribosomal protein L12	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RPL12 mRNA	PMID:31533062
1314871	RPL12	ribosomal protein L12	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of RPL12 mRNA	PMID:26352163
1314871	RPL12	ribosomal protein L12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of RPL12 mRNA	PMID:40419075
1314871	RPL12	ribosomal protein L12	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314872	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL12 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of RPL12 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of RPL12 mRNA	PMID:36331819
1314871	RPL12	ribosomal protein L12	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D014635	Valproic Acid affects the expression of RPL12 mRNA	PMID:17292431
1314871	RPL12	ribosomal protein L12	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D013629	Tamoxifen affects the expression of RPL12 mRNA	PMID:17555576
1314871	RPL12	ribosomal protein L12	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of RPL12 mRNA	PMID:36621641
1314871	RPL12	ribosomal protein L12	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314872	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RPL12 mRNA	PMID:28973697
1314871	RPL12	ribosomal protein L12	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of RPL12 protein	PMID:20543569
1314871	RPL12	ribosomal protein L12	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of RPL12 mRNA	PMID:17562736
1314871	RPL12	ribosomal protein L12	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of RPL12 mRNA	PMID:22230336
1314871	RPL12	ribosomal protein L12	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1565106	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RPL12 mRNA	PMID:33387578
1314871	RPL12	ribosomal protein L12	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of RPL12 mRNA	PMID:18175754
1314871	RPL12	ribosomal protein L12	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RPL12 mRNA	PMID:17555576
1314871	RPL12	ribosomal protein L12	gene	CHEBI:49662	indometacin	increases expression	ISO	RGD:1565106	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in increased expression of RPL12 mRNA	PMID:36868495
1314871	RPL12	ribosomal protein L12	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1314872	E	RGD:6480464	20200714	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of RPL12 mRNA	PMID:31978390
1314871	RPL12	ribosomal protein L12	gene	CHEBI:50867	ciprofibrate	increases expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:C019304	ciprofibrate results in increased expression of RPL12 mRNA	PMID:12771043
1314871	RPL12	ribosomal protein L12	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D008344	[Paraquat co-treated with Maneb] results in decreased expression of RPL12 mRNA	PMID:18386188
1314871	RPL12	ribosomal protein L12	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RPL12 protein	PMID:32959892
1314871	RPL12	ribosomal protein L12	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1314872	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of RPL12 mRNA	PMID:23650126
1314871	RPL12	ribosomal protein L12	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RPL12 mRNA	PMID:31758290
1314871	RPL12	ribosomal protein L12	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RPL12 protein	PMID:34186270
1314871	RPL12	ribosomal protein L12	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314872	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL12 mRNA	PMID:22206623
1314871	RPL12	ribosomal protein L12	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL12 protein	PMID:37664457
1314871	RPL12	ribosomal protein L12	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RPL12 mRNA	PMID:37199045
1314871	RPL12	ribosomal protein L12	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1565106	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of RPL12 mRNA	PMID:15215175
1314871	RPL12	ribosomal protein L12	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RPL12 gene]	PMID:28238834
1314871	RPL12	ribosomal protein L12	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital affects the expression of RPL12 mRNA	PMID:23091169
1314871	RPL12	ribosomal protein L12	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314872	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of RPL12 mRNA	PMID:30294300
1314871	RPL12	ribosomal protein L12	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1565106	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of RPL12 protein	PMID:28903499
1314871	RPL12	ribosomal protein L12	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of RPL12 protein	PMID:38348393
1314871	RPL12	ribosomal protein L12	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314872	E	RGD:6480464	20130618	CTD	MESH:C045950	propiconazole results in increased expression of RPL12 mRNA	PMID:21278054
1314871	RPL12	ribosomal protein L12	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314872	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of RPL12 mRNA]	PMID:39241906
1314871	RPL12	ribosomal protein L12	gene	CHEBI:88046	cylindrospermopsin	increases expression	ISO	RGD:1314872	E	RGD:6480464	20180703	CTD	MESH:C089595	cylindrospermopsin results in increased expression of RPL12 mRNA	PMID:20936652
1314871	RPL12	ribosomal protein L12	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL12 protein	PMID:37664457
1314871	RPL12	ribosomal protein L12	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RPL12 mRNA	PMID:38568856
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314876	E	RGD:6480464	20131220	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TCFAP2B gene	PMID:20938992
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of TFAP2B mRNA	PMID:23724009
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1314876	E	RGD:6480464	20220405	CTD	MESH:D019308	Palmitic Acid results in increased expression of TFAP2B mRNA	PMID:34968464
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1314876	E	RGD:6480464	20220405	CTD	MESH:D019308	[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA; Palmitic Acid inhibits the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA]; Palmitic Acid promotes the reaction [sodium arsenite results in increased expression of TFAP2B mRNA]; sodium arsenite promotes the reaction [Palmitic Acid results in increased expression of TFAP2B mRNA]	PMID:34968464
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TFAP2B mRNA	PMID:22378314
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TFAP2B mRNA	PMID:21179406
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314876	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of TFAP2B mRNA	PMID:33711761
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:16573	carbonyl sulfide	affects expression	ISO	RGD:1306321	E	RGD:6480464	20121009	CTD	MESH:C010063	carbonyl sulfide affects the expression of TFAP2B mRNA	PMID:19395590
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306321	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of TFAP2B mRNA	PMID:33387578
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314876	E	RGD:6480464	20131220	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TCFAP2B gene	PMID:20938992
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:167162	L-ascorbic acid 2-phosphate	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C011669	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2B mRNA	PMID:34480604
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:17650	cortisol	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:D006854	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TFAP2B mRNA	PMID:34480604
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:18291	manganese atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of TFAP2B mRNA	PMID:17175027
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1306321	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of TFAP2B mRNA	PMID:28522335
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of TFAP2B mRNA	PMID:21120746
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TFAP2B gene	PMID:27153756
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314876	E	RGD:6480464	20131220	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TCFAP2B gene	PMID:20938992
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of TFAP2B mRNA	PMID:28903495
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:28112	nickel atom	affects expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel affects the expression of TFAP2B mRNA	PMID:14575637
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TFAP2B mRNA	PMID:24768652|PMID:25583101
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:28112	nickel atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D009532	trichostatin A inhibits the reaction [Nickel affects the expression of TFAP2B mRNA]	PMID:14575637
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314876	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TFAP2B mRNA	PMID:24058054
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of TFAP2B mRNA	PMID:28001369
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of TFAP2B mRNA	PMID:26272509
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1314876	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in decreased methylation of TCFAP2B gene	PMID:32068019
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314876	E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in increased expression of TFAP2B mRNA	PMID:34968464
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314876	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA; Palmitic Acid inhibits the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA]; Palmitic Acid promotes the reaction [sodium arsenite results in increased expression of TFAP2B mRNA]; sodium arsenite promotes the reaction [Palmitic Acid results in increased expression of TFAP2B mRNA]	PMID:34968464
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of TFAP2B mRNA	PMID:22378314
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314876	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TFAP2B mRNA	PMID:22228805
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TFAP2B mRNA	PMID:22316170
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314876	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TFAP2B mRNA	PMID:22228805
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TFAP2B 3' UTR; Benzo(a)pyrene results in increased methylation of TFAP2B exon; Benzo(a)pyrene results in increased methylation of TFAP2B promoter	PMID:27901495
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:3020	benzalkonium chloride	multiple interactions	ISO	RGD:1314876	E	RGD:6480464	20190219	CTD	MESH:D001548	[IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of TFAP2B mRNA	PMID:30171875
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of TFAP2B mRNA	PMID:37690743
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C015358	methylparaben results in increased expression of TFAP2B mRNA	PMID:37690743
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306321	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TFAP2B mRNA	PMID:30047161
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314876	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TCFAP2B promoter	PMID:35295148
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314876	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TCFAP2B gene	PMID:35295148
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306321	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TFAP2B mRNA	PMID:25181051
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314876	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of TFAP2B mRNA	PMID:30951980
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1314876	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of TFAP2B mRNA	PMID:26682919
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314876	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of TFAP2B mRNA	PMID:30951980
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314876	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of TFAP2B mRNA	PMID:30951980
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:34698	diethyl phthalate	decreases expression	ISO	RGD:1306321	E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of TFAP2B mRNA	PMID:32341500
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	ISO	RGD:1314876	E	RGD:6480464	20220405	CTD	MESH:D015056	[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA; [sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA; Palmitic Acid inhibits the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA]	PMID:34968464
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306321	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TFAP2B mRNA	PMID:35163327
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:35154	manganese(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008345	Manganese results in increased expression of TFAP2B mRNA	PMID:17175027
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306321	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of TFAP2B mRNA	PMID:35163327
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TFAP2B mRNA	PMID:23179753|PMID:28001369
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314876	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in decreased expression of TCFAP2B mRNA	PMID:24896083
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TFAP2B gene	PMID:29154799
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of TFAP2B mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:37690743
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA	PMID:27188386
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306321	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TFAP2B mRNA	PMID:30047161
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1314876	E	RGD:6480464	20220405	CTD	MESH:D003907	[Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA; [sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA; Palmitic Acid inhibits the reaction [[sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of TFAP2B mRNA]	PMID:34968464
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of TFAP2B mRNA	PMID:26272509
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA	PMID:27188386
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of TFAP2B mRNA	PMID:24935251|PMID:26272509
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA; trichostatin A inhibits the reaction [Nickel affects the expression of TFAP2B mRNA]	PMID:14575637|PMID:27188386
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of TFAP2B mRNA	PMID:26690555
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of TFAP2B mRNA	PMID:24714768
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA	PMID:27188386
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306321	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TFAP2B mRNA	PMID:30047161
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of TFAP2B mRNA	PMID:26272509
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA	PMID:27188386
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:62878	XAV939	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C544261	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2B mRNA	PMID:34480604
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:63041	manganese(II) chloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C025340	manganese chloride results in increased expression of TFAP2B mRNA	PMID:17175027
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314876	E	RGD:6480464	20131220	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TCFAP2B mRNA	PMID:23650126
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314876	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TFAP2B mRNA	PMID:22206623
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1306321	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of TFAP2B mRNA	PMID:27840820
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of TFAP2B mRNA	PMID:34480604
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:75261	arotinoid acid	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C038864	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TFAP2B mRNA	PMID:34480604
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:75408	sulindac sulfide	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C025462	sulindac sulfide results in increased expression of TFAP2B mRNA	PMID:16184548
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA	PMID:27188386
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TFAP2B gene]	PMID:28238834
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of TFAP2B mRNA	PMID:26705709
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306321	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TFAP2B mRNA	PMID:30047161
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306321	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of TFAP2B mRNA	PMID:25825206
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:85990	panobinostat	affects expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat affects the expression of TFAP2B mRNA	PMID:26733615
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of TFAP2B mRNA	PMID:26272509
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	(+)-JQ1 compound promotes the reaction [Panobinostat affects the expression of TFAP2B mRNA]; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA; Panobinostat promotes the reaction [(+)-JQ1 compound affects the expression of TFAP2B mRNA]	PMID:26733615|PMID:27188386
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:88542	Butylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C038091	butylparaben results in increased expression of TFAP2B mRNA	PMID:37690743
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:91091	CHIR 99021	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C473711	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of TFAP2B mRNA; [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of TFAP2B mRNA	PMID:34480604
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of TFAP2B mRNA; [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TFAP2B mRNA	PMID:27188386|PMID:34480604
1314875	TFAP2B	transcription factor AP-2 beta	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of TFAP2B mRNA	PMID:22378314
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314878	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TSHZ3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TSHZ3 gene	PMID:20938992
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of TSHZ3 mRNA	PMID:21934132|PMID:23724009
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:15379	dioxygen	affects methylation	ISO	RGD:1314878	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency affects the methylation of TSHZ3 promoter	PMID:24205000
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1314878	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of TSHZ3 mRNA	PMID:24205000
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306322	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of TSHZ3 gene	PMID:35440735
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TSHZ3 mRNA	PMID:22378314
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of TSHZ3 mRNA	PMID:31614463
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of TSHZ3 mRNA	PMID:30165855
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314878	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TSHZ3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TSHZ3 gene	PMID:20938992
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of TSHZ3 mRNA	PMID:20655997
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TSHZ3 mRNA	PMID:21179406
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306322	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TSHZ3 mRNA	PMID:33387578
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in increased expression of TSHZ3 mRNA	PMID:20368581
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TSHZ3 mRNA	PMID:35301059
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TSHZ3 exon; Aflatoxin B1 results in increased methylation of TSHZ3 gene	PMID:27153756|PMID:30157460
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314878	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TSHZ3 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TSHZ3 gene	PMID:20938992
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of TSHZ3 mRNA	PMID:27392435
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of TSHZ3 mRNA	PMID:27392435
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314878	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TSHZ3 mRNA	PMID:24058054
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306322	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TSHZ3 mRNA	PMID:34747641
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314878	E	RGD:6480464	20240604	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TSHZ3 mRNA	PMID:37172768
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TSHZ3 mRNA	PMID:28001369
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TSHZ3 mRNA	PMID:33212167
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306322	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of TSHZ3 mRNA	PMID:28959563
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TSHZ3 mRNA	PMID:20971185
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of TSHZ3 mRNA	PMID:39719251
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TSHZ3 promoter	PMID:27901495
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314878	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TSHZ3 mRNA	PMID:32417428
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:29866	arsenite(3-)	decreases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased methylation of TSHZ3 promoter	PMID:23974009
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of TSHZ3 mRNA	PMID:20971185
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TSHZ3 mRNA	PMID:20382639
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of TSHZ3 mRNA	PMID:25258189
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314878	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TSHZ3 promoter	PMID:35295148
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306322	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TSHZ3 mRNA	PMID:34492290
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306322	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of TSHZ3 mRNA	PMID:25181051
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306322	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of TSHZ3 mRNA	PMID:30816183
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314878	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of TSHZ3 mRNA	PMID:30951980
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of TSHZ3 mRNA	PMID:25979313
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of TSHZ3 polyA tail	PMID:30157460
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314878	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TSHZ3 mRNA	PMID:21266533
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TSHZ3 mRNA	PMID:37042841
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TSHZ3 mRNA	PMID:38382870
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TSHZ3 mRNA	PMID:35301059
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:35559	furan	decreases methylation	ISO	RGD:1306322	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in decreased methylation of TSHZ3 gene	PMID:27387713
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306322	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of TSHZ3 mRNA	PMID:27387713
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314878	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TSHZ3 mRNA	PMID:40194260
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of TSHZ3 mRNA	PMID:23179753
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of TSHZ3 gene	PMID:29154799
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306322	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of TSHZ3 mRNA	PMID:38685447|PMID:41580965
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of TSHZ3 mRNA	PMID:27188386
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSHZ3 mRNA	PMID:27188386
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of TSHZ3 mRNA	PMID:24935251|PMID:26272509
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSHZ3 mRNA	PMID:27188386
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of TSHZ3 mRNA	PMID:26690555
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:46680	serpentine asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of TSHZ3 3' UTR	PMID:29523930
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of TSHZ3 mRNA	PMID:25258189
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306322	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of TSHZ3 mRNA	PMID:41580965
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TSHZ3 mRNA	PMID:26378955
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of TSHZ3 mRNA	PMID:24810058
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of TSHZ3 polyA tail	PMID:30157460
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306322	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TSHZ3 gene	PMID:35440735
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TSHZ3 mRNA	PMID:31758290
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSHZ3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSHZ3 mRNA	PMID:27188386
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TSHZ3 gene]	PMID:28238834
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of TSHZ3 mRNA	PMID:19095052
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of TSHZ3 mRNA	PMID:20368581
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314878	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of TSHZ3 mRNA	PMID:21795629
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1306322	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of TSHZ3 mRNA	PMID:24780913
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSHZ3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSHZ3 mRNA	PMID:27188386
1314877	TSHZ3	teashirt zinc finger homeobox 3	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1306322	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of TSHZ3 gene	PMID:31079544
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314880	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of OSGIN2 mRNA	PMID:33045310
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of OSGIN2 gene	PMID:20938992
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of OSGIN2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of OSGIN2 mRNA	PMID:32699268
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of OSGIN2 mRNA	PMID:24763279
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of OSGIN2 mRNA	PMID:26079696
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of OSGIN2 mRNA	PMID:20044591
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of OSGIN2 mRNA	PMID:21632981
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of OSGIN2 gene	PMID:20938992
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of OSGIN2 mRNA	PMID:37042841
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of OSGIN2 mRNA	PMID:37992649
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of OSGIN2 mRNA	PMID:37992649
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20241203	CTD	MESH:D004051	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OSGIN2 mRNA	PMID:39150890
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:177802	Cuprizon	affects expression	ISO	RGD:1306323	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone affects the expression of OSGIN2 mRNA	PMID:27523638
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306323	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of OSGIN2 mRNA	PMID:26577399
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306323	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of OSGIN2 mRNA	PMID:33387578
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of OSGIN2 mRNA	PMID:28818685
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of OSGIN2 mRNA	PMID:35301059
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of OSGIN2 gene	PMID:27153756
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of OSGIN2 mRNA	PMID:27153756
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314880	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of OSGIN2 mRNA	PMID:19770486
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of OSGIN2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of OSGIN2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of OSGIN2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of OSGIN2 mRNA	PMID:32699268|PMID:41430723
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:27086	tributylstannane	decreases expression	ISO	RGD:1306323	E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in decreased expression of OSGIN2 mRNA	PMID:31129395
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1306323	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in decreased expression of OSGIN2 mRNA	PMID:31129395
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314880	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of OSGIN2 mRNA	PMID:31919559
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of OSGIN2 gene	PMID:20938992
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of OSGIN2 mRNA	PMID:27392435
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of OSGIN2 mRNA	PMID:33212167
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of OSGIN2 mRNA	PMID:39709020
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:28358	rac-lactic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of OSGIN2 mRNA	PMID:30851411
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of OSGIN2 mRNA	PMID:32763439
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of OSGIN2 mRNA	PMID:29803840
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of OSGIN2 mRNA	PMID:37992649
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of OSGIN2 mRNA	PMID:38568856
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of OSGIN2 mRNA	PMID:26238291
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of OSGIN2 5' UTR	PMID:27901495
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314880	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of OSGIN2 mRNA	PMID:19073995|PMID:33720480
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306323	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of OSGIN2 mRNA	PMID:25729387
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314880	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of OSGIN2 promoter	PMID:35295148
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314880	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of OSGIN2 promoter	PMID:35295148
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306323	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of OSGIN2 mRNA	PMID:23411599|PMID:34492290
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314880	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of OSGIN2 mRNA	PMID:23811191
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of OSGIN2 mRNA	PMID:19710929
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306323	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of OSGIN2 mRNA	PMID:30816183
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306323	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of OSGIN2 mRNA	PMID:31129395
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306323	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in decreased expression of OSGIN2 mRNA	PMID:31129395
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1314880	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of OSGIN2 mRNA	PMID:26377693
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20241203	CTD	MESH:C027561	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OSGIN2 mRNA	PMID:39150890
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314880	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of OSGIN2 mRNA	PMID:37019170
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20241203	CTD	MESH:D003993	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OSGIN2 mRNA	PMID:39150890
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:34698	diethyl phthalate	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20241203	CTD	MESH:C007379	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OSGIN2 mRNA	PMID:39150890
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of OSGIN2 mRNA	PMID:37042841
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306323	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of OSGIN2 mRNA	PMID:35163327
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of OSGIN2 mRNA	PMID:38174414
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of OSGIN2 mRNA	PMID:35301059
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20241203	CTD	MESH:C012125	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OSGIN2 mRNA	PMID:39150890
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306323	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of OSGIN2 mRNA	PMID:35163327
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306323	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of OSGIN2 mRNA	PMID:25539665
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of OSGIN2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of OSGIN2 mRNA	PMID:32699268
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314880	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of OSGIN2 mRNA	PMID:40194260
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of OSGIN2 mRNA	PMID:28302478
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of OSGIN2 mRNA	PMID:31533062
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of OSGIN2 mRNA	PMID:25979313
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of OSGIN2 mRNA	PMID:26272509|PMID:28001369
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OSGIN2 mRNA	PMID:27188386
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of OSGIN2 mRNA	PMID:27989131
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of OSGIN2 mRNA	PMID:20106945|PMID:25562108
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314880	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of OSGIN2 mRNA	PMID:28973697
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of OSGIN2 mRNA	PMID:37992649
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of OSGIN2 mRNA	PMID:38832940
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314880	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of OSGIN2 mRNA	PMID:17562736
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306323	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of OSGIN2 mRNA	PMID:33387578
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of OSGIN2 mRNA	PMID:31838189
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of OSGIN2 mRNA	PMID:38568856
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314880	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of OSGIN2 mRNA	PMID:25620056
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of OSGIN2 mRNA	PMID:21641980
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306323	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of OSGIN2 mRNA	PMID:25729387
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314880	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of OSGIN2 mRNA	PMID:19812364
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of OSGIN2 mRNA	PMID:28988120
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314880	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of OSGIN2 mRNA	PMID:22206623
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:78320	2-hydroxypropanoic acid	affects expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid affects the expression of OSGIN2 mRNA	PMID:30851411
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OSGIN2 mRNA	PMID:27188386
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:79053	diisobutyl phthalate	multiple interactions	ISO	RGD:1314880	E	RGD:6480464	20241203	CTD	MESH:C025605	[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of OSGIN2 mRNA	PMID:39150890
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of OSGIN2 mRNA	PMID:27188386
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306323	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of OSGIN2 mRNA	PMID:19281266
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of OSGIN2 mRNA	PMID:38568856
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of OSGIN2 mRNA	PMID:29301935
1314879	OSGIN2	oxidative stress induced growth inhibitor family member 2	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306323	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of OSGIN2 mRNA	PMID:23034163
1314882	PPAN	peter pan homolog	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of PPAN protein	PMID:39638853
1314882	PPAN	peter pan homolog	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314883	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PPAN mRNA	PMID:20188158
1314882	PPAN	peter pan homolog	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PPAN gene	PMID:20938992
1314882	PPAN	peter pan homolog	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1306325	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of PPAN mRNA	PMID:33729688
1314882	PPAN	peter pan homolog	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPAN mRNA	PMID:30529165
1314882	PPAN	peter pan homolog	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PPAN mRNA	PMID:36331819
1314882	PPAN	peter pan homolog	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of PPAN mRNA	PMID:20044591
1314882	PPAN	peter pan homolog	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314883	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PPAN mRNA	PMID:39241906
1314882	PPAN	peter pan homolog	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306325	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PPAN mRNA	PMID:32145629
1314882	PPAN	peter pan homolog	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of PPAN mRNA	PMID:23019147|PMID:31614463
1314882	PPAN	peter pan homolog	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314883	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PPAN mRNA	PMID:39298647
1314882	PPAN	peter pan homolog	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314883	E	RGD:6480464	20201103	CTD	MESH:D007631	Chlordecone results in increased expression of PPAN mRNA	PMID:29980752
1314882	PPAN	peter pan homolog	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PPAN gene	PMID:20938992
1314882	PPAN	peter pan homolog	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PPAN mRNA	PMID:20655997
1314882	PPAN	peter pan homolog	gene	CHEBI:16856	glutathione	increases expression	ISO	RGD:1306325	E	RGD:6480464	20131220	CTD	MESH:D005978	Glutathione deficiency results in increased expression of PPAN mRNA	PMID:20621112
1314882	PPAN	peter pan homolog	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of PPAN mRNA	PMID:33359661
1314882	PPAN	peter pan homolog	gene	CHEBI:17688	(S)-nicotine	increases expression	ISO	RGD:1314883	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of PPAN mRNA	PMID:17456735
1314882	PPAN	peter pan homolog	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of PPAN protein	PMID:37730182
1314882	PPAN	peter pan homolog	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306325	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PPAN mRNA	PMID:22061828|PMID:33387578
1314882	PPAN	peter pan homolog	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PPAN mRNA	PMID:28818685
1314882	PPAN	peter pan homolog	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PPAN mRNA	PMID:36331819
1314882	PPAN	peter pan homolog	gene	CHEBI:18723	nicotine	increases expression	ISO	RGD:1314883	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of PPAN mRNA	PMID:17456735
1314882	PPAN	peter pan homolog	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of PPAN protein	PMID:23301498
1314882	PPAN	peter pan homolog	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PPAN mRNA	PMID:23649840
1314882	PPAN	peter pan homolog	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314883	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of PPAN mRNA	PMID:19770486
1314882	PPAN	peter pan homolog	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of PPAN mRNA	PMID:23649840
1314882	PPAN	peter pan homolog	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of PPAN mRNA	PMID:35430440
1314882	PPAN	peter pan homolog	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306325	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PPAN mRNA	PMID:30779732
1314882	PPAN	peter pan homolog	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306325	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PPAN mRNA	PMID:31150632
1314882	PPAN	peter pan homolog	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314883	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PPAN mRNA	PMID:27339419|PMID:31919559
1314882	PPAN	peter pan homolog	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PPAN gene	PMID:20938992
1314882	PPAN	peter pan homolog	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPAN gene	PMID:25304211
1314882	PPAN	peter pan homolog	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPAN mRNA	PMID:40504410
1314882	PPAN	peter pan homolog	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of PPAN mRNA	PMID:19684285
1314882	PPAN	peter pan homolog	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1314883	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of PPAN protein	PMID:25505154
1314882	PPAN	peter pan homolog	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PPAN mRNA	PMID:27392435
1314882	PPAN	peter pan homolog	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of PPAN mRNA	PMID:23019147
1314882	PPAN	peter pan homolog	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PPAN mRNA	PMID:25583101
1314882	PPAN	peter pan homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314883	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PPAN mRNA	PMID:18343893|PMID:21570461
1314882	PPAN	peter pan homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPAN mRNA	PMID:19684285
1314882	PPAN	peter pan homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314883	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PPAN mRNA	PMID:19770486
1314882	PPAN	peter pan homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of PPAN mRNA	PMID:19684285
1314882	PPAN	peter pan homolog	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPAN mRNA	PMID:17942748
1314882	PPAN	peter pan homolog	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of PPAN mRNA	PMID:32763439
1314882	PPAN	peter pan homolog	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PPAN mRNA	PMID:20971185
1314882	PPAN	peter pan homolog	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PPAN mRNA	PMID:20371982
1314882	PPAN	peter pan homolog	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPAN mRNA	PMID:40504410
1314882	PPAN	peter pan homolog	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1314883	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of PPAN mRNA	PMID:17127020
1314882	PPAN	peter pan homolog	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314883	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PPAN mRNA	PMID:21715664
1314882	PPAN	peter pan homolog	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PPAN promoter	PMID:27901495
1314882	PPAN	peter pan homolog	gene	CHEBI:3000	beauvericin	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C004456	beauvericin results in decreased expression of PPAN mRNA	PMID:29203277
1314882	PPAN	peter pan homolog	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of PPAN mRNA	PMID:20971185
1314882	PPAN	peter pan homolog	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of PPAN mRNA	PMID:25075043
1314882	PPAN	peter pan homolog	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of PPAN mRNA	PMID:25895662
1314882	PPAN	peter pan homolog	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306325	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of PPAN mRNA	PMID:24136188
1314882	PPAN	peter pan homolog	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1306325	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of PPAN mRNA	PMID:16507785
1314882	PPAN	peter pan homolog	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306325	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PPAN mRNA	PMID:23411599|PMID:34492290
1314882	PPAN	peter pan homolog	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314883	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of PPAN mRNA	PMID:28472532
1314882	PPAN	peter pan homolog	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of PPAN mRNA	PMID:28329830
1314882	PPAN	peter pan homolog	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306325	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of PPAN mRNA	PMID:32145629
1314882	PPAN	peter pan homolog	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306325	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PPAN mRNA	PMID:25181051|PMID:41034487
1314882	PPAN	peter pan homolog	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314883	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PPAN mRNA	PMID:39298647
1314882	PPAN	peter pan homolog	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314883	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of PPAN mRNA	PMID:38685157
1314882	PPAN	peter pan homolog	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314883	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of PPAN mRNA	PMID:37019170
1314882	PPAN	peter pan homolog	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314883	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PPAN mRNA	PMID:17361019|PMID:21266533
1314882	PPAN	peter pan homolog	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1306325	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of PPAN mRNA	PMID:32680482
1314882	PPAN	peter pan homolog	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PPAN mRNA	PMID:38174414
1314882	PPAN	peter pan homolog	gene	CHEBI:35572	phorone	affects expression	ISO	RGD:1306325	E	RGD:6480464	20131220	CTD	MESH:C018637	phorone affects the expression of PPAN mRNA	PMID:18198479
1314882	PPAN	peter pan homolog	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1314883	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of PPAN mRNA	PMID:28903501
1314882	PPAN	peter pan homolog	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314883	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of PPAN mRNA	PMID:18353800
1314882	PPAN	peter pan homolog	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PPAN mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PPAN mRNA	PMID:36331819
1314882	PPAN	peter pan homolog	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1306325	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of PPAN mRNA	PMID:25993096
1314882	PPAN	peter pan homolog	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in decreased expression of PPAN mRNA	PMID:22083351
1314882	PPAN	peter pan homolog	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314883	E	RGD:6480464	20120515	CTD	MESH:D014635	Valproic Acid results in decreased expression of PPAN mRNA	PMID:19136453|PMID:21427059
1314882	PPAN	peter pan homolog	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PPAN gene	PMID:29154799
1314882	PPAN	peter pan homolog	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PPAN mRNA	PMID:20106945|PMID:25562108
1314882	PPAN	peter pan homolog	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1306325	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PPAN mRNA	PMID:25596134
1314882	PPAN	peter pan homolog	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314883	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of PPAN mRNA	PMID:19770486
1314882	PPAN	peter pan homolog	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314883	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of PPAN mRNA	PMID:17555576
1314882	PPAN	peter pan homolog	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1314883	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of PPAN mRNA	PMID:18502557
1314882	PPAN	peter pan homolog	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1306325	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of PPAN mRNA	PMID:24136188
1314882	PPAN	peter pan homolog	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314883	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PPAN mRNA	PMID:17562736
1314882	PPAN	peter pan homolog	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306325	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PPAN mRNA	PMID:33387578
1314882	PPAN	peter pan homolog	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PPAN gene	PMID:25304211
1314882	PPAN	peter pan homolog	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PPAN mRNA	PMID:40504410
1314882	PPAN	peter pan homolog	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306325	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of PPAN mRNA	PMID:29391264
1314882	PPAN	peter pan homolog	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314883	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of PPAN mRNA	PMID:17555576
1314882	PPAN	peter pan homolog	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314883	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PPAN mRNA	PMID:17942748
1314882	PPAN	peter pan homolog	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPAN mRNA	PMID:17942748
1314882	PPAN	peter pan homolog	gene	CHEBI:5001	fenofibrate	affects expression	ISO	RGD:1306325	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate affects the expression of PPAN mRNA	PMID:25596134
1314882	PPAN	peter pan homolog	gene	CHEBI:50035	alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of PPAN mRNA	PMID:25075043
1314882	PPAN	peter pan homolog	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314883	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PPAN mRNA	PMID:25554681
1314882	PPAN	peter pan homolog	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314883	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PPAN mRNA	PMID:35964746
1314882	PPAN	peter pan homolog	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306325	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PPAN mRNA	PMID:24136188
1314882	PPAN	peter pan homolog	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1306325	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of PPAN mRNA	PMID:25596134
1314882	PPAN	peter pan homolog	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PPAN mRNA	PMID:31758290
1314882	PPAN	peter pan homolog	gene	CHEBI:749016	gossypol acetic acid	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C028178	gossypol acetic acid results in increased expression of PPAN protein	PMID:29938581
1314882	PPAN	peter pan homolog	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306325	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PPAN mRNA	PMID:24136188
1314882	PPAN	peter pan homolog	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PPAN gene]	PMID:28238834
1314882	PPAN	peter pan homolog	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1314883	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of PPAN mRNA	PMID:18343893
1314882	PPAN	peter pan homolog	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314883	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PPAN mRNA	PMID:30294300
1314882	PPAN	peter pan homolog	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306325	E	RGD:6480464	20131220	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of PPAN mRNA	PMID:21346803
1314882	PPAN	peter pan homolog	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1314883	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of PPAN mRNA	PMID:32835833
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314885	E	RGD:6480464	20250401	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of TADA3L mRNA	PMID:20188158
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TADA3 mRNA	PMID:33167477
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of TADA3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of TADA3 mRNA	PMID:32699268
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D011794	Quercetin results in decreased expression of TADA3 mRNA	PMID:36982678
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314885	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TADA3 mRNA	PMID:39241906
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TADA3 mRNA	PMID:37042841
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TADA3 protein	PMID:37730182
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1564009	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TADA3 mRNA	PMID:33387578
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:17846	(S)-naringenin	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C005273	[naringenin metabolite co-treated with bisphenol A] results in decreased expression of TADA3 mRNA	PMID:36235125
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TADA3 mRNA	PMID:39836092
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:22977	cadmium atom	decreases expression	ISO	RGD:1314885	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in decreased expression of TADA3 mRNA	PMID:24067728
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TADA3 gene	PMID:28458013
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of TADA3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of TADA3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of TADA3 mRNA	PMID:32699268
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314885	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TADA3 mRNA	PMID:31919559
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314885	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TADA3 mRNA]	PMID:22206623
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TADA3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TADA3 mRNA	PMID:39836092
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TADA3 mRNA	PMID:19244175
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314885	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of TADA3 mRNA	PMID:28960355
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20250401	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of TADA3L mRNA	PMID:23557933
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314885	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of TADA3 mRNA	PMID:30912803
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314885	E	RGD:6480464	20250401	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TADA3L mRNA	PMID:21570461
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1564009	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TADA3 mRNA	PMID:33387578
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TADA3 mRNA	PMID:33212167
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TADA3 mRNA	PMID:29803840
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of TADA3 mRNA	PMID:25879800
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TADA3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TADA3 mRNA	PMID:39836092
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TADA3 3' UTR	PMID:27901495
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1564009	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TADA3 mRNA	PMID:30047161
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314885	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TADA3 gene	PMID:35295148
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1564009	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of TADA3 mRNA	PMID:34492290
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of TADA3 mRNA	PMID:12419474
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314885	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of TADA3 promoter	PMID:27334623
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of TADA3 mRNA	PMID:36235125
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C006780	[naringenin metabolite co-treated with bisphenol A] results in decreased expression of TADA3 mRNA	PMID:36235125
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of TADA3 mRNA	PMID:19244175
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314885	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of TADA3 mRNA	PMID:37019170
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TADA3 mRNA	PMID:37042841
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TADA3 mRNA	PMID:39836092
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TADA3 mRNA	PMID:38568856
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1564009	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of TADA3 mRNA	PMID:30047161
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TADA3L mRNA	PMID:19320972|PMID:19376846
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of TADA3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of TADA3 mRNA	PMID:32699268
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of TADA3 mRNA	PMID:19244175
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:3962	curcumin	affects expression	ISO	RGD:1564009	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin affects the expression of TADA3 mRNA	PMID:18539377
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1564009	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of TADA3 mRNA	PMID:33387578
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TADA3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TADA3 mRNA	PMID:39836092
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1564009	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TADA3 mRNA	PMID:30047161
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:61057	tacrolimus hydrate	decreases expression	ISO	RGD:1314885	E	RGD:6480464	20150127	CTD	MESH:D016559	Tacrolimus results in decreased expression of TADA3 mRNA	PMID:25270620
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of TADA3 mRNA	PMID:39836092
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of TADA3 mRNA	PMID:12419474
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of TADA3L mRNA	PMID:22101062
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TADA3 mRNA	PMID:31758290
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314885	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of TADA3 mRNA	PMID:22206623
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314885	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of TADA3 mRNA]	PMID:22206623
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1564009	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TADA3 mRNA	PMID:30047161
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314885	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of TADA3 mRNA	PMID:40826991
1314884	TADA3	transcriptional adaptor 3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TADA3 mRNA	PMID:29301935
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314888	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PRPS1L1 mRNA	PMID:39241906
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PRPS1L1 mRNA	PMID:35811015
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306328	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PRPS1L1 mRNA	PMID:33387578
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314888	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PRPS1L1 mRNA	PMID:34319233
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PRPS1L1 mRNA	PMID:28818685
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PRPS1L1 mRNA	PMID:19549813
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PRPS1L1 gene	PMID:27153756
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1306328	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of PRPS1L1 mRNA	PMID:16483693
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in decreased expression of PRPS1L1 mRNA	PMID:31121516
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306328	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PRPS1L1 mRNA	PMID:25181051|PMID:41034487
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of PRPS1L1 mRNA	PMID:31121516
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:34575	bisphenol F	decreases expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of PRPS1L1 mRNA	PMID:31121516
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of PRPS1L1 mRNA	PMID:28628672
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314888	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PRPS1L1 mRNA	PMID:40194260
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:41774	tamoxifen	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of PRPS1L1 mRNA	PMID:15590111
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of PRPS1L1 mRNA	PMID:28628672
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314888	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PRPS1L1 mRNA	PMID:17562736
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PRPS1L1 mRNA	PMID:35811015
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of PRPS1L1 mRNA	PMID:28628672
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:72754	bisphenol AF	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in decreased expression of PRPS1L1 mRNA	PMID:31121516
1314887	PRPS1L1	phosphoribosyl pyrophosphate synthetase 1 like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PRPS1L1 gene]	PMID:28238834
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1622909	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of POLR2H mRNA	PMID:37995155
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of POLR2H mRNA	PMID:23724009
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1622909	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of POLR2H mRNA	PMID:30529165
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of POLR2H mRNA	PMID:26079696
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1561203	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of POLR2H mRNA	PMID:36841081
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1622909	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POLR2H mRNA	PMID:39241906
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1622909	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of POLR2H mRNA	PMID:39298647
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of POLR2H mRNA	PMID:37042841
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1561203	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of POLR2H mRNA	PMID:22061828
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1622909	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of POLR2H mRNA	PMID:36331819
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:18388	apigenin	increases expression	ISO	RGD:1622909	E	RGD:6480464	20121113	CTD	MESH:D047310	Apigenin results in increased expression of POLR2H mRNA	PMID:22359648
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of POLR2H mRNA	PMID:19549813
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1561203	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of POLR2H mRNA	PMID:33387578
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1622909	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of POLR2H mRNA	PMID:27339419|PMID:31919559
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1622909	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of POLR2H mRNA	PMID:25629700
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1622909	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POLR2H mRNA	PMID:22206623
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of POLR2H gene	PMID:25304211
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1622909	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of POLR2H mRNA	PMID:40504410
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:2762	antimycin A	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in increased expression of POLR2H mRNA	PMID:33512557
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased secretion of POLR2H protein	PMID:38460933
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of POLR2H mRNA	PMID:27392435
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of POLR2H mRNA	PMID:27392435
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1622909	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POLR2H mRNA	PMID:21570461
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1561203	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POLR2H mRNA	PMID:33387578
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of POLR2H mRNA	PMID:32763439
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of POLR2H mRNA	PMID:38568856
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1622909	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of POLR2H mRNA	PMID:40504410
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1622909	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of POLR2H mRNA]	PMID:22228805
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1561203	E	RGD:6480464	20150707	CTD	MESH:D000643	Ammonium Chloride affects the expression of POLR2H mRNA	PMID:16483693
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1622909	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of POLR2H promoter alternative form	PMID:35295148
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1622909	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of POLR2H gene	PMID:35295148
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1561203	E	RGD:6480464	20150707	CTD	MESH:C006253	pirinixic acid results in decreased expression of POLR2H mRNA	PMID:19162173
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1622909	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of POLR2H mRNA	PMID:18445702
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1622909	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of POLR2H mRNA	PMID:28472532
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1561203	E	RGD:6480464	20150707	CTD	MESH:C006780	bisphenol A results in increased expression of POLR2H mRNA	PMID:25181051
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1561203	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of POLR2H gene	PMID:28505145
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1622909	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of POLR2H mRNA	PMID:38685157
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1622909	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of POLR2H mRNA	PMID:37019170
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1622909	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of POLR2H protein	PMID:35362542
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1622909	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of POLR2H protein]	PMID:35362542
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:34873	N-nitrosodiethylamine	decreases expression	ISO	RGD:1561203	E	RGD:6480464	20150707	CTD	MESH:D004052	Diethylnitrosamine results in decreased expression of POLR2H mRNA	PMID:20360939
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1561203	E	RGD:6480464	20150707	CTD	MESH:D026023	Permethrin results in increased expression of POLR2H mRNA	PMID:19017407
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1622909	E	RGD:6480464	20230207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of POLR2H protein	PMID:36214631
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:38604	pyrimidifen	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in increased expression of POLR2H mRNA	PMID:33512557
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of POLR2H mRNA	PMID:19167446
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1622909	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of POLR2H mRNA	PMID:36331819
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of POLR2H mRNA	PMID:33512557
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622909	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of POLR2H mRNA	PMID:17562736
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1561203	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of POLR2H mRNA	PMID:33387578
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased secretion of POLR2H protein	PMID:38460933
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of POLR2H gene	PMID:25304211
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1622909	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of POLR2H mRNA	PMID:40504410
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1561203	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of POLR2H mRNA	PMID:29391264
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1622909	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of POLR2H mRNA	PMID:35436446
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1622909	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of POLR2H protein]	PMID:35362542
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1622909	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of POLR2H mRNA	PMID:25554681
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1622909	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of POLR2H mRNA	PMID:40234311
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:6078	ivermectin	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of POLR2H protein	PMID:32959892
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1622909	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of POLR2H mRNA	PMID:23650126
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:72676	versicolorin A	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:C029826	versicolorin A results in increased expression of POLR2H mRNA	PMID:32106047
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of POLR2H protein	PMID:34186270
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1622909	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of POLR2H mRNA	PMID:22206623
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of POLR2H protein	PMID:37664457
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of POLR2H mRNA	PMID:18548127
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of POLR2H mRNA	PMID:19159669
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1622909	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of POLR2H mRNA	PMID:30294300
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of POLR2H mRNA	PMID:33512557
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1561203	E	RGD:6480464	20150707	CTD	MESH:D011441	Propylthiouracil results in increased expression of POLR2H mRNA	PMID:24780913
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of POLR2H protein	PMID:37664457
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of POLR2H mRNA	PMID:33512557
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of POLR2H mRNA	PMID:38568856
1314889	POLR2H	RNA polymerase II, I and III subunit H	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1561203	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of POLR2H mRNA	PMID:23034163
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314891	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ING1 mRNA	PMID:33045310
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of ING1 mRNA	PMID:31016361
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314891	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ING1 gene	PMID:20938992
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ING1 mRNA	PMID:33167477
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314891	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ING1 mRNA	PMID:39241906
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306330	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ING1 gene	PMID:27618143
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314891	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ING1 gene	PMID:20938992
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1306330	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ING1 promoter	PMID:23359474
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ING1 mRNA	PMID:28818685
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ING1 mRNA	PMID:19549813
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:25187	p-menthan-3-ol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of ING1 mRNA	PMID:26760959
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ING1 mRNA	PMID:18593933
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306330	E	RGD:6480464	20211207	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ING1 mRNA	PMID:33387578
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314891	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ING1 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ING1 mRNA]	PMID:20938992|PMID:22206623
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314891	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ING1 mRNA	PMID:40504410
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of ING1 mRNA	PMID:23300844
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ING1 mRNA	PMID:27392435
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306330	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ING1 mRNA	PMID:22298810|PMID:34747641
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306330	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ING1 mRNA	PMID:21215274|PMID:33387578
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314891	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ING1 mRNA	PMID:17942748
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314891	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ING1 mRNA	PMID:17942748
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306330	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of ING1 mRNA	PMID:19013527
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ING1 mRNA	PMID:28001369
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314891	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ING1 mRNA	PMID:40504410
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ING1 mRNA]	PMID:32406909
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ING1 mRNA	PMID:18593933
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1306330	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of ING1 mRNA	PMID:24136188
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1314891	E	RGD:6480464	20150127	CTD	MESH:C008261	lead acetate results in decreased expression of ING1 mRNA	PMID:25270620
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314891	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ING1 gene; titanium dioxide results in decreased methylation of ING1 promoter alternative form	PMID:35295148
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314891	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ING1 gene; titanium dioxide results in increased methylation of ING1 promoter alternative form	PMID:35295148
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306330	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ING1 mRNA	PMID:25181051
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306330	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ING1 promoter	PMID:23359474
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314891	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ING1 mRNA	PMID:39298647
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1306330	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ING1 mRNA	PMID:21241498
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314891	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of ING1 intron	PMID:28392331
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1314891	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of ING1 mRNA	PMID:28392331
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1306330	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ING1 promoter	PMID:23359474
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306330	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of ING1 gene	PMID:33148267
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ING1 mRNA	PMID:37042841
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ING1 mRNA	PMID:38568856
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314891	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of ING1 mRNA	PMID:23811191
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of ING1 mRNA	PMID:40434365
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ING1 mRNA	PMID:31533062
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314891	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ING1 mRNA	PMID:17292431
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314891	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ING1 mRNA	PMID:17555576
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of ING1 mRNA	PMID:36621641
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314891	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ING1 mRNA	PMID:28973697
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ING1 mRNA	PMID:38832940
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of ING1 mRNA	PMID:28542535
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314891	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ING1 mRNA	PMID:17562736
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of ING1 mRNA	PMID:21420995
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306330	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ING1 mRNA	PMID:33387578
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314891	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of ING1 mRNA	PMID:29279043
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ING1 mRNA	PMID:18687144
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314891	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of ING1 mRNA	PMID:40504410
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of ING1 mRNA	PMID:36621641
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314891	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ING1 mRNA	PMID:17555576
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314891	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ING1 mRNA	PMID:17942748
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ING1 mRNA	PMID:23300844
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects methylation	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the methylation of ING1 promoter	PMID:17488656
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314891	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ING1 mRNA	PMID:25554681
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1314891	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of ING1 mRNA	PMID:40234311
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314891	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ING1 mRNA	PMID:35964746
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306330	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of ING1 mRNA	PMID:24136188
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of ING1 mRNA	PMID:15336504
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1306330	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of ING1 mRNA	PMID:30467583
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306330	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of ING1 gene	PMID:33148267
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314891	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ING1 mRNA	PMID:22206623
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314891	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ING1 mRNA]	PMID:22206623
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:77012	methylseleninic acid	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid affects the expression of ING1 mRNA	PMID:14617803
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1314891	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of ING1 mRNA	PMID:18958704
1314890	ING1	inhibitor of growth family member 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ING1 mRNA	PMID:38568856
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of TRMT10C mRNA	PMID:33167477
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314895	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TRMT10C mRNA	PMID:30529165
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TRMT10C mRNA	PMID:20044591
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314895	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of TRMT10C mRNA	PMID:39241906
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314895	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TRMT10C mRNA]	PMID:39241906
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314895	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TRMT10C mRNA	PMID:39298647
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of TRMT10C mRNA	PMID:38568856
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRMT10C mRNA	PMID:37042841
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C044887	beta-methylcholine affects the expression of TRMT10C mRNA	PMID:21179406
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of TRMT10C protein	PMID:37730182
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TRMT10C mRNA	PMID:28818685
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TRMT10C mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TRMT10C mRNA	PMID:39836092
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306333	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of TRMT10C protein	PMID:34915118
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRMT10C mRNA	PMID:35301059
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of TRMT10C mRNA	PMID:23649840
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of TRMT10C mRNA	PMID:23649840
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306333	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TRMT10C mRNA	PMID:31150632
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314895	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TRMT10C mRNA	PMID:27339419|PMID:31919559
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314895	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TRMT10C mRNA	PMID:25629700
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TRMT10C mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRMT10C mRNA	PMID:39836092
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1306333	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of TRMT10C mRNA	PMID:20187946
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314895	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of TRMT10C mRNA	PMID:30912803
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314895	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TRMT10C mRNA	PMID:21570461
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306333	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TRMT10C mRNA	PMID:21215274|PMID:33387578
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TRMT10C mRNA	PMID:28001369
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TRMT10C mRNA	PMID:33212167
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of TRMT10C mRNA	PMID:29803840
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:28876	melphalan	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D008558	Melphalan results in increased expression of TRMT10C mRNA	PMID:22363485
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of TRMT10C mRNA	PMID:38568856|PMID:39719251
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TRMT10C mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRMT10C mRNA	PMID:39836092
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314895	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of TRMT10C mRNA	PMID:22228805
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TRMT10C promoter	PMID:27901495
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of TRMT10C mRNA	PMID:31745603
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306333	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TRMT10C mRNA	PMID:30047161
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314895	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRMT10C gene	PMID:35295148
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314895	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TRMT10C gene	PMID:35295148
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306333	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TRMT10C mRNA	PMID:34492290
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314895	E	RGD:6480464	20141111	CTD	MESH:C006253	pirinixic acid results in increased expression of TRMT10C mRNA	PMID:23811191
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of TRMT10C mRNA	PMID:38479592
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314895	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of TRMT10C mRNA	PMID:28329830
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306333	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TRMT10C mRNA	PMID:25181051|PMID:34947998|PMID:41034487
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314895	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of TRMT10C mRNA	PMID:39298647
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of TRMT10C protein	PMID:34186270
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of TRMT10C protein	PMID:34186270
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1306333	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TRMT10C mRNA	PMID:21241498
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1314895	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TRMT10C mRNA	PMID:28392331
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314895	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TRMT10C mRNA]	PMID:39241906
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TRMT10C mRNA	PMID:37042841
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TRMT10C mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TRMT10C mRNA	PMID:39836092
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRMT10C mRNA	PMID:38568856
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TRMT10C mRNA	PMID:35301059
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of TRMT10C protein	PMID:26879310
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TRMT10C mRNA	PMID:28302478
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TRMT10C mRNA	PMID:25979313
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306333	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TRMT10C mRNA	PMID:30047161
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of TRMT10C mRNA	PMID:25562108|PMID:27989131
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:43572	kojic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of TRMT10C mRNA	PMID:16595896
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of TRMT10C mRNA	PMID:21420995|PMID:25704631
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TRMT10C mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TRMT10C mRNA	PMID:39836092
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of TRMT10C mRNA	PMID:18175754
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314895	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of TRMT10C mRNA	PMID:25554681
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306333	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of TRMT10C mRNA	PMID:24136188
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306333	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TRMT10C mRNA	PMID:30047161
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1314895	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of TRMT10C mRNA	PMID:40234311
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306333	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of TRMT10C mRNA	PMID:24136188
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of TRMT10C protein	PMID:32959892
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of TRMT10C mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of TRMT10C mRNA	PMID:39836092
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:64648	enniatin	decreases expression	ISO	RGD:1306333	E	RGD:6480464	20170228	CTD	MESH:C100264	enniatins results in decreased expression of TRMT10C mRNA	PMID:27163883
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TRMT10C protein	PMID:34186270
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314895	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TRMT10C mRNA	PMID:22206623
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TRMT10C protein	PMID:37664457
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1306333	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in decreased expression of TRMT10C mRNA	PMID:30047161
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306333	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TRMT10C mRNA	PMID:30047161
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314895	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of TRMT10C mRNA]	PMID:39241906
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of TRMT10C protein	PMID:37664457
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306333	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TRMT10C mRNA	PMID:19281266
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306333	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of TRMT10C mRNA	PMID:21346803
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1306333	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of TRMT10C protein	PMID:35544339
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306333	E	RGD:6480464	20170725	CTD	MESH:C025643	vinclozolin results in decreased expression of TRMT10C mRNA	PMID:22615374
1314894	TRMT10C	tRNA methyltransferase 10C, mitochondrial RNase P subunit	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306333	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of TRMT10C mRNA	PMID:23034163
1314896	IFNA4	interferon alpha 4	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of IFNA4 mRNA	PMID:37149095
1314896	IFNA4	interferon alpha 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Triclosan inhibits the reaction [Lipopolysaccharides results in increased expression of IFNA4 mRNA]	PMID:20507366
1314896	IFNA4	interferon alpha 4	gene	CHEBI:164200	triclosan	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014260	Triclosan inhibits the reaction [Lipopolysaccharides results in increased expression of IFNA4 mRNA]	PMID:20507366
1314896	IFNA4	interferon alpha 4	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1306334	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of IFNA4 mRNA	PMID:23829299
1314896	IFNA4	interferon alpha 4	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306334	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of IFNA4 mRNA	PMID:26577399|PMID:27523638
1314896	IFNA4	interferon alpha 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306334	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IFNA4 mRNA	PMID:39012411
1314896	IFNA4	interferon alpha 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of IFNA4 gene	PMID:27153756
1314896	IFNA4	interferon alpha 4	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of IFNA4 mRNA	PMID:31295307
1314896	IFNA4	interferon alpha 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IFNA4 exon	PMID:27901495
1314896	IFNA4	interferon alpha 4	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	affects expression	ISO	RGD:1306334	E	RGD:6480464	20160621	CTD	MESH:C009407	2,5,2',5'-tetrachlorobiphenyl affects the expression of IFNA4 mRNA	PMID:23829299
1314896	IFNA4	interferon alpha 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306334	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IFNA4 mRNA	PMID:39012411
1314896	IFNA4	interferon alpha 4	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in decreased expression of IFNA4 mRNA	PMID:17553155
1314896	IFNA4	interferon alpha 4	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:C018021	cobaltous chloride results in increased expression of IFNA4 mRNA	PMID:17553155
1314896	IFNA4	interferon alpha 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IFNA4 mRNA	PMID:24449571
1314896	IFNA4	interferon alpha 4	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306334	E	RGD:6480464	20160621	CTD	MESH:C025643	vinclozolin results in decreased expression of IFNA4 mRNA	PMID:23869203
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ARID3B mRNA	PMID:38218311
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314898	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ARID3B mRNA	PMID:33045310
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314898	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of ARID3B mRNA	PMID:37995155
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of ARID3B mRNA	PMID:31016361
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314898	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARID3B mRNA	PMID:39241906
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ARID3B mRNA	PMID:21179406
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ARID3B mRNA	PMID:16002434
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ARID3B mRNA	PMID:28818685
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314898	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARID3B mRNA	PMID:36331819
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in increased expression of ARID3B mRNA	PMID:20368581
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of ARID3B mRNA	PMID:24376830
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:232105	dicyclanil	increases expression	ISO	RGD:1314898	E	RGD:6480464	20241119	CTD	MESH:C121718	dicyclanil results in increased expression of ARID3B mRNA	PMID:15664270
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ARID3B mRNA	PMID:19549813
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314898	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARID3B mRNA	PMID:34911549
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ARID3B mRNA	PMID:32525701
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of ARID3B protein	PMID:35688186
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ARID3B mRNA	PMID:23557933
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ARID3B mRNA	PMID:27392435
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ARID3B mRNA	PMID:25583101
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314898	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARID3B mRNA	PMID:21570461
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306335	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARID3B mRNA	PMID:33387578
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314898	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARID3B mRNA	PMID:17942748
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ARID3B mRNA	PMID:33212167
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306335	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ARID3B mRNA	PMID:26033743
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARID3B mRNA	PMID:29803840
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ARID3B mRNA	PMID:38568856
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of ARID3B mRNA	PMID:29453283
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306335	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ARID3B mRNA	PMID:26033743
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ARID3B mRNA	PMID:25351596
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of ARID3B gene	PMID:31601247
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314898	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ARID3B mRNA	PMID:29264374
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314898	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARID3B promoter	PMID:35295148
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306335	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ARID3B mRNA	PMID:34492290
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306335	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ARID3B mRNA	PMID:19167457
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of ARID3B protein	PMID:37567409
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306335	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ARID3B mRNA	PMID:25181051
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of ARID3B gene	PMID:31601247
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314898	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ARID3B mRNA	PMID:37019170
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306335	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARID3B mRNA	PMID:21266533
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARID3B mRNA	PMID:37042841
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARID3B mRNA	PMID:38174414
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of ARID3B mRNA	PMID:19320972
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ARID3B mRNA	PMID:28302478
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ARID3B mRNA	PMID:31533062
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314898	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ARID3B mRNA	PMID:36331819
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314898	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ARID3B mRNA	PMID:17555576
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ARID3B mRNA	PMID:38832940
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314898	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARID3B mRNA	PMID:17562736
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ARID3B mRNA	PMID:29067470
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306335	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ARID3B mRNA	PMID:33387578
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ARID3B mRNA	PMID:32525701
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306335	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of ARID3B mRNA	PMID:29391264
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314898	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ARID3B mRNA	PMID:17555576
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314898	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ARID3B mRNA	PMID:17942748
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314898	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ARID3B mRNA	PMID:17942748
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306335	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of ARID3B mRNA	PMID:30307764
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314898	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARID3B mRNA; Nanotubes, Carbon results in decreased expression of ARID3B mRNA	PMID:25554681
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:52717	bortezomib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	[BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in increased expression of ARID3B mRNA	PMID:25522274
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306335	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ARID3B gene	PMID:35440735
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1314898	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of ARID3B mRNA	PMID:22206623
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ARID3B protein	PMID:37664457
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1306335	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of ARID3B mRNA	PMID:21346803
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARID3B gene]	PMID:28238834
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of ARID3B mRNA	PMID:20368581
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ARID3B mRNA	PMID:32525701
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306335	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARID3B mRNA	PMID:24780913|PMID:25825206
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ARID3B protein	PMID:37664457
1314897	ARID3B	AT-rich interaction domain 3B	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ARID3B mRNA	PMID:38568856
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ACP6 mRNA	PMID:38218311
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314900	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ACP6 mRNA	PMID:33045310
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ACP6 mRNA	PMID:35811015
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Resveratrol] results in increased expression of ACP6 mRNA; [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACP6 mRNA	PMID:26667767|PMID:35811015
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306336	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ACP6 gene	PMID:27618143
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACP6 mRNA	PMID:37042841
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306336	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of ACP6 mRNA	PMID:26496021
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314900	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACP6 mRNA	PMID:36331819
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306336	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ACP6 protein	PMID:34915118
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ACP6 mRNA	PMID:19549813
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ACP6 intron	PMID:30157460
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314900	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACP6 mRNA	PMID:22206623
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[Lipopolysaccharides co-treated with resveratrol] results in increased expression of ACP6 mRNA	PMID:26667767
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ACP6 mRNA	PMID:27392435
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ACP6 mRNA	PMID:24768652|PMID:25583101
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314900	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACP6 mRNA	PMID:26377647
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314900	E	RGD:6480464	20210209	CTD	MESH:D013749	[Tetrachlorodibenzodioxin affects the methylation of ACP6 intron] which results in decreased expression of ACP6 mRNA	PMID:33017471
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of ACP6 mRNA	PMID:32763439
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ACP6 mRNA	PMID:29803840
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of ACP6 gene	PMID:28589171
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of ACP6 mRNA	PMID:38568856
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1306336	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of ACP6 protein	PMID:29459688
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of ACP6 mRNA	PMID:29453283
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314900	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACP6 mRNA	PMID:22228805
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:3020	benzalkonium chloride	increases expression	ISO	RGD:1314900	E	RGD:6480464	20190910	CTD	MESH:D001548	Benzalkonium Compounds results in increased expression of ACP6 mRNA	PMID:31199489
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314900	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ACP6 gene	PMID:35295148
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306336	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ACP6 mRNA	PMID:19167457
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306336	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ACP6 mRNA	PMID:25181051
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306336	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ACP6 mRNA	PMID:34947998
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306336	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ACP6 gene	PMID:28505145
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306336	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of ACP6 mRNA	PMID:26496021
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314900	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ACP6 mRNA	PMID:37019170
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1314900	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in increased expression of ACP6 protein	PMID:35362542
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314900	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ACP6 protein]	PMID:35362542
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314900	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of ACP6 mRNA	PMID:17585979
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ACP6 mRNA	PMID:40419075
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314900	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACP6 mRNA	PMID:36331819
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ACP6 mRNA	PMID:23179753
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ACP6 gene	PMID:29154799
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ACP6 mRNA	PMID:25562108
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ACP6 mRNA	PMID:38832940
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314900	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACP6 mRNA	PMID:17562736
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of ACP6 mRNA	PMID:25704631
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACP6 mRNA	PMID:35811015
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1314900	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in increased expression of ACP6 protein]	PMID:35362542
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306336	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of ACP6 mRNA	PMID:24793618
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306336	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ACP6 mRNA	PMID:24136188
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of ACP6 mRNA	PMID:20436886
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1306336	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of ACP6 mRNA	PMID:20080153
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ACP6 mRNA	PMID:31758290
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314900	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ACP6 mRNA	PMID:22206623
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314900	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACP6 mRNA	PMID:22206623
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:76326	N-nitrosomorpholine	decreases expression	ISO	RGD:1306336	E	RGD:6480464	20140107	CTD	MESH:C002741	N-nitrosomorpholine results in decreased expression of ACP6 protein	PMID:19716841
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314900	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ACP6 mRNA	PMID:39847705
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1314900	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ACP6 mRNA	PMID:40826991
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ACP6 mRNA	PMID:38568856
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306336	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ACP6 mRNA	PMID:21346803
1314899	ACP6	acid phosphatase 6, lysophosphatidic	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306336	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ACP6 mRNA	PMID:23034163
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HACD2 mRNA	PMID:20938992
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of HACD2 mRNA	PMID:33167477
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C018475	butyraldehyde results in decreased expression of HACD2 mRNA	PMID:26079696
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314902	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of HACD2 mRNA	PMID:30319688
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of HACD2 mRNA	PMID:21632981
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314902	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HACD2 mRNA	PMID:39241906
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of HACD2 mRNA]	PMID:39241906
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of HACD2 mRNA	PMID:30510588
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of HACD2 mRNA	PMID:31614463
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HACD2 mRNA	PMID:20938992
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of HACD2 mRNA	PMID:23649840
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of HACD2 mRNA	PMID:21179406
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of HACD2 mRNA	PMID:33359661
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of HACD2 protein	PMID:31163220
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D002117	Calcitriol results in increased expression of HACD2 mRNA	PMID:26485663
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306337	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of HACD2 mRNA	PMID:33387578
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HACD2 mRNA	PMID:36331819
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HACD2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HACD2 mRNA	PMID:37236586|PMID:38382403
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HACD2 gene	PMID:27153756
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306337	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of HACD2 mRNA	PMID:31150632
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of HACD2 mRNA	PMID:20938992
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HACD2 gene	PMID:25304211
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HACD2 mRNA	PMID:40504410
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314902	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of HACD2 protein	PMID:25505154
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D002945	Cisplatin results in decreased expression of HACD2 mRNA	PMID:27392435
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of HACD2 mRNA	PMID:25583101
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314902	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HACD2 mRNA	PMID:21570461
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HACD2 mRNA	PMID:33212167
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HACD2 mRNA	PMID:29803840
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of HACD2 mRNA	PMID:38568856|PMID:39719251
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HACD2 mRNA	PMID:40504410
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314902	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HACD2 mRNA	PMID:20713471
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of HACD2 mRNA	PMID:20018196|PMID:26238291
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:31823	mercury dichloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of HACD2 mRNA	PMID:27188386
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306337	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HACD2 mRNA	PMID:25729387
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1306337	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of HACD2 mRNA	PMID:24136188
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314902	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of HACD2 gene	PMID:35295148
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314902	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of HACD2 mRNA	PMID:18301758|PMID:20813756|PMID:23811191
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HACD2 mRNA	PMID:19710929
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A affects the expression of HACD2 mRNA	PMID:20170705
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314902	E	RGD:6480464	20161115	CTD	MESH:C006780	bisphenol A results in decreased expression of HACD2 mRNA	PMID:26063408|PMID:26512966
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of HACD2 gene	PMID:31601247
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306337	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of HACD2 mRNA	PMID:32145629
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:34237	2,4-diaminotoluene	decreases expression	ISO	RGD:1314902	E	RGD:6480464	20131008	CTD	MESH:C010914	2,4-diaminotoluene results in decreased expression of HACD2 mRNA	PMID:20713471
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314902	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of HACD2 mRNA	PMID:39298647
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C543008	bisphenol S results in increased expression of HACD2 mRNA	PMID:27685785
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1314902	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of HACD2 intron	PMID:28392331
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306337	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of HACD2 mRNA	PMID:21266533
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of HACD2 mRNA]	PMID:39241906
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HACD2 mRNA	PMID:37042841
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HACD2 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HACD2 mRNA	PMID:37236586|PMID:38382403
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of HACD2 protein	PMID:26879310
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314902	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of HACD2 mRNA	PMID:18353800
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C480342	clothianidin results in increased expression of HACD2 mRNA	PMID:29044138
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of HACD2 mRNA	PMID:40419075
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of HACD2 mRNA	PMID:36331819
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of HACD2 mRNA	PMID:23179753
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of HACD2 mRNA	PMID:20106945
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D003907	Dexamethasone results in increased expression of HACD2 mRNA	PMID:25047013
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314902	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of HACD2 mRNA	PMID:28973697
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of HACD2 mRNA	PMID:27188386
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306337	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HACD2 mRNA	PMID:33387578
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HACD2 gene	PMID:25304211
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HACD2 mRNA	PMID:40504410
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of HACD2 mRNA	PMID:40706910
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of HACD2 mRNA	PMID:20170705
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1314902	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of HACD2 mRNA	PMID:17942748
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of HACD2 mRNA	PMID:23228038
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314902	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of HACD2 mRNA; Nanotubes, Carbon results in decreased expression of HACD2 mRNA	PMID:25620056
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314902	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of HACD2 mRNA; Nanotubes, Carbon results in increased expression of HACD2 mRNA	PMID:25554681
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306337	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of HACD2 mRNA	PMID:24136188
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:C001277	geldanamycin results in increased expression of HACD2 mRNA	PMID:26705709
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306337	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HACD2 mRNA	PMID:25729387
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:64243	monosodium L-glutamate	decreases expression	ISO	RGD:1314902	E	RGD:6480464	20200317	CTD	MESH:D012970	Sodium Glutamate results in decreased expression of HACD2 mRNA	PMID:22078008
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of HACD2 protein	PMID:34186270
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of HACD2 mRNA	PMID:18548127
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314902	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of HACD2 mRNA	PMID:19482888
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of HACD2 mRNA]	PMID:19482888
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314902	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of HACD2 mRNA	PMID:21278054
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314902	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of HACD2 mRNA]	PMID:39241906
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306337	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of HACD2 mRNA	PMID:21346803
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of HACD2 mRNA	PMID:38568856
1314901	HACD2	3-hydroxyacyl-CoA dehydratase 2	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of HACD2 mRNA	PMID:27188386
1314903	RND1	Rho family GTPase 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RND1 mRNA	PMID:38218311
1314903	RND1	Rho family GTPase 1	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314904	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RND1 mRNA	PMID:33045310
1314903	RND1	Rho family GTPase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306338	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RND1 mRNA]	PMID:31150632
1314903	RND1	Rho family GTPase 1	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	EXP		E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of RND1 mRNA	PMID:23792671
1314903	RND1	Rho family GTPase 1	gene	CHEBI:15343	acetaldehyde	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D000079	Acetaldehyde results in increased expression of RND1 mRNA	PMID:23416264
1314903	RND1	Rho family GTPase 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1306338	E	RGD:6480464	20120918	CTD	MESH:D014212	Tretinoin results in increased expression of RND1 mRNA	PMID:20488242|PMID:22262565
1314903	RND1	Rho family GTPase 1	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RND1 mRNA	PMID:25596134
1314903	RND1	Rho family GTPase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1306338	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of RND1 mRNA	PMID:33729688
1314903	RND1	Rho family GTPase 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1306338	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of RND1 mRNA	PMID:36841081
1314903	RND1	Rho family GTPase 1	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1314904	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of RND1 mRNA	PMID:40945087
1314903	RND1	Rho family GTPase 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314904	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RND1 mRNA	PMID:30319688
1314903	RND1	Rho family GTPase 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of RND1 mRNA	PMID:21632981
1314903	RND1	Rho family GTPase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RND1 mRNA	PMID:35811015
1314903	RND1	Rho family GTPase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RND1 mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of RND1 mRNA]	PMID:35811015
1314903	RND1	Rho family GTPase 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of RND1 mRNA	PMID:24758408|PMID:28711546
1314903	RND1	Rho family GTPase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D004958	Estradiol results in increased expression of RND1 mRNA	PMID:19153601|PMID:19619570
1314903	RND1	Rho family GTPase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314904	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RND1 mRNA	PMID:39298647
1314903	RND1	Rho family GTPase 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of RND1 mRNA; EGF protein inhibits the reaction [Estradiol results in decreased expression of RND1 mRNA]	PMID:19619570|PMID:24758408
1314903	RND1	Rho family GTPase 1	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of RND1 mRNA	PMID:23649840
1314903	RND1	Rho family GTPase 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1306338	E	RGD:6480464	20120412	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of RND1 mRNA	PMID:16809437
1314903	RND1	Rho family GTPase 1	gene	CHEBI:17315	D-glucosamine	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine results in decreased expression of RND1 mRNA	PMID:17178593
1314903	RND1	Rho family GTPase 1	gene	CHEBI:17315	D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D005944	Glucosamine analog inhibits the reaction [TNF results in increased expression of RND1 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of RND1 mRNA]	PMID:18173918
1314903	RND1	Rho family GTPase 1	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of RND1 mRNA	PMID:33647349
1314903	RND1	Rho family GTPase 1	gene	CHEBI:17602	4-aminophenol	decreases expression	ISO	RGD:1306338	E	RGD:6480464	20140610	CTD	MESH:C026729	4-aminophenol results in decreased expression of RND1 mRNA	PMID:23558518
1314903	RND1	Rho family GTPase 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of RND1 mRNA	PMID:26485663
1314903	RND1	Rho family GTPase 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RND1 mRNA	PMID:28818685
1314903	RND1	Rho family GTPase 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314904	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RND1 mRNA	PMID:36331819
1314903	RND1	Rho family GTPase 1	gene	CHEBI:188938	Allylamine	increases expression	ISO	RGD:1306338	E	RGD:6480464	20220208	CTD	MESH:D000499	Allylamine results in increased expression of RND1 mRNA	PMID:23558518
1314903	RND1	Rho family GTPase 1	gene	CHEBI:20993	aldehydo-D-glucosamine	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of RND1 mRNA	PMID:17178593
1314903	RND1	Rho family GTPase 1	gene	CHEBI:20993	aldehydo-D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine analog inhibits the reaction [TNF results in increased expression of RND1 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of RND1 mRNA]	PMID:18173918
1314903	RND1	Rho family GTPase 1	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1314904	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of RND1 mRNA	PMID:39984025
1314903	RND1	Rho family GTPase 1	gene	CHEBI:234430	gardiquimod	increases expression	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in increased expression of RND1 mRNA	PMID:28003376
1314903	RND1	Rho family GTPase 1	gene	CHEBI:234430	gardiquimod	multiple interactions	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of RND1 mRNA]	PMID:28003376
1314903	RND1	Rho family GTPase 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of RND1 protein	PMID:20106945
1314903	RND1	Rho family GTPase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306338	E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RND1 mRNA	PMID:25378103
1314903	RND1	Rho family GTPase 1	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RND1 mRNA	PMID:23649840
1314903	RND1	Rho family GTPase 1	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1314904	E	RGD:6480464	20201006	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene metabolite results in increased expression of RND1 mRNA	PMID:32553695
1314903	RND1	Rho family GTPase 1	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RND1 mRNA	PMID:18593933
1314903	RND1	Rho family GTPase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306338	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RND1 mRNA	PMID:31150632
1314903	RND1	Rho family GTPase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306338	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RND1 mRNA]	PMID:31150632
1314903	RND1	Rho family GTPase 1	gene	CHEBI:27563	arsenic atom	increases expression	ISO	RGD:1314904	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of RND1 mRNA	PMID:38723480
1314903	RND1	Rho family GTPase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314904	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in increased expression of RND1 mRNA]	PMID:38723480
1314903	RND1	Rho family GTPase 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of RND1 mRNA	PMID:19244175
1314903	RND1	Rho family GTPase 1	gene	CHEBI:2762	antimycin A	increases expression	ISO	RGD:1314904	E	RGD:6480464	20191105	CTD	MESH:D000968	Antimycin A results in increased expression of RND1 mRNA	PMID:19304788
1314903	RND1	Rho family GTPase 1	gene	CHEBI:27810	resorcinol	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C031389	resorcinol results in decreased expression of RND1 mRNA	PMID:22623647
1314903	RND1	Rho family GTPase 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306338	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RND1 mRNA	PMID:31881176
1314903	RND1	Rho family GTPase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RND1 mRNA	PMID:23557933
1314903	RND1	Rho family GTPase 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RND1 mRNA	PMID:27392435
1314903	RND1	Rho family GTPase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RND1 mRNA	PMID:22298810
1314903	RND1	Rho family GTPase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314904	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RND1 mRNA	PMID:21570461
1314903	RND1	Rho family GTPase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RND1 mRNA	PMID:19619570|PMID:20106945|PMID:21632981|PMID:22903824
1314903	RND1	Rho family GTPase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of RND1 mRNA	PMID:19619570
1314903	RND1	Rho family GTPase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314904	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RND1 mRNA	PMID:17942748
1314903	RND1	Rho family GTPase 1	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314904	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of RND1 mRNA	PMID:19304788
1314903	RND1	Rho family GTPase 1	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RND1 mRNA	PMID:33212167
1314903	RND1	Rho family GTPase 1	gene	CHEBI:28393	beta-D-glucosamine	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of RND1 mRNA	PMID:17178593
1314903	RND1	Rho family GTPase 1	gene	CHEBI:28393	beta-D-glucosamine	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine analog inhibits the reaction [TNF results in increased expression of RND1 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of RND1 mRNA]	PMID:18173918
1314903	RND1	Rho family GTPase 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of RND1 mRNA	PMID:32763439
1314903	RND1	Rho family GTPase 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of RND1 mRNA	PMID:20971185
1314903	RND1	Rho family GTPase 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1306338	E	RGD:6480464	20140610	CTD	MESH:D004317	Doxorubicin results in increased expression of RND1 mRNA	PMID:20211217|PMID:23558518|PMID:32289291
1314903	RND1	Rho family GTPase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RND1 mRNA	PMID:38568856
1314903	RND1	Rho family GTPase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RND1 mRNA	PMID:19770486
1314903	RND1	Rho family GTPase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RND1 promoter	PMID:27901495
1314903	RND1	Rho family GTPase 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of RND1 mRNA	PMID:20971185
1314903	RND1	Rho family GTPase 1	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RND1 mRNA	PMID:18593933
1314903	RND1	Rho family GTPase 1	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of RND1 mRNA	PMID:26014281
1314903	RND1	Rho family GTPase 1	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1314904	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of RND1 mRNA	PMID:27131904
1314903	RND1	Rho family GTPase 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RND1 mRNA	PMID:25895662
1314903	RND1	Rho family GTPase 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RND1 mRNA	PMID:25351596
1314903	RND1	Rho family GTPase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306338	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RND1 mRNA	PMID:25729387
1314903	RND1	Rho family GTPase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314904	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RND1 gene	PMID:35295148
1314903	RND1	Rho family GTPase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1306338	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of RND1 mRNA	PMID:30012374
1314903	RND1	Rho family GTPase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314904	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of RND1 mRNA	PMID:23557971
1314903	RND1	Rho family GTPase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306338	E	RGD:6480464	20140610	CTD	MESH:D013853	Thioacetamide results in increased expression of RND1 mRNA	PMID:23411599|PMID:23558518
1314903	RND1	Rho family GTPase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314904	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RND1 mRNA	PMID:19710929
1314903	RND1	Rho family GTPase 1	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of RND1 mRNA	PMID:19191707
1314903	RND1	Rho family GTPase 1	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314904	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of RND1 mRNA	PMID:28329830
1314903	RND1	Rho family GTPase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of RND1 mRNA	PMID:35598803
1314903	RND1	Rho family GTPase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of RND1 mRNA	PMID:36232920
1314903	RND1	Rho family GTPase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306338	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RND1 mRNA	PMID:25181051
1314903	RND1	Rho family GTPase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306338	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RND1 mRNA	PMID:36041667
1314903	RND1	Rho family GTPase 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1314904	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of RND1 mRNA	PMID:25172293
1314903	RND1	Rho family GTPase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RND1 mRNA	PMID:39298647
1314903	RND1	Rho family GTPase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306338	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RND1 mRNA	PMID:36041667
1314903	RND1	Rho family GTPase 1	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of RND1 mRNA	PMID:26377693
1314903	RND1	Rho family GTPase 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314904	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RND1 mRNA	PMID:38685157
1314903	RND1	Rho family GTPase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306338	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of RND1 mRNA	PMID:36041667
1314903	RND1	Rho family GTPase 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1306338	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of RND1 mRNA	PMID:21241498
1314903	RND1	Rho family GTPase 1	gene	CHEBI:34611	carbofuran	increases expression	ISO	RGD:1306338	E	RGD:6480464	20120412	CTD	MESH:D002235	Carbofuran results in increased expression of RND1 mRNA	PMID:20211217
1314903	RND1	Rho family GTPase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RND1 mRNA	PMID:20350560
1314903	RND1	Rho family GTPase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306338	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RND1 mRNA	PMID:21266533
1314903	RND1	Rho family GTPase 1	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1306338	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of RND1 mRNA	PMID:22110744
1314903	RND1	Rho family GTPase 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1306338	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of RND1 mRNA	PMID:32680482
1314903	RND1	Rho family GTPase 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314904	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of RND1 mRNA	PMID:36117858
1314903	RND1	Rho family GTPase 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306338	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of RND1 mRNA	PMID:35163327
1314903	RND1	Rho family GTPase 1	gene	CHEBI:35255	chloroform	increases expression	ISO	RGD:1306338	E	RGD:6480464	20140610	CTD	MESH:D002725	Chloroform results in increased expression of RND1 mRNA	PMID:23558518
1314903	RND1	Rho family GTPase 1	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of RND1 mRNA	PMID:26377693
1314903	RND1	Rho family GTPase 1	gene	CHEBI:3537	cefaloridine	increases expression	ISO	RGD:1306338	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in increased expression of RND1 mRNA	PMID:18500788
1314903	RND1	Rho family GTPase 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306338	E	RGD:6480464	20140610	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of RND1 mRNA	PMID:23558518|PMID:30723492
1314903	RND1	Rho family GTPase 1	gene	CHEBI:35456	cadmium dichloride	affects expression	ISO	RGD:1306338	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride affects the expression of RND1 mRNA	PMID:22110744
1314903	RND1	Rho family GTPase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RND1 mRNA	PMID:38382870
1314903	RND1	Rho family GTPase 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RND1 mRNA	PMID:25596134|PMID:38174414|PMID:38568856
1314903	RND1	Rho family GTPase 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306338	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of RND1 mRNA	PMID:35163327
1314903	RND1	Rho family GTPase 1	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20140812	CTD	MESH:C039281	furan results in decreased expression of RND1 mRNA	PMID:24183702
1314903	RND1	Rho family GTPase 1	gene	CHEBI:3647	chlorpromazine	decreases expression	ISO	RGD:1306338	E	RGD:6480464	20150825	CTD	MESH:D002746	Chlorpromazine results in decreased expression of RND1 mRNA	PMID:25596134
1314903	RND1	Rho family GTPase 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of RND1 mRNA	PMID:19244175
1314903	RND1	Rho family GTPase 1	gene	CHEBI:3696	cidofovir anhydrous	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in increased expression of RND1 mRNA	PMID:25596134
1314903	RND1	Rho family GTPase 1	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of RND1 mRNA]	PMID:28003376
1314903	RND1	Rho family GTPase 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1314904	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of RND1 mRNA	PMID:40194260
1314903	RND1	Rho family GTPase 1	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C480342	clothianidin results in increased expression of RND1 mRNA	PMID:29044138
1314903	RND1	Rho family GTPase 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314904	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RND1 mRNA	PMID:36331819
1314903	RND1	Rho family GTPase 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1306338	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of RND1 mRNA	PMID:23125180
1314903	RND1	Rho family GTPase 1	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of RND1 mRNA	PMID:23125180
1314903	RND1	Rho family GTPase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314904	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of RND1 mRNA	PMID:17292431
1314903	RND1	Rho family GTPase 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of RND1 mRNA	PMID:23179753|PMID:24935251|PMID:26272509
1314903	RND1	Rho family GTPase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of RND1 mRNA	PMID:29154799
1314903	RND1	Rho family GTPase 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RND1 mRNA	PMID:27188386
1314903	RND1	Rho family GTPase 1	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1306338	E	RGD:6480464	20140610	CTD	MESH:D003520	Cyclophosphamide results in increased expression of RND1 mRNA	PMID:23558518
1314903	RND1	Rho family GTPase 1	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine affects the expression of RND1 mRNA	PMID:20106945
1314903	RND1	Rho family GTPase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of RND1 mRNA	PMID:25562108|PMID:25596134
1314903	RND1	Rho family GTPase 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1306338	E	RGD:6480464	20140610	CTD	MESH:D016572	Cyclosporine results in increased expression of RND1 mRNA	PMID:23558518
1314903	RND1	Rho family GTPase 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314904	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RND1 mRNA	PMID:28973697
1314903	RND1	Rho family GTPase 1	gene	CHEBI:44616	afimoxifene	increases expression	EXP		E	RGD:6480464	20200211	CTD	MESH:C016601	afimoxifene results in increased expression of RND1 mRNA	PMID:19153601
1314903	RND1	Rho family GTPase 1	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of RND1 mRNA]; GPER1 protein affects the reaction [afimoxifene results in increased expression of RND1 mRNA]	PMID:19153601|PMID:21233418
1314903	RND1	Rho family GTPase 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RND1 mRNA	PMID:38832940
1314903	RND1	Rho family GTPase 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of RND1 mRNA	PMID:28542535
1314903	RND1	Rho family GTPase 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of RND1 mRNA	PMID:24935251|PMID:26272509
1314903	RND1	Rho family GTPase 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RND1 mRNA	PMID:27188386
1314903	RND1	Rho family GTPase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314904	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RND1 mRNA	PMID:17562736
1314903	RND1	Rho family GTPase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of RND1 mRNA	PMID:29067470
1314903	RND1	Rho family GTPase 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of RND1 mRNA	PMID:21420995
1314903	RND1	Rho family GTPase 1	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of RND1 mRNA	PMID:24714768|PMID:25596134
1314903	RND1	Rho family GTPase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of RND1 mRNA	PMID:33725128
1314903	RND1	Rho family GTPase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RND1 mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of RND1 mRNA]	PMID:35811015
1314903	RND1	Rho family GTPase 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of RND1 mRNA	PMID:25351596
1314903	RND1	Rho family GTPase 1	gene	CHEBI:47217	arsane	increases expression	ISO	RGD:1314904	E	RGD:6480464	20250902	CTD	MESH:D001151	Arsenic results in increased expression of RND1 mRNA	PMID:38723480
1314903	RND1	Rho family GTPase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314904	E	RGD:6480464	20250902	CTD	MESH:D001151	FTO protein inhibits the reaction [Arsenic results in increased expression of RND1 mRNA]	PMID:38723480
1314903	RND1	Rho family GTPase 1	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of RND1 mRNA	PMID:35537566
1314903	RND1	Rho family GTPase 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine results in decreased expression of RND1 mRNA	PMID:17178593
1314903	RND1	Rho family GTPase 1	gene	CHEBI:47977	2-amino-2-deoxy-D-glucopyranose	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D005944	Glucosamine analog inhibits the reaction [TNF results in increased expression of RND1 mRNA]; Glucosamine inhibits the reaction [TNF results in increased expression of RND1 mRNA]	PMID:18173918
1314903	RND1	Rho family GTPase 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RND1 mRNA	PMID:22079256
1314903	RND1	Rho family GTPase 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314904	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of RND1 mRNA	PMID:35436446
1314903	RND1	Rho family GTPase 1	gene	CHEBI:48574	phenylbutazone	increases expression	ISO	RGD:1306338	E	RGD:6480464	20140610	CTD	MESH:D010653	Phenylbutazone results in increased expression of RND1 mRNA	PMID:23558518
1314903	RND1	Rho family GTPase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314904	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RND1 mRNA	PMID:17942748
1314903	RND1	Rho family GTPase 1	gene	CHEBI:5001	fenofibrate	decreases expression	ISO	RGD:1306338	E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of RND1 mRNA	PMID:25596134
1314903	RND1	Rho family GTPase 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306338	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of RND1 mRNA	PMID:30307764
1314903	RND1	Rho family GTPase 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RND1 mRNA	PMID:25620056
1314903	RND1	Rho family GTPase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314904	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RND1 mRNA; Nanotubes, Carbon results in increased expression of RND1 mRNA	PMID:25554681
1314903	RND1	Rho family GTPase 1	gene	CHEBI:50729	mitoxantrone	increases expression	ISO	RGD:1306338	E	RGD:6480464	20140610	CTD	MESH:D008942	Mitoxantrone results in increased expression of RND1 mRNA	PMID:23558518
1314903	RND1	Rho family GTPase 1	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	ISO	RGD:1306338	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of RND1 mRNA	PMID:21983209
1314903	RND1	Rho family GTPase 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314904	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of RND1 mRNA	PMID:36117858
1314903	RND1	Rho family GTPase 1	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of RND1 mRNA	PMID:31629900
1314903	RND1	Rho family GTPase 1	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314904	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of RND1 mRNA	PMID:38701926
1314903	RND1	Rho family GTPase 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306338	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RND1 mRNA	PMID:25729387
1314903	RND1	Rho family GTPase 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of RND1 mRNA	PMID:28988120
1314903	RND1	Rho family GTPase 1	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1314904	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RND1 mRNA	PMID:22776087
1314903	RND1	Rho family GTPase 1	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1306338	E	RGD:6480464	20140610	CTD	MESH:D007545	Isoproterenol results in increased expression of RND1 mRNA	PMID:20211217|PMID:23558518
1314903	RND1	Rho family GTPase 1	gene	CHEBI:6792	metaproterenol	increases expression	ISO	RGD:1306338	E	RGD:6480464	20141111	CTD	MESH:D009921	Metaproterenol results in increased expression of RND1 mRNA	PMID:23558518
1314903	RND1	Rho family GTPase 1	gene	CHEBI:6801	metformin	affects expression	ISO	RGD:1306338	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin affects the expression of RND1 mRNA	PMID:25596134
1314903	RND1	Rho family GTPase 1	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1306338	E	RGD:6480464	20140610	CTD	MESH:D008701	Methapyrilene results in increased expression of RND1 mRNA	PMID:23558518|PMID:30467583
1314903	RND1	Rho family GTPase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RND1 mRNA	PMID:22206623
1314903	RND1	Rho family GTPase 1	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of RND1 mRNA	PMID:22079256
1314903	RND1	Rho family GTPase 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RND1 mRNA	PMID:22079256
1314903	RND1	Rho family GTPase 1	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1306338	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of RND1 mRNA	PMID:23665939
1314903	RND1	Rho family GTPase 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RND1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RND1 mRNA	PMID:27188386
1314903	RND1	Rho family GTPase 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314904	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of RND1 mRNA	PMID:23091169
1314903	RND1	Rho family GTPase 1	gene	CHEBI:8093	phenylephrine	increases expression	ISO	RGD:1306338	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in increased expression of RND1 mRNA	PMID:18158353
1314903	RND1	Rho family GTPase 1	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1306338	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of RND1 mRNA	PMID:20345932
1314903	RND1	Rho family GTPase 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1314904	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of RND1 mRNA	PMID:38648751
1314903	RND1	Rho family GTPase 1	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of RND1 mRNA	PMID:30458266
1314903	RND1	Rho family GTPase 1	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of RND1 mRNA	PMID:32234424
1314903	RND1	Rho family GTPase 1	gene	CHEBI:82719	orciprenaline	increases expression	ISO	RGD:1306338	E	RGD:6480464	20141104	CTD	MESH:D009921	Metaproterenol results in increased expression of RND1 mRNA	PMID:23558518
1314903	RND1	Rho family GTPase 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314904	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RND1 mRNA	PMID:39847705
1314903	RND1	Rho family GTPase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1306338	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil affects the expression of RND1 mRNA	PMID:24780913
1314903	RND1	Rho family GTPase 1	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of RND1 mRNA	PMID:31734321
1314903	RND1	Rho family GTPase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RND1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RND1 mRNA	PMID:27188386
1314903	RND1	Rho family GTPase 1	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of RND1 mRNA	PMID:26014281
1314903	RND1	Rho family GTPase 1	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1314904	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of RND1 mRNA	PMID:27131904
1314903	RND1	Rho family GTPase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306338	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RND1 mRNA	PMID:21346803
1314903	RND1	Rho family GTPase 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RND1 mRNA	PMID:38568856
1314903	RND1	Rho family GTPase 1	gene	CHEBI:9671	triamterene	increases expression	ISO	RGD:1306338	E	RGD:6480464	20191114	CTD	MESH:D014223	Triamterene results in increased expression of RND1 mRNA	PMID:23558518
1314903	RND1	Rho family GTPase 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1306338	E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in decreased expression of RND1 mRNA	PMID:25596134
1314903	RND1	Rho family GTPase 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314904	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of RND1 mRNA	PMID:35537566
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of TVP23B mRNA	PMID:33167477
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TVP23B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TVP23B mRNA	PMID:32699268
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of TVP23B mRNA	PMID:24236059
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314910	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of TVP23B mRNA	PMID:30319688
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1586539	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TVP23B mRNA	PMID:33387578
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1586539	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TVP23B gene	PMID:27618143
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TVP23B mRNA	PMID:37042841
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of TVP23B mRNA	PMID:39245080
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TVP23B mRNA	PMID:35301059
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TVP23B mRNA	PMID:19549813
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1586539	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of TVP23B mRNA	PMID:33354967
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TVP23B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TVP23B mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of TVP23B mRNA	PMID:32699268
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TVP23B mRNA	PMID:33212167
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1586539	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of TVP23B mRNA	PMID:28959563
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of TVP23B mRNA	PMID:39719251
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of TVP23B mRNA	PMID:38568856
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TVP23B promoter	PMID:27901495
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314910	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of TVP23B exon; Benzo(a)pyrene results in increased methylation of TVP23B intron	PMID:27901495
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TVP23B mRNA	PMID:20018196
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314910	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TVP23B mRNA	PMID:35676786
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314910	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TVP23B gene; titanium dioxide results in increased methylation of TVP23B promoter	PMID:35295148
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1586539	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TVP23B mRNA	PMID:30816183|PMID:32528016
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314910	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of TVP23B mRNA	PMID:38685157
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314910	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TVP23B exon	PMID:28392331
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of TVP23B mRNA	PMID:38568856
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TVP23B mRNA	PMID:35301059
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TVP23B mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TVP23B mRNA	PMID:32699268
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TVP23B mRNA	PMID:28302478
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TVP23B mRNA	PMID:31533062
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TVP23B mRNA	PMID:27153767
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314910	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of TVP23B mRNA	PMID:36331819
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1586539	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of TVP23B mRNA	PMID:24136188
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1586539	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TVP23B mRNA	PMID:33387578
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of TVP23B mRNA	PMID:29523930
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314910	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TVP23B mRNA	PMID:35676786
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314910	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TVP23B mRNA	PMID:23650126
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1586539	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of TVP23B gene	PMID:35440735
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of TVP23B protein	PMID:34186270
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314910	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TVP23B mRNA	PMID:22206623
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TVP23B gene]	PMID:28238834
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1586539	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of TVP23B mRNA	PMID:19281266
1314909	TVP23B	trans-golgi network vesicle protein 23 homolog B	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of TVP23B mRNA	PMID:38568856
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306345	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SNRPD1 mRNA]	PMID:31150632
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of SNRPD1 mRNA	PMID:21934132
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314913	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SNRPD1 mRNA	PMID:30319688
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of SNRPD1 mRNA	PMID:20044591
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314913	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of SNRPD1 mRNA	PMID:39241906
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SNRPD1 mRNA]	PMID:39241906
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1306345	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of SNRPD1 mRNA	PMID:32145629
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1314913	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of SNRPD1 mRNA	PMID:15598610
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of SNRPD1 mRNA	PMID:38568856
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306345	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SNRPD1 mRNA	PMID:33387578
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:166595	Yessotoxin	decreases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in decreased expression of SNRPD1 mRNA	PMID:30679557
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of SNRPD1 mRNA	PMID:23649840
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306345	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SNRPD1 mRNA	PMID:33387578
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNRPD1 mRNA	PMID:36331819
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNRPD1 mRNA	PMID:37236586
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SNRPD1 mRNA	PMID:19549813
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of SNRPD1 mRNA	PMID:23649840
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of SNRPD1 mRNA	PMID:23649840
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SNRPD1 mRNA	PMID:34911549
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306345	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SNRPD1 mRNA	PMID:31150632
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314913	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SNRPD1 mRNA	PMID:27339419|PMID:31919559
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306345	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SNRPD1 mRNA]	PMID:31150632
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314913	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SNRPD1 mRNA	PMID:25629700
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SNRPD1 mRNA]	PMID:22206623
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1314913	E	RGD:6480464	20251007	CTD	MESH:D001151	Arsenic results in decreased expression of SNRPD1 protein	PMID:37888683
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20251007	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNRPD1 mRNA; GW 4064 affects the reaction [Arsenic results in decreased expression of SNRPD1 protein]	PMID:37888683|PMID:40504410
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314913	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SNRPD1 mRNA	PMID:28960355
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306345	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SNRPD1 mRNA	PMID:31881176
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of SNRPD1 mRNA	PMID:27594783
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of SNRPD1 mRNA; [Piroxicam co-treated with Cisplatin] results in increased expression of SNRPD1 mRNA	PMID:21858171|PMID:27392435
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314913	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of SNRPD1 mRNA	PMID:30912803
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314913	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNRPD1 mRNA	PMID:21570461|PMID:24680724
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306345	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SNRPD1 mRNA	PMID:33387578
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306345	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNRPD1 mRNA	PMID:34747641
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314913	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SNRPD1 mRNA	PMID:17942748
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNRPD1 mRNA	PMID:17942748
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SNRPD1 mRNA	PMID:30851411
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306345	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SNRPD1 mRNA	PMID:28959563
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of SNRPD1 mRNA	PMID:20971185
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314913	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of SNRPD1 protein	PMID:28918527
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of SNRPD1 mRNA	PMID:20044591
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNRPD1 mRNA	PMID:38568856
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of SNRPD1 mRNA	PMID:28595984|PMID:34032870
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNRPD1 mRNA	PMID:40504410
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of SNRPD1 mRNA	PMID:22378314
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNRPD1 mRNA	PMID:20498004
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314913	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SNRPD1 mRNA	PMID:22228805
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SNRPD1 promoter	PMID:27901495
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of SNRPD1 mRNA]	PMID:22228805
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to SNRPD1 protein]; arsenite promotes the reaction [G3BP1 protein binds to SNRPD1 mRNA]	PMID:32406909
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of SNRPD1 mRNA	PMID:20971185
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SNRPD1 mRNA	PMID:20382639
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306345	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SNRPD1 mRNA	PMID:30047161
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306345	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SNRPD1 mRNA	PMID:34492290
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314913	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of SNRPD1 mRNA	PMID:18648102
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314913	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of SNRPD1 mRNA	PMID:28472532
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the expression of SNRPD1 protein	PMID:37567409
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306345	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of SNRPD1 mRNA	PMID:32145629
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of SNRPD1 mRNA; bisphenol A results in decreased expression of SNRPD1 protein	PMID:29275510|PMID:37664457
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314913	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SNRPD1 mRNA	PMID:33221593
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306345	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SNRPD1 mRNA	PMID:25181051
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314913	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SNRPD1 mRNA	PMID:39298647
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314913	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of SNRPD1 mRNA	PMID:38685157
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPD1 mRNA	PMID:28628672
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of SNRPD1 protein	PMID:34186270
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314913	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of SNRPD1 mRNA	PMID:17361019|PMID:21266533
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPD1 mRNA	PMID:28628672
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1306345	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of SNRPD1 mRNA	PMID:32680482
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SNRPD1 mRNA]	PMID:39241906
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1306345	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of SNRPD1 mRNA	PMID:30589522
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNRPD1 mRNA	PMID:37236586
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314913	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of SNRPD1 mRNA	PMID:18353800
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SNRPD1 mRNA	PMID:28302478
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SNRPD1 mRNA	PMID:31533062
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of SNRPD1 mRNA	PMID:19167446
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1314913	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of SNRPD1 mRNA	PMID:39529242
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SNRPD1 mRNA	PMID:36331819
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314913	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in decreased expression of SNRPD1 mRNA	PMID:20546886
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306345	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of SNRPD1 mRNA	PMID:41580965
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314913	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SNRPD1 mRNA	PMID:17555576
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPD1 mRNA	PMID:28628672
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314913	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SNRPD1 mRNA	PMID:28973697
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in increased expression of SNRPD1 mRNA]	PMID:21233418
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SNRPD1 mRNA	PMID:27188386
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314913	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNRPD1 mRNA	PMID:17562736
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306345	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SNRPD1 mRNA	PMID:33387578
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1314913	E	RGD:6480464	20251007	CTD	MESH:D001151	Arsenic results in decreased expression of SNRPD1 protein	PMID:37888683
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20251007	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNRPD1 mRNA; GW 4064 affects the reaction [Arsenic results in decreased expression of SNRPD1 protein]	PMID:37888683|PMID:40504410
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314913	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SNRPD1 mRNA	PMID:17555576
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314913	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SNRPD1 mRNA	PMID:17942748
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SNRPD1 mRNA	PMID:17942748
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of SNRPD1 mRNA	PMID:38568856
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SNRPD1 mRNA	PMID:28628672
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314913	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SNRPD1 mRNA; Nanotubes, Carbon results in increased expression of SNRPD1 mRNA	PMID:25554681
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306345	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SNRPD1 mRNA	PMID:30047161
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314913	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of SNRPD1 mRNA	PMID:19042947
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SNRPD1 protein	PMID:32959892
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of SNRPD1 protein	PMID:24806433
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1306345	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of SNRPD1 mRNA	PMID:30467583
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314913	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SNRPD1 mRNA	PMID:22206623
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SNRPD1 mRNA]	PMID:22206623
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SNRPD1 protein	PMID:37664457
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1306345	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of SNRPD1 mRNA	PMID:15215175
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SNRPD1 mRNA	PMID:30851411
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:79997	GW 4064	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20251007	CTD	MESH:C412815	GW 4064 affects the reaction [Arsenic results in decreased expression of SNRPD1 protein]	PMID:37888683
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1306345	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of SNRPD1 mRNA	PMID:30047161
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1314913	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SNRPD1 mRNA	PMID:30294300
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in increased expression of SNRPD1 mRNA	PMID:21858171
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1314913	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SNRPD1 mRNA	PMID:21278054
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306345	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SNRPD1 mRNA	PMID:30047161
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314913	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of SNRPD1 mRNA]	PMID:39241906
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of SNRPD1 protein	PMID:37664457
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306345	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SNRPD1 mRNA	PMID:21346803
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SNRPD1 mRNA	PMID:38568856
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1314913	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of SNRPD1 mRNA	PMID:26217789
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306345	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SNRPD1 mRNA	PMID:21346803
1314912	SNRPD1	small nuclear ribonucleoprotein D1 polypeptide	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1314913	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of SNRPD1 mRNA	PMID:28973697
1314915	NAV3	neuron navigator 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1621252	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NAV3 mRNA	PMID:33045310
1314915	NAV3	neuron navigator 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306259	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NAV3 mRNA]	PMID:31150632
1314915	NAV3	neuron navigator 3	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1621252	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NAV3 mRNA	PMID:26251327
1314915	NAV3	neuron navigator 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of NAV3 mRNA	PMID:21934132
1314915	NAV3	neuron navigator 3	gene	CHEBI:16170	mercury(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of NAV3 mRNA	PMID:16823088
1314915	NAV3	neuron navigator 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1621252	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of NAV3 mRNA	PMID:30319688
1314915	NAV3	neuron navigator 3	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D000431	Ethanol results in decreased expression of NAV3 mRNA	PMID:25566775
1314915	NAV3	neuron navigator 3	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1621252	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of NAV3 mRNA	PMID:29018328
1314915	NAV3	neuron navigator 3	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:D000431	[Folic Acid co-treated with Ethanol] results in decreased expression of NAV3 mRNA	PMID:25566775
1314915	NAV3	neuron navigator 3	gene	CHEBI:16412	lipopolysaccharide	affects expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D008070	Lipopolysaccharides affects the expression of NAV3 mRNA	PMID:28070326
1314915	NAV3	neuron navigator 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NAV3 mRNA	PMID:35811015
1314915	NAV3	neuron navigator 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20180313	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NAV3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of NAV3 mRNA; Plant Extracts affects the reaction [Lipopolysaccharides affects the expression of NAV3 mRNA]	PMID:28070326|PMID:35811015
1314915	NAV3	neuron navigator 3	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of NAV3 mRNA	PMID:22574217
1314915	NAV3	neuron navigator 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of NAV3 mRNA	PMID:30165855
1314915	NAV3	neuron navigator 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306259	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of NAV3 mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAV3 mRNA	PMID:26496021|PMID:32741896
1314915	NAV3	neuron navigator 3	gene	CHEBI:16548	chlordecone	multiple interactions	ISO	RGD:1621252	E	RGD:6480464	20201215	CTD	MESH:D007631	Chlordecone promotes the reaction [Biomarkers metabolite binds to NAV3 gene]	PMID:31084621
1314915	NAV3	neuron navigator 3	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of NAV3 mRNA	PMID:20655997|PMID:28937961
1314915	NAV3	neuron navigator 3	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in decreased expression of NAV3 mRNA	PMID:20864642
1314915	NAV3	neuron navigator 3	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of NAV3 mRNA	PMID:26079696
1314915	NAV3	neuron navigator 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1621252	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAV3 mRNA	PMID:37992649
1314915	NAV3	neuron navigator 3	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of NAV3 mRNA	PMID:21592394
1314915	NAV3	neuron navigator 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of NAV3 mRNA	PMID:21592394
1314915	NAV3	neuron navigator 3	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306259	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAV3 mRNA	PMID:32741896
1314915	NAV3	neuron navigator 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1621252	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAV3 mRNA	PMID:37992649
1314915	NAV3	neuron navigator 3	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306259	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of NAV3 mRNA	PMID:26577399
1314915	NAV3	neuron navigator 3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of NAV3 protein	PMID:37730182
1314915	NAV3	neuron navigator 3	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NAV3 mRNA	PMID:36139627
1314915	NAV3	neuron navigator 3	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of NAV3 mRNA	PMID:21592394
1314915	NAV3	neuron navigator 3	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of NAV3 mRNA	PMID:16002434
1314915	NAV3	neuron navigator 3	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of NAV3 mRNA	PMID:21592394
1314915	NAV3	neuron navigator 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NAV3 mRNA	PMID:39836092
1314915	NAV3	neuron navigator 3	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1621252	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of NAV3 mRNA	PMID:27462272
1314915	NAV3	neuron navigator 3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of NAV3 intron	PMID:30157460
1314915	NAV3	neuron navigator 3	gene	CHEBI:25195	mercury atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of NAV3 mRNA	PMID:16823088
1314915	NAV3	neuron navigator 3	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1621252	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of NAV3 mRNA	PMID:17484886
1314915	NAV3	neuron navigator 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306259	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NAV3 mRNA	PMID:31150632
1314915	NAV3	neuron navigator 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306259	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NAV3 mRNA]	PMID:31150632
1314915	NAV3	neuron navigator 3	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NAV3 mRNA	PMID:21867686
1314915	NAV3	neuron navigator 3	gene	CHEBI:27470	folic acid	multiple interactions	EXP		E	RGD:6480464	20240604	CTD	MESH:D005492	[Folic Acid co-treated with Ethanol] results in decreased expression of NAV3 mRNA	PMID:25566775
1314915	NAV3	neuron navigator 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NAV3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NAV3 mRNA	PMID:39836092
1314915	NAV3	neuron navigator 3	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306259	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of NAV3 mRNA	PMID:31881176
1314915	NAV3	neuron navigator 3	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of NAV3 mRNA	PMID:27392435
1314915	NAV3	neuron navigator 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of NAV3 mRNA	PMID:27392435
1314915	NAV3	neuron navigator 3	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1621252	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of NAV3 mRNA	PMID:32186404
1314915	NAV3	neuron navigator 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306259	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NAV3 mRNA	PMID:32109520
1314915	NAV3	neuron navigator 3	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1306259	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of NAV3 mRNA	PMID:28374803
1314915	NAV3	neuron navigator 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NAV3 mRNA	PMID:28001369
1314915	NAV3	neuron navigator 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NAV3 mRNA	PMID:30851411
1314915	NAV3	neuron navigator 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of NAV3 mRNA	PMID:20971185
1314915	NAV3	neuron navigator 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NAV3 mRNA	PMID:29803840
1314915	NAV3	neuron navigator 3	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of NAV3 mRNA	PMID:30031762
1314915	NAV3	neuron navigator 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1621252	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAV3 mRNA	PMID:37992649
1314915	NAV3	neuron navigator 3	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of NAV3 mRNA	PMID:34032870
1314915	NAV3	neuron navigator 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1621252	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of NAV3 mRNA	PMID:36209798
1314915	NAV3	neuron navigator 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of NAV3 mRNA	PMID:22714537|PMID:38568856
1314915	NAV3	neuron navigator 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NAV3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NAV3 mRNA	PMID:39836092
1314915	NAV3	neuron navigator 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NAV3 exon; Benzo(a)pyrene affects the methylation of NAV3 intron	PMID:27901495|PMID:30157460
1314915	NAV3	neuron navigator 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1621252	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of NAV3 3' UTR; Benzo(a)pyrene results in increased methylation of NAV3 exon	PMID:27901495
1314915	NAV3	neuron navigator 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of NAV3 mRNA	PMID:20971185
1314915	NAV3	neuron navigator 3	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of NAV3 mRNA; Silicon Dioxide results in increased expression of NAV3 mRNA	PMID:25351596|PMID:25895662
1314915	NAV3	neuron navigator 3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NAV3 mRNA	PMID:20382639
1314915	NAV3	neuron navigator 3	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of NAV3 mRNA	PMID:15761015
1314915	NAV3	neuron navigator 3	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of NAV3 mRNA	PMID:22521957
1314915	NAV3	neuron navigator 3	gene	CHEBI:30778	gallic acid	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of NAV3 mRNA	PMID:34408198
1314915	NAV3	neuron navigator 3	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of NAV3 gene	PMID:31601247
1314915	NAV3	neuron navigator 3	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of NAV3 mRNA	PMID:38568856
1314915	NAV3	neuron navigator 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306259	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NAV3 mRNA	PMID:25181051
1314915	NAV3	neuron navigator 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1621252	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of NAV3 mRNA	PMID:32156529|PMID:38074096
1314915	NAV3	neuron navigator 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1621252	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of NAV3 mRNA	PMID:26063408
1314915	NAV3	neuron navigator 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of NAV3 gene	PMID:31601247
1314915	NAV3	neuron navigator 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306259	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NAV3 gene	PMID:28505145
1314915	NAV3	neuron navigator 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306259	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of NAV3 mRNA	PMID:26496021
1314915	NAV3	neuron navigator 3	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of NAV3 mRNA	PMID:19244175
1314915	NAV3	neuron navigator 3	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1621252	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of NAV3 mRNA	PMID:26682919
1314915	NAV3	neuron navigator 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of NAV3 gene	PMID:31601247
1314915	NAV3	neuron navigator 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in increased expression of NAV3 mRNA	PMID:30616060
1314915	NAV3	neuron navigator 3	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of NAV3 intron	PMID:30157460
1314915	NAV3	neuron navigator 3	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1621252	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of NAV3 exon; butylbenzyl phthalate results in increased methylation of NAV3 intron	PMID:28392331
1314915	NAV3	neuron navigator 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NAV3 mRNA	PMID:39836092
1314915	NAV3	neuron navigator 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of NAV3 mRNA	PMID:38174414|PMID:38382870|PMID:38568856
1314915	NAV3	neuron navigator 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of NAV3 mRNA	PMID:24449571
1314915	NAV3	neuron navigator 3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of NAV3 mRNA	PMID:31533062
1314915	NAV3	neuron navigator 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of NAV3 mRNA	PMID:24383497|PMID:24935251|PMID:28001369
1314915	NAV3	neuron navigator 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV3 mRNA	PMID:27188386
1314915	NAV3	neuron navigator 3	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of NAV3 mRNA	PMID:25047013
1314915	NAV3	neuron navigator 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1621252	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of NAV3 mRNA	PMID:28973697
1314915	NAV3	neuron navigator 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1621252	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NAV3 mRNA	PMID:37992649
1314915	NAV3	neuron navigator 3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NAV3 mRNA	PMID:38832940
1314915	NAV3	neuron navigator 3	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of NAV3 mRNA	PMID:26272509|PMID:27188386
1314915	NAV3	neuron navigator 3	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV3 mRNA	PMID:27188386
1314915	NAV3	neuron navigator 3	gene	CHEBI:45863	paclitaxel	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	NAV3 protein affects the susceptibility to Paclitaxel	PMID:16217747
1314915	NAV3	neuron navigator 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of NAV3 mRNA	PMID:24935251
1314915	NAV3	neuron navigator 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C012589	trichostatin A results in increased expression of NAV3 mRNA	PMID:24935251|PMID:26272509|PMID:26705709
1314915	NAV3	neuron navigator 3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV3 mRNA	PMID:27188386
1314915	NAV3	neuron navigator 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306259	E	RGD:6480464	20190507	CTD	MESH:D000082	Acetaminophen results in decreased expression of NAV3 mRNA	PMID:30723492
1314915	NAV3	neuron navigator 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NAV3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of NAV3 mRNA	PMID:35811015
1314915	NAV3	neuron navigator 3	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of NAV3 mRNA	PMID:18687144
1314915	NAV3	neuron navigator 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NAV3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NAV3 mRNA	PMID:39836092
1314915	NAV3	neuron navigator 3	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of NAV3 mRNA	PMID:38568856
1314915	NAV3	neuron navigator 3	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of NAV3 mRNA	PMID:15761015
1314915	NAV3	neuron navigator 3	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of NAV3 mRNA	PMID:22521957
1314915	NAV3	neuron navigator 3	gene	CHEBI:50594	carbon nanotube	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NAV3 mRNA	PMID:25102311
1314915	NAV3	neuron navigator 3	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of NAV3 mRNA	PMID:17382205|PMID:22714537
1314915	NAV3	neuron navigator 3	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1621252	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of NAV3 mRNA	PMID:23608068
1314915	NAV3	neuron navigator 3	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of NAV3 mRNA	PMID:31629900
1314915	NAV3	neuron navigator 3	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of NAV3 mRNA	PMID:26272509
1314915	NAV3	neuron navigator 3	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1306259	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of NAV3 mRNA	PMID:20080153
1314915	NAV3	neuron navigator 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of NAV3 mRNA	PMID:39836092
1314915	NAV3	neuron navigator 3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of NAV3 mRNA	PMID:15336504
1314915	NAV3	neuron navigator 3	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NAV3 mRNA	PMID:22079614
1314915	NAV3	neuron navigator 3	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of NAV3 intron	PMID:30157460
1314915	NAV3	neuron navigator 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of NAV3 mRNA	PMID:37199045
1314915	NAV3	neuron navigator 3	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NAV3 mRNA	PMID:36139627
1314915	NAV3	neuron navigator 3	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1306259	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of NAV3 mRNA	PMID:32741896
1314915	NAV3	neuron navigator 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of NAV3 mRNA	PMID:30851411
1314915	NAV3	neuron navigator 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV3 mRNA	PMID:27188386
1314915	NAV3	neuron navigator 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NAV3 gene]	PMID:28238834
1314915	NAV3	neuron navigator 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306259	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of NAV3 mRNA	PMID:32109520
1314915	NAV3	neuron navigator 3	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1621252	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of NAV3 mRNA	PMID:38648751
1314915	NAV3	neuron navigator 3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1306259	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of NAV3 mRNA	PMID:21394737
1314915	NAV3	neuron navigator 3	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of NAV3 mRNA	PMID:26079696
1314915	NAV3	neuron navigator 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306259	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of NAV3 mRNA	PMID:24780913
1314915	NAV3	neuron navigator 3	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of NAV3 mRNA	PMID:26272509
1314915	NAV3	neuron navigator 3	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV3 mRNA	PMID:27188386
1314915	NAV3	neuron navigator 3	gene	CHEBI:88249	PD 0325901	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C506614	mirdametinib results in decreased expression of NAV3 mRNA	PMID:25119042
1314915	NAV3	neuron navigator 3	gene	CHEBI:88249	PD 0325901	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C506614	[(+)-JQ1 compound co-treated with mirdametinib] results in decreased expression of NAV3 mRNA	PMID:25119042
1314915	NAV3	neuron navigator 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NAV3 mRNA	PMID:27188386
1314915	NAV3	neuron navigator 3	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of NAV3 mRNA	PMID:38568856
1314915	NAV3	neuron navigator 3	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of NAV3 mRNA	PMID:27188386
1314915	NAV3	neuron navigator 3	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306259	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of NAV3 mRNA	PMID:23034163
1314916	PCDH9	protocadherin 9	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of PCDH9 mRNA	PMID:27188386
1314916	PCDH9	protocadherin 9	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	EXP		E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of PCDH9 mRNA	PMID:23792671
1314916	PCDH9	protocadherin 9	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of PCDH9 mRNA	PMID:21934132|PMID:23724009
1314916	PCDH9	protocadherin 9	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of PCDH9 mRNA	PMID:26516004
1314916	PCDH9	protocadherin 9	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of PCDH9 mRNA	PMID:26079696
1314916	PCDH9	protocadherin 9	gene	CHEBI:16130	DDT	decreases expression	ISO	RGD:1306348	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of PCDH9 mRNA	PMID:30207508
1314916	PCDH9	protocadherin 9	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1556980	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PCDH9 mRNA	PMID:39241906
1314916	PCDH9	protocadherin 9	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of PCDH9 mRNA	PMID:22574217
1314916	PCDH9	protocadherin 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of PCDH9 mRNA; [Estradiol co-treated with TGFB1 protein] results in increased expression of PCDH9 mRNA	PMID:20660070|PMID:30165855
1314916	PCDH9	protocadherin 9	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1556980	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCDH9 mRNA	PMID:25510870
1314916	PCDH9	protocadherin 9	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in increased expression of PCDH9 mRNA	PMID:20655997
1314916	PCDH9	protocadherin 9	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of PCDH9 mRNA	PMID:20660070
1314916	PCDH9	protocadherin 9	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PCDH9 mRNA	PMID:31163220
1314916	PCDH9	protocadherin 9	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1556980	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PCDH9 mRNA	PMID:32235866
1314916	PCDH9	protocadherin 9	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of PCDH9 mRNA	PMID:28818685
1314916	PCDH9	protocadherin 9	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of PCDH9 intron	PMID:30157460
1314916	PCDH9	protocadherin 9	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in decreased expression of PCDH9 mRNA	PMID:34773240
1314916	PCDH9	protocadherin 9	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Selenium inhibits the reaction [Cadmium results in decreased expression of PCDH9 mRNA]	PMID:34773240
1314916	PCDH9	protocadherin 9	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1556980	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCDH9 mRNA	PMID:25510870
1314916	PCDH9	protocadherin 9	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1556980	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCDH9 mRNA	PMID:25510870
1314916	PCDH9	protocadherin 9	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PCDH9 mRNA	PMID:22100608
1314916	PCDH9	protocadherin 9	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PCDH9 gene	PMID:27153756
1314916	PCDH9	protocadherin 9	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of PCDH9 exon	PMID:30157460
1314916	PCDH9	protocadherin 9	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1556980	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PCDH9 mRNA	PMID:27106289
1314916	PCDH9	protocadherin 9	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PCDH9 gene	PMID:25304211
1314916	PCDH9	protocadherin 9	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of PCDH9 mRNA]	PMID:34773240
1314916	PCDH9	protocadherin 9	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PCDH9 mRNA	PMID:26272509
1314916	PCDH9	protocadherin 9	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH9 mRNA	PMID:27188386
1314916	PCDH9	protocadherin 9	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PCDH9 mRNA	PMID:27392435
1314916	PCDH9	protocadherin 9	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1556980	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of PCDH9 mRNA	PMID:40618947
1314916	PCDH9	protocadherin 9	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1556980	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of PCDH9 mRNA	PMID:32186404
1314916	PCDH9	protocadherin 9	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of PCDH9 mRNA	PMID:25583101
1314916	PCDH9	protocadherin 9	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PCDH9 mRNA	PMID:23179753|PMID:28001369
1314916	PCDH9	protocadherin 9	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of PCDH9 mRNA	PMID:29803840
1314916	PCDH9	protocadherin 9	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PCDH9 gene	PMID:28589171
1314916	PCDH9	protocadherin 9	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PCDH9 mRNA	PMID:38568856
1314916	PCDH9	protocadherin 9	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1556980	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of PCDH9 mRNA	PMID:17127020
1314916	PCDH9	protocadherin 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PCDH9 5' UTR; Benzo(a)pyrene affects the methylation of PCDH9 intron	PMID:27901495|PMID:30157460
1314916	PCDH9	protocadherin 9	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of PCDH9 3' UTR	PMID:27901495
1314916	PCDH9	protocadherin 9	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PCDH9 promoter	PMID:27901495
1314916	PCDH9	protocadherin 9	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1556980	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of PCDH9 mRNA	PMID:18929588
1314916	PCDH9	protocadherin 9	gene	CHEBI:29866	arsenite(3-)	multiple interactions	ISO	RGD:1556980	E	RGD:6480464	20120412	CTD	MESH:C015001	TRP53 protein affects the reaction [arsenite results in increased expression of PCDH9 mRNA]	PMID:18929588
1314916	PCDH9	protocadherin 9	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of PCDH9 mRNA; Silicon Dioxide results in decreased expression of PCDH9 mRNA	PMID:22300531|PMID:25895662
1314916	PCDH9	protocadherin 9	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PCDH9 mRNA	PMID:20382639
1314916	PCDH9	protocadherin 9	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1556980	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of PCDH9 mRNA	PMID:35295148
1314916	PCDH9	protocadherin 9	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PCDH9 mRNA	PMID:19710929
1314916	PCDH9	protocadherin 9	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDH9 mRNA	PMID:36232920
1314916	PCDH9	protocadherin 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306348	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDH9 mRNA	PMID:25181051|PMID:41034487
1314916	PCDH9	protocadherin 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1556980	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of PCDH9 mRNA	PMID:32156529
1314916	PCDH9	protocadherin 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1556980	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of PCDH9 mRNA	PMID:30951980
1314916	PCDH9	protocadherin 9	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1556980	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCDH9 mRNA	PMID:25510870
1314916	PCDH9	protocadherin 9	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1556980	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of PCDH9 mRNA	PMID:25510870
1314916	PCDH9	protocadherin 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1556980	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of PCDH9 mRNA	PMID:30951980
1314916	PCDH9	protocadherin 9	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of PCDH9 exon; benzo(e)pyrene results in increased methylation of PCDH9 intron	PMID:30157460
1314916	PCDH9	protocadherin 9	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1556980	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PCDH9 mRNA	PMID:37019170
1314916	PCDH9	protocadherin 9	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306348	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of PCDH9 mRNA	PMID:32680482
1314916	PCDH9	protocadherin 9	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1556980	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of PCDH9 mRNA	PMID:36117858
1314916	PCDH9	protocadherin 9	gene	CHEBI:34911	permethrin	decreases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in decreased expression of PCDH9 mRNA	PMID:37047231
1314916	PCDH9	protocadherin 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PCDH9 mRNA	PMID:37042841
1314916	PCDH9	protocadherin 9	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1306348	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of PCDH9 mRNA	PMID:18500788
1314916	PCDH9	protocadherin 9	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of PCDH9 mRNA]	PMID:34773240
1314916	PCDH9	protocadherin 9	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1556980	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PCDH9 mRNA	PMID:40194260
1314916	PCDH9	protocadherin 9	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PCDH9 mRNA	PMID:25979313
1314916	PCDH9	protocadherin 9	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of PCDH9 mRNA	PMID:29154799
1314916	PCDH9	protocadherin 9	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of PCDH9 gene	PMID:29154799
1314916	PCDH9	protocadherin 9	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PCDH9 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1314916	PCDH9	protocadherin 9	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH9 mRNA	PMID:27188386
1314916	PCDH9	protocadherin 9	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306348	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of PCDH9 mRNA	PMID:38685447
1314916	PCDH9	protocadherin 9	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of PCDH9 mRNA	PMID:20106945|PMID:27989131
1314916	PCDH9	protocadherin 9	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1306348	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of PCDH9 mRNA	PMID:17005392
1314916	PCDH9	protocadherin 9	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of PCDH9 mRNA	PMID:26272509
1314916	PCDH9	protocadherin 9	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of PCDH9 mRNA	PMID:24935251|PMID:26272509
1314916	PCDH9	protocadherin 9	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH9 mRNA	PMID:27188386
1314916	PCDH9	protocadherin 9	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306348	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of PCDH9 mRNA	PMID:33387578
1314916	PCDH9	protocadherin 9	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of PCDH9 mRNA	PMID:18687144|PMID:29523930
1314916	PCDH9	protocadherin 9	gene	CHEBI:46666	crocidolite asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased methylation of PCDH9 gene	PMID:29523930
1314916	PCDH9	protocadherin 9	gene	CHEBI:46680	serpentine asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased methylation of PCDH9 gene	PMID:29523930
1314916	PCDH9	protocadherin 9	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of PCDH9 gene	PMID:25304211
1314916	PCDH9	protocadherin 9	gene	CHEBI:47286	CU-O LINKAGE	decreases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in decreased expression of PCDH9 mRNA	PMID:22077320
1314916	PCDH9	protocadherin 9	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of PCDH9 mRNA	PMID:36621641
1314916	PCDH9	protocadherin 9	gene	CHEBI:48843	disodium selenite	decreases expression	ISO	RGD:1556980	E	RGD:6480464	20130514	CTD	MESH:D018038	Sodium Selenite results in decreased expression of PCDH9 mRNA	PMID:23274088
1314916	PCDH9	protocadherin 9	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306348	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of PCDH9 mRNA	PMID:29097150
1314916	PCDH9	protocadherin 9	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of PCDH9 mRNA	PMID:38568856
1314916	PCDH9	protocadherin 9	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of PCDH9 mRNA	PMID:26272509
1314916	PCDH9	protocadherin 9	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306348	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of PCDH9 mRNA	PMID:30307764
1314916	PCDH9	protocadherin 9	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1556980	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of PCDH9 mRNA	PMID:36117858
1314916	PCDH9	protocadherin 9	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1556980	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of PCDH9 mRNA	PMID:23608068
1314916	PCDH9	protocadherin 9	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of PCDH9 mRNA	PMID:31629900
1314916	PCDH9	protocadherin 9	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of PCDH9 mRNA	PMID:15336504
1314916	PCDH9	protocadherin 9	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of PCDH9 mRNA	PMID:24810058
1314916	PCDH9	protocadherin 9	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of PCDH9 exon; Methapyrilene results in increased methylation of PCDH9 intron	PMID:30157460
1314916	PCDH9	protocadherin 9	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1306348	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of PCDH9 mRNA	PMID:27840820
1314916	PCDH9	protocadherin 9	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PCDH9 mRNA	PMID:37199045
1314916	PCDH9	protocadherin 9	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH9 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH9 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH9 mRNA	PMID:27188386
1314916	PCDH9	protocadherin 9	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PCDH9 gene]	PMID:28238834
1314916	PCDH9	protocadherin 9	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1306348	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of PCDH9 mRNA	PMID:27291303
1314916	PCDH9	protocadherin 9	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of PCDH9 mRNA	PMID:26079696
1314916	PCDH9	protocadherin 9	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306348	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PCDH9 mRNA	PMID:24780913
1314916	PCDH9	protocadherin 9	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH9 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH9 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH9 mRNA	PMID:27188386
1314916	PCDH9	protocadherin 9	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PCDH9 mRNA	PMID:38568856
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of ASH1L mRNA	PMID:21551480|PMID:25152437
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ASH1L mRNA	PMID:30071829
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314919	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ASH1L mRNA	PMID:20188158
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of ASH1L mRNA	PMID:40945087
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ASH1L mRNA	PMID:22378314
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:D000431	Ethanol results in decreased expression of ASH1L mRNA	PMID:35149083
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ASH1L mRNA	PMID:39241906
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of ASH1L mRNA	PMID:20068009|PMID:32145629
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ASH1L mRNA	PMID:37042841
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of ASH1L mRNA	PMID:20655997
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of ASH1L mRNA	PMID:23649840
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:17151	xylitol	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D014993	Xylitol results in increased expression of ASH1L mRNA	PMID:32275922
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ASH1L mRNA	PMID:33754040
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ASH1L mRNA	PMID:26577399
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ASH1L protein	PMID:37730182
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of ASH1L mRNA	PMID:27462272
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1314919	E	RGD:6480464	20140311	CTD	MESH:D002104	Cadmium results in increased expression of ASH1L mRNA	PMID:24067728
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306350	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASH1L mRNA	PMID:39012411
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314919	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASH1L mRNA	PMID:37236586
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314919	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ASH1L mRNA	PMID:19770486
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ASH1L mRNA	PMID:23649840
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ASH1L mRNA	PMID:41430723
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of ASH1L mRNA	PMID:25629700
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of ASH1L mRNA	PMID:26272509
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASH1L mRNA	PMID:27188386
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of ASH1L mRNA	PMID:34906888
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of ASH1L mRNA	PMID:25905778
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ASH1L mRNA	PMID:30912803
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of ASH1L mRNA	PMID:25583101
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306350	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASH1L mRNA	PMID:22298810
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314919	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASH1L mRNA	PMID:21570461
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ASH1L mRNA	PMID:33387578
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306350	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ASH1L mRNA	PMID:34747641
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314919	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ASH1L mRNA	PMID:21354282
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ASH1L mRNA	PMID:33212167
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ASH1L mRNA	PMID:29803840
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of ASH1L mRNA	PMID:17888722
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of ASH1L protein	PMID:35688186
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ASH1L mRNA	PMID:38568856
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314919	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of ASH1L mRNA	PMID:16322246
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASH1L mRNA alternative form	PMID:40419235
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ASH1L 5' UTR	PMID:27901495
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ASH1L mRNA	PMID:19150397
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306350	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] affects the expression of ASH1L mRNA	PMID:25729387
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306350	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ASH1L mRNA	PMID:34492290
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of ASH1L mRNA	PMID:19167457
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306350	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of ASH1L mRNA	PMID:32145629
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306350	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ASH1L mRNA	PMID:25181051|PMID:30816183
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314919	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of ASH1L mRNA	PMID:35598803
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ASH1L mRNA	PMID:39298647
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314919	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of ASH1L mRNA	PMID:40203079
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ASH1L intron	PMID:30157460
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314919	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ASH1L mRNA	PMID:38685157
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ASH1L mRNA	PMID:37042841
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:3537	cefaloridine	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20120412	CTD	MESH:D002509	Cephaloridine results in decreased expression of ASH1L mRNA	PMID:18500788
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ASH1L mRNA	PMID:25851441|PMID:38568856
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ASH1L mRNA	PMID:24982889
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306350	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASH1L mRNA	PMID:39012411
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314919	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASH1L mRNA	PMID:37236586
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ASH1L mRNA	PMID:28302478
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ASH1L mRNA	PMID:27153767
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1306350	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of ASH1L mRNA	PMID:23125180
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ASH1L mRNA	PMID:25979313
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1306350	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of ASH1L mRNA	PMID:29427782
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in decreased expression of ASH1L mRNA	PMID:23179753|PMID:25192806|PMID:28001369
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of ASH1L mRNA	PMID:29427782
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ASH1L gene	PMID:29154799
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of ASH1L mRNA	PMID:41580965
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314919	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ASH1L mRNA	PMID:17562736
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ASH1L mRNA	PMID:33387578
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ASH1L mRNA	PMID:26690555
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ASH1L mRNA	PMID:25554681
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1314919	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ASH1L mRNA	PMID:26378955
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:63632	topotecan	affects expression	ISO	RGD:1306350	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan affects the expression of ASH1L mRNA	PMID:25729387
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306350	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] affects the expression of ASH1L mRNA	PMID:25729387
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ASH1L mRNA	PMID:30467583
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ASH1L intron	PMID:30157460
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306350	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ASH1L gene	PMID:35440735
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:6923	miconazole	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in decreased expression of ASH1L mRNA	PMID:27462272
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ASH1L mRNA	PMID:22206623
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ASH1L mRNA	PMID:24136188
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASH1L mRNA	PMID:27188386
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ASH1L gene]	PMID:28238834
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314919	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ASH1L mRNA	PMID:23091169
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314919	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ASH1L mRNA	PMID:21795629
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of ASH1L mRNA	PMID:21278054
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASH1L mRNA	PMID:27188386
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306350	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ASH1L mRNA	PMID:21346803
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314919	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ASH1L mRNA	PMID:28973697
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306350	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of ASH1L mRNA	PMID:19015723
1314918	ASH1L	ASH1 like histone lysine methyltransferase	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306350	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of ASH1L mRNA	PMID:18042343
1314921	FBXO3	F-box protein 3	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of FBXO3 mRNA	PMID:38218311
1314921	FBXO3	F-box protein 3	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of FBXO3 mRNA	PMID:38218311
1314921	FBXO3	F-box protein 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1593433	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FBXO3 mRNA]	PMID:31150632
1314921	FBXO3	F-box protein 3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of FBXO3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of FBXO3 mRNA	PMID:32699268
1314921	FBXO3	F-box protein 3	gene	CHEBI:15422	ATP	multiple interactions	ISO	RGD:1593433	E	RGD:6480464	20230704	CTD	MESH:D000255	FBXO3 protein inhibits the reaction [MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of CASP1 protein]]; FBXO3 protein inhibits the reaction [MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of GSDMD protein]]; FBXO3 protein inhibits the reaction [MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL18 protein]]; FBXO3 protein inhibits the reaction [MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein]]; FBXO3 protein inhibits the reaction [MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of NLRP3 protein]]; FBXO3 protein inhibits the reaction [MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of PYCARD protein]]; FBXO3 protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of CASP1 protein]; FBXO3 protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of GSDMD protein]; FBXO3 protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL18 protein]; FBXO3 protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein]; FBXO3 protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of NLRP3 protein]; FBXO3 protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of PYCARD protein]	PMID:35962723
1314921	FBXO3	F-box protein 3	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314922	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of FBXO3 mRNA	PMID:30319688
1314921	FBXO3	F-box protein 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of FBXO3 mRNA	PMID:20044591
1314921	FBXO3	F-box protein 3	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of FBXO3 mRNA	PMID:21632981
1314921	FBXO3	F-box protein 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1593433	E	RGD:6480464	20230704	CTD	MESH:D008070	FBXO3 protein inhibits the reaction [MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of CASP1 protein]]; FBXO3 protein inhibits the reaction [MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of GSDMD protein]]; FBXO3 protein inhibits the reaction [MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL18 protein]]; FBXO3 protein inhibits the reaction [MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein]]; FBXO3 protein inhibits the reaction [MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of NLRP3 protein]]; FBXO3 protein inhibits the reaction [MIR219A1 mRNA inhibits the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of PYCARD protein]]; FBXO3 protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of CASP1 protein]; FBXO3 protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of GSDMD protein]; FBXO3 protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL18 protein]; FBXO3 protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of IL1B protein]; FBXO3 protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of NLRP3 protein]; FBXO3 protein promotes the reaction [[Lipopolysaccharides co-treated with Adenosine Triphosphate] results in increased expression of PYCARD protein]	PMID:35962723
1314921	FBXO3	F-box protein 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314922	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of FBXO3 mRNA	PMID:39298647
1314921	FBXO3	F-box protein 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1593433	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of FBXO3 mRNA	PMID:26496021
1314921	FBXO3	F-box protein 3	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1593433	E	RGD:6480464	20120412	CTD	MESH:D014241	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of FBXO3 mRNA	PMID:17905399
1314921	FBXO3	F-box protein 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FBXO3 mRNA	PMID:37042841
1314921	FBXO3	F-box protein 3	gene	CHEBI:16716	benzene	multiple interactions	ISO	RGD:1593433	E	RGD:6480464	20120412	CTD	MESH:D001554	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of FBXO3 mRNA	PMID:17905399
1314921	FBXO3	F-box protein 3	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of FBXO3 mRNA	PMID:21179406
1314921	FBXO3	F-box protein 3	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of FBXO3 mRNA	PMID:16002434
1314921	FBXO3	F-box protein 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1593433	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of FBXO3 mRNA	PMID:22061828
1314921	FBXO3	F-box protein 3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FBXO3 mRNA	PMID:39836092
1314921	FBXO3	F-box protein 3	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of FBXO3 mRNA	PMID:24376830
1314921	FBXO3	F-box protein 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXO3 mRNA	PMID:35301059
1314921	FBXO3	F-box protein 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314922	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXO3 mRNA	PMID:28111341
1314921	FBXO3	F-box protein 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FBXO3 mRNA	PMID:19549813
1314921	FBXO3	F-box protein 3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of FBXO3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of FBXO3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of FBXO3 mRNA	PMID:32699268
1314921	FBXO3	F-box protein 3	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of FBXO3 mRNA	PMID:22171008
1314921	FBXO3	F-box protein 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314922	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FBXO3 mRNA	PMID:31919559
1314921	FBXO3	F-box protein 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1593433	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FBXO3 mRNA	PMID:31150632
1314921	FBXO3	F-box protein 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1593433	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of FBXO3 mRNA]	PMID:31150632
1314921	FBXO3	F-box protein 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314922	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FBXO3 mRNA	PMID:25629700
1314921	FBXO3	F-box protein 3	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of FBXO3 mRNA	PMID:18414638
1314921	FBXO3	F-box protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FBXO3 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FBXO3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO3 mRNA	PMID:32525701|PMID:39836092|PMID:40512198
1314921	FBXO3	F-box protein 3	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1593433	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of FBXO3 mRNA	PMID:25905778
1314921	FBXO3	F-box protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314922	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXO3 mRNA	PMID:21570461
1314921	FBXO3	F-box protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314922	E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBXO3 mRNA	PMID:15034205
1314921	FBXO3	F-box protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1593433	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FBXO3 mRNA	PMID:21215274
1314921	FBXO3	F-box protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314922	E	RGD:6480464	20130312	CTD	MESH:D013749	AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of FBXO3 mRNA]	PMID:15034205
1314921	FBXO3	F-box protein 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of FBXO3 mRNA	PMID:28001369
1314921	FBXO3	F-box protein 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of FBXO3 mRNA	PMID:26272509
1314921	FBXO3	F-box protein 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO3 mRNA	PMID:27188386
1314921	FBXO3	F-box protein 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FBXO3 mRNA	PMID:29803840
1314921	FBXO3	F-box protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FBXO3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO3 mRNA	PMID:39836092|PMID:40512198
1314921	FBXO3	F-box protein 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FBXO3 promoter	PMID:27901495
1314921	FBXO3	F-box protein 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314922	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FBXO3 mRNA	PMID:15034205
1314921	FBXO3	F-box protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314922	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FBXO3 mRNA	PMID:22228805
1314921	FBXO3	F-box protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314922	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FBXO3 exon; Benzo(a)pyrene results in increased methylation of FBXO3 intron	PMID:27901495
1314921	FBXO3	F-box protein 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314922	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of FBXO3 mRNA]	PMID:15034205
1314921	FBXO3	F-box protein 3	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of FBXO3 mRNA	PMID:22171008
1314921	FBXO3	F-box protein 3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXO3 gene	PMID:31601247
1314921	FBXO3	F-box protein 3	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1593433	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of FBXO3 mRNA	PMID:24136188
1314921	FBXO3	F-box protein 3	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1593433	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of FBXO3 mRNA	PMID:25729387
1314921	FBXO3	F-box protein 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1593433	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of FBXO3 mRNA	PMID:25729387
1314921	FBXO3	F-box protein 3	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1593433	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of FBXO3 mRNA	PMID:30047161
1314921	FBXO3	F-box protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314922	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXO3 gene; titanium dioxide results in decreased methylation of FBXO3 promoter	PMID:35295148
1314921	FBXO3	F-box protein 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1593433	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FBXO3 mRNA	PMID:34492290
1314921	FBXO3	F-box protein 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314922	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of FBXO3 mRNA	PMID:18648102
1314921	FBXO3	F-box protein 3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314922	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of FBXO3 mRNA	PMID:18445702
1314921	FBXO3	F-box protein 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1593433	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FBXO3 mRNA	PMID:25181051
1314921	FBXO3	F-box protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1593433	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXO3 mRNA	PMID:34947998
1314921	FBXO3	F-box protein 3	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of FBXO3 gene	PMID:31601247
1314921	FBXO3	F-box protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXO3 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXO3 mRNA	PMID:28628672|PMID:31601247
1314921	FBXO3	F-box protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1593433	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of FBXO3 mRNA	PMID:26496021
1314921	FBXO3	F-box protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314922	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of FBXO3 mRNA	PMID:39298647
1314921	FBXO3	F-box protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of FBXO3 gene	PMID:31601247
1314921	FBXO3	F-box protein 3	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314922	E	RGD:6480464	20120918	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FBXO3 mRNA	PMID:20350560|PMID:37019170
1314921	FBXO3	F-box protein 3	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of FBXO3 gene	PMID:22964155
1314921	FBXO3	F-box protein 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXO3 mRNA	PMID:28628672
1314921	FBXO3	F-box protein 3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FBXO3 mRNA	PMID:39836092
1314921	FBXO3	F-box protein 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXO3 mRNA	PMID:35301059
1314921	FBXO3	F-box protein 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314922	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXO3 mRNA	PMID:28111341
1314921	FBXO3	F-box protein 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FBXO3 mRNA	PMID:24449571
1314921	FBXO3	F-box protein 3	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of FBXO3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of FBXO3 mRNA	PMID:32699268
1314921	FBXO3	F-box protein 3	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of FBXO3 mRNA	PMID:28302478
1314921	FBXO3	F-box protein 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FBXO3 mRNA	PMID:25979313
1314921	FBXO3	F-box protein 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of FBXO3 mRNA	PMID:28001369
1314921	FBXO3	F-box protein 3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of FBXO3 gene	PMID:29154799
1314921	FBXO3	F-box protein 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXO3 mRNA	PMID:22083351
1314921	FBXO3	F-box protein 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FBXO3 mRNA	PMID:25562108
1314921	FBXO3	F-box protein 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXO3 mRNA	PMID:28628672
1314921	FBXO3	F-box protein 3	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of FBXO3 mRNA	PMID:27188386
1314921	FBXO3	F-box protein 3	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of FBXO3 mRNA	PMID:28542535
1314921	FBXO3	F-box protein 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314922	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FBXO3 mRNA	PMID:17562736
1314921	FBXO3	F-box protein 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of FBXO3 mRNA	PMID:21420995
1314921	FBXO3	F-box protein 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1314922	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXO3 mRNA	PMID:17585979
1314921	FBXO3	F-box protein 3	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of FBXO3 mRNA	PMID:18414638
1314921	FBXO3	F-box protein 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FBXO3 mRNA; [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FBXO3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of FBXO3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXO3 mRNA	PMID:32525701|PMID:39836092|PMID:40512198
1314921	FBXO3	F-box protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314922	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of FBXO3 mRNA	PMID:17555576
1314921	FBXO3	F-box protein 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBXO3 mRNA	PMID:28628672
1314921	FBXO3	F-box protein 3	gene	CHEBI:49747	methylmercury(1+)	multiple interactions	ISO	RGD:1593433	E	RGD:6480464	20120412	CTD	MESH:C030957	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of FBXO3 mRNA	PMID:17905399
1314921	FBXO3	F-box protein 3	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1314922	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of FBXO3 mRNA	PMID:21318169
1314921	FBXO3	F-box protein 3	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1314922	E	RGD:6480464	20120613	CTD	MESH:D011345	PPARA protein affects the reaction [Fenofibrate results in increased expression of FBXO3 mRNA]	PMID:21318169
1314921	FBXO3	F-box protein 3	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1593433	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of FBXO3 mRNA	PMID:30047161
1314921	FBXO3	F-box protein 3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1593433	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of FBXO3 mRNA	PMID:24793618
1314921	FBXO3	F-box protein 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of FBXO3 protein	PMID:32959892
1314921	FBXO3	F-box protein 3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of FBXO3 mRNA	PMID:39836092
1314921	FBXO3	F-box protein 3	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1593433	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of FBXO3 mRNA	PMID:25729387
1314921	FBXO3	F-box protein 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1593433	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of FBXO3 mRNA	PMID:25729387
1314921	FBXO3	F-box protein 3	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314922	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of FBXO3 mRNA	PMID:23650126
1314921	FBXO3	F-box protein 3	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of FBXO3 mRNA	PMID:28988120
1314921	FBXO3	F-box protein 3	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1593433	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of FBXO3 mRNA	PMID:30467583
1314921	FBXO3	F-box protein 3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1593433	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FBXO3 gene	PMID:35440735
1314921	FBXO3	F-box protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314922	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of FBXO3 mRNA	PMID:22206623
1314921	FBXO3	F-box protein 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO3 mRNA	PMID:27188386
1314921	FBXO3	F-box protein 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314922	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of FBXO3 mRNA	PMID:39847705
1314921	FBXO3	F-box protein 3	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of FBXO3 mRNA	PMID:32525701
1314921	FBXO3	F-box protein 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1593433	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FBXO3 mRNA	PMID:30047161
1314921	FBXO3	F-box protein 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBXO3 mRNA	PMID:27188386
1314921	FBXO3	F-box protein 3	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1593433	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of FBXO3 mRNA	PMID:19281266
1314921	FBXO3	F-box protein 3	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of FBXO3 mRNA	PMID:27188386
1314924	SVIL	supervillin	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of SVIL mRNA	PMID:38218311
1314924	SVIL	supervillin	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of SVIL mRNA	PMID:21551480
1314924	SVIL	supervillin	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SVIL mRNA	PMID:27188386
1314924	SVIL	supervillin	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314925	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of SVIL; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SVIL gene	PMID:20938992
1314924	SVIL	supervillin	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SVIL mRNA	PMID:33167477
1314924	SVIL	supervillin	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SVIL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SVIL mRNA	PMID:32699268
1314924	SVIL	supervillin	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SVIL mRNA	PMID:26079696
1314924	SVIL	supervillin	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306354	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of SVIL gene	PMID:35440735
1314924	SVIL	supervillin	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314925	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of SVIL mRNA	PMID:30319688
1314924	SVIL	supervillin	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314925	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SVIL mRNA	PMID:30319688
1314924	SVIL	supervillin	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1306354	E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of SVIL mRNA	PMID:17347304
1314924	SVIL	supervillin	gene	CHEBI:16243	quercetin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in increased phosphorylation of SVIL protein	PMID:35688186
1314924	SVIL	supervillin	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D004958	Estradiol affects the expression of SVIL mRNA	PMID:25321415
1314924	SVIL	supervillin	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004958	Estradiol results in increased expression of SVIL mRNA	PMID:24758408|PMID:26865669|PMID:31614463
1314924	SVIL	supervillin	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314925	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of SVIL mRNA	PMID:39298647
1314924	SVIL	supervillin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of SVIL mRNA; EGF protein promotes the reaction [Estradiol results in increased expression of SVIL mRNA]	PMID:20660070|PMID:24758408
1314924	SVIL	supervillin	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306354	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of SVIL mRNA	PMID:26496021
1314924	SVIL	supervillin	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314925	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of SVIL mRNA	PMID:33711761
1314924	SVIL	supervillin	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1314925	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SVIL mRNA	PMID:25549359
1314924	SVIL	supervillin	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314925	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of SVIL; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SVIL gene	PMID:20938992
1314924	SVIL	supervillin	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SVIL mRNA	PMID:37042841
1314924	SVIL	supervillin	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SVIL mRNA	PMID:23649840
1314924	SVIL	supervillin	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of SVIL mRNA	PMID:20660070
1314924	SVIL	supervillin	gene	CHEBI:17263	estrone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004970	Estrone results in increased expression of SVIL mRNA	PMID:26865669
1314924	SVIL	supervillin	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SVIL protein	PMID:37730182
1314924	SVIL	supervillin	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306354	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of SVIL mRNA	PMID:22061828
1314924	SVIL	supervillin	gene	CHEBI:180654	N(4)-hydroxycytidine	decreases expression	ISO	RGD:1314925	E	RGD:6480464	20240305	CTD	MESH:C010737	N(4)-hydroxycytidine results in decreased expression of SVIL mRNA	PMID:37748715
1314924	SVIL	supervillin	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Cadmium results in decreased expression of SVIL mRNA	PMID:34773240
1314924	SVIL	supervillin	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D002104	Selenium inhibits the reaction [Cadmium results in decreased expression of SVIL mRNA]	PMID:34773240
1314924	SVIL	supervillin	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SVIL mRNA	PMID:19549813
1314924	SVIL	supervillin	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1314925	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in increased expression of SVIL mRNA	PMID:18579281
1314924	SVIL	supervillin	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SVIL gene	PMID:27153756
1314924	SVIL	supervillin	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SVIL mRNA	PMID:23649840
1314924	SVIL	supervillin	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	ISO	RGD:1306354	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of SVIL mRNA	PMID:15651846
1314924	SVIL	supervillin	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1306354	E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in increased expression of SVIL protein	PMID:33146391
1314924	SVIL	supervillin	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SVIL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SVIL mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of SVIL mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SVIL mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of SVIL mRNA	PMID:32699268|PMID:35430440|PMID:41430723
1314924	SVIL	supervillin	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of SVIL mRNA	PMID:19774075
1314924	SVIL	supervillin	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SVIL protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SVIL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SVIL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of SVIL protein	PMID:38598786
1314924	SVIL	supervillin	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314925	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SVIL mRNA	PMID:25629700
1314924	SVIL	supervillin	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314925	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of SVIL; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SVIL gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SVIL mRNA]	PMID:20938992|PMID:22206623
1314924	SVIL	supervillin	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SVIL gene	PMID:25304211
1314924	SVIL	supervillin	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314925	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of SVIL gene] which results in increased expression of SVIL mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of SVIL gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SVIL mRNA	PMID:40504410
1314924	SVIL	supervillin	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of SVIL mRNA]	PMID:34773240
1314924	SVIL	supervillin	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SVIL mRNA	PMID:26272509
1314924	SVIL	supervillin	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SVIL mRNA	PMID:27188386
1314924	SVIL	supervillin	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of SVIL protein	PMID:35688186
1314924	SVIL	supervillin	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314925	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of SVIL mRNA	PMID:28960355
1314924	SVIL	supervillin	gene	CHEBI:27903	(2,4,5-trichlorophenoxy)acetic acid	increases expression	ISO	RGD:1314925	E	RGD:6480464	20130514	CTD	MESH:D015085	2,4,5-Trichlorophenoxyacetic Acid results in increased expression of SVIL mRNA	PMID:18579281
1314924	SVIL	supervillin	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D019833	Genistein results in increased expression of SVIL mRNA	PMID:26865669
1314924	SVIL	supervillin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314925	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SVIL mRNA	PMID:26377647
1314924	SVIL	supervillin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SVIL mRNA	PMID:19901195
1314924	SVIL	supervillin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SVIL mRNA	PMID:33387578
1314924	SVIL	supervillin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314925	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SVIL mRNA	PMID:26290441
1314924	SVIL	supervillin	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306354	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SVIL mRNA	PMID:21215274|PMID:34747641
1314924	SVIL	supervillin	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SVIL mRNA	PMID:33212167
1314924	SVIL	supervillin	gene	CHEBI:28619	acrylamide	affects expression	ISO	RGD:1306354	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide affects the expression of SVIL mRNA	PMID:28959563
1314924	SVIL	supervillin	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1314925	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of SVIL protein	PMID:28918527
1314924	SVIL	supervillin	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SVIL mRNA	PMID:29803840
1314924	SVIL	supervillin	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of SVIL protein	PMID:35688186
1314924	SVIL	supervillin	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SVIL mRNA	PMID:38568856
1314924	SVIL	supervillin	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314925	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of SVIL gene] which results in increased expression of SVIL mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of SVIL gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SVIL mRNA	PMID:40504410
1314924	SVIL	supervillin	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SVIL 5' UTR; Benzo(a)pyrene affects the methylation of SVIL intron; Benzo(a)pyrene affects the methylation of SVIL promoter	PMID:27901495|PMID:30157460
1314924	SVIL	supervillin	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314925	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SVIL mRNA	PMID:19770486
1314924	SVIL	supervillin	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of SVIL promoter	PMID:23974009
1314924	SVIL	supervillin	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to SVIL mRNA]	PMID:32406909
1314924	SVIL	supervillin	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SVIL mRNA	PMID:19150397
1314924	SVIL	supervillin	gene	CHEBI:31638	fulvestrant	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C070081	fulvestrant results in decreased expression of SVIL mRNA	PMID:26865669
1314924	SVIL	supervillin	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of SVIL gene	PMID:31601247
1314924	SVIL	supervillin	gene	CHEBI:31669	hexestrol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D006589	Hexestrol results in increased expression of SVIL mRNA	PMID:26865669
1314924	SVIL	supervillin	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306354	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SVIL mRNA	PMID:25729387
1314924	SVIL	supervillin	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314925	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of SVIL mRNA	PMID:35295148
1314924	SVIL	supervillin	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314925	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of SVIL mRNA	PMID:18445702|PMID:20813756
1314924	SVIL	supervillin	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SVIL protein	PMID:33376534|PMID:34186270
1314924	SVIL	supervillin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SVIL mRNA	PMID:30816183|PMID:34947998|PMID:38750585
1314924	SVIL	supervillin	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314925	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SVIL mRNA	PMID:26063408
1314924	SVIL	supervillin	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of SVIL mRNA; bisphenol A results in increased expression of SVIL protein	PMID:27685785|PMID:29275510|PMID:37567409
1314924	SVIL	supervillin	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314925	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SVIL mRNA	PMID:30951980
1314924	SVIL	supervillin	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306354	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of SVIL mRNA	PMID:26496021
1314924	SVIL	supervillin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314925	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of SVIL mRNA	PMID:39298647
1314924	SVIL	supervillin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SVIL protein	PMID:34186270
1314924	SVIL	supervillin	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314925	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SVIL mRNA	PMID:30951980
1314924	SVIL	supervillin	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314925	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SVIL mRNA	PMID:30951980
1314924	SVIL	supervillin	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1314925	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of SVIL mRNA	PMID:35093514
1314924	SVIL	supervillin	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of SVIL protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of SVIL protein	PMID:38598786
1314924	SVIL	supervillin	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of SVIL mRNA	PMID:30589522
1314924	SVIL	supervillin	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of SVIL mRNA	PMID:29024780
1314924	SVIL	supervillin	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of SVIL mRNA	PMID:19162173
1314924	SVIL	supervillin	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of SVIL mRNA	PMID:19162173
1314924	SVIL	supervillin	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SVIL mRNA	PMID:19320972
1314924	SVIL	supervillin	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of SVIL mRNA	PMID:24386269
1314924	SVIL	supervillin	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314925	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of SVIL mRNA	PMID:18353800
1314924	SVIL	supervillin	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SVIL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SVIL mRNA	PMID:32699268
1314924	SVIL	supervillin	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:D012643	Selenium inhibits the reaction [Cadmium results in decreased expression of SVIL mRNA]	PMID:34773240
1314924	SVIL	supervillin	gene	CHEBI:3752	clomiphene	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D002996	Clomiphene results in decreased expression of SVIL mRNA	PMID:26865669
1314924	SVIL	supervillin	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SVIL mRNA	PMID:31533062
1314924	SVIL	supervillin	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SVIL mRNA	PMID:19162173
1314924	SVIL	supervillin	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SVIL mRNA	PMID:25979313
1314924	SVIL	supervillin	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of SVIL mRNA	PMID:19101580|PMID:24935251
1314924	SVIL	supervillin	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SVIL mRNA	PMID:20106945|PMID:25562108
1314924	SVIL	supervillin	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of SVIL mRNA	PMID:26865669
1314924	SVIL	supervillin	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of SVIL mRNA	PMID:24136188
1314924	SVIL	supervillin	gene	CHEBI:44616	afimoxifene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of SVIL mRNA	PMID:19901195
1314924	SVIL	supervillin	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SVIL mRNA	PMID:38832940
1314924	SVIL	supervillin	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[decitabine co-treated with vorinostat] affects the expression of SVIL mRNA	PMID:17330099
1314924	SVIL	supervillin	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SVIL mRNA	PMID:24935251
1314924	SVIL	supervillin	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of SVIL mRNA	PMID:21420995
1314924	SVIL	supervillin	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SVIL mRNA	PMID:33387578
1314924	SVIL	supervillin	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SVIL mRNA	PMID:22230336|PMID:29067470
1314924	SVIL	supervillin	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of SVIL mRNA	PMID:24714768
1314924	SVIL	supervillin	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of SVIL gene	PMID:25304211
1314924	SVIL	supervillin	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314925	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which affects the methylation of SVIL gene] which results in increased expression of SVIL mRNA; [sodium arsenite results in increased abundance of Arsenic] which affects the methylation of SVIL gene; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SVIL mRNA	PMID:40504410
1314924	SVIL	supervillin	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SVIL mRNA	PMID:29391264
1314924	SVIL	supervillin	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with Vorinostat] affects the expression of SVIL mRNA	PMID:17330099
1314924	SVIL	supervillin	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306354	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SVIL mRNA	PMID:30307764
1314924	SVIL	supervillin	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314925	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SVIL mRNA; Nanotubes, Carbon results in decreased expression of SVIL mRNA	PMID:25554681|PMID:25620056
1314924	SVIL	supervillin	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306354	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of SVIL mRNA	PMID:34044035
1314924	SVIL	supervillin	gene	CHEBI:50692	mifepristone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of SVIL mRNA	PMID:17584828
1314924	SVIL	supervillin	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of SVIL mRNA	PMID:19162173
1314924	SVIL	supervillin	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SVIL mRNA	PMID:25729387
1314924	SVIL	supervillin	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306354	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SVIL mRNA	PMID:25729387
1314924	SVIL	supervillin	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SVIL mRNA	PMID:20147733
1314924	SVIL	supervillin	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1314925	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of SVIL mRNA	PMID:36907384
1314924	SVIL	supervillin	gene	CHEBI:6784	mestranol	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D008656	Mestranol results in increased expression of SVIL mRNA	PMID:26865669
1314924	SVIL	supervillin	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1314925	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of SVIL mRNA	PMID:26307267
1314924	SVIL	supervillin	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SVIL protein	PMID:34186270
1314924	SVIL	supervillin	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314925	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of SVIL mRNA	PMID:22206623
1314924	SVIL	supervillin	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314925	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of SVIL mRNA]	PMID:22206623
1314924	SVIL	supervillin	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of SVIL mRNA	PMID:24136188
1314924	SVIL	supervillin	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of SVIL mRNA	PMID:22714537
1314924	SVIL	supervillin	gene	CHEBI:77012	methylseleninic acid	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of SVIL mRNA	PMID:18548127
1314924	SVIL	supervillin	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SVIL mRNA	PMID:27188386
1314924	SVIL	supervillin	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SVIL gene]	PMID:28238834
1314924	SVIL	supervillin	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306354	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of SVIL mRNA	PMID:32109520
1314924	SVIL	supervillin	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1314925	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of SVIL mRNA	PMID:27029645
1314924	SVIL	supervillin	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314925	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SVIL mRNA	PMID:21795629
1314924	SVIL	supervillin	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SVIL mRNA	PMID:27188386
1314924	SVIL	supervillin	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306354	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SVIL mRNA	PMID:21346803
1314924	SVIL	supervillin	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of SVIL protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of SVIL protein	PMID:38598786
1314924	SVIL	supervillin	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C057693	troglitazone results in increased expression of SVIL mRNA	PMID:19140230
1314924	SVIL	supervillin	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314925	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SVIL mRNA	PMID:35537566
1314924	SVIL	supervillin	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306354	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of SVIL mRNA	PMID:19015723
1314924	SVIL	supervillin	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306354	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of SVIL mRNA	PMID:23555832
1314924	SVIL	supervillin	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1306354	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of SVIL gene	PMID:31682807
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of SP140 mRNA	PMID:23830798|PMID:33167477
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of SP140 mRNA	PMID:26079696
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:D004958	Estradiol results in decreased expression of SP140 mRNA	PMID:39298647
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SP140 mRNA	PMID:37042841
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SP140 mRNA	PMID:26079696
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1621872	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SP140 mRNA	PMID:37992649
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1621872	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SP140 mRNA	PMID:37992649
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SP140 mRNA	PMID:31163220
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306355	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SP140 mRNA	PMID:26577399
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306355	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SP140 mRNA	PMID:33387578
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of SP140 intron	PMID:27776689
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SP140 mRNA	PMID:34911549
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:D005492	Folic Acid results in decreased expression of SP140 mRNA	PMID:25629700
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SP140 mRNA	PMID:28960355
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306355	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SP140 mRNA	PMID:31881176
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of SP140 promoter	PMID:22847954
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of SP140 mRNA	PMID:24768652|PMID:25583101
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SP140 mRNA	PMID:37172768
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SP140 mRNA	PMID:33212167
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1621872	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SP140 mRNA	PMID:37992649
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SP140 mRNA	PMID:38568856
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SP140 mRNA	PMID:34876320
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SP140 mRNA	PMID:34876320
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SP140 5' UTR; Benzo(a)pyrene results in increased methylation of SP140 promoter	PMID:27901495
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:301	(-)-alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of SP140 mRNA	PMID:25075043
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:D012834	Silver results in increased expression of SP140 mRNA	PMID:27131904
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:31575	ethylparaben	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in increased expression of SP140 mRNA	PMID:37690743
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SP140 gene	PMID:31601247
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306355	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of SP140 mRNA	PMID:34492290
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1306355	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SP140 mRNA	PMID:25380136
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:C006780	bisphenol A affects the methylation of SP140 promoter	PMID:27334623
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306355	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SP140 mRNA	PMID:30816183|PMID:32528016
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of SP140 gene	PMID:31601247
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1306355	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of SP140 mRNA	PMID:23196670
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of SP140 mRNA	PMID:25926378
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:C543008	bisphenol S results in decreased expression of SP140 mRNA	PMID:33297965|PMID:39298647
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306355	E	RGD:6480464	20120522	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of SP140 mRNA	PMID:21266533
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SP140 mRNA	PMID:37042841
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SP140 mRNA	PMID:26472689
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SP140 mRNA	PMID:38568856
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1306355	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of SP140 mRNA	PMID:25380136
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SP140 mRNA	PMID:24449571
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of SP140 promoter	PMID:22847954
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of SP140 promoter	PMID:22847954
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1621872	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of SP140 mRNA	PMID:39529242
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1621872	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SP140 mRNA	PMID:37992649
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:45863	paclitaxel	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	SP140 protein affects the susceptibility to Paclitaxel	PMID:16217747
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SP140 mRNA	PMID:34876320
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:50035	alpha-phellandrene	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in increased expression of SP140 mRNA	PMID:25075043
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of SP140 mRNA	PMID:25554681
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SP140 mRNA	PMID:25554681
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:D000069059	Atorvastatin results in increased expression of SP140 mRNA	PMID:40234311
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1621872	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SP140 mRNA	PMID:38701926
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of SP140 mRNA	PMID:34876320
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1621872	E	RGD:6480464	20260512	CTD	MESH:D012834	Silver results in increased expression of SP140 mRNA	PMID:27131904
1314926	SP140	SP140 nuclear body protein	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306355	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of SP140 mRNA	PMID:19281266
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of SUN5 mRNA	PMID:26079696
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314929	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SUN5 mRNA	PMID:25629700
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SUN5 mRNA	PMID:23557933
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1314929	E	RGD:6480464	20231003	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in increased methylation of SUN5 promoter	PMID:33445541
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314929	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SUN5 mRNA	PMID:21570461
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314929	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SUN5 promoter]	PMID:19654925
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306357	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SUN5 mRNA	PMID:26033743
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314929	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SUN5 mRNA	PMID:22228805
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SUN5 promoter	PMID:27901495
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314929	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to SUN5 promoter]	PMID:19654925
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306357	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of SUN5 mRNA	PMID:26033743
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1314929	E	RGD:6480464	20231003	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in increased methylation of SUN5 promoter	PMID:33445541
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306357	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SUN5 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1314929	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SUN5 promoter	PMID:27312807
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1314929	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of SUN5 mRNA	PMID:18502557
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314929	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SUN5 mRNA	PMID:17562736
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314929	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SUN5 mRNA	PMID:25554681
1314928	SUN5	Sad1 and UNC84 domain containing 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306357	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SUN5 mRNA	PMID:24780913
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF500 mRNA	PMID:37042841
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZNF500 mRNA	PMID:28818685
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of ZNF500 mRNA	PMID:18414638
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ZNF500 mRNA	PMID:19244175
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ZNF500 mRNA	PMID:27392435
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZNF500 mRNA	PMID:33212167
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ZNF500 mRNA	PMID:30851411
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of ZNF500 mRNA	PMID:25351596
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ZNF500 gene	PMID:31601247
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of ZNF500 mRNA	PMID:19244175
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ZNF500 mRNA	PMID:28302478
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ZNF500 mRNA	PMID:31533062
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF500 mRNA	PMID:23179753|PMID:26272509
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF500 mRNA	PMID:27188386
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of ZNF500 mRNA	PMID:18414638
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF500 protein	PMID:31285264
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of ZNF500 mRNA	PMID:30851411
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF500 mRNA	PMID:27188386
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ZNF500 gene]	PMID:28238834
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF500 mRNA	PMID:27188386
1314930	ZNF500	zinc finger protein 500	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZNF500 mRNA	PMID:29301935
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314933	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of CHFR mRNA	PMID:33045310
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314933	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CHFR mRNA	PMID:36331819
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CHFR mRNA	PMID:21179406
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1314933	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of CHFR mRNA	PMID:28973375
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of CHFR protein	PMID:37730182
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306360	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of CHFR mRNA	PMID:22061828
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306360	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CHFR mRNA	PMID:22061828
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314933	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CHFR mRNA	PMID:36331819
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CHFR mRNA	PMID:35301059
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CHFR mRNA	PMID:19549813
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CHFR intron	PMID:30157460
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of CHFR mRNA	PMID:35430440
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306360	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CHFR mRNA	PMID:31150632
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314933	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CHFR mRNA	PMID:17484886
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314933	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CHFR mRNA	PMID:22206623
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CHFR gene	PMID:25304211
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CHFR mRNA	PMID:39836092
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CHFR mRNA	PMID:23557933
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314933	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of CHFR mRNA	PMID:40618947
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	CHFR protein affects the susceptibility to [Cisplatin co-treated with Erlotinib Hydrochloride]	PMID:20705357
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:27958	cocaine	affects expression	ISO	RGD:1306360	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine affects the expression of CHFR mRNA	PMID:20187946
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314933	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CHFR mRNA	PMID:21570461
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314933	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CHFR promoter]	PMID:19654925
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of CHFR mRNA	PMID:33212167
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314933	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of CHFR mRNA	PMID:16014739
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CHFR mRNA	PMID:39836092
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CHFR promoter	PMID:27901495
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to CHFR mRNA]	PMID:32406909
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314933	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CHFR mRNA	PMID:18445702
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306360	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CHFR mRNA	PMID:25181051
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306360	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of CHFR mRNA	PMID:26982218|PMID:34947998
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CHFR gene	PMID:31601247
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of CHFR gene	PMID:32466334
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306360	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CHFR gene	PMID:28505145
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	ISO	RGD:1314933	E	RGD:6480464	20180515	CTD	MESH:D008748	[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of CHFR mRNA	PMID:25926378
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314933	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CHFR mRNA	PMID:32715474
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CHFR mRNA	PMID:37042841
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CHFR mRNA	PMID:35301059
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CHFR mRNA	PMID:19376846
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CHFR mRNA	PMID:24449571
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314933	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CHFR mRNA	PMID:18353800
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314933	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CHFR mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CHFR mRNA	PMID:36331819
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314933	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in increased expression of CHFR mRNA	PMID:19136453|PMID:21427059
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CHFR mRNA	PMID:25562108
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of CHFR mRNA	PMID:24449571
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:45863	paclitaxel	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	CHFR protein modified form affects the susceptibility to Paclitaxel	PMID:17786301
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:45863	paclitaxel	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	CHFR protein results in decreased susceptibility to Paclitaxel	PMID:17786301
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:46195	paracetamol	affects response to substance	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	CHFR gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of CHFR gene	PMID:25304211
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CHFR mRNA	PMID:39836092
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306360	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CHFR mRNA	PMID:29391264
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of CHFR mRNA	PMID:16367923
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:50594	carbon nanotube	multiple interactions	ISO	RGD:1314933	E	RGD:6480464	20180515	CTD	MESH:D037742	[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of CHFR mRNA	PMID:25926378
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306360	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of CHFR mRNA	PMID:24136188
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of CHFR mRNA	PMID:20977926
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:53509	erlotinib hydrochloride	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069347	CHFR protein affects the susceptibility to [Cisplatin co-treated with Erlotinib Hydrochloride]	PMID:20705357
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:63933	Aroclor 1254	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of CHFR mRNA	PMID:16934159
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CHFR mRNA	PMID:31758290
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1314933	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of CHFR mRNA	PMID:22206623
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314933	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of CHFR mRNA	PMID:22206623
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:755540	docetaxel	affects response to substance	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	CHFR protein modified form affects the susceptibility to Docetaxel	PMID:17786301
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:755540	docetaxel	decreases response to substance	EXP		E	RGD:6480464	20260714	CTD	MESH:D000077143	CHFR protein results in decreased susceptibility to Docetaxel	PMID:17786301
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1314933	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CHFR mRNA	PMID:18930950
1314932	CHFR	checkpoint with forkhead and ring finger domains	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306360	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of CHFR mRNA	PMID:23555832
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of UBE3A mRNA	PMID:38218311
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1314935	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of UBE3A mRNA	PMID:33045310
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of UBE3A mRNA	PMID:16140955|PMID:33167477
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of UBE3A mRNA	PMID:23724009
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of UBE3A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of UBE3A mRNA	PMID:32699268
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of UBE3A mRNA	PMID:22378314
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1314935	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of UBE3A mRNA	PMID:40945087
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20140610	CTD	MESH:D004958	Estradiol promotes the reaction [ESR1 protein binds to UBE3A protein]	PMID:23665804|PMID:29389661
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314935	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of UBE3A mRNA	PMID:33711761
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1314935	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of UBE3A mRNA	PMID:19448997
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of UBE3A mRNA	PMID:37042841
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314935	E	RGD:6480464	20250902	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with CGA protein] results in decreased expression of UBE3A protein	PMID:20463053
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of UBE3A mRNA	PMID:12588870
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Mecamylamine inhibits the reaction [Nicotine results in decreased expression of UBE3A mRNA]; Nicotine inhibits the reaction [alpha-cobratoxin results in decreased expression of UBE3A mRNA]; Tubocurarine inhibits the reaction [Nicotine results in decreased expression of UBE3A mRNA]	PMID:12588870
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:17793	calycosin	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C121707	7,3'-dihydroxy-4'-methoxyisoflavone results in increased expression of UBE3A mRNA	PMID:24455688
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306361	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of UBE3A mRNA	PMID:22061828
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of UBE3A mRNA	PMID:39836092
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1314935	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of UBE3A mRNA	PMID:33914522
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of UBE3A mRNA	PMID:12588870
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Mecamylamine inhibits the reaction [Nicotine results in decreased expression of UBE3A mRNA]; Nicotine inhibits the reaction [alpha-cobratoxin results in decreased expression of UBE3A mRNA]; Tubocurarine inhibits the reaction [Nicotine results in decreased expression of UBE3A mRNA]	PMID:12588870
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1306361	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of UBE3A protein	PMID:33236894
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of UBE3A gene	PMID:27153756
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1314935	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of UBE3A mRNA	PMID:15674844
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of UBE3A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of UBE3A mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of UBE3A mRNA	PMID:32699268
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314935	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of UBE3A mRNA	PMID:34911549
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306361	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of UBE3A mRNA	PMID:30779732
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306361	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of UBE3A mRNA	PMID:31150632
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of UBE3A mRNA	PMID:21867686
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of UBE3A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE3A mRNA	PMID:39836092
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1306361	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of UBE3A mRNA	PMID:25905778
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of UBE3A mRNA	PMID:23557933
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1314935	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of UBE3A protein	PMID:22006019
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:27958	cocaine	decreases expression	ISO	RGD:1306361	E	RGD:6480464	20171010	CTD	MESH:D003042	Cocaine results in decreased expression of UBE3A mRNA	PMID:24810662
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314935	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of UBE3A mRNA	PMID:21570461
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306361	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBE3A mRNA	PMID:32109520|PMID:33387578
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314935	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of UBE3A mRNA	PMID:19770486
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of UBE3A mRNA; aristolochic acid I results in decreased expression of UBE3A protein	PMID:33212167
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of UBE3A mRNA	PMID:29803840
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314935	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of UBE3A mRNA	PMID:25896364
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of UBE3A protein	PMID:38228842
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of UBE3A mRNA	PMID:38568856
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of UBE3A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE3A mRNA	PMID:39836092
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of UBE3A 5' UTR; Benzo(a)pyrene affects the methylation of UBE3A promoter	PMID:27901495
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314935	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of UBE3A mRNA	PMID:22228805
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314935	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of UBE3A mRNA	PMID:22228805
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1314935	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of UBE3A protein	PMID:37955338
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to UBE3A mRNA]	PMID:32406909
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of UBE3A mRNA	PMID:19150397
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of UBE3A mRNA	PMID:20458559
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1314935	E	RGD:6480464	20240402	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of UBE3A mRNA	PMID:35676786|PMID:39716349
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306361	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of UBE3A mRNA	PMID:25729387
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314935	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of UBE3A gene; titanium dioxide results in decreased methylation of UBE3A promoter	PMID:35295148
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306361	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of UBE3A mRNA	PMID:34492290
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314935	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of UBE3A mRNA	PMID:18445702
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1314935	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of UBE3A mRNA	PMID:33914522
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314935	E	RGD:6480464	20140812	CTD	MESH:C006780	bisphenol A results in decreased expression of UBE3A mRNA	PMID:23593014
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306361	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of UBE3A mRNA	PMID:25181051|PMID:30816183|PMID:33296240|PMID:34947998
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to UBE3A protein modified form]	PMID:28751236
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of UBE3A mRNA	PMID:19244175
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of UBE3A gene	PMID:31601247
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314935	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of UBE3A mRNA	PMID:39298647
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[bisphenol S binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to UBE3A protein modified form]	PMID:28751236
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of UBE3A intron	PMID:30157460
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314935	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of UBE3A mRNA	PMID:38685157
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:34682	diazinon	increases expression	ISO	RGD:1306361	E	RGD:6480464	20180410	CTD	MESH:D003976	Diazinon results in increased expression of UBE3A mRNA	PMID:29108742
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314935	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of UBE3A mRNA	PMID:34813904
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of UBE3A mRNA	PMID:37042841
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of UBE3A mRNA	PMID:39836092
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of UBE3A mRNA	PMID:19376846
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1314935	E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in increased expression of UBE3A mRNA	PMID:21139344
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of UBE3A mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of UBE3A mRNA	PMID:32699268
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314935	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of UBE3A mRNA	PMID:40194260
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1306361	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of UBE3A mRNA	PMID:23125180
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of UBE3A mRNA	PMID:25979313
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1306361	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of UBE3A mRNA	PMID:29427782
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306361	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of UBE3A mRNA	PMID:38685447|PMID:41580965
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in increased expression of UBE3A mRNA	PMID:16570282
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of UBE3A mRNA	PMID:28542535
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314935	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of UBE3A mRNA	PMID:17562736
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of UBE3A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of UBE3A mRNA	PMID:39836092
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of UBE3A mRNA	PMID:20458559
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1314935	E	RGD:6480464	20240402	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of UBE3A mRNA	PMID:35676786|PMID:39716349
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1314935	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of UBE3A mRNA	PMID:21318169
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1314935	E	RGD:6480464	20120613	CTD	MESH:D011345	PPARA protein affects the reaction [Fenofibrate results in increased expression of UBE3A mRNA]	PMID:21318169
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:50292	cadmium sulfate	multiple interactions	ISO	RGD:1314935	E	RGD:6480464	20120814	CTD	MESH:C037123	cadmium sulfate affects the reaction [MTF1 affects the expression of UBE3A mRNA]	PMID:16221973
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306361	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of UBE3A mRNA	PMID:24136188
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306361	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of UBE3A mRNA	PMID:41580965
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:50743	cyproterone acetate	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D017373	[Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to UBE3A protein modified form]	PMID:28751236
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306361	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of UBE3A mRNA	PMID:24136188
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of UBE3A protein	PMID:32959892
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of UBE3A mRNA	PMID:39836092
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306361	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of UBE3A mRNA	PMID:25729387
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306361	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of UBE3A mRNA	PMID:25729387
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:6706	Mecamylamine	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D008464	Mecamylamine results in decreased expression of UBE3A mRNA	PMID:12588870
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:6706	Mecamylamine	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:D008464	Mecamylamine inhibits the reaction [Nicotine results in decreased expression of UBE3A mRNA]	PMID:12588870
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of UBE3A intron	PMID:30157460
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306361	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of UBE3A gene	PMID:35440735
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of UBE3A mRNA	PMID:28025562
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of UBE3A mRNA	PMID:31758290
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:72754	bisphenol AF	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	[bisphenol AF binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to UBE3A protein modified form]	PMID:28751236
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314935	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of UBE3A mRNA	PMID:22206623
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306361	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of UBE3A mRNA	PMID:24136188
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of UBE3A mRNA	PMID:37199045
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to UBE3A gene]	PMID:28238834
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1314935	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of UBE3A mRNA	PMID:23091169
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1314935	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of UBE3A mRNA	PMID:40826991
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1306361	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of UBE3A mRNA	PMID:24136188
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314935	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of UBE3A mRNA	PMID:28973697
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:9774	tubocurarine	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014403	Tubocurarine results in increased expression of UBE3A mRNA	PMID:12588870
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:9774	tubocurarine	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D014403	Tubocurarine inhibits the reaction [Nicotine results in decreased expression of UBE3A mRNA]	PMID:12588870
1314934	UBE3A	ubiquitin protein ligase E3A	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306361	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of UBE3A mRNA	PMID:19015723
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RAB35 mRNA	PMID:38218311
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin affects the expression of RAB35 mRNA	PMID:15498508
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1552421	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of RAB35 mRNA	PMID:30319688
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RAB35 protein	PMID:37730182
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306362	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of RAB35 mRNA	PMID:33387578
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RAB35 mRNA	PMID:28818685
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552421	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RAB35 mRNA	PMID:37236586
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RAB35 mRNA	PMID:19549813
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1306362	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of RAB35 protein	PMID:33236894
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RAB35 intron	PMID:30157460
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552421	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RAB35 mRNA	PMID:22206623
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552421	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of RAB35 gene] which results in decreased expression of RAB35 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of RAB35 gene	PMID:40504410
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:27902	tetracycline	increases expression	ISO	RGD:1552421	E	RGD:6480464	20120412	CTD	MESH:D013752	Tetracycline results in increased expression of RAB35 mRNA	PMID:16917069
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552421	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAB35 mRNA	PMID:21570461
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306362	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RAB35 mRNA	PMID:33387578
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552421	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RAB35 mRNA	PMID:21354282
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of RAB35 mRNA; aristolochic acid I results in increased expression of RAB35 protein	PMID:33212167
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of RAB35 mRNA	PMID:31162603
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1552421	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of RAB35 protein	PMID:27548804
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RAB35 mRNA	PMID:29803840
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552421	E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of RAB35 gene] which results in decreased expression of RAB35 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of RAB35 gene	PMID:40504410
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20201215	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of RAB35 mRNA	PMID:31162603
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of RAB35 mRNA	PMID:25895662
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RAB35 mRNA	PMID:19150397
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306362	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RAB35 mRNA	PMID:30047161
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:32181	tamibarotene	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of RAB35 mRNA	PMID:15498508
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306362	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RAB35 mRNA	PMID:34492290
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1552421	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RAB35 mRNA	PMID:18648102
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of RAB35 protein	PMID:34186270
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306362	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RAB35 mRNA	PMID:25181051
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306362	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of RAB35 gene	PMID:28505145
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RAB35 intron	PMID:30157460
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of RAB35 protein	PMID:34186270
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RAB35 protein	PMID:34186270
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1552421	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of RAB35 mRNA	PMID:37019170
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RAB35 mRNA	PMID:37042841
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552421	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RAB35 mRNA	PMID:37236586
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306362	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of RAB35 gene	PMID:22079235
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RAB35 mRNA	PMID:31533062
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RAB35 mRNA	PMID:25979313
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RAB35 mRNA	PMID:23179753
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306362	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RAB35 mRNA	PMID:30047161
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RAB35 mRNA	PMID:38832940
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552421	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RAB35 mRNA	PMID:17562736
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RAB35 mRNA	PMID:22230336
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C088658	zoledronic acid results in increased expression of RAB35 protein	PMID:28871336
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552421	E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of RAB35 gene] which results in decreased expression of RAB35 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased methylation of RAB35 gene	PMID:40504410
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1552421	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of RAB35 mRNA	PMID:35436446
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552421	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RAB35 mRNA; Nanotubes, Carbon results in increased expression of RAB35 mRNA	PMID:25554681
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306362	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RAB35 mRNA	PMID:30047161
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552421	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RAB35 mRNA	PMID:35964746
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RAB35 protein	PMID:32959892
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RAB35 intron	PMID:30157460
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RAB35 protein	PMID:34186270
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552421	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RAB35 mRNA	PMID:22206623
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1552421	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RAB35 mRNA	PMID:22206623
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:7719	ochratoxin A	affects binding	EXP		E	RGD:6480464	20260505	CTD	MESH:C025589	RAB35 protein binds to ochratoxin A	PMID:40952447
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RAB35 gene]	PMID:28238834
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306362	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RAB35 mRNA	PMID:30047161
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RAB35 mRNA	PMID:38568856
1314936	RAB35	RAB35, member RAS oncogene family	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1306362	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of RAB35 gene	PMID:31079544
1314938	WDR41	WD repeat domain 41	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of WDR41 mRNA	PMID:38218311
1314938	WDR41	WD repeat domain 41	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of WDR41 mRNA	PMID:38218311
1314938	WDR41	WD repeat domain 41	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1623810	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of WDR41 mRNA	PMID:33045310
1314938	WDR41	WD repeat domain 41	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of WDR41 mRNA	PMID:21632981
1314938	WDR41	WD repeat domain 41	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1623810	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WDR41 mRNA	PMID:25510870
1314938	WDR41	WD repeat domain 41	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of WDR41 mRNA	PMID:37042841
1314938	WDR41	WD repeat domain 41	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of WDR41 mRNA	PMID:33359661
1314938	WDR41	WD repeat domain 41	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WDR41 mRNA	PMID:39836092
1314938	WDR41	WD repeat domain 41	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1623810	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WDR41 mRNA	PMID:25510870
1314938	WDR41	WD repeat domain 41	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1623810	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WDR41 mRNA	PMID:25510870
1314938	WDR41	WD repeat domain 41	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1623810	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of WDR41 mRNA	PMID:25629700
1314938	WDR41	WD repeat domain 41	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WDR41 mRNA	PMID:39836092
1314938	WDR41	WD repeat domain 41	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1623810	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of WDR41 mRNA	PMID:40618947
1314938	WDR41	WD repeat domain 41	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of WDR41 mRNA	PMID:27392435
1314938	WDR41	WD repeat domain 41	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of WDR41 promoter	PMID:22847954
1314938	WDR41	WD repeat domain 41	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306363	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WDR41 mRNA	PMID:33387578
1314938	WDR41	WD repeat domain 41	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of WDR41 mRNA	PMID:28001369
1314938	WDR41	WD repeat domain 41	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of WDR41 mRNA	PMID:33212167
1314938	WDR41	WD repeat domain 41	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of WDR41 mRNA	PMID:29803840
1314938	WDR41	WD repeat domain 41	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of WDR41 mRNA	PMID:29319823
1314938	WDR41	WD repeat domain 41	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of WDR41 mRNA	PMID:28595984|PMID:34032870
1314938	WDR41	WD repeat domain 41	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WDR41 mRNA	PMID:39836092
1314938	WDR41	WD repeat domain 41	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of WDR41 mRNA alternative form	PMID:40419235
1314938	WDR41	WD repeat domain 41	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of WDR41 promoter	PMID:27901495
1314938	WDR41	WD repeat domain 41	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of WDR41 mRNA	PMID:20458559
1314938	WDR41	WD repeat domain 41	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306363	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR41 mRNA	PMID:25181051
1314938	WDR41	WD repeat domain 41	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1623810	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR41 mRNA	PMID:32156529
1314938	WDR41	WD repeat domain 41	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306363	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of WDR41 mRNA	PMID:30816183|PMID:32528016
1314938	WDR41	WD repeat domain 41	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1623810	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WDR41 mRNA	PMID:25510870
1314938	WDR41	WD repeat domain 41	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1623810	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of WDR41 mRNA	PMID:25510870
1314938	WDR41	WD repeat domain 41	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1623810	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of WDR41 mRNA	PMID:37019170
1314938	WDR41	WD repeat domain 41	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1623810	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of WDR41 mRNA	PMID:21266533
1314938	WDR41	WD repeat domain 41	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of WDR41 mRNA	PMID:37042841
1314938	WDR41	WD repeat domain 41	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WDR41 mRNA	PMID:39836092
1314938	WDR41	WD repeat domain 41	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306363	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of WDR41 gene	PMID:22079235
1314938	WDR41	WD repeat domain 41	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of WDR41 mRNA	PMID:28302478
1314938	WDR41	WD repeat domain 41	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of WDR41 promoter	PMID:22847954
1314938	WDR41	WD repeat domain 41	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of WDR41 promoter	PMID:22847954
1314938	WDR41	WD repeat domain 41	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1623810	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of WDR41 mRNA	PMID:17292431
1314938	WDR41	WD repeat domain 41	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of WDR41 mRNA	PMID:23179753
1314938	WDR41	WD repeat domain 41	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of WDR41 mRNA	PMID:29154799
1314938	WDR41	WD repeat domain 41	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306363	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of WDR41 mRNA	PMID:41580965
1314938	WDR41	WD repeat domain 41	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of WDR41 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1314938	WDR41	WD repeat domain 41	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306363	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of WDR41 mRNA	PMID:33387578
1314938	WDR41	WD repeat domain 41	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WDR41 mRNA	PMID:39836092
1314938	WDR41	WD repeat domain 41	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1623810	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of WDR41 mRNA	PMID:35436446
1314938	WDR41	WD repeat domain 41	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of WDR41 mRNA	PMID:20458559
1314938	WDR41	WD repeat domain 41	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1623810	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of WDR41 mRNA	PMID:23608068
1314938	WDR41	WD repeat domain 41	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of WDR41 mRNA	PMID:39836092
1314938	WDR41	WD repeat domain 41	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1623810	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of WDR41 mRNA	PMID:22206623
1314938	WDR41	WD repeat domain 41	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of WDR41 mRNA	PMID:22714537
1314938	WDR41	WD repeat domain 41	gene	CHEBI:94287	erastin	decreases expression	EXP		E	RGD:6480464	20220809	CTD	MESH:C477224	erastin results in decreased expression of WDR41 mRNA alternative form	PMID:35234341
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of FAM20A mRNA	PMID:26272509
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM20A mRNA	PMID:27188386
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:135741	testosterone undecanoate	multiple interactions	EXP		E	RGD:6480464	20170307	CTD	MESH:C010792	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FAM20A mRNA	PMID:19074003
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314940	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FAM20A mRNA	PMID:36331819
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of FAM20A mRNA	PMID:39506029
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306364	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of FAM20A gene	PMID:28931070
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314940	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of FAM20A mRNA	PMID:30319688
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314940	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of FAM20A mRNA	PMID:30319688
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FAM20A mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of FAM20A mRNA	PMID:35811015
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314940	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of FAM20A mRNA	PMID:39298647
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306364	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of FAM20A mRNA	PMID:33387578
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306364	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of FAM20A gene	PMID:27618143
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FAM20A mRNA	PMID:31163220
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306364	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of FAM20A mRNA	PMID:26577399
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306364	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of FAM20A mRNA	PMID:33387578
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of FAM20A intron	PMID:30157460
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314940	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FAM20A mRNA	PMID:36331819
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1314940	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of FAM20A mRNA	PMID:39984025
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314940	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FAM20A mRNA	PMID:37236586
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FAM20A mRNA	PMID:19549813
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FAM20A mRNA	PMID:21641981|PMID:22100608|PMID:27153756
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FAM20A intron	PMID:30157460
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306364	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of FAM20A mRNA	PMID:33354967
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of FAM20A gene	PMID:27153756
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of FAM20A mRNA	PMID:21527772
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:25710	organophosphorus compound	multiple interactions	ISO	RGD:1306364	E	RGD:6480464	20250401	CTD	MESH:D009943	[Dust results in increased abundance of Organophosphorus Compounds] which results in increased expression of FAM20A mRNA	PMID:39658253
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314940	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of FAM20A mRNA	PMID:31919559
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314940	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of FAM20A mRNA	PMID:40504410
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1306364	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of FAM20A gene	PMID:28505145
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of FAM20A mRNA	PMID:24768652|PMID:25583101
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314940	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FAM20A mRNA	PMID:21570461
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1314940	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FAM20A mRNA	PMID:26290441
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FAM20A mRNA	PMID:20106945|PMID:21632981|PMID:26238291
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306364	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FAM20A mRNA	PMID:33387578
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of FAM20A mRNA	PMID:33212167
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1314940	E	RGD:6480464	20180703	CTD	MESH:D020106	Acrylamide results in decreased expression of FAM20A mRNA	PMID:29261810
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of FAM20A mRNA	PMID:29803840
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:29021	hexane	increases methylation	ISO	RGD:1306364	E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in increased methylation of FAM20A promoter	PMID:23740543
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of FAM20A mRNA	PMID:29301061
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314940	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of FAM20A mRNA	PMID:40504410
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FAM20A mRNA	PMID:32234424
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314940	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FAM20A mRNA	PMID:21569818
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FAM20A mRNA	PMID:22316170|PMID:26238291
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314940	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of FAM20A mRNA	PMID:22228805
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FAM20A promoter	PMID:27901495
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314940	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FAM20A gene; titanium dioxide results in decreased methylation of FAM20A promoter	PMID:35295148
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:32234	titanium dioxide	increases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C009495	titanium dioxide results in increased methylation of FAM20A gene; titanium dioxide results in increased methylation of FAM20A promoter	PMID:34973136
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306364	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FAM20A mRNA	PMID:34492290
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM20A mRNA	PMID:33476716
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306364	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of FAM20A mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314940	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of FAM20A mRNA	PMID:30951980
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306364	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of FAM20A gene	PMID:28505145
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of FAM20A mRNA	PMID:33476716
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314940	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FAM20A mRNA	PMID:30951980
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of FAM20A intron	PMID:30157460
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314940	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of FAM20A mRNA	PMID:30951980
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314940	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of FAM20A mRNA	PMID:32715474
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1314940	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of FAM20A mRNA	PMID:34813904
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1314940	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of FAM20A mRNA	PMID:34813904
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306364	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of FAM20A gene	PMID:33148267
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of FAM20A mRNA	PMID:29024780
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314940	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FAM20A mRNA	PMID:37236586
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of FAM20A mRNA	PMID:24449571
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of FAM20A mRNA	PMID:32588087
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of FAM20A mRNA	PMID:40434365
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of FAM20A mRNA	PMID:31533062
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314940	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FAM20A mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FAM20A mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of FAM20A mRNA	PMID:36331819
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1314940	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of FAM20A mRNA	PMID:23125180
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FAM20A mRNA	PMID:25979313
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of FAM20A mRNA	PMID:29154799
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1314940	E	RGD:6480464	20180703	CTD	MESH:D014635	Valproic Acid results in decreased expression of FAM20A mRNA	PMID:29261810
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306364	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of FAM20A mRNA	PMID:41580965
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of FAM20A mRNA	PMID:20106945|PMID:27989131
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1314940	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of FAM20A mRNA	PMID:19770486
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of FAM20A promoter	PMID:27989131
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:4042	cypermethrin	decreases expression	ISO	RGD:1314940	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in decreased expression of FAM20A mRNA	PMID:40633821
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of FAM20A mRNA	PMID:25047013
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1314940	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of FAM20A mRNA	PMID:22733784
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FAM20A mRNA	PMID:38832940
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of FAM20A mRNA	PMID:21420995|PMID:26690555|PMID:29067470
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306364	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FAM20A mRNA	PMID:33387578
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of FAM20A mRNA	PMID:24714768
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of FAM20A mRNA	PMID:35811015
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of FAM20A mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of FAM20A mRNA	PMID:35811015
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314940	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of FAM20A mRNA	PMID:40504410
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of FAM20A mRNA	PMID:28988120
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1314940	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of FAM20A mRNA	PMID:36851058
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:6443	levonorgestrel	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D016912	[testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FAM20A mRNA	PMID:19074003
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of FAM20A intron	PMID:30157460
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306364	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FAM20A gene	PMID:35440735
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306364	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of FAM20A gene	PMID:33148267
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314940	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of FAM20A mRNA	PMID:22206623
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of FAM20A mRNA	PMID:29522793
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM20A mRNA	PMID:27188386
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FAM20A gene]	PMID:28238834
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306364	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FAM20A mRNA	PMID:24780913|PMID:25825206
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FAM20A mRNA	PMID:27188386
1314939	FAM20A	FAM20A golgi associated secretory pathway pseudokinase	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1314940	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of FAM20A mRNA	PMID:28973697
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1619064	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of DGCR8 mRNA	PMID:20188158
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DGCR8 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of DGCR8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DGCR8 mRNA	PMID:32699268|PMID:32845096
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of DGCR8 mRNA	PMID:21632981
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1619064	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DGCR8 mRNA	PMID:39241906
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1619064	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DGCR8 mRNA	PMID:39298647
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306365	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of DGCR8 mRNA	PMID:26496021
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306365	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DGCR8 mRNA	PMID:33387578
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DGCR8 mRNA	PMID:21179406
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:17627	ferroheme b	affects binding	EXP		E	RGD:6480464	20120814	CTD	MESH:D006418	DGCR8 protein binds to Heme; DGCR8 protein mutant form binds to Heme	PMID:21454614
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1306365	E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Genistein] results in increased expression of DGCR8 mRNA	PMID:32533902
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of DGCR8 protein	PMID:37730182
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306365	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DGCR8 mRNA	PMID:33387578
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of DGCR8 intron	PMID:30157460
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1619064	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DGCR8 mRNA	PMID:36331819
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DGCR8 mRNA	PMID:39836092
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1619064	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of DGCR8 mRNA	PMID:33914522
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306365	E	RGD:6480464	20250506	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of DGCR8 mRNA	PMID:39119833
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of DGCR8 protein	PMID:23301498
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1619064	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DGCR8 mRNA	PMID:19770486
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DGCR8 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of DGCR8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DGCR8 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DGCR8 mRNA	PMID:32699268|PMID:32845096
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:26355	heme b	affects binding	EXP		E	RGD:6480464	20140805	CTD	MESH:D006418	DGCR8 protein binds to Heme; DGCR8 protein mutant form binds to Heme	PMID:21454614
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:26820	sulfates	multiple interactions	EXP		E	RGD:6480464	20210608	CTD	MESH:D013431	[DGCR8 gene SNP affects the susceptibility to [Air Pollutants results in increased abundance of Sulfates]] which affects the expression of MIR1-1; [DGCR8 gene SNP affects the susceptibility to [Air Pollutants results in increased abundance of Sulfates]] which affects the expression of MIR135A1	PMID:24257509
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DGCR8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DGCR8 mRNA	PMID:39836092
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DGCR8 mRNA	PMID:19244175
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of DGCR8 mRNA	PMID:19244175
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of DGCR8 protein	PMID:35688186
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1306365	E	RGD:6480464	20250311	CTD	MESH:D019833	[Diethylhexyl Phthalate co-treated with Genistein] results in increased expression of DGCR8 mRNA	PMID:32533902
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1619064	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DGCR8 mRNA	PMID:21570461
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306365	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DGCR8 mRNA	PMID:33387578
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1619064	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DGCR8 mRNA	PMID:28213091
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of DGCR8 mRNA	PMID:29955902
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of DGCR8 mRNA	PMID:23649840
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DGCR8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DGCR8 mRNA	PMID:39836092
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1619064	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DGCR8 mRNA	PMID:22228805
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of DGCR8 mRNA	PMID:25895662
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of DGCR8 mRNA	PMID:22521957
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of DGCR8 mRNA	PMID:34408198
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of DGCR8 mRNA	PMID:35984750
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1306365	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of DGCR8 mRNA	PMID:11578147
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306365	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of DGCR8 mRNA	PMID:34492290
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DGCR8 mRNA	PMID:19710929
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1619064	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DGCR8 mRNA	PMID:19710929
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:33191	potassium cyanide	decreases expression	ISO	RGD:1619064	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in decreased expression of DGCR8 mRNA	PMID:33914522
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306365	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DGCR8 mRNA	PMID:25181051
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1619064	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of DGCR8 mRNA	PMID:37761913
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306365	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of DGCR8 mRNA	PMID:26496021
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in increased expression of DGCR8 mRNA	PMID:19244175
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1619064	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of DGCR8 mRNA	PMID:37019170
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of DGCR8 gene	PMID:22964155
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1619064	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DGCR8 mRNA	PMID:21266533
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DGCR8 mRNA	PMID:37042841
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DGCR8 mRNA	PMID:39836092
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306365	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DGCR8 mRNA	PMID:33453195|PMID:35525383
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306365	E	RGD:6480464	20250506	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of DGCR8 mRNA	PMID:39119833
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DGCR8 mRNA	PMID:19376846
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DGCR8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DGCR8 mRNA	PMID:32699268
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DGCR8 mRNA	PMID:19244175
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in increased expression of DGCR8 mRNA	PMID:19244175
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:37943	colistin	decreases expression	ISO	RGD:1619064	E	RGD:6480464	20220111	CTD	MESH:D003091	Colistin results in decreased expression of DGCR8 protein	PMID:34560125
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of DGCR8 mRNA	PMID:28302478
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1619064	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DGCR8 mRNA	PMID:36331819
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DGCR8 mRNA	PMID:25979313
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D003907	Dexamethasone results in increased expression of DGCR8 mRNA	PMID:32234517
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1306365	E	RGD:6480464	20200714	CTD	MESH:D003907	Dexamethasone results in increased expression of DGCR8 mRNA	PMID:32234517
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:D003907	Dexamethasone promotes the reaction [NR3C1 protein binds to DGCR8 promoter]; Mifepristone inhibits the reaction [Dexamethasone results in increased expression of DGCR8 mRNA]	PMID:32234517
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of DGCR8 mRNA	PMID:23649840
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306365	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DGCR8 mRNA	PMID:33387578
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1619064	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of DGCR8 mRNA	PMID:29279043
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DGCR8 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DGCR8 mRNA	PMID:39836092
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of DGCR8 mRNA	PMID:31838189
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of DGCR8 mRNA	PMID:22521957
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1619064	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of DGCR8 mRNA	PMID:25554681|PMID:25620056
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:50692	mifepristone	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:D015735	Mifepristone inhibits the reaction [Dexamethasone results in increased expression of DGCR8 mRNA]	PMID:32234517
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306365	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of DGCR8 mRNA	PMID:24793618
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of DGCR8 mRNA	PMID:39836092
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of DGCR8 mRNA	PMID:28988120
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in decreased expression of DGCR8 mRNA	PMID:33244087
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:7553	niclosamide	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in decreased expression of DGCR8 mRNA	PMID:36318118
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of DGCR8 protein	PMID:31285264
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DGCR8 gene]	PMID:28238834
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog results in decreased expression of DGCR8 mRNA	PMID:18927307
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306365	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DGCR8 mRNA	PMID:21346803
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20220607	CTD	MESH:D013605	T-2 Toxin results in increased expression of DGCR8 mRNA	PMID:34581912
1314941	DGCR8	DGCR8 microprocessor complex subunit	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DGCR8 mRNA	PMID:38568856
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552425	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of HERC1 mRNA	PMID:26251327
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:15767	dichloromethane	decreases expression	ISO	RGD:1306366	E	RGD:6480464	20120412	CTD	MESH:D008752	Methylene Chloride results in decreased expression of HERC1 mRNA	PMID:20955722
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1552425	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in decreased expression of HERC1 mRNA	PMID:40945087
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:16101	ethylbenzene	decreases expression	ISO	RGD:1306366	E	RGD:6480464	20120412	CTD	MESH:C004912	ethylbenzene results in decreased expression of HERC1 mRNA	PMID:20955722
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of HERC1 mRNA	PMID:18951874
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552425	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of HERC1 mRNA	PMID:39298647
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306366	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HERC1 mRNA	PMID:20955722
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552425	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of HERC1 mRNA	PMID:33754040
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of HERC1 protein	PMID:37730182
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of HERC1 mRNA	PMID:28818685
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of HERC1 intron	PMID:30157460
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1552425	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of HERC1 mRNA	PMID:27462272
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552425	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HERC1 mRNA	PMID:37236586
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HERC1 intron	PMID:30157460
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1552425	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of HERC1 mRNA	PMID:19770486
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306366	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of HERC1 mRNA	PMID:30779732
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of HERC1 protein	PMID:35688186
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1306366	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of HERC1 mRNA	PMID:17898221
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1552425	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of HERC1 mRNA	PMID:30912803
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306366	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HERC1 mRNA	PMID:34747641
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HERC1 mRNA	PMID:18762178
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of HERC1 mRNA	PMID:39709020
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of HERC1 mRNA	PMID:30851411
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1552425	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of HERC1 mRNA	PMID:25896364|PMID:39631538
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of HERC1 protein	PMID:35688186
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of HERC1 mRNA	PMID:17879257
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HERC1 intron; Benzo(a)pyrene affects the methylation of HERC1 promoter	PMID:27901495|PMID:30157460
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HERC1 mRNA	PMID:20106945|PMID:21632981
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1552425	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HERC1 exon; Benzo(a)pyrene results in increased methylation of HERC1 intron	PMID:27901495
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of HERC1 gene	PMID:25435355
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to HERC1 mRNA]	PMID:32406909
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of HERC1 mRNA	PMID:20458559
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306366	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HERC1 mRNA	PMID:25729387
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306366	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of HERC1 mRNA	PMID:30047161
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552425	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of HERC1 mRNA	PMID:18301758|PMID:21318169
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1552425	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HERC1 mRNA; PPARA protein affects the reaction [pirinixic acid results in increased expression of HERC1 mRNA]	PMID:19710929|PMID:21318169
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306366	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A affects the expression of HERC1 mRNA	PMID:30816183
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552425	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of HERC1 mRNA	PMID:38074096
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of HERC1 mRNA	PMID:33670352
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306366	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of HERC1 mRNA	PMID:25181051
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552425	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased expression of HERC1 mRNA	PMID:33297965|PMID:40203079
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1552425	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of HERC1 mRNA	PMID:28392331
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552425	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of HERC1 intron	PMID:28392331
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1552425	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HERC1 mRNA	PMID:37019170
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of HERC1 mRNA	PMID:37042841
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552425	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of HERC1 mRNA	PMID:37236586
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of HERC1 mRNA	PMID:24449571
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1552425	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of HERC1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HERC1 mRNA]	PMID:17585979
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:3764	clotrimazole	decreases expression	ISO	RGD:1306366	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of HERC1 mRNA	PMID:30047161
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of HERC1 mRNA	PMID:28302478
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HERC1 mRNA	PMID:19167446
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1306366	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of HERC1 mRNA	PMID:29427782
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306366	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of HERC1 mRNA	PMID:30047161
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008727	Methotrexate results in increased expression of HERC1 mRNA	PMID:17400583
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of HERC1 mRNA	PMID:27188386
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of HERC1 mRNA	PMID:28542535
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1552425	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of HERC1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of HERC1 mRNA]	PMID:17585979
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552425	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of HERC1 mRNA	PMID:29279043
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1552425	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of HERC1 mRNA	PMID:29279043
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of HERC1 mRNA	PMID:22079256
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of HERC1 mRNA	PMID:22079256
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:49464	aluminium trifluoride	affects localization	EXP		E	RGD:6480464	20130312	CTD	MESH:C032311	aluminum fluoride affects the localization of HERC1 protein	PMID:14960311
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of HERC1 mRNA	PMID:20458559
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306366	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of HERC1 mRNA	PMID:30047161
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306366	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of HERC1 mRNA	PMID:24793618
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1552425	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of HERC1 mRNA	PMID:26377693
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1552425	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of HERC1 mRNA	PMID:23608068
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306366	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of HERC1 mRNA	PMID:25729387
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306366	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HERC1 mRNA	PMID:25729387
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of HERC1 mRNA	PMID:22079256
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of HERC1 mRNA	PMID:22079256
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of HERC1 mRNA	PMID:30851411
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HERC1 gene]	PMID:28238834
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of HERC1 mRNA	PMID:19167446
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306366	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HERC1 mRNA	PMID:30047161
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306366	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of HERC1 mRNA	PMID:21346803
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552425	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of HERC1 mRNA	PMID:28973697
1314942	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1552425	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of HERC1 mRNA	PMID:35537566
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of GTPBP2 mRNA	PMID:38218311
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306367	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GTPBP2 mRNA]	PMID:31150632
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1314944	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GTPBP2 mRNA	PMID:20188158
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:15365	acetylsalicylic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in decreased expression of GTPBP2 mRNA	PMID:15928584
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of GTPBP2 mRNA	PMID:33167477
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of GTPBP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of GTPBP2 mRNA	PMID:32699268
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of GTPBP2 mRNA	PMID:26079696
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314944	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of GTPBP2 mRNA	PMID:30319688
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314944	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GTPBP2 mRNA	PMID:39241906
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of GTPBP2 mRNA	PMID:20106945
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of GTPBP2 mRNA	PMID:38568856
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GTPBP2 mRNA	PMID:37042841
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:17489	3',5'-cyclic AMP	multiple interactions	ISO	RGD:1306367	E	RGD:6480464	20120412	CTD	MESH:D000242	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of GTPBP2 mRNA]	PMID:19414516
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of GTPBP2 mRNA	PMID:31256213
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306367	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GTPBP2 mRNA	PMID:33387578
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:17883	hydrogen chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006851	Hydrochloric Acid results in decreased expression of GTPBP2 mRNA	PMID:15046208
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314944	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GTPBP2 mRNA	PMID:36331819
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1314944	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of GTPBP2 mRNA	PMID:33914522
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of GTPBP2 mRNA	PMID:23649840
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of GTPBP2 gene	PMID:27153756
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1314944	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of GTPBP2 mRNA	PMID:15674844
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of GTPBP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of GTPBP2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of GTPBP2 mRNA	PMID:32699268
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314944	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GTPBP2 mRNA	PMID:34911549
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306367	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GTPBP2 mRNA	PMID:31150632
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314944	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of GTPBP2 mRNA	PMID:31919559
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306367	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GTPBP2 mRNA]	PMID:31150632
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314944	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GTPBP2 mRNA	PMID:25629700
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314944	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GTPBP2 mRNA	PMID:40504410
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314944	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of GTPBP2 mRNA	PMID:28960355
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of GTPBP2 mRNA	PMID:27594783
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:28088	genistein	increases methylation	ISO	RGD:1306367	E	RGD:6480464	20180116	CTD	MESH:D019833	Genistein results in increased methylation of GTPBP2 gene	PMID:28505145
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306367	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GTPBP2 mRNA	PMID:22298810
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314944	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GTPBP2 mRNA	PMID:21570461
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306367	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GTPBP2 mRNA	PMID:33387578
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314944	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GTPBP2 mRNA	PMID:17942748
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GTPBP2 mRNA; aristolochic acid I results in decreased expression of GTPBP2 protein	PMID:33212167
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GTPBP2 mRNA	PMID:30851411
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of GTPBP2 mRNA	PMID:20971185
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GTPBP2 mRNA	PMID:29803840
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of GTPBP2 mRNA	PMID:34032870
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of GTPBP2 mRNA	PMID:38568856
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314944	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of GTPBP2 mRNA	PMID:16014739
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314944	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GTPBP2 mRNA	PMID:40504410
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of GTPBP2 mRNA	PMID:22378314
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314944	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GTPBP2 mRNA	PMID:21715664
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of GTPBP2 mRNA	PMID:20971185
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GTPBP2 mRNA	PMID:20382639
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:3090	bicalutamide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C053541	bicalutamide results in increased expression of GTPBP2 mRNA	PMID:15638997
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1314944	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of GTPBP2 promoter alternative form	PMID:35295148
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1314944	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of GTPBP2 mRNA	PMID:28472532
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314944	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of GTPBP2 mRNA	PMID:28329830
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1306367	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of GTPBP2 mRNA	PMID:19167457
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1314944	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of GTPBP2 mRNA	PMID:33914522
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of GTPBP2 mRNA	PMID:30903817
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of GTPBP2 mRNA	PMID:20678512
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306367	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GTPBP2 mRNA	PMID:25181051
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of GTPBP2 mRNA	PMID:25979313
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	multiple interactions	ISO	RGD:1306367	E	RGD:6480464	20120412	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [Cyclic AMP affects the expression of GTPBP2 mRNA]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of GTPBP2 mRNA]	PMID:19414516
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314944	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of GTPBP2 mRNA	PMID:39298647
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of GTPBP2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of GTPBP2 mRNA	PMID:32699268
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314944	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of GTPBP2 mRNA	PMID:17585979
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1314944	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of GTPBP2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GTPBP2 mRNA]	PMID:17585979
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of GTPBP2 mRNA	PMID:32588087
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of GTPBP2 mRNA	PMID:31533062
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of GTPBP2 mRNA	PMID:40419075
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314944	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GTPBP2 mRNA	PMID:36331819
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GTPBP2 mRNA	PMID:20106945|PMID:21632981|PMID:22147139|PMID:25562108|PMID:27989131
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314944	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in increased expression of GTPBP2 mRNA	PMID:19770486
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of GTPBP2 promoter	PMID:27989131
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of GTPBP2 mRNA	PMID:24449571
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GTPBP2 mRNA	PMID:38832940
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in increased expression of GTPBP2 mRNA	PMID:20678512
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C012589	[decitabine co-treated with trichostatin A] results in increased expression of GTPBP2 mRNA	PMID:20678512
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314944	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GTPBP2 mRNA	PMID:17562736
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of GTPBP2 mRNA	PMID:29067470
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314944	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of GTPBP2 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GTPBP2 mRNA]	PMID:17585979
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of GTPBP2 mRNA	PMID:20977926
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314944	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GTPBP2 mRNA	PMID:40504410
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1314944	E	RGD:6480464	20221101	CTD	MESH:D004008	Diclofenac results in decreased expression of GTPBP2 mRNA	PMID:35537566
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306367	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GTPBP2 mRNA	PMID:29391264
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GTPBP2 mRNA	PMID:22079256
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314944	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of GTPBP2 mRNA	PMID:17942748
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314944	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GTPBP2 mRNA	PMID:17942748
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:49553	copper(II) chloride	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride affects the expression of GTPBP2 mRNA	PMID:17211630
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of GTPBP2 mRNA	PMID:20678512
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	[Decitabine co-treated with trichostatin A] results in increased expression of GTPBP2 mRNA	PMID:20678512
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306367	E	RGD:6480464	20200519	CTD	MESH:C082360	fipronil results in increased expression of GTPBP2 mRNA	PMID:31881178
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:51052	lucanthone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in decreased expression of GTPBP2 mRNA	PMID:21148553
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1314944	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of GTPBP2 mRNA	PMID:26377693
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:63959	celastrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C050414	celastrol results in increased expression of GTPBP2 mRNA	PMID:17010675
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GTPBP2 mRNA	PMID:24810058
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1306367	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GTPBP2 mRNA	PMID:28801915
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1314944	E	RGD:6480464	20130416	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of GTPBP2 mRNA	PMID:22776087
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:65954	gedunin	increases expression	EXP		E	RGD:6480464	20130305	CTD	MESH:C106014	gedunin results in increased expression of GTPBP2 mRNA	PMID:17010675
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1306367	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of GTPBP2 mRNA	PMID:30467583
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1314944	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of GTPBP2 mRNA	PMID:22206623
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:7438	N-methylformamide	affects expression	ISO	RGD:1314944	E	RGD:6480464	20120412	CTD	MESH:C002950	methylformamide affects the expression of GTPBP2 mRNA; methylformamide analog affects the expression of GTPBP2 mRNA	PMID:17040096
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of GTPBP2 mRNA	PMID:22079256
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GTPBP2 mRNA	PMID:22079256
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GTPBP2 mRNA	PMID:30851411
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314944	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of GTPBP2 mRNA	PMID:19482888
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1314944	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of GTPBP2 mRNA]	PMID:19482888
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of GTPBP2 mRNA	PMID:26079696
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of GTPBP2 mRNA	PMID:38568856
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GTPBP2 mRNA	PMID:29301935
1314943	GTPBP2	GTP binding protein 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314944	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of GTPBP2 mRNA	PMID:35537566
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:10022	deoxynivalenol	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C007262	[[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which affects the localization of ELAVL1 protein] which co-treated with deoxynivalenol] promotes the reaction [[ELAVL1 protein binds to ATF3 3' UTR] which results in increased stability of ATF3 mRNA]; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] affects the localization of ELAVL1 protein; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] affects the phosphorylation of RELA protein; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of ATF3 mRNA; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL1 mRNA; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL8 mRNA; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [deoxynivalenol results in increased expression of ATF3 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [deoxynivalenol results in increased expression of CXCL1 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; ATF3 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] affects the phosphorylation of RELA protein]; ELAVL1 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL1 mRNA]; ELAVL1 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL8 mRNA]	PMID:22003189
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:100241	ciprofloxacin	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002939	NOD2 gene SNP results in decreased susceptibility to Ciprofloxacin	PMID:18371140
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of NOD2 mRNA	PMID:27188386
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:146194	15-acetyldeoxynivalenol	multiple interactions	EXP		E	RGD:6480464	20200303	CTD	MESH:C046760	[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [15-acetyldeoxynivalenol results in increased expression of ATF3 mRNA]	PMID:22003189
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D010100	Oxygen deficiency results in increased expression of NOD2 mRNA	PMID:23880069
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D010100	HIF1A protein affects the reaction [Oxygen deficiency results in increased expression of NOD2 mRNA]; Oxygen deficiency promotes the reaction [HIF1A protein binds to NOD2 promoter]	PMID:23880069
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1306368	E	RGD:6480464	20260602	CTD	MESH:D010100	[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA]; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein]	PMID:20863826
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314946	E	RGD:6480464	20260602	CTD	MESH:D010100	[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA]; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein]	PMID:20863826
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of NOD2 mRNA	PMID:26079696
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NOD2 mRNA	PMID:35811015
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314946	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of NOD2 mRNA	PMID:25890327
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOD2 mRNA; [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NOD2 mRNA	PMID:21878375|PMID:35811015
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314946	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of NOD2 mRNA	PMID:39298647
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306368	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of NOD2 mRNA	PMID:33387578
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306368	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of NOD2 gene	PMID:27618143
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NOD2 mRNA	PMID:37042841
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1306368	E	RGD:6480464	20260602	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA]; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein]	PMID:20863826
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314946	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NOD2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA]; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein]	PMID:20863826|PMID:37992649
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of NOD2 mRNA	PMID:33359661
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1306368	E	RGD:6480464	20260602	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA]; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein]	PMID:20863826
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314946	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NOD2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA]; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein]	PMID:20863826|PMID:37992649
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of NOD2 mRNA	PMID:16002434
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:188851	Muraglitazar	decreases expression	ISO	RGD:1306368	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in decreased expression of NOD2 mRNA	PMID:21515302
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NOD2 mRNA	PMID:19549813
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:2430	aconitine	increases expression	ISO	RGD:1306368	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in increased expression of NOD2 protein	PMID:33236894
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:2430	aconitine	multiple interactions	ISO	RGD:1306368	E	RGD:6480464	20210309	CTD	MESH:D000157	NOD2 protein affects the reaction [Aconitine results in increased expression of CASP1 protein]; NOD2 protein affects the reaction [Aconitine results in increased expression of IL18 protein]; NOD2 protein affects the reaction [Aconitine results in increased expression of IL1B protein]; NOD2 protein affects the reaction [Aconitine results in increased expression of NLRP3 protein]	PMID:33236894
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NOD2 exon; Aflatoxin B1 results in increased methylation of NOD2 intron	PMID:30157460
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:25187	p-menthan-3-ol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of NOD2 mRNA	PMID:26760959
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:25710	organophosphorus compound	multiple interactions	ISO	RGD:1306368	E	RGD:6480464	20250401	CTD	MESH:D009943	[Dust results in increased abundance of Organophosphorus Compounds] which results in increased expression of NOD2 mRNA	PMID:39658253
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	Ozone results in increased expression of NOD2 mRNA	PMID:31476115
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of NOD2 mRNA; [Aripiprazole co-treated with Ozone] results in increased expression of NOD2 mRNA	PMID:31476115|PMID:41430723
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314946	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NOD2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of NOD2 mRNA	PMID:34911549
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:26828	sulfolipid I	affects binding	EXP		E	RGD:6480464	20200519	CTD	MESH:C009355	NOD2 protein binds to sulfolipid I	PMID:23880069
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:26828	sulfolipid I	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:C009355	sulfolipid I inhibits the reaction [NOD2 protein binds to Sulfoglycosphingolipids]	PMID:23880069
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D001151	Arsenic affects the expression of NOD2 mRNA	PMID:28793237
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D001151	[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of NOD2 mRNA	PMID:28793237
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306368	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of NOD2 mRNA	PMID:31881176
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314946	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of NOD2 mRNA	PMID:32186404
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of NOD2 mRNA	PMID:25583101
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306368	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NOD2 mRNA	PMID:32109520
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306368	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NOD2 mRNA	PMID:33387578
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314946	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NOD2 mRNA	PMID:37992649
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:29014	cordycepin	decreases expression	EXP		E	RGD:6480464	20241203	CTD	MESH:C058120	cordycepin results in decreased expression of NOD2 mRNA	PMID:39084503
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:29014	cordycepin	multiple interactions	EXP		E	RGD:6480464	20241203	CTD	MESH:C058120	[immune checkpoint inhibitor BMS-1 co-treated with cordycepin] results in decreased expression of NOD2 mRNA	PMID:39084503
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:2981	baicalin	multiple interactions	ISO	RGD:1306368	E	RGD:6480464	20260602	CTD	MESH:C038044	baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA]; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein]	PMID:20863826
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:2981	baicalin	multiple interactions	ISO	RGD:1314946	E	RGD:6480464	20260602	CTD	MESH:C038044	baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA]; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein]	PMID:20863826
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NOD2 promoter	PMID:27901495
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314946	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NOD2 mRNA	PMID:23735875
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of NOD2 mRNA	PMID:26014281
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:30805	dodecanoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C030358	Curcumin inhibits the reaction [lauric acid promotes the reaction [NOD2 protein binds to NOD2 protein]]; lauric acid promotes the reaction [NOD2 protein binds to NOD2 protein]	PMID:18413660
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:31236	aripiprazole	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C094645	Aripiprazole results in increased expression of NOD2 mRNA	PMID:31476115
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:31236	aripiprazole	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:C094645	[Aripiprazole co-treated with Ozone] results in increased expression of NOD2 mRNA	PMID:31476115
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1314946	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of NOD2 mRNA	PMID:20542052
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:32195	Tesaglitazar	decreases expression	ISO	RGD:1306368	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in decreased expression of NOD2 mRNA	PMID:21515302
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306368	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of NOD2 mRNA	PMID:34492290
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306368	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NOD2 mRNA	PMID:25181051
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306368	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NOD2 mRNA	PMID:36041667
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:338412	(-)-anisomycin	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D000841	[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [Anisomycin results in increased expression of ATF3 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [Anisomycin results in increased expression of CXCL1 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [Anisomycin results in increased expression of CXCL8 mRNA]	PMID:22003189
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1314946	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of NOD2 exon	PMID:33297965
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306368	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NOD2 mRNA	PMID:36041667
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of NOD2 intron	PMID:30157460
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306368	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NOD2 mRNA	PMID:36041667
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of NOD2 mRNA	PMID:37042841
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NOD2 mRNA	PMID:38382870
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of NOD2 mRNA	PMID:24449571
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:3638	chloroquine	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D002738	NOD2 protein affects the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein]	PMID:23880069
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314946	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of NOD2 mRNA	PMID:29038090
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Acetylmuramyl-Alanyl-Isoglutamine promotes the reaction [NOD2 protein binds to NOD2 protein]]; Curcumin inhibits the reaction [lauric acid promotes the reaction [NOD2 protein binds to NOD2 protein]]	PMID:18413660
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of NOD2 mRNA	PMID:27989131
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1306368	E	RGD:6480464	20260602	CTD	MESH:D005947	[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA]; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein]	PMID:20863826
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314946	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NOD2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 mRNA]; baicalin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of NOD2 protein]	PMID:20863826|PMID:37992649
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:D008727	Methotrexate results in decreased expression of NOD2 mRNA	PMID:17400583
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NOD2 mRNA	PMID:38832940
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of NOD2 mRNA	PMID:35811015
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D001151	Arsenic affects the expression of NOD2 mRNA	PMID:28793237
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D001151	[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of NOD2 mRNA	PMID:28793237
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D002101	[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of NOD2 mRNA	PMID:28793237
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314946	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NOD2 mRNA; Nanotubes, Carbon results in increased expression of NOD2 mRNA	PMID:25554681
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1306368	E	RGD:6480464	20150512	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of NOD2 mRNA	PMID:16891783
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1314946	E	RGD:6480464	20150512	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of NOD2 mRNA; Trinitrobenzenesulfonic Acid results in increased expression of NOD2 protein	PMID:22147983
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314946	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of NOD2 mRNA	PMID:38701926
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:59414	muramyl dipeptide	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:D000119	Acetylmuramyl-Alanyl-Isoglutamine results in increased expression of NOD2 protein	PMID:28450277
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:59414	muramyl dipeptide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D000119	[[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which affects the localization of ELAVL1 protein] which co-treated with deoxynivalenol] promotes the reaction [[ELAVL1 protein binds to ATF3 3' UTR] which results in increased stability of ATF3 mRNA]; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which affects the localization of ELAVL1 protein] promotes the reaction [[ELAVL1 protein binds to ATF3 3' UTR] which results in increased stability of ATF3 mRNA]; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] affects the localization of ELAVL1 protein; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] affects the phosphorylation of RELA protein; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of ATF3 mRNA; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL1 mRNA; [[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL8 mRNA; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [15-acetyldeoxynivalenol results in increased expression of ATF3 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [Anisomycin results in increased expression of ATF3 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [Anisomycin results in increased expression of CXCL1 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [Anisomycin results in increased expression of CXCL8 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [deoxynivalenol results in increased expression of ATF3 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [deoxynivalenol results in increased expression of CXCL1 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] promotes the reaction [deoxynivalenol results in increased expression of CXCL8 mRNA]; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which affects the localization of ELAVL1 protein; [Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which results in increased stability of ATF3 mRNA; Acetylmuramyl-Alanyl-Isoglutamine binds to and affects the activity of NOD2 protein; Acetylmuramyl-Alanyl-Isoglutamine promotes the reaction [NOD2 protein binds to NOD2 protein]; ATF3 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] affects the phosphorylation of RELA protein]; Curcumin inhibits the reaction [Acetylmuramyl-Alanyl-Isoglutamine promotes the reaction [NOD2 protein binds to NOD2 protein]]; ELAVL1 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL1 mRNA]; ELAVL1 protein affects the reaction [[[Acetylmuramyl-Alanyl-Isoglutamine binds to and results in increased activity of NOD2 protein] which co-treated with deoxynivalenol] results in increased stability of CXCL8 mRNA]	PMID:18413660|PMID:22003189
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of NOD2 intron	PMID:30157460
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314946	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of NOD2 mRNA	PMID:39847705
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of NOD2 mRNA	PMID:26014281
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of NOD2 mRNA	PMID:29301935
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1306368	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in decreased expression of NOD2 mRNA	PMID:21515302
1314945	NOD2	nucleotide binding oligomerization domain containing 2	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1306368	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of NOD2 gene	PMID:31682807
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1314948	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of SLC9A9 mRNA	PMID:37995155
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314948	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC9A9 mRNA	PMID:36189433
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1560736	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of SLC9A9 gene	PMID:28931070|PMID:35440735
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:16130	DDT	decreases methylation	ISO	RGD:1560736	E	RGD:6480464	20211012	CTD	MESH:D003634	DDT results in decreased methylation of SLC9A9 gene	PMID:31682807
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314948	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SLC9A9 mRNA	PMID:39241906
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC9A9 mRNA	PMID:30165855
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1560736	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SLC9A9 mRNA	PMID:33387578
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:16856	glutathione	increases expression	ISO	RGD:1560736	E	RGD:6480464	20120918	CTD	MESH:D005978	Glutathione deficiency results in increased expression of SLC9A9 mRNA	PMID:20621112
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314948	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of SLC9A9 mRNA	PMID:36189433
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of SLC9A9 protein	PMID:37730182
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of SLC9A9 intron	PMID:30157460
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:222613	Moniliformin	increases expression	ISO	RGD:1314948	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in increased expression of SLC9A9 mRNA	PMID:39984025
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1560736	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC9A9 mRNA	PMID:39012411
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SLC9A9 mRNA	PMID:22100608
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SLC9A9 intron	PMID:30157460
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314948	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLC9A9 mRNA	PMID:27106289
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1560736	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SLC9A9 mRNA	PMID:30779732
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314948	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SLC9A9 mRNA	PMID:17484886
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1560736	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SLC9A9 mRNA	PMID:31150632
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1314948	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of SLC9A9 mRNA	PMID:40618947
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1560736	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC9A9 mRNA	PMID:34747641
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC9A9 mRNA	PMID:20106945|PMID:26159488
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1560736	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC9A9 mRNA	PMID:33387578
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D013749	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of SLC9A9 mRNA	PMID:26159488
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of SLC9A9 mRNA	PMID:29955902
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC9A9 mRNA	PMID:30851411
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of SLC9A9 mRNA	PMID:23649840
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLC9A9 mRNA	PMID:29803840
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314948	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLC9A9 mRNA	PMID:39631538
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1314948	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC9A9 mRNA	PMID:39515575
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of SLC9A9 mRNA	PMID:20064835
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of SLC9A9 intron	PMID:30157460
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314948	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC9A9 mRNA	PMID:20713471
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC9A9 mRNA	PMID:20106945
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SLC9A9 mRNA	PMID:25895662
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314948	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of SLC9A9 mRNA	PMID:23221170
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:32692	4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016583	4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of SLC9A9 mRNA	PMID:19038236
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1560736	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC9A9 mRNA	PMID:30816183|PMID:34947998
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SLC9A9 gene	PMID:31601247
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SLC9A9 mRNA	PMID:29275510
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1560736	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SLC9A9 gene	PMID:28505145
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of SLC9A9 mRNA	PMID:25979313
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:34342	3-methylcholanthrene	decreases expression	ISO	RGD:1314948	E	RGD:6480464	20120412	CTD	MESH:D008748	Methylcholanthrene results in decreased expression of SLC9A9 mRNA	PMID:20713471
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314948	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of SLC9A9 mRNA	PMID:40203079
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC9A9 mRNA	PMID:37042841
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1560736	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of SLC9A9 mRNA	PMID:30589522
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1560736	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC9A9 mRNA	PMID:39012411
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of SLC9A9 mRNA	PMID:24449571
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLC9A9 mRNA	PMID:25979313
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SLC9A9 gene	PMID:29154799
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of SLC9A9 mRNA	PMID:20106945
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of SLC9A9 mRNA	PMID:25047013
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314948	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SLC9A9 mRNA	PMID:28973697
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of SLC9A9 mRNA	PMID:23649840
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1314948	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of SLC9A9 mRNA	PMID:18502557
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SLC9A9 mRNA	PMID:38832940
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC9A9 mRNA	PMID:29067470
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1560736	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SLC9A9 mRNA	PMID:29391264
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:4791	endosulfan	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D004726	[Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of SLC9A9 mRNA	PMID:26159488
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1314948	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of SLC9A9 mRNA	PMID:23608068
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:6716	medroxyprogesterone acetate	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D017258	Medroxyprogesterone Acetate results in increased expression of SLC9A9 mRNA	PMID:20843944
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SLC9A9 mRNA	PMID:31758290
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLC9A9 mRNA	PMID:30851411
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SLC9A9 gene]	PMID:28238834
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314948	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SLC9A9 mRNA	PMID:39847705
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:89700	3-iodothyronamine	affects uptake	EXP		E	RGD:6480464	20170110	CTD	MESH:C487948	SLC9A9 mRNA affects the uptake of 3-iodothyronamine	PMID:19074582
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:8984	sodium dodecyl sulfate	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in decreased expression of SLC9A9 mRNA	PMID:31734321
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1314948	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of SLC9A9 mRNA	PMID:28973697
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1314948	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SLC9A9 mRNA	PMID:35537566
1314947	SLC9A9	solute carrier family 9 member A9	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1560736	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of SLC9A9 gene	PMID:31682807
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1623282	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SUPT4A mRNA	PMID:33045310
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SUPT4H1 mRNA	PMID:33167477
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1623282	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SUPT4A mRNA	PMID:39241906
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:17688	(S)-nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of SUPT4H1 mRNA	PMID:18247414
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:18723	nicotine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of SUPT4H1 mRNA	PMID:18247414
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306372	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of SUPT4H1 mRNA	PMID:30779732
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SUPT4H1 mRNA]	PMID:11007951
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:27878	2-naphthylamine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015081	2-Naphthylamine results in increased expression of SUPT4H1 mRNA	PMID:18247414
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of SUPT4H1 mRNA	PMID:23300844
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306372	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SUPT4H1 mRNA	PMID:22298810
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1623282	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SUPT4H1 mRNA	PMID:21570461
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SUPT4H1 mRNA	PMID:11007951
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306372	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SUPT4H1 mRNA	PMID:34747641
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SUPT4H1 mRNA]	PMID:11007951
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1623282	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the reaction [AHR protein binds to SUPT4H1 promoter]	PMID:19654925
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of SUPT4H1 protein	PMID:39603559
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SUPT4H1 mRNA	PMID:30851411
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SUPT4H1 mRNA	PMID:24690739
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SUPT4H1 mRNA	PMID:18247414
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1623282	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SUPT4H1 mRNA	PMID:22228805
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1623282	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene affects the reaction [AHR protein binds to SUPT4H1 promoter]	PMID:19654925
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to SUPT4H1 mRNA]	PMID:32406909
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of SUPT4H1 mRNA	PMID:24690739
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1623282	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SUPT4H1 gene; titanium dioxide results in decreased methylation of SUPT4H1 promoter	PMID:35295148
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1623282	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SUPT4H1 promoter	PMID:35295148
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1623282	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of SUPT4H1 mRNA	PMID:18648102
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1623282	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SUPT4A mRNA	PMID:33221593
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306372	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SUPT4H1 mRNA	PMID:25181051|PMID:32145629
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of SUPT4H1 mRNA	PMID:19244175
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1623282	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SUPT4A mRNA	PMID:39298647
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1623282	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SUPT4A mRNA	PMID:36331819
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1623282	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SUPT4H1 mRNA	PMID:17555576
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of SUPT4H1 mRNA	PMID:24690739
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of SUPT4H1 mRNA	PMID:22077320
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1623282	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SUPT4H1 mRNA	PMID:17555576
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of SUPT4H1 mRNA	PMID:23300844
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1623282	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of SUPT4H1 mRNA	PMID:23650126
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1623282	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of SUPT4A protein	PMID:26558463
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1623282	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SUPT4A mRNA	PMID:22206623
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SUPT4H1 mRNA	PMID:30851411
1314951	SUPT4H1	SPT4 homolog, DSIF elongation factor subunit	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1623282	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of SUPT4A mRNA	PMID:35537566
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1306373	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of MGST3 mRNA	PMID:21551480
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306373	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MGST3 mRNA]	PMID:31150632
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:144400	dinophysistoxin 1	increases expression	EXP		E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in increased expression of MGST3 mRNA	PMID:28939011
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MGST3 mRNA	PMID:33167477
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of MGST3 mRNA	PMID:30951980
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MGST3 mRNA	PMID:36331819
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of MGST3 mRNA	PMID:36841081
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1314954	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MGST3 mRNA	PMID:30319688
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314954	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in increased expression of MGST3 mRNA	PMID:19167417
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of MGST3 mRNA	PMID:18951874
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of MGST3 mRNA	PMID:14729362
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:16359	cholic acid	increases expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D019826	Cholic Acid results in increased expression of MGST3 mRNA	PMID:17521389
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in decreased expression of MGST3 mRNA	PMID:23019147
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MGST3 mRNA	PMID:39298647
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306373	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of MGST3 mRNA	PMID:32145629
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of MGST3 mRNA	PMID:15289156
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MGST3 mRNA	PMID:25510870
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1314954	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of MGST3 mRNA	PMID:33711761
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1314954	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of MGST3 mRNA	PMID:25549359
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGST3 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGST3 mRNA	PMID:37992649
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGST3 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGST3 mRNA	PMID:37992649
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1314954	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of MGST3 mRNA	PMID:23892564
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MGST3 mRNA	PMID:31163220
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314954	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MGST3 mRNA	PMID:33754040
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of MGST3 mRNA	PMID:26577399
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MGST3 mRNA	PMID:36331819
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20120717	CTD	MESH:D008769	[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MGST3 mRNA	PMID:19840844
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MGST3 mRNA	PMID:37236586
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MGST3 mRNA	PMID:29950665
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MGST3 mRNA	PMID:25510870
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MGST3 mRNA	PMID:25510870
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MGST3 mRNA	PMID:19770486
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MGST3 gene	PMID:27153756
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MGST3 mRNA	PMID:34911549
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1314954	E	RGD:6480464	20150127	CTD	MESH:D000638	Amiodarone results in increased expression of MGST3 mRNA	PMID:24535564
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MGST3 mRNA	PMID:17484886
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MGST3 mRNA	PMID:31150632
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314954	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MGST3 mRNA	PMID:31919559
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306373	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MGST3 mRNA]	PMID:31150632
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MGST3 mRNA	PMID:25629700
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MGST3 mRNA	PMID:22206623
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MGST3 mRNA	PMID:40512198
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGST3 mRNA]	PMID:37992649
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1306373	E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in increased expression of MGST3 mRNA	PMID:19228061
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1314954	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of MGST3 mRNA	PMID:34813904
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of MGST3 mRNA	PMID:15289156
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1306373	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of MGST3 gene	PMID:28505145
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28112	nickel atom	affects expression	ISO	RGD:1306373	E	RGD:6480464	20120412	CTD	MESH:D009532	Nickel affects the expression of MGST3 mRNA	PMID:19440498
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306373	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MGST3 mRNA	PMID:34747641
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314954	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MGST3 mRNA	PMID:21570461|PMID:26377647
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20130122	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MGST3 mRNA	PMID:18465118|PMID:18796159|PMID:20959002|PMID:21724226
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306373	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MGST3 mRNA	PMID:32109520
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314954	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MGST3 mRNA	PMID:28213091
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with AHR protein mutant form] results in increased expression of MGST3 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MGST3 mRNA	PMID:17942748|PMID:22496397
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C004925	methylmercuric chloride results in increased expression of MGST3 mRNA	PMID:29581082
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20260407	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MGST3 mRNA	PMID:40480416
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MGST3 mRNA	PMID:28959563
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of MGST3 mRNA	PMID:30556269
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MGST3 mRNA	PMID:30911355
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MGST3 mRNA	PMID:15467011
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of MGST3 mRNA	PMID:29803840
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGST3 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGST3 mRNA	PMID:37992649
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28794	coumarin	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20120412	CTD	MESH:C030123	coumarin results in decreased expression of MGST3 mRNA	PMID:18480146
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGST3 mRNA]	PMID:37992649
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:28940	calciol	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in decreased expression of MGST3 mRNA	PMID:16508948
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of MGST3 mRNA	PMID:39719251
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite results in increased expression of MGST3 mRNA	PMID:28229933|PMID:34032870
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MGST3 mRNA	PMID:40512198
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of MGST3 mRNA	PMID:17127020
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MGST3 promoter	PMID:27901495
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314954	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MGST3 mRNA	PMID:19770486
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MGST3 mRNA]	PMID:22228805
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MGST3 mRNA]	PMID:32406909
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of MGST3 mRNA	PMID:30556269
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of MGST3 mRNA	PMID:30911355
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of MGST3 mRNA	PMID:15467011
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:3093	bifenthrin	increases expression	ISO	RGD:1314954	E	RGD:6480464	20160822	CTD	MESH:C099952	bifenthrin results in increased expression of MGST3 mRNA	PMID:26071804
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of MGST3 mRNA	PMID:24136188
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of MGST3 mRNA	PMID:25729387
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306373	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MGST3 mRNA	PMID:25729387
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:32090	Rebamipide	increases expression	ISO	RGD:1306373	E	RGD:6480464	20141111	CTD	MESH:C052785	rebamipide results in increased expression of MGST3 mRNA	PMID:18299717
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306373	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MGST3 mRNA	PMID:30047161
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314954	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MGST3 promoter	PMID:35295148
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MGST3 mRNA	PMID:29950665
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MGST3 mRNA	PMID:34492290
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314954	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MGST3 mRNA	PMID:11798191|PMID:16221962|PMID:17426115|PMID:18301758|PMID:20813756|PMID:23811191
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MGST3 mRNA	PMID:19710929
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in increased expression of MGST3 mRNA	PMID:20813756
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:33101	nitrogen dioxide	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D009585	Nitrogen Dioxide results in increased expression of MGST3 mRNA	PMID:27206323
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MGST3 mRNA	PMID:30903817
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306373	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of MGST3 mRNA	PMID:30903817
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of MGST3 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of MGST3 mRNA	PMID:35598803
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of MGST3 protein	PMID:37567409
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306373	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MGST3 mRNA	PMID:25181051|PMID:32145629
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314954	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MGST3 mRNA	PMID:34585602
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306373	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MGST3 gene	PMID:28505145
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306373	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of MGST3 gene	PMID:28505145
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1306373	E	RGD:6480464	20120412	CTD	MESH:C014024	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of MGST3 mRNA	PMID:16984957
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MGST3 mRNA; [NR1I2 protein affects the susceptibility to 2,4,5,2',4',5'-hexachlorobiphenyl] which affects the expression of MGST3 mRNA	PMID:25510870|PMID:32352317
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MGST3 mRNA	PMID:25510870
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20130122	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of MGST3 mRNA	PMID:19692669|PMID:20959002
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20120613	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of MGST3 mRNA	PMID:18723825
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	multiple interactions	ISO	RGD:1306373	E	RGD:6480464	20120412	CTD	MESH:C023035	[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of MGST3 mRNA	PMID:16984957
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of MGST3 mRNA	PMID:30951980
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MGST3 mRNA	PMID:38685157
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of MGST3 protein	PMID:34186270
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1314954	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of MGST3 intron	PMID:28392331
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20120412	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MGST3 mRNA	PMID:19440498
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MGST3 mRNA	PMID:29950665
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34682	diazinon	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon results in decreased expression of MGST3 mRNA	PMID:19440498
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MGST3 mRNA	PMID:21266533
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of MGST3 mRNA	PMID:36117858
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MGST3 mRNA	PMID:25993096
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MGST3 mRNA	PMID:37236586
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MGST3 mRNA	PMID:37302725
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1314954	E	RGD:6480464	20140311	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MGST3 mRNA	PMID:20118188|PMID:23626681
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:C023036	[perfluorooctanoic acid co-treated with Dietary Fats, Unsaturated] results in increased expression of MGST3 mRNA; PPARA promotes the reaction [perfluorooctanoic acid results in decreased expression of MGST3 mRNA]	PMID:20118188|PMID:23626681
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of MGST3 mRNA	PMID:19162173
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20120613	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of MGST3 mRNA	PMID:18723825
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MGST3 mRNA	PMID:24449571
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1314954	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of MGST3 mRNA	PMID:28962523
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1314954	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of MGST3 mRNA	PMID:18353800
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1314954	E	RGD:6480464	20140513	CTD	MESH:D002994	Clofibrate results in increased expression of MGST3 mRNA	PMID:18723825|PMID:22496397
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of MGST3 mRNA; [Clofibrate results in increased activity of PPARA protein] which results in increased expression of MGST3 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MGST3 mRNA]	PMID:17585979|PMID:22496397
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MGST3 mRNA	PMID:28302478
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:38757	isoflavones	affects expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D007529	Isoflavones affects the expression of MGST3 mRNA	PMID:16365062
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MGST3 mRNA	PMID:31533062
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of MGST3 mRNA	PMID:26352163
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20151215	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of MGST3 mRNA	PMID:26300304
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1314954	E	RGD:6480464	20130416	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MGST3 mRNA	PMID:20936131
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MGST3 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of MGST3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of MGST3 mRNA	PMID:36331819
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1314954	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of MGST3 mRNA	PMID:29038090
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in decreased expression of MGST3 mRNA	PMID:25993096
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MGST3 mRNA	PMID:25979313
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MGST3 mRNA	PMID:17292431
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MGST3 gene	PMID:29154799
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of MGST3 mRNA	PMID:23179753|PMID:24383497|PMID:27188386|PMID:28001369
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1314954	E	RGD:6480464	20150127	CTD	MESH:D014635	Valproic Acid results in increased expression of MGST3 mRNA	PMID:21427059|PMID:24535564
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306373	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MGST3 mRNA	PMID:30047161|PMID:41580965
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of MGST3 mRNA	PMID:25562108
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20120613	CTD	MESH:D003907	Dexamethasone results in decreased expression of MGST3 mRNA	PMID:18723825
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of MGST3 mRNA	PMID:25047013
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1314954	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of MGST3 mRNA	PMID:22733784
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of MGST3 mRNA	PMID:36621641
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:41922	diethylstilbestrol	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of MGST3 mRNA	PMID:21658437
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MGST3 mRNA	PMID:15289156
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D017313	Fenretinide results in decreased expression of MGST3 mRNA	PMID:16467112|PMID:28973697
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGST3 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MGST3 mRNA	PMID:37992649
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of MGST3 mRNA	PMID:24136188
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D019319	Okadaic Acid results in increased expression of MGST3 mRNA	PMID:28939011
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:44658	okadaic acid	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20120717	CTD	MESH:D019319	[Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of MGST3 mRNA	PMID:19840844
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:45285	pyrazinecarboxamide	increases expression	ISO	RGD:1306373	E	RGD:6480464	20180703	CTD	MESH:D011718	Pyrazinamide results in increased expression of MGST3 mRNA	PMID:22431067
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MGST3 mRNA	PMID:17562736
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of MGST3 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MGST3 mRNA]	PMID:17585979
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MGST3 mRNA	PMID:40512198
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MGST3 mRNA	PMID:29391264
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306373	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MGST3 mRNA	PMID:17557909
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MGST3 mRNA	PMID:17942748
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MGST3 mRNA	PMID:17942748
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D011345	Fenofibrate results in increased expression of MGST3 mRNA	PMID:11798191
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of MGST3 mRNA	PMID:25620056
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314954	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MGST3 mRNA; Nanotubes, Carbon results in increased expression of MGST3 mRNA	PMID:25554681
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306373	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MGST3 mRNA	PMID:30047161
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of MGST3 mRNA	PMID:24793618
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of MGST3 mRNA	PMID:36117858
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of MGST3 mRNA	PMID:19042947
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MGST3 protein	PMID:32959892
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1306373	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of MGST3 mRNA	PMID:28801915
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of MGST3 mRNA	PMID:25729387
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306373	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MGST3 mRNA	PMID:25729387
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of MGST3 mRNA	PMID:24136188
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:63918	artesunate	affects response to substance	EXP		E	RGD:6480464	20170228	CTD	MESH:C039726	MGST3 mRNA affects the susceptibility to artesunate	PMID:15796179
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of MGST3 mRNA	PMID:19812364
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of MGST3 mRNA	PMID:18178546
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of MGST3 mRNA	PMID:28988120
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:6402	leflunomide	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in decreased expression of MGST3 mRNA	PMID:24136188
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of MGST3 mRNA	PMID:15336504
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1314954	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of MGST3 mRNA	PMID:14729362|PMID:15336504
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20260804	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of MGST3 mRNA	PMID:37269647
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1314954	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of MGST3 mRNA	PMID:36851058
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20120412	CTD	MESH:D008701	Methapyrilene results in decreased expression of MGST3 mRNA	PMID:16393664|PMID:30467583
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of MGST3 mRNA	PMID:31758290
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MGST3 protein	PMID:34186270
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314954	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MGST3 mRNA	PMID:22206623
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MGST3 mRNA	PMID:22206623
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of MGST3 mRNA	PMID:24136188
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of MGST3 protein	PMID:31285264
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1306373	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of MGST3 mRNA	PMID:33484710
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:7596	nitroprusside	affects expression	ISO	RGD:1306373	E	RGD:6480464	20241105	CTD	MESH:D009599	Nitroprusside affects the expression of MGST3 mRNA	PMID:17496435
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:76290	PhIP	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20211012	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of MGST3 mRNA	PMID:33945839
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:76359	butylated hydroxyanisole	increases expression	ISO	RGD:1314954	E	RGD:6480464	20140107	CTD	MESH:D002083	Butylated Hydroxyanisole results in increased expression of MGST3 mRNA	PMID:18723825
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:77319	oltipraz	increases expression	ISO	RGD:1314954	E	RGD:6480464	20140513	CTD	MESH:C026209	oltipraz results in increased expression of MGST3 mRNA	PMID:18723825|PMID:22496397
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:77319	oltipraz	multiple interactions	ISO	RGD:1314954	E	RGD:6480464	20140513	CTD	MESH:C026209	[oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of MGST3 mRNA	PMID:22496397
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:77323	ethoxyquin	increases expression	ISO	RGD:1314954	E	RGD:6480464	20140304	CTD	MESH:D005015	Ethoxyquin results in increased expression of MGST3 mRNA	PMID:18723825
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MGST3 gene]	PMID:28238834
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of MGST3 mRNA	PMID:19159669
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1314954	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of MGST3 mRNA	PMID:23091169
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1314954	E	RGD:6480464	20200519	CTD	MESH:D010634	Phenobarbital results in increased expression of MGST3 mRNA	PMID:31836555
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306373	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of MGST3 mRNA	PMID:32109520
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314954	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of MGST3 mRNA	PMID:39847705
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1306373	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of MGST3 mRNA	PMID:30047161
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306373	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of MGST3 mRNA	PMID:21346803
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:9352	sulindac	multiple interactions	ISO	RGD:1306373	E	RGD:6480464	20120717	CTD	MESH:D013467	[Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of MGST3 mRNA	PMID:20371263
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:9753	troglitazone	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C057693	troglitazone results in increased expression of MGST3 mRNA	PMID:25572481
1314953	MGST3	microsomal glutathione S-transferase 3	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1314954	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of MGST3 mRNA	PMID:28973697
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRPL36 mRNA	PMID:22378314
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1314957	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MRPL36 mRNA	PMID:30319688
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314957	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPL36 mRNA	PMID:39241906
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL36 mRNA	PMID:31059760
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306375	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MRPL36 mRNA	PMID:33387578
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MRPL36 mRNA	PMID:37042841
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306375	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of MRPL36 mRNA	PMID:26496021
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314957	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MRPL36 mRNA	PMID:35550907
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306375	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MRPL36 mRNA	PMID:33387578
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MRPL36 mRNA	PMID:28818685
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1306375	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of MRPL36 mRNA	PMID:28522335
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MRPL36 mRNA	PMID:19549813
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MRPL36 mRNA	PMID:35430440
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314957	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL36 mRNA	PMID:22206623
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314957	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of MRPL36 mRNA	PMID:22610192
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314957	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPL36 mRNA	PMID:21570461
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306375	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPL36 mRNA	PMID:32109520|PMID:33387578|PMID:34747641
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314957	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL36 mRNA	PMID:17942748
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of MRPL36 mRNA	PMID:39709020
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPL36 mRNA	PMID:38568856
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of MRPL36 mRNA	PMID:34032870
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314957	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MRPL36 mRNA	PMID:27195522
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306375	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MRPL36 mRNA	PMID:34492290
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314957	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MRPL36 mRNA	PMID:18301758
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314957	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of MRPL36 mRNA	PMID:28329830
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314957	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL36 mRNA	PMID:30245210
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL36 mRNA	PMID:25047013
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306375	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL36 mRNA	PMID:25181051|PMID:34947998
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314957	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL36 mRNA	PMID:33221593
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306375	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of MRPL36 mRNA	PMID:26496021
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314957	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPL36 mRNA	PMID:39298647
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306375	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MRPL36 mRNA	PMID:21266533
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314957	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MRPL36 mRNA	PMID:21266533
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of MRPL36 mRNA	PMID:24449571
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in decreased expression of MRPL36 mRNA	PMID:26352163
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRPL36 mRNA	PMID:25979313
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MRPL36 mRNA	PMID:23179753|PMID:28001369
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MRPL36 gene	PMID:29154799
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:41791	calyculin A	decreases expression	ISO	RGD:1314957	E	RGD:6480464	20150127	CTD	MESH:C059041	calyculin A results in decreased expression of MRPL36 mRNA	PMID:25270620
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of MRPL36 mRNA	PMID:27188386
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314957	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MRPL36 mRNA	PMID:17562736
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL36 mRNA	PMID:31059760
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306375	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL36 mRNA	PMID:33387578
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of MRPL36 mRNA	PMID:31059760
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:47381	diclofenac	multiple interactions	ISO	RGD:1314957	E	RGD:6480464	20240702	CTD	MESH:D004008	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL36 mRNA	PMID:37844793
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314957	E	RGD:6480464	20120412	CTD	MESH:D004997	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL36 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL36 mRNA	PMID:17942748|PMID:37844793
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:50594	carbon nanotube	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of MRPL36 mRNA	PMID:28673683
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314957	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MRPL36 mRNA	PMID:35964746
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306375	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of MRPL36 mRNA	PMID:24793618
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:5855	ibuprofen	multiple interactions	ISO	RGD:1314957	E	RGD:6480464	20240702	CTD	MESH:D007052	[Ibuprofen co-treated with hydroxyibuprofen co-treated with Diclofenac co-treated with Ethinyl Estradiol] results in decreased expression of MRPL36 mRNA	PMID:37844793
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:1306375	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of MRPL36 mRNA	PMID:24136188
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314957	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MRPL36 mRNA	PMID:22206623
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314957	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL36 mRNA	PMID:22206623
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306375	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MRPL36 mRNA	PMID:24136188
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MRPL36 gene]	PMID:28238834
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	affects expression	ISO	RGD:1314957	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl affects the expression of MRPL36 mRNA	PMID:31388691
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MRPL36 mRNA	PMID:38568856
1314956	MRPL36	mitochondrial ribosomal protein L36	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306375	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MRPL36 mRNA	PMID:22570695
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1617454	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of AGL mRNA	PMID:33045310
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306376	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AGL mRNA]	PMID:31150632
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1617454	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of AGL mRNA	PMID:26251327
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of AGL mRNA	PMID:33167477
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AGL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of AGL mRNA	PMID:32699268
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of AGL mRNA	PMID:26079696
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1617454	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of AGL mRNA	PMID:30319688
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of AGL mRNA	PMID:21632981
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1617454	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of AGL mRNA	PMID:19484750|PMID:39298647
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:16602	trichloroethene	decreases methylation	ISO	RGD:1306376	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of AGL gene	PMID:27618143
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of AGL mRNA	PMID:21179406
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:17234	glucose	increases uptake	EXP		E	RGD:6480464	20160412	CTD	MESH:D005947	AGL protein results in increased uptake of Glucose	PMID:24700805
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1306376	E	RGD:6480464	20120501	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate binds to and affects the activity of AGL protein	PMID:19240039
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:174733	Licochalcone B	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of AGL mRNA	PMID:33647349
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:17634	D-glucose	increases uptake	EXP		E	RGD:6480464	20160412	CTD	MESH:D005947	AGL protein results in increased uptake of Glucose	PMID:24700805
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1617454	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of AGL mRNA	PMID:23892564
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of AGL mRNA	PMID:26485663
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AGL mRNA	PMID:35301059
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1617454	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AGL mRNA	PMID:37236586
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of AGL mRNA	PMID:19549813
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of AGL mRNA	PMID:22100608
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1617454	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of AGL mRNA	PMID:19770486
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AGL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of AGL mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of AGL mRNA	PMID:32699268
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306376	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AGL mRNA	PMID:31150632
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1617454	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of AGL mRNA	PMID:31919559
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306376	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of AGL mRNA]	PMID:31150632
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1617454	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of AGL mRNA]	PMID:22206623
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AGL gene	PMID:25304211
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1617454	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of AGL mRNA	PMID:34813904
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:28087	glycogen	affects metabolic processing	EXP		E	RGD:6480464	20160412	CTD	MESH:D006003	AGL protein affects the metabolism of Glycogen	PMID:24700805
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of AGL mRNA	PMID:23195993
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306376	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of AGL mRNA	PMID:21215274|PMID:33387578
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of AGL mRNA	PMID:23179753|PMID:28001369
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of AGL mRNA	PMID:33212167
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of AGL protein	PMID:33212167
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of AGL mRNA	PMID:32763439
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:28748	doxorubicin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	AGL protein affects the susceptibility to Doxorubicin	PMID:16217747
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of AGL gene	PMID:28589171
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of AGL mRNA	PMID:38568856
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of AGL mRNA	PMID:28595984
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of AGL mRNA	PMID:32234424
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1617454	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of AGL mRNA	PMID:19770486
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of AGL 5' UTR	PMID:27901495
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of AGL mRNA	PMID:26014281
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of AGL protein	PMID:25419056
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1617454	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of AGL mRNA	PMID:39716349
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1617454	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of AGL gene; titanium dioxide results in decreased methylation of AGL promoter	PMID:35295148
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306376	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of AGL mRNA	PMID:34492290
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1306376	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of AGL mRNA	PMID:25380136|PMID:30723492
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1617454	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of AGL mRNA	PMID:18445702
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1617454	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of AGL mRNA	PMID:18301758
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306376	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of AGL mRNA	PMID:25181051
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306376	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of AGL mRNA	PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of AGL protein	PMID:37567409
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306376	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AGL mRNA	PMID:36041667
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1617454	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of AGL mRNA	PMID:39298647
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306376	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AGL mRNA	PMID:36041667
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306376	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of AGL mRNA	PMID:36041667
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of AGL protein	PMID:34186270
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1617454	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of AGL intron	PMID:28392331
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1617454	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of AGL mRNA	PMID:37019170
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of AGL mRNA	PMID:37042841
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1306376	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of AGL mRNA	PMID:35163327
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306376	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of AGL mRNA	PMID:35163327
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1306376	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of AGL mRNA	PMID:25380136
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AGL mRNA	PMID:35301059
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1617454	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of AGL mRNA	PMID:37236586
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306376	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of AGL mRNA	PMID:35163327
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of AGL mRNA	PMID:19320972
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306376	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of AGL mRNA	PMID:24386269
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:35807	N-nitrosodimethylamine	decreases expression	ISO	RGD:1306376	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in decreased expression of AGL mRNA	PMID:25380136
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AGL mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of AGL mRNA	PMID:32699268
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of AGL mRNA	PMID:32588087
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of AGL mRNA	PMID:28302478
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of AGL mRNA	PMID:27153767
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of AGL gene	PMID:29154799
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of AGL mRNA	PMID:29154799
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1617454	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of AGL mRNA	PMID:21427059
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:4027	cyclophosphamide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D003520	AGL protein affects the susceptibility to Cyclophosphamide	PMID:16217747
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of AGL mRNA	PMID:20106945|PMID:25562108
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1617454	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of AGL mRNA	PMID:19770486
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:42758	aldehydo-D-glucose	increases uptake	EXP		E	RGD:6480464	20160412	CTD	MESH:D005947	AGL protein results in increased uptake of Glucose	PMID:24700805
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1617454	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of AGL mRNA	PMID:17562736
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of AGL mRNA	PMID:21420995|PMID:29067470
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of AGL gene	PMID:25304211
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306376	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of AGL mRNA	PMID:29391264
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of AGL mRNA	PMID:22079256
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of AGL protein	PMID:25419056
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1617454	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of AGL mRNA	PMID:39716349
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306376	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of AGL mRNA	PMID:30307764
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:50161	motexafin gadolinium	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in decreased expression of AGL mRNA	PMID:16357179
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of AGL mRNA	PMID:16357179
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306376	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of AGL mRNA	PMID:22504374
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1617454	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of AGL mRNA	PMID:23608068
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:53620	methylisothiazolinone	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in decreased expression of AGL mRNA	PMID:31629900
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of AGL protein	PMID:32959892
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:62984	zinc acetate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in decreased expression of AGL mRNA	PMID:16357179
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:62984	zinc acetate	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of AGL mRNA	PMID:16357179
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of AGL protein	PMID:34186270
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1617454	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of AGL mRNA	PMID:22206623
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1617454	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of AGL mRNA]	PMID:22206623
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of AGL mRNA	PMID:22079256
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of AGL mRNA	PMID:22079256
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of AGL mRNA	PMID:30928695
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of AGL mRNA	PMID:19159669
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1617454	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of AGL mRNA	PMID:23091169
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1617454	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of AGL mRNA	PMID:19270015|PMID:19482888
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:8069	phenobarbital	multiple interactions	ISO	RGD:1617454	E	RGD:6480464	20120412	CTD	MESH:D010634	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of AGL mRNA]	PMID:19482888
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1617454	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of AGL mRNA	PMID:31388691
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1306376	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of AGL mRNA	PMID:21394737
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1306376	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of AGL mRNA	PMID:23914054
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:84070	sodium arsenate	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in increased expression of AGL protein	PMID:38348393
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1617454	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of AGL mRNA	PMID:21795629
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1617454	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of AGL mRNA	PMID:21278054
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306376	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of AGL mRNA	PMID:24780913
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306376	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of AGL mRNA	PMID:22504374
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of AGL mRNA	PMID:26014281
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306376	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of AGL mRNA	PMID:21346803
1314958	AGL	amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1617454	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of AGL mRNA	PMID:35537566
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:10106	zearalenone	decreases expression	ISO	RGD:1314961	E	RGD:6480464	20140909	CTD	MESH:D015025	Zearalenone results in decreased expression of KDM4A mRNA	PMID:24412631
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KDM4A mRNA	PMID:38218311
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1314961	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of KDM4A mRNA	PMID:37995155
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:D010100	[cobaltous chloride results in decreased abundance of Oxygen] promotes the reaction [SUMO1 protein binds to KDM4A protein]; [cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of KDM4A protein; KDM4A protein affects the reaction [[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of GPX4 protein]; KDM4A protein affects the reaction [[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of SLC7A11 mRNA]; KDM4A protein affects the reaction [[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of SLC7A11 protein]	PMID:38727079
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314961	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of KDM4A mRNA	PMID:36331819
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:16118	berberine	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D001599	Berberine results in increased expression of KDM4A mRNA	PMID:27311644
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:16243	quercetin	multiple interactions	ISO	RGD:1314961	E	RGD:6480464	20171010	CTD	MESH:D011794	Quercetin inhibits the reaction [sodium arsenite results in increased expression of KDM4A mRNA]	PMID:28414027
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314961	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KDM4A mRNA	PMID:39241906
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314961	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of KDM4A mRNA	PMID:25890327
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314961	E	RGD:6480464	20161228	CTD	MESH:D008070	(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of KDM4A mRNA]; [Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of KDM4A mRNA]	PMID:25890327|PMID:39241906
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of KDM4A mRNA	PMID:31614463
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:16480	nitric oxide	increases expression	EXP		E	RGD:6480464	20140211	CTD	MESH:D009569	Nitric Oxide results in increased expression of KDM4A mRNA	PMID:23546878
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KDM4A mRNA	PMID:37042841
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in increased expression of KDM4A mRNA	PMID:18037150
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KDM4A protein	PMID:37730182
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306378	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KDM4A mRNA	PMID:33387578
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KDM4A mRNA	PMID:28818685
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314961	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of KDM4A mRNA	PMID:36331819
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KDM4A mRNA	PMID:39836092
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KDM4A mRNA	PMID:19549813
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of KDM4A gene; Aflatoxin B1 results in increased methylation of KDM4A intron	PMID:27153756|PMID:30157460
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	ISO	RGD:1314961	E	RGD:6480464	20160119	CTD	MESH:D009151	Mustard Gas results in decreased expression of KDM4A mRNA	PMID:26392148
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314961	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KDM4A mRNA	PMID:31919559
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314961	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KDM4A mRNA	PMID:22206623
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KDM4A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KDM4A mRNA	PMID:39836092
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314961	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KDM4A mRNA	PMID:40504410
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of KDM4A protein	PMID:35688186
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306378	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of KDM4A mRNA	PMID:31881176
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314961	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of KDM4A mRNA	PMID:30912803
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1306378	E	RGD:6480464	20150825	CTD	MESH:D019833	Genistein results in decreased expression of KDM4A protein	PMID:24552547
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KDM4A mRNA	PMID:22574217
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314961	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KDM4A mRNA	PMID:21570461
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314961	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KDM4A mRNA	PMID:19465110
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of KDM4A mRNA	PMID:29955902
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of KDM4A mRNA	PMID:32763439
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306378	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of KDM4A mRNA	PMID:30556269
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of KDM4A mRNA	PMID:29803840
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20210309	CTD	MESH:C017947	sodium arsenite results in decreased expression of KDM4A mRNA	PMID:32844245
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1306378	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of KDM4A mRNA	PMID:30557709|PMID:38578163
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314961	E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in increased expression of KDM4A mRNA	PMID:28414027
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KDM4A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KDM4A mRNA	PMID:39836092
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314961	E	RGD:6480464	20171010	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KDM4A mRNA; Quercetin inhibits the reaction [sodium arsenite results in increased expression of KDM4A mRNA]	PMID:28414027|PMID:40504410
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KDM4A intron; Benzo(a)pyrene affects the methylation of KDM4A promoter	PMID:27901495|PMID:30157460
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KDM4A 5' UTR	PMID:27901495
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KDM4A 3' UTR	PMID:27901495
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to KDM4A mRNA]	PMID:32406909
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306378	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of KDM4A mRNA	PMID:30556269
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306378	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of KDM4A mRNA	PMID:30047161
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314961	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of KDM4A mRNA	PMID:23557971
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306378	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KDM4A mRNA	PMID:25181051
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306378	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of KDM4A mRNA	PMID:36041667
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314961	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of KDM4A mRNA	PMID:39298647
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306378	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of KDM4A mRNA	PMID:36041667
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of KDM4A intron	PMID:30157460
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306378	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of KDM4A mRNA	PMID:36041667
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314961	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of KDM4A mRNA	PMID:37019170
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314961	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KDM4A mRNA	PMID:21266533
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306378	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of KDM4A gene	PMID:33148267
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314961	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of KDM4A mRNA]	PMID:39241906
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KDM4A mRNA	PMID:39836092
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:35696	cobalt dichloride	decreases activity	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased activity of KDM4A protein	PMID:19376846
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of KDM4A mRNA	PMID:19320972
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20250506	CTD	MESH:C018021	[cobaltous chloride results in decreased abundance of Oxygen] promotes the reaction [SUMO1 protein binds to KDM4A protein]; [cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of KDM4A protein; KDM4A protein affects the reaction [[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of GPX4 protein]; KDM4A protein affects the reaction [[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of SLC7A11 mRNA]; KDM4A protein affects the reaction [[cobaltous chloride results in decreased abundance of Oxygen] which results in increased expression of SLC7A11 protein]	PMID:38727079
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:3764	clotrimazole	decreases expression	ISO	RGD:1306378	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in decreased expression of KDM4A mRNA	PMID:30047161
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of KDM4A mRNA	PMID:31533062
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314961	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of KDM4A mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of KDM4A mRNA	PMID:36331819
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1314961	E	RGD:6480464	20120515	CTD	MESH:C031763	1,3-butadiene results in increased expression of KDM4A protein	PMID:21147608
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KDM4A mRNA	PMID:25979313
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of KDM4A mRNA	PMID:29154799
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306378	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of KDM4A mRNA	PMID:30047161
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:4356	desferrioxamine B	multiple interactions	EXP		E	RGD:6480464	20140715	CTD	MESH:D003676	Deferoxamine results in decreased expression of and results in decreased activity of KDM4A protein	PMID:23483119
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of KDM4A mRNA	PMID:27188386
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:46024	trichostatin A	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in decreased activity of KDM4A protein	PMID:15927959
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in decreased expression of KDM4A mRNA	PMID:15927959
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C012589	trichostatin A results in increased expression of KDM4A mRNA	PMID:15927959
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306378	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KDM4A mRNA	PMID:33387578
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:46666	crocidolite asbestos	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased methylation of KDM4A 5' UTR	PMID:29523930
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KDM4A mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KDM4A mRNA	PMID:39836092
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314961	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of KDM4A mRNA	PMID:40504410
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314961	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of KDM4A mRNA	PMID:25620056
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306378	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of KDM4A mRNA	PMID:30047161
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314961	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of KDM4A mRNA	PMID:35964746
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314961	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of KDM4A mRNA	PMID:19042947
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of KDM4A mRNA	PMID:39836092
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314961	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of KDM4A mRNA	PMID:23650126
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of KDM4A mRNA	PMID:28988120
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of KDM4A intron	PMID:30157460
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306378	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of KDM4A gene	PMID:35440735
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306378	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of KDM4A gene	PMID:33148267
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1314961	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of KDM4A mRNA	PMID:22206623
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1306378	E	RGD:6480464	20180220	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KDM4A mRNA	PMID:27840820
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314961	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KDM4A mRNA	PMID:22206623
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of KDM4A protein	PMID:31285264
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KDM4A gene]	PMID:28238834
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1314961	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of KDM4A mRNA	PMID:39847705
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306378	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KDM4A mRNA	PMID:30047161
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314961	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of KDM4A mRNA]	PMID:39241906
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of KDM4A mRNA	PMID:38568856
1314960	KDM4A	lysine demethylase 4A	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306378	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of KDM4A mRNA	PMID:23034163
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of HS3ST5 mRNA	PMID:27188386
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of HS3ST5 mRNA	PMID:26272509
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST5 mRNA	PMID:27188386
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of HS3ST5 mRNA	PMID:34925699
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1616451	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of HS3ST5 mRNA	PMID:26251327
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases methylation	ISO	RGD:1616451	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased methylation of HS3ST5 promoter	PMID:26251327
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of HS3ST5 mRNA	PMID:23724009
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of HS3ST5 mRNA	PMID:21632981
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HS3ST5 mRNA	PMID:35811015
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of HS3ST5 mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of HS3ST5 mRNA]	PMID:35811015
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306379	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of HS3ST5 mRNA	PMID:33387578
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306379	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of HS3ST5 mRNA	PMID:33387578
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of HS3ST5 mRNA	PMID:28818685
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of HS3ST5 mRNA	PMID:19549813
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of HS3ST5 mRNA	PMID:26272509
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST5 mRNA	PMID:27188386
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1306379	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of HS3ST5 gene	PMID:31011160
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1616451	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of HS3ST5 mRNA	PMID:28960355
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306379	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HS3ST5 mRNA	PMID:32109520
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306379	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HS3ST5 mRNA	PMID:33387578
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of HS3ST5 mRNA	PMID:20971185
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HS3ST5 promoter	PMID:27901495
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HS3ST5 mRNA	PMID:22316170
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of HS3ST5 mRNA	PMID:20971185
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1616451	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of HS3ST5 gene	PMID:35295148
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1616451	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of HS3ST5 mRNA	PMID:19710929
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306379	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of HS3ST5 mRNA	PMID:30816183|PMID:32528016
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1616451	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of HS3ST5 exon	PMID:33297965
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306379	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of HS3ST5 mRNA	PMID:35163327
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306379	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of HS3ST5 mRNA	PMID:35163327
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1616451	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of HS3ST5 mRNA	PMID:40194260
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of HS3ST5 mRNA	PMID:31533062
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of HS3ST5 mRNA	PMID:24383497|PMID:26272509|PMID:28001369
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST5 mRNA	PMID:27188386
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of HS3ST5 mRNA	PMID:25562108
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of HS3ST5 mRNA	PMID:38832940
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of HS3ST5 mRNA	PMID:27188386
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of HS3ST5 mRNA	PMID:24935251
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306379	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HS3ST5 mRNA	PMID:33387578
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of HS3ST5 mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of HS3ST5 mRNA]	PMID:35811015
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1616451	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of HS3ST5 mRNA	PMID:23608068
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1306379	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of HS3ST5 mRNA	PMID:20080153
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of HS3ST5 mRNA	PMID:28988120
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1306379	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in decreased expression of HS3ST5 mRNA	PMID:27840820
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST5 mRNA	PMID:27188386
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to HS3ST5 gene]	PMID:28238834
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306379	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of HS3ST5 mRNA	PMID:32109520
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306379	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of HS3ST5 mRNA	PMID:24780913
1314962	HS3ST5	heparan sulfate-glucosamine 3-sulfotransferase 5	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HS3ST5 mRNA	PMID:27188386
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of GULP1 mRNA	PMID:38218311
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in decreased expression of GULP1 mRNA	PMID:25152437
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:132889	graphene oxide	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C000628730	graphene oxide results in increased expression of GULP1 protein	PMID:33219560|PMID:33219585
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of GULP1 mRNA	PMID:23724009
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314964	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GULP1 mRNA	PMID:30529165
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314964	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GULP1 mRNA	PMID:36331819
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of GULP1 mRNA	PMID:26079696
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306380	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of GULP1 gene	PMID:35440735
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of GULP1 mRNA	PMID:22378314
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:16236	ethanol	decreases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:D000431	Ethanol results in decreased expression of GULP1 mRNA	PMID:23378141
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of GULP1 mRNA	PMID:21632981
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in decreased expression of GULP1 mRNA	PMID:19167446|PMID:21185374|PMID:24758408
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D004958	Estradiol results in increased expression of GULP1 mRNA	PMID:23397585
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	EGF protein inhibits the reaction [Estradiol results in decreased expression of GULP1 mRNA]	PMID:24758408
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1314964	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of GULP1 mRNA	PMID:37992649
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314964	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of GULP1 mRNA	PMID:22401849
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1314964	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of GULP1 mRNA	PMID:37992649
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306380	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GULP1 mRNA	PMID:33387578
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014284	Triiodothyronine results in decreased expression of GULP1 mRNA	PMID:23397585
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GULP1 mRNA	PMID:39836092
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of GULP1 mRNA	PMID:19549813
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of GULP1 protein	PMID:20106945
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of GULP1 mRNA	PMID:22100608
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of GULP1 mRNA	PMID:25378103
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GULP1 gene	PMID:27153756
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314964	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GULP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of GULP1 mRNA	PMID:27106289|PMID:34911549
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1314964	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of GULP1 mRNA	PMID:17484886
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GULP1 mRNA	PMID:21867686
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314964	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of GULP1 mRNA]	PMID:22206623
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GULP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GULP1 mRNA	PMID:39836092
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of GULP1 mRNA	PMID:19244175
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of GULP1 mRNA	PMID:26272509
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GULP1 mRNA	PMID:27188386
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of GULP1 mRNA	PMID:27392435
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of GULP1 mRNA	PMID:22023808
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in increased expression of GULP1 mRNA	PMID:21858171
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GULP1 mRNA	PMID:32109520
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314964	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GULP1 mRNA	PMID:19933214
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of GULP1 protein	PMID:39603559
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of GULP1 mRNA	PMID:28001369
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of GULP1 mRNA	PMID:28001369
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GULP1 mRNA	PMID:33212167
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GULP1 mRNA	PMID:30851411
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of GULP1 mRNA	PMID:28959563
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of GULP1 mRNA	PMID:20971185
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of GULP1 mRNA	PMID:16001973|PMID:29803840
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1314964	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of GULP1 mRNA	PMID:37992649
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:28939	N-acetyl-L-cysteine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine results in decreased expression of GULP1 mRNA	PMID:16084531
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of GULP1 mRNA	PMID:34032870
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of GULP1 mRNA	PMID:22714537|PMID:38568856
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GULP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GULP1 mRNA	PMID:39836092
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:29865	benzo[a]pyrene	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene affects the expression of GULP1 mRNA	PMID:21714911
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GULP1 5' UTR	PMID:27901495
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GULP1 mRNA	PMID:32234424
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314964	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GULP1 mRNA	PMID:20713471
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to GULP1 mRNA]	PMID:32406909
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of GULP1 mRNA	PMID:20971185
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of GULP1 mRNA	PMID:25895662
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GULP1 mRNA	PMID:20018196
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	GULP1 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of GULP1 gene	PMID:31601247
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in decreased expression of GULP1 mRNA	PMID:22641619
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314964	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GULP1 gene	PMID:35295148
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314964	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of GULP1 mRNA	PMID:20813756
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GULP1 mRNA	PMID:19710929
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314964	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid co-treated with PPARA] results in decreased expression of GULP1 mRNA	PMID:20813756
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GULP1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306380	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in increased expression of GULP1 mRNA	PMID:33296240
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1314964	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of GULP1 mRNA	PMID:30951980
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of GULP1 gene	PMID:31601247
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of GULP1 mRNA	PMID:25979313
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1314964	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of GULP1 mRNA	PMID:26682919
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:34342	3-methylcholanthrene	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008748	Methylcholanthrene results in increased expression of GULP1 mRNA	PMID:23397585
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314964	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of GULP1 mRNA	PMID:30951980
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314964	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of GULP1 mRNA	PMID:30951980
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314964	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of GULP1 intron	PMID:28392331
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314964	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GULP1 mRNA	PMID:37019170
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:34714	dimethoate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D004117	Dimethoate results in increased expression of GULP1 mRNA	PMID:23397585
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of GULP1 mRNA	PMID:32680482
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306380	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of GULP1 gene	PMID:33148267
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306380	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of GULP1 mRNA	PMID:35163327
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GULP1 mRNA	PMID:39836092
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306380	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of GULP1 mRNA	PMID:25380136
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GULP1 mRNA	PMID:38568856
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1306380	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of GULP1 promoter	PMID:22457795
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306380	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of GULP1 mRNA	PMID:35163327
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of GULP1 mRNA	PMID:19244175
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of GULP1 mRNA	PMID:31533062
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of GULP1 mRNA	PMID:19167446
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GULP1 mRNA	PMID:19167446
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of GULP1 mRNA	PMID:40419075
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314964	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GULP1 mRNA	PMID:36331819
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of GULP1 mRNA	PMID:25979313
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of GULP1 mRNA	PMID:28001369|PMID:29154799
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:40036	amitrole	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D000640	Amitrole results in increased expression of GULP1 mRNA	PMID:23397585
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of GULP1 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1314964	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in decreased expression of GULP1 mRNA	PMID:22733784
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314964	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of GULP1 mRNA	PMID:28973697
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1314964	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of GULP1 mRNA	PMID:37992649
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of GULP1 mRNA	PMID:24935251
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of GULP1 mRNA	PMID:24935251
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GULP1 mRNA	PMID:33387578
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GULP1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GULP1 mRNA	PMID:39836092
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of GULP1 mRNA	PMID:16084531
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1314964	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of GULP1 mRNA	PMID:35436446
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of GULP1 mRNA	PMID:18175754
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of GULP1 mRNA	PMID:32234424
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of GULP1 mRNA	PMID:26272509
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GULP1 mRNA	PMID:27188386
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	GULP1 protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:5014	fenvalerate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:C017690	fenvalerate results in decreased expression of GULP1 mRNA	PMID:23397585
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314964	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GULP1 mRNA; Nanotubes, Carbon results in decreased expression of GULP1 mRNA	PMID:25554681
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:50673	methimazole	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008713	Methimazole results in increased expression of GULP1 mRNA	PMID:23397585
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of GULP1 mRNA	PMID:19162173
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of GULP1 mRNA	PMID:22714537
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20120613	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of GULP1 mRNA	PMID:21893156
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1314964	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of GULP1 mRNA	PMID:19042947
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20120613	CTD	MESH:D010081	Oxazolone results in decreased expression of GULP1 mRNA	PMID:21893156
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:6076	itraconazole	decreases expression	ISO	RGD:1314964	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in decreased expression of GULP1 mRNA	PMID:31099283
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GULP1 mRNA	PMID:39836092
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of GULP1 mRNA	PMID:15336504
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in increased expression of GULP1 mRNA	PMID:22101062
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306380	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of GULP1 gene	PMID:33148267
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of GULP1 mRNA	PMID:31758290
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314964	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GULP1 mRNA	PMID:22206623
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314964	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of GULP1 mRNA]	PMID:22206623
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of GULP1 protein	PMID:37664457
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of GULP1 mRNA	PMID:22714537
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of GULP1 mRNA	PMID:30851411
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:78492	diallyl trisulfide	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C042577	diallyl trisulfide results in decreased expression of GULP1 mRNA	PMID:34995734
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GULP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GULP1 mRNA	PMID:27188386
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of GULP1 mRNA	PMID:30928695
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of GULP1 mRNA	PMID:32109520
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GULP1 mRNA	PMID:19167446
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in increased expression of GULP1 mRNA	PMID:21858171
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1314964	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of GULP1 mRNA	PMID:21795629
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306380	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GULP1 mRNA	PMID:24780913|PMID:25825206
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1314964	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of GULP1 mRNA	PMID:40826991
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of GULP1 protein; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GULP1 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GULP1 mRNA	PMID:27188386|PMID:37664457
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:94366	2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one	decreases expression	ISO	RGD:1314964	E	RGD:6480464	20230606	CTD	MESH:D017964	Itraconazole results in decreased expression of GULP1 mRNA	PMID:31099283
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of GULP1 mRNA	PMID:38568856
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1314964	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of GULP1 mRNA	PMID:26217789
1314963	GULP1	GULP PTB domain containing engulfment adaptor 1	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of GULP1 mRNA	PMID:27188386
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1596058	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TAF1B mRNA]	PMID:31150632
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of TAF1B mRNA	PMID:22378314
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1596058	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of TAF1B mRNA	PMID:32145629
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:16602	trichloroethene	increases expression	EXP		E	RGD:6480464	20130416	CTD	MESH:D014241	Trichloroethylene results in increased expression of TAF1B protein	PMID:22771849
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TAF1B mRNA	PMID:21179406
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TAF1B mRNA	PMID:35301059
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of TAF1B mRNA	PMID:19549813
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1596058	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of TAF1B mRNA	PMID:31150632
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1596058	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TAF1B mRNA]	PMID:31150632
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TAF1B mRNA	PMID:39836092
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of TAF1B mRNA	PMID:26272509
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAF1B mRNA	PMID:27188386
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TAF1B mRNA	PMID:23557933
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of TAF1B mRNA	PMID:19921347
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314967	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TAF1B mRNA	PMID:24680724
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TAF1B mRNA	PMID:33212167
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of TAF1B mRNA	PMID:39709020
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TAF1B mRNA	PMID:30851411
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TAF1B mRNA	PMID:39836092
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TAF1B promoter	PMID:27901495
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to TAF1B mRNA]	PMID:32406909
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of TAF1B mRNA	PMID:25895662
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314967	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of TAF1B mRNA	PMID:18648102
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1596058	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TAF1B mRNA	PMID:25181051
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF1B mRNA	PMID:29275510
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1596058	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of TAF1B mRNA	PMID:41034487
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1314967	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of TAF1B mRNA	PMID:39298647
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1314967	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TAF1B mRNA	PMID:28392331
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314967	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of TAF1B mRNA	PMID:17361019
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TAF1B mRNA	PMID:37042841
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TAF1B mRNA	PMID:38568856
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TAF1B mRNA	PMID:35301059
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of TAF1B mRNA	PMID:19320972
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TAF1B mRNA	PMID:28302478
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of TAF1B mRNA	PMID:23179753|PMID:26272509|PMID:27188386
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAF1B mRNA	PMID:27188386
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314967	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of TAF1B mRNA	PMID:29279043
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TAF1B mRNA	PMID:39836092
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TAF1B mRNA	PMID:22079256
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in decreased expression of TAF1B mRNA	PMID:16780908
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:53070	2,4-dinitrobenzenesulfonic acid	decreases expression	ISO	RGD:1314967	E	RGD:6480464	20190910	CTD	MESH:C001073	2,4-dinitrobenzenesulfonic acid results in decreased expression of TAF1B mRNA	PMID:30116771
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:53070	2,4-dinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1314967	E	RGD:6480464	20190910	CTD	MESH:C001073	[2,4-dinitrobenzenesulfonic acid co-treated with GR 159897] results in increased expression of TAF1B mRNA	PMID:30116771
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of TAF1B mRNA	PMID:31758290
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of TAF1B mRNA	PMID:22079256
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of TAF1B mRNA	PMID:22079256
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of TAF1B mRNA	PMID:30851411
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAF1B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAF1B mRNA	PMID:27188386
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAF1B mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TAF1B mRNA	PMID:27188386
1314966	TAF1B	TATA-box binding protein associated factor, RNA polymerase I subunit B	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of TAF1B mRNA	PMID:29301935
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of KRTAP3-1 mRNA	PMID:22574217
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in decreased expression of KRTAP3-1 mRNA	PMID:20106945|PMID:21632981
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1620002	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in decreased expression of KRTAP3-1 mRNA	PMID:19693291
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1620002	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in increased expression of KRTAP3-1 mRNA	PMID:19693291
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of KRTAP3-1 mRNA	PMID:28818685
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KRTAP3-1 mRNA	PMID:19549813
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of KRTAP3-1 mRNA	PMID:21632981|PMID:21641981
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of KRTAP3-1 mRNA	PMID:38460933
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of KRTAP3-1 mRNA	PMID:23557933
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KRTAP3-1 mRNA	PMID:20106945|PMID:21632981
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of KRTAP3-1 mRNA	PMID:39719251
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KRTAP3-1 promoter	PMID:27901495
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KRTAP3-1 mRNA	PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of KRTAP3-1 mRNA	PMID:26014281
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of KRTAP3-1 mRNA	PMID:26238291
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of KRTAP3-1 gene	PMID:31601247
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1620002	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of KRTAP3-1 mRNA	PMID:29264374
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1596817	E	RGD:6480464	20160712	CTD	MESH:C006780	bisphenol A results in decreased expression of KRTAP3-1 mRNA	PMID:25181051
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of KRTAP3-1 gene	PMID:31601247
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of KRTAP3-1 mRNA	PMID:29024780
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1596817	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KRTAP3-1 mRNA	PMID:35163327
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1596817	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRTAP3-1 mRNA	PMID:35163327
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1596817	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRTAP3-1 mRNA	PMID:35163327
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1620002	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of KRTAP3-1 mRNA	PMID:17585979
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1620002	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KRTAP3-1 mRNA	PMID:22206623
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of KRTAP3-1 mRNA	PMID:35486664
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C087114	tebuconazole results in decreased expression of KRTAP3-1 mRNA	PMID:30458266
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of KRTAP3-1 mRNA	PMID:24921660
1314968	KRTAP3-1	keratin associated protein 3-1	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of KRTAP3-1 mRNA	PMID:26014281
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1552155	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of TRMT11 mRNA	PMID:33045310
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TRMT11 mRNA	PMID:21632981
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TRMT11 mRNA	PMID:37042841
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of TRMT11 mRNA	PMID:19162166
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TRMT11 mRNA	PMID:21179406
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TRMT11 protein	PMID:23301498
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552155	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of TRMT11 mRNA	PMID:25629700
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TRMT11 mRNA	PMID:19244175
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of TRMT11 mRNA	PMID:23557933
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1552155	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of TRMT11 mRNA	PMID:30912803
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TRMT11 mRNA	PMID:20106945|PMID:21632981
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of TRMT11 protein	PMID:33212167
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of TRMT11 mRNA	PMID:32763439
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of TRMT11 mRNA	PMID:35984750
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:727798	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of TRMT11 mRNA	PMID:23411599
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TRMT11 mRNA	PMID:19710929
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:727798	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TRMT11 mRNA	PMID:25181051
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of TRMT11 mRNA	PMID:19244175
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552155	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of TRMT11 intron	PMID:28392331
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of TRMT11 mRNA	PMID:19244175
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TRMT11 mRNA	PMID:28302478
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TRMT11 mRNA	PMID:31533062
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TRMT11 mRNA	PMID:27153767
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TRMT11 mRNA	PMID:25979313
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552155	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of TRMT11 mRNA	PMID:17292431
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of TRMT11 mRNA	PMID:23179753|PMID:24935251|PMID:25192806|PMID:26272509|PMID:27188386|PMID:28001369
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRMT11 mRNA	PMID:27188386
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TRMT11 mRNA	PMID:20106945|PMID:25562108
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRMT11 mRNA	PMID:27188386
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1552155	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of TRMT11 mRNA	PMID:40826991
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TRMT11 mRNA	PMID:27188386
1314969	TRMT11	tRNA methyltransferase 11	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:727798	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TRMT11 mRNA	PMID:21346803
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1618114	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of BICRA mRNA	PMID:33045310
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of BICRA mRNA	PMID:26079696
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of BICRA mRNA	PMID:22378314
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1618114	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of BICRA mRNA	PMID:30319688
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1618114	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of BICRA mRNA	PMID:39241906
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol affects the expression of BICRA mRNA	PMID:22574217
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306385	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of BICRA gene	PMID:27618143
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of BICRA mRNA	PMID:21179406
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of BICRA mRNA	PMID:26079696
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1618114	E	RGD:6480464	20121009	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of BICRA mRNA	PMID:22401849
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1618114	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of BICRA mRNA	PMID:34319233
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of BICRA protein	PMID:37730182
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306385	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of BICRA mRNA	PMID:33387578
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of BICRA intron	PMID:30157460
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1618114	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BICRA mRNA	PMID:36331819
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1618114	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BICRA mRNA	PMID:28111341
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BICRA mRNA	PMID:19244175
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of BICRA mRNA	PMID:23557933
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of BICRA mRNA	PMID:27392435
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of BICRA mRNA	PMID:27392435
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1618114	E	RGD:6480464	20210608	CTD	MESH:D014414	Tungsten results in decreased expression of BICRA mRNA	PMID:30912803
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BICRA mRNA	PMID:22574217
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306385	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BICRA mRNA	PMID:22298810
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618114	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BICRA mRNA	PMID:21570461
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of BICRA mRNA	PMID:38568856
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20210608	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of BICRA promoter	PMID:27901495
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of BICRA gene	PMID:31601247
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306385	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of BICRA mRNA	PMID:32145629
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of BICRA gene	PMID:31601247
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of BICRA gene	PMID:31601247
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BICRA mRNA	PMID:37042841
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1306385	E	RGD:6480464	20130806	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of BICRA promoter	PMID:22457795
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1618114	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BICRA mRNA	PMID:28111341
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BICRA mRNA	PMID:19244175
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000944	dicrotophos results in increased expression of BICRA mRNA	PMID:28302478
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1618114	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BICRA mRNA	PMID:36331819
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1618114	E	RGD:6480464	20210608	CTD	MESH:C031763	1,3-butadiene results in decreased expression of BICRA mRNA	PMID:29038090
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20210608	CTD	MESH:D014635	Valproic Acid results in increased methylation of BICRA gene	PMID:29154799
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306385	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of BICRA mRNA	PMID:33387578
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1618114	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of BICRA mRNA	PMID:35436446
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of BICRA mRNA	PMID:18175754
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of BICRA mRNA	PMID:31758290
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:81781	tebuconazole	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C087114	tebuconazole results in decreased expression of BICRA mRNA	PMID:30458266
1314970	BICRA	BRD4 interacting chromatin remodeling complex associated protein	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1618114	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of BICRA mRNA	PMID:40826991
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of BCL3 mRNA	PMID:38218311
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of BCL3 mRNA	PMID:25596134
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of BCL3 mRNA	PMID:33045310
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:132844	glycidyl methacrylate	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in increased expression of BCL3 protein	PMID:36641056
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of BCL3 mRNA	PMID:26251327
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of BCL3 mRNA	PMID:17045167
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol S co-treated with Tretinoin] results in decreased expression of BCL3 mRNA	PMID:30951980
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of BCL3 mRNA	PMID:25596134
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D010100	Oxygen deficiency results in increased expression of BCL3 mRNA	PMID:23452621
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D010100	3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]; Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]; Genistein inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]; Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]	PMID:23452621
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BCL3 mRNA	PMID:30529165
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of BCL3 mRNA	PMID:36331819
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of BCL3 mRNA	PMID:26079696
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of BCL3 mRNA	PMID:39506029
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of BCL3 protein	PMID:28073184
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of BCL3 mRNA	PMID:20044591
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of BCL3 mRNA	PMID:32714076
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20240109	CTD	MESH:D006861	cordycepin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL3 mRNA]	PMID:32714076
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of BCL3 mRNA	PMID:25725100|PMID:35811015
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314972	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of BCL3 mRNA	PMID:25890327|PMID:39241906
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of BCL3 mRNA]; [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of BCL3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of BCL3 mRNA	PMID:25725100|PMID:35811015
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D004958	Estradiol results in decreased expression of BCL3 mRNA	PMID:23373633
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1589465	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of BCL3 mRNA	PMID:32145629
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of BCL3 mRNA	PMID:31614463
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1314972	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of BCL3 mRNA	PMID:39298647
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol inhibits the reaction [IL1B protein results in increased expression of BCL3 mRNA]	PMID:12072388
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1589465	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BCL3 mRNA	PMID:32741896
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of BCL3 mRNA	PMID:38568856
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of BCL3 mRNA	PMID:37042841
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of BCL3 mRNA	PMID:20655997
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16856	glutathione	decreases expression	ISO	RGD:1589465	E	RGD:6480464	20120918	CTD	MESH:D005978	Glutathione deficiency results in decreased expression of BCL3 mRNA	PMID:20621112
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of BCL3 mRNA	PMID:24530881
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:16971	benzene-1,2,4-triol	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:C013038	4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in increased expression of BCL3 mRNA]	PMID:24530881
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of BCL3 mRNA	PMID:17251523
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:17234	glucose	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in decreased expression of BCL3 mRNA	PMID:39613055
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of BCL3 mRNA	PMID:17945193
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of BCL3 mRNA	PMID:28973375
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1589465	E	RGD:6480464	20120412	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BCL3 mRNA; Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BCL3 mRNA]	PMID:20032058|PMID:32741896
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:17634	D-glucose	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in decreased expression of BCL3 mRNA	PMID:39613055
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of BCL3 mRNA	PMID:34319233
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of BCL3 mRNA	PMID:19850644
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of BCL3 mRNA]	PMID:19850644
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1589465	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of BCL3 mRNA	PMID:27523638
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1589465	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of BCL3 mRNA	PMID:22061828
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of BCL3 mRNA	PMID:28818685
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:18248	iron atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007501	Iron deficiency results in increased expression of BCL3 mRNA	PMID:20368581
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	ISO	RGD:1589465	E	RGD:6480464	20121009	CTD	MESH:D014284	Triiodothyronine results in increased expression of BCL3 mRNA	PMID:22015988
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1589465	E	RGD:6480464	20251104	CTD	MESH:D002104	Cadmium results in increased expression of BCL3 protein	PMID:35316447
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of BCL3 mRNA	PMID:37236586
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1589465	E	RGD:6480464	20251104	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BCL3 protein; carvacrol inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BCL3 protein]; carvacrol inhibits the reaction [Cadmium results in increased expression of BCL3 protein]	PMID:33989663|PMID:35316447
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:233355	4-aminobenzohydrazide	multiple interactions	EXP		E	RGD:6480464	20250408	CTD	MESH:C034343	4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in increased expression of BCL3 mRNA]	PMID:24530881
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of BCL3 mRNA	PMID:19549813
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314972	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BCL3 mRNA	PMID:19770486
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1589465	E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BCL3 mRNA	PMID:25378103
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:25187	p-menthan-3-ol	increases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in increased expression of BCL3 mRNA	PMID:26760959
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of BCL3 mRNA	PMID:23033980
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of BCL3 mRNA	PMID:35430440
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20150609	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of BCL3 mRNA; [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of BCL3 mRNA	PMID:25658374|PMID:34911549
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:26523	reactive oxygen species	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017382	Reactive Oxygen Species results in decreased expression of BCL3 mRNA	PMID:25800948
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:2663	amiodarone	increases expression	ISO	RGD:1589465	E	RGD:6480464	20121009	CTD	MESH:D000638	Amiodarone results in increased expression of BCL3 mRNA	PMID:22015988
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of BCL3 mRNA	PMID:18593933
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314972	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BCL3 mRNA	PMID:31919559
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BCL3 mRNA	PMID:22206623
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BCL3 mRNA	PMID:19244175
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of BCL3 protein	PMID:35688186
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of BCL3 mRNA	PMID:25596134
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in decreased expression of BCL3 mRNA; resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]	PMID:19167446|PMID:23452621
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1589465	E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Streptozocin] results in increased expression of BCL3 mRNA	PMID:25905778
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of BCL3 mRNA	PMID:28903495
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in increased expression of BCL3 mRNA	PMID:25596134
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314972	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of BCL3 mRNA	PMID:40618947
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1589465	E	RGD:6480464	20141223	CTD	MESH:D002945	Cisplatin results in increased expression of BCL3 mRNA	PMID:24880025
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of BCL3 mRNA	PMID:30912803
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28088	genistein	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D019833	Genistein inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]	PMID:23452621
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein inhibits the reaction [IL1B protein results in increased expression of BCL3 mRNA]	PMID:12072388
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of BCL3 mRNA	PMID:23195993|PMID:24768652|PMID:25583101
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1589465	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BCL3 mRNA	PMID:22298810
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BCL3 mRNA	PMID:12377990|PMID:20106945|PMID:21632981|PMID:22903824
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1314972	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BCL3 mRNA	PMID:18684927|PMID:24058054
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1589465	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BCL3 mRNA	PMID:33387578
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of BCL3 mRNA	PMID:25975270
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of BCL3 mRNA	PMID:33512557
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of BCL3 mRNA	PMID:32178731
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1589465	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of BCL3 mRNA	PMID:28374803
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28216	methylmercury chloride	increases expression	ISO	RGD:1589465	E	RGD:6480464	20200211	CTD	MESH:C004925	methylmercuric chloride results in increased expression of BCL3 mRNA	PMID:31378766
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of BCL3 mRNA	PMID:33212167
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of BCL3 mRNA	PMID:29803840
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314972	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in increased expression of BCL3 mRNA	PMID:26873546
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20160607	CTD	MESH:D004317	[Doxorubicin co-treated with Dexrazoxane] results in decreased expression of BCL3 mRNA	PMID:26873546
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of BCL3 mRNA	PMID:29432896
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:29014	cordycepin	multiple interactions	EXP		E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL3 mRNA]	PMID:32714076
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:29678	sodium arsenite	affects localization	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the localization of BCL3 protein	PMID:20420878
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of BCL3 mRNA	PMID:38568856
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of BCL3 protein	PMID:20420878|PMID:23562784
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314972	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of BCL3 mRNA	PMID:37682722
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	MIR2909 mRNA affects the reaction [sodium arsenite results in increased expression of BCL3 protein]; sodium arsenite promotes the reaction [[NFKB2 protein binds to BCL3 protein] which results in increased expression of CCND1 protein]; sodium arsenite promotes the reaction [NFKB2 protein binds to BCL3 protein]	PMID:20420878|PMID:23562784
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of BCL3 mRNA	PMID:17127020
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of BCL3 mRNA	PMID:19770486
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BCL3 mRNA	PMID:20106945|PMID:22316170
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL3 mRNA	PMID:27858113
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of BCL3 mRNA	PMID:18593933
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:3020	benzalkonium chloride	increases expression	ISO	RGD:1314972	E	RGD:6480464	20190219	CTD	MESH:D001548	Benzalkonium Compounds results in increased expression of BCL3 mRNA	PMID:30171875
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of BCL3 mRNA	PMID:25895662
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1314972	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of BCL3 mRNA	PMID:23221170|PMID:29341224
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BCL3 mRNA	PMID:20018196|PMID:20382639
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	[Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of BCL3 mRNA	PMID:20471514
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1589465	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of BCL3 mRNA	PMID:24136188
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1589465	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of BCL3 mRNA	PMID:25729387
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of BCL3 mRNA	PMID:29264374
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314972	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BCL3 gene	PMID:35295148
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314972	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of BCL3 mRNA	PMID:27760801
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314972	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of BCL3 promoter	PMID:35295148
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of BCL3 mRNA	PMID:17426115
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of BCL3 mRNA	PMID:18445702
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of BCL3 mRNA	PMID:19191707
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL3 mRNA; SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL3 mRNA]	PMID:28329830
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314972	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of BCL3 promoter	PMID:27334623
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of BCL3 mRNA	PMID:33221593
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1589465	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of BCL3 mRNA	PMID:34947998
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1589465	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of BCL3 mRNA	PMID:25181051
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1589465	E	RGD:6480464	20121009	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of BCL3 mRNA	PMID:22015988
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1314972	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of BCL3 mRNA	PMID:26682919
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314972	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of BCL3 mRNA	PMID:39298647
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with Tretinoin] results in decreased expression of BCL3 mRNA	PMID:30951980
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:3440	carvacrol	multiple interactions	ISO	RGD:1589465	E	RGD:6480464	20251104	CTD	MESH:C073316	carvacrol inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BCL3 protein]; carvacrol inhibits the reaction [Cadmium results in increased expression of BCL3 protein]	PMID:33989663|PMID:35316447
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL3 mRNA	PMID:27858113
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314972	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of BCL3 mRNA	PMID:30951980
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314972	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of BCL3 exon	PMID:28392331
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314972	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of BCL3 mRNA	PMID:37019170
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of BCL3 gene	PMID:22964155
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1589465	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of BCL3 mRNA	PMID:22546817
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1589465	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of BCL3 mRNA	PMID:22546817
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1589465	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of BCL3 mRNA	PMID:32680482
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BCL3 mRNA	PMID:37042841
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of BCL3 mRNA	PMID:29024780
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of BCL3 mRNA	PMID:16269432
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1589465	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of BCL3 mRNA	PMID:30723492
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1589465	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of BCL3 mRNA	PMID:25993096
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of BCL3 mRNA	PMID:37236586
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1589465	E	RGD:6480464	20260804	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BCL3 protein; carvacrol inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of BCL3 protein]	PMID:33989663
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1589465	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in decreased expression of BCL3 mRNA	PMID:25539665
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of BCL3 mRNA	PMID:24449571
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of BCL3 mRNA	PMID:19244175
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of BCL3 mRNA	PMID:40194260
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of BCL3 mRNA	PMID:28302478
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of BCL3 mRNA	PMID:40434365
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL3 mRNA; [Coumestrol co-treated with resveratrol] results in decreased expression of BCL3 mRNA	PMID:19167446
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of BCL3 mRNA	PMID:36331819
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of BCL3 mRNA	PMID:29038090
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1589465	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of BCL3 mRNA	PMID:25993096
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20150310	CTD	MESH:D003474	Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of BCL3 mRNA]	PMID:23452621
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL3 mRNA]	PMID:18200517
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of BCL3 mRNA	PMID:29154799
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of BCL3 gene	PMID:29154799
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of BCL3 mRNA	PMID:25596134
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1314972	E	RGD:6480464	20140114	CTD	MESH:D016572	Cyclosporine results in increased expression of BCL3 mRNA	PMID:23958496
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of BCL3 mRNA	PMID:20937368
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:41879	dexamethasone	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in decreased expression of BCL3 mRNA	PMID:25047013
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:41879	dexamethasone	decreases expression	ISO	RGD:1589465	E	RGD:6480464	20120412	CTD	MESH:D003907	Dexamethasone results in decreased expression of BCL3 mRNA	PMID:20032058
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1589465	E	RGD:6480464	20120412	CTD	MESH:D003907	Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BCL3 mRNA]	PMID:20032058
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1314972	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of BCL3 mRNA	PMID:28973697
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:42758	aldehydo-D-glucose	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in decreased expression of BCL3 mRNA	PMID:39613055
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of BCL3 mRNA	PMID:24449571
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of BCL3 mRNA]	PMID:21233418
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of BCL3 mRNA	PMID:22083351
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of BCL3 mRNA	PMID:17562736
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of BCL3 mRNA	PMID:21420995|PMID:29067470
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1589465	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of BCL3 mRNA	PMID:33387578
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of BCL3 mRNA	PMID:33725128
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of BCL3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of BCL3 mRNA	PMID:35811015
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of BCL3 mRNA	PMID:17331233
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1314972	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of BCL3 mRNA	PMID:26934552
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of BCL3 mRNA	PMID:31838189
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1589465	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of BCL3 mRNA	PMID:29391264
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of BCL3 mRNA	PMID:22079256
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BCL3 mRNA	PMID:22079256
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of BCL3 mRNA	PMID:35436446
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:48607	lithium chloride	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D018021	Lithium Chloride results in increased expression of BCL3 mRNA	PMID:23527032
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:D004997	[Ethinyl Estradiol co-treated with ESR1 protein] inhibits the reaction [IL1B protein results in increased expression of BCL3 mRNA]; Ethinyl Estradiol inhibits the reaction [IL1B protein results in increased expression of BCL3 mRNA]	PMID:12072388
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	[Arsenic Trioxide co-treated with Bortezomib] results in decreased expression of BCL3 mRNA	PMID:20471514
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:5001	fenofibrate	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in decreased expression of BCL3 mRNA	PMID:25596134
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:50223	(+)-dexrazoxane	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20170303	CTD	MESH:D064730	[Doxorubicin co-treated with Dexrazoxane] results in decreased expression of BCL3 mRNA	PMID:26873546
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314972	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of BCL3 mRNA; Nanotubes, Carbon results in increased expression of BCL3 mRNA	PMID:25554681|PMID:25620056
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of BCL3 mRNA	PMID:35964746
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL3 mRNA	PMID:27858113
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of BCL3 mRNA	PMID:27858113
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of BCL3 mRNA	PMID:20977926
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:52717	bortezomib	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	[arsenic trioxide co-treated with Bortezomib] results in decreased expression of BCL3 mRNA	PMID:20471514
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	increases expression	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in increased expression of BCL3 mRNA	PMID:18200517
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20120412	CTD	MESH:D014302	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL3 mRNA]	PMID:18200517
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1314972	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of BCL3 mRNA	PMID:38701926
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1314972	E	RGD:6480464	20140114	CTD	MESH:D016559	Tacrolimus results in increased expression of BCL3 mRNA	PMID:23958496
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1589465	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of BCL3 mRNA	PMID:25729387
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of BCL3 mRNA	PMID:28988120
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:68508	diethyl maleate	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20150127	CTD	MESH:C014476	diethyl maleate results in decreased expression of BCL3 mRNA	PMID:25270620
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of BCL3 mRNA	PMID:31758290
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BCL3 mRNA	PMID:22206623
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of BCL3 mRNA	PMID:22079256
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of BCL3 mRNA	PMID:22079256
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of BCL3 mRNA	PMID:36318118
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1589465	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of BCL3 mRNA	PMID:32741896
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:77053	closantel	increases expression	ISO	RGD:1589465	E	RGD:6480464	20140204	CTD	MESH:C023342	closantel results in increased expression of BCL3 mRNA	PMID:22015988
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:77131	sinapic acid	decreases expression	ISO	RGD:1314972	E	RGD:6480464	20230404	CTD	MESH:C073734	sinapinic acid analog results in decreased expression of BCL3 mRNA	PMID:36279966
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BCL3 gene]	PMID:28238834
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCL3 mRNA	PMID:19167446
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:82288	o-anisidine	affects expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C003898	2-anisidine affects the expression of BCL3 mRNA	PMID:28089782
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	ISO	RGD:1589465	E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of BCL3 mRNA	PMID:23914054
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:82664	iron(0)	increases expression	EXP		E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of BCL3 mRNA	PMID:20368581
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of BCL3 mRNA	PMID:33512557
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1589465	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of BCL3 mRNA	PMID:24780913|PMID:25825206
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:8772	raloxifene	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride inhibits the reaction [IL1B protein results in increased expression of BCL3 mRNA]	PMID:12072388
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:1314972	E	RGD:6480464	20170725	CTD	MESH:C093642	SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of BCL3 mRNA]	PMID:28329830
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1314972	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of BCL3 protein	PMID:35357534
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1589465	E	RGD:6480464	20160822	CTD	MESH:D013311	[resveratrol co-treated with Streptozocin] results in increased expression of BCL3 mRNA	PMID:25905778
1314971	BCL3	BCL3 transcription coactivator	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of BCL3 mRNA	PMID:38568856
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MRPL18 mRNA	PMID:38218311
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPL18 mRNA	PMID:33167477
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRPL18 mRNA	PMID:22378314
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of MRPL18 mRNA	PMID:21179406
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314974	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPL18 mRNA	PMID:39241906
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314974	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MRPL18 mRNA]	PMID:39241906
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of MRPL18 mRNA	PMID:20106945
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MRPL18 mRNA	PMID:37042841
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:16990	bilirubin IXalpha	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001663	Bilirubin results in decreased expression of MRPL18 mRNA	PMID:20196124
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MRPL18 mRNA	PMID:21179406
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of MRPL18 mRNA	PMID:33647349
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306387	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MRPL18 mRNA	PMID:22061828
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPL18 mRNA	PMID:35301059
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of MRPL18 mRNA	PMID:19549813
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MRPL18 mRNA	PMID:27153756
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1314974	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MRPL18 mRNA	PMID:19770486
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MRPL18 gene	PMID:27153756
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1306387	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of MRPL18 mRNA	PMID:31129395
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of MRPL18 mRNA	PMID:18593933
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314974	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MRPL18 mRNA	PMID:31919559
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314974	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL18 mRNA	PMID:22206623
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314974	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL18 mRNA	PMID:40504410
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of MRPL18 mRNA	PMID:27392435
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1314974	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of MRPL18 mRNA	PMID:30912803
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306387	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPL18 mRNA	PMID:22298810
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314974	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPL18 mRNA	PMID:21570461
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306387	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPL18 mRNA	PMID:21215274
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of MRPL18 protein	PMID:39603559
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of MRPL18 mRNA	PMID:32763439
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MRPL18 mRNA	PMID:24690739
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of MRPL18 mRNA	PMID:29319823
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MRPL18 mRNA	PMID:21457566|PMID:34032870
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314974	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL18 mRNA	PMID:40504410
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MRPL18 mRNA	PMID:20106945
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MRPL18 mRNA]	PMID:32406909
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MRPL18 mRNA	PMID:24690739
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:30145	lithium atom	multiple interactions	ISO	RGD:1306387	E	RGD:6480464	20120412	CTD	MESH:D008094	Lithium inhibits the reaction [Methamphetamine results in increased expression of MRPL18 mRNA]	PMID:19149911
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:30146	lithium hydride	multiple interactions	ISO	RGD:1306387	E	RGD:6480464	20140805	CTD	MESH:D008094	Lithium inhibits the reaction [Methamphetamine results in increased expression of MRPL18 mRNA]	PMID:19149911
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of MRPL18 mRNA	PMID:18593933
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of MRPL18 mRNA	PMID:26014281
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314974	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MRPL18 gene; titanium dioxide results in decreased methylation of MRPL18 promoter alternative form	PMID:35295148
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306387	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MRPL18 mRNA	PMID:34492290
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1314974	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of MRPL18 mRNA	PMID:18648102
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314974	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of MRPL18 mRNA	PMID:18445702
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL18 mRNA	PMID:29275510
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of MRPL18 gene	PMID:31601247
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306387	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL18 mRNA	PMID:25181051
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306387	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of MRPL18 mRNA	PMID:31129395
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314974	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MRPL18 mRNA	PMID:39298647
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314974	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of MRPL18 mRNA	PMID:38685157
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314974	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MRPL18 mRNA]	PMID:39241906
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MRPL18 mRNA	PMID:35301059
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of MRPL18 mRNA	PMID:26352163
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314974	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MRPL18 mRNA	PMID:17292431
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MRPL18 mRNA	PMID:20106945
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of MRPL18 mRNA	PMID:36621641
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1306387	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of MRPL18 mRNA	PMID:24136188
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314974	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MRPL18 mRNA	PMID:17562736
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL18 mRNA	PMID:31059760
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of MRPL18 mRNA	PMID:21420995
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of MRPL18 mRNA	PMID:24690739
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314974	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPL18 mRNA	PMID:40504410
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of MRPL18 mRNA	PMID:36621641
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of MRPL18 mRNA	PMID:18175754
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314974	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MRPL18 mRNA	PMID:17555576
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1306387	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of MRPL18 mRNA	PMID:36868495
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306387	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MRPL18 mRNA	PMID:24136188
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1314974	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MRPL18 mRNA	PMID:19042947
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:53620	methylisothiazolinone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C011506	2-methyl-4-isothiazolin-3-one results in increased expression of MRPL18 mRNA	PMID:31629900
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MRPL18 protein	PMID:32959892
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1306387	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of MRPL18 mRNA	PMID:20080153
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:1306387	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of MRPL18 mRNA	PMID:24136188
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:63959	celastrol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C050414	celastrol results in increased expression of MRPL18 mRNA	PMID:17010675
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:65954	gedunin	increases expression	EXP		E	RGD:6480464	20130305	CTD	MESH:C106014	gedunin results in increased expression of MRPL18 mRNA	PMID:17010675
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1306387	E	RGD:6480464	20120412	CTD	MESH:D008694	Lithium inhibits the reaction [Methamphetamine results in increased expression of MRPL18 mRNA]	PMID:19149911
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314974	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MRPL18 mRNA	PMID:22206623
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314974	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL18 mRNA	PMID:22206623
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306387	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MRPL18 mRNA	PMID:24136188
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306387	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MRPL18 mRNA	PMID:25825206
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314974	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MRPL18 mRNA]	PMID:39241906
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of MRPL18 mRNA	PMID:26014281
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306387	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of MRPL18 mRNA	PMID:19281266
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:9288	streptozocin	affects expression	ISO	RGD:1314974	E	RGD:6480464	20120501	CTD	MESH:D013311	Streptozocin affects the expression of MRPL18 mRNA	PMID:18583417
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of MRPL18 mRNA	PMID:38568856
1314973	MRPL18	mitochondrial ribosomal protein L18	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of MRPL18 mRNA	PMID:22378314
1314975	KLHL2	kelch like family member 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314976	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of KLHL2 mRNA	PMID:30319688
1314975	KLHL2	kelch like family member 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1314976	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of KLHL2 mRNA	PMID:30319688
1314975	KLHL2	kelch like family member 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of KLHL2 mRNA	PMID:21632981
1314975	KLHL2	kelch like family member 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314976	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of KLHL2 mRNA	PMID:39241906
1314975	KLHL2	kelch like family member 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314976	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of KLHL2 mRNA	PMID:19484750
1314975	KLHL2	kelch like family member 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of KLHL2 mRNA	PMID:22217510
1314975	KLHL2	kelch like family member 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306388	E	RGD:6480464	20210406	CTD	MESH:D004958	[Testosterone co-treated with Estradiol] results in increased expression of KLHL2 mRNA	PMID:32741896
1314975	KLHL2	kelch like family member 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KLHL2 mRNA	PMID:37042841
1314975	KLHL2	kelch like family member 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306388	E	RGD:6480464	20210406	CTD	MESH:D013739	[Testosterone co-treated with Estradiol] results in increased expression of KLHL2 mRNA	PMID:32741896
1314975	KLHL2	kelch like family member 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306388	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of KLHL2 mRNA	PMID:26577399
1314975	KLHL2	kelch like family member 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KLHL2 mRNA	PMID:28818685
1314975	KLHL2	kelch like family member 2	gene	CHEBI:190294	calcium silicate	decreases expression	ISO	RGD:1314976	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in decreased expression of KLHL2 mRNA	PMID:29279043
1314975	KLHL2	kelch like family member 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314976	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLHL2 mRNA	PMID:37236586
1314975	KLHL2	kelch like family member 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KLHL2 gene	PMID:27153756
1314975	KLHL2	kelch like family member 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of KLHL2 mRNA	PMID:35430440
1314975	KLHL2	kelch like family member 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314976	E	RGD:6480464	20120412	CTD	MESH:D010126	pyrazolanthrone inhibits the reaction [Ozone results in increased expression of KLHL2 mRNA]	PMID:17460151
1314975	KLHL2	kelch like family member 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314976	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of KLHL2 mRNA	PMID:31919559
1314975	KLHL2	kelch like family member 2	gene	CHEBI:28112	nickel atom	increases expression	ISO	RGD:1314976	E	RGD:6480464	20120717	CTD	MESH:D009532	Nickel results in increased expression of KLHL2 mRNA	PMID:12540486
1314975	KLHL2	kelch like family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KLHL2 mRNA	PMID:20106945|PMID:21632981
1314975	KLHL2	kelch like family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306388	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KLHL2 mRNA	PMID:21215274
1314975	KLHL2	kelch like family member 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314976	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of KLHL2 mRNA	PMID:25975270
1314975	KLHL2	kelch like family member 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of KLHL2 mRNA	PMID:29803840
1314975	KLHL2	kelch like family member 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1314976	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in increased expression of KLHL2 mRNA	PMID:25896364|PMID:39631538
1314975	KLHL2	kelch like family member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1314976	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KLHL2 mRNA	PMID:19770486
1314975	KLHL2	kelch like family member 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KLHL2 promoter	PMID:27901495
1314975	KLHL2	kelch like family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1306388	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KLHL2 mRNA	PMID:21839799
1314975	KLHL2	kelch like family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314976	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KLHL2 mRNA	PMID:21569818
1314975	KLHL2	kelch like family member 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1314976	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KLHL2 3' UTR; Benzo(a)pyrene results in increased methylation of KLHL2 exon; Benzo(a)pyrene results in increased methylation of KLHL2 intron	PMID:27901495
1314975	KLHL2	kelch like family member 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KLHL2 mRNA	PMID:19150397
1314975	KLHL2	kelch like family member 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of KLHL2 gene	PMID:31601247
1314975	KLHL2	kelch like family member 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306388	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of KLHL2 mRNA	PMID:25729387
1314975	KLHL2	kelch like family member 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314976	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of KLHL2 mRNA	PMID:29264374
1314975	KLHL2	kelch like family member 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314976	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KLHL2 gene	PMID:35295148
1314975	KLHL2	kelch like family member 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1314976	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of KLHL2 mRNA	PMID:27760801
1314975	KLHL2	kelch like family member 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314976	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of KLHL2 mRNA	PMID:17426115
1314975	KLHL2	kelch like family member 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306388	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of KLHL2 mRNA	PMID:25181051
1314975	KLHL2	kelch like family member 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306388	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of KLHL2 mRNA	PMID:30816183|PMID:34947998
1314975	KLHL2	kelch like family member 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of KLHL2 gene	PMID:31601247
1314975	KLHL2	kelch like family member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of KLHL2 gene	PMID:31601247
1314975	KLHL2	kelch like family member 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314976	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of KLHL2 mRNA	PMID:39298647
1314975	KLHL2	kelch like family member 2	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314976	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of KLHL2 mRNA	PMID:36117858
1314975	KLHL2	kelch like family member 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KLHL2 mRNA	PMID:37042841
1314975	KLHL2	kelch like family member 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KLHL2 mRNA	PMID:38568856
1314975	KLHL2	kelch like family member 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314976	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLHL2 mRNA	PMID:37236586
1314975	KLHL2	kelch like family member 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of KLHL2 mRNA	PMID:19376846
1314975	KLHL2	kelch like family member 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of KLHL2 mRNA	PMID:24449571
1314975	KLHL2	kelch like family member 2	gene	CHEBI:3763	clorgyline	increases expression	EXP		E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of KLHL2 mRNA	PMID:19691856
1314975	KLHL2	kelch like family member 2	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1314976	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of KLHL2 mRNA	PMID:29038090
1314975	KLHL2	kelch like family member 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in increased expression of KLHL2 mRNA	PMID:23179753|PMID:25192806|PMID:29154799
1314975	KLHL2	kelch like family member 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of KLHL2 mRNA	PMID:27989131
1314975	KLHL2	kelch like family member 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1314976	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of KLHL2 mRNA	PMID:28973697
1314975	KLHL2	kelch like family member 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of KLHL2 mRNA	PMID:26272509
1314975	KLHL2	kelch like family member 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL2 mRNA	PMID:27188386
1314975	KLHL2	kelch like family member 2	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314976	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of KLHL2 mRNA	PMID:29279043
1314975	KLHL2	kelch like family member 2	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1314976	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of KLHL2 mRNA	PMID:29279043
1314975	KLHL2	kelch like family member 2	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1314976	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of KLHL2 mRNA	PMID:30529165
1314975	KLHL2	kelch like family member 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314976	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of KLHL2 mRNA	PMID:35436446
1314975	KLHL2	kelch like family member 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314976	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of KLHL2 mRNA; Nanotubes, Carbon results in increased expression of KLHL2 mRNA	PMID:25554681
1314975	KLHL2	kelch like family member 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306388	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KLHL2 mRNA	PMID:24136188
1314975	KLHL2	kelch like family member 2	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314976	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of KLHL2 mRNA	PMID:36117858
1314975	KLHL2	kelch like family member 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306388	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of KLHL2 mRNA	PMID:25729387
1314975	KLHL2	kelch like family member 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1314976	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of KLHL2 mRNA	PMID:20003209
1314975	KLHL2	kelch like family member 2	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1306388	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of KLHL2 mRNA	PMID:30467583
1314975	KLHL2	kelch like family member 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314976	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KLHL2 mRNA	PMID:22206623
1314975	KLHL2	kelch like family member 2	gene	CHEBI:77012	methylseleninic acid	affects expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid affects the expression of KLHL2 mRNA	PMID:14617803
1314975	KLHL2	kelch like family member 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1306388	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of KLHL2 mRNA	PMID:21346803
1314975	KLHL2	kelch like family member 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL2 mRNA	PMID:27188386
1314975	KLHL2	kelch like family member 2	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1306388	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of KLHL2 mRNA	PMID:20345932
1314975	KLHL2	kelch like family member 2	gene	CHEBI:82272	Erionite	decreases expression	ISO	RGD:1314976	E	RGD:6480464	20200915	CTD	MESH:C083174	erionite results in decreased expression of KLHL2 mRNA	PMID:29279043
1314975	KLHL2	kelch like family member 2	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1314976	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of KLHL2 mRNA	PMID:21278054
1314975	KLHL2	kelch like family member 2	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1314976	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [Ozone results in increased expression of KLHL2 mRNA]	PMID:17460151
1314975	KLHL2	kelch like family member 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KLHL2 mRNA	PMID:27188386
1314975	KLHL2	kelch like family member 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306388	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of KLHL2 mRNA	PMID:21346803
1314975	KLHL2	kelch like family member 2	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of KLHL2 mRNA	PMID:29301935
1314977	FOXN4	forkhead box N4	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314978	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of FOXN4 mRNA	PMID:33045310
1314977	FOXN4	forkhead box N4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of FOXN4 mRNA	PMID:33167477
1314977	FOXN4	forkhead box N4	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of FOXN4 mRNA	PMID:26079696
1314977	FOXN4	forkhead box N4	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of FOXN4 mRNA	PMID:21179406
1314977	FOXN4	forkhead box N4	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of FOXN4 mRNA	PMID:26079696
1314977	FOXN4	forkhead box N4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of FOXN4 mRNA	PMID:31163220
1314977	FOXN4	forkhead box N4	gene	CHEBI:18291	manganese atom	increases expression	ISO	RGD:1306389	E	RGD:6480464	20161115	CTD	MESH:D008345	Manganese results in increased expression of FOXN4 mRNA	PMID:26745496
1314977	FOXN4	forkhead box N4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of FOXN4 intron	PMID:30157460
1314977	FOXN4	forkhead box N4	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1314978	E	RGD:6480464	20231205	CTD	MESH:D010126	Ozone results in increased expression of FOXN4 mRNA	PMID:33026818
1314977	FOXN4	forkhead box N4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1314978	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of FOXN4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FOXN4 mRNA	PMID:34911549
1314977	FOXN4	forkhead box N4	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306389	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of FOXN4 mRNA	PMID:31881176
1314977	FOXN4	forkhead box N4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of FOXN4 mRNA	PMID:23557933
1314977	FOXN4	forkhead box N4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314978	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FOXN4 mRNA	PMID:24058054
1314977	FOXN4	forkhead box N4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FOXN4 mRNA	PMID:20348232
1314977	FOXN4	forkhead box N4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to FOXN4 gene]	PMID:19574409
1314977	FOXN4	forkhead box N4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of FOXN4 mRNA	PMID:32763439
1314977	FOXN4	forkhead box N4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306389	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of FOXN4 mRNA	PMID:28959563
1314977	FOXN4	forkhead box N4	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of FOXN4 mRNA	PMID:22378314
1314977	FOXN4	forkhead box N4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FOXN4 3' UTR	PMID:27901495
1314977	FOXN4	forkhead box N4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FOXN4 exon	PMID:27901495
1314977	FOXN4	forkhead box N4	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of FOXN4 mRNA	PMID:35984750
1314977	FOXN4	forkhead box N4	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of FOXN4 mRNA	PMID:37690743
1314977	FOXN4	forkhead box N4	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1314978	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of FOXN4 promoter	PMID:35295148
1314977	FOXN4	forkhead box N4	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314978	E	RGD:6480464	20131008	CTD	MESH:C009495	titanium dioxide results in decreased expression of FOXN4 mRNA	PMID:23131501
1314977	FOXN4	forkhead box N4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1306389	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of FOXN4 mRNA	PMID:30012374
1314977	FOXN4	forkhead box N4	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306389	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of FOXN4 mRNA	PMID:19167457
1314977	FOXN4	forkhead box N4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1306389	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of FOXN4 promoter	PMID:27415467
1314977	FOXN4	forkhead box N4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306389	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FOXN4 mRNA	PMID:25181051
1314977	FOXN4	forkhead box N4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306389	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FOXN4 gene	PMID:28505145
1314977	FOXN4	forkhead box N4	gene	CHEBI:34342	3-methylcholanthrene	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene results in increased expression of FOXN4 mRNA	PMID:20348232
1314977	FOXN4	forkhead box N4	gene	CHEBI:34342	3-methylcholanthrene	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D008748	Methylcholanthrene promotes the reaction [AHR protein binds to FOXN4 promoter]; Methylcholanthrene promotes the reaction [ARNT protein binds to FOXN4 promoter]; Methylcholanthrene promotes the reaction [Methylcholanthrene results in increased expression of FOXN4 mRNA]	PMID:20348232
1314977	FOXN4	forkhead box N4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314978	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in decreased expression of FOXN4 mRNA	PMID:30951980
1314977	FOXN4	forkhead box N4	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of FOXN4 intron	PMID:30157460
1314977	FOXN4	forkhead box N4	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1314978	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in decreased expression of FOXN4 mRNA	PMID:30951980
1314977	FOXN4	forkhead box N4	gene	CHEBI:35154	manganese(0)	increases expression	ISO	RGD:1306389	E	RGD:6480464	20161115	CTD	MESH:D008345	Manganese results in increased expression of FOXN4 mRNA	PMID:26745496
1314977	FOXN4	forkhead box N4	gene	CHEBI:35176	zinc sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in increased expression of FOXN4 mRNA	PMID:16330358
1314977	FOXN4	forkhead box N4	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of FOXN4 mRNA	PMID:36326898
1314977	FOXN4	forkhead box N4	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306389	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of FOXN4 mRNA	PMID:25539665
1314977	FOXN4	forkhead box N4	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of FOXN4 mRNA	PMID:24449571
1314977	FOXN4	forkhead box N4	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of FOXN4 mRNA	PMID:38832940
1314977	FOXN4	forkhead box N4	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1314978	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of FOXN4 mRNA	PMID:25554681
1314977	FOXN4	forkhead box N4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314978	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of FOXN4 mRNA	PMID:25554681
1314977	FOXN4	forkhead box N4	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1306389	E	RGD:6480464	20161115	CTD	MESH:C025340	manganese chloride results in increased expression of FOXN4 mRNA	PMID:26745496
1314977	FOXN4	forkhead box N4	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of FOXN4 intron	PMID:30157460
1314977	FOXN4	forkhead box N4	gene	CHEBI:7071	N,N-diethyl-m-toluamide	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D003671	DEET results in increased expression of FOXN4 mRNA	PMID:27091632
1314977	FOXN4	forkhead box N4	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1314978	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FOXN4 mRNA	PMID:27935865
1314977	FOXN4	forkhead box N4	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of FOXN4 mRNA	PMID:37199045
1314977	FOXN4	forkhead box N4	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D010634	Phenobarbital affects the expression of FOXN4 mRNA	PMID:19084549
1314977	FOXN4	forkhead box N4	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1314978	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FOXN4 mRNA	PMID:27935865
1314977	FOXN4	forkhead box N4	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of FOXN4 mRNA	PMID:26079696
1314979	CAB39	calcium binding protein 39	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of CAB39 mRNA	PMID:38218311
1314979	CAB39	calcium binding protein 39	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1314980	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CAB39 mRNA	PMID:33045310
1314979	CAB39	calcium binding protein 39	gene	CHEBI:15379	dioxygen	affects methylation	ISO	RGD:1314980	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency affects the methylation of CAB39 promoter	PMID:24205000
1314979	CAB39	calcium binding protein 39	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1314980	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CAB39 mRNA	PMID:24205000
1314979	CAB39	calcium binding protein 39	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1314980	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CAB39 mRNA	PMID:30319688
1314979	CAB39	calcium binding protein 39	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314980	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CAB39 mRNA	PMID:39241906
1314979	CAB39	calcium binding protein 39	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306390	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of CAB39 gene	PMID:27618143
1314979	CAB39	calcium binding protein 39	gene	CHEBI:17336	all-trans-retinol	decreases expression	ISO	RGD:1306390	E	RGD:6480464	20150512	CTD	MESH:D014801	Vitamin A deficiency results in decreased expression of CAB39 mRNA	PMID:12163651
1314979	CAB39	calcium binding protein 39	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CAB39 mRNA	PMID:16002434
1314979	CAB39	calcium binding protein 39	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306390	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CAB39 mRNA	PMID:22061828
1314979	CAB39	calcium binding protein 39	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314980	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CAB39 mRNA	PMID:36331819
1314979	CAB39	calcium binding protein 39	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314980	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CAB39 mRNA	PMID:37236586
1314979	CAB39	calcium binding protein 39	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1314980	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CAB39 mRNA	PMID:29950665
1314979	CAB39	calcium binding protein 39	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of CAB39 mRNA	PMID:19549813
1314979	CAB39	calcium binding protein 39	gene	CHEBI:2430	aconitine	decreases expression	ISO	RGD:1306390	E	RGD:6480464	20210309	CTD	MESH:D000157	Aconitine results in decreased expression of CAB39 protein	PMID:33236894
1314979	CAB39	calcium binding protein 39	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1314980	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of CAB39 mRNA	PMID:19376150
1314979	CAB39	calcium binding protein 39	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CAB39 intron	PMID:30157460
1314979	CAB39	calcium binding protein 39	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CAB39 mRNA	PMID:23649840
1314979	CAB39	calcium binding protein 39	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306390	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CAB39 mRNA	PMID:31150632
1314979	CAB39	calcium binding protein 39	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314980	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CAB39 mRNA	PMID:31919559
1314979	CAB39	calcium binding protein 39	gene	CHEBI:27656	camptothecin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002166	Camptothecin results in decreased expression of CAB39 mRNA	PMID:17374387
1314979	CAB39	calcium binding protein 39	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of CAB39 mRNA	PMID:23557933
1314979	CAB39	calcium binding protein 39	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1314980	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of CAB39 mRNA	PMID:40618947
1314979	CAB39	calcium binding protein 39	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306390	E	RGD:6480464	20130806	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CAB39 mRNA	PMID:22298810
1314979	CAB39	calcium binding protein 39	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306390	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CAB39 mRNA	PMID:33387578
1314979	CAB39	calcium binding protein 39	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306390	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CAB39 mRNA	PMID:34747641
1314979	CAB39	calcium binding protein 39	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of CAB39 mRNA	PMID:33512557
1314979	CAB39	calcium binding protein 39	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CAB39 mRNA	PMID:29803840
1314979	CAB39	calcium binding protein 39	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased expression of CAB39 protein	PMID:38228842
1314979	CAB39	calcium binding protein 39	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CAB39 intron	PMID:30157460
1314979	CAB39	calcium binding protein 39	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to CAB39 mRNA]	PMID:32406909
1314979	CAB39	calcium binding protein 39	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CAB39 mRNA	PMID:19150397
1314979	CAB39	calcium binding protein 39	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of CAB39 gene	PMID:31601247
1314979	CAB39	calcium binding protein 39	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314980	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CAB39 gene	PMID:35295148
1314979	CAB39	calcium binding protein 39	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1314980	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CAB39 mRNA	PMID:29950665
1314979	CAB39	calcium binding protein 39	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306390	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CAB39 mRNA	PMID:23411599|PMID:34492290
1314979	CAB39	calcium binding protein 39	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1314980	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of CAB39 mRNA	PMID:18648102
1314979	CAB39	calcium binding protein 39	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of CAB39 protein	PMID:33376534
1314979	CAB39	calcium binding protein 39	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of CAB39 protein	PMID:37567409
1314979	CAB39	calcium binding protein 39	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306390	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CAB39 mRNA	PMID:25181051
1314979	CAB39	calcium binding protein 39	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of MO25 mRNA	PMID:19244175
1314979	CAB39	calcium binding protein 39	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1314980	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CAB39 mRNA	PMID:39298647
1314979	CAB39	calcium binding protein 39	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of CAB39 gene	PMID:31601247
1314979	CAB39	calcium binding protein 39	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of CAB39 intron	PMID:30157460
1314979	CAB39	calcium binding protein 39	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314980	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CAB39 mRNA	PMID:37019170
1314979	CAB39	calcium binding protein 39	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1314980	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CAB39 mRNA	PMID:29950665
1314979	CAB39	calcium binding protein 39	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306390	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of CAB39 mRNA	PMID:21266533
1314979	CAB39	calcium binding protein 39	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306390	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CAB39 mRNA	PMID:33453195
1314979	CAB39	calcium binding protein 39	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314980	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CAB39 mRNA	PMID:37236586
1314979	CAB39	calcium binding protein 39	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314980	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of CAB39 mRNA	PMID:17585979
1314979	CAB39	calcium binding protein 39	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CAB39 mRNA	PMID:28302478
1314979	CAB39	calcium binding protein 39	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314980	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CAB39 mRNA	PMID:36331819
1314979	CAB39	calcium binding protein 39	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306390	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of CAB39 mRNA	PMID:41580965
1314979	CAB39	calcium binding protein 39	gene	CHEBI:41977	daunorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003630	Daunorubicin results in decreased expression of CAB39 mRNA	PMID:17374387
1314979	CAB39	calcium binding protein 39	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314980	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CAB39 mRNA	PMID:17562736
1314979	CAB39	calcium binding protein 39	gene	CHEBI:4911	etoposide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in decreased expression of CAB39 mRNA	PMID:17374387
1314979	CAB39	calcium binding protein 39	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1314980	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of CAB39 mRNA	PMID:25554681
1314979	CAB39	calcium binding protein 39	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306390	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of CAB39 mRNA	PMID:24793618
1314979	CAB39	calcium binding protein 39	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306390	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CAB39 mRNA	PMID:24136188
1314979	CAB39	calcium binding protein 39	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of CAB39 mRNA	PMID:26705709
1314979	CAB39	calcium binding protein 39	gene	CHEBI:53063	2,4,6-trinitrobenzenesulfonic acid	decreases expression	ISO	RGD:1306390	E	RGD:6480464	20150512	CTD	MESH:D014302	Trinitrobenzenesulfonic Acid results in decreased expression of CAB39 mRNA	PMID:12163651
1314979	CAB39	calcium binding protein 39	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CAB39 protein	PMID:32959892
1314979	CAB39	calcium binding protein 39	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1314980	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of CAB39 mRNA	PMID:23650126
1314979	CAB39	calcium binding protein 39	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of CAB39 intron	PMID:30157460
1314979	CAB39	calcium binding protein 39	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306390	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CAB39 mRNA	PMID:24136188
1314979	CAB39	calcium binding protein 39	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1306390	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of CAB39 protein	PMID:28903499
1314979	CAB39	calcium binding protein 39	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306390	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CAB39 mRNA	PMID:21346803
1314979	CAB39	calcium binding protein 39	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CAB39 mRNA	PMID:38568856
1314979	CAB39	calcium binding protein 39	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306390	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CAB39 mRNA	PMID:21346803
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314982	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MRPL3 mRNA	PMID:33045310
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPL3 mRNA	PMID:23724009|PMID:33167477
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MRPL3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MRPL3 mRNA	PMID:32699268
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306391	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of MRPL3 gene	PMID:35440735
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MRPL3 mRNA	PMID:22378314
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of MRPL3 mRNA	PMID:29432896
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314982	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MRPL3 mRNA	PMID:39298647
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MRPL3 mRNA	PMID:38568856
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MRPL3 mRNA	PMID:28818685
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MRPL3 mRNA	PMID:19549813|PMID:20599845
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019327	Copper Sulfate results in increased expression of MRPL3 mRNA	PMID:20599845
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MRPL3 gene	PMID:27153756
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MRPL3 mRNA	PMID:27153756
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MRPL3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MRPL3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of MRPL3 mRNA	PMID:32699268
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314982	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL3 mRNA	PMID:22206623
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314982	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MRPL3 mRNA	PMID:40504410
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1314982	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in increased expression of MRPL3 mRNA	PMID:22610192
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MRPL3 mRNA	PMID:23557933
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314982	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPL3 mRNA	PMID:21570461
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306391	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPL3 mRNA	PMID:21215274
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306391	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPL3 mRNA	PMID:33387578
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314982	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL3 mRNA	PMID:17942748
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of MRPL3 mRNA	PMID:33512557
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306391	E	RGD:6480464	20221101	CTD	MESH:D012402	Rotenone results in increased expression of MRPL3 protein	PMID:35544339
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306391	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MRPL3 mRNA	PMID:28959563
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1314982	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of MRPL3 mRNA	PMID:26873546
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1314982	E	RGD:6480464	20160607	CTD	MESH:D004317	[Doxorubicin co-treated with Dexrazoxane] results in increased expression of MRPL3 mRNA	PMID:26873546
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:2877	aspartame	multiple interactions	ISO	RGD:1314982	E	RGD:6480464	20200317	CTD	MESH:D001218	[Fats, Unsaturated co-treated with Aspartame] affects the expression of MRPL3 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPL3 mRNA	PMID:23783067
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of MRPL3 mRNA	PMID:25523186
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPL3 mRNA	PMID:38568856|PMID:39719251
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314982	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MRPL3 mRNA	PMID:40504410
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MRPL3 mRNA]	PMID:32406909
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of MRPL3 mRNA	PMID:25523186
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MRPL3 mRNA	PMID:20382639
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1314982	E	RGD:6480464	20130416	CTD	MESH:C008261	lead acetate results in increased expression of MRPL3 mRNA	PMID:22609695
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306391	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of MRPL3 mRNA	PMID:34492290
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314982	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of MRPL3 mRNA	PMID:18445702|PMID:20813756
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1306391	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MRPL3 mRNA	PMID:19162173
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MRPL3 mRNA	PMID:29275510
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of MRPL3 gene	PMID:31601247
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306391	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL3 mRNA	PMID:25181051|PMID:30816183
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:3374	capsaicin	decreases expression	ISO	RGD:1306391	E	RGD:6480464	20120613	CTD	MESH:D002211	Capsaicin results in decreased expression of MRPL3 mRNA	PMID:16278290
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1306391	E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of MRPL3 mRNA	PMID:17316808
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1314982	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of MRPL3 mRNA	PMID:38685157
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:34648	clofibric acid	affects expression	ISO	RGD:1306391	E	RGD:6480464	20120412	CTD	MESH:D002995	Clofibric Acid affects the expression of MRPL3 mRNA	PMID:17602206
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314982	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MRPL3 mRNA	PMID:21266533
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MRPL3 mRNA	PMID:37042841
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MRPL3 mRNA	PMID:38568856
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306391	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MRPL3 mRNA	PMID:21297351
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of MRPL3 protein	PMID:26879310
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MRPL3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MRPL3 mRNA	PMID:32699268
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRPL3 mRNA	PMID:25979313
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:40909	azoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of MRPL3 mRNA	PMID:33512557
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314982	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MRPL3 mRNA	PMID:17555576
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1314982	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MRPL3 mRNA	PMID:17562736
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPL3 mRNA	PMID:25704631
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314982	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MRPL3 mRNA	PMID:40504410
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314982	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MRPL3 mRNA	PMID:17555576
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1314982	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of MRPL3 mRNA	PMID:17942748
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314982	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MRPL3 mRNA	PMID:17942748
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:50223	(+)-dexrazoxane	multiple interactions	ISO	RGD:1314982	E	RGD:6480464	20170303	CTD	MESH:D064730	[Doxorubicin co-treated with Dexrazoxane] results in increased expression of MRPL3 mRNA	PMID:26873546
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314982	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of MRPL3 mRNA	PMID:25554681
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of MRPL3 protein	PMID:24806433
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1314982	E	RGD:6480464	20200317	CTD	MESH:D012970	[Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of MRPL3 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of MRPL3 mRNA	PMID:23783067
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MRPL3 protein	PMID:34186270
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1314982	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MRPL3 mRNA	PMID:22206623
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1314982	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL3 mRNA	PMID:22206623
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of MRPL3 protein	PMID:31285264
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MRPL3 mRNA	PMID:38568856
1314981	MRPL3	mitochondrial ribosomal protein L3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306391	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of MRPL3 mRNA	PMID:21346803
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of IL17RC mRNA	PMID:38218311
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1618205	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of IL17RC mRNA	PMID:33045310
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1618205	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of IL17RC mRNA	PMID:37995155
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IL17RC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of IL17RC mRNA	PMID:32699268
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of IL17RC mRNA	PMID:37042841
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306392	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of IL17RC mRNA	PMID:33387578
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1618205	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL17RC mRNA	PMID:28111341
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IL17RC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of IL17RC mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of IL17RC mRNA	PMID:32699268
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1618205	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of IL17RC mRNA	PMID:34911549
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1618205	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of IL17RC mRNA]	PMID:22206623
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL17RC mRNA	PMID:40512198
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1618205	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL17RC mRNA	PMID:40504410
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of IL17RC mRNA	PMID:19244175
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of IL17RC promoter	PMID:22847954
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1618205	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of IL17RC mRNA	PMID:32186404
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618205	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IL17RC mRNA	PMID:21570461
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of IL17RC mRNA	PMID:33212167
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of IL17RC mRNA	PMID:32763439
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1618205	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of IL17RC mRNA	PMID:27862939
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IL17RC mRNA	PMID:29803840
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL17RC mRNA	PMID:40512198
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1618205	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL17RC mRNA	PMID:40504410
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of IL17RC mRNA	PMID:34408198
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1618205	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IL17RC gene	PMID:35295148
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1618205	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of IL17RC mRNA	PMID:17426115
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1618205	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of IL17RC mRNA	PMID:18301758
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1618205	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of IL17RC mRNA	PMID:30951980|PMID:33221593
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of IL17RC mRNA	PMID:28628672
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1618205	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of IL17RC mRNA	PMID:30951980
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1618205	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of IL17RC mRNA	PMID:38685157
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1618205	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of IL17RC mRNA	PMID:30951980
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1618205	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of IL17RC mRNA	PMID:21266533
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of IL17RC mRNA	PMID:28628672
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of IL17RC mRNA	PMID:38568856
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1618205	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of IL17RC mRNA	PMID:28111341
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of IL17RC mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of IL17RC mRNA	PMID:32699268
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of IL17RC mRNA	PMID:19244175
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1618205	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IL17RC mRNA	PMID:40194260
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of IL17RC promoter	PMID:22847954
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of IL17RC promoter	PMID:22847954
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of IL17RC gene	PMID:29154799
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of IL17RC mRNA	PMID:20106945
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of IL17RC mRNA	PMID:25047013
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of IL17RC mRNA	PMID:28628672
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL17RC mRNA	PMID:40512198
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1618205	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of IL17RC mRNA	PMID:40504410
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306392	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of IL17RC mRNA	PMID:29391264
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1618205	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of IL17RC mRNA	PMID:35436446
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of IL17RC mRNA	PMID:28628672
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1618205	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IL17RC mRNA	PMID:22206623
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1618205	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of IL17RC mRNA]	PMID:22206623
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:75701	sarin	increases expression	EXP		E	RGD:6480464	20131112	CTD	MESH:D012524	Sarin results in increased expression of IL17RC mRNA	PMID:19522546
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:7719	ochratoxin A	increases acetylation	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in increased acetylation of IL17RC promoter	PMID:29098329
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in increased expression of IL17RC mRNA	PMID:29098329
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	[ochratoxin A results in increased acetylation of IL17RC promoter] which results in increased expression of IL17RC mRNA	PMID:29098329
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of IL17RC mRNA	PMID:39904859
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1618205	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of IL17RC mRNA	PMID:21278054
1314983	IL17RC	interleukin 17 receptor C	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of IL17RC mRNA	PMID:29301935
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of MDN1 mRNA	PMID:35967413
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306394	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MDN1 mRNA]	PMID:31150632
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of MDN1 mRNA	PMID:15498508|PMID:33167477
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of MDN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of MDN1 mRNA	PMID:32699268
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of MDN1 mRNA	PMID:26079696
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of MDN1 protein	PMID:28073184
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of MDN1 mRNA	PMID:22378314
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of MDN1 protein	PMID:35688186
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1314986	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MDN1 mRNA	PMID:39241906
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MDN1 mRNA]	PMID:39241906
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of MDN1 mRNA	PMID:23019147|PMID:31614463
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of MDN1 mRNA	PMID:38568856
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of MDN1 mRNA	PMID:20655997|PMID:23649840
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1314986	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of MDN1 mRNA	PMID:17251523
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1314986	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MDN1 mRNA	PMID:33754040
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1314986	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MDN1 mRNA	PMID:34319233
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MDN1 protein	PMID:37730182
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of MDN1 mRNA	PMID:28818685
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of MDN1 exon; aflatoxin B2 results in decreased methylation of MDN1 intron	PMID:30157460
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MDN1 mRNA	PMID:39836092
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1314986	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of MDN1 mRNA	PMID:27462272
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MDN1 mRNA	PMID:35301059
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MDN1 mRNA	PMID:23649840
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MDN1 exon	PMID:30157460
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MDN1 mRNA	PMID:23649840
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of MDN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of MDN1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of MDN1 mRNA	PMID:32699268
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306394	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MDN1 mRNA	PMID:30779732
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306394	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MDN1 mRNA	PMID:31150632
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1314986	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MDN1 mRNA	PMID:31919559
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306394	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MDN1 mRNA]	PMID:31150632
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MDN1 mRNA	PMID:40504410
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of MDN1 protein	PMID:35688186
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of MDN1 mRNA	PMID:27594783
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1314986	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of MDN1 mRNA	PMID:32186404
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306394	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MDN1 mRNA	PMID:32109520|PMID:33387578
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MDN1 mRNA	PMID:17942748
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MDN1 mRNA	PMID:26272509
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:28262	dimethyl sulfoxide	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased expression of MDN1 mRNA	PMID:39709020
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MDN1 mRNA	PMID:30851411
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of MDN1 mRNA	PMID:23649840
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of MDN1 mRNA	PMID:29803840
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of MDN1 protein	PMID:35688186
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MDN1 mRNA	PMID:38568856
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MDN1 mRNA	PMID:40504410
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MDN1 exon	PMID:30157460
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1314986	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MDN1 mRNA	PMID:22228805
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MDN1 mRNA	PMID:27858113
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:301	(-)-alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of MDN1 mRNA	PMID:25075043
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MDN1 mRNA	PMID:19150397
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1314986	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MDN1 mRNA	PMID:39716349
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:32181	tamibarotene	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of MDN1 mRNA	PMID:15498508
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314986	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MDN1 gene	PMID:35295148
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1314986	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MDN1 mRNA	PMID:18301758|PMID:23811191
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MDN1 mRNA	PMID:19710929
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306394	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MDN1 mRNA	PMID:25181051
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306394	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of MDN1 mRNA	PMID:32145629
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1314986	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of MDN1 mRNA	PMID:32156529
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with LIF protein] results in decreased expression of MDN1 mRNA	PMID:30951980
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MDN1 mRNA	PMID:28628672
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20191112	CTD	MESH:C543008	[bisphenol S co-treated with LIF protein] results in decreased expression of MDN1 mRNA	PMID:30951980
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MDN1 mRNA	PMID:27858113
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MDN1 exon; benzo(e)pyrene results in decreased methylation of MDN1 intron	PMID:30157460
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MDN1 mRNA	PMID:28628672
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1314986	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MDN1 mRNA	PMID:37019170
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MDN1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MDN1 mRNA	PMID:28628672
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1306394	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of MDN1 mRNA	PMID:32680482
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MDN1 mRNA]	PMID:39241906
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MDN1 mRNA	PMID:37042841
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1306394	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of MDN1 mRNA	PMID:30589522
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MDN1 mRNA	PMID:39836092
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MDN1 mRNA	PMID:38568856
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MDN1 mRNA	PMID:35301059
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MDN1 mRNA	PMID:19320972
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of MDN1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of MDN1 mRNA	PMID:32699268
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of MDN1 mRNA	PMID:28302478
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MDN1 mRNA	PMID:31533062
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1306394	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of MDN1 mRNA	PMID:29427782
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of MDN1 mRNA	PMID:23179753
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1314986	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MDN1 mRNA	PMID:17555576
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MDN1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MDN1 mRNA	PMID:28628672
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of MDN1 mRNA	PMID:23649840
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of MDN1 mRNA	PMID:24935251|PMID:26272509
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MDN1 mRNA	PMID:21420995
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306394	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MDN1 mRNA	PMID:33387578
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MDN1 mRNA	PMID:40504410
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of MDN1 mRNA	PMID:40706910
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1314986	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of MDN1 mRNA	PMID:17555576
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MDN1 mRNA	PMID:17942748
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of MDN1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MDN1 mRNA	PMID:28628672
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1314986	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MDN1 mRNA	PMID:39716349
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:50035	alpha-phellandrene	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C005403	alpha phellandrene results in decreased expression of MDN1 mRNA	PMID:25075043
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314986	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of MDN1 mRNA	PMID:25554681
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306394	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of MDN1 mRNA	PMID:24793618
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306394	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MDN1 mRNA	PMID:24136188
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MDN1 mRNA	PMID:27858113
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MDN1 mRNA	PMID:27858113
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MDN1 mRNA	PMID:39836092
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MDN1 exon; Methapyrilene results in decreased methylation of MDN1 intron	PMID:30157460
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1314986	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MDN1 mRNA	PMID:22206623
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MDN1 protein	PMID:37664457
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:755208	eprenetapopt	affects expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	eprenetapopt affects the expression of MDN1 mRNA	PMID:19946333
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:755208	eprenetapopt	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C533410	TP53 protein affects the reaction [eprenetapopt affects the expression of MDN1 mRNA]	PMID:19946333
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of MDN1 mRNA	PMID:30851411
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:80630	irinotecan	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan analog affects the expression of MDN1 mRNA	PMID:18927307
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306394	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of MDN1 mRNA	PMID:32109520
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1314986	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of MDN1 mRNA	PMID:31388691
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1314986	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MDN1 mRNA]	PMID:39241906
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of MDN1 protein	PMID:37664457
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306394	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of MDN1 mRNA	PMID:19281266
1314985	MDN1	midasin AAA ATPase 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306394	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of MDN1 mRNA	PMID:20566332
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of TRAM1L1 mRNA	PMID:31016361
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of TRAM1L1 mRNA	PMID:21632981
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306398	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of TRAM1L1 mRNA	PMID:33387578
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of TRAM1L1 mRNA	PMID:28818685
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TRAM1L1 mRNA	PMID:19549813
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of TRAM1L1 gene	PMID:27153756
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1314991	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of TRAM1L1 mRNA	PMID:28960355
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306398	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of TRAM1L1 mRNA	PMID:31881176
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of TRAM1L1 mRNA; [Plant Extracts co-treated with Resveratrol] results in increased expression of TRAM1L1 mRNA	PMID:23557933
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of TRAM1L1 mRNA	PMID:24768652|PMID:25583101
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306398	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TRAM1L1 mRNA	PMID:33387578
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of TRAM1L1 mRNA	PMID:28001369
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of TRAM1L1 mRNA	PMID:33212167
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1314991	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of TRAM1L1 mRNA	PMID:30807115
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1314991	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased methylation of TRAM1L1 gene	PMID:24118411
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of TRAM1L1 promoter	PMID:27901495
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of TRAM1L1 mRNA	PMID:31745603
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306398	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of TRAM1L1 mRNA	PMID:30047161
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314991	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TRAM1L1 gene	PMID:35295148
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314991	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of TRAM1L1 promoter	PMID:35295148
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306398	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of TRAM1L1 mRNA	PMID:25181051
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306398	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of TRAM1L1 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1314991	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of TRAM1L1 mRNA	PMID:36117858
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:34911	permethrin	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D026023	Permethrin results in increased expression of TRAM1L1 mRNA	PMID:37047231
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306398	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of TRAM1L1 gene	PMID:33148267
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TRAM1L1 mRNA	PMID:38568856
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1306398	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of TRAM1L1 mRNA	PMID:30047161
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1314991	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of TRAM1L1 mRNA	PMID:40194260
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of TRAM1L1 mRNA	PMID:31533062
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TRAM1L1 mRNA	PMID:25979313
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of TRAM1L1 gene	PMID:29154799
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of TRAM1L1 mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306398	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TRAM1L1 mRNA	PMID:30047161
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of TRAM1L1 mRNA	PMID:20106945
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of TRAM1L1 mRNA	PMID:27188386
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1306398	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of TRAM1L1 mRNA	PMID:33387578
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of TRAM1L1 mRNA	PMID:26690555
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:48765	dimethylarsinic acid	increases methylation	ISO	RGD:1306398	E	RGD:6480464	20250902	CTD	MESH:D002101	Cacodylic Acid results in increased methylation of TRAM1L1 gene	PMID:37958445
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306398	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TRAM1L1 mRNA	PMID:30047161
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1314991	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of TRAM1L1 mRNA	PMID:36117858
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:6651	malathion	increases expression	EXP		E	RGD:6480464	20230606	CTD	MESH:D008294	Malathion results in increased expression of TRAM1L1 mRNA	PMID:37047231
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306398	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of TRAM1L1 gene	PMID:33148267
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TRAM1L1 gene]	PMID:28238834
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306398	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TRAM1L1 mRNA	PMID:30047161
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1314991	E	RGD:6480464	20240430	CTD	MESH:C028577	monobutyl phthalate results in increased expression of TRAM1L1 mRNA	PMID:35278568
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of TRAM1L1 mRNA	PMID:38568856
1314990	TRAM1L1	translocation associated membrane protein 1 like 1	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1314991	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of TRAM1L1 mRNA	PMID:26217789
1314992	CCNJ	cyclin J	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of CCNJ mRNA	PMID:27188386
1314992	CCNJ	cyclin J	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1314993	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CCNJ mRNA	PMID:33045310
1314992	CCNJ	cyclin J	gene	CHEBI:15365	acetylsalicylic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001241	Aspirin results in increased expression of CCNJ mRNA	PMID:11906190
1314992	CCNJ	cyclin J	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of CCNJ mRNA	PMID:33167477
1314992	CCNJ	cyclin J	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1314993	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCNJ mRNA	PMID:30529165
1314992	CCNJ	cyclin J	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of CCNJ mRNA	PMID:20044591
1314992	CCNJ	cyclin J	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of CCNJ mRNA	PMID:31614463
1314992	CCNJ	cyclin J	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306399	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CCNJ mRNA	PMID:33387578
1314992	CCNJ	cyclin J	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1314993	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in decreased expression of CCNJ mRNA	PMID:25549359
1314992	CCNJ	cyclin J	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of CCNJ mRNA	PMID:20655997
1314992	CCNJ	cyclin J	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306399	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of CCNJ mRNA	PMID:26577399
1314992	CCNJ	cyclin J	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306399	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of CCNJ mRNA	PMID:33387578
1314992	CCNJ	cyclin J	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CCNJ mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of CCNJ mRNA	PMID:39836092
1314992	CCNJ	cyclin J	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1314993	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCNJ mRNA	PMID:37236586
1314992	CCNJ	cyclin J	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of CCNJ mRNA	PMID:23649840
1314992	CCNJ	cyclin J	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1314993	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CCNJ mRNA	PMID:25629700
1314992	CCNJ	cyclin J	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CCNJ mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCNJ mRNA	PMID:39836092
1314992	CCNJ	cyclin J	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1314993	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CCNJ mRNA	PMID:28960355
1314992	CCNJ	cyclin J	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CCNJ mRNA	PMID:28903495
1314992	CCNJ	cyclin J	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1314993	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCNJ mRNA	PMID:26377647
1314992	CCNJ	cyclin J	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CCNJ mRNA	PMID:20106945
1314992	CCNJ	cyclin J	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306399	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CCNJ mRNA	PMID:33387578
1314992	CCNJ	cyclin J	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1314993	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of CCNJ mRNA	PMID:32937126
1314992	CCNJ	cyclin J	gene	CHEBI:28876	melphalan	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D008558	Melphalan results in increased expression of CCNJ mRNA	PMID:22363485
1314992	CCNJ	cyclin J	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1314993	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CCNJ mRNA	PMID:39232337
1314992	CCNJ	cyclin J	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CCNJ mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCNJ mRNA	PMID:39836092
1314992	CCNJ	cyclin J	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1314993	E	RGD:6480464	20250805	CTD	MESH:C017947	Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in increased expression of CCNJ mRNA]	PMID:39232337
1314992	CCNJ	cyclin J	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CCNJ mRNA	PMID:20106945
1314992	CCNJ	cyclin J	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CCNJ promoter	PMID:27901495
1314992	CCNJ	cyclin J	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1314993	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of CCNJ mRNA	PMID:19073995
1314992	CCNJ	cyclin J	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1314993	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of CCNJ mRNA	PMID:29264374
1314992	CCNJ	cyclin J	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314993	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CCNJ gene	PMID:35295148
1314992	CCNJ	cyclin J	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1314993	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of CCNJ promoter	PMID:35295148
1314992	CCNJ	cyclin J	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306399	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of CCNJ mRNA	PMID:23411599|PMID:34492290
1314992	CCNJ	cyclin J	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306399	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CCNJ mRNA	PMID:25181051
1314992	CCNJ	cyclin J	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306399	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CCNJ mRNA	PMID:30816183|PMID:34947998
1314992	CCNJ	cyclin J	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CCNJ mRNA	PMID:28628672
1314992	CCNJ	cyclin J	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1306399	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of CCNJ mRNA	PMID:22546817
1314992	CCNJ	cyclin J	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CCNJ mRNA	PMID:28628672
1314992	CCNJ	cyclin J	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1306399	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CCNJ mRNA	PMID:22110744|PMID:22546817
1314992	CCNJ	cyclin J	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CCNJ mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of CCNJ mRNA	PMID:39836092
1314992	CCNJ	cyclin J	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1306399	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of CCNJ mRNA	PMID:30723492
1314992	CCNJ	cyclin J	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1314993	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CCNJ mRNA	PMID:37236586
1314992	CCNJ	cyclin J	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:1306399	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of CCNJ mRNA	PMID:27638505
1314992	CCNJ	cyclin J	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CCNJ mRNA	PMID:25979313
1314992	CCNJ	cyclin J	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1314993	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CCNJ mRNA	PMID:17963808
1314992	CCNJ	cyclin J	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of CCNJ mRNA	PMID:23179753|PMID:27188386
1314992	CCNJ	cyclin J	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of CCNJ mRNA	PMID:25562108
1314992	CCNJ	cyclin J	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CCNJ mRNA	PMID:28628672
1314992	CCNJ	cyclin J	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of CCNJ mRNA	PMID:28542535
1314992	CCNJ	cyclin J	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306399	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CCNJ mRNA	PMID:33387578
1314992	CCNJ	cyclin J	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CCNJ mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCNJ mRNA	PMID:39836092
1314992	CCNJ	cyclin J	gene	CHEBI:47807	sulforaphane	decreases expression	ISO	RGD:1314993	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in decreased expression of CCNJ mRNA	PMID:30529165
1314992	CCNJ	cyclin J	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1314993	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of CCNJ mRNA	PMID:30529165
1314992	CCNJ	cyclin J	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314993	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CCNJ mRNA	PMID:35436446
1314992	CCNJ	cyclin J	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of CCNJ mRNA	PMID:28628672
1314992	CCNJ	cyclin J	gene	CHEBI:50161	motexafin gadolinium	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	motexafin gadolinium results in decreased expression of CCNJ mRNA	PMID:16357179
1314992	CCNJ	cyclin J	gene	CHEBI:50161	motexafin gadolinium	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C437683	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CCNJ mRNA	PMID:16357179
1314992	CCNJ	cyclin J	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1314993	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CCNJ mRNA	PMID:25554681
1314992	CCNJ	cyclin J	gene	CHEBI:62984	zinc acetate	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	Zinc Acetate results in decreased expression of CCNJ mRNA	PMID:16357179
1314992	CCNJ	cyclin J	gene	CHEBI:62984	zinc acetate	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:D019345	[Zinc Acetate co-treated with motexafin gadolinium] results in decreased expression of CCNJ mRNA	PMID:16357179
1314992	CCNJ	cyclin J	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of CCNJ mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of CCNJ mRNA	PMID:39836092
1314992	CCNJ	cyclin J	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of CCNJ mRNA	PMID:28988120
1314992	CCNJ	cyclin J	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of CCNJ mRNA	PMID:15336504
1314992	CCNJ	cyclin J	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306399	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of CCNJ gene	PMID:35440735
1314992	CCNJ	cyclin J	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of CCNJ mRNA	PMID:37199045
1314992	CCNJ	cyclin J	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CCNJ gene]	PMID:28238834
1314992	CCNJ	cyclin J	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306399	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CCNJ mRNA	PMID:24780913
1314992	CCNJ	cyclin J	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac results in decreased expression of CCNJ mRNA	PMID:11906190
1314992	CCNJ	cyclin J	gene	CHEBI:9410	taurodeoxycholic acid	multiple interactions	ISO	RGD:1314993	E	RGD:6480464	20250805	CTD	MESH:D013657	Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in increased expression of CCNJ mRNA]	PMID:39232337
1314992	CCNJ	cyclin J	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1314993	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of CCNJ mRNA	PMID:35537566
1314992	CCNJ	cyclin J	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306399	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of CCNJ mRNA	PMID:23034163
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1314996	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of CNOT8; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CNOT8 gene	PMID:20938992
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CNOT8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CNOT8 mRNA	PMID:32699268
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of CNOT8 mRNA	PMID:21632981
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1314996	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CNOT8 mRNA	PMID:39241906
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1314996	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CNOT8 mRNA	PMID:39298647
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306401	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of CNOT8 mRNA	PMID:26496021
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1314996	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of CNOT8; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CNOT8 gene	PMID:20938992
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306401	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of CNOT8 mRNA	PMID:33387578
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1314996	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CNOT8 mRNA	PMID:36331819
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of CNOT8 mRNA	PMID:19549813
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of CNOT8 gene	PMID:27153756
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CNOT8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CNOT8 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of CNOT8 mRNA	PMID:32699268
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1314996	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of CNOT8 mRNA	PMID:31919559
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1314996	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of CNOT8; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CNOT8 gene	PMID:20938992
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CNOT8 mRNA	PMID:40512198
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CNOT8 mRNA	PMID:19244175
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306401	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CNOT8 mRNA	PMID:34747641
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CNOT8 mRNA	PMID:33212167
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CNOT8 mRNA	PMID:30851411
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CNOT8 mRNA	PMID:29803840
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CNOT8 mRNA	PMID:40512198
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1314996	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CNOT8 promoter	PMID:35295148
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1314996	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of CNOT8 mRNA	PMID:18445702|PMID:23811191
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of CNOT8 mRNA	PMID:38479592
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CNOT8 mRNA	PMID:30903817
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1314996	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of CNOT8 promoter	PMID:27334623
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306401	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CNOT8 mRNA	PMID:25181051|PMID:34947998
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CNOT8 mRNA	PMID:28628672
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306401	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of CNOT8 mRNA	PMID:26496021
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1314996	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of CNOT8 mRNA	PMID:39298647
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1314996	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of CNOT8 intron	PMID:28392331
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1314996	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CNOT8 mRNA	PMID:37019170
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1314996	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CNOT8 mRNA	PMID:17361019|PMID:21266533
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CNOT8 mRNA	PMID:28628672
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CNOT8 mRNA	PMID:37042841
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CNOT8 mRNA	PMID:38568856
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CNOT8 mRNA	PMID:19376846
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CNOT8 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CNOT8 mRNA	PMID:32699268
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of CNOT8 mRNA	PMID:19244175
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1314996	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of CNOT8 mRNA	PMID:23811191
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of CNOT8 mRNA	PMID:28302478
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1314996	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CNOT8 mRNA	PMID:36331819
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of CNOT8 mRNA	PMID:25979313
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CNOT8 mRNA	PMID:25562108
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CNOT8 mRNA	PMID:28628672
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1314996	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of CNOT8 mRNA	PMID:29279043
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CNOT8 mRNA	PMID:40512198
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1314996	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CNOT8 mRNA	PMID:35436446
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CNOT8 mRNA	PMID:28628672
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1314996	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CNOT8 mRNA	PMID:35964746
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CNOT8 mRNA	PMID:15336504
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CNOT8 mRNA	PMID:30851411
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1314996	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of CNOT8 mRNA	PMID:21278054
1314995	CNOT8	CCR4-NOT transcription complex subunit 8	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CNOT8 mRNA	PMID:38568856
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of PDCD1LG2 mRNA	PMID:33167477
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Cisplatin inhibits the reaction [[TNF co-treated with Lipopolysaccharides] results in increased expression of PDCD1LG2]	PMID:21765211
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of PDCD1LG2 mRNA	PMID:30165855
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1552436	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PDCD1LG2 mRNA	PMID:37992649
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306403	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of PDCD1LG2 mRNA	PMID:26496021
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:17606	diiodine	increases expression	ISO	RGD:1552436	E	RGD:6480464	20240109	CTD	MESH:D007455	Iodine results in increased expression of PDCD1LG2 mRNA	PMID:37598415
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1552436	E	RGD:6480464	20240109	CTD	MESH:D007455	CD274 protein affects the reaction [Iodine results in increased expression of PDCD1LG2 mRNA]	PMID:37598415
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1552436	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PDCD1LG2 mRNA	PMID:37992649
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PDCD1LG2 mRNA	PMID:31163220
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PDCD1LG2 mRNA	PMID:39836092
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:234430	gardiquimod	increases expression	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in increased expression of PDCD1LG2 mRNA	PMID:28003376
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:234430	gardiquimod	multiple interactions	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of PDCD1LG2 mRNA]	PMID:28003376
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:23808	dimethylarsinous acid	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C472511	dimethylarsinous acid results in increased expression of PDCD1LG2 mRNA	PMID:23876855
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	Ozone results in increased expression of PDCD1LG2 mRNA	PMID:31476115
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PDCD1LG2 mRNA; [Aripiprazole co-treated with Ozone] results in increased expression of PDCD1LG2 mRNA	PMID:31476115|PMID:41430723
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1552436	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of PDCD1LG2 mRNA	PMID:25629700
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PDCD1LG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PDCD1LG2 mRNA	PMID:39836092
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of PDCD1LG2	PMID:21765211
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin inhibits the reaction [[TNF co-treated with IL4] results in increased expression of PDCD1LG2]; Cisplatin inhibits the reaction [[TNF co-treated with Lipopolysaccharides] results in increased expression of PDCD1LG2]	PMID:21765211
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:27974	estriol	increases expression	ISO	RGD:1552436	E	RGD:6480464	20120501	CTD	MESH:D004964	Estriol results in increased expression of PDCD1LG2 protein	PMID:21317386
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552436	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PDCD1LG2 mRNA	PMID:21570461
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306403	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PDCD1LG2 mRNA	PMID:34747641
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PDCD1LG2 mRNA	PMID:29803840
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1552436	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PDCD1LG2 mRNA	PMID:37992649
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of PDCD1LG2 mRNA	PMID:34032870|PMID:39719251
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PDCD1LG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PDCD1LG2 mRNA	PMID:39836092
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1552436	E	RGD:6480464	20250401	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PDCD1LG2 mRNA	PMID:38811393
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:31236	aripiprazole	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:C094645	[Aripiprazole co-treated with Ozone] results in increased expression of PDCD1LG2 mRNA	PMID:31476115
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:31355	carboplatin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016190	Carboplatin results in decreased expression of PDCD1LG2	PMID:21765211
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:31355	carboplatin	multiple interactions	ISO	RGD:1552436	E	RGD:6480464	20120412	CTD	MESH:D016190	STAT6 gene mutant form inhibits the reaction [Carboplatin results in decreased expression of PDCD1LG2]	PMID:21765211
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of PDCD1LG2 gene	PMID:31601247
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of PDCD1LG2	PMID:21765211
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PDCD1LG2 mRNA	PMID:29275510
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306403	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PDCD1LG2 mRNA	PMID:25181051
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of PDCD1LG2 gene	PMID:31601247
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306403	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of PDCD1LG2 mRNA	PMID:41034487
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306403	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of PDCD1LG2 gene	PMID:28505145
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306403	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of PDCD1LG2 mRNA	PMID:26496021
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1552436	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of PDCD1LG2 exon	PMID:33297965
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of PDCD1LG2 gene	PMID:31601247
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1552436	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of PDCD1LG2 intron	PMID:28392331
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1306403	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of PDCD1LG2 mRNA	PMID:35163327
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PDCD1LG2 mRNA	PMID:39836092
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of PDCD1LG2 mRNA	PMID:19320972
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:37415	alpha-amanitin	affects expression	ISO	RGD:1552436	E	RGD:6480464	20240903	CTD	MESH:D053959	Alpha-Amanitin affects the expression of PDCD1LG2 mRNA	PMID:38531469
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of PDCD1LG2 mRNA]	PMID:28003376
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552436	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PDCD1LG2 mRNA	PMID:40194260
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1552436	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PDCD1LG2 mRNA	PMID:37992649
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	TP53 protein affects the reaction [Fluorouracil results in decreased expression of PDCD1LG2 mRNA]	PMID:15016801
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PDCD1LG2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PDCD1LG2 mRNA	PMID:39836092
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552436	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PDCD1LG2 mRNA; Nanotubes, Carbon results in increased expression of PDCD1LG2 mRNA	PMID:25554681
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306403	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of PDCD1LG2 mRNA	PMID:24793618
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1552436	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PDCD1LG2 mRNA	PMID:19042947
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1552436	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of PDCD1LG2 mRNA	PMID:23608068
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1552436	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of PDCD1LG2 mRNA	PMID:38701926
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PDCD1LG2 mRNA	PMID:39836092
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of PDCD1LG2 mRNA	PMID:29522793
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of PDCD1LG2 mRNA	PMID:37199045
1314998	PDCD1LG2	programmed cell death 1 ligand 2	gene	CHEBI:88249	PD 0325901	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C506614	[(+)-JQ1 compound co-treated with mirdametinib] results in decreased expression of PDCD1LG2 mRNA	PMID:25119042
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550477	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of CPSF1; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CPSF1 gene	PMID:20938992
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550477	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CPSF1 mRNA	PMID:39298647
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550477	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of CPSF1; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CPSF1 gene	PMID:20938992
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CPSF1 mRNA	PMID:21179406
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Cannabidiol] results in decreased expression of CPSF1 protein	PMID:34122009
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of CPSF1 protein	PMID:37730182
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306406	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of CPSF1 mRNA	PMID:30779732
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550477	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CPSF1 mRNA	PMID:25629700
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550477	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of CPSF1; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of CPSF1 gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CPSF1 mRNA]	PMID:20938992|PMID:22206623
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CPSF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF1 mRNA	PMID:40512198
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550477	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF1 mRNA	PMID:40504410
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CPSF1 mRNA	PMID:19244175
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of CPSF1 protein	PMID:35688186
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1550477	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of CPSF1 protein	PMID:25505154
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CPSF1 mRNA	PMID:28903495
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in increased expression of CPSF1 mRNA	PMID:21858171
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550477	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CPSF1 mRNA	PMID:21570461|PMID:24680724
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of CPSF1 protein	PMID:39603559
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CPSF1 mRNA	PMID:32763439
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CPSF1 mRNA	PMID:38568856
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of CPSF1 mRNA	PMID:34032870|PMID:39719251
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CPSF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF1 mRNA	PMID:40512198
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550477	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF1 mRNA	PMID:40504410
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to CPSF1 mRNA]	PMID:32406909
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550477	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CPSF1 mRNA	PMID:17426115
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:33216	bisphenol A	affects splicing	ISO	RGD:1550477	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A affects the splicing of CPSF1 mRNA	PMID:37894381
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of CPSF1 protein	PMID:37567409
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306406	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of CPSF1 mRNA	PMID:30816183|PMID:32528016
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306406	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CPSF1 mRNA	PMID:25181051
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550477	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CPSF1 mRNA	PMID:33221593
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of CPSF1 mRNA	PMID:19244175
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1550477	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of CPSF1 gene	PMID:31683443
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1550477	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of CPSF1 mRNA	PMID:38685157
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CPSF1 mRNA	PMID:19376846
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of CPSF1 mRNA	PMID:19244175
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550477	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of CPSF1 mRNA	PMID:36331819
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1550477	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of CPSF1 mRNA	PMID:17292431
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CPSF1 gene	PMID:29154799
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	CPSF1 protein affects the susceptibility to Methotrexate	PMID:16217747
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of CPSF1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF1 mRNA	PMID:40512198
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550477	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CPSF1 mRNA	PMID:40504410
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550477	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of CPSF1 mRNA	PMID:35964746
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306406	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CPSF1 mRNA	PMID:24136188
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CPSF1 protein	PMID:32959892
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:63934	bathocuproine disulfonic acid	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:C028559	[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of CPSF1 mRNA	PMID:15477007
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cuprizone co-treated with Cannabidiol] results in decreased expression of CPSF1 protein	PMID:34122009
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1550477	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CPSF1 mRNA	PMID:22206623
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550477	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of CPSF1 mRNA]	PMID:22206623
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:749301	potassium perchlorate	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in decreased expression of CPSF1 mRNA	PMID:29673971
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of CPSF1 protein	PMID:39638853
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:78782	pyrrolidine dithiocarbamate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:C020972	pyrrolidine dithiocarbamic acid results in increased expression of CPSF1 mRNA	PMID:15477007
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:78782	pyrrolidine dithiocarbamate	multiple interactions	EXP		E	RGD:6480464	20140708	CTD	MESH:C020972	[pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of CPSF1 mRNA	PMID:15477007
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1550477	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CPSF1 mRNA	PMID:30294300
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in increased expression of CPSF1 mRNA	PMID:21858171
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1550477	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of CPSF1 protein	PMID:24648495
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306406	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CPSF1 mRNA	PMID:21346803
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1550477	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of CPSF1 mRNA	PMID:28973697
1315001	CPSF1	cleavage and polyadenylation specific factor 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1550477	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of CPSF1 mRNA	PMID:35537566
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of ISG20 mRNA	PMID:38218311
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ISG20 mRNA	PMID:35967413
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306407	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of ISG20 mRNA	PMID:21551480
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ISG20 mRNA	PMID:27188386
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ISG20 mRNA	PMID:20188158
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:149906	Tanshinone I	increases expression	EXP		E	RGD:6480464	20200602	CTD	MESH:C021751	tanshinone results in increased expression of ISG20 mRNA	PMID:15849732
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:15367	all-trans-retinoic acid	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin affects the expression of ISG20 mRNA	PMID:15498508
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ISG20 mRNA	PMID:33167477
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1315003	E	RGD:6480464	20121113	CTD	MESH:D010100	Oxygen deficiency results in increased expression of ISG20 mRNA	PMID:20880076
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1306407	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of ISG20 mRNA	PMID:33729688
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ISG20 mRNA	PMID:30529165
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of ISG20 mRNA	PMID:39506029
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1306407	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of ISG20 mRNA	PMID:36841081
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1315003	E	RGD:6480464	20121218	CTD	MESH:D011748	Pyrogallol results in increased expression of ISG20 mRNA	PMID:20362636
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ISG20 mRNA	PMID:35811015
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315003	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ISG20 mRNA	PMID:26582142|PMID:39241906
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of ISG20 mRNA]	PMID:35811015
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20161228	CTD	MESH:D008070	(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of ISG20 mRNA]	PMID:26582142
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of ISG20 mRNA	PMID:14699072
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D004958	Estradiol results in increased expression of ISG20 mRNA	PMID:15913882|PMID:19619570|PMID:20106945|PMID:24758408
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ISG20 mRNA; EGF protein promotes the reaction [Estradiol results in increased expression of ISG20 mRNA]	PMID:19619570|PMID:24758408
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306407	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of ISG20 mRNA	PMID:26496021
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of ISG20 mRNA	PMID:38568856
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:16856	glutathione	increases expression	ISO	RGD:1306407	E	RGD:6480464	20120918	CTD	MESH:D005978	Glutathione deficiency results in increased expression of ISG20 mRNA	PMID:20621112
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:17026	progesterone	affects expression	ISO	RGD:1315003	E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone affects the expression of ISG20 mRNA	PMID:17251523
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ISG20 mRNA	PMID:37992649
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of ISG20 mRNA	PMID:28973375
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of ISG20 mRNA	PMID:33848595
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of ISG20 mRNA	PMID:21592394
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of ISG20 mRNA	PMID:21592394
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ISG20 mRNA	PMID:36706583
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ISG20 mRNA	PMID:37992649
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D009538	[nickel chloride co-treated with Nicotine] results in increased expression of ISG20 mRNA	PMID:37951547
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306407	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ISG20 mRNA	PMID:26577399|PMID:27523638
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ISG20 mRNA	PMID:21592394
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of ISG20 mRNA	PMID:21592394
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ISG20 mRNA	PMID:28818685
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1306407	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of ISG20 mRNA	PMID:28522335
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:D009538	[nickel chloride co-treated with Nicotine] results in increased expression of ISG20 mRNA	PMID:37951547
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D002104	Cadmium results in decreased expression of ISG20 mRNA	PMID:21297354
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:23115	chlorohydrocarbon	multiple interactions	ISO	RGD:1306407	E	RGD:6480464	20210112	CTD	MESH:D006843	[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of ISG20 mRNA	PMID:30744511
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ISG20 mRNA	PMID:19549813
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ISG20 protein	PMID:20106945
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ISG20 mRNA	PMID:27153756
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306407	E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ISG20 mRNA	PMID:25378103
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ISG20 mRNA	PMID:23649840
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	ISO	RGD:1306407	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of ISG20 mRNA	PMID:15651846
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in increased expression of ISG20 mRNA	PMID:25102026
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:25812	ozone	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in decreased expression of ISG20 mRNA	PMID:23033980
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1306407	E	RGD:6480464	20260407	CTD	MESH:D010126	Ozone results in decreased expression of ISG20 mRNA	PMID:41580963
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	Ozone results in increased expression of ISG20 mRNA	PMID:31476115
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:D010126	[Aripiprazole co-treated with Ozone] results in increased expression of ISG20 mRNA	PMID:31476115
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ISG20 mRNA	PMID:34911549
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1315003	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ISG20 mRNA	PMID:31919559
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ISG20 mRNA	PMID:40504410
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of ISG20 mRNA	PMID:38460933
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306407	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ISG20 mRNA	PMID:31881176
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1306407	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ISG20 mRNA	PMID:25905778
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of ISG20 mRNA	PMID:23300844
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of ISG20 mRNA	PMID:40618947
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of ISG20 mRNA	PMID:32186404
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ISG20 mRNA	PMID:24768652|PMID:25583101
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ISG20 mRNA	PMID:19619570
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306407	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ISG20 mRNA	PMID:32109520|PMID:34747641
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ISG20 mRNA	PMID:19619570
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ISG20 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ISG20 mRNA	PMID:17942748|PMID:25975270
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1306407	E	RGD:6480464	20210112	CTD	MESH:C004925	[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of ISG20 mRNA	PMID:30744511
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ISG20 mRNA	PMID:33212167
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of ISG20 mRNA	PMID:23649840
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ISG20 mRNA	PMID:32763439
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ISG20 protein	PMID:28918527
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of ISG20 mRNA	PMID:39631538
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ISG20 mRNA	PMID:37992649
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of ISG20 mRNA	PMID:20044591
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D001379	Azathioprine results in decreased expression of ISG20 mRNA	PMID:19192274
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of ISG20 mRNA	PMID:20371982|PMID:21297354
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ISG20 mRNA	PMID:39719251
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ISG20 mRNA	PMID:40504410
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20210504	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ISG20 protein	PMID:32717239
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ISG20 mRNA	PMID:17942131
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ISG20 mRNA	PMID:26238291|PMID:32234424
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315003	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ISG20 mRNA	PMID:22228805
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ISG20 promoter	PMID:27901495
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ISG20 mRNA]	PMID:22228805
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to ISG20 mRNA]	PMID:32406909
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1315003	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of ISG20 mRNA	PMID:27131904
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ISG20 mRNA	PMID:25895662
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ISG20 mRNA	PMID:22300531|PMID:25351596
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1315003	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ISG20 mRNA	PMID:23221170
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:31236	aripiprazole	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C094645	Aripiprazole results in increased expression of ISG20 mRNA	PMID:31476115
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:31236	aripiprazole	multiple interactions	EXP		E	RGD:6480464	20191210	CTD	MESH:C094645	[Aripiprazole co-treated with Ozone] results in increased expression of ISG20 mRNA	PMID:31476115
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ISG20 gene	PMID:31601247
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:32181	tamibarotene	affects expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene affects the expression of ISG20 mRNA	PMID:15498508
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315003	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of ISG20 mRNA	PMID:23557971
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306407	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ISG20 mRNA	PMID:23411599
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1306407	E	RGD:6480464	20160315	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ISG20 mRNA	PMID:25380136
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1315003	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of ISG20 mRNA	PMID:18648102
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20120814	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of ISG20 mRNA	PMID:19191707
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ISG20 mRNA	PMID:30903817
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of ISG20 mRNA	PMID:27685785
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306407	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of ISG20 mRNA	PMID:32145629
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ISG20 gene	PMID:31601247
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20201103	CTD	MESH:C006780	bisphenol A analog results in increased expression of ISG20 mRNA	PMID:32387340
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306407	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ISG20 mRNA	PMID:25181051
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315003	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ISG20 mRNA	PMID:32156529
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of ISG20 gene	PMID:31601247
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306407	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of ISG20 mRNA	PMID:26496021
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ISG20 mRNA	PMID:25979313
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:34031	1,1-dichloroethene	increases expression	ISO	RGD:1315003	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in increased expression of ISG20 mRNA	PMID:26682919
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1306407	E	RGD:6480464	20140408	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ISG20 mRNA	PMID:23196670
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20230704	CTD	MESH:C008745	bisphenol F results in decreased expression of ISG20 mRNA	PMID:36706583|PMID:38685157
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1315003	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of ISG20 exon	PMID:28392331
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ISG20 mRNA	PMID:17361019
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306407	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ISG20 mRNA	PMID:21266533
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1315003	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ISG20 mRNA	PMID:17361019|PMID:21266533
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:34696	dieldrin	decreases expression	ISO	RGD:1306407	E	RGD:6480464	20210907	CTD	MESH:D004026	Dieldrin results in decreased expression of ISG20 mRNA	PMID:34051100
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1306407	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ISG20 mRNA	PMID:19638242
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306407	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ISG20 mRNA	PMID:18164116
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:34887	nickel dichloride	multiple interactions	EXP		E	RGD:6480464	20240430	CTD	MESH:C022838	[nickel chloride co-treated with Nicotine] results in increased expression of ISG20 mRNA	PMID:37951547
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:D010269	Paraquat results in increased expression of ISG20 mRNA	PMID:34097952
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1306407	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of ISG20 mRNA	PMID:32680482
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ISG20 mRNA	PMID:37042841
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:35033	triphenyl phosphate	increases expression	ISO	RGD:1306407	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in increased expression of ISG20 mRNA	PMID:30589522
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306407	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ISG20 mRNA	PMID:25380136
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ISG20 mRNA	PMID:38174414
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306407	E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ISG20 mRNA	PMID:25993096
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20210309	CTD	MESH:C023036	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of ISG20 mRNA	PMID:33325755
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20150512	CTD	MESH:C018021	cobaltous chloride results in increased expression of ISG20 mRNA	PMID:22941251
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:35807	N-nitrosodimethylamine	increases expression	ISO	RGD:1306407	E	RGD:6480464	20160315	CTD	MESH:D004128	Dimethylnitrosamine results in increased expression of ISG20 mRNA	PMID:25380136
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ISG20 mRNA	PMID:24449571
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1315003	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ISG20 mRNA	PMID:40194260
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1306407	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of ISG20 mRNA	PMID:25993096
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:4031	cyclosporin A	affects expression	EXP		E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine affects the expression of ISG20 mRNA	PMID:25224403
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in decreased expression of ISG20 mRNA	PMID:17942131|PMID:25224403
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of ISG20 promoter	PMID:27989131
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ISG20 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1315003	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in increased expression of ISG20 mRNA	PMID:25224403
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ISG20 mRNA	PMID:14699072
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR1 protein] results in increased expression of ISG20 mRNA	PMID:19059307
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:41791	calyculin A	increases expression	ISO	RGD:1315003	E	RGD:6480464	20150127	CTD	MESH:C059041	calyculin A results in increased expression of ISG20 mRNA	PMID:25270620
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of ISG20 mRNA	PMID:28973697
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ISG20 mRNA	PMID:37992649
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in decreased expression of ISG20 mRNA	PMID:19192274
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ISG20 mRNA	PMID:38832940
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1306407	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of ISG20 mRNA	PMID:21346803
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315003	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ISG20 mRNA	PMID:17562736
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ISG20 mRNA	PMID:21420995
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in decreased expression of ISG20 mRNA	PMID:17942131
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of ISG20 mRNA	PMID:26690555
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of ISG20 mRNA]	PMID:35811015
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ISG20 mRNA	PMID:25351596
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ISG20 mRNA	PMID:40504410
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:47286	CU-O LINKAGE	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C030973	cupric oxide results in increased expression of ISG20 mRNA	PMID:22077320
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:47381	diclofenac	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D004008	Diclofenac results in decreased expression of ISG20 mRNA	PMID:19192274
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of ISG20 mRNA	PMID:31838189
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1315003	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ISG20 mRNA	PMID:17555576
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306407	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ISG20 mRNA	PMID:17557909
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1315003	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of ISG20 mRNA	PMID:17942748
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ISG20 mRNA	PMID:17942748
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:4911	etoposide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	ISG20 protein affects the susceptibility to Etoposide	PMID:16217747
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ISG20 mRNA	PMID:23300844
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315003	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ISG20 mRNA; Nanotubes, Carbon results in increased expression of ISG20 mRNA	PMID:25554681
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:50729	mitoxantrone	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008942	ISG20 protein affects the susceptibility to Mitoxantrone	PMID:16217747
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306407	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ISG20 mRNA	PMID:24136188|PMID:24793618
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:53578	hexamethylene diisocyanate	increases methylation	EXP		E	RGD:6480464	20150414	CTD	MESH:C015262	1,6-hexamethylene diisocyanate results in increased methylation of ISG20 promoter	PMID:25445006
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:5516	sodium aurothiomalate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D006052	Gold Sodium Thiomalate results in decreased expression of ISG20 mRNA	PMID:19192274
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:5643	Heliotrine	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C010178	heliotrine results in increased expression of ISG20 mRNA	PMID:26100227
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ISG20 mRNA	PMID:26378955
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of ISG20 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ISG20 mRNA	PMID:21641980|PMID:26378955
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1315003	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of ISG20 mRNA	PMID:19812364
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of ISG20 mRNA	PMID:15336504
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1306407	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of ISG20 mRNA	PMID:35283115
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:6809	methamphetamine	increases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D008694	Methamphetamine results in increased expression of ISG20 mRNA	PMID:25290377
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:6888	6alpha-methylprednisolone	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008775	Methylprednisolone results in decreased expression of ISG20 mRNA	PMID:19192274
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of ISG20 mRNA	PMID:31758290
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:75408	sulindac sulfide	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C025462	sulindac sulfide results in increased expression of ISG20 mRNA	PMID:16184548
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:76989	phytoestrogen	multiple interactions	EXP		E	RGD:6480464	20210309	CTD	MESH:D048789	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in decreased expression of ISG20 mRNA	PMID:33325755
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:77013	beta-naphthoflavone	multiple interactions	ISO	RGD:1306407	E	RGD:6480464	20140204	CTD	MESH:D019324	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ISG20 mRNA	PMID:18164116
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of ISG20 mRNA	PMID:19159669
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of ISG20 mRNA	PMID:39904859
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1315003	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of ISG20 mRNA	PMID:17942131
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1315003	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of ISG20 mRNA	PMID:30294300
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of ISG20 mRNA	PMID:32234424
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D010894	Piroxicam results in decreased expression of ISG20 mRNA	PMID:19192274
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:8378	prednisolone	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D011239	Prednisolone results in decreased expression of ISG20 mRNA	PMID:19192274
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of ISG20 mRNA	PMID:35688559
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of ISG20 mRNA	PMID:36706583
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:8772	raloxifene	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride affects the expression of ISG20 mRNA	PMID:14699072
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of ISG20 mRNA	PMID:19059307
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:9107	senecionine	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C009237	senecionine results in increased expression of ISG20 mRNA	PMID:26100227
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:9111	Senkirkine	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C009238	senkirkine results in increased expression of ISG20 mRNA	PMID:26100227
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1315003	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of ISG20 mRNA	PMID:27131904
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306407	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ISG20 mRNA	PMID:21346803
1315002	ISG20	interferon stimulated exonuclease gene 20	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1315003	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ISG20 mRNA	PMID:18930950
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1315005	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of KCMF1 mRNA	PMID:30529165
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:16164	pyrogallol	increases expression	ISO	RGD:1315005	E	RGD:6480464	20130618	CTD	MESH:D011748	Pyrogallol results in increased expression of KCMF1 mRNA	PMID:20362636
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1315005	E	RGD:6480464	20161025	CTD	MESH:D000431	Ethanol affects the expression of KCMF1 mRNA	PMID:26730594
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1315005	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of KCMF1 mRNA	PMID:30319688
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of KCMF1 mRNA	PMID:38568856
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of KCMF1 mRNA	PMID:23649840
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1315005	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KCMF1 mRNA	PMID:33754040
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1591490	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of KCMF1 mRNA	PMID:33387578
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of KCMF1 mRNA	PMID:28818685
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of KCMF1 mRNA	PMID:19549813
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of KCMF1 protein	PMID:23301498
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of KCMF1 mRNA	PMID:23649840
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KCMF1 gene	PMID:27153756
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of KCMF1 mRNA	PMID:23649840
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1315005	E	RGD:6480464	20130618	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of KCMF1 mRNA	PMID:17484886
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1591490	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KCMF1 mRNA	PMID:31150632
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315005	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KCMF1 mRNA	PMID:22206623
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of KCMF1 protein	PMID:35688186
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of KCMF1 mRNA	PMID:23557933
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of KCMF1 mRNA	PMID:28903495
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315005	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KCMF1 mRNA	PMID:18343893|PMID:21570461
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315005	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KCMF1 mRNA	PMID:17942748
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315005	E	RGD:6480464	20130618	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KCMF1 mRNA	PMID:17942748
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of KCMF1 mRNA	PMID:28001369
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KCMF1 mRNA	PMID:30851411
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of KCMF1 mRNA	PMID:23649840
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of KCMF1 mRNA	PMID:32763439
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of KCMF1 mRNA	PMID:38568856
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315005	E	RGD:6480464	20130618	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KCMF1 mRNA	PMID:22228805
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to KCMF1 mRNA]	PMID:32406909
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of KCMF1 mRNA	PMID:26014281
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:31823	mercury dichloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D008627	[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCMF1 mRNA	PMID:27188386
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315005	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of KCMF1 mRNA	PMID:23811191
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of KCMF1 mRNA	PMID:30903817
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of KCMF1 protein	PMID:31675489
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315005	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of KCMF1 mRNA	PMID:33221593
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of KCMF1 mRNA	PMID:33670352
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315005	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of KCMF1 mRNA; bisphenol A results in increased expression of KCMF1 protein	PMID:26063408|PMID:26903627
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1591490	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KCMF1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of KCMF1 protein	PMID:31675489
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of KCMF1 mRNA	PMID:25979313
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1315005	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of KCMF1 mRNA	PMID:37019170
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1315005	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of KCMF1 mRNA	PMID:34813904
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1315005	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of KCMF1 mRNA	PMID:34813904
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KCMF1 mRNA	PMID:37042841
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of KCMF1 mRNA	PMID:19320972|PMID:19376846
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:38729	naled	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:D009267	Naled affects the expression of KCMF1 mRNA	PMID:40434365
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of KCMF1 mRNA	PMID:31533062
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KCMF1 mRNA	PMID:25979313
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315005	E	RGD:6480464	20130618	CTD	MESH:D014635	Valproic Acid affects the expression of KCMF1 mRNA	PMID:17963808
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of KCMF1 mRNA	PMID:23179753
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of KCMF1 gene	PMID:29154799
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of KCMF1 mRNA	PMID:20106945
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1315005	E	RGD:6480464	20130618	CTD	MESH:D016572	Cyclosporine results in increased expression of KCMF1 mRNA	PMID:19770486
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of KCMF1 mRNA	PMID:23649840
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	KCMF1 protein affects the susceptibility to Methotrexate	PMID:16217747
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1591490	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of KCMF1 mRNA	PMID:24136188
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of KCMF1 mRNA	PMID:28542535
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of KCMF1 mRNA	PMID:24935251|PMID:26272509
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCMF1 mRNA	PMID:27188386
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of KCMF1 mRNA	PMID:36621641
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1591490	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of KCMF1 mRNA	PMID:29391264
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1315005	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of KCMF1 mRNA	PMID:35436446
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1315005	E	RGD:6480464	20130618	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of KCMF1 mRNA	PMID:17942748
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315005	E	RGD:6480464	20130618	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of KCMF1 mRNA	PMID:17942748
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1591490	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KCMF1 mRNA	PMID:24136188
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:52717	bortezomib	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in increased expression of KCMF1 mRNA	PMID:20977926
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of KCMF1 protein	PMID:32959892
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1591490	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of KCMF1 mRNA	PMID:24136188
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1315005	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of KCMF1 mRNA	PMID:23650126
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of KCMF1 mRNA	PMID:28988120
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of KCMF1 protein	PMID:34186270
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315005	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of KCMF1 mRNA	PMID:22206623
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315005	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KCMF1 mRNA	PMID:22206623
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1591490	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of KCMF1 mRNA	PMID:24136188
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KCMF1 mRNA	PMID:30851411
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCMF1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCMF1 mRNA	PMID:27188386
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of KCMF1 mRNA	PMID:19159669
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1315005	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of KCMF1 mRNA	PMID:18343893
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1315005	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of KCMF1 mRNA	PMID:31388691
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of KCMF1 protein	PMID:31675489
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of KCMF1 protein	PMID:31675489
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Mercuric Chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCMF1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCMF1 mRNA	PMID:27188386
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of KCMF1 mRNA	PMID:26014281
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of KCMF1 mRNA	PMID:38568856
1315004	KCMF1	potassium channel modulatory factor 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of KCMF1 mRNA	PMID:29301935
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1620396	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of NEURL2 mRNA	PMID:33045310
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306409	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NEURL2 mRNA]	PMID:31150632
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1306409	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of NEURL2 mRNA	PMID:36841081
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1306409	E	RGD:6480464	20120412	CTD	MESH:D000431	[Fish Oils co-treated with Ethanol] results in increased expression of NEURL2 mRNA	PMID:17347304
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1620396	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of NEURL2 mRNA	PMID:39241906
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of NEURL2 mRNA	PMID:30510588
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of NEURL2 mRNA	PMID:31614463
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306409	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of NEURL2 mRNA	PMID:33387578
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306409	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of NEURL2 mRNA	PMID:33387578
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of NEURL2 mRNA	PMID:28818685
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of NEURL2 mRNA	PMID:19549813
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:23995	N-ethyl-N-nitrosourea	increases mutagenesis	ISO	RGD:1620396	E	RGD:6480464	20180313	CTD	MESH:D005038	Ethylnitrosourea results in increased mutagenesis of NEURL2 mRNA	PMID:27776689
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NEURL2 mRNA	PMID:21641981
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1620396	E	RGD:6480464	20130618	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of NEURL2 mRNA	PMID:17484886
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306409	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of NEURL2 mRNA	PMID:31150632
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306409	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NEURL2 mRNA]	PMID:31150632
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1620396	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of NEURL2 mRNA	PMID:28960355
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306409	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of NEURL2 mRNA	PMID:31881176
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of NEURL2 mRNA	PMID:27392435
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of NEURL2 mRNA	PMID:24768652|PMID:25583101
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NEURL2 mRNA	PMID:22298810
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620396	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NEURL2 mRNA	PMID:20702594
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306409	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NEURL2 mRNA	PMID:21215274
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NEURL2 mRNA	PMID:20106945|PMID:21632981
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306409	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NEURL2 mRNA	PMID:33387578
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1620396	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of NEURL2 mRNA	PMID:27862939
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of NEURL2 mRNA	PMID:29803840
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1620396	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of NEURL2 mRNA	PMID:37682722
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NEURL2 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:31823	mercury dichloride	decreases expression	ISO	RGD:1306409	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in decreased expression of NEURL2 mRNA	PMID:16507785
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620396	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of NEURL2 gene; titanium dioxide results in decreased methylation of NEURL2 promoter	PMID:35295148
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306409	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of NEURL2 mRNA	PMID:23411599|PMID:34492290
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1620396	E	RGD:6480464	20130618	CTD	MESH:C006253	pirinixic acid affects the expression of NEURL2 mRNA	PMID:19136022
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1620396	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NEURL2 mRNA	PMID:18301758|PMID:21318169|PMID:23811191
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1620396	E	RGD:6480464	20130618	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NEURL2 mRNA; PPARA protein affects the reaction [pirinixic acid results in increased expression of NEURL2 mRNA]	PMID:19710929|PMID:21318169
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306409	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NEURL2 mRNA	PMID:25181051|PMID:34947998
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306409	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of NEURL2 mRNA	PMID:30816183|PMID:32528016
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1620396	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of NEURL2 promoter	PMID:33297965
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1620396	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of NEURL2 mRNA	PMID:38685157
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1620396	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of NEURL2 mRNA	PMID:37019170
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1306409	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of NEURL2 mRNA	PMID:30723492
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306409	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NEURL2 mRNA	PMID:33453195
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1306409	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of NEURL2 promoter	PMID:22457795
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of NEURL2 mRNA	PMID:24449571
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1620396	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NEURL2 mRNA	PMID:40194260
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of NEURL2 mRNA	PMID:31533062
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of NEURL2 mRNA	PMID:40419075
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1620396	E	RGD:6480464	20130618	CTD	MESH:D014635	Valproic Acid affects the expression of NEURL2 mRNA	PMID:17963808
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NEURL2 mRNA	PMID:25562108
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1620396	E	RGD:6480464	20130618	CTD	MESH:D016572	Cyclosporine results in decreased expression of NEURL2 mRNA	PMID:19770486
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1620396	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of NEURL2 mRNA	PMID:28973697
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NEURL2 mRNA	PMID:38832940
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:50091	S-nitrosoglutathione	affects expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione affects the expression of NEURL2 mRNA	PMID:38825487
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620396	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of NEURL2 mRNA	PMID:25554681
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306409	E	RGD:6480464	20200519	CTD	MESH:C082360	fipronil results in increased expression of NEURL2 mRNA	PMID:31881178
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1620396	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of NEURL2 mRNA	PMID:36907384
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1306409	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of NEURL2 mRNA	PMID:19564919
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1306409	E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in decreased expression of NEURL2 mRNA	PMID:19564919
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:73297	SCH 23390	decreases expression	ISO	RGD:1306409	E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 results in decreased expression of NEURL2 mRNA	PMID:19564919
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:73297	SCH 23390	multiple interactions	ISO	RGD:1306409	E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in decreased expression of NEURL2 mRNA	PMID:19564919
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1620396	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of NEURL2 mRNA	PMID:22206623
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1620396	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of NEURL2 mRNA	PMID:25566086
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1306409	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased expression of NEURL2 mRNA	PMID:37162024
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:7719	ochratoxin A	increases methylation	ISO	RGD:1306409	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased methylation of NEURL2 gene	PMID:37162024
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1620396	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital affects the expression of NEURL2 mRNA	PMID:19136022
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	affects expression	ISO	RGD:1620396	E	RGD:6480464	20141111	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran affects the expression of NEURL2 mRNA	PMID:20702594
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306409	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of NEURL2 mRNA	PMID:24780913
1315006	NEURL2	neuralized E3 ubiquitin protein ligase 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306409	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of NEURL2 mRNA	PMID:23034163
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:132098	methoxyacetic acid	decreases expression	ISO	RGD:1306410	E	RGD:6480464	20230214	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of CCZ1 mRNA	PMID:20864626
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306410	E	RGD:6480464	20260811	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of CCZ1B protein	PMID:34915118
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1620597	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCZ1 mRNA	PMID:37325564
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1620597	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of CCZ1 mRNA	PMID:25629700
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1620597	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCZ1 mRNA	PMID:22206623
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:1306410	E	RGD:6480464	20230214	CTD	MESH:D002110	Caffeine results in decreased expression of CCZ1 mRNA	PMID:20864626
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CCZ1 protein	PMID:35688186
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1306410	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of CCZ1 mRNA	PMID:26302742
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1620597	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of CCZ1 mRNA	PMID:28960355
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of CCZ1 mRNA	PMID:12629581
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1620597	E	RGD:6480464	20161011	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of CCZ1 mRNA	PMID:24680724
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306410	E	RGD:6480464	20260811	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCZ1B mRNA	PMID:33387578
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1306410	E	RGD:6480464	20230214	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of CCZ1 mRNA	PMID:20864626
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CCZ1 mRNA	PMID:29803840
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CCZ1 mRNA	PMID:38568856
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CCZ1 promoter	PMID:27901495
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1620597	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CCZ1 gene	PMID:35295148
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306410	E	RGD:6480464	20230214	CTD	MESH:C006780	bisphenol A affects the expression of CCZ1 mRNA; bisphenol A affects the expression of CCZ1B mRNA	PMID:25181051|PMID:30816183
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306410	E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in decreased expression of CCZ1B mRNA	PMID:41034487
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306410	E	RGD:6480464	20260811	CTD	MESH:C006780	bisphenol A results in increased expression of CCZ1B mRNA	PMID:41034487
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1620597	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CCZ1 mRNA	PMID:39298647
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1620597	E	RGD:6480464	20161011	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CCZ1 mRNA	PMID:21266533
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1620597	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of CCZ1 mRNA	PMID:34813904
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CCZ1 mRNA	PMID:37042841
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1620597	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCZ1 mRNA	PMID:37325564
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1306410	E	RGD:6480464	20260811	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of CCZ1B protein	PMID:34958885
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1620597	E	RGD:6480464	20161011	CTD	MESH:D014635	Valproic Acid affects the expression of CCZ1 mRNA	PMID:17963808
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of CCZ1 mRNA	PMID:38832940
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306410	E	RGD:6480464	20260811	CTD	MESH:D000082	Acetaminophen results in decreased expression of CCZ1B mRNA	PMID:33387578
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306410	E	RGD:6480464	20260811	CTD	MESH:D018120	Finasteride results in increased expression of CCZ1B mRNA	PMID:24136188
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CCZ1 protein	PMID:32959892
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1620597	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CCZ1 mRNA	PMID:22206623
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1620597	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCZ1 mRNA	PMID:22206623
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1620597	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of CCZ1 mRNA	PMID:31388691
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1306410	E	RGD:6480464	20230214	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of CCZ1 mRNA	PMID:20864626
1315007	CCZ1	CCZ1 vacuolar protein trafficking and biogenesis associated	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1306410	E	RGD:6480464	20260811	CTD	MESH:D013467	Sulindac results in increased expression of CCZ1B mRNA	PMID:24136188
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of POP7 mRNA	PMID:33167477
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of POP7 mRNA	PMID:26516004
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315011	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of POP7 mRNA	PMID:30319688
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315011	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of POP7 mRNA	PMID:39241906
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306413	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of POP7 mRNA	PMID:32145629
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of POP7 mRNA	PMID:37042841
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315011	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of POP7 mRNA	PMID:34319233
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of POP7 mRNA	PMID:19549813
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306413	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of POP7 mRNA	PMID:31150632
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315011	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of POP7 mRNA	PMID:21570461
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306413	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of POP7 mRNA	PMID:33387578
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306413	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of POP7 mRNA	PMID:21215274
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315011	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POP7 mRNA	PMID:17942748
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of POP7 mRNA	PMID:33212167
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:28694	copper atom	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of POP7 mRNA	PMID:19747488
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of POP7 mRNA	PMID:20044591
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of POP7 mRNA	PMID:38568856
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of POP7 mRNA	PMID:34032870
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of POP7 3' UTR	PMID:27901495
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to POP7 mRNA]	PMID:32406909
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:30052	copper(0)	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	Copper results in decreased expression of POP7 mRNA	PMID:19747488
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of POP7 mRNA	PMID:20382639
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306413	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of POP7 mRNA	PMID:24136188
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306413	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of POP7 mRNA	PMID:25729387
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315011	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of POP7 gene	PMID:35295148
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306413	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of POP7 mRNA	PMID:23411599|PMID:34492290
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1315011	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of POP7 mRNA	PMID:18648102
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306413	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of POP7 mRNA	PMID:25181051
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of POP7 protein	PMID:33376534
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306413	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of POP7 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306413	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of POP7 mRNA	PMID:32145629
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315011	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of POP7 mRNA	PMID:39298647
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of POP7 mRNA	PMID:19320972
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:37825	p-toluidine	decreases expression	ISO	RGD:1306413	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in decreased expression of POP7 mRNA	PMID:27638505
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1306413	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of POP7 mRNA	PMID:25993096
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315011	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of POP7 mRNA	PMID:17963808
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1315011	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of POP7 mRNA	PMID:19136453|PMID:21427059
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of POP7 mRNA	PMID:23179753
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of POP7 mRNA	PMID:38832940
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315011	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of POP7 mRNA	PMID:17562736
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306413	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of POP7 mRNA	PMID:33387578
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of POP7 mRNA	PMID:29523930
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306413	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of POP7 mRNA	PMID:29391264
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315011	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POP7 mRNA	PMID:17942748
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315011	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of POP7 mRNA	PMID:25554681
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306413	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of POP7 mRNA	PMID:24793618
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306413	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of POP7 mRNA	PMID:24136188
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306413	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of POP7 mRNA	PMID:25729387
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of POP7 mRNA	PMID:28988120
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of POP7 mRNA	PMID:21858171
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1315011	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of POP7 mRNA	PMID:40826991
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306413	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of POP7 mRNA	PMID:19281266
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306413	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of POP7 mRNA	PMID:21346803
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of POP7 mRNA	PMID:22378314
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306413	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of POP7 mRNA	PMID:21346803
1315010	POP7	POP7 ribonuclease P/MRP subunit	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306413	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of POP7 mRNA	PMID:23034163
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of ASB2 mRNA	PMID:35967413
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ASB2 mRNA	PMID:33167477
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ASB2 mRNA	PMID:26079696
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:15756	hexadecanoic acid	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:D019308	Palmitic Acid results in increased expression of ASB2 mRNA	PMID:32347412
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1315013	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of ASB2 mRNA	PMID:40945087
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of ASB2 mRNA	PMID:21632981
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315013	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ASB2 mRNA	PMID:39241906
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ASB2 mRNA	PMID:30510588
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ASB2 mRNA	PMID:37042841
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:17026	progesterone	increases expression	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	Progesterone results in increased expression of ASB2 mRNA	PMID:21768398
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Progesterone co-treated with TGFB1 protein] results in increased expression of ASB2 mRNA	PMID:21768398
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of ASB2 mRNA	PMID:26079696
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315013	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASB2 mRNA	PMID:37992649
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1315013	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of ASB2 mRNA	PMID:28973375
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315013	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASB2 mRNA	PMID:37992649
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ASB2 mRNA	PMID:28818685
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ASB2 intron; aflatoxin B2 results in increased methylation of ASB2 promoter	PMID:30157460
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:188851	Muraglitazar	increases expression	ISO	RGD:1306414	E	RGD:6480464	20220104	CTD	MESH:C500085	muraglitazar results in increased expression of ASB2 mRNA	PMID:21515302
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:2038	5-azacytidine	increases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in increased expression of ASB2 mRNA	PMID:20823114
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1315013	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ASB2 mRNA	PMID:29950665
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ASB2 mRNA	PMID:19549813
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of ASB2 exon; Aflatoxin B1 results in decreased methylation of ASB2 intron; Aflatoxin B1 results in decreased methylation of ASB2 promoter	PMID:30157460
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ASB2 mRNA	PMID:35430440
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315013	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ASB2 mRNA	PMID:34911549
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:27638	cobalt atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003035	[tungsten carbide binds to Cobalt] which results in increased expression of ASB2 mRNA	PMID:20105288
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of ASB2 mRNA	PMID:19921347
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ASB2 mRNA	PMID:27594783
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1315013	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of ASB2 mRNA	PMID:32186404
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306414	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ASB2 mRNA	PMID:34747641
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306414	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ASB2 mRNA	PMID:32109520
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ASB2 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:27913140
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315013	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ASB2 mRNA	PMID:20819909|PMID:26290441
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315013	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ASB2 gene]	PMID:20819909
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of ASB2 mRNA	PMID:29955902
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1315013	E	RGD:6480464	20210907	CTD	MESH:D012402	Rotenone results in increased expression of ASB2 mRNA	PMID:32937126
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ASB2 mRNA	PMID:33212167
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306414	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ASB2 mRNA	PMID:30556269
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin affects the expression of ASB2 mRNA	PMID:29803840
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1315013	E	RGD:6480464	20150609	CTD	MESH:D004317	Doxorubicin results in decreased expression of ASB2 mRNA	PMID:25896364|PMID:39631538
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315013	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASB2 mRNA	PMID:37992649
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of ASB2 mRNA	PMID:39719251
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ASB2 3' UTR; Benzo(a)pyrene affects the methylation of ASB2 intron	PMID:27901495|PMID:30157460
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1306414	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ASB2 mRNA	PMID:21839799
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ASB2 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:21871943|PMID:22316170|PMID:30453624
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ASB2 5' UTR	PMID:27901495
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene results in increased expression of ASB2 mRNA]	PMID:20064835
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306414	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of ASB2 mRNA	PMID:30556269
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of ASB2 mRNA	PMID:25895662
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:3139	bleomycin A2	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:D001761	Bleomycin results in decreased expression of ASB2 mRNA	PMID:40645554
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:31941	oxaliplatin	increases expression	ISO	RGD:1306414	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of ASB2 mRNA	PMID:25729387
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306414	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of ASB2 mRNA	PMID:25729387
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C061133	tamibarotene results in increased expression of ASB2 mRNA	PMID:17229644
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:32195	Tesaglitazar	increases expression	ISO	RGD:1306414	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of ASB2 mRNA	PMID:21515302
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315013	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ASB2 mRNA	PMID:23557971
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1315013	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ASB2 mRNA	PMID:29950665
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306414	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ASB2 mRNA	PMID:25181051
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306414	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ASB2 mRNA	PMID:32145629|PMID:34947998|PMID:38750585
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306414	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ASB2 gene	PMID:28505145
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315013	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of ASB2 mRNA	PMID:39298647
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315013	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ASB2 mRNA	PMID:30951980
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1315013	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of ASB2 mRNA	PMID:26377693
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ASB2 intron; benzo(e)pyrene results in increased methylation of ASB2 promoter	PMID:30157460
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315013	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ASB2 mRNA	PMID:30951980
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1315013	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ASB2 mRNA	PMID:32715474
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1315013	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ASB2 mRNA	PMID:29950665
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1315013	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of ASB2 mRNA	PMID:34813904
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1315013	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of ASB2 mRNA	PMID:34813904
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate results in increased expression of ASB2 mRNA	PMID:29024780
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1306414	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of ASB2 mRNA	PMID:35163327
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306414	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ASB2 mRNA	PMID:35163327
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1306414	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of ASB2 mRNA	PMID:30723492
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ASB2 mRNA	PMID:38382870
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ASB2 mRNA	PMID:38568856
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306414	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ASB2 mRNA	PMID:35163327
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C018021	cobaltous chloride results in increased expression of ASB2 mRNA	PMID:20105288
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1315013	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of ASB2 mRNA	PMID:28962523
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1315013	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ASB2 mRNA	PMID:40194260
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of ASB2 mRNA	PMID:28001369
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ASB2 gene	PMID:29154799
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ASB2 mRNA	PMID:25562108
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:41879	dexamethasone	increases expression	ISO	RGD:1315013	E	RGD:6480464	20140408	CTD	MESH:D003907	Dexamethasone results in increased expression of ASB2 mRNA	PMID:22733784
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315013	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ASB2 mRNA	PMID:37992649
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of ASB2 mRNA	PMID:24935251
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1306414	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of ASB2 mRNA	PMID:21346803
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:47807	sulforaphane	increases expression	ISO	RGD:1315013	E	RGD:6480464	20190312	CTD	MESH:C016766	sulforaphane results in increased expression of ASB2 mRNA	PMID:30529165
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:53050	trimellitic anhydride	decreases expression	EXP		E	RGD:6480464	20260113	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of ASB2 mRNA	PMID:40645554
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1315013	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ASB2 mRNA	PMID:19042947
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1306414	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of ASB2 mRNA	PMID:25729387
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306414	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of ASB2 mRNA	PMID:25729387
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1315013	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of ASB2 mRNA	PMID:36907384
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ASB2 intron; Methapyrilene results in increased methylation of ASB2 promoter	PMID:30157460
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:69478	cannabidiol	increases expression	ISO	RGD:1315013	E	RGD:6480464	20201215	CTD	MESH:D002185	Cannabidiol results in increased expression of ASB2 mRNA	PMID:27256343
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315013	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ASB2 mRNA	PMID:22206623
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	ISO	RGD:1315013	E	RGD:6480464	20160315	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ASB2 mRNA	PMID:25566086
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1306414	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of ASB2 mRNA	PMID:33484710
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:79997	GW 4064	increases expression	ISO	RGD:1315013	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in increased expression of ASB2 mRNA	PMID:26655953
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:80630	irinotecan	affects expression	ISO	RGD:1306414	E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan affects the expression of ASB2 mRNA	PMID:20097248
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306414	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ASB2 mRNA	PMID:32109520
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:82283	Tungsten carbide	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C002802	[tungsten carbide binds to Cobalt] which results in increased expression of ASB2 mRNA	PMID:20105288
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of ASB2 mRNA	PMID:26079696
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1315013	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of ASB2 mRNA	PMID:39847705
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ASB2 mRNA	PMID:29301935
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1306414	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of ASB2 mRNA	PMID:21515302
1315012	ASB2	ankyrin repeat and SOCS box containing 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306414	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of ASB2 mRNA	PMID:23034163
1315016	EPN3	epsin 3	gene	CHEBI:10106	zearalenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in decreased expression of EPN3 mRNA	PMID:19371625
1315016	EPN3	epsin 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315017	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of EPN3 mRNA	PMID:33045310
1315016	EPN3	epsin 3	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1315017	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of EPN3 mRNA	PMID:37995155
1315016	EPN3	epsin 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1315017	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of EPN3 mRNA	PMID:36331819
1315016	EPN3	epsin 3	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of EPN3 mRNA	PMID:20044591
1315016	EPN3	epsin 3	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of EPN3 mRNA	PMID:21632981
1315016	EPN3	epsin 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of EPN3 mRNA	PMID:30165855
1315016	EPN3	epsin 3	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of EPN3 mRNA	PMID:26079696
1315016	EPN3	epsin 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315017	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPN3 mRNA	PMID:37992649
1315016	EPN3	epsin 3	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1315017	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of EPN3 mRNA	PMID:36706583
1315016	EPN3	epsin 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315017	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPN3 mRNA	PMID:37992649
1315016	EPN3	epsin 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of EPN3 mRNA	PMID:31163220
1315016	EPN3	epsin 3	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306416	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of EPN3 mRNA	PMID:33387578
1315016	EPN3	epsin 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of EPN3 mRNA	PMID:28818685
1315016	EPN3	epsin 3	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1315017	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of EPN3 mRNA	PMID:33914522
1315016	EPN3	epsin 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of EPN3 mRNA	PMID:19549813
1315016	EPN3	epsin 3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of EPN3 mRNA	PMID:21641981
1315016	EPN3	epsin 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of EPN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EPN3 mRNA	PMID:40512198
1315016	EPN3	epsin 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315017	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EPN3 mRNA	PMID:40504410
1315016	EPN3	epsin 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of EPN3 mRNA	PMID:26272509
1315016	EPN3	epsin 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA	PMID:27188386
1315016	EPN3	epsin 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of EPN3 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of EPN3 mRNA	PMID:23557933|PMID:41028656
1315016	EPN3	epsin 3	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of EPN3 mRNA	PMID:27392435
1315016	EPN3	epsin 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of EPN3 mRNA	PMID:27392435
1315016	EPN3	epsin 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315017	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EPN3 mRNA	PMID:21570461
1315016	EPN3	epsin 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPN3 mRNA	PMID:21632981
1315016	EPN3	epsin 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1315017	E	RGD:6480464	20210907	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EPN3 mRNA	PMID:33956508
1315016	EPN3	epsin 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of EPN3 mRNA	PMID:23152189
1315016	EPN3	epsin 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EPN3 mRNA	PMID:30851411
1315016	EPN3	epsin 3	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1315017	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide results in decreased expression of EPN3 mRNA	PMID:35032568
1315016	EPN3	epsin 3	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of EPN3 mRNA	PMID:41028656
1315016	EPN3	epsin 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315017	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPN3 mRNA	PMID:37992649
1315016	EPN3	epsin 3	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of EPN3 mRNA	PMID:20044591
1315016	EPN3	epsin 3	gene	CHEBI:29021	hexane	decreases methylation	ISO	RGD:1306416	E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of EPN3 promoter	PMID:23740543
1315016	EPN3	epsin 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of EPN3 mRNA	PMID:34032870|PMID:39719251
1315016	EPN3	epsin 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of EPN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EPN3 mRNA	PMID:40512198
1315016	EPN3	epsin 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315017	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EPN3 mRNA	PMID:40504410
1315016	EPN3	epsin 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EPN3 promoter	PMID:27901495
1315016	EPN3	epsin 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1306416	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EPN3 mRNA	PMID:21839799
1315016	EPN3	epsin 3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315017	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of EPN3 mRNA	PMID:22228805
1315016	EPN3	epsin 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of EPN3 5' UTR; Benzo(a)pyrene results in decreased methylation of EPN3 exon	PMID:27901495
1315016	EPN3	epsin 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EPN3 mRNA	PMID:21632981
1315016	EPN3	epsin 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315017	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EPN3 mRNA	PMID:27195522
1315016	EPN3	epsin 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of EPN3 3' UTR	PMID:27901495
1315016	EPN3	epsin 3	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of EPN3 mRNA	PMID:41028656
1315016	EPN3	epsin 3	gene	CHEBI:30563	silicon dioxide	affects expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog affects the expression of EPN3 mRNA	PMID:25895662
1315016	EPN3	epsin 3	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1306416	E	RGD:6480464	20180703	CTD	MESH:C004312	glycidol results in increased expression of EPN3 mRNA	PMID:24395379
1315016	EPN3	epsin 3	gene	CHEBI:31941	oxaliplatin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in increased expression of EPN3 mRNA	PMID:16510598
1315016	EPN3	epsin 3	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306416	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of EPN3 mRNA	PMID:30047161
1315016	EPN3	epsin 3	gene	CHEBI:32195	Tesaglitazar	increases expression	ISO	RGD:1306416	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of EPN3 mRNA	PMID:21515302
1315016	EPN3	epsin 3	gene	CHEBI:32234	titanium dioxide	affects methylation	ISO	RGD:1315017	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide affects the methylation of EPN3 gene	PMID:35295148
1315016	EPN3	epsin 3	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1315017	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of EPN3 mRNA	PMID:33914522
1315016	EPN3	epsin 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306416	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of EPN3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1315016	EPN3	epsin 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315017	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of EPN3 mRNA	PMID:32156529
1315016	EPN3	epsin 3	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of EPN3 mRNA	PMID:24752500|PMID:25979313
1315016	EPN3	epsin 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315017	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of EPN3 mRNA	PMID:30951980
1315016	EPN3	epsin 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1315017	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of EPN3 mRNA	PMID:38685157
1315016	EPN3	epsin 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315017	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of EPN3 mRNA	PMID:30951980
1315016	EPN3	epsin 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1306416	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of EPN3 mRNA	PMID:21241498
1315016	EPN3	epsin 3	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306416	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of EPN3 mRNA	PMID:35163327
1315016	EPN3	epsin 3	gene	CHEBI:351346	phenethyl isothiocyanate	increases expression	ISO	RGD:1306416	E	RGD:6480464	20120412	CTD	MESH:C058305	phenethyl isothiocyanate results in increased expression of EPN3 mRNA	PMID:17616710
1315016	EPN3	epsin 3	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306416	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of EPN3 mRNA	PMID:35163327
1315016	EPN3	epsin 3	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306416	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of EPN3 mRNA	PMID:27387713
1315016	EPN3	epsin 3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1315017	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of EPN3 mRNA	PMID:40194260
1315016	EPN3	epsin 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of EPN3 mRNA	PMID:31533062
1315016	EPN3	epsin 3	gene	CHEBI:39178	clothianidin	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in decreased expression of EPN3 mRNA	PMID:31626844
1315016	EPN3	epsin 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315017	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of EPN3 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of EPN3 mRNA	PMID:36331819
1315016	EPN3	epsin 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of EPN3 mRNA	PMID:25979313
1315016	EPN3	epsin 3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315017	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of EPN3 mRNA	PMID:17292431
1315016	EPN3	epsin 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of EPN3 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509
1315016	EPN3	epsin 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA	PMID:27188386
1315016	EPN3	epsin 3	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306416	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of EPN3 mRNA	PMID:30047161
1315016	EPN3	epsin 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315017	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of EPN3 mRNA	PMID:37992649
1315016	EPN3	epsin 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of EPN3 mRNA	PMID:24935251
1315016	EPN3	epsin 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1306416	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of EPN3 mRNA	PMID:33387578
1315016	EPN3	epsin 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315017	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of EPN3 mRNA	PMID:17562736
1315016	EPN3	epsin 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of EPN3 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EPN3 mRNA	PMID:40512198
1315016	EPN3	epsin 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315017	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of EPN3 mRNA	PMID:40504410
1315016	EPN3	epsin 3	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of EPN3 mRNA	PMID:24752500
1315016	EPN3	epsin 3	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306416	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of EPN3 mRNA	PMID:29391264
1315016	EPN3	epsin 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306416	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of EPN3 mRNA	PMID:17557909
1315016	EPN3	epsin 3	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of EPN3 mRNA	PMID:26272509
1315016	EPN3	epsin 3	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA	PMID:27188386
1315016	EPN3	epsin 3	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306416	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of EPN3 mRNA	PMID:30047161
1315016	EPN3	epsin 3	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of EPN3 mRNA	PMID:37939859
1315016	EPN3	epsin 3	gene	CHEBI:69478	cannabidiol	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D002185	Cannabidiol results in decreased expression of EPN3 mRNA	PMID:33244087
1315016	EPN3	epsin 3	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of EPN3 mRNA	PMID:37199045
1315016	EPN3	epsin 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of EPN3 mRNA	PMID:30851411
1315016	EPN3	epsin 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA	PMID:27188386
1315016	EPN3	epsin 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to EPN3 gene]	PMID:28238834
1315016	EPN3	epsin 3	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306416	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of EPN3 mRNA	PMID:24780913|PMID:25825206
1315016	EPN3	epsin 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306416	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of EPN3 mRNA	PMID:30047161
1315016	EPN3	epsin 3	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1315017	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of EPN3 mRNA	PMID:36706583
1315016	EPN3	epsin 3	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA	PMID:27188386
1315016	EPN3	epsin 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPN3 mRNA	PMID:27188386
1315016	EPN3	epsin 3	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1306416	E	RGD:6480464	20120918	CTD	MESH:C057693	troglitazone results in increased expression of EPN3 mRNA	PMID:21515302
1315016	EPN3	epsin 3	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306416	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of EPN3 mRNA	PMID:23034163
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PSMD14 mRNA	PMID:38218311
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315019	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PSMD14 mRNA	PMID:33045310
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1315019	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of PSMD14 mRNA	PMID:37995155
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1594532	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PSMD14 mRNA]	PMID:31150632
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PSMD14 protein]	PMID:38195004
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PSMD14 mRNA	PMID:33167477
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PSMD14 mRNA	PMID:36331819
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1594532	E	RGD:6480464	20161025	CTD	MESH:D000431	Ethanol results in decreased expression of PSMD14 protein	PMID:19609968
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315019	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PSMD14 mRNA	PMID:30319688
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315019	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PSMD14 mRNA	PMID:39241906
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1315019	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of PSMD14 mRNA	PMID:15598610
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1594532	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of PSMD14 mRNA	PMID:32145629
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of PSMD14 mRNA	PMID:16514628
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:16602	trichloroethene	affects expression	ISO	RGD:1315019	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene affects the expression of PSMD14 mRNA	PMID:21135412
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PSMD14 mRNA	PMID:37042841
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of PSMD14 mRNA	PMID:21179406
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1315019	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of PSMD14 mRNA	PMID:17945193
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315019	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PSMD14 mRNA	PMID:19850644
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of PSMD14 mRNA]	PMID:19850644
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMD14 mRNA	PMID:36331819
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PSMD14 mRNA	PMID:39836092
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PSMD14 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD14 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PSMD14 protein	PMID:35301059|PMID:38195004
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PSMD14 mRNA	PMID:19549813
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1594532	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of PSMD14 mRNA	PMID:33354967
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PSMD14 gene; Aflatoxin B1 results in decreased methylation of PSMD14 intron	PMID:27153756|PMID:30157460
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PSMD14 mRNA	PMID:34911549
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD14 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PSMD14 protein	PMID:38598786
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1315019	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PSMD14 mRNA	PMID:27339419|PMID:31919559
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1594532	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PSMD14 mRNA	PMID:31150632
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1594532	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PSMD14 mRNA]	PMID:31150632
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMD14 mRNA	PMID:22206623
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:27563	arsenic atom	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic affects the expression of PSMD14 mRNA	PMID:18414638
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PSMD14 mRNA; [arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD14 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PSMD14 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD14 mRNA	PMID:35809665|PMID:39836092|PMID:40512198
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD14 mRNA	PMID:40504410
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1315019	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of PSMD14 protein	PMID:25505154
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20200331	CTD	MESH:D002945	[Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of PSMD14 mRNA	PMID:30871063
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315019	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSMD14 mRNA	PMID:21570461
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMD14 mRNA	PMID:17942748
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of PSMD14 mRNA	PMID:33512557
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PSMD14 mRNA	PMID:33212167
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PSMD14 mRNA	PMID:30851411
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PSMD14 mRNA	PMID:32763439
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1594532	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of PSMD14 mRNA	PMID:28959563
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of PSMD14 mRNA	PMID:25523186
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of PSMD14 mRNA	PMID:38568856
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PSMD14 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PSMD14 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD14 mRNA	PMID:39836092|PMID:40512198
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD14 mRNA	PMID:40504410
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PSMD14 promoter	PMID:27901495
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315019	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PSMD14 mRNA	PMID:22228805
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of PSMD14 mRNA	PMID:25523186
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:31638	fulvestrant	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of PSMD14 mRNA	PMID:16514628
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1594532	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of PSMD14 mRNA	PMID:24136188
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1594532	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of PSMD14 mRNA	PMID:25729387
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315019	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PSMD14 mRNA	PMID:15375163|PMID:18301758|PMID:20059764|PMID:21318169|PMID:23811191
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of PSMD14 mRNA]; PPARA protein promotes the reaction [pirinixic acid results in increased expression of PSMD14 mRNA]	PMID:20059764|PMID:21318169
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of PSMD14 mRNA	PMID:30903817
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of PSMD14 mRNA; bisphenol A results in decreased expression of PSMD14 protein	PMID:29275510|PMID:34186270
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1594532	E	RGD:6480464	20210309	CTD	MESH:C006780	bisphenol A results in decreased expression of PSMD14 mRNA	PMID:32145629|PMID:33296240
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1594532	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PSMD14 mRNA	PMID:25181051|PMID:30816183
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	[[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of PSMD14 protein	PMID:33376534
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315019	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PSMD14 mRNA	PMID:39298647
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of PSMD14 protein	PMID:34186270
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PSMD14 protein	PMID:34186270
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1315019	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of PSMD14 mRNA	PMID:31558096
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:34631	chlorpyrifos	decreases methylation	ISO	RGD:1594532	E	RGD:6480464	20210907	CTD	MESH:D004390	Chlorpyrifos results in decreased methylation of PSMD14 gene	PMID:32905263
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD14 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD14 protein	PMID:38598786
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PSMD14 mRNA	PMID:37042841
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PSMD14 mRNA	PMID:39836092
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PSMD14 mRNA	PMID:38568856
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1594532	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased expression of PSMD14 mRNA	PMID:21297351
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PSMD14 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD14 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of PSMD14 protein	PMID:35301059|PMID:38195004
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1315019	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of PSMD14 mRNA	PMID:19429403
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1315019	E	RGD:6480464	20120613	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of PSMD14 mRNA	PMID:21318169
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20120613	CTD	MESH:C023036	PPARA protein affects the reaction [perfluorooctanoic acid results in increased expression of PSMD14 mRNA]	PMID:21318169
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1594532	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of PSMD14 gene	PMID:22079235
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PSMD14 mRNA	PMID:19376846
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1594532	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PSMD14 mRNA	PMID:24386269
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1315019	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of PSMD14 mRNA	PMID:25908611
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1315019	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of PSMD14 mRNA	PMID:23811191
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of PSMD14 protein	PMID:34122009
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:37918	fluorescein 5-isothiocyanate	affects binding	EXP		E	RGD:6480464	20180116	CTD	MESH:D016650	Fluorescein-5-isothiocyanate binds to PSMD14 protein	PMID:27129696
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of PSMD14 mRNA	PMID:28302478
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PSMD14 mRNA	PMID:31533062
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of PSMD14 mRNA	PMID:26352163
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1315019	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of PSMD14 mRNA	PMID:19429403
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1315019	E	RGD:6480464	20130416	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PSMD14 mRNA	PMID:20936131
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMD14 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of PSMD14 mRNA	PMID:36331819
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PSMD14 mRNA	PMID:25979313
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PSMD14 mRNA	PMID:23179753
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PSMD14 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of PSMD14 promoter	PMID:27989131
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1594532	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of PSMD14 mRNA	PMID:24136188
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:44616	afimoxifene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of PSMD14 mRNA	PMID:16514628
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of PSMD14 mRNA	PMID:38832940
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315019	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PSMD14 mRNA	PMID:17562736
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:47217	arsane	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic affects the expression of PSMD14 mRNA	PMID:18414638
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PSMD14 mRNA; [arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD14 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PSMD14 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD14 mRNA	PMID:35809665|PMID:39836092|PMID:40512198
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD14 mRNA	PMID:40504410
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PSMD14 mRNA	PMID:17942748
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of PSMD14 mRNA	PMID:17211630
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315019	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PSMD14 mRNA; Nanotubes, Carbon results in increased expression of PSMD14 mRNA	PMID:25554681
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1594532	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of PSMD14 mRNA	PMID:24136188
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	ISO	RGD:1315019	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of PSMD14 mRNA	PMID:15375163
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of PSMD14 mRNA	PMID:35964746
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1594532	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PSMD14 mRNA	PMID:24136188
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1315019	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PSMD14 mRNA	PMID:19042947
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PSMD14 protein	PMID:32959892
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PSMD14 mRNA	PMID:39836092
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1594532	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of PSMD14 mRNA	PMID:25729387
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1594532	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of PSMD14 mRNA	PMID:24136188
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1315019	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of PSMD14 mRNA	PMID:23650126
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:63952	arsenic trichloride	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD14 mRNA	PMID:35809665
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1594532	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of PSMD14 mRNA	PMID:24136188
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:64243	monosodium L-glutamate	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20200317	CTD	MESH:D012970	[Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of PSMD14 mRNA	PMID:22078008
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PSMD14 protein	PMID:34186270
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315019	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMD14 mRNA	PMID:22206623
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1594532	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PSMD14 mRNA	PMID:24136188
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PSMD14 mRNA	PMID:31806706
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of PSMD14 protein	PMID:39638853
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of PSMD14 protein	PMID:39638853
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PSMD14 mRNA	PMID:30851411
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of PSMD14 mRNA	PMID:19159669
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1315019	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of PSMD14 mRNA	PMID:22538082
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1315019	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of PSMD14 mRNA	PMID:30294300
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1315019	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of PSMD14 mRNA	PMID:31558096
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1315019	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of PSMD14 mRNA	PMID:21278054
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of PSMD14 mRNA	PMID:16514628
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of PSMD14 mRNA	PMID:38568856
1315018	PSMD14	proteasome 26S subunit, non-ATPase 14	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of PSMD14 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PSMD14 protein	PMID:38598786
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RASEF mRNA	PMID:26272509|PMID:27188386
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA	PMID:27188386
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1618122	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASEF gene	PMID:20938992
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of RASEF mRNA	PMID:23830798
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of RASEF mRNA	PMID:39506029
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:16130	DDT	decreases expression	ISO	RGD:1306418	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of RASEF mRNA	PMID:30207508
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of RASEF mRNA	PMID:19429434
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of RASEF mRNA	PMID:30165855
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306418	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in increased expression of RASEF mRNA	PMID:26496021
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1618122	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASEF gene	PMID:20938992
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of RASEF mRNA	PMID:23649840
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:181914	Aflatoxin B2 alpha	affects methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 affects the methylation of RASEF intron	PMID:30157460
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RASEF mRNA	PMID:23649840
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of RASEF mRNA	PMID:27153756
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of RASEF mRNA	PMID:23649840
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306418	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RASEF mRNA	PMID:31150632
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1618122	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RASEF gene	PMID:20938992
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of RASEF mRNA	PMID:26272509
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA	PMID:27188386
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306418	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of RASEF mRNA	PMID:31881176
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RASEF mRNA	PMID:23557933
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of RASEF mRNA	PMID:19921347
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of RASEF mRNA	PMID:27392435
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RASEF mRNA	PMID:27392435
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of RASEF promoter	PMID:22847954
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of RASEF mRNA	PMID:24768652
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618122	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RASEF mRNA	PMID:21570461
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RASEF mRNA	PMID:23179753|PMID:27188386
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of RASEF mRNA	PMID:23649840
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of RASEF mRNA	PMID:22714537|PMID:39719251
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RASEF intron	PMID:30157460
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RASEF promoter	PMID:27901495
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of RASEF mRNA	PMID:25895662
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RASEF mRNA	PMID:19150397
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of RASEF mRNA	PMID:20382639
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1618122	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of RASEF mRNA	PMID:35295148
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1618122	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RASEF promoter	PMID:35295148
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306418	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RASEF mRNA	PMID:34492290
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306418	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RASEF mRNA	PMID:25181051|PMID:34947998
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306418	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of RASEF mRNA	PMID:30816183|PMID:32528016
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1618122	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of RASEF mRNA	PMID:30951980|PMID:32156529
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306418	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in increased expression of RASEF mRNA	PMID:26496021
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1618122	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of RASEF mRNA	PMID:30951980
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of RASEF intron	PMID:30157460
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1618122	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of RASEF mRNA	PMID:26377693
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1618122	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of RASEF mRNA	PMID:30951980
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RASEF mRNA	PMID:38568856
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RASEF mRNA	PMID:26472689|PMID:38174414
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1618122	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RASEF mRNA	PMID:40194260
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of RASEF promoter	PMID:22847954
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of RASEF promoter	PMID:22847954
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of RASEF mRNA	PMID:19167446
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASEF mRNA	PMID:19167446
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of RASEF mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA	PMID:27188386
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:41774	tamoxifen	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of RASEF mRNA	PMID:19429434
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of RASEF mRNA	PMID:23649840
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RASEF mRNA	PMID:38832940
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of RASEF mRNA	PMID:24935251|PMID:26272509
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA	PMID:27188386
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1618122	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of RASEF mRNA	PMID:29279043
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of RASEF mRNA	PMID:18687144
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1618122	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of RASEF mRNA	PMID:35436446
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA	PMID:27188386
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1618122	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RASEF mRNA	PMID:25554681
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306418	E	RGD:6480464	20260303	CTD	MESH:D005485	Flutamide results in decreased expression of RASEF mRNA	PMID:40381864
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1618122	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of RASEF mRNA	PMID:38701926
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of RASEF mRNA	PMID:26272509
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of RASEF mRNA	PMID:24810058
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:6820	methapyrilene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene affects the methylation of RASEF intron	PMID:30157460
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of RASEF mRNA	PMID:31758290
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA	PMID:27188386
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RASEF mRNA	PMID:19167446
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of RASEF mRNA	PMID:32234424
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of RASEF mRNA	PMID:26272509
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA	PMID:27188386
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of RASEF mRNA	PMID:19429434
1315020	RASEF	RAS and EF-hand domain containing	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RASEF mRNA	PMID:27188386
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ELP2 mRNA	PMID:33167477
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1315023	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of ELP2 mRNA	PMID:30319688
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315023	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ELP2 mRNA	PMID:39241906
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315023	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ELP2 mRNA	PMID:39298647
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of ELP2 mRNA	PMID:19162166
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ELP2 mRNA	PMID:21179406
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of ELP2 mRNA	PMID:31256213
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306419	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ELP2 mRNA	PMID:33387578
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306419	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of ELP2 mRNA	PMID:22061828
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315023	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ELP2 mRNA	PMID:36331819
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315023	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ELP2 mRNA	PMID:37236586
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ELP2 protein	PMID:23301498
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of ELP2 mRNA	PMID:23649840
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of ELP2 mRNA	PMID:23649840
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ELP2 mRNA	PMID:35430440
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315023	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ELP2 mRNA	PMID:22206623
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315023	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELP2 mRNA	PMID:40504410
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ELP2 mRNA	PMID:23557933
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ELP2 mRNA	PMID:22298810
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315023	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ELP2 mRNA	PMID:21570461
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306419	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ELP2 mRNA	PMID:33387578
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315023	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ELP2 mRNA	PMID:18796159
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of ELP2 mRNA	PMID:29955902
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ELP2 mRNA	PMID:28001369
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ELP2 mRNA	PMID:29803840
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315023	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELP2 mRNA	PMID:40504410
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1306419	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ELP2 mRNA	PMID:21839799
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315023	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ELP2 mRNA	PMID:22228805
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:31835	methylparaben	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in increased expression of ELP2 mRNA	PMID:31745603
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306419	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ELP2 mRNA	PMID:25729387
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315023	E	RGD:6480464	20131008	CTD	MESH:C009495	titanium dioxide results in increased expression of ELP2 mRNA	PMID:23131501
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306419	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ELP2 mRNA	PMID:34492290
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of ELP2 protein	PMID:37567409
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306419	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ELP2 mRNA	PMID:34947998
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ELP2 gene	PMID:31601247
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306419	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ELP2 mRNA	PMID:25181051|PMID:41034487
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306419	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ELP2 mRNA	PMID:36041667
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ELP2 mRNA	PMID:25979313
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315023	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ELP2 mRNA	PMID:39298647
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306419	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ELP2 mRNA	PMID:36041667
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306419	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of ELP2 mRNA	PMID:36041667
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1315023	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ELP2 mRNA	PMID:34813904
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1315023	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ELP2 mRNA	PMID:34813904
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ELP2 mRNA	PMID:37042841
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315023	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ELP2 mRNA	PMID:37236586
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ELP2 mRNA	PMID:24449571
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ELP2 mRNA	PMID:28302478
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of ELP2 mRNA	PMID:31533062
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315023	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ELP2 mRNA	PMID:36331819
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ELP2 mRNA	PMID:25979313
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315023	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ELP2 mRNA	PMID:17292431
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ELP2 mRNA	PMID:23179753
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ELP2 mRNA	PMID:20106945|PMID:25562108
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ELP2 mRNA	PMID:38832940
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306419	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ELP2 mRNA	PMID:33387578
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of ELP2 mRNA	PMID:21420995
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315023	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ELP2 mRNA	PMID:40504410
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1315023	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ELP2 mRNA	PMID:35964746
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306419	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ELP2 mRNA	PMID:24136188
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1315023	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ELP2 mRNA	PMID:19042947
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:53444	potassium dichromate	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ELP2 protein	PMID:23718831
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ELP2 protein	PMID:32959892
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306419	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ELP2 mRNA	PMID:25729387
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1315023	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of ELP2 mRNA	PMID:23650126
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1306419	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ELP2 mRNA	PMID:30467583
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1315023	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of ELP2 mRNA	PMID:27462272
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315023	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ELP2 mRNA	PMID:22206623
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315023	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ELP2 mRNA	PMID:22206623
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306419	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of ELP2 mRNA	PMID:24136188
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1306419	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of ELP2 protein	PMID:28903499
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1315023	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of ELP2 mRNA	PMID:30953684
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306419	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of ELP2 mRNA	PMID:19281266
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306419	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ELP2 mRNA	PMID:21346803
1315022	ELP2	elongator acetyltransferase complex subunit 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306419	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of ELP2 mRNA	PMID:23555832
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1315025	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of KLK7 mRNA	PMID:37995155
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of KLK7 mRNA	PMID:16249480
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of KLK7 mRNA	PMID:17254854
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of KLK7 mRNA	PMID:30510588
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of KLK7 mRNA	PMID:30165855
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306420	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KLK7 mRNA	PMID:33387578
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in decreased expression of KLK7 mRNA	PMID:27905399
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KLK7 mRNA	PMID:31163220
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of KLK7 mRNA	PMID:26485663
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in increased expression of KLK7 mRNA	PMID:21120746
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306420	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of KLK7 mRNA	PMID:21396975
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of KLK7 mRNA	PMID:41430723
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KLK7 mRNA	PMID:32525701
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of KLK7 mRNA	PMID:41028656
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:27899	cisplatin	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	KLK7 protein affects the susceptibility to Cisplatin	PMID:16217747
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	ISO	RGD:1306420	E	RGD:6480464	20120717	CTD	MESH:C000228	aristolochic acid I results in decreased expression of KLK7 mRNA	PMID:17483316
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306420	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of KLK7 mRNA	PMID:28959563
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of KLK7 mRNA	PMID:41028656
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1315025	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of KLK7 mRNA	PMID:27862939
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of KLK7 mRNA	PMID:12634122
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1315025	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of KLK7 mRNA	PMID:37682722
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KLK7 5' UTR; Benzo(a)pyrene results in increased methylation of KLK7 promoter	PMID:27901495
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1315025	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to KLK7 promoter]	PMID:19654925
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of KLK7 mRNA	PMID:41028656
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:32195	Tesaglitazar	increases expression	ISO	RGD:1306420	E	RGD:6480464	20170303	CTD	MESH:C501413	tesaglitazar results in increased expression of KLK7 mRNA	PMID:21515302
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306420	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of KLK7 mRNA	PMID:23411599
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1315025	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of KLK7 mRNA	PMID:18648102
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306420	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of KLK7 mRNA	PMID:25181051
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of KLK7 mRNA	PMID:25979313
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1306420	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KLK7 mRNA	PMID:35163327
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306420	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KLK7 mRNA	PMID:35163327
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306420	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KLK7 mRNA	PMID:35163327
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306420	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of KLK7 gene	PMID:22079235
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:D001151	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KLK7 mRNA	PMID:32525701
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:4953	exemestane	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C056516	exemestane results in increased expression of KLK7 mRNA	PMID:17254854
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1315025	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of KLK7 mRNA	PMID:23608068
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KLK7 gene]	PMID:28238834
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of KLK7 mRNA	PMID:26079696
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20200915	CTD	MESH:C009277	[sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of KLK7 mRNA	PMID:32525701
1315024	KLK7	kallikrein related peptidase 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306420	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of KLK7 mRNA	PMID:24780913
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315028	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CCT7 mRNA	PMID:33045310
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306422	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCT7 mRNA]	PMID:31150632
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:144400	dinophysistoxin 1	increases expression	EXP		E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in increased expression of CCT7 mRNA	PMID:28939011
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CCT7 gene	PMID:20938992
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CCT7 mRNA	PMID:33167477
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1315028	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of CCT7 mRNA	PMID:40945087
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:16240	hydrogen peroxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of CCT7 mRNA	PMID:39709020
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:16356	3',5'-cyclic GMP	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D006152	CCT7 protein mutant form inhibits the reaction [S-Nitrosoglutathione results in increased abundance of Cyclic GMP]	PMID:24213632
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315028	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CCT7 mRNA	PMID:39241906
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT7 mRNA]	PMID:39241906
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1315028	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of CCT7 mRNA	PMID:15598610
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1315028	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of CCT7 mRNA	PMID:39298647
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CCT7 gene	PMID:20938992
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CCT7 mRNA	PMID:37042841
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CCT7 mRNA	PMID:21179406
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:17115	L-serine	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:D012694	Serine results in increased expression of CCT7 mRNA	PMID:29098664
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1315028	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of CCT7 mRNA	PMID:17945193
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306422	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of CCT7 mRNA	PMID:26496021
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315028	E	RGD:6480464	20120613	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of CCT7 protein	PMID:21318169
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20120613	CTD	MESH:D004051	PPARA protein affects the reaction [Diethylhexyl Phthalate results in increased expression of CCT7 protein]	PMID:21318169
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306422	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of CCT7 mRNA	PMID:22061828|PMID:33387578
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CCT7 mRNA	PMID:36331819
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of CCT7 mRNA	PMID:39836092
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1315028	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of CCT7 mRNA	PMID:27462272
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCT7 mRNA	PMID:35301059
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306422	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCT7 mRNA	PMID:39012411
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CCT7 protein	PMID:23301498
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CCT7 mRNA	PMID:27153756
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1306422	E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in increased expression of CCT7 protein	PMID:33146391
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CCT7 mRNA	PMID:34911549
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:2654	aminoglutethimide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000616	Aminoglutethimide results in decreased expression of CCT7 protein	PMID:26102013
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CCT7 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CCT7 protein	PMID:38598786
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1306422	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of CCT7 mRNA	PMID:31129395
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of CCT7 protein	PMID:15984569
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306422	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCT7 mRNA	PMID:31150632
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1315028	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of CCT7 mRNA	PMID:31919559
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306422	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CCT7 mRNA]	PMID:31150632
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1315028	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of CCT7 mRNA	PMID:25629700
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCT7 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CCT7 gene	PMID:20938992|PMID:22206623
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCT7 mRNA	PMID:40512198
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCT7 mRNA	PMID:40504410
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D007854	Lead results in increased expression of CCT7 protein	PMID:37834424
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315028	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CCT7 mRNA	PMID:17942748
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCT7 mRNA	PMID:17942748
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of CCT7 mRNA	PMID:39709020
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of CCT7 protein	PMID:29385562
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of CCT7 protein	PMID:35688186
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of CCT7 mRNA; sodium arsenite results in decreased expression of CCT7 protein	PMID:30528433|PMID:38568856
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of CCT7 mRNA	PMID:34032870
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCT7 mRNA; sodium arsenite promotes the reaction [CCT7 protein binds to CAPRIN1 protein]	PMID:33939924|PMID:40512198
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCT7 mRNA	PMID:40504410
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315028	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CCT7 mRNA	PMID:22228805
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to CCT7 mRNA]	PMID:32406909
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc results in decreased expression of CCT7 protein	PMID:15984569
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:3048	benzatropine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in decreased expression of CCT7 protein	PMID:34122009
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CCT7 protein]	PMID:26598702
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315028	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CCT7 gene	PMID:35295148
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306422	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of CCT7 mRNA	PMID:34492290
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315028	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of CCT7 mRNA; pirinixic acid results in increased expression of CCT7 protein	PMID:15375163|PMID:20059764|PMID:21318169|PMID:23811191
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20120412	CTD	MESH:C006253	PPARA protein promotes the reaction [pirinixic acid results in increased expression of CCT7 mRNA]; PPARA protein promotes the reaction [pirinixic acid results in increased expression of CCT7 protein]	PMID:20059764
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1315028	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of CCT7 mRNA	PMID:28472532
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306422	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of CCT7 mRNA	PMID:19167457
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of CCT7 protein	PMID:34186270
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306422	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of CCT7 mRNA	PMID:25181051
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306422	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of CCT7 mRNA; [bisphenol A co-treated with tributyltin] results in increased expression of CCT7 mRNA	PMID:26496021|PMID:31129395
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1306422	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of CCT7 mRNA	PMID:24096037
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1315028	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of CCT7 mRNA	PMID:24096037
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of CCT7 protein	PMID:34186270
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315028	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of CCT7 mRNA	PMID:39298647
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of CCT7 protein	PMID:34186270
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of CCT7 protein	PMID:34186270
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1315028	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of CCT7 mRNA	PMID:37019170
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1315028	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CCT7 mRNA	PMID:17361019
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of CCT7 protein	PMID:38598786
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1315028	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of CCT7 mRNA	PMID:34813904
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1306422	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of CCT7 mRNA	PMID:22546817
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT7 mRNA]	PMID:39241906
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of CCT7 mRNA	PMID:39836092
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306422	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CCT7 mRNA	PMID:18636176
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCT7 mRNA	PMID:35301059
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306422	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCT7 mRNA	PMID:39012411
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:3766	clozapine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of CCT7 protein	PMID:34122009
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CCT7 mRNA	PMID:36331819
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1306422	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of CCT7 mRNA	PMID:12325037|PMID:22561333|PMID:25993096
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1315028	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of CCT7 mRNA	PMID:22155349
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of CCT7 gene	PMID:29154799
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of CCT7 mRNA	PMID:17183730
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:4027	cyclophosphamide	decreases expression	ISO	RGD:1306422	E	RGD:6480464	20120412	CTD	MESH:D003520	Cyclophosphamide results in decreased expression of CCT7 mRNA	PMID:11906922
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1315028	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of CCT7 mRNA	PMID:17555576
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1306422	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of CCT7 mRNA	PMID:19400957
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1315028	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in increased expression of CCT7 mRNA	PMID:19400957
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of CCT7 mRNA	PMID:36621641
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1306422	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of CCT7 mRNA	PMID:24136188
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D019319	Okadaic Acid results in increased expression of CCT7 mRNA	PMID:28939011
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315028	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of CCT7 mRNA	PMID:17562736
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CCT7 mRNA	PMID:40512198
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCT7 mRNA	PMID:40504410
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1315028	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of CCT7 mRNA	PMID:17555576
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306422	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CCT7 mRNA	PMID:19400957|PMID:24096037
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1315028	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of CCT7 mRNA	PMID:17942748|PMID:19400957|PMID:24096037
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCT7 mRNA	PMID:17942748
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CCT7 protein]	PMID:26598702
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:50091	S-nitrosoglutathione	multiple interactions	EXP		E	RGD:6480464	20140513	CTD	MESH:D026422	CCT7 protein mutant form inhibits the reaction [S-Nitrosoglutathione results in increased abundance of Cyclic GMP]	PMID:24213632
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315028	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of CCT7 mRNA	PMID:25554681
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1315028	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of CCT7 mRNA	PMID:40234311
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	increases expression	ISO	RGD:1315028	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in increased expression of CCT7 mRNA	PMID:15375163
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306422	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of CCT7 mRNA	PMID:24136188
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1315028	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of CCT7 mRNA	PMID:19042947
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of CCT7 mRNA	PMID:17183730
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of CCT7 protein	PMID:32959892
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of CCT7 mRNA	PMID:39836092
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:63630	tolcapone	affects binding	ISO	RGD:1306422	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to CCT7 protein	PMID:19783845
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1306422	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of CCT7 mRNA	PMID:24136188
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of CCT7 protein	PMID:34186270
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:73295	WIN 55212-2	decreases expression	ISO	RGD:1315028	E	RGD:6480464	20170303	CTD	MESH:C070417	(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in decreased expression of CCT7 mRNA	PMID:12237329
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CCT7 mRNA	PMID:22206623
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306422	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of CCT7 mRNA	PMID:24136188
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of CCT7 protein	PMID:31285264
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:76290	PhIP	increases expression	ISO	RGD:1306422	E	RGD:6480464	20140107	CTD	MESH:C049584	2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CCT7 mRNA	PMID:15215175
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of CCT7 protein	PMID:39638853
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CCT7 gene]	PMID:28238834
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1315028	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of CCT7 mRNA	PMID:23091169
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1315028	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of CCT7 mRNA	PMID:22538082
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1315028	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of CCT7 mRNA	PMID:30294300
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1315028	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of CCT7 mRNA	PMID:30953684
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1315028	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of CCT7 mRNA]	PMID:39241906
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306422	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of CCT7 mRNA	PMID:21346803
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of CCT7 protein	PMID:38598786
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306422	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of CCT7 mRNA	PMID:21346803
1315027	CCT7	chaperonin containing TCP1 subunit 7	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306422	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of CCT7 mRNA	PMID:23555832
1315030	SNX17	sorting nexin 17	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306424	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SNX17 mRNA]	PMID:31150632
1315030	SNX17	sorting nexin 17	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1306424	E	RGD:6480464	20260602	CTD	MESH:D019308	[Glucose co-treated with Palmitic Acid] results in increased expression of SNX17 protein	PMID:40631627
1315030	SNX17	sorting nexin 17	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315031	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SNX17 mRNA	PMID:39241906
1315030	SNX17	sorting nexin 17	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SNX17 mRNA	PMID:37042841
1315030	SNX17	sorting nexin 17	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1306424	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of SNX17 protein	PMID:40631627
1315030	SNX17	sorting nexin 17	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1306424	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of SNX17 protein	PMID:40631627
1315030	SNX17	sorting nexin 17	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of SNX17 protein	PMID:37730182
1315030	SNX17	sorting nexin 17	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315031	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SNX17 mRNA	PMID:36331819
1315030	SNX17	sorting nexin 17	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1306424	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of SNX17 protein	PMID:34915118
1315030	SNX17	sorting nexin 17	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1315031	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of SNX17 mRNA	PMID:27462272
1315030	SNX17	sorting nexin 17	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306424	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNX17 mRNA	PMID:39012411
1315030	SNX17	sorting nexin 17	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315031	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNX17 mRNA	PMID:28111341
1315030	SNX17	sorting nexin 17	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SNX17 mRNA	PMID:19549813
1315030	SNX17	sorting nexin 17	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1315031	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of SNX17 mRNA	PMID:19376150
1315030	SNX17	sorting nexin 17	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1315031	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SNX17 mRNA	PMID:19770486
1315030	SNX17	sorting nexin 17	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SNX17 gene	PMID:27153756|PMID:28458013
1315030	SNX17	sorting nexin 17	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306424	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SNX17 mRNA	PMID:31150632
1315030	SNX17	sorting nexin 17	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306424	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SNX17 mRNA]	PMID:31150632
1315030	SNX17	sorting nexin 17	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315031	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX17 mRNA	PMID:22206623
1315030	SNX17	sorting nexin 17	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315031	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX17 mRNA	PMID:40504410
1315030	SNX17	sorting nexin 17	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of SNX17 mRNA	PMID:19244175
1315030	SNX17	sorting nexin 17	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of SNX17 protein	PMID:35688186
1315030	SNX17	sorting nexin 17	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SNX17 mRNA	PMID:28903495
1315030	SNX17	sorting nexin 17	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315031	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SNX17 mRNA	PMID:21570461
1315030	SNX17	sorting nexin 17	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SNX17 mRNA	PMID:33212167
1315030	SNX17	sorting nexin 17	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of SNX17 mRNA	PMID:32763439
1315030	SNX17	sorting nexin 17	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of SNX17 protein	PMID:35688186
1315030	SNX17	sorting nexin 17	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of SNX17 mRNA; sodium arsenite results in decreased expression of SNX17 protein	PMID:30528433|PMID:38568856
1315030	SNX17	sorting nexin 17	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315031	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX17 mRNA	PMID:40504410
1315030	SNX17	sorting nexin 17	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315031	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SNX17 gene	PMID:35295148
1315030	SNX17	sorting nexin 17	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306424	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SNX17 mRNA	PMID:34492290
1315030	SNX17	sorting nexin 17	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306424	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of SNX17 mRNA	PMID:25181051
1315030	SNX17	sorting nexin 17	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of SNX17 protein	PMID:31675489
1315030	SNX17	sorting nexin 17	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306424	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SNX17 gene	PMID:28505145
1315030	SNX17	sorting nexin 17	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of SNX17 protein	PMID:31675489
1315030	SNX17	sorting nexin 17	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of SNX17 mRNA	PMID:19244175
1315030	SNX17	sorting nexin 17	gene	CHEBI:34680	dipentyl phthalate	multiple interactions	ISO	RGD:1306424	E	RGD:6480464	20141223	CTD	MESH:C034171	[Simvastatin co-treated with di-n-pentyl phthalate] results in decreased expression of SNX17 mRNA	PMID:25055962
1315030	SNX17	sorting nexin 17	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1315031	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of SNX17 mRNA	PMID:34813904
1315030	SNX17	sorting nexin 17	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1315031	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SNX17 mRNA	PMID:34813904
1315030	SNX17	sorting nexin 17	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SNX17 mRNA	PMID:38568856
1315030	SNX17	sorting nexin 17	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306424	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNX17 mRNA	PMID:39012411
1315030	SNX17	sorting nexin 17	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315031	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SNX17 mRNA	PMID:28111341
1315030	SNX17	sorting nexin 17	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1315031	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of SNX17 mRNA	PMID:18353800
1315030	SNX17	sorting nexin 17	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of SNX17 mRNA	PMID:19244175
1315030	SNX17	sorting nexin 17	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315031	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SNX17 mRNA	PMID:36331819
1315030	SNX17	sorting nexin 17	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SNX17 gene	PMID:29154799
1315030	SNX17	sorting nexin 17	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SNX17 mRNA	PMID:25562108
1315030	SNX17	sorting nexin 17	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1306424	E	RGD:6480464	20260602	CTD	MESH:D005947	[Glucose co-treated with Palmitic Acid] results in increased expression of SNX17 protein	PMID:40631627
1315030	SNX17	sorting nexin 17	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1315031	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of SNX17 mRNA	PMID:18502557
1315030	SNX17	sorting nexin 17	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of SNX17 mRNA	PMID:28542535
1315030	SNX17	sorting nexin 17	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315031	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SNX17 mRNA	PMID:17562736
1315030	SNX17	sorting nexin 17	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315031	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SNX17 mRNA	PMID:40504410
1315030	SNX17	sorting nexin 17	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of SNX17 mRNA	PMID:31675489
1315030	SNX17	sorting nexin 17	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1315031	E	RGD:6480464	20141111	CTD	MESH:C109476	epoxiconazole results in decreased expression of SNX17 mRNA	PMID:22334560|PMID:35436446
1315030	SNX17	sorting nexin 17	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1315031	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SNX17 mRNA	PMID:35964746
1315030	SNX17	sorting nexin 17	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306424	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in decreased expression of SNX17 mRNA	PMID:24136188
1315030	SNX17	sorting nexin 17	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SNX17 protein	PMID:32959892
1315030	SNX17	sorting nexin 17	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315031	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SNX17 mRNA	PMID:22206623
1315030	SNX17	sorting nexin 17	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SNX17 protein	PMID:31675489
1315030	SNX17	sorting nexin 17	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SNX17 protein	PMID:37385330
1315030	SNX17	sorting nexin 17	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1315031	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in decreased expression of SNX17 mRNA	PMID:22334560
1315030	SNX17	sorting nexin 17	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SNX17 protein	PMID:31675489
1315030	SNX17	sorting nexin 17	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1315031	E	RGD:6480464	20120918	CTD	MESH:C045950	propiconazole results in decreased expression of SNX17 mRNA	PMID:21278054|PMID:22334560
1315030	SNX17	sorting nexin 17	gene	CHEBI:9150	simvastatin	decreases expression	ISO	RGD:1306424	E	RGD:6480464	20141223	CTD	MESH:D019821	Simvastatin results in decreased expression of SNX17 mRNA	PMID:25055962
1315030	SNX17	sorting nexin 17	gene	CHEBI:9150	simvastatin	multiple interactions	ISO	RGD:1306424	E	RGD:6480464	20141223	CTD	MESH:D019821	[Simvastatin co-treated with di-n-pentyl phthalate] results in decreased expression of SNX17 mRNA	PMID:25055962
1315030	SNX17	sorting nexin 17	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SNX17 mRNA	PMID:38568856
1315030	SNX17	sorting nexin 17	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SNX17 mRNA	PMID:29301935
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased expression of DUSP8 mRNA	PMID:23792671
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DUSP8 mRNA	PMID:38218311
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315033	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of DUSP8 mRNA	PMID:33045310
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306425	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DUSP8 mRNA]	PMID:31150632
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1306425	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of DUSP8 mRNA	PMID:30071829
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1315033	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of DUSP8 mRNA	PMID:20188158
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1315033	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of DUSP8 mRNA	PMID:20188158
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:146194	15-acetyldeoxynivalenol	increases expression	EXP		E	RGD:6480464	20200303	CTD	MESH:C046760	15-acetyldeoxynivalenol results in increased expression of DUSP8 mRNA	PMID:23792671
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:15343	acetaldehyde	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D000079	Acetaldehyde results in increased expression of DUSP8 mRNA	PMID:23416264
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306425	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of DUSP8 gene	PMID:35440735
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1315033	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DUSP8 mRNA	PMID:30319688
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DUSP8 mRNA	PMID:35811015
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DUSP8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of DUSP8 mRNA	PMID:35811015
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1315033	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of DUSP8 mRNA	PMID:15598610
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in decreased expression of DUSP8 mRNA	PMID:19167446
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315033	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DUSP8 mRNA	PMID:39298647
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of DUSP8 mRNA	PMID:38568856
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306425	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of DUSP8 mRNA	PMID:33387578
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1315033	E	RGD:6480464	20150310	CTD	MESH:D014241	Trichloroethylene results in increased expression of DUSP8 mRNA	PMID:25549359
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:16827	corticosterone	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20210209	CTD	MESH:D003345	[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone; CRH protein affects the reaction [[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone]; Dexamethasone affects the reaction [[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone]	PMID:32780722
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DUSP8 mRNA	PMID:37992649
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DUSP8 mRNA	PMID:37992649
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306425	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of DUSP8 mRNA	PMID:33387578
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:17883	hydrogen chloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006851	Hydrochloric Acid results in decreased expression of DUSP8 mRNA	PMID:15046208
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DUSP8 mRNA	PMID:37236586
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of DUSP8 mRNA	PMID:19549813
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306425	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of DUSP8 mRNA	PMID:21396975
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306425	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DUSP8 mRNA	PMID:33354967
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of DUSP8 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of DUSP8 mRNA	PMID:34911549
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306425	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of DUSP8 mRNA	PMID:9813294
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DUSP8 mRNA	PMID:18593933
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306425	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of DUSP8 mRNA	PMID:31150632
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306425	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DUSP8 mRNA]	PMID:31150632
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315033	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DUSP8 mRNA	PMID:25629700
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27563	arsenic atom	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001151	Arsenic results in decreased expression of DUSP8 mRNA	PMID:27838757
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DUSP8 mRNA	PMID:40504410
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DUSP8 mRNA	PMID:19244175
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of DUSP8 mRNA	PMID:26272509
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP8 mRNA	PMID:27188386
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27732	caffeine	increases expression	ISO	RGD:1306425	E	RGD:6480464	20120918	CTD	MESH:D002110	Caffeine results in increased expression of DUSP8 mRNA	PMID:9813294
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27744	glyphosate	affects expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the expression of DUSP8 mRNA	PMID:31295307
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1315033	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of DUSP8 mRNA	PMID:28960355
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306425	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DUSP8 mRNA	PMID:31881176
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in increased expression of DUSP8 mRNA	PMID:15280659
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of DUSP8 mRNA	PMID:27392435
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1306425	E	RGD:6480464	20120918	CTD	MESH:D003042	Cocaine results in increased expression of DUSP8 mRNA	PMID:9813294
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1306425	E	RGD:6480464	20120918	CTD	MESH:D003042	5,7-Dihydroxytryptamine inhibits the reaction [Cocaine results in increased expression of DUSP8 mRNA]	PMID:9813294
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28087	glycogen	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20210209	CTD	MESH:D006003	[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Glycogen	PMID:32780722
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of DUSP8 mRNA	PMID:23195993
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315033	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DUSP8 mRNA	PMID:21570461|PMID:28922406
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306425	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DUSP8 mRNA	PMID:32109520|PMID:33387578
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DUSP8 mRNA	PMID:17942748
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1306425	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of DUSP8 mRNA	PMID:28374803
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of DUSP8 mRNA	PMID:28001369
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of DUSP8 mRNA	PMID:33212167
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP8 mRNA	PMID:27188386
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28509	chloroethene	increases expression	ISO	RGD:1315033	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in increased expression of DUSP8 mRNA	PMID:18579281
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306425	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of DUSP8 mRNA	PMID:28959563
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1315033	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of DUSP8 mRNA	PMID:30807115
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of DUSP8 mRNA	PMID:20971185
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1315033	E	RGD:6480464	20120412	CTD	MESH:D004317	Doxorubicin results in decreased expression of DUSP8 mRNA	PMID:17888722
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DUSP8 mRNA	PMID:37992649
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of DUSP8 mRNA	PMID:34032870
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1306425	E	RGD:6480464	20230207	CTD	MESH:C017947	sodium arsenite results in decreased expression of DUSP8 mRNA	PMID:35314868
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DUSP8 mRNA	PMID:38568856
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1315033	E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of DUSP8 mRNA	PMID:39232337
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20250805	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DUSP8 mRNA; Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in increased expression of DUSP8 mRNA]	PMID:39232337|PMID:40504410
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315033	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DUSP8 mRNA	PMID:21569818
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of DUSP8 mRNA	PMID:20971185
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of DUSP8 mRNA	PMID:18593933
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1315033	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of DUSP8 mRNA	PMID:27131904
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DUSP8 mRNA	PMID:25351596
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1315033	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DUSP8 mRNA	PMID:19073995
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DUSP8 mRNA	PMID:20458559
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:30621	diarsenic trioxide	increases expression	ISO	RGD:1315033	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of DUSP8 mRNA	PMID:39716349
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:30966	glycidol	decreases expression	ISO	RGD:1306425	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in decreased expression of DUSP8 mRNA	PMID:24915197
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:31596	febuxostat	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D000069465	Febuxostat results in increased expression of DUSP8 mRNA	PMID:35866629
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1306425	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of DUSP8 mRNA	PMID:32479839
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1306425	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of DUSP8 mRNA	PMID:16507785
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1315033	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide affects the expression of DUSP8 mRNA	PMID:27760801
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1306425	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of DUSP8 mRNA	PMID:30012374
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315033	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DUSP8 gene; titanium dioxide results in decreased methylation of DUSP8 promoter	PMID:35295148
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306425	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of DUSP8 mRNA	PMID:23411599|PMID:34492290
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315033	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of DUSP8 mRNA	PMID:20813756
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DUSP8 mRNA	PMID:19710929
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of DUSP8 mRNA	PMID:28329830
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306425	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of DUSP8 mRNA	PMID:25181051
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315033	E	RGD:6480464	20150825	CTD	MESH:C006780	bisphenol A results in decreased expression of DUSP8 mRNA	PMID:25594700
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306425	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of DUSP8 mRNA	PMID:29097150|PMID:30816183|PMID:34947998|PMID:41034487
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:338412	(-)-anisomycin	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D000841	DUSP8 protein inhibits the reaction [Anisomycin results in increased phosphorylation of JUN protein]; DUSP8 protein inhibits the reaction [Anisomycin results in increased phosphorylation of NR3C1 protein]	PMID:32780722
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1315033	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S affects the methylation of DUSP8 exon	PMID:33297965
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315033	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DUSP8 mRNA	PMID:39298647|PMID:40203079
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1315033	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DUSP8 mRNA	PMID:32715474|PMID:37019170
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1315033	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of DUSP8 mRNA	PMID:21266533
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306425	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of DUSP8 mRNA	PMID:30723492
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306425	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DUSP8 mRNA	PMID:36928142
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DUSP8 mRNA	PMID:37236586
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1315033	E	RGD:6480464	20141223	CTD	MESH:C039281	furan results in increased expression of DUSP8 mRNA	PMID:24183702|PMID:24910943|PMID:37517673
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:35559	furan	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20141223	CTD	MESH:C039281	[Bromodeoxyuridine co-treated with furan] results in increased expression of DUSP8 mRNA	PMID:24910943
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1315033	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of DUSP8 mRNA	PMID:28962523
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DUSP8 mRNA	PMID:19244175
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of DUSP8 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DUSP8 mRNA]	PMID:17585979
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1315033	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DUSP8 mRNA	PMID:40194260
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of DUSP8 mRNA	PMID:28302478
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of DUSP8 mRNA	PMID:28001369
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DUSP8 gene	PMID:29154799
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DUSP8 mRNA	PMID:25562108
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1315033	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of DUSP8 mRNA	PMID:25123088
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:41879	dexamethasone	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20210209	CTD	MESH:D003907	Dexamethasone affects the reaction [[DUSP8 protein affects the susceptibility to Dietary Fats] which affects the abundance of Corticosterone]	PMID:32780722
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1315033	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of DUSP8 mRNA	PMID:28973697
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of DUSP8 mRNA	PMID:37992649
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of DUSP8 mRNA	PMID:38832940
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315033	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DUSP8 mRNA	PMID:17562736
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of DUSP8 mRNA	PMID:29067470
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306425	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DUSP8 mRNA	PMID:33387578
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1315033	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased expression of DUSP8 mRNA	PMID:18544908
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of DUSP8 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of DUSP8 mRNA]	PMID:17585979
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of DUSP8 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of DUSP8 mRNA	PMID:35811015
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of DUSP8 mRNA	PMID:17331233
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DUSP8 mRNA	PMID:25351596
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:47217	arsane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001151	Arsenic results in decreased expression of DUSP8 mRNA	PMID:27838757
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DUSP8 mRNA	PMID:40504410
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:472552	5-bromo-2'-deoxyuridine	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20191114	CTD	MESH:D001973	[Bromodeoxyuridine co-treated with furan] results in increased expression of DUSP8 mRNA	PMID:24910943
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of DUSP8 mRNA	PMID:31838189
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of DUSP8 mRNA	PMID:22079256
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DUSP8 mRNA	PMID:17942748
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP8 mRNA	PMID:27188386
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DUSP8 mRNA	PMID:20458559
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:49900	arsenous acid	increases expression	ISO	RGD:1315033	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of DUSP8 mRNA	PMID:39716349
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1315033	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of DUSP8 mRNA; Nanotubes, Carbon analog affects the expression of DUSP8 mRNA	PMID:25554681
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:5118	fluoxetine	increases expression	ISO	RGD:1306425	E	RGD:6480464	20120918	CTD	MESH:D005473	Fluoxetine results in increased expression of DUSP8 mRNA	PMID:9813294
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306425	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in increased expression of DUSP8 mRNA	PMID:24793618
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1315033	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of DUSP8 mRNA	PMID:23608068
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of DUSP8 mRNA	PMID:28988120
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1315033	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of DUSP8 mRNA	PMID:36851058
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1315033	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of DUSP8 mRNA	PMID:36907384
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1315033	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of DUSP8 mRNA	PMID:20003209
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315033	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DUSP8 mRNA	PMID:22206623
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of DUSP8 mRNA	PMID:22079256
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of DUSP8 mRNA	PMID:22079256
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of DUSP8 mRNA	PMID:36318118
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1306425	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of DUSP8 mRNA	PMID:33484710
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:76987	metacetamol	increases expression	ISO	RGD:1315033	E	RGD:6480464	20140204	CTD	MESH:C026137	3-hydroxyacetanilide results in increased expression of DUSP8 mRNA	PMID:18544908
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1306425	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of DUSP8 mRNA	PMID:23665939
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP8 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP8 mRNA	PMID:27188386
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of DUSP8 mRNA	PMID:32234424
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306425	E	RGD:6480464	20230704	CTD	MESH:D011441	Propylthiouracil results in increased expression of DUSP8 mRNA	PMID:36843608
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP8 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP8 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DUSP8 mRNA	PMID:27188386
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:9123	sertraline	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D020280	Sertraline results in increased expression of DUSP8 mRNA	PMID:24865413
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1315033	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of DUSP8 mRNA	PMID:27131904
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:9410	taurodeoxycholic acid	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20250805	CTD	MESH:D013657	Taurodeoxycholic Acid inhibits the reaction [sodium arsenite results in increased expression of DUSP8 mRNA]	PMID:39232337
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of DUSP8 mRNA	PMID:38568856
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:9513	thalidomide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013792	Thalidomide analog results in increased expression of DUSP8 mRNA	PMID:20525221
1315032	DUSP8	dual specificity phosphatase 8	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1315033	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of DUSP8 mRNA	PMID:18930950
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:144421	iron(III) citrate	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C025314	ferric citrate results in decreased expression of CA9 mRNA	PMID:29959986
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D010100	[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ABCC2 mRNA; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ALDH1A1 mRNA; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ALDH1A1 protein; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of IGF1 mRNA; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of LIN28A mRNA; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of SOX2 mRNA; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of TWIST1 mRNA; [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of WNT2 mRNA; Oxygen deficiency results in increased expression of CA9; Oxygen deficiency results in increased expression of CA9 mRNA; Oxygen deficiency results in increased expression of CA9 protein	PMID:18924134|PMID:19154183|PMID:19502547|PMID:19695866|PMID:19808899|PMID:20042640|PMID:20526721|PMID:21361354|PMID:21851094|PMID:22745725|PMID:23424623|PMID:24403227|PMID:25030372|PMID:25043185|PMID:25351418|PMID:26305601|PMID:26540049|PMID:27292261|PMID:29630948|PMID:29690507|PMID:33245928|PMID:34520103
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1315035	E	RGD:6480464	20120412	CTD	MESH:D010100	Oxygen deficiency results in increased expression of CA9; Oxygen deficiency results in increased expression of CA9 mRNA	PMID:19154183|PMID:21361354
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:15379	dioxygen	multiple interactions	EXP		E	RGD:6480464	20160315	CTD	MESH:D010100	(+)-JQ1 compound inhibits the reaction [Oxygen deficiency promotes the reaction [ARNT protein binds to CA9 promoter]]; (+)-JQ1 compound inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; (+)-JQ1 compound inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; 4-(4-((2',3',4',6'-tetra-O-acetylglucopyranosyl)thiomethyl)-5-iodo-1-H-1,2,3-triazol-1-yl)benzenesulfonamide inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; 4-(4-((2',3',4',6'-tetra-O-acetylglucopyranosyl)thiomethyl)-5-iodo-1-H-1,2,3-triazol-1-yl)benzenesulfonamide inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; [4-(4-((2',3',4',6'-tetra-O-acetylglucopyranosyl)thiomethyl)-5-iodo-1-H-1,2,3-triazol-1-yl)benzenesulfonamide inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]] which results in increased expression of CA12 protein; [Oxygen deficiency co-treated with Lipopolysaccharides] results in increased expression of CA9 mRNA; betulin analog inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; Betulinic Acid inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; Bezafibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Butyric Acid inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ABCC2 mRNA]; CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ALDH1A1 mRNA]; CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of LIN28A mRNA]; CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of TWIST1 mRNA]; CA9 mutant form inhibits the reaction [[Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of WNT2 mRNA]; CAY10591 inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; Clofibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; cobaltiprotoporphyrin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; cobaltiprotoporphyrin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; deguelin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Fenofibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Fenofibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; Gemfibrozil inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; genipin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; GSK1210151A inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; HIF1A mRNA promotes the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; molibresib inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Oxygen deficiency promotes the reaction [ARNT protein binds to CA9 promoter]; Oxygen deficiency promotes the reaction [BRD4 protein binds to CA9 promoter]; PTEN protein promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]]; PTEN protein promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]]; Tetrachlorodibenzodioxin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; Vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]	PMID:19154183|PMID:19808899|PMID:20042640|PMID:21851094|PMID:22745725|PMID:24403227|PMID:25351418|PMID:26305601|PMID:26540049|PMID:27292261|PMID:29630948|PMID:34520103|PMID:40024754
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1315035	E	RGD:6480464	20120412	CTD	MESH:D010100	ARNT protein affects the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]	PMID:19154183
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of CA9 mRNA	PMID:25014914|PMID:26079696
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:16170	mercury(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008628	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CA9 mRNA	PMID:32949613
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CA9 mRNA	PMID:29432896
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:D008070	[Oxygen deficiency co-treated with Lipopolysaccharides] results in increased expression of CA9 mRNA	PMID:40024754
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in decreased expression of CA9 mRNA	PMID:20106945|PMID:21632981
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of CA9 mRNA	PMID:30165855
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of CA9 mRNA	PMID:25014914|PMID:26079696
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:17322	chloric acid	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C022842	chloric acid results in decreased activity of CA9 protein	PMID:15664814
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:17594	hydroquinone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in decreased expression of CA9 mRNA	PMID:31256213
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CA9 mRNA	PMID:32949613
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CA9 mRNA	PMID:36139627
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of CA9 mRNA	PMID:26485663
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:17935	octanal	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C031639	caprylic aldehyde results in decreased expression of CA9 mRNA	PMID:25014914
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:17967	urethane	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane affects the expression of CA9 mRNA	PMID:28818685
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:186197	CAY10591	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C000627244	CAY10591 inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]	PMID:34520103
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:188736	Archazolid B	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C519728	archazolid B results in increased expression of CA9 mRNA	PMID:25218289
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:23016	carbonates	decreases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:D002254	Carbonates results in decreased activity of CA9 protein	PMID:15664814
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:232342	SLC-0111	multiple interactions	EXP		E	RGD:6480464	20241119	CTD	MESH:C000625353	SLC-0111 binds to and results in decreased activity of CA9 protein	PMID:28363153
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of CA9 mRNA	PMID:23876855
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:25195	mercury atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008628	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CA9 mRNA	PMID:32949613
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:2682	amphotericin B	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in decreased expression of CA9 mRNA	PMID:28534445
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:26820	sulfates	decreases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:D013431	Sulfates results in decreased activity of CA9 protein	PMID:15664814
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:27638	cobalt atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003035	[tungsten carbide binds to Cobalt] which results in increased expression of CA9 mRNA	PMID:20105288
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:27690	acetazolamide	decreases activity	EXP		E	RGD:6480464	20140812	CTD	MESH:D000086	Acetazolamide results in decreased activity of CA9 protein	PMID:21851094
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:27690	acetazolamide	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:D000086	Acetazolamide binds to and results in decreased activity of CA9 protein	PMID:28251759
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306426	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CA9 mRNA	PMID:31881176
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CA9 mRNA	PMID:23557933
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CA9 mRNA	PMID:28903495
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of CA9 mRNA	PMID:27392435
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]	PMID:19154183
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315035	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]	PMID:19154183
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of CA9 mRNA	PMID:33212167
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CA9 mRNA	PMID:30851411
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CA9 mRNA	PMID:32763439
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D004317	Doxorubicin results in decreased expression of CA9 mRNA	PMID:22908232
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:28971	ampicillin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000667	Ampicillin results in increased expression of CA9 mRNA	PMID:21632981
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D001205	Ascorbic Acid inhibits the reaction [nickel sulfate results in increased expression of CA9 protein]	PMID:16288478
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of CA9 mRNA	PMID:29319823
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of CA9 mRNA	PMID:38568856
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of CA9 mRNA	PMID:29301061
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CA9 promoter	PMID:27901495
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CA9 mRNA	PMID:20228066|PMID:35870112|PMID:40419235
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CA9 exon	PMID:27901495
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of CA9 protein; Benzo(a)pyrene inhibits the reaction [cobaltous chloride results in increased expression of CA9 mRNA]; Benzo(a)pyrene inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein]	PMID:20228066|PMID:36982514
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of CA9 mRNA	PMID:25895662
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of CA9 mRNA	PMID:25351596
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CA9 mRNA	PMID:21969006
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide promotes the reaction [Silybin results in decreased expression of CA9 mRNA]	PMID:21969006
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:30772	butyric acid	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D020148	Butyric Acid inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]	PMID:26305601
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:3086	betulin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:C002503	betulin analog inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]	PMID:26540049
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:3087	betulinic acid	decreases activity	EXP		E	RGD:6480464	20230207	CTD	MESH:C002070	Betulinic Acid analog results in decreased activity of CA9 protein	PMID:29454615
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:3087	betulinic acid	multiple interactions	EXP		E	RGD:6480464	20230207	CTD	MESH:C002070	Betulinic Acid inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]	PMID:26540049
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of CA9 mRNA	PMID:38568856
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:31941	oxaliplatin	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of CA9 mRNA	PMID:17762391
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of CA9 mRNA	PMID:30903817
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306426	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CA9 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of CA9 mRNA	PMID:31715268
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C543008	bisphenol S results in decreased expression of CA9 mRNA	PMID:27685785
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:34595	Butylbenzyl phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C027561	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CA9 mRNA	PMID:32949613
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:34787	heptanal	decreases expression	EXP		E	RGD:6480464	20150127	CTD	MESH:C046204	heptanal results in decreased expression of CA9 mRNA	PMID:25014914
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:34887	nickel dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in increased expression of CA9 mRNA	PMID:21455298|PMID:28552779
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:34887	nickel dichloride	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:C022838	HIF1A protein promotes the reaction [nickel chloride results in increased expression of CA9 protein]	PMID:28552779
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of CA9 mRNA	PMID:38568856
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CA9 mRNA	PMID:38174414|PMID:38382870
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:35459	diisononyl phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C012125	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CA9 mRNA	PMID:32949613
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of CA9 mRNA	PMID:23978341
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:C018021	cobaltous chloride results in increased expression of CA9 mRNA; cobaltous chloride results in increased expression of CA9 protein	PMID:19376846|PMID:19502547|PMID:19808899|PMID:20105288|PMID:20228066|PMID:20526721|PMID:22202117|PMID:24299737|PMID:24842335|PMID:25351418
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C018021	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein]; ARNT gene mutant form inhibits the reaction [cobaltous chloride results in increased expression of CA9 mRNA]; Benzo(a)pyrene inhibits the reaction [cobaltous chloride results in increased expression of CA9 mRNA]; Benzo(a)pyrene inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein]; PTEN protein promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein]]; PTEN protein promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein]]; triptolide inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein]; zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CA9 mRNA]	PMID:19808899|PMID:20228066|PMID:22202117|PMID:24299737|PMID:24842335
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of CA9 mRNA	PMID:24449571
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:36264	molybdate	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C044659	molybdate results in decreased activity of CA9 protein	PMID:15664814
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:37187	lead nitrate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017461	[Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with butylbenzyl phthalate co-treated with lead nitrate co-treated with Mercury] results in decreased expression of CA9 mRNA	PMID:32949613
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:3750	clofibrate	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:D002994	Clofibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]	PMID:34520103
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of CA9 mRNA	PMID:38568856
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in decreased expression of CA9 mRNA	PMID:20106945|PMID:21632981
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:4042	cypermethrin	increases expression	ISO	RGD:1315035	E	RGD:6480464	20260804	CTD	MESH:C017160	cypermethrin results in increased expression of CA9 mRNA	PMID:40633821
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:4356	desferrioxamine B	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D003676	Deferoxamine results in increased expression of CA9 mRNA	PMID:25351418
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:4357	deguelin	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C107676	deguelin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]	PMID:22745725
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CA9 mRNA	PMID:38832940
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:44975	1,10-phenanthroline	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C025205	1,10-phenanthroline results in increased expression of CA9 mRNA	PMID:19502547
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]	PMID:26305601
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of CA9 mRNA	PMID:29067470
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:46502	tungstate	decreases activity	EXP		E	RGD:6480464	20170303	CTD	MESH:C045951	tungstate results in decreased activity of CA9 protein	PMID:15664814
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CA9 mRNA	PMID:29523930
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of CA9 mRNA	PMID:29523930
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:47612	bezafibrate	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:D001629	Bezafibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]	PMID:34520103
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:48107	nitric acid	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D017942	Nitric Acid results in decreased activity of CA9 protein	PMID:15664814
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of CA9 mRNA	PMID:32234424
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of CA9 mRNA	PMID:38568856
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:49706	perchlorate	decreases activity	EXP		E	RGD:6480464	20170117	CTD	MESH:C494474	perchlorate results in decreased activity of CA9 protein	PMID:15664814
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CA9 mRNA	PMID:21969006
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide promotes the reaction [Silybin results in decreased expression of CA9 mRNA]	PMID:21969006
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:49976	zinc dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C016837	zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CA9 mRNA]	PMID:22202117
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:5001	fenofibrate	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:D011345	Fenofibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]; Fenofibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]	PMID:34520103
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of CA9 protein	PMID:16061869
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:5296	gemfibrozil	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:D015248	Gemfibrozil inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]	PMID:34520103
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:5298	Genipin	multiple interactions	EXP		E	RGD:6480464	20180828	CTD	MESH:C007834	genipin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]	PMID:29630948
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of CA9 mRNA	PMID:22714537
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	nickel sulfate results in increased expression of CA9 protein	PMID:16288478
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:53001	nickel sulfate	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C029938	Ascorbic Acid inhibits the reaction [nickel sulfate results in increased expression of CA9 protein]	PMID:16288478
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:53470	cobalt(2+) sulfate	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C026305	cobalt sulfate results in increased expression of CA9 mRNA	PMID:19502547
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20120814	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]; PTEN protein promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein]]; PTEN protein promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]]	PMID:19808899
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of CA9 mRNA	PMID:31758290
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:73163	oryzalin	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C012465	oryzalin binds to and results in decreased activity of CA9 protein	PMID:28251759
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CA9 mRNA	PMID:36139627
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:78160	bleomycin A5	decreases response to substance	EXP		E	RGD:6480464	20140520	CTD	MESH:C025703	CA9 protein results in decreased susceptibility to bleomycetin	PMID:21040473
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:78160	bleomycin A5	increases expression	EXP		E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in increased expression of CA9 mRNA; bleomycetin results in increased expression of CA9 protein	PMID:21040473
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:78160	bleomycin A5	multiple interactions	EXP		E	RGD:6480464	20140520	CTD	MESH:C025703	CA9 protein inhibits the reaction [bleomycetin results in increased activity of CASP3 protein]	PMID:21040473
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of CA9 mRNA	PMID:30851411
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:78708	Nonidet P-40	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C010615	Nonidet P-40 results in decreased expression of CA9 mRNA	PMID:26552463
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:79089	ceric oxide	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C030583	[Air Pollutants results in increased abundance of [Benzo(a)pyrene co-treated with ceric oxide]] which results in decreased expression of CA9 protein; [Air Pollutants results in increased abundance of ceric oxide] which results in decreased expression of CA9 protein	PMID:36982514
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CA9 gene]	PMID:28238834
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of CA9 mRNA	PMID:19159669
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:82283	Tungsten carbide	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C002802	tungsten carbide results in increased expression of CA9 mRNA	PMID:20105288
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:82283	Tungsten carbide	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C002802	[tungsten carbide binds to Cobalt] which results in increased expression of CA9 mRNA	PMID:20105288
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of CA9 mRNA	PMID:32234424
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of CA9 mRNA	PMID:25014914|PMID:26079696
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:88528	hexanal	decreases expression	EXP		E	RGD:6480464	20151103	CTD	MESH:C010463	n-hexanal results in decreased expression of CA9 mRNA	PMID:25014914
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:91116	4-methylumbelliferyl beta-D-galactoside	decreases activity	EXP		E	RGD:6480464	20160315	CTD	MESH:C026845	4-methylumbelliferyl-galactopyranoside analog results in decreased activity of CA9 protein	PMID:22077347
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:9144	silibinin	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C440975	Silybin results in decreased expression of CA9 mRNA	PMID:21969006
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:9144	silibinin	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C440975	Arsenic Trioxide promotes the reaction [Silybin results in decreased expression of CA9 mRNA]	PMID:21969006
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:9330	sulfamic acid	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C005741	sulfamic acid results in decreased activity of CA9 protein	PMID:15664814
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:9352	sulindac	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013467	Sulindac analog results in decreased expression of CA9 mRNA	PMID:18924134
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of CA9 mRNA	PMID:38568856
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:95082	molibresib	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C554645	molibresib results in decreased expression of CA9 mRNA	PMID:27292261
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:95082	molibresib	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C554645	molibresib inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA]	PMID:27292261
1315034	CA9	carbonic anhydrase 9	gene	CHEBI:9747	Triptolide	multiple interactions	EXP		E	RGD:6480464	20151013	CTD	MESH:C001899	triptolide inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein]	PMID:24842335
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552444	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DPP10 gene	PMID:20938992
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306427	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of DPP10 gene	PMID:28931070|PMID:35440735
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1552444	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of DPP10 mRNA	PMID:30319688
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1552444	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DPP10 mRNA	PMID:25510870
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:16598	DDE	multiple interactions	ISO	RGD:1306427	E	RGD:6480464	20160705	CTD	MESH:D003633	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA	PMID:25607892
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552444	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DPP10 gene	PMID:20938992
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1306427	E	RGD:6480464	20160705	CTD	MESH:D004051	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA	PMID:25607892
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1552444	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in increased expression of DPP10 mRNA	PMID:29279043
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DPP10 mRNA	PMID:35301059
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1552444	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DPP10 mRNA	PMID:25510870
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1552444	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DPP10 mRNA	PMID:25510870
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1552444	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of DPP10 mRNA	PMID:25629700
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552444	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of DPP10 gene	PMID:20938992
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1306427	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of DPP10 gene	PMID:35440735
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of DPP10 mRNA	PMID:41028656
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306427	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DPP10 mRNA	PMID:32109520
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DPP10 mRNA	PMID:28001369
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of DPP10 mRNA	PMID:41028656
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:29678	sodium arsenite	increases methylation	ISO	RGD:1552444	E	RGD:6480464	20200915	CTD	MESH:C017947	sodium arsenite results in increased methylation of DPP10 gene	PMID:32068019
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DPP10 exon	PMID:27901495
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DPP10 3' UTR	PMID:27901495
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DPP10 promoter	PMID:27901495
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of DPP10 mRNA	PMID:41028656
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552444	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DPP10 promoter	PMID:35295148
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:33101	nitrogen dioxide	multiple interactions	EXP		E	RGD:6480464	20250708	CTD	MESH:D009585	[Air Pollutants results in increased abundance of Nitrogen Dioxide] which affects the methylation of DPP10 gene	PMID:38723642
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306427	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DPP10 mRNA	PMID:34947998
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552444	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in decreased expression of DPP10 mRNA	PMID:32156529
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DPP10 gene	PMID:31601247
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1552444	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DPP10 mRNA	PMID:25510870
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1552444	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of DPP10 mRNA	PMID:25510870
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:34575	bisphenol F	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	bisphenol F results in decreased methylation of DPP10 gene	PMID:31601247
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1552444	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of DPP10 intron	PMID:28392331
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1306427	E	RGD:6480464	20160705	CTD	MESH:D003993	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA	PMID:25607892
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DPP10 mRNA	PMID:35301059
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1552444	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DPP10 mRNA	PMID:40194260
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DPP10 mRNA	PMID:25979313
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of DPP10 gene	PMID:29154799
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of DPP10 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPP10 mRNA	PMID:27188386
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of DPP10 mRNA	PMID:33512557
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1552444	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DPP10 mRNA	PMID:29279043
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:4811	epoxiconazole	multiple interactions	ISO	RGD:1306427	E	RGD:6480464	20160705	CTD	MESH:C109476	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA	PMID:25607892
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306427	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of DPP10 mRNA	PMID:29097150
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1552444	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of DPP10 mRNA	PMID:19042947
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1552444	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of DPP10 mRNA	PMID:23608068
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:6482	linuron	multiple interactions	ISO	RGD:1306427	E	RGD:6480464	20160705	CTD	MESH:D008044	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA	PMID:25607892
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306427	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DPP10 gene	PMID:35440735
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of DPP10 mRNA	PMID:37199045
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPP10 mRNA	PMID:27188386
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to DPP10 gene]	PMID:28238834
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:8069	phenobarbital	affects methylation	ISO	RGD:1552444	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the methylation of DPP10 gene	PMID:19233941
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306427	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of DPP10 mRNA	PMID:32109520
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of DPP10 mRNA	PMID:33512557
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:83258	fenamidone	decreases expression	ISO	RGD:1552444	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in decreased expression of DPP10 mRNA	PMID:27029645
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:8434	prochloraz	multiple interactions	ISO	RGD:1306427	E	RGD:6480464	20160705	CTD	MESH:C045362	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA	PMID:25607892
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:8450	procymidone	multiple interactions	ISO	RGD:1306427	E	RGD:6480464	20160705	CTD	MESH:C035988	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA	PMID:25607892
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306427	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DPP10 mRNA	PMID:24780913
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of DPP10 mRNA	PMID:27188386
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306427	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of DPP10 mRNA	PMID:19281266
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1306427	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of DPP10 gene	PMID:31682807
1315036	DPP10	dipeptidyl peptidase like 10	gene	CHEBI:9986	vinclozolin	multiple interactions	ISO	RGD:1306427	E	RGD:6480464	20160705	CTD	MESH:C025643	[Dibutyl Phthalate co-treated with Diethylhexyl Phthalate co-treated with vinclozolin co-treated with prochloraz co-treated with procymidone co-treated with Linuron co-treated with epoxiconazole co-treated with Dichlorodiphenyl Dichloroethylene] results in decreased expression of DPP10 mRNA	PMID:25607892
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of POLR3F mRNA	PMID:25596134
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552445	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of POLR3F mRNA	PMID:26251327
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1552445	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of POLR3F mRNA	PMID:20188158
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:15379	dioxygen	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency affects the expression of POLR3F mRNA	PMID:25596134
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552445	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of POLR3F mRNA	PMID:39241906
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of POLR3F mRNA	PMID:31614463
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552445	E	RGD:6480464	20250805	CTD	MESH:D004958	Estradiol results in increased expression of POLR3F protein	PMID:26903627
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of POLR3F mRNA	PMID:19162166
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306428	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of POLR3F mRNA	PMID:33387578
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POLR3F mRNA	PMID:39836092
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552445	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of POLR3F mRNA	PMID:37236586
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of POLR3F mRNA	PMID:23649840
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306428	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of POLR3F mRNA	PMID:31150632
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POLR3F mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POLR3F mRNA	PMID:39836092
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:27871	chloroacetaldehyde	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in increased expression of POLR3F mRNA	PMID:25596134
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of POLR3F mRNA	PMID:23557933
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of POLR3F mRNA	PMID:25596134
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552445	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLR3F mRNA	PMID:17942748
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1552445	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of POLR3F mRNA	PMID:27862939
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of POLR3F mRNA	PMID:29803840
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of POLR3F mRNA	PMID:22714537
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POLR3F mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POLR3F mRNA	PMID:39836092
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of POLR3F mRNA	PMID:25895662
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552445	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of POLR3F promoter alternative form	PMID:35295148
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of POLR3F mRNA	PMID:19710929
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306428	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of POLR3F mRNA	PMID:25181051
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	increases expression	ISO	RGD:1552445	E	RGD:6480464	20250805	CTD	MESH:C014024	2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of POLR3F protein	PMID:26903627
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306428	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of POLR3F mRNA	PMID:21266533
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1552445	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of POLR3F mRNA	PMID:34813904
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POLR3F mRNA	PMID:39836092
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:35456	cadmium dichloride	affects expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride affects the expression of POLR3F mRNA	PMID:25596134
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of POLR3F mRNA	PMID:38568856
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552445	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of POLR3F mRNA	PMID:37236586
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of POLR3F mRNA	PMID:19376846
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of POLR3F mRNA	PMID:25596134
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of POLR3F mRNA	PMID:28302478
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of POLR3F gene	PMID:29154799
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of POLR3F mRNA	PMID:29154799
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306428	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of POLR3F mRNA	PMID:38685447|PMID:41580965
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of POLR3F mRNA	PMID:25596134
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1306428	E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of POLR3F mRNA	PMID:25596134
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552445	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of POLR3F mRNA	PMID:17555576
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1552445	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of POLR3F mRNA	PMID:29279043
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POLR3F mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of POLR3F mRNA	PMID:39836092
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552445	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of POLR3F mRNA	PMID:17555576
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552445	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of POLR3F mRNA	PMID:17942748
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552445	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of POLR3F mRNA	PMID:17942748
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306428	E	RGD:6480464	20260407	CTD	MESH:D008713	Methimazole results in decreased expression of POLR3F mRNA	PMID:41580965
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of POLR3F mRNA	PMID:22714537
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1306428	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of POLR3F mRNA	PMID:20080153
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of POLR3F mRNA	PMID:39836092
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1306428	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of POLR3F mRNA	PMID:25596134
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of POLR3F mRNA	PMID:31758290
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1552445	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of POLR3F mRNA	PMID:22206623
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of POLR3F protein	PMID:31285264
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to POLR3F gene]	PMID:28238834
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1552445	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in increased expression of POLR3F mRNA	PMID:30953684
1315038	POLR3F	RNA polymerase III subunit F	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1552445	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of POLR3F mRNA	PMID:21278054
1315040	NMB	neuromedin B	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1315041	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NMB mRNA	PMID:26251327
1315040	NMB	neuromedin B	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315041	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of NMB; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NMB gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NMB mRNA	PMID:20938992
1315040	NMB	neuromedin B	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of NMB mRNA	PMID:23830798
1315040	NMB	neuromedin B	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of NMB mRNA	PMID:26079696
1315040	NMB	neuromedin B	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of NMB mRNA	PMID:21632981
1315040	NMB	neuromedin B	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1562710	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of NMB mRNA	PMID:33387578
1315040	NMB	neuromedin B	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315041	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of NMB; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NMB gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NMB mRNA	PMID:20938992
1315040	NMB	neuromedin B	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NMB mRNA	PMID:37042841
1315040	NMB	neuromedin B	gene	CHEBI:17026	progesterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011374	Progesterone results in decreased expression of NMB mRNA	PMID:17404688
1315040	NMB	neuromedin B	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1315041	E	RGD:6480464	20130723	CTD	MESH:D013739	Testosterone results in increased expression of NMB mRNA	PMID:19693291
1315040	NMB	neuromedin B	gene	CHEBI:174733	Licochalcone B	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in increased expression of NMB mRNA	PMID:33647349
1315040	NMB	neuromedin B	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1315041	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NMB mRNA	PMID:29950665
1315040	NMB	neuromedin B	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of NMB protein	PMID:20106945
1315040	NMB	neuromedin B	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of NMB mRNA	PMID:21632981|PMID:22100608
1315040	NMB	neuromedin B	gene	CHEBI:2666	amitriptyline	decreases expression	ISO	RGD:1562710	E	RGD:6480464	20130416	CTD	MESH:D000639	Amitriptyline results in decreased expression of NMB mRNA	PMID:22341215
1315040	NMB	neuromedin B	gene	CHEBI:27470	folic acid	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of NMB mRNA	PMID:27293554
1315040	NMB	neuromedin B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315041	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of NMB; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NMB gene; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NMB mRNA	PMID:20938992
1315040	NMB	neuromedin B	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in increased expression of NMB mRNA	PMID:24280081|PMID:27392435
1315040	NMB	neuromedin B	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1315041	E	RGD:6480464	20160412	CTD	MESH:D002945	Cisplatin results in increased expression of NMB mRNA	PMID:24280081
1315040	NMB	neuromedin B	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of NMB mRNA	PMID:27392435
1315040	NMB	neuromedin B	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of NMB mRNA	PMID:25583101
1315040	NMB	neuromedin B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315041	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NMB mRNA	PMID:21570461
1315040	NMB	neuromedin B	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of NMB mRNA	PMID:33212167
1315040	NMB	neuromedin B	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of NMB mRNA	PMID:30851411
1315040	NMB	neuromedin B	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1562710	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of NMB mRNA	PMID:28959563
1315040	NMB	neuromedin B	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of NMB mRNA	PMID:32763439
1315040	NMB	neuromedin B	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NMB mRNA	PMID:29803840
1315040	NMB	neuromedin B	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1315041	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in decreased expression of NMB mRNA	PMID:39631538
1315040	NMB	neuromedin B	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of NMB mRNA	PMID:20044591
1315040	NMB	neuromedin B	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D001379	Azathioprine results in decreased expression of NMB mRNA	PMID:19192274
1315040	NMB	neuromedin B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of NMB mRNA	PMID:39719251
1315040	NMB	neuromedin B	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of NMB mRNA	PMID:22378314
1315040	NMB	neuromedin B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NMB promoter	PMID:27901495
1315040	NMB	neuromedin B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NMB mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1315040	NMB	neuromedin B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315041	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NMB mRNA	PMID:21569818
1315040	NMB	neuromedin B	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1315041	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of NMB mRNA	PMID:18929588
1315040	NMB	neuromedin B	gene	CHEBI:30260	cyromazine	multiple interactions	ISO	RGD:1562710	E	RGD:6480464	20190219	CTD	MESH:C028704	[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in decreased expression of NMB mRNA	PMID:29321614
1315040	NMB	neuromedin B	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1315041	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NMB mRNA	PMID:29950665
1315040	NMB	neuromedin B	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315041	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of NMB mRNA	PMID:23811191
1315040	NMB	neuromedin B	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1315041	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NMB mRNA	PMID:19710929
1315040	NMB	neuromedin B	gene	CHEBI:32585	4-hydroxynon-2-enal	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C027576	4-hydroxy-2-nonenal results in decreased expression of NMB mRNA	PMID:12419474
1315040	NMB	neuromedin B	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1562710	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NMB mRNA	PMID:25181051
1315040	NMB	neuromedin B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1562710	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of NMB mRNA	PMID:34947998
1315040	NMB	neuromedin B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of NMB mRNA	PMID:27685785
1315040	NMB	neuromedin B	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1562710	E	RGD:6480464	20170613	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of NMB mRNA	PMID:28300664
1315040	NMB	neuromedin B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of NMB gene	PMID:31601247
1315040	NMB	neuromedin B	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] affects the expression of NMB mRNA	PMID:28628672
1315040	NMB	neuromedin B	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1315041	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of NMB mRNA	PMID:28392331
1315040	NMB	neuromedin B	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1315041	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of NMB mRNA	PMID:29950665
1315040	NMB	neuromedin B	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] affects the expression of NMB mRNA	PMID:28628672
1315040	NMB	neuromedin B	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1315041	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of NMB mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NMB mRNA]	PMID:17585979
1315040	NMB	neuromedin B	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of NMB mRNA	PMID:28302478
1315040	NMB	neuromedin B	gene	CHEBI:39478	buta-1,3-diene	increases expression	ISO	RGD:1315041	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in increased expression of NMB mRNA	PMID:29038090
1315040	NMB	neuromedin B	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1315041	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of NMB mRNA	PMID:23125180
1315040	NMB	neuromedin B	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NMB mRNA	PMID:25979313
1315040	NMB	neuromedin B	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of NMB mRNA	PMID:29154799
1315040	NMB	neuromedin B	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NMB mRNA	PMID:25562108
1315040	NMB	neuromedin B	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] affects the expression of NMB mRNA	PMID:28628672
1315040	NMB	neuromedin B	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008727	Methotrexate results in decreased expression of NMB mRNA	PMID:19192274
1315040	NMB	neuromedin B	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of NMB mRNA	PMID:38832940
1315040	NMB	neuromedin B	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315041	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NMB mRNA	PMID:17562736
1315040	NMB	neuromedin B	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1562710	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NMB mRNA	PMID:33387578
1315040	NMB	neuromedin B	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1315041	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of NMB mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of NMB mRNA]	PMID:17585979
1315040	NMB	neuromedin B	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] affects the expression of NMB mRNA	PMID:28628672
1315040	NMB	neuromedin B	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of NMB mRNA	PMID:21856257
1315040	NMB	neuromedin B	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315041	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of NMB mRNA; Nanotubes, Carbon results in increased expression of NMB mRNA	PMID:25554681|PMID:25620056
1315040	NMB	neuromedin B	gene	CHEBI:5516	sodium aurothiomalate	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D006052	Gold Sodium Thiomalate results in decreased expression of NMB mRNA	PMID:19192274
1315040	NMB	neuromedin B	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1562710	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of NMB mRNA	PMID:20080153
1315040	NMB	neuromedin B	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1562710	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of NMB mRNA	PMID:28801915
1315040	NMB	neuromedin B	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of NMB mRNA	PMID:24810058
1315040	NMB	neuromedin B	gene	CHEBI:6888	6alpha-methylprednisolone	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D008775	Methylprednisolone results in decreased expression of NMB mRNA	PMID:19192274
1315040	NMB	neuromedin B	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of NMB mRNA	PMID:31758290
1315040	NMB	neuromedin B	gene	CHEBI:7719	ochratoxin A	decreases methylation	ISO	RGD:1562710	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in decreased methylation of NMB gene	PMID:37162024
1315040	NMB	neuromedin B	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1562710	E	RGD:6480464	20240109	CTD	MESH:C025589	ochratoxin A results in increased expression of NMB mRNA	PMID:37162024
1315040	NMB	neuromedin B	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of NMB mRNA	PMID:30851411
1315040	NMB	neuromedin B	gene	CHEBI:79736	ziram	multiple interactions	ISO	RGD:1562710	E	RGD:6480464	20190219	CTD	MESH:D015039	[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in decreased expression of NMB mRNA	PMID:29321614
1315040	NMB	neuromedin B	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NMB gene]	PMID:28238834
1315040	NMB	neuromedin B	gene	CHEBI:81806	2-methyl-4-chlorophenoxybutyric acid	multiple interactions	ISO	RGD:1562710	E	RGD:6480464	20191114	CTD	MESH:C008418	[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in decreased expression of NMB mRNA	PMID:29321614
1315040	NMB	neuromedin B	gene	CHEBI:8248	pirimicarb	multiple interactions	ISO	RGD:1562710	E	RGD:6480464	20190219	CTD	MESH:C011994	[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in decreased expression of NMB mRNA	PMID:29321614
1315040	NMB	neuromedin B	gene	CHEBI:8378	prednisolone	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D011239	Prednisolone results in decreased expression of NMB mRNA	PMID:19192274
1315040	NMB	neuromedin B	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1562710	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of NMB mRNA	PMID:24780913
1315040	NMB	neuromedin B	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1562710	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of NMB mRNA	PMID:19281266
1315040	NMB	neuromedin B	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1562710	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of NMB mRNA	PMID:21346803
1315040	NMB	neuromedin B	gene	CHEBI:9495	thiram	multiple interactions	ISO	RGD:1562710	E	RGD:6480464	20190219	CTD	MESH:D013893	[2-amino-3-chloro-1,4-naphthoquinone co-treated with Ziram co-treated with cyromazine co-treated with 2-methyl-4-chlorophenoxy gamma-butyric acid co-treated with pirimicarb co-treated with Thiram] results in decreased expression of NMB mRNA	PMID:29321614
1315040	NMB	neuromedin B	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of NMB mRNA	PMID:22378314
1315040	NMB	neuromedin B	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1562710	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of NMB mRNA	PMID:21346803
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of KCTD14 mRNA	PMID:27188386
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD14 mRNA	PMID:27188386
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:132098	methoxyacetic acid	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of KCTD14 mRNA	PMID:20864626
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:132612	monobenzyl phthalate	multiple interactions	ISO	RGD:1550487	E	RGD:6480464	20250603	CTD	MESH:C103325	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KCTD14 mRNA	PMID:39752319
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of KCTD14 mRNA	PMID:21632981
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1550487	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCTD14 mRNA	PMID:25510870
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of KCTD14 mRNA	PMID:33387578
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1550487	E	RGD:6480464	20250603	CTD	MESH:C016599	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KCTD14 mRNA	PMID:39752319
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550487	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KCTD14 mRNA; Diethylhexyl Phthalate results in decreased expression of KCTD14 protein	PMID:34319233|PMID:35842051
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550487	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of KCTD14 mRNA	PMID:33754040
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of KCTD14 mRNA	PMID:33387578
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of KCTD14 mRNA	PMID:28818685
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1550487	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCTD14 mRNA	PMID:25510870
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1550487	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCTD14 mRNA	PMID:25510870
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of KCTD14 mRNA	PMID:19549813
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D009151	Mustard Gas results in decreased expression of KCTD14 mRNA	PMID:25102026
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of KCTD14 mRNA	PMID:19774075
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306430	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KCTD14 mRNA	PMID:31150632
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1550487	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KCTD14 mRNA	PMID:25629700
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCTD14 mRNA	PMID:27188386
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of KCTD14 mRNA	PMID:20864626
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550487	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of KCTD14 mRNA	PMID:28960355
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1550487	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of KCTD14 mRNA	PMID:40618947
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KCTD14 mRNA	PMID:33387578
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KCTD14 mRNA	PMID:23179753
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of KCTD14 mRNA	PMID:20864626
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of KCTD14 mRNA	PMID:32763439
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of KCTD14 mRNA	PMID:20971185
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of KCTD14 mRNA	PMID:38568856
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550487	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KCTD14 mRNA	PMID:22228805
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of KCTD14 mRNA	PMID:32234424
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KCTD14 exon; Benzo(a)pyrene results in increased methylation of KCTD14 promoter	PMID:27901495
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of KCTD14 mRNA	PMID:20971185
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of KCTD14 mRNA	PMID:26014281
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of KCTD14 mRNA	PMID:30047161
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550487	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of KCTD14 mRNA	PMID:35295148
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306430	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of KCTD14 mRNA	PMID:34492290
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of KCTD14 mRNA	PMID:30816183
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1550487	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCTD14 mRNA	PMID:25510870
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1550487	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of KCTD14 mRNA	PMID:25510870
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1550487	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of KCTD14 mRNA	PMID:26377693
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550487	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of KCTD14 mRNA	PMID:21266533
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306430	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of KCTD14 mRNA	PMID:21266533
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KCTD14 mRNA	PMID:35163327
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306430	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of KCTD14 mRNA	PMID:30723492
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KCTD14 mRNA	PMID:38174414|PMID:38568856
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1306430	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of KCTD14 mRNA	PMID:35163327
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of KCTD14 mRNA	PMID:24449571
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of KCTD14 mRNA	PMID:23179753|PMID:24383497
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD14 mRNA	PMID:27188386
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of KCTD14 mRNA	PMID:30047161
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of KCTD14 mRNA	PMID:20106945|PMID:25562108
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550487	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of KCTD14 mRNA	PMID:28973697
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550487	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KCTD14 mRNA	PMID:17562736
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of KCTD14 mRNA	PMID:21420995|PMID:29067470
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KCTD14 mRNA	PMID:33387578
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of KCTD14 mRNA	PMID:26690555
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1306430	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of KCTD14 mRNA	PMID:29391264
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550487	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of KCTD14 mRNA; Nanotubes, Carbon results in decreased expression of KCTD14 mRNA	PMID:25554681
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of KCTD14 mRNA	PMID:30047161
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1550487	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of KCTD14 mRNA	PMID:23608068
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1306430	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of KCTD14 mRNA	PMID:19564919
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:70973	monoethyl phthalate	multiple interactions	ISO	RGD:1550487	E	RGD:6480464	20250603	CTD	MESH:C581825	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KCTD14 mRNA	PMID:39752319
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of KCTD14 mRNA	PMID:22714537
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD14 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCTD14 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD14 mRNA	PMID:27188386
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KCTD14 mRNA	PMID:30047161
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of KCTD14 mRNA	PMID:20864626
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:88522	Monobutylphthalate	multiple interactions	ISO	RGD:1550487	E	RGD:6480464	20250603	CTD	MESH:C028577	[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl phthalate co-treated with mono-benzyl phthalate] affects the expression of KCTD14 mRNA	PMID:39752319
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD14 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of KCTD14 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of KCTD14 mRNA	PMID:27188386
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in decreased expression of KCTD14 mRNA	PMID:26014281
1315042	KCTD14	potassium channel tetramerization domain containing 14	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306430	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of KCTD14 mRNA	PMID:23034163
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:10022	deoxynivalenol	increases phosphorylation	EXP		E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol results in increased phosphorylation of MAP3K5 protein	PMID:20181660
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:10022	deoxynivalenol	multiple interactions	EXP		E	RGD:6480464	20141111	CTD	MESH:C007262	AG 1879 inhibits the reaction [deoxynivalenol results in increased phosphorylation of MAP3K5 protein]	PMID:20181660
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:119486	efavirenz	increases phosphorylation	EXP		E	RGD:6480464	20170228	CTD	MESH:C098320	efavirenz metabolite results in increased phosphorylation of MAP3K5 protein; efavirenz results in increased phosphorylation of MAP3K5 protein	PMID:21958719
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:131923	salubrinal	affects response to substance	EXP		E	RGD:6480464	20170303	CTD	MESH:C496827	salubrinal affects the susceptibility to MAP3K5 protein	PMID:20929985
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:131923	salubrinal	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C496827	salubrinal affects the susceptibility to [Paraquat co-treated with MAP3K5 protein]; salubrinal inhibits the reaction [MAP3K5 protein affects the localization of CYCS protein]; salubrinal inhibits the reaction [MAP3K5 protein results in increased activity of CASP3 protein]; salubrinal inhibits the reaction [Paraquat results in increased phosphorylation of and results in increased activity of MAP3K5 protein]; salubrinal promotes the reaction [[Paraquat co-treated with MAP3K5 protein] results in increased degradation of SQSTM1 protein]; salubrinal promotes the reaction [[Paraquat co-treated with MAP3K5 protein] results in increased expression of BECN1 protein]; salubrinal promotes the reaction [MAP3K5 protein results in increased degradation of SQSTM1 protein]; salubrinal promotes the reaction [MAP3K5 protein results in increased expression of BECN1 protein]	PMID:19735704|PMID:20929985
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of MAP3K5 mRNA	PMID:26272509
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA	PMID:27188386
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:144804	nickel subsulfide	affects response to substance	EXP		E	RGD:6480464	20191008	CTD	MESH:C017557	MAP3K5 protein affects the susceptibility to nickel subsulfide	PMID:20112989
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:144804	nickel subsulfide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide results in increased phosphorylation of and results in increased activity of MAP3K5 protein	PMID:20112989
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20121009	CTD	MESH:D014212	Tretinoin results in decreased expression of MAP3K5 mRNA	PMID:22498432
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of MAP3K5 mRNA	PMID:21934132|PMID:23724009
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAP3K5 mRNA	PMID:36331819
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of MAP3K5 mRNA	PMID:39506029
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:15756	hexadecanoic acid	increases expression	ISO	RGD:1315044	E	RGD:6480464	20220308	CTD	MESH:D019308	Palmitic Acid results in increased expression of MAP3K5 protein	PMID:34678374
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20220308	CTD	MESH:D019308	carnosol inhibits the reaction [Palmitic Acid results in increased expression of MAP3K5 protein]; PRDX3 protein inhibits the reaction [Palmitic Acid results in increased expression of MAP3K5 protein]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased expression of MAP3K5 protein]]	PMID:34678374
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16118	berberine	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20190219	CTD	MESH:D001599	Berberine inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with TNF protein] results in decreased expression of and results in increased phosphorylation of MAP3K5 protein]	PMID:30240693
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315044	E	RGD:6480464	20200310	CTD	MESH:D000431	Ethanol results in increased expression of MAP3K5 protein	PMID:29044621
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20120412	CTD	MESH:D000431	[Bicuculline co-treated with Ethanol] results in increased expression of MAP3K5 protein; gamma-Aminobutyric Acid inhibits the reaction [Ethanol results in increased expression of MAP3K5 protein]; Muscimol inhibits the reaction [Ethanol results in increased expression of MAP3K5 protein]	PMID:29044621
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16240	hydrogen peroxide	increases activity	ISO	RGD:1306565	E	RGD:6480464	20120522	CTD	MESH:D006861	Hydrogen Peroxide results in increased activity of MAP3K5 protein	PMID:15629441
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16240	hydrogen peroxide	increases expression	ISO	RGD:1306565	E	RGD:6480464	20120522	CTD	MESH:D006861	Hydrogen Peroxide results in increased expression of MAP3K5 protein	PMID:16157298
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20191112	CTD	MESH:D006861	ASK1 protein inhibits the reaction [Hydrogen Peroxide promotes the reaction [MAP3K5 protein binds to MAP2K7 protein]]; Hydrogen Peroxide promotes the reaction [MAP3K5 protein binds to MAP2K7 protein]	PMID:28939911
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16243	quercetin	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Acetylcysteine inhibits the reaction [Quercetin results in decreased phosphorylation of and results in increased activity of MAP3K5 protein]; Quercetin results in decreased phosphorylation of and results in increased activity of MAP3K5 protein	PMID:20083342
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MAP3K5 mRNA	PMID:35811015
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16412	lipopolysaccharide	increases response to substance	ISO	RGD:1315044	E	RGD:6480464	20161228	CTD	MESH:D008070	MAP3K5 protein results in increased susceptibility to Lipopolysaccharides	PMID:21449566
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MAP3K5 mRNA	PMID:35811015
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1306565	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of MAP3K5 mRNA	PMID:32145629
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of MAP3K5 mRNA	PMID:39298647
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of MAP3K5 mRNA	PMID:19619570
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MAP3K5 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of MAP3K5 mRNA	PMID:19619570|PMID:30165855
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of MAP3K5 mRNA	PMID:26496021
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MAP3K5 mRNA	PMID:37042841
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20210209	CTD	MESH:D001554	Benzene results in increased expression of MAP3K5 mRNA	PMID:33064461
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D002635	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP3K5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA	PMID:33819548
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of MAP3K5 gene	PMID:30521419
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16836	4-nitrophenol	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20220111	CTD	MESH:C024836	4-nitrophenol results in decreased expression of MAP3K5 mRNA	PMID:34673133
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D005557	Formaldehyde results in decreased expression of MAP3K5 mRNA	PMID:23416264
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:16865	gamma-aminobutyric acid	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20200310	CTD	MESH:D005680	gamma-Aminobutyric Acid inhibits the reaction [Ethanol results in increased expression of MAP3K5 protein]	PMID:29044621
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17234	glucose	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005947	Glucose results in increased expression of MAP3K5 protein	PMID:16731828
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17234	glucose	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005947	Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein	PMID:14505347|PMID:16731828
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20160412	CTD	MESH:D005947	[[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; [Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein	PMID:26660634
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1315044	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of MAP3K5 mRNA	PMID:28973375
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17573	glycyrrhetinate	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C119129	18alpha-glycyrrhetinic acid inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein]	PMID:29444456
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17634	D-glucose	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005947	Glucose results in increased expression of MAP3K5 protein	PMID:16731828
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17634	D-glucose	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005947	Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein	PMID:14505347|PMID:16731828
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20160412	CTD	MESH:D005947	[[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; [Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein	PMID:26660634
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D006000	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP3K5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA	PMID:33819548
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315044	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MAP3K5 mRNA	PMID:34319233
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17823	calcitriol	increases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased activity of MAP3K5 protein	PMID:10843682
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Calcitriol promotes the reaction [TXNIP protein binds to TNPO1 protein]] which results in increased activity of MAP3K5 protein	PMID:10843682
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306565	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of MAP3K5 mRNA	PMID:33387578
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17846	(S)-naringenin	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C005273	naringenin results in increased expression of MAP3K5 protein	PMID:27838343
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases phosphorylation	ISO	RGD:1315044	E	RGD:6480464	20191112	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased phosphorylation of MAP3K5 protein	PMID:28939911
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20191112	CTD	MESH:D015632	CIB1 gene mutant form promotes the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased phosphorylation of MAP3K5 protein]	PMID:28939911
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MAP3K5 mRNA	PMID:36331819
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:18320	1,4-dithiothreitol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D004229	Dithiothreitol inhibits the reaction [NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]]	PMID:18922898
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:192545	LY 379268	increases phosphorylation	ISO	RGD:1306565	E	RGD:6480464	20240806	CTD	MESH:C118218	LY 379268 results in increased phosphorylation of MAP3K5 protein	PMID:17293559
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1306565	E	RGD:6480464	20251202	CTD	MESH:D002104	Cadmium results in increased expression of MAP3K5 mRNA	PMID:33740178
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:233566	NCX-4040	multiple interactions	EXP		E	RGD:6480464	20250408	CTD	MESH:C498045	[NCX 4040 results in increased oxidation of TXN1 protein] inhibits the reaction [TXN1 protein binds to MAP3K5 protein]; Dithiothreitol inhibits the reaction [NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]]; NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]	PMID:18922898
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:23414	copper(II) sulfate	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MAP3K5 mRNA	PMID:18579281
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:234430	gardiquimod	increases expression	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	gardiquimod results in increased expression of MAP3K5 mRNA	PMID:28003376
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:234430	gardiquimod	multiple interactions	EXP		E	RGD:6480464	20250729	CTD	MESH:C546771	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of MAP3K5 mRNA]	PMID:28003376
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of MAP3K5 mRNA	PMID:23649840
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306565	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of MAP3K5 mRNA	PMID:21396975
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:24814	indole-3-methanol	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:C016517	Acetylcysteine inhibits the reaction [indole-3-carbinol results in decreased expression of and results in increased phosphorylation of MAP3K5 protein]; indole-3-carbinol results in decreased expression of and results in increased phosphorylation of MAP3K5 protein	PMID:33118390
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of MAP3K5 protein	PMID:20106945
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MAP3K5 mRNA	PMID:27153756
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of MAP3K5 mRNA	PMID:23649840
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of MAP3K5 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of MAP3K5 mRNA	PMID:35430440|PMID:41430723
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:26523	reactive oxygen species	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20170303	CTD	MESH:D017382	Reactive Oxygen Species affects the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]	PMID:16449798
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:C011559	tributyltin results in increased expression of and results in increased phosphorylation of MAP3K5 protein	PMID:24038145
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1315044	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MAP3K5 mRNA	PMID:31919559
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MAP3K5 mRNA	PMID:25629700
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D006002	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP3K5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA	PMID:33819548
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of MAP3K5 mRNA	PMID:19244175
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27656	camptothecin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002166	Camptothecin results in decreased expression of MAP3K5 mRNA	PMID:17374387
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of MAP3K5 mRNA	PMID:26272509
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA	PMID:27188386
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27881	resveratrol	increases activity	EXP		E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in increased activity of MAP3K5 protein	PMID:15217905
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MAP3K5 mRNA	PMID:23557933
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol inhibits the reaction [Streptozocin results in increased expression of MAP3K5 protein]	PMID:26499206
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20230801	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of MAP3K5 mRNA	PMID:36642386
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of MAP3K5 mRNA	PMID:19561079|PMID:27392435
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1315044	E	RGD:6480464	20240806	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of MAP3K5 protein	PMID:36178099
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of MAP3K5 mRNA	PMID:27392435
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20240806	CTD	MESH:D002945	Curcumin inhibits the reaction [Cisplatin results in increased phosphorylation of MAP3K5 protein]	PMID:36178099
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of MAP3K5 mRNA	PMID:30912803
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MAP3K5 mRNA	PMID:22574217
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MAP3K5 mRNA	PMID:19619570
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MAP3K5 mRNA	PMID:19619570
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of MAP3K5 mRNA	PMID:25975270
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306565	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of MAP3K5 mRNA	PMID:28374803
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28201	rotenone	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20120412	CTD	MESH:D012402	Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]]; Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]	PMID:16449798
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of MAP3K5 mRNA	PMID:33212167
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28262	dimethyl sulfoxide	decreases activity	ISO	RGD:1306565	E	RGD:6480464	20120522	CTD	MESH:D004121	Dimethyl Sulfoxide results in decreased activity of MAP3K5 protein	PMID:12370186
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28262	dimethyl sulfoxide	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20120522	CTD	MESH:D004121	Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in increased activity of MAP3K5 protein]	PMID:12370186
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MAP3K5 mRNA	PMID:30851411
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28509	chloroethene	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20130514	CTD	MESH:D014752	Vinyl Chloride results in decreased expression of MAP3K5 mRNA	PMID:18579281
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MAP3K5 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of MAP3K5 mRNA	PMID:20971185|PMID:30911355
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MAP3K5 mRNA	PMID:29803840
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1315044	E	RGD:6480464	20151215	CTD	MESH:D004317	Doxorubicin results in increased expression of MAP3K5 protein	PMID:25896364
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28748	doxorubicin	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20151215	CTD	MESH:D004317	PSMB10 protein inhibits the reaction [Doxorubicin results in increased expression of MAP3K5 protein]; PSMB8 protein inhibits the reaction [Doxorubicin results in increased expression of MAP3K5 protein]; PSMB9 protein inhibits the reaction [Doxorubicin results in increased expression of MAP3K5 protein]	PMID:25896364
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28757	fructose	increases phosphorylation	ISO	RGD:1306565	E	RGD:6480464	20250401	CTD	MESH:D005632	Fructose results in increased phosphorylation of ASK1 protein	PMID:37186242
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20250401	CTD	MESH:D005632	nuciferine inhibits the reaction [Fructose results in increased phosphorylation of ASK1 protein]; Pioglitazone inhibits the reaction [Fructose results in increased phosphorylation of ASK1 protein]	PMID:37186242
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D003840	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP3K5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA	PMID:33819548
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:150429751|PMID:25198898	20210923	RGD	MESH:D000111	N-acetyl-L-cysteine co-treated with Curcumin increases phosphorylation of MAP3K5 protein in uterine cervix	
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of MAP3K5 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein]; Acetylcysteine inhibits the reaction [indole-3-carbinol results in decreased expression of and results in increased phosphorylation of MAP3K5 protein]; Acetylcysteine inhibits the reaction [platycodin D affects the phosphorylation of and results in increased activity of MAP3K5 protein]; Acetylcysteine inhibits the reaction [Quercetin results in decreased phosphorylation of and results in increased activity of MAP3K5 protein]	PMID:18703135|PMID:20083342|PMID:22784044|PMID:33039870|PMID:33118390
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20120717	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein]	PMID:18703135
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Rotenone inhibits the reaction [TXN protein binds to and results in decreased activity of MAP3K5 protein]]	PMID:16449798
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D001205	Ascorbic Acid inhibits the reaction [Plant Extracts results in increased phosphorylation of MAP3K5 protein]	PMID:20206247
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite affects the expression of MAP3K5 mRNA	PMID:34032870
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MAP3K5 mRNA	PMID:38568856
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:29678	sodium arsenite	increases activity	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased activity of MAP3K5 protein	PMID:16337887
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of MAP3K5 mRNA	PMID:22714537
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:29681	surfactin	increases phosphorylation	EXP		E	RGD:6480464	20220809	CTD	MESH:C009365	surfactin peptide results in increased phosphorylation of MAP3K5 protein	PMID:34850538
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:29681	surfactin	multiple interactions	EXP		E	RGD:6480464	20220809	CTD	MESH:C009365	4-methylumbelliferone 8-carbaldehyde inhibits the reaction [surfactin peptide results in increased phosphorylation of MAP3K5 protein]; KIRA6 inhibits the reaction [surfactin peptide results in increased phosphorylation of MAP3K5 protein]	PMID:34850538
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:29699	tunicamycin	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D014415	Tunicamycin results in increased phosphorylation of and results in increased activity of MAP3K5 protein	PMID:19735704
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAP3K5 mRNA	PMID:20064835
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MAP3K5 mRNA	PMID:19770486
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1315044	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MAP3K5 intron	PMID:27901495
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in decreased expression of MAP3K5 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of MAP3K5 mRNA	PMID:20971185|PMID:30911355
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MAP3K5 mRNA	PMID:19150397
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:30853	glycyrrhetinic acid	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C119129	18alpha-glycyrrhetinic acid inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein]	PMID:29444456
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:3092	bicuculline	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20200310	CTD	MESH:D001640	[Bicuculline co-treated with Ethanol] results in increased expression of MAP3K5 protein	PMID:29044621
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:31530	edaravone	decreases activity	ISO	RGD:1315044	E	RGD:6480464	20120412	CTD	MESH:C005435	Edaravone results in decreased activity of MAP3K5 protein	PMID:15824197
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:31649	teprenone	multiple interactions	EXP		E	RGD:6480464	20231205	CTD	MESH:C031049	geranylgeranylacetone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein]	PMID:34732784
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:31746	kainic acid	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20120412	CTD	MESH:D007608	Kainic Acid results in decreased expression of MAP3K5 mRNA	PMID:17997037
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20230801	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of MAP3K5 mRNA	PMID:36642386
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:3179	bromobenzene	increases expression	ISO	RGD:1306565	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in increased expression of MAP3K5 mRNA	PMID:32479839
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:31823	mercury dichloride	increases activity	EXP		E	RGD:6480464	20120918	CTD	MESH:D008627	Mercuric Chloride results in increased activity of MAP3K5 protein	PMID:16337887
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315044	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MAP3K5 gene	PMID:35295148
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315044	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of MAP3K5 mRNA	PMID:23557971
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315044	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of MAP3K5 promoter	PMID:35295148
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:32497	thioacetamide	increases activity	ISO	RGD:1306565	E	RGD:6480464	20120522	CTD	MESH:D013853	Thioacetamide results in increased activity of MAP3K5 protein	PMID:12370186
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306565	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of MAP3K5 mRNA; Thioacetamide results in increased expression of MAP3K5 protein	PMID:23411599|PMID:35961375
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:32497	thioacetamide	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20120522	CTD	MESH:D013853	Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in increased activity of MAP3K5 protein]; Lactulose inhibits the reaction [Thioacetamide results in increased expression of MAP3K5 protein]; SB-332235 inhibits the reaction [Thioacetamide results in increased expression of MAP3K5 protein]	PMID:12370186|PMID:35961375
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315044	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MAP3K5 mRNA	PMID:18445702
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:C074702	chromium hexavalent ion inhibits the reaction [TXN protein binds to MAP3K5 protein]	PMID:19703554
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306565	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MAP3K5 mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:32528016
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306565	E	RGD:6480464	20150414	CTD	MESH:C006780	bisphenol A results in increased expression of MAP3K5 mRNA	PMID:25461909|PMID:41034487
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:33216	bisphenol A	increases phosphorylation	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased phosphorylation of MAP3K5 protein	PMID:33039870
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [bisphenol A results in increased phosphorylation of MAP3K5 protein]; Acetylcysteine inhibits the reaction [bisphenol A results in increased phosphorylation of MAP3K5 protein]	PMID:33039870
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of MAP3K5 mRNA	PMID:26496021
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of MAP3K5 mRNA	PMID:19244175
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:3429	Carnosol	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20220308	CTD	MESH:C068623	carnosol inhibits the reaction [Dietary Fats results in increased expression of MAP3K5 protein]; carnosol inhibits the reaction [Palmitic Acid results in increased expression of MAP3K5 protein]; PRDX3 protein promotes the reaction [carnosol inhibits the reaction [Palmitic Acid results in increased expression of MAP3K5 protein]]	PMID:34678374
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1315044	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of MAP3K5 mRNA	PMID:39298647
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315044	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of MAP3K5 mRNA	PMID:30951980
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1315044	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of MAP3K5 intron	PMID:28392331
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:34696	dieldrin	affects methylation	ISO	RGD:1315044	E	RGD:6480464	20241105	CTD	MESH:D004026	Dieldrin affects the methylation of MAP3K5 gene	PMID:38995845
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:34905	paraquat	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010269	[Paraquat co-treated with MAP3K5 protein] results in increased degradation of SQSTM1 protein; [Paraquat co-treated with MAP3K5 protein] results in increased expression of BECN1 protein; Paraquat promotes the reaction [MAP3K5 protein results in increased phosphorylation of ERN1 protein]; Paraquat results in increased phosphorylation of and results in increased activity of MAP3K5 protein; salubrinal affects the susceptibility to [Paraquat co-treated with MAP3K5 protein]; salubrinal inhibits the reaction [Paraquat results in increased phosphorylation of and results in increased activity of MAP3K5 protein]; salubrinal promotes the reaction [[Paraquat co-treated with MAP3K5 protein] results in increased degradation of SQSTM1 protein]; salubrinal promotes the reaction [[Paraquat co-treated with MAP3K5 protein] results in increased expression of BECN1 protein]	PMID:19735704|PMID:20929985
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MAP3K5 mRNA	PMID:38568856
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306565	E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MAP3K5 mRNA	PMID:36928142
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35456	cadmium dichloride	decreases phosphorylation	EXP		E	RGD:6480464	20251104	CTD	MESH:D019256	Cadmium Chloride results in decreased phosphorylation of ASK1 protein	PMID:28651161
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35456	cadmium dichloride	increases activity	EXP		E	RGD:6480464	20120918	CTD	MESH:D019256	Cadmium Chloride results in increased activity of MAP3K5 protein	PMID:16337887
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MAP3K5 mRNA; Cadmium Chloride results in increased expression of MAP3K5 protein	PMID:29444456|PMID:38382870
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35456	cadmium dichloride	increases phosphorylation	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased phosphorylation of MAP3K5 protein	PMID:18703135
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35456	cadmium dichloride	increases phosphorylation	ISO	RGD:1306565	E	RGD:6480464	20120918	CTD	MESH:D019256	Cadmium Chloride results in increased phosphorylation of MAP3K5 protein	PMID:18021293|PMID:18703135
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D019256	18alpha-glycyrrhetinic acid inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein]; 4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein]; Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein]; AKT activator SC79 inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein]; GJA1 promotes the reaction [Cadmium Chloride results in decreased phosphorylation of ASK1 protein]; MK 2206 promotes the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein]; STF 083010 inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein]	PMID:18703135|PMID:28651161|PMID:29444456
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20120717	CTD	MESH:D019256	Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased phosphorylation of MAP3K5 protein]	PMID:18703135
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306565	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of MAP3K5 mRNA	PMID:26194646
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35559	furan	increases phosphorylation	ISO	RGD:1315044	E	RGD:6480464	20220111	CTD	MESH:C039281	furan results in increased phosphorylation of MAP3K5 protein	PMID:34450210
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35559	furan	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20220111	CTD	MESH:C039281	rhodioloside inhibits the reaction [furan results in increased phosphorylation of MAP3K5 protein]	PMID:34450210
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1315044	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of MAP3K5 mRNA	PMID:28903501
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MAP3K5 mRNA	PMID:24449571
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D005999	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP3K5 mRNA; [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA	PMID:33819548
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1315044	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of MAP3K5 mRNA	PMID:18353800
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of MAP3K5 mRNA	PMID:19244175
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:37699	protein kinase inhibitor	multiple interactions	EXP		E	RGD:6480464	20180220	CTD	MESH:D047428	Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of MAP3K5 mRNA]	PMID:28003376
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:38635	3-methyladenine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:C025946	3-methyladenine affects the susceptibility to MAP3K5 protein	PMID:20929985
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:38635	3-methyladenine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C025946	3-methyladenine inhibits the reaction [MAP3K5 protein results in decreased phosphorylation of MTOR protein]; 3-methyladenine promotes the reaction [MAP3K5 protein affects the localization of CYCS protein]; 3-methyladenine promotes the reaction [MAP3K5 protein results in increased activity of CASP3 protein]	PMID:20929985
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:38940	sunitinib	increases expression	ISO	RGD:1315044	E	RGD:6480464	20260303	CTD	MESH:C473478	Sunitinib results in increased expression of ASK1 protein	PMID:40449751
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:38940	sunitinib	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20260303	CTD	MESH:C473478	2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of ASK1 protein]; N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole inhibits the reaction [Sunitinib results in increased expression of ASK1 protein]]	PMID:40449751
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1315044	E	RGD:6480464	20151215	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MAP3K5 mRNA	PMID:26300304
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MAP3K5 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MAP3K5 mRNA	PMID:36331819
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:39483	sodium dichromate	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in decreased expression of MAP3K5 mRNA	PMID:22155349
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1315044	E	RGD:6480464	20121009	CTD	MESH:C016104	sodium bichromate results in increased expression of MAP3K5 mRNA	PMID:22155349
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:3962	curcumin	increases phosphorylation	EXP		E	RGD:150429751|PMID:25198898	20210923	RGD	MESH:D003474	Curcumin increases phosphorylation of MAP3K5 protein in uterine cervix	
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:3962	curcumin	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20240806	CTD	MESH:D003474	Curcumin inhibits the reaction [Cisplatin results in increased phosphorylation of MAP3K5 protein]	PMID:36178099
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MAP3K5 mRNA	PMID:25979313
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315044	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of MAP3K5 mRNA	PMID:17292431
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of MAP3K5 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:28001369|PMID:29154799
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA	PMID:27188386
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:4027	cyclophosphamide	increases expression	ISO	RGD:1315044	E	RGD:6480464	20260303	CTD	MESH:D003520	Cyclophosphamide results in increased expression of MAP3K5 mRNA	PMID:40254105
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:4027	cyclophosphamide	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20260303	CTD	MESH:D003520	Cyclophosphamide results in increased expression of and results in increased phosphorylation of MAP3K5 protein	PMID:40254105
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:41500	4-phenylbutyric acid	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:C075773	4-phenylbutyric acid results in decreased expression of MAP3K5 protein	PMID:29444456
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:41500	4-phenylbutyric acid	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C075773	4-phenylbutyric acid inhibits the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein]	PMID:29444456
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:41774	tamoxifen	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	[Tamoxifen co-treated with ESR2 protein] results in decreased expression of MAP3K5 mRNA	PMID:19059307
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:41977	daunorubicin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003630	Daunorubicin results in decreased expression of MAP3K5 mRNA	PMID:17374387
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:42106	L-1,4-dithiothreitol	multiple interactions	EXP		E	RGD:6480464	20140805	CTD	MESH:D004229	Dithiothreitol inhibits the reaction [NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]]	PMID:18922898
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1315044	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MAP3K5 mRNA	PMID:28973697
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in increased expression of MAP3K5 protein	PMID:16731828
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	EXP		E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein]; Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein	PMID:14505347|PMID:16731828
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20160412	CTD	MESH:D005947	[[[[Glucose results in decreased expression of MIR17 mRNA] which results in increased expression of TXNIP mRNA] which results in increased expression of TXNIP protein] promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; [Glucose promotes the reaction [TXNIP protein binds to TXN1 protein]] which results in increased activity of MAP3K5 protein; Glucose results in increased phosphorylation of and results in increased activity of MAP3K5 protein	PMID:26660634
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:4356	desferrioxamine B	multiple interactions	EXP		E	RGD:6480464	20120918	CTD	MESH:D003676	Deferoxamine inhibits the reaction [Plant Extracts results in increased phosphorylation of MAP3K5 protein]	PMID:20206247
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:43602	obeticholic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C464660	obeticholic acid results in decreased expression of MAP3K5 mRNA	PMID:27939613
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:44658	okadaic acid	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20211207	CTD	MESH:D019319	[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in increased expression of MAP3K5 mRNA	PMID:33069748
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	MAP3K5 protein affects the reaction [Paclitaxel results in increased activity of CASP3 protein]; MAP3K5 protein affects the reaction [Paclitaxel results in increased cleavage of PARP1 protein]	PMID:10075725
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of MAP3K5 mRNA	PMID:24935251
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of MAP3K5 mRNA	PMID:21420995|PMID:29067470
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306565	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MAP3K5 mRNA	PMID:33387578
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:46195	paracetamol	increases activity	ISO	RGD:1315044	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in increased activity of MAP3K5 protein	PMID:18700144
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:46195	paracetamol	increases response to substance	ISO	RGD:1315044	E	RGD:6480464	20120412	CTD	MESH:D000082	MAP3K5 protein results in increased susceptibility to Acetaminophen	PMID:18700144
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D000082	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of MAP3K5 mRNA	PMID:33819548
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20120412	CTD	MESH:D000082	MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ACTG1 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of AK5 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ARIH1 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ARL4A mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ARL5B mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ARRDC5 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ASTN2 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of BCL2L14 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of BTC mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CASKIN1 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CCDC81 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CCL7 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CD3E mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CDS2 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CHIL3 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CHIL4 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CHKA mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CLASP1 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of COL3A1 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of COPG1 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of CXCL5 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of DLX4 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of DNAH5 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of DNAJB4 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of DNAJB9 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of DPP6 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of EEA1 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of FOS mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of FOSL2 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of GAB2 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of GNAL mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of GZMM mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of H2BC18 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of IFIT3 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of JUN mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of KDM3A mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of MAFF mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of MCL1 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of MX2 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of MYH3 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of NAIP6 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of NEDD9 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of NIPAL2 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of NSMCE2 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of OBP2A mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of OR13P5 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of OR4B1C mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of OR8B1C mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PCDH11X mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PCDH7 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PDCL2 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PDE4B mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PRRX1 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of PVR mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of RNF207 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of RTP1 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of SCT mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of SLC25A2 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of SLFN3 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of SPZ1 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of STAT3 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of SYF2 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of TMEM54 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of TRP63 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of TSC22D2 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of TWSG1 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of USP31 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of USP6NL mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of WDFY3 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ZDHHC6 mRNA]; MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of ZFAND2A mRNA]; MAP3K5 protein promotes the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK8 protein]; MAP3K5 protein promotes the reaction [Acetaminophen results in increased phosphorylation of and results in increased activity of MAPK9 protein]	PMID:18700144
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MAP3K5 mRNA	PMID:35811015
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:46666	crocidolite asbestos	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite affects the expression of MAP3K5 mRNA	PMID:17331233
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:46979	N-acetylsphingosine	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C064769	N-acetylsphingosine affects the phosphorylation of and results in increased activity of MAP3K5 protein; TXNIP affects the reaction [N-acetylsphingosine affects the phosphorylation of and results in increased activity of MAP3K5 protein]	PMID:18270325
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306565	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MAP3K5 mRNA	PMID:29391264|PMID:31464424
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:48765	dimethylarsinic acid	increases expression	ISO	RGD:1315044	E	RGD:6480464	20120412	CTD	MESH:D002101	Cacodylic Acid results in increased expression of MAP3K5 mRNA	PMID:17441966
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:48843	disodium selenite	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20160210	CTD	MESH:D018038	Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAP3K5 protein]	PMID:26522834
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:4911	etoposide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	Etoposide results in decreased expression of MAP3K5 mRNA	PMID:17374387
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of MAP3K5 mRNA	PMID:38568856
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA	PMID:27188386
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MAP3K5 mRNA; Nanotubes, Carbon results in decreased expression of MAP3K5 mRNA	PMID:25554681
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306565	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of MAP3K5 mRNA	PMID:30047161
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:50833	cadmium sulfide	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C034939	cadmium sulfide results in decreased expression of MAP3K5 mRNA	PMID:27866839
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1315044	E	RGD:6480464	20241105	CTD	MESH:D005485	Flutamide results in increased expression of MAP3K5 mRNA	PMID:32662666
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:52492	mancozeb	increases expression	ISO	RGD:1315044	E	RGD:6480464	20230905	CTD	MESH:C013099	mancozeb results in increased expression of MAP3K5 mRNA	PMID:36007320
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of MAP3K5 mRNA	PMID:26705709
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of MAP3K5 mRNA	PMID:22714537
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:59001	4-vinylcyclohexene dioxide	increases expression	ISO	RGD:1306565	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide results in increased expression of MAP3K5 mRNA	PMID:23274565
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of MAP3K5 mRNA	PMID:27188386
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:63112	fingolimod hydrochloride	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20211207	CTD	MESH:D000068876	[lipopolysaccharide, Escherichia coli O111 B4 co-treated with Okadaic Acid co-treated with Fingolimod Hydrochloride] results in increased expression of MAP3K5 mRNA	PMID:33069748
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:6359	lactulose	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20230606	CTD	MESH:D007792	Lactulose inhibits the reaction [Thioacetamide results in increased expression of MAP3K5 protein]	PMID:35961375
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAP3K5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MAP3K5 mRNA	PMID:21641980|PMID:26378955
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of MAP3K5 mRNA	PMID:15336504
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of MAP3K5 mRNA	PMID:25234470
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein	PMID:34732784
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1315044	E	RGD:6480464	20191112	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein	PMID:28939911
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases phosphorylation	EXP		E	RGD:6480464	20171010	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP3K5 protein	PMID:20946892
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases phosphorylation	ISO	RGD:1306565	E	RGD:6480464	20191112	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP3K5 protein	PMID:28939911
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D015655	1-methylpropyl-2-imidazolyl disulfide inhibits the reaction [schisanhenol inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein]]; 8-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo(5,6-g)quinoxaline-7,9-dione inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP3K5 protein]; geranylgeranylacetone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein]; schisanhenol inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of MAP3K5 protein]	PMID:20946892|PMID:34732784
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:641	N-methyl-4-phenylpyridinium	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20191112	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium promotes the reaction [MAP3K5 protein binds to MAP2K7 protein]; 1-Methyl-4-phenylpyridinium promotes the reaction [MAP3K5 protein binds to TRAF2 protein]; CIB1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium promotes the reaction [MAP3K5 protein binds to MAP2K7 protein]]; CIB1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium promotes the reaction [MAP3K5 protein binds to TRAF2 protein]]; CIB1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased phosphorylation of MAP3K5 protein]	PMID:28939911
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20121113	CTD	MESH:D007545	Isoproterenol results in decreased expression of MAP3K5 mRNA	PMID:21335049
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:65408	andrographolide	multiple interactions	EXP		E	RGD:6480464	20140812	CTD	MESH:C030419	andrographolide inhibits the reaction [VEGFA protein results in increased phosphorylation of MAP3K5 protein]	PMID:24814888
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:67271	MK-2206	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C548887	MK 2206 promotes the reaction [Cadmium Chloride results in increased expression of MAP3K5 protein]	PMID:29444456
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:68794	neoechinulin A	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20170228	CTD	MESH:C490266	neoechinulin A inhibits the reaction [[APP protein binds to APP protein binds to APP protein] which results in increased phosphorylation of MAP3K5 protein]	PMID:23261590
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:69477	cannabigerol	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20210112	CTD	MESH:C037036	cannabigerol results in decreased expression of MAP3K5 mRNA	PMID:33019509
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:69478	cannabidiol	decreases expression	ISO	RGD:1315044	E	RGD:6480464	20210112	CTD	MESH:D002185	Cannabidiol results in decreased expression of MAP3K5 mRNA	PMID:33019509
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cannabidiol co-treated with moringin] results in increased expression of MAP3K5 mRNA	PMID:30096889
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:7035	muscimol	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20200310	CTD	MESH:D009118	Muscimol inhibits the reaction [Ethanol results in increased expression of MAP3K5 protein]	PMID:29044621
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:70436	platycodin D	multiple interactions	EXP		E	RGD:6480464	20190910	CTD	MESH:C108953	Acetylcysteine inhibits the reaction [platycodin D affects the phosphorylation of and results in increased activity of MAP3K5 protein]; platycodin D affects the phosphorylation of and results in increased activity of MAP3K5 protein	PMID:22784044
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:71978	surfactin C	increases phosphorylation	EXP		E	RGD:6480464	20220809	CTD	MESH:C009365	surfactin peptide results in increased phosphorylation of MAP3K5 protein	PMID:34850538
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:71978	surfactin C	multiple interactions	EXP		E	RGD:6480464	20220809	CTD	MESH:C009365	4-methylumbelliferone 8-carbaldehyde inhibits the reaction [surfactin peptide results in increased phosphorylation of MAP3K5 protein]; KIRA6 inhibits the reaction [surfactin peptide results in increased phosphorylation of MAP3K5 protein]	PMID:34850538
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of MAP3K5 mRNA	PMID:31758290
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315044	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of MAP3K5 mRNA	PMID:22206623
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of MAP3K5 mRNA	PMID:22714537
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:75253	phenylarsine oxide	increases expression	ISO	RGD:1315044	E	RGD:6480464	20251007	CTD	MESH:C029341	oxophenylarsine results in increased expression of MAP3K5 mRNA	PMID:37699712
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:755197	troxerutin	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20260714	CTD	MESH:C005865	troxerutin inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MAP3K5 protein]	PMID:25639565
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of MAP3K5 mRNA	PMID:30851411
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:78420	icariin	decreases expression	ISO	RGD:1306565	E	RGD:6480464	20260303	CTD	MESH:C056599	icariin results in decreased expression of ASK1 protein	PMID:34018553
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA	PMID:27188386
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:80630	irinotecan	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	Irinotecan metabolite results in decreased expression of MAP3K5 mRNA; Irinotecan results in decreased expression of MAP3K5 mRNA	PMID:15956246
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1315044	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of MAP3K5 mRNA	PMID:19270015
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:8093	phenylephrine	increases activity	ISO	RGD:1306565	E	RGD:6480464	20120522	CTD	MESH:D010656	Phenylephrine results in increased activity of MAP3K5 protein	PMID:15629441
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:8093	phenylephrine	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20120522	CTD	MESH:D010656	CAMK2D protein promotes the reaction [Phenylephrine results in increased activity of MAP3K5 protein]; KN 93 inhibits the reaction [Phenylephrine results in increased activity of MAP3K5 protein]	PMID:15629441
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306565	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of MAP3K5 mRNA	PMID:32109520
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1315044	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MAP3K5 protein	PMID:25639565
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20170303	CTD	MESH:C511295	troxerutin inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of MAP3K5 protein]	PMID:25639565
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20250401	CTD	MESH:C060836	Pioglitazone inhibits the reaction [Fructose results in increased phosphorylation of ASK1 protein]	PMID:37186242
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:8450	procymidone	increases expression	ISO	RGD:1315044	E	RGD:6480464	20230704	CTD	MESH:C035988	procymidone results in increased expression of MAP3K5 mRNA	PMID:35913088
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306565	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MAP3K5 mRNA	PMID:24780913|PMID:25825206|PMID:30047161
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:85994	lenvatinib	increases expression	ISO	RGD:1306565	E	RGD:6480464	20220111	CTD	MESH:C531958	lenvatinib results in increased expression of MAP3K5 mRNA	PMID:34019861
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:8772	raloxifene	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	[Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of MAP3K5 mRNA	PMID:19059307
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:9009	Salidroside	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20220111	CTD	MESH:C009172	rhodioloside inhibits the reaction [furan results in increased phosphorylation of MAP3K5 protein]	PMID:34450210
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MAP3K5 mRNA	PMID:27188386
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:9130	sevoflurane	increases phosphorylation	EXP		E	RGD:6480464	20161213	CTD	MESH:C009250	sevoflurane results in increased phosphorylation of MAP3K5 protein	PMID:18349187
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:91460	KN-93	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20160503	CTD	MESH:C072105	KN 93 inhibits the reaction [Phenylephrine results in increased activity of MAP3K5 protein]	PMID:15629441
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1306565	E	RGD:6480464	20160822	CTD	MESH:D013311	Streptozocin results in increased expression of MAP3K5 protein	PMID:26499206
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1306565	E	RGD:6480464	20160822	CTD	MESH:D013311	resveratrol inhibits the reaction [Streptozocin results in increased expression of MAP3K5 protein]	PMID:26499206
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:9288	streptozocin	multiple interactions	ISO	RGD:1315044	E	RGD:6480464	20120412	CTD	MESH:D013311	[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAP3K5 protein; Sodium Selenite promotes the reaction [[Streptozocin co-treated with Dietary Fats] results in increased phosphorylation of MAP3K5 protein]; Streptozocin promotes the reaction [MAP3K5 protein results in increased expression of SERPINE1 protein]	PMID:16731828|PMID:26522834
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:9405	tartrazine	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D013645	[Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of MAP3K5 mRNA	PMID:33819548
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of MAP3K5 mRNA	PMID:38568856
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:9753	troglitazone	increases activity	EXP		E	RGD:6480464	20121009	CTD	MESH:C057693	troglitazone results in increased activity of MAP3K5 protein	PMID:17975114
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:9753	troglitazone	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C057693	mito-carboxy proxyl inhibits the reaction [troglitazone results in increased activity of MAP3K5 protein]	PMID:17975114
1315043	MAP3K5	mitogen-activated protein kinase kinase kinase 5	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1306565	E	RGD:6480464	20191112	CTD	MESH:C025643	vinclozolin results in increased methylation of MAP3K5 gene	PMID:30207508
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315048	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of RAPGEF2 mRNA	PMID:33045310
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1315048	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RAPGEF2 mRNA	PMID:26251327
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:144441	triacsin C	increases expression	EXP		E	RGD:6480464	20190903	CTD	MESH:C034613	triacsin C results in increased expression of RAPGEF2 mRNA	PMID:16704987
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of RAPGEF2 protein	PMID:28073184
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:15843	arachidonic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D016718	Arachidonic Acid results in increased expression of RAPGEF2 mRNA	PMID:16704987
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:15891	taurine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013654	Taurine results in decreased expression of RAPGEF2 mRNA	PMID:16579726
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RAPGEF2 mRNA	PMID:21632981
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315048	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RAPGEF2 mRNA	PMID:25890327
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315048	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RAPGEF2 mRNA	PMID:39298647
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of RAPGEF2 mRNA	PMID:30165855
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RAPGEF2 mRNA	PMID:37042841
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:167808	Nor-9-carboxy-delta9-THC	multiple interactions	EXP		E	RGD:6480464	20210406	CTD	MESH:C016780	[Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of RAPGEF2 gene	PMID:30521419
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of RAPGEF2 mRNA	PMID:20655997
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:17594	hydroquinone	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:C031927	[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 mRNA; [hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 protein; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 mRNA]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 protein]; MIR486-1 mRNA affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 mRNA]; MIR486-1 mRNA affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 protein]	PMID:32198055
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306434	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of RAPGEF2 mRNA	PMID:26577399
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of RAPGEF2 protein	PMID:37730182
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306434	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of RAPGEF2 mRNA	PMID:22061828|PMID:33387578
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RAPGEF2 mRNA	PMID:28818685
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAPGEF2 mRNA	PMID:39836092
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306434	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RAPGEF2 mRNA	PMID:39012411
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RAPGEF2 mRNA	PMID:19549813
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RAPGEF2 mRNA	PMID:22100608
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RAPGEF2 gene	PMID:27153756
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	ISO	RGD:1306434	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of RAPGEF2 mRNA	PMID:15651846
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of RAPGEF2 mRNA	PMID:41430723
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RAPGEF2 mRNA	PMID:18593933
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RAPGEF2 mRNA	PMID:21867686
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAPGEF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RAPGEF2 mRNA	PMID:39836092
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315048	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAPGEF2 mRNA	PMID:40504410
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of RAPGEF2 protein	PMID:35688186
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306434	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of RAPGEF2 mRNA	PMID:31881176
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306434	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RAPGEF2 mRNA	PMID:32109520
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306434	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAPGEF2 mRNA	PMID:33387578
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RAPGEF2 mRNA	PMID:28001369
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RAPGEF2 mRNA	PMID:33212167
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RAPGEF2 mRNA	PMID:30851411
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of RAPGEF2 mRNA; [NSC 689534 binds to Copper] which results in increased expression of RAPGEF2 mRNA	PMID:20971185|PMID:30911355
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of RAPGEF2 protein	PMID:35688186
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of RAPGEF2 mRNA	PMID:29301061|PMID:34032870
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RAPGEF2 mRNA	PMID:38568856
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAPGEF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RAPGEF2 mRNA	PMID:39836092
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315048	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAPGEF2 mRNA	PMID:40504410
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RAPGEF2 promoter	PMID:27901495
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RAPGEF2 mRNA]	PMID:32406909
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of RAPGEF2 mRNA; [NSC 689534 binds to Copper] which results in increased expression of RAPGEF2 mRNA	PMID:20971185|PMID:30911355
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of RAPGEF2 mRNA	PMID:18593933
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of RAPGEF2 mRNA	PMID:26014281
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RAPGEF2 mRNA	PMID:19150397
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306434	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RAPGEF2 mRNA	PMID:25729387
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306434	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RAPGEF2 mRNA	PMID:30047161
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306434	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RAPGEF2 mRNA	PMID:34492290
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:33007	chromium(6+)	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:C074702	chromium hexavalent ion results in decreased expression of RAPGEF2 mRNA	PMID:30690063
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1315048	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of RAPGEF2 mRNA	PMID:28329830
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306434	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RAPGEF2 mRNA	PMID:30816183
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306434	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RAPGEF2 mRNA	PMID:25181051
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of RAPGEF2 mRNA	PMID:19244175
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of RAPGEF2 mRNA	PMID:19692669
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315048	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RAPGEF2 mRNA	PMID:39298647
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1306434	E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RAPGEF2 protein	PMID:34896426
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315048	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RAPGEF2 mRNA	PMID:38685157
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1315048	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of RAPGEF2 intron	PMID:28392331
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1315048	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of RAPGEF2 mRNA	PMID:37019170
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306434	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RAPGEF2 mRNA	PMID:21266533
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306434	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of RAPGEF2 gene	PMID:33148267
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RAPGEF2 mRNA	PMID:37042841
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAPGEF2 mRNA	PMID:39836092
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306434	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RAPGEF2 mRNA	PMID:39012411
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RAPGEF2 mRNA	PMID:24449571
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAPGEF2 mRNA	PMID:19167446
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1306434	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of RAPGEF2 protein	PMID:34896426
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RAPGEF2 mRNA	PMID:25979313
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1306434	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of RAPGEF2 mRNA	PMID:29427782
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of RAPGEF2 mRNA	PMID:23179753|PMID:27188386
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of RAPGEF2 gene	PMID:29154799
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306434	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of RAPGEF2 mRNA	PMID:38685447
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306434	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RAPGEF2 mRNA	PMID:30047161
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1315048	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of RAPGEF2 mRNA	PMID:19770486
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1306434	E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RAPGEF2 protein	PMID:34896426
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1306434	E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RAPGEF2 protein	PMID:34896426
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of RAPGEF2 mRNA	PMID:24935251
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315048	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RAPGEF2 mRNA	PMID:17562736
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306434	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RAPGEF2 mRNA	PMID:33387578
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1306434	E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of RAPGEF2 mRNA	PMID:21061450
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAPGEF2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RAPGEF2 mRNA	PMID:39836092
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315048	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of RAPGEF2 mRNA	PMID:40504410
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:4791	endosulfan	decreases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in decreased expression of RAPGEF2 mRNA	PMID:40706910
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RAPGEF2 mRNA	PMID:22079256
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1306434	E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RAPGEF2 protein	PMID:34896426
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:50385	hemin	multiple interactions	EXP		E	RGD:6480464	20200714	CTD	MESH:D006427	[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 mRNA; [hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 protein; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 mRNA]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 protein]; MIR486-1 mRNA affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 mRNA]; MIR486-1 mRNA affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 protein]	PMID:32198055
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306434	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RAPGEF2 mRNA	PMID:24136188
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:5292	geldanamycin	increases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:C001277	geldanamycin results in increased expression of RAPGEF2 mRNA	PMID:26705709
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of RAPGEF2 mRNA	PMID:39836092
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306434	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of RAPGEF2 mRNA	PMID:25729387
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306434	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RAPGEF2 mRNA	PMID:25729387
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of RAPGEF2 mRNA	PMID:15336504
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306434	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of RAPGEF2 gene	PMID:35440735
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306434	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of RAPGEF2 gene	PMID:33148267
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315048	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RAPGEF2 mRNA	PMID:22206623
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of RAPGEF2 mRNA	PMID:22079256|PMID:22714537
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RAPGEF2 mRNA	PMID:22079256
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C025589	ochratoxin A results in decreased expression of RAPGEF2 mRNA	PMID:30763683
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RAPGEF2 mRNA	PMID:30851411
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306434	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of RAPGEF2 mRNA	PMID:32109520
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RAPGEF2 mRNA	PMID:19167446
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1315048	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of RAPGEF2 mRNA	PMID:31558096
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1306434	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of RAPGEF2 mRNA	PMID:30047161
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1315048	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of RAPGEF2 mRNA	PMID:21278054
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306434	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RAPGEF2 mRNA	PMID:30047161
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:9130	sevoflurane	decreases expression	ISO	RGD:1315048	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in decreased expression of RAPGEF2 protein	PMID:35249202
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of RAPGEF2 mRNA	PMID:26014281
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of RAPGEF2 mRNA	PMID:17440010
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of RAPGEF2 mRNA	PMID:27188386
1315047	RAPGEF2	Rap guanine nucleotide exchange factor 2	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1306434	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in increased expression of RAPGEF2 mRNA	PMID:30047161
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of PPP1R3D mRNA	PMID:26272509
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA	PMID:27188386
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of PPP1R3D mRNA	PMID:21934132
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PPP1R3D mRNA	PMID:21632981
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of PPP1R3D protein	PMID:35688186
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1622963	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PPP1R3D mRNA	PMID:39241906
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of PPP1R3D mRNA	PMID:20655997
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1622963	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPP1R3D mRNA	PMID:37992649
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1622963	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPP1R3D mRNA	PMID:37992649
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of PPP1R3D protein	PMID:37730182
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1586306	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of PPP1R3D mRNA	PMID:22061828
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1622963	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of PPP1R3D mRNA	PMID:17484886
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PPP1R3D mRNA	PMID:26272509
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA	PMID:27188386
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1586306	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PPP1R3D mRNA	PMID:31881176
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PPP1R3D mRNA	PMID:30851411
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PPP1R3D mRNA	PMID:29803840
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1622963	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPP1R3D mRNA	PMID:37992649
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PPP1R3D mRNA	PMID:22521957
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1622963	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of PPP1R3D mRNA	PMID:23557971
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1622963	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PPP1R3D gene	PMID:35295148
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1622963	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PPP1R3D mRNA	PMID:23811191
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1586306	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PPP1R3D mRNA	PMID:25181051
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1586306	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PPP1R3D mRNA	PMID:30816183|PMID:32528016
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1622963	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of PPP1R3D mRNA	PMID:26377693
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PPP1R3D mRNA	PMID:37042841
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1586306	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of PPP1R3D mRNA	PMID:30589522
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1586306	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PPP1R3D mRNA	PMID:35163327
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1586306	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PPP1R3D mRNA	PMID:35163327
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:35559	furan	decreases methylation	ISO	RGD:1586306	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in decreased methylation of PPP1R3D gene	PMID:22079235
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PPP1R3D mRNA	PMID:25979313
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PPP1R3D mRNA	PMID:24383497|PMID:26272509
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA	PMID:27188386
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PPP1R3D mRNA	PMID:25562108
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1622963	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPP1R3D mRNA	PMID:37992649
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of PPP1R3D mRNA	PMID:24935251|PMID:26272509
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA	PMID:27188386
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1622963	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PPP1R3D mRNA	PMID:17562736
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of PPP1R3D mRNA	PMID:25351596
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PPP1R3D mRNA	PMID:22521957
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1622963	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PPP1R3D mRNA; Nanotubes, Carbon results in increased expression of PPP1R3D mRNA	PMID:25554681
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1622963	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of PPP1R3D mRNA	PMID:38701926
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1622963	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PPP1R3D mRNA	PMID:36907384
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1622963	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PPP1R3D mRNA	PMID:22206623
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PPP1R3D mRNA	PMID:30851411
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA	PMID:27188386
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1586306	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PPP1R3D mRNA	PMID:27291303
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of PPP1R3D mRNA	PMID:26272509
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA	PMID:27188386
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPP1R3D mRNA	PMID:27188386
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PPP1R3D mRNA	PMID:38568856
1315049	PPP1R3D	protein phosphatase 1 regulatory subunit 3D	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1586306	E	RGD:6480464	20141111	CTD	MESH:C001899	triptolide results in increased expression of PPP1R3D mRNA	PMID:23639586
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RABL3 mRNA	PMID:38218311
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:132098	methoxyacetic acid	decreases expression	ISO	RGD:1306436	E	RGD:6480464	20160607	CTD	MESH:C013598	methoxyacetic acid results in decreased expression of RABL3 mRNA	PMID:20864626
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1315051	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of RABL3 mRNA	PMID:33045310
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RABL3 mRNA	PMID:26079696
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of RABL3 mRNA	PMID:22378314
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1315051	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of RABL3 mRNA	PMID:30319688
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315051	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RABL3 mRNA	PMID:30319688
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315051	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RABL3 mRNA	PMID:39298647
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306436	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of RABL3 mRNA	PMID:33387578
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of RABL3 mRNA	PMID:23649840
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of RABL3 mRNA	PMID:28818685
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:D002104	Cadmium results in decreased expression of RABL3 protein	PMID:37834424
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315051	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RABL3 mRNA	PMID:37236586
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RABL3 mRNA	PMID:19549813
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of RABL3 mRNA	PMID:23649840
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1315051	E	RGD:6480464	20150127	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RABL3 mRNA	PMID:25270620
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315051	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RABL3 mRNA	PMID:25629700
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:1306436	E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of RABL3 mRNA	PMID:20864626
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of RABL3 mRNA	PMID:27392435
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315051	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RABL3 mRNA	PMID:21570461
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306436	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RABL3 mRNA	PMID:33387578
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315051	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to RABL3 promoter]	PMID:19654925
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RABL3 mRNA	PMID:28001369
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	ISO	RGD:1306436	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of RABL3 mRNA	PMID:20864626
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RABL3 mRNA	PMID:33212167
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of RABL3 mRNA	PMID:39709020
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RABL3 mRNA	PMID:30851411
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RABL3 mRNA	PMID:29803840
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315051	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RABL3 mRNA	PMID:22228805
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1315051	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RABL3 3' UTR; Benzo(a)pyrene results in increased methylation of RABL3 exon	PMID:27901495
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1315051	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in decreased expression of RABL3 protein	PMID:37955338
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:3016	Benoxacor	decreases expression	ISO	RGD:1315051	E	RGD:6480464	20220405	CTD	MESH:C085163	benoxacor results in decreased expression of RABL3 mRNA	PMID:34850242
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RABL3 mRNA	PMID:23806026
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RABL3 protein]	PMID:26598702
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1315051	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RABL3 mRNA	PMID:18648102
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315051	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RABL3 mRNA	PMID:33221593
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315051	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RABL3 mRNA	PMID:39298647
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1315051	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of RABL3 mRNA	PMID:34813904
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RABL3 mRNA	PMID:37042841
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RABL3 protein	PMID:38185225
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315051	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of RABL3 mRNA	PMID:37236586
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of RABL3 mRNA	PMID:24449571
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1315051	E	RGD:6480464	20150127	CTD	MESH:D002994	Clofibrate results in decreased expression of RABL3 mRNA	PMID:25270620
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RABL3 mRNA	PMID:28302478
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RABL3 mRNA	PMID:31533062
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1315051	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of RABL3 mRNA	PMID:39529242
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RABL3 mRNA	PMID:23179753|PMID:28001369
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1315051	E	RGD:6480464	20120501	CTD	MESH:D014635	Valproic Acid results in decreased expression of RABL3 mRNA	PMID:19136453|PMID:21427059
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306436	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of RABL3 mRNA	PMID:38685447|PMID:41580965
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of RABL3 mRNA	PMID:29067470
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306436	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RABL3 mRNA	PMID:33387578
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RABL3 protein]	PMID:26598702
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315051	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of RABL3 mRNA	PMID:25620056
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306436	E	RGD:6480464	20240702	CTD	MESH:D008713	Methimazole results in decreased expression of RABL3 mRNA	PMID:38685447|PMID:41580965
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315051	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of RABL3 mRNA	PMID:22206623
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:7719	ochratoxin A	affects binding	EXP		E	RGD:6480464	20260505	CTD	MESH:C025589	RABL3 protein binds to ochratoxin A	PMID:40952447
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RABL3 mRNA	PMID:30851411
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RABL3 gene]	PMID:28238834
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:80799	Bufotalin	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in decreased expression of RABL3 mRNA	PMID:39904859
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1306436	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of RABL3 protein	PMID:28903499
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of RABL3 mRNA	PMID:24921660
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:88522	Monobutylphthalate	decreases expression	ISO	RGD:1306436	E	RGD:6480464	20151103	CTD	MESH:C028577	monobutyl phthalate results in decreased expression of RABL3 mRNA	PMID:20864626
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of RABL3 mRNA	PMID:29301935
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:9546	thimerosal	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in increased expression of RABL3 mRNA	PMID:27188386
1315050	RABL3	RAB, member of RAS oncogene family like 3	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306436	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RABL3 mRNA	PMID:21346803
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1306437	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of SPRYD7 mRNA	PMID:21551480
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of SPRYD7 mRNA	PMID:27188386
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315053	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SPRYD7 mRNA	PMID:33045310
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SPRYD7 protein]	PMID:38195004
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of SPRYD7 mRNA	PMID:33167477
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1315053	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SPRYD7 mRNA	PMID:36331819
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315053	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SPRYD7 mRNA	PMID:30319688
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of SPRYD7 mRNA	PMID:31614463
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306437	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SPRYD7 mRNA	PMID:33387578
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SPRYD7 mRNA	PMID:37042841
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306437	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of SPRYD7 mRNA	PMID:33387578
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315053	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPRYD7 mRNA	PMID:36331819
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SPRYD7 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SPRYD7 protein	PMID:38195004
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315053	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of SPRYD7 mRNA	PMID:28111341
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SPRYD7 mRNA	PMID:19549813
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SPRYD7 mRNA	PMID:23649840
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SPRYD7 mRNA	PMID:23649840
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306437	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of SPRYD7 mRNA	PMID:30779732
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315053	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SPRYD7 mRNA	PMID:22206623
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306437	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SPRYD7 mRNA	PMID:31881176
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SPRYD7 mRNA	PMID:28903495
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315053	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPRYD7 mRNA	PMID:24680724
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306437	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of SPRYD7 mRNA	PMID:28374803
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SPRYD7 mRNA	PMID:28001369
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SPRYD7 mRNA	PMID:33212167
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SPRYD7 mRNA	PMID:30851411
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SPRYD7 mRNA	PMID:29803840
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of SPRYD7 mRNA	PMID:29319823
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPRYD7 mRNA	PMID:22316170
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1315053	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of SPRYD7 protein	PMID:37955338
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to SPRYD7 protein]	PMID:26598702
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in increased expression of SPRYD7 mRNA	PMID:38568856
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306437	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of SPRYD7 mRNA	PMID:30047161
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of SPRYD7 mRNA	PMID:36232920
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306437	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SPRYD7 mRNA	PMID:25181051|PMID:34947998
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315053	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of SPRYD7 mRNA	PMID:39298647
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1315053	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SPRYD7 mRNA	PMID:37019170
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SPRYD7 mRNA	PMID:37042841
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SPRYD7 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of SPRYD7 protein	PMID:38195004
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315053	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of SPRYD7 mRNA	PMID:28111341
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1306437	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SPRYD7 mRNA	PMID:24386269
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315053	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SPRYD7 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SPRYD7 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SPRYD7 mRNA	PMID:36331819
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPRYD7 mRNA	PMID:25979313
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SPRYD7 mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369|PMID:29154799
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRYD7 mRNA	PMID:27188386
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306437	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of SPRYD7 mRNA	PMID:30047161
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of SPRYD7 mRNA	PMID:36621641
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1306437	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of SPRYD7 mRNA	PMID:24136188
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SPRYD7 mRNA	PMID:29067470
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306437	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SPRYD7 mRNA	PMID:33387578
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1315053	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SPRYD7 mRNA	PMID:35436446
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to SPRYD7 protein]	PMID:26598702
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315053	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SPRYD7 mRNA	PMID:25554681
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306437	E	RGD:6480464	20140408	CTD	MESH:C082360	fipronil results in increased expression of SPRYD7 mRNA	PMID:23962444
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306437	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of SPRYD7 mRNA	PMID:30047161
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306437	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SPRYD7 mRNA	PMID:24136188
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of SPRYD7 protein	PMID:32959892
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1306437	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of SPRYD7 mRNA	PMID:24136188
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315053	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SPRYD7 mRNA	PMID:22206623
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306437	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of SPRYD7 mRNA	PMID:24136188
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SPRYD7 mRNA	PMID:30851411
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRYD7 mRNA	PMID:27188386
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1315053	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of SPRYD7 mRNA	PMID:39847705
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1306437	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of SPRYD7 mRNA	PMID:30047161
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306437	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of SPRYD7 mRNA	PMID:30047161
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SPRYD7 mRNA	PMID:27188386
1315052	SPRYD7	SPRY domain containing 7	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1315053	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of SPRYD7 mRNA	PMID:28973697
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of PAPD4 mRNA	PMID:38218311
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of PAPD4 mRNA	PMID:38218311
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:137392	chlormequat chloride	increases expression	ISO	RGD:1306438	E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of TENT2 protein	PMID:34958886
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of TENT2 mRNA	PMID:23410634
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315055	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of TENT2 mRNA	PMID:39241906
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306438	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of TENT2 gene	PMID:27618143
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of TENT2 protein	PMID:37730182
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315055	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PAPD4 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TENT2 mRNA	PMID:37236586|PMID:37325564
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of TENT2 mRNA	PMID:19549813
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of TENT2 gene	PMID:27153756
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1306438	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of TENT2 mRNA	PMID:25905778
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315055	E	RGD:6480464	20181113	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TENT2 mRNA	PMID:21570461
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306438	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TENT2 mRNA	PMID:21215274
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315055	E	RGD:6480464	20181113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TENT2 mRNA	PMID:19465110
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of TENT2 mRNA	PMID:23649840
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D024483	Vitamin K 3 affects the expression of TENT2 mRNA	PMID:23410634
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C017947	sodium arsenite affects the expression of TENT2 mRNA	PMID:29319823
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of TENT2 gene	PMID:28589171
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:29678	sodium arsenite	increases stability	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased stability of TENT2 mRNA	PMID:25493608
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TENT2 mRNA	PMID:19150397
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of TENT2 mRNA	PMID:20458559
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:3223	buspirone	decreases expression	ISO	RGD:1306438	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in decreased expression of TENT2 mRNA	PMID:24136188
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315055	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PAPD4 promoter	PMID:35295148
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315055	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PAPD4 gene	PMID:35295148
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306438	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of TENT2 mRNA	PMID:34492290
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1315055	E	RGD:6480464	20181113	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of TENT2 mRNA	PMID:18648102
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315055	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of TENT2 mRNA	PMID:33221593
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306438	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PAPD4 mRNA; bisphenol A results in increased expression of TENT2 mRNA	PMID:25181051|PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315055	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TENT2 mRNA	PMID:39298647
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TENT2 mRNA	PMID:38568856
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315055	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PAPD4 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of TENT2 mRNA	PMID:37236586|PMID:37325564
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306438	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of TENT2 gene	PMID:22079235
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TENT2 mRNA	PMID:23179753
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of TENT2 mRNA	PMID:23649840
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:44445	nimesulide	decreases expression	ISO	RGD:1306438	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in decreased expression of TENT2 mRNA	PMID:24136188
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of TENT2 mRNA	PMID:26272509
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENT2 mRNA	PMID:27188386
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315055	E	RGD:6480464	20181113	CTD	MESH:D000082	Acetaminophen affects the expression of TENT2 mRNA	PMID:17562736
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of TENT2 mRNA	PMID:21420995
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of TENT2 mRNA	PMID:20458559
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306438	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of TENT2 mRNA	PMID:24136188
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:64090	tert-butyl hydroperoxide	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D020122	tert-Butylhydroperoxide affects the expression of TENT2 mRNA	PMID:23410634
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:6437	levetiracetam	increases expression	ISO	RGD:1306438	E	RGD:6480464	20181113	CTD	MESH:D000077287	Levetiracetam results in increased expression of TENT2 mRNA	PMID:20345932
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315055	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PAPD4 mRNA	PMID:22206623
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1306438	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of TENT2 mRNA	PMID:24136188
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENT2 mRNA	PMID:27188386
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1315055	E	RGD:6480464	20181113	CTD	MESH:D010634	Phenobarbital affects the expression of TENT2 mRNA	PMID:23091169
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TENT2 mRNA	PMID:27188386
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306438	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of TENT2 mRNA	PMID:21346803
1315054	TENT2	terminal nucleotidyltransferase 2	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1306438	E	RGD:6480464	20170303	CTD	MESH:C080163	trovafloxacin results in decreased expression of TENT2 mRNA	PMID:24136188
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ADAMTSL1 mRNA	PMID:27188386
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of ADAMTSL1 mRNA	PMID:30510588
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ADAMTSL1 mRNA	PMID:30165855
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:17026	progesterone	increases expression	ISO	RGD:1315057	E	RGD:6480464	20131008	CTD	MESH:D011374	Progesterone results in increased expression of ADAMTSL1 mRNA	PMID:22238285
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315057	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL1 mRNA	PMID:37992649
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:17578	toluene	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in decreased expression of ADAMTSL1 mRNA	PMID:26717081
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:17578	toluene	increases methylation	EXP		E	RGD:6480464	20200609	CTD	MESH:D014050	Toluene results in increased methylation of ADAMTSL1 gene	PMID:26717081
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315057	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL1 mRNA	PMID:37992649
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306439	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of ADAMTSL1 mRNA	PMID:26577399
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADAMTSL1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ADAMTSL1 mRNA	PMID:39836092
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315057	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ADAMTSL1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADAMTSL1 mRNA	PMID:37236586|PMID:37325564
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ADAMTSL1 mRNA	PMID:19549813
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ADAMTSL1 intron	PMID:30157460
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315057	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ADAMTSL1 mRNA	PMID:34911549
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADAMTSL1 gene	PMID:25304211
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADAMTSL1 mRNA	PMID:39836092
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:27789	1,2-dichloroethane	increases expression	ISO	RGD:1315057	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in increased expression of ADAMTSL1 mRNA	PMID:28960355
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ADAMTSL1 mRNA	PMID:23557933
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of ADAMTSL1 mRNA	PMID:25583101
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ADAMTSL1 mRNA	PMID:29803840
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315057	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL1 mRNA	PMID:37992649
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:29678	sodium arsenite	decreases methylation	ISO	RGD:1315057	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in decreased methylation of ADAMTSL1 gene	PMID:39894169
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADAMTSL1 mRNA	PMID:39836092
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ADAMTSL1 mRNA	PMID:22316170
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of ADAMTSL1 promoter	PMID:23974009
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of ADAMTSL1 mRNA	PMID:25895662
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of ADAMTSL1 mRNA	PMID:37690743
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of ADAMTSL1 gene	PMID:31601247
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ADAMTSL1 gene	PMID:31601247
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1315057	E	RGD:6480464	20150825	CTD	MESH:C008261	lead acetate results in increased expression of ADAMTSL1 mRNA	PMID:20542052|PMID:22613225
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306439	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ADAMTSL1 mRNA	PMID:30047161
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315057	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of ADAMTSL1 mRNA	PMID:35295148
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAMTSL1 protein	PMID:34186270
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306439	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ADAMTSL1 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315057	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ADAMTSL1 mRNA	PMID:32156529
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:33216	bisphenol A	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in increased methylation of ADAMTSL1 gene	PMID:31601247
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of ADAMTSL1 gene	PMID:31601247
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ADAMTSL1 mRNA	PMID:28628672
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of ADAMTSL1 intron	PMID:30157460
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315057	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ADAMTSL1 mRNA	PMID:30951980
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ADAMTSL1 mRNA	PMID:28628672
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of ADAMTSL1 protein	PMID:34186270
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ADAMTSL1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ADAMTSL1 mRNA	PMID:28628672
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADAMTSL1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ADAMTSL1 mRNA	PMID:39836092
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ADAMTSL1 mRNA	PMID:38382870
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315057	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ADAMTSL1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ADAMTSL1 mRNA	PMID:37236586|PMID:37325564
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ADAMTSL1 mRNA	PMID:19320972
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ADAMTSL1 mRNA	PMID:24449571
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ADAMTSL1 mRNA	PMID:31533062
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ADAMTSL1 mRNA	PMID:40419075
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315057	E	RGD:6480464	20130618	CTD	MESH:D014635	Valproic Acid affects the expression of ADAMTSL1 mRNA	PMID:17963808
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in increased expression of ADAMTSL1 mRNA	PMID:28001369
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ADAMTSL1 gene	PMID:29154799
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ADAMTSL1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ADAMTSL1 mRNA	PMID:28628672
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315057	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ADAMTSL1 mRNA	PMID:37992649
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ADAMTSL1 gene	PMID:25304211
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADAMTSL1 mRNA	PMID:39836092
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of ADAMTSL1 mRNA	PMID:40706910
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ADAMTSL1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ADAMTSL1 mRNA	PMID:28628672
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315057	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ADAMTSL1 mRNA; Nanotubes, Carbon results in decreased expression of ADAMTSL1 mRNA	PMID:25554681
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306439	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ADAMTSL1 mRNA	PMID:30047161
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of ADAMTSL1 mRNA	PMID:22714537
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of ADAMTSL1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of ADAMTSL1 mRNA	PMID:39836092
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of ADAMTSL1 intron	PMID:30157460
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306439	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of ADAMTSL1 gene	PMID:35440735
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ADAMTSL1 protein	PMID:34186270
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315057	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ADAMTSL1 mRNA	PMID:22206623
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ADAMTSL1 mRNA	PMID:37199045
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1315057	E	RGD:6480464	20130618	CTD	MESH:D010634	Phenobarbital affects the expression of ADAMTSL1 mRNA	PMID:23091169
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of ADAMTSL1 mRNA	PMID:26705709
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1315057	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of ADAMTSL1 mRNA	PMID:21795629
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306439	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ADAMTSL1 mRNA	PMID:30047161
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306439	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ADAMTSL1 mRNA	PMID:24780913
1315056	ADAMTSL1	ADAMTS like 1	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of ADAMTSL1 mRNA	PMID:29301935
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315059	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SH3YL1 gene	PMID:20938992
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SH3YL1 mRNA	PMID:21934132
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SH3YL1 mRNA	PMID:26079696
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of SH3YL1 mRNA	PMID:21632981
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315059	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of SH3YL1 mRNA	PMID:19484750
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of SH3YL1 mRNA	PMID:30165855
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315059	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SH3YL1 gene	PMID:20938992
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of SH3YL1 mRNA	PMID:21592394
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of SH3YL1 mRNA	PMID:21592394
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306440	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in increased expression of SH3YL1 mRNA	PMID:26496021
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SH3YL1 mRNA	PMID:34319233
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of SH3YL1 mRNA	PMID:21592394
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of SH3YL1 mRNA	PMID:21592394
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306440	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SH3YL1 mRNA	PMID:33387578
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SH3YL1 mRNA	PMID:28818685
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SH3YL1 mRNA	PMID:19549813
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SH3YL1 gene	PMID:27153756
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306440	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SH3YL1 mRNA	PMID:31150632
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of SH3YL1 mRNA	PMID:31919559
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315059	E	RGD:6480464	20121113	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SH3YL1 mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SH3YL1 gene	PMID:20938992|PMID:22206623
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of SH3YL1 mRNA	PMID:26272509
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3YL1 mRNA	PMID:27188386
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SH3YL1 mRNA	PMID:23557933
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1315059	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of SH3YL1 mRNA	PMID:34813904
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315059	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SH3YL1 mRNA	PMID:21570461
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SH3YL1 mRNA	PMID:23152189
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306440	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SH3YL1 mRNA	PMID:21215274
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SH3YL1 mRNA	PMID:21632981
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306440	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SH3YL1 mRNA	PMID:33387578
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315059	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SH3YL1 mRNA	PMID:17949056
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1306440	E	RGD:6480464	20120918	CTD	MESH:D013749	AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of SH3YL1 mRNA]	PMID:21215274
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of SH3YL1 mRNA	PMID:39709020
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of SH3YL1 mRNA	PMID:23649840
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SH3YL1 mRNA	PMID:29803840
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of SH3YL1 mRNA	PMID:20044591
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SH3YL1 mRNA	PMID:38568856
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SH3YL1 mRNA	PMID:37682722
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SH3YL1 mRNA	PMID:32234424
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SH3YL1 mRNA	PMID:17942131
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315059	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SH3YL1 mRNA	PMID:19770486
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20250805	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of SH3YL1 mRNA	PMID:39716349
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:31638	fulvestrant	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in increased methylation of SH3YL1 gene	PMID:31601247
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306440	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SH3YL1 mRNA	PMID:25729387
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315059	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SH3YL1 gene	PMID:35295148
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306440	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of SH3YL1 mRNA	PMID:34492290
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306440	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of SH3YL1 mRNA	PMID:34947998
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SH3YL1 gene	PMID:31601247
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of SH3YL1 mRNA; bisphenol A results in increased expression of SH3YL1 protein	PMID:25047013|PMID:33376534
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306440	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in increased expression of SH3YL1 mRNA	PMID:26496021
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1306440	E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of SH3YL1 mRNA	PMID:27914987
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SH3YL1 mRNA	PMID:26682919
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of SH3YL1 gene	PMID:31601247
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:34698	diethyl phthalate	decreases expression	ISO	RGD:1306440	E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of SH3YL1 mRNA	PMID:32341500
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1315059	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of SH3YL1 mRNA	PMID:36117858
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SH3YL1 mRNA	PMID:37042841
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	EXP		E	RGD:6480464	20210309	CTD	MESH:C023036	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of SH3YL1 mRNA	PMID:33325755
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in decreased expression of SH3YL1 mRNA	PMID:23811191
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SH3YL1 mRNA	PMID:28302478
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of SH3YL1 mRNA	PMID:31533062
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of SH3YL1 mRNA	PMID:19167446
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SH3YL1 mRNA	PMID:25979313
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SH3YL1 mRNA	PMID:24383497|PMID:26272509
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SH3YL1 gene	PMID:29154799
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3YL1 mRNA	PMID:27188386
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306440	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of SH3YL1 mRNA	PMID:30047161
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SH3YL1 mRNA	PMID:25562108
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of SH3YL1 mRNA	PMID:17942131
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:41774	tamoxifen	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in decreased expression of SH3YL1 mRNA	PMID:25123088
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1315059	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of SH3YL1 mRNA	PMID:28973697
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of SH3YL1 mRNA	PMID:24935251|PMID:26272509
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3YL1 mRNA	PMID:27188386
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315059	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SH3YL1 mRNA	PMID:17562736
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen results in decreased expression of SH3YL1 mRNA	PMID:17942131
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306440	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SH3YL1 mRNA	PMID:33387578
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306440	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SH3YL1 mRNA	PMID:17557909
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20250805	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of SH3YL1 mRNA	PMID:39716349
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306440	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SH3YL1 mRNA	PMID:30047161
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1315059	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of SH3YL1 mRNA	PMID:36117858
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306440	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SH3YL1 mRNA	PMID:25729387
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306440	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SH3YL1 mRNA	PMID:25729387
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1315059	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of SH3YL1 mRNA	PMID:19812364
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:6809	methamphetamine	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in decreased expression of SH3YL1 mRNA	PMID:26307267
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of SH3YL1 mRNA	PMID:31758290
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SH3YL1 mRNA	PMID:22206623
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315059	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SH3YL1 mRNA	PMID:22206623
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:754906	afuresertib	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in increased expression of SH3YL1 mRNA	PMID:28960945
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:76989	phytoestrogen	multiple interactions	EXP		E	RGD:6480464	20210309	CTD	MESH:D048789	[Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of SH3YL1 mRNA	PMID:33325755
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3YL1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3YL1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3YL1 mRNA	PMID:27188386
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SH3YL1 gene]	PMID:28238834
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1306440	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of SH3YL1 mRNA	PMID:20345932
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1315059	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of SH3YL1 mRNA	PMID:17942131
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1315059	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of SH3YL1 mRNA	PMID:21278054
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306440	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SH3YL1 mRNA	PMID:30047161
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306440	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of SH3YL1 mRNA	PMID:24780913
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3YL1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3YL1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SH3YL1 mRNA	PMID:27188386
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306440	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SH3YL1 mRNA	PMID:21346803
1315058	SH3YL1	SH3 and SYLF domain containing 1	gene	CHEBI:9665	triadimefon	decreases expression	ISO	RGD:1306440	E	RGD:6480464	20230606	CTD	MESH:C032910	triadimefon results in decreased expression of SH3YL1 mRNA	PMID:30047161
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D008070	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of MRPL10 mRNA	PMID:31059760
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MRPL10 mRNA	PMID:21179406
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of MRPL10 promoter	PMID:33872906
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1315062	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of MRPL10 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of MRPL10 mRNA]	PMID:20230807
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of MRPL10 promoter	PMID:33872906
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1315062	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of MRPL10 mRNA	PMID:20230807
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1315062	E	RGD:6480464	20120501	CTD	MESH:D015632	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of MRPL10 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of MRPL10 mRNA]	PMID:20230807
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315062	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL10 mRNA	PMID:36331819
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1315062	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of MRPL10 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of MRPL10 mRNA]	PMID:20230807
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MRPL10 protein	PMID:23301498
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of MRPL10 mRNA	PMID:23649840
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of MRPL10 mRNA	PMID:19774075
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315062	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL10 mRNA	PMID:22206623
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315062	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPL10 mRNA	PMID:40504410
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315062	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPL10 mRNA	PMID:21570461
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1588626	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPL10 mRNA	PMID:21215274
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1588626	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MRPL10 mRNA	PMID:33387578
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of MRPL10 mRNA	PMID:33212167
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MRPL10 mRNA	PMID:24690739
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315062	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPL10 mRNA	PMID:40504410
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315062	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of MRPL10 mRNA	PMID:20504355
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of MRPL10 mRNA	PMID:24690739
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315062	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MRPL10 mRNA	PMID:23811191
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1588626	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MRPL10 mRNA	PMID:25181051
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of MRPL10 protein	PMID:34186270
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	increases expression	ISO	RGD:1588626	E	RGD:6480464	20260707	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in increased expression of MRPL10 mRNA	PMID:17316808
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of MRPL10 protein	PMID:34186270
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MRPL10 mRNA	PMID:38568856
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of MRPL10 mRNA	PMID:31533062
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of MRPL10 mRNA	PMID:40419075
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315062	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MRPL10 mRNA	PMID:36331819
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRPL10 mRNA	PMID:25979313
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1588626	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of MRPL10 mRNA	PMID:30047161
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1588626	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MRPL10 mRNA	PMID:30047161
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of MRPL10 mRNA	PMID:25704631|PMID:31059760
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	[Acetaminophen co-treated with Lipopolysaccharides] results in increased expression of MRPL10 mRNA	PMID:31059760
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of MRPL10 mRNA	PMID:24690739
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315062	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MRPL10 mRNA	PMID:40504410
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315062	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of MRPL10 mRNA	PMID:25554681
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1588626	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of MRPL10 mRNA	PMID:30047161
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1588626	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MRPL10 mRNA	PMID:30047161
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1315062	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of MRPL10 mRNA	PMID:35964746
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of MRPL10 protein	PMID:24806433
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315062	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MRPL10 mRNA	PMID:22206623
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in decreased expression of MRPL10 protein	PMID:39638853
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1588626	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of MRPL10 mRNA	PMID:30047161
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1588626	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of MRPL10 mRNA	PMID:30047161
1315061	MRPL10	mitochondrial ribosomal protein L10	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of MRPL10 mRNA	PMID:27188386
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of GALNT3 mRNA	PMID:26272509
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA	PMID:27188386
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GALNT3 mRNA	PMID:20938992
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of GALNT3 mRNA	PMID:21934132|PMID:33167477
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of GALNT3 mRNA	PMID:24236059
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1306443	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of GALNT3 mRNA	PMID:33729688
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of GALNT3 mRNA	PMID:21632981
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GALNT3 mRNA	PMID:35811015
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315064	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GALNT3 mRNA	PMID:39241906
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GALNT3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GALNT3 mRNA	PMID:35811015
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306443	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GALNT3 mRNA	PMID:33387578
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306443	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of GALNT3 gene	PMID:27618143
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GALNT3 mRNA	PMID:20938992
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALNT3 mRNA	PMID:37992649
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALNT3 mRNA	PMID:37992649
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of GALNT3 protein	PMID:31163220
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of GALNT3 mRNA	PMID:31163220
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315064	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of GALNT3 mRNA	PMID:34319233
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306443	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GALNT3 mRNA	PMID:33387578
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:22977	cadmium atom	increases expression	ISO	RGD:1315064	E	RGD:6480464	20140610	CTD	MESH:D002104	Cadmium results in increased expression of GALNT3 mRNA; Cadmium results in increased expression of GALNT3 protein	PMID:24614234
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306443	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GALNT3 mRNA	PMID:39012411
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20140610	CTD	MESH:D002104	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in increased expression of GALNT3 mRNA]; 3',4'-dimethoxyflavone inhibits the reaction [Cadmium results in increased expression of GALNT3 mRNA]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GALNT3 mRNA; [Cadmium results in increased expression of GALNT3 protein] which results in decreased metabolism of and results in increased secretion of FGF23 protein; Cadmium promotes the reaction [[AHR protein binds to GALNT3 promoter] which results in increased expression of GALNT3 mRNA]; pyrazolanthrone inhibits the reaction [Cadmium results in increased expression of GALNT3 mRNA]; SB 203580 inhibits the reaction [Cadmium results in increased expression of GALNT3 mRNA]	PMID:24614234|PMID:37325564
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:232299	3',4'-dimethoxyflavone	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20241119	CTD	MESH:C509288	3',4'-dimethoxyflavone inhibits the reaction [Cadmium results in increased expression of GALNT3 mRNA]	PMID:24614234
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of GALNT3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of GALNT3 mRNA	PMID:34911549
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315064	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GALNT3 mRNA	PMID:25629700
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GALNT3 mRNA	PMID:20938992
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GALNT3 gene	PMID:25304211
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:2762	antimycin A	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D000968	Antimycin A results in decreased expression of GALNT3 mRNA	PMID:33512557
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of GALNT3 mRNA	PMID:26272509
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA	PMID:27188386
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1315064	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of GALNT3 mRNA	PMID:28960355
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306443	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of GALNT3 mRNA	PMID:31881176
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306443	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GALNT3 mRNA	PMID:33387578
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GALNT3 mRNA	PMID:17942748
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of GALNT3 mRNA	PMID:33512557
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of GALNT3 mRNA	PMID:28001369
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of GALNT3 mRNA	PMID:26272509
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA	PMID:27188386
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306443	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of GALNT3 mRNA	PMID:26033743
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1306443	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of GALNT3 mRNA	PMID:26033743
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALNT3 mRNA	PMID:37992649
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:29365	phosgene	affects expression	ISO	RGD:1315064	E	RGD:6480464	20120515	CTD	MESH:D010705	Phosgene affects the expression of GALNT3 mRNA	PMID:16300373
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of GALNT3 mRNA	PMID:38568856
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1315064	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of GALNT3 mRNA	PMID:37682722
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GALNT3 5' UTR	PMID:27901495
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of GALNT3 promoter	PMID:27901495
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306443	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of GALNT3 mRNA	PMID:26033743
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1306443	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of GALNT3 mRNA	PMID:26033743
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of GALNT3 mRNA	PMID:20458559
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1315064	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of GALNT3 mRNA	PMID:23557971
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306443	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of GALNT3 mRNA	PMID:34492290
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1315064	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of GALNT3 mRNA	PMID:18648102
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1315064	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of GALNT3 mRNA	PMID:28472532
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in decreased expression of GALNT3 mRNA	PMID:15223131
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306443	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GALNT3 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315064	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of GALNT3 mRNA	PMID:32156529|PMID:34585602
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of GALNT3 mRNA	PMID:19244175
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of GALNT3 mRNA	PMID:25979313
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315064	E	RGD:6480464	20241001	CTD	MESH:C543008	bisphenol S results in decreased expression of GALNT3 mRNA	PMID:38908815|PMID:40203079
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315064	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of GALNT3 mRNA	PMID:30951980
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1315064	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of GALNT3 protein	PMID:35362542
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of GALNT3 protein]	PMID:35362542
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:34696	dieldrin	increases expression	EXP		E	RGD:6480464	20201215	CTD	MESH:D004026	Dieldrin results in increased expression of GALNT3 mRNA	PMID:31068361
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:34698	diethyl phthalate	decreases expression	ISO	RGD:1306443	E	RGD:6480464	20250311	CTD	MESH:C007379	diethyl phthalate results in decreased expression of GALNT3 mRNA	PMID:32341500
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D019256	Cadmium Chloride results in increased expression of GALNT3 mRNA	PMID:26472689
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306443	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GALNT3 mRNA	PMID:39012411
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GALNT3 mRNA	PMID:37325564
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of GALNT3 mRNA	PMID:36326898
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306443	E	RGD:6480464	20170516	CTD	MESH:C039281	furan results in increased expression of GALNT3 mRNA	PMID:27387713
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of GALNT3 mRNA	PMID:24449571
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1315064	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of GALNT3 mRNA	PMID:18353800
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1315064	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of GALNT3 mRNA	PMID:40194260
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:38604	pyrimidifen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of GALNT3 mRNA	PMID:33512557
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of GALNT3 mRNA	PMID:27153767|PMID:40419075
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GALNT3 gene	PMID:29154799
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of GALNT3 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA	PMID:27188386
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1315064	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of GALNT3 mRNA	PMID:17555576
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GALNT3 mRNA	PMID:37992649
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:4357	deguelin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in decreased expression of GALNT3 mRNA	PMID:33512557
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GALNT3 mRNA	PMID:38832940
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA	PMID:27188386
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A results in decreased expression of GALNT3 mRNA	PMID:28542535
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of GALNT3 mRNA	PMID:24935251|PMID:26272509
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA	PMID:27188386
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of GALNT3 mRNA	PMID:26690555
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306443	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GALNT3 mRNA	PMID:33387578
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	GALNT3 protein affects the susceptibility to Fluorouracil	PMID:16217747
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of GALNT3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of GALNT3 mRNA	PMID:35811015
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GALNT3 gene	PMID:25304211
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1306443	E	RGD:6480464	20190507	CTD	MESH:D004008	Diclofenac results in increased expression of GALNT3 mRNA	PMID:30723492
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306443	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GALNT3 mRNA	PMID:29391264
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1315064	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of GALNT3 mRNA	PMID:17555576|PMID:17942748
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GALNT3 mRNA	PMID:17942748
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of GALNT3 protein]	PMID:35362542
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of GALNT3 mRNA	PMID:26272509
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA	PMID:27188386
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of GALNT3 mRNA	PMID:20458559
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315064	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of GALNT3 mRNA	PMID:25554681
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306443	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of GALNT3 mRNA	PMID:22504374
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:61076	belinostat	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in increased expression of GALNT3 mRNA	PMID:26272509
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:61076	belinostat	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA	PMID:27188386
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	GALNT3 protein affects the susceptibility to Topotecan	PMID:16217747
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased methylation of GALNT3 intron	PMID:29432895
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:64090	tert-butyl hydroperoxide	increases methylation	EXP		E	RGD:6480464	20180828	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased methylation of GALNT3 intron	PMID:29432895
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1306443	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of GALNT3 mRNA	PMID:35283115
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1315064	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of GALNT3 protein	PMID:35926579
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306443	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of GALNT3 gene	PMID:35440735
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1315064	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of GALNT3 mRNA	PMID:22206623
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of GALNT3 mRNA	PMID:22714537
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA	PMID:27188386
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GALNT3 gene]	PMID:28238834
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:81794	thifluzamide	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C494892	thifluzamide results in decreased expression of GALNT3 mRNA	PMID:33512557
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of GALNT3 mRNA	PMID:33512557
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:84491	poly(I:C)	multiple interactions	EXP		E	RGD:6480464	20241001	CTD	MESH:D011070	[TL8-506 co-treated with Poly I-C] results in increased expression of GALNT3 mRNA	PMID:35688559
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306443	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of GALNT3 mRNA	PMID:22504374|PMID:24780913
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of GALNT3 mRNA	PMID:26272509
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA	PMID:27188386
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [Cadmium results in increased expression of GALNT3 mRNA]	PMID:24614234
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:90705	SB 203580	multiple interactions	ISO	RGD:1315064	E	RGD:6480464	20170303	CTD	MESH:C093642	SB 203580 inhibits the reaction [Cadmium results in increased expression of GALNT3 mRNA]	PMID:24614234
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GALNT3 mRNA	PMID:27188386
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of GALNT3 mRNA	PMID:38568856
1315063	GALNT3	polypeptide N-acetylgalactosaminyltransferase 3	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1306443	E	RGD:6480464	20200915	CTD	MESH:C001899	triptolide results in increased expression of GALNT3 protein	PMID:32519852
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of FBXL15 mRNA	PMID:20044591|PMID:21179406
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of FBXL15 mRNA	PMID:37042841
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of FBXL15 mRNA	PMID:19549813
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of FBXL15 mRNA	PMID:22100608
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of FBXL15 mRNA	PMID:35430440
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315066	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXL15 mRNA	PMID:40504410
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of FBXL15 mRNA	PMID:28903495
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315066	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FBXL15 mRNA	PMID:21570461|PMID:24680724
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306444	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of FBXL15 mRNA	PMID:33387578
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315066	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FBXL15 mRNA	PMID:17942748
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of FBXL15 mRNA	PMID:32763439
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of FBXL15 mRNA	PMID:20044591
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of FBXL15 mRNA	PMID:38568856
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315066	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXL15 mRNA	PMID:40504410
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315066	E	RGD:6480464	20180220	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FBXL15 mRNA	PMID:27195522
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306444	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of FBXL15 mRNA	PMID:30047161
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315066	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of FBXL15 gene	PMID:35295148
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1315066	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of FBXL15 mRNA	PMID:18648102
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1315066	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in decreased expression of FBXL15 mRNA	PMID:21318169
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1315066	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of FBXL15 mRNA]	PMID:21318169
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306444	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of FBXL15 mRNA	PMID:25181051
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXL15 mRNA	PMID:36232920
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315066	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of FBXL15 mRNA	PMID:35598803
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315066	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of FBXL15 mRNA	PMID:32156529|PMID:33221593
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FBXL15 mRNA	PMID:28628672
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FBXL15 mRNA	PMID:28628672
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of FBXL15 mRNA	PMID:38568856
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1315066	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of FBXL15 mRNA	PMID:17585979
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1315066	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of FBXL15 mRNA	PMID:40194260
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of FBXL15 mRNA	PMID:40419075
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FBXL15 mRNA	PMID:25979313
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315066	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of FBXL15 mRNA	PMID:17963808
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of FBXL15 mRNA	PMID:23179753
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306444	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of FBXL15 mRNA	PMID:30047161
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FBXL15 mRNA	PMID:28628672
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306444	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of FBXL15 mRNA	PMID:33387578
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315066	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of FBXL15 mRNA	PMID:40504410
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:47519	ketoconazole	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in decreased expression of FBXL15 mRNA	PMID:36621641
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1315066	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of FBXL15 mRNA	PMID:35436446
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315066	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FBXL15 mRNA	PMID:17942748
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of FBXL15 mRNA	PMID:28628672
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1315066	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of FBXL15 mRNA	PMID:23650126
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1306444	E	RGD:6480464	20230606	CTD	MESH:C045950	propiconazole results in increased expression of FBXL15 mRNA	PMID:30047161
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306444	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of FBXL15 mRNA	PMID:30047161
1315065	FBXL15	F-box and leucine rich repeat protein 15	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306444	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of FBXL15 mRNA	PMID:19281266
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:137392	chlormequat chloride	increases expression	ISO	RGD:1306447	E	RGD:6480464	20220705	CTD	MESH:D002716	Chlormequat results in increased expression of SAMD8 protein	PMID:34958886
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315070	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SAMD8 gene	PMID:20938992
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of SAMD8 mRNA	PMID:33167477
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of SAMD8 mRNA	PMID:38568856
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315070	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SAMD8 gene	PMID:20938992
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SAMD8 mRNA	PMID:37042841
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1315070	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of SAMD8 mRNA	PMID:28973375
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SAMD8 mRNA	PMID:28818685
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315070	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SAMD8 mRNA	PMID:36331819
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SAMD8 mRNA	PMID:35301059
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of SAMD8 mRNA	PMID:19549813
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:23808	dimethylarsinous acid	increases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in increased expression of SAMD8 mRNA	PMID:23487506
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SAMD8 mRNA	PMID:21641981
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1315070	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SAMD8 mRNA	PMID:19770486
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SAMD8 mRNA	PMID:18593933
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306447	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of SAMD8 mRNA	PMID:31150632
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315070	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SAMD8 gene	PMID:20938992
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306447	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of SAMD8 mRNA	PMID:31881176
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of SAMD8 mRNA	PMID:28903495
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of SAMD8 mRNA	PMID:23195993
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1315070	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SAMD8 mRNA	PMID:28213091
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306447	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SAMD8 mRNA	PMID:21215274
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315070	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SAMD8 mRNA	PMID:19465110|PMID:24680724
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315070	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SAMD8 gene]	PMID:28213091
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306447	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of SAMD8 mRNA	PMID:19013527
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SAMD8 mRNA	PMID:28001369
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306447	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SAMD8 mRNA	PMID:28959563
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SAMD8 mRNA	PMID:29803840
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of SAMD8 mRNA	PMID:38568856
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315070	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SAMD8 mRNA	PMID:22228805
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SAMD8 3' UTR	PMID:27901495
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SAMD8 mRNA	PMID:20064835
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SAMD8 promoter	PMID:27901495
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of SAMD8 mRNA	PMID:18593933
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of SAMD8 mRNA	PMID:20458559
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315070	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SAMD8 gene	PMID:35295148
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306447	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of SAMD8 mRNA	PMID:25181051|PMID:29097150|PMID:30816183|PMID:32528016
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315070	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of SAMD8 mRNA	PMID:39298647
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of SAMD8 intron	PMID:30157460
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1315070	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of SAMD8 mRNA	PMID:28392331
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SAMD8 mRNA	PMID:37042841
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SAMD8 mRNA	PMID:38568856
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SAMD8 mRNA	PMID:35301059
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SAMD8 mRNA	PMID:19320972
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1306447	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of SAMD8 mRNA	PMID:24386269
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1315070	E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in increased expression of SAMD8 mRNA	PMID:21139344
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315070	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SAMD8 mRNA	PMID:36331819
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1306447	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of SAMD8 mRNA	PMID:23125180
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SAMD8 mRNA	PMID:23179753|PMID:29154799
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of SAMD8 gene	PMID:29154799
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:4031	cyclosporin A	decreases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased methylation of SAMD8 promoter	PMID:27989131
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SAMD8 mRNA	PMID:25562108
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306447	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of SAMD8 mRNA	PMID:33387578
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of SAMD8 mRNA	PMID:36621641
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306447	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SAMD8 mRNA	PMID:29097150
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:49203	torcetrapib	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C483909	torcetrapib results in increased expression of SAMD8 mRNA	PMID:23228038
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of SAMD8 mRNA	PMID:20458559
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SAMD8 mRNA	PMID:28988120
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of SAMD8 intron	PMID:30157460
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306447	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of SAMD8 gene	PMID:35440735
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315070	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SAMD8 mRNA	PMID:22206623
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1315070	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of SAMD8 mRNA	PMID:39847705
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1315070	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of SAMD8 mRNA	PMID:21795629
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306447	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SAMD8 mRNA	PMID:21346803
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of SAMD8 mRNA	PMID:38568856
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306447	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of SAMD8 mRNA	PMID:21346803
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1315070	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of SAMD8 mRNA	PMID:28973697
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306447	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of SAMD8 mRNA	PMID:19015723
1315069	SAMD8	sterile alpha motif domain containing 8	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1306447	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of SAMD8 gene	PMID:31682807
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315073	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of STK33 mRNA	PMID:33045310
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in decreased expression of STK33 mRNA	PMID:21934132
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of STK33 mRNA	PMID:23724009
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of STK33 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of STK33 mRNA	PMID:32699268
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1315073	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of STK33 mRNA	PMID:30529165
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STK33 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of STK33 mRNA	PMID:35811015
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of STK33 mRNA	PMID:26079696
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of STK33 mRNA	PMID:31163220
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of STK33 mRNA	PMID:19549813
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of STK33 gene	PMID:27153756
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of STK33 intron	PMID:30157460
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of STK33 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of STK33 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of STK33 mRNA	PMID:32699268
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315073	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STK33 mRNA	PMID:17942748
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of STK33 mRNA	PMID:28001369
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of STK33 mRNA	PMID:33212167
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1315073	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of STK33 protein	PMID:28918527
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of STK33 mRNA	PMID:29803840
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of STK33 mRNA	PMID:22714537
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of STK33 promoter	PMID:27901495
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STK33 mRNA	PMID:20106945|PMID:21632981|PMID:22316170
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315073	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of STK33 mRNA	PMID:23557971|PMID:35295148
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315073	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of STK33 gene	PMID:35295148
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1590972	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STK33 mRNA	PMID:25181051
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of STK33 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of STK33 mRNA	PMID:32699268
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of STK33 mRNA	PMID:31533062
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of STK33 mRNA	PMID:27153767
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:39481	chloroprene	increases expression	ISO	RGD:1315073	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in increased expression of STK33 mRNA	PMID:23125180
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of STK33 mRNA	PMID:25979313
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of STK33 gene	PMID:29154799
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of STK33 mRNA	PMID:24449571
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in increased expression of STK33 mRNA	PMID:35811015
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of STK33 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of STK33 mRNA	PMID:35811015
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1315073	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of STK33 mRNA	PMID:17942748
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315073	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STK33 mRNA	PMID:17942748
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315073	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of STK33 mRNA; Nanotubes, Carbon results in decreased expression of STK33 mRNA	PMID:25554681
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of STK33 mRNA	PMID:22714537
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1315073	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of STK33 mRNA	PMID:38701926
1315072	STK33	serine/threonine kinase 33	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to STK33 gene]	PMID:28238834
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315075	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of PSMD11 mRNA	PMID:33045310
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:132448	perfluorohexanesulfonic acid	multiple interactions	ISO	RGD:1306450	E	RGD:6480464	20260113	CTD	MESH:C471071	[perfluorohexanesulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorodecanoic acid] results in increased expression of PSMD11 protein	PMID:39306415
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306450	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PSMD11 mRNA]	PMID:31150632
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:144804	nickel subsulfide	increases expression	ISO	RGD:1306450	E	RGD:6480464	20191008	CTD	MESH:C017557	nickel subsulfide results in increased expression of PSMD11 mRNA	PMID:21086188
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of PSMD11 mRNA	PMID:16054129|PMID:33167477
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of PSMD11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of PSMD11 mRNA	PMID:32699268
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of PSMD11 mRNA	PMID:22378314
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1306450	E	RGD:6480464	20140114	CTD	MESH:D000431	Ethanol results in increased expression of PSMD11 protein	PMID:23702218
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1315075	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of and affects the splicing of PSMD11 mRNA	PMID:30319688
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of PSMD11 protein	PMID:35688186
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315075	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of PSMD11 mRNA	PMID:39241906
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315075	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of PSMD11 mRNA	PMID:39298647
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306450	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of PSMD11 gene	PMID:27618143
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:16716	benzene	increases expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D001554	Benzene results in increased expression of PSMD11 mRNA	PMID:19162166
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of PSMD11 mRNA	PMID:23649840
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1315075	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of PSMD11 mRNA	PMID:17945193
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1306450	E	RGD:6480464	20260203	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of PSMD11 protein	PMID:40089264
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1315075	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PSMD11 mRNA	PMID:23892564
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306450	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PSMD11 mRNA	PMID:22061828
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315075	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMD11 mRNA	PMID:36331819
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PSMD11 mRNA	PMID:39836092
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306450	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD11 mRNA	PMID:39012411
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315075	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD11 mRNA	PMID:28111341
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of PSMD11 mRNA	PMID:19549813
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	EXP		E	RGD:6480464	20230801	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of PSMD11 mRNA	PMID:23487506
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of PSMD11 mRNA	PMID:23649840
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1315075	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of PSMD11 mRNA	PMID:19376150
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of PSMD11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of PSMD11 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of PSMD11 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of PSMD11 mRNA	PMID:32699268|PMID:35430440
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of PSMD11 mRNA	PMID:19774075
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306450	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PSMD11 mRNA	PMID:31150632
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1315075	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PSMD11 mRNA	PMID:31919559
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306450	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PSMD11 mRNA]	PMID:31150632
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315075	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMD11 mRNA	PMID:22206623
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PSMD11 mRNA; [arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD11 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD11 mRNA	PMID:35809665|PMID:39836092
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1315075	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of PSMD11 protein	PMID:37208198
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315075	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PSMD11 mRNA	PMID:21570461
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306450	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PSMD11 mRNA	PMID:34747641
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PSMD11 mRNA	PMID:28001369
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of PSMD11 mRNA	PMID:26272509
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PSMD11 mRNA	PMID:27188386
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of PSMD11 mRNA	PMID:32763439
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1315075	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of PSMD11 mRNA	PMID:39631538
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:28925	mechlorethamine	increases expression	ISO	RGD:1315075	E	RGD:6480464	20161213	CTD	MESH:D008466	Mechlorethamine results in increased expression of PSMD11 mRNA	PMID:17107856
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of PSMD11 mRNA	PMID:34032870
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PSMD11 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD11 mRNA	PMID:39836092
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in decreased expression of PSMD11 mRNA	PMID:29453283
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315075	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PSMD11 mRNA	PMID:22228805
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PSMD11 promoter	PMID:27901495
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to PSMD11 protein]	PMID:32406909
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PSMD11 mRNA	PMID:25351596
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PSMD11 mRNA	PMID:19150397
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of PSMD11 mRNA	PMID:15894607|PMID:25258189|PMID:29633893
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1306450	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of PSMD11 mRNA	PMID:24136188
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315075	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PSMD11 gene; titanium dioxide results in decreased methylation of PSMD11 promoter	PMID:35295148
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315075	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of PSMD11 mRNA	PMID:18301758|PMID:23811191
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315075	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of PSMD11 mRNA	PMID:33221593
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of PSMD11 protein	PMID:34186270
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306450	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of PSMD11 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of PSMD11 protein	PMID:34186270
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315075	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of PSMD11 mRNA	PMID:39298647
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315075	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of PSMD11 mRNA	PMID:38685157
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of PSMD11 protein	PMID:34186270
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306450	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PSMD11 mRNA	PMID:21266533
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to PSMD11 protein	PMID:32991956
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1306450	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of PSMD11 mRNA	PMID:32680482
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PSMD11 mRNA	PMID:39836092
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306450	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD11 mRNA	PMID:39012411
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315075	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of PSMD11 mRNA	PMID:28111341
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:35546	perfluorodecanoic acid	multiple interactions	ISO	RGD:1306450	E	RGD:6480464	20260113	CTD	MESH:C036567	[perfluorohexanesulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorodecanoic acid] results in increased expression of PSMD11 protein	PMID:39306415
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1315075	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of PSMD11 mRNA	PMID:19429403
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306450	E	RGD:6480464	20260113	CTD	MESH:C023036	[perfluorohexanesulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorodecanoic acid] results in increased expression of PSMD11 protein	PMID:39306415
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1306450	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of PSMD11 mRNA	PMID:24386269
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:36009	omega-6 fatty acid	increases expression	EXP		E	RGD:6480464	20170117	CTD	MESH:D043371	Fatty Acids, Omega-6 results in increased expression of PSMD11 mRNA	PMID:16823509
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of PSMD11 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of PSMD11 mRNA	PMID:32699268
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:38397	perfluorononanoic acid	multiple interactions	ISO	RGD:1306450	E	RGD:6480464	20260113	CTD	MESH:C101816	[perfluorohexanesulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorodecanoic acid] results in increased expression of PSMD11 protein	PMID:39306415
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1315075	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of PSMD11 mRNA	PMID:19429403
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1315075	E	RGD:6480464	20130416	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of PSMD11 mRNA	PMID:20936131
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1306450	E	RGD:6480464	20260113	CTD	MESH:C076994	[perfluorohexanesulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluorooctane sulfonic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorodecanoic acid] results in increased expression of PSMD11 protein	PMID:39306415
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315075	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of PSMD11 mRNA	PMID:36331819
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PSMD11 mRNA	PMID:25979313
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1306450	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of PSMD11 mRNA	PMID:29427782
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of PSMD11 mRNA	PMID:24935251|PMID:26272509
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of PSMD11 mRNA	PMID:23179753|PMID:29154799
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSMD11 mRNA	PMID:27188386
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of PSMD11 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315075	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PSMD11 mRNA	PMID:17562736
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1315075	E	RGD:6480464	20120515	CTD	MESH:D000082	Acetaminophen results in increased expression of PSMD11 mRNA	PMID:17585979
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PSMD11 mRNA; [arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD11 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PSMD11 mRNA	PMID:35809665|PMID:39836092
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C029892	cupric chloride results in increased expression of PSMD11 mRNA	PMID:17211630
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of PSMD11 mRNA	PMID:15894607|PMID:25258189|PMID:29633893
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:50594	carbon nanotube	affects expression	ISO	RGD:1315075	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon affects the expression of PSMD11 protein	PMID:21135415
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315075	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of PSMD11 mRNA; Nanotubes, Carbon results in increased expression of PSMD11 mRNA	PMID:25554681
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306450	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of PSMD11 mRNA	PMID:24136188
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of PSMD11 protein	PMID:32959892
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of PSMD11 mRNA	PMID:39836092
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1306450	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of PSMD11 mRNA	PMID:24136188
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1315075	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of PSMD11 mRNA	PMID:19812364
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:63952	arsenic trichloride	multiple interactions	EXP		E	RGD:6480464	20240402	CTD	MESH:C050510	[arsenic trichloride results in increased abundance of Arsenic] which results in decreased expression of PSMD11 mRNA	PMID:35809665
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of PSMD11 mRNA	PMID:15336504
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:64163	diquat	increases expression	ISO	RGD:1315075	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in increased expression of PSMD11 mRNA	PMID:36851058
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1306450	E	RGD:6480464	20211109	CTD	MESH:D007545	[Isoproterenol co-treated with POSTN protein] results in decreased expression of PSMD11 mRNA	PMID:30303030
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:6773	Mesaconitine	increases expression	ISO	RGD:1306450	E	RGD:6480464	20231031	CTD	MESH:C019470	mesaconitine results in increased expression of PSMD11 protein	PMID:37182599
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1306450	E	RGD:6480464	20120412	CTD	MESH:D008701	Methapyrilene results in increased expression of PSMD11 mRNA	PMID:16393664
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:68233	(Z)-3-butylidenephthalide	decreases expression	EXP		E	RGD:6480464	20140311	CTD	MESH:C026105	butylidenephthalide results in decreased expression of PSMD11 protein	PMID:23770345
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of PSMD11 protein	PMID:34186270
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315075	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PSMD11 mRNA	PMID:22206623
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306450	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of PSMD11 mRNA	PMID:24136188
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of PSMD11 mRNA	PMID:31806706
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:755197	troxerutin	multiple interactions	ISO	RGD:1315075	E	RGD:6480464	20260714	CTD	MESH:C005865	troxerutin inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PSMD11 mRNA]	PMID:25639565
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:756894	tak-243	decreases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in decreased sumoylation of PSMD11 protein	PMID:31285264
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:757488	omega-3 fatty acids	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:D015525	Fatty Acids, Omega-3 results in increased expression of PSMD11 mRNA	PMID:16823509
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:7602	nobiletin	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C008661	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of PSMD11 protein]	PMID:38348393
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of PSMD11 protein	PMID:39638853
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in increased expression of PSMD11 protein	PMID:39638853
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1306450	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of PSMD11 mRNA	PMID:22124623
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PSMD11 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSMD11 mRNA	PMID:27188386
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1306450	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital results in increased expression of PSMD11 mRNA	PMID:19162173
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	increases expression	ISO	RGD:1306450	E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in increased expression of PSMD11 protein	PMID:19954255
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1315075	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PSMD11 mRNA	PMID:25639565
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1315075	E	RGD:6480464	20170303	CTD	MESH:C511295	troxerutin inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PSMD11 mRNA]	PMID:25639565
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1306450	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of PSMD11 protein	PMID:28903499
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of PSMD11 protein	PMID:38348393
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:84070	sodium arsenate	multiple interactions	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	nobiletin inhibits the reaction [sodium arsenate results in decreased expression of PSMD11 protein]	PMID:38348393
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1315075	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of PSMD11 mRNA	PMID:19363144
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PSMD11 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PSMD11 mRNA	PMID:27188386
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:9168	sirolimus	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020123	Sirolimus results in decreased expression of PSMD11 mRNA; Sirolimus results in decreased expression of PSMD11 protein	PMID:15782132
1315074	PSMD11	proteasome 26S subunit, non-ATPase 11	gene	CHEBI:9665	triadimefon	increases expression	ISO	RGD:1315075	E	RGD:6480464	20141111	CTD	MESH:C032910	triadimefon results in increased expression of PSMD11 mRNA	PMID:19363144
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of ARAP2 mRNA	PMID:33167477
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1315078	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ARAP2 mRNA	PMID:36189433
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1315078	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ARAP2 mRNA	PMID:30529165
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:16130	DDT	decreases expression	ISO	RGD:1306452	E	RGD:6480464	20191112	CTD	MESH:D003634	DDT results in decreased expression of ARAP2 mRNA	PMID:30207508
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1315078	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of ARAP2 mRNA	PMID:29018328
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of ARAP2 mRNA	PMID:29581250
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315078	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ARAP2 mRNA	PMID:39241906
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ARAP2 mRNA	PMID:21370964|PMID:35811015
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	coenzyme Q10 inhibits the reaction [Lipopolysaccharides results in increased expression of ARAP2 mRNA]; S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of ARAP2 mRNA]	PMID:21370964|PMID:35811015
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of ARAP2 mRNA	PMID:30510588
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of ARAP2 mRNA	PMID:31614463
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARAP2 mRNA	PMID:37042841
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of ARAP2 mRNA	PMID:23649840
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1315078	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ARAP2 mRNA	PMID:36189433
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:17300	tetrachloroethene	increases expression	ISO	RGD:1315078	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in increased expression of ARAP2 mRNA	PMID:28973375
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of ARAP2 mRNA	PMID:33359661
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of ARAP2 mRNA	PMID:21592394
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of ARAP2 mRNA	PMID:21592394
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:17558	quercitrin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of ARAP2 mRNA	PMID:25193878
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ARAP2 mRNA	PMID:31163220
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306452	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ARAP2 mRNA	PMID:27523638
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of ARAP2 mRNA	PMID:21592394
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of ARAP2 mRNA	PMID:21592394
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of ARAP2 mRNA	PMID:28818685
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of ARAP2 exon	PMID:30157460
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:181932	3-Nitrobenzanthrone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C117220	3-nitrobenzanthrone results in decreased expression of ARAP2 mRNA	PMID:34036453
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:18407	hydrogen cyanide	increases expression	ISO	RGD:1315078	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in increased expression of ARAP2 mRNA	PMID:33914522
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ARAP2 protein	PMID:20106945
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1315078	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ARAP2 mRNA	PMID:19770486
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ARAP2 exon	PMID:30157460
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of ARAP2 mRNA	PMID:41430723
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315078	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ARAP2 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ARAP2 mRNA	PMID:34911549
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ARAP2 mRNA	PMID:18593933
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306452	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ARAP2 mRNA	PMID:31150632
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of ARAP2 mRNA	PMID:26272509
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of ARAP2 mRNA	PMID:27188386
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of ARAP2 mRNA	PMID:27392435
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of ARAP2 mRNA	PMID:27392435
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:27899	cisplatin	multiple interactions	ISO	RGD:1315078	E	RGD:6480464	20140610	CTD	MESH:D002945	[Cisplatin co-treated with RELB mutant form] results in increased expression of ARAP2 mRNA	PMID:23625948
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1315078	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of ARAP2 mRNA	PMID:34813904
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of ARAP2 promoter	PMID:22847954
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1315078	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of ARAP2 mRNA	PMID:30912803
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306452	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARAP2 mRNA	PMID:34747641
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315078	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ARAP2 mRNA	PMID:26377647
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306452	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARAP2 mRNA	PMID:32109520
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of ARAP2 mRNA	PMID:29955902
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ARAP2 mRNA	PMID:33212167
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ARAP2 mRNA	PMID:30851411
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of ARAP2 mRNA	PMID:26272509
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARAP2 mRNA	PMID:27188386
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of ARAP2 mRNA	PMID:23649840
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ARAP2 mRNA	PMID:29803840
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:2948	azathioprine	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in increased expression of ARAP2 mRNA	PMID:22623647
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ARAP2 mRNA	PMID:38568856
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ARAP2 5' UTR	PMID:27901495
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1315078	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of ARAP2 intron	PMID:27901495
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARAP2 mRNA	PMID:32234424
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315078	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ARAP2 mRNA	PMID:19770486
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to ARAP2 mRNA]	PMID:32406909
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ARAP2 mRNA	PMID:18593933
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in increased expression of ARAP2 mRNA	PMID:25351596
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306452	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of ARAP2 mRNA	PMID:30047161
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315078	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ARAP2 mRNA	PMID:23557971
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315078	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of ARAP2 mRNA	PMID:35295148
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315078	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ARAP2 promoter	PMID:35295148
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306452	E	RGD:6480464	20150609	CTD	MESH:D013853	Thioacetamide results in increased expression of ARAP2 mRNA	PMID:23411599
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315078	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of ARAP2 mRNA	PMID:18301758|PMID:23811191
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1315078	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of ARAP2 mRNA	PMID:28329830
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1315078	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of ARAP2 mRNA	PMID:33914522
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306452	E	RGD:6480464	20150609	CTD	MESH:C006780	bisphenol A affects the expression of ARAP2 mRNA	PMID:25181051
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306452	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ARAP2 mRNA	PMID:30816183|PMID:34947998
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306452	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of ARAP2 mRNA	PMID:41034487
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1315078	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of ARAP2 mRNA	PMID:25172293
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1315078	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ARAP2 mRNA	PMID:37019170
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1315078	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ARAP2 mRNA	PMID:17361019|PMID:21266533
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ARAP2 mRNA	PMID:37042841
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306452	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARAP2 mRNA	PMID:35163327
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1315078	E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ARAP2 mRNA	PMID:24982889
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1306452	E	RGD:6480464	20150609	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of ARAP2 promoter	PMID:22457795
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ARAP2 mRNA	PMID:36326898
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306452	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ARAP2 mRNA	PMID:35163327
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1306452	E	RGD:6480464	20230606	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of ARAP2 mRNA	PMID:30047161
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ARAP2 mRNA	PMID:24449571
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:3763	clorgyline	increases expression	EXP		E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of ARAP2 mRNA	PMID:19691856
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1315078	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ARAP2 mRNA	PMID:40194260
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of ARAP2 promoter	PMID:22847954
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of ARAP2 promoter	PMID:22847954
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1315078	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of ARAP2 mRNA	PMID:39529242
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ARAP2 mRNA	PMID:27153767|PMID:40419075
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid affects the expression of ARAP2 mRNA	PMID:23179753
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:39867	valproic acid	affects splicing	ISO	RGD:1306452	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid affects the splicing of ARAP2 mRNA	PMID:29427782
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of ARAP2 mRNA	PMID:24383497|PMID:24935251
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ARAP2 gene	PMID:29154799
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of ARAP2 mRNA	PMID:26272509|PMID:29154799
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of ARAP2 mRNA	PMID:27188386
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306452	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of ARAP2 mRNA	PMID:30047161|PMID:38685447
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1306452	E	RGD:6480464	20150609	CTD	MESH:D016572	Cyclosporine results in decreased expression of ARAP2 mRNA	PMID:21865292
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ARAP2 mRNA	PMID:20106945|PMID:25562108
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of ARAP2 mRNA	PMID:23649840
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of ARAP2 mRNA	PMID:24935251|PMID:26272509
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARAP2 mRNA	PMID:27188386
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315078	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARAP2 mRNA	PMID:17562736
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of ARAP2 mRNA	PMID:29067470
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:46245	coenzyme Q10	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C024989	coenzyme Q10 inhibits the reaction [Lipopolysaccharides results in increased expression of ARAP2 mRNA]	PMID:21370964
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of ARAP2 mRNA]	PMID:35811015
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of ARAP2 mRNA	PMID:26272509
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of ARAP2 mRNA	PMID:27188386
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315078	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ARAP2 mRNA; Nanotubes, Carbon results in decreased expression of ARAP2 mRNA	PMID:25554681
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306452	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of ARAP2 mRNA	PMID:30047161
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1315078	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of ARAP2 mRNA	PMID:26377693
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of ARAP2 mRNA	PMID:22714537
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1315078	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ARAP2 mRNA	PMID:19042947
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1315078	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of ARAP2 mRNA	PMID:19812364
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1315078	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of ARAP2 mRNA	PMID:19751817
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315078	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ARAP2 mRNA	PMID:22206623
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ARAP2 mRNA	PMID:22714537
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:7719	ochratoxin A	increases methylation	ISO	RGD:1306452	E	RGD:6480464	20160210	CTD	MESH:C025589	ochratoxin A results in increased methylation of ARAP2 gene	PMID:26431795
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ARAP2 mRNA	PMID:30851411
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of ARAP2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARAP2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARAP2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of ARAP2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARAP2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of ARAP2 mRNA	PMID:27188386
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ARAP2 gene]	PMID:28238834
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1315078	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ARAP2 mRNA	PMID:23091169
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1315078	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of ARAP2 mRNA	PMID:39847705
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306452	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ARAP2 mRNA	PMID:30047161
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of ARAP2 mRNA	PMID:26272509
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARAP2 mRNA	PMID:27188386
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of ARAP2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARAP2 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARAP2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of ARAP2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ARAP2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression of ARAP2 mRNA	PMID:27188386
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ARAP2 mRNA	PMID:38568856
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of ARAP2 mRNA	PMID:29301935
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1315078	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ARAP2 mRNA	PMID:28973697
1315077	ARAP2	ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306452	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin affects the expression of ARAP2 mRNA	PMID:23034163
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315082	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of SPO11 mRNA	PMID:33045310
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306454	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of SPO11 mRNA	PMID:26496021
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:17606	diiodine	multiple interactions	ISO	RGD:1315082	E	RGD:6480464	20231003	CTD	MESH:D007455	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SPO11 mRNA	PMID:36706583
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315082	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of SPO11 mRNA	PMID:28771232|PMID:34319233
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases methylation	ISO	RGD:1315082	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased methylation of SPO11 gene	PMID:34319233
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SPO11 mRNA	PMID:19549813
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SPO11 gene	PMID:27153756
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306454	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of SPO11 mRNA	PMID:30779732
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1315082	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of SPO11 mRNA	PMID:25629700
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1315082	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SPO11 mRNA	PMID:28960355
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315082	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SPO11 mRNA	PMID:16962184|PMID:21570461
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPO11 mRNA	PMID:17879257
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SPO11 promoter	PMID:27901495
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315082	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of SPO11 promoter	PMID:35295148
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306454	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPO11 mRNA	PMID:25181051|PMID:41034487
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1315082	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of SPO11 promoter	PMID:27312807
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in increased expression of SPO11 mRNA	PMID:22121209
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1315082	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SPO11 promoter	PMID:27312807
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306454	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of SPO11 mRNA	PMID:26496021
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1315082	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of SPO11 mRNA	PMID:28392331
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306454	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of SPO11 gene	PMID:22079235
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of SPO11 gene	PMID:29154799
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of SPO11 mRNA	PMID:18175754
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1315082	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of SPO11 mRNA	PMID:38701926
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1315082	E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of SPO11 mRNA	PMID:18958704
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	ISO	RGD:1315082	E	RGD:6480464	20220510	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of SPO11 protein	PMID:34936917
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:8502	6-propyl-2-thiouracil	multiple interactions	ISO	RGD:1315082	E	RGD:6480464	20231003	CTD	MESH:D011441	[Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SPO11 mRNA	PMID:36706583
1315081	SPO11	SPO11 initiator of meiotic double strand breaks	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1306454	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of SPO11 gene	PMID:31079544
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315085	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ART4 mRNA	PMID:33045310
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ART4 mRNA	PMID:20938992
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ART4 mRNA	PMID:21632981
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D004958	Estradiol results in decreased expression of ART4 mRNA	PMID:20106945|PMID:21632981
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ART4 mRNA	PMID:25510870
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306456	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ART4 mRNA	PMID:33387578
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ART4 mRNA	PMID:20938992
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of ART4 mRNA	PMID:26079696
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ART4 mRNA	PMID:37992649
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ART4 mRNA	PMID:37992649
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ART4 mRNA	PMID:28818685
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ART4 mRNA	PMID:25510870
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ART4 mRNA	PMID:25510870
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of ART4 protein	PMID:20106945
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ART4 mRNA	PMID:20938992
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ART4 gene	PMID:25304211
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ART4 mRNA	PMID:40504410
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1315085	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ART4 mRNA	PMID:28960355
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306456	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ART4 mRNA	PMID:31881176
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1315085	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of ART4 mRNA	PMID:40618947
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ART4 mRNA	PMID:20106945
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306456	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ART4 mRNA	PMID:32109520
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315085	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ART4 mRNA	PMID:15328365
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1306456	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of ART4 mRNA	PMID:28374803
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of ART4 mRNA	PMID:39709020
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of ART4 mRNA	PMID:21198554
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306456	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ART4 mRNA	PMID:26033743
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ART4 mRNA	PMID:37992649
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:28939	N-acetyl-L-cysteine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000111	Acetylcysteine results in decreased expression of ART4 mRNA	PMID:16084531
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ART4 mRNA	PMID:40504410
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ART4 mRNA	PMID:26238291|PMID:32234424
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315085	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ART4 mRNA	PMID:22228805
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306456	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of ART4 mRNA	PMID:26033743
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of ART4 mRNA	PMID:35984750
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315085	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of ART4 mRNA	PMID:29264374
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306456	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ART4 mRNA	PMID:34492290
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1315085	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of ART4 mRNA	PMID:20813756
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ART4 mRNA	PMID:19710929
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ART4 mRNA	PMID:30903817
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306456	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ART4 mRNA	PMID:25181051
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ART4 mRNA	PMID:25510870
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ART4 mRNA	PMID:25510870
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C543008	bisphenol S results in decreased expression of ART4 mRNA	PMID:30616060
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315085	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ART4 mRNA	PMID:30951980
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1315085	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of ART4 mRNA	PMID:37019170
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1315085	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ART4 mRNA	PMID:32715474
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306456	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ART4 mRNA	PMID:21266533
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1315085	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ART4 mRNA	PMID:21266533
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1315085	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of ART4 mRNA	PMID:26377693
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of ART4 mRNA	PMID:32588087
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of ART4 mRNA	PMID:32588087
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ART4 mRNA	PMID:28302478
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of ART4 mRNA	PMID:32588087
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of ART4 mRNA	PMID:29154799
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ART4 mRNA	PMID:17183730
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306456	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of ART4 mRNA	PMID:41580965
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ART4 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1315085	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of ART4 mRNA	PMID:28973697
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of ART4 mRNA	PMID:37992649
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ART4 mRNA	PMID:38832940
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315085	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ART4 mRNA	PMID:17562736
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ART4 mRNA	PMID:21420995|PMID:29067470
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ART4 gene	PMID:25304211
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315085	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ART4 mRNA	PMID:40504410
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306456	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ART4 mRNA	PMID:29391264
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of ART4 mRNA	PMID:16084531
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of ART4 mRNA	PMID:18175754
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315085	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ART4 mRNA; Nanotubes, Carbon results in decreased expression of ART4 mRNA	PMID:25554681|PMID:25620056
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315085	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ART4 mRNA	PMID:25620056
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1315085	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of ART4 mRNA	PMID:26377693
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1315085	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of ART4 mRNA	PMID:23608068
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ART4 mRNA	PMID:17183730
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1315085	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of ART4 mRNA	PMID:19812364
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1315085	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of ART4 protein	PMID:36851058
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1315085	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of ART4 mRNA	PMID:36907384
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:75170	zaragozic acid A	decreases expression	ISO	RGD:1306456	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in decreased expression of ART4 mRNA	PMID:27225895
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:75170	zaragozic acid A	increases expression	ISO	RGD:1315085	E	RGD:6480464	20180220	CTD	MESH:C075117	squalestatin 1 results in increased expression of ART4 mRNA	PMID:27225895
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1306456	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of ART4 mRNA	PMID:26720608
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to ART4 gene]	PMID:28238834
1315084	ART4	ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1306456	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of ART4 mRNA	PMID:32109520
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of CLSTN1 mRNA	PMID:38218311
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1315088	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of CLSTN1 mRNA	PMID:33045310
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1315088	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CLSTN1 mRNA	PMID:20188158
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLSTN1 mRNA	PMID:20938992
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CLSTN1 mRNA	PMID:33167477
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CLSTN1 mRNA	PMID:30529165
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CLSTN1 mRNA	PMID:36331819
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1315088	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CLSTN1 mRNA	PMID:30319688
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1315088	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of CLSTN1 mRNA	PMID:30319688
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315088	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of CLSTN1 mRNA	PMID:39241906
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in decreased expression of CLSTN1 mRNA	PMID:16514628
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1306458	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of CLSTN1 mRNA	PMID:23829299
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLSTN1 mRNA	PMID:20938992
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of CLSTN1 mRNA	PMID:21179406
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLSTN1 mRNA	PMID:37992649
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLSTN1 mRNA	PMID:37992649
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of CLSTN1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLSTN1 mRNA]	PMID:20230807
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1315088	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLSTN1 mRNA	PMID:20230807
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of CLSTN1 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of CLSTN1 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLSTN1 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLSTN1 mRNA]	PMID:20230807
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of CLSTN1 mRNA	PMID:28818685
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of CLSTN1 intron	PMID:30157460
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLSTN1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of CLSTN1 mRNA	PMID:39836092
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of CLSTN1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLSTN1 mRNA]	PMID:20230807
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1315088	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of CLSTN1 mRNA	PMID:19770486
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of CLSTN1 intron	PMID:30157460
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CLSTN1 mRNA	PMID:34911549
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CLSTN1 mRNA	PMID:20938992
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLSTN1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CLSTN1 mRNA	PMID:39836092
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CLSTN1 mRNA	PMID:40504410
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of CLSTN1 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of CLSTN1 mRNA]	PMID:20230807
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306458	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of CLSTN1 mRNA	PMID:31881176
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of CLSTN1 mRNA	PMID:28903495
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of CLSTN1 mRNA	PMID:28903495
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1315088	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of CLSTN1 mRNA	PMID:40618947
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1306458	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in decreased methylation of CLSTN1 gene	PMID:28505145
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306458	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of CLSTN1 mRNA	PMID:33387578
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306458	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CLSTN1 mRNA	PMID:34747641
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in decreased expression of CLSTN1 mRNA	PMID:33512557
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLSTN1 mRNA	PMID:37992649
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of CLSTN1 mRNA	PMID:29432896
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of CLSTN1 mRNA	PMID:39719251
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1315088	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in increased expression of CLSTN1 mRNA	PMID:36209798
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLSTN1 mRNA; [sodium arsenite co-treated with lead acetate] results in decreased expression of CLSTN1 protein; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CLSTN1 mRNA	PMID:38072110|PMID:39836092
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CLSTN1 mRNA	PMID:40504410
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:29699	tunicamycin	decreases expression	ISO	RGD:1315088	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in decreased expression of CLSTN1 mRNA	PMID:17127020
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CLSTN1 promoter	PMID:27901495
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315088	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of CLSTN1 mRNA	PMID:22228805
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:30563	silicon dioxide	affects secretion	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog affects the secretion of CLSTN1 protein	PMID:25895662
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of CLSTN1 mRNA	PMID:22521957
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:31638	fulvestrant	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C070081	fulvestrant results in decreased expression of CLSTN1 mRNA	PMID:16514628
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:31767	lead diacetate	multiple interactions	EXP		E	RGD:6480464	20251007	CTD	MESH:C008261	[sodium arsenite co-treated with lead acetate] results in decreased expression of CLSTN1 protein	PMID:38072110
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306458	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of CLSTN1 mRNA	PMID:25729387
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315088	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CLSTN1 gene	PMID:35295148
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1315088	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CLSTN1 mRNA	PMID:18648102
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1315088	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of CLSTN1 mRNA	PMID:17426115
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306458	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of CLSTN1 mRNA	PMID:25181051
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306458	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of CLSTN1 mRNA	PMID:30816183|PMID:34947998
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306458	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in decreased methylation of CLSTN1 gene	PMID:28505145
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1315088	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of CLSTN1 mRNA	PMID:26682919
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1315088	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of CLSTN1 exon	PMID:33297965
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CLSTN1 mRNA	PMID:28628672
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1315088	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of CLSTN1 mRNA	PMID:31558096
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1315088	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of CLSTN1 mRNA	PMID:21266533
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CLSTN1 mRNA	PMID:28628672
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306458	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of CLSTN1 mRNA	PMID:32680482
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CLSTN1 mRNA	PMID:37042841
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLSTN1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of CLSTN1 mRNA	PMID:39836092
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of CLSTN1 mRNA	PMID:19320972
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1315088	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of CLSTN1 mRNA	PMID:18353800
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:38604	pyrimidifen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of CLSTN1 mRNA	PMID:33512557
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:39285	chloropicrin	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C100187	chloropicrin results in decreased expression of CLSTN1 mRNA	PMID:28476498
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CLSTN1 mRNA	PMID:36331819
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of CLSTN1 mRNA	PMID:23179753|PMID:27188386|PMID:29154799
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CLSTN1 gene	PMID:29154799
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306458	E	RGD:6480464	20240702	CTD	MESH:D000640	Amitrole results in decreased expression of CLSTN1 mRNA	PMID:38685447
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of CLSTN1 mRNA	PMID:25562108
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:40909	azoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in decreased expression of CLSTN1 mRNA	PMID:33512557
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CLSTN1 mRNA	PMID:28628672
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of CLSTN1 mRNA	PMID:37992649
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	CLSTN1 protein affects the susceptibility to Methotrexate	PMID:16217747
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:44616	afimoxifene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene results in decreased expression of CLSTN1 mRNA	PMID:16514628
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306458	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CLSTN1 mRNA	PMID:33387578
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of CLSTN1 mRNA	PMID:22230336
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of CLSTN1 protein	PMID:29553831
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLSTN1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CLSTN1 mRNA	PMID:39836092
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315088	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CLSTN1 mRNA	PMID:40504410
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306458	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of CLSTN1 mRNA	PMID:29391264
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1315088	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of CLSTN1 mRNA	PMID:35436446
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CLSTN1 mRNA	PMID:28628672
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of CLSTN1 mRNA	PMID:22521957
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315088	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of CLSTN1 mRNA	PMID:25554681
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CLSTN1 mRNA; [manganese chloride results in increased abundance of Manganese] which results in decreased expression of CLSTN1 mRNA	PMID:39836092
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306458	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of CLSTN1 mRNA	PMID:25729387
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:64090	tert-butyl hydroperoxide	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in decreased expression of CLSTN1 mRNA	PMID:15336504
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:67895	corosolic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of CLSTN1 mRNA	PMID:37939859
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315088	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of CLSTN1 mRNA	PMID:22206623
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CLSTN1 gene]	PMID:28238834
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1315088	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of CLSTN1 mRNA	PMID:31558096
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:83197	picoxystrobin	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in decreased expression of CLSTN1 mRNA	PMID:33512557
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1315088	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of CLSTN1 mRNA	PMID:39847705
1315087	CLSTN1	calsyntenin 1	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of CLSTN1 mRNA	PMID:16514628
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1315090	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CNTNAP4 mRNA	PMID:20188158
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of CNTNAP4 mRNA	PMID:23724009
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306459	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of CNTNAP4 gene	PMID:28931070|PMID:35440735
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CNTNAP4 mRNA	PMID:35811015
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1315090	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of CNTNAP4 mRNA	PMID:34319233
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of CNTNAP4 mRNA	PMID:16002434
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of CNTNAP4 mRNA	PMID:22100608
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:2564	aldrin	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D000452	Aldrin results in decreased expression of CNTNAP4 mRNA	PMID:38723972
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315090	E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of CNTNAP4 mRNA	PMID:26290441
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of CNTNAP4 mRNA	PMID:32763439
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306459	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CNTNAP4 mRNA	PMID:26033743
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1315090	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of CNTNAP4 mRNA	PMID:37682722
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CNTNAP4 mRNA	PMID:32234424
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of CNTNAP4 promoter	PMID:27901495
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306459	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of CNTNAP4 mRNA	PMID:26033743
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1306459	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of CNTNAP4 mRNA	PMID:32479839
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1315090	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of CNTNAP4 mRNA	PMID:18648102
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:32888	gamma-hexachlorocyclohexane	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D001556	Hexachlorocyclohexane results in decreased expression of CNTNAP4 mRNA	PMID:38723972
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306459	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of CNTNAP4 mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306459	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of CNTNAP4 mRNA	PMID:41034487
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306459	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of CNTNAP4 gene	PMID:28505145
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of CNTNAP4 mRNA	PMID:20106945
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of CNTNAP4 mRNA	PMID:38832940
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of CNTNAP4 mRNA	PMID:29067470
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306459	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of CNTNAP4 mRNA	PMID:33387578
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CNTNAP4 mRNA	PMID:35811015
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of CNTNAP4 mRNA	PMID:27188386
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1306459	E	RGD:6480464	20190219	CTD	MESH:C025589	ochratoxin A results in decreased expression of CNTNAP4 mRNA	PMID:30449730
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:81978	Tri-allate	decreases expression	EXP		E	RGD:6480464	20260707	CTD	MESH:D014214	Triallate results in decreased expression of CNTNAP4 mRNA	PMID:38723972
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of CNTNAP4 mRNA	PMID:32234424
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:83258	fenamidone	decreases expression	ISO	RGD:1315090	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in decreased expression of CNTNAP4 mRNA	PMID:27029645
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306459	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of CNTNAP4 mRNA	PMID:24780913
1315089	CNTNAP4	contactin associated protein family member 4	gene	CHEBI:88522	Monobutylphthalate	increases expression	ISO	RGD:1306459	E	RGD:6480464	20180515	CTD	MESH:C028577	monobutyl phthalate results in increased expression of CNTNAP4 mRNA	PMID:29162477
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of GPR63 mRNA	PMID:31614463
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of GPR63 mRNA	PMID:23649840
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315092	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GPR63 mRNA	PMID:37992649
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:17558	quercitrin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C012526	quercitrin results in increased expression of GPR63 mRNA	PMID:25193878
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315092	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GPR63 mRNA	PMID:37992649
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of GPR63 mRNA	PMID:23649840
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GPR63 gene	PMID:27153756
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of GPR63 mRNA	PMID:23649840
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315092	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of GPR63 mRNA	PMID:34911549
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GPR63 gene	PMID:25304211
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of GPR63 mRNA	PMID:26272509
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPR63 mRNA	PMID:27188386
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306460	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of GPR63 mRNA	PMID:32109520|PMID:33387578
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of GPR63 mRNA	PMID:33212167
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of GPR63 mRNA	PMID:23649840
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GPR63 mRNA	PMID:29803840
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315092	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GPR63 mRNA	PMID:37992649
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of GPR63 gene	PMID:28589171
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1315092	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of GPR63 mRNA	PMID:37682722
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GPR63 5' UTR; Benzo(a)pyrene affects the methylation of GPR63 promoter	PMID:27901495
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:29866	arsenite(3-)	decreases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased methylation of GPR63 promoter	PMID:23974009
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:30812	iron dichloride	increases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in increased expression of GPR63 mRNA	PMID:35984750
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GPR63 mRNA	PMID:19710929
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306460	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of GPR63 mRNA	PMID:25181051
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306460	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of GPR63 mRNA	PMID:30816183|PMID:32528016|PMID:41034487
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315092	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in increased expression of GPR63 mRNA	PMID:35598803
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1306460	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of GPR63 promoter	PMID:22457795
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1315092	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of GPR63 mRNA	PMID:40194260
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of GPR63 mRNA	PMID:31533062
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of GPR63 mRNA	PMID:28001369
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315092	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of GPR63 mRNA	PMID:37992649
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of GPR63 mRNA	PMID:38832940
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306460	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GPR63 mRNA	PMID:33387578
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of GPR63 gene	PMID:25304211
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306460	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of GPR63 mRNA	PMID:29097150
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of GPR63 mRNA	PMID:22714537
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPR63 mRNA	PMID:27188386
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPR63 mRNA	PMID:27188386
1315091	GPR63	G protein-coupled receptor 63	gene	CHEBI:9130	sevoflurane	increases methylation	ISO	RGD:1315092	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased methylation of GPR63 mRNA	PMID:35249202
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of USP1 mRNA	PMID:16249480|PMID:33167477
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of USP1 protein	PMID:28073184
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of USP1 mRNA	PMID:21179406
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:16243	quercetin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D011794	Quercetin results in decreased phosphorylation of USP1 protein	PMID:35688186
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315094	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of USP1 mRNA	PMID:39241906
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of USP1 mRNA	PMID:37042841
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of USP1 mRNA	PMID:21179406
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of USP1 mRNA	PMID:21592394
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of USP1 mRNA	PMID:21592394
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of USP1 protein	PMID:37730182
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of USP1 mRNA	PMID:21592394
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of USP1 mRNA	PMID:21592394
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306461	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of USP1 mRNA	PMID:33387578
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306461	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of USP1 mRNA	PMID:22061828
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315094	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of USP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of USP1 mRNA	PMID:28111341|PMID:37236586
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of USP1 mRNA	PMID:19549813
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1315094	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of USP1 mRNA	PMID:31919559
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315094	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of USP1 mRNA	PMID:22206623
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of USP1 protein	PMID:35688186
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of USP1 mRNA	PMID:19167446
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of USP1 mRNA	PMID:27392435
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306461	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of USP1 mRNA	PMID:34747641
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315094	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of USP1 mRNA	PMID:21570461
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315094	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of USP1 mRNA	PMID:17942748
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of USP1 mRNA	PMID:33212167
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1315094	E	RGD:6480464	20130910	CTD	MESH:D003300	Copper results in increased expression of USP1 mRNA	PMID:16629173
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:28794	coumarin	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in increased phosphorylation of USP1 protein	PMID:35688186
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of USP1 mRNA	PMID:25523186
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of USP1 mRNA	PMID:38568856
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in increased expression of USP1 mRNA; sodium arsenite results in increased expression of USP1 protein	PMID:30528433|PMID:39719251
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of USP1 mRNA	PMID:22316170
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315094	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of USP1 mRNA	PMID:22228805
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of USP1 mRNA	PMID:32234424
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315094	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of USP1 mRNA	PMID:22228805
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1315094	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in decreased expression of USP1 mRNA	PMID:33053406
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of USP1 mRNA	PMID:25523186
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1315094	E	RGD:6480464	20130910	CTD	MESH:D003300	Copper results in increased expression of USP1 mRNA	PMID:16629173
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of USP1 mRNA	PMID:20382639
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1306461	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of USP1 mRNA	PMID:25729387
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306461	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of USP1 mRNA	PMID:25729387
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315094	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of USP1 promoter	PMID:35295148
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306461	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of USP1 mRNA	PMID:34492290
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315094	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of USP1 mRNA	PMID:18301758|PMID:21318169
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1315094	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in increased expression of USP1 mRNA]	PMID:21318169
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of USP1 mRNA	PMID:29275510
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306461	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of USP1 mRNA	PMID:34947998
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315094	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of USP1 mRNA	PMID:33221593
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306461	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of USP1 mRNA	PMID:25181051|PMID:32145629
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of USP1 mRNA	PMID:25979313
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1306461	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of USP1 mRNA	PMID:24096037
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:34027	1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane	increases expression	ISO	RGD:1315094	E	RGD:6480464	20141111	CTD	MESH:C016340	o,p'-DDT results in increased expression of USP1 mRNA	PMID:24096037
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315094	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of USP1 mRNA	PMID:38685157
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306461	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of USP1 mRNA	PMID:21266533
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1315094	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of USP1 mRNA	PMID:17361019|PMID:21266533
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1315094	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of USP1 mRNA	PMID:34813904
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of USP1 mRNA	PMID:37042841
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:35033	triphenyl phosphate	affects expression	ISO	RGD:1306461	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate affects the expression of USP1 mRNA	PMID:30589522
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of USP1 mRNA	PMID:38174414
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315094	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of USP1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of USP1 mRNA	PMID:28111341|PMID:37236586
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of USP1 mRNA	PMID:28302478
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of USP1 mRNA	PMID:19167446
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of USP1 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of USP1 mRNA	PMID:19167446
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1306461	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of USP1 mRNA	PMID:22110744
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315094	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of USP1 mRNA	PMID:17963808
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306461	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of USP1 mRNA	PMID:41580965
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of USP1 mRNA	PMID:20106945|PMID:27989131
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1315094	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of USP1 mRNA	PMID:17555576
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:43572	kojic acid	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in decreased expression of USP1 mRNA	PMID:16595896
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of USP1 mRNA	PMID:23649840
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315094	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of USP1 mRNA	PMID:17562736
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306461	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of USP1 mRNA	PMID:29391264
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1315094	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of USP1 mRNA	PMID:17555576
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306461	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of USP1 mRNA	PMID:24096037
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1315094	E	RGD:6480464	20140311	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of USP1 mRNA	PMID:17942748|PMID:24096037
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315094	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of USP1 mRNA	PMID:17942748
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1315094	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of USP1 mRNA	PMID:21318169
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:5001	fenofibrate	multiple interactions	ISO	RGD:1315094	E	RGD:6480464	20120613	CTD	MESH:D011345	PPARA protein affects the reaction [Fenofibrate results in increased expression of USP1 mRNA]	PMID:21318169
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:63623	succimer	multiple interactions	EXP		E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of USP1 mRNA	PMID:26378955
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1315094	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP1 mRNA	PMID:21641980|PMID:26378955
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306461	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of USP1 mRNA	PMID:25729387
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1315094	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of USP1 mRNA	PMID:23650126
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315094	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of USP1 mRNA	PMID:22206623
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315094	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of USP1 mRNA	PMID:22206623
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of USP1 mRNA	PMID:37199045
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of USP1 protein	PMID:31285264
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of USP1 mRNA	PMID:30928695
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to USP1 gene]	PMID:28238834
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1315094	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in decreased expression of USP1 mRNA	PMID:23091169
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:8113	phlorizin	increases expression	ISO	RGD:1315094	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in increased expression of USP1 mRNA	PMID:22538082
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of USP1 mRNA	PMID:19167446
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1315094	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of USP1 mRNA	PMID:30294300
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of USP1 mRNA	PMID:21858171
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306461	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of USP1 mRNA	PMID:21346803
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of USP1 mRNA	PMID:17440010
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of USP1 mRNA	PMID:27188386
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306461	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of USP1 mRNA	PMID:21346803
1315093	USP1	ubiquitin specific peptidase 1	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1315094	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of USP1 mRNA	PMID:35537566
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1614914	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of HIRIP3 mRNA	PMID:33045310
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of HIRIP3 mRNA	PMID:22378314
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1614914	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HIRIP3 mRNA	PMID:39241906
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D004958	Estradiol results in increased expression of HIRIP3 mRNA	PMID:19167446
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1614914	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HIRIP3 mRNA	PMID:25510870
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HIRIP3 mRNA	PMID:37042841
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:17153	propanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in decreased expression of HIRIP3 mRNA	PMID:26079696
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of HIRIP3 mRNA	PMID:21592394
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in decreased expression of HIRIP3 mRNA	PMID:21592394
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1614914	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of HIRIP3 mRNA	PMID:34319233
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of HIRIP3 protein	PMID:37730182
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:17823	calcitriol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in decreased expression of HIRIP3 mRNA	PMID:21592394
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in decreased expression of HIRIP3 mRNA	PMID:21592394
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1614914	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HIRIP3 mRNA	PMID:37236586
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1614914	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HIRIP3 mRNA	PMID:25510870
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1614914	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HIRIP3 mRNA	PMID:25510870
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HIRIP3 protein	PMID:23301498
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of HIRIP3 gene	PMID:27153756
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of HIRIP3 mRNA	PMID:23649840
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1614914	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of HIRIP3 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of HIRIP3 mRNA	PMID:34911549
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1614914	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HIRIP3 mRNA	PMID:22206623
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HIRIP3 mRNA	PMID:39836092
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1614914	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HIRIP3 mRNA	PMID:40504410
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of HIRIP3 mRNA	PMID:19244175
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of HIRIP3 protein	PMID:35688186
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of HIRIP3 mRNA	PMID:19167446
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1614914	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of HIRIP3 mRNA	PMID:30912803
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HIRIP3 mRNA	PMID:22574217
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614914	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HIRIP3 mRNA	PMID:21570461
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306463	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HIRIP3 mRNA	PMID:21215274|PMID:34747641
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of HIRIP3 mRNA	PMID:28001369
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of HIRIP3 mRNA	PMID:33212167
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of HIRIP3 mRNA	PMID:30851411
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of HIRIP3 mRNA	PMID:32763439
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306463	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of HIRIP3 mRNA	PMID:28959563
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306463	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of HIRIP3 mRNA	PMID:30556269
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of HIRIP3 protein	PMID:35688186
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HIRIP3 mRNA	PMID:29432896
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of HIRIP3 mRNA	PMID:38568856
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of HIRIP3 mRNA	PMID:39719251
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HIRIP3 mRNA	PMID:39836092
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1614914	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HIRIP3 mRNA	PMID:40504410
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20190312	CTD	MESH:D014415	Tunicamycin results in increased expression of HIRIP3 mRNA	PMID:29453283
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1614914	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of HIRIP3 mRNA	PMID:22228805
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HIRIP3 promoter	PMID:27901495
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306463	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of HIRIP3 mRNA	PMID:30556269
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:31941	oxaliplatin	decreases expression	ISO	RGD:1306463	E	RGD:6480464	20161213	CTD	MESH:C030110	oxaliplatin results in decreased expression of HIRIP3 mRNA	PMID:25729387
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306463	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of HIRIP3 mRNA	PMID:25729387
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1614914	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HIRIP3 gene; titanium dioxide results in decreased methylation of HIRIP3 promoter alternative form	PMID:35295148
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306463	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of HIRIP3 mRNA	PMID:34492290
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:32687	piperonyl butoxide	increases expression	ISO	RGD:1306463	E	RGD:6480464	20121113	CTD	MESH:D010882	Piperonyl Butoxide results in increased expression of HIRIP3 mRNA	PMID:22484513
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of HIRIP3 mRNA	PMID:29275510
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306463	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of HIRIP3 mRNA	PMID:30816183|PMID:32528016
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1614914	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of HIRIP3 promoter	PMID:27312807
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306463	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of HIRIP3 mRNA	PMID:25181051
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HIRIP3 mRNA	PMID:28628672
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1614914	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HIRIP3 mRNA	PMID:25510870
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1614914	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of HIRIP3 mRNA	PMID:25510870
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1614914	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of HIRIP3 mRNA	PMID:40203079
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1614914	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of HIRIP3 mRNA	PMID:38685157
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1306463	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of HIRIP3 mRNA	PMID:21241498
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1614914	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of HIRIP3 mRNA	PMID:37019170
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1614914	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in increased expression of HIRIP3 mRNA	PMID:35093514
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306463	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of HIRIP3 mRNA	PMID:21266533
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1614914	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of HIRIP3 mRNA	PMID:17361019|PMID:21266533
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HIRIP3 mRNA	PMID:28628672
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of HIRIP3 mRNA	PMID:38174414
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1614914	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HIRIP3 mRNA	PMID:37236586
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of HIRIP3 mRNA	PMID:19244175
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of HIRIP3 mRNA	PMID:31533062
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of HIRIP3 mRNA	PMID:19167446
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HIRIP3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of HIRIP3 mRNA	PMID:19167446
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1614914	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of HIRIP3 mRNA	PMID:39529242
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1306463	E	RGD:6480464	20120717	CTD	MESH:C016104	sodium bichromate affects the expression of HIRIP3 mRNA	PMID:22110744
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of HIRIP3 mRNA	PMID:28001369
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1614914	E	RGD:6480464	20120814	CTD	MESH:D014635	Valproic Acid results in decreased expression of HIRIP3 mRNA	PMID:20546886
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of HIRIP3 gene	PMID:29154799
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of HIRIP3 mRNA	PMID:25562108
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HIRIP3 mRNA	PMID:28628672
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1614914	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HIRIP3 mRNA	PMID:17562736
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306463	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of HIRIP3 mRNA	PMID:33387578
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:46645	isobutanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:C040507	[[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HIRIP3 mRNA	PMID:29432896
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HIRIP3 mRNA	PMID:39836092
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1614914	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of HIRIP3 mRNA	PMID:40504410
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306463	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of HIRIP3 mRNA	PMID:29391264
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1306463	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of HIRIP3 mRNA	PMID:17557909
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of HIRIP3 mRNA	PMID:28628672
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306463	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of HIRIP3 mRNA	PMID:24136188
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1614914	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of HIRIP3 mRNA	PMID:19042947
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of HIRIP3 protein	PMID:23718831
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HIRIP3 protein	PMID:32959892
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306463	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of HIRIP3 mRNA	PMID:25729387
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:63634	valdecoxib	increases expression	ISO	RGD:1306463	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in increased expression of HIRIP3 mRNA	PMID:24136188
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1306463	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of HIRIP3 mRNA	PMID:30467583
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1614914	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HIRIP3 mRNA	PMID:22206623
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of HIRIP3 mRNA	PMID:30851411
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1614914	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital results in increased expression of HIRIP3 mRNA	PMID:23091169
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of HIRIP3 mRNA	PMID:19167446
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1614914	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of HIRIP3 mRNA	PMID:39847705
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of HIRIP3 mRNA	PMID:29301935
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:9513	thalidomide	decreases expression	ISO	RGD:1614914	E	RGD:6480464	20160119	CTD	MESH:D013792	Thalidomide results in decreased expression of HIRIP3 mRNA	PMID:26217789
1315096	HIRIP3	HIRA interacting protein 3	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1614914	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of HIRIP3 mRNA	PMID:35537566
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:10110	zidovudine	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D015215	Zidovudine results in increased expression of SLC30A9 mRNA	PMID:24292225
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1315098	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of SLC30A9 mRNA	PMID:33045310
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1315098	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of SLC30A9 mRNA	PMID:37995155
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1315098	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SLC30A9 mRNA	PMID:26251327
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315098	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC30A9 gene	PMID:20938992
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315098	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of SLC30A9 mRNA	PMID:39241906
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1315098	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of SLC30A9 mRNA	PMID:39298647
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20140610	CTD	MESH:D004958	Estradiol promotes the reaction [ESR1 protein binds to SLC30A9 protein]	PMID:23665804|PMID:29389661
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315098	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC30A9 gene	PMID:20938992
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1593180	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in decreased expression of SLC30A9 mRNA	PMID:22061828
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of SLC30A9 mRNA	PMID:19549813
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:27086	tributylstannane	increases expression	ISO	RGD:1593180	E	RGD:6480464	20191112	CTD	MESH:C011559	tributyltin results in increased expression of SLC30A9 mRNA	PMID:31129395
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1593180	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of SLC30A9 mRNA	PMID:31129395
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:27363	zinc atom	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	SLC30A9 protein results in increased transport of Zinc	PMID:18326752
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315098	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SLC30A9 gene	PMID:20938992
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1315098	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SLC30A9 mRNA	PMID:28960355
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SLC30A9 mRNA	PMID:23557933
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315098	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC30A9 mRNA	PMID:17942748
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315098	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SLC30A9 promoter]	PMID:19654925
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SLC30A9 mRNA	PMID:28001369
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of SLC30A9 mRNA	PMID:33212167
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLC30A9 mRNA	PMID:38568856
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to SLC30A9 mRNA]	PMID:32406909
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:30185	zinc(0)	increases transport	EXP		E	RGD:6480464	20120412	CTD	MESH:D015032	SLC30A9 protein results in increased transport of Zinc	PMID:18326752
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of SLC30A9 gene	PMID:31601247
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:31835	methylparaben	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C015358	methylparaben results in decreased expression of SLC30A9 mRNA	PMID:31745603
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1593180	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of SLC30A9 mRNA	PMID:25729387
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315098	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC30A9 promoter	PMID:35295148
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1315098	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of SLC30A9 promoter	PMID:27334623
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315098	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC30A9 mRNA	PMID:26063408
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of SLC30A9 protein	PMID:34186270
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315098	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of SLC30A9 mRNA	PMID:33221593
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1593180	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SLC30A9 mRNA	PMID:31129395
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to SLC30A9 protein modified form]; [bisphenol A co-treated with Fulvestrant] results in decreased methylation of SLC30A9 gene	PMID:28751236|PMID:31601247
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1593180	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of SLC30A9 mRNA	PMID:31129395
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of SLC30A9 protein	PMID:34186270
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[bisphenol S binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to SLC30A9 protein modified form]	PMID:28751236
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1315098	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of SLC30A9 mRNA	PMID:37019170
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1315098	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of SLC30A9 mRNA	PMID:34813904
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SLC30A9 mRNA	PMID:37042841
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015741	[Metribolone binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to SLC30A9 protein modified form]	PMID:28751236
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of SLC30A9 mRNA	PMID:28302478
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLC30A9 mRNA	PMID:25979313
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC30A9 mRNA	PMID:23179753
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC30A9 mRNA	PMID:25562108
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1315098	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of SLC30A9 mRNA	PMID:17555576
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of SLC30A9 mRNA	PMID:18175754
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1315098	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of SLC30A9 mRNA	PMID:17555576
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1315098	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SLC30A9 mRNA	PMID:17942748
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1593180	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SLC30A9 mRNA	PMID:30307764
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1593180	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of SLC30A9 mRNA	PMID:24136188
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1593180	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of SLC30A9 mRNA	PMID:25729387
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1593180	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of SLC30A9 mRNA	PMID:25729387
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1593180	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of SLC30A9 mRNA	PMID:30467583
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of SLC30A9 protein	PMID:34186270
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:72754	bisphenol AF	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	[bisphenol AF binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to SLC30A9 protein modified form]; bisphenol AF promotes the reaction [ESR1 protein binds to SLC30A9 protein]	PMID:28751236|PMID:29389661
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1315098	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of SLC30A9 mRNA	PMID:22206623
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1315098	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of SLC30A9 mRNA	PMID:39847705
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SLC30A9 mRNA	PMID:38568856
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of SLC30A9 mRNA	PMID:29301935
1315097	SLC30A9	solute carrier family 30 member 9	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1315098	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of SLC30A9 mRNA	PMID:35537566
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MST1R mRNA	PMID:38218311
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315100	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MST1R mRNA	PMID:33045310
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306465	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MST1R mRNA]	PMID:31150632
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of MST1R mRNA	PMID:26079696
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315100	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MST1R mRNA; Lipopolysaccharides results in increased expression of MST1R protein	PMID:20453108
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1315100	E	RGD:6480464	20161228	CTD	MESH:D008070	MST1R gene mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA]; MST1R gene mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; MST1R gene mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of SOD1 mRNA]; MST1R gene mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of SOD2 mRNA]; MST1R gene mutant form promotes the reaction [Lipopolysaccharides results in increased expression of PTGES mRNA]; TLR4 affects the reaction [Lipopolysaccharides results in increased expression of MST1R mRNA]	PMID:20453108
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:16856	glutathione	multiple interactions	ISO	RGD:1315100	E	RGD:6480464	20121009	CTD	MESH:D005978	MST1R protein affects the reaction [Acetaminophen results in decreased abundance of Glutathione]	PMID:22575169
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306465	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of MST1R mRNA	PMID:33387578
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MST1R intron	PMID:30157460
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MST1R mRNA	PMID:22100608
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306465	E	RGD:6480464	20180703	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MST1R mRNA	PMID:25378103
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:25549	nitrites	multiple interactions	ISO	RGD:1315100	E	RGD:6480464	20170303	CTD	MESH:D009573	MST1R protein affects the reaction [nickel sulfate results in increased abundance of Nitrites]	PMID:11751209
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315100	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MST1R mRNA	PMID:34911549
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306465	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of MST1R mRNA	PMID:30779732
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306465	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MST1R mRNA	PMID:31150632
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306465	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of MST1R mRNA]	PMID:31150632
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315100	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MST1R mRNA	PMID:22206623
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MST1R mRNA	PMID:40512198
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315100	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MST1R mRNA	PMID:40504410
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:27698	vanadium atom	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of MST1R mRNA	PMID:19000753
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1315100	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of MST1R mRNA	PMID:28960355
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306465	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MST1R mRNA	PMID:31881176
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MST1R mRNA	PMID:21296121
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1306465	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of MST1R mRNA	PMID:28374803
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1315100	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of MST1R mRNA	PMID:37682722
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MST1R mRNA	PMID:40512198
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315100	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MST1R mRNA	PMID:40504410
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MST1R exon; Benzo(a)pyrene affects the methylation of MST1R promoter	PMID:27901495
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1315100	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of MST1R promoter	PMID:27901495
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MST1R mRNA	PMID:32234424
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1315100	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of MST1R mRNA	PMID:19073995
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:30621	diarsenic trioxide	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	MST1R protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1306465	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of MST1R mRNA	PMID:32479839
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MST1R mRNA	PMID:19710929
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306465	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MST1R mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of MST1R gene	PMID:31601247
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in increased expression of MST1R mRNA	PMID:36232920
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315100	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of MST1R mRNA	PMID:32156529
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1315100	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MST1R promoter	PMID:27312807
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315100	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of MST1R mRNA	PMID:40203079
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of MST1R exon	PMID:30157460
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:35170	vanadium(0)	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in decreased expression of MST1R mRNA	PMID:19000753
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306465	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of MST1R mRNA	PMID:30723492
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MST1R mRNA	PMID:19376846
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of MST1R mRNA	PMID:24449571
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:3962	curcumin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin results in decreased expression of MST1R mRNA; Curcumin results in decreased expression of MST1R protein	PMID:18593918
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:3962	curcumin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003474	Curcumin inhibits the reaction [RELA protein binds to MST1R promoter]; Curcumin inhibits the reaction [RELA protein results in increased expression of MST1R mRNA]	PMID:18593918
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of MST1R mRNA	PMID:29154799
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of MST1R gene	PMID:29154799
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1315100	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of MST1R mRNA	PMID:28973697
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:44185	methotrexate	affects expression	ISO	RGD:1315100	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate affects the expression of MST1R mRNA	PMID:18502557
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of MST1R mRNA	PMID:38832940
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315100	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of MST1R mRNA	PMID:17562736
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:46195	paracetamol	affects response to substance	ISO	RGD:1315100	E	RGD:6480464	20121009	CTD	MESH:D000082	MST1R protein affects the susceptibility to Acetaminophen	PMID:22575169
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306465	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of MST1R mRNA	PMID:33387578
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1315100	E	RGD:6480464	20121009	CTD	MESH:D000082	[MST1R protein mutant form co-treated with Acetaminophen] results in increased expression of CX3CL1 mRNA; [MST1R protein mutant form co-treated with Acetaminophen] results in increased expression of CX3CR1 mRNA; [MST1R protein mutant form co-treated with Acetaminophen] results in increased expression of NOS2 protein; MST1R protein affects the reaction [Acetaminophen results in decreased abundance of Glutathione]; MST1R protein affects the reaction [Acetaminophen results in decreased expression of ADGRE1 protein]; MST1R protein affects the reaction [Acetaminophen results in increased expression of CCL2 mRNA]; MST1R protein affects the reaction [Acetaminophen results in increased expression of CCR2 mRNA]; MST1R protein affects the reaction [Acetaminophen results in increased expression of CXCL2 mRNA]; MST1R protein affects the reaction [Acetaminophen results in increased expression of HMOX1 mRNA]; MST1R protein affects the reaction [Acetaminophen results in increased expression of IL10 mRNA]; MST1R protein affects the reaction [Acetaminophen results in increased expression of IL12B mRNA]; MST1R protein affects the reaction [Acetaminophen results in increased expression of IL1B mRNA]; MST1R protein affects the reaction [Acetaminophen results in increased expression of TNF mRNA]; MST1R protein affects the reaction [Acetaminophen results in increased expression of TNFRSF1A protein]	PMID:22575169
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of MST1R mRNA	PMID:28056339
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in decreased expression of MST1R mRNA	PMID:40512198
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315100	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MST1R mRNA	PMID:40504410
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306465	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MST1R mRNA	PMID:29391264
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:4918	O-methyleugenol	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in increased expression of MST1R mRNA	PMID:32234424
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of MST1R mRNA	PMID:38568856
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:49900	arsenous acid	decreases response to substance	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	MST1R protein results in decreased susceptibility to Arsenic Trioxide	PMID:20707922
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315100	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of MST1R mRNA	PMID:25554681
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:51687	chrysene	increases expression	ISO	RGD:1315100	E	RGD:6480464	20160119	CTD	MESH:C031180	chrysene results in increased expression of MST1R mRNA	PMID:26377693
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:53001	nickel sulfate	affects response to substance	ISO	RGD:1315100	E	RGD:6480464	20120918	CTD	MESH:C029938	MST1R protein affects the susceptibility to nickel sulfate	PMID:11751209|PMID:16166746
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in decreased expression of MST1R mRNA	PMID:16780908
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C029938	nickel sulfate results in increased expression of MST1R mRNA	PMID:16780908
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:53001	nickel sulfate	multiple interactions	ISO	RGD:1315100	E	RGD:6480464	20120717	CTD	MESH:C029938	MST1R protein affects the reaction [nickel sulfate results in increased abundance of Nitrites]	PMID:11751209
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:64310	crizotinib	decreases activity	ISO	RGD:1315100	E	RGD:6480464	20170303	CTD	MESH:C551994	crizotinib results in decreased activity of MST1R protein	PMID:21812414
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of MST1R exon	PMID:30157460
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315100	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MST1R mRNA	PMID:22206623
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:7789	orphenadrine	affects expression	ISO	RGD:1306465	E	RGD:6480464	20140311	CTD	MESH:D009966	Orphenadrine affects the expression of MST1R mRNA	PMID:23665939
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:78782	pyrrolidine dithiocarbamate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:C020972	pyrrolidine dithiocarbamic acid results in decreased expression of MST1R mRNA	PMID:18593918
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:8064	phenformin	decreases expression	ISO	RGD:1306465	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of MST1R mRNA	PMID:31324951
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of MST1R mRNA	PMID:26079696
1315099	MST1R	macrophage stimulating 1 receptor	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1315100	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of MST1R mRNA	PMID:30953684
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:10022	deoxynivalenol	affects phosphorylation	ISO	RGD:1315104	E	RGD:6480464	20141111	CTD	MESH:C007262	deoxynivalenol affects the phosphorylation of PIK3CG protein	PMID:23811945
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D014212	Tretinoin results in increased expression of PIK3CG mRNA; Tretinoin results in increased expression of PIK3CG protein	PMID:15498508|PMID:16054129|PMID:19176369|PMID:33167477
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:15379	dioxygen	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of PIK3CG mRNA	PMID:24205000
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1306468	E	RGD:6480464	20240430	CTD	MESH:D010100	Oxygen deficiency results in increased expression of PIK3CG mRNA; Oxygen deficiency results in increased expression of PIK3CG protein	PMID:37923178
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20240430	CTD	MESH:D010100	kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of PIK3CG mRNA]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of PIK3CG protein]	PMID:37923178
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:15571	hydrazine	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20120412	CTD	MESH:C029424	hydrazine results in decreased expression of PIK3CG mRNA	PMID:15282401
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	ISO	RGD:1315104	E	RGD:6480464	20240903	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of PIK3CG protein	PMID:38174997
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:15756	hexadecanoic acid	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20240903	CTD	MESH:D019308	ADORA2B protein affects the reaction [Palmitic Acid results in decreased phosphorylation of PIK3CG protein]; ADORA2B protein inhibits the reaction [MYC protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of PIK3CG protein]]; ADORA2B protein promotes the reaction [Palmitic Acid results in decreased phosphorylation of PIK3CG protein]; MYC protein inhibits the reaction [Palmitic Acid results in decreased phosphorylation of PIK3CG protein]	PMID:38174997
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1306468	E	RGD:6480464	20201215	CTD	MESH:D001280	Atrazine results in decreased expression of PIK3CG mRNA	PMID:31187311
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:15939	glycyrrhizinic acid	decreases activity	ISO	RGD:1315104	E	RGD:6480464	20120412	CTD	MESH:D019695	Glycyrrhizic Acid results in decreased activity of PIK3CG protein	PMID:21644799
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315104	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of PIK3CG mRNA	PMID:30319688
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:16236	ethanol	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20190910	CTD	MESH:D000431	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of PIK3CG mRNA	PMID:30517762
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:16243	quercetin	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased activity of PIK3CG protein	PMID:16794257
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PIK3CG mRNA	PMID:39241906
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:16412	lipopolysaccharide	increases phosphorylation	ISO	RGD:1315104	E	RGD:38599186|PMID:20028656	20200914	RGD	MESH:D008070	lipopolysaccharide increases phosphorylation of Pik3cg protein in cardiac myocytes	
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306468	E	RGD:6480464	20250401	CTD	MESH:D004958	Estradiol results in increased expression of PIK3CG mRNA; Estradiol results in increased expression of PIK3CG protein	PMID:31212184
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PIK3CG mRNA	PMID:25510870
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of PIK3CG mRNA	PMID:23649840
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PIK3CG mRNA	PMID:37992649
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C016599	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of PIK3CG gene	PMID:33872906
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:17347	testosterone	increases expression	ISO	RGD:1315104	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in increased expression of PIK3CG mRNA	PMID:33848595
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:17573	glycyrrhetinate	decreases activity	ISO	RGD:1315104	E	RGD:6480464	20120412	CTD	MESH:C119129	18alpha-glycyrrhetinic acid results in decreased activity of PIK3CG protein	PMID:21644799
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PIK3CG mRNA	PMID:37992649
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of PIK3CG mRNA; Diethylhexyl Phthalate results in decreased expression of PIK3CG protein	PMID:33091774
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1306468	E	RGD:6480464	20250401	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of PIK3CG protein	PMID:31212184
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D004051	[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of PIK3CG gene	PMID:33872906
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20250401	CTD	MESH:D004051	[BMS 754807 co-treated with Diethylhexyl Phthalate] results in decreased expression of PIK3CG mRNA; [BMS 754807 co-treated with Diethylhexyl Phthalate] results in decreased phosphorylation of PIK3CG protein; [Sirolimus co-treated with Diethylhexyl Phthalate] results in decreased phosphorylation of PIK3CG protein; BMS 754807 inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PIK3CG protein]	PMID:31212184
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20250311	CTD	MESH:D004051	Dibutyl Phthalate promotes the reaction [Diethylhexyl Phthalate results in decreased expression of PIK3CG mRNA]; Dibutyl Phthalate promotes the reaction [Diethylhexyl Phthalate results in decreased expression of PIK3CG protein]	PMID:33091774
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:190294	calcium silicate	increases expression	ISO	RGD:1315104	E	RGD:6480464	20220405	CTD	MESH:C031293	calcium silicate results in increased expression of PIK3CG mRNA	PMID:29279043
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	ISO	RGD:1306468	E	RGD:6480464	20220906	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of PIK3CG mRNA	PMID:35103375
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20220906	CTD	MESH:D008769	corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PIK3CG mRNA]	PMID:35103375
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of PIK3CG mRNA	PMID:24376830
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PIK3CG mRNA	PMID:25510870
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PIK3CG mRNA	PMID:25510870
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:2422	acetohydrazide	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20120412	CTD	MESH:C014949	acetylhydrazine results in decreased expression of PIK3CG mRNA	PMID:15282401
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of PIK3CG gene	PMID:27153756
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1315104	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of PIK3CG mRNA	PMID:18955075
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of PIK3CG mRNA	PMID:41430723
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306468	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PIK3CG mRNA	PMID:30779732
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:27086	tributylstannane	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C011559	tributyltin results in increased expression of PIK3CG mRNA	PMID:26314263
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20190910	CTD	MESH:D002251	[Carbon Tetrachloride co-treated with Ethanol] results in increased expression of PIK3CG mRNA	PMID:30517762
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PIK3CG mRNA]	PMID:11007951
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PIK3CG mRNA	PMID:28960355
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:27881	resveratrol	decreases activity	EXP		E	RGD:6480464	20120412	CTD	MESH:C059514	resveratrol results in decreased activity of PIK3CG protein	PMID:17550345
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20231205	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased expression of PIK3CG mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PIK3CG protein	PMID:36652739
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	PIK3CG results in decreased susceptibility to Cisplatin	PMID:21652733
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PIK3CG mRNA	PMID:30912803
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of PIK3CG mRNA	PMID:25583101
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PIK3CG mRNA	PMID:11007951
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306468	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of PIK3CG mRNA	PMID:32109520|PMID:34747641
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PIK3CG mRNA]	PMID:11007951
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:28197	daidzein	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20260707	CTD	MESH:C004742	daidzein inhibits the reaction [bifenthrin results in decreased expression of PIK3CG mRNA]	PMID:39842227
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:28499	kaempferol	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20240430	CTD	MESH:C006552	kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of PIK3CG mRNA]; kaempferol inhibits the reaction [Oxygen deficiency results in increased expression of PIK3CG protein]	PMID:37923178
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PIK3CG mRNA	PMID:37992649
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:29014	cordycepin	affects binding	EXP		E	RGD:6480464	20240109	CTD	MESH:C058120	cordycepin binds to PIK3CG protein	PMID:33014856
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of PIK3CG gene	PMID:28589171
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of PIK3CG mRNA	PMID:24516582
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of PIK3CG mRNA	PMID:37682722
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of PIK3CG 5' UTR	PMID:27901495
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene metabolite results in increased expression of PIK3CG mRNA; Benzo(a)pyrene results in increased expression of PIK3CG mRNA	PMID:26314263|PMID:32234424
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of PIK3CG promoter	PMID:27901495
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of PIK3CG gene	PMID:25435355
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:29866	arsenite(3-)	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in decreased expression of PIK3CG mRNA	PMID:18191166
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1315104	E	RGD:6480464	20210504	CTD	MESH:C015001	arsenite results in increased expression of PIK3CG mRNA	PMID:33053406
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of PIK3CG mRNA	PMID:19073995
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1315104	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of PIK3CG mRNA	PMID:29341224
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of PIK3CG protein	PMID:34042274
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:30853	glycyrrhetinic acid	decreases activity	ISO	RGD:1315104	E	RGD:6480464	20120412	CTD	MESH:C119129	18alpha-glycyrrhetinic acid results in decreased activity of PIK3CG protein	PMID:21644799
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:3093	bifenthrin	decreases expression	ISO	RGD:1306468	E	RGD:6480464	20260707	CTD	MESH:C099952	bifenthrin results in decreased expression of PIK3CG mRNA	PMID:39842227
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:3093	bifenthrin	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20260707	CTD	MESH:C099952	daidzein inhibits the reaction [bifenthrin results in decreased expression of PIK3CG mRNA]	PMID:39842227
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20231205	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased expression of PIK3CG mRNA; [lead acetate results in increased abundance of Lead] which results in decreased expression of PIK3CG protein	PMID:36652739
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of PIK3CG mRNA	PMID:15020266|PMID:15498508
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:32181	tamibarotene	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tamibarotene results in increased expression of and results in increased activity of PIK3CG protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tamibarotene results in increased expression of PIK3CG mRNA]; tamibarotene results in increased expression of and results in increased activity of PIK3CG protein	PMID:15020266
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1315104	E	RGD:6480464	20140812	CTD	MESH:C009495	titanium dioxide affects the expression of PIK3CG mRNA	PMID:17656681
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315104	E	RGD:6480464	20131008	CTD	MESH:C009495	titanium dioxide results in increased expression of PIK3CG mRNA	PMID:23131501|PMID:35295148
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306468	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of PIK3CG mRNA	PMID:34492290
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306468	E	RGD:6480464	20250603	CTD	MESH:C006780	bisphenol A results in decreased expression of PIK3CG mRNA	PMID:39617347
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306468	E	RGD:6480464	20170516	CTD	MESH:C006780	bisphenol A results in increased expression of PIK3CG mRNA; bisphenol A results in increased expression of PIK3CG protein	PMID:27539358|PMID:30228064|PMID:35567931|PMID:41034487
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315104	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in increased expression of PIK3CG mRNA	PMID:38701888
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20181113	CTD	MESH:C006780	4-nonylphenol promotes the reaction [bisphenol A results in increased expression of PIK3CG mRNA]; bisphenol A promotes the reaction [4-nonylphenol results in increased expression of PIK3CG mRNA]	PMID:30228064
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PIK3CG mRNA	PMID:25510870
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of PIK3CG mRNA	PMID:25510870
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1315104	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of PIK3CG gene	PMID:31683443
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1306468	E	RGD:6480464	20160705	CTD	MESH:C543008	bisphenol S results in decreased expression of PIK3CG mRNA	PMID:26186136
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:34440	4-nonylphenol	increases expression	ISO	RGD:1306468	E	RGD:6480464	20181113	CTD	MESH:C041594	4-nonylphenol results in increased expression of PIK3CG mRNA	PMID:30228064
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:34440	4-nonylphenol	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20181113	CTD	MESH:C041594	4-nonylphenol promotes the reaction [bisphenol A results in increased expression of PIK3CG mRNA]; bisphenol A promotes the reaction [4-nonylphenol results in increased expression of PIK3CG mRNA]	PMID:30228064
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:34572	allethrin	decreases expression	ISO	RGD:1306468	E	RGD:6480464	20231003	CTD	MESH:D000487	Allethrins results in decreased expression of PIK3CG mRNA	PMID:35742842
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1306468	E	RGD:6480464	20170228	CTD	MESH:C008745	4,4'-bisphenol F results in decreased expression of PIK3CG mRNA	PMID:26186136
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:34608	captan	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in decreased expression of PIK3CG mRNA	PMID:31558096
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of PIK3CG mRNA	PMID:37019170
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20250311	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PIK3CG mRNA; Dibutyl Phthalate results in decreased expression of PIK3CG protein	PMID:33091774
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20250311	CTD	MESH:D003993	Dibutyl Phthalate promotes the reaction [Diethylhexyl Phthalate results in decreased expression of PIK3CG mRNA]; Dibutyl Phthalate promotes the reaction [Diethylhexyl Phthalate results in decreased expression of PIK3CG protein]	PMID:33091774
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:34757	fenitrothion	decreases expression	ISO	RGD:1306468	E	RGD:6480464	20260804	CTD	MESH:D005278	Fenitrothion results in decreased expression of PIK3CG mRNA	PMID:39277407
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PIK3CG mRNA	PMID:37042841
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1306468	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of PIK3CG mRNA	PMID:35163327
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306468	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PIK3CG mRNA	PMID:33453195
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C018021	cobaltous chloride results in increased expression of PIK3CG mRNA	PMID:26314263
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PIK3CG mRNA	PMID:40194260
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1315104	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PIK3CG mRNA	PMID:40194260
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:3884	corilagin	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20220906	CTD	MESH:C049096	corilagin inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of PIK3CG mRNA]	PMID:35103375
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of PIK3CG gene	PMID:29154799
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:4035	cyhalothrin	affects binding	EXP		E	RGD:6480464	20200804	CTD	MESH:C037304	cyhalothrin binds to PIK3CG protein	PMID:32278787
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PIK3CG mRNA	PMID:37992649
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:44616	afimoxifene	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	PIK3CG results in decreased susceptibility to afimoxifene	PMID:21233418
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of PIK3CG mRNA	PMID:38832940
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:46678	amosite asbestos	increases expression	ISO	RGD:1315104	E	RGD:6480464	20180116	CTD	MESH:D017639	Asbestos, Amosite results in increased expression of PIK3CG mRNA	PMID:29112861
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:49747	methylmercury(1+)	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C030957	methylmercury II results in increased expression of PIK3CG mRNA	PMID:26314263
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of PIK3CG protein	PMID:34042274
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:49976	zinc dichloride	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20130212	CTD	MESH:C016837	PIK3CG protein affects the reaction [zinc chloride results in increased activity of MAP3K1 protein]; PIK3CG protein affects the reaction [zinc chloride results in increased activity of MAPK8 protein]	PMID:11306679
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:50131	5-aza-2'-deoxycytidine	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine results in increased expression of PIK3CG mRNA	PMID:17785578
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315104	E	RGD:6480464	20180116	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of PIK3CG mRNA	PMID:29112861
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1315104	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of PIK3CG mRNA	PMID:40234311
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:51081	nitrates	increases expression	ISO	RGD:1306468	E	RGD:6480464	20200915	CTD	MESH:D009566	Nitrates results in increased expression of PIK3CG mRNA	PMID:30022042
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:52289	wortmannin	decreases activity	ISO	RGD:1315104	E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin results in decreased activity of PIK3CG protein	PMID:21644799
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:52289	wortmannin	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20180116	CTD	MESH:C009687	wortmannin promotes the reaction [GRK2 protein promotes the reaction [GRK2 protein binds to PIK3CG protein]]	PMID:28759639
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:52289	wortmannin	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20120412	CTD	MESH:C009687	wortmannin inhibits the reaction [Isoproterenol results in increased activity of PIK3CG protein]	PMID:15178407
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1315104	E	RGD:6480464	20210504	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of PIK3CG protein	PMID:33711354
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:53556	toluene 2,4-diisocyanate	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20210504	CTD	MESH:D014051	IC 87114 inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of PIK3CG protein]; N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of PIK3CG protein]	PMID:33711354
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1315104	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of PIK3CG mRNA	PMID:38701926
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:6413	letrozole	decreases expression	ISO	RGD:1306468	E	RGD:6480464	20210706	CTD	MESH:C067431	Letrozole results in decreased expression of PIK3CG mRNA	PMID:33491863
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:6413	letrozole	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20210706	CTD	MESH:C067431	ADM protein inhibits the reaction [Letrozole results in decreased expression of PIK3CG mRNA]	PMID:33491863
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of PIK3CG mRNA	PMID:36851058
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:64317	isoprenaline	increases activity	ISO	RGD:1315104	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased activity of PIK3CG protein	PMID:15178407
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:64317	isoprenaline	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20120515	CTD	MESH:D007545	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Isoproterenol results in increased activity of PIK3CG protein]; wortmannin inhibits the reaction [Isoproterenol results in increased activity of PIK3CG protein]	PMID:15178407
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1306468	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of PIK3CG mRNA	PMID:35283115
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:65329	LY294002	decreases activity	EXP		E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of PIK3CG protein	PMID:16794257
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:65329	LY294002	decreases activity	ISO	RGD:1315104	E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased activity of PIK3CG protein	PMID:16179367
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:65329	LY294002	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20210706	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of PIK3CG mRNA	PMID:31522336
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:65329	LY294002	multiple interactions	EXP		E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tamibarotene results in increased expression of and results in increased activity of PIK3CG protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [tamibarotene results in increased expression of PIK3CG mRNA]	PMID:15020266
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20120807	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Isoproterenol results in increased activity of PIK3CG protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [TGFB1 protein results in decreased expression of PIK3CG mRNA]	PMID:15178407|PMID:31522336
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:66331	xanthohumol	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20140211	CTD	MESH:C104536	xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of PIK3CG mRNA]	PMID:23994090
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:6801	metformin	decreases expression	EXP		E	RGD:6480464	20201006	CTD	MESH:D008687	Metformin results in decreased expression of PIK3CG mRNA	PMID:32589349
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:6801	metformin	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:D008687	[Metformin co-treated with Pioglitazone] results in decreased expression of PIK3CG mRNA	PMID:32589349
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315104	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of PIK3CG mRNA	PMID:22206623
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:7719	ochratoxin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C025589	ochratoxin A metabolite results in increased expression of PIK3CG mRNA; ochratoxin A results in increased expression of PIK3CG mRNA	PMID:26314263
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:79516	Nonylphenol	decreases expression	ISO	RGD:1306468	E	RGD:6480464	20170516	CTD	MESH:C025256	nonylphenol results in decreased expression of PIK3CG mRNA	PMID:27832966
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:79516	Nonylphenol	increases expression	ISO	RGD:1306468	E	RGD:6480464	20170516	CTD	MESH:C025256	nonylphenol results in increased expression of PIK3CG mRNA	PMID:27832966
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PIK3CG gene]	PMID:28238834
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:81543	Tributyltin oxide	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in increased expression of PIK3CG mRNA	PMID:26314263
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:82019	folpet	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in decreased expression of PIK3CG mRNA	PMID:31558096
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:8228	pioglitazone	multiple interactions	EXP		E	RGD:6480464	20201006	CTD	MESH:C060836	[Metformin co-treated with Pioglitazone] results in decreased expression of PIK3CG mRNA	PMID:32589349
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:82701	idelalisib	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20210706	CTD	MESH:C552946	idelalisib results in decreased expression of PIK3CG mRNA	PMID:31522336
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:88339	BMS-754807	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20250401	CTD	MESH:C545990	[BMS 754807 co-treated with Diethylhexyl Phthalate] results in decreased expression of PIK3CG mRNA; [BMS 754807 co-treated with Diethylhexyl Phthalate] results in decreased phosphorylation of PIK3CG protein; BMS 754807 inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PIK3CG protein]	PMID:31212184
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:90686	IC-87114	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20210504	CTD	MESH:C477872	IC 87114 inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of PIK3CG protein]	PMID:33711354
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:9168	sirolimus	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20210706	CTD	MESH:D020123	Sirolimus results in decreased expression of PIK3CG mRNA	PMID:31522336
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1306468	E	RGD:6480464	20250401	CTD	MESH:D020123	[Sirolimus co-treated with Diethylhexyl Phthalate] results in decreased phosphorylation of PIK3CG protein	PMID:31212184
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1315104	E	RGD:6480464	20210706	CTD	MESH:D020123	Sirolimus inhibits the reaction [TGFB1 protein results in decreased expression of PIK3CG mRNA]	PMID:31522336
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of PIK3CG mRNA	PMID:29301935
1315103	PIK3CG	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma	gene	CHEBI:9763	trovafloxacin	decreases expression	ISO	RGD:1315104	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in decreased expression of PIK3CG mRNA	PMID:35537566
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306470	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of SLC22A14 gene	PMID:27618143
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLC22A14 mRNA	PMID:41430723
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1614018	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SLC22A14 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SLC22A14 mRNA	PMID:34911549
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:2682	amphotericin B	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D000666	Amphotericin B analog results in increased expression of SLC22A14 mRNA	PMID:28534445
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:27698	vanadium atom	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of SLC22A14 mRNA	PMID:19000753
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of SLC22A14 promoter	PMID:22847954
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:27958	cocaine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in decreased expression of SLC22A14 mRNA	PMID:18000554
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1614018	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC22A14 mRNA	PMID:21570461
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1614018	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLC22A14 mRNA	PMID:19933214
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of SLC22A14 mRNA	PMID:33212167
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1614018	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC22A14 mRNA	PMID:22228805
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:31767	lead diacetate	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C008261	lead acetate results in increased expression of SLC22A14 mRNA	PMID:37939567
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306470	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC22A14 mRNA	PMID:25181051
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:35170	vanadium(0)	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased expression of SLC22A14 mRNA	PMID:19000753
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:36386	dichloroacetic acid	increases expression	ISO	RGD:1614018	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in increased expression of SLC22A14 mRNA	PMID:28962523
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of SLC22A14 promoter	PMID:22847954
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of SLC22A14 promoter	PMID:22847954
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:4031	cyclosporin A	increases methylation	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased methylation of SLC22A14 promoter	PMID:27989131
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC22A14 mRNA	PMID:22230336
1315106	SLC22A14	solute carrier family 22 member 14	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1614018	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of SLC22A14 mRNA	PMID:31388691
1315107	IL19	interleukin 19	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of IL19 mRNA	PMID:34925699
1315107	IL19	interleukin 19	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	Triclosan inhibits the reaction [Lipopolysaccharides results in increased expression of IL19 mRNA]	PMID:20507366
1315107	IL19	interleukin 19	gene	CHEBI:164200	triclosan	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014260	Triclosan inhibits the reaction [Lipopolysaccharides results in increased expression of IL19 mRNA]	PMID:20507366
1315107	IL19	interleukin 19	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1583546	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of IL19 mRNA	PMID:33387578
1315107	IL19	interleukin 19	gene	CHEBI:16907	4-nitroquinoline N-oxide	increases expression	ISO	RGD:1315108	E	RGD:6480464	20121009	CTD	MESH:D015112	4-Nitroquinoline-1-oxide results in increased expression of IL19 mRNA	PMID:22561872
1315107	IL19	interleukin 19	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1583546	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of IL19 mRNA	PMID:33387578
1315107	IL19	interleukin 19	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL19 mRNA	PMID:35301059
1315107	IL19	interleukin 19	gene	CHEBI:232612	Azoxymethane	multiple interactions	ISO	RGD:1315108	E	RGD:6480464	20241203	CTD	MESH:D001397	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL19 mRNA	PMID:29950665
1315107	IL19	interleukin 19	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1315108	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol inhibits the reaction [imiquimod results in increased expression of IL19 mRNA]	PMID:25965695
1315107	IL19	interleukin 19	gene	CHEBI:27899	cisplatin	increases secretion	EXP		E	RGD:6480464	20160119	CTD	MESH:D002945	Cisplatin results in increased secretion of IL19 protein	PMID:24714768
1315107	IL19	interleukin 19	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IL19 mRNA	PMID:25583101
1315107	IL19	interleukin 19	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1583546	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IL19 mRNA	PMID:33387578
1315107	IL19	interleukin 19	gene	CHEBI:29678	sodium arsenite	affects expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C017947	sodium arsenite affects the expression of IL19 mRNA	PMID:39900124
1315107	IL19	interleukin 19	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of IL19 mRNA	PMID:39719251
1315107	IL19	interleukin 19	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1315108	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of IL19 mRNA	PMID:37682722
1315107	IL19	interleukin 19	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IL19 promoter	PMID:27901495
1315107	IL19	interleukin 19	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of IL19 exon	PMID:27901495
1315107	IL19	interleukin 19	gene	CHEBI:30621	diarsenic trioxide	decreases expression	ISO	RGD:1315108	E	RGD:6480464	20231031	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of IL19 protein	PMID:37166470
1315107	IL19	interleukin 19	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of IL19 mRNA	PMID:20458559
1315107	IL19	interleukin 19	gene	CHEBI:31175	adefovir pivoxil	increases secretion	EXP		E	RGD:6480464	20160119	CTD	MESH:C106812	adefovir dipivoxil results in increased secretion of IL19 protein	PMID:24714768
1315107	IL19	interleukin 19	gene	CHEBI:32234	titanium dioxide	multiple interactions	ISO	RGD:1315108	E	RGD:6480464	20190702	CTD	MESH:C009495	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL19 mRNA	PMID:29950665
1315107	IL19	interleukin 19	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C006780	bisphenol A results in decreased expression of IL19 mRNA	PMID:36126549
1315107	IL19	interleukin 19	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C006780	bisphenol A results in increased expression of IL19 mRNA; bisphenol A results in increased expression of IL19 protein	PMID:31715268
1315107	IL19	interleukin 19	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1583546	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of IL19 mRNA	PMID:25181051
1315107	IL19	interleukin 19	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20231205	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of IL19 mRNA	PMID:36126549
1315107	IL19	interleukin 19	gene	CHEBI:34283	oxybenzone	increases expression	ISO	RGD:1583546	E	RGD:6480464	20190219	CTD	MESH:C005290	oxybenzone results in increased expression of IL19 mRNA	PMID:30316929
1315107	IL19	interleukin 19	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1315108	E	RGD:6480464	20190702	CTD	MESH:D016264	[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of IL19 mRNA	PMID:29950665
1315107	IL19	interleukin 19	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	increases expression	ISO	RGD:1315108	E	RGD:6480464	20120918	CTD	MESH:D004137	Dinitrochlorobenzene results in increased expression of IL19 mRNA	PMID:19647056
1315107	IL19	interleukin 19	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1315108	E	RGD:6480464	20130416	CTD	MESH:D010269	Paraquat results in increased expression of IL19 mRNA	PMID:21688324
1315107	IL19	interleukin 19	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1315108	E	RGD:6480464	20130416	CTD	MESH:D010269	APOD protein affects the reaction [Paraquat results in increased expression of IL19 mRNA]	PMID:21688324
1315107	IL19	interleukin 19	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL19 mRNA	PMID:35301059
1315107	IL19	interleukin 19	gene	CHEBI:36704	imiquimod	increases expression	ISO	RGD:1315108	E	RGD:6480464	20160822	CTD	MESH:C056493	imiquimod results in increased expression of IL19 mRNA	PMID:25965695
1315107	IL19	interleukin 19	gene	CHEBI:36704	imiquimod	multiple interactions	ISO	RGD:1315108	E	RGD:6480464	20160822	CTD	MESH:C056493	resveratrol inhibits the reaction [imiquimod results in increased expression of IL19 mRNA]	PMID:25965695
1315107	IL19	interleukin 19	gene	CHEBI:3696	cidofovir anhydrous	increases secretion	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in increased secretion of IL19 protein	PMID:24714768
1315107	IL19	interleukin 19	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1315108	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of IL19 mRNA	PMID:40194260
1315107	IL19	interleukin 19	gene	CHEBI:40279	allopurinol	increases expression	ISO	RGD:1583546	E	RGD:6480464	20241203	CTD	MESH:D000493	Allopurinol results in increased expression of IL19 mRNA	PMID:37876353
1315107	IL19	interleukin 19	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1583546	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of IL19 mRNA	PMID:33387578
1315107	IL19	interleukin 19	gene	CHEBI:46557	zoledronic acid	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased expression of IL19 mRNA	PMID:24714768
1315107	IL19	interleukin 19	gene	CHEBI:46557	zoledronic acid	increases secretion	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in increased secretion of IL19 protein	PMID:24714768
1315107	IL19	interleukin 19	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of IL19 mRNA	PMID:24160326
1315107	IL19	interleukin 19	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of IL19 mRNA	PMID:24160326
1315107	IL19	interleukin 19	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1583546	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of IL19 mRNA	PMID:29391264
1315107	IL19	interleukin 19	gene	CHEBI:49900	arsenous acid	decreases expression	ISO	RGD:1315108	E	RGD:6480464	20231031	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of IL19 protein	PMID:37166470
1315107	IL19	interleukin 19	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of IL19 mRNA	PMID:20458559
1315107	IL19	interleukin 19	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1315108	E	RGD:6480464	20120918	CTD	MESH:D010081	Oxazolone results in increased expression of IL19 mRNA	PMID:19647056
1315107	IL19	interleukin 19	gene	CHEBI:53556	toluene 2,4-diisocyanate	increases expression	ISO	RGD:1315108	E	RGD:6480464	20120918	CTD	MESH:D014051	Toluene 2,4-Diisocyanate results in increased expression of IL19 mRNA	PMID:19647056
1315107	IL19	interleukin 19	gene	CHEBI:5864	ifosfamide	increases secretion	EXP		E	RGD:6480464	20160119	CTD	MESH:D007069	Ifosfamide results in increased secretion of IL19 protein	PMID:24714768
1315107	IL19	interleukin 19	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1315108	E	RGD:6480464	20180220	CTD	MESH:C581157	[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of IL19 mRNA	PMID:27935865
1315107	IL19	interleukin 19	gene	CHEBI:75253	phenylarsine oxide	increases expression	ISO	RGD:1315108	E	RGD:6480464	20251007	CTD	MESH:C029341	oxophenylarsine results in increased expression of IL19 mRNA	PMID:37914412
1315107	IL19	interleukin 19	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1583546	E	RGD:6480464	20230404	CTD	MESH:C025589	ochratoxin A results in increased expression of IL19 mRNA	PMID:35843423
1315107	IL19	interleukin 19	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to IL19 gene]	PMID:28238834
1315107	IL19	interleukin 19	gene	CHEBI:80770	Brevetoxin B	increases expression	EXP		E	RGD:6480464	20170228	CTD	MESH:C043466	brevetoxin 2 results in increased expression of IL19 mRNA	PMID:20498034
1315110	MTX2	metaxin 2	gene	CHEBI:15379	dioxygen	increases expression	ISO	RGD:1315111	E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in increased expression of MTX2 protein	PMID:25937538
1315110	MTX2	metaxin 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315111	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of MTX2 mRNA	PMID:30319688
1315110	MTX2	metaxin 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315111	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MTX2 mRNA	PMID:39241906
1315110	MTX2	metaxin 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of MTX2 mRNA	PMID:37042841
1315110	MTX2	metaxin 2	gene	CHEBI:16716	benzene	multiple interactions	ISO	RGD:1315111	E	RGD:6480464	20120412	CTD	MESH:D001554	TRP53 protein promotes the reaction [Benzene results in decreased expression of MTX2]	PMID:15935813
1315110	MTX2	metaxin 2	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of MTX2 mRNA	PMID:21179406
1315110	MTX2	metaxin 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315111	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of MTX2 mRNA	PMID:34319233
1315110	MTX2	metaxin 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315111	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MTX2 mRNA	PMID:37236586
1315110	MTX2	metaxin 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of MTX2 mRNA	PMID:19549813
1315110	MTX2	metaxin 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315111	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTX2 mRNA	PMID:22206623
1315110	MTX2	metaxin 2	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1315111	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of MTX2 mRNA	PMID:30912803
1315110	MTX2	metaxin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315111	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MTX2 mRNA	PMID:21570461
1315110	MTX2	metaxin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315111	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MTX2 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to MTX2 promoter]	PMID:17942748|PMID:19654925
1315110	MTX2	metaxin 2	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of MTX2 protein	PMID:39603559
1315110	MTX2	metaxin 2	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1315111	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of MTX2 mRNA	PMID:26873546
1315110	MTX2	metaxin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1315111	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of MTX2 mRNA	PMID:36209798
1315110	MTX2	metaxin 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of MTX2 protein	PMID:38228842
1315110	MTX2	metaxin 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1315111	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene promotes the reaction [AHR protein binds to MTX2 promoter]	PMID:19654925
1315110	MTX2	metaxin 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MTX2 mRNA]	PMID:32406909
1315110	MTX2	metaxin 2	gene	CHEBI:30145	lithium atom	increases expression	ISO	RGD:1315111	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in increased expression of MTX2 protein	PMID:40770094
1315110	MTX2	metaxin 2	gene	CHEBI:30146	lithium hydride	increases expression	ISO	RGD:1315111	E	RGD:6480464	20250902	CTD	MESH:D008094	Lithium deficiency results in increased expression of MTX2 protein	PMID:40770094
1315110	MTX2	metaxin 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MTX2 mRNA	PMID:19150397
1315110	MTX2	metaxin 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of MTX2 gene	PMID:31601247
1315110	MTX2	metaxin 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306473	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MTX2 mRNA	PMID:25729387
1315110	MTX2	metaxin 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306473	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MTX2 mRNA	PMID:30047161
1315110	MTX2	metaxin 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315111	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MTX2 gene	PMID:35295148
1315110	MTX2	metaxin 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315111	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of MTX2 mRNA	PMID:23811191
1315110	MTX2	metaxin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306473	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MTX2 mRNA	PMID:34947998
1315110	MTX2	metaxin 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306473	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MTX2 mRNA	PMID:25181051
1315110	MTX2	metaxin 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315111	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MTX2 mRNA	PMID:39298647
1315110	MTX2	metaxin 2	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C008745	[bisphenol F co-treated with Fulvestrant] results in decreased methylation of MTX2 gene	PMID:31601247
1315110	MTX2	metaxin 2	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1315111	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of MTX2 mRNA	PMID:34813904
1315110	MTX2	metaxin 2	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306473	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MTX2 mRNA	PMID:35163327
1315110	MTX2	metaxin 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MTX2 mRNA	PMID:38568856
1315110	MTX2	metaxin 2	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1306473	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of MTX2 promoter	PMID:22457795
1315110	MTX2	metaxin 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315111	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MTX2 mRNA	PMID:37236586
1315110	MTX2	metaxin 2	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306473	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MTX2 mRNA	PMID:35163327
1315110	MTX2	metaxin 2	gene	CHEBI:35861	dibenzo[a,l]pyrene	decreases expression	ISO	RGD:1315111	E	RGD:6480464	20150714	CTD	MESH:C041517	dibenzo(a,l)pyrene results in decreased expression of MTX2 mRNA	PMID:25908611
1315110	MTX2	metaxin 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of MTX2 mRNA	PMID:28302478
1315110	MTX2	metaxin 2	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of MTX2 gene	PMID:29154799
1315110	MTX2	metaxin 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of MTX2 mRNA	PMID:29154799
1315110	MTX2	metaxin 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306473	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MTX2 mRNA	PMID:30047161
1315110	MTX2	metaxin 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of MTX2 mRNA	PMID:25704631
1315110	MTX2	metaxin 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MTX2 mRNA	PMID:22079256
1315110	MTX2	metaxin 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315111	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MTX2 mRNA	PMID:17942748
1315110	MTX2	metaxin 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306473	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MTX2 mRNA	PMID:30047161
1315110	MTX2	metaxin 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MTX2 protein	PMID:32959892
1315110	MTX2	metaxin 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306473	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MTX2 mRNA	PMID:25729387
1315110	MTX2	metaxin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315111	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of MTX2 mRNA	PMID:22206623
1315110	MTX2	metaxin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315111	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MTX2 mRNA	PMID:22206623
1315110	MTX2	metaxin 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MTX2 mRNA	PMID:22079256
1315110	MTX2	metaxin 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MTX2 mRNA	PMID:22079256
1315110	MTX2	metaxin 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MTX2 gene]	PMID:28238834
1315110	MTX2	metaxin 2	gene	CHEBI:8107	phenytoin	increases expression	ISO	RGD:1306473	E	RGD:6480464	20120515	CTD	MESH:D010672	Phenytoin results in increased expression of MTX2 mRNA	PMID:20345932
1315110	MTX2	metaxin 2	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1306473	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of MTX2 protein	PMID:28903499
1315110	MTX2	metaxin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306473	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of MTX2 mRNA	PMID:30047161
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1558381	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of ZNHIT3 mRNA	PMID:33045310
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1558381	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ZNHIT3 mRNA	PMID:36331819
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1558381	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ZNHIT3 mRNA	PMID:30319688
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1558381	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of ZNHIT3 mRNA	PMID:39241906
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20180703	CTD	MESH:D004958	Estradiol promotes the reaction [ESR1 protein binds to ZNHIT3 protein]	PMID:29389661|PMID:32088792
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNHIT3 mRNA	PMID:37042841
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1598226	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ZNHIT3 mRNA	PMID:26577399
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of ZNHIT3 protein	PMID:37730182
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZNHIT3 mRNA	PMID:35301059
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZNHIT3 mRNA	PMID:19549813
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZNHIT3 mRNA	PMID:23649840
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1558381	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ZNHIT3 mRNA	PMID:31919559
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1598226	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ZNHIT3 mRNA	PMID:31150632
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNHIT3 gene	PMID:25304211
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1558381	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of ZNHIT3 mRNA	PMID:28960355
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:27998	tungsten	increases expression	ISO	RGD:1558381	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in increased expression of ZNHIT3 mRNA	PMID:30912803
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1558381	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZNHIT3 mRNA	PMID:21570461
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1598226	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZNHIT3 mRNA	PMID:33387578
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1558381	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of ZNHIT3 mRNA	PMID:27862939
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ZNHIT3 promoter	PMID:27901495
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1558381	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ZNHIT3 mRNA	PMID:19770486|PMID:22228805
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1558381	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZNHIT3 gene	PMID:35295148
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1598226	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of ZNHIT3 mRNA	PMID:23411599
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1558381	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ZNHIT3 mRNA	PMID:18301758
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1558381	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ZNHIT3 mRNA	PMID:28472532
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1558381	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of ZNHIT3 mRNA	PMID:32156529
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1598226	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ZNHIT3 mRNA	PMID:25181051
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to ZNHIT3 protein modified form]	PMID:28751236
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ZNHIT3 mRNA	PMID:25979313
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNHIT3 mRNA	PMID:28628672
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNHIT3 mRNA	PMID:28628672
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNHIT3 mRNA	PMID:37042841
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ZNHIT3 mRNA	PMID:38568856
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZNHIT3 mRNA	PMID:35301059
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1558381	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ZNHIT3 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ZNHIT3 mRNA]	PMID:17585979
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015741	[Metribolone binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to ZNHIT3 protein modified form]	PMID:28751236
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ZNHIT3 mRNA	PMID:28302478
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1558381	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ZNHIT3 mRNA	PMID:36331819
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZNHIT3 mRNA	PMID:25979313
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNHIT3 mRNA	PMID:28628672
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1558381	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ZNHIT3 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ZNHIT3 mRNA]	PMID:17585979
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of ZNHIT3 gene	PMID:25304211
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D018038	Sodium Selenite results in increased expression of ZNHIT3 mRNA	PMID:18175754
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNHIT3 mRNA	PMID:28628672
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1558381	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of ZNHIT3 mRNA	PMID:25554681
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1598226	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ZNHIT3 mRNA	PMID:24136188
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1598226	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ZNHIT3 mRNA	PMID:24136188
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1558381	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ZNHIT3 mRNA	PMID:19042947
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1558381	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of ZNHIT3 mRNA	PMID:23650126
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:72754	bisphenol AF	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	[bisphenol AF binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to ZNHIT3 protein modified form]	PMID:28751236
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1598226	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of ZNHIT3 mRNA	PMID:24136188
1315114	ZNHIT3	zinc finger HIT-type containing 3	gene	CHEBI:9753	troglitazone	increases expression	ISO	RGD:1558381	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in increased expression of ZNHIT3 mRNA	PMID:28973697
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:10106	zearalenone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015025	Zearalenone results in decreased expression of RAB20 mRNA	PMID:19371625
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1593487	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of RAB20 mRNA	PMID:21551480
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RAB20 mRNA	PMID:26272509
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA	PMID:27188386
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of RAB20 protein	PMID:36641056
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RAB20 mRNA	PMID:33167477
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D010100	Oxygen deficiency results in increased expression of RAB20 mRNA	PMID:24236059
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1315117	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of RAB20 mRNA	PMID:30529165
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RAB20 mRNA	PMID:21632981
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of RAB20 mRNA	PMID:29581250
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315117	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RAB20 mRNA	PMID:39241906
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1315117	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RAB20 mRNA	PMID:39298647
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of RAB20 mRNA	PMID:30165855
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1593487	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of RAB20 mRNA	PMID:33387578
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RAB20 mRNA	PMID:37042841
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of RAB20 mRNA	PMID:23649840
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1593487	E	RGD:6480464	20120412	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of RAB20 mRNA	PMID:16809437
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RAB20 mRNA	PMID:31163220
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315117	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RAB20 mRNA	PMID:34319233
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1593487	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of RAB20 mRNA	PMID:33387578
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:181914	Aflatoxin B2 alpha	decreases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in decreased methylation of RAB20 exon	PMID:30157460
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315117	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RAB20 mRNA	PMID:36331819
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of RAB20 mRNA	PMID:19549813
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of RAB20 mRNA	PMID:23649840
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of RAB20 mRNA	PMID:23649840
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315117	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RAB20 mRNA	PMID:34911549
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1593487	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RAB20 mRNA	PMID:30779732
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:27504	mitomycin C	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	RAB20 protein affects the susceptibility to Mitomycin	PMID:16217747
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of RAB20 mRNA	PMID:26272509
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA	PMID:27188386
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1315117	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of RAB20 protein	PMID:25505154
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1315117	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of RAB20 mRNA	PMID:40618947
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in increased expression of RAB20 mRNA	PMID:24768652
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315117	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAB20 mRNA	PMID:21570461
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1315117	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RAB20 mRNA	PMID:20819909
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1593487	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAB20 mRNA	PMID:33387578
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315117	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RAB20 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to RAB20 gene]	PMID:17942748|PMID:20819909
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RAB20 mRNA	PMID:28001369
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RAB20 mRNA	PMID:33212167
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of RAB20 mRNA	PMID:26272509
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA	PMID:27188386
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:28445	vincristine	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in decreased expression of RAB20 mRNA	PMID:23649840
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1593487	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of RAB20 mRNA	PMID:28959563
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RAB20 mRNA	PMID:38568856
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RAB20 intron	PMID:30157460
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RAB20 mRNA	PMID:20064835
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315117	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RAB20 mRNA	PMID:19770486
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RAB20 promoter	PMID:27901495
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RAB20 mRNA	PMID:25895662
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1315117	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in increased expression of RAB20 mRNA	PMID:19073995|PMID:29203145
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RAB20 mRNA	PMID:19150397
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of RAB20 mRNA	PMID:35984750
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RAB20 gene	PMID:31601247
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1593487	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of RAB20 mRNA	PMID:25729387
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315117	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of RAB20 mRNA	PMID:27760801
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1593487	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RAB20 mRNA	PMID:34492290
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1315117	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of RAB20 mRNA	PMID:23811191
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1315117	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of RAB20 mRNA	PMID:28329830
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315117	E	RGD:6480464	20181113	CTD	MESH:C006780	bisphenol A results in decreased expression of RAB20 mRNA	PMID:30245210
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1593487	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RAB20 mRNA	PMID:34947998
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315117	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of RAB20 mRNA	PMID:32156529|PMID:34585602
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1593487	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RAB20 mRNA	PMID:25181051
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of RAB20 gene	PMID:31601247
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1315117	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of RAB20 mRNA	PMID:25172293
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of RAB20 mRNA	PMID:25979313
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:34107	1-nitropyrene	decreases expression	EXP		E	RGD:6480464	20140415	CTD	MESH:C032668	1-nitropyrene results in decreased expression of RAB20 mRNA	PMID:19041380
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315117	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RAB20 mRNA	PMID:39298647
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1593487	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RAB20 mRNA	PMID:21266533
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RAB20 mRNA	PMID:37042841
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:35176	zinc sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in increased expression of RAB20 mRNA	PMID:16330358
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1593487	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of RAB20 gene	PMID:22079235
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C018021	cobaltous chloride results in increased expression of RAB20 mRNA	PMID:22202117
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:35696	cobalt dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C018021	zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of RAB20 mRNA]	PMID:22202117
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RAB20 mRNA	PMID:24449571
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1315117	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of RAB20 mRNA	PMID:40194260
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of RAB20 mRNA	PMID:31533062
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315117	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RAB20 mRNA	PMID:36331819
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RAB20 mRNA	PMID:25979313
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RAB20 mRNA	PMID:19101580|PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1315117	E	RGD:6480464	20120515	CTD	MESH:D014635	Valproic Acid results in increased expression of RAB20 mRNA	PMID:19136453|PMID:21427059
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RAB20 gene	PMID:29154799
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA	PMID:27188386
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of RAB20 mRNA	PMID:19371625
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1315117	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of RAB20 mRNA	PMID:28973697
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:4393	(-)-demecolcine	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in decreased expression of RAB20 mRNA	PMID:23649840
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:44185	methotrexate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in decreased expression of RAB20 mRNA	PMID:24449571
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RAB20 mRNA	PMID:38832940
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of RAB20 mRNA	PMID:26272509
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA	PMID:27188386
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of RAB20 mRNA	PMID:24935251|PMID:26272509
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA	PMID:27188386
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315117	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RAB20 mRNA	PMID:17562736
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:46195	paracetamol	affects response to substance	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	RAB20 gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of RAB20 mRNA	PMID:21420995|PMID:29067470
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1593487	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RAB20 mRNA	PMID:33387578
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	RAB20 protein affects the susceptibility to Fluorouracil	PMID:16217747
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of RAB20 mRNA	PMID:31838189
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1315117	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RAB20 mRNA	PMID:17942748
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315117	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RAB20 mRNA	PMID:17942748
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:4911	etoposide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	RAB20 protein affects the susceptibility to Etoposide	PMID:16217747
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of RAB20 mRNA	PMID:26272509
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA	PMID:27188386
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:49976	zinc dichloride	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:C016837	zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of RAB20 mRNA]	PMID:22202117
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315117	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RAB20 mRNA; Nanotubes, Carbon results in decreased expression of RAB20 mRNA	PMID:25620056
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315117	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RAB20 mRNA; Nanotubes, Carbon results in increased expression of RAB20 mRNA	PMID:25554681
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:51397	1,3-dinitrobenzene	increases expression	ISO	RGD:1593487	E	RGD:6480464	20120613	CTD	MESH:C017906	3-dinitrobenzene results in increased expression of RAB20 mRNA	PMID:21983209
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1593487	E	RGD:6480464	20120613	CTD	MESH:C015559	trimellitic anhydride results in increased expression of RAB20 mRNA	PMID:21893156
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:53076	4-(ethoxymethylene)-2-phenyloxazol-5-one	increases expression	ISO	RGD:1593487	E	RGD:6480464	20120613	CTD	MESH:D010081	Oxazolone results in increased expression of RAB20 mRNA	PMID:21893156
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1593487	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of RAB20 mRNA	PMID:28801915
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:63632	topotecan	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D019772	RAB20 protein affects the susceptibility to Topotecan	PMID:16217747
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1593487	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of RAB20 mRNA	PMID:25729387
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1593487	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of RAB20 mRNA	PMID:25729387
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:63921	2-butoxyethanol	increases expression	ISO	RGD:1315117	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in increased expression of RAB20 mRNA	PMID:19812364
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:64210	4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C068073	Am 580 results in increased expression of RAB20 mRNA	PMID:16982809
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1593487	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of RAB20 mRNA	PMID:30467583
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315117	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RAB20 mRNA	PMID:22206623
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA	PMID:27188386
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RAB20 gene]	PMID:28238834
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1315117	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in decreased expression of RAB20 mRNA	PMID:39847705
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1593487	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of RAB20 mRNA	PMID:24780913|PMID:25825206
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of RAB20 mRNA	PMID:26272509
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA	PMID:27188386
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RAB20 mRNA	PMID:27188386
1315116	RAB20	RAB20, member RAS oncogene family	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in increased expression of RAB20 mRNA	PMID:31863870
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of EIF4B mRNA	PMID:38218311
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1306479	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in increased expression of EIF4B mRNA	PMID:21551480
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of EIF4B mRNA	PMID:20938992
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in decreased expression of EIF4B mRNA	PMID:15498508|PMID:33167477
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:15756	hexadecanoic acid	decreases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in decreased phosphorylation of EIF4B protein	PMID:28073184
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1315119	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of EIF4B mRNA	PMID:30319688
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20200211	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of EIF4B protein	PMID:31494107
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315119	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of EIF4B mRNA	PMID:39241906
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306479	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of EIF4B mRNA	PMID:32145629
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315119	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of EIF4B mRNA	PMID:39298647
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of EIF4B mRNA	PMID:20938992
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:17642	pentachlorophenol	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:D010416	Pentachlorophenol affects the expression of and affects the phosphorylation of EIF4B protein	PMID:36372856
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of EIF4B protein	PMID:37730182
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of EIF4B intron	PMID:30157460
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EIF4B mRNA	PMID:36331819
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306479	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of EIF4B protein	PMID:34915118
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in increased expression of EIF4B mRNA	PMID:24376830
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:23686	dibutylstannane	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:C056189	di-n-butyltin results in increased expression of and results in increased phosphorylation of EIF4B protein	PMID:36372856
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of EIF4B protein	PMID:23301498
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1306479	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of EIF4B mRNA	PMID:33354967
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of EIF4B gene; Aflatoxin B1 results in increased methylation of EIF4B intron	PMID:27153756|PMID:30157460
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:2504	aflatoxin B1	increases phosphorylation	EXP		E	RGD:6480464	20260203	CTD	MESH:D016604	Aflatoxin B1 results in increased phosphorylation of EIF4B protein	PMID:40054833
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:254496	7,12-dimethyltetraphene	affects expression	ISO	RGD:1315119	E	RGD:6480464	20120501	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene affects the expression of EIF4B mRNA	PMID:21785161
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:2663	amiodarone	affects expression	ISO	RGD:1306479	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of EIF4B mRNA	PMID:18355885
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:2666	amitriptyline	affects expression	ISO	RGD:1306479	E	RGD:6480464	20120412	CTD	MESH:D000639	Amitriptyline affects the expression of EIF4B mRNA	PMID:18355885
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of EIF4B protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of EIF4B protein	PMID:38598786
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27086	tributylstannane	multiple interactions	EXP		E	RGD:6480464	20230502	CTD	MESH:C011559	tributyltin affects the expression of and results in increased phosphorylation of EIF4B protein	PMID:36372856
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of EIF4B mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of EIF4B mRNA]	PMID:20938992|PMID:22206623
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of EIF4B gene	PMID:39164771
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of EIF4B mRNA	PMID:26272509
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EIF4B mRNA	PMID:27188386
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of EIF4B protein	PMID:35688186
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1315119	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of EIF4B mRNA	PMID:28960355
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306479	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of EIF4B mRNA	PMID:31881176
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1315119	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of EIF4B protein	PMID:25505154
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27881	resveratrol	decreases phosphorylation	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased phosphorylation of EIF4B protein	PMID:25311616
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27881	resveratrol	decreases phosphorylation	ISO	RGD:1306479	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased phosphorylation of EIF4B protein	PMID:24304514
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27881	resveratrol	decreases phosphorylation	ISO	RGD:1315119	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased phosphorylation of EIF4B protein	PMID:24304514
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Sirolimus] results in decreased phosphorylation of EIF4B protein	PMID:24304514
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1306479	E	RGD:6480464	20160822	CTD	MESH:C059514	[Sirolimus co-treated with resveratrol] results in decreased phosphorylation of EIF4B protein	PMID:24304514
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27881	resveratrol	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20160822	CTD	MESH:C059514	[resveratrol co-treated with Sirolimus] inhibits the reaction [TSC2 gene mutant form results in increased phosphorylation of EIF4B protein]; [Sirolimus co-treated with resveratrol] results in decreased phosphorylation of EIF4B protein	PMID:24304514
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27899	cisplatin	increases phosphorylation	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of EIF4B protein	PMID:21742020
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Piroxicam co-treated with Cisplatin] results in decreased expression of EIF4B mRNA	PMID:21858171
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1315119	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of EIF4B mRNA	PMID:18355967
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:27958	cocaine	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20120412	CTD	MESH:D003042	FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of EIF4B mRNA]	PMID:18355967
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315119	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of EIF4B mRNA	PMID:21570461
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306479	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of EIF4B mRNA; Tetrachlorodibenzodioxin results in decreased expression of EIF4B protein	PMID:16548065|PMID:21215274
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF4B mRNA	PMID:17942748
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:28177	theophylline	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	Theophylline results in increased expression of EIF4B mRNA	PMID:16083514
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306479	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in increased expression of EIF4B mRNA	PMID:28374803
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1315119	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in increased expression of EIF4B mRNA	PMID:30807115
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of EIF4B mRNA	PMID:30911355
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1315119	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of EIF4B protein	PMID:28918527
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of EIF4B mRNA	PMID:29803840
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of EIF4B protein	PMID:35688186
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of EIF4B mRNA	PMID:20044591
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:29678	sodium arsenite	affects localization	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite affects the localization of EIF4B protein	PMID:16951406
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of EIF4B protein	PMID:38228842
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1315119	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of EIF4B mRNA; sodium arsenite results in increased expression of EIF4B protein	PMID:21268130
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:29678	sodium arsenite	increases phosphorylation	ISO	RGD:1315119	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased phosphorylation of EIF4B protein	PMID:21268130
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:29678	sodium arsenite	increases response to substance	ISO	RGD:1315119	E	RGD:6480464	20161228	CTD	MESH:C017947	EIF4B protein results in increased susceptibility to sodium arsenite	PMID:21268130
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	sodium arsenite results in decreased expression of and results in increased activity of EIF4B protein	PMID:30528433
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20161228	CTD	MESH:C017947	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased phosphorylation of EIF4B protein]; EIF4B protein promotes the reaction [sodium arsenite results in increased expression of MYC mRNA]; Sirolimus inhibits the reaction [sodium arsenite results in increased phosphorylation of EIF4B protein]	PMID:21268130
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of EIF4B promoter	PMID:27901495
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315119	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of EIF4B mRNA	PMID:20504355
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D003300	[Chelating Agents binds to Copper] which results in increased expression of EIF4B mRNA	PMID:30911355
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of EIF4B mRNA	PMID:19150397
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of EIF4B mRNA	PMID:23911876
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to EIF4B protein]	PMID:26598702
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1306479	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of EIF4B mRNA	PMID:24136188
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:32181	tamibarotene	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in decreased expression of EIF4B mRNA	PMID:15498508
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:3223	buspirone	increases expression	ISO	RGD:1306479	E	RGD:6480464	20160412	CTD	MESH:D002065	Buspirone results in increased expression of EIF4B mRNA	PMID:24136188
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1315119	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of EIF4B mRNA	PMID:18648102
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1315119	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of EIF4B mRNA	PMID:18445702
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:32509	pirinixic acid	increases phosphorylation	ISO	RGD:1315119	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased phosphorylation of EIF4B protein	PMID:18602970
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1315119	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of EIF4B mRNA	PMID:28472532
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of EIF4B mRNA	PMID:30903817
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of EIF4B protein	PMID:31675489
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306479	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of EIF4B mRNA	PMID:32145629
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315119	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of EIF4B mRNA	PMID:33221593
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in increased expression of EIF4B mRNA	PMID:21890461
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306479	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of EIF4B mRNA	PMID:25181051|PMID:30816183|PMID:34947998
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of EIF4B protein	PMID:31675489
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315119	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of EIF4B mRNA	PMID:39298647
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1315119	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of EIF4B exon	PMID:33297965
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1315119	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of EIF4B mRNA	PMID:37019170
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:34718	1-chloro-2,4-dinitrobenzene	affects binding	EXP		E	RGD:6480464	20210406	CTD	MESH:D004137	Dinitrochlorobenzene binds to EIF4B protein	PMID:32991956
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of EIF4B protein	PMID:38598786
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306479	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in decreased methylation of EIF4B gene	PMID:33148267
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1306479	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of EIF4B promoter	PMID:22457795
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D019256	Cadmium Chloride results in increased expression of EIF4B mRNA	PMID:33129824
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:35549	perfluorooctanoic acid	increases phosphorylation	EXP		E	RGD:6480464	20260203	CTD	MESH:C023036	perfluorooctanoic acid results in increased phosphorylation of EIF4B protein	PMID:40054833
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306479	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of EIF4B mRNA	PMID:26194646
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of EIF4B mRNA	PMID:31533062
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:39285	chloropicrin	affects expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin affects the expression of EIF4B mRNA	PMID:26352163
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	ISO	RGD:1315119	E	RGD:6480464	20180515	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of EIF4B protein	PMID:26178269
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases phosphorylation	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased phosphorylation of EIF4B protein	PMID:40054833
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EIF4B mRNA	PMID:36331819
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1315119	E	RGD:6480464	20201103	CTD	MESH:C016104	sodium bichromate results in increased expression of EIF4B mRNA	PMID:31558096
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of EIF4B mRNA	PMID:23179753|PMID:27188386|PMID:28001369
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of EIF4B mRNA	PMID:17183730
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:40909	azoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C087670	azoxystrobin results in increased expression of EIF4B mRNA	PMID:33512557
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:40909	azoxystrobin	increases phosphorylation	EXP		E	RGD:6480464	20250401	CTD	MESH:C087670	azoxystrobin results in increased phosphorylation of EIF4B protein	PMID:39207506
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of EIF4B mRNA	PMID:33512557
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of EIF4B mRNA; Okadaic Acid results in decreased expression of EIF4B protein	PMID:38832940
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of EIF4B mRNA	PMID:21420995|PMID:29067470
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306479	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of EIF4B mRNA	PMID:33387578
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:46666	crocidolite asbestos	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of EIF4B protein	PMID:21570478
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260203	CTD	MESH:D001151	[Metals, Heavy results in increased abundance of Arsenic] which results in decreased methylation of EIF4B gene	PMID:39164771
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:47499	imipramine	affects expression	ISO	RGD:1306479	E	RGD:6480464	20120412	CTD	MESH:D007099	Imipramine affects the expression of EIF4B mRNA	PMID:18355885
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:47519	ketoconazole	affects expression	ISO	RGD:1306479	E	RGD:6480464	20120412	CTD	MESH:D007654	Ketoconazole affects the expression of EIF4B mRNA	PMID:18355885
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of EIF4B mRNA	PMID:31675489
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:47780	clomipramine	affects expression	ISO	RGD:1306479	E	RGD:6480464	20120412	CTD	MESH:D002997	Clomipramine affects the expression of EIF4B mRNA	PMID:18355885
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of EIF4B mRNA	PMID:22079256
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1315119	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of EIF4B mRNA	PMID:35436446
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of EIF4B mRNA	PMID:18175754
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EIF4B mRNA	PMID:17942748
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:4948	Evodiamine	decreases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine results in decreased expression of EIF4B mRNA	PMID:38878560
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of EIF4B mRNA	PMID:23911876
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to EIF4B protein]	PMID:26598702
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315119	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of EIF4B mRNA	PMID:25554681
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:50594	carbon nanotube	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of EIF4B mRNA	PMID:28673683
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of EIF4B mRNA	PMID:35964746
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of EIF4B mRNA	PMID:17183730
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of EIF4B protein	PMID:32959892
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1315119	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of EIF4B mRNA	PMID:23650126
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:64153	tanespimycin	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:C112765	[tanespimycin co-treated with VER 155008] results in increased expression of EIF4B protein	PMID:31370342
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:65329	LY294002	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20121113	CTD	MESH:C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased phosphorylation of EIF4B protein]	PMID:21268130
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:69478	cannabidiol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	[Cannabidiol co-treated with moringin] results in decreased expression of EIF4B mRNA	PMID:30096889
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306479	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in decreased methylation of EIF4B gene	PMID:33148267
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of EIF4B protein	PMID:34186270
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:73295	WIN 55212-2	decreases expression	ISO	RGD:1315119	E	RGD:6480464	20170303	CTD	MESH:C070417	(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone results in decreased expression of EIF4B mRNA	PMID:12237329
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315119	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of EIF4B mRNA	PMID:22206623
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of EIF4B mRNA]	PMID:22206623
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EIF4B protein	PMID:37664457
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:748435	pafuramidine	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20260714	CTD	MESH:C458513	EIF4B affects the reaction [pafuramidine results in increased expression of HAVCR1 protein]	PMID:22940726
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of EIF4B mRNA	PMID:22079256
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of EIF4B mRNA	PMID:22079256
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of EIF4B protein	PMID:39638853
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EIF4B mRNA	PMID:27188386
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:81543	Tributyltin oxide	decreases phosphorylation	ISO	RGD:1315119	E	RGD:6480464	20180703	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased phosphorylation of EIF4B protein	PMID:24375594
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:81758	cyproconazole	increases phosphorylation	EXP		E	RGD:6480464	20250401	CTD	MESH:C093628	cyproconazole results in increased phosphorylation of EIF4B protein	PMID:39207506
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1306479	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of EIF4B protein	PMID:28903499
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:81981	chlorotoluron	increases phosphorylation	EXP		E	RGD:6480464	20250401	CTD	MESH:C007033	chlortoluron results in increased phosphorylation of EIF4B protein	PMID:39207506
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1315119	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of EIF4B mRNA	PMID:31558096
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of EIF4B protein	PMID:31675489
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:8249	piroxicam	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	[Piroxicam co-treated with Cisplatin] results in decreased expression of EIF4B mRNA	PMID:21858171
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:83113	fluxapyroxad	increases phosphorylation	EXP		E	RGD:6480464	20250401	CTD	MESH:C000591719	fluxapyroxad results in increased phosphorylation of EIF4B protein	PMID:39207506
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of EIF4B mRNA	PMID:33512557
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1315119	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of EIF4B protein	PMID:35357534
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of EIF4B protein; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EIF4B mRNA	PMID:27188386|PMID:37664457
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:9168	sirolimus	decreases phosphorylation	EXP		E	RGD:6480464	20160822	CTD	MESH:D020123	Sirolimus results in decreased phosphorylation of EIF4B protein	PMID:24304514
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:9168	sirolimus	decreases phosphorylation	ISO	RGD:1306479	E	RGD:6480464	20160822	CTD	MESH:D020123	Sirolimus results in decreased phosphorylation of EIF4B protein	PMID:24304514
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:9168	sirolimus	decreases phosphorylation	ISO	RGD:1315119	E	RGD:6480464	20160822	CTD	MESH:D020123	Sirolimus results in decreased phosphorylation of EIF4B protein	PMID:24304514|PMID:24375594
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D020123	[resveratrol co-treated with Sirolimus] results in decreased phosphorylation of EIF4B protein	PMID:24304514
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1306479	E	RGD:6480464	20160822	CTD	MESH:D020123	[Sirolimus co-treated with resveratrol] results in decreased phosphorylation of EIF4B protein	PMID:24304514
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:9168	sirolimus	multiple interactions	ISO	RGD:1315119	E	RGD:6480464	20121113	CTD	MESH:D020123	[resveratrol co-treated with Sirolimus] inhibits the reaction [TSC2 gene mutant form results in increased phosphorylation of EIF4B protein]; [Sirolimus co-treated with resveratrol] results in decreased phosphorylation of EIF4B protein; Sirolimus inhibits the reaction [sodium arsenite results in increased phosphorylation of EIF4B protein]; Sirolimus inhibits the reaction [TSC2 gene mutant form results in increased phosphorylation of EIF4B protein]	PMID:21268130|PMID:24304514
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306479	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of EIF4B mRNA	PMID:21346803
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:9422	tebufenpyrad	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of EIF4B mRNA	PMID:33512557
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of EIF4B mRNA	PMID:38568856
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:95077	GSK-J4	increases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in increased expression of EIF4B mRNA	PMID:29301935
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of EIF4B mRNA	PMID:27188386
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of EIF4B protein	PMID:38598786
1315118	EIF4B	eukaryotic translation initiation factor 4B	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306479	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of EIF4B mRNA	PMID:21346803
1315120	APOL3	apolipoprotein L3	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1620480	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of APOL7B mRNA	PMID:33045310
1315120	APOL3	apolipoprotein L3	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of APOL3 mRNA	PMID:33167477
1315120	APOL3	apolipoprotein L3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of APOL3 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of APOL3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of APOL3 mRNA	PMID:32699268|PMID:32845096
1315120	APOL3	apolipoprotein L3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of APOL3 mRNA	PMID:30165855
1315120	APOL3	apolipoprotein L3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of APOL3 mRNA	PMID:35818422
1315120	APOL3	apolipoprotein L3	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	EXP		E	RGD:6480464	20250708	CTD	MESH:D004051	[Diethylhexyl Phthalate co-treated with Asian ginseng] results in decreased expression of APOL3 mRNA	PMID:35818422
1315120	APOL3	apolipoprotein L3	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of APOL3 mRNA	PMID:36139627
1315120	APOL3	apolipoprotein L3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of APOL3 mRNA	PMID:28818685
1315120	APOL3	apolipoprotein L3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of APOL3 mRNA	PMID:19549813
1315120	APOL3	apolipoprotein L3	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of APOL3 mRNA	PMID:27153756
1315120	APOL3	apolipoprotein L3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of APOL3 gene	PMID:27153756
1315120	APOL3	apolipoprotein L3	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of APOL3 mRNA	PMID:22100608
1315120	APOL3	apolipoprotein L3	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of APOL3 mRNA	PMID:23649840
1315120	APOL3	apolipoprotein L3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of APOL3 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in decreased expression of APOL3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of APOL3 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of APOL3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of APOL3 mRNA	PMID:32699268|PMID:32845096|PMID:35430440
1315120	APOL3	apolipoprotein L3	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of APOL3 gene	PMID:25304211
1315120	APOL3	apolipoprotein L3	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of APOL3 mRNA	PMID:19244175
1315120	APOL3	apolipoprotein L3	gene	CHEBI:27666	actinomycin D	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:D003609	[Dactinomycin co-treated with nutlin 3] results in increased expression of APOL3 mRNA	PMID:38460933
1315120	APOL3	apolipoprotein L3	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of APOL3 mRNA	PMID:23557933
1315120	APOL3	apolipoprotein L3	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of APOL3 mRNA	PMID:24768652|PMID:25583101
1315120	APOL3	apolipoprotein L3	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of APOL3 mRNA	PMID:33212167
1315120	APOL3	apolipoprotein L3	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of APOL3 mRNA	PMID:29803840
1315120	APOL3	apolipoprotein L3	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of APOL3 mRNA	PMID:12634122
1315120	APOL3	apolipoprotein L3	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of APOL3 5' UTR; Benzo(a)pyrene affects the methylation of APOL3 promoter	PMID:27901495
1315120	APOL3	apolipoprotein L3	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1620480	E	RGD:6480464	20181016	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of APOL3 mRNA	PMID:17942131
1315120	APOL3	apolipoprotein L3	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of APOL3 mRNA	PMID:32234424
1315120	APOL3	apolipoprotein L3	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in increased methylation of APOL3 gene	PMID:31601247
1315120	APOL3	apolipoprotein L3	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1620480	E	RGD:6480464	20181016	CTD	MESH:C006253	pirinixic acid results in decreased expression of APOL3 mRNA	PMID:20813756
1315120	APOL3	apolipoprotein L3	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in increased methylation of APOL3 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of APOL3 mRNA	PMID:28628672|PMID:31601247
1315120	APOL3	apolipoprotein L3	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of APOL3 mRNA	PMID:19244175
1315120	APOL3	apolipoprotein L3	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of APOL3 mRNA	PMID:28628672
1315120	APOL3	apolipoprotein L3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of APOL3 mRNA	PMID:37042841
1315120	APOL3	apolipoprotein L3	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1620480	E	RGD:6480464	20181016	CTD	MESH:C039281	furan results in decreased expression of APOL7B mRNA	PMID:24183702
1315120	APOL3	apolipoprotein L3	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of APOL3 mRNA	PMID:24449571
1315120	APOL3	apolipoprotein L3	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of APOL3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of APOL3 mRNA	PMID:32699268
1315120	APOL3	apolipoprotein L3	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of APOL3 mRNA	PMID:19244175
1315120	APOL3	apolipoprotein L3	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of APOL3 mRNA	PMID:29154799
1315120	APOL3	apolipoprotein L3	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1620480	E	RGD:6480464	20181016	CTD	MESH:D016572	Cyclosporine results in decreased expression of APOL3 mRNA	PMID:17942131
1315120	APOL3	apolipoprotein L3	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of APOL3 mRNA	PMID:28628672
1315120	APOL3	apolipoprotein L3	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of APOL3 mRNA	PMID:38832940
1315120	APOL3	apolipoprotein L3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of APOL3 mRNA	PMID:21420995
1315120	APOL3	apolipoprotein L3	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1620480	E	RGD:6480464	20181016	CTD	MESH:D000082	Acetaminophen results in decreased expression of APOL3 mRNA	PMID:17942131
1315120	APOL3	apolipoprotein L3	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of APOL3 mRNA	PMID:26690555
1315120	APOL3	apolipoprotein L3	gene	CHEBI:46742	Nutlin-3	multiple interactions	EXP		E	RGD:6480464	20240806	CTD	MESH:C482205	[Dactinomycin co-treated with nutlin 3] results in increased expression of APOL3 mRNA	PMID:38460933
1315120	APOL3	apolipoprotein L3	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of APOL3 gene	PMID:25304211
1315120	APOL3	apolipoprotein L3	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of APOL3 mRNA	PMID:28628672
1315120	APOL3	apolipoprotein L3	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1620480	E	RGD:6480464	20181016	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of APOL7B mRNA; Nanotubes, Carbon results in decreased expression of APOL7B mRNA	PMID:25620056
1315120	APOL3	apolipoprotein L3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1620480	E	RGD:6480464	20181016	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of APOL7B mRNA	PMID:25554681
1315120	APOL3	apolipoprotein L3	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1620480	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of APOL7B mRNA	PMID:38701926
1315120	APOL3	apolipoprotein L3	gene	CHEBI:67895	corosolic acid	decreases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in decreased expression of APOL3 mRNA	PMID:37939859
1315120	APOL3	apolipoprotein L3	gene	CHEBI:753435	ginseng, asian	multiple interactions	EXP		E	RGD:6480464	20260714	CTD	MESH:C000713447	[Diethylhexyl Phthalate co-treated with Asian ginseng] results in decreased expression of APOL3 mRNA	PMID:35818422
1315120	APOL3	apolipoprotein L3	gene	CHEBI:756028	mivebresib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000621792	mivebresib results in decreased expression of APOL3 mRNA	PMID:35486664
1315120	APOL3	apolipoprotein L3	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of APOL3 mRNA	PMID:36139627
1315120	APOL3	apolipoprotein L3	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to APOL3 gene]	PMID:28238834
1315120	APOL3	apolipoprotein L3	gene	CHEBI:81543	Tributyltin oxide	decreases expression	ISO	RGD:1620480	E	RGD:6480464	20181016	CTD	MESH:C005961	bis(tri-n-butyltin)oxide results in decreased expression of APOL3 mRNA	PMID:17942131
1315120	APOL3	apolipoprotein L3	gene	CHEBI:82362	N-Nitrosopyrrolidine	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in increased expression of APOL3 mRNA	PMID:32234424
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in increased expression of TXK mRNA	PMID:21934132|PMID:23830798|PMID:33167477
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306481	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of TXK mRNA	PMID:33387578
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of TXK mRNA	PMID:18849615
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1315123	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of TXK mRNA	PMID:39922521
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1306481	E	RGD:6480464	20120412	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of TXK mRNA	PMID:16809437
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1315123	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of TXK mRNA	PMID:39922521
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TXK mRNA	PMID:36139627
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306481	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of TXK mRNA	PMID:22061828|PMID:33387578
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of TXK mRNA	PMID:40512198
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1315123	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of TXK mRNA	PMID:28960355
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306481	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of TXK mRNA	PMID:31881176
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1315123	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of TXK mRNA	PMID:32186404
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of TXK mRNA	PMID:24768652|PMID:25583101
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306481	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TXK mRNA	PMID:34747641
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1315123	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TXK mRNA	PMID:23238561
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306481	E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TXK mRNA	PMID:23238561|PMID:33387578
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1315123	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of TXK mRNA	PMID:37682722
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of TXK mRNA	PMID:40512198
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315123	E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TXK mRNA	PMID:34876320
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:29852	methylarsonic acid	multiple interactions	ISO	RGD:1315123	E	RGD:6480464	20220405	CTD	MESH:C020300	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TXK mRNA	PMID:34876320
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315123	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of TXK mRNA	PMID:21569818
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1315123	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of TXK mRNA	PMID:29341224
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TXK gene	PMID:31601247
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306481	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of TXK mRNA	PMID:25729387
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315123	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of TXK mRNA	PMID:27760801|PMID:29264374
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315123	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of TXK mRNA	PMID:23557971
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315123	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TXK mRNA	PMID:20813756
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306481	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of TXK mRNA	PMID:41034487
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306481	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of TXK mRNA	PMID:25181051
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315123	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of TXK mRNA	PMID:26063408
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of TXK gene	PMID:31601247
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1315123	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TXK mRNA	PMID:28392331
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TXK mRNA	PMID:37042841
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:35064	alpha-Zearalanol	increases expression	ISO	RGD:1306481	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in increased expression of TXK mRNA	PMID:35163327
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306481	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of TXK gene	PMID:22079235
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1315123	E	RGD:6480464	20250603	CTD	MESH:D005947	Glucose results in increased expression of TXK mRNA	PMID:39922521
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of TXK mRNA	PMID:38832940
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[vorinostat co-treated with Isotretinoin] results in increased expression of TXK mRNA	PMID:18769122
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of TXK mRNA	PMID:26690555
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of TXK mRNA	PMID:40512198
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306481	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of TXK mRNA	PMID:29391264
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:48765	dimethylarsinic acid	multiple interactions	ISO	RGD:1315123	E	RGD:6480464	20220405	CTD	MESH:D002101	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TXK mRNA	PMID:34876320
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:50091	S-nitrosoglutathione	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in decreased expression of TXK mRNA	PMID:38825487
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315123	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of TXK mRNA; Nanotubes, Carbon results in decreased expression of TXK mRNA	PMID:25554681
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1306481	E	RGD:6480464	20180116	CTD	MESH:C082359	imidacloprid results in increased expression of TXK mRNA	PMID:27782041
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1315123	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of TXK mRNA	PMID:38701926
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:6067	isotretinoin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in increased expression of TXK mRNA	PMID:18769122
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:6067	isotretinoin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	[vorinostat co-treated with Isotretinoin] results in increased expression of TXK mRNA	PMID:18769122
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306481	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of TXK mRNA	PMID:25729387
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1315123	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of TXK mRNA	PMID:36851058
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:6820	methapyrilene	increases expression	ISO	RGD:1306481	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased expression of TXK mRNA	PMID:30467583
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315123	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of TXK mRNA	PMID:22206623
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TXK mRNA	PMID:36139627
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of TXK mRNA	PMID:30928695
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TXK gene]	PMID:28238834
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:79997	GW 4064	decreases expression	ISO	RGD:1315123	E	RGD:6480464	20170303	CTD	MESH:C412815	GW 4064 results in decreased expression of TXK mRNA	PMID:26655953
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1315123	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of TXK mRNA	PMID:38648751
1315122	TXK	TXK tyrosine kinase	gene	CHEBI:84070	sodium arsenate	multiple interactions	ISO	RGD:1315123	E	RGD:6480464	20220405	CTD	MESH:C009277	[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of TXK mRNA	PMID:34876320
1315124	RNF146	ring finger protein 146	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RNF146 mRNA	PMID:38218311
1315124	RNF146	ring finger protein 146	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RNF146 mRNA	PMID:38218311
1315124	RNF146	ring finger protein 146	gene	CHEBI:135947	bazedoxifene	increases expression	EXP		E	RGD:6480464	20170307	CTD	MESH:C447119	bazedoxifene results in increased expression of RNF146 mRNA	PMID:19914376
1315124	RNF146	ring finger protein 146	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552458	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RNF146 gene	PMID:20938992
1315124	RNF146	ring finger protein 146	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RNF146 mRNA	PMID:26079696
1315124	RNF146	ring finger protein 146	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RNF146 mRNA	PMID:21632981
1315124	RNF146	ring finger protein 146	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1552458	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RNF146 mRNA	PMID:39241906
1315124	RNF146	ring finger protein 146	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of RNF146 mRNA	PMID:38568856
1315124	RNF146	ring finger protein 146	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552458	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RNF146 gene	PMID:20938992
1315124	RNF146	ring finger protein 146	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of RNF146 mRNA	PMID:20655997
1315124	RNF146	ring finger protein 146	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552458	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of RNF146 mRNA	PMID:28111341
1315124	RNF146	ring finger protein 146	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RNF146 mRNA	PMID:19549813
1315124	RNF146	ring finger protein 146	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of RNF146 mRNA	PMID:23649840
1315124	RNF146	ring finger protein 146	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306482	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of RNF146 mRNA	PMID:21396975
1315124	RNF146	ring finger protein 146	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of RNF146 gene	PMID:27153756
1315124	RNF146	ring finger protein 146	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of RNF146 mRNA	PMID:19774075
1315124	RNF146	ring finger protein 146	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552458	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RNF146 gene	PMID:20938992
1315124	RNF146	ring finger protein 146	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of RNF146 mRNA	PMID:40512198
1315124	RNF146	ring finger protein 146	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1552458	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RNF146 mRNA	PMID:28189721|PMID:28960355
1315124	RNF146	ring finger protein 146	gene	CHEBI:27889	lead(0)	affects splicing	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the splicing of RNF146 mRNA	PMID:28903495
1315124	RNF146	ring finger protein 146	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of RNF146 mRNA	PMID:27594783
1315124	RNF146	ring finger protein 146	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306482	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RNF146 mRNA	PMID:33387578
1315124	RNF146	ring finger protein 146	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552458	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RNF146 mRNA	PMID:17942748
1315124	RNF146	ring finger protein 146	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of RNF146 mRNA	PMID:32763439
1315124	RNF146	ring finger protein 146	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RNF146 mRNA	PMID:29803840
1315124	RNF146	ring finger protein 146	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of RNF146 protein	PMID:35688186
1315124	RNF146	ring finger protein 146	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of RNF146 mRNA	PMID:34032870
1315124	RNF146	ring finger protein 146	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of RNF146 mRNA	PMID:40512198
1315124	RNF146	ring finger protein 146	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RNF146 mRNA	PMID:20498004
1315124	RNF146	ring finger protein 146	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1552458	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RNF146 mRNA	PMID:27131904
1315124	RNF146	ring finger protein 146	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of RNF146 gene	PMID:31601247
1315124	RNF146	ring finger protein 146	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1306482	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of RNF146 mRNA	PMID:24136188
1315124	RNF146	ring finger protein 146	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306482	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RNF146 mRNA	PMID:34492290
1315124	RNF146	ring finger protein 146	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306482	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RNF146 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1315124	RNF146	ring finger protein 146	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1552458	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of RNF146 mRNA	PMID:21266533
1315124	RNF146	ring finger protein 146	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552458	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of RNF146 mRNA	PMID:28111341
1315124	RNF146	ring finger protein 146	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of RNF146 mRNA	PMID:28302478
1315124	RNF146	ring finger protein 146	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RNF146 mRNA	PMID:25979313
1315124	RNF146	ring finger protein 146	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D014635	Valproic Acid results in decreased expression of RNF146 mRNA	PMID:23179753|PMID:25192806|PMID:29154799
1315124	RNF146	ring finger protein 146	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1552458	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RNF146 mRNA	PMID:17555576
1315124	RNF146	ring finger protein 146	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of RNF146 mRNA	PMID:38832940
1315124	RNF146	ring finger protein 146	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306482	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RNF146 mRNA	PMID:33387578
1315124	RNF146	ring finger protein 146	gene	CHEBI:46678	amosite asbestos	increases methylation	EXP		E	RGD:6480464	20200915	CTD	MESH:D017639	Asbestos, Amosite results in increased methylation of RNF146 promoter	PMID:29626692
1315124	RNF146	ring finger protein 146	gene	CHEBI:46790	2-methoxyethanol	increases expression	ISO	RGD:1306482	E	RGD:6480464	20121113	CTD	MESH:C005219	methyl cellosolve results in increased expression of RNF146 mRNA	PMID:21061450
1315124	RNF146	ring finger protein 146	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] which co-treated with MIR186] results in increased expression of RNF146 mRNA	PMID:40512198
1315124	RNF146	ring finger protein 146	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1552458	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RNF146 mRNA	PMID:17555576
1315124	RNF146	ring finger protein 146	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552458	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RNF146 mRNA	PMID:17942748
1315124	RNF146	ring finger protein 146	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1552458	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RNF146 mRNA; Nanotubes, Carbon results in decreased expression of RNF146 mRNA	PMID:25554681
1315124	RNF146	ring finger protein 146	gene	CHEBI:50692	mifepristone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015735	Mifepristone results in increased expression of RNF146 mRNA	PMID:17584828
1315124	RNF146	ring finger protein 146	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1552458	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of RNF146 mRNA	PMID:22206623
1315124	RNF146	ring finger protein 146	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of RNF146 mRNA	PMID:26079696
1315124	RNF146	ring finger protein 146	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306482	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of RNF146 mRNA	PMID:24780913
1315124	RNF146	ring finger protein 146	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1552458	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of RNF146 mRNA	PMID:27131904
1315124	RNF146	ring finger protein 146	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306482	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of RNF146 mRNA	PMID:23555832
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of GALT mRNA	PMID:35967413
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:132446	perfluorobutanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C539348	perfluorobutanesulfonic acid results in decreased expression of GALT mRNA	PMID:40885241
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1315127	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of GALT mRNA	PMID:37995155
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1315127	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of GALT mRNA	PMID:26251327
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014212	Tretinoin results in increased expression of GALT mRNA	PMID:15498508
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of GALT mRNA	PMID:22378314
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315127	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of GALT mRNA	PMID:39241906
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1315127	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of GALT mRNA	PMID:39298647
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of GALT mRNA	PMID:37042841
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of GALT mRNA	PMID:28818685
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GALT mRNA	PMID:39836092
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of GALT mRNA	PMID:19549813
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:23414	copper(II) sulfate	increases expression	ISO	RGD:1315127	E	RGD:6480464	20130514	CTD	MESH:D019327	Copper Sulfate results in increased expression of GALT mRNA	PMID:18579281
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of GALT mRNA	PMID:22100608
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:27363	zinc atom	decreases expression	ISO	RGD:1306483	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of GALT mRNA	PMID:12672911
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1315127	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of GALT mRNA	PMID:31919559
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315127	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of GALT mRNA	PMID:25629700
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GALT mRNA	PMID:39836092
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of GALT mRNA	PMID:19921347
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of GALT mRNA	PMID:23300844
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315127	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GALT mRNA	PMID:21570461
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306483	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GALT mRNA	PMID:33387578
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of GALT mRNA	PMID:28001369
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of GALT mRNA	PMID:32763439
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of GALT mRNA	PMID:29803840
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GALT mRNA	PMID:39836092
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of GALT mRNA	PMID:32234424
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:30185	zinc(0)	decreases expression	ISO	RGD:1306483	E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of GALT mRNA	PMID:12672911
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of GALT mRNA	PMID:25351596
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:31206	ammonium chloride	affects expression	ISO	RGD:1306483	E	RGD:6480464	20120412	CTD	MESH:D000643	Ammonium Chloride affects the expression of GALT mRNA	PMID:16483693
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306483	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of GALT mRNA	PMID:30047161
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:32181	tamibarotene	increases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:C061133	tamibarotene results in increased expression of GALT mRNA	PMID:15498508
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315127	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of GALT gene	PMID:35295148
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GALT mRNA	PMID:19710929
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:33146	vanadyl sulfate	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C034028	vanadyl sulfate results in decreased expression of GALT mRNA	PMID:16330358
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306483	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of GALT mRNA	PMID:30816183|PMID:32528016
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306483	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of GALT mRNA	PMID:25181051
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1315127	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of GALT mRNA	PMID:26682919
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1315127	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of GALT mRNA	PMID:38685157
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1315127	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of GALT mRNA	PMID:28392331
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of GALT gene	PMID:22964155
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306483	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of GALT mRNA	PMID:21266533
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of GALT mRNA	PMID:37042841
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GALT mRNA	PMID:39836092
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of GALT mRNA	PMID:38568856
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1306483	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of GALT promoter	PMID:22457795
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:35549	perfluorooctanoic acid	affects expression	ISO	RGD:1315127	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid affects the expression of GALT mRNA	PMID:19429403
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20200915	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of GALT mRNA	PMID:32588087
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306483	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of GALT mRNA	PMID:26194646
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306483	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of GALT gene	PMID:22079235
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of GALT mRNA	PMID:19376846
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	affects expression	ISO	RGD:1315127	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid affects the expression of GALT mRNA	PMID:19429403
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	ISO	RGD:1306483	E	RGD:6480464	20120412	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of GALT mRNA	PMID:19162173
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306483	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of GALT mRNA	PMID:30047161
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of GALT mRNA	PMID:20106945|PMID:25562108
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:41774	tamoxifen	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of GALT mRNA	PMID:14699072
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1315127	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of GALT mRNA	PMID:17555576
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of GALT mRNA	PMID:38832940
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315127	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of GALT mRNA	PMID:17562736
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of GALT mRNA	PMID:29067470
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306483	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of GALT mRNA	PMID:33387578
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GALT mRNA	PMID:39836092
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1315127	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of GALT mRNA	PMID:17555576
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:5001	fenofibrate	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D011345	Fenofibrate results in increased expression of GALT mRNA	PMID:25572481
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:50091	S-nitrosoglutathione	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D026422	S-Nitrosoglutathione results in increased expression of GALT mRNA	PMID:38825487
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of GALT mRNA	PMID:23300844
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315127	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of GALT mRNA; Nanotubes, Carbon results in decreased expression of GALT mRNA	PMID:25620056
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306483	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of GALT mRNA	PMID:30047161
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GALT mRNA	PMID:39836092
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1315127	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of GALT mRNA	PMID:26307267
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315127	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GALT mRNA	PMID:22206623
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:8069	phenobarbital	decreases expression	ISO	RGD:1306483	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in decreased expression of GALT mRNA	PMID:30047161
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1315127	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of GALT mRNA	PMID:21278054
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306483	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of GALT mRNA	PMID:30047161
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:9288	streptozocin	decreases expression	ISO	RGD:1306483	E	RGD:6480464	20160822	CTD	MESH:D013311	Streptozocin results in decreased expression of GALT mRNA	PMID:25905778
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of GALT mRNA	PMID:38568856
1315126	GALT	galactose-1-phosphate uridylyltransferase	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of GALT mRNA	PMID:29301935
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in increased expression of BCAS2 protein	PMID:39638853
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of BCAS2 mRNA	PMID:33167477
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of BCAS2 mRNA	PMID:24763279
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1315130	E	RGD:6480464	20260804	CTD	MESH:D001280	Atrazine results in increased expression of BCAS2 mRNA	PMID:40945087
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315130	E	RGD:6480464	20161228	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of BCAS2 mRNA	PMID:22687549
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1315130	E	RGD:6480464	20161228	CTD	MESH:D008070	genipin inhibits the reaction [Lipopolysaccharides results in increased expression of BCAS2 mRNA]	PMID:22687549
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1315130	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of BCAS2 mRNA	PMID:23892564
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of BCAS2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of BCAS2 mRNA	PMID:39836092
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in increased expression of BCAS2 mRNA	PMID:17103032
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315130	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of BCAS2 mRNA	PMID:37236586
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of BCAS2 mRNA	PMID:19549813
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of BCAS2 protein	PMID:23301498
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of BCAS2 mRNA	PMID:23649840
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315130	E	RGD:6480464	20120412	CTD	MESH:D010126	pyrazolanthrone inhibits the reaction [Ozone results in increased expression of BCAS2 mRNA]	PMID:17460151
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of BCAS2 mRNA	PMID:18593933
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1315130	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BCAS2 mRNA	PMID:31919559
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of BCAS2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BCAS2 mRNA	PMID:39836092
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1315130	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of BCAS2 protein	PMID:25505154
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315130	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of BCAS2 mRNA	PMID:21570461
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of BCAS2 protein	PMID:39603559
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of BCAS2 mRNA	PMID:33512557
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of BCAS2 mRNA	PMID:30851411
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of BCAS2 mRNA	PMID:32763439
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of BCAS2 mRNA	PMID:25523186
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of BCAS2 mRNA	PMID:38568856
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of BCAS2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BCAS2 mRNA	PMID:39836092
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315130	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BCAS2 mRNA	PMID:19770486|PMID:22228805
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to BCAS2 mRNA]	PMID:32406909
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D006046	Gold results in decreased expression of BCAS2 mRNA	PMID:25523186
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of BCAS2 mRNA	PMID:18593933
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315130	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of BCAS2 gene	PMID:35295148
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315130	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of BCAS2 mRNA	PMID:33221593
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306485	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of BCAS2 mRNA	PMID:25181051|PMID:32145629
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315130	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of BCAS2 mRNA	PMID:39298647
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1315130	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of BCAS2 mRNA	PMID:37019170
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of BCAS2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of BCAS2 mRNA	PMID:39836092
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315130	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of BCAS2 mRNA	PMID:37236586
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C018021	cobaltous chloride results in decreased expression of BCAS2 protein	PMID:16622835
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of BCAS2 mRNA	PMID:28302478
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of BCAS2 mRNA	PMID:27153767
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of BCAS2 mRNA	PMID:25979313
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of BCAS2 mRNA	PMID:29154799
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of BCAS2 mRNA	PMID:20106945|PMID:25562108
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:41922	diethylstilbestrol	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in decreased expression of BCAS2 mRNA	PMID:36621641
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of BCAS2 mRNA	PMID:21420995
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of BCAS2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BCAS2 mRNA	PMID:39836092
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:5063	fipronil	decreases expression	ISO	RGD:1306485	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in decreased expression of BCAS2 mRNA	PMID:34044035
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:5298	Genipin	multiple interactions	ISO	RGD:1315130	E	RGD:6480464	20141111	CTD	MESH:C007834	genipin inhibits the reaction [Lipopolysaccharides results in increased expression of BCAS2 mRNA]	PMID:22687549
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of BCAS2 protein	PMID:32959892
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of BCAS2 mRNA; [manganese chloride results in increased abundance of Manganese] which results in increased expression of BCAS2 mRNA	PMID:39836092
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:63630	tolcapone	decreases expression	ISO	RGD:1306485	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in decreased expression of BCAS2 mRNA	PMID:24136188
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1315130	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of BCAS2 protein	PMID:36851058
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:65585	carnosic acid	decreases expression	ISO	RGD:1315130	E	RGD:6480464	20230404	CTD	MESH:C018381	salvin results in decreased expression of BCAS2 protein	PMID:35926579
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315130	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of BCAS2 mRNA	PMID:22206623
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of BCAS2 protein	PMID:37664457
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:75142	N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCAS2 mRNA	PMID:31806706
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of BCAS2 mRNA	PMID:30851411
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of BCAS2 mRNA	PMID:30928695
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BCAS2 gene]	PMID:28238834
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of BCAS2 mRNA	PMID:19159669
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1315130	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of BCAS2 mRNA	PMID:30294300
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:87368	diethyl malate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C058705	diethyl malate results in increased expression of BCAS2 mRNA	PMID:38498338
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:90695	anthra[1,9-cd]pyrazol-6(2H)-one	multiple interactions	ISO	RGD:1315130	E	RGD:6480464	20170303	CTD	MESH:C432165	pyrazolanthrone inhibits the reaction [Ozone results in increased expression of BCAS2 mRNA]	PMID:17460151
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of BCAS2 protein	PMID:37664457
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of BCAS2 mRNA	PMID:38568856
1315129	BCAS2	BCAS2 pre-mRNA processing factor	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1315130	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in decreased expression of BCAS2 protein	PMID:24648495
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of HABP4 mRNA	PMID:31016361
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315132	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HABP4 mRNA	PMID:20938992
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of HABP4 mRNA	PMID:39506029
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306486	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of HABP4 gene	PMID:28931070
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:16170	mercury(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of HABP4 mRNA	PMID:16823088
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315132	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of HABP4 mRNA	PMID:39298647
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306486	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of HABP4 mRNA	PMID:33387578
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306486	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of HABP4 gene	PMID:27618143
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315132	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HABP4 mRNA	PMID:20938992
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HABP4 mRNA	PMID:37042841
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of HABP4 protein	PMID:37730182
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306486	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of HABP4 mRNA	PMID:33387578
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315132	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HABP4 mRNA	PMID:37236586
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:25195	mercury atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in increased expression of HABP4 mRNA	PMID:16823088
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315132	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of HABP4 mRNA	PMID:25629700
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315132	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of HABP4 mRNA; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of HABP4 mRNA]	PMID:20938992|PMID:22206623
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of HABP4 protein	PMID:35688186
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:27889	lead(0)	affects methylation	EXP		E	RGD:6480464	20230307	CTD	MESH:D007854	Lead affects the methylation of HABP4 gene	PMID:31636367
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of HABP4 mRNA	PMID:27392435
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315132	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HABP4 mRNA	PMID:21570461|PMID:24680724
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306486	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HABP4 mRNA	PMID:33387578
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of HABP4 mRNA	PMID:28001369
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of HABP4 mRNA	PMID:30851411
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:28619	acrylamide	affects methylation	ISO	RGD:1315132	E	RGD:6480464	20220705	CTD	MESH:D020106	Acrylamide affects the methylation of HABP4 gene	PMID:35032568
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1315132	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of HABP4 protein	PMID:28918527
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of HABP4 mRNA	PMID:29803840
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of HABP4 mRNA	PMID:38568856
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of HABP4 promoter	PMID:27901495
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315132	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HABP4 gene	PMID:35295148
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1315132	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of HABP4 mRNA	PMID:23811191
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306486	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HABP4 mRNA	PMID:25181051|PMID:34947998
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1315132	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of HABP4 mRNA	PMID:39298647
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315132	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in increased expression of HABP4 mRNA	PMID:40203079
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1315132	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of HABP4 mRNA	PMID:17361019|PMID:21266533
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1315132	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of HABP4 mRNA	PMID:36117858
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:35456	cadmium dichloride	decreases methylation	ISO	RGD:1306486	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in decreased methylation of HABP4 promoter	PMID:22457795
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315132	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HABP4 mRNA	PMID:37236586
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of HABP4 mRNA	PMID:24449571
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HABP4 mRNA	PMID:25979313
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of HABP4 mRNA	PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of HABP4 gene	PMID:29154799
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of HABP4 mRNA	PMID:24449571
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of HABP4 mRNA	PMID:38832940
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of HABP4 mRNA	PMID:28542535
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315132	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of HABP4 mRNA	PMID:17562736
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in increased expression of HABP4 mRNA	PMID:29067470
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306486	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HABP4 mRNA	PMID:33387578
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of HABP4 mRNA	PMID:38568856
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1315132	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of HABP4 mRNA	PMID:36117858
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1306486	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of HABP4 mRNA	PMID:20080153
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315132	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of HABP4 mRNA	PMID:22206623
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315132	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of HABP4 mRNA]	PMID:22206623
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of HABP4 mRNA	PMID:37199045
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:77012	methylseleninic acid	increases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in increased expression of HABP4 mRNA	PMID:18548127
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of HABP4 mRNA	PMID:30851411
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of HABP4 mRNA	PMID:19159669
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:81892	Brodifacoum	decreases expression	ISO	RGD:1306486	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in decreased expression of HABP4 protein	PMID:28903499
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306486	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of HABP4 mRNA	PMID:24780913
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:9130	sevoflurane	increases expression	ISO	RGD:1315132	E	RGD:6480464	20220809	CTD	MESH:C009250	Sevoflurane results in increased expression of HABP4 protein	PMID:35249202
1315131	HABP4	hyaluronan binding protein 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306486	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of HABP4 mRNA	PMID:21346803
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of APPBP2 mRNA	PMID:26079696
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of APPBP2 mRNA	PMID:29581250
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315135	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of APPBP2 mRNA	PMID:39241906
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in increased expression of APPBP2 mRNA	PMID:21592394
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of APPBP2 mRNA	PMID:21592394
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:17579	beta-carotene	multiple interactions	ISO	RGD:1315135	E	RGD:6480464	20140909	CTD	MESH:D019207	[BCO1 protein affects the susceptibility to beta Carotene] which affects the expression of APPBP2 mRNA	PMID:24657404
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of APPBP2 protein	PMID:37730182
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of APPBP2 mRNA	PMID:21592394
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of APPBP2 mRNA	PMID:21592394
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of APPBP2 mRNA	PMID:35301059
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of APPBP2 mRNA	PMID:19549813
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of APPBP2 mRNA	PMID:23649840
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:24757	hypochlorous acid	increases expression	ISO	RGD:1315135	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in increased expression of APPBP2 mRNA	PMID:19376150
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of APPBP2 mRNA	PMID:23649840
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315135	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of APPBP2 mRNA	PMID:25629700
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315135	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of APPBP2 mRNA	PMID:22206623
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of APPBP2 mRNA	PMID:19244175
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1306488	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of APPBP2 mRNA	PMID:25905778
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of APPBP2 mRNA	PMID:23557933
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1315135	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of APPBP2 mRNA	PMID:32186404
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315135	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of APPBP2 mRNA	PMID:21570461
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306488	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of APPBP2 mRNA	PMID:33387578
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of APPBP2 mRNA	PMID:30851411
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306488	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of APPBP2 mRNA	PMID:28959563
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of APPBP2 mRNA	PMID:29803840
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of APPBP2 mRNA; sodium arsenite results in decreased expression of APPBP2 protein	PMID:28595984|PMID:30528433|PMID:34032870
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of APPBP2 mRNA	PMID:38568856
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of APPBP2 mRNA	PMID:26238291
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315135	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of APPBP2 mRNA	PMID:19770486
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of APPBP2 mRNA	PMID:25895662
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of APPBP2 mRNA	PMID:26238291
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of APPBP2 mRNA	PMID:35984750
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:31429	colforsin daropate hydrochloride	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D005576	Colforsin results in decreased expression of APPBP2 mRNA	PMID:16751804
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1306488	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of APPBP2 mRNA	PMID:24136188
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315135	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of APPBP2 gene	PMID:35295148
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306488	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of APPBP2 mRNA	PMID:34492290
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315135	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of APPBP2 mRNA	PMID:20813756
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of APPBP2 mRNA	PMID:29275510
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306488	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of APPBP2 mRNA	PMID:25181051
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:33234	vitamin E	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in increased expression of APPBP2 mRNA	PMID:19244175
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of APPBP2 mRNA	PMID:19244175
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315135	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of APPBP2 mRNA	PMID:38685157
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1315135	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of APPBP2 mRNA	PMID:37019170
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of APPBP2 mRNA	PMID:35301059
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of APPBP2 mRNA	PMID:19376846
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of APPBP2 mRNA	PMID:24449571
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of APPBP2 mRNA	PMID:19244175
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of APPBP2 mRNA	PMID:16751804
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of APPBP2 mRNA	PMID:28302478
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of APPBP2 mRNA	PMID:31533062
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of APPBP2 mRNA	PMID:28001369
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of APPBP2 mRNA	PMID:24935251
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of APPBP2 mRNA	PMID:24935251|PMID:26272509
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of APPBP2 mRNA	PMID:24935251
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APPBP2 mRNA	PMID:27188386
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1306488	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen affects the expression of APPBP2 mRNA	PMID:33387578
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315135	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of APPBP2 mRNA	PMID:17562736
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of APPBP2 mRNA	PMID:21420995
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:6121	ketamine	decreases expression	ISO	RGD:1306488	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in decreased expression of APPBP2 mRNA	PMID:20080153
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:64317	isoprenaline	increases expression	ISO	RGD:1315135	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in increased expression of APPBP2 mRNA	PMID:20003209
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1315135	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of APPBP2 mRNA	PMID:22206623
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315135	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of APPBP2 mRNA	PMID:22206623
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1306488	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of APPBP2 mRNA	PMID:22124623
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of APPBP2 mRNA	PMID:30851411
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APPBP2 mRNA	PMID:27188386
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to APPBP2 gene]	PMID:28238834
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1315135	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of APPBP2 mRNA	PMID:31388691
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1315135	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of APPBP2 mRNA	PMID:21795629
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of APPBP2 mRNA	PMID:27188386
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306488	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of APPBP2 mRNA	PMID:21346803
1315134	APPBP2	amyloid beta precursor protein binding protein 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306488	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of APPBP2 mRNA	PMID:21346803
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RAB5B mRNA	PMID:38218311
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306489	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of RAB5B mRNA	PMID:21551480
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1315137	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of RAB5B mRNA	PMID:20188158
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315137	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RAB5B mRNA	PMID:20938992
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1315137	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RAB5B mRNA	PMID:25510870
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:16548	chlordecone	increases expression	ISO	RGD:1315137	E	RGD:6480464	20210810	CTD	MESH:D007631	Chlordecone results in increased expression of RAB5B mRNA	PMID:33711761
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of RAB5B mRNA	PMID:38568856
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315137	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RAB5B mRNA	PMID:20938992
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315137	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RAB5B mRNA	PMID:34319233
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1315137	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RAB5B mRNA	PMID:25510870
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1315137	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RAB5B mRNA	PMID:25510870
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306489	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of RAB5B mRNA	PMID:31150632
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315137	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RAB5B mRNA	PMID:20938992
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315137	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RAB5B mRNA	PMID:40504410
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:27744	glyphosate	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of RAB5B mRNA	PMID:31295307
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1315137	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of RAB5B protein	PMID:25505154
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of RAB5B mRNA	PMID:23557933
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of RAB5B mRNA	PMID:27594783
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of RAB5B mRNA	PMID:27392435
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315137	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAB5B mRNA	PMID:21570461
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306489	E	RGD:6480464	20130115	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RAB5B mRNA	PMID:21215274|PMID:33387578
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of RAB5B protein	PMID:39603559
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1315137	E	RGD:6480464	20190702	CTD	MESH:D020106	Acrylamide results in decreased expression of RAB5B mRNA	PMID:30807115
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:28680	cytarabine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003561	Cytarabine results in increased expression of RAB5B mRNA	PMID:19194470
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:29021	hexane	decreases methylation	ISO	RGD:1306489	E	RGD:6480464	20180703	CTD	MESH:C026385	n-hexane results in decreased methylation of RAB5B promoter	PMID:23740543
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RAB5B mRNA	PMID:38568856
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315137	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RAB5B mRNA	PMID:40504410
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315137	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RAB5B mRNA	PMID:22228805
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of RAB5B mRNA	PMID:26551752
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315137	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RAB5B gene	PMID:35295148
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315137	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of RAB5B mRNA	PMID:29264374
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315137	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of RAB5B gene	PMID:35295148
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1315137	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RAB5B mRNA	PMID:18648102
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1315137	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RAB5B mRNA	PMID:20813756
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315137	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RAB5B mRNA	PMID:33221593
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of RAB5B protein	PMID:34186270|PMID:37567409
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306489	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RAB5B mRNA	PMID:25181051
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1315137	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RAB5B mRNA	PMID:25510870
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1315137	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of RAB5B mRNA	PMID:25510870
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RAB5B mRNA	PMID:28628672
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:34567	benzo[e]pyrene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in decreased methylation of RAB5B intron	PMID:30157460
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315137	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of RAB5B mRNA	PMID:38685157
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RAB5B mRNA	PMID:28628672
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RAB5B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RAB5B mRNA	PMID:28628672
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of RAB5B mRNA	PMID:17312168
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RAB5B mRNA	PMID:37042841
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RAB5B protein	PMID:24527689
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1306489	E	RGD:6480464	20130115	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of RAB5B promoter	PMID:22457795
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	ISO	RGD:1306489	E	RGD:6480464	20120412	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of RAB5B mRNA	PMID:19162173
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:38561	fluvastatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C065180	[zoledronic acid co-treated with fluvastatin] results in increased expression of RAB5B mRNA	PMID:16996129
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RAB5B mRNA	PMID:25979313
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RAB5B mRNA	PMID:23179753
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RAB5B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RAB5B mRNA	PMID:28628672
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306489	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RAB5B mRNA	PMID:33387578
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:46557	zoledronic acid	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	[zoledronic acid co-treated with fluvastatin] results in increased expression of RAB5B mRNA	PMID:16996129
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315137	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RAB5B mRNA	PMID:40504410
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RAB5B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of RAB5B mRNA	PMID:28628672
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315137	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of RAB5B mRNA	PMID:25554681
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:50866	3H-1,2-dithiole-3-thione	decreases expression	ISO	RGD:1306489	E	RGD:6480464	20120412	CTD	MESH:C049325	1,2-dithiol-3-thione results in decreased expression of RAB5B mRNA	PMID:19162173
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of RAB5B protein	PMID:23718831
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RAB5B protein	PMID:32959892
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of RAB5B mRNA	PMID:28988120
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:641	N-methyl-4-phenylpyridinium	affects expression	EXP		E	RGD:6480464	20130611	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium affects the expression of RAB5B mRNA	PMID:12710931
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1315137	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of RAB5B protein	PMID:36851058
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:6820	methapyrilene	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased methylation of RAB5B intron	PMID:30157460
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315137	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RAB5B mRNA	PMID:22206623
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RAB5B protein	PMID:37664457
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of RAB5B protein	PMID:38348393
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1315137	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of RAB5B mRNA	PMID:21795629
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RAB5B protein	PMID:37664457
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of RAB5B mRNA	PMID:26551752
1315136	RAB5B	RAB5B, member RAS oncogene family	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306489	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of RAB5B mRNA	PMID:19015723
1315140	NIN	ninein	gene	CHEBI:110423	clodronic acid	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D004002	Clodronic Acid results in decreased expression of NIN mRNA	PMID:25596134
1315140	NIN	ninein	gene	CHEBI:116509	diuron	increases expression	ISO	RGD:1306492	E	RGD:6480464	20141223	CTD	MESH:D004237	Diuron results in increased expression of NIN mRNA	PMID:25152437
1315140	NIN	ninein	gene	CHEBI:132082	entinostat	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in decreased expression of NIN mRNA	PMID:26272509|PMID:27188386
1315140	NIN	ninein	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIN mRNA	PMID:27188386
1315140	NIN	ninein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1315141	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of NIN mRNA	PMID:26251327
1315140	NIN	ninein	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases methylation	ISO	RGD:1315141	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased methylation of NIN promoter	PMID:26251327
1315140	NIN	ninein	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of NIN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of NIN mRNA	PMID:32699268
1315140	NIN	ninein	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of NIN mRNA	PMID:25596134
1315140	NIN	ninein	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of NIN mRNA	PMID:22378314
1315140	NIN	ninein	gene	CHEBI:16236	ethanol	affects response to substance	ISO	RGD:1315141	E	RGD:6480464	20180313	CTD	MESH:D000431	NIN protein affects the susceptibility to Ethanol	PMID:26948279
1315140	NIN	ninein	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in decreased expression of NIN protein	PMID:15221776
1315140	NIN	ninein	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306492	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of NIN mRNA	PMID:33387578
1315140	NIN	ninein	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of NIN mRNA	PMID:37042841
1315140	NIN	ninein	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315141	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NIN mRNA	PMID:37992649
1315140	NIN	ninein	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1315141	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of NIN mRNA	PMID:20403060
1315140	NIN	ninein	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315141	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NIN mRNA	PMID:37992649
1315140	NIN	ninein	gene	CHEBI:17688	(S)-nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of NIN mRNA	PMID:16949557
1315140	NIN	ninein	gene	CHEBI:17688	(S)-nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	alpha-cobratoxin inhibits the reaction [Nicotine results in increased expression of NIN mRNA]; Tubocurarine inhibits the reaction [Nicotine results in increased expression of NIN mRNA]	PMID:16949557
1315140	NIN	ninein	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306492	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of NIN mRNA	PMID:26577399
1315140	NIN	ninein	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306492	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of NIN mRNA	PMID:33387578
1315140	NIN	ninein	gene	CHEBI:18723	nicotine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in increased expression of NIN mRNA	PMID:16949557
1315140	NIN	ninein	gene	CHEBI:18723	nicotine	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D009538	alpha-cobratoxin inhibits the reaction [Nicotine results in increased expression of NIN mRNA]; Tubocurarine inhibits the reaction [Nicotine results in increased expression of NIN mRNA]	PMID:16949557
1315140	NIN	ninein	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of NIN mRNA	PMID:23649840
1315140	NIN	ninein	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of NIN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of NIN mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of NIN mRNA	PMID:32699268
1315140	NIN	ninein	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315141	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of NIN mRNA	PMID:27106289
1315140	NIN	ninein	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1315141	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of NIN mRNA	PMID:17484886
1315140	NIN	ninein	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315141	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of NIN mRNA	PMID:25629700
1315140	NIN	ninein	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315141	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NIN mRNA	PMID:40504410
1315140	NIN	ninein	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of NIN protein	PMID:35688186
1315140	NIN	ninein	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306492	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of NIN mRNA	PMID:31881176
1315140	NIN	ninein	gene	CHEBI:27871	chloroacetaldehyde	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C004656	chloroacetaldehyde results in decreased expression of NIN mRNA	PMID:25596134
1315140	NIN	ninein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of NIN mRNA	PMID:23557933
1315140	NIN	ninein	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of NIN mRNA	PMID:28903495
1315140	NIN	ninein	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D002945	Cisplatin results in decreased expression of NIN mRNA	PMID:25596134
1315140	NIN	ninein	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1315141	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of NIN mRNA	PMID:40618947
1315140	NIN	ninein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315141	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of NIN mRNA	PMID:21570461
1315140	NIN	ninein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306492	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NIN mRNA	PMID:33387578
1315140	NIN	ninein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1315141	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NIN mRNA	PMID:19770486
1315140	NIN	ninein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130312	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NIN mRNA	PMID:22903824
1315140	NIN	ninein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315141	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of NIN mRNA	PMID:21354282
1315140	NIN	ninein	gene	CHEBI:28201	rotenone	increases expression	ISO	RGD:1306492	E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of NIN mRNA	PMID:19013527
1315140	NIN	ninein	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of NIN mRNA	PMID:28001369
1315140	NIN	ninein	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of NIN mRNA	PMID:33212167
1315140	NIN	ninein	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of NIN mRNA	PMID:39709020
1315140	NIN	ninein	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NIN mRNA	PMID:20971185
1315140	NIN	ninein	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of NIN mRNA	PMID:29803840
1315140	NIN	ninein	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315141	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NIN mRNA	PMID:37992649
1315140	NIN	ninein	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of NIN mRNA	PMID:38568856
1315140	NIN	ninein	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315141	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NIN mRNA	PMID:40504410
1315140	NIN	ninein	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NIN promoter	PMID:27901495
1315140	NIN	ninein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NIN mRNA	PMID:21632981|PMID:26238291
1315140	NIN	ninein	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315141	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of NIN mRNA	PMID:19770486
1315140	NIN	ninein	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of NIN 3' UTR; Benzo(a)pyrene results in decreased methylation of NIN 5' UTR	PMID:27901495
1315140	NIN	ninein	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315141	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of NIN mRNA	PMID:22228805
1315140	NIN	ninein	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of NIN mRNA	PMID:20971185
1315140	NIN	ninein	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NIN mRNA	PMID:19150397
1315140	NIN	ninein	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1315141	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of NIN mRNA	PMID:21829687
1315140	NIN	ninein	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306492	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of NIN mRNA	PMID:25729387
1315140	NIN	ninein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315141	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of NIN mRNA	PMID:29264374
1315140	NIN	ninein	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315141	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of NIN promoter	PMID:35295148
1315140	NIN	ninein	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306492	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of NIN mRNA	PMID:34492290
1315140	NIN	ninein	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1315141	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of NIN mRNA	PMID:18648102
1315140	NIN	ninein	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306492	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of NIN mRNA	PMID:25181051
1315140	NIN	ninein	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306492	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NIN gene	PMID:28505145
1315140	NIN	ninein	gene	CHEBI:3423	carmustine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	NIN mRNA affects the susceptibility to Carmustine	PMID:16365179
1315140	NIN	ninein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1315141	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of NIN gene	PMID:31683443
1315140	NIN	ninein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of NIN mRNA	PMID:28628672
1315140	NIN	ninein	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1315141	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of NIN mRNA	PMID:37019170
1315140	NIN	ninein	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of NIN mRNA	PMID:28628672
1315140	NIN	ninein	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of NIN mRNA	PMID:25596134
1315140	NIN	ninein	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of NIN mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of NIN mRNA	PMID:32699268
1315140	NIN	ninein	gene	CHEBI:3696	cidofovir anhydrous	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C059262	Cidofovir results in decreased expression of NIN mRNA	PMID:25596134
1315140	NIN	ninein	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of NIN mRNA	PMID:31533062
1315140	NIN	ninein	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of NIN mRNA	PMID:27153767|PMID:40419075
1315140	NIN	ninein	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NIN mRNA	PMID:25979313
1315140	NIN	ninein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of NIN mRNA	PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369
1315140	NIN	ninein	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of NIN gene	PMID:29154799
1315140	NIN	ninein	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIN mRNA	PMID:27188386
1315140	NIN	ninein	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of NIN mRNA	PMID:25596134
1315140	NIN	ninein	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1315141	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of NIN mRNA	PMID:19770486
1315140	NIN	ninein	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of NIN mRNA	PMID:28628672
1315140	NIN	ninein	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1315141	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of NIN mRNA	PMID:28973697
1315140	NIN	ninein	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315141	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of NIN mRNA	PMID:37992649
1315140	NIN	ninein	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of NIN mRNA	PMID:26272509
1315140	NIN	ninein	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIN mRNA	PMID:27188386
1315140	NIN	ninein	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of NIN mRNA	PMID:26272509
1315140	NIN	ninein	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIN mRNA	PMID:27188386
1315140	NIN	ninein	gene	CHEBI:46195	paracetamol	affects expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D000082	Acetaminophen affects the expression of NIN mRNA	PMID:25458485
1315140	NIN	ninein	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315141	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of NIN mRNA	PMID:17562736
1315140	NIN	ninein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of NIN mRNA	PMID:22230336|PMID:25596134|PMID:29067470
1315140	NIN	ninein	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306492	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of NIN mRNA	PMID:33387578
1315140	NIN	ninein	gene	CHEBI:46680	serpentine asbestos	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D017632	Asbestos, Serpentine results in increased expression of NIN mRNA	PMID:21148743
1315140	NIN	ninein	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315141	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NIN mRNA	PMID:40504410
1315140	NIN	ninein	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	increases expression	EXP		E	RGD:6480464	20230404	CTD	MESH:C045651	epigallocatechin gallate results in increased expression of NIN mRNA	PMID:35701726
1315140	NIN	ninein	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in increased expression of NIN mRNA	PMID:28628672
1315140	NIN	ninein	gene	CHEBI:5864	ifosfamide	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D007069	Ifosfamide results in decreased expression of NIN mRNA	PMID:25596134
1315140	NIN	ninein	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306492	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of NIN mRNA	PMID:25729387
1315140	NIN	ninein	gene	CHEBI:63933	Aroclor 1254	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of NIN mRNA	PMID:16934159
1315140	NIN	ninein	gene	CHEBI:6801	metformin	increases expression	ISO	RGD:1306492	E	RGD:6480464	20150825	CTD	MESH:D008687	Metformin results in increased expression of NIN mRNA	PMID:25596134
1315140	NIN	ninein	gene	CHEBI:72564	temozolomide	affects response to substance	EXP		E	RGD:6480464	20130305	CTD	MESH:C047246	NIN mRNA affects the susceptibility to temozolomide	PMID:16365179
1315140	NIN	ninein	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIN mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIN mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIN mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIN mRNA	PMID:27188386
1315140	NIN	ninein	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NIN gene]	PMID:28238834
1315140	NIN	ninein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIN mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIN mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIN mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIN mRNA	PMID:27188386
1315140	NIN	ninein	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306492	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of NIN mRNA	PMID:19281266
1315140	NIN	ninein	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of NIN mRNA	PMID:38568856
1315140	NIN	ninein	gene	CHEBI:9774	tubocurarine	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D014403	Tubocurarine results in decreased expression of NIN mRNA	PMID:16949557
1315140	NIN	ninein	gene	CHEBI:9774	tubocurarine	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D014403	Tubocurarine inhibits the reaction [Nicotine results in increased expression of NIN mRNA]	PMID:16949557
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of RAD1 mRNA	PMID:33167477
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RAD1 mRNA	PMID:26079696
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of RAD1 mRNA	PMID:18951874
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315146	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RAD1 mRNA	PMID:39241906
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1315146	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of RAD1 mRNA	PMID:39298647
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:17241	1H-pyrazole	increases expression	ISO	RGD:1315146	E	RGD:6480464	20120412	CTD	MESH:C031280	pyrazole results in increased expression of RAD1 mRNA	PMID:17945193
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1315146	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of RAD1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RAD1 mRNA]	PMID:20230807
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	increases expression	ISO	RGD:1315146	E	RGD:6480464	20120501	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RAD1 mRNA	PMID:20230807
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1315146	E	RGD:6480464	20120501	CTD	MESH:D015632	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of RAD1 mRNA; [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of RAD1 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RAD1 mRNA]; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RAD1 mRNA]	PMID:20230807
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1315146	E	RGD:6480464	20161213	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of RAD1 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RAD1 mRNA]	PMID:20230807
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002104	Cadmium results in decreased expression of RAD1 mRNA	PMID:21120746
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306496	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of RAD1 mRNA	PMID:21396975
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1315146	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RAD1 mRNA	PMID:31919559
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315146	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of RAD1 mRNA	PMID:25629700
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of RAD1 mRNA	PMID:26272509
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAD1 mRNA	PMID:27188386
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:27732	caffeine	multiple interactions	ISO	RGD:1315146	E	RGD:6480464	20120501	CTD	MESH:D002110	[Caffeine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of RAD1 mRNA; Caffeine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of RAD1 mRNA]	PMID:20230807
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of RAD1 mRNA	PMID:23557933
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315146	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RAD1 mRNA	PMID:21570461
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306496	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RAD1 mRNA	PMID:21215274
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306496	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RAD1 mRNA	PMID:33387578
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315146	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RAD1 mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of RAD1 mRNA	PMID:17942748|PMID:25975270
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:2814	arecoline	decreases expression	EXP		E	RGD:6480464	20131008	CTD	MESH:D001115	Arecoline results in decreased expression of RAD1 mRNA	PMID:17682004
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of RAD1 mRNA	PMID:18191903
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of RAD1 mRNA	PMID:29803840|PMID:36634904
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:28748	doxorubicin	multiple interactions	EXP		E	RGD:6480464	20230704	CTD	MESH:D004317	[TP53 protein affects the susceptibility to Doxorubicin] which affects the expression of RAD1 mRNA; TP53 protein affects the reaction [Doxorubicin results in decreased expression of RAD1 mRNA]	PMID:36634904
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:28939	N-acetyl-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D000111	Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of RAD1 mRNA]	PMID:33971260
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315146	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RAD1 mRNA	PMID:19770486|PMID:22228805
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1315146	E	RGD:6480464	20120501	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of RAD1 mRNA	PMID:19073995
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306496	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of RAD1 mRNA	PMID:25729387
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315146	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RAD1 gene	PMID:35295148
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1306496	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of RAD1 mRNA	PMID:30723492
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1315146	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of RAD1 mRNA	PMID:19136022
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315146	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in increased expression of RAD1 mRNA	PMID:18301758|PMID:18445702
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315146	E	RGD:6480464	20120515	CTD	MESH:C006780	bisphenol A results in decreased expression of RAD1 mRNA	PMID:21932408
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306496	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RAD1 mRNA	PMID:25181051
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315146	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RAD1 mRNA	PMID:39298647
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:34696	dieldrin	affects expression	ISO	RGD:1306496	E	RGD:6480464	20141014	CTD	MESH:D004026	Dieldrin affects the expression of RAD1 mRNA	PMID:22546817
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1306496	E	RGD:6480464	20141014	CTD	MESH:C022838	nickel chloride affects the expression of RAD1 mRNA	PMID:22546817
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RAD1 mRNA	PMID:37042841
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of RAD1 mRNA	PMID:38382870|PMID:38568856
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1315146	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of RAD1 mRNA	PMID:28903501
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of RAD1 mRNA	PMID:19167446
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RAD1 mRNA	PMID:25979313
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of RAD1 mRNA	PMID:23179753
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:43572	kojic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C011890	kojic acid results in increased expression of RAD1 mRNA	PMID:16595896
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315146	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RAD1 mRNA	PMID:17562736
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:D000082	Acetaminophen results in increased expression of RAD1 mRNA	PMID:33971260
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306496	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of RAD1 mRNA	PMID:33387578
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:46195	paracetamol	multiple interactions	EXP		E	RGD:6480464	20211012	CTD	MESH:D000082	Acetylcysteine inhibits the reaction [Acetaminophen results in increased expression of RAD1 mRNA]	PMID:33971260
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1315146	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RAD1 mRNA	PMID:17942748
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315146	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RAD1 mRNA	PMID:17942748
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:4918	O-methyleugenol	decreases expression	ISO	RGD:1306496	E	RGD:6480464	20120412	CTD	MESH:C005223	methyleugenol results in decreased expression of RAD1 mRNA	PMID:21659616
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:53700	quinoline yellow	increases expression	EXP		E	RGD:6480464	20250506	CTD	MESH:C019303	quinoline yellow results in increased expression of RAD1 mRNA	PMID:28893156
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306496	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of RAD1 mRNA	PMID:25729387
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:6382	Lasiocarpine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C005136	[CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RAD1 mRNA	PMID:33884520
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:63924	riddelliine	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:C013672	[CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RAD1 mRNA	PMID:33884520
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:6980	monocrotaline	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D016686	[CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of RAD1 mRNA	PMID:33884520
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:7719	ochratoxin A	decreases acetylation	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased acetylation of RAD1 promoter	PMID:29098329
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	ochratoxin A results in decreased expression of RAD1 mRNA	PMID:29098329
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:7719	ochratoxin A	multiple interactions	EXP		E	RGD:6480464	20180515	CTD	MESH:C025589	[ochratoxin A results in decreased acetylation of RAD1 promoter] which results in decreased expression of RAD1 mRNA	PMID:29098329
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAD1 mRNA	PMID:27188386
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RAD1 gene]	PMID:28238834
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1315146	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of RAD1 mRNA	PMID:19136022
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of RAD1 mRNA	PMID:21858171
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1315146	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of RAD1 mRNA	PMID:40826991
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:88046	cylindrospermopsin	decreases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in decreased expression of RAD1 mRNA	PMID:23726867
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RAD1 mRNA	PMID:27188386
1315145	RAD1	RAD1 checkpoint DNA exonuclease	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306496	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of RAD1 mRNA	PMID:21346803
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of SERPINB11 mRNA	PMID:26079696
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306497	E	RGD:6480464	20160705	CTD	MESH:D013739	[bisphenol A co-treated with Testosterone] results in decreased expression of SERPINB11 mRNA	PMID:26496021
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:2533	alachlor	affects expression	ISO	RGD:1306497	E	RGD:6480464	20130514	CTD	MESH:C000188	alachlor affects the expression of SERPINB11 mRNA	PMID:19425180
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:28088	genistein	affects expression	ISO	RGD:1315148	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein affects the expression of SERPINB11 mRNA	PMID:32186404
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315148	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SERPINB11 mRNA	PMID:21570461
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1315148	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of SERPINB11 mRNA	PMID:37682722
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of SERPINB11 promoter	PMID:27901495
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of SERPINB11 gene	PMID:31601247
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306497	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of SERPINB11 mRNA	PMID:25729387
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315148	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of SERPINB11 mRNA	PMID:29264374
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315148	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of SERPINB11 mRNA	PMID:35295148
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306497	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SERPINB11 mRNA	PMID:25181051|PMID:34947998
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315148	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SERPINB11 mRNA	PMID:30951980
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1315148	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of SERPINB11 promoter	PMID:27312807
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of SERPINB11 gene	PMID:31601247
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306497	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Testosterone] results in decreased expression of SERPINB11 mRNA	PMID:26496021
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315148	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SERPINB11 mRNA	PMID:30951980
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1315148	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of SERPINB11 mRNA	PMID:26377693
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315148	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SERPINB11 mRNA	PMID:30951980
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306497	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of SERPINB11 gene	PMID:33148267
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1306497	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of SERPINB11 promoter	PMID:22457795
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1315148	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of SERPINB11 mRNA	PMID:40194260
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1315148	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SERPINB11 mRNA	PMID:35436446
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306497	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SERPINB11 mRNA	PMID:17557909
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306497	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of SERPINB11 mRNA	PMID:30307764
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1315148	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of SERPINB11 mRNA	PMID:23608068
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306497	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of SERPINB11 mRNA	PMID:25729387
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306497	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of SERPINB11 gene	PMID:33148267
1315147	SERPINB11	serpin family B member 11	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SERPINB11 gene]	PMID:28238834
1315150	WDR20	WD repeat domain 20	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of WDR20 mRNA	PMID:31863870
1315150	WDR20	WD repeat domain 20	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1618347	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of WDR20 mRNA	PMID:33045310
1315150	WDR20	WD repeat domain 20	gene	CHEBI:16240	hydrogen peroxide	decreases expression	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	Hydrogen Peroxide results in decreased expression of WDR20 mRNA	PMID:18951874
1315150	WDR20	WD repeat domain 20	gene	CHEBI:16240	hydrogen peroxide	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D006861	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of WDR20 protein	PMID:18951874
1315150	WDR20	WD repeat domain 20	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of WDR20 mRNA	PMID:37042841
1315150	WDR20	WD repeat domain 20	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005557	Formaldehyde results in decreased expression of WDR20 mRNA	PMID:20655997
1315150	WDR20	WD repeat domain 20	gene	CHEBI:16899	D-mannitol	decreases expression	ISO	RGD:1618347	E	RGD:6480464	20150127	CTD	MESH:D008353	Mannitol results in decreased expression of WDR20 mRNA	PMID:25270620
1315150	WDR20	WD repeat domain 20	gene	CHEBI:178012	FR900359	decreases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in decreased phosphorylation of WDR20 protein	PMID:37730182
1315150	WDR20	WD repeat domain 20	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306499	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of WDR20 mRNA	PMID:33387578
1315150	WDR20	WD repeat domain 20	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1618347	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of WDR20 mRNA	PMID:37236586
1315150	WDR20	WD repeat domain 20	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of WDR20 mRNA	PMID:18593933
1315150	WDR20	WD repeat domain 20	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1618347	E	RGD:6480464	20250401	CTD	MESH:D005492	Folic Acid results in decreased expression of WDR20A mRNA	PMID:25629700
1315150	WDR20	WD repeat domain 20	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of WDR20 gene	PMID:25304211
1315150	WDR20	WD repeat domain 20	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of WDR20 protein	PMID:35688186
1315150	WDR20	WD repeat domain 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1618347	E	RGD:6480464	20140114	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of WDR20 mRNA	PMID:21570461
1315150	WDR20	WD repeat domain 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306499	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WDR20 mRNA	PMID:33387578
1315150	WDR20	WD repeat domain 20	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306499	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of WDR20 mRNA	PMID:32109520
1315150	WDR20	WD repeat domain 20	gene	CHEBI:28177	theophylline	multiple interactions	EXP		E	RGD:6480464	20120515	CTD	MESH:D013806	[Hydrogen Peroxide co-treated with Theophylline] results in increased expression of WDR20 protein	PMID:18951874
1315150	WDR20	WD repeat domain 20	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of WDR20 mRNA	PMID:28001369
1315150	WDR20	WD repeat domain 20	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306499	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of WDR20 mRNA	PMID:28959563
1315150	WDR20	WD repeat domain 20	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of WDR20 mRNA	PMID:24690739
1315150	WDR20	WD repeat domain 20	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of WDR20 mRNA	PMID:24690739
1315150	WDR20	WD repeat domain 20	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of WDR20 mRNA	PMID:18593933
1315150	WDR20	WD repeat domain 20	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of WDR20 mRNA	PMID:19150397
1315150	WDR20	WD repeat domain 20	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1618347	E	RGD:6480464	20250401	CTD	MESH:C009495	titanium dioxide results in increased methylation of WDR20A promoter	PMID:35295148
1315150	WDR20	WD repeat domain 20	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR20 mRNA	PMID:29275510
1315150	WDR20	WD repeat domain 20	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306499	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR20 mRNA	PMID:25181051
1315150	WDR20	WD repeat domain 20	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1618347	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR20 mRNA	PMID:26063408
1315150	WDR20	WD repeat domain 20	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of WDR20 gene	PMID:31601247
1315150	WDR20	WD repeat domain 20	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306499	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of WDR20 mRNA	PMID:30816183|PMID:34947998
1315150	WDR20	WD repeat domain 20	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306499	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of WDR20 gene	PMID:28505145
1315150	WDR20	WD repeat domain 20	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1618347	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of WDR20 mRNA	PMID:39298647
1315150	WDR20	WD repeat domain 20	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1618347	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of WDR20 intron	PMID:28392331
1315150	WDR20	WD repeat domain 20	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of WDR20 mRNA	PMID:37042841
1315150	WDR20	WD repeat domain 20	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1618347	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which affects the expression of WDR20 mRNA	PMID:37236586
1315150	WDR20	WD repeat domain 20	gene	CHEBI:35696	cobalt dichloride	increases expression	ISO	RGD:1306499	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in increased expression of WDR20 mRNA	PMID:24386269
1315150	WDR20	WD repeat domain 20	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of WDR20 mRNA	PMID:24449571
1315150	WDR20	WD repeat domain 20	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of WDR20 mRNA	PMID:28001369
1315150	WDR20	WD repeat domain 20	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306499	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of WDR20 mRNA	PMID:33387578
1315150	WDR20	WD repeat domain 20	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of WDR20 mRNA	PMID:24690739
1315150	WDR20	WD repeat domain 20	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1618347	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of WDR20 mRNA	PMID:29279043
1315150	WDR20	WD repeat domain 20	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of WDR20 mRNA	PMID:18687144
1315150	WDR20	WD repeat domain 20	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of WDR20 gene	PMID:25304211
1315150	WDR20	WD repeat domain 20	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1618347	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of WDR20 mRNA	PMID:25554681
1315150	WDR20	WD repeat domain 20	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1618347	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of WDR20 protein	PMID:36851058
1315150	WDR20	WD repeat domain 20	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1618347	E	RGD:6480464	20250401	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of WDR20A mRNA	PMID:22206623
1315150	WDR20	WD repeat domain 20	gene	CHEBI:80799	Bufotalin	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:C004600	bufotalin results in increased expression of WDR20 mRNA	PMID:39904859
1315150	WDR20	WD repeat domain 20	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306499	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of WDR20 mRNA	PMID:25825206
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:134751	avobenzone	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in decreased expression of SOCS4 mRNA	PMID:31016361
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SOCS4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SOCS4 mRNA	PMID:32699268
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315156	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of SOCS4 mRNA	PMID:30319688
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of SOCS4 mRNA	PMID:21632981
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of SOCS4 mRNA	PMID:37042841
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of SOCS4 mRNA	PMID:23649840
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:17151	xylitol	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D014993	Xylitol results in decreased expression of SOCS4 mRNA	PMID:32275922
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of SOCS4 mRNA	PMID:28818685
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315156	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SOCS4 mRNA	PMID:36331819
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of SOCS4 mRNA	PMID:17103032
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315156	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SOCS4 mRNA	PMID:37236586
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of SOCS4 mRNA	PMID:23649840
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1315156	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SOCS4 mRNA	PMID:19770486
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of SOCS4 gene	PMID:27153756
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of SOCS4 mRNA	PMID:23649840
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SOCS4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SOCS4 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of SOCS4 mRNA	PMID:32699268
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315156	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SOCS4 mRNA	PMID:40504410
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:27641	cycloheximide	increases expression	ISO	RGD:1315156	E	RGD:6480464	20130611	CTD	MESH:D003513	Cycloheximide results in increased expression of SOCS4 mRNA	PMID:23237828
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:27744	glyphosate	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased expression of SOCS4 mRNA	PMID:31295307
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306503	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of SOCS4 mRNA	PMID:31881176
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of SOCS4 mRNA	PMID:23557933
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315156	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SOCS4 mRNA	PMID:21570461
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306503	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SOCS4 mRNA	PMID:33387578
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SOCS4 mRNA	PMID:28001369
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of SOCS4 mRNA	PMID:28001369
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315156	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SOCS4 mRNA	PMID:40504410
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1315156	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of SOCS4 mRNA	PMID:17127020
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1315156	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SOCS4 mRNA	PMID:27131904
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315156	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SOCS4 gene	PMID:35295148
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315156	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SOCS4 mRNA	PMID:23557971
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306503	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of SOCS4 mRNA	PMID:23411599|PMID:34492290
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1315156	E	RGD:6480464	20120613	CTD	MESH:C006253	pirinixic acid results in decreased expression of SOCS4 mRNA	PMID:21318169
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1315156	E	RGD:6480464	20120613	CTD	MESH:C006253	PPARA protein affects the reaction [pirinixic acid results in decreased expression of SOCS4 mRNA]	PMID:21318169
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306503	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SOCS4 mRNA	PMID:25181051
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306503	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of SOCS4 mRNA	PMID:32145629
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315156	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of SOCS4 mRNA	PMID:38685157
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1315156	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of SOCS4 intron	PMID:28392331
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of SOCS4 mRNA	PMID:37042841
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315156	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SOCS4 mRNA	PMID:37236586
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of SOCS4 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of SOCS4 mRNA	PMID:32699268
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of SOCS4 mRNA	PMID:40419075
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315156	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SOCS4 mRNA	PMID:36331819
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315156	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of SOCS4 mRNA	PMID:17292431
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of SOCS4 mRNA	PMID:25562108
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in decreased expression of SOCS4 mRNA	PMID:24935251
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of SOCS4 mRNA	PMID:22230336
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315156	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SOCS4 mRNA	PMID:40504410
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306503	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of SOCS4 mRNA	PMID:29097150
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of SOCS4 mRNA	PMID:28988120
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315156	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of SOCS4 mRNA	PMID:22206623
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to SOCS4 gene]	PMID:28238834
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of SOCS4 mRNA	PMID:24921660
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1315156	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of SOCS4 mRNA	PMID:27131904
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:9150	simvastatin	increases expression	ISO	RGD:1315156	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of SOCS4 mRNA; Simvastatin results in increased expression of SOCS4 protein	PMID:19262002
1315155	SOCS4	suppressor of cytokine signaling 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306503	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of SOCS4 mRNA	PMID:21346803
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of KLHDC2 mRNA	PMID:33167477
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of KLHDC2 mRNA	PMID:26079696
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1315158	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of KLHDC2 mRNA	PMID:30319688
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of KLHDC2 mRNA	PMID:21632981
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315158	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KLHDC2 mRNA	PMID:39241906
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of KLHDC2 mRNA	PMID:31614463
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of KLHDC2 mRNA	PMID:37042841
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of KLHDC2 mRNA	PMID:23649840
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	Cuprizone results in decreased expression of KLHDC2 protein	PMID:34122009
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Benztropine] results in increased expression of KLHDC2 protein; [Cuprizone co-treated with Haloperidol] results in increased expression of KLHDC2 protein	PMID:34122009
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of KLHDC2 mRNA	PMID:28818685
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KLHDC2 mRNA	PMID:35301059
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of KLHDC2 mRNA	PMID:19549813
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of KLHDC2 mRNA	PMID:22100608
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of KLHDC2 gene	PMID:27153756
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of KLHDC2 mRNA	PMID:23649840
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1315158	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of KLHDC2 mRNA	PMID:27339419|PMID:31919559
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315158	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of KLHDC2 mRNA]	PMID:22206623
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of KLHDC2 mRNA	PMID:23557933
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of KLHDC2 mRNA	PMID:27392435
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of KLHDC2 mRNA	PMID:27392435
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315158	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KLHDC2 mRNA	PMID:21570461
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of KLHDC2 mRNA	PMID:33512557
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of KLHDC2 mRNA	PMID:33212167
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1315158	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of KLHDC2 mRNA	PMID:39631538
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of KLHDC2 mRNA	PMID:22378314
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KLHDC2 mRNA	PMID:32234424
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KLHDC2 promoter	PMID:27901495
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:3048	benzatropine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	[Cuprizone co-treated with Benztropine] results in increased expression of KLHDC2 protein	PMID:34122009
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of KLHDC2 mRNA	PMID:25895662
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of KLHDC2 mRNA	PMID:19150397
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:31767	lead diacetate	decreases expression	ISO	RGD:1315158	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in decreased expression of KLHDC2 mRNA	PMID:21829687
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306504	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of KLHDC2 mRNA	PMID:25729387
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315158	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of KLHDC2 gene	PMID:35295148
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306504	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KLHDC2 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306504	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of KLHDC2 mRNA	PMID:36041667
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1306504	E	RGD:6480464	20170516	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of KLHDC2 mRNA	PMID:27914987
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1315158	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of KLHDC2 gene	PMID:31683443
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315158	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of KLHDC2 mRNA	PMID:39298647
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306504	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of KLHDC2 mRNA	PMID:36041667
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306504	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of KLHDC2 mRNA	PMID:36041667
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1315158	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of KLHDC2 mRNA	PMID:28392331
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KLHDC2 mRNA	PMID:37042841
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KLHDC2 mRNA	PMID:38568856
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of KLHDC2 mRNA	PMID:35301059
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of KLHDC2 mRNA	PMID:24449571
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:3766	clozapine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of KLHDC2 protein	PMID:34122009
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of KLHDC2 mRNA	PMID:28302478
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of KLHDC2 mRNA	PMID:40419075
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of KLHDC2 mRNA	PMID:25979313
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of KLHDC2 mRNA	PMID:23179753
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of KLHDC2 mRNA	PMID:25562108
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of KLHDC2 mRNA	PMID:27989131
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1315158	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of KLHDC2 mRNA	PMID:17555576
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of KLHDC2 mRNA	PMID:38832940
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315158	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KLHDC2 mRNA	PMID:17562736
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of KLHDC2 mRNA	PMID:29067470
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306504	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of KLHDC2 mRNA	PMID:33387578
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KLHDC2 mRNA	PMID:22079256
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1315158	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of KLHDC2 mRNA	PMID:17555576
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315158	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of KLHDC2 mRNA	PMID:25554681
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306504	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of KLHDC2 mRNA	PMID:24136188
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1306504	E	RGD:6480464	20140909	CTD	MESH:D005485	Flutamide results in decreased expression of KLHDC2 mRNA	PMID:24793618
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306504	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of KLHDC2 mRNA	PMID:24136188
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:5613	haloperidol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in increased expression of KLHDC2 protein	PMID:34122009
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306504	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of KLHDC2 mRNA	PMID:25729387
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315158	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of KLHDC2 mRNA	PMID:22206623
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315158	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of KLHDC2 mRNA]	PMID:22206623
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306504	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of KLHDC2 mRNA	PMID:24136188
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of KLHDC2 mRNA	PMID:22079256
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of KLHDC2 mRNA	PMID:22079256
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in decreased expression of KLHDC2 mRNA	PMID:22124623
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:7903	pamidronate	decreases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:C019248	Pamidronate results in decreased expression of KLHDC2 mRNA	PMID:38447685
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KLHDC2 gene]	PMID:28238834
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:8489	propiconazole	increases expression	ISO	RGD:1315158	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in increased expression of KLHDC2 mRNA	PMID:21278054
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306504	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of KLHDC2 mRNA	PMID:21346803
1315157	KLHDC2	kelch domain containing 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306504	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of KLHDC2 mRNA	PMID:21346803
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315161	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MMD2 mRNA	PMID:33045310
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306506	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMD2 mRNA]	PMID:31150632
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MMD2 mRNA	PMID:36331819
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of MMD2 mRNA	PMID:24763279
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1315161	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MMD2 mRNA	PMID:30319688
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315161	E	RGD:6480464	20120814	CTD	MESH:D000431	Ethanol results in increased expression of MMD2 mRNA	PMID:19167417|PMID:30319688
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315161	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MMD2 mRNA	PMID:39241906
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MMD2 mRNA]	PMID:39241906
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of MMD2 mRNA	PMID:32145629
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315161	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of MMD2 mRNA	PMID:19484750|PMID:39298647
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20180116	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MMD2 mRNA	PMID:28973375
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MMD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MMD2 mRNA	PMID:37992649
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20120613	CTD	MESH:D013739	Testosterone results in decreased expression of MMD2 mRNA	PMID:20844152|PMID:21669218
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MMD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MMD2 mRNA	PMID:37992649
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of MMD2 mRNA	PMID:34319233
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MMD2 mRNA	PMID:36331819
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:18258	3,3',5-triiodo-L-thyronine	increases expression	ISO	RGD:1306506	E	RGD:6480464	20181016	CTD	MESH:D014284	Triiodothyronine results in increased expression of MMD2 mRNA	PMID:29357290
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306506	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of MMD2 mRNA	PMID:28522335
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:23115	chlorohydrocarbon	multiple interactions	ISO	RGD:1306506	E	RGD:6480464	20210112	CTD	MESH:D006843	[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of MMD2 mRNA	PMID:30744511
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306506	E	RGD:6480464	20120731	CTD	MESH:C016517	indole-3-carbinol affects the expression of MMD2 mRNA	PMID:21396975
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20121113	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MMD2 mRNA	PMID:22484513|PMID:33354967
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MMD2 intron	PMID:30157460
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MMD2 mRNA	PMID:31150632
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of MMD2 mRNA	PMID:31919559
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306506	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MMD2 mRNA]	PMID:31150632
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MMD2 mRNA	PMID:25629700
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MMD2 mRNA]	PMID:37992649
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MMD2 mRNA	PMID:31881176
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1315161	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of MMD2 mRNA	PMID:32186404
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315161	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MMD2 mRNA	PMID:26377647
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MMD2 mRNA	PMID:21215274|PMID:32109520
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MMD2 mRNA	PMID:18172886
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315161	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MMD2 mRNA	PMID:19465110
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MMD2 mRNA	PMID:17942748
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1306506	E	RGD:6480464	20210112	CTD	MESH:C004925	[Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of MMD2 mRNA	PMID:30744511
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1306506	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in decreased expression of MMD2 mRNA	PMID:26033743
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20260707	CTD	MESH:D005632	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MMD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MMD2 mRNA	PMID:37992649
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20260707	CTD	MESH:D015084	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MMD2 mRNA]	PMID:37992649
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MMD2 exon; Benzo(a)pyrene results in increased methylation of MMD2 promoter	PMID:27901495
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1306506	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in decreased expression of MMD2 mRNA	PMID:26033743
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:30563	silicon dioxide	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20140715	CTD	MESH:D012822	Silicon Dioxide results in decreased expression of MMD2 mRNA	PMID:23221170
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:31575	ethylparaben	decreases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C012313	ethyl-p-hydroxybenzoate results in decreased expression of MMD2 mRNA	PMID:37690743
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:3179	bromobenzene	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20200915	CTD	MESH:C032036	bromobenzene results in decreased expression of MMD2 mRNA	PMID:32479839
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315161	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MMD2 gene; titanium dioxide results in decreased methylation of MMD2 promoter	PMID:35295148
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in decreased expression of MMD2 mRNA	PMID:23411599
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in decreased expression of MMD2 mRNA	PMID:23811191
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20120731	CTD	MESH:C069837	fullerene C60 results in decreased expression of MMD2 mRNA	PMID:19167457
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306506	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of MMD2 mRNA	PMID:25181051|PMID:32145629
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MMD2 mRNA	PMID:34947998
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315161	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of MMD2 mRNA	PMID:33221593
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1315161	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MMD2 promoter	PMID:27312807
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:34260	anthracen-2-amine	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20130312	CTD	MESH:C006593	2-anthramine results in decreased expression of MMD2 mRNA	PMID:23038007
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of MMD2 mRNA	PMID:26377693
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of MMD2 intron	PMID:30157460
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:34569	Benzo[k]fluoranthene	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in decreased expression of MMD2 mRNA	PMID:26377693
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1315161	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of MMD2 intron	PMID:28392331
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:34631	chlorpyrifos	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in decreased expression of MMD2 mRNA	PMID:37019170
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20120731	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MMD2 mRNA	PMID:21266533
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of MMD2 mRNA	PMID:21266533
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306506	E	RGD:6480464	20210810	CTD	MESH:D026023	[Permethrin co-treated with DEET] results in increased methylation of MMD2 gene	PMID:33148267
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MMD2 mRNA]	PMID:39241906
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:35299	dibenz[a,h]anthracene	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in decreased expression of MMD2 mRNA	PMID:26377693
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in decreased expression of MMD2 mRNA	PMID:30723492
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of MMD2 mRNA	PMID:25812627
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:35559	furan	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in decreased expression of MMD2 mRNA	PMID:26194646
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MMD2 mRNA	PMID:25812627
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1315161	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of MMD2 mRNA	PMID:40194260
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:38922	dibenzofurans	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in decreased expression of MMD2 mRNA	PMID:34254344
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of MMD2 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MMD2 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of MMD2 mRNA	PMID:36331819
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306506	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in increased expression of MMD2 mRNA	PMID:41580965
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1315161	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of MMD2 mRNA	PMID:20937368
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1315161	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of MMD2 mRNA	PMID:22841776|PMID:25123088
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:41774	tamoxifen	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20130416	CTD	MESH:D013629	ESR1 protein affects the reaction [Tamoxifen results in increased expression of MMD2 mRNA]	PMID:22841776
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1315161	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MMD2 mRNA	PMID:28973697
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20260707	CTD	MESH:D005947	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MMD2 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of MMD2 mRNA	PMID:37992649
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306506	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of MMD2 mRNA	PMID:29391264
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of MMD2 mRNA	PMID:35436446
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MMD2 mRNA	PMID:17942748
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of MMD2 mRNA; Nanotubes, Carbon results in decreased expression of MMD2 mRNA	PMID:25620056
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of MMD2 mRNA	PMID:26377693
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:6121	ketamine	increases expression	ISO	RGD:1306506	E	RGD:6480464	20121218	CTD	MESH:D007649	Ketamine results in increased expression of MMD2 mRNA	PMID:20080153
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of MMD2 intron	PMID:30157460
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306506	E	RGD:6480464	20210810	CTD	MESH:D003671	[Permethrin co-treated with DEET] results in increased methylation of MMD2 gene	PMID:33148267
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to MMD2 gene]	PMID:28238834
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306506	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of MMD2 mRNA	PMID:32109520
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1315161	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of MMD2 mRNA]	PMID:39241906
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:8772	raloxifene	increases expression	ISO	RGD:1315161	E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in increased expression of MMD2 mRNA	PMID:22841776
1315160	MMD2	monocyte to macrophage differentiation associated 2	gene	CHEBI:9747	Triptolide	decreases expression	ISO	RGD:1315161	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in decreased expression of MMD2 mRNA	PMID:32835833
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ERLEC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ERLEC1 mRNA	PMID:32699268
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of ERLEC1 mRNA	PMID:29581250
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315164	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of ERLEC1 mRNA	PMID:39298647
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306508	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of ERLEC1 protein	PMID:34915118
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315164	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ERLEC1 mRNA	PMID:37325564
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ERLEC1 mRNA	PMID:19549813
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ERLEC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ERLEC1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of ERLEC1 mRNA	PMID:32699268
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315164	E	RGD:6480464	20230704	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ERLEC1 mRNA	PMID:27106289
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315164	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ERLEC1 mRNA	PMID:22206623
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306508	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ERLEC1 mRNA	PMID:33387578
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315164	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ERLEC1 promoter]	PMID:19654925
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ERLEC1 mRNA	PMID:33212167
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ERLEC1 mRNA	PMID:30851411
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306508	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of ERLEC1 mRNA	PMID:28959563
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ERLEC1 mRNA	PMID:38568856
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of ERLEC1 mRNA	PMID:22378314
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ERLEC1 mRNA	PMID:19150397
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315164	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of ERLEC1 gene	PMID:35295148
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306508	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ERLEC1 mRNA	PMID:34492290
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ERLEC1 mRNA	PMID:30903817
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in decreased expression of ERLEC1 mRNA	PMID:25047013|PMID:29275510
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315164	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ERLEC1 mRNA	PMID:33221593
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306508	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ERLEC1 mRNA	PMID:25181051
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:34568	Benzo[ghi]perylene	increases expression	ISO	RGD:1315164	E	RGD:6480464	20160119	CTD	MESH:C006718	1,12-benzoperylene results in increased expression of ERLEC1 mRNA	PMID:26377693
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1315164	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of ERLEC1 mRNA	PMID:28392331
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1315164	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ERLEC1 mRNA	PMID:34813904
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1315164	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ERLEC1 mRNA	PMID:34813904
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ERLEC1 mRNA	PMID:38568856
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306508	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ERLEC1 mRNA	PMID:33453195
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315164	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ERLEC1 mRNA	PMID:37325564
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ERLEC1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ERLEC1 mRNA	PMID:32699268
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ERLEC1 mRNA	PMID:40419075
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:3962	curcumin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D003474	Curcumin results in increased expression of ERLEC1 mRNA	PMID:38229314
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ERLEC1 mRNA	PMID:25979313
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of ERLEC1 mRNA	PMID:17183730
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of ERLEC1 mRNA	PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1306508	E	RGD:6480464	20201103	CTD	MESH:D004726	Endosulfan affects the expression of ERLEC1 mRNA	PMID:31464424
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ERLEC1 mRNA	PMID:22079256
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315164	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ERLEC1 mRNA; Nanotubes, Carbon results in decreased expression of ERLEC1 mRNA	PMID:25554681
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of ERLEC1 mRNA	PMID:17183730
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:6030	isoniazide	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in increased expression of ERLEC1 protein	PMID:40015660
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ERLEC1 protein	PMID:32959892
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of ERLEC1 protein	PMID:34186270
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315164	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ERLEC1 mRNA	PMID:22206623
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315164	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ERLEC1 mRNA	PMID:22206623
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ERLEC1 mRNA	PMID:22079256
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ERLEC1 mRNA	PMID:22079256
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ERLEC1 mRNA	PMID:30851411
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1315164	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of ERLEC1 mRNA	PMID:23091169
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1315164	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of ERLEC1 mRNA	PMID:30953684
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1315164	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in increased expression of ERLEC1 mRNA	PMID:21795629
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1315164	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of ERLEC1 mRNA	PMID:28973697
1315163	ERLEC1	endoplasmic reticulum lectin 1	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306508	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of ERLEC1 mRNA	PMID:23869203
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:10022	deoxynivalenol	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C007262	deoxynivalenol results in increased expression of RUVBL2 mRNA	PMID:31863870
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:10033	warfarin	decreases expression	ISO	RGD:1315166	E	RGD:6480464	20141111	CTD	MESH:D014859	Warfarin results in decreased expression of RUVBL2 mRNA	PMID:20493250
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of RUVBL2 mRNA	PMID:38218311
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1315166	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of RUVBL2 mRNA	PMID:33045310
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306509	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RUVBL2 mRNA]	PMID:31150632
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of RUVBL2 mRNA	PMID:16140955|PMID:23724009
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Thiophenes analog promotes the reaction [Tretinoin results in decreased expression of RUVBL2 mRNA]	PMID:16140955
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUVBL2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUVBL2 mRNA	PMID:32699268
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of RUVBL2 mRNA	PMID:22378314
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of RUVBL2 mRNA	PMID:20044591
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:16243	quercetin	affects binding	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin analog binds to RUVBL2 protein	PMID:21798748
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315166	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RUVBL2 mRNA	PMID:39241906
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306509	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of RUVBL2 mRNA	PMID:32145629
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of RUVBL2 mRNA	PMID:38568856
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RUVBL2 mRNA	PMID:37042841
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:17447	geraniol	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in decreased expression of RUVBL2 mRNA	PMID:27683099
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:17580	linalool	decreases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C018584	linalool results in decreased expression of RUVBL2 mRNA	PMID:27683099
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306509	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of RUVBL2 mRNA	PMID:26577399
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315166	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RUVBL2 mRNA	PMID:36331819
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1315166	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of RUVBL2 mRNA	PMID:27462272
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RUVBL2 protein	PMID:33040242
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:24757	hypochlorous acid	decreases expression	ISO	RGD:1315166	E	RGD:6480464	20120412	CTD	MESH:D006997	Hypochlorous Acid results in decreased expression of RUVBL2 mRNA	PMID:19376150
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RUVBL2 gene	PMID:27153756
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUVBL2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUVBL2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of RUVBL2 mRNA	PMID:32699268
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315166	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RUVBL2 mRNA	PMID:34911549
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of RUVBL2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of RUVBL2 protein	PMID:38598786
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:26961	thiophenes	multiple interactions	EXP		E	RGD:6480464	20170103	CTD	MESH:D013876	Thiophenes analog promotes the reaction [Tretinoin results in decreased expression of RUVBL2 mRNA]	PMID:16140955
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306509	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RUVBL2 mRNA	PMID:31150632
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1315166	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RUVBL2 mRNA	PMID:31919559
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306509	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RUVBL2 mRNA]	PMID:31150632
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of RUVBL2 mRNA	PMID:19244175
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RUVBL2 protein	PMID:35688186
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:27744	glyphosate	increases methylation	ISO	RGD:1306509	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased methylation of RUVBL2 gene	PMID:31011160
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of RUVBL2 mRNA	PMID:19921347
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D002945	Cisplatin results in increased expression of RUVBL2 protein	PMID:20540955
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306509	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RUVBL2 mRNA	PMID:22298810
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315166	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RUVBL2 mRNA	PMID:21570461|PMID:24680724
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306509	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RUVBL2 mRNA	PMID:21215274
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306509	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of RUVBL2 mRNA	PMID:33387578
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315166	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RUVBL2 mRNA	PMID:17942748
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of RUVBL2 mRNA	PMID:20971185
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of RUVBL2 mRNA	PMID:38568856
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1306509	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in decreased expression of RUVBL2 protein	PMID:29459688
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of RUVBL2 mRNA	PMID:34032870|PMID:39719251
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1315166	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RUVBL2 exon; Benzo(a)pyrene results in increased methylation of RUVBL2 intron	PMID:27901495
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to RUVBL2 protein]	PMID:32406909
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of RUVBL2 mRNA	PMID:20971185
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:3048	benzatropine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in increased expression of RUVBL2 protein	PMID:34122009
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:30621	diarsenic trioxide	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RUVBL2 protein]	PMID:26598702
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:32234	titanium dioxide	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C009495	titanium dioxide results in increased expression of RUVBL2 protein	PMID:30910687
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306509	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of RUVBL2 mRNA	PMID:23411599|PMID:34492290
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1315166	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of RUVBL2 mRNA	PMID:19710929
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of RUVBL2 mRNA; bisphenol A results in decreased expression of RUVBL2 protein	PMID:29275510|PMID:31675489
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306509	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RUVBL2 mRNA	PMID:25181051
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1315166	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of RUVBL2 mRNA	PMID:17361019|PMID:21266533
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1315166	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of RUVBL2 mRNA	PMID:34813904
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of RUVBL2 protein	PMID:38598786
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1315166	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of RUVBL2 mRNA	PMID:34813904
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:34905	paraquat	increases expression	ISO	RGD:1306509	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in increased expression of RUVBL2 mRNA	PMID:32680482
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20210706	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RUVBL2 protein	PMID:33040242
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RUVBL2 mRNA	PMID:19376846
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:36704	imiquimod	decreases expression	ISO	RGD:1315166	E	RGD:6480464	20120412	CTD	MESH:C056493	imiquimod results in decreased expression of RUVBL2 mRNA	PMID:21878529
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RUVBL2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RUVBL2 mRNA	PMID:32699268
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of RUVBL2 mRNA	PMID:19244175
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone promotes the reaction [NDRG1 protein binds to RUVBL2 protein]	PMID:17220478
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of RUVBL2 mRNA	PMID:31533062
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:3908	coumestrol	increases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in increased expression of RUVBL2 mRNA	PMID:19167446
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of RUVBL2 mRNA	PMID:27153767
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315166	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RUVBL2 mRNA	PMID:36331819
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of RUVBL2 mRNA	PMID:25979313
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of RUVBL2 mRNA	PMID:23179753|PMID:29154799
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RUVBL2 gene	PMID:29154799
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306509	E	RGD:6480464	20260407	CTD	MESH:D000640	Amitrole results in decreased expression of RUVBL2 mRNA	PMID:41580965
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:40303	lovastatin	decreases expression	ISO	RGD:1315166	E	RGD:6480464	20120814	CTD	MESH:D008148	Lovastatin results in decreased expression of RUVBL2 mRNA	PMID:20493250
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1315166	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of RUVBL2 mRNA	PMID:17555576
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:45863	paclitaxel	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of RUVBL2 protein	PMID:15907983
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315166	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RUVBL2 mRNA	PMID:17562736
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of RUVBL2 mRNA	PMID:22230336
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1315166	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of RUVBL2 mRNA	PMID:35436446
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1315166	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of RUVBL2 mRNA	PMID:17555576
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1315166	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RUVBL2 mRNA	PMID:17942748
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315166	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RUVBL2 mRNA	PMID:17942748
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:49900	arsenous acid	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to RUVBL2 protein]	PMID:26598702
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1315166	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RUVBL2 mRNA	PMID:35964746
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306509	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of RUVBL2 mRNA	PMID:24136188
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RUVBL2 protein	PMID:32959892
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1315166	E	RGD:6480464	20160210	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of RUVBL2 protein	PMID:26558463
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:64215	2,3-dimethoxynaphthalene-1,4-dione	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:C063002	2,3-dimethoxy-1,4-naphthoquinone results in increased expression of RUVBL2 mRNA	PMID:19031421
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of RUVBL2 mRNA	PMID:31758290
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315166	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of RUVBL2 mRNA	PMID:22206623
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306509	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of RUVBL2 mRNA	PMID:24136188
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of RUVBL2 protein	PMID:31285264
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of RUVBL2 protein	PMID:39638853
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:77424	4-amino-2,6-dinitrotoluene	affects expression	ISO	RGD:1306509	E	RGD:6480464	20140304	CTD	MESH:C035207	4-amino-2,6-dinitrotoluene affects the expression of RUVBL2 mRNA	PMID:21346803
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RUVBL2 gene]	PMID:28238834
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1315166	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of RUVBL2 mRNA	PMID:23091169
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1315166	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of RUVBL2 mRNA	PMID:30294300
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:82315	3,3'-Dichlorobenzidine	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D015101	3,3'-Dichlorobenzidine affects the expression of RUVBL2 protein	PMID:24604609
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306509	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of RUVBL2 mRNA	PMID:21346803
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:9381	T-2 toxin	affects expression	ISO	RGD:1306509	E	RGD:6480464	20151110	CTD	MESH:D013605	T-2 Toxin affects the expression of RUVBL2 protein	PMID:26141394
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:9381	T-2 toxin	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in increased expression of RUVBL2 mRNA	PMID:31863870
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of RUVBL2 mRNA	PMID:38568856
1315165	RUVBL2	RuvB like AAA ATPase 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of RUVBL2 protein	PMID:38598786
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1315168	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ZFP189 mRNA	PMID:20188158
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ZNF189 mRNA	PMID:21632981
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315168	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFP189 mRNA	PMID:39241906
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1306510	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in increased expression of ZFP189 mRNA	PMID:32145629
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of ZNF189 mRNA	PMID:21179406
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:17447	geraniol	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C007836	geraniol results in increased expression of ZNF189 mRNA	PMID:27683099
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306510	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of ZFP189 mRNA	PMID:26577399
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306510	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of ZFP189 mRNA	PMID:33387578
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ZNF189 mRNA	PMID:28818685
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:2038	5-azacytidine	decreases expression	EXP		E	RGD:6480464	20130910	CTD	MESH:D001374	Azacitidine results in decreased expression of ZNF189 mRNA	PMID:20823114
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZNF189 mRNA	PMID:35301059
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ZNF189 mRNA	PMID:19549813
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ZNF189 mRNA	PMID:22100608
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306510	E	RGD:6480464	20140311	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ZFP189 mRNA	PMID:23385219
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306510	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of ZFP189 mRNA	PMID:31150632
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF189 mRNA	PMID:39836092
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of ZNF189 mRNA	PMID:28903495
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306510	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ZFP189 mRNA	PMID:22298810
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306510	E	RGD:6480464	20121113	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ZFP189 mRNA	PMID:21215274|PMID:21724226
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF189 mRNA	PMID:29803840
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1315168	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of ZFP189 mRNA	PMID:39631538
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C017947	sodium arsenite results in decreased expression of ZNF189 mRNA	PMID:28595984|PMID:34032870
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF189 mRNA	PMID:38568856
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF189 mRNA	PMID:39836092
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ZNF189 mRNA	PMID:32234424
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315168	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ZFP189 gene	PMID:35295148
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306510	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ZNF189 mRNA	PMID:25181051
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306510	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of ZFP189 mRNA	PMID:32145629
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:3423	carmustine	increases expression	ISO	RGD:1306510	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in increased expression of ZNF189 mRNA	PMID:16005536
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF189 mRNA	PMID:28628672
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1315168	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ZFP189 mRNA	PMID:37019170
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF189 mRNA	PMID:28628672
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of ZNF189 mRNA	PMID:37042841
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306510	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of ZFP189 mRNA	PMID:30723492
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ZNF189 mRNA	PMID:35301059
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ZNF189 mRNA	PMID:28302478
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ZNF189 mRNA	PMID:31533062
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ZNF189 mRNA	PMID:25979313
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315168	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of ZFP189 mRNA	PMID:17292431
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of ZNF189 mRNA	PMID:23179753|PMID:28001369
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ZNF189 gene	PMID:29154799
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ZNF189 mRNA	PMID:20106945|PMID:25562108
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1315168	E	RGD:6480464	20150127	CTD	MESH:D016572	Cyclosporine results in increased expression of ZFP189 mRNA	PMID:25270620
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF189 mRNA	PMID:28628672
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1306510	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in increased expression of ZNF189 mRNA	PMID:16005536
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of ZNF189 mRNA	PMID:38832940
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315168	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ZFP189 mRNA	PMID:17562736
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZNF189 mRNA	PMID:21420995|PMID:29067470
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306510	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of ZFP189 mRNA	PMID:33387578
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of ZNF189 mRNA	PMID:22230336
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306510	E	RGD:6480464	20200915	CTD	MESH:D000082	Acetaminophen results in increased expression of ZFP189 mRNA	PMID:32479839
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZNF189 mRNA	PMID:39836092
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306510	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ZFP189 mRNA	PMID:29391264
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZNF189 mRNA	PMID:28628672
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1315168	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of ZFP189 mRNA	PMID:40234311
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1306510	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of ZFP189 mRNA	PMID:24136188
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1306510	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of ZFP189 mRNA	PMID:19564919
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1306510	E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of ZFP189 mRNA	PMID:19564919
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1306510	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of ZFP189 mRNA	PMID:30467583
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:73297	SCH 23390	multiple interactions	ISO	RGD:1306510	E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of ZFP189 mRNA	PMID:19564919
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315168	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ZFP189 mRNA	PMID:22206623
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF189 protein	PMID:31285264
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ZNF189 mRNA	PMID:30928695
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1306510	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ZFP189 mRNA	PMID:27291303
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:82341	Methylazoxymethanol acetate	increases expression	ISO	RGD:1306510	E	RGD:6480464	20171010	CTD	MESH:D008746	Methylazoxymethanol Acetate results in increased expression of ZFP189 mRNA	PMID:28349193
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306510	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of ZFP189 mRNA	PMID:24780913
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ZNF189 mRNA	PMID:29301935
1315167	ZNF189	zinc finger protein 189	gene	CHEBI:9555	tioguanine	increases expression	ISO	RGD:1306510	E	RGD:6480464	20130305	CTD	MESH:D013866	Thioguanine results in increased expression of ZNF189 mRNA	PMID:16005536
1315169	HOXD10	homeobox D10	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1315170	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of HOXD10 mRNA	PMID:37995155
1315169	HOXD10	homeobox D10	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315170	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HOXD10 gene	PMID:20938992
1315169	HOXD10	homeobox D10	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1306511	E	RGD:6480464	20120918	CTD	MESH:D014212	Tretinoin results in decreased expression of HOXD10 mRNA	PMID:22262565
1315169	HOXD10	homeobox D10	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of HOXD10 mRNA	PMID:23724009
1315169	HOXD10	homeobox D10	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of HOXD10 mRNA	PMID:26079696
1315169	HOXD10	homeobox D10	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of HOXD10 mRNA	PMID:35811015
1315169	HOXD10	homeobox D10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HOXD10 mRNA	PMID:35811015
1315169	HOXD10	homeobox D10	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol promotes the reaction [ESR2 protein affects the expression of HOXD10 mRNA]	PMID:20404318
1315169	HOXD10	homeobox D10	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315170	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HOXD10 gene	PMID:20938992
1315169	HOXD10	homeobox D10	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20200317	CTD	MESH:D005557	Formaldehyde results in increased expression of HOXD10 mRNA	PMID:27905399
1315169	HOXD10	homeobox D10	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of HOXD10 mRNA	PMID:26079696
1315169	HOXD10	homeobox D10	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306511	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of HOXD10 mRNA	PMID:33387578
1315169	HOXD10	homeobox D10	gene	CHEBI:196991	4-hydroperoxycyclophosphamide	increases expression	ISO	RGD:1315170	E	RGD:6480464	20120814	CTD	MESH:C011272	perfosfamide results in increased expression of HOXD10 mRNA	PMID:19429390
1315169	HOXD10	homeobox D10	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20150414	CTD	MESH:D002104	Cadmium results in decreased expression of HOXD10 mRNA	PMID:23369406
1315169	HOXD10	homeobox D10	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of HOXD10 exon; Aflatoxin B1 results in decreased methylation of HOXD10 gene	PMID:27153756|PMID:30157460
1315169	HOXD10	homeobox D10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315170	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of HOXD10 gene	PMID:20938992
1315169	HOXD10	homeobox D10	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of HOXD10 mRNA	PMID:27392435
1315169	HOXD10	homeobox D10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315170	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of HOXD10 mRNA	PMID:24058054
1315169	HOXD10	homeobox D10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306511	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of HOXD10 mRNA	PMID:33387578|PMID:34747641
1315169	HOXD10	homeobox D10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of HOXD10 mRNA	PMID:17101203
1315169	HOXD10	homeobox D10	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306511	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of HOXD10 mRNA	PMID:30556269
1315169	HOXD10	homeobox D10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1315170	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of HOXD10 mRNA	PMID:37682722
1315169	HOXD10	homeobox D10	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of HOXD10 exon	PMID:27901495
1315169	HOXD10	homeobox D10	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315170	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of HOXD10 mRNA	PMID:22228805
1315169	HOXD10	homeobox D10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of HOXD10 3' UTR; Benzo(a)pyrene results in decreased methylation of HOXD10 promoter	PMID:27901495
1315169	HOXD10	homeobox D10	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of HOXD10 promoter	PMID:23974009
1315169	HOXD10	homeobox D10	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306511	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of HOXD10 mRNA	PMID:30556269
1315169	HOXD10	homeobox D10	gene	CHEBI:30512	silver atom	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of HOXD10 mRNA	PMID:26551752
1315169	HOXD10	homeobox D10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315170	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of HOXD10 promoter	PMID:35295148
1315169	HOXD10	homeobox D10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306511	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of HOXD10 mRNA	PMID:25181051
1315169	HOXD10	homeobox D10	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1315170	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of HOXD10 mRNA	PMID:26682919
1315169	HOXD10	homeobox D10	gene	CHEBI:35546	perfluorodecanoic acid	increases expression	ISO	RGD:1315170	E	RGD:6480464	20200915	CTD	MESH:C036567	perfluorodecanoic acid results in increased expression of HOXD10 mRNA	PMID:32534105
1315169	HOXD10	homeobox D10	gene	CHEBI:35546	perfluorodecanoic acid	multiple interactions	ISO	RGD:1315170	E	RGD:6480464	20200915	CTD	MESH:C036567	PPARA protein affects the reaction [perfluorodecanoic acid results in increased expression of HOXD10 mRNA]	PMID:32534105
1315169	HOXD10	homeobox D10	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1315170	E	RGD:6480464	20200915	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of HOXD10 mRNA	PMID:32534105
1315169	HOXD10	homeobox D10	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1315170	E	RGD:6480464	20200915	CTD	MESH:C023036	PPARA protein affects the reaction [perfluorooctanoic acid results in increased expression of HOXD10 mRNA]	PMID:32534105
1315169	HOXD10	homeobox D10	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1315170	E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of HOXD10 mRNA	PMID:32534105
1315169	HOXD10	homeobox D10	gene	CHEBI:38397	perfluorononanoic acid	multiple interactions	ISO	RGD:1315170	E	RGD:6480464	20220111	CTD	MESH:C101816	NFE2L2 protein affects the reaction [perfluoro-n-nonanoic acid results in increased expression of HOXD10 mRNA]; PPARA protein affects the reaction [perfluoro-n-nonanoic acid results in increased expression of HOXD10 mRNA]	PMID:32534105
1315169	HOXD10	homeobox D10	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of HOXD10 mRNA	PMID:19101580
1315169	HOXD10	homeobox D10	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306511	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of HOXD10 mRNA	PMID:33387578
1315169	HOXD10	homeobox D10	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of HOXD10 mRNA	PMID:35811015
1315169	HOXD10	homeobox D10	gene	CHEBI:50924	sorafenib	increases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C471405	Sorafenib results in increased expression of HOXD10 protein	PMID:38197552
1315169	HOXD10	homeobox D10	gene	CHEBI:50924	sorafenib	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:C471405	[Sorafenib co-treated with Ropivacaine] results in increased expression of HOXD10 protein; MIR224 inhibits the reaction [[Sorafenib co-treated with Ropivacaine] results in increased expression of HOXD10 protein]	PMID:38197552
1315169	HOXD10	homeobox D10	gene	CHEBI:53050	trimellitic anhydride	decreases expression	ISO	RGD:1315170	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in decreased expression of HOXD10 mRNA	PMID:19042947
1315169	HOXD10	homeobox D10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1306511	E	RGD:6480464	20180220	CTD	MESH:D019813	[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of HOXD10 mRNA	PMID:27840820
1315169	HOXD10	homeobox D10	gene	CHEBI:84069	pentanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in increased expression of HOXD10 mRNA	PMID:26079696
1315169	HOXD10	homeobox D10	gene	CHEBI:8890	(S)-ropivacaine	increases expression	EXP		E	RGD:6480464	20240903	CTD	MESH:C037663	Ropivacaine results in increased expression of HOXD10 protein	PMID:38197552
1315169	HOXD10	homeobox D10	gene	CHEBI:8890	(S)-ropivacaine	multiple interactions	EXP		E	RGD:6480464	20240903	CTD	MESH:C037663	[Sorafenib co-treated with Ropivacaine] results in increased expression of HOXD10 protein; MIR224 inhibits the reaction [[Sorafenib co-treated with Ropivacaine] results in increased expression of HOXD10 protein]	PMID:38197552
1315169	HOXD10	homeobox D10	gene	CHEBI:9141	silver(0)	decreases expression	EXP		E	RGD:6480464	20160210	CTD	MESH:D012834	Silver results in decreased expression of HOXD10 mRNA	PMID:26551752
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306513	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACOT13 mRNA]	PMID:31150632
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ACOT13 mRNA	PMID:22378314
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of ACOT13 mRNA	PMID:21179406
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D011794	Quercetin results in decreased expression of ACOT13 mRNA	PMID:21632981
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306513	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of ACOT13 mRNA	PMID:32145629
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1315173	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of ACOT13 mRNA	PMID:39298647
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306513	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of ACOT13 mRNA	PMID:33387578
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACOT13 mRNA	PMID:37042841
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C044887	beta-methylcholine affects the expression of ACOT13 mRNA	PMID:21179406
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1315173	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of ACOT13 mRNA	PMID:17997037
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1315173	E	RGD:6480464	20240402	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ACOT13 mRNA	PMID:35550907
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315173	E	RGD:6480464	20151110	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ACOT13 mRNA	PMID:19850644|PMID:33754040|PMID:35716406
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1315173	E	RGD:6480464	20151110	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACOT13 mRNA]	PMID:19850644
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ACOT13 mRNA	PMID:28818685
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315173	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACOT13 mRNA	PMID:36331819
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1315173	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of ACOT13 mRNA	PMID:17997037
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ACOT13 mRNA	PMID:19549813
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of ACOT13 mRNA	PMID:22100608
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:25812	ozone	increases expression	ISO	RGD:1306513	E	RGD:6480464	20210209	CTD	MESH:D010126	Ozone results in increased expression of ACOT13 protein	PMID:33146391
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of ACOT13 protein	PMID:38598786
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:27375	vincaleukoblastine	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D014747	ACOT13 protein affects the susceptibility to Vinblastine	PMID:16217747
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306513	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACOT13 mRNA	PMID:31150632
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1315173	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of ACOT13 mRNA	PMID:27339419|PMID:31919559
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306513	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACOT13 mRNA]	PMID:31150632
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1315173	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of ACOT13 mRNA	PMID:25629700
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315173	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACOT13 mRNA	PMID:22206623
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306513	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ACOT13 mRNA	PMID:31881176
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:27881	resveratrol	increases expression	ISO	RGD:1315173	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ACOT13 protein	PMID:25505154
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of ACOT13 mRNA	PMID:23300844
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of ACOT13 mRNA	PMID:27392435
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315173	E	RGD:6480464	20151110	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACOT13 mRNA	PMID:21570461
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306513	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ACOT13 mRNA	PMID:21215274
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306513	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ACOT13 mRNA	PMID:33387578
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315173	E	RGD:6480464	20151110	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACOT13 mRNA	PMID:17942748
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1306513	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of ACOT13 mRNA	PMID:28374803
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in increased expression of ACOT13 mRNA	PMID:29955902
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of ACOT13 mRNA	PMID:27188386
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of ACOT13 mRNA	PMID:33212167
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ACOT13 mRNA	PMID:29803840
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D024483	Vitamin K 3 affects the expression of ACOT13 mRNA	PMID:20044591
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite results in increased expression of ACOT13 protein	PMID:38228842
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of ACOT13 mRNA	PMID:22378314
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of ACOT13 promoter	PMID:27901495
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ACOT13 mRNA	PMID:26238291|PMID:32234424
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of ACOT13 mRNA	PMID:20382639
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306513	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of ACOT13 mRNA	PMID:25729387
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315173	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of ACOT13 mRNA	PMID:23557971
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306513	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of ACOT13 mRNA	PMID:34492290
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1315173	E	RGD:6480464	20151110	CTD	MESH:C006253	pirinixic acid results in decreased expression of ACOT13 mRNA	PMID:18445702
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315173	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of ACOT13 mRNA	PMID:18301758
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306513	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ACOT13 mRNA	PMID:25181051
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in decreased expression of ACOT13 protein	PMID:34186270
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306513	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of ACOT13 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315173	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of ACOT13 mRNA	PMID:33221593
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306513	E	RGD:6480464	20190219	CTD	MESH:C006780	bisphenol A results in increased expression of ACOT13 mRNA	PMID:29552716
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315173	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of ACOT13 mRNA	PMID:26063408
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306513	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of ACOT13 gene	PMID:28505145
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of ACOT13 mRNA	PMID:25979313
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315173	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ACOT13 mRNA	PMID:39298647|PMID:40203079
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1315173	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ACOT13 mRNA	PMID:38685157
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of ACOT13 protein	PMID:34186270
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315173	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of ACOT13 mRNA	PMID:38685157
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306513	E	RGD:6480464	20151110	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of ACOT13 mRNA	PMID:21266533
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1315173	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of ACOT13 mRNA	PMID:34813904
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of ACOT13 protein	PMID:38598786
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1315173	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of ACOT13 mRNA	PMID:34813904
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306513	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ACOT13 mRNA	PMID:33453195
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1306513	E	RGD:6480464	20220705	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ACOT13 protein	PMID:34958885
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306513	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of ACOT13 mRNA	PMID:24386269
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1315173	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of ACOT13 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACOT13 mRNA]	PMID:17585979
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1315173	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ACOT13 mRNA	PMID:40194260
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of ACOT13 mRNA	PMID:28302478
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ACOT13 mRNA	PMID:31533062
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:39285	chloropicrin	increases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C100187	chloropicrin results in increased expression of ACOT13 mRNA	PMID:26352163
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315173	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACOT13 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ACOT13 mRNA	PMID:36331819
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of ACOT13 mRNA	PMID:25979313
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of ACOT13 gene	PMID:29154799
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of ACOT13 mRNA	PMID:25562108
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in increased expression of ACOT13 mRNA	PMID:27989131
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315173	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACOT13 mRNA	PMID:17562736
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in increased expression of ACOT13 mRNA	PMID:25704631
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306513	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of ACOT13 mRNA	PMID:33387578
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1315173	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of ACOT13 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACOT13 mRNA]	PMID:17585979
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	ACOT13 protein affects the susceptibility to Fluorouracil	PMID:16217747
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1306513	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of ACOT13 mRNA	PMID:29391264
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ACOT13 mRNA	PMID:22079256
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1315173	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of ACOT13 mRNA	PMID:35436446
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1315173	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ACOT13 mRNA	PMID:17555576
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315173	E	RGD:6480464	20151110	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACOT13 mRNA	PMID:17942748
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of ACOT13 mRNA	PMID:23300844
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315173	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ACOT13 mRNA; Nanotubes, Carbon results in decreased expression of ACOT13 mRNA	PMID:25554681|PMID:25620056
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1315173	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ACOT13 mRNA	PMID:35964746
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:53001	nickel sulfate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in increased expression of ACOT13 mRNA	PMID:22714537
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D015474	Isotretinoin results in decreased expression of ACOT13 mRNA	PMID:20436886
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ACOT13 protein	PMID:32959892
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:63632	topotecan	decreases expression	ISO	RGD:1306513	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in decreased expression of ACOT13 mRNA	PMID:25729387
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306513	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of ACOT13 mRNA	PMID:25729387
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:63634	valdecoxib	decreases expression	ISO	RGD:1306513	E	RGD:6480464	20170303	CTD	MESH:C406224	valdecoxib results in decreased expression of ACOT13 mRNA	PMID:24136188
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315173	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of ACOT13 mRNA	PMID:22206623
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315173	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACOT13 mRNA	PMID:22206623
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1306513	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of ACOT13 mRNA	PMID:24136188
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ACOT13 mRNA	PMID:22079256
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20151110	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ACOT13 mRNA	PMID:22079256
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:80025	Salinomycin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of ACOT13 mRNA	PMID:19682730
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	multiple interactions	ISO	RGD:1315173	E	RGD:6480464	20241105	CTD	MESH:C511295	[Flame Retardants results in increased abundance of 2,2',4,4'-tetrabromodiphenyl ether] which results in increased expression of ACOT13 mRNA	PMID:38995820
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:9107	senecionine	increases expression	ISO	RGD:1315173	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in increased expression of ACOT13 protein	PMID:35357534
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of ACOT13 mRNA	PMID:29301935
1315172	ACOT13	acyl-CoA thioesterase 13	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of ACOT13 mRNA	PMID:22378314
1315174	CAPN15	calpain 15	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315175	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of CAPN15 mRNA	PMID:33045310
1315174	CAPN15	calpain 15	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1306514	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CAPN15 mRNA	PMID:30071829
1315174	CAPN15	calpain 15	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1315175	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of CAPN15 mRNA	PMID:30319688
1315174	CAPN15	calpain 15	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of CAPN15 mRNA	PMID:21632981
1315174	CAPN15	calpain 15	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315175	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of CAPN15 mRNA	PMID:39241906
1315174	CAPN15	calpain 15	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	Estradiol results in increased expression of CAPN15 mRNA	PMID:23019147|PMID:31614463
1315174	CAPN15	calpain 15	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315175	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of CAPN15 mRNA	PMID:39298647
1315174	CAPN15	calpain 15	gene	CHEBI:16598	DDE	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in increased expression of CAPN15 mRNA	PMID:38568856
1315174	CAPN15	calpain 15	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of CAPN15 mRNA	PMID:37042841
1315174	CAPN15	calpain 15	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315175	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CAPN15 mRNA	PMID:36331819
1315174	CAPN15	calpain 15	gene	CHEBI:22977	cadmium atom	increases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:D002104	Cadmium results in increased expression of CAPN15 mRNA	PMID:24376830
1315174	CAPN15	calpain 15	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306514	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of CAPN15 mRNA	PMID:30779732
1315174	CAPN15	calpain 15	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1315175	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of CAPN15 mRNA	PMID:25629700
1315174	CAPN15	calpain 15	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20151013	CTD	MESH:D001151	Arsenic affects the methylation of CAPN15 gene	PMID:25304211
1315174	CAPN15	calpain 15	gene	CHEBI:27732	caffeine	increases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in increased phosphorylation of CAPN15 protein	PMID:35688186
1315174	CAPN15	calpain 15	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of CAPN15 mRNA	PMID:23557933
1315174	CAPN15	calpain 15	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1315175	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of CAPN15 mRNA	PMID:30912803
1315174	CAPN15	calpain 15	gene	CHEBI:28088	genistein	increases expression	EXP		E	RGD:6480464	20121218	CTD	MESH:D019833	Genistein results in increased expression of CAPN15 mRNA	PMID:23019147
1315174	CAPN15	calpain 15	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of CAPN15 mRNA	PMID:24768652|PMID:25583101
1315174	CAPN15	calpain 15	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306514	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of CAPN15 mRNA	PMID:28959563
1315174	CAPN15	calpain 15	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of CAPN15 mRNA	PMID:29803840
1315174	CAPN15	calpain 15	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of CAPN15 mRNA	PMID:29301061|PMID:34032870
1315174	CAPN15	calpain 15	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of CAPN15 mRNA	PMID:38568856
1315174	CAPN15	calpain 15	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of CAPN15 5' UTR	PMID:27901495
1315174	CAPN15	calpain 15	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315175	E	RGD:6480464	20130312	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of CAPN15 mRNA	PMID:15034205
1315174	CAPN15	calpain 15	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1315175	E	RGD:6480464	20130312	CTD	MESH:D001564	AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of CAPN15 mRNA]	PMID:15034205
1315174	CAPN15	calpain 15	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of CAPN15 mRNA	PMID:25895662
1315174	CAPN15	calpain 15	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CAPN15 mRNA	PMID:20382639
1315174	CAPN15	calpain 15	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1315175	E	RGD:6480464	20141111	CTD	MESH:C009495	titanium dioxide affects the expression of CAPN15 mRNA	PMID:17656681
1315174	CAPN15	calpain 15	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315175	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased expression of CAPN15 mRNA	PMID:35295148
1315174	CAPN15	calpain 15	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1315175	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of CAPN15 mRNA	PMID:19136022
1315174	CAPN15	calpain 15	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306514	E	RGD:6480464	20151013	CTD	MESH:C006780	bisphenol A affects the expression of CAPN15 mRNA	PMID:25181051
1315174	CAPN15	calpain 15	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1315175	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of CAPN15 promoter	PMID:27334623
1315174	CAPN15	calpain 15	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of CAPN15 gene	PMID:31601247
1315174	CAPN15	calpain 15	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306514	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of CAPN15 mRNA	PMID:34947998
1315174	CAPN15	calpain 15	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1315175	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of CAPN15 mRNA	PMID:37019170
1315174	CAPN15	calpain 15	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of CAPN15 gene	PMID:22964155
1315174	CAPN15	calpain 15	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1315175	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in increased expression of CAPN15 mRNA	PMID:36117858
1315174	CAPN15	calpain 15	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of CAPN15 mRNA	PMID:37042841
1315174	CAPN15	calpain 15	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of CAPN15 mRNA	PMID:38382870|PMID:38568856
1315174	CAPN15	calpain 15	gene	CHEBI:35696	cobalt dichloride	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in increased expression of CAPN15 mRNA	PMID:19376846
1315174	CAPN15	calpain 15	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of CAPN15 mRNA	PMID:28302478
1315174	CAPN15	calpain 15	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315175	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CAPN15 mRNA	PMID:36331819
1315174	CAPN15	calpain 15	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of CAPN15 gene	PMID:29154799
1315174	CAPN15	calpain 15	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D016572	Cyclosporine results in increased expression of CAPN15 mRNA	PMID:25562108
1315174	CAPN15	calpain 15	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of CAPN15 mRNA	PMID:21420995
1315174	CAPN15	calpain 15	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20151013	CTD	MESH:D001151	Arsenic affects the methylation of CAPN15 gene	PMID:25304211
1315174	CAPN15	calpain 15	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1315175	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of CAPN15 mRNA	PMID:35436446
1315174	CAPN15	calpain 15	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1315175	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in increased expression of CAPN15 mRNA	PMID:36117858
1315174	CAPN15	calpain 15	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of CAPN15 mRNA	PMID:20977926
1315174	CAPN15	calpain 15	gene	CHEBI:64211	8-Br-cAMP	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CAPN15 mRNA	PMID:22079614
1315174	CAPN15	calpain 15	gene	CHEBI:754906	afuresertib	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C000593263	afuresertib results in decreased expression of CAPN15 mRNA	PMID:28960945
1315174	CAPN15	calpain 15	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1306514	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of CAPN15 mRNA	PMID:33484710
1315174	CAPN15	calpain 15	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1315175	E	RGD:6480464	20120412	CTD	MESH:D010634	Phenobarbital affects the expression of CAPN15 mRNA	PMID:19136022
1315174	CAPN15	calpain 15	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306514	E	RGD:6480464	20151013	CTD	MESH:D011441	Propylthiouracil results in decreased expression of CAPN15 mRNA	PMID:24780913
1315174	CAPN15	calpain 15	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of CAPN15 mRNA	PMID:38568856
1315176	ACTR10	actin related protein 10	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of ACTR10 mRNA	PMID:22378314
1315176	ACTR10	actin related protein 10	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306515	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of ACTR10 gene	PMID:27618143
1315176	ACTR10	actin related protein 10	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ACTR10 mRNA	PMID:37042841
1315176	ACTR10	actin related protein 10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1315177	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of ACTR10 mRNA	PMID:33754040
1315176	ACTR10	actin related protein 10	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of ACTR10 protein	PMID:37730182
1315176	ACTR10	actin related protein 10	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ACTR10 mRNA	PMID:28818685
1315176	ACTR10	actin related protein 10	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACTR10 mRNA	PMID:35301059
1315176	ACTR10	actin related protein 10	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ACTR10 mRNA	PMID:27153756
1315176	ACTR10	actin related protein 10	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ACTR10 intron	PMID:30157460
1315176	ACTR10	actin related protein 10	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ACTR10 mRNA	PMID:23649840
1315176	ACTR10	actin related protein 10	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ACTR10 mRNA	PMID:35430440
1315176	ACTR10	actin related protein 10	gene	CHEBI:27470	folic acid	increases expression	ISO	RGD:1315177	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of ACTR10 mRNA	PMID:25629700
1315176	ACTR10	actin related protein 10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315177	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACTR10 mRNA	PMID:22206623
1315176	ACTR10	actin related protein 10	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of ACTR10 mRNA	PMID:23557933
1315176	ACTR10	actin related protein 10	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of ACTR10 mRNA	PMID:27594783
1315176	ACTR10	actin related protein 10	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1315177	E	RGD:6480464	20200114	CTD	MESH:D002945	Cisplatin results in increased expression of ACTR10 protein	PMID:31493026
1315176	ACTR10	actin related protein 10	gene	CHEBI:28077	rifampicin	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in increased expression of ACTR10 mRNA	PMID:24552687
1315176	ACTR10	actin related protein 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315177	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of ACTR10 mRNA	PMID:21570461
1315176	ACTR10	actin related protein 10	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ACTR10 protein	PMID:33212167
1315176	ACTR10	actin related protein 10	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ACTR10 mRNA	PMID:29803840
1315176	ACTR10	actin related protein 10	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ACTR10 mRNA	PMID:38568856
1315176	ACTR10	actin related protein 10	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1306515	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACTR10 mRNA	PMID:21839799
1315176	ACTR10	actin related protein 10	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315177	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ACTR10 mRNA	PMID:22228805
1315176	ACTR10	actin related protein 10	gene	CHEBI:30512	silver atom	decreases expression	ISO	RGD:1315177	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ACTR10 mRNA	PMID:27131904
1315176	ACTR10	actin related protein 10	gene	CHEBI:3139	bleomycin A2	increases expression	ISO	RGD:1315177	E	RGD:6480464	20230307	CTD	MESH:D001761	Bleomycin results in increased expression of ACTR10 mRNA	PMID:36087614
1315176	ACTR10	actin related protein 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306515	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of ACTR10 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1315176	ACTR10	actin related protein 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315177	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of ACTR10 mRNA	PMID:33221593
1315176	ACTR10	actin related protein 10	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1315177	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of ACTR10 mRNA	PMID:26682919
1315176	ACTR10	actin related protein 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C543008	bisphenol S results in increased expression of ACTR10 protein	PMID:34186270
1315176	ACTR10	actin related protein 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315177	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of ACTR10 mRNA	PMID:39298647
1315176	ACTR10	actin related protein 10	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of ACTR10 intron	PMID:30157460
1315176	ACTR10	actin related protein 10	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1306515	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ACTR10 mRNA	PMID:17602206
1315176	ACTR10	actin related protein 10	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306515	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ACTR10 mRNA	PMID:17602206
1315176	ACTR10	actin related protein 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACTR10 mRNA	PMID:35301059
1315176	ACTR10	actin related protein 10	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of ACTR10 mRNA	PMID:24449571
1315176	ACTR10	actin related protein 10	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ACTR10 mRNA	PMID:25812627
1315176	ACTR10	actin related protein 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ACTR10 mRNA	PMID:25812627
1315176	ACTR10	actin related protein 10	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of ACTR10 mRNA	PMID:23179753
1315176	ACTR10	actin related protein 10	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315177	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ACTR10 mRNA	PMID:17562736
1315176	ACTR10	actin related protein 10	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of ACTR10 mRNA	PMID:31675489
1315176	ACTR10	actin related protein 10	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ACTR10 mRNA	PMID:22079256
1315176	ACTR10	actin related protein 10	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306515	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of ACTR10 mRNA	PMID:24136188
1315176	ACTR10	actin related protein 10	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306515	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of ACTR10 mRNA	PMID:24136188
1315176	ACTR10	actin related protein 10	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of ACTR10 protein	PMID:32959892
1315176	ACTR10	actin related protein 10	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of ACTR10 intron	PMID:30157460
1315176	ACTR10	actin related protein 10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315177	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACTR10 mRNA	PMID:22206623
1315176	ACTR10	actin related protein 10	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of ACTR10 mRNA	PMID:22079256
1315176	ACTR10	actin related protein 10	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ACTR10 mRNA	PMID:22079256
1315176	ACTR10	actin related protein 10	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of ACTR10 mRNA	PMID:30928695
1315176	ACTR10	actin related protein 10	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ACTR10 protein	PMID:31675489
1315176	ACTR10	actin related protein 10	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of ACTR10 protein	PMID:31675489
1315176	ACTR10	actin related protein 10	gene	CHEBI:9141	silver(0)	decreases expression	ISO	RGD:1315177	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in decreased expression of ACTR10 mRNA	PMID:27131904
1315176	ACTR10	actin related protein 10	gene	CHEBI:9352	sulindac	decreases expression	ISO	RGD:1306515	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in decreased expression of ACTR10 mRNA	PMID:24136188
1315176	ACTR10	actin related protein 10	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306515	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of ACTR10 mRNA	PMID:21346803
1315176	ACTR10	actin related protein 10	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306515	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in decreased expression of ACTR10 mRNA	PMID:23555832
1315176	ACTR10	actin related protein 10	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306515	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of ACTR10 mRNA	PMID:23869203
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of FRAS1 protein	PMID:39638853
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of FRAS1 mRNA	PMID:38218311
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of FRAS1 mRNA	PMID:27188386
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	ISO	RGD:1315179	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of FRAS1 mRNA	PMID:37995155
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of FRAS1 mRNA	PMID:23724009
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of FRAS1 mRNA	PMID:21934132
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:15379	dioxygen	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in increased expression of FRAS1 mRNA	PMID:26516004
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of FRAS1 mRNA	PMID:26079696
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306516	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of FRAS1 gene	PMID:35440735
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1315179	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of FRAS1 mRNA	PMID:29018328
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of FRAS1 mRNA	PMID:30165855
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:16494	lipoic acid	multiple interactions	ISO	RGD:1315179	E	RGD:6480464	20140610	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Potassium Dichromate results in increased expression of FRAS1 mRNA]	PMID:23608068
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of FRAS1 mRNA	PMID:21179406
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315179	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of FRAS1 mRNA	PMID:37992649
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1315179	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of FRAS1 mRNA	PMID:28973375
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315179	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of FRAS1 mRNA	PMID:37992649
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315179	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of FRAS1 mRNA	PMID:33754040|PMID:34319233
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of FRAS1 mRNA	PMID:27523638
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306516	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of FRAS1 mRNA	PMID:26577399
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of FRAS1 mRNA	PMID:26485663
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of FRAS1 mRNA	PMID:33387578
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:18305	hydroquinone O-beta-D-glucopyranoside	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001104	Arbutin results in decreased expression of FRAS1 mRNA	PMID:17103032
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of FRAS1 mRNA	PMID:28522335
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315179	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FRAS1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FRAS1 mRNA	PMID:37236586|PMID:37325564
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of FRAS1 protein	PMID:20106945
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	ISO	RGD:1306516	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas affects the expression of FRAS1 mRNA	PMID:15651846
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315179	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FRAS1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FRAS1 mRNA	PMID:34911549
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of FRAS1 mRNA	PMID:19774075
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315179	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of FRAS1 mRNA	PMID:25629700
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of FRAS1 mRNA	PMID:26272509
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRAS1 mRNA	PMID:27188386
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of FRAS1 protein	PMID:35688186
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:27744	glyphosate	decreases methylation	ISO	RGD:1306516	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in decreased methylation of FRAS1 gene	PMID:31011160
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1315179	E	RGD:6480464	20170613	CTD	MESH:C024565	ethylene dichloride results in decreased expression of FRAS1 mRNA	PMID:28189721|PMID:28960355
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of FRAS1 mRNA	PMID:31881176
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of FRAS1 mRNA	PMID:27392435
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of FRAS1 mRNA; [Cisplatin co-treated with Paclitaxel] results in increased expression of FRAS1 mRNA; [Cisplatin co-treated with panobinostat] affects the expression of FRAS1 mRNA	PMID:20705681|PMID:21791302|PMID:27392435
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1306516	E	RGD:6480464	20120412	CTD	MESH:D003042	Cocaine results in increased expression of FRAS1 mRNA	PMID:17898221
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1315179	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of FRAS1 mRNA	PMID:32186404
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of FRAS1 mRNA	PMID:24768652
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315179	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of FRAS1 mRNA	PMID:26377647
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of FRAS1 mRNA	PMID:33387578
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of FRAS1 mRNA	PMID:28374803
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of FRAS1 mRNA	PMID:28001369
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of FRAS1 mRNA	PMID:33212167
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of FRAS1 mRNA	PMID:32763439
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315179	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of FRAS1 mRNA	PMID:37992649
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:29678	sodium arsenite	affects methylation	EXP		E	RGD:6480464	20171114	CTD	MESH:C017947	sodium arsenite affects the methylation of FRAS1 gene	PMID:28589171
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of FRAS1 mRNA	PMID:29301061|PMID:34032870
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of FRAS1 mRNA	PMID:39719251
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of FRAS1 intron	PMID:30157460
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of FRAS1 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of FRAS1 promoter	PMID:27901495
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:29866	arsenite(3-)	decreases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased expression of FRAS1 mRNA	PMID:23974009
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:30314	(R)-lipoic acid	multiple interactions	ISO	RGD:1315179	E	RGD:6480464	20140610	CTD	MESH:D008063	Thioctic Acid inhibits the reaction [Potassium Dichromate results in increased expression of FRAS1 mRNA]	PMID:23608068
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:30512	silver atom	affects expression	ISO	RGD:1315179	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of FRAS1 mRNA	PMID:27131904
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of FRAS1 mRNA	PMID:25895662
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of FRAS1 mRNA	PMID:23806026
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:32234	titanium dioxide	affects expression	ISO	RGD:1315179	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide affects the expression of FRAS1 mRNA	PMID:23557971
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in decreased expression of FRAS1 mRNA	PMID:30012374
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of FRAS1 mRNA	PMID:34492290
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1315179	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of FRAS1 mRNA	PMID:18648102
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of FRAS1 mRNA	PMID:25181051
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315179	E	RGD:6480464	20241105	CTD	MESH:C006780	bisphenol A results in decreased expression of FRAS1 mRNA	PMID:38701888
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306516	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of FRAS1 gene	PMID:28505145
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315179	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of FRAS1 mRNA	PMID:39298647
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in decreased methylation of FRAS1 gene	PMID:31601247
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315179	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of FRAS1 mRNA	PMID:30951980
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315179	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of FRAS1 mRNA	PMID:30951980
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1315179	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with LIF protein] results in decreased expression of FRAS1 mRNA	PMID:30951980
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1315179	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of FRAS1 intron	PMID:28392331
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of FRAS1 mRNA	PMID:32680482
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of FRAS1 mRNA	PMID:38174414|PMID:38568856
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315179	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FRAS1 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FRAS1 mRNA	PMID:37236586|PMID:37325564
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of FRAS1 mRNA	PMID:24449571
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:36386	dichloroacetic acid	decreases expression	ISO	RGD:1315179	E	RGD:6480464	20171114	CTD	MESH:D003999	Dichloroacetic Acid results in decreased expression of FRAS1 mRNA	PMID:28962523
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1315179	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of FRAS1 mRNA	PMID:40194260
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of FRAS1 mRNA	PMID:28302478
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of FRAS1 mRNA	PMID:25979313
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315179	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of FRAS1 mRNA	PMID:17292431
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20180828	CTD	MESH:D014635	Valproic Acid results in decreased expression of FRAS1 mRNA	PMID:29427782
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of FRAS1 mRNA	PMID:23179753|PMID:24383497|PMID:26272509|PMID:27188386
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRAS1 mRNA	PMID:27188386
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of FRAS1 mRNA	PMID:25562108
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of FRAS1 mRNA	PMID:25047013
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1315179	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of FRAS1 mRNA	PMID:28973697
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315179	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of FRAS1 mRNA	PMID:37992649
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:45863	paclitaxel	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	[Cisplatin co-treated with Paclitaxel] results in increased expression of FRAS1 mRNA	PMID:20705681
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of FRAS1 mRNA	PMID:26272509
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRAS1 mRNA	PMID:27188386
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315179	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of FRAS1 mRNA	PMID:17562736
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of FRAS1 mRNA	PMID:33387578
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:47032	1,4-dioxane	decreases expression	ISO	RGD:1315179	E	RGD:6480464	20211109	CTD	MESH:C025223	1,4-dioxane results in decreased expression of FRAS1 mRNA	PMID:33693819
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of FRAS1 mRNA	PMID:31838189
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of FRAS1 mRNA	PMID:29391264
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1315179	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of FRAS1 mRNA	PMID:17942748
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of FRAS1 mRNA	PMID:32234424
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315179	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of FRAS1 mRNA; Nanotubes, Carbon results in decreased expression of FRAS1 mRNA	PMID:25554681|PMID:25620056
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1315179	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of FRAS1 mRNA	PMID:40234311
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:51348	tetraphene	decreases expression	ISO	RGD:1315179	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in decreased expression of FRAS1 mRNA	PMID:26377693
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:53444	potassium dichromate	increases expression	ISO	RGD:1315179	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of FRAS1 mRNA	PMID:23608068
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:53444	potassium dichromate	multiple interactions	ISO	RGD:1315179	E	RGD:6480464	20140610	CTD	MESH:D011192	Thioctic Acid inhibits the reaction [Potassium Dichromate results in increased expression of FRAS1 mRNA]	PMID:23608068
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FRAS1 mRNA	PMID:22079614
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306516	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of FRAS1 gene	PMID:35440735
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of FRAS1 mRNA	PMID:31758290
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20170516	CTD	MESH:C007350	nitrofen results in decreased expression of FRAS1 mRNA; nitrofen results in decreased expression of FRAS1 protein	PMID:26519041
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1306516	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of FRAS1 mRNA	PMID:33484710
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:7599	Nivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C038405	nivalenol results in decreased expression of FRAS1 protein	PMID:39638853
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:7719	ochratoxin A	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C025589	ochratoxin A results in decreased expression of FRAS1 protein	PMID:39638853
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRAS1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRAS1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRAS1 mRNA	PMID:27188386
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to FRAS1 gene]	PMID:28238834
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:8064	phenformin	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20200114	CTD	MESH:D010629	Phenformin results in decreased expression of FRAS1 mRNA	PMID:31324951
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of FRAS1 mRNA	PMID:27291303
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306516	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in decreased expression of FRAS1 mRNA	PMID:25825206
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[Cisplatin co-treated with panobinostat] affects the expression of FRAS1 mRNA	PMID:21791302
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRAS1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRAS1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FRAS1 mRNA	PMID:27188386
1315178	FRAS1	Fraser extracellular matrix complex subunit 1	gene	CHEBI:9141	silver(0)	affects expression	ISO	RGD:1315179	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver affects the expression of FRAS1 mRNA	PMID:27131904
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of DOCK6 mRNA	PMID:38218311
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of DOCK6 mRNA	PMID:27188386
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1556889	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of DOCK6 mRNA	PMID:20938992
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DOCK6 mRNA	PMID:33167477
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306517	E	RGD:6480464	20230905	CTD	MESH:D001280	Atrazine affects the methylation of DOCK6 gene	PMID:35440735
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of DOCK6 mRNA	PMID:22378314
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1556889	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of DOCK6 mRNA	PMID:30319688
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1556889	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of DOCK6 mRNA	PMID:20938992
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:17300	tetrachloroethene	decreases expression	ISO	RGD:1556889	E	RGD:6480464	20180116	CTD	MESH:D013750	Tetrachloroethylene results in decreased expression of DOCK6 mRNA	PMID:28973375
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1556889	E	RGD:6480464	20120412	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of DOCK6 mRNA	PMID:19850644
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1306517	E	RGD:6480464	20130514	CTD	MESH:D004051	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DOCK6 promoter	PMID:23359474
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1556889	E	RGD:6480464	20120412	CTD	MESH:D004051	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of DOCK6 mRNA]	PMID:19850644
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306517	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of DOCK6 mRNA	PMID:26577399
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of DOCK6 protein	PMID:37730182
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:181914	Aflatoxin B2 alpha	increases methylation	EXP		E	RGD:6480464	20211109	CTD	MESH:C029753	aflatoxin B2 results in increased methylation of DOCK6 exon	PMID:30157460
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:194147	aristolochic acids	increases expression	ISO	RGD:1306517	E	RGD:6480464	20230103	CTD	MESH:D034341	Aristolochic Acids results in increased expression of DOCK6 mRNA	PMID:19717638
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DOCK6 mRNA	PMID:35301059
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DOCK6 intron	PMID:30157460
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1556889	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of DOCK6 mRNA	PMID:20938992
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1556889	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DOCK6 mRNA	PMID:40504410
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of DOCK6 mRNA	PMID:26272509
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DOCK6 mRNA	PMID:27188386
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306517	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of DOCK6 mRNA	PMID:31881176
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in increased expression of DOCK6 mRNA	PMID:19921347
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306517	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DOCK6 mRNA	PMID:34747641
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:2825	aristolochic acid A	increases expression	ISO	RGD:1306517	E	RGD:6480464	20241001	CTD	MESH:C000228	aristolochic acid I results in increased expression of DOCK6 protein	PMID:38428544
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:2825	aristolochic acid A	multiple interactions	ISO	RGD:1306517	E	RGD:6480464	20241001	CTD	MESH:C000228	[aristolochic acid I co-treated with Probenecid] results in increased expression of DOCK6 protein	PMID:38428544
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DOCK6 mRNA	PMID:30851411
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:28420	p-chloromercuribenzoic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in decreased expression of DOCK6 mRNA	PMID:26272509
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DOCK6 mRNA	PMID:27188386
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of DOCK6 mRNA	PMID:32763439
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DOCK6 mRNA	PMID:29803840
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DOCK6 mRNA	PMID:38568856
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1556889	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DOCK6 mRNA	PMID:40504410
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DOCK6 exon	PMID:30157460
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1556889	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DOCK6 exon; Benzo(a)pyrene results in increased methylation of DOCK6 intron	PMID:27901495
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:29866	arsenite(3-)	decreases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in decreased methylation of DOCK6 promoter	PMID:23974009
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to DOCK6 mRNA]	PMID:32406909
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of DOCK6 gene	PMID:31601247
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1556889	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of DOCK6 mRNA	PMID:23811191
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306517	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DOCK6 mRNA	PMID:25181051|PMID:34947998
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DOCK6 gene	PMID:31601247
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306517	E	RGD:6480464	20130514	CTD	MESH:C006780	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DOCK6 promoter	PMID:23359474
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1556889	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of DOCK6 exon	PMID:33297965
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of DOCK6 gene	PMID:31601247
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1556889	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of DOCK6 mRNA	PMID:38685157
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1556889	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DOCK6 mRNA	PMID:37019170
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:34687	dibutyl phthalate	multiple interactions	ISO	RGD:1306517	E	RGD:6480464	20130514	CTD	MESH:D003993	[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of DOCK6 promoter	PMID:23359474
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DOCK6 mRNA	PMID:37042841
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DOCK6 mRNA	PMID:35301059
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DOCK6 mRNA	PMID:19320972
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of DOCK6 mRNA	PMID:24449571
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1556889	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DOCK6 mRNA	PMID:40194260
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of DOCK6 mRNA	PMID:28302478
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DOCK6 mRNA	PMID:31533062
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DOCK6 mRNA	PMID:25979313
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1556889	E	RGD:6480464	20150414	CTD	MESH:D014635	Valproic Acid results in increased expression of DOCK6 mRNA	PMID:24896083
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of DOCK6 mRNA	PMID:25562108
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of DOCK6 mRNA	PMID:24449571
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1556889	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DOCK6 mRNA	PMID:17562736
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306517	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of DOCK6 mRNA	PMID:33387578
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1556889	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of DOCK6 mRNA	PMID:29279043
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:46676	tremolite asbestos	decreases expression	ISO	RGD:1556889	E	RGD:6480464	20200915	CTD	MESH:C005846	tremolite results in decreased expression of DOCK6 mRNA	PMID:29279043
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1556889	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DOCK6 mRNA	PMID:40504410
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:47519	ketoconazole	increases expression	ISO	RGD:1306517	E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in increased expression of DOCK6 mRNA	PMID:36653537
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1556889	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of DOCK6 mRNA	PMID:35436446
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:49639	mercury dibromide	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in decreased expression of DOCK6 mRNA	PMID:26272509
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DOCK6 mRNA	PMID:27188386
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1556889	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of DOCK6 mRNA; Nanotubes, Carbon results in decreased expression of DOCK6 mRNA	PMID:25554681|PMID:25620056
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:5063	fipronil	increases expression	ISO	RGD:1306517	E	RGD:6480464	20211109	CTD	MESH:C082360	fipronil results in increased expression of DOCK6 mRNA	PMID:34044035
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1556889	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of DOCK6 mRNA	PMID:40234311
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1556889	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of DOCK6 mRNA	PMID:26377693
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DOCK6 protein	PMID:32959892
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of DOCK6 mRNA	PMID:24810058
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:67895	corosolic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of DOCK6 mRNA	PMID:37939859
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1556889	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of DOCK6 mRNA	PMID:26307267
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306517	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DOCK6 gene	PMID:35440735
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of DOCK6 mRNA	PMID:31758290
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1556889	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of DOCK6 mRNA	PMID:22206623
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:7719	ochratoxin A	increases expression	ISO	RGD:1306517	E	RGD:6480464	20120613	CTD	MESH:C025589	ochratoxin A results in increased expression of DOCK6 mRNA	PMID:19717638
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of DOCK6 mRNA	PMID:30851411
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DOCK6 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DOCK6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DOCK6 mRNA	PMID:27188386
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:8426	probenecid	multiple interactions	ISO	RGD:1306517	E	RGD:6480464	20241001	CTD	MESH:D011339	[aristolochic acid I co-treated with Probenecid] results in increased expression of DOCK6 protein	PMID:38428544
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DOCK6 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DOCK6 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DOCK6 mRNA	PMID:27188386
1315180	DOCK6	dedicator of cytokinesis 6	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of DOCK6 mRNA	PMID:27188386
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:136608	Theaflavin 3,3'-digallate	affects expression	EXP		E	RGD:6480464	20240402	CTD	MESH:C585473	theaflavin-3,3'-digallate affects the expression of RGS18 mRNA	PMID:34925699
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315188	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS18 mRNA	PMID:20938992
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of RGS18 mRNA	PMID:33167477
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:16412	lipopolysaccharide	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of RGS18 mRNA	PMID:35811015
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RGS18 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RGS18 mRNA	PMID:35811015
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315188	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of RGS18 mRNA	PMID:19484750
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306522	E	RGD:6480464	20210406	CTD	MESH:D004958	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RGS18 mRNA	PMID:32741896
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:16602	trichloroethene	decreases methylation	ISO	RGD:1306522	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in decreased methylation of RGS18 gene	PMID:27618143
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315188	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS18 mRNA	PMID:20938992
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306522	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RGS18 mRNA	PMID:32741896
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:18721	3-chloropropane-1,2-diol	decreases expression	ISO	RGD:1306522	E	RGD:6480464	20171010	CTD	MESH:D000517	alpha-Chlorohydrin results in decreased expression of RGS18 mRNA	PMID:28522335
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:21759	N-methyl-N'-nitro-N-nitrosoguanidine	increases expression	ISO	RGD:1306522	E	RGD:6480464	20120412	CTD	MESH:D008769	Methylnitronitrosoguanidine results in increased expression of RGS18 mRNA	PMID:15120970
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:2504	aflatoxin B1	decreases expression	ISO	RGD:1306522	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of RGS18 mRNA	PMID:33354967
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of RGS18 intron	PMID:30157460
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306522	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RGS18 mRNA	PMID:30779732
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of RGS18 mRNA	PMID:22171008
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315188	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS18 mRNA	PMID:20938992
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:27563	arsenic atom	decreases expression	ISO	RGD:1315188	E	RGD:6480464	20120412	CTD	MESH:D001151	Arsenic results in decreased expression of RGS18 mRNA	PMID:19654921
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315188	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RGS18 mRNA	PMID:40504410
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1315188	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of RGS18 mRNA	PMID:28960355
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of RGS18 mRNA	PMID:27594783
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RGS18 mRNA	PMID:25583101
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306522	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RGS18 mRNA	PMID:34747641
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315188	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RGS18 mRNA	PMID:40504410
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:29699	tunicamycin	increases expression	ISO	RGD:1315188	E	RGD:6480464	20120412	CTD	MESH:D014415	Tunicamycin results in increased expression of RGS18 mRNA	PMID:17127020
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RGS18 mRNA	PMID:20064835
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of RGS18 3' UTR	PMID:27901495
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315188	E	RGD:6480464	20121113	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RGS18 mRNA	PMID:22610609
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of RGS18 mRNA	PMID:22171008
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	affects expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of RGS18 mRNA	PMID:20382639
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:31767	lead diacetate	affects expression	ISO	RGD:1306522	E	RGD:6480464	20120918	CTD	MESH:C008261	lead acetate affects the expression of RGS18 mRNA	PMID:21864555
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315188	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of RGS18 mRNA	PMID:23557971|PMID:29264374
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306522	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of RGS18 mRNA	PMID:34492290
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1315188	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of RGS18 mRNA	PMID:18648102
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306522	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of RGS18 mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315188	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of RGS18 mRNA	PMID:32156529
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315188	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of RGS18 mRNA	PMID:39298647
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:34565	benzo[b]fluoranthene	decreases expression	ISO	RGD:1315188	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in decreased expression of RGS18 mRNA	PMID:26377693
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:34569	Benzo[k]fluoranthene	increases expression	ISO	RGD:1315188	E	RGD:6480464	20160119	CTD	MESH:C022921	benzo(k)fluoranthene results in increased expression of RGS18 mRNA	PMID:26377693
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of RGS18 mRNA	PMID:37042841
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of RGS18 mRNA	PMID:24449571
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315188	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RGS18 mRNA	PMID:17562736
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	decreases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	S-(1,2-dichlorovinyl)cysteine results in decreased expression of RGS18 mRNA	PMID:35811015
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of RGS18 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of RGS18 mRNA	PMID:35811015
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:47217	arsane	decreases expression	ISO	RGD:1315188	E	RGD:6480464	20140805	CTD	MESH:D001151	Arsenic results in decreased expression of RGS18 mRNA	PMID:19654921
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315188	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RGS18 mRNA	PMID:40504410
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1315188	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RGS18 mRNA	PMID:35964746
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1315188	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of RGS18 mRNA	PMID:38701926
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1315188	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RGS18 mRNA	PMID:21641980
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1306522	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of RGS18 mRNA	PMID:35283115
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1306522	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of RGS18 mRNA	PMID:33484710
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1306522	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of RGS18 mRNA	PMID:32741896
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1315188	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of RGS18 mRNA	PMID:39847705
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306522	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of RGS18 mRNA	PMID:23034163
1315187	RGS18	regulator of G protein signaling 18	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306522	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in increased expression of RGS18 mRNA	PMID:23034163
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1619685	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ZFP408 mRNA	PMID:33045310
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1619685	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of ZFP408 mRNA	PMID:39241906
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ZNF408 mRNA	PMID:37042841
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1619685	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ZFP408 mRNA	PMID:34319233
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of ZNF408 protein	PMID:37730182
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of ZNF408 mRNA	PMID:19549813
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1619685	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ZFP408 mRNA	PMID:19770486
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of ZNF408 mRNA	PMID:23649840
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:27363	zinc atom	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ZNF408 mRNA	PMID:18593933
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1619685	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZFP408 mRNA	PMID:40504410
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ZNF408 protein	PMID:35688186
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ZNF408 mRNA	PMID:33212167
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of ZNF408 mRNA	PMID:32763439
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of ZNF408 mRNA	PMID:24690739
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ZNF408 mRNA	PMID:29803840
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ZNF408 mRNA	PMID:38568856
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1619685	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZFP408 mRNA	PMID:40504410
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D003300	[Disulfiram binds to Copper] which results in decreased expression of ZNF408 mRNA	PMID:24690739
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:30185	zinc(0)	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	[PCI 5002 co-treated with Zinc] results in increased expression of ZNF408 mRNA	PMID:18593933
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:30512	silver atom	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of ZNF408 mRNA	PMID:26014281
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ZNF408 mRNA	PMID:35984750
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1619685	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ZFP408 mRNA	PMID:38685157
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:46345	5-fluorouracil	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	[Fluorouracil co-treated with irinotecan] results in increased expression of ZNF408 mRNA	PMID:16391804
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:4659	disulfiram	multiple interactions	EXP		E	RGD:6480464	20150512	CTD	MESH:D004221	[Disulfiram binds to Copper] which results in decreased expression of ZNF408 mRNA	PMID:24690739
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1619685	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ZFP408 mRNA	PMID:40504410
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ZNF408 mRNA	PMID:22079256
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1619685	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of ZFP408 mRNA; Nanotubes, Carbon results in decreased expression of ZFP408 mRNA	PMID:25554681
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ZNF408 mRNA	PMID:22079256
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ZNF408 mRNA	PMID:22079256
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ZNF408 protein	PMID:31285264
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:80630	irinotecan	multiple interactions	EXP		E	RGD:6480464	20181113	CTD	MESH:D000077146	[Fluorouracil co-treated with Irinotecan] results in increased expression of ZNF408 mRNA	PMID:16391804
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:9141	silver(0)	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D012834	Silver results in increased expression of ZNF408 mRNA	PMID:26014281
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ZNF408 mRNA	PMID:38568856
1315189	ZNF408	zinc finger protein 408	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1619685	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of ZFP408 mRNA	PMID:35537566
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of ETV4 mRNA	PMID:38218311
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of ETV4 mRNA	PMID:26272509
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ETV4 mRNA	PMID:27188386
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of ETV4 mRNA	PMID:33045310
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:134751	avobenzone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C049935	avobenzone results in increased expression of ETV4 mRNA	PMID:31016361
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:138308	kahweol	increases expression	EXP		E	RGD:6480464	20190219	CTD	MESH:C053401	kahweol results in increased expression of ETV4 mRNA; kahweol results in increased expression of ETV4 protein	PMID:30205135
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:15343	acetaldehyde	affects expression	ISO	RGD:1315191	E	RGD:6480464	20121009	CTD	MESH:D000079	Acetaldehyde affects the expression of ETV4 mRNA	PMID:22634333
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of ETV4 mRNA	PMID:33167477
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in decreased expression of ETV4 mRNA	PMID:16604517
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1315191	E	RGD:6480464	20240402	CTD	MESH:D014212	Tretinoin results in increased expression of ETV4 mRNA	PMID:36189433
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1315191	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ETV4 mRNA	PMID:36189433
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of ETV4 mRNA	PMID:26516004
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:15930	atrazine	decreases expression	ISO	RGD:1306524	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in decreased expression of ETV4 mRNA	PMID:36841081
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315191	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of ETV4 mRNA	PMID:30319688
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of ETV4 mRNA	PMID:21632981
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with resveratrol] results in decreased expression of ETV4 mRNA	PMID:26667767
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D004958	Estradiol results in increased expression of ETV4 mRNA	PMID:21185374|PMID:31614463
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315191	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in increased expression of ETV4 mRNA	PMID:19484750
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of ETV4 mRNA	PMID:30165855
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D005557	Formaldehyde results in decreased expression of ETV4 mRNA	PMID:28937961
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of ETV4 mRNA	PMID:27664576
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:16971	benzene-1,2,4-triol	increases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in increased expression of ETV4 mRNA	PMID:39245080
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ETV4 mRNA	PMID:36695872
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315191	E	RGD:6480464	20240402	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of ETV4 mRNA	PMID:36189433
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1315191	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ETV4 mRNA	PMID:36189433
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of ETV4 mRNA	PMID:31256213
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of ETV4 mRNA	PMID:31163220
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:178199	sotorasib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C000706028	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ETV4 mRNA	PMID:36139627
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160510	CTD	MESH:D002117	Calcitriol results in increased expression of ETV4 mRNA	PMID:12040012
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:181932	3-Nitrobenzanthrone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:C117220	3-nitrobenzanthrone results in increased expression of ETV4 mRNA	PMID:34036453
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:22718	benzoates	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D001565	Benzoates analog results in decreased expression of ETV4 mRNA	PMID:29472718
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of ETV4 mRNA	PMID:19549813
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of ETV4 mRNA	PMID:22100608
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of ETV4 promoter	PMID:30157460
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	increases expression	ISO	RGD:1315191	E	RGD:6480464	20120412	CTD	MESH:D009151	Mustard Gas results in increased expression of ETV4 mRNA	PMID:15674843
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315191	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ETV4 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ETV4 mRNA	PMID:34911549
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:27363	zinc atom	increases activity	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased activity of ETV4 protein	PMID:18356318
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315191	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ETV4 mRNA]	PMID:22206623
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:27698	vanadium atom	increases activity	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased activity of ETV4 protein	PMID:19000753
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of ETV4 protein	PMID:35688186
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306524	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of ETV4 mRNA	PMID:31881176
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:27881	resveratrol	decreases activity	EXP		E	RGD:6480464	20121218	CTD	MESH:C059514	resveratrol results in decreased activity of ETV4 protein	PMID:22252971
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:27881	resveratrol	increases expression	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in increased expression of ETV4 protein	PMID:25448084
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of ETV4 mRNA; [Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of ETV4 mRNA	PMID:26667767|PMID:41028656
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:27889	lead(0)	multiple interactions	ISO	RGD:1315191	E	RGD:6480464	20231003	CTD	MESH:D007854	[lead acetate results in increased abundance of Lead] which results in decreased methylation of ETV4 exon	PMID:33445541
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1306524	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in decreased expression of ETV4 mRNA	PMID:22023808
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of ETV4 mRNA	PMID:16061661
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20160315	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ETV4 mRNA	PMID:24058054
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306524	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ETV4 mRNA	PMID:32109520|PMID:33387578
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:28216	methylmercury chloride	affects expression	ISO	RGD:1306524	E	RGD:6480464	20120412	CTD	MESH:C004925	methylmercuric chloride affects the expression of ETV4 mRNA	PMID:20864626
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in increased expression of ETV4 mRNA	PMID:28001369
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:28216	methylmercury chloride	multiple interactions	ISO	RGD:1306524	E	RGD:6480464	20171010	CTD	MESH:C004925	methylmercuric chloride inhibits the reaction [ETV4 protein binds to MMP9 promoter]	PMID:28526320
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ETV4 mRNA	PMID:33212167
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ETV4 mRNA	PMID:30851411
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ETV4 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of ETV4 mRNA	PMID:20971185|PMID:41028656
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of ETV4 mRNA	PMID:29803840
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of ETV4 mRNA	PMID:30031762
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1315191	E	RGD:6480464	20240109	CTD	MESH:D004317	Doxorubicin results in increased expression of ETV4 mRNA	PMID:36227756
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:28940	calciol	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20120412	CTD	MESH:D002762	Cholecalciferol results in decreased expression of ETV4 mRNA	PMID:16508948
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1315191	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in increased expression of ETV4 mRNA	PMID:37682722
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of and affects the splicing of ETV4 mRNA	PMID:25879800
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of ETV4 mRNA	PMID:22378314|PMID:29453283
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of ETV4 mRNA	PMID:20106945|PMID:21632981
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of ETV4 mRNA	PMID:32234424|PMID:35870112
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of ETV4 mRNA; [NSC 689534 binds to Copper] which results in decreased expression of ETV4 mRNA	PMID:20971185|PMID:41028656
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:30185	zinc(0)	increases activity	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased activity of ETV4 protein	PMID:18356318
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:30512	silver atom	increases expression	ISO	RGD:1315191	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ETV4 mRNA	PMID:27131904
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20250603	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ETV4 mRNA	PMID:39826883
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of ETV4 mRNA	PMID:20458559
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:31767	lead diacetate	multiple interactions	ISO	RGD:1315191	E	RGD:6480464	20231003	CTD	MESH:C008261	[lead acetate results in increased abundance of Lead] which results in decreased methylation of ETV4 exon	PMID:33445541
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:31823	mercury dichloride	increases expression	ISO	RGD:1306524	E	RGD:6480464	20140610	CTD	MESH:D008627	Mercuric Chloride results in increased expression of ETV4 mRNA	PMID:16507785
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315191	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ETV4 gene	PMID:35295148
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306524	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of ETV4 mRNA	PMID:34492290
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1315191	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of ETV4 mRNA	PMID:28472532
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1306524	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of ETV4 mRNA	PMID:19167457
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of ETV4 mRNA	PMID:30903817
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:33216	bisphenol A	affects methylation	ISO	RGD:1315191	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A affects the methylation of ETV4 promoter	PMID:27334623
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of ETV4 mRNA	PMID:29275510
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306524	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of ETV4 mRNA	PMID:25181051|PMID:30816183
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of ETV4 mRNA	PMID:35598803
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of ETV4 gene	PMID:31601247
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315191	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of ETV4 mRNA	PMID:30951980
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	increases expression	ISO	RGD:1315191	E	RGD:6480464	20141223	CTD	MESH:C020806	tetrabromobisphenol A results in increased expression of ETV4 mRNA	PMID:25172293
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of ETV4 mRNA	PMID:40203079
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1315191	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ETV4 exon	PMID:33297965
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315191	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of ETV4 mRNA	PMID:30951980
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of ETV4 mRNA	PMID:38685157
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315191	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of ETV4 mRNA	PMID:30951980
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:34620	quinomethionate	affects expression	EXP		E	RGD:6480464	20130611	CTD	MESH:C005266	quinomethionate affects the expression of ETV4 mRNA	PMID:15387888
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1315191	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of ETV4 mRNA	PMID:37019170
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306524	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ETV4 mRNA	PMID:21266533
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1315191	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of ETV4 mRNA	PMID:17361019
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:34849	mibolerone	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C100075	[mibolerone binds to and results in increased activity of AR protein] inhibits the reaction [ETV4 protein results in increased expression of MMP1 mRNA]	PMID:8798622
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:34873	N-nitrosodiethylamine	increases expression	ISO	RGD:1315191	E	RGD:6480464	20120412	CTD	MESH:D004052	Diethylnitrosamine results in increased expression of ETV4 mRNA	PMID:17854601
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1315191	E	RGD:6480464	20120412	CTD	MESH:D004052	RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of ETV4 mRNA]	PMID:17854601
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:34919	Phenylamil	increases expression	ISO	RGD:1315191	E	RGD:6480464	20141111	CTD	MESH:C047088	phenylamil results in increased expression of ETV4 mRNA	PMID:20519739
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1306524	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ETV4 mRNA	PMID:35163327
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:35170	vanadium(0)	increases activity	EXP		E	RGD:6480464	20121009	CTD	MESH:D014639	Vanadium results in increased activity of ETV4 protein	PMID:19000753
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of ETV4 mRNA	PMID:38568856
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ETV4 mRNA	PMID:38382870
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of ETV4 mRNA	PMID:25812627
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1306524	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ETV4 mRNA	PMID:35163327
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306524	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of ETV4 gene	PMID:22079235
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of ETV4 mRNA	PMID:24449571
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of ETV4 mRNA	PMID:25812627
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of ETV4 mRNA	PMID:28302478
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of ETV4 mRNA	PMID:31533062
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of ETV4 mRNA	PMID:39529242
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of ETV4 mRNA	PMID:40419075
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1306524	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of ETV4 mRNA	PMID:23125180
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20120918	CTD	MESH:D014635	Valproic Acid results in decreased expression of ETV4 mRNA	PMID:22045034
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1315191	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of ETV4 mRNA	PMID:17555576
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of ETV4 mRNA	PMID:24449571
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of ETV4 mRNA	PMID:38832940
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315191	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ETV4 mRNA	PMID:17562736
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:46557	zoledronic acid	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C088658	zoledronic acid results in decreased expression of ETV4 mRNA	PMID:24714768
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:46666	crocidolite asbestos	increases expression	EXP		E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of ETV4 mRNA	PMID:25351596
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:47807	sulforaphane	increases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in increased expression of ETV4 mRNA	PMID:31838189
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306524	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of ETV4 mRNA	PMID:29391264
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:48981	quinolin-8-ol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015125	Oxyquinoline results in increased expression of ETV4 mRNA	PMID:21632981
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1315191	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of ETV4 mRNA	PMID:17555576
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of ETV4 mRNA	PMID:38568856
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of ETV4 mRNA	PMID:20458559
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315191	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of ETV4 mRNA; Nanotubes, Carbon results in increased expression of ETV4 mRNA	PMID:25554681
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:52717	bortezomib	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000069286	Bortezomib results in decreased expression of ETV4 mRNA	PMID:20977926
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1315191	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of ETV4 mRNA	PMID:19042947
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1315191	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of ETV4 mRNA	PMID:38701926
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:63041	manganese(II) chloride	increases expression	ISO	RGD:1306524	E	RGD:6480464	20190219	CTD	MESH:C025340	manganese chloride results in increased expression of ETV4 mRNA	PMID:28801915
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of ETV4 mRNA	PMID:28988120
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:64090	tert-butyl hydroperoxide	increases expression	ISO	RGD:1315191	E	RGD:6480464	20120412	CTD	MESH:D020122	tert-Butylhydroperoxide results in increased expression of ETV4 mRNA	PMID:15003993
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	ISO	RGD:1306524	E	RGD:6480464	20190219	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of ETV4 mRNA	PMID:28801915
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315191	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of ETV4 mRNA	PMID:22206623
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315191	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ETV4 mRNA]	PMID:22206623
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:75249	potassium chromate	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in increased expression of ETV4 mRNA	PMID:22714537
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of ETV4 mRNA	PMID:37199045
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of ETV4 protein	PMID:31285264
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:75998	trametinib	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C560077	[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ETV4 mRNA	PMID:36139627
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of ETV4 mRNA	PMID:30851411
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ETV4 mRNA	PMID:27188386
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in decreased expression of ETV4 mRNA	PMID:31388691
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:81758	cyproconazole	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20141111	CTD	MESH:C093628	cyproconazole results in decreased expression of ETV4 mRNA	PMID:22045034
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:81766	hexaconazole	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20141111	CTD	MESH:C409722	hexaconazole results in decreased expression of ETV4 mRNA	PMID:22045034
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:81922	flusilazole	affects expression	ISO	RGD:1315191	E	RGD:6480464	20141111	CTD	MESH:C061365	flusilazole affects the expression of ETV4 mRNA	PMID:22634333
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306524	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of ETV4 mRNA	PMID:24780913
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1315191	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of ETV4 mRNA	PMID:40826991
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:88249	PD 0325901	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C506614	mirdametinib results in decreased expression of ETV4 mRNA	PMID:25119042
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:88249	PD 0325901	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C506614	[mirdametinib co-treated with (+)-JQ1 compound] results in decreased expression of ETV4 mRNA	PMID:25119042
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ETV4 mRNA	PMID:27188386
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:9141	silver(0)	increases expression	ISO	RGD:1315191	E	RGD:6480464	20161115	CTD	MESH:D012834	Silver results in increased expression of ETV4 mRNA	PMID:27131904
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:94686	orlistat	increases expression	EXP		E	RGD:6480464	20170808	CTD	MESH:C055122	orlistat results in increased expression of ETV4 protein	PMID:15870086
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of ETV4 mRNA	PMID:38568856
1315190	ETV4	ETS variant transcription factor 4	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of ETV4 mRNA	PMID:22378314
1315192	MLANA	melan-A	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1315193	E	RGD:6480464	20240402	CTD	MESH:D014212	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MLANA mRNA	PMID:36189433
1315192	MLANA	melan-A	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1315193	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MLANA mRNA	PMID:30529165
1315192	MLANA	melan-A	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306525	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MLANA gene	PMID:28931070
1315192	MLANA	melan-A	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1315193	E	RGD:6480464	20130723	CTD	MESH:D004958	Estradiol results in decreased expression of MLANA mRNA	PMID:19484750
1315192	MLANA	melan-A	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	multiple interactions	ISO	RGD:1315193	E	RGD:6480464	20240402	CTD	MESH:C016599	[mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of MLANA mRNA	PMID:36189433
1315192	MLANA	melan-A	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MLANA protein	PMID:37730182
1315192	MLANA	melan-A	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of MLANA gene	PMID:27153756
1315192	MLANA	melan-A	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1315193	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of MLANA mRNA	PMID:17484886
1315192	MLANA	melan-A	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1315193	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of MLANA mRNA	PMID:40618947
1315192	MLANA	melan-A	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1315193	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of MLANA mRNA	PMID:32186404
1315192	MLANA	melan-A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315193	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MLANA mRNA	PMID:21570461
1315192	MLANA	melan-A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306525	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MLANA mRNA	PMID:34747641
1315192	MLANA	melan-A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315193	E	RGD:6480464	20120515	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to MLANA promoter]	PMID:19654925
1315192	MLANA	melan-A	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1306525	E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of MLANA protein	PMID:21467743
1315192	MLANA	melan-A	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of MLANA promoter	PMID:27901495
1315192	MLANA	melan-A	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315193	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of MLANA mRNA	PMID:23557971
1315192	MLANA	melan-A	gene	CHEBI:32509	pirinixic acid	multiple interactions	ISO	RGD:1315193	E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MLANA mRNA	PMID:19710929
1315192	MLANA	melan-A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306525	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MLANA mRNA	PMID:25181051
1315192	MLANA	melan-A	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315193	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of MLANA mRNA	PMID:34585602
1315192	MLANA	melan-A	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of MLANA gene	PMID:31601247
1315192	MLANA	melan-A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1315193	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of MLANA gene	PMID:31683443
1315192	MLANA	melan-A	gene	CHEBI:35299	dibenz[a,h]anthracene	increases expression	ISO	RGD:1315193	E	RGD:6480464	20160119	CTD	MESH:C026486	1,2,5,6-dibenzanthracene results in increased expression of MLANA mRNA	PMID:26377693
1315192	MLANA	melan-A	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of MLANA mRNA	PMID:38174414
1315192	MLANA	melan-A	gene	CHEBI:39178	clothianidin	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in increased expression of MLANA mRNA	PMID:31626844
1315192	MLANA	melan-A	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of MLANA mRNA	PMID:23179753|PMID:27188386
1315192	MLANA	melan-A	gene	CHEBI:41774	tamoxifen	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen results in decreased expression of MLANA mRNA	PMID:15590111
1315192	MLANA	melan-A	gene	CHEBI:46666	crocidolite asbestos	increases expression	ISO	RGD:1315193	E	RGD:6480464	20161115	CTD	MESH:D017638	Asbestos, Crocidolite results in increased expression of MLANA mRNA	PMID:19446018
1315192	MLANA	melan-A	gene	CHEBI:48843	disodium selenite	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in decreased expression of MLANA mRNA	PMID:18175754
1315192	MLANA	melan-A	gene	CHEBI:4911	etoposide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	MLANA protein affects the susceptibility to Etoposide	PMID:16217747
1315192	MLANA	melan-A	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315193	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in decreased expression of MLANA mRNA	PMID:25554681
1315192	MLANA	melan-A	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of MLANA mRNA	PMID:27091632
1315192	MLANA	melan-A	gene	CHEBI:53227	poly(ethylene)	multiple interactions	ISO	RGD:1315193	E	RGD:6480464	20260602	CTD	MESH:D020959	[Polyethylene results in increased abundance of Microplastics] which results in decreased expression of MLANA mRNA	PMID:40262053
1315192	MLANA	melan-A	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of MLANA mRNA	PMID:20436886
1315192	MLANA	melan-A	gene	CHEBI:61076	belinostat	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C487081	belinostat results in decreased expression of MLANA mRNA	PMID:27188386
1315192	MLANA	melan-A	gene	CHEBI:63637	vemurafenib	increases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C551177	vemurafenib results in increased expression of MLANA mRNA; vemurafenib results in increased expression of MLANA protein	PMID:26640592
1315192	MLANA	melan-A	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of MLANA mRNA	PMID:27091632
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1552474	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine] results in decreased expression of DNAJA3 mRNA	PMID:18313992
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:132267	triptonide	affects expression	ISO	RGD:1552474	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide affects the expression of DNAJA3 mRNA	PMID:33045310
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of DNAJA3 mRNA	PMID:33167477
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJA3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJA3 mRNA	PMID:32699268
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of DNAJA3 mRNA	PMID:22378314
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552474	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of DNAJA3 mRNA	PMID:39241906
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1552474	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of DNAJA3 mRNA]	PMID:39241906
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of DNAJA3 mRNA	PMID:31614463
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552474	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DNAJA3 mRNA	PMID:39298647
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D004958	Estradiol promotes the reaction [DNAJA3 protein binds to ESR1 protein]	PMID:27156127
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DNAJA3 mRNA	PMID:37042841
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of DNAJA3 mRNA	PMID:21179406
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:177802	Cuprizon	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	Cuprizone results in decreased expression of DNAJA3 protein	PMID:34122009
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Clozapine] results in increased expression of DNAJA3 protein	PMID:34122009
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of DNAJA3 mRNA	PMID:28818685
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552474	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DNAJA3 mRNA	PMID:36331819
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of DNAJA3 mRNA	PMID:39836092
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DNAJA3 mRNA	PMID:19549813
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DNAJA3 intron	PMID:30157460
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJA3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJA3 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DNAJA3 mRNA	PMID:32699268
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306527	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of DNAJA3 mRNA	PMID:30779732
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:27568	selenium atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DNAJA3 mRNA	PMID:19244175
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of DNAJA3 mRNA	PMID:19244175
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306527	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of DNAJA3 mRNA	PMID:31881176
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:27889	lead(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D007854	Lead results in decreased expression of DNAJA3 mRNA	PMID:19921347
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552474	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DNAJA3 mRNA	PMID:21570461
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306527	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DNAJA3 mRNA	PMID:21215274
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552474	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of DNAJA3 mRNA	PMID:17942748
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of DNAJA3 mRNA	PMID:39709020
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:28748	doxorubicin	decreases expression	ISO	RGD:1552474	E	RGD:6480464	20160607	CTD	MESH:D004317	Doxorubicin results in decreased expression of DNAJA3 mRNA	PMID:26873546
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:29287	gold atom	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which results in increased expression of DNAJA3 mRNA	PMID:28433809
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1552474	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DNAJA3 mRNA	PMID:16014739
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of DNAJA3 mRNA	PMID:22378314
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1552474	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of DNAJA3 mRNA]	PMID:22228805
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:30050	gold(0)	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which results in increased expression of DNAJA3 mRNA	PMID:28433809
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DNAJA3 mRNA	PMID:19150397
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306527	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of DNAJA3 mRNA	PMID:25729387
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552474	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of DNAJA3 mRNA	PMID:18301758
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of DNAJA3 mRNA	PMID:30903817
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306527	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of DNAJA3 mRNA	PMID:25181051
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of DNAJA3 mRNA	PMID:19244175
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of DNAJA3 mRNA	PMID:19244175
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D002220	Carbamazepine affects the expression of DNAJA3 mRNA	PMID:24752500
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	EXP		E	RGD:6480464	20230117	CTD	MESH:C543008	bisphenol S affects the expression of DNAJA3 protein	PMID:31945527
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552474	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of DNAJA3 mRNA	PMID:39298647
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1552474	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of DNAJA3 mRNA	PMID:34813904
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1552474	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of DNAJA3 mRNA	PMID:34813904
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1552474	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of DNAJA3 mRNA]	PMID:39241906
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DNAJA3 mRNA	PMID:37042841
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of DNAJA3 mRNA	PMID:39836092
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of DNAJA3 mRNA	PMID:38568856
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306527	E	RGD:6480464	20160119	CTD	MESH:C039281	furan results in increased expression of DNAJA3 mRNA	PMID:26194646
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1552474	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of DNAJA3 mRNA	PMID:28903501
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DNAJA3 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DNAJA3 mRNA	PMID:32699268
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:36904	elemental selenium	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in decreased expression of DNAJA3 mRNA	PMID:19244175
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of DNAJA3 mRNA	PMID:19244175
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:3766	clozapine	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	[Cuprizone co-treated with Clozapine] results in increased expression of DNAJA3 protein	PMID:34122009
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DNAJA3 mRNA	PMID:32588087
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DNAJA3 mRNA	PMID:31533062
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552474	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DNAJA3 mRNA	PMID:36331819
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1552474	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of DNAJA3 mRNA	PMID:17292431
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of DNAJA3 mRNA	PMID:29154799
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	[Hydralazine co-treated with Valproic Acid] results in increased expression of DNAJA3 mRNA	PMID:17183730
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:44445	nimesulide	increases expression	ISO	RGD:1306527	E	RGD:6480464	20160412	CTD	MESH:C012655	nimesulide results in increased expression of DNAJA3 mRNA	PMID:24136188
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of DNAJA3 mRNA	PMID:25704631
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:472805	ouabain	increases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:D010042	Ouabain results in increased expression of DNAJA3 mRNA	PMID:28795476
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:47381	diclofenac	affects expression	EXP		E	RGD:6480464	20140715	CTD	MESH:D004008	Diclofenac affects the expression of DNAJA3 mRNA	PMID:24752500
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:47381	diclofenac	decreases expression	ISO	RGD:1552474	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in decreased expression of DNAJA3 mRNA	PMID:26934552
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552474	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of DNAJA3 mRNA	PMID:17942748
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:5001	fenofibrate	increases expression	ISO	RGD:1552474	E	RGD:6480464	20120613	CTD	MESH:D011345	Fenofibrate results in increased expression of DNAJA3 mRNA	PMID:21318169
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552474	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of DNAJA3 mRNA	PMID:25620056
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552474	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DNAJA3 mRNA	PMID:35964746
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:5132	flutamide	decreases expression	ISO	RGD:1552474	E	RGD:6480464	20120814	CTD	MESH:D005485	Flutamide results in decreased expression of DNAJA3 mRNA	PMID:19442681
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306527	E	RGD:6480464	20120814	CTD	MESH:D005485	Flutamide results in increased expression of DNAJA3 mRNA	PMID:20566332
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1552474	E	RGD:6480464	20120412	CTD	MESH:D005485	Flutamide results in increased expression of DNAJA3 mRNA	PMID:17702527
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:5775	hydralazine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D006830	[Hydralazine co-treated with Valproic Acid] results in increased expression of DNAJA3 mRNA	PMID:17183730
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of DNAJA3 mRNA	PMID:20436886
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DNAJA3 protein	PMID:32959892
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[manganese chloride results in increased abundance of Manganese] which results in decreased expression of DNAJA3 mRNA	PMID:39836092
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1552474	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine] results in decreased expression of DNAJA3 mRNA	PMID:18313992
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306527	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of DNAJA3 mRNA	PMID:25729387
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:6382	Lasiocarpine	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in decreased expression of DNAJA3 mRNA	PMID:40054833
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:641	N-methyl-4-phenylpyridinium	decreases expression	ISO	RGD:1552474	E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in decreased expression of DNAJA3 protein	PMID:22016808
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1552474	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of DNAJA3 protein	PMID:36851058
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1552474	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of DNAJA3 mRNA	PMID:22206623
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306527	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of DNAJA3 mRNA	PMID:24136188
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:78741	oxidopamine	decreases expression	ISO	RGD:1552474	E	RGD:6480464	20170725	CTD	MESH:D016627	Oxidopamine results in decreased expression of DNAJA3 protein	PMID:22016808
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:78741	oxidopamine	increases degradation	ISO	RGD:1306527	E	RGD:6480464	20170725	CTD	MESH:D016627	Oxidopamine results in increased degradation of DNAJA3 protein	PMID:22016808
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:8113	phlorizin	decreases expression	ISO	RGD:1552474	E	RGD:6480464	20121009	CTD	MESH:D010695	Phlorhizin results in decreased expression of DNAJA3 mRNA	PMID:22538082
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	ISO	RGD:1306527	E	RGD:6480464	20200915	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DNAJA3 mRNA	PMID:31826744|PMID:32679240
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1552474	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in increased expression of DNAJA3 mRNA]	PMID:39241906
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:88046	cylindrospermopsin	increases expression	EXP		E	RGD:6480464	20151006	CTD	MESH:C089595	cylindrospermopsin results in increased expression of DNAJA3 mRNA	PMID:24921660
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DNAJA3 mRNA	PMID:38568856
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of DNAJA3 mRNA	PMID:22378314
1315195	DNAJA3	DnaJ heat shock protein family (Hsp40) member A3	gene	CHEBI:9986	vinclozolin	increases methylation	ISO	RGD:1306527	E	RGD:6480464	20211012	CTD	MESH:C025643	vinclozolin results in increased methylation of DNAJA3 gene	PMID:31682807
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DHCR24 mRNA	PMID:38218311
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:116509	diuron	decreases expression	EXP		E	RGD:6480464	20230905	CTD	MESH:D004237	Diuron results in decreased expression of DHCR24 mRNA	PMID:35967413
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of DHCR24 protein	PMID:36641056
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:144400	dinophysistoxin 1	decreases expression	EXP		E	RGD:6480464	20190903	CTD	MESH:C051904	dinophysistoxin 1 results in decreased expression of DHCR24 mRNA	PMID:28939011
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1306529	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of DHCR24 mRNA	PMID:20488242
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1315198	E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of DHCR24 mRNA	PMID:16604517
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DHCR24 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DHCR24 mRNA	PMID:32699268
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:15379	dioxygen	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010100	Oxygen deficiency results in decreased expression of DHCR24 mRNA; Oxygen results in decreased expression of DHCR24 mRNA	PMID:26516004|PMID:27103661
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DHCR24 mRNA	PMID:30529165
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DHCR24 mRNA	PMID:26079696
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:15767	dichloromethane	affects expression	ISO	RGD:1315198	E	RGD:6480464	20171010	CTD	MESH:D008752	Methylene Chloride affects the expression of DHCR24 mRNA	PMID:28392392
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of DHCR24 mRNA	PMID:22378314
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16113	cholesterol	affects abundance	ISO	RGD:1315198	E	RGD:6480464	20120412	CTD	MESH:D002784	DHCR24 protein affects the abundance of Cholesterol	PMID:19260826
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16113	cholesterol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D002784	[DHCR24 protein results in increased metabolism of Desmosterol] which results in increased abundance of Cholesterol	PMID:23042211
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1315198	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of DHCR24 mRNA	PMID:30319688
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315198	E	RGD:6480464	20120918	CTD	MESH:D000431	Ethanol results in increased expression of DHCR24 mRNA	PMID:19167417|PMID:21955143
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of DHCR24 mRNA	PMID:21632981
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013196	Dihydrotestosterone affects the expression of DHCR24 mRNA	PMID:17094431
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of DHCR24 mRNA	PMID:29581250
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20191008	CTD	MESH:D013196	Dihydrotestosterone inhibits the reaction [Androgens deficiency results in increased expression of DHCR24 mRNA]	PMID:29367455
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1315198	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol affects the expression of DHCR24 mRNA	PMID:39298647
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D004958	Estradiol results in decreased expression of DHCR24 mRNA	PMID:18260696|PMID:23373633
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DHCR24 mRNA	PMID:15585566
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315198	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of DHCR24 mRNA	PMID:20826375|PMID:32186404
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of DHCR24 mRNA	PMID:33387578
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16602	trichloroethene	multiple interactions	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:D014241	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of DHCR24 mRNA	PMID:17905399
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DHCR24 mRNA	PMID:37042841
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:166595	Yessotoxin	increases expression	EXP		E	RGD:6480464	20201208	CTD	MESH:C066632	yessotoxin analog results in increased expression of DHCR24 mRNA	PMID:30679557
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16716	benzene	multiple interactions	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:D001554	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of DHCR24 mRNA	PMID:17905399
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of DHCR24 mRNA	PMID:23649840
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:16954	vitexin	increases expression	ISO	RGD:1315198	E	RGD:6480464	20180828	CTD	MESH:C032731	vitexin results in increased expression of DHCR24 mRNA	PMID:29545167
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in decreased expression of DHCR24 mRNA	PMID:23360888
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:17303	morphine	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20120515	CTD	MESH:D009020	Morphine results in decreased expression of DHCR24 mRNA	PMID:21955143
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:17688	(S)-nicotine	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of DHCR24 mRNA	PMID:21955143
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:17737	desmosterol	increases metabolic processing	EXP		E	RGD:6480464	20130723	CTD	MESH:D003897	DHCR24 protein results in increased metabolism of Desmosterol	PMID:23042211
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:17737	desmosterol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D003897	[DHCR24 protein results in increased metabolism of Desmosterol] which results in increased abundance of Cholesterol	PMID:23042211
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of DHCR24 mRNA	PMID:32235866|PMID:34319233
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D002117	Calcitriol results in increased expression of DHCR24 mRNA	PMID:26485663
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of DHCR24 mRNA	PMID:33387578
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DHCR24 mRNA	PMID:36331819
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:18723	nicotine	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20161213	CTD	MESH:D009538	Nicotine results in decreased expression of DHCR24 mRNA	PMID:21955143
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:188736	Archazolid B	increases expression	EXP		E	RGD:6480464	20220104	CTD	MESH:C519728	archazolid B results in increased expression of DHCR24 mRNA	PMID:25218289
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:205919	clobetasol	increases expression	ISO	RGD:1315198	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in increased expression of DHCR24 mRNA	PMID:27462272
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DHCR24 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DHCR24 mRNA	PMID:37236586|PMID:37325564
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DHCR24 mRNA	PMID:19549813
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of DHCR24 mRNA	PMID:23649840
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of DHCR24 mRNA	PMID:27153756
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of DHCR24 gene	PMID:27153756
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DHCR24 intron	PMID:30157460
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of DHCR24 mRNA	PMID:23649840
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:25812	ozone	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D010126	Ozone results in increased expression of DHCR24 mRNA	PMID:23033980
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DHCR24 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DHCR24 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased oxidation of DHCR24 mRNA	PMID:32699268
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:2663	amiodarone	affects expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone affects the expression of DHCR24 mRNA	PMID:19483382
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of DHCR24 mRNA	PMID:30779732
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1315198	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of DHCR24 mRNA	PMID:31919559
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of DHCR24 mRNA	PMID:16239168
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DHCR24 mRNA	PMID:39836092
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DHCR24 mRNA	PMID:40504410
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DHCR24 mRNA	PMID:19244175
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:27732	caffeine	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:D002110	Caffeine results in decreased expression of DHCR24 mRNA	PMID:20864626
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:27812	Se-methyl-L-selenocysteine	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:C002979	selenomethylselenocysteine results in decreased expression of DHCR24 mRNA	PMID:19025659
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of DHCR24 mRNA	PMID:31881176
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:27899	cisplatin	affects expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002945	Cisplatin affects the expression of DHCR24 mRNA	PMID:23300844
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of DHCR24 mRNA	PMID:27594783
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1315198	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased expression of DHCR24 mRNA	PMID:21151649
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin promotes the reaction [jinfukang results in increased expression of DHCR24 mRNA]; jinfukang promotes the reaction [Cisplatin results in increased expression of DHCR24 mRNA]	PMID:27392435
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28077	rifampicin	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:D012293	[Rifampin results in increased activity of NR1I2 protein] which results in increased expression of DHCR24 mRNA	PMID:22101211
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28088	genistein	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in decreased expression of DHCR24 mRNA	PMID:15378649
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28088	genistein	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in decreased expression of DHCR24 mRNA	PMID:32186404
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DHCR24 mRNA	PMID:32109520|PMID:33387578
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DHCR24 mRNA	PMID:28213091
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DHCR24 mRNA	PMID:17555868
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306529	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DHCR24 mRNA	PMID:21215274
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315198	E	RGD:6480464	20120501	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of DHCR24 mRNA	PMID:19770486
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to DHCR24 gene]	PMID:28213091
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28201	rotenone	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone results in decreased expression of DHCR24 mRNA	PMID:28374803
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in increased expression of DHCR24 protein	PMID:39603559
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28619	acrylamide	decreases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in decreased expression of DHCR24 mRNA	PMID:32763439
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of DHCR24 mRNA	PMID:21198554
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28689	dehydroepiandrosterone	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003687	Dehydroepiandrosterone affects the expression of DHCR24 mRNA	PMID:17094431
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28694	copper atom	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of DHCR24 mRNA	PMID:30556269
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of DHCR24 mRNA	PMID:20971185
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of DHCR24 mRNA	PMID:15467011
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29287	gold atom	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of DHCR24 mRNA	PMID:36057382
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29287	gold atom	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which results in decreased expression of DHCR24 mRNA	PMID:28433809
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29287	gold atom	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in decreased expression of DHCR24 mRNA	PMID:19695318
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of DHCR24 mRNA	PMID:38568856
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of DHCR24 mRNA	PMID:37682722
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of DHCR24 mRNA	PMID:34032870|PMID:39719251
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1315198	E	RGD:6480464	20250708	CTD	MESH:C017947	sodium arsenite results in increased expression of DHCR24 mRNA	PMID:39515575
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DHCR24 mRNA; sodium arsenite promotes the reaction [DHCR24 protein binds to CAPRIN1 protein]	PMID:33939924|PMID:39836092
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DHCR24 mRNA	PMID:40504410
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29699	tunicamycin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in decreased expression of DHCR24 mRNA	PMID:22378314|PMID:29453283
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DHCR24 promoter	PMID:27901495
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DHCR24 mRNA	PMID:20064835|PMID:26238291|PMID:32234424
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1306529	E	RGD:6480464	20250506	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DHCR24 mRNA	PMID:39423996
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315198	E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DHCR24 mRNA	PMID:20504355
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1306529	E	RGD:6480464	20250506	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with perfluorooctane sulfonic acid] results in increased expression of DHCR24 mRNA	PMID:39423996
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:30050	gold(0)	decreases expression	EXP		E	RGD:6480464	20230502	CTD	MESH:D006046	Gold analog results in decreased expression of DHCR24 mRNA	PMID:36057382
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:30050	gold(0)	multiple interactions	EXP		E	RGD:6480464	20171010	CTD	MESH:D006046	[Polyethyleneimine binds to Gold] which results in decreased expression of DHCR24 mRNA	PMID:28433809
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:30050	gold(0)	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20120918	CTD	MESH:D006046	[Gold co-treated with Polyethylene Glycols] results in decreased expression of DHCR24 mRNA	PMID:19695318
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:30052	copper(0)	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in decreased expression of DHCR24 mRNA	PMID:30556269
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of DHCR24 mRNA	PMID:20971185
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20120814	CTD	MESH:D003300	[ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of DHCR24 mRNA	PMID:15467011
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:3020	benzalkonium chloride	increases expression	ISO	RGD:1315198	E	RGD:6480464	20190910	CTD	MESH:D001548	Benzalkonium Compounds results in increased expression of DHCR24 mRNA	PMID:31199489
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:3023	benzbromarone	affects expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:D001553	Benzbromarone affects the expression of DHCR24 mRNA	PMID:19483382
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:3048	benzatropine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D001590	Benztropine results in increased expression of DHCR24 protein	PMID:34122009
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:30537	triphenylstannane	multiple interactions	ISO	RGD:1306529	E	RGD:6480464	20260707	CTD	MESH:C030665	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of DHCR24 mRNA	PMID:38458666
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of DHCR24 mRNA	PMID:23806026|PMID:25895662
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D012822	Silicon Dioxide results in increased expression of DHCR24 mRNA	PMID:23623845
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:30778	gallic acid	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in decreased expression of DHCR24 mRNA	PMID:34408198
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306529	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of DHCR24 mRNA	PMID:24136188
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315198	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of DHCR24 mRNA	PMID:23557971
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315198	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of DHCR24 gene	PMID:35295148
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:32497	thioacetamide	affects expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:D013853	Thioacetamide affects the expression of DHCR24 mRNA	PMID:19483382
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of DHCR24 mRNA	PMID:34492290
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:32509	pirinixic acid	affects expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid affects the expression of DHCR24 mRNA	PMID:19483382
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315198	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of DHCR24 mRNA	PMID:20813756
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of DHCR24 mRNA	PMID:38479592
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:33083	fluoranthene	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20170725	CTD	MESH:C007738	fluoranthene results in decreased expression of DHCR24 mRNA	PMID:28329830
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of DHCR24 mRNA	PMID:28329830
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of DHCR24 mRNA	PMID:30903817
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306529	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of DHCR24 mRNA	PMID:32145629
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in decreased expression of DHCR24 protein	PMID:37567409
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in decreased expression of DHCR24 mRNA	PMID:41034487
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of DHCR24 mRNA; bisphenol A results in increased expression of DHCR24 protein	PMID:29275510|PMID:34186270
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306529	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DHCR24 mRNA	PMID:25181051
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315198	E	RGD:6480464	20120412	CTD	MESH:C006780	bisphenol A results in increased expression of DHCR24 mRNA	PMID:20826375|PMID:32156529
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34025	1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane	increases expression	ISO	RGD:1315198	E	RGD:6480464	20120412	CTD	MESH:C404910	2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of DHCR24 mRNA	PMID:20826375
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects expression	ISO	RGD:1315198	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S affects the expression of DHCR24 mRNA	PMID:39298647
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of DHCR24 mRNA	PMID:40203079
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315198	E	RGD:6480464	20220809	CTD	MESH:C543008	bisphenol S results in increased expression of DHCR24 mRNA	PMID:34850234
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	ISO	RGD:1315198	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in increased methylation of DHCR24 exon	PMID:33297965
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1315198	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of DHCR24 mRNA	PMID:26377693
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of DHCR24 protein	PMID:34186270
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315198	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of DHCR24 mRNA	PMID:38685157
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of DHCR24 protein	PMID:34186270
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34595	Butylbenzyl phthalate	affects methylation	ISO	RGD:1315198	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate affects the methylation of DHCR24 intron	PMID:28392331
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of DHCR24 mRNA	PMID:35093514
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DHCR24 mRNA	PMID:21266533|PMID:33983380
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1315198	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of DHCR24 mRNA	PMID:34813904
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of DHCR24 mRNA	PMID:28628672
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34837	methidathion	increases expression	ISO	RGD:1315198	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in increased expression of DHCR24 mRNA	PMID:34813904
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1306529	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of DHCR24 mRNA	PMID:22110744
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34887	nickel dichloride	decreases expression	EXP		E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride results in decreased expression of DHCR24 mRNA	PMID:17312168
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34905	paraquat	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D010269	Paraquat results in decreased expression of DHCR24 mRNA	PMID:23315990
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34911	permethrin	increases expression	ISO	RGD:1315198	E	RGD:6480464	20190507	CTD	MESH:D026023	Permethrin results in increased expression of DHCR24 mRNA	PMID:30629241
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1306529	E	RGD:6480464	20171010	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of DHCR24 mRNA	PMID:28659758
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DHCR24 mRNA	PMID:37042841
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:35036	fentin chloride	multiple interactions	ISO	RGD:1306529	E	RGD:6480464	20260707	CTD	MESH:C012594	[triphenyltin chloride results in increased abundance of triphenyltin] which results in decreased expression of DHCR24 mRNA	PMID:38458666
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306529	E	RGD:6480464	20190507	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of DHCR24 mRNA	PMID:30723492
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DHCR24 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DHCR24 mRNA	PMID:37236586|PMID:37325564
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:35458	cerium trichloride	decreases expression	EXP		E	RGD:6480464	20180116	CTD	MESH:C026690	cerous chloride results in decreased expression of DHCR24 mRNA	PMID:28954213
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of DHCR24 protein	PMID:26879310
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:35549	perfluorooctanoic acid	increases expression	ISO	RGD:1306529	E	RGD:6480464	20240430	CTD	MESH:C023036	perfluorooctanoic acid results in increased expression of DHCR24 mRNA	PMID:35163327
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:35559	furan	increases methylation	ISO	RGD:1306529	E	RGD:6480464	20120918	CTD	MESH:C039281	furan results in increased methylation of DHCR24 gene	PMID:22079235
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DHCR24 mRNA	PMID:19320972
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:35696	cobalt dichloride	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20151215	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DHCR24 mRNA	PMID:24386269
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1315198	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of DHCR24 mRNA	PMID:18353800
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of DHCR24 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of DHCR24 mRNA	PMID:32699268
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of DHCR24 mRNA	PMID:19244175
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:3750	clofibrate	affects expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:D002994	Clofibrate affects the expression of DHCR24 mRNA	PMID:19483382
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:3766	clozapine	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in increased expression of DHCR24 protein	PMID:34122009
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of DHCR24 mRNA	PMID:40194260
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of DHCR24 mRNA	PMID:31533062
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of DHCR24 mRNA	PMID:36864359|PMID:40419075
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1306529	E	RGD:6480464	20250506	CTD	MESH:C076994	[Benzo(a)pyrene co-treated with perfluorooctane sulfonic acid] results in increased expression of DHCR24 mRNA	PMID:39423996
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of DHCR24 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of DHCR24 mRNA	PMID:36331819
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:3962	curcumin	affects expression	ISO	RGD:1315198	E	RGD:6480464	20161025	CTD	MESH:D003474	Curcumin affects the expression of DHCR24 mRNA	PMID:27208389
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:3962	curcumin	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20161025	CTD	MESH:D003474	Curcumin results in decreased expression of DHCR24 mRNA	PMID:27208389
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in decreased expression of DHCR24 mRNA	PMID:23179753|PMID:27188386
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:39867	valproic acid	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in decreased expression of DHCR24 mRNA	PMID:21427059
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of DHCR24 mRNA	PMID:23179753|PMID:24383497|PMID:24935251
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1315198	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of DHCR24 mRNA	PMID:21427059
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of DHCR24 mRNA	PMID:20106945|PMID:25562108
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of DHCR24 mRNA	PMID:19770486
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:D016572	[Cyclosporine co-treated with Cholic Acids] affects the expression of DHCR24 mRNA	PMID:27344345
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:41423	celecoxib	affects expression	ISO	RGD:1315198	E	RGD:6480464	20170303	CTD	MESH:C105934	Celecoxib affects the expression of DHCR24 mRNA	PMID:20562220
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of DHCR24 mRNA	PMID:25047013
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of DHCR24 mRNA	PMID:28628672
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of DHCR24 mRNA	PMID:28973697
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:4453	desogestrel	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D017135	[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of DHCR24 mRNA	PMID:18160741
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:44616	afimoxifene	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20230801	CTD	MESH:C016601	afimoxifene results in decreased expression of DHCR24 mRNA	PMID:26879975
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of DHCR24 mRNA	PMID:38832940
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of DHCR24 mRNA	PMID:27188386
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:45863	paclitaxel	affects response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	DHCR24 protein affects the susceptibility to Paclitaxel	PMID:16217747
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of DHCR24 mRNA	PMID:29067470
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of DHCR24 mRNA	PMID:39836092
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of DHCR24 mRNA	PMID:40504410
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:47318	6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime	multiple interactions	EXP		E	RGD:6480464	20170303	CTD	MESH:C475093	[6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime results in increased activity of NR1I3 protein] which results in increased expression of DHCR24 mRNA	PMID:22101211
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:47381	diclofenac	increases expression	ISO	RGD:1315198	E	RGD:6480464	20180313	CTD	MESH:D004008	Diclofenac results in increased expression of DHCR24 mRNA	PMID:26934552
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of DHCR24 mRNA	PMID:30529165
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306529	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of DHCR24 mRNA	PMID:29391264
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:4886	L-ethionine	affects expression	ISO	RGD:1306529	E	RGD:6480464	20121106	CTD	MESH:D005001	Ethionine affects the expression of DHCR24 mRNA	PMID:19483382
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:4903	17alpha-ethynylestradiol	affects expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol affects the expression of DHCR24 mRNA	PMID:17351261
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of DHCR24 mRNA	PMID:17108234
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of DHCR24 mRNA	PMID:38568856
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of DHCR24 mRNA	PMID:28628672
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:49747	methylmercury(1+)	multiple interactions	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:C030957	[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of DHCR24 mRNA	PMID:17905399
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:4994	Febrifugine	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C001207	febrifugine results in decreased expression of DHCR24 mRNA	PMID:38431229
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:50131	5-aza-2'-deoxycytidine	affects expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine affects the expression of DHCR24 mRNA	PMID:23300844
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:50833	cadmium sulfide	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C034939	cadmium sulfide results in increased expression of DHCR24 mRNA	PMID:27866839
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:51052	lucanthone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008154	Lucanthone results in increased expression of DHCR24 mRNA	PMID:21148553
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of DHCR24 mRNA	PMID:35964746
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:5118	fluoxetine	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D005473	Fluoxetine results in increased expression of DHCR24 mRNA	PMID:37386098
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:521033	dutasteride	decreases expression	EXP		E	RGD:6480464	20170110	CTD	MESH:D000068538	Dutasteride results in decreased expression of DHCR24 mRNA	PMID:17636412
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1315198	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of DHCR24 mRNA	PMID:19042947
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:53444	potassium dichromate	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in increased expression of DHCR24 protein	PMID:23718831
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:59224	cetrorelix	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C062876	[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of DHCR24 mRNA; [cetrorelix co-treated with testosterone enanthate] results in decreased expression of DHCR24 mRNA	PMID:18160741
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:6067	isotretinoin	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015474	Isotretinoin results in decreased expression of DHCR24 mRNA	PMID:20436886
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:6078	ivermectin	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in increased expression of DHCR24 protein	PMID:32959892
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:61057	tacrolimus hydrate	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20150127	CTD	MESH:D016559	Tacrolimus results in decreased expression of DHCR24 mRNA	PMID:25270620
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1315198	E	RGD:6480464	20151215	CTD	MESH:D004113	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DHCR24 mRNA	PMID:26378955
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:63630	tolcapone	affects binding	ISO	RGD:1306529	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone binds to DHCR24 protein	PMID:19783845
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:63630	tolcapone	increases expression	ISO	RGD:1306529	E	RGD:6480464	20161213	CTD	MESH:C066340	tolcapone results in increased expression of DHCR24 mRNA	PMID:24136188
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:6382	Lasiocarpine	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C005136	lasiocarpine results in decreased expression of DHCR24 mRNA	PMID:40054833
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:63949	2,3-bis(4-hydroxyphenyl)propionitrile	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C486182	2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of DHCR24 mRNA	PMID:15585566
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1306529	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of DHCR24 mRNA	PMID:24136188
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:64022	nebivolol	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:D000068577	Nebivolol results in increased expression of DHCR24 mRNA	PMID:17467819
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DHCR24 mRNA	PMID:22079614
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:64317	isoprenaline	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20120515	CTD	MESH:D007545	Isoproterenol results in decreased expression of DHCR24 mRNA	PMID:20003209
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:67895	corosolic acid	increases expression	EXP		E	RGD:6480464	20240430	CTD	MESH:C113861	corosolic acid results in increased expression of DHCR24 mRNA	PMID:37939859
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1306529	E	RGD:6480464	20230307	CTD	MESH:D008694	Methamphetamine results in increased expression of DHCR24 mRNA	PMID:35863504
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306529	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DHCR24 gene	PMID:35440735
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:6923	miconazole	increases expression	ISO	RGD:1315198	E	RGD:6480464	20190910	CTD	MESH:D008825	Miconazole results in increased expression of DHCR24 mRNA	PMID:27462272
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	ISO	RGD:1306529	E	RGD:6480464	20171010	CTD	MESH:D003671	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of DHCR24 mRNA	PMID:28659758
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of DHCR24 protein	PMID:34186270
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315198	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DHCR24 mRNA	PMID:22206623
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DHCR24 protein	PMID:37664457
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:753051	incobotulinumtoxina	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in increased expression of DHCR24 mRNA	PMID:29522793
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:75408	sulindac sulfide	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C025462	sulindac sulfide results in decreased expression of DHCR24 mRNA	PMID:16184548
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1306529	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of DHCR24 mRNA	PMID:33484710
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:77012	methylseleninic acid	decreases expression	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	methylselenic acid results in decreased expression of DHCR24 mRNA	PMID:16020662|PMID:18548127
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:77012	methylseleninic acid	multiple interactions	EXP		E	RGD:6480464	20140304	CTD	MESH:C008493	AR protein inhibits the reaction [methylselenic acid results in decreased expression of DHCR24 mRNA]	PMID:16020662
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:77013	beta-naphthoflavone	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019324	beta-Naphthoflavone results in decreased expression of DHCR24 protein	PMID:39638853
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:7719	ochratoxin A	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20130514	CTD	MESH:C025589	ochratoxin A results in decreased expression of DHCR24 mRNA	PMID:23358140
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:77260	5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole	affects expression	ISO	RGD:1306529	E	RGD:6480464	20140805	CTD	MESH:D009853	Omeprazole affects the expression of DHCR24 mRNA	PMID:19483382
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:7772	omeprazole	affects expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:D009853	Omeprazole affects the expression of DHCR24 mRNA	PMID:19483382
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:78160	bleomycin A5	decreases expression	EXP		E	RGD:6480464	20140520	CTD	MESH:C025703	bleomycetin results in decreased expression of DHCR24 mRNA	PMID:21040473
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1315198	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of DHCR24 mRNA	PMID:23091169
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of DHCR24 mRNA	PMID:32109520
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1315198	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of DHCR24 mRNA	PMID:38648751
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1315198	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of DHCR24 mRNA	PMID:30294300
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DHCR24 mRNA	PMID:25305463
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:84069	pentanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C046012	pentanal results in decreased expression of DHCR24 mRNA	PMID:26079696
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:8502	6-propyl-2-thiouracil	affects expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:D011441	Propylthiouracil affects the expression of DHCR24 mRNA	PMID:19483382
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of DHCR24 mRNA	PMID:24780913|PMID:25825206
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1306529	E	RGD:6480464	20171010	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of DHCR24 mRNA	PMID:28659758
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:87185	florfenicol	increases expression	ISO	RGD:1315198	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in increased expression of DHCR24 mRNA	PMID:40826991
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:8772	raloxifene	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D020849	Raloxifene Hydrochloride results in decreased expression of DHCR24 mRNA	PMID:15585566
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:9068	Se-methylselenocysteine	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:C002979	selenomethylselenocysteine results in decreased expression of DHCR24 mRNA	PMID:19025659
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20240206	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DHCR24 protein	PMID:37664457
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:9150	simvastatin	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of DHCR24	PMID:21987590
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:9150	simvastatin	increases expression	ISO	RGD:1306529	E	RGD:6480464	20141223	CTD	MESH:D019821	Simvastatin results in increased expression of DHCR24 mRNA	PMID:25055962
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:9150	simvastatin	increases expression	ISO	RGD:1315198	E	RGD:6480464	20120501	CTD	MESH:D019821	Simvastatin results in increased expression of DHCR24 mRNA; Simvastatin results in increased expression of DHCR24 protein	PMID:21987590
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DHCR24 mRNA	PMID:21346803
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:9381	T-2 toxin	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:D013605	T-2 Toxin results in decreased expression of DHCR24 mRNA	PMID:31863870|PMID:34581912
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:9464	testosterone enanthate	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	[cetrorelix co-treated with testosterone enanthate co-treated with Desogestrel] results in decreased expression of DHCR24 mRNA; [cetrorelix co-treated with testosterone enanthate] results in decreased expression of DHCR24 mRNA	PMID:18160741
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of DHCR24 mRNA	PMID:38568856
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:95077	GSK-J4	decreases expression	EXP		E	RGD:6480464	20250408	CTD	MESH:C000593030	GSK-J4 results in decreased expression of DHCR24 mRNA	PMID:29301935
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:9516	thapsigargin	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in decreased expression of DHCR24 mRNA	PMID:22378314
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1306529	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in increased expression of DHCR24 protein	PMID:35544339
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of DHCR24 mRNA	PMID:27188386
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306529	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of DHCR24 mRNA	PMID:21346803
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306529	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of DHCR24 mRNA	PMID:23034163
1315197	DHCR24	24-dehydrocholesterol reductase	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306529	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of DHCR24 mRNA	PMID:22570695
1315199	KRT31	keratin 31	gene	CHEBI:133152	2-bromohexadecanoic acid	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C022776	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT31 protein]	PMID:38195004
1315199	KRT31	keratin 31	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of KRT31 mRNA	PMID:22378314
1315199	KRT31	keratin 31	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of KRT31 mRNA	PMID:31163220
1315199	KRT31	keratin 31	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D002104	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT31 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT31 protein	PMID:38195004
1315199	KRT31	keratin 31	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1615966	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of KRT31 mRNA	PMID:25629700
1315199	KRT31	keratin 31	gene	CHEBI:28088	genistein	multiple interactions	ISO	RGD:1359411	E	RGD:6480464	20180116	CTD	MESH:D019833	[bisphenol A co-treated with Genistein] results in increased methylation of KRT31 gene	PMID:28505145
1315199	KRT31	keratin 31	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20130514	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KRT31 mRNA	PMID:23152189
1315199	KRT31	keratin 31	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20181016	CTD	MESH:D012402	Rotenone results in decreased expression of KRT31 mRNA	PMID:29955902
1315199	KRT31	keratin 31	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KRT31 mRNA	PMID:30851411
1315199	KRT31	keratin 31	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KRT31 exon; Benzo(a)pyrene results in increased methylation of KRT31 promoter	PMID:27901495
1315199	KRT31	keratin 31	gene	CHEBI:31991	phenol red	multiple interactions	EXP		E	RGD:6480464	20200519	CTD	MESH:D010637	[Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of KRT31 protein	PMID:31629898
1315199	KRT31	keratin 31	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1359411	E	RGD:6480464	20170418	CTD	MESH:C006780	bisphenol A results in decreased expression of KRT31 mRNA	PMID:25181051
1315199	KRT31	keratin 31	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1359411	E	RGD:6480464	20251202	CTD	MESH:C006780	bisphenol A results in increased expression of KRT31 mRNA	PMID:41034487
1315199	KRT31	keratin 31	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1359411	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of KRT31 gene	PMID:28505145
1315199	KRT31	keratin 31	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KRT31 mRNA; [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of KRT31 protein	PMID:28628672|PMID:31629898
1315199	KRT31	keratin 31	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1359411	E	RGD:6480464	20180116	CTD	MESH:C006780	[bisphenol A co-treated with Genistein] results in increased methylation of KRT31 gene	PMID:28505145
1315199	KRT31	keratin 31	gene	CHEBI:3423	carmustine	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in decreased expression of KRT31 mRNA	PMID:15980968
1315199	KRT31	keratin 31	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of KRT31 mRNA	PMID:28628672
1315199	KRT31	keratin 31	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KRT31 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of KRT31 mRNA	PMID:28628672
1315199	KRT31	keratin 31	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1359411	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of KRT31 mRNA	PMID:35163327
1315199	KRT31	keratin 31	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1359411	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT31 mRNA	PMID:35163327
1315199	KRT31	keratin 31	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT31 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of KRT31 protein	PMID:38195004
1315199	KRT31	keratin 31	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1359411	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of KRT31 mRNA	PMID:35163327
1315199	KRT31	keratin 31	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KRT31 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of KRT31 mRNA	PMID:28628672
1315199	KRT31	keratin 31	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1615966	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of KRT31 mRNA	PMID:28973697
1315199	KRT31	keratin 31	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of KRT31 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of KRT31 mRNA	PMID:28628672
1315199	KRT31	keratin 31	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1615966	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of KRT31 mRNA	PMID:25620056
1315199	KRT31	keratin 31	gene	CHEBI:51348	tetraphene	increases expression	ISO	RGD:1615966	E	RGD:6480464	20160119	CTD	MESH:C030935	benz(a)anthracene results in increased expression of KRT31 mRNA	PMID:26377693
1315199	KRT31	keratin 31	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of KRT31 mRNA	PMID:28988120
1315199	KRT31	keratin 31	gene	CHEBI:77013	beta-naphthoflavone	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D019324	beta-Naphthoflavone results in increased expression of KRT31 mRNA	PMID:32151702
1315199	KRT31	keratin 31	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of KRT31 mRNA	PMID:30851411
1315199	KRT31	keratin 31	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220705	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KRT31 gene]	PMID:28238834
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1315202	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of NDST4 mRNA	PMID:30319688
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of NDST4 mRNA	PMID:31163220
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of NDST4 exon; Aflatoxin B1 results in increased methylation of NDST4 intron	PMID:30157460
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of NDST4 mRNA	PMID:26272509
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDST4 mRNA	PMID:27188386
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:27744	glyphosate	decreases expression	ISO	RGD:1306531	E	RGD:6480464	20240903	CTD	MESH:C010974	Glyphosate results in decreased expression of NDST4 mRNA	PMID:38314887
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1315202	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of NDST4 mRNA	PMID:28960355
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:27899	cisplatin	increases expression	ISO	RGD:1315202	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in increased expression of NDST4 mRNA	PMID:40618947
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306531	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of NDST4 mRNA	PMID:32109520
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of NDST4 mRNA	PMID:29301061
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of NDST4 promoter	PMID:27901495
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of NDST4 mRNA	PMID:25895662
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NDST4 gene	PMID:31601247
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306531	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of NDST4 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:33296240|PMID:34947998|PMID:38750585
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315202	E	RGD:6480464	20230207	CTD	MESH:C006780	bisphenol A results in increased expression of NDST4 mRNA	PMID:32156529
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306531	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of NDST4 gene	PMID:28505145
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of NDST4 gene	PMID:31601247
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of NDST4 mRNA	PMID:25979313
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	affects methylation	ISO	RGD:1315202	E	RGD:6480464	20230207	CTD	MESH:C543008	bisphenol S affects the methylation of NDST4 gene	PMID:31683443
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1315202	E	RGD:6480464	20250311	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of NDST4 mRNA	PMID:31841868
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of NDST4 mRNA	PMID:24449571
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1315202	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of NDST4 mRNA	PMID:40194260
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of NDST4 mRNA	PMID:25979313
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of NDST4 mRNA	PMID:23179753|PMID:24935251|PMID:27188386|PMID:28001369
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of NDST4 mRNA	PMID:20106945
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of NDST4 mRNA	PMID:38832940
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of NDST4 mRNA	PMID:27188386
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:45863	paclitaxel	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D017239	Paclitaxel results in increased expression of NDST4 mRNA	PMID:40481235
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	trichostatin A results in increased expression of NDST4 mRNA	PMID:27188386
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDST4 mRNA	PMID:27188386
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDST4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDST4 mRNA	PMID:27188386
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to NDST4 gene]	PMID:28238834
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1306531	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of NDST4 mRNA	PMID:32109520
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	EXP		E	RGD:6480464	20220510	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of NDST4 mRNA	PMID:26705709
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306531	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of NDST4 mRNA	PMID:24780913|PMID:25825206
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDST4 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NDST4 mRNA	PMID:27188386
1315201	NDST4	N-deacetylase and N-sulfotransferase 4	gene	CHEBI:9986	vinclozolin	decreases methylation	ISO	RGD:1306531	E	RGD:6480464	20201215	CTD	MESH:C025643	vinclozolin results in decreased methylation of NDST4 gene	PMID:31079544
1315204	PKP2	plakophilin 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of PKP2 mRNA	PMID:21934132
1315204	PKP2	plakophilin 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	ISO	RGD:1306533	E	RGD:6480464	20120814	CTD	MESH:D014212	Tretinoin results in increased expression of PKP2 mRNA	PMID:20488242
1315204	PKP2	plakophilin 2	gene	CHEBI:15367	all-trans-retinoic acid	multiple interactions	ISO	RGD:1550508	E	RGD:6480464	20191112	CTD	MESH:D014212	[bisphenol F co-treated with Tretinoin] results in decreased expression of PKP2 mRNA	PMID:30951980
1315204	PKP2	plakophilin 2	gene	CHEBI:15379	dioxygen	affects expression	ISO	RGD:1550508	E	RGD:6480464	20120918	CTD	MESH:D010100	Oxygen deficiency affects the expression of PKP2 mRNA	PMID:17193925
1315204	PKP2	plakophilin 2	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1550508	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of PKP2 mRNA	PMID:30319688
1315204	PKP2	plakophilin 2	gene	CHEBI:16236	ethanol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D000431	[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PKP2 mRNA	PMID:29432896
1315204	PKP2	plakophilin 2	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of PKP2 mRNA	PMID:15309432|PMID:21632981
1315204	PKP2	plakophilin 2	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D008070	[Lipopolysaccharides co-treated with Resveratrol] results in decreased expression of PKP2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PKP2 mRNA	PMID:26667767|PMID:35811015
1315204	PKP2	plakophilin 2	gene	CHEBI:16469	17beta-estradiol	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of PKP2 mRNA	PMID:14699072
1315204	PKP2	plakophilin 2	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550508	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol results in increased expression of PKP2 mRNA	PMID:15289156
1315204	PKP2	plakophilin 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20121218	CTD	MESH:D004958	[Estradiol binds to ESR2 protein] which results in decreased expression of PKP2 mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of PKP2 mRNA	PMID:20404318|PMID:30165855
1315204	PKP2	plakophilin 2	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1550508	E	RGD:6480464	20120412	CTD	MESH:D014241	Trichloroethylene results in increased expression of PKP2 mRNA	PMID:19448997
1315204	PKP2	plakophilin 2	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of PKP2 mRNA	PMID:37042841
1315204	PKP2	plakophilin 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of PKP2 mRNA	PMID:27664576
1315204	PKP2	plakophilin 2	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of PKP2 mRNA	PMID:21592394
1315204	PKP2	plakophilin 2	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of PKP2 mRNA	PMID:21592394
1315204	PKP2	plakophilin 2	gene	CHEBI:17594	hydroquinone	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:C031927	hydroquinone results in increased expression of PKP2 mRNA	PMID:31256213
1315204	PKP2	plakophilin 2	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1550508	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of PKP2 mRNA	PMID:23892564
1315204	PKP2	plakophilin 2	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306533	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of PKP2 mRNA	PMID:26577399
1315204	PKP2	plakophilin 2	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306533	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PKP2 mRNA	PMID:27523638
1315204	PKP2	plakophilin 2	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	Calcitriol results in increased expression of PKP2 mRNA	PMID:21592394
1315204	PKP2	plakophilin 2	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of PKP2 mRNA	PMID:21592394
1315204	PKP2	plakophilin 2	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PKP2 mRNA	PMID:39836092
1315204	PKP2	plakophilin 2	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306533	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of PKP2 protein	PMID:34915118
1315204	PKP2	plakophilin 2	gene	CHEBI:233659	erianin	multiple interactions	ISO	RGD:1550508	E	RGD:6480464	20250408	CTD	MESH:C477638	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PKP2 protein]	PMID:32272095
1315204	PKP2	plakophilin 2	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of PKP2 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PKP2 protein	PMID:38598786
1315204	PKP2	plakophilin 2	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306533	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of PKP2 mRNA	PMID:30779732
1315204	PKP2	plakophilin 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1550508	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of PKP2 mRNA	PMID:27339419|PMID:31919559
1315204	PKP2	plakophilin 2	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550508	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PKP2 mRNA	PMID:22206623
1315204	PKP2	plakophilin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PKP2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PKP2 mRNA	PMID:39836092
1315204	PKP2	plakophilin 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1550508	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PKP2 mRNA	PMID:40504410
1315204	PKP2	plakophilin 2	gene	CHEBI:27684	phenylmercury acetate	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in increased expression of PKP2 mRNA	PMID:26272509
1315204	PKP2	plakophilin 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA	PMID:27188386
1315204	PKP2	plakophilin 2	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of PKP2 protein	PMID:35688186
1315204	PKP2	plakophilin 2	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1550508	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of PKP2 mRNA	PMID:28960355
1315204	PKP2	plakophilin 2	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1550508	E	RGD:6480464	20130212	CTD	MESH:C059514	resveratrol results in decreased expression of PKP2 mRNA	PMID:22610192
1315204	PKP2	plakophilin 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20160822	CTD	MESH:C059514	[Lipopolysaccharides co-treated with resveratrol] results in decreased expression of PKP2 mRNA	PMID:26667767
1315204	PKP2	plakophilin 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of PKP2 mRNA	PMID:27392435
1315204	PKP2	plakophilin 2	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1550508	E	RGD:6480464	20120412	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of PKP2 protein	PMID:22006019
1315204	PKP2	plakophilin 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of PKP2 mRNA	PMID:27392435
1315204	PKP2	plakophilin 2	gene	CHEBI:27958	cocaine	increases expression	ISO	RGD:1306533	E	RGD:6480464	20180313	CTD	MESH:D003042	Cocaine results in increased expression of PKP2 mRNA	PMID:27899881
1315204	PKP2	plakophilin 2	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1550508	E	RGD:6480464	20120412	CTD	MESH:D019833	Genistein results in increased expression of PKP2 mRNA	PMID:15289156|PMID:32186404
1315204	PKP2	plakophilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306533	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PKP2 mRNA	PMID:22298810
1315204	PKP2	plakophilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550508	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of PKP2 mRNA	PMID:21570461
1315204	PKP2	plakophilin 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1550508	E	RGD:6480464	20170516	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PKP2 mRNA	PMID:27913140
1315204	PKP2	plakophilin 2	gene	CHEBI:28201	rotenone	affects expression	ISO	RGD:1306533	E	RGD:6480464	20191112	CTD	MESH:D012402	Rotenone affects the expression of PKP2 mRNA	PMID:28374803
1315204	PKP2	plakophilin 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PKP2 mRNA	PMID:23179753|PMID:27188386
1315204	PKP2	plakophilin 2	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of PKP2 mRNA	PMID:23179753|PMID:26272509|PMID:28001369
1315204	PKP2	plakophilin 2	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA	PMID:27188386
1315204	PKP2	plakophilin 2	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of PKP2 mRNA	PMID:33212167
1315204	PKP2	plakophilin 2	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of PKP2 mRNA	PMID:39709020
1315204	PKP2	plakophilin 2	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PKP2 mRNA	PMID:30851411
1315204	PKP2	plakophilin 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of PKP2 mRNA	PMID:26272509
1315204	PKP2	plakophilin 2	gene	CHEBI:28420	p-chloromercuribenzoic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA	PMID:27188386
1315204	PKP2	plakophilin 2	gene	CHEBI:28680	cytarabine	decreases expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D003561	Cytarabine results in decreased expression of PKP2 mRNA	PMID:21198554
1315204	PKP2	plakophilin 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PKP2 mRNA	PMID:29803840
1315204	PKP2	plakophilin 2	gene	CHEBI:28748	doxorubicin	increases expression	ISO	RGD:1550508	E	RGD:6480464	20250902	CTD	MESH:D004317	Doxorubicin results in increased expression of PKP2 mRNA	PMID:39631538
1315204	PKP2	plakophilin 2	gene	CHEBI:28794	coumarin	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin affects the phosphorylation of PKP2 protein	PMID:35688186
1315204	PKP2	plakophilin 2	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of PKP2 mRNA	PMID:29432896
1315204	PKP2	plakophilin 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in decreased expression of PKP2 mRNA	PMID:34032870|PMID:38568856
1315204	PKP2	plakophilin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PKP2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PKP2 mRNA	PMID:39836092
1315204	PKP2	plakophilin 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1550508	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PKP2 mRNA	PMID:40504410
1315204	PKP2	plakophilin 2	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1550508	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PKP2 mRNA	PMID:22228805
1315204	PKP2	plakophilin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1306533	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PKP2 mRNA	PMID:21839799
1315204	PKP2	plakophilin 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550508	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of PKP2 mRNA	PMID:22228805
1315204	PKP2	plakophilin 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1550508	E	RGD:6480464	20120918	CTD	MESH:D001564	AHR protein affects the reaction [Benzo(a)pyrene affects the expression of PKP2 mRNA]	PMID:22228805
1315204	PKP2	plakophilin 2	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1550508	E	RGD:6480464	20120412	CTD	MESH:C015001	arsenite results in increased expression of PKP2 mRNA	PMID:18929588
1315204	PKP2	plakophilin 2	gene	CHEBI:30879	alcohol	affects expression	ISO	RGD:1550508	E	RGD:18337277|PMID:28714806	20250331	RGD	MESH:D000438	alcohol increases expression pf Pkp2 mRNA in prefrontal cortex	
1315204	PKP2	plakophilin 2	gene	CHEBI:30966	glycidol	increases expression	ISO	RGD:1306533	E	RGD:6480464	20150127	CTD	MESH:C004312	glycidol results in increased expression of PKP2 mRNA	PMID:24915197
1315204	PKP2	plakophilin 2	gene	CHEBI:31348	capecitabine	increases response to substance	EXP		E	RGD:6480464	20170228	CTD	MESH:C110904	PKP2 protein results in increased susceptibility to Capecitabine	PMID:16734730
1315204	PKP2	plakophilin 2	gene	CHEBI:31521	doxifluridine	increases response to substance	EXP		E	RGD:6480464	20130806	CTD	MESH:C025034	PKP2 protein results in increased susceptibility to doxifluridine	PMID:16734730
1315204	PKP2	plakophilin 2	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306533	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of PKP2 mRNA	PMID:24136188
1315204	PKP2	plakophilin 2	gene	CHEBI:31746	kainic acid	decreases expression	ISO	RGD:1550508	E	RGD:6480464	20120412	CTD	MESH:D007608	Kainic Acid results in decreased expression of PKP2 mRNA	PMID:17997037
1315204	PKP2	plakophilin 2	gene	CHEBI:31767	lead diacetate	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C008261	lead acetate results in decreased expression of PKP2 mRNA	PMID:38568856
1315204	PKP2	plakophilin 2	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306533	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of PKP2 mRNA	PMID:30047161
1315204	PKP2	plakophilin 2	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1550508	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of PKP2 promoter	PMID:35295148
1315204	PKP2	plakophilin 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306533	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of PKP2 mRNA	PMID:23411599
1315204	PKP2	plakophilin 2	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550508	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of PKP2 mRNA	PMID:18445702
1315204	PKP2	plakophilin 2	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1550508	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of PKP2 mRNA	PMID:18301758
1315204	PKP2	plakophilin 2	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306533	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of PKP2 mRNA	PMID:25181051
1315204	PKP2	plakophilin 2	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306533	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of PKP2 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1315204	PKP2	plakophilin 2	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of PKP2 protein	PMID:37567409
1315204	PKP2	plakophilin 2	gene	CHEBI:3423	carmustine	increases expression	ISO	RGD:1306533	E	RGD:6480464	20120412	CTD	MESH:D002330	Carmustine results in increased expression of PKP2 mRNA	PMID:16005536
1315204	PKP2	plakophilin 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1550508	E	RGD:6480464	20191112	CTD	MESH:C008745	[bisphenol F co-treated with Tretinoin] results in decreased expression of PKP2 mRNA	PMID:30951980
1315204	PKP2	plakophilin 2	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1550508	E	RGD:6480464	20200609	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of PKP2 protein	PMID:32272095
1315204	PKP2	plakophilin 2	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1550508	E	RGD:6480464	20200609	CTD	MESH:D016264	Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of PKP2 protein]	PMID:32272095
1315204	PKP2	plakophilin 2	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of PKP2 protein	PMID:38598786
1315204	PKP2	plakophilin 2	gene	CHEBI:35033	triphenyl phosphate	decreases expression	ISO	RGD:1306533	E	RGD:6480464	20200331	CTD	MESH:C005445	triphenyl phosphate results in decreased expression of PKP2 mRNA	PMID:30589522
1315204	PKP2	plakophilin 2	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PKP2 mRNA	PMID:39836092
1315204	PKP2	plakophilin 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of PKP2 mRNA	PMID:38568856
1315204	PKP2	plakophilin 2	gene	CHEBI:35559	furan	increases expression	ISO	RGD:1306533	E	RGD:6480464	20150414	CTD	MESH:C039281	furan results in increased expression of PKP2 mRNA	PMID:25539665
1315204	PKP2	plakophilin 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1550508	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of PKP2 mRNA	PMID:40194260
1315204	PKP2	plakophilin 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of PKP2 mRNA	PMID:31533062
1315204	PKP2	plakophilin 2	gene	CHEBI:39163	acetamiprid	decreases expression	ISO	RGD:1550508	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in decreased expression of PKP2 mRNA	PMID:39529242
1315204	PKP2	plakophilin 2	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PKP2 mRNA	PMID:40419075
1315204	PKP2	plakophilin 2	gene	CHEBI:39483	sodium dichromate	increases expression	ISO	RGD:1306533	E	RGD:6480464	20150825	CTD	MESH:C016104	sodium bichromate results in increased expression of PKP2 mRNA	PMID:25993096
1315204	PKP2	plakophilin 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of PKP2 mRNA	PMID:25979313
1315204	PKP2	plakophilin 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of PKP2 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1315204	PKP2	plakophilin 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA	PMID:27188386
1315204	PKP2	plakophilin 2	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306533	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of PKP2 mRNA	PMID:30047161
1315204	PKP2	plakophilin 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PKP2 mRNA	PMID:20106945|PMID:25562108
1315204	PKP2	plakophilin 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of PKP2 mRNA	PMID:36621641
1315204	PKP2	plakophilin 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1306533	E	RGD:6480464	20120918	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of PKP2 mRNA	PMID:21658437
1315204	PKP2	plakophilin 2	gene	CHEBI:41922	diethylstilbestrol	increases expression	ISO	RGD:1550508	E	RGD:6480464	20120412	CTD	MESH:D004054	Diethylstilbestrol results in increased expression of PKP2 mRNA	PMID:15289156
1315204	PKP2	plakophilin 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1550508	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of PKP2 mRNA	PMID:28973697
1315204	PKP2	plakophilin 2	gene	CHEBI:44185	methotrexate	increases expression	ISO	RGD:1306533	E	RGD:6480464	20120412	CTD	MESH:D008727	Methotrexate results in increased expression of PKP2 mRNA	PMID:16005536
1315204	PKP2	plakophilin 2	gene	CHEBI:45863	paclitaxel	decreases response to substance	EXP		E	RGD:6480464	20161213	CTD	MESH:D017239	PKP2 protein results in decreased susceptibility to Paclitaxel	PMID:16734730
1315204	PKP2	plakophilin 2	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of PKP2 mRNA	PMID:24935251|PMID:26272509
1315204	PKP2	plakophilin 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA	PMID:27188386
1315204	PKP2	plakophilin 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550508	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PKP2 mRNA	PMID:17562736
1315204	PKP2	plakophilin 2	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of PKP2 mRNA	PMID:21420995|PMID:22230336|PMID:29067470
1315204	PKP2	plakophilin 2	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of PKP2 mRNA	PMID:35811015
1315204	PKP2	plakophilin 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PKP2 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of PKP2 mRNA	PMID:39836092
1315204	PKP2	plakophilin 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1550508	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of PKP2 mRNA	PMID:40504410
1315204	PKP2	plakophilin 2	gene	CHEBI:47519	ketoconazole	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D007654	Ketoconazole results in increased expression of PKP2 mRNA	PMID:36621641
1315204	PKP2	plakophilin 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PKP2 mRNA	PMID:22079256
1315204	PKP2	plakophilin 2	gene	CHEBI:49639	mercury dibromide	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C042720	mercuric bromide results in increased expression of PKP2 mRNA	PMID:26272509
1315204	PKP2	plakophilin 2	gene	CHEBI:49639	mercury dibromide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C042720	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA	PMID:27188386
1315204	PKP2	plakophilin 2	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550508	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of PKP2 mRNA	PMID:25554681
1315204	PKP2	plakophilin 2	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306533	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of PKP2 mRNA	PMID:30047161
1315204	PKP2	plakophilin 2	gene	CHEBI:50692	mifepristone	decreases expression	ISO	RGD:1306533	E	RGD:6480464	20150825	CTD	MESH:D015735	Mifepristone results in decreased expression of PKP2 mRNA	PMID:25972201
1315204	PKP2	plakophilin 2	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of PKP2 mRNA	PMID:39836092
1315204	PKP2	plakophilin 2	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1550508	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of PKP2 mRNA	PMID:19751817
1315204	PKP2	plakophilin 2	gene	CHEBI:64213	cantharidin	decreases expression	ISO	RGD:1550508	E	RGD:6480464	20230704	CTD	MESH:D002193	Cantharidin results in decreased expression of PKP2 mRNA	PMID:36907384
1315204	PKP2	plakophilin 2	gene	CHEBI:6809	methamphetamine	increases expression	ISO	RGD:1306533	E	RGD:6480464	20151215	CTD	MESH:D008694	Methamphetamine results in increased expression of PKP2 mRNA	PMID:19564919
1315204	PKP2	plakophilin 2	gene	CHEBI:6809	methamphetamine	multiple interactions	ISO	RGD:1306533	E	RGD:6480464	20151215	CTD	MESH:D008694	[Methamphetamine co-treated with SCH 23390] results in increased expression of PKP2 mRNA	PMID:19564919
1315204	PKP2	plakophilin 2	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of PKP2 mRNA	PMID:31758290
1315204	PKP2	plakophilin 2	gene	CHEBI:73297	SCH 23390	increases expression	ISO	RGD:1306533	E	RGD:6480464	20170303	CTD	MESH:C534628	SCH 23390 results in increased expression of PKP2 mRNA	PMID:19564919
1315204	PKP2	plakophilin 2	gene	CHEBI:73297	SCH 23390	multiple interactions	ISO	RGD:1306533	E	RGD:6480464	20170303	CTD	MESH:C534628	[Methamphetamine co-treated with SCH 23390] results in increased expression of PKP2 mRNA	PMID:19564919
1315204	PKP2	plakophilin 2	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550508	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PKP2 mRNA	PMID:22206623
1315204	PKP2	plakophilin 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PKP2 protein	PMID:37664457
1315204	PKP2	plakophilin 2	gene	CHEBI:749301	potassium perchlorate	increases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C009006	potassium perchlorate results in increased expression of PKP2 mRNA	PMID:29673971
1315204	PKP2	plakophilin 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of PKP2 mRNA	PMID:22079256
1315204	PKP2	plakophilin 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PKP2 mRNA	PMID:22079256
1315204	PKP2	plakophilin 2	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1306533	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of PKP2 mRNA	PMID:33484710
1315204	PKP2	plakophilin 2	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of PKP2 mRNA	PMID:30851411
1315204	PKP2	plakophilin 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA	PMID:27188386
1315204	PKP2	plakophilin 2	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1550508	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of PKP2 mRNA	PMID:23091169
1315204	PKP2	plakophilin 2	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306533	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PKP2 mRNA	PMID:30047161
1315204	PKP2	plakophilin 2	gene	CHEBI:91108	SB 431542	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of PKP2 protein	PMID:25670856
1315204	PKP2	plakophilin 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of PKP2 protein; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKP2 mRNA	PMID:27188386|PMID:37664457
1315204	PKP2	plakophilin 2	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of PKP2 mRNA	PMID:38568856
1315204	PKP2	plakophilin 2	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in increased expression of and affects the localization of PKP2 protein	PMID:38598786
1315204	PKP2	plakophilin 2	gene	CHEBI:9555	tioguanine	increases expression	ISO	RGD:1306533	E	RGD:6480464	20130305	CTD	MESH:D013866	Thioguanine results in increased expression of PKP2 mRNA	PMID:16005536
1315204	PKP2	plakophilin 2	gene	CHEBI:957	2,6-dinitrotoluene	affects expression	ISO	RGD:1306533	E	RGD:6480464	20120412	CTD	MESH:C023514	2,6-dinitrotoluene affects the expression of PKP2 mRNA	PMID:21346803
1315204	PKP2	plakophilin 2	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1306533	E	RGD:6480464	20150825	CTD	MESH:C025643	vinclozolin results in decreased expression of PKP2 mRNA	PMID:23034163
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of DCAF5 mRNA	PMID:33167477
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DCAF5 mRNA	PMID:26079696
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of DCAF5 mRNA	PMID:22378314
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1315208	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of DCAF5 mRNA	PMID:30319688
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315208	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of DCAF5 mRNA	PMID:39241906
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315208	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of DCAF5 mRNA	PMID:39298647
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of DCAF5 mRNA	PMID:37042841
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of DCAF5 protein	PMID:37730182
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315208	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DCAF5 mRNA	PMID:36331819
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DCAF5 mRNA	PMID:35301059
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DCAF5 mRNA	PMID:19549813
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of DCAF5 mRNA	PMID:23649840
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1315208	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of DCAF5 mRNA	PMID:19770486
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of DCAF5 mRNA	PMID:23649840
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of DCAF5 protein	PMID:35688186
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1315208	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of DCAF5 mRNA	PMID:30912803
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:28077	rifampicin	decreases expression	EXP		E	RGD:6480464	20160412	CTD	MESH:D012293	Rifampin results in decreased expression of DCAF5 mRNA	PMID:24552687
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306535	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DCAF5 mRNA	PMID:22298810
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315208	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DCAF5 mRNA	PMID:21570461
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315208	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DCAF5 mRNA	PMID:17942748
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of DCAF5 mRNA	PMID:28001369
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of DCAF5 mRNA	PMID:29803840
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of DCAF5 mRNA	PMID:38568856
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315208	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DCAF5 mRNA	PMID:19770486
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of DCAF5 promoter	PMID:27901495
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DCAF5 mRNA	PMID:20018196
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DCAF5 gene	PMID:31601247
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1315208	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of DCAF5 mRNA	PMID:18648102
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315208	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of DCAF5 mRNA	PMID:18301758|PMID:23811191
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of DCAF5 mRNA	PMID:38479592
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of DCAF5 mRNA	PMID:29275510
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306535	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of DCAF5 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DCAF5 gene	PMID:31601247
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1315208	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of DCAF5 mRNA	PMID:37019170
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:34905	paraquat	multiple interactions	ISO	RGD:1315208	E	RGD:6480464	20230905	CTD	MESH:D010269	[Maneb co-treated with Paraquat] results in decreased expression of DCAF5 mRNA	PMID:36117858
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of DCAF5 mRNA	PMID:37042841
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:35456	cadmium dichloride	increases expression	ISO	RGD:1306535	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DCAF5 mRNA	PMID:33453195
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of DCAF5 mRNA	PMID:35301059
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of DCAF5 mRNA	PMID:24449571
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:3750	clofibrate	increases expression	ISO	RGD:1315208	E	RGD:6480464	20140610	CTD	MESH:D002994	Clofibrate results in increased expression of DCAF5 mRNA	PMID:23811191
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1315208	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of DCAF5 mRNA	PMID:40194260
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:3908	coumestrol	decreases expression	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	Coumestrol results in decreased expression of DCAF5 mRNA	PMID:19167446
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF5 mRNA	PMID:19167446
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315208	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DCAF5 mRNA	PMID:36331819
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DCAF5 mRNA	PMID:25979313
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of DCAF5 mRNA	PMID:28001369
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid results in increased expression of DCAF5 mRNA	PMID:19101580
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DCAF5 gene	PMID:29154799
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1315208	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of DCAF5 mRNA	PMID:28973697
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315208	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DCAF5 mRNA	PMID:17562736
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:4791	endosulfan	increases expression	EXP		E	RGD:6480464	20260505	CTD	MESH:D004726	Endosulfan results in increased expression of DCAF5 mRNA	PMID:40706910
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315208	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DCAF5 mRNA	PMID:17942748
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306535	E	RGD:6480464	20121009	CTD	MESH:D008713	Methimazole results in increased expression of DCAF5 mRNA	PMID:22504374
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:52497	maneb	multiple interactions	ISO	RGD:1315208	E	RGD:6480464	20230905	CTD	MESH:D008344	[Maneb co-treated with Paraquat] results in decreased expression of DCAF5 mRNA	PMID:36117858
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:72564	temozolomide	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in decreased expression of DCAF5 mRNA	PMID:31758290
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315208	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DCAF5 mRNA	PMID:22206623
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:81555	Enterolactone	multiple interactions	EXP		E	RGD:6480464	20151103	CTD	MESH:C029497	[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of DCAF5 mRNA	PMID:19167446
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306535	E	RGD:6480464	20121009	CTD	MESH:D011441	Propylthiouracil results in increased expression of DCAF5 mRNA	PMID:22504374
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306535	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of DCAF5 mRNA	PMID:21346803
1315207	DCAF5	DDB1 and CUL4 associated factor 5	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1315208	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of DCAF5 mRNA	PMID:28973697
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:10022	deoxynivalenol	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:C007262	deoxynivalenol results in decreased expression of RRBP1 protein	PMID:39638853
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of RRBP1 mRNA	PMID:38218311
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:132082	entinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	entinostat results in increased expression of RRBP1 mRNA	PMID:26272509
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:132082	entinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C118739	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRBP1 mRNA	PMID:27188386
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RRBP1 mRNA	PMID:26251327
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases methylation	ISO	RGD:1552478	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of RRBP1 promoter	PMID:26251327
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1552478	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RRBP1 mRNA	PMID:20938992
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of RRBP1 mRNA	PMID:16054129|PMID:33167477
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of RRBP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of RRBP1 mRNA	PMID:32699268
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of RRBP1 mRNA	PMID:26079696
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:15756	hexadecanoic acid	increases phosphorylation	EXP		E	RGD:6480464	20190702	CTD	MESH:D019308	Palmitic Acid results in increased phosphorylation of RRBP1 protein	PMID:28073184
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:16170	mercury(0)	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of RRBP1 mRNA	PMID:19937285
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1306536	E	RGD:6480464	20161025	CTD	MESH:D000431	Ethanol results in increased expression of RRBP1 protein	PMID:19609968
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1552478	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of RRBP1 mRNA	PMID:30319688
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of RRBP1 mRNA	PMID:21632981
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of RRBP1 mRNA	PMID:29581250
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1552478	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of RRBP1 mRNA	PMID:39241906
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:164200	triclosan	increases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in increased expression of RRBP1 mRNA	PMID:30510588
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1306536	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of RRBP1 protein	PMID:32145629
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1552478	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of RRBP1 mRNA	PMID:39298647
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in increased expression of RRBP1 mRNA	PMID:30165855
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1552478	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RRBP1 mRNA	PMID:20938992
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of RRBP1 mRNA	PMID:37042841
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of RRBP1 mRNA	PMID:33848595
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1552478	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of RRBP1 mRNA]	PMID:33848595
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:17642	pentachlorophenol	increases expression	ISO	RGD:1552478	E	RGD:6480464	20140311	CTD	MESH:D010416	Pentachlorophenol results in increased expression of RRBP1 mRNA	PMID:23892564
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of RRBP1 mRNA	PMID:33754040
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of RRBP1 mRNA	PMID:31163220
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of RRBP1 protein	PMID:37730182
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:17967	urethane	increases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in increased expression of RRBP1 mRNA	PMID:28818685
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1552478	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RRBP1 mRNA	PMID:36331819
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306536	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of RRBP1 protein	PMID:34915118
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:22977	cadmium atom	increases oxidation	ISO	RGD:1552478	E	RGD:6480464	20150310	CTD	MESH:D002104	Cadmium results in increased oxidation of RRBP1 protein	PMID:24077948
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019327	Copper Sulfate results in decreased expression of RRBP1 mRNA	PMID:20599845
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D019327	Copper Sulfate results in increased expression of RRBP1 mRNA	PMID:20599845
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RRBP1 protein	PMID:23301498
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:25195	mercury atom	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D008628	Mercury results in decreased expression of RRBP1 mRNA	PMID:19937285
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of RRBP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of RRBP1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of RRBP1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of RRBP1 mRNA	PMID:32699268|PMID:35430440
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of RRBP1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of RRBP1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RRBP1 protein	PMID:38598786
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306536	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of RRBP1 mRNA	PMID:30779732
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of RRBP1 mRNA	PMID:18356318
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:27363	zinc atom	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of RRBP1 mRNA	PMID:22171008
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1552478	E	RGD:6480464	20160822	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of RRBP1 mRNA	PMID:27339419|PMID:31919559
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1552478	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of RRBP1 mRNA	PMID:20938992
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RRBP1 mRNA	PMID:39836092
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1552478	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RRBP1 mRNA	PMID:40504410
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:27568	selenium atom	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of RRBP1 mRNA	PMID:19244175
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of RRBP1 protein	PMID:35688186
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:27744	glyphosate	increases expression	ISO	RGD:1552478	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate results in increased expression of RRBP1 protein	PMID:36173347
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:27881	resveratrol	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20160822	CTD	MESH:C059514	resveratrol results in decreased expression of RRBP1 protein	PMID:25505154
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of RRBP1 mRNA	PMID:27594783
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of RRBP1 mRNA	PMID:24768652|PMID:25583101
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552478	E	RGD:6480464	20160210	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of RRBP1 mRNA	PMID:21570461|PMID:26377647
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306536	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of RRBP1 mRNA	PMID:34747641
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1552478	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RRBP1 mRNA	PMID:17942748
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:28216	methylmercury chloride	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C004925	methylmercuric chloride results in increased expression of RRBP1 mRNA	PMID:23179753|PMID:26272509
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:28216	methylmercury chloride	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C004925	[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRBP1 mRNA	PMID:27188386
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of RRBP1 mRNA	PMID:33212167
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RRBP1 mRNA	PMID:30851411
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:28748	doxorubicin	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D004317	Doxorubicin affects the expression of RRBP1 protein	PMID:29385562
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of RRBP1 mRNA	PMID:29803840
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of RRBP1 mRNA	PMID:20044591
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of RRBP1 mRNA	PMID:38568856|PMID:39719251
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RRBP1 mRNA; sodium arsenite promotes the reaction [RRBP1 protein binds to CAPRIN1 protein]	PMID:33939924|PMID:39836092
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1552478	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RRBP1 mRNA	PMID:40504410
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of RRBP1 3' UTR; Benzo(a)pyrene affects the methylation of RRBP1 5' UTR	PMID:27901495|PMID:30157460
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of RRBP1 mRNA	PMID:19770486
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1552478	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of RRBP1 mRNA	PMID:22228805
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of RRBP1 promoter	PMID:27901495
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:29866	arsenite(3-)	increases methylation	EXP		E	RGD:6480464	20140610	CTD	MESH:C015001	arsenite results in increased methylation of RRBP1 promoter	PMID:23974009
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to RRBP1 protein]	PMID:32406909
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of RRBP1 mRNA	PMID:18356318
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:30185	zinc(0)	increases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in increased expression of RRBP1 mRNA	PMID:22171008
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of RRBP1 mRNA	PMID:25895662
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:30621	diarsenic trioxide	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in increased expression of RRBP1 mRNA	PMID:15761015
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:31653	glafenine	increases expression	ISO	RGD:1306536	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in increased expression of RRBP1 mRNA	PMID:24136188
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306536	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of RRBP1 mRNA	PMID:30047161
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552478	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of RRBP1 gene; titanium dioxide results in decreased methylation of RRBP1 promoter	PMID:35295148
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1552478	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide analog results in increased expression of RRBP1 mRNA; titanium dioxide results in increased expression of RRBP1 mRNA	PMID:23557971|PMID:25111187|PMID:27760801|PMID:29264374
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of RRBP1 mRNA	PMID:17426115
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of RRBP1 mRNA	PMID:30903817
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306536	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A affects the expression of RRBP1 protein	PMID:32145629
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306536	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of RRBP1 mRNA	PMID:30816183
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of RRBP1 mRNA; bisphenol A results in decreased expression of RRBP1 protein	PMID:33221593|PMID:35999755|PMID:40036665
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C006780	bisphenol A results in increased expression of RRBP1 protein	PMID:34186270
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306536	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of RRBP1 mRNA	PMID:25181051
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552478	E	RGD:6480464	20160705	CTD	MESH:C006780	bisphenol A results in increased expression of RRBP1 mRNA	PMID:26063408
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:33234	vitamin E	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	[Selenium co-treated with Vitamin E] results in decreased expression of RRBP1 mRNA	PMID:19244175
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1552478	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of RRBP1 mRNA	PMID:39298647
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C543008	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RRBP1 mRNA	PMID:28628672
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:34565	benzo[b]fluoranthene	increases expression	ISO	RGD:1552478	E	RGD:6480464	20160119	CTD	MESH:C006703	benzo(b)fluoranthene results in increased expression of RRBP1 mRNA	PMID:26377693
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of RRBP1 5' UTR	PMID:30157460
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:34575	bisphenol F	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C008745	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RRBP1 mRNA	PMID:28628672
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of RRBP1 protein	PMID:34186270
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:34674	dextran sulfate	increases expression	ISO	RGD:1552478	E	RGD:6480464	20220607	CTD	MESH:D016264	Dextran Sulfate results in increased expression of RRBP1 mRNA	PMID:35093514
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:34682	diazinon	increases methylation	EXP		E	RGD:6480464	20141014	CTD	MESH:D003976	Diazinon results in increased methylation of RRBP1 gene	PMID:22964155
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RRBP1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of RRBP1 protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of RRBP1 protein	PMID:38598786
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RRBP1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RRBP1 mRNA	PMID:28628672
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1306536	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of RRBP1 mRNA	PMID:22110744
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:34905	paraquat	increases expression	EXP		E	RGD:6480464	20240604	CTD	MESH:D010269	Paraquat results in increased expression of RRBP1 protein	PMID:34064677
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of RRBP1 mRNA	PMID:38568856
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1306536	E	RGD:6480464	20120412	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of RRBP1 mRNA	PMID:19162173
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of RRBP1 mRNA	PMID:19320972
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:36467	ciguatoxin CTX1B	affects expression	ISO	RGD:1552478	E	RGD:6480464	20121009	CTD	MESH:D002922	Ciguatoxins affects the expression of RRBP1 mRNA	PMID:18353800
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of RRBP1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of RRBP1 mRNA	PMID:32699268
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:36904	elemental selenium	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	[Selenium co-treated with Vitamin E] results in decreased expression of RRBP1 mRNA	PMID:19244175
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:3766	clozapine	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D003024	Clozapine results in decreased expression of RRBP1 protein	PMID:34122009
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of RRBP1 mRNA	PMID:28302478
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20180703	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of RRBP1 protein	PMID:24301089
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552478	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RRBP1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of RRBP1 mRNA	PMID:36331819
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of RRBP1 mRNA	PMID:19101580|PMID:23179753|PMID:26272509
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of RRBP1 gene	PMID:29154799
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRBP1 mRNA	PMID:27188386
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306536	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of RRBP1 mRNA	PMID:30047161
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of RRBP1 mRNA	PMID:25562108
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of RRBP1 mRNA	PMID:20106945
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RRBP1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RRBP1 mRNA	PMID:28628672
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of RRBP1 mRNA	PMID:28973697
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of RRBP1 mRNA	PMID:38832940
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of RRBP1 mRNA	PMID:24935251|PMID:26272509
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRBP1 mRNA	PMID:27188386
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552478	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of RRBP1 mRNA	PMID:17562736
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306536	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of RRBP1 mRNA	PMID:33387578
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:46345	5-fluorouracil	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	RRBP1 protein affects the susceptibility to Fluorouracil	PMID:15352031
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:46345	5-fluorouracil	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D005472	Fluorouracil results in decreased expression of RRBP1 protein	PMID:15352031
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of RRBP1 mRNA	PMID:39836092
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1552478	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of RRBP1 mRNA	PMID:40504410
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1552478	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of RRBP1 mRNA	PMID:17942748
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1552478	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RRBP1 mRNA	PMID:17942748
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of RRBP1 mRNA	PMID:38568856
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of RRBP1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of RRBP1 mRNA	PMID:28628672
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:49900	arsenous acid	increases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in increased expression of RRBP1 mRNA	PMID:15761015
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1552478	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of RRBP1 mRNA; Nanotubes, Carbon results in increased expression of RRBP1 mRNA	PMID:25554681|PMID:25620056
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306536	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of RRBP1 mRNA	PMID:30047161
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1552478	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of RRBP1 mRNA	PMID:35964746
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:53001	nickel sulfate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C029938	nickel sulfate results in decreased expression of RRBP1 mRNA	PMID:22714537
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:5613	haloperidol	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	Haloperidol results in decreased expression of RRBP1 protein	PMID:34122009
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:6030	isoniazide	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D007538	Isoniazid results in decreased expression of RRBP1 protein	PMID:40015660
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of RRBP1 protein	PMID:32959892
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of RRBP1 mRNA	PMID:23650126
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1306536	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of RRBP1 mRNA	PMID:24136188
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:6820	methapyrilene	decreases expression	ISO	RGD:1306536	E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in decreased expression of RRBP1 mRNA	PMID:30467583
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of RRBP1 5' UTR	PMID:30157460
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of RRBP1 protein	PMID:34186270
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:73755	1,2-dimethylhydrazine	affects expression	ISO	RGD:1552478	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine affects the expression of RRBP1 mRNA	PMID:22206623
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of RRBP1 mRNA	PMID:37199045
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of RRBP1 mRNA	PMID:30851411
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRBP1 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRBP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRBP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRBP1 mRNA	PMID:27188386
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to RRBP1 gene]	PMID:28238834
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:8069	phenobarbital	affects expression	ISO	RGD:1552478	E	RGD:6480464	20130514	CTD	MESH:D010634	Phenobarbital affects the expression of RRBP1 mRNA	PMID:23091169
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:8069	phenobarbital	increases expression	ISO	RGD:1306536	E	RGD:6480464	20230606	CTD	MESH:D010634	Phenobarbital results in increased expression of RRBP1 mRNA	PMID:30047161
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:81892	Brodifacoum	increases expression	ISO	RGD:1306536	E	RGD:6480464	20171114	CTD	MESH:C013418	bromfenacoum results in increased expression of RRBP1 protein	PMID:28903499
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of RRBP1 protein	PMID:38348393
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20190702	CTD	MESH:C009277	sodium arsenate results in decreased expression of RRBP1 mRNA	PMID:30953684
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:8489	propiconazole	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20120412	CTD	MESH:C045950	propiconazole results in decreased expression of RRBP1 mRNA	PMID:21278054
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306536	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of RRBP1 mRNA	PMID:30047161
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:87185	florfenicol	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20260602	CTD	MESH:C035534	florfenicol results in decreased expression of RRBP1 mRNA	PMID:40826991
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:9107	senecionine	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20230117	CTD	MESH:C009237	senecionine results in decreased expression of RRBP1 protein	PMID:35357534
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRBP1 mRNA; [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRBP1 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRBP1 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RRBP1 mRNA	PMID:27188386
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306536	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of RRBP1 mRNA	PMID:19281266
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:9464	testosterone enanthate	affects expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C004648	testosterone enanthate affects the expression of RRBP1 mRNA	PMID:17440010
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of RRBP1 mRNA	PMID:38568856
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:9516	thapsigargin	increases expression	ISO	RGD:1552478	E	RGD:6480464	20160412	CTD	MESH:D019284	Thapsigargin results in increased expression of RRBP1 protein	PMID:24648495
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:955	2,6-dimethoxyphenol	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:C010120	[pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of RRBP1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of RRBP1 protein	PMID:38598786
1315209	RRBP1	ribosome binding protein 1	gene	CHEBI:9753	troglitazone	decreases expression	ISO	RGD:1552478	E	RGD:6480464	20180220	CTD	MESH:C057693	troglitazone results in decreased expression of RRBP1 mRNA	PMID:28973697
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of VPS28 mRNA	PMID:33167477
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:15368	acrolein	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D000171	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of VPS28 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of VPS28 mRNA	PMID:32699268
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of VPS28 mRNA	PMID:20044591|PMID:21179406
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550509	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of VPS28 mRNA	PMID:39241906
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1550509	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of VPS28 mRNA	PMID:39298647
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:17688	(S)-nicotine	multiple interactions	ISO	RGD:1550509	E	RGD:6480464	20180417	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of VPS28 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of VPS28 mRNA]	PMID:20230807
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1550509	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of VPS28 mRNA	PMID:33754040
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	decreases expression	ISO	RGD:1550509	E	RGD:6480464	20180417	CTD	MESH:D015632	1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of VPS28 mRNA	PMID:20230807
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:17963	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	multiple interactions	ISO	RGD:1550509	E	RGD:6480464	20180417	CTD	MESH:D015632	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of VPS28 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of VPS28 mRNA]	PMID:20230807
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:18723	nicotine	multiple interactions	ISO	RGD:1550509	E	RGD:6480464	20180417	CTD	MESH:D009538	[Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of VPS28 mRNA; Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of VPS28 mRNA]	PMID:20230807
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of VPS28 gene	PMID:27153756
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:D010126	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of VPS28 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of VPS28 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of and results in increased oxidation of VPS28 mRNA	PMID:32699268
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:27568	selenium atom	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of VPS28 mRNA	PMID:19244175
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550509	E	RGD:6480464	20180417	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of VPS28 mRNA	PMID:21570461
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306537	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of VPS28 mRNA	PMID:33387578
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550509	E	RGD:6480464	20180417	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VPS28 mRNA	PMID:17942748
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of VPS28 mRNA	PMID:29803840
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of VPS28 mRNA	PMID:20044591
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of VPS28 mRNA	PMID:38568856
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of VPS28 promoter	PMID:27901495
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of VPS28 3' UTR	PMID:27901495
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550509	E	RGD:6480464	20180417	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of VPS28 mRNA	PMID:22228805
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1550509	E	RGD:6480464	20180417	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of VPS28 mRNA	PMID:18648102
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of VPS28 gene	PMID:31601247
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306537	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of VPS28 mRNA	PMID:25181051|PMID:41034487
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1550509	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of VPS28 mRNA	PMID:39298647|PMID:40203079
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550509	E	RGD:6480464	20230606	CTD	MESH:D004390	Chlorpyrifos results in increased expression of VPS28 mRNA	PMID:37019170
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1550509	E	RGD:6480464	20180417	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of VPS28 mRNA	PMID:17361019
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1550509	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of VPS28 mRNA	PMID:34813904
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of VPS28 mRNA	PMID:37042841
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:35456	cadmium dichloride	increases methylation	ISO	RGD:1306537	E	RGD:6480464	20120717	CTD	MESH:D019256	Cadmium Chloride results in increased methylation of VPS28 promoter	PMID:22457795
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of VPS28 mRNA	PMID:19320972
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:36740	alpha-pinene	multiple interactions	EXP		E	RGD:6480464	20210112	CTD	MESH:C005451	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of and results in increased oxidation of VPS28 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of and results in increased oxidation of VPS28 mRNA	PMID:32699268
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:36904	elemental selenium	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012643	Selenium results in increased expression of VPS28 mRNA	PMID:19244175
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550509	E	RGD:6480464	20180417	CTD	MESH:D002994	Clofibrate results in decreased expression of VPS28 mRNA	PMID:17585979
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of VPS28 mRNA	PMID:23179753|PMID:27188386
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of VPS28 gene	PMID:29154799
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of VPS28 mRNA	PMID:25562108
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550509	E	RGD:6480464	20180417	CTD	MESH:D000082	Acetaminophen affects the expression of VPS28 mRNA	PMID:17562736
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1550509	E	RGD:6480464	20180417	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of VPS28 mRNA	PMID:17555576
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550509	E	RGD:6480464	20180417	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VPS28 mRNA	PMID:17942748
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of VPS28 protein	PMID:32959892
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550509	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of VPS28 mRNA	PMID:22206623
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of VPS28 mRNA	PMID:22714537
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:1550509	E	RGD:6480464	20200310	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether affects the expression of VPS28 mRNA	PMID:30294300
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:8249	piroxicam	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D010894	Piroxicam results in decreased expression of VPS28 mRNA	PMID:21858171
1315210	VPS28	VPS28 subunit of ESCRT-I	gene	CHEBI:9986	vinclozolin	increases expression	ISO	RGD:1306537	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin results in increased expression of VPS28 mRNA	PMID:22570695
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:10110	zidovudine	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20120412	CTD	MESH:D015215	[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of SPINK5 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SPINK5 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of SPINK5 mRNA	PMID:16931933
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPINK5 mRNA	PMID:20938992
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D014212	Tretinoin results in increased expression of SPINK5 mRNA	PMID:16249480
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:15940	nicotinic acid	increases expression	ISO	RGD:1306540	E	RGD:6480464	20161213	CTD	MESH:D009525	Niacin results in increased expression of SPINK5 mRNA	PMID:20303128
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of SPINK5 mRNA	PMID:31614463
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in increased expression of SPINK5 mRNA	PMID:20660070
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:16469	17beta-estradiol	multiple interactions	ISO	RGD:1306540	E	RGD:6480464	20160705	CTD	MESH:D004958	[bisphenol A co-treated with Estradiol] results in decreased expression of SPINK5 mRNA; [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SPINK5 mRNA	PMID:26496021|PMID:32741896
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:16482	naphthalene	decreases reduction	ISO	RGD:1550511	E	RGD:6480464	20121009	CTD	MESH:C031721	naphthalene results in decreased reduction of SPINK5 protein	PMID:19843705
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306540	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of SPINK5 mRNA	PMID:33387578
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPINK5 mRNA	PMID:20938992
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130723	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in increased expression of SPINK5 mRNA	PMID:20660070
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20260707	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA	PMID:37992649
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1550511	E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone deficiency results in decreased expression of SPINK5 mRNA	PMID:33848595
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1306540	E	RGD:6480464	20210406	CTD	MESH:D013739	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SPINK5 mRNA	PMID:32741896
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:17347	testosterone	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20211109	CTD	MESH:D013739	1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [Testosterone deficiency results in decreased expression of SPINK5 mRNA]	PMID:33848595
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20260707	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA	PMID:37992649
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of SPINK5 mRNA	PMID:31163220
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:2208	purine-6-thiol	increases expression	ISO	RGD:1306540	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of SPINK5 mRNA	PMID:23358152
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of SPINK5 mRNA	PMID:22100608
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:254496	7,12-dimethyltetraphene	increases expression	ISO	RGD:1306540	E	RGD:6480464	20161025	CTD	MESH:D015127	9,10-Dimethyl-1,2-benzanthracene results in increased expression of SPINK5 mRNA	PMID:19480007
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20260707	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which results in increased expression of SPINK5 mRNA	PMID:41430723
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:26710	sodium chloride	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D012965	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of SPINK5 protein	PMID:38598786
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SPINK5 mRNA	PMID:20938992
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20260707	CTD	MESH:C010974	[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA]	PMID:37992649
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306540	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of SPINK5 mRNA	PMID:28959563
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:28694	copper atom	multiple interactions	ISO	RGD:1306540	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of SPINK5 mRNA	PMID:26033743
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1550511	E	RGD:6480464	20180116	CTD	MESH:D012969	Sodium Fluoride results in increased expression of SPINK5 protein	PMID:28918527
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20260707	CTD	MESH:D005632	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA	PMID:37992649
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:28854	2,4-D	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20260707	CTD	MESH:D015084	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA]	PMID:37992649
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1550511	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of SPINK5 mRNA	PMID:36209798
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPINK5 mRNA	PMID:32234424
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1550511	E	RGD:6480464	20120501	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SPINK5 mRNA	PMID:19770486
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SPINK5 3' UTR; Benzo(a)pyrene results in increased methylation of SPINK5 promoter	PMID:27901495
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:29865	benzo[a]pyrene	increases mutagenesis	EXP		E	RGD:6480464	20160315	CTD	MESH:D001564	Benzo(a)pyrene results in increased mutagenesis of SPINK5 gene	PMID:25435355
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:30052	copper(0)	multiple interactions	ISO	RGD:1306540	E	RGD:6480464	20151013	CTD	MESH:D003300	[Copper co-treated with Dietary Sucrose] results in increased expression of SPINK5 mRNA	PMID:26033743
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20140610	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of SPINK5 mRNA	PMID:23806026
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1550511	E	RGD:6480464	20200310	CTD	MESH:D012822	Silicon Dioxide results in increased expression of SPINK5 mRNA	PMID:29341224
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1550511	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in decreased expression of SPINK5 mRNA	PMID:27760801
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1550511	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in increased expression of SPINK5 mRNA	PMID:23557971
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306540	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SPINK5 mRNA	PMID:25181051
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306540	E	RGD:6480464	20160705	CTD	MESH:C006780	[bisphenol A co-treated with Estradiol] results in decreased expression of SPINK5 mRNA	PMID:26496021
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:34768	furfural	multiple interactions	EXP		E	RGD:6480464	20250114	CTD	MESH:D005662	[Sodium Chloride co-treated with Furaldehyde] results in increased expression of SPINK5 protein	PMID:38598786
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019256	Cadmium Chloride results in increased expression of SPINK5 mRNA	PMID:38174414
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SPINK5 mRNA	PMID:25979313
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of SPINK5 mRNA	PMID:23179753|PMID:28001369
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20260707	CTD	MESH:D005947	2,4-Dichlorophenoxyacetic Acid inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA]; [2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate] inhibits the reaction [[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA]; [Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of SPINK5 mRNA	PMID:37992649
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:44032	indinavir	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20120412	CTD	MESH:D019469	[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of SPINK5 mRNA	PMID:16931933
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:44658	okadaic acid	increases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in increased expression of SPINK5 mRNA	PMID:38832940
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SPINK5 mRNA	PMID:24935251
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550511	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of SPINK5 mRNA	PMID:17562736
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of SPINK5 mRNA	PMID:29067470
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306540	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SPINK5 mRNA	PMID:33387578
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:4811	epoxiconazole	decreases expression	ISO	RGD:1550511	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in decreased expression of SPINK5 mRNA	PMID:35436446
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:50667	mercaptopurine	increases expression	ISO	RGD:1306540	E	RGD:6480464	20130514	CTD	MESH:D015122	Mercaptopurine results in increased expression of SPINK5 mRNA	PMID:23358152
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:63577	lamivudine	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20120412	CTD	MESH:D019259	[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of SPINK5 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SPINK5 mRNA; [Zidovudine co-treated with Lamivudine] results in increased expression of SPINK5 mRNA	PMID:16931933
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:63621	saquinavir	multiple interactions	ISO	RGD:1550511	E	RGD:6480464	20120412	CTD	MESH:D019258	[Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of SPINK5 mRNA	PMID:16931933
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1550511	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of SPINK5 mRNA	PMID:23650126
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:64211	8-Br-cAMP	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D015124	8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPINK5 mRNA	PMID:22079614
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:756894	tak-243	increases sumoylation	EXP		E	RGD:6480464	20260714	CTD	MESH:C000622638	TAK-243 results in increased sumoylation of SPINK5 protein	PMID:31285264
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:77006	17beta-estradiol 3-benzoate	multiple interactions	ISO	RGD:1306540	E	RGD:6480464	20210406	CTD	MESH:C074283	[estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of SPINK5 mRNA	PMID:32741896
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:94796	3,7-dihydropurine-6-thione	increases expression	ISO	RGD:1306540	E	RGD:6480464	20170307	CTD	MESH:D015122	Mercaptopurine results in increased expression of SPINK5 mRNA	PMID:23358152
1315213	SPINK5	serine peptidase inhibitor Kazal type 5	gene	CHEBI:9747	Triptolide	increases expression	ISO	RGD:1550511	E	RGD:6480464	20210706	CTD	MESH:C001899	triptolide results in increased expression of SPINK5 mRNA	PMID:32835833
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1315216	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of PIK3C2B mRNA	PMID:33045310
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:132448	perfluorohexanesulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C471071	perfluorohexanesulfonic acid results in decreased expression of PIK3C2B mRNA	PMID:25812627
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of PIK3C2B mRNA	PMID:33167477
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D011794	Quercetin results in increased expression of PIK3C2B protein	PMID:19207037
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315216	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of PIK3C2B mRNA	PMID:39241906
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of PIK3C2B mRNA	PMID:30165855
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306541	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of PIK3C2B mRNA	PMID:33387578
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:16755	chenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D002635	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2B mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2B mRNA	PMID:32152650
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:16971	benzene-1,2,4-triol	decreases expression	EXP		E	RGD:6480464	20250311	CTD	MESH:C013038	hydroxyhydroquinone results in decreased expression of PIK3C2B mRNA	PMID:39245080
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:17687	glycocholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006000	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2B mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2B mRNA	PMID:32152650
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306541	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of PIK3C2B mRNA	PMID:26577399
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306541	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of PIK3C2B mRNA	PMID:22061828
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:18152	myricetin	decreases expression	EXP		E	RGD:6480464	20180828	CTD	MESH:C040015	myricetin results in decreased expression of PIK3C2B protein	PMID:29698783
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:18248	iron atom	increases expression	ISO	RGD:1306541	E	RGD:6480464	20120814	CTD	MESH:D007501	Iron deficiency results in increased expression of PIK3C2B mRNA	PMID:16629162
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:205919	clobetasol	decreases expression	ISO	RGD:1315216	E	RGD:6480464	20190910	CTD	MESH:D002990	Clobetasol results in decreased expression of PIK3C2B mRNA	PMID:27462272
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of PIK3C2B mRNA	PMID:19549813
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:2679	amphetamine	decreases expression	ISO	RGD:1306541	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in decreased expression of PIK3C2B mRNA	PMID:30779732
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:27471	glycodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D006002	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2B mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2B mRNA	PMID:32152650
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306541	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of PIK3C2B mRNA	PMID:31881176
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:27899	cisplatin	decreases response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D002945	PIK3C2B results in decreased susceptibility to Cisplatin	PMID:21986133
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of PIK3C2B mRNA	PMID:27392435
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of PIK3C2B mRNA	PMID:27392435
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:27928	parathion	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D010278	Parathion results in increased methylation of PIK3C2B promoter	PMID:22847954
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1315216	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of PIK3C2B mRNA	PMID:30912803
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PIK3C2B mRNA	PMID:26238291
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306541	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of PIK3C2B mRNA	PMID:33387578
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of PIK3C2B mRNA	PMID:28001369
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of PIK3C2B mRNA	PMID:29803840
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:28834	deoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D003840	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2B mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2B mRNA	PMID:32152650
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D024483	Vitamin K 3 affects the expression of PIK3C2B mRNA	PMID:20044591
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of PIK3C2B mRNA	PMID:38568856
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of PIK3C2B mRNA	PMID:26238291
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PIK3C2B mRNA	PMID:19150397
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306541	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in increased expression of PIK3C2B mRNA	PMID:25729387
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315216	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of PIK3C2B gene	PMID:35295148
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315216	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of PIK3C2B mRNA	PMID:35295148
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306541	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of PIK3C2B mRNA	PMID:25181051|PMID:30816183|PMID:32528016
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315216	E	RGD:6480464	20250708	CTD	MESH:C006780	bisphenol A results in increased expression of PIK3C2B mRNA	PMID:39742910
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:C006780	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PIK3C2B mRNA	PMID:28628672
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1306541	E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PIK3C2B mRNA	PMID:32119087
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1315216	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of PIK3C2B mRNA	PMID:31558096
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1306541	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of PIK3C2B mRNA	PMID:21266533
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:34795	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D015056	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PIK3C2B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PIK3C2B mRNA	PMID:28628672
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of PIK3C2B mRNA	PMID:37042841
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of PIK3C2B mRNA	PMID:25812627
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	decreases expression	ISO	RGD:1315216	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in decreased expression of PIK3C2B mRNA	PMID:28903501
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:36274	glycochenodeoxycholic acid	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D005999	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2B mRNA; [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2B mRNA	PMID:32152650
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of PIK3C2B mRNA	PMID:25812627
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:38604	pyrimidifen	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C476509	pyrimidifen results in decreased expression of PIK3C2B mRNA	PMID:33512557
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:38658	dicrotophos	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in increased expression of PIK3C2B mRNA	PMID:28302478
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:38689	fonofos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:D004397	Fonofos results in increased methylation of PIK3C2B promoter	PMID:22847954
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of PIK3C2B mRNA	PMID:31533062
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:38960	terbufos	increases methylation	EXP		E	RGD:6480464	20130416	CTD	MESH:C012568	terbufos results in increased methylation of PIK3C2B promoter	PMID:22847954
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:39178	clothianidin	decreases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:C480342	clothianidin results in decreased expression of PIK3C2B mRNA	PMID:31626844
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of PIK3C2B mRNA	PMID:25812627
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1315216	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of PIK3C2B mRNA	PMID:29038090
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:39481	chloroprene	decreases expression	ISO	RGD:1306541	E	RGD:6480464	20130514	CTD	MESH:D002737	Chloroprene results in decreased expression of PIK3C2B mRNA	PMID:23125180
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D014635	Valproic Acid results in decreased expression of PIK3C2B mRNA	PMID:28001369
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of PIK3C2B mRNA	PMID:20106945|PMID:25562108
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:4031	cyclosporin A	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:D016572	[Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2B mRNA	PMID:32152650
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:41879	dexamethasone	increases expression	EXP		E	RGD:6480464	20160705	CTD	MESH:D003907	Dexamethasone results in increased expression of PIK3C2B mRNA	PMID:25047013
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:41879	dexamethasone	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D003907	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PIK3C2B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PIK3C2B mRNA	PMID:28628672
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:44185	methotrexate	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D008727	PIK3C2B protein affects the susceptibility to Methotrexate	PMID:16217747
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:44616	afimoxifene	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C016601	afimoxifene inhibits the reaction [Estrogens results in decreased expression of PIK3C2B mRNA]	PMID:21233418
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315216	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of PIK3C2B mRNA	PMID:17562736
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:46195	paracetamol	affects response to substance	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	PIK3C2B gene polymorphism affects the susceptibility to Acetaminophen	PMID:26104854
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306541	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of PIK3C2B mRNA	PMID:33387578
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:4791	endosulfan	affects expression	ISO	RGD:1306541	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan affects the expression of PIK3C2B mRNA	PMID:29391264
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D018038	Sodium Selenite results in increased expression of PIK3C2B mRNA	PMID:18175754
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:49553	copper(II) chloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in decreased expression of PIK3C2B mRNA	PMID:38568856
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:49662	indometacin	multiple interactions	EXP		E	RGD:6480464	20180116	CTD	MESH:D007213	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PIK3C2B mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PIK3C2B mRNA	PMID:28628672
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:5011	fenpyroximate	decreases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C415144	fenpyroximate results in decreased expression of PIK3C2B mRNA	PMID:33512557
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:51081	nitrates	increases expression	ISO	RGD:1306541	E	RGD:6480464	20200915	CTD	MESH:D009566	Nitrates results in increased expression of PIK3C2B mRNA	PMID:30022042
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1315216	E	RGD:6480464	20120501	CTD	MESH:C015559	trimellitic anhydride results in increased expression of PIK3C2B mRNA	PMID:19042947
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:63632	topotecan	increases expression	ISO	RGD:1306541	E	RGD:6480464	20160315	CTD	MESH:D019772	Topotecan results in increased expression of PIK3C2B mRNA	PMID:25729387
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306541	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in increased expression of PIK3C2B mRNA	PMID:25729387
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306541	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of PIK3C2B gene	PMID:35440735
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315216	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of PIK3C2B mRNA	PMID:22206623
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:7494	nefazodone	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:C051752	nefazodone results in decreased expression of PIK3C2B mRNA	PMID:32152650
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:7494	nefazodone	multiple interactions	EXP		E	RGD:6480464	20200804	CTD	MESH:C051752	[nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of PIK3C2B mRNA	PMID:32152650
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1306541	E	RGD:6480464	20190312	CTD	MESH:C007350	nitrofen results in decreased expression of PIK3C2B mRNA	PMID:26720608
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to PIK3C2B gene]	PMID:28238834
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1315216	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of PIK3C2B mRNA	PMID:31558096
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:82664	iron(0)	increases expression	ISO	RGD:1306541	E	RGD:6480464	20140902	CTD	MESH:D007501	Iron deficiency results in increased expression of PIK3C2B mRNA	PMID:16629162
1315215	PIK3C2B	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306541	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of PIK3C2B mRNA	PMID:24780913|PMID:25825206
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1590513	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MLIP gene	PMID:28931070
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:16236	ethanol	affects expression	ISO	RGD:1618346	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the expression of MLIP mRNA	PMID:30319688
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:16412	lipopolysaccharide	increases expression	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MLIP mRNA	PMID:35811015
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MLIP mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MLIP mRNA	PMID:35811015
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of MLIP mRNA	PMID:30510588
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:165219	PCB138	multiple interactions	ISO	RGD:1618346	E	RGD:6480464	20201208	CTD	MESH:C029790	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MLIP mRNA	PMID:25510870
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:167162	L-ascorbic acid 2-phosphate	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C011669	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MLIP mRNA	PMID:34480604
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:17650	cortisol	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:D006854	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of MLIP mRNA	PMID:34480604
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of MLIP protein	PMID:37730182
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:233161	2,4,4'-trichlorobiphenyl	multiple interactions	ISO	RGD:1618346	E	RGD:6480464	20250408	CTD	MESH:C081766	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MLIP mRNA	PMID:25510870
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:233349	1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene	multiple interactions	ISO	RGD:1618346	E	RGD:6480464	20250408	CTD	MESH:C009828	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MLIP mRNA	PMID:25510870
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of MLIP mRNA	PMID:27153756|PMID:32234424
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of MLIP gene	PMID:27153756
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in increased expression of MLIP mRNA	PMID:41028656
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1618346	E	RGD:6480464	20260113	CTD	MESH:D002945	Cisplatin results in decreased expression of MLIP mRNA	PMID:40618947
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1618346	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of MLIP mRNA	PMID:32186404
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1590513	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MLIP mRNA	PMID:32109520
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1590513	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of MLIP mRNA	PMID:28959563
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of MLIP mRNA	PMID:41028656
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MLIP mRNA	PMID:29803840
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:29073	L-ascorbic acid	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:D001205	[[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MLIP mRNA	PMID:34480604
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in increased expression of MLIP mRNA	PMID:41028656
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:30621	diarsenic trioxide	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C006632	Arsenic Trioxide results in decreased expression of MLIP mRNA	PMID:26705709
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol S co-treated with Fulvestrant] results in increased methylation of MLIP gene	PMID:31601247
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1618346	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of MLIP mRNA	PMID:23557971
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1590513	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of MLIP mRNA	PMID:25181051
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of MLIP protein	PMID:37567409
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:34202	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	RGD:1618346	E	RGD:6480464	20150414	CTD	MESH:C014024	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MLIP mRNA	PMID:25510870
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:34206	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	RGD:1618346	E	RGD:6480464	20150414	CTD	MESH:C009407	[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of MLIP mRNA	PMID:25510870
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of MLIP gene	PMID:31601247
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:35064	alpha-Zearalanol	decreases expression	ISO	RGD:1590513	E	RGD:6480464	20240430	CTD	MESH:D015029	Zeranol results in decreased expression of MLIP mRNA	PMID:35163327
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:35064	alpha-Zearalanol	multiple interactions	ISO	RGD:1590513	E	RGD:6480464	20240430	CTD	MESH:D015029	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MLIP mRNA	PMID:35163327
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:35549	perfluorooctanoic acid	multiple interactions	ISO	RGD:1590513	E	RGD:6480464	20240430	CTD	MESH:C023036	[Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of MLIP mRNA	PMID:35163327
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MLIP mRNA	PMID:31533062
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased expression of MLIP mRNA	PMID:29154799
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in decreased expression of MLIP mRNA	PMID:20106945
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:44185	methotrexate	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D008727	Methotrexate results in increased expression of MLIP mRNA	PMID:24449571
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:D000082	Acetaminophen results in decreased expression of MLIP mRNA	PMID:29067470
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in increased expression of MLIP mRNA	PMID:26690555
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of MLIP mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of MLIP mRNA	PMID:35811015
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1618346	E	RGD:6480464	20190312	CTD	MESH:C016766	[NFE2L2 protein affects the susceptibility to sulforaphane] which affects the expression of MLIP mRNA	PMID:30529165
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of MLIP mRNA	PMID:32234424
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:49900	arsenous acid	decreases expression	EXP		E	RGD:6480464	20191114	CTD	MESH:C032793	Arsenic Trioxide results in decreased expression of MLIP mRNA	PMID:26705709
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1590513	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of MLIP mRNA	PMID:30307764
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:62878	XAV939	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C544261	[[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MLIP mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MLIP mRNA	PMID:34480604
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:72754	bisphenol AF	decreases expression	ISO	RGD:1590513	E	RGD:6480464	20250603	CTD	MESH:C583074	bisphenol AF results in decreased expression of MLIP mRNA	PMID:39938710
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of MLIP mRNA	PMID:34480604
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:75261	arotinoid acid	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C038864	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of MLIP mRNA	PMID:34480604
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	decreases expression	ISO	RGD:1590513	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in decreased expression of MLIP mRNA	PMID:32109520
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:8228	pioglitazone	multiple interactions	ISO	RGD:1618346	E	RGD:6480464	20180220	CTD	MESH:C060836	[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of MLIP mRNA	PMID:27935865
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:91091	CHIR 99021	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C473711	[4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of MLIP mRNA; [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MLIP mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of MLIP mRNA	PMID:34480604
1315218	MLIP	muscular LMNA interacting protein	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20220208	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of MLIP mRNA	PMID:34480604
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1552485	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TGDS mRNA	PMID:36331819
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:15846	NAD(+)	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D009243	NAD binds to and results in increased activity of TGDS protein	PMID:25526675
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1552485	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of TGDS mRNA	PMID:39298647
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D004958	[Estradiol co-treated with Progesterone] results in decreased expression of TGDS mRNA	PMID:21453500
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of TGDS mRNA	PMID:37042841
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:17026	progesterone	multiple interactions	EXP		E	RGD:6480464	20130611	CTD	MESH:D011374	[Estradiol co-treated with Progesterone] results in decreased expression of TGDS mRNA	PMID:21453500
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:17059	2-methylcholine	affects expression	EXP		E	RGD:6480464	20121113	CTD	MESH:C044887	beta-methylcholine affects the expression of TGDS mRNA	PMID:21179406
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306544	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of TGDS mRNA	PMID:33387578
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1552485	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TGDS mRNA	PMID:37236586
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of TGDS mRNA	PMID:23649840
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:27363	zinc atom	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of TGDS mRNA	PMID:22171008
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:27504	mitomycin C	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D016685	TGDS protein affects the susceptibility to Mitomycin	PMID:16217747
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TGDS mRNA	PMID:40512198
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:27744	glyphosate	multiple interactions	ISO	RGD:1306544	E	RGD:6480464	20240206	CTD	MESH:C010974	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TGDS mRNA	PMID:33854195
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1552485	E	RGD:6480464	20140909	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of TGDS mRNA	PMID:24680724
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1552485	E	RGD:6480464	20170725	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of TGDS mRNA	PMID:28213091
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1552485	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of TGDS mRNA	PMID:16922920
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:28445	vincristine	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:D014750	Vincristine results in increased expression of TGDS mRNA	PMID:23649840
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TGDS mRNA	PMID:40512198
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of TGDS mRNA	PMID:22378314
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of TGDS promoter	PMID:27901495
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:30185	zinc(0)	decreases expression	EXP		E	RGD:6480464	20130122	CTD	MESH:D015032	Zinc deficiency results in decreased expression of TGDS mRNA	PMID:22171008
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TGDS mRNA	PMID:20018196
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1552485	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of TGDS mRNA	PMID:29264374
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1552485	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of TGDS gene	PMID:35295148
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1552485	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of TGDS mRNA	PMID:18301758
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:32588	potassium chloride	multiple interactions	EXP		E	RGD:6480464	20210209	CTD	MESH:D011189	[Dronabinol results in decreased susceptibility to Potassium Chloride] which results in decreased expression of TGDS mRNA	PMID:29691375
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in decreased expression of TGDS mRNA	PMID:27685785
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306544	E	RGD:6480464	20150602	CTD	MESH:C006780	bisphenol A results in increased expression of TGDS mRNA	PMID:25181051|PMID:27571134
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1552485	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of TGDS mRNA	PMID:33221593
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1552485	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of TGDS mRNA	PMID:39298647
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1552485	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of TGDS mRNA	PMID:28392331
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:34631	chlorpyrifos	multiple interactions	ISO	RGD:1306544	E	RGD:6480464	20210706	CTD	MESH:D004390	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TGDS mRNA	PMID:33854195
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of TGDS mRNA	PMID:37042841
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of TGDS mRNA	PMID:38568856
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1552485	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TGDS mRNA	PMID:37236586
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1552485	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of TGDS mRNA	PMID:28903501
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of TGDS mRNA	PMID:28302478
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of TGDS mRNA	PMID:31533062
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C076994	perfluorooctane sulfonic acid results in decreased expression of TGDS mRNA	PMID:27153767
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1552485	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of TGDS mRNA	PMID:36331819
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of TGDS mRNA	PMID:25979313
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in decreased expression of TGDS mRNA	PMID:23179753
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20231031	CTD	MESH:D014635	Valproic Acid results in increased expression of TGDS mRNA	PMID:37505509
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:40036	amitrole	decreases expression	ISO	RGD:1306544	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in decreased expression of TGDS mRNA	PMID:30047161
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of TGDS mRNA	PMID:20106945|PMID:25562108
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:40909	azoxystrobin	multiple interactions	ISO	RGD:1306544	E	RGD:6480464	20210706	CTD	MESH:C087670	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TGDS mRNA	PMID:33854195
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:44215	NAD zwitterion	multiple interactions	EXP		E	RGD:6480464	20150414	CTD	MESH:D009243	NAD binds to and results in increased activity of TGDS protein	PMID:25526675
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:45979	thiabendazole	multiple interactions	ISO	RGD:1306544	E	RGD:6480464	20210706	CTD	MESH:D013827	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TGDS mRNA	PMID:33854195
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1552485	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of TGDS mRNA	PMID:17562736
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306544	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of TGDS mRNA	PMID:33387578
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of TGDS mRNA	PMID:40512198
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1552485	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of TGDS mRNA	PMID:35436446
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:4911	etoposide	affects response to substance	EXP		E	RGD:6480464	20120412	CTD	MESH:D005047	TGDS protein affects the susceptibility to Etoposide	PMID:16217747
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306544	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of TGDS mRNA	PMID:30047161
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306544	E	RGD:6480464	20150602	CTD	MESH:D005485	Flutamide results in increased expression of TGDS mRNA	PMID:24793618
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:5870	imidacloprid	multiple interactions	ISO	RGD:1306544	E	RGD:6480464	20210706	CTD	MESH:C082359	[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TGDS mRNA	PMID:33854195
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:63933	Aroclor 1254	decreases expression	ISO	RGD:1552485	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in decreased expression of TGDS mRNA	PMID:23650126
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:7590	nitrofen	decreases expression	ISO	RGD:1306544	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in decreased expression of TGDS mRNA	PMID:33484710
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:78576	aflatoxin M1	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D016607	Aflatoxin M1 results in decreased expression of TGDS mRNA	PMID:30928695
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to TGDS gene]	PMID:28238834
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:8069	phenobarbital	affects expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D010634	Phenobarbital affects the expression of TGDS mRNA	PMID:19159669
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of TGDS mRNA	PMID:19095052
1315219	TGDS	TDP-glucose 4,6-dehydratase	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306544	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of TGDS mRNA	PMID:30047161
1315220	WDR35	WD repeat domain 35	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315221	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of WDR35 mRNA	PMID:33045310
1315220	WDR35	WD repeat domain 35	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1315221	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of WDR35 mRNA	PMID:37995155
1315220	WDR35	WD repeat domain 35	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1315221	E	RGD:6480464	20160210	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of WDR35 mRNA	PMID:26251327
1315220	WDR35	WD repeat domain 35	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of WDR35 mRNA	PMID:33167477
1315220	WDR35	WD repeat domain 35	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1315221	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of WDR35 mRNA	PMID:30319688
1315220	WDR35	WD repeat domain 35	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315221	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of WDR35 mRNA	PMID:39241906
1315220	WDR35	WD repeat domain 35	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1564116	E	RGD:6480464	20171010	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of WDR35 mRNA; Lipopolysaccharides results in increased expression of WDR35 protein	PMID:24803807
1315220	WDR35	WD repeat domain 35	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1564116	E	RGD:6480464	20171010	CTD	MESH:D008070	TNF protein affects the reaction [Lipopolysaccharides results in increased expression of WDR35 mRNA]; TNF protein affects the reaction [Lipopolysaccharides results in increased expression of WDR35 protein]	PMID:24803807
1315220	WDR35	WD repeat domain 35	gene	CHEBI:16469	17beta-estradiol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in increased expression of WDR35 mRNA	PMID:31614463
1315220	WDR35	WD repeat domain 35	gene	CHEBI:165219	PCB138	decreases expression	ISO	RGD:1564116	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of WDR35 mRNA	PMID:23829299
1315220	WDR35	WD repeat domain 35	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1564116	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of WDR35 mRNA	PMID:33387578
1315220	WDR35	WD repeat domain 35	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1564116	E	RGD:6480464	20190702	CTD	MESH:D014241	Trichloroethylene results in increased methylation of WDR35 gene	PMID:27618143
1315220	WDR35	WD repeat domain 35	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1564116	E	RGD:6480464	20171010	CTD	MESH:D005947	Glucose results in increased expression of WDR35 mRNA	PMID:20224876
1315220	WDR35	WD repeat domain 35	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1564116	E	RGD:6480464	20171010	CTD	MESH:D005947	WDR35 protein affects the reaction [Glucose results in increased activity of CASP3 protein]	PMID:20224876
1315220	WDR35	WD repeat domain 35	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1564116	E	RGD:6480464	20171010	CTD	MESH:D005947	Glucose results in increased expression of WDR35 mRNA	PMID:20224876
1315220	WDR35	WD repeat domain 35	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1564116	E	RGD:6480464	20171010	CTD	MESH:D005947	WDR35 protein affects the reaction [Glucose results in increased activity of CASP3 protein]	PMID:20224876
1315220	WDR35	WD repeat domain 35	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of WDR35 mRNA	PMID:35301059
1315220	WDR35	WD repeat domain 35	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1564116	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of WDR35 mRNA	PMID:21396975
1315220	WDR35	WD repeat domain 35	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1315221	E	RGD:6480464	20120501	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WDR35 mRNA	PMID:19770486
1315220	WDR35	WD repeat domain 35	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1564116	E	RGD:6480464	20151215	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of WDR35 mRNA	PMID:23630614
1315220	WDR35	WD repeat domain 35	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of WDR35 mRNA	PMID:23649840
1315220	WDR35	WD repeat domain 35	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of WDR35 mRNA	PMID:26272509
1315220	WDR35	WD repeat domain 35	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDR35 mRNA	PMID:27188386
1315220	WDR35	WD repeat domain 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WDR35 mRNA	PMID:20106945|PMID:21632981
1315220	WDR35	WD repeat domain 35	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1564116	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of WDR35 mRNA	PMID:33387578
1315220	WDR35	WD repeat domain 35	gene	CHEBI:28262	dimethyl sulfoxide	increases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:D004121	Dimethyl Sulfoxide results in increased expression of WDR35 mRNA	PMID:39709020
1315220	WDR35	WD repeat domain 35	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of WDR35 mRNA	PMID:20971185
1315220	WDR35	WD repeat domain 35	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of WDR35 mRNA	PMID:38568856
1315220	WDR35	WD repeat domain 35	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of WDR35 promoter	PMID:27901495
1315220	WDR35	WD repeat domain 35	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in decreased expression of WDR35 mRNA	PMID:20971185
1315220	WDR35	WD repeat domain 35	gene	CHEBI:31073	2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline	multiple interactions	ISO	RGD:1564116	E	RGD:6480464	20171010	CTD	MESH:C062865	2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline inhibits the reaction [domoic acid results in increased expression of WDR35 protein]	PMID:23289926
1315220	WDR35	WD repeat domain 35	gene	CHEBI:31530	edaravone	multiple interactions	ISO	RGD:1564116	E	RGD:6480464	20171010	CTD	MESH:C005435	Edaravone inhibits the reaction [domoic acid results in increased expression of WDR35 protein]	PMID:23289926
1315220	WDR35	WD repeat domain 35	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1315221	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of WDR35 mRNA	PMID:20542052
1315220	WDR35	WD repeat domain 35	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315221	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of WDR35 gene	PMID:35295148
1315220	WDR35	WD repeat domain 35	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315221	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of WDR35 promoter	PMID:35295148
1315220	WDR35	WD repeat domain 35	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1564116	E	RGD:6480464	20140408	CTD	MESH:D013853	Thioacetamide results in increased expression of WDR35 mRNA	PMID:23411599|PMID:34492290
1315220	WDR35	WD repeat domain 35	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1315221	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of WDR35 mRNA	PMID:20813756
1315220	WDR35	WD repeat domain 35	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1564116	E	RGD:6480464	20151215	CTD	MESH:C006780	bisphenol A results in decreased expression of WDR35 mRNA	PMID:25181051
1315220	WDR35	WD repeat domain 35	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of WDR35 gene	PMID:31601247
1315220	WDR35	WD repeat domain 35	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1564116	E	RGD:6480464	20190702	CTD	MESH:C006780	bisphenol A results in increased methylation of WDR35 gene	PMID:28505145
1315220	WDR35	WD repeat domain 35	gene	CHEBI:34727	domoic acid	increases expression	ISO	RGD:1564116	E	RGD:6480464	20171010	CTD	MESH:C012301	domoic acid results in increased expression of WDR35 mRNA; domoic acid results in increased expression of WDR35 protein	PMID:23289926
1315220	WDR35	WD repeat domain 35	gene	CHEBI:34727	domoic acid	multiple interactions	ISO	RGD:1564116	E	RGD:6480464	20171010	CTD	MESH:C012301	2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline inhibits the reaction [domoic acid results in increased expression of WDR35 protein]; Edaravone inhibits the reaction [domoic acid results in increased expression of WDR35 protein]	PMID:23289926
1315220	WDR35	WD repeat domain 35	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of WDR35 mRNA	PMID:37042841
1315220	WDR35	WD repeat domain 35	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of WDR35 mRNA	PMID:38568856
1315220	WDR35	WD repeat domain 35	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of WDR35 mRNA	PMID:35301059
1315220	WDR35	WD repeat domain 35	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of WDR35 mRNA	PMID:31533062
1315220	WDR35	WD repeat domain 35	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of WDR35 mRNA	PMID:25979313
1315220	WDR35	WD repeat domain 35	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D014635	Valproic Acid results in increased expression of WDR35 mRNA	PMID:23179753|PMID:29154799
1315220	WDR35	WD repeat domain 35	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1564116	E	RGD:6480464	20171010	CTD	MESH:D005947	Glucose results in increased expression of WDR35 mRNA	PMID:20224876
1315220	WDR35	WD repeat domain 35	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1564116	E	RGD:6480464	20171010	CTD	MESH:D005947	WDR35 protein affects the reaction [Glucose results in increased activity of CASP3 protein]	PMID:20224876
1315220	WDR35	WD repeat domain 35	gene	CHEBI:45863	paclitaxel	decreases expression	ISO	RGD:1564116	E	RGD:6480464	20161213	CTD	MESH:D017239	Paclitaxel results in decreased expression of WDR35 mRNA	PMID:18472094
1315220	WDR35	WD repeat domain 35	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1564116	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of WDR35 mRNA	PMID:33387578
1315220	WDR35	WD repeat domain 35	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1564116	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of WDR35 mRNA	PMID:29391264
1315220	WDR35	WD repeat domain 35	gene	CHEBI:50102	N-methyl-N-nitrosourea	increases expression	ISO	RGD:1315221	E	RGD:6480464	20150127	CTD	MESH:D008770	Methylnitrosourea results in increased expression of WDR35 mRNA	PMID:25270620
1315220	WDR35	WD repeat domain 35	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1564116	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of WDR35 mRNA	PMID:30307764
1315220	WDR35	WD repeat domain 35	gene	CHEBI:5870	imidacloprid	decreases expression	ISO	RGD:1315221	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in decreased expression of WDR35 mRNA	PMID:38701926
1315220	WDR35	WD repeat domain 35	gene	CHEBI:6402	leflunomide	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in increased expression of WDR35 mRNA	PMID:28988120
1315220	WDR35	WD repeat domain 35	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDR35 mRNA	PMID:27188386
1315220	WDR35	WD repeat domain 35	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to WDR35 gene]	PMID:28238834
1315220	WDR35	WD repeat domain 35	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of WDR35 mRNA	PMID:27188386
1315220	WDR35	WD repeat domain 35	gene	CHEBI:9288	streptozocin	increases expression	ISO	RGD:1564116	E	RGD:6480464	20171010	CTD	MESH:D013311	Streptozocin results in increased expression of WDR35 mRNA	PMID:20224876
1315220	WDR35	WD repeat domain 35	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of WDR35 mRNA	PMID:38568856
1315220	WDR35	WD repeat domain 35	gene	CHEBI:9986	vinclozolin	decreases expression	ISO	RGD:1564116	E	RGD:6480464	20151215	CTD	MESH:C025643	vinclozolin results in decreased expression of WDR35 mRNA	PMID:23555832
1315222	GSG1	germ cell associated 1	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of GSG1 mRNA	PMID:26079696
1315222	GSG1	germ cell associated 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306546	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of GSG1 mRNA	PMID:33387578
1315222	GSG1	germ cell associated 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	ISO	RGD:1550517	E	RGD:6480464	20250311	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of GSG1 mRNA	PMID:33162236
1315222	GSG1	germ cell associated 1	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306546	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of GSG1 mRNA	PMID:33387578
1315222	GSG1	germ cell associated 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306546	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GSG1 mRNA	PMID:39012411
1315222	GSG1	germ cell associated 1	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of GSG1 mRNA	PMID:19549813
1315222	GSG1	germ cell associated 1	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of GSG1 gene	PMID:27153756
1315222	GSG1	germ cell associated 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of GSG1 intron	PMID:30157460
1315222	GSG1	germ cell associated 1	gene	CHEBI:2679	amphetamine	increases expression	ISO	RGD:1306546	E	RGD:6480464	20191114	CTD	MESH:D000661	Amphetamine results in increased expression of GSG1 mRNA	PMID:30779732
1315222	GSG1	germ cell associated 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Copper co-treated with Resveratrol] results in decreased expression of GSG1 mRNA; [Plant Extracts co-treated with Resveratrol] results in decreased expression of GSG1 mRNA	PMID:23557933|PMID:41028656
1315222	GSG1	germ cell associated 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of GSG1 mRNA	PMID:27392435
1315222	GSG1	germ cell associated 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1550517	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of GSG1 mRNA	PMID:21570461
1315222	GSG1	germ cell associated 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306546	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of GSG1 mRNA	PMID:33387578
1315222	GSG1	germ cell associated 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1550517	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GSG1 mRNA	PMID:17942748
1315222	GSG1	germ cell associated 1	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306546	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of GSG1 mRNA	PMID:28959563
1315222	GSG1	germ cell associated 1	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306546	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of GSG1 mRNA	PMID:26033743
1315222	GSG1	germ cell associated 1	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of GSG1 mRNA	PMID:41028656
1315222	GSG1	germ cell associated 1	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1550517	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in increased expression of GSG1 mRNA	PMID:27862939
1315222	GSG1	germ cell associated 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of GSG1 intron	PMID:30157460
1315222	GSG1	germ cell associated 1	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306546	E	RGD:6480464	20151013	CTD	MESH:D003300	Copper deficiency results in increased expression of GSG1 mRNA	PMID:26033743
1315222	GSG1	germ cell associated 1	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20260113	CTD	MESH:D003300	[Copper co-treated with Resveratrol] results in decreased expression of GSG1 mRNA	PMID:41028656
1315222	GSG1	germ cell associated 1	gene	CHEBI:30563	silicon dioxide	increases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in increased expression of GSG1 mRNA	PMID:25895662
1315222	GSG1	germ cell associated 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20140805	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of GSG1 mRNA	PMID:20382639
1315222	GSG1	germ cell associated 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1306546	E	RGD:6480464	20181113	CTD	MESH:C009495	titanium dioxide results in increased expression of GSG1 mRNA	PMID:30012374
1315222	GSG1	germ cell associated 1	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306546	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of GSG1 mRNA	PMID:34492290
1315222	GSG1	germ cell associated 1	gene	CHEBI:32509	pirinixic acid	decreases expression	ISO	RGD:1550517	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in decreased expression of GSG1 mRNA	PMID:20813756
1315222	GSG1	germ cell associated 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306546	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of GSG1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:41034487
1315222	GSG1	germ cell associated 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1550517	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of GSG1 promoter	PMID:27312807
1315222	GSG1	germ cell associated 1	gene	CHEBI:34631	chlorpyrifos	increases expression	ISO	RGD:1550517	E	RGD:6480464	20210706	CTD	MESH:D004390	Chlorpyrifos results in increased expression of GSG1 mRNA	PMID:32715474
1315222	GSG1	germ cell associated 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306546	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GSG1 mRNA	PMID:39012411
1315222	GSG1	germ cell associated 1	gene	CHEBI:37187	lead nitrate	decreases expression	ISO	RGD:1306546	E	RGD:6480464	20170303	CTD	MESH:C017461	lead nitrate results in decreased expression of GSG1 mRNA	PMID:21628963
1315222	GSG1	germ cell associated 1	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550517	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of GSG1 mRNA	PMID:17585979
1315222	GSG1	germ cell associated 1	gene	CHEBI:39867	valproic acid	decreases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in decreased methylation of GSG1 gene	PMID:29154799
1315222	GSG1	germ cell associated 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306546	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of GSG1 mRNA	PMID:33387578
1315222	GSG1	germ cell associated 1	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306546	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of GSG1 mRNA	PMID:29391264
1315222	GSG1	germ cell associated 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1550517	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of GSG1 mRNA	PMID:17942748
1315222	GSG1	germ cell associated 1	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1550517	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GSG1 mRNA	PMID:17942748
1315222	GSG1	germ cell associated 1	gene	CHEBI:5063	fipronil	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C082360	[fipronil co-treated with DEET] results in decreased expression of GSG1 mRNA	PMID:27091632
1315222	GSG1	germ cell associated 1	gene	CHEBI:63623	succimer	multiple interactions	ISO	RGD:1550517	E	RGD:6480464	20120918	CTD	MESH:D004113	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSG1 mRNA	PMID:21641980
1315222	GSG1	germ cell associated 1	gene	CHEBI:6456	lidocaine	increases expression	ISO	RGD:1306546	E	RGD:6480464	20220705	CTD	MESH:D008012	Lidocaine results in increased expression of GSG1 mRNA	PMID:35283115
1315222	GSG1	germ cell associated 1	gene	CHEBI:7071	N,N-diethyl-m-toluamide	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D003671	[fipronil co-treated with DEET] results in decreased expression of GSG1 mRNA	PMID:27091632
1315222	GSG1	germ cell associated 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1550517	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of GSG1 mRNA	PMID:22206623
1315222	GSG1	germ cell associated 1	gene	CHEBI:753051	incobotulinumtoxina	decreases expression	EXP		E	RGD:6480464	20260714	CTD	MESH:C545476	incobotulinumtoxinA results in decreased expression of GSG1 mRNA	PMID:29522793
1315222	GSG1	germ cell associated 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of GSG1 mRNA	PMID:37199045
1315222	GSG1	germ cell associated 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to GSG1 gene]	PMID:28238834
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of MYEF2 mRNA	PMID:38218311
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:132267	triptonide	increases expression	ISO	RGD:1315224	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in increased expression of MYEF2 mRNA	PMID:33045310
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:132448	perfluorohexanesulfonic acid	increases expression	ISO	RGD:1315224	E	RGD:6480464	20240206	CTD	MESH:C471071	perfluorohexanesulfonic acid results in increased expression of MYEF2 mRNA	PMID:37995155
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306547	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of MYEF2 gene	PMID:28931070
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of MYEF2 mRNA	PMID:22378314
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:16236	ethanol	affects splicing	ISO	RGD:1315224	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol affects the splicing of MYEF2 mRNA	PMID:30319688
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20190611	CTD	MESH:D004958	[Estradiol co-treated with TGFB1 protein] results in decreased expression of MYEF2 mRNA	PMID:30165855
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306547	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of MYEF2 mRNA	PMID:33387578
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:16842	formaldehyde	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in decreased expression of MYEF2 mRNA	PMID:23649840
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20170207	CTD	MESH:D005557	Formaldehyde results in increased expression of MYEF2 mRNA	PMID:20655997|PMID:27664576
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of MYEF2 mRNA	PMID:33359661
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of MYEF2 protein	PMID:37730182
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MYEF2 mRNA	PMID:35301059
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315224	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MYEF2 mRNA	PMID:28111341|PMID:37236586
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:24814	indole-3-methanol	multiple interactions	ISO	RGD:1306547	E	RGD:6480464	20121009	CTD	MESH:C016517	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MYEF2 mRNA	PMID:22129741
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306547	E	RGD:6480464	20140610	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of MYEF2 mRNA	PMID:23630614|PMID:33354967
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:2663	amiodarone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D000638	Amiodarone results in increased expression of MYEF2 mRNA	PMID:19774075
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1315224	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of MYEF2 mRNA	PMID:31919559
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MYEF2 mRNA	PMID:39836092
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315224	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MYEF2 mRNA	PMID:40504410
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:27684	phenylmercury acetate	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D010662	Phenylmercuric Acetate results in decreased expression of MYEF2 mRNA	PMID:26272509
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:27684	phenylmercury acetate	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D010662	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYEF2 mRNA	PMID:27188386
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306547	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of MYEF2 mRNA	PMID:31881176
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MYEF2 mRNA	PMID:23557933
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in decreased expression of MYEF2 mRNA	PMID:27392435
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:27899	cisplatin	increases phosphorylation	ISO	RGD:1315224	E	RGD:6480464	20130618	CTD	MESH:D002945	Cisplatin results in increased phosphorylation of MYEF2 protein	PMID:22006019
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of MYEF2 mRNA	PMID:27392435
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:28001	vancomycin	decreases expression	ISO	RGD:1315224	E	RGD:6480464	20130618	CTD	MESH:D014640	Vancomycin results in decreased expression of MYEF2 mRNA	PMID:18930951
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of MYEF2 mRNA	PMID:24768652|PMID:25583101
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315224	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MYEF2 mRNA	PMID:21570461
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306547	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MYEF2 mRNA	PMID:33387578
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1315224	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MYEF2 mRNA	PMID:19770486
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315224	E	RGD:6480464	20130618	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of MYEF2 mRNA	PMID:21354282
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315224	E	RGD:6480464	20130618	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of MYEF2 mRNA	PMID:19465110
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of MYEF2 mRNA	PMID:28001369
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306547	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of MYEF2 mRNA	PMID:28959563
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:28694	copper atom	increases expression	ISO	RGD:1306547	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of MYEF2 mRNA	PMID:30556269
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of MYEF2 mRNA	PMID:29803840
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MYEF2 mRNA	PMID:39836092
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315224	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MYEF2 mRNA	PMID:40504410
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1315224	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of MYEF2 protein	PMID:37955338
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:30052	copper(0)	increases expression	ISO	RGD:1306547	E	RGD:6480464	20190409	CTD	MESH:D003300	Copper results in increased expression of MYEF2 mRNA	PMID:30556269
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of MYEF2 gene	PMID:31601247
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:32161	sulfadimethoxine	increases expression	ISO	RGD:1306547	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in increased expression of MYEF2 mRNA	PMID:30047161
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315224	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MYEF2 promoter	PMID:35295148
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306547	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of MYEF2 mRNA	PMID:34492290
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1315224	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of MYEF2 mRNA	PMID:28472532
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of MYEF2 mRNA; bisphenol A results in decreased expression of MYEF2 protein	PMID:29275510|PMID:31675489
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1315224	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of MYEF2 promoter	PMID:27312807
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of MYEF2 gene	PMID:31601247
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306547	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MYEF2 mRNA	PMID:36041667
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of MYEF2 protein	PMID:31675489
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315224	E	RGD:6480464	20260113	CTD	MESH:C543008	bisphenol S results in decreased expression of MYEF2 mRNA	PMID:40203079
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315224	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in increased expression of MYEF2 mRNA	PMID:39298647
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306547	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MYEF2 mRNA	PMID:36041667
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306547	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MYEF2 mRNA	PMID:36041667
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:34682	diazinon	affects expression	ISO	RGD:1306547	E	RGD:6480464	20120412	CTD	MESH:D003976	Diazinon affects the expression of MYEF2 mRNA	PMID:17452286
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1315224	E	RGD:6480464	20130618	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of MYEF2 mRNA	PMID:17361019
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306547	E	RGD:6480464	20121009	CTD	MESH:D004052	[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of MYEF2 mRNA	PMID:22129741
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:35038	tris(2-butoxyethyl) phosphate	affects expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C013320	tris(2-butoxyethyl) phosphate affects the expression of MYEF2 mRNA	PMID:29024780
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:35176	zinc sulfate	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D019287	Zinc Sulfate results in increased expression of MYEF2 mRNA	PMID:16330358
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MYEF2 mRNA	PMID:38174414|PMID:38568856
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MYEF2 mRNA	PMID:35301059
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315224	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MYEF2 mRNA	PMID:28111341|PMID:37236586
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of MYEF2 mRNA	PMID:19320972
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:3764	clotrimazole	increases expression	ISO	RGD:1306547	E	RGD:6480464	20230606	CTD	MESH:D003022	Clotrimazole results in increased expression of MYEF2 mRNA	PMID:30047161
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of MYEF2 mRNA	PMID:31533062
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MYEF2 mRNA	PMID:25979313
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in decreased expression of MYEF2 mRNA	PMID:23179753|PMID:24383497|PMID:26272509
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased expression of MYEF2 mRNA	PMID:29154799
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYEF2 mRNA	PMID:27188386
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:40036	amitrole	increases expression	ISO	RGD:1306547	E	RGD:6480464	20230606	CTD	MESH:D000640	Amitrole results in increased expression of MYEF2 mRNA	PMID:30047161
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D016572	Cyclosporine results in decreased expression of MYEF2 mRNA	PMID:27989131
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016572	Cyclosporine results in increased expression of MYEF2 mRNA	PMID:20106945
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1315224	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of MYEF2 mRNA	PMID:28973697
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:46024	trichostatin A	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in decreased expression of MYEF2 mRNA	PMID:24935251|PMID:26272509
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYEF2 mRNA	PMID:27188386
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315224	E	RGD:6480464	20130618	CTD	MESH:D000082	Acetaminophen affects the expression of MYEF2 mRNA	PMID:17562736
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MYEF2 mRNA	PMID:39836092
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315224	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which affects the expression of MYEF2 mRNA	PMID:40504410
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306547	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of MYEF2 mRNA	PMID:29391264
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MYEF2 mRNA	PMID:22079256
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:50131	5-aza-2'-deoxycytidine	multiple interactions	EXP		E	RGD:6480464	20191114	CTD	MESH:C014347	Decitabine inhibits the reaction [Smoke results in decreased expression of MYEF2 mRNA]	PMID:21095227
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306547	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of MYEF2 mRNA	PMID:30307764
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315224	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon results in increased expression of MYEF2 mRNA	PMID:25554681
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:50673	methimazole	increases expression	ISO	RGD:1306547	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in increased expression of MYEF2 mRNA	PMID:30047161
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:53050	trimellitic anhydride	increases expression	ISO	RGD:1315224	E	RGD:6480464	20130618	CTD	MESH:C015559	trimellitic anhydride results in increased expression of MYEF2 mRNA	PMID:19042947
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MYEF2 protein	PMID:32959892
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:747377	LDN-193189	multiple interactions	EXP		E	RGD:6480464	20260324	CTD	MESH:C554430	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of MYEF2 protein	PMID:37664457
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:75175	3',5'-cyclic UMP	affects binding	EXP		E	RGD:6480464	20220405	CTD	MESH:C045338	MYEF2 protein binds to cyclic 3',5'-uridine monophosphate	PMID:30528433
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of MYEF2 mRNA	PMID:22079256
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MYEF2 mRNA	PMID:22079256
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYEF2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYEF2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYEF2 mRNA	PMID:27188386
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:81520	2,3',4,4',5-Pentachlorobiphenyl	increases expression	ISO	RGD:1315224	E	RGD:6480464	20200114	CTD	MESH:C070055	2,3',4,4',5-pentachlorobiphenyl results in increased expression of MYEF2 mRNA	PMID:31388691
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	decreases expression	ISO	RGD:1306547	E	RGD:6480464	20181113	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether results in decreased expression of MYEF2 protein	PMID:19954255
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of MYEF2 protein	PMID:31675489
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of MYEF2 protein	PMID:31675489
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306547	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in increased expression of MYEF2 mRNA	PMID:30047161
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:8984	sodium dodecyl sulfate	increases expression	EXP		E	RGD:6480464	20200519	CTD	MESH:D012967	Sodium Dodecyl Sulfate results in increased expression of MYEF2 mRNA	PMID:31734321
1315223	MYEF2	myelin expression factor 2	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of MYEF2 protein; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYEF2 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYEF2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MYEF2 mRNA	PMID:27188386|PMID:37664457
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of STARD10 mRNA	PMID:38218311
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of STARD10 mRNA	PMID:38218311
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:116509	diuron	decreases expression	ISO	RGD:1306548	E	RGD:6480464	20120412	CTD	MESH:D004237	Diuron results in decreased expression of STARD10 mRNA	PMID:21551480
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1315226	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of STARD10 mRNA	PMID:33045310
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306548	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of STARD10 mRNA]	PMID:31150632
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in increased expression of STARD10 mRNA	PMID:33167477
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:15756	hexadecanoic acid	decreases expression	EXP		E	RGD:6480464	20250603	CTD	MESH:D019308	Palmitic Acid results in decreased expression of STARD10 mRNA	PMID:39506029
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1315226	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of STARD10 mRNA	PMID:39298647
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:16469	17beta-estradiol	multiple interactions	EXP		E	RGD:6480464	20230801	CTD	MESH:D004958	[Estradiol co-treated with Norethindrone Acetate] results in increased expression of STARD10 mRNA	PMID:22217510
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of STARD10 mRNA	PMID:38568856
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of STARD10 mRNA	PMID:23649840
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of STARD10 mRNA	PMID:31163220
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of STARD10 protein	PMID:37730182
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306548	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of STARD10 mRNA	PMID:33387578
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:18407	hydrogen cyanide	decreases expression	ISO	RGD:1315226	E	RGD:6480464	20211109	CTD	MESH:D006856	Hydrogen Cyanide results in decreased expression of STARD10 mRNA	PMID:33914522
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of STARD10 mRNA	PMID:19549813
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of STARD10 mRNA	PMID:23649840
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of STARD10 protein	PMID:20106945
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1315226	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of STARD10 mRNA	PMID:17484886
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306548	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of STARD10 mRNA	PMID:31150632
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306548	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of STARD10 mRNA]	PMID:31150632
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315226	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of STARD10 mRNA]	PMID:22206623
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306548	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of STARD10 mRNA	PMID:31881176
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:27889	lead(0)	affects expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D007854	Lead affects the expression of STARD10 mRNA	PMID:28903495
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:27928	parathion	increases expression	ISO	RGD:1315226	E	RGD:6480464	20220607	CTD	MESH:D010278	Parathion results in increased expression of STARD10 mRNA	PMID:34813904
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1315226	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of STARD10 mRNA	PMID:30912803
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306548	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STARD10 mRNA	PMID:34747641
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315226	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of STARD10 mRNA	PMID:21570461
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315226	E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STARD10 mRNA	PMID:17942748
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of STARD10 mRNA	PMID:33212167
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:28420	p-chloromercuribenzoic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D020245	p-Chloromercuribenzoic Acid results in increased expression of STARD10 mRNA	PMID:27188386
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of STARD10 mRNA	PMID:29803840
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:28885	butan-1-ol	multiple interactions	EXP		E	RGD:6480464	20181016	CTD	MESH:D020001	[[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of STARD10 mRNA	PMID:29432896
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:29678	sodium arsenite	affects methylation	ISO	RGD:1315226	E	RGD:6480464	20251007	CTD	MESH:C017947	sodium arsenite affects the methylation of STARD10 gene	PMID:39894169
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in decreased expression of STARD10 mRNA	PMID:29301061
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1315226	E	RGD:6480464	20230307	CTD	MESH:C017947	sodium arsenite results in decreased expression of STARD10 mRNA	PMID:36209798
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of STARD10 mRNA	PMID:21457566
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1306548	E	RGD:6480464	20190507	CTD	MESH:C017947	sodium arsenite results in increased expression of STARD10 protein	PMID:29459688
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	[sodium arsenite affects the acetylation of H3-4 protein] which affects the methylation of STARD10 promoter	PMID:18448484
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STARD10 mRNA	PMID:32234424
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1306548	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STARD10 mRNA	PMID:21839799
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315226	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of STARD10 mRNA	PMID:22228805
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of STARD10 5' UTR	PMID:27901495
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of STARD10 mRNA	PMID:25895662
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:30563	silicon dioxide	decreases methylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D012822	Silicon Dioxide results in decreased methylation of STARD10 promoter	PMID:34973136
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:30778	gallic acid	increases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D005707	Gallic Acid results in increased expression of STARD10 mRNA	PMID:34408198
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315226	E	RGD:6480464	20140211	CTD	MESH:C009495	titanium dioxide results in decreased expression of STARD10 mRNA	PMID:23557971
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315226	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of STARD10 gene	PMID:35295148
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315226	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of STARD10 gene	PMID:35295148
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306548	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of STARD10 mRNA	PMID:34492290
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	decreases expression	ISO	RGD:1306548	E	RGD:6480464	20190507	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in decreased expression of STARD10 mRNA	PMID:30723492
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1315226	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in decreased expression of STARD10 mRNA	PMID:28329830
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:33191	potassium cyanide	increases expression	ISO	RGD:1315226	E	RGD:6480464	20211109	CTD	MESH:D011190	Potassium Cyanide results in increased expression of STARD10 mRNA	PMID:33914522
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of STARD10 mRNA	PMID:30903817
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of STARD10 protein	PMID:31675489
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306548	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of STARD10 mRNA	PMID:25181051
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315226	E	RGD:6480464	20221206	CTD	MESH:C006780	bisphenol A results in decreased expression of STARD10 mRNA	PMID:35598803
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1306548	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of STARD10 gene	PMID:28505145
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:33216	bisphenol A	decreases methylation	ISO	RGD:1315226	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in decreased methylation of STARD10 promoter	PMID:27312807
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:C006780	bisphenol A results in increased expression of STARD10 mRNA	PMID:27685785|PMID:29275510
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315226	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of STARD10 mRNA	PMID:32156529|PMID:34585602
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1306548	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of STARD10 gene	PMID:28505145
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306548	E	RGD:6480464	20230307	CTD	MESH:C006780	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STARD10 mRNA	PMID:36041667
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1306548	E	RGD:6480464	20230307	CTD	MESH:C543008	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STARD10 mRNA	PMID:36041667
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:34575	bisphenol F	multiple interactions	ISO	RGD:1306548	E	RGD:6480464	20230307	CTD	MESH:C008745	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of STARD10 mRNA	PMID:36041667
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1315226	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of STARD10 mRNA	PMID:34813904
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:34837	methidathion	affects expression	ISO	RGD:1315226	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion affects the expression of STARD10 mRNA	PMID:34813904
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:34887	nickel dichloride	affects expression	ISO	RGD:1306548	E	RGD:6480464	20120717	CTD	MESH:C022838	nickel chloride affects the expression of STARD10 mRNA	PMID:22110744
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of STARD10 mRNA	PMID:37042841
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of STARD10 mRNA	PMID:38568856
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1315226	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of STARD10 mRNA	PMID:17585979
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:379896	17beta-hydroxy-17-methylestra-4,9,11-trien-3-one	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D015741	Metribolone results in increased expression of STARD10 mRNA	PMID:17010196
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:38940	sunitinib	increases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in increased expression of STARD10 mRNA	PMID:31533062
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of STARD10 mRNA	PMID:26272509
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STARD10 mRNA	PMID:27188386
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of STARD10 mRNA	PMID:20106945|PMID:25562108|PMID:27989131
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:4031	cyclosporin A	decreases expression	ISO	RGD:1306548	E	RGD:6480464	20120501	CTD	MESH:D016572	Cyclosporine results in decreased expression of STARD10 mRNA	PMID:21865292
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1315226	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of STARD10 mRNA	PMID:28973697
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of STARD10 mRNA	PMID:38832940
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of STARD10 mRNA	PMID:27188386
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of STARD10 mRNA	PMID:28542535
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of STARD10 mRNA	PMID:26690555|PMID:29067470
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306548	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of STARD10 mRNA	PMID:33387578
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of STARD10 mRNA	PMID:22230336
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of STARD10 mRNA	PMID:31675489
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:47807	sulforaphane	decreases expression	EXP		E	RGD:6480464	20200609	CTD	MESH:C016766	sulforaphane results in decreased expression of STARD10 mRNA	PMID:31838189
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:4903	17alpha-ethynylestradiol	decreases expression	ISO	RGD:1306548	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in decreased expression of STARD10 mRNA	PMID:17108234
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1315226	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of STARD10 mRNA	PMID:17942748
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:4903	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:1315226	E	RGD:6480464	20120412	CTD	MESH:D004997	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of STARD10 mRNA	PMID:17942748
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1315226	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of STARD10 mRNA	PMID:40234311
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1315226	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of STARD10 mRNA	PMID:35964746
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:53227	poly(ethylene)	multiple interactions	ISO	RGD:1315226	E	RGD:6480464	20260602	CTD	MESH:D020959	[Polyethylene results in increased abundance of Microplastics] which results in decreased expression of STARD10 mRNA	PMID:40262053
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:641	N-methyl-4-phenylpyridinium	increases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:D015655	1-Methyl-4-phenylpyridinium results in increased expression of STARD10 mRNA	PMID:24810058
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1306548	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of STARD10 gene	PMID:35440735
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:69808	14-Deoxy-11,12-didehydroandrographolide	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C495626	14-deoxy-11,12-didehydroandrographolide results in decreased expression of STARD10 mRNA	PMID:22101062
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:71957	XL147	multiple interactions	ISO	RGD:1315226	E	RGD:6480464	20190910	CTD	MESH:C581157	XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of STARD10 mRNA]	PMID:29891994
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315226	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of STARD10 mRNA	PMID:22206623
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315226	E	RGD:6480464	20200804	CTD	MESH:D019813	Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of STARD10 mRNA]	PMID:22206623
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1306548	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of STARD10 mRNA	PMID:33484710
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STARD10 mRNA	PMID:27188386
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to STARD10 gene]	PMID:28238834
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:81582	2,4-dibromophenyl 2,4,5-tribromophenyl ether	affects expression	ISO	RGD:1315226	E	RGD:6480464	20240903	CTD	MESH:C477694	2,2',4,4',5-brominated diphenyl ether affects the expression of STARD10 mRNA	PMID:38648751
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of STARD10 protein	PMID:31675489
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306548	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of STARD10 mRNA	PMID:24780913
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STARD10 mRNA	PMID:27188386
1315225	STARD10	StAR related lipid transfer domain containing 10	gene	CHEBI:9168	sirolimus	multiple interactions	EXP		E	RGD:6480464	20121113	CTD	MESH:D020123	Sirolimus inhibits the reaction [TP73 protein results in increased expression of STARD10 mRNA]	PMID:21245298
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of DOCK1 mRNA	PMID:38218311
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1315228	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of DOCK1 mRNA	PMID:33045310
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of DOCK1 mRNA	PMID:23724009
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:15738	staurosporine	multiple interactions	EXP		E	RGD:6480464	20150825	CTD	MESH:D019311	DOCK1 protein inhibits the reaction [Staurosporine results in increased activity of CASP3 protein]; DOCK1 protein inhibits the reaction [Staurosporine results in increased activity of CASP7 protein]	PMID:25586182
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:15743	butanal	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in decreased expression of DOCK1 mRNA	PMID:26079696
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1566072	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of DOCK1 gene	PMID:28931070
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:15930	atrazine	decreases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in decreased expression of DOCK1 mRNA	PMID:22378314
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:16236	ethanol	decreases expression	ISO	RGD:1315228	E	RGD:6480464	20180220	CTD	MESH:D000431	Ethanol results in decreased expression of DOCK1 mRNA	PMID:29018328
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315228	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of DOCK1 mRNA	PMID:30319688
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1566072	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of DOCK1 mRNA	PMID:26577399
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315228	E	RGD:6480464	20251007	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DOCK1 mRNA	PMID:37236586
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of DOCK1 mRNA	PMID:19549813
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of DOCK1 mRNA	PMID:21641981|PMID:22100608
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of DOCK1 intron	PMID:30157460
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:25187	p-menthan-3-ol	decreases expression	EXP		E	RGD:6480464	20190611	CTD	MESH:D008610	Menthol results in decreased expression of DOCK1 mRNA	PMID:26760959
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:25434	bis(2-chloroethyl) sulfide	affects expression	ISO	RGD:1566072	E	RGD:6480464	20150721	CTD	MESH:D009151	Mustard Gas affects the expression of DOCK1 mRNA	PMID:15651846
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315228	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DOCK1 mRNA	PMID:22206623
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:27563	arsenic atom	increases methylation	EXP		E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in increased methylation of DOCK1 gene	PMID:24525453
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of DOCK1 protein	PMID:35688186
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of DOCK1 mRNA	PMID:19561079|PMID:27392435
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:27899	cisplatin	decreases expression	ISO	RGD:1566072	E	RGD:6480464	20150721	CTD	MESH:D002945	Cisplatin results in decreased expression of DOCK1 mRNA	PMID:22023808
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in decreased expression of DOCK1 mRNA	PMID:27392435
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315228	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DOCK1 mRNA	PMID:21570461
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1566072	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of DOCK1 mRNA	PMID:34747641
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1566072	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of DOCK1 mRNA	PMID:33387578
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of DOCK1 protein	PMID:39603559
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of DOCK1 mRNA	PMID:33212167
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1566072	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of DOCK1 mRNA	PMID:28959563
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1566072	E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of DOCK1 mRNA	PMID:21297353
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of DOCK1 intron	PMID:30157460
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DOCK1 mRNA	PMID:20064835|PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1315228	E	RGD:6480464	20120515	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of DOCK1 mRNA	PMID:19770486|PMID:21715664
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20260407	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of DOCK1 mRNA alternative form	PMID:40419235
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	ISO	RGD:1315228	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of DOCK1 intron	PMID:27901495
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to DOCK1 mRNA]	PMID:32406909
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	decreases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DOCK1 mRNA	PMID:26238291
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DOCK1 gene; [bisphenol S co-treated with Fulvestrant] results in increased methylation of DOCK1 gene	PMID:31601247
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1315228	E	RGD:6480464	20120814	CTD	MESH:C008261	lead acetate results in increased expression of DOCK1 mRNA	PMID:20542052
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315228	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of DOCK1 gene	PMID:35295148
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315228	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in increased expression of DOCK1 mRNA	PMID:29264374
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of DOCK1 protein	PMID:31675489
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315228	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of DOCK1 mRNA	PMID:33221593
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1566072	E	RGD:6480464	20150721	CTD	MESH:C006780	bisphenol A results in decreased expression of DOCK1 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998|PMID:38750585
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of DOCK1 gene	PMID:31601247
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:33216	bisphenol A	increases methylation	ISO	RGD:1566072	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased methylation of DOCK1 gene	PMID:28505145
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of DOCK1 gene	PMID:31601247
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1315228	E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of and affects the splicing of DOCK1 mRNA	PMID:37894381
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of DOCK1 protein	PMID:31675489
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:33234	vitamin E	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D024502	Vitamin E results in decreased expression of DOCK1 mRNA	PMID:19244175
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315228	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of DOCK1 mRNA	PMID:30951980
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	[bisphenol S co-treated with Fulvestrant] results in increased methylation of DOCK1 gene	PMID:31601247
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315228	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of DOCK1 mRNA	PMID:30951980|PMID:38685157
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1315228	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of DOCK1 mRNA	PMID:28392331
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:34674	dextran sulfate	decreases expression	ISO	RGD:1315228	E	RGD:6480464	20250114	CTD	MESH:D016264	Dextran Sulfate results in decreased expression of DOCK1 protein	PMID:35362542
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:34674	dextran sulfate	multiple interactions	ISO	RGD:1315228	E	RGD:6480464	20250114	CTD	MESH:D016264	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of DOCK1 protein]	PMID:35362542
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:34687	dibutyl phthalate	decreases expression	ISO	RGD:1566072	E	RGD:6480464	20150721	CTD	MESH:D003993	Dibutyl Phthalate results in decreased expression of DOCK1 mRNA	PMID:21266533
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of DOCK1 mRNA	PMID:38382870
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315228	E	RGD:6480464	20251007	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of DOCK1 mRNA	PMID:37236586
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:35696	cobalt dichloride	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:C018021	cobaltous chloride results in decreased expression of DOCK1 mRNA	PMID:19320972
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of DOCK1 mRNA	PMID:24449571
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:38397	perfluorononanoic acid	increases expression	ISO	RGD:1315228	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of DOCK1 mRNA	PMID:40194260
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:39483	sodium dichromate	affects expression	ISO	RGD:1566072	E	RGD:6480464	20150721	CTD	MESH:C016104	sodium bichromate affects the expression of DOCK1 mRNA	PMID:22110744
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of DOCK1 mRNA	PMID:25979313
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of DOCK1 gene	PMID:29154799
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315228	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of DOCK1 mRNA	PMID:17562736
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of DOCK1 mRNA	PMID:26690555
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1566072	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of DOCK1 mRNA	PMID:33387578
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:46666	crocidolite asbestos	decreases expression	ISO	RGD:1315228	E	RGD:6480464	20200915	CTD	MESH:D017638	Asbestos, Crocidolite results in decreased expression of DOCK1 mRNA	PMID:29279043
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:47217	arsane	increases methylation	EXP		E	RGD:6480464	20160607	CTD	MESH:D001151	Arsenic results in increased methylation of DOCK1 gene	PMID:24525453
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:47519	ketoconazole	decreases expression	ISO	RGD:1566072	E	RGD:6480464	20230905	CTD	MESH:D007654	Ketoconazole results in decreased expression of DOCK1 mRNA	PMID:36653537
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:47696	2,4,6-tribromophenol	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in increased expression of DOCK1 mRNA	PMID:31675489
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1566072	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of DOCK1 mRNA	PMID:29391264
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of DOCK1 mRNA	PMID:32234424
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:4948	Evodiamine	multiple interactions	ISO	RGD:1315228	E	RGD:6480464	20250114	CTD	MESH:C049639	evodiamine inhibits the reaction [Dextran Sulfate results in decreased expression of DOCK1 protein]	PMID:35362542
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:59001	4-vinylcyclohexene dioxide	affects expression	ISO	RGD:1315228	E	RGD:6480464	20161213	CTD	MESH:C012606	4-vinyl-1-cyclohexene dioxide affects the expression of DOCK1 mRNA	PMID:20829426
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of DOCK1 protein	PMID:32959892
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:6842	methoxychlor	affects methylation	ISO	RGD:1566072	E	RGD:6480464	20230905	CTD	MESH:D008731	Methoxychlor affects the methylation of DOCK1 gene	PMID:35440735
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315228	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of DOCK1 mRNA	PMID:22206623
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315228	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DOCK1 mRNA	PMID:22206623
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:7719	ochratoxin A	increases methylation	ISO	RGD:1566072	E	RGD:6480464	20160210	CTD	MESH:C025589	ochratoxin A results in increased methylation of DOCK1 gene	PMID:26431795
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DOCK1 protein	PMID:31675489
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:82436	decabromodiphenyl ether	increases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in increased expression of DOCK1 protein	PMID:31675489
1315227	DOCK1	dedicator of cytokinesis 1	gene	CHEBI:83258	fenamidone	increases expression	ISO	RGD:1315228	E	RGD:6480464	20180116	CTD	MESH:C540355	fenamidone results in increased expression of DOCK1 mRNA	PMID:27029645
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of SLITRK6 mRNA	PMID:23724009
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20120501	CTD	MESH:D014212	Tretinoin results in increased expression of SLITRK6 mRNA	PMID:21934132
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:15930	atrazine	affects methylation	ISO	RGD:1306550	E	RGD:6480464	20190219	CTD	MESH:D001280	Atrazine affects the methylation of SLITRK6 gene	PMID:28931070
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:15930	atrazine	increases expression	ISO	RGD:1306550	E	RGD:6480464	20230606	CTD	MESH:D001280	Atrazine results in increased expression of SLITRK6 mRNA	PMID:36841081
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:16330	17beta-hydroxy-5alpha-androstan-3-one	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D013196	Dihydrotestosterone results in increased expression of SLITRK6 mRNA	PMID:29581250
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of SLITRK6 mRNA	PMID:31614463
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:16602	trichloroethene	decreases expression	ISO	RGD:1306550	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in decreased expression of SLITRK6 mRNA	PMID:33387578
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:17153	propanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C005556	propionaldehyde results in increased expression of SLITRK6 mRNA	PMID:26079696
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315230	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLITRK6 mRNA	PMID:37567420
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:174733	Licochalcone B	decreases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C541528	licochalcone B results in decreased expression of SLITRK6 mRNA	PMID:33647349
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315230	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLITRK6 mRNA	PMID:37567420
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:177802	Cuprizon	decreases expression	ISO	RGD:1306550	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in decreased expression of SLITRK6 mRNA	PMID:27523638
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306550	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of SLITRK6 mRNA	PMID:33387578
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:222613	Moniliformin	decreases expression	ISO	RGD:1315230	E	RGD:6480464	20250902	CTD	MESH:C008539	moniliformin results in decreased expression of SLITRK6 mRNA	PMID:39984025
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:22977	cadmium atom	decreases expression	EXP		E	RGD:6480464	20140513	CTD	MESH:D002104	Cadmium results in decreased expression of SLITRK6 mRNA	PMID:24376830
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1306550	E	RGD:6480464	20251202	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLITRK6 mRNA	PMID:39012411
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:23808	dimethylarsinous acid	decreases expression	EXP		E	RGD:6480464	20170303	CTD	MESH:C472511	dimethylarsinous acid results in decreased expression of SLITRK6 mRNA	PMID:23876855
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLITRK6 gene	PMID:27153756
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:28088	genistein	increases expression	ISO	RGD:1315230	E	RGD:6480464	20200804	CTD	MESH:D019833	Genistein results in increased expression of SLITRK6 mRNA	PMID:32186404
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of SLITRK6 mRNA	PMID:24768652|PMID:25583101
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315230	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLITRK6 mRNA	PMID:21570461
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306550	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLITRK6 mRNA	PMID:33387578
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306550	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of SLITRK6 mRNA	PMID:32109520
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of SLITRK6 mRNA	PMID:28001369
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLITRK6 mRNA	PMID:30851411
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:28694	copper atom	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of SLITRK6 mRNA	PMID:20971185
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315230	E	RGD:6480464	20231031	CTD	MESH:D005632	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLITRK6 mRNA	PMID:37567420
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in decreased expression of SLITRK6 mRNA	PMID:23876855|PMID:39719251
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of SLITRK6 mRNA	PMID:34032870
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	ISO	RGD:1306550	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLITRK6 mRNA	PMID:21839799
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315230	E	RGD:6480464	20140311	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLITRK6 mRNA	PMID:23735875
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:30052	copper(0)	multiple interactions	EXP		E	RGD:6480464	20120717	CTD	MESH:D003300	[NSC 689534 binds to Copper] which results in increased expression of SLITRK6 mRNA	PMID:20971185
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of SLITRK6 mRNA	PMID:25895662
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:31638	fulvestrant	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of SLITRK6 gene	PMID:31601247
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1306550	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of SLITRK6 mRNA	PMID:22641619
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306550	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of SLITRK6 mRNA	PMID:30047161
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:33007	chromium(6+)	multiple interactions	EXP		E	RGD:6480464	20240702	CTD	MESH:C074702	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression of SLITRK6 mRNA	PMID:38479592
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306550	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLITRK6 mRNA	PMID:25181051|PMID:34947998
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:33216	bisphenol A	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased methylation of SLITRK6 gene	PMID:31601247
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SLITRK6 mRNA	PMID:29275510
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306550	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in increased expression of SLITRK6 mRNA	PMID:30816183|PMID:32528016
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315230	E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A results in increased expression of SLITRK6 mRNA	PMID:30951980
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:33216	bisphenol A	multiple interactions	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	[bisphenol A co-treated with Fulvestrant] results in decreased methylation of SLITRK6 gene	PMID:31601247
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:34031	1,1-dichloroethene	decreases expression	ISO	RGD:1315230	E	RGD:6480464	20170725	CTD	MESH:C029297	vinylidene chloride results in decreased expression of SLITRK6 mRNA	PMID:26682919
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases expression	ISO	RGD:1315230	E	RGD:6480464	20191112	CTD	MESH:C543008	bisphenol S results in increased expression of SLITRK6 mRNA	PMID:30951980
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315230	E	RGD:6480464	20191112	CTD	MESH:C008745	bisphenol F results in increased expression of SLITRK6 mRNA	PMID:30951980
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306550	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SLITRK6 mRNA	PMID:32680482
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306550	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of SLITRK6 mRNA	PMID:33453195
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1306550	E	RGD:6480464	20251202	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLITRK6 mRNA	PMID:39012411
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:3763	clorgyline	increases expression	EXP		E	RGD:6480464	20130604	CTD	MESH:D003010	Clorgyline results in increased expression of SLITRK6 mRNA	PMID:19691856
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1315230	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of SLITRK6 mRNA	PMID:40194260
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:38922	dibenzofurans	decreases expression	ISO	RGD:1315230	E	RGD:6480464	20230704	CTD	MESH:D000072318	Dibenzofurans results in decreased expression of SLITRK6 mRNA	PMID:34254344
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLITRK6 mRNA	PMID:25979313
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of SLITRK6 mRNA	PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:28001369
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLITRK6 mRNA	PMID:27188386
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315230	E	RGD:6480464	20231031	CTD	MESH:D005947	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLITRK6 mRNA	PMID:37567420
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SLITRK6 mRNA	PMID:38832940
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:45716	vorinostat	increases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in increased expression of SLITRK6 mRNA	PMID:26272509
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:45716	vorinostat	multiple interactions	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLITRK6 mRNA	PMID:27188386
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:C012589	trichostatin A results in increased expression of SLITRK6 mRNA	PMID:24935251|PMID:26272509
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:46024	trichostatin A	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:C012589	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLITRK6 mRNA	PMID:27188386
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1315230	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of SLITRK6 mRNA	PMID:25554681
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306550	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of SLITRK6 mRNA	PMID:30047161
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:60799	esketamine	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C000629870	Esketamine results in increased expression of SLITRK6 mRNA	PMID:38219984
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:64163	diquat	decreases expression	ISO	RGD:1315230	E	RGD:6480464	20230704	CTD	MESH:D004178	Diquat results in decreased expression of SLITRK6 mRNA	PMID:36851058
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:753160	lard	multiple interactions	ISO	RGD:1315230	E	RGD:6480464	20260714	CTD	MESH:C029310	[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLITRK6 mRNA	PMID:37567420
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:7590	nitrofen	increases expression	ISO	RGD:1306550	E	RGD:6480464	20210810	CTD	MESH:C007350	nitrofen results in increased expression of SLITRK6 mRNA	PMID:33484710
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of SLITRK6 mRNA	PMID:30851411
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLITRK6 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLITRK6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLITRK6 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLITRK6 mRNA	PMID:27188386
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306550	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of SLITRK6 mRNA	PMID:24780913
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306550	E	RGD:6480464	20180703	CTD	MESH:D011441	Propylthiouracil results in increased expression of SLITRK6 mRNA	PMID:25825206
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:85990	panobinostat	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	panobinostat results in increased expression of SLITRK6 mRNA	PMID:26272509
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:85990	panobinostat	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C496932	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLITRK6 mRNA	PMID:27188386
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C459179	[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLITRK6 mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLITRK6 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLITRK6 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLITRK6 mRNA	PMID:27188386
1315229	SLITRK6	SLIT and NTRK like family member 6	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of SLITRK6 mRNA	PMID:38568856
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306551	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BLOC1S2 mRNA]	PMID:31150632
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of BLOC1S2 mRNA	PMID:23724009|PMID:33167477
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1315232	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BLOC1S2 mRNA	PMID:30529165
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315232	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of BLOC1S2 mRNA	PMID:30319688
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of BLOC1S2 mRNA	PMID:21632981
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:16842	formaldehyde	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D005557	Formaldehyde results in increased expression of BLOC1S2 mRNA	PMID:23649840
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:17347	testosterone	decreases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in decreased expression of BLOC1S2 mRNA	PMID:33359661
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of BLOC1S2 mRNA	PMID:19549813
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:23994	ethyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in increased expression of BLOC1S2 mRNA	PMID:23649840
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of BLOC1S2 protein	PMID:20106945
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of BLOC1S2 intron	PMID:30157460
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:2504	aflatoxin B1	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BLOC1S2 mRNA	PMID:21632981|PMID:21641981|PMID:22100608|PMID:27153756
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1315232	E	RGD:6480464	20130115	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of BLOC1S2 mRNA	PMID:19770486
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:25255	methyl methanesulfonate	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in increased expression of BLOC1S2 mRNA	PMID:23649840
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of BLOC1S2 mRNA	PMID:35430440
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315232	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of BLOC1S2 mRNA	PMID:34911549
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1306551	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of BLOC1S2 mRNA	PMID:31150632
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306551	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of BLOC1S2 mRNA]	PMID:31150632
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:27504	mitomycin C	increases expression	ISO	RGD:1315232	E	RGD:6480464	20150127	CTD	MESH:D016685	Mitomycin results in increased expression of BLOC1S2 mRNA	PMID:25270620
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of BLOC1S2 gene	PMID:25304211
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BLOC1S2 mRNA	PMID:39836092
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:27656	camptothecin	increases expression	EXP		E	RGD:6480464	20240806	CTD	MESH:D002166	Camptothecin results in increased expression of BLOC1S2 mRNA	PMID:38460933
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306551	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of BLOC1S2 mRNA	PMID:31881176
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of BLOC1S2 mRNA	PMID:23557933
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:27889	lead(0)	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:D007854	Lead results in increased expression of BLOC1S2 mRNA	PMID:37386098
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D002945	Cisplatin results in decreased expression of BLOC1S2 mRNA	PMID:19561079
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in increased expression of BLOC1S2 mRNA	PMID:27594783
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306551	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of BLOC1S2 mRNA	PMID:34747641
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306551	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of BLOC1S2 mRNA	PMID:33387578
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:D012402	Rotenone results in increased expression of BLOC1S2 mRNA	PMID:33512557
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of BLOC1S2 mRNA	PMID:30851411
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of BLOC1S2 mRNA	PMID:39719251
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of BLOC1S2 mRNA	PMID:38568856
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BLOC1S2 mRNA	PMID:39836092
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:29699	tunicamycin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D014415	Tunicamycin results in increased expression of BLOC1S2 mRNA	PMID:22378314
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	ISO	RGD:1315232	E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of BLOC1S2 intron	PMID:27901495
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BLOC1S2 mRNA	PMID:20106945|PMID:21632981|PMID:22316170|PMID:26238291|PMID:32234424
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315232	E	RGD:6480464	20130115	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of BLOC1S2 mRNA	PMID:19770486
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:29865	benzo[a]pyrene	multiple interactions	ISO	RGD:1315232	E	RGD:6480464	20170516	CTD	MESH:D001564	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BLOC1S2 mRNA	PMID:27858113
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:30614	benzo[a]pyrene diol epoxide I	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of BLOC1S2 mRNA	PMID:26238291
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1306551	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of BLOC1S2 mRNA	PMID:22641619
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:32234	titanium dioxide	decreases expression	ISO	RGD:1315232	E	RGD:6480464	20191112	CTD	MESH:C009495	titanium dioxide results in decreased expression of BLOC1S2 mRNA	PMID:29264374
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315232	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of BLOC1S2 gene	PMID:35295148
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306551	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of BLOC1S2 mRNA	PMID:34492290
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:33007	chromium(6+)	affects expression	ISO	RGD:1315232	E	RGD:6480464	20171010	CTD	MESH:C074702	chromium hexavalent ion affects the expression of BLOC1S2 mRNA	PMID:28472532
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306551	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of BLOC1S2 mRNA	PMID:25181051
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:3387	carbamazepine	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D002220	Carbamazepine affects the expression of BLOC1S2 mRNA	PMID:25979313
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1306551	E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of BLOC1S2 mRNA	PMID:32119087
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315232	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of BLOC1S2 mRNA	PMID:39298647
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:34565	benzo[b]fluoranthene	multiple interactions	ISO	RGD:1315232	E	RGD:6480464	20170516	CTD	MESH:C006703	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BLOC1S2 mRNA	PMID:27858113
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:34608	captan	increases expression	ISO	RGD:1315232	E	RGD:6480464	20201103	CTD	MESH:D002215	Captan results in increased expression of BLOC1S2 mRNA	PMID:31558096
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:34648	clofibric acid	multiple interactions	ISO	RGD:1306551	E	RGD:6480464	20120412	CTD	MESH:D002995	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BLOC1S2 mRNA	PMID:17602206
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1315232	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of BLOC1S2 mRNA	PMID:34813904
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:34873	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1306551	E	RGD:6480464	20120412	CTD	MESH:D004052	[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of BLOC1S2 mRNA	PMID:17602206
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of BLOC1S2 mRNA	PMID:37042841
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:35455	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1306551	E	RGD:6480464	20160315	CTD	MESH:D015058	1-Naphthylisothiocyanate results in increased expression of BLOC1S2 mRNA	PMID:25380136
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of BLOC1S2 mRNA	PMID:38382870
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:38397	perfluorononanoic acid	increases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in increased expression of BLOC1S2 mRNA	PMID:32588087
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:38658	dicrotophos	decreases expression	EXP		E	RGD:6480464	20170725	CTD	MESH:C000944	dicrotophos results in decreased expression of BLOC1S2 mRNA	PMID:28302478
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in increased expression of BLOC1S2 mRNA	PMID:20106945|PMID:25562108
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1315232	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of BLOC1S2 mRNA	PMID:28973697
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:4357	deguelin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C107676	deguelin results in increased expression of BLOC1S2 mRNA	PMID:33512557
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:4393	(-)-demecolcine	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D003703	Demecolcine results in increased expression of BLOC1S2 mRNA	PMID:23649840
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in increased expression of BLOC1S2 mRNA	PMID:22230336
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306551	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of BLOC1S2 mRNA	PMID:33387578
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of BLOC1S2 gene	PMID:25304211
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BLOC1S2 mRNA	PMID:39836092
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1315232	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of BLOC1S2 mRNA	PMID:35964746
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306551	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of BLOC1S2 mRNA	PMID:24136188
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:51348	tetraphene	multiple interactions	ISO	RGD:1315232	E	RGD:6480464	20170516	CTD	MESH:C030935	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BLOC1S2 mRNA	PMID:27858113
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:51687	chrysene	multiple interactions	ISO	RGD:1315232	E	RGD:6480464	20170516	CTD	MESH:C031180	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BLOC1S2 mRNA	PMID:27858113
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of BLOC1S2 protein	PMID:32959892
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of BLOC1S2 mRNA	PMID:27918106
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of BLOC1S2 mRNA	PMID:30851411
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to BLOC1S2 gene]	PMID:28238834
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:81506	2,3,7,8-Tetrachlorodibenzofuran	increases expression	ISO	RGD:1306551	E	RGD:6480464	20200609	CTD	MESH:C014211	2,3,7,8-tetrachlorodibenzofuran results in increased expression of BLOC1S2 mRNA	PMID:32109520
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:82019	folpet	increases expression	ISO	RGD:1315232	E	RGD:6480464	20201103	CTD	MESH:C005020	folpet results in increased expression of BLOC1S2 mRNA	PMID:31558096
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:83197	picoxystrobin	increases expression	EXP		E	RGD:6480464	20210810	CTD	MESH:C556557	picoxystrobin results in increased expression of BLOC1S2 mRNA	PMID:33512557
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306551	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of BLOC1S2 mRNA	PMID:21346803
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of BLOC1S2 mRNA	PMID:38568856
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:9516	thapsigargin	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D019284	Thapsigargin results in increased expression of BLOC1S2 mRNA	PMID:22378314
1315231	BLOC1S2	biogenesis of lysosomal organelles complex 1 subunit 2	gene	CHEBI:9763	trovafloxacin	increases expression	ISO	RGD:1315232	E	RGD:6480464	20221101	CTD	MESH:C080163	trovafloxacin results in increased expression of BLOC1S2 mRNA	PMID:35537566
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:10110	zidovudine	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D015215	Zidovudine results in decreased expression of SLC2A10 mRNA	PMID:24292225
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:134926	drometrizole	affects expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C033674	benazol P affects the expression of SLC2A10 mRNA	PMID:36586167
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20160607	CTD	MESH:D014212	Tretinoin results in decreased expression of SLC2A10 mRNA	PMID:23830798
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in increased expression of SLC2A10 mRNA	PMID:21632981
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLC2A10 mRNA	PMID:35811015
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of SLC2A10 mRNA	PMID:31614463
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315234	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC2A10 mRNA	PMID:37992649
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:17243	mono(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C016599	mono-(2-ethylhexyl)phthalate results in increased expression of SLC2A10 mRNA	PMID:38685446
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315234	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC2A10 mRNA	PMID:37992649
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306552	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of SLC2A10 mRNA	PMID:26577399
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of SLC2A10 mRNA	PMID:28818685
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A10 mRNA	PMID:35301059
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of SLC2A10 mRNA	PMID:22100608|PMID:27153756
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of SLC2A10 intron	PMID:30157460
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:27385	tetrachloromethane	affects expression	ISO	RGD:1315234	E	RGD:6480464	20120412	CTD	MESH:D002251	Carbon Tetrachloride affects the expression of SLC2A10 mRNA	PMID:17484886
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:27470	folic acid	decreases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of SLC2A10 mRNA	PMID:21867686
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC2A10 mRNA	PMID:39836092
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:27732	caffeine	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D002110	Caffeine results in decreased expression of SLC2A10 protein	PMID:31195006
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1315234	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of SLC2A10 mRNA	PMID:28960355
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC2A10 mRNA	PMID:23557933
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315234	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of SLC2A10 mRNA	PMID:21570461
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306552	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of SLC2A10 mRNA	PMID:33387578
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306552	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of SLC2A10 mRNA	PMID:28959563
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of SLC2A10 mRNA	PMID:29803840
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315234	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC2A10 mRNA	PMID:37992649
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:2948	azathioprine	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D001379	Azathioprine results in decreased expression of SLC2A10 mRNA	PMID:22623647
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC2A10 mRNA	PMID:39836092
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of SLC2A10 mRNA	PMID:21632981
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315234	E	RGD:6480464	20120613	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of SLC2A10 mRNA	PMID:21569818
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of SLC2A10 promoter	PMID:27901495
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of SLC2A10 gene	PMID:31601247
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:31767	lead diacetate	increases expression	ISO	RGD:1306552	E	RGD:6480464	20130312	CTD	MESH:C008261	lead acetate results in increased expression of SLC2A10 mRNA	PMID:22641619
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315234	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of SLC2A10 gene	PMID:35295148
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306552	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of SLC2A10 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of SLC2A10 mRNA	PMID:29275510
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:34595	Butylbenzyl phthalate	decreases methylation	ISO	RGD:1315234	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased methylation of SLC2A10 intron	PMID:28392331
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:34905	paraquat	decreases expression	ISO	RGD:1306552	E	RGD:6480464	20210907	CTD	MESH:D010269	Paraquat results in decreased expression of SLC2A10 mRNA	PMID:32680482
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC2A10 mRNA	PMID:35301059
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of SLC2A10 mRNA	PMID:31533062
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of SLC2A10 mRNA	PMID:40419075
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of SLC2A10 mRNA	PMID:25979313
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:39867	valproic acid	decreases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in decreased expression of SLC2A10 mRNA	PMID:24935251|PMID:28001369|PMID:29154799
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:D014635	Valproic Acid results in increased expression of SLC2A10 mRNA	PMID:24935251
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of SLC2A10 mRNA	PMID:25562108
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:4031	cyclosporin A	increases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016572	Cyclosporine results in increased expression of SLC2A10 mRNA	PMID:20106945|PMID:21632981|PMID:27989131
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1315234	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of SLC2A10 mRNA	PMID:28973697
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315234	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of SLC2A10 mRNA	PMID:37992649
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of SLC2A10 mRNA	PMID:38832940
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:45716	vorinostat	decreases expression	EXP		E	RGD:6480464	20161213	CTD	MESH:C111237	vorinostat results in decreased expression of SLC2A10 mRNA	PMID:27188386
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:46024	trichostatin A	increases expression	EXP		E	RGD:6480464	20140909	CTD	MESH:C012589	trichostatin A results in increased expression of SLC2A10 mRNA	PMID:24935251
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:46195	paracetamol	decreases expression	ISO	RGD:1306552	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in decreased expression of SLC2A10 mRNA	PMID:33387578
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLC2A10 mRNA	PMID:35811015
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of SLC2A10 mRNA	PMID:39836092
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:4791	endosulfan	decreases expression	ISO	RGD:1306552	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in decreased expression of SLC2A10 mRNA	PMID:29391264
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	decreases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:C045651	epigallocatechin gallate results in decreased expression of SLC2A10 protein	PMID:31195006
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:4811	epoxiconazole	increases expression	ISO	RGD:1315234	E	RGD:6480464	20220906	CTD	MESH:C109476	epoxiconazole results in increased expression of SLC2A10 mRNA	PMID:35436446
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315234	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of SLC2A10 mRNA; Nanotubes, Carbon results in increased expression of SLC2A10 mRNA	PMID:25554681
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:69478	cannabidiol	increases expression	EXP		E	RGD:6480464	20211207	CTD	MESH:D002185	Cannabidiol results in increased expression of SLC2A10 mRNA	PMID:31518892
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:82436	decabromodiphenyl ether	affects expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010902	decabromobiphenyl ether affects the expression of SLC2A10 mRNA	PMID:24834073
1315233	SLC2A10	solute carrier family 2 member 10	gene	CHEBI:84070	sodium arsenate	decreases expression	ISO	RGD:1315234	E	RGD:6480464	20170303	CTD	MESH:C009277	sodium arsenate results in decreased expression of SLC2A10 mRNA	PMID:21795629
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	decreases expression	ISO	RGD:1306553	E	RGD:6480464	20201215	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ARMC5 mRNA	PMID:30071829
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:15743	butanal	increases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:C018475	butyraldehyde results in increased expression of ARMC5 mRNA	PMID:26079696
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of ARMC5 mRNA	PMID:37042841
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306553	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of ARMC5 mRNA	PMID:33387578
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:17967	urethane	decreases expression	EXP		E	RGD:6480464	20171114	CTD	MESH:D014520	Urethane results in decreased expression of ARMC5 mRNA	PMID:28818685
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of ARMC5 mRNA	PMID:35430440
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315236	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARMC5 mRNA	PMID:22206623
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315236	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARMC5 mRNA	PMID:40504410
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:27641	cycloheximide	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003513	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of ARMC5 mRNA	PMID:19684285
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of ARMC5 mRNA	PMID:23557933
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306553	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of ARMC5 mRNA	PMID:33387578
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of ARMC5 mRNA	PMID:19684285
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D013749	[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of ARMC5 mRNA	PMID:19684285
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of ARMC5 mRNA	PMID:33212167
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of ARMC5 mRNA	PMID:38568856
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315236	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARMC5 mRNA	PMID:40504410
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of ARMC5 promoter	PMID:27901495
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:30812	iron dichloride	decreases expression	EXP		E	RGD:6480464	20231003	CTD	MESH:C029451	ferrous chloride results in decreased expression of ARMC5 mRNA	PMID:35984750
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315236	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of ARMC5 gene	PMID:35295148
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306553	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of ARMC5 mRNA	PMID:25181051
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases methylation	ISO	RGD:1315236	E	RGD:6480464	20220208	CTD	MESH:C543008	bisphenol S results in decreased methylation of ARMC5 promoter	PMID:33297965
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:34572	allethrin	multiple interactions	ISO	RGD:1306553	E	RGD:6480464	20230905	CTD	MESH:D000487	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ARMC5 protein	PMID:34896426
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:D019256	Cadmium Chloride results in increased expression of ARMC5 mRNA	PMID:38382870
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:39098	pyrethrins	decreases expression	ISO	RGD:1306553	E	RGD:6480464	20230905	CTD	MESH:D011722	Pyrethrins results in decreased expression of ARMC5 protein	PMID:34896426
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of ARMC5 gene	PMID:29154799
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:4035	cyhalothrin	multiple interactions	ISO	RGD:1306553	E	RGD:6480464	20230905	CTD	MESH:C037304	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ARMC5 protein	PMID:34896426
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:4042	cypermethrin	multiple interactions	ISO	RGD:1306553	E	RGD:6480464	20230905	CTD	MESH:C017160	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ARMC5 protein	PMID:34896426
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315236	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of ARMC5 mRNA	PMID:17562736
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315236	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of ARMC5 mRNA	PMID:40504410
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:49553	copper(II) chloride	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C029892	cupric chloride results in increased expression of ARMC5 mRNA	PMID:38568856
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:5014	fenvalerate	multiple interactions	ISO	RGD:1306553	E	RGD:6480464	20230905	CTD	MESH:C017690	[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ARMC5 protein	PMID:34896426
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of ARMC5 mRNA	PMID:28988120
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1315236	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ARMC5 mRNA	PMID:22206623
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306553	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of ARMC5 mRNA	PMID:21346803
1315235	ARMC5	armadillo repeat containing 5	gene	CHEBI:9495	thiram	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in increased expression of ARMC5 mRNA	PMID:38568856
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:132844	glycidyl methacrylate	decreases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:C007870	glycidyl methacrylate results in decreased expression of XPR1 protein	PMID:36641056
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:1391	3,4-methylenedioxymethamphetamine	increases expression	ISO	RGD:1315238	E	RGD:6480464	20120918	CTD	MESH:D018817	N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of XPR1 mRNA	PMID:20188158
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:15367	all-trans-retinoic acid	increases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in increased expression of XPR1 mRNA	PMID:23724009
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:16236	ethanol	increases expression	ISO	RGD:1315238	E	RGD:6480464	20190507	CTD	MESH:D000431	Ethanol results in increased expression of XPR1 mRNA	PMID:30319688
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315238	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of XPR1 mRNA	PMID:39241906
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:164200	triclosan	decreases expression	EXP		E	RGD:6480464	20190507	CTD	MESH:D014260	Triclosan results in decreased expression of XPR1 mRNA	PMID:30510588
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1306554	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol results in decreased expression of XPR1 mRNA	PMID:32145629
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:165219	PCB138	increases expression	ISO	RGD:1306554	E	RGD:6480464	20201208	CTD	MESH:C029790	2,2',3',4,4',5-hexachlorobiphenyl results in increased expression of XPR1 mRNA	PMID:23829299
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of XPR1 mRNA	PMID:37042841
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:17347	testosterone	decreases expression	ISO	RGD:1315238	E	RGD:6480464	20120412	CTD	MESH:D013739	Testosterone results in decreased expression of XPR1 mRNA	PMID:20403060
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306554	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of XPR1 mRNA	PMID:26577399
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of XPR1 protein	PMID:37730182
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:24814	indole-3-methanol	affects expression	ISO	RGD:1306554	E	RGD:6480464	20120613	CTD	MESH:C016517	indole-3-carbinol affects the expression of XPR1 mRNA	PMID:21396975
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315238	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of XPR1 mRNA	PMID:25629700
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPR1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of XPR1 mRNA	PMID:39836092|PMID:40512198
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315238	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPR1 mRNA	PMID:40504410
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of XPR1 protein	PMID:35688186
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:27899	cisplatin	decreases expression	EXP		E	RGD:6480464	20180220	CTD	MESH:D002945	Cisplatin results in decreased expression of XPR1 mRNA	PMID:27594783
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306554	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of XPR1 mRNA	PMID:22298810
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306554	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of XPR1 mRNA	PMID:33387578
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1315238	E	RGD:6480464	20120412	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of XPR1 mRNA	PMID:19933214
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:28216	methylmercury chloride	decreases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:C004925	methylmercuric chloride results in decreased expression of XPR1 mRNA	PMID:28001369
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:2825	aristolochic acid A	decreases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in decreased expression of XPR1 mRNA	PMID:33212167
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:28358	rac-lactic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of XPR1 mRNA	PMID:30851411
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:28741	sodium fluoride	decreases expression	ISO	RGD:1315238	E	RGD:6480464	20170516	CTD	MESH:D012969	Sodium Fluoride results in decreased expression of XPR1 mRNA	PMID:27862939
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:28794	coumarin	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:C030123	coumarin results in decreased phosphorylation of XPR1 protein	PMID:35688186
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in decreased expression of XPR1 mRNA	PMID:39719251
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPR1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of XPR1 mRNA	PMID:39836092|PMID:40512198
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315238	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPR1 mRNA	PMID:40504410
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of XPR1 mRNA	PMID:20064835
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite inhibits the reaction [G3BP1 protein binds to XPR1 mRNA]	PMID:32406909
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306554	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of XPR1 mRNA	PMID:25729387
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315238	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of XPR1 promoter	PMID:35295148
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315238	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of XPR1 mRNA	PMID:35295148
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315238	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of XPR1 gene	PMID:35295148
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:32506	4,4'-diaminodiphenylmethane	increases expression	ISO	RGD:1315238	E	RGD:6480464	20120412	CTD	MESH:C009505	4,4'-diaminodiphenylmethane results in increased expression of XPR1 mRNA	PMID:18648102
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:33128	C60 fullerene	decreases expression	ISO	RGD:1306554	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in decreased expression of XPR1 mRNA	PMID:19167457
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306554	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of XPR1 mRNA	PMID:25181051
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306554	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in decreased expression of XPR1 mRNA	PMID:32145629
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1315238	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in decreased expression of XPR1 mRNA	PMID:33221593
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in increased expression of XPR1 mRNA	PMID:29275510
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306554	E	RGD:6480464	20180116	CTD	MESH:C006780	bisphenol A results in increased expression of XPR1 mRNA	PMID:29097150|PMID:30816183|PMID:34947998
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315238	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of XPR1 mRNA	PMID:39298647
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:34567	benzo[e]pyrene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene results in increased methylation of XPR1 intron	PMID:30157460
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:34575	bisphenol F	increases expression	ISO	RGD:1315238	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in increased expression of XPR1 mRNA	PMID:38685157
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:34595	Butylbenzyl phthalate	decreases expression	ISO	RGD:1315238	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in decreased expression of XPR1 mRNA	PMID:28392331
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of XPR1 mRNA	PMID:38568856
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of XPR1 mRNA	PMID:24449571
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:3750	clofibrate	multiple interactions	ISO	RGD:1315238	E	RGD:6480464	20120515	CTD	MESH:D002994	[Clofibrate co-treated with Acetaminophen] affects the expression of XPR1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of XPR1 mRNA]	PMID:17585979
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of XPR1 mRNA	PMID:31533062
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of XPR1 mRNA	PMID:25979313
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	Valproic Acid results in increased expression of XPR1 mRNA	PMID:23179753|PMID:27188386|PMID:28001369|PMID:29154799
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:42588	4-hydroxyphenyl retinamide	decreases expression	ISO	RGD:1315238	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in decreased expression of XPR1 mRNA	PMID:28973697
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:46024	trichostatin A	affects expression	EXP		E	RGD:6480464	20170613	CTD	MESH:C012589	trichostatin A affects the expression of XPR1 mRNA	PMID:28542535
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20180313	CTD	MESH:D000082	Acetaminophen results in decreased expression of XPR1 mRNA	PMID:26690555
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in increased expression of XPR1 mRNA	PMID:21420995
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306554	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of XPR1 mRNA	PMID:33387578
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:46195	paracetamol	multiple interactions	ISO	RGD:1315238	E	RGD:6480464	20120515	CTD	MESH:D000082	[Clofibrate co-treated with Acetaminophen] affects the expression of XPR1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of XPR1 mRNA]	PMID:17585979
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPR1 mRNA; [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of XPR1 mRNA	PMID:39836092|PMID:40512198
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315238	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of XPR1 mRNA	PMID:40504410
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:4806	(-)-epigallocatechin 3-gallate	multiple interactions	EXP		E	RGD:6480464	20121009	CTD	MESH:C045651	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of XPR1 mRNA	PMID:22079256
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1306554	E	RGD:6480464	20180116	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of XPR1 mRNA	PMID:29097150
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306554	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of XPR1 mRNA	PMID:24136188
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:53444	potassium dichromate	decreases expression	ISO	RGD:1315238	E	RGD:6480464	20140610	CTD	MESH:D011192	Potassium Dichromate results in decreased expression of XPR1 mRNA	PMID:23608068
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of XPR1 protein	PMID:32959892
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306554	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of XPR1 mRNA	PMID:25729387
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:6402	leflunomide	increases expression	ISO	RGD:1306554	E	RGD:6480464	20161213	CTD	MESH:C045463	leflunomide results in increased expression of XPR1 mRNA	PMID:24136188
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:6820	methapyrilene	increases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D008701	Methapyrilene results in increased methylation of XPR1 intron	PMID:30157460
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:73755	1,2-dimethylhydrazine	decreases expression	ISO	RGD:1315238	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in decreased expression of XPR1 mRNA	PMID:22206623
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:75249	potassium chromate	decreases expression	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	potassium chromate(VI) results in decreased expression of XPR1 mRNA	PMID:22079256
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:75249	potassium chromate	multiple interactions	EXP		E	RGD:6480464	20130903	CTD	MESH:C027373	[potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of XPR1 mRNA	PMID:22079256
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:78320	2-hydroxypropanoic acid	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in increased expression of XPR1 mRNA	PMID:30851411
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:80025	Salinomycin	decreases expression	EXP		E	RGD:6480464	20141111	CTD	MESH:C010327	salinomycin results in decreased expression of XPR1 mRNA	PMID:19682730
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:8093	phenylephrine	increases expression	ISO	RGD:1306554	E	RGD:6480464	20120412	CTD	MESH:D010656	Phenylephrine results in increased expression of XPR1 mRNA	PMID:18158353
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306554	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in decreased expression of XPR1 mRNA	PMID:24780913
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1306554	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of XPR1 mRNA	PMID:24136188
1315237	XPR1	xenotropic and polytropic retrovirus receptor 1	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of XPR1 mRNA	PMID:38568856
1315239	KLC4	kinesin light chain 4	gene	CHEBI:10429	beta-lapachone	decreases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in decreased expression of KLC4 mRNA	PMID:38218311
1315239	KLC4	kinesin light chain 4	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of KLC4 mRNA	PMID:38218311
1315239	KLC4	kinesin light chain 4	gene	CHEBI:132471	(+)-schisandrin B	multiple interactions	ISO	RGD:1306555	E	RGD:6480464	20190910	CTD	MESH:C015499	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of KLC4 mRNA]	PMID:31150632
1315239	KLC4	kinesin light chain 4	gene	CHEBI:16243	quercetin	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D011794	Quercetin results in decreased expression of KLC4 mRNA	PMID:21632981
1315239	KLC4	kinesin light chain 4	gene	CHEBI:16243	quercetin	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D011794	Quercetin results in increased expression of KLC4 mRNA	PMID:19729006
1315239	KLC4	kinesin light chain 4	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1550520	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of KLC4 mRNA	PMID:39241906
1315239	KLC4	kinesin light chain 4	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1550520	E	RGD:6480464	20260707	CTD	MESH:D008070	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of KLC4 mRNA]	PMID:39241906
1315239	KLC4	kinesin light chain 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:D004958	Estradiol results in decreased expression of KLC4 mRNA	PMID:31614463
1315239	KLC4	kinesin light chain 4	gene	CHEBI:16469	17beta-estradiol	decreases expression	ISO	RGD:1550520	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in decreased expression of KLC4 mRNA	PMID:39298647
1315239	KLC4	kinesin light chain 4	gene	CHEBI:16598	DDE	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D003633	Dichlorodiphenyl Dichloroethylene results in decreased expression of KLC4 mRNA	PMID:38568856
1315239	KLC4	kinesin light chain 4	gene	CHEBI:177802	Cuprizon	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D003471	[Cuprizone co-treated with Haloperidol] results in increased expression of KLC4 protein	PMID:34122009
1315239	KLC4	kinesin light chain 4	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of KLC4 protein	PMID:37730182
1315239	KLC4	kinesin light chain 4	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306555	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in increased expression of KLC4 mRNA	PMID:33387578
1315239	KLC4	kinesin light chain 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1550520	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of KLC4 mRNA	PMID:36331819
1315239	KLC4	kinesin light chain 4	gene	CHEBI:18721	3-chloropropane-1,2-diol	increases expression	ISO	RGD:1306555	E	RGD:6480464	20220705	CTD	MESH:D000517	alpha-Chlorohydrin results in increased expression of KLC4 protein	PMID:34915118
1315239	KLC4	kinesin light chain 4	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1550520	E	RGD:6480464	20231205	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLC4 mRNA	PMID:37325564
1315239	KLC4	kinesin light chain 4	gene	CHEBI:23414	copper(II) sulfate	decreases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in decreased expression of KLC4 mRNA	PMID:19549813
1315239	KLC4	kinesin light chain 4	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of KLC4 protein	PMID:23301498
1315239	KLC4	kinesin light chain 4	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of KLC4 protein	PMID:20106945
1315239	KLC4	kinesin light chain 4	gene	CHEBI:2504	aflatoxin B1	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D016604	Aflatoxin B1 results in decreased expression of KLC4 mRNA	PMID:22100608
1315239	KLC4	kinesin light chain 4	gene	CHEBI:27385	tetrachloromethane	decreases expression	ISO	RGD:1306555	E	RGD:6480464	20190910	CTD	MESH:D002251	Carbon Tetrachloride results in decreased expression of KLC4 mRNA	PMID:31150632
1315239	KLC4	kinesin light chain 4	gene	CHEBI:27385	tetrachloromethane	multiple interactions	ISO	RGD:1306555	E	RGD:6480464	20190910	CTD	MESH:D002251	schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of KLC4 mRNA]	PMID:31150632
1315239	KLC4	kinesin light chain 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1550520	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KLC4 mRNA	PMID:22206623
1315239	KLC4	kinesin light chain 4	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KLC4 gene	PMID:25304211
1315239	KLC4	kinesin light chain 4	gene	CHEBI:27732	caffeine	affects phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine affects the phosphorylation of KLC4 protein	PMID:35688186
1315239	KLC4	kinesin light chain 4	gene	CHEBI:27998	tungsten	decreases expression	ISO	RGD:1550520	E	RGD:6480464	20190910	CTD	MESH:D014414	Tungsten results in decreased expression of KLC4 mRNA	PMID:30912803
1315239	KLC4	kinesin light chain 4	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in decreased expression of KLC4 mRNA	PMID:25583101
1315239	KLC4	kinesin light chain 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306555	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of KLC4 mRNA	PMID:22298810
1315239	KLC4	kinesin light chain 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306555	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of KLC4 mRNA	PMID:21215274|PMID:32109520
1315239	KLC4	kinesin light chain 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306555	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of KLC4 mRNA	PMID:33387578
1315239	KLC4	kinesin light chain 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of KLC4 mRNA	PMID:33212167
1315239	KLC4	kinesin light chain 4	gene	CHEBI:28619	acrylamide	decreases expression	ISO	RGD:1306555	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in decreased expression of KLC4 mRNA	PMID:28959563
1315239	KLC4	kinesin light chain 4	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of KLC4 mRNA	PMID:29803840
1315239	KLC4	kinesin light chain 4	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of KLC4 exon	PMID:30157460
1315239	KLC4	kinesin light chain 4	gene	CHEBI:29865	benzo[a]pyrene	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in decreased expression of KLC4 mRNA	PMID:22316170|PMID:32234424
1315239	KLC4	kinesin light chain 4	gene	CHEBI:29865	benzo[a]pyrene	decreases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in decreased methylation of KLC4 5' UTR; Benzo(a)pyrene results in decreased methylation of KLC4 promoter	PMID:27901495
1315239	KLC4	kinesin light chain 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of KLC4 3' UTR	PMID:27901495
1315239	KLC4	kinesin light chain 4	gene	CHEBI:29866	arsenite(3-)	increases expression	ISO	RGD:1550520	E	RGD:6480464	20241105	CTD	MESH:C015001	arsenite results in increased expression of KLC4 protein	PMID:37955338
1315239	KLC4	kinesin light chain 4	gene	CHEBI:30563	silicon dioxide	decreases expression	EXP		E	RGD:6480464	20160315	CTD	MESH:D012822	Silicon Dioxide analog results in decreased expression of KLC4 mRNA	PMID:25895662
1315239	KLC4	kinesin light chain 4	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1306555	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of KLC4 mRNA	PMID:24136188
1315239	KLC4	kinesin light chain 4	gene	CHEBI:32161	sulfadimethoxine	decreases expression	ISO	RGD:1306555	E	RGD:6480464	20230606	CTD	MESH:D013412	Sulfadimethoxine results in decreased expression of KLC4 mRNA	PMID:30047161
1315239	KLC4	kinesin light chain 4	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306555	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of KLC4 mRNA	PMID:34492290
1315239	KLC4	kinesin light chain 4	gene	CHEBI:33216	bisphenol A	affects expression	EXP		E	RGD:6480464	20191112	CTD	MESH:C006780	bisphenol A affects the expression of KLC4 mRNA	PMID:30903817
1315239	KLC4	kinesin light chain 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C006780	bisphenol A results in decreased expression of KLC4 protein	PMID:31675489
1315239	KLC4	kinesin light chain 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306555	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of KLC4 mRNA	PMID:30816183|PMID:32528016|PMID:34947998
1315239	KLC4	kinesin light chain 4	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of KLC4 protein	PMID:37567409
1315239	KLC4	kinesin light chain 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306555	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of KLC4 mRNA	PMID:25181051
1315239	KLC4	kinesin light chain 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1550520	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of KLC4 mRNA	PMID:34585602
1315239	KLC4	kinesin light chain 4	gene	CHEBI:33217	3,3',5,5'-tetrabromobisphenol A	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C020806	tetrabromobisphenol A results in decreased expression of KLC4 protein	PMID:31675489
1315239	KLC4	kinesin light chain 4	gene	CHEBI:34317	3,3',4,4',5-pentachlorobiphenyl	decreases expression	ISO	RGD:1306555	E	RGD:6480464	20200609	CTD	MESH:C023035	3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of KLC4 mRNA	PMID:32119087
1315239	KLC4	kinesin light chain 4	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1550520	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of KLC4 mRNA	PMID:39298647
1315239	KLC4	kinesin light chain 4	gene	CHEBI:34761	fenthion	increases expression	ISO	RGD:1550520	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in increased expression of KLC4 mRNA	PMID:34813904
1315239	KLC4	kinesin light chain 4	gene	CHEBI:34911	permethrin	multiple interactions	ISO	RGD:1550520	E	RGD:6480464	20260707	CTD	MESH:D026023	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of KLC4 mRNA]	PMID:39241906
1315239	KLC4	kinesin light chain 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of KLC4 mRNA	PMID:37042841
1315239	KLC4	kinesin light chain 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of KLC4 mRNA	PMID:38568856
1315239	KLC4	kinesin light chain 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1550520	E	RGD:6480464	20231205	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of KLC4 mRNA	PMID:37325564
1315239	KLC4	kinesin light chain 4	gene	CHEBI:35842	antirheumatic drug	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in increased expression of KLC4 mRNA	PMID:24449571
1315239	KLC4	kinesin light chain 4	gene	CHEBI:3750	clofibrate	decreases expression	ISO	RGD:1550520	E	RGD:6480464	20120515	CTD	MESH:D002994	Clofibrate results in decreased expression of KLC4 mRNA	PMID:17585979
1315239	KLC4	kinesin light chain 4	gene	CHEBI:37825	p-toluidine	increases expression	ISO	RGD:1306555	E	RGD:6480464	20170516	CTD	MESH:C029370	4-toluidine results in increased expression of KLC4 mRNA	PMID:27638505
1315239	KLC4	kinesin light chain 4	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	EXP		E	RGD:6480464	20220111	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of KLC4 mRNA	PMID:32588087
1315239	KLC4	kinesin light chain 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1550520	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of KLC4 mRNA	PMID:36331819
1315239	KLC4	kinesin light chain 4	gene	CHEBI:4031	cyclosporin A	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D016572	Cyclosporine results in decreased expression of KLC4 mRNA	PMID:20106945|PMID:25562108
1315239	KLC4	kinesin light chain 4	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1550520	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of KLC4 mRNA	PMID:28973697
1315239	KLC4	kinesin light chain 4	gene	CHEBI:44658	okadaic acid	decreases expression	EXP		E	RGD:6480464	20250401	CTD	MESH:D019319	Okadaic Acid results in decreased expression of KLC4 mRNA	PMID:38832940
1315239	KLC4	kinesin light chain 4	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1550520	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of KLC4 mRNA	PMID:17562736
1315239	KLC4	kinesin light chain 4	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20121009	CTD	MESH:D000082	Acetaminophen results in decreased expression of KLC4 mRNA	PMID:22230336|PMID:29067470
1315239	KLC4	kinesin light chain 4	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306555	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of KLC4 mRNA	PMID:33387578
1315239	KLC4	kinesin light chain 4	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of KLC4 gene	PMID:25304211
1315239	KLC4	kinesin light chain 4	gene	CHEBI:47696	2,4,6-tribromophenol	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C004554	2,4,6-tribromophenol results in decreased expression of KLC4 mRNA	PMID:31675489
1315239	KLC4	kinesin light chain 4	gene	CHEBI:4918	O-methyleugenol	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:C005223	methyleugenol results in decreased expression of KLC4 mRNA	PMID:32234424
1315239	KLC4	kinesin light chain 4	gene	CHEBI:50594	carbon nanotube	decreases expression	ISO	RGD:1550520	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in decreased expression of KLC4 mRNA	PMID:25554681
1315239	KLC4	kinesin light chain 4	gene	CHEBI:50673	methimazole	decreases expression	ISO	RGD:1306555	E	RGD:6480464	20230606	CTD	MESH:D008713	Methimazole results in decreased expression of KLC4 mRNA	PMID:30047161
1315239	KLC4	kinesin light chain 4	gene	CHEBI:51081	nitrates	multiple interactions	ISO	RGD:1550520	E	RGD:6480464	20250204	CTD	MESH:D009566	[Particulate Matter results in increased abundance of Nitrates] which results in increased expression of KLC4 mRNA	PMID:35964746
1315239	KLC4	kinesin light chain 4	gene	CHEBI:5613	haloperidol	multiple interactions	EXP		E	RGD:6480464	20211207	CTD	MESH:D006220	[Cuprizone co-treated with Haloperidol] results in increased expression of KLC4 protein	PMID:34122009
1315239	KLC4	kinesin light chain 4	gene	CHEBI:6402	leflunomide	decreases expression	EXP		E	RGD:6480464	20180410	CTD	MESH:C045463	leflunomide results in decreased expression of KLC4 mRNA	PMID:28988120
1315239	KLC4	kinesin light chain 4	gene	CHEBI:73755	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:1550520	E	RGD:6480464	20200804	CTD	MESH:D019813	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of KLC4 mRNA	PMID:22206623
1315239	KLC4	kinesin light chain 4	gene	CHEBI:7553	niclosamide	increases expression	EXP		E	RGD:6480464	20230704	CTD	MESH:D009534	Niclosamide results in increased expression of KLC4 mRNA	PMID:36318118
1315239	KLC4	kinesin light chain 4	gene	CHEBI:7852	oxycodone	increases expression	ISO	RGD:1306555	E	RGD:6480464	20161025	CTD	MESH:D010098	Oxycodone results in increased expression of KLC4 mRNA	PMID:23439660
1315239	KLC4	kinesin light chain 4	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to KLC4 gene]	PMID:28238834
1315239	KLC4	kinesin light chain 4	gene	CHEBI:81584	2,2',4,4'-Tetrabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C511295	2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of KLC4 protein	PMID:31675489
1315239	KLC4	kinesin light chain 4	gene	CHEBI:82362	N-Nitrosopyrrolidine	decreases expression	EXP		E	RGD:6480464	20200714	CTD	MESH:D009242	N-Nitrosopyrrolidine results in decreased expression of KLC4 mRNA	PMID:32234424
1315239	KLC4	kinesin light chain 4	gene	CHEBI:82436	decabromodiphenyl ether	decreases expression	EXP		E	RGD:6480464	20220308	CTD	MESH:C010902	decabromobiphenyl ether results in decreased expression of KLC4 protein	PMID:31675489
1315239	KLC4	kinesin light chain 4	gene	CHEBI:84070	sodium arsenate	increases expression	ISO	RGD:1550520	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate results in increased expression of KLC4 mRNA	PMID:39847705
1315239	KLC4	kinesin light chain 4	gene	CHEBI:8502	6-propyl-2-thiouracil	decreases expression	ISO	RGD:1306555	E	RGD:6480464	20230606	CTD	MESH:D011441	Propylthiouracil results in decreased expression of KLC4 mRNA	PMID:30047161
1315239	KLC4	kinesin light chain 4	gene	CHEBI:8666	Pyridostigmine bromide	multiple interactions	ISO	RGD:1550520	E	RGD:6480464	20260707	CTD	MESH:D011729	[Pyridostigmine Bromide co-treated with Permethrin] inhibits the reaction [Lipopolysaccharides results in decreased expression of KLC4 mRNA]	PMID:39241906
1315239	KLC4	kinesin light chain 4	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306555	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of KLC4 mRNA	PMID:21346803
1315239	KLC4	kinesin light chain 4	gene	CHEBI:9516	thapsigargin	decreases expression	ISO	RGD:1306555	E	RGD:6480464	20221101	CTD	MESH:D019284	Thapsigargin results in decreased expression of KLC4 protein	PMID:35544339
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:10429	beta-lapachone	increases expression	EXP		E	RGD:6480464	20241001	CTD	MESH:C014638	beta-lapachone results in increased expression of HDHD5 mRNA	PMID:38218311
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of CECR5 mRNA	PMID:33167477
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:16412	lipopolysaccharide	decreases expression	ISO	RGD:1315243	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in decreased expression of HDHD5 mRNA	PMID:39241906
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:166473	Dibutyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C065087	di-n-butylphosphoric acid affects the expression of HDHD5 mRNA	PMID:37042841
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:23924	enzyme inhibitor	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:D004791	[Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HDHD5 protein	PMID:23301498
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:23994	ethyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140708	CTD	MESH:D005020	Ethyl Methanesulfonate results in decreased expression of HDHD5 mRNA	PMID:23649840
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:25255	methyl methanesulfonate	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D008741	Methyl Methanesulfonate results in decreased expression of HDHD5 mRNA	PMID:23649840
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:27086	tributylstannane	multiple interactions	ISO	RGD:1306557	E	RGD:6480464	20191112	CTD	MESH:C011559	[bisphenol A co-treated with tributyltin] results in increased expression of HDHD5 mRNA	PMID:31129395
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315243	E	RGD:6480464	20241105	CTD	MESH:D005492	Folic Acid results in decreased expression of CECR5 mRNA	PMID:25629700
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:27563	arsenic atom	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HDHD5 gene	PMID:25304211
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306557	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of HDHD5 mRNA	PMID:31881176
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:28201	rotenone	decreases expression	EXP		E	RGD:6480464	20250708	CTD	MESH:D012402	Rotenone results in decreased expression of HDHD5 protein	PMID:39603559
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of HDHD5 mRNA	PMID:29803840
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of HDHD5 mRNA	PMID:38568856
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20211012	CTD	MESH:C017947	sodium arsenite results in increased expression of HDHD5 mRNA	PMID:34032870
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of CECR5 promoter	PMID:27901495
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315243	E	RGD:6480464	20241105	CTD	MESH:C009495	titanium dioxide results in decreased methylation of CECR5 gene; titanium dioxide results in decreased methylation of CECR5 promoter	PMID:35295148
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:32509	pirinixic acid	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C006253	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HDHD5 mRNA	PMID:19710929
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20240206	CTD	MESH:C006780	bisphenol A results in increased expression of HDHD5 protein	PMID:37567409
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306557	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of HDHD5 mRNA	PMID:25181051
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1315243	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of HDHD5 mRNA	PMID:33221593
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:33216	bisphenol A	multiple interactions	ISO	RGD:1306557	E	RGD:6480464	20191112	CTD	MESH:C006780	[bisphenol A co-treated with tributyltin] results in increased expression of HDHD5 mRNA	PMID:31129395
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:34581	Bisphenol B	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C492482	bisphenol B results in increased expression of HDHD5 protein	PMID:34186270
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of HDHD5 mRNA	PMID:25979313
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315243	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of HDHD5 mRNA	PMID:17963808
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:46053	2,4,6-trinitrotoluene	affects expression	ISO	RGD:1306557	E	RGD:6480464	20120412	CTD	MESH:D014303	Trinitrotoluene affects the expression of HDHD5 mRNA	PMID:21346803
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20120918	CTD	MESH:D000082	Acetaminophen results in decreased expression of HDHD5 mRNA	PMID:21420995
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306557	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of HDHD5 mRNA	PMID:33387578
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:47217	arsane	affects methylation	EXP		E	RGD:6480464	20150310	CTD	MESH:D001151	Arsenic affects the methylation of HDHD5 gene	PMID:25304211
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of HDHD5 protein	PMID:32959892
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:72564	temozolomide	increases expression	EXP		E	RGD:6480464	20210706	CTD	MESH:C047246	Temozolomide results in increased expression of HDHD5 mRNA	PMID:31758290
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of HDHD5 protein	PMID:34186270
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315243	E	RGD:6480464	20241105	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of CECR5 mRNA	PMID:22206623
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to CECR5 gene]	PMID:28238834
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:84070	sodium arsenate	decreases expression	EXP		E	RGD:6480464	20250902	CTD	MESH:C009277	sodium arsenate results in decreased expression of HDHD5 protein	PMID:38348393
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306557	E	RGD:6480464	20120412	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of HDHD5 mRNA	PMID:21346803
1315242	HDHD5	haloacid dehalogenase like hydrolase domain containing 5	gene	CHEBI:9495	thiram	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D013893	Thiram results in decreased expression of HDHD5 mRNA	PMID:38568856
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:132267	triptonide	decreases expression	ISO	RGD:1315245	E	RGD:6480464	20210406	CTD	MESH:C084079	triptonide results in decreased expression of MRPS9 mRNA	PMID:33045310
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:15354	choline	multiple interactions	ISO	RGD:1315245	E	RGD:6480464	20121113	CTD	MESH:D002794	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MRPS9 gene	PMID:20938992
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of MRPS9 mRNA	PMID:33167477
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315245	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of MRPS9 mRNA	PMID:39241906
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:16602	trichloroethene	increases methylation	ISO	RGD:1306558	E	RGD:6480464	20170110	CTD	MESH:D014241	Trichloroethylene results in increased methylation of MRPS9 gene	PMID:27618143
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:16643	L-methionine	multiple interactions	ISO	RGD:1315245	E	RGD:6480464	20121113	CTD	MESH:D008715	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MRPS9 gene	PMID:20938992
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306558	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of MRPS9 mRNA	PMID:22061828
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:18291	manganese atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPS9 mRNA	PMID:39836092
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:27470	folic acid	decreases expression	ISO	RGD:1315245	E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in decreased expression of MRPS9 mRNA	PMID:25629700
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315245	E	RGD:6480464	20121113	CTD	MESH:D005492	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MRPS9 gene	PMID:20938992
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:27563	arsenic atom	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPS9 mRNA	PMID:39836092
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315245	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS9 mRNA	PMID:40504410
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:27744	glyphosate	affects methylation	ISO	RGD:1306558	E	RGD:6480464	20240206	CTD	MESH:C010974	Glyphosate affects the methylation of MRPS9 gene	PMID:35440735
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:27856	acetamide	decreases expression	ISO	RGD:1306558	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in decreased expression of MRPS9 mRNA	PMID:31881176
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in increased expression of MRPS9 mRNA	PMID:23557933
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315245	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of MRPS9 mRNA	PMID:21570461
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306558	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of MRPS9 mRNA	PMID:21215274
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:28201	rotenone	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D012402	Rotenone results in increased expression of MRPS9 mRNA	PMID:18191903
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of MRPS9 mRNA	PMID:38568856
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:29678	sodium arsenite	increases expression	ISO	RGD:1315245	E	RGD:6480464	20190409	CTD	MESH:C017947	sodium arsenite results in increased expression of MRPS9 protein	PMID:29044176
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:29678	sodium arsenite	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C017947	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPS9 mRNA	PMID:39836092
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315245	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS9 mRNA	PMID:40504410
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of MRPS9 promoter	PMID:27901495
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:29866	arsenite(3-)	multiple interactions	EXP		E	RGD:6480464	20220405	CTD	MESH:C015001	arsenite promotes the reaction [G3BP1 protein binds to MRPS9 mRNA]	PMID:32406909
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:31604	ferric ammonium citrate	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:C013531	ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of MRPS9 protein]	PMID:19515424
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:31638	fulvestrant	decreases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C070081	Fulvestrant results in decreased methylation of MRPS9 gene	PMID:31601247
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:31941	oxaliplatin	multiple interactions	ISO	RGD:1306558	E	RGD:6480464	20161213	CTD	MESH:C030110	[oxaliplatin co-treated with Topotecan] results in decreased expression of MRPS9 mRNA	PMID:25729387
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315245	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of MRPS9 gene	PMID:35295148
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315245	E	RGD:6480464	20120412	CTD	MESH:C006253	pirinixic acid results in increased expression of MRPS9 mRNA	PMID:18301758
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306558	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of MRPS9 mRNA	PMID:25181051|PMID:30816183|PMID:32528016|PMID:41034487
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:34575	bisphenol F	increases expression	EXP		E	RGD:6480464	20230307	CTD	MESH:C008745	bisphenol F results in increased expression of MRPS9 protein	PMID:34186270
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:34761	fenthion	decreases expression	ISO	RGD:1315245	E	RGD:6480464	20220607	CTD	MESH:D005284	Fenthion results in decreased expression of MRPS9 mRNA	PMID:34813904
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:34837	methidathion	decreases expression	ISO	RGD:1315245	E	RGD:6480464	20220607	CTD	MESH:C005828	methidathion results in decreased expression of MRPS9 mRNA	PMID:34813904
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of MRPS9 mRNA	PMID:37042841
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:35154	manganese(0)	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D008345	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPS9 mRNA	PMID:39836092
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:35456	cadmium dichloride	increases expression	EXP		E	RGD:6480464	20150310	CTD	MESH:D019256	Cadmium Chloride results in increased expression of MRPS9 protein	PMID:24527689
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of MRPS9 mRNA	PMID:25979313
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:4356	desferrioxamine B	increases expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D003676	Deferoxamine results in increased expression of MRPS9 protein	PMID:19515424
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:4356	desferrioxamine B	multiple interactions	EXP		E	RGD:6480464	20120412	CTD	MESH:D003676	ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of MRPS9 protein]	PMID:19515424
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:46195	paracetamol	decreases expression	EXP		E	RGD:6480464	20150825	CTD	MESH:D000082	Acetaminophen results in decreased expression of MRPS9 mRNA	PMID:25704631|PMID:29067470
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:46195	paracetamol	increases expression	EXP		E	RGD:6480464	20191008	CTD	MESH:D000082	Acetaminophen results in increased expression of MRPS9 mRNA	PMID:31059760
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:47217	arsane	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:D001151	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPS9 mRNA	PMID:39836092
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:47217	arsane	multiple interactions	ISO	RGD:1315245	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MRPS9 mRNA	PMID:40504410
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:49662	indometacin	decreases expression	ISO	RGD:1306558	E	RGD:6480464	20230704	CTD	MESH:D007213	Indomethacin results in decreased expression of MRPS9 mRNA	PMID:36868495
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:5062	finasteride	increases expression	ISO	RGD:1306558	E	RGD:6480464	20160412	CTD	MESH:D018120	Finasteride results in increased expression of MRPS9 mRNA	PMID:24136188
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:50686	atorvastatin calcium	decreases expression	ISO	RGD:1315245	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in decreased expression of MRPS9 mRNA	PMID:40234311
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:5132	flutamide	increases expression	ISO	RGD:1306558	E	RGD:6480464	20160412	CTD	MESH:D005485	Flutamide results in increased expression of MRPS9 mRNA	PMID:24136188
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:6078	ivermectin	decreases expression	EXP		E	RGD:6480464	20210907	CTD	MESH:D007559	Ivermectin results in decreased expression of MRPS9 protein	PMID:32959892
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:63041	manganese(II) chloride	multiple interactions	EXP		E	RGD:6480464	20250311	CTD	MESH:C025340	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of MRPS9 mRNA	PMID:39836092
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:63632	topotecan	multiple interactions	ISO	RGD:1306558	E	RGD:6480464	20160315	CTD	MESH:D019772	[oxaliplatin co-treated with Topotecan] results in decreased expression of MRPS9 mRNA	PMID:25729387
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:63921	2-butoxyethanol	decreases expression	ISO	RGD:1315245	E	RGD:6480464	20120412	CTD	MESH:C017096	n-butoxyethanol results in decreased expression of MRPS9 mRNA	PMID:19812364
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:72754	bisphenol AF	increases expression	EXP		E	RGD:6480464	20250114	CTD	MESH:C583074	bisphenol AF results in increased expression of MRPS9 protein	PMID:34186270
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:7494	nefazodone	increases expression	ISO	RGD:1306558	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in increased expression of MRPS9 mRNA	PMID:24136188
1315244	MRPS9	mitochondrial ribosomal protein S9	gene	CHEBI:9352	sulindac	increases expression	ISO	RGD:1306558	E	RGD:6480464	20160412	CTD	MESH:D013467	Sulindac results in increased expression of MRPS9 mRNA	PMID:24136188
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:D014212	Tretinoin results in decreased expression of IL17RA mRNA	PMID:33167477
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1306559	E	RGD:6480464	20220510	CTD	MESH:D010100	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of IL17RA mRNA	PMID:33729688
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20190312	CTD	MESH:D010100	[NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of IL17RA mRNA	PMID:30529165
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:15551	prostaglandin E2	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20121113	CTD	MESH:D015232	IL17RA gene mutant form inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone]	PMID:22359662
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:15600	(+)-catechin	multiple interactions	EXP		E	RGD:6480464	20141014	CTD	MESH:D002392	[Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of IL17RA mRNA	PMID:24763279
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315247	E	RGD:6480464	20260602	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of IL17RA protein	PMID:40852845
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20260602	CTD	MESH:D008070	CDKN1A protein affects the reaction [Lipopolysaccharides results in increased expression of IL17RA protein]	PMID:40852845
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1315247	E	RGD:6480464	20120412	CTD	MESH:D004958	Estradiol affects the expression of IL17RA mRNA	PMID:15598610
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:16716	benzene	decreases expression	ISO	RGD:1315247	E	RGD:6480464	20120918	CTD	MESH:D001554	Benzene results in decreased expression of IL17RA mRNA	PMID:15120971|PMID:15122651
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:17234	glucose	increases expression	ISO	RGD:1315247	E	RGD:6480464	20130122	CTD	MESH:D005947	Glucose results in increased expression of IL17RA mRNA	PMID:18310510
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20131220	CTD	MESH:D013739	Testosterone results in increased expression of IL17R mRNA	PMID:21592394
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:17347	testosterone	multiple interactions	EXP		E	RGD:6480464	20131220	CTD	MESH:D013739	[Testosterone co-treated with Calcitriol] results in increased expression of IL17R mRNA	PMID:21592394
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:17634	D-glucose	increases expression	ISO	RGD:1315247	E	RGD:6480464	20130122	CTD	MESH:D005947	Glucose results in increased expression of IL17RA mRNA	PMID:18310510
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:178012	FR900359	increases phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 results in increased phosphorylation of IL17RA protein	PMID:37730182
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:17823	calcitriol	increases expression	EXP		E	RGD:6480464	20131220	CTD	MESH:D002117	Calcitriol results in increased expression of IL17R mRNA	PMID:21592394
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:17823	calcitriol	multiple interactions	EXP		E	RGD:6480464	20131220	CTD	MESH:D002117	[Testosterone co-treated with Calcitriol] results in increased expression of IL17R mRNA	PMID:21592394
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:17833	gentamycin	increases expression	ISO	RGD:1306559	E	RGD:6480464	20161228	CTD	MESH:D005839	Gentamicins results in increased expression of IL17R mRNA	PMID:22061828
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IL17RA mRNA	PMID:36331819
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:22977	cadmium atom	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20260203	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL17RA mRNA	PMID:40850461
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:23414	copper(II) sulfate	increases expression	EXP		E	RGD:6480464	20120814	CTD	MESH:D019327	Copper Sulfate results in increased expression of IL17RA mRNA	PMID:19549813
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:2504	aflatoxin B1	increases methylation	EXP		E	RGD:6480464	20161025	CTD	MESH:D016604	Aflatoxin B1 results in increased methylation of IL17RA gene	PMID:27153756
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:254496	7,12-dimethyltetraphene	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20121113	CTD	MESH:D015127	IL17RA results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate]	PMID:22359662
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1306559	E	RGD:6480464	20221004	CTD	MESH:D010126	Ozone results in decreased expression of IL17RA mRNA	PMID:35737395
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:25812	ozone	multiple interactions	EXP		E	RGD:6480464	20231031	CTD	MESH:D010126	[Air Pollutants results in increased abundance of Ozone] which affects the expression of IL17RA mRNA	PMID:35430440
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of IL17RA mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of IL17RA mRNA	PMID:34911549
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:27843	cyanidin cation	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20200714	CTD	MESH:C017154	cyanidin inhibits the reaction [[IL17A protein co-treated with Freund's Adjuvant] results in increased expression of IL17RA mRNA]; cyanidin inhibits the reaction [[IL17A protein co-treated with Freund's Adjuvant] results in increased expression of IL17RA protein]	PMID:32044269
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:28112	nickel atom	decreases expression	EXP		E	RGD:6480464	20150609	CTD	MESH:D009532	Nickel results in decreased expression of IL17RA mRNA	PMID:23195993
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:28112	nickel atom	increases expression	EXP		E	RGD:6480464	20151110	CTD	MESH:D009532	Nickel results in increased expression of IL17RA mRNA	PMID:24768652|PMID:25583101
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1306559	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of IL17RA mRNA	PMID:22298810
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306559	E	RGD:6480464	20120918	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of IL17RA mRNA	PMID:21215274
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306559	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of IL17RA mRNA	PMID:34747641
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20150825	CTD	MESH:D013749	[TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of IL17RA mRNA	PMID:25975270
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of IL17RA mRNA	PMID:33212167
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of IL17RA mRNA	PMID:30851411
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:28619	acrylamide	increases expression	EXP		E	RGD:6480464	20210406	CTD	MESH:D020106	Acrylamide results in increased expression of IL17RA mRNA	PMID:32763439
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:28741	sodium fluoride	increases expression	ISO	RGD:1315247	E	RGD:6480464	20190219	CTD	MESH:D012969	Sodium Fluoride results in increased expression of IL17RA mRNA; Sodium Fluoride results in increased expression of IL17RA protein	PMID:30225638
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:28748	doxorubicin	decreases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in decreased expression of IL17RA mRNA	PMID:29803840
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in increased expression of IL17RA mRNA	PMID:38568856
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of IL17RA promoter	PMID:27901495
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:30563	silicon dioxide	increases expression	ISO	RGD:1306559	E	RGD:6480464	20120412	CTD	MESH:D012822	Silicon Dioxide results in increased expression of IL17RA mRNA	PMID:21602193|PMID:32721576
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:30563	silicon dioxide	increases response to substance	ISO	RGD:1315247	E	RGD:6480464	20131220	CTD	MESH:D012822	IL17R results in increased susceptibility to Silicon Dioxide	PMID:20421647
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:30563	silicon dioxide	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20131220	CTD	MESH:D012822	IL17R protein affects the reaction [Silicon Dioxide results in increased activity of MPO protein]; IL17R protein affects the reaction [Silicon Dioxide results in increased expression of CXCL1 protein]; IL17R protein affects the reaction [Silicon Dioxide results in increased expression of CXCL2 protein]; IL17R protein affects the reaction [Silicon Dioxide results in increased expression of IL1B protein]; IL17R protein affects the reaction [Silicon Dioxide results in increased expression of IL6 protein]	PMID:20421647
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:32234	titanium dioxide	decreases methylation	ISO	RGD:1315247	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in decreased methylation of IL17RA gene	PMID:35295148
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315247	E	RGD:6480464	20180220	CTD	MESH:C009495	titanium dioxide results in increased expression of IL17RA mRNA	PMID:27760801
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:32497	thioacetamide	increases expression	ISO	RGD:1306559	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in increased expression of IL17RA mRNA	PMID:34492290
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:33083	fluoranthene	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20170725	CTD	MESH:C007738	[1-methylanthracene co-treated with fluoranthene] results in increased expression of IL17RA mRNA	PMID:28329830
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:33128	C60 fullerene	increases expression	ISO	RGD:1306559	E	RGD:6480464	20120717	CTD	MESH:C069837	fullerene C60 results in increased expression of IL17RA mRNA	PMID:19167457
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306559	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in increased expression of IL17RA mRNA	PMID:25181051
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1315247	E	RGD:6480464	20250311	CTD	MESH:C543008	bisphenol S results in decreased expression of IL17RA mRNA	PMID:39298647
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:34372	4,4'-sulfonyldiphenol	increases methylation	EXP		E	RGD:6480464	20220308	CTD	MESH:C543008	bisphenol S results in increased methylation of IL17RA gene	PMID:31601247
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:34595	Butylbenzyl phthalate	increases expression	ISO	RGD:1315247	E	RGD:6480464	20250311	CTD	MESH:C027561	butylbenzyl phthalate results in increased expression of IL17R mRNA	PMID:32308655
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:34595	Butylbenzyl phthalate	increases methylation	ISO	RGD:1315247	E	RGD:6480464	20250805	CTD	MESH:C027561	butylbenzyl phthalate results in increased methylation of IL17RA promoter	PMID:28392331
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1315247	E	RGD:6480464	20121113	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of IL17RA mRNA	PMID:17361019
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of IL17RA mRNA	PMID:37042841
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:35456	cadmium dichloride	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20260203	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of IL17RA mRNA	PMID:40850461
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:35591	pregnenolone 16alpha-carbonitrile	increases expression	ISO	RGD:1315247	E	RGD:6480464	20171114	CTD	MESH:D011285	Pregnenolone Carbonitrile results in increased expression of IL17RA mRNA	PMID:28903501
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of IL17RA mRNA	PMID:24449571
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	decreases response to substance	ISO	RGD:1315247	E	RGD:6480464	20121113	CTD	MESH:D013755	IL17RA gene mutant form results in decreased susceptibility to Tetradecanoylphorbol Acetate	PMID:22359662
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:37537	phorbol 13-acetate 12-myristate	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20121113	CTD	MESH:D013755	[IL17RA gene mutant form results in decreased susceptibility to Tetradecanoylphorbol Acetate] which results in decreased expression of IL1B protein; [IL17RA gene mutant form results in decreased susceptibility to Tetradecanoylphorbol Acetate] which results in decreased expression of TNF protein; IL17RA gene mutant form inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein] which results in increased abundance of Dinoprostone]; IL17RA gene mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CXCL10 mRNA]; IL17RA gene mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CXCL16 mRNA]; IL17RA gene mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CXCL9 mRNA]; IL17RA gene mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CXCL1 mRNA]; IL17RA gene mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]; IL17RA gene mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of S100A8 mRNA]; IL17RA gene mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of S100A9 mRNA]; IL17RA gene mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of S100A9 protein]; IL17RA results in increased susceptibility to [9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate]	PMID:22359662
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1315247	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of IL17RA mRNA	PMID:40194260
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:38940	sunitinib	decreases expression	EXP		E	RGD:6480464	20191210	CTD	MESH:C473478	Sunitinib results in decreased expression of IL17RA mRNA	PMID:31533062
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:39163	acetamiprid	increases expression	ISO	RGD:1315247	E	RGD:6480464	20260707	CTD	MESH:C464485	acetamiprid results in increased expression of IL17RA mRNA	PMID:39529242
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of IL17RA mRNA	PMID:36331819
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:39478	buta-1,3-diene	decreases expression	ISO	RGD:1315247	E	RGD:6480464	20180703	CTD	MESH:C031763	1,3-butadiene results in decreased expression of IL17RA mRNA	PMID:29038090
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:39867	valproic acid	increases expression	EXP		E	RGD:6480464	20160119	CTD	MESH:D014635	Valproic Acid results in increased expression of IL17RA mRNA	PMID:23179753|PMID:26272509
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of IL17RA gene	PMID:29154799
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:39867	valproic acid	multiple interactions	EXP		E	RGD:6480464	20161025	CTD	MESH:D014635	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL17RA mRNA	PMID:27188386
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:4031	cyclosporin A	increases expression	ISO	RGD:1315247	E	RGD:6480464	20140114	CTD	MESH:D016572	Cyclosporine results in increased expression of IL17RA mRNA	PMID:23958496
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:41774	tamoxifen	affects expression	ISO	RGD:1315247	E	RGD:6480464	20120412	CTD	MESH:D013629	Tamoxifen affects the expression of IL17RA mRNA	PMID:20937368
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:41774	tamoxifen	increases expression	ISO	RGD:1315247	E	RGD:6480464	20141223	CTD	MESH:D013629	Tamoxifen results in increased expression of IL17RA mRNA	PMID:25123088
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:42588	4-hydroxyphenyl retinamide	increases expression	ISO	RGD:1315247	E	RGD:6480464	20180220	CTD	MESH:D017313	Fenretinide results in increased expression of IL17RA mRNA	PMID:28973697
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:42758	aldehydo-D-glucose	increases expression	ISO	RGD:1315247	E	RGD:6480464	20140304	CTD	MESH:D005947	Glucose results in increased expression of IL17RA mRNA	PMID:18310510
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:46195	paracetamol	affects expression	ISO	RGD:1315247	E	RGD:6480464	20120412	CTD	MESH:D000082	Acetaminophen affects the expression of IL17RA mRNA	PMID:17562736
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:46195	paracetamol	increases expression	ISO	RGD:1306559	E	RGD:6480464	20211207	CTD	MESH:D000082	Acetaminophen results in increased expression of IL17RA mRNA	PMID:33387578
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:4791	endosulfan	increases expression	ISO	RGD:1306559	E	RGD:6480464	20180828	CTD	MESH:D004726	Endosulfan results in increased expression of IL17RA mRNA	PMID:29391264
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:48843	disodium selenite	increases expression	EXP		E	RGD:6480464	20131220	CTD	MESH:D018038	Sodium Selenite results in increased expression of IL17R mRNA	PMID:18175754
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:4903	17alpha-ethynylestradiol	increases expression	ISO	RGD:1315247	E	RGD:6480464	20120412	CTD	MESH:D004997	Ethinyl Estradiol results in increased expression of IL17RA mRNA	PMID:12072388|PMID:36329302
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:50594	carbon nanotube	increases expression	ISO	RGD:1315247	E	RGD:6480464	20161228	CTD	MESH:D037742	Nanotubes, Carbon analog results in increased expression of IL17RA mRNA; Nanotubes, Carbon results in increased expression of IL17RA mRNA	PMID:25554681|PMID:25620056
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:50686	atorvastatin calcium	increases expression	ISO	RGD:1315247	E	RGD:6480464	20260505	CTD	MESH:D000069059	Atorvastatin results in increased expression of IL17RA mRNA	PMID:40234311
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:5870	imidacloprid	increases expression	ISO	RGD:1315247	E	RGD:6480464	20260707	CTD	MESH:C082359	imidacloprid results in increased expression of IL17RA mRNA	PMID:38701926
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:61057	tacrolimus hydrate	increases expression	ISO	RGD:1315247	E	RGD:6480464	20140114	CTD	MESH:D016559	Tacrolimus results in increased expression of IL17RA mRNA	PMID:23958496
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:6925	microcystin-LR	increases expression	ISO	RGD:1315247	E	RGD:6480464	20231031	CTD	MESH:C057862	cyanoginosin LR results in increased expression of IL17RA mRNA	PMID:37342990
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:73755	1,2-dimethylhydrazine	increases expression	ISO	RGD:1315247	E	RGD:6480464	20200804	CTD	MESH:D019813	1,2-Dimethylhydrazine results in increased expression of IL17RA mRNA	PMID:22206623
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:7494	nefazodone	decreases expression	ISO	RGD:1306559	E	RGD:6480464	20160412	CTD	MESH:C051752	nefazodone results in decreased expression of IL17RA mRNA	PMID:24136188
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:78320	2-hydroxypropanoic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of IL17RA mRNA	PMID:30851411
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:78510	dorsomorphin	multiple interactions	EXP		E	RGD:6480464	20161228	CTD	MESH:C516138	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL17RA mRNA	PMID:27188386
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:84070	sodium arsenate	affects expression	ISO	RGD:1315247	E	RGD:6480464	20251007	CTD	MESH:C009277	sodium arsenate affects the expression of IL17RA mRNA	PMID:39847705
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:91108	SB 431542	multiple interactions	EXP		E	RGD:6480464	20161220	CTD	MESH:C459179	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of IL17RA mRNA	PMID:27188386
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:9195	Soman	increases expression	ISO	RGD:1306559	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in increased expression of IL17R mRNA	PMID:19281266
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:920	2,4-dinitrotoluene	affects expression	ISO	RGD:1306559	E	RGD:6480464	20131220	CTD	MESH:C016403	2,4-dinitrotoluene affects the expression of IL17R mRNA	PMID:21346803
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:9546	thimerosal	decreases expression	EXP		E	RGD:6480464	20161025	CTD	MESH:D013849	Thimerosal results in decreased expression of IL17RA mRNA	PMID:27188386
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:9763	trovafloxacin	multiple interactions	ISO	RGD:1315247	E	RGD:6480464	20170303	CTD	MESH:C080163	[trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of IL17RA mRNA	PMID:18930950
1315246	IL17RA	interleukin 17 receptor A	gene	CHEBI:9986	vinclozolin	affects expression	ISO	RGD:1306559	E	RGD:6480464	20141111	CTD	MESH:C025643	vinclozolin affects the expression of IL17R mRNA	PMID:19015723
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:15379	dioxygen	multiple interactions	ISO	RGD:1315249	E	RGD:6480464	20190312	CTD	MESH:D010100	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of REM1 mRNA	PMID:30529165
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:16412	lipopolysaccharide	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D008070	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of REM1 mRNA	PMID:35811015
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:16602	trichloroethene	increases expression	ISO	RGD:1306560	E	RGD:6480464	20211207	CTD	MESH:D014241	Trichloroethylene results in increased expression of REM1 mRNA	PMID:33387578
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:17234	glucose	multiple interactions	ISO	RGD:1315249	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of REM1 mRNA	PMID:37992649
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:17634	D-glucose	multiple interactions	ISO	RGD:1315249	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of REM1 mRNA	PMID:37992649
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in decreased expression of REM1 mRNA	PMID:31163220
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of REM1 protein	PMID:31163220
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:2504	aflatoxin B1	increases expression	ISO	RGD:1306560	E	RGD:6480464	20210309	CTD	MESH:D016604	Aflatoxin B1 results in increased expression of REM1 mRNA	PMID:33354967
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315249	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of REM1 mRNA	PMID:34911549
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:27470	folic acid	increases expression	EXP		E	RGD:6480464	20200804	CTD	MESH:D005492	Folic Acid results in increased expression of REM1 mRNA	PMID:21867686
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306560	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of REM1 mRNA	PMID:31881176
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20220510	CTD	MESH:C059514	[Plant Extracts co-treated with Resveratrol] results in decreased expression of REM1 mRNA	PMID:23557933
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315249	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of REM1 mRNA	PMID:21570461
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1306560	E	RGD:6480464	20200609	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in decreased expression of REM1 mRNA	PMID:32109520
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306560	E	RGD:6480464	20211207	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of REM1 mRNA	PMID:33387578|PMID:34747641
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:28757	fructose	multiple interactions	ISO	RGD:1315249	E	RGD:6480464	20260707	CTD	MESH:D005632	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of REM1 mRNA	PMID:37992649
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:29678	sodium arsenite	decreases expression	ISO	RGD:1315249	E	RGD:6480464	20240206	CTD	MESH:C017947	sodium arsenite results in decreased expression of REM1 mRNA	PMID:37682722
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:C017947	sodium arsenite results in increased expression of REM1 mRNA	PMID:25879800
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:29865	benzo[a]pyrene	affects methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene affects the methylation of REM1 promoter	PMID:27901495
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:29865	benzo[a]pyrene	increases expression	ISO	RGD:1315249	E	RGD:6480464	20120918	CTD	MESH:D001564	Benzo(a)pyrene results in increased expression of REM1 mRNA	PMID:22228805
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of REM1 5' UTR	PMID:27901495
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:32234	titanium dioxide	increases expression	ISO	RGD:1315249	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased expression of REM1 mRNA	PMID:35295148
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315249	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of REM1 gene	PMID:35295148
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306560	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A results in decreased expression of REM1 mRNA	PMID:25181051
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:33216	bisphenol A	increases expression	EXP		E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of REM1 protein	PMID:33376534
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306560	E	RGD:6480464	20220208	CTD	MESH:C006780	bisphenol A results in increased expression of REM1 mRNA	PMID:34947998
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:34575	bisphenol F	decreases expression	ISO	RGD:1315249	E	RGD:6480464	20241105	CTD	MESH:C008745	bisphenol F results in decreased expression of REM1 mRNA	PMID:38685157
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:34687	dibutyl phthalate	increases expression	ISO	RGD:1306560	E	RGD:6480464	20120412	CTD	MESH:D003993	Dibutyl Phthalate results in increased expression of REM1 mRNA	PMID:21266533
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:35456	cadmium dichloride	decreases expression	ISO	RGD:1306560	E	RGD:6480464	20210504	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of REM1 mRNA	PMID:33453195
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:38397	perfluorononanoic acid	decreases expression	ISO	RGD:1315249	E	RGD:6480464	20260113	CTD	MESH:C101816	perfluoro-n-nonanoic acid results in decreased expression of REM1 mRNA	PMID:40194260
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:42758	aldehydo-D-glucose	multiple interactions	ISO	RGD:1315249	E	RGD:6480464	20260707	CTD	MESH:D005947	[Glucose co-treated with Fructose co-treated with Dietary Fats co-treated with Dietary Sucrose] results in increased expression of REM1 mRNA	PMID:37992649
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:46650	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:C039961	[S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of REM1 mRNA	PMID:35811015
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:47807	sulforaphane	multiple interactions	ISO	RGD:1315249	E	RGD:6480464	20190312	CTD	MESH:C016766	[sulforaphane affects the susceptibility to Oxygen] which affects the expression of REM1 mRNA	PMID:30529165
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:5014	fenvalerate	increases expression	ISO	RGD:1306560	E	RGD:6480464	20201103	CTD	MESH:C017690	fenvalerate results in increased expression of REM1 mRNA	PMID:30307764
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:63933	Aroclor 1254	increases expression	ISO	RGD:1315249	E	RGD:6480464	20131210	CTD	MESH:D020111	Chlorodiphenyl (54% Chlorine) results in increased expression of REM1 mRNA	PMID:23650126
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:75455	2-palmitoylglycerol	increases expression	EXP		E	RGD:6480464	20240109	CTD	MESH:C114956	2-palmitoylglycerol results in increased expression of REM1 mRNA	PMID:37199045
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:79994	CGP 52608	multiple interactions	EXP		E	RGD:6480464	20220607	CTD	MESH:C092451	CGP 52608 promotes the reaction [RORA protein binds to REM1 gene]	PMID:28238834
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:8502	6-propyl-2-thiouracil	increases expression	ISO	RGD:1306560	E	RGD:6480464	20150310	CTD	MESH:D011441	Propylthiouracil results in increased expression of REM1 mRNA	PMID:24780913
1315248	REM1	RRAD and GEM like GTPase 1	gene	CHEBI:9195	Soman	decreases expression	ISO	RGD:1306560	E	RGD:6480464	20141111	CTD	MESH:D012999	Soman results in decreased expression of REM1 mRNA	PMID:19281266
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:15367	all-trans-retinoic acid	decreases expression	EXP		E	RGD:6480464	20140408	CTD	MESH:D014212	Tretinoin results in decreased expression of REEP4 mRNA	PMID:23724009|PMID:33167477
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:15443	inulin	multiple interactions	ISO	RGD:1315251	E	RGD:6480464	20230502	CTD	MESH:D007444	[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of REEP4 mRNA	PMID:36331819
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:15930	atrazine	increases expression	EXP		E	RGD:6480464	20141014	CTD	MESH:D001280	Atrazine results in increased expression of REEP4 mRNA	PMID:22378314
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:16240	hydrogen peroxide	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D006861	Hydrogen Peroxide affects the expression of REEP4 mRNA	PMID:23410634
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:16412	lipopolysaccharide	increases expression	ISO	RGD:1315251	E	RGD:6480464	20260707	CTD	MESH:D008070	Lipopolysaccharides results in increased expression of REEP4 mRNA	PMID:39241906
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:16469	17beta-estradiol	affects expression	ISO	RGD:1306561	E	RGD:6480464	20230606	CTD	MESH:D004958	Estradiol affects the expression of REEP4 mRNA	PMID:32145629
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:16469	17beta-estradiol	increases expression	ISO	RGD:1315251	E	RGD:6480464	20250311	CTD	MESH:D004958	Estradiol results in increased expression of REEP4 mRNA	PMID:39298647
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:17347	testosterone	increases expression	EXP		E	RGD:6480464	20211109	CTD	MESH:D013739	Testosterone results in increased expression of REEP4 mRNA	PMID:33359661
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:17747	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1315251	E	RGD:6480464	20250204	CTD	MESH:D004051	Diethylhexyl Phthalate results in increased expression of REEP4 mRNA	PMID:34319233
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:177802	Cuprizon	increases expression	ISO	RGD:1306561	E	RGD:6480464	20210907	CTD	MESH:D003471	Cuprizone results in increased expression of REEP4 mRNA	PMID:26577399
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:178012	FR900359	affects phosphorylation	EXP		E	RGD:6480464	20240305	CTD	MESH:C000607068	FR900359 affects the phosphorylation of REEP4 protein	PMID:37730182
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:17833	gentamycin	decreases expression	ISO	RGD:1306561	E	RGD:6480464	20211207	CTD	MESH:D005839	Gentamicins results in decreased expression of REEP4 mRNA	PMID:33387578
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:18246	(1->4)-beta-D-glucan	multiple interactions	ISO	RGD:1315251	E	RGD:6480464	20230502	CTD	MESH:D002482	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of REEP4 mRNA	PMID:36331819
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:22977	cadmium atom	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D002104	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of REEP4 mRNA	PMID:35301059
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:2504	aflatoxin B1	affects expression	EXP		E	RGD:6480464	20120412	CTD	MESH:D016604	Aflatoxin B1 affects the expression of REEP4 protein	PMID:20106945
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:2504	aflatoxin B1	decreases methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:D016604	Aflatoxin B1 results in decreased methylation of REEP4 3' UTR	PMID:30157460
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:25812	ozone	decreases expression	ISO	RGD:1306561	E	RGD:6480464	20171010	CTD	MESH:D010126	Ozone results in decreased expression of REEP4 mRNA	PMID:28623178
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:25812	ozone	multiple interactions	ISO	RGD:1315251	E	RGD:6480464	20220809	CTD	MESH:D010126	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of REEP4 mRNA	PMID:34911549
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:27385	tetrachloromethane	increases expression	ISO	RGD:1315251	E	RGD:6480464	20200804	CTD	MESH:D002251	Carbon Tetrachloride results in increased expression of REEP4 mRNA	PMID:31919559
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:27470	folic acid	multiple interactions	ISO	RGD:1315251	E	RGD:6480464	20200804	CTD	MESH:D005492	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of REEP4 mRNA	PMID:22206623
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:27563	arsenic atom	multiple interactions	ISO	RGD:1315251	E	RGD:6480464	20260505	CTD	MESH:D001151	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of REEP4 mRNA	PMID:40504410
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:27732	caffeine	decreases phosphorylation	EXP		E	RGD:6480464	20221004	CTD	MESH:D002110	Caffeine results in decreased phosphorylation of REEP4 protein	PMID:35688186
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:27789	1,2-dichloroethane	decreases expression	ISO	RGD:1315251	E	RGD:6480464	20200310	CTD	MESH:C024565	ethylene dichloride results in decreased expression of REEP4 mRNA	PMID:28960355
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:27856	acetamide	increases expression	ISO	RGD:1306561	E	RGD:6480464	20200519	CTD	MESH:C030686	acetamide results in increased expression of REEP4 mRNA	PMID:31881176
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:27881	resveratrol	multiple interactions	EXP		E	RGD:6480464	20130122	CTD	MESH:C059514	[Coumestrol co-treated with resveratrol] results in increased expression of REEP4 mRNA	PMID:19167446
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:27899	cisplatin	increases expression	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	Cisplatin results in increased expression of REEP4 mRNA	PMID:27392435
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:27899	cisplatin	multiple interactions	EXP		E	RGD:6480464	20170516	CTD	MESH:D002945	[Cisplatin co-treated with jinfukang] results in increased expression of REEP4 mRNA	PMID:27392435
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1315251	E	RGD:6480464	20121009	CTD	MESH:D013749	Tetrachlorodibenzodioxin affects the expression of REEP4 mRNA	PMID:21570461
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:28119	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	RGD:1306561	E	RGD:6480464	20220111	CTD	MESH:D013749	Tetrachlorodibenzodioxin results in increased expression of REEP4 mRNA	PMID:34747641
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:2825	aristolochic acid A	increases expression	EXP		E	RGD:6480464	20210608	CTD	MESH:C000228	aristolochic acid I results in increased expression of REEP4 mRNA	PMID:33212167
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:28358	rac-lactic acid	decreases expression	EXP		E	RGD:6480464	20190910	CTD	MESH:D019344	Lactic Acid results in decreased expression of REEP4 mRNA	PMID:30851411
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:28619	acrylamide	increases expression	ISO	RGD:1306561	E	RGD:6480464	20180410	CTD	MESH:D020106	Acrylamide results in increased expression of REEP4 mRNA	PMID:28959563
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:28748	doxorubicin	increases expression	EXP		E	RGD:6480464	20181113	CTD	MESH:D004317	Doxorubicin results in increased expression of REEP4 mRNA	PMID:29803840
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:28869	menadione	affects expression	EXP		E	RGD:6480464	20140114	CTD	MESH:D024483	Vitamin K 3 affects the expression of REEP4 mRNA	PMID:23410634
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:29678	sodium arsenite	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:C017947	sodium arsenite results in decreased expression of REEP4 mRNA	PMID:38568856
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:29678	sodium arsenite	increases expression	EXP		E	RGD:6480464	20250805	CTD	MESH:C017947	sodium arsenite results in increased expression of REEP4 mRNA	PMID:39719251
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:29678	sodium arsenite	multiple interactions	ISO	RGD:1315251	E	RGD:6480464	20260505	CTD	MESH:C017947	[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of REEP4 mRNA	PMID:40504410
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:29865	benzo[a]pyrene	increases methylation	EXP		E	RGD:6480464	20201006	CTD	MESH:D001564	Benzo(a)pyrene results in increased methylation of REEP4 promoter	PMID:27901495
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:31653	glafenine	decreases expression	ISO	RGD:1306561	E	RGD:6480464	20160412	CTD	MESH:D005897	Glafenine results in decreased expression of REEP4 mRNA	PMID:24136188
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:32234	titanium dioxide	increases methylation	ISO	RGD:1315251	E	RGD:6480464	20241001	CTD	MESH:C009495	titanium dioxide results in increased methylation of REEP4 promoter	PMID:35295148
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:32497	thioacetamide	decreases expression	ISO	RGD:1306561	E	RGD:6480464	20220405	CTD	MESH:D013853	Thioacetamide results in decreased expression of REEP4 mRNA	PMID:34492290
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:32509	pirinixic acid	increases expression	ISO	RGD:1315251	E	RGD:6480464	20140610	CTD	MESH:C006253	pirinixic acid results in increased expression of REEP4 mRNA	PMID:23811191
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:33216	bisphenol A	affects expression	ISO	RGD:1306561	E	RGD:6480464	20150310	CTD	MESH:C006780	bisphenol A affects the expression of REEP4 mRNA	PMID:25181051
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:33216	bisphenol A	decreases expression	EXP		E	RGD:6480464	20180515	CTD	MESH:C006780	bisphenol A results in decreased expression of REEP4 mRNA	PMID:29275510
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:33216	bisphenol A	decreases expression	ISO	RGD:1306561	E	RGD:6480464	20191210	CTD	MESH:C006780	bisphenol A results in decreased expression of REEP4 mRNA	PMID:30816183|PMID:32528016
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:33216	bisphenol A	increases expression	ISO	RGD:1306561	E	RGD:6480464	20230606	CTD	MESH:C006780	bisphenol A results in increased expression of REEP4 mRNA	PMID:32145629
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:34567	benzo[e]pyrene	affects methylation	EXP		E	RGD:6480464	20190219	CTD	MESH:C026487	benzo(e)pyrene affects the methylation of REEP4 3' UTR	PMID:30157460
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:35033	triphenyl phosphate	affects expression	EXP		E	RGD:6480464	20240604	CTD	MESH:C005445	triphenyl phosphate affects the expression of REEP4 mRNA	PMID:37042841
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:35456	cadmium dichloride	decreases expression	EXP		E	RGD:6480464	20240702	CTD	MESH:D019256	Cadmium Chloride results in decreased expression of REEP4 mRNA	PMID:38568856
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:35456	cadmium dichloride	multiple interactions	EXP		E	RGD:6480464	20221101	CTD	MESH:D019256	[Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of REEP4 mRNA	PMID:35301059
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:35549	perfluorooctanoic acid	decreases expression	EXP		E	RGD:6480464	20171010	CTD	MESH:C023036	perfluorooctanoic acid results in decreased expression of REEP4 protein	PMID:26879310
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:35842	antirheumatic drug	decreases expression	EXP		E	RGD:6480464	20161228	CTD	MESH:D018501	Antirheumatic Agents results in decreased expression of REEP4 mRNA	PMID:24449571
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:3908	coumestrol	multiple interactions	EXP		E	RGD:6480464	20130409	CTD	MESH:D003375	[Coumestrol co-treated with resveratrol] results in increased expression of REEP4 mRNA	PMID:19167446
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	increases expression	EXP		E	RGD:6480464	20260203	CTD	MESH:C076994	perfluorooctane sulfonic acid results in increased expression of REEP4 mRNA	PMID:40419075
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:39421	perfluorooctane-1-sulfonic acid	multiple interactions	ISO	RGD:1315251	E	RGD:6480464	20230502	CTD	MESH:C076994	[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of REEP4 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of REEP4 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of REEP4 mRNA	PMID:36331819
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:39867	valproic acid	affects expression	EXP		E	RGD:6480464	20151013	CTD	MESH:D014635	Valproic Acid affects the expression of REEP4 mRNA	PMID:25979313
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:39867	valproic acid	affects expression	ISO	RGD:1315251	E	RGD:6480464	20120412	CTD	MESH:D014635	Valproic Acid affects the expression of REEP4 mRNA	PMID:17963808
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:39867	valproic acid	increases expression	ISO	RGD:1315251	E	RGD:6480464	20120918	CTD	MESH:D014635	Valproic Acid results in increased expression of REEP4 mRNA	PMID:20546886|PMID:21427059
1315250	REEP4	receptor accessory protein 4	gene	CHEBI:39867	valproic acid	increases methylation	EXP		E	RGD:6480464	20180410	CTD	MESH:D014635	Valproic Acid results in increased methylation of REEP4 gene	PMID:29154799
13152
[file cut: first 33554432 bytes kept]
[document cut: first 30985211 of 33554432 characters kept]
